id|nct_id|result_group_id|ctgov_group_code|title|period|description|count
34|NCT04113785|60|P1|NOT COMPLETED|Overall Study||0
35|NCT04113785|60|P1|COMPLETED|Overall Study||21
36|NCT04113785|60|P1|STARTED|Overall Study||21
37|NCT04106817|70|P3|NOT COMPLETED|Overall Study||0
38|NCT04106817|71|P2|NOT COMPLETED|Overall Study||0
39|NCT04106817|72|P1|NOT COMPLETED|Overall Study||1
40|NCT04106817|70|P3|COMPLETED|Overall Study||12
41|NCT04106817|71|P2|COMPLETED|Overall Study||11
42|NCT04106817|72|P1|COMPLETED|Overall Study||11
43|NCT04106817|70|P3|STARTED|Overall Study||12
44|NCT04106817|71|P2|STARTED|Overall Study||11
45|NCT04106817|72|P1|STARTED|Overall Study||12
46|NCT04076787|89|P3|NOT COMPLETED|Overall Study||0
47|NCT04076787|90|P2|NOT COMPLETED|Overall Study||0
48|NCT04076787|91|P1|NOT COMPLETED|Overall Study||0
49|NCT04076787|89|P3|COMPLETED|Overall Study||420
50|NCT04076787|90|P2|COMPLETED|Overall Study||1031
51|NCT04076787|91|P1|COMPLETED|Overall Study||318
52|NCT04076787|89|P3|STARTED|Overall Study||420
53|NCT04076787|90|P2|STARTED|Overall Study||1031
54|NCT04076787|91|P1|STARTED|Overall Study||318
55|NCT04069221|116|P4|NOT COMPLETED|Overall Study||0
56|NCT04069221|117|P3|NOT COMPLETED|Overall Study||0
57|NCT04069221|118|P2|NOT COMPLETED|Overall Study||0
58|NCT04069221|119|P1|NOT COMPLETED|Overall Study||0
59|NCT04069221|116|P4|COMPLETED|Overall Study||6
60|NCT04069221|117|P3|COMPLETED|Overall Study||6
61|NCT04069221|118|P2|COMPLETED|Overall Study||6
62|NCT04069221|119|P1|COMPLETED|Overall Study||8
63|NCT04069221|116|P4|STARTED|Overall Study||6
64|NCT04069221|117|P3|STARTED|Overall Study||6
65|NCT04069221|118|P2|STARTED|Overall Study||6
66|NCT04069221|119|P1|STARTED|Overall Study||8
67|NCT04053270|140|P2|NOT COMPLETED|Overall Study||5
68|NCT04053270|141|P1|NOT COMPLETED|Overall Study||2
69|NCT04053270|140|P2|COMPLETED|Overall Study||46
70|NCT04053270|141|P1|COMPLETED|Overall Study||47
71|NCT04053270|140|P2|STARTED|Overall Study||51
72|NCT04053270|141|P1|STARTED|Overall Study||49
73|NCT04045964|159|P2|NOT COMPLETED|Overall Study||1
74|NCT04045964|160|P1|NOT COMPLETED|Overall Study||1
75|NCT04045964|159|P2|COMPLETED|Overall Study||15
76|NCT04045964|160|P1|COMPLETED|Overall Study||15
77|NCT04045964|159|P2|Follow up Visit 2|Overall Study||15
78|NCT04045964|160|P1|Follow up Visit 2|Overall Study||15
79|NCT04045964|159|P2|Follow up Visit 1|Overall Study||15
80|NCT04045964|160|P1|Follow up Visit 1|Overall Study||15
81|NCT04045964|159|P2|Intervention Visit(s)|Overall Study||16
82|NCT04045964|160|P1|Intervention Visit(s)|Overall Study||15
83|NCT04045964|159|P2|STARTED|Overall Study||16
84|NCT04045964|160|P1|STARTED|Overall Study||16
85|NCT04039412|192|P3|NOT COMPLETED|Overall Study||2
86|NCT04039412|193|P2|NOT COMPLETED|Overall Study||3
87|NCT04039412|194|P1|NOT COMPLETED|Overall Study||1
88|NCT04039412|192|P3|COMPLETED|Overall Study||108
89|NCT04039412|193|P2|COMPLETED|Overall Study||107
90|NCT04039412|194|P1|COMPLETED|Overall Study||109
91|NCT04039412|192|P3|STARTED|Overall Study||110
92|NCT04039412|193|P2|STARTED|Overall Study||110
93|NCT04039412|194|P1|STARTED|Overall Study||110
94|NCT04036838|208|P1|NOT COMPLETED|Overall Study||91
95|NCT04036838|208|P1|COMPLETED|Overall Study||324
96|NCT04036838|208|P1|STARTED|Overall Study||415
97|NCT04034043|212|P1|NOT COMPLETED|Overall Study||0
98|NCT04034043|212|P1|COMPLETED|Overall Study||68
99|NCT04034043|212|P1|STARTED|Overall Study||68
100|NCT04032652|221|P2|NOT COMPLETED|Overall Study||1
101|NCT04032652|222|P1|NOT COMPLETED|Overall Study||1
102|NCT04032652|221|P2|COMPLETED|Overall Study||0
103|NCT04032652|222|P1|COMPLETED|Overall Study||0
104|NCT04032652|221|P2|STARTED|Overall Study||1
105|NCT04032652|222|P1|STARTED|Overall Study||1
106|NCT04027218|236|P6|NOT COMPLETED|Overall Study||0
107|NCT04027218|237|P5|NOT COMPLETED|Overall Study||0
108|NCT04027218|238|P4|NOT COMPLETED|Overall Study||0
109|NCT04027218|239|P3|NOT COMPLETED|Overall Study||0
110|NCT04027218|240|P2|NOT COMPLETED|Overall Study||3
111|NCT04027218|241|P1|NOT COMPLETED|Overall Study||0
112|NCT04027218|236|P6|COMPLETED|Overall Study||11
113|NCT04027218|237|P5|COMPLETED|Overall Study||10
114|NCT04027218|238|P4|COMPLETED|Overall Study||11
115|NCT04027218|239|P3|COMPLETED|Overall Study||9
116|NCT04027218|240|P2|COMPLETED|Overall Study||8
117|NCT04027218|241|P1|COMPLETED|Overall Study||10
118|NCT04027218|236|P6|STARTED|Overall Study||11
119|NCT04027218|237|P5|STARTED|Overall Study||10
120|NCT04027218|238|P4|STARTED|Overall Study||11
121|NCT04027218|239|P3|STARTED|Overall Study||9
122|NCT04027218|240|P2|STARTED|Overall Study||11
123|NCT04027218|241|P1|STARTED|Overall Study||10
124|NCT04023695|273|P2|NOT COMPLETED|Overall Study||0
125|NCT04023695|274|P1|NOT COMPLETED|Overall Study||0
126|NCT04023695|273|P2|COMPLETED|Overall Study||53
127|NCT04023695|274|P1|COMPLETED|Overall Study||57
128|NCT04023695|273|P2|STARTED|Overall Study||53
129|NCT04023695|274|P1|STARTED|Overall Study||57
130|NCT04015232|284|P2|NOT COMPLETED|Overall Study||7
131|NCT04015232|285|P1|NOT COMPLETED|Overall Study||11
132|NCT04015232|284|P2|COMPLETED|Overall Study||93
133|NCT04015232|285|P1|COMPLETED|Overall Study||89
134|NCT04015232|284|P2|STARTED|Overall Study||100
135|NCT04015232|285|P1|STARTED|Overall Study||100
136|NCT04014062|357|P2|NOT COMPLETED|Period II: Crossover Dosing||0
137|NCT04014062|358|P1|NOT COMPLETED|Period II: Crossover Dosing||0
138|NCT04014062|357|P2|COMPLETED|Period II: Crossover Dosing||65
139|NCT04014062|358|P1|COMPLETED|Period II: Crossover Dosing||64
140|NCT04014062|357|P2|STARTED|Period II: Crossover Dosing||65
141|NCT04014062|358|P1|STARTED|Period II: Crossover Dosing||64
142|NCT04014062|357|P2|NOT COMPLETED|Period I: Dosing||6
143|NCT04014062|358|P1|NOT COMPLETED|Period I: Dosing||7
144|NCT04014062|357|P2|COMPLETED|Period I: Dosing|Period I: Dosing, includes a washout period of 42 days before starting Period II: Crossover Dosing|65
145|NCT04014062|358|P1|COMPLETED|Period I: Dosing|Period I: Dosing, includes a washout period of 42 days before starting Period II: Crossover Dosing|64
146|NCT04014062|357|P2|STARTED|Period I: Dosing||71
147|NCT04014062|358|P1|STARTED|Period I: Dosing||71
160|NCT03991715|411|P1|NOT COMPLETED|Overall Study||0
161|NCT03991715|411|P1|COMPLETED|Overall Study||5
162|NCT03991715|411|P1|STARTED|Overall Study||5
163|NCT03975790|423|P3|NOT COMPLETED|Overall Study||0
164|NCT03975790|424|P2|NOT COMPLETED|Overall Study||0
165|NCT03975790|425|P1|NOT COMPLETED|Overall Study||0
166|NCT03975790|423|P3|COMPLETED|Overall Study||48
167|NCT03975790|424|P2|COMPLETED|Overall Study||94
168|NCT03975790|425|P1|COMPLETED|Overall Study||337
169|NCT03975790|423|P3|STARTED|Overall Study||48
170|NCT03975790|424|P2|STARTED|Overall Study||94
171|NCT03975790|425|P1|STARTED|Overall Study||337
172|NCT03961308|640|P2|NOT COMPLETED|Overall Study||2
173|NCT03961308|641|P1|NOT COMPLETED|Overall Study||2
174|NCT03961308|640|P2|COMPLETED|Overall Study||100
175|NCT03961308|641|P1|COMPLETED|Overall Study||100
176|NCT03961308|640|P2|STARTED|Overall Study||102
177|NCT03961308|641|P1|STARTED|Overall Study||102
178|NCT03961295|653|P2|NOT COMPLETED|Overall Study||0
179|NCT03961295|654|P1|NOT COMPLETED|Overall Study||0
180|NCT03961295|653|P2|COMPLETED|Overall Study||12
181|NCT03961295|654|P1|COMPLETED|Overall Study||12
182|NCT03961295|653|P2|STARTED|Overall Study||12
183|NCT03961295|654|P1|STARTED|Overall Study||12
184|NCT03949621|666|P2|NOT COMPLETED|Overall Study||0
185|NCT03949621|667|P1|NOT COMPLETED|Overall Study||0
186|NCT03949621|666|P2|COMPLETED|Overall Study||12
187|NCT03949621|667|P1|COMPLETED|Overall Study||12
188|NCT03949621|666|P2|STARTED|Overall Study||12
189|NCT03949621|667|P1|STARTED|Overall Study||12
190|NCT03948581|679|P2|NOT COMPLETED|Overall Study||1
191|NCT03948581|680|P1|NOT COMPLETED|Overall Study||0
192|NCT03948581|679|P2|COMPLETED|Overall Study||50
193|NCT03948581|680|P1|COMPLETED|Overall Study||51
194|NCT03948581|679|P2|STARTED|Overall Study||51
195|NCT03948581|680|P1|STARTED|Overall Study||51
196|NCT03933618|696|P6|NOT COMPLETED|Week 16 to Week 24||0
197|NCT03933618|697|P5|NOT COMPLETED|Week 16 to Week 24||0
198|NCT03933618|698|P4|NOT COMPLETED|Week 16 to Week 24||0
199|NCT03933618|699|P3|NOT COMPLETED|Week 16 to Week 24||0
200|NCT03933618|700|P2|NOT COMPLETED|Week 16 to Week 24||0
201|NCT03933618|701|P1|NOT COMPLETED|Week 16 to Week 24||0
202|NCT03933618|696|P6|COMPLETED|Week 16 to Week 24||4
203|NCT03933618|697|P5|COMPLETED|Week 16 to Week 24||4
204|NCT03933618|698|P4|COMPLETED|Week 16 to Week 24||4
205|NCT03933618|699|P3|COMPLETED|Week 16 to Week 24||4
206|NCT03933618|700|P2|COMPLETED|Week 16 to Week 24||4
207|NCT03933618|701|P1|COMPLETED|Week 16 to Week 24||4
208|NCT03933618|696|P6|STARTED|Week 16 to Week 24||4
209|NCT03933618|697|P5|STARTED|Week 16 to Week 24||4
210|NCT03933618|698|P4|STARTED|Week 16 to Week 24||4
211|NCT03933618|699|P3|STARTED|Week 16 to Week 24||4
212|NCT03933618|700|P2|STARTED|Week 16 to Week 24||4
213|NCT03933618|701|P1|STARTED|Week 16 to Week 24||4
214|NCT03933618|696|P6|NOT COMPLETED|Week 8 to Week 16||0
215|NCT03933618|697|P5|NOT COMPLETED|Week 8 to Week 16||0
216|NCT03933618|698|P4|NOT COMPLETED|Week 8 to Week 16||0
217|NCT03933618|699|P3|NOT COMPLETED|Week 8 to Week 16||0
218|NCT03933618|700|P2|NOT COMPLETED|Week 8 to Week 16||0
219|NCT03933618|701|P1|NOT COMPLETED|Week 8 to Week 16||0
220|NCT03933618|696|P6|COMPLETED|Week 8 to Week 16||4
221|NCT03933618|697|P5|COMPLETED|Week 8 to Week 16||4
222|NCT03933618|698|P4|COMPLETED|Week 8 to Week 16||4
223|NCT03933618|699|P3|COMPLETED|Week 8 to Week 16||4
224|NCT03933618|700|P2|COMPLETED|Week 8 to Week 16||4
225|NCT03933618|701|P1|COMPLETED|Week 8 to Week 16||4
226|NCT03933618|696|P6|STARTED|Week 8 to Week 16||4
227|NCT03933618|697|P5|STARTED|Week 8 to Week 16||4
228|NCT03933618|698|P4|STARTED|Week 8 to Week 16||4
229|NCT03933618|699|P3|STARTED|Week 8 to Week 16||4
230|NCT03933618|700|P2|STARTED|Week 8 to Week 16||4
231|NCT03933618|701|P1|STARTED|Week 8 to Week 16||4
232|NCT03933618|696|P6|NOT COMPLETED|Baseline to Week 8||0
233|NCT03933618|697|P5|NOT COMPLETED|Baseline to Week 8||0
234|NCT03933618|698|P4|NOT COMPLETED|Baseline to Week 8||0
235|NCT03933618|699|P3|NOT COMPLETED|Baseline to Week 8||0
236|NCT03933618|700|P2|NOT COMPLETED|Baseline to Week 8||0
237|NCT03933618|701|P1|NOT COMPLETED|Baseline to Week 8||0
238|NCT03933618|696|P6|COMPLETED|Baseline to Week 8||4
239|NCT03933618|697|P5|COMPLETED|Baseline to Week 8||4
240|NCT03933618|698|P4|COMPLETED|Baseline to Week 8||4
241|NCT03933618|699|P3|COMPLETED|Baseline to Week 8||4
242|NCT03933618|700|P2|COMPLETED|Baseline to Week 8||4
243|NCT03933618|701|P1|COMPLETED|Baseline to Week 8||4
244|NCT03933618|696|P6|STARTED|Baseline to Week 8||4
245|NCT03933618|697|P5|STARTED|Baseline to Week 8||4
246|NCT03933618|698|P4|STARTED|Baseline to Week 8||4
247|NCT03933618|699|P3|STARTED|Baseline to Week 8||4
248|NCT03933618|700|P2|STARTED|Baseline to Week 8||4
249|NCT03933618|701|P1|STARTED|Baseline to Week 8||4
250|NCT03933618|696|P6|NOT COMPLETED|Baseline||0
251|NCT03933618|697|P5|NOT COMPLETED|Baseline||0
252|NCT03933618|698|P4|NOT COMPLETED|Baseline||0
253|NCT03933618|699|P3|NOT COMPLETED|Baseline||0
254|NCT03933618|700|P2|NOT COMPLETED|Baseline||0
255|NCT03933618|701|P1|NOT COMPLETED|Baseline||0
256|NCT03933618|696|P6|COMPLETED|Baseline||4
257|NCT03933618|697|P5|COMPLETED|Baseline||4
258|NCT03933618|698|P4|COMPLETED|Baseline||4
259|NCT03933618|699|P3|COMPLETED|Baseline||4
260|NCT03933618|700|P2|COMPLETED|Baseline||4
261|NCT03933618|701|P1|COMPLETED|Baseline||4
262|NCT03933618|696|P6|STARTED|Baseline||4
263|NCT03933618|697|P5|STARTED|Baseline||4
264|NCT03933618|698|P4|STARTED|Baseline||4
265|NCT03933618|699|P3|STARTED|Baseline||4
266|NCT03933618|700|P2|STARTED|Baseline||4
267|NCT03933618|701|P1|STARTED|Baseline||4
268|NCT03927950|949|P1|NOT COMPLETED|Overall Study||9
269|NCT03927950|949|P1|COMPLETED|Overall Study||126
270|NCT03927950|949|P1|STARTED|Overall Study||135
271|NCT03911752|957|P3|NOT COMPLETED|Overall Study||0
272|NCT03911752|958|P2|NOT COMPLETED|Overall Study||0
273|NCT03911752|959|P1|NOT COMPLETED|Overall Study||0
274|NCT03911752|957|P3|COMPLETED|Overall Study||2
275|NCT03911752|958|P2|COMPLETED|Overall Study||2
276|NCT03911752|959|P1|COMPLETED|Overall Study||8
277|NCT03911752|957|P3|STARTED|Overall Study||2
278|NCT03911752|958|P2|STARTED|Overall Study||2
279|NCT03911752|959|P1|STARTED|Overall Study||8
280|NCT03905642|976|P1|NOT COMPLETED|Overall Study||8
281|NCT03905642|976|P1|COMPLETED|Overall Study||41
282|NCT03905642|976|P1|STARTED|Overall Study||49
283|NCT03894449|990|P5|NOT COMPLETED|Overall Study||0
284|NCT03894449|991|P4|NOT COMPLETED|Overall Study||0
285|NCT03894449|992|P3|NOT COMPLETED|Overall Study||0
286|NCT03894449|993|P2|NOT COMPLETED|Overall Study||0
287|NCT03894449|994|P1|NOT COMPLETED|Overall Study||0
288|NCT03894449|990|P5|COMPLETED|Overall Study||15
289|NCT03894449|991|P4|COMPLETED|Overall Study||15
290|NCT03894449|992|P3|COMPLETED|Overall Study||15
291|NCT03894449|993|P2|COMPLETED|Overall Study||15
292|NCT03894449|994|P1|COMPLETED|Overall Study||15
293|NCT03894449|990|P5|STARTED|Overall Study||15
294|NCT03894449|991|P4|STARTED|Overall Study||15
295|NCT03894449|992|P3|STARTED|Overall Study||15
296|NCT03894449|993|P2|STARTED|Overall Study||15
297|NCT03894449|994|P1|STARTED|Overall Study||15
298|NCT03888755|1106|P1|NOT COMPLETED|Overall Study||0
299|NCT03888755|1106|P1|COMPLETED|Overall Study||8
300|NCT03888755|1106|P1|STARTED|Overall Study||8
301|NCT03888391|1127|P1|NOT COMPLETED|Overall Study||15
302|NCT03888391|1127|P1|COMPLETED|Overall Study||3
303|NCT03888391|1127|P1|STARTED|Overall Study||18
304|NCT03882047|1140|P3|NOT COMPLETED|Overall Study||16
305|NCT03882047|1141|P2|NOT COMPLETED|Overall Study||10
306|NCT03882047|1142|P1|NOT COMPLETED|Overall Study||6
307|NCT03882047|1140|P3|COMPLETED|Overall Study||88
308|NCT03882047|1141|P2|COMPLETED|Overall Study||95
309|NCT03882047|1142|P1|COMPLETED|Overall Study||98
310|NCT03882047|1140|P3|Treated|Overall Study||103
311|NCT03882047|1141|P2|Treated|Overall Study||104
312|NCT03882047|1142|P1|Treated|Overall Study||104
313|NCT03882047|1140|P3|STARTED|Overall Study||104
314|NCT03882047|1141|P2|STARTED|Overall Study||105
315|NCT03882047|1142|P1|STARTED|Overall Study||104
316|NCT03879772|1185|P5|NOT COMPLETED|Overall Study||8
317|NCT03879772|1186|P4|NOT COMPLETED|Overall Study||8
318|NCT03879772|1187|P3|NOT COMPLETED|Overall Study||10
319|NCT03879772|1188|P2|NOT COMPLETED|Overall Study||3
320|NCT03879772|1189|P1|NOT COMPLETED|Overall Study||4
321|NCT03879772|1185|P5|COMPLETED|Overall Study||128
322|NCT03879772|1186|P4|COMPLETED|Overall Study||130
323|NCT03879772|1187|P3|COMPLETED|Overall Study||123
324|NCT03879772|1188|P2|COMPLETED|Overall Study||132
325|NCT03879772|1189|P1|COMPLETED|Overall Study||133
326|NCT03879772|1185|P5|STARTED|Overall Study||136
327|NCT03879772|1186|P4|STARTED|Overall Study||138
328|NCT03879772|1187|P3|STARTED|Overall Study||133
329|NCT03879772|1188|P2|STARTED|Overall Study||135
330|NCT03879772|1189|P1|STARTED|Overall Study||137
331|NCT03870737|1226|P1|NOT COMPLETED|Overall Study||2
332|NCT03870737|1226|P1|COMPLETED|Overall Study||20
333|NCT03870737|1226|P1|STARTED|Overall Study||22
334|NCT03861559|1238|P2|NOT COMPLETED|Overall Study||5
335|NCT03861559|1239|P1|NOT COMPLETED|Overall Study||2
336|NCT03861559|1238|P2|COMPLETED|Overall Study||95
337|NCT03861559|1239|P1|COMPLETED|Overall Study||99
338|NCT03861559|1238|P2|STARTED|Overall Study||100
339|NCT03861559|1239|P1|STARTED|Overall Study||101
340|NCT03859622|1285|P1|NOT COMPLETED|Overall Study||0
341|NCT03859622|1285|P1|COMPLETED|Overall Study||289
342|NCT03859622|1285|P1|STARTED|Overall Study||289
343|NCT03857243|1295|P2|NOT COMPLETED|Overall Study||0
344|NCT03857243|1296|P1|NOT COMPLETED|Overall Study||0
345|NCT03857243|1295|P2|COMPLETED|Overall Study||1
346|NCT03857243|1296|P1|COMPLETED|Overall Study||1
347|NCT03857243|1295|P2|STARTED|Overall Study||1
348|NCT03857243|1296|P1|STARTED|Overall Study||1
349|NCT03857230|1308|P2|NOT COMPLETED|Period 2 (Gonal-F-Primapur)||0
350|NCT03857230|1309|P1|NOT COMPLETED|Period 2 (Gonal-F-Primapur)||0
351|NCT03857230|1308|P2|COMPLETED|Period 2 (Gonal-F-Primapur)||12
352|NCT03857230|1309|P1|COMPLETED|Period 2 (Gonal-F-Primapur)||12
353|NCT03857230|1308|P2|STARTED|Period 2 (Gonal-F-Primapur)||12
354|NCT03857230|1309|P1|STARTED|Period 2 (Gonal-F-Primapur)||12
355|NCT03857230|1308|P2|NOT COMPLETED|Period 1 (Primapur-Gonal-F)||0
356|NCT03857230|1309|P1|NOT COMPLETED|Period 1 (Primapur-Gonal-F)||0
357|NCT03857230|1308|P2|COMPLETED|Period 1 (Primapur-Gonal-F)||12
358|NCT03857230|1309|P1|COMPLETED|Period 1 (Primapur-Gonal-F)||12
359|NCT03857230|1308|P2|STARTED|Period 1 (Primapur-Gonal-F)||12
360|NCT03857230|1309|P1|STARTED|Period 1 (Primapur-Gonal-F)||12
361|NCT03855228|1327|P4|NOT COMPLETED|Overall Study||19
362|NCT03855228|1328|P3|NOT COMPLETED|Overall Study||8
363|NCT03855228|1329|P2|NOT COMPLETED|Overall Study||9
364|NCT03855228|1330|P1|NOT COMPLETED|Overall Study||3
365|NCT03855228|1327|P4|COMPLETED|Overall Study||158
366|NCT03855228|1328|P3|COMPLETED|Overall Study||174
367|NCT03855228|1329|P2|COMPLETED|Overall Study||167
368|NCT03855228|1330|P1|COMPLETED|Overall Study||166
369|NCT03855228|1327|P4|Treated|Overall Study|1 participant immediately dropped out prior to starting study intervention.|176
370|NCT03855228|1328|P3|Treated|Overall Study|1 participant immediately dropped out prior to starting study intervention.|181
371|NCT03855228|1329|P2|Treated|Overall Study||176
372|NCT03855228|1330|P1|Treated|Overall Study||169
373|NCT03855228|1327|P4|STARTED|Overall Study||177
374|NCT03855228|1328|P3|STARTED|Overall Study||182
375|NCT03855228|1329|P2|STARTED|Overall Study||176
376|NCT03855228|1330|P1|STARTED|Overall Study||169
377|NCT03855189|1379|P3|NOT COMPLETED|Overall Study||6
378|NCT03855189|1380|P2|NOT COMPLETED|Overall Study||7
379|NCT03855189|1381|P1|NOT COMPLETED|Overall Study||10
380|NCT03855189|1379|P3|COMPLETED|Overall Study||110
381|NCT03855189|1380|P2|COMPLETED|Overall Study||109
382|NCT03855189|1381|P1|COMPLETED|Overall Study||103
383|NCT03855189|1379|P3|Treated|Overall Study||116
384|NCT03855189|1380|P2|Treated|Overall Study||116
385|NCT03855189|1381|P1|Treated|Overall Study|Does not include 1 participant who received first dose but was excluded from safety analysis.|112
386|NCT03855189|1379|P3|STARTED|Overall Study||116
387|NCT03855189|1380|P2|STARTED|Overall Study||116
388|NCT03855189|1381|P1|STARTED|Overall Study||113
389|NCT03850496|1473|P3|NOT COMPLETED|Overall Study||4
390|NCT03850496|1474|P2|NOT COMPLETED|Overall Study||1
391|NCT03850496|1475|P1|NOT COMPLETED|Overall Study||1
392|NCT03850496|1473|P3|COMPLETED|Overall Study||21
393|NCT03850496|1474|P2|COMPLETED|Overall Study||24
394|NCT03850496|1475|P1|COMPLETED|Overall Study||25
395|NCT03850496|1473|P3|STARTED|Overall Study||25
396|NCT03850496|1474|P2|STARTED|Overall Study||25
397|NCT03850496|1475|P1|STARTED|Overall Study||26
398|NCT03850444|1485|P2|NOT COMPLETED|Overall Study||134
399|NCT03850444|1486|P1|NOT COMPLETED|Overall Study||128
400|NCT03850444|1485|P2|COMPLETED|Overall Study||0
401|NCT03850444|1486|P1|COMPLETED|Overall Study||0
402|NCT03850444|1485|P2|STARTED|Overall Study||134
403|NCT03850444|1486|P1|STARTED|Overall Study||128
404|NCT03850093|1515|P3|NOT COMPLETED|Overall Study||2
405|NCT03850093|1516|P2|NOT COMPLETED|Overall Study||0
406|NCT03850093|1517|P1|NOT COMPLETED|Overall Study||1
407|NCT03850093|1515|P3|COMPLETED|Overall Study||17
408|NCT03850093|1516|P2|COMPLETED|Overall Study||22
409|NCT03850093|1517|P1|COMPLETED|Overall Study||21
410|NCT03850093|1515|P3|STARTED|Overall Study||19
411|NCT03850093|1516|P2|STARTED|Overall Study||22
412|NCT03850093|1517|P1|STARTED|Overall Study||22
413|NCT03842683|1549|P1|NOT COMPLETED|Overall Study||0
414|NCT03842683|1549|P1|COMPLETED|Overall Study||472
415|NCT03842683|1549|P1|STARTED|Overall Study||472
416|NCT03836664|1556|P2|NOT COMPLETED|Overall Study||3
417|NCT03836664|1557|P1|NOT COMPLETED|Overall Study||3
418|NCT03836664|1556|P2|COMPLETED|Overall Study||8
419|NCT03836664|1557|P1|COMPLETED|Overall Study||11
420|NCT03836664|1556|P2|STARTED|Overall Study||11
421|NCT03836664|1557|P1|STARTED|Overall Study||14
422|NCT03832387|1569|P2|NOT COMPLETED|Overall Study||7
423|NCT03832387|1570|P1|NOT COMPLETED|Overall Study||5
424|NCT03832387|1569|P2|COMPLETED|Overall Study||32
425|NCT03832387|1570|P1|COMPLETED|Overall Study||33
426|NCT03832387|1569|P2|STARTED|Overall Study||39
427|NCT03832387|1570|P1|STARTED|Overall Study||38
428|NCT03832322|1600|P2|NOT COMPLETED|Overall Study||1
429|NCT03832322|1601|P1|NOT COMPLETED|Overall Study||3
430|NCT03832322|1600|P2|COMPLETED|Overall Study||86
431|NCT03832322|1601|P1|COMPLETED|Overall Study||86
432|NCT03832322|1600|P2|STARTED|Overall Study||87
433|NCT03832322|1601|P1|STARTED|Overall Study||89
434|NCT03831451|1611|P2|NOT COMPLETED|Overall Study||0
435|NCT03831451|1612|P1|NOT COMPLETED|Overall Study||0
436|NCT03831451|1611|P2|COMPLETED|Overall Study||55
437|NCT03831451|1612|P1|COMPLETED|Overall Study||74
438|NCT03831451|1611|P2|STARTED|Overall Study||55
439|NCT03831451|1612|P1|STARTED|Overall Study||74
440|NCT03824912|1621|P3|NOT COMPLETED|Overall Study||68
441|NCT03824912|1622|P2|NOT COMPLETED|Overall Study||134
442|NCT03824912|1623|P1|NOT COMPLETED|Overall Study||140
443|NCT03824912|1621|P3|COMPLETED|Overall Study||96
444|NCT03824912|1622|P2|COMPLETED|Overall Study||201
445|NCT03824912|1623|P1|COMPLETED|Overall Study||192
446|NCT03824912|1621|P3|STARTED|Overall Study||164
447|NCT03824912|1622|P2|STARTED|Overall Study||335
448|NCT03824912|1623|P1|STARTED|Overall Study||332
449|NCT03822078|1649|P6|NOT COMPLETED|Overall Study||0
450|NCT03822078|1650|P5|NOT COMPLETED|Overall Study||1
451|NCT03822078|1651|P4|NOT COMPLETED|Overall Study||2
452|NCT03822078|1652|P3|NOT COMPLETED|Overall Study||0
453|NCT03822078|1653|P2|NOT COMPLETED|Overall Study||0
454|NCT03822078|1654|P1|NOT COMPLETED|Overall Study||2
455|NCT03822078|1649|P6|COMPLETED|Overall Study||6
456|NCT03822078|1650|P5|COMPLETED|Overall Study||6
457|NCT03822078|1651|P4|COMPLETED|Overall Study||6
458|NCT03822078|1652|P3|COMPLETED|Overall Study||6
459|NCT03822078|1653|P2|COMPLETED|Overall Study||6
460|NCT03822078|1654|P1|COMPLETED|Overall Study||10
461|NCT03822078|1649|P6|Received Study Drug|Overall Study||6
462|NCT03822078|1650|P5|Received Study Drug|Overall Study||6
463|NCT03822078|1651|P4|Received Study Drug|Overall Study||6
464|NCT03822078|1652|P3|Received Study Drug|Overall Study||6
465|NCT03822078|1653|P2|Received Study Drug|Overall Study||6
466|NCT03822078|1654|P1|Received Study Drug|Overall Study||10
467|NCT03822078|1649|P6|STARTED|Overall Study||6
468|NCT03822078|1650|P5|STARTED|Overall Study||7
469|NCT03822078|1651|P4|STARTED|Overall Study||8
470|NCT03822078|1652|P3|STARTED|Overall Study||6
471|NCT03822078|1653|P2|STARTED|Overall Study||6
472|NCT03822078|1654|P1|STARTED|Overall Study||12
473|NCT03820544|1714|P2|NOT COMPLETED|Overall Study||0
474|NCT03820544|1715|P1|NOT COMPLETED|Overall Study||0
475|NCT03820544|1714|P2|COMPLETED|Overall Study||2
476|NCT03820544|1715|P1|COMPLETED|Overall Study||2
477|NCT03820544|1714|P2|STARTED|Overall Study||2
478|NCT03820544|1715|P1|STARTED|Overall Study||2
479|NCT03819491|1725|P2|NOT COMPLETED|After Randomization||0
480|NCT03819491|1726|P1|NOT COMPLETED|After Randomization||0
481|NCT03819491|1725|P2|COMPLETED|After Randomization||12
482|NCT03819491|1726|P1|COMPLETED|After Randomization||12
483|NCT03819491|1725|P2|STARTED|After Randomization||12
484|NCT03819491|1726|P1|STARTED|After Randomization||12
485|NCT03819491|1725|P2|NOT COMPLETED|Before Randomization||0
486|NCT03819491|1726|P1|NOT COMPLETED|Before Randomization||0
487|NCT03819491|1725|P2|COMPLETED|Before Randomization||0
488|NCT03819491|1726|P1|COMPLETED|Before Randomization||24
489|NCT03819491|1725|P2|STARTED|Before Randomization||0
490|NCT03819491|1726|P1|STARTED|Before Randomization||24
491|NCT03817775|1739|P2|NOT COMPLETED|Overall Study||0
492|NCT03817775|1740|P1|NOT COMPLETED|Overall Study||0
493|NCT03817775|1739|P2|COMPLETED|Overall Study||54
494|NCT03817775|1740|P1|COMPLETED|Overall Study||22
495|NCT03817775|1739|P2|STARTED|Overall Study||54
496|NCT03817775|1740|P1|STARTED|Overall Study||22
497|NCT03811093|1766|P2|NOT COMPLETED|Overall Study||4
498|NCT03811093|1767|P1|NOT COMPLETED|Overall Study||2
499|NCT03811093|1766|P2|COMPLETED|Overall Study||15
500|NCT03811093|1767|P1|COMPLETED|Overall Study||18
501|NCT03811093|1766|P2|STARTED|Overall Study||19
502|NCT03811093|1767|P1|STARTED|Overall Study||20
503|NCT03807089|1779|P2|NOT COMPLETED|Overall Study||0
504|NCT03807089|1780|P1|NOT COMPLETED|Overall Study||0
505|NCT03807089|1779|P2|COMPLETED|Overall Study||93
506|NCT03807089|1780|P1|COMPLETED|Overall Study||101
507|NCT03807089|1779|P2|STARTED|Overall Study||93
508|NCT03807089|1780|P1|STARTED|Overall Study||101
509|NCT03806270|1797|P3|NOT COMPLETED|Overall Study||0
510|NCT03806270|1798|P2|NOT COMPLETED|Overall Study||0
511|NCT03806270|1799|P1|NOT COMPLETED|Overall Study||0
512|NCT03806270|1797|P3|COMPLETED|Overall Study||15
513|NCT03806270|1798|P2|COMPLETED|Overall Study||15
514|NCT03806270|1799|P1|COMPLETED|Overall Study||15
515|NCT03806270|1797|P3|STARTED|Overall Study||15
516|NCT03806270|1798|P2|STARTED|Overall Study||15
517|NCT03806270|1799|P1|STARTED|Overall Study||15
518|NCT03805672|1827|P2|NOT COMPLETED|Overall Study||0
519|NCT03805672|1828|P1|NOT COMPLETED|Overall Study||0
520|NCT03805672|1827|P2|COMPLETED|Overall Study||2
521|NCT03805672|1828|P1|COMPLETED|Overall Study||2
522|NCT03805672|1827|P2|STARTED|Overall Study||2
523|NCT03805672|1828|P1|STARTED|Overall Study||2
524|NCT03783780|1834|P1|NOT COMPLETED|Overall Study||1
525|NCT03783780|1834|P1|COMPLETED|Overall Study||20
526|NCT03783780|1834|P1|STARTED|Overall Study||21
527|NCT03781375|1841|P2|NOT COMPLETED|Open-label Phase||3
528|NCT03781375|1842|P1|NOT COMPLETED|Open-label Phase||3
529|NCT03781375|1841|P2|COMPLETED|Open-label Phase||6
530|NCT03781375|1842|P1|COMPLETED|Open-label Phase||8
531|NCT03781375|1841|P2|Received Study Drug|Open-label Phase||9
532|NCT03781375|1842|P1|Received Study Drug|Open-label Phase||10
533|NCT03781375|1841|P2|STARTED|Open-label Phase||9
534|NCT03781375|1842|P1|STARTED|Open-label Phase||11
535|NCT03781375|1841|P2|NOT COMPLETED|Double-blind Phase||6
536|NCT03781375|1842|P1|NOT COMPLETED|Double-blind Phase||7
537|NCT03781375|1841|P2|COMPLETED|Double-blind Phase||7
538|NCT03781375|1842|P1|COMPLETED|Double-blind Phase||5
539|NCT03781375|1841|P2|Received Study Drug|Double-blind Phase||13
540|NCT03781375|1842|P1|Received Study Drug|Double-blind Phase||12
541|NCT03781375|1841|P2|STARTED|Double-blind Phase||13
542|NCT03781375|1842|P1|STARTED|Double-blind Phase||12
543|NCT03780959|1856|P3|NOT COMPLETED|Part 2||6
544|NCT03780959|1857|P2|NOT COMPLETED|Part 2||19
545|NCT03780959|1858|P1|NOT COMPLETED|Part 2||0
546|NCT03780959|1856|P3|COMPLETED|Part 2||19
547|NCT03780959|1857|P2|COMPLETED|Part 2||7
548|NCT03780959|1858|P1|COMPLETED|Part 2||0
549|NCT03780959|1856|P3|STARTED|Part 2||25
550|NCT03780959|1857|P2|STARTED|Part 2||26
551|NCT03780959|1858|P1|STARTED|Part 2||0
552|NCT03780959|1856|P3|NOT COMPLETED|Part 1||0
553|NCT03780959|1857|P2|NOT COMPLETED|Part 1||0
554|NCT03780959|1858|P1|NOT COMPLETED|Part 1||5
555|NCT03780959|1856|P3|COMPLETED|Part 1||0
556|NCT03780959|1857|P2|COMPLETED|Part 1||0
557|NCT03780959|1858|P1|COMPLETED|Part 1||64
558|NCT03780959|1856|P3|STARTED|Part 1||0
559|NCT03780959|1857|P2|STARTED|Part 1||0
560|NCT03780959|1858|P1|STARTED|Part 1||69
561|NCT03780010|1872|P2|NOT COMPLETED|Overall Study||0
562|NCT03780010|1873|P1|NOT COMPLETED|Overall Study||0
563|NCT03780010|1872|P2|COMPLETED|Overall Study||12
564|NCT03780010|1873|P1|COMPLETED|Overall Study||3
565|NCT03780010|1872|P2|STARTED|Overall Study||12
566|NCT03780010|1873|P1|STARTED|Overall Study||3
567|NCT03779724|1900|P2|NOT COMPLETED|Overall Study||4
568|NCT03779724|1901|P1|NOT COMPLETED|Overall Study||6
569|NCT03779724|1900|P2|COMPLETED|Overall Study||21
570|NCT03779724|1901|P1|COMPLETED|Overall Study||19
571|NCT03779724|1900|P2|STARTED|Overall Study||25
572|NCT03779724|1901|P1|STARTED|Overall Study||25
573|NCT03772327|1927|P2|NOT COMPLETED|Overall Study||7
574|NCT03772327|1928|P1|NOT COMPLETED|Overall Study||5
575|NCT03772327|1927|P2|COMPLETED|Overall Study||26
576|NCT03772327|1928|P1|COMPLETED|Overall Study||25
577|NCT03772327|1927|P2|Week 0 Visit|Overall Study||33
578|NCT03772327|1928|P1|Week 0 Visit|Overall Study|2 participants were lost to follow up after randomization prior to any study interventions.|28
579|NCT03772327|1927|P2|STARTED|Overall Study||33
580|NCT03772327|1928|P1|STARTED|Overall Study||30
581|NCT03766373|1946|P2|NOT COMPLETED|Overall Study||0
582|NCT03766373|1947|P1|NOT COMPLETED|Overall Study||0
583|NCT03766373|1946|P2|COMPLETED|Overall Study||12
584|NCT03766373|1947|P1|COMPLETED|Overall Study||12
585|NCT03766373|1946|P2|STARTED|Overall Study||12
586|NCT03766373|1947|P1|STARTED|Overall Study||12
587|NCT03765138|1953|P1|NOT COMPLETED|Overall Study||1
588|NCT03765138|1953|P1|COMPLETED|Overall Study||0
589|NCT03765138|1953|P1|STARTED|Overall Study||1
590|NCT03763058|1959|P1|NOT COMPLETED|Overall Study||2
591|NCT03763058|1959|P1|COMPLETED|Overall Study||18
592|NCT03763058|1959|P1|STARTED|Overall Study||20
593|NCT03760510|1969|P2|NOT COMPLETED|Overall Study||97
594|NCT03760510|1970|P1|NOT COMPLETED|Overall Study||105
595|NCT03760510|1969|P2|COMPLETED|Overall Study||153
596|NCT03760510|1970|P1|COMPLETED|Overall Study||145
597|NCT03760510|1969|P2|STARTED|Overall Study||250
598|NCT03760510|1970|P1|STARTED|Overall Study||250
599|NCT03744780|1982|P1|NOT COMPLETED|Overall Study||0
600|NCT03744780|1982|P1|COMPLETED|Overall Study||32
601|NCT03744780|1982|P1|STARTED|Overall Study||32
602|NCT03739242|2002|P2|NOT COMPLETED|Overall Study||2
603|NCT03739242|2003|P1|NOT COMPLETED|Overall Study||1
604|NCT03739242|2002|P2|COMPLETED|Overall Study||42
605|NCT03739242|2003|P1|COMPLETED|Overall Study||43
606|NCT03739242|2002|P2|STARTED|Overall Study||44
607|NCT03739242|2003|P1|STARTED|Overall Study||44
608|NCT03735862|2039|P1|NOT COMPLETED|Overall Study||0
609|NCT03735862|2039|P1|COMPLETED|Overall Study||73
610|NCT03735862|2039|P1|STARTED|Overall Study||73
611|NCT03734822|2047|P1|NOT COMPLETED|Overall Study||0
612|NCT03734822|2047|P1|COMPLETED|Overall Study||47
613|NCT03734822|2047|P1|STARTED|Overall Study||47
614|NCT03733470|2053|P2|NOT COMPLETED|Overall Study||1
615|NCT03733470|2054|P1|NOT COMPLETED|Overall Study||1
616|NCT03733470|2053|P2|COMPLETED|Overall Study||10
617|NCT03733470|2054|P1|COMPLETED|Overall Study||7
618|NCT03733470|2053|P2|STARTED|Overall Study||11
619|NCT03733470|2054|P1|STARTED|Overall Study||8
620|NCT03725085|2060|P1|NOT COMPLETED|Overall Study||2
621|NCT03725085|2060|P1|COMPLETED|Overall Study||550
622|NCT03725085|2060|P1|STARTED|Overall Study||552
623|NCT03723980|2070|P2|NOT COMPLETED|Overall Study||5
624|NCT03723980|2071|P1|NOT COMPLETED|Overall Study||7
625|NCT03723980|2070|P2|COMPLETED|Overall Study||35
626|NCT03723980|2071|P1|COMPLETED|Overall Study||33
627|NCT03723980|2070|P2|STARTED|Overall Study||40
628|NCT03723980|2071|P1|STARTED|Overall Study||40
629|NCT03720847|2087|P2|NOT COMPLETED|Condition 2||0
630|NCT03720847|2088|P1|NOT COMPLETED|Condition 2||0
631|NCT03720847|2087|P2|COMPLETED|Condition 2||13
632|NCT03720847|2088|P1|COMPLETED|Condition 2||14
633|NCT03720847|2087|P2|STARTED|Condition 2||13
634|NCT03720847|2088|P1|STARTED|Condition 2||14
635|NCT03720847|2087|P2|NOT COMPLETED|Washout||2
636|NCT03720847|2088|P1|NOT COMPLETED|Washout||1
637|NCT03720847|2087|P2|COMPLETED|Washout||13
638|NCT03720847|2088|P1|COMPLETED|Washout||14
639|NCT03720847|2087|P2|STARTED|Washout||15
640|NCT03720847|2088|P1|STARTED|Washout||15
641|NCT03720847|2087|P2|NOT COMPLETED|Condition 1||0
642|NCT03720847|2088|P1|NOT COMPLETED|Condition 1||0
643|NCT03720847|2087|P2|COMPLETED|Condition 1||15
644|NCT03720847|2088|P1|COMPLETED|Condition 1||15
645|NCT03720847|2087|P2|STARTED|Condition 1||15
646|NCT03720847|2088|P1|STARTED|Condition 1||15
647|NCT03720119|2106|P1|NOT COMPLETED|Overall Study||9
648|NCT03720119|2106|P1|COMPLETED|Overall Study||69
649|NCT03720119|2106|P1|STARTED|Overall Study||78
650|NCT03718000|2114|P2|NOT COMPLETED|Overall Study||5
651|NCT03718000|2115|P1|NOT COMPLETED|Overall Study||2
652|NCT03718000|2114|P2|COMPLETED|Overall Study||51
653|NCT03718000|2115|P1|COMPLETED|Overall Study||53
654|NCT03718000|2114|P2|STARTED|Overall Study||56
655|NCT03718000|2115|P1|STARTED|Overall Study||55
656|NCT03715530|2140|P3|NOT COMPLETED|Overall Study||2
657|NCT03715530|2141|P2|NOT COMPLETED|Overall Study||1
658|NCT03715530|2142|P1|NOT COMPLETED|Overall Study||3
659|NCT03715530|2140|P3|COMPLETED|Overall Study||85
660|NCT03715530|2141|P2|COMPLETED|Overall Study||41
661|NCT03715530|2142|P1|COMPLETED|Overall Study||30
662|NCT03715530|2140|P3|STARTED|Overall Study||87
663|NCT03715530|2141|P2|STARTED|Overall Study||42
664|NCT03715530|2142|P1|STARTED|Overall Study||33
665|NCT03715426|2152|P2|NOT COMPLETED|Overall Study||25
666|NCT03715426|2153|P1|NOT COMPLETED|Overall Study||21
667|NCT03715426|2152|P2|COMPLETED|Overall Study||92
668|NCT03715426|2153|P1|COMPLETED|Overall Study||112
669|NCT03715426|2152|P2|4-Month Follow-Up Survey|Overall Study||92
670|NCT03715426|2153|P1|4-Month Follow-Up Survey|Overall Study||112
671|NCT03715426|2152|P2|1-Month Follow-Up Survey|Overall Study||97
672|NCT03715426|2153|P1|1-Month Follow-Up Survey|Overall Study||113
673|NCT03715426|2152|P2|STARTED|Overall Study||117
674|NCT03715426|2153|P1|STARTED|Overall Study||133
675|NCT03714672|2197|P4|NOT COMPLETED|Overall Study||1
676|NCT03714672|2198|P3|NOT COMPLETED|Overall Study||4
677|NCT03714672|2199|P2|NOT COMPLETED|Overall Study||4
678|NCT03714672|2200|P1|NOT COMPLETED|Overall Study||2
679|NCT03714672|2197|P4|COMPLETED|Overall Study||207
680|NCT03714672|2198|P3|COMPLETED|Overall Study||202
681|NCT03714672|2199|P2|COMPLETED|Overall Study||202
682|NCT03714672|2200|P1|COMPLETED|Overall Study||207
683|NCT03714672|2197|P4|Safety Set|Overall Study||207
684|NCT03714672|2198|P3|Safety Set|Overall Study||206
685|NCT03714672|2199|P2|Safety Set|Overall Study||205
686|NCT03714672|2200|P1|Safety Set|Overall Study||208
687|NCT03714672|2197|P4|STARTED|Overall Study||208
688|NCT03714672|2198|P3|STARTED|Overall Study||206
689|NCT03714672|2199|P2|STARTED|Overall Study||206
690|NCT03714672|2200|P1|STARTED|Overall Study||209
691|NCT03714659|2246|P1|NOT COMPLETED|Overall Study||1
692|NCT03714659|2246|P1|COMPLETED|Overall Study||19
693|NCT03714659|2246|P1|STARTED|Overall Study||20
694|NCT03708770|2251|P1|NOT COMPLETED|Overall Study||10
695|NCT03708770|2251|P1|COMPLETED|Overall Study||22
696|NCT03708770|2251|P1|STARTED|Overall Study||32
697|NCT03707522|2266|P4|NOT COMPLETED|Overall Study||36
698|NCT03707522|2267|P3|NOT COMPLETED|Overall Study||41
699|NCT03707522|2268|P2|NOT COMPLETED|Overall Study||27
700|NCT03707522|2269|P1|NOT COMPLETED|Overall Study||24
701|NCT03707522|2266|P4|COMPLETED|Overall Study||7
702|NCT03707522|2267|P3|COMPLETED|Overall Study||11
703|NCT03707522|2268|P2|COMPLETED|Overall Study||9
704|NCT03707522|2269|P1|COMPLETED|Overall Study||7
705|NCT03707522|2266|P4|STARTED|Overall Study||43
706|NCT03707522|2267|P3|STARTED|Overall Study||52
707|NCT03707522|2268|P2|STARTED|Overall Study||36
708|NCT03707522|2269|P1|STARTED|Overall Study||31
709|NCT03704376|2297|P2|NOT COMPLETED|Overall Study||4
710|NCT03704376|2298|P1|NOT COMPLETED|Overall Study||4
711|NCT03704376|2297|P2|COMPLETED|Overall Study||40
712|NCT03704376|2298|P1|COMPLETED|Overall Study||38
713|NCT03704376|2297|P2|STARTED|Overall Study||44
714|NCT03704376|2298|P1|STARTED|Overall Study||42
715|NCT03697083|2343|P3|NOT COMPLETED|Overall Study||0
716|NCT03697083|2344|P2|NOT COMPLETED|Overall Study||10
717|NCT03697083|2345|P1|NOT COMPLETED|Overall Study||0
718|NCT03697083|2343|P3|COMPLETED|Overall Study||255
719|NCT03697083|2344|P2|COMPLETED|Overall Study||250
720|NCT03697083|2345|P1|COMPLETED|Overall Study||262
721|NCT03697083|2343|P3|STARTED|Overall Study||255
722|NCT03697083|2344|P2|STARTED|Overall Study||260
723|NCT03697083|2345|P1|STARTED|Overall Study||262
724|NCT03693950|2355|P2|NOT COMPLETED|Overall Study||0
725|NCT03693950|2356|P1|NOT COMPLETED|Overall Study||1
726|NCT03693950|2355|P2|COMPLETED|Overall Study||28
727|NCT03693950|2356|P1|COMPLETED|Overall Study||28
728|NCT03693950|2355|P2|STARTED|Overall Study||28
729|NCT03693950|2356|P1|STARTED|Overall Study||29
730|NCT03693937|2374|P1|NOT COMPLETED|Overall Study||0
731|NCT03693937|2374|P1|COMPLETED|Overall Study||776
732|NCT03693937|2374|P1|STARTED|Overall Study||776
733|NCT03685968|2381|P3|NOT COMPLETED|Overall Study||0
734|NCT03685968|2382|P2|NOT COMPLETED|Overall Study||0
735|NCT03685968|2383|P1|NOT COMPLETED|Overall Study||0
736|NCT03685968|2381|P3|COMPLETED|Overall Study||75
737|NCT03685968|2382|P2|COMPLETED|Overall Study||75
738|NCT03685968|2383|P1|COMPLETED|Overall Study||75
739|NCT03685968|2381|P3|STARTED|Overall Study||75
740|NCT03685968|2382|P2|STARTED|Overall Study||75
741|NCT03685968|2383|P1|STARTED|Overall Study||75
742|NCT03685396|2399|P2|NOT COMPLETED|Overall Study||0
743|NCT03685396|2400|P1|NOT COMPLETED|Overall Study||0
744|NCT03685396|2399|P2|COMPLETED|Overall Study||21
745|NCT03685396|2400|P1|COMPLETED|Overall Study||21
746|NCT03685396|2399|P2|STARTED|Overall Study||21
747|NCT03685396|2400|P1|STARTED|Overall Study||21
748|NCT03684265|2414|P2|NOT COMPLETED|Treatment Period 2||0
749|NCT03684265|2415|P1|NOT COMPLETED|Treatment Period 2||0
750|NCT03684265|2414|P2|COMPLETED|Treatment Period 2||13
751|NCT03684265|2415|P1|COMPLETED|Treatment Period 2||13
752|NCT03684265|2414|P2|STARTED|Treatment Period 2||13
753|NCT03684265|2415|P1|STARTED|Treatment Period 2||13
754|NCT03684265|2414|P2|NOT COMPLETED|Washout Period of 1 Week||0
755|NCT03684265|2415|P1|NOT COMPLETED|Washout Period of 1 Week||0
756|NCT03684265|2414|P2|COMPLETED|Washout Period of 1 Week||13
757|NCT03684265|2415|P1|COMPLETED|Washout Period of 1 Week||13
758|NCT03684265|2414|P2|STARTED|Washout Period of 1 Week||13
759|NCT03684265|2415|P1|STARTED|Washout Period of 1 Week||13
760|NCT03684265|2414|P2|NOT COMPLETED|Treatment Period 1||0
761|NCT03684265|2415|P1|NOT COMPLETED|Treatment Period 1||0
762|NCT03684265|2414|P2|COMPLETED|Treatment Period 1||13
763|NCT03684265|2415|P1|COMPLETED|Treatment Period 1||13
764|NCT03684265|2414|P2|STARTED|Treatment Period 1||13
765|NCT03684265|2415|P1|STARTED|Treatment Period 1||13
766|NCT03683901|2425|P1|NOT COMPLETED|Overall Study||0
767|NCT03683901|2425|P1|COMPLETED|Overall Study||10
768|NCT03683901|2425|P1|STARTED|Overall Study||10
769|NCT03683758|2436|P2|NOT COMPLETED|Overall Study||3
770|NCT03683758|2437|P1|NOT COMPLETED|Overall Study||3
771|NCT03683758|2436|P2|COMPLETED|Overall Study||7
772|NCT03683758|2437|P1|COMPLETED|Overall Study||8
773|NCT03683758|2436|P2|STARTED|Overall Study||10
774|NCT03683758|2437|P1|STARTED|Overall Study||11
775|NCT03677375|2449|P1|NOT COMPLETED|Overall Study||12
776|NCT03677375|2449|P1|COMPLETED|Overall Study||81
777|NCT03677375|2449|P1|STARTED|Overall Study||93
778|NCT03676803|2455|P2|NOT COMPLETED|Overall Study||0
779|NCT03676803|2456|P1|NOT COMPLETED|Overall Study||0
780|NCT03676803|2455|P2|COMPLETED|Overall Study||16
781|NCT03676803|2456|P1|COMPLETED|Overall Study||15
782|NCT03676803|2455|P2|STARTED|Overall Study||16
783|NCT03676803|2456|P1|STARTED|Overall Study||15
784|NCT03673670|2470|P6|NOT COMPLETED|Treatment Period 3 (3 Days)||0
785|NCT03673670|2471|P5|NOT COMPLETED|Treatment Period 3 (3 Days)||1
786|NCT03673670|2472|P4|NOT COMPLETED|Treatment Period 3 (3 Days)||0
787|NCT03673670|2473|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
788|NCT03673670|2474|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
789|NCT03673670|2475|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
790|NCT03673670|2470|P6|COMPLETED|Treatment Period 3 (3 Days)||11
791|NCT03673670|2471|P5|COMPLETED|Treatment Period 3 (3 Days)||10
792|NCT03673670|2472|P4|COMPLETED|Treatment Period 3 (3 Days)||12
793|NCT03673670|2473|P3|COMPLETED|Treatment Period 3 (3 Days)||11
794|NCT03673670|2474|P2|COMPLETED|Treatment Period 3 (3 Days)||14
795|NCT03673670|2475|P1|COMPLETED|Treatment Period 3 (3 Days)||13
796|NCT03673670|2470|P6|STARTED|Treatment Period 3 (3 Days)||11
797|NCT03673670|2471|P5|STARTED|Treatment Period 3 (3 Days)||11
798|NCT03673670|2472|P4|STARTED|Treatment Period 3 (3 Days)||12
799|NCT03673670|2473|P3|STARTED|Treatment Period 3 (3 Days)||11
800|NCT03673670|2474|P2|STARTED|Treatment Period 3 (3 Days)||14
801|NCT03673670|2475|P1|STARTED|Treatment Period 3 (3 Days)||13
802|NCT03673670|2470|P6|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
803|NCT03673670|2471|P5|NOT COMPLETED|Washout Period 2 (7-14 Days)||1
804|NCT03673670|2472|P4|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
805|NCT03673670|2473|P3|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
806|NCT03673670|2474|P2|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
807|NCT03673670|2475|P1|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
808|NCT03673670|2470|P6|COMPLETED|Washout Period 2 (7-14 Days)||11
809|NCT03673670|2471|P5|COMPLETED|Washout Period 2 (7-14 Days)||11
810|NCT03673670|2472|P4|COMPLETED|Washout Period 2 (7-14 Days)||12
811|NCT03673670|2473|P3|COMPLETED|Washout Period 2 (7-14 Days)||11
812|NCT03673670|2474|P2|COMPLETED|Washout Period 2 (7-14 Days)||14
813|NCT03673670|2475|P1|COMPLETED|Washout Period 2 (7-14 Days)||13
814|NCT03673670|2470|P6|STARTED|Washout Period 2 (7-14 Days)||11
815|NCT03673670|2471|P5|STARTED|Washout Period 2 (7-14 Days)||12
816|NCT03673670|2472|P4|STARTED|Washout Period 2 (7-14 Days)||12
817|NCT03673670|2473|P3|STARTED|Washout Period 2 (7-14 Days)||11
818|NCT03673670|2474|P2|STARTED|Washout Period 2 (7-14 Days)||14
819|NCT03673670|2475|P1|STARTED|Washout Period 2 (7-14 Days)||13
820|NCT03673670|2470|P6|NOT COMPLETED|Treatment Period 2 (3 Days)||0
821|NCT03673670|2471|P5|NOT COMPLETED|Treatment Period 2 (3 Days)||1
822|NCT03673670|2472|P4|NOT COMPLETED|Treatment Period 2 (3 Days)||0
823|NCT03673670|2473|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||1
824|NCT03673670|2474|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||0
825|NCT03673670|2475|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
826|NCT03673670|2470|P6|COMPLETED|Treatment Period 2 (3 Days)||11
827|NCT03673670|2471|P5|COMPLETED|Treatment Period 2 (3 Days)||12
828|NCT03673670|2472|P4|COMPLETED|Treatment Period 2 (3 Days)||12
829|NCT03673670|2473|P3|COMPLETED|Treatment Period 2 (3 Days)||11
830|NCT03673670|2474|P2|COMPLETED|Treatment Period 2 (3 Days)||14
831|NCT03673670|2475|P1|COMPLETED|Treatment Period 2 (3 Days)||13
832|NCT03673670|2470|P6|STARTED|Treatment Period 2 (3 Days)||11
833|NCT03673670|2471|P5|STARTED|Treatment Period 2 (3 Days)||13
834|NCT03673670|2472|P4|STARTED|Treatment Period 2 (3 Days)||12
835|NCT03673670|2473|P3|STARTED|Treatment Period 2 (3 Days)||12
836|NCT03673670|2474|P2|STARTED|Treatment Period 2 (3 Days)||14
837|NCT03673670|2475|P1|STARTED|Treatment Period 2 (3 Days)||13
838|NCT03673670|2470|P6|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
839|NCT03673670|2471|P5|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
840|NCT03673670|2472|P4|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
841|NCT03673670|2473|P3|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
842|NCT03673670|2474|P2|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
843|NCT03673670|2475|P1|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
844|NCT03673670|2470|P6|COMPLETED|Washout Period 1 (7-14 Days)||11
845|NCT03673670|2471|P5|COMPLETED|Washout Period 1 (7-14 Days)||13
846|NCT03673670|2472|P4|COMPLETED|Washout Period 1 (7-14 Days)||12
847|NCT03673670|2473|P3|COMPLETED|Washout Period 1 (7-14 Days)||12
848|NCT03673670|2474|P2|COMPLETED|Washout Period 1 (7-14 Days)||14
849|NCT03673670|2475|P1|COMPLETED|Washout Period 1 (7-14 Days)||13
850|NCT03673670|2470|P6|STARTED|Washout Period 1 (7-14 Days)||11
851|NCT03673670|2471|P5|STARTED|Washout Period 1 (7-14 Days)||13
852|NCT03673670|2472|P4|STARTED|Washout Period 1 (7-14 Days)||12
853|NCT03673670|2473|P3|STARTED|Washout Period 1 (7-14 Days)||12
854|NCT03673670|2474|P2|STARTED|Washout Period 1 (7-14 Days)||14
855|NCT03673670|2475|P1|STARTED|Washout Period 1 (7-14 Days)||13
856|NCT03673670|2470|P6|NOT COMPLETED|Treatment Period 1 (3 Days)||2
857|NCT03673670|2471|P5|NOT COMPLETED|Treatment Period 1 (3 Days)||0
858|NCT03673670|2472|P4|NOT COMPLETED|Treatment Period 1 (3 Days)||0
859|NCT03673670|2473|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||1
860|NCT03673670|2474|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
861|NCT03673670|2475|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||1
862|NCT03673670|2470|P6|COMPLETED|Treatment Period 1 (3 Days)||11
863|NCT03673670|2471|P5|COMPLETED|Treatment Period 1 (3 Days)||13
864|NCT03673670|2472|P4|COMPLETED|Treatment Period 1 (3 Days)||12
865|NCT03673670|2473|P3|COMPLETED|Treatment Period 1 (3 Days)||12
866|NCT03673670|2474|P2|COMPLETED|Treatment Period 1 (3 Days)||14
867|NCT03673670|2475|P1|COMPLETED|Treatment Period 1 (3 Days)||13
868|NCT03673670|2470|P6|STARTED|Treatment Period 1 (3 Days)||13
869|NCT03673670|2471|P5|STARTED|Treatment Period 1 (3 Days)||13
870|NCT03673670|2472|P4|STARTED|Treatment Period 1 (3 Days)||12
871|NCT03673670|2473|P3|STARTED|Treatment Period 1 (3 Days)||13
872|NCT03673670|2474|P2|STARTED|Treatment Period 1 (3 Days)||14
873|NCT03673670|2475|P1|STARTED|Treatment Period 1 (3 Days)||14
874|NCT03670537|2522|P1|NOT COMPLETED|Overall Study||1
875|NCT03670537|2522|P1|COMPLETED|Overall Study||101
876|NCT03670537|2522|P1|STARTED|Overall Study||102
877|NCT03669081|2528|P2|NOT COMPLETED|Overall Study||1
878|NCT03669081|2529|P1|NOT COMPLETED|Overall Study||1
879|NCT03669081|2528|P2|COMPLETED|Overall Study||29
880|NCT03669081|2529|P1|COMPLETED|Overall Study||33
881|NCT03669081|2528|P2|STARTED|Overall Study||30
882|NCT03669081|2529|P1|STARTED|Overall Study||34
883|NCT03667547|2545|P1|NOT COMPLETED|Overall Study||0
884|NCT03667547|2545|P1|COMPLETED|Overall Study||12
885|NCT03667547|2545|P1|STARTED|Overall Study||12
886|NCT03663179|2561|P2|NOT COMPLETED|Overall Study||1
887|NCT03663179|2562|P1|NOT COMPLETED|Overall Study||4
888|NCT03663179|2561|P2|COMPLETED|Overall Study||13
889|NCT03663179|2562|P1|COMPLETED|Overall Study||14
890|NCT03663179|2561|P2|STARTED|Overall Study||14
891|NCT03663179|2562|P1|STARTED|Overall Study||18
892|NCT03662334|2572|P2|NOT COMPLETED|Part 3: Treatment Period 2||0
893|NCT03662334|2573|P1|NOT COMPLETED|Part 3: Treatment Period 2||0
894|NCT03662334|2572|P2|COMPLETED|Part 3: Treatment Period 2||0
895|NCT03662334|2573|P1|COMPLETED|Part 3: Treatment Period 2||0
896|NCT03662334|2572|P2|STARTED|Part 3: Treatment Period 2||0
897|NCT03662334|2573|P1|STARTED|Part 3: Treatment Period 2||0
898|NCT03662334|2572|P2|NOT COMPLETED|Part 3: Treatment Period 1||0
899|NCT03662334|2573|P1|NOT COMPLETED|Part 3: Treatment Period 1||0
900|NCT03662334|2572|P2|COMPLETED|Part 3: Treatment Period 1||0
901|NCT03662334|2573|P1|COMPLETED|Part 3: Treatment Period 1||0
902|NCT03662334|2572|P2|STARTED|Part 3: Treatment Period 1|Part 3 of the study was not conducted. No participants were enrolled in this part of the study.|0
903|NCT03662334|2573|P1|STARTED|Part 3: Treatment Period 1|Part 3 of the study was not conducted. No participants were enrolled in this part of the study.|0
904|NCT03662334|2572|P2|NOT COMPLETED|Part 2: Treatment Period 2 (2 Days)||0
905|NCT03662334|2573|P1|NOT COMPLETED|Part 2: Treatment Period 2 (2 Days)||1
906|NCT03662334|2572|P2|COMPLETED|Part 2: Treatment Period 2 (2 Days)||7
907|NCT03662334|2573|P1|COMPLETED|Part 2: Treatment Period 2 (2 Days)||6
908|NCT03662334|2572|P2|STARTED|Part 2: Treatment Period 2 (2 Days)||7
909|NCT03662334|2573|P1|STARTED|Part 2: Treatment Period 2 (2 Days)||7
910|NCT03662334|2572|P2|NOT COMPLETED|Part 2: Treatment Period 1 (2 Days)||0
911|NCT03662334|2573|P1|NOT COMPLETED|Part 2: Treatment Period 1 (2 Days)||0
912|NCT03662334|2572|P2|COMPLETED|Part 2: Treatment Period 1 (2 Days)||7
913|NCT03662334|2573|P1|COMPLETED|Part 2: Treatment Period 1 (2 Days)||7
914|NCT03662334|2572|P2|STARTED|Part 2: Treatment Period 1 (2 Days)|Part 1 of the study was not conducted. Participants were enrolled starting with Part 2.|7
915|NCT03662334|2573|P1|STARTED|Part 2: Treatment Period 1 (2 Days)|Part 1 of the study was not conducted. Participants were enrolled starting with Part 2.|7
916|NCT03662334|2572|P2|NOT COMPLETED|Part 1: Treatment Period 2||0
917|NCT03662334|2573|P1|NOT COMPLETED|Part 1: Treatment Period 2||0
918|NCT03662334|2572|P2|COMPLETED|Part 1: Treatment Period 2||0
919|NCT03662334|2573|P1|COMPLETED|Part 1: Treatment Period 2||0
920|NCT03662334|2572|P2|STARTED|Part 1: Treatment Period 2||0
921|NCT03662334|2573|P1|STARTED|Part 1: Treatment Period 2||0
922|NCT03662334|2572|P2|NOT COMPLETED|Part 1: Treatment Period 1||0
923|NCT03662334|2573|P1|NOT COMPLETED|Part 1: Treatment Period 1||0
924|NCT03662334|2572|P2|COMPLETED|Part 1: Treatment Period 1||0
925|NCT03662334|2573|P1|COMPLETED|Part 1: Treatment Period 1||0
926|NCT03662334|2572|P2|STARTED|Part 1: Treatment Period 1||0
927|NCT03662334|2573|P1|STARTED|Part 1: Treatment Period 1||0
928|NCT03662139|2611|P2|NOT COMPLETED|Overall Study||0
929|NCT03662139|2612|P1|NOT COMPLETED|Overall Study||0
930|NCT03662139|2611|P2|COMPLETED|Overall Study||16
931|NCT03662139|2612|P1|COMPLETED|Overall Study||16
932|NCT03662139|2611|P2|STARTED|Overall Study||16
933|NCT03662139|2612|P1|STARTED|Overall Study||16
934|NCT03660787|2628|P4|NOT COMPLETED|Overall Study||0
935|NCT03660787|2629|P3|NOT COMPLETED|Overall Study||1
936|NCT03660787|2630|P2|NOT COMPLETED|Overall Study||1
937|NCT03660787|2631|P1|NOT COMPLETED|Overall Study||1
938|NCT03660787|2628|P4|COMPLETED|Overall Study||26
939|NCT03660787|2629|P3|COMPLETED|Overall Study||25
940|NCT03660787|2630|P2|COMPLETED|Overall Study||25
941|NCT03660787|2631|P1|COMPLETED|Overall Study||25
942|NCT03660787|2628|P4|STARTED|Overall Study||26
943|NCT03660787|2629|P3|STARTED|Overall Study||26
944|NCT03660787|2630|P2|STARTED|Overall Study||26
945|NCT03660787|2631|P1|STARTED|Overall Study||26
946|NCT03658876|2667|P2|NOT COMPLETED|Overall Study||12
947|NCT03658876|2668|P1|NOT COMPLETED|Overall Study||12
948|NCT03658876|2667|P2|COMPLETED|Overall Study||84
949|NCT03658876|2668|P1|COMPLETED|Overall Study||76
950|NCT03658876|2667|P2|STARTED|Overall Study||96
951|NCT03658876|2668|P1|STARTED|Overall Study||88
952|NCT03658811|2674|P1|NOT COMPLETED|Overall Study||3
953|NCT03658811|2674|P1|COMPLETED|Overall Study||16
954|NCT03658811|2674|P1|STARTED|Overall Study||19
955|NCT03657407|2683|P2|NOT COMPLETED|Overall Study||0
956|NCT03657407|2684|P1|NOT COMPLETED|Overall Study||0
957|NCT03657407|2683|P2|COMPLETED|Overall Study||27
958|NCT03657407|2684|P1|COMPLETED|Overall Study||29
959|NCT03657407|2683|P2|STARTED|Overall Study||27
960|NCT03657407|2684|P1|STARTED|Overall Study||29
961|NCT03657264|2700|P4|NOT COMPLETED|Overall Study||0
962|NCT03657264|2701|P3|NOT COMPLETED|Overall Study||0
963|NCT03657264|2702|P2|NOT COMPLETED|Overall Study||0
964|NCT03657264|2703|P1|NOT COMPLETED|Overall Study||0
965|NCT03657264|2700|P4|COMPLETED|Overall Study||12
966|NCT03657264|2701|P3|COMPLETED|Overall Study||12
967|NCT03657264|2702|P2|COMPLETED|Overall Study||12
968|NCT03657264|2703|P1|COMPLETED|Overall Study||12
969|NCT03657264|2700|P4|STARTED|Overall Study||12
970|NCT03657264|2701|P3|STARTED|Overall Study||12
971|NCT03657264|2702|P2|STARTED|Overall Study||12
972|NCT03657264|2703|P1|STARTED|Overall Study||12
973|NCT03651856|2716|P1|NOT COMPLETED|Overall Study||0
974|NCT03651856|2716|P1|COMPLETED|Overall Study||10
975|NCT03651856|2716|P1|STARTED|Overall Study||10
976|NCT03649750|2720|P2|NOT COMPLETED|Period 2||0
977|NCT03649750|2721|P1|NOT COMPLETED|Period 2||0
978|NCT03649750|2720|P2|COMPLETED|Period 2||24
979|NCT03649750|2721|P1|COMPLETED|Period 2||12
980|NCT03649750|2720|P2|STARTED|Period 2||24
981|NCT03649750|2721|P1|STARTED|Period 2||12
982|NCT03649750|2720|P2|NOT COMPLETED|Washout: 7 Days||0
983|NCT03649750|2721|P1|NOT COMPLETED|Washout: 7 Days||0
984|NCT03649750|2720|P2|COMPLETED|Washout: 7 Days||24
985|NCT03649750|2721|P1|COMPLETED|Washout: 7 Days||12
986|NCT03649750|2720|P2|STARTED|Washout: 7 Days||24
987|NCT03649750|2721|P1|STARTED|Washout: 7 Days||12
988|NCT03649750|2720|P2|NOT COMPLETED|Period 1||0
989|NCT03649750|2721|P1|NOT COMPLETED|Period 1||0
990|NCT03649750|2720|P2|COMPLETED|Period 1||24
991|NCT03649750|2721|P1|COMPLETED|Period 1||12
992|NCT03649750|2720|P2|STARTED|Period 1||24
993|NCT03649750|2721|P1|STARTED|Period 1||12
994|NCT03648983|2740|P1|NOT COMPLETED|Overall Study||95
995|NCT03648983|2740|P1|COMPLETED|Overall Study||0
996|NCT03648983|2740|P1|STARTED|Overall Study||95
997|NCT03647033|2748|P2|NOT COMPLETED|Overall Study||0
998|NCT03647033|2749|P1|NOT COMPLETED|Overall Study||0
999|NCT03647033|2748|P2|COMPLETED|Overall Study||16
1000|NCT03647033|2749|P1|COMPLETED|Overall Study||16
1001|NCT03647033|2748|P2|STARTED|Overall Study||16
1002|NCT03647033|2749|P1|STARTED|Overall Study||16
1003|NCT03644108|2757|P1|NOT COMPLETED|Overall Study||0
1004|NCT03644108|2757|P1|COMPLETED|Overall Study||30
1005|NCT03644108|2757|P1|STARTED|Overall Study||30
1006|NCT03644095|2768|P2|NOT COMPLETED|Period 2||0
1007|NCT03644095|2769|P1|NOT COMPLETED|Period 2||0
1008|NCT03644095|2768|P2|COMPLETED|Period 2||15
1009|NCT03644095|2769|P1|COMPLETED|Period 2||15
1010|NCT03644095|2768|P2|STARTED|Period 2||15
1011|NCT03644095|2769|P1|STARTED|Period 2||15
1012|NCT03644095|2768|P2|NOT COMPLETED|Washout (7 Days)||0
1013|NCT03644095|2769|P1|NOT COMPLETED|Washout (7 Days)||0
1014|NCT03644095|2768|P2|COMPLETED|Washout (7 Days)||15
1015|NCT03644095|2769|P1|COMPLETED|Washout (7 Days)||15
1016|NCT03644095|2768|P2|STARTED|Washout (7 Days)||15
1017|NCT03644095|2769|P1|STARTED|Washout (7 Days)||15
1018|NCT03644095|2768|P2|NOT COMPLETED|Period 1||0
1019|NCT03644095|2769|P1|NOT COMPLETED|Period 1||0
1020|NCT03644095|2768|P2|COMPLETED|Period 1||15
1021|NCT03644095|2769|P1|COMPLETED|Period 1||15
1022|NCT03644095|2768|P2|STARTED|Period 1||15
1023|NCT03644095|2769|P1|STARTED|Period 1||15
1024|NCT03643575|2789|P6|NOT COMPLETED|Period 3||0
1025|NCT03643575|2790|P5|NOT COMPLETED|Period 3||0
1026|NCT03643575|2791|P4|NOT COMPLETED|Period 3||0
1027|NCT03643575|2792|P3|NOT COMPLETED|Period 3||0
1028|NCT03643575|2793|P2|NOT COMPLETED|Period 3||0
1029|NCT03643575|2794|P1|NOT COMPLETED|Period 3||0
1030|NCT03643575|2789|P6|COMPLETED|Period 3||5
1031|NCT03643575|2790|P5|COMPLETED|Period 3||5
1032|NCT03643575|2791|P4|COMPLETED|Period 3||4
1033|NCT03643575|2792|P3|COMPLETED|Period 3||5
1034|NCT03643575|2793|P2|COMPLETED|Period 3||4
1035|NCT03643575|2794|P1|COMPLETED|Period 3||4
1036|NCT03643575|2789|P6|STARTED|Period 3||5
1037|NCT03643575|2790|P5|STARTED|Period 3||5
1038|NCT03643575|2791|P4|STARTED|Period 3||4
1039|NCT03643575|2792|P3|STARTED|Period 3||5
1040|NCT03643575|2793|P2|STARTED|Period 3||4
1041|NCT03643575|2794|P1|STARTED|Period 3||4
1042|NCT03643575|2789|P6|NOT COMPLETED|Washout: 7 Days||0
1043|NCT03643575|2790|P5|NOT COMPLETED|Washout: 7 Days||0
1044|NCT03643575|2791|P4|NOT COMPLETED|Washout: 7 Days||0
1045|NCT03643575|2792|P3|NOT COMPLETED|Washout: 7 Days||0
1046|NCT03643575|2793|P2|NOT COMPLETED|Washout: 7 Days||1
1047|NCT03643575|2794|P1|NOT COMPLETED|Washout: 7 Days||0
1048|NCT03643575|2789|P6|COMPLETED|Washout: 7 Days||5
1049|NCT03643575|2790|P5|COMPLETED|Washout: 7 Days||5
1050|NCT03643575|2791|P4|COMPLETED|Washout: 7 Days||4
1051|NCT03643575|2792|P3|COMPLETED|Washout: 7 Days||5
1052|NCT03643575|2793|P2|COMPLETED|Washout: 7 Days||4
1053|NCT03643575|2794|P1|COMPLETED|Washout: 7 Days||4
1054|NCT03643575|2789|P6|STARTED|Washout: 7 Days||5
1055|NCT03643575|2790|P5|STARTED|Washout: 7 Days||5
1056|NCT03643575|2791|P4|STARTED|Washout: 7 Days||4
1057|NCT03643575|2792|P3|STARTED|Washout: 7 Days||5
1058|NCT03643575|2793|P2|STARTED|Washout: 7 Days||5
1059|NCT03643575|2794|P1|STARTED|Washout: 7 Days||4
1060|NCT03643575|2789|P6|NOT COMPLETED|Period 2||0
1061|NCT03643575|2790|P5|NOT COMPLETED|Period 2||0
1062|NCT03643575|2791|P4|NOT COMPLETED|Period 2||0
1063|NCT03643575|2792|P3|NOT COMPLETED|Period 2||0
1064|NCT03643575|2793|P2|NOT COMPLETED|Period 2||0
1065|NCT03643575|2794|P1|NOT COMPLETED|Period 2||0
1066|NCT03643575|2789|P6|COMPLETED|Period 2||5
1067|NCT03643575|2790|P5|COMPLETED|Period 2||5
1068|NCT03643575|2791|P4|COMPLETED|Period 2||4
1069|NCT03643575|2792|P3|COMPLETED|Period 2||5
1070|NCT03643575|2793|P2|COMPLETED|Period 2||5
1071|NCT03643575|2794|P1|COMPLETED|Period 2||4
1072|NCT03643575|2789|P6|STARTED|Period 2||5
1073|NCT03643575|2790|P5|STARTED|Period 2||5
1074|NCT03643575|2791|P4|STARTED|Period 2||4
1075|NCT03643575|2792|P3|STARTED|Period 2||5
1076|NCT03643575|2793|P2|STARTED|Period 2||5
1077|NCT03643575|2794|P1|STARTED|Period 2||4
1078|NCT03643575|2789|P6|NOT COMPLETED|Washout: 7 Days||0
1079|NCT03643575|2790|P5|NOT COMPLETED|Washout: 7 Days||0
1080|NCT03643575|2791|P4|NOT COMPLETED|Washout: 7 Days||1
1081|NCT03643575|2792|P3|NOT COMPLETED|Washout: 7 Days||0
1082|NCT03643575|2793|P2|NOT COMPLETED|Washout: 7 Days||0
1083|NCT03643575|2794|P1|NOT COMPLETED|Washout: 7 Days||1
1084|NCT03643575|2789|P6|COMPLETED|Washout: 7 Days||5
1085|NCT03643575|2790|P5|COMPLETED|Washout: 7 Days||5
1086|NCT03643575|2791|P4|COMPLETED|Washout: 7 Days||4
1087|NCT03643575|2792|P3|COMPLETED|Washout: 7 Days||5
1088|NCT03643575|2793|P2|COMPLETED|Washout: 7 Days||5
1089|NCT03643575|2794|P1|COMPLETED|Washout: 7 Days||4
1090|NCT03643575|2789|P6|STARTED|Washout: 7 Days||5
1091|NCT03643575|2790|P5|STARTED|Washout: 7 Days||5
1092|NCT03643575|2791|P4|STARTED|Washout: 7 Days||5
1093|NCT03643575|2792|P3|STARTED|Washout: 7 Days||5
1094|NCT03643575|2793|P2|STARTED|Washout: 7 Days||5
1095|NCT03643575|2794|P1|STARTED|Washout: 7 Days||5
1096|NCT03643575|2789|P6|NOT COMPLETED|Period 1||0
1097|NCT03643575|2790|P5|NOT COMPLETED|Period 1||0
1098|NCT03643575|2791|P4|NOT COMPLETED|Period 1||0
1099|NCT03643575|2792|P3|NOT COMPLETED|Period 1||0
1100|NCT03643575|2793|P2|NOT COMPLETED|Period 1||0
1101|NCT03643575|2794|P1|NOT COMPLETED|Period 1||0
1102|NCT03643575|2789|P6|COMPLETED|Period 1||5
1103|NCT03643575|2790|P5|COMPLETED|Period 1||5
1104|NCT03643575|2791|P4|COMPLETED|Period 1||5
1105|NCT03643575|2792|P3|COMPLETED|Period 1||5
1106|NCT03643575|2793|P2|COMPLETED|Period 1||5
1107|NCT03643575|2794|P1|COMPLETED|Period 1||5
1108|NCT03643575|2789|P6|STARTED|Period 1||5
1109|NCT03643575|2790|P5|STARTED|Period 1||5
1110|NCT03643575|2791|P4|STARTED|Period 1||5
1111|NCT03643575|2792|P3|STARTED|Period 1||5
1112|NCT03643575|2793|P2|STARTED|Period 1||5
1113|NCT03643575|2794|P1|STARTED|Period 1||5
1114|NCT03643159|2852|P1|NOT COMPLETED|Overall Study||2
1115|NCT03643159|2852|P1|COMPLETED|Overall Study||0
1116|NCT03643159|2852|P1|Received At Least 1 Dose Of Study Drug|Overall Study||2
1117|NCT03643159|2852|P1|STARTED|Overall Study||2
1118|NCT03642873|2859|P6|NOT COMPLETED|Third Intervention (1 Day)||0
1119|NCT03642873|2860|P5|NOT COMPLETED|Third Intervention (1 Day)||1
1120|NCT03642873|2861|P4|NOT COMPLETED|Third Intervention (1 Day)||0
1121|NCT03642873|2862|P3|NOT COMPLETED|Third Intervention (1 Day)||0
1122|NCT03642873|2863|P2|NOT COMPLETED|Third Intervention (1 Day)||0
1123|NCT03642873|2864|P1|NOT COMPLETED|Third Intervention (1 Day)||0
1124|NCT03642873|2859|P6|COMPLETED|Third Intervention (1 Day)||4
1125|NCT03642873|2860|P5|COMPLETED|Third Intervention (1 Day)||3
1126|NCT03642873|2861|P4|COMPLETED|Third Intervention (1 Day)||4
1127|NCT03642873|2862|P3|COMPLETED|Third Intervention (1 Day)||4
1128|NCT03642873|2863|P2|COMPLETED|Third Intervention (1 Day)||4
1129|NCT03642873|2864|P1|COMPLETED|Third Intervention (1 Day)||4
1130|NCT03642873|2859|P6|STARTED|Third Intervention (1 Day)||4
1131|NCT03642873|2860|P5|STARTED|Third Intervention (1 Day)||4
1132|NCT03642873|2861|P4|STARTED|Third Intervention (1 Day)||4
1133|NCT03642873|2862|P3|STARTED|Third Intervention (1 Day)||4
1134|NCT03642873|2863|P2|STARTED|Third Intervention (1 Day)||4
1135|NCT03642873|2864|P1|STARTED|Third Intervention (1 Day)||4
1136|NCT03642873|2859|P6|NOT COMPLETED|Washout (7 Days)||0
1137|NCT03642873|2860|P5|NOT COMPLETED|Washout (7 Days)||0
1138|NCT03642873|2861|P4|NOT COMPLETED|Washout (7 Days)||0
1139|NCT03642873|2862|P3|NOT COMPLETED|Washout (7 Days)||0
1140|NCT03642873|2863|P2|NOT COMPLETED|Washout (7 Days)||0
1141|NCT03642873|2864|P1|NOT COMPLETED|Washout (7 Days)||0
1142|NCT03642873|2859|P6|COMPLETED|Washout (7 Days)||4
1143|NCT03642873|2860|P5|COMPLETED|Washout (7 Days)||4
1144|NCT03642873|2861|P4|COMPLETED|Washout (7 Days)||4
1145|NCT03642873|2862|P3|COMPLETED|Washout (7 Days)||4
1146|NCT03642873|2863|P2|COMPLETED|Washout (7 Days)||4
1147|NCT03642873|2864|P1|COMPLETED|Washout (7 Days)||4
1148|NCT03642873|2859|P6|STARTED|Washout (7 Days)||4
1149|NCT03642873|2860|P5|STARTED|Washout (7 Days)||4
1150|NCT03642873|2861|P4|STARTED|Washout (7 Days)||4
1151|NCT03642873|2862|P3|STARTED|Washout (7 Days)||4
1152|NCT03642873|2863|P2|STARTED|Washout (7 Days)||4
1153|NCT03642873|2864|P1|STARTED|Washout (7 Days)||4
1154|NCT03642873|2859|P6|NOT COMPLETED|Second Intervention (1 Day)||0
1155|NCT03642873|2860|P5|NOT COMPLETED|Second Intervention (1 Day)||0
1156|NCT03642873|2861|P4|NOT COMPLETED|Second Intervention (1 Day)||0
1157|NCT03642873|2862|P3|NOT COMPLETED|Second Intervention (1 Day)||0
1158|NCT03642873|2863|P2|NOT COMPLETED|Second Intervention (1 Day)||0
1159|NCT03642873|2864|P1|NOT COMPLETED|Second Intervention (1 Day)||0
1160|NCT03642873|2859|P6|COMPLETED|Second Intervention (1 Day)||4
1161|NCT03642873|2860|P5|COMPLETED|Second Intervention (1 Day)||4
1162|NCT03642873|2861|P4|COMPLETED|Second Intervention (1 Day)||4
1163|NCT03642873|2862|P3|COMPLETED|Second Intervention (1 Day)||4
1164|NCT03642873|2863|P2|COMPLETED|Second Intervention (1 Day)||4
1165|NCT03642873|2864|P1|COMPLETED|Second Intervention (1 Day)||4
1166|NCT03642873|2859|P6|STARTED|Second Intervention (1 Day)||4
1167|NCT03642873|2860|P5|STARTED|Second Intervention (1 Day)||4
1168|NCT03642873|2861|P4|STARTED|Second Intervention (1 Day)||4
1169|NCT03642873|2862|P3|STARTED|Second Intervention (1 Day)||4
1170|NCT03642873|2863|P2|STARTED|Second Intervention (1 Day)||4
1171|NCT03642873|2864|P1|STARTED|Second Intervention (1 Day)||4
1172|NCT03642873|2859|P6|NOT COMPLETED|Washout (7 Days)||0
1173|NCT03642873|2860|P5|NOT COMPLETED|Washout (7 Days)||0
1174|NCT03642873|2861|P4|NOT COMPLETED|Washout (7 Days)||0
1175|NCT03642873|2862|P3|NOT COMPLETED|Washout (7 Days)||0
1176|NCT03642873|2863|P2|NOT COMPLETED|Washout (7 Days)||0
1177|NCT03642873|2864|P1|NOT COMPLETED|Washout (7 Days)||0
1178|NCT03642873|2859|P6|COMPLETED|Washout (7 Days)||4
1179|NCT03642873|2860|P5|COMPLETED|Washout (7 Days)||4
1180|NCT03642873|2861|P4|COMPLETED|Washout (7 Days)||4
1181|NCT03642873|2862|P3|COMPLETED|Washout (7 Days)||4
1182|NCT03642873|2863|P2|COMPLETED|Washout (7 Days)||4
1183|NCT03642873|2864|P1|COMPLETED|Washout (7 Days)||4
1184|NCT03642873|2859|P6|STARTED|Washout (7 Days)||4
1185|NCT03642873|2860|P5|STARTED|Washout (7 Days)||4
1186|NCT03642873|2861|P4|STARTED|Washout (7 Days)||4
1187|NCT03642873|2862|P3|STARTED|Washout (7 Days)||4
1188|NCT03642873|2863|P2|STARTED|Washout (7 Days)||4
1189|NCT03642873|2864|P1|STARTED|Washout (7 Days)||4
1190|NCT03642873|2859|P6|NOT COMPLETED|First Intervention (1 Day)||0
1191|NCT03642873|2860|P5|NOT COMPLETED|First Intervention (1 Day)||0
1192|NCT03642873|2861|P4|NOT COMPLETED|First Intervention (1 Day)||0
1193|NCT03642873|2862|P3|NOT COMPLETED|First Intervention (1 Day)||0
1194|NCT03642873|2863|P2|NOT COMPLETED|First Intervention (1 Day)||0
1195|NCT03642873|2864|P1|NOT COMPLETED|First Intervention (1 Day)||0
1196|NCT03642873|2859|P6|COMPLETED|First Intervention (1 Day)||4
1197|NCT03642873|2860|P5|COMPLETED|First Intervention (1 Day)||4
1198|NCT03642873|2861|P4|COMPLETED|First Intervention (1 Day)||4
1199|NCT03642873|2862|P3|COMPLETED|First Intervention (1 Day)||4
1200|NCT03642873|2863|P2|COMPLETED|First Intervention (1 Day)||4
1201|NCT03642873|2864|P1|COMPLETED|First Intervention (1 Day)||4
1202|NCT03642873|2859|P6|STARTED|First Intervention (1 Day)||4
1203|NCT03642873|2860|P5|STARTED|First Intervention (1 Day)||4
1204|NCT03642873|2861|P4|STARTED|First Intervention (1 Day)||4
1205|NCT03642873|2862|P3|STARTED|First Intervention (1 Day)||4
1206|NCT03642873|2863|P2|STARTED|First Intervention (1 Day)||4
1207|NCT03642873|2864|P1|STARTED|First Intervention (1 Day)||4
1208|NCT03642262|2896|P2|NOT COMPLETED|Period 2||0
1209|NCT03642262|2897|P1|NOT COMPLETED|Period 2||0
1210|NCT03642262|2896|P2|COMPLETED|Period 2||16
1211|NCT03642262|2897|P1|COMPLETED|Period 2||11
1212|NCT03642262|2896|P2|STARTED|Period 2||16
1213|NCT03642262|2897|P1|STARTED|Period 2||11
1214|NCT03642262|2896|P2|NOT COMPLETED|Washout: 7 Days||0
1215|NCT03642262|2897|P1|NOT COMPLETED|Washout: 7 Days||0
1216|NCT03642262|2896|P2|COMPLETED|Washout: 7 Days||16
1217|NCT03642262|2897|P1|COMPLETED|Washout: 7 Days||11
1218|NCT03642262|2896|P2|STARTED|Washout: 7 Days||16
1219|NCT03642262|2897|P1|STARTED|Washout: 7 Days||11
1220|NCT03642262|2896|P2|NOT COMPLETED|Period 1||2
1221|NCT03642262|2897|P1|NOT COMPLETED|Period 1||1
1222|NCT03642262|2896|P2|COMPLETED|Period 1||16
1223|NCT03642262|2897|P1|COMPLETED|Period 1||11
1224|NCT03642262|2896|P2|STARTED|Period 1||18
1225|NCT03642262|2897|P1|STARTED|Period 1||12
1226|NCT03641508|2918|P2|NOT COMPLETED|Follow-up/Second Injection||0
1227|NCT03641508|2919|P1|NOT COMPLETED|Follow-up/Second Injection||0
1228|NCT03641508|2918|P2|COMPLETED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|10
1229|NCT03641508|2919|P1|COMPLETED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|2
1230|NCT03641508|2918|P2|STARTED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|10
1231|NCT03641508|2919|P1|STARTED|Follow-up/Second Injection||2
1232|NCT03641508|2918|P2|NOT COMPLETED|First Injection||0
1233|NCT03641508|2919|P1|NOT COMPLETED|First Injection||2
1234|NCT03641508|2918|P2|COMPLETED|First Injection||32
1235|NCT03641508|2919|P1|COMPLETED|First Injection||35
1236|NCT03641508|2918|P2|STARTED|First Injection||32
1237|NCT03641508|2919|P1|STARTED|First Injection||37
1238|NCT03640832|2931|P2|NOT COMPLETED|Overall Study||0
1239|NCT03640832|2932|P1|NOT COMPLETED|Overall Study||0
1240|NCT03640832|2931|P2|COMPLETED|Overall Study||46
1241|NCT03640832|2932|P1|COMPLETED|Overall Study||44
1242|NCT03640832|2931|P2|STARTED|Overall Study||46
1243|NCT03640832|2932|P1|STARTED|Overall Study||44
1244|NCT03640559|2946|P2|NOT COMPLETED|Overall Study||1
1245|NCT03640559|2947|P1|NOT COMPLETED|Overall Study||2
1246|NCT03640559|2946|P2|COMPLETED|Overall Study||24
1247|NCT03640559|2947|P1|COMPLETED|Overall Study||23
1248|NCT03640559|2946|P2|STARTED|Overall Study||25
1249|NCT03640559|2947|P1|STARTED|Overall Study||25
1250|NCT03638908|2953|P1|NOT COMPLETED|Overall Study||1
1251|NCT03638908|2953|P1|COMPLETED|Overall Study||7
1252|NCT03638908|2953|P1|STARTED|Overall Study||8
1253|NCT03638635|2970|P2|NOT COMPLETED|Follow-Up (30 Days After Discharge)||22
1254|NCT03638635|2971|P1|NOT COMPLETED|Follow-Up (30 Days After Discharge)||39
1255|NCT03638635|2970|P2|COMPLETED|Follow-Up (30 Days After Discharge)||0
1256|NCT03638635|2971|P1|COMPLETED|Follow-Up (30 Days After Discharge)||0
1257|NCT03638635|2970|P2|STARTED|Follow-Up (30 Days After Discharge)||22
1258|NCT03638635|2971|P1|STARTED|Follow-Up (30 Days After Discharge)||39
1259|NCT03638635|2970|P2|NOT COMPLETED|Initial Hospitalization||2
1260|NCT03638635|2971|P1|NOT COMPLETED|Initial Hospitalization||0
1261|NCT03638635|2970|P2|COMPLETED|Initial Hospitalization||22
1262|NCT03638635|2971|P1|COMPLETED|Initial Hospitalization||39
1263|NCT03638635|2970|P2|STARTED|Initial Hospitalization||24
1264|NCT03638635|2971|P1|STARTED|Initial Hospitalization||39
1265|NCT03638323|3001|P1|NOT COMPLETED|Overall Study||1
1266|NCT03638323|3001|P1|COMPLETED|Overall Study||37
1267|NCT03638323|3001|P1|STARTED|Overall Study||38
1268|NCT03633825|3024|P2|NOT COMPLETED|Analysis||0
1269|NCT03633825|3025|P1|NOT COMPLETED|Analysis||0
1270|NCT03633825|3024|P2|COMPLETED|Analysis||325
1271|NCT03633825|3025|P1|COMPLETED|Analysis||327
1272|NCT03633825|3024|P2|STARTED|Analysis||325
1273|NCT03633825|3025|P1|STARTED|Analysis||327
1274|NCT03633825|3024|P2|NOT COMPLETED|Follow up||450
1275|NCT03633825|3025|P1|NOT COMPLETED|Follow up||478
1276|NCT03633825|3024|P2|COMPLETED|Follow up||325
1277|NCT03633825|3025|P1|COMPLETED|Follow up||327
1278|NCT03633825|3024|P2|STARTED|Follow up||775
1279|NCT03633825|3025|P1|STARTED|Follow up||805
1280|NCT03633825|3024|P2|NOT COMPLETED|Allocation||0
1281|NCT03633825|3025|P1|NOT COMPLETED|Allocation||0
1282|NCT03633825|3024|P2|COMPLETED|Allocation||775
1283|NCT03633825|3025|P1|COMPLETED|Allocation||805
1284|NCT03633825|3024|P2|STARTED|Allocation||775
1285|NCT03633825|3025|P1|STARTED|Allocation||805
1286|NCT03633825|3024|P2|NOT COMPLETED|Enrollment||18837
1287|NCT03633825|3025|P1|NOT COMPLETED|Enrollment||19033
1288|NCT03633825|3024|P2|COMPLETED|Enrollment||775
1289|NCT03633825|3025|P1|COMPLETED|Enrollment||805
1290|NCT03633825|3024|P2|STARTED|Enrollment||19612
1291|NCT03633825|3025|P1|STARTED|Enrollment||19838
1292|NCT03633487|3033|P1|NOT COMPLETED|Overall Study||0
1293|NCT03633487|3033|P1|COMPLETED|Overall Study||24
1294|NCT03633487|3033|P1|STARTED|Overall Study||24
1295|NCT03633448|3047|P2|NOT COMPLETED|Period 2 (1 Day)||0
1296|NCT03633448|3048|P1|NOT COMPLETED|Period 2 (1 Day)||0
1297|NCT03633448|3047|P2|COMPLETED|Period 2 (1 Day)||12
1298|NCT03633448|3048|P1|COMPLETED|Period 2 (1 Day)||12
1299|NCT03633448|3047|P2|STARTED|Period 2 (1 Day)||12
1300|NCT03633448|3048|P1|STARTED|Period 2 (1 Day)||12
1301|NCT03633448|3047|P2|NOT COMPLETED|Washout (7 Days)||0
1302|NCT03633448|3048|P1|NOT COMPLETED|Washout (7 Days)||0
1303|NCT03633448|3047|P2|COMPLETED|Washout (7 Days)||12
1304|NCT03633448|3048|P1|COMPLETED|Washout (7 Days)||12
1305|NCT03633448|3047|P2|STARTED|Washout (7 Days)||12
1306|NCT03633448|3048|P1|STARTED|Washout (7 Days)||12
1307|NCT03633448|3047|P2|NOT COMPLETED|Period 1 (1 Day)||0
1308|NCT03633448|3048|P1|NOT COMPLETED|Period 1 (1 Day)||0
1309|NCT03633448|3047|P2|COMPLETED|Period 1 (1 Day)||12
1310|NCT03633448|3048|P1|COMPLETED|Period 1 (1 Day)||12
1311|NCT03633448|3047|P2|STARTED|Period 1 (1 Day)||12
1312|NCT03633448|3048|P1|STARTED|Period 1 (1 Day)||12
1313|NCT03633344|3088|P2|NOT COMPLETED|Overall Study||0
1314|NCT03633344|3089|P1|NOT COMPLETED|Overall Study||0
1315|NCT03633344|3088|P2|COMPLETED|Overall Study||24
1316|NCT03633344|3089|P1|COMPLETED|Overall Study||120
1317|NCT03633344|3088|P2|STARTED|Overall Study||24
1318|NCT03633344|3089|P1|STARTED|Overall Study||120
1319|NCT03630016|3101|P1|NOT COMPLETED|Overall Study||1
1320|NCT03630016|3101|P1|COMPLETED|Overall Study||10
1321|NCT03630016|3101|P1|STARTED|Overall Study||11
1322|NCT03629041|3105|P4|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
1323|NCT03629041|3106|P3|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
1324|NCT03629041|3107|P2|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||1
1325|NCT03629041|3108|P1|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
1326|NCT03629041|3105|P4|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
1327|NCT03629041|3106|P3|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
1328|NCT03629041|3107|P2|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||3
1329|NCT03629041|3108|P1|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
1330|NCT03629041|3105|P4|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
1331|NCT03629041|3106|P3|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
1332|NCT03629041|3107|P2|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
1333|NCT03629041|3108|P1|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
1334|NCT03629041|3105|P4|NOT COMPLETED|Visit 1||0
1335|NCT03629041|3106|P3|NOT COMPLETED|Visit 1||0
1336|NCT03629041|3107|P2|NOT COMPLETED|Visit 1||0
1337|NCT03629041|3108|P1|NOT COMPLETED|Visit 1||0
1338|NCT03629041|3105|P4|COMPLETED|Visit 1||4
1339|NCT03629041|3106|P3|COMPLETED|Visit 1||4
1340|NCT03629041|3107|P2|COMPLETED|Visit 1||4
1341|NCT03629041|3108|P1|COMPLETED|Visit 1||4
1342|NCT03629041|3105|P4|STARTED|Visit 1||4
1343|NCT03629041|3106|P3|STARTED|Visit 1||4
1344|NCT03629041|3107|P2|STARTED|Visit 1||4
1345|NCT03629041|3108|P1|STARTED|Visit 1||4
1346|NCT03628885|3137|P3|NOT COMPLETED|Overall Study||60
1347|NCT03628885|3138|P2|NOT COMPLETED|Overall Study||47
1348|NCT03628885|3139|P1|NOT COMPLETED|Overall Study||39
1349|NCT03628885|3137|P3|COMPLETED|Overall Study||243
1350|NCT03628885|3138|P2|COMPLETED|Overall Study||252
1351|NCT03628885|3139|P1|COMPLETED|Overall Study||267
1352|NCT03628885|3137|P3|STARTED|Overall Study||303
1353|NCT03628885|3138|P2|STARTED|Overall Study||299
1354|NCT03628885|3139|P1|STARTED|Overall Study||306
1355|NCT03628599|3149|P2|NOT COMPLETED|Overall Study||1
1356|NCT03628599|3150|P1|NOT COMPLETED|Overall Study||0
1357|NCT03628599|3149|P2|COMPLETED|Overall Study||18
1358|NCT03628599|3150|P1|COMPLETED|Overall Study||18
1359|NCT03628599|3149|P2|STARTED|Overall Study||19
1360|NCT03628599|3150|P1|STARTED|Overall Study||18
1361|NCT03628456|3160|P1|NOT COMPLETED|Overall Study||0
1362|NCT03628456|3160|P1|COMPLETED|Overall Study||10
1363|NCT03628456|3160|P1|STARTED|Overall Study||10
1364|NCT03626714|3180|P1|NOT COMPLETED|Overall Study||0
1365|NCT03626714|3180|P1|COMPLETED|Overall Study||8
1366|NCT03626714|3180|P1|STARTED|Overall Study||8
1367|NCT03623035|3189|P1|NOT COMPLETED|Overall Study||0
1368|NCT03623035|3189|P1|COMPLETED|Overall Study||10
1369|NCT03623035|3189|P1|STARTED|Overall Study||10
1370|NCT03621878|3198|P3|NOT COMPLETED|Overall Study||0
1371|NCT03621878|3199|P2|NOT COMPLETED|Overall Study||0
1372|NCT03621878|3200|P1|NOT COMPLETED|Overall Study||0
1373|NCT03621878|3198|P3|COMPLETED|Overall Study||17
1374|NCT03621878|3199|P2|COMPLETED|Overall Study||17
1375|NCT03621878|3200|P1|COMPLETED|Overall Study||17
1376|NCT03621878|3198|P3|STARTED|Overall Study||17
1377|NCT03621878|3199|P2|STARTED|Overall Study||17
1378|NCT03621878|3200|P1|STARTED|Overall Study||17
1379|NCT03620708|3223|P3|NOT COMPLETED|Overall Study||3
1380|NCT03620708|3224|P2|NOT COMPLETED|Overall Study||1
1381|NCT03620708|3225|P1|NOT COMPLETED|Overall Study||1
1382|NCT03620708|3223|P3|COMPLETED|Overall Study||17
1383|NCT03620708|3224|P2|COMPLETED|Overall Study||18
1384|NCT03620708|3225|P1|COMPLETED|Overall Study||18
1385|NCT03620708|3223|P3|STARTED|Overall Study||20
1386|NCT03620708|3224|P2|STARTED|Overall Study||19
1387|NCT03620708|3225|P1|STARTED|Overall Study||19
1388|NCT03620383|3247|P2|NOT COMPLETED|Overall Study||0
1389|NCT03620383|3248|P1|NOT COMPLETED|Overall Study||0
1390|NCT03620383|3247|P2|COMPLETED|Overall Study||15
1391|NCT03620383|3248|P1|COMPLETED|Overall Study||30
1392|NCT03620383|3247|P2|STARTED|Overall Study||15
1393|NCT03620383|3248|P1|STARTED|Overall Study||30
1394|NCT03619889|3256|P2|NOT COMPLETED|Overall Study||0
1395|NCT03619889|3257|P1|NOT COMPLETED|Overall Study||2
1396|NCT03619889|3256|P2|COMPLETED|Overall Study||37
1397|NCT03619889|3257|P1|COMPLETED|Overall Study||35
1398|NCT03619889|3256|P2|STARTED|Overall Study||37
1399|NCT03619889|3257|P1|STARTED|Overall Study||37
1400|NCT03619590|3287|P1|NOT COMPLETED|Overall Study||0
1401|NCT03619590|3287|P1|COMPLETED|Overall Study||103
1402|NCT03619590|3287|P1|STARTED|Overall Study||103
1403|NCT03619135|3297|P2|NOT COMPLETED|Overall Study||0
1404|NCT03619135|3298|P1|NOT COMPLETED|Overall Study||0
1405|NCT03619135|3297|P2|COMPLETED|Overall Study||50
1406|NCT03619135|3298|P1|COMPLETED|Overall Study||50
1407|NCT03619135|3297|P2|STARTED|Overall Study||50
1408|NCT03619135|3298|P1|STARTED|Overall Study||50
1409|NCT03618628|3306|P1|NOT COMPLETED|Overall Study||2
1410|NCT03618628|3306|P1|COMPLETED|Overall Study||1
1411|NCT03618628|3306|P1|STARTED|Overall Study||3
1412|NCT03618147|3310|P1|NOT COMPLETED|Overall Study||0
1413|NCT03618147|3310|P1|COMPLETED|Overall Study||314
1414|NCT03618147|3310|P1|STARTED|Overall Study||314
1415|NCT03617523|3320|P5|NOT COMPLETED|Overall Study||0
1416|NCT03617523|3321|P4|NOT COMPLETED|Overall Study||0
1417|NCT03617523|3322|P3|NOT COMPLETED|Overall Study||0
1418|NCT03617523|3323|P2|NOT COMPLETED|Overall Study||0
1419|NCT03617523|3324|P1|NOT COMPLETED|Overall Study||0
1420|NCT03617523|3320|P5|COMPLETED|Overall Study||60
1421|NCT03617523|3321|P4|COMPLETED|Overall Study||59
1422|NCT03617523|3322|P3|COMPLETED|Overall Study||61
1423|NCT03617523|3323|P2|COMPLETED|Overall Study||30
1424|NCT03617523|3324|P1|COMPLETED|Overall Study||30
1425|NCT03617523|3320|P5|STARTED|Overall Study||60
1426|NCT03617523|3321|P4|STARTED|Overall Study||59
1427|NCT03617523|3322|P3|STARTED|Overall Study||61
1428|NCT03617523|3323|P2|STARTED|Overall Study||30
1429|NCT03617523|3324|P1|STARTED|Overall Study||30
1430|NCT03617419|3356|P1|NOT COMPLETED|Part 2||0
1431|NCT03617419|3356|P1|COMPLETED|Part 2||14
1432|NCT03617419|3356|P1|STARTED|Part 2||14
1433|NCT03617419|3356|P1|NOT COMPLETED|Part 1||0
1434|NCT03617419|3356|P1|COMPLETED|Part 1||2
1435|NCT03617419|3356|P1|STARTED|Part 1||2
1436|NCT03615534|3368|P4|NOT COMPLETED|Overall Study||1
1437|NCT03615534|3369|P3|NOT COMPLETED|Overall Study||0
1438|NCT03615534|3370|P2|NOT COMPLETED|Overall Study||0
1439|NCT03615534|3371|P1|NOT COMPLETED|Overall Study||2
1440|NCT03615534|3368|P4|COMPLETED|Overall Study||13
1441|NCT03615534|3369|P3|COMPLETED|Overall Study||14
1442|NCT03615534|3370|P2|COMPLETED|Overall Study||15
1443|NCT03615534|3371|P1|COMPLETED|Overall Study||12
1444|NCT03615534|3368|P4|STARTED|Overall Study||14
1445|NCT03615534|3369|P3|STARTED|Overall Study||14
1446|NCT03615534|3370|P2|STARTED|Overall Study||15
1447|NCT03615534|3371|P1|STARTED|Overall Study||14
1448|NCT03614975|3415|P2|NOT COMPLETED|Overall Study||8
1449|NCT03614975|3416|P1|NOT COMPLETED|Overall Study||10
1450|NCT03614975|3415|P2|COMPLETED|Overall Study||73
1451|NCT03614975|3416|P1|COMPLETED|Overall Study||75
1452|NCT03614975|3415|P2|STARTED|Overall Study||81
1453|NCT03614975|3416|P1|STARTED|Overall Study||85
1454|NCT03613493|3430|P4|NOT COMPLETED|Overall Study||7
1455|NCT03613493|3431|P3|NOT COMPLETED|Overall Study||0
1456|NCT03613493|3432|P2|NOT COMPLETED|Overall Study||2
1457|NCT03613493|3433|P1|NOT COMPLETED|Overall Study||0
1458|NCT03613493|3430|P4|COMPLETED|Overall Study||83
1459|NCT03613493|3431|P3|COMPLETED|Overall Study||0
1460|NCT03613493|3432|P2|COMPLETED|Overall Study||73
1461|NCT03613493|3433|P1|COMPLETED|Overall Study||10
1462|NCT03613493|3430|P4|Enrollment Criteria Met|Overall Study||89
1463|NCT03613493|3431|P3|Enrollment Criteria Met|Overall Study||0
1464|NCT03613493|3432|P2|Enrollment Criteria Met|Overall Study||74
1465|NCT03613493|3433|P1|Enrollment Criteria Met|Overall Study||10
1466|NCT03613493|3430|P4|STARTED|Overall Study||90
1467|NCT03613493|3431|P3|STARTED|Overall Study||0
1468|NCT03613493|3432|P2|STARTED|Overall Study||75
1469|NCT03613493|3433|P1|STARTED|Overall Study||10
1470|NCT03611829|3444|P2|NOT COMPLETED|Overall Study||25
1471|NCT03611829|3445|P1|NOT COMPLETED|Overall Study||22
1472|NCT03611829|3444|P2|COMPLETED|Overall Study||19
1473|NCT03611829|3445|P1|COMPLETED|Overall Study||21
1474|NCT03611829|3444|P2|STARTED|Overall Study||44
1475|NCT03611829|3445|P1|STARTED|Overall Study||43
1476|NCT03610633|3478|P2|NOT COMPLETED|Overall Study||1
1477|NCT03610633|3479|P1|NOT COMPLETED|Overall Study||0
1478|NCT03610633|3478|P2|COMPLETED|Overall Study||5
1479|NCT03610633|3479|P1|COMPLETED|Overall Study||5
1480|NCT03610633|3478|P2|STARTED|Overall Study||6
1481|NCT03610633|3479|P1|STARTED|Overall Study||5
1482|NCT03610464|3485|P1|NOT COMPLETED|Overall Study||0
1483|NCT03610464|3485|P1|COMPLETED|Overall Study||5
1484|NCT03610464|3485|P1|STARTED|Overall Study||5
1485|NCT03610269|3490|P1|NOT COMPLETED|Overall Study||16
1486|NCT03610269|3490|P1|COMPLETED|Overall Study||127
1487|NCT03610269|3490|P1|STARTED|Overall Study||143
1488|NCT03609619|3496|P2|NOT COMPLETED|Overall Study||6
1489|NCT03609619|3497|P1|NOT COMPLETED|Overall Study||10
1490|NCT03609619|3496|P2|COMPLETED|Overall Study||49
1491|NCT03609619|3497|P1|COMPLETED|Overall Study||44
1492|NCT03609619|3496|P2|STARTED|Overall Study||55
1493|NCT03609619|3497|P1|STARTED|Overall Study||54
1494|NCT03608839|3508|P3|NOT COMPLETED|Overall Study||0
1495|NCT03608839|3509|P2|NOT COMPLETED|Overall Study||0
1496|NCT03608839|3510|P1|NOT COMPLETED|Overall Study||0
1497|NCT03608839|3508|P3|COMPLETED|Overall Study||9
1498|NCT03608839|3509|P2|COMPLETED|Overall Study||9
1499|NCT03608839|3510|P1|COMPLETED|Overall Study||9
1500|NCT03608839|3508|P3|STARTED|Overall Study||9
1501|NCT03608839|3509|P2|STARTED|Overall Study||9
1502|NCT03608839|3510|P1|STARTED|Overall Study||9
1503|NCT03605303|3533|P2|NOT COMPLETED|Period 2||0
1504|NCT03605303|3534|P1|NOT COMPLETED|Period 2||0
1505|NCT03605303|3533|P2|COMPLETED|Period 2||0
1506|NCT03605303|3534|P1|COMPLETED|Period 2||0
1507|NCT03605303|3533|P2|STARTED|Period 2||0
1508|NCT03605303|3534|P1|STARTED|Period 2||0
1509|NCT03605303|3533|P2|NOT COMPLETED|Period 1||1
1510|NCT03605303|3534|P1|NOT COMPLETED|Period 1||2
1511|NCT03605303|3533|P2|COMPLETED|Period 1||0
1512|NCT03605303|3534|P1|COMPLETED|Period 1||0
1513|NCT03605303|3533|P2|STARTED|Period 1||1
1514|NCT03605303|3534|P1|STARTED|Period 1||2
1515|NCT03603106|3553|P11|NOT COMPLETED|Overall Study||0
1516|NCT03603106|3554|P10|NOT COMPLETED|Overall Study||0
1517|NCT03603106|3555|P9|NOT COMPLETED|Overall Study||0
1518|NCT03603106|3556|P8|NOT COMPLETED|Overall Study||0
1519|NCT03603106|3557|P7|NOT COMPLETED|Overall Study||0
1520|NCT03603106|3558|P6|NOT COMPLETED|Overall Study||0
1521|NCT03603106|3559|P5|NOT COMPLETED|Overall Study||0
1522|NCT03603106|3560|P4|NOT COMPLETED|Overall Study||0
1523|NCT03603106|3561|P3|NOT COMPLETED|Overall Study||0
1524|NCT03603106|3562|P2|NOT COMPLETED|Overall Study||0
1525|NCT03603106|3563|P1|NOT COMPLETED|Overall Study||0
1526|NCT03603106|3553|P11|COMPLETED|Overall Study||3
1527|NCT03603106|3554|P10|COMPLETED|Overall Study||3
1528|NCT03603106|3555|P9|COMPLETED|Overall Study||3
1529|NCT03603106|3556|P8|COMPLETED|Overall Study||3
1530|NCT03603106|3557|P7|COMPLETED|Overall Study||18
1531|NCT03603106|3558|P6|COMPLETED|Overall Study||6
1532|NCT03603106|3559|P5|COMPLETED|Overall Study||6
1533|NCT03603106|3560|P4|COMPLETED|Overall Study||6
1534|NCT03603106|3561|P3|COMPLETED|Overall Study||6
1535|NCT03603106|3562|P2|COMPLETED|Overall Study||6
1536|NCT03603106|3563|P1|COMPLETED|Overall Study||6
1537|NCT03603106|3553|P11|STARTED|Overall Study||3
1538|NCT03603106|3554|P10|STARTED|Overall Study||3
1539|NCT03603106|3555|P9|STARTED|Overall Study||3
1540|NCT03603106|3556|P8|STARTED|Overall Study||3
1541|NCT03603106|3557|P7|STARTED|Overall Study||18
1542|NCT03603106|3558|P6|STARTED|Overall Study||6
1543|NCT03603106|3559|P5|STARTED|Overall Study||6
1544|NCT03603106|3560|P4|STARTED|Overall Study||6
1545|NCT03603106|3561|P3|STARTED|Overall Study||6
1546|NCT03603106|3562|P2|STARTED|Overall Study||6
1547|NCT03603106|3563|P1|STARTED|Overall Study||6
1548|NCT03599349|3616|P1|NOT COMPLETED|Overall Study||1
1549|NCT03599349|3616|P1|COMPLETED|Overall Study||19
1550|NCT03599349|3616|P1|Treated|Overall Study||20
1551|NCT03599349|3616|P1|STARTED|Overall Study||20
1552|NCT03597178|3628|P1|NOT COMPLETED|Overall Study||0
1553|NCT03597178|3628|P1|COMPLETED|Overall Study||14
1554|NCT03597178|3628|P1|STARTED|Overall Study||14
1555|NCT03591458|3634|P2|NOT COMPLETED|Overall Study||0
1556|NCT03591458|3635|P1|NOT COMPLETED|Overall Study||0
1557|NCT03591458|3634|P2|COMPLETED|Overall Study||1
1558|NCT03591458|3635|P1|COMPLETED|Overall Study||1
1559|NCT03591458|3634|P2|STARTED|Overall Study||1
1560|NCT03591458|3635|P1|STARTED|Overall Study||1
1561|NCT03590613|3663|P4|NOT COMPLETED|Period 4, 4 Days||0
1562|NCT03590613|3664|P3|NOT COMPLETED|Period 4, 4 Days||0
1563|NCT03590613|3665|P2|NOT COMPLETED|Period 4, 4 Days||0
1564|NCT03590613|3666|P1|NOT COMPLETED|Period 4, 4 Days||0
1565|NCT03590613|3663|P4|COMPLETED|Period 4, 4 Days||3
1566|NCT03590613|3664|P3|COMPLETED|Period 4, 4 Days||3
1567|NCT03590613|3665|P2|COMPLETED|Period 4, 4 Days||3
1568|NCT03590613|3666|P1|COMPLETED|Period 4, 4 Days||3
1569|NCT03590613|3663|P4|STARTED|Period 4, 4 Days||3
1570|NCT03590613|3664|P3|STARTED|Period 4, 4 Days||3
1571|NCT03590613|3665|P2|STARTED|Period 4, 4 Days||3
1572|NCT03590613|3666|P1|STARTED|Period 4, 4 Days||3
1573|NCT03590613|3663|P4|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
1574|NCT03590613|3664|P3|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
1575|NCT03590613|3665|P2|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
1576|NCT03590613|3666|P1|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
1577|NCT03590613|3663|P4|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
1578|NCT03590613|3664|P3|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
1579|NCT03590613|3665|P2|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
1580|NCT03590613|3666|P1|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
1581|NCT03590613|3663|P4|STARTED|Period 3,Wash-out, at Least 3 Days||3
1582|NCT03590613|3664|P3|STARTED|Period 3,Wash-out, at Least 3 Days||3
1583|NCT03590613|3665|P2|STARTED|Period 3,Wash-out, at Least 3 Days||3
1584|NCT03590613|3666|P1|STARTED|Period 3,Wash-out, at Least 3 Days||3
1585|NCT03590613|3663|P4|NOT COMPLETED|Period 3, 4 Days||0
1586|NCT03590613|3664|P3|NOT COMPLETED|Period 3, 4 Days||0
1587|NCT03590613|3665|P2|NOT COMPLETED|Period 3, 4 Days||0
1588|NCT03590613|3666|P1|NOT COMPLETED|Period 3, 4 Days||0
1589|NCT03590613|3663|P4|COMPLETED|Period 3, 4 Days||3
1590|NCT03590613|3664|P3|COMPLETED|Period 3, 4 Days||3
1591|NCT03590613|3665|P2|COMPLETED|Period 3, 4 Days||3
1592|NCT03590613|3666|P1|COMPLETED|Period 3, 4 Days||3
1593|NCT03590613|3663|P4|STARTED|Period 3, 4 Days||3
1594|NCT03590613|3664|P3|STARTED|Period 3, 4 Days||3
1595|NCT03590613|3665|P2|STARTED|Period 3, 4 Days||3
1596|NCT03590613|3666|P1|STARTED|Period 3, 4 Days||3
1597|NCT03590613|3663|P4|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
1598|NCT03590613|3664|P3|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
1599|NCT03590613|3665|P2|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
1600|NCT03590613|3666|P1|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
1601|NCT03590613|3663|P4|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
1602|NCT03590613|3664|P3|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
1603|NCT03590613|3665|P2|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
1604|NCT03590613|3666|P1|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
1605|NCT03590613|3663|P4|STARTED|Period 2, Wash-out, at Least 3 Days||3
1606|NCT03590613|3664|P3|STARTED|Period 2, Wash-out, at Least 3 Days||3
1607|NCT03590613|3665|P2|STARTED|Period 2, Wash-out, at Least 3 Days||3
1608|NCT03590613|3666|P1|STARTED|Period 2, Wash-out, at Least 3 Days||3
1609|NCT03590613|3663|P4|NOT COMPLETED|Period 2, 4 Days||1
1610|NCT03590613|3664|P3|NOT COMPLETED|Period 2, 4 Days||0
1611|NCT03590613|3665|P2|NOT COMPLETED|Period 2, 4 Days||0
1612|NCT03590613|3666|P1|NOT COMPLETED|Period 2, 4 Days||0
1613|NCT03590613|3663|P4|COMPLETED|Period 2, 4 Days||3
1614|NCT03590613|3664|P3|COMPLETED|Period 2, 4 Days||3
1615|NCT03590613|3665|P2|COMPLETED|Period 2, 4 Days||3
1616|NCT03590613|3666|P1|COMPLETED|Period 2, 4 Days||3
1617|NCT03590613|3663|P4|STARTED|Period 2, 4 Days|One additional participant was enrolled in Period 2.|4
1618|NCT03590613|3664|P3|STARTED|Period 2, 4 Days||3
1619|NCT03590613|3665|P2|STARTED|Period 2, 4 Days||3
1620|NCT03590613|3666|P1|STARTED|Period 2, 4 Days||3
1621|NCT03590613|3663|P4|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
1622|NCT03590613|3664|P3|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
1623|NCT03590613|3665|P2|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
1624|NCT03590613|3666|P1|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
1625|NCT03590613|3663|P4|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
1626|NCT03590613|3664|P3|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
1627|NCT03590613|3665|P2|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
1628|NCT03590613|3666|P1|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
1629|NCT03590613|3663|P4|STARTED|Period 1, Wash-out, at Least 3 Days||3
1630|NCT03590613|3664|P3|STARTED|Period 1, Wash-out, at Least 3 Days||3
1631|NCT03590613|3665|P2|STARTED|Period 1, Wash-out, at Least 3 Days||3
1632|NCT03590613|3666|P1|STARTED|Period 1, Wash-out, at Least 3 Days||3
1633|NCT03590613|3663|P4|NOT COMPLETED|Period 1, 4 Days||0
1634|NCT03590613|3664|P3|NOT COMPLETED|Period 1, 4 Days||0
1635|NCT03590613|3665|P2|NOT COMPLETED|Period 1, 4 Days||0
1636|NCT03590613|3666|P1|NOT COMPLETED|Period 1, 4 Days||0
1637|NCT03590613|3663|P4|COMPLETED|Period 1, 4 Days||3
1638|NCT03590613|3664|P3|COMPLETED|Period 1, 4 Days||3
1639|NCT03590613|3665|P2|COMPLETED|Period 1, 4 Days||3
1640|NCT03590613|3666|P1|COMPLETED|Period 1, 4 Days||3
1641|NCT03590613|3663|P4|STARTED|Period 1, 4 Days||3
1642|NCT03590613|3664|P3|STARTED|Period 1, 4 Days||3
1643|NCT03590613|3665|P2|STARTED|Period 1, 4 Days||3
1644|NCT03590613|3666|P1|STARTED|Period 1, 4 Days||3
1645|NCT03588572|3786|P2|NOT COMPLETED|Visitation 3||2
1646|NCT03588572|3787|P1|NOT COMPLETED|Visitation 3||3
1647|NCT03588572|3786|P2|COMPLETED|Visitation 3||16
1648|NCT03588572|3787|P1|COMPLETED|Visitation 3||16
1649|NCT03588572|3786|P2|STARTED|Visitation 3||18
1650|NCT03588572|3787|P1|STARTED|Visitation 3||19
1651|NCT03588572|3786|P2|NOT COMPLETED|Visitation 2||2
1652|NCT03588572|3787|P1|NOT COMPLETED|Visitation 2||2
1653|NCT03588572|3786|P2|COMPLETED|Visitation 2||18
1654|NCT03588572|3787|P1|COMPLETED|Visitation 2||19
1655|NCT03588572|3786|P2|STARTED|Visitation 2||20
1656|NCT03588572|3787|P1|STARTED|Visitation 2||21
1657|NCT03588572|3786|P2|NOT COMPLETED|Visitation 1||1
1658|NCT03588572|3787|P1|NOT COMPLETED|Visitation 1||1
1659|NCT03588572|3786|P2|COMPLETED|Visitation 1||20
1660|NCT03588572|3787|P1|COMPLETED|Visitation 1||21
1661|NCT03588572|3786|P2|STARTED|Visitation 1||21
1662|NCT03588572|3787|P1|STARTED|Visitation 1||22
1663|NCT03587428|3803|P6|NOT COMPLETED|Period 3||0
1664|NCT03587428|3804|P5|NOT COMPLETED|Period 3||0
1665|NCT03587428|3805|P4|NOT COMPLETED|Period 3||0
1666|NCT03587428|3806|P3|NOT COMPLETED|Period 3||0
1667|NCT03587428|3807|P2|NOT COMPLETED|Period 3||0
1668|NCT03587428|3808|P1|NOT COMPLETED|Period 3||0
1669|NCT03587428|3803|P6|COMPLETED|Period 3||2
1670|NCT03587428|3804|P5|COMPLETED|Period 3||2
1671|NCT03587428|3805|P4|COMPLETED|Period 3||3
1672|NCT03587428|3806|P3|COMPLETED|Period 3||3
1673|NCT03587428|3807|P2|COMPLETED|Period 3||2
1674|NCT03587428|3808|P1|COMPLETED|Period 3||3
1675|NCT03587428|3803|P6|STARTED|Period 3||2
1676|NCT03587428|3804|P5|STARTED|Period 3||2
1677|NCT03587428|3805|P4|STARTED|Period 3||3
1678|NCT03587428|3806|P3|STARTED|Period 3||3
1679|NCT03587428|3807|P2|STARTED|Period 3||2
1680|NCT03587428|3808|P1|STARTED|Period 3||3
1681|NCT03587428|3803|P6|NOT COMPLETED|Period 2||0
1682|NCT03587428|3804|P5|NOT COMPLETED|Period 2||0
1683|NCT03587428|3805|P4|NOT COMPLETED|Period 2||0
1684|NCT03587428|3806|P3|NOT COMPLETED|Period 2||0
1685|NCT03587428|3807|P2|NOT COMPLETED|Period 2||0
1686|NCT03587428|3808|P1|NOT COMPLETED|Period 2||0
1687|NCT03587428|3803|P6|COMPLETED|Period 2||2
1688|NCT03587428|3804|P5|COMPLETED|Period 2||2
1689|NCT03587428|3805|P4|COMPLETED|Period 2||3
1690|NCT03587428|3806|P3|COMPLETED|Period 2||3
1691|NCT03587428|3807|P2|COMPLETED|Period 2||2
1692|NCT03587428|3808|P1|COMPLETED|Period 2||3
1693|NCT03587428|3803|P6|STARTED|Period 2||2
1694|NCT03587428|3804|P5|STARTED|Period 2||2
1695|NCT03587428|3805|P4|STARTED|Period 2||3
1696|NCT03587428|3806|P3|STARTED|Period 2||3
1697|NCT03587428|3807|P2|STARTED|Period 2||2
1698|NCT03587428|3808|P1|STARTED|Period 2||3
1699|NCT03587428|3803|P6|NOT COMPLETED|Period 1||0
1700|NCT03587428|3804|P5|NOT COMPLETED|Period 1||0
1701|NCT03587428|3805|P4|NOT COMPLETED|Period 1||0
1702|NCT03587428|3806|P3|NOT COMPLETED|Period 1||0
1703|NCT03587428|3807|P2|NOT COMPLETED|Period 1||0
1704|NCT03587428|3808|P1|NOT COMPLETED|Period 1||0
1705|NCT03587428|3803|P6|COMPLETED|Period 1||2
1706|NCT03587428|3804|P5|COMPLETED|Period 1||2
1707|NCT03587428|3805|P4|COMPLETED|Period 1||3
1708|NCT03587428|3806|P3|COMPLETED|Period 1||3
1709|NCT03587428|3807|P2|COMPLETED|Period 1||2
1710|NCT03587428|3808|P1|COMPLETED|Period 1||3
1711|NCT03587428|3803|P6|STARTED|Period 1||2
1712|NCT03587428|3804|P5|STARTED|Period 1||2
1713|NCT03587428|3805|P4|STARTED|Period 1||3
1714|NCT03587428|3806|P3|STARTED|Period 1||3
1715|NCT03587428|3807|P2|STARTED|Period 1||2
1716|NCT03587428|3808|P1|STARTED|Period 1||3
1717|NCT03586726|3825|P1|NOT COMPLETED|Overall Study||1
1718|NCT03586726|3825|P1|COMPLETED|Overall Study||15
1719|NCT03586726|3825|P1|STARTED|Overall Study||16
1720|NCT03585504|3844|P2|NOT COMPLETED|Overall Study||29
1721|NCT03585504|3845|P1|NOT COMPLETED|Overall Study||26
1722|NCT03585504|3844|P2|COMPLETED|Overall Study||11
1723|NCT03585504|3845|P1|COMPLETED|Overall Study||15
1724|NCT03585504|3844|P2|STARTED|Overall Study||40
1725|NCT03585504|3845|P1|STARTED|Overall Study||41
1726|NCT03583385|3855|P2|NOT COMPLETED|Treatment Period 2||0
1727|NCT03583385|3856|P1|NOT COMPLETED|Treatment Period 2||1
1728|NCT03583385|3855|P2|COMPLETED|Treatment Period 2||23
1729|NCT03583385|3856|P1|COMPLETED|Treatment Period 2||21
1730|NCT03583385|3855|P2|STARTED|Treatment Period 2||23
1731|NCT03583385|3856|P1|STARTED|Treatment Period 2|Of 46 participants who completed period 1, 45 entered period2 & 1 participant didn’t attend period2.|22
1732|NCT03583385|3855|P2|NOT COMPLETED|Treatment Period 1||1
1733|NCT03583385|3856|P1|NOT COMPLETED|Treatment Period 1||1
1734|NCT03583385|3855|P2|COMPLETED|Treatment Period 1||23
1735|NCT03583385|3856|P1|COMPLETED|Treatment Period 1||23
1736|NCT03583385|3855|P2|STARTED|Treatment Period 1||24
1737|NCT03583385|3856|P1|STARTED|Treatment Period 1||24
1738|NCT03582943|3874|P2|NOT COMPLETED|Analyzed||1
1739|NCT03582943|3875|P1|NOT COMPLETED|Analyzed||4
1740|NCT03582943|3874|P2|COMPLETED|Analyzed||36
1741|NCT03582943|3875|P1|COMPLETED|Analyzed||33
1742|NCT03582943|3874|P2|STARTED|Analyzed||37
1743|NCT03582943|3875|P1|STARTED|Analyzed||37
1744|NCT03582943|3874|P2|NOT COMPLETED|Intervention and Follow up||2
1745|NCT03582943|3875|P1|NOT COMPLETED|Intervention and Follow up||4
1746|NCT03582943|3874|P2|COMPLETED|Intervention and Follow up||37
1747|NCT03582943|3875|P1|COMPLETED|Intervention and Follow up||37
1748|NCT03582943|3874|P2|STARTED|Intervention and Follow up||39
1749|NCT03582943|3875|P1|STARTED|Intervention and Follow up||41
1750|NCT03582943|3874|P2|NOT COMPLETED|Allocated to Groups||1
1751|NCT03582943|3875|P1|NOT COMPLETED|Allocated to Groups||1
1752|NCT03582943|3874|P2|COMPLETED|Allocated to Groups||39
1753|NCT03582943|3875|P1|COMPLETED|Allocated to Groups||41
1754|NCT03582943|3874|P2|STARTED|Allocated to Groups||40
1755|NCT03582943|3875|P1|STARTED|Allocated to Groups||42
1756|NCT03581097|3883|P2|NOT COMPLETED|Overall Study||0
1757|NCT03581097|3884|P1|NOT COMPLETED|Overall Study||0
1758|NCT03581097|3883|P2|COMPLETED|Overall Study||47
1759|NCT03581097|3884|P1|COMPLETED|Overall Study||46
1760|NCT03581097|3883|P2|STARTED|Overall Study||47
1761|NCT03581097|3884|P1|STARTED|Overall Study||46
1872|NCT03579719|3965|P1|NOT COMPLETED|Overall Study||1
1873|NCT03579719|3965|P1|COMPLETED|Overall Study||14
1874|NCT03579719|3965|P1|STARTED|Overall Study||15
1875|NCT03578146|3988|P6|NOT COMPLETED|Overall Study||3
1876|NCT03578146|3989|P5|NOT COMPLETED|Overall Study||0
1877|NCT03578146|3990|P4|NOT COMPLETED|Overall Study||0
1878|NCT03578146|3991|P3|NOT COMPLETED|Overall Study||1
1879|NCT03578146|3992|P2|NOT COMPLETED|Overall Study||1
1880|NCT03578146|3993|P1|NOT COMPLETED|Overall Study||1
1881|NCT03578146|3988|P6|COMPLETED|Overall Study||5
1882|NCT03578146|3989|P5|COMPLETED|Overall Study||6
1883|NCT03578146|3990|P4|COMPLETED|Overall Study||6
1884|NCT03578146|3991|P3|COMPLETED|Overall Study||5
1885|NCT03578146|3992|P2|COMPLETED|Overall Study||5
1886|NCT03578146|3993|P1|COMPLETED|Overall Study||15
1887|NCT03578146|3988|P6|STARTED|Overall Study||8
1888|NCT03578146|3989|P5|STARTED|Overall Study||6
1889|NCT03578146|3990|P4|STARTED|Overall Study||6
1890|NCT03578146|3991|P3|STARTED|Overall Study||6
1891|NCT03578146|3992|P2|STARTED|Overall Study||6
1892|NCT03578146|3993|P1|STARTED|Overall Study||16
1893|NCT03577275|4055|P1|NOT COMPLETED|Overall Study||0
1894|NCT03577275|4055|P1|COMPLETED|Overall Study||32
1895|NCT03577275|4055|P1|NST-4016 2000mg|Overall Study||32
1896|NCT03577275|4055|P1|NST-4016 600mg|Overall Study||32
1897|NCT03577275|4055|P1|Moxifloxacin 400mg|Overall Study||32
1898|NCT03577275|4055|P1|Placebo|Overall Study||32
1899|NCT03577275|4055|P1|STARTED|Overall Study|All participants received all of the 4 interventions|32
1900|NCT03575962|4081|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1901|NCT03575962|4082|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
1902|NCT03575962|4081|P2|COMPLETED|Treatment Period 2 (4 Days)||7
1903|NCT03575962|4082|P1|COMPLETED|Treatment Period 2 (4 Days)||7
1904|NCT03575962|4081|P2|STARTED|Treatment Period 2 (4 Days)||7
1905|NCT03575962|4082|P1|STARTED|Treatment Period 2 (4 Days)||7
1906|NCT03575962|4081|P2|NOT COMPLETED|Washout Period (7 Days)||0
1907|NCT03575962|4082|P1|NOT COMPLETED|Washout Period (7 Days)||0
1908|NCT03575962|4081|P2|COMPLETED|Washout Period (7 Days)||7
1909|NCT03575962|4082|P1|COMPLETED|Washout Period (7 Days)||7
1910|NCT03575962|4081|P2|STARTED|Washout Period (7 Days)||7
1911|NCT03575962|4082|P1|STARTED|Washout Period (7 Days)||7
1912|NCT03575962|4081|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
1913|NCT03575962|4082|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
1914|NCT03575962|4081|P2|COMPLETED|Treatment Period 1 (4 Days)||7
1915|NCT03575962|4082|P1|COMPLETED|Treatment Period 1 (4 Days)||7
1916|NCT03575962|4081|P2|STARTED|Treatment Period 1 (4 Days)||7
1917|NCT03575962|4082|P1|STARTED|Treatment Period 1 (4 Days)||7
1918|NCT03575702|4124|P2|NOT COMPLETED|Overall Study||4
1919|NCT03575702|4125|P1|NOT COMPLETED|Overall Study||6
1920|NCT03575702|4124|P2|COMPLETED|Overall Study||146
1921|NCT03575702|4125|P1|COMPLETED|Overall Study||143
1922|NCT03575702|4124|P2|STARTED|Overall Study||150
1923|NCT03575702|4125|P1|STARTED|Overall Study||149
1924|NCT03574441|4162|P3|NOT COMPLETED|Overall Study||0
1925|NCT03574441|4163|P2|NOT COMPLETED|Overall Study||0
1926|NCT03574441|4164|P1|NOT COMPLETED|Overall Study||0
1927|NCT03574441|4162|P3|COMPLETED|Overall Study||30
1928|NCT03574441|4163|P2|COMPLETED|Overall Study||30
1929|NCT03574441|4164|P1|COMPLETED|Overall Study||31
1930|NCT03574441|4162|P3|STARTED|Overall Study||30
1931|NCT03574441|4163|P2|STARTED|Overall Study||30
1932|NCT03574441|4164|P1|STARTED|Overall Study||31
1933|NCT03570047|4180|P5|NOT COMPLETED|Overall Study||0
1934|NCT03570047|4181|P4|NOT COMPLETED|Overall Study||0
1935|NCT03570047|4182|P3|NOT COMPLETED|Overall Study||0
1936|NCT03570047|4183|P2|NOT COMPLETED|Overall Study||0
1937|NCT03570047|4184|P1|NOT COMPLETED|Overall Study||0
1938|NCT03570047|4180|P5|COMPLETED|Overall Study||12262
1939|NCT03570047|4181|P4|COMPLETED|Overall Study||16564
1940|NCT03570047|4182|P3|COMPLETED|Overall Study||6925
1941|NCT03570047|4183|P2|COMPLETED|Overall Study||22336
1942|NCT03570047|4184|P1|COMPLETED|Overall Study||15902
1943|NCT03570047|4180|P5|STARTED|Overall Study||12262
1944|NCT03570047|4181|P4|STARTED|Overall Study||16564
1945|NCT03570047|4182|P3|STARTED|Overall Study||6925
1946|NCT03570047|4183|P2|STARTED|Overall Study||22336
1947|NCT03570047|4184|P1|STARTED|Overall Study||15902
1948|NCT03567005|4241|P2|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
1949|NCT03567005|4242|P1|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
1950|NCT03567005|4241|P2|COMPLETED|Period 2, Second 7 Days of Wear||31
1951|NCT03567005|4242|P1|COMPLETED|Period 2, Second 7 Days of Wear||29
1952|NCT03567005|4241|P2|STARTED|Period 2, Second 7 Days of Wear||31
1953|NCT03567005|4242|P1|STARTED|Period 2, Second 7 Days of Wear||29
1954|NCT03567005|4241|P2|NOT COMPLETED|Period 1, First 7 Days of Wear||0
1955|NCT03567005|4242|P1|NOT COMPLETED|Period 1, First 7 Days of Wear||0
1956|NCT03567005|4241|P2|COMPLETED|Period 1, First 7 Days of Wear||31
1957|NCT03567005|4242|P1|COMPLETED|Period 1, First 7 Days of Wear||29
1958|NCT03567005|4241|P2|STARTED|Period 1, First 7 Days of Wear||31
1959|NCT03567005|4242|P1|STARTED|Period 1, First 7 Days of Wear||29
1960|NCT03565874|4250|P1|NOT COMPLETED|Overall Study||2
1961|NCT03565874|4250|P1|COMPLETED|Overall Study||4
1962|NCT03565874|4250|P1|STARTED|Overall Study||6
1963|NCT03565679|4263|P1|NOT COMPLETED|Overall Study||0
1964|NCT03565679|4263|P1|COMPLETED|Overall Study||10
1965|NCT03565679|4263|P1|STARTED|Overall Study||10
1966|NCT03565666|4270|P3|NOT COMPLETED|Overall Study||1
1967|NCT03565666|4271|P2|NOT COMPLETED|Overall Study||0
1968|NCT03565666|4272|P1|NOT COMPLETED|Overall Study||0
1969|NCT03565666|4270|P3|COMPLETED|Overall Study||11
1970|NCT03565666|4271|P2|COMPLETED|Overall Study||12
1971|NCT03565666|4272|P1|COMPLETED|Overall Study||12
1972|NCT03565666|4270|P3|STARTED|Overall Study||12
1973|NCT03565666|4271|P2|STARTED|Overall Study||12
1974|NCT03565666|4272|P1|STARTED|Overall Study||12
1975|NCT03563209|4309|P1|NOT COMPLETED|Overall Study||0
1976|NCT03563209|4309|P1|COMPLETED|Overall Study||60
1977|NCT03563209|4309|P1|STARTED|Overall Study||60
1978|NCT03562559|4315|P1|NOT COMPLETED|Overall Study||0
1979|NCT03562559|4315|P1|COMPLETED|Overall Study||40
1980|NCT03562559|4315|P1|STARTED|Overall Study||40
1981|NCT03560128|4321|P2|NOT COMPLETED|Overall Study||8
1982|NCT03560128|4322|P1|NOT COMPLETED|Overall Study||12
1983|NCT03560128|4321|P2|COMPLETED|Overall Study||298
1984|NCT03560128|4322|P1|COMPLETED|Overall Study||294
1985|NCT03560128|4321|P2|STARTED|Overall Study||306
1986|NCT03560128|4322|P1|STARTED|Overall Study||306
1987|NCT03559829|4342|P1|NOT COMPLETED|Overall Study||0
1988|NCT03559829|4342|P1|COMPLETED|Overall Study||20
1989|NCT03559829|4342|P1|STARTED|Overall Study||20
1990|NCT03558230|4357|P2|NOT COMPLETED|Overall Study||0
1991|NCT03558230|4358|P1|NOT COMPLETED|Overall Study||0
1992|NCT03558230|4357|P2|COMPLETED|Overall Study||6
1993|NCT03558230|4358|P1|COMPLETED|Overall Study||7
1994|NCT03558230|4357|P2|STARTED|Overall Study||6
1995|NCT03558230|4358|P1|STARTED|Overall Study||7
1996|NCT03557801|4367|P3|NOT COMPLETED|Overall Study||3
1997|NCT03557801|4368|P2|NOT COMPLETED|Overall Study||1
1998|NCT03557801|4369|P1|NOT COMPLETED|Overall Study||2
1999|NCT03557801|4367|P3|COMPLETED|Overall Study||30
2000|NCT03557801|4368|P2|COMPLETED|Overall Study||32
2001|NCT03557801|4369|P1|COMPLETED|Overall Study||32
2002|NCT03557801|4367|P3|STARTED|Overall Study||33
2003|NCT03557801|4368|P2|STARTED|Overall Study||33
2004|NCT03557801|4369|P1|STARTED|Overall Study||34
2005|NCT03557476|4385|P2|NOT COMPLETED|Overall Study||0
2006|NCT03557476|4386|P1|NOT COMPLETED|Overall Study||0
2007|NCT03557476|4385|P2|COMPLETED|Overall Study||13
2008|NCT03557476|4386|P1|COMPLETED|Overall Study||13
2009|NCT03557476|4385|P2|STARTED|Overall Study||13
2010|NCT03557476|4386|P1|STARTED|Overall Study||13
2011|NCT03556579|4404|P4|NOT COMPLETED|Visit 2||0
2012|NCT03556579|4405|P3|NOT COMPLETED|Visit 2||0
2013|NCT03556579|4406|P2|NOT COMPLETED|Visit 2||0
2014|NCT03556579|4407|P1|NOT COMPLETED|Visit 2||0
2015|NCT03556579|4404|P4|COMPLETED|Visit 2||16
2016|NCT03556579|4405|P3|COMPLETED|Visit 2||14
2017|NCT03556579|4406|P2|COMPLETED|Visit 2||14
2018|NCT03556579|4407|P1|COMPLETED|Visit 2||16
2019|NCT03556579|4404|P4|STARTED|Visit 2||16
2020|NCT03556579|4405|P3|STARTED|Visit 2||14
2021|NCT03556579|4406|P2|STARTED|Visit 2||14
2022|NCT03556579|4407|P1|STARTED|Visit 2||16
2023|NCT03556579|4404|P4|NOT COMPLETED|Visit 1||0
2024|NCT03556579|4405|P3|NOT COMPLETED|Visit 1||0
2025|NCT03556579|4406|P2|NOT COMPLETED|Visit 1||0
2026|NCT03556579|4407|P1|NOT COMPLETED|Visit 1||0
2027|NCT03556579|4404|P4|COMPLETED|Visit 1||16
2028|NCT03556579|4405|P3|COMPLETED|Visit 1||14
2029|NCT03556579|4406|P2|COMPLETED|Visit 1||14
2030|NCT03556579|4407|P1|COMPLETED|Visit 1||16
2031|NCT03556579|4404|P4|STARTED|Visit 1||16
2032|NCT03556579|4405|P3|STARTED|Visit 1||14
2033|NCT03556579|4406|P2|STARTED|Visit 1||14
2034|NCT03556579|4407|P1|STARTED|Visit 1||16
2035|NCT03555890|4435|P4|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
2036|NCT03555890|4436|P3|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
2037|NCT03555890|4437|P2|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
2038|NCT03555890|4438|P1|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
2039|NCT03555890|4435|P4|COMPLETED|Part 2:Treatment Period 2 (10 Days)||23
2040|NCT03555890|4436|P3|COMPLETED|Part 2:Treatment Period 2 (10 Days)||24
2041|NCT03555890|4437|P2|COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
2042|NCT03555890|4438|P1|COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
2043|NCT03555890|4435|P4|STARTED|Part 2:Treatment Period 2 (10 Days)||23
2044|NCT03555890|4436|P3|STARTED|Part 2:Treatment Period 2 (10 Days)||24
2045|NCT03555890|4437|P2|STARTED|Part 2:Treatment Period 2 (10 Days)||0
2046|NCT03555890|4438|P1|STARTED|Part 2:Treatment Period 2 (10 Days)||0
2047|NCT03555890|4435|P4|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||1
2048|NCT03555890|4436|P3|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
2049|NCT03555890|4437|P2|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
2050|NCT03555890|4438|P1|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
2051|NCT03555890|4435|P4|COMPLETED|Part 2:Washout Period (at Least 5 Days)||23
2052|NCT03555890|4436|P3|COMPLETED|Part 2:Washout Period (at Least 5 Days)||24
2053|NCT03555890|4437|P2|COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
2054|NCT03555890|4438|P1|COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
2055|NCT03555890|4435|P4|STARTED|Part 2:Washout Period (at Least 5 Days)||24
2056|NCT03555890|4436|P3|STARTED|Part 2:Washout Period (at Least 5 Days)||24
2057|NCT03555890|4437|P2|STARTED|Part 2:Washout Period (at Least 5 Days)||0
2058|NCT03555890|4438|P1|STARTED|Part 2:Washout Period (at Least 5 Days)||0
2059|NCT03555890|4435|P4|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
2060|NCT03555890|4436|P3|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
2061|NCT03555890|4437|P2|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
2062|NCT03555890|4438|P1|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
2063|NCT03555890|4435|P4|COMPLETED|Part 2:Treatment Period 1 (3 Days)||24
2064|NCT03555890|4436|P3|COMPLETED|Part 2:Treatment Period 1 (3 Days)||24
2065|NCT03555890|4437|P2|COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
2066|NCT03555890|4438|P1|COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
2067|NCT03555890|4435|P4|STARTED|Part 2:Treatment Period 1 (3 Days)||24
2068|NCT03555890|4436|P3|STARTED|Part 2:Treatment Period 1 (3 Days)||24
2069|NCT03555890|4437|P2|STARTED|Part 2:Treatment Period 1 (3 Days)||0
2070|NCT03555890|4438|P1|STARTED|Part 2:Treatment Period 1 (3 Days)||0
2071|NCT03555890|4435|P4|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
2072|NCT03555890|4436|P3|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
2073|NCT03555890|4437|P2|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
2074|NCT03555890|4438|P1|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
2075|NCT03555890|4435|P4|COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
2076|NCT03555890|4436|P3|COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
2077|NCT03555890|4437|P2|COMPLETED|Part 1:Treatment Period 2 (10 Days)||12
2078|NCT03555890|4438|P1|COMPLETED|Part 1:Treatment Period 2 (10 Days)||12
2079|NCT03555890|4435|P4|STARTED|Part 1:Treatment Period 2 (10 Days)||0
2080|NCT03555890|4436|P3|STARTED|Part 1:Treatment Period 2 (10 Days)||0
2081|NCT03555890|4437|P2|STARTED|Part 1:Treatment Period 2 (10 Days)||12
2082|NCT03555890|4438|P1|STARTED|Part 1:Treatment Period 2 (10 Days)||12
2083|NCT03555890|4435|P4|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
2084|NCT03555890|4436|P3|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
2085|NCT03555890|4437|P2|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
2086|NCT03555890|4438|P1|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
2087|NCT03555890|4435|P4|COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
2088|NCT03555890|4436|P3|COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
2089|NCT03555890|4437|P2|COMPLETED|Part 1:Washout Period (at Least 5 Days)||12
2090|NCT03555890|4438|P1|COMPLETED|Part 1:Washout Period (at Least 5 Days)||12
2091|NCT03555890|4435|P4|STARTED|Part 1:Washout Period (at Least 5 Days)||0
2092|NCT03555890|4436|P3|STARTED|Part 1:Washout Period (at Least 5 Days)||0
2093|NCT03555890|4437|P2|STARTED|Part 1:Washout Period (at Least 5 Days)||12
2094|NCT03555890|4438|P1|STARTED|Part 1:Washout Period (at Least 5 Days)||12
2095|NCT03555890|4435|P4|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
2096|NCT03555890|4436|P3|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
2097|NCT03555890|4437|P2|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
2098|NCT03555890|4438|P1|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
2099|NCT03555890|4435|P4|COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
2100|NCT03555890|4436|P3|COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
2101|NCT03555890|4437|P2|COMPLETED|Part 1:Treatment Period 1 (3 Days)||12
2102|NCT03555890|4438|P1|COMPLETED|Part 1:Treatment Period 1 (3 Days)||12
2103|NCT03555890|4435|P4|STARTED|Part 1:Treatment Period 1 (3 Days)||0
2104|NCT03555890|4436|P3|STARTED|Part 1:Treatment Period 1 (3 Days)||0
2105|NCT03555890|4437|P2|STARTED|Part 1:Treatment Period 1 (3 Days)||12
2106|NCT03555890|4438|P1|STARTED|Part 1:Treatment Period 1 (3 Days)||12
2107|NCT03554746|4574|P2|NOT COMPLETED|Overall Study||0
2108|NCT03554746|4575|P1|NOT COMPLETED|Overall Study||0
2109|NCT03554746|4574|P2|COMPLETED|Overall Study||24
2110|NCT03554746|4575|P1|COMPLETED|Overall Study||24
2111|NCT03554746|4574|P2|STARTED|Overall Study||24
2112|NCT03554746|4575|P1|STARTED|Overall Study||24
2113|NCT03554005|4597|P6|NOT COMPLETED|Overall Study||11
2114|NCT03554005|4598|P5|NOT COMPLETED|Overall Study||6
2115|NCT03554005|4599|P4|NOT COMPLETED|Overall Study||1
2116|NCT03554005|4600|P3|NOT COMPLETED|Overall Study||1
2117|NCT03554005|4601|P2|NOT COMPLETED|Overall Study||1
2118|NCT03554005|4602|P1|NOT COMPLETED|Overall Study||1
2119|NCT03554005|4597|P6|COMPLETED|Overall Study||0
2120|NCT03554005|4598|P5|COMPLETED|Overall Study||5
2121|NCT03554005|4599|P4|COMPLETED|Overall Study||1
2122|NCT03554005|4600|P3|COMPLETED|Overall Study||1
2123|NCT03554005|4601|P2|COMPLETED|Overall Study||1
2124|NCT03554005|4602|P1|COMPLETED|Overall Study||0
2125|NCT03554005|4597|P6|STARTED|Overall Study||11
2126|NCT03554005|4598|P5|STARTED|Overall Study||11
2127|NCT03554005|4599|P4|STARTED|Overall Study||2
2128|NCT03554005|4600|P3|STARTED|Overall Study||2
2129|NCT03554005|4601|P2|STARTED|Overall Study||2
2130|NCT03554005|4602|P1|STARTED|Overall Study||1
2131|NCT03552549|4630|P2|NOT COMPLETED|Overall Study||52
2132|NCT03552549|4631|P1|NOT COMPLETED|Overall Study||53
2133|NCT03552549|4630|P2|COMPLETED|Overall Study||11
2134|NCT03552549|4631|P1|COMPLETED|Overall Study||10
2135|NCT03552549|4630|P2|Treated|Overall Study||62
2136|NCT03552549|4631|P1|Treated|Overall Study||62
2137|NCT03552549|4630|P2|STARTED|Overall Study||63
2138|NCT03552549|4631|P1|STARTED|Overall Study||63
2139|NCT03552523|4639|P2|NOT COMPLETED|Overall Study||1
2140|NCT03552523|4640|P1|NOT COMPLETED|Overall Study||1
2141|NCT03552523|4639|P2|COMPLETED|Overall Study||1
2142|NCT03552523|4640|P1|COMPLETED|Overall Study||4
2143|NCT03552523|4639|P2|STARTED|Overall Study||2
2144|NCT03552523|4640|P1|STARTED|Overall Study||5
2145|NCT03551743|4652|P4|NOT COMPLETED|Overall Study||0
2146|NCT03551743|4653|P3|NOT COMPLETED|Overall Study||0
2147|NCT03551743|4654|P2|NOT COMPLETED|Overall Study||0
2148|NCT03551743|4655|P1|NOT COMPLETED|Overall Study||2
2149|NCT03551743|4652|P4|COMPLETED|Overall Study||6
2150|NCT03551743|4653|P3|COMPLETED|Overall Study||6
2151|NCT03551743|4654|P2|COMPLETED|Overall Study||6
2152|NCT03551743|4655|P1|COMPLETED|Overall Study||8
2153|NCT03551743|4652|P4|STARTED|Overall Study||6
2154|NCT03551743|4653|P3|STARTED|Overall Study||6
2155|NCT03551743|4654|P2|STARTED|Overall Study||6
2156|NCT03551743|4655|P1|STARTED|Overall Study||10
2157|NCT03551730|4701|P4|NOT COMPLETED|Overall Study||0
2158|NCT03551730|4702|P3|NOT COMPLETED|Overall Study||0
2159|NCT03551730|4703|P2|NOT COMPLETED|Overall Study||0
2160|NCT03551730|4704|P1|NOT COMPLETED|Overall Study||1
2161|NCT03551730|4701|P4|COMPLETED|Overall Study||6
2162|NCT03551730|4702|P3|COMPLETED|Overall Study||6
2163|NCT03551730|4703|P2|COMPLETED|Overall Study||6
2164|NCT03551730|4704|P1|COMPLETED|Overall Study||8
2165|NCT03551730|4701|P4|STARTED|Overall Study||6
2166|NCT03551730|4702|P3|STARTED|Overall Study||6
2167|NCT03551730|4703|P2|STARTED|Overall Study||6
2168|NCT03551730|4704|P1|STARTED|Overall Study||9
2169|NCT03550989|4746|P4|NOT COMPLETED|Overall Study||0
2170|NCT03550989|4747|P3|NOT COMPLETED|Overall Study||1
2171|NCT03550989|4748|P2|NOT COMPLETED|Overall Study||1
2172|NCT03550989|4749|P1|NOT COMPLETED|Overall Study||2
2173|NCT03550989|4746|P4|COMPLETED|Overall Study||60
2174|NCT03550989|4747|P3|COMPLETED|Overall Study||76
2175|NCT03550989|4748|P2|COMPLETED|Overall Study||73
2176|NCT03550989|4749|P1|COMPLETED|Overall Study||188
2177|NCT03550989|4746|P4|STARTED|Overall Study||60
2178|NCT03550989|4747|P3|STARTED|Overall Study||77
2179|NCT03550989|4748|P2|STARTED|Overall Study||74
2180|NCT03550989|4749|P1|STARTED|Overall Study||190
2181|NCT03550066|4826|P2|NOT COMPLETED|Overall Study||0
2182|NCT03550066|4827|P1|NOT COMPLETED|Overall Study||0
2183|NCT03550066|4826|P2|COMPLETED|Overall Study||41
2184|NCT03550066|4827|P1|COMPLETED|Overall Study||49
2185|NCT03550066|4826|P2|STARTED|Overall Study||41
2186|NCT03550066|4827|P1|STARTED|Overall Study||49
2187|NCT03549429|4839|P2|NOT COMPLETED|Overall Study||3
2188|NCT03549429|4840|P1|NOT COMPLETED|Overall Study||5
2189|NCT03549429|4839|P2|COMPLETED|Overall Study||75
2190|NCT03549429|4840|P1|COMPLETED|Overall Study||76
2191|NCT03549429|4839|P2|STARTED|Overall Study||78
2192|NCT03549429|4840|P1|STARTED|Overall Study||81
2193|NCT03549130|4852|P2|NOT COMPLETED|Overall Study||2
2194|NCT03549130|4853|P1|NOT COMPLETED|Overall Study||0
2195|NCT03549130|4852|P2|COMPLETED|Overall Study||64
2196|NCT03549130|4853|P1|COMPLETED|Overall Study||64
2197|NCT03549130|4852|P2|STARTED|Overall Study||66
2198|NCT03549130|4853|P1|STARTED|Overall Study||64
2199|NCT03549117|4871|P2|NOT COMPLETED|Overall Study||0
2200|NCT03549117|4872|P1|NOT COMPLETED|Overall Study||1
2201|NCT03549117|4871|P2|COMPLETED|Overall Study||70
2202|NCT03549117|4872|P1|COMPLETED|Overall Study||69
2203|NCT03549117|4871|P2|STARTED|Overall Study||70
2204|NCT03549117|4872|P1|STARTED|Overall Study||70
2205|NCT03547531|4900|P2|NOT COMPLETED|Overall Study||4
2206|NCT03547531|4901|P1|NOT COMPLETED|Overall Study||2
2207|NCT03547531|4900|P2|COMPLETED|Overall Study||58
2208|NCT03547531|4901|P1|COMPLETED|Overall Study||60
2209|NCT03547531|4900|P2|STARTED|Overall Study||62
2210|NCT03547531|4901|P1|STARTED|Overall Study||62
2211|NCT03547154|4915|P2|NOT COMPLETED|Overall Study||116
2212|NCT03547154|4916|P1|NOT COMPLETED|Overall Study||123
2213|NCT03547154|4915|P2|COMPLETED|Overall Study||55
2214|NCT03547154|4916|P1|COMPLETED|Overall Study||50
2215|NCT03547154|4915|P2|STARTED|Overall Study||171
2216|NCT03547154|4916|P1|STARTED|Overall Study||173
2217|NCT03546491|4928|P1|NOT COMPLETED|Overall Study||2
2218|NCT03546491|4928|P1|COMPLETED|Overall Study||30
2219|NCT03546491|4928|P1|Received Test Product 2|Overall Study||32
2220|NCT03546491|4928|P1|Recieved Test Product 1|Overall Study||32
2221|NCT03546491|4928|P1|STARTED|Overall Study||32
2222|NCT03546270|4942|P2|NOT COMPLETED|Overall Study||0
2223|NCT03546270|4943|P1|NOT COMPLETED|Overall Study||0
2224|NCT03546270|4942|P2|COMPLETED|Overall Study||48
2225|NCT03546270|4943|P1|COMPLETED|Overall Study||52
2226|NCT03546270|4942|P2|STARTED|Overall Study||48
2227|NCT03546270|4943|P1|STARTED|Overall Study||52
2228|NCT03546192|4961|P2|NOT COMPLETED|Overall Study||0
2229|NCT03546192|4962|P1|NOT COMPLETED|Overall Study||0
2230|NCT03546192|4961|P2|COMPLETED|Overall Study||60
2231|NCT03546192|4962|P1|COMPLETED|Overall Study||60
2232|NCT03546192|4961|P2|STARTED|Overall Study||60
2233|NCT03546192|4962|P1|STARTED|Overall Study||60
2234|NCT03545984|4980|P2|NOT COMPLETED|Overall Study||9
2235|NCT03545984|4981|P1|NOT COMPLETED|Overall Study||11
2236|NCT03545984|4980|P2|COMPLETED|Overall Study||15
2237|NCT03545984|4981|P1|COMPLETED|Overall Study||13
2238|NCT03545984|4980|P2|STARTED|Overall Study||24
2239|NCT03545984|4981|P1|STARTED|Overall Study||24
2240|NCT03545412|4987|P1|NOT COMPLETED|Overall Study||0
2241|NCT03545412|4987|P1|COMPLETED|Overall Study||25
2242|NCT03545412|4987|P1|STARTED|Overall Study||25
2243|NCT03544879|4999|P2|NOT COMPLETED|Overall Study||1
2244|NCT03544879|5000|P1|NOT COMPLETED|Overall Study||0
2245|NCT03544879|4999|P2|COMPLETED|Overall Study||23
2246|NCT03544879|5000|P1|COMPLETED|Overall Study||22
2247|NCT03544879|4999|P2|Completed Follow-up Physical Assessment|Overall Study||21
2248|NCT03544879|5000|P1|Completed Follow-up Physical Assessment|Overall Study||20
2249|NCT03544879|4999|P2|STARTED|Overall Study||24
2250|NCT03544879|5000|P1|STARTED|Overall Study||22
2251|NCT03544307|5028|P2|NOT COMPLETED|Overall Study||0
2252|NCT03544307|5029|P1|NOT COMPLETED|Overall Study||0
2253|NCT03544307|5028|P2|COMPLETED|Overall Study||10
2254|NCT03544307|5029|P1|COMPLETED|Overall Study||10
2255|NCT03544307|5028|P2|STARTED|Overall Study||10
2256|NCT03544307|5029|P1|STARTED|Overall Study||10
2257|NCT03544216|5049|P2|NOT COMPLETED|Overall Study||0
2258|NCT03544216|5050|P1|NOT COMPLETED|Overall Study||0
2259|NCT03544216|5049|P2|COMPLETED|Overall Study||42
2260|NCT03544216|5050|P1|COMPLETED|Overall Study||42
2261|NCT03544216|5049|P2|STARTED|Overall Study||42
2262|NCT03544216|5050|P1|STARTED|Overall Study||42
2263|NCT03537404|5060|P2|NOT COMPLETED|Third Intervention (A or B or C)||0
2264|NCT03537404|5061|P1|NOT COMPLETED|Third Intervention (A or B or C)||0
2265|NCT03537404|5060|P2|COMPLETED|Third Intervention (A or B or C)||18
2266|NCT03537404|5061|P1|COMPLETED|Third Intervention (A or B or C)||18
2267|NCT03537404|5060|P2|STARTED|Third Intervention (A or B or C)||18
2268|NCT03537404|5061|P1|STARTED|Third Intervention (A or B or C)||18
2269|NCT03537404|5060|P2|NOT COMPLETED|Second Washout Period (8 Days)||0
2270|NCT03537404|5061|P1|NOT COMPLETED|Second Washout Period (8 Days)||0
2271|NCT03537404|5060|P2|COMPLETED|Second Washout Period (8 Days)||18
2272|NCT03537404|5061|P1|COMPLETED|Second Washout Period (8 Days)||18
2273|NCT03537404|5060|P2|STARTED|Second Washout Period (8 Days)||18
2274|NCT03537404|5061|P1|STARTED|Second Washout Period (8 Days)||18
2275|NCT03537404|5060|P2|NOT COMPLETED|Second Intervention (A or B or C)||0
2276|NCT03537404|5061|P1|NOT COMPLETED|Second Intervention (A or B or C)||0
2277|NCT03537404|5060|P2|COMPLETED|Second Intervention (A or B or C)||18
2278|NCT03537404|5061|P1|COMPLETED|Second Intervention (A or B or C)||18
2279|NCT03537404|5060|P2|STARTED|Second Intervention (A or B or C)||18
2280|NCT03537404|5061|P1|STARTED|Second Intervention (A or B or C)||18
2281|NCT03537404|5060|P2|NOT COMPLETED|First Washout Period (8 Days)||0
2282|NCT03537404|5061|P1|NOT COMPLETED|First Washout Period (8 Days)||0
2283|NCT03537404|5060|P2|COMPLETED|First Washout Period (8 Days)||18
2284|NCT03537404|5061|P1|COMPLETED|First Washout Period (8 Days)||18
2285|NCT03537404|5060|P2|STARTED|First Washout Period (8 Days)||18
2286|NCT03537404|5061|P1|STARTED|First Washout Period (8 Days)||18
2287|NCT03537404|5060|P2|NOT COMPLETED|First Intervention (A or B or C)||0
2288|NCT03537404|5061|P1|NOT COMPLETED|First Intervention (A or B or C)||0
2289|NCT03537404|5060|P2|COMPLETED|First Intervention (A or B or C)||18
2290|NCT03537404|5061|P1|COMPLETED|First Intervention (A or B or C)||18
2291|NCT03537404|5060|P2|STARTED|First Intervention (A or B or C)||18
2292|NCT03537404|5061|P1|STARTED|First Intervention (A or B or C)||18
2293|NCT03537274|5107|P4|NOT COMPLETED|Overall Study||76
2294|NCT03537274|5108|P3|NOT COMPLETED|Overall Study||76
2295|NCT03537274|5109|P2|NOT COMPLETED|Overall Study||69
2296|NCT03537274|5110|P1|NOT COMPLETED|Overall Study||60
2297|NCT03537274|5107|P4|COMPLETED|Overall Study||231
2298|NCT03537274|5108|P3|COMPLETED|Overall Study||228
2299|NCT03537274|5109|P2|COMPLETED|Overall Study||229
2300|NCT03537274|5110|P1|COMPLETED|Overall Study||255
2301|NCT03537274|5107|P4|Treated|Overall Study||303
2302|NCT03537274|5108|P3|Treated|Overall Study||304
2303|NCT03537274|5109|P2|Treated|Overall Study||297
2304|NCT03537274|5110|P1|Treated|Overall Study||315
2305|NCT03537274|5107|P4|STARTED|Overall Study||307
2306|NCT03537274|5108|P3|STARTED|Overall Study||304
2307|NCT03537274|5109|P2|STARTED|Overall Study||298
2308|NCT03537274|5110|P1|STARTED|Overall Study||315
2309|NCT03536923|5124|P1|NOT COMPLETED|Overall Study||0
2310|NCT03536923|5124|P1|COMPLETED|Overall Study||23
2311|NCT03536923|5124|P1|STARTED|Overall Study||23
2312|NCT03535571|5131|P1|NOT COMPLETED|Overall Study||1
2313|NCT03535571|5131|P1|COMPLETED|Overall Study||19
2314|NCT03535571|5131|P1|STARTED|Overall Study||20
2315|NCT03534986|5163|P3|NOT COMPLETED|Overall Study||2
2316|NCT03534986|5164|P2|NOT COMPLETED|Overall Study||0
2317|NCT03534986|5165|P1|NOT COMPLETED|Overall Study||0
2318|NCT03534986|5163|P3|COMPLETED|Overall Study||10
2319|NCT03534986|5164|P2|COMPLETED|Overall Study||10
2320|NCT03534986|5165|P1|COMPLETED|Overall Study||10
2321|NCT03534986|5163|P3|STARTED|Overall Study||12
2322|NCT03534986|5164|P2|STARTED|Overall Study||10
2323|NCT03534986|5165|P1|STARTED|Overall Study||10
2324|NCT03534427|5187|P2|NOT COMPLETED|Overall Study||0
2325|NCT03534427|5188|P1|NOT COMPLETED|Overall Study||0
2326|NCT03534427|5187|P2|COMPLETED|Overall Study||20
2327|NCT03534427|5188|P1|COMPLETED|Overall Study||20
2328|NCT03534427|5187|P2|STARTED|Overall Study||20
2329|NCT03534427|5188|P1|STARTED|Overall Study||20
2330|NCT03533829|5217|P3|NOT COMPLETED|Overall Study||0
2331|NCT03533829|5218|P2|NOT COMPLETED|Overall Study||0
2332|NCT03533829|5219|P1|NOT COMPLETED|Overall Study||0
2333|NCT03533829|5217|P3|COMPLETED|Overall Study||10
2334|NCT03533829|5218|P2|COMPLETED|Overall Study||10
2335|NCT03533829|5219|P1|COMPLETED|Overall Study||10
2336|NCT03533829|5217|P3|STARTED|Overall Study||10
2337|NCT03533829|5218|P2|STARTED|Overall Study||10
2338|NCT03533829|5219|P1|STARTED|Overall Study||10
2339|NCT03533036|5319|P2|NOT COMPLETED|Overall Study||0
2340|NCT03533036|5320|P1|NOT COMPLETED|Overall Study||0
2341|NCT03533036|5319|P2|COMPLETED|Overall Study||15
2342|NCT03533036|5320|P1|COMPLETED|Overall Study||15
2343|NCT03533036|5319|P2|STARTED|Overall Study||15
2344|NCT03533036|5320|P1|STARTED|Overall Study||15
2345|NCT03530631|5327|P1|NOT COMPLETED|Placebo/Deception||0
2346|NCT03530631|5327|P1|COMPLETED|Placebo/Deception||4
2347|NCT03530631|5327|P1|STARTED|Placebo/Deception||4
2348|NCT03530631|5327|P1|NOT COMPLETED|Adderall/Deception||0
2349|NCT03530631|5327|P1|COMPLETED|Adderall/Deception||4
2350|NCT03530631|5327|P1|STARTED|Adderall/Deception||4
2351|NCT03530631|5327|P1|NOT COMPLETED|Placebo/Truth||0
2352|NCT03530631|5327|P1|COMPLETED|Placebo/Truth||4
2353|NCT03530631|5327|P1|STARTED|Placebo/Truth||4
2354|NCT03530631|5327|P1|NOT COMPLETED|Adderall/Truth||0
2355|NCT03530631|5327|P1|COMPLETED|Adderall/Truth||4
2356|NCT03530631|5327|P1|STARTED|Adderall/Truth||4
2357|NCT03529461|5339|P2|NOT COMPLETED|Overall Study||0
2358|NCT03529461|5340|P1|NOT COMPLETED|Overall Study||0
2359|NCT03529461|5339|P2|COMPLETED|Overall Study||28
2360|NCT03529461|5340|P1|COMPLETED|Overall Study||28
2361|NCT03529461|5339|P2|STARTED|Overall Study||28
2362|NCT03529461|5340|P1|STARTED|Overall Study||28
2363|NCT03528174|5349|P1|NOT COMPLETED|Overall Study||2
2364|NCT03528174|5349|P1|COMPLETED|Overall Study||8
2365|NCT03528174|5349|P1|STARTED|Overall Study||10
2366|NCT03527966|5369|P2|NOT COMPLETED|Overall Study||0
2367|NCT03527966|5370|P1|NOT COMPLETED|Overall Study||3
2368|NCT03527966|5369|P2|COMPLETED|Overall Study||0
2369|NCT03527966|5370|P1|COMPLETED|Overall Study||0
2370|NCT03527966|5369|P2|STARTED|Overall Study||0
2371|NCT03527966|5370|P1|STARTED|Overall Study||3
2372|NCT03526055|5382|P2|NOT COMPLETED|Second Program||0
2373|NCT03526055|5383|P1|NOT COMPLETED|Second Program||0
2374|NCT03526055|5382|P2|COMPLETED|Second Program||5
2375|NCT03526055|5383|P1|COMPLETED|Second Program||5
2376|NCT03526055|5382|P2|STARTED|Second Program||5
2377|NCT03526055|5383|P1|STARTED|Second Program||5
2378|NCT03526055|5382|P2|NOT COMPLETED|Initial Program||0
2379|NCT03526055|5383|P1|NOT COMPLETED|Initial Program||0
2380|NCT03526055|5382|P2|COMPLETED|Initial Program||5
2381|NCT03526055|5383|P1|COMPLETED|Initial Program||5
2382|NCT03526055|5382|P2|STARTED|Initial Program||5
2383|NCT03526055|5383|P1|STARTED|Initial Program||5
2384|NCT03524157|5400|P3|NOT COMPLETED|Overall Study||1
2385|NCT03524157|5401|P2|NOT COMPLETED|Overall Study||0
2386|NCT03524157|5402|P1|NOT COMPLETED|Overall Study||0
2387|NCT03524157|5400|P3|COMPLETED|Overall Study||9
2388|NCT03524157|5401|P2|COMPLETED|Overall Study||10
2389|NCT03524157|5402|P1|COMPLETED|Overall Study||10
2390|NCT03524157|5400|P3|STARTED|Overall Study||10
2391|NCT03524157|5401|P2|STARTED|Overall Study||10
2392|NCT03524157|5402|P1|STARTED|Overall Study||10
2393|NCT03523988|5440|P3|NOT COMPLETED|Overall Study||18
2394|NCT03523988|5441|P2|NOT COMPLETED|Overall Study||16
2395|NCT03523988|5442|P1|NOT COMPLETED|Overall Study||17
2396|NCT03523988|5440|P3|COMPLETED|Overall Study||7
2397|NCT03523988|5441|P2|COMPLETED|Overall Study||8
2398|NCT03523988|5442|P1|COMPLETED|Overall Study||7
2399|NCT03523988|5440|P3|STARTED|Overall Study||25
2400|NCT03523988|5441|P2|STARTED|Overall Study||24
2401|NCT03523988|5442|P1|STARTED|Overall Study||24
2402|NCT03522675|5456|P1|NOT COMPLETED|Overall Study||2
2403|NCT03522675|5456|P1|COMPLETED|Overall Study||20
2404|NCT03522675|5456|P1|STARTED|Overall Study||22
2405|NCT03522506|5474|P4|NOT COMPLETED|Treatment Period 4 (2 Days)||0
2406|NCT03522506|5475|P3|NOT COMPLETED|Treatment Period 4 (2 Days)||0
2407|NCT03522506|5476|P2|NOT COMPLETED|Treatment Period 4 (2 Days)||0
2408|NCT03522506|5477|P1|NOT COMPLETED|Treatment Period 4 (2 Days)||0
2409|NCT03522506|5474|P4|COMPLETED|Treatment Period 4 (2 Days)||3
2410|NCT03522506|5475|P3|COMPLETED|Treatment Period 4 (2 Days)||5
2411|NCT03522506|5476|P2|COMPLETED|Treatment Period 4 (2 Days)||5
2412|NCT03522506|5477|P1|COMPLETED|Treatment Period 4 (2 Days)||5
2413|NCT03522506|5474|P4|STARTED|Treatment Period 4 (2 Days)||3
2414|NCT03522506|5475|P3|STARTED|Treatment Period 4 (2 Days)||5
2415|NCT03522506|5476|P2|STARTED|Treatment Period 4 (2 Days)||5
2416|NCT03522506|5477|P1|STARTED|Treatment Period 4 (2 Days)||5
2417|NCT03522506|5474|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
2418|NCT03522506|5475|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
2419|NCT03522506|5476|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
2420|NCT03522506|5477|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
2421|NCT03522506|5474|P4|COMPLETED|Washout Period 3 (7 Days)||3
2422|NCT03522506|5475|P3|COMPLETED|Washout Period 3 (7 Days)||5
2423|NCT03522506|5476|P2|COMPLETED|Washout Period 3 (7 Days)||5
2424|NCT03522506|5477|P1|COMPLETED|Washout Period 3 (7 Days)||5
2425|NCT03522506|5474|P4|STARTED|Washout Period 3 (7 Days)||3
2426|NCT03522506|5475|P3|STARTED|Washout Period 3 (7 Days)||5
2427|NCT03522506|5476|P2|STARTED|Washout Period 3 (7 Days)||5
2428|NCT03522506|5477|P1|STARTED|Washout Period 3 (7 Days)||5
2429|NCT03522506|5474|P4|NOT COMPLETED|Treatment Period 3 (2 Days)||0
2430|NCT03522506|5475|P3|NOT COMPLETED|Treatment Period 3 (2 Days)||0
2431|NCT03522506|5476|P2|NOT COMPLETED|Treatment Period 3 (2 Days)||0
2432|NCT03522506|5477|P1|NOT COMPLETED|Treatment Period 3 (2 Days)||0
2433|NCT03522506|5474|P4|COMPLETED|Treatment Period 3 (2 Days)||3
2434|NCT03522506|5475|P3|COMPLETED|Treatment Period 3 (2 Days)||5
2435|NCT03522506|5476|P2|COMPLETED|Treatment Period 3 (2 Days)||5
2436|NCT03522506|5477|P1|COMPLETED|Treatment Period 3 (2 Days)||5
2437|NCT03522506|5474|P4|STARTED|Treatment Period 3 (2 Days)||3
2438|NCT03522506|5475|P3|STARTED|Treatment Period 3 (2 Days)||5
2439|NCT03522506|5476|P2|STARTED|Treatment Period 3 (2 Days)||5
2440|NCT03522506|5477|P1|STARTED|Treatment Period 3 (2 Days)||5
2441|NCT03522506|5474|P4|NOT COMPLETED|Washout Period 2 (7 Days)||1
2442|NCT03522506|5475|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
2443|NCT03522506|5476|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
2444|NCT03522506|5477|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
2445|NCT03522506|5474|P4|COMPLETED|Washout Period 2 (7 Days)||3
2446|NCT03522506|5475|P3|COMPLETED|Washout Period 2 (7 Days)||5
2447|NCT03522506|5476|P2|COMPLETED|Washout Period 2 (7 Days)||5
2448|NCT03522506|5477|P1|COMPLETED|Washout Period 2 (7 Days)||5
2449|NCT03522506|5474|P4|STARTED|Washout Period 2 (7 Days)||4
2450|NCT03522506|5475|P3|STARTED|Washout Period 2 (7 Days)||5
2451|NCT03522506|5476|P2|STARTED|Washout Period 2 (7 Days)||5
2452|NCT03522506|5477|P1|STARTED|Washout Period 2 (7 Days)||5
2453|NCT03522506|5474|P4|NOT COMPLETED|Treatment Period 2 (2 Days)||0
2454|NCT03522506|5475|P3|NOT COMPLETED|Treatment Period 2 (2 Days)||0
2455|NCT03522506|5476|P2|NOT COMPLETED|Treatment Period 2 (2 Days)||0
2456|NCT03522506|5477|P1|NOT COMPLETED|Treatment Period 2 (2 Days)||0
2457|NCT03522506|5474|P4|COMPLETED|Treatment Period 2 (2 Days)||4
2458|NCT03522506|5475|P3|COMPLETED|Treatment Period 2 (2 Days)||5
2459|NCT03522506|5476|P2|COMPLETED|Treatment Period 2 (2 Days)||5
2460|NCT03522506|5477|P1|COMPLETED|Treatment Period 2 (2 Days)||5
2461|NCT03522506|5474|P4|STARTED|Treatment Period 2 (2 Days)||4
2462|NCT03522506|5475|P3|STARTED|Treatment Period 2 (2 Days)||5
2463|NCT03522506|5476|P2|STARTED|Treatment Period 2 (2 Days)||5
2464|NCT03522506|5477|P1|STARTED|Treatment Period 2 (2 Days)||5
2465|NCT03522506|5474|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
2466|NCT03522506|5475|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
2467|NCT03522506|5476|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
2468|NCT03522506|5477|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
2469|NCT03522506|5474|P4|COMPLETED|Washout Period 1 (7 Days)||4
2470|NCT03522506|5475|P3|COMPLETED|Washout Period 1 (7 Days)||5
2471|NCT03522506|5476|P2|COMPLETED|Washout Period 1 (7 Days)||5
2472|NCT03522506|5477|P1|COMPLETED|Washout Period 1 (7 Days)||5
2473|NCT03522506|5474|P4|STARTED|Washout Period 1 (7 Days)||5
2474|NCT03522506|5475|P3|STARTED|Washout Period 1 (7 Days)||5
2475|NCT03522506|5476|P2|STARTED|Washout Period 1 (7 Days)||5
2476|NCT03522506|5477|P1|STARTED|Washout Period 1 (7 Days)||5
2477|NCT03522506|5474|P4|NOT COMPLETED|Treatment Period 1 (2 Days)||0
2478|NCT03522506|5475|P3|NOT COMPLETED|Treatment Period 1 (2 Days)||0
2479|NCT03522506|5476|P2|NOT COMPLETED|Treatment Period 1 (2 Days)||0
2480|NCT03522506|5477|P1|NOT COMPLETED|Treatment Period 1 (2 Days)||0
2481|NCT03522506|5474|P4|COMPLETED|Treatment Period 1 (2 Days)||5
2482|NCT03522506|5475|P3|COMPLETED|Treatment Period 1 (2 Days)||5
2483|NCT03522506|5476|P2|COMPLETED|Treatment Period 1 (2 Days)||5
2484|NCT03522506|5477|P1|COMPLETED|Treatment Period 1 (2 Days)||5
2485|NCT03522506|5474|P4|STARTED|Treatment Period 1 (2 Days)||5
2486|NCT03522506|5475|P3|STARTED|Treatment Period 1 (2 Days)||5
2487|NCT03522506|5476|P2|STARTED|Treatment Period 1 (2 Days)||5
2488|NCT03522506|5477|P1|STARTED|Treatment Period 1 (2 Days)||5
2489|NCT03522350|5525|P2|NOT COMPLETED|Overall Study||0
2490|NCT03522350|5526|P1|NOT COMPLETED|Overall Study||0
2491|NCT03522350|5525|P2|COMPLETED|Overall Study||18
2492|NCT03522350|5526|P1|COMPLETED|Overall Study||18
2493|NCT03522350|5525|P2|STARTED|Overall Study||18
2494|NCT03522350|5526|P1|STARTED|Overall Study||18
2495|NCT03521791|5539|P2|NOT COMPLETED|Overall Study||17
2496|NCT03521791|5540|P1|NOT COMPLETED|Overall Study||7
2497|NCT03521791|5539|P2|COMPLETED|Overall Study||73
2498|NCT03521791|5540|P1|COMPLETED|Overall Study||69
2499|NCT03521791|5539|P2|STARTED|Overall Study||90
2500|NCT03521791|5540|P1|STARTED|Overall Study||76
2501|NCT03520348|5566|P2|NOT COMPLETED|Overall Study||0
2502|NCT03520348|5567|P1|NOT COMPLETED|Overall Study||0
2503|NCT03520348|5566|P2|COMPLETED|Overall Study||12
2504|NCT03520348|5567|P1|COMPLETED|Overall Study||12
2505|NCT03520348|5566|P2|STARTED|Overall Study||12
2506|NCT03520348|5567|P1|STARTED|Overall Study||12
2507|NCT03519867|5601|P10|NOT COMPLETED|Overall Study||0
2508|NCT03519867|5602|P9|NOT COMPLETED|Overall Study||1
2509|NCT03519867|5603|P8|NOT COMPLETED|Overall Study||1
2510|NCT03519867|5604|P7|NOT COMPLETED|Overall Study||1
2511|NCT03519867|5605|P6|NOT COMPLETED|Overall Study||3
2512|NCT03519867|5606|P5|NOT COMPLETED|Overall Study||0
2513|NCT03519867|5607|P4|NOT COMPLETED|Overall Study||1
2514|NCT03519867|5608|P3|NOT COMPLETED|Overall Study||1
2515|NCT03519867|5609|P2|NOT COMPLETED|Overall Study||3
2516|NCT03519867|5610|P1|NOT COMPLETED|Overall Study||3
2517|NCT03519867|5601|P10|COMPLETED|Overall Study||4
2518|NCT03519867|5602|P9|COMPLETED|Overall Study||3
2519|NCT03519867|5603|P8|COMPLETED|Overall Study||4
2520|NCT03519867|5604|P7|COMPLETED|Overall Study||3
2521|NCT03519867|5605|P6|COMPLETED|Overall Study||2
2522|NCT03519867|5606|P5|COMPLETED|Overall Study||5
2523|NCT03519867|5607|P4|COMPLETED|Overall Study||3
2524|NCT03519867|5608|P3|COMPLETED|Overall Study||5
2525|NCT03519867|5609|P2|COMPLETED|Overall Study||4
2526|NCT03519867|5610|P1|COMPLETED|Overall Study||3
2527|NCT03519867|5601|P10|Treated|Overall Study||4
2528|NCT03519867|5602|P9|Treated|Overall Study||3
2529|NCT03519867|5603|P8|Treated|Overall Study||4
2530|NCT03519867|5604|P7|Treated|Overall Study||4
2531|NCT03519867|5605|P6|Treated|Overall Study||4
2532|NCT03519867|5606|P5|Treated|Overall Study||5
2533|NCT03519867|5607|P4|Treated|Overall Study||3
2534|NCT03519867|5608|P3|Treated|Overall Study||5
2535|NCT03519867|5609|P2|Treated|Overall Study||6
2536|NCT03519867|5610|P1|Treated|Overall Study||5
2537|NCT03519867|5601|P10|STARTED|Overall Study||4
2538|NCT03519867|5602|P9|STARTED|Overall Study||4
2539|NCT03519867|5603|P8|STARTED|Overall Study||5
2540|NCT03519867|5604|P7|STARTED|Overall Study||4
2541|NCT03519867|5605|P6|STARTED|Overall Study||5
2542|NCT03519867|5606|P5|STARTED|Overall Study||5
2543|NCT03519867|5607|P4|STARTED|Overall Study||4
2544|NCT03519867|5608|P3|STARTED|Overall Study||6
2545|NCT03519867|5609|P2|STARTED|Overall Study|One participant randomized to receive MK-8616 8.0 mg/kg received MK-8616 0.8 mg/kg.|7
2546|NCT03519867|5610|P1|STARTED|Overall Study||6
2547|NCT03519854|5660|P18|NOT COMPLETED|Overall Study||0
2548|NCT03519854|5661|P17|NOT COMPLETED|Overall Study||0
2549|NCT03519854|5662|P16|NOT COMPLETED|Overall Study||0
2550|NCT03519854|5663|P15|NOT COMPLETED|Overall Study||0
2551|NCT03519854|5664|P14|NOT COMPLETED|Overall Study||0
2552|NCT03519854|5665|P13|NOT COMPLETED|Overall Study||0
2553|NCT03519854|5666|P12|NOT COMPLETED|Overall Study||0
2554|NCT03519854|5667|P11|NOT COMPLETED|Overall Study||0
2555|NCT03519854|5668|P10|NOT COMPLETED|Overall Study||0
2556|NCT03519854|5669|P9|NOT COMPLETED|Overall Study||0
2557|NCT03519854|5670|P8|NOT COMPLETED|Overall Study||0
2558|NCT03519854|5671|P7|NOT COMPLETED|Overall Study||0
2559|NCT03519854|5672|P6|NOT COMPLETED|Overall Study||0
2560|NCT03519854|5673|P5|NOT COMPLETED|Overall Study||0
2561|NCT03519854|5674|P4|NOT COMPLETED|Overall Study||0
2562|NCT03519854|5675|P3|NOT COMPLETED|Overall Study||1
2563|NCT03519854|5676|P2|NOT COMPLETED|Overall Study||0
2564|NCT03519854|5677|P1|NOT COMPLETED|Overall Study||0
2565|NCT03519854|5660|P18|COMPLETED|Overall Study||6
2566|NCT03519854|5661|P17|COMPLETED|Overall Study||6
2567|NCT03519854|5662|P16|COMPLETED|Overall Study||6
2568|NCT03519854|5663|P15|COMPLETED|Overall Study||6
2569|NCT03519854|5664|P14|COMPLETED|Overall Study||6
2570|NCT03519854|5665|P13|COMPLETED|Overall Study||3
2571|NCT03519854|5666|P12|COMPLETED|Overall Study||6
2572|NCT03519854|5667|P11|COMPLETED|Overall Study||6
2573|NCT03519854|5668|P10|COMPLETED|Overall Study||6
2574|NCT03519854|5669|P9|COMPLETED|Overall Study||6
2575|NCT03519854|5670|P8|COMPLETED|Overall Study||6
2576|NCT03519854|5671|P7|COMPLETED|Overall Study||3
2577|NCT03519854|5672|P6|COMPLETED|Overall Study||6
2578|NCT03519854|5673|P5|COMPLETED|Overall Study||6
2579|NCT03519854|5674|P4|COMPLETED|Overall Study||6
2580|NCT03519854|5675|P3|COMPLETED|Overall Study||4
2581|NCT03519854|5676|P2|COMPLETED|Overall Study||6
2582|NCT03519854|5677|P1|COMPLETED|Overall Study||4
2583|NCT03519854|5660|P18|Treated|Overall Study||6
2584|NCT03519854|5661|P17|Treated|Overall Study||6
2585|NCT03519854|5662|P16|Treated|Overall Study||6
2586|NCT03519854|5663|P15|Treated|Overall Study||6
2587|NCT03519854|5664|P14|Treated|Overall Study||6
2588|NCT03519854|5665|P13|Treated|Overall Study||3
2589|NCT03519854|5666|P12|Treated|Overall Study||6
2590|NCT03519854|5667|P11|Treated|Overall Study||6
2591|NCT03519854|5668|P10|Treated|Overall Study||6
2592|NCT03519854|5669|P9|Treated|Overall Study||6
2593|NCT03519854|5670|P8|Treated|Overall Study||6
2594|NCT03519854|5671|P7|Treated|Overall Study||3
2595|NCT03519854|5672|P6|Treated|Overall Study||6
2596|NCT03519854|5673|P5|Treated|Overall Study||6
2597|NCT03519854|5674|P4|Treated|Overall Study||6
2598|NCT03519854|5675|P3|Treated|Overall Study||4
2599|NCT03519854|5676|P2|Treated|Overall Study||6
2600|NCT03519854|5677|P1|Treated|Overall Study|N=1 (randomized to Arm C) received placebo, 3 min after 1.2 mg/kg Esmeron®|4
2601|NCT03519854|5660|P18|STARTED|Overall Study||6
2602|NCT03519854|5661|P17|STARTED|Overall Study||6
2603|NCT03519854|5662|P16|STARTED|Overall Study||6
2604|NCT03519854|5663|P15|STARTED|Overall Study||6
2605|NCT03519854|5664|P14|STARTED|Overall Study||6
2606|NCT03519854|5665|P13|STARTED|Overall Study||3
2607|NCT03519854|5666|P12|STARTED|Overall Study||6
2608|NCT03519854|5667|P11|STARTED|Overall Study||6
2609|NCT03519854|5668|P10|STARTED|Overall Study||6
2610|NCT03519854|5669|P9|STARTED|Overall Study||6
2611|NCT03519854|5670|P8|STARTED|Overall Study||6
2612|NCT03519854|5671|P7|STARTED|Overall Study||3
2613|NCT03519854|5672|P6|STARTED|Overall Study||6
2614|NCT03519854|5673|P5|STARTED|Overall Study||6
2615|NCT03519854|5674|P4|STARTED|Overall Study||6
2616|NCT03519854|5675|P3|STARTED|Overall Study||5
2617|NCT03519854|5676|P2|STARTED|Overall Study||6
2618|NCT03519854|5677|P1|STARTED|Overall Study|N=3 randomized to Arm A. An additional N=1 (randomized to Arm C) is counted as Started in Arm A|4
2619|NCT03519516|5843|P2|NOT COMPLETED|Overall Study||1
2620|NCT03519516|5844|P1|NOT COMPLETED|Overall Study||0
2621|NCT03519516|5843|P2|COMPLETED|Overall Study||14
2622|NCT03519516|5844|P1|COMPLETED|Overall Study||15
2623|NCT03519516|5843|P2|STARTED|Overall Study||15
2624|NCT03519516|5844|P1|STARTED|Overall Study||15
2625|NCT03519243|5871|P4|NOT COMPLETED|Overall Study||1
2626|NCT03519243|5872|P3|NOT COMPLETED|Overall Study||0
2627|NCT03519243|5873|P2|NOT COMPLETED|Overall Study||4
2628|NCT03519243|5874|P1|NOT COMPLETED|Overall Study||5
2629|NCT03519243|5871|P4|COMPLETED|Overall Study||24
2630|NCT03519243|5872|P3|COMPLETED|Overall Study||0
2631|NCT03519243|5873|P2|COMPLETED|Overall Study||21
2632|NCT03519243|5874|P1|COMPLETED|Overall Study||20
2633|NCT03519243|5871|P4|STARTED|Overall Study||25
2634|NCT03519243|5872|P3|STARTED|Overall Study|The dose level was not studied due to the dose level l.7 µg/kg demonstrated the sufficient PD effect|0
2635|NCT03519243|5873|P2|STARTED|Overall Study||25
2636|NCT03519243|5874|P1|STARTED|Overall Study||25
2637|NCT03519204|5905|P2|NOT COMPLETED|Overall Study||15
2638|NCT03519204|5906|P1|NOT COMPLETED|Overall Study||13
2639|NCT03519204|5905|P2|COMPLETED|Overall Study||118
2640|NCT03519204|5906|P1|COMPLETED|Overall Study||30
2641|NCT03519204|5905|P2|Safety Population|Overall Study||136
2642|NCT03519204|5906|P1|Safety Population|Overall Study||40
2643|NCT03519204|5905|P2|mITT Population|Overall Study||130
2644|NCT03519204|5906|P1|mITT Population|Overall Study||33
2645|NCT03519204|5905|P2|STARTED|Overall Study||133
2646|NCT03519204|5906|P1|STARTED|Overall Study|3 control participants were treated in error; 29 participants received treatment after 3 months.|43
2647|NCT03518008|5923|P2|NOT COMPLETED|Period 2, Second Week of Wear||1
2648|NCT03518008|5924|P1|NOT COMPLETED|Period 2, Second Week of Wear||0
2649|NCT03518008|5923|P2|COMPLETED|Period 2, Second Week of Wear||10
2650|NCT03518008|5924|P1|COMPLETED|Period 2, Second Week of Wear||11
2651|NCT03518008|5923|P2|STARTED|Period 2, Second Week of Wear||11
2652|NCT03518008|5924|P1|STARTED|Period 2, Second Week of Wear||11
2653|NCT03518008|5923|P2|NOT COMPLETED|Period 1, First Week of Wear||0
2654|NCT03518008|5924|P1|NOT COMPLETED|Period 1, First Week of Wear||0
2655|NCT03518008|5923|P2|COMPLETED|Period 1, First Week of Wear||11
2656|NCT03518008|5924|P1|COMPLETED|Period 1, First Week of Wear||11
2657|NCT03518008|5923|P2|STARTED|Period 1, First Week of Wear||11
2658|NCT03518008|5924|P1|STARTED|Period 1, First Week of Wear||11
2659|NCT03516227|5932|P2|NOT COMPLETED|Overall Study||4
2660|NCT03516227|5933|P1|NOT COMPLETED|Overall Study||1
2661|NCT03516227|5932|P2|COMPLETED|Overall Study||16
2662|NCT03516227|5933|P1|COMPLETED|Overall Study||19
2663|NCT03516227|5932|P2|STARTED|Overall Study||20
2664|NCT03516227|5933|P1|STARTED|Overall Study||20
2665|NCT03514966|5949|P2|NOT COMPLETED|Overall Study||0
2666|NCT03514966|5950|P1|NOT COMPLETED|Overall Study||0
2667|NCT03514966|5949|P2|COMPLETED|Overall Study||43
2668|NCT03514966|5950|P1|COMPLETED|Overall Study||40
2669|NCT03514966|5949|P2|STARTED|Overall Study||43
2670|NCT03514966|5950|P1|STARTED|Overall Study||40
2671|NCT03513848|5962|P2|NOT COMPLETED|Overall Study||0
2672|NCT03513848|5963|P1|NOT COMPLETED|Overall Study||0
2673|NCT03513848|5962|P2|COMPLETED|Overall Study||6
2674|NCT03513848|5963|P1|COMPLETED|Overall Study||9
2675|NCT03513848|5962|P2|STARTED|Overall Study||6
2676|NCT03513848|5963|P1|STARTED|Overall Study||9
2677|NCT03512067|5971|P1|NOT COMPLETED|Overall Study||0
2678|NCT03512067|5971|P1|COMPLETED|Overall Study||1
2679|NCT03512067|5971|P1|STARTED|Overall Study||1
2680|NCT03512041|5980|P4|NOT COMPLETED|Overall Study||0
2681|NCT03512041|5981|P3|NOT COMPLETED|Overall Study||0
2682|NCT03512041|5982|P2|NOT COMPLETED|Overall Study||0
2683|NCT03512041|5983|P1|NOT COMPLETED|Overall Study||0
2684|NCT03512041|5980|P4|COMPLETED|Overall Study||9
2685|NCT03512041|5981|P3|COMPLETED|Overall Study||11
2686|NCT03512041|5982|P2|COMPLETED|Overall Study||10
2687|NCT03512041|5983|P1|COMPLETED|Overall Study||10
2688|NCT03512041|5980|P4|STARTED|Overall Study||9
2689|NCT03512041|5981|P3|STARTED|Overall Study||11
2690|NCT03512041|5982|P2|STARTED|Overall Study||10
2691|NCT03512041|5983|P1|STARTED|Overall Study||10
2692|NCT03509948|6001|P2|NOT COMPLETED|Overall Study||1
2693|NCT03509948|6002|P1|NOT COMPLETED|Overall Study||0
2694|NCT03509948|6001|P2|COMPLETED|Overall Study||6
2695|NCT03509948|6002|P1|COMPLETED|Overall Study||6
2696|NCT03509948|6001|P2|STARTED|Overall Study||7
2697|NCT03509948|6002|P1|STARTED|Overall Study||6
2698|NCT03509766|6024|P1|NOT COMPLETED|Overall Study||0
2699|NCT03509766|6024|P1|COMPLETED|Overall Study||24
2700|NCT03509766|6024|P1|STARTED|Overall Study||24
2701|NCT03508843|6030|P1|NOT COMPLETED|Overall Study||3
2702|NCT03508843|6030|P1|COMPLETED|Overall Study||147
2703|NCT03508843|6030|P1|STARTED|Overall Study||150
2704|NCT03507569|6040|P4|NOT COMPLETED|Overall Study||0
2705|NCT03507569|6041|P3|NOT COMPLETED|Overall Study||0
2706|NCT03507569|6042|P2|NOT COMPLETED|Overall Study||0
2707|NCT03507569|6043|P1|NOT COMPLETED|Overall Study||0
2708|NCT03507569|6040|P4|COMPLETED|Overall Study||1
2709|NCT03507569|6041|P3|COMPLETED|Overall Study||2
2710|NCT03507569|6042|P2|COMPLETED|Overall Study||1
2711|NCT03507569|6043|P1|COMPLETED|Overall Study||2
2712|NCT03507569|6040|P4|STARTED|Overall Study||1
2713|NCT03507569|6041|P3|STARTED|Overall Study||2
2714|NCT03507569|6042|P2|STARTED|Overall Study||1
2715|NCT03507569|6043|P1|STARTED|Overall Study||2
2716|NCT03506295|6061|P1|NOT COMPLETED|Overall Study||0
2717|NCT03506295|6061|P1|COMPLETED|Overall Study||10
2718|NCT03506295|6061|P1|STARTED|Overall Study||10
2719|NCT03503578|6074|P1|NOT COMPLETED|Overall Study||0
2720|NCT03503578|6074|P1|COMPLETED|Overall Study||12
2721|NCT03503578|6074|P1|STARTED|Overall Study||12
2722|NCT03502915|6080|P2|NOT COMPLETED|Overall Study||0
2723|NCT03502915|6081|P1|NOT COMPLETED|Overall Study||0
2724|NCT03502915|6080|P2|COMPLETED|Overall Study||24
2725|NCT03502915|6081|P1|COMPLETED|Overall Study||24
2726|NCT03502915|6080|P2|STARTED|Overall Study||24
2727|NCT03502915|6081|P1|STARTED|Overall Study||24
2728|NCT03501277|6099|P4|NOT COMPLETED|Intervention Period 4 (4 Days)||0
2729|NCT03501277|6100|P3|NOT COMPLETED|Intervention Period 4 (4 Days)||0
2730|NCT03501277|6101|P2|NOT COMPLETED|Intervention Period 4 (4 Days)||0
2731|NCT03501277|6102|P1|NOT COMPLETED|Intervention Period 4 (4 Days)||0
2732|NCT03501277|6099|P4|COMPLETED|Intervention Period 4 (4 Days)||15
2733|NCT03501277|6100|P3|COMPLETED|Intervention Period 4 (4 Days)||17
2734|NCT03501277|6101|P2|COMPLETED|Intervention Period 4 (4 Days)||18
2735|NCT03501277|6102|P1|COMPLETED|Intervention Period 4 (4 Days)||18
2736|NCT03501277|6099|P4|STARTED|Intervention Period 4 (4 Days)||15
2737|NCT03501277|6100|P3|STARTED|Intervention Period 4 (4 Days)||17
2738|NCT03501277|6101|P2|STARTED|Intervention Period 4 (4 Days)||18
2739|NCT03501277|6102|P1|STARTED|Intervention Period 4 (4 Days)||18
2740|NCT03501277|6099|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
2741|NCT03501277|6100|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
2742|NCT03501277|6101|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
2743|NCT03501277|6102|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
2744|NCT03501277|6099|P4|COMPLETED|Washout Period 3 (7 Days)||15
2745|NCT03501277|6100|P3|COMPLETED|Washout Period 3 (7 Days)||17
2746|NCT03501277|6101|P2|COMPLETED|Washout Period 3 (7 Days)||18
2747|NCT03501277|6102|P1|COMPLETED|Washout Period 3 (7 Days)||18
2748|NCT03501277|6099|P4|STARTED|Washout Period 3 (7 Days)||15
2749|NCT03501277|6100|P3|STARTED|Washout Period 3 (7 Days)||17
2750|NCT03501277|6101|P2|STARTED|Washout Period 3 (7 Days)||18
2751|NCT03501277|6102|P1|STARTED|Washout Period 3 (7 Days)||18
2752|NCT03501277|6099|P4|NOT COMPLETED|Intervention Period 3 (4 Days)||1
2753|NCT03501277|6100|P3|NOT COMPLETED|Intervention Period 3 (4 Days)||0
2754|NCT03501277|6101|P2|NOT COMPLETED|Intervention Period 3 (4 Days)||0
2755|NCT03501277|6102|P1|NOT COMPLETED|Intervention Period 3 (4 Days)||0
2756|NCT03501277|6099|P4|COMPLETED|Intervention Period 3 (4 Days)||15
2757|NCT03501277|6100|P3|COMPLETED|Intervention Period 3 (4 Days)||17
2758|NCT03501277|6101|P2|COMPLETED|Intervention Period 3 (4 Days)||18
2759|NCT03501277|6102|P1|COMPLETED|Intervention Period 3 (4 Days)||18
2760|NCT03501277|6099|P4|STARTED|Intervention Period 3 (4 Days)||16
2761|NCT03501277|6100|P3|STARTED|Intervention Period 3 (4 Days)||17
2762|NCT03501277|6101|P2|STARTED|Intervention Period 3 (4 Days)||18
2763|NCT03501277|6102|P1|STARTED|Intervention Period 3 (4 Days)||18
2764|NCT03501277|6099|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
2765|NCT03501277|6100|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
2766|NCT03501277|6101|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
2767|NCT03501277|6102|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
2768|NCT03501277|6099|P4|COMPLETED|Washout Period 2 (7 Days)||16
2769|NCT03501277|6100|P3|COMPLETED|Washout Period 2 (7 Days)||17
2770|NCT03501277|6101|P2|COMPLETED|Washout Period 2 (7 Days)||18
2771|NCT03501277|6102|P1|COMPLETED|Washout Period 2 (7 Days)||18
2772|NCT03501277|6099|P4|STARTED|Washout Period 2 (7 Days)||16
2773|NCT03501277|6100|P3|STARTED|Washout Period 2 (7 Days)||17
2774|NCT03501277|6101|P2|STARTED|Washout Period 2 (7 Days)||18
2775|NCT03501277|6102|P1|STARTED|Washout Period 2 (7 Days)||18
2776|NCT03501277|6099|P4|NOT COMPLETED|Intervention Period 2 (4 Days)||1
2777|NCT03501277|6100|P3|NOT COMPLETED|Intervention Period 2 (4 Days)||0
2778|NCT03501277|6101|P2|NOT COMPLETED|Intervention Period 2 (4 Days)||0
2779|NCT03501277|6102|P1|NOT COMPLETED|Intervention Period 2 (4 Days)||0
2780|NCT03501277|6099|P4|COMPLETED|Intervention Period 2 (4 Days)||16
2781|NCT03501277|6100|P3|COMPLETED|Intervention Period 2 (4 Days)||17
2782|NCT03501277|6101|P2|COMPLETED|Intervention Period 2 (4 Days)||18
2783|NCT03501277|6102|P1|COMPLETED|Intervention Period 2 (4 Days)||18
2784|NCT03501277|6099|P4|STARTED|Intervention Period 2 (4 Days)||17
2785|NCT03501277|6100|P3|STARTED|Intervention Period 2 (4 Days)||17
2786|NCT03501277|6101|P2|STARTED|Intervention Period 2 (4 Days)||18
2787|NCT03501277|6102|P1|STARTED|Intervention Period 2 (4 Days)||18
2788|NCT03501277|6099|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
2789|NCT03501277|6100|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
2790|NCT03501277|6101|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
2791|NCT03501277|6102|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
2792|NCT03501277|6099|P4|COMPLETED|Washout Period 1 (7 Days)||17
2793|NCT03501277|6100|P3|COMPLETED|Washout Period 1 (7 Days)||17
2794|NCT03501277|6101|P2|COMPLETED|Washout Period 1 (7 Days)||18
2795|NCT03501277|6102|P1|COMPLETED|Washout Period 1 (7 Days)||18
2796|NCT03501277|6099|P4|STARTED|Washout Period 1 (7 Days)||17
2797|NCT03501277|6100|P3|STARTED|Washout Period 1 (7 Days)||17
2798|NCT03501277|6101|P2|STARTED|Washout Period 1 (7 Days)||18
2799|NCT03501277|6102|P1|STARTED|Washout Period 1 (7 Days)||18
2800|NCT03501277|6099|P4|NOT COMPLETED|Intervention Period 1 (4 Days)||1
2801|NCT03501277|6100|P3|NOT COMPLETED|Intervention Period 1 (4 Days)||1
2802|NCT03501277|6101|P2|NOT COMPLETED|Intervention Period 1 (4 Days)||0
2803|NCT03501277|6102|P1|NOT COMPLETED|Intervention Period 1 (4 Days)||0
2804|NCT03501277|6099|P4|COMPLETED|Intervention Period 1 (4 Days)||17
2805|NCT03501277|6100|P3|COMPLETED|Intervention Period 1 (4 Days)||17
2806|NCT03501277|6101|P2|COMPLETED|Intervention Period 1 (4 Days)||18
2807|NCT03501277|6102|P1|COMPLETED|Intervention Period 1 (4 Days)||18
2808|NCT03501277|6099|P4|Safety Analysis Set|Intervention Period 1 (4 Days)||17
2809|NCT03501277|6100|P3|Safety Analysis Set|Intervention Period 1 (4 Days)||17
2810|NCT03501277|6101|P2|Safety Analysis Set|Intervention Period 1 (4 Days)||18
2811|NCT03501277|6102|P1|Safety Analysis Set|Intervention Period 1 (4 Days)||18
2812|NCT03501277|6099|P4|STARTED|Intervention Period 1 (4 Days)||18
2813|NCT03501277|6100|P3|STARTED|Intervention Period 1 (4 Days)||18
2814|NCT03501277|6101|P2|STARTED|Intervention Period 1 (4 Days)||18
2815|NCT03501277|6102|P1|STARTED|Intervention Period 1 (4 Days)||18
2816|NCT03501264|6118|P2|NOT COMPLETED|Overall Study||0
2817|NCT03501264|6119|P1|NOT COMPLETED|Overall Study||0
2818|NCT03501264|6118|P2|COMPLETED|Overall Study||120
2819|NCT03501264|6119|P1|COMPLETED|Overall Study||120
2820|NCT03501264|6118|P2|STARTED|Overall Study||120
2821|NCT03501264|6119|P1|STARTED|Overall Study||120
2822|NCT03500679|6127|P2|NOT COMPLETED|Overall Study||3
2823|NCT03500679|6128|P1|NOT COMPLETED|Overall Study||9
2824|NCT03500679|6127|P2|COMPLETED|Overall Study||22
2825|NCT03500679|6128|P1|COMPLETED|Overall Study||66
2826|NCT03500679|6127|P2|STARTED|Overall Study||25
2827|NCT03500679|6128|P1|STARTED|Overall Study||75
2828|NCT03500224|6174|P1|NOT COMPLETED|Overall Study||2
2829|NCT03500224|6174|P1|COMPLETED|Overall Study||4
2830|NCT03500224|6174|P1|STARTED|Overall Study||6
2831|NCT03500159|6213|P2|NOT COMPLETED|Overall Study||1
2832|NCT03500159|6214|P1|NOT COMPLETED|Overall Study||2
2833|NCT03500159|6213|P2|COMPLETED|Overall Study||0
2834|NCT03500159|6214|P1|COMPLETED|Overall Study||0
2835|NCT03500159|6213|P2|STARTED|Overall Study||1
2836|NCT03500159|6214|P1|STARTED|Overall Study||2
2837|NCT03496987|6222|P2|NOT COMPLETED|Overall Study||0
2838|NCT03496987|6223|P1|NOT COMPLETED|Overall Study||0
2839|NCT03496987|6222|P2|COMPLETED|Overall Study||51
2840|NCT03496987|6223|P1|COMPLETED|Overall Study||49
2841|NCT03496987|6222|P2|STARTED|Overall Study||51
2842|NCT03496987|6223|P1|STARTED|Overall Study||49
2843|NCT03496974|6243|P2|NOT COMPLETED|Overall Study||8
2844|NCT03496974|6244|P1|NOT COMPLETED|Overall Study||1
2845|NCT03496974|6243|P2|COMPLETED|Overall Study||20
2846|NCT03496974|6244|P1|COMPLETED|Overall Study||9
2847|NCT03496974|6243|P2|STARTED|Overall Study||28
2848|NCT03496974|6244|P1|STARTED|Overall Study||10
2849|NCT03496428|6278|P1|NOT COMPLETED|Overall Study||0
2850|NCT03496428|6278|P1|COMPLETED|Overall Study|304 locations distributed for the analyzed teeth 108 locations distributed for the implant spots|6
2851|NCT03496428|6278|P1|STARTED|Overall Study|304 locations distributed for the analyzed teeth 108 locations distributed for the implant spots|6
2852|NCT03496324|6283|P4|NOT COMPLETED|Period 7: Period 4||0
2853|NCT03496324|6284|P3|NOT COMPLETED|Period 7: Period 4||0
2854|NCT03496324|6285|P2|NOT COMPLETED|Period 7: Period 4||0
2855|NCT03496324|6286|P1|NOT COMPLETED|Period 7: Period 4||0
2856|NCT03496324|6283|P4|COMPLETED|Period 7: Period 4||6
2857|NCT03496324|6284|P3|COMPLETED|Period 7: Period 4||6
2858|NCT03496324|6285|P2|COMPLETED|Period 7: Period 4||6
2859|NCT03496324|6286|P1|COMPLETED|Period 7: Period 4||6
2860|NCT03496324|6283|P4|STARTED|Period 7: Period 4||6
2861|NCT03496324|6284|P3|STARTED|Period 7: Period 4||6
2862|NCT03496324|6285|P2|STARTED|Period 7: Period 4||6
2863|NCT03496324|6286|P1|STARTED|Period 7: Period 4||6
2864|NCT03496324|6283|P4|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
2865|NCT03496324|6284|P3|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
2866|NCT03496324|6285|P2|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
2867|NCT03496324|6286|P1|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
2868|NCT03496324|6283|P4|COMPLETED|Period 3: Washout (3 to 7 Days)||6
2869|NCT03496324|6284|P3|COMPLETED|Period 3: Washout (3 to 7 Days)||6
2870|NCT03496324|6285|P2|COMPLETED|Period 3: Washout (3 to 7 Days)||6
2871|NCT03496324|6286|P1|COMPLETED|Period 3: Washout (3 to 7 Days)||6
2872|NCT03496324|6283|P4|STARTED|Period 3: Washout (3 to 7 Days)||6
2873|NCT03496324|6284|P3|STARTED|Period 3: Washout (3 to 7 Days)||6
2874|NCT03496324|6285|P2|STARTED|Period 3: Washout (3 to 7 Days)||6
2875|NCT03496324|6286|P1|STARTED|Period 3: Washout (3 to 7 Days)||6
2876|NCT03496324|6283|P4|NOT COMPLETED|Period 3||0
2877|NCT03496324|6284|P3|NOT COMPLETED|Period 3||0
2878|NCT03496324|6285|P2|NOT COMPLETED|Period 3||0
2879|NCT03496324|6286|P1|NOT COMPLETED|Period 3||0
2880|NCT03496324|6283|P4|COMPLETED|Period 3||6
2881|NCT03496324|6284|P3|COMPLETED|Period 3||6
2882|NCT03496324|6285|P2|COMPLETED|Period 3||6
2883|NCT03496324|6286|P1|COMPLETED|Period 3||6
2884|NCT03496324|6283|P4|STARTED|Period 3||6
2885|NCT03496324|6284|P3|STARTED|Period 3||6
2886|NCT03496324|6285|P2|STARTED|Period 3||6
2887|NCT03496324|6286|P1|STARTED|Period 3||6
2888|NCT03496324|6283|P4|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
2889|NCT03496324|6284|P3|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
2890|NCT03496324|6285|P2|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
2891|NCT03496324|6286|P1|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
2892|NCT03496324|6283|P4|COMPLETED|Period 2: Washout (3 to 7 Days)||6
2893|NCT03496324|6284|P3|COMPLETED|Period 2: Washout (3 to 7 Days)||6
2894|NCT03496324|6285|P2|COMPLETED|Period 2: Washout (3 to 7 Days)||6
2895|NCT03496324|6286|P1|COMPLETED|Period 2: Washout (3 to 7 Days)||6
2896|NCT03496324|6283|P4|STARTED|Period 2: Washout (3 to 7 Days)||6
2897|NCT03496324|6284|P3|STARTED|Period 2: Washout (3 to 7 Days)||6
2898|NCT03496324|6285|P2|STARTED|Period 2: Washout (3 to 7 Days)||6
2899|NCT03496324|6286|P1|STARTED|Period 2: Washout (3 to 7 Days)||6
2900|NCT03496324|6283|P4|NOT COMPLETED|Period 2||0
2901|NCT03496324|6284|P3|NOT COMPLETED|Period 2||0
2902|NCT03496324|6285|P2|NOT COMPLETED|Period 2||0
2903|NCT03496324|6286|P1|NOT COMPLETED|Period 2||0
2904|NCT03496324|6283|P4|COMPLETED|Period 2||6
2905|NCT03496324|6284|P3|COMPLETED|Period 2||6
2906|NCT03496324|6285|P2|COMPLETED|Period 2||6
2907|NCT03496324|6286|P1|COMPLETED|Period 2||6
2908|NCT03496324|6283|P4|STARTED|Period 2||6
2909|NCT03496324|6284|P3|STARTED|Period 2||6
2910|NCT03496324|6285|P2|STARTED|Period 2||6
2911|NCT03496324|6286|P1|STARTED|Period 2||6
2912|NCT03496324|6283|P4|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
2913|NCT03496324|6284|P3|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
2914|NCT03496324|6285|P2|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
2915|NCT03496324|6286|P1|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
2916|NCT03496324|6283|P4|COMPLETED|Period 1: Washout (3 to 7 Days)||6
2917|NCT03496324|6284|P3|COMPLETED|Period 1: Washout (3 to 7 Days)||6
2918|NCT03496324|6285|P2|COMPLETED|Period 1: Washout (3 to 7 Days)||6
2919|NCT03496324|6286|P1|COMPLETED|Period 1: Washout (3 to 7 Days)||6
2920|NCT03496324|6283|P4|STARTED|Period 1: Washout (3 to 7 Days)||6
2921|NCT03496324|6284|P3|STARTED|Period 1: Washout (3 to 7 Days)||6
2922|NCT03496324|6285|P2|STARTED|Period 1: Washout (3 to 7 Days)||6
2923|NCT03496324|6286|P1|STARTED|Period 1: Washout (3 to 7 Days)||6
2924|NCT03496324|6283|P4|NOT COMPLETED|Period 1||0
2925|NCT03496324|6284|P3|NOT COMPLETED|Period 1||0
2926|NCT03496324|6285|P2|NOT COMPLETED|Period 1||0
2927|NCT03496324|6286|P1|NOT COMPLETED|Period 1||0
2928|NCT03496324|6283|P4|COMPLETED|Period 1||6
2929|NCT03496324|6284|P3|COMPLETED|Period 1||6
2930|NCT03496324|6285|P2|COMPLETED|Period 1||6
2931|NCT03496324|6286|P1|COMPLETED|Period 1||6
2932|NCT03496324|6283|P4|STARTED|Period 1||6
2933|NCT03496324|6284|P3|STARTED|Period 1||6
2934|NCT03496324|6285|P2|STARTED|Period 1||6
2935|NCT03496324|6286|P1|STARTED|Period 1||6
2936|NCT03495856|6324|P1|NOT COMPLETED|Overall Study||1
2937|NCT03495856|6324|P1|COMPLETED|Overall Study||22
2938|NCT03495856|6324|P1|STARTED|Overall Study||23
2939|NCT03494985|6346|P4|NOT COMPLETED|Overall Study||5
2940|NCT03494985|6347|P3|NOT COMPLETED|Overall Study||6
2941|NCT03494985|6348|P2|NOT COMPLETED|Overall Study||6
2942|NCT03494985|6349|P1|NOT COMPLETED|Overall Study||5
2943|NCT03494985|6346|P4|COMPLETED|Overall Study||94
2944|NCT03494985|6347|P3|COMPLETED|Overall Study||92
2945|NCT03494985|6348|P2|COMPLETED|Overall Study||92
2946|NCT03494985|6349|P1|COMPLETED|Overall Study||96
2947|NCT03494985|6346|P4|STARTED|Overall Study||99
2948|NCT03494985|6347|P3|STARTED|Overall Study||98
2949|NCT03494985|6348|P2|STARTED|Overall Study||98
2950|NCT03494985|6349|P1|STARTED|Overall Study||101
2951|NCT03493828|6386|P3|NOT COMPLETED|Overall Study||0
2952|NCT03493828|6387|P2|NOT COMPLETED|Overall Study||0
2953|NCT03493828|6388|P1|NOT COMPLETED|Overall Study||0
2954|NCT03493828|6386|P3|COMPLETED|Overall Study||20
2955|NCT03493828|6387|P2|COMPLETED|Overall Study||20
2956|NCT03493828|6388|P1|COMPLETED|Overall Study||20
2957|NCT03493828|6386|P3|STARTED|Overall Study||20
2958|NCT03493828|6387|P2|STARTED|Overall Study||20
2959|NCT03493828|6388|P1|STARTED|Overall Study||20
2960|NCT03493386|6398|P4|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
2961|NCT03493386|6399|P3|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
2962|NCT03493386|6400|P2|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
2963|NCT03493386|6401|P1|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
2964|NCT03493386|6398|P4|COMPLETED|Part 2, Intervention Period 2 (2 Days)||6
2965|NCT03493386|6399|P3|COMPLETED|Part 2, Intervention Period 2 (2 Days)||6
2966|NCT03493386|6400|P2|COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
2967|NCT03493386|6401|P1|COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
2968|NCT03493386|6398|P4|STARTED|Part 2, Intervention Period 2 (2 Days)||6
2969|NCT03493386|6399|P3|STARTED|Part 2, Intervention Period 2 (2 Days)||6
2970|NCT03493386|6400|P2|STARTED|Part 2, Intervention Period 2 (2 Days)||0
2971|NCT03493386|6401|P1|STARTED|Part 2, Intervention Period 2 (2 Days)||0
2972|NCT03493386|6398|P4|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
2973|NCT03493386|6399|P3|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
2974|NCT03493386|6400|P2|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
2975|NCT03493386|6401|P1|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
2976|NCT03493386|6398|P4|COMPLETED|Part 2, Washout Period (at Least 5 Days)||6
2977|NCT03493386|6399|P3|COMPLETED|Part 2, Washout Period (at Least 5 Days)||6
2978|NCT03493386|6400|P2|COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
2979|NCT03493386|6401|P1|COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
2980|NCT03493386|6398|P4|STARTED|Part 2, Washout Period (at Least 5 Days)||6
2981|NCT03493386|6399|P3|STARTED|Part 2, Washout Period (at Least 5 Days)||6
2982|NCT03493386|6400|P2|STARTED|Part 2, Washout Period (at Least 5 Days)||0
2983|NCT03493386|6401|P1|STARTED|Part 2, Washout Period (at Least 5 Days)||0
2984|NCT03493386|6398|P4|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
2985|NCT03493386|6399|P3|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
2986|NCT03493386|6400|P2|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
2987|NCT03493386|6401|P1|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
2988|NCT03493386|6398|P4|COMPLETED|Part 2, Intervention Period 1 (2 Days)||6
2989|NCT03493386|6399|P3|COMPLETED|Part 2, Intervention Period 1 (2 Days)||6
2990|NCT03493386|6400|P2|COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
2991|NCT03493386|6401|P1|COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
2992|NCT03493386|6398|P4|STARTED|Part 2, Intervention Period 1 (2 Days)||6
2993|NCT03493386|6399|P3|STARTED|Part 2, Intervention Period 1 (2 Days)||6
2994|NCT03493386|6400|P2|STARTED|Part 2, Intervention Period 1 (2 Days)||0
2995|NCT03493386|6401|P1|STARTED|Part 2, Intervention Period 1 (2 Days)||0
2996|NCT03493386|6398|P4|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
2997|NCT03493386|6399|P3|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
2998|NCT03493386|6400|P2|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
2999|NCT03493386|6401|P1|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
3000|NCT03493386|6398|P4|COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
3001|NCT03493386|6399|P3|COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
3002|NCT03493386|6400|P2|COMPLETED|Part 1, Intervention Period 2 (2 Days)||25
3003|NCT03493386|6401|P1|COMPLETED|Part 1, Intervention Period 2 (2 Days)||26
3004|NCT03493386|6398|P4|STARTED|Part 1, Intervention Period 2 (2 Days)||0
3005|NCT03493386|6399|P3|STARTED|Part 1, Intervention Period 2 (2 Days)||0
3006|NCT03493386|6400|P2|STARTED|Part 1, Intervention Period 2 (2 Days)||25
3007|NCT03493386|6401|P1|STARTED|Part 1, Intervention Period 2 (2 Days)||26
3008|NCT03493386|6398|P4|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
3009|NCT03493386|6399|P3|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
3010|NCT03493386|6400|P2|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||1
3011|NCT03493386|6401|P1|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
3012|NCT03493386|6398|P4|COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
3013|NCT03493386|6399|P3|COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
3014|NCT03493386|6400|P2|COMPLETED|Part 1, Washout Period (at Least 5 Days)||25
3015|NCT03493386|6401|P1|COMPLETED|Part 1, Washout Period (at Least 5 Days)||26
3016|NCT03493386|6398|P4|STARTED|Part 1, Washout Period (at Least 5 Days)||0
3017|NCT03493386|6399|P3|STARTED|Part 1, Washout Period (at Least 5 Days)||0
3018|NCT03493386|6400|P2|STARTED|Part 1, Washout Period (at Least 5 Days)||26
3019|NCT03493386|6401|P1|STARTED|Part 1, Washout Period (at Least 5 Days)||26
3020|NCT03493386|6398|P4|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
3021|NCT03493386|6399|P3|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
3022|NCT03493386|6400|P2|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
3023|NCT03493386|6401|P1|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
3024|NCT03493386|6398|P4|COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
3025|NCT03493386|6399|P3|COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
3026|NCT03493386|6400|P2|COMPLETED|Part 1, Intervention Period 1 (2 Days)||26
3027|NCT03493386|6401|P1|COMPLETED|Part 1, Intervention Period 1 (2 Days)||26
3028|NCT03493386|6398|P4|STARTED|Part 1, Intervention Period 1 (2 Days)||0
3029|NCT03493386|6399|P3|STARTED|Part 1, Intervention Period 1 (2 Days)||0
3030|NCT03493386|6400|P2|STARTED|Part 1, Intervention Period 1 (2 Days)||26
3031|NCT03493386|6401|P1|STARTED|Part 1, Intervention Period 1 (2 Days)||26
3032|NCT03492554|6521|P2|NOT COMPLETED|Overall Study||14
3033|NCT03492554|6522|P1|NOT COMPLETED|Overall Study||0
3034|NCT03492554|6521|P2|COMPLETED|Overall Study||287
3035|NCT03492554|6522|P1|COMPLETED|Overall Study||301
3036|NCT03492554|6521|P2|STARTED|Overall Study||301
3037|NCT03492554|6522|P1|STARTED|Overall Study||301
3038|NCT03491891|6536|P2|NOT COMPLETED|Overall Study||380
3039|NCT03491891|6537|P1|NOT COMPLETED|Overall Study||853
3040|NCT03491891|6536|P2|COMPLETED|Overall Study||2058
3041|NCT03491891|6537|P1|COMPLETED|Overall Study||5185
3042|NCT03491891|6536|P2|STARTED|Overall Study||2438
3043|NCT03491891|6537|P1|STARTED|Overall Study||6038
3044|NCT03491228|6543|P1|NOT COMPLETED|Overall Study||0
3045|NCT03491228|6543|P1|COMPLETED|Overall Study||107
3046|NCT03491228|6543|P1|STARTED|Overall Study||107
3047|NCT03490916|6551|P2|NOT COMPLETED|Overall Study||0
3048|NCT03490916|6552|P1|NOT COMPLETED|Overall Study||0
3049|NCT03490916|6551|P2|COMPLETED|Overall Study||0
3050|NCT03490916|6552|P1|COMPLETED|Overall Study||0
3051|NCT03490916|6551|P2|STARTED|Overall Study||0
3052|NCT03490916|6552|P1|STARTED|Overall Study||0
3053|NCT03489551|6560|P1|NOT COMPLETED|Overall Study||2
3054|NCT03489551|6560|P1|COMPLETED|Overall Study||15
3055|NCT03489551|6560|P1|STARTED|Overall Study||17
3056|NCT03489304|6564|P1|NOT COMPLETED|Overall Study||4
3057|NCT03489304|6564|P1|COMPLETED|Overall Study||16
3058|NCT03489304|6564|P1|STARTED|Overall Study||20
3059|NCT03487588|6570|P1|NOT COMPLETED|Overall Study||0
3060|NCT03487588|6570|P1|COMPLETED|Overall Study||41
3061|NCT03487588|6570|P1|STARTED|Overall Study||41
3062|NCT03483896|6578|P2|NOT COMPLETED|Overall Study||4
3063|NCT03483896|6579|P1|NOT COMPLETED|Overall Study||2
3064|NCT03483896|6578|P2|COMPLETED|Overall Study||46
3065|NCT03483896|6579|P1|COMPLETED|Overall Study||31
3066|NCT03483896|6578|P2|STARTED|Overall Study||50
3067|NCT03483896|6579|P1|STARTED|Overall Study||33
3068|NCT03482713|6589|P2|NOT COMPLETED|Overall Study||0
3069|NCT03482713|6590|P1|NOT COMPLETED|Overall Study||0
3070|NCT03482713|6589|P2|COMPLETED|Overall Study||12
3071|NCT03482713|6590|P1|COMPLETED|Overall Study||11
3072|NCT03482713|6589|P2|STARTED|Overall Study||12
3073|NCT03482713|6590|P1|STARTED|Overall Study||11
3074|NCT03481309|6608|P6|NOT COMPLETED|Third Intervention (1 Day)||0
3075|NCT03481309|6609|P5|NOT COMPLETED|Third Intervention (1 Day)||0
3076|NCT03481309|6610|P4|NOT COMPLETED|Third Intervention (1 Day)||0
3077|NCT03481309|6611|P3|NOT COMPLETED|Third Intervention (1 Day)||0
3078|NCT03481309|6612|P2|NOT COMPLETED|Third Intervention (1 Day)||0
3079|NCT03481309|6613|P1|NOT COMPLETED|Third Intervention (1 Day)||0
3080|NCT03481309|6608|P6|COMPLETED|Third Intervention (1 Day)||3
3081|NCT03481309|6609|P5|COMPLETED|Third Intervention (1 Day)||3
3082|NCT03481309|6610|P4|COMPLETED|Third Intervention (1 Day)||3
3083|NCT03481309|6611|P3|COMPLETED|Third Intervention (1 Day)||3
3084|NCT03481309|6612|P2|COMPLETED|Third Intervention (1 Day)||3
3085|NCT03481309|6613|P1|COMPLETED|Third Intervention (1 Day)||3
3086|NCT03481309|6608|P6|STARTED|Third Intervention (1 Day)||3
3087|NCT03481309|6609|P5|STARTED|Third Intervention (1 Day)||3
3088|NCT03481309|6610|P4|STARTED|Third Intervention (1 Day)||3
3089|NCT03481309|6611|P3|STARTED|Third Intervention (1 Day)||3
3090|NCT03481309|6612|P2|STARTED|Third Intervention (1 Day)||3
3091|NCT03481309|6613|P1|STARTED|Third Intervention (1 Day)||3
3092|NCT03481309|6608|P6|NOT COMPLETED|Washout (at Least 3 Days)||0
3093|NCT03481309|6609|P5|NOT COMPLETED|Washout (at Least 3 Days)||0
3094|NCT03481309|6610|P4|NOT COMPLETED|Washout (at Least 3 Days)||0
3095|NCT03481309|6611|P3|NOT COMPLETED|Washout (at Least 3 Days)||0
3096|NCT03481309|6612|P2|NOT COMPLETED|Washout (at Least 3 Days)||0
3097|NCT03481309|6613|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
3098|NCT03481309|6608|P6|COMPLETED|Washout (at Least 3 Days)||3
3099|NCT03481309|6609|P5|COMPLETED|Washout (at Least 3 Days)||3
3100|NCT03481309|6610|P4|COMPLETED|Washout (at Least 3 Days)||3
3101|NCT03481309|6611|P3|COMPLETED|Washout (at Least 3 Days)||3
3102|NCT03481309|6612|P2|COMPLETED|Washout (at Least 3 Days)||3
3103|NCT03481309|6613|P1|COMPLETED|Washout (at Least 3 Days)||3
3104|NCT03481309|6608|P6|STARTED|Washout (at Least 3 Days)||3
3105|NCT03481309|6609|P5|STARTED|Washout (at Least 3 Days)||3
3106|NCT03481309|6610|P4|STARTED|Washout (at Least 3 Days)||3
3107|NCT03481309|6611|P3|STARTED|Washout (at Least 3 Days)||3
3108|NCT03481309|6612|P2|STARTED|Washout (at Least 3 Days)||3
3109|NCT03481309|6613|P1|STARTED|Washout (at Least 3 Days)||3
3110|NCT03481309|6608|P6|NOT COMPLETED|Second Intervention (1 Day)||0
3111|NCT03481309|6609|P5|NOT COMPLETED|Second Intervention (1 Day)||0
3112|NCT03481309|6610|P4|NOT COMPLETED|Second Intervention (1 Day)||0
3113|NCT03481309|6611|P3|NOT COMPLETED|Second Intervention (1 Day)||0
3114|NCT03481309|6612|P2|NOT COMPLETED|Second Intervention (1 Day)||0
3115|NCT03481309|6613|P1|NOT COMPLETED|Second Intervention (1 Day)||0
3116|NCT03481309|6608|P6|COMPLETED|Second Intervention (1 Day)||3
3117|NCT03481309|6609|P5|COMPLETED|Second Intervention (1 Day)||3
3118|NCT03481309|6610|P4|COMPLETED|Second Intervention (1 Day)||3
3119|NCT03481309|6611|P3|COMPLETED|Second Intervention (1 Day)||3
3120|NCT03481309|6612|P2|COMPLETED|Second Intervention (1 Day)||3
3121|NCT03481309|6613|P1|COMPLETED|Second Intervention (1 Day)||3
3122|NCT03481309|6608|P6|STARTED|Second Intervention (1 Day)||3
3123|NCT03481309|6609|P5|STARTED|Second Intervention (1 Day)||3
3124|NCT03481309|6610|P4|STARTED|Second Intervention (1 Day)||3
3125|NCT03481309|6611|P3|STARTED|Second Intervention (1 Day)||3
3126|NCT03481309|6612|P2|STARTED|Second Intervention (1 Day)||3
3127|NCT03481309|6613|P1|STARTED|Second Intervention (1 Day)||3
3128|NCT03481309|6608|P6|NOT COMPLETED|Washout (at Least 3 Days)||0
3129|NCT03481309|6609|P5|NOT COMPLETED|Washout (at Least 3 Days)||0
3130|NCT03481309|6610|P4|NOT COMPLETED|Washout (at Least 3 Days)||0
3131|NCT03481309|6611|P3|NOT COMPLETED|Washout (at Least 3 Days)||0
3132|NCT03481309|6612|P2|NOT COMPLETED|Washout (at Least 3 Days)||0
3133|NCT03481309|6613|P1|NOT COMPLETED|Washout (at Least 3 Days)||1
3134|NCT03481309|6608|P6|COMPLETED|Washout (at Least 3 Days)||3
3135|NCT03481309|6609|P5|COMPLETED|Washout (at Least 3 Days)||3
3136|NCT03481309|6610|P4|COMPLETED|Washout (at Least 3 Days)||3
3137|NCT03481309|6611|P3|COMPLETED|Washout (at Least 3 Days)||3
3138|NCT03481309|6612|P2|COMPLETED|Washout (at Least 3 Days)||3
3139|NCT03481309|6613|P1|COMPLETED|Washout (at Least 3 Days)||3
3140|NCT03481309|6608|P6|STARTED|Washout (at Least 3 Days)||3
3141|NCT03481309|6609|P5|STARTED|Washout (at Least 3 Days)||3
3142|NCT03481309|6610|P4|STARTED|Washout (at Least 3 Days)||3
3143|NCT03481309|6611|P3|STARTED|Washout (at Least 3 Days)||3
3144|NCT03481309|6612|P2|STARTED|Washout (at Least 3 Days)||3
3145|NCT03481309|6613|P1|STARTED|Washout (at Least 3 Days)||4
3146|NCT03481309|6608|P6|NOT COMPLETED|First Intervention (1 Day)||0
3147|NCT03481309|6609|P5|NOT COMPLETED|First Intervention (1 Day)||0
3148|NCT03481309|6610|P4|NOT COMPLETED|First Intervention (1 Day)||0
3149|NCT03481309|6611|P3|NOT COMPLETED|First Intervention (1 Day)||0
3150|NCT03481309|6612|P2|NOT COMPLETED|First Intervention (1 Day)||0
3151|NCT03481309|6613|P1|NOT COMPLETED|First Intervention (1 Day)||0
3152|NCT03481309|6608|P6|COMPLETED|First Intervention (1 Day)||3
3153|NCT03481309|6609|P5|COMPLETED|First Intervention (1 Day)||3
3154|NCT03481309|6610|P4|COMPLETED|First Intervention (1 Day)||3
3155|NCT03481309|6611|P3|COMPLETED|First Intervention (1 Day)||3
3156|NCT03481309|6612|P2|COMPLETED|First Intervention (1 Day)||3
3157|NCT03481309|6613|P1|COMPLETED|First Intervention (1 Day)||4
3158|NCT03481309|6608|P6|STARTED|First Intervention (1 Day)||3
3159|NCT03481309|6609|P5|STARTED|First Intervention (1 Day)||3
3160|NCT03481309|6610|P4|STARTED|First Intervention (1 Day)||3
3161|NCT03481309|6611|P3|STARTED|First Intervention (1 Day)||3
3162|NCT03481309|6612|P2|STARTED|First Intervention (1 Day)||3
3163|NCT03481309|6613|P1|STARTED|First Intervention (1 Day)||4
3164|NCT03481270|6629|P2|NOT COMPLETED|Overall Study||0
3165|NCT03481270|6630|P1|NOT COMPLETED|Overall Study||0
3166|NCT03481270|6629|P2|COMPLETED|Overall Study||313
3167|NCT03481270|6630|P1|COMPLETED|Overall Study||324
3168|NCT03481270|6629|P2|STARTED|Overall Study||313
3169|NCT03481270|6630|P1|STARTED|Overall Study||324
3170|NCT03480919|6639|P3|NOT COMPLETED|Overall Study||0
3171|NCT03480919|6640|P2|NOT COMPLETED|Overall Study||0
3172|NCT03480919|6641|P1|NOT COMPLETED|Overall Study||0
3173|NCT03480919|6639|P3|COMPLETED|Overall Study||1
3174|NCT03480919|6640|P2|COMPLETED|Overall Study||2
3175|NCT03480919|6641|P1|COMPLETED|Overall Study||1
3176|NCT03480919|6639|P3|STARTED|Overall Study||1
3177|NCT03480919|6640|P2|STARTED|Overall Study||2
3178|NCT03480919|6641|P1|STARTED|Overall Study||1
3179|NCT03480048|6657|P2|NOT COMPLETED|Overall Study||8
3180|NCT03480048|6658|P1|NOT COMPLETED|Overall Study||10
3181|NCT03480048|6657|P2|COMPLETED|Overall Study||17
3182|NCT03480048|6658|P1|COMPLETED|Overall Study||18
3183|NCT03480048|6657|P2|STARTED|Overall Study||25
3184|NCT03480048|6658|P1|STARTED|Overall Study||28
3185|NCT03479216|6668|P2|NOT COMPLETED|Overall Study||5
3186|NCT03479216|6669|P1|NOT COMPLETED|Overall Study||5
3187|NCT03479216|6668|P2|COMPLETED|Overall Study||26
3188|NCT03479216|6669|P1|COMPLETED|Overall Study||26
3189|NCT03479216|6668|P2|STARTED|Overall Study||31
3190|NCT03479216|6669|P1|STARTED|Overall Study||31
3191|NCT03478891|6690|P3|NOT COMPLETED|Overall Study||3
3192|NCT03478891|6691|P2|NOT COMPLETED|Overall Study||0
3193|NCT03478891|6692|P1|NOT COMPLETED|Overall Study||1
3194|NCT03478891|6690|P3|COMPLETED|Overall Study||8
3195|NCT03478891|6691|P2|COMPLETED|Overall Study||5
3196|NCT03478891|6692|P1|COMPLETED|Overall Study||2
3197|NCT03478891|6690|P3|Received MAb114|Overall Study|A Group 3 subject discontinued prior to MAb114 infusion due to suboptimal IV access|10
3198|NCT03478891|6691|P2|Received MAb114|Overall Study||5
3199|NCT03478891|6692|P1|Received MAb114|Overall Study||3
3200|NCT03478891|6690|P3|STARTED|Overall Study||11
3201|NCT03478891|6691|P2|STARTED|Overall Study||5
3202|NCT03478891|6692|P1|STARTED|Overall Study||3
3203|NCT03478644|6743|P2|NOT COMPLETED|Phase 2||1
3204|NCT03478644|6744|P1|NOT COMPLETED|Phase 2||3
3205|NCT03478644|6743|P2|COMPLETED|Phase 2||75
3206|NCT03478644|6744|P1|COMPLETED|Phase 2||73
3207|NCT03478644|6743|P2|STARTED|Phase 2||76
3208|NCT03478644|6744|P1|STARTED|Phase 2||76
3209|NCT03478644|6743|P2|NOT COMPLETED|Phase 1||0
3210|NCT03478644|6744|P1|NOT COMPLETED|Phase 1||0
3211|NCT03478644|6743|P2|COMPLETED|Phase 1||0
3212|NCT03478644|6744|P1|COMPLETED|Phase 1|In Phase 1, only the wipe treatment was administered to eligible participants.|31
3213|NCT03478644|6743|P2|STARTED|Phase 1||0
3214|NCT03478644|6744|P1|STARTED|Phase 1|In Phase 1, only the wipe treatment was administered to eligible participants.|31
3215|NCT03478371|6756|P1|NOT COMPLETED|Overall Study||5
3216|NCT03478371|6756|P1|COMPLETED|Overall Study||89
3217|NCT03478371|6756|P1|Received Tampon V|Overall Study||91
3218|NCT03478371|6756|P1|Recived Tampon T|Overall Study||90
3219|NCT03478371|6756|P1|Received Tampon M|Overall Study||92
3220|NCT03478371|6756|P1|Received Tampon D|Overall Study||91
3221|NCT03478371|6756|P1|STARTED|Overall Study||94
3222|NCT03477903|6778|P1|NOT COMPLETED|Overall Study||1
3223|NCT03477903|6778|P1|COMPLETED|Overall Study||0
3224|NCT03477903|6778|P1|STARTED|Overall Study||1
3225|NCT03476278|6789|P1|NOT COMPLETED|Overall Study||0
3226|NCT03476278|6789|P1|COMPLETED|Overall Study||300
3227|NCT03476278|6789|P1|STARTED|Overall Study||300
3228|NCT03475875|6835|P2|NOT COMPLETED|Period 3||0
3229|NCT03475875|6836|P1|NOT COMPLETED|Period 3||0
3230|NCT03475875|6835|P2|COMPLETED|Period 3||43
3231|NCT03475875|6836|P1|COMPLETED|Period 3||40
3232|NCT03475875|6835|P2|STARTED|Period 3||43
3233|NCT03475875|6836|P1|STARTED|Period 3||40
3234|NCT03475875|6835|P2|NOT COMPLETED|Period 2||1
3235|NCT03475875|6836|P1|NOT COMPLETED|Period 2||3
3236|NCT03475875|6835|P2|COMPLETED|Period 2||43
3237|NCT03475875|6836|P1|COMPLETED|Period 2||40
3238|NCT03475875|6835|P2|STARTED|Period 2||44
3239|NCT03475875|6836|P1|STARTED|Period 2||43
3240|NCT03475875|6835|P2|NOT COMPLETED|Period 1||1
3241|NCT03475875|6836|P1|NOT COMPLETED|Period 1||3
3242|NCT03475875|6835|P2|COMPLETED|Period 1||44
3243|NCT03475875|6836|P1|COMPLETED|Period 1||43
3244|NCT03475875|6835|P2|STARTED|Period 1||45
3245|NCT03475875|6836|P1|STARTED|Period 1||46
3246|NCT03474874|6844|P1|NOT COMPLETED|Overall Study||14
3247|NCT03474874|6844|P1|COMPLETED|Overall Study||54
3248|NCT03474874|6844|P1|STARTED|Overall Study||68
3249|NCT03473808|6853|P1|NOT COMPLETED|Overall Study||1
3250|NCT03473808|6853|P1|COMPLETED|Overall Study||4
3251|NCT03473808|6853|P1|STARTED|Overall Study||5
3252|NCT03472547|6860|P1|NOT COMPLETED|Overall Study||30
3253|NCT03472547|6860|P1|COMPLETED|Overall Study||204
3254|NCT03472547|6860|P1|STARTED|Overall Study||234
3255|NCT03471975|6866|P2|NOT COMPLETED|Overall Study||0
3256|NCT03471975|6867|P1|NOT COMPLETED|Overall Study||0
3257|NCT03471975|6866|P2|COMPLETED|Overall Study||20
3258|NCT03471975|6867|P1|COMPLETED|Overall Study||17
3259|NCT03471975|6866|P2|STARTED|Overall Study||20
3260|NCT03471975|6867|P1|STARTED|Overall Study||17
3261|NCT03470740|6877|P2|NOT COMPLETED|Overall Study||6
3262|NCT03470740|6878|P1|NOT COMPLETED|Overall Study||4
3263|NCT03470740|6877|P2|COMPLETED|Overall Study||106
3264|NCT03470740|6878|P1|COMPLETED|Overall Study||108
3265|NCT03470740|6877|P2|STARTED|Overall Study||112
3266|NCT03470740|6878|P1|STARTED|Overall Study||112
3267|NCT03468920|6898|P2|NOT COMPLETED|Overall Study||0
3268|NCT03468920|6899|P1|NOT COMPLETED|Overall Study||0
3269|NCT03468920|6898|P2|COMPLETED|Overall Study||60
3270|NCT03468920|6899|P1|COMPLETED|Overall Study||60
3271|NCT03468920|6898|P2|STARTED|Overall Study||60
3272|NCT03468920|6899|P1|STARTED|Overall Study||60
3273|NCT03468543|6916|P1|NOT COMPLETED|Overall Study||3
3274|NCT03468543|6916|P1|COMPLETED|Overall Study||0
3275|NCT03468543|6916|P1|STARTED|Overall Study||3
3276|NCT03467971|6922|P2|NOT COMPLETED|Treatment Period 2||1
3277|NCT03467971|6923|P1|NOT COMPLETED|Treatment Period 2||0
3278|NCT03467971|6922|P2|COMPLETED|Treatment Period 2||10
3279|NCT03467971|6923|P1|COMPLETED|Treatment Period 2||10
3280|NCT03467971|6922|P2|STARTED|Treatment Period 2||11
3281|NCT03467971|6923|P1|STARTED|Treatment Period 2||10
3282|NCT03467971|6922|P2|NOT COMPLETED|Treatment Period 1||0
3283|NCT03467971|6923|P1|NOT COMPLETED|Treatment Period 1||0
3284|NCT03467971|6922|P2|COMPLETED|Treatment Period 1||11
3285|NCT03467971|6923|P1|COMPLETED|Treatment Period 1||10
3286|NCT03467971|6922|P2|STARTED|Treatment Period 1||11
3287|NCT03467971|6923|P1|STARTED|Treatment Period 1||10
3288|NCT03467945|6947|P4|NOT COMPLETED|Treatment Period 4||0
3289|NCT03467945|6948|P3|NOT COMPLETED|Treatment Period 4||0
3290|NCT03467945|6949|P2|NOT COMPLETED|Treatment Period 4||0
3291|NCT03467945|6950|P1|NOT COMPLETED|Treatment Period 4||0
3292|NCT03467945|6947|P4|COMPLETED|Treatment Period 4||9
3293|NCT03467945|6948|P3|COMPLETED|Treatment Period 4||8
3294|NCT03467945|6949|P2|COMPLETED|Treatment Period 4||9
3295|NCT03467945|6950|P1|COMPLETED|Treatment Period 4||9
3296|NCT03467945|6947|P4|STARTED|Treatment Period 4||9
3297|NCT03467945|6948|P3|STARTED|Treatment Period 4||8
3298|NCT03467945|6949|P2|STARTED|Treatment Period 4||9
3299|NCT03467945|6950|P1|STARTED|Treatment Period 4||9
3300|NCT03467945|6947|P4|NOT COMPLETED|Treatment Period 3||1
3301|NCT03467945|6948|P3|NOT COMPLETED|Treatment Period 3||2
3302|NCT03467945|6949|P2|NOT COMPLETED|Treatment Period 3||0
3303|NCT03467945|6950|P1|NOT COMPLETED|Treatment Period 3||1
3304|NCT03467945|6947|P4|COMPLETED|Treatment Period 3||9
3305|NCT03467945|6948|P3|COMPLETED|Treatment Period 3||8
3306|NCT03467945|6949|P2|COMPLETED|Treatment Period 3||9
3307|NCT03467945|6950|P1|COMPLETED|Treatment Period 3||9
3308|NCT03467945|6947|P4|STARTED|Treatment Period 3||10
3309|NCT03467945|6948|P3|STARTED|Treatment Period 3||10
3310|NCT03467945|6949|P2|STARTED|Treatment Period 3||9
3311|NCT03467945|6950|P1|STARTED|Treatment Period 3||10
3312|NCT03467945|6947|P4|NOT COMPLETED|Treatment Period 2||0
3313|NCT03467945|6948|P3|NOT COMPLETED|Treatment Period 2||0
3314|NCT03467945|6949|P2|NOT COMPLETED|Treatment Period 2||1
3315|NCT03467945|6950|P1|NOT COMPLETED|Treatment Period 2||0
3316|NCT03467945|6947|P4|COMPLETED|Treatment Period 2||10
3317|NCT03467945|6948|P3|COMPLETED|Treatment Period 2||10
3318|NCT03467945|6949|P2|COMPLETED|Treatment Period 2||9
3319|NCT03467945|6950|P1|COMPLETED|Treatment Period 2||10
3320|NCT03467945|6947|P4|STARTED|Treatment Period 2||10
3321|NCT03467945|6948|P3|STARTED|Treatment Period 2||10
3322|NCT03467945|6949|P2|STARTED|Treatment Period 2||10
3323|NCT03467945|6950|P1|STARTED|Treatment Period 2||10
3324|NCT03467945|6947|P4|NOT COMPLETED|Treatment Period 1||0
3325|NCT03467945|6948|P3|NOT COMPLETED|Treatment Period 1||0
3326|NCT03467945|6949|P2|NOT COMPLETED|Treatment Period 1||0
3327|NCT03467945|6950|P1|NOT COMPLETED|Treatment Period 1||0
3328|NCT03467945|6947|P4|COMPLETED|Treatment Period 1||10
3329|NCT03467945|6948|P3|COMPLETED|Treatment Period 1||10
3330|NCT03467945|6949|P2|COMPLETED|Treatment Period 1||10
3331|NCT03467945|6950|P1|COMPLETED|Treatment Period 1||10
3332|NCT03467945|6947|P4|STARTED|Treatment Period 1||10
3333|NCT03467945|6948|P3|STARTED|Treatment Period 1||10
3334|NCT03467945|6949|P2|STARTED|Treatment Period 1||10
3335|NCT03467945|6950|P1|STARTED|Treatment Period 1||10
3336|NCT03466086|7002|P2|NOT COMPLETED|Period 2||0
3337|NCT03466086|7003|P1|NOT COMPLETED|Period 2||0
3338|NCT03466086|7002|P2|COMPLETED|Period 2||27
3339|NCT03466086|7003|P1|COMPLETED|Period 2||26
3340|NCT03466086|7002|P2|STARTED|Period 2||27
3341|NCT03466086|7003|P1|STARTED|Period 2||26
3342|NCT03466086|7002|P2|NOT COMPLETED|Period 1||0
3343|NCT03466086|7003|P1|NOT COMPLETED|Period 1||2
3344|NCT03466086|7002|P2|COMPLETED|Period 1||27
3345|NCT03466086|7003|P1|COMPLETED|Period 1||26
3346|NCT03466086|7002|P2|STARTED|Period 1||27
3347|NCT03466086|7003|P1|STARTED|Period 1||28
3348|NCT03466060|7014|P6|NOT COMPLETED|Period 2||0
3349|NCT03466060|7015|P5|NOT COMPLETED|Period 2||0
3350|NCT03466060|7016|P4|NOT COMPLETED|Period 2||0
3351|NCT03466060|7017|P3|NOT COMPLETED|Period 2||1
3352|NCT03466060|7018|P2|NOT COMPLETED|Period 2||0
3353|NCT03466060|7019|P1|NOT COMPLETED|Period 2||0
3354|NCT03466060|7014|P6|COMPLETED|Period 2||18
3355|NCT03466060|7015|P5|COMPLETED|Period 2||20
3356|NCT03466060|7016|P4|COMPLETED|Period 2||17
3357|NCT03466060|7017|P3|COMPLETED|Period 2||16
3358|NCT03466060|7018|P2|COMPLETED|Period 2||16
3359|NCT03466060|7019|P1|COMPLETED|Period 2||19
3360|NCT03466060|7014|P6|STARTED|Period 2||18
3361|NCT03466060|7015|P5|STARTED|Period 2||20
3362|NCT03466060|7016|P4|STARTED|Period 2||17
3363|NCT03466060|7017|P3|STARTED|Period 2||17
3364|NCT03466060|7018|P2|STARTED|Period 2||16
3365|NCT03466060|7019|P1|STARTED|Period 2||19
3366|NCT03466060|7014|P6|NOT COMPLETED|Period 1||0
3367|NCT03466060|7015|P5|NOT COMPLETED|Period 1||0
3368|NCT03466060|7016|P4|NOT COMPLETED|Period 1||1
3369|NCT03466060|7017|P3|NOT COMPLETED|Period 1||3
3370|NCT03466060|7018|P2|NOT COMPLETED|Period 1||2
3371|NCT03466060|7019|P1|NOT COMPLETED|Period 1||0
3372|NCT03466060|7014|P6|COMPLETED|Period 1||18
3373|NCT03466060|7015|P5|COMPLETED|Period 1||20
3374|NCT03466060|7016|P4|COMPLETED|Period 1||17
3375|NCT03466060|7017|P3|COMPLETED|Period 1||17
3376|NCT03466060|7018|P2|COMPLETED|Period 1||16
3377|NCT03466060|7019|P1|COMPLETED|Period 1||19
3378|NCT03466060|7014|P6|STARTED|Period 1||18
3379|NCT03466060|7015|P5|STARTED|Period 1||20
3380|NCT03466060|7016|P4|STARTED|Period 1||18
3381|NCT03466060|7017|P3|STARTED|Period 1||20
3382|NCT03466060|7018|P2|STARTED|Period 1||18
3383|NCT03466060|7019|P1|STARTED|Period 1||19
3384|NCT03465904|7035|P2|NOT COMPLETED|Overall Study||66
3385|NCT03465904|7036|P1|NOT COMPLETED|Overall Study||89
3386|NCT03465904|7035|P2|COMPLETED|Overall Study||237
3387|NCT03465904|7036|P1|COMPLETED|Overall Study||209
3388|NCT03465904|7035|P2|STARTED|Overall Study||303
3389|NCT03465904|7036|P1|STARTED|Overall Study||298
3390|NCT03463512|7056|P2|NOT COMPLETED|Overall Study||0
3391|NCT03463512|7057|P1|NOT COMPLETED|Overall Study||0
3392|NCT03463512|7056|P2|COMPLETED|Overall Study||62
3393|NCT03463512|7057|P1|COMPLETED|Overall Study||62
3394|NCT03463512|7056|P2|STARTED|Overall Study||62
3395|NCT03463512|7057|P1|STARTED|Overall Study||62
3396|NCT03463031|7069|P2|NOT COMPLETED|Overall Study||5
3397|NCT03463031|7070|P1|NOT COMPLETED|Overall Study||10
3398|NCT03463031|7069|P2|COMPLETED|Overall Study||216
3399|NCT03463031|7070|P1|COMPLETED|Overall Study||215
3400|NCT03463031|7069|P2|STARTED|Overall Study||221
3401|NCT03463031|7070|P1|STARTED|Overall Study||225
3402|NCT03462745|7084|P2|NOT COMPLETED|Overall Study||0
3403|NCT03462745|7085|P1|NOT COMPLETED|Overall Study||0
3404|NCT03462745|7084|P2|COMPLETED|Overall Study||92
3405|NCT03462745|7085|P1|COMPLETED|Overall Study||92
3406|NCT03462745|7084|P2|STARTED|Overall Study||92
3407|NCT03462745|7085|P1|STARTED|Overall Study||92
3408|NCT03460990|7093|P2|NOT COMPLETED|Overall Study||0
3409|NCT03460990|7094|P1|NOT COMPLETED|Overall Study||0
3410|NCT03460990|7093|P2|COMPLETED|Overall Study||54
3411|NCT03460990|7094|P1|COMPLETED|Overall Study||57
3412|NCT03460990|7093|P2|STARTED|Overall Study||54
3413|NCT03460990|7094|P1|STARTED|Overall Study||57
3414|NCT03460899|7108|P1|NOT COMPLETED|Hyperinsulinaemic/Hypoglycaemic Clamp||0
3415|NCT03460899|7108|P1|COMPLETED|Hyperinsulinaemic/Hypoglycaemic Clamp|Last Hyperinsulinaemic/Hypoglycaemic Clamp completed: 05. June 2018|14
3416|NCT03460899|7108|P1|STARTED|Hyperinsulinaemic/Hypoglycaemic Clamp|First Hyperinsulinaemic/Hypoglycaemic Clamp completed: 15. March 2018|14
3417|NCT03460899|7108|P1|NOT COMPLETED|Euglycaemic Clamp||0
3418|NCT03460899|7108|P1|COMPLETED|Euglycaemic Clamp|Last Euglycaemic clamp completed: 23. May 2018|14
3419|NCT03460899|7108|P1|STARTED|Euglycaemic Clamp|First Euglycaemic Clamp completed: 05. March 2018|14
3420|NCT03459794|7117|P2|NOT COMPLETED|Overall Study||0
3421|NCT03459794|7118|P1|NOT COMPLETED|Overall Study||0
3422|NCT03459794|7117|P2|COMPLETED|Overall Study||4
3423|NCT03459794|7118|P1|COMPLETED|Overall Study||8
3424|NCT03459794|7117|P2|STARTED|Overall Study||4
3425|NCT03459794|7118|P1|STARTED|Overall Study||8
3426|NCT03459196|7134|P1|NOT COMPLETED|Overall Study||2
3427|NCT03459196|7134|P1|COMPLETED|Overall Study||52
3428|NCT03459196|7134|P1|STARTED|Overall Study||54
3429|NCT03459131|7139|P2|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
3430|NCT03459131|7140|P1|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
3431|NCT03459131|7139|P2|COMPLETED|Period 2, Second 7 Days of Wear||8
3432|NCT03459131|7140|P1|COMPLETED|Period 2, Second 7 Days of Wear||7
3433|NCT03459131|7139|P2|STARTED|Period 2, Second 7 Days of Wear||8
3434|NCT03459131|7140|P1|STARTED|Period 2, Second 7 Days of Wear||7
3435|NCT03459131|7139|P2|NOT COMPLETED|Period 1, First 7 Days of Wear||0
3436|NCT03459131|7140|P1|NOT COMPLETED|Period 1, First 7 Days of Wear||0
3437|NCT03459131|7139|P2|COMPLETED|Period 1, First 7 Days of Wear||8
3438|NCT03459131|7140|P1|COMPLETED|Period 1, First 7 Days of Wear||7
3439|NCT03459131|7139|P2|STARTED|Period 1, First 7 Days of Wear||8
3440|NCT03459131|7140|P1|STARTED|Period 1, First 7 Days of Wear||7
3441|NCT03458702|7148|P2|NOT COMPLETED|Picture Rating/Body Composition||0
3442|NCT03458702|7149|P1|NOT COMPLETED|Picture Rating/Body Composition||0
3443|NCT03458702|7148|P2|COMPLETED|Picture Rating/Body Composition||20
3444|NCT03458702|7149|P1|COMPLETED|Picture Rating/Body Composition||20
3445|NCT03458702|7148|P2|STARTED|Picture Rating/Body Composition||20
3446|NCT03458702|7149|P1|STARTED|Picture Rating/Body Composition||20
3447|NCT03458702|7148|P2|NOT COMPLETED|Study Condition B (Yoga or Rest)||2
3448|NCT03458702|7149|P1|NOT COMPLETED|Study Condition B (Yoga or Rest)||4
3449|NCT03458702|7148|P2|COMPLETED|Study Condition B (Yoga or Rest)||20
3450|NCT03458702|7149|P1|COMPLETED|Study Condition B (Yoga or Rest)||20
3451|NCT03458702|7148|P2|STARTED|Study Condition B (Yoga or Rest)||22
3452|NCT03458702|7149|P1|STARTED|Study Condition B (Yoga or Rest)||24
3453|NCT03458702|7148|P2|NOT COMPLETED|Study Condition A (Yoga or Rest)||6
3454|NCT03458702|7149|P1|NOT COMPLETED|Study Condition A (Yoga or Rest)||4
3455|NCT03458702|7148|P2|COMPLETED|Study Condition A (Yoga or Rest)||22
3456|NCT03458702|7149|P1|COMPLETED|Study Condition A (Yoga or Rest)||24
3457|NCT03458702|7148|P2|STARTED|Study Condition A (Yoga or Rest)||28
3458|NCT03458702|7149|P1|STARTED|Study Condition A (Yoga or Rest)||28
3459|NCT03457909|7165|P1|NOT COMPLETED|Overall Study||0
3460|NCT03457909|7165|P1|COMPLETED|Overall Study||25
3461|NCT03457909|7165|P1|STARTED|Overall Study||25
3462|NCT03457727|7178|P4|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
3463|NCT03457727|7179|P3|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
3464|NCT03457727|7180|P2|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
3465|NCT03457727|7181|P1|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
3466|NCT03457727|7178|P4|COMPLETED|Part 2, Period 4 (1 Day)||0
3467|NCT03457727|7179|P3|COMPLETED|Part 2, Period 4 (1 Day)||12
3468|NCT03457727|7180|P2|COMPLETED|Part 2, Period 4 (1 Day)||0
3469|NCT03457727|7181|P1|COMPLETED|Part 2, Period 4 (1 Day)||0
3470|NCT03457727|7178|P4|STARTED|Part 2, Period 4 (1 Day)||0
3471|NCT03457727|7179|P3|STARTED|Part 2, Period 4 (1 Day)||12
3472|NCT03457727|7180|P2|STARTED|Part 2, Period 4 (1 Day)||0
3473|NCT03457727|7181|P1|STARTED|Part 2, Period 4 (1 Day)||0
3474|NCT03457727|7178|P4|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
3475|NCT03457727|7179|P3|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
3476|NCT03457727|7180|P2|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
3477|NCT03457727|7181|P1|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
3478|NCT03457727|7178|P4|COMPLETED|Part 2, Washout Period 3 (5 Days)||11
3479|NCT03457727|7179|P3|COMPLETED|Part 2, Washout Period 3 (5 Days)||12
3480|NCT03457727|7180|P2|COMPLETED|Part 2, Washout Period 3 (5 Days)||0
3481|NCT03457727|7181|P1|COMPLETED|Part 2, Washout Period 3 (5 Days)||0
3482|NCT03457727|7178|P4|STARTED|Part 2, Washout Period 3 (5 Days)||11
3483|NCT03457727|7179|P3|STARTED|Part 2, Washout Period 3 (5 Days)||12
3484|NCT03457727|7180|P2|STARTED|Part 2, Washout Period 3 (5 Days)||0
3485|NCT03457727|7181|P1|STARTED|Part 2, Washout Period 3 (5 Days)||0
3486|NCT03457727|7178|P4|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
3487|NCT03457727|7179|P3|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
3488|NCT03457727|7180|P2|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
3489|NCT03457727|7181|P1|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
3490|NCT03457727|7178|P4|COMPLETED|Part 2, Period 3 (1 Day)||11
3491|NCT03457727|7179|P3|COMPLETED|Part 2, Period 3 (1 Day)||12
3492|NCT03457727|7180|P2|COMPLETED|Part 2, Period 3 (1 Day)||0
3493|NCT03457727|7181|P1|COMPLETED|Part 2, Period 3 (1 Day)||0
3494|NCT03457727|7178|P4|STARTED|Part 2, Period 3 (1 Day)||11
3495|NCT03457727|7179|P3|STARTED|Part 2, Period 3 (1 Day)||12
3496|NCT03457727|7180|P2|STARTED|Part 2, Period 3 (1 Day)||0
3497|NCT03457727|7181|P1|STARTED|Part 2, Period 3 (1 Day)||0
3498|NCT03457727|7178|P4|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
3499|NCT03457727|7179|P3|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
3500|NCT03457727|7180|P2|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
3501|NCT03457727|7181|P1|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
3502|NCT03457727|7178|P4|COMPLETED|Part 2, Washout Period 2 (5 Days)||11
3503|NCT03457727|7179|P3|COMPLETED|Part 2, Washout Period 2 (5 Days)||12
3504|NCT03457727|7180|P2|COMPLETED|Part 2, Washout Period 2 (5 Days)||0
3505|NCT03457727|7181|P1|COMPLETED|Part 2, Washout Period 2 (5 Days)||0
3506|NCT03457727|7178|P4|STARTED|Part 2, Washout Period 2 (5 Days)||11
3507|NCT03457727|7179|P3|STARTED|Part 2, Washout Period 2 (5 Days)||12
3508|NCT03457727|7180|P2|STARTED|Part 2, Washout Period 2 (5 Days)||0
3509|NCT03457727|7181|P1|STARTED|Part 2, Washout Period 2 (5 Days)||0
3510|NCT03457727|7178|P4|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
3511|NCT03457727|7179|P3|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
3512|NCT03457727|7180|P2|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
3513|NCT03457727|7181|P1|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
3514|NCT03457727|7178|P4|COMPLETED|Part 2, Period 2 (1 Day)||11
3515|NCT03457727|7179|P3|COMPLETED|Part 2, Period 2 (1 Day)||12
3516|NCT03457727|7180|P2|COMPLETED|Part 2, Period 2 (1 Day)||0
3517|NCT03457727|7181|P1|COMPLETED|Part 2, Period 2 (1 Day)||0
3518|NCT03457727|7178|P4|STARTED|Part 2, Period 2 (1 Day)||11
3519|NCT03457727|7179|P3|STARTED|Part 2, Period 2 (1 Day)||12
3520|NCT03457727|7180|P2|STARTED|Part 2, Period 2 (1 Day)||0
3521|NCT03457727|7181|P1|STARTED|Part 2, Period 2 (1 Day)||0
3522|NCT03457727|7178|P4|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||1
3523|NCT03457727|7179|P3|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
3524|NCT03457727|7180|P2|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
3525|NCT03457727|7181|P1|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
3526|NCT03457727|7178|P4|COMPLETED|Part 2, Washout Period 1 (5 Days)||11
3527|NCT03457727|7179|P3|COMPLETED|Part 2, Washout Period 1 (5 Days)||12
3528|NCT03457727|7180|P2|COMPLETED|Part 2, Washout Period 1 (5 Days)||0
3529|NCT03457727|7181|P1|COMPLETED|Part 2, Washout Period 1 (5 Days)||0
3530|NCT03457727|7178|P4|STARTED|Part 2, Washout Period 1 (5 Days)||12
3531|NCT03457727|7179|P3|STARTED|Part 2, Washout Period 1 (5 Days)||12
3532|NCT03457727|7180|P2|STARTED|Part 2, Washout Period 1 (5 Days)||0
3533|NCT03457727|7181|P1|STARTED|Part 2, Washout Period 1 (5 Days)||0
3534|NCT03457727|7178|P4|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
3535|NCT03457727|7179|P3|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
3536|NCT03457727|7180|P2|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
3537|NCT03457727|7181|P1|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
3538|NCT03457727|7178|P4|COMPLETED|Part 2, Period 1 (1 Day)||12
3539|NCT03457727|7179|P3|COMPLETED|Part 2, Period 1 (1 Day)||12
3540|NCT03457727|7180|P2|COMPLETED|Part 2, Period 1 (1 Day)||0
3541|NCT03457727|7181|P1|COMPLETED|Part 2, Period 1 (1 Day)||0
3542|NCT03457727|7178|P4|STARTED|Part 2, Period 1 (1 Day)||12
3543|NCT03457727|7179|P3|STARTED|Part 2, Period 1 (1 Day)||12
3544|NCT03457727|7180|P2|STARTED|Part 2, Period 1 (1 Day)||0
3545|NCT03457727|7181|P1|STARTED|Part 2, Period 1 (1 Day)||0
3546|NCT03457727|7178|P4|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
3547|NCT03457727|7179|P3|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
3548|NCT03457727|7180|P2|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
3549|NCT03457727|7181|P1|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
3550|NCT03457727|7178|P4|COMPLETED|Part 1, Period 4 (1 Day)||0
3551|NCT03457727|7179|P3|COMPLETED|Part 1, Period 4 (1 Day)||0
3552|NCT03457727|7180|P2|COMPLETED|Part 1, Period 4 (1 Day)||8
3553|NCT03457727|7181|P1|COMPLETED|Part 1, Period 4 (1 Day)||8
3554|NCT03457727|7178|P4|STARTED|Part 1, Period 4 (1 Day)||0
3555|NCT03457727|7179|P3|STARTED|Part 1, Period 4 (1 Day)||0
3556|NCT03457727|7180|P2|STARTED|Part 1, Period 4 (1 Day)||8
3557|NCT03457727|7181|P1|STARTED|Part 1, Period 4 (1 Day)||8
3558|NCT03457727|7178|P4|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
3559|NCT03457727|7179|P3|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
3560|NCT03457727|7180|P2|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
3561|NCT03457727|7181|P1|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
3562|NCT03457727|7178|P4|COMPLETED|Part 1, Washout Period 3 (5 Days)||0
3563|NCT03457727|7179|P3|COMPLETED|Part 1, Washout Period 3 (5 Days)||0
3564|NCT03457727|7180|P2|COMPLETED|Part 1, Washout Period 3 (5 Days)||8
3565|NCT03457727|7181|P1|COMPLETED|Part 1, Washout Period 3 (5 Days)||8
3566|NCT03457727|7178|P4|STARTED|Part 1, Washout Period 3 (5 Days)||0
3567|NCT03457727|7179|P3|STARTED|Part 1, Washout Period 3 (5 Days)||0
3568|NCT03457727|7180|P2|STARTED|Part 1, Washout Period 3 (5 Days)||8
3569|NCT03457727|7181|P1|STARTED|Part 1, Washout Period 3 (5 Days)||8
3570|NCT03457727|7178|P4|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
3571|NCT03457727|7179|P3|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
3572|NCT03457727|7180|P2|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
3573|NCT03457727|7181|P1|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
3574|NCT03457727|7178|P4|COMPLETED|Part 1, Period 3 (1 Day)||0
3575|NCT03457727|7179|P3|COMPLETED|Part 1, Period 3 (1 Day)||0
3576|NCT03457727|7180|P2|COMPLETED|Part 1, Period 3 (1 Day)||8
3577|NCT03457727|7181|P1|COMPLETED|Part 1, Period 3 (1 Day)||8
3578|NCT03457727|7178|P4|STARTED|Part 1, Period 3 (1 Day)||0
3579|NCT03457727|7179|P3|STARTED|Part 1, Period 3 (1 Day)||0
3580|NCT03457727|7180|P2|STARTED|Part 1, Period 3 (1 Day)||8
3581|NCT03457727|7181|P1|STARTED|Part 1, Period 3 (1 Day)||8
3582|NCT03457727|7178|P4|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
3583|NCT03457727|7179|P3|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
3584|NCT03457727|7180|P2|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
3585|NCT03457727|7181|P1|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
3586|NCT03457727|7178|P4|COMPLETED|Part 1, Washout Period 2 (5 Days)||0
3587|NCT03457727|7179|P3|COMPLETED|Part 1, Washout Period 2 (5 Days)||0
3588|NCT03457727|7180|P2|COMPLETED|Part 1, Washout Period 2 (5 Days)||8
3589|NCT03457727|7181|P1|COMPLETED|Part 1, Washout Period 2 (5 Days)||8
3590|NCT03457727|7178|P4|STARTED|Part 1, Washout Period 2 (5 Days)||0
3591|NCT03457727|7179|P3|STARTED|Part 1, Washout Period 2 (5 Days)||0
3592|NCT03457727|7180|P2|STARTED|Part 1, Washout Period 2 (5 Days)||8
3593|NCT03457727|7181|P1|STARTED|Part 1, Washout Period 2 (5 Days)||8
3594|NCT03457727|7178|P4|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
3595|NCT03457727|7179|P3|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
3596|NCT03457727|7180|P2|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
3597|NCT03457727|7181|P1|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
3598|NCT03457727|7178|P4|COMPLETED|Part 1, Period 2 (1 Day)||0
3599|NCT03457727|7179|P3|COMPLETED|Part 1, Period 2 (1 Day)||0
3600|NCT03457727|7180|P2|COMPLETED|Part 1, Period 2 (1 Day)||8
3601|NCT03457727|7181|P1|COMPLETED|Part 1, Period 2 (1 Day)||8
3602|NCT03457727|7178|P4|STARTED|Part 1, Period 2 (1 Day)||0
3603|NCT03457727|7179|P3|STARTED|Part 1, Period 2 (1 Day)||0
3604|NCT03457727|7180|P2|STARTED|Part 1, Period 2 (1 Day)||8
3605|NCT03457727|7181|P1|STARTED|Part 1, Period 2 (1 Day)||8
3606|NCT03457727|7178|P4|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
3607|NCT03457727|7179|P3|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
3608|NCT03457727|7180|P2|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
3609|NCT03457727|7181|P1|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
3610|NCT03457727|7178|P4|COMPLETED|Part 1, Washout Period 1 (5 Days)||0
3611|NCT03457727|7179|P3|COMPLETED|Part 1, Washout Period 1 (5 Days)||0
3612|NCT03457727|7180|P2|COMPLETED|Part 1, Washout Period 1 (5 Days)||8
3613|NCT03457727|7181|P1|COMPLETED|Part 1, Washout Period 1 (5 Days)||8
3614|NCT03457727|7178|P4|STARTED|Part 1, Washout Period 1 (5 Days)||0
3615|NCT03457727|7179|P3|STARTED|Part 1, Washout Period 1 (5 Days)||0
3616|NCT03457727|7180|P2|STARTED|Part 1, Washout Period 1 (5 Days)||8
3617|NCT03457727|7181|P1|STARTED|Part 1, Washout Period 1 (5 Days)||8
3618|NCT03457727|7178|P4|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
3619|NCT03457727|7179|P3|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
3620|NCT03457727|7180|P2|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
3621|NCT03457727|7181|P1|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
3622|NCT03457727|7178|P4|COMPLETED|Part 1, Period 1 (1 Day)||0
3623|NCT03457727|7179|P3|COMPLETED|Part 1, Period 1 (1 Day)||0
3624|NCT03457727|7180|P2|COMPLETED|Part 1, Period 1 (1 Day)||8
3625|NCT03457727|7181|P1|COMPLETED|Part 1, Period 1 (1 Day)||8
3626|NCT03457727|7178|P4|STARTED|Part 1, Period 1 (1 Day)||0
3627|NCT03457727|7179|P3|STARTED|Part 1, Period 1 (1 Day)||0
3628|NCT03457727|7180|P2|STARTED|Part 1, Period 1 (1 Day)||8
3629|NCT03457727|7181|P1|STARTED|Part 1, Period 1 (1 Day)||8
3630|NCT03457636|7378|P1|NOT COMPLETED|Overall Study||2
3631|NCT03457636|7378|P1|COMPLETED|Overall Study||20
3632|NCT03457636|7378|P1|STARTED|Overall Study||22
3633|NCT03456960|7391|P6|NOT COMPLETED|Period 2 (1 Day)||0
3634|NCT03456960|7392|P5|NOT COMPLETED|Period 2 (1 Day)||0
3635|NCT03456960|7393|P4|NOT COMPLETED|Period 2 (1 Day)||1
3636|NCT03456960|7394|P3|NOT COMPLETED|Period 2 (1 Day)||0
3637|NCT03456960|7395|P2|NOT COMPLETED|Period 2 (1 Day)||0
3638|NCT03456960|7396|P1|NOT COMPLETED|Period 2 (1 Day)||1
3639|NCT03456960|7391|P6|COMPLETED|Period 2 (1 Day)||6
3640|NCT03456960|7392|P5|COMPLETED|Period 2 (1 Day)||6
3641|NCT03456960|7393|P4|COMPLETED|Period 2 (1 Day)||117
3642|NCT03456960|7394|P3|COMPLETED|Period 2 (1 Day)||119
3643|NCT03456960|7395|P2|COMPLETED|Period 2 (1 Day)||12
3644|NCT03456960|7396|P1|COMPLETED|Period 2 (1 Day)||11
3645|NCT03456960|7391|P6|STARTED|Period 2 (1 Day)||6
3646|NCT03456960|7392|P5|STARTED|Period 2 (1 Day)||6
3647|NCT03456960|7393|P4|STARTED|Period 2 (1 Day)||118
3648|NCT03456960|7394|P3|STARTED|Period 2 (1 Day)||119
3649|NCT03456960|7395|P2|STARTED|Period 2 (1 Day)||12
3650|NCT03456960|7396|P1|STARTED|Period 2 (1 Day)||12
3651|NCT03456960|7391|P6|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3652|NCT03456960|7392|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3653|NCT03456960|7393|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||2
3654|NCT03456960|7394|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||1
3655|NCT03456960|7395|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3656|NCT03456960|7396|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
3657|NCT03456960|7391|P6|COMPLETED|Washout Period (at Least 14 Days)||6
3658|NCT03456960|7392|P5|COMPLETED|Washout Period (at Least 14 Days)||6
3659|NCT03456960|7393|P4|COMPLETED|Washout Period (at Least 14 Days)||118
3660|NCT03456960|7394|P3|COMPLETED|Washout Period (at Least 14 Days)||119
3661|NCT03456960|7395|P2|COMPLETED|Washout Period (at Least 14 Days)||12
3662|NCT03456960|7396|P1|COMPLETED|Washout Period (at Least 14 Days)||12
3663|NCT03456960|7391|P6|STARTED|Washout Period (at Least 14 Days)||6
3664|NCT03456960|7392|P5|STARTED|Washout Period (at Least 14 Days)||6
3665|NCT03456960|7393|P4|STARTED|Washout Period (at Least 14 Days)||120
3666|NCT03456960|7394|P3|STARTED|Washout Period (at Least 14 Days)||120
3667|NCT03456960|7395|P2|STARTED|Washout Period (at Least 14 Days)||12
3668|NCT03456960|7396|P1|STARTED|Washout Period (at Least 14 Days)||12
3669|NCT03456960|7391|P6|NOT COMPLETED|Period 1 (1 Day)||0
3670|NCT03456960|7392|P5|NOT COMPLETED|Period 1 (1 Day)||0
3671|NCT03456960|7393|P4|NOT COMPLETED|Period 1 (1 Day)||0
3672|NCT03456960|7394|P3|NOT COMPLETED|Period 1 (1 Day)||0
3673|NCT03456960|7395|P2|NOT COMPLETED|Period 1 (1 Day)||0
3674|NCT03456960|7396|P1|NOT COMPLETED|Period 1 (1 Day)||0
3675|NCT03456960|7391|P6|COMPLETED|Period 1 (1 Day)||6
3676|NCT03456960|7392|P5|COMPLETED|Period 1 (1 Day)||6
3677|NCT03456960|7393|P4|COMPLETED|Period 1 (1 Day)||120
3678|NCT03456960|7394|P3|COMPLETED|Period 1 (1 Day)||120
3679|NCT03456960|7395|P2|COMPLETED|Period 1 (1 Day)||12
3680|NCT03456960|7396|P1|COMPLETED|Period 1 (1 Day)||12
3681|NCT03456960|7391|P6|STARTED|Period 1 (1 Day)||6
3682|NCT03456960|7392|P5|STARTED|Period 1 (1 Day)||6
3683|NCT03456960|7393|P4|STARTED|Period 1 (1 Day)||120
3684|NCT03456960|7394|P3|STARTED|Period 1 (1 Day)||120
3685|NCT03456960|7395|P2|STARTED|Period 1 (1 Day)||12
3686|NCT03456960|7396|P1|STARTED|Period 1 (1 Day)||12
3687|NCT03456427|7488|P1|NOT COMPLETED|Overall Study||3
3688|NCT03456427|7488|P1|COMPLETED|Overall Study||33
3689|NCT03456427|7488|P1|STARTED|Overall Study||36
3690|NCT03455491|7500|P3|NOT COMPLETED|Overall Study||0
3691|NCT03455491|7501|P2|NOT COMPLETED|Overall Study||0
3692|NCT03455491|7502|P1|NOT COMPLETED|Overall Study||0
3693|NCT03455491|7500|P3|COMPLETED|Overall Study||40
3694|NCT03455491|7501|P2|COMPLETED|Overall Study||40
3695|NCT03455491|7502|P1|COMPLETED|Overall Study||40
3696|NCT03455491|7500|P3|STARTED|Overall Study||40
3697|NCT03455491|7501|P2|STARTED|Overall Study||40
3698|NCT03455491|7502|P1|STARTED|Overall Study||40
3699|NCT03454581|7522|P3|NOT COMPLETED|Overall Study||3
3700|NCT03454581|7523|P2|NOT COMPLETED|Overall Study||3
3701|NCT03454581|7524|P1|NOT COMPLETED|Overall Study||4
3702|NCT03454581|7522|P3|COMPLETED|Overall Study||14
3703|NCT03454581|7523|P2|COMPLETED|Overall Study||13
3704|NCT03454581|7524|P1|COMPLETED|Overall Study||14
3705|NCT03454581|7522|P3|STARTED|Overall Study||17
3706|NCT03454581|7523|P2|STARTED|Overall Study||16
3707|NCT03454581|7524|P1|STARTED|Overall Study||18
3708|NCT03453060|7558|P5|NOT COMPLETED|Overall Study||0
3709|NCT03453060|7559|P4|NOT COMPLETED|Overall Study||0
3710|NCT03453060|7560|P3|NOT COMPLETED|Overall Study||0
3711|NCT03453060|7561|P2|NOT COMPLETED|Overall Study||0
3712|NCT03453060|7562|P1|NOT COMPLETED|Overall Study||0
3713|NCT03453060|7558|P5|COMPLETED|Overall Study||5
3714|NCT03453060|7559|P4|COMPLETED|Overall Study||4
3715|NCT03453060|7560|P3|COMPLETED|Overall Study||4
3716|NCT03453060|7561|P2|COMPLETED|Overall Study||4
3717|NCT03453060|7562|P1|COMPLETED|Overall Study||4
3718|NCT03453060|7558|P5|STARTED|Overall Study||5
3719|NCT03453060|7559|P4|STARTED|Overall Study||4
3720|NCT03453060|7560|P3|STARTED|Overall Study||4
3721|NCT03453060|7561|P2|STARTED|Overall Study||4
3722|NCT03453060|7562|P1|STARTED|Overall Study||4
3723|NCT03450070|7779|P1|NOT COMPLETED|Overall Study||8
3724|NCT03450070|7779|P1|COMPLETED|Overall Study||110
3725|NCT03450070|7779|P1|STARTED|Overall Study||118
3726|NCT03448536|7785|P2|NOT COMPLETED|Overall Study||4
3727|NCT03448536|7786|P1|NOT COMPLETED|Overall Study||12
3728|NCT03448536|7785|P2|COMPLETED|Overall Study||97
3729|NCT03448536|7786|P1|COMPLETED|Overall Study||88
3730|NCT03448536|7785|P2|Completed Second Intervention|Overall Study||87
3731|NCT03448536|7786|P1|Completed Second Intervention|Overall Study||82
3732|NCT03448536|7785|P2|Completed First Intervention|Overall Study||97
3733|NCT03448536|7786|P1|Completed First Intervention|Overall Study||95
3734|NCT03448536|7785|P2|Completed First Intervention|Overall Study||78
3735|NCT03448536|7786|P1|Completed First Intervention|Overall Study||83
3736|NCT03448536|7785|P2|STARTED|Overall Study||101
3737|NCT03448536|7786|P1|STARTED|Overall Study||100
3738|NCT03447821|7813|P3|NOT COMPLETED|Overall Study||1
3739|NCT03447821|7814|P2|NOT COMPLETED|Overall Study||1
3740|NCT03447821|7815|P1|NOT COMPLETED|Overall Study||1
3741|NCT03447821|7813|P3|COMPLETED|Overall Study||12
3742|NCT03447821|7814|P2|COMPLETED|Overall Study||12
3743|NCT03447821|7815|P1|COMPLETED|Overall Study||13
3744|NCT03447821|7813|P3|STARTED|Overall Study||13
3745|NCT03447821|7814|P2|STARTED|Overall Study||13
3746|NCT03447821|7815|P1|STARTED|Overall Study||14
3747|NCT03447639|7840|P2|NOT COMPLETED|Overall Study||2
3748|NCT03447639|7841|P1|NOT COMPLETED|Overall Study||0
3749|NCT03447639|7840|P2|COMPLETED|Overall Study|2 patients were withdrawn because their catheters had to be re-inserted.|1
3750|NCT03447639|7841|P1|COMPLETED|Overall Study|No patients were randomized to the Povidone-Iodine irrigation arm|0
3751|NCT03447639|7840|P2|STARTED|Overall Study|3 patients were randomized to the Standard of Care arm.|3
3752|NCT03447639|7841|P1|STARTED|Overall Study|No patients were randomized to the Povidone-Iodine irrigation arm|0
3753|NCT03447353|7847|P1|NOT COMPLETED|Overall Study||10
3754|NCT03447353|7847|P1|COMPLETED|Overall Study||8
3755|NCT03447353|7847|P1|STARTED|Overall Study||18
3756|NCT03447015|7863|P2|NOT COMPLETED|Overall Study||44
3757|NCT03447015|7864|P1|NOT COMPLETED|Overall Study||45
3758|NCT03447015|7863|P2|COMPLETED|Overall Study||106
3759|NCT03447015|7864|P1|COMPLETED|Overall Study||95
3760|NCT03447015|7863|P2|STARTED|Overall Study||150
3761|NCT03447015|7864|P1|STARTED|Overall Study||140
3762|NCT03446690|7882|P2|NOT COMPLETED|Overall Study||0
3763|NCT03446690|7883|P1|NOT COMPLETED|Overall Study||7
3764|NCT03446690|7882|P2|COMPLETED|Overall Study||29
3765|NCT03446690|7883|P1|COMPLETED|Overall Study||26
3766|NCT03446690|7882|P2|STARTED|Overall Study||29
3767|NCT03446690|7883|P1|STARTED|Overall Study||33
3768|NCT03445390|7889|P2|NOT COMPLETED|Second Intervention||1
3769|NCT03445390|7890|P1|NOT COMPLETED|Second Intervention||2
3770|NCT03445390|7889|P2|COMPLETED|Second Intervention||10
3771|NCT03445390|7890|P1|COMPLETED|Second Intervention||10
3772|NCT03445390|7889|P2|STARTED|Second Intervention||11
3773|NCT03445390|7890|P1|STARTED|Second Intervention||12
3774|NCT03445390|7889|P2|NOT COMPLETED|First Intervention||2
3775|NCT03445390|7890|P1|NOT COMPLETED|First Intervention||2
3776|NCT03445390|7889|P2|COMPLETED|First Intervention||11
3777|NCT03445390|7890|P1|COMPLETED|First Intervention||12
3778|NCT03445390|7889|P2|STARTED|First Intervention||13
3779|NCT03445390|7890|P1|STARTED|First Intervention||14
3780|NCT03445195|7902|P2|NOT COMPLETED|Overall Study||0
3781|NCT03445195|7903|P1|NOT COMPLETED|Overall Study||2
3782|NCT03445195|7902|P2|COMPLETED|Overall Study||27
3783|NCT03445195|7903|P1|COMPLETED|Overall Study||51
3784|NCT03445195|7902|P2|STARTED|Overall Study||27
3785|NCT03445195|7903|P1|STARTED|Overall Study||53
3786|NCT03445156|7918|P3|NOT COMPLETED|Experiment Proper||0
3787|NCT03445156|7919|P2|NOT COMPLETED|Experiment Proper||0
3788|NCT03445156|7920|P1|NOT COMPLETED|Experiment Proper||0
3789|NCT03445156|7918|P3|COMPLETED|Experiment Proper||59
3790|NCT03445156|7919|P2|COMPLETED|Experiment Proper||115
3791|NCT03445156|7920|P1|COMPLETED|Experiment Proper||113
3792|NCT03445156|7918|P3|STARTED|Experiment Proper||59
3793|NCT03445156|7919|P2|STARTED|Experiment Proper||115
3794|NCT03445156|7920|P1|STARTED|Experiment Proper||113
3795|NCT03445156|7918|P3|NOT COMPLETED|Pilot Study||0
3796|NCT03445156|7919|P2|NOT COMPLETED|Pilot Study||0
3797|NCT03445156|7920|P1|NOT COMPLETED|Pilot Study||0
3798|NCT03445156|7918|P3|COMPLETED|Pilot Study||0
3799|NCT03445156|7919|P2|COMPLETED|Pilot Study||20
3800|NCT03445156|7920|P1|COMPLETED|Pilot Study||20
3801|NCT03445156|7918|P3|STARTED|Pilot Study||0
3802|NCT03445156|7919|P2|STARTED|Pilot Study||20
3803|NCT03445156|7920|P1|STARTED|Pilot Study||20
3804|NCT03444090|7939|P2|NOT COMPLETED|Overall Study||4
3805|NCT03444090|7940|P1|NOT COMPLETED|Overall Study||3
3806|NCT03444090|7939|P2|COMPLETED|Overall Study||210
3807|NCT03444090|7940|P1|COMPLETED|Overall Study||211
3808|NCT03444090|7939|P2|STARTED|Overall Study||214
3809|NCT03444090|7940|P1|STARTED|Overall Study||214
3810|NCT03443414|7953|P5|NOT COMPLETED|Overall Study||5
3811|NCT03443414|7954|P4|NOT COMPLETED|Overall Study||5
3812|NCT03443414|7955|P3|NOT COMPLETED|Overall Study||6
3813|NCT03443414|7956|P2|NOT COMPLETED|Overall Study||3
3814|NCT03443414|7957|P1|NOT COMPLETED|Overall Study||11
3815|NCT03443414|7953|P5|COMPLETED|Overall Study||75
3816|NCT03443414|7954|P4|COMPLETED|Overall Study||75
3817|NCT03443414|7955|P3|COMPLETED|Overall Study||76
3818|NCT03443414|7956|P2|COMPLETED|Overall Study||78
3819|NCT03443414|7957|P1|COMPLETED|Overall Study||71
3820|NCT03443414|7953|P5|Received Treatment|Overall Study||79
3821|NCT03443414|7954|P4|Received Treatment|Overall Study||80
3822|NCT03443414|7955|P3|Received Treatment|Overall Study||82
3823|NCT03443414|7956|P2|Received Treatment|Overall Study||81
3824|NCT03443414|7957|P1|Received Treatment|Overall Study||81
3825|NCT03443414|7953|P5|STARTED|Overall Study||80
3826|NCT03443414|7954|P4|STARTED|Overall Study||80
3827|NCT03443414|7955|P3|STARTED|Overall Study||82
3828|NCT03443414|7956|P2|STARTED|Overall Study||81
3829|NCT03443414|7957|P1|STARTED|Overall Study||82
3830|NCT03442933|7994|P2|NOT COMPLETED|Overall Study||0
3831|NCT03442933|7995|P1|NOT COMPLETED|Overall Study||0
3832|NCT03442933|7994|P2|COMPLETED|Overall Study||20
3833|NCT03442933|7995|P1|COMPLETED|Overall Study||20
3834|NCT03442933|7994|P2|STARTED|Overall Study||20
3835|NCT03442933|7995|P1|STARTED|Overall Study||20
3836|NCT03442725|8008|P2|NOT COMPLETED|Overall Study||0
3837|NCT03442725|8009|P1|NOT COMPLETED|Overall Study||0
3838|NCT03442725|8008|P2|COMPLETED|Overall Study||8
3839|NCT03442725|8009|P1|COMPLETED|Overall Study||8
3840|NCT03442725|8008|P2|STARTED|Overall Study||8
3841|NCT03442725|8009|P1|STARTED|Overall Study||8
3842|NCT03441789|8043|P2|NOT COMPLETED|Overall Study||4
3843|NCT03441789|8044|P1|NOT COMPLETED|Overall Study||1
3844|NCT03441789|8043|P2|COMPLETED|Overall Study||10
3845|NCT03441789|8044|P1|COMPLETED|Overall Study||13
3846|NCT03441789|8043|P2|STARTED|Overall Study||14
3847|NCT03441789|8044|P1|STARTED|Overall Study||14
3848|NCT03441633|8070|P10|NOT COMPLETED|Overall Study||0
3849|NCT03441633|8071|P9|NOT COMPLETED|Overall Study||0
3850|NCT03441633|8072|P8|NOT COMPLETED|Overall Study||0
3851|NCT03441633|8073|P7|NOT COMPLETED|Overall Study||0
3852|NCT03441633|8074|P6|NOT COMPLETED|Overall Study||0
3853|NCT03441633|8075|P5|NOT COMPLETED|Overall Study||0
3854|NCT03441633|8076|P4|NOT COMPLETED|Overall Study||0
3855|NCT03441633|8077|P3|NOT COMPLETED|Overall Study||0
3856|NCT03441633|8078|P2|NOT COMPLETED|Overall Study||0
3857|NCT03441633|8079|P1|NOT COMPLETED|Overall Study||0
3858|NCT03441633|8070|P10|COMPLETED|Overall Study||1562
3859|NCT03441633|8071|P9|COMPLETED|Overall Study||5132
3860|NCT03441633|8072|P8|COMPLETED|Overall Study||953
3861|NCT03441633|8073|P7|COMPLETED|Overall Study||2855
3862|NCT03441633|8074|P6|COMPLETED|Overall Study||363
3863|NCT03441633|8075|P5|COMPLETED|Overall Study||2286
3864|NCT03441633|8076|P4|COMPLETED|Overall Study||192
3865|NCT03441633|8077|P3|COMPLETED|Overall Study||32212
3866|NCT03441633|8078|P2|COMPLETED|Overall Study||1423
3867|NCT03441633|8079|P1|COMPLETED|Overall Study||4712
3868|NCT03441633|8070|P10|STARTED|Overall Study||1562
3869|NCT03441633|8071|P9|STARTED|Overall Study||5132
3870|NCT03441633|8072|P8|STARTED|Overall Study||953
3871|NCT03441633|8073|P7|STARTED|Overall Study||2855
3872|NCT03441633|8074|P6|STARTED|Overall Study||363
3873|NCT03441633|8075|P5|STARTED|Overall Study||2286
3874|NCT03441633|8076|P4|STARTED|Overall Study||192
3875|NCT03441633|8077|P3|STARTED|Overall Study||32212
3876|NCT03441633|8078|P2|STARTED|Overall Study||1423
3877|NCT03441633|8079|P1|STARTED|Overall Study||4712
3878|NCT03440619|8219|P1|NOT COMPLETED|Overall Study||0
3879|NCT03440619|8219|P1|COMPLETED|Overall Study||28
3880|NCT03440619|8219|P1|STARTED|Overall Study||28
3881|NCT03439072|8223|P2|NOT COMPLETED|Overall Study||4
3882|NCT03439072|8224|P1|NOT COMPLETED|Overall Study||2
3883|NCT03439072|8223|P2|COMPLETED|Overall Study|1 subject dropped before Lilly Glucagon; 3 others after Lilly Glucagon (N=39 Lilly; N=36 G-Pen)|36
3884|NCT03439072|8224|P1|COMPLETED|Overall Study|1 subject dropped before G-Pen; another after G-Pen (n=40 G-Pen; N=39 Lilly Glucagon)|39
3885|NCT03439072|8223|P2|STARTED|Overall Study||40
3886|NCT03439072|8224|P1|STARTED|Overall Study||41
3887|NCT03438266|8256|P1|NOT COMPLETED|Overall Study||0
3888|NCT03438266|8256|P1|COMPLETED|Overall Study||60
3889|NCT03438266|8256|P1|STARTED|Overall Study||60
3890|NCT03437564|8267|P2|NOT COMPLETED|Overall Study||0
3891|NCT03437564|8268|P1|NOT COMPLETED|Overall Study||0
3892|NCT03437564|8267|P2|COMPLETED|Overall Study||14
3893|NCT03437564|8268|P1|COMPLETED|Overall Study||14
3894|NCT03437564|8267|P2|STARTED|Overall Study||14
3895|NCT03437564|8268|P1|STARTED|Overall Study||14
3896|NCT03437447|8299|P3|NOT COMPLETED|Treatment Period 3||0
3897|NCT03437447|8300|P2|NOT COMPLETED|Treatment Period 3||0
3898|NCT03437447|8301|P1|NOT COMPLETED|Treatment Period 3||0
3899|NCT03437447|8299|P3|COMPLETED|Treatment Period 3||19
3900|NCT03437447|8300|P2|COMPLETED|Treatment Period 3||20
3901|NCT03437447|8301|P1|COMPLETED|Treatment Period 3||20
3902|NCT03437447|8299|P3|STARTED|Treatment Period 3||19
3903|NCT03437447|8300|P2|STARTED|Treatment Period 3||20
3904|NCT03437447|8301|P1|STARTED|Treatment Period 3||20
3905|NCT03437447|8299|P3|NOT COMPLETED|Treatment Period 2||0
3906|NCT03437447|8300|P2|NOT COMPLETED|Treatment Period 2||0
3907|NCT03437447|8301|P1|NOT COMPLETED|Treatment Period 2||0
3908|NCT03437447|8299|P3|COMPLETED|Treatment Period 2||19
3909|NCT03437447|8300|P2|COMPLETED|Treatment Period 2||20
3910|NCT03437447|8301|P1|COMPLETED|Treatment Period 2||20
3911|NCT03437447|8299|P3|STARTED|Treatment Period 2||19
3912|NCT03437447|8300|P2|STARTED|Treatment Period 2||20
3913|NCT03437447|8301|P1|STARTED|Treatment Period 2||20
3914|NCT03437447|8299|P3|NOT COMPLETED|Treatment Period 1||1
3915|NCT03437447|8300|P2|NOT COMPLETED|Treatment Period 1||0
3916|NCT03437447|8301|P1|NOT COMPLETED|Treatment Period 1||0
3917|NCT03437447|8299|P3|COMPLETED|Treatment Period 1||19
3918|NCT03437447|8300|P2|COMPLETED|Treatment Period 1||20
3919|NCT03437447|8301|P1|COMPLETED|Treatment Period 1||20
3920|NCT03437447|8299|P3|STARTED|Treatment Period 1||20
3921|NCT03437447|8300|P2|STARTED|Treatment Period 1||20
3922|NCT03437447|8301|P1|STARTED|Treatment Period 1||20
3923|NCT03436732|8356|P2|NOT COMPLETED|Overall Study||1
3924|NCT03436732|8357|P1|NOT COMPLETED|Overall Study||4
3925|NCT03436732|8356|P2|COMPLETED|Overall Study||0
3926|NCT03436732|8357|P1|COMPLETED|Overall Study||0
3927|NCT03436732|8356|P2|STARTED|Overall Study||1
3928|NCT03436732|8357|P1|STARTED|Overall Study||4
3929|NCT03435783|8372|P2|NOT COMPLETED|Overall Study||1
3930|NCT03435783|8373|P1|NOT COMPLETED|Overall Study||0
3931|NCT03435783|8372|P2|COMPLETED|Overall Study||19
3932|NCT03435783|8373|P1|COMPLETED|Overall Study||20
3933|NCT03435783|8372|P2|STARTED|Overall Study||20
3934|NCT03435783|8373|P1|STARTED|Overall Study||20
3935|NCT03435185|8389|P2|NOT COMPLETED|Overall Study||15
3936|NCT03435185|8390|P1|NOT COMPLETED|Overall Study||1
3937|NCT03435185|8389|P2|COMPLETED|Overall Study||28
3938|NCT03435185|8390|P1|COMPLETED|Overall Study||43
3939|NCT03435185|8389|P2|STARTED|Overall Study||43
3940|NCT03435185|8390|P1|STARTED|Overall Study||44
3941|NCT03434977|8400|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
3942|NCT03434977|8401|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
3943|NCT03434977|8400|P2|COMPLETED|Intervention Period 2 (6 Days)||5
3944|NCT03434977|8401|P1|COMPLETED|Intervention Period 2 (6 Days)||6
3945|NCT03434977|8400|P2|STARTED|Intervention Period 2 (6 Days)||5
3946|NCT03434977|8401|P1|STARTED|Intervention Period 2 (6 Days)||6
3947|NCT03434977|8400|P2|NOT COMPLETED|Washout Period (at Least 6 Days)||1
3948|NCT03434977|8401|P1|NOT COMPLETED|Washout Period (at Least 6 Days)||0
3949|NCT03434977|8400|P2|COMPLETED|Washout Period (at Least 6 Days)||5
3950|NCT03434977|8401|P1|COMPLETED|Washout Period (at Least 6 Days)||6
3951|NCT03434977|8400|P2|STARTED|Washout Period (at Least 6 Days)||6
3952|NCT03434977|8401|P1|STARTED|Washout Period (at Least 6 Days)||6
3953|NCT03434977|8400|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
3954|NCT03434977|8401|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
3955|NCT03434977|8400|P2|COMPLETED|Intervention Period 1 (6 Days)||6
3956|NCT03434977|8401|P1|COMPLETED|Intervention Period 1 (6 Days)||6
3957|NCT03434977|8400|P2|STARTED|Intervention Period 1 (6 Days)||6
3958|NCT03434977|8401|P1|STARTED|Intervention Period 1 (6 Days)||6
3959|NCT03433677|8437|P2|NOT COMPLETED|Period 2||1
3960|NCT03433677|8438|P1|NOT COMPLETED|Period 2||1
3961|NCT03433677|8437|P2|COMPLETED|Period 2||24
3962|NCT03433677|8438|P1|COMPLETED|Period 2||22
3963|NCT03433677|8437|P2|Received at Least 1 Dose of Study Drug|Period 2||25
3964|NCT03433677|8438|P1|Received at Least 1 Dose of Study Drug|Period 2||23
3965|NCT03433677|8437|P2|STARTED|Period 2||25
3966|NCT03433677|8438|P1|STARTED|Period 2||23
3967|NCT03433677|8437|P2|NOT COMPLETED|Period 1||0
3968|NCT03433677|8438|P1|NOT COMPLETED|Period 1||1
3969|NCT03433677|8437|P2|COMPLETED|Period 1||25
3970|NCT03433677|8438|P1|COMPLETED|Period 1||23
3971|NCT03433677|8437|P2|Received at Least 1 Dose of Study Drug|Period 1||25
3972|NCT03433677|8438|P1|Received at Least 1 Dose of Study Drug|Period 1||24
3973|NCT03433677|8437|P2|STARTED|Period 1||25
3974|NCT03433677|8438|P1|STARTED|Period 1||24
3975|NCT03432390|8458|P2|NOT COMPLETED|Recovery Period||0
3976|NCT03432390|8459|P1|NOT COMPLETED|Recovery Period||0
3977|NCT03432390|8458|P2|COMPLETED|Recovery Period||34
3978|NCT03432390|8459|P1|COMPLETED|Recovery Period||34
3979|NCT03432390|8458|P2|STARTED|Recovery Period||34
3980|NCT03432390|8459|P1|STARTED|Recovery Period||34
3981|NCT03432390|8458|P2|NOT COMPLETED|Apnea Period||2
3982|NCT03432390|8459|P1|NOT COMPLETED|Apnea Period||2
3983|NCT03432390|8458|P2|COMPLETED|Apnea Period||34
3984|NCT03432390|8459|P1|COMPLETED|Apnea Period||34
3985|NCT03432390|8458|P2|STARTED|Apnea Period||36
3986|NCT03432390|8459|P1|STARTED|Apnea Period||36
3987|NCT03431441|8469|P1|NOT COMPLETED|Overall Study||5
3988|NCT03431441|8469|P1|COMPLETED|Overall Study||19
3989|NCT03431441|8469|P1|STARTED|Overall Study||24
3990|NCT03430050|8475|P2|NOT COMPLETED|Overall Study||0
3991|NCT03430050|8476|P1|NOT COMPLETED|Overall Study||0
3992|NCT03430050|8475|P2|COMPLETED|Overall Study||5
3993|NCT03430050|8476|P1|COMPLETED|Overall Study||3
3994|NCT03430050|8475|P2|STARTED|Overall Study||5
3995|NCT03430050|8476|P1|STARTED|Overall Study||3
3999|NCT03429556|8492|P4|NOT COMPLETED|Overall Study||0
4000|NCT03429556|8493|P3|NOT COMPLETED|Overall Study||0
4001|NCT03429556|8494|P2|NOT COMPLETED|Overall Study||1
4002|NCT03429556|8495|P1|NOT COMPLETED|Overall Study||0
4003|NCT03429556|8492|P4|COMPLETED|Overall Study||3
4004|NCT03429556|8493|P3|COMPLETED|Overall Study||4
4005|NCT03429556|8494|P2|COMPLETED|Overall Study||3
4006|NCT03429556|8495|P1|COMPLETED|Overall Study||12
4007|NCT03429556|8492|P4|STARTED|Overall Study||3
4008|NCT03429556|8493|P3|STARTED|Overall Study||4
4009|NCT03429556|8494|P2|STARTED|Overall Study||4
4010|NCT03429556|8495|P1|STARTED|Overall Study||12
4011|NCT03428997|8541|P1|NOT COMPLETED|Overall Study||8
4012|NCT03428997|8541|P1|COMPLETED|Overall Study||16
4013|NCT03428997|8541|P1|STARTED|Overall Study||24
4014|NCT03428152|8549|P2|NOT COMPLETED|Overall Study||11
4015|NCT03428152|8550|P1|NOT COMPLETED|Overall Study||7
4016|NCT03428152|8549|P2|COMPLETED|Overall Study|exclusions: epidural / TAP / wound infiltration malignity retroperitone was opened age >65|30
4017|NCT03428152|8550|P1|COMPLETED|Overall Study||30
4018|NCT03428152|8549|P2|STARTED|Overall Study||41
4019|NCT03428152|8550|P1|STARTED|Overall Study||37
4020|NCT03427892|8566|P1|NOT COMPLETED|Overall Study||2
4021|NCT03427892|8566|P1|COMPLETED|Overall Study|Of the 21 recruited, 19 completed at least one post baseline visit, included in the analysis.|19
4022|NCT03427892|8566|P1|STARTED|Overall Study||21
4023|NCT03427073|8590|P8|NOT COMPLETED|Overall Study||4
4024|NCT03427073|8591|P7|NOT COMPLETED|Overall Study||3
4025|NCT03427073|8592|P6|NOT COMPLETED|Overall Study||4
4026|NCT03427073|8593|P5|NOT COMPLETED|Overall Study||3
4027|NCT03427073|8594|P4|NOT COMPLETED|Overall Study||3
4028|NCT03427073|8595|P3|NOT COMPLETED|Overall Study||1
4029|NCT03427073|8596|P2|NOT COMPLETED|Overall Study||1
4030|NCT03427073|8597|P1|NOT COMPLETED|Overall Study||1
4031|NCT03427073|8590|P8|COMPLETED|Overall Study||0
4032|NCT03427073|8591|P7|COMPLETED|Overall Study||0
4033|NCT03427073|8592|P6|COMPLETED|Overall Study||0
4034|NCT03427073|8593|P5|COMPLETED|Overall Study||0
4035|NCT03427073|8594|P4|COMPLETED|Overall Study||0
4036|NCT03427073|8595|P3|COMPLETED|Overall Study||0
4037|NCT03427073|8596|P2|COMPLETED|Overall Study||0
4038|NCT03427073|8597|P1|COMPLETED|Overall Study||0
4039|NCT03427073|8590|P8|STARTED|Overall Study||4
4040|NCT03427073|8591|P7|STARTED|Overall Study||3
4041|NCT03427073|8592|P6|STARTED|Overall Study||4
4042|NCT03427073|8593|P5|STARTED|Overall Study||3
4043|NCT03427073|8594|P4|STARTED|Overall Study||3
4044|NCT03427073|8595|P3|STARTED|Overall Study||1
4045|NCT03427073|8596|P2|STARTED|Overall Study||1
4046|NCT03427073|8597|P1|STARTED|Overall Study||1
4047|NCT03426787|8647|P1|NOT COMPLETED|Overall Study||14
4048|NCT03426787|8647|P1|COMPLETED|Overall Study||56
4049|NCT03426787|8647|P1|STARTED|Overall Study||70
4050|NCT03426566|8657|P1|NOT COMPLETED|Overall Study||0
4051|NCT03426566|8657|P1|COMPLETED|Overall Study||974
4052|NCT03426566|8657|P1|STARTED|Overall Study||974
4053|NCT03426436|8663|P1|NOT COMPLETED|Overall Study||19
4054|NCT03426436|8663|P1|COMPLETED|Overall Study||295
4055|NCT03426436|8663|P1|STARTED|Overall Study||314
4056|NCT03423641|8670|P2|NOT COMPLETED|Overall Study||8074
4057|NCT03423641|8671|P1|NOT COMPLETED|Overall Study||331
4058|NCT03423641|8670|P2|COMPLETED|Overall Study||10210
4059|NCT03423641|8671|P1|COMPLETED|Overall Study||15193
4060|NCT03423641|8670|P2|STARTED|Overall Study||18284
4061|NCT03423641|8671|P1|STARTED|Overall Study||15524
4062|NCT03421730|8702|P12|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
4063|NCT03421730|8703|P11|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
4064|NCT03421730|8704|P10|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
4065|NCT03421730|8705|P9|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
4066|NCT03421730|8706|P8|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
4067|NCT03421730|8707|P7|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
4068|NCT03421730|8708|P6|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
4069|NCT03421730|8709|P5|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
4070|NCT03421730|8710|P4|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
4071|NCT03421730|8711|P3|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
4072|NCT03421730|8712|P2|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
4073|NCT03421730|8713|P1|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
4074|NCT03421730|8702|P12|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
4075|NCT03421730|8703|P11|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
4076|NCT03421730|8704|P10|COMPLETED|Second Intervention (Day 8±3, Visit 3)||2
4077|NCT03421730|8705|P9|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
4078|NCT03421730|8706|P8|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
4079|NCT03421730|8707|P7|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
4080|NCT03421730|8708|P6|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
4081|NCT03421730|8709|P5|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
4082|NCT03421730|8710|P4|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
4083|NCT03421730|8711|P3|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
4084|NCT03421730|8712|P2|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
4085|NCT03421730|8713|P1|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
4086|NCT03421730|8702|P12|STARTED|Second Intervention (Day 8±3, Visit 3)||1
4087|NCT03421730|8703|P11|STARTED|Second Intervention (Day 8±3, Visit 3)||1
4088|NCT03421730|8704|P10|STARTED|Second Intervention (Day 8±3, Visit 3)||2
4089|NCT03421730|8705|P9|STARTED|Second Intervention (Day 8±3, Visit 3)||1
4090|NCT03421730|8706|P8|STARTED|Second Intervention (Day 8±3, Visit 3)||1
4091|NCT03421730|8707|P7|STARTED|Second Intervention (Day 8±3, Visit 3)||1
4092|NCT03421730|8708|P6|STARTED|Second Intervention (Day 8±3, Visit 3)||1
4093|NCT03421730|8709|P5|STARTED|Second Intervention (Day 8±3, Visit 3)||1
4094|NCT03421730|8710|P4|STARTED|Second Intervention (Day 8±3, Visit 3)||1
4095|NCT03421730|8711|P3|STARTED|Second Intervention (Day 8±3, Visit 3)||1
4096|NCT03421730|8712|P2|STARTED|Second Intervention (Day 8±3, Visit 3)||1
4097|NCT03421730|8713|P1|STARTED|Second Intervention (Day 8±3, Visit 3)||1
4098|NCT03421730|8702|P12|NOT COMPLETED|Washout (Days 4 to 10)||0
4099|NCT03421730|8703|P11|NOT COMPLETED|Washout (Days 4 to 10)||0
4100|NCT03421730|8704|P10|NOT COMPLETED|Washout (Days 4 to 10)||0
4101|NCT03421730|8705|P9|NOT COMPLETED|Washout (Days 4 to 10)||0
4102|NCT03421730|8706|P8|NOT COMPLETED|Washout (Days 4 to 10)||0
4103|NCT03421730|8707|P7|NOT COMPLETED|Washout (Days 4 to 10)||0
4104|NCT03421730|8708|P6|NOT COMPLETED|Washout (Days 4 to 10)||0
4105|NCT03421730|8709|P5|NOT COMPLETED|Washout (Days 4 to 10)||2
4106|NCT03421730|8710|P4|NOT COMPLETED|Washout (Days 4 to 10)||0
4107|NCT03421730|8711|P3|NOT COMPLETED|Washout (Days 4 to 10)||0
4108|NCT03421730|8712|P2|NOT COMPLETED|Washout (Days 4 to 10)||0
4109|NCT03421730|8713|P1|NOT COMPLETED|Washout (Days 4 to 10)||0
4110|NCT03421730|8702|P12|COMPLETED|Washout (Days 4 to 10)||1
4111|NCT03421730|8703|P11|COMPLETED|Washout (Days 4 to 10)||1
4112|NCT03421730|8704|P10|COMPLETED|Washout (Days 4 to 10)||2
4113|NCT03421730|8705|P9|COMPLETED|Washout (Days 4 to 10)||1
4114|NCT03421730|8706|P8|COMPLETED|Washout (Days 4 to 10)||1
4115|NCT03421730|8707|P7|COMPLETED|Washout (Days 4 to 10)||1
4116|NCT03421730|8708|P6|COMPLETED|Washout (Days 4 to 10)||1
4117|NCT03421730|8709|P5|COMPLETED|Washout (Days 4 to 10)|Two subjects withdrew after receiving treatment with B but before receiving treatment with C.|1
4118|NCT03421730|8710|P4|COMPLETED|Washout (Days 4 to 10)||1
4119|NCT03421730|8711|P3|COMPLETED|Washout (Days 4 to 10)||1
4120|NCT03421730|8712|P2|COMPLETED|Washout (Days 4 to 10)||1
4121|NCT03421730|8713|P1|COMPLETED|Washout (Days 4 to 10)||1
4122|NCT03421730|8702|P12|STARTED|Washout (Days 4 to 10)||1
4123|NCT03421730|8703|P11|STARTED|Washout (Days 4 to 10)||1
4124|NCT03421730|8704|P10|STARTED|Washout (Days 4 to 10)||2
4125|NCT03421730|8705|P9|STARTED|Washout (Days 4 to 10)||1
4126|NCT03421730|8706|P8|STARTED|Washout (Days 4 to 10)||1
4127|NCT03421730|8707|P7|STARTED|Washout (Days 4 to 10)||1
4128|NCT03421730|8708|P6|STARTED|Washout (Days 4 to 10)||1
4129|NCT03421730|8709|P5|STARTED|Washout (Days 4 to 10)||3
4130|NCT03421730|8710|P4|STARTED|Washout (Days 4 to 10)||1
4131|NCT03421730|8711|P3|STARTED|Washout (Days 4 to 10)||1
4132|NCT03421730|8712|P2|STARTED|Washout (Days 4 to 10)||1
4133|NCT03421730|8713|P1|STARTED|Washout (Days 4 to 10)||1
4134|NCT03421730|8702|P12|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
4135|NCT03421730|8703|P11|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
4136|NCT03421730|8704|P10|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
4137|NCT03421730|8705|P9|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
4138|NCT03421730|8706|P8|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
4139|NCT03421730|8707|P7|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
4140|NCT03421730|8708|P6|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
4141|NCT03421730|8709|P5|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
4142|NCT03421730|8710|P4|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
4143|NCT03421730|8711|P3|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
4144|NCT03421730|8712|P2|NOT COMPLETED|First Intervention (Day 1, Visit 2)||2
4145|NCT03421730|8713|P1|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
4146|NCT03421730|8702|P12|COMPLETED|First Intervention (Day 1, Visit 2)||1
4147|NCT03421730|8703|P11|COMPLETED|First Intervention (Day 1, Visit 2)||1
4148|NCT03421730|8704|P10|COMPLETED|First Intervention (Day 1, Visit 2)||2
4149|NCT03421730|8705|P9|COMPLETED|First Intervention (Day 1, Visit 2)||1
4150|NCT03421730|8706|P8|COMPLETED|First Intervention (Day 1, Visit 2)||1
4151|NCT03421730|8707|P7|COMPLETED|First Intervention (Day 1, Visit 2)||1
4152|NCT03421730|8708|P6|COMPLETED|First Intervention (Day 1, Visit 2)||1
4153|NCT03421730|8709|P5|COMPLETED|First Intervention (Day 1, Visit 2)||3
4154|NCT03421730|8710|P4|COMPLETED|First Intervention (Day 1, Visit 2)||1
4155|NCT03421730|8711|P3|COMPLETED|First Intervention (Day 1, Visit 2)||1
4156|NCT03421730|8712|P2|COMPLETED|First Intervention (Day 1, Visit 2)|Two subjects withdrew without receiving treatment with either A or C.|1
4157|NCT03421730|8713|P1|COMPLETED|First Intervention (Day 1, Visit 2)||1
4158|NCT03421730|8702|P12|STARTED|First Intervention (Day 1, Visit 2)||1
4159|NCT03421730|8703|P11|STARTED|First Intervention (Day 1, Visit 2)||1
4160|NCT03421730|8704|P10|STARTED|First Intervention (Day 1, Visit 2)||2
4161|NCT03421730|8705|P9|STARTED|First Intervention (Day 1, Visit 2)||1
4162|NCT03421730|8706|P8|STARTED|First Intervention (Day 1, Visit 2)||1
4163|NCT03421730|8707|P7|STARTED|First Intervention (Day 1, Visit 2)||1
4164|NCT03421730|8708|P6|STARTED|First Intervention (Day 1, Visit 2)||1
4165|NCT03421730|8709|P5|STARTED|First Intervention (Day 1, Visit 2)||3
4166|NCT03421730|8710|P4|STARTED|First Intervention (Day 1, Visit 2)||1
4167|NCT03421730|8711|P3|STARTED|First Intervention (Day 1, Visit 2)||1
4168|NCT03421730|8712|P2|STARTED|First Intervention (Day 1, Visit 2)||3
4169|NCT03421730|8713|P1|STARTED|First Intervention (Day 1, Visit 2)||1
4170|NCT03421379|8786|P2|NOT COMPLETED|Period 2||0
4171|NCT03421379|8787|P1|NOT COMPLETED|Period 2||0
4172|NCT03421379|8786|P2|COMPLETED|Period 2||37
4173|NCT03421379|8787|P1|COMPLETED|Period 2||32
4174|NCT03421379|8786|P2|STARTED|Period 2||37
4175|NCT03421379|8787|P1|STARTED|Period 2||32
4176|NCT03421379|8786|P2|NOT COMPLETED|Washout Period (3 to 14 Days)||0
4177|NCT03421379|8787|P1|NOT COMPLETED|Washout Period (3 to 14 Days)||0
4178|NCT03421379|8786|P2|COMPLETED|Washout Period (3 to 14 Days)||37
4179|NCT03421379|8787|P1|COMPLETED|Washout Period (3 to 14 Days)||32
4180|NCT03421379|8786|P2|STARTED|Washout Period (3 to 14 Days)||37
4181|NCT03421379|8787|P1|STARTED|Washout Period (3 to 14 Days)||32
4182|NCT03421379|8786|P2|NOT COMPLETED|Period 1||4
4183|NCT03421379|8787|P1|NOT COMPLETED|Period 1||2
4184|NCT03421379|8786|P2|COMPLETED|Period 1||37
4185|NCT03421379|8787|P1|COMPLETED|Period 1||32
4186|NCT03421379|8786|P2|Received at Least One Dose of Study Drug|Period 1||39
4187|NCT03421379|8787|P1|Received at Least One Dose of Study Drug|Period 1||33
4188|NCT03421379|8786|P2|STARTED|Period 1||41
4189|NCT03421379|8787|P1|STARTED|Period 1||34
4190|NCT03420625|8803|P1|NOT COMPLETED|Overall Study||0
4191|NCT03420625|8803|P1|COMPLETED|Overall Study||10
4192|NCT03420625|8803|P1|Calf NMES|Overall Study||10
4193|NCT03420625|8803|P1|Slow Calf IPC|Overall Study||10
4194|NCT03420625|8803|P1|Rapid Calf IPC|Overall Study||10
4195|NCT03420625|8803|P1|Foot IPC|Overall Study||10
4196|NCT03420625|8803|P1|Baseline|Overall Study||10
4197|NCT03420625|8803|P1|STARTED|Overall Study||10
4198|NCT03419078|8836|P3|NOT COMPLETED|Overall Study||0
4199|NCT03419078|8837|P2|NOT COMPLETED|Overall Study||0
4200|NCT03419078|8838|P1|NOT COMPLETED|Overall Study||0
4201|NCT03419078|8836|P3|COMPLETED|Overall Study||91
4202|NCT03419078|8837|P2|COMPLETED|Overall Study||148
4203|NCT03419078|8838|P1|COMPLETED|Overall Study||245
4204|NCT03419078|8836|P3|STARTED|Overall Study||91
4205|NCT03419078|8837|P2|STARTED|Overall Study||148
4206|NCT03419078|8838|P1|STARTED|Overall Study||245
4207|NCT03418662|8857|P2|NOT COMPLETED|Overall Study||4
4208|NCT03418662|8858|P1|NOT COMPLETED|Overall Study||3
4209|NCT03418662|8857|P2|COMPLETED|Overall Study||278
4210|NCT03418662|8858|P1|COMPLETED|Overall Study||284
4211|NCT03418662|8857|P2|STARTED|Overall Study||282
4212|NCT03418662|8858|P1|STARTED|Overall Study||287
4213|NCT03418571|8882|P2|NOT COMPLETED|Overall Study||0
4214|NCT03418571|8883|P1|NOT COMPLETED|Overall Study||1
4215|NCT03418571|8882|P2|COMPLETED|Overall Study||3
4216|NCT03418571|8883|P1|COMPLETED|Overall Study||11
4217|NCT03418571|8882|P2|STARTED|Overall Study||3
4218|NCT03418571|8883|P1|STARTED|Overall Study||12
4219|NCT03418064|8891|P2|NOT COMPLETED|Second Intervention (1 Month)||0
4220|NCT03418064|8892|P1|NOT COMPLETED|Second Intervention (1 Month)||0
4221|NCT03418064|8891|P2|COMPLETED|Second Intervention (1 Month)||21
4222|NCT03418064|8892|P1|COMPLETED|Second Intervention (1 Month)||21
4223|NCT03418064|8891|P2|STARTED|Second Intervention (1 Month)||21
4224|NCT03418064|8892|P1|STARTED|Second Intervention (1 Month)||21
4225|NCT03418064|8891|P2|NOT COMPLETED|First Intervention (1 Month)||0
4226|NCT03418064|8892|P1|NOT COMPLETED|First Intervention (1 Month)||0
4227|NCT03418064|8891|P2|COMPLETED|First Intervention (1 Month)||21
4228|NCT03418064|8892|P1|COMPLETED|First Intervention (1 Month)||21
4229|NCT03418064|8891|P2|STARTED|First Intervention (1 Month)||21
4230|NCT03418064|8892|P1|STARTED|First Intervention (1 Month)||21
4231|NCT03417830|8923|P2|NOT COMPLETED|Part B (up to 26 Days)||0
4232|NCT03417830|8924|P1|NOT COMPLETED|Part B (up to 26 Days)||0
4233|NCT03417830|8923|P2|COMPLETED|Part B (up to 26 Days)||0
4234|NCT03417830|8924|P1|COMPLETED|Part B (up to 26 Days)||0
4235|NCT03417830|8923|P2|STARTED|Part B (up to 26 Days)||0
4236|NCT03417830|8924|P1|STARTED|Part B (up to 26 Days)||0
4237|NCT03417830|8923|P2|NOT COMPLETED|Part A (up to 26 Days)||0
4238|NCT03417830|8924|P1|NOT COMPLETED|Part A (up to 26 Days)||1
4239|NCT03417830|8923|P2|COMPLETED|Part A (up to 26 Days)||0
4240|NCT03417830|8924|P1|COMPLETED|Part A (up to 26 Days)||1
4241|NCT03417830|8923|P2|STARTED|Part A (up to 26 Days)||0
4242|NCT03417830|8924|P1|STARTED|Part A (up to 26 Days)||2
4243|NCT03417713|9018|P1|NOT COMPLETED|Overall Study||3
4244|NCT03417713|9018|P1|COMPLETED|Overall Study||30
4245|NCT03417713|9018|P1|STARTED|Overall Study||33
4246|NCT03417466|9023|P1|NOT COMPLETED|Overall Study||0
4247|NCT03417466|9023|P1|COMPLETED|Overall Study||66
4248|NCT03417466|9023|P1|STARTED|Overall Study||66
4249|NCT03417219|9032|P2|NOT COMPLETED|Overall Study||3
4250|NCT03417219|9033|P1|NOT COMPLETED|Overall Study||0
4251|NCT03417219|9032|P2|COMPLETED|Overall Study||5
4252|NCT03417219|9033|P1|COMPLETED|Overall Study||8
4253|NCT03417219|9032|P2|STARTED|Overall Study||8
4254|NCT03417219|9033|P1|STARTED|Overall Study||8
4255|NCT03417024|9043|P1|NOT COMPLETED|Overall Study||13
4256|NCT03417024|9043|P1|COMPLETED|Overall Study||0
4257|NCT03417024|9043|P1|STARTED|Overall Study||13
4258|NCT03415243|9051|P2|NOT COMPLETED|Overall Study||0
4259|NCT03415243|9052|P1|NOT COMPLETED|Overall Study||0
4260|NCT03415243|9051|P2|COMPLETED|Overall Study||14
4261|NCT03415243|9052|P1|COMPLETED|Overall Study||14
4262|NCT03415243|9051|P2|STARTED|Overall Study||14
4263|NCT03415243|9052|P1|STARTED|Overall Study||14
4264|NCT03415178|9116|P2|NOT COMPLETED|Single Arm Period (up to Week 16)||1
4265|NCT03415178|9117|P1|NOT COMPLETED|Single Arm Period (up to Week 16)||0
4266|NCT03415178|9116|P2|COMPLETED|Single Arm Period (up to Week 16)||65
4267|NCT03415178|9117|P1|COMPLETED|Single Arm Period (up to Week 16)||0
4268|NCT03415178|9116|P2|STARTED|Single Arm Period (up to Week 16)|65 (participants completed period 1) + 1 (randomized to SYDNEY arm but not treated in period 1).|66
4269|NCT03415178|9117|P1|STARTED|Single Arm Period (up to Week 16)|Out of 34 participants from AI group, 33 participants entered entered in single arm period.|0
4270|NCT03415178|9116|P2|NOT COMPLETED|Parallel-Arm Period (up to Week 4)||2
4271|NCT03415178|9117|P1|NOT COMPLETED|Parallel-Arm Period (up to Week 4)||0
4272|NCT03415178|9116|P2|COMPLETED|Parallel-Arm Period (up to Week 4)|32 participants entered in single arm period & 1 participant decided not to enter single arm period.|33
4273|NCT03415178|9117|P1|COMPLETED|Parallel-Arm Period (up to Week 4)|33 participants entered in single arm period & 1 participant decided not to enter single arm period.|34
4274|NCT03415178|9116|P2|Treated|Parallel-Arm Period (up to Week 4)||33
4275|NCT03415178|9117|P1|Treated|Parallel-Arm Period (up to Week 4)||34
4276|NCT03415178|9116|P2|STARTED|Parallel-Arm Period (up to Week 4)|Randomized|35
4277|NCT03415178|9117|P1|STARTED|Parallel-Arm Period (up to Week 4)|Randomized|34
4278|NCT03410628|9152|P1|NOT COMPLETED|Overall Study||6
4279|NCT03410628|9152|P1|COMPLETED|Overall Study||15
4280|NCT03410628|9152|P1|STARTED|Overall Study||21
4281|NCT03409731|9157|P1|NOT COMPLETED|Overall Study||0
4282|NCT03409731|9157|P1|COMPLETED|Overall Study||135
4283|NCT03409731|9157|P1|STARTED|Overall Study||135
4284|NCT03408639|9191|P2|NOT COMPLETED|Overall Study||22
4285|NCT03408639|9192|P1|NOT COMPLETED|Overall Study||11
4286|NCT03408639|9191|P2|COMPLETED|Overall Study||56
4287|NCT03408639|9192|P1|COMPLETED|Overall Study||67
4288|NCT03408639|9191|P2|STARTED|Overall Study||78
4289|NCT03408639|9192|P1|STARTED|Overall Study||78
4290|NCT03408392|9220|P2|NOT COMPLETED|Treatment Period 2 (16 Days)||0
4291|NCT03408392|9221|P1|NOT COMPLETED|Treatment Period 2 (16 Days)||0
4292|NCT03408392|9220|P2|COMPLETED|Treatment Period 2 (16 Days)||14
4293|NCT03408392|9221|P1|COMPLETED|Treatment Period 2 (16 Days)||14
4294|NCT03408392|9220|P2|STARTED|Treatment Period 2 (16 Days)||14
4295|NCT03408392|9221|P1|STARTED|Treatment Period 2 (16 Days)||14
4296|NCT03408392|9220|P2|NOT COMPLETED|Wash-out Period (14 Days)||0
4297|NCT03408392|9221|P1|NOT COMPLETED|Wash-out Period (14 Days)||0
4298|NCT03408392|9220|P2|COMPLETED|Wash-out Period (14 Days)||14
4299|NCT03408392|9221|P1|COMPLETED|Wash-out Period (14 Days)||14
4300|NCT03408392|9220|P2|STARTED|Wash-out Period (14 Days)||14
4301|NCT03408392|9221|P1|STARTED|Wash-out Period (14 Days)||14
4302|NCT03408392|9220|P2|NOT COMPLETED|Treatment Period 1 (16 Days)||0
4303|NCT03408392|9221|P1|NOT COMPLETED|Treatment Period 1 (16 Days)||0
4304|NCT03408392|9220|P2|COMPLETED|Treatment Period 1 (16 Days)||14
4305|NCT03408392|9221|P1|COMPLETED|Treatment Period 1 (16 Days)||14
4306|NCT03408392|9220|P2|STARTED|Treatment Period 1 (16 Days)||14
4307|NCT03408392|9221|P1|STARTED|Treatment Period 1 (16 Days)||14
4308|NCT03407612|9275|P2|NOT COMPLETED|Overall Study||0
4309|NCT03407612|9276|P1|NOT COMPLETED|Overall Study||0
4310|NCT03407612|9275|P2|COMPLETED|Overall Study||23
4311|NCT03407612|9276|P1|COMPLETED|Overall Study||19
4312|NCT03407612|9275|P2|STARTED|Overall Study||23
4313|NCT03407612|9276|P1|STARTED|Overall Study||19
4314|NCT03407430|9288|P2|NOT COMPLETED|Second Intervention||0
4315|NCT03407430|9289|P1|NOT COMPLETED|Second Intervention||0
4316|NCT03407430|9288|P2|COMPLETED|Second Intervention||3
4317|NCT03407430|9289|P1|COMPLETED|Second Intervention||4
4318|NCT03407430|9288|P2|STARTED|Second Intervention||3
4319|NCT03407430|9289|P1|STARTED|Second Intervention||4
4320|NCT03407430|9288|P2|NOT COMPLETED|Washout||0
4321|NCT03407430|9289|P1|NOT COMPLETED|Washout||1
4322|NCT03407430|9288|P2|COMPLETED|Washout||3
4323|NCT03407430|9289|P1|COMPLETED|Washout||4
4324|NCT03407430|9288|P2|STARTED|Washout||3
4325|NCT03407430|9289|P1|STARTED|Washout||5
4326|NCT03407430|9288|P2|NOT COMPLETED|First Intervention||0
4327|NCT03407430|9289|P1|NOT COMPLETED|First Intervention||0
4328|NCT03407430|9288|P2|COMPLETED|First Intervention||3
4329|NCT03407430|9289|P1|COMPLETED|First Intervention||5
4330|NCT03407430|9288|P2|STARTED|First Intervention||3
4331|NCT03407430|9289|P1|STARTED|First Intervention||5
4332|NCT03405818|9321|P1|NOT COMPLETED|Overall Study||8
4333|NCT03405818|9321|P1|COMPLETED|Overall Study||47
4334|NCT03405818|9321|P1|STARTED|Overall Study||55
4335|NCT03405259|9364|P2|NOT COMPLETED|Overall Study||0
4336|NCT03405259|9365|P1|NOT COMPLETED|Overall Study||0
4337|NCT03405259|9364|P2|COMPLETED|Overall Study||11
4338|NCT03405259|9365|P1|COMPLETED|Overall Study||11
4339|NCT03405259|9364|P2|STARTED|Overall Study||11
4340|NCT03405259|9365|P1|STARTED|Overall Study||11
4341|NCT03404206|9376|P3|NOT COMPLETED|Overall Study||0
4342|NCT03404206|9377|P2|NOT COMPLETED|Overall Study||2
4343|NCT03404206|9378|P1|NOT COMPLETED|Overall Study||4
4344|NCT03404206|9376|P3|COMPLETED|Overall Study||55
4345|NCT03404206|9377|P2|COMPLETED|Overall Study||164
4346|NCT03404206|9378|P1|COMPLETED|Overall Study||162
4347|NCT03404206|9376|P3|STARTED|Overall Study||55
4348|NCT03404206|9377|P2|STARTED|Overall Study||166
4349|NCT03404206|9378|P1|STARTED|Overall Study||166
4350|NCT03404167|9392|P1|NOT COMPLETED|Overall Study||0
4351|NCT03404167|9392|P1|COMPLETED|Overall Study||8
4352|NCT03404167|9392|P1|STARTED|Overall Study||8
4353|NCT03403504|9429|P2|NOT COMPLETED|Period 2||0
4354|NCT03403504|9430|P1|NOT COMPLETED|Period 2||0
4355|NCT03403504|9429|P2|COMPLETED|Period 2||11
4356|NCT03403504|9430|P1|COMPLETED|Period 2||12
4357|NCT03403504|9429|P2|STARTED|Period 2||11
4358|NCT03403504|9430|P1|STARTED|Period 2||12
4359|NCT03403504|9429|P2|NOT COMPLETED|Period 1||1
4360|NCT03403504|9430|P1|NOT COMPLETED|Period 1||0
4361|NCT03403504|9429|P2|COMPLETED|Period 1||11
4362|NCT03403504|9430|P1|COMPLETED|Period 1||12
4363|NCT03403504|9429|P2|STARTED|Period 1||12
4364|NCT03403504|9430|P1|STARTED|Period 1||12
4365|NCT03403036|9450|P1|NOT COMPLETED|Overall Study||5
4366|NCT03403036|9450|P1|COMPLETED|Overall Study||34
4367|NCT03403036|9450|P1|STARTED|Overall Study||39
4368|NCT03402932|9460|P4|NOT COMPLETED|Overall Study||0
4369|NCT03402932|9461|P3|NOT COMPLETED|Overall Study||0
4370|NCT03402932|9462|P2|NOT COMPLETED|Overall Study||0
4371|NCT03402932|9463|P1|NOT COMPLETED|Overall Study||0
4372|NCT03402932|9460|P4|COMPLETED|Overall Study||8
4373|NCT03402932|9461|P3|COMPLETED|Overall Study||8
4374|NCT03402932|9462|P2|COMPLETED|Overall Study||8
4375|NCT03402932|9463|P1|COMPLETED|Overall Study||13
4376|NCT03402932|9460|P4|STARTED|Overall Study||8
4377|NCT03402932|9461|P3|STARTED|Overall Study||8
4378|NCT03402932|9462|P2|STARTED|Overall Study||8
4379|NCT03402932|9463|P1|STARTED|Overall Study||13
4380|NCT03402893|9477|P1|NOT COMPLETED|Overall Study||1
4381|NCT03402893|9477|P1|COMPLETED|Overall Study||20
4382|NCT03402893|9477|P1|STARTED|Overall Study||21
4383|NCT03402750|9488|P2|NOT COMPLETED|Overall Study||1
4384|NCT03402750|9489|P1|NOT COMPLETED|Overall Study||2
4385|NCT03402750|9488|P2|COMPLETED|Overall Study||19
4386|NCT03402750|9489|P1|COMPLETED|Overall Study||18
4387|NCT03402750|9488|P2|STARTED|Overall Study||20
4388|NCT03402750|9489|P1|STARTED|Overall Study||20
4389|NCT03401671|9505|P2|NOT COMPLETED|Overall Study||0
4390|NCT03401671|9506|P1|NOT COMPLETED|Overall Study||0
4391|NCT03401671|9505|P2|COMPLETED|Overall Study||16
4392|NCT03401671|9506|P1|COMPLETED|Overall Study||16
4393|NCT03401671|9505|P2|STARTED|Overall Study||16
4394|NCT03401671|9506|P1|STARTED|Overall Study||16
4395|NCT03400475|9548|P2|NOT COMPLETED|Overall Study||0
4396|NCT03400475|9549|P1|NOT COMPLETED|Overall Study||0
4397|NCT03400475|9548|P2|COMPLETED|Overall Study||22
4398|NCT03400475|9549|P1|COMPLETED|Overall Study||24
4399|NCT03400475|9548|P2|STARTED|Overall Study||22
4400|NCT03400475|9549|P1|STARTED|Overall Study||24
4401|NCT03400449|9591|P2|NOT COMPLETED|Overall Study||0
4402|NCT03400449|9592|P1|NOT COMPLETED|Overall Study||1
4403|NCT03400449|9591|P2|COMPLETED|Overall Study||119
4404|NCT03400449|9592|P1|COMPLETED|Overall Study||120
4405|NCT03400449|9591|P2|STARTED|Overall Study||119
4406|NCT03400449|9592|P1|STARTED|Overall Study||121
4407|NCT03398421|9602|P2|NOT COMPLETED|Treatment Period 2 (Up to 11 Days)||0
4408|NCT03398421|9603|P1|NOT COMPLETED|Treatment Period 2 (Up to 11 Days)||0
4409|NCT03398421|9602|P2|COMPLETED|Treatment Period 2 (Up to 11 Days)||20
4410|NCT03398421|9603|P1|COMPLETED|Treatment Period 2 (Up to 11 Days)||0
4411|NCT03398421|9602|P2|STARTED|Treatment Period 2 (Up to 11 Days)||20
4412|NCT03398421|9603|P1|STARTED|Treatment Period 2 (Up to 11 Days)||0
4413|NCT03398421|9602|P2|NOT COMPLETED|Washout Period (Up to 14 Days)||0
4414|NCT03398421|9603|P1|NOT COMPLETED|Washout Period (Up to 14 Days)||0
4415|NCT03398421|9602|P2|COMPLETED|Washout Period (Up to 14 Days)||0
4416|NCT03398421|9603|P1|COMPLETED|Washout Period (Up to 14 Days)||20
4417|NCT03398421|9602|P2|STARTED|Washout Period (Up to 14 Days)||0
4418|NCT03398421|9603|P1|STARTED|Washout Period (Up to 14 Days)||20
4419|NCT03398421|9602|P2|NOT COMPLETED|Treatment Period 1 (Up to 6 Days)||0
4420|NCT03398421|9603|P1|NOT COMPLETED|Treatment Period 1 (Up to 6 Days)||0
4421|NCT03398421|9602|P2|COMPLETED|Treatment Period 1 (Up to 6 Days)||0
4422|NCT03398421|9603|P1|COMPLETED|Treatment Period 1 (Up to 6 Days)||20
4423|NCT03398421|9602|P2|STARTED|Treatment Period 1 (Up to 6 Days)||0
4424|NCT03398421|9603|P1|STARTED|Treatment Period 1 (Up to 6 Days)||20
4425|NCT03398330|9666|P2|NOT COMPLETED|Period 2||0
4426|NCT03398330|9667|P1|NOT COMPLETED|Period 2||1
4427|NCT03398330|9666|P2|COMPLETED|Period 2||17
4428|NCT03398330|9667|P1|COMPLETED|Period 2||19
4429|NCT03398330|9666|P2|STARTED|Period 2||17
4430|NCT03398330|9667|P1|STARTED|Period 2||20
4431|NCT03398330|9666|P2|NOT COMPLETED|Period 1||4
4432|NCT03398330|9667|P1|NOT COMPLETED|Period 1||1
4433|NCT03398330|9666|P2|COMPLETED|Period 1||17
4434|NCT03398330|9667|P1|COMPLETED|Period 1||20
4435|NCT03398330|9666|P2|STARTED|Period 1||21
4436|NCT03398330|9667|P1|STARTED|Period 1||21
4437|NCT03398278|9689|P2|NOT COMPLETED|Period 2||2
4438|NCT03398278|9690|P1|NOT COMPLETED|Period 2||2
4439|NCT03398278|9689|P2|COMPLETED|Period 2||17
4440|NCT03398278|9690|P1|COMPLETED|Period 2||16
4441|NCT03398278|9689|P2|STARTED|Period 2||19
4442|NCT03398278|9690|P1|STARTED|Period 2||18
4443|NCT03398278|9689|P2|NOT COMPLETED|Period 1||0
4444|NCT03398278|9690|P1|NOT COMPLETED|Period 1||1
4445|NCT03398278|9689|P2|COMPLETED|Period 1||19
4446|NCT03398278|9690|P1|COMPLETED|Period 1||18
4447|NCT03398278|9689|P2|STARTED|Period 1||19
4448|NCT03398278|9690|P1|STARTED|Period 1||19
4449|NCT03396835|9710|P1|NOT COMPLETED|Overall Study||2
4450|NCT03396835|9710|P1|COMPLETED|Overall Study||14
4451|NCT03396835|9710|P1|STARTED|Overall Study||16
4458|NCT03394391|9727|P2|NOT COMPLETED|Overall Study||2
4459|NCT03394391|9728|P1|NOT COMPLETED|Overall Study||1
4460|NCT03394391|9727|P2|COMPLETED|Overall Study||104
4461|NCT03394391|9728|P1|COMPLETED|Overall Study||105
4462|NCT03394391|9727|P2|STARTED|Overall Study||106
4463|NCT03394391|9728|P1|STARTED|Overall Study||106
4464|NCT03393208|9748|P4|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
4465|NCT03393208|9749|P3|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
4466|NCT03393208|9750|P2|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
4467|NCT03393208|9751|P1|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
4468|NCT03393208|9748|P4|COMPLETED|Treatment Period 2 (Day 8- Day 10)||9
4469|NCT03393208|9749|P3|COMPLETED|Treatment Period 2 (Day 8- Day 10)||9
4470|NCT03393208|9750|P2|COMPLETED|Treatment Period 2 (Day 8- Day 10)||13
4471|NCT03393208|9751|P1|COMPLETED|Treatment Period 2 (Day 8- Day 10)||13
4472|NCT03393208|9748|P4|STARTED|Treatment Period 2 (Day 8- Day 10)||9
4473|NCT03393208|9749|P3|STARTED|Treatment Period 2 (Day 8- Day 10)||9
4474|NCT03393208|9750|P2|STARTED|Treatment Period 2 (Day 8- Day 10)||13
4475|NCT03393208|9751|P1|STARTED|Treatment Period 2 (Day 8- Day 10)||13
4476|NCT03393208|9748|P4|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
4477|NCT03393208|9749|P3|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
4478|NCT03393208|9750|P2|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
4479|NCT03393208|9751|P1|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
4480|NCT03393208|9748|P4|COMPLETED|Treatment Period 1 (Day 1-Day 3)||9
4481|NCT03393208|9749|P3|COMPLETED|Treatment Period 1 (Day 1-Day 3)||9
4482|NCT03393208|9750|P2|COMPLETED|Treatment Period 1 (Day 1-Day 3)||13
4483|NCT03393208|9751|P1|COMPLETED|Treatment Period 1 (Day 1-Day 3)||13
4484|NCT03393208|9748|P4|STARTED|Treatment Period 1 (Day 1-Day 3)||9
4485|NCT03393208|9749|P3|STARTED|Treatment Period 1 (Day 1-Day 3)||9
4486|NCT03393208|9750|P2|STARTED|Treatment Period 1 (Day 1-Day 3)||13
4487|NCT03393208|9751|P1|STARTED|Treatment Period 1 (Day 1-Day 3)||13
4488|NCT03392532|9805|P2|NOT COMPLETED|Period 2, Second 30 Minutes of Wear||0
4489|NCT03392532|9806|P1|NOT COMPLETED|Period 2, Second 30 Minutes of Wear||0
4490|NCT03392532|9805|P2|COMPLETED|Period 2, Second 30 Minutes of Wear||18
4491|NCT03392532|9806|P1|COMPLETED|Period 2, Second 30 Minutes of Wear||18
4492|NCT03392532|9805|P2|STARTED|Period 2, Second 30 Minutes of Wear||18
4493|NCT03392532|9806|P1|STARTED|Period 2, Second 30 Minutes of Wear||18
4494|NCT03392532|9805|P2|NOT COMPLETED|Period 1, FIrst 30 Minutes of Wear||0
4495|NCT03392532|9806|P1|NOT COMPLETED|Period 1, FIrst 30 Minutes of Wear||0
4496|NCT03392532|9805|P2|COMPLETED|Period 1, FIrst 30 Minutes of Wear||18
4497|NCT03392532|9806|P1|COMPLETED|Period 1, FIrst 30 Minutes of Wear||18
4498|NCT03392532|9805|P2|STARTED|Period 1, FIrst 30 Minutes of Wear||18
4499|NCT03392532|9806|P1|STARTED|Period 1, FIrst 30 Minutes of Wear||18
4500|NCT03392194|9814|P2|NOT COMPLETED|Overall Study||2
4501|NCT03392194|9815|P1|NOT COMPLETED|Overall Study||2
4502|NCT03392194|9814|P2|COMPLETED|Overall Study||15
4503|NCT03392194|9815|P1|COMPLETED|Overall Study||14
4504|NCT03392194|9814|P2|STARTED|Overall Study||17
4505|NCT03392194|9815|P1|STARTED|Overall Study||16
4506|NCT03391986|9824|P3|NOT COMPLETED|Overall Study||0
4507|NCT03391986|9825|P2|NOT COMPLETED|Overall Study||0
4508|NCT03391986|9826|P1|NOT COMPLETED|Overall Study||0
4509|NCT03391986|9824|P3|COMPLETED|Overall Study||50
4510|NCT03391986|9825|P2|COMPLETED|Overall Study||50
4511|NCT03391986|9826|P1|COMPLETED|Overall Study||53
4512|NCT03391986|9824|P3|STARTED|Overall Study||50
4513|NCT03391986|9825|P2|STARTED|Overall Study||50
4514|NCT03391986|9826|P1|STARTED|Overall Study||53
4515|NCT03390426|9839|P2|NOT COMPLETED|Overall Study||1
4516|NCT03390426|9840|P1|NOT COMPLETED|Overall Study||0
4517|NCT03390426|9839|P2|COMPLETED|Overall Study||15
4518|NCT03390426|9840|P1|COMPLETED|Overall Study||15
4519|NCT03390426|9839|P2|STARTED|Overall Study||16
4520|NCT03390426|9840|P1|STARTED|Overall Study||15
4521|NCT03387059|9854|P2|NOT COMPLETED|Overall Study||4
4522|NCT03387059|9855|P1|NOT COMPLETED|Overall Study||5
4523|NCT03387059|9854|P2|COMPLETED|Overall Study||0
4524|NCT03387059|9855|P1|COMPLETED|Overall Study||0
4525|NCT03387059|9854|P2|STARTED|Overall Study||4
4526|NCT03387059|9855|P1|STARTED|Overall Study||5
4527|NCT03386448|9869|P2|NOT COMPLETED|Overall Study||2
4528|NCT03386448|9870|P1|NOT COMPLETED|Overall Study||0
4529|NCT03386448|9869|P2|COMPLETED|Overall Study||6
4530|NCT03386448|9870|P1|COMPLETED|Overall Study||6
4531|NCT03386448|9869|P2|STARTED|Overall Study||8
4532|NCT03386448|9870|P1|STARTED|Overall Study||6
4533|NCT03386435|9878|P2|NOT COMPLETED|Overall Study||7
4534|NCT03386435|9879|P1|NOT COMPLETED|Overall Study||5
4535|NCT03386435|9878|P2|COMPLETED|Overall Study||73
4536|NCT03386435|9879|P1|COMPLETED|Overall Study||75
4537|NCT03386435|9878|P2|STARTED|Overall Study||80
4538|NCT03386435|9879|P1|STARTED|Overall Study||80
4539|NCT03383783|9891|P1|NOT COMPLETED|Overall Study||2
4540|NCT03383783|9891|P1|COMPLETED|Overall Study||25
4541|NCT03383783|9891|P1|STARTED|Overall Study||27
4542|NCT03381742|9959|P4|NOT COMPLETED|Overall Study||0
4543|NCT03381742|9960|P3|NOT COMPLETED|Overall Study||0
4544|NCT03381742|9961|P2|NOT COMPLETED|Overall Study||0
4545|NCT03381742|9962|P1|NOT COMPLETED|Overall Study||0
4546|NCT03381742|9959|P4|COMPLETED|Overall Study||506
4547|NCT03381742|9960|P3|COMPLETED|Overall Study||1511
4548|NCT03381742|9961|P2|COMPLETED|Overall Study||501
4549|NCT03381742|9962|P1|COMPLETED|Overall Study||525
4550|NCT03381742|9959|P4|STARTED|Overall Study||506
4551|NCT03381742|9960|P3|STARTED|Overall Study||1511
4552|NCT03381742|9961|P2|STARTED|Overall Study||501
4553|NCT03381742|9962|P1|STARTED|Overall Study||525
4554|NCT03380845|9992|P1|NOT COMPLETED|Overall Study||0
4555|NCT03380845|9992|P1|COMPLETED|Overall Study||4
4556|NCT03380845|9992|P1|STARTED|Overall Study|Participants got bilateral face treatments with Fraxel on one side of face; Fractora on the other.|4
4557|NCT03380780|10002|P1|NOT COMPLETED|Overall Study||0
4558|NCT03380780|10002|P1|COMPLETED|Overall Study||16
4559|NCT03380780|10002|P1|STARTED|Overall Study||16
4560|NCT03380572|10071|P2|NOT COMPLETED|Overall Study||0
4561|NCT03380572|10072|P1|NOT COMPLETED|Overall Study||0
4562|NCT03380572|10071|P2|COMPLETED|Overall Study||20
4563|NCT03380572|10072|P1|COMPLETED|Overall Study||20
4564|NCT03380572|10071|P2|STARTED|Overall Study||20
4565|NCT03380572|10072|P1|STARTED|Overall Study||20
4566|NCT03380390|10080|P1|NOT COMPLETED|Overall Study||3
4567|NCT03380390|10080|P1|COMPLETED|Overall Study||43
4568|NCT03380390|10080|P1|STARTED|Overall Study||46
4569|NCT03379740|10088|P2|NOT COMPLETED|Overall Study||0
4570|NCT03379740|10089|P1|NOT COMPLETED|Overall Study||0
4571|NCT03379740|10088|P2|COMPLETED|Overall Study||7
4572|NCT03379740|10089|P1|COMPLETED|Overall Study||8
4573|NCT03379740|10088|P2|STARTED|Overall Study||7
4574|NCT03379740|10089|P1|STARTED|Overall Study||8
4575|NCT03378076|10169|P2|NOT COMPLETED|Overall Study||0
4576|NCT03378076|10170|P1|NOT COMPLETED|Overall Study||0
4577|NCT03378076|10169|P2|COMPLETED|Overall Study||12
4578|NCT03378076|10170|P1|COMPLETED|Overall Study||12
4579|NCT03378076|10169|P2|STARTED|Overall Study||12
4580|NCT03378076|10170|P1|STARTED|Overall Study||12
4581|NCT03376295|10180|P2|NOT COMPLETED|Overall Study||0
4582|NCT03376295|10181|P1|NOT COMPLETED|Overall Study||0
4583|NCT03376295|10180|P2|COMPLETED|Overall Study||1977
4584|NCT03376295|10181|P1|COMPLETED|Overall Study||1977
4585|NCT03376295|10180|P2|STARTED|Overall Study||1977
4586|NCT03376295|10181|P1|STARTED|Overall Study||1977
4587|NCT03376061|10193|P2|NOT COMPLETED|Overall Study||0
4588|NCT03376061|10194|P1|NOT COMPLETED|Overall Study||0
4589|NCT03376061|10193|P2|COMPLETED|Overall Study||48
4590|NCT03376061|10194|P1|COMPLETED|Overall Study||49
4591|NCT03376061|10193|P2|STARTED|Overall Study||48
4592|NCT03376061|10194|P1|STARTED|Overall Study||49
4593|NCT03374488|10214|P2|NOT COMPLETED|Overall Study||37
4594|NCT03374488|10215|P1|NOT COMPLETED|Overall Study||41
4595|NCT03374488|10214|P2|COMPLETED|Overall Study||5
4596|NCT03374488|10215|P1|COMPLETED|Overall Study||1
4597|NCT03374488|10214|P2|All Participants as Treated (APaT)|Overall Study||41
4598|NCT03374488|10215|P1|All Participants as Treated (APaT)|Overall Study||42
4599|NCT03374488|10214|P2|Intention-to-Treat (ITT)|Overall Study||42
4600|NCT03374488|10215|P1|Intention-to-Treat (ITT)|Overall Study||42
4601|NCT03374488|10214|P2|STARTED|Overall Study||42
4602|NCT03374488|10215|P1|STARTED|Overall Study||42
4603|NCT03374189|10227|P2|NOT COMPLETED|Overall Study||0
4604|NCT03374189|10228|P1|NOT COMPLETED|Overall Study||1
4605|NCT03374189|10227|P2|COMPLETED|Overall Study||39
4606|NCT03374189|10228|P1|COMPLETED|Overall Study||39
4607|NCT03374189|10227|P2|STARTED|Overall Study||39
4608|NCT03374189|10228|P1|STARTED|Overall Study||40
4609|NCT03373890|10248|P2|NOT COMPLETED|Overall Study||0
4610|NCT03373890|10249|P1|NOT COMPLETED|Overall Study||0
4611|NCT03373890|10248|P2|COMPLETED|Overall Study||6
4612|NCT03373890|10249|P1|COMPLETED|Overall Study||6
4613|NCT03373890|10248|P2|STARTED|Overall Study||6
4614|NCT03373890|10249|P1|STARTED|Overall Study||6
4615|NCT03373591|10272|P3|NOT COMPLETED|Overall Study||0
4616|NCT03373591|10273|P2|NOT COMPLETED|Overall Study||0
4617|NCT03373591|10274|P1|NOT COMPLETED|Overall Study||0
4618|NCT03373591|10272|P3|COMPLETED|Overall Study||73
4619|NCT03373591|10273|P2|COMPLETED|Overall Study||71
4620|NCT03373591|10274|P1|COMPLETED|Overall Study||75
4621|NCT03373591|10272|P3|STARTED|Overall Study||73
4622|NCT03373591|10273|P2|STARTED|Overall Study||71
4623|NCT03373591|10274|P1|STARTED|Overall Study||75
4624|NCT03373162|10303|P1|NOT COMPLETED|Overall Study||0
4625|NCT03373162|10303|P1|COMPLETED|Overall Study||10
4626|NCT03373162|10303|P1|STARTED|Overall Study||10
4627|NCT03372603|10309|P2|NOT COMPLETED|Treatment Period 2 (Up to 7 Days)||0
4628|NCT03372603|10310|P1|NOT COMPLETED|Treatment Period 2 (Up to 7 Days)||1
4629|NCT03372603|10309|P2|COMPLETED|Treatment Period 2 (Up to 7 Days)||8
4630|NCT03372603|10310|P1|COMPLETED|Treatment Period 2 (Up to 7 Days)||7
4631|NCT03372603|10309|P2|STARTED|Treatment Period 2 (Up to 7 Days)||8
4632|NCT03372603|10310|P1|STARTED|Treatment Period 2 (Up to 7 Days)||8
4633|NCT03372603|10309|P2|NOT COMPLETED|Wash-out Period (14-21 Days)||0
4634|NCT03372603|10310|P1|NOT COMPLETED|Wash-out Period (14-21 Days)||1
4635|NCT03372603|10309|P2|COMPLETED|Wash-out Period (14-21 Days)||8
4636|NCT03372603|10310|P1|COMPLETED|Wash-out Period (14-21 Days)||8
4637|NCT03372603|10309|P2|STARTED|Wash-out Period (14-21 Days)||8
4638|NCT03372603|10310|P1|STARTED|Wash-out Period (14-21 Days)||9
4639|NCT03372603|10309|P2|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
4640|NCT03372603|10310|P1|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
4641|NCT03372603|10309|P2|COMPLETED|Treatment Period 1 (Up to 7 Days)||8
4642|NCT03372603|10310|P1|COMPLETED|Treatment Period 1 (Up to 7 Days)||9
4643|NCT03372603|10309|P2|STARTED|Treatment Period 1 (Up to 7 Days)||8
4644|NCT03372603|10310|P1|STARTED|Treatment Period 1 (Up to 7 Days)||9
4645|NCT03372551|10352|P2|NOT COMPLETED|Second Intervention (1 Week)||0
4646|NCT03372551|10353|P1|NOT COMPLETED|Second Intervention (1 Week)||0
4647|NCT03372551|10352|P2|COMPLETED|Second Intervention (1 Week)||16
4648|NCT03372551|10353|P1|COMPLETED|Second Intervention (1 Week)||16
4649|NCT03372551|10352|P2|STARTED|Second Intervention (1 Week)||16
4650|NCT03372551|10353|P1|STARTED|Second Intervention (1 Week)||16
4651|NCT03372551|10352|P2|NOT COMPLETED|First Intervention (1 Week)||0
4652|NCT03372551|10353|P1|NOT COMPLETED|First Intervention (1 Week)||1
4653|NCT03372551|10352|P2|COMPLETED|First Intervention (1 Week)||16
4654|NCT03372551|10353|P1|COMPLETED|First Intervention (1 Week)||16
4655|NCT03372551|10352|P2|STARTED|First Intervention (1 Week)||16
4656|NCT03372551|10353|P1|STARTED|First Intervention (1 Week)||17
4657|NCT03372382|10372|P2|NOT COMPLETED|Overall Study||4
4658|NCT03372382|10373|P1|NOT COMPLETED|Overall Study||9
4659|NCT03372382|10372|P2|COMPLETED|Overall Study||81
4660|NCT03372382|10373|P1|COMPLETED|Overall Study||76
4661|NCT03372382|10372|P2|STARTED|Overall Study||85
4662|NCT03372382|10373|P1|STARTED|Overall Study||85
4663|NCT03372369|10383|P2|NOT COMPLETED|Intervention and Follow-Up Period||3
4664|NCT03372369|10384|P1|NOT COMPLETED|Intervention and Follow-Up Period||3
4665|NCT03372369|10383|P2|COMPLETED|Intervention and Follow-Up Period||470
4666|NCT03372369|10384|P1|COMPLETED|Intervention and Follow-Up Period||466
4667|NCT03372369|10383|P2|STARTED|Intervention and Follow-Up Period||473
4668|NCT03372369|10384|P1|STARTED|Intervention and Follow-Up Period||469
4669|NCT03372369|10383|P2|NOT COMPLETED|Qualification Period||22
4670|NCT03372369|10384|P1|NOT COMPLETED|Qualification Period||26
4671|NCT03372369|10383|P2|COMPLETED|Qualification Period||473
4672|NCT03372369|10384|P1|COMPLETED|Qualification Period||469
4673|NCT03372369|10383|P2|STARTED|Qualification Period||495
4674|NCT03372369|10384|P1|STARTED|Qualification Period||495
4675|NCT03371459|10396|P2|NOT COMPLETED|Period 2||0
4676|NCT03371459|10397|P1|NOT COMPLETED|Period 2||0
4677|NCT03371459|10396|P2|COMPLETED|Period 2||22
4678|NCT03371459|10397|P1|COMPLETED|Period 2||23
4679|NCT03371459|10396|P2|STARTED|Period 2||22
4680|NCT03371459|10397|P1|STARTED|Period 2||23
4681|NCT03371459|10396|P2|NOT COMPLETED|Washout||1
4682|NCT03371459|10397|P1|NOT COMPLETED|Washout||0
4683|NCT03371459|10396|P2|COMPLETED|Washout||22
4684|NCT03371459|10397|P1|COMPLETED|Washout||23
4685|NCT03371459|10396|P2|STARTED|Washout||23
4686|NCT03371459|10397|P1|STARTED|Washout||23
4687|NCT03371459|10396|P2|NOT COMPLETED|Period 1||0
4688|NCT03371459|10397|P1|NOT COMPLETED|Period 1||0
4689|NCT03371459|10396|P2|COMPLETED|Period 1||23
4690|NCT03371459|10397|P1|COMPLETED|Period 1||23
4691|NCT03371459|10396|P2|STARTED|Period 1||23
4692|NCT03371459|10397|P1|STARTED|Period 1||23
4693|NCT03370289|10405|P1|NOT COMPLETED|Overall Study||5
4694|NCT03370289|10405|P1|COMPLETED|Overall Study||50
4695|NCT03370289|10405|P1|STARTED|Overall Study||55
4696|NCT03369704|10424|P2|NOT COMPLETED|Follow-up Epoch||0
4697|NCT03369704|10425|P1|NOT COMPLETED|Follow-up Epoch||1
4698|NCT03369704|10424|P2|COMPLETED|Follow-up Epoch||174
4699|NCT03369704|10425|P1|COMPLETED|Follow-up Epoch||160
4700|NCT03369704|10424|P2|STARTED|Follow-up Epoch||174
4701|NCT03369704|10425|P1|STARTED|Follow-up Epoch||161
4702|NCT03369704|10424|P2|NOT COMPLETED|Treatment Epoch||3
4703|NCT03369704|10425|P1|NOT COMPLETED|Treatment Epoch||4
4704|NCT03369704|10424|P2|COMPLETED|Treatment Epoch||172
4705|NCT03369704|10425|P1|COMPLETED|Treatment Epoch||158
4706|NCT03369704|10424|P2|STARTED|Treatment Epoch||175
4707|NCT03369704|10425|P1|STARTED|Treatment Epoch||162
4708|NCT03368937|10458|P1|NOT COMPLETED|Overall Study||0
4709|NCT03368937|10458|P1|COMPLETED|Overall Study||5
4710|NCT03368937|10458|P1|STARTED|Overall Study||5
4711|NCT03368807|10462|P1|NOT COMPLETED|Period 2 (Unblinded CGM)||0
4712|NCT03368807|10462|P1|COMPLETED|Period 2 (Unblinded CGM)||73
4713|NCT03368807|10462|P1|STARTED|Period 2 (Unblinded CGM)||73
4714|NCT03368807|10462|P1|NOT COMPLETED|Period 1 (Blinded CGM)||6
4715|NCT03368807|10462|P1|COMPLETED|Period 1 (Blinded CGM)||73
4716|NCT03368807|10462|P1|Received at Least 1 Dose of Study Drug|Period 1 (Blinded CGM)||78
4717|NCT03368807|10462|P1|STARTED|Period 1 (Blinded CGM)||79
4718|NCT03368053|10476|P1|NOT COMPLETED|Overall Study||0
4719|NCT03368053|10476|P1|COMPLETED|Overall Study||36
4720|NCT03368053|10476|P1|STARTED|Overall Study||36
4721|NCT03366207|10491|P1|NOT COMPLETED|Overall Study||8
4722|NCT03366207|10491|P1|COMPLETED|Overall Study||242
4723|NCT03366207|10491|P1|STARTED|Overall Study||250
4724|NCT03365934|10496|P1|NOT COMPLETED|Overall Study||2
4725|NCT03365934|10496|P1|COMPLETED|Overall Study||33
4726|NCT03365934|10496|P1|STARTED|Overall Study||35
4727|NCT03365011|10771|P2|NOT COMPLETED|Overall Study||2
4728|NCT03365011|10772|P1|NOT COMPLETED|Overall Study||1
4729|NCT03365011|10771|P2|COMPLETED|Overall Study||18
4730|NCT03365011|10772|P1|COMPLETED|Overall Study||19
4731|NCT03365011|10771|P2|STARTED|Overall Study||20
4732|NCT03365011|10772|P1|STARTED|Overall Study||20
4733|NCT03364608|10782|P1|NOT COMPLETED|Overall Study||8
4734|NCT03364608|10782|P1|COMPLETED|Overall Study||78
4735|NCT03364608|10782|P1|Proventil 180 µg|Overall Study||79
4736|NCT03364608|10782|P1|Proventil 90 µg|Overall Study||82
4737|NCT03364608|10782|P1|AS MDI 180 µg|Overall Study||81
4738|NCT03364608|10782|P1|AS MDI 90 µg|Overall Study||81
4739|NCT03364608|10782|P1|Placebo MDI|Overall Study||82
4740|NCT03364608|10782|P1|STARTED|Overall Study||86
4741|NCT03364335|10809|P5|NOT COMPLETED|Overall Study||11
4742|NCT03364335|10810|P4|NOT COMPLETED|Overall Study||13
4743|NCT03364335|10811|P3|NOT COMPLETED|Overall Study||11
4744|NCT03364335|10812|P2|NOT COMPLETED|Overall Study||11
4745|NCT03364335|10813|P1|NOT COMPLETED|Overall Study||10
4746|NCT03364335|10809|P5|COMPLETED|Overall Study||41
4747|NCT03364335|10810|P4|COMPLETED|Overall Study||37
4748|NCT03364335|10811|P3|COMPLETED|Overall Study||42
4749|NCT03364335|10812|P2|COMPLETED|Overall Study||40
4750|NCT03364335|10813|P1|COMPLETED|Overall Study||42
4751|NCT03364335|10809|P5|STARTED|Overall Study||52
4752|NCT03364335|10810|P4|STARTED|Overall Study||50
4753|NCT03364335|10811|P3|STARTED|Overall Study||53
4754|NCT03364335|10812|P2|STARTED|Overall Study||51
4755|NCT03364335|10813|P1|STARTED|Overall Study||52
4756|NCT03363906|10885|P2|NOT COMPLETED|Period 2 (Test or Reference)||1
4757|NCT03363906|10886|P1|NOT COMPLETED|Period 2 (Test or Reference)||4
4758|NCT03363906|10885|P2|COMPLETED|Period 2 (Test or Reference)||9
4759|NCT03363906|10886|P1|COMPLETED|Period 2 (Test or Reference)||10
4760|NCT03363906|10885|P2|Received at Least One Dose of Study Drug|Period 2 (Test or Reference)||9
4761|NCT03363906|10886|P1|Received at Least One Dose of Study Drug|Period 2 (Test or Reference)||12
4762|NCT03363906|10885|P2|STARTED|Period 2 (Test or Reference)||10
4763|NCT03363906|10886|P1|STARTED|Period 2 (Test or Reference)||14
4764|NCT03363906|10885|P2|NOT COMPLETED|Period 1 (Reference or Test)||2
4765|NCT03363906|10886|P1|NOT COMPLETED|Period 1 (Reference or Test)||1
4766|NCT03363906|10885|P2|COMPLETED|Period 1 (Reference or Test)||10
4767|NCT03363906|10886|P1|COMPLETED|Period 1 (Reference or Test)||14
4768|NCT03363906|10885|P2|Received at Least One Dose of Study Drug|Period 1 (Reference or Test)||11
4769|NCT03363906|10886|P1|Received at Least One Dose of Study Drug|Period 1 (Reference or Test)||15
4770|NCT03363906|10885|P2|STARTED|Period 1 (Reference or Test)||12
4771|NCT03363906|10886|P1|STARTED|Period 1 (Reference or Test)||15
4772|NCT03363633|10894|P1|NOT COMPLETED|Overall Study||12
4773|NCT03363633|10894|P1|COMPLETED|Overall Study|See note in Pre-Assignment Details|0
4774|NCT03363633|10894|P1|STARTED|Overall Study||12
4775|NCT03362944|10902|P2|NOT COMPLETED|Second Intervention||0
4776|NCT03362944|10903|P1|NOT COMPLETED|Second Intervention||0
4777|NCT03362944|10902|P2|COMPLETED|Second Intervention||8
4778|NCT03362944|10903|P1|COMPLETED|Second Intervention||8
4779|NCT03362944|10902|P2|STARTED|Second Intervention||8
4780|NCT03362944|10903|P1|STARTED|Second Intervention||8
4781|NCT03362944|10902|P2|NOT COMPLETED|Single Week Washout Period||0
4782|NCT03362944|10903|P1|NOT COMPLETED|Single Week Washout Period||0
4783|NCT03362944|10902|P2|COMPLETED|Single Week Washout Period||8
4784|NCT03362944|10903|P1|COMPLETED|Single Week Washout Period||8
4785|NCT03362944|10902|P2|STARTED|Single Week Washout Period||8
4786|NCT03362944|10903|P1|STARTED|Single Week Washout Period||8
4787|NCT03362944|10902|P2|NOT COMPLETED|First Intervention||0
4788|NCT03362944|10903|P1|NOT COMPLETED|First Intervention||0
4789|NCT03362944|10902|P2|COMPLETED|First Intervention||8
4790|NCT03362944|10903|P1|COMPLETED|First Intervention||8
4791|NCT03362944|10902|P2|STARTED|First Intervention||8
4792|NCT03362944|10903|P1|STARTED|First Intervention||8
4793|NCT03361917|10921|P2|NOT COMPLETED|Overall Study||0
4794|NCT03361917|10922|P1|NOT COMPLETED|Overall Study||0
4795|NCT03361917|10921|P2|COMPLETED|Overall Study||101
4796|NCT03361917|10922|P1|COMPLETED|Overall Study||99
4797|NCT03361917|10921|P2|STARTED|Overall Study||101
4798|NCT03361917|10922|P1|STARTED|Overall Study||99
4799|NCT03361865|10940|P2|NOT COMPLETED|Overall Study||49
4800|NCT03361865|10941|P1|NOT COMPLETED|Overall Study||43
4801|NCT03361865|10940|P2|COMPLETED|Overall Study||0
4802|NCT03361865|10941|P1|COMPLETED|Overall Study||1
4803|NCT03361865|10940|P2|All Participants as Treated (APaT)|Overall Study||49
4804|NCT03361865|10941|P1|All Participants as Treated (APaT)|Overall Study||43
4805|NCT03361865|10940|P2|Intention-to-Treat (ITT)|Overall Study||49
4806|NCT03361865|10941|P1|Intention-to-Treat (ITT)|Overall Study||44
4807|NCT03361865|10940|P2|STARTED|Overall Study||49
4808|NCT03361865|10941|P1|STARTED|Overall Study||44
4809|NCT03361176|10953|P2|NOT COMPLETED|Overall Study||5
4810|NCT03361176|10954|P1|NOT COMPLETED|Overall Study||1
4811|NCT03361176|10953|P2|COMPLETED|Overall Study||15
4812|NCT03361176|10954|P1|COMPLETED|Overall Study||9
4813|NCT03361176|10953|P2|STARTED|Overall Study||20
4814|NCT03361176|10954|P1|STARTED|Overall Study||10
4815|NCT03360903|10966|P2|NOT COMPLETED|Second Intervention||0
4816|NCT03360903|10967|P1|NOT COMPLETED|Second Intervention||0
4817|NCT03360903|10966|P2|COMPLETED|Second Intervention||4
4818|NCT03360903|10967|P1|COMPLETED|Second Intervention||4
4819|NCT03360903|10966|P2|STARTED|Second Intervention||4
4820|NCT03360903|10967|P1|STARTED|Second Intervention||4
4821|NCT03360903|10966|P2|NOT COMPLETED|Washout (2 Weeks)||0
4822|NCT03360903|10967|P1|NOT COMPLETED|Washout (2 Weeks)||0
4823|NCT03360903|10966|P2|COMPLETED|Washout (2 Weeks)||4
4824|NCT03360903|10967|P1|COMPLETED|Washout (2 Weeks)||4
4825|NCT03360903|10966|P2|STARTED|Washout (2 Weeks)||4
4826|NCT03360903|10967|P1|STARTED|Washout (2 Weeks)||4
4827|NCT03360903|10966|P2|NOT COMPLETED|First Intervention||0
4828|NCT03360903|10967|P1|NOT COMPLETED|First Intervention||0
4829|NCT03360903|10966|P2|COMPLETED|First Intervention||4
4830|NCT03360903|10967|P1|COMPLETED|First Intervention||4
4831|NCT03360903|10966|P2|STARTED|First Intervention||4
4832|NCT03360903|10967|P1|STARTED|First Intervention||4
4833|NCT03360071|10987|P2|NOT COMPLETED|Overall Study||0
4834|NCT03360071|10988|P1|NOT COMPLETED|Overall Study||1
4835|NCT03360071|10987|P2|COMPLETED|Overall Study||14
4836|NCT03360071|10988|P1|COMPLETED|Overall Study||16
4837|NCT03360071|10987|P2|STARTED|Overall Study||14
4838|NCT03360071|10988|P1|STARTED|Overall Study||17
4839|NCT03359629|11002|P2|NOT COMPLETED|Overall Study||0
4840|NCT03359629|11003|P1|NOT COMPLETED|Overall Study||0
4841|NCT03359629|11002|P2|COMPLETED|Overall Study||10
4842|NCT03359629|11003|P1|COMPLETED|Overall Study||200
4843|NCT03359629|11002|P2|STARTED|Overall Study||10
4844|NCT03359629|11003|P1|STARTED|Overall Study||200
4845|NCT03358472|11012|P3|NOT COMPLETED|Overall Study||16
4846|NCT03358472|11013|P2|NOT COMPLETED|Overall Study||10
4847|NCT03358472|11014|P1|NOT COMPLETED|Overall Study||15
4848|NCT03358472|11012|P3|COMPLETED|Overall Study||19
4849|NCT03358472|11013|P2|COMPLETED|Overall Study||9
4850|NCT03358472|11014|P1|COMPLETED|Overall Study||20
4851|NCT03358472|11012|P3|All Participants as Treated (APaT)|Overall Study||34
4852|NCT03358472|11013|P2|All Participants as Treated (APaT)|Overall Study||19
4853|NCT03358472|11014|P1|All Participants as Treated (APaT)|Overall Study||34
4854|NCT03358472|11012|P3|Intention-to-Treat (ITT)|Overall Study||35
4855|NCT03358472|11013|P2|Intention-to-Treat (ITT)|Overall Study||19
4856|NCT03358472|11014|P1|Intention-to-Treat (ITT)|Overall Study||35
4857|NCT03358472|11012|P3|STARTED|Overall Study||35
4858|NCT03358472|11013|P2|STARTED|Overall Study||19
4859|NCT03358472|11014|P1|STARTED|Overall Study||35
4863|NCT03357952|11036|P2|NOT COMPLETED|Overall Study||1
4864|NCT03357952|11037|P1|NOT COMPLETED|Overall Study||9
4865|NCT03357952|11036|P2|COMPLETED|Overall Study||0
4866|NCT03357952|11037|P1|COMPLETED|Overall Study||0
4867|NCT03357952|11036|P2|STARTED|Overall Study||1
4868|NCT03357952|11037|P1|STARTED|Overall Study||9
4869|NCT03357471|11046|P2|NOT COMPLETED|Overall Study||0
4870|NCT03357471|11047|P1|NOT COMPLETED|Overall Study||2
4871|NCT03357471|11046|P2|COMPLETED|Overall Study||32
4872|NCT03357471|11047|P1|COMPLETED|Overall Study||33
4873|NCT03357471|11046|P2|STARTED|Overall Study||32
4874|NCT03357471|11047|P1|STARTED|Overall Study||35
4875|NCT03356977|11071|P1|NOT COMPLETED|Overall Study||5
4876|NCT03356977|11071|P1|COMPLETED|Overall Study||132
4877|NCT03356977|11071|P1|STARTED|Overall Study||137
4878|NCT03355820|11083|P1|NOT COMPLETED|Overall Study||0
4879|NCT03355820|11083|P1|COMPLETED|Overall Study||227
4880|NCT03355820|11083|P1|STARTED|Overall Study||227
4881|NCT03354754|11096|P2|NOT COMPLETED|Overall Study||0
4882|NCT03354754|11097|P1|NOT COMPLETED|Overall Study||0
4883|NCT03354754|11096|P2|COMPLETED|Overall Study||1
4884|NCT03354754|11097|P1|COMPLETED|Overall Study||2
4885|NCT03354754|11096|P2|STARTED|Overall Study||1
4886|NCT03354754|11097|P1|STARTED|Overall Study||2
4887|NCT03354663|11119|P1|NOT COMPLETED|Completed 30-day Visit||2
4888|NCT03354663|11119|P1|COMPLETED|Completed 30-day Visit||149
4889|NCT03354663|11119|P1|STARTED|Completed 30-day Visit||151
4890|NCT03354663|11119|P1|NOT COMPLETED|Enrollment to Catheter Insertion||5
4891|NCT03354663|11119|P1|COMPLETED|Enrollment to Catheter Insertion||151
4892|NCT03354663|11119|P1|STARTED|Enrollment to Catheter Insertion||156
4893|NCT03353246|11135|P1|NOT COMPLETED|Overall Study||0
4894|NCT03353246|11135|P1|COMPLETED|Overall Study||500
4895|NCT03353246|11135|P1|STARTED|Overall Study||500
4896|NCT03352882|11152|P1|NOT COMPLETED|Overall Study||0
4897|NCT03352882|11152|P1|COMPLETED|Overall Study||1
4898|NCT03352882|11152|P1|STARTED|Overall Study||1
4899|NCT03352609|11162|P2|NOT COMPLETED|Overall Study||0
4900|NCT03352609|11163|P1|NOT COMPLETED|Overall Study||0
4901|NCT03352609|11162|P2|COMPLETED|Overall Study||3
4902|NCT03352609|11163|P1|COMPLETED|Overall Study||2
4903|NCT03352609|11162|P2|STARTED|Overall Study||3
4904|NCT03352609|11163|P1|STARTED|Overall Study||2
4905|NCT03351933|11173|P1|NOT COMPLETED|Overall Study||2
4906|NCT03351933|11173|P1|COMPLETED|Overall Study||26
4907|NCT03351933|11173|P1|STARTED|Overall Study||28
4908|NCT03351699|11182|P5|NOT COMPLETED|Overall Study||0
4909|NCT03351699|11183|P4|NOT COMPLETED|Overall Study||0
4910|NCT03351699|11184|P3|NOT COMPLETED|Overall Study||0
4911|NCT03351699|11185|P2|NOT COMPLETED|Overall Study||0
4912|NCT03351699|11186|P1|NOT COMPLETED|Overall Study||0
4913|NCT03351699|11182|P5|COMPLETED|Overall Study|Panel F did not enroll, following evaluation of earlier Panel data.|0
4914|NCT03351699|11183|P4|COMPLETED|Overall Study||6
4915|NCT03351699|11184|P3|COMPLETED|Overall Study||6
4916|NCT03351699|11185|P2|COMPLETED|Overall Study||6
4917|NCT03351699|11186|P1|COMPLETED|Overall Study||6
4918|NCT03351699|11182|P5|STARTED|Overall Study|Panel F did not enroll, following evaluation of earlier Panel data.|0
4919|NCT03351699|11183|P4|STARTED|Overall Study||6
4920|NCT03351699|11184|P3|STARTED|Overall Study||6
4921|NCT03351699|11185|P2|STARTED|Overall Study||6
4922|NCT03351699|11186|P1|STARTED|Overall Study||6
4923|NCT03351335|11258|P3|NOT COMPLETED|Overall Study||4
4924|NCT03351335|11259|P2|NOT COMPLETED|Overall Study||0
4925|NCT03351335|11260|P1|NOT COMPLETED|Overall Study||0
4926|NCT03351335|11258|P3|COMPLETED|Overall Study||16
4927|NCT03351335|11259|P2|COMPLETED|Overall Study||19
4928|NCT03351335|11260|P1|COMPLETED|Overall Study||21
4929|NCT03351335|11258|P3|STARTED|Overall Study||20
4930|NCT03351335|11259|P2|STARTED|Overall Study||19
4931|NCT03351335|11260|P1|STARTED|Overall Study||21
4932|NCT03351231|11280|P1|NOT COMPLETED|Safety Follow-Up Period||3
4933|NCT03351231|11280|P1|COMPLETED|Safety Follow-Up Period|Completed = Finishing safety follow-up and continuing in study|0
4934|NCT03351231|11280|P1|STARTED|Safety Follow-Up Period|Started = Initiated Safety Follow-up|3
4935|NCT03351231|11280|P1|NOT COMPLETED|Combination Therapy Period||5
4936|NCT03351231|11280|P1|COMPLETED|Combination Therapy Period|Completed = finished combination therapy|0
4937|NCT03351231|11280|P1|STARTED|Combination Therapy Period|Started = initiated and completed monotherapy, then initiated combination therapy|5
4938|NCT03350724|11304|P2|NOT COMPLETED|Overall Study||0
4939|NCT03350724|11305|P1|NOT COMPLETED|Overall Study||0
4940|NCT03350724|11304|P2|COMPLETED|Overall Study||17
4941|NCT03350724|11305|P1|COMPLETED|Overall Study||17
4942|NCT03350724|11304|P2|STARTED|Overall Study||17
4943|NCT03350724|11305|P1|STARTED|Overall Study||17
4944|NCT03349632|11359|P6|NOT COMPLETED|Period 2, Second Week of Wear||0
4945|NCT03349632|11360|P5|NOT COMPLETED|Period 2, Second Week of Wear||0
4946|NCT03349632|11361|P4|NOT COMPLETED|Period 2, Second Week of Wear||0
4947|NCT03349632|11362|P3|NOT COMPLETED|Period 2, Second Week of Wear||0
4948|NCT03349632|11363|P2|NOT COMPLETED|Period 2, Second Week of Wear||0
4949|NCT03349632|11364|P1|NOT COMPLETED|Period 2, Second Week of Wear||0
4950|NCT03349632|11359|P6|COMPLETED|Period 2, Second Week of Wear||11
4951|NCT03349632|11360|P5|COMPLETED|Period 2, Second Week of Wear||11
4952|NCT03349632|11361|P4|COMPLETED|Period 2, Second Week of Wear||11
4953|NCT03349632|11362|P3|COMPLETED|Period 2, Second Week of Wear||11
4954|NCT03349632|11363|P2|COMPLETED|Period 2, Second Week of Wear||11
4955|NCT03349632|11364|P1|COMPLETED|Period 2, Second Week of Wear||11
4956|NCT03349632|11359|P6|STARTED|Period 2, Second Week of Wear||11
4957|NCT03349632|11360|P5|STARTED|Period 2, Second Week of Wear||11
4958|NCT03349632|11361|P4|STARTED|Period 2, Second Week of Wear||11
4959|NCT03349632|11362|P3|STARTED|Period 2, Second Week of Wear||11
4960|NCT03349632|11363|P2|STARTED|Period 2, Second Week of Wear||11
4961|NCT03349632|11364|P1|STARTED|Period 2, Second Week of Wear||11
4962|NCT03349632|11359|P6|NOT COMPLETED|Period 1, First Week of Wear||0
4963|NCT03349632|11360|P5|NOT COMPLETED|Period 1, First Week of Wear||0
4964|NCT03349632|11361|P4|NOT COMPLETED|Period 1, First Week of Wear||0
4965|NCT03349632|11362|P3|NOT COMPLETED|Period 1, First Week of Wear||0
4966|NCT03349632|11363|P2|NOT COMPLETED|Period 1, First Week of Wear||0
4967|NCT03349632|11364|P1|NOT COMPLETED|Period 1, First Week of Wear||0
4968|NCT03349632|11359|P6|COMPLETED|Period 1, First Week of Wear||11
4969|NCT03349632|11360|P5|COMPLETED|Period 1, First Week of Wear||11
4970|NCT03349632|11361|P4|COMPLETED|Period 1, First Week of Wear||11
4971|NCT03349632|11362|P3|COMPLETED|Period 1, First Week of Wear||11
4972|NCT03349632|11363|P2|COMPLETED|Period 1, First Week of Wear||11
4973|NCT03349632|11364|P1|COMPLETED|Period 1, First Week of Wear||11
4974|NCT03349632|11359|P6|STARTED|Period 1, First Week of Wear||11
4975|NCT03349632|11360|P5|STARTED|Period 1, First Week of Wear||11
4976|NCT03349632|11361|P4|STARTED|Period 1, First Week of Wear||11
4977|NCT03349632|11362|P3|STARTED|Period 1, First Week of Wear||11
4978|NCT03349632|11363|P2|STARTED|Period 1, First Week of Wear||11
4979|NCT03349632|11364|P1|STARTED|Period 1, First Week of Wear||11
4980|NCT03349515|11380|P2|NOT COMPLETED|Overall Study||1
4981|NCT03349515|11381|P1|NOT COMPLETED|Overall Study||5
4982|NCT03349515|11380|P2|COMPLETED|Overall Study||50
4983|NCT03349515|11381|P1|COMPLETED|Overall Study||50
4984|NCT03349515|11380|P2|STARTED|Overall Study||51
4985|NCT03349515|11381|P1|STARTED|Overall Study||55
4986|NCT03349437|11387|P3|NOT COMPLETED|Intervention||0
4987|NCT03349437|11388|P2|NOT COMPLETED|Intervention||0
4988|NCT03349437|11389|P1|NOT COMPLETED|Intervention||0
4989|NCT03349437|11387|P3|COMPLETED|Intervention||10
4990|NCT03349437|11388|P2|COMPLETED|Intervention||10
4991|NCT03349437|11389|P1|COMPLETED|Intervention||0
4992|NCT03349437|11387|P3|STARTED|Intervention||10
4993|NCT03349437|11388|P2|STARTED|Intervention||10
4994|NCT03349437|11389|P1|STARTED|Intervention||0
4995|NCT03349437|11387|P3|NOT COMPLETED|Screening||0
4996|NCT03349437|11388|P2|NOT COMPLETED|Screening||0
4997|NCT03349437|11389|P1|NOT COMPLETED|Screening||5
4998|NCT03349437|11387|P3|COMPLETED|Screening||0
4999|NCT03349437|11388|P2|COMPLETED|Screening||0
5000|NCT03349437|11389|P1|COMPLETED|Screening||20
5001|NCT03349437|11387|P3|STARTED|Screening||0
5002|NCT03349437|11388|P2|STARTED|Screening||0
5003|NCT03349437|11389|P1|STARTED|Screening||25
5004|NCT03349333|11396|P1|NOT COMPLETED|Overall Study||71
5005|NCT03349333|11396|P1|COMPLETED|Overall Study||0
5006|NCT03349333|11396|P1|STARTED|Overall Study||71
5007|NCT03349099|11419|P2|NOT COMPLETED|Overall Study||4
5008|NCT03349099|11420|P1|NOT COMPLETED|Overall Study||4
5009|NCT03349099|11419|P2|COMPLETED|Overall Study||43
5010|NCT03349099|11420|P1|COMPLETED|Overall Study||44
5011|NCT03349099|11419|P2|STARTED|Overall Study||47
5012|NCT03349099|11420|P1|STARTED|Overall Study||48
5013|NCT03348904|11433|P3|NOT COMPLETED|Overall Study||0
5014|NCT03348904|11434|P2|NOT COMPLETED|Overall Study||1
5015|NCT03348904|11435|P1|NOT COMPLETED|Overall Study||0
5016|NCT03348904|11433|P3|COMPLETED|Overall Study||0
5017|NCT03348904|11434|P2|COMPLETED|Overall Study||1
5018|NCT03348904|11435|P1|COMPLETED|Overall Study||0
5019|NCT03348904|11433|P3|STARTED|Overall Study||0
5020|NCT03348904|11434|P2|STARTED|Overall Study||2
5021|NCT03348904|11435|P1|STARTED|Overall Study||0
5022|NCT03346902|11454|P2|NOT COMPLETED|Overall Study||0
5023|NCT03346902|11455|P1|NOT COMPLETED|Overall Study||0
5024|NCT03346902|11454|P2|COMPLETED|Overall Study||8
5025|NCT03346902|11455|P1|COMPLETED|Overall Study||4
5026|NCT03346902|11454|P2|STARTED|Overall Study||8
5027|NCT03346902|11455|P1|STARTED|Overall Study||4
5028|NCT03346759|11463|P2|NOT COMPLETED|Third Menstrual Cycle||0
5029|NCT03346759|11464|P1|NOT COMPLETED|Third Menstrual Cycle||0
5030|NCT03346759|11463|P2|COMPLETED|Third Menstrual Cycle||10
5031|NCT03346759|11464|P1|COMPLETED|Third Menstrual Cycle||11
5032|NCT03346759|11463|P2|STARTED|Third Menstrual Cycle||10
5033|NCT03346759|11464|P1|STARTED|Third Menstrual Cycle||11
5034|NCT03346759|11463|P2|NOT COMPLETED|Second Menstrual Cycle||0
5035|NCT03346759|11464|P1|NOT COMPLETED|Second Menstrual Cycle||1
5036|NCT03346759|11463|P2|COMPLETED|Second Menstrual Cycle||10
5037|NCT03346759|11464|P1|COMPLETED|Second Menstrual Cycle||11
5038|NCT03346759|11463|P2|STARTED|Second Menstrual Cycle||10
5039|NCT03346759|11464|P1|STARTED|Second Menstrual Cycle||12
5040|NCT03346759|11463|P2|NOT COMPLETED|First Menstrual Cycle||0
5041|NCT03346759|11464|P1|NOT COMPLETED|First Menstrual Cycle||1
5042|NCT03346759|11463|P2|COMPLETED|First Menstrual Cycle||10
5043|NCT03346759|11464|P1|COMPLETED|First Menstrual Cycle||12
5044|NCT03346759|11463|P2|STARTED|First Menstrual Cycle||10
5045|NCT03346759|11464|P1|STARTED|First Menstrual Cycle||13
5046|NCT03346759|11463|P2|NOT COMPLETED|Enrollment to Baseline Data Collected||3
5047|NCT03346759|11464|P1|NOT COMPLETED|Enrollment to Baseline Data Collected||2
5048|NCT03346759|11463|P2|COMPLETED|Enrollment to Baseline Data Collected|Participants assigned to the Tampon B First arm who provided at least one vaginal microbiota sample.|10
5049|NCT03346759|11464|P1|COMPLETED|Enrollment to Baseline Data Collected|Participants assigned to the Tampon A First arm who provided at least one vaginal microbiota sample.|13
5050|NCT03346759|11463|P2|STARTED|Enrollment to Baseline Data Collected||13
5051|NCT03346759|11464|P1|STARTED|Enrollment to Baseline Data Collected||15
5052|NCT03346161|11475|P2|NOT COMPLETED|Overall Study||0
5053|NCT03346161|11476|P1|NOT COMPLETED|Overall Study||0
5054|NCT03346161|11475|P2|COMPLETED|Overall Study||60
5055|NCT03346161|11476|P1|COMPLETED|Overall Study||60
5056|NCT03346161|11475|P2|STARTED|Overall Study||60
5057|NCT03346161|11476|P1|STARTED|Overall Study||60
5058|NCT03345108|11504|P6|NOT COMPLETED|Period-3||0
5059|NCT03345108|11505|P5|NOT COMPLETED|Period-3||0
5060|NCT03345108|11506|P4|NOT COMPLETED|Period-3||0
5061|NCT03345108|11507|P3|NOT COMPLETED|Period-3||0
5062|NCT03345108|11508|P2|NOT COMPLETED|Period-3||0
5063|NCT03345108|11509|P1|NOT COMPLETED|Period-3||0
5064|NCT03345108|11504|P6|COMPLETED|Period-3||8
5065|NCT03345108|11505|P5|COMPLETED|Period-3||8
5066|NCT03345108|11506|P4|COMPLETED|Period-3||8
5067|NCT03345108|11507|P3|COMPLETED|Period-3||8
5068|NCT03345108|11508|P2|COMPLETED|Period-3||8
5069|NCT03345108|11509|P1|COMPLETED|Period-3||7
5070|NCT03345108|11504|P6|STARTED|Period-3||8
5071|NCT03345108|11505|P5|STARTED|Period-3||8
5072|NCT03345108|11506|P4|STARTED|Period-3||8
5073|NCT03345108|11507|P3|STARTED|Period-3||8
5074|NCT03345108|11508|P2|STARTED|Period-3||8
5075|NCT03345108|11509|P1|STARTED|Period-3||7
5076|NCT03345108|11504|P6|NOT COMPLETED|Period-2||0
5077|NCT03345108|11505|P5|NOT COMPLETED|Period-2||0
5078|NCT03345108|11506|P4|NOT COMPLETED|Period-2||0
5079|NCT03345108|11507|P3|NOT COMPLETED|Period-2||0
5080|NCT03345108|11508|P2|NOT COMPLETED|Period-2||0
5081|NCT03345108|11509|P1|NOT COMPLETED|Period-2||0
5082|NCT03345108|11504|P6|COMPLETED|Period-2||8
5083|NCT03345108|11505|P5|COMPLETED|Period-2||8
5084|NCT03345108|11506|P4|COMPLETED|Period-2||8
5085|NCT03345108|11507|P3|COMPLETED|Period-2||8
5086|NCT03345108|11508|P2|COMPLETED|Period-2||8
5087|NCT03345108|11509|P1|COMPLETED|Period-2||8
5088|NCT03345108|11504|P6|STARTED|Period-2||8
5089|NCT03345108|11505|P5|STARTED|Period-2||8
5090|NCT03345108|11506|P4|STARTED|Period-2||8
5091|NCT03345108|11507|P3|STARTED|Period-2||8
5092|NCT03345108|11508|P2|STARTED|Period-2||8
5093|NCT03345108|11509|P1|STARTED|Period-2||8
5094|NCT03345108|11504|P6|NOT COMPLETED|Period-1||0
5095|NCT03345108|11505|P5|NOT COMPLETED|Period-1||0
5096|NCT03345108|11506|P4|NOT COMPLETED|Period-1||0
5097|NCT03345108|11507|P3|NOT COMPLETED|Period-1||0
5098|NCT03345108|11508|P2|NOT COMPLETED|Period-1||0
5099|NCT03345108|11509|P1|NOT COMPLETED|Period-1||0
5100|NCT03345108|11504|P6|COMPLETED|Period-1||8
5101|NCT03345108|11505|P5|COMPLETED|Period-1||8
5102|NCT03345108|11506|P4|COMPLETED|Period-1||8
5103|NCT03345108|11507|P3|COMPLETED|Period-1||8
5104|NCT03345108|11508|P2|COMPLETED|Period-1||8
5105|NCT03345108|11509|P1|COMPLETED|Period-1||8
5106|NCT03345108|11504|P6|STARTED|Period-1||8
5107|NCT03345108|11505|P5|STARTED|Period-1||8
5108|NCT03345108|11506|P4|STARTED|Period-1||8
5109|NCT03345108|11507|P3|STARTED|Period-1||8
5110|NCT03345108|11508|P2|STARTED|Period-1||8
5111|NCT03345108|11509|P1|STARTED|Period-1||8
5112|NCT03344510|11517|P2|NOT COMPLETED|Second Injection (5 Minutes)||0
5113|NCT03344510|11518|P1|NOT COMPLETED|Second Injection (5 Minutes)||0
5114|NCT03344510|11517|P2|COMPLETED|Second Injection (5 Minutes)||26
5115|NCT03344510|11518|P1|COMPLETED|Second Injection (5 Minutes)||21
5116|NCT03344510|11517|P2|Received Injection|Second Injection (5 Minutes)||26
5117|NCT03344510|11518|P1|Received Injection|Second Injection (5 Minutes)||21
5118|NCT03344510|11517|P2|STARTED|Second Injection (5 Minutes)||26
5119|NCT03344510|11518|P1|STARTED|Second Injection (5 Minutes)||21
5120|NCT03344510|11517|P2|NOT COMPLETED|Wash Out (10 Minutes||0
5121|NCT03344510|11518|P1|NOT COMPLETED|Wash Out (10 Minutes||0
5122|NCT03344510|11517|P2|COMPLETED|Wash Out (10 Minutes||26
5123|NCT03344510|11518|P1|COMPLETED|Wash Out (10 Minutes||21
5124|NCT03344510|11517|P2|STARTED|Wash Out (10 Minutes||26
5125|NCT03344510|11518|P1|STARTED|Wash Out (10 Minutes||21
5126|NCT03344510|11517|P2|NOT COMPLETED|First Injection (5 Minutes)||0
5127|NCT03344510|11518|P1|NOT COMPLETED|First Injection (5 Minutes)||0
5128|NCT03344510|11517|P2|COMPLETED|First Injection (5 Minutes)||26
5129|NCT03344510|11518|P1|COMPLETED|First Injection (5 Minutes)||21
5130|NCT03344510|11517|P2|Received Injection|First Injection (5 Minutes)||26
5131|NCT03344510|11518|P1|Received Injection|First Injection (5 Minutes)||21
5132|NCT03344510|11517|P2|STARTED|First Injection (5 Minutes)||26
5133|NCT03344510|11518|P1|STARTED|First Injection (5 Minutes)||21
5134|NCT03343639|11527|P2|NOT COMPLETED|Overall Study||12
5135|NCT03343639|11528|P1|NOT COMPLETED|Overall Study||14
5136|NCT03343639|11527|P2|COMPLETED|Overall Study||90
5137|NCT03343639|11528|P1|COMPLETED|Overall Study||88
5138|NCT03343639|11527|P2|STARTED|Overall Study||102
5139|NCT03343639|11528|P1|STARTED|Overall Study||102
5140|NCT03343080|11542|P2|NOT COMPLETED|Overall Study||0
5141|NCT03343080|11543|P1|NOT COMPLETED|Overall Study||0
5142|NCT03343080|11542|P2|COMPLETED|Overall Study||18
5143|NCT03343080|11543|P1|COMPLETED|Overall Study||14
5144|NCT03343080|11542|P2|STARTED|Overall Study||18
5145|NCT03343080|11543|P1|STARTED|Overall Study||14
5164|NCT03342560|11683|P1|NOT COMPLETED|Overall Study||2
5165|NCT03342560|11683|P1|COMPLETED|Overall Study||28
5166|NCT03342560|11683|P1|STARTED|Overall Study||30
5167|NCT03341923|11691|P2|NOT COMPLETED|Period 2, Second 14 Days of Wear||1
5168|NCT03341923|11692|P1|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
5169|NCT03341923|11691|P2|COMPLETED|Period 2, Second 14 Days of Wear||65
5170|NCT03341923|11692|P1|COMPLETED|Period 2, Second 14 Days of Wear||67
5171|NCT03341923|11691|P2|STARTED|Period 2, Second 14 Days of Wear|Subject completed Period 1 but was discontinued before starting Period 2.|66
5172|NCT03341923|11692|P1|STARTED|Period 2, Second 14 Days of Wear||67
5173|NCT03341923|11691|P2|NOT COMPLETED|Period 1, First 14 Days of Wear||0
5174|NCT03341923|11692|P1|NOT COMPLETED|Period 1, First 14 Days of Wear||0
5175|NCT03341923|11691|P2|COMPLETED|Period 1, First 14 Days of Wear||67
5176|NCT03341923|11692|P1|COMPLETED|Period 1, First 14 Days of Wear||67
5177|NCT03341923|11691|P2|STARTED|Period 1, First 14 Days of Wear||67
5178|NCT03341923|11692|P1|STARTED|Period 1, First 14 Days of Wear||67
5179|NCT03341728|11700|P2|NOT COMPLETED|Session 2||0
5180|NCT03341728|11701|P1|NOT COMPLETED|Session 2||0
5181|NCT03341728|11700|P2|COMPLETED|Session 2||7
5182|NCT03341728|11701|P1|COMPLETED|Session 2||7
5183|NCT03341728|11700|P2|STARTED|Session 2||7
5184|NCT03341728|11701|P1|STARTED|Session 2||7
5185|NCT03341728|11700|P2|NOT COMPLETED|Washout (1 Week)||0
5186|NCT03341728|11701|P1|NOT COMPLETED|Washout (1 Week)||0
5187|NCT03341728|11700|P2|COMPLETED|Washout (1 Week)||7
5188|NCT03341728|11701|P1|COMPLETED|Washout (1 Week)||7
5189|NCT03341728|11700|P2|STARTED|Washout (1 Week)||7
5190|NCT03341728|11701|P1|STARTED|Washout (1 Week)||7
5191|NCT03341728|11700|P2|NOT COMPLETED|Session 1||0
5192|NCT03341728|11701|P1|NOT COMPLETED|Session 1||0
5193|NCT03341728|11700|P2|COMPLETED|Session 1||7
5194|NCT03341728|11701|P1|COMPLETED|Session 1||7
5195|NCT03341728|11700|P2|STARTED|Session 1||7
5196|NCT03341728|11701|P1|STARTED|Session 1||7
5197|NCT03341637|11719|P2|NOT COMPLETED|Overall Study||4
5198|NCT03341637|11720|P1|NOT COMPLETED|Overall Study||5
5199|NCT03341637|11719|P2|COMPLETED|Overall Study||296
5200|NCT03341637|11720|P1|COMPLETED|Overall Study||95
5201|NCT03341637|11719|P2|STARTED|Overall Study||300
5202|NCT03341637|11720|P1|STARTED|Overall Study||100
5203|NCT03341546|11742|P1|NOT COMPLETED|Overall Study||0
5204|NCT03341546|11742|P1|COMPLETED|Overall Study||20
5205|NCT03341546|11742|P1|STARTED|Overall Study||20
5206|NCT03340805|11748|P2|NOT COMPLETED|Overall Study||0
5207|NCT03340805|11749|P1|NOT COMPLETED|Overall Study||0
5208|NCT03340805|11748|P2|COMPLETED|Overall Study||26
5209|NCT03340805|11749|P1|COMPLETED|Overall Study|1 subject withdrew early from study fluid administration but stayed in trial for outcome assessment|24
5210|NCT03340805|11748|P2|STARTED|Overall Study||26
5211|NCT03340805|11749|P1|STARTED|Overall Study||24
5212|NCT03340610|11769|P1|NOT COMPLETED|Overall Study||3
5213|NCT03340610|11769|P1|COMPLETED|Overall Study||27
5214|NCT03340610|11769|P1|STARTED|Overall Study||30
5215|NCT03339726|11776|P3|NOT COMPLETED|Overall Study||0
5216|NCT03339726|11777|P2|NOT COMPLETED|Overall Study||1
5217|NCT03339726|11778|P1|NOT COMPLETED|Overall Study||1
5218|NCT03339726|11776|P3|COMPLETED|Overall Study||63
5219|NCT03339726|11777|P2|COMPLETED|Overall Study||65
5220|NCT03339726|11778|P1|COMPLETED|Overall Study||63
5221|NCT03339726|11776|P3|STARTED|Overall Study||63
5222|NCT03339726|11777|P2|STARTED|Overall Study||66
5223|NCT03339726|11778|P1|STARTED|Overall Study||64
5224|NCT03339583|11836|P2|NOT COMPLETED|Follow-up (14 Days)||3
5225|NCT03339583|11837|P1|NOT COMPLETED|Follow-up (14 Days)||6
5226|NCT03339583|11836|P2|COMPLETED|Follow-up (14 Days)||18
5227|NCT03339583|11837|P1|COMPLETED|Follow-up (14 Days)||12
5228|NCT03339583|11836|P2|STARTED|Follow-up (14 Days)||21
5229|NCT03339583|11837|P1|STARTED|Follow-up (14 Days)||18
5230|NCT03339583|11836|P2|NOT COMPLETED|Second Intervention (14 Days)||2
5231|NCT03339583|11837|P1|NOT COMPLETED|Second Intervention (14 Days)||0
5232|NCT03339583|11836|P2|COMPLETED|Second Intervention (14 Days)||21
5233|NCT03339583|11837|P1|COMPLETED|Second Intervention (14 Days)||18
5234|NCT03339583|11836|P2|STARTED|Second Intervention (14 Days)||23
5235|NCT03339583|11837|P1|STARTED|Second Intervention (14 Days)||18
5236|NCT03339583|11836|P2|NOT COMPLETED|Washout (14 Days)||0
5237|NCT03339583|11837|P1|NOT COMPLETED|Washout (14 Days)||0
5238|NCT03339583|11836|P2|COMPLETED|Washout (14 Days)||23
5239|NCT03339583|11837|P1|COMPLETED|Washout (14 Days)||18
5240|NCT03339583|11836|P2|STARTED|Washout (14 Days)||23
5241|NCT03339583|11837|P1|STARTED|Washout (14 Days)||18
5242|NCT03339583|11836|P2|NOT COMPLETED|First Intervention (14 Days)||0
5243|NCT03339583|11837|P1|NOT COMPLETED|First Intervention (14 Days)||1
5244|NCT03339583|11836|P2|COMPLETED|First Intervention (14 Days)||23
5245|NCT03339583|11837|P1|COMPLETED|First Intervention (14 Days)||18
5246|NCT03339583|11836|P2|STARTED|First Intervention (14 Days)||23
5247|NCT03339583|11837|P1|STARTED|First Intervention (14 Days)||19
5248|NCT03339453|11875|P2|NOT COMPLETED|Second Visit for Alternate Glucagon||0
5249|NCT03339453|11876|P1|NOT COMPLETED|Second Visit for Alternate Glucagon||0
5250|NCT03339453|11875|P2|COMPLETED|Second Visit for Alternate Glucagon||34
5251|NCT03339453|11876|P1|COMPLETED|Second Visit for Alternate Glucagon||35
5252|NCT03339453|11875|P2|STARTED|Second Visit for Alternate Glucagon||34
5253|NCT03339453|11876|P1|STARTED|Second Visit for Alternate Glucagon||35
5254|NCT03339453|11875|P2|NOT COMPLETED|First Visit of Glucagon Treatment||1
5255|NCT03339453|11876|P1|NOT COMPLETED|First Visit of Glucagon Treatment||0
5256|NCT03339453|11875|P2|COMPLETED|First Visit of Glucagon Treatment||34
5257|NCT03339453|11876|P1|COMPLETED|First Visit of Glucagon Treatment||35
5258|NCT03339453|11875|P2|Received at Least 1 Dose of Study Drug|First Visit of Glucagon Treatment||35
5259|NCT03339453|11876|P1|Received at Least 1 Dose of Study Drug|First Visit of Glucagon Treatment||35
5260|NCT03339453|11875|P2|STARTED|First Visit of Glucagon Treatment||35
5261|NCT03339453|11876|P1|STARTED|First Visit of Glucagon Treatment||35
5262|NCT03338803|11892|P1|NOT COMPLETED|Overall Study||0
5263|NCT03338803|11892|P1|COMPLETED|Overall Study||11001
5264|NCT03338803|11892|P1|STARTED|Overall Study||11001
5265|NCT03338556|11903|P4|NOT COMPLETED|Overall Study||2
5266|NCT03338556|11904|P3|NOT COMPLETED|Overall Study||2
5267|NCT03338556|11905|P2|NOT COMPLETED|Overall Study||4
5268|NCT03338556|11906|P1|NOT COMPLETED|Overall Study||2
5269|NCT03338556|11903|P4|COMPLETED|Overall Study||24
5270|NCT03338556|11904|P3|COMPLETED|Overall Study||22
5271|NCT03338556|11905|P2|COMPLETED|Overall Study||23
5272|NCT03338556|11906|P1|COMPLETED|Overall Study||23
5273|NCT03338556|11903|P4|STARTED|Overall Study||26
5274|NCT03338556|11904|P3|STARTED|Overall Study||24
5275|NCT03338556|11905|P2|STARTED|Overall Study||27
5276|NCT03338556|11906|P1|STARTED|Overall Study||25
5277|NCT03338400|11926|P2|NOT COMPLETED|Overall Study||2
5278|NCT03338400|11927|P1|NOT COMPLETED|Overall Study||1
5279|NCT03338400|11926|P2|COMPLETED|Overall Study||24
5280|NCT03338400|11927|P1|COMPLETED|Overall Study||24
5281|NCT03338400|11926|P2|STARTED|Overall Study||26
5282|NCT03338400|11927|P1|STARTED|Overall Study||25
5283|NCT03336853|11935|P2|NOT COMPLETED|Overall Study||0
5284|NCT03336853|11936|P1|NOT COMPLETED|Overall Study||0
5285|NCT03336853|11935|P2|COMPLETED|Overall Study||30
5286|NCT03336853|11936|P1|COMPLETED|Overall Study||30
5287|NCT03336853|11935|P2|STARTED|Overall Study||30
5288|NCT03336853|11936|P1|STARTED|Overall Study||30
5289|NCT03335566|11944|P2|NOT COMPLETED|Overall Study||3
5290|NCT03335566|11945|P1|NOT COMPLETED|Overall Study||4
5291|NCT03335566|11944|P2|COMPLETED|Overall Study||203
5292|NCT03335566|11945|P1|COMPLETED|Overall Study||214
5293|NCT03335566|11944|P2|STARTED|Overall Study||206
5294|NCT03335566|11945|P1|STARTED|Overall Study||218
5295|NCT03335254|11977|P20|NOT COMPLETED|Period 3, Day 26-30||0
5296|NCT03335254|11978|P19|NOT COMPLETED|Period 3, Day 26-30||0
5297|NCT03335254|11979|P18|NOT COMPLETED|Period 3, Day 26-30||0
5298|NCT03335254|11980|P17|NOT COMPLETED|Period 3, Day 26-30||0
5299|NCT03335254|11981|P16|NOT COMPLETED|Period 3, Day 26-30||0
5300|NCT03335254|11982|P15|NOT COMPLETED|Period 3, Day 26-30||0
5301|NCT03335254|11983|P14|NOT COMPLETED|Period 3, Day 26-30||0
5302|NCT03335254|11984|P13|NOT COMPLETED|Period 3, Day 26-30||0
5303|NCT03335254|11985|P12|NOT COMPLETED|Period 3, Day 26-30||0
5304|NCT03335254|11986|P11|NOT COMPLETED|Period 3, Day 26-30||0
5305|NCT03335254|11987|P10|NOT COMPLETED|Period 3, Day 26-30||0
5306|NCT03335254|11988|P9|NOT COMPLETED|Period 3, Day 26-30||0
5307|NCT03335254|11989|P8|NOT COMPLETED|Period 3, Day 26-30||0
5308|NCT03335254|11990|P7|NOT COMPLETED|Period 3, Day 26-30||0
5309|NCT03335254|11991|P6|NOT COMPLETED|Period 3, Day 26-30||0
5310|NCT03335254|11992|P5|NOT COMPLETED|Period 3, Day 26-30||0
5311|NCT03335254|11993|P4|NOT COMPLETED|Period 3, Day 26-30||0
5312|NCT03335254|11994|P3|NOT COMPLETED|Period 3, Day 26-30||0
5313|NCT03335254|11995|P2|NOT COMPLETED|Period 3, Day 26-30||0
5314|NCT03335254|11996|P1|NOT COMPLETED|Period 3, Day 26-30||0
5315|NCT03335254|11977|P20|COMPLETED|Period 3, Day 26-30||0
5316|NCT03335254|11978|P19|COMPLETED|Period 3, Day 26-30||0
5317|NCT03335254|11979|P18|COMPLETED|Period 3, Day 26-30||0
5318|NCT03335254|11980|P17|COMPLETED|Period 3, Day 26-30||0
5319|NCT03335254|11981|P16|COMPLETED|Period 3, Day 26-30||0
5320|NCT03335254|11982|P15|COMPLETED|Period 3, Day 26-30||0
5321|NCT03335254|11983|P14|COMPLETED|Period 3, Day 26-30||0
5322|NCT03335254|11984|P13|COMPLETED|Period 3, Day 26-30||0
5323|NCT03335254|11985|P12|COMPLETED|Period 3, Day 26-30||0
5324|NCT03335254|11986|P11|COMPLETED|Period 3, Day 26-30||0
5325|NCT03335254|11987|P10|COMPLETED|Period 3, Day 26-30||0
5326|NCT03335254|11988|P9|COMPLETED|Period 3, Day 26-30||0
5327|NCT03335254|11989|P8|COMPLETED|Period 3, Day 26-30||0
5328|NCT03335254|11990|P7|COMPLETED|Period 3, Day 26-30||0
5329|NCT03335254|11991|P6|COMPLETED|Period 3, Day 26-30||0
5330|NCT03335254|11992|P5|COMPLETED|Period 3, Day 26-30||0
5331|NCT03335254|11993|P4|COMPLETED|Period 3, Day 26-30||0
5332|NCT03335254|11994|P3|COMPLETED|Period 3, Day 26-30||0
5333|NCT03335254|11995|P2|COMPLETED|Period 3, Day 26-30||0
5334|NCT03335254|11996|P1|COMPLETED|Period 3, Day 26-30||9
5335|NCT03335254|11977|P20|STARTED|Period 3, Day 26-30||0
5336|NCT03335254|11978|P19|STARTED|Period 3, Day 26-30||0
5337|NCT03335254|11979|P18|STARTED|Period 3, Day 26-30||0
5338|NCT03335254|11980|P17|STARTED|Period 3, Day 26-30||0
5339|NCT03335254|11981|P16|STARTED|Period 3, Day 26-30||0
5340|NCT03335254|11982|P15|STARTED|Period 3, Day 26-30||0
5341|NCT03335254|11983|P14|STARTED|Period 3, Day 26-30||0
5342|NCT03335254|11984|P13|STARTED|Period 3, Day 26-30||0
5343|NCT03335254|11985|P12|STARTED|Period 3, Day 26-30||0
5344|NCT03335254|11986|P11|STARTED|Period 3, Day 26-30||0
5345|NCT03335254|11987|P10|STARTED|Period 3, Day 26-30||0
5346|NCT03335254|11988|P9|STARTED|Period 3, Day 26-30||0
5347|NCT03335254|11989|P8|STARTED|Period 3, Day 26-30||0
5348|NCT03335254|11990|P7|STARTED|Period 3, Day 26-30||0
5349|NCT03335254|11991|P6|STARTED|Period 3, Day 26-30||0
5350|NCT03335254|11992|P5|STARTED|Period 3, Day 26-30||0
5351|NCT03335254|11993|P4|STARTED|Period 3, Day 26-30||0
5352|NCT03335254|11994|P3|STARTED|Period 3, Day 26-30||0
5353|NCT03335254|11995|P2|STARTED|Period 3, Day 26-30||0
5354|NCT03335254|11996|P1|STARTED|Period 3, Day 26-30||9
5355|NCT03335254|11977|P20|NOT COMPLETED|Period 3, Day 16-25||0
5356|NCT03335254|11978|P19|NOT COMPLETED|Period 3, Day 16-25||0
5357|NCT03335254|11979|P18|NOT COMPLETED|Period 3, Day 16-25||0
5358|NCT03335254|11980|P17|NOT COMPLETED|Period 3, Day 16-25||0
5359|NCT03335254|11981|P16|NOT COMPLETED|Period 3, Day 16-25||0
5360|NCT03335254|11982|P15|NOT COMPLETED|Period 3, Day 16-25||0
5361|NCT03335254|11983|P14|NOT COMPLETED|Period 3, Day 16-25||0
5362|NCT03335254|11984|P13|NOT COMPLETED|Period 3, Day 16-25||0
5363|NCT03335254|11985|P12|NOT COMPLETED|Period 3, Day 16-25||0
5364|NCT03335254|11986|P11|NOT COMPLETED|Period 3, Day 16-25||0
5365|NCT03335254|11987|P10|NOT COMPLETED|Period 3, Day 16-25||0
5366|NCT03335254|11988|P9|NOT COMPLETED|Period 3, Day 16-25||0
5367|NCT03335254|11989|P8|NOT COMPLETED|Period 3, Day 16-25||0
5368|NCT03335254|11990|P7|NOT COMPLETED|Period 3, Day 16-25||0
5369|NCT03335254|11991|P6|NOT COMPLETED|Period 3, Day 16-25||0
5370|NCT03335254|11992|P5|NOT COMPLETED|Period 3, Day 16-25||0
5371|NCT03335254|11993|P4|NOT COMPLETED|Period 3, Day 16-25||0
5372|NCT03335254|11994|P3|NOT COMPLETED|Period 3, Day 16-25||0
5373|NCT03335254|11995|P2|NOT COMPLETED|Period 3, Day 16-25||0
5374|NCT03335254|11996|P1|NOT COMPLETED|Period 3, Day 16-25||0
5375|NCT03335254|11977|P20|COMPLETED|Period 3, Day 16-25||0
5376|NCT03335254|11978|P19|COMPLETED|Period 3, Day 16-25||0
5377|NCT03335254|11979|P18|COMPLETED|Period 3, Day 16-25||0
5378|NCT03335254|11980|P17|COMPLETED|Period 3, Day 16-25||0
5379|NCT03335254|11981|P16|COMPLETED|Period 3, Day 16-25||0
5380|NCT03335254|11982|P15|COMPLETED|Period 3, Day 16-25||0
5381|NCT03335254|11983|P14|COMPLETED|Period 3, Day 16-25||0
5382|NCT03335254|11984|P13|COMPLETED|Period 3, Day 16-25||0
5383|NCT03335254|11985|P12|COMPLETED|Period 3, Day 16-25||0
5384|NCT03335254|11986|P11|COMPLETED|Period 3, Day 16-25||0
5385|NCT03335254|11987|P10|COMPLETED|Period 3, Day 16-25||0
5386|NCT03335254|11988|P9|COMPLETED|Period 3, Day 16-25||0
5387|NCT03335254|11989|P8|COMPLETED|Period 3, Day 16-25||0
5388|NCT03335254|11990|P7|COMPLETED|Period 3, Day 16-25||0
5389|NCT03335254|11991|P6|COMPLETED|Period 3, Day 16-25||0
5390|NCT03335254|11992|P5|COMPLETED|Period 3, Day 16-25||0
5391|NCT03335254|11993|P4|COMPLETED|Period 3, Day 16-25||0
5392|NCT03335254|11994|P3|COMPLETED|Period 3, Day 16-25||0
5393|NCT03335254|11995|P2|COMPLETED|Period 3, Day 16-25||0
5394|NCT03335254|11996|P1|COMPLETED|Period 3, Day 16-25||9
5395|NCT03335254|11977|P20|STARTED|Period 3, Day 16-25||0
5396|NCT03335254|11978|P19|STARTED|Period 3, Day 16-25||0
5397|NCT03335254|11979|P18|STARTED|Period 3, Day 16-25||0
5398|NCT03335254|11980|P17|STARTED|Period 3, Day 16-25||0
5399|NCT03335254|11981|P16|STARTED|Period 3, Day 16-25||0
5400|NCT03335254|11982|P15|STARTED|Period 3, Day 16-25||0
5401|NCT03335254|11983|P14|STARTED|Period 3, Day 16-25||0
5402|NCT03335254|11984|P13|STARTED|Period 3, Day 16-25||0
5403|NCT03335254|11985|P12|STARTED|Period 3, Day 16-25||0
5404|NCT03335254|11986|P11|STARTED|Period 3, Day 16-25||0
5405|NCT03335254|11987|P10|STARTED|Period 3, Day 16-25||0
5406|NCT03335254|11988|P9|STARTED|Period 3, Day 16-25||0
5407|NCT03335254|11989|P8|STARTED|Period 3, Day 16-25||0
5408|NCT03335254|11990|P7|STARTED|Period 3, Day 16-25||0
5409|NCT03335254|11991|P6|STARTED|Period 3, Day 16-25||0
5410|NCT03335254|11992|P5|STARTED|Period 3, Day 16-25||0
5411|NCT03335254|11993|P4|STARTED|Period 3, Day 16-25||0
5412|NCT03335254|11994|P3|STARTED|Period 3, Day 16-25||0
5413|NCT03335254|11995|P2|STARTED|Period 3, Day 16-25||0
5414|NCT03335254|11996|P1|STARTED|Period 3, Day 16-25||9
5415|NCT03335254|11977|P20|NOT COMPLETED|Period 2, Day 1-15||0
5416|NCT03335254|11978|P19|NOT COMPLETED|Period 2, Day 1-15||0
5417|NCT03335254|11979|P18|NOT COMPLETED|Period 2, Day 1-15||0
5418|NCT03335254|11980|P17|NOT COMPLETED|Period 2, Day 1-15||0
5419|NCT03335254|11981|P16|NOT COMPLETED|Period 2, Day 1-15||0
5420|NCT03335254|11982|P15|NOT COMPLETED|Period 2, Day 1-15||0
5421|NCT03335254|11983|P14|NOT COMPLETED|Period 2, Day 1-15||0
5422|NCT03335254|11984|P13|NOT COMPLETED|Period 2, Day 1-15||0
5423|NCT03335254|11985|P12|NOT COMPLETED|Period 2, Day 1-15||0
5424|NCT03335254|11986|P11|NOT COMPLETED|Period 2, Day 1-15||0
5425|NCT03335254|11987|P10|NOT COMPLETED|Period 2, Day 1-15||0
5426|NCT03335254|11988|P9|NOT COMPLETED|Period 2, Day 1-15||0
5427|NCT03335254|11989|P8|NOT COMPLETED|Period 2, Day 1-15||0
5428|NCT03335254|11990|P7|NOT COMPLETED|Period 2, Day 1-15||0
5429|NCT03335254|11991|P6|NOT COMPLETED|Period 2, Day 1-15||0
5430|NCT03335254|11992|P5|NOT COMPLETED|Period 2, Day 1-15||0
5431|NCT03335254|11993|P4|NOT COMPLETED|Period 2, Day 1-15||0
5432|NCT03335254|11994|P3|NOT COMPLETED|Period 2, Day 1-15||0
5433|NCT03335254|11995|P2|NOT COMPLETED|Period 2, Day 1-15||0
5434|NCT03335254|11996|P1|NOT COMPLETED|Period 2, Day 1-15||0
5435|NCT03335254|11977|P20|COMPLETED|Period 2, Day 1-15||0
5436|NCT03335254|11978|P19|COMPLETED|Period 2, Day 1-15||0
5437|NCT03335254|11979|P18|COMPLETED|Period 2, Day 1-15||0
5438|NCT03335254|11980|P17|COMPLETED|Period 2, Day 1-15||0
5439|NCT03335254|11981|P16|COMPLETED|Period 2, Day 1-15||0
5440|NCT03335254|11982|P15|COMPLETED|Period 2, Day 1-15||0
5441|NCT03335254|11983|P14|COMPLETED|Period 2, Day 1-15||0
5442|NCT03335254|11984|P13|COMPLETED|Period 2, Day 1-15||0
5443|NCT03335254|11985|P12|COMPLETED|Period 2, Day 1-15||0
5444|NCT03335254|11986|P11|COMPLETED|Period 2, Day 1-15||0
5445|NCT03335254|11987|P10|COMPLETED|Period 2, Day 1-15||0
5446|NCT03335254|11988|P9|COMPLETED|Period 2, Day 1-15||0
5447|NCT03335254|11989|P8|COMPLETED|Period 2, Day 1-15||0
5448|NCT03335254|11990|P7|COMPLETED|Period 2, Day 1-15||0
5449|NCT03335254|11991|P6|COMPLETED|Period 2, Day 1-15||0
5450|NCT03335254|11992|P5|COMPLETED|Period 2, Day 1-15||0
5451|NCT03335254|11993|P4|COMPLETED|Period 2, Day 1-15||0
5452|NCT03335254|11994|P3|COMPLETED|Period 2, Day 1-15||0
5453|NCT03335254|11995|P2|COMPLETED|Period 2, Day 1-15||0
5454|NCT03335254|11996|P1|COMPLETED|Period 2, Day 1-15||9
5455|NCT03335254|11977|P20|STARTED|Period 2, Day 1-15||0
5456|NCT03335254|11978|P19|STARTED|Period 2, Day 1-15||0
5457|NCT03335254|11979|P18|STARTED|Period 2, Day 1-15||0
5458|NCT03335254|11980|P17|STARTED|Period 2, Day 1-15||0
5459|NCT03335254|11981|P16|STARTED|Period 2, Day 1-15||0
5460|NCT03335254|11982|P15|STARTED|Period 2, Day 1-15||0
5461|NCT03335254|11983|P14|STARTED|Period 2, Day 1-15||0
5462|NCT03335254|11984|P13|STARTED|Period 2, Day 1-15||0
5463|NCT03335254|11985|P12|STARTED|Period 2, Day 1-15||0
5464|NCT03335254|11986|P11|STARTED|Period 2, Day 1-15||0
5465|NCT03335254|11987|P10|STARTED|Period 2, Day 1-15||0
5466|NCT03335254|11988|P9|STARTED|Period 2, Day 1-15||0
5467|NCT03335254|11989|P8|STARTED|Period 2, Day 1-15||0
5468|NCT03335254|11990|P7|STARTED|Period 2, Day 1-15||0
5469|NCT03335254|11991|P6|STARTED|Period 2, Day 1-15||0
5470|NCT03335254|11992|P5|STARTED|Period 2, Day 1-15||0
5471|NCT03335254|11993|P4|STARTED|Period 2, Day 1-15||0
5472|NCT03335254|11994|P3|STARTED|Period 2, Day 1-15||0
5473|NCT03335254|11995|P2|STARTED|Period 2, Day 1-15||0
5474|NCT03335254|11996|P1|STARTED|Period 2, Day 1-15||9
5475|NCT03335254|11977|P20|NOT COMPLETED|Period 1||0
5476|NCT03335254|11978|P19|NOT COMPLETED|Period 1||0
5477|NCT03335254|11979|P18|NOT COMPLETED|Period 1||0
5478|NCT03335254|11980|P17|NOT COMPLETED|Period 1||0
5479|NCT03335254|11981|P16|NOT COMPLETED|Period 1||0
5480|NCT03335254|11982|P15|NOT COMPLETED|Period 1||0
5481|NCT03335254|11983|P14|NOT COMPLETED|Period 1||0
5482|NCT03335254|11984|P13|NOT COMPLETED|Period 1||0
5483|NCT03335254|11985|P12|NOT COMPLETED|Period 1||0
5484|NCT03335254|11986|P11|NOT COMPLETED|Period 1||0
5485|NCT03335254|11987|P10|NOT COMPLETED|Period 1||0
5486|NCT03335254|11988|P9|NOT COMPLETED|Period 1||0
5487|NCT03335254|11989|P8|NOT COMPLETED|Period 1||0
5488|NCT03335254|11990|P7|NOT COMPLETED|Period 1||0
5489|NCT03335254|11991|P6|NOT COMPLETED|Period 1||0
5490|NCT03335254|11992|P5|NOT COMPLETED|Period 1||0
5491|NCT03335254|11993|P4|NOT COMPLETED|Period 1||0
5492|NCT03335254|11994|P3|NOT COMPLETED|Period 1||0
5493|NCT03335254|11995|P2|NOT COMPLETED|Period 1||0
5494|NCT03335254|11996|P1|NOT COMPLETED|Period 1||0
5495|NCT03335254|11977|P20|COMPLETED|Period 1||0
5496|NCT03335254|11978|P19|COMPLETED|Period 1||0
5497|NCT03335254|11979|P18|COMPLETED|Period 1||0
5498|NCT03335254|11980|P17|COMPLETED|Period 1||0
5499|NCT03335254|11981|P16|COMPLETED|Period 1||0
5500|NCT03335254|11982|P15|COMPLETED|Period 1||0
5501|NCT03335254|11983|P14|COMPLETED|Period 1||0
5502|NCT03335254|11984|P13|COMPLETED|Period 1||0
5503|NCT03335254|11985|P12|COMPLETED|Period 1||0
5504|NCT03335254|11986|P11|COMPLETED|Period 1||0
5505|NCT03335254|11987|P10|COMPLETED|Period 1||0
5506|NCT03335254|11988|P9|COMPLETED|Period 1||0
5507|NCT03335254|11989|P8|COMPLETED|Period 1||0
5508|NCT03335254|11990|P7|COMPLETED|Period 1||0
5509|NCT03335254|11991|P6|COMPLETED|Period 1||0
5510|NCT03335254|11992|P5|COMPLETED|Period 1||0
5511|NCT03335254|11993|P4|COMPLETED|Period 1||0
5512|NCT03335254|11994|P3|COMPLETED|Period 1||0
5513|NCT03335254|11995|P2|COMPLETED|Period 1||0
5514|NCT03335254|11996|P1|COMPLETED|Period 1||9
5515|NCT03335254|11977|P20|STARTED|Period 1||0
5516|NCT03335254|11978|P19|STARTED|Period 1||0
5517|NCT03335254|11979|P18|STARTED|Period 1||0
5518|NCT03335254|11980|P17|STARTED|Period 1||0
5519|NCT03335254|11981|P16|STARTED|Period 1||0
5520|NCT03335254|11982|P15|STARTED|Period 1||0
5521|NCT03335254|11983|P14|STARTED|Period 1||0
5522|NCT03335254|11984|P13|STARTED|Period 1||0
5523|NCT03335254|11985|P12|STARTED|Period 1||0
5524|NCT03335254|11986|P11|STARTED|Period 1||0
5525|NCT03335254|11987|P10|STARTED|Period 1||0
5526|NCT03335254|11988|P9|STARTED|Period 1||0
5527|NCT03335254|11989|P8|STARTED|Period 1||0
5528|NCT03335254|11990|P7|STARTED|Period 1||0
5529|NCT03335254|11991|P6|STARTED|Period 1||0
5530|NCT03335254|11992|P5|STARTED|Period 1||0
5531|NCT03335254|11993|P4|STARTED|Period 1||0
5532|NCT03335254|11994|P3|STARTED|Period 1||0
5533|NCT03335254|11995|P2|STARTED|Period 1||0
5534|NCT03335254|11996|P1|STARTED|Period 1||9
5535|NCT03334825|12027|P2|NOT COMPLETED|Overall Study||4
5536|NCT03334825|12028|P1|NOT COMPLETED|Overall Study||7
5537|NCT03334825|12027|P2|COMPLETED|Overall Study||113
5538|NCT03334825|12028|P1|COMPLETED|Overall Study||112
5539|NCT03334825|12027|P2|STARTED|Overall Study||117
5540|NCT03334825|12028|P1|STARTED|Overall Study||119
5541|NCT03333876|12040|P1|NOT COMPLETED|Positional Therapy||0
5542|NCT03333876|12040|P1|COMPLETED|Positional Therapy||54
5543|NCT03333876|12040|P1|STARTED|Positional Therapy||54
5544|NCT03333876|12040|P1|NOT COMPLETED|Mandibular Advancement||4
5545|NCT03333876|12040|P1|COMPLETED|Mandibular Advancement||50
5546|NCT03333876|12040|P1|STARTED|Mandibular Advancement||54
5547|NCT03333876|12040|P1|NOT COMPLETED|Nasal Dilator||6
5548|NCT03333876|12040|P1|COMPLETED|Nasal Dilator||48
5549|NCT03333876|12040|P1|STARTED|Nasal Dilator||54
5550|NCT03333876|12040|P1|NOT COMPLETED|Screening Period||4
5551|NCT03333876|12040|P1|COMPLETED|Screening Period||54
5552|NCT03333876|12040|P1|STARTED|Screening Period||58
5553|NCT03333746|12061|P1|NOT COMPLETED|Overall Study||1
5554|NCT03333746|12061|P1|COMPLETED|Overall Study||0
5555|NCT03333746|12061|P1|STARTED|Overall Study||1
5556|NCT03333577|12072|P1|NOT COMPLETED|Overall Study||7
5557|NCT03333577|12072|P1|COMPLETED|Overall Study||25
5558|NCT03333577|12072|P1|STARTED|Overall Study||32
5559|NCT03331315|12079|P2|NOT COMPLETED|Overall Study||14
5560|NCT03331315|12080|P1|NOT COMPLETED|Overall Study||18
5561|NCT03331315|12079|P2|COMPLETED|Overall Study||68
5562|NCT03331315|12080|P1|COMPLETED|Overall Study||70
5563|NCT03331315|12079|P2|STARTED|Overall Study||82
5564|NCT03331315|12080|P1|STARTED|Overall Study||88
5565|NCT03331042|12104|P4|NOT COMPLETED|Overall Study||1
5566|NCT03331042|12105|P3|NOT COMPLETED|Overall Study||1
5567|NCT03331042|12106|P2|NOT COMPLETED|Overall Study||0
5568|NCT03331042|12107|P1|NOT COMPLETED|Overall Study||1
5569|NCT03331042|12104|P4|COMPLETED|Overall Study||20
5570|NCT03331042|12105|P3|COMPLETED|Overall Study||20
5571|NCT03331042|12106|P2|COMPLETED|Overall Study||21
5572|NCT03331042|12107|P1|COMPLETED|Overall Study||21
5573|NCT03331042|12104|P4|STARTED|Overall Study||21
5574|NCT03331042|12105|P3|STARTED|Overall Study||21
5575|NCT03331042|12106|P2|STARTED|Overall Study||21
5576|NCT03331042|12107|P1|STARTED|Overall Study||22
5577|NCT03330275|12153|P10|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
5578|NCT03330275|12154|P9|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
5579|NCT03330275|12155|P8|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
5580|NCT03330275|12156|P7|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
5581|NCT03330275|12157|P6|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
5582|NCT03330275|12158|P5|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
5583|NCT03330275|12159|P4|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
5584|NCT03330275|12160|P3|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
5585|NCT03330275|12161|P2|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
5586|NCT03330275|12162|P1|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
5587|NCT03330275|12153|P10|COMPLETED|Visits 2, 3 and 4 - Period 3||4
5588|NCT03330275|12154|P9|COMPLETED|Visits 2, 3 and 4 - Period 3||4
5589|NCT03330275|12155|P8|COMPLETED|Visits 2, 3 and 4 - Period 3||4
5590|NCT03330275|12156|P7|COMPLETED|Visits 2, 3 and 4 - Period 3||4
5591|NCT03330275|12157|P6|COMPLETED|Visits 2, 3 and 4 - Period 3||4
5592|NCT03330275|12158|P5|COMPLETED|Visits 2, 3 and 4 - Period 3||4
5593|NCT03330275|12159|P4|COMPLETED|Visits 2, 3 and 4 - Period 3||0
5594|NCT03330275|12160|P3|COMPLETED|Visits 2, 3 and 4 - Period 3||0
5595|NCT03330275|12161|P2|COMPLETED|Visits 2, 3 and 4 - Period 3||0
5596|NCT03330275|12162|P1|COMPLETED|Visits 2, 3 and 4 - Period 3||0
5597|NCT03330275|12153|P10|STARTED|Visits 2, 3 and 4 - Period 3||4
5598|NCT03330275|12154|P9|STARTED|Visits 2, 3 and 4 - Period 3||4
5599|NCT03330275|12155|P8|STARTED|Visits 2, 3 and 4 - Period 3||4
5600|NCT03330275|12156|P7|STARTED|Visits 2, 3 and 4 - Period 3||4
5601|NCT03330275|12157|P6|STARTED|Visits 2, 3 and 4 - Period 3||4
5602|NCT03330275|12158|P5|STARTED|Visits 2, 3 and 4 - Period 3||4
5603|NCT03330275|12159|P4|STARTED|Visits 2, 3 and 4 - Period 3||0
5604|NCT03330275|12160|P3|STARTED|Visits 2, 3 and 4 - Period 3||0
5605|NCT03330275|12161|P2|STARTED|Visits 2, 3 and 4 - Period 3||0
5606|NCT03330275|12162|P1|STARTED|Visits 2, 3 and 4 - Period 3||0
5607|NCT03330275|12153|P10|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
5608|NCT03330275|12154|P9|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
5609|NCT03330275|12155|P8|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
5610|NCT03330275|12156|P7|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
5611|NCT03330275|12157|P6|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
5612|NCT03330275|12158|P5|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
5613|NCT03330275|12159|P4|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
5614|NCT03330275|12160|P3|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
5615|NCT03330275|12161|P2|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
5616|NCT03330275|12162|P1|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
5617|NCT03330275|12153|P10|COMPLETED|Visits 2, 3 and 4 - Period 2||4
5618|NCT03330275|12154|P9|COMPLETED|Visits 2, 3 and 4 - Period 2||4
5619|NCT03330275|12155|P8|COMPLETED|Visits 2, 3 and 4 - Period 2||4
5620|NCT03330275|12156|P7|COMPLETED|Visits 2, 3 and 4 - Period 2||4
5621|NCT03330275|12157|P6|COMPLETED|Visits 2, 3 and 4 - Period 2||4
5622|NCT03330275|12158|P5|COMPLETED|Visits 2, 3 and 4 - Period 2||4
5623|NCT03330275|12159|P4|COMPLETED|Visits 2, 3 and 4 - Period 2||0
5624|NCT03330275|12160|P3|COMPLETED|Visits 2, 3 and 4 - Period 2||0
5625|NCT03330275|12161|P2|COMPLETED|Visits 2, 3 and 4 - Period 2||0
5626|NCT03330275|12162|P1|COMPLETED|Visits 2, 3 and 4 - Period 2||0
5627|NCT03330275|12153|P10|STARTED|Visits 2, 3 and 4 - Period 2||4
5628|NCT03330275|12154|P9|STARTED|Visits 2, 3 and 4 - Period 2||4
5629|NCT03330275|12155|P8|STARTED|Visits 2, 3 and 4 - Period 2||4
5630|NCT03330275|12156|P7|STARTED|Visits 2, 3 and 4 - Period 2||4
5631|NCT03330275|12157|P6|STARTED|Visits 2, 3 and 4 - Period 2||4
5632|NCT03330275|12158|P5|STARTED|Visits 2, 3 and 4 - Period 2||4
5633|NCT03330275|12159|P4|STARTED|Visits 2, 3 and 4 - Period 2||0
5634|NCT03330275|12160|P3|STARTED|Visits 2, 3 and 4 - Period 2||0
5635|NCT03330275|12161|P2|STARTED|Visits 2, 3 and 4 - Period 2||0
5636|NCT03330275|12162|P1|STARTED|Visits 2, 3 and 4 - Period 2||0
5637|NCT03330275|12153|P10|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
5638|NCT03330275|12154|P9|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
5639|NCT03330275|12155|P8|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
5640|NCT03330275|12156|P7|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
5641|NCT03330275|12157|P6|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
5642|NCT03330275|12158|P5|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
5643|NCT03330275|12159|P4|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
5644|NCT03330275|12160|P3|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
5645|NCT03330275|12161|P2|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
5646|NCT03330275|12162|P1|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
5647|NCT03330275|12153|P10|COMPLETED|Visits 2, 3 and 4 - Period 1||4
5648|NCT03330275|12154|P9|COMPLETED|Visits 2, 3 and 4 - Period 1||4
5649|NCT03330275|12155|P8|COMPLETED|Visits 2, 3 and 4 - Period 1||4
5650|NCT03330275|12156|P7|COMPLETED|Visits 2, 3 and 4 - Period 1||4
5651|NCT03330275|12157|P6|COMPLETED|Visits 2, 3 and 4 - Period 1||4
5652|NCT03330275|12158|P5|COMPLETED|Visits 2, 3 and 4 - Period 1||4
5653|NCT03330275|12159|P4|COMPLETED|Visits 2, 3 and 4 - Period 1||0
5654|NCT03330275|12160|P3|COMPLETED|Visits 2, 3 and 4 - Period 1||0
5655|NCT03330275|12161|P2|COMPLETED|Visits 2, 3 and 4 - Period 1||0
5656|NCT03330275|12162|P1|COMPLETED|Visits 2, 3 and 4 - Period 1||0
5657|NCT03330275|12153|P10|STARTED|Visits 2, 3 and 4 - Period 1||4
5658|NCT03330275|12154|P9|STARTED|Visits 2, 3 and 4 - Period 1||4
5659|NCT03330275|12155|P8|STARTED|Visits 2, 3 and 4 - Period 1||4
5660|NCT03330275|12156|P7|STARTED|Visits 2, 3 and 4 - Period 1||4
5661|NCT03330275|12157|P6|STARTED|Visits 2, 3 and 4 - Period 1||4
5662|NCT03330275|12158|P5|STARTED|Visits 2, 3 and 4 - Period 1||4
5663|NCT03330275|12159|P4|STARTED|Visits 2, 3 and 4 - Period 1||0
5664|NCT03330275|12160|P3|STARTED|Visits 2, 3 and 4 - Period 1||0
5665|NCT03330275|12161|P2|STARTED|Visits 2, 3 and 4 - Period 1||0
5666|NCT03330275|12162|P1|STARTED|Visits 2, 3 and 4 - Period 1||0
5667|NCT03330275|12153|P10|NOT COMPLETED|Visit 1 - Period 2||0
5668|NCT03330275|12154|P9|NOT COMPLETED|Visit 1 - Period 2||0
5669|NCT03330275|12155|P8|NOT COMPLETED|Visit 1 - Period 2||0
5670|NCT03330275|12156|P7|NOT COMPLETED|Visit 1 - Period 2||0
5671|NCT03330275|12157|P6|NOT COMPLETED|Visit 1 - Period 2||0
5672|NCT03330275|12158|P5|NOT COMPLETED|Visit 1 - Period 2||0
5673|NCT03330275|12159|P4|NOT COMPLETED|Visit 1 - Period 2||0
5674|NCT03330275|12160|P3|NOT COMPLETED|Visit 1 - Period 2||0
5675|NCT03330275|12161|P2|NOT COMPLETED|Visit 1 - Period 2||0
5676|NCT03330275|12162|P1|NOT COMPLETED|Visit 1 - Period 2||0
5677|NCT03330275|12153|P10|COMPLETED|Visit 1 - Period 2||0
5678|NCT03330275|12154|P9|COMPLETED|Visit 1 - Period 2||0
5679|NCT03330275|12155|P8|COMPLETED|Visit 1 - Period 2||0
5680|NCT03330275|12156|P7|COMPLETED|Visit 1 - Period 2||0
5681|NCT03330275|12157|P6|COMPLETED|Visit 1 - Period 2||0
5682|NCT03330275|12158|P5|COMPLETED|Visit 1 - Period 2||0
5683|NCT03330275|12159|P4|COMPLETED|Visit 1 - Period 2||6
5684|NCT03330275|12160|P3|COMPLETED|Visit 1 - Period 2||6
5685|NCT03330275|12161|P2|COMPLETED|Visit 1 - Period 2||6
5686|NCT03330275|12162|P1|COMPLETED|Visit 1 - Period 2||6
5687|NCT03330275|12153|P10|STARTED|Visit 1 - Period 2||0
5688|NCT03330275|12154|P9|STARTED|Visit 1 - Period 2||0
5689|NCT03330275|12155|P8|STARTED|Visit 1 - Period 2||0
5690|NCT03330275|12156|P7|STARTED|Visit 1 - Period 2||0
5691|NCT03330275|12157|P6|STARTED|Visit 1 - Period 2||0
5692|NCT03330275|12158|P5|STARTED|Visit 1 - Period 2||0
5693|NCT03330275|12159|P4|STARTED|Visit 1 - Period 2||6
5694|NCT03330275|12160|P3|STARTED|Visit 1 - Period 2||6
5695|NCT03330275|12161|P2|STARTED|Visit 1 - Period 2||6
5696|NCT03330275|12162|P1|STARTED|Visit 1 - Period 2||6
5697|NCT03330275|12153|P10|NOT COMPLETED|Visit 1 - Period 1||0
5698|NCT03330275|12154|P9|NOT COMPLETED|Visit 1 - Period 1||0
5699|NCT03330275|12155|P8|NOT COMPLETED|Visit 1 - Period 1||0
5700|NCT03330275|12156|P7|NOT COMPLETED|Visit 1 - Period 1||0
5701|NCT03330275|12157|P6|NOT COMPLETED|Visit 1 - Period 1||0
5702|NCT03330275|12158|P5|NOT COMPLETED|Visit 1 - Period 1||0
5703|NCT03330275|12159|P4|NOT COMPLETED|Visit 1 - Period 1||0
5704|NCT03330275|12160|P3|NOT COMPLETED|Visit 1 - Period 1||0
5705|NCT03330275|12161|P2|NOT COMPLETED|Visit 1 - Period 1||0
5706|NCT03330275|12162|P1|NOT COMPLETED|Visit 1 - Period 1||0
5707|NCT03330275|12153|P10|COMPLETED|Visit 1 - Period 1||0
5708|NCT03330275|12154|P9|COMPLETED|Visit 1 - Period 1||0
5709|NCT03330275|12155|P8|COMPLETED|Visit 1 - Period 1||0
5710|NCT03330275|12156|P7|COMPLETED|Visit 1 - Period 1||0
5711|NCT03330275|12157|P6|COMPLETED|Visit 1 - Period 1||0
5712|NCT03330275|12158|P5|COMPLETED|Visit 1 - Period 1||0
5713|NCT03330275|12159|P4|COMPLETED|Visit 1 - Period 1||6
5714|NCT03330275|12160|P3|COMPLETED|Visit 1 - Period 1||6
5715|NCT03330275|12161|P2|COMPLETED|Visit 1 - Period 1||6
5716|NCT03330275|12162|P1|COMPLETED|Visit 1 - Period 1||6
5717|NCT03330275|12153|P10|STARTED|Visit 1 - Period 1||0
5718|NCT03330275|12154|P9|STARTED|Visit 1 - Period 1||0
5719|NCT03330275|12155|P8|STARTED|Visit 1 - Period 1||0
5720|NCT03330275|12156|P7|STARTED|Visit 1 - Period 1||0
5721|NCT03330275|12157|P6|STARTED|Visit 1 - Period 1||0
5722|NCT03330275|12158|P5|STARTED|Visit 1 - Period 1||0
5723|NCT03330275|12159|P4|STARTED|Visit 1 - Period 1||6
5724|NCT03330275|12160|P3|STARTED|Visit 1 - Period 1||6
5725|NCT03330275|12161|P2|STARTED|Visit 1 - Period 1||6
5726|NCT03330275|12162|P1|STARTED|Visit 1 - Period 1||6
5727|NCT03329885|12194|P9|NOT COMPLETED|Overall Study||0
5728|NCT03329885|12195|P8|NOT COMPLETED|Overall Study||1
5729|NCT03329885|12196|P7|NOT COMPLETED|Overall Study||1
5730|NCT03329885|12197|P6|NOT COMPLETED|Overall Study||0
5731|NCT03329885|12198|P5|NOT COMPLETED|Overall Study||0
5732|NCT03329885|12199|P4|NOT COMPLETED|Overall Study||0
5733|NCT03329885|12200|P3|NOT COMPLETED|Overall Study||0
5734|NCT03329885|12201|P2|NOT COMPLETED|Overall Study||0
5735|NCT03329885|12202|P1|NOT COMPLETED|Overall Study||0
5736|NCT03329885|12194|P9|COMPLETED|Overall Study||0
5737|NCT03329885|12195|P8|COMPLETED|Overall Study||0
5738|NCT03329885|12196|P7|COMPLETED|Overall Study||0
5739|NCT03329885|12197|P6|COMPLETED|Overall Study||3
5740|NCT03329885|12198|P5|COMPLETED|Overall Study||6
5741|NCT03329885|12199|P4|COMPLETED|Overall Study||6
5742|NCT03329885|12200|P3|COMPLETED|Overall Study||6
5743|NCT03329885|12201|P2|COMPLETED|Overall Study||6
5744|NCT03329885|12202|P1|COMPLETED|Overall Study||9
5745|NCT03329885|12194|P9|STARTED|Overall Study|Due to early termination of study, Part C was cancelled and no patients were dosed|0
5746|NCT03329885|12195|P8|STARTED|Overall Study||1
5747|NCT03329885|12196|P7|STARTED|Overall Study||1
5748|NCT03329885|12197|P6|STARTED|Overall Study||3
5749|NCT03329885|12198|P5|STARTED|Overall Study||6
5750|NCT03329885|12199|P4|STARTED|Overall Study||6
5751|NCT03329885|12200|P3|STARTED|Overall Study||6
5752|NCT03329885|12201|P2|STARTED|Overall Study||6
5753|NCT03329885|12202|P1|STARTED|Overall Study||9
5754|NCT03329573|12370|P4|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||0
5755|NCT03329573|12371|P3|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||0
5756|NCT03329573|12372|P2|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||1
5757|NCT03329573|12373|P1|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||1
5758|NCT03329573|12370|P4|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||19
5759|NCT03329573|12371|P3|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||19
5760|NCT03329573|12372|P2|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||20
5761|NCT03329573|12373|P1|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||21
5762|NCT03329573|12370|P4|STARTED|Treatment Period 2 (Day 12 to Day 26)||19
5763|NCT03329573|12371|P3|STARTED|Treatment Period 2 (Day 12 to Day 26)||19
5764|NCT03329573|12372|P2|STARTED|Treatment Period 2 (Day 12 to Day 26)||21
5765|NCT03329573|12373|P1|STARTED|Treatment Period 2 (Day 12 to Day 26)||22
5766|NCT03329573|12370|P4|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
5767|NCT03329573|12371|P3|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
5768|NCT03329573|12372|P2|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
5769|NCT03329573|12373|P1|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
5770|NCT03329573|12370|P4|COMPLETED|Washout Period (Day 6 to Day 11)||19
5771|NCT03329573|12371|P3|COMPLETED|Washout Period (Day 6 to Day 11)||19
5772|NCT03329573|12372|P2|COMPLETED|Washout Period (Day 6 to Day 11)||21
5773|NCT03329573|12373|P1|COMPLETED|Washout Period (Day 6 to Day 11)||22
5774|NCT03329573|12370|P4|STARTED|Washout Period (Day 6 to Day 11)||19
5775|NCT03329573|12371|P3|STARTED|Washout Period (Day 6 to Day 11)||19
5776|NCT03329573|12372|P2|STARTED|Washout Period (Day 6 to Day 11)||21
5777|NCT03329573|12373|P1|STARTED|Washout Period (Day 6 to Day 11)||22
5778|NCT03329573|12370|P4|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||0
5779|NCT03329573|12371|P3|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||0
5780|NCT03329573|12372|P2|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||3
5781|NCT03329573|12373|P1|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||1
5782|NCT03329573|12370|P4|COMPLETED|Treatment Period 1 (Up to 5 Days)||19
5783|NCT03329573|12371|P3|COMPLETED|Treatment Period 1 (Up to 5 Days)||19
5784|NCT03329573|12372|P2|COMPLETED|Treatment Period 1 (Up to 5 Days)||21
5785|NCT03329573|12373|P1|COMPLETED|Treatment Period 1 (Up to 5 Days)||22
5786|NCT03329573|12370|P4|STARTED|Treatment Period 1 (Up to 5 Days)||19
5787|NCT03329573|12371|P3|STARTED|Treatment Period 1 (Up to 5 Days)||19
5788|NCT03329573|12372|P2|STARTED|Treatment Period 1 (Up to 5 Days)||24
5789|NCT03329573|12373|P1|STARTED|Treatment Period 1 (Up to 5 Days)||23
5790|NCT03329209|12439|P1|NOT COMPLETED|Overall Study||0
5791|NCT03329209|12439|P1|COMPLETED|Overall Study||16
5792|NCT03329209|12439|P1|STARTED|Overall Study||16
5793|NCT03328949|12447|P1|NOT COMPLETED|Overall Study||0
5794|NCT03328949|12447|P1|COMPLETED|Overall Study||120
5795|NCT03328949|12447|P1|STARTED|Overall Study||120
5796|NCT03328624|12454|P1|NOT COMPLETED|Overall Study||0
5797|NCT03328624|12454|P1|COMPLETED|Overall Study||36
5798|NCT03328624|12454|P1|STARTED|Overall Study||36
5799|NCT03328182|12458|P1|NOT COMPLETED|Overall Study||4
5800|NCT03328182|12458|P1|COMPLETED|Overall Study||30
5801|NCT03328182|12458|P1|STARTED|Overall Study||34
5802|NCT03325881|12465|P2|NOT COMPLETED|Overall Study||3
5803|NCT03325881|12466|P1|NOT COMPLETED|Overall Study||3
5804|NCT03325881|12465|P2|COMPLETED|Overall Study||42
5805|NCT03325881|12466|P1|COMPLETED|Overall Study||41
5806|NCT03325881|12465|P2|Treated|Overall Study||45
5807|NCT03325881|12466|P1|Treated|Overall Study||43
5808|NCT03325881|12465|P2|STARTED|Overall Study||45
5809|NCT03325881|12466|P1|STARTED|Overall Study||44
5810|NCT03323723|12492|P1|NOT COMPLETED|Treatment Phase||9
5811|NCT03323723|12492|P1|COMPLETED|Treatment Phase||51
5812|NCT03323723|12492|P1|STARTED|Treatment Phase||60
5813|NCT03323723|12492|P1|NOT COMPLETED|Baseline Phase||4
5814|NCT03323723|12492|P1|COMPLETED|Baseline Phase||60
5815|NCT03323723|12492|P1|STARTED|Baseline Phase||64
5816|NCT03323723|12492|P1|NOT COMPLETED|Screening||9
5817|NCT03323723|12492|P1|COMPLETED|Screening||64
5818|NCT03323723|12492|P1|STARTED|Screening||73
5819|NCT03322514|12501|P2|NOT COMPLETED|Overall Study||1
5820|NCT03322514|12502|P1|NOT COMPLETED|Overall Study||1
5821|NCT03322514|12501|P2|COMPLETED|Overall Study||5
5822|NCT03322514|12502|P1|COMPLETED|Overall Study||5
5823|NCT03322514|12501|P2|STARTED|Overall Study||6
5824|NCT03322514|12502|P1|STARTED|Overall Study||6
5825|NCT03322423|12512|P2|NOT COMPLETED|Period 2||2
5826|NCT03322423|12513|P1|NOT COMPLETED|Period 2||1
5827|NCT03322423|12512|P2|COMPLETED|Period 2||36
5828|NCT03322423|12513|P1|COMPLETED|Period 2||35
5829|NCT03322423|12512|P2|STARTED|Period 2||38
5830|NCT03322423|12513|P1|STARTED|Period 2||36
5831|NCT03322423|12512|P2|NOT COMPLETED|Period 1||2
5832|NCT03322423|12513|P1|NOT COMPLETED|Period 1||2
5833|NCT03322423|12512|P2|COMPLETED|Period 1||38
5834|NCT03322423|12513|P1|COMPLETED|Period 1||36
5835|NCT03322423|12512|P2|STARTED|Period 1||40
5836|NCT03322423|12513|P1|STARTED|Period 1||38
5837|NCT03322293|12526|P3|NOT COMPLETED|Overall Study||1
5838|NCT03322293|12527|P2|NOT COMPLETED|Overall Study||0
5839|NCT03322293|12528|P1|NOT COMPLETED|Overall Study||0
5840|NCT03322293|12526|P3|COMPLETED|Overall Study||7
5841|NCT03322293|12527|P2|COMPLETED|Overall Study||8
5842|NCT03322293|12528|P1|COMPLETED|Overall Study||8
5843|NCT03322293|12526|P3|STARTED|Overall Study||8
5844|NCT03322293|12527|P2|STARTED|Overall Study||8
5845|NCT03322293|12528|P1|STARTED|Overall Study||8
5846|NCT03321396|12548|P1|NOT COMPLETED|Overall Study||1
5847|NCT03321396|12548|P1|COMPLETED|Overall Study||12
5848|NCT03321396|12548|P1|STARTED|Overall Study||13
5849|NCT03321253|12554|P1|NOT COMPLETED|Overall Study||0
5850|NCT03321253|12554|P1|COMPLETED|Overall Study||38
5851|NCT03321253|12554|P1|STARTED|Overall Study||38
5852|NCT03320941|12567|P5|NOT COMPLETED|Overall Study||0
5853|NCT03320941|12568|P4|NOT COMPLETED|Overall Study||1
5854|NCT03320941|12569|P3|NOT COMPLETED|Overall Study||0
5855|NCT03320941|12570|P2|NOT COMPLETED|Overall Study||0
5856|NCT03320941|12571|P1|NOT COMPLETED|Overall Study||0
5857|NCT03320941|12567|P5|COMPLETED|Overall Study||29
5858|NCT03320941|12568|P4|COMPLETED|Overall Study||30
5859|NCT03320941|12569|P3|COMPLETED|Overall Study||28
5860|NCT03320941|12570|P2|COMPLETED|Overall Study||19
5861|NCT03320941|12571|P1|COMPLETED|Overall Study||19
5862|NCT03320941|12567|P5|STARTED|Overall Study||29
5863|NCT03320941|12568|P4|STARTED|Overall Study||31
5864|NCT03320941|12569|P3|STARTED|Overall Study||28
5865|NCT03320941|12570|P2|STARTED|Overall Study||19
5866|NCT03320941|12571|P1|STARTED|Overall Study||19
5867|NCT03320564|12672|P1|NOT COMPLETED|Overall Study||1
5868|NCT03320564|12672|P1|COMPLETED|Overall Study||1
5869|NCT03320564|12672|P1|STARTED|Overall Study||2
5870|NCT03320096|12676|P1|NOT COMPLETED|Overall Study||0
5871|NCT03320096|12676|P1|COMPLETED|Overall Study||20
5872|NCT03320096|12676|P1|STARTED|Overall Study||20
5873|NCT03319810|12683|P1|NOT COMPLETED|Overall Study||0
5874|NCT03319810|12683|P1|COMPLETED|Overall Study||5
5875|NCT03319810|12683|P1|STARTED|Overall Study||5
5876|NCT03319719|12688|P1|NOT COMPLETED|Overall Study||1
5877|NCT03319719|12688|P1|COMPLETED|Overall Study||51
5878|NCT03319719|12688|P1|STARTED|Overall Study||52
5879|NCT03319407|12702|P1|NOT COMPLETED|Overall Study||21
5880|NCT03319407|12702|P1|COMPLETED|Overall Study||0
5881|NCT03319407|12702|P1|STARTED|Overall Study||21
5882|NCT03319277|12708|P2|NOT COMPLETED|Overall Study||0
5883|NCT03319277|12709|P1|NOT COMPLETED|Overall Study||0
5884|NCT03319277|12708|P2|COMPLETED|Overall Study||59
5885|NCT03319277|12709|P1|COMPLETED|Overall Study||59
5886|NCT03319277|12708|P2|STARTED|Overall Study||59
5887|NCT03319277|12709|P1|STARTED|Overall Study||59
5888|NCT03319212|12721|P2|NOT COMPLETED|Overall Study||5
5889|NCT03319212|12722|P1|NOT COMPLETED|Overall Study||3
5890|NCT03319212|12721|P2|COMPLETED|Overall Study||47
5891|NCT03319212|12722|P1|COMPLETED|Overall Study||26
5892|NCT03319212|12721|P2|STARTED|Overall Study||52
5893|NCT03319212|12722|P1|STARTED|Overall Study||29
5894|NCT03319173|12749|P2|NOT COMPLETED|Overall Study||0
5895|NCT03319173|12750|P1|NOT COMPLETED|Overall Study||0
5896|NCT03319173|12749|P2|COMPLETED|Overall Study||50
5897|NCT03319173|12750|P1|COMPLETED|Overall Study||48
5898|NCT03319173|12749|P2|STARTED|Overall Study||50
5899|NCT03319173|12750|P1|STARTED|Overall Study||48
5900|NCT03318341|12788|P2|NOT COMPLETED|Month 2||0
5901|NCT03318341|12789|P1|NOT COMPLETED|Month 2||0
5902|NCT03318341|12788|P2|COMPLETED|Month 2||12
5903|NCT03318341|12789|P1|COMPLETED|Month 2||13
5904|NCT03318341|12788|P2|STARTED|Month 2||12
5905|NCT03318341|12789|P1|STARTED|Month 2||13
5906|NCT03318341|12788|P2|NOT COMPLETED|Month 1||1
5907|NCT03318341|12789|P1|NOT COMPLETED|Month 1||0
5908|NCT03318341|12788|P2|COMPLETED|Month 1||12
5909|NCT03318341|12789|P1|COMPLETED|Month 1||13
5910|NCT03318341|12788|P2|STARTED|Month 1||13
5911|NCT03318341|12789|P1|STARTED|Month 1||13
5912|NCT03317431|12799|P1|NOT COMPLETED|Overall Study||0
5913|NCT03317431|12799|P1|COMPLETED|Overall Study||46
5914|NCT03317431|12799|P1|STARTED|Overall Study||46
5915|NCT03316976|12809|P2|NOT COMPLETED|Overall Study||0
5916|NCT03316976|12810|P1|NOT COMPLETED|Overall Study||0
5917|NCT03316976|12809|P2|COMPLETED|Overall Study||20
5918|NCT03316976|12810|P1|COMPLETED|Overall Study||20
5919|NCT03316976|12809|P2|STARTED|Overall Study||20
5920|NCT03316976|12810|P1|STARTED|Overall Study||20
5921|NCT03316911|12822|P2|NOT COMPLETED|Overall Study||29
5922|NCT03316911|12823|P1|NOT COMPLETED|Overall Study||33
5923|NCT03316911|12822|P2|COMPLETED|Overall Study||110
5924|NCT03316911|12823|P1|COMPLETED|Overall Study||89
5925|NCT03316911|12822|P2|5-Month Follow-up Survey|Overall Study||110
5926|NCT03316911|12823|P1|5-Month Follow-up Survey|Overall Study||89
5927|NCT03316911|12822|P2|3-Month Follow-up Survey|Overall Study||112
5928|NCT03316911|12823|P1|3-Month Follow-up Survey|Overall Study||93
5929|NCT03316911|12822|P2|STARTED|Overall Study|3 did not complete baseline survey|139
5930|NCT03316911|12823|P1|STARTED|Overall Study|2 did not complete baseline survey|122
5931|NCT03316378|12857|P2|NOT COMPLETED|Overall Study||0
5932|NCT03316378|12858|P1|NOT COMPLETED|Overall Study||0
5933|NCT03316378|12857|P2|COMPLETED|Overall Study||23
5934|NCT03316378|12858|P1|COMPLETED|Overall Study||23
5935|NCT03316378|12857|P2|STARTED|Overall Study||23
5936|NCT03316378|12858|P1|STARTED|Overall Study||23
5937|NCT03316131|12868|P2|NOT COMPLETED|Treatment Period 2||0
5938|NCT03316131|12869|P1|NOT COMPLETED|Treatment Period 2||1
5939|NCT03316131|12868|P2|COMPLETED|Treatment Period 2||18
5940|NCT03316131|12869|P1|COMPLETED|Treatment Period 2||17
5941|NCT03316131|12868|P2|STARTED|Treatment Period 2||18
5942|NCT03316131|12869|P1|STARTED|Treatment Period 2||18
5943|NCT03316131|12868|P2|NOT COMPLETED|Treatment Period 1||0
5944|NCT03316131|12869|P1|NOT COMPLETED|Treatment Period 1||0
5945|NCT03316131|12868|P2|COMPLETED|Treatment Period 1||18
5946|NCT03316131|12869|P1|COMPLETED|Treatment Period 1||18
5947|NCT03316131|12868|P2|STARTED|Treatment Period 1||18
5948|NCT03316131|12869|P1|STARTED|Treatment Period 1||18
5949|NCT03316105|12889|P2|NOT COMPLETED|Overall Study||0
5950|NCT03316105|12890|P1|NOT COMPLETED|Overall Study||0
5951|NCT03316105|12889|P2|COMPLETED|Overall Study||7
5952|NCT03316105|12890|P1|COMPLETED|Overall Study||9
5953|NCT03316105|12889|P2|STARTED|Overall Study||7
5954|NCT03316105|12890|P1|STARTED|Overall Study||9
5955|NCT03315780|12896|P2|NOT COMPLETED|Period 2||0
5956|NCT03315780|12897|P1|NOT COMPLETED|Period 2||0
5957|NCT03315780|12896|P2|COMPLETED|Period 2||6
5958|NCT03315780|12897|P1|COMPLETED|Period 2||6
5959|NCT03315780|12896|P2|STARTED|Period 2||6
5960|NCT03315780|12897|P1|STARTED|Period 2||6
5961|NCT03315780|12896|P2|NOT COMPLETED|Period 1||0
5962|NCT03315780|12897|P1|NOT COMPLETED|Period 1||0
5963|NCT03315780|12896|P2|COMPLETED|Period 1||6
5964|NCT03315780|12897|P1|COMPLETED|Period 1||6
5965|NCT03315780|12896|P2|Received One Dose of Study Drug|Period 1||6
5966|NCT03315780|12897|P1|Received One Dose of Study Drug|Period 1||6
5967|NCT03315780|12896|P2|STARTED|Period 1||6
5968|NCT03315780|12897|P1|STARTED|Period 1||6
5969|NCT03315702|12917|P1|NOT COMPLETED|Overall Study||0
5970|NCT03315702|12917|P1|COMPLETED|Overall Study||52
5971|NCT03315702|12917|P1|STARTED|Overall Study||52
5972|NCT03315572|12926|P2|NOT COMPLETED|Overall Study||0
5973|NCT03315572|12927|P1|NOT COMPLETED|Overall Study||0
5974|NCT03315572|12926|P2|COMPLETED|Overall Study||14
5975|NCT03315572|12927|P1|COMPLETED|Overall Study||14
5976|NCT03315572|12926|P2|STARTED|Overall Study||14
5977|NCT03315572|12927|P1|STARTED|Overall Study||14
5978|NCT03315559|12950|P1|NOT COMPLETED|Treatment Period 2 (15 Days)||0
5979|NCT03315559|12950|P1|COMPLETED|Treatment Period 2 (15 Days)||6
5980|NCT03315559|12950|P1|STARTED|Treatment Period 2 (15 Days)||6
5981|NCT03315559|12950|P1|NOT COMPLETED|Washout Period (14 Days)||0
5982|NCT03315559|12950|P1|COMPLETED|Washout Period (14 Days)||6
5983|NCT03315559|12950|P1|STARTED|Washout Period (14 Days)||6
5984|NCT03315559|12950|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
5985|NCT03315559|12950|P1|COMPLETED|Treatment Period 1 (8 Days)||6
5986|NCT03315559|12950|P1|STARTED|Treatment Period 1 (8 Days)||6
5987|NCT03315286|12990|P2|NOT COMPLETED|Overall Study||4
5988|NCT03315286|12991|P1|NOT COMPLETED|Overall Study||1
5989|NCT03315286|12990|P2|COMPLETED|Overall Study||43
5990|NCT03315286|12991|P1|COMPLETED|Overall Study||49
5991|NCT03315286|12990|P2|STARTED|Overall Study||47
5992|NCT03315286|12991|P1|STARTED|Overall Study||50
5993|NCT03314753|13001|P2|NOT COMPLETED|Overall Study||0
5994|NCT03314753|13002|P1|NOT COMPLETED|Overall Study||0
5995|NCT03314753|13001|P2|COMPLETED|Overall Study||36
5996|NCT03314753|13002|P1|COMPLETED|Overall Study||53
5997|NCT03314753|13001|P2|STARTED|Overall Study||36
5998|NCT03314753|13002|P1|STARTED|Overall Study||53
5999|NCT03312933|13024|P1|NOT COMPLETED|Overall Study||54
6000|NCT03312933|13024|P1|COMPLETED|Overall Study||46
6001|NCT03312933|13024|P1|STARTED|Overall Study||100
6002|NCT03312543|13030|P2|NOT COMPLETED|Regression (Week 12 to Week 24)||2
6003|NCT03312543|13031|P1|NOT COMPLETED|Regression (Week 12 to Week 24)||1
6004|NCT03312543|13030|P2|COMPLETED|Regression (Week 12 to Week 24)||52
6005|NCT03312543|13031|P1|COMPLETED|Regression (Week 12 to Week 24)||55
6006|NCT03312543|13030|P2|STARTED|Regression (Week 12 to Week 24)||54
6007|NCT03312543|13031|P1|STARTED|Regression (Week 12 to Week 24)||56
6008|NCT03312543|13030|P2|NOT COMPLETED|Treatment (Baseline to Week 12)||5
6009|NCT03312543|13031|P1|NOT COMPLETED|Treatment (Baseline to Week 12)||4
6010|NCT03312543|13030|P2|COMPLETED|Treatment (Baseline to Week 12)||54
6011|NCT03312543|13031|P1|COMPLETED|Treatment (Baseline to Week 12)||56
6012|NCT03312543|13030|P2|STARTED|Treatment (Baseline to Week 12)||59
6013|NCT03312543|13031|P1|STARTED|Treatment (Baseline to Week 12)||60
6014|NCT03312543|13030|P2|NOT COMPLETED|Before Treatment (Screening to Baseline)||4
6015|NCT03312543|13031|P1|NOT COMPLETED|Before Treatment (Screening to Baseline)||1
6016|NCT03312543|13030|P2|COMPLETED|Before Treatment (Screening to Baseline)||59
6017|NCT03312543|13031|P1|COMPLETED|Before Treatment (Screening to Baseline)||60
6018|NCT03312543|13030|P2|STARTED|Before Treatment (Screening to Baseline)||63
6019|NCT03312543|13031|P1|STARTED|Before Treatment (Screening to Baseline)||61
6020|NCT03312517|13105|P6|NOT COMPLETED|Overall Study||0
6021|NCT03312517|13106|P5|NOT COMPLETED|Overall Study||0
6022|NCT03312517|13107|P4|NOT COMPLETED|Overall Study||0
6023|NCT03312517|13108|P3|NOT COMPLETED|Overall Study||0
6024|NCT03312517|13109|P2|NOT COMPLETED|Overall Study||0
6025|NCT03312517|13110|P1|NOT COMPLETED|Overall Study||0
6026|NCT03312517|13105|P6|COMPLETED|Overall Study||2
6027|NCT03312517|13106|P5|COMPLETED|Overall Study||2
6028|NCT03312517|13107|P4|COMPLETED|Overall Study||2
6029|NCT03312517|13108|P3|COMPLETED|Overall Study||2
6030|NCT03312517|13109|P2|COMPLETED|Overall Study||2
6031|NCT03312517|13110|P1|COMPLETED|Overall Study||2
6032|NCT03312517|13105|P6|STARTED|Overall Study||2
6033|NCT03312517|13106|P5|STARTED|Overall Study||2
6034|NCT03312517|13107|P4|STARTED|Overall Study||2
6035|NCT03312517|13108|P3|STARTED|Overall Study||2
6036|NCT03312517|13109|P2|STARTED|Overall Study||2
6037|NCT03312517|13110|P1|STARTED|Overall Study||2
6038|NCT03312348|13118|P1|NOT COMPLETED|Overall Study||0
6039|NCT03312348|13118|P1|COMPLETED|Overall Study||30
6040|NCT03312348|13118|P1|STARTED|Overall Study||30
6041|NCT03311659|13122|P1|NOT COMPLETED|Overall Study||1
6042|NCT03311659|13122|P1|COMPLETED|Overall Study||446
6043|NCT03311659|13122|P1|STARTED|Overall Study||447
6044|NCT03310580|13140|P3|NOT COMPLETED|Overall Study||0
6045|NCT03310580|13141|P2|NOT COMPLETED|Overall Study||1
6046|NCT03310580|13142|P1|NOT COMPLETED|Overall Study||0
6047|NCT03310580|13140|P3|COMPLETED|Overall Study||12
6048|NCT03310580|13141|P2|COMPLETED|Overall Study||14
6049|NCT03310580|13142|P1|COMPLETED|Overall Study||15
6050|NCT03310580|13140|P3|STARTED|Overall Study||12
6051|NCT03310580|13141|P2|STARTED|Overall Study||15
6052|NCT03310580|13142|P1|STARTED|Overall Study||15
6053|NCT03310450|13156|P3|NOT COMPLETED|Overall Study||0
6054|NCT03310450|13157|P2|NOT COMPLETED|Overall Study||4
6055|NCT03310450|13158|P1|NOT COMPLETED|Overall Study||2
6056|NCT03310450|13156|P3|COMPLETED|Overall Study||28
6057|NCT03310450|13157|P2|COMPLETED|Overall Study||30
6058|NCT03310450|13158|P1|COMPLETED|Overall Study||30
6059|NCT03310450|13156|P3|STARTED|Overall Study||28
6060|NCT03310450|13157|P2|STARTED|Overall Study||34
6061|NCT03310450|13158|P1|STARTED|Overall Study||32
6062|NCT03310411|13175|P4|NOT COMPLETED|Period Title: Period 4||0
6063|NCT03310411|13176|P3|NOT COMPLETED|Period Title: Period 4||0
6064|NCT03310411|13177|P2|NOT COMPLETED|Period Title: Period 4||0
6065|NCT03310411|13178|P1|NOT COMPLETED|Period Title: Period 4||0
6066|NCT03310411|13175|P4|COMPLETED|Period Title: Period 4||9
6067|NCT03310411|13176|P3|COMPLETED|Period Title: Period 4||10
6068|NCT03310411|13177|P2|COMPLETED|Period Title: Period 4||10
6069|NCT03310411|13178|P1|COMPLETED|Period Title: Period 4||10
6070|NCT03310411|13175|P4|STARTED|Period Title: Period 4||9
6071|NCT03310411|13176|P3|STARTED|Period Title: Period 4||10
6072|NCT03310411|13177|P2|STARTED|Period Title: Period 4||10
6073|NCT03310411|13178|P1|STARTED|Period Title: Period 4||10
6074|NCT03310411|13175|P4|NOT COMPLETED|Period 3||0
6075|NCT03310411|13176|P3|NOT COMPLETED|Period 3||0
6076|NCT03310411|13177|P2|NOT COMPLETED|Period 3||0
6077|NCT03310411|13178|P1|NOT COMPLETED|Period 3||0
6078|NCT03310411|13175|P4|COMPLETED|Period 3||9
6079|NCT03310411|13176|P3|COMPLETED|Period 3||10
6080|NCT03310411|13177|P2|COMPLETED|Period 3||10
6081|NCT03310411|13178|P1|COMPLETED|Period 3||10
6082|NCT03310411|13175|P4|STARTED|Period 3||9
6083|NCT03310411|13176|P3|STARTED|Period 3||10
6084|NCT03310411|13177|P2|STARTED|Period 3||10
6085|NCT03310411|13178|P1|STARTED|Period 3||10
6086|NCT03310411|13175|P4|NOT COMPLETED|Period 2||0
6087|NCT03310411|13176|P3|NOT COMPLETED|Period 2||0
6088|NCT03310411|13177|P2|NOT COMPLETED|Period 2||0
6089|NCT03310411|13178|P1|NOT COMPLETED|Period 2||0
6090|NCT03310411|13175|P4|COMPLETED|Period 2||9
6091|NCT03310411|13176|P3|COMPLETED|Period 2||10
6092|NCT03310411|13177|P2|COMPLETED|Period 2||10
6093|NCT03310411|13178|P1|COMPLETED|Period 2||10
6094|NCT03310411|13175|P4|STARTED|Period 2||9
6095|NCT03310411|13176|P3|STARTED|Period 2||10
6096|NCT03310411|13177|P2|STARTED|Period 2||10
6097|NCT03310411|13178|P1|STARTED|Period 2||10
6098|NCT03310411|13175|P4|NOT COMPLETED|Period 1||1
6099|NCT03310411|13176|P3|NOT COMPLETED|Period 1||0
6100|NCT03310411|13177|P2|NOT COMPLETED|Period 1||0
6101|NCT03310411|13178|P1|NOT COMPLETED|Period 1||0
6102|NCT03310411|13175|P4|COMPLETED|Period 1||9
6103|NCT03310411|13176|P3|COMPLETED|Period 1||10
6104|NCT03310411|13177|P2|COMPLETED|Period 1||10
6105|NCT03310411|13178|P1|COMPLETED|Period 1||10
6106|NCT03310411|13175|P4|Received at Least 1 Dose of Study Drug|Period 1||10
6107|NCT03310411|13176|P3|Received at Least 1 Dose of Study Drug|Period 1||10
6108|NCT03310411|13177|P2|Received at Least 1 Dose of Study Drug|Period 1||10
6109|NCT03310411|13178|P1|Received at Least 1 Dose of Study Drug|Period 1||10
6110|NCT03310411|13175|P4|STARTED|Period 1||10
6111|NCT03310411|13176|P3|STARTED|Period 1||10
6112|NCT03310411|13177|P2|STARTED|Period 1||10
6113|NCT03310411|13178|P1|STARTED|Period 1||10
6114|NCT03310268|13199|P3|NOT COMPLETED|Overall Study||0
6115|NCT03310268|13200|P2|NOT COMPLETED|Overall Study||5
6116|NCT03310268|13201|P1|NOT COMPLETED|Overall Study||1
6117|NCT03310268|13199|P3|COMPLETED|Overall Study||61
6118|NCT03310268|13200|P2|COMPLETED|Overall Study||57
6119|NCT03310268|13201|P1|COMPLETED|Overall Study||61
6120|NCT03310268|13199|P3|STARTED|Overall Study||61
6121|NCT03310268|13200|P2|STARTED|Overall Study||62
6122|NCT03310268|13201|P1|STARTED|Overall Study||62
6123|NCT03309202|13216|P4|NOT COMPLETED|Overall Study||0
6124|NCT03309202|13217|P3|NOT COMPLETED|Overall Study||0
6125|NCT03309202|13218|P2|NOT COMPLETED|Overall Study||0
6126|NCT03309202|13219|P1|NOT COMPLETED|Overall Study||1
6127|NCT03309202|13216|P4|COMPLETED|Overall Study||6
6128|NCT03309202|13217|P3|COMPLETED|Overall Study||6
6129|NCT03309202|13218|P2|COMPLETED|Overall Study||6
6130|NCT03309202|13219|P1|COMPLETED|Overall Study||5
6131|NCT03309202|13216|P4|STARTED|Overall Study||6
6132|NCT03309202|13217|P3|STARTED|Overall Study||6
6133|NCT03309202|13218|P2|STARTED|Overall Study||6
6134|NCT03309202|13219|P1|STARTED|Overall Study||6
6135|NCT03308968|13304|P3|NOT COMPLETED|Open-Label Period (12 Weeks)||12
6136|NCT03308968|13305|P2|NOT COMPLETED|Open-Label Period (12 Weeks)||12
6137|NCT03308968|13306|P1|NOT COMPLETED|Open-Label Period (12 Weeks)||11
6138|NCT03308968|13304|P3|COMPLETED|Open-Label Period (12 Weeks)||260
6139|NCT03308968|13305|P2|COMPLETED|Open-Label Period (12 Weeks)||259
6140|NCT03308968|13306|P1|COMPLETED|Open-Label Period (12 Weeks)||253
6141|NCT03308968|13304|P3|OL mITT Analysis Set|Open-Label Period (12 Weeks)||272
6142|NCT03308968|13305|P2|OL mITT Analysis Set|Open-Label Period (12 Weeks)||271
6143|NCT03308968|13306|P1|OL mITT Analysis Set|Open-Label Period (12 Weeks)||263
6144|NCT03308968|13304|P3|STARTED|Open-Label Period (12 Weeks)||272
6145|NCT03308968|13305|P2|STARTED|Open-Label Period (12 Weeks)||271
6146|NCT03308968|13306|P1|STARTED|Open-Label Period (12 Weeks)||264
6147|NCT03308968|13304|P3|NOT COMPLETED|Double-Blind Period (12 Weeks)||11
6148|NCT03308968|13305|P2|NOT COMPLETED|Double-Blind Period (12 Weeks)||5
6149|NCT03308968|13306|P1|NOT COMPLETED|Double-Blind Period (12 Weeks)||15
6150|NCT03308968|13304|P3|COMPLETED|Double-Blind Period (12 Weeks)||272
6151|NCT03308968|13305|P2|COMPLETED|Double-Blind Period (12 Weeks)||271
6152|NCT03308968|13306|P1|COMPLETED|Double-Blind Period (12 Weeks)||264
6153|NCT03308968|13304|P3|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||283
6154|NCT03308968|13305|P2|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||276
6155|NCT03308968|13306|P1|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||278
6156|NCT03308968|13304|P3|DB Safety Analysis Set|Double-Blind Period (12 Weeks)|2 participants (1 with CM and 1 with EM) randomized to placebo but received Fremanezumab monthly.|285
6157|NCT03308968|13305|P2|DB Safety Analysis Set|Double-Blind Period (12 Weeks)||276
6158|NCT03308968|13306|P1|DB Safety Analysis Set|Double-Blind Period (12 Weeks)|2 participants (1 with CM and 1 with EM) randomized to placebo but received Fremanezumab monthly.|277
6159|NCT03308968|13304|P3|STARTED|Double-Blind Period (12 Weeks)||283
6160|NCT03308968|13305|P2|STARTED|Double-Blind Period (12 Weeks)||276
6161|NCT03308968|13306|P1|STARTED|Double-Blind Period (12 Weeks)||279
6162|NCT03308825|13384|P4|NOT COMPLETED|Overall Study||0
6163|NCT03308825|13385|P3|NOT COMPLETED|Overall Study||1
6164|NCT03308825|13386|P2|NOT COMPLETED|Overall Study||4
6165|NCT03308825|13387|P1|NOT COMPLETED|Overall Study||2
6166|NCT03308825|13384|P4|COMPLETED|Overall Study||60
6167|NCT03308825|13385|P3|COMPLETED|Overall Study||59
6168|NCT03308825|13386|P2|COMPLETED|Overall Study||57
6169|NCT03308825|13387|P1|COMPLETED|Overall Study||57
6170|NCT03308825|13384|P4|STARTED|Overall Study||60
6171|NCT03308825|13385|P3|STARTED|Overall Study||60
6172|NCT03308825|13386|P2|STARTED|Overall Study|1 child in Group 1 received a 0.5mL dose instead of a 0.25 mL dose and is included in Group 2.|61
6173|NCT03308825|13387|P1|STARTED|Overall Study|1 child in Group 1 received a 0.5mL dose instead of a 0.25 mL dose and is included in Group 2.|59
6174|NCT03308799|13416|P3|NOT COMPLETED|Overall Study||21
6175|NCT03308799|13417|P2|NOT COMPLETED|Overall Study||28
6176|NCT03308799|13418|P1|NOT COMPLETED|Overall Study||22
6177|NCT03308799|13416|P3|COMPLETED|Overall Study||94
6178|NCT03308799|13417|P2|COMPLETED|Overall Study||309
6179|NCT03308799|13418|P1|COMPLETED|Overall Study||320
6180|NCT03308799|13416|P3|STARTED|Overall Study||115
6181|NCT03308799|13417|P2|STARTED|Overall Study||337
6182|NCT03308799|13418|P1|STARTED|Overall Study||342
6183|NCT03308669|13434|P2|NOT COMPLETED|Overall Study||0
6184|NCT03308669|13435|P1|NOT COMPLETED|Overall Study||0
6185|NCT03308669|13434|P2|COMPLETED|Overall Study||20
6186|NCT03308669|13435|P1|COMPLETED|Overall Study||10
6187|NCT03308669|13434|P2|Received at Least One Dose of Study Drug|Overall Study||20
6188|NCT03308669|13435|P1|Received at Least One Dose of Study Drug|Overall Study||10
6189|NCT03308669|13434|P2|STARTED|Overall Study||20
6190|NCT03308669|13435|P1|STARTED|Overall Study||10
6191|NCT03308058|13457|P2|NOT COMPLETED|Overall Study||0
6192|NCT03308058|13458|P1|NOT COMPLETED|Overall Study||0
6193|NCT03308058|13457|P2|COMPLETED|Overall Study||23
6194|NCT03308058|13458|P1|COMPLETED|Overall Study||23
6195|NCT03308058|13457|P2|STARTED|Overall Study||23
6196|NCT03308058|13458|P1|STARTED|Overall Study||23
6197|NCT03307252|13475|P11|NOT COMPLETED|Part 3, Period 4||0
6198|NCT03307252|13476|P10|NOT COMPLETED|Part 3, Period 4||0
6199|NCT03307252|13477|P9|NOT COMPLETED|Part 3, Period 4||0
6200|NCT03307252|13478|P8|NOT COMPLETED|Part 3, Period 4||0
6201|NCT03307252|13479|P7|NOT COMPLETED|Part 3, Period 4||0
6202|NCT03307252|13480|P6|NOT COMPLETED|Part 3, Period 4||0
6203|NCT03307252|13481|P5|NOT COMPLETED|Part 3, Period 4||0
6204|NCT03307252|13482|P4|NOT COMPLETED|Part 3, Period 4||0
6205|NCT03307252|13483|P3|NOT COMPLETED|Part 3, Period 4||0
6206|NCT03307252|13484|P2|NOT COMPLETED|Part 3, Period 4||0
6207|NCT03307252|13485|P1|NOT COMPLETED|Part 3, Period 4||0
6208|NCT03307252|13475|P11|COMPLETED|Part 3, Period 4||3
6209|NCT03307252|13476|P10|COMPLETED|Part 3, Period 4||4
6210|NCT03307252|13477|P9|COMPLETED|Part 3, Period 4||4
6211|NCT03307252|13478|P8|COMPLETED|Part 3, Period 4||4
6212|NCT03307252|13479|P7|COMPLETED|Part 3, Period 4||0
6213|NCT03307252|13480|P6|COMPLETED|Part 3, Period 4||0
6214|NCT03307252|13481|P5|COMPLETED|Part 3, Period 4||0
6215|NCT03307252|13482|P4|COMPLETED|Part 3, Period 4||0
6216|NCT03307252|13483|P3|COMPLETED|Part 3, Period 4||0
6217|NCT03307252|13484|P2|COMPLETED|Part 3, Period 4||0
6218|NCT03307252|13485|P1|COMPLETED|Part 3, Period 4||0
6219|NCT03307252|13475|P11|STARTED|Part 3, Period 4||3
6220|NCT03307252|13476|P10|STARTED|Part 3, Period 4||4
6221|NCT03307252|13477|P9|STARTED|Part 3, Period 4||4
6222|NCT03307252|13478|P8|STARTED|Part 3, Period 4||4
6223|NCT03307252|13479|P7|STARTED|Part 3, Period 4||0
6224|NCT03307252|13480|P6|STARTED|Part 3, Period 4||0
6225|NCT03307252|13481|P5|STARTED|Part 3, Period 4||0
6226|NCT03307252|13482|P4|STARTED|Part 3, Period 4||0
6227|NCT03307252|13483|P3|STARTED|Part 3, Period 4||0
6228|NCT03307252|13484|P2|STARTED|Part 3, Period 4||0
6229|NCT03307252|13485|P1|STARTED|Part 3, Period 4||0
6230|NCT03307252|13475|P11|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||1
6231|NCT03307252|13476|P10|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6232|NCT03307252|13477|P9|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6233|NCT03307252|13478|P8|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6234|NCT03307252|13479|P7|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6235|NCT03307252|13480|P6|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6236|NCT03307252|13481|P5|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6237|NCT03307252|13482|P4|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6238|NCT03307252|13483|P3|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6239|NCT03307252|13484|P2|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6240|NCT03307252|13485|P1|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6241|NCT03307252|13475|P11|COMPLETED|Part 3, Washout Period 3 (7 Days)||3
6242|NCT03307252|13476|P10|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
6243|NCT03307252|13477|P9|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
6244|NCT03307252|13478|P8|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
6245|NCT03307252|13479|P7|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6246|NCT03307252|13480|P6|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6247|NCT03307252|13481|P5|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6248|NCT03307252|13482|P4|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6249|NCT03307252|13483|P3|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6250|NCT03307252|13484|P2|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6251|NCT03307252|13485|P1|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6252|NCT03307252|13475|P11|STARTED|Part 3, Washout Period 3 (7 Days)||4
6253|NCT03307252|13476|P10|STARTED|Part 3, Washout Period 3 (7 Days)||4
6254|NCT03307252|13477|P9|STARTED|Part 3, Washout Period 3 (7 Days)||4
6255|NCT03307252|13478|P8|STARTED|Part 3, Washout Period 3 (7 Days)||4
6256|NCT03307252|13479|P7|STARTED|Part 3, Washout Period 3 (7 Days)||0
6257|NCT03307252|13480|P6|STARTED|Part 3, Washout Period 3 (7 Days)||0
6258|NCT03307252|13481|P5|STARTED|Part 3, Washout Period 3 (7 Days)||0
6259|NCT03307252|13482|P4|STARTED|Part 3, Washout Period 3 (7 Days)||0
6260|NCT03307252|13483|P3|STARTED|Part 3, Washout Period 3 (7 Days)||0
6261|NCT03307252|13484|P2|STARTED|Part 3, Washout Period 3 (7 Days)||0
6262|NCT03307252|13485|P1|STARTED|Part 3, Washout Period 3 (7 Days)||0
6263|NCT03307252|13475|P11|NOT COMPLETED|Part 3, Period 3||0
6264|NCT03307252|13476|P10|NOT COMPLETED|Part 3, Period 3||0
6265|NCT03307252|13477|P9|NOT COMPLETED|Part 3, Period 3||0
6266|NCT03307252|13478|P8|NOT COMPLETED|Part 3, Period 3||0
6267|NCT03307252|13479|P7|NOT COMPLETED|Part 3, Period 3||0
6268|NCT03307252|13480|P6|NOT COMPLETED|Part 3, Period 3||0
6269|NCT03307252|13481|P5|NOT COMPLETED|Part 3, Period 3||0
6270|NCT03307252|13482|P4|NOT COMPLETED|Part 3, Period 3||0
6271|NCT03307252|13483|P3|NOT COMPLETED|Part 3, Period 3||0
6272|NCT03307252|13484|P2|NOT COMPLETED|Part 3, Period 3||0
6273|NCT03307252|13485|P1|NOT COMPLETED|Part 3, Period 3||0
6274|NCT03307252|13475|P11|COMPLETED|Part 3, Period 3||4
6275|NCT03307252|13476|P10|COMPLETED|Part 3, Period 3||4
6276|NCT03307252|13477|P9|COMPLETED|Part 3, Period 3||4
6277|NCT03307252|13478|P8|COMPLETED|Part 3, Period 3||4
6278|NCT03307252|13479|P7|COMPLETED|Part 3, Period 3||0
6279|NCT03307252|13480|P6|COMPLETED|Part 3, Period 3||0
6280|NCT03307252|13481|P5|COMPLETED|Part 3, Period 3||0
6281|NCT03307252|13482|P4|COMPLETED|Part 3, Period 3||0
6282|NCT03307252|13483|P3|COMPLETED|Part 3, Period 3||0
6283|NCT03307252|13484|P2|COMPLETED|Part 3, Period 3||0
6284|NCT03307252|13485|P1|COMPLETED|Part 3, Period 3||0
6285|NCT03307252|13475|P11|STARTED|Part 3, Period 3||4
6286|NCT03307252|13476|P10|STARTED|Part 3, Period 3||4
6287|NCT03307252|13477|P9|STARTED|Part 3, Period 3||4
6288|NCT03307252|13478|P8|STARTED|Part 3, Period 3||4
6289|NCT03307252|13479|P7|STARTED|Part 3, Period 3||0
6290|NCT03307252|13480|P6|STARTED|Part 3, Period 3||0
6291|NCT03307252|13481|P5|STARTED|Part 3, Period 3||0
6292|NCT03307252|13482|P4|STARTED|Part 3, Period 3||0
6293|NCT03307252|13483|P3|STARTED|Part 3, Period 3||0
6294|NCT03307252|13484|P2|STARTED|Part 3, Period 3||0
6295|NCT03307252|13485|P1|STARTED|Part 3, Period 3||0
6296|NCT03307252|13475|P11|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6297|NCT03307252|13476|P10|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6298|NCT03307252|13477|P9|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6299|NCT03307252|13478|P8|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6300|NCT03307252|13479|P7|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6301|NCT03307252|13480|P6|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6302|NCT03307252|13481|P5|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6303|NCT03307252|13482|P4|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6304|NCT03307252|13483|P3|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6305|NCT03307252|13484|P2|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6306|NCT03307252|13485|P1|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6307|NCT03307252|13475|P11|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
6308|NCT03307252|13476|P10|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
6309|NCT03307252|13477|P9|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
6310|NCT03307252|13478|P8|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
6311|NCT03307252|13479|P7|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6312|NCT03307252|13480|P6|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6313|NCT03307252|13481|P5|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6314|NCT03307252|13482|P4|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6315|NCT03307252|13483|P3|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6316|NCT03307252|13484|P2|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6317|NCT03307252|13485|P1|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6318|NCT03307252|13475|P11|STARTED|Part 3, Washout Period 2 (7 Days)||4
6319|NCT03307252|13476|P10|STARTED|Part 3, Washout Period 2 (7 Days)||4
6320|NCT03307252|13477|P9|STARTED|Part 3, Washout Period 2 (7 Days)||4
6321|NCT03307252|13478|P8|STARTED|Part 3, Washout Period 2 (7 Days)||4
6322|NCT03307252|13479|P7|STARTED|Part 3, Washout Period 2 (7 Days)||0
6323|NCT03307252|13480|P6|STARTED|Part 3, Washout Period 2 (7 Days)||0
6324|NCT03307252|13481|P5|STARTED|Part 3, Washout Period 2 (7 Days)||0
6325|NCT03307252|13482|P4|STARTED|Part 3, Washout Period 2 (7 Days)||0
6326|NCT03307252|13483|P3|STARTED|Part 3, Washout Period 2 (7 Days)||0
6327|NCT03307252|13484|P2|STARTED|Part 3, Washout Period 2 (7 Days)||0
6328|NCT03307252|13485|P1|STARTED|Part 3, Washout Period 2 (7 Days)||0
6329|NCT03307252|13475|P11|NOT COMPLETED|Part 3, Period 2||0
6330|NCT03307252|13476|P10|NOT COMPLETED|Part 3, Period 2||0
6331|NCT03307252|13477|P9|NOT COMPLETED|Part 3, Period 2||0
6332|NCT03307252|13478|P8|NOT COMPLETED|Part 3, Period 2||0
6333|NCT03307252|13479|P7|NOT COMPLETED|Part 3, Period 2||0
6334|NCT03307252|13480|P6|NOT COMPLETED|Part 3, Period 2||0
6335|NCT03307252|13481|P5|NOT COMPLETED|Part 3, Period 2||0
6336|NCT03307252|13482|P4|NOT COMPLETED|Part 3, Period 2||0
6337|NCT03307252|13483|P3|NOT COMPLETED|Part 3, Period 2||0
6338|NCT03307252|13484|P2|NOT COMPLETED|Part 3, Period 2||0
6339|NCT03307252|13485|P1|NOT COMPLETED|Part 3, Period 2||0
6340|NCT03307252|13475|P11|COMPLETED|Part 3, Period 2||4
6341|NCT03307252|13476|P10|COMPLETED|Part 3, Period 2||4
6342|NCT03307252|13477|P9|COMPLETED|Part 3, Period 2||4
6343|NCT03307252|13478|P8|COMPLETED|Part 3, Period 2||4
6344|NCT03307252|13479|P7|COMPLETED|Part 3, Period 2||0
6345|NCT03307252|13480|P6|COMPLETED|Part 3, Period 2||0
6346|NCT03307252|13481|P5|COMPLETED|Part 3, Period 2||0
6347|NCT03307252|13482|P4|COMPLETED|Part 3, Period 2||0
6348|NCT03307252|13483|P3|COMPLETED|Part 3, Period 2||0
6349|NCT03307252|13484|P2|COMPLETED|Part 3, Period 2||0
6350|NCT03307252|13485|P1|COMPLETED|Part 3, Period 2||0
6351|NCT03307252|13475|P11|STARTED|Part 3, Period 2||4
6352|NCT03307252|13476|P10|STARTED|Part 3, Period 2||4
6353|NCT03307252|13477|P9|STARTED|Part 3, Period 2||4
6354|NCT03307252|13478|P8|STARTED|Part 3, Period 2||4
6355|NCT03307252|13479|P7|STARTED|Part 3, Period 2||0
6356|NCT03307252|13480|P6|STARTED|Part 3, Period 2||0
6357|NCT03307252|13481|P5|STARTED|Part 3, Period 2||0
6358|NCT03307252|13482|P4|STARTED|Part 3, Period 2||0
6359|NCT03307252|13483|P3|STARTED|Part 3, Period 2||0
6360|NCT03307252|13484|P2|STARTED|Part 3, Period 2||0
6361|NCT03307252|13485|P1|STARTED|Part 3, Period 2||0
6362|NCT03307252|13475|P11|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6363|NCT03307252|13476|P10|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6364|NCT03307252|13477|P9|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6365|NCT03307252|13478|P8|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6366|NCT03307252|13479|P7|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6367|NCT03307252|13480|P6|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6368|NCT03307252|13481|P5|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6369|NCT03307252|13482|P4|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6370|NCT03307252|13483|P3|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6371|NCT03307252|13484|P2|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6372|NCT03307252|13485|P1|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6373|NCT03307252|13475|P11|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
6374|NCT03307252|13476|P10|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
6375|NCT03307252|13477|P9|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
6376|NCT03307252|13478|P8|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
6377|NCT03307252|13479|P7|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6378|NCT03307252|13480|P6|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6379|NCT03307252|13481|P5|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6380|NCT03307252|13482|P4|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6381|NCT03307252|13483|P3|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6382|NCT03307252|13484|P2|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6383|NCT03307252|13485|P1|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6384|NCT03307252|13475|P11|STARTED|Part 3, Washout Period 1 (7 Days)||4
6385|NCT03307252|13476|P10|STARTED|Part 3, Washout Period 1 (7 Days)||4
6386|NCT03307252|13477|P9|STARTED|Part 3, Washout Period 1 (7 Days)||4
6387|NCT03307252|13478|P8|STARTED|Part 3, Washout Period 1 (7 Days)||4
6388|NCT03307252|13479|P7|STARTED|Part 3, Washout Period 1 (7 Days)||0
6389|NCT03307252|13480|P6|STARTED|Part 3, Washout Period 1 (7 Days)||0
6390|NCT03307252|13481|P5|STARTED|Part 3, Washout Period 1 (7 Days)||0
6391|NCT03307252|13482|P4|STARTED|Part 3, Washout Period 1 (7 Days)||0
6392|NCT03307252|13483|P3|STARTED|Part 3, Washout Period 1 (7 Days)||0
6393|NCT03307252|13484|P2|STARTED|Part 3, Washout Period 1 (7 Days)||0
6394|NCT03307252|13485|P1|STARTED|Part 3, Washout Period 1 (7 Days)||0
6395|NCT03307252|13475|P11|NOT COMPLETED|Part 3, Period 1||0
6396|NCT03307252|13476|P10|NOT COMPLETED|Part 3, Period 1||0
6397|NCT03307252|13477|P9|NOT COMPLETED|Part 3, Period 1||0
6398|NCT03307252|13478|P8|NOT COMPLETED|Part 3, Period 1||0
6399|NCT03307252|13479|P7|NOT COMPLETED|Part 3, Period 1||0
6400|NCT03307252|13480|P6|NOT COMPLETED|Part 3, Period 1||0
6401|NCT03307252|13481|P5|NOT COMPLETED|Part 3, Period 1||0
6402|NCT03307252|13482|P4|NOT COMPLETED|Part 3, Period 1||0
6403|NCT03307252|13483|P3|NOT COMPLETED|Part 3, Period 1||0
6404|NCT03307252|13484|P2|NOT COMPLETED|Part 3, Period 1||0
6405|NCT03307252|13485|P1|NOT COMPLETED|Part 3, Period 1||0
6406|NCT03307252|13475|P11|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
6407|NCT03307252|13476|P10|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
6408|NCT03307252|13477|P9|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
6409|NCT03307252|13478|P8|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
6410|NCT03307252|13479|P7|COMPLETED|Part 3, Period 1||0
6411|NCT03307252|13480|P6|COMPLETED|Part 3, Period 1||0
6412|NCT03307252|13481|P5|COMPLETED|Part 3, Period 1||0
6413|NCT03307252|13482|P4|COMPLETED|Part 3, Period 1||0
6414|NCT03307252|13483|P3|COMPLETED|Part 3, Period 1||0
6415|NCT03307252|13484|P2|COMPLETED|Part 3, Period 1||0
6416|NCT03307252|13485|P1|COMPLETED|Part 3, Period 1||0
6417|NCT03307252|13475|P11|STARTED|Part 3, Period 1||4
6418|NCT03307252|13476|P10|STARTED|Part 3, Period 1||4
6419|NCT03307252|13477|P9|STARTED|Part 3, Period 1||4
6420|NCT03307252|13478|P8|STARTED|Part 3, Period 1||4
6421|NCT03307252|13479|P7|STARTED|Part 3, Period 1||0
6422|NCT03307252|13480|P6|STARTED|Part 3, Period 1||0
6423|NCT03307252|13481|P5|STARTED|Part 3, Period 1||0
6424|NCT03307252|13482|P4|STARTED|Part 3, Period 1||0
6425|NCT03307252|13483|P3|STARTED|Part 3, Period 1||0
6426|NCT03307252|13484|P2|STARTED|Part 3, Period 1||0
6427|NCT03307252|13485|P1|STARTED|Part 3, Period 1||0
6428|NCT03307252|13475|P11|NOT COMPLETED|Part 2, Period 4||0
6429|NCT03307252|13476|P10|NOT COMPLETED|Part 2, Period 4||0
6430|NCT03307252|13477|P9|NOT COMPLETED|Part 2, Period 4||0
6431|NCT03307252|13478|P8|NOT COMPLETED|Part 2, Period 4||0
6432|NCT03307252|13479|P7|NOT COMPLETED|Part 2, Period 4||1
6433|NCT03307252|13480|P6|NOT COMPLETED|Part 2, Period 4||0
6434|NCT03307252|13481|P5|NOT COMPLETED|Part 2, Period 4||0
6435|NCT03307252|13482|P4|NOT COMPLETED|Part 2, Period 4||0
6436|NCT03307252|13483|P3|NOT COMPLETED|Part 2, Period 4||0
6437|NCT03307252|13484|P2|NOT COMPLETED|Part 2, Period 4||0
6438|NCT03307252|13485|P1|NOT COMPLETED|Part 2, Period 4||0
6439|NCT03307252|13475|P11|COMPLETED|Part 2, Period 4||0
6440|NCT03307252|13476|P10|COMPLETED|Part 2, Period 4||0
6441|NCT03307252|13477|P9|COMPLETED|Part 2, Period 4||0
6442|NCT03307252|13478|P8|COMPLETED|Part 2, Period 4||0
6443|NCT03307252|13479|P7|COMPLETED|Part 2, Period 4||4
6444|NCT03307252|13480|P6|COMPLETED|Part 2, Period 4||3
6445|NCT03307252|13481|P5|COMPLETED|Part 2, Period 4||3
6446|NCT03307252|13482|P4|COMPLETED|Part 2, Period 4||4
6447|NCT03307252|13483|P3|COMPLETED|Part 2, Period 4||0
6448|NCT03307252|13484|P2|COMPLETED|Part 2, Period 4||0
6449|NCT03307252|13485|P1|COMPLETED|Part 2, Period 4||0
6450|NCT03307252|13475|P11|STARTED|Part 2, Period 4||0
6451|NCT03307252|13476|P10|STARTED|Part 2, Period 4||0
6452|NCT03307252|13477|P9|STARTED|Part 2, Period 4||0
6453|NCT03307252|13478|P8|STARTED|Part 2, Period 4||0
6454|NCT03307252|13479|P7|STARTED|Part 2, Period 4||5
6455|NCT03307252|13480|P6|STARTED|Part 2, Period 4||3
6456|NCT03307252|13481|P5|STARTED|Part 2, Period 4||3
6457|NCT03307252|13482|P4|STARTED|Part 2, Period 4||4
6458|NCT03307252|13483|P3|STARTED|Part 2, Period 4||0
6459|NCT03307252|13484|P2|STARTED|Part 2, Period 4||0
6460|NCT03307252|13485|P1|STARTED|Part 2, Period 4||0
6461|NCT03307252|13475|P11|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6462|NCT03307252|13476|P10|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6463|NCT03307252|13477|P9|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6464|NCT03307252|13478|P8|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6465|NCT03307252|13479|P7|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||1
6466|NCT03307252|13480|P6|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6467|NCT03307252|13481|P5|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6468|NCT03307252|13482|P4|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6469|NCT03307252|13483|P3|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6470|NCT03307252|13484|P2|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6471|NCT03307252|13485|P1|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6472|NCT03307252|13475|P11|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6473|NCT03307252|13476|P10|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6474|NCT03307252|13477|P9|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6475|NCT03307252|13478|P8|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6476|NCT03307252|13479|P7|COMPLETED|Part 2, Washout Period 3 (7 Days)||4
6477|NCT03307252|13480|P6|COMPLETED|Part 2, Washout Period 3 (7 Days)||3
6478|NCT03307252|13481|P5|COMPLETED|Part 2, Washout Period 3 (7 Days)||3
6479|NCT03307252|13482|P4|COMPLETED|Part 2, Washout Period 3 (7 Days)||4
6480|NCT03307252|13483|P3|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6481|NCT03307252|13484|P2|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6482|NCT03307252|13485|P1|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6483|NCT03307252|13475|P11|STARTED|Part 2, Washout Period 3 (7 Days)||0
6484|NCT03307252|13476|P10|STARTED|Part 2, Washout Period 3 (7 Days)||0
6485|NCT03307252|13477|P9|STARTED|Part 2, Washout Period 3 (7 Days)||0
6486|NCT03307252|13478|P8|STARTED|Part 2, Washout Period 3 (7 Days)||0
6487|NCT03307252|13479|P7|STARTED|Part 2, Washout Period 3 (7 Days)||5
6488|NCT03307252|13480|P6|STARTED|Part 2, Washout Period 3 (7 Days)||3
6489|NCT03307252|13481|P5|STARTED|Part 2, Washout Period 3 (7 Days)||3
6490|NCT03307252|13482|P4|STARTED|Part 2, Washout Period 3 (7 Days)||4
6491|NCT03307252|13483|P3|STARTED|Part 2, Washout Period 3 (7 Days)||0
6492|NCT03307252|13484|P2|STARTED|Part 2, Washout Period 3 (7 Days)||0
6493|NCT03307252|13485|P1|STARTED|Part 2, Washout Period 3 (7 Days)||0
6494|NCT03307252|13475|P11|NOT COMPLETED|Part 2, Period 3||0
6495|NCT03307252|13476|P10|NOT COMPLETED|Part 2, Period 3||0
6496|NCT03307252|13477|P9|NOT COMPLETED|Part 2, Period 3||0
6497|NCT03307252|13478|P8|NOT COMPLETED|Part 2, Period 3||0
6498|NCT03307252|13479|P7|NOT COMPLETED|Part 2, Period 3||0
6499|NCT03307252|13480|P6|NOT COMPLETED|Part 2, Period 3||0
6500|NCT03307252|13481|P5|NOT COMPLETED|Part 2, Period 3||1
6501|NCT03307252|13482|P4|NOT COMPLETED|Part 2, Period 3||0
6502|NCT03307252|13483|P3|NOT COMPLETED|Part 2, Period 3||0
6503|NCT03307252|13484|P2|NOT COMPLETED|Part 2, Period 3||0
6504|NCT03307252|13485|P1|NOT COMPLETED|Part 2, Period 3||0
6505|NCT03307252|13475|P11|COMPLETED|Part 2, Period 3||0
6506|NCT03307252|13476|P10|COMPLETED|Part 2, Period 3||0
6507|NCT03307252|13477|P9|COMPLETED|Part 2, Period 3||0
6508|NCT03307252|13478|P8|COMPLETED|Part 2, Period 3||0
6509|NCT03307252|13479|P7|COMPLETED|Part 2, Period 3||5
6510|NCT03307252|13480|P6|COMPLETED|Part 2, Period 3||3
6511|NCT03307252|13481|P5|COMPLETED|Part 2, Period 3||3
6512|NCT03307252|13482|P4|COMPLETED|Part 2, Period 3||4
6513|NCT03307252|13483|P3|COMPLETED|Part 2, Period 3||0
6514|NCT03307252|13484|P2|COMPLETED|Part 2, Period 3||0
6515|NCT03307252|13485|P1|COMPLETED|Part 2, Period 3||0
6516|NCT03307252|13475|P11|STARTED|Part 2, Period 3||0
6517|NCT03307252|13476|P10|STARTED|Part 2, Period 3||0
6518|NCT03307252|13477|P9|STARTED|Part 2, Period 3||0
6519|NCT03307252|13478|P8|STARTED|Part 2, Period 3||0
6520|NCT03307252|13479|P7|STARTED|Part 2, Period 3||5
6521|NCT03307252|13480|P6|STARTED|Part 2, Period 3||3
6522|NCT03307252|13481|P5|STARTED|Part 2, Period 3||4
6523|NCT03307252|13482|P4|STARTED|Part 2, Period 3||4
6524|NCT03307252|13483|P3|STARTED|Part 2, Period 3||0
6525|NCT03307252|13484|P2|STARTED|Part 2, Period 3||0
6526|NCT03307252|13485|P1|STARTED|Part 2, Period 3||0
6527|NCT03307252|13475|P11|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6528|NCT03307252|13476|P10|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6529|NCT03307252|13477|P9|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6530|NCT03307252|13478|P8|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6531|NCT03307252|13479|P7|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6532|NCT03307252|13480|P6|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6533|NCT03307252|13481|P5|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6534|NCT03307252|13482|P4|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6535|NCT03307252|13483|P3|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6536|NCT03307252|13484|P2|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6537|NCT03307252|13485|P1|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6538|NCT03307252|13475|P11|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6539|NCT03307252|13476|P10|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6540|NCT03307252|13477|P9|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6541|NCT03307252|13478|P8|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6542|NCT03307252|13479|P7|COMPLETED|Part 2, Washout Period 2 (7 Days)||5
6543|NCT03307252|13480|P6|COMPLETED|Part 2, Washout Period 2 (7 Days)||3
6544|NCT03307252|13481|P5|COMPLETED|Part 2, Washout Period 2 (7 Days)||4
6545|NCT03307252|13482|P4|COMPLETED|Part 2, Washout Period 2 (7 Days)||4
6546|NCT03307252|13483|P3|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6547|NCT03307252|13484|P2|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6548|NCT03307252|13485|P1|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6549|NCT03307252|13475|P11|STARTED|Part 2, Washout Period 2 (7 Days)||0
6550|NCT03307252|13476|P10|STARTED|Part 2, Washout Period 2 (7 Days)||0
6551|NCT03307252|13477|P9|STARTED|Part 2, Washout Period 2 (7 Days)||0
6552|NCT03307252|13478|P8|STARTED|Part 2, Washout Period 2 (7 Days)||0
6553|NCT03307252|13479|P7|STARTED|Part 2, Washout Period 2 (7 Days)||5
6554|NCT03307252|13480|P6|STARTED|Part 2, Washout Period 2 (7 Days)||3
6555|NCT03307252|13481|P5|STARTED|Part 2, Washout Period 2 (7 Days)||4
6556|NCT03307252|13482|P4|STARTED|Part 2, Washout Period 2 (7 Days)||4
6557|NCT03307252|13483|P3|STARTED|Part 2, Washout Period 2 (7 Days)||0
6558|NCT03307252|13484|P2|STARTED|Part 2, Washout Period 2 (7 Days)||0
6559|NCT03307252|13485|P1|STARTED|Part 2, Washout Period 2 (7 Days)||0
6560|NCT03307252|13475|P11|NOT COMPLETED|Part 2, Period 2||0
6561|NCT03307252|13476|P10|NOT COMPLETED|Part 2, Period 2||0
6562|NCT03307252|13477|P9|NOT COMPLETED|Part 2, Period 2||0
6563|NCT03307252|13478|P8|NOT COMPLETED|Part 2, Period 2||0
6564|NCT03307252|13479|P7|NOT COMPLETED|Part 2, Period 2||0
6565|NCT03307252|13480|P6|NOT COMPLETED|Part 2, Period 2||0
6566|NCT03307252|13481|P5|NOT COMPLETED|Part 2, Period 2||0
6567|NCT03307252|13482|P4|NOT COMPLETED|Part 2, Period 2||0
6568|NCT03307252|13483|P3|NOT COMPLETED|Part 2, Period 2||0
6569|NCT03307252|13484|P2|NOT COMPLETED|Part 2, Period 2||0
6570|NCT03307252|13485|P1|NOT COMPLETED|Part 2, Period 2||0
6571|NCT03307252|13475|P11|COMPLETED|Part 2, Period 2||0
6572|NCT03307252|13476|P10|COMPLETED|Part 2, Period 2||0
6573|NCT03307252|13477|P9|COMPLETED|Part 2, Period 2||0
6574|NCT03307252|13478|P8|COMPLETED|Part 2, Period 2||0
6575|NCT03307252|13479|P7|COMPLETED|Part 2, Period 2||5
6576|NCT03307252|13480|P6|COMPLETED|Part 2, Period 2||3
6577|NCT03307252|13481|P5|COMPLETED|Part 2, Period 2||4
6578|NCT03307252|13482|P4|COMPLETED|Part 2, Period 2||4
6579|NCT03307252|13483|P3|COMPLETED|Part 2, Period 2||0
6580|NCT03307252|13484|P2|COMPLETED|Part 2, Period 2||0
6581|NCT03307252|13485|P1|COMPLETED|Part 2, Period 2||0
6582|NCT03307252|13475|P11|STARTED|Part 2, Period 2||0
6583|NCT03307252|13476|P10|STARTED|Part 2, Period 2||0
6584|NCT03307252|13477|P9|STARTED|Part 2, Period 2||0
6585|NCT03307252|13478|P8|STARTED|Part 2, Period 2||0
6586|NCT03307252|13479|P7|STARTED|Part 2, Period 2||5
6587|NCT03307252|13480|P6|STARTED|Part 2, Period 2||3
6588|NCT03307252|13481|P5|STARTED|Part 2, Period 2||4
6589|NCT03307252|13482|P4|STARTED|Part 2, Period 2||4
6590|NCT03307252|13483|P3|STARTED|Part 2, Period 2||0
6591|NCT03307252|13484|P2|STARTED|Part 2, Period 2||0
6592|NCT03307252|13485|P1|STARTED|Part 2, Period 2||0
6593|NCT03307252|13475|P11|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6594|NCT03307252|13476|P10|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6595|NCT03307252|13477|P9|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6596|NCT03307252|13478|P8|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6597|NCT03307252|13479|P7|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6598|NCT03307252|13480|P6|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6599|NCT03307252|13481|P5|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6600|NCT03307252|13482|P4|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6601|NCT03307252|13483|P3|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6602|NCT03307252|13484|P2|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6603|NCT03307252|13485|P1|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6604|NCT03307252|13475|P11|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6605|NCT03307252|13476|P10|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6606|NCT03307252|13477|P9|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6607|NCT03307252|13478|P8|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6608|NCT03307252|13479|P7|COMPLETED|Part 2, Washout Period 1 (7 Days)||5
6609|NCT03307252|13480|P6|COMPLETED|Part 2, Washout Period 1 (7 Days)||3
6610|NCT03307252|13481|P5|COMPLETED|Part 2, Washout Period 1 (7 Days)||4
6611|NCT03307252|13482|P4|COMPLETED|Part 2, Washout Period 1 (7 Days)||4
6612|NCT03307252|13483|P3|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6613|NCT03307252|13484|P2|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6614|NCT03307252|13485|P1|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6615|NCT03307252|13475|P11|STARTED|Part 2, Washout Period 1 (7 Days)||0
6616|NCT03307252|13476|P10|STARTED|Part 2, Washout Period 1 (7 Days)||0
6617|NCT03307252|13477|P9|STARTED|Part 2, Washout Period 1 (7 Days)||0
6618|NCT03307252|13478|P8|STARTED|Part 2, Washout Period 1 (7 Days)||0
6619|NCT03307252|13479|P7|STARTED|Part 2, Washout Period 1 (7 Days)||5
6620|NCT03307252|13480|P6|STARTED|Part 2, Washout Period 1 (7 Days)||3
6621|NCT03307252|13481|P5|STARTED|Part 2, Washout Period 1 (7 Days)||4
6622|NCT03307252|13482|P4|STARTED|Part 2, Washout Period 1 (7 Days)||4
6623|NCT03307252|13483|P3|STARTED|Part 2, Washout Period 1 (7 Days)||0
6624|NCT03307252|13484|P2|STARTED|Part 2, Washout Period 1 (7 Days)||0
6625|NCT03307252|13485|P1|STARTED|Part 2, Washout Period 1 (7 Days)||0
6626|NCT03307252|13475|P11|NOT COMPLETED|Part 2, Period 1||0
6627|NCT03307252|13476|P10|NOT COMPLETED|Part 2, Period 1||0
6628|NCT03307252|13477|P9|NOT COMPLETED|Part 2, Period 1||0
6629|NCT03307252|13478|P8|NOT COMPLETED|Part 2, Period 1||0
6630|NCT03307252|13479|P7|NOT COMPLETED|Part 2, Period 1||0
6631|NCT03307252|13480|P6|NOT COMPLETED|Part 2, Period 1||1
6632|NCT03307252|13481|P5|NOT COMPLETED|Part 2, Period 1||0
6633|NCT03307252|13482|P4|NOT COMPLETED|Part 2, Period 1||0
6634|NCT03307252|13483|P3|NOT COMPLETED|Part 2, Period 1||0
6635|NCT03307252|13484|P2|NOT COMPLETED|Part 2, Period 1||0
6636|NCT03307252|13485|P1|NOT COMPLETED|Part 2, Period 1||0
6637|NCT03307252|13475|P11|COMPLETED|Part 2, Period 1||0
6638|NCT03307252|13476|P10|COMPLETED|Part 2, Period 1||0
6639|NCT03307252|13477|P9|COMPLETED|Part 2, Period 1||0
6640|NCT03307252|13478|P8|COMPLETED|Part 2, Period 1||0
6641|NCT03307252|13479|P7|COMPLETED|Part 2, Period 1||5
6642|NCT03307252|13480|P6|COMPLETED|Part 2, Period 1||3
6643|NCT03307252|13481|P5|COMPLETED|Part 2, Period 1||4
6644|NCT03307252|13482|P4|COMPLETED|Part 2, Period 1||4
6645|NCT03307252|13483|P3|COMPLETED|Part 2, Period 1||0
6646|NCT03307252|13484|P2|COMPLETED|Part 2, Period 1||0
6647|NCT03307252|13485|P1|COMPLETED|Part 2, Period 1||0
6648|NCT03307252|13475|P11|STARTED|Part 2, Period 1||0
6649|NCT03307252|13476|P10|STARTED|Part 2, Period 1||0
6650|NCT03307252|13477|P9|STARTED|Part 2, Period 1||0
6651|NCT03307252|13478|P8|STARTED|Part 2, Period 1||0
6652|NCT03307252|13479|P7|STARTED|Part 2, Period 1|Participants randomized in Part 2|5
6653|NCT03307252|13480|P6|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
6654|NCT03307252|13481|P5|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
6655|NCT03307252|13482|P4|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
6656|NCT03307252|13483|P3|STARTED|Part 2, Period 1||0
6657|NCT03307252|13484|P2|STARTED|Part 2, Period 1||0
6658|NCT03307252|13485|P1|STARTED|Part 2, Period 1||0
6659|NCT03307252|13475|P11|NOT COMPLETED|Part 1, Period 3||0
6660|NCT03307252|13476|P10|NOT COMPLETED|Part 1, Period 3||0
6661|NCT03307252|13477|P9|NOT COMPLETED|Part 1, Period 3||0
6662|NCT03307252|13478|P8|NOT COMPLETED|Part 1, Period 3||0
6663|NCT03307252|13479|P7|NOT COMPLETED|Part 1, Period 3||0
6664|NCT03307252|13480|P6|NOT COMPLETED|Part 1, Period 3||0
6665|NCT03307252|13481|P5|NOT COMPLETED|Part 1, Period 3||0
6666|NCT03307252|13482|P4|NOT COMPLETED|Part 1, Period 3||0
6667|NCT03307252|13483|P3|NOT COMPLETED|Part 1, Period 3||0
6668|NCT03307252|13484|P2|NOT COMPLETED|Part 1, Period 3||0
6669|NCT03307252|13485|P1|NOT COMPLETED|Part 1, Period 3||0
6670|NCT03307252|13475|P11|COMPLETED|Part 1, Period 3||0
6671|NCT03307252|13476|P10|COMPLETED|Part 1, Period 3||0
6672|NCT03307252|13477|P9|COMPLETED|Part 1, Period 3||0
6673|NCT03307252|13478|P8|COMPLETED|Part 1, Period 3||0
6674|NCT03307252|13479|P7|COMPLETED|Part 1, Period 3||0
6675|NCT03307252|13480|P6|COMPLETED|Part 1, Period 3||0
6676|NCT03307252|13481|P5|COMPLETED|Part 1, Period 3||0
6677|NCT03307252|13482|P4|COMPLETED|Part 1, Period 3||0
6678|NCT03307252|13483|P3|COMPLETED|Part 1, Period 3||4
6679|NCT03307252|13484|P2|COMPLETED|Part 1, Period 3||4
6680|NCT03307252|13485|P1|COMPLETED|Part 1, Period 3||4
6681|NCT03307252|13475|P11|STARTED|Part 1, Period 3||0
6682|NCT03307252|13476|P10|STARTED|Part 1, Period 3||0
6683|NCT03307252|13477|P9|STARTED|Part 1, Period 3||0
6684|NCT03307252|13478|P8|STARTED|Part 1, Period 3||0
6685|NCT03307252|13479|P7|STARTED|Part 1, Period 3||0
6686|NCT03307252|13480|P6|STARTED|Part 1, Period 3||0
6687|NCT03307252|13481|P5|STARTED|Part 1, Period 3||0
6688|NCT03307252|13482|P4|STARTED|Part 1, Period 3||0
6689|NCT03307252|13483|P3|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
6690|NCT03307252|13484|P2|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
6691|NCT03307252|13485|P1|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
6692|NCT03307252|13475|P11|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6693|NCT03307252|13476|P10|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6694|NCT03307252|13477|P9|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6695|NCT03307252|13478|P8|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6696|NCT03307252|13479|P7|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6697|NCT03307252|13480|P6|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6698|NCT03307252|13481|P5|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6699|NCT03307252|13482|P4|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6700|NCT03307252|13483|P3|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6701|NCT03307252|13484|P2|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6702|NCT03307252|13485|P1|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6703|NCT03307252|13475|P11|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6704|NCT03307252|13476|P10|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6705|NCT03307252|13477|P9|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6706|NCT03307252|13478|P8|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6707|NCT03307252|13479|P7|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6708|NCT03307252|13480|P6|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6709|NCT03307252|13481|P5|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6710|NCT03307252|13482|P4|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6711|NCT03307252|13483|P3|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
6712|NCT03307252|13484|P2|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
6713|NCT03307252|13485|P1|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
6714|NCT03307252|13475|P11|STARTED|Part 1, Washout Period 2 (13 Days)||0
6715|NCT03307252|13476|P10|STARTED|Part 1, Washout Period 2 (13 Days)||0
6716|NCT03307252|13477|P9|STARTED|Part 1, Washout Period 2 (13 Days)||0
6717|NCT03307252|13478|P8|STARTED|Part 1, Washout Period 2 (13 Days)||0
6718|NCT03307252|13479|P7|STARTED|Part 1, Washout Period 2 (13 Days)||0
6719|NCT03307252|13480|P6|STARTED|Part 1, Washout Period 2 (13 Days)||0
6720|NCT03307252|13481|P5|STARTED|Part 1, Washout Period 2 (13 Days)||0
6721|NCT03307252|13482|P4|STARTED|Part 1, Washout Period 2 (13 Days)||0
6722|NCT03307252|13483|P3|STARTED|Part 1, Washout Period 2 (13 Days)||4
6723|NCT03307252|13484|P2|STARTED|Part 1, Washout Period 2 (13 Days)||4
6724|NCT03307252|13485|P1|STARTED|Part 1, Washout Period 2 (13 Days)||4
6725|NCT03307252|13475|P11|NOT COMPLETED|Part 1, Period 2||0
6726|NCT03307252|13476|P10|NOT COMPLETED|Part 1, Period 2||0
6727|NCT03307252|13477|P9|NOT COMPLETED|Part 1, Period 2||0
6728|NCT03307252|13478|P8|NOT COMPLETED|Part 1, Period 2||0
6729|NCT03307252|13479|P7|NOT COMPLETED|Part 1, Period 2||0
6730|NCT03307252|13480|P6|NOT COMPLETED|Part 1, Period 2||0
6731|NCT03307252|13481|P5|NOT COMPLETED|Part 1, Period 2||0
6732|NCT03307252|13482|P4|NOT COMPLETED|Part 1, Period 2||0
6733|NCT03307252|13483|P3|NOT COMPLETED|Part 1, Period 2||0
6734|NCT03307252|13484|P2|NOT COMPLETED|Part 1, Period 2||0
6735|NCT03307252|13485|P1|NOT COMPLETED|Part 1, Period 2||0
6736|NCT03307252|13475|P11|COMPLETED|Part 1, Period 2||0
6737|NCT03307252|13476|P10|COMPLETED|Part 1, Period 2||0
6738|NCT03307252|13477|P9|COMPLETED|Part 1, Period 2||0
6739|NCT03307252|13478|P8|COMPLETED|Part 1, Period 2||0
6740|NCT03307252|13479|P7|COMPLETED|Part 1, Period 2||0
6741|NCT03307252|13480|P6|COMPLETED|Part 1, Period 2||0
6742|NCT03307252|13481|P5|COMPLETED|Part 1, Period 2||0
6743|NCT03307252|13482|P4|COMPLETED|Part 1, Period 2||0
6744|NCT03307252|13483|P3|COMPLETED|Part 1, Period 2||4
6745|NCT03307252|13484|P2|COMPLETED|Part 1, Period 2||4
6746|NCT03307252|13485|P1|COMPLETED|Part 1, Period 2||4
6747|NCT03307252|13475|P11|STARTED|Part 1, Period 2||0
6748|NCT03307252|13476|P10|STARTED|Part 1, Period 2||0
6749|NCT03307252|13477|P9|STARTED|Part 1, Period 2||0
6750|NCT03307252|13478|P8|STARTED|Part 1, Period 2||0
6751|NCT03307252|13479|P7|STARTED|Part 1, Period 2||0
6752|NCT03307252|13480|P6|STARTED|Part 1, Period 2||0
6753|NCT03307252|13481|P5|STARTED|Part 1, Period 2||0
6754|NCT03307252|13482|P4|STARTED|Part 1, Period 2||0
6755|NCT03307252|13483|P3|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
6756|NCT03307252|13484|P2|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
6757|NCT03307252|13485|P1|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
6758|NCT03307252|13475|P11|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6759|NCT03307252|13476|P10|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6760|NCT03307252|13477|P9|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6761|NCT03307252|13478|P8|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6762|NCT03307252|13479|P7|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6763|NCT03307252|13480|P6|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6764|NCT03307252|13481|P5|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6765|NCT03307252|13482|P4|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6766|NCT03307252|13483|P3|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6767|NCT03307252|13484|P2|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6768|NCT03307252|13485|P1|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6769|NCT03307252|13475|P11|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6770|NCT03307252|13476|P10|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6771|NCT03307252|13477|P9|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6772|NCT03307252|13478|P8|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6773|NCT03307252|13479|P7|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6774|NCT03307252|13480|P6|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6775|NCT03307252|13481|P5|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6776|NCT03307252|13482|P4|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6777|NCT03307252|13483|P3|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
6778|NCT03307252|13484|P2|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
6779|NCT03307252|13485|P1|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
6780|NCT03307252|13475|P11|STARTED|Part 1, Washout Period 1 (13 Days)||0
6781|NCT03307252|13476|P10|STARTED|Part 1, Washout Period 1 (13 Days)||0
6782|NCT03307252|13477|P9|STARTED|Part 1, Washout Period 1 (13 Days)||0
6783|NCT03307252|13478|P8|STARTED|Part 1, Washout Period 1 (13 Days)||0
6784|NCT03307252|13479|P7|STARTED|Part 1, Washout Period 1 (13 Days)||0
6785|NCT03307252|13480|P6|STARTED|Part 1, Washout Period 1 (13 Days)||0
6786|NCT03307252|13481|P5|STARTED|Part 1, Washout Period 1 (13 Days)||0
6787|NCT03307252|13482|P4|STARTED|Part 1, Washout Period 1 (13 Days)||0
6788|NCT03307252|13483|P3|STARTED|Part 1, Washout Period 1 (13 Days)||4
6789|NCT03307252|13484|P2|STARTED|Part 1, Washout Period 1 (13 Days)||4
6790|NCT03307252|13485|P1|STARTED|Part 1, Washout Period 1 (13 Days)||4
6791|NCT03307252|13475|P11|NOT COMPLETED|Part 1, Period 1||0
6792|NCT03307252|13476|P10|NOT COMPLETED|Part 1, Period 1||0
6793|NCT03307252|13477|P9|NOT COMPLETED|Part 1, Period 1||0
6794|NCT03307252|13478|P8|NOT COMPLETED|Part 1, Period 1||0
6795|NCT03307252|13479|P7|NOT COMPLETED|Part 1, Period 1||0
6796|NCT03307252|13480|P6|NOT COMPLETED|Part 1, Period 1||0
6797|NCT03307252|13481|P5|NOT COMPLETED|Part 1, Period 1||0
6798|NCT03307252|13482|P4|NOT COMPLETED|Part 1, Period 1||0
6799|NCT03307252|13483|P3|NOT COMPLETED|Part 1, Period 1||0
6800|NCT03307252|13484|P2|NOT COMPLETED|Part 1, Period 1||0
6801|NCT03307252|13485|P1|NOT COMPLETED|Part 1, Period 1||0
6802|NCT03307252|13475|P11|COMPLETED|Part 1, Period 1||0
6803|NCT03307252|13476|P10|COMPLETED|Part 1, Period 1||0
6804|NCT03307252|13477|P9|COMPLETED|Part 1, Period 1||0
6805|NCT03307252|13478|P8|COMPLETED|Part 1, Period 1||0
6806|NCT03307252|13479|P7|COMPLETED|Part 1, Period 1||0
6807|NCT03307252|13480|P6|COMPLETED|Part 1, Period 1||0
6808|NCT03307252|13481|P5|COMPLETED|Part 1, Period 1||0
6809|NCT03307252|13482|P4|COMPLETED|Part 1, Period 1||0
6810|NCT03307252|13483|P3|COMPLETED|Part 1, Period 1||4
6811|NCT03307252|13484|P2|COMPLETED|Part 1, Period 1||4
6812|NCT03307252|13485|P1|COMPLETED|Part 1, Period 1||4
6813|NCT03307252|13475|P11|STARTED|Part 1, Period 1||0
6814|NCT03307252|13476|P10|STARTED|Part 1, Period 1||0
6815|NCT03307252|13477|P9|STARTED|Part 1, Period 1||0
6816|NCT03307252|13478|P8|STARTED|Part 1, Period 1||0
6817|NCT03307252|13479|P7|STARTED|Part 1, Period 1||0
6818|NCT03307252|13480|P6|STARTED|Part 1, Period 1||0
6819|NCT03307252|13481|P5|STARTED|Part 1, Period 1||0
6820|NCT03307252|13482|P4|STARTED|Part 1, Period 1||0
6821|NCT03307252|13483|P3|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
6822|NCT03307252|13484|P2|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
6823|NCT03307252|13485|P1|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
6824|NCT03306589|13526|P6|NOT COMPLETED|Part 2 (69 Days)||0
6825|NCT03306589|13527|P5|NOT COMPLETED|Part 2 (69 Days)||0
6826|NCT03306589|13528|P4|NOT COMPLETED|Part 2 (69 Days)||0
6827|NCT03306589|13529|P3|NOT COMPLETED|Part 2 (69 Days)||0
6828|NCT03306589|13530|P2|NOT COMPLETED|Part 2 (69 Days)||0
6829|NCT03306589|13531|P1|NOT COMPLETED|Part 2 (69 Days)||0
6830|NCT03306589|13526|P6|COMPLETED|Part 2 (69 Days)||0
6831|NCT03306589|13527|P5|COMPLETED|Part 2 (69 Days)||0
6832|NCT03306589|13528|P4|COMPLETED|Part 2 (69 Days)||0
6833|NCT03306589|13529|P3|COMPLETED|Part 2 (69 Days)||0
6834|NCT03306589|13530|P2|COMPLETED|Part 2 (69 Days)||0
6835|NCT03306589|13531|P1|COMPLETED|Part 2 (69 Days)||0
6836|NCT03306589|13526|P6|STARTED|Part 2 (69 Days)||0
6837|NCT03306589|13527|P5|STARTED|Part 2 (69 Days)||0
6838|NCT03306589|13528|P4|STARTED|Part 2 (69 Days)||0
6839|NCT03306589|13529|P3|STARTED|Part 2 (69 Days)||0
6840|NCT03306589|13530|P2|STARTED|Part 2 (69 Days)||0
6841|NCT03306589|13531|P1|STARTED|Part 2 (69 Days)||0
6842|NCT03306589|13526|P6|NOT COMPLETED|Part 1 (69 Days)||0
6843|NCT03306589|13527|P5|NOT COMPLETED|Part 1 (69 Days)||0
6844|NCT03306589|13528|P4|NOT COMPLETED|Part 1 (69 Days)||0
6845|NCT03306589|13529|P3|NOT COMPLETED|Part 1 (69 Days)||0
6846|NCT03306589|13530|P2|NOT COMPLETED|Part 1 (69 Days)||0
6847|NCT03306589|13531|P1|NOT COMPLETED|Part 1 (69 Days)||0
6848|NCT03306589|13526|P6|COMPLETED|Part 1 (69 Days)||0
6849|NCT03306589|13527|P5|COMPLETED|Part 1 (69 Days)||0
6850|NCT03306589|13528|P4|COMPLETED|Part 1 (69 Days)||4
6851|NCT03306589|13529|P3|COMPLETED|Part 1 (69 Days)||2
6852|NCT03306589|13530|P2|COMPLETED|Part 1 (69 Days)||4
6853|NCT03306589|13531|P1|COMPLETED|Part 1 (69 Days)||2
6854|NCT03306589|13526|P6|STARTED|Part 1 (69 Days)||0
6855|NCT03306589|13527|P5|STARTED|Part 1 (69 Days)||0
6856|NCT03306589|13528|P4|STARTED|Part 1 (69 Days)||4
6857|NCT03306589|13529|P3|STARTED|Part 1 (69 Days)||2
6858|NCT03306589|13530|P2|STARTED|Part 1 (69 Days)||4
6859|NCT03306589|13531|P1|STARTED|Part 1 (69 Days)||2
6860|NCT03306199|13632|P1|NOT COMPLETED|Overall Study||15
6861|NCT03306199|13632|P1|COMPLETED|Overall Study||67
6862|NCT03306199|13632|P1|STARTED|Overall Study||82
6863|NCT03305770|13638|P2|NOT COMPLETED|Overall Study||1
6864|NCT03305770|13639|P1|NOT COMPLETED|Overall Study||1
6865|NCT03305770|13638|P2|COMPLETED|Overall Study||36
6866|NCT03305770|13639|P1|COMPLETED|Overall Study||69
6867|NCT03305770|13638|P2|Completed Analysis Set|Overall Study||36
6868|NCT03305770|13639|P1|Completed Analysis Set|Overall Study||69
6869|NCT03305770|13638|P2|Enrolled Dispensed Analysis Set|Overall Study||36
6870|NCT03305770|13639|P1|Enrolled Dispensed Analysis Set|Overall Study||70
6871|NCT03305770|13638|P2|STARTED|Overall Study||37
6872|NCT03305770|13639|P1|STARTED|Overall Study||70
6873|NCT03305419|13655|P8|NOT COMPLETED|Part B (14 Days)||0
6874|NCT03305419|13656|P7|NOT COMPLETED|Part B (14 Days)||5
6875|NCT03305419|13657|P6|NOT COMPLETED|Part B (14 Days)||10
6876|NCT03305419|13658|P5|NOT COMPLETED|Part B (14 Days)||3
6877|NCT03305419|13659|P4|NOT COMPLETED|Part B (14 Days)||0
6878|NCT03305419|13660|P3|NOT COMPLETED|Part B (14 Days)||0
6879|NCT03305419|13661|P2|NOT COMPLETED|Part B (14 Days)||0
6880|NCT03305419|13662|P1|NOT COMPLETED|Part B (14 Days)||0
6881|NCT03305419|13655|P8|COMPLETED|Part B (14 Days)||0
6882|NCT03305419|13656|P7|COMPLETED|Part B (14 Days)||8
6883|NCT03305419|13657|P6|COMPLETED|Part B (14 Days)||10
6884|NCT03305419|13658|P5|COMPLETED|Part B (14 Days)||11
6885|NCT03305419|13659|P4|COMPLETED|Part B (14 Days)||0
6886|NCT03305419|13660|P3|COMPLETED|Part B (14 Days)||0
6887|NCT03305419|13661|P2|COMPLETED|Part B (14 Days)||0
6888|NCT03305419|13662|P1|COMPLETED|Part B (14 Days)||0
6889|NCT03305419|13655|P8|STARTED|Part B (14 Days)||0
6890|NCT03305419|13656|P7|STARTED|Part B (14 Days)||13
6891|NCT03305419|13657|P6|STARTED|Part B (14 Days)||20
6892|NCT03305419|13658|P5|STARTED|Part B (14 Days)||14
6893|NCT03305419|13659|P4|STARTED|Part B (14 Days)||0
6894|NCT03305419|13660|P3|STARTED|Part B (14 Days)||0
6895|NCT03305419|13661|P2|STARTED|Part B (14 Days)||0
6896|NCT03305419|13662|P1|STARTED|Part B (14 Days)||0
6897|NCT03305419|13655|P8|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6898|NCT03305419|13656|P7|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6899|NCT03305419|13657|P6|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6900|NCT03305419|13658|P5|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6901|NCT03305419|13659|P4|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6902|NCT03305419|13660|P3|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6903|NCT03305419|13661|P2|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6904|NCT03305419|13662|P1|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6905|NCT03305419|13655|P8|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6906|NCT03305419|13656|P7|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6907|NCT03305419|13657|P6|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6908|NCT03305419|13658|P5|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6909|NCT03305419|13659|P4|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
6910|NCT03305419|13660|P3|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
6911|NCT03305419|13661|P2|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
6912|NCT03305419|13662|P1|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
6913|NCT03305419|13655|P8|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
6914|NCT03305419|13656|P7|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
6915|NCT03305419|13657|P6|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
6916|NCT03305419|13658|P5|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
6917|NCT03305419|13659|P4|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
6918|NCT03305419|13660|P3|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
6919|NCT03305419|13661|P2|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
6920|NCT03305419|13662|P1|STARTED|Part A Period 3 (1Day) + Washout (7days)|2 participants were added to GSK2982772 120 mg TID/240 mg TID/360 mg BID arm after Washout Period.|3
6921|NCT03305419|13655|P8|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6922|NCT03305419|13656|P7|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6923|NCT03305419|13657|P6|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6924|NCT03305419|13658|P5|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6925|NCT03305419|13659|P4|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6926|NCT03305419|13660|P3|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6927|NCT03305419|13661|P2|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6928|NCT03305419|13662|P1|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||2
6929|NCT03305419|13655|P8|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6930|NCT03305419|13656|P7|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6931|NCT03305419|13657|P6|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6932|NCT03305419|13658|P5|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6933|NCT03305419|13659|P4|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
6934|NCT03305419|13660|P3|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
6935|NCT03305419|13661|P2|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
6936|NCT03305419|13662|P1|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||1
6937|NCT03305419|13655|P8|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
6938|NCT03305419|13656|P7|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
6939|NCT03305419|13657|P6|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
6940|NCT03305419|13658|P5|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
6941|NCT03305419|13659|P4|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
6942|NCT03305419|13660|P3|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
6943|NCT03305419|13661|P2|STARTED|Part A Period 2 (1Day) + Washout (7days)|1 participant was added to GSK2982772 120 mg TID/240 mg TID/Placebo arm|3
6944|NCT03305419|13662|P1|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
6945|NCT03305419|13655|P8|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6946|NCT03305419|13656|P7|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6947|NCT03305419|13657|P6|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6948|NCT03305419|13658|P5|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6949|NCT03305419|13659|P4|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6950|NCT03305419|13660|P3|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6951|NCT03305419|13661|P2|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||1
6952|NCT03305419|13662|P1|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6953|NCT03305419|13655|P8|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6954|NCT03305419|13656|P7|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6955|NCT03305419|13657|P6|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6956|NCT03305419|13658|P5|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6957|NCT03305419|13659|P4|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
6958|NCT03305419|13660|P3|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
6959|NCT03305419|13661|P2|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||2
6960|NCT03305419|13662|P1|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
6961|NCT03305419|13655|P8|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
6962|NCT03305419|13656|P7|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
6963|NCT03305419|13657|P6|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
6964|NCT03305419|13658|P5|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
6965|NCT03305419|13659|P4|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
6966|NCT03305419|13660|P3|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
6967|NCT03305419|13661|P2|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
6968|NCT03305419|13662|P1|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
6969|NCT03305159|13794|P2|NOT COMPLETED|Overall Study||8
6970|NCT03305159|13795|P1|NOT COMPLETED|Overall Study||3
6971|NCT03305159|13794|P2|COMPLETED|Overall Study||60
6972|NCT03305159|13795|P1|COMPLETED|Overall Study||63
6973|NCT03305159|13794|P2|STARTED|Overall Study||68
6974|NCT03305159|13795|P1|STARTED|Overall Study||66
6975|NCT03305055|13803|P2|NOT COMPLETED|Overall Study||2
6976|NCT03305055|13804|P1|NOT COMPLETED|Overall Study||1
6977|NCT03305055|13803|P2|COMPLETED|Overall Study||0
6978|NCT03305055|13804|P1|COMPLETED|Overall Study||1
6979|NCT03305055|13803|P2|STARTED|Overall Study||2
6980|NCT03305055|13804|P1|STARTED|Overall Study||2
6981|NCT03304119|13822|P2|NOT COMPLETED|Overall Study||0
6982|NCT03304119|13823|P1|NOT COMPLETED|Overall Study||0
6983|NCT03304119|13822|P2|COMPLETED|Overall Study||55
6984|NCT03304119|13823|P1|COMPLETED|Overall Study||37
6985|NCT03304119|13822|P2|STARTED|Overall Study||55
6986|NCT03304119|13823|P1|STARTED|Overall Study||37
6987|NCT03303911|13835|P2|NOT COMPLETED|Overall Study||0
6988|NCT03303911|13836|P1|NOT COMPLETED|Overall Study||0
6989|NCT03303911|13835|P2|COMPLETED|Overall Study||13
6990|NCT03303911|13836|P1|COMPLETED|Overall Study||13
6991|NCT03303911|13835|P2|STARTED|Overall Study||13
6992|NCT03303911|13836|P1|STARTED|Overall Study||13
6993|NCT03303417|13890|P2|NOT COMPLETED|Overall Study||1
6994|NCT03303417|13891|P1|NOT COMPLETED|Overall Study||1
6995|NCT03303417|13890|P2|COMPLETED|Overall Study||7
6996|NCT03303417|13891|P1|COMPLETED|Overall Study||7
6997|NCT03303417|13890|P2|STARTED|Overall Study||8
6998|NCT03303417|13891|P1|STARTED|Overall Study||8
6999|NCT03302936|13907|P2|NOT COMPLETED|Overall Study||4
7000|NCT03302936|13908|P1|NOT COMPLETED|Overall Study||3
7001|NCT03302936|13907|P2|COMPLETED|Overall Study||45
7002|NCT03302936|13908|P1|COMPLETED|Overall Study||46
7003|NCT03302936|13907|P2|STARTED|Overall Study||49
7004|NCT03302936|13908|P1|STARTED|Overall Study||49
7005|NCT03302793|13918|P2|NOT COMPLETED|Overall Study||2
7006|NCT03302793|13919|P1|NOT COMPLETED|Overall Study||0
7007|NCT03302793|13918|P2|COMPLETED|Overall Study||4
7008|NCT03302793|13919|P1|COMPLETED|Overall Study||6
7009|NCT03302793|13918|P2|STARTED|Overall Study||6
7010|NCT03302793|13919|P1|STARTED|Overall Study||6
7011|NCT03302559|13929|P1|NOT COMPLETED|Overall Study||6
7012|NCT03302559|13929|P1|COMPLETED|Overall Study||23
7013|NCT03302559|13929|P1|STARTED|Overall Study||29
7014|NCT03301298|13950|P7|NOT COMPLETED|Fed Conditions||0
7015|NCT03301298|13951|P6|NOT COMPLETED|Fed Conditions||0
7016|NCT03301298|13952|P5|NOT COMPLETED|Fed Conditions||0
7017|NCT03301298|13953|P4|NOT COMPLETED|Fed Conditions||0
7018|NCT03301298|13954|P3|NOT COMPLETED|Fed Conditions||0
7019|NCT03301298|13955|P2|NOT COMPLETED|Fed Conditions||0
7020|NCT03301298|13956|P1|NOT COMPLETED|Fed Conditions||0
7021|NCT03301298|13950|P7|COMPLETED|Fed Conditions||2
7022|NCT03301298|13951|P6|COMPLETED|Fed Conditions||0
7023|NCT03301298|13952|P5|COMPLETED|Fed Conditions||5
7024|NCT03301298|13953|P4|COMPLETED|Fed Conditions||0
7025|NCT03301298|13954|P3|COMPLETED|Fed Conditions||0
7026|NCT03301298|13955|P2|COMPLETED|Fed Conditions||0
7027|NCT03301298|13956|P1|COMPLETED|Fed Conditions||0
7028|NCT03301298|13950|P7|STARTED|Fed Conditions||2
7029|NCT03301298|13951|P6|STARTED|Fed Conditions||0
7030|NCT03301298|13952|P5|STARTED|Fed Conditions||5
7031|NCT03301298|13953|P4|STARTED|Fed Conditions||0
7032|NCT03301298|13954|P3|STARTED|Fed Conditions||0
7033|NCT03301298|13955|P2|STARTED|Fed Conditions||0
7034|NCT03301298|13956|P1|STARTED|Fed Conditions||0
7035|NCT03301298|13950|P7|NOT COMPLETED|Unfed Conditions||0
7036|NCT03301298|13951|P6|NOT COMPLETED|Unfed Conditions||0
7037|NCT03301298|13952|P5|NOT COMPLETED|Unfed Conditions||0
7038|NCT03301298|13953|P4|NOT COMPLETED|Unfed Conditions||0
7039|NCT03301298|13954|P3|NOT COMPLETED|Unfed Conditions||0
7040|NCT03301298|13955|P2|NOT COMPLETED|Unfed Conditions||0
7041|NCT03301298|13956|P1|NOT COMPLETED|Unfed Conditions||0
7042|NCT03301298|13950|P7|COMPLETED|Unfed Conditions||12
7043|NCT03301298|13951|P6|COMPLETED|Unfed Conditions||6
7044|NCT03301298|13952|P5|COMPLETED|Unfed Conditions||6
7045|NCT03301298|13953|P4|COMPLETED|Unfed Conditions||6
7046|NCT03301298|13954|P3|COMPLETED|Unfed Conditions||6
7047|NCT03301298|13955|P2|COMPLETED|Unfed Conditions||6
7048|NCT03301298|13956|P1|COMPLETED|Unfed Conditions||6
7049|NCT03301298|13950|P7|STARTED|Unfed Conditions||12
7050|NCT03301298|13951|P6|STARTED|Unfed Conditions||6
7051|NCT03301298|13952|P5|STARTED|Unfed Conditions||6
7052|NCT03301298|13953|P4|STARTED|Unfed Conditions||6
7053|NCT03301298|13954|P3|STARTED|Unfed Conditions||6
7054|NCT03301298|13955|P2|STARTED|Unfed Conditions||6
7055|NCT03301298|13956|P1|STARTED|Unfed Conditions||6
7056|NCT03300674|13994|P2|NOT COMPLETED|Overall Study||0
7057|NCT03300674|13995|P1|NOT COMPLETED|Overall Study||0
7058|NCT03300674|13994|P2|COMPLETED|Overall Study||77
7059|NCT03300674|13995|P1|COMPLETED|Overall Study||77
7060|NCT03300674|13994|P2|STARTED|Overall Study||77
7061|NCT03300674|13995|P1|STARTED|Overall Study||77
7062|NCT03300024|14007|P2|NOT COMPLETED|Overall Study||6
7063|NCT03300024|14008|P1|NOT COMPLETED|Overall Study||4
7064|NCT03300024|14007|P2|COMPLETED|Overall Study||0
7065|NCT03300024|14008|P1|COMPLETED|Overall Study||0
7066|NCT03300024|14007|P2|STARTED|Overall Study||6
7067|NCT03300024|14008|P1|STARTED|Overall Study||4
7068|NCT03298113|14062|P2|NOT COMPLETED|Overall Study||0
7069|NCT03298113|14063|P1|NOT COMPLETED|Overall Study||0
7070|NCT03298113|14062|P2|COMPLETED|Overall Study||10
7071|NCT03298113|14063|P1|COMPLETED|Overall Study||10
7072|NCT03298113|14062|P2|IAD 2A|Overall Study||6
7073|NCT03298113|14063|P1|IAD 2A|Overall Study||7
7074|NCT03298113|14062|P2|IAD 1A|Overall Study||4
7075|NCT03298113|14063|P1|IAD 1A|Overall Study||3
7076|NCT03298113|14062|P2|STARTED|Overall Study|10 subjects were treated with IAD Hospital Standard Care. Study terminated due to low enrollment.|10
7077|NCT03298113|14063|P1|STARTED|Overall Study|10 subjects were treated w/ Cavilon Advanced Skin Protectant. Study terminated due to low enrollment|10
7078|NCT03297112|14099|P1|NOT COMPLETED|Overall Study||0
7079|NCT03297112|14099|P1|COMPLETED|Overall Study||12
7080|NCT03297112|14099|P1|STARTED|Overall Study||12
7081|NCT03296072|14104|P6|NOT COMPLETED|Treament Period 3||0
7082|NCT03296072|14105|P5|NOT COMPLETED|Treament Period 3||0
7083|NCT03296072|14106|P4|NOT COMPLETED|Treament Period 3||0
7084|NCT03296072|14107|P3|NOT COMPLETED|Treament Period 3||0
7085|NCT03296072|14108|P2|NOT COMPLETED|Treament Period 3||0
7086|NCT03296072|14109|P1|NOT COMPLETED|Treament Period 3||0
7087|NCT03296072|14104|P6|COMPLETED|Treament Period 3||11
7088|NCT03296072|14105|P5|COMPLETED|Treament Period 3||10
7089|NCT03296072|14106|P4|COMPLETED|Treament Period 3||10
7090|NCT03296072|14107|P3|COMPLETED|Treament Period 3||10
7091|NCT03296072|14108|P2|COMPLETED|Treament Period 3||11
7092|NCT03296072|14109|P1|COMPLETED|Treament Period 3||10
7093|NCT03296072|14104|P6|STARTED|Treament Period 3||11
7094|NCT03296072|14105|P5|STARTED|Treament Period 3||10
7095|NCT03296072|14106|P4|STARTED|Treament Period 3||10
7096|NCT03296072|14107|P3|STARTED|Treament Period 3||10
7097|NCT03296072|14108|P2|STARTED|Treament Period 3||11
7098|NCT03296072|14109|P1|STARTED|Treament Period 3||10
7099|NCT03296072|14104|P6|NOT COMPLETED|Treament Period 2: Wash Out Period||0
7100|NCT03296072|14105|P5|NOT COMPLETED|Treament Period 2: Wash Out Period||0
7101|NCT03296072|14106|P4|NOT COMPLETED|Treament Period 2: Wash Out Period||0
7102|NCT03296072|14107|P3|NOT COMPLETED|Treament Period 2: Wash Out Period||0
7103|NCT03296072|14108|P2|NOT COMPLETED|Treament Period 2: Wash Out Period||0
7104|NCT03296072|14109|P1|NOT COMPLETED|Treament Period 2: Wash Out Period||0
7105|NCT03296072|14104|P6|COMPLETED|Treament Period 2: Wash Out Period||11
7106|NCT03296072|14105|P5|COMPLETED|Treament Period 2: Wash Out Period||10
7107|NCT03296072|14106|P4|COMPLETED|Treament Period 2: Wash Out Period||10
7108|NCT03296072|14107|P3|COMPLETED|Treament Period 2: Wash Out Period||10
7109|NCT03296072|14108|P2|COMPLETED|Treament Period 2: Wash Out Period||11
7110|NCT03296072|14109|P1|COMPLETED|Treament Period 2: Wash Out Period||10
7111|NCT03296072|14104|P6|STARTED|Treament Period 2: Wash Out Period||11
7112|NCT03296072|14105|P5|STARTED|Treament Period 2: Wash Out Period||10
7113|NCT03296072|14106|P4|STARTED|Treament Period 2: Wash Out Period||10
7114|NCT03296072|14107|P3|STARTED|Treament Period 2: Wash Out Period||10
7115|NCT03296072|14108|P2|STARTED|Treament Period 2: Wash Out Period||11
7116|NCT03296072|14109|P1|STARTED|Treament Period 2: Wash Out Period||10
7117|NCT03296072|14104|P6|NOT COMPLETED|Treament Period 2||0
7118|NCT03296072|14105|P5|NOT COMPLETED|Treament Period 2||0
7119|NCT03296072|14106|P4|NOT COMPLETED|Treament Period 2||0
7120|NCT03296072|14107|P3|NOT COMPLETED|Treament Period 2||0
7121|NCT03296072|14108|P2|NOT COMPLETED|Treament Period 2||0
7122|NCT03296072|14109|P1|NOT COMPLETED|Treament Period 2||0
7123|NCT03296072|14104|P6|COMPLETED|Treament Period 2||11
7124|NCT03296072|14105|P5|COMPLETED|Treament Period 2||10
7125|NCT03296072|14106|P4|COMPLETED|Treament Period 2||10
7126|NCT03296072|14107|P3|COMPLETED|Treament Period 2||10
7127|NCT03296072|14108|P2|COMPLETED|Treament Period 2||11
7128|NCT03296072|14109|P1|COMPLETED|Treament Period 2||10
7129|NCT03296072|14104|P6|STARTED|Treament Period 2||11
7130|NCT03296072|14105|P5|STARTED|Treament Period 2||10
7131|NCT03296072|14106|P4|STARTED|Treament Period 2||10
7132|NCT03296072|14107|P3|STARTED|Treament Period 2||10
7133|NCT03296072|14108|P2|STARTED|Treament Period 2||11
7134|NCT03296072|14109|P1|STARTED|Treament Period 2||10
7135|NCT03296072|14104|P6|NOT COMPLETED|Treament Period 1: Wash Out Period||0
7136|NCT03296072|14105|P5|NOT COMPLETED|Treament Period 1: Wash Out Period||0
7137|NCT03296072|14106|P4|NOT COMPLETED|Treament Period 1: Wash Out Period||0
7138|NCT03296072|14107|P3|NOT COMPLETED|Treament Period 1: Wash Out Period||0
7139|NCT03296072|14108|P2|NOT COMPLETED|Treament Period 1: Wash Out Period||0
7140|NCT03296072|14109|P1|NOT COMPLETED|Treament Period 1: Wash Out Period||0
7141|NCT03296072|14104|P6|COMPLETED|Treament Period 1: Wash Out Period||11
7142|NCT03296072|14105|P5|COMPLETED|Treament Period 1: Wash Out Period||10
7143|NCT03296072|14106|P4|COMPLETED|Treament Period 1: Wash Out Period||10
7144|NCT03296072|14107|P3|COMPLETED|Treament Period 1: Wash Out Period||10
7145|NCT03296072|14108|P2|COMPLETED|Treament Period 1: Wash Out Period||11
7146|NCT03296072|14109|P1|COMPLETED|Treament Period 1: Wash Out Period||10
7147|NCT03296072|14104|P6|STARTED|Treament Period 1: Wash Out Period||11
7148|NCT03296072|14105|P5|STARTED|Treament Period 1: Wash Out Period||10
7149|NCT03296072|14106|P4|STARTED|Treament Period 1: Wash Out Period||10
7150|NCT03296072|14107|P3|STARTED|Treament Period 1: Wash Out Period||10
7151|NCT03296072|14108|P2|STARTED|Treament Period 1: Wash Out Period||11
7152|NCT03296072|14109|P1|STARTED|Treament Period 1: Wash Out Period||10
7153|NCT03296072|14104|P6|NOT COMPLETED|Treatment Period 1||0
7154|NCT03296072|14105|P5|NOT COMPLETED|Treatment Period 1||0
7155|NCT03296072|14106|P4|NOT COMPLETED|Treatment Period 1||0
7156|NCT03296072|14107|P3|NOT COMPLETED|Treatment Period 1||0
7157|NCT03296072|14108|P2|NOT COMPLETED|Treatment Period 1||0
7158|NCT03296072|14109|P1|NOT COMPLETED|Treatment Period 1||0
7159|NCT03296072|14104|P6|COMPLETED|Treatment Period 1||11
7160|NCT03296072|14105|P5|COMPLETED|Treatment Period 1||10
7161|NCT03296072|14106|P4|COMPLETED|Treatment Period 1||10
7162|NCT03296072|14107|P3|COMPLETED|Treatment Period 1||10
7163|NCT03296072|14108|P2|COMPLETED|Treatment Period 1||11
7164|NCT03296072|14109|P1|COMPLETED|Treatment Period 1||10
7165|NCT03296072|14104|P6|STARTED|Treatment Period 1||11
7166|NCT03296072|14105|P5|STARTED|Treatment Period 1||10
7167|NCT03296072|14106|P4|STARTED|Treatment Period 1||10
7168|NCT03296072|14107|P3|STARTED|Treatment Period 1||10
7169|NCT03296072|14108|P2|STARTED|Treatment Period 1||11
7170|NCT03296072|14109|P1|STARTED|Treatment Period 1||10
7171|NCT03295630|14126|P1|NOT COMPLETED|Overall Study||0
7172|NCT03295630|14126|P1|COMPLETED|Overall Study||20
7173|NCT03295630|14126|P1|STARTED|Overall Study||20
7174|NCT03295266|14133|P2|NOT COMPLETED|Overall Study||0
7175|NCT03295266|14134|P1|NOT COMPLETED|Overall Study||0
7176|NCT03295266|14133|P2|COMPLETED|Overall Study||4
7177|NCT03295266|14134|P1|COMPLETED|Overall Study||5
7178|NCT03295266|14133|P2|STARTED|Overall Study||4
7179|NCT03295266|14134|P1|STARTED|Overall Study||5
7180|NCT03295201|14164|P2|NOT COMPLETED|Overall Study||2
7181|NCT03295201|14165|P1|NOT COMPLETED|Overall Study||1
7182|NCT03295201|14164|P2|COMPLETED|Overall Study||9
7183|NCT03295201|14165|P1|COMPLETED|Overall Study||10
7184|NCT03295201|14164|P2|STARTED|Overall Study||11
7185|NCT03295201|14165|P1|STARTED|Overall Study||11
7186|NCT03294629|14219|P2|NOT COMPLETED|Second Intervention (2 Weeks)||2
7187|NCT03294629|14220|P1|NOT COMPLETED|Second Intervention (2 Weeks)||2
7188|NCT03294629|14219|P2|COMPLETED|Second Intervention (2 Weeks)||13
7189|NCT03294629|14220|P1|COMPLETED|Second Intervention (2 Weeks)||12
7190|NCT03294629|14219|P2|STARTED|Second Intervention (2 Weeks)||15
7191|NCT03294629|14220|P1|STARTED|Second Intervention (2 Weeks)||14
7192|NCT03294629|14219|P2|NOT COMPLETED|First Intervention (2 Weeks)||4
7193|NCT03294629|14220|P1|NOT COMPLETED|First Intervention (2 Weeks)||2
7194|NCT03294629|14219|P2|COMPLETED|First Intervention (2 Weeks)||15
7195|NCT03294629|14220|P1|COMPLETED|First Intervention (2 Weeks)||14
7196|NCT03294629|14219|P2|STARTED|First Intervention (2 Weeks)||19
7197|NCT03294629|14220|P1|STARTED|First Intervention (2 Weeks)||16
7198|NCT03293485|14248|P1|NOT COMPLETED|Overall Study||5
7199|NCT03293485|14248|P1|COMPLETED|Overall Study||78
7200|NCT03293485|14248|P1|Treated|Overall Study||81
7201|NCT03293485|14248|P1|STARTED|Overall Study||83
7202|NCT03293394|14259|P2|NOT COMPLETED|Follow-up (6 Months)||2
7203|NCT03293394|14260|P1|NOT COMPLETED|Follow-up (6 Months)||4
7204|NCT03293394|14259|P2|COMPLETED|Follow-up (6 Months)||8
7205|NCT03293394|14260|P1|COMPLETED|Follow-up (6 Months)||16
7206|NCT03293394|14259|P2|STARTED|Follow-up (6 Months)||10
7207|NCT03293394|14260|P1|STARTED|Follow-up (6 Months)||20
7208|NCT03293394|14259|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
7209|NCT03293394|14260|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
7210|NCT03293394|14259|P2|COMPLETED|First Intervention (2 Weeks)||10
7211|NCT03293394|14260|P1|COMPLETED|First Intervention (2 Weeks)||20
7212|NCT03293394|14259|P2|STARTED|First Intervention (2 Weeks)||10
7213|NCT03293394|14260|P1|STARTED|First Intervention (2 Weeks)||20
7214|NCT03293238|14284|P4|NOT COMPLETED|Overall Study||0
7215|NCT03293238|14285|P3|NOT COMPLETED|Overall Study||0
7216|NCT03293238|14286|P2|NOT COMPLETED|Overall Study||0
7217|NCT03293238|14287|P1|NOT COMPLETED|Overall Study||0
7218|NCT03293238|14284|P4|COMPLETED|Overall Study||14
7219|NCT03293238|14285|P3|COMPLETED|Overall Study||14
7220|NCT03293238|14286|P2|COMPLETED|Overall Study||16
7221|NCT03293238|14287|P1|COMPLETED|Overall Study||19
7222|NCT03293238|14284|P4|STARTED|Overall Study||14
7223|NCT03293238|14285|P3|STARTED|Overall Study||14
7224|NCT03293238|14286|P2|STARTED|Overall Study||16
7225|NCT03293238|14287|P1|STARTED|Overall Study||19
7226|NCT03292692|14307|P2|NOT COMPLETED|Overall Study||38
7227|NCT03292692|14308|P1|NOT COMPLETED|Overall Study||38
7228|NCT03292692|14307|P2|COMPLETED|Overall Study||260
7229|NCT03292692|14308|P1|COMPLETED|Overall Study||264
7230|NCT03292692|14307|P2|STARTED|Overall Study||298
7231|NCT03292692|14308|P1|STARTED|Overall Study||302
7232|NCT03292614|14320|P1|NOT COMPLETED|Overall Study||0
7233|NCT03292614|14320|P1|COMPLETED|Overall Study||25
7234|NCT03292614|14320|P1|STARTED|Overall Study||25
7235|NCT03291613|14324|P1|NOT COMPLETED|Overall Study||1
7236|NCT03291613|14324|P1|COMPLETED|Overall Study||12
7237|NCT03291613|14324|P1|STARTED|Overall Study||13
7238|NCT03291197|14328|P1|NOT COMPLETED|Overall Study||0
7239|NCT03291197|14328|P1|COMPLETED|Overall Study||5
7240|NCT03291197|14328|P1|STARTED|Overall Study||5
7241|NCT03290768|14336|P1|NOT COMPLETED|Overall Study||165
7242|NCT03290768|14336|P1|COMPLETED|Overall Study||193
7243|NCT03290768|14336|P1|STARTED|Overall Study||358
7244|NCT03290300|14347|P1|NOT COMPLETED|Overall Study||3
7245|NCT03290300|14347|P1|COMPLETED|Overall Study||36
7246|NCT03290300|14347|P1|STARTED|Overall Study||39
7247|NCT03289676|14358|P2|NOT COMPLETED|Overall Study||1
7248|NCT03289676|14359|P1|NOT COMPLETED|Overall Study||4
7249|NCT03289676|14358|P2|COMPLETED|Overall Study|Received 80% of the allotted intervention|25
7250|NCT03289676|14359|P1|COMPLETED|Overall Study||23
7251|NCT03289676|14358|P2|STARTED|Overall Study||26
7252|NCT03289676|14359|P1|STARTED|Overall Study||27
7253|NCT03289481|14371|P2|NOT COMPLETED|Overall Study||2
7254|NCT03289481|14372|P1|NOT COMPLETED|Overall Study||2
7255|NCT03289481|14371|P2|COMPLETED|Overall Study||5
7256|NCT03289481|14372|P1|COMPLETED|Overall Study||4
7257|NCT03289481|14371|P2|STARTED|Overall Study||7
7258|NCT03289481|14372|P1|STARTED|Overall Study||6
7259|NCT03288779|14384|P1|NOT COMPLETED|Overall Study||3
7260|NCT03288779|14384|P1|COMPLETED|Overall Study||3
7261|NCT03288779|14384|P1|STARTED|Overall Study||6
7262|NCT03287843|14391|P2|NOT COMPLETED|Overall Study||8
7263|NCT03287843|14392|P1|NOT COMPLETED|Overall Study||15
7264|NCT03287843|14391|P2|COMPLETED|Overall Study||167
7265|NCT03287843|14392|P1|COMPLETED|Overall Study||160
7266|NCT03287843|14391|P2|Lost to Follow up|Overall Study||0
7267|NCT03287843|14392|P1|Lost to Follow up|Overall Study||3
7268|NCT03287843|14391|P2|Excluded|Overall Study|No surgery n=4 R2 resection n=2 Stage IV n=2|8
7269|NCT03287843|14392|P1|Excluded|Overall Study|No surgery n=5 R2 resection n=5 Stage IV n=2|12
7270|NCT03287843|14391|P2|STARTED|Overall Study||175
7271|NCT03287843|14392|P1|STARTED|Overall Study||175
7272|NCT03287791|14407|P3|NOT COMPLETED|Overall Study||36
7273|NCT03287791|14408|P2|NOT COMPLETED|Overall Study||36
7274|NCT03287791|14409|P1|NOT COMPLETED|Overall Study||32
7275|NCT03287791|14407|P3|COMPLETED|Overall Study||264
7276|NCT03287791|14408|P2|COMPLETED|Overall Study||276
7277|NCT03287791|14409|P1|COMPLETED|Overall Study||280
7278|NCT03287791|14407|P3|PP Population|Overall Study||245
7279|NCT03287791|14408|P2|PP Population|Overall Study||259
7280|NCT03287791|14409|P1|PP Population|Overall Study||262
7281|NCT03287791|14407|P3|mITT Population|Overall Study||283
7282|NCT03287791|14408|P2|mITT Population|Overall Study||291
7283|NCT03287791|14409|P1|mITT Population|Overall Study||291
7284|NCT03287791|14407|P3|Safety Population|Overall Study||291
7285|NCT03287791|14408|P2|Safety Population|Overall Study||297
7286|NCT03287791|14409|P1|Safety Population|Overall Study||306
7287|NCT03287791|14407|P3|STARTED|Overall Study||300
7288|NCT03287791|14408|P2|STARTED|Overall Study||312
7289|NCT03287791|14409|P1|STARTED|Overall Study||312
7290|NCT03286283|14420|P1|NOT COMPLETED|Overall Study||0
7291|NCT03286283|14420|P1|COMPLETED|Overall Study||55
7292|NCT03286283|14420|P1|STARTED|Overall Study||55
7293|NCT03285984|14436|P1|NOT COMPLETED|Overall Study||0
7294|NCT03285984|14436|P1|COMPLETED|Overall Study||56
7295|NCT03285984|14436|P1|Received Test Product 4|Overall Study||56
7296|NCT03285984|14436|P1|Received Test Product 3|Overall Study||56
7297|NCT03285984|14436|P1|Received Test Product 2|Overall Study||56
7298|NCT03285984|14436|P1|Received Test Product 1|Overall Study||56
7299|NCT03285984|14436|P1|STARTED|Overall Study||56
7300|NCT03285724|14448|P1|NOT COMPLETED|Overall Study||0
7301|NCT03285724|14448|P1|COMPLETED|Overall Study||1
7302|NCT03285724|14448|P1|STARTED|Overall Study||1
7303|NCT03285295|14460|P5|NOT COMPLETED|Alinity s Chagas Follow-Up||0
7304|NCT03285295|14461|P4|NOT COMPLETED|Alinity s Chagas Follow-Up||0
7305|NCT03285295|14462|P3|NOT COMPLETED|Alinity s Chagas Follow-Up||0
7306|NCT03285295|14463|P2|NOT COMPLETED|Alinity s Chagas Follow-Up||0
7307|NCT03285295|14464|P1|NOT COMPLETED|Alinity s Chagas Follow-Up||13
7308|NCT03285295|14460|P5|COMPLETED|Alinity s Chagas Follow-Up||0
7309|NCT03285295|14461|P4|COMPLETED|Alinity s Chagas Follow-Up||0
7310|NCT03285295|14462|P3|COMPLETED|Alinity s Chagas Follow-Up||0
7311|NCT03285295|14463|P2|COMPLETED|Alinity s Chagas Follow-Up||0
7312|NCT03285295|14464|P1|COMPLETED|Alinity s Chagas Follow-Up||1
7313|NCT03285295|14460|P5|STARTED|Alinity s Chagas Follow-Up||0
7314|NCT03285295|14461|P4|STARTED|Alinity s Chagas Follow-Up||0
7315|NCT03285295|14462|P3|STARTED|Alinity s Chagas Follow-Up||0
7316|NCT03285295|14463|P2|STARTED|Alinity s Chagas Follow-Up||0
7317|NCT03285295|14464|P1|STARTED|Alinity s Chagas Follow-Up||14
7318|NCT03285295|14460|P5|NOT COMPLETED|Alinity s Chagas||0
7319|NCT03285295|14461|P4|NOT COMPLETED|Alinity s Chagas||0
7320|NCT03285295|14462|P3|NOT COMPLETED|Alinity s Chagas||0
7321|NCT03285295|14463|P2|NOT COMPLETED|Alinity s Chagas||0
7322|NCT03285295|14464|P1|NOT COMPLETED|Alinity s Chagas||219
7323|NCT03285295|14460|P5|COMPLETED|Alinity s Chagas||0
7324|NCT03285295|14461|P4|COMPLETED|Alinity s Chagas||615
7325|NCT03285295|14462|P3|COMPLETED|Alinity s Chagas||0
7326|NCT03285295|14463|P2|COMPLETED|Alinity s Chagas||320
7327|NCT03285295|14464|P1|COMPLETED|Alinity s Chagas||15804
7328|NCT03285295|14460|P5|STARTED|Alinity s Chagas||0
7329|NCT03285295|14461|P4|STARTED|Alinity s Chagas||615
7330|NCT03285295|14462|P3|STARTED|Alinity s Chagas||0
7331|NCT03285295|14463|P2|STARTED|Alinity s Chagas||320
7332|NCT03285295|14464|P1|STARTED|Alinity s Chagas||16023
7333|NCT03285295|14460|P5|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
7334|NCT03285295|14461|P4|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
7335|NCT03285295|14462|P3|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
7336|NCT03285295|14463|P2|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
7337|NCT03285295|14464|P1|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||14
7338|NCT03285295|14460|P5|COMPLETED|Alinity s Anti-HBc Follow-Up||0
7339|NCT03285295|14461|P4|COMPLETED|Alinity s Anti-HBc Follow-Up||0
7340|NCT03285295|14462|P3|COMPLETED|Alinity s Anti-HBc Follow-Up||0
7341|NCT03285295|14463|P2|COMPLETED|Alinity s Anti-HBc Follow-Up||0
7342|NCT03285295|14464|P1|COMPLETED|Alinity s Anti-HBc Follow-Up||2
7343|NCT03285295|14460|P5|STARTED|Alinity s Anti-HBc Follow-Up||0
7344|NCT03285295|14461|P4|STARTED|Alinity s Anti-HBc Follow-Up||0
7345|NCT03285295|14462|P3|STARTED|Alinity s Anti-HBc Follow-Up||0
7346|NCT03285295|14463|P2|STARTED|Alinity s Anti-HBc Follow-Up||0
7347|NCT03285295|14464|P1|STARTED|Alinity s Anti-HBc Follow-Up||16
7348|NCT03285295|14460|P5|NOT COMPLETED|Alinity s Anti-HBc||0
7349|NCT03285295|14461|P4|NOT COMPLETED|Alinity s Anti-HBc||0
7350|NCT03285295|14462|P3|NOT COMPLETED|Alinity s Anti-HBc||0
7351|NCT03285295|14463|P2|NOT COMPLETED|Alinity s Anti-HBc||1
7352|NCT03285295|14464|P1|NOT COMPLETED|Alinity s Anti-HBc||91
7353|NCT03285295|14460|P5|COMPLETED|Alinity s Anti-HBc||0
7354|NCT03285295|14461|P4|COMPLETED|Alinity s Anti-HBc||0
7355|NCT03285295|14462|P3|COMPLETED|Alinity s Anti-HBc||403
7356|NCT03285295|14463|P2|COMPLETED|Alinity s Anti-HBc||404
7357|NCT03285295|14464|P1|COMPLETED|Alinity s Anti-HBc||15877
7358|NCT03285295|14460|P5|STARTED|Alinity s Anti-HBc||0
7359|NCT03285295|14461|P4|STARTED|Alinity s Anti-HBc||0
7360|NCT03285295|14462|P3|STARTED|Alinity s Anti-HBc||403
7361|NCT03285295|14463|P2|STARTED|Alinity s Anti-HBc||405
7362|NCT03285295|14464|P1|STARTED|Alinity s Anti-HBc||15968
7363|NCT03285295|14460|P5|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
7364|NCT03285295|14461|P4|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
7365|NCT03285295|14462|P3|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
7366|NCT03285295|14463|P2|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
7367|NCT03285295|14464|P1|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||11
7368|NCT03285295|14460|P5|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
7369|NCT03285295|14461|P4|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
7370|NCT03285295|14462|P3|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
7371|NCT03285295|14463|P2|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
7372|NCT03285295|14464|P1|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||4
7373|NCT03285295|14460|P5|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
7374|NCT03285295|14461|P4|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
7375|NCT03285295|14462|P3|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
7376|NCT03285295|14463|P2|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
7377|NCT03285295|14464|P1|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||15
7378|NCT03285295|14460|P5|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
7379|NCT03285295|14461|P4|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
7380|NCT03285295|14462|P3|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
7381|NCT03285295|14463|P2|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
7382|NCT03285295|14464|P1|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||99
7383|NCT03285295|14460|P5|COMPLETED|Alinity s HIV Ag/Ab Combo||0
7384|NCT03285295|14461|P4|COMPLETED|Alinity s HIV Ag/Ab Combo|Individuals at Increased Risk of HIV Infection from HIV-2 Endemic Areas|535
7385|NCT03285295|14462|P3|COMPLETED|Alinity s HIV Ag/Ab Combo||605
7386|NCT03285295|14463|P2|COMPLETED|Alinity s HIV Ag/Ab Combo||1336
7387|NCT03285295|14464|P1|COMPLETED|Alinity s HIV Ag/Ab Combo||16996
7388|NCT03285295|14460|P5|STARTED|Alinity s HIV Ag/Ab Combo||0
7389|NCT03285295|14461|P4|STARTED|Alinity s HIV Ag/Ab Combo|Individuals at Increased Risk of HIV Infection from HIV-2 Endemic Areas|535
7390|NCT03285295|14462|P3|STARTED|Alinity s HIV Ag/Ab Combo||605
7391|NCT03285295|14463|P2|STARTED|Alinity s HIV Ag/Ab Combo||1336
7392|NCT03285295|14464|P1|STARTED|Alinity s HIV Ag/Ab Combo||17095
7393|NCT03285295|14460|P5|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
7394|NCT03285295|14461|P4|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
7395|NCT03285295|14462|P3|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
7396|NCT03285295|14463|P2|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
7397|NCT03285295|14464|P1|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||18
7398|NCT03285295|14460|P5|COMPLETED|Alinity s Anti-HCV Follow-Up||0
7399|NCT03285295|14461|P4|COMPLETED|Alinity s Anti-HCV Follow-Up||0
7400|NCT03285295|14462|P3|COMPLETED|Alinity s Anti-HCV Follow-Up||0
7401|NCT03285295|14463|P2|COMPLETED|Alinity s Anti-HCV Follow-Up||0
7402|NCT03285295|14464|P1|COMPLETED|Alinity s Anti-HCV Follow-Up||2
7403|NCT03285295|14460|P5|STARTED|Alinity s Anti-HCV Follow-Up||0
7404|NCT03285295|14461|P4|STARTED|Alinity s Anti-HCV Follow-Up||0
7405|NCT03285295|14462|P3|STARTED|Alinity s Anti-HCV Follow-Up||0
7406|NCT03285295|14463|P2|STARTED|Alinity s Anti-HCV Follow-Up||0
7407|NCT03285295|14464|P1|STARTED|Alinity s Anti-HCV Follow-Up||20
7408|NCT03285295|14460|P5|NOT COMPLETED|Alinity s Anti-HCV||0
7409|NCT03285295|14461|P4|NOT COMPLETED|Alinity s Anti-HCV||0
7410|NCT03285295|14462|P3|NOT COMPLETED|Alinity s Anti-HCV||0
7411|NCT03285295|14463|P2|NOT COMPLETED|Alinity s Anti-HCV||0
7412|NCT03285295|14464|P1|NOT COMPLETED|Alinity s Anti-HCV||96
7413|NCT03285295|14460|P5|COMPLETED|Alinity s Anti-HCV||0
7414|NCT03285295|14461|P4|COMPLETED|Alinity s Anti-HCV||0
7415|NCT03285295|14462|P3|COMPLETED|Alinity s Anti-HCV||407
7416|NCT03285295|14463|P2|COMPLETED|Alinity s Anti-HCV||402
7417|NCT03285295|14464|P1|COMPLETED|Alinity s Anti-HCV||16999
7418|NCT03285295|14460|P5|STARTED|Alinity s Anti-HCV||0
7419|NCT03285295|14461|P4|STARTED|Alinity s Anti-HCV||0
7420|NCT03285295|14462|P3|STARTED|Alinity s Anti-HCV||407
7421|NCT03285295|14463|P2|STARTED|Alinity s Anti-HCV||402
7422|NCT03285295|14464|P1|STARTED|Alinity s Anti-HCV||17095
7423|NCT03285295|14460|P5|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
7424|NCT03285295|14461|P4|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
7425|NCT03285295|14462|P3|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
7426|NCT03285295|14463|P2|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
7427|NCT03285295|14464|P1|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||4
7428|NCT03285295|14460|P5|COMPLETED|Alinity s HTLV I/II Follow-Up||0
7429|NCT03285295|14461|P4|COMPLETED|Alinity s HTLV I/II Follow-Up||0
7430|NCT03285295|14462|P3|COMPLETED|Alinity s HTLV I/II Follow-Up||0
7431|NCT03285295|14463|P2|COMPLETED|Alinity s HTLV I/II Follow-Up||0
7432|NCT03285295|14464|P1|COMPLETED|Alinity s HTLV I/II Follow-Up||8
7433|NCT03285295|14460|P5|STARTED|Alinity s HTLV I/II Follow-Up||0
7434|NCT03285295|14461|P4|STARTED|Alinity s HTLV I/II Follow-Up||0
7435|NCT03285295|14462|P3|STARTED|Alinity s HTLV I/II Follow-Up||0
7436|NCT03285295|14463|P2|STARTED|Alinity s HTLV I/II Follow-Up||0
7437|NCT03285295|14464|P1|STARTED|Alinity s HTLV I/II Follow-Up||12
7438|NCT03285295|14460|P5|NOT COMPLETED|Alinity s HTLV I/II||0
7439|NCT03285295|14461|P4|NOT COMPLETED|Alinity s HTLV I/II||0
7440|NCT03285295|14462|P3|NOT COMPLETED|Alinity s HTLV I/II||0
7441|NCT03285295|14463|P2|NOT COMPLETED|Alinity s HTLV I/II||0
7442|NCT03285295|14464|P1|NOT COMPLETED|Alinity s HTLV I/II||91
7443|NCT03285295|14460|P5|COMPLETED|Alinity s HTLV I/II||0
7444|NCT03285295|14461|P4|COMPLETED|Alinity s HTLV I/II||509
7445|NCT03285295|14462|P3|COMPLETED|Alinity s HTLV I/II||502
7446|NCT03285295|14463|P2|COMPLETED|Alinity s HTLV I/II||706
7447|NCT03285295|14464|P1|COMPLETED|Alinity s HTLV I/II||15877
7448|NCT03285295|14460|P5|STARTED|Alinity s HTLV I/II||0
7449|NCT03285295|14461|P4|STARTED|Alinity s HTLV I/II||509
7450|NCT03285295|14462|P3|STARTED|Alinity s HTLV I/II||502
7451|NCT03285295|14463|P2|STARTED|Alinity s HTLV I/II||706
7452|NCT03285295|14464|P1|STARTED|Alinity s HTLV I/II||15968
7453|NCT03285295|14460|P5|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
7454|NCT03285295|14461|P4|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
7455|NCT03285295|14462|P3|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
7456|NCT03285295|14463|P2|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
7457|NCT03285295|14464|P1|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
7458|NCT03285295|14460|P5|COMPLETED|Alinity s HBsAg Follow-Up||0
7459|NCT03285295|14461|P4|COMPLETED|Alinity s HBsAg Follow-Up||0
7460|NCT03285295|14462|P3|COMPLETED|Alinity s HBsAg Follow-Up||0
7461|NCT03285295|14463|P2|COMPLETED|Alinity s HBsAg Follow-Up||0
7462|NCT03285295|14464|P1|COMPLETED|Alinity s HBsAg Follow-Up||0
7463|NCT03285295|14460|P5|STARTED|Alinity s HBsAg Follow-Up||0
7464|NCT03285295|14461|P4|STARTED|Alinity s HBsAg Follow-Up||0
7465|NCT03285295|14462|P3|STARTED|Alinity s HBsAg Follow-Up||0
7466|NCT03285295|14463|P2|STARTED|Alinity s HBsAg Follow-Up||0
7467|NCT03285295|14464|P1|STARTED|Alinity s HBsAg Follow-Up||0
7468|NCT03285295|14460|P5|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
7469|NCT03285295|14461|P4|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
7470|NCT03285295|14462|P3|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
7471|NCT03285295|14463|P2|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
7472|NCT03285295|14464|P1|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
7473|NCT03285295|14460|P5|COMPLETED|Alinity s HBsAg Confirmatory||0
7474|NCT03285295|14461|P4|COMPLETED|Alinity s HBsAg Confirmatory||0
7475|NCT03285295|14462|P3|COMPLETED|Alinity s HBsAg Confirmatory||3
7476|NCT03285295|14463|P2|COMPLETED|Alinity s HBsAg Confirmatory||432
7477|NCT03285295|14464|P1|COMPLETED|Alinity s HBsAg Confirmatory||8
7478|NCT03285295|14460|P5|STARTED|Alinity s HBsAg Confirmatory||0
7479|NCT03285295|14461|P4|STARTED|Alinity s HBsAg Confirmatory||0
7480|NCT03285295|14462|P3|STARTED|Alinity s HBsAg Confirmatory||3
7481|NCT03285295|14463|P2|STARTED|Alinity s HBsAg Confirmatory||432
7482|NCT03285295|14464|P1|STARTED|Alinity s HBsAg Confirmatory||8
7483|NCT03285295|14460|P5|NOT COMPLETED|Alinity s HBsAg||0
7484|NCT03285295|14461|P4|NOT COMPLETED|Alinity s HBsAg||0
7485|NCT03285295|14462|P3|NOT COMPLETED|Alinity s HBsAg||0
7486|NCT03285295|14463|P2|NOT COMPLETED|Alinity s HBsAg||6
7487|NCT03285295|14464|P1|NOT COMPLETED|Alinity s HBsAg||102
7488|NCT03285295|14460|P5|COMPLETED|Alinity s HBsAg||51
7489|NCT03285295|14461|P4|COMPLETED|Alinity s HBsAg||0
7490|NCT03285295|14462|P3|COMPLETED|Alinity s HBsAg||403
7491|NCT03285295|14463|P2|COMPLETED|Alinity s HBsAg||432
7492|NCT03285295|14464|P1|COMPLETED|Alinity s HBsAg||16993
7493|NCT03285295|14460|P5|STARTED|Alinity s HBsAg||51
7494|NCT03285295|14461|P4|STARTED|Alinity s HBsAg||0
7495|NCT03285295|14462|P3|STARTED|Alinity s HBsAg||403
7496|NCT03285295|14463|P2|STARTED|Alinity s HBsAg||438
7497|NCT03285295|14464|P1|STARTED|Alinity s HBsAg||17095
7498|NCT03283319|14499|P6|NOT COMPLETED|Overall Study||4
7499|NCT03283319|14500|P5|NOT COMPLETED|Overall Study||4
7500|NCT03283319|14501|P4|NOT COMPLETED|Overall Study||7
7501|NCT03283319|14502|P3|NOT COMPLETED|Overall Study||7
7502|NCT03283319|14503|P2|NOT COMPLETED|Overall Study||6
7503|NCT03283319|14504|P1|NOT COMPLETED|Overall Study||7
7504|NCT03283319|14499|P6|COMPLETED|Overall Study||57
7505|NCT03283319|14500|P5|COMPLETED|Overall Study||56
7506|NCT03283319|14501|P4|COMPLETED|Overall Study||54
7507|NCT03283319|14502|P3|COMPLETED|Overall Study||55
7508|NCT03283319|14503|P2|COMPLETED|Overall Study||54
7509|NCT03283319|14504|P1|COMPLETED|Overall Study||55
7510|NCT03283319|14499|P6|STARTED|Overall Study||61
7511|NCT03283319|14500|P5|STARTED|Overall Study||60
7512|NCT03283319|14501|P4|STARTED|Overall Study||61
7513|NCT03283319|14502|P3|STARTED|Overall Study||62
7514|NCT03283319|14503|P2|STARTED|Overall Study||60
7515|NCT03283319|14504|P1|STARTED|Overall Study||62
7516|NCT03282591|14646|P2|NOT COMPLETED|Overall Study||4
7517|NCT03282591|14647|P1|NOT COMPLETED|Overall Study||4
7518|NCT03282591|14646|P2|COMPLETED|Overall Study||89
7519|NCT03282591|14647|P1|COMPLETED|Overall Study||88
7520|NCT03282591|14646|P2|STARTED|Overall Study||93
7521|NCT03282591|14647|P1|STARTED|Overall Study||92
7522|NCT03281668|14661|P1|NOT COMPLETED|Overall Study||8
7523|NCT03281668|14661|P1|COMPLETED|Overall Study||21
7524|NCT03281668|14661|P1|STARTED|Overall Study||29
7525|NCT03281200|14685|P1|NOT COMPLETED|Overall Study||0
7526|NCT03281200|14685|P1|COMPLETED|Overall Study||172
7527|NCT03281200|14685|P1|STARTED|Overall Study||172
7528|NCT03280615|14709|P2|NOT COMPLETED|Overall Study||5
7529|NCT03280615|14710|P1|NOT COMPLETED|Overall Study||4
7530|NCT03280615|14709|P2|COMPLETED|Overall Study||45
7531|NCT03280615|14710|P1|COMPLETED|Overall Study||46
7532|NCT03280615|14709|P2|STARTED|Overall Study||50
7533|NCT03280615|14710|P1|STARTED|Overall Study||50
7534|NCT03280381|14722|P2|NOT COMPLETED|Overall Study||2
7535|NCT03280381|14723|P1|NOT COMPLETED|Overall Study||0
7536|NCT03280381|14722|P2|COMPLETED|Overall Study||97
7537|NCT03280381|14723|P1|COMPLETED|Overall Study||101
7538|NCT03280381|14722|P2|STARTED|Overall Study||99
7539|NCT03280381|14723|P1|STARTED|Overall Study||101
7540|NCT03280108|14733|P2|NOT COMPLETED|Overall Study||0
7541|NCT03280108|14734|P1|NOT COMPLETED|Overall Study||2
7542|NCT03280108|14733|P2|COMPLETED|Overall Study||114
7543|NCT03280108|14734|P1|COMPLETED|Overall Study||127
7544|NCT03280108|14733|P2|STARTED|Overall Study||114
7545|NCT03280108|14734|P1|STARTED|Overall Study||129
7546|NCT03279458|14765|P1|NOT COMPLETED|Overall Study||0
7547|NCT03279458|14765|P1|COMPLETED|Overall Study||40
7548|NCT03279458|14765|P1|STARTED|Overall Study||40
7549|NCT03278106|14771|P1|NOT COMPLETED|Overall Study||1
7550|NCT03278106|14771|P1|COMPLETED|Overall Study||27
7551|NCT03278106|14771|P1|STARTED|Overall Study||28
7552|NCT03278028|14781|P2|NOT COMPLETED|Overall Study||2
7553|NCT03278028|14782|P1|NOT COMPLETED|Overall Study||4
7554|NCT03278028|14781|P2|COMPLETED|Overall Study||76
7555|NCT03278028|14782|P1|COMPLETED|Overall Study||77
7556|NCT03278028|14781|P2|STARTED|Overall Study||78
7557|NCT03278028|14782|P1|STARTED|Overall Study||81
7558|NCT03277846|14790|P2|NOT COMPLETED|Overall Study||11
7559|NCT03277846|14791|P1|NOT COMPLETED|Overall Study||12
7560|NCT03277846|14790|P2|COMPLETED|Overall Study||40
7561|NCT03277846|14791|P1|COMPLETED|Overall Study||38
7562|NCT03277846|14790|P2|STARTED|Overall Study||51
7563|NCT03277846|14791|P1|STARTED|Overall Study||50
7564|NCT03277274|14800|P3|NOT COMPLETED|Overall Study||0
7565|NCT03277274|14801|P2|NOT COMPLETED|Overall Study||0
7566|NCT03277274|14802|P1|NOT COMPLETED|Overall Study||0
7567|NCT03277274|14800|P3|COMPLETED|Overall Study||7
7568|NCT03277274|14801|P2|COMPLETED|Overall Study||10
7569|NCT03277274|14802|P1|COMPLETED|Overall Study||8
7570|NCT03277274|14800|P3|STARTED|Overall Study||7
7571|NCT03277274|14801|P2|STARTED|Overall Study||10
7572|NCT03277274|14802|P1|STARTED|Overall Study||8
7573|NCT03276494|14831|P1|NOT COMPLETED|Overall Study||1
7574|NCT03276494|14831|P1|COMPLETED|Overall Study||5
7575|NCT03276494|14831|P1|STARTED|Overall Study||6
7576|NCT03276078|14836|P1|NOT COMPLETED|Overall Study||1
7577|NCT03276078|14836|P1|COMPLETED|Overall Study||19
7578|NCT03276078|14836|P1|STARTED|Overall Study||20
7579|NCT03276026|14865|P2|NOT COMPLETED|Overall Study||0
7580|NCT03276026|14866|P1|NOT COMPLETED|Overall Study||1
7581|NCT03276026|14865|P2|COMPLETED|Overall Study||33
7582|NCT03276026|14866|P1|COMPLETED|Overall Study||34
7583|NCT03276026|14865|P2|STARTED|Overall Study||33
7584|NCT03276026|14866|P1|STARTED|Overall Study||35
7585|NCT03274518|14878|P2|NOT COMPLETED|Second Intervention||0
7586|NCT03274518|14879|P1|NOT COMPLETED|Second Intervention||0
7587|NCT03274518|14878|P2|COMPLETED|Second Intervention||8
7588|NCT03274518|14879|P1|COMPLETED|Second Intervention||8
7589|NCT03274518|14878|P2|STARTED|Second Intervention|Second intervention: patients from this group underwent online hemodiafiltration for 30 days.|8
7590|NCT03274518|14879|P1|STARTED|Second Intervention||8
7591|NCT03274518|14878|P2|NOT COMPLETED|Washout Period||0
7592|NCT03274518|14879|P1|NOT COMPLETED|Washout Period||0
7593|NCT03274518|14878|P2|COMPLETED|Washout Period||8
7594|NCT03274518|14879|P1|COMPLETED|Washout Period||8
7595|NCT03274518|14878|P2|STARTED|Washout Period|Patients returned from expanded hemodialysis to conventional hemodialysis for 15 days.|8
7596|NCT03274518|14879|P1|STARTED|Washout Period||8
7597|NCT03274518|14878|P2|NOT COMPLETED|First Intervention||0
7598|NCT03274518|14879|P1|NOT COMPLETED|First Intervention||0
7599|NCT03274518|14878|P2|COMPLETED|First Intervention||8
7600|NCT03274518|14879|P1|COMPLETED|First Intervention||8
7601|NCT03274518|14878|P2|STARTED|First Intervention|First intervention: expanded hemodialysis, for 30 days.|8
7602|NCT03274518|14879|P1|STARTED|First Intervention||8
7603|NCT03274453|14895|P4|NOT COMPLETED|Overall Study||4
7604|NCT03274453|14896|P3|NOT COMPLETED|Overall Study||4
7605|NCT03274453|14897|P2|NOT COMPLETED|Overall Study||6
7606|NCT03274453|14898|P1|NOT COMPLETED|Overall Study||4
7607|NCT03274453|14895|P4|COMPLETED|Overall Study||25
7608|NCT03274453|14896|P3|COMPLETED|Overall Study||28
7609|NCT03274453|14897|P2|COMPLETED|Overall Study||24
7610|NCT03274453|14898|P1|COMPLETED|Overall Study||34
7611|NCT03274453|14895|P4|STARTED|Overall Study||29
7612|NCT03274453|14896|P3|STARTED|Overall Study||32
7613|NCT03274453|14897|P2|STARTED|Overall Study||30
7614|NCT03274453|14898|P1|STARTED|Overall Study||38
7615|NCT03273946|14908|P1|NOT COMPLETED|Overall Study||9
7616|NCT03273946|14908|P1|COMPLETED|Overall Study||149
7617|NCT03273946|14908|P1|STARTED|Overall Study||158
7618|NCT03273387|14916|P2|NOT COMPLETED|Overall Study||3
7619|NCT03273387|14917|P1|NOT COMPLETED|Overall Study||3
7620|NCT03273387|14916|P2|COMPLETED|Overall Study||10
7621|NCT03273387|14917|P1|COMPLETED|Overall Study||10
7622|NCT03273387|14916|P2|STARTED|Overall Study||13
7623|NCT03273387|14917|P1|STARTED|Overall Study||13
7624|NCT03271424|14930|P3|NOT COMPLETED|April-May 2016||0
7625|NCT03271424|14931|P2|NOT COMPLETED|April-May 2016||0
7626|NCT03271424|14932|P1|NOT COMPLETED|April-May 2016||0
7627|NCT03271424|14930|P3|COMPLETED|April-May 2016||40
7628|NCT03271424|14931|P2|COMPLETED|April-May 2016||0
7629|NCT03271424|14932|P1|COMPLETED|April-May 2016||0
7630|NCT03271424|14930|P3|STARTED|April-May 2016||40
7631|NCT03271424|14931|P2|STARTED|April-May 2016||0
7632|NCT03271424|14932|P1|STARTED|April-May 2016||0
7633|NCT03271424|14930|P3|NOT COMPLETED|December 2015||0
7634|NCT03271424|14931|P2|NOT COMPLETED|December 2015||0
7635|NCT03271424|14932|P1|NOT COMPLETED|December 2015||0
7636|NCT03271424|14930|P3|COMPLETED|December 2015||0
7637|NCT03271424|14931|P2|COMPLETED|December 2015||35
7638|NCT03271424|14932|P1|COMPLETED|December 2015||0
7639|NCT03271424|14930|P3|STARTED|December 2015||0
7640|NCT03271424|14931|P2|STARTED|December 2015||35
7641|NCT03271424|14932|P1|STARTED|December 2015||0
7642|NCT03271424|14930|P3|NOT COMPLETED|November 2015||0
7643|NCT03271424|14931|P2|NOT COMPLETED|November 2015||0
7644|NCT03271424|14932|P1|NOT COMPLETED|November 2015||0
7645|NCT03271424|14930|P3|COMPLETED|November 2015||0
7646|NCT03271424|14931|P2|COMPLETED|November 2015||0
7647|NCT03271424|14932|P1|COMPLETED|November 2015||20
7648|NCT03271424|14930|P3|STARTED|November 2015||0
7649|NCT03271424|14931|P2|STARTED|November 2015||0
7650|NCT03271424|14932|P1|STARTED|November 2015||20
7651|NCT03268941|14946|P7|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
7652|NCT03268941|14947|P6|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
7653|NCT03268941|14948|P5|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
7654|NCT03268941|14949|P4|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
7655|NCT03268941|14950|P3|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
7656|NCT03268941|14951|P2|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
7657|NCT03268941|14952|P1|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
7658|NCT03268941|14946|P7|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
7659|NCT03268941|14947|P6|COMPLETED|Part 2: Period 2: Fasted (Day 25)||6
7660|NCT03268941|14948|P5|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
7661|NCT03268941|14949|P4|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
7662|NCT03268941|14950|P3|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
7663|NCT03268941|14951|P2|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
7664|NCT03268941|14952|P1|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
7665|NCT03268941|14946|P7|STARTED|Part 2: Period 2: Fasted (Day 25)||0
7666|NCT03268941|14947|P6|STARTED|Part 2: Period 2: Fasted (Day 25)||6
7667|NCT03268941|14948|P5|STARTED|Part 2: Period 2: Fasted (Day 25)||0
7668|NCT03268941|14949|P4|STARTED|Part 2: Period 2: Fasted (Day 25)||0
7669|NCT03268941|14950|P3|STARTED|Part 2: Period 2: Fasted (Day 25)||0
7670|NCT03268941|14951|P2|STARTED|Part 2: Period 2: Fasted (Day 25)||0
7671|NCT03268941|14952|P1|STARTED|Part 2: Period 2: Fasted (Day 25)||0
7672|NCT03268941|14946|P7|NOT COMPLETED|Part 2: Days 17 to 25||2
7673|NCT03268941|14947|P6|NOT COMPLETED|Part 2: Days 17 to 25||0
7674|NCT03268941|14948|P5|NOT COMPLETED|Part 2: Days 17 to 25||0
7675|NCT03268941|14949|P4|NOT COMPLETED|Part 2: Days 17 to 25||0
7676|NCT03268941|14950|P3|NOT COMPLETED|Part 2: Days 17 to 25||0
7677|NCT03268941|14951|P2|NOT COMPLETED|Part 2: Days 17 to 25||0
7678|NCT03268941|14952|P1|NOT COMPLETED|Part 2: Days 17 to 25||0
7679|NCT03268941|14946|P7|COMPLETED|Part 2: Days 17 to 25||13
7680|NCT03268941|14947|P6|COMPLETED|Part 2: Days 17 to 25||0
7681|NCT03268941|14948|P5|COMPLETED|Part 2: Days 17 to 25||6
7682|NCT03268941|14949|P4|COMPLETED|Part 2: Days 17 to 25||0
7683|NCT03268941|14950|P3|COMPLETED|Part 2: Days 17 to 25||0
7684|NCT03268941|14951|P2|COMPLETED|Part 2: Days 17 to 25||0
7685|NCT03268941|14952|P1|COMPLETED|Part 2: Days 17 to 25||0
7686|NCT03268941|14946|P7|Treated|Part 2: Days 17 to 25||13
7687|NCT03268941|14947|P6|Treated|Part 2: Days 17 to 25||0
7688|NCT03268941|14948|P5|Treated|Part 2: Days 17 to 25||6
7689|NCT03268941|14949|P4|Treated|Part 2: Days 17 to 25||0
7690|NCT03268941|14950|P3|Treated|Part 2: Days 17 to 25||0
7691|NCT03268941|14951|P2|Treated|Part 2: Days 17 to 25||0
7692|NCT03268941|14952|P1|Treated|Part 2: Days 17 to 25||0
7693|NCT03268941|14946|P7|STARTED|Part 2: Days 17 to 25||15
7694|NCT03268941|14947|P6|STARTED|Part 2: Days 17 to 25||0
7695|NCT03268941|14948|P5|STARTED|Part 2: Days 17 to 25||6
7696|NCT03268941|14949|P4|STARTED|Part 2: Days 17 to 25||0
7697|NCT03268941|14950|P3|STARTED|Part 2: Days 17 to 25||0
7698|NCT03268941|14951|P2|STARTED|Part 2: Days 17 to 25||0
7699|NCT03268941|14952|P1|STARTED|Part 2: Days 17 to 25||0
7700|NCT03268941|14946|P7|NOT COMPLETED|Part 1 (Days 1 to 9)||0
7701|NCT03268941|14947|P6|NOT COMPLETED|Part 1 (Days 1 to 9)||0
7702|NCT03268941|14948|P5|NOT COMPLETED|Part 1 (Days 1 to 9)||0
7703|NCT03268941|14949|P4|NOT COMPLETED|Part 1 (Days 1 to 9)||2
7704|NCT03268941|14950|P3|NOT COMPLETED|Part 1 (Days 1 to 9)||0
7705|NCT03268941|14951|P2|NOT COMPLETED|Part 1 (Days 1 to 9)||0
7706|NCT03268941|14952|P1|NOT COMPLETED|Part 1 (Days 1 to 9)||1
7707|NCT03268941|14946|P7|COMPLETED|Part 1 (Days 1 to 9)||0
7708|NCT03268941|14947|P6|COMPLETED|Part 1 (Days 1 to 9)||0
7709|NCT03268941|14948|P5|COMPLETED|Part 1 (Days 1 to 9)||0
7710|NCT03268941|14949|P4|COMPLETED|Part 1 (Days 1 to 9)||11
7711|NCT03268941|14950|P3|COMPLETED|Part 1 (Days 1 to 9)||12
7712|NCT03268941|14951|P2|COMPLETED|Part 1 (Days 1 to 9)||14
7713|NCT03268941|14952|P1|COMPLETED|Part 1 (Days 1 to 9)||11
7714|NCT03268941|14946|P7|STARTED|Part 1 (Days 1 to 9)||0
7715|NCT03268941|14947|P6|STARTED|Part 1 (Days 1 to 9)||0
7716|NCT03268941|14948|P5|STARTED|Part 1 (Days 1 to 9)||0
7717|NCT03268941|14949|P4|STARTED|Part 1 (Days 1 to 9)||13
7718|NCT03268941|14950|P3|STARTED|Part 1 (Days 1 to 9)||12
7719|NCT03268941|14951|P2|STARTED|Part 1 (Days 1 to 9)||14
7720|NCT03268941|14952|P1|STARTED|Part 1 (Days 1 to 9)||12
7721|NCT03268746|15014|P1|NOT COMPLETED|Overall Study||1
7722|NCT03268746|15014|P1|COMPLETED|Overall Study||44
7723|NCT03268746|15014|P1|STARTED|Overall Study||45
7724|NCT03268590|15036|P1|NOT COMPLETED|Overall Study||1
7725|NCT03268590|15036|P1|COMPLETED|Overall Study|One participant did not complete MRI due to a previously undiagnosed subdermal metal shard in scalp.|32
7726|NCT03268590|15036|P1|STARTED|Overall Study||33
7727|NCT03268343|15043|P2|NOT COMPLETED|Overall Study||0
7728|NCT03268343|15044|P1|NOT COMPLETED|Overall Study||0
7729|NCT03268343|15043|P2|COMPLETED|Overall Study||12
7730|NCT03268343|15044|P1|COMPLETED|Overall Study||12
7731|NCT03268343|15043|P2|STARTED|Overall Study||12
7732|NCT03268343|15044|P1|STARTED|Overall Study||12
7733|NCT03267576|15071|P2|NOT COMPLETED|Period 2: Day 44 to 71||2
7734|NCT03267576|15072|P1|NOT COMPLETED|Period 2: Day 44 to 71||1
7735|NCT03267576|15071|P2|COMPLETED|Period 2: Day 44 to 71||30
7736|NCT03267576|15072|P1|COMPLETED|Period 2: Day 44 to 71||30
7737|NCT03267576|15071|P2|STARTED|Period 2: Day 44 to 71||32
7738|NCT03267576|15072|P1|STARTED|Period 2: Day 44 to 71||31
7739|NCT03267576|15071|P2|NOT COMPLETED|Washout Period: 16 Days||0
7740|NCT03267576|15072|P1|NOT COMPLETED|Washout Period: 16 Days||0
7741|NCT03267576|15071|P2|COMPLETED|Washout Period: 16 Days||32
7742|NCT03267576|15072|P1|COMPLETED|Washout Period: 16 Days||31
7743|NCT03267576|15071|P2|STARTED|Washout Period: 16 Days||32
7744|NCT03267576|15072|P1|STARTED|Washout Period: 16 Days||31
7745|NCT03267576|15071|P2|NOT COMPLETED|Period 1: Day 0 to 27||0
7746|NCT03267576|15072|P1|NOT COMPLETED|Period 1: Day 0 to 27||0
7747|NCT03267576|15071|P2|COMPLETED|Period 1: Day 0 to 27||32
7748|NCT03267576|15072|P1|COMPLETED|Period 1: Day 0 to 27||31
7749|NCT03267576|15071|P2|STARTED|Period 1: Day 0 to 27||32
7750|NCT03267576|15072|P1|STARTED|Period 1: Day 0 to 27||31
7751|NCT03267511|15110|P4|NOT COMPLETED|Overall Study||1
7752|NCT03267511|15111|P3|NOT COMPLETED|Overall Study||0
7753|NCT03267511|15112|P2|NOT COMPLETED|Overall Study||0
7754|NCT03267511|15113|P1|NOT COMPLETED|Overall Study||0
7755|NCT03267511|15110|P4|COMPLETED|Overall Study||30
7756|NCT03267511|15111|P3|COMPLETED|Overall Study||30
7757|NCT03267511|15112|P2|COMPLETED|Overall Study||31
7758|NCT03267511|15113|P1|COMPLETED|Overall Study||31
7759|NCT03267511|15110|P4|STARTED|Overall Study||31
7760|NCT03267511|15111|P3|STARTED|Overall Study||30
7761|NCT03267511|15112|P2|STARTED|Overall Study||31
7762|NCT03267511|15113|P1|STARTED|Overall Study||31
7763|NCT03267264|15129|P4|NOT COMPLETED|Overall Study||4
7764|NCT03267264|15130|P3|NOT COMPLETED|Overall Study||2
7765|NCT03267264|15131|P2|NOT COMPLETED|Overall Study||0
7766|NCT03267264|15132|P1|NOT COMPLETED|Overall Study||1
7767|NCT03267264|15129|P4|COMPLETED|Overall Study||61
7768|NCT03267264|15130|P3|COMPLETED|Overall Study||66
7769|NCT03267264|15131|P2|COMPLETED|Overall Study||49
7770|NCT03267264|15132|P1|COMPLETED|Overall Study||65
7771|NCT03267264|15129|P4|Sequence B(Comparator)|Overall Study||32
7772|NCT03267264|15130|P3|Sequence B(Comparator)|Overall Study||33
7773|NCT03267264|15131|P2|Sequence B(Comparator)|Overall Study||24
7774|NCT03267264|15132|P1|Sequence B(Comparator)|Overall Study||32
7775|NCT03267264|15129|P4|Sequence A(Nucleus)|Overall Study||33
7776|NCT03267264|15130|P3|Sequence A(Nucleus)|Overall Study||33
7777|NCT03267264|15131|P2|Sequence A(Nucleus)|Overall Study||25
7778|NCT03267264|15132|P1|Sequence A(Nucleus)|Overall Study||34
7779|NCT03267264|15129|P4|STARTED|Overall Study||65
7780|NCT03267264|15130|P3|STARTED|Overall Study||68
7781|NCT03267264|15131|P2|STARTED|Overall Study||49
7782|NCT03267264|15132|P1|STARTED|Overall Study||66
7783|NCT03266419|15151|P2|NOT COMPLETED|Overall Study||0
7784|NCT03266419|15152|P1|NOT COMPLETED|Overall Study||0
7785|NCT03266419|15151|P2|COMPLETED|Overall Study||49
7786|NCT03266419|15152|P1|COMPLETED|Overall Study||51
7787|NCT03266419|15151|P2|STARTED|Overall Study||49
7788|NCT03266419|15152|P1|STARTED|Overall Study||51
7789|NCT03265119|15162|P2|NOT COMPLETED|Overall Study||7
7790|NCT03265119|15163|P1|NOT COMPLETED|Overall Study||10
7791|NCT03265119|15162|P2|COMPLETED|Overall Study||28
7792|NCT03265119|15163|P1|COMPLETED|Overall Study||24
7793|NCT03265119|15162|P2|STARTED|Overall Study||35
7794|NCT03265119|15163|P1|STARTED|Overall Study||34
7795|NCT03264248|15171|P1|NOT COMPLETED|Overall Study||0
7796|NCT03264248|15171|P1|COMPLETED|Overall Study||9
7797|NCT03264248|15171|P1|STARTED|Overall Study||9
7798|NCT03263806|15180|P2|NOT COMPLETED|Overall Study||7
7799|NCT03263806|15181|P1|NOT COMPLETED|Overall Study||6
7800|NCT03263806|15180|P2|COMPLETED|Overall Study|Study Terminated due to lack of enrollment|0
7801|NCT03263806|15181|P1|COMPLETED|Overall Study|Study Terminated due to lack of enrollment|0
7802|NCT03263806|15180|P2|STARTED|Overall Study||7
7803|NCT03263806|15181|P1|STARTED|Overall Study||6
7804|NCT03262233|15197|P4|NOT COMPLETED|Overall Study||29
7805|NCT03262233|15198|P3|NOT COMPLETED|Overall Study||25
7806|NCT03262233|15199|P2|NOT COMPLETED|Overall Study||21
7807|NCT03262233|15200|P1|NOT COMPLETED|Overall Study||18
7808|NCT03262233|15197|P4|COMPLETED|Overall Study||32
7809|NCT03262233|15198|P3|COMPLETED|Overall Study||34
7810|NCT03262233|15199|P2|COMPLETED|Overall Study||32
7811|NCT03262233|15200|P1|COMPLETED|Overall Study||35
7812|NCT03262233|15197|P4|STARTED|Overall Study||61
7813|NCT03262233|15198|P3|STARTED|Overall Study||59
7814|NCT03262233|15199|P2|STARTED|Overall Study||53
7815|NCT03262233|15200|P1|STARTED|Overall Study||53
7816|NCT03261167|15224|P2|NOT COMPLETED|Overall Study||3
7817|NCT03261167|15225|P1|NOT COMPLETED|Overall Study||4
7818|NCT03261167|15224|P2|COMPLETED|Overall Study||58
7819|NCT03261167|15225|P1|COMPLETED|Overall Study||59
7820|NCT03261167|15224|P2|STARTED|Overall Study||61
7821|NCT03261167|15225|P1|STARTED|Overall Study||63
7822|NCT03260894|15255|P2|NOT COMPLETED|Overall Study||50
7823|NCT03260894|15256|P1|NOT COMPLETED|Overall Study||46
7824|NCT03260894|15255|P2|COMPLETED|Overall Study||15
7825|NCT03260894|15256|P1|COMPLETED|Overall Study||18
7826|NCT03260894|15255|P2|All Subjects as Treated (ASaT)|Overall Study||63
7827|NCT03260894|15256|P1|All Subjects as Treated (ASaT)|Overall Study||64
7828|NCT03260894|15255|P2|Intention-to-Treat (ITT)|Overall Study||65
7829|NCT03260894|15256|P1|Intention-to-Treat (ITT)|Overall Study||64
7830|NCT03260894|15255|P2|STARTED|Overall Study||65
7831|NCT03260894|15256|P1|STARTED|Overall Study||64
7832|NCT03260699|15268|P2|NOT COMPLETED|Overall Study||2
7833|NCT03260699|15269|P1|NOT COMPLETED|Overall Study||0
7834|NCT03260699|15268|P2|COMPLETED|Overall Study||2
7835|NCT03260699|15269|P1|COMPLETED|Overall Study||5
7836|NCT03260699|15268|P2|STARTED|Overall Study||4
7837|NCT03260699|15269|P1|STARTED|Overall Study||5
7838|NCT03260595|15298|P3|NOT COMPLETED|Overall Study||0
7839|NCT03260595|15299|P2|NOT COMPLETED|Overall Study||0
7840|NCT03260595|15300|P1|NOT COMPLETED|Overall Study||0
7841|NCT03260595|15298|P3|COMPLETED|Overall Study||2
7842|NCT03260595|15299|P2|COMPLETED|Overall Study||10
7843|NCT03260595|15300|P1|COMPLETED|Overall Study||20
7844|NCT03260595|15298|P3|STARTED|Overall Study||2
7845|NCT03260595|15299|P2|STARTED|Overall Study||10
7846|NCT03260595|15300|P1|STARTED|Overall Study||20
7847|NCT03259425|15322|P1|NOT COMPLETED|Overall Study||1
7848|NCT03259425|15322|P1|COMPLETED|Overall Study||6
7849|NCT03259425|15322|P1|Surgery|Overall Study||6
7850|NCT03259425|15322|P1|STARTED|Overall Study||7
7851|NCT03259087|15331|P5|NOT COMPLETED|Period 2 of Part 2||1
7852|NCT03259087|15332|P4|NOT COMPLETED|Period 2 of Part 2||0
7853|NCT03259087|15333|P3|NOT COMPLETED|Period 2 of Part 2||0
7854|NCT03259087|15334|P2|NOT COMPLETED|Period 2 of Part 2||0
7855|NCT03259087|15335|P1|NOT COMPLETED|Period 2 of Part 2||0
7856|NCT03259087|15331|P5|COMPLETED|Period 2 of Part 2||6
7857|NCT03259087|15332|P4|COMPLETED|Period 2 of Part 2||0
7858|NCT03259087|15333|P3|COMPLETED|Period 2 of Part 2||0
7859|NCT03259087|15334|P2|COMPLETED|Period 2 of Part 2||0
7860|NCT03259087|15335|P1|COMPLETED|Period 2 of Part 2||0
7861|NCT03259087|15331|P5|STARTED|Period 2 of Part 2||7
7862|NCT03259087|15332|P4|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
7863|NCT03259087|15333|P3|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
7864|NCT03259087|15334|P2|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
7865|NCT03259087|15335|P1|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
7866|NCT03259087|15331|P5|NOT COMPLETED|Part 1 and Period 1 of Part 2||1
7867|NCT03259087|15332|P4|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
7868|NCT03259087|15333|P3|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
7869|NCT03259087|15334|P2|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
7870|NCT03259087|15335|P1|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
7871|NCT03259087|15331|P5|COMPLETED|Part 1 and Period 1 of Part 2||7
7872|NCT03259087|15332|P4|COMPLETED|Part 1 and Period 1 of Part 2||10
7873|NCT03259087|15333|P3|COMPLETED|Part 1 and Period 1 of Part 2||8
7874|NCT03259087|15334|P2|COMPLETED|Part 1 and Period 1 of Part 2||8
7875|NCT03259087|15335|P1|COMPLETED|Part 1 and Period 1 of Part 2||8
7876|NCT03259087|15331|P5|STARTED|Part 1 and Period 1 of Part 2||8
7877|NCT03259087|15332|P4|STARTED|Part 1 and Period 1 of Part 2||10
7878|NCT03259087|15333|P3|STARTED|Part 1 and Period 1 of Part 2||8
7879|NCT03259087|15334|P2|STARTED|Part 1 and Period 1 of Part 2||8
7880|NCT03259087|15335|P1|STARTED|Part 1 and Period 1 of Part 2||8
7881|NCT03258814|15463|P3|NOT COMPLETED|Overall Study||10
7882|NCT03258814|15464|P2|NOT COMPLETED|Overall Study||3
7883|NCT03258814|15465|P1|NOT COMPLETED|Overall Study||4
7884|NCT03258814|15463|P3|COMPLETED|Overall Study||0
7885|NCT03258814|15464|P2|COMPLETED|Overall Study||0
7886|NCT03258814|15465|P1|COMPLETED|Overall Study||0
7887|NCT03258814|15463|P3|STARTED|Overall Study||10
7888|NCT03258814|15464|P2|STARTED|Overall Study||3
7889|NCT03258814|15465|P1|STARTED|Overall Study||4
7890|NCT03258762|15520|P2|NOT COMPLETED|Overall Study||1
7891|NCT03258762|15521|P1|NOT COMPLETED|Overall Study||0
7892|NCT03258762|15520|P2|COMPLETED|Overall Study||6
7893|NCT03258762|15521|P1|COMPLETED|Overall Study||7
7894|NCT03258762|15520|P2|STARTED|Overall Study||7
7895|NCT03258762|15521|P1|STARTED|Overall Study||7
7896|NCT03257995|15581|P6|NOT COMPLETED|Overall Study||2
7897|NCT03257995|15582|P5|NOT COMPLETED|Overall Study||0
7898|NCT03257995|15583|P4|NOT COMPLETED|Overall Study||0
7899|NCT03257995|15584|P3|NOT COMPLETED|Overall Study||0
7900|NCT03257995|15585|P2|NOT COMPLETED|Overall Study||1
7901|NCT03257995|15586|P1|NOT COMPLETED|Overall Study||0
7902|NCT03257995|15581|P6|COMPLETED|Overall Study||7
7903|NCT03257995|15582|P5|COMPLETED|Overall Study||9
7904|NCT03257995|15583|P4|COMPLETED|Overall Study||9
7905|NCT03257995|15584|P3|COMPLETED|Overall Study||9
7906|NCT03257995|15585|P2|COMPLETED|Overall Study||8
7907|NCT03257995|15586|P1|COMPLETED|Overall Study||9
7908|NCT03257995|15581|P6|STARTED|Overall Study||9
7909|NCT03257995|15582|P5|STARTED|Overall Study||9
7910|NCT03257995|15583|P4|STARTED|Overall Study||9
7911|NCT03257995|15584|P3|STARTED|Overall Study||9
7912|NCT03257995|15585|P2|STARTED|Overall Study||9
7913|NCT03257995|15586|P1|STARTED|Overall Study||9
7914|NCT03257202|15634|P1|NOT COMPLETED|Overall Study||0
7915|NCT03257202|15634|P1|COMPLETED|Overall Study||12
7916|NCT03257202|15634|P1|STARTED|Overall Study||12
7917|NCT03257189|15644|P1|NOT COMPLETED|Overall Study||0
7918|NCT03257189|15644|P1|COMPLETED|Overall Study||30
7919|NCT03257189|15644|P1|STARTED|Overall Study||30
7920|NCT03256851|15658|P2|NOT COMPLETED|Overall Study||0
7921|NCT03256851|15659|P1|NOT COMPLETED|Overall Study||1
7922|NCT03256851|15658|P2|COMPLETED|Overall Study||10
7923|NCT03256851|15659|P1|COMPLETED|Overall Study||9
7924|NCT03256851|15658|P2|STARTED|Overall Study||10
7925|NCT03256851|15659|P1|STARTED|Overall Study||10
7926|NCT03256799|15667|P1|NOT COMPLETED|Overall Study||0
7927|NCT03256799|15667|P1|COMPLETED|Overall Study||1
7928|NCT03256799|15667|P1|STARTED|Overall Study||1
7929|NCT03256695|15671|P1|NOT COMPLETED|Overall Study||39
7930|NCT03256695|15671|P1|COMPLETED|Overall Study||366
7931|NCT03256695|15671|P1|Used ABS eMDPI at Least Once|Overall Study||390
7932|NCT03256695|15671|P1|STARTED|Overall Study||405
7933|NCT03256552|15679|P1|NOT COMPLETED|Overall Study||5
7934|NCT03256552|15679|P1|COMPLETED|Overall Study||61
7935|NCT03256552|15679|P1|Placebo MDI|Overall Study||65
7936|NCT03256552|15679|P1|GP MDI 7.2 µg|Overall Study||62
7937|NCT03256552|15679|P1|GP MDI 14.4 µg|Overall Study||63
7938|NCT03256552|15679|P1|GP MDI 28.8 µg|Overall Study||61
7939|NCT03256552|15679|P1|STARTED|Overall Study||66
7940|NCT03256526|15704|P3|NOT COMPLETED|Overall Study||3
7941|NCT03256526|15705|P2|NOT COMPLETED|Overall Study||0
7942|NCT03256526|15706|P1|NOT COMPLETED|Overall Study||2
7943|NCT03256526|15704|P3|COMPLETED|Overall Study||14
7944|NCT03256526|15705|P2|COMPLETED|Overall Study||17
7945|NCT03256526|15706|P1|COMPLETED|Overall Study||17
7946|NCT03256526|15704|P3|STARTED|Overall Study||17
7947|NCT03256526|15705|P2|STARTED|Overall Study||17
7948|NCT03256526|15706|P1|STARTED|Overall Study||19
7949|NCT03255902|15726|P1|NOT COMPLETED|Overall Study||2
7950|NCT03255902|15726|P1|COMPLETED|Overall Study||5
7951|NCT03255902|15726|P1|STARTED|Overall Study||7
7952|NCT03255733|15731|P1|NOT COMPLETED|Overall Study||4
7953|NCT03255733|15731|P1|COMPLETED|Overall Study||25
7954|NCT03255733|15731|P1|STARTED|Overall Study||29
7955|NCT03255655|15738|P2|NOT COMPLETED|Overall Study||4
7956|NCT03255655|15739|P1|NOT COMPLETED|Overall Study||7
7957|NCT03255655|15738|P2|COMPLETED|Overall Study||8
7958|NCT03255655|15739|P1|COMPLETED|Overall Study||22
7959|NCT03255655|15738|P2|STARTED|Overall Study||12
7960|NCT03255655|15739|P1|STARTED|Overall Study||29
7961|NCT03255382|15749|P2|NOT COMPLETED|Overall Study||0
7962|NCT03255382|15750|P1|NOT COMPLETED|Overall Study||13
7963|NCT03255382|15749|P2|COMPLETED|Overall Study||60
7964|NCT03255382|15750|P1|COMPLETED|Overall Study||47
7965|NCT03255382|15749|P2|STARTED|Overall Study||60
7966|NCT03255382|15750|P1|STARTED|Overall Study||60
7967|NCT03254602|15918|P1|NOT COMPLETED|Overall Study||4
7968|NCT03254602|15918|P1|COMPLETED|Overall Study||29
7969|NCT03254602|15918|P1|STARTED|Overall Study||33
7970|NCT03254459|15926|P2|NOT COMPLETED|Overall Study||23
7971|NCT03254459|15927|P1|NOT COMPLETED|Overall Study||10
7972|NCT03254459|15926|P2|COMPLETED|Overall Study||27
7973|NCT03254459|15927|P1|COMPLETED|Overall Study||40
7974|NCT03254459|15926|P2|STARTED|Overall Study||50
7975|NCT03254459|15927|P1|STARTED|Overall Study||50
7976|NCT03254147|15945|P1|NOT COMPLETED|Overall Study||0
7977|NCT03254147|15945|P1|COMPLETED|Overall Study||53969
7978|NCT03254147|15945|P1|STARTED|Overall Study|The number of patients meeting the inclusion and exclusion criteria|53969
7979|NCT03254134|15952|P2|NOT COMPLETED|Overall Study||3630
7980|NCT03254134|15953|P1|NOT COMPLETED|Overall Study||599
7981|NCT03254134|15952|P2|COMPLETED|Overall Study||13115
7982|NCT03254134|15953|P1|COMPLETED|Overall Study||5146
7983|NCT03254134|15952|P2|STARTED|Overall Study||16745
7984|NCT03254134|15953|P1|STARTED|Overall Study||5745
7985|NCT03252964|15961|P1|NOT COMPLETED|Overall Study||32
7986|NCT03252964|15961|P1|COMPLETED|Overall Study||20
7987|NCT03252964|15961|P1|STARTED|Overall Study||52
7988|NCT03251482|15980|P5|NOT COMPLETED|Overall Study||0
7989|NCT03251482|15981|P4|NOT COMPLETED|Overall Study||0
7990|NCT03251482|15982|P3|NOT COMPLETED|Overall Study||0
7991|NCT03251482|15983|P2|NOT COMPLETED|Overall Study||1
7992|NCT03251482|15984|P1|NOT COMPLETED|Overall Study||0
7993|NCT03251482|15980|P5|COMPLETED|Overall Study||63
7994|NCT03251482|15981|P4|COMPLETED|Overall Study||122
7995|NCT03251482|15982|P3|COMPLETED|Overall Study||43
7996|NCT03251482|15983|P2|COMPLETED|Overall Study||40
7997|NCT03251482|15984|P1|COMPLETED|Overall Study||39
7998|NCT03251482|15980|P5|Treated|Overall Study||63
7999|NCT03251482|15981|P4|Treated|Overall Study||122
8000|NCT03251482|15982|P3|Treated|Overall Study||42
8001|NCT03251482|15983|P2|Treated|Overall Study||40
8002|NCT03251482|15984|P1|Treated|Overall Study||38
8003|NCT03251482|15980|P5|STARTED|Overall Study||63
8004|NCT03251482|15981|P4|STARTED|Overall Study||122
8005|NCT03251482|15982|P3|STARTED|Overall Study||43
8006|NCT03251482|15983|P2|STARTED|Overall Study||41
8007|NCT03251482|15984|P1|STARTED|Overall Study||39
8008|NCT03250845|16056|P1|NOT COMPLETED|Multigam 10% Infusion (3-4 Weeks Later)||0
8009|NCT03250845|16056|P1|COMPLETED|Multigam 10% Infusion (3-4 Weeks Later)||30
8010|NCT03250845|16056|P1|STARTED|Multigam 10% Infusion (3-4 Weeks Later)||30
8011|NCT03250845|16056|P1|NOT COMPLETED|Multigam 5% Infusion (Baseline)||0
8012|NCT03250845|16056|P1|COMPLETED|Multigam 5% Infusion (Baseline)||30
8013|NCT03250845|16056|P1|STARTED|Multigam 5% Infusion (Baseline)||30
8014|NCT03250689|16067|P2|NOT COMPLETED|Overall Study||0
8015|NCT03250689|16068|P1|NOT COMPLETED|Overall Study||0
8016|NCT03250689|16067|P2|COMPLETED|Overall Study||14
8017|NCT03250689|16068|P1|COMPLETED|Overall Study||5
8018|NCT03250689|16067|P2|STARTED|Overall Study||14
8019|NCT03250689|16068|P1|STARTED|Overall Study||5
8020|NCT03249935|16128|P1|NOT COMPLETED|Overall Study||45
8021|NCT03249935|16128|P1|COMPLETED|Overall Study||55
8022|NCT03249935|16128|P1|STARTED|Overall Study||100
8023|NCT03249779|16134|P1|NOT COMPLETED|Overall Study||0
8024|NCT03249779|16134|P1|COMPLETED|Overall Study||8
8025|NCT03249779|16134|P1|STARTED|Overall Study||8
8026|NCT03248141|16141|P2|NOT COMPLETED|Overall Study||0
8027|NCT03248141|16142|P1|NOT COMPLETED|Overall Study||0
8028|NCT03248141|16141|P2|COMPLETED|Overall Study||0
8029|NCT03248141|16142|P1|COMPLETED|Overall Study|Participants who were present in the study till termination were considered as completed.|11
8030|NCT03248141|16141|P2|STARTED|Overall Study|No enrollment occurred in this arm prior to study termination.|0
8031|NCT03248141|16142|P1|STARTED|Overall Study||11
8032|NCT03247985|16152|P2|NOT COMPLETED|Overall Study||0
8033|NCT03247985|16153|P1|NOT COMPLETED|Overall Study||0
8034|NCT03247985|16152|P2|COMPLETED|Overall Study||19
8035|NCT03247985|16153|P1|COMPLETED|Overall Study||19
8036|NCT03247985|16152|P2|STARTED|Overall Study||19
8037|NCT03247985|16153|P1|STARTED|Overall Study||19
8038|NCT03247673|16170|P3|NOT COMPLETED|Overall Study||4
8039|NCT03247673|16171|P2|NOT COMPLETED|Overall Study||0
8040|NCT03247673|16172|P1|NOT COMPLETED|Overall Study||1
8041|NCT03247673|16170|P3|COMPLETED|Overall Study||44
8042|NCT03247673|16171|P2|COMPLETED|Overall Study||47
8043|NCT03247673|16172|P1|COMPLETED|Overall Study||45
8044|NCT03247673|16170|P3|STARTED|Overall Study||48
8045|NCT03247673|16171|P2|STARTED|Overall Study||47
8046|NCT03247673|16172|P1|STARTED|Overall Study||46
8047|NCT03246672|16192|P1|NOT COMPLETED|Overall Study||2
8048|NCT03246672|16192|P1|COMPLETED|Overall Study||28
8049|NCT03246672|16192|P1|Completed First Phone Call|Overall Study||29
8050|NCT03246672|16192|P1|STARTED|Overall Study||30
8051|NCT03245762|16200|P2|NOT COMPLETED|Overall Study||0
8052|NCT03245762|16201|P1|NOT COMPLETED|Overall Study||0
8053|NCT03245762|16200|P2|COMPLETED|Overall Study||5
8054|NCT03245762|16201|P1|COMPLETED|Overall Study||10
8055|NCT03245762|16200|P2|STARTED|Overall Study||5
8056|NCT03245762|16201|P1|STARTED|Overall Study||10
8057|NCT03245619|16224|P17|NOT COMPLETED|Part C (Up to 34 Days)||0
8058|NCT03245619|16225|P16|NOT COMPLETED|Part C (Up to 34 Days)||0
8059|NCT03245619|16226|P15|NOT COMPLETED|Part C (Up to 34 Days)||0
8060|NCT03245619|16227|P14|NOT COMPLETED|Part C (Up to 34 Days)||0
8061|NCT03245619|16228|P13|NOT COMPLETED|Part C (Up to 34 Days)||0
8062|NCT03245619|16229|P12|NOT COMPLETED|Part C (Up to 34 Days)||0
8063|NCT03245619|16230|P11|NOT COMPLETED|Part C (Up to 34 Days)||0
8064|NCT03245619|16231|P10|NOT COMPLETED|Part C (Up to 34 Days)||0
8065|NCT03245619|16232|P9|NOT COMPLETED|Part C (Up to 34 Days)||0
8066|NCT03245619|16233|P8|NOT COMPLETED|Part C (Up to 34 Days)||0
8067|NCT03245619|16234|P7|NOT COMPLETED|Part C (Up to 34 Days)||0
8068|NCT03245619|16235|P6|NOT COMPLETED|Part C (Up to 34 Days)||0
8069|NCT03245619|16236|P5|NOT COMPLETED|Part C (Up to 34 Days)||0
8070|NCT03245619|16237|P4|NOT COMPLETED|Part C (Up to 34 Days)||0
8071|NCT03245619|16238|P3|NOT COMPLETED|Part C (Up to 34 Days)||0
8072|NCT03245619|16239|P2|NOT COMPLETED|Part C (Up to 34 Days)||0
8073|NCT03245619|16240|P1|NOT COMPLETED|Part C (Up to 34 Days)||0
8074|NCT03245619|16224|P17|COMPLETED|Part C (Up to 34 Days)||0
8075|NCT03245619|16225|P16|COMPLETED|Part C (Up to 34 Days)||0
8076|NCT03245619|16226|P15|COMPLETED|Part C (Up to 34 Days)||0
8077|NCT03245619|16227|P14|COMPLETED|Part C (Up to 34 Days)||0
8078|NCT03245619|16228|P13|COMPLETED|Part C (Up to 34 Days)||0
8079|NCT03245619|16229|P12|COMPLETED|Part C (Up to 34 Days)||0
8080|NCT03245619|16230|P11|COMPLETED|Part C (Up to 34 Days)||0
8081|NCT03245619|16231|P10|COMPLETED|Part C (Up to 34 Days)||0
8082|NCT03245619|16232|P9|COMPLETED|Part C (Up to 34 Days)||0
8083|NCT03245619|16233|P8|COMPLETED|Part C (Up to 34 Days)||0
8084|NCT03245619|16234|P7|COMPLETED|Part C (Up to 34 Days)||0
8085|NCT03245619|16235|P6|COMPLETED|Part C (Up to 34 Days)||0
8086|NCT03245619|16236|P5|COMPLETED|Part C (Up to 34 Days)||0
8087|NCT03245619|16237|P4|COMPLETED|Part C (Up to 34 Days)||0
8088|NCT03245619|16238|P3|COMPLETED|Part C (Up to 34 Days)||0
8089|NCT03245619|16239|P2|COMPLETED|Part C (Up to 34 Days)||0
8090|NCT03245619|16240|P1|COMPLETED|Part C (Up to 34 Days)||0
8091|NCT03245619|16224|P17|STARTED|Part C (Up to 34 Days)||0
8092|NCT03245619|16225|P16|STARTED|Part C (Up to 34 Days)||0
8093|NCT03245619|16226|P15|STARTED|Part C (Up to 34 Days)||0
8094|NCT03245619|16227|P14|STARTED|Part C (Up to 34 Days)||0
8095|NCT03245619|16228|P13|STARTED|Part C (Up to 34 Days)||0
8096|NCT03245619|16229|P12|STARTED|Part C (Up to 34 Days)||0
8097|NCT03245619|16230|P11|STARTED|Part C (Up to 34 Days)||0
8098|NCT03245619|16231|P10|STARTED|Part C (Up to 34 Days)||0
8099|NCT03245619|16232|P9|STARTED|Part C (Up to 34 Days)||0
8100|NCT03245619|16233|P8|STARTED|Part C (Up to 34 Days)||0
8101|NCT03245619|16234|P7|STARTED|Part C (Up to 34 Days)||0
8102|NCT03245619|16235|P6|STARTED|Part C (Up to 34 Days)||0
8103|NCT03245619|16236|P5|STARTED|Part C (Up to 34 Days)||0
8104|NCT03245619|16237|P4|STARTED|Part C (Up to 34 Days)||0
8105|NCT03245619|16238|P3|STARTED|Part C (Up to 34 Days)||0
8106|NCT03245619|16239|P2|STARTED|Part C (Up to 34 Days)||0
8107|NCT03245619|16240|P1|STARTED|Part C (Up to 34 Days)||0
8108|NCT03245619|16224|P17|NOT COMPLETED|Part B (Up to 34 Days)||0
8109|NCT03245619|16225|P16|NOT COMPLETED|Part B (Up to 34 Days)||0
8110|NCT03245619|16226|P15|NOT COMPLETED|Part B (Up to 34 Days)||0
8111|NCT03245619|16227|P14|NOT COMPLETED|Part B (Up to 34 Days)||0
8112|NCT03245619|16228|P13|NOT COMPLETED|Part B (Up to 34 Days)||0
8113|NCT03245619|16229|P12|NOT COMPLETED|Part B (Up to 34 Days)||0
8114|NCT03245619|16230|P11|NOT COMPLETED|Part B (Up to 34 Days)||0
8115|NCT03245619|16231|P10|NOT COMPLETED|Part B (Up to 34 Days)||0
8116|NCT03245619|16232|P9|NOT COMPLETED|Part B (Up to 34 Days)||0
8117|NCT03245619|16233|P8|NOT COMPLETED|Part B (Up to 34 Days)||0
8118|NCT03245619|16234|P7|NOT COMPLETED|Part B (Up to 34 Days)||0
8119|NCT03245619|16235|P6|NOT COMPLETED|Part B (Up to 34 Days)||0
8120|NCT03245619|16236|P5|NOT COMPLETED|Part B (Up to 34 Days)||0
8121|NCT03245619|16237|P4|NOT COMPLETED|Part B (Up to 34 Days)||0
8122|NCT03245619|16238|P3|NOT COMPLETED|Part B (Up to 34 Days)||0
8123|NCT03245619|16239|P2|NOT COMPLETED|Part B (Up to 34 Days)||0
8124|NCT03245619|16240|P1|NOT COMPLETED|Part B (Up to 34 Days)||0
8125|NCT03245619|16224|P17|COMPLETED|Part B (Up to 34 Days)||0
8126|NCT03245619|16225|P16|COMPLETED|Part B (Up to 34 Days)||0
8127|NCT03245619|16226|P15|COMPLETED|Part B (Up to 34 Days)||0
8128|NCT03245619|16227|P14|COMPLETED|Part B (Up to 34 Days)||0
8129|NCT03245619|16228|P13|COMPLETED|Part B (Up to 34 Days)||0
8130|NCT03245619|16229|P12|COMPLETED|Part B (Up to 34 Days)||0
8131|NCT03245619|16230|P11|COMPLETED|Part B (Up to 34 Days)||0
8132|NCT03245619|16231|P10|COMPLETED|Part B (Up to 34 Days)||0
8133|NCT03245619|16232|P9|COMPLETED|Part B (Up to 34 Days)||0
8134|NCT03245619|16233|P8|COMPLETED|Part B (Up to 34 Days)||0
8135|NCT03245619|16234|P7|COMPLETED|Part B (Up to 34 Days)||0
8136|NCT03245619|16235|P6|COMPLETED|Part B (Up to 34 Days)||0
8137|NCT03245619|16236|P5|COMPLETED|Part B (Up to 34 Days)||0
8138|NCT03245619|16237|P4|COMPLETED|Part B (Up to 34 Days)||0
8139|NCT03245619|16238|P3|COMPLETED|Part B (Up to 34 Days)||0
8140|NCT03245619|16239|P2|COMPLETED|Part B (Up to 34 Days)||0
8141|NCT03245619|16240|P1|COMPLETED|Part B (Up to 34 Days)||0
8142|NCT03245619|16224|P17|STARTED|Part B (Up to 34 Days)||0
8143|NCT03245619|16225|P16|STARTED|Part B (Up to 34 Days)||0
8144|NCT03245619|16226|P15|STARTED|Part B (Up to 34 Days)||0
8145|NCT03245619|16227|P14|STARTED|Part B (Up to 34 Days)||0
8146|NCT03245619|16228|P13|STARTED|Part B (Up to 34 Days)||0
8147|NCT03245619|16229|P12|STARTED|Part B (Up to 34 Days)||0
8148|NCT03245619|16230|P11|STARTED|Part B (Up to 34 Days)||0
8149|NCT03245619|16231|P10|STARTED|Part B (Up to 34 Days)||0
8150|NCT03245619|16232|P9|STARTED|Part B (Up to 34 Days)||0
8151|NCT03245619|16233|P8|STARTED|Part B (Up to 34 Days)||0
8152|NCT03245619|16234|P7|STARTED|Part B (Up to 34 Days)||0
8153|NCT03245619|16235|P6|STARTED|Part B (Up to 34 Days)||0
8154|NCT03245619|16236|P5|STARTED|Part B (Up to 34 Days)||0
8155|NCT03245619|16237|P4|STARTED|Part B (Up to 34 Days)||0
8156|NCT03245619|16238|P3|STARTED|Part B (Up to 34 Days)||0
8157|NCT03245619|16239|P2|STARTED|Part B (Up to 34 Days)||0
8158|NCT03245619|16240|P1|STARTED|Part B (Up to 34 Days)||0
8159|NCT03245619|16224|P17|NOT COMPLETED|Part A (Up to Day 22)||0
8160|NCT03245619|16225|P16|NOT COMPLETED|Part A (Up to Day 22)||0
8161|NCT03245619|16226|P15|NOT COMPLETED|Part A (Up to Day 22)||0
8162|NCT03245619|16227|P14|NOT COMPLETED|Part A (Up to Day 22)||0
8163|NCT03245619|16228|P13|NOT COMPLETED|Part A (Up to Day 22)||0
8164|NCT03245619|16229|P12|NOT COMPLETED|Part A (Up to Day 22)||0
8165|NCT03245619|16230|P11|NOT COMPLETED|Part A (Up to Day 22)||0
8166|NCT03245619|16231|P10|NOT COMPLETED|Part A (Up to Day 22)||0
8167|NCT03245619|16232|P9|NOT COMPLETED|Part A (Up to Day 22)||0
8168|NCT03245619|16233|P8|NOT COMPLETED|Part A (Up to Day 22)||0
8169|NCT03245619|16234|P7|NOT COMPLETED|Part A (Up to Day 22)||0
8170|NCT03245619|16235|P6|NOT COMPLETED|Part A (Up to Day 22)||0
8171|NCT03245619|16236|P5|NOT COMPLETED|Part A (Up to Day 22)||0
8172|NCT03245619|16237|P4|NOT COMPLETED|Part A (Up to Day 22)||0
8173|NCT03245619|16238|P3|NOT COMPLETED|Part A (Up to Day 22)||6
8174|NCT03245619|16239|P2|NOT COMPLETED|Part A (Up to Day 22)||6
8175|NCT03245619|16240|P1|NOT COMPLETED|Part A (Up to Day 22)||4
8176|NCT03245619|16224|P17|COMPLETED|Part A (Up to Day 22)||0
8177|NCT03245619|16225|P16|COMPLETED|Part A (Up to Day 22)||0
8178|NCT03245619|16226|P15|COMPLETED|Part A (Up to Day 22)||0
8179|NCT03245619|16227|P14|COMPLETED|Part A (Up to Day 22)||0
8180|NCT03245619|16228|P13|COMPLETED|Part A (Up to Day 22)||0
8181|NCT03245619|16229|P12|COMPLETED|Part A (Up to Day 22)||0
8182|NCT03245619|16230|P11|COMPLETED|Part A (Up to Day 22)||0
8183|NCT03245619|16231|P10|COMPLETED|Part A (Up to Day 22)||0
8184|NCT03245619|16232|P9|COMPLETED|Part A (Up to Day 22)||0
8185|NCT03245619|16233|P8|COMPLETED|Part A (Up to Day 22)||0
8186|NCT03245619|16234|P7|COMPLETED|Part A (Up to Day 22)||0
8187|NCT03245619|16235|P6|COMPLETED|Part A (Up to Day 22)||0
8188|NCT03245619|16236|P5|COMPLETED|Part A (Up to Day 22)||0
8189|NCT03245619|16237|P4|COMPLETED|Part A (Up to Day 22)||1
8190|NCT03245619|16238|P3|COMPLETED|Part A (Up to Day 22)||0
8191|NCT03245619|16239|P2|COMPLETED|Part A (Up to Day 22)||0
8192|NCT03245619|16240|P1|COMPLETED|Part A (Up to Day 22)||1
8193|NCT03245619|16224|P17|STARTED|Part A (Up to Day 22)||0
8194|NCT03245619|16225|P16|STARTED|Part A (Up to Day 22)||0
8195|NCT03245619|16226|P15|STARTED|Part A (Up to Day 22)||0
8196|NCT03245619|16227|P14|STARTED|Part A (Up to Day 22)||0
8197|NCT03245619|16228|P13|STARTED|Part A (Up to Day 22)||0
8198|NCT03245619|16229|P12|STARTED|Part A (Up to Day 22)||0
8199|NCT03245619|16230|P11|STARTED|Part A (Up to Day 22)||0
8200|NCT03245619|16231|P10|STARTED|Part A (Up to Day 22)||0
8201|NCT03245619|16232|P9|STARTED|Part A (Up to Day 22)||0
8202|NCT03245619|16233|P8|STARTED|Part A (Up to Day 22)||0
8203|NCT03245619|16234|P7|STARTED|Part A (Up to Day 22)||0
8204|NCT03245619|16235|P6|STARTED|Part A (Up to Day 22)||0
8205|NCT03245619|16236|P5|STARTED|Part A (Up to Day 22)||0
8206|NCT03245619|16237|P4|STARTED|Part A (Up to Day 22)||1
8207|NCT03245619|16238|P3|STARTED|Part A (Up to Day 22)||6
8208|NCT03245619|16239|P2|STARTED|Part A (Up to Day 22)||6
8209|NCT03245619|16240|P1|STARTED|Part A (Up to Day 22)||5
8210|NCT03245463|16495|P2|NOT COMPLETED|Overall Study||0
8211|NCT03245463|16496|P1|NOT COMPLETED|Overall Study||0
8212|NCT03245463|16495|P2|COMPLETED|Overall Study||12
8213|NCT03245463|16496|P1|COMPLETED|Overall Study||12
8214|NCT03245463|16495|P2|STARTED|Overall Study||12
8215|NCT03245463|16496|P1|STARTED|Overall Study||12
8216|NCT03245398|16514|P2|NOT COMPLETED|Overall Study||0
8217|NCT03245398|16515|P1|NOT COMPLETED|Overall Study||1
8218|NCT03245398|16514|P2|COMPLETED|Overall Study||93
8219|NCT03245398|16515|P1|COMPLETED|Overall Study||92
8220|NCT03245398|16514|P2|STARTED|Overall Study||93
8221|NCT03245398|16515|P1|STARTED|Overall Study||93
8222|NCT03244865|16537|P1|NOT COMPLETED|Overall Study||0
8223|NCT03244865|16537|P1|COMPLETED|Overall Study||35
8224|NCT03244865|16537|P1|STARTED|Overall Study||35
8225|NCT03244800|16545|P4|NOT COMPLETED|Overall Study||2
8226|NCT03244800|16546|P3|NOT COMPLETED|Overall Study||0
8227|NCT03244800|16547|P2|NOT COMPLETED|Overall Study||1
8228|NCT03244800|16548|P1|NOT COMPLETED|Overall Study||0
8229|NCT03244800|16545|P4|COMPLETED|Overall Study||18
8230|NCT03244800|16546|P3|COMPLETED|Overall Study||6
8231|NCT03244800|16547|P2|COMPLETED|Overall Study||25
8232|NCT03244800|16548|P1|COMPLETED|Overall Study||13
8233|NCT03244800|16545|P4|STARTED|Overall Study||20
8234|NCT03244800|16546|P3|STARTED|Overall Study||6
8235|NCT03244800|16547|P2|STARTED|Overall Study||26
8236|NCT03244800|16548|P1|STARTED|Overall Study||13
8237|NCT03243981|16606|P1|NOT COMPLETED|Overall Study||0
8238|NCT03243981|16606|P1|COMPLETED|Overall Study||5
8239|NCT03243981|16606|P1|STARTED|Overall Study||5
8240|NCT03243084|16627|P2|NOT COMPLETED|Session 2||0
8241|NCT03243084|16628|P1|NOT COMPLETED|Session 2||0
8242|NCT03243084|16627|P2|COMPLETED|Session 2||10
8243|NCT03243084|16628|P1|COMPLETED|Session 2||10
8244|NCT03243084|16627|P2|STARTED|Session 2||10
8245|NCT03243084|16628|P1|STARTED|Session 2||10
8246|NCT03243084|16627|P2|NOT COMPLETED|Washout (1-3 Weeks)||0
8247|NCT03243084|16628|P1|NOT COMPLETED|Washout (1-3 Weeks)||1
8248|NCT03243084|16627|P2|COMPLETED|Washout (1-3 Weeks)||10
8249|NCT03243084|16628|P1|COMPLETED|Washout (1-3 Weeks)||10
8250|NCT03243084|16627|P2|STARTED|Washout (1-3 Weeks)||10
8251|NCT03243084|16628|P1|STARTED|Washout (1-3 Weeks)||11
8252|NCT03243084|16627|P2|NOT COMPLETED|Session 1||0
8253|NCT03243084|16628|P1|NOT COMPLETED|Session 1||0
8254|NCT03243084|16627|P2|COMPLETED|Session 1||10
8255|NCT03243084|16628|P1|COMPLETED|Session 1||11
8256|NCT03243084|16627|P2|STARTED|Session 1||10
8257|NCT03243084|16628|P1|STARTED|Session 1||11
8258|NCT03242941|16638|P1|NOT COMPLETED|Overall Study||2
8259|NCT03242941|16638|P1|COMPLETED|Overall Study||14
8260|NCT03242941|16638|P1|STARTED|Overall Study||16
8261|NCT03242590|16644|P1|NOT COMPLETED|Overall Study||0
8262|NCT03242590|16644|P1|COMPLETED|Overall Study||95
8263|NCT03242590|16644|P1|STARTED|Overall Study||95
8264|NCT03242434|16650|P2|NOT COMPLETED|Overall Study||2
8265|NCT03242434|16651|P1|NOT COMPLETED|Overall Study||0
8266|NCT03242434|16650|P2|COMPLETED|Overall Study||1
8267|NCT03242434|16651|P1|COMPLETED|Overall Study||15
8268|NCT03242434|16650|P2|STARTED|Overall Study||3
8269|NCT03242434|16651|P1|STARTED|Overall Study||15
8270|NCT03242408|16659|P1|NOT COMPLETED|Overall Study||2
8271|NCT03242408|16659|P1|COMPLETED|Overall Study||98
8272|NCT03242408|16659|P1|STARTED|Overall Study||100
8273|NCT03239873|16665|P2|NOT COMPLETED|Overall Study||27
8274|NCT03239873|16666|P1|NOT COMPLETED|Overall Study||32
8275|NCT03239873|16665|P2|COMPLETED|Overall Study||273
8276|NCT03239873|16666|P1|COMPLETED|Overall Study||268
8277|NCT03239873|16665|P2|Vaccination 2|Overall Study||282
8278|NCT03239873|16666|P1|Vaccination 2|Overall Study||276
8279|NCT03239873|16665|P2|Vaccination 1|Overall Study||300
8280|NCT03239873|16666|P1|Vaccination 1|Overall Study||299
8281|NCT03239873|16665|P2|STARTED|Overall Study||300
8282|NCT03239873|16666|P1|STARTED|Overall Study||300
8283|NCT03239522|16710|P1|NOT COMPLETED|Treatment Period 2 (Up to 15 Days)||0
8284|NCT03239522|16710|P1|COMPLETED|Treatment Period 2 (Up to 15 Days)||6
8285|NCT03239522|16710|P1|STARTED|Treatment Period 2 (Up to 15 Days)||6
8286|NCT03239522|16710|P1|NOT COMPLETED|Washout Period (Up to 7 Days)||0
8287|NCT03239522|16710|P1|COMPLETED|Washout Period (Up to 7 Days)||6
8288|NCT03239522|16710|P1|STARTED|Washout Period (Up to 7 Days)||6
8289|NCT03239522|16710|P1|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
8290|NCT03239522|16710|P1|COMPLETED|Treatment Period 1 (Up to 7 Days)||6
8291|NCT03239522|16710|P1|STARTED|Treatment Period 1 (Up to 7 Days)||6
8292|NCT03239483|16798|P2|NOT COMPLETED|Overall Study||0
8293|NCT03239483|16799|P1|NOT COMPLETED|Overall Study||2
8294|NCT03239483|16798|P2|COMPLETED|Overall Study||9
8295|NCT03239483|16799|P1|COMPLETED|Overall Study||17
8296|NCT03239483|16798|P2|STARTED|Overall Study||9
8297|NCT03239483|16799|P1|STARTED|Overall Study||19
8298|NCT03238924|16815|P2|NOT COMPLETED|Overall Study||2
8299|NCT03238924|16816|P1|NOT COMPLETED|Overall Study||2
8300|NCT03238924|16815|P2|COMPLETED|Overall Study||7
8301|NCT03238924|16816|P1|COMPLETED|Overall Study||6
8302|NCT03238924|16815|P2|STARTED|Overall Study||9
8303|NCT03238924|16816|P1|STARTED|Overall Study||8
8304|NCT03238352|16829|P3|NOT COMPLETED|Overall Study||1
8305|NCT03238352|16830|P2|NOT COMPLETED|Overall Study||3
8306|NCT03238352|16831|P1|NOT COMPLETED|Overall Study||0
8307|NCT03238352|16829|P3|COMPLETED|Overall Study||22
8308|NCT03238352|16830|P2|COMPLETED|Overall Study||20
8309|NCT03238352|16831|P1|COMPLETED|Overall Study||43
8310|NCT03238352|16829|P3|STARTED|Overall Study||23
8311|NCT03238352|16830|P2|STARTED|Overall Study||23
8312|NCT03238352|16831|P1|STARTED|Overall Study||43
8313|NCT03238001|16842|P1|NOT COMPLETED|Visit 2 (Secondary Endpoint Cohort)||29
8314|NCT03238001|16842|P1|COMPLETED|Visit 2 (Secondary Endpoint Cohort)||403
8315|NCT03238001|16842|P1|STARTED|Visit 2 (Secondary Endpoint Cohort)||432
8316|NCT03238001|16842|P1|NOT COMPLETED|Visit 1 (Primary Endpoint Cohort)||4
8317|NCT03238001|16842|P1|COMPLETED|Visit 1 (Primary Endpoint Cohort)||432
8318|NCT03238001|16842|P1|STARTED|Visit 1 (Primary Endpoint Cohort)||436
8319|NCT03237871|16865|P1|NOT COMPLETED|Overall Study||6
8320|NCT03237871|16865|P1|COMPLETED|Overall Study||11
8321|NCT03237871|16865|P1|STARTED|Overall Study||17
8322|NCT03237156|16875|P4|NOT COMPLETED|Overall Study||0
8323|NCT03237156|16876|P3|NOT COMPLETED|Overall Study||0
8324|NCT03237156|16877|P2|NOT COMPLETED|Overall Study||0
8325|NCT03237156|16878|P1|NOT COMPLETED|Overall Study||0
8326|NCT03237156|16875|P4|COMPLETED|Overall Study||6
8327|NCT03237156|16876|P3|COMPLETED|Overall Study||6
8328|NCT03237156|16877|P2|COMPLETED|Overall Study||6
8329|NCT03237156|16878|P1|COMPLETED|Overall Study||6
8330|NCT03237156|16875|P4|STARTED|Overall Study||6
8331|NCT03237156|16876|P3|STARTED|Overall Study||6
8332|NCT03237156|16877|P2|STARTED|Overall Study||6
8333|NCT03237156|16878|P1|STARTED|Overall Study||6
8334|NCT03237013|16972|P3|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||37
8335|NCT03237013|16973|P2|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||30
8336|NCT03237013|16974|P1|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||43
8337|NCT03237013|16972|P3|COMPLETED|Immediate Post-treatment to 1-mo F/u||36
8338|NCT03237013|16973|P2|COMPLETED|Immediate Post-treatment to 1-mo F/u||43
8339|NCT03237013|16974|P1|COMPLETED|Immediate Post-treatment to 1-mo F/u||30
8340|NCT03237013|16972|P3|STARTED|Immediate Post-treatment to 1-mo F/u||73
8341|NCT03237013|16973|P2|STARTED|Immediate Post-treatment to 1-mo F/u||73
8342|NCT03237013|16974|P1|STARTED|Immediate Post-treatment to 1-mo F/u||73
8343|NCT03237013|16972|P3|NOT COMPLETED|Baseline to Immediate Post-treatment||0
8344|NCT03237013|16973|P2|NOT COMPLETED|Baseline to Immediate Post-treatment||0
8345|NCT03237013|16974|P1|NOT COMPLETED|Baseline to Immediate Post-treatment||0
8346|NCT03237013|16972|P3|COMPLETED|Baseline to Immediate Post-treatment||73
8347|NCT03237013|16973|P2|COMPLETED|Baseline to Immediate Post-treatment||73
8348|NCT03237013|16974|P1|COMPLETED|Baseline to Immediate Post-treatment||73
8349|NCT03237013|16972|P3|STARTED|Baseline to Immediate Post-treatment||73
8350|NCT03237013|16973|P2|STARTED|Baseline to Immediate Post-treatment||73
8351|NCT03237013|16974|P1|STARTED|Baseline to Immediate Post-treatment||73
8352|NCT03236311|17023|P2|NOT COMPLETED|Overall Study||3
8353|NCT03236311|17024|P1|NOT COMPLETED|Overall Study||0
8354|NCT03236311|17023|P2|COMPLETED|Overall Study||2
8355|NCT03236311|17024|P1|COMPLETED|Overall Study||5
8356|NCT03236311|17023|P2|STARTED|Overall Study||5
8357|NCT03236311|17024|P1|STARTED|Overall Study||5
8358|NCT03236168|17034|P1|NOT COMPLETED|Overall Study||11
8359|NCT03236168|17034|P1|COMPLETED|Overall Study||107
8360|NCT03236168|17034|P1|STARTED|Overall Study||118
8361|NCT03235817|17041|P3|NOT COMPLETED|Overall Study||2
8362|NCT03235817|17042|P2|NOT COMPLETED|Overall Study||1
8363|NCT03235817|17043|P1|NOT COMPLETED|Overall Study||3
8364|NCT03235817|17041|P3|COMPLETED|Overall Study||11
8365|NCT03235817|17042|P2|COMPLETED|Overall Study||12
8366|NCT03235817|17043|P1|COMPLETED|Overall Study||10
8367|NCT03235817|17041|P3|STARTED|Overall Study||13
8368|NCT03235817|17042|P2|STARTED|Overall Study||13
8369|NCT03235817|17043|P1|STARTED|Overall Study||13
8370|NCT03235726|17068|P10|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8371|NCT03235726|17069|P9|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8372|NCT03235726|17070|P8|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8373|NCT03235726|17071|P7|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8374|NCT03235726|17072|P6|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8375|NCT03235726|17073|P5|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8376|NCT03235726|17074|P4|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8377|NCT03235726|17075|P3|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8378|NCT03235726|17076|P2|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8379|NCT03235726|17077|P1|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8380|NCT03235726|17068|P10|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||8
8381|NCT03235726|17069|P9|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8382|NCT03235726|17070|P8|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8383|NCT03235726|17071|P7|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8384|NCT03235726|17072|P6|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8385|NCT03235726|17073|P5|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8386|NCT03235726|17074|P4|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8387|NCT03235726|17075|P3|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8388|NCT03235726|17076|P2|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8389|NCT03235726|17077|P1|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8390|NCT03235726|17068|P10|STARTED|Part 2 (Cohort B - Days 1 to 14)||8
8391|NCT03235726|17069|P9|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
8392|NCT03235726|17070|P8|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
8393|NCT03235726|17071|P7|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
8394|NCT03235726|17072|P6|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
8395|NCT03235726|17073|P5|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
8396|NCT03235726|17074|P4|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
8397|NCT03235726|17075|P3|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
8398|NCT03235726|17076|P2|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
8399|NCT03235726|17077|P1|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
8400|NCT03235726|17068|P10|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
8401|NCT03235726|17069|P9|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
8402|NCT03235726|17070|P8|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
8403|NCT03235726|17071|P7|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
8404|NCT03235726|17072|P6|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
8405|NCT03235726|17073|P5|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
8406|NCT03235726|17074|P4|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
8407|NCT03235726|17075|P3|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
8408|NCT03235726|17076|P2|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
8409|NCT03235726|17077|P1|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
8410|NCT03235726|17068|P10|COMPLETED|Part 2 (Cohort A - Day 1)||0
8411|NCT03235726|17069|P9|COMPLETED|Part 2 (Cohort A - Day 1)||2
8412|NCT03235726|17070|P8|COMPLETED|Part 2 (Cohort A - Day 1)||6
8413|NCT03235726|17071|P7|COMPLETED|Part 2 (Cohort A - Day 1)||0
8414|NCT03235726|17072|P6|COMPLETED|Part 2 (Cohort A - Day 1)||0
8415|NCT03235726|17073|P5|COMPLETED|Part 2 (Cohort A - Day 1)||0
8416|NCT03235726|17074|P4|COMPLETED|Part 2 (Cohort A - Day 1)||0
8417|NCT03235726|17075|P3|COMPLETED|Part 2 (Cohort A - Day 1)||0
8418|NCT03235726|17076|P2|COMPLETED|Part 2 (Cohort A - Day 1)||0
8419|NCT03235726|17077|P1|COMPLETED|Part 2 (Cohort A - Day 1)||0
8420|NCT03235726|17068|P10|STARTED|Part 2 (Cohort A - Day 1)||0
8421|NCT03235726|17069|P9|STARTED|Part 2 (Cohort A - Day 1)||2
8422|NCT03235726|17070|P8|STARTED|Part 2 (Cohort A - Day 1)||6
8423|NCT03235726|17071|P7|STARTED|Part 2 (Cohort A - Day 1)||0
8424|NCT03235726|17072|P6|STARTED|Part 2 (Cohort A - Day 1)||0
8425|NCT03235726|17073|P5|STARTED|Part 2 (Cohort A - Day 1)||0
8426|NCT03235726|17074|P4|STARTED|Part 2 (Cohort A - Day 1)||0
8427|NCT03235726|17075|P3|STARTED|Part 2 (Cohort A - Day 1)||0
8428|NCT03235726|17076|P2|STARTED|Part 2 (Cohort A - Day 1)||0
8429|NCT03235726|17077|P1|STARTED|Part 2 (Cohort A - Day 1)||0
8430|NCT03235726|17068|P10|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8431|NCT03235726|17069|P9|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8432|NCT03235726|17070|P8|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8433|NCT03235726|17071|P7|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8434|NCT03235726|17072|P6|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8435|NCT03235726|17073|P5|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||2
8436|NCT03235726|17074|P4|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8437|NCT03235726|17075|P3|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8438|NCT03235726|17076|P2|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8439|NCT03235726|17077|P1|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8440|NCT03235726|17068|P10|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8441|NCT03235726|17069|P9|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8442|NCT03235726|17070|P8|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8443|NCT03235726|17071|P7|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||14
8444|NCT03235726|17072|P6|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||2
8445|NCT03235726|17073|P5|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||10
8446|NCT03235726|17074|P4|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8447|NCT03235726|17075|P3|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8448|NCT03235726|17076|P2|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8449|NCT03235726|17077|P1|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8450|NCT03235726|17068|P10|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
8451|NCT03235726|17069|P9|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
8452|NCT03235726|17070|P8|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
8453|NCT03235726|17071|P7|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||14
8454|NCT03235726|17072|P6|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||2
8455|NCT03235726|17073|P5|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||12
8456|NCT03235726|17074|P4|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
8457|NCT03235726|17075|P3|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
8458|NCT03235726|17076|P2|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
8459|NCT03235726|17077|P1|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
8460|NCT03235726|17068|P10|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8461|NCT03235726|17069|P9|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8462|NCT03235726|17070|P8|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8463|NCT03235726|17071|P7|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8464|NCT03235726|17072|P6|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8465|NCT03235726|17073|P5|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8466|NCT03235726|17074|P4|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8467|NCT03235726|17075|P3|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8468|NCT03235726|17076|P2|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8469|NCT03235726|17077|P1|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8470|NCT03235726|17068|P10|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8471|NCT03235726|17069|P9|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8472|NCT03235726|17070|P8|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8473|NCT03235726|17071|P7|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8474|NCT03235726|17072|P6|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8475|NCT03235726|17073|P5|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8476|NCT03235726|17074|P4|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||2
8477|NCT03235726|17075|P3|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||6
8478|NCT03235726|17076|P2|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8479|NCT03235726|17077|P1|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8480|NCT03235726|17068|P10|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8481|NCT03235726|17069|P9|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8482|NCT03235726|17070|P8|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8483|NCT03235726|17071|P7|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8484|NCT03235726|17072|P6|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8485|NCT03235726|17073|P5|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8486|NCT03235726|17074|P4|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||2
8487|NCT03235726|17075|P3|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||6
8488|NCT03235726|17076|P2|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8489|NCT03235726|17077|P1|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8490|NCT03235726|17068|P10|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8491|NCT03235726|17069|P9|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8492|NCT03235726|17070|P8|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8493|NCT03235726|17071|P7|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8494|NCT03235726|17072|P6|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8495|NCT03235726|17073|P5|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8496|NCT03235726|17074|P4|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8497|NCT03235726|17075|P3|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8498|NCT03235726|17076|P2|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8499|NCT03235726|17077|P1|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8500|NCT03235726|17068|P10|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8501|NCT03235726|17069|P9|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8502|NCT03235726|17070|P8|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8503|NCT03235726|17071|P7|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8504|NCT03235726|17072|P6|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8505|NCT03235726|17073|P5|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8506|NCT03235726|17074|P4|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||2
8507|NCT03235726|17075|P3|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8508|NCT03235726|17076|P2|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||6
8509|NCT03235726|17077|P1|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8510|NCT03235726|17068|P10|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
8511|NCT03235726|17069|P9|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
8512|NCT03235726|17070|P8|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
8513|NCT03235726|17071|P7|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
8514|NCT03235726|17072|P6|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
8515|NCT03235726|17073|P5|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
8516|NCT03235726|17074|P4|STARTED|Part 1 (Cohort A 120 mg - Day 3)||2
8517|NCT03235726|17075|P3|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
8518|NCT03235726|17076|P2|STARTED|Part 1 (Cohort A 120 mg - Day 3)||6
8519|NCT03235726|17077|P1|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
8520|NCT03235726|17068|P10|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8521|NCT03235726|17069|P9|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8522|NCT03235726|17070|P8|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8523|NCT03235726|17071|P7|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8524|NCT03235726|17072|P6|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8525|NCT03235726|17073|P5|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8526|NCT03235726|17074|P4|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8527|NCT03235726|17075|P3|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8528|NCT03235726|17076|P2|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8529|NCT03235726|17077|P1|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8530|NCT03235726|17068|P10|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8531|NCT03235726|17069|P9|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8532|NCT03235726|17070|P8|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8533|NCT03235726|17071|P7|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8534|NCT03235726|17072|P6|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8535|NCT03235726|17073|P5|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8536|NCT03235726|17074|P4|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||2
8537|NCT03235726|17075|P3|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8538|NCT03235726|17076|P2|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8539|NCT03235726|17077|P1|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||6
8540|NCT03235726|17068|P10|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
8541|NCT03235726|17069|P9|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
8542|NCT03235726|17070|P8|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
8543|NCT03235726|17071|P7|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
8544|NCT03235726|17072|P6|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
8545|NCT03235726|17073|P5|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
8546|NCT03235726|17074|P4|STARTED|Part 1 (Cohort A 60 mg - Day 1)||2
8547|NCT03235726|17075|P3|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
8548|NCT03235726|17076|P2|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
8549|NCT03235726|17077|P1|STARTED|Part 1 (Cohort A 60 mg - Day 1)||6
8550|NCT03235349|17229|P1|NOT COMPLETED|Overall Study||2
8551|NCT03235349|17229|P1|COMPLETED|Overall Study||158
8552|NCT03235349|17229|P1|STARTED|Overall Study||160
8553|NCT03235284|17239|P3|NOT COMPLETED|Overall Study||1
8554|NCT03235284|17240|P2|NOT COMPLETED|Overall Study||2
8555|NCT03235284|17241|P1|NOT COMPLETED|Overall Study||1
8556|NCT03235284|17239|P3|COMPLETED|Overall Study||14
8557|NCT03235284|17240|P2|COMPLETED|Overall Study||13
8558|NCT03235284|17241|P1|COMPLETED|Overall Study||14
8559|NCT03235284|17239|P3|STARTED|Overall Study||15
8560|NCT03235284|17240|P2|STARTED|Overall Study||15
8561|NCT03235284|17241|P1|STARTED|Overall Study||15
8562|NCT03235115|17258|P6|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
8563|NCT03235115|17259|P5|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
8564|NCT03235115|17260|P4|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
8565|NCT03235115|17261|P3|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
8566|NCT03235115|17262|P2|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
8567|NCT03235115|17263|P1|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
8568|NCT03235115|17258|P6|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||5
8569|NCT03235115|17259|P5|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
8570|NCT03235115|17260|P4|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
8571|NCT03235115|17261|P3|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||7
8572|NCT03235115|17262|P2|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
8573|NCT03235115|17263|P1|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||9
8574|NCT03235115|17258|P6|STARTED|Third Intervention ( 1 Hour, Visit 6)||5
8575|NCT03235115|17259|P5|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
8576|NCT03235115|17260|P4|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
8577|NCT03235115|17261|P3|STARTED|Third Intervention ( 1 Hour, Visit 6)||7
8578|NCT03235115|17262|P2|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
8579|NCT03235115|17263|P1|STARTED|Third Intervention ( 1 Hour, Visit 6)||9
8580|NCT03235115|17258|P6|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
8581|NCT03235115|17259|P5|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
8582|NCT03235115|17260|P4|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
8583|NCT03235115|17261|P3|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
8584|NCT03235115|17262|P2|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
8585|NCT03235115|17263|P1|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
8586|NCT03235115|17258|P6|COMPLETED|Second Intervention (1 Hour, Visit 4)||5
8587|NCT03235115|17259|P5|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
8588|NCT03235115|17260|P4|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
8589|NCT03235115|17261|P3|COMPLETED|Second Intervention (1 Hour, Visit 4)||7
8590|NCT03235115|17262|P2|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
8591|NCT03235115|17263|P1|COMPLETED|Second Intervention (1 Hour, Visit 4)||9
8592|NCT03235115|17258|P6|STARTED|Second Intervention (1 Hour, Visit 4)||5
8593|NCT03235115|17259|P5|STARTED|Second Intervention (1 Hour, Visit 4)||6
8594|NCT03235115|17260|P4|STARTED|Second Intervention (1 Hour, Visit 4)||6
8595|NCT03235115|17261|P3|STARTED|Second Intervention (1 Hour, Visit 4)||7
8596|NCT03235115|17262|P2|STARTED|Second Intervention (1 Hour, Visit 4)||6
8597|NCT03235115|17263|P1|STARTED|Second Intervention (1 Hour, Visit 4)||9
8598|NCT03235115|17258|P6|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||1
8599|NCT03235115|17259|P5|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
8600|NCT03235115|17260|P4|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
8601|NCT03235115|17261|P3|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
8602|NCT03235115|17262|P2|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
8603|NCT03235115|17263|P1|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
8604|NCT03235115|17258|P6|COMPLETED|First Intervention (1 Hour, Visit 2)||5
8605|NCT03235115|17259|P5|COMPLETED|First Intervention (1 Hour, Visit 2)||6
8606|NCT03235115|17260|P4|COMPLETED|First Intervention (1 Hour, Visit 2)||6
8607|NCT03235115|17261|P3|COMPLETED|First Intervention (1 Hour, Visit 2)||7
8608|NCT03235115|17262|P2|COMPLETED|First Intervention (1 Hour, Visit 2)||6
8609|NCT03235115|17263|P1|COMPLETED|First Intervention (1 Hour, Visit 2)||9
8610|NCT03235115|17258|P6|STARTED|First Intervention (1 Hour, Visit 2)||6
8611|NCT03235115|17259|P5|STARTED|First Intervention (1 Hour, Visit 2)||6
8612|NCT03235115|17260|P4|STARTED|First Intervention (1 Hour, Visit 2)||6
8613|NCT03235115|17261|P3|STARTED|First Intervention (1 Hour, Visit 2)||7
8614|NCT03235115|17262|P2|STARTED|First Intervention (1 Hour, Visit 2)||6
8615|NCT03235115|17263|P1|STARTED|First Intervention (1 Hour, Visit 2)||9
8616|NCT03234036|17286|P4|NOT COMPLETED|Part 2 (Up to 25 Days)||0
8617|NCT03234036|17287|P3|NOT COMPLETED|Part 2 (Up to 25 Days)||0
8618|NCT03234036|17288|P2|NOT COMPLETED|Part 2 (Up to 25 Days)||0
8619|NCT03234036|17289|P1|NOT COMPLETED|Part 2 (Up to 25 Days)||0
8620|NCT03234036|17286|P4|COMPLETED|Part 2 (Up to 25 Days)||7
8621|NCT03234036|17287|P3|COMPLETED|Part 2 (Up to 25 Days)||3
8622|NCT03234036|17288|P2|COMPLETED|Part 2 (Up to 25 Days)||0
8623|NCT03234036|17289|P1|COMPLETED|Part 2 (Up to 25 Days)||0
8624|NCT03234036|17286|P4|STARTED|Part 2 (Up to 25 Days)||7
8625|NCT03234036|17287|P3|STARTED|Part 2 (Up to 25 Days)||3
8626|NCT03234036|17288|P2|STARTED|Part 2 (Up to 25 Days)||0
8627|NCT03234036|17289|P1|STARTED|Part 2 (Up to 25 Days)||0
8628|NCT03234036|17286|P4|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
8629|NCT03234036|17287|P3|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
8630|NCT03234036|17288|P2|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
8631|NCT03234036|17289|P1|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
8632|NCT03234036|17286|P4|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
8633|NCT03234036|17287|P3|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
8634|NCT03234036|17288|P2|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||7
8635|NCT03234036|17289|P1|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||7
8636|NCT03234036|17286|P4|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||0
8637|NCT03234036|17287|P3|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||0
8638|NCT03234036|17288|P2|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||7
8639|NCT03234036|17289|P1|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||7
8640|NCT03234036|17286|P4|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
8641|NCT03234036|17287|P3|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
8642|NCT03234036|17288|P2|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
8643|NCT03234036|17289|P1|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
8644|NCT03234036|17286|P4|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
8645|NCT03234036|17287|P3|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
8646|NCT03234036|17288|P2|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||7
8647|NCT03234036|17289|P1|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||7
8648|NCT03234036|17286|P4|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||0
8649|NCT03234036|17287|P3|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||0
8650|NCT03234036|17288|P2|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||7
8651|NCT03234036|17289|P1|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||7
8652|NCT03234036|17286|P4|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
8653|NCT03234036|17287|P3|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
8654|NCT03234036|17288|P2|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
8655|NCT03234036|17289|P1|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
8656|NCT03234036|17286|P4|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
8657|NCT03234036|17287|P3|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
8658|NCT03234036|17288|P2|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||7
8659|NCT03234036|17289|P1|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||7
8660|NCT03234036|17286|P4|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||0
8661|NCT03234036|17287|P3|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||0
8662|NCT03234036|17288|P2|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||7
8663|NCT03234036|17289|P1|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||7
8664|NCT03234036|17286|P4|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
8665|NCT03234036|17287|P3|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
8666|NCT03234036|17288|P2|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||1
8667|NCT03234036|17289|P1|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||1
8668|NCT03234036|17286|P4|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
8669|NCT03234036|17287|P3|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
8670|NCT03234036|17288|P2|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||7
8671|NCT03234036|17289|P1|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||7
8672|NCT03234036|17286|P4|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||0
8673|NCT03234036|17287|P3|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||0
8674|NCT03234036|17288|P2|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||8
8675|NCT03234036|17289|P1|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||8
8676|NCT03234036|17286|P4|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
8677|NCT03234036|17287|P3|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
8678|NCT03234036|17288|P2|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
8679|NCT03234036|17289|P1|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
8680|NCT03234036|17286|P4|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
8681|NCT03234036|17287|P3|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
8682|NCT03234036|17288|P2|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||8
8683|NCT03234036|17289|P1|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||8
8684|NCT03234036|17286|P4|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||0
8685|NCT03234036|17287|P3|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||0
8686|NCT03234036|17288|P2|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||8
8687|NCT03234036|17289|P1|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||8
8688|NCT03233737|17396|P5|NOT COMPLETED|Overall Study||0
8689|NCT03233737|17397|P4|NOT COMPLETED|Overall Study||0
8690|NCT03233737|17398|P3|NOT COMPLETED|Overall Study||0
8691|NCT03233737|17399|P2|NOT COMPLETED|Overall Study||0
8692|NCT03233737|17400|P1|NOT COMPLETED|Overall Study||0
8693|NCT03233737|17396|P5|COMPLETED|Overall Study||26
8694|NCT03233737|17397|P4|COMPLETED|Overall Study||24
8695|NCT03233737|17398|P3|COMPLETED|Overall Study||5
8696|NCT03233737|17399|P2|COMPLETED|Overall Study||10
8697|NCT03233737|17400|P1|COMPLETED|Overall Study||10
8698|NCT03233737|17396|P5|STARTED|Overall Study||26
8699|NCT03233737|17397|P4|STARTED|Overall Study||24
8700|NCT03233737|17398|P3|STARTED|Overall Study||5
8701|NCT03233737|17399|P2|STARTED|Overall Study||10
8702|NCT03233737|17400|P1|STARTED|Overall Study||10
8703|NCT03233529|17460|P1|NOT COMPLETED|Open-Label Period (Day 15 to Day 71)||1
8704|NCT03233529|17460|P1|COMPLETED|Open-Label Period (Day 15 to Day 71)||38
8705|NCT03233529|17460|P1|STARTED|Open-Label Period (Day 15 to Day 71)||39
8706|NCT03233529|17460|P1|NOT COMPLETED|Double-Blind Period (Day 1 to Day 15)||1
8707|NCT03233529|17460|P1|COMPLETED|Double-Blind Period (Day 1 to Day 15)||39
8708|NCT03233529|17460|P1|STARTED|Double-Blind Period (Day 1 to Day 15)||40
8709|NCT03233308|17502|P1|NOT COMPLETED|Overall Study||2
8710|NCT03233308|17502|P1|COMPLETED|Overall Study||18
8711|NCT03233308|17502|P1|STARTED|Overall Study||20
8712|NCT03233009|17514|P1|NOT COMPLETED|Overall Study||1
8713|NCT03233009|17514|P1|COMPLETED|Overall Study||39
8714|NCT03233009|17514|P1|Reference Product|Overall Study||39
8715|NCT03233009|17514|P1|Test Product 4|Overall Study||39
8716|NCT03233009|17514|P1|Test Product 3|Overall Study||39
8717|NCT03233009|17514|P1|Test Product 2|Overall Study||39
8718|NCT03233009|17514|P1|Test Product 1|Overall Study||39
8719|NCT03233009|17514|P1|STARTED|Overall Study||40
8720|NCT03232827|17557|P1|NOT COMPLETED|Flavored-very Low Sweetened||0
8721|NCT03232827|17557|P1|COMPLETED|Flavored-very Low Sweetened||66
8722|NCT03232827|17557|P1|STARTED|Flavored-very Low Sweetened||66
8723|NCT03232827|17557|P1|NOT COMPLETED|Unflavored-very Low Sweetened (UU)||0
8724|NCT03232827|17557|P1|COMPLETED|Unflavored-very Low Sweetened (UU)||66
8725|NCT03232827|17557|P1|STARTED|Unflavored-very Low Sweetened (UU)||66
8726|NCT03232827|17557|P1|NOT COMPLETED|Unflavored-sweetened (US)||0
8727|NCT03232827|17557|P1|COMPLETED|Unflavored-sweetened (US)||86
8728|NCT03232827|17557|P1|STARTED|Unflavored-sweetened (US)||86
8729|NCT03232827|17557|P1|NOT COMPLETED|Flavored-sweetened (FS)||0
8730|NCT03232827|17557|P1|COMPLETED|Flavored-sweetened (FS)||80
8731|NCT03232827|17557|P1|STARTED|Flavored-sweetened (FS)||80
8732|NCT03232567|17575|P4|NOT COMPLETED|Overall Study||0
8733|NCT03232567|17576|P3|NOT COMPLETED|Overall Study||0
8734|NCT03232567|17577|P2|NOT COMPLETED|Overall Study||1
8735|NCT03232567|17578|P1|NOT COMPLETED|Overall Study||0
8736|NCT03232567|17575|P4|COMPLETED|Overall Study||15
8737|NCT03232567|17576|P3|COMPLETED|Overall Study||15
8738|NCT03232567|17577|P2|COMPLETED|Overall Study||14
8739|NCT03232567|17578|P1|COMPLETED|Overall Study||15
8740|NCT03232567|17575|P4|STARTED|Overall Study||15
8741|NCT03232567|17576|P3|STARTED|Overall Study||15
8742|NCT03232567|17577|P2|STARTED|Overall Study||15
8743|NCT03232567|17578|P1|STARTED|Overall Study||15
8744|NCT03232333|17600|P1|NOT COMPLETED|Overall Study||15
8745|NCT03232333|17600|P1|COMPLETED|Overall Study||38
8746|NCT03232333|17600|P1|STARTED|Overall Study||53
8747|NCT03231943|17617|P13|NOT COMPLETED|Part 2||0
8748|NCT03231943|17618|P12|NOT COMPLETED|Part 2||1
8749|NCT03231943|17619|P11|NOT COMPLETED|Part 2||1
8750|NCT03231943|17620|P10|NOT COMPLETED|Part 2||0
8751|NCT03231943|17621|P9|NOT COMPLETED|Part 2||0
8752|NCT03231943|17622|P8|NOT COMPLETED|Part 2||0
8753|NCT03231943|17623|P7|NOT COMPLETED|Part 2||0
8754|NCT03231943|17624|P6|NOT COMPLETED|Part 2||0
8755|NCT03231943|17625|P5|NOT COMPLETED|Part 2||0
8756|NCT03231943|17626|P4|NOT COMPLETED|Part 2||0
8757|NCT03231943|17627|P3|NOT COMPLETED|Part 2||0
8758|NCT03231943|17628|P2|NOT COMPLETED|Part 2||0
8759|NCT03231943|17629|P1|NOT COMPLETED|Part 2||0
8760|NCT03231943|17617|P13|COMPLETED|Part 2||14
8761|NCT03231943|17618|P12|COMPLETED|Part 2||6
8762|NCT03231943|17619|P11|COMPLETED|Part 2||24
8763|NCT03231943|17620|P10|COMPLETED|Part 2||6
8764|NCT03231943|17621|P9|COMPLETED|Part 2||6
8765|NCT03231943|17622|P8|COMPLETED|Part 2||0
8766|NCT03231943|17623|P7|COMPLETED|Part 2||0
8767|NCT03231943|17624|P6|COMPLETED|Part 2||0
8768|NCT03231943|17625|P5|COMPLETED|Part 2||0
8769|NCT03231943|17626|P4|COMPLETED|Part 2||0
8770|NCT03231943|17627|P3|COMPLETED|Part 2||0
8771|NCT03231943|17628|P2|COMPLETED|Part 2||0
8772|NCT03231943|17629|P1|COMPLETED|Part 2||0
8773|NCT03231943|17617|P13|STARTED|Part 2||14
8774|NCT03231943|17618|P12|STARTED|Part 2||7
8775|NCT03231943|17619|P11|STARTED|Part 2||25
8776|NCT03231943|17620|P10|STARTED|Part 2||6
8777|NCT03231943|17621|P9|STARTED|Part 2||6
8778|NCT03231943|17622|P8|STARTED|Part 2||0
8779|NCT03231943|17623|P7|STARTED|Part 2||0
8780|NCT03231943|17624|P6|STARTED|Part 2||0
8781|NCT03231943|17625|P5|STARTED|Part 2||0
8782|NCT03231943|17626|P4|STARTED|Part 2||0
8783|NCT03231943|17627|P3|STARTED|Part 2||0
8784|NCT03231943|17628|P2|STARTED|Part 2||0
8785|NCT03231943|17629|P1|STARTED|Part 2||0
8786|NCT03231943|17617|P13|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8787|NCT03231943|17618|P12|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8788|NCT03231943|17619|P11|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8789|NCT03231943|17620|P10|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8790|NCT03231943|17621|P9|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8791|NCT03231943|17622|P8|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8792|NCT03231943|17623|P7|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8793|NCT03231943|17624|P6|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8794|NCT03231943|17625|P5|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8795|NCT03231943|17626|P4|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8796|NCT03231943|17627|P3|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8797|NCT03231943|17628|P2|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8798|NCT03231943|17629|P1|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8799|NCT03231943|17617|P13|COMPLETED|Part 1 Period 4 (up to Day 60)||0
8800|NCT03231943|17618|P12|COMPLETED|Part 1 Period 4 (up to Day 60)||0
8801|NCT03231943|17619|P11|COMPLETED|Part 1 Period 4 (up to Day 60)||0
8802|NCT03231943|17620|P10|COMPLETED|Part 1 Period 4 (up to Day 60)||0
8803|NCT03231943|17621|P9|COMPLETED|Part 1 Period 4 (up to Day 60)||0
8804|NCT03231943|17622|P8|COMPLETED|Part 1 Period 4 (up to Day 60)||2
8805|NCT03231943|17623|P7|COMPLETED|Part 1 Period 4 (up to Day 60)||2
8806|NCT03231943|17624|P6|COMPLETED|Part 1 Period 4 (up to Day 60)||2
8807|NCT03231943|17625|P5|COMPLETED|Part 1 Period 4 (up to Day 60)||2
8808|NCT03231943|17626|P4|COMPLETED|Part 1 Period 4 (up to Day 60)||2
8809|NCT03231943|17627|P3|COMPLETED|Part 1 Period 4 (up to Day 60)||2
8810|NCT03231943|17628|P2|COMPLETED|Part 1 Period 4 (up to Day 60)||2
8811|NCT03231943|17629|P1|COMPLETED|Part 1 Period 4 (up to Day 60)||2
8812|NCT03231943|17617|P13|STARTED|Part 1 Period 4 (up to Day 60)||0
8813|NCT03231943|17618|P12|STARTED|Part 1 Period 4 (up to Day 60)||0
8814|NCT03231943|17619|P11|STARTED|Part 1 Period 4 (up to Day 60)||0
8815|NCT03231943|17620|P10|STARTED|Part 1 Period 4 (up to Day 60)||0
8816|NCT03231943|17621|P9|STARTED|Part 1 Period 4 (up to Day 60)||0
8817|NCT03231943|17622|P8|STARTED|Part 1 Period 4 (up to Day 60)||2
8818|NCT03231943|17623|P7|STARTED|Part 1 Period 4 (up to Day 60)||2
8819|NCT03231943|17624|P6|STARTED|Part 1 Period 4 (up to Day 60)||2
8820|NCT03231943|17625|P5|STARTED|Part 1 Period 4 (up to Day 60)||2
8821|NCT03231943|17626|P4|STARTED|Part 1 Period 4 (up to Day 60)||2
8822|NCT03231943|17627|P3|STARTED|Part 1 Period 4 (up to Day 60)||2
8823|NCT03231943|17628|P2|STARTED|Part 1 Period 4 (up to Day 60)||2
8824|NCT03231943|17629|P1|STARTED|Part 1 Period 4 (up to Day 60)||2
8825|NCT03231943|17617|P13|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8826|NCT03231943|17618|P12|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8827|NCT03231943|17619|P11|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8828|NCT03231943|17620|P10|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8829|NCT03231943|17621|P9|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8830|NCT03231943|17622|P8|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8831|NCT03231943|17623|P7|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8832|NCT03231943|17624|P6|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8833|NCT03231943|17625|P5|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8834|NCT03231943|17626|P4|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8835|NCT03231943|17627|P3|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8836|NCT03231943|17628|P2|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8837|NCT03231943|17629|P1|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||1
8838|NCT03231943|17617|P13|COMPLETED|Part 1, Period 3 (up to Day 45)||0
8839|NCT03231943|17618|P12|COMPLETED|Part 1, Period 3 (up to Day 45)||0
8840|NCT03231943|17619|P11|COMPLETED|Part 1, Period 3 (up to Day 45)||0
8841|NCT03231943|17620|P10|COMPLETED|Part 1, Period 3 (up to Day 45)||0
8842|NCT03231943|17621|P9|COMPLETED|Part 1, Period 3 (up to Day 45)||0
8843|NCT03231943|17622|P8|COMPLETED|Part 1, Period 3 (up to Day 45)||2
8844|NCT03231943|17623|P7|COMPLETED|Part 1, Period 3 (up to Day 45)||2
8845|NCT03231943|17624|P6|COMPLETED|Part 1, Period 3 (up to Day 45)||2
8846|NCT03231943|17625|P5|COMPLETED|Part 1, Period 3 (up to Day 45)||2
8847|NCT03231943|17626|P4|COMPLETED|Part 1, Period 3 (up to Day 45)||2
8848|NCT03231943|17627|P3|COMPLETED|Part 1, Period 3 (up to Day 45)||2
8849|NCT03231943|17628|P2|COMPLETED|Part 1, Period 3 (up to Day 45)||2
8850|NCT03231943|17629|P1|COMPLETED|Part 1, Period 3 (up to Day 45)|One participant withdrawn was replaced|1
8851|NCT03231943|17617|P13|STARTED|Part 1, Period 3 (up to Day 45)||0
8852|NCT03231943|17618|P12|STARTED|Part 1, Period 3 (up to Day 45)||0
8853|NCT03231943|17619|P11|STARTED|Part 1, Period 3 (up to Day 45)||0
8854|NCT03231943|17620|P10|STARTED|Part 1, Period 3 (up to Day 45)||0
8855|NCT03231943|17621|P9|STARTED|Part 1, Period 3 (up to Day 45)||0
8856|NCT03231943|17622|P8|STARTED|Part 1, Period 3 (up to Day 45)||2
8857|NCT03231943|17623|P7|STARTED|Part 1, Period 3 (up to Day 45)||2
8858|NCT03231943|17624|P6|STARTED|Part 1, Period 3 (up to Day 45)||2
8859|NCT03231943|17625|P5|STARTED|Part 1, Period 3 (up to Day 45)||2
8860|NCT03231943|17626|P4|STARTED|Part 1, Period 3 (up to Day 45)||2
8861|NCT03231943|17627|P3|STARTED|Part 1, Period 3 (up to Day 45)||2
8862|NCT03231943|17628|P2|STARTED|Part 1, Period 3 (up to Day 45)||2
8863|NCT03231943|17629|P1|STARTED|Part 1, Period 3 (up to Day 45)||2
8864|NCT03231943|17617|P13|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8865|NCT03231943|17618|P12|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8866|NCT03231943|17619|P11|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8867|NCT03231943|17620|P10|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8868|NCT03231943|17621|P9|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8869|NCT03231943|17622|P8|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8870|NCT03231943|17623|P7|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8871|NCT03231943|17624|P6|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8872|NCT03231943|17625|P5|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8873|NCT03231943|17626|P4|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8874|NCT03231943|17627|P3|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||1
8875|NCT03231943|17628|P2|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||2
8876|NCT03231943|17629|P1|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8877|NCT03231943|17617|P13|COMPLETED|Part 1, Period 2 (up to Day 30)||0
8878|NCT03231943|17618|P12|COMPLETED|Part 1, Period 2 (up to Day 30)||0
8879|NCT03231943|17619|P11|COMPLETED|Part 1, Period 2 (up to Day 30)||0
8880|NCT03231943|17620|P10|COMPLETED|Part 1, Period 2 (up to Day 30)||0
8881|NCT03231943|17621|P9|COMPLETED|Part 1, Period 2 (up to Day 30)||0
8882|NCT03231943|17622|P8|COMPLETED|Part 1, Period 2 (up to Day 30)||2
8883|NCT03231943|17623|P7|COMPLETED|Part 1, Period 2 (up to Day 30)||2
8884|NCT03231943|17624|P6|COMPLETED|Part 1, Period 2 (up to Day 30)||2
8885|NCT03231943|17625|P5|COMPLETED|Part 1, Period 2 (up to Day 30)||2
8886|NCT03231943|17626|P4|COMPLETED|Part 1, Period 2 (up to Day 30)||2
8887|NCT03231943|17627|P3|COMPLETED|Part 1, Period 2 (up to Day 30)|One participant withdrawn was replaced|1
8888|NCT03231943|17628|P2|COMPLETED|Part 1, Period 2 (up to Day 30)|Two participants withdrawn were replaced|0
8889|NCT03231943|17629|P1|COMPLETED|Part 1, Period 2 (up to Day 30)||2
8890|NCT03231943|17617|P13|STARTED|Part 1, Period 2 (up to Day 30)||0
8891|NCT03231943|17618|P12|STARTED|Part 1, Period 2 (up to Day 30)||0
8892|NCT03231943|17619|P11|STARTED|Part 1, Period 2 (up to Day 30)||0
8893|NCT03231943|17620|P10|STARTED|Part 1, Period 2 (up to Day 30)||0
8894|NCT03231943|17621|P9|STARTED|Part 1, Period 2 (up to Day 30)||0
8895|NCT03231943|17622|P8|STARTED|Part 1, Period 2 (up to Day 30)||2
8896|NCT03231943|17623|P7|STARTED|Part 1, Period 2 (up to Day 30)||2
8897|NCT03231943|17624|P6|STARTED|Part 1, Period 2 (up to Day 30)||2
8898|NCT03231943|17625|P5|STARTED|Part 1, Period 2 (up to Day 30)||2
8899|NCT03231943|17626|P4|STARTED|Part 1, Period 2 (up to Day 30)||2
8900|NCT03231943|17627|P3|STARTED|Part 1, Period 2 (up to Day 30)||2
8901|NCT03231943|17628|P2|STARTED|Part 1, Period 2 (up to Day 30)||2
8902|NCT03231943|17629|P1|STARTED|Part 1, Period 2 (up to Day 30)||2
8903|NCT03231943|17617|P13|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8904|NCT03231943|17618|P12|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8905|NCT03231943|17619|P11|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8906|NCT03231943|17620|P10|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8907|NCT03231943|17621|P9|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8908|NCT03231943|17622|P8|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8909|NCT03231943|17623|P7|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8910|NCT03231943|17624|P6|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8911|NCT03231943|17625|P5|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8912|NCT03231943|17626|P4|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8913|NCT03231943|17627|P3|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8914|NCT03231943|17628|P2|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8915|NCT03231943|17629|P1|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8916|NCT03231943|17617|P13|COMPLETED|Part 1, Period 1 (up to Day 15)||0
8917|NCT03231943|17618|P12|COMPLETED|Part 1, Period 1 (up to Day 15)||0
8918|NCT03231943|17619|P11|COMPLETED|Part 1, Period 1 (up to Day 15)||0
8919|NCT03231943|17620|P10|COMPLETED|Part 1, Period 1 (up to Day 15)||0
8920|NCT03231943|17621|P9|COMPLETED|Part 1, Period 1 (up to Day 15)||0
8921|NCT03231943|17622|P8|COMPLETED|Part 1, Period 1 (up to Day 15)||2
8922|NCT03231943|17623|P7|COMPLETED|Part 1, Period 1 (up to Day 15)||2
8923|NCT03231943|17624|P6|COMPLETED|Part 1, Period 1 (up to Day 15)||2
8924|NCT03231943|17625|P5|COMPLETED|Part 1, Period 1 (up to Day 15)||2
8925|NCT03231943|17626|P4|COMPLETED|Part 1, Period 1 (up to Day 15)||2
8926|NCT03231943|17627|P3|COMPLETED|Part 1, Period 1 (up to Day 15)||2
8927|NCT03231943|17628|P2|COMPLETED|Part 1, Period 1 (up to Day 15)||2
8928|NCT03231943|17629|P1|COMPLETED|Part 1, Period 1 (up to Day 15)||2
8929|NCT03231943|17617|P13|STARTED|Part 1, Period 1 (up to Day 15)||0
8930|NCT03231943|17618|P12|STARTED|Part 1, Period 1 (up to Day 15)||0
8931|NCT03231943|17619|P11|STARTED|Part 1, Period 1 (up to Day 15)||0
8932|NCT03231943|17620|P10|STARTED|Part 1, Period 1 (up to Day 15)||0
8933|NCT03231943|17621|P9|STARTED|Part 1, Period 1 (up to Day 15)||0
8934|NCT03231943|17622|P8|STARTED|Part 1, Period 1 (up to Day 15)||2
8935|NCT03231943|17623|P7|STARTED|Part 1, Period 1 (up to Day 15)||2
8936|NCT03231943|17624|P6|STARTED|Part 1, Period 1 (up to Day 15)||2
8937|NCT03231943|17625|P5|STARTED|Part 1, Period 1 (up to Day 15)||2
8938|NCT03231943|17626|P4|STARTED|Part 1, Period 1 (up to Day 15)||2
8939|NCT03231943|17627|P3|STARTED|Part 1, Period 1 (up to Day 15)||2
8940|NCT03231943|17628|P2|STARTED|Part 1, Period 1 (up to Day 15)||2
8941|NCT03231943|17629|P1|STARTED|Part 1, Period 1 (up to Day 15)||2
8942|NCT03231917|18079|P2|NOT COMPLETED|Overall Study||0
8943|NCT03231917|18080|P1|NOT COMPLETED|Overall Study||0
8944|NCT03231917|18079|P2|COMPLETED|Overall Study||61
8945|NCT03231917|18080|P1|COMPLETED|Overall Study||60
8946|NCT03231917|18079|P2|STARTED|Overall Study||61
8947|NCT03231917|18080|P1|STARTED|Overall Study||60
8948|NCT03231709|18092|P2|NOT COMPLETED|Treatment Period 2||1
8949|NCT03231709|18093|P1|NOT COMPLETED|Treatment Period 2||0
8950|NCT03231709|18092|P2|COMPLETED|Treatment Period 2||28
8951|NCT03231709|18093|P1|COMPLETED|Treatment Period 2||30
8952|NCT03231709|18092|P2|STARTED|Treatment Period 2||29
8953|NCT03231709|18093|P1|STARTED|Treatment Period 2||30
8954|NCT03231709|18092|P2|NOT COMPLETED|Treatment Period 1||1
8955|NCT03231709|18093|P1|NOT COMPLETED|Treatment Period 1||0
8956|NCT03231709|18092|P2|COMPLETED|Treatment Period 1||29
8957|NCT03231709|18093|P1|COMPLETED|Treatment Period 1||30
8958|NCT03231709|18092|P2|STARTED|Treatment Period 1||30
8959|NCT03231709|18093|P1|STARTED|Treatment Period 1||30
8960|NCT03231371|18111|P1|NOT COMPLETED|Overall Study||13
8961|NCT03231371|18111|P1|COMPLETED|Overall Study||9
8962|NCT03231371|18111|P1|Optional and Age Limited (12 Yrs+) MRI|Overall Study||9
8963|NCT03231371|18111|P1|STARTED|Overall Study||22
8964|NCT03231345|18116|P1|NOT COMPLETED|Overall Study||0
8965|NCT03231345|18116|P1|COMPLETED|Overall Study||35
8966|NCT03231345|18116|P1|STARTED|Overall Study||35
8967|NCT03229109|18126|P4|NOT COMPLETED|Overall Study||1
8968|NCT03229109|18127|P3|NOT COMPLETED|Overall Study||0
8969|NCT03229109|18128|P2|NOT COMPLETED|Overall Study||0
8970|NCT03229109|18129|P1|NOT COMPLETED|Overall Study||0
8971|NCT03229109|18126|P4|COMPLETED|Overall Study||50
8972|NCT03229109|18127|P3|COMPLETED|Overall Study||50
8973|NCT03229109|18128|P2|COMPLETED|Overall Study||50
8974|NCT03229109|18129|P1|COMPLETED|Overall Study||50
8975|NCT03229109|18126|P4|STARTED|Overall Study||51
8976|NCT03229109|18127|P3|STARTED|Overall Study||50
8977|NCT03229109|18128|P2|STARTED|Overall Study||50
8978|NCT03229109|18129|P1|STARTED|Overall Study||50
8979|NCT03228433|18145|P6|NOT COMPLETED|Overall Study||0
8980|NCT03228433|18146|P5|NOT COMPLETED|Overall Study||0
8981|NCT03228433|18147|P4|NOT COMPLETED|Overall Study||1
8982|NCT03228433|18148|P3|NOT COMPLETED|Overall Study||0
8983|NCT03228433|18149|P2|NOT COMPLETED|Overall Study||0
8984|NCT03228433|18150|P1|NOT COMPLETED|Overall Study||1
8985|NCT03228433|18145|P6|COMPLETED|Overall Study||6
8986|NCT03228433|18146|P5|COMPLETED|Overall Study||6
8987|NCT03228433|18147|P4|COMPLETED|Overall Study||5
8988|NCT03228433|18148|P3|COMPLETED|Overall Study||6
8989|NCT03228433|18149|P2|COMPLETED|Overall Study||6
8990|NCT03228433|18150|P1|COMPLETED|Overall Study||9
8991|NCT03228433|18145|P6|STARTED|Overall Study||6
8992|NCT03228433|18146|P5|STARTED|Overall Study||6
8993|NCT03228433|18147|P4|STARTED|Overall Study||6
8994|NCT03228433|18148|P3|STARTED|Overall Study||6
8995|NCT03228433|18149|P2|STARTED|Overall Study||6
8996|NCT03228433|18150|P1|STARTED|Overall Study||10
8997|NCT03228212|18225|P2|NOT COMPLETED|Period 3||0
8998|NCT03228212|18226|P1|NOT COMPLETED|Period 3||0
8999|NCT03228212|18225|P2|COMPLETED|Period 3||64
9000|NCT03228212|18226|P1|COMPLETED|Period 3||63
9001|NCT03228212|18225|P2|STARTED|Period 3||64
9002|NCT03228212|18226|P1|STARTED|Period 3||63
9003|NCT03228212|18225|P2|NOT COMPLETED|Period 2||0
9004|NCT03228212|18226|P1|NOT COMPLETED|Period 2||1
9005|NCT03228212|18225|P2|COMPLETED|Period 2||64
9006|NCT03228212|18226|P1|COMPLETED|Period 2||63
9007|NCT03228212|18225|P2|STARTED|Period 2||64
9008|NCT03228212|18226|P1|STARTED|Period 2||64
9009|NCT03228212|18225|P2|NOT COMPLETED|Period 1||1
9010|NCT03228212|18226|P1|NOT COMPLETED|Period 1||1
9011|NCT03228212|18225|P2|COMPLETED|Period 1||64
9012|NCT03228212|18226|P1|COMPLETED|Period 1||64
9013|NCT03228212|18225|P2|STARTED|Period 1||65
9014|NCT03228212|18226|P1|STARTED|Period 1||65
9015|NCT03226353|18242|P1|NOT COMPLETED|Overall Study||6
9016|NCT03226353|18242|P1|COMPLETED|Overall Study|Study participants completed includes the Omafilcon A habitual wearers.|71
9017|NCT03226353|18242|P1|Other Habitual Lens Types|Overall Study||75
9018|NCT03226353|18242|P1|Habitual Wearers of Proclear 1 Day|Overall Study||2
9019|NCT03226353|18242|P1|STARTED|Overall Study||77
9020|NCT03226275|18266|P4|NOT COMPLETED|Treatment Period 2 (8 Days)||0
9021|NCT03226275|18267|P3|NOT COMPLETED|Treatment Period 2 (8 Days)||0
9022|NCT03226275|18268|P2|NOT COMPLETED|Treatment Period 2 (8 Days)||0
9023|NCT03226275|18269|P1|NOT COMPLETED|Treatment Period 2 (8 Days)||0
9024|NCT03226275|18266|P4|COMPLETED|Treatment Period 2 (8 Days)||7
9025|NCT03226275|18267|P3|COMPLETED|Treatment Period 2 (8 Days)||7
9026|NCT03226275|18268|P2|COMPLETED|Treatment Period 2 (8 Days)||8
9027|NCT03226275|18269|P1|COMPLETED|Treatment Period 2 (8 Days)||8
9028|NCT03226275|18266|P4|STARTED|Treatment Period 2 (8 Days)||7
9029|NCT03226275|18267|P3|STARTED|Treatment Period 2 (8 Days)||7
9030|NCT03226275|18268|P2|STARTED|Treatment Period 2 (8 Days)||8
9031|NCT03226275|18269|P1|STARTED|Treatment Period 2 (8 Days)||8
9032|NCT03226275|18266|P4|NOT COMPLETED|Treatment Period 1 (8 Days)||1
9033|NCT03226275|18267|P3|NOT COMPLETED|Treatment Period 1 (8 Days)||1
9034|NCT03226275|18268|P2|NOT COMPLETED|Treatment Period 1 (8 Days)||0
9035|NCT03226275|18269|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
9036|NCT03226275|18266|P4|COMPLETED|Treatment Period 1 (8 Days)||7
9037|NCT03226275|18267|P3|COMPLETED|Treatment Period 1 (8 Days)||7
9038|NCT03226275|18268|P2|COMPLETED|Treatment Period 1 (8 Days)||8
9039|NCT03226275|18269|P1|COMPLETED|Treatment Period 1 (8 Days)||8
9040|NCT03226275|18266|P4|STARTED|Treatment Period 1 (8 Days)||8
9041|NCT03226275|18267|P3|STARTED|Treatment Period 1 (8 Days)||8
9042|NCT03226275|18268|P2|STARTED|Treatment Period 1 (8 Days)||8
9043|NCT03226275|18269|P1|STARTED|Treatment Period 1 (8 Days)||8
9044|NCT03225599|18315|P1|NOT COMPLETED|Overall Study||2
9045|NCT03225599|18315|P1|COMPLETED|Overall Study||7
9046|NCT03225599|18315|P1|STARTED|Overall Study||9
9047|NCT03225313|18322|P3|NOT COMPLETED|Overall Study||0
9048|NCT03225313|18323|P2|NOT COMPLETED|Overall Study||0
9049|NCT03225313|18324|P1|NOT COMPLETED|Overall Study||0
9050|NCT03225313|18322|P3|COMPLETED|Overall Study|25 Patients|25
9051|NCT03225313|18323|P2|COMPLETED|Overall Study|25 Patients|25
9052|NCT03225313|18324|P1|COMPLETED|Overall Study|25 Patients|25
9053|NCT03225313|18322|P3|STARTED|Overall Study|25 Patients|25
9054|NCT03225313|18323|P2|STARTED|Overall Study|25 Patients|25
9055|NCT03225313|18324|P1|STARTED|Overall Study|25 Patients|25
9056|NCT03225001|18356|P1|NOT COMPLETED|Overall Study||9
9057|NCT03225001|18356|P1|COMPLETED|Overall Study||188
9058|NCT03225001|18356|P1|Valve-Implanted|Overall Study||195
9059|NCT03225001|18356|P1|STARTED|Overall Study||197
9060|NCT03224390|18363|P2|NOT COMPLETED|Overall Study||35
9061|NCT03224390|18364|P1|NOT COMPLETED|Overall Study||27
9062|NCT03224390|18363|P2|COMPLETED|Overall Study||21
9063|NCT03224390|18364|P1|COMPLETED|Overall Study||29
9064|NCT03224390|18363|P2|STARTED|Overall Study||56
9065|NCT03224390|18364|P1|STARTED|Overall Study||56
9066|NCT03224325|18379|P7|NOT COMPLETED|Overall Study||1
9067|NCT03224325|18380|P6|NOT COMPLETED|Overall Study||0
9068|NCT03224325|18381|P5|NOT COMPLETED|Overall Study||0
9069|NCT03224325|18382|P4|NOT COMPLETED|Overall Study||1
9070|NCT03224325|18383|P3|NOT COMPLETED|Overall Study||0
9071|NCT03224325|18384|P2|NOT COMPLETED|Overall Study||0
9072|NCT03224325|18385|P1|NOT COMPLETED|Overall Study||1
9073|NCT03224325|18379|P7|COMPLETED|Overall Study||6
9074|NCT03224325|18380|P6|COMPLETED|Overall Study||6
9075|NCT03224325|18381|P5|COMPLETED|Overall Study||6
9076|NCT03224325|18382|P4|COMPLETED|Overall Study||5
9077|NCT03224325|18383|P3|COMPLETED|Overall Study||6
9078|NCT03224325|18384|P2|COMPLETED|Overall Study||6
9079|NCT03224325|18385|P1|COMPLETED|Overall Study||12
9080|NCT03224325|18379|P7|STARTED|Overall Study||7
9081|NCT03224325|18380|P6|STARTED|Overall Study||6
9082|NCT03224325|18381|P5|STARTED|Overall Study||6
9083|NCT03224325|18382|P4|STARTED|Overall Study||6
9084|NCT03224325|18383|P3|STARTED|Overall Study||6
9085|NCT03224325|18384|P2|STARTED|Overall Study||6
9086|NCT03224325|18385|P1|STARTED|Overall Study||13
9087|NCT03224130|18448|P2|NOT COMPLETED|Overall Study||1
9088|NCT03224130|18449|P1|NOT COMPLETED|Overall Study||0
9089|NCT03224130|18448|P2|COMPLETED|Overall Study||482
9090|NCT03224130|18449|P1|COMPLETED|Overall Study||483
9091|NCT03224130|18448|P2|STARTED|Overall Study||483
9092|NCT03224130|18449|P1|STARTED|Overall Study||483
9093|NCT03223909|18470|P3|NOT COMPLETED|Overall Study||16
9094|NCT03223909|18471|P2|NOT COMPLETED|Overall Study||45
9095|NCT03223909|18472|P1|NOT COMPLETED|Overall Study||48
9096|NCT03223909|18470|P3|COMPLETED|Overall Study||81
9097|NCT03223909|18471|P2|COMPLETED|Overall Study||64
9098|NCT03223909|18472|P1|COMPLETED|Overall Study||72
9099|NCT03223909|18470|P3|STARTED|Overall Study||97
9100|NCT03223909|18471|P2|STARTED|Overall Study||109
9101|NCT03223909|18472|P1|STARTED|Overall Study||120
9102|NCT03223662|18501|P1|NOT COMPLETED|Overall Study||2
9103|NCT03223662|18501|P1|COMPLETED|Overall Study||0
9104|NCT03223662|18501|P1|STARTED|Overall Study||2
9105|NCT03223337|18515|P4|NOT COMPLETED|Part 2 (Up to 16 Days)||0
9106|NCT03223337|18516|P3|NOT COMPLETED|Part 2 (Up to 16 Days)||0
9107|NCT03223337|18517|P2|NOT COMPLETED|Part 2 (Up to 16 Days)||0
9108|NCT03223337|18518|P1|NOT COMPLETED|Part 2 (Up to 16 Days)||0
9109|NCT03223337|18515|P4|COMPLETED|Part 2 (Up to 16 Days)||9
9110|NCT03223337|18516|P3|COMPLETED|Part 2 (Up to 16 Days)||12
9111|NCT03223337|18517|P2|COMPLETED|Part 2 (Up to 16 Days)||0
9112|NCT03223337|18518|P1|COMPLETED|Part 2 (Up to 16 Days)||0
9113|NCT03223337|18515|P4|STARTED|Part 2 (Up to 16 Days)||9
9114|NCT03223337|18516|P3|STARTED|Part 2 (Up to 16 Days)||12
9115|NCT03223337|18517|P2|STARTED|Part 2 (Up to 16 Days)||0
9116|NCT03223337|18518|P1|STARTED|Part 2 (Up to 16 Days)||0
9117|NCT03223337|18515|P4|NOT COMPLETED|Part 1 (Up to 16 Days)||0
9118|NCT03223337|18516|P3|NOT COMPLETED|Part 1 (Up to 16 Days)||0
9119|NCT03223337|18517|P2|NOT COMPLETED|Part 1 (Up to 16 Days)||0
9120|NCT03223337|18518|P1|NOT COMPLETED|Part 1 (Up to 16 Days)||0
9121|NCT03223337|18515|P4|COMPLETED|Part 1 (Up to 16 Days)||0
9122|NCT03223337|18516|P3|COMPLETED|Part 1 (Up to 16 Days)||0
9123|NCT03223337|18517|P2|COMPLETED|Part 1 (Up to 16 Days)||8
9124|NCT03223337|18518|P1|COMPLETED|Part 1 (Up to 16 Days)||8
9125|NCT03223337|18515|P4|STARTED|Part 1 (Up to 16 Days)||0
9126|NCT03223337|18516|P3|STARTED|Part 1 (Up to 16 Days)||0
9127|NCT03223337|18517|P2|STARTED|Part 1 (Up to 16 Days)||8
9128|NCT03223337|18518|P1|STARTED|Part 1 (Up to 16 Days)||8
9129|NCT03222505|18586|P2|NOT COMPLETED|Overall Study||0
9130|NCT03222505|18587|P1|NOT COMPLETED|Overall Study||0
9131|NCT03222505|18586|P2|COMPLETED|Overall Study||7
9132|NCT03222505|18587|P1|COMPLETED|Overall Study||5
9133|NCT03222505|18586|P2|STARTED|Overall Study||7
9134|NCT03222505|18587|P1|STARTED|Overall Study||5
9135|NCT03222427|18597|P1|NOT COMPLETED|Overall Study||0
9136|NCT03222427|18597|P1|COMPLETED|Overall Study||8
9137|NCT03222427|18597|P1|Received One Dose of Study Drug|Overall Study||8
9138|NCT03222427|18597|P1|STARTED|Overall Study||8
9139|NCT03222141|18604|P1|NOT COMPLETED|Overall Study||18
9140|NCT03222141|18604|P1|COMPLETED|Overall Study||565
9141|NCT03222141|18604|P1|STARTED|Overall Study||583
9142|NCT03222128|18610|P1|NOT COMPLETED|Overall Study||106
9143|NCT03222128|18610|P1|COMPLETED|Overall Study||968
9144|NCT03222128|18610|P1|Valve-Implanted|Overall Study||1069
9145|NCT03222128|18610|P1|STARTED|Overall Study||1074
9146|NCT03222037|18615|P2|NOT COMPLETED|Period 2||0
9147|NCT03222037|18616|P1|NOT COMPLETED|Period 2||0
9148|NCT03222037|18615|P2|COMPLETED|Period 2||22
9149|NCT03222037|18616|P1|COMPLETED|Period 2||21
9150|NCT03222037|18615|P2|STARTED|Period 2||22
9151|NCT03222037|18616|P1|STARTED|Period 2||21
9152|NCT03222037|18615|P2|NOT COMPLETED|Period 1||0
9153|NCT03222037|18616|P1|NOT COMPLETED|Period 1||0
9154|NCT03222037|18615|P2|COMPLETED|Period 1||22
9155|NCT03222037|18616|P1|COMPLETED|Period 1||21
9156|NCT03222037|18615|P2|STARTED|Period 1||22
9157|NCT03222037|18616|P1|STARTED|Period 1||21
9158|NCT03221738|18624|P1|NOT COMPLETED|Overall Study||0
9159|NCT03221738|18624|P1|COMPLETED|Overall Study||10
9160|NCT03221738|18624|P1|STARTED|Overall Study||10
9161|NCT03221192|18630|P1|NOT COMPLETED|Overall Study||0
9162|NCT03221192|18630|P1|COMPLETED|Overall Study||27
9163|NCT03221192|18630|P1|STARTED|Overall Study||27
9164|NCT03220412|18671|P2|NOT COMPLETED|Overall Study||0
9165|NCT03220412|18672|P1|NOT COMPLETED|Overall Study||0
9166|NCT03220412|18671|P2|COMPLETED|Overall Study||50
9167|NCT03220412|18672|P1|COMPLETED|Overall Study||54
9168|NCT03220412|18671|P2|STARTED|Overall Study||50
9169|NCT03220412|18672|P1|STARTED|Overall Study||54
9170|NCT03220230|18680|P1|NOT COMPLETED|Overall Study||0
9171|NCT03220230|18680|P1|COMPLETED|Overall Study||4240
9172|NCT03220230|18680|P1|STARTED|Overall Study||4240
9173|NCT03220048|18693|P3|NOT COMPLETED|Overall Study||1
9174|NCT03220048|18694|P2|NOT COMPLETED|Overall Study||2
9175|NCT03220048|18695|P1|NOT COMPLETED|Overall Study||0
9176|NCT03220048|18693|P3|COMPLETED|Overall Study||27
9177|NCT03220048|18694|P2|COMPLETED|Overall Study||25
9178|NCT03220048|18695|P1|COMPLETED|Overall Study||11
9179|NCT03220048|18693|P3|STARTED|Overall Study||28
9180|NCT03220048|18694|P2|STARTED|Overall Study||27
9181|NCT03220048|18695|P1|STARTED|Overall Study||11
9182|NCT03219723|18718|P1|NOT COMPLETED|Overall Study||10
9183|NCT03219723|18718|P1|COMPLETED|Overall Study||550
9184|NCT03219723|18718|P1|STARTED|Overall Study||560
9185|NCT03219294|18725|P2|NOT COMPLETED|Overall Study||0
9186|NCT03219294|18726|P1|NOT COMPLETED|Overall Study||0
9187|NCT03219294|18725|P2|COMPLETED|Overall Study||58
9188|NCT03219294|18726|P1|COMPLETED|Overall Study||58
9189|NCT03219294|18725|P2|STARTED|Overall Study||58
9190|NCT03219294|18726|P1|STARTED|Overall Study||58
9191|NCT03218592|18737|P3|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
9192|NCT03218592|18738|P2|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
9193|NCT03218592|18739|P1|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
9194|NCT03218592|18737|P3|COMPLETED|Phase 3: 3 Doses Per Week||4
9195|NCT03218592|18738|P2|COMPLETED|Phase 3: 3 Doses Per Week||4
9196|NCT03218592|18739|P1|COMPLETED|Phase 3: 3 Doses Per Week||4
9197|NCT03218592|18737|P3|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
9198|NCT03218592|18738|P2|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
9199|NCT03218592|18739|P1|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
9200|NCT03218592|18737|P3|STARTED|Phase 3: 3 Doses Per Week||4
9201|NCT03218592|18738|P2|STARTED|Phase 3: 3 Doses Per Week||4
9202|NCT03218592|18739|P1|STARTED|Phase 3: 3 Doses Per Week||4
9203|NCT03218592|18737|P3|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
9204|NCT03218592|18738|P2|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
9205|NCT03218592|18739|P1|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
9206|NCT03218592|18737|P3|COMPLETED|Phase 3: 1 Dose Per Period||4
9207|NCT03218592|18738|P2|COMPLETED|Phase 3: 1 Dose Per Period||4
9208|NCT03218592|18739|P1|COMPLETED|Phase 3: 1 Dose Per Period||4
9209|NCT03218592|18737|P3|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
9210|NCT03218592|18738|P2|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
9211|NCT03218592|18739|P1|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
9212|NCT03218592|18737|P3|STARTED|Phase 3: 1 Dose Per Period||4
9213|NCT03218592|18738|P2|STARTED|Phase 3: 1 Dose Per Period||4
9214|NCT03218592|18739|P1|STARTED|Phase 3: 1 Dose Per Period||4
9215|NCT03218592|18737|P3|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
9216|NCT03218592|18738|P2|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
9217|NCT03218592|18739|P1|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
9218|NCT03218592|18737|P3|COMPLETED|Phase 3: 0 Doses Per Week||4
9219|NCT03218592|18738|P2|COMPLETED|Phase 3: 0 Doses Per Week||4
9220|NCT03218592|18739|P1|COMPLETED|Phase 3: 0 Doses Per Week||4
9221|NCT03218592|18737|P3|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
9222|NCT03218592|18738|P2|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
9223|NCT03218592|18739|P1|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
9224|NCT03218592|18737|P3|STARTED|Phase 3: 0 Doses Per Week||4
9225|NCT03218592|18738|P2|STARTED|Phase 3: 0 Doses Per Week||4
9226|NCT03218592|18739|P1|STARTED|Phase 3: 0 Doses Per Week||4
9227|NCT03218592|18737|P3|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
9228|NCT03218592|18738|P2|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
9229|NCT03218592|18739|P1|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
9230|NCT03218592|18737|P3|COMPLETED|Phase 2: Daily Doses x 28 Days||12
9231|NCT03218592|18738|P2|COMPLETED|Phase 2: Daily Doses x 28 Days||12
9232|NCT03218592|18739|P1|COMPLETED|Phase 2: Daily Doses x 28 Days||12
9233|NCT03218592|18737|P3|STARTED|Phase 2: Daily Doses x 28 Days||12
9234|NCT03218592|18738|P2|STARTED|Phase 2: Daily Doses x 28 Days||12
9235|NCT03218592|18739|P1|STARTED|Phase 2: Daily Doses x 28 Days||12
9236|NCT03218592|18737|P3|NOT COMPLETED|Phase 1: 1 Dose||0
9237|NCT03218592|18738|P2|NOT COMPLETED|Phase 1: 1 Dose||0
9238|NCT03218592|18739|P1|NOT COMPLETED|Phase 1: 1 Dose||0
9239|NCT03218592|18737|P3|COMPLETED|Phase 1: 1 Dose||12
9240|NCT03218592|18738|P2|COMPLETED|Phase 1: 1 Dose||12
9241|NCT03218592|18739|P1|COMPLETED|Phase 1: 1 Dose||12
9242|NCT03218592|18737|P3|STARTED|Phase 1: 1 Dose||12
9243|NCT03218592|18738|P2|STARTED|Phase 1: 1 Dose||12
9244|NCT03218592|18739|P1|STARTED|Phase 1: 1 Dose||12
9245|NCT03218397|18761|P2|NOT COMPLETED|Overall Study||29
9246|NCT03218397|18762|P1|NOT COMPLETED|Overall Study||23
9247|NCT03218397|18761|P2|COMPLETED|Overall Study||222
9248|NCT03218397|18762|P1|COMPLETED|Overall Study||226
9249|NCT03218397|18761|P2|STARTED|Overall Study||251
9250|NCT03218397|18762|P1|STARTED|Overall Study||249
9251|NCT03218163|18790|P1|NOT COMPLETED|Overall Study||0
9252|NCT03218163|18790|P1|COMPLETED|Overall Study||0
9253|NCT03218163|18790|P1|STARTED|Overall Study||0
9254|NCT03217968|18794|P1|NOT COMPLETED|Overall Study||11
9255|NCT03217968|18794|P1|COMPLETED|Overall Study||48
9256|NCT03217968|18794|P1|STARTED|Overall Study||59
9257|NCT03217175|18803|P2|NOT COMPLETED|Overall Study||1
9258|NCT03217175|18804|P1|NOT COMPLETED|Overall Study||4
9259|NCT03217175|18803|P2|COMPLETED|Overall Study||0
9260|NCT03217175|18804|P1|COMPLETED|Overall Study||0
9261|NCT03217175|18803|P2|STARTED|Overall Study||1
9262|NCT03217175|18804|P1|STARTED|Overall Study||4
9263|NCT03216850|18818|P1|NOT COMPLETED|Overall Study||6
9264|NCT03216850|18818|P1|COMPLETED|Overall Study|6 patients did not complete the study because of the pre-analytical error.|9
9265|NCT03216850|18818|P1|STARTED|Overall Study||15
9266|NCT03216265|18825|P3|NOT COMPLETED|Overall Study||3
9267|NCT03216265|18826|P2|NOT COMPLETED|Overall Study||1
9268|NCT03216265|18827|P1|NOT COMPLETED|Overall Study||2
9269|NCT03216265|18825|P3|COMPLETED|Overall Study||19
9270|NCT03216265|18826|P2|COMPLETED|Overall Study||21
9271|NCT03216265|18827|P1|COMPLETED|Overall Study||20
9272|NCT03216265|18825|P3|STARTED|Overall Study||22
9273|NCT03216265|18826|P2|STARTED|Overall Study||22
9274|NCT03216265|18827|P1|STARTED|Overall Study||22
9275|NCT03216200|18877|P1|NOT COMPLETED|Overall Study||0
9276|NCT03216200|18877|P1|COMPLETED|Overall Study||5
9277|NCT03216200|18877|P1|STARTED|Overall Study||5
9278|NCT03214406|18884|P2|NOT COMPLETED|Overall Study||15
9279|NCT03214406|18885|P1|NOT COMPLETED|Overall Study||10
9280|NCT03214406|18884|P2|COMPLETED|Overall Study||78
9281|NCT03214406|18885|P1|COMPLETED|Overall Study||78
9282|NCT03214406|18884|P2|STARTED|Overall Study||93
9283|NCT03214406|18885|P1|STARTED|Overall Study||88
9284|NCT03214224|18898|P3|NOT COMPLETED|Longitudinal PFT Study||0
9285|NCT03214224|18899|P2|NOT COMPLETED|Longitudinal PFT Study||0
9286|NCT03214224|18900|P1|NOT COMPLETED|Longitudinal PFT Study||0
9287|NCT03214224|18898|P3|COMPLETED|Longitudinal PFT Study||0
9288|NCT03214224|18899|P2|COMPLETED|Longitudinal PFT Study||0
9289|NCT03214224|18900|P1|COMPLETED|Longitudinal PFT Study||0
9290|NCT03214224|18898|P3|STARTED|Longitudinal PFT Study||0
9291|NCT03214224|18899|P2|STARTED|Longitudinal PFT Study||0
9292|NCT03214224|18900|P1|STARTED|Longitudinal PFT Study||0
9293|NCT03214224|18898|P3|NOT COMPLETED|Validation Study||9
9294|NCT03214224|18899|P2|NOT COMPLETED|Validation Study||0
9295|NCT03214224|18900|P1|NOT COMPLETED|Validation Study||0
9296|NCT03214224|18898|P3|COMPLETED|Validation Study|3 therapists enrolled. 3 controls enrolled but not included in analysis set. 3 patients also.|40
9297|NCT03214224|18899|P2|COMPLETED|Validation Study||0
9298|NCT03214224|18900|P1|COMPLETED|Validation Study||0
9299|NCT03214224|18898|P3|STARTED|Validation Study|Subjects did both standard and remote assessments in the validation study. Total enrollment 49.|49
9300|NCT03214224|18899|P2|STARTED|Validation Study||0
9301|NCT03214224|18900|P1|STARTED|Validation Study||0
9302|NCT03214081|18909|P1|NOT COMPLETED|Overall Study||63
9303|NCT03214081|18909|P1|COMPLETED|Overall Study||1174
9304|NCT03214081|18909|P1|STARTED|Overall Study||1237
9305|NCT03213509|18926|P2|NOT COMPLETED|Overall Study||5
9306|NCT03213509|18927|P1|NOT COMPLETED|Overall Study||4
9307|NCT03213509|18926|P2|COMPLETED|Overall Study||85
9308|NCT03213509|18927|P1|COMPLETED|Overall Study||76
9309|NCT03213509|18926|P2|STARTED|Overall Study||90
9310|NCT03213509|18927|P1|STARTED|Overall Study||80
9311|NCT03213366|18940|P2|NOT COMPLETED|Overall Study||4
9312|NCT03213366|18941|P1|NOT COMPLETED|Overall Study||9
9313|NCT03213366|18940|P2|COMPLETED|Overall Study||67
9314|NCT03213366|18941|P1|COMPLETED|Overall Study||72
9315|NCT03213366|18940|P2|STARTED|Overall Study||71
9316|NCT03213366|18941|P1|STARTED|Overall Study||81
9317|NCT03212638|18969|P5|NOT COMPLETED|Period 5||0
9318|NCT03212638|18970|P4|NOT COMPLETED|Period 5||0
9319|NCT03212638|18971|P3|NOT COMPLETED|Period 5||0
9320|NCT03212638|18972|P2|NOT COMPLETED|Period 5||0
9321|NCT03212638|18973|P1|NOT COMPLETED|Period 5||0
9322|NCT03212638|18969|P5|COMPLETED|Period 5||9
9323|NCT03212638|18970|P4|COMPLETED|Period 5||9
9324|NCT03212638|18971|P3|COMPLETED|Period 5||0
9325|NCT03212638|18972|P2|COMPLETED|Period 5||0
9326|NCT03212638|18973|P1|COMPLETED|Period 5||0
9327|NCT03212638|18969|P5|Received at Least 1 Dose of Study Drug|Period 5||9
9328|NCT03212638|18970|P4|Received at Least 1 Dose of Study Drug|Period 5||9
9329|NCT03212638|18971|P3|Received at Least 1 Dose of Study Drug|Period 5||0
9330|NCT03212638|18972|P2|Received at Least 1 Dose of Study Drug|Period 5||0
9331|NCT03212638|18973|P1|Received at Least 1 Dose of Study Drug|Period 5||0
9332|NCT03212638|18969|P5|STARTED|Period 5||9
9333|NCT03212638|18970|P4|STARTED|Period 5||9
9334|NCT03212638|18971|P3|STARTED|Period 5||0
9335|NCT03212638|18972|P2|STARTED|Period 5||0
9336|NCT03212638|18973|P1|STARTED|Period 5||0
9337|NCT03212638|18969|P5|NOT COMPLETED|Period 4||0
9338|NCT03212638|18970|P4|NOT COMPLETED|Period 4||0
9339|NCT03212638|18971|P3|NOT COMPLETED|Period 4||0
9340|NCT03212638|18972|P2|NOT COMPLETED|Period 4||0
9341|NCT03212638|18973|P1|NOT COMPLETED|Period 4||0
9342|NCT03212638|18969|P5|COMPLETED|Period 4||9
9343|NCT03212638|18970|P4|COMPLETED|Period 4||9
9344|NCT03212638|18971|P3|COMPLETED|Period 4||0
9345|NCT03212638|18972|P2|COMPLETED|Period 4||0
9346|NCT03212638|18973|P1|COMPLETED|Period 4||0
9347|NCT03212638|18969|P5|Received at Least 1 Dose of Study Drug|Period 4||9
9348|NCT03212638|18970|P4|Received at Least 1 Dose of Study Drug|Period 4||9
9349|NCT03212638|18971|P3|Received at Least 1 Dose of Study Drug|Period 4||0
9350|NCT03212638|18972|P2|Received at Least 1 Dose of Study Drug|Period 4||0
9351|NCT03212638|18973|P1|Received at Least 1 Dose of Study Drug|Period 4||0
9352|NCT03212638|18969|P5|STARTED|Period 4|New Participants in Part B, no participants from Part A participated in Part B.|9
9353|NCT03212638|18970|P4|STARTED|Period 4|New Participants in Part B, no participants from Part A participated in Part B.|9
9354|NCT03212638|18971|P3|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
9355|NCT03212638|18972|P2|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
9356|NCT03212638|18973|P1|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
9357|NCT03212638|18969|P5|NOT COMPLETED|Period 3||0
9358|NCT03212638|18970|P4|NOT COMPLETED|Period 3||0
9359|NCT03212638|18971|P3|NOT COMPLETED|Period 3||0
9360|NCT03212638|18972|P2|NOT COMPLETED|Period 3||0
9361|NCT03212638|18973|P1|NOT COMPLETED|Period 3||0
9362|NCT03212638|18969|P5|COMPLETED|Period 3||0
9363|NCT03212638|18970|P4|COMPLETED|Period 3||0
9364|NCT03212638|18971|P3|COMPLETED|Period 3||8
9365|NCT03212638|18972|P2|COMPLETED|Period 3||8
9366|NCT03212638|18973|P1|COMPLETED|Period 3||8
9367|NCT03212638|18969|P5|Received at Least 1 Dose of Study Drug|Period 3||0
9368|NCT03212638|18970|P4|Received at Least 1 Dose of Study Drug|Period 3||0
9369|NCT03212638|18971|P3|Received at Least 1 Dose of Study Drug|Period 3||8
9370|NCT03212638|18972|P2|Received at Least 1 Dose of Study Drug|Period 3||8
9371|NCT03212638|18973|P1|Received at Least 1 Dose of Study Drug|Period 3||8
9372|NCT03212638|18969|P5|STARTED|Period 3||0
9373|NCT03212638|18970|P4|STARTED|Period 3||0
9374|NCT03212638|18971|P3|STARTED|Period 3||8
9375|NCT03212638|18972|P2|STARTED|Period 3||8
9376|NCT03212638|18973|P1|STARTED|Period 3||8
9377|NCT03212638|18969|P5|NOT COMPLETED|Period 2||0
9378|NCT03212638|18970|P4|NOT COMPLETED|Period 2||0
9379|NCT03212638|18971|P3|NOT COMPLETED|Period 2||0
9380|NCT03212638|18972|P2|NOT COMPLETED|Period 2||0
9381|NCT03212638|18973|P1|NOT COMPLETED|Period 2||0
9382|NCT03212638|18969|P5|COMPLETED|Period 2||0
9383|NCT03212638|18970|P4|COMPLETED|Period 2||0
9384|NCT03212638|18971|P3|COMPLETED|Period 2||8
9385|NCT03212638|18972|P2|COMPLETED|Period 2||8
9386|NCT03212638|18973|P1|COMPLETED|Period 2||8
9387|NCT03212638|18969|P5|Received at Least 1 Dose of Study Drug|Period 2||0
9388|NCT03212638|18970|P4|Received at Least 1 Dose of Study Drug|Period 2||0
9389|NCT03212638|18971|P3|Received at Least 1 Dose of Study Drug|Period 2||8
9390|NCT03212638|18972|P2|Received at Least 1 Dose of Study Drug|Period 2||8
9391|NCT03212638|18973|P1|Received at Least 1 Dose of Study Drug|Period 2||8
9392|NCT03212638|18969|P5|STARTED|Period 2||0
9393|NCT03212638|18970|P4|STARTED|Period 2||0
9394|NCT03212638|18971|P3|STARTED|Period 2||8
9395|NCT03212638|18972|P2|STARTED|Period 2||8
9396|NCT03212638|18973|P1|STARTED|Period 2||8
9397|NCT03212638|18969|P5|NOT COMPLETED|Period 1||0
9398|NCT03212638|18970|P4|NOT COMPLETED|Period 1||0
9399|NCT03212638|18971|P3|NOT COMPLETED|Period 1||0
9400|NCT03212638|18972|P2|NOT COMPLETED|Period 1||0
9401|NCT03212638|18973|P1|NOT COMPLETED|Period 1||0
9402|NCT03212638|18969|P5|COMPLETED|Period 1||0
9403|NCT03212638|18970|P4|COMPLETED|Period 1||0
9404|NCT03212638|18971|P3|COMPLETED|Period 1||8
9405|NCT03212638|18972|P2|COMPLETED|Period 1||8
9406|NCT03212638|18973|P1|COMPLETED|Period 1||8
9407|NCT03212638|18969|P5|Received at Least 1 Dose of Study Drug|Period 1||0
9408|NCT03212638|18970|P4|Received at Least 1 Dose of Study Drug|Period 1||0
9409|NCT03212638|18971|P3|Received at Least 1 Dose of Study Drug|Period 1||8
9410|NCT03212638|18972|P2|Received at Least 1 Dose of Study Drug|Period 1||8
9411|NCT03212638|18973|P1|Received at Least 1 Dose of Study Drug|Period 1||8
9412|NCT03212638|18969|P5|STARTED|Period 1||0
9413|NCT03212638|18970|P4|STARTED|Period 1||0
9414|NCT03212638|18971|P3|STARTED|Period 1||8
9415|NCT03212638|18972|P2|STARTED|Period 1||8
9416|NCT03212638|18973|P1|STARTED|Period 1||8
9417|NCT03212521|18995|P1|NOT COMPLETED|Overall Study||7
9418|NCT03212521|18995|P1|COMPLETED|Overall Study||223
9419|NCT03212521|18995|P1|STARTED|Overall Study||230
9420|NCT03212326|19002|P1|NOT COMPLETED|Overall Study||4
9421|NCT03212326|19002|P1|COMPLETED|Overall Study||20
9422|NCT03212326|19002|P1|STARTED|Overall Study||24
9423|NCT03212261|19007|P1|NOT COMPLETED|Overall Study||16
9424|NCT03212261|19007|P1|COMPLETED|Overall Study||21
9425|NCT03212261|19007|P1|One Month Follow-up|Overall Study|Lost to follow up (n=1)|21
9426|NCT03212261|19007|P1|Post-intervention Survey|Overall Study|Lost to follow up (n=4)|22
9427|NCT03212261|19007|P1|Program Initiation|Overall Study|Lost patients: Tech trouble no first visit (n=1), Too busy/no time (n=2), LTFU (n=1)|26
9428|NCT03212261|19007|P1|Baseline Completion|Overall Study|Lost patients: Technology difficulties (n=2), Family Emergency (n=1), Too busy (n=3), LTFU (n=1)|30
9429|NCT03212261|19007|P1|Remained Eligible|Overall Study||35
9430|NCT03212261|19007|P1|STARTED|Overall Study|Enrolled: eligible at time of approach and signed a consent.|37
9431|NCT03211858|19015|P2|NOT COMPLETED|Overall Study||22
9432|NCT03211858|19016|P1|NOT COMPLETED|Overall Study||22
9433|NCT03211858|19015|P2|COMPLETED|Overall Study||274
9434|NCT03211858|19016|P1|COMPLETED|Overall Study||279
9435|NCT03211858|19015|P2|Treated|Overall Study||296
9436|NCT03211858|19016|P1|Treated|Overall Study||301
9437|NCT03211858|19015|P2|STARTED|Overall Study||296
9438|NCT03211858|19016|P1|STARTED|Overall Study||301
9439|NCT03211117|19042|P2|NOT COMPLETED|Overall Study||0
9440|NCT03211117|19043|P1|NOT COMPLETED|Overall Study||0
9441|NCT03211117|19042|P2|COMPLETED|Overall Study||3
9442|NCT03211117|19043|P1|COMPLETED|Overall Study||0
9443|NCT03211117|19042|P2|STARTED|Overall Study||3
9444|NCT03211117|19043|P1|STARTED|Overall Study||0
9445|NCT03210376|19052|P2|NOT COMPLETED|Overall Study||0
9446|NCT03210376|19053|P1|NOT COMPLETED|Overall Study||0
9447|NCT03210376|19052|P2|COMPLETED|Overall Study||50
9448|NCT03210376|19053|P1|COMPLETED|Overall Study||50
9449|NCT03210376|19052|P2|STARTED|Overall Study||50
9450|NCT03210376|19053|P1|STARTED|Overall Study||50
9451|NCT03210337|19073|P2|NOT COMPLETED|Overall Study||5
9452|NCT03210337|19074|P1|NOT COMPLETED|Overall Study||8
9453|NCT03210337|19073|P2|COMPLETED|Overall Study||74
9454|NCT03210337|19074|P1|COMPLETED|Overall Study||70
9455|NCT03210337|19073|P2|STARTED|Overall Study||79
9456|NCT03210337|19074|P1|STARTED|Overall Study||78
9457|NCT03210220|19082|P2|NOT COMPLETED|Overall Study||0
9458|NCT03210220|19083|P1|NOT COMPLETED|Overall Study||1
9459|NCT03210220|19082|P2|COMPLETED|Overall Study||20
9460|NCT03210220|19083|P1|COMPLETED|Overall Study||19
9461|NCT03210220|19082|P2|STARTED|Overall Study||20
9462|NCT03210220|19083|P1|STARTED|Overall Study||20
9463|NCT03209570|19091|P2|NOT COMPLETED|Overall Study||13
9464|NCT03209570|19092|P1|NOT COMPLETED|Overall Study||10
9465|NCT03209570|19091|P2|COMPLETED|Overall Study||12
9466|NCT03209570|19092|P1|COMPLETED|Overall Study||14
9467|NCT03209570|19091|P2|STARTED|Overall Study||25
9468|NCT03209570|19092|P1|STARTED|Overall Study||24
9469|NCT03209518|19102|P1|NOT COMPLETED|Overall Study||2
9470|NCT03209518|19102|P1|COMPLETED|Overall Study||310
9471|NCT03209518|19102|P1|STARTED|Overall Study||312
9472|NCT03209492|19107|P1|NOT COMPLETED|Overall Study||5
9473|NCT03209492|19107|P1|COMPLETED|Overall Study||328
9474|NCT03209492|19107|P1|STARTED|Overall Study||333
9475|NCT03208673|19112|P1|NOT COMPLETED|Overall Study||0
9476|NCT03208673|19112|P1|COMPLETED|Overall Study||32
9477|NCT03208673|19112|P1|STARTED|Overall Study||32
9478|NCT03208166|19120|P2|NOT COMPLETED|Overall Study||0
9479|NCT03208166|19121|P1|NOT COMPLETED|Overall Study||0
9480|NCT03208166|19120|P2|COMPLETED|Overall Study||1
9481|NCT03208166|19121|P1|COMPLETED|Overall Study||1
9482|NCT03208166|19120|P2|STARTED|Overall Study||1
9483|NCT03208166|19121|P1|STARTED|Overall Study||1
9484|NCT03207776|19131|P2|NOT COMPLETED|Overall Study||0
9485|NCT03207776|19132|P1|NOT COMPLETED|Overall Study||0
9486|NCT03207776|19131|P2|COMPLETED|Overall Study||2353
9487|NCT03207776|19132|P1|COMPLETED|Overall Study||2479
9488|NCT03207776|19131|P2|STARTED|Overall Study||2353
9489|NCT03207776|19132|P1|STARTED|Overall Study||2479
9490|NCT03207750|19146|P2|NOT COMPLETED|Overall Study||66
9491|NCT03207750|19147|P1|NOT COMPLETED|Overall Study||58
9492|NCT03207750|19146|P2|COMPLETED|Overall Study||574
9493|NCT03207750|19147|P1|COMPLETED|Overall Study||574
9494|NCT03207750|19146|P2|STARTED|Overall Study||640
9495|NCT03207750|19147|P1|STARTED|Overall Study||632
9496|NCT03207399|19189|P1|NOT COMPLETED|Overall Study||0
9497|NCT03207399|19189|P1|COMPLETED|Overall Study||1
9498|NCT03207399|19189|P1|STARTED|Overall Study||1
9499|NCT03206216|19203|P2|NOT COMPLETED|Overall Study||1
9500|NCT03206216|19204|P1|NOT COMPLETED|Overall Study||0
9501|NCT03206216|19203|P2|COMPLETED|Overall Study||0
9502|NCT03206216|19204|P1|COMPLETED|Overall Study||0
9503|NCT03206216|19203|P2|STARTED|Overall Study||1
9504|NCT03206216|19204|P1|STARTED|Overall Study||0
9505|NCT03204643|19214|P2|NOT COMPLETED|Overall Study||0
9506|NCT03204643|19215|P1|NOT COMPLETED|Overall Study||0
9507|NCT03204643|19214|P2|COMPLETED|Overall Study||314
9508|NCT03204643|19215|P1|COMPLETED|Overall Study||323
9509|NCT03204643|19214|P2|STARTED|Overall Study||314
9510|NCT03204643|19215|P1|STARTED|Overall Study||323
9511|NCT03203291|19227|P1|NOT COMPLETED|Overall Study||1
9512|NCT03203291|19227|P1|COMPLETED|Overall Study||11
9513|NCT03203291|19227|P1|STARTED|Overall Study||12
9514|NCT03200925|19239|P2|NOT COMPLETED|Overall Study||0
9515|NCT03200925|19240|P1|NOT COMPLETED|Overall Study||0
9516|NCT03200925|19239|P2|COMPLETED|Overall Study||120
9517|NCT03200925|19240|P1|COMPLETED|Overall Study||120
9518|NCT03200925|19239|P2|STARTED|Overall Study||120
9519|NCT03200925|19240|P1|STARTED|Overall Study||120
9520|NCT03198767|19257|P7|NOT COMPLETED|Overall Study||0
9521|NCT03198767|19258|P6|NOT COMPLETED|Overall Study||0
9522|NCT03198767|19259|P5|NOT COMPLETED|Overall Study||0
9523|NCT03198767|19260|P4|NOT COMPLETED|Overall Study||6
9524|NCT03198767|19261|P3|NOT COMPLETED|Overall Study||0
9525|NCT03198767|19262|P2|NOT COMPLETED|Overall Study||0
9526|NCT03198767|19263|P1|NOT COMPLETED|Overall Study||0
9527|NCT03198767|19257|P7|COMPLETED|Overall Study||8
9528|NCT03198767|19258|P6|COMPLETED|Overall Study||8
9529|NCT03198767|19259|P5|COMPLETED|Overall Study||8
9530|NCT03198767|19260|P4|COMPLETED|Overall Study||0
9531|NCT03198767|19261|P3|COMPLETED|Overall Study||8
9532|NCT03198767|19262|P2|COMPLETED|Overall Study||8
9533|NCT03198767|19263|P1|COMPLETED|Overall Study||8
9534|NCT03198767|19257|P7|STARTED|Overall Study||8
9535|NCT03198767|19258|P6|STARTED|Overall Study||8
9536|NCT03198767|19259|P5|STARTED|Overall Study||8
9537|NCT03198767|19260|P4|STARTED|Overall Study||6
9538|NCT03198767|19261|P3|STARTED|Overall Study||8
9539|NCT03198767|19262|P2|STARTED|Overall Study||8
9540|NCT03198767|19263|P1|STARTED|Overall Study||8
9541|NCT03198000|19305|P3|NOT COMPLETED|Overall Study||0
9542|NCT03198000|19306|P2|NOT COMPLETED|Overall Study||0
9543|NCT03198000|19307|P1|NOT COMPLETED|Overall Study||0
9544|NCT03198000|19305|P3|COMPLETED|Overall Study||41
9545|NCT03198000|19306|P2|COMPLETED|Overall Study||38
9546|NCT03198000|19307|P1|COMPLETED|Overall Study||41
9547|NCT03198000|19305|P3|STARTED|Overall Study||41
9548|NCT03198000|19306|P2|STARTED|Overall Study||38
9549|NCT03198000|19307|P1|STARTED|Overall Study||41
9550|NCT03197883|19416|P2|NOT COMPLETED|Overall Study||6
9551|NCT03197883|19417|P1|NOT COMPLETED|Overall Study||3
9552|NCT03197883|19416|P2|COMPLETED|Overall Study||44
9553|NCT03197883|19417|P1|COMPLETED|Overall Study||47
9554|NCT03197883|19416|P2|STARTED|Overall Study||50
9555|NCT03197883|19417|P1|STARTED|Overall Study||50
9556|NCT03197376|19451|P4|NOT COMPLETED|Overall Study||25
9557|NCT03197376|19452|P3|NOT COMPLETED|Overall Study||20
9558|NCT03197376|19453|P2|NOT COMPLETED|Overall Study||13
9559|NCT03197376|19454|P1|NOT COMPLETED|Overall Study||15
9560|NCT03197376|19451|P4|COMPLETED|Overall Study||722
9561|NCT03197376|19452|P3|COMPLETED|Overall Study||480
9562|NCT03197376|19453|P2|COMPLETED|Overall Study||488
9563|NCT03197376|19454|P1|COMPLETED|Overall Study||487
9564|NCT03197376|19451|P4|Ongoing in Immune Persistence Phase|Overall Study||211
9565|NCT03197376|19452|P3|Ongoing in Immune Persistence Phase|Overall Study||138
9566|NCT03197376|19453|P2|Ongoing in Immune Persistence Phase|Overall Study||144
9567|NCT03197376|19454|P1|Ongoing in Immune Persistence Phase|Overall Study||144
9568|NCT03197376|19451|P4|Received Booster Vaccine|Overall Study||213
9569|NCT03197376|19452|P3|Received Booster Vaccine|Overall Study||139
9570|NCT03197376|19453|P2|Received Booster Vaccine|Overall Study||144
9571|NCT03197376|19454|P1|Received Booster Vaccine|Overall Study||145
9572|NCT03197376|19451|P4|Booster Cohort|Overall Study||224
9573|NCT03197376|19452|P3|Booster Cohort|Overall Study||150
9574|NCT03197376|19453|P2|Booster Cohort|Overall Study||151
9575|NCT03197376|19454|P1|Booster Cohort|Overall Study||150
9576|NCT03197376|19451|P4|Primary Reactogenicity Cohort|Overall Study||364
9577|NCT03197376|19452|P3|Primary Reactogenicity Cohort|Overall Study||257
9578|NCT03197376|19453|P2|Primary Reactogenicity Cohort|Overall Study||243
9579|NCT03197376|19454|P1|Primary Reactogenicity Cohort|Overall Study||251
9580|NCT03197376|19451|P4|Vaccinated-Dose 3|Overall Study||731
9581|NCT03197376|19452|P3|Vaccinated-Dose 3|Overall Study||490
9582|NCT03197376|19453|P2|Vaccinated-Dose 3|Overall Study||493
9583|NCT03197376|19454|P1|Vaccinated-Dose 3|Overall Study||492
9584|NCT03197376|19451|P4|Vaccinated-Dose 2|Overall Study||738
9585|NCT03197376|19452|P3|Vaccinated-Dose 2|Overall Study||491
9586|NCT03197376|19453|P2|Vaccinated-Dose 2|Overall Study||495
9587|NCT03197376|19454|P1|Vaccinated-Dose 2|Overall Study||495
9588|NCT03197376|19451|P4|Vaccinated-Dose 1|Overall Study||747
9589|NCT03197376|19452|P3|Vaccinated-Dose 1|Overall Study||500
9590|NCT03197376|19453|P2|Vaccinated-Dose 1|Overall Study||501
9591|NCT03197376|19454|P1|Vaccinated-Dose 1|Overall Study||502
9592|NCT03197376|19451|P4|STARTED|Overall Study||747
9593|NCT03197376|19452|P3|STARTED|Overall Study||500
9594|NCT03197376|19453|P2|STARTED|Overall Study||501
9595|NCT03197376|19454|P1|STARTED|Overall Study||502
9596|NCT03197025|19505|P1|NOT COMPLETED|Overall Study||0
9597|NCT03197025|19505|P1|COMPLETED|Overall Study||1
9598|NCT03197025|19505|P1|STARTED|Overall Study||1
9599|NCT03196635|19512|P1|NOT COMPLETED|Overall Study||1
9600|NCT03196635|19512|P1|COMPLETED|Overall Study||30
9601|NCT03196635|19512|P1|STARTED|Overall Study||31
9602|NCT03196349|19533|P3|NOT COMPLETED|Overall Study||13
9603|NCT03196349|19534|P2|NOT COMPLETED|Overall Study||14
9604|NCT03196349|19535|P1|NOT COMPLETED|Overall Study||17
9605|NCT03196349|19533|P3|COMPLETED|Overall Study||0
9606|NCT03196349|19534|P2|COMPLETED|Overall Study||0
9607|NCT03196349|19535|P1|COMPLETED|Overall Study||0
9608|NCT03196349|19533|P3|STARTED|Overall Study||13
9609|NCT03196349|19534|P2|STARTED|Overall Study||14
9610|NCT03196349|19535|P1|STARTED|Overall Study||17
9611|NCT03195517|19552|P1|NOT COMPLETED|Overall Study||0
9612|NCT03195517|19552|P1|COMPLETED|Overall Study||33
9613|NCT03195517|19552|P1|STARTED|Overall Study||33
9614|NCT03195010|19567|P2|NOT COMPLETED|Overall Study||0
9615|NCT03195010|19568|P1|NOT COMPLETED|Overall Study||0
9616|NCT03195010|19567|P2|COMPLETED|Overall Study||2
9617|NCT03195010|19568|P1|COMPLETED|Overall Study||2
9618|NCT03195010|19567|P2|STARTED|Overall Study||2
9619|NCT03195010|19568|P1|STARTED|Overall Study||2
9620|NCT03194490|19595|P2|NOT COMPLETED|Overall Study||3
9621|NCT03194490|19596|P1|NOT COMPLETED|Overall Study||2
9622|NCT03194490|19595|P2|COMPLETED|Overall Study||20
9623|NCT03194490|19596|P1|COMPLETED|Overall Study||18
9624|NCT03194490|19595|P2|STARTED|Overall Study||23
9625|NCT03194490|19596|P1|STARTED|Overall Study||20
9626|NCT03194334|19641|P3|NOT COMPLETED|3-6 Months||0
9627|NCT03194334|19642|P2|NOT COMPLETED|3-6 Months||0
9628|NCT03194334|19643|P1|NOT COMPLETED|3-6 Months||0
9629|NCT03194334|19641|P3|COMPLETED|3-6 Months||14
9630|NCT03194334|19642|P2|COMPLETED|3-6 Months||15
9631|NCT03194334|19643|P1|COMPLETED|3-6 Months||10
9632|NCT03194334|19641|P3|STARTED|3-6 Months||14
9633|NCT03194334|19642|P2|STARTED|3-6 Months||15
9634|NCT03194334|19643|P1|STARTED|3-6 Months||10
9635|NCT03194334|19641|P3|NOT COMPLETED|0-3 Months||1
9636|NCT03194334|19642|P2|NOT COMPLETED|0-3 Months||0
9637|NCT03194334|19643|P1|NOT COMPLETED|0-3 Months||0
9638|NCT03194334|19641|P3|COMPLETED|0-3 Months||14
9639|NCT03194334|19642|P2|COMPLETED|0-3 Months||15
9640|NCT03194334|19643|P1|COMPLETED|0-3 Months||10
9641|NCT03194334|19641|P3|STARTED|0-3 Months||15
9642|NCT03194334|19642|P2|STARTED|0-3 Months||15
9643|NCT03194334|19643|P1|STARTED|0-3 Months||10
9644|NCT03193593|19721|P7|NOT COMPLETED|Overall Study||4
9645|NCT03193593|19722|P6|NOT COMPLETED|Overall Study||3
9646|NCT03193593|19723|P5|NOT COMPLETED|Overall Study||1
9647|NCT03193593|19724|P4|NOT COMPLETED|Overall Study||0
9648|NCT03193593|19725|P3|NOT COMPLETED|Overall Study||1
9649|NCT03193593|19726|P2|NOT COMPLETED|Overall Study||1
9650|NCT03193593|19727|P1|NOT COMPLETED|Overall Study||4
9651|NCT03193593|19721|P7|COMPLETED|Overall Study||8
9652|NCT03193593|19722|P6|COMPLETED|Overall Study||13
9653|NCT03193593|19723|P5|COMPLETED|Overall Study||7
9654|NCT03193593|19724|P4|COMPLETED|Overall Study||4
9655|NCT03193593|19725|P3|COMPLETED|Overall Study||3
9656|NCT03193593|19726|P2|COMPLETED|Overall Study||3
9657|NCT03193593|19727|P1|COMPLETED|Overall Study||14
9658|NCT03193593|19721|P7|STARTED|Overall Study||12
9659|NCT03193593|19722|P6|STARTED|Overall Study||16
9660|NCT03193593|19723|P5|STARTED|Overall Study||8
9661|NCT03193593|19724|P4|STARTED|Overall Study||4
9662|NCT03193593|19725|P3|STARTED|Overall Study||4
9663|NCT03193593|19726|P2|STARTED|Overall Study||4
9664|NCT03193593|19727|P1|STARTED|Overall Study||18
9665|NCT03192826|19746|P3|NOT COMPLETED|Overall Study||0
9666|NCT03192826|19747|P2|NOT COMPLETED|Overall Study||0
9667|NCT03192826|19748|P1|NOT COMPLETED|Overall Study||0
9668|NCT03192826|19746|P3|COMPLETED|Overall Study||25
9669|NCT03192826|19747|P2|COMPLETED|Overall Study||27
9670|NCT03192826|19748|P1|COMPLETED|Overall Study||27
9671|NCT03192826|19746|P3|STARTED|Overall Study||25
9672|NCT03192826|19747|P2|STARTED|Overall Study||27
9673|NCT03192826|19748|P1|STARTED|Overall Study||27
9674|NCT03192475|19767|P2|NOT COMPLETED|Overall Study||9
9675|NCT03192475|19768|P1|NOT COMPLETED|Overall Study||13
9676|NCT03192475|19767|P2|COMPLETED|Overall Study||151
9677|NCT03192475|19768|P1|COMPLETED|Overall Study||149
9678|NCT03192475|19767|P2|STARTED|Overall Study||160
9679|NCT03192475|19768|P1|STARTED|Overall Study||162
9680|NCT03192306|19804|P2|NOT COMPLETED|Overall Study||145
9681|NCT03192306|19805|P1|NOT COMPLETED|Overall Study||152
9682|NCT03192306|19804|P2|COMPLETED|Overall Study||79
9683|NCT03192306|19805|P1|COMPLETED|Overall Study||75
9684|NCT03192306|19804|P2|Modified Intent to Treat (MITT)|Overall Study||80
9685|NCT03192306|19805|P1|Modified Intent to Treat (MITT)|Overall Study||76
9686|NCT03192306|19804|P2|STARTED|Overall Study||224
9687|NCT03192306|19805|P1|STARTED|Overall Study||227
9688|NCT03191552|19826|P3|NOT COMPLETED|Overall Study||0
9689|NCT03191552|19827|P2|NOT COMPLETED|Overall Study||1
9690|NCT03191552|19828|P1|NOT COMPLETED|Overall Study||1
9691|NCT03191552|19826|P3|COMPLETED|Overall Study||8
9692|NCT03191552|19827|P2|COMPLETED|Overall Study||8
9693|NCT03191552|19828|P1|COMPLETED|Overall Study||8
9694|NCT03191552|19826|P3|STARTED|Overall Study||8
9695|NCT03191552|19827|P2|STARTED|Overall Study||9
9696|NCT03191552|19828|P1|STARTED|Overall Study||9
9697|NCT03191396|19881|P2|NOT COMPLETED|Overall Study||5
9698|NCT03191396|19882|P1|NOT COMPLETED|Overall Study||3
9699|NCT03191396|19881|P2|COMPLETED|Overall Study||282
9700|NCT03191396|19882|P1|COMPLETED|Overall Study||287
9701|NCT03191396|19881|P2|STARTED|Overall Study||287
9702|NCT03191396|19882|P1|STARTED|Overall Study||290
9703|NCT03190005|19975|P7|NOT COMPLETED|Overall Study||0
9704|NCT03190005|19976|P6|NOT COMPLETED|Overall Study||0
9705|NCT03190005|19977|P5|NOT COMPLETED|Overall Study||0
9706|NCT03190005|19978|P4|NOT COMPLETED|Overall Study||0
9707|NCT03190005|19979|P3|NOT COMPLETED|Overall Study||0
9708|NCT03190005|19980|P2|NOT COMPLETED|Overall Study||0
9709|NCT03190005|19981|P1|NOT COMPLETED|Overall Study||0
9710|NCT03190005|19975|P7|COMPLETED|Overall Study||5
9711|NCT03190005|19976|P6|COMPLETED|Overall Study||5
9712|NCT03190005|19977|P5|COMPLETED|Overall Study||5
9713|NCT03190005|19978|P4|COMPLETED|Overall Study||5
9714|NCT03190005|19979|P3|COMPLETED|Overall Study||5
9715|NCT03190005|19980|P2|COMPLETED|Overall Study||5
9716|NCT03190005|19981|P1|COMPLETED|Overall Study||5
9717|NCT03190005|19975|P7|STARTED|Overall Study||5
9718|NCT03190005|19976|P6|STARTED|Overall Study||5
9719|NCT03190005|19977|P5|STARTED|Overall Study||5
9720|NCT03190005|19978|P4|STARTED|Overall Study||5
9721|NCT03190005|19979|P3|STARTED|Overall Study||5
9722|NCT03190005|19980|P2|STARTED|Overall Study||5
9723|NCT03190005|19981|P1|STARTED|Overall Study||5
9724|NCT03189589|19999|P2|NOT COMPLETED|Overall Study||0
9725|NCT03189589|20000|P1|NOT COMPLETED|Overall Study||0
9726|NCT03189589|19999|P2|COMPLETED|Overall Study||6
9727|NCT03189589|20000|P1|COMPLETED|Overall Study||6
9728|NCT03189589|19999|P2|STARTED|Overall Study||6
9729|NCT03189589|20000|P1|STARTED|Overall Study||6
9730|NCT03188523|20026|P4|NOT COMPLETED|Overall Study||0
9731|NCT03188523|20027|P3|NOT COMPLETED|Overall Study||0
9732|NCT03188523|20028|P2|NOT COMPLETED|Overall Study||0
9733|NCT03188523|20029|P1|NOT COMPLETED|Overall Study||0
9734|NCT03188523|20026|P4|COMPLETED|Overall Study||0
9735|NCT03188523|20027|P3|COMPLETED|Overall Study||0
9736|NCT03188523|20028|P2|COMPLETED|Overall Study||6
9737|NCT03188523|20029|P1|COMPLETED|Overall Study||6
9738|NCT03188523|20026|P4|STARTED|Overall Study||0
9739|NCT03188523|20027|P3|STARTED|Overall Study||0
9740|NCT03188523|20028|P2|STARTED|Overall Study||6
9741|NCT03188523|20029|P1|STARTED|Overall Study||6
9742|NCT03188120|20079|P1|NOT COMPLETED|Overall Study||47
9743|NCT03188120|20079|P1|COMPLETED|Overall Study||146
9744|NCT03188120|20079|P1|STARTED|Overall Study||193
9745|NCT03187678|20084|P1|NOT COMPLETED|Period 3 (Oral Selexipag)||0
9746|NCT03187678|20084|P1|COMPLETED|Period 3 (Oral Selexipag)||20
9747|NCT03187678|20084|P1|STARTED|Period 3 (Oral Selexipag)||20
9748|NCT03187678|20084|P1|NOT COMPLETED|Period 2 (Intravenous Selexipag)||0
9749|NCT03187678|20084|P1|COMPLETED|Period 2 (Intravenous Selexipag)||20
9750|NCT03187678|20084|P1|STARTED|Period 2 (Intravenous Selexipag)||20
9751|NCT03187678|20084|P1|NOT COMPLETED|Period 1 (Oral Selexipag)||0
9752|NCT03187678|20084|P1|COMPLETED|Period 1 (Oral Selexipag)||20
9753|NCT03187678|20084|P1|STARTED|Period 1 (Oral Selexipag)||20
9754|NCT03185481|20092|P1|NOT COMPLETED|Overall Study||5
9755|NCT03185481|20092|P1|COMPLETED|Overall Study||0
9756|NCT03185481|20092|P1|STARTED|Overall Study||5
9757|NCT03185455|20111|P2|NOT COMPLETED|Overall Study||0
9758|NCT03185455|20112|P1|NOT COMPLETED|Overall Study||0
9759|NCT03185455|20111|P2|COMPLETED|Overall Study||103
9760|NCT03185455|20112|P1|COMPLETED|Overall Study||103
9761|NCT03185455|20111|P2|STARTED|Overall Study||103
9762|NCT03185455|20112|P1|STARTED|Overall Study||103
9763|NCT03185182|20126|P1|NOT COMPLETED|Overall Study||0
9764|NCT03185182|20126|P1|COMPLETED|Overall Study||5
9765|NCT03185182|20126|P1|STARTED|Overall Study||5
9766|NCT03184441|20131|P1|NOT COMPLETED|Overall Study||1
9767|NCT03184441|20131|P1|COMPLETED|Overall Study|Last subject completed study|10
9768|NCT03184441|20131|P1|STARTED|Overall Study||11
9769|NCT03184077|20141|P2|NOT COMPLETED|Overall Study||21
9770|NCT03184077|20142|P1|NOT COMPLETED|Overall Study||21
9771|NCT03184077|20141|P2|COMPLETED|Overall Study||131
9772|NCT03184077|20142|P1|COMPLETED|Overall Study||145
9773|NCT03184077|20141|P2|STARTED|Overall Study||152
9774|NCT03184077|20142|P1|STARTED|Overall Study||166
9775|NCT03183518|20152|P1|NOT COMPLETED|Overall Study||3
9776|NCT03183518|20152|P1|COMPLETED|Overall Study||33
9777|NCT03183518|20152|P1|Negative Control|Overall Study||36
9778|NCT03183518|20152|P1|Test Product|Overall Study||36
9779|NCT03183518|20152|P1|STARTED|Overall Study||36
9780|NCT03182933|20185|P2|NOT COMPLETED|Overall Study||0
9781|NCT03182933|20186|P1|NOT COMPLETED|Overall Study||1
9782|NCT03182933|20185|P2|COMPLETED|Overall Study||32
9783|NCT03182933|20186|P1|COMPLETED|Overall Study||31
9784|NCT03182933|20185|P2|STARTED|Overall Study||32
9785|NCT03182933|20186|P1|STARTED|Overall Study||32
9786|NCT03182582|20200|P2|NOT COMPLETED|Treatment 2||0
9787|NCT03182582|20201|P1|NOT COMPLETED|Treatment 2||0
9788|NCT03182582|20200|P2|COMPLETED|Treatment 2||10
9789|NCT03182582|20201|P1|COMPLETED|Treatment 2||12
9790|NCT03182582|20200|P2|STARTED|Treatment 2||10
9791|NCT03182582|20201|P1|STARTED|Treatment 2||12
9792|NCT03182582|20200|P2|NOT COMPLETED|Treatment 1||0
9793|NCT03182582|20201|P1|NOT COMPLETED|Treatment 1||0
9794|NCT03182582|20200|P2|COMPLETED|Treatment 1||10
9795|NCT03182582|20201|P1|COMPLETED|Treatment 1||12
9796|NCT03182582|20200|P2|STARTED|Treatment 1||10
9797|NCT03182582|20201|P1|STARTED|Treatment 1||12
9798|NCT03181724|20218|P2|NOT COMPLETED|Overall Study||0
9799|NCT03181724|20219|P1|NOT COMPLETED|Overall Study||0
9800|NCT03181724|20218|P2|COMPLETED|Overall Study||45
9801|NCT03181724|20219|P1|COMPLETED|Overall Study||45
9802|NCT03181724|20218|P2|STARTED|Overall Study||45
9803|NCT03181724|20219|P1|STARTED|Overall Study||45
9804|NCT03181594|20235|P1|NOT COMPLETED|Overall Study||2
9805|NCT03181594|20235|P1|COMPLETED|Overall Study||98
9806|NCT03181594|20235|P1|90-day Follow-up|Overall Study||98
9807|NCT03181594|20235|P1|30-day Follow-up|Overall Study||99
9808|NCT03181594|20235|P1|STARTED|Overall Study||100
9809|NCT03181009|20243|P2|NOT COMPLETED|Overall Study||2
9810|NCT03181009|20244|P1|NOT COMPLETED|Overall Study||0
9811|NCT03181009|20243|P2|COMPLETED|Overall Study||28
9812|NCT03181009|20244|P1|COMPLETED|Overall Study||30
9813|NCT03181009|20243|P2|STARTED|Overall Study||30
9814|NCT03181009|20244|P1|STARTED|Overall Study||30
9815|NCT03180801|20253|P3|NOT COMPLETED|Overall Study||10
9816|NCT03180801|20254|P2|NOT COMPLETED|Overall Study||12
9817|NCT03180801|20255|P1|NOT COMPLETED|Overall Study||8
9818|NCT03180801|20253|P3|COMPLETED|Overall Study||41
9819|NCT03180801|20254|P2|COMPLETED|Overall Study||40
9820|NCT03180801|20255|P1|COMPLETED|Overall Study||42
9821|NCT03180801|20253|P3|Intention to Treat|Overall Study||41
9822|NCT03180801|20254|P2|Intention to Treat|Overall Study||40
9823|NCT03180801|20255|P1|Intention to Treat|Overall Study||42
9824|NCT03180801|20253|P3|Safety Population|Overall Study||51
9825|NCT03180801|20254|P2|Safety Population|Overall Study||52
9826|NCT03180801|20255|P1|Safety Population|Overall Study||50
9827|NCT03180801|20253|P3|STARTED|Overall Study||51
9828|NCT03180801|20254|P2|STARTED|Overall Study||52
9829|NCT03180801|20255|P1|STARTED|Overall Study||50
9830|NCT03180645|20296|P3|NOT COMPLETED|Overall Study||2
9831|NCT03180645|20297|P2|NOT COMPLETED|Overall Study||1
9832|NCT03180645|20298|P1|NOT COMPLETED|Overall Study||0
9833|NCT03180645|20296|P3|COMPLETED|Overall Study||22
9834|NCT03180645|20297|P2|COMPLETED|Overall Study||23
9835|NCT03180645|20298|P1|COMPLETED|Overall Study||24
9836|NCT03180645|20296|P3|STARTED|Overall Study||24
9837|NCT03180645|20297|P2|STARTED|Overall Study||24
9838|NCT03180645|20298|P1|STARTED|Overall Study||24
9839|NCT03180515|20337|P1|NOT COMPLETED|Aim 3||0
9840|NCT03180515|20337|P1|COMPLETED|Aim 3||1
9841|NCT03180515|20337|P1|STARTED|Aim 3||1
9842|NCT03180515|20337|P1|NOT COMPLETED|Aim 2||0
9843|NCT03180515|20337|P1|COMPLETED|Aim 2||12
9844|NCT03180515|20337|P1|STARTED|Aim 2||12
9845|NCT03180515|20337|P1|NOT COMPLETED|Aim 1||0
9846|NCT03180515|20337|P1|COMPLETED|Aim 1||12
9847|NCT03180515|20337|P1|STARTED|Aim 1||12
9848|NCT03180385|20382|P2|NOT COMPLETED|Overall Study||0
9849|NCT03180385|20383|P1|NOT COMPLETED|Overall Study||0
9850|NCT03180385|20382|P2|COMPLETED|Overall Study||2
9851|NCT03180385|20383|P1|COMPLETED|Overall Study||0
9852|NCT03180385|20382|P2|STARTED|Overall Study||2
9853|NCT03180385|20383|P1|STARTED|Overall Study||0
9854|NCT03180138|20410|P3|NOT COMPLETED|Overall Study||24
9855|NCT03180138|20411|P2|NOT COMPLETED|Overall Study||13
9856|NCT03180138|20412|P1|NOT COMPLETED|Overall Study||22
9857|NCT03180138|20410|P3|COMPLETED|Overall Study||179
9858|NCT03180138|20411|P2|COMPLETED|Overall Study||188
9859|NCT03180138|20412|P1|COMPLETED|Overall Study||182
9860|NCT03180138|20410|P3|STARTED|Overall Study||203
9861|NCT03180138|20411|P2|STARTED|Overall Study||201
9862|NCT03180138|20412|P1|STARTED|Overall Study||204
9863|NCT03178942|20425|P2|NOT COMPLETED|Overall Study||2
9864|NCT03178942|20426|P1|NOT COMPLETED|Overall Study||3
9865|NCT03178942|20425|P2|COMPLETED|Overall Study||123
9866|NCT03178942|20426|P1|COMPLETED|Overall Study||126
9867|NCT03178942|20425|P2|STARTED|Overall Study||125
9868|NCT03178942|20426|P1|STARTED|Overall Study||129
9869|NCT03178344|20438|P2|NOT COMPLETED|Second Session||0
9870|NCT03178344|20439|P1|NOT COMPLETED|Second Session||0
9871|NCT03178344|20438|P2|COMPLETED|Second Session||10
9872|NCT03178344|20439|P1|COMPLETED|Second Session||10
9873|NCT03178344|20438|P2|STARTED|Second Session||10
9874|NCT03178344|20439|P1|STARTED|Second Session||10
9875|NCT03178344|20438|P2|NOT COMPLETED|Washout Period (5-9 Days)||0
9876|NCT03178344|20439|P1|NOT COMPLETED|Washout Period (5-9 Days)||0
9877|NCT03178344|20438|P2|COMPLETED|Washout Period (5-9 Days)||10
9878|NCT03178344|20439|P1|COMPLETED|Washout Period (5-9 Days)||10
9879|NCT03178344|20438|P2|STARTED|Washout Period (5-9 Days)||10
9880|NCT03178344|20439|P1|STARTED|Washout Period (5-9 Days)||10
9881|NCT03178344|20438|P2|NOT COMPLETED|First Session||0
9882|NCT03178344|20439|P1|NOT COMPLETED|First Session||0
9883|NCT03178344|20438|P2|COMPLETED|First Session||10
9884|NCT03178344|20439|P1|COMPLETED|First Session||10
9885|NCT03178344|20438|P2|STARTED|First Session||10
9886|NCT03178344|20439|P1|STARTED|First Session||10
9887|NCT03178266|20455|P2|NOT COMPLETED|Overall Study||4
9888|NCT03178266|20456|P1|NOT COMPLETED|Overall Study||0
9889|NCT03178266|20455|P2|COMPLETED|Overall Study||16
9890|NCT03178266|20456|P1|COMPLETED|Overall Study||21
9891|NCT03178266|20455|P2|STARTED|Overall Study||20
9892|NCT03178266|20456|P1|STARTED|Overall Study||21
9893|NCT03177798|20466|P2|NOT COMPLETED|Overall Study||0
9894|NCT03177798|20467|P1|NOT COMPLETED|Overall Study||0
9895|NCT03177798|20466|P2|COMPLETED|Overall Study||6
9896|NCT03177798|20467|P1|COMPLETED|Overall Study||5
9897|NCT03177798|20466|P2|Intervention 2|Overall Study||6
9898|NCT03177798|20467|P1|Intervention 2|Overall Study||5
9899|NCT03177798|20466|P2|Washout|Overall Study||6
9900|NCT03177798|20467|P1|Washout|Overall Study||5
9901|NCT03177798|20466|P2|Intervention 1|Overall Study||6
9902|NCT03177798|20467|P1|Intervention 1|Overall Study||5
9903|NCT03177798|20466|P2|STARTED|Overall Study||6
9904|NCT03177798|20467|P1|STARTED|Overall Study||5
9905|NCT03177395|20479|P4|NOT COMPLETED|Overall Study||0
9906|NCT03177395|20480|P3|NOT COMPLETED|Overall Study||0
9907|NCT03177395|20481|P2|NOT COMPLETED|Overall Study||0
9908|NCT03177395|20482|P1|NOT COMPLETED|Overall Study||0
9909|NCT03177395|20479|P4|COMPLETED|Overall Study||6
9910|NCT03177395|20480|P3|COMPLETED|Overall Study||6
9911|NCT03177395|20481|P2|COMPLETED|Overall Study||6
9912|NCT03177395|20482|P1|COMPLETED|Overall Study||6
9913|NCT03177395|20479|P4|STARTED|Overall Study||6
9914|NCT03177395|20480|P3|STARTED|Overall Study||6
9915|NCT03177395|20481|P2|STARTED|Overall Study||6
9916|NCT03177395|20482|P1|STARTED|Overall Study||6
9917|NCT03176654|20586|P2|NOT COMPLETED|Overall Study||0
9918|NCT03176654|20587|P1|NOT COMPLETED|Overall Study||0
9919|NCT03176654|20586|P2|COMPLETED|Overall Study||15
9920|NCT03176654|20587|P1|COMPLETED|Overall Study||13
9921|NCT03176654|20586|P2|STARTED|Overall Study||15
9922|NCT03176654|20587|P1|STARTED|Overall Study||13
9923|NCT03176407|20607|P1|NOT COMPLETED|Overall Study||3
9924|NCT03176407|20607|P1|COMPLETED|Overall Study||27
9925|NCT03176407|20607|P1|STARTED|Overall Study||30
9926|NCT03175562|20615|P1|NOT COMPLETED|Overall Study||16
9927|NCT03175562|20615|P1|COMPLETED|Overall Study||224
9928|NCT03175562|20615|P1|Negative Control|Overall Study||240
9929|NCT03175562|20615|P1|Test Product|Overall Study||240
9930|NCT03175562|20615|P1|STARTED|Overall Study||240
9931|NCT03175172|20640|P1|NOT COMPLETED|Overall Study||10
9932|NCT03175172|20640|P1|COMPLETED|Overall Study||0
9933|NCT03175172|20640|P1|STARTED|Overall Study||10
9934|NCT03174366|20648|P1|NOT COMPLETED|Overall Study||0
9935|NCT03174366|20648|P1|COMPLETED|Overall Study||7
9936|NCT03174366|20648|P1|STARTED|Overall Study||7
9937|NCT03174132|20653|P1|NOT COMPLETED|Overall Study||0
9938|NCT03174132|20653|P1|COMPLETED|Overall Study||70
9939|NCT03174132|20653|P1|STARTED|Overall Study||70
9940|NCT03173170|20658|P1|NOT COMPLETED|Intervention Period 2 (9 Days)||0
9941|NCT03173170|20658|P1|COMPLETED|Intervention Period 2 (9 Days)||10
9942|NCT03173170|20658|P1|STARTED|Intervention Period 2 (9 Days)||10
9943|NCT03173170|20658|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9944|NCT03173170|20658|P1|COMPLETED|Washout Period (at Least 7 Days)||10
9945|NCT03173170|20658|P1|STARTED|Washout Period (at Least 7 Days)||10
9946|NCT03173170|20658|P1|NOT COMPLETED|First Intervention Period (6 Days)||0
9947|NCT03173170|20658|P1|COMPLETED|First Intervention Period (6 Days)||10
9948|NCT03173170|20658|P1|STARTED|First Intervention Period (6 Days)||10
9949|NCT03172481|20669|P2|NOT COMPLETED|Double-blind||0
9950|NCT03172481|20670|P1|NOT COMPLETED|Double-blind||1
9951|NCT03172481|20669|P2|COMPLETED|Double-blind||73
9952|NCT03172481|20670|P1|COMPLETED|Double-blind||74
9953|NCT03172481|20669|P2|STARTED|Double-blind|From 148 subjects who completed the Open-label period, 73 randomly received Placebo|73
9954|NCT03172481|20670|P1|STARTED|Double-blind||75
9955|NCT03172481|20669|P2|NOT COMPLETED|Open-label||0
9956|NCT03172481|20670|P1|NOT COMPLETED|Open-label||8
9957|NCT03172481|20669|P2|COMPLETED|Open-label||0
9958|NCT03172481|20670|P1|COMPLETED|Open-label||148
9959|NCT03172481|20669|P2|STARTED|Open-label||0
9960|NCT03172481|20670|P1|STARTED|Open-label||156
9961|NCT03172364|20678|P2|NOT COMPLETED|Overall Study||1
9962|NCT03172364|20679|P1|NOT COMPLETED|Overall Study||2
9963|NCT03172364|20678|P2|COMPLETED|Overall Study||57
9964|NCT03172364|20679|P1|COMPLETED|Overall Study||53
9965|NCT03172364|20678|P2|STARTED|Overall Study||58
9966|NCT03172364|20679|P1|STARTED|Overall Study||55
9967|NCT03171415|20700|P5|NOT COMPLETED|Overall Study||2
9968|NCT03171415|20701|P4|NOT COMPLETED|Overall Study||0
9969|NCT03171415|20702|P3|NOT COMPLETED|Overall Study||0
9970|NCT03171415|20703|P2|NOT COMPLETED|Overall Study||0
9971|NCT03171415|20704|P1|NOT COMPLETED|Overall Study||0
9972|NCT03171415|20700|P5|COMPLETED|Overall Study||7
9973|NCT03171415|20701|P4|COMPLETED|Overall Study||6
9974|NCT03171415|20702|P3|COMPLETED|Overall Study||6
9975|NCT03171415|20703|P2|COMPLETED|Overall Study||6
9976|NCT03171415|20704|P1|COMPLETED|Overall Study||6
9977|NCT03171415|20700|P5|STARTED|Overall Study||9
9978|NCT03171415|20701|P4|STARTED|Overall Study||6
9979|NCT03171415|20702|P3|STARTED|Overall Study||6
9980|NCT03171415|20703|P2|STARTED|Overall Study||6
9981|NCT03171415|20704|P1|STARTED|Overall Study||6
9982|NCT03170609|20772|P7|NOT COMPLETED|Overall Study||1
9983|NCT03170609|20773|P6|NOT COMPLETED|Overall Study||2
9984|NCT03170609|20774|P5|NOT COMPLETED|Overall Study||1
9985|NCT03170609|20775|P4|NOT COMPLETED|Overall Study||2
9986|NCT03170609|20776|P3|NOT COMPLETED|Overall Study||6
9987|NCT03170609|20777|P2|NOT COMPLETED|Overall Study||2
9988|NCT03170609|20778|P1|NOT COMPLETED|Overall Study||3
9989|NCT03170609|20772|P7|COMPLETED|Overall Study||51
9990|NCT03170609|20773|P6|COMPLETED|Overall Study||50
9991|NCT03170609|20774|P5|COMPLETED|Overall Study||51
9992|NCT03170609|20775|P4|COMPLETED|Overall Study||50
9993|NCT03170609|20776|P3|COMPLETED|Overall Study||46
9994|NCT03170609|20777|P2|COMPLETED|Overall Study||50
9995|NCT03170609|20778|P1|COMPLETED|Overall Study||50
9996|NCT03170609|20772|P7|Vaccinated|Overall Study||52
9997|NCT03170609|20773|P6|Vaccinated|Overall Study||52
9998|NCT03170609|20774|P5|Vaccinated|Overall Study||52
9999|NCT03170609|20775|P4|Vaccinated|Overall Study||52
10000|NCT03170609|20776|P3|Vaccinated|Overall Study||52
10001|NCT03170609|20777|P2|Vaccinated|Overall Study||52
10002|NCT03170609|20778|P1|Vaccinated|Overall Study||52
10003|NCT03170609|20772|P7|STARTED|Overall Study||52
10004|NCT03170609|20773|P6|STARTED|Overall Study||52
10005|NCT03170609|20774|P5|STARTED|Overall Study||52
10006|NCT03170609|20775|P4|STARTED|Overall Study||52
10007|NCT03170609|20776|P3|STARTED|Overall Study||52
10008|NCT03170609|20777|P2|STARTED|Overall Study||52
10009|NCT03170609|20778|P1|STARTED|Overall Study||53
10010|NCT03170544|20848|P12|NOT COMPLETED|Part 4||0
10011|NCT03170544|20849|P11|NOT COMPLETED|Part 4||0
10012|NCT03170544|20850|P10|NOT COMPLETED|Part 4||0
10013|NCT03170544|20851|P9|NOT COMPLETED|Part 4||0
10014|NCT03170544|20852|P8|NOT COMPLETED|Part 4||0
10015|NCT03170544|20853|P7|NOT COMPLETED|Part 4||0
10016|NCT03170544|20854|P6|NOT COMPLETED|Part 4||0
10017|NCT03170544|20855|P5|NOT COMPLETED|Part 4||0
10018|NCT03170544|20856|P4|NOT COMPLETED|Part 4||0
10019|NCT03170544|20857|P3|NOT COMPLETED|Part 4||0
10020|NCT03170544|20858|P2|NOT COMPLETED|Part 4||0
10021|NCT03170544|20859|P1|NOT COMPLETED|Part 4||0
10022|NCT03170544|20848|P12|COMPLETED|Part 4||6
10023|NCT03170544|20849|P11|COMPLETED|Part 4||3
10024|NCT03170544|20850|P10|COMPLETED|Part 4||0
10025|NCT03170544|20851|P9|COMPLETED|Part 4||0
10026|NCT03170544|20852|P8|COMPLETED|Part 4||0
10027|NCT03170544|20853|P7|COMPLETED|Part 4||0
10028|NCT03170544|20854|P6|COMPLETED|Part 4||0
10029|NCT03170544|20855|P5|COMPLETED|Part 4||0
10030|NCT03170544|20856|P4|COMPLETED|Part 4||0
10031|NCT03170544|20857|P3|COMPLETED|Part 4||0
10032|NCT03170544|20858|P2|COMPLETED|Part 4||0
10033|NCT03170544|20859|P1|COMPLETED|Part 4||0
10034|NCT03170544|20848|P12|STARTED|Part 4||6
10035|NCT03170544|20849|P11|STARTED|Part 4||3
10036|NCT03170544|20850|P10|STARTED|Part 4||0
10037|NCT03170544|20851|P9|STARTED|Part 4||0
10038|NCT03170544|20852|P8|STARTED|Part 4||0
10039|NCT03170544|20853|P7|STARTED|Part 4||0
10040|NCT03170544|20854|P6|STARTED|Part 4||0
10041|NCT03170544|20855|P5|STARTED|Part 4||0
10042|NCT03170544|20856|P4|STARTED|Part 4||0
10043|NCT03170544|20857|P3|STARTED|Part 4||0
10044|NCT03170544|20858|P2|STARTED|Part 4||0
10045|NCT03170544|20859|P1|STARTED|Part 4||0
10046|NCT03170544|20848|P12|NOT COMPLETED|Part 3||0
10047|NCT03170544|20849|P11|NOT COMPLETED|Part 3||0
10048|NCT03170544|20850|P10|NOT COMPLETED|Part 3||0
10049|NCT03170544|20851|P9|NOT COMPLETED|Part 3||0
10050|NCT03170544|20852|P8|NOT COMPLETED|Part 3||0
10051|NCT03170544|20853|P7|NOT COMPLETED|Part 3||0
10052|NCT03170544|20854|P6|NOT COMPLETED|Part 3||0
10053|NCT03170544|20855|P5|NOT COMPLETED|Part 3||0
10054|NCT03170544|20856|P4|NOT COMPLETED|Part 3||0
10055|NCT03170544|20857|P3|NOT COMPLETED|Part 3||0
10056|NCT03170544|20858|P2|NOT COMPLETED|Part 3||0
10057|NCT03170544|20859|P1|NOT COMPLETED|Part 3||0
10058|NCT03170544|20848|P12|COMPLETED|Part 3||0
10059|NCT03170544|20849|P11|COMPLETED|Part 3||0
10060|NCT03170544|20850|P10|COMPLETED|Part 3||6
10061|NCT03170544|20851|P9|COMPLETED|Part 3||6
10062|NCT03170544|20852|P8|COMPLETED|Part 3||4
10063|NCT03170544|20853|P7|COMPLETED|Part 3||0
10064|NCT03170544|20854|P6|COMPLETED|Part 3||0
10065|NCT03170544|20855|P5|COMPLETED|Part 3||0
10066|NCT03170544|20856|P4|COMPLETED|Part 3||0
10067|NCT03170544|20857|P3|COMPLETED|Part 3||0
10068|NCT03170544|20858|P2|COMPLETED|Part 3||0
10069|NCT03170544|20859|P1|COMPLETED|Part 3||0
10070|NCT03170544|20848|P12|STARTED|Part 3||0
10071|NCT03170544|20849|P11|STARTED|Part 3||0
10072|NCT03170544|20850|P10|STARTED|Part 3||6
10073|NCT03170544|20851|P9|STARTED|Part 3||6
10074|NCT03170544|20852|P8|STARTED|Part 3||4
10075|NCT03170544|20853|P7|STARTED|Part 3||0
10076|NCT03170544|20854|P6|STARTED|Part 3||0
10077|NCT03170544|20855|P5|STARTED|Part 3||0
10078|NCT03170544|20856|P4|STARTED|Part 3||0
10079|NCT03170544|20857|P3|STARTED|Part 3||0
10080|NCT03170544|20858|P2|STARTED|Part 3||0
10081|NCT03170544|20859|P1|STARTED|Part 3||0
10082|NCT03170544|20848|P12|NOT COMPLETED|Part 2||0
10083|NCT03170544|20849|P11|NOT COMPLETED|Part 2||0
10084|NCT03170544|20850|P10|NOT COMPLETED|Part 2||0
10085|NCT03170544|20851|P9|NOT COMPLETED|Part 2||0
10086|NCT03170544|20852|P8|NOT COMPLETED|Part 2||0
10087|NCT03170544|20853|P7|NOT COMPLETED|Part 2||0
10088|NCT03170544|20854|P6|NOT COMPLETED|Part 2||0
10089|NCT03170544|20855|P5|NOT COMPLETED|Part 2||0
10090|NCT03170544|20856|P4|NOT COMPLETED|Part 2||0
10091|NCT03170544|20857|P3|NOT COMPLETED|Part 2||0
10092|NCT03170544|20858|P2|NOT COMPLETED|Part 2||0
10093|NCT03170544|20859|P1|NOT COMPLETED|Part 2||0
10094|NCT03170544|20848|P12|COMPLETED|Part 2||0
10095|NCT03170544|20849|P11|COMPLETED|Part 2||0
10096|NCT03170544|20850|P10|COMPLETED|Part 2||0
10097|NCT03170544|20851|P9|COMPLETED|Part 2||0
10098|NCT03170544|20852|P8|COMPLETED|Part 2||0
10099|NCT03170544|20853|P7|COMPLETED|Part 2||4
10100|NCT03170544|20854|P6|COMPLETED|Part 2||0
10101|NCT03170544|20855|P5|COMPLETED|Part 2||0
10102|NCT03170544|20856|P4|COMPLETED|Part 2||0
10103|NCT03170544|20857|P3|COMPLETED|Part 2||0
10104|NCT03170544|20858|P2|COMPLETED|Part 2||0
10105|NCT03170544|20859|P1|COMPLETED|Part 2||0
10106|NCT03170544|20848|P12|STARTED|Part 2||0
10107|NCT03170544|20849|P11|STARTED|Part 2||0
10108|NCT03170544|20850|P10|STARTED|Part 2||0
10109|NCT03170544|20851|P9|STARTED|Part 2||0
10110|NCT03170544|20852|P8|STARTED|Part 2||0
10111|NCT03170544|20853|P7|STARTED|Part 2||4
10112|NCT03170544|20854|P6|STARTED|Part 2||0
10113|NCT03170544|20855|P5|STARTED|Part 2||0
10114|NCT03170544|20856|P4|STARTED|Part 2||0
10115|NCT03170544|20857|P3|STARTED|Part 2||0
10116|NCT03170544|20858|P2|STARTED|Part 2||0
10117|NCT03170544|20859|P1|STARTED|Part 2||0
10118|NCT03170544|20848|P12|NOT COMPLETED|Part 1||0
10119|NCT03170544|20849|P11|NOT COMPLETED|Part 1||0
10120|NCT03170544|20850|P10|NOT COMPLETED|Part 1||0
10121|NCT03170544|20851|P9|NOT COMPLETED|Part 1||0
10122|NCT03170544|20852|P8|NOT COMPLETED|Part 1||0
10123|NCT03170544|20853|P7|NOT COMPLETED|Part 1||0
10124|NCT03170544|20854|P6|NOT COMPLETED|Part 1||0
10125|NCT03170544|20855|P5|NOT COMPLETED|Part 1||0
10126|NCT03170544|20856|P4|NOT COMPLETED|Part 1||1
10127|NCT03170544|20857|P3|NOT COMPLETED|Part 1||0
10128|NCT03170544|20858|P2|NOT COMPLETED|Part 1||0
10129|NCT03170544|20859|P1|NOT COMPLETED|Part 1||1
10130|NCT03170544|20848|P12|COMPLETED|Part 1||0
10131|NCT03170544|20849|P11|COMPLETED|Part 1||0
10132|NCT03170544|20850|P10|COMPLETED|Part 1||0
10133|NCT03170544|20851|P9|COMPLETED|Part 1||0
10134|NCT03170544|20852|P8|COMPLETED|Part 1||0
10135|NCT03170544|20853|P7|COMPLETED|Part 1||0
10136|NCT03170544|20854|P6|COMPLETED|Part 1||6
10137|NCT03170544|20855|P5|COMPLETED|Part 1||6
10138|NCT03170544|20856|P4|COMPLETED|Part 1||6
10139|NCT03170544|20857|P3|COMPLETED|Part 1||6
10140|NCT03170544|20858|P2|COMPLETED|Part 1||6
10141|NCT03170544|20859|P1|COMPLETED|Part 1||9
10142|NCT03170544|20848|P12|STARTED|Part 1||0
10143|NCT03170544|20849|P11|STARTED|Part 1||0
10144|NCT03170544|20850|P10|STARTED|Part 1||0
10145|NCT03170544|20851|P9|STARTED|Part 1||0
10146|NCT03170544|20852|P8|STARTED|Part 1||0
10147|NCT03170544|20853|P7|STARTED|Part 1||0
10148|NCT03170544|20854|P6|STARTED|Part 1||6
10149|NCT03170544|20855|P5|STARTED|Part 1||6
10150|NCT03170544|20856|P4|STARTED|Part 1||7
10151|NCT03170544|20857|P3|STARTED|Part 1||6
10152|NCT03170544|20858|P2|STARTED|Part 1||6
10153|NCT03170544|20859|P1|STARTED|Part 1||10
10154|NCT03170219|21023|P2|NOT COMPLETED|Overall Study||0
10155|NCT03170219|21024|P1|NOT COMPLETED|Overall Study||0
10156|NCT03170219|21023|P2|COMPLETED|Overall Study||4
10157|NCT03170219|21024|P1|COMPLETED|Overall Study||7
10158|NCT03170219|21023|P2|STARTED|Overall Study||4
10159|NCT03170219|21024|P1|STARTED|Overall Study||7
10160|NCT03170193|21055|P7|NOT COMPLETED|Overall Study||0
10161|NCT03170193|21056|P6|NOT COMPLETED|Overall Study||0
10162|NCT03170193|21057|P5|NOT COMPLETED|Overall Study||0
10163|NCT03170193|21058|P4|NOT COMPLETED|Overall Study||1
10164|NCT03170193|21059|P3|NOT COMPLETED|Overall Study||0
10165|NCT03170193|21060|P2|NOT COMPLETED|Overall Study||1
10166|NCT03170193|21061|P1|NOT COMPLETED|Overall Study||1
10167|NCT03170193|21055|P7|COMPLETED|Overall Study||6
10168|NCT03170193|21056|P6|COMPLETED|Overall Study||6
10169|NCT03170193|21057|P5|COMPLETED|Overall Study||6
10170|NCT03170193|21058|P4|COMPLETED|Overall Study||5
10171|NCT03170193|21059|P3|COMPLETED|Overall Study||6
10172|NCT03170193|21060|P2|COMPLETED|Overall Study||5
10173|NCT03170193|21061|P1|COMPLETED|Overall Study||11
10174|NCT03170193|21055|P7|STARTED|Overall Study||6
10175|NCT03170193|21056|P6|STARTED|Overall Study||6
10176|NCT03170193|21057|P5|STARTED|Overall Study||6
10177|NCT03170193|21058|P4|STARTED|Overall Study||6
10178|NCT03170193|21059|P3|STARTED|Overall Study||6
10179|NCT03170193|21060|P2|STARTED|Overall Study||6
10180|NCT03170193|21061|P1|STARTED|Overall Study||12
10181|NCT03169530|21132|P2|NOT COMPLETED|Overall Study||17
10182|NCT03169530|21133|P1|NOT COMPLETED|Overall Study||15
10183|NCT03169530|21132|P2|COMPLETED|Overall Study||0
10184|NCT03169530|21133|P1|COMPLETED|Overall Study||0
10185|NCT03169530|21132|P2|STARTED|Overall Study||17
10186|NCT03169530|21133|P1|STARTED|Overall Study||15
10187|NCT03169153|21151|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
10188|NCT03169153|21152|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
10189|NCT03169153|21151|P2|COMPLETED|Period 2, Second 30 Days of Wear||32
10190|NCT03169153|21152|P1|COMPLETED|Period 2, Second 30 Days of Wear||37
10191|NCT03169153|21151|P2|STARTED|Period 2, Second 30 Days of Wear|One subject discontinued after completing Period 1 and was not exposed in Period 2.|34
10192|NCT03169153|21152|P1|STARTED|Period 2, Second 30 Days of Wear||39
10193|NCT03169153|21151|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||4
10194|NCT03169153|21152|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||3
10195|NCT03169153|21151|P2|COMPLETED|Period 1, First 30 Days of Wear||35
10196|NCT03169153|21152|P1|COMPLETED|Period 1, First 30 Days of Wear||39
10197|NCT03169153|21151|P2|STARTED|Period 1, First 30 Days of Wear||39
10198|NCT03169153|21152|P1|STARTED|Period 1, First 30 Days of Wear||42
10199|NCT03168919|21158|P1|NOT COMPLETED|Overall Study||2
10200|NCT03168919|21158|P1|COMPLETED|Overall Study||3
10201|NCT03168919|21158|P1|STARTED|Overall Study||5
10202|NCT03168841|21166|P1|NOT COMPLETED|Overall Study||4
10203|NCT03168841|21166|P1|COMPLETED|Overall Study||36
10204|NCT03168841|21166|P1|STARTED|Overall Study||40
10205|NCT03168542|21171|P3|NOT COMPLETED|Overall Study||0
10206|NCT03168542|21172|P2|NOT COMPLETED|Overall Study||0
10207|NCT03168542|21173|P1|NOT COMPLETED|Overall Study||0
10208|NCT03168542|21171|P3|COMPLETED|Overall Study||9
10209|NCT03168542|21172|P2|COMPLETED|Overall Study||5
10210|NCT03168542|21173|P1|COMPLETED|Overall Study||7
10211|NCT03168542|21171|P3|STARTED|Overall Study||9
10212|NCT03168542|21172|P2|STARTED|Overall Study||5
10213|NCT03168542|21173|P1|STARTED|Overall Study||7
10214|NCT03168425|21190|P2|NOT COMPLETED|Overall Study||11
10215|NCT03168425|21191|P1|NOT COMPLETED|Overall Study||7
10216|NCT03168425|21190|P2|COMPLETED|Overall Study||85
10217|NCT03168425|21191|P1|COMPLETED|Overall Study||87
10218|NCT03168425|21190|P2|STARTED|Overall Study||96
10219|NCT03168425|21191|P1|STARTED|Overall Study||94
10220|NCT03168022|21199|P2|NOT COMPLETED|Overall Study||1
10221|NCT03168022|21200|P1|NOT COMPLETED|Overall Study||0
10222|NCT03168022|21199|P2|COMPLETED|Overall Study||21
10223|NCT03168022|21200|P1|COMPLETED|Overall Study||21
10224|NCT03168022|21199|P2|STARTED|Overall Study||22
10225|NCT03168022|21200|P1|STARTED|Overall Study||21
10226|NCT03167541|21208|P2|NOT COMPLETED|Second Intervention||0
10227|NCT03167541|21209|P1|NOT COMPLETED|Second Intervention||0
10228|NCT03167541|21208|P2|COMPLETED|Second Intervention||9
10229|NCT03167541|21209|P1|COMPLETED|Second Intervention||9
10230|NCT03167541|21208|P2|STARTED|Second Intervention||9
10231|NCT03167541|21209|P1|STARTED|Second Intervention||9
10232|NCT03167541|21208|P2|NOT COMPLETED|Washout: 5-8 Days||0
10233|NCT03167541|21209|P1|NOT COMPLETED|Washout: 5-8 Days||0
10234|NCT03167541|21208|P2|COMPLETED|Washout: 5-8 Days||9
10235|NCT03167541|21209|P1|COMPLETED|Washout: 5-8 Days||9
10236|NCT03167541|21208|P2|STARTED|Washout: 5-8 Days||9
10237|NCT03167541|21209|P1|STARTED|Washout: 5-8 Days||9
10238|NCT03167541|21208|P2|NOT COMPLETED|First Intervention||0
10239|NCT03167541|21209|P1|NOT COMPLETED|First Intervention||0
10240|NCT03167541|21208|P2|COMPLETED|First Intervention||9
10241|NCT03167541|21209|P1|COMPLETED|First Intervention||9
10242|NCT03167541|21208|P2|STARTED|First Intervention||9
10243|NCT03167541|21209|P1|STARTED|First Intervention||9
10244|NCT03166618|21233|P2|NOT COMPLETED|Overall Study||1
10245|NCT03166618|21234|P1|NOT COMPLETED|Overall Study||0
10246|NCT03166618|21233|P2|COMPLETED|Overall Study||0
10247|NCT03166618|21234|P1|COMPLETED|Overall Study||0
10248|NCT03166618|21233|P2|STARTED|Overall Study||1
10249|NCT03166618|21234|P1|STARTED|Overall Study||0
10250|NCT03165981|21246|P2|NOT COMPLETED|Overall Study||4
10251|NCT03165981|21247|P1|NOT COMPLETED|Overall Study||11
10252|NCT03165981|21246|P2|COMPLETED|Overall Study||107
10253|NCT03165981|21247|P1|COMPLETED|Overall Study||99
10254|NCT03165981|21246|P2|Per Protocol Population|Overall Study||107
10255|NCT03165981|21247|P1|Per Protocol Population|Overall Study||99
10256|NCT03165981|21246|P2|STARTED|Overall Study||111
10257|NCT03165981|21247|P1|STARTED|Overall Study||110
10258|NCT03165175|21277|P2|NOT COMPLETED|Baseline to 3-month||0
10259|NCT03165175|21278|P1|NOT COMPLETED|Baseline to 3-month||4
10260|NCT03165175|21277|P2|COMPLETED|Baseline to 3-month||39
10261|NCT03165175|21278|P1|COMPLETED|Baseline to 3-month||31
10262|NCT03165175|21277|P2|STARTED|Baseline to 3-month||39
10263|NCT03165175|21278|P1|STARTED|Baseline to 3-month||35
10264|NCT03165175|21277|P2|NOT COMPLETED|1-month to 3-month||0
10265|NCT03165175|21278|P1|NOT COMPLETED|1-month to 3-month||6
10266|NCT03165175|21277|P2|COMPLETED|1-month to 3-month||39
10267|NCT03165175|21278|P1|COMPLETED|1-month to 3-month||35
10268|NCT03165175|21277|P2|STARTED|1-month to 3-month||39
10269|NCT03165175|21278|P1|STARTED|1-month to 3-month||41
10270|NCT03165110|21292|P1|NOT COMPLETED|Overall Study||1
10271|NCT03165110|21292|P1|COMPLETED|Overall Study||46
10272|NCT03165110|21292|P1|STARTED|Overall Study||47
10273|NCT03164629|21306|P2|NOT COMPLETED|Overall Study||0
10274|NCT03164629|21307|P1|NOT COMPLETED|Overall Study||0
10275|NCT03164629|21306|P2|COMPLETED|Overall Study||25
10276|NCT03164629|21307|P1|COMPLETED|Overall Study||25
10277|NCT03164629|21306|P2|STARTED|Overall Study||25
10278|NCT03164629|21307|P1|STARTED|Overall Study||25
10279|NCT03163342|21313|P1|NOT COMPLETED|Overall Study||0
10280|NCT03163342|21313|P1|COMPLETED|Overall Study||20
10281|NCT03163342|21313|P1|STARTED|Overall Study||20
10282|NCT03163134|21322|P2|NOT COMPLETED|Overall Study||0
10283|NCT03163134|21323|P1|NOT COMPLETED|Overall Study||0
10284|NCT03163134|21322|P2|COMPLETED|Overall Study||85
10285|NCT03163134|21323|P1|COMPLETED|Overall Study||85
10286|NCT03163134|21322|P2|STARTED|Overall Study||85
10287|NCT03163134|21323|P1|STARTED|Overall Study||85
10288|NCT03163017|21331|P1|NOT COMPLETED|Overall Study||0
10289|NCT03163017|21331|P1|COMPLETED|Overall Study||30
10290|NCT03163017|21331|P1|STARTED|Overall Study||30
10291|NCT03162614|21353|P6|NOT COMPLETED|Overall Study||0
10292|NCT03162614|21354|P5|NOT COMPLETED|Overall Study||5
10293|NCT03162614|21355|P4|NOT COMPLETED|Overall Study||7
10294|NCT03162614|21356|P3|NOT COMPLETED|Overall Study||4
10295|NCT03162614|21357|P2|NOT COMPLETED|Overall Study||5
10296|NCT03162614|21358|P1|NOT COMPLETED|Overall Study||6
10297|NCT03162614|21353|P6|COMPLETED|Overall Study||24
10298|NCT03162614|21354|P5|COMPLETED|Overall Study||21
10299|NCT03162614|21355|P4|COMPLETED|Overall Study||19
10300|NCT03162614|21356|P3|COMPLETED|Overall Study||22
10301|NCT03162614|21357|P2|COMPLETED|Overall Study||21
10302|NCT03162614|21358|P1|COMPLETED|Overall Study||20
10303|NCT03162614|21353|P6|STARTED|Overall Study||24
10304|NCT03162614|21354|P5|STARTED|Overall Study||26
10305|NCT03162614|21355|P4|STARTED|Overall Study||26
10306|NCT03162614|21356|P3|STARTED|Overall Study||26
10307|NCT03162614|21357|P2|STARTED|Overall Study||26
10308|NCT03162614|21358|P1|STARTED|Overall Study||26
10309|NCT03162458|21452|P2|NOT COMPLETED|Overall Study||0
10310|NCT03162458|21453|P1|NOT COMPLETED|Overall Study||0
10311|NCT03162458|21452|P2|COMPLETED|Overall Study||71
10312|NCT03162458|21453|P1|COMPLETED|Overall Study||71
10313|NCT03162458|21452|P2|STARTED|Overall Study||71
10314|NCT03162458|21453|P1|STARTED|Overall Study||71
10315|NCT03162328|21477|P3|NOT COMPLETED|Study Period||1
10316|NCT03162328|21478|P2|NOT COMPLETED|Study Period||0
10317|NCT03162328|21479|P1|NOT COMPLETED|Study Period||0
10318|NCT03162328|21477|P3|COMPLETED|Study Period||31
10319|NCT03162328|21478|P2|COMPLETED|Study Period||30
10320|NCT03162328|21479|P1|COMPLETED|Study Period||0
10321|NCT03162328|21477|P3|STARTED|Study Period||32
10322|NCT03162328|21478|P2|STARTED|Study Period||30
10323|NCT03162328|21479|P1|STARTED|Study Period||0
10324|NCT03162328|21477|P3|NOT COMPLETED|Screening Period||0
10325|NCT03162328|21478|P2|NOT COMPLETED|Screening Period||0
10326|NCT03162328|21479|P1|NOT COMPLETED|Screening Period||22
10327|NCT03162328|21477|P3|COMPLETED|Screening Period||0
10328|NCT03162328|21478|P2|COMPLETED|Screening Period||0
10329|NCT03162328|21479|P1|COMPLETED|Screening Period||62
10330|NCT03162328|21477|P3|STARTED|Screening Period||0
10331|NCT03162328|21478|P2|STARTED|Screening Period||0
10332|NCT03162328|21479|P1|STARTED|Screening Period||84
10333|NCT03162055|21508|P2|NOT COMPLETED|Overall Study||43
10334|NCT03162055|21509|P1|NOT COMPLETED|Overall Study||62
10335|NCT03162055|21508|P2|COMPLETED|Overall Study||517
10336|NCT03162055|21509|P1|COMPLETED|Overall Study||497
10337|NCT03162055|21508|P2|Per Protocol (PP) Analysis Set|Overall Study||510
10338|NCT03162055|21509|P1|Per Protocol (PP) Analysis Set|Overall Study||506
10339|NCT03162055|21508|P2|Full Analysis Set (FAS)|Overall Study||552
10340|NCT03162055|21509|P1|Full Analysis Set (FAS)|Overall Study||552
10341|NCT03162055|21508|P2|Safety Analysis Set|Overall Study||552
10342|NCT03162055|21509|P1|Safety Analysis Set|Overall Study||552
10343|NCT03162055|21508|P2|Received Treatment|Overall Study||560
10344|NCT03162055|21509|P1|Received Treatment|Overall Study||557
10345|NCT03162055|21508|P2|STARTED|Overall Study||560
10346|NCT03162055|21509|P1|STARTED|Overall Study||559
10347|NCT03161405|21533|P1|NOT COMPLETED|Second Intervention Period (6 Days)||1
10348|NCT03161405|21533|P1|COMPLETED|Second Intervention Period (6 Days)||11
10349|NCT03161405|21533|P1|STARTED|Second Intervention Period (6 Days)||12
10350|NCT03161405|21533|P1|NOT COMPLETED|Washout Period (at Least 4 Days)||0
10351|NCT03161405|21533|P1|COMPLETED|Washout Period (at Least 4 Days)||12
10352|NCT03161405|21533|P1|STARTED|Washout Period (at Least 4 Days)||12
10353|NCT03161405|21533|P1|NOT COMPLETED|First Intervention Period (3 Days)||0
10354|NCT03161405|21533|P1|COMPLETED|First Intervention Period (3 Days)||12
10355|NCT03161405|21533|P1|STARTED|First Intervention Period (3 Days)||12
10356|NCT03161327|21544|P1|NOT COMPLETED|Overall Study||0
10357|NCT03161327|21544|P1|COMPLETED|Overall Study||238
10358|NCT03161327|21544|P1|STARTED|Overall Study||238
10359|NCT03160716|21549|P1|NOT COMPLETED|Overall Study||1
10360|NCT03160716|21549|P1|COMPLETED|Overall Study||59
10361|NCT03160716|21549|P1|STARTED|Overall Study||60
10362|NCT03160703|21560|P4|NOT COMPLETED|Overall Study||1
10363|NCT03160703|21561|P3|NOT COMPLETED|Overall Study||0
10364|NCT03160703|21562|P2|NOT COMPLETED|Overall Study||0
10365|NCT03160703|21563|P1|NOT COMPLETED|Overall Study||0
10366|NCT03160703|21560|P4|COMPLETED|Overall Study||54
10367|NCT03160703|21561|P3|COMPLETED|Overall Study||55
10368|NCT03160703|21562|P2|COMPLETED|Overall Study||55
10369|NCT03160703|21563|P1|COMPLETED|Overall Study||55
10370|NCT03160703|21560|P4|STARTED|Overall Study||55
10371|NCT03160703|21561|P3|STARTED|Overall Study||55
10372|NCT03160703|21562|P2|STARTED|Overall Study||55
10373|NCT03160703|21563|P1|STARTED|Overall Study||55
10374|NCT03160170|21575|P2|NOT COMPLETED|Overall Study||0
10375|NCT03160170|21576|P1|NOT COMPLETED|Overall Study||0
10376|NCT03160170|21575|P2|COMPLETED|Overall Study||10
10377|NCT03160170|21576|P1|COMPLETED|Overall Study||10
10378|NCT03160170|21575|P2|STARTED|Overall Study||10
10379|NCT03160170|21576|P1|STARTED|Overall Study||10
10380|NCT03160027|21590|P4|NOT COMPLETED|Overall Study||0
10381|NCT03160027|21591|P3|NOT COMPLETED|Overall Study||0
10382|NCT03160027|21592|P2|NOT COMPLETED|Overall Study||0
10383|NCT03160027|21593|P1|NOT COMPLETED|Overall Study||0
10384|NCT03160027|21590|P4|COMPLETED|Overall Study||4
10385|NCT03160027|21591|P3|COMPLETED|Overall Study||6
10386|NCT03160027|21592|P2|COMPLETED|Overall Study||4
10387|NCT03160027|21593|P1|COMPLETED|Overall Study||6
10388|NCT03160027|21590|P4|STARTED|Overall Study||4
10389|NCT03160027|21591|P3|STARTED|Overall Study||6
10390|NCT03160027|21592|P2|STARTED|Overall Study||4
10391|NCT03160027|21593|P1|STARTED|Overall Study||6
10392|NCT03159624|21628|P2|NOT COMPLETED|Overall Study||1
10393|NCT03159624|21629|P1|NOT COMPLETED|Overall Study||0
10394|NCT03159624|21628|P2|COMPLETED|Overall Study||25
10395|NCT03159624|21629|P1|COMPLETED|Overall Study||21
10396|NCT03159624|21628|P2|STARTED|Overall Study||26
10397|NCT03159624|21629|P1|STARTED|Overall Study||21
10398|NCT03159611|21641|P2|NOT COMPLETED|Overall Study||15
10399|NCT03159611|21642|P1|NOT COMPLETED|Overall Study||23
10400|NCT03159611|21641|P2|COMPLETED|Overall Study||72
10401|NCT03159611|21642|P1|COMPLETED|Overall Study||72
10402|NCT03159611|21641|P2|STARTED|Overall Study||87
10403|NCT03159611|21642|P1|STARTED|Overall Study||95
10404|NCT03159468|21662|P6|NOT COMPLETED|Overall Study||0
10405|NCT03159468|21663|P5|NOT COMPLETED|Overall Study||0
10406|NCT03159468|21664|P4|NOT COMPLETED|Overall Study||0
10407|NCT03159468|21665|P3|NOT COMPLETED|Overall Study||3
10408|NCT03159468|21666|P2|NOT COMPLETED|Overall Study||0
10409|NCT03159468|21667|P1|NOT COMPLETED|Overall Study||0
10410|NCT03159468|21662|P6|COMPLETED|Overall Study||34
10411|NCT03159468|21663|P5|COMPLETED|Overall Study||34
10412|NCT03159468|21664|P4|COMPLETED|Overall Study||34
10413|NCT03159468|21665|P3|COMPLETED|Overall Study||34
10414|NCT03159468|21666|P2|COMPLETED|Overall Study||35
10415|NCT03159468|21667|P1|COMPLETED|Overall Study||35
10416|NCT03159468|21662|P6|STARTED|Overall Study||34
10417|NCT03159468|21663|P5|STARTED|Overall Study||34
10418|NCT03159468|21664|P4|STARTED|Overall Study||34
10419|NCT03159468|21665|P3|STARTED|Overall Study||37
10420|NCT03159468|21666|P2|STARTED|Overall Study||35
10421|NCT03159468|21667|P1|STARTED|Overall Study||35
10422|NCT03159260|21683|P2|NOT COMPLETED|Overall Study||4
10423|NCT03159260|21684|P1|NOT COMPLETED|Overall Study||3
10424|NCT03159260|21683|P2|COMPLETED|Overall Study||25
10425|NCT03159260|21684|P1|COMPLETED|Overall Study||25
10426|NCT03159260|21683|P2|STARTED|Overall Study||29
10427|NCT03159260|21684|P1|STARTED|Overall Study||28
10428|NCT03159143|21698|P1|NOT COMPLETED|Overall Study||0
10429|NCT03159143|21698|P1|COMPLETED|Overall Study||22
10430|NCT03159143|21698|P1|STARTED|Overall Study||22
10431|NCT03158220|21707|P2|NOT COMPLETED|Overall Study||16
10432|NCT03158220|21708|P1|NOT COMPLETED|Overall Study||17
10433|NCT03158220|21707|P2|COMPLETED|Overall Study||626
10434|NCT03158220|21708|P1|COMPLETED|Overall Study||553
10435|NCT03158220|21707|P2|Vaccination 3|Overall Study||629
10436|NCT03158220|21708|P1|Vaccination 3|Overall Study||556
10437|NCT03158220|21707|P2|Vaccination 2|Overall Study||635
10438|NCT03158220|21708|P1|Vaccination 2|Overall Study||563
10439|NCT03158220|21707|P2|Vaccination 1|Overall Study||640
10440|NCT03158220|21708|P1|Vaccination 1|Overall Study||570
10441|NCT03158220|21707|P2|STARTED|Overall Study||642
10442|NCT03158220|21708|P1|STARTED|Overall Study||570
10443|NCT03158038|21728|P2|NOT COMPLETED|Overall Study||0
10444|NCT03158038|21729|P1|NOT COMPLETED|Overall Study||0
10445|NCT03158038|21728|P2|COMPLETED|Overall Study||60
10446|NCT03158038|21729|P1|COMPLETED|Overall Study||240
10447|NCT03158038|21728|P2|STARTED|Overall Study||60
10448|NCT03158038|21729|P1|STARTED|Overall Study||240
10449|NCT03158012|21745|P2|NOT COMPLETED|Overall Study||1
10450|NCT03158012|21746|P1|NOT COMPLETED|Overall Study||0
10451|NCT03158012|21745|P2|COMPLETED|Overall Study||6
10452|NCT03158012|21746|P1|COMPLETED|Overall Study||8
10453|NCT03158012|21745|P2|STARTED|Overall Study||7
10454|NCT03158012|21746|P1|STARTED|Overall Study||8
10455|NCT03157583|21752|P1|NOT COMPLETED|Overall Study||1
10456|NCT03157583|21752|P1|COMPLETED|Overall Study||7
10457|NCT03157583|21752|P1|STARTED|Overall Study||8
10458|NCT03157531|21770|P1|NOT COMPLETED|Overall Study||6
10459|NCT03157531|21770|P1|COMPLETED|Overall Study||91
10460|NCT03157531|21770|P1|Analyzed at 30 Days For MAEs|Overall Study||93
10461|NCT03157531|21770|P1|STARTED|Overall Study||97
10462|NCT03157232|21785|P1|NOT COMPLETED|Overall Study||0
10463|NCT03157232|21785|P1|COMPLETED|Overall Study||18
10464|NCT03157232|21785|P1|STARTED|Overall Study||18
10465|NCT03155269|21791|P2|NOT COMPLETED|Overall Study||7
10466|NCT03155269|21792|P1|NOT COMPLETED|Overall Study||5
10467|NCT03155269|21791|P2|COMPLETED|Overall Study||50
10468|NCT03155269|21792|P1|COMPLETED|Overall Study||52
10469|NCT03155269|21791|P2|STARTED|Overall Study||57
10470|NCT03155269|21792|P1|STARTED|Overall Study||57
10471|NCT03154333|21836|P2|NOT COMPLETED|Overall Study||5
10472|NCT03154333|21837|P1|NOT COMPLETED|Overall Study||7
10473|NCT03154333|21836|P2|COMPLETED|Overall Study||21
10474|NCT03154333|21837|P1|COMPLETED|Overall Study||21
10475|NCT03154333|21836|P2|STARTED|Overall Study||26
10476|NCT03154333|21837|P1|STARTED|Overall Study||28
10477|NCT03154086|21860|P15|NOT COMPLETED|Part B (Up to 25 Days)||0
10478|NCT03154086|21861|P14|NOT COMPLETED|Part B (Up to 25 Days)||0
10479|NCT03154086|21862|P13|NOT COMPLETED|Part B (Up to 25 Days)||0
10480|NCT03154086|21863|P12|NOT COMPLETED|Part B (Up to 25 Days)||0
10481|NCT03154086|21864|P11|NOT COMPLETED|Part B (Up to 25 Days)||1
10482|NCT03154086|21865|P10|NOT COMPLETED|Part B (Up to 25 Days)||0
10483|NCT03154086|21866|P9|NOT COMPLETED|Part B (Up to 25 Days)||0
10484|NCT03154086|21867|P8|NOT COMPLETED|Part B (Up to 25 Days)||0
10485|NCT03154086|21868|P7|NOT COMPLETED|Part B (Up to 25 Days)||0
10486|NCT03154086|21869|P6|NOT COMPLETED|Part B (Up to 25 Days)||0
10487|NCT03154086|21870|P5|NOT COMPLETED|Part B (Up to 25 Days)||0
10488|NCT03154086|21871|P4|NOT COMPLETED|Part B (Up to 25 Days)||0
10489|NCT03154086|21872|P3|NOT COMPLETED|Part B (Up to 25 Days)||0
10490|NCT03154086|21873|P2|NOT COMPLETED|Part B (Up to 25 Days)||0
10491|NCT03154086|21874|P1|NOT COMPLETED|Part B (Up to 25 Days)||0
10492|NCT03154086|21860|P15|COMPLETED|Part B (Up to 25 Days)||6
10493|NCT03154086|21861|P14|COMPLETED|Part B (Up to 25 Days)||6
10494|NCT03154086|21862|P13|COMPLETED|Part B (Up to 25 Days)||6
10495|NCT03154086|21863|P12|COMPLETED|Part B (Up to 25 Days)||6
10496|NCT03154086|21864|P11|COMPLETED|Part B (Up to 25 Days)||5
10497|NCT03154086|21865|P10|COMPLETED|Part B (Up to 25 Days)||10
10498|NCT03154086|21866|P9|COMPLETED|Part B (Up to 25 Days)||0
10499|NCT03154086|21867|P8|COMPLETED|Part B (Up to 25 Days)||0
10500|NCT03154086|21868|P7|COMPLETED|Part B (Up to 25 Days)||0
10501|NCT03154086|21869|P6|COMPLETED|Part B (Up to 25 Days)||0
10502|NCT03154086|21870|P5|COMPLETED|Part B (Up to 25 Days)||0
10503|NCT03154086|21871|P4|COMPLETED|Part B (Up to 25 Days)||0
10504|NCT03154086|21872|P3|COMPLETED|Part B (Up to 25 Days)||0
10505|NCT03154086|21873|P2|COMPLETED|Part B (Up to 25 Days)||0
10506|NCT03154086|21874|P1|COMPLETED|Part B (Up to 25 Days)||0
10507|NCT03154086|21860|P15|STARTED|Part B (Up to 25 Days)||6
10508|NCT03154086|21861|P14|STARTED|Part B (Up to 25 Days)||6
10509|NCT03154086|21862|P13|STARTED|Part B (Up to 25 Days)||6
10510|NCT03154086|21863|P12|STARTED|Part B (Up to 25 Days)||6
10511|NCT03154086|21864|P11|STARTED|Part B (Up to 25 Days)||6
10512|NCT03154086|21865|P10|STARTED|Part B (Up to 25 Days)||10
10513|NCT03154086|21866|P9|STARTED|Part B (Up to 25 Days)||0
10514|NCT03154086|21867|P8|STARTED|Part B (Up to 25 Days)||0
10515|NCT03154086|21868|P7|STARTED|Part B (Up to 25 Days)||0
10516|NCT03154086|21869|P6|STARTED|Part B (Up to 25 Days)||0
10517|NCT03154086|21870|P5|STARTED|Part B (Up to 25 Days)||0
10518|NCT03154086|21871|P4|STARTED|Part B (Up to 25 Days)||0
10519|NCT03154086|21872|P3|STARTED|Part B (Up to 25 Days)||0
10520|NCT03154086|21873|P2|STARTED|Part B (Up to 25 Days)||0
10521|NCT03154086|21874|P1|STARTED|Part B (Up to 25 Days)||0
10522|NCT03154086|21860|P15|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10523|NCT03154086|21861|P14|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10524|NCT03154086|21862|P13|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10525|NCT03154086|21863|P12|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10526|NCT03154086|21864|P11|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10527|NCT03154086|21865|P10|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10528|NCT03154086|21866|P9|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
10529|NCT03154086|21867|P8|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
10530|NCT03154086|21868|P7|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10531|NCT03154086|21869|P6|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10532|NCT03154086|21870|P5|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10533|NCT03154086|21871|P4|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10534|NCT03154086|21872|P3|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10535|NCT03154086|21873|P2|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10536|NCT03154086|21874|P1|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10537|NCT03154086|21860|P15|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10538|NCT03154086|21861|P14|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10539|NCT03154086|21862|P13|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10540|NCT03154086|21863|P12|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10541|NCT03154086|21864|P11|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10542|NCT03154086|21865|P10|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10543|NCT03154086|21866|P9|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||4
10544|NCT03154086|21867|P8|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
10545|NCT03154086|21868|P7|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||2
10546|NCT03154086|21869|P6|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10547|NCT03154086|21870|P5|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10548|NCT03154086|21871|P4|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10549|NCT03154086|21872|P3|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10550|NCT03154086|21873|P2|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10551|NCT03154086|21874|P1|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10552|NCT03154086|21860|P15|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10553|NCT03154086|21861|P14|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10554|NCT03154086|21862|P13|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10555|NCT03154086|21863|P12|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10556|NCT03154086|21864|P11|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10557|NCT03154086|21865|P10|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10558|NCT03154086|21866|P9|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)|1 par was unwell on Day-1 of Period 2 and discontinued; hence,1 replacement was enrolled and dosed|5
10559|NCT03154086|21867|P8|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||2
10560|NCT03154086|21868|P7|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||2
10561|NCT03154086|21869|P6|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10562|NCT03154086|21870|P5|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10563|NCT03154086|21871|P4|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10564|NCT03154086|21872|P3|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10565|NCT03154086|21873|P2|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10566|NCT03154086|21874|P1|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
10567|NCT03154086|21860|P15|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10568|NCT03154086|21861|P14|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10569|NCT03154086|21862|P13|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10570|NCT03154086|21863|P12|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10571|NCT03154086|21864|P11|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10572|NCT03154086|21865|P10|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10573|NCT03154086|21866|P9|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10574|NCT03154086|21867|P8|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10575|NCT03154086|21868|P7|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10576|NCT03154086|21869|P6|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10577|NCT03154086|21870|P5|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10578|NCT03154086|21871|P4|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10579|NCT03154086|21872|P3|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10580|NCT03154086|21873|P2|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10581|NCT03154086|21874|P1|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10582|NCT03154086|21860|P15|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10583|NCT03154086|21861|P14|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10584|NCT03154086|21862|P13|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10585|NCT03154086|21863|P12|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10586|NCT03154086|21864|P11|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10587|NCT03154086|21865|P10|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10588|NCT03154086|21866|P9|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||4
10589|NCT03154086|21867|P8|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
10590|NCT03154086|21868|P7|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
10591|NCT03154086|21869|P6|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10592|NCT03154086|21870|P5|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10593|NCT03154086|21871|P4|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10594|NCT03154086|21872|P3|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10595|NCT03154086|21873|P2|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10596|NCT03154086|21874|P1|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10597|NCT03154086|21860|P15|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10598|NCT03154086|21861|P14|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10599|NCT03154086|21862|P13|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10600|NCT03154086|21863|P12|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10601|NCT03154086|21864|P11|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10602|NCT03154086|21865|P10|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10603|NCT03154086|21866|P9|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||4
10604|NCT03154086|21867|P8|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
10605|NCT03154086|21868|P7|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
10606|NCT03154086|21869|P6|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10607|NCT03154086|21870|P5|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10608|NCT03154086|21871|P4|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10609|NCT03154086|21872|P3|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10610|NCT03154086|21873|P2|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10611|NCT03154086|21874|P1|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
10612|NCT03154086|21860|P15|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10613|NCT03154086|21861|P14|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10614|NCT03154086|21862|P13|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10615|NCT03154086|21863|P12|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10616|NCT03154086|21864|P11|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10617|NCT03154086|21865|P10|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10618|NCT03154086|21866|P9|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10619|NCT03154086|21867|P8|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11135|NCT03152552|22312|P1|STARTED|Treatment Period 2 (24 Weeks)||7
10620|NCT03154086|21868|P7|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10621|NCT03154086|21869|P6|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10622|NCT03154086|21870|P5|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10623|NCT03154086|21871|P4|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10624|NCT03154086|21872|P3|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10625|NCT03154086|21873|P2|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10626|NCT03154086|21874|P1|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10627|NCT03154086|21860|P15|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10628|NCT03154086|21861|P14|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10629|NCT03154086|21862|P13|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10630|NCT03154086|21863|P12|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10631|NCT03154086|21864|P11|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10632|NCT03154086|21865|P10|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10633|NCT03154086|21866|P9|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||4
10634|NCT03154086|21867|P8|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||2
10635|NCT03154086|21868|P7|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||2
10636|NCT03154086|21869|P6|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10637|NCT03154086|21870|P5|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10638|NCT03154086|21871|P4|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10639|NCT03154086|21872|P3|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10640|NCT03154086|21873|P2|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10641|NCT03154086|21874|P1|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10642|NCT03154086|21860|P15|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10643|NCT03154086|21861|P14|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10644|NCT03154086|21862|P13|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10645|NCT03154086|21863|P12|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10646|NCT03154086|21864|P11|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10647|NCT03154086|21865|P10|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10648|NCT03154086|21866|P9|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||4
10649|NCT03154086|21867|P8|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||2
10650|NCT03154086|21868|P7|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||2
10651|NCT03154086|21869|P6|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10652|NCT03154086|21870|P5|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10653|NCT03154086|21871|P4|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10654|NCT03154086|21872|P3|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10655|NCT03154086|21873|P2|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10656|NCT03154086|21874|P1|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
10657|NCT03154086|21860|P15|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10658|NCT03154086|21861|P14|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10659|NCT03154086|21862|P13|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10660|NCT03154086|21863|P12|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10661|NCT03154086|21864|P11|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10662|NCT03154086|21865|P10|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10663|NCT03154086|21866|P9|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10664|NCT03154086|21867|P8|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10665|NCT03154086|21868|P7|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10666|NCT03154086|21869|P6|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10667|NCT03154086|21870|P5|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10668|NCT03154086|21871|P4|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10669|NCT03154086|21872|P3|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10670|NCT03154086|21873|P2|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10671|NCT03154086|21874|P1|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10672|NCT03154086|21860|P15|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10673|NCT03154086|21861|P14|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10674|NCT03154086|21862|P13|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10675|NCT03154086|21863|P12|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10676|NCT03154086|21864|P11|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10677|NCT03154086|21865|P10|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10678|NCT03154086|21866|P9|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10679|NCT03154086|21867|P8|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10680|NCT03154086|21868|P7|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10681|NCT03154086|21869|P6|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||2
10682|NCT03154086|21870|P5|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||6
10683|NCT03154086|21871|P4|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10684|NCT03154086|21872|P3|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10685|NCT03154086|21873|P2|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10686|NCT03154086|21874|P1|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10687|NCT03154086|21860|P15|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10688|NCT03154086|21861|P14|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10689|NCT03154086|21862|P13|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10690|NCT03154086|21863|P12|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10691|NCT03154086|21864|P11|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10692|NCT03154086|21865|P10|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10693|NCT03154086|21866|P9|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10694|NCT03154086|21867|P8|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10695|NCT03154086|21868|P7|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10696|NCT03154086|21869|P6|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||2
10697|NCT03154086|21870|P5|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||6
10698|NCT03154086|21871|P4|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10699|NCT03154086|21872|P3|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10700|NCT03154086|21873|P2|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10701|NCT03154086|21874|P1|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
10702|NCT03154086|21860|P15|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10703|NCT03154086|21861|P14|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10704|NCT03154086|21862|P13|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10705|NCT03154086|21863|P12|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10706|NCT03154086|21864|P11|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10707|NCT03154086|21865|P10|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10708|NCT03154086|21866|P9|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10709|NCT03154086|21867|P8|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10710|NCT03154086|21868|P7|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10711|NCT03154086|21869|P6|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10712|NCT03154086|21870|P5|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10713|NCT03154086|21871|P4|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10714|NCT03154086|21872|P3|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10715|NCT03154086|21873|P2|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10716|NCT03154086|21874|P1|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10717|NCT03154086|21860|P15|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10718|NCT03154086|21861|P14|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10719|NCT03154086|21862|P13|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10720|NCT03154086|21863|P12|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10721|NCT03154086|21864|P11|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10722|NCT03154086|21865|P10|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10723|NCT03154086|21866|P9|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10724|NCT03154086|21867|P8|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10725|NCT03154086|21868|P7|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10726|NCT03154086|21869|P6|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||2
10727|NCT03154086|21870|P5|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||6
10728|NCT03154086|21871|P4|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10729|NCT03154086|21872|P3|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10730|NCT03154086|21873|P2|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10731|NCT03154086|21874|P1|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10732|NCT03154086|21860|P15|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10733|NCT03154086|21861|P14|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10734|NCT03154086|21862|P13|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10735|NCT03154086|21863|P12|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10736|NCT03154086|21864|P11|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10737|NCT03154086|21865|P10|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10738|NCT03154086|21866|P9|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10739|NCT03154086|21867|P8|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10740|NCT03154086|21868|P7|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10741|NCT03154086|21869|P6|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||2
10742|NCT03154086|21870|P5|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||6
10743|NCT03154086|21871|P4|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10744|NCT03154086|21872|P3|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10745|NCT03154086|21873|P2|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10746|NCT03154086|21874|P1|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
10747|NCT03154086|21860|P15|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10748|NCT03154086|21861|P14|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10749|NCT03154086|21862|P13|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10750|NCT03154086|21863|P12|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10751|NCT03154086|21864|P11|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10752|NCT03154086|21865|P10|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10753|NCT03154086|21866|P9|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10754|NCT03154086|21867|P8|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10755|NCT03154086|21868|P7|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10756|NCT03154086|21869|P6|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10757|NCT03154086|21870|P5|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10758|NCT03154086|21871|P4|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10759|NCT03154086|21872|P3|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10760|NCT03154086|21873|P2|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10761|NCT03154086|21874|P1|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10762|NCT03154086|21860|P15|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10763|NCT03154086|21861|P14|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10764|NCT03154086|21862|P13|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10765|NCT03154086|21863|P12|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10766|NCT03154086|21864|P11|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10767|NCT03154086|21865|P10|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10768|NCT03154086|21866|P9|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10769|NCT03154086|21867|P8|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10770|NCT03154086|21868|P7|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10771|NCT03154086|21869|P6|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||2
10772|NCT03154086|21870|P5|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||6
10773|NCT03154086|21871|P4|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10774|NCT03154086|21872|P3|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10775|NCT03154086|21873|P2|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10776|NCT03154086|21874|P1|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10777|NCT03154086|21860|P15|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10778|NCT03154086|21861|P14|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10779|NCT03154086|21862|P13|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10780|NCT03154086|21863|P12|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10781|NCT03154086|21864|P11|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10782|NCT03154086|21865|P10|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10783|NCT03154086|21866|P9|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10784|NCT03154086|21867|P8|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10785|NCT03154086|21868|P7|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10786|NCT03154086|21869|P6|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||2
10787|NCT03154086|21870|P5|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||6
10788|NCT03154086|21871|P4|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10789|NCT03154086|21872|P3|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10790|NCT03154086|21873|P2|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10791|NCT03154086|21874|P1|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
10792|NCT03154086|21860|P15|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10793|NCT03154086|21861|P14|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10794|NCT03154086|21862|P13|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10795|NCT03154086|21863|P12|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10796|NCT03154086|21864|P11|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10797|NCT03154086|21865|P10|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10798|NCT03154086|21866|P9|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10799|NCT03154086|21867|P8|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10800|NCT03154086|21868|P7|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10801|NCT03154086|21869|P6|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10802|NCT03154086|21870|P5|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10803|NCT03154086|21871|P4|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10804|NCT03154086|21872|P3|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10805|NCT03154086|21873|P2|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10806|NCT03154086|21874|P1|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||1
10807|NCT03154086|21860|P15|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10808|NCT03154086|21861|P14|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10809|NCT03154086|21862|P13|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10810|NCT03154086|21863|P12|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10811|NCT03154086|21864|P11|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10812|NCT03154086|21865|P10|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10813|NCT03154086|21866|P9|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10814|NCT03154086|21867|P8|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10815|NCT03154086|21868|P7|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10816|NCT03154086|21869|P6|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10817|NCT03154086|21870|P5|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10818|NCT03154086|21871|P4|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
10819|NCT03154086|21872|P3|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||1
10820|NCT03154086|21873|P2|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
10821|NCT03154086|21874|P1|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
10822|NCT03154086|21860|P15|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10823|NCT03154086|21861|P14|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10824|NCT03154086|21862|P13|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10825|NCT03154086|21863|P12|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10826|NCT03154086|21864|P11|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10827|NCT03154086|21865|P10|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10828|NCT03154086|21866|P9|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10829|NCT03154086|21867|P8|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10830|NCT03154086|21868|P7|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10831|NCT03154086|21869|P6|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10832|NCT03154086|21870|P5|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
10833|NCT03154086|21871|P4|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||2
10834|NCT03154086|21872|P3|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||1
10835|NCT03154086|21873|P2|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||2
10836|NCT03154086|21874|P1|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)|1 par was not dosed on day of dosing due to elevated lab; hence 1 replacement was enrolled and dosed|3
10837|NCT03154086|21860|P15|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10838|NCT03154086|21861|P14|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10839|NCT03154086|21862|P13|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10840|NCT03154086|21863|P12|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10841|NCT03154086|21864|P11|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10842|NCT03154086|21865|P10|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10843|NCT03154086|21866|P9|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10844|NCT03154086|21867|P8|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10845|NCT03154086|21868|P7|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10846|NCT03154086|21869|P6|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10847|NCT03154086|21870|P5|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10848|NCT03154086|21871|P4|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10849|NCT03154086|21872|P3|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||1
10850|NCT03154086|21873|P2|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10851|NCT03154086|21874|P1|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10852|NCT03154086|21860|P15|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10853|NCT03154086|21861|P14|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10854|NCT03154086|21862|P13|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10855|NCT03154086|21863|P12|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10856|NCT03154086|21864|P11|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10857|NCT03154086|21865|P10|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10858|NCT03154086|21866|P9|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10859|NCT03154086|21867|P8|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10860|NCT03154086|21868|P7|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10861|NCT03154086|21869|P6|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10862|NCT03154086|21870|P5|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10863|NCT03154086|21871|P4|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
10864|NCT03154086|21872|P3|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||1
10865|NCT03154086|21873|P2|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
10866|NCT03154086|21874|P1|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
10867|NCT03154086|21860|P15|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10868|NCT03154086|21861|P14|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10869|NCT03154086|21862|P13|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10870|NCT03154086|21863|P12|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10871|NCT03154086|21864|P11|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10872|NCT03154086|21865|P10|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10873|NCT03154086|21866|P9|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10874|NCT03154086|21867|P8|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10875|NCT03154086|21868|P7|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10876|NCT03154086|21869|P6|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10877|NCT03154086|21870|P5|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
10878|NCT03154086|21871|P4|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
10879|NCT03154086|21872|P3|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
10880|NCT03154086|21873|P2|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
10881|NCT03154086|21874|P1|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
10882|NCT03154086|21860|P15|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10883|NCT03154086|21861|P14|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10884|NCT03154086|21862|P13|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10885|NCT03154086|21863|P12|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10886|NCT03154086|21864|P11|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10887|NCT03154086|21865|P10|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10888|NCT03154086|21866|P9|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10889|NCT03154086|21867|P8|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10890|NCT03154086|21868|P7|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10891|NCT03154086|21869|P6|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10892|NCT03154086|21870|P5|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10893|NCT03154086|21871|P4|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10894|NCT03154086|21872|P3|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10895|NCT03154086|21873|P2|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10896|NCT03154086|21874|P1|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10897|NCT03154086|21860|P15|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10898|NCT03154086|21861|P14|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10899|NCT03154086|21862|P13|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10900|NCT03154086|21863|P12|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10901|NCT03154086|21864|P11|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10902|NCT03154086|21865|P10|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10903|NCT03154086|21866|P9|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10904|NCT03154086|21867|P8|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10905|NCT03154086|21868|P7|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10906|NCT03154086|21869|P6|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10907|NCT03154086|21870|P5|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10908|NCT03154086|21871|P4|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
10909|NCT03154086|21872|P3|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
10910|NCT03154086|21873|P2|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
10911|NCT03154086|21874|P1|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
10912|NCT03154086|21860|P15|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10913|NCT03154086|21861|P14|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10914|NCT03154086|21862|P13|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10915|NCT03154086|21863|P12|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10916|NCT03154086|21864|P11|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10917|NCT03154086|21865|P10|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10918|NCT03154086|21866|P9|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10919|NCT03154086|21867|P8|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10920|NCT03154086|21868|P7|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10921|NCT03154086|21869|P6|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10922|NCT03154086|21870|P5|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
10923|NCT03154086|21871|P4|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
10924|NCT03154086|21872|P3|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
10925|NCT03154086|21873|P2|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)|One replacement par was enrolled and dosed|2
10926|NCT03154086|21874|P1|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
10927|NCT03154086|21860|P15|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10928|NCT03154086|21861|P14|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10929|NCT03154086|21862|P13|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10930|NCT03154086|21863|P12|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10931|NCT03154086|21864|P11|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10932|NCT03154086|21865|P10|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10933|NCT03154086|21866|P9|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10934|NCT03154086|21867|P8|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10935|NCT03154086|21868|P7|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10936|NCT03154086|21869|P6|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10937|NCT03154086|21870|P5|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10938|NCT03154086|21871|P4|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10939|NCT03154086|21872|P3|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10940|NCT03154086|21873|P2|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||1
10941|NCT03154086|21874|P1|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10942|NCT03154086|21860|P15|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10943|NCT03154086|21861|P14|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10944|NCT03154086|21862|P13|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10945|NCT03154086|21863|P12|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10946|NCT03154086|21864|P11|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10947|NCT03154086|21865|P10|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10948|NCT03154086|21866|P9|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10949|NCT03154086|21867|P8|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10950|NCT03154086|21868|P7|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10951|NCT03154086|21869|P6|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10952|NCT03154086|21870|P5|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10953|NCT03154086|21871|P4|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
10954|NCT03154086|21872|P3|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
10955|NCT03154086|21873|P2|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||1
10956|NCT03154086|21874|P1|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
10957|NCT03154086|21860|P15|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10958|NCT03154086|21861|P14|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10959|NCT03154086|21862|P13|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10960|NCT03154086|21863|P12|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10961|NCT03154086|21864|P11|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10962|NCT03154086|21865|P10|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10963|NCT03154086|21866|P9|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10964|NCT03154086|21867|P8|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10965|NCT03154086|21868|P7|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10966|NCT03154086|21869|P6|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10967|NCT03154086|21870|P5|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
10968|NCT03154086|21871|P4|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
10969|NCT03154086|21872|P3|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
10970|NCT03154086|21873|P2|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
10971|NCT03154086|21874|P1|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
10972|NCT03154086|21860|P15|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10973|NCT03154086|21861|P14|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10974|NCT03154086|21862|P13|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10975|NCT03154086|21863|P12|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10976|NCT03154086|21864|P11|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10977|NCT03154086|21865|P10|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10978|NCT03154086|21866|P9|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10979|NCT03154086|21867|P8|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10980|NCT03154086|21868|P7|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10981|NCT03154086|21869|P6|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10982|NCT03154086|21870|P5|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10983|NCT03154086|21871|P4|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10984|NCT03154086|21872|P3|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10985|NCT03154086|21873|P2|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10986|NCT03154086|21874|P1|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10987|NCT03154086|21860|P15|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10988|NCT03154086|21861|P14|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10989|NCT03154086|21862|P13|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10990|NCT03154086|21863|P12|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10991|NCT03154086|21864|P11|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10992|NCT03154086|21865|P10|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10993|NCT03154086|21866|P9|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10994|NCT03154086|21867|P8|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10995|NCT03154086|21868|P7|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10996|NCT03154086|21869|P6|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10997|NCT03154086|21870|P5|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
10998|NCT03154086|21871|P4|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
10999|NCT03154086|21872|P3|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
11000|NCT03154086|21873|P2|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
11001|NCT03154086|21874|P1|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
11002|NCT03154086|21860|P15|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11003|NCT03154086|21861|P14|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11004|NCT03154086|21862|P13|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11005|NCT03154086|21863|P12|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11006|NCT03154086|21864|P11|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11007|NCT03154086|21865|P10|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11008|NCT03154086|21866|P9|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11009|NCT03154086|21867|P8|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11010|NCT03154086|21868|P7|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11011|NCT03154086|21869|P6|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11012|NCT03154086|21870|P5|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11013|NCT03154086|21871|P4|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)|One replacement participant (par) was enrolled and dosed|2
11014|NCT03154086|21872|P3|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
11015|NCT03154086|21873|P2|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
11016|NCT03154086|21874|P1|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
11017|NCT03154086|21860|P15|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11018|NCT03154086|21861|P14|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11019|NCT03154086|21862|P13|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11020|NCT03154086|21863|P12|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11021|NCT03154086|21864|P11|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11022|NCT03154086|21865|P10|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11023|NCT03154086|21866|P9|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11024|NCT03154086|21867|P8|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11025|NCT03154086|21868|P7|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11026|NCT03154086|21869|P6|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11027|NCT03154086|21870|P5|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11028|NCT03154086|21871|P4|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||1
11029|NCT03154086|21872|P3|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11030|NCT03154086|21873|P2|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11031|NCT03154086|21874|P1|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11032|NCT03154086|21860|P15|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11033|NCT03154086|21861|P14|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11034|NCT03154086|21862|P13|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11035|NCT03154086|21863|P12|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11036|NCT03154086|21864|P11|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11037|NCT03154086|21865|P10|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11038|NCT03154086|21866|P9|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11039|NCT03154086|21867|P8|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11040|NCT03154086|21868|P7|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11041|NCT03154086|21869|P6|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11042|NCT03154086|21870|P5|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11043|NCT03154086|21871|P4|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||1
11044|NCT03154086|21872|P3|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
11045|NCT03154086|21873|P2|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
11046|NCT03154086|21874|P1|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
11047|NCT03154086|21860|P15|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11048|NCT03154086|21861|P14|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11049|NCT03154086|21862|P13|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11050|NCT03154086|21863|P12|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11051|NCT03154086|21864|P11|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11052|NCT03154086|21865|P10|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11053|NCT03154086|21866|P9|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11054|NCT03154086|21867|P8|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11055|NCT03154086|21868|P7|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11056|NCT03154086|21869|P6|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11057|NCT03154086|21870|P5|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11058|NCT03154086|21871|P4|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
11136|NCT03152552|22308|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||21
11059|NCT03154086|21872|P3|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
11060|NCT03154086|21873|P2|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
11061|NCT03154086|21874|P1|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
11062|NCT03154086|21860|P15|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11063|NCT03154086|21861|P14|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11064|NCT03154086|21862|P13|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11065|NCT03154086|21863|P12|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11066|NCT03154086|21864|P11|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11067|NCT03154086|21865|P10|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11068|NCT03154086|21866|P9|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11069|NCT03154086|21867|P8|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11070|NCT03154086|21868|P7|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11071|NCT03154086|21869|P6|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11072|NCT03154086|21870|P5|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11073|NCT03154086|21871|P4|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11074|NCT03154086|21872|P3|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11075|NCT03154086|21873|P2|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11076|NCT03154086|21874|P1|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11077|NCT03154086|21860|P15|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11078|NCT03154086|21861|P14|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11079|NCT03154086|21862|P13|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11080|NCT03154086|21863|P12|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11081|NCT03154086|21864|P11|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11082|NCT03154086|21865|P10|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11083|NCT03154086|21866|P9|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11084|NCT03154086|21867|P8|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11085|NCT03154086|21868|P7|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11086|NCT03154086|21869|P6|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11087|NCT03154086|21870|P5|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11088|NCT03154086|21871|P4|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
11089|NCT03154086|21872|P3|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
11090|NCT03154086|21873|P2|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
11091|NCT03154086|21874|P1|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
11092|NCT03154086|21860|P15|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11093|NCT03154086|21861|P14|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11094|NCT03154086|21862|P13|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11095|NCT03154086|21863|P12|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11096|NCT03154086|21864|P11|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11097|NCT03154086|21865|P10|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11098|NCT03154086|21866|P9|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11099|NCT03154086|21867|P8|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11100|NCT03154086|21868|P7|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11101|NCT03154086|21869|P6|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11102|NCT03154086|21870|P5|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11103|NCT03154086|21871|P4|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
11104|NCT03154086|21872|P3|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
11105|NCT03154086|21873|P2|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
11106|NCT03154086|21874|P1|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
11107|NCT03154047|22274|P1|NOT COMPLETED|Overall Study||80
11108|NCT03154047|22274|P1|COMPLETED|Overall Study||0
11109|NCT03154047|22274|P1|Number of Patients Dosed|Overall Study||80
11110|NCT03154047|22274|P1|STARTED|Overall Study||80
11111|NCT03152591|22280|P2|NOT COMPLETED|Overall Study||0
11112|NCT03152591|22281|P1|NOT COMPLETED|Overall Study||0
11113|NCT03152591|22280|P2|COMPLETED|Overall Study||14
11114|NCT03152591|22281|P1|COMPLETED|Overall Study||15
11115|NCT03152591|22280|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||14
11116|NCT03152591|22281|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||15
11117|NCT03152591|22280|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||0
11118|NCT03152591|22281|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||14
11119|NCT03152591|22280|P2|STARTED|Overall Study||14
11120|NCT03152591|22281|P1|STARTED|Overall Study||15
11121|NCT03152552|22308|P5|NOT COMPLETED|Treatment Period 2 (24 Weeks)||11
11122|NCT03152552|22309|P4|NOT COMPLETED|Treatment Period 2 (24 Weeks)||9
11123|NCT03152552|22310|P3|NOT COMPLETED|Treatment Period 2 (24 Weeks)||9
11124|NCT03152552|22311|P2|NOT COMPLETED|Treatment Period 2 (24 Weeks)||5
11125|NCT03152552|22312|P1|NOT COMPLETED|Treatment Period 2 (24 Weeks)||6
11126|NCT03152552|22308|P5|COMPLETED|Treatment Period 2 (24 Weeks)||0
11127|NCT03152552|22309|P4|COMPLETED|Treatment Period 2 (24 Weeks)||0
11128|NCT03152552|22310|P3|COMPLETED|Treatment Period 2 (24 Weeks)||0
11129|NCT03152552|22311|P2|COMPLETED|Treatment Period 2 (24 Weeks)||0
11130|NCT03152552|22312|P1|COMPLETED|Treatment Period 2 (24 Weeks)||1
11131|NCT03152552|22308|P5|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|11
11132|NCT03152552|22309|P4|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|9
11133|NCT03152552|22310|P3|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|9
11134|NCT03152552|22311|P2|STARTED|Treatment Period 2 (24 Weeks)||5
11137|NCT03152552|22309|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||20
11138|NCT03152552|22310|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||21
11139|NCT03152552|22311|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
11140|NCT03152552|22312|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
11141|NCT03152552|22308|P5|COMPLETED|Treatment Period 1 (12 Weeks)||12
11142|NCT03152552|22309|P4|COMPLETED|Treatment Period 1 (12 Weeks)||10
11143|NCT03152552|22310|P3|COMPLETED|Treatment Period 1 (12 Weeks)||10
11144|NCT03152552|22311|P2|COMPLETED|Treatment Period 1 (12 Weeks)||5
11145|NCT03152552|22312|P1|COMPLETED|Treatment Period 1 (12 Weeks)||7
11146|NCT03152552|22308|P5|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||33
11147|NCT03152552|22309|P4|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||30
11148|NCT03152552|22310|P3|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||30
11149|NCT03152552|22311|P2|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||16
11150|NCT03152552|22312|P1|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||15
11151|NCT03152552|22308|P5|STARTED|Treatment Period 1 (12 Weeks)||33
11152|NCT03152552|22309|P4|STARTED|Treatment Period 1 (12 Weeks)||30
11153|NCT03152552|22310|P3|STARTED|Treatment Period 1 (12 Weeks)||31
11154|NCT03152552|22311|P2|STARTED|Treatment Period 1 (12 Weeks)||16
11155|NCT03152552|22312|P1|STARTED|Treatment Period 1 (12 Weeks)||15
11156|NCT03152526|22445|P2|NOT COMPLETED|Overall Study||1
11157|NCT03152526|22446|P1|NOT COMPLETED|Overall Study||0
11158|NCT03152526|22445|P2|COMPLETED|Overall Study|The one participant enrolled on this arm withdrew from the study early.|0
11159|NCT03152526|22446|P1|COMPLETED|Overall Study|No participants were enrolled on this arm.|0
11160|NCT03152526|22445|P2|STARTED|Overall Study|One participant was enrolled on this arm.|1
11161|NCT03152526|22446|P1|STARTED|Overall Study|No participants were enrolled on this arm.|0
11162|NCT03152136|22457|P3|NOT COMPLETED|Overall Study||1
11163|NCT03152136|22458|P2|NOT COMPLETED|Overall Study||0
11164|NCT03152136|22459|P1|NOT COMPLETED|Overall Study||3
11165|NCT03152136|22457|P3|COMPLETED|Overall Study||14
11166|NCT03152136|22458|P2|COMPLETED|Overall Study||15
11167|NCT03152136|22459|P1|COMPLETED|Overall Study||29
11168|NCT03152136|22457|P3|STARTED|Overall Study||15
11169|NCT03152136|22458|P2|STARTED|Overall Study||15
11170|NCT03152136|22459|P1|STARTED|Overall Study||32
11171|NCT03151551|22468|P2|NOT COMPLETED|Overall Study||276
11172|NCT03151551|22469|P1|NOT COMPLETED|Overall Study||275
11173|NCT03151551|22468|P2|COMPLETED|Overall Study||7
11174|NCT03151551|22469|P1|COMPLETED|Overall Study||8
11175|NCT03151551|22468|P2|ADA 40 mg at Baseline, 40 mg Q2W|Overall Study||219
11176|NCT03151551|22469|P1|ADA 40 mg at Baseline, 40 mg Q2W|Overall Study|Row represents adalimumab data only.|0
11177|NCT03151551|22468|P2|ADA 80 mg at Baseline, 40 mg Q2W|Overall Study||64
11178|NCT03151551|22469|P1|ADA 80 mg at Baseline, 40 mg Q2W|Overall Study|Row represents adalimumab data only.|0
11179|NCT03151551|22468|P2|IXE 160 mg at Baseline, 80 mg Q4W|Overall Study|Row represents Ixekizumab data only.|0
11180|NCT03151551|22469|P1|IXE 160 mg at Baseline, 80 mg Q4W|Overall Study||218
11181|NCT03151551|22468|P2|IXE 160 mg at Baseline, 80 mg Q2W/Q4W|Overall Study|Row represents Ixekizumab data only.|0
11182|NCT03151551|22469|P1|IXE 160 mg at Baseline, 80 mg Q2W/Q4W|Overall Study||65
11183|NCT03151551|22468|P2|Received at Least One Dose of Study Drug|Overall Study||283
11184|NCT03151551|22469|P1|Received at Least One Dose of Study Drug|Overall Study||283
11185|NCT03151551|22468|P2|STARTED|Overall Study||283
11186|NCT03151551|22469|P1|STARTED|Overall Study||283
11187|NCT03151265|22481|P2|NOT COMPLETED|Overall Study||0
11188|NCT03151265|22482|P1|NOT COMPLETED|Overall Study||0
11189|NCT03151265|22481|P2|COMPLETED|Overall Study||20
11190|NCT03151265|22482|P1|COMPLETED|Overall Study||20
11191|NCT03151265|22481|P2|STARTED|Overall Study||20
11192|NCT03151265|22482|P1|STARTED|Overall Study||20
11193|NCT03151226|22504|P1|NOT COMPLETED|Overall Study||3
11194|NCT03151226|22504|P1|COMPLETED|Overall Study||0
11195|NCT03151226|22504|P1|STARTED|Overall Study||3
11196|NCT03150719|22510|P2|NOT COMPLETED|Overall Study||2
11197|NCT03150719|22511|P1|NOT COMPLETED|Overall Study||1
11198|NCT03150719|22510|P2|COMPLETED|Overall Study||48
11199|NCT03150719|22511|P1|COMPLETED|Overall Study||46
11200|NCT03150719|22510|P2|STARTED|Overall Study||50
11201|NCT03150719|22511|P1|STARTED|Overall Study||47
11202|NCT03150485|22527|P6|NOT COMPLETED|Overall Study||0
11203|NCT03150485|22528|P5|NOT COMPLETED|Overall Study||0
11204|NCT03150485|22529|P4|NOT COMPLETED|Overall Study||0
11205|NCT03150485|22530|P3|NOT COMPLETED|Overall Study||0
11206|NCT03150485|22531|P2|NOT COMPLETED|Overall Study||1
11207|NCT03150485|22532|P1|NOT COMPLETED|Overall Study||0
11208|NCT03150485|22527|P6|COMPLETED|Overall Study||1
11209|NCT03150485|22528|P5|COMPLETED|Overall Study||2
11210|NCT03150485|22529|P4|COMPLETED|Overall Study||5
11211|NCT03150485|22530|P3|COMPLETED|Overall Study||4
11212|NCT03150485|22531|P2|COMPLETED|Overall Study||8
11213|NCT03150485|22532|P1|COMPLETED|Overall Study||2
11214|NCT03150485|22527|P6|STARTED|Overall Study||1
11215|NCT03150485|22528|P5|STARTED|Overall Study||2
11216|NCT03150485|22529|P4|STARTED|Overall Study||5
11217|NCT03150485|22530|P3|STARTED|Overall Study||4
11218|NCT03150485|22531|P2|STARTED|Overall Study||9
11219|NCT03150485|22532|P1|STARTED|Overall Study||2
11220|NCT03150160|22549|P2|NOT COMPLETED|Overall Study||0
11221|NCT03150160|22550|P1|NOT COMPLETED|Overall Study||0
11222|NCT03150160|22549|P2|COMPLETED|Overall Study||1
11223|NCT03150160|22550|P1|COMPLETED|Overall Study||0
11224|NCT03150160|22549|P2|STARTED|Overall Study||1
11225|NCT03150160|22550|P1|STARTED|Overall Study||0
11226|NCT03150108|22566|P2|NOT COMPLETED|Overall Study||0
11227|NCT03150108|22567|P1|NOT COMPLETED|Overall Study||0
11228|NCT03150108|22566|P2|COMPLETED|Overall Study||12
11229|NCT03150108|22567|P1|COMPLETED|Overall Study||12
11230|NCT03150108|22566|P2|STARTED|Overall Study||12
11231|NCT03150108|22567|P1|STARTED|Overall Study||12
11232|NCT03150082|22657|P2|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
11233|NCT03150082|22658|P1|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
11234|NCT03150082|22657|P2|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||13
11235|NCT03150082|22658|P1|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||12
11236|NCT03150082|22657|P2|STARTED|Treatment Period 2 (Up to 4 Weeks)||13
11237|NCT03150082|22658|P1|STARTED|Treatment Period 2 (Up to 4 Weeks)||12
11238|NCT03150082|22657|P2|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
11239|NCT03150082|22658|P1|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
11240|NCT03150082|22657|P2|COMPLETED|Washout Period (Up to 4 Weeks)||13
11241|NCT03150082|22658|P1|COMPLETED|Washout Period (Up to 4 Weeks)||12
11242|NCT03150082|22657|P2|STARTED|Washout Period (Up to 4 Weeks)||13
11243|NCT03150082|22658|P1|STARTED|Washout Period (Up to 4 Weeks)||12
11244|NCT03150082|22657|P2|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||0
11245|NCT03150082|22658|P1|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||1
11246|NCT03150082|22657|P2|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||13
11247|NCT03150082|22658|P1|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||12
11248|NCT03150082|22657|P2|STARTED|Treatment Period 1 (Up to 4 Weeks)||13
11249|NCT03150082|22658|P1|STARTED|Treatment Period 1 (Up to 4 Weeks)||13
11250|NCT03149848|22712|P1|NOT COMPLETED|Period 2 (Day 15 to Day 28)||2
11251|NCT03149848|22712|P1|COMPLETED|Period 2 (Day 15 to Day 28)||12
11252|NCT03149848|22712|P1|STARTED|Period 2 (Day 15 to Day 28)||14
11253|NCT03149848|22712|P1|NOT COMPLETED|Period 1 (Day 1 to Day 14)||1
11254|NCT03149848|22712|P1|COMPLETED|Period 1 (Day 1 to Day 14)||14
11255|NCT03149848|22712|P1|STARTED|Period 1 (Day 1 to Day 14)||15
11256|NCT03148756|22751|P2|NOT COMPLETED|Overall Study||1
11257|NCT03148756|22752|P1|NOT COMPLETED|Overall Study||0
11258|NCT03148756|22751|P2|COMPLETED|Overall Study||1
11259|NCT03148756|22752|P1|COMPLETED|Overall Study||0
11260|NCT03148756|22751|P2|STARTED|Overall Study||2
11261|NCT03148756|22752|P1|STARTED|Overall Study||0
11262|NCT03148691|22785|P3|NOT COMPLETED|Overall Study||8
11263|NCT03148691|22786|P2|NOT COMPLETED|Overall Study||2
11264|NCT03148691|22787|P1|NOT COMPLETED|Overall Study||3
11265|NCT03148691|22785|P3|COMPLETED|Overall Study||92
11266|NCT03148691|22786|P2|COMPLETED|Overall Study||101
11267|NCT03148691|22787|P1|COMPLETED|Overall Study||47
11268|NCT03148691|22785|P3|STARTED|Overall Study||100
11269|NCT03148691|22786|P2|STARTED|Overall Study||103
11270|NCT03148691|22787|P1|STARTED|Overall Study||50
11271|NCT03148262|22797|P2|NOT COMPLETED|Overall Study||1
11272|NCT03148262|22798|P1|NOT COMPLETED|Overall Study||3
11273|NCT03148262|22797|P2|COMPLETED|Overall Study||31
11274|NCT03148262|22798|P1|COMPLETED|Overall Study||28
11275|NCT03148262|22797|P2|STARTED|Overall Study||32
11276|NCT03148262|22798|P1|STARTED|Overall Study||31
11277|NCT03148236|22806|P2|NOT COMPLETED|Overall Study||0
11278|NCT03148236|22807|P1|NOT COMPLETED|Overall Study||0
11279|NCT03148236|22806|P2|COMPLETED|Overall Study||10
11280|NCT03148236|22807|P1|COMPLETED|Overall Study||10
11281|NCT03148236|22806|P2|STARTED|Overall Study||10
11282|NCT03148236|22807|P1|STARTED|Overall Study||10
11283|NCT03148067|22833|P1|NOT COMPLETED|Overall Study||4
11284|NCT03148067|22833|P1|COMPLETED|Overall Study||221
11285|NCT03148067|22833|P1|STARTED|Overall Study||225
11286|NCT03146403|22840|P2|NOT COMPLETED|Overall Study||3
11287|NCT03146403|22841|P1|NOT COMPLETED|Overall Study||2
11288|NCT03146403|22840|P2|COMPLETED|Overall Study||14
11289|NCT03146403|22841|P1|COMPLETED|Overall Study||14
11290|NCT03146403|22840|P2|STARTED|Overall Study||17
11291|NCT03146403|22841|P1|STARTED|Overall Study||16
11292|NCT03144635|22855|P1|NOT COMPLETED|Overall Study||80
11293|NCT03144635|22855|P1|COMPLETED|Overall Study||0
11294|NCT03144635|22855|P1|STARTED|Overall Study||80
11295|NCT03144518|22867|P2|NOT COMPLETED|16 Week Post-Vaccination||2
11296|NCT03144518|22868|P1|NOT COMPLETED|16 Week Post-Vaccination||3
11297|NCT03144518|22867|P2|COMPLETED|16 Week Post-Vaccination||49
11298|NCT03144518|22868|P1|COMPLETED|16 Week Post-Vaccination||49
11299|NCT03144518|22867|P2|STARTED|16 Week Post-Vaccination||51
11300|NCT03144518|22868|P1|STARTED|16 Week Post-Vaccination||52
11301|NCT03144518|22867|P2|NOT COMPLETED|4 Weeks Post-Vaccination||0
11302|NCT03144518|22868|P1|NOT COMPLETED|4 Weeks Post-Vaccination||1
11303|NCT03144518|22867|P2|COMPLETED|4 Weeks Post-Vaccination||51
11304|NCT03144518|22868|P1|COMPLETED|4 Weeks Post-Vaccination||51
11305|NCT03144518|22867|P2|STARTED|4 Weeks Post-Vaccination||51
11306|NCT03144518|22868|P1|STARTED|4 Weeks Post-Vaccination||52
11307|NCT03144518|22867|P2|NOT COMPLETED|Primary Outcome (Mood)||0
11308|NCT03144518|22868|P1|NOT COMPLETED|Primary Outcome (Mood)||0
11309|NCT03144518|22867|P2|COMPLETED|Primary Outcome (Mood)||51
11310|NCT03144518|22868|P1|COMPLETED|Primary Outcome (Mood)||52
11311|NCT03144518|22867|P2|STARTED|Primary Outcome (Mood)||51
11312|NCT03144518|22868|P1|STARTED|Primary Outcome (Mood)||52
11313|NCT03143166|22883|P1|NOT COMPLETED|Period 2 (Washout of at Least 4 Days)||1
11314|NCT03143166|22883|P1|COMPLETED|Period 2 (Washout of at Least 4 Days)||35
11315|NCT03143166|22883|P1|STARTED|Period 2 (Washout of at Least 4 Days)||36
11316|NCT03143166|22883|P1|NOT COMPLETED|Period 1||0
11317|NCT03143166|22883|P1|COMPLETED|Period 1||36
11318|NCT03143166|22883|P1|STARTED|Period 1||36
11319|NCT03143101|22902|P3|NOT COMPLETED|Overall Study||0
11320|NCT03143101|22903|P2|NOT COMPLETED|Overall Study||3
11321|NCT03143101|22904|P1|NOT COMPLETED|Overall Study||2
11322|NCT03143101|22902|P3|COMPLETED|Overall Study||67
11323|NCT03143101|22903|P2|COMPLETED|Overall Study||63
11324|NCT03143101|22904|P1|COMPLETED|Overall Study||65
11325|NCT03143101|22902|P3|STARTED|Overall Study||67
11326|NCT03143101|22903|P2|STARTED|Overall Study||66
11327|NCT03143101|22904|P1|STARTED|Overall Study||67
11328|NCT03142932|22959|P2|NOT COMPLETED|Overall Study||11
11329|NCT03142932|22960|P1|NOT COMPLETED|Overall Study||2
11330|NCT03142932|22959|P2|COMPLETED|Overall Study||39
11331|NCT03142932|22960|P1|COMPLETED|Overall Study||50
11332|NCT03142932|22959|P2|STARTED|Overall Study||50
11333|NCT03142932|22960|P1|STARTED|Overall Study||52
11334|NCT03141372|22976|P2|NOT COMPLETED|Overall Study||2
11335|NCT03141372|22977|P1|NOT COMPLETED|Overall Study||0
11336|NCT03141372|22976|P2|COMPLETED|Overall Study||40
11337|NCT03141372|22977|P1|COMPLETED|Overall Study||42
11338|NCT03141372|22976|P2|STARTED|Overall Study||42
11339|NCT03141372|22977|P1|STARTED|Overall Study||42
11340|NCT03141307|22997|P2|NOT COMPLETED|Follow-Up||54
11341|NCT03141307|22998|P1|NOT COMPLETED|Follow-Up||97
11342|NCT03141307|22997|P2|COMPLETED|Follow-Up||184
11343|NCT03141307|22998|P1|COMPLETED|Follow-Up||370
11344|NCT03141307|22997|P2|STARTED|Follow-Up||238
11345|NCT03141307|22998|P1|STARTED|Follow-Up||467
11346|NCT03141307|22997|P2|NOT COMPLETED|In-Hospital||2
11347|NCT03141307|22998|P1|NOT COMPLETED|In-Hospital||4
11348|NCT03141307|22997|P2|COMPLETED|In-Hospital||238
11349|NCT03141307|22998|P1|COMPLETED|In-Hospital||467
11350|NCT03141307|22997|P2|STARTED|In-Hospital||240
11351|NCT03141307|22998|P1|STARTED|In-Hospital||471
11352|NCT03141086|23016|P2|NOT COMPLETED|Overall Study||5
11353|NCT03141086|23017|P1|NOT COMPLETED|Overall Study||1
11354|NCT03141086|23016|P2|COMPLETED|Overall Study||12
11355|NCT03141086|23017|P1|COMPLETED|Overall Study||6
11356|NCT03141086|23016|P2|STARTED|Overall Study||17
11357|NCT03141086|23017|P1|STARTED|Overall Study||7
11358|NCT03140631|23046|P2|NOT COMPLETED|Overall Study||0
11359|NCT03140631|23047|P1|NOT COMPLETED|Overall Study||0
11360|NCT03140631|23046|P2|COMPLETED|Overall Study||77
11361|NCT03140631|23047|P1|COMPLETED|Overall Study||73
11362|NCT03140631|23046|P2|STARTED|Overall Study||77
11363|NCT03140631|23047|P1|STARTED|Overall Study||73
11364|NCT03139578|23055|P4|NOT COMPLETED|Period 2||0
11365|NCT03139578|23056|P3|NOT COMPLETED|Period 2||0
11366|NCT03139578|23057|P2|NOT COMPLETED|Period 2||0
11367|NCT03139578|23058|P1|NOT COMPLETED|Period 2||0
11368|NCT03139578|23055|P4|COMPLETED|Period 2||13
11369|NCT03139578|23056|P3|COMPLETED|Period 2||12
11370|NCT03139578|23057|P2|COMPLETED|Period 2||13
11371|NCT03139578|23058|P1|COMPLETED|Period 2||12
11372|NCT03139578|23055|P4|Discontinued|Period 2||0
11373|NCT03139578|23056|P3|Discontinued|Period 2||0
11374|NCT03139578|23057|P2|Discontinued|Period 2||0
11375|NCT03139578|23058|P1|Discontinued|Period 2||0
11376|NCT03139578|23055|P4|STARTED|Period 2||13
11377|NCT03139578|23056|P3|STARTED|Period 2||12
11378|NCT03139578|23057|P2|STARTED|Period 2||13
11379|NCT03139578|23058|P1|STARTED|Period 2||12
11380|NCT03139578|23055|P4|NOT COMPLETED|Period 1||0
11381|NCT03139578|23056|P3|NOT COMPLETED|Period 1||0
11382|NCT03139578|23057|P2|NOT COMPLETED|Period 1||0
11383|NCT03139578|23058|P1|NOT COMPLETED|Period 1||0
11384|NCT03139578|23055|P4|COMPLETED|Period 1||13
11385|NCT03139578|23056|P3|COMPLETED|Period 1||12
11386|NCT03139578|23057|P2|COMPLETED|Period 1||13
11387|NCT03139578|23058|P1|COMPLETED|Period 1||12
11388|NCT03139578|23055|P4|Discontinued|Period 1||0
11389|NCT03139578|23056|P3|Discontinued|Period 1||0
11390|NCT03139578|23057|P2|Discontinued|Period 1||0
11391|NCT03139578|23058|P1|Discontinued|Period 1||0
11392|NCT03139578|23055|P4|STARTED|Period 1||13
11393|NCT03139578|23056|P3|STARTED|Period 1||12
11394|NCT03139578|23057|P2|STARTED|Period 1||13
11395|NCT03139578|23058|P1|STARTED|Period 1||12
11396|NCT03139552|23092|P1|NOT COMPLETED|Overall Study||3
11397|NCT03139552|23092|P1|COMPLETED|Overall Study||147
11398|NCT03139552|23092|P1|STARTED|Overall Study||150
11399|NCT03139448|23135|P2|NOT COMPLETED|Overall Study||26
11400|NCT03139448|23136|P1|NOT COMPLETED|Overall Study||12
11401|NCT03139448|23135|P2|COMPLETED|Overall Study||63
11402|NCT03139448|23136|P1|COMPLETED|Overall Study||73
11403|NCT03139448|23135|P2|Intervention Started|Overall Study||70
11404|NCT03139448|23136|P1|Intervention Started|Overall Study||79
11405|NCT03139448|23135|P2|STARTED|Overall Study||89
11406|NCT03139448|23136|P1|STARTED|Overall Study||85
11407|NCT03139279|23160|P2|NOT COMPLETED|Overall Study||6
11408|NCT03139279|23161|P1|NOT COMPLETED|Overall Study||7
11409|NCT03139279|23160|P2|COMPLETED|Overall Study||50
11410|NCT03139279|23161|P1|COMPLETED|Overall Study||51
11411|NCT03139279|23160|P2|STARTED|Overall Study||56
11412|NCT03139279|23161|P1|STARTED|Overall Study||58
11413|NCT03139240|23179|P4|NOT COMPLETED|Overall Study||0
11414|NCT03139240|23180|P3|NOT COMPLETED|Overall Study||1
11415|NCT03139240|23181|P2|NOT COMPLETED|Overall Study||1
11416|NCT03139240|23182|P1|NOT COMPLETED|Overall Study||0
11417|NCT03139240|23179|P4|COMPLETED|Overall Study||38
11418|NCT03139240|23180|P3|COMPLETED|Overall Study||37
11419|NCT03139240|23181|P2|COMPLETED|Overall Study||47
11420|NCT03139240|23182|P1|COMPLETED|Overall Study||48
11421|NCT03139240|23179|P4|STARTED|Overall Study||38
11422|NCT03139240|23180|P3|STARTED|Overall Study||38
11423|NCT03139240|23181|P2|STARTED|Overall Study||48
11424|NCT03139240|23182|P1|STARTED|Overall Study||48
11425|NCT03138967|23194|P2|NOT COMPLETED|Overall Study||4
11426|NCT03138967|23195|P1|NOT COMPLETED|Overall Study||1
11427|NCT03138967|23194|P2|COMPLETED|Overall Study||24
11428|NCT03138967|23195|P1|COMPLETED|Overall Study||25
11429|NCT03138967|23194|P2|Post-operative Day(POD) 7 Follow-up|Overall Study||24
11430|NCT03138967|23195|P1|Post-operative Day(POD) 7 Follow-up|Overall Study||25
11431|NCT03138967|23194|P2|Post-operative Day(POD) 1 Follow-up|Overall Study||25
11432|NCT03138967|23195|P1|Post-operative Day(POD) 1 Follow-up|Overall Study||25
11433|NCT03138967|23194|P2|STARTED|Overall Study||28
11434|NCT03138967|23195|P1|STARTED|Overall Study||26
11435|NCT03138876|23205|P1|NOT COMPLETED|Overall Study||0
11436|NCT03138876|23205|P1|COMPLETED|Overall Study||20
11437|NCT03138876|23205|P1|STARTED|Overall Study||20
11438|NCT03138798|23214|P2|NOT COMPLETED|Overall Study||4
11439|NCT03138798|23215|P1|NOT COMPLETED|Overall Study||6
11440|NCT03138798|23214|P2|COMPLETED|Overall Study||171
11441|NCT03138798|23215|P1|COMPLETED|Overall Study||167
11442|NCT03138798|23214|P2|Randomized But Did Not Meet Eligibility|Overall Study||4
11443|NCT03138798|23215|P1|Randomized But Did Not Meet Eligibility|Overall Study||6
11444|NCT03138798|23214|P2|STARTED|Overall Study||175
11445|NCT03138798|23215|P1|STARTED|Overall Study||173
11446|NCT03138382|23240|P2|NOT COMPLETED|Overall Study||0
11447|NCT03138382|23241|P1|NOT COMPLETED|Overall Study||0
11448|NCT03138382|23240|P2|COMPLETED|Overall Study||10
11449|NCT03138382|23241|P1|COMPLETED|Overall Study||10
11450|NCT03138382|23240|P2|STARTED|Overall Study||10
11451|NCT03138382|23241|P1|STARTED|Overall Study||10
11452|NCT03137784|23249|P6|NOT COMPLETED|Overall Study||0
11453|NCT03137784|23250|P5|NOT COMPLETED|Overall Study||1
11454|NCT03137784|23251|P4|NOT COMPLETED|Overall Study||0
11455|NCT03137784|23252|P3|NOT COMPLETED|Overall Study||0
11456|NCT03137784|23253|P2|NOT COMPLETED|Overall Study||1
11457|NCT03137784|23254|P1|NOT COMPLETED|Overall Study||2
11458|NCT03137784|23249|P6|COMPLETED|Overall Study||25
11459|NCT03137784|23250|P5|COMPLETED|Overall Study||24
11460|NCT03137784|23251|P4|COMPLETED|Overall Study||24
11461|NCT03137784|23252|P3|COMPLETED|Overall Study||25
11462|NCT03137784|23253|P2|COMPLETED|Overall Study||24
11463|NCT03137784|23254|P1|COMPLETED|Overall Study||22
11464|NCT03137784|23249|P6|STARTED|Overall Study||25
11465|NCT03137784|23250|P5|STARTED|Overall Study||25
11466|NCT03137784|23251|P4|STARTED|Overall Study||24
11467|NCT03137784|23252|P3|STARTED|Overall Study||25
11468|NCT03137784|23253|P2|STARTED|Overall Study||25
11469|NCT03137784|23254|P1|STARTED|Overall Study||24
11470|NCT03137225|23291|P2|NOT COMPLETED|Second 4 Hour Measurement Period||0
11471|NCT03137225|23292|P1|NOT COMPLETED|Second 4 Hour Measurement Period||0
11472|NCT03137225|23291|P2|COMPLETED|Second 4 Hour Measurement Period||0
11473|NCT03137225|23292|P1|COMPLETED|Second 4 Hour Measurement Period||1
11474|NCT03137225|23291|P2|STARTED|Second 4 Hour Measurement Period||0
11475|NCT03137225|23292|P1|STARTED|Second 4 Hour Measurement Period||1
11476|NCT03137225|23291|P2|NOT COMPLETED|First 4 Hour Measurement Period||0
11477|NCT03137225|23292|P1|NOT COMPLETED|First 4 Hour Measurement Period||0
11478|NCT03137225|23291|P2|COMPLETED|First 4 Hour Measurement Period||0
11479|NCT03137225|23292|P1|COMPLETED|First 4 Hour Measurement Period||1
11480|NCT03137225|23291|P2|STARTED|First 4 Hour Measurement Period||0
11481|NCT03137225|23292|P1|STARTED|First 4 Hour Measurement Period||1
11482|NCT03136380|23306|P5|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
11483|NCT03136380|23307|P4|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
11484|NCT03136380|23308|P3|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
11485|NCT03136380|23309|P2|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
11486|NCT03136380|23310|P1|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
11487|NCT03136380|23306|P5|COMPLETED|Part 2, Period 2 (3 Days)||8
11488|NCT03136380|23307|P4|COMPLETED|Part 2, Period 2 (3 Days)||8
11489|NCT03136380|23308|P3|COMPLETED|Part 2, Period 2 (3 Days)||0
11490|NCT03136380|23309|P2|COMPLETED|Part 2, Period 2 (3 Days)||0
11491|NCT03136380|23310|P1|COMPLETED|Part 2, Period 2 (3 Days)||0
11492|NCT03136380|23306|P5|STARTED|Part 2, Period 2 (3 Days)||8
11493|NCT03136380|23307|P4|STARTED|Part 2, Period 2 (3 Days)||8
11494|NCT03136380|23308|P3|STARTED|Part 2, Period 2 (3 Days)||0
11495|NCT03136380|23309|P2|STARTED|Part 2, Period 2 (3 Days)||0
11496|NCT03136380|23310|P1|STARTED|Part 2, Period 2 (3 Days)||0
11497|NCT03136380|23306|P5|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11498|NCT03136380|23307|P4|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11499|NCT03136380|23308|P3|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11500|NCT03136380|23309|P2|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11501|NCT03136380|23310|P1|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11502|NCT03136380|23306|P5|COMPLETED|Part 2, Washout Period 1 (7 Days)||8
11503|NCT03136380|23307|P4|COMPLETED|Part 2, Washout Period 1 (7 Days)||8
11504|NCT03136380|23308|P3|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11505|NCT03136380|23309|P2|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11506|NCT03136380|23310|P1|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11507|NCT03136380|23306|P5|STARTED|Part 2, Washout Period 1 (7 Days)||8
11508|NCT03136380|23307|P4|STARTED|Part 2, Washout Period 1 (7 Days)||8
11509|NCT03136380|23308|P3|STARTED|Part 2, Washout Period 1 (7 Days)||0
11510|NCT03136380|23309|P2|STARTED|Part 2, Washout Period 1 (7 Days)||0
11511|NCT03136380|23310|P1|STARTED|Part 2, Washout Period 1 (7 Days)||0
11512|NCT03136380|23306|P5|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
11513|NCT03136380|23307|P4|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
11514|NCT03136380|23308|P3|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
11515|NCT03136380|23309|P2|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
11516|NCT03136380|23310|P1|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
11517|NCT03136380|23306|P5|COMPLETED|Part 2, Period 1 (3 Days)||8
11518|NCT03136380|23307|P4|COMPLETED|Part 2, Period 1 (3 Days)||8
11519|NCT03136380|23308|P3|COMPLETED|Part 2, Period 1 (3 Days)||0
11520|NCT03136380|23309|P2|COMPLETED|Part 2, Period 1 (3 Days)||0
11521|NCT03136380|23310|P1|COMPLETED|Part 2, Period 1 (3 Days)||0
11522|NCT03136380|23306|P5|STARTED|Part 2, Period 1 (3 Days)||8
11523|NCT03136380|23307|P4|STARTED|Part 2, Period 1 (3 Days)||8
11524|NCT03136380|23308|P3|STARTED|Part 2, Period 1 (3 Days)||0
11525|NCT03136380|23309|P2|STARTED|Part 2, Period 1 (3 Days)||0
11526|NCT03136380|23310|P1|STARTED|Part 2, Period 1 (3 Days)||0
11527|NCT03136380|23306|P5|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
11528|NCT03136380|23307|P4|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
11529|NCT03136380|23308|P3|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
11530|NCT03136380|23309|P2|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
11531|NCT03136380|23310|P1|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
11532|NCT03136380|23306|P5|COMPLETED|Part 1, Period 3 (4 Days)||0
11533|NCT03136380|23307|P4|COMPLETED|Part 1, Period 3 (4 Days)||0
11534|NCT03136380|23308|P3|COMPLETED|Part 1, Period 3 (4 Days)||6
11535|NCT03136380|23309|P2|COMPLETED|Part 1, Period 3 (4 Days)||5
11536|NCT03136380|23310|P1|COMPLETED|Part 1, Period 3 (4 Days)||6
11537|NCT03136380|23306|P5|STARTED|Part 1, Period 3 (4 Days)||0
11538|NCT03136380|23307|P4|STARTED|Part 1, Period 3 (4 Days)||0
11539|NCT03136380|23308|P3|STARTED|Part 1, Period 3 (4 Days)||6
11540|NCT03136380|23309|P2|STARTED|Part 1, Period 3 (4 Days)||5
11541|NCT03136380|23310|P1|STARTED|Part 1, Period 3 (4 Days)||6
11542|NCT03136380|23306|P5|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11543|NCT03136380|23307|P4|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11544|NCT03136380|23308|P3|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11545|NCT03136380|23309|P2|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||1
11546|NCT03136380|23310|P1|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11547|NCT03136380|23306|P5|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11548|NCT03136380|23307|P4|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11549|NCT03136380|23308|P3|COMPLETED|Part 1, Washout Period 2 (7 Days)||6
11550|NCT03136380|23309|P2|COMPLETED|Part 1, Washout Period 2 (7 Days)||5
11551|NCT03136380|23310|P1|COMPLETED|Part 1, Washout Period 2 (7 Days)||6
11552|NCT03136380|23306|P5|STARTED|Part 1, Washout Period 2 (7 Days)||0
11553|NCT03136380|23307|P4|STARTED|Part 1, Washout Period 2 (7 Days)||0
11554|NCT03136380|23308|P3|STARTED|Part 1, Washout Period 2 (7 Days)||6
11555|NCT03136380|23309|P2|STARTED|Part 1, Washout Period 2 (7 Days)||6
11556|NCT03136380|23310|P1|STARTED|Part 1, Washout Period 2 (7 Days)||6
11557|NCT03136380|23306|P5|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
11558|NCT03136380|23307|P4|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
11559|NCT03136380|23308|P3|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
11560|NCT03136380|23309|P2|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
11561|NCT03136380|23310|P1|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
11562|NCT03136380|23306|P5|COMPLETED|Part 1, Period 2 (3 Days)||0
11563|NCT03136380|23307|P4|COMPLETED|Part 1, Period 2 (3 Days)||0
11564|NCT03136380|23308|P3|COMPLETED|Part 1, Period 2 (3 Days)||6
11565|NCT03136380|23309|P2|COMPLETED|Part 1, Period 2 (3 Days)||6
11566|NCT03136380|23310|P1|COMPLETED|Part 1, Period 2 (3 Days)||6
11567|NCT03136380|23306|P5|STARTED|Part 1, Period 2 (3 Days)||0
11568|NCT03136380|23307|P4|STARTED|Part 1, Period 2 (3 Days)||0
11569|NCT03136380|23308|P3|STARTED|Part 1, Period 2 (3 Days)||6
11570|NCT03136380|23309|P2|STARTED|Part 1, Period 2 (3 Days)||6
11571|NCT03136380|23310|P1|STARTED|Part 1, Period 2 (3 Days)||6
11572|NCT03136380|23306|P5|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11573|NCT03136380|23307|P4|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11574|NCT03136380|23308|P3|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11575|NCT03136380|23309|P2|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11576|NCT03136380|23310|P1|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11577|NCT03136380|23306|P5|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11578|NCT03136380|23307|P4|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11579|NCT03136380|23308|P3|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
11580|NCT03136380|23309|P2|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
11581|NCT03136380|23310|P1|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
11582|NCT03136380|23306|P5|STARTED|Part 1, Washout Period 1 (7 Days)||0
11583|NCT03136380|23307|P4|STARTED|Part 1, Washout Period 1 (7 Days)||0
11584|NCT03136380|23308|P3|STARTED|Part 1, Washout Period 1 (7 Days)||6
11585|NCT03136380|23309|P2|STARTED|Part 1, Washout Period 1 (7 Days)||6
11586|NCT03136380|23310|P1|STARTED|Part 1, Washout Period 1 (7 Days)||6
11587|NCT03136380|23306|P5|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
11588|NCT03136380|23307|P4|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
11589|NCT03136380|23308|P3|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
11590|NCT03136380|23309|P2|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
11591|NCT03136380|23310|P1|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
11592|NCT03136380|23306|P5|COMPLETED|Part 1, Period 1 (3 Days)||0
11593|NCT03136380|23307|P4|COMPLETED|Part 1, Period 1 (3 Days)||0
11594|NCT03136380|23308|P3|COMPLETED|Part 1, Period 1 (3 Days)||6
11595|NCT03136380|23309|P2|COMPLETED|Part 1, Period 1 (3 Days)||6
11596|NCT03136380|23310|P1|COMPLETED|Part 1, Period 1 (3 Days)||6
11597|NCT03136380|23306|P5|STARTED|Part 1, Period 1 (3 Days)||0
11598|NCT03136380|23307|P4|STARTED|Part 1, Period 1 (3 Days)||0
11599|NCT03136380|23308|P3|STARTED|Part 1, Period 1 (3 Days)||6
11600|NCT03136380|23309|P2|STARTED|Part 1, Period 1 (3 Days)||6
11601|NCT03136380|23310|P1|STARTED|Part 1, Period 1 (3 Days)||6
11602|NCT03136328|23483|P1|NOT COMPLETED|Overall Study||0
11603|NCT03136328|23483|P1|COMPLETED|Overall Study||11
11604|NCT03136328|23483|P1|STARTED|Overall Study||11
11605|NCT03136107|23489|P1|NOT COMPLETED|Overall Study||1
11606|NCT03136107|23489|P1|COMPLETED|Overall Study||25
11607|NCT03136107|23489|P1|Negative Control|Overall Study||26
11608|NCT03136107|23489|P1|Reference Product|Overall Study||26
11609|NCT03136107|23489|P1|Test Product|Overall Study||26
11610|NCT03136107|23489|P1|STARTED|Overall Study||26
11611|NCT03136068|23499|P2|NOT COMPLETED|Overall Study||1
11612|NCT03136068|23500|P1|NOT COMPLETED|Overall Study||2
11613|NCT03136068|23499|P2|COMPLETED|Overall Study||89
11614|NCT03136068|23500|P1|COMPLETED|Overall Study||86
11615|NCT03136068|23499|P2|STARTED|Overall Study||90
11616|NCT03136068|23500|P1|STARTED|Overall Study||88
11617|NCT03135899|23522|P8|NOT COMPLETED|Overall Study||0
11618|NCT03135899|23523|P7|NOT COMPLETED|Overall Study||1
11619|NCT03135899|23524|P6|NOT COMPLETED|Overall Study||2
11620|NCT03135899|23525|P5|NOT COMPLETED|Overall Study||0
11621|NCT03135899|23526|P4|NOT COMPLETED|Overall Study||0
11622|NCT03135899|23527|P3|NOT COMPLETED|Overall Study||0
11623|NCT03135899|23528|P2|NOT COMPLETED|Overall Study||0
11624|NCT03135899|23529|P1|NOT COMPLETED|Overall Study||0
11625|NCT03135899|23522|P8|COMPLETED|Overall Study||8
11626|NCT03135899|23523|P7|COMPLETED|Overall Study||7
11627|NCT03135899|23524|P6|COMPLETED|Overall Study||7
11628|NCT03135899|23525|P5|COMPLETED|Overall Study||8
11629|NCT03135899|23526|P4|COMPLETED|Overall Study||1
11630|NCT03135899|23527|P3|COMPLETED|Overall Study||1
11631|NCT03135899|23528|P2|COMPLETED|Overall Study||1
11632|NCT03135899|23529|P1|COMPLETED|Overall Study||1
11633|NCT03135899|23522|P8|STARTED|Overall Study||8
11634|NCT03135899|23523|P7|STARTED|Overall Study||8
11635|NCT03135899|23524|P6|STARTED|Overall Study||9
11636|NCT03135899|23525|P5|STARTED|Overall Study||8
11637|NCT03135899|23526|P4|STARTED|Overall Study||1
11638|NCT03135899|23527|P3|STARTED|Overall Study||1
11639|NCT03135899|23528|P2|STARTED|Overall Study||1
11640|NCT03135899|23529|P1|STARTED|Overall Study||1
11641|NCT03135548|23562|P3|NOT COMPLETED|Overall Study||3
11642|NCT03135548|23563|P2|NOT COMPLETED|Overall Study||4
11643|NCT03135548|23564|P1|NOT COMPLETED|Overall Study||5
11644|NCT03135548|23562|P3|COMPLETED|Overall Study||18
11645|NCT03135548|23563|P2|COMPLETED|Overall Study||15
11646|NCT03135548|23564|P1|COMPLETED|Overall Study||14
11647|NCT03135548|23562|P3|STARTED|Overall Study||21
11648|NCT03135548|23563|P2|STARTED|Overall Study||19
11649|NCT03135548|23564|P1|STARTED|Overall Study||19
11650|NCT03135431|23586|P2|NOT COMPLETED|Overall Study||0
11651|NCT03135431|23587|P1|NOT COMPLETED|Overall Study||2
11652|NCT03135431|23586|P2|COMPLETED|Overall Study||20
11653|NCT03135431|23587|P1|COMPLETED|Overall Study||18
11654|NCT03135431|23586|P2|STARTED|Overall Study||20
11655|NCT03135431|23587|P1|STARTED|Overall Study||20
11656|NCT03135379|23599|P2|NOT COMPLETED|Overall Study||3
11657|NCT03135379|23600|P1|NOT COMPLETED|Overall Study||1
11658|NCT03135379|23599|P2|COMPLETED|Overall Study||59
11659|NCT03135379|23600|P1|COMPLETED|Overall Study||61
11660|NCT03135379|23599|P2|STARTED|Overall Study||62
11661|NCT03135379|23600|P1|STARTED|Overall Study||62
11662|NCT03134911|23610|P1|NOT COMPLETED|Overall Study||34
11663|NCT03134911|23610|P1|COMPLETED|Overall Study||501
11664|NCT03134911|23610|P1|STARTED|Overall Study||535
11665|NCT03134599|23637|P6|NOT COMPLETED|Week 3||1
11666|NCT03134599|23638|P5|NOT COMPLETED|Week 3||0
11667|NCT03134599|23639|P4|NOT COMPLETED|Week 3||1
11668|NCT03134599|23640|P3|NOT COMPLETED|Week 3||0
11669|NCT03134599|23641|P2|NOT COMPLETED|Week 3||0
11670|NCT03134599|23642|P1|NOT COMPLETED|Week 3||0
11671|NCT03134599|23637|P6|COMPLETED|Week 3||8
11672|NCT03134599|23638|P5|COMPLETED|Week 3||8
11673|NCT03134599|23639|P4|COMPLETED|Week 3||9
11674|NCT03134599|23640|P3|COMPLETED|Week 3||10
11675|NCT03134599|23641|P2|COMPLETED|Week 3||10
11676|NCT03134599|23642|P1|COMPLETED|Week 3||9
11677|NCT03134599|23637|P6|STARTED|Week 3||9
11678|NCT03134599|23638|P5|STARTED|Week 3||8
11679|NCT03134599|23639|P4|STARTED|Week 3||10
11680|NCT03134599|23640|P3|STARTED|Week 3||10
11681|NCT03134599|23641|P2|STARTED|Week 3||10
11682|NCT03134599|23642|P1|STARTED|Week 3||9
11683|NCT03134599|23637|P6|NOT COMPLETED|Week 2||0
11684|NCT03134599|23638|P5|NOT COMPLETED|Week 2||1
11685|NCT03134599|23639|P4|NOT COMPLETED|Week 2||1
11686|NCT03134599|23640|P3|NOT COMPLETED|Week 2||0
11687|NCT03134599|23641|P2|NOT COMPLETED|Week 2||0
11688|NCT03134599|23642|P1|NOT COMPLETED|Week 2||1
11689|NCT03134599|23637|P6|COMPLETED|Week 2||9
11690|NCT03134599|23638|P5|COMPLETED|Week 2||8
11691|NCT03134599|23639|P4|COMPLETED|Week 2||10
11692|NCT03134599|23640|P3|COMPLETED|Week 2||10
11693|NCT03134599|23641|P2|COMPLETED|Week 2||10
11694|NCT03134599|23642|P1|COMPLETED|Week 2||9
11695|NCT03134599|23637|P6|STARTED|Week 2||9
11696|NCT03134599|23638|P5|STARTED|Week 2||9
11697|NCT03134599|23639|P4|STARTED|Week 2||11
11698|NCT03134599|23640|P3|STARTED|Week 2||10
11699|NCT03134599|23641|P2|STARTED|Week 2||10
11700|NCT03134599|23642|P1|STARTED|Week 2||10
11701|NCT03134599|23637|P6|NOT COMPLETED|Week 1||0
11702|NCT03134599|23638|P5|NOT COMPLETED|Week 1||1
11703|NCT03134599|23639|P4|NOT COMPLETED|Week 1||0
11704|NCT03134599|23640|P3|NOT COMPLETED|Week 1||0
11705|NCT03134599|23641|P2|NOT COMPLETED|Week 1||0
11706|NCT03134599|23642|P1|NOT COMPLETED|Week 1||0
11707|NCT03134599|23637|P6|COMPLETED|Week 1||9
11708|NCT03134599|23638|P5|COMPLETED|Week 1||9
11709|NCT03134599|23639|P4|COMPLETED|Week 1||11
11710|NCT03134599|23640|P3|COMPLETED|Week 1||10
11711|NCT03134599|23641|P2|COMPLETED|Week 1||10
11712|NCT03134599|23642|P1|COMPLETED|Week 1||10
11713|NCT03134599|23637|P6|STARTED|Week 1||9
11714|NCT03134599|23638|P5|STARTED|Week 1||10
11715|NCT03134599|23639|P4|STARTED|Week 1||11
11716|NCT03134599|23640|P3|STARTED|Week 1||10
11717|NCT03134599|23641|P2|STARTED|Week 1||10
11718|NCT03134599|23642|P1|STARTED|Week 1||10
11719|NCT03134326|23650|P1|NOT COMPLETED|Overall Study||0
11720|NCT03134326|23650|P1|COMPLETED|Overall Study||21
11721|NCT03134326|23650|P1|STARTED|Overall Study||21
11722|NCT03134313|23654|P1|NOT COMPLETED|Overall Study||0
11723|NCT03134313|23654|P1|COMPLETED|Overall Study||25
11724|NCT03134313|23654|P1|STARTED|Overall Study||25
11725|NCT03134248|23658|P6|NOT COMPLETED|Week 3||0
11726|NCT03134248|23659|P5|NOT COMPLETED|Week 3||0
11727|NCT03134248|23660|P4|NOT COMPLETED|Week 3||0
11728|NCT03134248|23661|P3|NOT COMPLETED|Week 3||0
11729|NCT03134248|23662|P2|NOT COMPLETED|Week 3||0
11730|NCT03134248|23663|P1|NOT COMPLETED|Week 3||0
11731|NCT03134248|23658|P6|COMPLETED|Week 3||9
11732|NCT03134248|23659|P5|COMPLETED|Week 3||9
11733|NCT03134248|23660|P4|COMPLETED|Week 3||7
11734|NCT03134248|23661|P3|COMPLETED|Week 3||9
11735|NCT03134248|23662|P2|COMPLETED|Week 3||8
11736|NCT03134248|23663|P1|COMPLETED|Week 3||7
11737|NCT03134248|23658|P6|STARTED|Week 3||9
11738|NCT03134248|23659|P5|STARTED|Week 3||9
11739|NCT03134248|23660|P4|STARTED|Week 3||7
11740|NCT03134248|23661|P3|STARTED|Week 3||9
11741|NCT03134248|23662|P2|STARTED|Week 3||8
11742|NCT03134248|23663|P1|STARTED|Week 3||7
11743|NCT03134248|23658|P6|NOT COMPLETED|Week 2||0
11744|NCT03134248|23659|P5|NOT COMPLETED|Week 2||0
11745|NCT03134248|23660|P4|NOT COMPLETED|Week 2||0
11746|NCT03134248|23661|P3|NOT COMPLETED|Week 2||0
11747|NCT03134248|23662|P2|NOT COMPLETED|Week 2||0
11748|NCT03134248|23663|P1|NOT COMPLETED|Week 2||0
11749|NCT03134248|23658|P6|COMPLETED|Week 2||9
11750|NCT03134248|23659|P5|COMPLETED|Week 2||9
11751|NCT03134248|23660|P4|COMPLETED|Week 2||7
11752|NCT03134248|23661|P3|COMPLETED|Week 2||9
11753|NCT03134248|23662|P2|COMPLETED|Week 2||8
11754|NCT03134248|23663|P1|COMPLETED|Week 2||7
11755|NCT03134248|23658|P6|STARTED|Week 2||9
11756|NCT03134248|23659|P5|STARTED|Week 2||9
11757|NCT03134248|23660|P4|STARTED|Week 2||7
11758|NCT03134248|23661|P3|STARTED|Week 2||9
11759|NCT03134248|23662|P2|STARTED|Week 2||8
11760|NCT03134248|23663|P1|STARTED|Week 2||7
11761|NCT03134248|23658|P6|NOT COMPLETED|Week 1||0
11762|NCT03134248|23659|P5|NOT COMPLETED|Week 1||0
11763|NCT03134248|23660|P4|NOT COMPLETED|Week 1||0
11764|NCT03134248|23661|P3|NOT COMPLETED|Week 1||0
11765|NCT03134248|23662|P2|NOT COMPLETED|Week 1||0
11766|NCT03134248|23663|P1|NOT COMPLETED|Week 1||0
11767|NCT03134248|23658|P6|COMPLETED|Week 1||9
11768|NCT03134248|23659|P5|COMPLETED|Week 1||9
11769|NCT03134248|23660|P4|COMPLETED|Week 1||7
11770|NCT03134248|23661|P3|COMPLETED|Week 1||9
11771|NCT03134248|23662|P2|COMPLETED|Week 1||8
11772|NCT03134248|23663|P1|COMPLETED|Week 1||7
11773|NCT03134248|23658|P6|STARTED|Week 1||9
11774|NCT03134248|23659|P5|STARTED|Week 1||9
11775|NCT03134248|23660|P4|STARTED|Week 1||7
11776|NCT03134248|23661|P3|STARTED|Week 1||9
11777|NCT03134248|23662|P2|STARTED|Week 1||8
11778|NCT03134248|23663|P1|STARTED|Week 1||7
11779|NCT03134183|23681|P2|NOT COMPLETED|Overall Study||1
11780|NCT03134183|23682|P1|NOT COMPLETED|Overall Study||1
11781|NCT03134183|23681|P2|COMPLETED|Overall Study||33
11782|NCT03134183|23682|P1|COMPLETED|Overall Study||35
11783|NCT03134183|23681|P2|STARTED|Overall Study||34
11784|NCT03134183|23682|P1|STARTED|Overall Study||36
11785|NCT03133767|23692|P2|NOT COMPLETED|Overall Study||25
11786|NCT03133767|23693|P1|NOT COMPLETED|Overall Study||38
11787|NCT03133767|23692|P2|COMPLETED|Overall Study||53
11788|NCT03133767|23693|P1|COMPLETED|Overall Study||41
11789|NCT03133767|23692|P2|STARTED|Overall Study||78
11790|NCT03133767|23693|P1|STARTED|Overall Study||79
11791|NCT03133481|23709|P2|NOT COMPLETED|Overall Study||4
11792|NCT03133481|23710|P1|NOT COMPLETED|Overall Study||0
11793|NCT03133481|23709|P2|COMPLETED|Overall Study||45
11794|NCT03133481|23710|P1|COMPLETED|Overall Study||45
11795|NCT03133481|23709|P2|STARTED|Overall Study||49
11796|NCT03133481|23710|P1|STARTED|Overall Study||45
11797|NCT03132571|23740|P2|NOT COMPLETED|Overall Study||0
11798|NCT03132571|23741|P1|NOT COMPLETED|Overall Study||0
11799|NCT03132571|23740|P2|COMPLETED|Overall Study||2
11800|NCT03132571|23741|P1|COMPLETED|Overall Study||3
11801|NCT03132571|23740|P2|STARTED|Overall Study||2
11802|NCT03132571|23741|P1|STARTED|Overall Study||3
11803|NCT03132298|23755|P2|NOT COMPLETED|Overall Study||13
11804|NCT03132298|23756|P1|NOT COMPLETED|Overall Study||12
11805|NCT03132298|23755|P2|COMPLETED|Overall Study||35
11806|NCT03132298|23756|P1|COMPLETED|Overall Study||36
11807|NCT03132298|23755|P2|STARTED|Overall Study||48
11808|NCT03132298|23756|P1|STARTED|Overall Study||48
11809|NCT03131895|23788|P4|NOT COMPLETED|Intervention Period 2 (2 Days)||0
11810|NCT03131895|23789|P3|NOT COMPLETED|Intervention Period 2 (2 Days)||0
11811|NCT03131895|23790|P2|NOT COMPLETED|Intervention Period 2 (2 Days)||1
11812|NCT03131895|23791|P1|NOT COMPLETED|Intervention Period 2 (2 Days)||1
11813|NCT03131895|23788|P4|COMPLETED|Intervention Period 2 (2 Days)||25
11814|NCT03131895|23789|P3|COMPLETED|Intervention Period 2 (2 Days)||26
11815|NCT03131895|23790|P2|COMPLETED|Intervention Period 2 (2 Days)||22
11816|NCT03131895|23791|P1|COMPLETED|Intervention Period 2 (2 Days)||26
11817|NCT03131895|23788|P4|STARTED|Intervention Period 2 (2 Days)||25
11818|NCT03131895|23789|P3|STARTED|Intervention Period 2 (2 Days)||26
11819|NCT03131895|23790|P2|STARTED|Intervention Period 2 (2 Days)||23
11820|NCT03131895|23791|P1|STARTED|Intervention Period 2 (2 Days)||27
11821|NCT03131895|23788|P4|NOT COMPLETED|Washout Period (at Least 5 Days)||5
11822|NCT03131895|23789|P3|NOT COMPLETED|Washout Period (at Least 5 Days)||4
11823|NCT03131895|23790|P2|NOT COMPLETED|Washout Period (at Least 5 Days)||5
11824|NCT03131895|23791|P1|NOT COMPLETED|Washout Period (at Least 5 Days)||1
11825|NCT03131895|23788|P4|COMPLETED|Washout Period (at Least 5 Days)||25
11826|NCT03131895|23789|P3|COMPLETED|Washout Period (at Least 5 Days)||26
11827|NCT03131895|23790|P2|COMPLETED|Washout Period (at Least 5 Days)||23
11828|NCT03131895|23791|P1|COMPLETED|Washout Period (at Least 5 Days)||27
11829|NCT03131895|23788|P4|STARTED|Washout Period (at Least 5 Days)||30
11830|NCT03131895|23789|P3|STARTED|Washout Period (at Least 5 Days)||30
11831|NCT03131895|23790|P2|STARTED|Washout Period (at Least 5 Days)||28
11832|NCT03131895|23791|P1|STARTED|Washout Period (at Least 5 Days)||28
11833|NCT03131895|23788|P4|NOT COMPLETED|Intervention Period 1 (2 Days)||0
11834|NCT03131895|23789|P3|NOT COMPLETED|Intervention Period 1 (2 Days)||0
11835|NCT03131895|23790|P2|NOT COMPLETED|Intervention Period 1 (2 Days)||0
11836|NCT03131895|23791|P1|NOT COMPLETED|Intervention Period 1 (2 Days)||0
11837|NCT03131895|23788|P4|COMPLETED|Intervention Period 1 (2 Days)||30
11838|NCT03131895|23789|P3|COMPLETED|Intervention Period 1 (2 Days)||30
11839|NCT03131895|23790|P2|COMPLETED|Intervention Period 1 (2 Days)||28
11840|NCT03131895|23791|P1|COMPLETED|Intervention Period 1 (2 Days)||28
11841|NCT03131895|23788|P4|STARTED|Intervention Period 1 (2 Days)||30
11842|NCT03131895|23789|P3|STARTED|Intervention Period 1 (2 Days)||30
11843|NCT03131895|23790|P2|STARTED|Intervention Period 1 (2 Days)||28
11844|NCT03131895|23791|P1|STARTED|Intervention Period 1 (2 Days)||28
11845|NCT03131713|23811|P2|NOT COMPLETED|Overall Study||0
11846|NCT03131713|23812|P1|NOT COMPLETED|Overall Study||5
11847|NCT03131713|23811|P2|COMPLETED|Overall Study||51
11848|NCT03131713|23812|P1|COMPLETED|Overall Study||45
11849|NCT03131713|23811|P2|STARTED|Overall Study|1 intervention subject was added on after the protocol was initiated.|51
11850|NCT03131713|23812|P1|STARTED|Overall Study||50
11851|NCT03131687|23836|P6|NOT COMPLETED|Overall Study||5
11852|NCT03131687|23837|P5|NOT COMPLETED|Overall Study||8
11853|NCT03131687|23838|P4|NOT COMPLETED|Overall Study||4
11854|NCT03131687|23839|P3|NOT COMPLETED|Overall Study||3
11855|NCT03131687|23840|P2|NOT COMPLETED|Overall Study||9
11856|NCT03131687|23841|P1|NOT COMPLETED|Overall Study||6
11857|NCT03131687|23836|P6|COMPLETED|Overall Study||49
11858|NCT03131687|23837|P5|COMPLETED|Overall Study||45
11859|NCT03131687|23838|P4|COMPLETED|Overall Study||48
11860|NCT03131687|23839|P3|COMPLETED|Overall Study||52
11861|NCT03131687|23840|P2|COMPLETED|Overall Study||44
11862|NCT03131687|23841|P1|COMPLETED|Overall Study||45
11863|NCT03131687|23836|P6|Received at Least One Dose of Study Drug|Overall Study||54
11864|NCT03131687|23837|P5|Received at Least One Dose of Study Drug|Overall Study||53
11865|NCT03131687|23838|P4|Received at Least One Dose of Study Drug|Overall Study||51
11866|NCT03131687|23839|P3|Received at Least One Dose of Study Drug|Overall Study||55
11867|NCT03131687|23840|P2|Received at Least One Dose of Study Drug|Overall Study||52
11868|NCT03131687|23841|P1|Received at Least One Dose of Study Drug|Overall Study||51
11869|NCT03131687|23836|P6|STARTED|Overall Study||54
11870|NCT03131687|23837|P5|STARTED|Overall Study||53
11871|NCT03131687|23838|P4|STARTED|Overall Study||52
11872|NCT03131687|23839|P3|STARTED|Overall Study||55
11873|NCT03131687|23840|P2|STARTED|Overall Study||53
11874|NCT03131687|23841|P1|STARTED|Overall Study||51
11875|NCT03131596|23951|P2|NOT COMPLETED|Overall Study||3
11876|NCT03131596|23952|P1|NOT COMPLETED|Overall Study||6
11877|NCT03131596|23951|P2|COMPLETED|Overall Study||97
11878|NCT03131596|23952|P1|COMPLETED|Overall Study||94
11879|NCT03131596|23951|P2|STARTED|Overall Study||100
11880|NCT03131596|23952|P1|STARTED|Overall Study||100
11881|NCT03131479|23969|P5|NOT COMPLETED|Overall Study||0
11882|NCT03131479|23970|P4|NOT COMPLETED|Overall Study||2
11883|NCT03131479|23971|P3|NOT COMPLETED|Overall Study||1
11884|NCT03131479|23972|P2|NOT COMPLETED|Overall Study||0
11885|NCT03131479|23973|P1|NOT COMPLETED|Overall Study||0
11886|NCT03131479|23969|P5|COMPLETED|Overall Study||10
11887|NCT03131479|23970|P4|COMPLETED|Overall Study||10
11888|NCT03131479|23971|P3|COMPLETED|Overall Study||10
11889|NCT03131479|23972|P2|COMPLETED|Overall Study||10
11890|NCT03131479|23973|P1|COMPLETED|Overall Study||10
11891|NCT03131479|23969|P5|Pharcodynamic Analysis Set (PD)|Overall Study||10
11892|NCT03131479|23970|P4|Pharcodynamic Analysis Set (PD)|Overall Study||12
11893|NCT03131479|23971|P3|Pharcodynamic Analysis Set (PD)|Overall Study||11
11894|NCT03131479|23972|P2|Pharcodynamic Analysis Set (PD)|Overall Study||10
11895|NCT03131479|23973|P1|Pharcodynamic Analysis Set (PD)|Overall Study||10
11896|NCT03131479|23969|P5|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
11897|NCT03131479|23970|P4|Pharmacokinetic Analysis Set (PAS)|Overall Study||12
11898|NCT03131479|23971|P3|Pharmacokinetic Analysis Set (PAS)|Overall Study||11
11899|NCT03131479|23972|P2|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
11900|NCT03131479|23973|P1|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
11901|NCT03131479|23969|P5|Safety Analysis Set (SS)|Overall Study||10
11902|NCT03131479|23970|P4|Safety Analysis Set (SS)|Overall Study||12
11903|NCT03131479|23971|P3|Safety Analysis Set (SS)|Overall Study||11
11904|NCT03131479|23972|P2|Safety Analysis Set (SS)|Overall Study||10
11905|NCT03131479|23973|P1|Safety Analysis Set (SS)|Overall Study||10
11906|NCT03131479|23969|P5|STARTED|Overall Study||10
11907|NCT03131479|23970|P4|STARTED|Overall Study||12
11908|NCT03131479|23971|P3|STARTED|Overall Study||11
11909|NCT03131479|23972|P2|STARTED|Overall Study||10
11910|NCT03131479|23973|P1|STARTED|Overall Study||10
11911|NCT03131206|24034|P4|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
11912|NCT03131206|24035|P3|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
11913|NCT03131206|24036|P2|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
11914|NCT03131206|24037|P1|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
11915|NCT03131206|24034|P4|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
11916|NCT03131206|24035|P3|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
11917|NCT03131206|24036|P2|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
11918|NCT03131206|24037|P1|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
11919|NCT03131206|24034|P4|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
11920|NCT03131206|24035|P3|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
11921|NCT03131206|24036|P2|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
11922|NCT03131206|24037|P1|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
11923|NCT03131206|24034|P4|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
11924|NCT03131206|24035|P3|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
11925|NCT03131206|24036|P2|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
11926|NCT03131206|24037|P1|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
11927|NCT03131206|24034|P4|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
11928|NCT03131206|24035|P3|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
11929|NCT03131206|24036|P2|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
11930|NCT03131206|24037|P1|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||5
11931|NCT03131206|24034|P4|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
11932|NCT03131206|24035|P3|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
11933|NCT03131206|24036|P2|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
11934|NCT03131206|24037|P1|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||5
11935|NCT03131167|24068|P13|NOT COMPLETED|Overall Study||0
11936|NCT03131167|24069|P12|NOT COMPLETED|Overall Study||0
11937|NCT03131167|24070|P11|NOT COMPLETED|Overall Study||0
11938|NCT03131167|24071|P10|NOT COMPLETED|Overall Study||0
11939|NCT03131167|24072|P9|NOT COMPLETED|Overall Study||0
11940|NCT03131167|24073|P8|NOT COMPLETED|Overall Study||0
11941|NCT03131167|24074|P7|NOT COMPLETED|Overall Study||0
11942|NCT03131167|24075|P6|NOT COMPLETED|Overall Study||1
11943|NCT03131167|24076|P5|NOT COMPLETED|Overall Study||0
11944|NCT03131167|24077|P4|NOT COMPLETED|Overall Study||0
11945|NCT03131167|24078|P3|NOT COMPLETED|Overall Study||0
11946|NCT03131167|24079|P2|NOT COMPLETED|Overall Study||0
11947|NCT03131167|24080|P1|NOT COMPLETED|Overall Study||0
11948|NCT03131167|24068|P13|COMPLETED|Overall Study||5
11949|NCT03131167|24069|P12|COMPLETED|Overall Study||5
11950|NCT03131167|24070|P11|COMPLETED|Overall Study||4
11951|NCT03131167|24071|P10|COMPLETED|Overall Study||5
11952|NCT03131167|24072|P9|COMPLETED|Overall Study||2
11953|NCT03131167|24073|P8|COMPLETED|Overall Study||5
11954|NCT03131167|24074|P7|COMPLETED|Overall Study||5
11955|NCT03131167|24075|P6|COMPLETED|Overall Study||4
11956|NCT03131167|24076|P5|COMPLETED|Overall Study||6
11957|NCT03131167|24077|P4|COMPLETED|Overall Study||5
11958|NCT03131167|24078|P3|COMPLETED|Overall Study||5
11959|NCT03131167|24079|P2|COMPLETED|Overall Study||5
11960|NCT03131167|24080|P1|COMPLETED|Overall Study||6
11961|NCT03131167|24068|P13|STARTED|Overall Study||5
11962|NCT03131167|24069|P12|STARTED|Overall Study||5
11963|NCT03131167|24070|P11|STARTED|Overall Study||4
11964|NCT03131167|24071|P10|STARTED|Overall Study||5
11965|NCT03131167|24072|P9|STARTED|Overall Study||2
11966|NCT03131167|24073|P8|STARTED|Overall Study||5
11967|NCT03131167|24074|P7|STARTED|Overall Study||5
11968|NCT03131167|24075|P6|STARTED|Overall Study||5
11969|NCT03131167|24076|P5|STARTED|Overall Study||6
11970|NCT03131167|24077|P4|STARTED|Overall Study||5
11971|NCT03131167|24078|P3|STARTED|Overall Study||5
11972|NCT03131167|24079|P2|STARTED|Overall Study||5
11973|NCT03131167|24080|P1|STARTED|Overall Study||6
11974|NCT03129321|24124|P3|NOT COMPLETED|Overall Study||55
11975|NCT03129321|24125|P2|NOT COMPLETED|Overall Study||109
11976|NCT03129321|24126|P1|NOT COMPLETED|Overall Study||98
11977|NCT03129321|24124|P3|COMPLETED|Overall Study||120
11978|NCT03129321|24125|P2|COMPLETED|Overall Study||241
11979|NCT03129321|24126|P1|COMPLETED|Overall Study||253
11980|NCT03129321|24124|P3|STARTED|Overall Study||175
11981|NCT03129321|24125|P2|STARTED|Overall Study||350
11982|NCT03129321|24126|P1|STARTED|Overall Study||351
11983|NCT03128723|24146|P1|NOT COMPLETED|Overall Study||2
11984|NCT03128723|24146|P1|COMPLETED|Overall Study||43
11985|NCT03128723|24146|P1|STARTED|Overall Study||45
11986|NCT03128372|24161|P1|NOT COMPLETED|Overall Study||0
11987|NCT03128372|24161|P1|COMPLETED|Overall Study||32
11988|NCT03128372|24161|P1|STARTED|Overall Study||32
11989|NCT03128307|24165|P1|NOT COMPLETED|Overall Study||34
11990|NCT03128307|24165|P1|COMPLETED|Overall Study||570
11991|NCT03128307|24165|P1|STARTED|Overall Study||604
11992|NCT03127956|24170|P1|NOT COMPLETED|Overall Study||317
11993|NCT03127956|24170|P1|COMPLETED|Overall Study||431
11994|NCT03127956|24170|P1|STARTED|Overall Study||748
11995|NCT03127943|24174|P2|NOT COMPLETED|Second Intervention||0
11996|NCT03127943|24175|P1|NOT COMPLETED|Second Intervention||0
11997|NCT03127943|24174|P2|COMPLETED|Second Intervention||12
11998|NCT03127943|24175|P1|COMPLETED|Second Intervention||12
11999|NCT03127943|24174|P2|STARTED|Second Intervention||12
12000|NCT03127943|24175|P1|STARTED|Second Intervention||12
12001|NCT03127943|24174|P2|NOT COMPLETED|Washout (1 Week)||0
12002|NCT03127943|24175|P1|NOT COMPLETED|Washout (1 Week)||0
12003|NCT03127943|24174|P2|COMPLETED|Washout (1 Week)||12
12004|NCT03127943|24175|P1|COMPLETED|Washout (1 Week)||12
12005|NCT03127943|24174|P2|STARTED|Washout (1 Week)||12
12006|NCT03127943|24175|P1|STARTED|Washout (1 Week)||12
12007|NCT03127943|24174|P2|NOT COMPLETED|First Intervention||0
12008|NCT03127943|24175|P1|NOT COMPLETED|First Intervention||0
12009|NCT03127943|24174|P2|COMPLETED|First Intervention||12
12010|NCT03127943|24175|P1|COMPLETED|First Intervention||12
12011|NCT03127943|24174|P2|STARTED|First Intervention||12
12012|NCT03127943|24175|P1|STARTED|First Intervention||12
12013|NCT03127644|24186|P3|NOT COMPLETED|Overall Study||2
12014|NCT03127644|24187|P2|NOT COMPLETED|Overall Study||0
12015|NCT03127644|24188|P1|NOT COMPLETED|Overall Study||0
12016|NCT03127644|24186|P3|COMPLETED|Overall Study||31
12017|NCT03127644|24187|P2|COMPLETED|Overall Study||36
12018|NCT03127644|24188|P1|COMPLETED|Overall Study||34
12019|NCT03127644|24186|P3|STARTED|Overall Study||33
12020|NCT03127644|24187|P2|STARTED|Overall Study||36
12021|NCT03127644|24188|P1|STARTED|Overall Study||34
12022|NCT03127384|24220|P1|NOT COMPLETED|Overall Study||6
12023|NCT03127384|24220|P1|COMPLETED|Overall Study||43
12024|NCT03127384|24220|P1|Completed 3 Month Visit|Overall Study||47
12025|NCT03127384|24220|P1|STARTED|Overall Study||49
12026|NCT03127228|24228|P2|NOT COMPLETED|Overall Study||0
12027|NCT03127228|24229|P1|NOT COMPLETED|Overall Study||0
12028|NCT03127228|24228|P2|COMPLETED|Overall Study||12
12029|NCT03127228|24229|P1|COMPLETED|Overall Study||12
12030|NCT03127228|24228|P2|STARTED|Overall Study||12
12031|NCT03127228|24229|P1|STARTED|Overall Study||12
12032|NCT03126682|24243|P2|NOT COMPLETED|Overall Study||0
12033|NCT03126682|24244|P1|NOT COMPLETED|Overall Study||0
12034|NCT03126682|24243|P2|COMPLETED|Overall Study||5
12035|NCT03126682|24244|P1|COMPLETED|Overall Study||5
12036|NCT03126682|24243|P2|STARTED|Overall Study||5
12037|NCT03126682|24244|P1|STARTED|Overall Study||5
12038|NCT03125200|24261|P7|NOT COMPLETED|Overall Study||3
12039|NCT03125200|24262|P6|NOT COMPLETED|Overall Study||3
12040|NCT03125200|24263|P5|NOT COMPLETED|Overall Study||4
12041|NCT03125200|24264|P4|NOT COMPLETED|Overall Study||5
12042|NCT03125200|24265|P3|NOT COMPLETED|Overall Study||2
12043|NCT03125200|24266|P2|NOT COMPLETED|Overall Study||2
12044|NCT03125200|24267|P1|NOT COMPLETED|Overall Study||2
12045|NCT03125200|24261|P7|COMPLETED|Overall Study||0
12046|NCT03125200|24262|P6|COMPLETED|Overall Study||0
12047|NCT03125200|24263|P5|COMPLETED|Overall Study||0
12048|NCT03125200|24264|P4|COMPLETED|Overall Study||0
12049|NCT03125200|24265|P3|COMPLETED|Overall Study||0
12050|NCT03125200|24266|P2|COMPLETED|Overall Study||0
12051|NCT03125200|24267|P1|COMPLETED|Overall Study||0
12052|NCT03125200|24261|P7|STARTED|Overall Study||3
12053|NCT03125200|24262|P6|STARTED|Overall Study||3
12054|NCT03125200|24263|P5|STARTED|Overall Study||4
12055|NCT03125200|24264|P4|STARTED|Overall Study||5
12056|NCT03125200|24265|P3|STARTED|Overall Study||2
12057|NCT03125200|24266|P2|STARTED|Overall Study||2
12058|NCT03125200|24267|P1|STARTED|Overall Study||2
12059|NCT03125031|24465|P2|NOT COMPLETED|Overall Study||0
12060|NCT03125031|24466|P1|NOT COMPLETED|Overall Study||0
12061|NCT03125031|24465|P2|COMPLETED|Overall Study||44
12062|NCT03125031|24466|P1|COMPLETED|Overall Study||44
12063|NCT03125031|24465|P2|STARTED|Overall Study||44
12064|NCT03125031|24466|P1|STARTED|Overall Study||44
12065|NCT03125018|24471|P1|NOT COMPLETED|Overall Study||0
12066|NCT03125018|24471|P1|COMPLETED|Overall Study||13
12067|NCT03125018|24471|P1|STARTED|Overall Study||13
12068|NCT03125005|24475|P1|NOT COMPLETED|Overall Study||0
12069|NCT03125005|24475|P1|COMPLETED|Overall Study||51
12070|NCT03125005|24475|P1|STARTED|Overall Study||51
12071|NCT03124979|24479|P1|NOT COMPLETED|Overall Study||0
12072|NCT03124979|24479|P1|COMPLETED|Overall Study||13
12073|NCT03124979|24479|P1|STARTED|Overall Study||13
12074|NCT03124966|24483|P1|NOT COMPLETED|Overall Study||0
12075|NCT03124966|24483|P1|COMPLETED|Overall Study||118
12076|NCT03124966|24483|P1|STARTED|Overall Study||118
12077|NCT03124927|24487|P1|NOT COMPLETED|Overall Study||0
12078|NCT03124927|24487|P1|COMPLETED|Overall Study||25
12079|NCT03124927|24487|P1|STARTED|Overall Study||25
12080|NCT03124901|24491|P1|NOT COMPLETED|Overall Study||0
12081|NCT03124901|24491|P1|COMPLETED|Overall Study||147
12082|NCT03124901|24491|P1|STARTED|Overall Study||147
12083|NCT03124836|24495|P1|NOT COMPLETED|Overall Study||0
12084|NCT03124836|24495|P1|COMPLETED|Overall Study||28
12085|NCT03124836|24495|P1|STARTED|Overall Study||28
12086|NCT03124823|24499|P1|NOT COMPLETED|Overall Study||0
12087|NCT03124823|24499|P1|COMPLETED|Overall Study||11
12088|NCT03124823|24499|P1|STARTED|Overall Study||11
12089|NCT03124797|24503|P1|NOT COMPLETED|Overall Study||0
12090|NCT03124797|24503|P1|COMPLETED|Overall Study||18
12091|NCT03124797|24503|P1|STARTED|Overall Study||18
12092|NCT03124784|24507|P1|NOT COMPLETED|Overall Study||2
12093|NCT03124784|24507|P1|COMPLETED|Overall Study||25
12094|NCT03124784|24507|P1|STARTED|Overall Study||27
12095|NCT03124771|24511|P1|NOT COMPLETED|Overall Study||0
12096|NCT03124771|24511|P1|COMPLETED|Overall Study||132
12097|NCT03124771|24511|P1|STARTED|Overall Study||132
12098|NCT03124758|24515|P1|NOT COMPLETED|Overall Study||0
12099|NCT03124758|24515|P1|COMPLETED|Overall Study||354
12100|NCT03124758|24515|P1|STARTED|Overall Study||354
12101|NCT03124693|24519|P1|NOT COMPLETED|Overall Study||0
12102|NCT03124693|24519|P1|COMPLETED|Overall Study||90
12103|NCT03124693|24519|P1|STARTED|Overall Study||90
12104|NCT03124602|24523|P1|NOT COMPLETED|Overall Study||10
12105|NCT03124602|24523|P1|COMPLETED|Overall Study||25
12106|NCT03124602|24523|P1|STARTED|Overall Study||35
12107|NCT03124563|24529|P2|NOT COMPLETED|Overall Study||2
12108|NCT03124563|24530|P1|NOT COMPLETED|Overall Study||2
12109|NCT03124563|24529|P2|COMPLETED|Overall Study||29
12110|NCT03124563|24530|P1|COMPLETED|Overall Study||30
12111|NCT03124563|24529|P2|Pre-test|Overall Study||30
12112|NCT03124563|24530|P1|Pre-test|Overall Study||30
12113|NCT03124563|24529|P2|STARTED|Overall Study||31
12114|NCT03124563|24530|P1|STARTED|Overall Study||32
12115|NCT03124381|24548|P2|NOT COMPLETED|Overall Study||6
12116|NCT03124381|24549|P1|NOT COMPLETED|Overall Study||9
12117|NCT03124381|24548|P2|COMPLETED|Overall Study||55
12118|NCT03124381|24549|P1|COMPLETED|Overall Study||56
12119|NCT03124381|24548|P2|STARTED|Overall Study||61
12120|NCT03124381|24549|P1|STARTED|Overall Study||65
12121|NCT03124342|24641|P2|NOT COMPLETED|Overall Study||0
12122|NCT03124342|24642|P1|NOT COMPLETED|Overall Study||0
12123|NCT03124342|24641|P2|COMPLETED|Overall Study||121
12124|NCT03124342|24642|P1|COMPLETED|Overall Study||111
12125|NCT03124342|24641|P2|STARTED|Overall Study||121
12126|NCT03124342|24642|P1|STARTED|Overall Study||111
12127|NCT03124199|24656|P1|NOT COMPLETED|Overall Study||4
12128|NCT03124199|24656|P1|COMPLETED|Overall Study||36
12129|NCT03124199|24656|P1|STARTED|Overall Study||40
12130|NCT03124108|24665|P3|NOT COMPLETED|Overall Study||0
12131|NCT03124108|24666|P2|NOT COMPLETED|Overall Study||1
12132|NCT03124108|24667|P1|NOT COMPLETED|Overall Study||0
12133|NCT03124108|24665|P3|COMPLETED|Overall Study||15
12134|NCT03124108|24666|P2|COMPLETED|Overall Study||14
12135|NCT03124108|24667|P1|COMPLETED|Overall Study||15
12136|NCT03124108|24665|P3|STARTED|Overall Study||15
12137|NCT03124108|24666|P2|STARTED|Overall Study||15
12138|NCT03124108|24667|P1|STARTED|Overall Study||15
12139|NCT03123874|24800|P2|NOT COMPLETED|Overall Study||0
12140|NCT03123874|24801|P1|NOT COMPLETED|Overall Study||0
12141|NCT03123874|24800|P2|COMPLETED|Overall Study||25
12142|NCT03123874|24801|P1|COMPLETED|Overall Study||27
12143|NCT03123874|24800|P2|STARTED|Overall Study||25
12144|NCT03123874|24801|P1|STARTED|Overall Study||27
12145|NCT03123848|24811|P1|NOT COMPLETED|Overall Study||0
12146|NCT03123848|24811|P1|COMPLETED|Overall Study||8
12147|NCT03123848|24811|P1|STARTED|Overall Study||8
12148|NCT03123471|24835|P2|NOT COMPLETED|Apremilast Extension Phase||25
12149|NCT03123471|24836|P1|NOT COMPLETED|Apremilast Extension Phase||8
12150|NCT03123471|24835|P2|COMPLETED|Apremilast Extension Phase||140
12151|NCT03123471|24836|P1|COMPLETED|Apremilast Extension Phase||76
12152|NCT03123471|24835|P2|Received at Least 1 Dose of Study Drug|Apremilast Extension Phase||163
12153|NCT03123471|24836|P1|Received at Least 1 Dose of Study Drug|Apremilast Extension Phase||84
12154|NCT03123471|24835|P2|STARTED|Apremilast Extension Phase|3 participants completed the first phase; did not enter in extension phase|165
12155|NCT03123471|24836|P1|STARTED|Apremilast Extension Phase||84
12156|NCT03123471|24835|P2|NOT COMPLETED|Placebo-controlled Phase||33
12157|NCT03123471|24836|P1|NOT COMPLETED|Placebo-controlled Phase||18
12158|NCT03123471|24835|P2|COMPLETED|Placebo-controlled Phase||168
12159|NCT03123471|24836|P1|COMPLETED|Placebo-controlled Phase||84
12160|NCT03123471|24835|P2|Received at Least 1 Dose of Study Drug|Placebo-controlled Phase||200
12161|NCT03123471|24836|P1|Received at Least 1 Dose of Study Drug|Placebo-controlled Phase||102
12162|NCT03123471|24835|P2|STARTED|Placebo-controlled Phase||201
12163|NCT03123471|24836|P1|STARTED|Placebo-controlled Phase||102
12164|NCT03123354|24861|P1|NOT COMPLETED|Overall Study||6
12165|NCT03123354|24861|P1|COMPLETED|Overall Study||38
12166|NCT03123354|24861|P1|STARTED|Overall Study||44
12167|NCT03123263|24865|P1|NOT COMPLETED|Overall Study||0
12168|NCT03123263|24865|P1|COMPLETED|Overall Study||60
12169|NCT03123263|24865|P1|STARTED|Overall Study||60
12170|NCT03122548|24872|P1|NOT COMPLETED|Overall Study||5
12171|NCT03122548|24872|P1|COMPLETED|Overall Study||0
12172|NCT03122548|24872|P1|STARTED|Overall Study||5
12173|NCT03122184|24882|P2|NOT COMPLETED|Overall Study||6
12174|NCT03122184|24883|P1|NOT COMPLETED|Overall Study||8
12175|NCT03122184|24882|P2|COMPLETED|Overall Study||17
12176|NCT03122184|24883|P1|COMPLETED|Overall Study||16
12177|NCT03122184|24882|P2|STARTED|Overall Study||23
12178|NCT03122184|24883|P1|STARTED|Overall Study||24
12179|NCT03121950|24922|P2|NOT COMPLETED|Overall Study||2
12180|NCT03121950|24923|P1|NOT COMPLETED|Overall Study||10
12181|NCT03121950|24922|P2|COMPLETED|Overall Study||1
12182|NCT03121950|24923|P1|COMPLETED|Overall Study||7
12183|NCT03121950|24922|P2|STARTED|Overall Study||3
12184|NCT03121950|24923|P1|STARTED|Overall Study||17
12185|NCT03121820|24935|P2|NOT COMPLETED|Second Period (After Washout)||0
12186|NCT03121820|24936|P1|NOT COMPLETED|Second Period (After Washout)||0
12187|NCT03121820|24935|P2|COMPLETED|Second Period (After Washout)||9
12188|NCT03121820|24936|P1|COMPLETED|Second Period (After Washout)||9
12189|NCT03121820|24935|P2|STARTED|Second Period (After Washout)||9
12190|NCT03121820|24936|P1|STARTED|Second Period (After Washout)||9
12191|NCT03121820|24935|P2|NOT COMPLETED|First Period||0
12192|NCT03121820|24936|P1|NOT COMPLETED|First Period||0
12193|NCT03121820|24935|P2|COMPLETED|First Period||9
12194|NCT03121820|24936|P1|COMPLETED|First Period||9
12195|NCT03121820|24935|P2|STARTED|First Period||9
12196|NCT03121820|24936|P1|STARTED|First Period||9
12197|NCT03121612|24946|P2|NOT COMPLETED|Overall Study||0
12198|NCT03121612|24947|P1|NOT COMPLETED|Overall Study||0
12199|NCT03121612|24946|P2|COMPLETED|Overall Study||25
12200|NCT03121612|24947|P1|COMPLETED|Overall Study||26
12201|NCT03121612|24946|P2|STARTED|Overall Study||25
12202|NCT03121612|24947|P1|STARTED|Overall Study||26
12203|NCT03121365|24991|P2|NOT COMPLETED|12 Months||8
12204|NCT03121365|24992|P1|NOT COMPLETED|12 Months||11
12205|NCT03121365|24991|P2|COMPLETED|12 Months||37
12206|NCT03121365|24992|P1|COMPLETED|12 Months||43
12207|NCT03121365|24991|P2|STARTED|12 Months||45
12208|NCT03121365|24992|P1|STARTED|12 Months||54
12209|NCT03121365|24991|P2|NOT COMPLETED|9 Months||1
12210|NCT03121365|24992|P1|NOT COMPLETED|9 Months||3
12211|NCT03121365|24991|P2|COMPLETED|9 Months||44
12212|NCT03121365|24992|P1|COMPLETED|9 Months||52
12213|NCT03121365|24991|P2|STARTED|9 Months||45
12214|NCT03121365|24992|P1|STARTED|9 Months||55
12215|NCT03121365|24991|P2|NOT COMPLETED|6 Months||1
12216|NCT03121365|24992|P1|NOT COMPLETED|6 Months||2
12217|NCT03121365|24991|P2|COMPLETED|6 Months||45
12218|NCT03121365|24992|P1|COMPLETED|6 Months||53
12219|NCT03121365|24991|P2|STARTED|6 Months||46
12220|NCT03121365|24992|P1|STARTED|6 Months||55
12221|NCT03121365|24991|P2|NOT COMPLETED|Baseline||1
12222|NCT03121365|24992|P1|NOT COMPLETED|Baseline||0
12223|NCT03121365|24991|P2|COMPLETED|Baseline||48
12224|NCT03121365|24992|P1|COMPLETED|Baseline||55
12225|NCT03121365|24991|P2|STARTED|Baseline||49
12226|NCT03121365|24992|P1|STARTED|Baseline||55
12227|NCT03120676|25000|P1|NOT COMPLETED|Overall Study||1
12228|NCT03120676|25000|P1|COMPLETED|Overall Study||2
12229|NCT03120676|25000|P1|STARTED|Overall Study||3
12230|NCT03120520|25008|P4|NOT COMPLETED|Overall Study||3
12231|NCT03120520|25009|P3|NOT COMPLETED|Overall Study||4
12232|NCT03120520|25010|P2|NOT COMPLETED|Overall Study||4
12233|NCT03120520|25011|P1|NOT COMPLETED|Overall Study||4
12234|NCT03120520|25008|P4|COMPLETED|Overall Study||29
12235|NCT03120520|25009|P3|COMPLETED|Overall Study||26
12236|NCT03120520|25010|P2|COMPLETED|Overall Study||27
12237|NCT03120520|25011|P1|COMPLETED|Overall Study||27
12238|NCT03120520|25008|P4|STARTED|Overall Study||32
12239|NCT03120520|25009|P3|STARTED|Overall Study||30
12240|NCT03120520|25010|P2|STARTED|Overall Study||31
12241|NCT03120520|25011|P1|STARTED|Overall Study||31
12242|NCT03120013|25033|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
12243|NCT03120013|25034|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
12244|NCT03120013|25033|P2|COMPLETED|Second Intervention (2 Weeks)||10
12245|NCT03120013|25034|P1|COMPLETED|Second Intervention (2 Weeks)||10
12246|NCT03120013|25033|P2|STARTED|Second Intervention (2 Weeks)||10
12247|NCT03120013|25034|P1|STARTED|Second Intervention (2 Weeks)||10
12248|NCT03120013|25033|P2|NOT COMPLETED|Washout (6 Months)||0
12249|NCT03120013|25034|P1|NOT COMPLETED|Washout (6 Months)||0
12250|NCT03120013|25033|P2|COMPLETED|Washout (6 Months)||10
12251|NCT03120013|25034|P1|COMPLETED|Washout (6 Months)||10
12252|NCT03120013|25033|P2|STARTED|Washout (6 Months)||10
12253|NCT03120013|25034|P1|STARTED|Washout (6 Months)||10
12254|NCT03120013|25033|P2|NOT COMPLETED|First Intervention (2 Weeks)||1
12255|NCT03120013|25034|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
12256|NCT03120013|25033|P2|COMPLETED|First Intervention (2 Weeks)||10
12257|NCT03120013|25034|P1|COMPLETED|First Intervention (2 Weeks)||10
12258|NCT03120013|25033|P2|Received Intervention|First Intervention (2 Weeks)||11
12259|NCT03120013|25034|P1|Received Intervention|First Intervention (2 Weeks)||10
12260|NCT03120013|25033|P2|STARTED|First Intervention (2 Weeks)||11
12261|NCT03120013|25034|P1|STARTED|First Intervention (2 Weeks)||10
12262|NCT03119831|25057|P3|NOT COMPLETED|Overall Study||0
12263|NCT03119831|25058|P2|NOT COMPLETED|Overall Study||0
12264|NCT03119831|25059|P1|NOT COMPLETED|Overall Study||0
12265|NCT03119831|25057|P3|COMPLETED|Overall Study||14
12266|NCT03119831|25058|P2|COMPLETED|Overall Study||14
12267|NCT03119831|25059|P1|COMPLETED|Overall Study||14
12268|NCT03119831|25057|P3|STARTED|Overall Study||14
12269|NCT03119831|25058|P2|STARTED|Overall Study||14
12270|NCT03119831|25059|P1|STARTED|Overall Study||14
12271|NCT03119688|25076|P1|NOT COMPLETED|Overall Study||4
12272|NCT03119688|25076|P1|COMPLETED|Overall Study||44
12273|NCT03119688|25076|P1|STARTED|Overall Study||48
12274|NCT03119649|25112|P5|NOT COMPLETED|Overall Study||0
12275|NCT03119649|25113|P4|NOT COMPLETED|Overall Study||0
12276|NCT03119649|25114|P3|NOT COMPLETED|Overall Study||0
12277|NCT03119649|25115|P2|NOT COMPLETED|Overall Study||0
12278|NCT03119649|25116|P1|NOT COMPLETED|Overall Study||0
12279|NCT03119649|25112|P5|COMPLETED|Overall Study||14
12280|NCT03119649|25113|P4|COMPLETED|Overall Study||14
12281|NCT03119649|25114|P3|COMPLETED|Overall Study||10
12282|NCT03119649|25115|P2|COMPLETED|Overall Study||10
12283|NCT03119649|25116|P1|COMPLETED|Overall Study||11
12284|NCT03119649|25112|P5|STARTED|Overall Study||14
12285|NCT03119649|25113|P4|STARTED|Overall Study||14
12286|NCT03119649|25114|P3|STARTED|Overall Study||10
12287|NCT03119649|25115|P2|STARTED|Overall Study||10
12288|NCT03119649|25116|P1|STARTED|Overall Study||11
12289|NCT03119168|25161|P2|NOT COMPLETED|Overall Study||0
12290|NCT03119168|25162|P1|NOT COMPLETED|Overall Study||0
12291|NCT03119168|25161|P2|COMPLETED|Overall Study||139
12292|NCT03119168|25162|P1|COMPLETED|Overall Study||129
12293|NCT03119168|25161|P2|STARTED|Overall Study||139
12294|NCT03119168|25162|P1|STARTED|Overall Study||129
12295|NCT03119025|25174|P1|NOT COMPLETED|Overall Study||0
12296|NCT03119025|25174|P1|COMPLETED|Overall Study||10
12297|NCT03119025|25174|P1|STARTED|Overall Study||10
12298|NCT03118934|25184|P6|NOT COMPLETED|Overall Study||2
12299|NCT03118934|25185|P5|NOT COMPLETED|Overall Study||2
12300|NCT03118934|25186|P4|NOT COMPLETED|Overall Study||1
12301|NCT03118934|25187|P3|NOT COMPLETED|Overall Study||1
12302|NCT03118934|25188|P2|NOT COMPLETED|Overall Study||1
12303|NCT03118934|25189|P1|NOT COMPLETED|Overall Study||0
12304|NCT03118934|25184|P6|COMPLETED|Overall Study||23
12305|NCT03118934|25185|P5|COMPLETED|Overall Study||27
12306|NCT03118934|25186|P4|COMPLETED|Overall Study||28
12307|NCT03118934|25187|P3|COMPLETED|Overall Study||33
12308|NCT03118934|25188|P2|COMPLETED|Overall Study||30
12309|NCT03118934|25189|P1|COMPLETED|Overall Study||34
12310|NCT03118934|25184|P6|Safety Analysis Set|Overall Study||25
12311|NCT03118934|25185|P5|Safety Analysis Set|Overall Study||26
12312|NCT03118934|25186|P4|Safety Analysis Set|Overall Study||29
12313|NCT03118934|25187|P3|Safety Analysis Set|Overall Study||34
12314|NCT03118934|25188|P2|Safety Analysis Set|Overall Study||29
12315|NCT03118934|25189|P1|Safety Analysis Set|Overall Study||34
12316|NCT03118934|25184|P6|STARTED|Overall Study||25
12317|NCT03118934|25185|P5|STARTED|Overall Study||29
12318|NCT03118934|25186|P4|STARTED|Overall Study||29
12319|NCT03118934|25187|P3|STARTED|Overall Study||34
12320|NCT03118934|25188|P2|STARTED|Overall Study||31
12321|NCT03118934|25189|P1|STARTED|Overall Study||34
12322|NCT03118843|25199|P1|NOT COMPLETED|Overall Study||0
12323|NCT03118843|25199|P1|COMPLETED|Overall Study||31
12324|NCT03118843|25199|P1|STARTED|Overall Study||31
12325|NCT03118765|25213|P5|NOT COMPLETED|Overall Study||2
12326|NCT03118765|25214|P4|NOT COMPLETED|Overall Study||3
12327|NCT03118765|25215|P3|NOT COMPLETED|Overall Study||5
12328|NCT03118765|25216|P2|NOT COMPLETED|Overall Study||2
12329|NCT03118765|25217|P1|NOT COMPLETED|Overall Study||4
12330|NCT03118765|25213|P5|COMPLETED|Overall Study||28
12331|NCT03118765|25214|P4|COMPLETED|Overall Study||29
12332|NCT03118765|25215|P3|COMPLETED|Overall Study||26
12333|NCT03118765|25216|P2|COMPLETED|Overall Study||30
12334|NCT03118765|25217|P1|COMPLETED|Overall Study||26
12335|NCT03118765|25213|P5|STARTED|Overall Study||30
12336|NCT03118765|25214|P4|STARTED|Overall Study||32
12337|NCT03118765|25215|P3|STARTED|Overall Study||31
12338|NCT03118765|25216|P2|STARTED|Overall Study||32
12339|NCT03118765|25217|P1|STARTED|Overall Study||30
12340|NCT03118596|25313|P2|NOT COMPLETED|Overall Study||4
12341|NCT03118596|25314|P1|NOT COMPLETED|Overall Study||0
12342|NCT03118596|25313|P2|COMPLETED|Overall Study||86
12343|NCT03118596|25314|P1|COMPLETED|Overall Study||90
12344|NCT03118596|25313|P2|Failed|Overall Study||4
12345|NCT03118596|25314|P1|Failed|Overall Study||0
12346|NCT03118596|25313|P2|Treated|Overall Study||0
12347|NCT03118596|25314|P1|Treated|Overall Study||2
12348|NCT03118596|25313|P2|STARTED|Overall Study||90
12349|NCT03118596|25314|P1|STARTED|Overall Study||90
12350|NCT03118297|25334|P2|NOT COMPLETED|Overall Study||2
12351|NCT03118297|25335|P1|NOT COMPLETED|Overall Study||0
12352|NCT03118297|25334|P2|COMPLETED|Overall Study||31
12353|NCT03118297|25335|P1|COMPLETED|Overall Study||32
12354|NCT03118297|25334|P2|STARTED|Overall Study||33
12355|NCT03118297|25335|P1|STARTED|Overall Study||32
12356|NCT03117140|25353|P4|NOT COMPLETED|Overall Study||0
12357|NCT03117140|25354|P3|NOT COMPLETED|Overall Study||0
12358|NCT03117140|25355|P2|NOT COMPLETED|Overall Study||0
12359|NCT03117140|25356|P1|NOT COMPLETED|Overall Study||0
12360|NCT03117140|25353|P4|COMPLETED|Overall Study||40
12361|NCT03117140|25354|P3|COMPLETED|Overall Study||40
12362|NCT03117140|25355|P2|COMPLETED|Overall Study||40
12363|NCT03117140|25356|P1|COMPLETED|Overall Study||40
12364|NCT03117140|25353|P4|STARTED|Overall Study||40
12365|NCT03117140|25354|P3|STARTED|Overall Study||40
12366|NCT03117140|25355|P2|STARTED|Overall Study||40
12367|NCT03117140|25356|P1|STARTED|Overall Study||40
12368|NCT03116841|25422|P1|NOT COMPLETED|Overall Study||0
12369|NCT03116841|25422|P1|COMPLETED|Overall Study||3
12370|NCT03116841|25422|P1|STARTED|Overall Study||3
12371|NCT03116698|25443|P4|NOT COMPLETED|Overall Study||2
12372|NCT03116698|25444|P3|NOT COMPLETED|Overall Study||8
12373|NCT03116698|25445|P2|NOT COMPLETED|Overall Study||6
12374|NCT03116698|25446|P1|NOT COMPLETED|Overall Study||6
12375|NCT03116698|25443|P4|COMPLETED|Overall Study||55
12376|NCT03116698|25444|P3|COMPLETED|Overall Study||54
12377|NCT03116698|25445|P2|COMPLETED|Overall Study||51
12378|NCT03116698|25446|P1|COMPLETED|Overall Study||56
12379|NCT03116698|25443|P4|STARTED|Overall Study||57
12380|NCT03116698|25444|P3|STARTED|Overall Study||62
12381|NCT03116698|25445|P2|STARTED|Overall Study||57
12382|NCT03116698|25446|P1|STARTED|Overall Study||62
12383|NCT03115853|25460|P1|NOT COMPLETED|Overall Study||0
12384|NCT03115853|25460|P1|COMPLETED|Overall Study||31
12385|NCT03115853|25460|P1|STARTED|Overall Study||31
12386|NCT03115476|25481|P3|NOT COMPLETED|LP0084-1369||162
12387|NCT03115476|25482|P2|NOT COMPLETED|LP0084-1369||210
12388|NCT03115476|25483|P1|NOT COMPLETED|LP0084-1369||191
12389|NCT03115476|25481|P3|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
12390|NCT03115476|25482|P2|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
12391|NCT03115476|25483|P1|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
12392|NCT03115476|25481|P3|STARTED|LP0084-1369||162
12393|NCT03115476|25482|P2|STARTED|LP0084-1369||210
12394|NCT03115476|25483|P1|STARTED|LP0084-1369||191
12395|NCT03115476|25481|P3|NOT COMPLETED|Main Trials (LP0084-119x)||0
12396|NCT03115476|25482|P2|NOT COMPLETED|Main Trials (LP0084-119x)||0
12397|NCT03115476|25483|P1|NOT COMPLETED|Main Trials (LP0084-119x)||0
12398|NCT03115476|25481|P3|COMPLETED|Main Trials (LP0084-119x)||409
12399|NCT03115476|25482|P2|COMPLETED|Main Trials (LP0084-119x)||418
12400|NCT03115476|25483|P1|COMPLETED|Main Trials (LP0084-119x)||407
12401|NCT03115476|25481|P3|STARTED|Main Trials (LP0084-119x)||409
12402|NCT03115476|25482|P2|STARTED|Main Trials (LP0084-119x)||418
12403|NCT03115476|25483|P1|STARTED|Main Trials (LP0084-119x)||407
12404|NCT03115411|25494|P1|NOT COMPLETED|Overall Study||0
12405|NCT03115411|25494|P1|COMPLETED|Overall Study||23
12406|NCT03115411|25494|P1|STARTED|Overall Study||23
12407|NCT03115177|25500|P2|NOT COMPLETED|Overall Study||0
12408|NCT03115177|25501|P1|NOT COMPLETED|Overall Study||0
12409|NCT03115177|25500|P2|COMPLETED|Overall Study||29
12410|NCT03115177|25501|P1|COMPLETED|Overall Study||27
12411|NCT03115177|25500|P2|STARTED|Overall Study||29
12412|NCT03115177|25501|P1|STARTED|Overall Study||27
12413|NCT03114995|25510|P3|NOT COMPLETED|Overall Study||0
12414|NCT03114995|25511|P2|NOT COMPLETED|Overall Study||1
12415|NCT03114995|25512|P1|NOT COMPLETED|Overall Study||1
12416|NCT03114995|25510|P3|COMPLETED|Overall Study||78
12417|NCT03114995|25511|P2|COMPLETED|Overall Study||30
12418|NCT03114995|25512|P1|COMPLETED|Overall Study||30
12419|NCT03114995|25510|P3|STARTED|Overall Study||78
12420|NCT03114995|25511|P2|STARTED|Overall Study||31
12421|NCT03114995|25512|P1|STARTED|Overall Study||31
12422|NCT03114969|25532|P9|NOT COMPLETED|Overall Study||2
12423|NCT03114969|25533|P8|NOT COMPLETED|Overall Study||0
12424|NCT03114969|25534|P7|NOT COMPLETED|Overall Study||1
12425|NCT03114969|25535|P6|NOT COMPLETED|Overall Study||1
12426|NCT03114969|25536|P5|NOT COMPLETED|Overall Study||0
12427|NCT03114969|25537|P4|NOT COMPLETED|Overall Study||2
12428|NCT03114969|25538|P3|NOT COMPLETED|Overall Study||4
12429|NCT03114969|25539|P2|NOT COMPLETED|Overall Study||0
12430|NCT03114969|25540|P1|NOT COMPLETED|Overall Study||0
12431|NCT03114969|25532|P9|COMPLETED|Overall Study||48
12432|NCT03114969|25533|P8|COMPLETED|Overall Study||50
12433|NCT03114969|25534|P7|COMPLETED|Overall Study||49
12434|NCT03114969|25535|P6|COMPLETED|Overall Study||48
12435|NCT03114969|25536|P5|COMPLETED|Overall Study||51
12436|NCT03114969|25537|P4|COMPLETED|Overall Study||48
12437|NCT03114969|25538|P3|COMPLETED|Overall Study||46
12438|NCT03114969|25539|P2|COMPLETED|Overall Study||50
12439|NCT03114969|25540|P1|COMPLETED|Overall Study||50
12440|NCT03114969|25532|P9|STARTED|Overall Study||50
12441|NCT03114969|25533|P8|STARTED|Overall Study||50
12442|NCT03114969|25534|P7|STARTED|Overall Study||50
12443|NCT03114969|25535|P6|STARTED|Overall Study||49
12444|NCT03114969|25536|P5|STARTED|Overall Study||51
12445|NCT03114969|25537|P4|STARTED|Overall Study||50
12446|NCT03114969|25538|P3|STARTED|Overall Study||50
12447|NCT03114969|25539|P2|STARTED|Overall Study||50
12448|NCT03114969|25540|P1|STARTED|Overall Study||50
12449|NCT03113656|25637|P2|NOT COMPLETED|Overall Study||0
12450|NCT03113656|25638|P1|NOT COMPLETED|Overall Study||0
12451|NCT03113656|25637|P2|COMPLETED|Overall Study||7
12452|NCT03113656|25638|P1|COMPLETED|Overall Study||9
12453|NCT03113656|25637|P2|STARTED|Overall Study||7
12454|NCT03113656|25638|P1|STARTED|Overall Study||9
12455|NCT03111316|25648|P4|NOT COMPLETED|Overall Study||0
12456|NCT03111316|25649|P3|NOT COMPLETED|Overall Study||0
12457|NCT03111316|25650|P2|NOT COMPLETED|Overall Study||0
12458|NCT03111316|25651|P1|NOT COMPLETED|Overall Study||0
12459|NCT03111316|25648|P4|COMPLETED|Overall Study||25
12460|NCT03111316|25649|P3|COMPLETED|Overall Study||25
12461|NCT03111316|25650|P2|COMPLETED|Overall Study||24
12462|NCT03111316|25651|P1|COMPLETED|Overall Study||26
12463|NCT03111316|25648|P4|STARTED|Overall Study||25
12464|NCT03111316|25649|P3|STARTED|Overall Study||25
12465|NCT03111316|25650|P2|STARTED|Overall Study||24
12466|NCT03111316|25651|P1|STARTED|Overall Study||26
12467|NCT03111108|25667|P2|NOT COMPLETED|Overall Study||1
12468|NCT03111108|25668|P1|NOT COMPLETED|Overall Study||1
12469|NCT03111108|25667|P2|COMPLETED|Overall Study||63
12470|NCT03111108|25668|P1|COMPLETED|Overall Study||52
12471|NCT03111108|25667|P2|STARTED|Overall Study||64
12472|NCT03111108|25668|P1|STARTED|Overall Study||53
12473|NCT03110900|25686|P2|NOT COMPLETED|Overall Study||1
12474|NCT03110900|25687|P1|NOT COMPLETED|Overall Study||1
12475|NCT03110900|25686|P2|COMPLETED|Overall Study||0
12476|NCT03110900|25687|P1|COMPLETED|Overall Study||0
12477|NCT03110900|25686|P2|STARTED|Overall Study||1
12478|NCT03110900|25687|P1|STARTED|Overall Study||1
12479|NCT03110601|25693|P1|NOT COMPLETED|Stimgenics SCS Parameters||3
12480|NCT03110601|25693|P1|COMPLETED|Stimgenics SCS Parameters||20
12481|NCT03110601|25693|P1|STARTED|Stimgenics SCS Parameters||23
12482|NCT03110601|25693|P1|NOT COMPLETED|Washout Period||1
12483|NCT03110601|25693|P1|COMPLETED|Washout Period||23
12484|NCT03110601|25693|P1|STARTED|Washout Period||24
12485|NCT03110601|25693|P1|NOT COMPLETED|Conventional SCS Parameters||1
12486|NCT03110601|25693|P1|COMPLETED|Conventional SCS Parameters||24
12487|NCT03110601|25693|P1|STARTED|Conventional SCS Parameters||25
12488|NCT03110380|25702|P2|NOT COMPLETED|Overall Study||283
12489|NCT03110380|25703|P1|NOT COMPLETED|Overall Study||284
12490|NCT03110380|25702|P2|COMPLETED|Overall Study||0
12491|NCT03110380|25703|P1|COMPLETED|Overall Study||0
12492|NCT03110380|25702|P2|STARTED|Overall Study||283
12493|NCT03110380|25703|P1|STARTED|Overall Study||284
12494|NCT03110159|25713|P1|NOT COMPLETED|Overall Study||1
12495|NCT03110159|25713|P1|COMPLETED|Overall Study||0
12496|NCT03110159|25713|P1|STARTED|Overall Study||1
12497|NCT03110029|25724|P2|NOT COMPLETED|Overall Study||1
12498|NCT03110029|25725|P1|NOT COMPLETED|Overall Study||1
12499|NCT03110029|25724|P2|COMPLETED|Overall Study||5
12500|NCT03110029|25725|P1|COMPLETED|Overall Study||6
12501|NCT03110029|25724|P2|STARTED|Overall Study||6
12502|NCT03110029|25725|P1|STARTED|Overall Study||7
12503|NCT03110003|25735|P2|NOT COMPLETED|Overall Study||0
12504|NCT03110003|25736|P1|NOT COMPLETED|Overall Study||0
12505|NCT03110003|25735|P2|COMPLETED|Overall Study||24
12506|NCT03110003|25736|P1|COMPLETED|Overall Study||21
12507|NCT03110003|25735|P2|STARTED|Overall Study||24
12508|NCT03110003|25736|P1|STARTED|Overall Study||21
12509|NCT03109873|25754|P2|NOT COMPLETED|Overall Study||0
12510|NCT03109873|25755|P1|NOT COMPLETED|Overall Study||0
12511|NCT03109873|25754|P2|COMPLETED|Overall Study||3
12512|NCT03109873|25755|P1|COMPLETED|Overall Study||4
12513|NCT03109873|25754|P2|STARTED|Overall Study||3
12514|NCT03109873|25755|P1|STARTED|Overall Study||4
12515|NCT03109769|25771|P2|NOT COMPLETED|Overall Study||0
12516|NCT03109769|25772|P1|NOT COMPLETED|Overall Study||0
12517|NCT03109769|25771|P2|COMPLETED|Overall Study||22
12518|NCT03109769|25772|P1|COMPLETED|Overall Study||22
12519|NCT03109769|25771|P2|STARTED|Overall Study||22
12520|NCT03109769|25772|P1|STARTED|Overall Study||22
12521|NCT03109184|25782|P2|NOT COMPLETED|Overall Study||7
12522|NCT03109184|25783|P1|NOT COMPLETED|Overall Study||7
12523|NCT03109184|25782|P2|COMPLETED|Overall Study||52
12524|NCT03109184|25783|P1|COMPLETED|Overall Study||53
12525|NCT03109184|25782|P2|STARTED|Overall Study||59
12526|NCT03109184|25783|P1|STARTED|Overall Study||60
12527|NCT03108924|25805|P4|NOT COMPLETED|Overall Study||0
12528|NCT03108924|25806|P3|NOT COMPLETED|Overall Study||0
12529|NCT03108924|25807|P2|NOT COMPLETED|Overall Study||0
12530|NCT03108924|25808|P1|NOT COMPLETED|Overall Study||0
12531|NCT03108924|25805|P4|COMPLETED|Overall Study||6
12532|NCT03108924|25806|P3|COMPLETED|Overall Study||6
12533|NCT03108924|25807|P2|COMPLETED|Overall Study||6
12534|NCT03108924|25808|P1|COMPLETED|Overall Study||6
12535|NCT03108924|25805|P4|STARTED|Overall Study||6
12536|NCT03108924|25806|P3|STARTED|Overall Study||6
12537|NCT03108924|25807|P2|STARTED|Overall Study||6
12538|NCT03108924|25808|P1|STARTED|Overall Study||6
12539|NCT03108482|25906|P4|NOT COMPLETED|Overall Study||3
12540|NCT03108482|25907|P3|NOT COMPLETED|Overall Study||2
12541|NCT03108482|25908|P2|NOT COMPLETED|Overall Study||4
12542|NCT03108482|25909|P1|NOT COMPLETED|Overall Study||0
12543|NCT03108482|25906|P4|COMPLETED|Overall Study||86
12544|NCT03108482|25907|P3|COMPLETED|Overall Study||180
12545|NCT03108482|25908|P2|COMPLETED|Overall Study||179
12546|NCT03108482|25909|P1|COMPLETED|Overall Study||183
12547|NCT03108482|25906|P4|STARTED|Overall Study||89
12548|NCT03108482|25907|P3|STARTED|Overall Study||182
12549|NCT03108482|25908|P2|STARTED|Overall Study||183
12550|NCT03108482|25909|P1|STARTED|Overall Study||183
12551|NCT03108027|25919|P6|NOT COMPLETED|Period 3||0
12552|NCT03108027|25920|P5|NOT COMPLETED|Period 3||0
12553|NCT03108027|25921|P4|NOT COMPLETED|Period 3||0
12554|NCT03108027|25922|P3|NOT COMPLETED|Period 3||0
12555|NCT03108027|25923|P2|NOT COMPLETED|Period 3||1
12556|NCT03108027|25924|P1|NOT COMPLETED|Period 3||0
12557|NCT03108027|25919|P6|COMPLETED|Period 3||6
12558|NCT03108027|25920|P5|COMPLETED|Period 3||6
12559|NCT03108027|25921|P4|COMPLETED|Period 3||4
12560|NCT03108027|25922|P3|COMPLETED|Period 3||6
12561|NCT03108027|25923|P2|COMPLETED|Period 3||5
12562|NCT03108027|25924|P1|COMPLETED|Period 3||7
12563|NCT03108027|25919|P6|STARTED|Period 3||6
12564|NCT03108027|25920|P5|STARTED|Period 3||6
12565|NCT03108027|25921|P4|STARTED|Period 3||4
12566|NCT03108027|25922|P3|STARTED|Period 3||6
12567|NCT03108027|25923|P2|STARTED|Period 3||6
12568|NCT03108027|25924|P1|STARTED|Period 3||7
12569|NCT03108027|25919|P6|NOT COMPLETED|Period 2||0
12570|NCT03108027|25920|P5|NOT COMPLETED|Period 2||0
12571|NCT03108027|25921|P4|NOT COMPLETED|Period 2||0
12572|NCT03108027|25922|P3|NOT COMPLETED|Period 2||0
12573|NCT03108027|25923|P2|NOT COMPLETED|Period 2||0
12574|NCT03108027|25924|P1|NOT COMPLETED|Period 2||0
12575|NCT03108027|25919|P6|COMPLETED|Period 2||6
12576|NCT03108027|25920|P5|COMPLETED|Period 2||6
12577|NCT03108027|25921|P4|COMPLETED|Period 2||4
12578|NCT03108027|25922|P3|COMPLETED|Period 2||6
12579|NCT03108027|25923|P2|COMPLETED|Period 2||6
12580|NCT03108027|25924|P1|COMPLETED|Period 2||7
12581|NCT03108027|25919|P6|STARTED|Period 2||6
12582|NCT03108027|25920|P5|STARTED|Period 2||6
12583|NCT03108027|25921|P4|STARTED|Period 2||4
12584|NCT03108027|25922|P3|STARTED|Period 2||6
12585|NCT03108027|25923|P2|STARTED|Period 2||6
12586|NCT03108027|25924|P1|STARTED|Period 2||7
12587|NCT03108027|25919|P6|NOT COMPLETED|Period 1||0
12588|NCT03108027|25920|P5|NOT COMPLETED|Period 1||0
12589|NCT03108027|25921|P4|NOT COMPLETED|Period 1||2
12590|NCT03108027|25922|P3|NOT COMPLETED|Period 1||0
12591|NCT03108027|25923|P2|NOT COMPLETED|Period 1||0
12592|NCT03108027|25924|P1|NOT COMPLETED|Period 1||0
12593|NCT03108027|25919|P6|COMPLETED|Period 1||6
12594|NCT03108027|25920|P5|COMPLETED|Period 1||6
12595|NCT03108027|25921|P4|COMPLETED|Period 1||4
12596|NCT03108027|25922|P3|COMPLETED|Period 1||6
12597|NCT03108027|25923|P2|COMPLETED|Period 1||6
12598|NCT03108027|25924|P1|COMPLETED|Period 1||7
12599|NCT03108027|25919|P6|STARTED|Period 1||6
12600|NCT03108027|25920|P5|STARTED|Period 1||6
12601|NCT03108027|25921|P4|STARTED|Period 1||6
12602|NCT03108027|25922|P3|STARTED|Period 1||6
12603|NCT03108027|25923|P2|STARTED|Period 1||6
12604|NCT03108027|25924|P1|STARTED|Period 1||7
12605|NCT03106870|25940|P2|NOT COMPLETED|Overall Study||0
12606|NCT03106870|25941|P1|NOT COMPLETED|Overall Study||0
12607|NCT03106870|25940|P2|COMPLETED|Overall Study||31
12608|NCT03106870|25941|P1|COMPLETED|Overall Study||31
12609|NCT03106870|25940|P2|STARTED|Overall Study||31
12610|NCT03106870|25941|P1|STARTED|Overall Study||31
12611|NCT03106337|25951|P1|NOT COMPLETED|Overall Study||0
12612|NCT03106337|25951|P1|COMPLETED|Overall Study||35
12613|NCT03106337|25951|P1|STARTED|Overall Study||35
12614|NCT03105518|25956|P1|NOT COMPLETED|Overall Study||0
12615|NCT03105518|25956|P1|COMPLETED|Overall Study||100
12616|NCT03105518|25956|P1|STARTED|Overall Study||100
12617|NCT03105479|25961|P7|NOT COMPLETED|Overall Study||0
12618|NCT03105479|25962|P6|NOT COMPLETED|Overall Study||0
12619|NCT03105479|25963|P5|NOT COMPLETED|Overall Study||0
12620|NCT03105479|25964|P4|NOT COMPLETED|Overall Study||0
12621|NCT03105479|25965|P3|NOT COMPLETED|Overall Study||0
12622|NCT03105479|25966|P2|NOT COMPLETED|Overall Study||0
12623|NCT03105479|25967|P1|NOT COMPLETED|Overall Study||0
12624|NCT03105479|25961|P7|COMPLETED|Overall Study||0
12625|NCT03105479|25962|P6|COMPLETED|Overall Study||0
12626|NCT03105479|25963|P5|COMPLETED|Overall Study||0
12627|NCT03105479|25964|P4|COMPLETED|Overall Study||0
12628|NCT03105479|25965|P3|COMPLETED|Overall Study||0
12629|NCT03105479|25966|P2|COMPLETED|Overall Study||0
12630|NCT03105479|25967|P1|COMPLETED|Overall Study||1
12631|NCT03105479|25961|P7|STARTED|Overall Study||0
12632|NCT03105479|25962|P6|STARTED|Overall Study||0
12633|NCT03105479|25963|P5|STARTED|Overall Study||0
12634|NCT03105479|25964|P4|STARTED|Overall Study||0
12635|NCT03105479|25965|P3|STARTED|Overall Study||0
12636|NCT03105479|25966|P2|STARTED|Overall Study||0
12637|NCT03105479|25967|P1|STARTED|Overall Study||1
12638|NCT03105297|25990|P1|NOT COMPLETED|Nasal Resistance Phase (Day 30, 31)||8
12639|NCT03105297|25990|P1|COMPLETED|Nasal Resistance Phase (Day 30, 31)||48
12640|NCT03105297|25990|P1|Treated|Nasal Resistance Phase (Day 30, 31)||55
12641|NCT03105297|25990|P1|STARTED|Nasal Resistance Phase (Day 30, 31)|14 participants withdrew from the study after the completion of active phase|56
12642|NCT03105297|25990|P1|NOT COMPLETED|Active Phase (Day 2-29)||0
12643|NCT03105297|25990|P1|COMPLETED|Active Phase (Day 2-29)||70
12644|NCT03105297|25990|P1|STARTED|Active Phase (Day 2-29)||70
12645|NCT03105297|25990|P1|NOT COMPLETED|Baseline Phase (Day 1)||21
12646|NCT03105297|25990|P1|COMPLETED|Baseline Phase (Day 1)||70
12647|NCT03105297|25990|P1|STARTED|Baseline Phase (Day 1)||91
12648|NCT03104985|26024|P2|NOT COMPLETED|Overall Study||0
12649|NCT03104985|26025|P1|NOT COMPLETED|Overall Study||0
12650|NCT03104985|26024|P2|COMPLETED|Overall Study||34
12651|NCT03104985|26025|P1|COMPLETED|Overall Study||34
12652|NCT03104985|26024|P2|STARTED|Overall Study||34
12653|NCT03104985|26025|P1|STARTED|Overall Study||34
12654|NCT03104816|26034|P3|NOT COMPLETED|Overall Study||2
12655|NCT03104816|26035|P2|NOT COMPLETED|Overall Study||2
12656|NCT03104816|26036|P1|NOT COMPLETED|Overall Study||2
12657|NCT03104816|26034|P3|COMPLETED|Overall Study||4
12658|NCT03104816|26035|P2|COMPLETED|Overall Study||9
12659|NCT03104816|26036|P1|COMPLETED|Overall Study||9
12660|NCT03104816|26034|P3|STARTED|Overall Study||6
12661|NCT03104816|26035|P2|STARTED|Overall Study||11
12662|NCT03104816|26036|P1|STARTED|Overall Study||11
12663|NCT03104738|26046|P2|NOT COMPLETED|Overall Study||0
12664|NCT03104738|26047|P1|NOT COMPLETED|Overall Study||0
12665|NCT03104738|26046|P2|COMPLETED|Overall Study||20
12666|NCT03104738|26047|P1|COMPLETED|Overall Study||20
12667|NCT03104738|26046|P2|STARTED|Overall Study||20
12668|NCT03104738|26047|P1|STARTED|Overall Study||20
12669|NCT03104647|26073|P1|NOT COMPLETED|Overall Study||0
12670|NCT03104647|26073|P1|COMPLETED|Overall Study||20
12671|NCT03104647|26073|P1|STARTED|Overall Study||20
12672|NCT03104322|26078|P1|NOT COMPLETED|Overall Study||1
12673|NCT03104322|26078|P1|COMPLETED|Overall Study||6
12674|NCT03104322|26078|P1|STARTED|Overall Study||7
12675|NCT03103919|26088|P2|NOT COMPLETED|Overall Study||2
12676|NCT03103919|26089|P1|NOT COMPLETED|Overall Study||2
12677|NCT03103919|26088|P2|COMPLETED|Overall Study||17
12678|NCT03103919|26089|P1|COMPLETED|Overall Study||18
12679|NCT03103919|26088|P2|STARTED|Overall Study||19
12680|NCT03103919|26089|P1|STARTED|Overall Study||20
12681|NCT03103906|26125|P2|NOT COMPLETED|Overall Study||3
12682|NCT03103906|26126|P1|NOT COMPLETED|Overall Study||4
12683|NCT03103906|26125|P2|COMPLETED|Overall Study||39
12684|NCT03103906|26126|P1|COMPLETED|Overall Study||36
12685|NCT03103906|26125|P2|STARTED|Overall Study||42
12686|NCT03103906|26126|P1|STARTED|Overall Study||40
12687|NCT03103061|26146|P1|NOT COMPLETED|Overall Study||0
12688|NCT03103061|26146|P1|COMPLETED|Overall Study||24
12689|NCT03103061|26146|P1|STARTED|Overall Study||24
12690|NCT03102918|26153|P2|NOT COMPLETED|Overall Study||0
12691|NCT03102918|26154|P1|NOT COMPLETED|Overall Study||1
12692|NCT03102918|26153|P2|COMPLETED|Overall Study||5
12693|NCT03102918|26154|P1|COMPLETED|Overall Study||4
12694|NCT03102918|26153|P2|STARTED|Overall Study||5
12695|NCT03102918|26154|P1|STARTED|Overall Study||5
12696|NCT03102411|26160|P1|NOT COMPLETED|Overall Study||163
12697|NCT03102411|26160|P1|COMPLETED|Overall Study||1718
12698|NCT03102411|26160|P1|STARTED|Overall Study||1881
12699|NCT03102190|26165|P1|NOT COMPLETED|Overall Study||0
12700|NCT03102190|26165|P1|COMPLETED|Overall Study||6
12701|NCT03102190|26165|P1|STARTED|Overall Study||6
12702|NCT03102034|26171|P2|NOT COMPLETED|Overall Study||0
12703|NCT03102034|26172|P1|NOT COMPLETED|Overall Study||1
12704|NCT03102034|26171|P2|COMPLETED|Overall Study||11
12705|NCT03102034|26172|P1|COMPLETED|Overall Study||20
12706|NCT03102034|26171|P2|STARTED|Overall Study||11
12707|NCT03102034|26172|P1|STARTED|Overall Study||21
12708|NCT03101462|26200|P2|NOT COMPLETED|Overall Study||1
12709|NCT03101462|26201|P1|NOT COMPLETED|Overall Study||1
12710|NCT03101462|26200|P2|COMPLETED|Overall Study||18
12711|NCT03101462|26201|P1|COMPLETED|Overall Study||18
12712|NCT03101462|26200|P2|STARTED|Overall Study||19
12713|NCT03101462|26201|P1|STARTED|Overall Study||19
12714|NCT03101293|26217|P2|NOT COMPLETED|Intervention Period 2||0
12715|NCT03101293|26218|P1|NOT COMPLETED|Intervention Period 2||0
12716|NCT03101293|26217|P2|COMPLETED|Intervention Period 2||8
12717|NCT03101293|26218|P1|COMPLETED|Intervention Period 2||6
12718|NCT03101293|26217|P2|STARTED|Intervention Period 2||8
12719|NCT03101293|26218|P1|STARTED|Intervention Period 2||6
12720|NCT03101293|26217|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
12721|NCT03101293|26218|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||1
12722|NCT03101293|26217|P2|COMPLETED|Washout Period (at Least 7 Days)||8
12723|NCT03101293|26218|P1|COMPLETED|Washout Period (at Least 7 Days)||6
12724|NCT03101293|26217|P2|STARTED|Washout Period (at Least 7 Days)||8
12725|NCT03101293|26218|P1|STARTED|Washout Period (at Least 7 Days)||7
12726|NCT03101293|26217|P2|NOT COMPLETED|Intervention Period 1||0
12727|NCT03101293|26218|P1|NOT COMPLETED|Intervention Period 1||0
12728|NCT03101293|26217|P2|COMPLETED|Intervention Period 1||8
12729|NCT03101293|26218|P1|COMPLETED|Intervention Period 1||7
12730|NCT03101293|26217|P2|STARTED|Intervention Period 1||8
12731|NCT03101293|26218|P1|STARTED|Intervention Period 1||7
12732|NCT03101150|26232|P2|NOT COMPLETED|Overall Study||10
12733|NCT03101150|26233|P1|NOT COMPLETED|Overall Study||5
12734|NCT03101150|26232|P2|COMPLETED|Overall Study||83
12735|NCT03101150|26233|P1|COMPLETED|Overall Study||81
12736|NCT03101150|26232|P2|STARTED|Overall Study||93
12737|NCT03101150|26233|P1|STARTED|Overall Study||86
12738|NCT03101033|26245|P2|NOT COMPLETED|Overall Study||9
12739|NCT03101033|26246|P1|NOT COMPLETED|Overall Study||5
12740|NCT03101033|26245|P2|COMPLETED|Overall Study||51
12741|NCT03101033|26246|P1|COMPLETED|Overall Study||27
12742|NCT03101033|26245|P2|STARTED|Overall Study||60
12743|NCT03101033|26246|P1|STARTED|Overall Study||32
12744|NCT03101020|26268|P2|NOT COMPLETED|Overall Study||3
12745|NCT03101020|26269|P1|NOT COMPLETED|Overall Study||1
12746|NCT03101020|26268|P2|COMPLETED|Overall Study||7
12747|NCT03101020|26269|P1|COMPLETED|Overall Study||9
12748|NCT03101020|26268|P2|STARTED|Overall Study||10
12749|NCT03101020|26269|P1|STARTED|Overall Study||10
12750|NCT03100968|26283|P2|NOT COMPLETED|Overall Study||0
12751|NCT03100968|26284|P1|NOT COMPLETED|Overall Study||0
12752|NCT03100968|26283|P2|COMPLETED|Overall Study||75
12753|NCT03100968|26284|P1|COMPLETED|Overall Study||75
12754|NCT03100968|26283|P2|STARTED|Overall Study||75
12755|NCT03100968|26284|P1|STARTED|Overall Study||75
12756|NCT03100838|26300|P4|NOT COMPLETED|Overall Study||1
12757|NCT03100838|26301|P3|NOT COMPLETED|Overall Study||2
12758|NCT03100838|26302|P2|NOT COMPLETED|Overall Study||2
12759|NCT03100838|26303|P1|NOT COMPLETED|Overall Study||2
12760|NCT03100838|26300|P4|COMPLETED|Overall Study||15
12761|NCT03100838|26301|P3|COMPLETED|Overall Study||14
12762|NCT03100838|26302|P2|COMPLETED|Overall Study||14
12763|NCT03100838|26303|P1|COMPLETED|Overall Study||14
12764|NCT03100838|26300|P4|STARTED|Overall Study||16
12765|NCT03100838|26301|P3|STARTED|Overall Study||16
12766|NCT03100838|26302|P2|STARTED|Overall Study||16
12767|NCT03100838|26303|P1|STARTED|Overall Study||16
12768|NCT03100344|26333|P4|NOT COMPLETED|Overall Study||12
12769|NCT03100344|26334|P3|NOT COMPLETED|Overall Study||7
12770|NCT03100344|26335|P2|NOT COMPLETED|Overall Study||11
12771|NCT03100344|26336|P1|NOT COMPLETED|Overall Study||14
12772|NCT03100344|26333|P4|COMPLETED|Overall Study||45
12773|NCT03100344|26334|P3|COMPLETED|Overall Study||50
12774|NCT03100344|26335|P2|COMPLETED|Overall Study||44
12775|NCT03100344|26336|P1|COMPLETED|Overall Study||43
12776|NCT03100344|26333|P4|STARTED|Overall Study||57
12777|NCT03100344|26334|P3|STARTED|Overall Study||57
12778|NCT03100344|26335|P2|STARTED|Overall Study||55
12779|NCT03100344|26336|P1|STARTED|Overall Study||57
12780|NCT03099694|26416|P2|NOT COMPLETED|Overall Study||18
12781|NCT03099694|26417|P1|NOT COMPLETED|Overall Study||20
12782|NCT03099694|26416|P2|COMPLETED|Overall Study||152
12783|NCT03099694|26417|P1|COMPLETED|Overall Study||150
12784|NCT03099694|26416|P2|STARTED|Overall Study||170
12785|NCT03099694|26417|P1|STARTED|Overall Study||170
12786|NCT03099369|26447|P2|NOT COMPLETED|Overall Study||4
12787|NCT03099369|26448|P1|NOT COMPLETED|Overall Study||6
12788|NCT03099369|26447|P2|COMPLETED|Overall Study||5
12789|NCT03099369|26448|P1|COMPLETED|Overall Study||5
12790|NCT03099369|26447|P2|STARTED|Overall Study||9
12791|NCT03099369|26448|P1|STARTED|Overall Study||11
12792|NCT03099161|26461|P3|NOT COMPLETED|Overall Study||3
12793|NCT03099161|26462|P2|NOT COMPLETED|Overall Study||4
12794|NCT03099161|26463|P1|NOT COMPLETED|Overall Study||3
12795|NCT03099161|26461|P3|COMPLETED|Overall Study||0
12796|NCT03099161|26462|P2|COMPLETED|Overall Study||0
12797|NCT03099161|26463|P1|COMPLETED|Overall Study||0
12798|NCT03099161|26461|P3|STARTED|Overall Study||3
12799|NCT03099161|26462|P2|STARTED|Overall Study||4
12800|NCT03099161|26463|P1|STARTED|Overall Study||3
12801|NCT03099096|26480|P1|NOT COMPLETED|Overall Study||2
12802|NCT03099096|26480|P1|COMPLETED|Overall Study||157
12803|NCT03099096|26480|P1|STARTED|Overall Study||159
12804|NCT03098979|26493|P6|NOT COMPLETED|Overall Study||4
12805|NCT03098979|26494|P5|NOT COMPLETED|Overall Study||9
12806|NCT03098979|26495|P4|NOT COMPLETED|Overall Study||5
12807|NCT03098979|26496|P3|NOT COMPLETED|Overall Study||4
12808|NCT03098979|26497|P2|NOT COMPLETED|Overall Study||2
12809|NCT03098979|26498|P1|NOT COMPLETED|Overall Study||6
12810|NCT03098979|26493|P6|COMPLETED|Overall Study||47
12811|NCT03098979|26494|P5|COMPLETED|Overall Study||41
12812|NCT03098979|26495|P4|COMPLETED|Overall Study||46
12813|NCT03098979|26496|P3|COMPLETED|Overall Study||46
12814|NCT03098979|26497|P2|COMPLETED|Overall Study||25
12815|NCT03098979|26498|P1|COMPLETED|Overall Study||70
12816|NCT03098979|26493|P6|STARTED|Overall Study||51
12817|NCT03098979|26494|P5|STARTED|Overall Study||50
12818|NCT03098979|26495|P4|STARTED|Overall Study||51
12819|NCT03098979|26496|P3|STARTED|Overall Study||50
12820|NCT03098979|26497|P2|STARTED|Overall Study||27
12821|NCT03098979|26498|P1|STARTED|Overall Study||76
12822|NCT03098966|26536|P1|NOT COMPLETED|Overall Study||0
12823|NCT03098966|26536|P1|COMPLETED|Overall Study||368
12824|NCT03098966|26536|P1|STARTED|Overall Study||368
12825|NCT03098745|26542|P6|NOT COMPLETED|Day 3||0
12826|NCT03098745|26543|P5|NOT COMPLETED|Day 3||0
12827|NCT03098745|26544|P4|NOT COMPLETED|Day 3||0
12828|NCT03098745|26545|P3|NOT COMPLETED|Day 3||0
12829|NCT03098745|26546|P2|NOT COMPLETED|Day 3||0
12830|NCT03098745|26547|P1|NOT COMPLETED|Day 3||0
12831|NCT03098745|26542|P6|COMPLETED|Day 3||4
12832|NCT03098745|26543|P5|COMPLETED|Day 3||10
12833|NCT03098745|26544|P4|COMPLETED|Day 3||8
12834|NCT03098745|26545|P3|COMPLETED|Day 3||8
12835|NCT03098745|26546|P2|COMPLETED|Day 3||3
12836|NCT03098745|26547|P1|COMPLETED|Day 3||7
12837|NCT03098745|26542|P6|STARTED|Day 3||4
12838|NCT03098745|26543|P5|STARTED|Day 3||10
12839|NCT03098745|26544|P4|STARTED|Day 3||8
12840|NCT03098745|26545|P3|STARTED|Day 3||8
12841|NCT03098745|26546|P2|STARTED|Day 3||3
12842|NCT03098745|26547|P1|STARTED|Day 3||7
12843|NCT03098745|26542|P6|NOT COMPLETED|Day 2||0
12844|NCT03098745|26543|P5|NOT COMPLETED|Day 2||0
12845|NCT03098745|26544|P4|NOT COMPLETED|Day 2||0
12846|NCT03098745|26545|P3|NOT COMPLETED|Day 2||0
12847|NCT03098745|26546|P2|NOT COMPLETED|Day 2||0
12848|NCT03098745|26547|P1|NOT COMPLETED|Day 2||0
12849|NCT03098745|26542|P6|COMPLETED|Day 2||4
12850|NCT03098745|26543|P5|COMPLETED|Day 2||10
12851|NCT03098745|26544|P4|COMPLETED|Day 2||8
12852|NCT03098745|26545|P3|COMPLETED|Day 2||8
12853|NCT03098745|26546|P2|COMPLETED|Day 2||3
12854|NCT03098745|26547|P1|COMPLETED|Day 2||7
12855|NCT03098745|26542|P6|STARTED|Day 2||4
12856|NCT03098745|26543|P5|STARTED|Day 2||10
12857|NCT03098745|26544|P4|STARTED|Day 2||8
12858|NCT03098745|26545|P3|STARTED|Day 2||8
12859|NCT03098745|26546|P2|STARTED|Day 2||3
12860|NCT03098745|26547|P1|STARTED|Day 2||7
12861|NCT03098745|26542|P6|NOT COMPLETED|Day 1||0
12862|NCT03098745|26543|P5|NOT COMPLETED|Day 1||0
12863|NCT03098745|26544|P4|NOT COMPLETED|Day 1||0
12864|NCT03098745|26545|P3|NOT COMPLETED|Day 1||0
12865|NCT03098745|26546|P2|NOT COMPLETED|Day 1||0
12866|NCT03098745|26547|P1|NOT COMPLETED|Day 1||0
12867|NCT03098745|26542|P6|COMPLETED|Day 1||4
12868|NCT03098745|26543|P5|COMPLETED|Day 1||10
12869|NCT03098745|26544|P4|COMPLETED|Day 1||8
12870|NCT03098745|26545|P3|COMPLETED|Day 1||8
12871|NCT03098745|26546|P2|COMPLETED|Day 1||3
12872|NCT03098745|26547|P1|COMPLETED|Day 1||7
12873|NCT03098745|26542|P6|STARTED|Day 1||4
12874|NCT03098745|26543|P5|STARTED|Day 1||10
12875|NCT03098745|26544|P4|STARTED|Day 1||8
12876|NCT03098745|26545|P3|STARTED|Day 1||8
12877|NCT03098745|26546|P2|STARTED|Day 1||3
12878|NCT03098745|26547|P1|STARTED|Day 1||7
12879|NCT03098641|26583|P1|NOT COMPLETED|Overall Study||52
12880|NCT03098641|26583|P1|COMPLETED|Overall Study||220
12881|NCT03098641|26583|P1|STARTED|Overall Study||272
12882|NCT03098615|26601|P1|NOT COMPLETED|Overall Study||2
12883|NCT03098615|26601|P1|COMPLETED|Overall Study||17
12884|NCT03098615|26601|P1|STARTED|Overall Study||19
12885|NCT03098173|26608|P2|NOT COMPLETED|Overall Study||2
12886|NCT03098173|26609|P1|NOT COMPLETED|Overall Study||1
12887|NCT03098173|26608|P2|COMPLETED|Overall Study||79
12888|NCT03098173|26609|P1|COMPLETED|Overall Study||80
12889|NCT03098173|26608|P2|STARTED|Overall Study||81
12890|NCT03098173|26609|P1|STARTED|Overall Study||81
12891|NCT03097614|26637|P1|NOT COMPLETED|Overall Study||3
12892|NCT03097614|26637|P1|COMPLETED|Overall Study||54
12893|NCT03097614|26637|P1|STARTED|Overall Study||57
12894|NCT03097484|26643|P2|NOT COMPLETED|Overall Study||0
12895|NCT03097484|26644|P1|NOT COMPLETED|Overall Study||0
12896|NCT03097484|26643|P2|COMPLETED|Overall Study||19
12897|NCT03097484|26644|P1|COMPLETED|Overall Study||19
12898|NCT03097484|26643|P2|STARTED|Overall Study||19
12899|NCT03097484|26644|P1|STARTED|Overall Study||19
12900|NCT03097341|26657|P5|NOT COMPLETED|Overall Study||0
12901|NCT03097341|26658|P4|NOT COMPLETED|Overall Study||0
12902|NCT03097341|26659|P3|NOT COMPLETED|Overall Study||0
12903|NCT03097341|26660|P2|NOT COMPLETED|Overall Study||0
12904|NCT03097341|26661|P1|NOT COMPLETED|Overall Study||0
12905|NCT03097341|26657|P5|COMPLETED|Overall Study||5
12906|NCT03097341|26658|P4|COMPLETED|Overall Study||4
12907|NCT03097341|26659|P3|COMPLETED|Overall Study||4
12908|NCT03097341|26660|P2|COMPLETED|Overall Study||4
12909|NCT03097341|26661|P1|COMPLETED|Overall Study||4
12910|NCT03097341|26657|P5|STARTED|Overall Study||5
12911|NCT03097341|26658|P4|STARTED|Overall Study||4
12912|NCT03097341|26659|P3|STARTED|Overall Study||4
12913|NCT03097341|26660|P2|STARTED|Overall Study||4
12914|NCT03097341|26661|P1|STARTED|Overall Study||4
12915|NCT03097289|26739|P1|NOT COMPLETED|Overall Study||6
12916|NCT03097289|26739|P1|COMPLETED|Overall Study||26
12917|NCT03097289|26739|P1|STARTED|Overall Study||32
12918|NCT03096873|26748|P2|NOT COMPLETED|Overall Study||0
12919|NCT03096873|26749|P1|NOT COMPLETED|Overall Study||0
12920|NCT03096873|26748|P2|COMPLETED|Overall Study||20
12921|NCT03096873|26749|P1|COMPLETED|Overall Study||20
12922|NCT03096873|26748|P2|STARTED|Overall Study||20
12923|NCT03096873|26749|P1|STARTED|Overall Study||20
12924|NCT03096483|26783|P1|NOT COMPLETED|Overall Study||1
12925|NCT03096483|26783|P1|COMPLETED|Overall Study||11
12926|NCT03096483|26783|P1|STARTED|Overall Study||12
12927|NCT03096444|26788|P1|NOT COMPLETED|Overall Study||0
12928|NCT03096444|26788|P1|COMPLETED|Overall Study||13
12929|NCT03096444|26788|P1|STARTED|Overall Study||13
12930|NCT03095651|26818|P8|NOT COMPLETED|Overall Study||0
12931|NCT03095651|26819|P7|NOT COMPLETED|Overall Study||0
12932|NCT03095651|26820|P6|NOT COMPLETED|Overall Study||1
12933|NCT03095651|26821|P5|NOT COMPLETED|Overall Study||0
12934|NCT03095651|26822|P4|NOT COMPLETED|Overall Study||1
12935|NCT03095651|26823|P3|NOT COMPLETED|Overall Study||0
12936|NCT03095651|26824|P2|NOT COMPLETED|Overall Study||1
12937|NCT03095651|26825|P1|NOT COMPLETED|Overall Study||1
12938|NCT03095651|26818|P8|COMPLETED|Overall Study||4
12939|NCT03095651|26819|P7|COMPLETED|Overall Study||6
12940|NCT03095651|26820|P6|COMPLETED|Overall Study||6
12941|NCT03095651|26821|P5|COMPLETED|Overall Study||0
12942|NCT03095651|26822|P4|COMPLETED|Overall Study||3
12943|NCT03095651|26823|P3|COMPLETED|Overall Study||0
12944|NCT03095651|26824|P2|COMPLETED|Overall Study||5
12945|NCT03095651|26825|P1|COMPLETED|Overall Study||5
12946|NCT03095651|26818|P8|STARTED|Overall Study||4
12947|NCT03095651|26819|P7|STARTED|Overall Study||6
12948|NCT03095651|26820|P6|STARTED|Overall Study||7
12949|NCT03095651|26821|P5|STARTED|Overall Study||0
12950|NCT03095651|26822|P4|STARTED|Overall Study||4
12951|NCT03095651|26823|P3|STARTED|Overall Study||0
12952|NCT03095651|26824|P2|STARTED|Overall Study||6
12953|NCT03095651|26825|P1|STARTED|Overall Study||6
12954|NCT03095638|26949|P8|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
12955|NCT03095638|26950|P7|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
12956|NCT03095638|26951|P6|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
12957|NCT03095638|26952|P5|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
12958|NCT03095638|26953|P4|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
12959|NCT03095638|26954|P3|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
12960|NCT03095638|26955|P2|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
12961|NCT03095638|26956|P1|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
12962|NCT03095638|26949|P8|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
12963|NCT03095638|26950|P7|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
12964|NCT03095638|26951|P6|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
12965|NCT03095638|26952|P5|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
12966|NCT03095638|26953|P4|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
12967|NCT03095638|26954|P3|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
12968|NCT03095638|26955|P2|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
12969|NCT03095638|26956|P1|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
12970|NCT03095638|26949|P8|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
12971|NCT03095638|26950|P7|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
12972|NCT03095638|26951|P6|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
12973|NCT03095638|26952|P5|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
12974|NCT03095638|26953|P4|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
12975|NCT03095638|26954|P3|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
12976|NCT03095638|26955|P2|STARTED|P2: Period 3, Washout (7[-4 Hours])||0
12977|NCT03095638|26956|P1|STARTED|P2: Period 3, Washout (7[-4 Hours])||0
12978|NCT03095638|26949|P8|NOT COMPLETED|P2: Period 3 (4 Days)||0
12979|NCT03095638|26950|P7|NOT COMPLETED|P2: Period 3 (4 Days)||0
12980|NCT03095638|26951|P6|NOT COMPLETED|P2: Period 3 (4 Days)||0
12981|NCT03095638|26952|P5|NOT COMPLETED|P2: Period 3 (4 Days)||0
12982|NCT03095638|26953|P4|NOT COMPLETED|P2: Period 3 (4 Days)||0
12983|NCT03095638|26954|P3|NOT COMPLETED|P2: Period 3 (4 Days)||0
12984|NCT03095638|26955|P2|NOT COMPLETED|P2: Period 3 (4 Days)||0
12985|NCT03095638|26956|P1|NOT COMPLETED|P2: Period 3 (4 Days)||0
12986|NCT03095638|26949|P8|COMPLETED|P2: Period 3 (4 Days)||4
12987|NCT03095638|26950|P7|COMPLETED|P2: Period 3 (4 Days)||4
12988|NCT03095638|26951|P6|COMPLETED|P2: Period 3 (4 Days)||4
12989|NCT03095638|26952|P5|COMPLETED|P2: Period 3 (4 Days)||4
12990|NCT03095638|26953|P4|COMPLETED|P2: Period 3 (4 Days)||4
12991|NCT03095638|26954|P3|COMPLETED|P2: Period 3 (4 Days)||4
12992|NCT03095638|26955|P2|COMPLETED|P2: Period 3 (4 Days)||0
12993|NCT03095638|26956|P1|COMPLETED|P2: Period 3 (4 Days)||0
12994|NCT03095638|26949|P8|STARTED|P2: Period 3 (4 Days)||4
12995|NCT03095638|26950|P7|STARTED|P2: Period 3 (4 Days)||4
12996|NCT03095638|26951|P6|STARTED|P2: Period 3 (4 Days)||4
12997|NCT03095638|26952|P5|STARTED|P2: Period 3 (4 Days)||4
12998|NCT03095638|26953|P4|STARTED|P2: Period 3 (4 Days)||4
12999|NCT03095638|26954|P3|STARTED|P2: Period 3 (4 Days)||4
13000|NCT03095638|26955|P2|STARTED|P2: Period 3 (4 Days)||0
13001|NCT03095638|26956|P1|STARTED|P2: Period 3 (4 Days)||0
13002|NCT03095638|26949|P8|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
13003|NCT03095638|26950|P7|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
13004|NCT03095638|26951|P6|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
13005|NCT03095638|26952|P5|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
13006|NCT03095638|26953|P4|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
13007|NCT03095638|26954|P3|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
13008|NCT03095638|26955|P2|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
13009|NCT03095638|26956|P1|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
13010|NCT03095638|26949|P8|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
13011|NCT03095638|26950|P7|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
13012|NCT03095638|26951|P6|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
13013|NCT03095638|26952|P5|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
13014|NCT03095638|26953|P4|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
13015|NCT03095638|26954|P3|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
13016|NCT03095638|26955|P2|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
13017|NCT03095638|26956|P1|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
13018|NCT03095638|26949|P8|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
13019|NCT03095638|26950|P7|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
13020|NCT03095638|26951|P6|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
13021|NCT03095638|26952|P5|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
13022|NCT03095638|26953|P4|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
13023|NCT03095638|26954|P3|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
13024|NCT03095638|26955|P2|STARTED|P2: Period 2, Washout (7[-4 Hours])||0
13025|NCT03095638|26956|P1|STARTED|P2: Period 2, Washout (7[-4 Hours])||0
13026|NCT03095638|26949|P8|NOT COMPLETED|P2: Period 2 (4 Days)||0
13027|NCT03095638|26950|P7|NOT COMPLETED|P2: Period 2 (4 Days)||0
13028|NCT03095638|26951|P6|NOT COMPLETED|P2: Period 2 (4 Days)||0
13029|NCT03095638|26952|P5|NOT COMPLETED|P2: Period 2 (4 Days)||0
13030|NCT03095638|26953|P4|NOT COMPLETED|P2: Period 2 (4 Days)||0
13031|NCT03095638|26954|P3|NOT COMPLETED|P2: Period 2 (4 Days)||0
13032|NCT03095638|26955|P2|NOT COMPLETED|P2: Period 2 (4 Days)||0
13033|NCT03095638|26956|P1|NOT COMPLETED|P2: Period 2 (4 Days)||0
13034|NCT03095638|26949|P8|COMPLETED|P2: Period 2 (4 Days)||4
13035|NCT03095638|26950|P7|COMPLETED|P2: Period 2 (4 Days)||4
13036|NCT03095638|26951|P6|COMPLETED|P2: Period 2 (4 Days)||4
13037|NCT03095638|26952|P5|COMPLETED|P2: Period 2 (4 Days)||4
13038|NCT03095638|26953|P4|COMPLETED|P2: Period 2 (4 Days)||4
13039|NCT03095638|26954|P3|COMPLETED|P2: Period 2 (4 Days)||4
13040|NCT03095638|26955|P2|COMPLETED|P2: Period 2 (4 Days)||0
13041|NCT03095638|26956|P1|COMPLETED|P2: Period 2 (4 Days)||0
13042|NCT03095638|26949|P8|STARTED|P2: Period 2 (4 Days)||4
13043|NCT03095638|26950|P7|STARTED|P2: Period 2 (4 Days)||4
13044|NCT03095638|26951|P6|STARTED|P2: Period 2 (4 Days)||4
13045|NCT03095638|26952|P5|STARTED|P2: Period 2 (4 Days)||4
13046|NCT03095638|26953|P4|STARTED|P2: Period 2 (4 Days)||4
13047|NCT03095638|26954|P3|STARTED|P2: Period 2 (4 Days)||4
13048|NCT03095638|26955|P2|STARTED|P2: Period 2 (4 Days)||0
13049|NCT03095638|26956|P1|STARTED|P2: Period 2 (4 Days)||0
13050|NCT03095638|26949|P8|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
13051|NCT03095638|26950|P7|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
13052|NCT03095638|26951|P6|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
13053|NCT03095638|26952|P5|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
13054|NCT03095638|26953|P4|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
13055|NCT03095638|26954|P3|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
13056|NCT03095638|26955|P2|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
13057|NCT03095638|26956|P1|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
13058|NCT03095638|26949|P8|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
13059|NCT03095638|26950|P7|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
13060|NCT03095638|26951|P6|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
13061|NCT03095638|26952|P5|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
13062|NCT03095638|26953|P4|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
13063|NCT03095638|26954|P3|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
13064|NCT03095638|26955|P2|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
13065|NCT03095638|26956|P1|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
13066|NCT03095638|26949|P8|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
13067|NCT03095638|26950|P7|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
13068|NCT03095638|26951|P6|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
13069|NCT03095638|26952|P5|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
13070|NCT03095638|26953|P4|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
13071|NCT03095638|26954|P3|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
13072|NCT03095638|26955|P2|STARTED|P2: Period 1, Washout (7[-4 Hours])||0
13073|NCT03095638|26956|P1|STARTED|P2: Period 1, Washout (7[-4 Hours])||0
13074|NCT03095638|26949|P8|NOT COMPLETED|P2: Period 1 (4 Days)||0
13075|NCT03095638|26950|P7|NOT COMPLETED|P2: Period 1 (4 Days)||0
13076|NCT03095638|26951|P6|NOT COMPLETED|P2: Period 1 (4 Days)||0
13077|NCT03095638|26952|P5|NOT COMPLETED|P2: Period 1 (4 Days)||0
13078|NCT03095638|26953|P4|NOT COMPLETED|P2: Period 1 (4 Days)||0
13079|NCT03095638|26954|P3|NOT COMPLETED|P2: Period 1 (4 Days)||0
13080|NCT03095638|26955|P2|NOT COMPLETED|P2: Period 1 (4 Days)||0
13081|NCT03095638|26956|P1|NOT COMPLETED|P2: Period 1 (4 Days)||0
13082|NCT03095638|26949|P8|COMPLETED|P2: Period 1 (4 Days)||4
13083|NCT03095638|26950|P7|COMPLETED|P2: Period 1 (4 Days)||4
13084|NCT03095638|26951|P6|COMPLETED|P2: Period 1 (4 Days)||4
13085|NCT03095638|26952|P5|COMPLETED|P2: Period 1 (4 Days)||4
13086|NCT03095638|26953|P4|COMPLETED|P2: Period 1 (4 Days)||4
13087|NCT03095638|26954|P3|COMPLETED|P2: Period 1 (4 Days)||4
13088|NCT03095638|26955|P2|COMPLETED|P2: Period 1 (4 Days)||0
13089|NCT03095638|26956|P1|COMPLETED|P2: Period 1 (4 Days)||0
13090|NCT03095638|26949|P8|STARTED|P2: Period 1 (4 Days)||4
13091|NCT03095638|26950|P7|STARTED|P2: Period 1 (4 Days)||4
13092|NCT03095638|26951|P6|STARTED|P2: Period 1 (4 Days)||4
13093|NCT03095638|26952|P5|STARTED|P2: Period 1 (4 Days)||4
13094|NCT03095638|26953|P4|STARTED|P2: Period 1 (4 Days)||4
13095|NCT03095638|26954|P3|STARTED|P2: Period 1 (4 Days)||4
13096|NCT03095638|26955|P2|STARTED|P2: Period 1 (4 Days)||0
13097|NCT03095638|26956|P1|STARTED|P2: Period 1 (4 Days)||0
13098|NCT03095638|26949|P8|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
13099|NCT03095638|26950|P7|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
13100|NCT03095638|26951|P6|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
13101|NCT03095638|26952|P5|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
13102|NCT03095638|26953|P4|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
13103|NCT03095638|26954|P3|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
13104|NCT03095638|26955|P2|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
13105|NCT03095638|26956|P1|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
13106|NCT03095638|26949|P8|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
13107|NCT03095638|26950|P7|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
13108|NCT03095638|26951|P6|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
13109|NCT03095638|26952|P5|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
13110|NCT03095638|26953|P4|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
13111|NCT03095638|26954|P3|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
13112|NCT03095638|26955|P2|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7
13113|NCT03095638|26956|P1|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7
13114|NCT03095638|26949|P8|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
13115|NCT03095638|26950|P7|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
13116|NCT03095638|26951|P6|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
13117|NCT03095638|26952|P5|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
13118|NCT03095638|26953|P4|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
13119|NCT03095638|26954|P3|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
13120|NCT03095638|26955|P2|STARTED|P1: Period 2, Washout (7[-4 Hours])||7
13121|NCT03095638|26956|P1|STARTED|P1: Period 2, Washout (7[-4 Hours])||7
13122|NCT03095638|26949|P8|NOT COMPLETED|P1: Period 2 (4 Days)||0
13123|NCT03095638|26950|P7|NOT COMPLETED|P1: Period 2 (4 Days)||0
13124|NCT03095638|26951|P6|NOT COMPLETED|P1: Period 2 (4 Days)||0
13125|NCT03095638|26952|P5|NOT COMPLETED|P1: Period 2 (4 Days)||0
13126|NCT03095638|26953|P4|NOT COMPLETED|P1: Period 2 (4 Days)||0
13127|NCT03095638|26954|P3|NOT COMPLETED|P1: Period 2 (4 Days)||0
13128|NCT03095638|26955|P2|NOT COMPLETED|P1: Period 2 (4 Days)||0
13129|NCT03095638|26956|P1|NOT COMPLETED|P1: Period 2 (4 Days)||0
13130|NCT03095638|26949|P8|COMPLETED|P1: Period 2 (4 Days)||0
13131|NCT03095638|26950|P7|COMPLETED|P1: Period 2 (4 Days)||0
13132|NCT03095638|26951|P6|COMPLETED|P1: Period 2 (4 Days)||0
13133|NCT03095638|26952|P5|COMPLETED|P1: Period 2 (4 Days)||0
13134|NCT03095638|26953|P4|COMPLETED|P1: Period 2 (4 Days)||0
13135|NCT03095638|26954|P3|COMPLETED|P1: Period 2 (4 Days)||0
13136|NCT03095638|26955|P2|COMPLETED|P1: Period 2 (4 Days)||7
13137|NCT03095638|26956|P1|COMPLETED|P1: Period 2 (4 Days)||7
13138|NCT03095638|26949|P8|STARTED|P1: Period 2 (4 Days)||0
13139|NCT03095638|26950|P7|STARTED|P1: Period 2 (4 Days)||0
13140|NCT03095638|26951|P6|STARTED|P1: Period 2 (4 Days)||0
13141|NCT03095638|26952|P5|STARTED|P1: Period 2 (4 Days)||0
13142|NCT03095638|26953|P4|STARTED|P1: Period 2 (4 Days)||0
13143|NCT03095638|26954|P3|STARTED|P1: Period 2 (4 Days)||0
13144|NCT03095638|26955|P2|STARTED|P1: Period 2 (4 Days)||7
13145|NCT03095638|26956|P1|STARTED|P1: Period 2 (4 Days)||7
13146|NCT03095638|26949|P8|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
13147|NCT03095638|26950|P7|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
13148|NCT03095638|26951|P6|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
13149|NCT03095638|26952|P5|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
13150|NCT03095638|26953|P4|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
13151|NCT03095638|26954|P3|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
13152|NCT03095638|26955|P2|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
13153|NCT03095638|26956|P1|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
13154|NCT03095638|26949|P8|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
13155|NCT03095638|26950|P7|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
13156|NCT03095638|26951|P6|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
13157|NCT03095638|26952|P5|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
13158|NCT03095638|26953|P4|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
13159|NCT03095638|26954|P3|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
13160|NCT03095638|26955|P2|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7
13161|NCT03095638|26956|P1|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7
13162|NCT03095638|26949|P8|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
13163|NCT03095638|26950|P7|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
13164|NCT03095638|26951|P6|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
13165|NCT03095638|26952|P5|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
13166|NCT03095638|26953|P4|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
13167|NCT03095638|26954|P3|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
13168|NCT03095638|26955|P2|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7
13169|NCT03095638|26956|P1|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7
13170|NCT03095638|26949|P8|NOT COMPLETED|P1: Period 1 (4 Days)||0
13171|NCT03095638|26950|P7|NOT COMPLETED|P1: Period 1 (4 Days)||0
13172|NCT03095638|26951|P6|NOT COMPLETED|P1: Period 1 (4 Days)||0
13173|NCT03095638|26952|P5|NOT COMPLETED|P1: Period 1 (4 Days)||0
13174|NCT03095638|26953|P4|NOT COMPLETED|P1: Period 1 (4 Days)||0
13175|NCT03095638|26954|P3|NOT COMPLETED|P1: Period 1 (4 Days)||0
13176|NCT03095638|26955|P2|NOT COMPLETED|P1: Period 1 (4 Days)||0
13177|NCT03095638|26956|P1|NOT COMPLETED|P1: Period 1 (4 Days)||0
13178|NCT03095638|26949|P8|COMPLETED|P1: Period 1 (4 Days)||0
13179|NCT03095638|26950|P7|COMPLETED|P1: Period 1 (4 Days)||0
13180|NCT03095638|26951|P6|COMPLETED|P1: Period 1 (4 Days)||0
13181|NCT03095638|26952|P5|COMPLETED|P1: Period 1 (4 Days)||0
13182|NCT03095638|26953|P4|COMPLETED|P1: Period 1 (4 Days)||0
13183|NCT03095638|26954|P3|COMPLETED|P1: Period 1 (4 Days)||0
13184|NCT03095638|26955|P2|COMPLETED|P1: Period 1 (4 Days)||7
13185|NCT03095638|26956|P1|COMPLETED|P1: Period 1 (4 Days)||7
13186|NCT03095638|26949|P8|STARTED|P1: Period 1 (4 Days)||0
13187|NCT03095638|26950|P7|STARTED|P1: Period 1 (4 Days)||0
13188|NCT03095638|26951|P6|STARTED|P1: Period 1 (4 Days)||0
13189|NCT03095638|26952|P5|STARTED|P1: Period 1 (4 Days)||0
13190|NCT03095638|26953|P4|STARTED|P1: Period 1 (4 Days)||0
13191|NCT03095638|26954|P3|STARTED|P1: Period 1 (4 Days)||0
13192|NCT03095638|26955|P2|STARTED|P1: Period 1 (4 Days)||7
13193|NCT03095638|26956|P1|STARTED|P1: Period 1 (4 Days)||7
13194|NCT03095599|27104|P2|NOT COMPLETED|Overall Study||0
13195|NCT03095599|27105|P1|NOT COMPLETED|Overall Study||3
13196|NCT03095599|27104|P2|COMPLETED|Overall Study||148
13197|NCT03095599|27105|P1|COMPLETED|Overall Study||738
13198|NCT03095599|27104|P2|Vaccinated|Overall Study||148
13199|NCT03095599|27105|P1|Vaccinated|Overall Study||740
13200|NCT03095599|27104|P2|Withdrawal Before Vaccination|Overall Study||0
13201|NCT03095599|27105|P1|Withdrawal Before Vaccination|Overall Study||1
13202|NCT03095599|27104|P2|STARTED|Overall Study||148
13203|NCT03095599|27105|P1|STARTED|Overall Study||741
13204|NCT03095521|27141|P2|NOT COMPLETED|Overall Study||2
13205|NCT03095521|27142|P1|NOT COMPLETED|Overall Study||0
13206|NCT03095521|27141|P2|COMPLETED|Overall Study||111
13207|NCT03095521|27142|P1|COMPLETED|Overall Study||115
13208|NCT03095521|27141|P2|Safety Population|Overall Study||113
13209|NCT03095521|27142|P1|Safety Population|Overall Study||115
13210|NCT03095521|27141|P2|Per Protocol Population PP|Overall Study||107
13211|NCT03095521|27142|P1|Per Protocol Population PP|Overall Study||113
13212|NCT03095521|27141|P2|Intent to Treat Population ITT|Overall Study||113
13213|NCT03095521|27142|P1|Intent to Treat Population ITT|Overall Study||115
13214|NCT03095521|27141|P2|STARTED|Overall Study||113
13215|NCT03095521|27142|P1|STARTED|Overall Study||115
13216|NCT03095508|27160|P2|NOT COMPLETED|Overall Study||1
13217|NCT03095508|27161|P1|NOT COMPLETED|Overall Study||0
13218|NCT03095508|27160|P2|COMPLETED|Overall Study||114
13219|NCT03095508|27161|P1|COMPLETED|Overall Study||114
13220|NCT03095508|27160|P2|ITT Population|Overall Study||115
13221|NCT03095508|27161|P1|ITT Population|Overall Study||114
13222|NCT03095508|27160|P2|Safety Population|Overall Study||115
13223|NCT03095508|27161|P1|Safety Population|Overall Study||114
13224|NCT03095508|27160|P2|Per Protocol Population|Overall Study||111
13225|NCT03095508|27161|P1|Per Protocol Population|Overall Study||112
13226|NCT03095508|27160|P2|STARTED|Overall Study||115
13227|NCT03095508|27161|P1|STARTED|Overall Study||114
13228|NCT03095456|27179|P2|NOT COMPLETED|Overall Study||8
13229|NCT03095456|27180|P1|NOT COMPLETED|Overall Study||4
13230|NCT03095456|27179|P2|COMPLETED|Overall Study||96
13231|NCT03095456|27180|P1|COMPLETED|Overall Study||99
13232|NCT03095456|27179|P2|STARTED|Overall Study||104
13233|NCT03095456|27180|P1|STARTED|Overall Study||103
13234|NCT03095053|27198|P2|NOT COMPLETED|Overall Study||0
13235|NCT03095053|27199|P1|NOT COMPLETED|Overall Study||29
13236|NCT03095053|27198|P2|COMPLETED|Overall Study||111
13237|NCT03095053|27199|P1|COMPLETED|Overall Study|29 excluded as blastocyst was predicted to be aneuploid|80
13238|NCT03095053|27198|P2|STARTED|Overall Study|All blastocysts scored morphologically|111
13239|NCT03095053|27199|P1|STARTED|Overall Study|All blastocysts scored morphologically PGT-A of the single best blastocyst from the cohort|109
13240|NCT03095027|27209|P2|NOT COMPLETED|Period 2, Second Week of Wear||0
13241|NCT03095027|27210|P1|NOT COMPLETED|Period 2, Second Week of Wear||1
13242|NCT03095027|27209|P2|COMPLETED|Period 2, Second Week of Wear||24
13243|NCT03095027|27210|P1|COMPLETED|Period 2, Second Week of Wear||26
13244|NCT03095027|27209|P2|STARTED|Period 2, Second Week of Wear||24
13245|NCT03095027|27210|P1|STARTED|Period 2, Second Week of Wear||27
13246|NCT03095027|27209|P2|NOT COMPLETED|Period 1, First Week of Wear||0
13247|NCT03095027|27210|P1|NOT COMPLETED|Period 1, First Week of Wear||0
13248|NCT03095027|27209|P2|COMPLETED|Period 1, First Week of Wear||24
13249|NCT03095027|27210|P1|COMPLETED|Period 1, First Week of Wear||27
13250|NCT03095027|27209|P2|STARTED|Period 1, First Week of Wear||24
13251|NCT03095027|27210|P1|STARTED|Period 1, First Week of Wear||27
13252|NCT03094806|27218|P2|NOT COMPLETED|Overall Study||0
13253|NCT03094806|27219|P1|NOT COMPLETED|Overall Study||0
13254|NCT03094806|27218|P2|COMPLETED|Overall Study||47
13255|NCT03094806|27219|P1|COMPLETED|Overall Study||44
13256|NCT03094806|27218|P2|STARTED|Overall Study||47
13257|NCT03094806|27219|P1|STARTED|Overall Study||44
13258|NCT03092752|27237|P1|NOT COMPLETED|Overall Study||361469
13259|NCT03092752|27237|P1|COMPLETED|Overall Study||162116
13260|NCT03092752|27237|P1|STARTED|Overall Study||523585
13261|NCT03092726|27302|P2|NOT COMPLETED|Overall Study||14
13262|NCT03092726|27303|P1|NOT COMPLETED|Overall Study||9
13263|NCT03092726|27302|P2|COMPLETED|Overall Study||81
13264|NCT03092726|27303|P1|COMPLETED|Overall Study||79
13265|NCT03092726|27302|P2|Treated|Overall Study||95
13266|NCT03092726|27303|P1|Treated|Overall Study||88
13267|NCT03092726|27302|P2|STARTED|Overall Study||95
13268|NCT03092726|27303|P1|STARTED|Overall Study||88
13269|NCT03091777|27330|P3|NOT COMPLETED|Overall Study||37
13270|NCT03091777|27331|P2|NOT COMPLETED|Overall Study||33
13271|NCT03091777|27332|P1|NOT COMPLETED|Overall Study||32
13272|NCT03091777|27330|P3|COMPLETED|Overall Study||257
13273|NCT03091777|27331|P2|COMPLETED|Overall Study||255
13274|NCT03091777|27332|P1|COMPLETED|Overall Study||257
13275|NCT03091777|27330|P3|STARTED|Overall Study||294
13276|NCT03091777|27331|P2|STARTED|Overall Study||288
13277|NCT03091777|27332|P1|STARTED|Overall Study||289
13278|NCT03091751|27340|P1|NOT COMPLETED|Overall Study||0
13279|NCT03091751|27340|P1|COMPLETED|Overall Study||22
13280|NCT03091751|27340|P1|STARTED|Overall Study||22
13281|NCT03091673|27351|P2|NOT COMPLETED|Second Dose||0
13282|NCT03091673|27352|P1|NOT COMPLETED|Second Dose||0
13283|NCT03091673|27351|P2|COMPLETED|Second Dose||11
13284|NCT03091673|27352|P1|COMPLETED|Second Dose||0
13285|NCT03091673|27351|P2|STARTED|Second Dose|Only the 11 study subjects ages 12-<18 years were assigned the 1 mg dose during period 2.|11
13286|NCT03091673|27352|P1|STARTED|Second Dose|No subjects received the 0.5 mg dose during period 2.|0
13287|NCT03091673|27351|P2|NOT COMPLETED|First Dose||0
13288|NCT03091673|27352|P1|NOT COMPLETED|First Dose||0
13289|NCT03091673|27351|P2|COMPLETED|First Dose||0
13290|NCT03091673|27352|P1|COMPLETED|First Dose||31
13291|NCT03091673|27351|P2|STARTED|First Dose|All 31 subjects received the 0.5 mg dose during period 1.|0
13292|NCT03091673|27352|P1|STARTED|First Dose||31
13293|NCT03091439|27374|P2|NOT COMPLETED|Overall Study||0
13294|NCT03091439|27375|P1|NOT COMPLETED|Overall Study||1
13295|NCT03091439|27374|P2|COMPLETED|Overall Study||0
13296|NCT03091439|27375|P1|COMPLETED|Overall Study||0
13297|NCT03091439|27374|P2|STARTED|Overall Study||0
13298|NCT03091439|27375|P1|STARTED|Overall Study||1
13299|NCT03091348|27399|P2|NOT COMPLETED|Overall Study||1
13300|NCT03091348|27400|P1|NOT COMPLETED|Overall Study||2
13301|NCT03091348|27399|P2|COMPLETED|Overall Study||1
13302|NCT03091348|27400|P1|COMPLETED|Overall Study||0
13303|NCT03091348|27399|P2|STARTED|Overall Study||2
13304|NCT03091348|27400|P1|STARTED|Overall Study||2
13305|NCT03091179|27426|P2|NOT COMPLETED|Overall Study||0
13306|NCT03091179|27427|P1|NOT COMPLETED|Overall Study||0
13307|NCT03091179|27426|P2|COMPLETED|Overall Study||10
13308|NCT03091179|27427|P1|COMPLETED|Overall Study||10
13309|NCT03091179|27426|P2|STARTED|Overall Study||10
13310|NCT03091179|27427|P1|STARTED|Overall Study||10
13311|NCT03090958|27453|P1|NOT COMPLETED|Overall Study||0
13312|NCT03090958|27453|P1|COMPLETED|Overall Study||20
13313|NCT03090958|27453|P1|STARTED|Overall Study||20
13314|NCT03090256|27465|P1|NOT COMPLETED|Overall Study||0
13315|NCT03090256|27465|P1|COMPLETED|Overall Study||68
13316|NCT03090256|27465|P1|STARTED|Overall Study||68
13317|NCT03090100|27476|P2|NOT COMPLETED|Overall Study||48
13318|NCT03090100|27477|P1|NOT COMPLETED|Overall Study||27
13319|NCT03090100|27476|P2|COMPLETED|Overall Study||466
13320|NCT03090100|27477|P1|COMPLETED|Overall Study||507
13321|NCT03090100|27476|P2|Treated|Overall Study||511
13322|NCT03090100|27477|P1|Treated|Overall Study||534
13323|NCT03090100|27476|P2|STARTED|Overall Study||514
13324|NCT03090100|27477|P1|STARTED|Overall Study||534
13325|NCT03089879|27520|P3|NOT COMPLETED|Overall Study||0
13326|NCT03089879|27521|P2|NOT COMPLETED|Overall Study||0
13327|NCT03089879|27522|P1|NOT COMPLETED|Overall Study||0
13328|NCT03089879|27520|P3|COMPLETED|Overall Study||26
13329|NCT03089879|27521|P2|COMPLETED|Overall Study||2
13330|NCT03089879|27522|P1|COMPLETED|Overall Study||7
13331|NCT03089879|27520|P3|STARTED|Overall Study||26
13332|NCT03089879|27521|P2|STARTED|Overall Study||2
13333|NCT03089879|27522|P1|STARTED|Overall Study||7
13334|NCT03089580|27551|P1|NOT COMPLETED|Overall Study||2
13335|NCT03089580|27551|P1|COMPLETED|Overall Study||12
13336|NCT03089580|27551|P1|STARTED|Overall Study||14
13337|NCT03089216|27562|P4|NOT COMPLETED|Overall Study||1
13338|NCT03089216|27563|P3|NOT COMPLETED|Overall Study||0
13339|NCT03089216|27564|P2|NOT COMPLETED|Overall Study||0
13340|NCT03089216|27565|P1|NOT COMPLETED|Overall Study||0
13341|NCT03089216|27562|P4|COMPLETED|Overall Study||26
13342|NCT03089216|27563|P3|COMPLETED|Overall Study||27
13343|NCT03089216|27564|P2|COMPLETED|Overall Study||27
13344|NCT03089216|27565|P1|COMPLETED|Overall Study||27
13345|NCT03089216|27562|P4|STARTED|Overall Study||27
13346|NCT03089216|27563|P3|STARTED|Overall Study||27
13347|NCT03089216|27564|P2|STARTED|Overall Study||27
13348|NCT03089216|27565|P1|STARTED|Overall Study||27
13349|NCT03088267|27579|P2|NOT COMPLETED|Overall Study||0
13350|NCT03088267|27580|P1|NOT COMPLETED|Overall Study||0
13351|NCT03088267|27579|P2|COMPLETED|Overall Study||9
13352|NCT03088267|27580|P1|COMPLETED|Overall Study||9
13353|NCT03088267|27579|P2|STARTED|Overall Study||9
13354|NCT03088267|27580|P1|STARTED|Overall Study||9
13355|NCT03088137|27591|P2|NOT COMPLETED|Overall Study||0
13356|NCT03088137|27592|P1|NOT COMPLETED|Overall Study||0
13357|NCT03088137|27591|P2|COMPLETED|Overall Study||55
13358|NCT03088137|27592|P1|COMPLETED|Overall Study||55
13359|NCT03088137|27591|P2|STARTED|Overall Study||55
13360|NCT03088137|27592|P1|STARTED|Overall Study||55
13361|NCT03087643|27622|P2|NOT COMPLETED|Overall Study||6
13362|NCT03087643|27623|P1|NOT COMPLETED|Overall Study||4
13363|NCT03087643|27622|P2|COMPLETED|Overall Study||19
13364|NCT03087643|27623|P1|COMPLETED|Overall Study||22
13365|NCT03087643|27622|P2|STARTED|Overall Study||25
13366|NCT03087643|27623|P1|STARTED|Overall Study||26
13367|NCT03087604|27639|P2|NOT COMPLETED|Overall Study||0
13368|NCT03087604|27640|P1|NOT COMPLETED|Overall Study||0
13369|NCT03087604|27639|P2|COMPLETED|Overall Study||50
13370|NCT03087604|27640|P1|COMPLETED|Overall Study||50
13371|NCT03087604|27639|P2|STARTED|Overall Study||50
13372|NCT03087604|27640|P1|STARTED|Overall Study||50
13373|NCT03086447|27652|P2|NOT COMPLETED|Overall Study||20
13374|NCT03086447|27653|P1|NOT COMPLETED|Overall Study||11
13375|NCT03086447|27652|P2|COMPLETED|Overall Study||110
13376|NCT03086447|27653|P1|COMPLETED|Overall Study||121
13377|NCT03086447|27652|P2|STARTED|Overall Study||130
13378|NCT03086447|27653|P1|STARTED|Overall Study||132
13379|NCT03086356|27673|P1|NOT COMPLETED|Overall Study||0
13380|NCT03086356|27673|P1|COMPLETED|Overall Study||12
13381|NCT03086356|27673|P1|STARTED|Overall Study||12
13382|NCT03086330|27684|P2|NOT COMPLETED|Overall Study||4
13383|NCT03086330|27685|P1|NOT COMPLETED|Overall Study||4
13384|NCT03086330|27684|P2|COMPLETED|Overall Study||147
13385|NCT03086330|27685|P1|COMPLETED|Overall Study||147
13386|NCT03086330|27684|P2|Exposed|Overall Study||151
13387|NCT03086330|27685|P1|Exposed|Overall Study||150
13388|NCT03086330|27684|P2|STARTED|Overall Study||151
13389|NCT03086330|27685|P1|STARTED|Overall Study||151
13390|NCT03086018|27805|P1|NOT COMPLETED|Final Testing for End of Trial||2
13391|NCT03086018|27805|P1|COMPLETED|Final Testing for End of Trial||28
13392|NCT03086018|27805|P1|STARTED|Final Testing for End of Trial||30
13393|NCT03086018|27805|P1|NOT COMPLETED|Field Testing||0
13394|NCT03086018|27805|P1|COMPLETED|Field Testing||30
13395|NCT03086018|27805|P1|STARTED|Field Testing||30
13396|NCT03085836|27816|P3|NOT COMPLETED|Overall Study||0
13397|NCT03085836|27817|P2|NOT COMPLETED|Overall Study||0
13398|NCT03085836|27818|P1|NOT COMPLETED|Overall Study||0
13399|NCT03085836|27816|P3|COMPLETED|Overall Study||10
13400|NCT03085836|27817|P2|COMPLETED|Overall Study||11
13401|NCT03085836|27818|P1|COMPLETED|Overall Study||12
13402|NCT03085836|27816|P3|STARTED|Overall Study||10
13403|NCT03085836|27817|P2|STARTED|Overall Study||11
13404|NCT03085836|27818|P1|STARTED|Overall Study||12
13405|NCT03083769|27867|P2|NOT COMPLETED|Overall Study||32
13406|NCT03083769|27868|P1|NOT COMPLETED|Overall Study||20
13407|NCT03083769|27867|P2|COMPLETED|Overall Study||631
13408|NCT03083769|27868|P1|COMPLETED|Overall Study||819
13409|NCT03083769|27867|P2|STARTED|Overall Study||663
13410|NCT03083769|27868|P1|STARTED|Overall Study||839
13411|NCT03083639|27880|P2|NOT COMPLETED|Intervention Period 2 (1 Day)||0
13412|NCT03083639|27881|P1|NOT COMPLETED|Intervention Period 2 (1 Day)||0
13413|NCT03083639|27880|P2|COMPLETED|Intervention Period 2 (1 Day)||25
13414|NCT03083639|27881|P1|COMPLETED|Intervention Period 2 (1 Day)||25
13415|NCT03083639|27880|P2|STARTED|Intervention Period 2 (1 Day)||25
13416|NCT03083639|27881|P1|STARTED|Intervention Period 2 (1 Day)||25
13417|NCT03083639|27880|P2|NOT COMPLETED|Washout Period (at Least 6 Days)||1
13418|NCT03083639|27881|P1|NOT COMPLETED|Washout Period (at Least 6 Days)||1
13419|NCT03083639|27880|P2|COMPLETED|Washout Period (at Least 6 Days)||25
13420|NCT03083639|27881|P1|COMPLETED|Washout Period (at Least 6 Days)||25
13421|NCT03083639|27880|P2|STARTED|Washout Period (at Least 6 Days)||26
13422|NCT03083639|27881|P1|STARTED|Washout Period (at Least 6 Days)||26
13423|NCT03083639|27880|P2|NOT COMPLETED|Intervention Period 1 (1 Day)||0
13424|NCT03083639|27881|P1|NOT COMPLETED|Intervention Period 1 (1 Day)||0
13425|NCT03083639|27880|P2|COMPLETED|Intervention Period 1 (1 Day)||26
13426|NCT03083639|27881|P1|COMPLETED|Intervention Period 1 (1 Day)||26
13427|NCT03083639|27880|P2|STARTED|Intervention Period 1 (1 Day)||26
13428|NCT03083639|27881|P1|STARTED|Intervention Period 1 (1 Day)||26
13429|NCT03083483|27894|P3|NOT COMPLETED|Overall Study||3
13430|NCT03083483|27895|P2|NOT COMPLETED|Overall Study||2
13431|NCT03083483|27896|P1|NOT COMPLETED|Overall Study||4
13432|NCT03083483|27894|P3|COMPLETED|Overall Study||20
13433|NCT03083483|27895|P2|COMPLETED|Overall Study||20
13434|NCT03083483|27896|P1|COMPLETED|Overall Study||20
13435|NCT03083483|27894|P3|STARTED|Overall Study||23
13436|NCT03083483|27895|P2|STARTED|Overall Study||22
13437|NCT03083483|27896|P1|STARTED|Overall Study||24
13438|NCT03083470|27915|P5|NOT COMPLETED|Overall Study||2
13439|NCT03083470|27916|P4|NOT COMPLETED|Overall Study||0
13440|NCT03083470|27917|P3|NOT COMPLETED|Overall Study||0
13441|NCT03083470|27918|P2|NOT COMPLETED|Overall Study||0
13442|NCT03083470|27919|P1|NOT COMPLETED|Overall Study||0
13443|NCT03083470|27915|P5|COMPLETED|Overall Study||7
13444|NCT03083470|27916|P4|COMPLETED|Overall Study||6
13445|NCT03083470|27917|P3|COMPLETED|Overall Study||6
13446|NCT03083470|27918|P2|COMPLETED|Overall Study||6
13447|NCT03083470|27919|P1|COMPLETED|Overall Study||6
13448|NCT03083470|27915|P5|STARTED|Overall Study||9
13449|NCT03083470|27916|P4|STARTED|Overall Study||6
13450|NCT03083470|27917|P3|STARTED|Overall Study||6
13451|NCT03083470|27918|P2|STARTED|Overall Study||6
13452|NCT03083470|27919|P1|STARTED|Overall Study||6
13453|NCT03083379|27958|P2|NOT COMPLETED|Overall Study||0
13454|NCT03083379|27959|P1|NOT COMPLETED|Overall Study||0
13455|NCT03083379|27958|P2|COMPLETED|Overall Study||15
13456|NCT03083379|27959|P1|COMPLETED|Overall Study||15
13457|NCT03083379|27958|P2|STARTED|Overall Study||15
13458|NCT03083379|27959|P1|STARTED|Overall Study||15
13459|NCT03080454|27965|P1|NOT COMPLETED|Anodal FU (7 Days)||4
13460|NCT03080454|27965|P1|COMPLETED|Anodal FU (7 Days)||19
13461|NCT03080454|27965|P1|STARTED|Anodal FU (7 Days)||23
13462|NCT03080454|27965|P1|NOT COMPLETED|Anodal Doublestim (5 Days)||1
13463|NCT03080454|27965|P1|COMPLETED|Anodal Doublestim (5 Days)||23
13464|NCT03080454|27965|P1|STARTED|Anodal Doublestim (5 Days)||24
13465|NCT03080454|27965|P1|NOT COMPLETED|Sham FU (7days)||0
13466|NCT03080454|27965|P1|COMPLETED|Sham FU (7days)||24
13467|NCT03080454|27965|P1|STARTED|Sham FU (7days)||24
13468|NCT03080454|27965|P1|NOT COMPLETED|Sham Doublestim (5days)||0
13469|NCT03080454|27965|P1|COMPLETED|Sham Doublestim (5days)||24
13470|NCT03080454|27965|P1|STARTED|Sham Doublestim (5days)||24
13471|NCT03080454|27965|P1|NOT COMPLETED|Baseline||2
13472|NCT03080454|27965|P1|COMPLETED|Baseline|Two participants (pts) dropped out after consent due to hospitalizations unrelated to the study.|24
13473|NCT03080454|27965|P1|STARTED|Baseline||26
13474|NCT03078647|27977|P3|NOT COMPLETED|Overall Study||0
13475|NCT03078647|27978|P2|NOT COMPLETED|Overall Study||1
13476|NCT03078647|27979|P1|NOT COMPLETED|Overall Study||0
13477|NCT03078647|27977|P3|COMPLETED|Overall Study||3
13478|NCT03078647|27978|P2|COMPLETED|Overall Study||10
13479|NCT03078647|27979|P1|COMPLETED|Overall Study||17
13480|NCT03078647|27977|P3|STARTED|Overall Study||3
13481|NCT03078647|27978|P2|STARTED|Overall Study||11
13482|NCT03078647|27979|P1|STARTED|Overall Study||17
13483|NCT03078556|27998|P4|NOT COMPLETED|Treatment Period 3 (4 Days)||0
13484|NCT03078556|27999|P3|NOT COMPLETED|Treatment Period 3 (4 Days)||0
13485|NCT03078556|28000|P2|NOT COMPLETED|Treatment Period 3 (4 Days)||0
13486|NCT03078556|28001|P1|NOT COMPLETED|Treatment Period 3 (4 Days)||0
13487|NCT03078556|27998|P4|COMPLETED|Treatment Period 3 (4 Days)||9
13488|NCT03078556|27999|P3|COMPLETED|Treatment Period 3 (4 Days)||7
13489|NCT03078556|28000|P2|COMPLETED|Treatment Period 3 (4 Days)||7
13490|NCT03078556|28001|P1|COMPLETED|Treatment Period 3 (4 Days)||9
13491|NCT03078556|27998|P4|STARTED|Treatment Period 3 (4 Days)||9
13492|NCT03078556|27999|P3|STARTED|Treatment Period 3 (4 Days)||7
13493|NCT03078556|28000|P2|STARTED|Treatment Period 3 (4 Days)||7
13494|NCT03078556|28001|P1|STARTED|Treatment Period 3 (4 Days)||9
13495|NCT03078556|27998|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
13496|NCT03078556|27999|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
13497|NCT03078556|28000|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
13498|NCT03078556|28001|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
13499|NCT03078556|27998|P4|COMPLETED|Washout Period 2 (7 Days)||9
13500|NCT03078556|27999|P3|COMPLETED|Washout Period 2 (7 Days)||7
13501|NCT03078556|28000|P2|COMPLETED|Washout Period 2 (7 Days)||7
13502|NCT03078556|28001|P1|COMPLETED|Washout Period 2 (7 Days)||9
13503|NCT03078556|27998|P4|STARTED|Washout Period 2 (7 Days)||9
13504|NCT03078556|27999|P3|STARTED|Washout Period 2 (7 Days)||7
13505|NCT03078556|28000|P2|STARTED|Washout Period 2 (7 Days)||7
13506|NCT03078556|28001|P1|STARTED|Washout Period 2 (7 Days)||9
13507|NCT03078556|27998|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
13508|NCT03078556|27999|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
13509|NCT03078556|28000|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
13510|NCT03078556|28001|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
13511|NCT03078556|27998|P4|COMPLETED|Treatment Period 2 (4 Days)||37
13512|NCT03078556|27999|P3|COMPLETED|Treatment Period 2 (4 Days)||37
13513|NCT03078556|28000|P2|COMPLETED|Treatment Period 2 (4 Days)||36
13514|NCT03078556|28001|P1|COMPLETED|Treatment Period 2 (4 Days)||37
13515|NCT03078556|27998|P4|STARTED|Treatment Period 2 (4 Days)||37
13516|NCT03078556|27999|P3|STARTED|Treatment Period 2 (4 Days)||37
13517|NCT03078556|28000|P2|STARTED|Treatment Period 2 (4 Days)||36
13518|NCT03078556|28001|P1|STARTED|Treatment Period 2 (4 Days)||37
13519|NCT03078556|27998|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
13520|NCT03078556|27999|P3|NOT COMPLETED|Washout Period 1 (7 Days)||1
13521|NCT03078556|28000|P2|NOT COMPLETED|Washout Period 1 (7 Days)||2
13522|NCT03078556|28001|P1|NOT COMPLETED|Washout Period 1 (7 Days)||2
13523|NCT03078556|27998|P4|COMPLETED|Washout Period 1 (7 Days)||37
13524|NCT03078556|27999|P3|COMPLETED|Washout Period 1 (7 Days)||37
13525|NCT03078556|28000|P2|COMPLETED|Washout Period 1 (7 Days)||36
13526|NCT03078556|28001|P1|COMPLETED|Washout Period 1 (7 Days)||37
13527|NCT03078556|27998|P4|STARTED|Washout Period 1 (7 Days)||38
13528|NCT03078556|27999|P3|STARTED|Washout Period 1 (7 Days)||38
13529|NCT03078556|28000|P2|STARTED|Washout Period 1 (7 Days)||38
13530|NCT03078556|28001|P1|STARTED|Washout Period 1 (7 Days)||39
13531|NCT03078556|27998|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
13532|NCT03078556|27999|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
13533|NCT03078556|28000|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||1
13534|NCT03078556|28001|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
13535|NCT03078556|27998|P4|COMPLETED|Treatment Period 1 (4 Days)||38
13536|NCT03078556|27999|P3|COMPLETED|Treatment Period 1 (4 Days)||38
13537|NCT03078556|28000|P2|COMPLETED|Treatment Period 1 (4 Days)||38
13538|NCT03078556|28001|P1|COMPLETED|Treatment Period 1 (4 Days)||39
13539|NCT03078556|27998|P4|STARTED|Treatment Period 1 (4 Days)||38
13540|NCT03078556|27999|P3|STARTED|Treatment Period 1 (4 Days)||38
13541|NCT03078556|28000|P2|STARTED|Treatment Period 1 (4 Days)||39
13542|NCT03078556|28001|P1|STARTED|Treatment Period 1 (4 Days)||39
13543|NCT03078270|28141|P2|NOT COMPLETED|Overall Study||0
13544|NCT03078270|28142|P1|NOT COMPLETED|Overall Study||4
13545|NCT03078270|28141|P2|COMPLETED|Overall Study||0
13546|NCT03078270|28142|P1|COMPLETED|Overall Study||0
13547|NCT03078270|28141|P2|STARTED|Overall Study||0
13548|NCT03078270|28142|P1|STARTED|Overall Study||4
13549|NCT03078127|28151|P3|NOT COMPLETED|Third Intervention||0
13550|NCT03078127|28152|P2|NOT COMPLETED|Third Intervention||0
13551|NCT03078127|28153|P1|NOT COMPLETED|Third Intervention||0
13552|NCT03078127|28151|P3|COMPLETED|Third Intervention||3
13553|NCT03078127|28152|P2|COMPLETED|Third Intervention||3
13554|NCT03078127|28153|P1|COMPLETED|Third Intervention||4
13555|NCT03078127|28151|P3|STARTED|Third Intervention||3
13556|NCT03078127|28152|P2|STARTED|Third Intervention||3
13557|NCT03078127|28153|P1|STARTED|Third Intervention||4
13558|NCT03078127|28151|P3|NOT COMPLETED|Washout (3-21 Days)||0
13559|NCT03078127|28152|P2|NOT COMPLETED|Washout (3-21 Days)||0
13560|NCT03078127|28153|P1|NOT COMPLETED|Washout (3-21 Days)||0
13561|NCT03078127|28151|P3|COMPLETED|Washout (3-21 Days)||3
13562|NCT03078127|28152|P2|COMPLETED|Washout (3-21 Days)||3
13563|NCT03078127|28153|P1|COMPLETED|Washout (3-21 Days)||4
13564|NCT03078127|28151|P3|STARTED|Washout (3-21 Days)||3
13565|NCT03078127|28152|P2|STARTED|Washout (3-21 Days)||3
13566|NCT03078127|28153|P1|STARTED|Washout (3-21 Days)||4
13567|NCT03078127|28151|P3|NOT COMPLETED|Second Intervention||0
13568|NCT03078127|28152|P2|NOT COMPLETED|Second Intervention||0
13569|NCT03078127|28153|P1|NOT COMPLETED|Second Intervention||0
13570|NCT03078127|28151|P3|COMPLETED|Second Intervention||3
13571|NCT03078127|28152|P2|COMPLETED|Second Intervention||3
13572|NCT03078127|28153|P1|COMPLETED|Second Intervention||4
13573|NCT03078127|28151|P3|STARTED|Second Intervention||3
13574|NCT03078127|28152|P2|STARTED|Second Intervention||3
13575|NCT03078127|28153|P1|STARTED|Second Intervention||4
13576|NCT03078127|28151|P3|NOT COMPLETED|Washout (3-21 Days)||0
13577|NCT03078127|28152|P2|NOT COMPLETED|Washout (3-21 Days)||0
13578|NCT03078127|28153|P1|NOT COMPLETED|Washout (3-21 Days)||0
13579|NCT03078127|28151|P3|COMPLETED|Washout (3-21 Days)||3
13580|NCT03078127|28152|P2|COMPLETED|Washout (3-21 Days)||3
13581|NCT03078127|28153|P1|COMPLETED|Washout (3-21 Days)||4
13582|NCT03078127|28151|P3|STARTED|Washout (3-21 Days)||3
13583|NCT03078127|28152|P2|STARTED|Washout (3-21 Days)||3
13584|NCT03078127|28153|P1|STARTED|Washout (3-21 Days)||4
13585|NCT03078127|28151|P3|NOT COMPLETED|First Intervention||0
13586|NCT03078127|28152|P2|NOT COMPLETED|First Intervention||0
13587|NCT03078127|28153|P1|NOT COMPLETED|First Intervention||0
13588|NCT03078127|28151|P3|COMPLETED|First Intervention||3
13589|NCT03078127|28152|P2|COMPLETED|First Intervention||3
13590|NCT03078127|28153|P1|COMPLETED|First Intervention||4
13591|NCT03078127|28151|P3|STARTED|First Intervention||3
13592|NCT03078127|28152|P2|STARTED|First Intervention||3
13593|NCT03078127|28153|P1|STARTED|First Intervention||4
13594|NCT03077893|28189|P2|NOT COMPLETED|Overall Study||3
13595|NCT03077893|28190|P1|NOT COMPLETED|Overall Study||4
13596|NCT03077893|28189|P2|COMPLETED|Overall Study||16
13597|NCT03077893|28190|P1|COMPLETED|Overall Study||14
13598|NCT03077893|28189|P2|STARTED|Overall Study||19
13599|NCT03077893|28190|P1|STARTED|Overall Study||18
13600|NCT03077724|28219|P2|NOT COMPLETED|Overall Study||2
13601|NCT03077724|28220|P1|NOT COMPLETED|Overall Study||8
13602|NCT03077724|28219|P2|COMPLETED|Overall Study||12
13603|NCT03077724|28220|P1|COMPLETED|Overall Study||6
13604|NCT03077724|28219|P2|STARTED|Overall Study||14
13605|NCT03077724|28220|P1|STARTED|Overall Study||14
13606|NCT03077659|28233|P3|NOT COMPLETED|Overall Study||1
13607|NCT03077659|28234|P2|NOT COMPLETED|Overall Study||0
13608|NCT03077659|28235|P1|NOT COMPLETED|Overall Study||0
13609|NCT03077659|28233|P3|COMPLETED|Overall Study||9
13610|NCT03077659|28234|P2|COMPLETED|Overall Study||3
13611|NCT03077659|28235|P1|COMPLETED|Overall Study||3
13612|NCT03077659|28233|P3|STARTED|Overall Study||10
13613|NCT03077659|28234|P2|STARTED|Overall Study||3
13614|NCT03077659|28235|P1|STARTED|Overall Study||3
13615|NCT03077607|28266|P2|NOT COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||2
13616|NCT03077607|28267|P1|NOT COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||3
13617|NCT03077607|28266|P2|COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
13618|NCT03077607|28267|P1|COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||14
13619|NCT03077607|28266|P2|Received Talazoparib|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
13620|NCT03077607|28267|P1|Received Talazoparib|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
13621|NCT03077607|28266|P2|Treated (With Any Study Drug)|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
13622|NCT03077607|28267|P1|Treated (With Any Study Drug)|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
13623|NCT03077607|28266|P2|STARTED|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
13624|NCT03077607|28267|P1|STARTED|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
13625|NCT03077607|28266|P2|NOT COMPLETED|Period 1 (15 Days)||0
13626|NCT03077607|28267|P1|NOT COMPLETED|Period 1 (15 Days)||2
13627|NCT03077607|28266|P2|COMPLETED|Period 1 (15 Days)||17
13628|NCT03077607|28267|P1|COMPLETED|Period 1 (15 Days)||17
13629|NCT03077607|28266|P2|Received Talazoparib|Period 1 (15 Days)||17
13630|NCT03077607|28267|P1|Received Talazoparib|Period 1 (15 Days)||19
13631|NCT03077607|28266|P2|Treated (With Any Study Drug)|Period 1 (15 Days)||17
13632|NCT03077607|28267|P1|Treated (With Any Study Drug)|Period 1 (15 Days)||19
13633|NCT03077607|28266|P2|STARTED|Period 1 (15 Days)||17
13634|NCT03077607|28267|P1|STARTED|Period 1 (15 Days)||19
13635|NCT03076996|28333|P1|NOT COMPLETED|Overall Study||6
13636|NCT03076996|28333|P1|COMPLETED|Overall Study||35
13637|NCT03076996|28333|P1|STARTED|Overall Study||41
13638|NCT03076983|28342|P2|NOT COMPLETED|Overall Study||0
13639|NCT03076983|28343|P1|NOT COMPLETED|Overall Study||0
13640|NCT03076983|28342|P2|COMPLETED|Overall Study||25
13641|NCT03076983|28343|P1|COMPLETED|Overall Study||55
13642|NCT03076983|28342|P2|STARTED|Overall Study||25
13643|NCT03076983|28343|P1|STARTED|Overall Study||55
13644|NCT03075891|28361|P2|NOT COMPLETED|Overall Study||13
13645|NCT03075891|28362|P1|NOT COMPLETED|Overall Study||9
13646|NCT03075891|28361|P2|COMPLETED|Overall Study||125
13647|NCT03075891|28362|P1|COMPLETED|Overall Study||126
13648|NCT03075891|28361|P2|STARTED|Overall Study||138
13649|NCT03075891|28362|P1|STARTED|Overall Study||135
13650|NCT03075527|28368|P1|NOT COMPLETED|Overall Study||2
13651|NCT03075527|28368|P1|COMPLETED|Overall Study||17
13652|NCT03075527|28368|P1|STARTED|Overall Study||19
13653|NCT03075410|28381|P9|NOT COMPLETED|Part B (up to 28 Days)||0
13654|NCT03075410|28382|P8|NOT COMPLETED|Part B (up to 28 Days)||0
13655|NCT03075410|28383|P7|NOT COMPLETED|Part B (up to 28 Days)||0
13656|NCT03075410|28384|P6|NOT COMPLETED|Part B (up to 28 Days)||0
13657|NCT03075410|28385|P5|NOT COMPLETED|Part B (up to 28 Days)||0
13658|NCT03075410|28386|P4|NOT COMPLETED|Part B (up to 28 Days)||0
13659|NCT03075410|28387|P3|NOT COMPLETED|Part B (up to 28 Days)||0
13660|NCT03075410|28388|P2|NOT COMPLETED|Part B (up to 28 Days)||0
13661|NCT03075410|28389|P1|NOT COMPLETED|Part B (up to 28 Days)||0
13662|NCT03075410|28381|P9|COMPLETED|Part B (up to 28 Days)||8
13663|NCT03075410|28382|P8|COMPLETED|Part B (up to 28 Days)||7
13664|NCT03075410|28383|P7|COMPLETED|Part B (up to 28 Days)||4
13665|NCT03075410|28384|P6|COMPLETED|Part B (up to 28 Days)||0
13666|NCT03075410|28385|P5|COMPLETED|Part B (up to 28 Days)||0
13667|NCT03075410|28386|P4|COMPLETED|Part B (up to 28 Days)||0
13668|NCT03075410|28387|P3|COMPLETED|Part B (up to 28 Days)||0
13669|NCT03075410|28388|P2|COMPLETED|Part B (up to 28 Days)||0
13670|NCT03075410|28389|P1|COMPLETED|Part B (up to 28 Days)||0
13671|NCT03075410|28381|P9|STARTED|Part B (up to 28 Days)||8
13672|NCT03075410|28382|P8|STARTED|Part B (up to 28 Days)||7
13673|NCT03075410|28383|P7|STARTED|Part B (up to 28 Days)||4
13674|NCT03075410|28384|P6|STARTED|Part B (up to 28 Days)||0
13675|NCT03075410|28385|P5|STARTED|Part B (up to 28 Days)||0
13676|NCT03075410|28386|P4|STARTED|Part B (up to 28 Days)||0
13677|NCT03075410|28387|P3|STARTED|Part B (up to 28 Days)||0
13678|NCT03075410|28388|P2|STARTED|Part B (up to 28 Days)||0
13679|NCT03075410|28389|P1|STARTED|Part B (up to 28 Days)||0
13680|NCT03075410|28381|P9|NOT COMPLETED|Part A-Period 4 (14 Days)||0
13681|NCT03075410|28382|P8|NOT COMPLETED|Part A-Period 4 (14 Days)||0
13682|NCT03075410|28383|P7|NOT COMPLETED|Part A-Period 4 (14 Days)||0
13683|NCT03075410|28384|P6|NOT COMPLETED|Part A-Period 4 (14 Days)||0
13684|NCT03075410|28385|P5|NOT COMPLETED|Part A-Period 4 (14 Days)||0
13685|NCT03075410|28386|P4|NOT COMPLETED|Part A-Period 4 (14 Days)||0
13686|NCT03075410|28387|P3|NOT COMPLETED|Part A-Period 4 (14 Days)||0
13687|NCT03075410|28388|P2|NOT COMPLETED|Part A-Period 4 (14 Days)||0
13688|NCT03075410|28389|P1|NOT COMPLETED|Part A-Period 4 (14 Days)||0
13689|NCT03075410|28381|P9|COMPLETED|Part A-Period 4 (14 Days)||0
13690|NCT03075410|28382|P8|COMPLETED|Part A-Period 4 (14 Days)||0
13691|NCT03075410|28383|P7|COMPLETED|Part A-Period 4 (14 Days)||0
13692|NCT03075410|28384|P6|COMPLETED|Part A-Period 4 (14 Days)||1
13693|NCT03075410|28385|P5|COMPLETED|Part A-Period 4 (14 Days)||2
13694|NCT03075410|28386|P4|COMPLETED|Part A-Period 4 (14 Days)||1
13695|NCT03075410|28387|P3|COMPLETED|Part A-Period 4 (14 Days)||2
13696|NCT03075410|28388|P2|COMPLETED|Part A-Period 4 (14 Days)||1
13697|NCT03075410|28389|P1|COMPLETED|Part A-Period 4 (14 Days)||1
13698|NCT03075410|28381|P9|STARTED|Part A-Period 4 (14 Days)||0
13699|NCT03075410|28382|P8|STARTED|Part A-Period 4 (14 Days)||0
13700|NCT03075410|28383|P7|STARTED|Part A-Period 4 (14 Days)||0
13701|NCT03075410|28384|P6|STARTED|Part A-Period 4 (14 Days)||1
13702|NCT03075410|28385|P5|STARTED|Part A-Period 4 (14 Days)||2
13703|NCT03075410|28386|P4|STARTED|Part A-Period 4 (14 Days)||1
13704|NCT03075410|28387|P3|STARTED|Part A-Period 4 (14 Days)||2
13705|NCT03075410|28388|P2|STARTED|Part A-Period 4 (14 Days)||1
13706|NCT03075410|28389|P1|STARTED|Part A-Period 4 (14 Days)||1
13707|NCT03075410|28381|P9|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
13708|NCT03075410|28382|P8|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
13709|NCT03075410|28383|P7|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
13710|NCT03075410|28384|P6|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
13711|NCT03075410|28385|P5|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
13712|NCT03075410|28386|P4|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
13713|NCT03075410|28387|P3|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
13714|NCT03075410|28388|P2|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
13715|NCT03075410|28389|P1|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
13716|NCT03075410|28381|P9|COMPLETED|Part A-Washout Period 3 (14 Days)||0
13717|NCT03075410|28382|P8|COMPLETED|Part A-Washout Period 3 (14 Days)||0
13718|NCT03075410|28383|P7|COMPLETED|Part A-Washout Period 3 (14 Days)||0
13719|NCT03075410|28384|P6|COMPLETED|Part A-Washout Period 3 (14 Days)||1
13720|NCT03075410|28385|P5|COMPLETED|Part A-Washout Period 3 (14 Days)||2
13721|NCT03075410|28386|P4|COMPLETED|Part A-Washout Period 3 (14 Days)||1
13722|NCT03075410|28387|P3|COMPLETED|Part A-Washout Period 3 (14 Days)||2
13723|NCT03075410|28388|P2|COMPLETED|Part A-Washout Period 3 (14 Days)||1
13724|NCT03075410|28389|P1|COMPLETED|Part A-Washout Period 3 (14 Days)||1
13725|NCT03075410|28381|P9|STARTED|Part A-Washout Period 3 (14 Days)||0
13726|NCT03075410|28382|P8|STARTED|Part A-Washout Period 3 (14 Days)||0
13727|NCT03075410|28383|P7|STARTED|Part A-Washout Period 3 (14 Days)||0
13728|NCT03075410|28384|P6|STARTED|Part A-Washout Period 3 (14 Days)||1
13729|NCT03075410|28385|P5|STARTED|Part A-Washout Period 3 (14 Days)||2
13730|NCT03075410|28386|P4|STARTED|Part A-Washout Period 3 (14 Days)||1
13731|NCT03075410|28387|P3|STARTED|Part A-Washout Period 3 (14 Days)||2
13732|NCT03075410|28388|P2|STARTED|Part A-Washout Period 3 (14 Days)||1
13733|NCT03075410|28389|P1|STARTED|Part A-Washout Period 3 (14 Days)||1
13734|NCT03075410|28381|P9|NOT COMPLETED|Part A-Period 3 (14 Days)||0
13735|NCT03075410|28382|P8|NOT COMPLETED|Part A-Period 3 (14 Days)||0
13736|NCT03075410|28383|P7|NOT COMPLETED|Part A-Period 3 (14 Days)||0
13737|NCT03075410|28384|P6|NOT COMPLETED|Part A-Period 3 (14 Days)||0
13738|NCT03075410|28385|P5|NOT COMPLETED|Part A-Period 3 (14 Days)||0
13739|NCT03075410|28386|P4|NOT COMPLETED|Part A-Period 3 (14 Days)||0
13740|NCT03075410|28387|P3|NOT COMPLETED|Part A-Period 3 (14 Days)||0
13741|NCT03075410|28388|P2|NOT COMPLETED|Part A-Period 3 (14 Days)||0
13742|NCT03075410|28389|P1|NOT COMPLETED|Part A-Period 3 (14 Days)||1
13743|NCT03075410|28381|P9|COMPLETED|Part A-Period 3 (14 Days)||0
13744|NCT03075410|28382|P8|COMPLETED|Part A-Period 3 (14 Days)||0
13745|NCT03075410|28383|P7|COMPLETED|Part A-Period 3 (14 Days)||0
13746|NCT03075410|28384|P6|COMPLETED|Part A-Period 3 (14 Days)||1
13747|NCT03075410|28385|P5|COMPLETED|Part A-Period 3 (14 Days)||2
13748|NCT03075410|28386|P4|COMPLETED|Part A-Period 3 (14 Days)||1
13749|NCT03075410|28387|P3|COMPLETED|Part A-Period 3 (14 Days)||2
13750|NCT03075410|28388|P2|COMPLETED|Part A-Period 3 (14 Days)||1
13751|NCT03075410|28389|P1|COMPLETED|Part A-Period 3 (14 Days)||1
13752|NCT03075410|28381|P9|STARTED|Part A-Period 3 (14 Days)||0
13753|NCT03075410|28382|P8|STARTED|Part A-Period 3 (14 Days)||0
13754|NCT03075410|28383|P7|STARTED|Part A-Period 3 (14 Days)||0
13755|NCT03075410|28384|P6|STARTED|Part A-Period 3 (14 Days)||1
13756|NCT03075410|28385|P5|STARTED|Part A-Period 3 (14 Days)||2
13757|NCT03075410|28386|P4|STARTED|Part A-Period 3 (14 Days)||1
13758|NCT03075410|28387|P3|STARTED|Part A-Period 3 (14 Days)|Participants who withdrew in Period 2 were replaced (2 new participants entered Part A period 3).|2
13759|NCT03075410|28388|P2|STARTED|Part A-Period 3 (14 Days)||1
13760|NCT03075410|28389|P1|STARTED|Part A-Period 3 (14 Days)|Participants who withdrew in Period 2 were replaced (2 new participants entered Part A period 3).|2
13761|NCT03075410|28381|P9|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
13762|NCT03075410|28382|P8|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
13763|NCT03075410|28383|P7|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
13764|NCT03075410|28384|P6|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
13765|NCT03075410|28385|P5|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
13766|NCT03075410|28386|P4|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
13767|NCT03075410|28387|P3|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
13768|NCT03075410|28388|P2|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
13769|NCT03075410|28389|P1|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
13770|NCT03075410|28381|P9|COMPLETED|Part A-Washout Period 2 (14 Days)||0
13771|NCT03075410|28382|P8|COMPLETED|Part A-Washout Period 2 (14 Days)||0
13772|NCT03075410|28383|P7|COMPLETED|Part A-Washout Period 2 (14 Days)||0
13773|NCT03075410|28384|P6|COMPLETED|Part A-Washout Period 2 (14 Days)||1
13774|NCT03075410|28385|P5|COMPLETED|Part A-Washout Period 2 (14 Days)||2
13775|NCT03075410|28386|P4|COMPLETED|Part A-Washout Period 2 (14 Days)||1
13776|NCT03075410|28387|P3|COMPLETED|Part A-Washout Period 2 (14 Days)||1
13777|NCT03075410|28388|P2|COMPLETED|Part A-Washout Period 2 (14 Days)||1
13778|NCT03075410|28389|P1|COMPLETED|Part A-Washout Period 2 (14 Days)||1
13779|NCT03075410|28381|P9|STARTED|Part A-Washout Period 2 (14 Days)||0
13780|NCT03075410|28382|P8|STARTED|Part A-Washout Period 2 (14 Days)||0
13781|NCT03075410|28383|P7|STARTED|Part A-Washout Period 2 (14 Days)||0
13782|NCT03075410|28384|P6|STARTED|Part A-Washout Period 2 (14 Days)||1
13783|NCT03075410|28385|P5|STARTED|Part A-Washout Period 2 (14 Days)||2
13784|NCT03075410|28386|P4|STARTED|Part A-Washout Period 2 (14 Days)||1
13785|NCT03075410|28387|P3|STARTED|Part A-Washout Period 2 (14 Days)||1
13786|NCT03075410|28388|P2|STARTED|Part A-Washout Period 2 (14 Days)||1
13787|NCT03075410|28389|P1|STARTED|Part A-Washout Period 2 (14 Days)||1
13788|NCT03075410|28381|P9|NOT COMPLETED|Part A-Period 2 (14 Days)||0
13789|NCT03075410|28382|P8|NOT COMPLETED|Part A-Period 2 (14 Days)||0
13790|NCT03075410|28383|P7|NOT COMPLETED|Part A-Period 2 (14 Days)||0
13791|NCT03075410|28384|P6|NOT COMPLETED|Part A-Period 2 (14 Days)||0
13792|NCT03075410|28385|P5|NOT COMPLETED|Part A-Period 2 (14 Days)||0
13793|NCT03075410|28386|P4|NOT COMPLETED|Part A-Period 2 (14 Days)||0
13794|NCT03075410|28387|P3|NOT COMPLETED|Part A-Period 2 (14 Days)||1
13795|NCT03075410|28388|P2|NOT COMPLETED|Part A-Period 2 (14 Days)||0
13796|NCT03075410|28389|P1|NOT COMPLETED|Part A-Period 2 (14 Days)||1
13797|NCT03075410|28381|P9|COMPLETED|Part A-Period 2 (14 Days)||0
13798|NCT03075410|28382|P8|COMPLETED|Part A-Period 2 (14 Days)||0
13799|NCT03075410|28383|P7|COMPLETED|Part A-Period 2 (14 Days)||0
13800|NCT03075410|28384|P6|COMPLETED|Part A-Period 2 (14 Days)||1
13801|NCT03075410|28385|P5|COMPLETED|Part A-Period 2 (14 Days)||2
13802|NCT03075410|28386|P4|COMPLETED|Part A-Period 2 (14 Days)||1
13803|NCT03075410|28387|P3|COMPLETED|Part A-Period 2 (14 Days)||1
13804|NCT03075410|28388|P2|COMPLETED|Part A-Period 2 (14 Days)||1
13805|NCT03075410|28389|P1|COMPLETED|Part A-Period 2 (14 Days)||1
13806|NCT03075410|28381|P9|STARTED|Part A-Period 2 (14 Days)||0
13807|NCT03075410|28382|P8|STARTED|Part A-Period 2 (14 Days)||0
13808|NCT03075410|28383|P7|STARTED|Part A-Period 2 (14 Days)||0
13809|NCT03075410|28384|P6|STARTED|Part A-Period 2 (14 Days)||1
13810|NCT03075410|28385|P5|STARTED|Part A-Period 2 (14 Days)||2
13811|NCT03075410|28386|P4|STARTED|Part A-Period 2 (14 Days)||1
13812|NCT03075410|28387|P3|STARTED|Part A-Period 2 (14 Days)||2
13813|NCT03075410|28388|P2|STARTED|Part A-Period 2 (14 Days)||1
13814|NCT03075410|28389|P1|STARTED|Part A-Period 2 (14 Days)||2
13815|NCT03075410|28381|P9|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
13816|NCT03075410|28382|P8|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
13817|NCT03075410|28383|P7|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
13818|NCT03075410|28384|P6|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
13819|NCT03075410|28385|P5|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
13820|NCT03075410|28386|P4|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
13821|NCT03075410|28387|P3|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
13822|NCT03075410|28388|P2|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
13823|NCT03075410|28389|P1|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
13824|NCT03075410|28381|P9|COMPLETED|Part A-Washout Period 1 (14 Days)||0
13825|NCT03075410|28382|P8|COMPLETED|Part A-Washout Period 1 (14 Days)||0
13826|NCT03075410|28383|P7|COMPLETED|Part A-Washout Period 1 (14 Days)||0
13827|NCT03075410|28384|P6|COMPLETED|Part A-Washout Period 1 (14 Days)||1
13828|NCT03075410|28385|P5|COMPLETED|Part A-Washout Period 1 (14 Days)||2
13829|NCT03075410|28386|P4|COMPLETED|Part A-Washout Period 1 (14 Days)||1
13830|NCT03075410|28387|P3|COMPLETED|Part A-Washout Period 1 (14 Days)||2
13831|NCT03075410|28388|P2|COMPLETED|Part A-Washout Period 1 (14 Days)||1
13832|NCT03075410|28389|P1|COMPLETED|Part A-Washout Period 1 (14 Days)||2
13833|NCT03075410|28381|P9|STARTED|Part A-Washout Period 1 (14 Days)||0
13834|NCT03075410|28382|P8|STARTED|Part A-Washout Period 1 (14 Days)||0
13835|NCT03075410|28383|P7|STARTED|Part A-Washout Period 1 (14 Days)||0
13836|NCT03075410|28384|P6|STARTED|Part A-Washout Period 1 (14 Days)||1
13837|NCT03075410|28385|P5|STARTED|Part A-Washout Period 1 (14 Days)||2
13838|NCT03075410|28386|P4|STARTED|Part A-Washout Period 1 (14 Days)||1
13839|NCT03075410|28387|P3|STARTED|Part A-Washout Period 1 (14 Days)||2
13840|NCT03075410|28388|P2|STARTED|Part A-Washout Period 1 (14 Days)||1
13841|NCT03075410|28389|P1|STARTED|Part A-Washout Period 1 (14 Days)||2
13842|NCT03075410|28381|P9|NOT COMPLETED|Part A-Period 1 (14 Days)||0
13843|NCT03075410|28382|P8|NOT COMPLETED|Part A-Period 1 (14 Days)||0
13844|NCT03075410|28383|P7|NOT COMPLETED|Part A-Period 1 (14 Days)||0
13845|NCT03075410|28384|P6|NOT COMPLETED|Part A-Period 1 (14 Days)||0
13846|NCT03075410|28385|P5|NOT COMPLETED|Part A-Period 1 (14 Days)||0
13847|NCT03075410|28386|P4|NOT COMPLETED|Part A-Period 1 (14 Days)||0
13848|NCT03075410|28387|P3|NOT COMPLETED|Part A-Period 1 (14 Days)||0
13849|NCT03075410|28388|P2|NOT COMPLETED|Part A-Period 1 (14 Days)||0
13850|NCT03075410|28389|P1|NOT COMPLETED|Part A-Period 1 (14 Days)||0
13851|NCT03075410|28381|P9|COMPLETED|Part A-Period 1 (14 Days)||0
13852|NCT03075410|28382|P8|COMPLETED|Part A-Period 1 (14 Days)||0
13853|NCT03075410|28383|P7|COMPLETED|Part A-Period 1 (14 Days)||0
13854|NCT03075410|28384|P6|COMPLETED|Part A-Period 1 (14 Days)||1
13855|NCT03075410|28385|P5|COMPLETED|Part A-Period 1 (14 Days)||2
13856|NCT03075410|28386|P4|COMPLETED|Part A-Period 1 (14 Days)||1
13857|NCT03075410|28387|P3|COMPLETED|Part A-Period 1 (14 Days)||2
13858|NCT03075410|28388|P2|COMPLETED|Part A-Period 1 (14 Days)||1
13859|NCT03075410|28389|P1|COMPLETED|Part A-Period 1 (14 Days)||2
13860|NCT03075410|28381|P9|STARTED|Part A-Period 1 (14 Days)||0
13861|NCT03075410|28382|P8|STARTED|Part A-Period 1 (14 Days)||0
13862|NCT03075410|28383|P7|STARTED|Part A-Period 1 (14 Days)||0
13863|NCT03075410|28384|P6|STARTED|Part A-Period 1 (14 Days)||1
13864|NCT03075410|28385|P5|STARTED|Part A-Period 1 (14 Days)||2
13865|NCT03075410|28386|P4|STARTED|Part A-Period 1 (14 Days)||1
13866|NCT03075410|28387|P3|STARTED|Part A-Period 1 (14 Days)||2
13867|NCT03075410|28388|P2|STARTED|Part A-Period 1 (14 Days)||1
13868|NCT03075410|28389|P1|STARTED|Part A-Period 1 (14 Days)||2
13869|NCT03075163|28555|P2|NOT COMPLETED|Overall Study||138
13870|NCT03075163|28556|P1|NOT COMPLETED|Overall Study||138
13871|NCT03075163|28555|P2|COMPLETED|Overall Study||12
13872|NCT03075163|28556|P1|COMPLETED|Overall Study||12
13873|NCT03075163|28555|P2|STARTED|Overall Study||150
13874|NCT03075163|28556|P1|STARTED|Overall Study||150
13875|NCT03074682|28565|P3|NOT COMPLETED|Overall Study||0
13876|NCT03074682|28566|P2|NOT COMPLETED|Overall Study||0
13877|NCT03074682|28567|P1|NOT COMPLETED|Overall Study||0
13878|NCT03074682|28565|P3|COMPLETED|Overall Study||18
13879|NCT03074682|28566|P2|COMPLETED|Overall Study||18
13880|NCT03074682|28567|P1|COMPLETED|Overall Study||18
13881|NCT03074682|28565|P3|STARTED|Overall Study||18
13882|NCT03074682|28566|P2|STARTED|Overall Study||18
13883|NCT03074682|28567|P1|STARTED|Overall Study||18
13884|NCT03074500|28587|P3|NOT COMPLETED|Overall Study||1
13885|NCT03074500|28588|P2|NOT COMPLETED|Overall Study||1
13886|NCT03074500|28589|P1|NOT COMPLETED|Overall Study||1
13887|NCT03074500|28587|P3|COMPLETED|Overall Study||10
13888|NCT03074500|28588|P2|COMPLETED|Overall Study||10
13889|NCT03074500|28589|P1|COMPLETED|Overall Study||10
13890|NCT03074500|28587|P3|STARTED|Overall Study||11
13891|NCT03074500|28588|P2|STARTED|Overall Study||11
13892|NCT03074500|28589|P1|STARTED|Overall Study||11
13893|NCT03074409|28617|P2|NOT COMPLETED|Overall Study||4
13894|NCT03074409|28618|P1|NOT COMPLETED|Overall Study||4
13895|NCT03074409|28617|P2|COMPLETED|Overall Study||38
13896|NCT03074409|28618|P1|COMPLETED|Overall Study||37
13897|NCT03074409|28617|P2|STARTED|Overall Study||42
13898|NCT03074409|28618|P1|STARTED|Overall Study||41
13899|NCT03074331|28626|P1|NOT COMPLETED|Overall Study||7
13900|NCT03074331|28626|P1|COMPLETED|Overall Study||123
13901|NCT03074331|28626|P1|STARTED|Overall Study||130
13902|NCT03074162|28638|P6|NOT COMPLETED|Period 3||0
13903|NCT03074162|28639|P5|NOT COMPLETED|Period 3||1
13904|NCT03074162|28640|P4|NOT COMPLETED|Period 3||0
13905|NCT03074162|28641|P3|NOT COMPLETED|Period 3||0
13906|NCT03074162|28642|P2|NOT COMPLETED|Period 3||0
13907|NCT03074162|28643|P1|NOT COMPLETED|Period 3||1
13908|NCT03074162|28638|P6|COMPLETED|Period 3||7
13909|NCT03074162|28639|P5|COMPLETED|Period 3||7
13910|NCT03074162|28640|P4|COMPLETED|Period 3||8
13911|NCT03074162|28641|P3|COMPLETED|Period 3||6
13912|NCT03074162|28642|P2|COMPLETED|Period 3||8
13913|NCT03074162|28643|P1|COMPLETED|Period 3||7
13914|NCT03074162|28638|P6|STARTED|Period 3||7
13915|NCT03074162|28639|P5|STARTED|Period 3||8
13916|NCT03074162|28640|P4|STARTED|Period 3||8
13917|NCT03074162|28641|P3|STARTED|Period 3||6
13918|NCT03074162|28642|P2|STARTED|Period 3||8
13919|NCT03074162|28643|P1|STARTED|Period 3||8
13920|NCT03074162|28638|P6|NOT COMPLETED|Period 2 Including Washout 2||1
13921|NCT03074162|28639|P5|NOT COMPLETED|Period 2 Including Washout 2||0
13922|NCT03074162|28640|P4|NOT COMPLETED|Period 2 Including Washout 2||0
13923|NCT03074162|28641|P3|NOT COMPLETED|Period 2 Including Washout 2||1
13924|NCT03074162|28642|P2|NOT COMPLETED|Period 2 Including Washout 2||0
13925|NCT03074162|28643|P1|NOT COMPLETED|Period 2 Including Washout 2||0
13926|NCT03074162|28638|P6|COMPLETED|Period 2 Including Washout 2||7
13927|NCT03074162|28639|P5|COMPLETED|Period 2 Including Washout 2||8
13928|NCT03074162|28640|P4|COMPLETED|Period 2 Including Washout 2||8
13929|NCT03074162|28641|P3|COMPLETED|Period 2 Including Washout 2||6
13930|NCT03074162|28642|P2|COMPLETED|Period 2 Including Washout 2||8
13931|NCT03074162|28643|P1|COMPLETED|Period 2 Including Washout 2||8
13932|NCT03074162|28638|P6|STARTED|Period 2 Including Washout 2||8
13933|NCT03074162|28639|P5|STARTED|Period 2 Including Washout 2||8
13934|NCT03074162|28640|P4|STARTED|Period 2 Including Washout 2||8
13935|NCT03074162|28641|P3|STARTED|Period 2 Including Washout 2||7
13936|NCT03074162|28642|P2|STARTED|Period 2 Including Washout 2||8
13937|NCT03074162|28643|P1|STARTED|Period 2 Including Washout 2||8
13938|NCT03074162|28638|P6|NOT COMPLETED|Period 1 Including Washout 1||0
13939|NCT03074162|28639|P5|NOT COMPLETED|Period 1 Including Washout 1||0
13940|NCT03074162|28640|P4|NOT COMPLETED|Period 1 Including Washout 1||0
13941|NCT03074162|28641|P3|NOT COMPLETED|Period 1 Including Washout 1||1
13942|NCT03074162|28642|P2|NOT COMPLETED|Period 1 Including Washout 1||0
13943|NCT03074162|28643|P1|NOT COMPLETED|Period 1 Including Washout 1||0
13944|NCT03074162|28638|P6|COMPLETED|Period 1 Including Washout 1||8
13945|NCT03074162|28639|P5|COMPLETED|Period 1 Including Washout 1||8
13946|NCT03074162|28640|P4|COMPLETED|Period 1 Including Washout 1||8
13947|NCT03074162|28641|P3|COMPLETED|Period 1 Including Washout 1||7
13948|NCT03074162|28642|P2|COMPLETED|Period 1 Including Washout 1||8
13949|NCT03074162|28643|P1|COMPLETED|Period 1 Including Washout 1||8
13950|NCT03074162|28638|P6|STARTED|Period 1 Including Washout 1||8
13951|NCT03074162|28639|P5|STARTED|Period 1 Including Washout 1||8
13952|NCT03074162|28640|P4|STARTED|Period 1 Including Washout 1||8
13953|NCT03074162|28641|P3|STARTED|Period 1 Including Washout 1||8
13954|NCT03074162|28642|P2|STARTED|Period 1 Including Washout 1||8
13955|NCT03074162|28643|P1|STARTED|Period 1 Including Washout 1||8
13956|NCT03073876|28665|P2|NOT COMPLETED|Overall Study||0
13957|NCT03073876|28666|P1|NOT COMPLETED|Overall Study||0
13958|NCT03073876|28665|P2|COMPLETED|Overall Study||11
13959|NCT03073876|28666|P1|COMPLETED|Overall Study||12
13960|NCT03073876|28665|P2|STARTED|Overall Study||11
13961|NCT03073876|28666|P1|STARTED|Overall Study||12
13962|NCT03073798|28705|P1|NOT COMPLETED|Overall Study||2
13963|NCT03073798|28705|P1|COMPLETED|Overall Study||10
13964|NCT03073798|28705|P1|STARTED|Overall Study||12
13965|NCT03073486|28718|P2|NOT COMPLETED|Overall Study||44
13966|NCT03073486|28719|P1|NOT COMPLETED|Overall Study||88
13967|NCT03073486|28718|P2|COMPLETED|Overall Study||207
13968|NCT03073486|28719|P1|COMPLETED|Overall Study||405
13969|NCT03073486|28718|P2|STARTED|Overall Study||251
13970|NCT03073486|28719|P1|STARTED|Overall Study||493
13971|NCT03072875|28729|P1|NOT COMPLETED|Overall Study||1
13972|NCT03072875|28729|P1|COMPLETED|Overall Study||25
13973|NCT03072875|28729|P1|STARTED|Overall Study||26
13974|NCT03072719|28736|P2|NOT COMPLETED|Overall Study||1
13975|NCT03072719|28737|P1|NOT COMPLETED|Overall Study||1
13976|NCT03072719|28736|P2|COMPLETED|Overall Study||59
13977|NCT03072719|28737|P1|COMPLETED|Overall Study||59
13978|NCT03072719|28736|P2|STARTED|Overall Study||60
13979|NCT03072719|28737|P1|STARTED|Overall Study||60
13980|NCT03072550|28747|P1|NOT COMPLETED|Overall Study||2
13981|NCT03072550|28747|P1|COMPLETED|Overall Study||24
13982|NCT03072550|28747|P1|STARTED|Overall Study||26
13983|NCT03071887|28751|P1|NOT COMPLETED|Overall Study||6
13984|NCT03071887|28751|P1|COMPLETED|Overall Study||7
13985|NCT03071887|28751|P1|STARTED|Overall Study||13
13986|NCT03071744|28756|P1|NOT COMPLETED|Overall Study||2
13987|NCT03071744|28756|P1|COMPLETED|Overall Study||4
13988|NCT03071744|28756|P1|STARTED|Overall Study||6
13989|NCT03070730|28765|P3|NOT COMPLETED|Overall Study||0
13990|NCT03070730|28766|P2|NOT COMPLETED|Overall Study||0
13991|NCT03070730|28767|P1|NOT COMPLETED|Overall Study||0
13992|NCT03070730|28765|P3|COMPLETED|Overall Study||0
13993|NCT03070730|28766|P2|COMPLETED|Overall Study||0
13994|NCT03070730|28767|P1|COMPLETED|Overall Study||0
13995|NCT03070730|28765|P3|STARTED|Overall Study||0
13996|NCT03070730|28766|P2|STARTED|Overall Study||0
13997|NCT03070730|28767|P1|STARTED|Overall Study||0
13998|NCT03070548|28898|P1|NOT COMPLETED|Overall Study||0
13999|NCT03070548|28898|P1|COMPLETED|Overall Study||6
14000|NCT03070548|28898|P1|STARTED|Overall Study||6
14001|NCT03070171|28936|P2|NOT COMPLETED|Treatment Period 4 + Washout||1
14002|NCT03070171|28937|P1|NOT COMPLETED|Treatment Period 4 + Washout||0
14003|NCT03070171|28936|P2|COMPLETED|Treatment Period 4 + Washout||78
14004|NCT03070171|28937|P1|COMPLETED|Treatment Period 4 + Washout||80
14005|NCT03070171|28936|P2|STARTED|Treatment Period 4 + Washout||79
14006|NCT03070171|28937|P1|STARTED|Treatment Period 4 + Washout||80
14007|NCT03070171|28936|P2|NOT COMPLETED|Treatment Period 3 + Washout||0
14008|NCT03070171|28937|P1|NOT COMPLETED|Treatment Period 3 + Washout||0
14009|NCT03070171|28936|P2|COMPLETED|Treatment Period 3 + Washout||79
14010|NCT03070171|28937|P1|COMPLETED|Treatment Period 3 + Washout||80
14011|NCT03070171|28936|P2|STARTED|Treatment Period 3 + Washout||79
14012|NCT03070171|28937|P1|STARTED|Treatment Period 3 + Washout||80
14013|NCT03070171|28936|P2|NOT COMPLETED|Treatment Period 2 + Washout||1
14014|NCT03070171|28937|P1|NOT COMPLETED|Treatment Period 2 + Washout||0
14015|NCT03070171|28936|P2|COMPLETED|Treatment Period 2 + Washout||79
14016|NCT03070171|28937|P1|COMPLETED|Treatment Period 2 + Washout||80
14017|NCT03070171|28936|P2|STARTED|Treatment Period 2 + Washout||80
14018|NCT03070171|28937|P1|STARTED|Treatment Period 2 + Washout||80
14019|NCT03070171|28936|P2|NOT COMPLETED|Treatment Period 1 + Washout||0
14020|NCT03070171|28937|P1|NOT COMPLETED|Treatment Period 1 + Washout||0
14021|NCT03070171|28936|P2|COMPLETED|Treatment Period 1 + Washout||80
14022|NCT03070171|28937|P1|COMPLETED|Treatment Period 1 + Washout||80
14023|NCT03070171|28936|P2|STARTED|Treatment Period 1 + Washout||80
14024|NCT03070171|28937|P1|STARTED|Treatment Period 1 + Washout||80
14025|NCT03070002|28953|P1|NOT COMPLETED|Follow up for 2 Years||1
14026|NCT03070002|28953|P1|COMPLETED|Follow up for 2 Years||0
14027|NCT03070002|28953|P1|STARTED|Follow up for 2 Years||1
14028|NCT03070002|28953|P1|NOT COMPLETED|3 Cycles of Treatment||0
14029|NCT03070002|28953|P1|COMPLETED|3 Cycles of Treatment||1
14030|NCT03070002|28953|P1|STARTED|3 Cycles of Treatment||1
14031|NCT03069989|28961|P2|NOT COMPLETED|Dosing Period 2 (Up to 16 Days)||0
14032|NCT03069989|28962|P1|NOT COMPLETED|Dosing Period 2 (Up to 16 Days)||1
14033|NCT03069989|28961|P2|COMPLETED|Dosing Period 2 (Up to 16 Days)||5
14034|NCT03069989|28962|P1|COMPLETED|Dosing Period 2 (Up to 16 Days)||2
14035|NCT03069989|28961|P2|STARTED|Dosing Period 2 (Up to 16 Days)||5
14036|NCT03069989|28962|P1|STARTED|Dosing Period 2 (Up to 16 Days)||3
14037|NCT03069989|28961|P2|NOT COMPLETED|Wash Out Period (Up to 28 Days))||0
14038|NCT03069989|28962|P1|NOT COMPLETED|Wash Out Period (Up to 28 Days))||0
14039|NCT03069989|28961|P2|COMPLETED|Wash Out Period (Up to 28 Days))||5
14040|NCT03069989|28962|P1|COMPLETED|Wash Out Period (Up to 28 Days))||3
14041|NCT03069989|28961|P2|STARTED|Wash Out Period (Up to 28 Days))||5
14042|NCT03069989|28962|P1|STARTED|Wash Out Period (Up to 28 Days))||3
14043|NCT03069989|28961|P2|NOT COMPLETED|Dosing Period 1 (Up to 2 Days)||0
14044|NCT03069989|28962|P1|NOT COMPLETED|Dosing Period 1 (Up to 2 Days)||0
14045|NCT03069989|28961|P2|COMPLETED|Dosing Period 1 (Up to 2 Days)||5
14046|NCT03069989|28962|P1|COMPLETED|Dosing Period 1 (Up to 2 Days)||3
14047|NCT03069989|28961|P2|STARTED|Dosing Period 1 (Up to 2 Days)||5
14048|NCT03069989|28962|P1|STARTED|Dosing Period 1 (Up to 2 Days)||3
14049|NCT03069677|29050|P2|NOT COMPLETED|Overall Study||3
14050|NCT03069677|29051|P1|NOT COMPLETED|Overall Study||3
14051|NCT03069677|29050|P2|COMPLETED|Overall Study||77
14052|NCT03069677|29051|P1|COMPLETED|Overall Study||77
14053|NCT03069677|29050|P2|STARTED|Overall Study||80
14054|NCT03069677|29051|P1|STARTED|Overall Study||80
14055|NCT03069365|29067|P1|NOT COMPLETED|Overall Study||1
14056|NCT03069365|29067|P1|COMPLETED|Overall Study||100
14057|NCT03069365|29067|P1|STARTED|Overall Study||101
14058|NCT03069313|29073|P1|NOT COMPLETED|Overall Study||5
14059|NCT03069313|29073|P1|COMPLETED|Overall Study||36
14060|NCT03069313|29073|P1|STARTED|Overall Study||41
14061|NCT03068611|29082|P2|NOT COMPLETED|Overall Study||25
14062|NCT03068611|29083|P1|NOT COMPLETED|Overall Study||31
14063|NCT03068611|29082|P2|COMPLETED|Overall Study|This is the number of participants followed through 6 months from enrollment.|33
14064|NCT03068611|29083|P1|COMPLETED|Overall Study|This is the number of participants followed through 6 months from enrollment.|30
14065|NCT03068611|29082|P2|STARTED|Overall Study||58
14066|NCT03068611|29083|P1|STARTED|Overall Study||61
14067|NCT03067948|29095|P1|NOT COMPLETED|Overall Study||0
14068|NCT03067948|29095|P1|COMPLETED|Overall Study||32
14069|NCT03067948|29095|P1|STARTED|Overall Study||32
14070|NCT03067506|29100|P1|NOT COMPLETED|Overall Study||0
14071|NCT03067506|29100|P1|COMPLETED|Overall Study||30
14072|NCT03067506|29100|P1|STARTED|Overall Study||30
14073|NCT03066999|29109|P2|NOT COMPLETED|Overall Study||2
14074|NCT03066999|29110|P1|NOT COMPLETED|Overall Study||0
14075|NCT03066999|29109|P2|COMPLETED|Overall Study||1
14076|NCT03066999|29110|P1|COMPLETED|Overall Study||2
14077|NCT03066999|29109|P2|STARTED|Overall Study||3
14078|NCT03066999|29110|P1|STARTED|Overall Study||2
14079|NCT03066622|29130|P2|NOT COMPLETED|Overall Study||26
14080|NCT03066622|29131|P1|NOT COMPLETED|Overall Study||26
14081|NCT03066622|29130|P2|COMPLETED|Overall Study||35
14082|NCT03066622|29131|P1|COMPLETED|Overall Study||35
14083|NCT03066622|29130|P2|STARTED|Overall Study||61
14084|NCT03066622|29131|P1|STARTED|Overall Study||61
14085|NCT03066102|29141|P1|NOT COMPLETED|Overall Study||0
14086|NCT03066102|29141|P1|COMPLETED|Overall Study||30
14087|NCT03066102|29141|P1|STARTED|Overall Study||30
14088|NCT03065933|29150|P1|NOT COMPLETED|Overall Study||5
14089|NCT03065933|29150|P1|COMPLETED|Overall Study||0
14090|NCT03065933|29150|P1|STARTED|Overall Study||5
14091|NCT03065075|29156|P2|NOT COMPLETED|Overall Study||0
14092|NCT03065075|29157|P1|NOT COMPLETED|Overall Study||0
14093|NCT03065075|29156|P2|COMPLETED|Overall Study||76
14094|NCT03065075|29157|P1|COMPLETED|Overall Study||76
14095|NCT03065075|29156|P2|As-treated Analysis|Overall Study||77
14096|NCT03065075|29157|P1|As-treated Analysis|Overall Study||69
14097|NCT03065075|29156|P2|Intent-to-treat Analysis|Overall Study||74
14098|NCT03065075|29157|P1|Intent-to-treat Analysis|Overall Study||72
14099|NCT03065075|29156|P2|STARTED|Overall Study||76
14100|NCT03065075|29157|P1|STARTED|Overall Study||76
14101|NCT03065023|29169|P5|NOT COMPLETED|Overall Study||0
14102|NCT03065023|29170|P4|NOT COMPLETED|Overall Study||3
14103|NCT03065023|29171|P3|NOT COMPLETED|Overall Study||1
14104|NCT03065023|29172|P2|NOT COMPLETED|Overall Study||2
14105|NCT03065023|29173|P1|NOT COMPLETED|Overall Study||2
14106|NCT03065023|29169|P5|COMPLETED|Overall Study||0
14107|NCT03065023|29170|P4|COMPLETED|Overall Study||3
14108|NCT03065023|29171|P3|COMPLETED|Overall Study||2
14109|NCT03065023|29172|P2|COMPLETED|Overall Study||1
14110|NCT03065023|29173|P1|COMPLETED|Overall Study||1
14111|NCT03065023|29169|P5|STARTED|Overall Study|Group B not started for business reasons.|0
14112|NCT03065023|29170|P4|STARTED|Overall Study||6
14113|NCT03065023|29171|P3|STARTED|Overall Study||3
14114|NCT03065023|29172|P2|STARTED|Overall Study||3
14115|NCT03065023|29173|P1|STARTED|Overall Study||3
14116|NCT03064841|29239|P1|NOT COMPLETED|Overall Study||17
14117|NCT03064841|29239|P1|COMPLETED|Overall Study||1520
14118|NCT03064841|29239|P1|STARTED|Overall Study||1537
14119|NCT03064113|29258|P4|NOT COMPLETED|Washout (7 Days)||0
14120|NCT03064113|29259|P3|NOT COMPLETED|Washout (7 Days)||0
14121|NCT03064113|29260|P2|NOT COMPLETED|Washout (7 Days)||0
14122|NCT03064113|29261|P1|NOT COMPLETED|Washout (7 Days)||0
14123|NCT03064113|29258|P4|COMPLETED|Washout (7 Days)||8
14124|NCT03064113|29259|P3|COMPLETED|Washout (7 Days)||8
14125|NCT03064113|29260|P2|COMPLETED|Washout (7 Days)||8
14126|NCT03064113|29261|P1|COMPLETED|Washout (7 Days)||8
14127|NCT03064113|29258|P4|STARTED|Washout (7 Days)||8
14128|NCT03064113|29259|P3|STARTED|Washout (7 Days)||8
14129|NCT03064113|29260|P2|STARTED|Washout (7 Days)||8
14130|NCT03064113|29261|P1|STARTED|Washout (7 Days)||8
14131|NCT03064113|29258|P4|NOT COMPLETED|Intervention 4 (2 Days)||0
14132|NCT03064113|29259|P3|NOT COMPLETED|Intervention 4 (2 Days)||0
14133|NCT03064113|29260|P2|NOT COMPLETED|Intervention 4 (2 Days)||0
14134|NCT03064113|29261|P1|NOT COMPLETED|Intervention 4 (2 Days)||0
14135|NCT03064113|29258|P4|COMPLETED|Intervention 4 (2 Days)||8
14136|NCT03064113|29259|P3|COMPLETED|Intervention 4 (2 Days)||8
14137|NCT03064113|29260|P2|COMPLETED|Intervention 4 (2 Days)||8
14138|NCT03064113|29261|P1|COMPLETED|Intervention 4 (2 Days)||8
14139|NCT03064113|29258|P4|STARTED|Intervention 4 (2 Days)||8
14140|NCT03064113|29259|P3|STARTED|Intervention 4 (2 Days)||8
14141|NCT03064113|29260|P2|STARTED|Intervention 4 (2 Days)||8
14142|NCT03064113|29261|P1|STARTED|Intervention 4 (2 Days)||8
14143|NCT03064113|29258|P4|NOT COMPLETED|Washout (7 Days)||0
14144|NCT03064113|29259|P3|NOT COMPLETED|Washout (7 Days)||0
14145|NCT03064113|29260|P2|NOT COMPLETED|Washout (7 Days)||0
14146|NCT03064113|29261|P1|NOT COMPLETED|Washout (7 Days)||0
14147|NCT03064113|29258|P4|COMPLETED|Washout (7 Days)||8
14148|NCT03064113|29259|P3|COMPLETED|Washout (7 Days)||8
14149|NCT03064113|29260|P2|COMPLETED|Washout (7 Days)||8
14150|NCT03064113|29261|P1|COMPLETED|Washout (7 Days)||8
14151|NCT03064113|29258|P4|STARTED|Washout (7 Days)||8
14152|NCT03064113|29259|P3|STARTED|Washout (7 Days)||8
14153|NCT03064113|29260|P2|STARTED|Washout (7 Days)||8
14154|NCT03064113|29261|P1|STARTED|Washout (7 Days)||8
14155|NCT03064113|29258|P4|NOT COMPLETED|Intervention 3 (2 Days)||0
14156|NCT03064113|29259|P3|NOT COMPLETED|Intervention 3 (2 Days)||0
14157|NCT03064113|29260|P2|NOT COMPLETED|Intervention 3 (2 Days)||0
14158|NCT03064113|29261|P1|NOT COMPLETED|Intervention 3 (2 Days)||0
14159|NCT03064113|29258|P4|COMPLETED|Intervention 3 (2 Days)||8
14160|NCT03064113|29259|P3|COMPLETED|Intervention 3 (2 Days)||8
14161|NCT03064113|29260|P2|COMPLETED|Intervention 3 (2 Days)||8
14162|NCT03064113|29261|P1|COMPLETED|Intervention 3 (2 Days)||8
14163|NCT03064113|29258|P4|STARTED|Intervention 3 (2 Days)||8
14164|NCT03064113|29259|P3|STARTED|Intervention 3 (2 Days)||8
14165|NCT03064113|29260|P2|STARTED|Intervention 3 (2 Days)||8
14166|NCT03064113|29261|P1|STARTED|Intervention 3 (2 Days)||8
14167|NCT03064113|29258|P4|NOT COMPLETED|Washout (7 Days)||0
14168|NCT03064113|29259|P3|NOT COMPLETED|Washout (7 Days)||0
14169|NCT03064113|29260|P2|NOT COMPLETED|Washout (7 Days)||0
14170|NCT03064113|29261|P1|NOT COMPLETED|Washout (7 Days)||0
14171|NCT03064113|29258|P4|COMPLETED|Washout (7 Days)||8
14172|NCT03064113|29259|P3|COMPLETED|Washout (7 Days)||8
14173|NCT03064113|29260|P2|COMPLETED|Washout (7 Days)||8
14174|NCT03064113|29261|P1|COMPLETED|Washout (7 Days)||8
14175|NCT03064113|29258|P4|STARTED|Washout (7 Days)||8
14176|NCT03064113|29259|P3|STARTED|Washout (7 Days)||8
14177|NCT03064113|29260|P2|STARTED|Washout (7 Days)||8
14178|NCT03064113|29261|P1|STARTED|Washout (7 Days)||8
14179|NCT03064113|29258|P4|NOT COMPLETED|Intervention 2 (2 Days)||0
14180|NCT03064113|29259|P3|NOT COMPLETED|Intervention 2 (2 Days)||0
14181|NCT03064113|29260|P2|NOT COMPLETED|Intervention 2 (2 Days)||0
14182|NCT03064113|29261|P1|NOT COMPLETED|Intervention 2 (2 Days)||0
14183|NCT03064113|29258|P4|COMPLETED|Intervention 2 (2 Days)||8
14184|NCT03064113|29259|P3|COMPLETED|Intervention 2 (2 Days)||8
14185|NCT03064113|29260|P2|COMPLETED|Intervention 2 (2 Days)||8
14186|NCT03064113|29261|P1|COMPLETED|Intervention 2 (2 Days)||8
14187|NCT03064113|29258|P4|STARTED|Intervention 2 (2 Days)||8
14188|NCT03064113|29259|P3|STARTED|Intervention 2 (2 Days)||8
14189|NCT03064113|29260|P2|STARTED|Intervention 2 (2 Days)||8
14190|NCT03064113|29261|P1|STARTED|Intervention 2 (2 Days)||8
14191|NCT03064113|29258|P4|NOT COMPLETED|Washout (7 Days)||0
14192|NCT03064113|29259|P3|NOT COMPLETED|Washout (7 Days)||0
14193|NCT03064113|29260|P2|NOT COMPLETED|Washout (7 Days)||0
14194|NCT03064113|29261|P1|NOT COMPLETED|Washout (7 Days)||0
14195|NCT03064113|29258|P4|COMPLETED|Washout (7 Days)||8
14196|NCT03064113|29259|P3|COMPLETED|Washout (7 Days)||8
14197|NCT03064113|29260|P2|COMPLETED|Washout (7 Days)||8
14198|NCT03064113|29261|P1|COMPLETED|Washout (7 Days)||8
14199|NCT03064113|29258|P4|STARTED|Washout (7 Days)||8
14200|NCT03064113|29259|P3|STARTED|Washout (7 Days)||8
14201|NCT03064113|29260|P2|STARTED|Washout (7 Days)||8
14202|NCT03064113|29261|P1|STARTED|Washout (7 Days)||8
14203|NCT03064113|29258|P4|NOT COMPLETED|Intervention 1 (2 Days)||0
14204|NCT03064113|29259|P3|NOT COMPLETED|Intervention 1 (2 Days)||0
14205|NCT03064113|29260|P2|NOT COMPLETED|Intervention 1 (2 Days)||0
14206|NCT03064113|29261|P1|NOT COMPLETED|Intervention 1 (2 Days)||0
14207|NCT03064113|29258|P4|COMPLETED|Intervention 1 (2 Days)||8
14208|NCT03064113|29259|P3|COMPLETED|Intervention 1 (2 Days)||8
14209|NCT03064113|29260|P2|COMPLETED|Intervention 1 (2 Days)||8
14210|NCT03064113|29261|P1|COMPLETED|Intervention 1 (2 Days)||8
14211|NCT03064113|29258|P4|STARTED|Intervention 1 (2 Days)||8
14212|NCT03064113|29259|P3|STARTED|Intervention 1 (2 Days)||8
14213|NCT03064113|29260|P2|STARTED|Intervention 1 (2 Days)||8
14214|NCT03064113|29261|P1|STARTED|Intervention 1 (2 Days)||8
14215|NCT03063476|29295|P1|NOT COMPLETED|Overall Study||0
14216|NCT03063476|29295|P1|COMPLETED|Overall Study||2
14217|NCT03063476|29295|P1|STARTED|Overall Study||2
14218|NCT03063385|29302|P2|NOT COMPLETED|Overall Study||76
14219|NCT03063385|29303|P1|NOT COMPLETED|Overall Study||87
14220|NCT03063385|29302|P2|COMPLETED|Overall Study||254
14221|NCT03063385|29303|P1|COMPLETED|Overall Study||243
14222|NCT03063385|29302|P2|12-month Follow-up|Overall Study||254
14223|NCT03063385|29303|P1|12-month Follow-up|Overall Study||243
14224|NCT03063385|29302|P2|6-month Follow-up|Overall Study||259
14225|NCT03063385|29303|P1|6-month Follow-up|Overall Study||265
14226|NCT03063385|29302|P2|3-month Follow-up|Overall Study||259
14227|NCT03063385|29303|P1|3-month Follow-up|Overall Study||257
14228|NCT03063385|29302|P2|STARTED|Overall Study||330
14229|NCT03063385|29303|P1|STARTED|Overall Study||330
14230|NCT03062917|29318|P5|NOT COMPLETED|Overall Study||0
14231|NCT03062917|29319|P4|NOT COMPLETED|Overall Study||0
14232|NCT03062917|29320|P3|NOT COMPLETED|Overall Study||0
14233|NCT03062917|29321|P2|NOT COMPLETED|Overall Study||0
14234|NCT03062917|29322|P1|NOT COMPLETED|Overall Study||0
14235|NCT03062917|29318|P5|COMPLETED|Overall Study||0
14236|NCT03062917|29319|P4|COMPLETED|Overall Study||20
14237|NCT03062917|29320|P3|COMPLETED|Overall Study||49
14238|NCT03062917|29321|P2|COMPLETED|Overall Study||51
14239|NCT03062917|29322|P1|COMPLETED|Overall Study||32
14240|NCT03062917|29318|P5|STARTED|Overall Study||0
14241|NCT03062917|29319|P4|STARTED|Overall Study||20
14242|NCT03062917|29320|P3|STARTED|Overall Study||49
14243|NCT03062917|29321|P2|STARTED|Overall Study||51
14244|NCT03062917|29322|P1|STARTED|Overall Study||32
14245|NCT03061513|29336|P2|NOT COMPLETED|Overall Study||1
14246|NCT03061513|29337|P1|NOT COMPLETED|Overall Study||0
14247|NCT03061513|29336|P2|COMPLETED|Overall Study||4
14248|NCT03061513|29337|P1|COMPLETED|Overall Study||6
14249|NCT03061513|29336|P2|STARTED|Overall Study||5
14250|NCT03061513|29337|P1|STARTED|Overall Study||6
14251|NCT03061331|29347|P2|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
14252|NCT03061331|29348|P1|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
14253|NCT03061331|29347|P2|COMPLETED|Treatment Period 2 (8 Weeks)||9
14254|NCT03061331|29348|P1|COMPLETED|Treatment Period 2 (8 Weeks)||8
14255|NCT03061331|29347|P2|STARTED|Treatment Period 2 (8 Weeks)||9
14256|NCT03061331|29348|P1|STARTED|Treatment Period 2 (8 Weeks)||8
14257|NCT03061331|29347|P2|NOT COMPLETED|Washout Period (8 Weeks)||1
14258|NCT03061331|29348|P1|NOT COMPLETED|Washout Period (8 Weeks)||2
14259|NCT03061331|29347|P2|COMPLETED|Washout Period (8 Weeks)||9
14260|NCT03061331|29348|P1|COMPLETED|Washout Period (8 Weeks)||8
14261|NCT03061331|29347|P2|STARTED|Washout Period (8 Weeks)||10
14262|NCT03061331|29348|P1|STARTED|Washout Period (8 Weeks)||10
14263|NCT03061331|29347|P2|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
14264|NCT03061331|29348|P1|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
14265|NCT03061331|29347|P2|COMPLETED|Treatment Period 1 (8 Weeks)||10
14266|NCT03061331|29348|P1|COMPLETED|Treatment Period 1 (8 Weeks)||10
14267|NCT03061331|29347|P2|STARTED|Treatment Period 1 (8 Weeks)||10
14268|NCT03061331|29348|P1|STARTED|Treatment Period 1 (8 Weeks)||10
14269|NCT03060512|29356|P2|NOT COMPLETED|Overall Study||9
14270|NCT03060512|29357|P1|NOT COMPLETED|Overall Study||7
14271|NCT03060512|29356|P2|COMPLETED|Overall Study||130
14272|NCT03060512|29357|P1|COMPLETED|Overall Study||130
14273|NCT03060512|29356|P2|Treated With PEG 3350|Overall Study||138
14274|NCT03060512|29357|P1|Treated With PEG 3350|Overall Study||130
14275|NCT03060512|29356|P2|Treated With Movantik|Overall Study||135
14276|NCT03060512|29357|P1|Treated With Movantik|Overall Study||136
14277|NCT03060512|29356|P2|STARTED|Overall Study||139
14278|NCT03060512|29357|P1|STARTED|Overall Study||137
14279|NCT03060486|29374|P1|NOT COMPLETED|Overall Study||0
14280|NCT03060486|29374|P1|COMPLETED|Overall Study||15
14281|NCT03060486|29374|P1|STARTED|Overall Study||15
14282|NCT03059901|29380|P2|NOT COMPLETED|Overall Study||2
14283|NCT03059901|29381|P1|NOT COMPLETED|Overall Study||4
14284|NCT03059901|29380|P2|COMPLETED|Overall Study||28
14285|NCT03059901|29381|P1|COMPLETED|Overall Study||26
14286|NCT03059901|29380|P2|STARTED|Overall Study||30
14287|NCT03059901|29381|P1|STARTED|Overall Study||30
14288|NCT03058705|29387|P1|NOT COMPLETED|Overall Study||4
14289|NCT03058705|29387|P1|COMPLETED|Overall Study||6
14290|NCT03058705|29387|P1|STARTED|Overall Study||10
14291|NCT03057704|29393|P2|NOT COMPLETED|Overall Study||0
14292|NCT03057704|29394|P1|NOT COMPLETED|Overall Study||0
14293|NCT03057704|29393|P2|COMPLETED|Overall Study||25
14294|NCT03057704|29394|P1|COMPLETED|Overall Study||25
14295|NCT03057704|29393|P2|STARTED|Overall Study||25
14296|NCT03057704|29394|P1|STARTED|Overall Study||25
14297|NCT03057366|29404|P3|NOT COMPLETED|Part B||0
14298|NCT03057366|29405|P2|NOT COMPLETED|Part B||0
14299|NCT03057366|29406|P1|NOT COMPLETED|Part B||0
14300|NCT03057366|29404|P3|COMPLETED|Part B||2
14301|NCT03057366|29405|P2|COMPLETED|Part B||5
14302|NCT03057366|29406|P1|COMPLETED|Part B||0
14303|NCT03057366|29404|P3|STARTED|Part B|Participants completed Part A, met eligibility criteria, and provided consent for Part B.|2
14304|NCT03057366|29405|P2|STARTED|Part B|Participants completed Part A, met eligibility criteria, and provided consent for Part B.|5
14305|NCT03057366|29406|P1|STARTED|Part B||0
14306|NCT03057366|29404|P3|NOT COMPLETED|Part A||0
14307|NCT03057366|29405|P2|NOT COMPLETED|Part A||0
14308|NCT03057366|29406|P1|NOT COMPLETED|Part A||0
14309|NCT03057366|29404|P3|COMPLETED|Part A||0
14310|NCT03057366|29405|P2|COMPLETED|Part A||0
14311|NCT03057366|29406|P1|COMPLETED|Part A||8
14312|NCT03057366|29404|P3|STARTED|Part A||0
14313|NCT03057366|29405|P2|STARTED|Part A||0
14314|NCT03057366|29406|P1|STARTED|Part A||8
14315|NCT03057132|29429|P1|NOT COMPLETED|Overall Study||0
14316|NCT03057132|29429|P1|COMPLETED|Overall Study||1
14317|NCT03057132|29429|P1|STARTED|Overall Study||1
14318|NCT03056352|29434|P1|NOT COMPLETED|Overall Study||1
14319|NCT03056352|29434|P1|COMPLETED|Overall Study||20
14320|NCT03056352|29434|P1|STARTED|Overall Study||21
14321|NCT03056300|29440|P1|NOT COMPLETED|Overall Study||3
14322|NCT03056300|29440|P1|COMPLETED|Overall Study||47
14323|NCT03056300|29440|P1|STARTED|Overall Study||50
14324|NCT03056144|29445|P1|NOT COMPLETED|Overall Study||0
14325|NCT03056144|29445|P1|COMPLETED|Overall Study||1
14326|NCT03056144|29445|P1|STARTED|Overall Study||1
14327|NCT03056040|29457|P2|NOT COMPLETED|Extension Period||95
14328|NCT03056040|29458|P1|NOT COMPLETED|Extension Period||96
14329|NCT03056040|29457|P2|COMPLETED|Extension Period||0
14330|NCT03056040|29458|P1|COMPLETED|Extension Period||0
14331|NCT03056040|29457|P2|Received at Least 1 Dose of Ravulizumab|Extension Period||95
14332|NCT03056040|29458|P1|Received at Least 1 Dose of Ravulizumab|Extension Period||96
14333|NCT03056040|29457|P2|STARTED|Extension Period||95
14334|NCT03056040|29458|P1|STARTED|Extension Period||96
14335|NCT03056040|29457|P2|NOT COMPLETED|Primary Evaluation Period||3
14336|NCT03056040|29458|P1|NOT COMPLETED|Primary Evaluation Period||1
14337|NCT03056040|29457|P2|COMPLETED|Primary Evaluation Period||95
14338|NCT03056040|29458|P1|COMPLETED|Primary Evaluation Period||96
14339|NCT03056040|29457|P2|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||98
14340|NCT03056040|29458|P1|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||97
14341|NCT03056040|29457|P2|STARTED|Primary Evaluation Period||98
14342|NCT03056040|29458|P1|STARTED|Primary Evaluation Period||97
14343|NCT03055988|29472|P2|NOT COMPLETED|Period 2||2
14344|NCT03055988|29473|P1|NOT COMPLETED|Period 2||1
14345|NCT03055988|29472|P2|COMPLETED|Period 2||31
14346|NCT03055988|29473|P1|COMPLETED|Period 2||36
14347|NCT03055988|29472|P2|STARTED|Period 2||33
14348|NCT03055988|29473|P1|STARTED|Period 2||37
14349|NCT03055988|29472|P2|NOT COMPLETED|Period 1||5
14350|NCT03055988|29473|P1|NOT COMPLETED|Period 1||1
14351|NCT03055988|29472|P2|COMPLETED|Period 1||33
14352|NCT03055988|29473|P1|COMPLETED|Period 1||37
14353|NCT03055988|29472|P2|STARTED|Period 1||38
14354|NCT03055988|29473|P1|STARTED|Period 1||38
14355|NCT03055832|29497|P2|NOT COMPLETED|Week 4||0
14356|NCT03055832|29498|P1|NOT COMPLETED|Week 4||0
14357|NCT03055832|29497|P2|COMPLETED|Week 4||71
14358|NCT03055832|29498|P1|COMPLETED|Week 4||70
14359|NCT03055832|29497|P2|STARTED|Week 4||71
14360|NCT03055832|29498|P1|STARTED|Week 4||70
14361|NCT03055832|29497|P2|NOT COMPLETED|Week 2||0
14362|NCT03055832|29498|P1|NOT COMPLETED|Week 2||1
14363|NCT03055832|29497|P2|COMPLETED|Week 2||71
14364|NCT03055832|29498|P1|COMPLETED|Week 2||70
14365|NCT03055832|29497|P2|STARTED|Week 2||71
14366|NCT03055832|29498|P1|STARTED|Week 2||71
14367|NCT03055832|29497|P2|NOT COMPLETED|Day 1||0
14368|NCT03055832|29498|P1|NOT COMPLETED|Day 1||0
14369|NCT03055832|29497|P2|COMPLETED|Day 1||71
14370|NCT03055832|29498|P1|COMPLETED|Day 1||71
14371|NCT03055832|29497|P2|STARTED|Day 1||71
14372|NCT03055832|29498|P1|STARTED|Day 1||71
14373|NCT03055832|29497|P2|NOT COMPLETED|Immediately Post-Procedure (Hour 1)||0
14374|NCT03055832|29498|P1|NOT COMPLETED|Immediately Post-Procedure (Hour 1)||0
14375|NCT03055832|29497|P2|COMPLETED|Immediately Post-Procedure (Hour 1)||71
14376|NCT03055832|29498|P1|COMPLETED|Immediately Post-Procedure (Hour 1)||71
14377|NCT03055832|29497|P2|STARTED|Immediately Post-Procedure (Hour 1)||71
14378|NCT03055832|29498|P1|STARTED|Immediately Post-Procedure (Hour 1)||71
14379|NCT03055832|29497|P2|NOT COMPLETED|Baseline||0
14380|NCT03055832|29498|P1|NOT COMPLETED|Baseline||0
14381|NCT03055832|29497|P2|COMPLETED|Baseline||71
14382|NCT03055832|29498|P1|COMPLETED|Baseline||71
14383|NCT03055832|29497|P2|STARTED|Baseline||71
14384|NCT03055832|29498|P1|STARTED|Baseline||71
14385|NCT03055806|29558|P4|NOT COMPLETED|Overall Study||15
14386|NCT03055806|29559|P3|NOT COMPLETED|Overall Study||13
14387|NCT03055806|29560|P2|NOT COMPLETED|Overall Study||7
14388|NCT03055806|29561|P1|NOT COMPLETED|Overall Study||6
14389|NCT03055806|29558|P4|COMPLETED|Overall Study||57
14390|NCT03055806|29559|P3|COMPLETED|Overall Study||58
14391|NCT03055806|29560|P2|COMPLETED|Overall Study||41
14392|NCT03055806|29561|P1|COMPLETED|Overall Study||42
14393|NCT03055806|29558|P4|STARTED|Overall Study||72
14394|NCT03055806|29559|P3|STARTED|Overall Study||71
14395|NCT03055806|29560|P2|STARTED|Overall Study||48
14396|NCT03055806|29561|P1|STARTED|Overall Study||48
14397|NCT03055338|29606|P3|NOT COMPLETED|Overall Study||12
14398|NCT03055338|29607|P2|NOT COMPLETED|Overall Study||11
14399|NCT03055338|29608|P1|NOT COMPLETED|Overall Study||18
14400|NCT03055338|29606|P3|COMPLETED|Overall Study||77
14401|NCT03055338|29607|P2|COMPLETED|Overall Study||34
14402|NCT03055338|29608|P1|COMPLETED|Overall Study||72
14403|NCT03055338|29606|P3|STARTED|Overall Study||89
14404|NCT03055338|29607|P2|STARTED|Overall Study||45
14405|NCT03055338|29608|P1|STARTED|Overall Study||90
14406|NCT03055221|29625|P1|NOT COMPLETED|Overall Study||16
14407|NCT03055221|29625|P1|COMPLETED|Overall Study||0
14408|NCT03055221|29625|P1|STARTED|Overall Study||16
14409|NCT03055195|29632|P2|NOT COMPLETED|Overall Study||14
14410|NCT03055195|29633|P1|NOT COMPLETED|Overall Study||12
14411|NCT03055195|29632|P2|COMPLETED|Overall Study||4
14412|NCT03055195|29633|P1|COMPLETED|Overall Study||4
14413|NCT03055195|29632|P2|STARTED|Overall Study||18
14414|NCT03055195|29633|P1|STARTED|Overall Study||16
14415|NCT03054857|29687|P2|NOT COMPLETED|Overall Study||0
14416|NCT03054857|29688|P1|NOT COMPLETED|Overall Study||1
14417|NCT03054857|29687|P2|COMPLETED|Overall Study||50
14418|NCT03054857|29688|P1|COMPLETED|Overall Study||49
14419|NCT03054857|29687|P2|STARTED|Overall Study||50
14420|NCT03054857|29688|P1|STARTED|Overall Study||50
14421|NCT03054844|29704|P2|NOT COMPLETED|Overall Study||1
14422|NCT03054844|29705|P1|NOT COMPLETED|Overall Study||3
14423|NCT03054844|29704|P2|COMPLETED|Overall Study||26
14424|NCT03054844|29705|P1|COMPLETED|Overall Study||25
14425|NCT03054844|29704|P2|STARTED|Overall Study||27
14426|NCT03054844|29705|P1|STARTED|Overall Study||28
14427|NCT03054805|29724|P3|NOT COMPLETED|Overall Study||2
14428|NCT03054805|29725|P2|NOT COMPLETED|Overall Study||10
14429|NCT03054805|29726|P1|NOT COMPLETED|Overall Study||16
14430|NCT03054805|29724|P3|COMPLETED|Overall Study||42
14431|NCT03054805|29725|P2|COMPLETED|Overall Study||41
14432|NCT03054805|29726|P1|COMPLETED|Overall Study||42
14433|NCT03054805|29724|P3|STARTED|Overall Study||44
14434|NCT03054805|29725|P2|STARTED|Overall Study||51
14435|NCT03054805|29726|P1|STARTED|Overall Study||58
14436|NCT03054740|29736|P2|NOT COMPLETED|Overall Study||0
14437|NCT03054740|29737|P1|NOT COMPLETED|Overall Study||0
14438|NCT03054740|29736|P2|COMPLETED|Overall Study||15
14439|NCT03054740|29737|P1|COMPLETED|Overall Study||15
14440|NCT03054740|29736|P2|STARTED|Overall Study||15
14441|NCT03054740|29737|P1|STARTED|Overall Study||15
14442|NCT03054506|29754|P3|NOT COMPLETED|Overall Study||0
14443|NCT03054506|29755|P2|NOT COMPLETED|Overall Study||0
14444|NCT03054506|29756|P1|NOT COMPLETED|Overall Study||1
14445|NCT03054506|29754|P3|COMPLETED|Overall Study||9
14446|NCT03054506|29755|P2|COMPLETED|Overall Study||11
14447|NCT03054506|29756|P1|COMPLETED|Overall Study||19
14448|NCT03054506|29754|P3|STARTED|Overall Study||9
14449|NCT03054506|29755|P2|STARTED|Overall Study||11
14450|NCT03054506|29756|P1|STARTED|Overall Study||20
14451|NCT03054428|29800|P3|NOT COMPLETED|Overall Study||79
14452|NCT03054428|29801|P2|NOT COMPLETED|Overall Study||80
14453|NCT03054428|29802|P1|NOT COMPLETED|Overall Study||83
14454|NCT03054428|29800|P3|COMPLETED|Overall Study||3
14455|NCT03054428|29801|P2|COMPLETED|Overall Study||4
14456|NCT03054428|29802|P1|COMPLETED|Overall Study||2
14457|NCT03054428|29800|P3|Completed Week 28 (End of Study)|Overall Study||3
14458|NCT03054428|29801|P2|Completed Week 28 (End of Study)|Overall Study||4
14459|NCT03054428|29802|P1|Completed Week 28 (End of Study)|Overall Study||2
14460|NCT03054428|29800|P3|Completed Wk 16 End of Treatment (EOT)|Overall Study||79
14461|NCT03054428|29801|P2|Completed Wk 16 End of Treatment (EOT)|Overall Study||81
14462|NCT03054428|29802|P1|Completed Wk 16 End of Treatment (EOT)|Overall Study||80
14463|NCT03054428|29800|P3|STARTED|Overall Study||82
14464|NCT03054428|29801|P2|STARTED|Overall Study||84
14465|NCT03054428|29802|P1|STARTED|Overall Study||85
14466|NCT03054103|29870|P3|NOT COMPLETED|Overall Study||0
14467|NCT03054103|29871|P2|NOT COMPLETED|Overall Study||0
14468|NCT03054103|29872|P1|NOT COMPLETED|Overall Study||0
14469|NCT03054103|29870|P3|COMPLETED|Overall Study||35
14470|NCT03054103|29871|P2|COMPLETED|Overall Study||29
14471|NCT03054103|29872|P1|COMPLETED|Overall Study||41
14472|NCT03054103|29870|P3|STARTED|Overall Study||35
14473|NCT03054103|29871|P2|STARTED|Overall Study||29
14474|NCT03054103|29872|P1|STARTED|Overall Study||41
14475|NCT03054077|29891|P2|NOT COMPLETED|Overall Study||0
14476|NCT03054077|29892|P1|NOT COMPLETED|Overall Study||0
14477|NCT03054077|29891|P2|COMPLETED|Overall Study||12
14478|NCT03054077|29892|P1|COMPLETED|Overall Study||12
14479|NCT03054077|29891|P2|STARTED|Overall Study||12
14480|NCT03054077|29892|P1|STARTED|Overall Study||12
14481|NCT03054051|29900|P2|NOT COMPLETED|Overall Study||0
14482|NCT03054051|29901|P1|NOT COMPLETED|Overall Study||0
14483|NCT03054051|29900|P2|COMPLETED|Overall Study||30
14484|NCT03054051|29901|P1|COMPLETED|Overall Study||30
14485|NCT03054051|29900|P2|STARTED|Overall Study||30
14486|NCT03054051|29901|P1|STARTED|Overall Study||30
14487|NCT03053427|29932|P2|NOT COMPLETED|Overall Study||16
14488|NCT03053427|29933|P1|NOT COMPLETED|Overall Study||13
14489|NCT03053427|29932|P2|COMPLETED|Overall Study||173
14490|NCT03053427|29933|P1|COMPLETED|Overall Study||173
14491|NCT03053427|29932|P2|STARTED|Overall Study||189
14492|NCT03053427|29933|P1|STARTED|Overall Study||186
14493|NCT03053180|29955|P1|NOT COMPLETED|Overall Study||1
14494|NCT03053180|29955|P1|COMPLETED|Overall Study||59
14495|NCT03053180|29955|P1|STARTED|Overall Study||60
14496|NCT03052725|29966|P2|NOT COMPLETED|Overall Study||150
14497|NCT03052725|29967|P1|NOT COMPLETED|Overall Study||148
14498|NCT03052725|29966|P2|COMPLETED|Overall Study||47
14499|NCT03052725|29967|P1|COMPLETED|Overall Study||46
14500|NCT03052725|29966|P2|Safety Analysis Set|Overall Study||196
14501|NCT03052725|29967|P1|Safety Analysis Set|Overall Study||194
14502|NCT03052725|29966|P2|STARTED|Overall Study||197
14503|NCT03052725|29967|P1|STARTED|Overall Study||194
14504|NCT03052530|30004|P1|NOT COMPLETED|Overall Study||0
14505|NCT03052530|30004|P1|COMPLETED|Overall Study||61
14506|NCT03052530|30004|P1|STARTED|Overall Study||61
14507|NCT03052426|30014|P3|NOT COMPLETED|Overall Study||1
14508|NCT03052426|30015|P2|NOT COMPLETED|Overall Study||1
14509|NCT03052426|30016|P1|NOT COMPLETED|Overall Study||2
14510|NCT03052426|30014|P3|COMPLETED|Overall Study||5
14511|NCT03052426|30015|P2|COMPLETED|Overall Study||5
14512|NCT03052426|30016|P1|COMPLETED|Overall Study||4
14513|NCT03052426|30014|P3|STARTED|Overall Study||6
14514|NCT03052426|30015|P2|STARTED|Overall Study||6
14515|NCT03052426|30016|P1|STARTED|Overall Study||6
14516|NCT03052322|30031|P2|NOT COMPLETED|Overall Study||32
14517|NCT03052322|30032|P1|NOT COMPLETED|Overall Study||21
14518|NCT03052322|30031|P2|COMPLETED|Overall Study||113
14519|NCT03052322|30032|P1|COMPLETED|Overall Study||122
14520|NCT03052322|30031|P2|STARTED|Overall Study||145
14521|NCT03052322|30032|P1|STARTED|Overall Study||143
14522|NCT03051646|30084|P2|NOT COMPLETED|Overall Study||0
14523|NCT03051646|30085|P1|NOT COMPLETED|Overall Study||0
14524|NCT03051646|30084|P2|COMPLETED|Overall Study||6
14525|NCT03051646|30085|P1|COMPLETED|Overall Study||6
14526|NCT03051646|30084|P2|STARTED|Overall Study||6
14527|NCT03051646|30085|P1|STARTED|Overall Study||6
14528|NCT03051607|30093|P1|NOT COMPLETED|Overall Study||66
14529|NCT03051607|30093|P1|COMPLETED|Overall Study||0
14530|NCT03051607|30093|P1|STARTED|Overall Study||66
14531|NCT03051165|30100|P1|NOT COMPLETED|Overall Study||13
14532|NCT03051165|30100|P1|COMPLETED|Overall Study||0
14533|NCT03051165|30100|P1|Completed Some Day 137 Assessments|Overall Study||0
14534|NCT03051165|30100|P1|Began HGNS Treatment Withdrawal|Overall Study||0
14535|NCT03051165|30100|P1|Completed Some Day 105 Assessments|Overall Study||1
14536|NCT03051165|30100|P1|Completed Some Baseline Assessments|Overall Study||1
14537|NCT03051165|30100|P1|STARTED|Overall Study||13
14538|NCT03050918|30114|P2|NOT COMPLETED|Overall Study||0
14539|NCT03050918|30115|P1|NOT COMPLETED|Overall Study||0
14540|NCT03050918|30114|P2|COMPLETED|Overall Study||1520
14541|NCT03050918|30115|P1|COMPLETED|Overall Study||1534
14542|NCT03050918|30114|P2|STARTED|Overall Study||1520
14543|NCT03050918|30115|P1|STARTED|Overall Study||1534
14544|NCT03050775|30137|P2|NOT COMPLETED|Overall Study||0
14545|NCT03050775|30138|P1|NOT COMPLETED|Overall Study||0
14546|NCT03050775|30137|P2|COMPLETED|Overall Study||35
14547|NCT03050775|30138|P1|COMPLETED|Overall Study||35
14548|NCT03050775|30137|P2|STARTED|Overall Study||35
14549|NCT03050775|30138|P1|STARTED|Overall Study||35
14550|NCT03050619|30162|P6|NOT COMPLETED|Overall Study||0
14551|NCT03050619|30163|P5|NOT COMPLETED|Overall Study||0
14552|NCT03050619|30164|P4|NOT COMPLETED|Overall Study||0
14553|NCT03050619|30165|P3|NOT COMPLETED|Overall Study||0
14554|NCT03050619|30166|P2|NOT COMPLETED|Overall Study||0
14555|NCT03050619|30167|P1|NOT COMPLETED|Overall Study||0
14556|NCT03050619|30162|P6|COMPLETED|Overall Study||1351
14557|NCT03050619|30163|P5|COMPLETED|Overall Study||6079
14558|NCT03050619|30164|P4|COMPLETED|Overall Study||14007
14559|NCT03050619|30165|P3|COMPLETED|Overall Study||6416
14560|NCT03050619|30166|P2|COMPLETED|Overall Study||3926
14561|NCT03050619|30167|P1|COMPLETED|Overall Study||129
14562|NCT03050619|30162|P6|STARTED|Overall Study||1351
14563|NCT03050619|30163|P5|STARTED|Overall Study||6079
14564|NCT03050619|30164|P4|STARTED|Overall Study||14007
14565|NCT03050619|30165|P3|STARTED|Overall Study||6416
14566|NCT03050619|30166|P2|STARTED|Overall Study||3926
14567|NCT03050619|30167|P1|STARTED|Overall Study||129
14568|NCT03050541|30304|P3|NOT COMPLETED|Overall Study||8
14569|NCT03050541|30305|P2|NOT COMPLETED|Overall Study||8
14570|NCT03050541|30306|P1|NOT COMPLETED|Overall Study||8
14571|NCT03050541|30304|P3|COMPLETED|Overall Study||20
14572|NCT03050541|30305|P2|COMPLETED|Overall Study||20
14573|NCT03050541|30306|P1|COMPLETED|Overall Study||20
14574|NCT03050541|30304|P3|STARTED|Overall Study||28
14575|NCT03050541|30305|P2|STARTED|Overall Study||28
14576|NCT03050541|30306|P1|STARTED|Overall Study||28
14577|NCT03050320|30319|P2|NOT COMPLETED|Overall Study||1
14578|NCT03050320|30320|P1|NOT COMPLETED|Overall Study||1
14579|NCT03050320|30319|P2|COMPLETED|Overall Study||21
14580|NCT03050320|30320|P1|COMPLETED|Overall Study||20
14581|NCT03050320|30319|P2|STARTED|Overall Study||22
14582|NCT03050320|30320|P1|STARTED|Overall Study||21
14583|NCT03050294|30354|P4|NOT COMPLETED|Overall Study||0
14584|NCT03050294|30355|P3|NOT COMPLETED|Overall Study||0
14585|NCT03050294|30356|P2|NOT COMPLETED|Overall Study||0
14586|NCT03050294|30357|P1|NOT COMPLETED|Overall Study||0
14587|NCT03050294|30354|P4|COMPLETED|Overall Study||6
14588|NCT03050294|30355|P3|COMPLETED|Overall Study||6
14589|NCT03050294|30356|P2|COMPLETED|Overall Study||6
14590|NCT03050294|30357|P1|COMPLETED|Overall Study||6
14591|NCT03050294|30354|P4|STARTED|Overall Study||6
14592|NCT03050294|30355|P3|STARTED|Overall Study||6
14593|NCT03050294|30356|P2|STARTED|Overall Study||6
14594|NCT03050294|30357|P1|STARTED|Overall Study||6
14595|NCT03050203|30381|P2|NOT COMPLETED|Overall Study||0
14596|NCT03050203|30382|P1|NOT COMPLETED|Overall Study||0
14597|NCT03050203|30381|P2|COMPLETED|Overall Study||18
14598|NCT03050203|30382|P1|COMPLETED|Overall Study||19
14599|NCT03050203|30381|P2|STARTED|Overall Study||18
14600|NCT03050203|30382|P1|STARTED|Overall Study||19
14601|NCT03049501|30390|P2|NOT COMPLETED|Overall Study||29
14602|NCT03049501|30391|P1|NOT COMPLETED|Overall Study||22
14603|NCT03049501|30390|P2|COMPLETED|Overall Study||92
14604|NCT03049501|30391|P1|COMPLETED|Overall Study||101
14605|NCT03049501|30390|P2|12 Month Follow up|Overall Study||92
14606|NCT03049501|30391|P1|12 Month Follow up|Overall Study||101
14607|NCT03049501|30390|P2|6 Month Follow up|Overall Study||91
14608|NCT03049501|30391|P1|6 Month Follow up|Overall Study||107
14609|NCT03049501|30390|P2|STARTED|Overall Study||121
14610|NCT03049501|30391|P1|STARTED|Overall Study||123
14611|NCT03048383|30410|P3|NOT COMPLETED|Overall Study||12
14612|NCT03048383|30411|P2|NOT COMPLETED|Overall Study||8
14613|NCT03048383|30412|P1|NOT COMPLETED|Overall Study||13
14614|NCT03048383|30410|P3|COMPLETED|Overall Study||10
14615|NCT03048383|30411|P2|COMPLETED|Overall Study||13
14616|NCT03048383|30412|P1|COMPLETED|Overall Study||15
14617|NCT03048383|30410|P3|STARTED|Overall Study||22
14618|NCT03048383|30411|P2|STARTED|Overall Study||21
14619|NCT03048383|30412|P1|STARTED|Overall Study||28
14620|NCT03048058|30425|P2|NOT COMPLETED|Overall Study||4
14621|NCT03048058|30426|P1|NOT COMPLETED|Overall Study||4
14622|NCT03048058|30425|P2|COMPLETED|Overall Study||6
14623|NCT03048058|30426|P1|COMPLETED|Overall Study||6
14624|NCT03048058|30425|P2|STARTED|Overall Study||10
14625|NCT03048058|30426|P1|STARTED|Overall Study||10
14626|NCT03048006|30444|P1|NOT COMPLETED|Overall Study||0
14627|NCT03048006|30444|P1|COMPLETED|Overall Study||44456
14628|NCT03048006|30444|P1|STARTED|Overall Study||44456
14629|NCT03047551|30452|P2|NOT COMPLETED|Overall Study||3
14630|NCT03047551|30453|P1|NOT COMPLETED|Overall Study||2
14631|NCT03047551|30452|P2|COMPLETED|Overall Study||312
14632|NCT03047551|30453|P1|COMPLETED|Overall Study||317
14633|NCT03047551|30452|P2|STARTED|Overall Study||315
14634|NCT03047551|30453|P1|STARTED|Overall Study||319
14635|NCT03047447|30464|P3|NOT COMPLETED|Overall Study||0
14636|NCT03047447|30465|P2|NOT COMPLETED|Overall Study||0
14637|NCT03047447|30466|P1|NOT COMPLETED|Overall Study||0
14638|NCT03047447|30464|P3|COMPLETED|Overall Study||10
14639|NCT03047447|30465|P2|COMPLETED|Overall Study||10
14640|NCT03047447|30466|P1|COMPLETED|Overall Study||10
14641|NCT03047447|30464|P3|STARTED|Overall Study||10
14642|NCT03047447|30465|P2|STARTED|Overall Study||10
14643|NCT03047447|30466|P1|STARTED|Overall Study||10
14644|NCT03046446|30486|P1|NOT COMPLETED|Overall Study||59
14645|NCT03046446|30486|P1|COMPLETED|Overall Study||149
14646|NCT03046446|30486|P1|Completed at Week 52|Overall Study||133
14647|NCT03046446|30486|P1|Completed at Week 24|Overall Study||6
14648|NCT03046446|30486|P1|Completed at Week 12|Overall Study||10
14649|NCT03046446|30486|P1|Second Injection|Overall Study||179
14650|NCT03046446|30486|P1|STARTED|Overall Study||208
14651|NCT03046225|30496|P2|NOT COMPLETED|Overall Study||0
14652|NCT03046225|30497|P1|NOT COMPLETED|Overall Study||0
14653|NCT03046225|30496|P2|COMPLETED|Overall Study||13
14654|NCT03046225|30497|P1|COMPLETED|Overall Study||13
14655|NCT03046225|30496|P2|STARTED|Overall Study||13
14656|NCT03046225|30497|P1|STARTED|Overall Study||13
14657|NCT03046212|30509|P2|NOT COMPLETED|Overall Study||0
14658|NCT03046212|30510|P1|NOT COMPLETED|Overall Study||0
14659|NCT03046212|30509|P2|COMPLETED|Overall Study||15
14660|NCT03046212|30510|P1|COMPLETED|Overall Study||15
14661|NCT03046212|30509|P2|STARTED|Overall Study||15
14662|NCT03046212|30510|P1|STARTED|Overall Study||15
14663|NCT03045926|30520|P1|NOT COMPLETED|Overall Study||0
14664|NCT03045926|30520|P1|COMPLETED|Overall Study||35
14665|NCT03045926|30520|P1|STARTED|Overall Study||35
14666|NCT03045887|30549|P10|NOT COMPLETED|Part B (14 Days)||0
14667|NCT03045887|30550|P9|NOT COMPLETED|Part B (14 Days)||0
14668|NCT03045887|30551|P8|NOT COMPLETED|Part B (14 Days)||0
14669|NCT03045887|30552|P7|NOT COMPLETED|Part B (14 Days)||0
14670|NCT03045887|30553|P6|NOT COMPLETED|Part B (14 Days)||0
14671|NCT03045887|30554|P5|NOT COMPLETED|Part B (14 Days)||0
14672|NCT03045887|30555|P4|NOT COMPLETED|Part B (14 Days)||0
14673|NCT03045887|30556|P3|NOT COMPLETED|Part B (14 Days)||0
14674|NCT03045887|30557|P2|NOT COMPLETED|Part B (14 Days)||0
14675|NCT03045887|30558|P1|NOT COMPLETED|Part B (14 Days)||0
14676|NCT03045887|30549|P10|COMPLETED|Part B (14 Days)||9
14677|NCT03045887|30550|P9|COMPLETED|Part B (14 Days)||3
14678|NCT03045887|30551|P8|COMPLETED|Part B (14 Days)||0
14679|NCT03045887|30552|P7|COMPLETED|Part B (14 Days)||0
14680|NCT03045887|30553|P6|COMPLETED|Part B (14 Days)||0
14681|NCT03045887|30554|P5|COMPLETED|Part B (14 Days)||0
14682|NCT03045887|30555|P4|COMPLETED|Part B (14 Days)||0
14683|NCT03045887|30556|P3|COMPLETED|Part B (14 Days)||0
14684|NCT03045887|30557|P2|COMPLETED|Part B (14 Days)||0
14685|NCT03045887|30558|P1|COMPLETED|Part B (14 Days)||0
14686|NCT03045887|30549|P10|STARTED|Part B (14 Days)||9
14687|NCT03045887|30550|P9|STARTED|Part B (14 Days)||3
14688|NCT03045887|30551|P8|STARTED|Part B (14 Days)||0
14689|NCT03045887|30552|P7|STARTED|Part B (14 Days)||0
14690|NCT03045887|30553|P6|STARTED|Part B (14 Days)||0
14691|NCT03045887|30554|P5|STARTED|Part B (14 Days)||0
14692|NCT03045887|30555|P4|STARTED|Part B (14 Days)||0
14693|NCT03045887|30556|P3|STARTED|Part B (14 Days)||0
14694|NCT03045887|30557|P2|STARTED|Part B (14 Days)||0
14695|NCT03045887|30558|P1|STARTED|Part B (14 Days)||0
14696|NCT03045887|30549|P10|NOT COMPLETED|Part A, Period 3 (1 Day)||0
14697|NCT03045887|30550|P9|NOT COMPLETED|Part A, Period 3 (1 Day)||0
14698|NCT03045887|30551|P8|NOT COMPLETED|Part A, Period 3 (1 Day)||0
14699|NCT03045887|30552|P7|NOT COMPLETED|Part A, Period 3 (1 Day)||0
14700|NCT03045887|30553|P6|NOT COMPLETED|Part A, Period 3 (1 Day)||0
14701|NCT03045887|30554|P5|NOT COMPLETED|Part A, Period 3 (1 Day)||0
14702|NCT03045887|30555|P4|NOT COMPLETED|Part A, Period 3 (1 Day)||0
14703|NCT03045887|30556|P3|NOT COMPLETED|Part A, Period 3 (1 Day)||0
14704|NCT03045887|30557|P2|NOT COMPLETED|Part A, Period 3 (1 Day)||0
14705|NCT03045887|30558|P1|NOT COMPLETED|Part A, Period 3 (1 Day)||0
14706|NCT03045887|30549|P10|COMPLETED|Part A, Period 3 (1 Day)||0
14707|NCT03045887|30550|P9|COMPLETED|Part A, Period 3 (1 Day)||0
14708|NCT03045887|30551|P8|COMPLETED|Part A, Period 3 (1 Day)||4
14709|NCT03045887|30552|P7|COMPLETED|Part A, Period 3 (1 Day)||4
14710|NCT03045887|30553|P6|COMPLETED|Part A, Period 3 (1 Day)||4
14711|NCT03045887|30554|P5|COMPLETED|Part A, Period 3 (1 Day)||4
14712|NCT03045887|30555|P4|COMPLETED|Part A, Period 3 (1 Day)||2
14713|NCT03045887|30556|P3|COMPLETED|Part A, Period 3 (1 Day)||4
14714|NCT03045887|30557|P2|COMPLETED|Part A, Period 3 (1 Day)||4
14715|NCT03045887|30558|P1|COMPLETED|Part A, Period 3 (1 Day)||3
14716|NCT03045887|30549|P10|STARTED|Part A, Period 3 (1 Day)||0
14717|NCT03045887|30550|P9|STARTED|Part A, Period 3 (1 Day)||0
14718|NCT03045887|30551|P8|STARTED|Part A, Period 3 (1 Day)||4
14719|NCT03045887|30552|P7|STARTED|Part A, Period 3 (1 Day)||4
14720|NCT03045887|30553|P6|STARTED|Part A, Period 3 (1 Day)||4
14721|NCT03045887|30554|P5|STARTED|Part A, Period 3 (1 Day)||4
14722|NCT03045887|30555|P4|STARTED|Part A, Period 3 (1 Day)||2
14723|NCT03045887|30556|P3|STARTED|Part A, Period 3 (1 Day)||4
14724|NCT03045887|30557|P2|STARTED|Part A, Period 3 (1 Day)||4
14725|NCT03045887|30558|P1|STARTED|Part A, Period 3 (1 Day)||3
14726|NCT03045887|30549|P10|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
14727|NCT03045887|30550|P9|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
14728|NCT03045887|30551|P8|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
14729|NCT03045887|30552|P7|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
14730|NCT03045887|30553|P6|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
14731|NCT03045887|30554|P5|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
14732|NCT03045887|30555|P4|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||2
14733|NCT03045887|30556|P3|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||1
14734|NCT03045887|30557|P2|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
14735|NCT03045887|30558|P1|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
14736|NCT03045887|30549|P10|COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
14737|NCT03045887|30550|P9|COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
14738|NCT03045887|30551|P8|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
14739|NCT03045887|30552|P7|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
14740|NCT03045887|30553|P6|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
14741|NCT03045887|30554|P5|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
14742|NCT03045887|30555|P4|COMPLETED|Part A,Washout Period 2 (4 Weeks)||2
14743|NCT03045887|30556|P3|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
14744|NCT03045887|30557|P2|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
14745|NCT03045887|30558|P1|COMPLETED|Part A,Washout Period 2 (4 Weeks)||3
14746|NCT03045887|30549|P10|STARTED|Part A,Washout Period 2 (4 Weeks)||0
14747|NCT03045887|30550|P9|STARTED|Part A,Washout Period 2 (4 Weeks)||0
14748|NCT03045887|30551|P8|STARTED|Part A,Washout Period 2 (4 Weeks)||4
14749|NCT03045887|30552|P7|STARTED|Part A,Washout Period 2 (4 Weeks)||4
14750|NCT03045887|30553|P6|STARTED|Part A,Washout Period 2 (4 Weeks)||4
14751|NCT03045887|30554|P5|STARTED|Part A,Washout Period 2 (4 Weeks)||4
14752|NCT03045887|30555|P4|STARTED|Part A,Washout Period 2 (4 Weeks)||4
14753|NCT03045887|30556|P3|STARTED|Part A,Washout Period 2 (4 Weeks)||5
14754|NCT03045887|30557|P2|STARTED|Part A,Washout Period 2 (4 Weeks)||4
14755|NCT03045887|30558|P1|STARTED|Part A,Washout Period 2 (4 Weeks)||3
14756|NCT03045887|30549|P10|NOT COMPLETED|Part A, Period 2 (1 Day)||0
14757|NCT03045887|30550|P9|NOT COMPLETED|Part A, Period 2 (1 Day)||0
14758|NCT03045887|30551|P8|NOT COMPLETED|Part A, Period 2 (1 Day)||0
14759|NCT03045887|30552|P7|NOT COMPLETED|Part A, Period 2 (1 Day)||0
14760|NCT03045887|30553|P6|NOT COMPLETED|Part A, Period 2 (1 Day)||0
14761|NCT03045887|30554|P5|NOT COMPLETED|Part A, Period 2 (1 Day)||0
14762|NCT03045887|30555|P4|NOT COMPLETED|Part A, Period 2 (1 Day)||0
14763|NCT03045887|30556|P3|NOT COMPLETED|Part A, Period 2 (1 Day)||0
14764|NCT03045887|30557|P2|NOT COMPLETED|Part A, Period 2 (1 Day)||0
14765|NCT03045887|30558|P1|NOT COMPLETED|Part A, Period 2 (1 Day)||1
14766|NCT03045887|30549|P10|COMPLETED|Part A, Period 2 (1 Day)||0
14767|NCT03045887|30550|P9|COMPLETED|Part A, Period 2 (1 Day)||0
14768|NCT03045887|30551|P8|COMPLETED|Part A, Period 2 (1 Day)||4
14769|NCT03045887|30552|P7|COMPLETED|Part A, Period 2 (1 Day)||4
14770|NCT03045887|30553|P6|COMPLETED|Part A, Period 2 (1 Day)||4
14771|NCT03045887|30554|P5|COMPLETED|Part A, Period 2 (1 Day)||4
14772|NCT03045887|30555|P4|COMPLETED|Part A, Period 2 (1 Day)||4
14773|NCT03045887|30556|P3|COMPLETED|Part A, Period 2 (1 Day)||5
14774|NCT03045887|30557|P2|COMPLETED|Part A, Period 2 (1 Day)||4
14775|NCT03045887|30558|P1|COMPLETED|Part A, Period 2 (1 Day)||3
14776|NCT03045887|30549|P10|STARTED|Part A, Period 2 (1 Day)||0
14777|NCT03045887|30550|P9|STARTED|Part A, Period 2 (1 Day)||0
14778|NCT03045887|30551|P8|STARTED|Part A, Period 2 (1 Day)||4
14779|NCT03045887|30552|P7|STARTED|Part A, Period 2 (1 Day)||4
14780|NCT03045887|30553|P6|STARTED|Part A, Period 2 (1 Day)||4
14781|NCT03045887|30554|P5|STARTED|Part A, Period 2 (1 Day)||4
14782|NCT03045887|30555|P4|STARTED|Part A, Period 2 (1 Day)||4
14783|NCT03045887|30556|P3|STARTED|Part A, Period 2 (1 Day)||5
14784|NCT03045887|30557|P2|STARTED|Part A, Period 2 (1 Day)||4
14785|NCT03045887|30558|P1|STARTED|Part A, Period 2 (1 Day)||4
14786|NCT03045887|30549|P10|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
14787|NCT03045887|30550|P9|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
14788|NCT03045887|30551|P8|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
14789|NCT03045887|30552|P7|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
14790|NCT03045887|30553|P6|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
14791|NCT03045887|30554|P5|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
14792|NCT03045887|30555|P4|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||1
14793|NCT03045887|30556|P3|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
14794|NCT03045887|30557|P2|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
14795|NCT03045887|30558|P1|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||3
14796|NCT03045887|30549|P10|COMPLETED|Part A,Washout Period 1(4 Weeks)||0
14797|NCT03045887|30550|P9|COMPLETED|Part A,Washout Period 1(4 Weeks)||0
14798|NCT03045887|30551|P8|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
14799|NCT03045887|30552|P7|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
14800|NCT03045887|30553|P6|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
14801|NCT03045887|30554|P5|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
14802|NCT03045887|30555|P4|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
14803|NCT03045887|30556|P3|COMPLETED|Part A,Washout Period 1(4 Weeks)||5
14804|NCT03045887|30557|P2|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
14805|NCT03045887|30558|P1|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
14806|NCT03045887|30549|P10|STARTED|Part A,Washout Period 1(4 Weeks)||0
14807|NCT03045887|30550|P9|STARTED|Part A,Washout Period 1(4 Weeks)||0
14808|NCT03045887|30551|P8|STARTED|Part A,Washout Period 1(4 Weeks)||4
14809|NCT03045887|30552|P7|STARTED|Part A,Washout Period 1(4 Weeks)||4
14810|NCT03045887|30553|P6|STARTED|Part A,Washout Period 1(4 Weeks)||4
14811|NCT03045887|30554|P5|STARTED|Part A,Washout Period 1(4 Weeks)||4
14812|NCT03045887|30555|P4|STARTED|Part A,Washout Period 1(4 Weeks)||5
14813|NCT03045887|30556|P3|STARTED|Part A,Washout Period 1(4 Weeks)||5
14814|NCT03045887|30557|P2|STARTED|Part A,Washout Period 1(4 Weeks)||4
14815|NCT03045887|30558|P1|STARTED|Part A,Washout Period 1(4 Weeks)||7
14816|NCT03045887|30549|P10|NOT COMPLETED|Part A, Period (1 Day)||0
14817|NCT03045887|30550|P9|NOT COMPLETED|Part A, Period (1 Day)||0
14818|NCT03045887|30551|P8|NOT COMPLETED|Part A, Period (1 Day)||0
14819|NCT03045887|30552|P7|NOT COMPLETED|Part A, Period (1 Day)||0
14820|NCT03045887|30553|P6|NOT COMPLETED|Part A, Period (1 Day)||0
14821|NCT03045887|30554|P5|NOT COMPLETED|Part A, Period (1 Day)||0
14822|NCT03045887|30555|P4|NOT COMPLETED|Part A, Period (1 Day)||0
14823|NCT03045887|30556|P3|NOT COMPLETED|Part A, Period (1 Day)||0
14824|NCT03045887|30557|P2|NOT COMPLETED|Part A, Period (1 Day)||0
14825|NCT03045887|30558|P1|NOT COMPLETED|Part A, Period (1 Day)||0
14826|NCT03045887|30549|P10|COMPLETED|Part A, Period (1 Day)||0
14827|NCT03045887|30550|P9|COMPLETED|Part A, Period (1 Day)||0
14828|NCT03045887|30551|P8|COMPLETED|Part A, Period (1 Day)||4
14829|NCT03045887|30552|P7|COMPLETED|Part A, Period (1 Day)||4
14830|NCT03045887|30553|P6|COMPLETED|Part A, Period (1 Day)||4
14831|NCT03045887|30554|P5|COMPLETED|Part A, Period (1 Day)||4
14832|NCT03045887|30555|P4|COMPLETED|Part A, Period (1 Day)||5
14833|NCT03045887|30556|P3|COMPLETED|Part A, Period (1 Day)||5
14834|NCT03045887|30557|P2|COMPLETED|Part A, Period (1 Day)||4
14835|NCT03045887|30558|P1|COMPLETED|Part A, Period (1 Day)||7
14836|NCT03045887|30549|P10|STARTED|Part A, Period (1 Day)||0
14837|NCT03045887|30550|P9|STARTED|Part A, Period (1 Day)||0
14838|NCT03045887|30551|P8|STARTED|Part A, Period (1 Day)||4
14839|NCT03045887|30552|P7|STARTED|Part A, Period (1 Day)||4
14840|NCT03045887|30553|P6|STARTED|Part A, Period (1 Day)||4
14841|NCT03045887|30554|P5|STARTED|Part A, Period (1 Day)||4
14842|NCT03045887|30555|P4|STARTED|Part A, Period (1 Day)||5
14843|NCT03045887|30556|P3|STARTED|Part A, Period (1 Day)||5
14844|NCT03045887|30557|P2|STARTED|Part A, Period (1 Day)||4
14845|NCT03045887|30558|P1|STARTED|Part A, Period (1 Day)||7
14846|NCT03045861|30700|P4|NOT COMPLETED|Part B (Up to 10 Days)||0
14847|NCT03045861|30701|P3|NOT COMPLETED|Part B (Up to 10 Days)||0
14848|NCT03045861|30702|P2|NOT COMPLETED|Part B (Up to 10 Days)||0
14849|NCT03045861|30703|P1|NOT COMPLETED|Part B (Up to 10 Days)||0
14850|NCT03045861|30700|P4|COMPLETED|Part B (Up to 10 Days)||8
14851|NCT03045861|30701|P3|COMPLETED|Part B (Up to 10 Days)||0
14852|NCT03045861|30702|P2|COMPLETED|Part B (Up to 10 Days)||8
14853|NCT03045861|30703|P1|COMPLETED|Part B (Up to 10 Days)||7
14854|NCT03045861|30700|P4|STARTED|Part B (Up to 10 Days)||8
14855|NCT03045861|30701|P3|STARTED|Part B (Up to 10 Days)||0
14856|NCT03045861|30702|P2|STARTED|Part B (Up to 10 Days)||8
14857|NCT03045861|30703|P1|STARTED|Part B (Up to 10 Days)||7
14858|NCT03045861|30700|P4|NOT COMPLETED|Part A (Up to 10 Days)||0
14859|NCT03045861|30701|P3|NOT COMPLETED|Part A (Up to 10 Days)||0
14860|NCT03045861|30702|P2|NOT COMPLETED|Part A (Up to 10 Days)||0
14861|NCT03045861|30703|P1|NOT COMPLETED|Part A (Up to 10 Days)||0
14862|NCT03045861|30700|P4|COMPLETED|Part A (Up to 10 Days)||0
14863|NCT03045861|30701|P3|COMPLETED|Part A (Up to 10 Days)||10
14864|NCT03045861|30702|P2|COMPLETED|Part A (Up to 10 Days)||0
14865|NCT03045861|30703|P1|COMPLETED|Part A (Up to 10 Days)||0
14866|NCT03045861|30700|P4|STARTED|Part A (Up to 10 Days)||0
14867|NCT03045861|30701|P3|STARTED|Part A (Up to 10 Days)||10
14868|NCT03045861|30702|P2|STARTED|Part A (Up to 10 Days)||0
14869|NCT03045861|30703|P1|STARTED|Part A (Up to 10 Days)||0
14870|NCT03045809|30829|P1|NOT COMPLETED|Overall Study||0
14871|NCT03045809|30829|P1|COMPLETED|Overall Study||705
14872|NCT03045809|30829|P1|Attended an Additional Visit (if Needed)|Overall Study|(only if needed, for medical follow-up, to complete study procedures, or to report adverse events).|51
14873|NCT03045809|30829|P1|STARTED|Overall Study||705
14874|NCT03045653|30836|P1|NOT COMPLETED|Overall Study||0
14875|NCT03045653|30836|P1|COMPLETED|Overall Study||30
14876|NCT03045653|30836|P1|STARTED|Overall Study||30
14877|NCT03045302|30840|P1|NOT COMPLETED|Overall Study||1
14878|NCT03045302|30840|P1|COMPLETED|Overall Study||3
14879|NCT03045302|30840|P1|STARTED|Overall Study||4
14880|NCT03045081|30846|P2|NOT COMPLETED|Overall Study||11
14881|NCT03045081|30847|P1|NOT COMPLETED|Overall Study||6
14882|NCT03045081|30846|P2|COMPLETED|Overall Study||37
14883|NCT03045081|30847|P1|COMPLETED|Overall Study||45
14884|NCT03045081|30846|P2|STARTED|Overall Study||48
14885|NCT03045081|30847|P1|STARTED|Overall Study||51
14886|NCT03044886|30866|P3|NOT COMPLETED|Overall Study||12
14887|NCT03044886|30867|P2|NOT COMPLETED|Overall Study||10
14888|NCT03044886|30868|P1|NOT COMPLETED|Overall Study||15
14889|NCT03044886|30866|P3|COMPLETED|Overall Study||108
14890|NCT03044886|30867|P2|COMPLETED|Overall Study||110
14891|NCT03044886|30868|P1|COMPLETED|Overall Study||105
14892|NCT03044886|30866|P3|STARTED|Overall Study||120
14893|NCT03044886|30867|P2|STARTED|Overall Study||120
14894|NCT03044886|30868|P1|STARTED|Overall Study||120
14895|NCT03044691|30911|P2|NOT COMPLETED|Overall Study||0
14896|NCT03044691|30912|P1|NOT COMPLETED|Overall Study||0
14897|NCT03044691|30911|P2|COMPLETED|Overall Study||84
14898|NCT03044691|30912|P1|COMPLETED|Overall Study||0
14899|NCT03044691|30911|P2|STARTED|Overall Study||84
14900|NCT03044691|30912|P1|STARTED|Overall Study||0
14901|NCT03044431|30918|P1|NOT COMPLETED|Overall Study||59
14902|NCT03044431|30918|P1|COMPLETED|Overall Study||148
14903|NCT03044431|30918|P1|STARTED|Overall Study||207
14904|NCT03044353|30931|P3|NOT COMPLETED|Overall Study||0
14905|NCT03044353|30932|P2|NOT COMPLETED|Overall Study||1
14906|NCT03044353|30933|P1|NOT COMPLETED|Overall Study||0
14907|NCT03044353|30931|P3|COMPLETED|Overall Study||0
14908|NCT03044353|30932|P2|COMPLETED|Overall Study||0
14909|NCT03044353|30933|P1|COMPLETED|Overall Study||6
14910|NCT03044353|30931|P3|STARTED|Overall Study|No participant was enrolled in Group-3 due to early termination of the study.|0
14911|NCT03044353|30932|P2|STARTED|Overall Study||1
14912|NCT03044353|30933|P1|STARTED|Overall Study||6
14913|NCT03044197|31016|P2|NOT COMPLETED|Overall Study||1
14914|NCT03044197|31017|P1|NOT COMPLETED|Overall Study||3
14915|NCT03044197|31016|P2|COMPLETED|Overall Study||11
14916|NCT03044197|31017|P1|COMPLETED|Overall Study||9
14917|NCT03044197|31016|P2|STARTED|Overall Study||12
14918|NCT03044197|31017|P1|STARTED|Overall Study||12
14919|NCT03044106|31027|P2|NOT COMPLETED|Visit 2||0
14920|NCT03044106|31028|P1|NOT COMPLETED|Visit 2||0
14921|NCT03044106|31027|P2|COMPLETED|Visit 2||20
14922|NCT03044106|31028|P1|COMPLETED|Visit 2||22
14923|NCT03044106|31027|P2|STARTED|Visit 2||20
14924|NCT03044106|31028|P1|STARTED|Visit 2||22
14925|NCT03044106|31027|P2|NOT COMPLETED|Washout (1 Week)||2
14926|NCT03044106|31028|P1|NOT COMPLETED|Washout (1 Week)||0
14927|NCT03044106|31027|P2|COMPLETED|Washout (1 Week)||20
14928|NCT03044106|31028|P1|COMPLETED|Washout (1 Week)||22
14929|NCT03044106|31027|P2|STARTED|Washout (1 Week)||22
14930|NCT03044106|31028|P1|STARTED|Washout (1 Week)||22
14931|NCT03044106|31027|P2|NOT COMPLETED|Visit 1||0
14932|NCT03044106|31028|P1|NOT COMPLETED|Visit 1||0
14933|NCT03044106|31027|P2|COMPLETED|Visit 1||22
14934|NCT03044106|31028|P1|COMPLETED|Visit 1||22
14935|NCT03044106|31027|P2|STARTED|Visit 1||22
14936|NCT03044106|31028|P1|STARTED|Visit 1||22
14937|NCT03043885|31046|P4|NOT COMPLETED|Overall Study||0
14938|NCT03043885|31047|P3|NOT COMPLETED|Overall Study||0
14939|NCT03043885|31048|P2|NOT COMPLETED|Overall Study||0
14940|NCT03043885|31049|P1|NOT COMPLETED|Overall Study||0
14941|NCT03043885|31046|P4|COMPLETED|Overall Study||10
14942|NCT03043885|31047|P3|COMPLETED|Overall Study||10
14943|NCT03043885|31048|P2|COMPLETED|Overall Study||10
14944|NCT03043885|31049|P1|COMPLETED|Overall Study||10
14945|NCT03043885|31046|P4|STARTED|Overall Study||10
14946|NCT03043885|31047|P3|STARTED|Overall Study||10
14947|NCT03043885|31048|P2|STARTED|Overall Study||10
14948|NCT03043885|31049|P1|STARTED|Overall Study||10
14949|NCT03043599|31063|P1|NOT COMPLETED|Overall Study||0
14950|NCT03043599|31063|P1|COMPLETED|Overall Study||21
14951|NCT03043599|31063|P1|STARTED|Overall Study||21
14952|NCT03043534|31071|P2|NOT COMPLETED|Overall Study||0
14953|NCT03043534|31072|P1|NOT COMPLETED|Overall Study||0
14954|NCT03043534|31071|P2|COMPLETED|Overall Study||14
14955|NCT03043534|31072|P1|COMPLETED|Overall Study||15
14956|NCT03043534|31071|P2|STARTED|Overall Study||14
14957|NCT03043534|31072|P1|STARTED|Overall Study||15
14958|NCT03042780|31086|P1|NOT COMPLETED|Overall Study||0
14959|NCT03042780|31086|P1|COMPLETED|Overall Study||2
14960|NCT03042780|31086|P1|STARTED|Overall Study||2
14961|NCT03042702|31092|P1|NOT COMPLETED|Overall Study||0
14962|NCT03042702|31092|P1|COMPLETED|Overall Study||2
14963|NCT03042702|31092|P1|STARTED|Overall Study||2
14964|NCT03042559|31103|P2|NOT COMPLETED|Overall Study||1
14965|NCT03042559|31104|P1|NOT COMPLETED|Overall Study||1
14966|NCT03042559|31103|P2|COMPLETED|Overall Study||20
14967|NCT03042559|31104|P1|COMPLETED|Overall Study||21
14968|NCT03042559|31103|P2|STARTED|Overall Study||21
14969|NCT03042559|31104|P1|STARTED|Overall Study||22
14970|NCT03042299|31166|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
14971|NCT03042299|31167|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
14972|NCT03042299|31166|P2|COMPLETED|Intervention Period 2 (6 Days)||7
14973|NCT03042299|31167|P1|COMPLETED|Intervention Period 2 (6 Days)||7
14974|NCT03042299|31166|P2|STARTED|Intervention Period 2 (6 Days)||7
14975|NCT03042299|31167|P1|STARTED|Intervention Period 2 (6 Days)||7
14976|NCT03042299|31166|P2|NOT COMPLETED|Washout Period (at Least 6 Days)||0
14977|NCT03042299|31167|P1|NOT COMPLETED|Washout Period (at Least 6 Days)||0
14978|NCT03042299|31166|P2|COMPLETED|Washout Period (at Least 6 Days)||7
14979|NCT03042299|31167|P1|COMPLETED|Washout Period (at Least 6 Days)||7
14980|NCT03042299|31166|P2|STARTED|Washout Period (at Least 6 Days)||7
14981|NCT03042299|31167|P1|STARTED|Washout Period (at Least 6 Days)||7
14982|NCT03042299|31166|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
14983|NCT03042299|31167|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
14984|NCT03042299|31166|P2|COMPLETED|Intervention Period 1 (6 Days)||7
14985|NCT03042299|31167|P1|COMPLETED|Intervention Period 1 (6 Days)||7
14986|NCT03042299|31166|P2|STARTED|Intervention Period 1 (6 Days)||7
14987|NCT03042299|31167|P1|STARTED|Intervention Period 1 (6 Days)||7
14988|NCT03041909|31196|P3|NOT COMPLETED|Overall Study||0
14989|NCT03041909|31197|P2|NOT COMPLETED|Overall Study||0
14990|NCT03041909|31198|P1|NOT COMPLETED|Overall Study||0
14991|NCT03041909|31196|P3|COMPLETED|Overall Study||1
14992|NCT03041909|31197|P2|COMPLETED|Overall Study||1
14993|NCT03041909|31198|P1|COMPLETED|Overall Study||3
14994|NCT03041909|31196|P3|STARTED|Overall Study||1
14995|NCT03041909|31197|P2|STARTED|Overall Study||1
14996|NCT03041909|31198|P1|STARTED|Overall Study||3
14997|NCT03041792|31217|P2|NOT COMPLETED|Overall Study||3
14998|NCT03041792|31218|P1|NOT COMPLETED|Overall Study||4
14999|NCT03041792|31217|P2|COMPLETED|Overall Study||26
15000|NCT03041792|31218|P1|COMPLETED|Overall Study||28
15001|NCT03041792|31217|P2|Received Treatment|Overall Study||28
15002|NCT03041792|31218|P1|Received Treatment|Overall Study||32
15003|NCT03041792|31217|P2|STARTED|Overall Study||29
15004|NCT03041792|31218|P1|STARTED|Overall Study||32
15005|NCT03041298|31240|P1|NOT COMPLETED|Overall Study||0
15006|NCT03041298|31240|P1|COMPLETED|Overall Study||1537
15007|NCT03041298|31240|P1|STARTED|Overall Study||1537
15008|NCT03041181|31250|P2|NOT COMPLETED|Overall Study||2
15009|NCT03041181|31251|P1|NOT COMPLETED|Overall Study||1
15010|NCT03041181|31250|P2|COMPLETED|Overall Study||0
15011|NCT03041181|31251|P1|COMPLETED|Overall Study||0
15012|NCT03041181|31250|P2|STARTED|Overall Study||2
15013|NCT03041181|31251|P1|STARTED|Overall Study||1
15014|NCT03041090|31267|P2|NOT COMPLETED|Overall Study||3
15015|NCT03041090|31268|P1|NOT COMPLETED|Overall Study||0
15016|NCT03041090|31267|P2|COMPLETED|Overall Study|3 consented subjects in the dynamic arm were not included in analysis due to technical errors.|21
15017|NCT03041090|31268|P1|COMPLETED|Overall Study||109
15018|NCT03041090|31267|P2|STARTED|Overall Study||24
15019|NCT03041090|31268|P1|STARTED|Overall Study||109
15020|NCT03040687|31281|P3|NOT COMPLETED|Overall Study||0
15021|NCT03040687|31282|P2|NOT COMPLETED|Overall Study||0
15022|NCT03040687|31283|P1|NOT COMPLETED|Overall Study||1
15023|NCT03040687|31281|P3|COMPLETED|Overall Study||20
15024|NCT03040687|31282|P2|COMPLETED|Overall Study||20
15025|NCT03040687|31283|P1|COMPLETED|Overall Study||19
15026|NCT03040687|31281|P3|STARTED|Overall Study||20
15027|NCT03040687|31282|P2|STARTED|Overall Study||20
15028|NCT03040687|31283|P1|STARTED|Overall Study||20
15029|NCT03040479|31297|P3|NOT COMPLETED|Overall Study||0
15030|NCT03040479|31298|P2|NOT COMPLETED|Overall Study||0
15031|NCT03040479|31299|P1|NOT COMPLETED|Overall Study||0
15032|NCT03040479|31297|P3|COMPLETED|Overall Study||8
15033|NCT03040479|31298|P2|COMPLETED|Overall Study||8
15034|NCT03040479|31299|P1|COMPLETED|Overall Study||8
15035|NCT03040479|31297|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
15036|NCT03040479|31298|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
15037|NCT03040479|31299|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
15038|NCT03040479|31297|P3|STARTED|Overall Study||8
15039|NCT03040479|31298|P2|STARTED|Overall Study||8
15040|NCT03040479|31299|P1|STARTED|Overall Study||8
15041|NCT03040323|31327|P2|NOT COMPLETED|Overall Study||0
15042|NCT03040323|31328|P1|NOT COMPLETED|Overall Study||0
15043|NCT03040323|31327|P2|COMPLETED|Overall Study||0
15044|NCT03040323|31328|P1|COMPLETED|Overall Study||0
15136|NCT03037307|31501|P4|STARTED|Period 3||6
15045|NCT03040323|31327|P2|STARTED|Overall Study|No information available regarding how many participants Started and Completed the study in each arm|0
15046|NCT03040323|31328|P1|STARTED|Overall Study|No information available regarding how many participants Started and Completed the study in each arm|0
15047|NCT03039738|31338|P2|NOT COMPLETED|Overall Study||0
15048|NCT03039738|31339|P1|NOT COMPLETED|Overall Study||54
15049|NCT03039738|31338|P2|COMPLETED|Overall Study||0
15050|NCT03039738|31339|P1|COMPLETED|Overall Study||152
15051|NCT03039738|31338|P2|STARTED|Overall Study|This arm did not initiate. The study was terminated following the completion of the telemetry phase.|0
15052|NCT03039738|31339|P1|STARTED|Overall Study||206
15053|NCT03039569|31361|P2|NOT COMPLETED|Overall Study||4
15054|NCT03039569|31362|P1|NOT COMPLETED|Overall Study||5
15055|NCT03039569|31361|P2|COMPLETED|Overall Study||35
15056|NCT03039569|31362|P1|COMPLETED|Overall Study||35
15057|NCT03039569|31361|P2|STARTED|Overall Study||39
15058|NCT03039569|31362|P1|STARTED|Overall Study||40
15059|NCT03039543|31392|P2|NOT COMPLETED|Overall Study||3
15060|NCT03039543|31393|P1|NOT COMPLETED|Overall Study||1
15061|NCT03039543|31392|P2|COMPLETED|Overall Study||51
15062|NCT03039543|31393|P1|COMPLETED|Overall Study||53
15063|NCT03039543|31392|P2|STARTED|Overall Study||54
15064|NCT03039543|31393|P1|STARTED|Overall Study||54
15065|NCT03039283|31407|P1|NOT COMPLETED|Overall Study||2
15066|NCT03039283|31407|P1|COMPLETED|Overall Study||160
15067|NCT03039283|31407|P1|STARTED|Overall Study||162
15068|NCT03039179|31418|P2|NOT COMPLETED|Overall Study||0
15069|NCT03039179|31419|P1|NOT COMPLETED|Overall Study||0
15070|NCT03039179|31418|P2|COMPLETED|Overall Study||42
15071|NCT03039179|31419|P1|COMPLETED|Overall Study||38
15072|NCT03039179|31418|P2|STARTED|Overall Study||42
15073|NCT03039179|31419|P1|STARTED|Overall Study||38
15074|NCT03039088|31429|P2|NOT COMPLETED|Overall Study||0
15075|NCT03039088|31430|P1|NOT COMPLETED|Overall Study||0
15076|NCT03039088|31429|P2|COMPLETED|Overall Study||316
15077|NCT03039088|31430|P1|COMPLETED|Overall Study||192
15078|NCT03039088|31429|P2|STARTED|Overall Study||316
15079|NCT03039088|31430|P1|STARTED|Overall Study||192
15080|NCT03038815|31438|P2|NOT COMPLETED|Intervention 2, 1 Hour||0
15081|NCT03038815|31439|P1|NOT COMPLETED|Intervention 2, 1 Hour||0
15082|NCT03038815|31438|P2|COMPLETED|Intervention 2, 1 Hour||10
15083|NCT03038815|31439|P1|COMPLETED|Intervention 2, 1 Hour||10
15084|NCT03038815|31438|P2|STARTED|Intervention 2, 1 Hour||10
15085|NCT03038815|31439|P1|STARTED|Intervention 2, 1 Hour||10
15086|NCT03038815|31438|P2|NOT COMPLETED|Intervention 1, 1 Hour||0
15087|NCT03038815|31439|P1|NOT COMPLETED|Intervention 1, 1 Hour||0
15088|NCT03038815|31438|P2|COMPLETED|Intervention 1, 1 Hour||10
15089|NCT03038815|31439|P1|COMPLETED|Intervention 1, 1 Hour||10
15090|NCT03038815|31438|P2|STARTED|Intervention 1, 1 Hour||10
15091|NCT03038815|31439|P1|STARTED|Intervention 1, 1 Hour||10
15092|NCT03038815|31438|P2|NOT COMPLETED|Controll Condition, 1 Hour||0
15093|NCT03038815|31439|P1|NOT COMPLETED|Controll Condition, 1 Hour||0
15094|NCT03038815|31438|P2|COMPLETED|Controll Condition, 1 Hour||10
15095|NCT03038815|31439|P1|COMPLETED|Controll Condition, 1 Hour||10
15096|NCT03038815|31438|P2|STARTED|Controll Condition, 1 Hour||10
15097|NCT03038815|31439|P1|STARTED|Controll Condition, 1 Hour||10
15098|NCT03037905|31451|P2|NOT COMPLETED|Overall Study||0
15099|NCT03037905|31452|P1|NOT COMPLETED|Overall Study||0
15100|NCT03037905|31451|P2|COMPLETED|Overall Study||50
15101|NCT03037905|31452|P1|COMPLETED|Overall Study||50
15102|NCT03037905|31451|P2|STARTED|Overall Study||50
15103|NCT03037905|31452|P1|STARTED|Overall Study||50
15104|NCT03037619|31466|P2|NOT COMPLETED|Overall Study||1
15105|NCT03037619|31467|P1|NOT COMPLETED|Overall Study||0
15106|NCT03037619|31466|P2|COMPLETED|Overall Study|7 participants and 7 buddies|14
15107|NCT03037619|31467|P1|COMPLETED|Overall Study||8
15108|NCT03037619|31466|P2|STARTED|Overall Study|8 participants and 7 buddies|15
15109|NCT03037619|31467|P1|STARTED|Overall Study||8
15110|NCT03037541|31481|P2|NOT COMPLETED|Overall Study||0
15111|NCT03037541|31482|P1|NOT COMPLETED|Overall Study||0
15112|NCT03037541|31481|P2|COMPLETED|Overall Study||30
15113|NCT03037541|31482|P1|COMPLETED|Overall Study||30
15114|NCT03037541|31481|P2|STARTED|Overall Study||30
15115|NCT03037541|31482|P1|STARTED|Overall Study||30
15116|NCT03037489|31492|P2|NOT COMPLETED|Overall Study||0
15117|NCT03037489|31493|P1|NOT COMPLETED|Overall Study||7
15118|NCT03037489|31492|P2|COMPLETED|Overall Study||4
15119|NCT03037489|31493|P1|COMPLETED|Overall Study||39
15120|NCT03037489|31492|P2|STARTED|Overall Study||4
15121|NCT03037489|31493|P1|STARTED|Overall Study||46
15122|NCT03037307|31499|P6|NOT COMPLETED|Period 3||0
15123|NCT03037307|31500|P5|NOT COMPLETED|Period 3||0
15124|NCT03037307|31501|P4|NOT COMPLETED|Period 3||0
15125|NCT03037307|31502|P3|NOT COMPLETED|Period 3||0
15126|NCT03037307|31503|P2|NOT COMPLETED|Period 3||0
15127|NCT03037307|31504|P1|NOT COMPLETED|Period 3||0
15128|NCT03037307|31499|P6|COMPLETED|Period 3||8
15129|NCT03037307|31500|P5|COMPLETED|Period 3||7
15130|NCT03037307|31501|P4|COMPLETED|Period 3||6
15131|NCT03037307|31502|P3|COMPLETED|Period 3||8
15132|NCT03037307|31503|P2|COMPLETED|Period 3||7
15133|NCT03037307|31504|P1|COMPLETED|Period 3||7
15134|NCT03037307|31499|P6|STARTED|Period 3||8
15135|NCT03037307|31500|P5|STARTED|Period 3||7
15137|NCT03037307|31502|P3|STARTED|Period 3||8
15138|NCT03037307|31503|P2|STARTED|Period 3||7
15139|NCT03037307|31504|P1|STARTED|Period 3||7
15140|NCT03037307|31499|P6|NOT COMPLETED|Wash Out Period 2||0
15141|NCT03037307|31500|P5|NOT COMPLETED|Wash Out Period 2||0
15142|NCT03037307|31501|P4|NOT COMPLETED|Wash Out Period 2||0
15143|NCT03037307|31502|P3|NOT COMPLETED|Wash Out Period 2||0
15144|NCT03037307|31503|P2|NOT COMPLETED|Wash Out Period 2||0
15145|NCT03037307|31504|P1|NOT COMPLETED|Wash Out Period 2||0
15146|NCT03037307|31499|P6|COMPLETED|Wash Out Period 2||8
15147|NCT03037307|31500|P5|COMPLETED|Wash Out Period 2||7
15148|NCT03037307|31501|P4|COMPLETED|Wash Out Period 2||6
15149|NCT03037307|31502|P3|COMPLETED|Wash Out Period 2||8
15150|NCT03037307|31503|P2|COMPLETED|Wash Out Period 2||7
15151|NCT03037307|31504|P1|COMPLETED|Wash Out Period 2||7
15152|NCT03037307|31499|P6|STARTED|Wash Out Period 2||8
15153|NCT03037307|31500|P5|STARTED|Wash Out Period 2||7
15154|NCT03037307|31501|P4|STARTED|Wash Out Period 2||6
15155|NCT03037307|31502|P3|STARTED|Wash Out Period 2||8
15156|NCT03037307|31503|P2|STARTED|Wash Out Period 2||7
15157|NCT03037307|31504|P1|STARTED|Wash Out Period 2||7
15158|NCT03037307|31499|P6|NOT COMPLETED|Period 2||0
15159|NCT03037307|31500|P5|NOT COMPLETED|Period 2||0
15160|NCT03037307|31501|P4|NOT COMPLETED|Period 2||0
15161|NCT03037307|31502|P3|NOT COMPLETED|Period 2||0
15162|NCT03037307|31503|P2|NOT COMPLETED|Period 2||0
15163|NCT03037307|31504|P1|NOT COMPLETED|Period 2||0
15164|NCT03037307|31499|P6|COMPLETED|Period 2||8
15165|NCT03037307|31500|P5|COMPLETED|Period 2||7
15166|NCT03037307|31501|P4|COMPLETED|Period 2||6
15167|NCT03037307|31502|P3|COMPLETED|Period 2||8
15168|NCT03037307|31503|P2|COMPLETED|Period 2||7
15169|NCT03037307|31504|P1|COMPLETED|Period 2||7
15170|NCT03037307|31499|P6|STARTED|Period 2||8
15171|NCT03037307|31500|P5|STARTED|Period 2||7
15172|NCT03037307|31501|P4|STARTED|Period 2||6
15173|NCT03037307|31502|P3|STARTED|Period 2||8
15174|NCT03037307|31503|P2|STARTED|Period 2||7
15175|NCT03037307|31504|P1|STARTED|Period 2||7
15176|NCT03037307|31499|P6|NOT COMPLETED|Wash Out Period 1||0
15177|NCT03037307|31500|P5|NOT COMPLETED|Wash Out Period 1||0
15178|NCT03037307|31501|P4|NOT COMPLETED|Wash Out Period 1||0
15179|NCT03037307|31502|P3|NOT COMPLETED|Wash Out Period 1||0
15180|NCT03037307|31503|P2|NOT COMPLETED|Wash Out Period 1||0
15181|NCT03037307|31504|P1|NOT COMPLETED|Wash Out Period 1||0
15182|NCT03037307|31499|P6|COMPLETED|Wash Out Period 1||8
15183|NCT03037307|31500|P5|COMPLETED|Wash Out Period 1||7
15184|NCT03037307|31501|P4|COMPLETED|Wash Out Period 1||6
15185|NCT03037307|31502|P3|COMPLETED|Wash Out Period 1||8
15186|NCT03037307|31503|P2|COMPLETED|Wash Out Period 1||7
15187|NCT03037307|31504|P1|COMPLETED|Wash Out Period 1||7
15188|NCT03037307|31499|P6|STARTED|Wash Out Period 1||8
15189|NCT03037307|31500|P5|STARTED|Wash Out Period 1||7
15190|NCT03037307|31501|P4|STARTED|Wash Out Period 1||6
15191|NCT03037307|31502|P3|STARTED|Wash Out Period 1||8
15192|NCT03037307|31503|P2|STARTED|Wash Out Period 1||7
15193|NCT03037307|31504|P1|STARTED|Wash Out Period 1||7
15194|NCT03037307|31499|P6|NOT COMPLETED|Period 1||0
15195|NCT03037307|31500|P5|NOT COMPLETED|Period 1||0
15196|NCT03037307|31501|P4|NOT COMPLETED|Period 1||1
15197|NCT03037307|31502|P3|NOT COMPLETED|Period 1||0
15198|NCT03037307|31503|P2|NOT COMPLETED|Period 1||0
15199|NCT03037307|31504|P1|NOT COMPLETED|Period 1||0
15200|NCT03037307|31499|P6|COMPLETED|Period 1||8
15201|NCT03037307|31500|P5|COMPLETED|Period 1||7
15202|NCT03037307|31501|P4|COMPLETED|Period 1||6
15203|NCT03037307|31502|P3|COMPLETED|Period 1||8
15204|NCT03037307|31503|P2|COMPLETED|Period 1||7
15205|NCT03037307|31504|P1|COMPLETED|Period 1||7
15206|NCT03037307|31499|P6|STARTED|Period 1||8
15207|NCT03037307|31500|P5|STARTED|Period 1||7
15208|NCT03037307|31501|P4|STARTED|Period 1||7
15209|NCT03037307|31502|P3|STARTED|Period 1||8
15210|NCT03037307|31503|P2|STARTED|Period 1||7
15211|NCT03037307|31504|P1|STARTED|Period 1||7
15212|NCT03036852|31520|P1|NOT COMPLETED|Overall Study||6
15213|NCT03036852|31520|P1|COMPLETED|Overall Study||53
15214|NCT03036852|31520|P1|STARTED|Overall Study||59
15215|NCT03036735|31574|P1|NOT COMPLETED|Overall Study||10
15216|NCT03036735|31574|P1|COMPLETED|Overall Study||0
15217|NCT03036735|31574|P1|STARTED|Overall Study||10
15218|NCT03036215|31580|P2|NOT COMPLETED|Overall Study||3
15219|NCT03036215|31581|P1|NOT COMPLETED|Overall Study||2
15220|NCT03036215|31580|P2|COMPLETED|Overall Study||36
15221|NCT03036215|31581|P1|COMPLETED|Overall Study||39
15222|NCT03036215|31580|P2|STARTED|Overall Study||39
15223|NCT03036215|31581|P1|STARTED|Overall Study||41
15224|NCT03035955|31593|P2|NOT COMPLETED|Overall Study||1
15225|NCT03035955|31594|P1|NOT COMPLETED|Overall Study||1
15226|NCT03035955|31593|P2|COMPLETED|Overall Study||9
15227|NCT03035955|31594|P1|COMPLETED|Overall Study||9
15228|NCT03035955|31593|P2|STARTED|Overall Study||10
15229|NCT03035955|31594|P1|STARTED|Overall Study||10
15230|NCT03035929|31600|P1|NOT COMPLETED|Overall Study||0
15231|NCT03035929|31600|P1|COMPLETED|Overall Study||10
15232|NCT03035929|31600|P1|STARTED|Overall Study||10
15233|NCT03035916|31612|P3|NOT COMPLETED|Overall Study||0
15234|NCT03035916|31613|P2|NOT COMPLETED|Overall Study||2
15235|NCT03035916|31614|P1|NOT COMPLETED|Overall Study||0
15236|NCT03035916|31612|P3|COMPLETED|Overall Study||31
15237|NCT03035916|31613|P2|COMPLETED|Overall Study||28
15238|NCT03035916|31614|P1|COMPLETED|Overall Study||30
15239|NCT03035916|31612|P3|STARTED|Overall Study||31
15240|NCT03035916|31613|P2|STARTED|Overall Study||30
15241|NCT03035916|31614|P1|STARTED|Overall Study||30
15242|NCT03035864|31663|P2|NOT COMPLETED|Follow-up Period||4
15243|NCT03035864|31664|P1|NOT COMPLETED|Follow-up Period||11
15244|NCT03035864|31663|P2|COMPLETED|Follow-up Period||55
15245|NCT03035864|31664|P1|COMPLETED|Follow-up Period||105
15246|NCT03035864|31663|P2|STARTED|Follow-up Period||59
15247|NCT03035864|31664|P1|STARTED|Follow-up Period||116
15248|NCT03035864|31663|P2|NOT COMPLETED|Treatment Period||1
15249|NCT03035864|31664|P1|NOT COMPLETED|Treatment Period||4
15250|NCT03035864|31663|P2|COMPLETED|Treatment Period||59
15251|NCT03035864|31664|P1|COMPLETED|Treatment Period||116
15252|NCT03035864|31663|P2|STARTED|Treatment Period||60
15253|NCT03035864|31664|P1|STARTED|Treatment Period||120
15254|NCT03035708|31682|P2|NOT COMPLETED|Overall Study||11
15255|NCT03035708|31683|P1|NOT COMPLETED|Overall Study||4
15256|NCT03035708|31682|P2|COMPLETED|Overall Study||13
15257|NCT03035708|31683|P1|COMPLETED|Overall Study||19
15258|NCT03035708|31682|P2|STARTED|Overall Study||24
15259|NCT03035708|31683|P1|STARTED|Overall Study||23
15260|NCT03035487|31697|P1|NOT COMPLETED|Overall Study||0
15261|NCT03035487|31697|P1|COMPLETED|Overall Study||9
15262|NCT03035487|31697|P1|STARTED|Overall Study||9
15263|NCT03034967|31707|P6|NOT COMPLETED|Overall Study||15
15264|NCT03034967|31708|P5|NOT COMPLETED|Overall Study||14
15265|NCT03034967|31709|P4|NOT COMPLETED|Overall Study||11
15266|NCT03034967|31710|P3|NOT COMPLETED|Overall Study||13
15267|NCT03034967|31711|P2|NOT COMPLETED|Overall Study||5
15268|NCT03034967|31712|P1|NOT COMPLETED|Overall Study||14
15269|NCT03034967|31707|P6|COMPLETED|Overall Study||87
15270|NCT03034967|31708|P5|COMPLETED|Overall Study||88
15271|NCT03034967|31709|P4|COMPLETED|Overall Study||92
15272|NCT03034967|31710|P3|COMPLETED|Overall Study||90
15273|NCT03034967|31711|P2|COMPLETED|Overall Study||97
15274|NCT03034967|31712|P1|COMPLETED|Overall Study||88
15275|NCT03034967|31707|P6|STARTED|Overall Study||102
15276|NCT03034967|31708|P5|STARTED|Overall Study||102
15277|NCT03034967|31709|P4|STARTED|Overall Study||103
15278|NCT03034967|31710|P3|STARTED|Overall Study||103
15279|NCT03034967|31711|P2|STARTED|Overall Study||102
15280|NCT03034967|31712|P1|STARTED|Overall Study||102
15281|NCT03034954|31910|P2|NOT COMPLETED|Overall Study||0
15282|NCT03034954|31911|P1|NOT COMPLETED|Overall Study||1
15283|NCT03034954|31910|P2|COMPLETED|Overall Study||21
15284|NCT03034954|31911|P1|COMPLETED|Overall Study||20
15285|NCT03034954|31910|P2|STARTED|Overall Study||21
15286|NCT03034954|31911|P1|STARTED|Overall Study||21
15287|NCT03034915|31966|P3|NOT COMPLETED|Overall Study||126
15288|NCT03034915|31967|P2|NOT COMPLETED|Overall Study||154
15289|NCT03034915|31968|P1|NOT COMPLETED|Overall Study||95
15290|NCT03034915|31966|P3|COMPLETED|Overall Study||683
15291|NCT03034915|31967|P2|COMPLETED|Overall Study||650
15292|NCT03034915|31968|P1|COMPLETED|Overall Study||717
15293|NCT03034915|31966|P3|STARTED|Overall Study||809
15294|NCT03034915|31967|P2|STARTED|Overall Study||804
15295|NCT03034915|31968|P1|STARTED|Overall Study||812
15296|NCT03034577|32008|P2|NOT COMPLETED|Overall Study||35
15297|NCT03034577|32009|P1|NOT COMPLETED|Overall Study||31
15298|NCT03034577|32008|P2|COMPLETED|Overall Study||140
15299|NCT03034577|32009|P1|COMPLETED|Overall Study||144
15300|NCT03034577|32008|P2|STARTED|Overall Study||175
15301|NCT03034577|32009|P1|STARTED|Overall Study||175
15302|NCT03034057|32025|P1|NOT COMPLETED|Overall Study||55
15303|NCT03034057|32025|P1|COMPLETED|Overall Study||114
15304|NCT03034057|32025|P1|STARTED|Overall Study||169
15305|NCT03034044|32031|P1|NOT COMPLETED|Overall Study||1
15306|NCT03034044|32031|P1|COMPLETED|Overall Study||105
15307|NCT03034044|32031|P1|Received Xyntha|Overall Study||105
15308|NCT03034044|32031|P1|STARTED|Overall Study||106
15309|NCT03033134|32053|P2|NOT COMPLETED|Overall Study||12
15310|NCT03033134|32054|P1|NOT COMPLETED|Overall Study||42
15311|NCT03033134|32053|P2|COMPLETED|Overall Study||0
15312|NCT03033134|32054|P1|COMPLETED|Overall Study||0
15313|NCT03033134|32053|P2|6-month Primary Endpoints|Overall Study||12
15314|NCT03033134|32054|P1|6-month Primary Endpoints|Overall Study||42
15315|NCT03033134|32053|P2|STARTED|Overall Study||12
15316|NCT03033134|32054|P1|STARTED|Overall Study||42
15317|NCT03032965|32076|P2|NOT COMPLETED|Overall Study||0
15318|NCT03032965|32077|P1|NOT COMPLETED|Overall Study||0
15319|NCT03032965|32076|P2|COMPLETED|Overall Study||68
15320|NCT03032965|32077|P1|COMPLETED|Overall Study||61
15321|NCT03032965|32076|P2|STARTED|Overall Study||68
15322|NCT03032965|32077|P1|STARTED|Overall Study||61
15323|NCT03032523|32101|P2|NOT COMPLETED|Overall Study||2
15324|NCT03032523|32102|P1|NOT COMPLETED|Overall Study||3
15325|NCT03032523|32101|P2|COMPLETED|Overall Study||4
15326|NCT03032523|32102|P1|COMPLETED|Overall Study||12
15327|NCT03032523|32101|P2|STARTED|Overall Study||6
15328|NCT03032523|32102|P1|STARTED|Overall Study||15
15329|NCT03032510|32114|P2|NOT COMPLETED|Overall Study||18
15330|NCT03032510|32115|P1|NOT COMPLETED|Overall Study||27
15331|NCT03032510|32114|P2|COMPLETED|Overall Study||584
15332|NCT03032510|32115|P1|COMPLETED|Overall Study||576
15333|NCT03032510|32114|P2|STARTED|Overall Study||602
15334|NCT03032510|32115|P1|STARTED|Overall Study||603
15335|NCT03032263|32127|P2|NOT COMPLETED|Overall Study||0
15336|NCT03032263|32128|P1|NOT COMPLETED|Overall Study||0
15337|NCT03032263|32127|P2|COMPLETED|Overall Study||6
15338|NCT03032263|32128|P1|COMPLETED|Overall Study||6
15339|NCT03032263|32127|P2|STARTED|Overall Study||6
15340|NCT03032263|32128|P1|STARTED|Overall Study||6
15341|NCT03031899|32142|P1|NOT COMPLETED|Overall Study||2
15342|NCT03031899|32142|P1|COMPLETED|Overall Study||25
15343|NCT03031899|32142|P1|STARTED|Overall Study||27
15344|NCT03031795|32152|P2|NOT COMPLETED|Overall Study||1
15345|NCT03031795|32153|P1|NOT COMPLETED|Overall Study||0
15346|NCT03031795|32152|P2|COMPLETED|Overall Study||35
15347|NCT03031795|32153|P1|COMPLETED|Overall Study||35
15348|NCT03031795|32152|P2|STARTED|Overall Study||36
15349|NCT03031795|32153|P1|STARTED|Overall Study||35
15350|NCT03031496|32159|P2|NOT COMPLETED|Period 2||0
15351|NCT03031496|32160|P1|NOT COMPLETED|Period 2||0
15352|NCT03031496|32159|P2|COMPLETED|Period 2||19
15353|NCT03031496|32160|P1|COMPLETED|Period 2||19
15354|NCT03031496|32159|P2|STARTED|Period 2||19
15355|NCT03031496|32160|P1|STARTED|Period 2||19
15356|NCT03031496|32159|P2|NOT COMPLETED|Period 1||2
15357|NCT03031496|32160|P1|NOT COMPLETED|Period 1||2
15358|NCT03031496|32159|P2|COMPLETED|Period 1||19
15359|NCT03031496|32160|P1|COMPLETED|Period 1||19
15360|NCT03031496|32159|P2|STARTED|Period 1||21
15361|NCT03031496|32160|P1|STARTED|Period 1||21
15362|NCT03031340|32198|P2|NOT COMPLETED|Overall Study||1
15363|NCT03031340|32199|P1|NOT COMPLETED|Overall Study||2
15364|NCT03031340|32198|P2|COMPLETED|Overall Study||0
15365|NCT03031340|32199|P1|COMPLETED|Overall Study||0
15366|NCT03031340|32198|P2|STARTED|Overall Study||1
15367|NCT03031340|32199|P1|STARTED|Overall Study||2
15368|NCT03030638|32223|P8|NOT COMPLETED|Overall Study||0
15369|NCT03030638|32224|P7|NOT COMPLETED|Overall Study||0
15370|NCT03030638|32225|P6|NOT COMPLETED|Overall Study||0
15371|NCT03030638|32226|P5|NOT COMPLETED|Overall Study||0
15372|NCT03030638|32227|P4|NOT COMPLETED|Overall Study||0
15373|NCT03030638|32228|P3|NOT COMPLETED|Overall Study||0
15374|NCT03030638|32229|P2|NOT COMPLETED|Overall Study||0
15375|NCT03030638|32230|P1|NOT COMPLETED|Overall Study||0
15376|NCT03030638|32223|P8|COMPLETED|Overall Study||127
15377|NCT03030638|32224|P7|COMPLETED|Overall Study||364
15378|NCT03030638|32225|P6|COMPLETED|Overall Study||1592
15379|NCT03030638|32226|P5|COMPLETED|Overall Study||696
15380|NCT03030638|32227|P4|COMPLETED|Overall Study||6406
15381|NCT03030638|32228|P3|COMPLETED|Overall Study||1712
15382|NCT03030638|32229|P2|COMPLETED|Overall Study||1841
15383|NCT03030638|32230|P1|COMPLETED|Overall Study||1386
15384|NCT03030638|32223|P8|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
15385|NCT03030638|32224|P7|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
15386|NCT03030638|32225|P6|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
15387|NCT03030638|32226|P5|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
15388|NCT03030638|32227|P4|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
15389|NCT03030638|32228|P3|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
15390|NCT03030638|32229|P2|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||636
15391|NCT03030638|32230|P1|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||372
15392|NCT03030638|32223|P8|STARTED|Overall Study||127
15393|NCT03030638|32224|P7|STARTED|Overall Study||364
15394|NCT03030638|32225|P6|STARTED|Overall Study||1592
15395|NCT03030638|32226|P5|STARTED|Overall Study||696
15396|NCT03030638|32227|P4|STARTED|Overall Study||6406
15397|NCT03030638|32228|P3|STARTED|Overall Study||1712
15398|NCT03030638|32229|P2|STARTED|Overall Study||1841
15399|NCT03030638|32230|P1|STARTED|Overall Study||1386
15400|NCT03029988|32260|P1|NOT COMPLETED|Overall Study||0
15401|NCT03029988|32260|P1|COMPLETED|Overall Study||3
15402|NCT03029988|32260|P1|STARTED|Overall Study||3
15403|NCT03029832|32267|P2|NOT COMPLETED|Overall Study||1
15404|NCT03029832|32268|P1|NOT COMPLETED|Overall Study||4
15405|NCT03029832|32267|P2|COMPLETED|Overall Study||0
15406|NCT03029832|32268|P1|COMPLETED|Overall Study||0
15407|NCT03029832|32267|P2|STARTED|Overall Study||1
15408|NCT03029832|32268|P1|STARTED|Overall Study||4
15409|NCT03029819|32298|P2|NOT COMPLETED|Overall Study||6
15410|NCT03029819|32299|P1|NOT COMPLETED|Overall Study||3
15411|NCT03029819|32298|P2|COMPLETED|Overall Study||33
15412|NCT03029819|32299|P1|COMPLETED|Overall Study||30
15413|NCT03029819|32298|P2|STARTED|Overall Study||39
15414|NCT03029819|32299|P1|STARTED|Overall Study||33
15415|NCT03029780|32313|P2|NOT COMPLETED|Overall Study||11
15416|NCT03029780|32314|P1|NOT COMPLETED|Overall Study||6
15417|NCT03029780|32313|P2|COMPLETED|Overall Study||41
15418|NCT03029780|32314|P1|COMPLETED|Overall Study||46
15419|NCT03029780|32313|P2|STARTED|Overall Study||52
15420|NCT03029780|32314|P1|STARTED|Overall Study||52
15421|NCT03029650|32326|P2|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0
15422|NCT03029650|32327|P1|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0
15423|NCT03029650|32326|P2|COMPLETED|2nd Intervention (3 - 6 Days)||10
15424|NCT03029650|32327|P1|COMPLETED|2nd Intervention (3 - 6 Days)||13
15425|NCT03029650|32326|P2|STARTED|2nd Intervention (3 - 6 Days)||10
15426|NCT03029650|32327|P1|STARTED|2nd Intervention (3 - 6 Days)||13
15427|NCT03029650|32326|P2|NOT COMPLETED|Washout (1 Week)||2
15428|NCT03029650|32327|P1|NOT COMPLETED|Washout (1 Week)||1
15429|NCT03029650|32326|P2|COMPLETED|Washout (1 Week)||10
15430|NCT03029650|32327|P1|COMPLETED|Washout (1 Week)||13
15431|NCT03029650|32326|P2|STARTED|Washout (1 Week)||12
15432|NCT03029650|32327|P1|STARTED|Washout (1 Week)||14
15433|NCT03029650|32326|P2|NOT COMPLETED|First Intervention (3 - 6 Days)||0
15434|NCT03029650|32327|P1|NOT COMPLETED|First Intervention (3 - 6 Days)||0
15435|NCT03029650|32326|P2|COMPLETED|First Intervention (3 - 6 Days)||12
15436|NCT03029650|32327|P1|COMPLETED|First Intervention (3 - 6 Days)||14
15437|NCT03029650|32326|P2|STARTED|First Intervention (3 - 6 Days)||12
15438|NCT03029650|32327|P1|STARTED|First Intervention (3 - 6 Days)|More subjects not enrolled after consent in other group leaving uneven number.|14
15439|NCT03029234|32342|P1|NOT COMPLETED|Overall Study||67
15440|NCT03029234|32342|P1|COMPLETED|Overall Study||59
15441|NCT03029234|32342|P1|Received Carfilzomib|Overall Study||123
15442|NCT03029234|32342|P1|STARTED|Overall Study||126
15443|NCT03029000|32367|P1|NOT COMPLETED|Overall Study||0
15444|NCT03029000|32367|P1|COMPLETED|Overall Study||1
15445|NCT03029000|32367|P1|STARTED|Overall Study||1
15446|NCT03028987|32380|P2|NOT COMPLETED|Overall Study||0
15447|NCT03028987|32381|P1|NOT COMPLETED|Overall Study||0
15448|NCT03028987|32380|P2|COMPLETED|Overall Study||5
15449|NCT03028987|32381|P1|COMPLETED|Overall Study||5
15450|NCT03028987|32380|P2|STARTED|Overall Study||5
15451|NCT03028987|32381|P1|STARTED|Overall Study||5
15452|NCT03028974|32394|P7|NOT COMPLETED|2017-2018||0
15453|NCT03028974|32395|P6|NOT COMPLETED|2017-2018||0
15454|NCT03028974|32396|P5|NOT COMPLETED|2017-2018||0
15455|NCT03028974|32397|P4|NOT COMPLETED|2017-2018||0
15456|NCT03028974|32398|P3|NOT COMPLETED|2017-2018||0
15457|NCT03028974|32399|P2|NOT COMPLETED|2017-2018||0
15458|NCT03028974|32400|P1|NOT COMPLETED|2017-2018||0
15459|NCT03028974|32394|P7|COMPLETED|2017-2018||5
15460|NCT03028974|32395|P6|COMPLETED|2017-2018||0
15461|NCT03028974|32396|P5|COMPLETED|2017-2018||0
15462|NCT03028974|32397|P4|COMPLETED|2017-2018||5
15463|NCT03028974|32398|P3|COMPLETED|2017-2018||0
15464|NCT03028974|32399|P2|COMPLETED|2017-2018||0
15465|NCT03028974|32400|P1|COMPLETED|2017-2018||0
15466|NCT03028974|32394|P7|STARTED|2017-2018|5 new participants were enrolled.|5
15467|NCT03028974|32395|P6|STARTED|2017-2018||0
15468|NCT03028974|32396|P5|STARTED|2017-2018||0
15469|NCT03028974|32397|P4|STARTED|2017-2018||5
15470|NCT03028974|32398|P3|STARTED|2017-2018||0
15471|NCT03028974|32399|P2|STARTED|2017-2018||0
15472|NCT03028974|32400|P1|STARTED|2017-2018||0
15473|NCT03028974|32394|P7|NOT COMPLETED|2016-2017||0
15474|NCT03028974|32395|P6|NOT COMPLETED|2016-2017||0
15475|NCT03028974|32396|P5|NOT COMPLETED|2016-2017||0
15476|NCT03028974|32397|P4|NOT COMPLETED|2016-2017||0
15477|NCT03028974|32398|P3|NOT COMPLETED|2016-2017||0
15478|NCT03028974|32399|P2|NOT COMPLETED|2016-2017||0
15479|NCT03028974|32400|P1|NOT COMPLETED|2016-2017||0
15480|NCT03028974|32394|P7|COMPLETED|2016-2017|18 participants did not continue to the next period.|18
15481|NCT03028974|32395|P6|COMPLETED|2016-2017||0
15482|NCT03028974|32396|P5|COMPLETED|2016-2017|2 participants did not continue to the next period|2
15483|NCT03028974|32397|P4|COMPLETED|2016-2017||4
15484|NCT03028974|32398|P3|COMPLETED|2016-2017||0
15485|NCT03028974|32399|P2|COMPLETED|2016-2017||0
15486|NCT03028974|32400|P1|COMPLETED|2016-2017||0
15487|NCT03028974|32394|P7|STARTED|2016-2017|18 new participants were enrolled.|18
15488|NCT03028974|32395|P6|STARTED|2016-2017||0
15489|NCT03028974|32396|P5|STARTED|2016-2017|2 new participants were enrolled.|2
15490|NCT03028974|32397|P4|STARTED|2016-2017|1 new participant was enrolled.|4
15491|NCT03028974|32398|P3|STARTED|2016-2017||0
15492|NCT03028974|32399|P2|STARTED|2016-2017||0
15493|NCT03028974|32400|P1|STARTED|2016-2017||0
15494|NCT03028974|32394|P7|NOT COMPLETED|2015-2016||0
15495|NCT03028974|32395|P6|NOT COMPLETED|2015-2016||0
15496|NCT03028974|32396|P5|NOT COMPLETED|2015-2016||0
15497|NCT03028974|32397|P4|NOT COMPLETED|2015-2016||0
15498|NCT03028974|32398|P3|NOT COMPLETED|2015-2016||0
15499|NCT03028974|32399|P2|NOT COMPLETED|2015-2016||0
15500|NCT03028974|32400|P1|NOT COMPLETED|2015-2016||0
15501|NCT03028974|32394|P7|COMPLETED|2015-2016|20 participants did not continue to the next period.|20
15502|NCT03028974|32395|P6|COMPLETED|2015-2016|14 participants did not continue to the next period.|14
15503|NCT03028974|32396|P5|COMPLETED|2015-2016||0
15504|NCT03028974|32397|P4|COMPLETED|2015-2016|3 participants did not continue to the next period. 1 Participant returned in period 4 (2017-2018).|6
15505|NCT03028974|32398|P3|COMPLETED|2015-2016||0
15506|NCT03028974|32399|P2|COMPLETED|2015-2016||0
15507|NCT03028974|32400|P1|COMPLETED|2015-2016||0
15508|NCT03028974|32394|P7|STARTED|2015-2016|11 new participants were enrolled; 9 subjects switched from Group F.|20
15509|NCT03028974|32395|P6|STARTED|2015-2016|10 new participants were enrolled; 4 subjects switched from Group G.|14
15510|NCT03028974|32396|P5|STARTED|2015-2016||0
15511|NCT03028974|32397|P4|STARTED|2015-2016|One participant joined from Group A, 2 new were enrolled.|6
15512|NCT03028974|32398|P3|STARTED|2015-2016||0
15513|NCT03028974|32399|P2|STARTED|2015-2016||0
15514|NCT03028974|32400|P1|STARTED|2015-2016||0
15515|NCT03028974|32394|P7|NOT COMPLETED|2014-2015||0
15516|NCT03028974|32395|P6|NOT COMPLETED|2014-2015||0
15517|NCT03028974|32396|P5|NOT COMPLETED|2014-2015||0
15518|NCT03028974|32397|P4|NOT COMPLETED|2014-2015||0
15519|NCT03028974|32398|P3|NOT COMPLETED|2014-2015||0
15520|NCT03028974|32399|P2|NOT COMPLETED|2014-2015||0
15521|NCT03028974|32400|P1|NOT COMPLETED|2014-2015||0
15522|NCT03028974|32394|P7|COMPLETED|2014-2015|13 participants did not continue to the next period.|13
15523|NCT03028974|32395|P6|COMPLETED|2014-2015|2 participants did not continue to the next period.|11
15524|NCT03028974|32396|P5|COMPLETED|2014-2015||0
15525|NCT03028974|32397|P4|COMPLETED|2014-2015||3
15526|NCT03028974|32398|P3|COMPLETED|2014-2015||0
15527|NCT03028974|32399|P2|COMPLETED|2014-2015||0
15528|NCT03028974|32400|P1|COMPLETED|2014-2015||1
15529|NCT03028974|32394|P7|STARTED|2014-2015||13
15530|NCT03028974|32395|P6|STARTED|2014-2015||11
15531|NCT03028974|32396|P5|STARTED|2014-2015||0
15532|NCT03028974|32397|P4|STARTED|2014-2015||3
15533|NCT03028974|32398|P3|STARTED|2014-2015||0
15534|NCT03028974|32399|P2|STARTED|2014-2015||0
15535|NCT03028974|32400|P1|STARTED|2014-2015||1
15536|NCT03028896|32419|P2|NOT COMPLETED|Overall Study||0
15537|NCT03028896|32420|P1|NOT COMPLETED|Overall Study||3
15538|NCT03028896|32419|P2|COMPLETED|Overall Study||66
15539|NCT03028896|32420|P1|COMPLETED|Overall Study||63
15540|NCT03028896|32419|P2|STARTED|Overall Study||66
15541|NCT03028896|32420|P1|STARTED|Overall Study||66
15542|NCT03028870|32436|P4|NOT COMPLETED|Overall Study||9
15543|NCT03028870|32437|P3|NOT COMPLETED|Overall Study||16
15544|NCT03028870|32438|P2|NOT COMPLETED|Overall Study||10
15545|NCT03028870|32439|P1|NOT COMPLETED|Overall Study||17
15546|NCT03028870|32436|P4|COMPLETED|Overall Study||65
15547|NCT03028870|32437|P3|COMPLETED|Overall Study||60
15548|NCT03028870|32438|P2|COMPLETED|Overall Study||57
15549|NCT03028870|32439|P1|COMPLETED|Overall Study||57
15550|NCT03028870|32436|P4|STARTED|Overall Study||74
15551|NCT03028870|32437|P3|STARTED|Overall Study||76
15552|NCT03028870|32438|P2|STARTED|Overall Study||67
15553|NCT03028870|32439|P1|STARTED|Overall Study||74
15554|NCT03028467|32521|P4|NOT COMPLETED|Overall Study||0
15555|NCT03028467|32522|P3|NOT COMPLETED|Overall Study||0
15556|NCT03028467|32523|P2|NOT COMPLETED|Overall Study||0
15557|NCT03028467|32524|P1|NOT COMPLETED|Overall Study||0
15558|NCT03028467|32521|P4|COMPLETED|Overall Study||4
15559|NCT03028467|32522|P3|COMPLETED|Overall Study||4
15560|NCT03028467|32523|P2|COMPLETED|Overall Study||3
15561|NCT03028467|32524|P1|COMPLETED|Overall Study||4
15562|NCT03028467|32521|P4|STARTED|Overall Study||4
15563|NCT03028467|32522|P3|STARTED|Overall Study||4
15564|NCT03028467|32523|P2|STARTED|Overall Study||3
15565|NCT03028467|32524|P1|STARTED|Overall Study||4
15566|NCT03028363|32588|P2|NOT COMPLETED|Overall Study||33
15567|NCT03028363|32589|P1|NOT COMPLETED|Overall Study||78
15568|NCT03028363|32588|P2|COMPLETED|Overall Study||228
15569|NCT03028363|32589|P1|COMPLETED|Overall Study||420
15570|NCT03028363|32588|P2|STARTED|Overall Study||261
15571|NCT03028363|32589|P1|STARTED|Overall Study||498
15572|NCT03028220|32601|P2|NOT COMPLETED|Overall Study||0
15573|NCT03028220|32602|P1|NOT COMPLETED|Overall Study||0
15574|NCT03028220|32601|P2|COMPLETED|Overall Study||20
15575|NCT03028220|32602|P1|COMPLETED|Overall Study||20
15576|NCT03028220|32601|P2|STARTED|Overall Study||20
15577|NCT03028220|32602|P1|STARTED|Overall Study||20
15578|NCT03028142|32630|P6|NOT COMPLETED|Overall Study||1
15579|NCT03028142|32631|P5|NOT COMPLETED|Overall Study||1
15580|NCT03028142|32632|P4|NOT COMPLETED|Overall Study||0
15581|NCT03028142|32633|P3|NOT COMPLETED|Overall Study||0
15582|NCT03028142|32634|P2|NOT COMPLETED|Overall Study||1
15583|NCT03028142|32635|P1|NOT COMPLETED|Overall Study||1
15584|NCT03028142|32630|P6|COMPLETED|Overall Study||3
15585|NCT03028142|32631|P5|COMPLETED|Overall Study||5
15586|NCT03028142|32632|P4|COMPLETED|Overall Study||4
15587|NCT03028142|32633|P3|COMPLETED|Overall Study||6
15588|NCT03028142|32634|P2|COMPLETED|Overall Study||4
15589|NCT03028142|32635|P1|COMPLETED|Overall Study||4
15590|NCT03028142|32630|P6|STARTED|Overall Study||4
15591|NCT03028142|32631|P5|STARTED|Overall Study||6
15592|NCT03028142|32632|P4|STARTED|Overall Study||4
15593|NCT03028142|32633|P3|STARTED|Overall Study||6
15594|NCT03028142|32634|P2|STARTED|Overall Study||5
15595|NCT03028142|32635|P1|STARTED|Overall Study||5
15596|NCT03028129|32654|P2|NOT COMPLETED|Overall Study||87
15597|NCT03028129|32655|P1|NOT COMPLETED|Overall Study||126
15598|NCT03028129|32654|P2|COMPLETED|Overall Study||122
15599|NCT03028129|32655|P1|COMPLETED|Overall Study||132
15600|NCT03028129|32654|P2|STARTED|Overall Study||209
15601|NCT03028129|32655|P1|STARTED|Overall Study||258
15602|NCT03028025|32663|P2|NOT COMPLETED|Overall Study||1
15603|NCT03028025|32664|P1|NOT COMPLETED|Overall Study||3
15604|NCT03028025|32663|P2|COMPLETED|Overall Study||93
15605|NCT03028025|32664|P1|COMPLETED|Overall Study||87
15606|NCT03028025|32663|P2|STARTED|Overall Study||94
15607|NCT03028025|32664|P1|STARTED|Overall Study||90
15608|NCT03027661|32674|P2|NOT COMPLETED|Overall Study||0
15609|NCT03027661|32675|P1|NOT COMPLETED|Overall Study||0
15610|NCT03027661|32674|P2|COMPLETED|Overall Study||21
15611|NCT03027661|32675|P1|COMPLETED|Overall Study||20
15612|NCT03027661|32674|P2|STARTED|Overall Study||21
15613|NCT03027661|32675|P1|STARTED|Overall Study||20
15614|NCT03026803|32683|P1|NOT COMPLETED|Overall Study||0
15615|NCT03026803|32683|P1|COMPLETED|Overall Study||4
15616|NCT03026803|32683|P1|STARTED|Overall Study||4
15617|NCT03026556|32690|P3|NOT COMPLETED|Overall Study||0
15618|NCT03026556|32691|P2|NOT COMPLETED|Overall Study||0
15619|NCT03026556|32692|P1|NOT COMPLETED|Overall Study||0
15620|NCT03026556|32690|P3|COMPLETED|Overall Study||12594
15621|NCT03026556|32691|P2|COMPLETED|Overall Study||17177
15622|NCT03026556|32692|P1|COMPLETED|Overall Study||12763
15623|NCT03026556|32690|P3|STARTED|Overall Study||12594
15624|NCT03026556|32691|P2|STARTED|Overall Study||17177
15625|NCT03026556|32692|P1|STARTED|Overall Study||12763
15626|NCT03026530|32751|P2|NOT COMPLETED|Overall Study||29
15627|NCT03026530|32752|P1|NOT COMPLETED|Overall Study||21
15628|NCT03026530|32751|P2|COMPLETED|Overall Study||71
15629|NCT03026530|32752|P1|COMPLETED|Overall Study||79
15630|NCT03026530|32751|P2|STARTED|Overall Study||100
15631|NCT03026530|32752|P1|STARTED|Overall Study||100
15632|NCT03026257|32766|P6|NOT COMPLETED|Overall Study||0
15633|NCT03026257|32767|P5|NOT COMPLETED|Overall Study||1
15634|NCT03026257|32768|P4|NOT COMPLETED|Overall Study||1
15635|NCT03026257|32769|P3|NOT COMPLETED|Overall Study||0
15636|NCT03026257|32770|P2|NOT COMPLETED|Overall Study||1
15637|NCT03026257|32771|P1|NOT COMPLETED|Overall Study||6
15638|NCT03026257|32766|P6|COMPLETED|Overall Study||46
15639|NCT03026257|32767|P5|COMPLETED|Overall Study||22
15640|NCT03026257|32768|P4|COMPLETED|Overall Study||24
15641|NCT03026257|32769|P3|COMPLETED|Overall Study||34
15642|NCT03026257|32770|P2|COMPLETED|Overall Study||63
15643|NCT03026257|32771|P1|COMPLETED|Overall Study||54
15644|NCT03026257|32766|P6|Treated|Overall Study||47
15645|NCT03026257|32767|P5|Treated|Overall Study||23
15646|NCT03026257|32768|P4|Treated|Overall Study||24
15647|NCT03026257|32769|P3|Treated|Overall Study||35
15648|NCT03026257|32770|P2|Treated|Overall Study||65
15649|NCT03026257|32771|P1|Treated|Overall Study||58
15650|NCT03026257|32766|P6|STARTED|Overall Study||46
15651|NCT03026257|32767|P5|STARTED|Overall Study||23
15652|NCT03026257|32768|P4|STARTED|Overall Study||25
15653|NCT03026257|32769|P3|STARTED|Overall Study||34
15654|NCT03026257|32770|P2|STARTED|Overall Study||64
15655|NCT03026257|32771|P1|STARTED|Overall Study||60
15656|NCT03026075|32785|P1|NOT COMPLETED|Overall Study||1
15657|NCT03026075|32785|P1|COMPLETED|Overall Study||46
15658|NCT03026075|32785|P1|STARTED|Overall Study||47
15659|NCT03025945|32791|P2|NOT COMPLETED|Overall Study||0
15660|NCT03025945|32792|P1|NOT COMPLETED|Overall Study||0
15661|NCT03025945|32791|P2|COMPLETED|Overall Study||331
15662|NCT03025945|32792|P1|COMPLETED|Overall Study||331
15663|NCT03025945|32791|P2|STARTED|Overall Study||331
15664|NCT03025945|32792|P1|STARTED|Overall Study||331
15665|NCT03025217|32798|P1|NOT COMPLETED|Overall Study||4
15666|NCT03025217|32798|P1|COMPLETED|Overall Study||27
15667|NCT03025217|32798|P1|STARTED|Overall Study||31
15668|NCT03024606|32805|P2|NOT COMPLETED|Overall Study||10
15669|NCT03024606|32806|P1|NOT COMPLETED|Overall Study||9
15670|NCT03024606|32805|P2|COMPLETED|Overall Study||16
15671|NCT03024606|32806|P1|COMPLETED|Overall Study||14
15672|NCT03024606|32805|P2|STARTED|Overall Study||26
15673|NCT03024606|32806|P1|STARTED|Overall Study||23
15674|NCT03024112|32814|P2|NOT COMPLETED|Overall Study||0
15675|NCT03024112|32815|P1|NOT COMPLETED|Overall Study||7
15676|NCT03024112|32814|P2|COMPLETED|Overall Study||26
15677|NCT03024112|32815|P1|COMPLETED|Overall Study||18
15678|NCT03024112|32814|P2|STARTED|Overall Study||26
15679|NCT03024112|32815|P1|STARTED|Overall Study||25
15680|NCT03023709|32829|P2|NOT COMPLETED|Overall Study||0
15681|NCT03023709|32830|P1|NOT COMPLETED|Overall Study||0
15682|NCT03023709|32829|P2|COMPLETED|Overall Study||0
15683|NCT03023709|32830|P1|COMPLETED|Overall Study||3
15684|NCT03023709|32829|P2|STARTED|Overall Study||0
15685|NCT03023709|32830|P1|STARTED|Overall Study||3
15686|NCT03023683|32840|P2|NOT COMPLETED|Overall Study||1
15687|NCT03023683|32841|P1|NOT COMPLETED|Overall Study||0
15688|NCT03023683|32840|P2|COMPLETED|Overall Study||17
15689|NCT03023683|32841|P1|COMPLETED|Overall Study||0
15690|NCT03023683|32840|P2|STARTED|Overall Study||18
15691|NCT03023683|32841|P1|STARTED|Overall Study||0
15692|NCT03023553|32851|P2|NOT COMPLETED|Overall Study||1
15693|NCT03023553|32852|P1|NOT COMPLETED|Overall Study||0
15694|NCT03023553|32851|P2|COMPLETED|Overall Study||8
15695|NCT03023553|32852|P1|COMPLETED|Overall Study||4
15696|NCT03023553|32851|P2|STARTED|Overall Study||9
15697|NCT03023553|32852|P1|STARTED|Overall Study||4
15698|NCT03023488|32860|P1|NOT COMPLETED|Overall Study||0
15699|NCT03023488|32860|P1|COMPLETED|Overall Study||46
15700|NCT03023488|32860|P1|STARTED|Overall Study||46
15701|NCT03023423|32876|P3|NOT COMPLETED|Overall Study||46
15702|NCT03023423|32877|P2|NOT COMPLETED|Overall Study||46
15703|NCT03023423|32878|P1|NOT COMPLETED|Overall Study||7
15704|NCT03023423|32876|P3|COMPLETED|Overall Study||0
15705|NCT03023423|32877|P2|COMPLETED|Overall Study||0
15706|NCT03023423|32878|P1|COMPLETED|Overall Study||0
15707|NCT03023423|32876|P3|Crossover From Atezo to Dara + Atezo|Overall Study||0
15708|NCT03023423|32877|P2|Crossover From Atezo to Dara + Atezo|Overall Study|Participants who met crossover eligibility criteria entered to Dara + Atezo arm.|8
15709|NCT03023423|32878|P1|Crossover From Atezo to Dara + Atezo|Overall Study||0
15710|NCT03023423|32876|P3|Treated|Overall Study||44
15711|NCT03023423|32877|P2|Treated|Overall Study||44
15712|NCT03023423|32878|P1|Treated|Overall Study||7
15713|NCT03023423|32876|P3|STARTED|Overall Study||46
15714|NCT03023423|32877|P2|STARTED|Overall Study||46
15715|NCT03023423|32878|P1|STARTED|Overall Study||7
15716|NCT03023176|32908|P1|NOT COMPLETED|Overall Study||0
15717|NCT03023176|32908|P1|COMPLETED|Overall Study||20
15718|NCT03023176|32908|P1|STARTED|Overall Study||20
15719|NCT03023137|32915|P2|NOT COMPLETED|Overall Study||9
15720|NCT03023137|32916|P1|NOT COMPLETED|Overall Study||4
15721|NCT03023137|32915|P2|COMPLETED|Overall Study||162
15722|NCT03023137|32916|P1|COMPLETED|Overall Study||174
15723|NCT03023137|32915|P2|STARTED|Overall Study||171
15724|NCT03023137|32916|P1|STARTED|Overall Study||178
15725|NCT03022630|32944|P2|NOT COMPLETED|Overall Study||12
15726|NCT03022630|32945|P1|NOT COMPLETED|Overall Study||9
15727|NCT03022630|32944|P2|COMPLETED|Overall Study||20
15728|NCT03022630|32945|P1|COMPLETED|Overall Study||22
15729|NCT03022630|32944|P2|STARTED|Overall Study||32
15730|NCT03022630|32945|P1|STARTED|Overall Study||31
15731|NCT03022435|32998|P5|NOT COMPLETED|Overall Study||0
15732|NCT03022435|32999|P4|NOT COMPLETED|Overall Study||0
15733|NCT03022435|33000|P3|NOT COMPLETED|Overall Study||0
15734|NCT03022435|33001|P2|NOT COMPLETED|Overall Study||0
15735|NCT03022435|33002|P1|NOT COMPLETED|Overall Study||0
15736|NCT03022435|32998|P5|COMPLETED|Overall Study||3
15737|NCT03022435|32999|P4|COMPLETED|Overall Study||3
15738|NCT03022435|33000|P3|COMPLETED|Overall Study||6
15739|NCT03022435|33001|P2|COMPLETED|Overall Study||5
15740|NCT03022435|33002|P1|COMPLETED|Overall Study||5
15741|NCT03022435|32998|P5|STARTED|Overall Study||3
15742|NCT03022435|32999|P4|STARTED|Overall Study||3
15743|NCT03022435|33000|P3|STARTED|Overall Study||6
15744|NCT03022435|33001|P2|STARTED|Overall Study||5
15745|NCT03022435|33002|P1|STARTED|Overall Study||5
15746|NCT03022422|33025|P6|NOT COMPLETED|Overall Study||0
15747|NCT03022422|33026|P5|NOT COMPLETED|Overall Study||0
15748|NCT03022422|33027|P4|NOT COMPLETED|Overall Study||0
15749|NCT03022422|33028|P3|NOT COMPLETED|Overall Study||3
15750|NCT03022422|33029|P2|NOT COMPLETED|Overall Study||0
15751|NCT03022422|33030|P1|NOT COMPLETED|Overall Study||0
15752|NCT03022422|33025|P6|COMPLETED|Overall Study||5
15753|NCT03022422|33026|P5|COMPLETED|Overall Study||5
15754|NCT03022422|33027|P4|COMPLETED|Overall Study||12
15755|NCT03022422|33028|P3|COMPLETED|Overall Study||20
15756|NCT03022422|33029|P2|COMPLETED|Overall Study||10
15757|NCT03022422|33030|P1|COMPLETED|Overall Study||8
15758|NCT03022422|33025|P6|STARTED|Overall Study||5
15759|NCT03022422|33026|P5|STARTED|Overall Study||5
15760|NCT03022422|33027|P4|STARTED|Overall Study||12
15761|NCT03022422|33028|P3|STARTED|Overall Study||23
15762|NCT03022422|33029|P2|STARTED|Overall Study||10
15763|NCT03022422|33030|P1|STARTED|Overall Study||8
15764|NCT03022396|33056|P6|NOT COMPLETED|Overall Study||0
15765|NCT03022396|33057|P5|NOT COMPLETED|Overall Study||0
15766|NCT03022396|33058|P4|NOT COMPLETED|Overall Study||0
15767|NCT03022396|33059|P3|NOT COMPLETED|Overall Study||0
15768|NCT03022396|33060|P2|NOT COMPLETED|Overall Study||0
15769|NCT03022396|33061|P1|NOT COMPLETED|Overall Study||0
15770|NCT03022396|33056|P6|COMPLETED|Overall Study||8
15771|NCT03022396|33057|P5|COMPLETED|Overall Study||14
15772|NCT03022396|33058|P4|COMPLETED|Overall Study||20
15773|NCT03022396|33059|P3|COMPLETED|Overall Study||10
15774|NCT03022396|33060|P2|COMPLETED|Overall Study||14
15775|NCT03022396|33061|P1|COMPLETED|Overall Study||16
15776|NCT03022396|33056|P6|STARTED|Overall Study||8
15777|NCT03022396|33057|P5|STARTED|Overall Study||14
15778|NCT03022396|33058|P4|STARTED|Overall Study||20
15779|NCT03022396|33059|P3|STARTED|Overall Study||10
15780|NCT03022396|33060|P2|STARTED|Overall Study||14
15781|NCT03022396|33061|P1|STARTED|Overall Study||16
15782|NCT03022045|33083|P2|NOT COMPLETED|Overall Study||2
15783|NCT03022045|33084|P1|NOT COMPLETED|Overall Study||1
15784|NCT03022045|33083|P2|COMPLETED|Overall Study||6
15785|NCT03022045|33084|P1|COMPLETED|Overall Study||8
15786|NCT03022045|33083|P2|STARTED|Overall Study||8
15787|NCT03022045|33084|P1|STARTED|Overall Study||9
15788|NCT03021759|33101|P3|NOT COMPLETED|Overall Study||0
15789|NCT03021759|33102|P2|NOT COMPLETED|Overall Study||0
15790|NCT03021759|33103|P1|NOT COMPLETED|Overall Study||0
15791|NCT03021759|33101|P3|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1465
15792|NCT03021759|33102|P2|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1743
15793|NCT03021759|33103|P1|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1566
15794|NCT03021759|33101|P3|STARTED|Overall Study||1465
15795|NCT03021759|33102|P2|STARTED|Overall Study||1743
15796|NCT03021759|33103|P1|STARTED|Overall Study||1566
15797|NCT03021668|33113|P2|NOT COMPLETED|Overall Study||1
15798|NCT03021668|33114|P1|NOT COMPLETED|Overall Study||0
15799|NCT03021668|33113|P2|COMPLETED|Overall Study||61
15800|NCT03021668|33114|P1|COMPLETED|Overall Study||62
15801|NCT03021668|33113|P2|STARTED|Overall Study||62
15802|NCT03021668|33114|P1|STARTED|Overall Study||62
15803|NCT03021642|33126|P2|NOT COMPLETED|Treatment Period 2 (Day 22)||0
15804|NCT03021642|33127|P1|NOT COMPLETED|Treatment Period 2 (Day 22)||0
15805|NCT03021642|33126|P2|COMPLETED|Treatment Period 2 (Day 22)||11
15806|NCT03021642|33127|P1|COMPLETED|Treatment Period 2 (Day 22)||11
15807|NCT03021642|33126|P2|STARTED|Treatment Period 2 (Day 22)||11
15808|NCT03021642|33127|P1|STARTED|Treatment Period 2 (Day 22)||11
15809|NCT03021642|33126|P2|NOT COMPLETED|Washout Period (21 Days)||1
15810|NCT03021642|33127|P1|NOT COMPLETED|Washout Period (21 Days)||1
15811|NCT03021642|33126|P2|COMPLETED|Washout Period (21 Days)||11
15812|NCT03021642|33127|P1|COMPLETED|Washout Period (21 Days)||11
15813|NCT03021642|33126|P2|STARTED|Washout Period (21 Days)||12
15814|NCT03021642|33127|P1|STARTED|Washout Period (21 Days)||12
15815|NCT03021642|33126|P2|NOT COMPLETED|Treatment Period 1 (Day 1)||0
15816|NCT03021642|33127|P1|NOT COMPLETED|Treatment Period 1 (Day 1)||0
15817|NCT03021642|33126|P2|COMPLETED|Treatment Period 1 (Day 1)||12
15818|NCT03021642|33127|P1|COMPLETED|Treatment Period 1 (Day 1)||12
15819|NCT03021642|33126|P2|STARTED|Treatment Period 1 (Day 1)||12
15820|NCT03021642|33127|P1|STARTED|Treatment Period 1 (Day 1)||12
15821|NCT03021343|33167|P2|NOT COMPLETED|Overall Study||7
15822|NCT03021343|33168|P1|NOT COMPLETED|Overall Study||5
15823|NCT03021343|33167|P2|COMPLETED|Overall Study||174
15824|NCT03021343|33168|P1|COMPLETED|Overall Study||174
15825|NCT03021343|33167|P2|STARTED|Overall Study||181
15826|NCT03021343|33168|P1|STARTED|Overall Study||179
15827|NCT03021304|33176|P1|NOT COMPLETED|Overall Study||1
15828|NCT03021304|33176|P1|COMPLETED|Overall Study||55
15829|NCT03021304|33176|P1|STARTED|Overall Study||56
15830|NCT03021187|33185|P4|NOT COMPLETED|Overall Study||9
15831|NCT03021187|33186|P3|NOT COMPLETED|Overall Study||6
15832|NCT03021187|33187|P2|NOT COMPLETED|Overall Study||9
15833|NCT03021187|33188|P1|NOT COMPLETED|Overall Study||10
15834|NCT03021187|33185|P4|COMPLETED|Overall Study||175
15835|NCT03021187|33186|P3|COMPLETED|Overall Study||175
15836|NCT03021187|33187|P2|COMPLETED|Overall Study||173
15837|NCT03021187|33188|P1|COMPLETED|Overall Study||174
15838|NCT03021187|33185|P4|Exposed|Overall Study||184
15839|NCT03021187|33186|P3|Exposed|Overall Study||181
15840|NCT03021187|33187|P2|Exposed|Overall Study||181
15841|NCT03021187|33188|P1|Exposed|Overall Study||184
15842|NCT03021187|33185|P4|STARTED|Overall Study||184
15843|NCT03021187|33186|P3|STARTED|Overall Study||181
15844|NCT03021187|33187|P2|STARTED|Overall Study||182
15845|NCT03021187|33188|P1|STARTED|Overall Study||184
15846|NCT03021018|33344|P3|NOT COMPLETED|Overall Study||0
15847|NCT03021018|33345|P2|NOT COMPLETED|Overall Study||0
15848|NCT03021018|33346|P1|NOT COMPLETED|Overall Study||2
15849|NCT03021018|33344|P3|COMPLETED|Overall Study||15
15850|NCT03021018|33345|P2|COMPLETED|Overall Study||15
15851|NCT03021018|33346|P1|COMPLETED|Overall Study||14
15852|NCT03021018|33344|P3|STARTED|Overall Study||15
15853|NCT03021018|33345|P2|STARTED|Overall Study||15
15854|NCT03021018|33346|P1|STARTED|Overall Study||16
15855|NCT03020576|33377|P2|NOT COMPLETED|Overall Study||2
15856|NCT03020576|33378|P1|NOT COMPLETED|Overall Study||1
15857|NCT03020576|33377|P2|COMPLETED|Overall Study||14
15858|NCT03020576|33378|P1|COMPLETED|Overall Study||14
15859|NCT03020576|33377|P2|STARTED|Overall Study||16
15860|NCT03020576|33378|P1|STARTED|Overall Study||15
15861|NCT03020537|33400|P2|NOT COMPLETED|Overall Study||0
15862|NCT03020537|33401|P1|NOT COMPLETED|Overall Study||0
15863|NCT03020537|33400|P2|COMPLETED|Overall Study||7
15864|NCT03020537|33401|P1|COMPLETED|Overall Study||1
15865|NCT03020537|33400|P2|STARTED|Overall Study||7
15866|NCT03020537|33401|P1|STARTED|Overall Study||1
15867|NCT03020498|33412|P3|NOT COMPLETED|Overall Study||0
15868|NCT03020498|33413|P2|NOT COMPLETED|Overall Study||3
15869|NCT03020498|33414|P1|NOT COMPLETED|Overall Study||0
15870|NCT03020498|33412|P3|COMPLETED|Overall Study||36
15871|NCT03020498|33413|P2|COMPLETED|Overall Study||38
15872|NCT03020498|33414|P1|COMPLETED|Overall Study||14
15873|NCT03020498|33412|P3|STARTED|Overall Study||36
15874|NCT03020498|33413|P2|STARTED|Overall Study||41
15875|NCT03020498|33414|P1|STARTED|Overall Study||14
15876|NCT03020472|33425|P1|NOT COMPLETED|Overall Study||0
15877|NCT03020472|33425|P1|COMPLETED|Overall Study||6
15878|NCT03020472|33425|P1|STARTED|Overall Study||6
15879|NCT03020160|33433|P2|NOT COMPLETED|Overall Study||41
15880|NCT03020160|33434|P1|NOT COMPLETED|Overall Study||7
15881|NCT03020160|33433|P2|COMPLETED|Overall Study||0
15882|NCT03020160|33434|P1|COMPLETED|Overall Study||0
15883|NCT03020160|33433|P2|Completed 24 Weeks in the Study|Overall Study||41
15884|NCT03020160|33434|P1|Completed 24 Weeks in the Study|Overall Study||7
15885|NCT03020160|33433|P2|STARTED|Overall Study||41
15886|NCT03020160|33434|P1|STARTED|Overall Study||7
15887|NCT03020004|33487|P1|NOT COMPLETED|Overall Study||1
15888|NCT03020004|33487|P1|COMPLETED|Overall Study||69
15889|NCT03020004|33487|P1|STARTED|Overall Study||70
15890|NCT03019783|33493|P2|NOT COMPLETED|Overall Study||0
15891|NCT03019783|33494|P1|NOT COMPLETED|Overall Study||0
15892|NCT03019783|33493|P2|COMPLETED|Overall Study||31
15893|NCT03019783|33494|P1|COMPLETED|Overall Study||29
15894|NCT03019783|33493|P2|STARTED|Overall Study||31
15895|NCT03019783|33494|P1|STARTED|Overall Study||29
15896|NCT03019744|33504|P2|NOT COMPLETED|Overall Study||8
15897|NCT03019744|33505|P1|NOT COMPLETED|Overall Study||6
15898|NCT03019744|33504|P2|COMPLETED|Overall Study||36
15899|NCT03019744|33505|P1|COMPLETED|Overall Study||32
15900|NCT03019744|33504|P2|STARTED|Overall Study||44
15901|NCT03019744|33505|P1|STARTED|Overall Study||38
15902|NCT03019627|33521|P2|NOT COMPLETED|Overall Study||8
15903|NCT03019627|33522|P1|NOT COMPLETED|Overall Study||15
15904|NCT03019627|33521|P2|COMPLETED|Overall Study||42
15905|NCT03019627|33522|P1|COMPLETED|Overall Study||85
15906|NCT03019627|33521|P2|STARTED|Overall Study||50
15907|NCT03019627|33522|P1|STARTED|Overall Study||100
15908|NCT03019549|33538|P1|NOT COMPLETED|Period 2||5
15909|NCT03019549|33538|P1|COMPLETED|Period 2||26
15910|NCT03019549|33538|P1|Received at Least 1 Dose of Study Drug|Period 2||29
15911|NCT03019549|33538|P1|STARTED|Period 2||31
15912|NCT03019549|33538|P1|NOT COMPLETED|Washout||11
15913|NCT03019549|33538|P1|COMPLETED|Washout||31
15914|NCT03019549|33538|P1|STARTED|Washout||42
15915|NCT03019549|33538|P1|NOT COMPLETED|Period 1||0
15916|NCT03019549|33538|P1|COMPLETED|Period 1||42
15917|NCT03019549|33538|P1|Received 1 Dose of Study Drug|Period 1||42
15918|NCT03019549|33538|P1|STARTED|Period 1||42
15919|NCT03018340|33551|P2|NOT COMPLETED|Overall Study||30
15920|NCT03018340|33552|P1|NOT COMPLETED|Overall Study||8
15921|NCT03018340|33551|P2|COMPLETED|Overall Study||125
15922|NCT03018340|33552|P1|COMPLETED|Overall Study||44
15923|NCT03018340|33551|P2|STARTED|Overall Study||155
15924|NCT03018340|33552|P1|STARTED|Overall Study||52
15925|NCT03018106|33604|P2|NOT COMPLETED|Overall Study||1
15926|NCT03018106|33605|P1|NOT COMPLETED|Overall Study||0
15927|NCT03018106|33604|P2|COMPLETED|Overall Study||0
15928|NCT03018106|33605|P1|COMPLETED|Overall Study||0
15929|NCT03018106|33604|P2|STARTED|Overall Study||1
15930|NCT03018106|33605|P1|STARTED|Overall Study||0
15931|NCT03017846|33613|P1|NOT COMPLETED|Overall Study||5
15932|NCT03017846|33613|P1|COMPLETED|Overall Study||25
15933|NCT03017846|33613|P1|STARTED|Overall Study||30
15934|NCT03017612|33621|P1|NOT COMPLETED|Overall Study||2
15935|NCT03017612|33621|P1|COMPLETED|Overall Study||11
15936|NCT03017612|33621|P1|STARTED|Overall Study||13
15937|NCT03017235|33631|P2|NOT COMPLETED|Overall Study||14
15938|NCT03017235|33632|P1|NOT COMPLETED|Overall Study||12
15939|NCT03017235|33631|P2|COMPLETED|Overall Study||447
15940|NCT03017235|33632|P1|COMPLETED|Overall Study||444
15941|NCT03017235|33631|P2|STARTED|Overall Study||461
15942|NCT03017235|33632|P1|STARTED|Overall Study||456
15943|NCT03017040|33682|P2|NOT COMPLETED|Overall Study||1
15944|NCT03017040|33683|P1|NOT COMPLETED|Overall Study||1
15945|NCT03017040|33682|P2|COMPLETED|Overall Study||0
15946|NCT03017040|33683|P1|COMPLETED|Overall Study||0
15947|NCT03017040|33682|P2|STARTED|Overall Study|Participants enroll one wrist into each group,thus, one participant flows into both groups.|1
15948|NCT03017040|33683|P1|STARTED|Overall Study|Participants enroll one wrist into each group,thus, one participant flows into both groups.|1
15949|NCT03016078|33693|P1|NOT COMPLETED|Overall Study||2
15950|NCT03016078|33693|P1|COMPLETED|Overall Study||19
15951|NCT03016078|33693|P1|STARTED|Overall Study||21
15952|NCT03015181|33711|P7|NOT COMPLETED|Overall Study||1
15953|NCT03015181|33712|P6|NOT COMPLETED|Overall Study||1
15954|NCT03015181|33713|P5|NOT COMPLETED|Overall Study||0
15955|NCT03015181|33714|P4|NOT COMPLETED|Overall Study||0
15956|NCT03015181|33715|P3|NOT COMPLETED|Overall Study||0
15957|NCT03015181|33716|P2|NOT COMPLETED|Overall Study||0
15958|NCT03015181|33717|P1|NOT COMPLETED|Overall Study||1
15959|NCT03015181|33711|P7|COMPLETED|Overall Study|Group 7 subject who received only 1 dose was withdrawn after unrelated intercurrent illness resolved|4
15960|NCT03015181|33712|P6|COMPLETED|Overall Study|Group 6 subject who received only 1 dose chose to withdraw from study after the first administration|4
15961|NCT03015181|33713|P5|COMPLETED|Overall Study||3
15962|NCT03015181|33714|P4|COMPLETED|Overall Study||3
15963|NCT03015181|33715|P3|COMPLETED|Overall Study||3
15964|NCT03015181|33716|P2|COMPLETED|Overall Study||3
15965|NCT03015181|33717|P1|COMPLETED|Overall Study||3
15966|NCT03015181|33711|P7|Discontinued VRC07-523LS Administrations|Overall Study|One Group 7 subject received only 1 of 3 scheduled doses due to an unrelated intercurrent illness|1
15967|NCT03015181|33712|P6|Discontinued VRC07-523LS Administrations|Overall Study|One Group 6 subject received only 1 of 3 scheduled doses prior to withdrawing from the study|1
15968|NCT03015181|33713|P5|Discontinued VRC07-523LS Administrations|Overall Study||0
15969|NCT03015181|33714|P4|Discontinued VRC07-523LS Administrations|Overall Study||0
15970|NCT03015181|33715|P3|Discontinued VRC07-523LS Administrations|Overall Study||0
15971|NCT03015181|33716|P2|Discontinued VRC07-523LS Administrations|Overall Study||0
15972|NCT03015181|33717|P1|Discontinued VRC07-523LS Administrations|Overall Study|One Group 1 subject decided not to receive the VRC07-523LS infusion|1
15973|NCT03015181|33711|P7|Received VRC07-523LS Per Protocol|Overall Study||4
15974|NCT03015181|33712|P6|Received VRC07-523LS Per Protocol|Overall Study||4
15975|NCT03015181|33713|P5|Received VRC07-523LS Per Protocol|Overall Study||3
15976|NCT03015181|33714|P4|Received VRC07-523LS Per Protocol|Overall Study||3
15977|NCT03015181|33715|P3|Received VRC07-523LS Per Protocol|Overall Study||3
15978|NCT03015181|33716|P2|Received VRC07-523LS Per Protocol|Overall Study||3
15979|NCT03015181|33717|P1|Received VRC07-523LS Per Protocol|Overall Study||3
15980|NCT03015181|33711|P7|STARTED|Overall Study||5
15981|NCT03015181|33712|P6|STARTED|Overall Study||5
15982|NCT03015181|33713|P5|STARTED|Overall Study||3
15983|NCT03015181|33714|P4|STARTED|Overall Study||3
15984|NCT03015181|33715|P3|STARTED|Overall Study||3
15985|NCT03015181|33716|P2|STARTED|Overall Study||3
15986|NCT03015181|33717|P1|STARTED|Overall Study||4
15987|NCT03015142|33828|P1|NOT COMPLETED|Overall Study||1
15988|NCT03015142|33828|P1|COMPLETED|Overall Study||20
15989|NCT03015142|33828|P1|STARTED|Overall Study||21
15990|NCT03014700|33843|P2|NOT COMPLETED|Overall Study||1
15991|NCT03014700|33844|P1|NOT COMPLETED|Overall Study||5
15992|NCT03014700|33843|P2|COMPLETED|Overall Study||29
15993|NCT03014700|33844|P1|COMPLETED|Overall Study||25
15994|NCT03014700|33843|P2|STARTED|Overall Study||30
15995|NCT03014700|33844|P1|STARTED|Overall Study||30
15996|NCT03014674|33863|P3|NOT COMPLETED|Overall Study||0
15997|NCT03014674|33864|P2|NOT COMPLETED|Overall Study||0
15998|NCT03014674|33865|P1|NOT COMPLETED|Overall Study||1
15999|NCT03014674|33863|P3|COMPLETED|Overall Study||80
16000|NCT03014674|33864|P2|COMPLETED|Overall Study||79
16001|NCT03014674|33865|P1|COMPLETED|Overall Study||84
16002|NCT03014674|33863|P3|STARTED|Overall Study||80
16003|NCT03014674|33864|P2|STARTED|Overall Study||79
16004|NCT03014674|33865|P1|STARTED|Overall Study||85
16005|NCT03014479|33929|P2|NOT COMPLETED|Overall Study||4
16006|NCT03014479|33930|P1|NOT COMPLETED|Overall Study||0
16007|NCT03014479|33929|P2|COMPLETED|Overall Study||105
16008|NCT03014479|33930|P1|COMPLETED|Overall Study||110
16009|NCT03014479|33929|P2|STARTED|Overall Study||109
16010|NCT03014479|33930|P1|STARTED|Overall Study||110
16011|NCT03014206|33976|P1|NOT COMPLETED|Overall Study||12
16012|NCT03014206|33976|P1|COMPLETED|Overall Study||684
16013|NCT03014206|33976|P1|STARTED|Overall Study||696
16014|NCT03014180|33980|P1|NOT COMPLETED|Overall Study||2
16015|NCT03014180|33980|P1|COMPLETED|Overall Study||58
16016|NCT03014180|33980|P1|STARTED|Overall Study||60
16017|NCT03012828|33995|P6|NOT COMPLETED|Overall Study||2
16018|NCT03012828|33996|P5|NOT COMPLETED|Overall Study||2
16019|NCT03012828|33997|P4|NOT COMPLETED|Overall Study||0
16020|NCT03012828|33998|P3|NOT COMPLETED|Overall Study||2
16021|NCT03012828|33999|P2|NOT COMPLETED|Overall Study||0
16022|NCT03012828|34000|P1|NOT COMPLETED|Overall Study||1
16023|NCT03012828|33995|P6|COMPLETED|Overall Study||8
16024|NCT03012828|33996|P5|COMPLETED|Overall Study||8
16025|NCT03012828|33997|P4|COMPLETED|Overall Study||10
16026|NCT03012828|33998|P3|COMPLETED|Overall Study||8
16027|NCT03012828|33999|P2|COMPLETED|Overall Study||10
16028|NCT03012828|34000|P1|COMPLETED|Overall Study||9
16029|NCT03012828|33995|P6|STARTED|Overall Study||10
16030|NCT03012828|33996|P5|STARTED|Overall Study||10
16031|NCT03012828|33997|P4|STARTED|Overall Study||10
16032|NCT03012828|33998|P3|STARTED|Overall Study||10
16033|NCT03012828|33999|P2|STARTED|Overall Study||10
16034|NCT03012828|34000|P1|STARTED|Overall Study||10
16035|NCT03012191|34036|P3|NOT COMPLETED|Overall Study||0
16036|NCT03012191|34037|P2|NOT COMPLETED|Overall Study||0
16037|NCT03012191|34038|P1|NOT COMPLETED|Overall Study||0
16038|NCT03012191|34036|P3|COMPLETED|Overall Study||2
16039|NCT03012191|34037|P2|COMPLETED|Overall Study||2
16040|NCT03012191|34038|P1|COMPLETED|Overall Study||2
16041|NCT03012191|34036|P3|STARTED|Overall Study||2
16042|NCT03012191|34037|P2|STARTED|Overall Study||2
16043|NCT03012191|34038|P1|STARTED|Overall Study||2
16044|NCT03012061|34056|P3|NOT COMPLETED|Overall Study||8
16045|NCT03012061|34057|P2|NOT COMPLETED|Overall Study||9
16046|NCT03012061|34058|P1|NOT COMPLETED|Overall Study||6
16047|NCT03012061|34056|P3|COMPLETED|Overall Study||131
16048|NCT03012061|34057|P2|COMPLETED|Overall Study||130
16049|NCT03012061|34058|P1|COMPLETED|Overall Study||137
16050|NCT03012061|34056|P3|STARTED|Overall Study||139
16051|NCT03012061|34057|P2|STARTED|Overall Study||139
16052|NCT03012061|34058|P1|STARTED|Overall Study||143
16053|NCT03011840|34083|P2|NOT COMPLETED|Overall Study||21
16054|NCT03011840|34084|P1|NOT COMPLETED|Overall Study||0
16055|NCT03011840|34083|P2|COMPLETED|Overall Study||196
16056|NCT03011840|34084|P1|COMPLETED|Overall Study||232
16057|NCT03011840|34083|P2|STARTED|Overall Study||217
16058|NCT03011840|34084|P1|STARTED|Overall Study||232
16059|NCT03011099|34094|P2|NOT COMPLETED|Overall Study||2
16060|NCT03011099|34095|P1|NOT COMPLETED|Overall Study||0
16061|NCT03011099|34094|P2|COMPLETED|Overall Study||3
16062|NCT03011099|34095|P1|COMPLETED|Overall Study||6
16063|NCT03011099|34094|P2|STARTED|Overall Study||5
16064|NCT03011099|34095|P1|STARTED|Overall Study||6
16065|NCT03010800|34121|P2|NOT COMPLETED|Cross Over||0
16066|NCT03010800|34122|P1|NOT COMPLETED|Cross Over||0
16067|NCT03010800|34121|P2|COMPLETED|Cross Over||4
16068|NCT03010800|34122|P1|COMPLETED|Cross Over||4
16069|NCT03010800|34121|P2|STARTED|Cross Over||4
16070|NCT03010800|34122|P1|STARTED|Cross Over||4
16071|NCT03010800|34121|P2|NOT COMPLETED|Initial Assignment||0
16072|NCT03010800|34122|P1|NOT COMPLETED|Initial Assignment||0
16073|NCT03010800|34121|P2|COMPLETED|Initial Assignment||4
16074|NCT03010800|34122|P1|COMPLETED|Initial Assignment||4
16075|NCT03010800|34121|P2|STARTED|Initial Assignment||4
16076|NCT03010800|34122|P1|STARTED|Initial Assignment||4
16077|NCT03010501|34128|P6|NOT COMPLETED|Study Week 3||0
16078|NCT03010501|34129|P5|NOT COMPLETED|Study Week 3||0
16079|NCT03010501|34130|P4|NOT COMPLETED|Study Week 3||1
16080|NCT03010501|34131|P3|NOT COMPLETED|Study Week 3||0
16081|NCT03010501|34132|P2|NOT COMPLETED|Study Week 3||0
16082|NCT03010501|34133|P1|NOT COMPLETED|Study Week 3||0
16083|NCT03010501|34128|P6|COMPLETED|Study Week 3||11
16084|NCT03010501|34129|P5|COMPLETED|Study Week 3||7
16085|NCT03010501|34130|P4|COMPLETED|Study Week 3||4
16086|NCT03010501|34131|P3|COMPLETED|Study Week 3||7
16087|NCT03010501|34132|P2|COMPLETED|Study Week 3||14
16088|NCT03010501|34133|P1|COMPLETED|Study Week 3||7
16089|NCT03010501|34128|P6|STARTED|Study Week 3||11
16090|NCT03010501|34129|P5|STARTED|Study Week 3||7
16091|NCT03010501|34130|P4|STARTED|Study Week 3||5
16092|NCT03010501|34131|P3|STARTED|Study Week 3||7
16093|NCT03010501|34132|P2|STARTED|Study Week 3||14
16094|NCT03010501|34133|P1|STARTED|Study Week 3||7
16095|NCT03010501|34128|P6|NOT COMPLETED|Study Week 2||0
16096|NCT03010501|34129|P5|NOT COMPLETED|Study Week 2||0
16097|NCT03010501|34130|P4|NOT COMPLETED|Study Week 2||0
16098|NCT03010501|34131|P3|NOT COMPLETED|Study Week 2||0
16099|NCT03010501|34132|P2|NOT COMPLETED|Study Week 2||0
16100|NCT03010501|34133|P1|NOT COMPLETED|Study Week 2||0
16101|NCT03010501|34128|P6|COMPLETED|Study Week 2||11
16102|NCT03010501|34129|P5|COMPLETED|Study Week 2||7
16103|NCT03010501|34130|P4|COMPLETED|Study Week 2||5
16104|NCT03010501|34131|P3|COMPLETED|Study Week 2||7
16105|NCT03010501|34132|P2|COMPLETED|Study Week 2||14
16106|NCT03010501|34133|P1|COMPLETED|Study Week 2||7
16107|NCT03010501|34128|P6|STARTED|Study Week 2||11
16108|NCT03010501|34129|P5|STARTED|Study Week 2||7
16109|NCT03010501|34130|P4|STARTED|Study Week 2||5
16110|NCT03010501|34131|P3|STARTED|Study Week 2||7
16111|NCT03010501|34132|P2|STARTED|Study Week 2||14
16112|NCT03010501|34133|P1|STARTED|Study Week 2||7
16113|NCT03010501|34128|P6|NOT COMPLETED|Study Week 1||0
16114|NCT03010501|34129|P5|NOT COMPLETED|Study Week 1||0
16115|NCT03010501|34130|P4|NOT COMPLETED|Study Week 1||2
16116|NCT03010501|34131|P3|NOT COMPLETED|Study Week 1||0
16117|NCT03010501|34132|P2|NOT COMPLETED|Study Week 1||1
16118|NCT03010501|34133|P1|NOT COMPLETED|Study Week 1||2
16119|NCT03010501|34128|P6|COMPLETED|Study Week 1||11
16120|NCT03010501|34129|P5|COMPLETED|Study Week 1||7
16121|NCT03010501|34130|P4|COMPLETED|Study Week 1||5
16122|NCT03010501|34131|P3|COMPLETED|Study Week 1||7
16123|NCT03010501|34132|P2|COMPLETED|Study Week 1||14
16124|NCT03010501|34133|P1|COMPLETED|Study Week 1||7
16125|NCT03010501|34128|P6|STARTED|Study Week 1||11
16126|NCT03010501|34129|P5|STARTED|Study Week 1||7
16127|NCT03010501|34130|P4|STARTED|Study Week 1||7
16128|NCT03010501|34131|P3|STARTED|Study Week 1||7
16129|NCT03010501|34132|P2|STARTED|Study Week 1||15
16130|NCT03010501|34133|P1|STARTED|Study Week 1||9
16131|NCT03008707|34149|P2|NOT COMPLETED|Overall Study||0
16132|NCT03008707|34150|P1|NOT COMPLETED|Overall Study||0
16133|NCT03008707|34149|P2|COMPLETED|Overall Study||38
16134|NCT03008707|34150|P1|COMPLETED|Overall Study||28
16135|NCT03008707|34149|P2|STARTED|Overall Study||38
16136|NCT03008707|34150|P1|STARTED|Overall Study||28
16137|NCT03008213|34170|P1|NOT COMPLETED|Overall Study||0
16138|NCT03008213|34170|P1|COMPLETED|Overall Study||1
16139|NCT03008213|34170|P1|STARTED|Overall Study||1
16140|NCT03007966|34176|P2|NOT COMPLETED|Overall Study||0
16141|NCT03007966|34177|P1|NOT COMPLETED|Overall Study||1
16142|NCT03007966|34176|P2|COMPLETED|Overall Study||30
16143|NCT03007966|34177|P1|COMPLETED|Overall Study||29
16144|NCT03007966|34176|P2|STARTED|Overall Study||30
16145|NCT03007966|34177|P1|STARTED|Overall Study||30
16146|NCT03006341|34211|P4|NOT COMPLETED|Overall Study||10685
16147|NCT03006341|34212|P3|NOT COMPLETED|Overall Study||30993
16148|NCT03006341|34213|P2|NOT COMPLETED|Overall Study||67505
16149|NCT03006341|34214|P1|NOT COMPLETED|Overall Study||25069
16150|NCT03006341|34211|P4|COMPLETED|Overall Study||637
16151|NCT03006341|34212|P3|COMPLETED|Overall Study||1602
16152|NCT03006341|34213|P2|COMPLETED|Overall Study||2566
16153|NCT03006341|34214|P1|COMPLETED|Overall Study||1130
16154|NCT03006341|34211|P4|STARTED|Overall Study||11322
16155|NCT03006341|34212|P3|STARTED|Overall Study||32595
16156|NCT03006341|34213|P2|STARTED|Overall Study||70071
16157|NCT03006341|34214|P1|STARTED|Overall Study||26199
16158|NCT03005067|34258|P2|NOT COMPLETED|Overall Study||7
16159|NCT03005067|34259|P1|NOT COMPLETED|Overall Study||10
16160|NCT03005067|34258|P2|COMPLETED|Overall Study||74
16161|NCT03005067|34259|P1|COMPLETED|Overall Study||80
16162|NCT03005067|34258|P2|STARTED|Overall Study||81
16163|NCT03005067|34259|P1|STARTED|Overall Study||90
16164|NCT03005041|34271|P2|NOT COMPLETED|Period 2||0
16165|NCT03005041|34272|P1|NOT COMPLETED|Period 2||0
16166|NCT03005041|34271|P2|COMPLETED|Period 2||27
16167|NCT03005041|34272|P1|COMPLETED|Period 2||28
16168|NCT03005041|34271|P2|STARTED|Period 2||27
16169|NCT03005041|34272|P1|STARTED|Period 2||28
16170|NCT03005041|34271|P2|NOT COMPLETED|Washout Period 1||0
16171|NCT03005041|34272|P1|NOT COMPLETED|Washout Period 1||0
16172|NCT03005041|34271|P2|COMPLETED|Washout Period 1||27
16173|NCT03005041|34272|P1|COMPLETED|Washout Period 1||28
16174|NCT03005041|34271|P2|STARTED|Washout Period 1||27
16175|NCT03005041|34272|P1|STARTED|Washout Period 1||28
16176|NCT03005041|34271|P2|NOT COMPLETED|Period 1||0
16177|NCT03005041|34272|P1|NOT COMPLETED|Period 1||0
16178|NCT03005041|34271|P2|COMPLETED|Period 1||27
16179|NCT03005041|34272|P1|COMPLETED|Period 1||28
16180|NCT03005041|34271|P2|STARTED|Period 1||27
16181|NCT03005041|34272|P1|STARTED|Period 1||28
16182|NCT03004924|34287|P3|NOT COMPLETED|Overall Study||28
16183|NCT03004924|34288|P2|NOT COMPLETED|Overall Study||14
16184|NCT03004924|34289|P1|NOT COMPLETED|Overall Study||27
16185|NCT03004924|34287|P3|COMPLETED|Overall Study||293
16186|NCT03004924|34288|P2|COMPLETED|Overall Study||94
16187|NCT03004924|34289|P1|COMPLETED|Overall Study||297
16188|NCT03004924|34287|P3|STARTED|Overall Study||321
16189|NCT03004924|34288|P2|STARTED|Overall Study||108
16190|NCT03004924|34289|P1|STARTED|Overall Study||324
16191|NCT03004911|34341|P2|NOT COMPLETED|Overall Study||3
16192|NCT03004911|34342|P1|NOT COMPLETED|Overall Study||1
16193|NCT03004911|34341|P2|COMPLETED|Overall Study||17
16194|NCT03004911|34342|P1|COMPLETED|Overall Study||19
16195|NCT03004911|34341|P2|STARTED|Overall Study||20
16196|NCT03004911|34342|P1|STARTED|Overall Study||20
16197|NCT03004846|34360|P3|NOT COMPLETED|Part B (Up to 14 Weeks)||0
16198|NCT03004846|34361|P2|NOT COMPLETED|Part B (Up to 14 Weeks)||0
16199|NCT03004846|34362|P1|NOT COMPLETED|Part B (Up to 14 Weeks)||0
16200|NCT03004846|34360|P3|COMPLETED|Part B (Up to 14 Weeks)||0
16201|NCT03004846|34361|P2|COMPLETED|Part B (Up to 14 Weeks)||0
16202|NCT03004846|34362|P1|COMPLETED|Part B (Up to 14 Weeks)||0
16203|NCT03004846|34360|P3|STARTED|Part B (Up to 14 Weeks)||0
16204|NCT03004846|34361|P2|STARTED|Part B (Up to 14 Weeks)||0
16205|NCT03004846|34362|P1|STARTED|Part B (Up to 14 Weeks)||0
16206|NCT03004846|34360|P3|NOT COMPLETED|Part A (Up to 14 Weeks)||0
16207|NCT03004846|34361|P2|NOT COMPLETED|Part A (Up to 14 Weeks)||0
16208|NCT03004846|34362|P1|NOT COMPLETED|Part A (Up to 14 Weeks)||0
16209|NCT03004846|34360|P3|COMPLETED|Part A (Up to 14 Weeks)||0
16210|NCT03004846|34361|P2|COMPLETED|Part A (Up to 14 Weeks)||0
16211|NCT03004846|34362|P1|COMPLETED|Part A (Up to 14 Weeks)||8
16212|NCT03004846|34360|P3|STARTED|Part A (Up to 14 Weeks)||0
16213|NCT03004846|34361|P2|STARTED|Part A (Up to 14 Weeks)||0
16214|NCT03004846|34362|P1|STARTED|Part A (Up to 14 Weeks)||8
16215|NCT03004638|34414|P6|NOT COMPLETED|Overall Study||0
16216|NCT03004638|34415|P5|NOT COMPLETED|Overall Study||0
16217|NCT03004638|34416|P4|NOT COMPLETED|Overall Study||0
16218|NCT03004638|34417|P3|NOT COMPLETED|Overall Study||0
16219|NCT03004638|34418|P2|NOT COMPLETED|Overall Study||0
16220|NCT03004638|34419|P1|NOT COMPLETED|Overall Study||0
16221|NCT03004638|34414|P6|COMPLETED|Overall Study||7
16222|NCT03004638|34415|P5|COMPLETED|Overall Study||1
16223|NCT03004638|34416|P4|COMPLETED|Overall Study||6
16224|NCT03004638|34417|P3|COMPLETED|Overall Study||6
16225|NCT03004638|34418|P2|COMPLETED|Overall Study||6
16226|NCT03004638|34419|P1|COMPLETED|Overall Study||6
16227|NCT03004638|34414|P6|STARTED|Overall Study||7
16228|NCT03004638|34415|P5|STARTED|Overall Study||1
16229|NCT03004638|34416|P4|STARTED|Overall Study||6
16230|NCT03004638|34417|P3|STARTED|Overall Study||6
16231|NCT03004638|34418|P2|STARTED|Overall Study||6
16232|NCT03004638|34419|P1|STARTED|Overall Study||6
16233|NCT03004469|34528|P3|NOT COMPLETED|Overall Study||25
16234|NCT03004469|34529|P2|NOT COMPLETED|Overall Study||49
16235|NCT03004469|34530|P1|NOT COMPLETED|Overall Study||61
16236|NCT03004469|34528|P3|COMPLETED|Overall Study||60
16237|NCT03004469|34529|P2|COMPLETED|Overall Study||135
16238|NCT03004469|34530|P1|COMPLETED|Overall Study||128
16239|NCT03004469|34528|P3|STARTED|Overall Study||85
16240|NCT03004469|34529|P2|STARTED|Overall Study||184
16241|NCT03004469|34530|P1|STARTED|Overall Study||189
16242|NCT03003793|34564|P2|NOT COMPLETED|Overall Study||0
16243|NCT03003793|34565|P1|NOT COMPLETED|Overall Study||0
16244|NCT03003793|34564|P2|COMPLETED|Overall Study||16
16245|NCT03003793|34565|P1|COMPLETED|Overall Study||16
16246|NCT03003793|34564|P2|STARTED|Overall Study||16
16247|NCT03003793|34565|P1|STARTED|Overall Study||16
16248|NCT03003520|34573|P2|NOT COMPLETED|Follow-up||3
16249|NCT03003520|34574|P1|NOT COMPLETED|Follow-up||14
16250|NCT03003520|34573|P2|COMPLETED|Follow-up||0
16251|NCT03003520|34574|P1|COMPLETED|Follow-up||0
16252|NCT03003520|34573|P2|STARTED|Follow-up||3
16253|NCT03003520|34574|P1|STARTED|Follow-up||14
16254|NCT03003520|34573|P2|NOT COMPLETED|Consolidation||1
16255|NCT03003520|34574|P1|NOT COMPLETED|Consolidation||24
16256|NCT03003520|34573|P2|COMPLETED|Consolidation||2
16257|NCT03003520|34574|P1|COMPLETED|Consolidation||1
16258|NCT03003520|34573|P2|STARTED|Consolidation||3
16259|NCT03003520|34574|P1|STARTED|Consolidation||25
16260|NCT03003520|34573|P2|NOT COMPLETED|Induction||0
16261|NCT03003520|34574|P1|NOT COMPLETED|Induction||13
16262|NCT03003520|34573|P2|COMPLETED|Induction||3
16263|NCT03003520|34574|P1|COMPLETED|Induction||30
16264|NCT03003520|34573|P2|Efficacy Evaluable Population|Induction||3
16265|NCT03003520|34574|P1|Efficacy Evaluable Population|Induction||37
16266|NCT03003520|34573|P2|Safety Population|Induction||3
16267|NCT03003520|34574|P1|Safety Population|Induction||43
16268|NCT03003520|34573|P2|STARTED|Induction||3
16269|NCT03003520|34574|P1|STARTED|Induction||43
16270|NCT03003494|34592|P1|NOT COMPLETED|Overall Study||28
16271|NCT03003494|34592|P1|COMPLETED|Overall Study||278
16272|NCT03003494|34592|P1|STARTED|Overall Study||306
16273|NCT03003000|34604|P3|NOT COMPLETED|Overall Study||5
16274|NCT03003000|34605|P2|NOT COMPLETED|Overall Study||4
16275|NCT03003000|34606|P1|NOT COMPLETED|Overall Study||5
16276|NCT03003000|34604|P3|COMPLETED|Overall Study||251
16277|NCT03003000|34605|P2|COMPLETED|Overall Study||249
16278|NCT03003000|34606|P1|COMPLETED|Overall Study||121
16279|NCT03003000|34604|P3|STARTED|Overall Study||256
16280|NCT03003000|34605|P2|STARTED|Overall Study||253
16281|NCT03003000|34606|P1|STARTED|Overall Study||126
16282|NCT03002818|34632|P1|NOT COMPLETED|Overall Study||1
16283|NCT03002818|34632|P1|COMPLETED|Overall Study||40
16284|NCT03002818|34632|P1|STARTED|Overall Study||41
16285|NCT03002753|34646|P3|NOT COMPLETED|Second Randomization (Re-randomization)||0
16286|NCT03002753|34647|P2|NOT COMPLETED|Second Randomization (Re-randomization)||1
16287|NCT03002753|34648|P1|NOT COMPLETED|Second Randomization (Re-randomization)||0
16288|NCT03002753|34646|P3|COMPLETED|Second Randomization (Re-randomization)||0
16289|NCT03002753|34647|P2|COMPLETED|Second Randomization (Re-randomization)||9
16290|NCT03002753|34648|P1|COMPLETED|Second Randomization (Re-randomization)||11
16291|NCT03002753|34646|P3|STARTED|Second Randomization (Re-randomization)||0
16292|NCT03002753|34647|P2|STARTED|Second Randomization (Re-randomization)||10
16293|NCT03002753|34648|P1|STARTED|Second Randomization (Re-randomization)||11
16294|NCT03002753|34646|P3|NOT COMPLETED|First Randomization||0
16295|NCT03002753|34647|P2|NOT COMPLETED|First Randomization||1
16296|NCT03002753|34648|P1|NOT COMPLETED|First Randomization||1
16297|NCT03002753|34646|P3|COMPLETED|First Randomization||21
16298|NCT03002753|34647|P2|COMPLETED|First Randomization||11
16299|NCT03002753|34648|P1|COMPLETED|First Randomization||9
16300|NCT03002753|34646|P3|STARTED|First Randomization||21
16301|NCT03002753|34647|P2|STARTED|First Randomization||12
16302|NCT03002753|34648|P1|STARTED|First Randomization||10
16303|NCT03002623|34658|P2|NOT COMPLETED|Overall Study||1
16304|NCT03002623|34659|P1|NOT COMPLETED|Overall Study||2
16305|NCT03002623|34658|P2|COMPLETED|Overall Study||2
16306|NCT03002623|34659|P1|COMPLETED|Overall Study||2
16307|NCT03002623|34658|P2|STARTED|Overall Study||3
16308|NCT03002623|34659|P1|STARTED|Overall Study||4
16309|NCT03002610|34676|P3|NOT COMPLETED|Overall Study||13
16310|NCT03002610|34677|P2|NOT COMPLETED|Overall Study||25
16311|NCT03002610|34678|P1|NOT COMPLETED|Overall Study||6
16312|NCT03002610|34676|P3|COMPLETED|Overall Study||21
16313|NCT03002610|34677|P2|COMPLETED|Overall Study||25
16314|NCT03002610|34678|P1|COMPLETED|Overall Study||18
16315|NCT03002610|34676|P3|STARTED|Overall Study||34
16316|NCT03002610|34677|P2|STARTED|Overall Study||50
16317|NCT03002610|34678|P1|STARTED|Overall Study||24
16318|NCT03002454|34695|P1|NOT COMPLETED|Overall Study||0
16319|NCT03002454|34695|P1|COMPLETED|Overall Study||4
16320|NCT03002454|34695|P1|STARTED|Overall Study||4
16321|NCT03001778|34702|P2|NOT COMPLETED|Overall Study||0
16322|NCT03001778|34703|P1|NOT COMPLETED|Overall Study||0
16323|NCT03001778|34702|P2|COMPLETED|Overall Study||46
16324|NCT03001778|34703|P1|COMPLETED|Overall Study||21
16325|NCT03001778|34702|P2|STARTED|Overall Study||46
16326|NCT03001778|34703|P1|STARTED|Overall Study||21
16327|NCT03001674|34711|P2|NOT COMPLETED|Overall Study||0
16328|NCT03001674|34712|P1|NOT COMPLETED|Overall Study||0
16329|NCT03001674|34711|P2|COMPLETED|Overall Study||5
16330|NCT03001674|34712|P1|COMPLETED|Overall Study||10
16331|NCT03001674|34711|P2|STARTED|Overall Study||5
16332|NCT03001674|34712|P1|STARTED|Overall Study||10
16333|NCT03001453|34720|P2|NOT COMPLETED|Overall Study||0
16334|NCT03001453|34721|P1|NOT COMPLETED|Overall Study||0
16335|NCT03001453|34720|P2|COMPLETED|Overall Study||57
16336|NCT03001453|34721|P1|COMPLETED|Overall Study||50
16337|NCT03001453|34720|P2|STARTED|Overall Study||57
16338|NCT03001453|34721|P1|STARTED|Overall Study||50
16339|NCT03001258|34738|P3|NOT COMPLETED|Overall Study||0
16340|NCT03001258|34739|P2|NOT COMPLETED|Overall Study||0
16341|NCT03001258|34740|P1|NOT COMPLETED|Overall Study||0
16342|NCT03001258|34738|P3|COMPLETED|Overall Study||485
16343|NCT03001258|34739|P2|COMPLETED|Overall Study||751
16344|NCT03001258|34740|P1|COMPLETED|Overall Study||765
16345|NCT03001258|34738|P3|STARTED|Overall Study||485
16346|NCT03001258|34739|P2|STARTED|Overall Study||751
16347|NCT03001258|34740|P1|STARTED|Overall Study||765
16348|NCT03000608|34750|P2|NOT COMPLETED|Overall Study||4
16349|NCT03000608|34751|P1|NOT COMPLETED|Overall Study||6
16350|NCT03000608|34750|P2|COMPLETED|Overall Study||19
16351|NCT03000608|34751|P1|COMPLETED|Overall Study||40
16352|NCT03000608|34750|P2|STARTED|Overall Study||23
16353|NCT03000608|34751|P1|STARTED|Overall Study||46
16354|NCT03000452|34759|P1|NOT COMPLETED|Follow-Up Period||7
16355|NCT03000452|34759|P1|COMPLETED|Follow-Up Period||10
16356|NCT03000452|34759|P1|STARTED|Follow-Up Period|1 participant died in Cycle 1 due to PD prior to evaluation.|17
16357|NCT03000452|34759|P1|NOT COMPLETED|Treatment Period||18
16358|NCT03000452|34759|P1|COMPLETED|Treatment Period||0
16359|NCT03000452|34759|P1|STARTED|Treatment Period||18
16360|NCT03000309|34775|P1|NOT COMPLETED|Overall Study||1
16361|NCT03000309|34775|P1|COMPLETED|Overall Study||19
16362|NCT03000309|34775|P1|STARTED|Overall Study||20
16363|NCT03000088|34797|P2|NOT COMPLETED|Overall Study||0
16364|NCT03000088|34798|P1|NOT COMPLETED|Overall Study||0
16365|NCT03000088|34797|P2|COMPLETED|Overall Study||70
16366|NCT03000088|34798|P1|COMPLETED|Overall Study||70
16367|NCT03000088|34797|P2|STARTED|Overall Study||70
16368|NCT03000088|34798|P1|STARTED|Overall Study||70
16369|NCT03000075|34807|P7|NOT COMPLETED|Part B||1
16370|NCT03000075|34808|P6|NOT COMPLETED|Part B||2
16371|NCT03000075|34809|P5|NOT COMPLETED|Part B||1
16372|NCT03000075|34810|P4|NOT COMPLETED|Part B||0
16373|NCT03000075|34811|P3|NOT COMPLETED|Part B||0
16374|NCT03000075|34812|P2|NOT COMPLETED|Part B||0
16375|NCT03000075|34813|P1|NOT COMPLETED|Part B||0
16376|NCT03000075|34807|P7|COMPLETED|Part B||54
16377|NCT03000075|34808|P6|COMPLETED|Part B||56
16378|NCT03000075|34809|P5|COMPLETED|Part B||26
16379|NCT03000075|34810|P4|COMPLETED|Part B||27
16380|NCT03000075|34811|P3|COMPLETED|Part B||0
16381|NCT03000075|34812|P2|COMPLETED|Part B||0
16382|NCT03000075|34813|P1|COMPLETED|Part B||0
16383|NCT03000075|34807|P7|STARTED|Part B|Participants who received risankizumab 150 mg in Part A received risankizumab 150 mg in Part B|55
16384|NCT03000075|34808|P6|STARTED|Part B|Participants who received risankizumab 75 mg in Part A received risankizumab 75 mg in Part B|58
16385|NCT03000075|34809|P5|STARTED|Part B|Participants who received placebo in Part A received risankizumab 150 mg in Part B|27
16386|NCT03000075|34810|P4|STARTED|Part B|Participants who received placebo in Part A received risankizumab 75 mg in Part B|27
16387|NCT03000075|34811|P3|STARTED|Part B||0
16388|NCT03000075|34812|P2|STARTED|Part B||0
16389|NCT03000075|34813|P1|STARTED|Part B||0
16390|NCT03000075|34807|P7|NOT COMPLETED|Part A||0
16391|NCT03000075|34808|P6|NOT COMPLETED|Part A||0
16392|NCT03000075|34809|P5|NOT COMPLETED|Part A||0
16393|NCT03000075|34810|P4|NOT COMPLETED|Part A||0
16394|NCT03000075|34811|P3|NOT COMPLETED|Part A||0
16395|NCT03000075|34812|P2|NOT COMPLETED|Part A||0
16396|NCT03000075|34813|P1|NOT COMPLETED|Part A||4
16397|NCT03000075|34807|P7|COMPLETED|Part A||0
16398|NCT03000075|34808|P6|COMPLETED|Part A||0
16399|NCT03000075|34809|P5|COMPLETED|Part A||0
16400|NCT03000075|34810|P4|COMPLETED|Part A||0
16401|NCT03000075|34811|P3|COMPLETED|Part A||55
16402|NCT03000075|34812|P2|COMPLETED|Part A||58
16403|NCT03000075|34813|P1|COMPLETED|Part A||54
16404|NCT03000075|34807|P7|STARTED|Part A||0
16405|NCT03000075|34808|P6|STARTED|Part A||0
16406|NCT03000075|34809|P5|STARTED|Part A||0
16407|NCT03000075|34810|P4|STARTED|Part A||0
16408|NCT03000075|34811|P3|STARTED|Part A||55
16409|NCT03000075|34812|P2|STARTED|Part A||58
16410|NCT03000075|34813|P1|STARTED|Part A||58
16411|NCT02999763|34857|P1|NOT COMPLETED|Overall Study||12
16412|NCT02999763|34857|P1|COMPLETED|Overall Study||58
16413|NCT02999763|34857|P1|STARTED|Overall Study||70
16414|NCT02999672|34866|P2|NOT COMPLETED|Overall Study||7
16415|NCT02999672|34867|P1|NOT COMPLETED|Overall Study||13
16416|NCT02999672|34866|P2|COMPLETED|Overall Study||0
16417|NCT02999672|34867|P1|COMPLETED|Overall Study||0
16418|NCT02999672|34866|P2|STARTED|Overall Study||7
16419|NCT02999672|34867|P1|STARTED|Overall Study||13
16420|NCT02998996|34889|P6|NOT COMPLETED|Overall Study||0
16421|NCT02998996|34890|P5|NOT COMPLETED|Overall Study||1
16422|NCT02998996|34891|P4|NOT COMPLETED|Overall Study||0
16423|NCT02998996|34892|P3|NOT COMPLETED|Overall Study||1
16424|NCT02998996|34893|P2|NOT COMPLETED|Overall Study||1
16425|NCT02998996|34894|P1|NOT COMPLETED|Overall Study||0
16426|NCT02998996|34889|P6|COMPLETED|Overall Study||19
16427|NCT02998996|34890|P5|COMPLETED|Overall Study||17
16428|NCT02998996|34891|P4|COMPLETED|Overall Study||18
16429|NCT02998996|34892|P3|COMPLETED|Overall Study||35
16430|NCT02998996|34893|P2|COMPLETED|Overall Study||34
16431|NCT02998996|34894|P1|COMPLETED|Overall Study||36
16432|NCT02998996|34889|P6|STARTED|Overall Study||19
16433|NCT02998996|34890|P5|STARTED|Overall Study||18
16434|NCT02998996|34891|P4|STARTED|Overall Study||18
16435|NCT02998996|34892|P3|STARTED|Overall Study||36
16436|NCT02998996|34893|P2|STARTED|Overall Study||35
16437|NCT02998996|34894|P1|STARTED|Overall Study||36
16438|NCT02998684|34914|P2|NOT COMPLETED|Overall Study||1
16439|NCT02998684|34915|P1|NOT COMPLETED|Overall Study||3
16440|NCT02998684|34914|P2|COMPLETED|Overall Study||6
16441|NCT02998684|34915|P1|COMPLETED|Overall Study||4
16442|NCT02998684|34914|P2|STARTED|Overall Study||7
16443|NCT02998684|34915|P1|STARTED|Overall Study||7
16444|NCT02998671|34928|P5|NOT COMPLETED|Period 2||0
16445|NCT02998671|34929|P4|NOT COMPLETED|Period 2||4
16446|NCT02998671|34930|P3|NOT COMPLETED|Period 2||1
16447|NCT02998671|34931|P2|NOT COMPLETED|Period 2||7
16448|NCT02998671|34932|P1|NOT COMPLETED|Period 2||3
16449|NCT02998671|34928|P5|COMPLETED|Period 2||0
16450|NCT02998671|34929|P4|COMPLETED|Period 2||4
16451|NCT02998671|34930|P3|COMPLETED|Period 2||5
16452|NCT02998671|34931|P2|COMPLETED|Period 2||3
16453|NCT02998671|34932|P1|COMPLETED|Period 2||14
16454|NCT02998671|34928|P5|STARTED|Period 2||0
16455|NCT02998671|34929|P4|STARTED|Period 2||8
16456|NCT02998671|34930|P3|STARTED|Period 2||6
16457|NCT02998671|34931|P2|STARTED|Period 2||10
16458|NCT02998671|34932|P1|STARTED|Period 2||17
16459|NCT02998671|34928|P5|NOT COMPLETED|Period 1||4
16460|NCT02998671|34929|P4|NOT COMPLETED|Period 1||0
16461|NCT02998671|34930|P3|NOT COMPLETED|Period 1||0
16462|NCT02998671|34931|P2|NOT COMPLETED|Period 1||3
16463|NCT02998671|34932|P1|NOT COMPLETED|Period 1||4
16464|NCT02998671|34928|P5|COMPLETED|Period 1||0
16465|NCT02998671|34929|P4|COMPLETED|Period 1||8
16466|NCT02998671|34930|P3|COMPLETED|Period 1||6
16467|NCT02998671|34931|P2|COMPLETED|Period 1||10
16468|NCT02998671|34932|P1|COMPLETED|Period 1||17
16469|NCT02998671|34928|P5|STARTED|Period 1||4
16470|NCT02998671|34929|P4|STARTED|Period 1||8
16471|NCT02998671|34930|P3|STARTED|Period 1||6
16472|NCT02998671|34931|P2|STARTED|Period 1||13
16473|NCT02998671|34932|P1|STARTED|Period 1||21
16474|NCT02997904|34977|P2|NOT COMPLETED|Overall Study||0
16475|NCT02997904|34978|P1|NOT COMPLETED|Overall Study||0
16476|NCT02997904|34977|P2|COMPLETED|Overall Study||49
16477|NCT02997904|34978|P1|COMPLETED|Overall Study||51
16478|NCT02997904|34977|P2|STARTED|Overall Study||49
16479|NCT02997904|34978|P1|STARTED|Overall Study||51
16480|NCT02997735|34990|P2|NOT COMPLETED|Overall Study||0
16481|NCT02997735|34991|P1|NOT COMPLETED|Overall Study||0
16482|NCT02997735|34990|P2|COMPLETED|Overall Study||251
16483|NCT02997735|34991|P1|COMPLETED|Overall Study||233
16484|NCT02997735|34990|P2|STARTED|Overall Study||251
16485|NCT02997735|34991|P1|STARTED|Overall Study||233
16486|NCT02996968|35015|P2|NOT COMPLETED|Overall Study||0
16487|NCT02996968|35016|P1|NOT COMPLETED|Overall Study||1
16488|NCT02996968|35015|P2|COMPLETED|Overall Study||79
16489|NCT02996968|35016|P1|COMPLETED|Overall Study||78
16490|NCT02996968|35015|P2|STARTED|Overall Study||79
16491|NCT02996968|35016|P1|STARTED|Overall Study||79
16492|NCT02996682|35024|P2|NOT COMPLETED|Overall Study||3
16493|NCT02996682|35025|P1|NOT COMPLETED|Overall Study||0
16494|NCT02996682|35024|P2|COMPLETED|Overall Study||48
16495|NCT02996682|35025|P1|COMPLETED|Overall Study||51
16496|NCT02996682|35024|P2|STARTED|Overall Study||51
16497|NCT02996682|35025|P1|STARTED|Overall Study||51
16498|NCT02996591|35049|P2|NOT COMPLETED|Overall Study||0
16499|NCT02996591|35050|P1|NOT COMPLETED|Overall Study||0
16500|NCT02996591|35049|P2|COMPLETED|Overall Study||18
16501|NCT02996591|35050|P1|COMPLETED|Overall Study||18
16502|NCT02996591|35049|P2|STARTED|Overall Study||18
16503|NCT02996591|35050|P1|STARTED|Overall Study||18
16504|NCT02996097|35098|P2|NOT COMPLETED|Overall Study||11
16505|NCT02996097|35099|P1|NOT COMPLETED|Overall Study||11
16506|NCT02996097|35098|P2|COMPLETED|Overall Study||19
16507|NCT02996097|35099|P1|COMPLETED|Overall Study||19
16508|NCT02996097|35098|P2|Per Protocol Population|Overall Study||22
16509|NCT02996097|35099|P1|Per Protocol Population|Overall Study||22
16510|NCT02996097|35098|P2|STARTED|Overall Study||30
16511|NCT02996097|35099|P1|STARTED|Overall Study||30
16512|NCT02995980|35106|P1|NOT COMPLETED|Overall Study||14
16513|NCT02995980|35106|P1|COMPLETED|Overall Study||114
16514|NCT02995980|35106|P1|STARTED|Overall Study||128
16515|NCT02995967|35117|P2|NOT COMPLETED|Overall Study||0
16516|NCT02995967|35118|P1|NOT COMPLETED|Overall Study||0
16517|NCT02995967|35117|P2|COMPLETED|Overall Study||2
16518|NCT02995967|35118|P1|COMPLETED|Overall Study||1
16519|NCT02995967|35117|P2|STARTED|Overall Study||2
16520|NCT02995967|35118|P1|STARTED|Overall Study||1
16521|NCT02994979|35144|P2|NOT COMPLETED|Overall Study||0
16522|NCT02994979|35145|P1|NOT COMPLETED|Overall Study||0
16523|NCT02994979|35144|P2|COMPLETED|Overall Study||105
16524|NCT02994979|35145|P1|COMPLETED|Overall Study||114
16525|NCT02994979|35144|P2|STARTED|Overall Study||105
16526|NCT02994979|35145|P1|STARTED|Overall Study||114
16527|NCT02994732|35157|P1|NOT COMPLETED|Overall Study||0
16528|NCT02994732|35157|P1|COMPLETED|Overall Study|All subjects were discharged from the clinic by Jan 24, 2017|6
16529|NCT02994732|35157|P1|STARTED|Overall Study|All subjects entered clinic on January 11, 2017|6
16530|NCT02994056|35171|P1|NOT COMPLETED|Overall Study||9
16531|NCT02994056|35171|P1|COMPLETED|Overall Study||23
16532|NCT02994056|35171|P1|STARTED|Overall Study||32
16533|NCT02993926|35205|P3|NOT COMPLETED|Follow-Up Phase||0
16534|NCT02993926|35206|P2|NOT COMPLETED|Follow-Up Phase||0
16535|NCT02993926|35207|P1|NOT COMPLETED|Follow-Up Phase||0
16536|NCT02993926|35205|P3|COMPLETED|Follow-Up Phase||26
16537|NCT02993926|35206|P2|COMPLETED|Follow-Up Phase||44
16538|NCT02993926|35207|P1|COMPLETED|Follow-Up Phase||0
16539|NCT02993926|35205|P3|STARTED|Follow-Up Phase||26
16540|NCT02993926|35206|P2|STARTED|Follow-Up Phase||44
16541|NCT02993926|35207|P1|STARTED|Follow-Up Phase||0
16542|NCT02993926|35205|P3|NOT COMPLETED|Enantone Treatment Phase||0
16543|NCT02993926|35206|P2|NOT COMPLETED|Enantone Treatment Phase||0
16544|NCT02993926|35207|P1|NOT COMPLETED|Enantone Treatment Phase||32
16545|NCT02993926|35205|P3|COMPLETED|Enantone Treatment Phase||0
16546|NCT02993926|35206|P2|COMPLETED|Enantone Treatment Phase||0
16547|NCT02993926|35207|P1|COMPLETED|Enantone Treatment Phase||76
16548|NCT02993926|35205|P3|STARTED|Enantone Treatment Phase||0
16549|NCT02993926|35206|P2|STARTED|Enantone Treatment Phase||0
16550|NCT02993926|35207|P1|STARTED|Enantone Treatment Phase||108
16551|NCT02993783|35239|P2|NOT COMPLETED|Overall Study||9
16552|NCT02993783|35240|P1|NOT COMPLETED|Overall Study||6
16553|NCT02993783|35239|P2|COMPLETED|Overall Study||0
16554|NCT02993783|35240|P1|COMPLETED|Overall Study||2
16555|NCT02993783|35239|P2|STARTED|Overall Study||9
16556|NCT02993783|35240|P1|STARTED|Overall Study||8
16557|NCT02993471|35270|P1|NOT COMPLETED|Period 2 (Drug Cocktail + Ixekizumab)||2
16558|NCT02993471|35270|P1|COMPLETED|Period 2 (Drug Cocktail + Ixekizumab)||26
16559|NCT02993471|35270|P1|Received at Least 1 Dose of Study Drug|Period 2 (Drug Cocktail + Ixekizumab)||27
16560|NCT02993471|35270|P1|STARTED|Period 2 (Drug Cocktail + Ixekizumab)||28
16561|NCT02993471|35270|P1|NOT COMPLETED|Period 1 (Drug Cocktail)||0
16562|NCT02993471|35270|P1|COMPLETED|Period 1 (Drug Cocktail)||28
16563|NCT02993471|35270|P1|Received at Least 1 Dose of Study Drug|Period 1 (Drug Cocktail)||28
16564|NCT02993471|35270|P1|STARTED|Period 1 (Drug Cocktail)||28
16565|NCT02993250|35306|P2|NOT COMPLETED|Overall Study||1
16566|NCT02993250|35307|P1|NOT COMPLETED|Overall Study||0
16567|NCT02993250|35306|P2|COMPLETED|Overall Study||10
16568|NCT02993250|35307|P1|COMPLETED|Overall Study||22
16569|NCT02993250|35306|P2|STARTED|Overall Study||11
16570|NCT02993250|35307|P1|STARTED|Overall Study||22
16571|NCT02992691|35327|P1|NOT COMPLETED|Overall Study||3
16572|NCT02992691|35327|P1|COMPLETED|Overall Study||53
16573|NCT02992691|35327|P1|Received Negative Control|Overall Study||55
16574|NCT02992691|35327|P1|Received Positive Control|Overall Study||55
16575|NCT02992691|35327|P1|Received Test Product 3|Overall Study||52
16576|NCT02992691|35327|P1|Received Test Product 2|Overall Study||55
16577|NCT02992691|35327|P1|Received Test Product 1|Overall Study||55
16578|NCT02992691|35327|P1|STARTED|Overall Study||56
16579|NCT02992288|35350|P6|NOT COMPLETED|Overall Study||13
16580|NCT02992288|35351|P5|NOT COMPLETED|Overall Study||8
16581|NCT02992288|35352|P4|NOT COMPLETED|Overall Study||9
16582|NCT02992288|35353|P3|NOT COMPLETED|Overall Study||7
16583|NCT02992288|35354|P2|NOT COMPLETED|Overall Study||5
16584|NCT02992288|35355|P1|NOT COMPLETED|Overall Study||17
16585|NCT02992288|35350|P6|COMPLETED|Overall Study||59
16586|NCT02992288|35351|P5|COMPLETED|Overall Study||61
16587|NCT02992288|35352|P4|COMPLETED|Overall Study||64
16588|NCT02992288|35353|P3|COMPLETED|Overall Study||63
16589|NCT02992288|35354|P2|COMPLETED|Overall Study||32
16590|NCT02992288|35355|P1|COMPLETED|Overall Study||89
16591|NCT02992288|35350|P6|Treated|Overall Study||72
16592|NCT02992288|35351|P5|Treated|Overall Study||69
16593|NCT02992288|35352|P4|Treated|Overall Study||72
16594|NCT02992288|35353|P3|Treated|Overall Study||70
16595|NCT02992288|35354|P2|Treated|Overall Study||37
16596|NCT02992288|35355|P1|Treated|Overall Study||106
16597|NCT02992288|35350|P6|STARTED|Overall Study||72
16598|NCT02992288|35351|P5|STARTED|Overall Study||69
16599|NCT02992288|35352|P4|STARTED|Overall Study||73
16600|NCT02992288|35353|P3|STARTED|Overall Study||70
16601|NCT02992288|35354|P2|STARTED|Overall Study||37
16602|NCT02992288|35355|P1|STARTED|Overall Study||106
16603|NCT02992236|35413|P2|NOT COMPLETED|Overall Study||0
16604|NCT02992236|35414|P1|NOT COMPLETED|Overall Study||0
16605|NCT02992236|35413|P2|COMPLETED|Overall Study||8
16606|NCT02992236|35414|P1|COMPLETED|Overall Study||8
16607|NCT02992236|35413|P2|STARTED|Overall Study||8
16608|NCT02992236|35414|P1|STARTED|Overall Study||8
16609|NCT02992132|35427|P3|NOT COMPLETED|Overall Study||7
16610|NCT02992132|35428|P2|NOT COMPLETED|Overall Study||8
16611|NCT02992132|35429|P1|NOT COMPLETED|Overall Study||13
16612|NCT02992132|35427|P3|COMPLETED|Overall Study||29
16613|NCT02992132|35428|P2|COMPLETED|Overall Study||27
16614|NCT02992132|35429|P1|COMPLETED|Overall Study||27
16615|NCT02992132|35427|P3|STARTED|Overall Study||36
16616|NCT02992132|35428|P2|STARTED|Overall Study||35
16617|NCT02992132|35429|P1|STARTED|Overall Study||40
16618|NCT02992119|35447|P7|NOT COMPLETED|Overall Study||3
16619|NCT02992119|35448|P6|NOT COMPLETED|Overall Study||0
16620|NCT02992119|35449|P5|NOT COMPLETED|Overall Study||0
16621|NCT02992119|35450|P4|NOT COMPLETED|Overall Study||0
16622|NCT02992119|35451|P3|NOT COMPLETED|Overall Study||1
16623|NCT02992119|35452|P2|NOT COMPLETED|Overall Study||1
16624|NCT02992119|35453|P1|NOT COMPLETED|Overall Study||2
16625|NCT02992119|35447|P7|COMPLETED|Overall Study||28
16626|NCT02992119|35448|P6|COMPLETED|Overall Study||30
16627|NCT02992119|35449|P5|COMPLETED|Overall Study||30
16628|NCT02992119|35450|P4|COMPLETED|Overall Study||30
16629|NCT02992119|35451|P3|COMPLETED|Overall Study||29
16630|NCT02992119|35452|P2|COMPLETED|Overall Study||20
16631|NCT02992119|35453|P1|COMPLETED|Overall Study||19
16632|NCT02992119|35447|P7|STARTED|Overall Study||31
16633|NCT02992119|35448|P6|STARTED|Overall Study||30
16634|NCT02992119|35449|P5|STARTED|Overall Study||30
16635|NCT02992119|35450|P4|STARTED|Overall Study||30
16636|NCT02992119|35451|P3|STARTED|Overall Study||30
16637|NCT02992119|35452|P2|STARTED|Overall Study||21
16638|NCT02992119|35453|P1|STARTED|Overall Study||21
16639|NCT02992067|35504|P1|NOT COMPLETED|Overall Study||0
16640|NCT02992067|35504|P1|COMPLETED|Overall Study||359
16641|NCT02992067|35504|P1|STARTED|Overall Study||359
16642|NCT02991820|35510|P2|NOT COMPLETED|Overall Study||0
16643|NCT02991820|35511|P1|NOT COMPLETED|Overall Study||0
16644|NCT02991820|35510|P2|COMPLETED|Overall Study||31
16645|NCT02991820|35511|P1|COMPLETED|Overall Study||12
16646|NCT02991820|35510|P2|STARTED|Overall Study||31
16647|NCT02991820|35511|P1|STARTED|Overall Study||12
16648|NCT02991729|35521|P2|NOT COMPLETED|Overall Study||0
16649|NCT02991729|35522|P1|NOT COMPLETED|Overall Study||0
16650|NCT02991729|35521|P2|COMPLETED|Overall Study||92
16651|NCT02991729|35522|P1|COMPLETED|Overall Study||105
16652|NCT02991729|35521|P2|STARTED|Overall Study||92
16653|NCT02991729|35522|P1|STARTED|Overall Study||105
16654|NCT02991599|35536|P2|NOT COMPLETED|Overall Study||37
16655|NCT02991599|35537|P1|NOT COMPLETED|Overall Study||38
16656|NCT02991599|35536|P2|COMPLETED|Overall Study||61
16657|NCT02991599|35537|P1|COMPLETED|Overall Study||60
16658|NCT02991599|35536|P2|STARTED|Overall Study||98
16659|NCT02991599|35537|P1|STARTED|Overall Study||98
16660|NCT02991430|35560|P3|NOT COMPLETED|Post-treatment Observation Period||5
16661|NCT02991430|35561|P2|NOT COMPLETED|Post-treatment Observation Period||6
16662|NCT02991430|35562|P1|NOT COMPLETED|Post-treatment Observation Period||3
16663|NCT02991430|35560|P3|COMPLETED|Post-treatment Observation Period||5
16664|NCT02991430|35561|P2|COMPLETED|Post-treatment Observation Period||2
16665|NCT02991430|35562|P1|COMPLETED|Post-treatment Observation Period||4
16666|NCT02991430|35560|P3|STARTED|Post-treatment Observation Period||10
16667|NCT02991430|35561|P2|STARTED|Post-treatment Observation Period||8
16668|NCT02991430|35562|P1|STARTED|Post-treatment Observation Period||7
16669|NCT02991430|35560|P3|NOT COMPLETED|Treatment Period 2||4
16670|NCT02991430|35561|P2|NOT COMPLETED|Treatment Period 2||3
16671|NCT02991430|35562|P1|NOT COMPLETED|Treatment Period 2||6
16672|NCT02991430|35560|P3|COMPLETED|Treatment Period 2||10
16673|NCT02991430|35561|P2|COMPLETED|Treatment Period 2||8
16674|NCT02991430|35562|P1|COMPLETED|Treatment Period 2||7
16675|NCT02991430|35560|P3|STARTED|Treatment Period 2||14
16676|NCT02991430|35561|P2|STARTED|Treatment Period 2||11
16677|NCT02991430|35562|P1|STARTED|Treatment Period 2||13
16678|NCT02991430|35560|P3|NOT COMPLETED|Treatment Period 1||2
16679|NCT02991430|35561|P2|NOT COMPLETED|Treatment Period 1||4
16680|NCT02991430|35562|P1|NOT COMPLETED|Treatment Period 1||1
16681|NCT02991430|35560|P3|COMPLETED|Treatment Period 1||14
16682|NCT02991430|35561|P2|COMPLETED|Treatment Period 1||11
16683|NCT02991430|35562|P1|COMPLETED|Treatment Period 1||13
16684|NCT02991430|35560|P3|STARTED|Treatment Period 1||16
16685|NCT02991430|35561|P2|STARTED|Treatment Period 1||15
16686|NCT02991430|35562|P1|STARTED|Treatment Period 1||14
16687|NCT02991040|35597|P1|NOT COMPLETED|Overall Study||4
16688|NCT02991040|35597|P1|COMPLETED|Overall Study||96
16689|NCT02991040|35597|P1|STARTED|Overall Study||100
16690|NCT02990910|35612|P2|NOT COMPLETED|Overall Study||10
16691|NCT02990910|35613|P1|NOT COMPLETED|Overall Study||6
16692|NCT02990910|35612|P2|COMPLETED|Overall Study||130
16693|NCT02990910|35613|P1|COMPLETED|Overall Study||134
16694|NCT02990910|35612|P2|STARTED|Overall Study||140
16695|NCT02990910|35613|P1|STARTED|Overall Study||140
16696|NCT02989727|35625|P4|NOT COMPLETED|Overall Study||0
16697|NCT02989727|35626|P3|NOT COMPLETED|Overall Study||0
16698|NCT02989727|35627|P2|NOT COMPLETED|Overall Study||0
16699|NCT02989727|35628|P1|NOT COMPLETED|Overall Study||0
16700|NCT02989727|35625|P4|COMPLETED|Overall Study||30
16701|NCT02989727|35626|P3|COMPLETED|Overall Study||30
16702|NCT02989727|35627|P2|COMPLETED|Overall Study||44
16703|NCT02989727|35628|P1|COMPLETED|Overall Study||46
16704|NCT02989727|35625|P4|STARTED|Overall Study||30
16705|NCT02989727|35626|P3|STARTED|Overall Study||30
16706|NCT02989727|35627|P2|STARTED|Overall Study||44
16707|NCT02989727|35628|P1|STARTED|Overall Study||46
16708|NCT02989649|35704|P1|NOT COMPLETED|Overall Study||420
16709|NCT02989649|35704|P1|COMPLETED|Overall Study||173
16710|NCT02989649|35704|P1|Eligible to Enter Into Treatment Period|Overall Study||509
16711|NCT02989649|35704|P1|Started But Not Treated|Overall Study||84
16712|NCT02989649|35704|P1|STARTED|Overall Study||593
16713|NCT02988882|35718|P2|NOT COMPLETED|Overall Study||2
16714|NCT02988882|35719|P1|NOT COMPLETED|Overall Study||3
16715|NCT02988882|35718|P2|COMPLETED|Overall Study||40
16716|NCT02988882|35719|P1|COMPLETED|Overall Study||41
16717|NCT02988882|35718|P2|STARTED|Overall Study||42
16718|NCT02988882|35719|P1|STARTED|Overall Study||44
16719|NCT02988622|35729|P1|NOT COMPLETED|Overall Study||17
16720|NCT02988622|35729|P1|COMPLETED|Overall Study||83
16721|NCT02988622|35729|P1|STARTED|Overall Study||100
16722|NCT02988349|35753|P2|NOT COMPLETED|Overall Study||0
16723|NCT02988349|35754|P1|NOT COMPLETED|Overall Study||0
16724|NCT02988349|35753|P2|COMPLETED|Overall Study||21
16725|NCT02988349|35754|P1|COMPLETED|Overall Study||21
16726|NCT02988349|35753|P2|STARTED|Overall Study||21
16727|NCT02988349|35754|P1|STARTED|Overall Study||21
16728|NCT02988219|35764|P2|NOT COMPLETED|Overall Study||3
16729|NCT02988219|35765|P1|NOT COMPLETED|Overall Study||1
16730|NCT02988219|35764|P2|COMPLETED|Overall Study||22
16731|NCT02988219|35765|P1|COMPLETED|Overall Study||24
16732|NCT02988219|35764|P2|STARTED|Overall Study||25
16733|NCT02988219|35765|P1|STARTED|Overall Study||25
16734|NCT02988193|35775|P2|NOT COMPLETED|Overall Study||0
16735|NCT02988193|35776|P1|NOT COMPLETED|Overall Study||0
16736|NCT02988193|35775|P2|COMPLETED|Overall Study||16
16737|NCT02988193|35776|P1|COMPLETED|Overall Study||12
16738|NCT02988193|35775|P2|STARTED|Overall Study||16
16739|NCT02988193|35776|P1|STARTED|Overall Study||12
16740|NCT02987972|35785|P3|NOT COMPLETED|Overall Study||42
16741|NCT02987972|35786|P2|NOT COMPLETED|Overall Study||45
16742|NCT02987972|35787|P1|NOT COMPLETED|Overall Study||43
16743|NCT02987972|35785|P3|COMPLETED|Overall Study||308
16744|NCT02987972|35786|P2|COMPLETED|Overall Study||305
16745|NCT02987972|35787|P1|COMPLETED|Overall Study||308
16746|NCT02987972|35785|P3|Vaccination 4|Overall Study||311
16747|NCT02987972|35786|P2|Vaccination 4|Overall Study||306
16748|NCT02987972|35787|P1|Vaccination 4|Overall Study||310
16749|NCT02987972|35785|P3|Vaccination 3|Overall Study||332
16750|NCT02987972|35786|P2|Vaccination 3|Overall Study||331
16751|NCT02987972|35787|P1|Vaccination 3|Overall Study||330
16752|NCT02987972|35785|P3|Vaccination 2|Overall Study||335
16753|NCT02987972|35786|P2|Vaccination 2|Overall Study||335
16754|NCT02987972|35787|P1|Vaccination 2|Overall Study||333
16755|NCT02987972|35785|P3|Vaccination 1|Overall Study||347
16756|NCT02987972|35786|P2|Vaccination 1|Overall Study||347
16757|NCT02987972|35787|P1|Vaccination 1|Overall Study||350
16758|NCT02987972|35785|P3|STARTED|Overall Study||350
16759|NCT02987972|35786|P2|STARTED|Overall Study||350
16760|NCT02987972|35787|P1|STARTED|Overall Study||351
16761|NCT02987868|35816|P2|NOT COMPLETED|Second Intervention||0
16762|NCT02987868|35817|P1|NOT COMPLETED|Second Intervention||0
16763|NCT02987868|35816|P2|COMPLETED|Second Intervention||8
16764|NCT02987868|35817|P1|COMPLETED|Second Intervention||8
16765|NCT02987868|35816|P2|STARTED|Second Intervention||8
16766|NCT02987868|35817|P1|STARTED|Second Intervention||8
16767|NCT02987868|35816|P2|NOT COMPLETED|Wash Out Period 1 Week||0
16768|NCT02987868|35817|P1|NOT COMPLETED|Wash Out Period 1 Week||0
16769|NCT02987868|35816|P2|COMPLETED|Wash Out Period 1 Week||8
16770|NCT02987868|35817|P1|COMPLETED|Wash Out Period 1 Week||8
16771|NCT02987868|35816|P2|STARTED|Wash Out Period 1 Week||8
16772|NCT02987868|35817|P1|STARTED|Wash Out Period 1 Week||8
16773|NCT02987868|35816|P2|NOT COMPLETED|First Intervention||0
16774|NCT02987868|35817|P1|NOT COMPLETED|First Intervention||0
16775|NCT02987868|35816|P2|COMPLETED|First Intervention||8
16776|NCT02987868|35817|P1|COMPLETED|First Intervention||8
16777|NCT02987868|35816|P2|STARTED|First Intervention||8
16778|NCT02987868|35817|P1|STARTED|First Intervention||8
16779|NCT02987660|35825|P2|NOT COMPLETED|Overall Study||10
16780|NCT02987660|35826|P1|NOT COMPLETED|Overall Study||10
16781|NCT02987660|35825|P2|COMPLETED|Overall Study||0
16782|NCT02987660|35826|P1|COMPLETED|Overall Study||0
16783|NCT02987660|35825|P2|STARTED|Overall Study||10
16784|NCT02987660|35826|P1|STARTED|Overall Study||10
16785|NCT02987374|35836|P1|NOT COMPLETED|Overall Study||0
16786|NCT02987374|35836|P1|COMPLETED|Overall Study||10
16787|NCT02987374|35836|P1|STARTED|Overall Study||10
16788|NCT02987231|35843|P2|NOT COMPLETED|Overall Study||0
16789|NCT02987231|35844|P1|NOT COMPLETED|Overall Study||0
16790|NCT02987231|35843|P2|COMPLETED|Overall Study||30
16791|NCT02987231|35844|P1|COMPLETED|Overall Study||30
16792|NCT02987231|35843|P2|STARTED|Overall Study||30
16793|NCT02987231|35844|P1|STARTED|Overall Study||30
16794|NCT02987205|35852|P1|NOT COMPLETED|Overall Study||4
16795|NCT02987205|35852|P1|COMPLETED|Overall Study|Treatment is bilateral, subject lost to Restylane AE was lost to further Revanesse Ultra treatment|159
16796|NCT02987205|35852|P1|Treated - Bilateral NLF Injection|Overall Study||163
16797|NCT02987205|35852|P1|STARTED|Overall Study||163
16798|NCT02986958|35862|P2|NOT COMPLETED|Overall Study||0
16799|NCT02986958|35863|P1|NOT COMPLETED|Overall Study||0
16800|NCT02986958|35862|P2|COMPLETED|Overall Study||44
16801|NCT02986958|35863|P1|COMPLETED|Overall Study||49
16802|NCT02986958|35862|P2|STARTED|Overall Study||44
16803|NCT02986958|35863|P1|STARTED|Overall Study||49
16804|NCT02986854|35886|P3|NOT COMPLETED|Overall Study||3
16805|NCT02986854|35887|P2|NOT COMPLETED|Overall Study||12
16806|NCT02986854|35888|P1|NOT COMPLETED|Overall Study||3
16807|NCT02986854|35886|P3|COMPLETED|Overall Study||97
16808|NCT02986854|35887|P2|COMPLETED|Overall Study||288
16809|NCT02986854|35888|P1|COMPLETED|Overall Study||298
16810|NCT02986854|35886|P3|STARTED|Overall Study||100
16811|NCT02986854|35887|P2|STARTED|Overall Study||300
16812|NCT02986854|35888|P1|STARTED|Overall Study||301
16813|NCT02986711|35963|P2|NOT COMPLETED|Overall Study||10
16814|NCT02986711|35964|P1|NOT COMPLETED|Overall Study||8
16815|NCT02986711|35963|P2|COMPLETED|Overall Study||70
16816|NCT02986711|35964|P1|COMPLETED|Overall Study||70
16817|NCT02986711|35963|P2|STARTED|Overall Study||80
16818|NCT02986711|35964|P1|STARTED|Overall Study||78
16819|NCT02986373|35972|P1|NOT COMPLETED|Overall Study||39
16820|NCT02986373|35972|P1|COMPLETED|Overall Study||106
16821|NCT02986373|35972|P1|STARTED|Overall Study||145
16822|NCT02986282|36007|P1|NOT COMPLETED|Overall Study||16
16823|NCT02986282|36007|P1|COMPLETED|Overall Study||99
16824|NCT02986282|36007|P1|STARTED|Overall Study||115
16825|NCT02986139|36014|P2|NOT COMPLETED|Overall Study||4
16826|NCT02986139|36015|P1|NOT COMPLETED|Overall Study||1
16827|NCT02986139|36014|P2|COMPLETED|Overall Study||51
16828|NCT02986139|36015|P1|COMPLETED|Overall Study||55
16829|NCT02986139|36014|P2|Received Etanercept|Overall Study||53
16830|NCT02986139|36015|P1|Received Etanercept|Overall Study||56
16831|NCT02986139|36014|P2|STARTED|Overall Study||55
16832|NCT02986139|36015|P1|STARTED|Overall Study||56
16833|NCT02985996|36032|P5|NOT COMPLETED|Overall Study||0
16834|NCT02985996|36033|P4|NOT COMPLETED|Overall Study||0
16835|NCT02985996|36034|P3|NOT COMPLETED|Overall Study||1
16836|NCT02985996|36035|P2|NOT COMPLETED|Overall Study||1
16837|NCT02985996|36036|P1|NOT COMPLETED|Overall Study||0
16838|NCT02985996|36032|P5|COMPLETED|Overall Study||9
16839|NCT02985996|36033|P4|COMPLETED|Overall Study||7
16840|NCT02985996|36034|P3|COMPLETED|Overall Study||9
16841|NCT02985996|36035|P2|COMPLETED|Overall Study||7
16842|NCT02985996|36036|P1|COMPLETED|Overall Study||5
16843|NCT02985996|36032|P5|STARTED|Overall Study||9
16844|NCT02985996|36033|P4|STARTED|Overall Study||7
16845|NCT02985996|36034|P3|STARTED|Overall Study||10
16846|NCT02985996|36035|P2|STARTED|Overall Study||8
16847|NCT02985996|36036|P1|STARTED|Overall Study||5
16848|NCT02985840|36150|P2|NOT COMPLETED|Overall Study||0
16849|NCT02985840|36151|P1|NOT COMPLETED|Overall Study||0
16850|NCT02985840|36150|P2|COMPLETED|Overall Study||63
16851|NCT02985840|36151|P1|COMPLETED|Overall Study||64
16852|NCT02985840|36150|P2|STARTED|Overall Study||63
16853|NCT02985840|36151|P1|STARTED|Overall Study||64
16854|NCT02985827|36161|P2|NOT COMPLETED|Overall Study||0
16855|NCT02985827|36162|P1|NOT COMPLETED|Overall Study||0
16856|NCT02985827|36161|P2|COMPLETED|Overall Study||15
16857|NCT02985827|36162|P1|COMPLETED|Overall Study||33
16858|NCT02985827|36161|P2|STARTED|Overall Study||15
16859|NCT02985827|36162|P1|STARTED|Overall Study||33
16860|NCT02984982|36172|P2|NOT COMPLETED|Overall Study||10
16861|NCT02984982|36173|P1|NOT COMPLETED|Overall Study||8
16862|NCT02984982|36172|P2|COMPLETED|Overall Study||94
16863|NCT02984982|36173|P1|COMPLETED|Overall Study||94
16864|NCT02984982|36172|P2|Treated|Overall Study||103
16865|NCT02984982|36173|P1|Treated|Overall Study||102
16866|NCT02984982|36172|P2|STARTED|Overall Study||104
16867|NCT02984982|36173|P1|STARTED|Overall Study||102
16868|NCT02984878|36227|P2|NOT COMPLETED|Overall Study||0
16869|NCT02984878|36228|P1|NOT COMPLETED|Overall Study||0
16870|NCT02984878|36227|P2|COMPLETED|Overall Study||41
16871|NCT02984878|36228|P1|COMPLETED|Overall Study||30
16872|NCT02984878|36227|P2|STARTED|Overall Study||41
16873|NCT02984878|36228|P1|STARTED|Overall Study||30
16874|NCT02984709|36240|P2|NOT COMPLETED|Overall Study||0
16875|NCT02984709|36241|P1|NOT COMPLETED|Overall Study||0
16876|NCT02984709|36240|P2|COMPLETED|Overall Study||24
16877|NCT02984709|36241|P1|COMPLETED|Overall Study||24
16878|NCT02984709|36240|P2|STARTED|Overall Study|We enrolled 24 adolescent-parent dyads.|24
16879|NCT02984709|36241|P1|STARTED|Overall Study|We enrolled 24 adolescent-parent dyads.|24
16880|NCT02984267|36265|P2|NOT COMPLETED|Overall Study||1
16881|NCT02984267|36266|P1|NOT COMPLETED|Overall Study||1
16882|NCT02984267|36265|P2|COMPLETED|Overall Study||9
16883|NCT02984267|36266|P1|COMPLETED|Overall Study||7
16884|NCT02984267|36265|P2|STARTED|Overall Study||10
16885|NCT02984267|36266|P1|STARTED|Overall Study||8
16886|NCT02983981|36290|P1|NOT COMPLETED|Overall Study||0
16887|NCT02983981|36290|P1|COMPLETED|Overall Study||20
16888|NCT02983981|36290|P1|STARTED|Overall Study||20
16889|NCT02983604|36301|P4|NOT COMPLETED|Overall Study||0
16890|NCT02983604|36302|P3|NOT COMPLETED|Overall Study||1
16891|NCT02983604|36303|P2|NOT COMPLETED|Overall Study||0
16892|NCT02983604|36304|P1|NOT COMPLETED|Overall Study||0
16893|NCT02983604|36301|P4|COMPLETED|Overall Study||3
16894|NCT02983604|36302|P3|COMPLETED|Overall Study||3
16895|NCT02983604|36303|P2|COMPLETED|Overall Study||3
16896|NCT02983604|36304|P1|COMPLETED|Overall Study||4
16897|NCT02983604|36301|P4|STARTED|Overall Study||3
16898|NCT02983604|36302|P3|STARTED|Overall Study||4
16899|NCT02983604|36303|P2|STARTED|Overall Study||3
16900|NCT02983604|36304|P1|STARTED|Overall Study||4
16901|NCT02983448|36342|P2|NOT COMPLETED|Overall Study||0
16902|NCT02983448|36343|P1|NOT COMPLETED|Overall Study||0
16903|NCT02983448|36342|P2|COMPLETED|Overall Study||12
16904|NCT02983448|36343|P1|COMPLETED|Overall Study||12
16905|NCT02983448|36342|P2|STARTED|Overall Study||12
16906|NCT02983448|36343|P1|STARTED|Overall Study||12
16907|NCT02983305|36353|P2|NOT COMPLETED|Overall Study||0
16908|NCT02983305|36354|P1|NOT COMPLETED|Overall Study||2
16909|NCT02983305|36353|P2|COMPLETED|Overall Study||10
16910|NCT02983305|36354|P1|COMPLETED|Overall Study||10
16911|NCT02983305|36353|P2|STARTED|Overall Study||10
16912|NCT02983305|36354|P1|STARTED|Overall Study||12
16913|NCT02982928|36362|P1|NOT COMPLETED|Overall Study||0
16914|NCT02982928|36362|P1|COMPLETED|Overall Study||11
16915|NCT02982928|36362|P1|STARTED|Overall Study||11
16916|NCT02982863|36371|P5|NOT COMPLETED|Overall Study||492
16917|NCT02982863|36372|P4|NOT COMPLETED|Overall Study||1400
16918|NCT02982863|36373|P3|NOT COMPLETED|Overall Study||1852
16919|NCT02982863|36374|P2|NOT COMPLETED|Overall Study||4261
16920|NCT02982863|36375|P1|NOT COMPLETED|Overall Study||809
16921|NCT02982863|36371|P5|COMPLETED|Overall Study||2268
16922|NCT02982863|36372|P4|COMPLETED|Overall Study||8758
16923|NCT02982863|36373|P3|COMPLETED|Overall Study||11386
16924|NCT02982863|36374|P2|COMPLETED|Overall Study||12484
16925|NCT02982863|36375|P1|COMPLETED|Overall Study||4936
16926|NCT02982863|36371|P5|STARTED|Overall Study||2760
16927|NCT02982863|36372|P4|STARTED|Overall Study||10158
16928|NCT02982863|36373|P3|STARTED|Overall Study||13238
16929|NCT02982863|36374|P2|STARTED|Overall Study||16745
16930|NCT02982863|36375|P1|STARTED|Overall Study||5745
16931|NCT02982720|36432|P1|NOT COMPLETED|Overall Study||4
16932|NCT02982720|36432|P1|COMPLETED|Overall Study||0
16933|NCT02982720|36432|P1|STARTED|Overall Study||4
16934|NCT02982239|36442|P2|NOT COMPLETED|Overall Study||2
16935|NCT02982239|36443|P1|NOT COMPLETED|Overall Study||3
16936|NCT02982239|36442|P2|COMPLETED|Overall Study||18
16937|NCT02982239|36443|P1|COMPLETED|Overall Study||17
16938|NCT02982239|36442|P2|STARTED|Overall Study||20
16939|NCT02982239|36443|P1|STARTED|Overall Study||20
16940|NCT02982187|36459|P8|NOT COMPLETED|Overall Study||0
16941|NCT02982187|36460|P7|NOT COMPLETED|Overall Study||1
16942|NCT02982187|36461|P6|NOT COMPLETED|Overall Study||0
16943|NCT02982187|36462|P5|NOT COMPLETED|Overall Study||0
16944|NCT02982187|36463|P4|NOT COMPLETED|Overall Study||0
16945|NCT02982187|36464|P3|NOT COMPLETED|Overall Study||0
16946|NCT02982187|36465|P2|NOT COMPLETED|Overall Study||0
16947|NCT02982187|36466|P1|NOT COMPLETED|Overall Study||0
16948|NCT02982187|36459|P8|COMPLETED|Overall Study||20
16949|NCT02982187|36460|P7|COMPLETED|Overall Study||19
16950|NCT02982187|36461|P6|COMPLETED|Overall Study||20
16951|NCT02982187|36462|P5|COMPLETED|Overall Study||20
16952|NCT02982187|36463|P4|COMPLETED|Overall Study||20
16953|NCT02982187|36464|P3|COMPLETED|Overall Study||20
16954|NCT02982187|36465|P2|COMPLETED|Overall Study||20
16955|NCT02982187|36466|P1|COMPLETED|Overall Study||20
16956|NCT02982187|36459|P8|STARTED|Overall Study||20
16957|NCT02982187|36460|P7|STARTED|Overall Study||20
16958|NCT02982187|36461|P6|STARTED|Overall Study||20
16959|NCT02982187|36462|P5|STARTED|Overall Study||20
16960|NCT02982187|36463|P4|STARTED|Overall Study||20
16961|NCT02982187|36464|P3|STARTED|Overall Study||20
16962|NCT02982187|36465|P2|STARTED|Overall Study||20
16963|NCT02982187|36466|P1|STARTED|Overall Study||20
16964|NCT02982018|36516|P2|NOT COMPLETED|Overall Study||3
16965|NCT02982018|36517|P1|NOT COMPLETED|Overall Study||5
16966|NCT02982018|36516|P2|COMPLETED|Overall Study||61
16967|NCT02982018|36517|P1|COMPLETED|Overall Study||62
16968|NCT02982018|36516|P2|STARTED|Overall Study||64
16969|NCT02982018|36517|P1|STARTED|Overall Study||67
16970|NCT02981524|36531|P1|NOT COMPLETED|Overall Study||17
16971|NCT02981524|36531|P1|COMPLETED|Overall Study||0
16972|NCT02981524|36531|P1|STARTED|Overall Study||17
16973|NCT02981342|36543|P4|NOT COMPLETED|Overall Study||14
16974|NCT02981342|36544|P3|NOT COMPLETED|Overall Study||13
16975|NCT02981342|36545|P2|NOT COMPLETED|Overall Study||11
16976|NCT02981342|36546|P1|NOT COMPLETED|Overall Study||0
16977|NCT02981342|36543|P4|COMPLETED|Overall Study||19
16978|NCT02981342|36544|P3|COMPLETED|Overall Study||20
16979|NCT02981342|36545|P2|COMPLETED|Overall Study||22
16980|NCT02981342|36546|P1|COMPLETED|Overall Study||7
16981|NCT02981342|36543|P4|Received at Least One Dose of Study Drug|Overall Study||26
16982|NCT02981342|36544|P3|Received at Least One Dose of Study Drug|Overall Study||33
16983|NCT02981342|36545|P2|Received at Least One Dose of Study Drug|Overall Study||32
16984|NCT02981342|36546|P1|Received at Least One Dose of Study Drug|Overall Study||7
16985|NCT02981342|36543|P4|STARTED|Overall Study||33
16986|NCT02981342|36544|P3|STARTED|Overall Study||33
16987|NCT02981342|36545|P2|STARTED|Overall Study||33
16988|NCT02981342|36546|P1|STARTED|Overall Study||7
16989|NCT02980978|36589|P2|NOT COMPLETED|Overall Study||8
16990|NCT02980978|36590|P1|NOT COMPLETED|Overall Study||6
16991|NCT02980978|36589|P2|COMPLETED|Overall Study||50
16992|NCT02980978|36590|P1|COMPLETED|Overall Study||54
16993|NCT02980978|36589|P2|STARTED|Overall Study||58
16994|NCT02980978|36590|P1|STARTED|Overall Study||60
16995|NCT02980783|36604|P1|NOT COMPLETED|Overall Study||1
16996|NCT02980783|36604|P1|COMPLETED|Overall Study||52
16997|NCT02980783|36604|P1|STARTED|Overall Study||53
16998|NCT02980601|36617|P2|NOT COMPLETED|Overall Study||3
16999|NCT02980601|36618|P1|NOT COMPLETED|Overall Study||5
17000|NCT02980601|36617|P2|COMPLETED|Overall Study||1
17001|NCT02980601|36618|P1|COMPLETED|Overall Study||1
17002|NCT02980601|36617|P2|STARTED|Overall Study||4
17003|NCT02980601|36618|P1|STARTED|Overall Study||6
17004|NCT02980523|36711|P5|NOT COMPLETED|Overall Study||10
17005|NCT02980523|36712|P4|NOT COMPLETED|Overall Study||9
17006|NCT02980523|36713|P3|NOT COMPLETED|Overall Study||6
17007|NCT02980523|36714|P2|NOT COMPLETED|Overall Study||11
17008|NCT02980523|36715|P1|NOT COMPLETED|Overall Study||3
17009|NCT02980523|36711|P5|COMPLETED|Overall Study||20
17010|NCT02980523|36712|P4|COMPLETED|Overall Study||21
17011|NCT02980523|36713|P3|COMPLETED|Overall Study||24
17012|NCT02980523|36714|P2|COMPLETED|Overall Study||19
17013|NCT02980523|36715|P1|COMPLETED|Overall Study||27
17014|NCT02980523|36711|P5|STARTED|Overall Study||30
17015|NCT02980523|36712|P4|STARTED|Overall Study||30
17016|NCT02980523|36713|P3|STARTED|Overall Study||30
17017|NCT02980523|36714|P2|STARTED|Overall Study||30
17018|NCT02980523|36715|P1|STARTED|Overall Study||30
17019|NCT02980224|36759|P2|NOT COMPLETED|Overall Study||3
17020|NCT02980224|36760|P1|NOT COMPLETED|Overall Study||4
17021|NCT02980224|36759|P2|COMPLETED|Overall Study||88
17022|NCT02980224|36760|P1|COMPLETED|Overall Study||85
17023|NCT02980224|36759|P2|STARTED|Overall Study||91
17024|NCT02980224|36760|P1|STARTED|Overall Study||89
17025|NCT02980107|36772|P2|NOT COMPLETED|Overall Study||62
17026|NCT02980107|36773|P1|NOT COMPLETED|Overall Study||51
17027|NCT02980107|36772|P2|COMPLETED|Overall Study||45
17028|NCT02980107|36773|P1|COMPLETED|Overall Study||54
17029|NCT02980107|36772|P2|STARTED|Overall Study||107
17030|NCT02980107|36773|P1|STARTED|Overall Study||105
17031|NCT02979639|36785|P1|NOT COMPLETED|Overall Study||14
17032|NCT02979639|36785|P1|COMPLETED|Overall Study||387
17033|NCT02979639|36785|P1|STARTED|Overall Study||401
17034|NCT02979613|36817|P2|NOT COMPLETED|Open-Label Extension (OLE) Phase||227
17035|NCT02979613|36818|P1|NOT COMPLETED|Open-Label Extension (OLE) Phase||223
17036|NCT02979613|36817|P2|COMPLETED|Open-Label Extension (OLE) Phase||10
17037|NCT02979613|36818|P1|COMPLETED|Open-Label Extension (OLE) Phase||12
17038|NCT02979613|36817|P2|STARTED|Open-Label Extension (OLE) Phase||237
17039|NCT02979613|36818|P1|STARTED|Open-Label Extension (OLE) Phase||235
17040|NCT02979613|36817|P2|NOT COMPLETED|Double-Blind Phase||8
17041|NCT02979613|36818|P1|NOT COMPLETED|Double-Blind Phase||10
17042|NCT02979613|36817|P2|COMPLETED|Double-Blind Phase||237
17043|NCT02979613|36818|P1|COMPLETED|Double-Blind Phase||235
17044|NCT02979613|36817|P2|STARTED|Double-Blind Phase||245
17045|NCT02979613|36818|P1|STARTED|Double-Blind Phase||245
17046|NCT02979431|36854|P4|NOT COMPLETED|Overall Study||1
17047|NCT02979431|36855|P3|NOT COMPLETED|Overall Study||2
17048|NCT02979431|36856|P2|NOT COMPLETED|Overall Study||2
17049|NCT02979431|36857|P1|NOT COMPLETED|Overall Study||4
17050|NCT02979431|36854|P4|COMPLETED|Overall Study||44
17051|NCT02979431|36855|P3|COMPLETED|Overall Study||43
17052|NCT02979431|36856|P2|COMPLETED|Overall Study||44
17053|NCT02979431|36857|P1|COMPLETED|Overall Study||40
17054|NCT02979431|36854|P4|Included in the Safety Population|Overall Study|Includes a subject that was randomized to placebo but received a dose of ALX-0171 9.0 mg/kg|46
17055|NCT02979431|36855|P3|Included in the Safety Population|Overall Study|Includes a subject that was randomized to placebo but received a dose of ALX-0171 6.0 mg/kg|44
17056|NCT02979431|36856|P2|Included in the Safety Population|Overall Study||45
17057|NCT02979431|36857|P1|Included in the Safety Population|Overall Study||40
17058|NCT02979431|36854|P4|Included in the mITT Population|Overall Study||45
17059|NCT02979431|36855|P3|Included in the mITT Population|Overall Study||43
17060|NCT02979431|36856|P2|Included in the mITT Population|Overall Study||45
17061|NCT02979431|36857|P1|Included in the mITT Population|Overall Study||42
17062|NCT02979431|36854|P4|STARTED|Overall Study||45
17063|NCT02979431|36855|P3|STARTED|Overall Study||45
17064|NCT02979431|36856|P2|STARTED|Overall Study||46
17065|NCT02979431|36857|P1|STARTED|Overall Study||44
17066|NCT02979301|36909|P2|NOT COMPLETED|Overall Study||0
17067|NCT02979301|36910|P1|NOT COMPLETED|Overall Study||1
17068|NCT02979301|36909|P2|COMPLETED|Overall Study||11
17069|NCT02979301|36910|P1|COMPLETED|Overall Study||10
17070|NCT02979301|36909|P2|STARTED|Overall Study||11
17071|NCT02979301|36910|P1|STARTED|Overall Study||11
17072|NCT02979197|36919|P3|NOT COMPLETED|Overall Study||0
17073|NCT02979197|36920|P2|NOT COMPLETED|Overall Study||4
17074|NCT02979197|36921|P1|NOT COMPLETED|Overall Study||4
17075|NCT02979197|36919|P3|COMPLETED|Overall Study||8
17076|NCT02979197|36920|P2|COMPLETED|Overall Study||45
17077|NCT02979197|36921|P1|COMPLETED|Overall Study||44
17078|NCT02979197|36919|P3|STARTED|Overall Study||8
17079|NCT02979197|36920|P2|STARTED|Overall Study||49
17080|NCT02979197|36921|P1|STARTED|Overall Study||48
17081|NCT02979054|36949|P2|NOT COMPLETED|Overall Study||0
17082|NCT02979054|36950|P1|NOT COMPLETED|Overall Study||0
17083|NCT02979054|36949|P2|COMPLETED|Overall Study||64
17084|NCT02979054|36950|P1|COMPLETED|Overall Study||71
17085|NCT02979054|36949|P2|STARTED|Overall Study||64
17086|NCT02979054|36950|P1|STARTED|Overall Study||71
17087|NCT02978833|36964|P2|NOT COMPLETED|Overall Study||1
17088|NCT02978833|36965|P1|NOT COMPLETED|Overall Study||1
17089|NCT02978833|36964|P2|COMPLETED|Overall Study||0
17090|NCT02978833|36965|P1|COMPLETED|Overall Study||0
17091|NCT02978833|36964|P2|STARTED|Overall Study||1
17092|NCT02978833|36965|P1|STARTED|Overall Study||1
17093|NCT02978157|36983|P2|NOT COMPLETED|Overall Study||0
17094|NCT02978157|36984|P1|NOT COMPLETED|Overall Study||0
17095|NCT02978157|36983|P2|COMPLETED|Overall Study||50
17096|NCT02978157|36984|P1|COMPLETED|Overall Study||52
17097|NCT02978157|36983|P2|STARTED|Overall Study||50
17098|NCT02978157|36984|P1|STARTED|Overall Study||52
17099|NCT02977572|36992|P2|NOT COMPLETED|Overall Study||2
17100|NCT02977572|36993|P1|NOT COMPLETED|Overall Study||2
17101|NCT02977572|36992|P2|COMPLETED|Overall Study||54
17102|NCT02977572|36993|P1|COMPLETED|Overall Study||56
17103|NCT02977572|36992|P2|STARTED|Overall Study||56
17104|NCT02977572|36993|P1|STARTED|Overall Study||58
17105|NCT02977507|37015|P2|NOT COMPLETED|Overall Study||0
17106|NCT02977507|37016|P1|NOT COMPLETED|Overall Study||2
17107|NCT02977507|37015|P2|COMPLETED|Overall Study||10
17108|NCT02977507|37016|P1|COMPLETED|Overall Study||6
17109|NCT02977507|37015|P2|STARTED|Overall Study||10
17110|NCT02977507|37016|P1|STARTED|Overall Study||8
17111|NCT02976519|37046|P7|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||1
17112|NCT02976519|37047|P6|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
17113|NCT02976519|37048|P5|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
17114|NCT02976519|37049|P4|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
17115|NCT02976519|37050|P3|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
17116|NCT02976519|37051|P2|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
17117|NCT02976519|37052|P1|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
17118|NCT02976519|37046|P7|COMPLETED|Treatment Period 2 (Part 2 Only)||9
17119|NCT02976519|37047|P6|COMPLETED|Treatment Period 2 (Part 2 Only)||12
17120|NCT02976519|37048|P5|COMPLETED|Treatment Period 2 (Part 2 Only)||0
17121|NCT02976519|37049|P4|COMPLETED|Treatment Period 2 (Part 2 Only)||0
17122|NCT02976519|37050|P3|COMPLETED|Treatment Period 2 (Part 2 Only)||0
17123|NCT02976519|37051|P2|COMPLETED|Treatment Period 2 (Part 2 Only)||0
17124|NCT02976519|37052|P1|COMPLETED|Treatment Period 2 (Part 2 Only)||0
17125|NCT02976519|37046|P7|STARTED|Treatment Period 2 (Part 2 Only)||10
17126|NCT02976519|37047|P6|STARTED|Treatment Period 2 (Part 2 Only)||12
17127|NCT02976519|37048|P5|STARTED|Treatment Period 2 (Part 2 Only)||0
17128|NCT02976519|37049|P4|STARTED|Treatment Period 2 (Part 2 Only)||0
17129|NCT02976519|37050|P3|STARTED|Treatment Period 2 (Part 2 Only)||0
17130|NCT02976519|37051|P2|STARTED|Treatment Period 2 (Part 2 Only)||0
17131|NCT02976519|37052|P1|STARTED|Treatment Period 2 (Part 2 Only)||0
17132|NCT02976519|37046|P7|NOT COMPLETED|Wash-out Period (Part 2 Only)||2
17133|NCT02976519|37047|P6|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
17134|NCT02976519|37048|P5|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
17135|NCT02976519|37049|P4|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
17136|NCT02976519|37050|P3|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
17137|NCT02976519|37051|P2|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
17138|NCT02976519|37052|P1|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
17139|NCT02976519|37046|P7|COMPLETED|Wash-out Period (Part 2 Only)||10
17140|NCT02976519|37047|P6|COMPLETED|Wash-out Period (Part 2 Only)||12
17141|NCT02976519|37048|P5|COMPLETED|Wash-out Period (Part 2 Only)||0
17142|NCT02976519|37049|P4|COMPLETED|Wash-out Period (Part 2 Only)||0
17143|NCT02976519|37050|P3|COMPLETED|Wash-out Period (Part 2 Only)||0
17144|NCT02976519|37051|P2|COMPLETED|Wash-out Period (Part 2 Only)||0
17145|NCT02976519|37052|P1|COMPLETED|Wash-out Period (Part 2 Only)||0
17146|NCT02976519|37046|P7|STARTED|Wash-out Period (Part 2 Only)||12
17147|NCT02976519|37047|P6|STARTED|Wash-out Period (Part 2 Only)||12
17148|NCT02976519|37048|P5|STARTED|Wash-out Period (Part 2 Only)||0
17149|NCT02976519|37049|P4|STARTED|Wash-out Period (Part 2 Only)||0
17150|NCT02976519|37050|P3|STARTED|Wash-out Period (Part 2 Only)||0
17151|NCT02976519|37051|P2|STARTED|Wash-out Period (Part 2 Only)||0
17152|NCT02976519|37052|P1|STARTED|Wash-out Period (Part 2 Only)||0
17153|NCT02976519|37046|P7|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
17154|NCT02976519|37047|P6|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
17155|NCT02976519|37048|P5|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
17156|NCT02976519|37049|P4|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||1
17157|NCT02976519|37050|P3|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
17158|NCT02976519|37051|P2|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||1
17159|NCT02976519|37052|P1|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
17160|NCT02976519|37046|P7|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||12
17161|NCT02976519|37047|P6|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||12
17162|NCT02976519|37048|P5|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
17163|NCT02976519|37049|P4|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||7
17164|NCT02976519|37050|P3|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
17165|NCT02976519|37051|P2|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||7
17166|NCT02976519|37052|P1|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
17167|NCT02976519|37046|P7|STARTED|Treatment Period 1 (Part 1 and Part 2)||12
17168|NCT02976519|37047|P6|STARTED|Treatment Period 1 (Part 1 and Part 2)||12
17169|NCT02976519|37048|P5|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
17170|NCT02976519|37049|P4|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
17171|NCT02976519|37050|P3|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
17172|NCT02976519|37051|P2|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
17173|NCT02976519|37052|P1|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
17174|NCT02976181|37076|P1|NOT COMPLETED|Overall Study||1
17175|NCT02976181|37076|P1|COMPLETED|Overall Study||112
17176|NCT02976181|37076|P1|STARTED|Overall Study||113
17177|NCT02975804|37083|P2|NOT COMPLETED|Overall Study||0
17178|NCT02975804|37084|P1|NOT COMPLETED|Overall Study||0
17179|NCT02975804|37083|P2|COMPLETED|Overall Study||9
17180|NCT02975804|37084|P1|COMPLETED|Overall Study||9
17181|NCT02975804|37083|P2|STARTED|Overall Study||9
17182|NCT02975804|37084|P1|STARTED|Overall Study||9
17183|NCT02975557|37125|P3|NOT COMPLETED|Overall Study||1
17184|NCT02975557|37126|P2|NOT COMPLETED|Overall Study||3
17185|NCT02975557|37127|P1|NOT COMPLETED|Overall Study||1
17186|NCT02975557|37125|P3|COMPLETED|Overall Study||5
17187|NCT02975557|37126|P2|COMPLETED|Overall Study||2
17188|NCT02975557|37127|P1|COMPLETED|Overall Study||3
17189|NCT02975557|37125|P3|STARTED|Overall Study||6
17190|NCT02975557|37126|P2|STARTED|Overall Study||5
17191|NCT02975557|37127|P1|STARTED|Overall Study||4
17192|NCT02975206|37138|P3|NOT COMPLETED|Overall Study||17
17193|NCT02975206|37139|P2|NOT COMPLETED|Overall Study||17
17194|NCT02975206|37140|P1|NOT COMPLETED|Overall Study||27
17195|NCT02975206|37138|P3|COMPLETED|Overall Study||145
17196|NCT02975206|37139|P2|COMPLETED|Overall Study||144
17197|NCT02975206|37140|P1|COMPLETED|Overall Study||134
17198|NCT02975206|37138|P3|STARTED|Overall Study||162
17199|NCT02975206|37139|P2|STARTED|Overall Study||161
17200|NCT02975206|37140|P1|STARTED|Overall Study||161
17201|NCT02974543|37156|P2|NOT COMPLETED|Overall Study||0
17202|NCT02974543|37157|P1|NOT COMPLETED|Overall Study||1
17203|NCT02974543|37156|P2|COMPLETED|Overall Study||10
17204|NCT02974543|37157|P1|COMPLETED|Overall Study||10
17205|NCT02974543|37156|P2|Began Crossover Assignment|Overall Study||10
17206|NCT02974543|37157|P1|Began Crossover Assignment|Overall Study||10
17207|NCT02974543|37156|P2|Began Washout Period|Overall Study||10
17208|NCT02974543|37157|P1|Began Washout Period|Overall Study||10
17209|NCT02974543|37156|P2|STARTED|Overall Study||10
17210|NCT02974543|37157|P1|STARTED|Overall Study||11
17211|NCT02974140|37177|P1|NOT COMPLETED|Overall Study||39
17212|NCT02974140|37177|P1|COMPLETED|Overall Study||0
17213|NCT02974140|37177|P1|Manual (Fellow Eye)|Overall Study||38
17214|NCT02974140|37177|P1|CRS (Left or Right Eye)|Overall Study||38
17215|NCT02974140|37177|P1|STARTED|Overall Study||39
17216|NCT02974114|37193|P3|NOT COMPLETED|Overall Study||2
17217|NCT02974114|37194|P2|NOT COMPLETED|Overall Study||1
17218|NCT02974114|37195|P1|NOT COMPLETED|Overall Study||0
17219|NCT02974114|37193|P3|COMPLETED|Overall Study||6
17220|NCT02974114|37194|P2|COMPLETED|Overall Study||6
17221|NCT02974114|37195|P1|COMPLETED|Overall Study||6
17222|NCT02974114|37193|P3|STARTED|Overall Study||8
17223|NCT02974114|37194|P2|STARTED|Overall Study||7
17224|NCT02974114|37195|P1|STARTED|Overall Study||6
17225|NCT02974088|37238|P2|NOT COMPLETED|Overall Study||3
17226|NCT02974088|37239|P1|NOT COMPLETED|Overall Study||0
17227|NCT02974088|37238|P2|COMPLETED|Overall Study|Nurse left without notice and took CRFs and data for 2 subjects.|21
17228|NCT02974088|37239|P1|COMPLETED|Overall Study||23
17229|NCT02974088|37238|P2|STARTED|Overall Study||24
17230|NCT02974088|37239|P1|STARTED|Overall Study||23
17231|NCT02973802|37245|P1|NOT COMPLETED|Overall Study||2
17232|NCT02973802|37245|P1|COMPLETED|Overall Study||10
17233|NCT02973802|37245|P1|STARTED|Overall Study||12
17234|NCT02973100|37263|P4|NOT COMPLETED|Overall Study||7
17235|NCT02973100|37264|P3|NOT COMPLETED|Overall Study||4
17236|NCT02973100|37265|P2|NOT COMPLETED|Overall Study||8
17237|NCT02973100|37266|P1|NOT COMPLETED|Overall Study||7
17238|NCT02973100|37263|P4|COMPLETED|Overall Study||69
17239|NCT02973100|37264|P3|COMPLETED|Overall Study||75
17240|NCT02973100|37265|P2|COMPLETED|Overall Study||73
17241|NCT02973100|37266|P1|COMPLETED|Overall Study||75
17242|NCT02973100|37263|P4|Received at Least 1 Dose of Study Drug|Overall Study||76
17243|NCT02973100|37264|P3|Received at Least 1 Dose of Study Drug|Overall Study||79
17244|NCT02973100|37265|P2|Received at Least 1 Dose of Study Drug|Overall Study||81
17245|NCT02973100|37266|P1|Received at Least 1 Dose of Study Drug|Overall Study||81
17246|NCT02973100|37263|P4|STARTED|Overall Study||76
17247|NCT02973100|37264|P3|STARTED|Overall Study||79
17248|NCT02973100|37265|P2|STARTED|Overall Study||81
17249|NCT02973100|37266|P1|STARTED|Overall Study||82
17250|NCT02972658|37306|P4|NOT COMPLETED|Overall Study||131
17251|NCT02972658|37307|P3|NOT COMPLETED|Overall Study||75
17252|NCT02972658|37308|P2|NOT COMPLETED|Overall Study||138
17253|NCT02972658|37309|P1|NOT COMPLETED|Overall Study||76
17254|NCT02972658|37306|P4|COMPLETED|Overall Study||0
17255|NCT02972658|37307|P3|COMPLETED|Overall Study||0
17256|NCT02972658|37308|P2|COMPLETED|Overall Study|1 participant was incorrectly marked as “Completed” rather than study terminated by Sponsor.|1
17257|NCT02972658|37309|P1|COMPLETED|Overall Study||0
17258|NCT02972658|37306|P4|Received at Least 1 Dose of Study Drug|Overall Study||131
17259|NCT02972658|37307|P3|Received at Least 1 Dose of Study Drug|Overall Study||74
17260|NCT02972658|37308|P2|Received at Least 1 Dose of Study Drug|Overall Study||139
17261|NCT02972658|37309|P1|Received at Least 1 Dose of Study Drug|Overall Study||76
17262|NCT02972658|37306|P4|STARTED|Overall Study||131
17263|NCT02972658|37307|P3|STARTED|Overall Study||75
17264|NCT02972658|37308|P2|STARTED|Overall Study||139
17265|NCT02972658|37309|P1|STARTED|Overall Study||76
17266|NCT02972632|37339|P1|NOT COMPLETED|Overall Study||17
17267|NCT02972632|37339|P1|COMPLETED|Overall Study||106
17268|NCT02972632|37339|P1|Safety Analysis Set|Overall Study||122
17269|NCT02972632|37339|P1|STARTED|Overall Study||123
17270|NCT02972554|37352|P2|NOT COMPLETED|Overall Study||0
17271|NCT02972554|37353|P1|NOT COMPLETED|Overall Study||0
17272|NCT02972554|37352|P2|COMPLETED|Overall Study||48
17273|NCT02972554|37353|P1|COMPLETED|Overall Study||44
17274|NCT02972554|37352|P2|STARTED|Overall Study||48
17275|NCT02972554|37353|P1|STARTED|Overall Study||44
17276|NCT02972515|37369|P1|NOT COMPLETED|Overall Study||78
17277|NCT02972515|37369|P1|COMPLETED|Overall Study||88
17278|NCT02972515|37369|P1|STARTED|Overall Study||166
17279|NCT02972502|37378|P2|NOT COMPLETED|Overall Study||2
17280|NCT02972502|37379|P1|NOT COMPLETED|Overall Study||4
17281|NCT02972502|37378|P2|COMPLETED|Overall Study||29
17282|NCT02972502|37379|P1|COMPLETED|Overall Study||31
17283|NCT02972502|37378|P2|STARTED|Overall Study||31
17284|NCT02972502|37379|P1|STARTED|Overall Study||35
17285|NCT02972359|37389|P1|NOT COMPLETED|Overall Study||71
17286|NCT02972359|37389|P1|COMPLETED|Overall Study||247
17287|NCT02972359|37389|P1|STARTED|Overall Study||318
17288|NCT02971670|37404|P4|NOT COMPLETED|Overall Study||2
17289|NCT02971670|37405|P3|NOT COMPLETED|Overall Study||1
17290|NCT02971670|37406|P2|NOT COMPLETED|Overall Study||1
17291|NCT02971670|37407|P1|NOT COMPLETED|Overall Study||4
17292|NCT02971670|37404|P4|COMPLETED|Overall Study||1
17293|NCT02971670|37405|P3|COMPLETED|Overall Study||4
17294|NCT02971670|37406|P2|COMPLETED|Overall Study||1
17295|NCT02971670|37407|P1|COMPLETED|Overall Study||9
17296|NCT02971670|37404|P4|STARTED|Overall Study||3
17297|NCT02971670|37405|P3|STARTED|Overall Study||5
17298|NCT02971670|37406|P2|STARTED|Overall Study||2
17299|NCT02971670|37407|P1|STARTED|Overall Study||13
17300|NCT02971631|37425|P2|NOT COMPLETED|Second Intervention - One Day||0
17301|NCT02971631|37426|P1|NOT COMPLETED|Second Intervention - One Day||0
17302|NCT02971631|37425|P2|COMPLETED|Second Intervention - One Day||2
17303|NCT02971631|37426|P1|COMPLETED|Second Intervention - One Day||3
17304|NCT02971631|37425|P2|STARTED|Second Intervention - One Day||2
17305|NCT02971631|37426|P1|STARTED|Second Intervention - One Day||3
17306|NCT02971631|37425|P2|NOT COMPLETED|First Intervention - One Day||0
17307|NCT02971631|37426|P1|NOT COMPLETED|First Intervention - One Day||0
17308|NCT02971631|37425|P2|COMPLETED|First Intervention - One Day||2
17309|NCT02971631|37426|P1|COMPLETED|First Intervention - One Day||3
17310|NCT02971631|37425|P2|STARTED|First Intervention - One Day||2
17311|NCT02971631|37426|P1|STARTED|First Intervention - One Day||3
17312|NCT02971605|37446|P1|NOT COMPLETED|Overall Study||1
17313|NCT02971605|37446|P1|COMPLETED|Overall Study||12
17314|NCT02971605|37446|P1|STARTED|Overall Study||13
17315|NCT02971488|37461|P1|NOT COMPLETED|Overall Study||0
17316|NCT02971488|37461|P1|COMPLETED|Overall Study||529
17317|NCT02971488|37461|P1|STARTED|Overall Study||529
17318|NCT02971293|37471|P1|NOT COMPLETED|Overall Study||11
17319|NCT02971293|37471|P1|COMPLETED|Overall Study||31
17320|NCT02971293|37471|P1|STARTED|Overall Study||42
17321|NCT02971202|37560|P3|NOT COMPLETED|Overall Study||1
17322|NCT02971202|37561|P2|NOT COMPLETED|Overall Study||0
17323|NCT02971202|37562|P1|NOT COMPLETED|Overall Study||2
17324|NCT02971202|37560|P3|COMPLETED|Overall Study||10
17325|NCT02971202|37561|P2|COMPLETED|Overall Study||10
17326|NCT02971202|37562|P1|COMPLETED|Overall Study||10
17327|NCT02971202|37560|P3|Started Study|Overall Study||10
17328|NCT02971202|37561|P2|Started Study|Overall Study||10
17329|NCT02971202|37562|P1|Started Study|Overall Study||11
17330|NCT02971202|37560|P3|STARTED|Overall Study||11
17331|NCT02971202|37561|P2|STARTED|Overall Study||10
17332|NCT02971202|37562|P1|STARTED|Overall Study||12
17333|NCT02971007|37579|P3|NOT COMPLETED|Overall Study||1
17334|NCT02971007|37580|P2|NOT COMPLETED|Overall Study||3
17335|NCT02971007|37581|P1|NOT COMPLETED|Overall Study||2
17336|NCT02971007|37579|P3|COMPLETED|Overall Study||45
17337|NCT02971007|37580|P2|COMPLETED|Overall Study||42
17338|NCT02971007|37581|P1|COMPLETED|Overall Study||44
17339|NCT02971007|37579|P3|STARTED|Overall Study||46
17340|NCT02971007|37580|P2|STARTED|Overall Study||45
17341|NCT02971007|37581|P1|STARTED|Overall Study||46
17342|NCT02970812|37600|P2|NOT COMPLETED|Overall Study||2
17343|NCT02970812|37601|P1|NOT COMPLETED|Overall Study||8
17344|NCT02970812|37600|P2|COMPLETED|Overall Study||28
17345|NCT02970812|37601|P1|COMPLETED|Overall Study||22
17346|NCT02970812|37600|P2|STARTED|Overall Study||30
17347|NCT02970812|37601|P1|STARTED|Overall Study||30
17348|NCT02970669|37609|P2|NOT COMPLETED|Open-label Period||2
17349|NCT02970669|37610|P1|NOT COMPLETED|Open-label Period||4
17350|NCT02970669|37609|P2|COMPLETED|Open-label Period||62
17351|NCT02970669|37610|P1|COMPLETED|Open-label Period||58
17352|NCT02970669|37609|P2|STARTED|Open-label Period||64
17353|NCT02970669|37610|P1|STARTED|Open-label Period||62
17354|NCT02970669|37609|P2|NOT COMPLETED|Double-blind Period||6
17355|NCT02970669|37610|P1|NOT COMPLETED|Double-blind Period||8
17356|NCT02970669|37609|P2|COMPLETED|Double-blind Period||64
17357|NCT02970669|37610|P1|COMPLETED|Double-blind Period||62
17358|NCT02970669|37609|P2|STARTED|Double-blind Period||70
17359|NCT02970669|37610|P1|STARTED|Double-blind Period||70
17360|NCT02970162|37630|P2|NOT COMPLETED|Overall Study||0
17361|NCT02970162|37631|P1|NOT COMPLETED|Overall Study||0
17362|NCT02970162|37630|P2|COMPLETED|Overall Study||13
17363|NCT02970162|37631|P1|COMPLETED|Overall Study||13
17364|NCT02970162|37630|P2|STARTED|Overall Study||13
17365|NCT02970162|37631|P1|STARTED|Overall Study||13
17366|NCT02970032|37643|P1|NOT COMPLETED|Real Time Heparin Dose Adjustment||0
17367|NCT02970032|37643|P1|COMPLETED|Real Time Heparin Dose Adjustment||20
17368|NCT02970032|37643|P1|STARTED|Real Time Heparin Dose Adjustment||20
17369|NCT02970032|37643|P1|NOT COMPLETED|Standard Heparin Dose||0
17370|NCT02970032|37643|P1|COMPLETED|Standard Heparin Dose||20
17371|NCT02970032|37643|P1|STARTED|Standard Heparin Dose||20
17372|NCT02969876|37649|P1|NOT COMPLETED|Overall Study||0
17373|NCT02969876|37649|P1|COMPLETED|Overall Study||2
17374|NCT02969876|37649|P1|STARTED|Overall Study||2
17375|NCT02969863|37655|P6|NOT COMPLETED|Overall Study||0
17376|NCT02969863|37656|P5|NOT COMPLETED|Overall Study||0
17377|NCT02969863|37657|P4|NOT COMPLETED|Overall Study||0
17378|NCT02969863|37658|P3|NOT COMPLETED|Overall Study||0
17379|NCT02969863|37659|P2|NOT COMPLETED|Overall Study||0
17380|NCT02969863|37660|P1|NOT COMPLETED|Overall Study||1
17381|NCT02969863|37655|P6|COMPLETED|Overall Study||4
17382|NCT02969863|37656|P5|COMPLETED|Overall Study||4
17383|NCT02969863|37657|P4|COMPLETED|Overall Study||4
17384|NCT02969863|37658|P3|COMPLETED|Overall Study||4
17385|NCT02969863|37659|P2|COMPLETED|Overall Study||4
17386|NCT02969863|37660|P1|COMPLETED|Overall Study||3
17387|NCT02969863|37655|P6|STARTED|Overall Study||4
17388|NCT02969863|37656|P5|STARTED|Overall Study||4
17389|NCT02969863|37657|P4|STARTED|Overall Study||4
17390|NCT02969863|37658|P3|STARTED|Overall Study||4
17391|NCT02969863|37659|P2|STARTED|Overall Study||4
17392|NCT02969863|37660|P1|STARTED|Overall Study||4
17393|NCT02969655|37676|P2|NOT COMPLETED|Overall Study||15
17394|NCT02969655|37677|P1|NOT COMPLETED|Overall Study||21
17395|NCT02969655|37676|P2|COMPLETED|Overall Study||120
17396|NCT02969655|37677|P1|COMPLETED|Overall Study||115
17397|NCT02969655|37676|P2|STARTED|Overall Study||135
17398|NCT02969655|37677|P1|STARTED|Overall Study||136
17399|NCT02969590|37712|P3|NOT COMPLETED|Treatment Period 2||0
17400|NCT02969590|37713|P2|NOT COMPLETED|Treatment Period 2||0
17401|NCT02969590|37714|P1|NOT COMPLETED|Treatment Period 2||0
17402|NCT02969590|37712|P3|COMPLETED|Treatment Period 2||2
17403|NCT02969590|37713|P2|COMPLETED|Treatment Period 2||2
17404|NCT02969590|37714|P1|COMPLETED|Treatment Period 2||0
17405|NCT02969590|37712|P3|STARTED|Treatment Period 2||2
17406|NCT02969590|37713|P2|STARTED|Treatment Period 2||2
17407|NCT02969590|37714|P1|STARTED|Treatment Period 2||0
17408|NCT02969590|37712|P3|NOT COMPLETED|Treatment Period 1||0
17409|NCT02969590|37713|P2|NOT COMPLETED|Treatment Period 1||0
17410|NCT02969590|37714|P1|NOT COMPLETED|Treatment Period 1||0
17411|NCT02969590|37712|P3|COMPLETED|Treatment Period 1||2
17412|NCT02969590|37713|P2|COMPLETED|Treatment Period 1||2
17413|NCT02969590|37714|P1|COMPLETED|Treatment Period 1||0
17414|NCT02969590|37712|P3|STARTED|Treatment Period 1||2
17415|NCT02969590|37713|P2|STARTED|Treatment Period 1||2
17416|NCT02969590|37714|P1|STARTED|Treatment Period 1||0
17417|NCT02969590|37712|P3|NOT COMPLETED|Screening Period||0
17418|NCT02969590|37713|P2|NOT COMPLETED|Screening Period||0
17419|NCT02969590|37714|P1|NOT COMPLETED|Screening Period||1
17420|NCT02969590|37712|P3|COMPLETED|Screening Period||0
17421|NCT02969590|37713|P2|COMPLETED|Screening Period||0
17422|NCT02969590|37714|P1|COMPLETED|Screening Period||4
17423|NCT02969590|37712|P3|STARTED|Screening Period||0
17424|NCT02969590|37713|P2|STARTED|Screening Period||0
17425|NCT02969590|37714|P1|STARTED|Screening Period||5
17426|NCT02969421|37734|P2|NOT COMPLETED|Overall Study||0
17427|NCT02969421|37735|P1|NOT COMPLETED|Overall Study||0
17428|NCT02969421|37734|P2|COMPLETED|Overall Study||33
17429|NCT02969421|37735|P1|COMPLETED|Overall Study||33
17430|NCT02969421|37734|P2|STARTED|Overall Study||33
17431|NCT02969421|37735|P1|STARTED|Overall Study||33
17432|NCT02969408|37745|P1|NOT COMPLETED|Overall Study||16
17433|NCT02969408|37745|P1|COMPLETED|Overall Study||381
17434|NCT02969408|37745|P1|Used ABS eMDPI at Least Once|Overall Study||370
17435|NCT02969408|37745|P1|STARTED|Overall Study||397
17436|NCT02969356|37753|P1|NOT COMPLETED|Overall Study||23
17437|NCT02969356|37753|P1|COMPLETED|Overall Study||134
17438|NCT02969356|37753|P1|Intent-to-Treat (ITT) Population|Overall Study||153
17439|NCT02969356|37753|P1|STARTED|Overall Study||157
17440|NCT02969317|37771|P1|NOT COMPLETED|Overall Study||0
17441|NCT02969317|37771|P1|COMPLETED|Overall Study||12
17442|NCT02969317|37771|P1|STARTED|Overall Study||12
17443|NCT02969044|37796|P2|NOT COMPLETED|Overall Study||6
17444|NCT02969044|37797|P1|NOT COMPLETED|Overall Study||5
17445|NCT02969044|37796|P2|COMPLETED|Overall Study||22
17446|NCT02969044|37797|P1|COMPLETED|Overall Study||37
17447|NCT02969044|37796|P2|STARTED|Overall Study||28
17448|NCT02969044|37797|P1|STARTED|Overall Study||42
17449|NCT02969018|37845|P8|NOT COMPLETED|Overall Study||7
17450|NCT02969018|37846|P7|NOT COMPLETED|Overall Study||8
17451|NCT02969018|37847|P6|NOT COMPLETED|Overall Study||8
17452|NCT02969018|37848|P5|NOT COMPLETED|Overall Study||2
17453|NCT02969018|37849|P4|NOT COMPLETED|Overall Study||5
17454|NCT02969018|37850|P3|NOT COMPLETED|Overall Study||6
17455|NCT02969018|37851|P2|NOT COMPLETED|Overall Study||8
17456|NCT02969018|37852|P1|NOT COMPLETED|Overall Study||4
17457|NCT02969018|37845|P8|COMPLETED|Overall Study||16
17458|NCT02969018|37846|P7|COMPLETED|Overall Study||22
17459|NCT02969018|37847|P6|COMPLETED|Overall Study||17
17460|NCT02969018|37848|P5|COMPLETED|Overall Study||27
17461|NCT02969018|37849|P4|COMPLETED|Overall Study||20
17462|NCT02969018|37850|P3|COMPLETED|Overall Study||20
17463|NCT02969018|37851|P2|COMPLETED|Overall Study||21
17464|NCT02969018|37852|P1|COMPLETED|Overall Study||21
17465|NCT02969018|37845|P8|STARTED|Overall Study||23
17466|NCT02969018|37846|P7|STARTED|Overall Study||30
17467|NCT02969018|37847|P6|STARTED|Overall Study||25
17468|NCT02969018|37848|P5|STARTED|Overall Study||29
17469|NCT02969018|37849|P4|STARTED|Overall Study||25
17470|NCT02969018|37850|P3|STARTED|Overall Study||26
17471|NCT02969018|37851|P2|STARTED|Overall Study||29
17472|NCT02969018|37852|P1|STARTED|Overall Study||25
17473|NCT02968979|37969|P1|NOT COMPLETED|Overall Study||8
17474|NCT02968979|37969|P1|COMPLETED|Overall Study|This cross-sectional study had only 1 visit.|531
17475|NCT02968979|37969|P1|STARTED|Overall Study||539
17476|NCT02968914|38057|P2|NOT COMPLETED|Overall Study||0
17477|NCT02968914|38058|P1|NOT COMPLETED|Overall Study||0
17478|NCT02968914|38057|P2|COMPLETED|Overall Study||90
17479|NCT02968914|38058|P1|COMPLETED|Overall Study||90
17480|NCT02968914|38057|P2|STARTED|Overall Study||90
17481|NCT02968914|38058|P1|STARTED|Overall Study||90
17482|NCT02968758|38082|P2|NOT COMPLETED|Overall Study||0
17483|NCT02968758|38083|P1|NOT COMPLETED|Overall Study||0
17484|NCT02968758|38082|P2|COMPLETED|Overall Study||1664
17485|NCT02968758|38083|P1|COMPLETED|Overall Study||797
17486|NCT02968758|38082|P2|STARTED|Overall Study||1664
17487|NCT02968758|38083|P1|STARTED|Overall Study||797
17488|NCT02968576|38094|P2|NOT COMPLETED|Overall Study||1
17489|NCT02968576|38095|P1|NOT COMPLETED|Overall Study||0
17490|NCT02968576|38094|P2|COMPLETED|Overall Study||13
17491|NCT02968576|38095|P1|COMPLETED|Overall Study||11
17492|NCT02968576|38094|P2|STARTED|Overall Study||14
17493|NCT02968576|38095|P1|STARTED|Overall Study||11
17494|NCT02968277|38103|P3|NOT COMPLETED|Overall Study||0
17495|NCT02968277|38104|P2|NOT COMPLETED|Overall Study||0
17496|NCT02968277|38105|P1|NOT COMPLETED|Overall Study||0
17497|NCT02968277|38103|P3|COMPLETED|Overall Study||13
17498|NCT02968277|38104|P2|COMPLETED|Overall Study||7
17499|NCT02968277|38105|P1|COMPLETED|Overall Study||10
17500|NCT02968277|38103|P3|STARTED|Overall Study||13
17501|NCT02968277|38104|P2|STARTED|Overall Study||7
17502|NCT02968277|38105|P1|STARTED|Overall Study||10
17503|NCT02968173|38131|P1|NOT COMPLETED|Overall Study||1
17504|NCT02968173|38131|P1|COMPLETED|Overall Study||49
17505|NCT02968173|38131|P1|STARTED|Overall Study||50
17506|NCT02968134|38143|P1|NOT COMPLETED|Overall Study||0
17507|NCT02968134|38143|P1|COMPLETED|Overall Study||8
17508|NCT02968134|38143|P1|STARTED|Overall Study||8
17509|NCT02967991|38148|P2|NOT COMPLETED|Overall Study||0
17510|NCT02967991|38149|P1|NOT COMPLETED|Overall Study||0
17511|NCT02967991|38148|P2|COMPLETED|Overall Study||10
17512|NCT02967991|38149|P1|COMPLETED|Overall Study||10
17513|NCT02967991|38148|P2|STARTED|Overall Study|First Intervention: 10 minutes Washout: 1 minute Second Intervention: 10 minutes|10
17514|NCT02967991|38149|P1|STARTED|Overall Study|First Intervention: 10 minutes Washout: 1 minute Second Intervention: 10 minutes|10
17515|NCT02967510|38172|P4|NOT COMPLETED|Overall Study||8
17516|NCT02967510|38173|P3|NOT COMPLETED|Overall Study||7
17517|NCT02967510|38174|P2|NOT COMPLETED|Overall Study||3
17518|NCT02967510|38175|P1|NOT COMPLETED|Overall Study||4
17519|NCT02967510|38172|P4|COMPLETED|Overall Study||63
17520|NCT02967510|38173|P3|COMPLETED|Overall Study||65
17521|NCT02967510|38174|P2|COMPLETED|Overall Study||67
17522|NCT02967510|38175|P1|COMPLETED|Overall Study||66
17523|NCT02967510|38172|P4|STARTED|Overall Study||71
17524|NCT02967510|38173|P3|STARTED|Overall Study||72
17525|NCT02967510|38174|P2|STARTED|Overall Study||70
17526|NCT02967510|38175|P1|STARTED|Overall Study||70
17527|NCT02967458|38301|P1|NOT COMPLETED|Overall Study||0
17528|NCT02967458|38301|P1|COMPLETED|Overall Study||55
17529|NCT02967458|38301|P1|STARTED|Overall Study||55
17530|NCT02967393|38309|P2|NOT COMPLETED|Overall Study||0
17531|NCT02967393|38310|P1|NOT COMPLETED|Overall Study||0
17532|NCT02967393|38309|P2|COMPLETED|Overall Study||20
17533|NCT02967393|38310|P1|COMPLETED|Overall Study||20
17534|NCT02967393|38309|P2|STARTED|Overall Study||20
17535|NCT02967393|38310|P1|STARTED|Overall Study||20
17536|NCT02967354|38340|P5|NOT COMPLETED|Overall Study||0
17537|NCT02967354|38341|P4|NOT COMPLETED|Overall Study||0
17538|NCT02967354|38342|P3|NOT COMPLETED|Overall Study||0
17539|NCT02967354|38343|P2|NOT COMPLETED|Overall Study||0
17540|NCT02967354|38344|P1|NOT COMPLETED|Overall Study||0
17541|NCT02967354|38340|P5|COMPLETED|Overall Study||8
17542|NCT02967354|38341|P4|COMPLETED|Overall Study||7
17543|NCT02967354|38342|P3|COMPLETED|Overall Study||9
17544|NCT02967354|38343|P2|COMPLETED|Overall Study||7
17545|NCT02967354|38344|P1|COMPLETED|Overall Study||8
17546|NCT02967354|38340|P5|STARTED|Overall Study||8
17547|NCT02967354|38341|P4|STARTED|Overall Study||7
17548|NCT02967354|38342|P3|STARTED|Overall Study||9
17549|NCT02967354|38343|P2|STARTED|Overall Study||7
17550|NCT02967354|38344|P1|STARTED|Overall Study||8
17551|NCT02966795|38378|P2|NOT COMPLETED|Overall Study||1
17552|NCT02966795|38379|P1|NOT COMPLETED|Overall Study||0
17553|NCT02966795|38378|P2|COMPLETED|Overall Study||60
17554|NCT02966795|38379|P1|COMPLETED|Overall Study||23
17555|NCT02966795|38378|P2|STARTED|Overall Study||61
17556|NCT02966795|38379|P1|STARTED|Overall Study||23
17557|NCT02966509|38390|P2|NOT COMPLETED|End of Life Utilization and Cost 15month||48
17558|NCT02966509|38391|P1|NOT COMPLETED|End of Life Utilization and Cost 15month||45
17559|NCT02966509|38390|P2|COMPLETED|End of Life Utilization and Cost 15month||60
17560|NCT02966509|38391|P1|COMPLETED|End of Life Utilization and Cost 15month||60
17561|NCT02966509|38390|P2|STARTED|End of Life Utilization and Cost 15month||108
17562|NCT02966509|38391|P1|STARTED|End of Life Utilization and Cost 15month||105
17563|NCT02966509|38390|P2|NOT COMPLETED|End of Life Utilization and Cost 6 Month||75
17564|NCT02966509|38391|P1|NOT COMPLETED|End of Life Utilization and Cost 6 Month||69
17651|NCT02965820|38500|P2|STARTED|Period 2, Second 30 Days||62
17565|NCT02966509|38390|P2|COMPLETED|End of Life Utilization and Cost 6 Month||33
17566|NCT02966509|38391|P1|COMPLETED|End of Life Utilization and Cost 6 Month||36
17567|NCT02966509|38390|P2|STARTED|End of Life Utilization and Cost 6 Month||108
17568|NCT02966509|38391|P1|STARTED|End of Life Utilization and Cost 6 Month||105
17569|NCT02966509|38390|P2|NOT COMPLETED|15-Month Utilization and Cost||0
17570|NCT02966509|38391|P1|NOT COMPLETED|15-Month Utilization and Cost||0
17571|NCT02966509|38390|P2|COMPLETED|15-Month Utilization and Cost||108
17572|NCT02966509|38391|P1|COMPLETED|15-Month Utilization and Cost||105
17573|NCT02966509|38390|P2|STARTED|15-Month Utilization and Cost||108
17574|NCT02966509|38391|P1|STARTED|15-Month Utilization and Cost||105
17575|NCT02966509|38390|P2|NOT COMPLETED|6-Month Utilization and Cost||0
17576|NCT02966509|38391|P1|NOT COMPLETED|6-Month Utilization and Cost||0
17577|NCT02966509|38390|P2|COMPLETED|6-Month Utilization and Cost||108
17578|NCT02966509|38391|P1|COMPLETED|6-Month Utilization and Cost||105
17579|NCT02966509|38390|P2|STARTED|6-Month Utilization and Cost||108
17580|NCT02966509|38391|P1|STARTED|6-Month Utilization and Cost||105
17581|NCT02966509|38390|P2|NOT COMPLETED|6 Month Satisfaction Survey||48
17582|NCT02966509|38391|P1|NOT COMPLETED|6 Month Satisfaction Survey||47
17583|NCT02966509|38390|P2|COMPLETED|6 Month Satisfaction Survey||60
17584|NCT02966509|38391|P1|COMPLETED|6 Month Satisfaction Survey||58
17585|NCT02966509|38390|P2|STARTED|6 Month Satisfaction Survey||108
17586|NCT02966509|38391|P1|STARTED|6 Month Satisfaction Survey||105
17587|NCT02966509|38390|P2|NOT COMPLETED|6 Month Satisfaction Decision Survey||31
17588|NCT02966509|38391|P1|NOT COMPLETED|6 Month Satisfaction Decision Survey||25
17589|NCT02966509|38390|P2|COMPLETED|6 Month Satisfaction Decision Survey||77
17590|NCT02966509|38391|P1|COMPLETED|6 Month Satisfaction Decision Survey||80
17591|NCT02966509|38390|P2|STARTED|6 Month Satisfaction Decision Survey||108
17592|NCT02966509|38391|P1|STARTED|6 Month Satisfaction Decision Survey||105
17593|NCT02966509|38390|P2|NOT COMPLETED|Baseline Satisfaction Survey||7
17594|NCT02966509|38391|P1|NOT COMPLETED|Baseline Satisfaction Survey||4
17595|NCT02966509|38390|P2|COMPLETED|Baseline Satisfaction Survey||101
17596|NCT02966509|38391|P1|COMPLETED|Baseline Satisfaction Survey||101
17597|NCT02966509|38390|P2|STARTED|Baseline Satisfaction Survey||108
17598|NCT02966509|38391|P1|STARTED|Baseline Satisfaction Survey||105
17599|NCT02966340|38415|P2|NOT COMPLETED|Overall Study||3
17600|NCT02966340|38416|P1|NOT COMPLETED|Overall Study||3
17601|NCT02966340|38415|P2|COMPLETED|Overall Study||30
17602|NCT02966340|38416|P1|COMPLETED|Overall Study||34
17603|NCT02966340|38415|P2|STARTED|Overall Study||33
17604|NCT02966340|38416|P1|STARTED|Overall Study||37
17605|NCT02966275|38424|P1|NOT COMPLETED|Overall Study||0
17606|NCT02966275|38424|P1|COMPLETED|Overall Study||10
17607|NCT02966275|38424|P1|STARTED|Overall Study||10
17608|NCT02966015|38461|P2|NOT COMPLETED|Test Period||0
17609|NCT02966015|38462|P1|NOT COMPLETED|Test Period||0
17610|NCT02966015|38461|P2|COMPLETED|Test Period||55
17611|NCT02966015|38462|P1|COMPLETED|Test Period||87
17612|NCT02966015|38461|P2|STARTED|Test Period||55
17613|NCT02966015|38462|P1|STARTED|Test Period||87
17614|NCT02966015|38461|P2|NOT COMPLETED|Inclusion Visit||3
17615|NCT02966015|38462|P1|NOT COMPLETED|Inclusion Visit||8
17616|NCT02966015|38461|P2|COMPLETED|Inclusion Visit||55
17617|NCT02966015|38462|P1|COMPLETED|Inclusion Visit||87
17618|NCT02966015|38461|P2|STARTED|Inclusion Visit||58
17619|NCT02966015|38462|P1|STARTED|Inclusion Visit||95
17620|NCT02966002|38468|P1|NOT COMPLETED|Overall Study||4
17621|NCT02966002|38468|P1|COMPLETED|Overall Study||5
17622|NCT02966002|38468|P1|STARTED|Overall Study||9
17623|NCT02965924|38475|P1|NOT COMPLETED|Overall Study||0
17624|NCT02965924|38475|P1|COMPLETED|Overall Study||20
17625|NCT02965924|38475|P1|STARTED|Overall Study||20
17626|NCT02965846|38483|P3|NOT COMPLETED|Overall Study||33
17627|NCT02965846|38484|P2|NOT COMPLETED|Overall Study||5
17628|NCT02965846|38485|P1|NOT COMPLETED|Overall Study||5
17629|NCT02965846|38483|P3|COMPLETED|Overall Study||0
17630|NCT02965846|38484|P2|COMPLETED|Overall Study||0
17631|NCT02965846|38485|P1|COMPLETED|Overall Study||0
17632|NCT02965846|38483|P3|STARTED|Overall Study||33
17633|NCT02965846|38484|P2|STARTED|Overall Study||5
17634|NCT02965846|38485|P1|STARTED|Overall Study||5
17635|NCT02965833|38493|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
17636|NCT02965833|38494|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
17637|NCT02965833|38493|P2|COMPLETED|Period 2, Second 30 Days of Wear||52
17638|NCT02965833|38494|P1|COMPLETED|Period 2, Second 30 Days of Wear||62
17639|NCT02965833|38493|P2|STARTED|Period 2, Second 30 Days of Wear||52
17640|NCT02965833|38494|P1|STARTED|Period 2, Second 30 Days of Wear||64
17641|NCT02965833|38493|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||2
17642|NCT02965833|38494|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||3
17643|NCT02965833|38493|P2|COMPLETED|Period 1, First 30 Days of Wear||52
17644|NCT02965833|38494|P1|COMPLETED|Period 1, First 30 Days of Wear||64
17645|NCT02965833|38493|P2|STARTED|Period 1, First 30 Days of Wear||54
17646|NCT02965833|38494|P1|STARTED|Period 1, First 30 Days of Wear||67
17647|NCT02965820|38500|P2|NOT COMPLETED|Period 2, Second 30 Days||1
17648|NCT02965820|38501|P1|NOT COMPLETED|Period 2, Second 30 Days||1
17649|NCT02965820|38500|P2|COMPLETED|Period 2, Second 30 Days||61
17650|NCT02965820|38501|P1|COMPLETED|Period 2, Second 30 Days||57
17652|NCT02965820|38501|P1|STARTED|Period 2, Second 30 Days|One subject discontinued due to an AE after completion of Period 1 but before beginning Period 2.|58
17653|NCT02965820|38500|P2|NOT COMPLETED|Period 1, First 30 Days||0
17654|NCT02965820|38501|P1|NOT COMPLETED|Period 1, First 30 Days||0
17655|NCT02965820|38500|P2|COMPLETED|Period 1, First 30 Days||62
17656|NCT02965820|38501|P1|COMPLETED|Period 1, First 30 Days||59
17657|NCT02965820|38500|P2|STARTED|Period 1, First 30 Days||62
17658|NCT02965820|38501|P1|STARTED|Period 1, First 30 Days||59
17659|NCT02965729|38510|P3|NOT COMPLETED|Overall Study||11
17660|NCT02965729|38511|P2|NOT COMPLETED|Overall Study||3
17661|NCT02965729|38512|P1|NOT COMPLETED|Overall Study||7
17662|NCT02965729|38510|P3|COMPLETED|Overall Study||45
17663|NCT02965729|38511|P2|COMPLETED|Overall Study||22
17664|NCT02965729|38512|P1|COMPLETED|Overall Study||17
17665|NCT02965729|38510|P3|STARTED|Overall Study||56
17666|NCT02965729|38511|P2|STARTED|Overall Study||25
17667|NCT02965729|38512|P1|STARTED|Overall Study||24
17668|NCT02965599|38540|P2|NOT COMPLETED|Overall Study||0
17669|NCT02965599|38541|P1|NOT COMPLETED|Overall Study||1
17670|NCT02965599|38540|P2|COMPLETED|Overall Study||1
17671|NCT02965599|38541|P1|COMPLETED|Overall Study||1
17672|NCT02965599|38540|P2|STARTED|Overall Study||1
17673|NCT02965599|38541|P1|STARTED|Overall Study||2
17674|NCT02965534|38603|P2|NOT COMPLETED|Overall Study||0
17675|NCT02965534|38604|P1|NOT COMPLETED|Overall Study||0
17676|NCT02965534|38603|P2|COMPLETED|Overall Study||55
17677|NCT02965534|38604|P1|COMPLETED|Overall Study||45
17678|NCT02965534|38603|P2|STARTED|Overall Study|test period: 14 days with each test glasses|55
17679|NCT02965534|38604|P1|STARTED|Overall Study|test period: 14 days with each test glasses|45
17680|NCT02964910|38620|P2|NOT COMPLETED|Overall Study||44
17681|NCT02964910|38621|P1|NOT COMPLETED|Overall Study||43
17682|NCT02964910|38620|P2|COMPLETED|Overall Study||196
17683|NCT02964910|38621|P1|COMPLETED|Overall Study||192
17684|NCT02964910|38620|P2|STARTED|Overall Study||240
17685|NCT02964910|38621|P1|STARTED|Overall Study||235
17686|NCT02964767|38647|P2|NOT COMPLETED|Overall Study||0
17687|NCT02964767|38648|P1|NOT COMPLETED|Overall Study||0
17688|NCT02964767|38647|P2|COMPLETED|Overall Study||48
17689|NCT02964767|38648|P1|COMPLETED|Overall Study||171
17690|NCT02964767|38647|P2|STARTED|Overall Study||48
17691|NCT02964767|38648|P1|STARTED|Overall Study||171
17692|NCT02964338|38658|P3|NOT COMPLETED|Overall Study||19
17693|NCT02964338|38659|P2|NOT COMPLETED|Overall Study||24
17694|NCT02964338|38660|P1|NOT COMPLETED|Overall Study||17
17695|NCT02964338|38658|P3|COMPLETED|Overall Study||68
17696|NCT02964338|38659|P2|COMPLETED|Overall Study||64
17697|NCT02964338|38660|P1|COMPLETED|Overall Study||67
17698|NCT02964338|38658|P3|Full Analysis Set|Overall Study||87
17699|NCT02964338|38659|P2|Full Analysis Set|Overall Study||86
17700|NCT02964338|38660|P1|Full Analysis Set|Overall Study||81
17701|NCT02964338|38658|P3|Safety Analysis Set|Overall Study||87
17702|NCT02964338|38659|P2|Safety Analysis Set|Overall Study||88
17703|NCT02964338|38660|P1|Safety Analysis Set|Overall Study||83
17704|NCT02964338|38658|P3|STARTED|Overall Study||87
17705|NCT02964338|38659|P2|STARTED|Overall Study||88
17706|NCT02964338|38660|P1|STARTED|Overall Study||84
17707|NCT02964312|38704|P1|NOT COMPLETED|Overall Study||27
17708|NCT02964312|38704|P1|COMPLETED|Overall Study||139
17709|NCT02964312|38704|P1|12-Month Follow-up|Overall Study||139
17710|NCT02964312|38704|P1|6-Month Follow-up|Overall Study||152
17711|NCT02964312|38704|P1|3-Month Follow-up|Overall Study||159
17712|NCT02964312|38704|P1|1-Month Follow-up|Overall Study||164
17713|NCT02964312|38704|P1|STARTED|Overall Study||166
17714|NCT02964247|38712|P2|NOT COMPLETED|Overall Study||2
17715|NCT02964247|38713|P1|NOT COMPLETED|Overall Study||3
17716|NCT02964247|38712|P2|COMPLETED|Overall Study||98
17717|NCT02964247|38713|P1|COMPLETED|Overall Study||200
17718|NCT02964247|38712|P2|Exposed to Trial Product|Overall Study||100
17719|NCT02964247|38713|P1|Exposed to Trial Product|Overall Study||202
17720|NCT02964247|38712|P2|STARTED|Overall Study||100
17721|NCT02964247|38713|P1|STARTED|Overall Study||203
17722|NCT02963987|38769|P2|NOT COMPLETED|Second Intervention Period||0
17723|NCT02963987|38770|P1|NOT COMPLETED|Second Intervention Period||0
17724|NCT02963987|38769|P2|COMPLETED|Second Intervention Period||19
17725|NCT02963987|38770|P1|COMPLETED|Second Intervention Period||31
17726|NCT02963987|38769|P2|STARTED|Second Intervention Period||19
17727|NCT02963987|38770|P1|STARTED|Second Intervention Period||31
17728|NCT02963987|38769|P2|NOT COMPLETED|First Intervention Period||0
17729|NCT02963987|38770|P1|NOT COMPLETED|First Intervention Period||0
17730|NCT02963987|38769|P2|COMPLETED|First Intervention Period||19
17731|NCT02963987|38770|P1|COMPLETED|First Intervention Period||31
17732|NCT02963987|38769|P2|STARTED|First Intervention Period||19
17733|NCT02963987|38770|P1|STARTED|First Intervention Period||31
17734|NCT02963935|38782|P2|NOT COMPLETED|Overall Study||37
17735|NCT02963935|38783|P1|NOT COMPLETED|Overall Study||28
17736|NCT02963935|38782|P2|COMPLETED|Overall Study||103
17737|NCT02963935|38783|P1|COMPLETED|Overall Study||114
17738|NCT02963935|38782|P2|STARTED|Overall Study||140
17739|NCT02963935|38783|P1|STARTED|Overall Study||142
17740|NCT02963922|38891|P2|NOT COMPLETED|Overall Study||30
17741|NCT02963922|38892|P1|NOT COMPLETED|Overall Study||32
17742|NCT02963922|38891|P2|COMPLETED|Overall Study||168
17743|NCT02963922|38892|P1|COMPLETED|Overall Study||166
17744|NCT02963922|38891|P2|STARTED|Overall Study||198
17745|NCT02963922|38892|P1|STARTED|Overall Study||198
17746|NCT02963701|38990|P2|NOT COMPLETED|Period 2 (2 Days)||0
17747|NCT02963701|38991|P1|NOT COMPLETED|Period 2 (2 Days)||0
17748|NCT02963701|38990|P2|COMPLETED|Period 2 (2 Days)||28
17749|NCT02963701|38991|P1|COMPLETED|Period 2 (2 Days)||27
17750|NCT02963701|38990|P2|STARTED|Period 2 (2 Days)||28
17751|NCT02963701|38991|P1|STARTED|Period 2 (2 Days)||27
17752|NCT02963701|38990|P2|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||0
17753|NCT02963701|38991|P1|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||1
17754|NCT02963701|38990|P2|COMPLETED|Period 1 (Including Washout) (2 Days)||28
17755|NCT02963701|38991|P1|COMPLETED|Period 1 (Including Washout) (2 Days)|One subject withdrawn from the study after period 1|27
17756|NCT02963701|38990|P2|STARTED|Period 1 (Including Washout) (2 Days)||28
17757|NCT02963701|38991|P1|STARTED|Period 1 (Including Washout) (2 Days)||28
17758|NCT02962934|39023|P2|NOT COMPLETED|Overall Study||0
17759|NCT02962934|39024|P1|NOT COMPLETED|Overall Study||0
17760|NCT02962934|39023|P2|COMPLETED|Overall Study||6
17761|NCT02962934|39024|P1|COMPLETED|Overall Study||12
17762|NCT02962934|39023|P2|STARTED|Overall Study||6
17763|NCT02962934|39024|P1|STARTED|Overall Study||12
17764|NCT02962908|39034|P4|NOT COMPLETED|Overall Study||3
17765|NCT02962908|39035|P3|NOT COMPLETED|Overall Study||0
17766|NCT02962908|39036|P2|NOT COMPLETED|Overall Study||8
17767|NCT02962908|39037|P1|NOT COMPLETED|Overall Study||0
17768|NCT02962908|39034|P4|COMPLETED|Overall Study||24
17769|NCT02962908|39035|P3|COMPLETED|Overall Study||32
17770|NCT02962908|39036|P2|COMPLETED|Overall Study||50
17771|NCT02962908|39037|P1|COMPLETED|Overall Study||58
17772|NCT02962908|39034|P4|STARTED|Overall Study||27
17773|NCT02962908|39035|P3|STARTED|Overall Study||32
17774|NCT02962908|39036|P2|STARTED|Overall Study||58
17775|NCT02962908|39037|P1|STARTED|Overall Study||58
17776|NCT02962882|39079|P1|NOT COMPLETED|Overall Study||36
17777|NCT02962882|39079|P1|COMPLETED|Overall Study||14
17778|NCT02962882|39079|P1|STARTED|Overall Study||50
17779|NCT02962687|39090|P2|NOT COMPLETED|Overall Study||8
17780|NCT02962687|39091|P1|NOT COMPLETED|Overall Study||10
17781|NCT02962687|39090|P2|COMPLETED|Overall Study|This number represents 16 dyads (1 Veteran and 1 caregiver in each dyad)|32
17782|NCT02962687|39091|P1|COMPLETED|Overall Study|This number represents 15 dyads (1 Veteran and 1 caregiver in each dyad)|30
17783|NCT02962687|39090|P2|STARTED|Overall Study|This number represents 20 dyads (1 Veteran and 1 caregiver in each dyad)|40
17784|NCT02962687|39091|P1|STARTED|Overall Study|This number represents 20 dyads (1 Veteran and 1 caregiver in each dyad)|40
17785|NCT02962609|39117|P2|NOT COMPLETED|Overall Study||0
17786|NCT02962609|39118|P1|NOT COMPLETED|Overall Study||0
17787|NCT02962609|39117|P2|COMPLETED|Overall Study||42
17788|NCT02962609|39118|P1|COMPLETED|Overall Study||38
17789|NCT02962609|39117|P2|STARTED|Overall Study||42
17790|NCT02962609|39118|P1|STARTED|Overall Study||38
17791|NCT02962284|39130|P2|NOT COMPLETED|Overall Study||3
17792|NCT02962284|39131|P1|NOT COMPLETED|Overall Study||5
17793|NCT02962284|39130|P2|COMPLETED|Overall Study||8
17794|NCT02962284|39131|P1|COMPLETED|Overall Study||4
17795|NCT02962284|39130|P2|STARTED|Overall Study||11
17796|NCT02962284|39131|P1|STARTED|Overall Study||9
17797|NCT02961946|39150|P3|NOT COMPLETED|Overall Study||0
17798|NCT02961946|39151|P2|NOT COMPLETED|Overall Study||0
17799|NCT02961946|39152|P1|NOT COMPLETED|Overall Study||0
17800|NCT02961946|39150|P3|COMPLETED|Overall Study||66
17801|NCT02961946|39151|P2|COMPLETED|Overall Study||66
17802|NCT02961946|39152|P1|COMPLETED|Overall Study||66
17803|NCT02961946|39150|P3|STARTED|Overall Study||66
17804|NCT02961946|39151|P2|STARTED|Overall Study||66
17805|NCT02961946|39152|P1|STARTED|Overall Study||66
17806|NCT02961920|39162|P2|NOT COMPLETED|Overall Study||1
17807|NCT02961920|39163|P1|NOT COMPLETED|Overall Study||1
17808|NCT02961920|39162|P2|COMPLETED|Overall Study||24
17809|NCT02961920|39163|P1|COMPLETED|Overall Study||24
17810|NCT02961920|39162|P2|STARTED|Overall Study||25
17811|NCT02961920|39163|P1|STARTED|Overall Study||25
17812|NCT02961790|39173|P4|NOT COMPLETED|Overall Study||5
17813|NCT02961790|39174|P3|NOT COMPLETED|Overall Study||6
17814|NCT02961790|39175|P2|NOT COMPLETED|Overall Study||11
17815|NCT02961790|39176|P1|NOT COMPLETED|Overall Study||15
17816|NCT02961790|39173|P4|COMPLETED|Overall Study||20
17817|NCT02961790|39174|P3|COMPLETED|Overall Study||18
17818|NCT02961790|39175|P2|COMPLETED|Overall Study||40
17819|NCT02961790|39176|P1|COMPLETED|Overall Study||35
17820|NCT02961790|39173|P4|STARTED|Overall Study||25
17821|NCT02961790|39174|P3|STARTED|Overall Study||24
17822|NCT02961790|39175|P2|STARTED|Overall Study||51
17823|NCT02961790|39176|P1|STARTED|Overall Study||50
17824|NCT02961244|39199|P2|NOT COMPLETED|Overall Study||9
17825|NCT02961244|39200|P1|NOT COMPLETED|Overall Study||1
17826|NCT02961244|39199|P2|COMPLETED|Overall Study||55
17827|NCT02961244|39200|P1|COMPLETED|Overall Study||63
17828|NCT02961244|39199|P2|Patients Excluded During Randomization|Overall Study||1
17829|NCT02961244|39200|P1|Patients Excluded During Randomization|Overall Study||0
17830|NCT02961244|39199|P2|STARTED|Overall Study||64
17831|NCT02961244|39200|P1|STARTED|Overall Study||64
17832|NCT02961062|39210|P2|NOT COMPLETED|Overall Study||0
17833|NCT02961062|39211|P1|NOT COMPLETED|Overall Study||0
17834|NCT02961062|39210|P2|COMPLETED|Overall Study||20
17835|NCT02961062|39211|P1|COMPLETED|Overall Study||20
17836|NCT02961062|39210|P2|STARTED|Overall Study||20
17837|NCT02961062|39211|P1|STARTED|Overall Study||20
17838|NCT02960854|39227|P2|NOT COMPLETED|Overall Study||9
17839|NCT02960854|39228|P1|NOT COMPLETED|Overall Study||7
17840|NCT02960854|39227|P2|COMPLETED|Overall Study||7
17841|NCT02960854|39228|P1|COMPLETED|Overall Study||8
17842|NCT02960854|39227|P2|STARTED|Overall Study||16
17843|NCT02960854|39228|P1|STARTED|Overall Study||15
17844|NCT02960295|39258|P1|NOT COMPLETED|Overall Study||0
17845|NCT02960295|39258|P1|COMPLETED|Overall Study||10
17846|NCT02960295|39258|P1|STARTED|Overall Study||10
17847|NCT02959996|39267|P2|NOT COMPLETED|Overall Study||0
17848|NCT02959996|39268|P1|NOT COMPLETED|Overall Study||0
17849|NCT02959996|39267|P2|COMPLETED|Overall Study||39
17850|NCT02959996|39268|P1|COMPLETED|Overall Study||40
17851|NCT02959996|39267|P2|STARTED|Overall Study||39
17852|NCT02959996|39268|P1|STARTED|Overall Study||40
17853|NCT02959983|39292|P2|NOT COMPLETED|Overall Study||25
17854|NCT02959983|39293|P1|NOT COMPLETED|Overall Study||26
17855|NCT02959983|39292|P2|COMPLETED|Overall Study||149
17856|NCT02959983|39293|P1|COMPLETED|Overall Study||146
17857|NCT02959983|39292|P2|STARTED|Overall Study||174
17858|NCT02959983|39293|P1|STARTED|Overall Study||172
17859|NCT02959866|39305|P1|NOT COMPLETED|Overall Study||1
17860|NCT02959866|39305|P1|COMPLETED|Overall Study||58
17861|NCT02959866|39305|P1|Telephone Interview at 1 Month Follow-up|Overall Study||59
17862|NCT02959866|39305|P1|STARTED|Overall Study||59
17863|NCT02959840|39313|P3|NOT COMPLETED|Overall Study||0
17864|NCT02959840|39314|P2|NOT COMPLETED|Overall Study||0
17865|NCT02959840|39315|P1|NOT COMPLETED|Overall Study||0
17866|NCT02959840|39313|P3|COMPLETED|Overall Study||60
17867|NCT02959840|39314|P2|COMPLETED|Overall Study||60
17868|NCT02959840|39315|P1|COMPLETED|Overall Study||60
17869|NCT02959840|39313|P3|STARTED|Overall Study||60
17870|NCT02959840|39314|P2|STARTED|Overall Study||60
17871|NCT02959840|39315|P1|STARTED|Overall Study||60
17872|NCT02959827|39356|P1|NOT COMPLETED|Overall Study||0
17873|NCT02959827|39356|P1|COMPLETED|Overall Study||2320
17874|NCT02959827|39356|P1|STARTED|Overall Study||2320
17875|NCT02959138|39378|P3|NOT COMPLETED|Overall Study||0
17876|NCT02959138|39379|P2|NOT COMPLETED|Overall Study||1
17877|NCT02959138|39380|P1|NOT COMPLETED|Overall Study||0
17878|NCT02959138|39378|P3|COMPLETED|Overall Study||16
17879|NCT02959138|39379|P2|COMPLETED|Overall Study||9
17880|NCT02959138|39380|P1|COMPLETED|Overall Study||10
17881|NCT02959138|39378|P3|STARTED|Overall Study||16
17882|NCT02959138|39379|P2|STARTED|Overall Study||10
17883|NCT02959138|39380|P1|STARTED|Overall Study||10
17884|NCT02958995|39405|P2|NOT COMPLETED|Overall Study||0
17885|NCT02958995|39406|P1|NOT COMPLETED|Overall Study||0
17886|NCT02958995|39405|P2|COMPLETED|Overall Study||107495
17887|NCT02958995|39406|P1|COMPLETED|Overall Study||2630666
17888|NCT02958995|39405|P2|STARTED|Overall Study||107495
17889|NCT02958995|39406|P1|STARTED|Overall Study||2630666
17890|NCT02958982|39425|P11|NOT COMPLETED|Proof of Concept Study||0
17891|NCT02958982|39426|P10|NOT COMPLETED|Proof of Concept Study||0
17892|NCT02958982|39427|P9|NOT COMPLETED|Proof of Concept Study||0
17893|NCT02958982|39428|P8|NOT COMPLETED|Proof of Concept Study||0
17894|NCT02958982|39429|P7|NOT COMPLETED|Proof of Concept Study||0
17895|NCT02958982|39430|P6|NOT COMPLETED|Proof of Concept Study||0
17896|NCT02958982|39431|P5|NOT COMPLETED|Proof of Concept Study||0
17897|NCT02958982|39432|P4|NOT COMPLETED|Proof of Concept Study||0
17898|NCT02958982|39433|P3|NOT COMPLETED|Proof of Concept Study||0
17899|NCT02958982|39434|P2|NOT COMPLETED|Proof of Concept Study||0
17900|NCT02958982|39435|P1|NOT COMPLETED|Proof of Concept Study||0
17901|NCT02958982|39425|P11|COMPLETED|Proof of Concept Study||1
17902|NCT02958982|39426|P10|COMPLETED|Proof of Concept Study||0
17903|NCT02958982|39427|P9|COMPLETED|Proof of Concept Study||0
17904|NCT02958982|39428|P8|COMPLETED|Proof of Concept Study||0
17905|NCT02958982|39429|P7|COMPLETED|Proof of Concept Study||0
17906|NCT02958982|39430|P6|COMPLETED|Proof of Concept Study||0
17907|NCT02958982|39431|P5|COMPLETED|Proof of Concept Study||0
17908|NCT02958982|39432|P4|COMPLETED|Proof of Concept Study||0
17909|NCT02958982|39433|P3|COMPLETED|Proof of Concept Study||0
17910|NCT02958982|39434|P2|COMPLETED|Proof of Concept Study||0
17911|NCT02958982|39435|P1|COMPLETED|Proof of Concept Study||0
17912|NCT02958982|39425|P11|STARTED|Proof of Concept Study||1
17913|NCT02958982|39426|P10|STARTED|Proof of Concept Study||0
17914|NCT02958982|39427|P9|STARTED|Proof of Concept Study||0
17915|NCT02958982|39428|P8|STARTED|Proof of Concept Study||0
17916|NCT02958982|39429|P7|STARTED|Proof of Concept Study||0
17917|NCT02958982|39430|P6|STARTED|Proof of Concept Study||0
17918|NCT02958982|39431|P5|STARTED|Proof of Concept Study||0
17919|NCT02958982|39432|P4|STARTED|Proof of Concept Study||0
17920|NCT02958982|39433|P3|STARTED|Proof of Concept Study||0
17921|NCT02958982|39434|P2|STARTED|Proof of Concept Study||0
17922|NCT02958982|39435|P1|STARTED|Proof of Concept Study||0
17923|NCT02958982|39425|P11|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
17924|NCT02958982|39426|P10|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
17925|NCT02958982|39427|P9|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
17926|NCT02958982|39428|P8|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
17927|NCT02958982|39429|P7|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
17928|NCT02958982|39430|P6|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
17929|NCT02958982|39431|P5|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
17930|NCT02958982|39432|P4|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
17931|NCT02958982|39433|P3|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
17932|NCT02958982|39434|P2|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
17933|NCT02958982|39435|P1|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
17934|NCT02958982|39425|P11|COMPLETED|Cohort 3: 400 mg in MAD Study||0
17935|NCT02958982|39426|P10|COMPLETED|Cohort 3: 400 mg in MAD Study||6
17936|NCT02958982|39427|P9|COMPLETED|Cohort 3: 400 mg in MAD Study||0
17937|NCT02958982|39428|P8|COMPLETED|Cohort 3: 400 mg in MAD Study||0
17938|NCT02958982|39429|P7|COMPLETED|Cohort 3: 400 mg in MAD Study||2
17939|NCT02958982|39430|P6|COMPLETED|Cohort 3: 400 mg in MAD Study||0
17940|NCT02958982|39431|P5|COMPLETED|Cohort 3: 400 mg in MAD Study||0
17941|NCT02958982|39432|P4|COMPLETED|Cohort 3: 400 mg in MAD Study||0
17942|NCT02958982|39433|P3|COMPLETED|Cohort 3: 400 mg in MAD Study||0
17943|NCT02958982|39434|P2|COMPLETED|Cohort 3: 400 mg in MAD Study||0
17944|NCT02958982|39435|P1|COMPLETED|Cohort 3: 400 mg in MAD Study||0
17945|NCT02958982|39425|P11|STARTED|Cohort 3: 400 mg in MAD Study||0
17946|NCT02958982|39426|P10|STARTED|Cohort 3: 400 mg in MAD Study||6
17947|NCT02958982|39427|P9|STARTED|Cohort 3: 400 mg in MAD Study||0
17948|NCT02958982|39428|P8|STARTED|Cohort 3: 400 mg in MAD Study||0
17949|NCT02958982|39429|P7|STARTED|Cohort 3: 400 mg in MAD Study||2
17950|NCT02958982|39430|P6|STARTED|Cohort 3: 400 mg in MAD Study||0
17951|NCT02958982|39431|P5|STARTED|Cohort 3: 400 mg in MAD Study||0
17952|NCT02958982|39432|P4|STARTED|Cohort 3: 400 mg in MAD Study||0
17953|NCT02958982|39433|P3|STARTED|Cohort 3: 400 mg in MAD Study||0
17954|NCT02958982|39434|P2|STARTED|Cohort 3: 400 mg in MAD Study||0
17955|NCT02958982|39435|P1|STARTED|Cohort 3: 400 mg in MAD Study||0
17956|NCT02958982|39425|P11|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
17957|NCT02958982|39426|P10|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
17958|NCT02958982|39427|P9|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
17959|NCT02958982|39428|P8|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
17960|NCT02958982|39429|P7|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
17961|NCT02958982|39430|P6|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
17962|NCT02958982|39431|P5|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
17963|NCT02958982|39432|P4|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
17964|NCT02958982|39433|P3|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
17965|NCT02958982|39434|P2|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
17966|NCT02958982|39435|P1|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
17967|NCT02958982|39425|P11|COMPLETED|Cohort 2: 100 mg in MAD Study||0
17968|NCT02958982|39426|P10|COMPLETED|Cohort 2: 100 mg in MAD Study||0
17969|NCT02958982|39427|P9|COMPLETED|Cohort 2: 100 mg in MAD Study||6
17970|NCT02958982|39428|P8|COMPLETED|Cohort 2: 100 mg in MAD Study||0
17971|NCT02958982|39429|P7|COMPLETED|Cohort 2: 100 mg in MAD Study||2
17972|NCT02958982|39430|P6|COMPLETED|Cohort 2: 100 mg in MAD Study||0
17973|NCT02958982|39431|P5|COMPLETED|Cohort 2: 100 mg in MAD Study||0
17974|NCT02958982|39432|P4|COMPLETED|Cohort 2: 100 mg in MAD Study||0
17975|NCT02958982|39433|P3|COMPLETED|Cohort 2: 100 mg in MAD Study||0
17976|NCT02958982|39434|P2|COMPLETED|Cohort 2: 100 mg in MAD Study||0
17977|NCT02958982|39435|P1|COMPLETED|Cohort 2: 100 mg in MAD Study||0
17978|NCT02958982|39425|P11|STARTED|Cohort 2: 100 mg in MAD Study||0
17979|NCT02958982|39426|P10|STARTED|Cohort 2: 100 mg in MAD Study||0
17980|NCT02958982|39427|P9|STARTED|Cohort 2: 100 mg in MAD Study||6
17981|NCT02958982|39428|P8|STARTED|Cohort 2: 100 mg in MAD Study||0
17982|NCT02958982|39429|P7|STARTED|Cohort 2: 100 mg in MAD Study||2
17983|NCT02958982|39430|P6|STARTED|Cohort 2: 100 mg in MAD Study||0
17984|NCT02958982|39431|P5|STARTED|Cohort 2: 100 mg in MAD Study||0
17985|NCT02958982|39432|P4|STARTED|Cohort 2: 100 mg in MAD Study||0
17986|NCT02958982|39433|P3|STARTED|Cohort 2: 100 mg in MAD Study||0
17987|NCT02958982|39434|P2|STARTED|Cohort 2: 100 mg in MAD Study||0
17988|NCT02958982|39435|P1|STARTED|Cohort 2: 100 mg in MAD Study||0
17989|NCT02958982|39425|P11|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
17990|NCT02958982|39426|P10|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
17991|NCT02958982|39427|P9|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
17992|NCT02958982|39428|P8|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
17993|NCT02958982|39429|P7|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
17994|NCT02958982|39430|P6|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
17995|NCT02958982|39431|P5|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
17996|NCT02958982|39432|P4|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
17997|NCT02958982|39433|P3|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
17998|NCT02958982|39434|P2|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
17999|NCT02958982|39435|P1|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
18000|NCT02958982|39425|P11|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
18001|NCT02958982|39426|P10|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
18002|NCT02958982|39427|P9|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
18003|NCT02958982|39428|P8|COMPLETED|Cohort 1 : 25 mg in MAD Study||6
18004|NCT02958982|39429|P7|COMPLETED|Cohort 1 : 25 mg in MAD Study||2
18005|NCT02958982|39430|P6|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
18006|NCT02958982|39431|P5|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
18007|NCT02958982|39432|P4|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
18008|NCT02958982|39433|P3|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
18009|NCT02958982|39434|P2|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
18010|NCT02958982|39435|P1|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
18011|NCT02958982|39425|P11|STARTED|Cohort 1 : 25 mg in MAD Study||0
18012|NCT02958982|39426|P10|STARTED|Cohort 1 : 25 mg in MAD Study||0
18013|NCT02958982|39427|P9|STARTED|Cohort 1 : 25 mg in MAD Study||0
18014|NCT02958982|39428|P8|STARTED|Cohort 1 : 25 mg in MAD Study||6
18015|NCT02958982|39429|P7|STARTED|Cohort 1 : 25 mg in MAD Study||2
18016|NCT02958982|39430|P6|STARTED|Cohort 1 : 25 mg in MAD Study||0
18017|NCT02958982|39431|P5|STARTED|Cohort 1 : 25 mg in MAD Study||0
18018|NCT02958982|39432|P4|STARTED|Cohort 1 : 25 mg in MAD Study||0
18019|NCT02958982|39433|P3|STARTED|Cohort 1 : 25 mg in MAD Study||0
18020|NCT02958982|39434|P2|STARTED|Cohort 1 : 25 mg in MAD Study||0
18021|NCT02958982|39435|P1|STARTED|Cohort 1 : 25 mg in MAD Study||0
18022|NCT02958982|39425|P11|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
18023|NCT02958982|39426|P10|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
18024|NCT02958982|39427|P9|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
18025|NCT02958982|39428|P8|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
18026|NCT02958982|39429|P7|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
18027|NCT02958982|39430|P6|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
18028|NCT02958982|39431|P5|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
18029|NCT02958982|39432|P4|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
18030|NCT02958982|39433|P3|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
18031|NCT02958982|39434|P2|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
18032|NCT02958982|39435|P1|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
18033|NCT02958982|39425|P11|COMPLETED|Cohort 5: 400 mg in SAD Study||0
18034|NCT02958982|39426|P10|COMPLETED|Cohort 5: 400 mg in SAD Study||0
18035|NCT02958982|39427|P9|COMPLETED|Cohort 5: 400 mg in SAD Study||0
18036|NCT02958982|39428|P8|COMPLETED|Cohort 5: 400 mg in SAD Study||0
18037|NCT02958982|39429|P7|COMPLETED|Cohort 5: 400 mg in SAD Study||0
18038|NCT02958982|39430|P6|COMPLETED|Cohort 5: 400 mg in SAD Study||6
18039|NCT02958982|39431|P5|COMPLETED|Cohort 5: 400 mg in SAD Study||0
18040|NCT02958982|39432|P4|COMPLETED|Cohort 5: 400 mg in SAD Study||0
18041|NCT02958982|39433|P3|COMPLETED|Cohort 5: 400 mg in SAD Study||0
18042|NCT02958982|39434|P2|COMPLETED|Cohort 5: 400 mg in SAD Study||0
18043|NCT02958982|39435|P1|COMPLETED|Cohort 5: 400 mg in SAD Study||2
18044|NCT02958982|39425|P11|STARTED|Cohort 5: 400 mg in SAD Study||0
18045|NCT02958982|39426|P10|STARTED|Cohort 5: 400 mg in SAD Study||0
18046|NCT02958982|39427|P9|STARTED|Cohort 5: 400 mg in SAD Study||0
18047|NCT02958982|39428|P8|STARTED|Cohort 5: 400 mg in SAD Study||0
18048|NCT02958982|39429|P7|STARTED|Cohort 5: 400 mg in SAD Study||0
18049|NCT02958982|39430|P6|STARTED|Cohort 5: 400 mg in SAD Study||6
18050|NCT02958982|39431|P5|STARTED|Cohort 5: 400 mg in SAD Study||0
18051|NCT02958982|39432|P4|STARTED|Cohort 5: 400 mg in SAD Study||0
18052|NCT02958982|39433|P3|STARTED|Cohort 5: 400 mg in SAD Study||0
18053|NCT02958982|39434|P2|STARTED|Cohort 5: 400 mg in SAD Study||0
18054|NCT02958982|39435|P1|STARTED|Cohort 5: 400 mg in SAD Study||2
18055|NCT02958982|39425|P11|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
18056|NCT02958982|39426|P10|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
18057|NCT02958982|39427|P9|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
18058|NCT02958982|39428|P8|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
18059|NCT02958982|39429|P7|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
18060|NCT02958982|39430|P6|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
18061|NCT02958982|39431|P5|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
18062|NCT02958982|39432|P4|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
18063|NCT02958982|39433|P3|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
18064|NCT02958982|39434|P2|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
18065|NCT02958982|39435|P1|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
18066|NCT02958982|39425|P11|COMPLETED|Cohort 4: 200 mg in SAD Study||0
18067|NCT02958982|39426|P10|COMPLETED|Cohort 4: 200 mg in SAD Study||0
18068|NCT02958982|39427|P9|COMPLETED|Cohort 4: 200 mg in SAD Study||0
18069|NCT02958982|39428|P8|COMPLETED|Cohort 4: 200 mg in SAD Study||0
18070|NCT02958982|39429|P7|COMPLETED|Cohort 4: 200 mg in SAD Study||0
18071|NCT02958982|39430|P6|COMPLETED|Cohort 4: 200 mg in SAD Study||0
18072|NCT02958982|39431|P5|COMPLETED|Cohort 4: 200 mg in SAD Study||6
18073|NCT02958982|39432|P4|COMPLETED|Cohort 4: 200 mg in SAD Study||0
18074|NCT02958982|39433|P3|COMPLETED|Cohort 4: 200 mg in SAD Study||0
18075|NCT02958982|39434|P2|COMPLETED|Cohort 4: 200 mg in SAD Study||0
18076|NCT02958982|39435|P1|COMPLETED|Cohort 4: 200 mg in SAD Study||2
18077|NCT02958982|39425|P11|STARTED|Cohort 4: 200 mg in SAD Study||0
18078|NCT02958982|39426|P10|STARTED|Cohort 4: 200 mg in SAD Study||0
18079|NCT02958982|39427|P9|STARTED|Cohort 4: 200 mg in SAD Study||0
18080|NCT02958982|39428|P8|STARTED|Cohort 4: 200 mg in SAD Study||0
18081|NCT02958982|39429|P7|STARTED|Cohort 4: 200 mg in SAD Study||0
18082|NCT02958982|39430|P6|STARTED|Cohort 4: 200 mg in SAD Study||0
18083|NCT02958982|39431|P5|STARTED|Cohort 4: 200 mg in SAD Study||6
18084|NCT02958982|39432|P4|STARTED|Cohort 4: 200 mg in SAD Study||0
18085|NCT02958982|39433|P3|STARTED|Cohort 4: 200 mg in SAD Study||0
18086|NCT02958982|39434|P2|STARTED|Cohort 4: 200 mg in SAD Study||0
18087|NCT02958982|39435|P1|STARTED|Cohort 4: 200 mg in SAD Study||2
18088|NCT02958982|39425|P11|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
18089|NCT02958982|39426|P10|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
18090|NCT02958982|39427|P9|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
18091|NCT02958982|39428|P8|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
18092|NCT02958982|39429|P7|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
18093|NCT02958982|39430|P6|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
18094|NCT02958982|39431|P5|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
18095|NCT02958982|39432|P4|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
18096|NCT02958982|39433|P3|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
18097|NCT02958982|39434|P2|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
18098|NCT02958982|39435|P1|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
18099|NCT02958982|39425|P11|COMPLETED|Cohort 3: 100 mg in SAD Study||0
18100|NCT02958982|39426|P10|COMPLETED|Cohort 3: 100 mg in SAD Study||0
18101|NCT02958982|39427|P9|COMPLETED|Cohort 3: 100 mg in SAD Study||0
18102|NCT02958982|39428|P8|COMPLETED|Cohort 3: 100 mg in SAD Study||0
18103|NCT02958982|39429|P7|COMPLETED|Cohort 3: 100 mg in SAD Study||0
18104|NCT02958982|39430|P6|COMPLETED|Cohort 3: 100 mg in SAD Study||0
18105|NCT02958982|39431|P5|COMPLETED|Cohort 3: 100 mg in SAD Study||0
18106|NCT02958982|39432|P4|COMPLETED|Cohort 3: 100 mg in SAD Study||4
18107|NCT02958982|39433|P3|COMPLETED|Cohort 3: 100 mg in SAD Study||0
18108|NCT02958982|39434|P2|COMPLETED|Cohort 3: 100 mg in SAD Study||0
18109|NCT02958982|39435|P1|COMPLETED|Cohort 3: 100 mg in SAD Study||2
18110|NCT02958982|39425|P11|STARTED|Cohort 3: 100 mg in SAD Study||0
18111|NCT02958982|39426|P10|STARTED|Cohort 3: 100 mg in SAD Study||0
18112|NCT02958982|39427|P9|STARTED|Cohort 3: 100 mg in SAD Study||0
18113|NCT02958982|39428|P8|STARTED|Cohort 3: 100 mg in SAD Study||0
18114|NCT02958982|39429|P7|STARTED|Cohort 3: 100 mg in SAD Study||0
18115|NCT02958982|39430|P6|STARTED|Cohort 3: 100 mg in SAD Study||0
18116|NCT02958982|39431|P5|STARTED|Cohort 3: 100 mg in SAD Study||0
18117|NCT02958982|39432|P4|STARTED|Cohort 3: 100 mg in SAD Study||4
18118|NCT02958982|39433|P3|STARTED|Cohort 3: 100 mg in SAD Study||0
18119|NCT02958982|39434|P2|STARTED|Cohort 3: 100 mg in SAD Study||0
18120|NCT02958982|39435|P1|STARTED|Cohort 3: 100 mg in SAD Study||2
18121|NCT02958982|39425|P11|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
18122|NCT02958982|39426|P10|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
18123|NCT02958982|39427|P9|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
18124|NCT02958982|39428|P8|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
18125|NCT02958982|39429|P7|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
18126|NCT02958982|39430|P6|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
18127|NCT02958982|39431|P5|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
18128|NCT02958982|39432|P4|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
18129|NCT02958982|39433|P3|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
18130|NCT02958982|39434|P2|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
18131|NCT02958982|39435|P1|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
18132|NCT02958982|39425|P11|COMPLETED|Cohort 2: 50 mg in SAD Study||0
18133|NCT02958982|39426|P10|COMPLETED|Cohort 2: 50 mg in SAD Study||0
18134|NCT02958982|39427|P9|COMPLETED|Cohort 2: 50 mg in SAD Study||0
18135|NCT02958982|39428|P8|COMPLETED|Cohort 2: 50 mg in SAD Study||0
18136|NCT02958982|39429|P7|COMPLETED|Cohort 2: 50 mg in SAD Study||0
18137|NCT02958982|39430|P6|COMPLETED|Cohort 2: 50 mg in SAD Study||0
18138|NCT02958982|39431|P5|COMPLETED|Cohort 2: 50 mg in SAD Study||0
18139|NCT02958982|39432|P4|COMPLETED|Cohort 2: 50 mg in SAD Study||0
18140|NCT02958982|39433|P3|COMPLETED|Cohort 2: 50 mg in SAD Study||4
18141|NCT02958982|39434|P2|COMPLETED|Cohort 2: 50 mg in SAD Study||0
18142|NCT02958982|39435|P1|COMPLETED|Cohort 2: 50 mg in SAD Study||2
18143|NCT02958982|39425|P11|STARTED|Cohort 2: 50 mg in SAD Study||0
18144|NCT02958982|39426|P10|STARTED|Cohort 2: 50 mg in SAD Study||0
18145|NCT02958982|39427|P9|STARTED|Cohort 2: 50 mg in SAD Study||0
18146|NCT02958982|39428|P8|STARTED|Cohort 2: 50 mg in SAD Study||0
18147|NCT02958982|39429|P7|STARTED|Cohort 2: 50 mg in SAD Study||0
18148|NCT02958982|39430|P6|STARTED|Cohort 2: 50 mg in SAD Study||0
18149|NCT02958982|39431|P5|STARTED|Cohort 2: 50 mg in SAD Study||0
18150|NCT02958982|39432|P4|STARTED|Cohort 2: 50 mg in SAD Study||0
18151|NCT02958982|39433|P3|STARTED|Cohort 2: 50 mg in SAD Study||4
18152|NCT02958982|39434|P2|STARTED|Cohort 2: 50 mg in SAD Study||0
18153|NCT02958982|39435|P1|STARTED|Cohort 2: 50 mg in SAD Study||2
18154|NCT02958982|39425|P11|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
18155|NCT02958982|39426|P10|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
18156|NCT02958982|39427|P9|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
18157|NCT02958982|39428|P8|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
18158|NCT02958982|39429|P7|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
18159|NCT02958982|39430|P6|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
18160|NCT02958982|39431|P5|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
18161|NCT02958982|39432|P4|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
18162|NCT02958982|39433|P3|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
18163|NCT02958982|39434|P2|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
18164|NCT02958982|39435|P1|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
18165|NCT02958982|39425|P11|COMPLETED|Cohort 1: 25 mg in SAD Study||0
18166|NCT02958982|39426|P10|COMPLETED|Cohort 1: 25 mg in SAD Study||0
18167|NCT02958982|39427|P9|COMPLETED|Cohort 1: 25 mg in SAD Study||0
18168|NCT02958982|39428|P8|COMPLETED|Cohort 1: 25 mg in SAD Study||0
18169|NCT02958982|39429|P7|COMPLETED|Cohort 1: 25 mg in SAD Study||0
18170|NCT02958982|39430|P6|COMPLETED|Cohort 1: 25 mg in SAD Study||0
18171|NCT02958982|39431|P5|COMPLETED|Cohort 1: 25 mg in SAD Study||0
18172|NCT02958982|39432|P4|COMPLETED|Cohort 1: 25 mg in SAD Study||0
18173|NCT02958982|39433|P3|COMPLETED|Cohort 1: 25 mg in SAD Study||0
18174|NCT02958982|39434|P2|COMPLETED|Cohort 1: 25 mg in SAD Study||3
18175|NCT02958982|39435|P1|COMPLETED|Cohort 1: 25 mg in SAD Study||1
18176|NCT02958982|39425|P11|STARTED|Cohort 1: 25 mg in SAD Study||0
18177|NCT02958982|39426|P10|STARTED|Cohort 1: 25 mg in SAD Study||0
18178|NCT02958982|39427|P9|STARTED|Cohort 1: 25 mg in SAD Study||0
18179|NCT02958982|39428|P8|STARTED|Cohort 1: 25 mg in SAD Study||0
18180|NCT02958982|39429|P7|STARTED|Cohort 1: 25 mg in SAD Study||0
18181|NCT02958982|39430|P6|STARTED|Cohort 1: 25 mg in SAD Study||0
18182|NCT02958982|39431|P5|STARTED|Cohort 1: 25 mg in SAD Study||0
18183|NCT02958982|39432|P4|STARTED|Cohort 1: 25 mg in SAD Study||0
18184|NCT02958982|39433|P3|STARTED|Cohort 1: 25 mg in SAD Study||0
18185|NCT02958982|39434|P2|STARTED|Cohort 1: 25 mg in SAD Study||3
18186|NCT02958982|39435|P1|STARTED|Cohort 1: 25 mg in SAD Study||1
18187|NCT02958956|39483|P2|NOT COMPLETED|Overall Study||0
18188|NCT02958956|39484|P1|NOT COMPLETED|Overall Study||0
18189|NCT02958956|39483|P2|COMPLETED|Overall Study||198317
18190|NCT02958956|39484|P1|COMPLETED|Overall Study||38190
18191|NCT02958956|39483|P2|STARTED|Overall Study||198317
18192|NCT02958956|39484|P1|STARTED|Overall Study||38190
18193|NCT02958826|39499|P2|NOT COMPLETED|Overall Study||0
18194|NCT02958826|39500|P1|NOT COMPLETED|Overall Study||0
18195|NCT02958826|39499|P2|COMPLETED|Overall Study||80
18196|NCT02958826|39500|P1|COMPLETED|Overall Study||80
18197|NCT02958826|39499|P2|STARTED|Overall Study||80
18198|NCT02958826|39500|P1|STARTED|Overall Study||80
18199|NCT02958787|39510|P1|NOT COMPLETED|Overall Study||0
18200|NCT02958787|39510|P1|COMPLETED|Overall Study||135
18201|NCT02958787|39510|P1|STARTED|Overall Study||135
18202|NCT02958345|39516|P2|NOT COMPLETED|Overall Study||1
18203|NCT02958345|39517|P1|NOT COMPLETED|Overall Study||1
18204|NCT02958345|39516|P2|COMPLETED|Overall Study||13
18205|NCT02958345|39517|P1|COMPLETED|Overall Study||13
18206|NCT02958345|39516|P2|STARTED|Overall Study||14
18207|NCT02958345|39517|P1|STARTED|Overall Study||14
18208|NCT02958267|39527|P2|NOT COMPLETED|Follow-up Visits||1
18209|NCT02958267|39528|P1|NOT COMPLETED|Follow-up Visits||2
18210|NCT02958267|39527|P2|COMPLETED|Follow-up Visits||14
18211|NCT02958267|39528|P1|COMPLETED|Follow-up Visits||13
18212|NCT02958267|39527|P2|12 Month Follow-up|Follow-up Visits||14
18213|NCT02958267|39528|P1|12 Month Follow-up|Follow-up Visits||13
18214|NCT02958267|39527|P2|6 Month Follow-up|Follow-up Visits||14
18215|NCT02958267|39528|P1|6 Month Follow-up|Follow-up Visits||14
18216|NCT02958267|39527|P2|3 Month Follow-up|Follow-up Visits||15
18217|NCT02958267|39528|P1|3 Month Follow-up|Follow-up Visits||15
18218|NCT02958267|39527|P2|STARTED|Follow-up Visits||15
18219|NCT02958267|39528|P1|STARTED|Follow-up Visits||15
18220|NCT02958267|39527|P2|NOT COMPLETED|Enrollment to Actual Treatment Complete||0
18221|NCT02958267|39528|P1|NOT COMPLETED|Enrollment to Actual Treatment Complete||2
18222|NCT02958267|39527|P2|COMPLETED|Enrollment to Actual Treatment Complete||15
18223|NCT02958267|39528|P1|COMPLETED|Enrollment to Actual Treatment Complete||15
18224|NCT02958267|39527|P2|STARTED|Enrollment to Actual Treatment Complete||15
18225|NCT02958267|39528|P1|STARTED|Enrollment to Actual Treatment Complete||17
18226|NCT02958267|39527|P2|NOT COMPLETED|Enrollment||0
18227|NCT02958267|39528|P1|NOT COMPLETED|Enrollment||0
18228|NCT02958267|39527|P2|COMPLETED|Enrollment||15
18229|NCT02958267|39528|P1|COMPLETED|Enrollment||17
18230|NCT02958267|39527|P2|STARTED|Enrollment||15
18231|NCT02958267|39528|P1|STARTED|Enrollment||17
18232|NCT02956967|39538|P1|NOT COMPLETED|Overall Study||48
18233|NCT02956967|39538|P1|COMPLETED|Overall Study||123
18234|NCT02956967|39538|P1|STARTED|Overall Study||171
18235|NCT02956837|39565|P4|NOT COMPLETED|Overall Study||3
18236|NCT02956837|39566|P3|NOT COMPLETED|Overall Study||2
18237|NCT02956837|39567|P2|NOT COMPLETED|Overall Study||3
18238|NCT02956837|39568|P1|NOT COMPLETED|Overall Study||0
18239|NCT02956837|39565|P4|COMPLETED|Overall Study||99
18240|NCT02956837|39566|P3|COMPLETED|Overall Study||97
18241|NCT02956837|39567|P2|COMPLETED|Overall Study||96
18242|NCT02956837|39568|P1|COMPLETED|Overall Study||100
18243|NCT02956837|39565|P4|STARTED|Overall Study||102
18244|NCT02956837|39566|P3|STARTED|Overall Study||99
18245|NCT02956837|39567|P2|STARTED|Overall Study||99
18246|NCT02956837|39568|P1|STARTED|Overall Study||100
18247|NCT02956746|39662|P4|NOT COMPLETED|Overall Study||4
18248|NCT02956746|39663|P3|NOT COMPLETED|Overall Study||6
18249|NCT02956746|39664|P2|NOT COMPLETED|Overall Study||3
18250|NCT02956746|39665|P1|NOT COMPLETED|Overall Study||2
18251|NCT02956746|39662|P4|COMPLETED|Overall Study||38
18252|NCT02956746|39663|P3|COMPLETED|Overall Study||36
18253|NCT02956746|39664|P2|COMPLETED|Overall Study||37
18254|NCT02956746|39665|P1|COMPLETED|Overall Study||38
18255|NCT02956746|39662|P4|STARTED|Overall Study||42
18256|NCT02956746|39663|P3|STARTED|Overall Study||42
18257|NCT02956746|39664|P2|STARTED|Overall Study||40
18258|NCT02956746|39665|P1|STARTED|Overall Study||40
18259|NCT02956629|39703|P6|NOT COMPLETED|Overall Study||1
18260|NCT02956629|39704|P5|NOT COMPLETED|Overall Study||0
18261|NCT02956629|39705|P4|NOT COMPLETED|Overall Study||1
18262|NCT02956629|39706|P3|NOT COMPLETED|Overall Study||4
18263|NCT02956629|39707|P2|NOT COMPLETED|Overall Study||6
18264|NCT02956629|39708|P1|NOT COMPLETED|Overall Study||5
18265|NCT02956629|39703|P6|COMPLETED|Overall Study||21
18266|NCT02956629|39704|P5|COMPLETED|Overall Study||18
18267|NCT02956629|39705|P4|COMPLETED|Overall Study||55
18268|NCT02956629|39706|P3|COMPLETED|Overall Study||57
18269|NCT02956629|39707|P2|COMPLETED|Overall Study||41
18270|NCT02956629|39708|P1|COMPLETED|Overall Study||73
18271|NCT02956629|39703|P6|STARTED|Overall Study||22
18272|NCT02956629|39704|P5|STARTED|Overall Study||18
18273|NCT02956629|39705|P4|STARTED|Overall Study||56
18274|NCT02956629|39706|P3|STARTED|Overall Study||61
18275|NCT02956629|39707|P2|STARTED|Overall Study||47
18276|NCT02956629|39708|P1|STARTED|Overall Study||78
18277|NCT02956616|39772|P2|NOT COMPLETED|Overall Study||0
18278|NCT02956616|39773|P1|NOT COMPLETED|Overall Study||0
18279|NCT02956616|39772|P2|COMPLETED|Overall Study||60
18280|NCT02956616|39773|P1|COMPLETED|Overall Study||58
18281|NCT02956616|39772|P2|STARTED|Overall Study||60
18282|NCT02956616|39773|P1|STARTED|Overall Study||58
18283|NCT02956460|39787|P2|NOT COMPLETED|Lens 2||0
18284|NCT02956460|39788|P1|NOT COMPLETED|Lens 2||0
18285|NCT02956460|39787|P2|COMPLETED|Lens 2||34
18286|NCT02956460|39788|P1|COMPLETED|Lens 2||29
18287|NCT02956460|39787|P2|STARTED|Lens 2||34
18288|NCT02956460|39788|P1|STARTED|Lens 2||29
18289|NCT02956460|39787|P2|NOT COMPLETED|Lens 1||0
18290|NCT02956460|39788|P1|NOT COMPLETED|Lens 1||1
18291|NCT02956460|39787|P2|COMPLETED|Lens 1||34
18292|NCT02956460|39788|P1|COMPLETED|Lens 1||29
18293|NCT02956460|39787|P2|STARTED|Lens 1||34
18294|NCT02956460|39788|P1|STARTED|Lens 1||30
18295|NCT02956122|39814|P1|NOT COMPLETED|Overall Study||0
18296|NCT02956122|39814|P1|COMPLETED|Overall Study||1
18297|NCT02956122|39814|P1|STARTED|Overall Study||1
18298|NCT02954952|39868|P3|NOT COMPLETED|Overall Study||0
18299|NCT02954952|39869|P2|NOT COMPLETED|Overall Study||1
18300|NCT02954952|39870|P1|NOT COMPLETED|Overall Study||1
18301|NCT02954952|39868|P3|COMPLETED|Overall Study||3
18302|NCT02954952|39869|P2|COMPLETED|Overall Study||4
18303|NCT02954952|39870|P1|COMPLETED|Overall Study||35
18304|NCT02954952|39868|P3|STARTED|Overall Study||3
18305|NCT02954952|39869|P2|STARTED|Overall Study||5
18306|NCT02954952|39870|P1|STARTED|Overall Study||36
18307|NCT02954848|39880|P2|NOT COMPLETED|Overall Study||5
18308|NCT02954848|39881|P1|NOT COMPLETED|Overall Study||2
18309|NCT02954848|39880|P2|COMPLETED|Overall Study||234
18310|NCT02954848|39881|P1|COMPLETED|Overall Study||243
18311|NCT02954848|39880|P2|Treated|Overall Study||238
18312|NCT02954848|39881|P1|Treated|Overall Study||245
18313|NCT02954848|39880|P2|STARTED|Overall Study||239
18314|NCT02954848|39881|P1|STARTED|Overall Study||245
18315|NCT02954653|39941|P9|NOT COMPLETED|Overall Study||0
18316|NCT02954653|39942|P8|NOT COMPLETED|Overall Study||0
18317|NCT02954653|39943|P7|NOT COMPLETED|Overall Study||0
18318|NCT02954653|39944|P6|NOT COMPLETED|Overall Study||0
18319|NCT02954653|39945|P5|NOT COMPLETED|Overall Study||0
18320|NCT02954653|39946|P4|NOT COMPLETED|Overall Study||0
18321|NCT02954653|39947|P3|NOT COMPLETED|Overall Study||0
18322|NCT02954653|39948|P2|NOT COMPLETED|Overall Study||3
18323|NCT02954653|39949|P1|NOT COMPLETED|Overall Study||4
18324|NCT02954653|39941|P9|COMPLETED|Overall Study||0
18325|NCT02954653|39942|P8|COMPLETED|Overall Study||0
18326|NCT02954653|39943|P7|COMPLETED|Overall Study||0
18327|NCT02954653|39944|P6|COMPLETED|Overall Study||0
18328|NCT02954653|39945|P5|COMPLETED|Overall Study||0
18329|NCT02954653|39946|P4|COMPLETED|Overall Study||0
18330|NCT02954653|39947|P3|COMPLETED|Overall Study||0
18331|NCT02954653|39948|P2|COMPLETED|Overall Study||1
18332|NCT02954653|39949|P1|COMPLETED|Overall Study||0
18333|NCT02954653|39941|P9|Received Treatment|Overall Study||0
18334|NCT02954653|39942|P8|Received Treatment|Overall Study||0
18335|NCT02954653|39943|P7|Received Treatment|Overall Study||0
18336|NCT02954653|39944|P6|Received Treatment|Overall Study||0
18337|NCT02954653|39945|P5|Received Treatment|Overall Study||0
18338|NCT02954653|39946|P4|Received Treatment|Overall Study||0
18339|NCT02954653|39947|P3|Received Treatment|Overall Study||0
18340|NCT02954653|39948|P2|Received Treatment|Overall Study||4
18341|NCT02954653|39949|P1|Received Treatment|Overall Study||3
18342|NCT02954653|39941|P9|STARTED|Overall Study|No participants were enrolled in this arm.|0
18343|NCT02954653|39942|P8|STARTED|Overall Study|No participants were enrolled in this arm.|0
18344|NCT02954653|39943|P7|STARTED|Overall Study|No participants were enrolled in this arm.|0
18345|NCT02954653|39944|P6|STARTED|Overall Study|No participants were enrolled in this arm.|0
18346|NCT02954653|39945|P5|STARTED|Overall Study|No participants were enrolled in this arm.|0
18347|NCT02954653|39946|P4|STARTED|Overall Study|No participants were enrolled in this arm.|0
18348|NCT02954653|39947|P3|STARTED|Overall Study|No participants were enrolled in this arm.|0
18349|NCT02954653|39948|P2|STARTED|Overall Study||4
18350|NCT02954653|39949|P1|STARTED|Overall Study||4
18351|NCT02954601|40068|P4|NOT COMPLETED|Third Intervention (Five Days)||0
18352|NCT02954601|40069|P3|NOT COMPLETED|Third Intervention (Five Days)||0
18353|NCT02954601|40070|P2|NOT COMPLETED|Third Intervention (Five Days)||0
18354|NCT02954601|40071|P1|NOT COMPLETED|Third Intervention (Five Days)||0
18355|NCT02954601|40068|P4|COMPLETED|Third Intervention (Five Days)||8
18356|NCT02954601|40069|P3|COMPLETED|Third Intervention (Five Days)||6
18357|NCT02954601|40070|P2|COMPLETED|Third Intervention (Five Days)||8
18358|NCT02954601|40071|P1|COMPLETED|Third Intervention (Five Days)||9
18359|NCT02954601|40068|P4|STARTED|Third Intervention (Five Days)||8
18360|NCT02954601|40069|P3|STARTED|Third Intervention (Five Days)||6
18361|NCT02954601|40070|P2|STARTED|Third Intervention (Five Days)||8
18362|NCT02954601|40071|P1|STARTED|Third Intervention (Five Days)||9
18363|NCT02954601|40068|P4|NOT COMPLETED|Second Intervention (Five Days)||0
18364|NCT02954601|40069|P3|NOT COMPLETED|Second Intervention (Five Days)||0
18365|NCT02954601|40070|P2|NOT COMPLETED|Second Intervention (Five Days)||0
18366|NCT02954601|40071|P1|NOT COMPLETED|Second Intervention (Five Days)||0
18367|NCT02954601|40068|P4|COMPLETED|Second Intervention (Five Days)||6
18368|NCT02954601|40069|P3|COMPLETED|Second Intervention (Five Days)||8
18369|NCT02954601|40070|P2|COMPLETED|Second Intervention (Five Days)||6
18370|NCT02954601|40071|P1|COMPLETED|Second Intervention (Five Days)||11
18371|NCT02954601|40068|P4|STARTED|Second Intervention (Five Days)||6
18372|NCT02954601|40069|P3|STARTED|Second Intervention (Five Days)||8
18373|NCT02954601|40070|P2|STARTED|Second Intervention (Five Days)||6
18374|NCT02954601|40071|P1|STARTED|Second Intervention (Five Days)||11
18375|NCT02954601|40068|P4|NOT COMPLETED|First Intervention (Five Days)||0
18376|NCT02954601|40069|P3|NOT COMPLETED|First Intervention (Five Days)||1
18377|NCT02954601|40070|P2|NOT COMPLETED|First Intervention (Five Days)||0
18378|NCT02954601|40071|P1|NOT COMPLETED|First Intervention (Five Days)||0
18379|NCT02954601|40068|P4|COMPLETED|First Intervention (Five Days)||7
18380|NCT02954601|40069|P3|COMPLETED|First Intervention (Five Days)||7
18381|NCT02954601|40070|P2|COMPLETED|First Intervention (Five Days)||6
18382|NCT02954601|40071|P1|COMPLETED|First Intervention (Five Days)||11
18383|NCT02954601|40068|P4|STARTED|First Intervention (Five Days)||7
18384|NCT02954601|40069|P3|STARTED|First Intervention (Five Days)||8
18385|NCT02954601|40070|P2|STARTED|First Intervention (Five Days)||6
18386|NCT02954601|40071|P1|STARTED|First Intervention (Five Days)||11
18387|NCT02954354|40096|P3|NOT COMPLETED|Overall Study||16
18388|NCT02954354|40097|P2|NOT COMPLETED|Overall Study||20
18389|NCT02954354|40098|P1|NOT COMPLETED|Overall Study||34
18390|NCT02954354|40096|P3|COMPLETED|Overall Study||498
18391|NCT02954354|40097|P2|COMPLETED|Overall Study||290
18392|NCT02954354|40098|P1|COMPLETED|Overall Study||578
18393|NCT02954354|40096|P3|Intention to Treat Infected Population|Overall Study||377
18394|NCT02954354|40097|P2|Intention to Treat Infected Population|Overall Study||231
18395|NCT02954354|40098|P1|Intention to Treat Infected Population|Overall Study||456
18396|NCT02954354|40096|P3|Received Study Drug|Overall Study||513
18397|NCT02954354|40097|P2|Received Study Drug|Overall Study||309
18398|NCT02954354|40098|P1|Received Study Drug|Overall Study||610
18399|NCT02954354|40096|P3|STARTED|Overall Study||514
18400|NCT02954354|40097|P2|STARTED|Overall Study||310
18401|NCT02954354|40098|P1|STARTED|Overall Study||612
18402|NCT02953886|40182|P1|NOT COMPLETED|Overall Study||0
18403|NCT02953886|40182|P1|COMPLETED|Overall Study||20
18404|NCT02953886|40182|P1|STARTED|Overall Study||20
18405|NCT02953678|40188|P1|NOT COMPLETED|Overall Study||60
18406|NCT02953678|40188|P1|COMPLETED|Overall Study||11
18407|NCT02953678|40188|P1|Participants Continuing in Study|Overall Study||19
18408|NCT02953678|40188|P1|Participants Discontinued From Study|Overall Study||41
18409|NCT02953678|40188|P1|STARTED|Overall Study||71
18410|NCT02952898|40200|P3|NOT COMPLETED|Overall Study||15
18411|NCT02952898|40201|P2|NOT COMPLETED|Overall Study||19
18412|NCT02952898|40202|P1|NOT COMPLETED|Overall Study||22
18413|NCT02952898|40200|P3|COMPLETED|Overall Study||209
18414|NCT02952898|40201|P2|COMPLETED|Overall Study||202
18415|NCT02952898|40202|P1|COMPLETED|Overall Study||198
18416|NCT02952898|40200|P3|STARTED|Overall Study||224
18417|NCT02952898|40201|P2|STARTED|Overall Study||221
18418|NCT02952898|40202|P1|STARTED|Overall Study||220
18419|NCT02952872|40226|P16|NOT COMPLETED|Overall Study||0
18420|NCT02952872|40227|P15|NOT COMPLETED|Overall Study||0
18421|NCT02952872|40228|P14|NOT COMPLETED|Overall Study||0
18422|NCT02952872|40229|P13|NOT COMPLETED|Overall Study||0
18423|NCT02952872|40230|P12|NOT COMPLETED|Overall Study||0
18424|NCT02952872|40231|P11|NOT COMPLETED|Overall Study||0
18425|NCT02952872|40232|P10|NOT COMPLETED|Overall Study||0
18426|NCT02952872|40233|P9|NOT COMPLETED|Overall Study||0
18427|NCT02952872|40234|P8|NOT COMPLETED|Overall Study||0
18428|NCT02952872|40235|P7|NOT COMPLETED|Overall Study||0
18429|NCT02952872|40236|P6|NOT COMPLETED|Overall Study||0
18430|NCT02952872|40237|P5|NOT COMPLETED|Overall Study||0
18431|NCT02952872|40238|P4|NOT COMPLETED|Overall Study||0
18432|NCT02952872|40239|P3|NOT COMPLETED|Overall Study||0
18433|NCT02952872|40240|P2|NOT COMPLETED|Overall Study||0
18434|NCT02952872|40241|P1|NOT COMPLETED|Overall Study||0
18435|NCT02952872|40226|P16|COMPLETED|Overall Study||23
18436|NCT02952872|40227|P15|COMPLETED|Overall Study||22
18437|NCT02952872|40228|P14|COMPLETED|Overall Study||22
18438|NCT02952872|40229|P13|COMPLETED|Overall Study||22
18439|NCT02952872|40230|P12|COMPLETED|Overall Study||22
18440|NCT02952872|40231|P11|COMPLETED|Overall Study||23
18441|NCT02952872|40232|P10|COMPLETED|Overall Study||22
18442|NCT02952872|40233|P9|COMPLETED|Overall Study||22
18443|NCT02952872|40234|P8|COMPLETED|Overall Study||21
18444|NCT02952872|40235|P7|COMPLETED|Overall Study||22
18445|NCT02952872|40236|P6|COMPLETED|Overall Study||21
18446|NCT02952872|40237|P5|COMPLETED|Overall Study||22
18447|NCT02952872|40238|P4|COMPLETED|Overall Study||22
18448|NCT02952872|40239|P3|COMPLETED|Overall Study||22
18449|NCT02952872|40240|P2|COMPLETED|Overall Study||22
18450|NCT02952872|40241|P1|COMPLETED|Overall Study||22
18451|NCT02952872|40226|P16|STARTED|Overall Study||23
18452|NCT02952872|40227|P15|STARTED|Overall Study||22
18453|NCT02952872|40228|P14|STARTED|Overall Study||22
18454|NCT02952872|40229|P13|STARTED|Overall Study||22
18455|NCT02952872|40230|P12|STARTED|Overall Study||22
18456|NCT02952872|40231|P11|STARTED|Overall Study||23
18457|NCT02952872|40232|P10|STARTED|Overall Study||22
18458|NCT02952872|40233|P9|STARTED|Overall Study||22
18459|NCT02952872|40234|P8|STARTED|Overall Study||21
18460|NCT02952872|40235|P7|STARTED|Overall Study||22
18461|NCT02952872|40236|P6|STARTED|Overall Study||21
18462|NCT02952872|40237|P5|STARTED|Overall Study||22
18463|NCT02952872|40238|P4|STARTED|Overall Study||22
18464|NCT02952872|40239|P3|STARTED|Overall Study||22
18465|NCT02952872|40240|P2|STARTED|Overall Study||22
18466|NCT02952872|40241|P1|STARTED|Overall Study||22
18467|NCT02952313|40323|P1|NOT COMPLETED|Overall Study||7
18468|NCT02952313|40323|P1|COMPLETED|Overall Study||106
18469|NCT02952313|40323|P1|6 Months|Overall Study||106
18470|NCT02952313|40323|P1|STARTED|Overall Study||113
18471|NCT02952261|40331|P2|NOT COMPLETED|Overall Study||5
18472|NCT02952261|40332|P1|NOT COMPLETED|Overall Study||5
18473|NCT02952261|40331|P2|COMPLETED|Overall Study||95
18474|NCT02952261|40332|P1|COMPLETED|Overall Study||95
18475|NCT02952261|40331|P2|STARTED|Overall Study||100
18476|NCT02952261|40332|P1|STARTED|Overall Study||100
18477|NCT02951884|40347|P3|NOT COMPLETED|Overall Study||0
18478|NCT02951884|40348|P2|NOT COMPLETED|Overall Study||0
18479|NCT02951884|40349|P1|NOT COMPLETED|Overall Study||0
18480|NCT02951884|40347|P3|COMPLETED|Overall Study||1
18481|NCT02951884|40348|P2|COMPLETED|Overall Study||1
18482|NCT02951884|40349|P1|COMPLETED|Overall Study||0
18483|NCT02951884|40347|P3|STARTED|Overall Study||1
18484|NCT02951884|40348|P2|STARTED|Overall Study||1
18485|NCT02951884|40349|P1|STARTED|Overall Study||0
18486|NCT02951819|40362|P2|NOT COMPLETED|Overall Study||14
18487|NCT02951819|40363|P1|NOT COMPLETED|Overall Study||87
18488|NCT02951819|40362|P2|COMPLETED|Overall Study||0
18489|NCT02951819|40363|P1|COMPLETED|Overall Study||0
18490|NCT02951819|40362|P2|Treated|Overall Study||14
18491|NCT02951819|40363|P1|Treated|Overall Study||86
18492|NCT02951819|40362|P2|STARTED|Overall Study||14
18493|NCT02951819|40363|P1|STARTED|Overall Study||87
18494|NCT02951780|40394|P9|NOT COMPLETED|Period 3||0
18495|NCT02951780|40395|P8|NOT COMPLETED|Period 3||0
18496|NCT02951780|40396|P7|NOT COMPLETED|Period 3||0
18497|NCT02951780|40397|P6|NOT COMPLETED|Period 3||0
18498|NCT02951780|40398|P5|NOT COMPLETED|Period 3||0
18499|NCT02951780|40399|P4|NOT COMPLETED|Period 3||0
18500|NCT02951780|40400|P3|NOT COMPLETED|Period 3||0
18501|NCT02951780|40401|P2|NOT COMPLETED|Period 3||0
18502|NCT02951780|40402|P1|NOT COMPLETED|Period 3||0
18503|NCT02951780|40394|P9|COMPLETED|Period 3||2
18504|NCT02951780|40395|P8|COMPLETED|Period 3||1
18505|NCT02951780|40396|P7|COMPLETED|Period 3||2
18506|NCT02951780|40397|P6|COMPLETED|Period 3||3
18507|NCT02951780|40398|P5|COMPLETED|Period 3||2
18508|NCT02951780|40399|P4|COMPLETED|Period 3||2
18509|NCT02951780|40400|P3|COMPLETED|Period 3||3
18510|NCT02951780|40401|P2|COMPLETED|Period 3||2
18511|NCT02951780|40402|P1|COMPLETED|Period 3||3
18512|NCT02951780|40394|P9|STARTED|Period 3||2
18513|NCT02951780|40395|P8|STARTED|Period 3||1
18514|NCT02951780|40396|P7|STARTED|Period 3||2
18515|NCT02951780|40397|P6|STARTED|Period 3||3
18516|NCT02951780|40398|P5|STARTED|Period 3||2
18517|NCT02951780|40399|P4|STARTED|Period 3||2
18518|NCT02951780|40400|P3|STARTED|Period 3||3
18519|NCT02951780|40401|P2|STARTED|Period 3||2
18520|NCT02951780|40402|P1|STARTED|Period 3||3
18521|NCT02951780|40394|P9|NOT COMPLETED|Period 2||0
18522|NCT02951780|40395|P8|NOT COMPLETED|Period 2||1
18523|NCT02951780|40396|P7|NOT COMPLETED|Period 2||0
18524|NCT02951780|40397|P6|NOT COMPLETED|Period 2||0
18525|NCT02951780|40398|P5|NOT COMPLETED|Period 2||0
18526|NCT02951780|40399|P4|NOT COMPLETED|Period 2||0
18527|NCT02951780|40400|P3|NOT COMPLETED|Period 2||0
18528|NCT02951780|40401|P2|NOT COMPLETED|Period 2||0
18529|NCT02951780|40402|P1|NOT COMPLETED|Period 2||0
18530|NCT02951780|40394|P9|COMPLETED|Period 2||2
18531|NCT02951780|40395|P8|COMPLETED|Period 2||1
18532|NCT02951780|40396|P7|COMPLETED|Period 2||2
18533|NCT02951780|40397|P6|COMPLETED|Period 2||3
18534|NCT02951780|40398|P5|COMPLETED|Period 2||2
18535|NCT02951780|40399|P4|COMPLETED|Period 2||2
18536|NCT02951780|40400|P3|COMPLETED|Period 2||3
18537|NCT02951780|40401|P2|COMPLETED|Period 2||2
18538|NCT02951780|40402|P1|COMPLETED|Period 2||3
18539|NCT02951780|40394|P9|STARTED|Period 2||2
18540|NCT02951780|40395|P8|STARTED|Period 2||2
18541|NCT02951780|40396|P7|STARTED|Period 2||2
18542|NCT02951780|40397|P6|STARTED|Period 2||3
18543|NCT02951780|40398|P5|STARTED|Period 2||2
18544|NCT02951780|40399|P4|STARTED|Period 2||2
18545|NCT02951780|40400|P3|STARTED|Period 2||3
18546|NCT02951780|40401|P2|STARTED|Period 2||2
18547|NCT02951780|40402|P1|STARTED|Period 2||3
18548|NCT02951780|40394|P9|NOT COMPLETED|Period 1||0
18549|NCT02951780|40395|P8|NOT COMPLETED|Period 1||1
18550|NCT02951780|40396|P7|NOT COMPLETED|Period 1||0
18551|NCT02951780|40397|P6|NOT COMPLETED|Period 1||0
18552|NCT02951780|40398|P5|NOT COMPLETED|Period 1||0
18553|NCT02951780|40399|P4|NOT COMPLETED|Period 1||1
18554|NCT02951780|40400|P3|NOT COMPLETED|Period 1||0
18555|NCT02951780|40401|P2|NOT COMPLETED|Period 1||0
18556|NCT02951780|40402|P1|NOT COMPLETED|Period 1||0
18557|NCT02951780|40394|P9|COMPLETED|Period 1||2
18558|NCT02951780|40395|P8|COMPLETED|Period 1||2
18559|NCT02951780|40396|P7|COMPLETED|Period 1||2
18560|NCT02951780|40397|P6|COMPLETED|Period 1||3
18561|NCT02951780|40398|P5|COMPLETED|Period 1||2
18562|NCT02951780|40399|P4|COMPLETED|Period 1||2
18563|NCT02951780|40400|P3|COMPLETED|Period 1||3
18564|NCT02951780|40401|P2|COMPLETED|Period 1||2
18565|NCT02951780|40402|P1|COMPLETED|Period 1||3
18566|NCT02951780|40394|P9|STARTED|Period 1||2
18567|NCT02951780|40395|P8|STARTED|Period 1||3
18568|NCT02951780|40396|P7|STARTED|Period 1||2
18569|NCT02951780|40397|P6|STARTED|Period 1||3
18570|NCT02951780|40398|P5|STARTED|Period 1||2
18571|NCT02951780|40399|P4|STARTED|Period 1||3
18572|NCT02951780|40400|P3|STARTED|Period 1||3
18573|NCT02951780|40401|P2|STARTED|Period 1||2
18574|NCT02951780|40402|P1|STARTED|Period 1||3
18575|NCT02951767|40467|P1|NOT COMPLETED|Overall Study||119
18576|NCT02951767|40467|P1|COMPLETED|Overall Study||0
18577|NCT02951767|40467|P1|STARTED|Overall Study||119
18578|NCT02951702|40486|P2|NOT COMPLETED|Overall Study||0
18579|NCT02951702|40487|P1|NOT COMPLETED|Overall Study||0
18580|NCT02951702|40486|P2|COMPLETED|Overall Study||17
18581|NCT02951702|40487|P1|COMPLETED|Overall Study||34
18582|NCT02951702|40486|P2|STARTED|Overall Study||17
18583|NCT02951702|40487|P1|STARTED|Overall Study||34
18584|NCT02951533|40499|P2|NOT COMPLETED|Overall Study||23
18585|NCT02951533|40500|P1|NOT COMPLETED|Overall Study||4
18586|NCT02951533|40499|P2|COMPLETED|Overall Study||36
18587|NCT02951533|40500|P1|COMPLETED|Overall Study||56
18588|NCT02951533|40499|P2|Treated|Overall Study||58
18589|NCT02951533|40500|P1|Treated|Overall Study||60
18590|NCT02951533|40499|P2|STARTED|Overall Study||59
18591|NCT02951533|40500|P1|STARTED|Overall Study||60
18592|NCT02951351|40530|P2|NOT COMPLETED|Overall Study||0
18593|NCT02951351|40531|P1|NOT COMPLETED|Overall Study||0
18594|NCT02951351|40530|P2|COMPLETED|Overall Study||17
18595|NCT02951351|40531|P1|COMPLETED|Overall Study||19
18596|NCT02951351|40530|P2|STARTED|Overall Study||17
18597|NCT02951351|40531|P1|STARTED|Overall Study||19
18598|NCT02951312|40555|P4|NOT COMPLETED|Study Part 2||0
18599|NCT02951312|40556|P3|NOT COMPLETED|Study Part 2||0
18600|NCT02951312|40557|P2|NOT COMPLETED|Study Part 2||0
18601|NCT02951312|40558|P1|NOT COMPLETED|Study Part 2||0
18602|NCT02951312|40555|P4|COMPLETED|Study Part 2||6
18603|NCT02951312|40556|P3|COMPLETED|Study Part 2||6
18604|NCT02951312|40557|P2|COMPLETED|Study Part 2||0
18605|NCT02951312|40558|P1|COMPLETED|Study Part 2||0
18606|NCT02951312|40555|P4|STARTED|Study Part 2||6
18607|NCT02951312|40556|P3|STARTED|Study Part 2||6
18608|NCT02951312|40557|P2|STARTED|Study Part 2||0
18609|NCT02951312|40558|P1|STARTED|Study Part 2||0
18610|NCT02951312|40555|P4|NOT COMPLETED|Study Part 1||0
18611|NCT02951312|40556|P3|NOT COMPLETED|Study Part 1||0
18612|NCT02951312|40557|P2|NOT COMPLETED|Study Part 1||0
18613|NCT02951312|40558|P1|NOT COMPLETED|Study Part 1||0
18614|NCT02951312|40555|P4|COMPLETED|Study Part 1||0
18615|NCT02951312|40556|P3|COMPLETED|Study Part 1||0
18616|NCT02951312|40557|P2|COMPLETED|Study Part 1||6
18617|NCT02951312|40558|P1|COMPLETED|Study Part 1||6
18618|NCT02951312|40555|P4|STARTED|Study Part 1||0
18619|NCT02951312|40556|P3|STARTED|Study Part 1||0
18620|NCT02951312|40557|P2|STARTED|Study Part 1||6
18621|NCT02951312|40558|P1|STARTED|Study Part 1||6
18622|NCT02951273|40678|P1|NOT COMPLETED|Overall Study||3
18623|NCT02951273|40678|P1|COMPLETED|Overall Study||27
18624|NCT02951273|40678|P1|STARTED|Overall Study||30
18625|NCT02951052|40695|P2|NOT COMPLETED|Overall Study||18
18626|NCT02951052|40696|P1|NOT COMPLETED|Overall Study||27
18627|NCT02951052|40695|P2|COMPLETED|Overall Study||290
18628|NCT02951052|40696|P1|COMPLETED|Overall Study||281
18629|NCT02951052|40695|P2|STARTED|Overall Study||308
18630|NCT02951052|40696|P1|STARTED|Overall Study||308
18631|NCT02950896|40860|P1|NOT COMPLETED|Overall Study||0
18632|NCT02950896|40860|P1|COMPLETED|Overall Study||4
18633|NCT02950896|40860|P1|STARTED|Overall Study||4
18634|NCT02950831|40864|P1|NOT COMPLETED|Overall Study||9
18635|NCT02950831|40864|P1|COMPLETED|Overall Study||18
18636|NCT02950831|40864|P1|8 Weeks Follow up|Overall Study||19
18637|NCT02950831|40864|P1|4 Week Follow up|Overall Study||20
18638|NCT02950831|40864|P1|Permanent Implant|Overall Study||20
18639|NCT02950831|40864|P1|Complete Trial|Overall Study||26
18640|NCT02950831|40864|P1|STARTED|Overall Study||27
18641|NCT02950753|40889|P2|NOT COMPLETED|Overall Study||0
18642|NCT02950753|40890|P1|NOT COMPLETED|Overall Study||0
18643|NCT02950753|40889|P2|COMPLETED|Overall Study||15
18644|NCT02950753|40890|P1|COMPLETED|Overall Study||15
18645|NCT02950753|40889|P2|STARTED|Overall Study||15
18646|NCT02950753|40890|P1|STARTED|Overall Study||15
18647|NCT02950480|40902|P2|NOT COMPLETED|Overall Study||0
18648|NCT02950480|40903|P1|NOT COMPLETED|Overall Study||1
18649|NCT02950480|40902|P2|COMPLETED|Overall Study||2
18650|NCT02950480|40903|P1|COMPLETED|Overall Study||1
18651|NCT02950480|40902|P2|STARTED|Overall Study||2
18652|NCT02950480|40903|P1|STARTED|Overall Study||2
18653|NCT02950025|40915|P2|NOT COMPLETED|Overall Study||0
18654|NCT02950025|40916|P1|NOT COMPLETED|Overall Study||0
18655|NCT02950025|40915|P2|COMPLETED|Overall Study||3
18656|NCT02950025|40916|P1|COMPLETED|Overall Study||2
18657|NCT02950025|40915|P2|STARTED|Overall Study||3
18658|NCT02950025|40916|P1|STARTED|Overall Study||2
18659|NCT02949921|40936|P2|NOT COMPLETED|Overall Study||0
18660|NCT02949921|40937|P1|NOT COMPLETED|Overall Study||0
18661|NCT02949921|40936|P2|COMPLETED|Overall Study||10
18662|NCT02949921|40937|P1|COMPLETED|Overall Study||10
18663|NCT02949921|40936|P2|STARTED|Overall Study||10
18664|NCT02949921|40937|P1|STARTED|Overall Study||10
18665|NCT02949908|40961|P1|NOT COMPLETED|Overall Study||2
18666|NCT02949908|40961|P1|COMPLETED|Overall Study||0
18667|NCT02949908|40961|P1|STARTED|Overall Study||2
18668|NCT02949674|40984|P3|NOT COMPLETED|Overall Study||0
18669|NCT02949674|40985|P2|NOT COMPLETED|Overall Study||0
18670|NCT02949674|40986|P1|NOT COMPLETED|Overall Study||0
18671|NCT02949674|40984|P3|COMPLETED|Overall Study||31
18672|NCT02949674|40985|P2|COMPLETED|Overall Study||31
18673|NCT02949674|40986|P1|COMPLETED|Overall Study||31
18674|NCT02949674|40984|P3|STARTED|Overall Study||31
18675|NCT02949674|40985|P2|STARTED|Overall Study||31
18676|NCT02949674|40986|P1|STARTED|Overall Study||31
18677|NCT02949271|40996|P2|NOT COMPLETED|Overall Study||30
18678|NCT02949271|40997|P1|NOT COMPLETED|Overall Study||29
18679|NCT02949271|40996|P2|COMPLETED|Overall Study||59
18680|NCT02949271|40997|P1|COMPLETED|Overall Study||61
18681|NCT02949271|40996|P2|STARTED|Overall Study||89
18682|NCT02949271|40997|P1|STARTED|Overall Study||90
18683|NCT02949141|41023|P1|NOT COMPLETED|Overall Study||0
18684|NCT02949141|41023|P1|COMPLETED|Overall Study||62
18685|NCT02949141|41023|P1|STARTED|Overall Study||62
18686|NCT02949011|41033|P3|NOT COMPLETED|Overall Study||42
18687|NCT02949011|41034|P2|NOT COMPLETED|Overall Study||34
18688|NCT02949011|41035|P1|NOT COMPLETED|Overall Study||33
18689|NCT02949011|41033|P3|COMPLETED|Overall Study||683
18690|NCT02949011|41034|P2|COMPLETED|Overall Study||695
18691|NCT02949011|41035|P1|COMPLETED|Overall Study||697
18692|NCT02949011|41033|P3|Intention to Treat Infected Population|Overall Study||389
18693|NCT02949011|41034|P2|Intention to Treat Infected Population|Overall Study||386
18694|NCT02949011|41035|P1|Intention to Treat Infected Population|Overall Study||388
18695|NCT02949011|41033|P3|Received Study Drug|Overall Study|Includes one participant who received baloxavir marboxil in error|722
18696|NCT02949011|41034|P2|Received Study Drug|Overall Study|Includes one participant who received baloxavir marboxil in error|728
18697|NCT02949011|41035|P1|Received Study Drug|Overall Study||728
18698|NCT02949011|41033|P3|STARTED|Overall Study||725
18699|NCT02949011|41034|P2|STARTED|Overall Study||729
18700|NCT02949011|41035|P1|STARTED|Overall Study||730
18701|NCT02948582|41103|P6|NOT COMPLETED|Wshout Period 6||0
18702|NCT02948582|41104|P5|NOT COMPLETED|Wshout Period 6||0
18703|NCT02948582|41105|P4|NOT COMPLETED|Wshout Period 6||0
18704|NCT02948582|41106|P3|NOT COMPLETED|Wshout Period 6||0
18705|NCT02948582|41107|P2|NOT COMPLETED|Wshout Period 6||0
18706|NCT02948582|41108|P1|NOT COMPLETED|Wshout Period 6||0
18707|NCT02948582|41103|P6|COMPLETED|Wshout Period 6||6
18708|NCT02948582|41104|P5|COMPLETED|Wshout Period 6||7
18709|NCT02948582|41105|P4|COMPLETED|Wshout Period 6||6
18710|NCT02948582|41106|P3|COMPLETED|Wshout Period 6||6
18711|NCT02948582|41107|P2|COMPLETED|Wshout Period 6||4
18712|NCT02948582|41108|P1|COMPLETED|Wshout Period 6||6
18713|NCT02948582|41103|P6|STARTED|Wshout Period 6||6
18714|NCT02948582|41104|P5|STARTED|Wshout Period 6||7
18715|NCT02948582|41105|P4|STARTED|Wshout Period 6||6
18716|NCT02948582|41106|P3|STARTED|Wshout Period 6||6
18717|NCT02948582|41107|P2|STARTED|Wshout Period 6||4
18718|NCT02948582|41108|P1|STARTED|Wshout Period 6||6
18719|NCT02948582|41103|P6|NOT COMPLETED|Treatment Period 6||0
18720|NCT02948582|41104|P5|NOT COMPLETED|Treatment Period 6||0
18721|NCT02948582|41105|P4|NOT COMPLETED|Treatment Period 6||0
18722|NCT02948582|41106|P3|NOT COMPLETED|Treatment Period 6||0
18723|NCT02948582|41107|P2|NOT COMPLETED|Treatment Period 6||0
18724|NCT02948582|41108|P1|NOT COMPLETED|Treatment Period 6||0
18725|NCT02948582|41103|P6|COMPLETED|Treatment Period 6||6
18726|NCT02948582|41104|P5|COMPLETED|Treatment Period 6||7
18727|NCT02948582|41105|P4|COMPLETED|Treatment Period 6||6
18728|NCT02948582|41106|P3|COMPLETED|Treatment Period 6||6
18729|NCT02948582|41107|P2|COMPLETED|Treatment Period 6||4
18730|NCT02948582|41108|P1|COMPLETED|Treatment Period 6||6
18731|NCT02948582|41103|P6|STARTED|Treatment Period 6||6
18732|NCT02948582|41104|P5|STARTED|Treatment Period 6||7
18733|NCT02948582|41105|P4|STARTED|Treatment Period 6||6
18734|NCT02948582|41106|P3|STARTED|Treatment Period 6||6
18735|NCT02948582|41107|P2|STARTED|Treatment Period 6||4
18736|NCT02948582|41108|P1|STARTED|Treatment Period 6||6
18737|NCT02948582|41103|P6|NOT COMPLETED|Washout Period 5||0
18738|NCT02948582|41104|P5|NOT COMPLETED|Washout Period 5||0
18739|NCT02948582|41105|P4|NOT COMPLETED|Washout Period 5||0
18740|NCT02948582|41106|P3|NOT COMPLETED|Washout Period 5||0
18741|NCT02948582|41107|P2|NOT COMPLETED|Washout Period 5||0
18742|NCT02948582|41108|P1|NOT COMPLETED|Washout Period 5||0
18743|NCT02948582|41103|P6|COMPLETED|Washout Period 5||6
18744|NCT02948582|41104|P5|COMPLETED|Washout Period 5||7
18745|NCT02948582|41105|P4|COMPLETED|Washout Period 5||6
18746|NCT02948582|41106|P3|COMPLETED|Washout Period 5||6
18747|NCT02948582|41107|P2|COMPLETED|Washout Period 5||4
18748|NCT02948582|41108|P1|COMPLETED|Washout Period 5||6
18749|NCT02948582|41103|P6|STARTED|Washout Period 5||6
18750|NCT02948582|41104|P5|STARTED|Washout Period 5||7
18751|NCT02948582|41105|P4|STARTED|Washout Period 5||6
18752|NCT02948582|41106|P3|STARTED|Washout Period 5||6
18753|NCT02948582|41107|P2|STARTED|Washout Period 5||4
18754|NCT02948582|41108|P1|STARTED|Washout Period 5||6
18755|NCT02948582|41103|P6|NOT COMPLETED|Treatment Period 5||0
18756|NCT02948582|41104|P5|NOT COMPLETED|Treatment Period 5||0
18757|NCT02948582|41105|P4|NOT COMPLETED|Treatment Period 5||0
18758|NCT02948582|41106|P3|NOT COMPLETED|Treatment Period 5||0
18759|NCT02948582|41107|P2|NOT COMPLETED|Treatment Period 5||0
18760|NCT02948582|41108|P1|NOT COMPLETED|Treatment Period 5||0
18761|NCT02948582|41103|P6|COMPLETED|Treatment Period 5||6
18762|NCT02948582|41104|P5|COMPLETED|Treatment Period 5||7
18763|NCT02948582|41105|P4|COMPLETED|Treatment Period 5||6
18764|NCT02948582|41106|P3|COMPLETED|Treatment Period 5||6
18765|NCT02948582|41107|P2|COMPLETED|Treatment Period 5||4
18766|NCT02948582|41108|P1|COMPLETED|Treatment Period 5||6
18767|NCT02948582|41103|P6|STARTED|Treatment Period 5||6
18768|NCT02948582|41104|P5|STARTED|Treatment Period 5||7
18769|NCT02948582|41105|P4|STARTED|Treatment Period 5||6
18770|NCT02948582|41106|P3|STARTED|Treatment Period 5||6
18771|NCT02948582|41107|P2|STARTED|Treatment Period 5||4
18772|NCT02948582|41108|P1|STARTED|Treatment Period 5||6
18773|NCT02948582|41103|P6|NOT COMPLETED|Washout Period 4||0
18774|NCT02948582|41104|P5|NOT COMPLETED|Washout Period 4||0
18775|NCT02948582|41105|P4|NOT COMPLETED|Washout Period 4||0
18776|NCT02948582|41106|P3|NOT COMPLETED|Washout Period 4||1
18777|NCT02948582|41107|P2|NOT COMPLETED|Washout Period 4||0
18778|NCT02948582|41108|P1|NOT COMPLETED|Washout Period 4||1
18779|NCT02948582|41103|P6|COMPLETED|Washout Period 4||6
18780|NCT02948582|41104|P5|COMPLETED|Washout Period 4||7
18781|NCT02948582|41105|P4|COMPLETED|Washout Period 4||6
18782|NCT02948582|41106|P3|COMPLETED|Washout Period 4||6
18783|NCT02948582|41107|P2|COMPLETED|Washout Period 4||4
18784|NCT02948582|41108|P1|COMPLETED|Washout Period 4||6
18785|NCT02948582|41103|P6|STARTED|Washout Period 4||6
18786|NCT02948582|41104|P5|STARTED|Washout Period 4||7
18787|NCT02948582|41105|P4|STARTED|Washout Period 4||6
18788|NCT02948582|41106|P3|STARTED|Washout Period 4||7
18789|NCT02948582|41107|P2|STARTED|Washout Period 4||4
18790|NCT02948582|41108|P1|STARTED|Washout Period 4||7
18791|NCT02948582|41103|P6|NOT COMPLETED|Treatment Period 4||0
18792|NCT02948582|41104|P5|NOT COMPLETED|Treatment Period 4||0
18793|NCT02948582|41105|P4|NOT COMPLETED|Treatment Period 4||0
18794|NCT02948582|41106|P3|NOT COMPLETED|Treatment Period 4||0
18795|NCT02948582|41107|P2|NOT COMPLETED|Treatment Period 4||0
18796|NCT02948582|41108|P1|NOT COMPLETED|Treatment Period 4||0
18797|NCT02948582|41103|P6|COMPLETED|Treatment Period 4||6
18798|NCT02948582|41104|P5|COMPLETED|Treatment Period 4||7
18799|NCT02948582|41105|P4|COMPLETED|Treatment Period 4||6
18800|NCT02948582|41106|P3|COMPLETED|Treatment Period 4||7
18801|NCT02948582|41107|P2|COMPLETED|Treatment Period 4||4
18802|NCT02948582|41108|P1|COMPLETED|Treatment Period 4||7
18803|NCT02948582|41103|P6|STARTED|Treatment Period 4||6
18804|NCT02948582|41104|P5|STARTED|Treatment Period 4||7
18805|NCT02948582|41105|P4|STARTED|Treatment Period 4||6
18806|NCT02948582|41106|P3|STARTED|Treatment Period 4||7
18807|NCT02948582|41107|P2|STARTED|Treatment Period 4||4
18808|NCT02948582|41108|P1|STARTED|Treatment Period 4||7
18809|NCT02948582|41103|P6|NOT COMPLETED|Washout Period 3||0
18810|NCT02948582|41104|P5|NOT COMPLETED|Washout Period 3||0
18811|NCT02948582|41105|P4|NOT COMPLETED|Washout Period 3||0
18812|NCT02948582|41106|P3|NOT COMPLETED|Washout Period 3||0
18813|NCT02948582|41107|P2|NOT COMPLETED|Washout Period 3||0
18814|NCT02948582|41108|P1|NOT COMPLETED|Washout Period 3||0
18815|NCT02948582|41103|P6|COMPLETED|Washout Period 3||6
18816|NCT02948582|41104|P5|COMPLETED|Washout Period 3||7
18817|NCT02948582|41105|P4|COMPLETED|Washout Period 3||6
18818|NCT02948582|41106|P3|COMPLETED|Washout Period 3||7
18819|NCT02948582|41107|P2|COMPLETED|Washout Period 3||4
18820|NCT02948582|41108|P1|COMPLETED|Washout Period 3||7
18821|NCT02948582|41103|P6|STARTED|Washout Period 3||6
18822|NCT02948582|41104|P5|STARTED|Washout Period 3||7
18823|NCT02948582|41105|P4|STARTED|Washout Period 3||6
18824|NCT02948582|41106|P3|STARTED|Washout Period 3||7
18825|NCT02948582|41107|P2|STARTED|Washout Period 3||4
18826|NCT02948582|41108|P1|STARTED|Washout Period 3||7
18827|NCT02948582|41103|P6|NOT COMPLETED|Treatment Period 3||0
18828|NCT02948582|41104|P5|NOT COMPLETED|Treatment Period 3||0
18829|NCT02948582|41105|P4|NOT COMPLETED|Treatment Period 3||0
18830|NCT02948582|41106|P3|NOT COMPLETED|Treatment Period 3||0
18831|NCT02948582|41107|P2|NOT COMPLETED|Treatment Period 3||0
18832|NCT02948582|41108|P1|NOT COMPLETED|Treatment Period 3||0
18833|NCT02948582|41103|P6|COMPLETED|Treatment Period 3||6
18834|NCT02948582|41104|P5|COMPLETED|Treatment Period 3||7
18835|NCT02948582|41105|P4|COMPLETED|Treatment Period 3||6
18836|NCT02948582|41106|P3|COMPLETED|Treatment Period 3||7
18837|NCT02948582|41107|P2|COMPLETED|Treatment Period 3||4
18838|NCT02948582|41108|P1|COMPLETED|Treatment Period 3||7
18839|NCT02948582|41103|P6|STARTED|Treatment Period 3||6
18840|NCT02948582|41104|P5|STARTED|Treatment Period 3||7
18841|NCT02948582|41105|P4|STARTED|Treatment Period 3||6
18842|NCT02948582|41106|P3|STARTED|Treatment Period 3||7
18843|NCT02948582|41107|P2|STARTED|Treatment Period 3||4
18844|NCT02948582|41108|P1|STARTED|Treatment Period 3||7
18845|NCT02948582|41103|P6|NOT COMPLETED|Washout Period 2||0
18846|NCT02948582|41104|P5|NOT COMPLETED|Washout Period 2||0
18847|NCT02948582|41105|P4|NOT COMPLETED|Washout Period 2||1
18848|NCT02948582|41106|P3|NOT COMPLETED|Washout Period 2||0
18849|NCT02948582|41107|P2|NOT COMPLETED|Washout Period 2||1
18850|NCT02948582|41108|P1|NOT COMPLETED|Washout Period 2||0
18851|NCT02948582|41103|P6|COMPLETED|Washout Period 2||6
18852|NCT02948582|41104|P5|COMPLETED|Washout Period 2||7
18853|NCT02948582|41105|P4|COMPLETED|Washout Period 2||6
18854|NCT02948582|41106|P3|COMPLETED|Washout Period 2||7
18855|NCT02948582|41107|P2|COMPLETED|Washout Period 2||4
18856|NCT02948582|41108|P1|COMPLETED|Washout Period 2||7
18857|NCT02948582|41103|P6|STARTED|Washout Period 2||6
18858|NCT02948582|41104|P5|STARTED|Washout Period 2||7
18859|NCT02948582|41105|P4|STARTED|Washout Period 2||7
18860|NCT02948582|41106|P3|STARTED|Washout Period 2||7
18861|NCT02948582|41107|P2|STARTED|Washout Period 2||5
18862|NCT02948582|41108|P1|STARTED|Washout Period 2||7
18863|NCT02948582|41103|P6|NOT COMPLETED|Treatment Period 2||0
18864|NCT02948582|41104|P5|NOT COMPLETED|Treatment Period 2||0
18865|NCT02948582|41105|P4|NOT COMPLETED|Treatment Period 2||0
18866|NCT02948582|41106|P3|NOT COMPLETED|Treatment Period 2||0
18867|NCT02948582|41107|P2|NOT COMPLETED|Treatment Period 2||0
18868|NCT02948582|41108|P1|NOT COMPLETED|Treatment Period 2||0
18869|NCT02948582|41103|P6|COMPLETED|Treatment Period 2||6
18870|NCT02948582|41104|P5|COMPLETED|Treatment Period 2||7
18871|NCT02948582|41105|P4|COMPLETED|Treatment Period 2||7
18872|NCT02948582|41106|P3|COMPLETED|Treatment Period 2||7
18873|NCT02948582|41107|P2|COMPLETED|Treatment Period 2||5
18874|NCT02948582|41108|P1|COMPLETED|Treatment Period 2||7
18875|NCT02948582|41103|P6|STARTED|Treatment Period 2||6
18876|NCT02948582|41104|P5|STARTED|Treatment Period 2||7
18877|NCT02948582|41105|P4|STARTED|Treatment Period 2||7
18878|NCT02948582|41106|P3|STARTED|Treatment Period 2||7
18879|NCT02948582|41107|P2|STARTED|Treatment Period 2||5
18880|NCT02948582|41108|P1|STARTED|Treatment Period 2||7
18881|NCT02948582|41103|P6|NOT COMPLETED|Washout Period 1||1
18882|NCT02948582|41104|P5|NOT COMPLETED|Washout Period 1||0
18883|NCT02948582|41105|P4|NOT COMPLETED|Washout Period 1||0
18884|NCT02948582|41106|P3|NOT COMPLETED|Washout Period 1||0
18885|NCT02948582|41107|P2|NOT COMPLETED|Washout Period 1||2
18886|NCT02948582|41108|P1|NOT COMPLETED|Washout Period 1||0
18887|NCT02948582|41103|P6|COMPLETED|Washout Period 1||6
18888|NCT02948582|41104|P5|COMPLETED|Washout Period 1||7
18889|NCT02948582|41105|P4|COMPLETED|Washout Period 1||7
18890|NCT02948582|41106|P3|COMPLETED|Washout Period 1||7
18891|NCT02948582|41107|P2|COMPLETED|Washout Period 1||5
18892|NCT02948582|41108|P1|COMPLETED|Washout Period 1||7
18893|NCT02948582|41103|P6|STARTED|Washout Period 1||7
18894|NCT02948582|41104|P5|STARTED|Washout Period 1||7
18895|NCT02948582|41105|P4|STARTED|Washout Period 1||7
18896|NCT02948582|41106|P3|STARTED|Washout Period 1||7
18897|NCT02948582|41107|P2|STARTED|Washout Period 1||7
18898|NCT02948582|41108|P1|STARTED|Washout Period 1||7
18899|NCT02948582|41103|P6|NOT COMPLETED|Treatment Period 1||0
18900|NCT02948582|41104|P5|NOT COMPLETED|Treatment Period 1||0
18901|NCT02948582|41105|P4|NOT COMPLETED|Treatment Period 1||0
18902|NCT02948582|41106|P3|NOT COMPLETED|Treatment Period 1||0
18903|NCT02948582|41107|P2|NOT COMPLETED|Treatment Period 1||0
18904|NCT02948582|41108|P1|NOT COMPLETED|Treatment Period 1||0
18905|NCT02948582|41103|P6|COMPLETED|Treatment Period 1||7
18906|NCT02948582|41104|P5|COMPLETED|Treatment Period 1||7
18907|NCT02948582|41105|P4|COMPLETED|Treatment Period 1||7
18908|NCT02948582|41106|P3|COMPLETED|Treatment Period 1||7
18909|NCT02948582|41107|P2|COMPLETED|Treatment Period 1||7
18910|NCT02948582|41108|P1|COMPLETED|Treatment Period 1||7
18911|NCT02948582|41103|P6|STARTED|Treatment Period 1||7
18912|NCT02948582|41104|P5|STARTED|Treatment Period 1||7
18913|NCT02948582|41105|P4|STARTED|Treatment Period 1||7
18914|NCT02948582|41106|P3|STARTED|Treatment Period 1||7
18915|NCT02948582|41107|P2|STARTED|Treatment Period 1||7
18916|NCT02948582|41108|P1|STARTED|Treatment Period 1||7
18917|NCT02947997|41201|P1|NOT COMPLETED|Overall Study||0
18918|NCT02947997|41201|P1|COMPLETED|Overall Study||4
18919|NCT02947997|41201|P1|STARTED|Overall Study||4
18920|NCT02947984|41207|P2|NOT COMPLETED|Overall Study||0
18921|NCT02947984|41208|P1|NOT COMPLETED|Overall Study||0
18922|NCT02947984|41207|P2|COMPLETED|Overall Study||22
18923|NCT02947984|41208|P1|COMPLETED|Overall Study||22
18924|NCT02947984|41207|P2|STARTED|Overall Study||22
18925|NCT02947984|41208|P1|STARTED|Overall Study||22
18926|NCT02947022|41220|P1|NOT COMPLETED|Overall Study||1
18927|NCT02947022|41220|P1|COMPLETED|Overall Study||0
18928|NCT02947022|41220|P1|STARTED|Overall Study||1
18929|NCT02946580|41241|P2|NOT COMPLETED|Overall Study||5
18930|NCT02946580|41242|P1|NOT COMPLETED|Overall Study||1
18931|NCT02946580|41241|P2|COMPLETED|Overall Study||20
18932|NCT02946580|41242|P1|COMPLETED|Overall Study||27
18933|NCT02946580|41241|P2|STARTED|Overall Study||25
18934|NCT02946580|41242|P1|STARTED|Overall Study||28
18935|NCT02946515|41260|P2|NOT COMPLETED|Overall Study||1
18936|NCT02946515|41261|P1|NOT COMPLETED|Overall Study||2
18937|NCT02946515|41260|P2|COMPLETED|Overall Study||21
18938|NCT02946515|41261|P1|COMPLETED|Overall Study||20
18939|NCT02946515|41260|P2|STARTED|Overall Study||22
18940|NCT02946515|41261|P1|STARTED|Overall Study||22
18941|NCT02946463|41269|P2|NOT COMPLETED|Extension Period||119
18942|NCT02946463|41270|P1|NOT COMPLETED|Extension Period||124
18943|NCT02946463|41269|P2|COMPLETED|Extension Period||0
18944|NCT02946463|41270|P1|COMPLETED|Extension Period||0
18945|NCT02946463|41269|P2|Received at Least 1 Dose of Ravulizumab|Extension Period||119
18946|NCT02946463|41270|P1|Received at Least 1 Dose of Ravulizumab|Extension Period||124
18947|NCT02946463|41269|P2|STARTED|Extension Period||119
18948|NCT02946463|41270|P1|STARTED|Extension Period||124
18949|NCT02946463|41269|P2|NOT COMPLETED|Primary Evaluation Period||2
18950|NCT02946463|41270|P1|NOT COMPLETED|Primary Evaluation Period||0
18951|NCT02946463|41269|P2|COMPLETED|Primary Evaluation Period||119
18952|NCT02946463|41270|P1|COMPLETED|Primary Evaluation Period||125
18953|NCT02946463|41269|P2|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||121
18954|NCT02946463|41270|P1|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||125
18955|NCT02946463|41269|P2|STARTED|Primary Evaluation Period||121
18956|NCT02946463|41270|P1|STARTED|Primary Evaluation Period||125
18957|NCT02946385|41292|P6|NOT COMPLETED|Overall Study||1
18958|NCT02946385|41293|P5|NOT COMPLETED|Overall Study||2
18959|NCT02946385|41294|P4|NOT COMPLETED|Overall Study||0
18960|NCT02946385|41295|P3|NOT COMPLETED|Overall Study||3
18961|NCT02946385|41296|P2|NOT COMPLETED|Overall Study||0
18962|NCT02946385|41297|P1|NOT COMPLETED|Overall Study||0
18963|NCT02946385|41292|P6|COMPLETED|Overall Study||76
18964|NCT02946385|41293|P5|COMPLETED|Overall Study||99
18965|NCT02946385|41294|P4|COMPLETED|Overall Study||74
18966|NCT02946385|41295|P3|COMPLETED|Overall Study||96
18967|NCT02946385|41296|P2|COMPLETED|Overall Study||127
18968|NCT02946385|41297|P1|COMPLETED|Overall Study||126
18969|NCT02946385|41292|P6|STARTED|Overall Study||77
18970|NCT02946385|41293|P5|STARTED|Overall Study||101
18971|NCT02946385|41294|P4|STARTED|Overall Study||74
18972|NCT02946385|41295|P3|STARTED|Overall Study||99
18973|NCT02946385|41296|P2|STARTED|Overall Study||127
18974|NCT02946385|41297|P1|STARTED|Overall Study||126
18975|NCT02946229|41381|P1|NOT COMPLETED|Overall Study||0
18976|NCT02946229|41381|P1|COMPLETED|Overall Study||142
18977|NCT02946229|41381|P1|STARTED|Overall Study||142
18978|NCT02946021|41387|P2|NOT COMPLETED|Overall Study||0
18979|NCT02946021|41388|P1|NOT COMPLETED|Overall Study||0
18980|NCT02946021|41387|P2|COMPLETED|Overall Study||5
18981|NCT02946021|41388|P1|COMPLETED|Overall Study||6
18982|NCT02946021|41387|P2|STARTED|Overall Study||5
18983|NCT02946021|41388|P1|STARTED|Overall Study||6
18984|NCT02945657|41400|P1|NOT COMPLETED|Overall Study||4
18985|NCT02945657|41400|P1|COMPLETED|Overall Study||28
18986|NCT02945657|41400|P1|STARTED|Overall Study||32
18987|NCT02945254|41419|P2|NOT COMPLETED|Overall Study||0
18988|NCT02945254|41420|P1|NOT COMPLETED|Overall Study||2
18989|NCT02945254|41419|P2|COMPLETED|Overall Study||10
18990|NCT02945254|41420|P1|COMPLETED|Overall Study||8
18991|NCT02945254|41419|P2|STARTED|Overall Study||10
18992|NCT02945254|41420|P1|STARTED|Overall Study||10
18993|NCT02944968|41428|P1|NOT COMPLETED|Overall Study||3
18994|NCT02944968|41428|P1|COMPLETED|Overall Study||48
18995|NCT02944968|41428|P1|STARTED|Overall Study||51
18996|NCT02944656|41435|P2|NOT COMPLETED|Overall Study||10
18997|NCT02944656|41436|P1|NOT COMPLETED|Overall Study||10
18998|NCT02944656|41435|P2|COMPLETED|Overall Study||47
18999|NCT02944656|41436|P1|COMPLETED|Overall Study||47
19000|NCT02944656|41435|P2|Completed Day 1 Follow up|Overall Study||47
19001|NCT02944656|41436|P1|Completed Day 1 Follow up|Overall Study||47
19002|NCT02944656|41435|P2|Completed Procedure Day|Overall Study||57
19003|NCT02944656|41436|P1|Completed Procedure Day|Overall Study||54
19004|NCT02944656|41435|P2|STARTED|Overall Study||57
19005|NCT02944656|41436|P1|STARTED|Overall Study||57
19006|NCT02944565|41464|P1|NOT COMPLETED|Overall Study||0
19007|NCT02944565|41464|P1|COMPLETED|Overall Study||28
19008|NCT02944565|41464|P1|STARTED|Overall Study||28
19009|NCT02944513|41472|P2|NOT COMPLETED|Overall Study||1
19010|NCT02944513|41473|P1|NOT COMPLETED|Overall Study||4
19011|NCT02944513|41472|P2|COMPLETED|Overall Study||32
19012|NCT02944513|41473|P1|COMPLETED|Overall Study||31
19013|NCT02944513|41472|P2|STARTED|Overall Study||33
19014|NCT02944513|41473|P1|STARTED|Overall Study||35
19015|NCT02944461|41489|P1|NOT COMPLETED|Overall Study||5
19016|NCT02944461|41489|P1|COMPLETED|Overall Study||15
19017|NCT02944461|41489|P1|STARTED|Overall Study||20
19018|NCT02943941|41496|P1|NOT COMPLETED|Overall Study||0
19019|NCT02943941|41496|P1|COMPLETED|Overall Study||16
19020|NCT02943941|41496|P1|STARTED|Overall Study||16
19021|NCT02943577|41504|P2|NOT COMPLETED|Overall Study||5
19022|NCT02943577|41505|P1|NOT COMPLETED|Overall Study||5
19023|NCT02943577|41504|P2|COMPLETED|Overall Study||201
19024|NCT02943577|41505|P1|COMPLETED|Overall Study||204
19025|NCT02943577|41504|P2|STARTED|Overall Study||206
19026|NCT02943577|41505|P1|STARTED|Overall Study||209
19027|NCT02943499|41519|P2|NOT COMPLETED|Overall Study||5
19028|NCT02943499|41520|P1|NOT COMPLETED|Overall Study||7
19029|NCT02943499|41519|P2|COMPLETED|Overall Study||34
19030|NCT02943499|41520|P1|COMPLETED|Overall Study||34
19031|NCT02943499|41519|P2|STARTED|Overall Study||39
19032|NCT02943499|41520|P1|STARTED|Overall Study||41
19033|NCT02943460|41529|P3|NOT COMPLETED|Open Label Extension (OLE)||9
19034|NCT02943460|41530|P2|NOT COMPLETED|Open Label Extension (OLE)||18
19035|NCT02943460|41531|P1|NOT COMPLETED|Open Label Extension (OLE)||19
19036|NCT02943460|41529|P3|COMPLETED|Open Label Extension (OLE)||0
19037|NCT02943460|41530|P2|COMPLETED|Open Label Extension (OLE)||0
19038|NCT02943460|41531|P1|COMPLETED|Open Label Extension (OLE)||0
19039|NCT02943460|41529|P3|STARTED|Open Label Extension (OLE)|1 participant who discontinued study drug in the Blinded Phase did not enter the OLE Phase.|9
19040|NCT02943460|41530|P2|STARTED|Open Label Extension (OLE)|1 participant completed the Blinded Study Phase, but did not continue in the OLE Phase.|18
19041|NCT02943460|41531|P1|STARTED|Open Label Extension (OLE)||19
19042|NCT02943460|41529|P3|NOT COMPLETED|Blinded Study||0
19043|NCT02943460|41530|P2|NOT COMPLETED|Blinded Study||1
19044|NCT02943460|41531|P1|NOT COMPLETED|Blinded Study||3
19045|NCT02943460|41529|P3|COMPLETED|Blinded Study|1 participant discontinued from study drug in the Blinded Phase, but did not discontinue the study.|10
19046|NCT02943460|41530|P2|COMPLETED|Blinded Study||19
19047|NCT02943460|41531|P1|COMPLETED|Blinded Study||19
19048|NCT02943460|41529|P3|STARTED|Blinded Study||10
19049|NCT02943460|41530|P2|STARTED|Blinded Study||20
19050|NCT02943460|41531|P1|STARTED|Blinded Study||22
19051|NCT02943226|41548|P2|NOT COMPLETED|Overall Study||0
19052|NCT02943226|41549|P1|NOT COMPLETED|Overall Study||0
19053|NCT02943226|41548|P2|COMPLETED|Overall Study||30
19054|NCT02943226|41549|P1|COMPLETED|Overall Study||31
19055|NCT02943226|41548|P2|STARTED|Overall Study||30
19056|NCT02943226|41549|P1|STARTED|Overall Study||31
19057|NCT02943213|41565|P1|NOT COMPLETED|Treatment Period 2||0
19058|NCT02943213|41565|P1|COMPLETED|Treatment Period 2||20
19059|NCT02943213|41565|P1|STARTED|Treatment Period 2||20
19060|NCT02943213|41565|P1|NOT COMPLETED|Treatment Period 1||0
19061|NCT02943213|41565|P1|COMPLETED|Treatment Period 1||20
19062|NCT02943213|41565|P1|STARTED|Treatment Period 1||20
19063|NCT02943096|41595|P2|NOT COMPLETED|Overall Study||1
19064|NCT02943096|41596|P1|NOT COMPLETED|Overall Study||0
19065|NCT02943096|41595|P2|COMPLETED|Overall Study||2
19066|NCT02943096|41596|P1|COMPLETED|Overall Study||3
19067|NCT02943096|41595|P2|STARTED|Overall Study||3
19068|NCT02943096|41596|P1|STARTED|Overall Study||3
19069|NCT02942576|41612|P2|NOT COMPLETED|Overall Study||23
19070|NCT02942576|41613|P1|NOT COMPLETED|Overall Study||46
19071|NCT02942576|41612|P2|COMPLETED|Overall Study||174
19072|NCT02942576|41613|P1|COMPLETED|Overall Study||359
19073|NCT02942576|41612|P2|STARTED|Overall Study||197
19074|NCT02942576|41613|P1|STARTED|Overall Study||405
19075|NCT02942017|41627|P2|NOT COMPLETED|Overall Study||6
19076|NCT02942017|41628|P1|NOT COMPLETED|Overall Study||2
19077|NCT02942017|41627|P2|COMPLETED|Overall Study||48
19078|NCT02942017|41628|P1|COMPLETED|Overall Study||52
19079|NCT02942017|41627|P2|Treated|Overall Study||51
19080|NCT02942017|41628|P1|Treated|Overall Study||53
19081|NCT02942017|41627|P2|STARTED|Overall Study||54
19082|NCT02942017|41628|P1|STARTED|Overall Study||54
19083|NCT02942004|41659|P3|NOT COMPLETED|Overall Study||9
19084|NCT02942004|41660|P2|NOT COMPLETED|Overall Study||12
19085|NCT02942004|41661|P1|NOT COMPLETED|Overall Study||4
19086|NCT02942004|41659|P3|COMPLETED|Overall Study||36
19087|NCT02942004|41660|P2|COMPLETED|Overall Study||35
19088|NCT02942004|41661|P1|COMPLETED|Overall Study||42
19089|NCT02942004|41659|P3|Participants Who Received Study Drug|Overall Study||41
19090|NCT02942004|41660|P2|Participants Who Received Study Drug|Overall Study||38
19091|NCT02942004|41661|P1|Participants Who Received Study Drug|Overall Study||43
19092|NCT02942004|41659|P3|STARTED|Overall Study||45
19093|NCT02942004|41660|P2|STARTED|Overall Study||47
19094|NCT02942004|41661|P1|STARTED|Overall Study||46
19095|NCT02941692|41704|P2|NOT COMPLETED|Overall Study||0
19096|NCT02941692|41705|P1|NOT COMPLETED|Overall Study||0
19097|NCT02941692|41704|P2|COMPLETED|Overall Study||34
19098|NCT02941692|41705|P1|COMPLETED|Overall Study||32
19099|NCT02941692|41704|P2|STARTED|Overall Study||34
19100|NCT02941692|41705|P1|STARTED|Overall Study||32
19101|NCT02941640|41717|P4|NOT COMPLETED|Overall Study||0
19102|NCT02941640|41718|P3|NOT COMPLETED|Overall Study||0
19103|NCT02941640|41719|P2|NOT COMPLETED|Overall Study||0
19104|NCT02941640|41720|P1|NOT COMPLETED|Overall Study||0
19105|NCT02941640|41717|P4|COMPLETED|Overall Study||30
19106|NCT02941640|41718|P3|COMPLETED|Overall Study||30
19107|NCT02941640|41719|P2|COMPLETED|Overall Study||30
19108|NCT02941640|41720|P1|COMPLETED|Overall Study||30
19109|NCT02941640|41717|P4|STARTED|Overall Study||30
19110|NCT02941640|41718|P3|STARTED|Overall Study||30
19111|NCT02941640|41719|P2|STARTED|Overall Study||30
19112|NCT02941640|41720|P1|STARTED|Overall Study||30
19113|NCT02940626|41752|P2|NOT COMPLETED|Overall Study||35
19114|NCT02940626|41753|P1|NOT COMPLETED|Overall Study||47
19115|NCT02940626|41752|P2|COMPLETED|Overall Study||43
19116|NCT02940626|41753|P1|COMPLETED|Overall Study||30
19117|NCT02940626|41752|P2|Completed Through Study Day 22|Overall Study||49
19118|NCT02940626|41753|P1|Completed Through Study Day 22|Overall Study||42
19119|NCT02940626|41752|P2|Received Study Treatment|Overall Study||77
19120|NCT02940626|41753|P1|Received Study Treatment|Overall Study||77
19121|NCT02940626|41752|P2|Randomized Into Treatment Sub-study|Overall Study||1
19122|NCT02940626|41753|P1|Randomized Into Treatment Sub-study|Overall Study||0
19123|NCT02940626|41752|P2|Randomized Into Primary Prevention Study|Overall Study||77
19124|NCT02940626|41753|P1|Randomized Into Primary Prevention Study|Overall Study||77
19125|NCT02940626|41752|P2|STARTED|Overall Study||78
19126|NCT02940626|41753|P1|STARTED|Overall Study||77
19127|NCT02940522|41775|P2|NOT COMPLETED|Overall Study||2
19128|NCT02940522|41776|P1|NOT COMPLETED|Overall Study||2
19129|NCT02940522|41775|P2|COMPLETED|Overall Study||59
19130|NCT02940522|41776|P1|COMPLETED|Overall Study||57
19131|NCT02940522|41775|P2|STARTED|Overall Study||61
19132|NCT02940522|41776|P1|STARTED|Overall Study||59
19133|NCT02939937|41794|P2|NOT COMPLETED|Overall Study||3
19134|NCT02939937|41795|P1|NOT COMPLETED|Overall Study||6
19135|NCT02939937|41794|P2|COMPLETED|Overall Study||47
19136|NCT02939937|41795|P1|COMPLETED|Overall Study||15
19137|NCT02939937|41794|P2|STARTED|Overall Study|3 patients excluded from study|50
19138|NCT02939937|41795|P1|STARTED|Overall Study|5 patients had drug reaction and 1 patient excluded from study,|21
19139|NCT02939560|41809|P1|NOT COMPLETED|Overall Study||3
19140|NCT02939560|41809|P1|COMPLETED|Overall Study||10
19141|NCT02939560|41809|P1|STARTED|Overall Study||13
19142|NCT02939326|41826|P8|NOT COMPLETED|Overall Study||0
19143|NCT02939326|41827|P7|NOT COMPLETED|Overall Study||0
19144|NCT02939326|41828|P6|NOT COMPLETED|Overall Study||0
19145|NCT02939326|41829|P5|NOT COMPLETED|Overall Study||0
19146|NCT02939326|41830|P4|NOT COMPLETED|Overall Study||0
19147|NCT02939326|41831|P3|NOT COMPLETED|Overall Study||0
19148|NCT02939326|41832|P2|NOT COMPLETED|Overall Study||0
19149|NCT02939326|41833|P1|NOT COMPLETED|Overall Study||0
19150|NCT02939326|41826|P8|COMPLETED|Overall Study||5
19151|NCT02939326|41827|P7|COMPLETED|Overall Study||5
19152|NCT02939326|41828|P6|COMPLETED|Overall Study||5
19153|NCT02939326|41829|P5|COMPLETED|Overall Study||5
19154|NCT02939326|41830|P4|COMPLETED|Overall Study||5
19155|NCT02939326|41831|P3|COMPLETED|Overall Study||5
19156|NCT02939326|41832|P2|COMPLETED|Overall Study||5
19157|NCT02939326|41833|P1|COMPLETED|Overall Study||7
19158|NCT02939326|41826|P8|STARTED|Overall Study||5
19159|NCT02939326|41827|P7|STARTED|Overall Study||5
19160|NCT02939326|41828|P6|STARTED|Overall Study||5
19161|NCT02939326|41829|P5|STARTED|Overall Study||5
19162|NCT02939326|41830|P4|STARTED|Overall Study||5
19163|NCT02939326|41831|P3|STARTED|Overall Study||5
19164|NCT02939326|41832|P2|STARTED|Overall Study||5
19165|NCT02939326|41833|P1|STARTED|Overall Study||7
19166|NCT02939170|41853|P2|NOT COMPLETED|Overall Study||0
19167|NCT02939170|41854|P1|NOT COMPLETED|Overall Study||0
19168|NCT02939170|41853|P2|COMPLETED|Overall Study||40
19169|NCT02939170|41854|P1|COMPLETED|Overall Study||40
19170|NCT02939170|41853|P2|STARTED|Overall Study||40
19171|NCT02939170|41854|P1|STARTED|Overall Study||40
19172|NCT02939079|41867|P2|NOT COMPLETED|Overall Study||5
19173|NCT02939079|41868|P1|NOT COMPLETED|Overall Study||4
19174|NCT02939079|41867|P2|COMPLETED|Overall Study||20
19175|NCT02939079|41868|P1|COMPLETED|Overall Study||21
19176|NCT02939079|41867|P2|STARTED|Overall Study||25
19177|NCT02939079|41868|P1|STARTED|Overall Study||25
19178|NCT02939014|41898|P2|NOT COMPLETED|Overall Study||9
19179|NCT02939014|41899|P1|NOT COMPLETED|Overall Study||30
19180|NCT02939014|41898|P2|COMPLETED|Overall Study||0
19181|NCT02939014|41899|P1|COMPLETED|Overall Study||0
19182|NCT02939014|41898|P2|STARTED|Overall Study||9
19183|NCT02939014|41899|P1|STARTED|Overall Study||30
19184|NCT02938949|41928|P2|NOT COMPLETED|Overall Study||0
19185|NCT02938949|41929|P1|NOT COMPLETED|Overall Study||0
19186|NCT02938949|41928|P2|COMPLETED|Overall Study||10
19187|NCT02938949|41929|P1|COMPLETED|Overall Study||10
19188|NCT02938949|41928|P2|STARTED|Overall Study||10
19189|NCT02938949|41929|P1|STARTED|Overall Study||10
19190|NCT02938585|41943|P4|NOT COMPLETED|Overall Study||1
19191|NCT02938585|41944|P3|NOT COMPLETED|Overall Study||0
19192|NCT02938585|41945|P2|NOT COMPLETED|Overall Study||1
19193|NCT02938585|41946|P1|NOT COMPLETED|Overall Study||0
19194|NCT02938585|41943|P4|COMPLETED|Overall Study||14
19195|NCT02938585|41944|P3|COMPLETED|Overall Study||11
19196|NCT02938585|41945|P2|COMPLETED|Overall Study||32
19197|NCT02938585|41946|P1|COMPLETED|Overall Study||9
19198|NCT02938585|41943|P4|On-demand|Overall Study||8
19199|NCT02938585|41944|P3|On-demand|Overall Study||1
19200|NCT02938585|41945|P2|On-demand|Overall Study||7
19201|NCT02938585|41946|P1|On-demand|Overall Study||1
19202|NCT02938585|41943|P4|Prophylaxis|Overall Study||7
19203|NCT02938585|41944|P3|Prophylaxis|Overall Study||10
19204|NCT02938585|41945|P2|Prophylaxis|Overall Study||26
19205|NCT02938585|41946|P1|Prophylaxis|Overall Study||8
19206|NCT02938585|41943|P4|STARTED|Overall Study||15
19207|NCT02938585|41944|P3|STARTED|Overall Study||11
19208|NCT02938585|41945|P2|STARTED|Overall Study||33
19209|NCT02938585|41946|P1|STARTED|Overall Study||9
19210|NCT02938520|42042|P2|NOT COMPLETED|Overall Study||283
19211|NCT02938520|42043|P1|NOT COMPLETED|Overall Study||283
19212|NCT02938520|42042|P2|COMPLETED|Overall Study||0
19213|NCT02938520|42043|P1|COMPLETED|Overall Study||0
19214|NCT02938520|42042|P2|STARTED|Overall Study||283
19215|NCT02938520|42043|P1|STARTED|Overall Study||283
19216|NCT02938052|42168|P1|NOT COMPLETED|Overall Study||1
19217|NCT02938052|42168|P1|COMPLETED|Overall Study||10
19218|NCT02938052|42168|P1|STARTED|Overall Study||11
19219|NCT02937870|42187|P1|NOT COMPLETED|Overall Study||3
19220|NCT02937870|42187|P1|COMPLETED|Overall Study||20
19221|NCT02937870|42187|P1|Received no Adhesive|Overall Study||20
19222|NCT02937870|42187|P1|Received Positive Control Adhesive|Overall Study||21
19223|NCT02937870|42187|P1|Received Test Adhesive 2|Overall Study||22
19224|NCT02937870|42187|P1|Received Test Adhesive 1|Overall Study||21
19225|NCT02937870|42187|P1|STARTED|Overall Study||23
19226|NCT02937766|42205|P2|NOT COMPLETED|Overall Study||0
19227|NCT02937766|42206|P1|NOT COMPLETED|Overall Study||7
19228|NCT02937766|42205|P2|COMPLETED|Overall Study||30
19229|NCT02937766|42206|P1|COMPLETED|Overall Study||23
19230|NCT02937766|42205|P2|STARTED|Overall Study||30
19231|NCT02937766|42206|P1|STARTED|Overall Study||30
19232|NCT02937740|42218|P2|NOT COMPLETED|Uptitrated to TID on Day 90 for 30 Days||2
19233|NCT02937740|42219|P1|NOT COMPLETED|Uptitrated to TID on Day 90 for 30 Days||1
19234|NCT02937740|42218|P2|COMPLETED|Uptitrated to TID on Day 90 for 30 Days||15
19235|NCT02937740|42219|P1|COMPLETED|Uptitrated to TID on Day 90 for 30 Days||12
19236|NCT02937740|42218|P2|STARTED|Uptitrated to TID on Day 90 for 30 Days||17
19237|NCT02937740|42219|P1|STARTED|Uptitrated to TID on Day 90 for 30 Days||13
19238|NCT02937740|42218|P2|NOT COMPLETED|BID for 90 Days, 22 mg/Day||31
19239|NCT02937740|42219|P1|NOT COMPLETED|BID for 90 Days, 22 mg/Day||5
19240|NCT02937740|42218|P2|COMPLETED|BID for 90 Days, 22 mg/Day||62
19241|NCT02937740|42219|P1|COMPLETED|BID for 90 Days, 22 mg/Day||19
19242|NCT02937740|42218|P2|STARTED|BID for 90 Days, 22 mg/Day||93
19243|NCT02937740|42219|P1|STARTED|BID for 90 Days, 22 mg/Day||24
19244|NCT02937701|42235|P5|NOT COMPLETED|Week 22 to Week 50||9
19245|NCT02937701|42236|P4|NOT COMPLETED|Week 22 to Week 50||8
19246|NCT02937701|42237|P3|NOT COMPLETED|Week 22 to Week 50||32
19247|NCT02937701|42238|P2|NOT COMPLETED|Week 22 to Week 50||0
19248|NCT02937701|42239|P1|NOT COMPLETED|Week 22 to Week 50||0
19249|NCT02937701|42235|P5|COMPLETED|Week 22 to Week 50||110
19250|NCT02937701|42236|P4|COMPLETED|Week 22 to Week 50||113
19251|NCT02937701|42237|P3|COMPLETED|Week 22 to Week 50||212
19252|NCT02937701|42238|P2|COMPLETED|Week 22 to Week 50||0
19253|NCT02937701|42239|P1|COMPLETED|Week 22 to Week 50||0
19254|NCT02937701|42235|P5|STARTED|Week 22 to Week 50||119
19255|NCT02937701|42236|P4|STARTED|Week 22 to Week 50||121
19256|NCT02937701|42237|P3|STARTED|Week 22 to Week 50||244
19257|NCT02937701|42238|P2|STARTED|Week 22 to Week 50||0
19258|NCT02937701|42239|P1|STARTED|Week 22 to Week 50||0
19259|NCT02937701|42235|P5|NOT COMPLETED|Day 1 to Week 22||0
19260|NCT02937701|42236|P4|NOT COMPLETED|Day 1 to Week 22||0
19261|NCT02937701|42237|P3|NOT COMPLETED|Day 1 to Week 22||0
19262|NCT02937701|42238|P2|NOT COMPLETED|Day 1 to Week 22||39
19263|NCT02937701|42239|P1|NOT COMPLETED|Day 1 to Week 22||35
19264|NCT02937701|42235|P5|COMPLETED|Day 1 to Week 22||0
19265|NCT02937701|42236|P4|COMPLETED|Day 1 to Week 22||0
19266|NCT02937701|42237|P3|COMPLETED|Day 1 to Week 22||0
19267|NCT02937701|42238|P2|COMPLETED|Day 1 to Week 22||240
19268|NCT02937701|42239|P1|COMPLETED|Day 1 to Week 22||244
19269|NCT02937701|42235|P5|Received Treatment|Day 1 to Week 22||0
19270|NCT02937701|42236|P4|Received Treatment|Day 1 to Week 22||0
19271|NCT02937701|42237|P3|Received Treatment|Day 1 to Week 22||0
19272|NCT02937701|42238|P2|Received Treatment|Day 1 to Week 22||278
19273|NCT02937701|42239|P1|Received Treatment|Day 1 to Week 22||278
19274|NCT02937701|42235|P5|STARTED|Day 1 to Week 22||0
19275|NCT02937701|42236|P4|STARTED|Day 1 to Week 22||0
19276|NCT02937701|42237|P3|STARTED|Day 1 to Week 22||0
19277|NCT02937701|42238|P2|STARTED|Day 1 to Week 22||279
19278|NCT02937701|42239|P1|STARTED|Day 1 to Week 22||279
19279|NCT02937636|42270|P2|NOT COMPLETED|Overall Study||2
19280|NCT02937636|42271|P1|NOT COMPLETED|Overall Study||3
19281|NCT02937636|42270|P2|COMPLETED|Overall Study||63
19282|NCT02937636|42271|P1|COMPLETED|Overall Study||60
19283|NCT02937636|42270|P2|STARTED|Overall Study||65
19284|NCT02937636|42271|P1|STARTED|Overall Study||63
19285|NCT02937623|42285|P2|NOT COMPLETED|Overall Study||0
19286|NCT02937623|42286|P1|NOT COMPLETED|Overall Study||0
19287|NCT02937623|42285|P2|COMPLETED|Overall Study||60
19288|NCT02937623|42286|P1|COMPLETED|Overall Study||60
19289|NCT02937623|42285|P2|STARTED|Overall Study||60
19290|NCT02937623|42286|P1|STARTED|Overall Study||60
19291|NCT02937584|42298|P2|NOT COMPLETED|Period 2||0
19292|NCT02937584|42299|P1|NOT COMPLETED|Period 2||0
19293|NCT02937584|42298|P2|COMPLETED|Period 2||9
19294|NCT02937584|42299|P1|COMPLETED|Period 2||10
19295|NCT02937584|42298|P2|STARTED|Period 2||9
19296|NCT02937584|42299|P1|STARTED|Period 2||10
19297|NCT02937584|42298|P2|NOT COMPLETED|Washout||1
19298|NCT02937584|42299|P1|NOT COMPLETED|Washout||0
19299|NCT02937584|42298|P2|COMPLETED|Washout||9
19300|NCT02937584|42299|P1|COMPLETED|Washout||10
19301|NCT02937584|42298|P2|STARTED|Washout||10
19302|NCT02937584|42299|P1|STARTED|Washout||10
19303|NCT02937584|42298|P2|NOT COMPLETED|Period 1||2
19304|NCT02937584|42299|P1|NOT COMPLETED|Period 1||1
19305|NCT02937584|42298|P2|COMPLETED|Period 1||10
19306|NCT02937584|42299|P1|COMPLETED|Period 1||10
19307|NCT02937584|42298|P2|STARTED|Period 1||12
19308|NCT02937584|42299|P1|STARTED|Period 1||11
19309|NCT02937506|42317|P2|NOT COMPLETED|Overall Study||0
19310|NCT02937506|42318|P1|NOT COMPLETED|Overall Study||0
19311|NCT02937506|42317|P2|COMPLETED|Overall Study||300
19312|NCT02937506|42318|P1|COMPLETED|Overall Study||300
19313|NCT02937506|42317|P2|STARTED|Overall Study||300
19314|NCT02937506|42318|P1|STARTED|Overall Study||300
19315|NCT02937168|42324|P3|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
19316|NCT02937168|42325|P2|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
19317|NCT02937168|42326|P1|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
19318|NCT02937168|42324|P3|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
19319|NCT02937168|42325|P2|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
19320|NCT02937168|42326|P1|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
19321|NCT02937168|42324|P3|STARTED|Double-Blind Treatment Period (6 Weeks)||0
19322|NCT02937168|42325|P2|STARTED|Double-Blind Treatment Period (6 Weeks)||0
19323|NCT02937168|42326|P1|STARTED|Double-Blind Treatment Period (6 Weeks)||0
19324|NCT02937168|42324|P3|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
19325|NCT02937168|42325|P2|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
19326|NCT02937168|42326|P1|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
19327|NCT02937168|42324|P3|COMPLETED|PET/CT Screening Period (21 Days)||0
19328|NCT02937168|42325|P2|COMPLETED|PET/CT Screening Period (21 Days)||0
19329|NCT02937168|42326|P1|COMPLETED|PET/CT Screening Period (21 Days)||5
19330|NCT02937168|42324|P3|STARTED|PET/CT Screening Period (21 Days)||0
19331|NCT02937168|42325|P2|STARTED|PET/CT Screening Period (21 Days)||0
19332|NCT02937168|42326|P1|STARTED|PET/CT Screening Period (21 Days)||5
19333|NCT02936869|42346|P2|NOT COMPLETED|Overall Study||5
19334|NCT02936869|42347|P1|NOT COMPLETED|Overall Study||2
19335|NCT02936869|42346|P2|COMPLETED|Overall Study||98
19336|NCT02936869|42347|P1|COMPLETED|Overall Study||102
19337|NCT02936869|42346|P2|STARTED|Overall Study||103
19338|NCT02936869|42347|P1|STARTED|Overall Study||104
19339|NCT02936648|42355|P1|NOT COMPLETED|Overall Study||0
19340|NCT02936648|42355|P1|COMPLETED|Overall Study||2209
19341|NCT02936648|42355|P1|STARTED|Overall Study||2209
19342|NCT02936479|42359|P1|NOT COMPLETED|Overall Study||0
19343|NCT02936479|42359|P1|COMPLETED|Overall Study||1
19344|NCT02936479|42359|P1|STARTED|Overall Study||1
19345|NCT02936076|42365|P2|NOT COMPLETED|Overall Study||4
19346|NCT02936076|42366|P1|NOT COMPLETED|Overall Study||6
19347|NCT02936076|42365|P2|COMPLETED|Overall Study||20
19348|NCT02936076|42366|P1|COMPLETED|Overall Study||19
19349|NCT02936076|42365|P2|STARTED|Overall Study||24
19350|NCT02936076|42366|P1|STARTED|Overall Study||25
19351|NCT02935894|42378|P1|NOT COMPLETED|Overall Study||1
19352|NCT02935894|42378|P1|COMPLETED|Overall Study||13
19353|NCT02935894|42378|P1|STARTED|Overall Study||14
19354|NCT02935699|42391|P2|NOT COMPLETED|Overall Study||0
19355|NCT02935699|42392|P1|NOT COMPLETED|Overall Study||0
19356|NCT02935699|42391|P2|COMPLETED|Overall Study||135
19357|NCT02935699|42392|P1|COMPLETED|Overall Study||127
19358|NCT02935699|42391|P2|STARTED|Overall Study||135
19359|NCT02935699|42392|P1|STARTED|Overall Study||127
19360|NCT02935192|42406|P2|NOT COMPLETED|Overall Study||4
19361|NCT02935192|42407|P1|NOT COMPLETED|Overall Study||8
19362|NCT02935192|42406|P2|COMPLETED|Overall Study||156
19363|NCT02935192|42407|P1|COMPLETED|Overall Study||312
19364|NCT02935192|42406|P2|Received Vaccine/Placebo|Overall Study||156
19365|NCT02935192|42407|P1|Received Vaccine/Placebo|Overall Study||312
19366|NCT02935192|42406|P2|STARTED|Overall Study|156 subjects were included in the Full Protocol Analysis because 4 withdrew without getting product.|160
19367|NCT02935192|42407|P1|STARTED|Overall Study|312 subjects were included in the Full Protocol Analysis because 8 withdrew without getting product.|320
19368|NCT02935179|42431|P2|NOT COMPLETED|Overall Study||1
19369|NCT02935179|42432|P1|NOT COMPLETED|Overall Study||1
19370|NCT02935179|42431|P2|COMPLETED|Overall Study||29
19371|NCT02935179|42432|P1|COMPLETED|Overall Study||29
19372|NCT02935179|42431|P2|STARTED|Overall Study||30
19373|NCT02935179|42432|P1|STARTED|Overall Study||30
19374|NCT02935036|42442|P2|NOT COMPLETED|Overall Study||11
19375|NCT02935036|42443|P1|NOT COMPLETED|Overall Study||10
19376|NCT02935036|42442|P2|COMPLETED|Overall Study||136
19377|NCT02935036|42443|P1|COMPLETED|Overall Study||137
19378|NCT02935036|42442|P2|STARTED|Overall Study||147
19379|NCT02935036|42443|P1|STARTED|Overall Study||147
19380|NCT02934932|42453|P1|NOT COMPLETED|Overall Study||3
19381|NCT02934932|42453|P1|COMPLETED|Overall Study||6
19382|NCT02934932|42453|P1|STARTED|Overall Study||9
19383|NCT02934698|42462|P1|NOT COMPLETED|Overall Study||0
19384|NCT02934698|42462|P1|COMPLETED|Overall Study||2
19385|NCT02934698|42462|P1|STARTED|Overall Study||2
19386|NCT02934347|42470|P2|NOT COMPLETED|Overall Study||0
19387|NCT02934347|42471|P1|NOT COMPLETED|Overall Study||0
19388|NCT02934347|42470|P2|COMPLETED|Overall Study||407
19389|NCT02934347|42471|P1|COMPLETED|Overall Study||374
19390|NCT02934347|42470|P2|STARTED|Overall Study||407
19391|NCT02934347|42471|P1|STARTED|Overall Study||374
19392|NCT02934191|42485|P2|NOT COMPLETED|Overall Study||0
19393|NCT02934191|42486|P1|NOT COMPLETED|Overall Study||0
19394|NCT02934191|42485|P2|COMPLETED|Overall Study||85
19395|NCT02934191|42486|P1|COMPLETED|Overall Study||87
19396|NCT02934191|42485|P2|STARTED|Overall Study||85
19397|NCT02934191|42486|P1|STARTED|Overall Study||87
19398|NCT02933879|42497|P3|NOT COMPLETED|Overall Study||17
19399|NCT02933879|42498|P2|NOT COMPLETED|Overall Study||14
19400|NCT02933879|42499|P1|NOT COMPLETED|Overall Study||16
19401|NCT02933879|42497|P3|COMPLETED|Overall Study||41
19402|NCT02933879|42498|P2|COMPLETED|Overall Study||48
19403|NCT02933879|42499|P1|COMPLETED|Overall Study||48
19404|NCT02933879|42497|P3|STARTED|Overall Study||58
19405|NCT02933879|42498|P2|STARTED|Overall Study||62
19406|NCT02933879|42499|P1|STARTED|Overall Study||64
19407|NCT02933866|42535|P2|NOT COMPLETED|Overall Study||9
19408|NCT02933866|42536|P1|NOT COMPLETED|Overall Study||12
19409|NCT02933866|42535|P2|COMPLETED|Overall Study||176
19410|NCT02933866|42536|P1|COMPLETED|Overall Study||174
19411|NCT02933866|42535|P2|STARTED|Overall Study||185
19412|NCT02933866|42536|P1|STARTED|Overall Study||186
19413|NCT02933528|42542|P1|NOT COMPLETED|Overall Study||2
19414|NCT02933528|42542|P1|COMPLETED|Overall Study||22
19415|NCT02933528|42542|P1|STARTED|Overall Study||24
19416|NCT02933502|42546|P1|NOT COMPLETED|Overall Study||0
19417|NCT02933502|42546|P1|COMPLETED|Overall Study||3
19418|NCT02933502|42546|P1|STARTED|Overall Study||3
19419|NCT02933476|42550|P1|NOT COMPLETED|Overall Study||0
19420|NCT02933476|42550|P1|COMPLETED|Overall Study||5
19421|NCT02933476|42550|P1|STARTED|Overall Study||5
19422|NCT02933450|42559|P2|NOT COMPLETED|Overall Study||8
19423|NCT02933450|42560|P1|NOT COMPLETED|Overall Study||5
19424|NCT02933450|42559|P2|COMPLETED|Overall Study||15
19425|NCT02933450|42560|P1|COMPLETED|Overall Study||15
19426|NCT02933450|42559|P2|STARTED|Overall Study||23
19427|NCT02933450|42560|P1|STARTED|Overall Study||20
19428|NCT02933060|42570|P2|NOT COMPLETED|Overall Study||1
19429|NCT02933060|42571|P1|NOT COMPLETED|Overall Study||0
19430|NCT02933060|42570|P2|COMPLETED|Overall Study||24
19431|NCT02933060|42571|P1|COMPLETED|Overall Study||25
19432|NCT02933060|42570|P2|STARTED|Overall Study||25
19433|NCT02933060|42571|P1|STARTED|Overall Study||25
19434|NCT02932943|42597|P2|NOT COMPLETED|Overall Study||7
19435|NCT02932943|42598|P1|NOT COMPLETED|Overall Study||5
19436|NCT02932943|42597|P2|COMPLETED|Overall Study||224
19437|NCT02932943|42598|P1|COMPLETED|Overall Study||222
19438|NCT02932943|42597|P2|STARTED|Overall Study||231
19439|NCT02932943|42598|P1|STARTED|Overall Study||227
19440|NCT02932904|42614|P4|NOT COMPLETED|Overall Study||14
19441|NCT02932904|42615|P3|NOT COMPLETED|Overall Study||23
19442|NCT02932904|42616|P2|NOT COMPLETED|Overall Study||18
19443|NCT02932904|42617|P1|NOT COMPLETED|Overall Study||16
19444|NCT02932904|42614|P4|COMPLETED|Overall Study||79
19445|NCT02932904|42615|P3|COMPLETED|Overall Study||68
19446|NCT02932904|42616|P2|COMPLETED|Overall Study||67
19447|NCT02932904|42617|P1|COMPLETED|Overall Study||76
19448|NCT02932904|42614|P4|Treated|Overall Study||91
19449|NCT02932904|42615|P3|Treated|Overall Study||91
19450|NCT02932904|42616|P2|Treated|Overall Study||84
19451|NCT02932904|42617|P1|Treated|Overall Study||91
19452|NCT02932904|42614|P4|STARTED|Overall Study||93
19453|NCT02932904|42615|P3|STARTED|Overall Study||91
19454|NCT02932904|42616|P2|STARTED|Overall Study||85
19455|NCT02932904|42617|P1|STARTED|Overall Study||92
19456|NCT02932891|42652|P1|NOT COMPLETED|Overall Study||4
19457|NCT02932891|42652|P1|COMPLETED|Overall Study||24
19458|NCT02932891|42652|P1|STARTED|Overall Study||28
19459|NCT02932878|42658|P2|NOT COMPLETED|Overall Study||1
19460|NCT02932878|42659|P1|NOT COMPLETED|Overall Study||2
19461|NCT02932878|42658|P2|COMPLETED|Overall Study||0
19462|NCT02932878|42659|P1|COMPLETED|Overall Study||13
19463|NCT02932878|42658|P2|STARTED|Overall Study||1
19464|NCT02932878|42659|P1|STARTED|Overall Study||15
19465|NCT02932462|42667|P2|NOT COMPLETED|Overall Study||13
19466|NCT02932462|42668|P1|NOT COMPLETED|Overall Study||7
19467|NCT02932462|42667|P2|COMPLETED|Overall Study||176
19468|NCT02932462|42668|P1|COMPLETED|Overall Study||177
19469|NCT02932462|42667|P2|STARTED|Overall Study||189
19470|NCT02932462|42668|P1|STARTED|Overall Study||184
19471|NCT02932267|42678|P1|NOT COMPLETED|Overall Study||8
19472|NCT02932267|42678|P1|COMPLETED|Overall Study||42
19473|NCT02932267|42678|P1|STARTED|Overall Study||50
19474|NCT02932228|42684|P2|NOT COMPLETED|Overall Study||28
19475|NCT02932228|42685|P1|NOT COMPLETED|Overall Study||10
19476|NCT02932228|42684|P2|COMPLETED|Overall Study||405
19477|NCT02932228|42685|P1|COMPLETED|Overall Study||140
19478|NCT02932228|42684|P2|STARTED|Overall Study||433
19479|NCT02932228|42685|P1|STARTED|Overall Study||150
19480|NCT02931396|42706|P2|NOT COMPLETED|Overall Study||0
19481|NCT02931396|42707|P1|NOT COMPLETED|Overall Study||5
19482|NCT02931396|42706|P2|COMPLETED|Overall Study||10
19483|NCT02931396|42707|P1|COMPLETED|Overall Study||5
19484|NCT02931396|42706|P2|STARTED|Overall Study||10
19485|NCT02931396|42707|P1|STARTED|Overall Study||10
19486|NCT02930980|42717|P1|NOT COMPLETED|Overall Study||0
19487|NCT02930980|42717|P1|COMPLETED|Overall Study||43
19488|NCT02930980|42717|P1|STARTED|Overall Study||43
19489|NCT02930837|42721|P1|NOT COMPLETED|Overall Study||12
19490|NCT02930837|42721|P1|COMPLETED|Overall Study|Completed the trial|108
19491|NCT02930837|42721|P1|STARTED|Overall Study|Started are treated patients|120
19492|NCT02930590|42731|P6|NOT COMPLETED|Third Intervention (2 Hours)||0
19493|NCT02930590|42732|P5|NOT COMPLETED|Third Intervention (2 Hours)||0
19494|NCT02930590|42733|P4|NOT COMPLETED|Third Intervention (2 Hours)||0
19495|NCT02930590|42734|P3|NOT COMPLETED|Third Intervention (2 Hours)||0
19496|NCT02930590|42735|P2|NOT COMPLETED|Third Intervention (2 Hours)||0
19497|NCT02930590|42736|P1|NOT COMPLETED|Third Intervention (2 Hours)||0
19498|NCT02930590|42731|P6|COMPLETED|Third Intervention (2 Hours)||2
19499|NCT02930590|42732|P5|COMPLETED|Third Intervention (2 Hours)||2
19500|NCT02930590|42733|P4|COMPLETED|Third Intervention (2 Hours)||2
19501|NCT02930590|42734|P3|COMPLETED|Third Intervention (2 Hours)||3
19502|NCT02930590|42735|P2|COMPLETED|Third Intervention (2 Hours)||3
19503|NCT02930590|42736|P1|COMPLETED|Third Intervention (2 Hours)||3
19504|NCT02930590|42731|P6|STARTED|Third Intervention (2 Hours)||2
19505|NCT02930590|42732|P5|STARTED|Third Intervention (2 Hours)||2
19506|NCT02930590|42733|P4|STARTED|Third Intervention (2 Hours)||2
19507|NCT02930590|42734|P3|STARTED|Third Intervention (2 Hours)||3
19508|NCT02930590|42735|P2|STARTED|Third Intervention (2 Hours)||3
19509|NCT02930590|42736|P1|STARTED|Third Intervention (2 Hours)||3
19510|NCT02930590|42731|P6|NOT COMPLETED|Second Intervention (2 Hours)||0
19511|NCT02930590|42732|P5|NOT COMPLETED|Second Intervention (2 Hours)||0
19512|NCT02930590|42733|P4|NOT COMPLETED|Second Intervention (2 Hours)||0
19513|NCT02930590|42734|P3|NOT COMPLETED|Second Intervention (2 Hours)||0
19514|NCT02930590|42735|P2|NOT COMPLETED|Second Intervention (2 Hours)||0
19515|NCT02930590|42736|P1|NOT COMPLETED|Second Intervention (2 Hours)||0
19516|NCT02930590|42731|P6|COMPLETED|Second Intervention (2 Hours)||2
19517|NCT02930590|42732|P5|COMPLETED|Second Intervention (2 Hours)||2
19518|NCT02930590|42733|P4|COMPLETED|Second Intervention (2 Hours)||2
19519|NCT02930590|42734|P3|COMPLETED|Second Intervention (2 Hours)||3
19520|NCT02930590|42735|P2|COMPLETED|Second Intervention (2 Hours)||3
19521|NCT02930590|42736|P1|COMPLETED|Second Intervention (2 Hours)||3
19522|NCT02930590|42731|P6|STARTED|Second Intervention (2 Hours)||2
19523|NCT02930590|42732|P5|STARTED|Second Intervention (2 Hours)||2
19524|NCT02930590|42733|P4|STARTED|Second Intervention (2 Hours)||2
19525|NCT02930590|42734|P3|STARTED|Second Intervention (2 Hours)||3
19526|NCT02930590|42735|P2|STARTED|Second Intervention (2 Hours)||3
19527|NCT02930590|42736|P1|STARTED|Second Intervention (2 Hours)||3
19528|NCT02930590|42731|P6|NOT COMPLETED|First Intervention (2 Hours)||0
19529|NCT02930590|42732|P5|NOT COMPLETED|First Intervention (2 Hours)||0
19530|NCT02930590|42733|P4|NOT COMPLETED|First Intervention (2 Hours)||0
19531|NCT02930590|42734|P3|NOT COMPLETED|First Intervention (2 Hours)||0
19532|NCT02930590|42735|P2|NOT COMPLETED|First Intervention (2 Hours)||0
19533|NCT02930590|42736|P1|NOT COMPLETED|First Intervention (2 Hours)||0
19534|NCT02930590|42731|P6|COMPLETED|First Intervention (2 Hours)||2
19535|NCT02930590|42732|P5|COMPLETED|First Intervention (2 Hours)||2
19536|NCT02930590|42733|P4|COMPLETED|First Intervention (2 Hours)||2
19537|NCT02930590|42734|P3|COMPLETED|First Intervention (2 Hours)||3
19538|NCT02930590|42735|P2|COMPLETED|First Intervention (2 Hours)||3
19539|NCT02930590|42736|P1|COMPLETED|First Intervention (2 Hours)||3
19540|NCT02930590|42731|P6|STARTED|First Intervention (2 Hours)||2
19541|NCT02930590|42732|P5|STARTED|First Intervention (2 Hours)||2
19542|NCT02930590|42733|P4|STARTED|First Intervention (2 Hours)||2
19543|NCT02930590|42734|P3|STARTED|First Intervention (2 Hours)||3
19544|NCT02930590|42735|P2|STARTED|First Intervention (2 Hours)||3
19545|NCT02930590|42736|P1|STARTED|First Intervention (2 Hours)||3
19546|NCT02930174|43013|P2|NOT COMPLETED|Overall Study||0
19547|NCT02930174|43014|P1|NOT COMPLETED|Overall Study||0
19548|NCT02930174|43013|P2|COMPLETED|Overall Study||8
19549|NCT02930174|43014|P1|COMPLETED|Overall Study||12
19550|NCT02930174|43013|P2|STARTED|Overall Study||8
19551|NCT02930174|43014|P1|STARTED|Overall Study||12
19552|NCT02930005|43031|P2|NOT COMPLETED|Overall Study||5
19553|NCT02930005|43032|P1|NOT COMPLETED|Overall Study||1
19554|NCT02930005|43031|P2|COMPLETED|Overall Study||1
19555|NCT02930005|43032|P1|COMPLETED|Overall Study||1
19556|NCT02930005|43031|P2|Completed 2 Weeks|Overall Study||2
19557|NCT02930005|43032|P1|Completed 2 Weeks|Overall Study||2
19558|NCT02930005|43031|P2|STARTED|Overall Study||6
19559|NCT02930005|43032|P1|STARTED|Overall Study||2
19560|NCT02929823|43043|P3|NOT COMPLETED|Overall Study||4
19561|NCT02929823|43044|P2|NOT COMPLETED|Overall Study||6
19562|NCT02929823|43045|P1|NOT COMPLETED|Overall Study||3
19563|NCT02929823|43043|P3|COMPLETED|Overall Study||38
19564|NCT02929823|43044|P2|COMPLETED|Overall Study||40
19565|NCT02929823|43045|P1|COMPLETED|Overall Study||39
19566|NCT02929823|43043|P3|STARTED|Overall Study||42
19567|NCT02929823|43044|P2|STARTED|Overall Study||46
19568|NCT02929823|43045|P1|STARTED|Overall Study||42
19569|NCT02929498|43056|P3|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
19570|NCT02929498|43057|P2|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
19571|NCT02929498|43058|P1|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
19572|NCT02929498|43056|P3|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
19573|NCT02929498|43057|P2|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
19574|NCT02929498|43058|P1|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
19575|NCT02929498|43056|P3|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
19576|NCT02929498|43057|P2|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
19577|NCT02929498|43058|P1|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
19578|NCT02929498|43056|P3|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
19579|NCT02929498|43057|P2|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
19580|NCT02929498|43058|P1|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||5
19581|NCT02929498|43056|P3|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
19582|NCT02929498|43057|P2|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
19583|NCT02929498|43058|P1|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
19584|NCT02929498|43056|P3|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||0
19585|NCT02929498|43057|P2|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||0
19586|NCT02929498|43058|P1|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||5
19587|NCT02929407|43152|P1|NOT COMPLETED|Overall Study||1
19588|NCT02929407|43152|P1|COMPLETED|Overall Study||3
19589|NCT02929407|43152|P1|STARTED|Overall Study||4
19590|NCT02928770|43167|P1|NOT COMPLETED|Overall Study||2
19591|NCT02928770|43167|P1|COMPLETED|Overall Study||30
19592|NCT02928770|43167|P1|STARTED|Overall Study||32
19593|NCT02928536|43171|P1|NOT COMPLETED|Overall Study||0
19594|NCT02928536|43171|P1|COMPLETED|Overall Study||11902
19595|NCT02928536|43171|P1|STARTED|Overall Study||11902
19596|NCT02928380|43178|P6|NOT COMPLETED|Period 3||0
19597|NCT02928380|43179|P5|NOT COMPLETED|Period 3||0
19598|NCT02928380|43180|P4|NOT COMPLETED|Period 3||0
19599|NCT02928380|43181|P3|NOT COMPLETED|Period 3||0
19600|NCT02928380|43182|P2|NOT COMPLETED|Period 3||0
19601|NCT02928380|43183|P1|NOT COMPLETED|Period 3||0
19602|NCT02928380|43178|P6|COMPLETED|Period 3||14
19603|NCT02928380|43179|P5|COMPLETED|Period 3||14
19604|NCT02928380|43180|P4|COMPLETED|Period 3||14
19605|NCT02928380|43181|P3|COMPLETED|Period 3||14
19606|NCT02928380|43182|P2|COMPLETED|Period 3||14
19607|NCT02928380|43183|P1|COMPLETED|Period 3||13
19608|NCT02928380|43178|P6|STARTED|Period 3||14
19609|NCT02928380|43179|P5|STARTED|Period 3||14
19610|NCT02928380|43180|P4|STARTED|Period 3||14
19611|NCT02928380|43181|P3|STARTED|Period 3||14
19612|NCT02928380|43182|P2|STARTED|Period 3||14
19613|NCT02928380|43183|P1|STARTED|Period 3||13
19614|NCT02928380|43178|P6|NOT COMPLETED|Wash Out Period 2||0
19615|NCT02928380|43179|P5|NOT COMPLETED|Wash Out Period 2||0
19616|NCT02928380|43180|P4|NOT COMPLETED|Wash Out Period 2||0
19617|NCT02928380|43181|P3|NOT COMPLETED|Wash Out Period 2||0
19618|NCT02928380|43182|P2|NOT COMPLETED|Wash Out Period 2||0
19619|NCT02928380|43183|P1|NOT COMPLETED|Wash Out Period 2||0
19620|NCT02928380|43178|P6|COMPLETED|Wash Out Period 2||14
19621|NCT02928380|43179|P5|COMPLETED|Wash Out Period 2||14
19622|NCT02928380|43180|P4|COMPLETED|Wash Out Period 2||14
19623|NCT02928380|43181|P3|COMPLETED|Wash Out Period 2||14
19624|NCT02928380|43182|P2|COMPLETED|Wash Out Period 2||14
19625|NCT02928380|43183|P1|COMPLETED|Wash Out Period 2||13
19626|NCT02928380|43178|P6|STARTED|Wash Out Period 2||14
19627|NCT02928380|43179|P5|STARTED|Wash Out Period 2||14
19628|NCT02928380|43180|P4|STARTED|Wash Out Period 2||14
19629|NCT02928380|43181|P3|STARTED|Wash Out Period 2||14
19630|NCT02928380|43182|P2|STARTED|Wash Out Period 2||14
19631|NCT02928380|43183|P1|STARTED|Wash Out Period 2||13
19632|NCT02928380|43178|P6|NOT COMPLETED|Period 2||0
19633|NCT02928380|43179|P5|NOT COMPLETED|Period 2||0
19634|NCT02928380|43180|P4|NOT COMPLETED|Period 2||0
19635|NCT02928380|43181|P3|NOT COMPLETED|Period 2||0
19636|NCT02928380|43182|P2|NOT COMPLETED|Period 2||0
19637|NCT02928380|43183|P1|NOT COMPLETED|Period 2||0
19638|NCT02928380|43178|P6|COMPLETED|Period 2||14
19639|NCT02928380|43179|P5|COMPLETED|Period 2||14
19640|NCT02928380|43180|P4|COMPLETED|Period 2||14
19641|NCT02928380|43181|P3|COMPLETED|Period 2||14
19642|NCT02928380|43182|P2|COMPLETED|Period 2||14
19643|NCT02928380|43183|P1|COMPLETED|Period 2||13
19644|NCT02928380|43178|P6|STARTED|Period 2||14
19645|NCT02928380|43179|P5|STARTED|Period 2||14
19646|NCT02928380|43180|P4|STARTED|Period 2||14
19647|NCT02928380|43181|P3|STARTED|Period 2||14
19648|NCT02928380|43182|P2|STARTED|Period 2||14
19649|NCT02928380|43183|P1|STARTED|Period 2||13
19650|NCT02928380|43178|P6|NOT COMPLETED|Wash Out Period 1||0
19651|NCT02928380|43179|P5|NOT COMPLETED|Wash Out Period 1||0
19652|NCT02928380|43180|P4|NOT COMPLETED|Wash Out Period 1||0
19653|NCT02928380|43181|P3|NOT COMPLETED|Wash Out Period 1||0
19654|NCT02928380|43182|P2|NOT COMPLETED|Wash Out Period 1||0
19655|NCT02928380|43183|P1|NOT COMPLETED|Wash Out Period 1||0
19656|NCT02928380|43178|P6|COMPLETED|Wash Out Period 1||14
19657|NCT02928380|43179|P5|COMPLETED|Wash Out Period 1||14
19658|NCT02928380|43180|P4|COMPLETED|Wash Out Period 1||14
19659|NCT02928380|43181|P3|COMPLETED|Wash Out Period 1||14
19660|NCT02928380|43182|P2|COMPLETED|Wash Out Period 1||14
19661|NCT02928380|43183|P1|COMPLETED|Wash Out Period 1||13
19662|NCT02928380|43178|P6|STARTED|Wash Out Period 1||14
19663|NCT02928380|43179|P5|STARTED|Wash Out Period 1||14
19664|NCT02928380|43180|P4|STARTED|Wash Out Period 1||14
19665|NCT02928380|43181|P3|STARTED|Wash Out Period 1||14
19666|NCT02928380|43182|P2|STARTED|Wash Out Period 1||14
19667|NCT02928380|43183|P1|STARTED|Wash Out Period 1||13
19668|NCT02928380|43178|P6|NOT COMPLETED|Period 1||0
19669|NCT02928380|43179|P5|NOT COMPLETED|Period 1||0
19670|NCT02928380|43180|P4|NOT COMPLETED|Period 1||0
19671|NCT02928380|43181|P3|NOT COMPLETED|Period 1||0
19672|NCT02928380|43182|P2|NOT COMPLETED|Period 1||0
19673|NCT02928380|43183|P1|NOT COMPLETED|Period 1||0
19674|NCT02928380|43178|P6|COMPLETED|Period 1||14
19675|NCT02928380|43179|P5|COMPLETED|Period 1||14
19676|NCT02928380|43180|P4|COMPLETED|Period 1||14
19677|NCT02928380|43181|P3|COMPLETED|Period 1||14
19678|NCT02928380|43182|P2|COMPLETED|Period 1||14
19679|NCT02928380|43183|P1|COMPLETED|Period 1||13
19680|NCT02928380|43178|P6|STARTED|Period 1||14
19681|NCT02928380|43179|P5|STARTED|Period 1||14
19682|NCT02928380|43180|P4|STARTED|Period 1||14
19683|NCT02928380|43181|P3|STARTED|Period 1||14
19684|NCT02928380|43182|P2|STARTED|Period 1||14
19685|NCT02928380|43183|P1|STARTED|Period 1||13
19686|NCT02927795|43203|P1|NOT COMPLETED|Overall Study||23
19687|NCT02927795|43203|P1|COMPLETED|Overall Study||234
19688|NCT02927795|43203|P1|Treated|Overall Study||253
19689|NCT02927795|43203|P1|STARTED|Overall Study||257
19690|NCT02927457|43214|P2|NOT COMPLETED|Overall Study||0
19691|NCT02927457|43215|P1|NOT COMPLETED|Overall Study||0
19692|NCT02927457|43214|P2|COMPLETED|Overall Study||11
19693|NCT02927457|43215|P1|COMPLETED|Overall Study||0
19694|NCT02927457|43214|P2|STARTED|Overall Study||11
19695|NCT02927457|43215|P1|STARTED|Overall Study||0
19696|NCT02927431|43250|P3|NOT COMPLETED|Overall Study||1
19697|NCT02927431|43251|P2|NOT COMPLETED|Overall Study||0
19698|NCT02927431|43252|P1|NOT COMPLETED|Overall Study||0
19699|NCT02927431|43250|P3|COMPLETED|Overall Study||3
19700|NCT02927431|43251|P2|COMPLETED|Overall Study||4
19701|NCT02927431|43252|P1|COMPLETED|Overall Study||2
19702|NCT02927431|43250|P3|STARTED|Overall Study||4
19703|NCT02927431|43251|P2|STARTED|Overall Study||4
19704|NCT02927431|43252|P1|STARTED|Overall Study||2
19705|NCT02927366|43330|P2|NOT COMPLETED|Overall Study||0
19706|NCT02927366|43331|P1|NOT COMPLETED|Overall Study||2
19707|NCT02927366|43330|P2|COMPLETED|Overall Study||2
19708|NCT02927366|43331|P1|COMPLETED|Overall Study||4
19709|NCT02927366|43330|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||0
19710|NCT02927366|43331|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||4
19711|NCT02927366|43330|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||2
19712|NCT02927366|43331|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||6
19713|NCT02927366|43330|P2|STARTED|Overall Study||2
19714|NCT02927366|43331|P1|STARTED|Overall Study||6
19715|NCT02927327|43365|P2|NOT COMPLETED|Overall Study||0
19716|NCT02927327|43366|P1|NOT COMPLETED|Overall Study||0
19717|NCT02927327|43365|P2|COMPLETED|Overall Study||31
19718|NCT02927327|43366|P1|COMPLETED|Overall Study||30
19719|NCT02927327|43365|P2|STARTED|Overall Study||31
19720|NCT02927327|43366|P1|STARTED|Overall Study||30
19721|NCT02926573|43380|P2|NOT COMPLETED|Overall Study||9
19722|NCT02926573|43381|P1|NOT COMPLETED|Overall Study||11
19723|NCT02926573|43380|P2|COMPLETED|Overall Study||46
19724|NCT02926573|43381|P1|COMPLETED|Overall Study||44
19725|NCT02926573|43380|P2|STARTED|Overall Study||55
19726|NCT02926573|43381|P1|STARTED|Overall Study||55
19727|NCT02926209|43399|P2|NOT COMPLETED|Training Cohort - First Patients||0
19728|NCT02926209|43400|P1|NOT COMPLETED|Training Cohort - First Patients||0
19729|NCT02926209|43399|P2|COMPLETED|Training Cohort - First Patients||0
19730|NCT02926209|43400|P1|COMPLETED|Training Cohort - First Patients||20
19731|NCT02926209|43399|P2|STARTED|Training Cohort - First Patients||0
19732|NCT02926209|43400|P1|STARTED|Training Cohort - First Patients||20
19733|NCT02926209|43399|P2|NOT COMPLETED|Study Cohort||0
19734|NCT02926209|43400|P1|NOT COMPLETED|Study Cohort||1
19735|NCT02926209|43399|P2|COMPLETED|Study Cohort||37
19736|NCT02926209|43400|P1|COMPLETED|Study Cohort||41
19737|NCT02926209|43399|P2|STARTED|Study Cohort||37
19738|NCT02926209|43400|P1|STARTED|Study Cohort|Training cohort patients Aer-O-Scope as first followed by a conventional colonoscopy|42
19739|NCT02925858|43413|P2|NOT COMPLETED|Overall Study||0
19740|NCT02925858|43414|P1|NOT COMPLETED|Overall Study||0
19741|NCT02925858|43413|P2|COMPLETED|Overall Study||38
19742|NCT02925858|43414|P1|COMPLETED|Overall Study||42
19743|NCT02925858|43413|P2|STARTED|Overall Study||38
19744|NCT02925858|43414|P1|STARTED|Overall Study||42
19745|NCT02925741|43440|P2|NOT COMPLETED|Overall Study||0
19746|NCT02925741|43441|P1|NOT COMPLETED|Overall Study||0
19747|NCT02925741|43440|P2|COMPLETED|Overall Study||1706
19748|NCT02925741|43441|P1|COMPLETED|Overall Study||1626
19749|NCT02925741|43440|P2|STARTED|Overall Study||1706
19750|NCT02925741|43441|P1|STARTED|Overall Study||1626
19751|NCT02925611|43453|P2|NOT COMPLETED|Overall Study||0
19752|NCT02925611|43454|P1|NOT COMPLETED|Overall Study||0
19753|NCT02925611|43453|P2|COMPLETED|Overall Study||30
19754|NCT02925611|43454|P1|COMPLETED|Overall Study||30
19755|NCT02925611|43453|P2|STARTED|Overall Study||30
19756|NCT02925611|43454|P1|STARTED|Overall Study||30
19757|NCT02925403|43472|P2|NOT COMPLETED|Overall Study||1
19758|NCT02925403|43473|P1|NOT COMPLETED|Overall Study||0
19759|NCT02925403|43472|P2|COMPLETED|Overall Study||4
19760|NCT02925403|43473|P1|COMPLETED|Overall Study||8
19761|NCT02925403|43472|P2|STARTED|Overall Study||5
19762|NCT02925403|43473|P1|STARTED|Overall Study||8
19763|NCT02924883|43487|P2|NOT COMPLETED|Overall Study||133
19764|NCT02924883|43488|P1|NOT COMPLETED|Overall Study||69
19765|NCT02924883|43487|P2|COMPLETED|Overall Study||0
19766|NCT02924883|43488|P1|COMPLETED|Overall Study||0
19767|NCT02924883|43487|P2|STARTED|Overall Study||133
19768|NCT02924883|43488|P1|STARTED|Overall Study||69
19769|NCT02924350|43509|P2|NOT COMPLETED|Overall Study||2
19770|NCT02924350|43510|P1|NOT COMPLETED|Overall Study||0
19771|NCT02924350|43509|P2|COMPLETED|Overall Study||100
19772|NCT02924350|43510|P1|COMPLETED|Overall Study||102
19773|NCT02924350|43509|P2|STARTED|Overall Study||102
19774|NCT02924350|43510|P1|STARTED|Overall Study||102
19775|NCT02924051|43522|P2|NOT COMPLETED|Overall Study||9
19776|NCT02924051|43523|P1|NOT COMPLETED|Overall Study||1
19777|NCT02924051|43522|P2|COMPLETED|Overall Study||97
19778|NCT02924051|43523|P1|COMPLETED|Overall Study||81
19779|NCT02924051|43522|P2|STARTED|Overall Study||106
19780|NCT02924051|43523|P1|STARTED|Overall Study||82
19781|NCT02923895|43535|P2|NOT COMPLETED|Overall Study||0
19782|NCT02923895|43536|P1|NOT COMPLETED|Overall Study||0
19783|NCT02923895|43535|P2|COMPLETED|Overall Study||95
19784|NCT02923895|43536|P1|COMPLETED|Overall Study||97
19785|NCT02923895|43535|P2|STARTED|Overall Study||95
19786|NCT02923895|43536|P1|STARTED|Overall Study||97
19787|NCT02923830|43550|P2|NOT COMPLETED|Overall Study||15
19788|NCT02923830|43551|P1|NOT COMPLETED|Overall Study||13
19789|NCT02923830|43550|P2|COMPLETED|Overall Study|Study terminated|0
19790|NCT02923830|43551|P1|COMPLETED|Overall Study|Study terminated|0
19791|NCT02923830|43550|P2|STARTED|Overall Study||15
19792|NCT02923830|43551|P1|STARTED|Overall Study||13
19793|NCT02923271|43571|P2|NOT COMPLETED|Overall Study||2
19794|NCT02923271|43572|P1|NOT COMPLETED|Overall Study||8
19795|NCT02923271|43571|P2|COMPLETED|Overall Study||14
19796|NCT02923271|43572|P1|COMPLETED|Overall Study||10
19797|NCT02923271|43571|P2|STARTED|Overall Study||16
19798|NCT02923271|43572|P1|STARTED|Overall Study||18
19799|NCT02923245|43582|P2|NOT COMPLETED|Overall Study||1
19800|NCT02923245|43583|P1|NOT COMPLETED|Overall Study||2
19801|NCT02923245|43582|P2|COMPLETED|Overall Study||59
19802|NCT02923245|43583|P1|COMPLETED|Overall Study||58
19803|NCT02923245|43582|P2|STARTED|Overall Study||60
19804|NCT02923245|43583|P1|STARTED|Overall Study||60
19805|NCT02922985|43602|P2|NOT COMPLETED|Overall Study||0
19806|NCT02922985|43603|P1|NOT COMPLETED|Overall Study||0
19807|NCT02922985|43602|P2|COMPLETED|Overall Study||60
19808|NCT02922985|43603|P1|COMPLETED|Overall Study||60
19809|NCT02922985|43602|P2|STARTED|Overall Study||60
19810|NCT02922985|43603|P1|STARTED|Overall Study||60
19811|NCT02922868|43629|P2|NOT COMPLETED|Overall Study||0
19812|NCT02922868|43630|P1|NOT COMPLETED|Overall Study||0
19813|NCT02922868|43629|P2|COMPLETED|Overall Study||30
19814|NCT02922868|43630|P1|COMPLETED|Overall Study||30
19815|NCT02922868|43629|P2|STARTED|Overall Study||30
19816|NCT02922868|43630|P1|STARTED|Overall Study||30
19817|NCT02922738|43650|P2|NOT COMPLETED|Overall Study||0
19818|NCT02922738|43651|P1|NOT COMPLETED|Overall Study||0
19819|NCT02922738|43650|P2|COMPLETED|Overall Study||290
19820|NCT02922738|43651|P1|COMPLETED|Overall Study||175
19821|NCT02922738|43650|P2|STARTED|Overall Study|275 patients and 15 providers|290
19822|NCT02922738|43651|P1|STARTED|Overall Study|158 patients and 17 providers|175
19823|NCT02921425|43659|P1|NOT COMPLETED|Overall Study||9
19824|NCT02921425|43659|P1|COMPLETED|Overall Study||38
19825|NCT02921425|43659|P1|Second Visit|Overall Study|Participants had to wear an accelerometer and make entries into their PHR over the previous 7 days.|47
19826|NCT02921425|43659|P1|STARTED|Overall Study||47
19827|NCT02921412|43673|P1|NOT COMPLETED|Overall Study||0
19828|NCT02921412|43673|P1|COMPLETED|Overall Study||36
19829|NCT02921412|43673|P1|STARTED|Overall Study||36
19830|NCT02921386|43696|P1|NOT COMPLETED|Sequence E: FDA High Fat Breakfast||0
19831|NCT02921386|43696|P1|COMPLETED|Sequence E: FDA High Fat Breakfast||18
19832|NCT02921386|43696|P1|STARTED|Sequence E: FDA High Fat Breakfast||18
19833|NCT02921386|43696|P1|NOT COMPLETED|Sequence D: 45 g Fat Breakfast||0
19834|NCT02921386|43696|P1|COMPLETED|Sequence D: 45 g Fat Breakfast||18
19835|NCT02921386|43696|P1|STARTED|Sequence D: 45 g Fat Breakfast||18
19836|NCT02921386|43696|P1|NOT COMPLETED|Sequence C: 30 g Fat Breakfast||0
19837|NCT02921386|43696|P1|COMPLETED|Sequence C: 30 g Fat Breakfast||18
19838|NCT02921386|43696|P1|STARTED|Sequence C: 30 g Fat Breakfast||18
19839|NCT02921386|43696|P1|NOT COMPLETED|Sequence B: 15 g Fat Breakfast||0
19840|NCT02921386|43696|P1|COMPLETED|Sequence B: 15 g Fat Breakfast||18
19841|NCT02921386|43696|P1|STARTED|Sequence B: 15 g Fat Breakfast||18
19842|NCT02921386|43696|P1|NOT COMPLETED|Sequence A: Fasting||0
19843|NCT02921386|43696|P1|COMPLETED|Sequence A: Fasting||18
19844|NCT02921386|43696|P1|STARTED|Sequence A: Fasting||18
19845|NCT02921295|43719|P1|NOT COMPLETED|Conventional Prostheses||0
19846|NCT02921295|43719|P1|COMPLETED|Conventional Prostheses||1
19847|NCT02921295|43719|P1|STARTED|Conventional Prostheses||1
19848|NCT02921295|43719|P1|NOT COMPLETED|Sidekicks||0
19849|NCT02921295|43719|P1|COMPLETED|Sidekicks||1
19850|NCT02921295|43719|P1|STARTED|Sidekicks||1
19851|NCT02921087|43731|P2|NOT COMPLETED|Overall Study||1
19852|NCT02921087|43732|P1|NOT COMPLETED|Overall Study||0
19853|NCT02921087|43731|P2|COMPLETED|Overall Study|One subject dropped out prior to 1 week of lens wear while wearing the control lens (lens 1).|10
19854|NCT02921087|43732|P1|COMPLETED|Overall Study||12
19855|NCT02921087|43731|P2|STARTED|Overall Study||11
19856|NCT02921087|43732|P1|STARTED|Overall Study||12
19857|NCT02920983|43752|P6|NOT COMPLETED|Dispense 3||0
19858|NCT02920983|43753|P5|NOT COMPLETED|Dispense 3||1
19859|NCT02920983|43754|P4|NOT COMPLETED|Dispense 3||0
19860|NCT02920983|43755|P3|NOT COMPLETED|Dispense 3||0
19861|NCT02920983|43756|P2|NOT COMPLETED|Dispense 3||1
19862|NCT02920983|43757|P1|NOT COMPLETED|Dispense 3||1
19863|NCT02920983|43752|P6|COMPLETED|Dispense 3||7
19864|NCT02920983|43753|P5|COMPLETED|Dispense 3||12
19865|NCT02920983|43754|P4|COMPLETED|Dispense 3||6
19866|NCT02920983|43755|P3|COMPLETED|Dispense 3||7
19867|NCT02920983|43756|P2|COMPLETED|Dispense 3||9
19868|NCT02920983|43757|P1|COMPLETED|Dispense 3||7
19869|NCT02920983|43752|P6|STARTED|Dispense 3||7
19870|NCT02920983|43753|P5|STARTED|Dispense 3||13
19871|NCT02920983|43754|P4|STARTED|Dispense 3||6
19872|NCT02920983|43755|P3|STARTED|Dispense 3||7
19873|NCT02920983|43756|P2|STARTED|Dispense 3||10
19874|NCT02920983|43757|P1|STARTED|Dispense 3||8
19875|NCT02920983|43752|P6|NOT COMPLETED|Dispense 2||0
19876|NCT02920983|43753|P5|NOT COMPLETED|Dispense 2||1
19877|NCT02920983|43754|P4|NOT COMPLETED|Dispense 2||0
19878|NCT02920983|43755|P3|NOT COMPLETED|Dispense 2||0
19879|NCT02920983|43756|P2|NOT COMPLETED|Dispense 2||0
19880|NCT02920983|43757|P1|NOT COMPLETED|Dispense 2||1
19881|NCT02920983|43752|P6|COMPLETED|Dispense 2||7
19882|NCT02920983|43753|P5|COMPLETED|Dispense 2||12
19883|NCT02920983|43754|P4|COMPLETED|Dispense 2||6
19884|NCT02920983|43755|P3|COMPLETED|Dispense 2||7
19885|NCT02920983|43756|P2|COMPLETED|Dispense 2||10
19886|NCT02920983|43757|P1|COMPLETED|Dispense 2||7
19887|NCT02920983|43752|P6|STARTED|Dispense 2||7
19888|NCT02920983|43753|P5|STARTED|Dispense 2||13
19889|NCT02920983|43754|P4|STARTED|Dispense 2||6
19890|NCT02920983|43755|P3|STARTED|Dispense 2||7
19891|NCT02920983|43756|P2|STARTED|Dispense 2||10
19892|NCT02920983|43757|P1|STARTED|Dispense 2||8
19893|NCT02920983|43752|P6|NOT COMPLETED|Dispense 1||0
19894|NCT02920983|43753|P5|NOT COMPLETED|Dispense 1||1
19895|NCT02920983|43754|P4|NOT COMPLETED|Dispense 1||0
19896|NCT02920983|43755|P3|NOT COMPLETED|Dispense 1||0
19897|NCT02920983|43756|P2|NOT COMPLETED|Dispense 1||0
19898|NCT02920983|43757|P1|NOT COMPLETED|Dispense 1||0
19899|NCT02920983|43752|P6|COMPLETED|Dispense 1||7
19900|NCT02920983|43753|P5|COMPLETED|Dispense 1||12
19901|NCT02920983|43754|P4|COMPLETED|Dispense 1||6
19902|NCT02920983|43755|P3|COMPLETED|Dispense 1||7
19903|NCT02920983|43756|P2|COMPLETED|Dispense 1||10
19904|NCT02920983|43757|P1|COMPLETED|Dispense 1||8
19905|NCT02920983|43752|P6|STARTED|Dispense 1||7
19906|NCT02920983|43753|P5|STARTED|Dispense 1||13
19907|NCT02920983|43754|P4|STARTED|Dispense 1||6
19908|NCT02920983|43755|P3|STARTED|Dispense 1||7
19909|NCT02920983|43756|P2|STARTED|Dispense 1||10
19910|NCT02920983|43757|P1|STARTED|Dispense 1||8
19911|NCT02920970|43786|P2|NOT COMPLETED|Second Intervention||0
19912|NCT02920970|43787|P1|NOT COMPLETED|Second Intervention||1
19913|NCT02920970|43786|P2|COMPLETED|Second Intervention||30
19914|NCT02920970|43787|P1|COMPLETED|Second Intervention||37
19915|NCT02920970|43786|P2|STARTED|Second Intervention||30
19916|NCT02920970|43787|P1|STARTED|Second Intervention||38
19917|NCT02920970|43786|P2|NOT COMPLETED|First Intervention||2
19918|NCT02920970|43787|P1|NOT COMPLETED|First Intervention||0
19919|NCT02920970|43786|P2|COMPLETED|First Intervention||30
19920|NCT02920970|43787|P1|COMPLETED|First Intervention||38
19921|NCT02920970|43786|P2|STARTED|First Intervention||32
19922|NCT02920970|43787|P1|STARTED|First Intervention||38
19923|NCT02920957|43813|P2|NOT COMPLETED|Second Intervention: 1 Month||1
19924|NCT02920957|43814|P1|NOT COMPLETED|Second Intervention: 1 Month||0
19925|NCT02920957|43813|P2|COMPLETED|Second Intervention: 1 Month||40
19926|NCT02920957|43814|P1|COMPLETED|Second Intervention: 1 Month||42
19927|NCT02920957|43813|P2|STARTED|Second Intervention: 1 Month||41
19928|NCT02920957|43814|P1|STARTED|Second Intervention: 1 Month||42
19929|NCT02920957|43813|P2|NOT COMPLETED|First Intervention : 1 Month||0
19930|NCT02920957|43814|P1|NOT COMPLETED|First Intervention : 1 Month||4
19931|NCT02920957|43813|P2|COMPLETED|First Intervention : 1 Month||41
19932|NCT02920957|43814|P1|COMPLETED|First Intervention : 1 Month||42
19933|NCT02920957|43813|P2|STARTED|First Intervention : 1 Month||41
19934|NCT02920957|43814|P1|STARTED|First Intervention : 1 Month||46
19935|NCT02920918|43868|P2|NOT COMPLETED|Overall Study||0
19936|NCT02920918|43869|P1|NOT COMPLETED|Overall Study||0
19937|NCT02920918|43868|P2|COMPLETED|Overall Study||19
19938|NCT02920918|43869|P1|COMPLETED|Overall Study||17
19939|NCT02920918|43868|P2|STARTED|Overall Study||19
19940|NCT02920918|43869|P1|STARTED|Overall Study||17
19941|NCT02920749|43881|P4|NOT COMPLETED|Overall Study||0
19942|NCT02920749|43882|P3|NOT COMPLETED|Overall Study||0
19943|NCT02920749|43883|P2|NOT COMPLETED|Overall Study||0
19944|NCT02920749|43884|P1|NOT COMPLETED|Overall Study||0
19945|NCT02920749|43881|P4|COMPLETED|Overall Study||30
19946|NCT02920749|43882|P3|COMPLETED|Overall Study||30
19947|NCT02920749|43883|P2|COMPLETED|Overall Study||30
19948|NCT02920749|43884|P1|COMPLETED|Overall Study||30
19949|NCT02920749|43881|P4|STARTED|Overall Study||30
19950|NCT02920749|43882|P3|STARTED|Overall Study||30
19951|NCT02920749|43883|P2|STARTED|Overall Study||30
19952|NCT02920749|43884|P1|STARTED|Overall Study||30
19953|NCT02920450|43898|P4|NOT COMPLETED|Overall Study||0
19954|NCT02920450|43899|P3|NOT COMPLETED|Overall Study||0
19955|NCT02920450|43900|P2|NOT COMPLETED|Overall Study||0
19956|NCT02920450|43901|P1|NOT COMPLETED|Overall Study||2
19957|NCT02920450|43898|P4|COMPLETED|Overall Study||0
19958|NCT02920450|43899|P3|COMPLETED|Overall Study||0
19959|NCT02920450|43900|P2|COMPLETED|Overall Study||0
19960|NCT02920450|43901|P1|COMPLETED|Overall Study||1
19961|NCT02920450|43898|P4|STARTED|Overall Study||0
19962|NCT02920450|43899|P3|STARTED|Overall Study||0
19963|NCT02920450|43900|P2|STARTED|Overall Study||0
19964|NCT02920450|43901|P1|STARTED|Overall Study||3
19965|NCT02920242|43912|P3|NOT COMPLETED|Overall Study||1
19966|NCT02920242|43913|P2|NOT COMPLETED|Overall Study||0
19967|NCT02920242|43914|P1|NOT COMPLETED|Overall Study||2
19968|NCT02920242|43912|P3|COMPLETED|Overall Study||3
19969|NCT02920242|43913|P2|COMPLETED|Overall Study||11
19970|NCT02920242|43914|P1|COMPLETED|Overall Study||11
19971|NCT02920242|43912|P3|Safety Set|Overall Study||4
19972|NCT02920242|43913|P2|Safety Set|Overall Study||11
19973|NCT02920242|43914|P1|Safety Set|Overall Study||12
19974|NCT02920242|43912|P3|STARTED|Overall Study||4
19975|NCT02920242|43913|P2|STARTED|Overall Study||11
19976|NCT02920242|43914|P1|STARTED|Overall Study||13
19977|NCT02919995|43946|P6|NOT COMPLETED|Overall Study||1
19978|NCT02919995|43947|P5|NOT COMPLETED|Overall Study||0
19979|NCT02919995|43948|P4|NOT COMPLETED|Overall Study||0
19980|NCT02919995|43949|P3|NOT COMPLETED|Overall Study||0
19981|NCT02919995|43950|P2|NOT COMPLETED|Overall Study||0
19982|NCT02919995|43951|P1|NOT COMPLETED|Overall Study||0
19983|NCT02919995|43946|P6|COMPLETED|Overall Study||1
19984|NCT02919995|43947|P5|COMPLETED|Overall Study||1
19985|NCT02919995|43948|P4|COMPLETED|Overall Study||2
19986|NCT02919995|43949|P3|COMPLETED|Overall Study||2
19987|NCT02919995|43950|P2|COMPLETED|Overall Study||2
19988|NCT02919995|43951|P1|COMPLETED|Overall Study||1
19989|NCT02919995|43946|P6|STARTED|Overall Study||2
19990|NCT02919995|43947|P5|STARTED|Overall Study||1
19991|NCT02919995|43948|P4|STARTED|Overall Study||2
19992|NCT02919995|43949|P3|STARTED|Overall Study||2
19993|NCT02919995|43950|P2|STARTED|Overall Study||2
19994|NCT02919995|43951|P1|STARTED|Overall Study||1
19995|NCT02919657|43976|P2|NOT COMPLETED|Overall Study||0
19996|NCT02919657|43977|P1|NOT COMPLETED|Overall Study||0
19997|NCT02919657|43976|P2|COMPLETED|Overall Study|completed with the same initial 10 participants|10
19998|NCT02919657|43977|P1|COMPLETED|Overall Study|completed with the same initial 10 participants|10
19999|NCT02919657|43976|P2|STARTED|Overall Study|10 Participants|10
20000|NCT02919657|43977|P1|STARTED|Overall Study|10 Participants|10
20001|NCT02919618|43983|P1|NOT COMPLETED|Overall Study||1
20002|NCT02919618|43983|P1|COMPLETED|Overall Study||18
20003|NCT02919618|43983|P1|Primary Efficacy Endpoint (6 Months)|Overall Study||18
20004|NCT02919618|43983|P1|Primary Safety Endpoint (</=90 Days)|Overall Study||19
20005|NCT02919618|43983|P1|STARTED|Overall Study||19
20006|NCT02919423|44002|P2|NOT COMPLETED|Overall Study||9
20007|NCT02919423|44003|P1|NOT COMPLETED|Overall Study||2
20008|NCT02919423|44002|P2|COMPLETED|Overall Study||16
20009|NCT02919423|44003|P1|COMPLETED|Overall Study||4
20010|NCT02919423|44002|P2|STARTED|Overall Study||25
20011|NCT02919423|44003|P1|STARTED|Overall Study||6
20012|NCT02919267|44013|P4|NOT COMPLETED|Overall Study||4
20013|NCT02919267|44014|P3|NOT COMPLETED|Overall Study||3
20014|NCT02919267|44015|P2|NOT COMPLETED|Overall Study||3
20015|NCT02919267|44016|P1|NOT COMPLETED|Overall Study||0
20016|NCT02919267|44013|P4|COMPLETED|Overall Study||10
20017|NCT02919267|44014|P3|COMPLETED|Overall Study||10
20018|NCT02919267|44015|P2|COMPLETED|Overall Study||9
20019|NCT02919267|44016|P1|COMPLETED|Overall Study||10
20020|NCT02919267|44013|P4|STARTED|Overall Study||14
20021|NCT02919267|44014|P3|STARTED|Overall Study||13
20022|NCT02919267|44015|P2|STARTED|Overall Study||12
20023|NCT02919267|44016|P1|STARTED|Overall Study||10
20024|NCT02919007|44026|P1|NOT COMPLETED|Overall Study||0
20025|NCT02919007|44026|P1|COMPLETED|Overall Study||25
20026|NCT02919007|44026|P1|STARTED|Overall Study||25
20027|NCT02918773|44032|P2|NOT COMPLETED|Overall Study||0
20028|NCT02918773|44033|P1|NOT COMPLETED|Overall Study||0
20029|NCT02918773|44032|P2|COMPLETED|Overall Study||11
20030|NCT02918773|44033|P1|COMPLETED|Overall Study||11
20031|NCT02918773|44032|P2|STARTED|Overall Study||11
20032|NCT02918773|44033|P1|STARTED|Overall Study||11
20033|NCT02918669|44044|P1|NOT COMPLETED|Overall Study||0
20034|NCT02918669|44044|P1|COMPLETED|Overall Study||10
20035|NCT02918669|44044|P1|STARTED|Overall Study||10
20036|NCT02918656|44054|P3|NOT COMPLETED|Overall Study||0
20037|NCT02918656|44055|P2|NOT COMPLETED|Overall Study||0
20038|NCT02918656|44056|P1|NOT COMPLETED|Overall Study||0
20039|NCT02918656|44054|P3|COMPLETED|Overall Study||57
20040|NCT02918656|44055|P2|COMPLETED|Overall Study||60
20041|NCT02918656|44056|P1|COMPLETED|Overall Study||54
20042|NCT02918656|44054|P3|STARTED|Overall Study||57
20043|NCT02918656|44055|P2|STARTED|Overall Study||60
20044|NCT02918656|44056|P1|STARTED|Overall Study||54
20045|NCT02918630|44075|P2|NOT COMPLETED|Overall Study||0
20046|NCT02918630|44076|P1|NOT COMPLETED|Overall Study||0
20047|NCT02918630|44075|P2|COMPLETED|Overall Study||3
20048|NCT02918630|44076|P1|COMPLETED|Overall Study||4
20049|NCT02918630|44075|P2|STARTED|Overall Study||3
20050|NCT02918630|44076|P1|STARTED|Overall Study||4
20051|NCT02918617|44099|P9|NOT COMPLETED|Overall Study||0
20052|NCT02918617|44100|P8|NOT COMPLETED|Overall Study||1
20053|NCT02918617|44101|P7|NOT COMPLETED|Overall Study||0
20054|NCT02918617|44102|P6|NOT COMPLETED|Overall Study||0
20055|NCT02918617|44103|P5|NOT COMPLETED|Overall Study||0
20056|NCT02918617|44104|P4|NOT COMPLETED|Overall Study||0
20057|NCT02918617|44105|P3|NOT COMPLETED|Overall Study||3
20058|NCT02918617|44106|P2|NOT COMPLETED|Overall Study||0
20059|NCT02918617|44107|P1|NOT COMPLETED|Overall Study||1
20060|NCT02918617|44099|P9|COMPLETED|Overall Study||26
20061|NCT02918617|44100|P8|COMPLETED|Overall Study||25
20062|NCT02918617|44101|P7|COMPLETED|Overall Study||22
20063|NCT02918617|44102|P6|COMPLETED|Overall Study||20
20064|NCT02918617|44103|P5|COMPLETED|Overall Study||24
20065|NCT02918617|44104|P4|COMPLETED|Overall Study||22
20066|NCT02918617|44105|P3|COMPLETED|Overall Study||19
20067|NCT02918617|44106|P2|COMPLETED|Overall Study||20
20068|NCT02918617|44107|P1|COMPLETED|Overall Study||20
20069|NCT02918617|44099|P9|STARTED|Overall Study||26
20070|NCT02918617|44100|P8|STARTED|Overall Study||26
20071|NCT02918617|44101|P7|STARTED|Overall Study||22
20072|NCT02918617|44102|P6|STARTED|Overall Study||20
20073|NCT02918617|44103|P5|STARTED|Overall Study||24
20074|NCT02918617|44104|P4|STARTED|Overall Study||22
20075|NCT02918617|44105|P3|STARTED|Overall Study||22
20076|NCT02918617|44106|P2|STARTED|Overall Study||20
20077|NCT02918617|44107|P1|STARTED|Overall Study||21
20078|NCT02918396|44157|P3|NOT COMPLETED|Overall Study||0
20079|NCT02918396|44158|P2|NOT COMPLETED|Overall Study||0
20080|NCT02918396|44159|P1|NOT COMPLETED|Overall Study||0
20081|NCT02918396|44157|P3|COMPLETED|Overall Study||2
20082|NCT02918396|44158|P2|COMPLETED|Overall Study||1
20083|NCT02918396|44159|P1|COMPLETED|Overall Study||2
20084|NCT02918396|44157|P3|STARTED|Overall Study||2
20085|NCT02918396|44158|P2|STARTED|Overall Study||1
20086|NCT02918396|44159|P1|STARTED|Overall Study||2
20087|NCT02918266|44178|P11|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
20088|NCT02918266|44179|P10|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
20089|NCT02918266|44180|P9|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
20090|NCT02918266|44181|P8|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
20091|NCT02918266|44182|P7|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
20092|NCT02918266|44183|P6|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
20093|NCT02918266|44184|P5|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
20094|NCT02918266|44185|P4|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
20095|NCT02918266|44186|P3|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
20096|NCT02918266|44187|P2|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
20097|NCT02918266|44188|P1|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
20098|NCT02918266|44178|P11|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
20099|NCT02918266|44179|P10|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
20100|NCT02918266|44180|P9|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
20101|NCT02918266|44181|P8|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
20102|NCT02918266|44182|P7|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
20103|NCT02918266|44183|P6|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
20104|NCT02918266|44184|P5|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
20105|NCT02918266|44185|P4|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
20106|NCT02918266|44186|P3|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
20107|NCT02918266|44187|P2|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
20417|NCT02918071|44287|P1|NOT COMPLETED|Overall Study||3
20108|NCT02918266|44188|P1|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
20109|NCT02918266|44178|P11|STARTED|Part 2: Intervention Period 5 (2 Days)||0
20110|NCT02918266|44179|P10|STARTED|Part 2: Intervention Period 5 (2 Days)||0
20111|NCT02918266|44180|P9|STARTED|Part 2: Intervention Period 5 (2 Days)||0
20112|NCT02918266|44181|P8|STARTED|Part 2: Intervention Period 5 (2 Days)||0
20113|NCT02918266|44182|P7|STARTED|Part 2: Intervention Period 5 (2 Days)||0
20114|NCT02918266|44183|P6|STARTED|Part 2: Intervention Period 5 (2 Days)||0
20115|NCT02918266|44184|P5|STARTED|Part 2: Intervention Period 5 (2 Days)||0
20116|NCT02918266|44185|P4|STARTED|Part 2: Intervention Period 5 (2 Days)||0
20117|NCT02918266|44186|P3|STARTED|Part 2: Intervention Period 5 (2 Days)||0
20118|NCT02918266|44187|P2|STARTED|Part 2: Intervention Period 5 (2 Days)||0
20119|NCT02918266|44188|P1|STARTED|Part 2: Intervention Period 5 (2 Days)||0
20120|NCT02918266|44178|P11|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
20121|NCT02918266|44179|P10|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
20122|NCT02918266|44180|P9|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
20123|NCT02918266|44181|P8|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
20124|NCT02918266|44182|P7|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
20125|NCT02918266|44183|P6|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
20126|NCT02918266|44184|P5|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
20127|NCT02918266|44185|P4|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
20128|NCT02918266|44186|P3|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
20129|NCT02918266|44187|P2|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
20130|NCT02918266|44188|P1|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
20131|NCT02918266|44178|P11|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
20132|NCT02918266|44179|P10|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
20133|NCT02918266|44180|P9|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
20134|NCT02918266|44181|P8|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
20135|NCT02918266|44182|P7|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
20136|NCT02918266|44183|P6|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
20137|NCT02918266|44184|P5|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
20138|NCT02918266|44185|P4|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
20139|NCT02918266|44186|P3|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
20140|NCT02918266|44187|P2|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
20141|NCT02918266|44188|P1|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
20142|NCT02918266|44178|P11|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
20143|NCT02918266|44179|P10|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
20144|NCT02918266|44180|P9|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
20145|NCT02918266|44181|P8|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
20146|NCT02918266|44182|P7|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
20147|NCT02918266|44183|P6|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
20148|NCT02918266|44184|P5|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
20149|NCT02918266|44185|P4|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
20150|NCT02918266|44186|P3|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
20151|NCT02918266|44187|P2|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
20152|NCT02918266|44188|P1|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
20153|NCT02918266|44178|P11|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
20154|NCT02918266|44179|P10|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
20155|NCT02918266|44180|P9|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
20156|NCT02918266|44181|P8|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
20157|NCT02918266|44182|P7|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
20158|NCT02918266|44183|P6|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
20159|NCT02918266|44184|P5|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
20160|NCT02918266|44185|P4|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
20161|NCT02918266|44186|P3|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
20162|NCT02918266|44187|P2|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
20163|NCT02918266|44188|P1|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
20164|NCT02918266|44178|P11|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
20165|NCT02918266|44179|P10|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
20166|NCT02918266|44180|P9|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
20167|NCT02918266|44181|P8|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
20168|NCT02918266|44182|P7|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
20169|NCT02918266|44183|P6|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
20170|NCT02918266|44184|P5|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
20171|NCT02918266|44185|P4|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
20172|NCT02918266|44186|P3|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
20173|NCT02918266|44187|P2|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
20174|NCT02918266|44188|P1|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
20175|NCT02918266|44178|P11|STARTED|Part 2: Intervention Period 4 (2 Days)||0
20176|NCT02918266|44179|P10|STARTED|Part 2: Intervention Period 4 (2 Days)||0
20177|NCT02918266|44180|P9|STARTED|Part 2: Intervention Period 4 (2 Days)||0
20178|NCT02918266|44181|P8|STARTED|Part 2: Intervention Period 4 (2 Days)||0
20179|NCT02918266|44182|P7|STARTED|Part 2: Intervention Period 4 (2 Days)||0
20180|NCT02918266|44183|P6|STARTED|Part 2: Intervention Period 4 (2 Days)||0
20181|NCT02918266|44184|P5|STARTED|Part 2: Intervention Period 4 (2 Days)||0
20182|NCT02918266|44185|P4|STARTED|Part 2: Intervention Period 4 (2 Days)||0
20183|NCT02918266|44186|P3|STARTED|Part 2: Intervention Period 4 (2 Days)||0
20184|NCT02918266|44187|P2|STARTED|Part 2: Intervention Period 4 (2 Days)||0
20185|NCT02918266|44188|P1|STARTED|Part 2: Intervention Period 4 (2 Days)||0
20186|NCT02918266|44178|P11|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
20187|NCT02918266|44179|P10|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
20188|NCT02918266|44180|P9|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
20189|NCT02918266|44181|P8|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
20190|NCT02918266|44182|P7|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
20191|NCT02918266|44183|P6|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
20192|NCT02918266|44184|P5|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
20193|NCT02918266|44185|P4|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
20194|NCT02918266|44186|P3|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
20195|NCT02918266|44187|P2|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
20196|NCT02918266|44188|P1|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
20197|NCT02918266|44178|P11|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
20198|NCT02918266|44179|P10|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
20199|NCT02918266|44180|P9|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
20200|NCT02918266|44181|P8|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
20201|NCT02918266|44182|P7|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
20202|NCT02918266|44183|P6|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
20203|NCT02918266|44184|P5|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
20204|NCT02918266|44185|P4|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
20205|NCT02918266|44186|P3|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
20206|NCT02918266|44187|P2|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
20207|NCT02918266|44188|P1|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
20208|NCT02918266|44178|P11|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
20209|NCT02918266|44179|P10|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
20210|NCT02918266|44180|P9|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
20211|NCT02918266|44181|P8|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
20212|NCT02918266|44182|P7|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
20213|NCT02918266|44183|P6|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
20214|NCT02918266|44184|P5|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
20215|NCT02918266|44185|P4|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
20216|NCT02918266|44186|P3|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
20217|NCT02918266|44187|P2|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
20218|NCT02918266|44188|P1|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
20219|NCT02918266|44178|P11|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
20220|NCT02918266|44179|P10|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
20221|NCT02918266|44180|P9|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
20222|NCT02918266|44181|P8|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
20223|NCT02918266|44182|P7|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
20224|NCT02918266|44183|P6|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
20225|NCT02918266|44184|P5|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
20226|NCT02918266|44185|P4|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
20227|NCT02918266|44186|P3|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
20228|NCT02918266|44187|P2|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
20229|NCT02918266|44188|P1|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
20230|NCT02918266|44178|P11|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
20231|NCT02918266|44179|P10|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
20232|NCT02918266|44180|P9|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
20233|NCT02918266|44181|P8|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
20234|NCT02918266|44182|P7|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
20235|NCT02918266|44183|P6|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
20236|NCT02918266|44184|P5|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
20237|NCT02918266|44185|P4|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
20238|NCT02918266|44186|P3|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
20239|NCT02918266|44187|P2|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
20240|NCT02918266|44188|P1|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
20241|NCT02918266|44178|P11|STARTED|Part 2: Intervention Period 3 (2 Days)||0
20242|NCT02918266|44179|P10|STARTED|Part 2: Intervention Period 3 (2 Days)||0
20243|NCT02918266|44180|P9|STARTED|Part 2: Intervention Period 3 (2 Days)||0
20244|NCT02918266|44181|P8|STARTED|Part 2: Intervention Period 3 (2 Days)||0
20245|NCT02918266|44182|P7|STARTED|Part 2: Intervention Period 3 (2 Days)||0
20246|NCT02918266|44183|P6|STARTED|Part 2: Intervention Period 3 (2 Days)||0
20247|NCT02918266|44184|P5|STARTED|Part 2: Intervention Period 3 (2 Days)||0
20248|NCT02918266|44185|P4|STARTED|Part 2: Intervention Period 3 (2 Days)||0
20249|NCT02918266|44186|P3|STARTED|Part 2: Intervention Period 3 (2 Days)||0
20250|NCT02918266|44187|P2|STARTED|Part 2: Intervention Period 3 (2 Days)||0
20251|NCT02918266|44188|P1|STARTED|Part 2: Intervention Period 3 (2 Days)||0
20252|NCT02918266|44178|P11|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
20253|NCT02918266|44179|P10|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
20254|NCT02918266|44180|P9|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
20255|NCT02918266|44181|P8|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
20256|NCT02918266|44182|P7|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
20257|NCT02918266|44183|P6|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
20258|NCT02918266|44184|P5|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
20259|NCT02918266|44185|P4|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
20260|NCT02918266|44186|P3|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
20261|NCT02918266|44187|P2|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
20262|NCT02918266|44188|P1|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
20263|NCT02918266|44178|P11|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
20264|NCT02918266|44179|P10|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
20265|NCT02918266|44180|P9|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
20266|NCT02918266|44181|P8|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
20267|NCT02918266|44182|P7|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
20268|NCT02918266|44183|P6|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
20269|NCT02918266|44184|P5|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
20270|NCT02918266|44185|P4|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
20271|NCT02918266|44186|P3|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
20272|NCT02918266|44187|P2|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
20273|NCT02918266|44188|P1|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
20274|NCT02918266|44178|P11|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
20275|NCT02918266|44179|P10|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
20276|NCT02918266|44180|P9|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
20277|NCT02918266|44181|P8|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
20278|NCT02918266|44182|P7|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
20279|NCT02918266|44183|P6|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
20280|NCT02918266|44184|P5|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
20281|NCT02918266|44185|P4|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
20282|NCT02918266|44186|P3|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
20283|NCT02918266|44187|P2|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
20284|NCT02918266|44188|P1|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
20285|NCT02918266|44178|P11|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
20286|NCT02918266|44179|P10|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
20287|NCT02918266|44180|P9|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
20288|NCT02918266|44181|P8|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
20289|NCT02918266|44182|P7|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
20290|NCT02918266|44183|P6|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
20291|NCT02918266|44184|P5|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
20292|NCT02918266|44185|P4|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
20293|NCT02918266|44186|P3|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
20294|NCT02918266|44187|P2|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
20295|NCT02918266|44188|P1|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
20296|NCT02918266|44178|P11|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
20297|NCT02918266|44179|P10|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
20298|NCT02918266|44180|P9|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
20299|NCT02918266|44181|P8|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
20300|NCT02918266|44182|P7|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
20301|NCT02918266|44183|P6|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
20302|NCT02918266|44184|P5|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
20303|NCT02918266|44185|P4|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
20304|NCT02918266|44186|P3|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
20305|NCT02918266|44187|P2|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
20306|NCT02918266|44188|P1|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
20307|NCT02918266|44178|P11|STARTED|Part 2: Intervention Period 2 (2 Days)||0
20308|NCT02918266|44179|P10|STARTED|Part 2: Intervention Period 2 (2 Days)||0
20309|NCT02918266|44180|P9|STARTED|Part 2: Intervention Period 2 (2 Days)||0
20310|NCT02918266|44181|P8|STARTED|Part 2: Intervention Period 2 (2 Days)||0
20311|NCT02918266|44182|P7|STARTED|Part 2: Intervention Period 2 (2 Days)||0
20312|NCT02918266|44183|P6|STARTED|Part 2: Intervention Period 2 (2 Days)||0
20313|NCT02918266|44184|P5|STARTED|Part 2: Intervention Period 2 (2 Days)||0
20314|NCT02918266|44185|P4|STARTED|Part 2: Intervention Period 2 (2 Days)||0
20315|NCT02918266|44186|P3|STARTED|Part 2: Intervention Period 2 (2 Days)||0
20316|NCT02918266|44187|P2|STARTED|Part 2: Intervention Period 2 (2 Days)||0
20317|NCT02918266|44188|P1|STARTED|Part 2: Intervention Period 2 (2 Days)||0
20318|NCT02918266|44178|P11|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
20319|NCT02918266|44179|P10|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
20320|NCT02918266|44180|P9|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
20321|NCT02918266|44181|P8|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
20322|NCT02918266|44182|P7|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
20323|NCT02918266|44183|P6|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
20324|NCT02918266|44184|P5|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
20325|NCT02918266|44185|P4|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
20326|NCT02918266|44186|P3|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
20327|NCT02918266|44187|P2|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
20328|NCT02918266|44188|P1|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
20329|NCT02918266|44178|P11|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
20330|NCT02918266|44179|P10|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
20331|NCT02918266|44180|P9|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
20332|NCT02918266|44181|P8|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
20333|NCT02918266|44182|P7|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
20334|NCT02918266|44183|P6|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
20335|NCT02918266|44184|P5|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
20336|NCT02918266|44185|P4|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
20337|NCT02918266|44186|P3|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
20338|NCT02918266|44187|P2|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
20339|NCT02918266|44188|P1|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
20340|NCT02918266|44178|P11|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
20341|NCT02918266|44179|P10|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
20342|NCT02918266|44180|P9|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
20343|NCT02918266|44181|P8|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
20344|NCT02918266|44182|P7|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
20345|NCT02918266|44183|P6|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
20346|NCT02918266|44184|P5|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
20347|NCT02918266|44185|P4|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
20348|NCT02918266|44186|P3|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
20349|NCT02918266|44187|P2|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
20350|NCT02918266|44188|P1|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
20351|NCT02918266|44178|P11|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
20352|NCT02918266|44179|P10|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
20353|NCT02918266|44180|P9|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||2
20354|NCT02918266|44181|P8|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
20355|NCT02918266|44182|P7|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||2
20356|NCT02918266|44183|P6|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
20357|NCT02918266|44184|P5|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
20358|NCT02918266|44185|P4|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
20359|NCT02918266|44186|P3|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
20360|NCT02918266|44187|P2|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
20361|NCT02918266|44188|P1|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
20362|NCT02918266|44178|P11|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
20363|NCT02918266|44179|P10|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
20364|NCT02918266|44180|P9|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
20365|NCT02918266|44181|P8|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
20366|NCT02918266|44182|P7|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
20367|NCT02918266|44183|P6|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
20368|NCT02918266|44184|P5|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
20369|NCT02918266|44185|P4|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
20370|NCT02918266|44186|P3|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
20371|NCT02918266|44187|P2|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
20372|NCT02918266|44188|P1|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
20373|NCT02918266|44178|P11|STARTED|Part 2: Intervention Period 1 (2 Days)||1
20374|NCT02918266|44179|P10|STARTED|Part 2: Intervention Period 1 (2 Days)||1
20375|NCT02918266|44180|P9|STARTED|Part 2: Intervention Period 1 (2 Days)||2
20376|NCT02918266|44181|P8|STARTED|Part 2: Intervention Period 1 (2 Days)||1
20377|NCT02918266|44182|P7|STARTED|Part 2: Intervention Period 1 (2 Days)||2
20378|NCT02918266|44183|P6|STARTED|Part 2: Intervention Period 1 (2 Days)||1
20379|NCT02918266|44184|P5|STARTED|Part 2: Intervention Period 1 (2 Days)||1
20380|NCT02918266|44185|P4|STARTED|Part 2: Intervention Period 1 (2 Days)||1
20381|NCT02918266|44186|P3|STARTED|Part 2: Intervention Period 1 (2 Days)||1
20382|NCT02918266|44187|P2|STARTED|Part 2: Intervention Period 1 (2 Days)||1
20383|NCT02918266|44188|P1|STARTED|Part 2: Intervention Period 1 (2 Days)||0
20384|NCT02918266|44178|P11|NOT COMPLETED|Part 1||0
20385|NCT02918266|44179|P10|NOT COMPLETED|Part 1||0
20386|NCT02918266|44180|P9|NOT COMPLETED|Part 1||0
20387|NCT02918266|44181|P8|NOT COMPLETED|Part 1||0
20388|NCT02918266|44182|P7|NOT COMPLETED|Part 1||0
20389|NCT02918266|44183|P6|NOT COMPLETED|Part 1||0
20390|NCT02918266|44184|P5|NOT COMPLETED|Part 1||0
20391|NCT02918266|44185|P4|NOT COMPLETED|Part 1||0
20392|NCT02918266|44186|P3|NOT COMPLETED|Part 1||0
20393|NCT02918266|44187|P2|NOT COMPLETED|Part 1||0
20394|NCT02918266|44188|P1|NOT COMPLETED|Part 1||0
20395|NCT02918266|44178|P11|COMPLETED|Part 1||0
20396|NCT02918266|44179|P10|COMPLETED|Part 1||0
20397|NCT02918266|44180|P9|COMPLETED|Part 1||0
20398|NCT02918266|44181|P8|COMPLETED|Part 1||0
20399|NCT02918266|44182|P7|COMPLETED|Part 1||0
20400|NCT02918266|44183|P6|COMPLETED|Part 1||0
20401|NCT02918266|44184|P5|COMPLETED|Part 1||0
20402|NCT02918266|44185|P4|COMPLETED|Part 1||0
20403|NCT02918266|44186|P3|COMPLETED|Part 1||0
20404|NCT02918266|44187|P2|COMPLETED|Part 1||0
20405|NCT02918266|44188|P1|COMPLETED|Part 1||6
20406|NCT02918266|44178|P11|STARTED|Part 1||0
20407|NCT02918266|44179|P10|STARTED|Part 1||0
20408|NCT02918266|44180|P9|STARTED|Part 1||0
20409|NCT02918266|44181|P8|STARTED|Part 1||0
20410|NCT02918266|44182|P7|STARTED|Part 1||0
20411|NCT02918266|44183|P6|STARTED|Part 1||0
20412|NCT02918266|44184|P5|STARTED|Part 1||0
20413|NCT02918266|44185|P4|STARTED|Part 1||0
20414|NCT02918266|44186|P3|STARTED|Part 1||0
20415|NCT02918266|44187|P2|STARTED|Part 1||0
20416|NCT02918266|44188|P1|STARTED|Part 1||6
20418|NCT02918071|44287|P1|COMPLETED|Overall Study||118
20419|NCT02918071|44287|P1|STARTED|Overall Study||121
20420|NCT02917642|44299|P2|NOT COMPLETED|Overall Study||0
20421|NCT02917642|44300|P1|NOT COMPLETED|Overall Study||0
20422|NCT02917642|44299|P2|COMPLETED|Overall Study||25
20423|NCT02917642|44300|P1|COMPLETED|Overall Study||25
20424|NCT02917642|44299|P2|STARTED|Overall Study||25
20425|NCT02917642|44300|P1|STARTED|Overall Study||25
20426|NCT02917265|44310|P2|NOT COMPLETED|Overall Study||0
20427|NCT02917265|44311|P1|NOT COMPLETED|Overall Study||2
20428|NCT02917265|44310|P2|COMPLETED|Overall Study||2
20429|NCT02917265|44311|P1|COMPLETED|Overall Study||3
20430|NCT02917265|44310|P2|STARTED|Overall Study||2
20431|NCT02917265|44311|P1|STARTED|Overall Study||5
20432|NCT02916498|44327|P2|NOT COMPLETED|Second Intervention, 21 Days||0
20433|NCT02916498|44328|P1|NOT COMPLETED|Second Intervention, 21 Days||0
20434|NCT02916498|44327|P2|COMPLETED|Second Intervention, 21 Days||4
20435|NCT02916498|44328|P1|COMPLETED|Second Intervention, 21 Days||2
20436|NCT02916498|44327|P2|STARTED|Second Intervention, 21 Days||4
20437|NCT02916498|44328|P1|STARTED|Second Intervention, 21 Days||2
20438|NCT02916498|44327|P2|NOT COMPLETED|First Intervention, 21 Days||0
20439|NCT02916498|44328|P1|NOT COMPLETED|First Intervention, 21 Days||0
20440|NCT02916498|44327|P2|COMPLETED|First Intervention, 21 Days||4
20441|NCT02916498|44328|P1|COMPLETED|First Intervention, 21 Days||2
20442|NCT02916498|44327|P2|STARTED|First Intervention, 21 Days||4
20443|NCT02916498|44328|P1|STARTED|First Intervention, 21 Days||2
20444|NCT02916407|44336|P2|NOT COMPLETED|Overall Study||0
20445|NCT02916407|44337|P1|NOT COMPLETED|Overall Study||0
20446|NCT02916407|44336|P2|COMPLETED|Overall Study||28
20447|NCT02916407|44337|P1|COMPLETED|Overall Study||28
20448|NCT02916407|44336|P2|STARTED|Overall Study||28
20449|NCT02916407|44337|P1|STARTED|Overall Study||28
20450|NCT02915978|44348|P3|NOT COMPLETED|Overall Study||0
20451|NCT02915978|44349|P2|NOT COMPLETED|Overall Study||1
20452|NCT02915978|44350|P1|NOT COMPLETED|Overall Study||2
20453|NCT02915978|44348|P3|COMPLETED|Overall Study||15
20454|NCT02915978|44349|P2|COMPLETED|Overall Study||14
20455|NCT02915978|44350|P1|COMPLETED|Overall Study||13
20456|NCT02915978|44348|P3|STARTED|Overall Study||15
20457|NCT02915978|44349|P2|STARTED|Overall Study||15
20458|NCT02915978|44350|P1|STARTED|Overall Study||15
20459|NCT02915874|44402|P2|NOT COMPLETED|Overall Study||6
20460|NCT02915874|44403|P1|NOT COMPLETED|Overall Study||6
20461|NCT02915874|44402|P2|COMPLETED|Overall Study||22
20462|NCT02915874|44403|P1|COMPLETED|Overall Study||38
20463|NCT02915874|44402|P2|Week 6 Follow Up|Overall Study||26
20464|NCT02915874|44403|P1|Week 6 Follow Up|Overall Study||41
20465|NCT02915874|44402|P2|STARTED|Overall Study||28
20466|NCT02915874|44403|P1|STARTED|Overall Study||44
20467|NCT02915835|44423|P2|NOT COMPLETED|Overall Study||1
20468|NCT02915835|44424|P1|NOT COMPLETED|Overall Study||1
20469|NCT02915835|44423|P2|COMPLETED|Overall Study||7
20470|NCT02915835|44424|P1|COMPLETED|Overall Study||8
20471|NCT02915835|44423|P2|STARTED|Overall Study||8
20472|NCT02915835|44424|P1|STARTED|Overall Study||9
20473|NCT02915705|44550|P2|NOT COMPLETED|Overall Study||25
20474|NCT02915705|44551|P1|NOT COMPLETED|Overall Study||26
20475|NCT02915705|44550|P2|COMPLETED|Overall Study||4
20476|NCT02915705|44551|P1|COMPLETED|Overall Study||6
20477|NCT02915705|44550|P2|Completed Week 64|Overall Study||29
20478|NCT02915705|44551|P1|Completed Week 64|Overall Study||32
20479|NCT02915705|44550|P2|Completed Week 40|Overall Study||29
20480|NCT02915705|44551|P1|Completed Week 40|Overall Study||32
20481|NCT02915705|44550|P2|STARTED|Overall Study||29
20482|NCT02915705|44551|P1|STARTED|Overall Study||32
20483|NCT02915302|44623|P2|NOT COMPLETED|Overall Study||78
20484|NCT02915302|44624|P1|NOT COMPLETED|Overall Study||65
20485|NCT02915302|44623|P2|COMPLETED|Overall Study||917
20486|NCT02915302|44624|P1|COMPLETED|Overall Study||890
20487|NCT02915302|44623|P2|Vaccinated (Safety Analysis Set)|Overall Study||992
20488|NCT02915302|44624|P1|Vaccinated (Safety Analysis Set)|Overall Study||949
20489|NCT02915302|44623|P2|STARTED|Overall Study||995
20490|NCT02915302|44624|P1|STARTED|Overall Study||955
20491|NCT02914275|44636|P2|NOT COMPLETED|Overall Study||42
20492|NCT02914275|44637|P1|NOT COMPLETED|Overall Study||121
20493|NCT02914275|44636|P2|COMPLETED|Overall Study||521
20494|NCT02914275|44637|P1|COMPLETED|Overall Study||1566
20495|NCT02914275|44636|P2|Included in Clinical Database / FAS|Overall Study||563
20496|NCT02914275|44637|P1|Included in Clinical Database / FAS|Overall Study||1684
20497|NCT02914275|44636|P2|STARTED|Overall Study||563
20498|NCT02914275|44637|P1|STARTED|Overall Study||1687
20499|NCT02914236|44669|P1|NOT COMPLETED|Overall Study||1
20500|NCT02914236|44669|P1|COMPLETED|Overall Study||49
20501|NCT02914236|44669|P1|26-week Follow-up Visit|Overall Study||49
20502|NCT02914236|44669|P1|12-week Follow-up Visit|Overall Study||50
20503|NCT02914236|44669|P1|4-week Follow-up Visit|Overall Study||50
20504|NCT02914236|44669|P1|STARTED|Overall Study||50
20505|NCT02914184|44681|P4|NOT COMPLETED|Overall Study||11
20506|NCT02914184|44682|P3|NOT COMPLETED|Overall Study||17
20507|NCT02914184|44683|P2|NOT COMPLETED|Overall Study||13
20508|NCT02914184|44684|P1|NOT COMPLETED|Overall Study||14
20509|NCT02914184|44681|P4|COMPLETED|Overall Study||391
20510|NCT02914184|44682|P3|COMPLETED|Overall Study||385
20511|NCT02914184|44683|P2|COMPLETED|Overall Study||383
20512|NCT02914184|44684|P1|COMPLETED|Overall Study||386
20513|NCT02914184|44681|P4|STARTED|Overall Study||402
20514|NCT02914184|44682|P3|STARTED|Overall Study||402
20515|NCT02914184|44683|P2|STARTED|Overall Study||396
20516|NCT02914184|44684|P1|STARTED|Overall Study||400
20517|NCT02914132|44723|P1|NOT COMPLETED|Overall Study||0
20518|NCT02914132|44723|P1|COMPLETED|Overall Study||15
20519|NCT02914132|44723|P1|STARTED|Overall Study||15
20520|NCT02914119|44728|P1|NOT COMPLETED|Overall Study||0
20521|NCT02914119|44728|P1|COMPLETED|Overall Study||30430
20522|NCT02914119|44728|P1|STARTED|Overall Study||30430
20523|NCT02913326|44741|P2|NOT COMPLETED|Overall Study||2
20524|NCT02913326|44742|P1|NOT COMPLETED|Overall Study||1
20525|NCT02913326|44741|P2|COMPLETED|Overall Study||58
20526|NCT02913326|44742|P1|COMPLETED|Overall Study||59
20527|NCT02913326|44741|P2|STARTED|Overall Study||60
20528|NCT02913326|44742|P1|STARTED|Overall Study||60
20529|NCT02913105|44765|P3|NOT COMPLETED|Overall Study||7
20530|NCT02913105|44766|P2|NOT COMPLETED|Overall Study||5
20531|NCT02913105|44767|P1|NOT COMPLETED|Overall Study||15
20532|NCT02913105|44765|P3|COMPLETED|Overall Study||33
20533|NCT02913105|44766|P2|COMPLETED|Overall Study||39
20534|NCT02913105|44767|P1|COMPLETED|Overall Study||22
20535|NCT02913105|44765|P3|STARTED|Overall Study||40
20536|NCT02913105|44766|P2|STARTED|Overall Study||44
20537|NCT02913105|44767|P1|STARTED|Overall Study||37
20538|NCT02912650|44820|P4|NOT COMPLETED|Overall Study||5
20539|NCT02912650|44821|P3|NOT COMPLETED|Overall Study||2
20540|NCT02912650|44822|P2|NOT COMPLETED|Overall Study||0
20541|NCT02912650|44823|P1|NOT COMPLETED|Overall Study||1
20542|NCT02912650|44820|P4|COMPLETED|Overall Study||160
20543|NCT02912650|44821|P3|COMPLETED|Overall Study||173
20544|NCT02912650|44822|P2|COMPLETED|Overall Study||172
20545|NCT02912650|44823|P1|COMPLETED|Overall Study||55
20546|NCT02912650|44820|P4|STARTED|Overall Study||165
20547|NCT02912650|44821|P3|STARTED|Overall Study||175
20548|NCT02912650|44822|P2|STARTED|Overall Study||172
20549|NCT02912650|44823|P1|STARTED|Overall Study||56
20550|NCT02912468|44907|P2|NOT COMPLETED|Overall Study||5
20551|NCT02912468|44908|P1|NOT COMPLETED|Overall Study||9
20552|NCT02912468|44907|P2|COMPLETED|Overall Study||138
20553|NCT02912468|44908|P1|COMPLETED|Overall Study||124
20554|NCT02912468|44907|P2|Safety Population|Overall Study||143
20555|NCT02912468|44908|P1|Safety Population|Overall Study||132
20556|NCT02912468|44907|P2|Treated|Overall Study||142
20557|NCT02912468|44908|P1|Treated|Overall Study||133
20558|NCT02912468|44907|P2|STARTED|Overall Study||143
20559|NCT02912468|44908|P1|STARTED|Overall Study||133
20560|NCT02912364|44985|P2|NOT COMPLETED|Treatment 2||0
20561|NCT02912364|44986|P1|NOT COMPLETED|Treatment 2||1
20562|NCT02912364|44985|P2|COMPLETED|Treatment 2||11
20563|NCT02912364|44986|P1|COMPLETED|Treatment 2||12
20564|NCT02912364|44985|P2|Received Intervention|Treatment 2||11
20565|NCT02912364|44986|P1|Received Intervention|Treatment 2||12
20566|NCT02912364|44985|P2|STARTED|Treatment 2||11
20567|NCT02912364|44986|P1|STARTED|Treatment 2||13
20568|NCT02912364|44985|P2|NOT COMPLETED|Washout Period||0
20569|NCT02912364|44986|P1|NOT COMPLETED|Washout Period||0
20570|NCT02912364|44985|P2|COMPLETED|Washout Period||11
20571|NCT02912364|44986|P1|COMPLETED|Washout Period||13
20572|NCT02912364|44985|P2|STARTED|Washout Period||11
20573|NCT02912364|44986|P1|STARTED|Washout Period||13
20574|NCT02912364|44985|P2|NOT COMPLETED|Treatment 1||12
20575|NCT02912364|44986|P1|NOT COMPLETED|Treatment 1||10
20576|NCT02912364|44985|P2|COMPLETED|Treatment 1||11
20577|NCT02912364|44986|P1|COMPLETED|Treatment 1||13
20578|NCT02912364|44985|P2|Received Intervention|Treatment 1||18
20579|NCT02912364|44986|P1|Received Intervention|Treatment 1||18
20580|NCT02912364|44985|P2|STARTED|Treatment 1||23
20581|NCT02912364|44986|P1|STARTED|Treatment 1||23
20582|NCT02911948|45005|P2|NOT COMPLETED|Overall Study||7
20583|NCT02911948|45006|P1|NOT COMPLETED|Overall Study||0
20584|NCT02911948|45005|P2|COMPLETED|Overall Study||98
20585|NCT02911948|45006|P1|COMPLETED|Overall Study||105
20586|NCT02911948|45005|P2|STARTED|Overall Study||105
20587|NCT02911948|45006|P1|STARTED|Overall Study||105
20588|NCT02911922|45068|P2|NOT COMPLETED|Overall Study||0
20589|NCT02911922|45069|P1|NOT COMPLETED|Overall Study||0
20590|NCT02911922|45068|P2|COMPLETED|Overall Study||0
20591|NCT02911922|45069|P1|COMPLETED|Overall Study||1
20592|NCT02911922|45068|P2|STARTED|Overall Study||0
20593|NCT02911922|45069|P1|STARTED|Overall Study||1
20594|NCT02911857|45090|P3|NOT COMPLETED|Overall Study||0
20595|NCT02911857|45091|P2|NOT COMPLETED|Overall Study||0
20596|NCT02911857|45092|P1|NOT COMPLETED|Overall Study||0
20597|NCT02911857|45090|P3|COMPLETED|Overall Study||1
20598|NCT02911857|45091|P2|COMPLETED|Overall Study||1
20599|NCT02911857|45092|P1|COMPLETED|Overall Study||2
20600|NCT02911857|45090|P3|STARTED|Overall Study||1
20601|NCT02911857|45091|P2|STARTED|Overall Study||1
20602|NCT02911857|45092|P1|STARTED|Overall Study||2
20603|NCT02911818|45103|P5|NOT COMPLETED|12 Week Extension Study||1
20604|NCT02911818|45104|P4|NOT COMPLETED|12 Week Extension Study||0
20605|NCT02911818|45105|P3|NOT COMPLETED|12 Week Extension Study||0
20606|NCT02911818|45106|P2|NOT COMPLETED|12 Week Extension Study||0
20607|NCT02911818|45107|P1|NOT COMPLETED|12 Week Extension Study||0
20608|NCT02911818|45103|P5|COMPLETED|12 Week Extension Study||22
20609|NCT02911818|45104|P4|COMPLETED|12 Week Extension Study||22
20610|NCT02911818|45105|P3|COMPLETED|12 Week Extension Study||0
20611|NCT02911818|45106|P2|COMPLETED|12 Week Extension Study||0
20612|NCT02911818|45107|P1|COMPLETED|12 Week Extension Study||0
20613|NCT02911818|45103|P5|STARTED|12 Week Extension Study||23
20614|NCT02911818|45104|P4|STARTED|12 Week Extension Study||22
20615|NCT02911818|45105|P3|STARTED|12 Week Extension Study||0
20616|NCT02911818|45106|P2|STARTED|12 Week Extension Study||0
20617|NCT02911818|45107|P1|STARTED|12 Week Extension Study||0
20618|NCT02911818|45103|P5|NOT COMPLETED|52 Week Study||0
20619|NCT02911818|45104|P4|NOT COMPLETED|52 Week Study||0
20620|NCT02911818|45105|P3|NOT COMPLETED|52 Week Study||4
20621|NCT02911818|45106|P2|NOT COMPLETED|52 Week Study||5
20622|NCT02911818|45107|P1|NOT COMPLETED|52 Week Study||4
20623|NCT02911818|45103|P5|COMPLETED|52 Week Study||0
20624|NCT02911818|45104|P4|COMPLETED|52 Week Study||0
20625|NCT02911818|45105|P3|COMPLETED|52 Week Study||46
20626|NCT02911818|45106|P2|COMPLETED|52 Week Study||45
20627|NCT02911818|45107|P1|COMPLETED|52 Week Study||46
20628|NCT02911818|45103|P5|STARTED|52 Week Study||0
20629|NCT02911818|45104|P4|STARTED|52 Week Study||0
20630|NCT02911818|45105|P3|STARTED|52 Week Study||50
20631|NCT02911818|45106|P2|STARTED|52 Week Study||50
20632|NCT02911818|45107|P1|STARTED|52 Week Study||50
20633|NCT02911753|45202|P3|NOT COMPLETED|Overall Study||0
20634|NCT02911753|45203|P2|NOT COMPLETED|Overall Study||3
20635|NCT02911753|45204|P1|NOT COMPLETED|Overall Study||3
20636|NCT02911753|45202|P3|COMPLETED|Overall Study||10
20637|NCT02911753|45203|P2|COMPLETED|Overall Study||16
20638|NCT02911753|45204|P1|COMPLETED|Overall Study||18
20639|NCT02911753|45202|P3|STARTED|Overall Study||10
20640|NCT02911753|45203|P2|STARTED|Overall Study||19
20641|NCT02911753|45204|P1|STARTED|Overall Study||21
20642|NCT02910739|45232|P4|NOT COMPLETED|Overall Study||0
20643|NCT02910739|45233|P3|NOT COMPLETED|Overall Study||0
20644|NCT02910739|45234|P2|NOT COMPLETED|Overall Study||0
20645|NCT02910739|45235|P1|NOT COMPLETED|Overall Study||1
20646|NCT02910739|45232|P4|COMPLETED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
20647|NCT02910739|45233|P3|COMPLETED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
20648|NCT02910739|45234|P2|COMPLETED|Overall Study||8
20649|NCT02910739|45235|P1|COMPLETED|Overall Study||7
20650|NCT02910739|45232|P4|STARTED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
20651|NCT02910739|45233|P3|STARTED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
20652|NCT02910739|45234|P2|STARTED|Overall Study||8
20653|NCT02910739|45235|P1|STARTED|Overall Study||8
20654|NCT02910362|45263|P2|NOT COMPLETED|Overall Study||0
20655|NCT02910362|45264|P1|NOT COMPLETED|Overall Study||0
20656|NCT02910362|45263|P2|COMPLETED|Overall Study||7
20657|NCT02910362|45264|P1|COMPLETED|Overall Study||8
20658|NCT02910362|45263|P2|STARTED|Overall Study||7
20659|NCT02910362|45264|P1|STARTED|Overall Study||8
20660|NCT02910167|45270|P1|NOT COMPLETED|Overall Study||19
20661|NCT02910167|45270|P1|COMPLETED|Overall Study||341
20662|NCT02910167|45270|P1|STARTED|Overall Study||360
20663|NCT02910089|45280|P2|NOT COMPLETED|Overall Study||16
20664|NCT02910089|45281|P1|NOT COMPLETED|Overall Study||22
20665|NCT02910089|45280|P2|COMPLETED|Overall Study|16 Patients ineligible (2.3%)|684
20666|NCT02910089|45281|P1|COMPLETED|Overall Study|22 patients ineligible (3.1%)|678
20667|NCT02910089|45280|P2|STARTED|Overall Study|Patients allocated to control|700
20668|NCT02910089|45281|P1|STARTED|Overall Study|Patients allocated to intervention|700
20669|NCT02909907|45295|P2|NOT COMPLETED|Overall Study||1
20670|NCT02909907|45296|P1|NOT COMPLETED|Overall Study||0
20671|NCT02909907|45295|P2|COMPLETED|Overall Study||9
20672|NCT02909907|45296|P1|COMPLETED|Overall Study||10
20673|NCT02909907|45295|P2|STARTED|Overall Study||10
20674|NCT02909907|45296|P1|STARTED|Overall Study||10
20675|NCT02909764|45320|P2|NOT COMPLETED|Overall Study||0
20676|NCT02909764|45321|P1|NOT COMPLETED|Overall Study||0
20677|NCT02909764|45320|P2|COMPLETED|Overall Study||20
20678|NCT02909764|45321|P1|COMPLETED|Overall Study||19
20679|NCT02909764|45320|P2|STARTED|Overall Study||20
20680|NCT02909764|45321|P1|STARTED|Overall Study||19
20681|NCT02909153|45342|P5|NOT COMPLETED|Overall Study||0
20682|NCT02909153|45343|P4|NOT COMPLETED|Overall Study||0
20683|NCT02909153|45344|P3|NOT COMPLETED|Overall Study||0
20684|NCT02909153|45345|P2|NOT COMPLETED|Overall Study||1
20685|NCT02909153|45346|P1|NOT COMPLETED|Overall Study||0
20686|NCT02909153|45342|P5|COMPLETED|Overall Study||6
20687|NCT02909153|45343|P4|COMPLETED|Overall Study||6
20688|NCT02909153|45344|P3|COMPLETED|Overall Study||6
20689|NCT02909153|45345|P2|COMPLETED|Overall Study||5
20690|NCT02909153|45346|P1|COMPLETED|Overall Study||6
20691|NCT02909153|45342|P5|Triferic in Extraneal PD Solution|Overall Study||6
20692|NCT02909153|45343|P4|Triferic in Extraneal PD Solution|Overall Study||6
20693|NCT02909153|45344|P3|Triferic in Extraneal PD Solution|Overall Study||0
20867|NCT02906813|46034|P1|STARTED|Washout Period 2 (at Least 3 Days)||3
20694|NCT02909153|45345|P2|Triferic in Extraneal PD Solution|Overall Study||0
20695|NCT02909153|45346|P1|Triferic in Extraneal PD Solution|Overall Study||0
20696|NCT02909153|45342|P5|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
20697|NCT02909153|45343|P4|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
20698|NCT02909153|45344|P3|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
20699|NCT02909153|45345|P2|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||5
20700|NCT02909153|45346|P1|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
20701|NCT02909153|45342|P5|Triferic in Dianeal PD Solution|Overall Study||0
20702|NCT02909153|45343|P4|Triferic in Dianeal PD Solution|Overall Study||0
20703|NCT02909153|45344|P3|Triferic in Dianeal PD Solution|Overall Study||6
20704|NCT02909153|45345|P2|Triferic in Dianeal PD Solution|Overall Study||6
20705|NCT02909153|45346|P1|Triferic in Dianeal PD Solution|Overall Study||6
20706|NCT02909153|45342|P5|STARTED|Overall Study||6
20707|NCT02909153|45343|P4|STARTED|Overall Study||6
20708|NCT02909153|45344|P3|STARTED|Overall Study||6
20709|NCT02909153|45345|P2|STARTED|Overall Study||6
20710|NCT02909153|45346|P1|STARTED|Overall Study||6
20711|NCT02909140|45391|P3|NOT COMPLETED|Overall Study||0
20712|NCT02909140|45392|P2|NOT COMPLETED|Overall Study||0
20713|NCT02909140|45393|P1|NOT COMPLETED|Overall Study||0
20714|NCT02909140|45391|P3|COMPLETED|Overall Study||0
20715|NCT02909140|45392|P2|COMPLETED|Overall Study||2
20716|NCT02909140|45393|P1|COMPLETED|Overall Study||0
20717|NCT02909140|45391|P3|STARTED|Overall Study||0
20718|NCT02909140|45392|P2|STARTED|Overall Study||2
20719|NCT02909140|45393|P1|STARTED|Overall Study||0
20720|NCT02909101|45436|P2|NOT COMPLETED|Overall Study||1
20721|NCT02909101|45437|P1|NOT COMPLETED|Overall Study||1
20722|NCT02909101|45436|P2|COMPLETED|Overall Study||28
20723|NCT02909101|45437|P1|COMPLETED|Overall Study||28
20724|NCT02909101|45436|P2|STARTED|Overall Study||29
20725|NCT02909101|45437|P1|STARTED|Overall Study||29
20726|NCT02908880|45455|P1|NOT COMPLETED|Overall Study||27
20727|NCT02908880|45455|P1|COMPLETED|Overall Study|Subjects within the Primary Analysis Cohort that completed all follow-up time points.|236
20728|NCT02908880|45455|P1|STARTED|Overall Study|Subjects within the Primary Analysis Cohort that received the MANTA Device|263
20729|NCT02908620|45467|P4|NOT COMPLETED|Overall Study||0
20730|NCT02908620|45468|P3|NOT COMPLETED|Overall Study||0
20731|NCT02908620|45469|P2|NOT COMPLETED|Overall Study||0
20732|NCT02908620|45470|P1|NOT COMPLETED|Overall Study||0
20733|NCT02908620|45467|P4|COMPLETED|Overall Study||10
20734|NCT02908620|45468|P3|COMPLETED|Overall Study||10
20735|NCT02908620|45469|P2|COMPLETED|Overall Study||10
20736|NCT02908620|45470|P1|COMPLETED|Overall Study||10
20737|NCT02908620|45467|P4|STARTED|Overall Study||10
20738|NCT02908620|45468|P3|STARTED|Overall Study||10
20739|NCT02908620|45469|P2|STARTED|Overall Study||10
20740|NCT02908620|45470|P1|STARTED|Overall Study||10
20741|NCT02908529|45504|P2|NOT COMPLETED|Overall Study||2
20742|NCT02908529|45505|P1|NOT COMPLETED|Overall Study||0
20743|NCT02908529|45504|P2|COMPLETED|Overall Study||10
20744|NCT02908529|45505|P1|COMPLETED|Overall Study||10
20745|NCT02908529|45504|P2|STARTED|Overall Study||12
20746|NCT02908529|45505|P1|STARTED|Overall Study||10
20747|NCT02908516|45515|P2|NOT COMPLETED|Overall Study||3
20748|NCT02908516|45516|P1|NOT COMPLETED|Overall Study||3
20749|NCT02908516|45515|P2|COMPLETED|Overall Study||0
20750|NCT02908516|45516|P1|COMPLETED|Overall Study||0
20751|NCT02908516|45515|P2|STARTED|Overall Study||3
20752|NCT02908516|45516|P1|STARTED|Overall Study||3
20753|NCT02908347|45532|P2|NOT COMPLETED|Overall Study||1
20754|NCT02908347|45533|P1|NOT COMPLETED|Overall Study||1
20755|NCT02908347|45532|P2|COMPLETED|Overall Study||22
20756|NCT02908347|45533|P1|COMPLETED|Overall Study||22
20757|NCT02908347|45532|P2|STARTED|Overall Study||23
20758|NCT02908347|45533|P1|STARTED|Overall Study||23
20759|NCT02908269|45584|P3|NOT COMPLETED|Overall Study||0
20760|NCT02908269|45585|P2|NOT COMPLETED|Overall Study||0
20761|NCT02908269|45586|P1|NOT COMPLETED|Overall Study||0
20762|NCT02908269|45584|P3|COMPLETED|Overall Study||60
20763|NCT02908269|45585|P2|COMPLETED|Overall Study||60
20764|NCT02908269|45586|P1|COMPLETED|Overall Study||60
20765|NCT02908269|45584|P3|STARTED|Overall Study||60
20766|NCT02908269|45585|P2|STARTED|Overall Study||60
20767|NCT02908269|45586|P1|STARTED|Overall Study||60
20768|NCT02908178|45604|P4|NOT COMPLETED|Overall Study||6819
20769|NCT02908178|45605|P3|NOT COMPLETED|Overall Study||0
20770|NCT02908178|45606|P2|NOT COMPLETED|Overall Study||8388
20771|NCT02908178|45607|P1|NOT COMPLETED|Overall Study||0
20772|NCT02908178|45604|P4|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|3965
20773|NCT02908178|45605|P3|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|1992
20774|NCT02908178|45606|P2|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|4718
20775|NCT02908178|45607|P1|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|2409
20776|NCT02908178|45604|P4|STARTED|Overall Study|The sample prior to Mahalanobis matching.|10784
20777|NCT02908178|45605|P3|STARTED|Overall Study|The sample prior to Mahalanobis matching.|1992
20778|NCT02908178|45606|P2|STARTED|Overall Study|The sample prior to Mahalanobis matching.|13106
21036|NCT02900378|46346|P1|COMPLETED|Treatment Phase||309
20779|NCT02908178|45607|P1|STARTED|Overall Study|The sample prior to Mahalanobis matching.|2409
20780|NCT02907892|45628|P2|NOT COMPLETED|Overall Study||40
20781|NCT02907892|45629|P1|NOT COMPLETED|Overall Study||27
20782|NCT02907892|45628|P2|COMPLETED|Overall Study||236
20783|NCT02907892|45629|P1|COMPLETED|Overall Study||250
20784|NCT02907892|45628|P2|STARTED|Overall Study||276
20785|NCT02907892|45629|P1|STARTED|Overall Study||277
20786|NCT02907814|45637|P2|NOT COMPLETED|Overall Study||0
20787|NCT02907814|45638|P1|NOT COMPLETED|Overall Study||6
20788|NCT02907814|45637|P2|COMPLETED|Overall Study||0
20789|NCT02907814|45638|P1|COMPLETED|Overall Study||0
20790|NCT02907814|45637|P2|STARTED|Overall Study||0
20791|NCT02907814|45638|P1|STARTED|Overall Study||6
20792|NCT02907619|45649|P3|NOT COMPLETED|Overall Study||20
20793|NCT02907619|45650|P2|NOT COMPLETED|Overall Study||20
20794|NCT02907619|45651|P1|NOT COMPLETED|Overall Study||19
20795|NCT02907619|45649|P3|COMPLETED|Overall Study||0
20796|NCT02907619|45650|P2|COMPLETED|Overall Study||0
20797|NCT02907619|45651|P1|COMPLETED|Overall Study||0
20798|NCT02907619|45649|P3|Received Treatment|Overall Study||20
20799|NCT02907619|45650|P2|Received Treatment|Overall Study||20
20800|NCT02907619|45651|P1|Received Treatment|Overall Study||19
20801|NCT02907619|45649|P3|STARTED|Overall Study||20
20802|NCT02907619|45650|P2|STARTED|Overall Study||20
20803|NCT02907619|45651|P1|STARTED|Overall Study||19
20804|NCT02907489|45858|P2|NOT COMPLETED|Overall Study||1
20805|NCT02907489|45859|P1|NOT COMPLETED|Overall Study||2
20806|NCT02907489|45858|P2|COMPLETED|Overall Study||41
20807|NCT02907489|45859|P1|COMPLETED|Overall Study||40
20808|NCT02907489|45858|P2|STARTED|Overall Study||42
20809|NCT02907489|45859|P1|STARTED|Overall Study||42
20810|NCT02907463|45867|P1|NOT COMPLETED|Overall Study||37
20811|NCT02907463|45867|P1|COMPLETED|Overall Study||243
20812|NCT02907463|45867|P1|Per Protocol Cohort|Overall Study||276
20813|NCT02907463|45867|P1|Enrolled Cohort|Overall Study||280
20814|NCT02907463|45867|P1|STARTED|Overall Study||280
20815|NCT02907268|45939|P2|NOT COMPLETED|Overall Study||0
20816|NCT02907268|45940|P1|NOT COMPLETED|Overall Study||0
20817|NCT02907268|45939|P2|COMPLETED|Overall Study||5
20818|NCT02907268|45940|P1|COMPLETED|Overall Study||5
20819|NCT02907268|45939|P2|STARTED|Overall Study||5
20820|NCT02907268|45940|P1|STARTED|Overall Study||5
20821|NCT02907216|45949|P2|NOT COMPLETED|Overall Study||1
20822|NCT02907216|45950|P1|NOT COMPLETED|Overall Study||1
20823|NCT02907216|45949|P2|COMPLETED|Overall Study||144
20824|NCT02907216|45950|P1|COMPLETED|Overall Study||146
20825|NCT02907216|45949|P2|STARTED|Overall Study||145
20826|NCT02907216|45950|P1|STARTED|Overall Study||147
20827|NCT02907073|45985|P3|NOT COMPLETED|Overall Study||0
20828|NCT02907073|45986|P2|NOT COMPLETED|Overall Study||0
20829|NCT02907073|45987|P1|NOT COMPLETED|Overall Study||0
20830|NCT02907073|45985|P3|COMPLETED|Overall Study||0
20831|NCT02907073|45986|P2|COMPLETED|Overall Study||0
20832|NCT02907073|45987|P1|COMPLETED|Overall Study||8
20833|NCT02907073|45985|P3|STARTED|Overall Study||0
20834|NCT02907073|45986|P2|STARTED|Overall Study||0
20835|NCT02907073|45987|P1|STARTED|Overall Study||8
20836|NCT02906917|46000|P2|NOT COMPLETED|Intensification Period (Week 26-38)||7
20837|NCT02906917|46001|P1|NOT COMPLETED|Intensification Period (Week 26-38)||9
20838|NCT02906917|46000|P2|COMPLETED|Intensification Period (Week 26-38)||247
20839|NCT02906917|46001|P1|COMPLETED|Intensification Period (Week 26-38)||252
20840|NCT02906917|46000|P2|STARTED|Intensification Period (Week 26-38)||254
20841|NCT02906917|46001|P1|STARTED|Intensification Period (Week 26-38)||261
20842|NCT02906917|46000|P2|NOT COMPLETED|Initiation Period (Week 0-26)||11
20843|NCT02906917|46001|P1|NOT COMPLETED|Initiation Period (Week 0-26)||6
20844|NCT02906917|46000|P2|COMPLETED|Initiation Period (Week 0-26)||254
20845|NCT02906917|46001|P1|COMPLETED|Initiation Period (Week 0-26)||261
20846|NCT02906917|46000|P2|Exposed|Initiation Period (Week 0-26)||263
20847|NCT02906917|46001|P1|Exposed|Initiation Period (Week 0-26)||265
20848|NCT02906917|46000|P2|STARTED|Initiation Period (Week 0-26)||265
20849|NCT02906917|46001|P1|STARTED|Initiation Period (Week 0-26)||267
20850|NCT02906813|46032|P3|NOT COMPLETED|Intervention Period 3 (3 Days)||0
20851|NCT02906813|46033|P2|NOT COMPLETED|Intervention Period 3 (3 Days)||0
20852|NCT02906813|46034|P1|NOT COMPLETED|Intervention Period 3 (3 Days)||0
20853|NCT02906813|46032|P3|COMPLETED|Intervention Period 3 (3 Days)||3
20854|NCT02906813|46033|P2|COMPLETED|Intervention Period 3 (3 Days)||3
20855|NCT02906813|46034|P1|COMPLETED|Intervention Period 3 (3 Days)||3
20856|NCT02906813|46032|P3|STARTED|Intervention Period 3 (3 Days)||3
20857|NCT02906813|46033|P2|STARTED|Intervention Period 3 (3 Days)||3
20858|NCT02906813|46034|P1|STARTED|Intervention Period 3 (3 Days)||3
20859|NCT02906813|46032|P3|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
20860|NCT02906813|46033|P2|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
20861|NCT02906813|46034|P1|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
20862|NCT02906813|46032|P3|COMPLETED|Washout Period 2 (at Least 3 Days)||3
20863|NCT02906813|46033|P2|COMPLETED|Washout Period 2 (at Least 3 Days)||3
20864|NCT02906813|46034|P1|COMPLETED|Washout Period 2 (at Least 3 Days)||3
20865|NCT02906813|46032|P3|STARTED|Washout Period 2 (at Least 3 Days)||3
20866|NCT02906813|46033|P2|STARTED|Washout Period 2 (at Least 3 Days)||3
20868|NCT02906813|46032|P3|NOT COMPLETED|Intervention Period 2 (3 Days)||0
20869|NCT02906813|46033|P2|NOT COMPLETED|Intervention Period 2 (3 Days)||0
20870|NCT02906813|46034|P1|NOT COMPLETED|Intervention Period 2 (3 Days)||0
20871|NCT02906813|46032|P3|COMPLETED|Intervention Period 2 (3 Days)||3
20872|NCT02906813|46033|P2|COMPLETED|Intervention Period 2 (3 Days)||3
20873|NCT02906813|46034|P1|COMPLETED|Intervention Period 2 (3 Days)||3
20874|NCT02906813|46032|P3|STARTED|Intervention Period 2 (3 Days)||3
20875|NCT02906813|46033|P2|STARTED|Intervention Period 2 (3 Days)||3
20876|NCT02906813|46034|P1|STARTED|Intervention Period 2 (3 Days)||3
20877|NCT02906813|46032|P3|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
20878|NCT02906813|46033|P2|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
20879|NCT02906813|46034|P1|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
20880|NCT02906813|46032|P3|COMPLETED|Washout Period 1 (at Least 3 Days)||3
20881|NCT02906813|46033|P2|COMPLETED|Washout Period 1 (at Least 3 Days)||3
20882|NCT02906813|46034|P1|COMPLETED|Washout Period 1 (at Least 3 Days)||3
20883|NCT02906813|46032|P3|STARTED|Washout Period 1 (at Least 3 Days)||3
20884|NCT02906813|46033|P2|STARTED|Washout Period 1 (at Least 3 Days)||3
20885|NCT02906813|46034|P1|STARTED|Washout Period 1 (at Least 3 Days)||3
20886|NCT02906813|46032|P3|NOT COMPLETED|Intervention Period 1 (3 Days)||0
20887|NCT02906813|46033|P2|NOT COMPLETED|Intervention Period 1 (3 Days)||0
20888|NCT02906813|46034|P1|NOT COMPLETED|Intervention Period 1 (3 Days)||0
20889|NCT02906813|46032|P3|COMPLETED|Intervention Period 1 (3 Days)||3
20890|NCT02906813|46033|P2|COMPLETED|Intervention Period 1 (3 Days)||3
20891|NCT02906813|46034|P1|COMPLETED|Intervention Period 1 (3 Days)||3
20892|NCT02906813|46032|P3|STARTED|Intervention Period 1 (3 Days)||3
20893|NCT02906813|46033|P2|STARTED|Intervention Period 1 (3 Days)||3
20894|NCT02906813|46034|P1|STARTED|Intervention Period 1 (3 Days)||3
20895|NCT02906709|46062|P2|NOT COMPLETED|Phase B (Extension, Week 17 to Week 52)||0
20896|NCT02906709|46063|P1|NOT COMPLETED|Phase B (Extension, Week 17 to Week 52)||5
20897|NCT02906709|46062|P2|COMPLETED|Phase B (Extension, Week 17 to Week 52)||58
20898|NCT02906709|46063|P1|COMPLETED|Phase B (Extension, Week 17 to Week 52)||117
20899|NCT02906709|46062|P2|STARTED|Phase B (Extension, Week 17 to Week 52)||58
20900|NCT02906709|46063|P1|STARTED|Phase B (Extension, Week 17 to Week 52)||122
20901|NCT02906709|46062|P2|NOT COMPLETED|Phase A (Week 0 to Week 16)||3
20902|NCT02906709|46063|P1|NOT COMPLETED|Phase A (Week 0 to Week 16)||1
20903|NCT02906709|46062|P2|COMPLETED|Phase A (Week 0 to Week 16)||58
20904|NCT02906709|46063|P1|COMPLETED|Phase A (Week 0 to Week 16)||122
20905|NCT02906709|46062|P2|STARTED|Phase A (Week 0 to Week 16)||61
20906|NCT02906709|46063|P1|STARTED|Phase A (Week 0 to Week 16)||123
20907|NCT02906644|46097|P2|NOT COMPLETED|Weeks 3 to 14||11
20908|NCT02906644|46098|P1|NOT COMPLETED|Weeks 3 to 14||16
20909|NCT02906644|46097|P2|COMPLETED|Weeks 3 to 14||16
20910|NCT02906644|46098|P1|COMPLETED|Weeks 3 to 14||14
20911|NCT02906644|46097|P2|Follow-up (6 Months Post Quit Day)|Weeks 3 to 14||16
20912|NCT02906644|46098|P1|Follow-up (6 Months Post Quit Day)|Weeks 3 to 14||14
20913|NCT02906644|46097|P2|Final Study Visit|Weeks 3 to 14|All participants receiving only 1 week of 14mg & 1 week of 7mg nicotine patches at this visit.|20
20914|NCT02906644|46098|P1|Final Study Visit|Weeks 3 to 14|All participants receiving only 1 week of 14mg & 1 week of 7mg nicotine patches at this visit.|17
20915|NCT02906644|46097|P2|STARTED|Weeks 3 to 14|All participants receiving active Lorcaserin plus nicotine patches starting at the 2nd study visit.|27
20916|NCT02906644|46098|P1|STARTED|Weeks 3 to 14|All participants receiving active Lorcaserin plus nicotine patches starting at the 2nd study visit.|30
20917|NCT02906644|46097|P2|NOT COMPLETED|First 2 Weeks||3
20918|NCT02906644|46098|P1|NOT COMPLETED|First 2 Weeks||1
20919|NCT02906644|46097|P2|COMPLETED|First 2 Weeks||27
20920|NCT02906644|46098|P1|COMPLETED|First 2 Weeks||30
20921|NCT02906644|46097|P2|STARTED|First 2 Weeks||30
20922|NCT02906644|46098|P1|STARTED|First 2 Weeks||31
20923|NCT02906566|46116|P2|NOT COMPLETED|Overall Study||0
20924|NCT02906566|46117|P1|NOT COMPLETED|Overall Study||3
20925|NCT02906566|46116|P2|COMPLETED|Overall Study||10
20926|NCT02906566|46117|P1|COMPLETED|Overall Study||21
20927|NCT02906566|46116|P2|STARTED|Overall Study||10
20928|NCT02906566|46117|P1|STARTED|Overall Study||24
20929|NCT02906358|46133|P2|NOT COMPLETED|Overall Study||22
20930|NCT02906358|46134|P1|NOT COMPLETED|Overall Study||22
20931|NCT02906358|46133|P2|COMPLETED|Overall Study||31
20932|NCT02906358|46134|P1|COMPLETED|Overall Study||36
20933|NCT02906358|46133|P2|Completed 3 Month Measures|Overall Study||33
20934|NCT02906358|46134|P1|Completed 3 Month Measures|Overall Study||36
20935|NCT02906358|46133|P2|STARTED|Overall Study||53
20936|NCT02906358|46134|P1|STARTED|Overall Study||58
20937|NCT02905825|46162|P1|NOT COMPLETED|Overall Study||12
20938|NCT02905825|46162|P1|COMPLETED|Overall Study||41
20939|NCT02905825|46162|P1|STARTED|Overall Study||53
20940|NCT02905331|46170|P3|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0
20941|NCT02905331|46171|P2|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||8
20942|NCT02905331|46172|P1|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0
20943|NCT02905331|46170|P3|COMPLETED|Active Treatment and Follow up (wk16-40)||13
20944|NCT02905331|46171|P2|COMPLETED|Active Treatment and Follow up (wk16-40)||53
20945|NCT02905331|46172|P1|COMPLETED|Active Treatment and Follow up (wk16-40)||0
20946|NCT02905331|46170|P3|STARTED|Active Treatment and Follow up (wk16-40)||13
20947|NCT02905331|46171|P2|STARTED|Active Treatment and Follow up (wk16-40)||61
20948|NCT02905331|46172|P1|STARTED|Active Treatment and Follow up (wk16-40)||0
20949|NCT02905331|46170|P3|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0
20950|NCT02905331|46171|P2|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||1
20951|NCT02905331|46172|P1|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||3
20952|NCT02905331|46170|P3|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0
20953|NCT02905331|46171|P2|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||61
20954|NCT02905331|46172|P1|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||13
20955|NCT02905331|46170|P3|STARTED|Placebo Controlled Period(Week[wk] 0-16)||0
20956|NCT02905331|46171|P2|STARTED|Placebo Controlled Period(Week[wk] 0-16)||62
20957|NCT02905331|46172|P1|STARTED|Placebo Controlled Period(Week[wk] 0-16)||16
20958|NCT02905266|46200|P2|NOT COMPLETED|Maintenance Phase Part 2||22
20959|NCT02905266|46201|P1|NOT COMPLETED|Maintenance Phase Part 2||19
20960|NCT02905266|46200|P2|COMPLETED|Maintenance Phase Part 2||0
20961|NCT02905266|46201|P1|COMPLETED|Maintenance Phase Part 2||0
20962|NCT02905266|46200|P2|STARTED|Maintenance Phase Part 2||22
20963|NCT02905266|46201|P1|STARTED|Maintenance Phase Part 2||19
20964|NCT02905266|46200|P2|NOT COMPLETED|Treatment Period Part 1||23
20965|NCT02905266|46201|P1|NOT COMPLETED|Treatment Period Part 1||29
20966|NCT02905266|46200|P2|COMPLETED|Treatment Period Part 1||30
20967|NCT02905266|46201|P1|COMPLETED|Treatment Period Part 1||24
20968|NCT02905266|46200|P2|STARTED|Treatment Period Part 1||53
20969|NCT02905266|46201|P1|STARTED|Treatment Period Part 1||53
20970|NCT02904915|46223|P2|NOT COMPLETED|Overall Study||0
20971|NCT02904915|46224|P1|NOT COMPLETED|Overall Study||0
20972|NCT02904915|46223|P2|COMPLETED|Overall Study||25
20973|NCT02904915|46224|P1|COMPLETED|Overall Study||25
20974|NCT02904915|46223|P2|STARTED|Overall Study||25
20975|NCT02904915|46224|P1|STARTED|Overall Study||25
20976|NCT02904902|46234|P1|NOT COMPLETED|Overall Study||1
20977|NCT02904902|46234|P1|COMPLETED|Overall Study|completed 24 weeks of treatment and continued on study|14
20978|NCT02904902|46234|P1|STARTED|Overall Study||15
20979|NCT02904356|46241|P1|NOT COMPLETED|Overall Study||0
20980|NCT02904356|46241|P1|COMPLETED|Overall Study||2
20981|NCT02904356|46241|P1|STARTED|Overall Study||2
20982|NCT02903394|46247|P2|NOT COMPLETED|Overall Study||0
20983|NCT02903394|46248|P1|NOT COMPLETED|Overall Study||0
20984|NCT02903394|46247|P2|COMPLETED|Overall Study||50
20985|NCT02903394|46248|P1|COMPLETED|Overall Study||5
20986|NCT02903394|46247|P2|STARTED|Overall Study||50
20987|NCT02903394|46248|P1|STARTED|Overall Study||5
20988|NCT02903238|46258|P1|NOT COMPLETED|Overall Study||4
20989|NCT02903238|46258|P1|COMPLETED|Overall Study||17
20990|NCT02903238|46258|P1|STARTED|Overall Study||21
20991|NCT02902913|46267|P1|NOT COMPLETED|Overall Study||0
20992|NCT02902913|46267|P1|COMPLETED|Overall Study||9
20993|NCT02902913|46267|P1|Ibuprofen (400mg)|Overall Study||9
20994|NCT02902913|46267|P1|Washout (7 Days)|Overall Study||9
20995|NCT02902913|46267|P1|Third Intervention (1 Day)|Overall Study||9
20996|NCT02902913|46267|P1|Washout (7 Days)|Overall Study||9
20997|NCT02902913|46267|P1|Second Intervention (1 Day)|Overall Study||9
20998|NCT02902913|46267|P1|Washout (7 Days)|Overall Study||9
20999|NCT02902913|46267|P1|First Intervention (1 Day)|Overall Study||9
21000|NCT02902913|46267|P1|STARTED|Overall Study||9
21001|NCT02902809|46275|P1|NOT COMPLETED|Overall Study||28
21002|NCT02902809|46275|P1|COMPLETED|Overall Study||0
21003|NCT02902809|46275|P1|Treatment Completed|Overall Study||2
21004|NCT02902809|46275|P1|Treatment Received|Overall Study||28
21005|NCT02902809|46275|P1|STARTED|Overall Study||28
21006|NCT02902172|46285|P2|NOT COMPLETED|Overall Study||0
21007|NCT02902172|46286|P1|NOT COMPLETED|Overall Study||0
21008|NCT02902172|46285|P2|COMPLETED|Overall Study||20
21009|NCT02902172|46286|P1|COMPLETED|Overall Study||16
21010|NCT02902172|46285|P2|STARTED|Overall Study||20
21011|NCT02902172|46286|P1|STARTED|Overall Study||16
21012|NCT02902146|46296|P2|NOT COMPLETED|Overall Study||0
21013|NCT02902146|46297|P1|NOT COMPLETED|Overall Study||0
21014|NCT02902146|46296|P2|COMPLETED|Overall Study||376
21015|NCT02902146|46297|P1|COMPLETED|Overall Study||381
21016|NCT02902146|46296|P2|STARTED|Overall Study||376
21017|NCT02902146|46297|P1|STARTED|Overall Study||381
21018|NCT02902081|46311|P1|NOT COMPLETED|Overall Study||0
21019|NCT02902081|46311|P1|COMPLETED|Overall Study||38
21020|NCT02902081|46311|P1|STARTED|Overall Study||38
21021|NCT02901951|46319|P1|NOT COMPLETED|Overall Study||0
21022|NCT02901951|46319|P1|COMPLETED|Overall Study||103
21023|NCT02901951|46319|P1|STARTED|Overall Study||103
21024|NCT02901054|46330|P1|NOT COMPLETED|Overall Study||4
21025|NCT02901054|46330|P1|COMPLETED|Overall Study||15
21026|NCT02901054|46330|P1|STARTED|Overall Study|19 consented, 3 withdrew prior to intervention, 1 received study drug but surgery was cancelled.|19
21027|NCT02900781|46336|P2|NOT COMPLETED|Overall Study||5
21028|NCT02900781|46337|P1|NOT COMPLETED|Overall Study||4
21029|NCT02900781|46336|P2|COMPLETED|Overall Study||0
21030|NCT02900781|46337|P1|COMPLETED|Overall Study||0
21031|NCT02900781|46336|P2|STARTED|Overall Study||5
21032|NCT02900781|46337|P1|STARTED|Overall Study||4
21033|NCT02900378|46345|P2|NOT COMPLETED|Treatment Phase||0
21034|NCT02900378|46346|P1|NOT COMPLETED|Treatment Phase||0
21035|NCT02900378|46345|P2|COMPLETED|Treatment Phase||310
21037|NCT02900378|46345|P2|Full Analysis Set|Treatment Phase||302
21038|NCT02900378|46346|P1|Full Analysis Set|Treatment Phase||302
21039|NCT02900378|46345|P2|STARTED|Treatment Phase||310
21040|NCT02900378|46346|P1|STARTED|Treatment Phase||309
21041|NCT02900378|46345|P2|NOT COMPLETED|Randomization (Visit 2)||28
21042|NCT02900378|46346|P1|NOT COMPLETED|Randomization (Visit 2)||23
21043|NCT02900378|46345|P2|COMPLETED|Randomization (Visit 2)||283
21044|NCT02900378|46346|P1|COMPLETED|Randomization (Visit 2)||287
21045|NCT02900378|46345|P2|STARTED|Randomization (Visit 2)||311
21046|NCT02900378|46346|P1|STARTED|Randomization (Visit 2)||310
21047|NCT02900092|46390|P1|NOT COMPLETED|Overall Study||1
21048|NCT02900092|46390|P1|COMPLETED|Overall Study||9
21049|NCT02900092|46390|P1|STARTED|Overall Study||10
21050|NCT02899884|46394|P1|NOT COMPLETED|Overall Study||0
21051|NCT02899884|46394|P1|COMPLETED|Overall Study||3765
21052|NCT02899884|46394|P1|STARTED|Overall Study||3765
21053|NCT02899377|46408|P2|NOT COMPLETED|Overall Study||0
21054|NCT02899377|46409|P1|NOT COMPLETED|Overall Study||1
21055|NCT02899377|46408|P2|COMPLETED|Overall Study||12
21056|NCT02899377|46409|P1|COMPLETED|Overall Study||12
21057|NCT02899377|46408|P2|STARTED|Overall Study||12
21058|NCT02899377|46409|P1|STARTED|Overall Study||13
21059|NCT02899338|46442|P2|NOT COMPLETED|Overall Study||2
21060|NCT02899338|46443|P1|NOT COMPLETED|Overall Study||3
21061|NCT02899338|46442|P2|COMPLETED|Overall Study||79
21062|NCT02899338|46443|P1|COMPLETED|Overall Study||78
21063|NCT02899338|46442|P2|STARTED|Overall Study||81
21064|NCT02899338|46443|P1|STARTED|Overall Study||81
21065|NCT02898740|46457|P2|NOT COMPLETED|Overall Study||0
21066|NCT02898740|46458|P1|NOT COMPLETED|Overall Study||0
21067|NCT02898740|46457|P2|COMPLETED|Overall Study||19
21068|NCT02898740|46458|P1|COMPLETED|Overall Study||21
21069|NCT02898740|46457|P2|STARTED|Overall Study||19
21070|NCT02898740|46458|P1|STARTED|Overall Study||21
21071|NCT02898662|46466|P2|NOT COMPLETED|Overall Study||28
21072|NCT02898662|46467|P1|NOT COMPLETED|Overall Study||29
21073|NCT02898662|46466|P2|COMPLETED|Overall Study||13
21074|NCT02898662|46467|P1|COMPLETED|Overall Study||11
21075|NCT02898662|46466|P2|Completed Treatment|Overall Study||29
21076|NCT02898662|46467|P1|Completed Treatment|Overall Study||25
21077|NCT02898662|46466|P2|STARTED|Overall Study||41
21078|NCT02898662|46467|P1|STARTED|Overall Study||40
21079|NCT02898597|46491|P2|NOT COMPLETED|Overall Study||12
21080|NCT02898597|46492|P1|NOT COMPLETED|Overall Study||4
21081|NCT02898597|46491|P2|COMPLETED|Overall Study||12
21082|NCT02898597|46492|P1|COMPLETED|Overall Study||21
21083|NCT02898597|46491|P2|STARTED|Overall Study||24
21084|NCT02898597|46492|P1|STARTED|Overall Study||25
21085|NCT02898454|46501|P3|NOT COMPLETED|Overall Study||6
21086|NCT02898454|46502|P2|NOT COMPLETED|Overall Study||5
21087|NCT02898454|46503|P1|NOT COMPLETED|Overall Study||17
21088|NCT02898454|46501|P3|COMPLETED|Overall Study||144
21089|NCT02898454|46502|P2|COMPLETED|Overall Study||140
21090|NCT02898454|46503|P1|COMPLETED|Overall Study||136
21091|NCT02898454|46501|P3|Safety Population|Overall Study||149
21092|NCT02898454|46502|P2|Safety Population|Overall Study|1 randomized to dupilumab q2w arm received 1dose of placebo: counted in 300 mg q2w then q4w arm.|148
21093|NCT02898454|46503|P1|Safety Population|Overall Study|2 participants randomized to placebo received 1 dose of dupilumab:counted in 300 mg q2w then q4w arm|150
21094|NCT02898454|46501|P3|Treated|Overall Study||150
21095|NCT02898454|46502|P2|Treated|Overall Study||145
21096|NCT02898454|46503|P1|Treated|Overall Study||152
21097|NCT02898454|46501|P3|Intent-to-Treat (ITT) Population|Overall Study||150
21098|NCT02898454|46502|P2|Intent-to-Treat (ITT) Population|Overall Study||145
21099|NCT02898454|46503|P1|Intent-to-Treat (ITT) Population|Overall Study||153
21100|NCT02898454|46501|P3|STARTED|Overall Study||150
21101|NCT02898454|46502|P2|STARTED|Overall Study||145
21102|NCT02898454|46503|P1|STARTED|Overall Study||153
21103|NCT02898116|46616|P1|NOT COMPLETED|Overall Study||2
21104|NCT02898116|46616|P1|COMPLETED|Overall Study||0
21105|NCT02898116|46616|P1|STARTED|Overall Study||2
21106|NCT02897141|46624|P2|NOT COMPLETED|Overall Study||1
21107|NCT02897141|46625|P1|NOT COMPLETED|Overall Study||2
21108|NCT02897141|46624|P2|COMPLETED|Overall Study||39
21109|NCT02897141|46625|P1|COMPLETED|Overall Study||38
21110|NCT02897141|46624|P2|STARTED|Overall Study||40
21111|NCT02897141|46625|P1|STARTED|Overall Study||40
21112|NCT02897115|46644|P2|NOT COMPLETED|Overall Study||8
21113|NCT02897115|46645|P1|NOT COMPLETED|Overall Study||11
21114|NCT02897115|46644|P2|COMPLETED|Overall Study||0
21115|NCT02897115|46645|P1|COMPLETED|Overall Study||3
21116|NCT02897115|46644|P2|STARTED|Overall Study||8
21117|NCT02897115|46645|P1|STARTED|Overall Study||14
21118|NCT02896855|46717|P2|NOT COMPLETED|Overall Study||122
21119|NCT02896855|46718|P1|NOT COMPLETED|Overall Study||121
21120|NCT02896855|46717|P2|COMPLETED|Overall Study||0
21121|NCT02896855|46718|P1|COMPLETED|Overall Study||0
21122|NCT02896855|46717|P2|Received Any Study Treatment|Overall Study||122
21123|NCT02896855|46718|P1|Received Any Study Treatment|Overall Study||120
21124|NCT02896855|46717|P2|STARTED|Overall Study||122
21125|NCT02896855|46718|P1|STARTED|Overall Study||121
21126|NCT02896361|46748|P3|NOT COMPLETED|Third Intervention (2 Weeks)||0
21127|NCT02896361|46749|P2|NOT COMPLETED|Third Intervention (2 Weeks)||1
21128|NCT02896361|46750|P1|NOT COMPLETED|Third Intervention (2 Weeks)||1
21129|NCT02896361|46748|P3|COMPLETED|Third Intervention (2 Weeks)||8
21130|NCT02896361|46749|P2|COMPLETED|Third Intervention (2 Weeks)||9
21131|NCT02896361|46750|P1|COMPLETED|Third Intervention (2 Weeks)||8
21132|NCT02896361|46748|P3|STARTED|Third Intervention (2 Weeks)||8
21133|NCT02896361|46749|P2|STARTED|Third Intervention (2 Weeks)||10
21134|NCT02896361|46750|P1|STARTED|Third Intervention (2 Weeks)||9
21135|NCT02896361|46748|P3|NOT COMPLETED|Second Intervention (2 Weeks)||0
21136|NCT02896361|46749|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
21137|NCT02896361|46750|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
21138|NCT02896361|46748|P3|COMPLETED|Second Intervention (2 Weeks)||8
21139|NCT02896361|46749|P2|COMPLETED|Second Intervention (2 Weeks)||10
21140|NCT02896361|46750|P1|COMPLETED|Second Intervention (2 Weeks)||9
21141|NCT02896361|46748|P3|STARTED|Second Intervention (2 Weeks)||8
21142|NCT02896361|46749|P2|STARTED|Second Intervention (2 Weeks)||10
21143|NCT02896361|46750|P1|STARTED|Second Intervention (2 Weeks)||9
21144|NCT02896361|46748|P3|NOT COMPLETED|First Intervention (2 Weeks)||0
21145|NCT02896361|46749|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
21146|NCT02896361|46750|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
21147|NCT02896361|46748|P3|COMPLETED|First Intervention (2 Weeks)||8
21148|NCT02896361|46749|P2|COMPLETED|First Intervention (2 Weeks)||10
21149|NCT02896361|46750|P1|COMPLETED|First Intervention (2 Weeks)||9
21150|NCT02896361|46748|P3|STARTED|First Intervention (2 Weeks)||8
21151|NCT02896361|46749|P2|STARTED|First Intervention (2 Weeks)||10
21152|NCT02896361|46750|P1|STARTED|First Intervention (2 Weeks)||9
21153|NCT02896296|46768|P1|NOT COMPLETED|Overall Study||42
21154|NCT02896296|46768|P1|COMPLETED|Overall Study||166
21155|NCT02896296|46768|P1|STARTED|Overall Study||208
21156|NCT02895347|46776|P2|NOT COMPLETED|Overall Study||1
21157|NCT02895347|46777|P1|NOT COMPLETED|Overall Study||3
21158|NCT02895347|46776|P2|COMPLETED|Overall Study||19
21159|NCT02895347|46777|P1|COMPLETED|Overall Study||17
21160|NCT02895347|46776|P2|STARTED|Overall Study||20
21161|NCT02895347|46777|P1|STARTED|Overall Study||20
21162|NCT02895295|46789|P3|NOT COMPLETED|Overall Study||92
21163|NCT02895295|46790|P2|NOT COMPLETED|Overall Study||94
21164|NCT02895295|46791|P1|NOT COMPLETED|Overall Study||71
21165|NCT02895295|46789|P3|COMPLETED|Overall Study||299
21166|NCT02895295|46790|P2|COMPLETED|Overall Study||316
21167|NCT02895295|46791|P1|COMPLETED|Overall Study||313
21168|NCT02895295|46789|P3|STARTED|Overall Study||391
21169|NCT02895295|46790|P2|STARTED|Overall Study||410
21170|NCT02895295|46791|P1|STARTED|Overall Study||384
21171|NCT02894840|46812|P4|NOT COMPLETED|Overall Study||0
21172|NCT02894840|46813|P3|NOT COMPLETED|Overall Study||3
21173|NCT02894840|46814|P2|NOT COMPLETED|Overall Study||0
21174|NCT02894840|46815|P1|NOT COMPLETED|Overall Study||1
21175|NCT02894840|46812|P4|COMPLETED|Overall Study||100
21176|NCT02894840|46813|P3|COMPLETED|Overall Study||197
21177|NCT02894840|46814|P2|COMPLETED|Overall Study||20
21178|NCT02894840|46815|P1|COMPLETED|Overall Study||19
21179|NCT02894840|46812|P4|STARTED|Overall Study||100
21180|NCT02894840|46813|P3|STARTED|Overall Study||200
21181|NCT02894840|46814|P2|STARTED|Overall Study||20
21182|NCT02894840|46815|P1|STARTED|Overall Study||20
21183|NCT02893878|46840|P3|NOT COMPLETED|Overall Study||0
21184|NCT02893878|46841|P2|NOT COMPLETED|Overall Study||0
21185|NCT02893878|46842|P1|NOT COMPLETED|Overall Study||0
21186|NCT02893878|46840|P3|COMPLETED|Overall Study||3178
21187|NCT02893878|46841|P2|COMPLETED|Overall Study||2295
21188|NCT02893878|46842|P1|COMPLETED|Overall Study||13861
21189|NCT02893878|46840|P3|STARTED|Overall Study||3178
21190|NCT02893878|46841|P2|STARTED|Overall Study||2295
21191|NCT02893878|46842|P1|STARTED|Overall Study||13861
21192|NCT02892734|47087|P1|NOT COMPLETED|Follow up for 2 Years||3
21193|NCT02892734|47087|P1|COMPLETED|Follow up for 2 Years||0
21194|NCT02892734|47087|P1|STARTED|Follow up for 2 Years||3
21195|NCT02892734|47087|P1|NOT COMPLETED|Treatment on Study||2
21196|NCT02892734|47087|P1|COMPLETED|Treatment on Study||1
21197|NCT02892734|47087|P1|Went on to Start Cycle 2|Treatment on Study||1
21198|NCT02892734|47087|P1|Completed 1st Cycle/Response at 12 Weeks|Treatment on Study||1
21199|NCT02892734|47087|P1|STARTED|Treatment on Study||3
21200|NCT02892513|47093|P2|NOT COMPLETED|Overall Study||1
21201|NCT02892513|47094|P1|NOT COMPLETED|Overall Study||0
21202|NCT02892513|47093|P2|COMPLETED|Overall Study|Discontinued intervention early = 6; excluded from analysis = 1|24
21203|NCT02892513|47094|P1|COMPLETED|Overall Study|Discontinued intervention early = 5; excluded from analysis = 0|28
21204|NCT02892513|47093|P2|STARTED|Overall Study|did not receive allocated intervention = 1 (withdrew per participant request)|25
21205|NCT02892513|47094|P1|STARTED|Overall Study||28
21206|NCT02892409|47102|P2|NOT COMPLETED|Overall Study||1
21207|NCT02892409|47103|P1|NOT COMPLETED|Overall Study||3
21208|NCT02892409|47102|P2|COMPLETED|Overall Study||14
21209|NCT02892409|47103|P1|COMPLETED|Overall Study||12
21210|NCT02892409|47102|P2|STARTED|Overall Study||15
21211|NCT02892409|47103|P1|STARTED|Overall Study||15
21212|NCT02892344|47125|P2|NOT COMPLETED|Overall Study||21
21213|NCT02892344|47126|P1|NOT COMPLETED|Overall Study||4
21214|NCT02892344|47125|P2|COMPLETED|Overall Study||383
21215|NCT02892344|47126|P1|COMPLETED|Overall Study||394
21216|NCT02892344|47125|P2|Full Analysis Set|Overall Study||399
21217|NCT02892344|47126|P1|Full Analysis Set|Overall Study||395
21218|NCT02892344|47125|P2|STARTED|Overall Study||404
21219|NCT02892344|47126|P1|STARTED|Overall Study||398
21220|NCT02891863|47160|P1|NOT COMPLETED|Overall Study||0
21221|NCT02891863|47160|P1|COMPLETED|Overall Study||9
21222|NCT02891863|47160|P1|STARTED|Overall Study||9
21223|NCT02891629|47167|P2|NOT COMPLETED|Overall Study||1
21224|NCT02891629|47168|P1|NOT COMPLETED|Overall Study||0
21225|NCT02891629|47167|P2|COMPLETED|Overall Study||4
21226|NCT02891629|47168|P1|COMPLETED|Overall Study||10
21227|NCT02891629|47167|P2|STARTED|Overall Study||5
21228|NCT02891629|47168|P1|STARTED|Overall Study||10
21229|NCT02891174|47178|P2|NOT COMPLETED|Second Intervention (24 Hours)||7
21230|NCT02891174|47179|P1|NOT COMPLETED|Second Intervention (24 Hours)||6
21231|NCT02891174|47178|P2|COMPLETED|Second Intervention (24 Hours)||3
21232|NCT02891174|47179|P1|COMPLETED|Second Intervention (24 Hours)||11
21233|NCT02891174|47178|P2|STARTED|Second Intervention (24 Hours)||10
21234|NCT02891174|47179|P1|STARTED|Second Intervention (24 Hours)||17
21235|NCT02891174|47178|P2|NOT COMPLETED|First Intervention (24 Hours)||13
21236|NCT02891174|47179|P1|NOT COMPLETED|First Intervention (24 Hours)||3
21237|NCT02891174|47178|P2|COMPLETED|First Intervention (24 Hours)||10
21238|NCT02891174|47179|P1|COMPLETED|First Intervention (24 Hours)||17
21239|NCT02891174|47178|P2|Received First Intervention|First Intervention (24 Hours)||18
21240|NCT02891174|47179|P1|Received First Intervention|First Intervention (24 Hours)||19
21241|NCT02891174|47178|P2|STARTED|First Intervention (24 Hours)||23
21242|NCT02891174|47179|P1|STARTED|First Intervention (24 Hours)||20
21243|NCT02891070|47193|P2|NOT COMPLETED|Overall Study||8
21244|NCT02891070|47194|P1|NOT COMPLETED|Overall Study||10
21245|NCT02891070|47193|P2|COMPLETED|Overall Study||106
21246|NCT02891070|47194|P1|COMPLETED|Overall Study||100
21247|NCT02891070|47193|P2|STARTED|Overall Study||114
21248|NCT02891070|47194|P1|STARTED|Overall Study||110
21249|NCT02890992|47220|P8|NOT COMPLETED|130 Weeks Open-Label Extension Period||1
21250|NCT02890992|47221|P7|NOT COMPLETED|130 Weeks Open-Label Extension Period||1
21251|NCT02890992|47222|P6|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
21252|NCT02890992|47223|P5|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
21253|NCT02890992|47224|P4|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
21254|NCT02890992|47225|P3|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
21255|NCT02890992|47226|P2|NOT COMPLETED|130 Weeks Open-Label Extension Period||3
21256|NCT02890992|47227|P1|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
21257|NCT02890992|47220|P8|COMPLETED|130 Weeks Open-Label Extension Period||4
21258|NCT02890992|47221|P7|COMPLETED|130 Weeks Open-Label Extension Period||5
21259|NCT02890992|47222|P6|COMPLETED|130 Weeks Open-Label Extension Period||5
21260|NCT02890992|47223|P5|COMPLETED|130 Weeks Open-Label Extension Period||6
21261|NCT02890992|47224|P4|COMPLETED|130 Weeks Open-Label Extension Period||6
21262|NCT02890992|47225|P3|COMPLETED|130 Weeks Open-Label Extension Period||4
21263|NCT02890992|47226|P2|COMPLETED|130 Weeks Open-Label Extension Period||3
21264|NCT02890992|47227|P1|COMPLETED|130 Weeks Open-Label Extension Period||3
21265|NCT02890992|47220|P8|Treated|130 Weeks Open-Label Extension Period||4
21266|NCT02890992|47221|P7|Treated|130 Weeks Open-Label Extension Period||5
21267|NCT02890992|47222|P6|Treated|130 Weeks Open-Label Extension Period||5
21268|NCT02890992|47223|P5|Treated|130 Weeks Open-Label Extension Period||6
21269|NCT02890992|47224|P4|Treated|130 Weeks Open-Label Extension Period||6
21270|NCT02890992|47225|P3|Treated|130 Weeks Open-Label Extension Period||4
21271|NCT02890992|47226|P2|Treated|130 Weeks Open-Label Extension Period||6
21272|NCT02890992|47227|P1|Treated|130 Weeks Open-Label Extension Period||3
21273|NCT02890992|47220|P8|STARTED|130 Weeks Open-Label Extension Period||5
21274|NCT02890992|47221|P7|STARTED|130 Weeks Open-Label Extension Period||6
21275|NCT02890992|47222|P6|STARTED|130 Weeks Open-Label Extension Period||5
21276|NCT02890992|47223|P5|STARTED|130 Weeks Open-Label Extension Period||6
21277|NCT02890992|47224|P4|STARTED|130 Weeks Open-Label Extension Period||6
21278|NCT02890992|47225|P3|STARTED|130 Weeks Open-Label Extension Period||4
21279|NCT02890992|47226|P2|STARTED|130 Weeks Open-Label Extension Period||6
21280|NCT02890992|47227|P1|STARTED|130 Weeks Open-Label Extension Period|3 participants from Open-Label Dose Finding Period (OLDFI) entered in OLE period.|3
21281|NCT02890992|47220|P8|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
21282|NCT02890992|47221|P7|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
21283|NCT02890992|47222|P6|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
21284|NCT02890992|47223|P5|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
21285|NCT02890992|47224|P4|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
21286|NCT02890992|47225|P3|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
21287|NCT02890992|47226|P2|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
21288|NCT02890992|47227|P1|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
21289|NCT02890992|47220|P8|COMPLETED|12 Weeks Open-Label Dose Finding Period||5
21290|NCT02890992|47221|P7|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
21291|NCT02890992|47222|P6|COMPLETED|12 Weeks Open-Label Dose Finding Period||5
21292|NCT02890992|47223|P5|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
21293|NCT02890992|47224|P4|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
21382|NCT02885506|47537|P8|COMPLETED|Part B||0
21294|NCT02890992|47225|P3|COMPLETED|12 Weeks Open-Label Dose Finding Period||4
21295|NCT02890992|47226|P2|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
21296|NCT02890992|47227|P1|COMPLETED|12 Weeks Open-Label Dose Finding Period|Out of 4 participants, 3 participants entered into the open-label extension (OLE) period.|4
21297|NCT02890992|47220|P8|Treated|12 Weeks Open-Label Dose Finding Period||5
21298|NCT02890992|47221|P7|Treated|12 Weeks Open-Label Dose Finding Period||6
21299|NCT02890992|47222|P6|Treated|12 Weeks Open-Label Dose Finding Period||5
21300|NCT02890992|47223|P5|Treated|12 Weeks Open-Label Dose Finding Period||6
21301|NCT02890992|47224|P4|Treated|12 Weeks Open-Label Dose Finding Period||6
21302|NCT02890992|47225|P3|Treated|12 Weeks Open-Label Dose Finding Period||4
21303|NCT02890992|47226|P2|Treated|12 Weeks Open-Label Dose Finding Period||6
21304|NCT02890992|47227|P1|Treated|12 Weeks Open-Label Dose Finding Period||4
21305|NCT02890992|47220|P8|STARTED|12 Weeks Open-Label Dose Finding Period||5
21306|NCT02890992|47221|P7|STARTED|12 Weeks Open-Label Dose Finding Period||6
21307|NCT02890992|47222|P6|STARTED|12 Weeks Open-Label Dose Finding Period||5
21308|NCT02890992|47223|P5|STARTED|12 Weeks Open-Label Dose Finding Period||6
21309|NCT02890992|47224|P4|STARTED|12 Weeks Open-Label Dose Finding Period||6
21310|NCT02890992|47225|P3|STARTED|12 Weeks Open-Label Dose Finding Period||4
21311|NCT02890992|47226|P2|STARTED|12 Weeks Open-Label Dose Finding Period||6
21312|NCT02890992|47227|P1|STARTED|12 Weeks Open-Label Dose Finding Period||4
21313|NCT02890381|47395|P2|NOT COMPLETED|Overall Study||0
21314|NCT02890381|47396|P1|NOT COMPLETED|Overall Study||0
21315|NCT02890381|47395|P2|COMPLETED|Overall Study||6
21316|NCT02890381|47396|P1|COMPLETED|Overall Study||11
21317|NCT02890381|47395|P2|STARTED|Overall Study||6
21318|NCT02890381|47396|P1|STARTED|Overall Study||11
21319|NCT02890303|47422|P1|NOT COMPLETED|Overall Study||0
21320|NCT02890303|47422|P1|COMPLETED|Overall Study||100
21321|NCT02890303|47422|P1|STARTED|Overall Study||100
21322|NCT02889289|47426|P1|NOT COMPLETED|Overall Study||0
21323|NCT02889289|47426|P1|COMPLETED|Overall Study||1
21324|NCT02889289|47426|P1|STARTED|Overall Study||1
21325|NCT02887989|47437|P2|NOT COMPLETED|Overall Study||11
21326|NCT02887989|47438|P1|NOT COMPLETED|Overall Study||9
21327|NCT02887989|47437|P2|COMPLETED|Overall Study||59
21328|NCT02887989|47438|P1|COMPLETED|Overall Study||61
21329|NCT02887989|47437|P2|STARTED|Overall Study||70
21330|NCT02887989|47438|P1|STARTED|Overall Study||70
21331|NCT02886715|47451|P3|NOT COMPLETED|Overall Study||20
21332|NCT02886715|47452|P2|NOT COMPLETED|Overall Study||55
21333|NCT02886715|47453|P1|NOT COMPLETED|Overall Study||64
21334|NCT02886715|47451|P3|COMPLETED|Overall Study||203
21335|NCT02886715|47452|P2|COMPLETED|Overall Study||390
21336|NCT02886715|47453|P1|COMPLETED|Overall Study||378
21337|NCT02886715|47451|P3|Per Protocol (PP) Population|Overall Study||176
21338|NCT02886715|47452|P2|Per Protocol (PP) Population|Overall Study||351
21339|NCT02886715|47453|P1|Per Protocol (PP) Population|Overall Study||346
21340|NCT02886715|47451|P3|Modified ITT (mITT)|Overall Study||217
21341|NCT02886715|47452|P2|Modified ITT (mITT)|Overall Study||418
21342|NCT02886715|47453|P1|Modified ITT (mITT)|Overall Study||421
21343|NCT02886715|47451|P3|STARTED|Overall Study||223
21344|NCT02886715|47452|P2|STARTED|Overall Study||445
21345|NCT02886715|47453|P1|STARTED|Overall Study||442
21346|NCT02886702|47470|P3|NOT COMPLETED|Overall Study||53
21347|NCT02886702|47471|P2|NOT COMPLETED|Overall Study||51
21348|NCT02886702|47472|P1|NOT COMPLETED|Overall Study||48
21349|NCT02886702|47470|P3|COMPLETED|Overall Study||232
21350|NCT02886702|47471|P2|COMPLETED|Overall Study||235
21351|NCT02886702|47472|P1|COMPLETED|Overall Study||236
21352|NCT02886702|47470|P3|Per-Protocol Population (PP)|Overall Study||201
21353|NCT02886702|47471|P2|Per-Protocol Population (PP)|Overall Study||209
21354|NCT02886702|47472|P1|Per-Protocol Population (PP)|Overall Study||208
21355|NCT02886702|47470|P3|Modified Intent-to Treat (mITT)|Overall Study||275
21356|NCT02886702|47471|P2|Modified Intent-to Treat (mITT)|Overall Study||266
21357|NCT02886702|47472|P1|Modified Intent-to Treat (mITT)|Overall Study||263
21358|NCT02886702|47470|P3|STARTED|Overall Study||285
21359|NCT02886702|47471|P2|STARTED|Overall Study||286
21360|NCT02886702|47472|P1|STARTED|Overall Study||284
21361|NCT02886338|47486|P1|NOT COMPLETED|Overall Study||1
21362|NCT02886338|47486|P1|COMPLETED|Overall Study||9
21363|NCT02886338|47486|P1|STARTED|Overall Study||10
21364|NCT02885636|47492|P2|NOT COMPLETED|Overall Study||0
21365|NCT02885636|47493|P1|NOT COMPLETED|Overall Study||0
21366|NCT02885636|47492|P2|COMPLETED|Overall Study||15
21367|NCT02885636|47493|P1|COMPLETED|Overall Study||15
21368|NCT02885636|47492|P2|STARTED|Overall Study||15
21369|NCT02885636|47493|P1|STARTED|Overall Study||15
21370|NCT02885506|47535|P10|NOT COMPLETED|Part B||0
21371|NCT02885506|47536|P9|NOT COMPLETED|Part B||0
21372|NCT02885506|47537|P8|NOT COMPLETED|Part B||0
21373|NCT02885506|47538|P7|NOT COMPLETED|Part B||0
21374|NCT02885506|47539|P6|NOT COMPLETED|Part B||0
21375|NCT02885506|47540|P5|NOT COMPLETED|Part B||0
21376|NCT02885506|47541|P4|NOT COMPLETED|Part B||0
21377|NCT02885506|47542|P3|NOT COMPLETED|Part B||0
21378|NCT02885506|47543|P2|NOT COMPLETED|Part B||0
21379|NCT02885506|47544|P1|NOT COMPLETED|Part B||0
21380|NCT02885506|47535|P10|COMPLETED|Part B||4
21381|NCT02885506|47536|P9|COMPLETED|Part B||4
21383|NCT02885506|47538|P7|COMPLETED|Part B||0
21384|NCT02885506|47539|P6|COMPLETED|Part B||0
21385|NCT02885506|47540|P5|COMPLETED|Part B||0
21386|NCT02885506|47541|P4|COMPLETED|Part B||0
21387|NCT02885506|47542|P3|COMPLETED|Part B||0
21388|NCT02885506|47543|P2|COMPLETED|Part B||0
21389|NCT02885506|47544|P1|COMPLETED|Part B||0
21390|NCT02885506|47535|P10|STARTED|Part B||4
21391|NCT02885506|47536|P9|STARTED|Part B||4
21392|NCT02885506|47537|P8|STARTED|Part B||0
21393|NCT02885506|47538|P7|STARTED|Part B||0
21394|NCT02885506|47539|P6|STARTED|Part B||0
21395|NCT02885506|47540|P5|STARTED|Part B||0
21396|NCT02885506|47541|P4|STARTED|Part B||0
21397|NCT02885506|47542|P3|STARTED|Part B||0
21398|NCT02885506|47543|P2|STARTED|Part B||0
21399|NCT02885506|47544|P1|STARTED|Part B||0
21400|NCT02885506|47535|P10|NOT COMPLETED|Part A||0
21401|NCT02885506|47536|P9|NOT COMPLETED|Part A||0
21402|NCT02885506|47537|P8|NOT COMPLETED|Part A||0
21403|NCT02885506|47538|P7|NOT COMPLETED|Part A||0
21404|NCT02885506|47539|P6|NOT COMPLETED|Part A||0
21405|NCT02885506|47540|P5|NOT COMPLETED|Part A||0
21406|NCT02885506|47541|P4|NOT COMPLETED|Part A||0
21407|NCT02885506|47542|P3|NOT COMPLETED|Part A||0
21408|NCT02885506|47543|P2|NOT COMPLETED|Part A||0
21409|NCT02885506|47544|P1|NOT COMPLETED|Part A||0
21410|NCT02885506|47535|P10|COMPLETED|Part A||0
21411|NCT02885506|47536|P9|COMPLETED|Part A||0
21412|NCT02885506|47537|P8|COMPLETED|Part A||14
21413|NCT02885506|47538|P7|COMPLETED|Part A||6
21414|NCT02885506|47539|P6|COMPLETED|Part A||6
21415|NCT02885506|47540|P5|COMPLETED|Part A||6
21416|NCT02885506|47541|P4|COMPLETED|Part A||6
21417|NCT02885506|47542|P3|COMPLETED|Part A||6
21418|NCT02885506|47543|P2|COMPLETED|Part A||6
21419|NCT02885506|47544|P1|COMPLETED|Part A||6
21420|NCT02885506|47535|P10|STARTED|Part A||0
21421|NCT02885506|47536|P9|STARTED|Part A||0
21422|NCT02885506|47537|P8|STARTED|Part A||14
21423|NCT02885506|47538|P7|STARTED|Part A||6
21424|NCT02885506|47539|P6|STARTED|Part A||6
21425|NCT02885506|47540|P5|STARTED|Part A||6
21426|NCT02885506|47541|P4|STARTED|Part A||6
21427|NCT02885506|47542|P3|STARTED|Part A||6
21428|NCT02885506|47543|P2|STARTED|Part A||6
21429|NCT02885506|47544|P1|STARTED|Part A||6
21430|NCT02885181|47640|P4|NOT COMPLETED|Overall Study||3
21431|NCT02885181|47641|P3|NOT COMPLETED|Overall Study||0
21432|NCT02885181|47642|P2|NOT COMPLETED|Overall Study||1
21433|NCT02885181|47643|P1|NOT COMPLETED|Overall Study||0
21434|NCT02885181|47640|P4|COMPLETED|Overall Study||19
21435|NCT02885181|47641|P3|COMPLETED|Overall Study||21
21436|NCT02885181|47642|P2|COMPLETED|Overall Study||19
21437|NCT02885181|47643|P1|COMPLETED|Overall Study||20
21438|NCT02885181|47640|P4|STARTED|Overall Study||22
21439|NCT02885181|47641|P3|STARTED|Overall Study||21
21440|NCT02885181|47642|P2|STARTED|Overall Study||20
21441|NCT02885181|47643|P1|STARTED|Overall Study||20
21442|NCT02885012|47671|P2|NOT COMPLETED|Overall Study||0
21443|NCT02885012|47672|P1|NOT COMPLETED|Overall Study||0
21444|NCT02885012|47671|P2|COMPLETED|Overall Study||2
21445|NCT02885012|47672|P1|COMPLETED|Overall Study||1
21446|NCT02885012|47671|P2|STARTED|Overall Study||2
21447|NCT02885012|47672|P1|STARTED|Overall Study||1
21448|NCT02884492|47684|P2|NOT COMPLETED|Overall Study||0
21449|NCT02884492|47685|P1|NOT COMPLETED|Overall Study||0
21450|NCT02884492|47684|P2|COMPLETED|Overall Study||10
21451|NCT02884492|47685|P1|COMPLETED|Overall Study||7
21452|NCT02884492|47684|P2|STARTED|Overall Study||10
21453|NCT02884492|47685|P1|STARTED|Overall Study||7
21454|NCT02884427|47694|P3|NOT COMPLETED|Overall Study||0
21455|NCT02884427|47695|P2|NOT COMPLETED|Overall Study||0
21456|NCT02884427|47696|P1|NOT COMPLETED|Overall Study||0
21457|NCT02884427|47694|P3|COMPLETED|Overall Study||50
21458|NCT02884427|47695|P2|COMPLETED|Overall Study||52
21459|NCT02884427|47696|P1|COMPLETED|Overall Study||48
21460|NCT02884427|47694|P3|STARTED|Overall Study||50
21461|NCT02884427|47695|P2|STARTED|Overall Study||52
21462|NCT02884427|47696|P1|STARTED|Overall Study||48
21463|NCT02884089|47710|P4|NOT COMPLETED|Follow-up Visit||1
21464|NCT02884089|47711|P3|NOT COMPLETED|Follow-up Visit||0
21465|NCT02884089|47712|P2|NOT COMPLETED|Follow-up Visit||0
21466|NCT02884089|47713|P1|NOT COMPLETED|Follow-up Visit||1
21467|NCT02884089|47710|P4|COMPLETED|Follow-up Visit||6
21468|NCT02884089|47711|P3|COMPLETED|Follow-up Visit||7
21469|NCT02884089|47712|P2|COMPLETED|Follow-up Visit||6
21470|NCT02884089|47713|P1|COMPLETED|Follow-up Visit||6
21471|NCT02884089|47710|P4|STARTED|Follow-up Visit||7
21472|NCT02884089|47711|P3|STARTED|Follow-up Visit||7
21473|NCT02884089|47712|P2|STARTED|Follow-up Visit||6
21474|NCT02884089|47713|P1|STARTED|Follow-up Visit||7
21475|NCT02884089|47710|P4|NOT COMPLETED|Period 4||0
21476|NCT02884089|47711|P3|NOT COMPLETED|Period 4||0
21477|NCT02884089|47712|P2|NOT COMPLETED|Period 4||1
21478|NCT02884089|47713|P1|NOT COMPLETED|Period 4||1
21479|NCT02884089|47710|P4|COMPLETED|Period 4||7
21480|NCT02884089|47711|P3|COMPLETED|Period 4||7
21481|NCT02884089|47712|P2|COMPLETED|Period 4||6
21482|NCT02884089|47713|P1|COMPLETED|Period 4||7
21483|NCT02884089|47710|P4|STARTED|Period 4||7
21484|NCT02884089|47711|P3|STARTED|Period 4||7
21485|NCT02884089|47712|P2|STARTED|Period 4||7
21486|NCT02884089|47713|P1|STARTED|Period 4||8
21487|NCT02884089|47710|P4|NOT COMPLETED|Washout Period 3||1
21488|NCT02884089|47711|P3|NOT COMPLETED|Washout Period 3||1
21489|NCT02884089|47712|P2|NOT COMPLETED|Washout Period 3||0
21490|NCT02884089|47713|P1|NOT COMPLETED|Washout Period 3||0
21491|NCT02884089|47710|P4|COMPLETED|Washout Period 3||7
21492|NCT02884089|47711|P3|COMPLETED|Washout Period 3||7
21493|NCT02884089|47712|P2|COMPLETED|Washout Period 3||7
21494|NCT02884089|47713|P1|COMPLETED|Washout Period 3||8
21495|NCT02884089|47710|P4|STARTED|Washout Period 3||8
21496|NCT02884089|47711|P3|STARTED|Washout Period 3||8
21497|NCT02884089|47712|P2|STARTED|Washout Period 3||7
21498|NCT02884089|47713|P1|STARTED|Washout Period 3||8
21499|NCT02884089|47710|P4|NOT COMPLETED|Period 3||0
21500|NCT02884089|47711|P3|NOT COMPLETED|Period 3||1
21501|NCT02884089|47712|P2|NOT COMPLETED|Period 3||0
21502|NCT02884089|47713|P1|NOT COMPLETED|Period 3||0
21503|NCT02884089|47710|P4|COMPLETED|Period 3||8
21504|NCT02884089|47711|P3|COMPLETED|Period 3||8
21505|NCT02884089|47712|P2|COMPLETED|Period 3||7
21506|NCT02884089|47713|P1|COMPLETED|Period 3||8
21507|NCT02884089|47710|P4|STARTED|Period 3||8
21508|NCT02884089|47711|P3|STARTED|Period 3||9
21509|NCT02884089|47712|P2|STARTED|Period 3||7
21510|NCT02884089|47713|P1|STARTED|Period 3||8
21511|NCT02884089|47710|P4|NOT COMPLETED|Washout Period 2||0
21512|NCT02884089|47711|P3|NOT COMPLETED|Washout Period 2||0
21513|NCT02884089|47712|P2|NOT COMPLETED|Washout Period 2||0
21514|NCT02884089|47713|P1|NOT COMPLETED|Washout Period 2||0
21515|NCT02884089|47710|P4|COMPLETED|Washout Period 2||8
21516|NCT02884089|47711|P3|COMPLETED|Washout Period 2||9
21517|NCT02884089|47712|P2|COMPLETED|Washout Period 2||7
21518|NCT02884089|47713|P1|COMPLETED|Washout Period 2||8
21519|NCT02884089|47710|P4|STARTED|Washout Period 2||8
21520|NCT02884089|47711|P3|STARTED|Washout Period 2||9
21521|NCT02884089|47712|P2|STARTED|Washout Period 2||7
21522|NCT02884089|47713|P1|STARTED|Washout Period 2||8
21523|NCT02884089|47710|P4|NOT COMPLETED|Period 2||0
21524|NCT02884089|47711|P3|NOT COMPLETED|Period 2||0
21525|NCT02884089|47712|P2|NOT COMPLETED|Period 2||0
21526|NCT02884089|47713|P1|NOT COMPLETED|Period 2||1
21527|NCT02884089|47710|P4|COMPLETED|Period 2||8
21528|NCT02884089|47711|P3|COMPLETED|Period 2||9
21529|NCT02884089|47712|P2|COMPLETED|Period 2||7
21530|NCT02884089|47713|P1|COMPLETED|Period 2||8
21531|NCT02884089|47710|P4|STARTED|Period 2||8
21532|NCT02884089|47711|P3|STARTED|Period 2||9
21533|NCT02884089|47712|P2|STARTED|Period 2||7
21534|NCT02884089|47713|P1|STARTED|Period 2||9
21535|NCT02884089|47710|P4|NOT COMPLETED|Washout Period 1||1
21536|NCT02884089|47711|P3|NOT COMPLETED|Washout Period 1||0
21537|NCT02884089|47712|P2|NOT COMPLETED|Washout Period 1||2
21538|NCT02884089|47713|P1|NOT COMPLETED|Washout Period 1||0
21539|NCT02884089|47710|P4|COMPLETED|Washout Period 1||8
21540|NCT02884089|47711|P3|COMPLETED|Washout Period 1||9
21541|NCT02884089|47712|P2|COMPLETED|Washout Period 1||7
21542|NCT02884089|47713|P1|COMPLETED|Washout Period 1||9
21543|NCT02884089|47710|P4|STARTED|Washout Period 1||9
21544|NCT02884089|47711|P3|STARTED|Washout Period 1||9
21545|NCT02884089|47712|P2|STARTED|Washout Period 1||9
21546|NCT02884089|47713|P1|STARTED|Washout Period 1||9
21547|NCT02884089|47710|P4|NOT COMPLETED|Period 1||0
21548|NCT02884089|47711|P3|NOT COMPLETED|Period 1||0
21549|NCT02884089|47712|P2|NOT COMPLETED|Period 1||2
21550|NCT02884089|47713|P1|NOT COMPLETED|Period 1||2
21551|NCT02884089|47710|P4|COMPLETED|Period 1||9
21552|NCT02884089|47711|P3|COMPLETED|Period 1||9
21553|NCT02884089|47712|P2|COMPLETED|Period 1||9
21554|NCT02884089|47713|P1|COMPLETED|Period 1||9
21555|NCT02884089|47710|P4|Received at Least One Dose of Study Drug|Period 1||9
21556|NCT02884089|47711|P3|Received at Least One Dose of Study Drug|Period 1||9
21557|NCT02884089|47712|P2|Received at Least One Dose of Study Drug|Period 1||11
21558|NCT02884089|47713|P1|Received at Least One Dose of Study Drug|Period 1||11
21559|NCT02884089|47710|P4|STARTED|Period 1||9
21560|NCT02884089|47711|P3|STARTED|Period 1||9
21561|NCT02884089|47712|P2|STARTED|Period 1||11
21562|NCT02884089|47713|P1|STARTED|Period 1||11
21563|NCT02883244|47729|P2|NOT COMPLETED|Overall Study||1
21564|NCT02883244|47730|P1|NOT COMPLETED|Overall Study||0
21565|NCT02883244|47729|P2|COMPLETED|Overall Study||25
21566|NCT02883244|47730|P1|COMPLETED|Overall Study||24
21567|NCT02883244|47729|P2|STARTED|Overall Study||26
21568|NCT02883244|47730|P1|STARTED|Overall Study||24
21569|NCT02882854|47748|P2|NOT COMPLETED|Overall Study||3
21570|NCT02882854|47749|P1|NOT COMPLETED|Overall Study||1
21571|NCT02882854|47748|P2|COMPLETED|Overall Study||41
21572|NCT02882854|47749|P1|COMPLETED|Overall Study||39
21573|NCT02882854|47748|P2|STARTED|Overall Study||44
21574|NCT02882854|47749|P1|STARTED|Overall Study||40
21575|NCT02882633|47773|P2|NOT COMPLETED|Overall Study||0
21576|NCT02882633|47774|P1|NOT COMPLETED|Overall Study||2
21577|NCT02882633|47773|P2|COMPLETED|Overall Study||25
21578|NCT02882633|47774|P1|COMPLETED|Overall Study||23
21579|NCT02882633|47773|P2|STARTED|Overall Study||25
21580|NCT02882633|47774|P1|STARTED|Overall Study||25
21581|NCT02882152|47786|P2|NOT COMPLETED|Overall Study||0
21582|NCT02882152|47787|P1|NOT COMPLETED|Overall Study||1
21583|NCT02882152|47786|P2|COMPLETED|Overall Study||20
21584|NCT02882152|47787|P1|COMPLETED|Overall Study||19
21585|NCT02882152|47786|P2|STARTED|Overall Study||20
21586|NCT02882152|47787|P1|STARTED|Overall Study||20
21587|NCT02881840|47795|P1|NOT COMPLETED|Overall Study||0
21588|NCT02881840|47795|P1|COMPLETED|Overall Study||6
21589|NCT02881840|47795|P1|STARTED|Overall Study||6
21590|NCT02881775|47799|P2|NOT COMPLETED|Second Intervention (1-Hour Session)||0
21591|NCT02881775|47800|P1|NOT COMPLETED|Second Intervention (1-Hour Session)||0
21592|NCT02881775|47799|P2|COMPLETED|Second Intervention (1-Hour Session)||7
21593|NCT02881775|47800|P1|COMPLETED|Second Intervention (1-Hour Session)||9
21594|NCT02881775|47799|P2|STARTED|Second Intervention (1-Hour Session)||7
21595|NCT02881775|47800|P1|STARTED|Second Intervention (1-Hour Session)||9
21596|NCT02881775|47799|P2|NOT COMPLETED|Washout (1 Week)||0
21597|NCT02881775|47800|P1|NOT COMPLETED|Washout (1 Week)||0
21598|NCT02881775|47799|P2|COMPLETED|Washout (1 Week)||7
21599|NCT02881775|47800|P1|COMPLETED|Washout (1 Week)||9
21600|NCT02881775|47799|P2|STARTED|Washout (1 Week)||7
21601|NCT02881775|47800|P1|STARTED|Washout (1 Week)||9
21602|NCT02881775|47799|P2|NOT COMPLETED|First Intervention (1-hr Session)||0
21603|NCT02881775|47800|P1|NOT COMPLETED|First Intervention (1-hr Session)||0
21604|NCT02881775|47799|P2|COMPLETED|First Intervention (1-hr Session)||7
21605|NCT02881775|47800|P1|COMPLETED|First Intervention (1-hr Session)||9
21606|NCT02881775|47799|P2|STARTED|First Intervention (1-hr Session)|Two participants dropped out prior to First Intervention (1-hr Session).|7
21607|NCT02881775|47800|P1|STARTED|First Intervention (1-hr Session)|Two participants dropped out prior to First Intervention (1-hr Session).|9
21608|NCT02881775|47799|P2|NOT COMPLETED|Baseline||0
21609|NCT02881775|47800|P1|NOT COMPLETED|Baseline||0
21610|NCT02881775|47799|P2|COMPLETED|Baseline||9
21611|NCT02881775|47800|P1|COMPLETED|Baseline||11
21612|NCT02881775|47799|P2|STARTED|Baseline||9
21613|NCT02881775|47800|P1|STARTED|Baseline||11
21614|NCT02881658|47822|P2|NOT COMPLETED|Overall Study||5
21615|NCT02881658|47823|P1|NOT COMPLETED|Overall Study||2
21616|NCT02881658|47822|P2|COMPLETED|Overall Study||96
21617|NCT02881658|47823|P1|COMPLETED|Overall Study||98
21618|NCT02881658|47822|P2|STARTED|Overall Study||101
21619|NCT02881658|47823|P1|STARTED|Overall Study||100
21620|NCT02881567|47857|P1|NOT COMPLETED|Overall Study||18
21621|NCT02881567|47857|P1|COMPLETED|Overall Study||23
21622|NCT02881567|47857|P1|STARTED|Overall Study||41
21623|NCT02881112|47869|P1|NOT COMPLETED|Overall Study||28
21624|NCT02881112|47869|P1|COMPLETED|Overall Study||152
21625|NCT02881112|47869|P1|STARTED|Overall Study||180
21626|NCT02881008|47879|P6|NOT COMPLETED|Overall Study||0
21627|NCT02881008|47880|P5|NOT COMPLETED|Overall Study||0
21628|NCT02881008|47881|P4|NOT COMPLETED|Overall Study||0
21629|NCT02881008|47882|P3|NOT COMPLETED|Overall Study||0
21630|NCT02881008|47883|P2|NOT COMPLETED|Overall Study||0
21631|NCT02881008|47884|P1|NOT COMPLETED|Overall Study||0
21632|NCT02881008|47879|P6|COMPLETED|Overall Study||8
21633|NCT02881008|47880|P5|COMPLETED|Overall Study||8
21634|NCT02881008|47881|P4|COMPLETED|Overall Study||8
21635|NCT02881008|47882|P3|COMPLETED|Overall Study||8
21636|NCT02881008|47883|P2|COMPLETED|Overall Study||8
21637|NCT02881008|47884|P1|COMPLETED|Overall Study||8
21638|NCT02881008|47879|P6|STARTED|Overall Study||8
21639|NCT02881008|47880|P5|STARTED|Overall Study||8
21640|NCT02881008|47881|P4|STARTED|Overall Study||8
21641|NCT02881008|47882|P3|STARTED|Overall Study||8
21642|NCT02881008|47883|P2|STARTED|Overall Study||8
21643|NCT02881008|47884|P1|STARTED|Overall Study||8
21644|NCT02880852|47917|P1|NOT COMPLETED|Overall Study||0
21645|NCT02880852|47917|P1|COMPLETED|Overall Study||20
21646|NCT02880852|47917|P1|STARTED|Overall Study||20
21647|NCT02880761|47945|P2|NOT COMPLETED|Overall Study||21
21648|NCT02880761|47946|P1|NOT COMPLETED|Overall Study||16
21649|NCT02880761|47945|P2|COMPLETED|Overall Study||85
21650|NCT02880761|47946|P1|COMPLETED|Overall Study||87
21651|NCT02880761|47945|P2|STARTED|Overall Study||106
21652|NCT02880761|47946|P1|STARTED|Overall Study||103
21653|NCT02880514|47956|P2|NOT COMPLETED|Overall Study||0
21654|NCT02880514|47957|P1|NOT COMPLETED|Overall Study||0
21655|NCT02880514|47956|P2|COMPLETED|Overall Study||50
21656|NCT02880514|47957|P1|COMPLETED|Overall Study||50
21657|NCT02880514|47956|P2|STARTED|Overall Study|A total of 50 subjects with one sinus side assigned to the control group|50
21658|NCT02880514|47957|P1|STARTED|Overall Study|A total of 50 subjects with one sinus side assigned to the treatment group|50
21659|NCT02880475|47966|P2|NOT COMPLETED|Overall Study||0
21660|NCT02880475|47967|P1|NOT COMPLETED|Overall Study||0
21661|NCT02880475|47966|P2|COMPLETED|Overall Study||17
21662|NCT02880475|47967|P1|COMPLETED|Overall Study||13
21663|NCT02880475|47966|P2|STARTED|Overall Study||17
21664|NCT02880475|47967|P1|STARTED|Overall Study||13
21665|NCT02880254|48101|P2|NOT COMPLETED|Overall Study||10
21666|NCT02880254|48102|P1|NOT COMPLETED|Overall Study||9
21667|NCT02880254|48101|P2|COMPLETED|Overall Study||4
21668|NCT02880254|48102|P1|COMPLETED|Overall Study||4
21669|NCT02880254|48101|P2|STARTED|Overall Study||14
21670|NCT02880254|48102|P1|STARTED|Overall Study||13
21671|NCT02880228|48110|P1|NOT COMPLETED|Overall Study||0
21672|NCT02880228|48110|P1|COMPLETED|Overall Study||11
21673|NCT02880228|48110|P1|STARTED|Overall Study||11
21674|NCT02880189|48118|P1|NOT COMPLETED|Overall Study||0
21675|NCT02880189|48118|P1|COMPLETED|Overall Study||21
21676|NCT02880189|48118|P1|STARTED|Overall Study||21
21677|NCT02880137|48123|P1|NOT COMPLETED|Overall Study||0
21678|NCT02880137|48123|P1|COMPLETED|Overall Study||36
21679|NCT02880137|48123|P1|STARTED|Overall Study||36
21680|NCT02879747|48130|P3|NOT COMPLETED|Overall Study||2
21681|NCT02879747|48131|P2|NOT COMPLETED|Overall Study||6
21682|NCT02879747|48132|P1|NOT COMPLETED|Overall Study||4
21683|NCT02879747|48130|P3|COMPLETED|Overall Study||31
21684|NCT02879747|48131|P2|COMPLETED|Overall Study||32
21685|NCT02879747|48132|P1|COMPLETED|Overall Study||23
21686|NCT02879747|48130|P3|STARTED|Overall Study||33
21687|NCT02879747|48131|P2|STARTED|Overall Study||38
21688|NCT02879747|48132|P1|STARTED|Overall Study||27
21689|NCT02879032|48149|P1|NOT COMPLETED|Overall Study||0
21690|NCT02879032|48149|P1|COMPLETED|Overall Study||130
21691|NCT02879032|48149|P1|STARTED|Overall Study||130
21692|NCT02878590|48155|P1|NOT COMPLETED|Overall Study||2
21693|NCT02878590|48155|P1|COMPLETED|Overall Study||10
21694|NCT02878590|48155|P1|STARTED|Overall Study||12
21695|NCT02878486|48161|P2|NOT COMPLETED|Overall Study||0
21696|NCT02878486|48162|P1|NOT COMPLETED|Overall Study||0
21697|NCT02878486|48161|P2|COMPLETED|Overall Study||3
21698|NCT02878486|48162|P1|COMPLETED|Overall Study||3
21699|NCT02878486|48161|P2|STARTED|Overall Study||3
21700|NCT02878486|48162|P1|STARTED|Overall Study||3
21701|NCT02878330|48180|P2|NOT COMPLETED|Overall Study||56
21702|NCT02878330|48181|P1|NOT COMPLETED|Overall Study||29
21703|NCT02878330|48180|P2|COMPLETED|Overall Study||913
21704|NCT02878330|48181|P1|COMPLETED|Overall Study||455
21705|NCT02878330|48180|P2|STARTED|Overall Study||969
21706|NCT02878330|48181|P1|STARTED|Overall Study||484
21707|NCT02878213|48197|P1|NOT COMPLETED|Overall Study||3
21708|NCT02878213|48197|P1|COMPLETED|Overall Study||36
21709|NCT02878213|48197|P1|STARTED|Overall Study||39
21710|NCT02877927|48204|P2|NOT COMPLETED|Overall Study||57
21711|NCT02877927|48205|P1|NOT COMPLETED|Overall Study||54
21712|NCT02877927|48204|P2|COMPLETED|Overall Study||310
21713|NCT02877927|48205|P1|COMPLETED|Overall Study||314
21714|NCT02877927|48204|P2|STARTED|Overall Study||367
21715|NCT02877927|48205|P1|STARTED|Overall Study||368
21716|NCT02877732|48217|P2|NOT COMPLETED|Overall Study||6
21717|NCT02877732|48218|P1|NOT COMPLETED|Overall Study||6
21718|NCT02877732|48217|P2|COMPLETED|Overall Study||0
21719|NCT02877732|48218|P1|COMPLETED|Overall Study||0
21720|NCT02877732|48217|P2|STARTED|Overall Study||6
21721|NCT02877732|48218|P1|STARTED|Overall Study||6
21722|NCT02877095|48236|P2|NOT COMPLETED|Overall Study||0
21723|NCT02877095|48237|P1|NOT COMPLETED|Overall Study||0
21724|NCT02877095|48236|P2|COMPLETED|Overall Study||20
21725|NCT02877095|48237|P1|COMPLETED|Overall Study||20
21726|NCT02877095|48236|P2|STARTED|Overall Study||20
21727|NCT02877095|48237|P1|STARTED|Overall Study|First patient enrolled 1/9/17.|20
21728|NCT02877082|48243|P1|NOT COMPLETED|Overall Study||5
21729|NCT02877082|48243|P1|COMPLETED|Overall Study||0
21730|NCT02877082|48243|P1|STARTED|Overall Study||5
21731|NCT02877004|48254|P3|NOT COMPLETED|Overall Study||1
21732|NCT02877004|48255|P2|NOT COMPLETED|Overall Study||0
21733|NCT02877004|48256|P1|NOT COMPLETED|Overall Study||0
21734|NCT02877004|48254|P3|COMPLETED|Overall Study||19
21735|NCT02877004|48255|P2|COMPLETED|Overall Study||20
21736|NCT02877004|48256|P1|COMPLETED|Overall Study||20
21737|NCT02877004|48254|P3|STARTED|Overall Study||20
21738|NCT02877004|48255|P2|STARTED|Overall Study||20
21739|NCT02877004|48256|P1|STARTED|Overall Study||20
21740|NCT02876926|48270|P3|NOT COMPLETED|Overall Study||20
21741|NCT02876926|48271|P2|NOT COMPLETED|Overall Study||19
21742|NCT02876926|48272|P1|NOT COMPLETED|Overall Study||18
21743|NCT02876926|48270|P3|COMPLETED|Overall Study||2
21744|NCT02876926|48271|P2|COMPLETED|Overall Study||3
21745|NCT02876926|48272|P1|COMPLETED|Overall Study||3
21746|NCT02876926|48270|P3|STARTED|Overall Study||22
21747|NCT02876926|48271|P2|STARTED|Overall Study||22
21748|NCT02876926|48272|P1|STARTED|Overall Study||21
21749|NCT02876757|48288|P2|NOT COMPLETED|Overall Study||0
21750|NCT02876757|48289|P1|NOT COMPLETED|Overall Study||0
21751|NCT02876757|48288|P2|COMPLETED|Overall Study||93197
21752|NCT02876757|48289|P1|COMPLETED|Overall Study||93197
21753|NCT02876757|48288|P2|STARTED|Overall Study||93197
21754|NCT02876757|48289|P1|STARTED|Overall Study||93197
21755|NCT02876159|48301|P2|NOT COMPLETED|Overall Study||0
21756|NCT02876159|48302|P1|NOT COMPLETED|Overall Study||0
21757|NCT02876159|48301|P2|COMPLETED|Overall Study||10
21758|NCT02876159|48302|P1|COMPLETED|Overall Study||10
21759|NCT02876159|48301|P2|STARTED|Overall Study||10
21760|NCT02876159|48302|P1|STARTED|Overall Study||10
21761|NCT02876055|48321|P3|NOT COMPLETED|Overall Study||0
21762|NCT02876055|48322|P2|NOT COMPLETED|Overall Study||0
21763|NCT02876055|48323|P1|NOT COMPLETED|Overall Study||0
21764|NCT02876055|48321|P3|COMPLETED|Overall Study||42
21765|NCT02876055|48322|P2|COMPLETED|Overall Study||41
21766|NCT02876055|48323|P1|COMPLETED|Overall Study||42
21767|NCT02876055|48321|P3|STARTED|Overall Study||42
21768|NCT02876055|48322|P2|STARTED|Overall Study||41
21769|NCT02876055|48323|P1|STARTED|Overall Study||42
21770|NCT02875977|48333|P2|NOT COMPLETED|Overall Study||29
21771|NCT02875977|48334|P1|NOT COMPLETED|Overall Study||42
21772|NCT02875977|48333|P2|COMPLETED|Overall Study||71
21773|NCT02875977|48334|P1|COMPLETED|Overall Study||58
21774|NCT02875977|48333|P2|STARTED|Overall Study||100
21775|NCT02875977|48334|P1|STARTED|Overall Study||100
21776|NCT02875613|48348|P1|NOT COMPLETED|Overall Study||1
21777|NCT02875613|48348|P1|COMPLETED|Overall Study||4
21778|NCT02875613|48348|P1|STARTED|Overall Study||5
21779|NCT02875366|48354|P2|NOT COMPLETED|Overall Study||3
21780|NCT02875366|48355|P1|NOT COMPLETED|Overall Study||0
21781|NCT02875366|48354|P2|COMPLETED|Overall Study||31
21782|NCT02875366|48355|P1|COMPLETED|Overall Study||36
21783|NCT02875366|48354|P2|STARTED|Overall Study||34
21784|NCT02875366|48355|P1|STARTED|Overall Study||36
21785|NCT02875340|48407|P1|NOT COMPLETED|Overall Study||8
21786|NCT02875340|48407|P1|COMPLETED|Overall Study|No patients completed 6 months of continuous treatment|0
21787|NCT02875340|48407|P1|STARTED|Overall Study||8
21788|NCT02874924|48432|P3|NOT COMPLETED|Overall Study||0
21789|NCT02874924|48433|P2|NOT COMPLETED|Overall Study||0
21790|NCT02874924|48434|P1|NOT COMPLETED|Overall Study||3
21791|NCT02874924|48432|P3|COMPLETED|Overall Study||6
21792|NCT02874924|48433|P2|COMPLETED|Overall Study||14
21793|NCT02874924|48434|P1|COMPLETED|Overall Study||11
21794|NCT02874924|48432|P3|STARTED|Overall Study||6
21795|NCT02874924|48433|P2|STARTED|Overall Study||14
21796|NCT02874924|48434|P1|STARTED|Overall Study||14
21797|NCT02874846|48456|P2|NOT COMPLETED|Overall Study||0
21798|NCT02874846|48457|P1|NOT COMPLETED|Overall Study||0
21799|NCT02874846|48456|P2|COMPLETED|Overall Study||4
21800|NCT02874846|48457|P1|COMPLETED|Overall Study||8
21801|NCT02874846|48456|P2|STARTED|Overall Study||4
21802|NCT02874846|48457|P1|STARTED|Overall Study||8
21803|NCT02874066|48465|P1|NOT COMPLETED|Overall Study||0
21804|NCT02874066|48465|P1|COMPLETED|Overall Study||46
21805|NCT02874066|48465|P1|STARTED|Overall Study||46
21806|NCT02873754|48473|P1|NOT COMPLETED|Overall Study||6
21807|NCT02873754|48473|P1|COMPLETED|Overall Study||5
21808|NCT02873754|48473|P1|STARTED|Overall Study||11
21809|NCT02873702|48490|P4|NOT COMPLETED|Maintenance Period (up to Month 6)||2
21810|NCT02873702|48491|P3|NOT COMPLETED|Maintenance Period (up to Month 6)||7
21811|NCT02873702|48492|P2|NOT COMPLETED|Maintenance Period (up to Month 6)||0
21812|NCT02873702|48493|P1|NOT COMPLETED|Maintenance Period (up to Month 6)||0
21813|NCT02873702|48490|P4|COMPLETED|Maintenance Period (up to Month 6)||6
21814|NCT02873702|48491|P3|COMPLETED|Maintenance Period (up to Month 6)||1
21815|NCT02873702|48492|P2|COMPLETED|Maintenance Period (up to Month 6)||0
21816|NCT02873702|48493|P1|COMPLETED|Maintenance Period (up to Month 6)||0
21817|NCT02873702|48490|P4|STARTED|Maintenance Period (up to Month 6)||8
21818|NCT02873702|48491|P3|STARTED|Maintenance Period (up to Month 6)||8
21819|NCT02873702|48492|P2|STARTED|Maintenance Period (up to Month 6)||0
21820|NCT02873702|48493|P1|STARTED|Maintenance Period (up to Month 6)||0
21821|NCT02873702|48490|P4|NOT COMPLETED|Healing Period (up to Week 8)||0
21822|NCT02873702|48491|P3|NOT COMPLETED|Healing Period (up to Week 8)||0
21823|NCT02873702|48492|P2|NOT COMPLETED|Healing Period (up to Week 8)||1
21824|NCT02873702|48493|P1|NOT COMPLETED|Healing Period (up to Week 8)||1
21825|NCT02873702|48490|P4|COMPLETED|Healing Period (up to Week 8)||0
21826|NCT02873702|48491|P3|COMPLETED|Healing Period (up to Week 8)||0
21827|NCT02873702|48492|P2|COMPLETED|Healing Period (up to Week 8)||16
21828|NCT02873702|48493|P1|COMPLETED|Healing Period (up to Week 8)||19
21829|NCT02873702|48490|P4|STARTED|Healing Period (up to Week 8)||0
21830|NCT02873702|48491|P3|STARTED|Healing Period (up to Week 8)||0
21831|NCT02873702|48492|P2|STARTED|Healing Period (up to Week 8)||17
21832|NCT02873702|48493|P1|STARTED|Healing Period (up to Week 8)||20
21833|NCT02873689|48505|P2|NOT COMPLETED|Overall Study||5
21834|NCT02873689|48506|P1|NOT COMPLETED|Overall Study||7
21835|NCT02873689|48505|P2|COMPLETED|Overall Study||103
21836|NCT02873689|48506|P1|COMPLETED|Overall Study||102
21837|NCT02873689|48505|P2|Treated|Overall Study||107
21838|NCT02873689|48506|P1|Treated|Overall Study||108
21839|NCT02873689|48505|P2|STARTED|Overall Study||108
21840|NCT02873689|48506|P1|STARTED|Overall Study||109
21841|NCT02873481|48516|P2|NOT COMPLETED|Overall Study||0
21842|NCT02873481|48517|P1|NOT COMPLETED|Overall Study||0
21843|NCT02873481|48516|P2|COMPLETED|Overall Study||17
21844|NCT02873481|48517|P1|COMPLETED|Overall Study||15
21845|NCT02873481|48516|P2|STARTED|Overall Study||17
21846|NCT02873481|48517|P1|STARTED|Overall Study||15
21847|NCT02873429|48534|P2|NOT COMPLETED|16 Weeks||2
21848|NCT02873429|48535|P1|NOT COMPLETED|16 Weeks||5
21849|NCT02873429|48534|P2|COMPLETED|16 Weeks||96
21850|NCT02873429|48535|P1|COMPLETED|16 Weeks||100
21851|NCT02873429|48534|P2|STARTED|16 Weeks|1 Conv. participant Missed 6-8 week but was eligible for 16 week|98
21852|NCT02873429|48535|P1|STARTED|16 Weeks|10 CAM participants Missed 6-8 week but are eligible for 16 week|105
21853|NCT02873429|48534|P2|NOT COMPLETED|6-8 Weeks||1
21854|NCT02873429|48535|P1|NOT COMPLETED|6-8 Weeks||10
21855|NCT02873429|48534|P2|COMPLETED|6-8 Weeks||97
21856|NCT02873429|48535|P1|COMPLETED|6-8 Weeks||95
21857|NCT02873429|48534|P2|STARTED|6-8 Weeks|2 Con. participants not eligible to complete follow ups because they did not continue treatment.|98
21858|NCT02873429|48535|P1|STARTED|6-8 Weeks|4 CAM participants not eligible to complete follow ups because they did not continue treatment.|105
21859|NCT02873429|48534|P2|NOT COMPLETED|Baseline||0
21860|NCT02873429|48535|P1|NOT COMPLETED|Baseline||0
21861|NCT02873429|48534|P2|COMPLETED|Baseline||100
21862|NCT02873429|48535|P1|COMPLETED|Baseline||109
21863|NCT02873429|48534|P2|STARTED|Baseline||100
21864|NCT02873429|48535|P1|STARTED|Baseline||109
21865|NCT02873377|48547|P2|NOT COMPLETED|Period Title 3: 6 Months Follow up||23
21866|NCT02873377|48548|P1|NOT COMPLETED|Period Title 3: 6 Months Follow up||15
21867|NCT02873377|48547|P2|COMPLETED|Period Title 3: 6 Months Follow up||46
21868|NCT02873377|48548|P1|COMPLETED|Period Title 3: 6 Months Follow up||50
21869|NCT02873377|48547|P2|STARTED|Period Title 3: 6 Months Follow up||69
21870|NCT02873377|48548|P1|STARTED|Period Title 3: 6 Months Follow up||65
21871|NCT02873377|48547|P2|NOT COMPLETED|Period Title 2: 3 Months Follow up||22
21872|NCT02873377|48548|P1|NOT COMPLETED|Period Title 2: 3 Months Follow up||22
21873|NCT02873377|48547|P2|COMPLETED|Period Title 2: 3 Months Follow up||47
21874|NCT02873377|48548|P1|COMPLETED|Period Title 2: 3 Months Follow up||43
21875|NCT02873377|48547|P2|STARTED|Period Title 2: 3 Months Follow up||69
21876|NCT02873377|48548|P1|STARTED|Period Title 2: 3 Months Follow up||65
21877|NCT02873377|48547|P2|NOT COMPLETED|Period 1: Enrollment||0
21878|NCT02873377|48548|P1|NOT COMPLETED|Period 1: Enrollment||0
21879|NCT02873377|48547|P2|COMPLETED|Period 1: Enrollment||69
21880|NCT02873377|48548|P1|COMPLETED|Period 1: Enrollment||65
21881|NCT02873377|48547|P2|STARTED|Period 1: Enrollment||69
21882|NCT02873377|48548|P1|STARTED|Period 1: Enrollment||65
21883|NCT02873221|48570|P3|NOT COMPLETED|Safety Follow-up Period||14
21884|NCT02873221|48571|P2|NOT COMPLETED|Safety Follow-up Period||17
21885|NCT02873221|48572|P1|NOT COMPLETED|Safety Follow-up Period||7
21886|NCT02873221|48570|P3|COMPLETED|Safety Follow-up Period||350
21887|NCT02873221|48571|P2|COMPLETED|Safety Follow-up Period||339
21888|NCT02873221|48572|P1|COMPLETED|Safety Follow-up Period||343
21889|NCT02873221|48570|P3|STARTED|Safety Follow-up Period||364
21890|NCT02873221|48571|P2|STARTED|Safety Follow-up Period||356
21891|NCT02873221|48572|P1|STARTED|Safety Follow-up Period||350
21892|NCT02873221|48570|P3|NOT COMPLETED|Treatment Period||105
21893|NCT02873221|48571|P2|NOT COMPLETED|Treatment Period||126
21894|NCT02873221|48572|P1|NOT COMPLETED|Treatment Period||88
21895|NCT02873221|48570|P3|COMPLETED|Treatment Period||315
21896|NCT02873221|48571|P2|COMPLETED|Treatment Period||291
21897|NCT02873221|48572|P1|COMPLETED|Treatment Period||329
21898|NCT02873221|48570|P3|Safety Population: Received Study Drug|Treatment Period||409
21899|NCT02873221|48571|P2|Safety Population: Received Study Drug|Treatment Period||404
21900|NCT02873221|48572|P1|Safety Population: Received Study Drug|Treatment Period||417
21901|NCT02873221|48570|P3|STARTED|Treatment Period||420
21902|NCT02873221|48571|P2|STARTED|Treatment Period||417
21903|NCT02873221|48572|P1|STARTED|Treatment Period||417
21904|NCT02873104|48594|P2|NOT COMPLETED|Overall Study||0
21905|NCT02873104|48595|P1|NOT COMPLETED|Overall Study||1
21906|NCT02873104|48594|P2|COMPLETED|Overall Study||23
21907|NCT02873104|48595|P1|COMPLETED|Overall Study||46
21908|NCT02873104|48594|P2|STARTED|Overall Study||23
21909|NCT02873104|48595|P1|STARTED|Overall Study||47
21910|NCT02872909|48609|P2|NOT COMPLETED|Overall Study||0
21911|NCT02872909|48610|P1|NOT COMPLETED|Overall Study||0
21912|NCT02872909|48609|P2|COMPLETED|Overall Study||18
21913|NCT02872909|48610|P1|COMPLETED|Overall Study||32
21914|NCT02872909|48609|P2|STARTED|Overall Study||18
21915|NCT02872909|48610|P1|STARTED|Overall Study||32
21916|NCT02872285|48624|P2|NOT COMPLETED|Overall Study||2
21917|NCT02872285|48625|P1|NOT COMPLETED|Overall Study||5
21918|NCT02872285|48624|P2|COMPLETED|Overall Study||9
21919|NCT02872285|48625|P1|COMPLETED|Overall Study||17
21920|NCT02872285|48624|P2|STARTED|Overall Study||11
21921|NCT02872285|48625|P1|STARTED|Overall Study||22
21922|NCT02872103|48641|P2|NOT COMPLETED|Cycle 2-4||1
21923|NCT02872103|48642|P1|NOT COMPLETED|Cycle 2-4||2
21924|NCT02872103|48641|P2|COMPLETED|Cycle 2-4||37
21925|NCT02872103|48642|P1|COMPLETED|Cycle 2-4||81
21926|NCT02872103|48641|P2|STARTED|Cycle 2-4|1 subject withdrawn in Cycle 1|38
21927|NCT02872103|48642|P1|STARTED|Cycle 2-4||83
21928|NCT02872103|48641|P2|NOT COMPLETED|Cycle 1||1
21929|NCT02872103|48642|P1|NOT COMPLETED|Cycle 1||0
21930|NCT02872103|48641|P2|COMPLETED|Cycle 1||38
21931|NCT02872103|48642|P1|COMPLETED|Cycle 1||83
21932|NCT02872103|48641|P2|STARTED|Cycle 1||39
21933|NCT02872103|48642|P1|STARTED|Cycle 1||83
21934|NCT02872012|48671|P5|NOT COMPLETED|Overall Study||0
21935|NCT02872012|48672|P4|NOT COMPLETED|Overall Study||0
21936|NCT02872012|48673|P3|NOT COMPLETED|Overall Study||0
21937|NCT02872012|48674|P2|NOT COMPLETED|Overall Study||0
21938|NCT02872012|48675|P1|NOT COMPLETED|Overall Study||1
21939|NCT02872012|48671|P5|COMPLETED|Overall Study||5
21940|NCT02872012|48672|P4|COMPLETED|Overall Study||3
21941|NCT02872012|48673|P3|COMPLETED|Overall Study||4
21942|NCT02872012|48674|P2|COMPLETED|Overall Study||7
21943|NCT02872012|48675|P1|COMPLETED|Overall Study||3
21944|NCT02872012|48671|P5|STARTED|Overall Study||5
21945|NCT02872012|48672|P4|STARTED|Overall Study||3
21946|NCT02872012|48673|P3|STARTED|Overall Study||4
21947|NCT02872012|48674|P2|STARTED|Overall Study||7
21948|NCT02872012|48675|P1|STARTED|Overall Study||4
21949|NCT02871739|48693|P4|NOT COMPLETED|Overall Study||2
21950|NCT02871739|48694|P3|NOT COMPLETED|Overall Study||0
21951|NCT02871739|48695|P2|NOT COMPLETED|Overall Study||2
21952|NCT02871739|48696|P1|NOT COMPLETED|Overall Study||3
21953|NCT02871739|48693|P4|COMPLETED|Overall Study||5
21954|NCT02871739|48694|P3|COMPLETED|Overall Study||4
21955|NCT02871739|48695|P2|COMPLETED|Overall Study||4
21956|NCT02871739|48696|P1|COMPLETED|Overall Study||3
21957|NCT02871739|48693|P4|Complete Final Survey|Overall Study||5
21958|NCT02871739|48694|P3|Complete Final Survey|Overall Study||4
21959|NCT02871739|48695|P2|Complete Final Survey|Overall Study||4
21960|NCT02871739|48696|P1|Complete Final Survey|Overall Study||3
21961|NCT02871739|48693|P4|Completed Second SPI|Overall Study||5
21962|NCT02871739|48694|P3|Completed Second SPI|Overall Study||4
21963|NCT02871739|48695|P2|Completed Second SPI|Overall Study||4
21964|NCT02871739|48696|P1|Completed Second SPI|Overall Study||3
21965|NCT02871739|48693|P4|Completed First SPI|Overall Study||6
21966|NCT02871739|48694|P3|Completed First SPI|Overall Study||4
21967|NCT02871739|48695|P2|Completed First SPI|Overall Study||5
21968|NCT02871739|48696|P1|Completed First SPI|Overall Study||3
21969|NCT02871739|48693|P4|STARTED|Overall Study||7
21970|NCT02871739|48694|P3|STARTED|Overall Study||4
21971|NCT02871739|48695|P2|STARTED|Overall Study||6
21972|NCT02871739|48696|P1|STARTED|Overall Study||6
21973|NCT02871570|48708|P2|NOT COMPLETED|Overall Study||0
21974|NCT02871570|48709|P1|NOT COMPLETED|Overall Study||0
21975|NCT02871570|48708|P2|COMPLETED|Overall Study||8
21976|NCT02871570|48709|P1|COMPLETED|Overall Study||8
21977|NCT02871570|48708|P2|STARTED|Overall Study||8
21978|NCT02871570|48709|P1|STARTED|Overall Study||8
21979|NCT02871479|48740|P3|NOT COMPLETED|Overall Study||0
21980|NCT02871479|48741|P2|NOT COMPLETED|Overall Study||3
21981|NCT02871479|48742|P1|NOT COMPLETED|Overall Study||3
21982|NCT02871479|48740|P3|COMPLETED|Overall Study||11
21983|NCT02871479|48741|P2|COMPLETED|Overall Study||21
21984|NCT02871479|48742|P1|COMPLETED|Overall Study||33
21985|NCT02871479|48740|P3|STARTED|Overall Study||11
21986|NCT02871479|48741|P2|STARTED|Overall Study||24
21987|NCT02871479|48742|P1|STARTED|Overall Study||36
21988|NCT02871375|48753|P2|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
21989|NCT02871375|48754|P1|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
21990|NCT02871375|48753|P2|COMPLETED|Period 2, Second 14 Days of Wear||76
21991|NCT02871375|48754|P1|COMPLETED|Period 2, Second 14 Days of Wear||89
21992|NCT02871375|48753|P2|STARTED|Period 2, Second 14 Days of Wear||76
21993|NCT02871375|48754|P1|STARTED|Period 2, Second 14 Days of Wear||89
21994|NCT02871375|48753|P2|NOT COMPLETED|Period 1, First 14 Days of Wear||1
21995|NCT02871375|48754|P1|NOT COMPLETED|Period 1, First 14 Days of Wear||0
21996|NCT02871375|48753|P2|COMPLETED|Period 1, First 14 Days of Wear||76
21997|NCT02871375|48754|P1|COMPLETED|Period 1, First 14 Days of Wear||89
21998|NCT02871375|48753|P2|STARTED|Period 1, First 14 Days of Wear||77
21999|NCT02871375|48754|P1|STARTED|Period 1, First 14 Days of Wear||89
22000|NCT02871011|48765|P2|NOT COMPLETED|Overall Study||0
22001|NCT02871011|48766|P1|NOT COMPLETED|Overall Study||0
22002|NCT02871011|48765|P2|COMPLETED|Overall Study||13
22003|NCT02871011|48766|P1|COMPLETED|Overall Study||7
22004|NCT02871011|48765|P2|STARTED|Overall Study||13
22005|NCT02871011|48766|P1|STARTED|Overall Study||7
22006|NCT02870205|48786|P4|NOT COMPLETED|Overall Study||7
22007|NCT02870205|48787|P3|NOT COMPLETED|Overall Study||7
22008|NCT02870205|48788|P2|NOT COMPLETED|Overall Study||5
22009|NCT02870205|48789|P1|NOT COMPLETED|Overall Study||10
22010|NCT02870205|48786|P4|COMPLETED|Overall Study||287
22011|NCT02870205|48787|P3|COMPLETED|Overall Study||287
22012|NCT02870205|48788|P2|COMPLETED|Overall Study||289
22013|NCT02870205|48789|P1|COMPLETED|Overall Study||284
22014|NCT02870205|48786|P4|STARTED|Overall Study||294
22015|NCT02870205|48787|P3|STARTED|Overall Study||294
22016|NCT02870205|48788|P2|STARTED|Overall Study||294
22017|NCT02870205|48789|P1|STARTED|Overall Study||294
22018|NCT02870101|48799|P1|NOT COMPLETED|Overall Study||169
22019|NCT02870101|48799|P1|COMPLETED|Overall Study||2598
22020|NCT02870101|48799|P1|STARTED|Overall Study||2767
22021|NCT02869451|48814|P1|NOT COMPLETED|Overall Study||0
22022|NCT02869451|48814|P1|COMPLETED|Overall Study||5
22023|NCT02869451|48814|P1|STARTED|Overall Study||5
22024|NCT02869438|48838|P2|NOT COMPLETED|Overall Study||2
22025|NCT02869438|48839|P1|NOT COMPLETED|Overall Study||3
22026|NCT02869438|48838|P2|COMPLETED|Overall Study||113
22027|NCT02869438|48839|P1|COMPLETED|Overall Study||115
22028|NCT02869438|48838|P2|STARTED|Overall Study||115
22029|NCT02869438|48839|P1|STARTED|Overall Study||118
22030|NCT02868892|48887|P1|NOT COMPLETED|Overall Study||6
22031|NCT02868892|48887|P1|COMPLETED|Overall Study||0
22032|NCT02868892|48887|P1|STARTED|Overall Study||6
22033|NCT02868242|48893|P1|NOT COMPLETED|Overall Study||0
22034|NCT02868242|48893|P1|COMPLETED|Overall Study||19
22035|NCT02868242|48893|P1|STARTED|Overall Study||19
22036|NCT02868216|48905|P2|NOT COMPLETED|Overall Study||6
22037|NCT02868216|48906|P1|NOT COMPLETED|Overall Study||8
22038|NCT02868216|48905|P2|COMPLETED|Overall Study||41
22039|NCT02868216|48906|P1|COMPLETED|Overall Study||35
22040|NCT02868216|48905|P2|STARTED|Overall Study||47
22041|NCT02868216|48906|P1|STARTED|Overall Study||43
22042|NCT02867995|48914|P2|NOT COMPLETED|Overall Study||3
22043|NCT02867995|48915|P1|NOT COMPLETED|Overall Study||0
22044|NCT02867995|48914|P2|COMPLETED|Overall Study|Total patients completed|27
22045|NCT02867995|48915|P1|COMPLETED|Overall Study|Total patients completed|9
22046|NCT02867995|48914|P2|STARTED|Overall Study|Total patients consented|30
22047|NCT02867995|48915|P1|STARTED|Overall Study|Total patients consented|9
22048|NCT02867709|48934|P3|NOT COMPLETED|Safety Follow-up Period||14
22049|NCT02867709|48935|P2|NOT COMPLETED|Safety Follow-up Period||15
22050|NCT02867709|48936|P1|NOT COMPLETED|Safety Follow-up Period||11
22051|NCT02867709|48934|P3|COMPLETED|Safety Follow-up Period||473
22052|NCT02867709|48935|P2|COMPLETED|Safety Follow-up Period||459
22053|NCT02867709|48936|P1|COMPLETED|Safety Follow-up Period||482
22054|NCT02867709|48934|P3|STARTED|Safety Follow-up Period||487
22055|NCT02867709|48935|P2|STARTED|Safety Follow-up Period||474
22056|NCT02867709|48936|P1|STARTED|Safety Follow-up Period||493
22057|NCT02867709|48934|P3|NOT COMPLETED|Treatment Period||75
22058|NCT02867709|48935|P2|NOT COMPLETED|Treatment Period||87
22059|NCT02867709|48936|P1|NOT COMPLETED|Treatment Period||70
22060|NCT02867709|48934|P3|COMPLETED|Treatment Period||487
22061|NCT02867709|48935|P2|COMPLETED|Treatment Period||474
22062|NCT02867709|48936|P1|COMPLETED|Treatment Period||493
22063|NCT02867709|48934|P3|Safety Population: Received Study Drug|Treatment Period||488
22064|NCT02867709|48935|P2|Safety Population: Received Study Drug|Treatment Period||478
22065|NCT02867709|48936|P1|Safety Population: Received Study Drug|Treatment Period||499
22066|NCT02867709|48934|P3|STARTED|Treatment Period||562
22067|NCT02867709|48935|P2|STARTED|Treatment Period||561
22068|NCT02867709|48936|P1|STARTED|Treatment Period||563
22069|NCT02867163|48965|P1|NOT COMPLETED|Overall Study||0
22070|NCT02867163|48965|P1|COMPLETED|Overall Study||25
22071|NCT02867163|48965|P1|STARTED|Overall Study||25
22072|NCT02867150|48969|P1|NOT COMPLETED|Overall Study||0
22073|NCT02867150|48969|P1|COMPLETED|Overall Study||58
22074|NCT02867150|48969|P1|STARTED|Overall Study||58
22075|NCT02866942|48973|P1|NOT COMPLETED|Overall Study||1
22076|NCT02866942|48973|P1|COMPLETED|Overall Study||478
22077|NCT02866942|48973|P1|STARTED|Overall Study||479
22078|NCT02866695|48978|P1|NOT COMPLETED|Overall Study||2
22079|NCT02866695|48978|P1|COMPLETED|Overall Study||18
22080|NCT02866695|48978|P1|STARTED|Overall Study||20
22081|NCT02865720|48986|P2|NOT COMPLETED|Overall Study||0
22082|NCT02865720|48987|P1|NOT COMPLETED|Overall Study||0
22083|NCT02865720|48986|P2|COMPLETED|Overall Study||8
22084|NCT02865720|48987|P1|COMPLETED|Overall Study||0
22085|NCT02865720|48986|P2|STARTED|Overall Study||8
22086|NCT02865720|48987|P1|STARTED|Overall Study||0
22087|NCT02865499|49010|P1|NOT COMPLETED|12 Weeks||0
22088|NCT02865499|49010|P1|COMPLETED|12 Weeks||6
22089|NCT02865499|49010|P1|STARTED|12 Weeks||6
22090|NCT02865499|49010|P1|NOT COMPLETED|8 Weeks||0
22091|NCT02865499|49010|P1|COMPLETED|8 Weeks||6
22092|NCT02865499|49010|P1|STARTED|8 Weeks||6
22093|NCT02865499|49010|P1|NOT COMPLETED|Baseline||2
22094|NCT02865499|49010|P1|COMPLETED|Baseline||6
22095|NCT02865499|49010|P1|STARTED|Baseline||8
22096|NCT02865395|49017|P3|NOT COMPLETED|Overall Study||7
22097|NCT02865395|49018|P2|NOT COMPLETED|Overall Study||10
22098|NCT02865395|49019|P1|NOT COMPLETED|Overall Study||6
22099|NCT02865395|49017|P3|COMPLETED|Overall Study|Data Not Collected|0
22100|NCT02865395|49018|P2|COMPLETED|Overall Study|Data Not Collected|0
22101|NCT02865395|49019|P1|COMPLETED|Overall Study|Data Not Collected|0
22102|NCT02865395|49017|P3|STARTED|Overall Study||7
22103|NCT02865395|49018|P2|STARTED|Overall Study||10
22104|NCT02865395|49019|P1|STARTED|Overall Study||6
22105|NCT02865083|49032|P2|NOT COMPLETED|Overall Study||1
22106|NCT02865083|49033|P1|NOT COMPLETED|Overall Study||3
22107|NCT02865083|49032|P2|COMPLETED|Overall Study||0
22108|NCT02865083|49033|P1|COMPLETED|Overall Study||0
22109|NCT02865083|49032|P2|STARTED|Overall Study||1
22110|NCT02865083|49033|P1|STARTED|Overall Study||3
22111|NCT02864732|49053|P2|NOT COMPLETED|Overall Study||2
22112|NCT02864732|49054|P1|NOT COMPLETED|Overall Study||2
22113|NCT02864732|49053|P2|COMPLETED|Overall Study||13
22114|NCT02864732|49054|P1|COMPLETED|Overall Study||13
22115|NCT02864732|49053|P2|STARTED|Overall Study||15
22116|NCT02864732|49054|P1|STARTED|Overall Study||15
22117|NCT02864706|49071|P2|NOT COMPLETED|Overall Study||0
22118|NCT02864706|49072|P1|NOT COMPLETED|Overall Study||0
22119|NCT02864706|49071|P2|COMPLETED|Overall Study||47
22120|NCT02864706|49072|P1|COMPLETED|Overall Study||48
22121|NCT02864706|49071|P2|Intent to Treat|Overall Study||47
22122|NCT02864706|49072|P1|Intent to Treat|Overall Study||46
22123|NCT02864706|49071|P2|Safety Set|Overall Study||47
22124|NCT02864706|49072|P1|Safety Set|Overall Study||48
22125|NCT02864706|49071|P2|STARTED|Overall Study||47
22126|NCT02864706|49072|P1|STARTED|Overall Study||48
22127|NCT02864342|49094|P2|NOT COMPLETED|Overall Study||19
22128|NCT02864342|49095|P1|NOT COMPLETED|Overall Study||15
22129|NCT02864342|49094|P2|COMPLETED|Overall Study||49
22130|NCT02864342|49095|P1|COMPLETED|Overall Study||55
22131|NCT02864342|49094|P2|Full Analysis Set (FAS)|Overall Study||67
22132|NCT02864342|49095|P1|Full Analysis Set (FAS)|Overall Study||70
22133|NCT02864342|49094|P2|STARTED|Overall Study||68
22134|NCT02864342|49095|P1|STARTED|Overall Study||70
22135|NCT02864316|49112|P2|NOT COMPLETED|Overall Study||2
22136|NCT02864316|49113|P1|NOT COMPLETED|Overall Study||2
22137|NCT02864316|49112|P2|COMPLETED|Overall Study||0
22138|NCT02864316|49113|P1|COMPLETED|Overall Study||0
22139|NCT02864316|49112|P2|STARTED|Overall Study||2
22140|NCT02864316|49113|P1|STARTED|Overall Study||2
22141|NCT02863575|49132|P3|NOT COMPLETED|Overall Study||1
22142|NCT02863575|49133|P2|NOT COMPLETED|Overall Study||2
22143|NCT02863575|49134|P1|NOT COMPLETED|Overall Study||1
22144|NCT02863575|49132|P3|COMPLETED|Overall Study||51
22145|NCT02863575|49133|P2|COMPLETED|Overall Study||159
22146|NCT02863575|49134|P1|COMPLETED|Overall Study||160
22147|NCT02863575|49132|P3|STARTED|Overall Study||52
22148|NCT02863575|49133|P2|STARTED|Overall Study||161
22149|NCT02863575|49134|P1|STARTED|Overall Study||161
22150|NCT02863419|49186|P3|NOT COMPLETED|Overall Study||8
22151|NCT02863419|49187|P2|NOT COMPLETED|Overall Study||10
22152|NCT02863419|49188|P1|NOT COMPLETED|Overall Study||8
22153|NCT02863419|49186|P3|COMPLETED|Overall Study||134
22154|NCT02863419|49187|P2|COMPLETED|Overall Study||274
22155|NCT02863419|49188|P1|COMPLETED|Overall Study||277
22156|NCT02863419|49186|P3|STARTED|Overall Study||142
22157|NCT02863419|49187|P2|STARTED|Overall Study||284
22158|NCT02863419|49188|P1|STARTED|Overall Study||285
22159|NCT02863289|49303|P1|NOT COMPLETED|Overall Study||83
22160|NCT02863289|49303|P1|COMPLETED|Overall Study|Study completed on 01/03/2017, 35 study participants have returned the questionnaire.|35
22161|NCT02863289|49303|P1|STARTED|Overall Study|Study started on 01/11/2016, with 118 study participants.|118
22162|NCT02863263|49310|P2|NOT COMPLETED|Overall Study||1
22163|NCT02863263|49311|P1|NOT COMPLETED|Overall Study||1
22164|NCT02863263|49310|P2|COMPLETED|Overall Study||1
22165|NCT02863263|49311|P1|COMPLETED|Overall Study||2
22166|NCT02863263|49310|P2|STARTED|Overall Study||2
22167|NCT02863263|49311|P1|STARTED|Overall Study||3
22168|NCT02863198|49333|P2|NOT COMPLETED|Overall Study||0
22169|NCT02863198|49334|P1|NOT COMPLETED|Overall Study||0
22170|NCT02863198|49333|P2|COMPLETED|Overall Study||60
22171|NCT02863198|49334|P1|COMPLETED|Overall Study||60
22172|NCT02863198|49333|P2|STARTED|Overall Study||60
22173|NCT02863198|49334|P1|STARTED|Overall Study||60
22174|NCT02862730|49350|P7|NOT COMPLETED|Fourth Intervention (84 Hours)||0
22175|NCT02862730|49351|P6|NOT COMPLETED|Fourth Intervention (84 Hours)||0
22176|NCT02862730|49352|P5|NOT COMPLETED|Fourth Intervention (84 Hours)||0
22177|NCT02862730|49353|P4|NOT COMPLETED|Fourth Intervention (84 Hours)||0
22178|NCT02862730|49354|P3|NOT COMPLETED|Fourth Intervention (84 Hours)||0
22179|NCT02862730|49355|P2|NOT COMPLETED|Fourth Intervention (84 Hours)||0
22180|NCT02862730|49356|P1|NOT COMPLETED|Fourth Intervention (84 Hours)||0
22181|NCT02862730|49350|P7|COMPLETED|Fourth Intervention (84 Hours)||1
22182|NCT02862730|49351|P6|COMPLETED|Fourth Intervention (84 Hours)||1
22183|NCT02862730|49352|P5|COMPLETED|Fourth Intervention (84 Hours)||4
22184|NCT02862730|49353|P4|COMPLETED|Fourth Intervention (84 Hours)||4
22185|NCT02862730|49354|P3|COMPLETED|Fourth Intervention (84 Hours)||6
22186|NCT02862730|49355|P2|COMPLETED|Fourth Intervention (84 Hours)||1
22187|NCT02862730|49356|P1|COMPLETED|Fourth Intervention (84 Hours)||3
22188|NCT02862730|49350|P7|STARTED|Fourth Intervention (84 Hours)||1
22189|NCT02862730|49351|P6|STARTED|Fourth Intervention (84 Hours)||1
22190|NCT02862730|49352|P5|STARTED|Fourth Intervention (84 Hours)||4
22191|NCT02862730|49353|P4|STARTED|Fourth Intervention (84 Hours)||4
22192|NCT02862730|49354|P3|STARTED|Fourth Intervention (84 Hours)||6
22193|NCT02862730|49355|P2|STARTED|Fourth Intervention (84 Hours)||1
22194|NCT02862730|49356|P1|STARTED|Fourth Intervention (84 Hours)||3
22195|NCT02862730|49350|P7|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
22196|NCT02862730|49351|P6|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
22197|NCT02862730|49352|P5|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
22198|NCT02862730|49353|P4|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
22199|NCT02862730|49354|P3|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
22200|NCT02862730|49355|P2|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
22201|NCT02862730|49356|P1|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
22202|NCT02862730|49350|P7|COMPLETED|Fourth Rest Period (7-45 Days)||1
22203|NCT02862730|49351|P6|COMPLETED|Fourth Rest Period (7-45 Days)||1
22204|NCT02862730|49352|P5|COMPLETED|Fourth Rest Period (7-45 Days)||4
22205|NCT02862730|49353|P4|COMPLETED|Fourth Rest Period (7-45 Days)||4
22206|NCT02862730|49354|P3|COMPLETED|Fourth Rest Period (7-45 Days)||6
22207|NCT02862730|49355|P2|COMPLETED|Fourth Rest Period (7-45 Days)||1
22208|NCT02862730|49356|P1|COMPLETED|Fourth Rest Period (7-45 Days)||3
22209|NCT02862730|49350|P7|STARTED|Fourth Rest Period (7-45 Days)||1
22210|NCT02862730|49351|P6|STARTED|Fourth Rest Period (7-45 Days)||1
22211|NCT02862730|49352|P5|STARTED|Fourth Rest Period (7-45 Days)||4
22212|NCT02862730|49353|P4|STARTED|Fourth Rest Period (7-45 Days)||4
22213|NCT02862730|49354|P3|STARTED|Fourth Rest Period (7-45 Days)||6
22214|NCT02862730|49355|P2|STARTED|Fourth Rest Period (7-45 Days)||1
22215|NCT02862730|49356|P1|STARTED|Fourth Rest Period (7-45 Days)||3
22216|NCT02862730|49350|P7|NOT COMPLETED|Third Intervention (84 Hours)||0
22217|NCT02862730|49351|P6|NOT COMPLETED|Third Intervention (84 Hours)||0
22218|NCT02862730|49352|P5|NOT COMPLETED|Third Intervention (84 Hours)||0
22219|NCT02862730|49353|P4|NOT COMPLETED|Third Intervention (84 Hours)||1
22220|NCT02862730|49354|P3|NOT COMPLETED|Third Intervention (84 Hours)||0
22221|NCT02862730|49355|P2|NOT COMPLETED|Third Intervention (84 Hours)||0
22222|NCT02862730|49356|P1|NOT COMPLETED|Third Intervention (84 Hours)||0
22223|NCT02862730|49350|P7|COMPLETED|Third Intervention (84 Hours)||1
22224|NCT02862730|49351|P6|COMPLETED|Third Intervention (84 Hours)||1
22225|NCT02862730|49352|P5|COMPLETED|Third Intervention (84 Hours)||4
22226|NCT02862730|49353|P4|COMPLETED|Third Intervention (84 Hours)||4
22227|NCT02862730|49354|P3|COMPLETED|Third Intervention (84 Hours)||6
22228|NCT02862730|49355|P2|COMPLETED|Third Intervention (84 Hours)||1
22229|NCT02862730|49356|P1|COMPLETED|Third Intervention (84 Hours)||3
22230|NCT02862730|49350|P7|STARTED|Third Intervention (84 Hours)||1
22231|NCT02862730|49351|P6|STARTED|Third Intervention (84 Hours)||1
22232|NCT02862730|49352|P5|STARTED|Third Intervention (84 Hours)||4
22233|NCT02862730|49353|P4|STARTED|Third Intervention (84 Hours)||5
22234|NCT02862730|49354|P3|STARTED|Third Intervention (84 Hours)||6
22235|NCT02862730|49355|P2|STARTED|Third Intervention (84 Hours)||1
22236|NCT02862730|49356|P1|STARTED|Third Intervention (84 Hours)||3
22237|NCT02862730|49350|P7|NOT COMPLETED|Third Rest Period (7-45 Days)||0
22238|NCT02862730|49351|P6|NOT COMPLETED|Third Rest Period (7-45 Days)||0
22239|NCT02862730|49352|P5|NOT COMPLETED|Third Rest Period (7-45 Days)||1
22240|NCT02862730|49353|P4|NOT COMPLETED|Third Rest Period (7-45 Days)||0
22241|NCT02862730|49354|P3|NOT COMPLETED|Third Rest Period (7-45 Days)||1
22242|NCT02862730|49355|P2|NOT COMPLETED|Third Rest Period (7-45 Days)||0
22243|NCT02862730|49356|P1|NOT COMPLETED|Third Rest Period (7-45 Days)||0
22244|NCT02862730|49350|P7|COMPLETED|Third Rest Period (7-45 Days)||1
22245|NCT02862730|49351|P6|COMPLETED|Third Rest Period (7-45 Days)||1
22246|NCT02862730|49352|P5|COMPLETED|Third Rest Period (7-45 Days)||4
22247|NCT02862730|49353|P4|COMPLETED|Third Rest Period (7-45 Days)||5
22248|NCT02862730|49354|P3|COMPLETED|Third Rest Period (7-45 Days)||6
22249|NCT02862730|49355|P2|COMPLETED|Third Rest Period (7-45 Days)||1
22250|NCT02862730|49356|P1|COMPLETED|Third Rest Period (7-45 Days)||3
22251|NCT02862730|49350|P7|STARTED|Third Rest Period (7-45 Days)||1
22252|NCT02862730|49351|P6|STARTED|Third Rest Period (7-45 Days)||1
22253|NCT02862730|49352|P5|STARTED|Third Rest Period (7-45 Days)||5
22254|NCT02862730|49353|P4|STARTED|Third Rest Period (7-45 Days)||5
22255|NCT02862730|49354|P3|STARTED|Third Rest Period (7-45 Days)||7
22256|NCT02862730|49355|P2|STARTED|Third Rest Period (7-45 Days)||1
22257|NCT02862730|49356|P1|STARTED|Third Rest Period (7-45 Days)||3
22258|NCT02862730|49350|P7|NOT COMPLETED|Second Intervention (84 Hours)||0
22259|NCT02862730|49351|P6|NOT COMPLETED|Second Intervention (84 Hours)||0
22260|NCT02862730|49352|P5|NOT COMPLETED|Second Intervention (84 Hours)||0
22261|NCT02862730|49353|P4|NOT COMPLETED|Second Intervention (84 Hours)||0
22262|NCT02862730|49354|P3|NOT COMPLETED|Second Intervention (84 Hours)||0
22263|NCT02862730|49355|P2|NOT COMPLETED|Second Intervention (84 Hours)||0
22264|NCT02862730|49356|P1|NOT COMPLETED|Second Intervention (84 Hours)||1
22265|NCT02862730|49350|P7|COMPLETED|Second Intervention (84 Hours)||1
22266|NCT02862730|49351|P6|COMPLETED|Second Intervention (84 Hours)||1
22267|NCT02862730|49352|P5|COMPLETED|Second Intervention (84 Hours)||5
22268|NCT02862730|49353|P4|COMPLETED|Second Intervention (84 Hours)||5
22269|NCT02862730|49354|P3|COMPLETED|Second Intervention (84 Hours)||7
22270|NCT02862730|49355|P2|COMPLETED|Second Intervention (84 Hours)||1
22271|NCT02862730|49356|P1|COMPLETED|Second Intervention (84 Hours)||3
22272|NCT02862730|49350|P7|STARTED|Second Intervention (84 Hours)||1
22273|NCT02862730|49351|P6|STARTED|Second Intervention (84 Hours)||1
22274|NCT02862730|49352|P5|STARTED|Second Intervention (84 Hours)||5
22275|NCT02862730|49353|P4|STARTED|Second Intervention (84 Hours)||5
22276|NCT02862730|49354|P3|STARTED|Second Intervention (84 Hours)||7
22277|NCT02862730|49355|P2|STARTED|Second Intervention (84 Hours)||1
22278|NCT02862730|49356|P1|STARTED|Second Intervention (84 Hours)||4
22279|NCT02862730|49350|P7|NOT COMPLETED|Second Rest Period (7-45 Days)||0
22280|NCT02862730|49351|P6|NOT COMPLETED|Second Rest Period (7-45 Days)||0
22281|NCT02862730|49352|P5|NOT COMPLETED|Second Rest Period (7-45 Days)||0
22282|NCT02862730|49353|P4|NOT COMPLETED|Second Rest Period (7-45 Days)||0
22283|NCT02862730|49354|P3|NOT COMPLETED|Second Rest Period (7-45 Days)||0
22284|NCT02862730|49355|P2|NOT COMPLETED|Second Rest Period (7-45 Days)||0
22285|NCT02862730|49356|P1|NOT COMPLETED|Second Rest Period (7-45 Days)||0
22286|NCT02862730|49350|P7|COMPLETED|Second Rest Period (7-45 Days)||1
22287|NCT02862730|49351|P6|COMPLETED|Second Rest Period (7-45 Days)||1
22288|NCT02862730|49352|P5|COMPLETED|Second Rest Period (7-45 Days)||5
22289|NCT02862730|49353|P4|COMPLETED|Second Rest Period (7-45 Days)||5
22290|NCT02862730|49354|P3|COMPLETED|Second Rest Period (7-45 Days)||7
22291|NCT02862730|49355|P2|COMPLETED|Second Rest Period (7-45 Days)||1
22292|NCT02862730|49356|P1|COMPLETED|Second Rest Period (7-45 Days)||4
22293|NCT02862730|49350|P7|STARTED|Second Rest Period (7-45 Days)||1
22294|NCT02862730|49351|P6|STARTED|Second Rest Period (7-45 Days)||1
22295|NCT02862730|49352|P5|STARTED|Second Rest Period (7-45 Days)||5
22296|NCT02862730|49353|P4|STARTED|Second Rest Period (7-45 Days)||5
22297|NCT02862730|49354|P3|STARTED|Second Rest Period (7-45 Days)||7
22298|NCT02862730|49355|P2|STARTED|Second Rest Period (7-45 Days)||1
22299|NCT02862730|49356|P1|STARTED|Second Rest Period (7-45 Days)||4
22300|NCT02862730|49350|P7|NOT COMPLETED|First Intervention (84 Hours)||0
22301|NCT02862730|49351|P6|NOT COMPLETED|First Intervention (84 Hours)||0
22302|NCT02862730|49352|P5|NOT COMPLETED|First Intervention (84 Hours)||0
22303|NCT02862730|49353|P4|NOT COMPLETED|First Intervention (84 Hours)||0
22304|NCT02862730|49354|P3|NOT COMPLETED|First Intervention (84 Hours)||0
22305|NCT02862730|49355|P2|NOT COMPLETED|First Intervention (84 Hours)||0
22306|NCT02862730|49356|P1|NOT COMPLETED|First Intervention (84 Hours)||0
22307|NCT02862730|49350|P7|COMPLETED|First Intervention (84 Hours)||1
22308|NCT02862730|49351|P6|COMPLETED|First Intervention (84 Hours)||1
22309|NCT02862730|49352|P5|COMPLETED|First Intervention (84 Hours)||5
22310|NCT02862730|49353|P4|COMPLETED|First Intervention (84 Hours)||5
22311|NCT02862730|49354|P3|COMPLETED|First Intervention (84 Hours)||7
22312|NCT02862730|49355|P2|COMPLETED|First Intervention (84 Hours)||1
22313|NCT02862730|49356|P1|COMPLETED|First Intervention (84 Hours)||4
22314|NCT02862730|49350|P7|STARTED|First Intervention (84 Hours)||1
22315|NCT02862730|49351|P6|STARTED|First Intervention (84 Hours)||1
22316|NCT02862730|49352|P5|STARTED|First Intervention (84 Hours)||5
22317|NCT02862730|49353|P4|STARTED|First Intervention (84 Hours)||5
22318|NCT02862730|49354|P3|STARTED|First Intervention (84 Hours)||7
22319|NCT02862730|49355|P2|STARTED|First Intervention (84 Hours)||1
22320|NCT02862730|49356|P1|STARTED|First Intervention (84 Hours)||4
22321|NCT02862730|49350|P7|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
22322|NCT02862730|49351|P6|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
22323|NCT02862730|49352|P5|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
22324|NCT02862730|49353|P4|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
22325|NCT02862730|49354|P3|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
22326|NCT02862730|49355|P2|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
22327|NCT02862730|49356|P1|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
22328|NCT02862730|49350|P7|COMPLETED|First Rest Period (1-12 Weeks)||1
22329|NCT02862730|49351|P6|COMPLETED|First Rest Period (1-12 Weeks)||1
22330|NCT02862730|49352|P5|COMPLETED|First Rest Period (1-12 Weeks)||5
22331|NCT02862730|49353|P4|COMPLETED|First Rest Period (1-12 Weeks)||5
22332|NCT02862730|49354|P3|COMPLETED|First Rest Period (1-12 Weeks)||7
22333|NCT02862730|49355|P2|COMPLETED|First Rest Period (1-12 Weeks)||1
22334|NCT02862730|49356|P1|COMPLETED|First Rest Period (1-12 Weeks)||4
22335|NCT02862730|49350|P7|STARTED|First Rest Period (1-12 Weeks)||1
22336|NCT02862730|49351|P6|STARTED|First Rest Period (1-12 Weeks)||1
22337|NCT02862730|49352|P5|STARTED|First Rest Period (1-12 Weeks)||5
22338|NCT02862730|49353|P4|STARTED|First Rest Period (1-12 Weeks)||5
22339|NCT02862730|49354|P3|STARTED|First Rest Period (1-12 Weeks)||7
22340|NCT02862730|49355|P2|STARTED|First Rest Period (1-12 Weeks)||1
22341|NCT02862730|49356|P1|STARTED|First Rest Period (1-12 Weeks)||4
22342|NCT02862730|49350|P7|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
22343|NCT02862730|49351|P6|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
22344|NCT02862730|49352|P5|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
22345|NCT02862730|49353|P4|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
22346|NCT02862730|49354|P3|NOT COMPLETED|Tslim Training Visit (2 Weeks)||1
22347|NCT02862730|49355|P2|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
22348|NCT02862730|49356|P1|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
22349|NCT02862730|49350|P7|COMPLETED|Tslim Training Visit (2 Weeks)||1
22350|NCT02862730|49351|P6|COMPLETED|Tslim Training Visit (2 Weeks)||1
22351|NCT02862730|49352|P5|COMPLETED|Tslim Training Visit (2 Weeks)||5
22352|NCT02862730|49353|P4|COMPLETED|Tslim Training Visit (2 Weeks)||5
22353|NCT02862730|49354|P3|COMPLETED|Tslim Training Visit (2 Weeks)||7
22354|NCT02862730|49355|P2|COMPLETED|Tslim Training Visit (2 Weeks)||1
22355|NCT02862730|49356|P1|COMPLETED|Tslim Training Visit (2 Weeks)||4
22356|NCT02862730|49350|P7|STARTED|Tslim Training Visit (2 Weeks)||1
22357|NCT02862730|49351|P6|STARTED|Tslim Training Visit (2 Weeks)||1
22358|NCT02862730|49352|P5|STARTED|Tslim Training Visit (2 Weeks)||5
22359|NCT02862730|49353|P4|STARTED|Tslim Training Visit (2 Weeks)||5
22360|NCT02862730|49354|P3|STARTED|Tslim Training Visit (2 Weeks)||8
22361|NCT02862730|49355|P2|STARTED|Tslim Training Visit (2 Weeks)||1
22362|NCT02862730|49356|P1|STARTED|Tslim Training Visit (2 Weeks)||4
22363|NCT02862600|49411|P1|NOT COMPLETED|Period 2--Perhexiline-high Target Range||7
22364|NCT02862600|49411|P1|COMPLETED|Period 2--Perhexiline-high Target Range|Study terminated on April 26, 2017 due to lack of efficacy in first 15 subjects completing Period 2.|15
22365|NCT02862600|49411|P1|STARTED|Period 2--Perhexiline-high Target Range|First subject completed Period 1 and moved into Period 2 perhexiline dosing on October 17, 2016|22
22366|NCT02862600|49411|P1|NOT COMPLETED|Period 1--Perhexiline-low Target Range||13
22367|NCT02862600|49411|P1|COMPLETED|Period 1--Perhexiline-low Target Range|Study terminated on April 26, 2017 due to lack of efficacy.|22
22368|NCT02862600|49411|P1|STARTED|Period 1--Perhexiline-low Target Range|First subject underwent baseline functional assessment and perhexiline dosing on August 22, 2016|35
22369|NCT02862574|49421|P3|NOT COMPLETED|Open-Label Treatment Period||1
22370|NCT02862574|49422|P2|NOT COMPLETED|Open-Label Treatment Period||3
22371|NCT02862574|49423|P1|NOT COMPLETED|Open-Label Treatment Period||2
22372|NCT02862574|49421|P3|COMPLETED|Open-Label Treatment Period||0
22373|NCT02862574|49422|P2|COMPLETED|Open-Label Treatment Period||0
22374|NCT02862574|49423|P1|COMPLETED|Open-Label Treatment Period||0
22375|NCT02862574|49421|P3|STARTED|Open-Label Treatment Period||1
22376|NCT02862574|49422|P2|STARTED|Open-Label Treatment Period||3
22377|NCT02862574|49423|P1|STARTED|Open-Label Treatment Period||2
22378|NCT02862574|49421|P3|NOT COMPLETED|Double-Blind Treatment Period||4
22379|NCT02862574|49422|P2|NOT COMPLETED|Double-Blind Treatment Period||2
22380|NCT02862574|49423|P1|NOT COMPLETED|Double-Blind Treatment Period||3
22381|NCT02862574|49421|P3|COMPLETED|Double-Blind Treatment Period||1
22382|NCT02862574|49422|P2|COMPLETED|Double-Blind Treatment Period||3
22383|NCT02862574|49423|P1|COMPLETED|Double-Blind Treatment Period||2
22384|NCT02862574|49421|P3|STARTED|Double-Blind Treatment Period||5
22385|NCT02862574|49422|P2|STARTED|Double-Blind Treatment Period||5
22386|NCT02862574|49423|P1|STARTED|Double-Blind Treatment Period||5
22387|NCT02862548|49443|P2|NOT COMPLETED|Open-Label Extension Phase||24
22388|NCT02862548|49444|P1|NOT COMPLETED|Open-Label Extension Phase||26
22389|NCT02862548|49443|P2|COMPLETED|Open-Label Extension Phase||0
22390|NCT02862548|49444|P1|COMPLETED|Open-Label Extension Phase||0
22391|NCT02862548|49443|P2|STARTED|Open-Label Extension Phase||24
22392|NCT02862548|49444|P1|STARTED|Open-Label Extension Phase||26
22393|NCT02862548|49443|P2|NOT COMPLETED|Open-Label Phase||1
22394|NCT02862548|49444|P1|NOT COMPLETED|Open-Label Phase||0
22395|NCT02862548|49443|P2|COMPLETED|Open-Label Phase||24
22396|NCT02862548|49444|P1|COMPLETED|Open-Label Phase||26
22397|NCT02862548|49443|P2|STARTED|Open-Label Phase||25
22398|NCT02862548|49444|P1|STARTED|Open-Label Phase||26
22399|NCT02862106|49474|P2|NOT COMPLETED|Overall Study||6
22400|NCT02862106|49475|P1|NOT COMPLETED|Overall Study||38
22401|NCT02862106|49474|P2|COMPLETED|Overall Study||20
22402|NCT02862106|49475|P1|COMPLETED|Overall Study||145
22403|NCT02862106|49474|P2|STARTED|Overall Study||26
22404|NCT02862106|49475|P1|STARTED|Overall Study||183
22405|NCT02861807|49535|P2|NOT COMPLETED|Overall Study||14
22406|NCT02861807|49536|P1|NOT COMPLETED|Overall Study||12
22407|NCT02861807|49535|P2|COMPLETED|Overall Study||23
22408|NCT02861807|49536|P1|COMPLETED|Overall Study||35
22409|NCT02861807|49535|P2|Attended 2-month Follow-up|Overall Study||20
22410|NCT02861807|49536|P1|Attended 2-month Follow-up|Overall Study||32
22411|NCT02861807|49535|P2|Attended Post-treatment Assessment|Overall Study||18
22412|NCT02861807|49536|P1|Attended Post-treatment Assessment|Overall Study||34
22413|NCT02861807|49535|P2|STARTED|Overall Study||37
22414|NCT02861807|49536|P1|STARTED|Overall Study||47
22415|NCT02861664|49552|P2|NOT COMPLETED|Overall Study||1
22416|NCT02861664|49553|P1|NOT COMPLETED|Overall Study||0
22417|NCT02861664|49552|P2|COMPLETED|Overall Study||67
22418|NCT02861664|49553|P1|COMPLETED|Overall Study||67
22419|NCT02861664|49552|P2|STARTED|Overall Study||68
22420|NCT02861664|49553|P1|STARTED|Overall Study||67
22421|NCT02861118|49565|P2|NOT COMPLETED|Overall Study||0
22422|NCT02861118|49566|P1|NOT COMPLETED|Overall Study||0
22423|NCT02861118|49565|P2|COMPLETED|Overall Study||116
22424|NCT02861118|49566|P1|COMPLETED|Overall Study||194
22425|NCT02861118|49565|P2|STARTED|Overall Study||116
22426|NCT02861118|49566|P1|STARTED|Overall Study||194
22427|NCT02860845|49580|P2|NOT COMPLETED|Overall Study||1
22428|NCT02860845|49581|P1|NOT COMPLETED|Overall Study||2
22429|NCT02860845|49580|P2|COMPLETED|Overall Study||23
22430|NCT02860845|49581|P1|COMPLETED|Overall Study||22
22431|NCT02860845|49580|P2|Analyzed Patients|Overall Study||23
22432|NCT02860845|49581|P1|Analyzed Patients|Overall Study||22
22433|NCT02860845|49580|P2|STARTED|Overall Study||24
22434|NCT02860845|49581|P1|STARTED|Overall Study||24
22435|NCT02860507|49597|P2|NOT COMPLETED|Overall Study||0
22436|NCT02860507|49598|P1|NOT COMPLETED|Overall Study||0
22437|NCT02860507|49597|P2|COMPLETED|Overall Study||25
22438|NCT02860507|49598|P1|COMPLETED|Overall Study||25
22439|NCT02860507|49597|P2|STARTED|Overall Study||25
22440|NCT02860507|49598|P1|STARTED|Overall Study||25
22441|NCT02860169|49608|P1|NOT COMPLETED|Part C||1
22442|NCT02860169|49608|P1|COMPLETED|Part C||47
22443|NCT02860169|49608|P1|Participants With Cold and Flu|Part C||42
22444|NCT02860169|49608|P1|Healthy Participants|Part C||6
22445|NCT02860169|49608|P1|STARTED|Part C||48
22446|NCT02860169|49608|P1|NOT COMPLETED|Part B||11
22447|NCT02860169|49608|P1|COMPLETED|Part B||9
22448|NCT02860169|49608|P1|Participants With Cold and Flu|Part B||10
22449|NCT02860169|49608|P1|Healthy Participants|Part B||10
22450|NCT02860169|49608|P1|STARTED|Part B||20
22451|NCT02860169|49608|P1|NOT COMPLETED|Part A||11
22452|NCT02860169|49608|P1|COMPLETED|Part A||35
22453|NCT02860169|49608|P1|Participants With Cold and Flu|Part A||0
22454|NCT02860169|49608|P1|Healthy Participants|Part A||46
22455|NCT02860169|49608|P1|STARTED|Part A||46
22456|NCT02859454|49624|P1|NOT COMPLETED|Overall Study||1
22457|NCT02859454|49624|P1|COMPLETED|Overall Study||12
22458|NCT02859454|49624|P1|STARTED|Overall Study||13
22459|NCT02858713|49634|P2|NOT COMPLETED|Overall Study||5
22460|NCT02858713|49635|P1|NOT COMPLETED|Overall Study||7
22461|NCT02858713|49634|P2|COMPLETED|Overall Study||61
22462|NCT02858713|49635|P1|COMPLETED|Overall Study||61
22463|NCT02858713|49634|P2|STARTED|Overall Study||66
22464|NCT02858713|49635|P1|STARTED|Overall Study||68
22465|NCT02858492|49649|P4|NOT COMPLETED|Overall Study||6
22466|NCT02858492|49650|P3|NOT COMPLETED|Overall Study||0
22467|NCT02858492|49651|P2|NOT COMPLETED|Overall Study||1
22468|NCT02858492|49652|P1|NOT COMPLETED|Overall Study||0
22469|NCT02858492|49649|P4|COMPLETED|Overall Study||22
22470|NCT02858492|49650|P3|COMPLETED|Overall Study||5
22471|NCT02858492|49651|P2|COMPLETED|Overall Study||14
22472|NCT02858492|49652|P1|COMPLETED|Overall Study||3
22473|NCT02858492|49649|P4|STARTED|Overall Study||28
22474|NCT02858492|49650|P3|STARTED|Overall Study||5
22475|NCT02858492|49651|P2|STARTED|Overall Study||15
22476|NCT02858492|49652|P1|STARTED|Overall Study||3
22477|NCT02858440|49828|P1|NOT COMPLETED|Overall Study||12
22478|NCT02858440|49828|P1|COMPLETED|Overall Study||223
22479|NCT02858440|49828|P1|STARTED|Overall Study||235
22480|NCT02858349|49854|P1|NOT COMPLETED|Overall Study||0
22481|NCT02858349|49854|P1|COMPLETED|Overall Study||10
22482|NCT02858349|49854|P1|STARTED|Overall Study||10
22483|NCT02858050|49860|P2|NOT COMPLETED|Overall Study||0
22484|NCT02858050|49861|P1|NOT COMPLETED|Overall Study||0
22485|NCT02858050|49860|P2|COMPLETED|Overall Study||20
22486|NCT02858050|49861|P1|COMPLETED|Overall Study||20
22487|NCT02858050|49860|P2|STARTED|Overall Study||20
22488|NCT02858050|49861|P1|STARTED|Overall Study||20
22489|NCT02857816|49867|P1|NOT COMPLETED|Overall Study||38
22490|NCT02857816|49867|P1|COMPLETED|Overall Study||116
22491|NCT02857816|49867|P1|Subjects Qualified and Treated With PTNM|Overall Study||120
22492|NCT02857816|49867|P1|STARTED|Overall Study||154
22493|NCT02856880|49873|P1|NOT COMPLETED|Overall Study||1
22494|NCT02856880|49873|P1|COMPLETED|Overall Study||44
22495|NCT02856880|49873|P1|Received SLS Negative Control|Overall Study||44
22496|NCT02856880|49873|P1|Received Non-SLS Negative Control|Overall Study||44
22497|NCT02856880|49873|P1|Received Positive Control|Overall Study||45
22498|NCT02856880|49873|P1|Received Test Zinc Non-IPMP|Overall Study||44
22499|NCT02856880|49873|P1|Received Test Zinc-IPMP|Overall Study||44
22500|NCT02856880|49873|P1|STARTED|Overall Study||45
22501|NCT02856828|49899|P2|NOT COMPLETED|Overall Study||0
22502|NCT02856828|49900|P1|NOT COMPLETED|Overall Study||0
22503|NCT02856828|49899|P2|COMPLETED|Overall Study||3
22504|NCT02856828|49900|P1|COMPLETED|Overall Study||2
22505|NCT02856828|49899|P2|STARTED|Overall Study||3
22506|NCT02856828|49900|P1|STARTED|Overall Study||2
22507|NCT02856282|49914|P1|NOT COMPLETED|Overall Study||1
22508|NCT02856282|49914|P1|COMPLETED|Overall Study||45
22509|NCT02856282|49914|P1|STARTED|Overall Study||46
22510|NCT02855567|49926|P2|NOT COMPLETED|Overall Study||0
22511|NCT02855567|49927|P1|NOT COMPLETED|Overall Study||0
22512|NCT02855567|49926|P2|COMPLETED|Overall Study||56
22513|NCT02855567|49927|P1|COMPLETED|Overall Study||54
22514|NCT02855567|49926|P2|STARTED|Overall Study||56
22515|NCT02855567|49927|P1|STARTED|Overall Study||54
22516|NCT02855541|49941|P1|NOT COMPLETED|Overall Study||4
22517|NCT02855541|49941|P1|COMPLETED|Overall Study||21
22518|NCT02855541|49941|P1|STARTED|Overall Study||25
22519|NCT02855437|49952|P2|NOT COMPLETED|Phase 2||1
22520|NCT02855437|49953|P1|NOT COMPLETED|Phase 2||1
22521|NCT02855437|49952|P2|COMPLETED|Phase 2||18
22522|NCT02855437|49953|P1|COMPLETED|Phase 2||20
22523|NCT02855437|49952|P2|STARTED|Phase 2||19
22524|NCT02855437|49953|P1|STARTED|Phase 2||21
22525|NCT02855437|49952|P2|NOT COMPLETED|Crossover Period (Same Day)||0
22526|NCT02855437|49953|P1|NOT COMPLETED|Crossover Period (Same Day)||0
22527|NCT02855437|49952|P2|COMPLETED|Crossover Period (Same Day)||19
22528|NCT02855437|49953|P1|COMPLETED|Crossover Period (Same Day)||21
22529|NCT02855437|49952|P2|STARTED|Crossover Period (Same Day)||19
22530|NCT02855437|49953|P1|STARTED|Crossover Period (Same Day)||21
22531|NCT02855437|49952|P2|NOT COMPLETED|Phase 1||2
22532|NCT02855437|49953|P1|NOT COMPLETED|Phase 1||2
22533|NCT02855437|49952|P2|COMPLETED|Phase 1||19
22534|NCT02855437|49953|P1|COMPLETED|Phase 1||21
22535|NCT02855437|49952|P2|STARTED|Phase 1||21
22536|NCT02855437|49953|P1|STARTED|Phase 1||23
22537|NCT02855411|49961|P1|NOT COMPLETED|Overall Study||35
22538|NCT02855411|49961|P1|COMPLETED|Overall Study||0
22539|NCT02855411|49961|P1|Assigned to Study Treatment|Overall Study||0
22540|NCT02855411|49961|P1|STARTED|Overall Study||35
22541|NCT02855359|49983|P4|NOT COMPLETED|Overall Study||0
22542|NCT02855359|49984|P3|NOT COMPLETED|Overall Study||0
22543|NCT02855359|49985|P2|NOT COMPLETED|Overall Study||13
22544|NCT02855359|49986|P1|NOT COMPLETED|Overall Study||11
22545|NCT02855359|49983|P4|COMPLETED|Overall Study||0
22546|NCT02855359|49984|P3|COMPLETED|Overall Study||0
22547|NCT02855359|49985|P2|COMPLETED|Overall Study||0
22548|NCT02855359|49986|P1|COMPLETED|Overall Study||0
22549|NCT02855359|49983|P4|STARTED|Overall Study||0
22550|NCT02855359|49984|P3|STARTED|Overall Study||0
22551|NCT02855359|49985|P2|STARTED|Overall Study||13
22552|NCT02855359|49986|P1|STARTED|Overall Study||11
22553|NCT02855086|50020|P2|NOT COMPLETED|Overall Study||0
22554|NCT02855086|50021|P1|NOT COMPLETED|Overall Study||0
22555|NCT02855086|50020|P2|COMPLETED|Overall Study||1
22556|NCT02855086|50021|P1|COMPLETED|Overall Study||2
22557|NCT02855086|50020|P2|STARTED|Overall Study||1
22558|NCT02855086|50021|P1|STARTED|Overall Study||2
22559|NCT02854631|50031|P2|NOT COMPLETED|Overall Study||15
22560|NCT02854631|50032|P1|NOT COMPLETED|Overall Study||26
22561|NCT02854631|50031|P2|COMPLETED|Overall Study||37
22562|NCT02854631|50032|P1|COMPLETED|Overall Study||26
22563|NCT02854631|50031|P2|STARTED|Overall Study||52
22564|NCT02854631|50032|P1|STARTED|Overall Study||52
22565|NCT02854605|50093|P3|NOT COMPLETED|Overall Study||4
22566|NCT02854605|50094|P2|NOT COMPLETED|Overall Study||7
22567|NCT02854605|50095|P1|NOT COMPLETED|Overall Study||3
22568|NCT02854605|50093|P3|COMPLETED|Overall Study||24
22569|NCT02854605|50094|P2|COMPLETED|Overall Study||49
22570|NCT02854605|50095|P1|COMPLETED|Overall Study||53
22571|NCT02854605|50093|P3|STARTED|Overall Study||28
22572|NCT02854605|50094|P2|STARTED|Overall Study||56
22573|NCT02854605|50095|P1|STARTED|Overall Study||56
22574|NCT02854540|50106|P1|NOT COMPLETED|Overall Study||2
22575|NCT02854540|50106|P1|COMPLETED|Overall Study||11
22576|NCT02854540|50106|P1|STARTED|Overall Study||13
22577|NCT02854527|50125|P10|NOT COMPLETED|Overall Study||0
22578|NCT02854527|50126|P9|NOT COMPLETED|Overall Study||0
22579|NCT02854527|50127|P8|NOT COMPLETED|Overall Study||0
22580|NCT02854527|50128|P7|NOT COMPLETED|Overall Study||0
22581|NCT02854527|50129|P6|NOT COMPLETED|Overall Study||0
22582|NCT02854527|50130|P5|NOT COMPLETED|Overall Study||1
22583|NCT02854527|50131|P4|NOT COMPLETED|Overall Study||1
22584|NCT02854527|50132|P3|NOT COMPLETED|Overall Study||0
22585|NCT02854527|50133|P2|NOT COMPLETED|Overall Study||0
22586|NCT02854527|50134|P1|NOT COMPLETED|Overall Study||0
22587|NCT02854527|50125|P10|COMPLETED|Overall Study||3
22588|NCT02854527|50126|P9|COMPLETED|Overall Study||3
22589|NCT02854527|50127|P8|COMPLETED|Overall Study||3
22590|NCT02854527|50128|P7|COMPLETED|Overall Study||3
22591|NCT02854527|50129|P6|COMPLETED|Overall Study||3
22592|NCT02854527|50130|P5|COMPLETED|Overall Study||2
22593|NCT02854527|50131|P4|COMPLETED|Overall Study||2
22594|NCT02854527|50132|P3|COMPLETED|Overall Study||3
22595|NCT02854527|50133|P2|COMPLETED|Overall Study||3
22596|NCT02854527|50134|P1|COMPLETED|Overall Study||3
22597|NCT02854527|50125|P10|Received T|Overall Study||3
22598|NCT02854527|50126|P9|Received T|Overall Study||3
22599|NCT02854527|50127|P8|Received T|Overall Study||3
22600|NCT02854527|50128|P7|Received T|Overall Study||3
22601|NCT02854527|50129|P6|Received T|Overall Study||3
22602|NCT02854527|50130|P5|Received T|Overall Study||2
22603|NCT02854527|50131|P4|Received T|Overall Study||2
22604|NCT02854527|50132|P3|Received T|Overall Study||3
22605|NCT02854527|50133|P2|Received T|Overall Study||3
22606|NCT02854527|50134|P1|Received T|Overall Study||3
22607|NCT02854527|50125|P10|Received R4|Overall Study||3
22608|NCT02854527|50126|P9|Received R4|Overall Study||3
22609|NCT02854527|50127|P8|Received R4|Overall Study||3
22610|NCT02854527|50128|P7|Received R4|Overall Study||3
22611|NCT02854527|50129|P6|Received R4|Overall Study||3
22612|NCT02854527|50130|P5|Received R4|Overall Study||3
22613|NCT02854527|50131|P4|Received R4|Overall Study||2
22614|NCT02854527|50132|P3|Received R4|Overall Study||3
22615|NCT02854527|50133|P2|Received R4|Overall Study||3
22616|NCT02854527|50134|P1|Received R4|Overall Study||3
22617|NCT02854527|50125|P10|Received R3|Overall Study||3
22618|NCT02854527|50126|P9|Received R3|Overall Study||3
22619|NCT02854527|50127|P8|Received R3|Overall Study||3
22620|NCT02854527|50128|P7|Received R3|Overall Study||3
22621|NCT02854527|50129|P6|Received R3|Overall Study||3
22622|NCT02854527|50130|P5|Received R3|Overall Study||3
22623|NCT02854527|50131|P4|Received R3|Overall Study||2
22624|NCT02854527|50132|P3|Received R3|Overall Study||3
22625|NCT02854527|50133|P2|Received R3|Overall Study||3
22626|NCT02854527|50134|P1|Received R3|Overall Study||3
22627|NCT02854527|50125|P10|Received R2|Overall Study||3
22628|NCT02854527|50126|P9|Received R2|Overall Study||3
22629|NCT02854527|50127|P8|Received R2|Overall Study||3
22630|NCT02854527|50128|P7|Received R2|Overall Study||3
22631|NCT02854527|50129|P6|Received R2|Overall Study||3
22632|NCT02854527|50130|P5|Received R2|Overall Study||3
22633|NCT02854527|50131|P4|Received R2|Overall Study||3
22634|NCT02854527|50132|P3|Received R2|Overall Study||3
22635|NCT02854527|50133|P2|Received R2|Overall Study||3
22636|NCT02854527|50134|P1|Received R2|Overall Study||3
22637|NCT02854527|50125|P10|Received R1|Overall Study||3
22638|NCT02854527|50126|P9|Received R1|Overall Study||3
22639|NCT02854527|50127|P8|Received R1|Overall Study||3
22640|NCT02854527|50128|P7|Received R1|Overall Study||3
22641|NCT02854527|50129|P6|Received R1|Overall Study||3
22642|NCT02854527|50130|P5|Received R1|Overall Study||2
22643|NCT02854527|50131|P4|Received R1|Overall Study||2
22644|NCT02854527|50132|P3|Received R1|Overall Study||3
22645|NCT02854527|50133|P2|Received R1|Overall Study||3
22646|NCT02854527|50134|P1|Received R1|Overall Study||3
22647|NCT02854527|50125|P10|STARTED|Overall Study||3
22648|NCT02854527|50126|P9|STARTED|Overall Study||3
22649|NCT02854527|50127|P8|STARTED|Overall Study||3
22650|NCT02854527|50128|P7|STARTED|Overall Study||3
22651|NCT02854527|50129|P6|STARTED|Overall Study||3
22652|NCT02854527|50130|P5|STARTED|Overall Study||3
22653|NCT02854527|50131|P4|STARTED|Overall Study||3
22654|NCT02854527|50132|P3|STARTED|Overall Study||3
22655|NCT02854527|50133|P2|STARTED|Overall Study||3
22656|NCT02854527|50134|P1|STARTED|Overall Study||3
22657|NCT02854059|50167|P2|NOT COMPLETED|Overall Study||0
22658|NCT02854059|50168|P1|NOT COMPLETED|Overall Study||0
22659|NCT02854059|50167|P2|COMPLETED|Overall Study||0
22660|NCT02854059|50168|P1|COMPLETED|Overall Study||2
22661|NCT02854059|50167|P2|STARTED|Overall Study||0
22662|NCT02854059|50168|P1|STARTED|Overall Study||2
22663|NCT02853435|50193|P6|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
22664|NCT02853435|50194|P5|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
22665|NCT02853435|50195|P4|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
22666|NCT02853435|50196|P3|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
22667|NCT02853435|50197|P2|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
22668|NCT02853435|50198|P1|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
22669|NCT02853435|50193|P6|COMPLETED|Part 3, Period 3 (3 Days)||2
22670|NCT02853435|50194|P5|COMPLETED|Part 3, Period 3 (3 Days)||9
22671|NCT02853435|50195|P4|COMPLETED|Part 3, Period 3 (3 Days)||0
22672|NCT02853435|50196|P3|COMPLETED|Part 3, Period 3 (3 Days)||0
22673|NCT02853435|50197|P2|COMPLETED|Part 3, Period 3 (3 Days)||0
22674|NCT02853435|50198|P1|COMPLETED|Part 3, Period 3 (3 Days)||0
22675|NCT02853435|50193|P6|STARTED|Part 3, Period 3 (3 Days)||2
22676|NCT02853435|50194|P5|STARTED|Part 3, Period 3 (3 Days)||9
22677|NCT02853435|50195|P4|STARTED|Part 3, Period 3 (3 Days)||0
22678|NCT02853435|50196|P3|STARTED|Part 3, Period 3 (3 Days)||0
22679|NCT02853435|50197|P2|STARTED|Part 3, Period 3 (3 Days)||0
22680|NCT02853435|50198|P1|STARTED|Part 3, Period 3 (3 Days)||0
22681|NCT02853435|50193|P6|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
22682|NCT02853435|50194|P5|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||1
22683|NCT02853435|50195|P4|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
22684|NCT02853435|50196|P3|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
22685|NCT02853435|50197|P2|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
22686|NCT02853435|50198|P1|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
22687|NCT02853435|50193|P6|COMPLETED|Part 3, Washout Period 2 (3 Days)||2
22688|NCT02853435|50194|P5|COMPLETED|Part 3, Washout Period 2 (3 Days)||9
22689|NCT02853435|50195|P4|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
22690|NCT02853435|50196|P3|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
22691|NCT02853435|50197|P2|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
22692|NCT02853435|50198|P1|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
22693|NCT02853435|50193|P6|STARTED|Part 3, Washout Period 2 (3 Days)||2
22694|NCT02853435|50194|P5|STARTED|Part 3, Washout Period 2 (3 Days)||10
22695|NCT02853435|50195|P4|STARTED|Part 3, Washout Period 2 (3 Days)||0
22696|NCT02853435|50196|P3|STARTED|Part 3, Washout Period 2 (3 Days)||0
22697|NCT02853435|50197|P2|STARTED|Part 3, Washout Period 2 (3 Days)||0
22698|NCT02853435|50198|P1|STARTED|Part 3, Washout Period 2 (3 Days)||0
22699|NCT02853435|50193|P6|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
22700|NCT02853435|50194|P5|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
22701|NCT02853435|50195|P4|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
22702|NCT02853435|50196|P3|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
22703|NCT02853435|50197|P2|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
22704|NCT02853435|50198|P1|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
22705|NCT02853435|50193|P6|COMPLETED|Part 3, Period 2 (3 Days)||2
22706|NCT02853435|50194|P5|COMPLETED|Part 3, Period 2 (3 Days)||10
22707|NCT02853435|50195|P4|COMPLETED|Part 3, Period 2 (3 Days)||0
22708|NCT02853435|50196|P3|COMPLETED|Part 3, Period 2 (3 Days)||0
22709|NCT02853435|50197|P2|COMPLETED|Part 3, Period 2 (3 Days)||0
22710|NCT02853435|50198|P1|COMPLETED|Part 3, Period 2 (3 Days)||0
22711|NCT02853435|50193|P6|STARTED|Part 3, Period 2 (3 Days)||2
22712|NCT02853435|50194|P5|STARTED|Part 3, Period 2 (3 Days)||10
22713|NCT02853435|50195|P4|STARTED|Part 3, Period 2 (3 Days)||0
22714|NCT02853435|50196|P3|STARTED|Part 3, Period 2 (3 Days)||0
22715|NCT02853435|50197|P2|STARTED|Part 3, Period 2 (3 Days)||0
22716|NCT02853435|50198|P1|STARTED|Part 3, Period 2 (3 Days)||0
22717|NCT02853435|50193|P6|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
22718|NCT02853435|50194|P5|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
22719|NCT02853435|50195|P4|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
22720|NCT02853435|50196|P3|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
22721|NCT02853435|50197|P2|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
22722|NCT02853435|50198|P1|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
22723|NCT02853435|50193|P6|COMPLETED|Part 3, Washout Period 1 (3 Days)||2
22724|NCT02853435|50194|P5|COMPLETED|Part 3, Washout Period 1 (3 Days)||10
22725|NCT02853435|50195|P4|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
22726|NCT02853435|50196|P3|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
22727|NCT02853435|50197|P2|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
22728|NCT02853435|50198|P1|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
22729|NCT02853435|50193|P6|STARTED|Part 3, Washout Period 1 (3 Days)||2
22730|NCT02853435|50194|P5|STARTED|Part 3, Washout Period 1 (3 Days)||10
22731|NCT02853435|50195|P4|STARTED|Part 3, Washout Period 1 (3 Days)||0
22732|NCT02853435|50196|P3|STARTED|Part 3, Washout Period 1 (3 Days)||0
22733|NCT02853435|50197|P2|STARTED|Part 3, Washout Period 1 (3 Days)||0
22734|NCT02853435|50198|P1|STARTED|Part 3, Washout Period 1 (3 Days)||0
22735|NCT02853435|50193|P6|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
22736|NCT02853435|50194|P5|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
22737|NCT02853435|50195|P4|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
22738|NCT02853435|50196|P3|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
22739|NCT02853435|50197|P2|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
22740|NCT02853435|50198|P1|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
22741|NCT02853435|50193|P6|COMPLETED|Part 3, Period 1 (3 Days)||2
22742|NCT02853435|50194|P5|COMPLETED|Part 3, Period 1 (3 Days)||10
22743|NCT02853435|50195|P4|COMPLETED|Part 3, Period 1 (3 Days)||0
22744|NCT02853435|50196|P3|COMPLETED|Part 3, Period 1 (3 Days)||0
22745|NCT02853435|50197|P2|COMPLETED|Part 3, Period 1 (3 Days)||0
22746|NCT02853435|50198|P1|COMPLETED|Part 3, Period 1 (3 Days)||0
22747|NCT02853435|50193|P6|STARTED|Part 3, Period 1 (3 Days)||2
22748|NCT02853435|50194|P5|STARTED|Part 3, Period 1 (3 Days)||10
22749|NCT02853435|50195|P4|STARTED|Part 3, Period 1 (3 Days)||0
22750|NCT02853435|50196|P3|STARTED|Part 3, Period 1 (3 Days)||0
22751|NCT02853435|50197|P2|STARTED|Part 3, Period 1 (3 Days)||0
22752|NCT02853435|50198|P1|STARTED|Part 3, Period 1 (3 Days)||0
22753|NCT02853435|50193|P6|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
22754|NCT02853435|50194|P5|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
22755|NCT02853435|50195|P4|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
22756|NCT02853435|50196|P3|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
22757|NCT02853435|50197|P2|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
22758|NCT02853435|50198|P1|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
22759|NCT02853435|50193|P6|COMPLETED|Part 2, Period 2 (3 Days)||0
22760|NCT02853435|50194|P5|COMPLETED|Part 2, Period 2 (3 Days)||0
22761|NCT02853435|50195|P4|COMPLETED|Part 2, Period 2 (3 Days)||10
22762|NCT02853435|50196|P3|COMPLETED|Part 2, Period 2 (3 Days)||0
22763|NCT02853435|50197|P2|COMPLETED|Part 2, Period 2 (3 Days)||0
22764|NCT02853435|50198|P1|COMPLETED|Part 2, Period 2 (3 Days)||0
22765|NCT02853435|50193|P6|STARTED|Part 2, Period 2 (3 Days)||0
22766|NCT02853435|50194|P5|STARTED|Part 2, Period 2 (3 Days)||0
22767|NCT02853435|50195|P4|STARTED|Part 2, Period 2 (3 Days)||10
22768|NCT02853435|50196|P3|STARTED|Part 2, Period 2 (3 Days)||0
22769|NCT02853435|50197|P2|STARTED|Part 2, Period 2 (3 Days)||0
22770|NCT02853435|50198|P1|STARTED|Part 2, Period 2 (3 Days)||0
22771|NCT02853435|50193|P6|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
22772|NCT02853435|50194|P5|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
22773|NCT02853435|50195|P4|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
22774|NCT02853435|50196|P3|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
22775|NCT02853435|50197|P2|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
22776|NCT02853435|50198|P1|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
22777|NCT02853435|50193|P6|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
22778|NCT02853435|50194|P5|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
22779|NCT02853435|50195|P4|COMPLETED|Part 2, Washout Period 1 (3 Days)||10
22780|NCT02853435|50196|P3|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
22781|NCT02853435|50197|P2|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
22782|NCT02853435|50198|P1|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
22783|NCT02853435|50193|P6|STARTED|Part 2, Washout Period 1 (3 Days)||0
22784|NCT02853435|50194|P5|STARTED|Part 2, Washout Period 1 (3 Days)||0
22785|NCT02853435|50195|P4|STARTED|Part 2, Washout Period 1 (3 Days)||10
22786|NCT02853435|50196|P3|STARTED|Part 2, Washout Period 1 (3 Days)||0
22787|NCT02853435|50197|P2|STARTED|Part 2, Washout Period 1 (3 Days)||0
22788|NCT02853435|50198|P1|STARTED|Part 2, Washout Period 1 (3 Days)||0
22789|NCT02853435|50193|P6|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
22790|NCT02853435|50194|P5|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
22791|NCT02853435|50195|P4|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
22792|NCT02853435|50196|P3|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
22793|NCT02853435|50197|P2|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
22794|NCT02853435|50198|P1|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
22795|NCT02853435|50193|P6|COMPLETED|Part 2, Period 1 (3 Days)||0
22796|NCT02853435|50194|P5|COMPLETED|Part 2, Period 1 (3 Days)||0
22797|NCT02853435|50195|P4|COMPLETED|Part 2, Period 1 (3 Days)||10
22798|NCT02853435|50196|P3|COMPLETED|Part 2, Period 1 (3 Days)||0
22799|NCT02853435|50197|P2|COMPLETED|Part 2, Period 1 (3 Days)||0
22800|NCT02853435|50198|P1|COMPLETED|Part 2, Period 1 (3 Days)||0
22801|NCT02853435|50193|P6|STARTED|Part 2, Period 1 (3 Days)||0
22802|NCT02853435|50194|P5|STARTED|Part 2, Period 1 (3 Days)||0
22803|NCT02853435|50195|P4|STARTED|Part 2, Period 1 (3 Days)||10
22804|NCT02853435|50196|P3|STARTED|Part 2, Period 1 (3 Days)||0
22805|NCT02853435|50197|P2|STARTED|Part 2, Period 1 (3 Days)||0
22806|NCT02853435|50198|P1|STARTED|Part 2, Period 1 (3 Days)||0
22807|NCT02853435|50193|P6|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
22808|NCT02853435|50194|P5|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
22809|NCT02853435|50195|P4|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
22810|NCT02853435|50196|P3|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
22811|NCT02853435|50197|P2|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
22812|NCT02853435|50198|P1|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
22813|NCT02853435|50193|P6|COMPLETED|Part 1a, Period 3 (3 Days)||0
22814|NCT02853435|50194|P5|COMPLETED|Part 1a, Period 3 (3 Days)||0
22815|NCT02853435|50195|P4|COMPLETED|Part 1a, Period 3 (3 Days)||0
22816|NCT02853435|50196|P3|COMPLETED|Part 1a, Period 3 (3 Days)||8
22817|NCT02853435|50197|P2|COMPLETED|Part 1a, Period 3 (3 Days)||9
22818|NCT02853435|50198|P1|COMPLETED|Part 1a, Period 3 (3 Days)||9
22819|NCT02853435|50193|P6|STARTED|Part 1a, Period 3 (3 Days)||0
22820|NCT02853435|50194|P5|STARTED|Part 1a, Period 3 (3 Days)||0
22821|NCT02853435|50195|P4|STARTED|Part 1a, Period 3 (3 Days)||0
22822|NCT02853435|50196|P3|STARTED|Part 1a, Period 3 (3 Days)||8
22823|NCT02853435|50197|P2|STARTED|Part 1a, Period 3 (3 Days)||9
22824|NCT02853435|50198|P1|STARTED|Part 1a, Period 3 (3 Days)||9
22825|NCT02853435|50193|P6|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
22826|NCT02853435|50194|P5|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
22827|NCT02853435|50195|P4|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
22828|NCT02853435|50196|P3|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
22829|NCT02853435|50197|P2|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
22830|NCT02853435|50198|P1|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
22831|NCT02853435|50193|P6|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
22832|NCT02853435|50194|P5|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
22833|NCT02853435|50195|P4|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
22834|NCT02853435|50196|P3|COMPLETED|Part 1a, Washout Period 2 (3 Days)||8
22835|NCT02853435|50197|P2|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9
22836|NCT02853435|50198|P1|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9
22837|NCT02853435|50193|P6|STARTED|Part 1a, Washout Period 2 (3 Days)||0
22838|NCT02853435|50194|P5|STARTED|Part 1a, Washout Period 2 (3 Days)||0
22839|NCT02853435|50195|P4|STARTED|Part 1a, Washout Period 2 (3 Days)||0
22840|NCT02853435|50196|P3|STARTED|Part 1a, Washout Period 2 (3 Days)||8
22841|NCT02853435|50197|P2|STARTED|Part 1a, Washout Period 2 (3 Days)||9
22842|NCT02853435|50198|P1|STARTED|Part 1a, Washout Period 2 (3 Days)||9
22843|NCT02853435|50193|P6|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
22844|NCT02853435|50194|P5|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
22845|NCT02853435|50195|P4|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
22846|NCT02853435|50196|P3|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
22847|NCT02853435|50197|P2|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
22848|NCT02853435|50198|P1|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
22849|NCT02853435|50193|P6|COMPLETED|Part 1a, Period 2 (3 Days)||0
22850|NCT02853435|50194|P5|COMPLETED|Part 1a, Period 2 (3 Days)||0
22851|NCT02853435|50195|P4|COMPLETED|Part 1a, Period 2 (3 Days)||0
22852|NCT02853435|50196|P3|COMPLETED|Part 1a, Period 2 (3 Days)||8
22853|NCT02853435|50197|P2|COMPLETED|Part 1a, Period 2 (3 Days)||9
22854|NCT02853435|50198|P1|COMPLETED|Part 1a, Period 2 (3 Days)||9
22855|NCT02853435|50193|P6|STARTED|Part 1a, Period 2 (3 Days)||0
22856|NCT02853435|50194|P5|STARTED|Part 1a, Period 2 (3 Days)||0
22857|NCT02853435|50195|P4|STARTED|Part 1a, Period 2 (3 Days)||0
22858|NCT02853435|50196|P3|STARTED|Part 1a, Period 2 (3 Days)||8
22859|NCT02853435|50197|P2|STARTED|Part 1a, Period 2 (3 Days)||9
22860|NCT02853435|50198|P1|STARTED|Part 1a, Period 2 (3 Days)||9
22861|NCT02853435|50193|P6|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
22862|NCT02853435|50194|P5|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
22863|NCT02853435|50195|P4|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
22864|NCT02853435|50196|P3|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
22865|NCT02853435|50197|P2|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
22866|NCT02853435|50198|P1|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
22867|NCT02853435|50193|P6|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
22868|NCT02853435|50194|P5|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
22869|NCT02853435|50195|P4|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
22870|NCT02853435|50196|P3|COMPLETED|Part 1a, Washout Period 1 (3 Days)||8
22871|NCT02853435|50197|P2|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9
22872|NCT02853435|50198|P1|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9
22873|NCT02853435|50193|P6|STARTED|Part 1a, Washout Period 1 (3 Days)||0
22874|NCT02853435|50194|P5|STARTED|Part 1a, Washout Period 1 (3 Days)||0
22875|NCT02853435|50195|P4|STARTED|Part 1a, Washout Period 1 (3 Days)||0
22876|NCT02853435|50196|P3|STARTED|Part 1a, Washout Period 1 (3 Days)||8
22877|NCT02853435|50197|P2|STARTED|Part 1a, Washout Period 1 (3 Days)||9
22878|NCT02853435|50198|P1|STARTED|Part 1a, Washout Period 1 (3 Days)||9
22879|NCT02853435|50193|P6|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
22880|NCT02853435|50194|P5|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
22881|NCT02853435|50195|P4|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
22882|NCT02853435|50196|P3|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
22883|NCT02853435|50197|P2|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
22884|NCT02853435|50198|P1|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
22885|NCT02853435|50193|P6|COMPLETED|Part 1a, Period 1 (3 Days)||0
22886|NCT02853435|50194|P5|COMPLETED|Part 1a, Period 1 (3 Days)||0
22887|NCT02853435|50195|P4|COMPLETED|Part 1a, Period 1 (3 Days)||0
22888|NCT02853435|50196|P3|COMPLETED|Part 1a, Period 1 (3 Days)||8
22889|NCT02853435|50197|P2|COMPLETED|Part 1a, Period 1 (3 Days)||9
22890|NCT02853435|50198|P1|COMPLETED|Part 1a, Period 1 (3 Days)||9
22891|NCT02853435|50193|P6|STARTED|Part 1a, Period 1 (3 Days)||0
22892|NCT02853435|50194|P5|STARTED|Part 1a, Period 1 (3 Days)||0
22893|NCT02853435|50195|P4|STARTED|Part 1a, Period 1 (3 Days)||0
22894|NCT02853435|50196|P3|STARTED|Part 1a, Period 1 (3 Days)||8
22895|NCT02853435|50197|P2|STARTED|Part 1a, Period 1 (3 Days)||9
22896|NCT02853435|50198|P1|STARTED|Part 1a, Period 1 (3 Days)||9
22897|NCT02853331|50508|P2|NOT COMPLETED|Overall Study||429
22898|NCT02853331|50509|P1|NOT COMPLETED|Overall Study||432
22899|NCT02853331|50508|P2|COMPLETED|Overall Study||0
22900|NCT02853331|50509|P1|COMPLETED|Overall Study||0
22901|NCT02853331|50508|P2|Treated|Overall Study||425
22902|NCT02853331|50509|P1|Treated|Overall Study||429
22903|NCT02853331|50508|P2|STARTED|Overall Study||429
22904|NCT02853331|50509|P1|STARTED|Overall Study||432
22905|NCT02853123|50541|P2|NOT COMPLETED|Treatment Period 2||0
22906|NCT02853123|50542|P1|NOT COMPLETED|Treatment Period 2||0
22907|NCT02853123|50541|P2|COMPLETED|Treatment Period 2||48
22908|NCT02853123|50542|P1|COMPLETED|Treatment Period 2||51
22909|NCT02853123|50541|P2|STARTED|Treatment Period 2||48
22910|NCT02853123|50542|P1|STARTED|Treatment Period 2||51
22911|NCT02853123|50541|P2|NOT COMPLETED|Washout Period||3
22912|NCT02853123|50542|P1|NOT COMPLETED|Washout Period||1
22913|NCT02853123|50541|P2|COMPLETED|Washout Period||48
22914|NCT02853123|50542|P1|COMPLETED|Washout Period||51
22915|NCT02853123|50541|P2|STARTED|Washout Period||51
22916|NCT02853123|50542|P1|STARTED|Washout Period||52
22917|NCT02853123|50541|P2|NOT COMPLETED|Treatment Period 1||3
22918|NCT02853123|50542|P1|NOT COMPLETED|Treatment Period 1||0
22919|NCT02853123|50541|P2|COMPLETED|Treatment Period 1||51
22920|NCT02853123|50542|P1|COMPLETED|Treatment Period 1||52
22921|NCT02853123|50541|P2|STARTED|Treatment Period 1||54
22922|NCT02853123|50542|P1|STARTED|Treatment Period 1||52
22923|NCT02852434|50565|P2|NOT COMPLETED|Overall Study||1
22924|NCT02852434|50566|P1|NOT COMPLETED|Overall Study||2
22925|NCT02852434|50565|P2|COMPLETED|Overall Study||35
22926|NCT02852434|50566|P1|COMPLETED|Overall Study||34
22927|NCT02852434|50565|P2|STARTED|Overall Study||36
22928|NCT02852434|50566|P1|STARTED|Overall Study||36
22929|NCT02852265|50582|P2|NOT COMPLETED|6-month Follow-up||0
22930|NCT02852265|50583|P1|NOT COMPLETED|6-month Follow-up||0
22931|NCT02852265|50582|P2|COMPLETED|6-month Follow-up||9
22932|NCT02852265|50583|P1|COMPLETED|6-month Follow-up||9
22933|NCT02852265|50582|P2|STARTED|6-month Follow-up||9
22934|NCT02852265|50583|P1|STARTED|6-month Follow-up||9
22935|NCT02852265|50582|P2|NOT COMPLETED|3-month Follow-up||1
22936|NCT02852265|50583|P1|NOT COMPLETED|3-month Follow-up||1
22937|NCT02852265|50582|P2|COMPLETED|3-month Follow-up||9
22938|NCT02852265|50583|P1|COMPLETED|3-month Follow-up||9
22939|NCT02852265|50582|P2|STARTED|3-month Follow-up||10
22940|NCT02852265|50583|P1|STARTED|3-month Follow-up||10
22941|NCT02852265|50582|P2|NOT COMPLETED|1-month Follow-up||0
22942|NCT02852265|50583|P1|NOT COMPLETED|1-month Follow-up||0
22943|NCT02852265|50582|P2|COMPLETED|1-month Follow-up||10
22944|NCT02852265|50583|P1|COMPLETED|1-month Follow-up||10
22945|NCT02852265|50582|P2|STARTED|1-month Follow-up||10
22946|NCT02852265|50583|P1|STARTED|1-month Follow-up||10
22947|NCT02851823|50599|P1|NOT COMPLETED|Overall Study||0
22948|NCT02851823|50599|P1|COMPLETED|Overall Study||25
22949|NCT02851823|50599|P1|3 Months|Overall Study||25
22950|NCT02851823|50599|P1|1 Month|Overall Study||25
22951|NCT02851823|50599|P1|STARTED|Overall Study||25
22952|NCT02851069|50607|P1|NOT COMPLETED|Overall Study||6
22953|NCT02851069|50607|P1|COMPLETED|Overall Study||59
22954|NCT02851069|50607|P1|STARTED|Overall Study||65
22955|NCT02850965|50631|P2|NOT COMPLETED|Overall Study||25
22956|NCT02850965|50632|P1|NOT COMPLETED|Overall Study||18
22957|NCT02850965|50631|P2|COMPLETED|Overall Study||134
22958|NCT02850965|50632|P1|COMPLETED|Overall Study||141
22959|NCT02850965|50631|P2|Treated|Overall Study||158
22960|NCT02850965|50632|P1|Treated|Overall Study||159
22961|NCT02850965|50631|P2|STARTED|Overall Study||159
22962|NCT02850965|50632|P1|STARTED|Overall Study||159
22963|NCT02850276|50648|P1|NOT COMPLETED|Overall Study||61
22964|NCT02850276|50648|P1|COMPLETED|Overall Study||15
22965|NCT02850276|50648|P1|STARTED|Overall Study||76
22966|NCT02850159|50661|P2|NOT COMPLETED|Overall Study||0
22967|NCT02850159|50662|P1|NOT COMPLETED|Overall Study||0
22968|NCT02850159|50661|P2|COMPLETED|Overall Study||16
22969|NCT02850159|50662|P1|COMPLETED|Overall Study||16
22970|NCT02850159|50661|P2|STARTED|Overall Study||16
22971|NCT02850159|50662|P1|STARTED|Overall Study||16
22972|NCT02850068|50668|P1|NOT COMPLETED|Overall Study||20
22973|NCT02850068|50668|P1|COMPLETED|Overall Study||0
22974|NCT02850068|50668|P1|STARTED|Overall Study||20
22975|NCT02849938|50677|P2|NOT COMPLETED|Overall Study||0
22976|NCT02849938|50678|P1|NOT COMPLETED|Overall Study||0
22977|NCT02849938|50677|P2|COMPLETED|Overall Study||15
22978|NCT02849938|50678|P1|COMPLETED|Overall Study||9
22979|NCT02849938|50677|P2|STARTED|Overall Study||15
22980|NCT02849938|50678|P1|STARTED|Overall Study||9
22981|NCT02849704|50690|P2|NOT COMPLETED|Assessment on PERT - CP Subj - 16 Days||0
22982|NCT02849704|50691|P1|NOT COMPLETED|Assessment on PERT - CP Subj - 16 Days||3
22983|NCT02849704|50690|P2|COMPLETED|Assessment on PERT - CP Subj - 16 Days||0
22984|NCT02849704|50691|P1|COMPLETED|Assessment on PERT - CP Subj - 16 Days||21
22985|NCT02849704|50690|P2|STARTED|Assessment on PERT - CP Subj - 16 Days||0
22986|NCT02849704|50691|P1|STARTED|Assessment on PERT - CP Subj - 16 Days||24
22987|NCT02849704|50690|P2|NOT COMPLETED|Baseline Assessments - All Subj - 7 Days||0
22988|NCT02849704|50691|P1|NOT COMPLETED|Baseline Assessments - All Subj - 7 Days||0
22989|NCT02849704|50690|P2|COMPLETED|Baseline Assessments - All Subj - 7 Days||24
22990|NCT02849704|50691|P1|COMPLETED|Baseline Assessments - All Subj - 7 Days||24
22991|NCT02849704|50690|P2|STARTED|Baseline Assessments - All Subj - 7 Days||24
22992|NCT02849704|50691|P1|STARTED|Baseline Assessments - All Subj - 7 Days||24
22993|NCT02849704|50690|P2|NOT COMPLETED|Washout Period - CP Subj on PERT - 3days||0
22994|NCT02849704|50691|P1|NOT COMPLETED|Washout Period - CP Subj on PERT - 3days||0
22995|NCT02849704|50690|P2|COMPLETED|Washout Period - CP Subj on PERT - 3days||0
22996|NCT02849704|50691|P1|COMPLETED|Washout Period - CP Subj on PERT - 3days||11
22997|NCT02849704|50690|P2|STARTED|Washout Period - CP Subj on PERT - 3days||0
22998|NCT02849704|50691|P1|STARTED|Washout Period - CP Subj on PERT - 3days||11
22999|NCT02849678|50706|P2|NOT COMPLETED|Overall Study||6
23000|NCT02849678|50707|P1|NOT COMPLETED|Overall Study||3
23001|NCT02849678|50706|P2|COMPLETED|Overall Study||18
23002|NCT02849678|50707|P1|COMPLETED|Overall Study||17
23003|NCT02849678|50706|P2|STARTED|Overall Study||24
23004|NCT02849678|50707|P1|STARTED|Overall Study||20
23005|NCT02849509|50728|P3|NOT COMPLETED|Overall Study||85
23006|NCT02849509|50729|P2|NOT COMPLETED|Overall Study||166
23007|NCT02849509|50730|P1|NOT COMPLETED|Overall Study||90
23008|NCT02849509|50728|P3|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|258
23009|NCT02849509|50729|P2|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|425
23010|NCT02849509|50730|P1|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|289
23011|NCT02849509|50728|P3|STARTED|Overall Study||343
23012|NCT02849509|50729|P2|STARTED|Overall Study||591
23013|NCT02849509|50730|P1|STARTED|Overall Study||379
23014|NCT02849418|50759|P2|NOT COMPLETED|Overall Study||0
23015|NCT02849418|50760|P1|NOT COMPLETED|Overall Study||0
23016|NCT02849418|50759|P2|COMPLETED|Overall Study||11
23017|NCT02849418|50760|P1|COMPLETED|Overall Study||10
23018|NCT02849418|50759|P2|STARTED|Overall Study||11
23019|NCT02849418|50760|P1|STARTED|Overall Study||10
23020|NCT02849184|50818|P2|NOT COMPLETED|Overall Study||0
23021|NCT02849184|50819|P1|NOT COMPLETED|Overall Study||0
23022|NCT02849184|50818|P2|COMPLETED|Overall Study||42
23023|NCT02849184|50819|P1|COMPLETED|Overall Study||40
23024|NCT02849184|50818|P2|STARTED|Overall Study||42
23025|NCT02849184|50819|P1|STARTED|Overall Study||40
23026|NCT02848664|50839|P1|NOT COMPLETED|Overall Study||4
23027|NCT02848664|50839|P1|COMPLETED|Overall Study||7
23028|NCT02848664|50839|P1|STARTED|Overall Study||11
23029|NCT02848326|50853|P6|NOT COMPLETED|Safety Follow-up Period||5
23030|NCT02848326|50854|P5|NOT COMPLETED|Safety Follow-up Period||1
23031|NCT02848326|50855|P4|NOT COMPLETED|Safety Follow-up Period||0
23032|NCT02848326|50856|P3|NOT COMPLETED|Safety Follow-up Period||3
23033|NCT02848326|50857|P2|NOT COMPLETED|Safety Follow-up Period||1
23034|NCT02848326|50858|P1|NOT COMPLETED|Safety Follow-up Period||4
23035|NCT02848326|50853|P6|COMPLETED|Safety Follow-up Period||77
23036|NCT02848326|50854|P5|COMPLETED|Safety Follow-up Period||76
23037|NCT02848326|50855|P4|COMPLETED|Safety Follow-up Period||169
23038|NCT02848326|50856|P3|COMPLETED|Safety Follow-up Period||153
23039|NCT02848326|50857|P2|COMPLETED|Safety Follow-up Period||83
23040|NCT02848326|50858|P1|COMPLETED|Safety Follow-up Period||157
23041|NCT02848326|50853|P6|STARTED|Safety Follow-up Period||82
23042|NCT02848326|50854|P5|STARTED|Safety Follow-up Period||77
23043|NCT02848326|50855|P4|STARTED|Safety Follow-up Period||169
23044|NCT02848326|50856|P3|STARTED|Safety Follow-up Period||156
23045|NCT02848326|50857|P2|STARTED|Safety Follow-up Period||84
23046|NCT02848326|50858|P1|STARTED|Safety Follow-up Period||161
23047|NCT02848326|50853|P6|NOT COMPLETED|Treatment Period||20
23048|NCT02848326|50854|P5|NOT COMPLETED|Treatment Period||19
23049|NCT02848326|50855|P4|NOT COMPLETED|Treatment Period||23
23050|NCT02848326|50856|P3|NOT COMPLETED|Treatment Period||36
23051|NCT02848326|50857|P2|NOT COMPLETED|Treatment Period||14
23052|NCT02848326|50858|P1|NOT COMPLETED|Treatment Period||38
23053|NCT02848326|50853|P6|COMPLETED|Treatment Period||73
23054|NCT02848326|50854|P5|COMPLETED|Treatment Period||70
23055|NCT02848326|50855|P4|COMPLETED|Treatment Period||164
23056|NCT02848326|50856|P3|COMPLETED|Treatment Period||149
23057|NCT02848326|50857|P2|COMPLETED|Treatment Period||80
23058|NCT02848326|50858|P1|COMPLETED|Treatment Period||148
23059|NCT02848326|50853|P6|Safety Population: Received Study Drug|Treatment Period||91
23060|NCT02848326|50854|P5|Safety Population: Received Study Drug|Treatment Period||86
23061|NCT02848326|50855|P4|Safety Population: Received Study Drug|Treatment Period||186
23062|NCT02848326|50856|P3|Safety Population: Received Study Drug|Treatment Period||183
23063|NCT02848326|50857|P2|Safety Population: Received Study Drug|Treatment Period||93
23064|NCT02848326|50858|P1|Safety Population: Received Study Drug|Treatment Period||186
23065|NCT02848326|50853|P6|STARTED|Treatment Period||93
23066|NCT02848326|50854|P5|STARTED|Treatment Period||89
23067|NCT02848326|50855|P4|STARTED|Treatment Period||187
23068|NCT02848326|50856|P3|STARTED|Treatment Period||185
23069|NCT02848326|50857|P2|STARTED|Treatment Period||94
23070|NCT02848326|50858|P1|STARTED|Treatment Period||186
23071|NCT02848222|50893|P3|NOT COMPLETED|Overall Study||0
23072|NCT02848222|50894|P2|NOT COMPLETED|Overall Study||1
23073|NCT02848222|50895|P1|NOT COMPLETED|Overall Study||7
23074|NCT02848222|50893|P3|COMPLETED|Overall Study||17
23075|NCT02848222|50894|P2|COMPLETED|Overall Study||17
23076|NCT02848222|50895|P1|COMPLETED|Overall Study||18
23077|NCT02848222|50893|P3|STARTED|Overall Study||17
23078|NCT02848222|50894|P2|STARTED|Overall Study||18
23079|NCT02848222|50895|P1|STARTED|Overall Study||25
23080|NCT02847858|50905|P2|NOT COMPLETED|Overall Study||269
23081|NCT02847858|50906|P1|NOT COMPLETED|Overall Study||401
23082|NCT02847858|50905|P2|COMPLETED|Overall Study||398
23083|NCT02847858|50906|P1|COMPLETED|Overall Study||292
23084|NCT02847858|50905|P2|STARTED|Overall Study||667
23085|NCT02847858|50906|P1|STARTED|Overall Study||693
23086|NCT02847650|50932|P2|NOT COMPLETED|Overall Study||6
23087|NCT02847650|50933|P1|NOT COMPLETED|Overall Study||4
23088|NCT02847650|50932|P2|COMPLETED|Overall Study||22
23089|NCT02847650|50933|P1|COMPLETED|Overall Study||25
23090|NCT02847650|50932|P2|STARTED|Overall Study||28
23091|NCT02847650|50933|P1|STARTED|Overall Study||29
23092|NCT02847637|50957|P4|NOT COMPLETED|Overall Study||63
23093|NCT02847637|50958|P3|NOT COMPLETED|Overall Study||35
23094|NCT02847637|50959|P2|NOT COMPLETED|Overall Study||35
23095|NCT02847637|50960|P1|NOT COMPLETED|Overall Study||17
23096|NCT02847637|50957|P4|COMPLETED|Overall Study||0
23097|NCT02847637|50958|P3|COMPLETED|Overall Study||0
23098|NCT02847637|50959|P2|COMPLETED|Overall Study||1
23099|NCT02847637|50960|P1|COMPLETED|Overall Study||1
23100|NCT02847637|50957|P4|Completed 24 Weeks Emicizumab Treatment|Overall Study||58
23101|NCT02847637|50958|P3|Completed 24 Weeks Emicizumab Treatment|Overall Study||34
23102|NCT02847637|50959|P2|Completed 24 Weeks Emicizumab Treatment|Overall Study||35
23103|NCT02847637|50960|P1|Completed 24 Weeks Emicizumab Treatment|Overall Study|Participants started on 24 weeks No Prophylaxis first before switching to emicizumab.|1
23104|NCT02847637|50957|P4|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
23105|NCT02847637|50958|P3|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
23106|NCT02847637|50959|P2|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
23107|NCT02847637|50960|P1|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||16
23108|NCT02847637|50957|P4|Completed 24 Weeks on No Prophylaxis|Overall Study||0
23109|NCT02847637|50958|P3|Completed 24 Weeks on No Prophylaxis|Overall Study||0
23110|NCT02847637|50959|P2|Completed 24 Weeks on No Prophylaxis|Overall Study||0
23111|NCT02847637|50960|P1|Completed 24 Weeks on No Prophylaxis|Overall Study|One participant switched to emicizumab prior to completing 24 weeks No Prophylaxis (at 23.5 weeks).|16
23112|NCT02847637|50957|P4|STARTED|Overall Study||63
23113|NCT02847637|50958|P3|STARTED|Overall Study||35
23114|NCT02847637|50959|P2|STARTED|Overall Study||36
23115|NCT02847637|50960|P1|STARTED|Overall Study||18
23116|NCT02847494|51074|P2|NOT COMPLETED|Overall Study||5
23117|NCT02847494|51075|P1|NOT COMPLETED|Overall Study||8
23118|NCT02847494|51074|P2|COMPLETED|Overall Study||106
23119|NCT02847494|51075|P1|COMPLETED|Overall Study||101
23120|NCT02847494|51074|P2|STARTED|Overall Study||111
23121|NCT02847494|51075|P1|STARTED|Overall Study||109
23122|NCT02847260|51085|P1|NOT COMPLETED|Overall Study||7
23123|NCT02847260|51085|P1|COMPLETED|Overall Study||32
23124|NCT02847260|51085|P1|STARTED|Overall Study||39
23125|NCT02847169|51097|P2|NOT COMPLETED|Second Intervention (1 Week)||0
23126|NCT02847169|51098|P1|NOT COMPLETED|Second Intervention (1 Week)||0
23127|NCT02847169|51097|P2|COMPLETED|Second Intervention (1 Week)||15
23128|NCT02847169|51098|P1|COMPLETED|Second Intervention (1 Week)||15
23129|NCT02847169|51097|P2|STARTED|Second Intervention (1 Week)||15
23130|NCT02847169|51098|P1|STARTED|Second Intervention (1 Week)||15
23131|NCT02847169|51097|P2|NOT COMPLETED|First Intervention (1 Week)||0
23132|NCT02847169|51098|P1|NOT COMPLETED|First Intervention (1 Week)||0
23133|NCT02847169|51097|P2|COMPLETED|First Intervention (1 Week)||15
23134|NCT02847169|51098|P1|COMPLETED|First Intervention (1 Week)||15
23135|NCT02847169|51097|P2|STARTED|First Intervention (1 Week)||15
23136|NCT02847169|51098|P1|STARTED|First Intervention (1 Week)||15
23137|NCT02846792|51132|P1|NOT COMPLETED|Overall Study||0
23138|NCT02846792|51132|P1|COMPLETED|Overall Study||5
23139|NCT02846792|51132|P1|STARTED|Overall Study||5
23140|NCT02846779|51145|P3|NOT COMPLETED|Overall Study||138
23141|NCT02846779|51146|P2|NOT COMPLETED|Overall Study||127
23142|NCT02846779|51147|P1|NOT COMPLETED|Overall Study||139
23143|NCT02846779|51145|P3|COMPLETED|Overall Study||1862
23144|NCT02846779|51146|P2|COMPLETED|Overall Study||1873
23145|NCT02846779|51147|P1|COMPLETED|Overall Study||1861
23146|NCT02846779|51145|P3|STARTED|Overall Study||2000
23147|NCT02846779|51146|P2|STARTED|Overall Study||2000
23148|NCT02846779|51147|P1|STARTED|Overall Study||2000
23149|NCT02846714|51170|P1|NOT COMPLETED|Overall Study||6
23150|NCT02846714|51170|P1|COMPLETED|Overall Study||36
23151|NCT02846714|51170|P1|STARTED|Overall Study||42
23152|NCT02846558|51190|P4|NOT COMPLETED|Overall Study||2
23153|NCT02846558|51191|P3|NOT COMPLETED|Overall Study||2
23154|NCT02846558|51192|P2|NOT COMPLETED|Overall Study||4
23155|NCT02846558|51193|P1|NOT COMPLETED|Overall Study||8
23156|NCT02846558|51190|P4|COMPLETED|Overall Study||11
23157|NCT02846558|51191|P3|COMPLETED|Overall Study||12
23158|NCT02846558|51192|P2|COMPLETED|Overall Study||8
23159|NCT02846558|51193|P1|COMPLETED|Overall Study||7
23160|NCT02846558|51190|P4|3 Month Study Visit|Overall Study||11
23161|NCT02846558|51191|P3|3 Month Study Visit|Overall Study||12
23162|NCT02846558|51192|P2|3 Month Study Visit|Overall Study||8
23163|NCT02846558|51193|P1|3 Month Study Visit|Overall Study||7
23164|NCT02846558|51190|P4|Baseline Study Visit|Overall Study||12
23165|NCT02846558|51191|P3|Baseline Study Visit|Overall Study||14
23166|NCT02846558|51192|P2|Baseline Study Visit|Overall Study||9
23167|NCT02846558|51193|P1|Baseline Study Visit|Overall Study||10
23168|NCT02846558|51190|P4|STARTED|Overall Study||13
23169|NCT02846558|51191|P3|STARTED|Overall Study||14
23170|NCT02846558|51192|P2|STARTED|Overall Study||12
23171|NCT02846558|51193|P1|STARTED|Overall Study||15
23172|NCT02845700|51231|P2|NOT COMPLETED|Month 1 Follow-Up||0
23173|NCT02845700|51232|P1|NOT COMPLETED|Month 1 Follow-Up||0
23174|NCT02845700|51231|P2|COMPLETED|Month 1 Follow-Up||4
23175|NCT02845700|51232|P1|COMPLETED|Month 1 Follow-Up||2
23176|NCT02845700|51231|P2|STARTED|Month 1 Follow-Up|2 participants withdrew after completing the Intervention 2 Appointment|4
23177|NCT02845700|51232|P1|STARTED|Month 1 Follow-Up|3 participants withdrew after completing the Intervention 2 Appointment|2
23178|NCT02845700|51231|P2|NOT COMPLETED|Intervention Session 2||0
23179|NCT02845700|51232|P1|NOT COMPLETED|Intervention Session 2||0
23180|NCT02845700|51231|P2|COMPLETED|Intervention Session 2||6
23181|NCT02845700|51232|P1|COMPLETED|Intervention Session 2||5
23182|NCT02845700|51231|P2|STARTED|Intervention Session 2||6
23183|NCT02845700|51232|P1|STARTED|Intervention Session 2||5
23184|NCT02845700|51231|P2|NOT COMPLETED|Intervention Session 1||0
23185|NCT02845700|51232|P1|NOT COMPLETED|Intervention Session 1||0
23186|NCT02845700|51231|P2|COMPLETED|Intervention Session 1||6
23187|NCT02845700|51232|P1|COMPLETED|Intervention Session 1||5
23188|NCT02845700|51231|P2|STARTED|Intervention Session 1|1 participant withdrew after completing the Baseline Appointment|6
23189|NCT02845700|51232|P1|STARTED|Intervention Session 1|1 participant withdrew after completing the Baseline Appointment|5
23190|NCT02845700|51231|P2|NOT COMPLETED|Baseline Appointment||0
23191|NCT02845700|51232|P1|NOT COMPLETED|Baseline Appointment||0
23192|NCT02845700|51231|P2|COMPLETED|Baseline Appointment||7
23193|NCT02845700|51232|P1|COMPLETED|Baseline Appointment||6
23194|NCT02845700|51231|P2|STARTED|Baseline Appointment||7
23195|NCT02845700|51232|P1|STARTED|Baseline Appointment||6
23196|NCT02845674|51248|P2|NOT COMPLETED|Overall Study||50
23197|NCT02845674|51249|P1|NOT COMPLETED|Overall Study||18
23198|NCT02845674|51248|P2|COMPLETED|Overall Study||79
23199|NCT02845674|51249|P1|COMPLETED|Overall Study||111
23200|NCT02845674|51248|P2|STARTED|Overall Study||129
23201|NCT02845674|51249|P1|STARTED|Overall Study||129
23202|NCT02844998|51258|P3|NOT COMPLETED|Overall Study||4
23203|NCT02844998|51259|P2|NOT COMPLETED|Overall Study||4
23204|NCT02844998|51260|P1|NOT COMPLETED|Overall Study||7
23205|NCT02844998|51258|P3|COMPLETED|Overall Study||35
23206|NCT02844998|51259|P2|COMPLETED|Overall Study||35
23207|NCT02844998|51260|P1|COMPLETED|Overall Study||35
23208|NCT02844998|51258|P3|STARTED|Overall Study||39
23209|NCT02844998|51259|P2|STARTED|Overall Study||39
23210|NCT02844998|51260|P1|STARTED|Overall Study||42
23211|NCT02844946|51273|P2|NOT COMPLETED|Overall Study||0
23212|NCT02844946|51274|P1|NOT COMPLETED|Overall Study||7
23213|NCT02844946|51273|P2|COMPLETED|Overall Study||12
23214|NCT02844946|51274|P1|COMPLETED|Overall Study||20
23215|NCT02844946|51273|P2|STARTED|Overall Study||12
23216|NCT02844946|51274|P1|STARTED|Overall Study||27
23217|NCT02844920|51292|P1|NOT COMPLETED|Overall Study||2
23218|NCT02844920|51292|P1|COMPLETED|Overall Study|Participants with completed the follow-up|35
23219|NCT02844920|51292|P1|Completed, Eval. Data, Opposing Fibroids|Overall Study|Participants with completed the follow-up, evaluable hysteroscopy videos, and opposing fibroids|6
23220|NCT02844920|51292|P1|Completed With Evaluable Videos|Overall Study|Participants with completed the follow-up and evaluable hysteroscopy videos|34
23221|NCT02844920|51292|P1|Completed Without Evaluable Videos|Overall Study|Participants with completed the follow-up but without evaluable hysteroscopy videos|1
23222|NCT02844920|51292|P1|STARTED|Overall Study||37
23223|NCT02844569|51299|P2|NOT COMPLETED|Overall Study||0
23224|NCT02844569|51300|P1|NOT COMPLETED|Overall Study||0
23225|NCT02844569|51299|P2|COMPLETED|Overall Study||12
23226|NCT02844569|51300|P1|COMPLETED|Overall Study||12
23227|NCT02844569|51299|P2|STARTED|Overall Study||12
23228|NCT02844569|51300|P1|STARTED|Overall Study||12
23229|NCT02844543|51310|P1|NOT COMPLETED|Overall Study||5
23230|NCT02844543|51310|P1|COMPLETED|Overall Study||150
23231|NCT02844543|51310|P1|STARTED|Overall Study||155
23232|NCT02843659|51320|P3|NOT COMPLETED|Overall Study||5
23233|NCT02843659|51321|P2|NOT COMPLETED|Overall Study||6
23234|NCT02843659|51322|P1|NOT COMPLETED|Overall Study||4
23235|NCT02843659|51320|P3|COMPLETED|Overall Study||2
23236|NCT02843659|51321|P2|COMPLETED|Overall Study||0
23237|NCT02843659|51322|P1|COMPLETED|Overall Study||1
23238|NCT02843659|51320|P3|STARTED|Overall Study||7
23239|NCT02843659|51321|P2|STARTED|Overall Study||6
23240|NCT02843659|51322|P1|STARTED|Overall Study||5
23241|NCT02843178|51391|P4|NOT COMPLETED|Overall Study||4
23242|NCT02843178|51392|P3|NOT COMPLETED|Overall Study||7
23243|NCT02843178|51393|P2|NOT COMPLETED|Overall Study||8
23244|NCT02843178|51394|P1|NOT COMPLETED|Overall Study||8
23245|NCT02843178|51391|P4|COMPLETED|Overall Study||87
23246|NCT02843178|51392|P3|COMPLETED|Overall Study||85
23247|NCT02843178|51393|P2|COMPLETED|Overall Study||82
23248|NCT02843178|51394|P1|COMPLETED|Overall Study||78
23249|NCT02843178|51391|P4|STARTED|Overall Study||91
23250|NCT02843178|51392|P3|STARTED|Overall Study||92
23251|NCT02843178|51393|P2|STARTED|Overall Study||90
23252|NCT02843178|51394|P1|STARTED|Overall Study||86
23253|NCT02842736|51432|P1|NOT COMPLETED|Overall Study||12
23254|NCT02842736|51432|P1|COMPLETED|Overall Study|Known Month 12 outcome|230
23255|NCT02842736|51432|P1|STARTED|Overall Study|Treated|242
23256|NCT02842151|51437|P1|NOT COMPLETED|Overall Study||2
23257|NCT02842151|51437|P1|COMPLETED|Overall Study||148
23258|NCT02842151|51437|P1|STARTED|Overall Study||150
23259|NCT02842073|51443|P1|NOT COMPLETED|Overall Study||1
23260|NCT02842073|51443|P1|COMPLETED|Overall Study||11
23261|NCT02842073|51443|P1|STARTED|Overall Study||12
23262|NCT02842060|51453|P2|NOT COMPLETED|Overall Study||0
23263|NCT02842060|51454|P1|NOT COMPLETED|Overall Study||0
23264|NCT02842060|51453|P2|COMPLETED|Overall Study||60
23265|NCT02842060|51454|P1|COMPLETED|Overall Study||120
23266|NCT02842060|51453|P2|STARTED|Overall Study||60
23267|NCT02842060|51454|P1|STARTED|Overall Study||120
23268|NCT02841787|51469|P3|NOT COMPLETED|Overall Study||0
23269|NCT02841787|51470|P2|NOT COMPLETED|Overall Study||4
23270|NCT02841787|51471|P1|NOT COMPLETED|Overall Study||3
23271|NCT02841787|51469|P3|COMPLETED|Overall Study||12
23272|NCT02841787|51470|P2|COMPLETED|Overall Study||19
23273|NCT02841787|51471|P1|COMPLETED|Overall Study||9
23274|NCT02841787|51469|P3|STARTED|Overall Study||12
23275|NCT02841787|51470|P2|STARTED|Overall Study||23
23276|NCT02841787|51471|P1|STARTED|Overall Study||12
23277|NCT02841241|51485|P1|NOT COMPLETED|Overall Study||0
23278|NCT02841241|51485|P1|COMPLETED|Overall Study||7
23279|NCT02841241|51485|P1|STARTED|Overall Study||7
23280|NCT02840916|51498|P2|NOT COMPLETED|Overall Study||3
23281|NCT02840916|51499|P1|NOT COMPLETED|Overall Study||1
23282|NCT02840916|51498|P2|COMPLETED|Overall Study||30
23283|NCT02840916|51499|P1|COMPLETED|Overall Study||32
23284|NCT02840916|51498|P2|STARTED|Overall Study||33
23285|NCT02840916|51499|P1|STARTED|Overall Study||33
23286|NCT02840721|51509|P1|NOT COMPLETED|Follow-Up||7
23287|NCT02840721|51509|P1|COMPLETED|Follow-Up||42
23288|NCT02840721|51509|P1|STARTED|Follow-Up||49
23289|NCT02840721|51509|P1|NOT COMPLETED|Treatment Period||1
23290|NCT02840721|51509|P1|COMPLETED|Treatment Period||49
23291|NCT02840721|51509|P1|STARTED|Treatment Period||50
23292|NCT02840253|51528|P1|NOT COMPLETED|Overall Study||4
23293|NCT02840253|51528|P1|COMPLETED|Overall Study||19
23294|NCT02840253|51528|P1|STARTED|Overall Study||23
23295|NCT02839902|51535|P2|NOT COMPLETED|Overall Study||0
23296|NCT02839902|51536|P1|NOT COMPLETED|Overall Study||0
23297|NCT02839902|51535|P2|COMPLETED|Overall Study||29
23298|NCT02839902|51536|P1|COMPLETED|Overall Study||24
23299|NCT02839902|51535|P2|STARTED|Overall Study||29
23300|NCT02839902|51536|P1|STARTED|Overall Study||24
23301|NCT02839889|51574|P2|NOT COMPLETED|Open-Label Period||1
23302|NCT02839889|51575|P1|NOT COMPLETED|Open-Label Period||0
23303|NCT02839889|51574|P2|COMPLETED|Open-Label Period||4
23304|NCT02839889|51575|P1|COMPLETED|Open-Label Period||0
23305|NCT02839889|51574|P2|STARTED|Open-Label Period||5
23306|NCT02839889|51575|P1|STARTED|Open-Label Period||0
23307|NCT02839889|51574|P2|NOT COMPLETED|Randomization Period||0
23308|NCT02839889|51575|P1|NOT COMPLETED|Randomization Period||0
23309|NCT02839889|51574|P2|COMPLETED|Randomization Period||3
23310|NCT02839889|51575|P1|COMPLETED|Randomization Period||2
23311|NCT02839889|51574|P2|STARTED|Randomization Period||3
23312|NCT02839889|51575|P1|STARTED|Randomization Period||2
23313|NCT02839772|51613|P2|NOT COMPLETED|Overall Study||0
23314|NCT02839772|51614|P1|NOT COMPLETED|Overall Study||1
23315|NCT02839772|51613|P2|COMPLETED|Overall Study||96
23316|NCT02839772|51614|P1|COMPLETED|Overall Study|1 participant in Clinic B did not return for the 3 months post- intervention data collection.|96
23317|NCT02839772|51613|P2|STARTED|Overall Study||96
23318|NCT02839772|51614|P1|STARTED|Overall Study|Stratification was used. Clinic A enrolled 94 participants and Clinic B 99 participants|97
23319|NCT02839746|51651|P1|NOT COMPLETED|Overall Study||12
23320|NCT02839746|51651|P1|COMPLETED|Overall Study||659
23321|NCT02839746|51651|P1|STARTED|Overall Study||671
23322|NCT02839681|51665|P1|NOT COMPLETED|Overall Study||2
23323|NCT02839681|51665|P1|COMPLETED|Overall Study||0
23324|NCT02839681|51665|P1|STARTED|Overall Study||2
23325|NCT02839330|51678|P4|NOT COMPLETED|Overall Study||51
23326|NCT02839330|51679|P3|NOT COMPLETED|Overall Study||48
23327|NCT02839330|51680|P2|NOT COMPLETED|Overall Study||58
23328|NCT02839330|51681|P1|NOT COMPLETED|Overall Study||58
23329|NCT02839330|51678|P4|COMPLETED|Overall Study||747
23330|NCT02839330|51679|P3|COMPLETED|Overall Study||747
23331|NCT02839330|51680|P2|COMPLETED|Overall Study||741
23332|NCT02839330|51681|P1|COMPLETED|Overall Study||746
23333|NCT02839330|51678|P4|Exposed|Overall Study||797
23334|NCT02839330|51679|P3|Exposed|Overall Study||793
23335|NCT02839330|51680|P2|Exposed|Overall Study||797
23336|NCT02839330|51681|P1|Exposed|Overall Study||804
23337|NCT02839330|51678|P4|STARTED|Overall Study||798
23338|NCT02839330|51679|P3|STARTED|Overall Study||795
23339|NCT02839330|51680|P2|STARTED|Overall Study||799
23340|NCT02839330|51681|P1|STARTED|Overall Study||804
23341|NCT02838901|51712|P2|NOT COMPLETED|Overall Study||2
23342|NCT02838901|51713|P1|NOT COMPLETED|Overall Study||2
23343|NCT02838901|51712|P2|COMPLETED|Overall Study||7
23344|NCT02838901|51713|P1|COMPLETED|Overall Study||7
23345|NCT02838901|51712|P2|STARTED|Overall Study||9
23346|NCT02838901|51713|P1|STARTED|Overall Study||9
23347|NCT02838420|51743|P2|NOT COMPLETED|Overall Study||62
23348|NCT02838420|51744|P1|NOT COMPLETED|Overall Study||125
23349|NCT02838420|51743|P2|COMPLETED|Overall Study||0
23350|NCT02838420|51744|P1|COMPLETED|Overall Study||0
23351|NCT02838420|51743|P2|STARTED|Overall Study||62
23352|NCT02838420|51744|P1|STARTED|Overall Study||125
23353|NCT02838407|51758|P1|NOT COMPLETED|Overall Study||0
23354|NCT02838407|51758|P1|COMPLETED|Overall Study||197
23355|NCT02838407|51758|P1|STARTED|Overall Study||197
23356|NCT02838134|51807|P2|NOT COMPLETED|Overall Study||3
23357|NCT02838134|51808|P1|NOT COMPLETED|Overall Study||2
23358|NCT02838134|51807|P2|COMPLETED|Overall Study||48
23359|NCT02838134|51808|P1|COMPLETED|Overall Study||48
23360|NCT02838134|51807|P2|STARTED|Overall Study||51
23361|NCT02838134|51808|P1|STARTED|Overall Study||50
23362|NCT02838017|51840|P2|NOT COMPLETED|Overall Study||11
23363|NCT02838017|51841|P1|NOT COMPLETED|Overall Study||14
23364|NCT02838017|51840|P2|COMPLETED|Overall Study||241
23365|NCT02838017|51841|P1|COMPLETED|Overall Study||238
23366|NCT02838017|51840|P2|STARTED|Overall Study||252
23367|NCT02838017|51841|P1|STARTED|Overall Study||252
23368|NCT02837952|51859|P2|NOT COMPLETED|Overall Study||6
23369|NCT02837952|51860|P1|NOT COMPLETED|Overall Study||5
23370|NCT02837952|51859|P2|COMPLETED|Overall Study||76
23371|NCT02837952|51860|P1|COMPLETED|Overall Study||36
23372|NCT02837952|51859|P2|STARTED|Overall Study||82
23373|NCT02837952|51860|P1|STARTED|Overall Study||41
23374|NCT02837913|51874|P2|NOT COMPLETED|Overall Study||0
23375|NCT02837913|51875|P1|NOT COMPLETED|Overall Study||0
23376|NCT02837913|51874|P2|COMPLETED|Overall Study||9
23377|NCT02837913|51875|P1|COMPLETED|Overall Study||10
23378|NCT02837913|51874|P2|STARTED|Overall Study||9
23379|NCT02837913|51875|P1|STARTED|Overall Study||10
23380|NCT02837328|51897|P2|NOT COMPLETED|Overall Study||0
23381|NCT02837328|51898|P1|NOT COMPLETED|Overall Study||0
23382|NCT02837328|51897|P2|COMPLETED|Overall Study||30
23383|NCT02837328|51898|P1|COMPLETED|Overall Study||29
23384|NCT02837328|51897|P2|STARTED|Overall Study||30
23385|NCT02837328|51898|P1|STARTED|Overall Study||29
23386|NCT02837237|51906|P1|NOT COMPLETED|Overall Study||0
23387|NCT02837237|51906|P1|COMPLETED|Overall Study||11
23388|NCT02837237|51906|P1|STARTED|Overall Study||11
23389|NCT02836613|51912|P2|NOT COMPLETED|Overall Study||3
23390|NCT02836613|51913|P1|NOT COMPLETED|Overall Study||1
23391|NCT02836613|51912|P2|COMPLETED|Overall Study||77
23392|NCT02836613|51913|P1|COMPLETED|Overall Study||79
23393|NCT02836613|51912|P2|STARTED|Overall Study||80
23394|NCT02836613|51913|P1|STARTED|Overall Study||80
23395|NCT02836249|51927|P2|NOT COMPLETED|Overall Study||58
23396|NCT02836249|51928|P1|NOT COMPLETED|Overall Study||123
23397|NCT02836249|51927|P2|COMPLETED|Overall Study||0
23398|NCT02836249|51928|P1|COMPLETED|Overall Study||0
23399|NCT02836249|51927|P2|STARTED|Overall Study||58
23400|NCT02836249|51928|P1|STARTED|Overall Study||123
23401|NCT02836236|51946|P2|NOT COMPLETED|Overall Study||50
23402|NCT02836236|51947|P1|NOT COMPLETED|Overall Study||105
23403|NCT02836236|51946|P2|COMPLETED|Overall Study||0
23404|NCT02836236|51947|P1|COMPLETED|Overall Study||0
23405|NCT02836236|51946|P2|STARTED|Overall Study||50
23406|NCT02836236|51947|P1|STARTED|Overall Study||105
23407|NCT02835690|51964|P3|NOT COMPLETED|Overall Study||15
23408|NCT02835690|51965|P2|NOT COMPLETED|Overall Study||15
23409|NCT02835690|51966|P1|NOT COMPLETED|Overall Study||14
23410|NCT02835690|51964|P3|COMPLETED|Overall Study||0
23411|NCT02835690|51965|P2|COMPLETED|Overall Study||0
23412|NCT02835690|51966|P1|COMPLETED|Overall Study||0
23413|NCT02835690|51964|P3|Treated|Overall Study||15
23414|NCT02835690|51965|P2|Treated|Overall Study||13
23415|NCT02835690|51966|P1|Treated|Overall Study||14
23416|NCT02835690|51964|P3|STARTED|Overall Study||15
23417|NCT02835690|51965|P2|STARTED|Overall Study||15
23418|NCT02835690|51966|P1|STARTED|Overall Study||14
23419|NCT02835677|52019|P1|NOT COMPLETED|Overall Study||0
23420|NCT02835677|52019|P1|COMPLETED|Overall Study||25
23421|NCT02835677|52019|P1|STARTED|Overall Study||25
23422|NCT02835092|52030|P3|NOT COMPLETED|Overall Study||3
23423|NCT02835092|52031|P2|NOT COMPLETED|Overall Study||8
23424|NCT02835092|52032|P1|NOT COMPLETED|Overall Study||3
23425|NCT02835092|52030|P3|COMPLETED|Overall Study||64
23426|NCT02835092|52031|P2|COMPLETED|Overall Study||57
23427|NCT02835092|52032|P1|COMPLETED|Overall Study||63
23428|NCT02835092|52030|P3|STARTED|Overall Study||67
23429|NCT02835092|52031|P2|STARTED|Overall Study||65
23430|NCT02835092|52032|P1|STARTED|Overall Study||66
23431|NCT02834624|52042|P2|NOT COMPLETED|Overall Study||0
23432|NCT02834624|52043|P1|NOT COMPLETED|Overall Study||0
23433|NCT02834624|52042|P2|COMPLETED|Overall Study||15
23434|NCT02834624|52043|P1|COMPLETED|Overall Study||15
23435|NCT02834624|52042|P2|STARTED|Overall Study||15
23436|NCT02834624|52043|P1|STARTED|Overall Study||15
23437|NCT02833974|52055|P2|NOT COMPLETED|Overall Study||3
23438|NCT02833974|52056|P1|NOT COMPLETED|Overall Study||1
23439|NCT02833974|52055|P2|COMPLETED|Overall Study||19
23440|NCT02833974|52056|P1|COMPLETED|Overall Study||13
23441|NCT02833974|52055|P2|STARTED|Overall Study||22
23442|NCT02833974|52056|P1|STARTED|Overall Study||14
23443|NCT02833857|52080|P1|NOT COMPLETED|Overall Study||0
23444|NCT02833857|52080|P1|COMPLETED|Overall Study||11
23445|NCT02833857|52080|P1|STARTED|Overall Study||11
23446|NCT02833415|52107|P2|NOT COMPLETED|Overall Study||3
23447|NCT02833415|52108|P1|NOT COMPLETED|Overall Study||2
23448|NCT02833415|52107|P2|COMPLETED|Overall Study||17
23449|NCT02833415|52108|P1|COMPLETED|Overall Study||18
23450|NCT02833415|52107|P2|STARTED|Overall Study||20
23451|NCT02833415|52108|P1|STARTED|Overall Study||20
23452|NCT02833350|52121|P7|NOT COMPLETED|Overall Study||5
23453|NCT02833350|52122|P6|NOT COMPLETED|Overall Study||1
23454|NCT02833350|52123|P5|NOT COMPLETED|Overall Study||3
23455|NCT02833350|52124|P4|NOT COMPLETED|Overall Study||8
23456|NCT02833350|52125|P3|NOT COMPLETED|Overall Study||8
23457|NCT02833350|52126|P2|NOT COMPLETED|Overall Study||9
23458|NCT02833350|52127|P1|NOT COMPLETED|Overall Study||3
23459|NCT02833350|52121|P7|COMPLETED|Overall Study||44
23460|NCT02833350|52122|P6|COMPLETED|Overall Study||48
23461|NCT02833350|52123|P5|COMPLETED|Overall Study||108
23462|NCT02833350|52124|P4|COMPLETED|Overall Study||102
23463|NCT02833350|52125|P3|COMPLETED|Overall Study||102
23464|NCT02833350|52126|P2|COMPLETED|Overall Study||100
23465|NCT02833350|52127|P1|COMPLETED|Overall Study||37
23466|NCT02833350|52121|P7|Randomized|Overall Study||50
23467|NCT02833350|52122|P6|Randomized|Overall Study||48
23468|NCT02833350|52123|P5|Randomized|Overall Study||111
23469|NCT02833350|52124|P4|Randomized|Overall Study||110
23470|NCT02833350|52125|P3|Randomized|Overall Study||110
23471|NCT02833350|52126|P2|Randomized|Overall Study||109
23472|NCT02833350|52127|P1|Randomized|Overall Study||40
23473|NCT02833350|52121|P7|STARTED|Overall Study||49
23474|NCT02833350|52122|P6|STARTED|Overall Study||49
23475|NCT02833350|52123|P5|STARTED|Overall Study||111
23476|NCT02833350|52124|P4|STARTED|Overall Study||110
23477|NCT02833350|52125|P3|STARTED|Overall Study||110
23478|NCT02833350|52126|P2|STARTED|Overall Study||109
23479|NCT02833350|52127|P1|STARTED|Overall Study||40
23480|NCT02832674|52328|P1|NOT COMPLETED|Overall Study||5
23481|NCT02832674|52328|P1|COMPLETED|Overall Study||67
23482|NCT02832674|52328|P1|STARTED|Overall Study||72
23483|NCT02832375|52339|P2|NOT COMPLETED|Overall Study||0
23484|NCT02832375|52340|P1|NOT COMPLETED|Overall Study||2
23485|NCT02832375|52339|P2|COMPLETED|Overall Study||121
23486|NCT02832375|52340|P1|COMPLETED|Overall Study||119
23487|NCT02832375|52339|P2|STARTED|Overall Study||121
23488|NCT02832375|52340|P1|STARTED|Overall Study||121
23489|NCT02832284|52350|P1|NOT COMPLETED|Overall Study||0
23490|NCT02832284|52350|P1|COMPLETED|Overall Study||23
23491|NCT02832284|52350|P1|STARTED|Overall Study||23
23492|NCT02831764|52360|P2|NOT COMPLETED|Overall Study||359
23493|NCT02831764|52361|P1|NOT COMPLETED|Overall Study||360
23494|NCT02831764|52360|P2|COMPLETED|Overall Study||0
23495|NCT02831764|52361|P1|COMPLETED|Overall Study||0
23496|NCT02831764|52360|P2|STARTED|Overall Study||359
23497|NCT02831764|52361|P1|STARTED|Overall Study||360
23498|NCT02831673|52425|P2|NOT COMPLETED|Overall Study||358
23499|NCT02831673|52426|P1|NOT COMPLETED|Overall Study||356
23500|NCT02831673|52425|P2|COMPLETED|Overall Study||0
23501|NCT02831673|52426|P1|COMPLETED|Overall Study||0
23502|NCT02831673|52425|P2|STARTED|Overall Study||358
23503|NCT02831673|52426|P1|STARTED|Overall Study||356
23504|NCT02831660|52488|P1|NOT COMPLETED|Overall Study||0
23505|NCT02831660|52488|P1|COMPLETED|Overall Study||1
23506|NCT02831660|52488|P1|STARTED|Overall Study||1
23507|NCT02831569|52492|P1|NOT COMPLETED|Overall Study||0
23508|NCT02831569|52492|P1|COMPLETED|Overall Study||80
23509|NCT02831569|52492|P1|STARTED|Overall Study||80
23510|NCT02831387|52499|P2|NOT COMPLETED|Overall Study||2
23511|NCT02831387|52500|P1|NOT COMPLETED|Overall Study||1
23512|NCT02831387|52499|P2|COMPLETED|Overall Study||22
23513|NCT02831387|52500|P1|COMPLETED|Overall Study||22
23514|NCT02831387|52499|P2|STARTED|Overall Study||24
23515|NCT02831387|52500|P1|STARTED|Overall Study||23
23516|NCT02830087|52524|P6|NOT COMPLETED|Overall Study||3
23517|NCT02830087|52525|P5|NOT COMPLETED|Overall Study||3
23518|NCT02830087|52526|P4|NOT COMPLETED|Overall Study||3
23519|NCT02830087|52527|P3|NOT COMPLETED|Overall Study||4
23520|NCT02830087|52528|P2|NOT COMPLETED|Overall Study||4
23521|NCT02830087|52529|P1|NOT COMPLETED|Overall Study||4
23522|NCT02830087|52524|P6|COMPLETED|Overall Study||0
23523|NCT02830087|52525|P5|COMPLETED|Overall Study||0
23524|NCT02830087|52526|P4|COMPLETED|Overall Study||0
23525|NCT02830087|52527|P3|COMPLETED|Overall Study||0
23526|NCT02830087|52528|P2|COMPLETED|Overall Study||0
23527|NCT02830087|52529|P1|COMPLETED|Overall Study||0
23528|NCT02830087|52524|P6|STARTED|Overall Study||3
23529|NCT02830087|52525|P5|STARTED|Overall Study||3
23530|NCT02830087|52526|P4|STARTED|Overall Study||3
23531|NCT02830087|52527|P3|STARTED|Overall Study||4
23532|NCT02830087|52528|P2|STARTED|Overall Study||4
23533|NCT02830087|52529|P1|STARTED|Overall Study||4
23534|NCT02829996|52596|P5|NOT COMPLETED|Overall Study||0
23535|NCT02829996|52597|P4|NOT COMPLETED|Overall Study||0
23536|NCT02829996|52598|P3|NOT COMPLETED|Overall Study||0
23537|NCT02829996|52599|P2|NOT COMPLETED|Overall Study||0
23538|NCT02829996|52600|P1|NOT COMPLETED|Overall Study||1
23539|NCT02829996|52596|P5|COMPLETED|Overall Study||42
23540|NCT02829996|52597|P4|COMPLETED|Overall Study||41
23541|NCT02829996|52598|P3|COMPLETED|Overall Study||40
23542|NCT02829996|52599|P2|COMPLETED|Overall Study||39
23543|NCT02829996|52600|P1|COMPLETED|Overall Study||38
23544|NCT02829996|52596|P5|STARTED|Overall Study||42
23545|NCT02829996|52597|P4|STARTED|Overall Study||41
23546|NCT02829996|52598|P3|STARTED|Overall Study||40
23547|NCT02829996|52599|P2|STARTED|Overall Study||39
23548|NCT02829996|52600|P1|STARTED|Overall Study||39
23549|NCT02829983|52614|P2|NOT COMPLETED|Overall Study||0
23550|NCT02829983|52615|P1|NOT COMPLETED|Overall Study||0
23551|NCT02829983|52614|P2|COMPLETED|Overall Study||20
23552|NCT02829983|52615|P1|COMPLETED|Overall Study||20
23553|NCT02829983|52614|P2|STARTED|Overall Study||20
23554|NCT02829983|52615|P1|STARTED|Overall Study||20
23555|NCT02829775|52623|P1|NOT COMPLETED|Overall Study||5
23556|NCT02829775|52623|P1|COMPLETED|Overall Study||4
23557|NCT02829775|52623|P1|STARTED|Overall Study||9
23558|NCT02829463|52630|P2|NOT COMPLETED|Overall Study||0
23559|NCT02829463|52631|P1|NOT COMPLETED|Overall Study||0
23560|NCT02829463|52630|P2|COMPLETED|Overall Study||62
23561|NCT02829463|52631|P1|COMPLETED|Overall Study||59
23562|NCT02829463|52630|P2|STARTED|Overall Study||62
23563|NCT02829463|52631|P1|STARTED|Overall Study||59
23564|NCT02829320|52637|P1|NOT COMPLETED|Overall Study||0
23565|NCT02829320|52637|P1|COMPLETED|Overall Study||28
23566|NCT02829320|52637|P1|STARTED|Overall Study||28
23567|NCT02829307|52674|P1|NOT COMPLETED|Overall Study||0
23568|NCT02829307|52674|P1|COMPLETED|Overall Study||8
23569|NCT02829307|52674|P1|STARTED|Overall Study||8
23570|NCT02829294|52697|P1|NOT COMPLETED|Overall Study||0
23571|NCT02829294|52697|P1|COMPLETED|Overall Study||19
23572|NCT02829294|52697|P1|STARTED|Overall Study||19
23573|NCT02829138|52705|P2|NOT COMPLETED|Overall Study||0
23574|NCT02829138|52706|P1|NOT COMPLETED|Overall Study||1
23575|NCT02829138|52705|P2|COMPLETED|Overall Study||28
23576|NCT02829138|52706|P1|COMPLETED|Overall Study||28
23577|NCT02829138|52705|P2|STARTED|Overall Study||28
23578|NCT02829138|52706|P1|STARTED|Overall Study||29
23579|NCT02829034|52718|P2|NOT COMPLETED|Overall Study||2
23580|NCT02829034|52719|P1|NOT COMPLETED|Overall Study||5
23581|NCT02829034|52718|P2|COMPLETED|Overall Study||6
23582|NCT02829034|52719|P1|COMPLETED|Overall Study||9
23583|NCT02829034|52718|P2|STARTED|Overall Study||8
23584|NCT02829034|52719|P1|STARTED|Overall Study||14
23585|NCT02828644|52731|P2|NOT COMPLETED|Overall Study||22
23586|NCT02828644|52732|P1|NOT COMPLETED|Overall Study||23
23587|NCT02828644|52731|P2|COMPLETED|Overall Study||65
23588|NCT02828644|52732|P1|COMPLETED|Overall Study||65
23589|NCT02828644|52731|P2|STARTED|Overall Study||87
23590|NCT02828644|52732|P1|STARTED|Overall Study||88
23591|NCT02828241|52741|P2|NOT COMPLETED|Overall Study||2
23592|NCT02828241|52742|P1|NOT COMPLETED|Overall Study||8
23593|NCT02828241|52741|P2|COMPLETED|Overall Study||21
23594|NCT02828241|52742|P1|COMPLETED|Overall Study||30
23595|NCT02828241|52741|P2|STARTED|Overall Study||23
23596|NCT02828241|52742|P1|STARTED|Overall Study||38
23597|NCT02828137|52755|P3|NOT COMPLETED|Overall Study||0
23598|NCT02828137|52756|P2|NOT COMPLETED|Overall Study||0
23599|NCT02828137|52757|P1|NOT COMPLETED|Overall Study||0
23600|NCT02828137|52755|P3|COMPLETED|Overall Study||41
23601|NCT02828137|52756|P2|COMPLETED|Overall Study||41
23602|NCT02828137|52757|P1|COMPLETED|Overall Study||41
23603|NCT02828137|52755|P3|STARTED|Overall Study||41
23604|NCT02828137|52756|P2|STARTED|Overall Study||41
23605|NCT02828137|52757|P1|STARTED|Overall Study||41
23606|NCT02828124|52769|P4|NOT COMPLETED|Overall Study||6
23607|NCT02828124|52770|P3|NOT COMPLETED|Overall Study||1
23608|NCT02828124|52771|P2|NOT COMPLETED|Overall Study||2
23609|NCT02828124|52772|P1|NOT COMPLETED|Overall Study||1
23610|NCT02828124|52769|P4|COMPLETED|Overall Study||0
23611|NCT02828124|52770|P3|COMPLETED|Overall Study||0
23612|NCT02828124|52771|P2|COMPLETED|Overall Study||0
23613|NCT02828124|52772|P1|COMPLETED|Overall Study||0
23614|NCT02828124|52769|P4|STARTED|Overall Study||6
23615|NCT02828124|52770|P3|STARTED|Overall Study||1
23616|NCT02828124|52771|P2|STARTED|Overall Study||2
23617|NCT02828124|52772|P1|STARTED|Overall Study||1
23618|NCT02828111|52887|P5|NOT COMPLETED|Overall Study||1
23619|NCT02828111|52888|P4|NOT COMPLETED|Overall Study||1
23620|NCT02828111|52889|P3|NOT COMPLETED|Overall Study||2
23621|NCT02828111|52890|P2|NOT COMPLETED|Overall Study||0
23622|NCT02828111|52891|P1|NOT COMPLETED|Overall Study||0
23623|NCT02828111|52887|P5|COMPLETED|Overall Study||11
23624|NCT02828111|52888|P4|COMPLETED|Overall Study||5
23625|NCT02828111|52889|P3|COMPLETED|Overall Study||4
23626|NCT02828111|52890|P2|COMPLETED|Overall Study||6
23627|NCT02828111|52891|P1|COMPLETED|Overall Study||6
23628|NCT02828111|52887|P5|Received at Least 1 Dose of Study Drug|Overall Study||12
23629|NCT02828111|52888|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
23630|NCT02828111|52889|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
23631|NCT02828111|52890|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
23632|NCT02828111|52891|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
23633|NCT02828111|52887|P5|STARTED|Overall Study||12
23634|NCT02828111|52888|P4|STARTED|Overall Study||6
23635|NCT02828111|52889|P3|STARTED|Overall Study||6
23636|NCT02828111|52890|P2|STARTED|Overall Study||6
23637|NCT02828111|52891|P1|STARTED|Overall Study||6
23638|NCT02828020|52952|P3|NOT COMPLETED|Safety Follow-up Period||19
23639|NCT02828020|52953|P2|NOT COMPLETED|Safety Follow-up Period||18
23640|NCT02828020|52954|P1|NOT COMPLETED|Safety Follow-up Period||20
23641|NCT02828020|52952|P3|COMPLETED|Safety Follow-up Period||461
23642|NCT02828020|52953|P2|COMPLETED|Safety Follow-up Period||440
23643|NCT02828020|52954|P1|COMPLETED|Safety Follow-up Period||460
23644|NCT02828020|52952|P3|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|480
23645|NCT02828020|52953|P2|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|458
23646|NCT02828020|52954|P1|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|480
23647|NCT02828020|52952|P3|NOT COMPLETED|Treatment Period||78
23648|NCT02828020|52953|P2|NOT COMPLETED|Treatment Period||99
23649|NCT02828020|52954|P1|NOT COMPLETED|Treatment Period||80
23650|NCT02828020|52952|P3|COMPLETED|Treatment Period||479
23651|NCT02828020|52953|P2|COMPLETED|Treatment Period||457
23652|NCT02828020|52954|P1|COMPLETED|Treatment Period||479
23653|NCT02828020|52952|P3|Safety Population: Received Study Drug|Treatment Period||485
23654|NCT02828020|52953|P2|Safety Population: Received Study Drug|Treatment Period||466
23655|NCT02828020|52954|P1|Safety Population: Received Study Drug|Treatment Period||485
23656|NCT02828020|52952|P3|STARTED|Treatment Period||557
23657|NCT02828020|52953|P2|STARTED|Treatment Period||556
23658|NCT02828020|52954|P1|STARTED|Treatment Period||559
23659|NCT02827500|52985|P2|NOT COMPLETED|Overall Study||7
23660|NCT02827500|52986|P1|NOT COMPLETED|Overall Study||19
23661|NCT02827500|52985|P2|COMPLETED|Overall Study||45
23662|NCT02827500|52986|P1|COMPLETED|Overall Study||33
23663|NCT02827500|52985|P2|STARTED|Overall Study||52
23664|NCT02827500|52986|P1|STARTED|Overall Study||52
23665|NCT02826603|53004|P2|NOT COMPLETED|Overall Study||64
23666|NCT02826603|53005|P1|NOT COMPLETED|Overall Study||61
23667|NCT02826603|53004|P2|COMPLETED|Overall Study||488
23668|NCT02826603|53005|P1|COMPLETED|Overall Study||489
23669|NCT02826603|53004|P2|STARTED|Overall Study||552
23670|NCT02826603|53005|P1|STARTED|Overall Study||550
23671|NCT02826551|53032|P2|NOT COMPLETED|Overall Study||0
23672|NCT02826551|53033|P1|NOT COMPLETED|Overall Study||0
23673|NCT02826551|53032|P2|COMPLETED|Overall Study||12
23674|NCT02826551|53033|P1|COMPLETED|Overall Study||11
23675|NCT02826551|53032|P2|STARTED|Overall Study||12
23676|NCT02826551|53033|P1|STARTED|Overall Study||11
23677|NCT02826421|53045|P4|NOT COMPLETED|Overall Study||2
23678|NCT02826421|53046|P3|NOT COMPLETED|Overall Study||2
23679|NCT02826421|53047|P2|NOT COMPLETED|Overall Study||3
23680|NCT02826421|53048|P1|NOT COMPLETED|Overall Study||3
23681|NCT02826421|53045|P4|COMPLETED|Overall Study||28
23682|NCT02826421|53046|P3|COMPLETED|Overall Study||26
23683|NCT02826421|53047|P2|COMPLETED|Overall Study||26
23684|NCT02826421|53048|P1|COMPLETED|Overall Study||19
23685|NCT02826421|53045|P4|Treated|Overall Study||28
23686|NCT02826421|53046|P3|Treated|Overall Study||26
23687|NCT02826421|53047|P2|Treated|Overall Study||26
23688|NCT02826421|53048|P1|Treated|Overall Study||19
23689|NCT02826421|53045|P4|STARTED|Overall Study||30
23690|NCT02826421|53046|P3|STARTED|Overall Study||28
23691|NCT02826421|53047|P2|STARTED|Overall Study||29
23692|NCT02826421|53048|P1|STARTED|Overall Study||22
23693|NCT02825550|53060|P1|NOT COMPLETED|Overall Study||1
23694|NCT02825550|53060|P1|COMPLETED|Overall Study||12
23695|NCT02825550|53060|P1|STARTED|Overall Study||13
23696|NCT02825251|53068|P2|NOT COMPLETED|Overall Study||6
23697|NCT02825251|53069|P1|NOT COMPLETED|Overall Study||3
23698|NCT02825251|53068|P2|COMPLETED|Overall Study||230
23699|NCT02825251|53069|P1|COMPLETED|Overall Study||233
23700|NCT02825251|53068|P2|STARTED|Overall Study||236
23701|NCT02825251|53069|P1|STARTED|Overall Study||236
23702|NCT02824913|53257|P2|NOT COMPLETED|Second Intervention (1 Day)||0
23703|NCT02824913|53258|P1|NOT COMPLETED|Second Intervention (1 Day)||0
23704|NCT02824913|53257|P2|COMPLETED|Second Intervention (1 Day)||0
23705|NCT02824913|53258|P1|COMPLETED|Second Intervention (1 Day)||1
23706|NCT02824913|53257|P2|STARTED|Second Intervention (1 Day)||0
23707|NCT02824913|53258|P1|STARTED|Second Intervention (1 Day)||1
23708|NCT02824913|53257|P2|NOT COMPLETED|Washout (7-14 Days)||0
23709|NCT02824913|53258|P1|NOT COMPLETED|Washout (7-14 Days)||0
23710|NCT02824913|53257|P2|COMPLETED|Washout (7-14 Days)||0
23711|NCT02824913|53258|P1|COMPLETED|Washout (7-14 Days)||1
23712|NCT02824913|53257|P2|STARTED|Washout (7-14 Days)||0
23713|NCT02824913|53258|P1|STARTED|Washout (7-14 Days)||1
23714|NCT02824913|53257|P2|NOT COMPLETED|First Intervention (1 Day)||0
23715|NCT02824913|53258|P1|NOT COMPLETED|First Intervention (1 Day)||0
23716|NCT02824913|53257|P2|COMPLETED|First Intervention (1 Day)||0
23717|NCT02824913|53258|P1|COMPLETED|First Intervention (1 Day)|Only one subject was enrolled in the study and received both study treatments.|1
23718|NCT02824913|53257|P2|STARTED|First Intervention (1 Day)||0
23719|NCT02824913|53258|P1|STARTED|First Intervention (1 Day)||1
23720|NCT02824562|53272|P2|NOT COMPLETED|Overall Study||5
23721|NCT02824562|53273|P1|NOT COMPLETED|Overall Study||3
23722|NCT02824562|53272|P2|COMPLETED|Overall Study||17
23723|NCT02824562|53273|P1|COMPLETED|Overall Study||19
23724|NCT02824562|53272|P2|STARTED|Overall Study||22
23725|NCT02824562|53273|P1|STARTED|Overall Study||22
23726|NCT02824432|53282|P2|NOT COMPLETED|Overall Study||0
23727|NCT02824432|53283|P1|NOT COMPLETED|Overall Study||1
23728|NCT02824432|53282|P2|COMPLETED|Overall Study||19
23729|NCT02824432|53283|P1|COMPLETED|Overall Study||17
23730|NCT02824432|53282|P2|STARTED|Overall Study||19
23731|NCT02824432|53283|P1|STARTED|Overall Study||18
23732|NCT02824224|53359|P2|NOT COMPLETED|Overall Study||1
23733|NCT02824224|53360|P1|NOT COMPLETED|Overall Study||2
23734|NCT02824224|53359|P2|COMPLETED|Overall Study||17
23735|NCT02824224|53360|P1|COMPLETED|Overall Study||17
23736|NCT02824224|53359|P2|STARTED|Overall Study||18
23737|NCT02824224|53360|P1|STARTED|Overall Study||19
23738|NCT02824198|53380|P2|NOT COMPLETED|Overall Study||1
23739|NCT02824198|53381|P1|NOT COMPLETED|Overall Study||1
23740|NCT02824198|53380|P2|COMPLETED|Overall Study||28
23741|NCT02824198|53381|P1|COMPLETED|Overall Study||88
23742|NCT02824198|53380|P2|STARTED|Overall Study||29
23743|NCT02824198|53381|P1|STARTED|Overall Study||89
23744|NCT02823964|53405|P1|NOT COMPLETED|Overall Study||5
23745|NCT02823964|53405|P1|COMPLETED|Overall Study||20
23746|NCT02823964|53405|P1|STARTED|Overall Study||25
23747|NCT02823600|53409|P1|NOT COMPLETED|Overall Study||0
23748|NCT02823600|53409|P1|COMPLETED|Overall Study||68
23749|NCT02823600|53409|P1|STARTED|Overall Study||68
23750|NCT02823470|53419|P2|NOT COMPLETED|Overall Study||15
23751|NCT02823470|53420|P1|NOT COMPLETED|Overall Study||9
23752|NCT02823470|53419|P2|COMPLETED|Overall Study||0
23753|NCT02823470|53420|P1|COMPLETED|Overall Study||0
23754|NCT02823470|53419|P2|STARTED|Overall Study||15
23755|NCT02823470|53420|P1|STARTED|Overall Study||9
23756|NCT02823431|53434|P2|NOT COMPLETED|Overall Study||0
23757|NCT02823431|53435|P1|NOT COMPLETED|Overall Study||0
23758|NCT02823431|53434|P2|COMPLETED|Overall Study||12
23759|NCT02823431|53435|P1|COMPLETED|Overall Study||11
23760|NCT02823431|53434|P2|STARTED|Overall Study||12
23761|NCT02823431|53435|P1|STARTED|Overall Study||11
23762|NCT02823080|53449|P2|NOT COMPLETED|Overall Study||0
23763|NCT02823080|53450|P1|NOT COMPLETED|Overall Study||0
23764|NCT02823080|53449|P2|COMPLETED|Overall Study||24
23765|NCT02823080|53450|P1|COMPLETED|Overall Study||24
23766|NCT02823080|53449|P2|STARTED|Overall Study||24
23767|NCT02823080|53450|P1|STARTED|Overall Study||24
23768|NCT02822950|53468|P1|NOT COMPLETED|Overall Study||0
23769|NCT02822950|53468|P1|COMPLETED|Overall Study||10
23770|NCT02822950|53468|P1|STARTED|Overall Study||10
23771|NCT02822885|53476|P1|NOT COMPLETED|Overall Study||0
23772|NCT02822885|53476|P1|COMPLETED|Overall Study||70
23773|NCT02822885|53476|P1|STARTED|Overall Study||70
23774|NCT02822794|53488|P2|NOT COMPLETED|Overall Study||0
23775|NCT02822794|53489|P1|NOT COMPLETED|Overall Study||1
23776|NCT02822794|53488|P2|COMPLETED|Overall Study||60
23777|NCT02822794|53489|P1|COMPLETED|Overall Study||56
23778|NCT02822794|53488|P2|STARTED|Overall Study||60
23779|NCT02822794|53489|P1|STARTED|Overall Study||57
23780|NCT02822287|53547|P1|NOT COMPLETED|Overall Study||0
23781|NCT02822287|53547|P1|COMPLETED|Overall Study||57
23782|NCT02822287|53547|P1|STARTED|Overall Study||57
23783|NCT02821962|53559|P2|NOT COMPLETED|Overall Study||0
23784|NCT02821962|53560|P1|NOT COMPLETED|Overall Study||2
23785|NCT02821962|53559|P2|COMPLETED|Overall Study||21
23786|NCT02821962|53560|P1|COMPLETED|Overall Study||17
23787|NCT02821962|53559|P2|STARTED|Overall Study||21
23788|NCT02821962|53560|P1|STARTED|Overall Study||19
23789|NCT02821819|53598|P1|NOT COMPLETED|Overall Study||1
23790|NCT02821819|53598|P1|COMPLETED|Overall Study||14
23791|NCT02821819|53598|P1|STARTED|Overall Study||15
23792|NCT02821455|53603|P1|NOT COMPLETED|Overall Study||0
23793|NCT02821455|53603|P1|COMPLETED|Overall Study||19
23794|NCT02821455|53603|P1|STARTED|Overall Study||19
23795|NCT02821403|53610|P2|NOT COMPLETED|"Third Intervention (1 Month)"||0
23796|NCT02821403|53611|P1|NOT COMPLETED|"Third Intervention (1 Month)"||0
23797|NCT02821403|53610|P2|COMPLETED|"Third Intervention (1 Month)"||40
23798|NCT02821403|53611|P1|COMPLETED|"Third Intervention (1 Month)"||40
23799|NCT02821403|53610|P2|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||14
23800|NCT02821403|53611|P1|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||13
23801|NCT02821403|53610|P2|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
23802|NCT02821403|53611|P1|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
23803|NCT02821403|53610|P2|Used Clear Lens|"Third Intervention (1 Month)"||13
23804|NCT02821403|53611|P1|Used Clear Lens|"Third Intervention (1 Month)"||14
23805|NCT02821403|53610|P2|STARTED|"Third Intervention (1 Month)"||40
23806|NCT02821403|53611|P1|STARTED|"Third Intervention (1 Month)"||40
23807|NCT02821403|53610|P2|NOT COMPLETED|"Second Intervention (1 Month)"||0
23808|NCT02821403|53611|P1|NOT COMPLETED|"Second Intervention (1 Month)"||0
23809|NCT02821403|53610|P2|COMPLETED|"Second Intervention (1 Month)"||40
23810|NCT02821403|53611|P1|COMPLETED|"Second Intervention (1 Month)"||40
23811|NCT02821403|53610|P2|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
23812|NCT02821403|53611|P1|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
23813|NCT02821403|53610|P2|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||13
23814|NCT02821403|53611|P1|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||14
23815|NCT02821403|53610|P2|Used Clear Lens|"Second Intervention (1 Month)"||14
23816|NCT02821403|53611|P1|Used Clear Lens|"Second Intervention (1 Month)"||13
23817|NCT02821403|53610|P2|STARTED|"Second Intervention (1 Month)"||40
23818|NCT02821403|53611|P1|STARTED|"Second Intervention (1 Month)"||40
23819|NCT02821403|53610|P2|NOT COMPLETED|"First Intervention (1 Month)"||0
23820|NCT02821403|53611|P1|NOT COMPLETED|"First Intervention (1 Month)"||0
23821|NCT02821403|53610|P2|COMPLETED|"First Intervention (1 Month)"||40
23822|NCT02821403|53611|P1|COMPLETED|"First Intervention (1 Month)"||40
23823|NCT02821403|53610|P2|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||13
23824|NCT02821403|53611|P1|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||14
23825|NCT02821403|53610|P2|Used Yellow Tinted Lens|"First Intervention (1 Month)"||14
23826|NCT02821403|53611|P1|Used Yellow Tinted Lens|"First Intervention (1 Month)"||13
23827|NCT02821403|53610|P2|Used Clear Lens|"First Intervention (1 Month)"||13
23828|NCT02821403|53611|P1|Used Clear Lens|"First Intervention (1 Month)"||13
23829|NCT02821403|53610|P2|STARTED|"First Intervention (1 Month)"||40
23830|NCT02821403|53611|P1|STARTED|"First Intervention (1 Month)"||40
23831|NCT02821000|53629|P1|NOT COMPLETED|Overall Study||103
23832|NCT02821000|53629|P1|COMPLETED|Overall Study||0
23833|NCT02821000|53629|P1|Treated|Overall Study||103
23834|NCT02821000|53629|P1|STARTED|Overall Study||103
23835|NCT02820844|53654|P6|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||1
23836|NCT02820844|53655|P5|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||2
23837|NCT02820844|53656|P4|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
23838|NCT02820844|53657|P3|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
23839|NCT02820844|53658|P2|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
23840|NCT02820844|53659|P1|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
23841|NCT02820844|53654|P6|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||42
23842|NCT02820844|53655|P5|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||54
23843|NCT02820844|53656|P4|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
23844|NCT02820844|53657|P3|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
23845|NCT02820844|53658|P2|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
23846|NCT02820844|53659|P1|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
23847|NCT02820844|53654|P6|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||43
23848|NCT02820844|53655|P5|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||56
23849|NCT02820844|53656|P4|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
23850|NCT02820844|53657|P3|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
23851|NCT02820844|53658|P2|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
23852|NCT02820844|53659|P1|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
23853|NCT02820844|53654|P6|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
23854|NCT02820844|53655|P5|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
23855|NCT02820844|53656|P4|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||4
23856|NCT02820844|53657|P3|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||9
23857|NCT02820844|53658|P2|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
23858|NCT02820844|53659|P1|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
23859|NCT02820844|53654|P6|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
23860|NCT02820844|53655|P5|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
23861|NCT02820844|53656|P4|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||84
23862|NCT02820844|53657|P3|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||99
23863|NCT02820844|53658|P2|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
23864|NCT02820844|53659|P1|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
23865|NCT02820844|53654|P6|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
23866|NCT02820844|53655|P5|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
23867|NCT02820844|53656|P4|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||88
23868|NCT02820844|53657|P3|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||108
23869|NCT02820844|53658|P2|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
23870|NCT02820844|53659|P1|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
23871|NCT02820844|53654|P6|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
23872|NCT02820844|53655|P5|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
23873|NCT02820844|53656|P4|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
23874|NCT02820844|53657|P3|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
23875|NCT02820844|53658|P2|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||9
23876|NCT02820844|53659|P1|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||5
23877|NCT02820844|53654|P6|COMPLETED|Double-blinded (Up to 48 Weeks)||0
23878|NCT02820844|53655|P5|COMPLETED|Double-blinded (Up to 48 Weeks)||0
23879|NCT02820844|53656|P4|COMPLETED|Double-blinded (Up to 48 Weeks)||0
23880|NCT02820844|53657|P3|COMPLETED|Double-blinded (Up to 48 Weeks)||0
23881|NCT02820844|53658|P2|COMPLETED|Double-blinded (Up to 48 Weeks)||115
23882|NCT02820844|53659|P1|COMPLETED|Double-blinded (Up to 48 Weeks)||119
23883|NCT02820844|53654|P6|STARTED|Double-blinded (Up to 48 Weeks)||0
23884|NCT02820844|53655|P5|STARTED|Double-blinded (Up to 48 Weeks)||0
23885|NCT02820844|53656|P4|STARTED|Double-blinded (Up to 48 Weeks)||0
23886|NCT02820844|53657|P3|STARTED|Double-blinded (Up to 48 Weeks)||0
23887|NCT02820844|53658|P2|STARTED|Double-blinded (Up to 48 Weeks)||124
23888|NCT02820844|53659|P1|STARTED|Double-blinded (Up to 48 Weeks)||124
23889|NCT02820597|53873|P1|NOT COMPLETED|Overall Study||12
23890|NCT02820597|53873|P1|COMPLETED|Overall Study|12 participants were lost to follow-up.|15
23891|NCT02820597|53873|P1|180-day Post Treatment|Overall Study|3 participants missed the 180-day visit, 3 participants were lost to follow-up.|21
23892|NCT02820597|53873|P1|90-day Post Treatment|Overall Study|2 participants missed the 90-day visit, 1 participant was lost to follow-up.|24
23893|NCT02820597|53873|P1|30-day Post Treatment|Overall Study||27
23894|NCT02820597|53873|P1|7-day Post Treatment|Overall Study||27
23895|NCT02820597|53873|P1|1-day Post Treatment|Overall Study||27
23896|NCT02820597|53873|P1|STARTED|Overall Study||27
23897|NCT02818777|53881|P1|NOT COMPLETED|Overall Study||3
23898|NCT02818777|53881|P1|COMPLETED|Overall Study||10
23899|NCT02818777|53881|P1|STARTED|Overall Study|The number of baseline participants was 13.|13
23900|NCT02818569|53909|P2|NOT COMPLETED|Overall Study||0
23901|NCT02818569|53910|P1|NOT COMPLETED|Overall Study||0
23902|NCT02818569|53909|P2|COMPLETED|Overall Study||7
23903|NCT02818569|53910|P1|COMPLETED|Overall Study||8
23904|NCT02818569|53909|P2|STARTED|Overall Study||7
23905|NCT02818569|53910|P1|STARTED|Overall Study||8
23906|NCT02818244|53928|P4|NOT COMPLETED|Overall Study||0
23907|NCT02818244|53929|P3|NOT COMPLETED|Overall Study||0
23908|NCT02818244|53930|P2|NOT COMPLETED|Overall Study||0
23909|NCT02818244|53931|P1|NOT COMPLETED|Overall Study||0
23910|NCT02818244|53928|P4|COMPLETED|Overall Study||25
23911|NCT02818244|53929|P3|COMPLETED|Overall Study||25
23912|NCT02818244|53930|P2|COMPLETED|Overall Study||25
23913|NCT02818244|53931|P1|COMPLETED|Overall Study||25
23914|NCT02818244|53928|P4|STARTED|Overall Study||25
23915|NCT02818244|53929|P3|STARTED|Overall Study||25
23916|NCT02818244|53930|P2|STARTED|Overall Study||25
23917|NCT02818244|53931|P1|STARTED|Overall Study||25
23918|NCT02818114|53941|P1|NOT COMPLETED|Overall Study||1
23919|NCT02818114|53941|P1|COMPLETED|Overall Study||7
23920|NCT02818114|53941|P1|STARTED|Overall Study||8
23921|NCT02818036|53948|P2|NOT COMPLETED|Overall Study||0
23922|NCT02818036|53949|P1|NOT COMPLETED|Overall Study||2
23923|NCT02818036|53948|P2|COMPLETED|Overall Study||40
23924|NCT02818036|53949|P1|COMPLETED|Overall Study||40
23925|NCT02818036|53948|P2|STARTED|Overall Study||40
23926|NCT02818036|53949|P1|STARTED|Overall Study||42
23927|NCT02817841|53957|P1|NOT COMPLETED|Overall Study||848
23928|NCT02817841|53957|P1|COMPLETED|Overall Study||1016
23929|NCT02817841|53957|P1|STARTED|Overall Study||1864
23930|NCT02817828|53980|P1|NOT COMPLETED|Overall Study||335
23931|NCT02817828|53980|P1|COMPLETED|Overall Study||1218
23932|NCT02817828|53980|P1|STARTED|Overall Study||1553
23933|NCT02817763|54006|P2|NOT COMPLETED|Overall Study||0
23934|NCT02817763|54007|P1|NOT COMPLETED|Overall Study||0
23935|NCT02817763|54006|P2|COMPLETED|Overall Study||20
23936|NCT02817763|54007|P1|COMPLETED|Overall Study||20
23937|NCT02817763|54006|P2|STARTED|Overall Study||20
23938|NCT02817763|54007|P1|STARTED|Overall Study||20
23939|NCT02817594|54015|P1|NOT COMPLETED|Overall Study||3
23940|NCT02817594|54015|P1|COMPLETED|Overall Study||48
23941|NCT02817594|54015|P1|Received Treatment|Overall Study||50
23942|NCT02817594|54015|P1|STARTED|Overall Study||51
23943|NCT02817555|54036|P2|NOT COMPLETED|Overall Study||5
23944|NCT02817555|54037|P1|NOT COMPLETED|Overall Study||3
23945|NCT02817555|54036|P2|COMPLETED|Overall Study||21
23946|NCT02817555|54037|P1|COMPLETED|Overall Study||21
23947|NCT02817555|54036|P2|STARTED|Overall Study||26
23948|NCT02817555|54037|P1|STARTED|Overall Study||24
23949|NCT02817516|54057|P4|NOT COMPLETED|Overall Study||0
23950|NCT02817516|54058|P3|NOT COMPLETED|Overall Study||1
23951|NCT02817516|54059|P2|NOT COMPLETED|Overall Study||0
23952|NCT02817516|54060|P1|NOT COMPLETED|Overall Study||0
23953|NCT02817516|54057|P4|COMPLETED|Overall Study||6
23954|NCT02817516|54058|P3|COMPLETED|Overall Study||5
23955|NCT02817516|54059|P2|COMPLETED|Overall Study||6
23956|NCT02817516|54060|P1|COMPLETED|Overall Study||6
23957|NCT02817516|54057|P4|STARTED|Overall Study||6
23958|NCT02817516|54058|P3|STARTED|Overall Study||6
23959|NCT02817516|54059|P2|STARTED|Overall Study||6
23960|NCT02817516|54060|P1|STARTED|Overall Study||6
23961|NCT02816710|54098|P3|NOT COMPLETED|Overall Study||7
23962|NCT02816710|54099|P2|NOT COMPLETED|Overall Study||3
23963|NCT02816710|54100|P1|NOT COMPLETED|Overall Study||4
23964|NCT02816710|54098|P3|COMPLETED|Overall Study||29
23965|NCT02816710|54099|P2|COMPLETED|Overall Study||35
23966|NCT02816710|54100|P1|COMPLETED|Overall Study||34
23967|NCT02816710|54098|P3|STARTED|Overall Study||36
23968|NCT02816710|54099|P2|STARTED|Overall Study||38
23969|NCT02816710|54100|P1|STARTED|Overall Study||38
23970|NCT02816346|54140|P5|NOT COMPLETED|Overall Study||0
23971|NCT02816346|54141|P4|NOT COMPLETED|Overall Study||0
23972|NCT02816346|54142|P3|NOT COMPLETED|Overall Study||0
23973|NCT02816346|54143|P2|NOT COMPLETED|Overall Study||0
23974|NCT02816346|54144|P1|NOT COMPLETED|Overall Study||0
23975|NCT02816346|54140|P5|COMPLETED|Overall Study||16
23976|NCT02816346|54141|P4|COMPLETED|Overall Study||10
23977|NCT02816346|54142|P3|COMPLETED|Overall Study||10
23978|NCT02816346|54143|P2|COMPLETED|Overall Study||10
23979|NCT02816346|54144|P1|COMPLETED|Overall Study||10
23980|NCT02816346|54140|P5|STARTED|Overall Study||16
23981|NCT02816346|54141|P4|STARTED|Overall Study||10
23982|NCT02816346|54142|P3|STARTED|Overall Study||10
23983|NCT02816346|54143|P2|STARTED|Overall Study||10
23984|NCT02816346|54144|P1|STARTED|Overall Study||10
23985|NCT02816138|54186|P1|NOT COMPLETED|Overall Study||1
23986|NCT02816138|54186|P1|COMPLETED|Overall Study||14
23987|NCT02816138|54186|P1|STARTED|Overall Study||15
23988|NCT02815982|54203|P4|NOT COMPLETED|Overall Study||0
23989|NCT02815982|54204|P3|NOT COMPLETED|Overall Study||0
23990|NCT02815982|54205|P2|NOT COMPLETED|Overall Study||0
23991|NCT02815982|54206|P1|NOT COMPLETED|Overall Study||0
23992|NCT02815982|54203|P4|COMPLETED|Overall Study||26
23993|NCT02815982|54204|P3|COMPLETED|Overall Study||27
23994|NCT02815982|54205|P2|COMPLETED|Overall Study||26
23995|NCT02815982|54206|P1|COMPLETED|Overall Study||27
23996|NCT02815982|54203|P4|STARTED|Overall Study||26
23997|NCT02815982|54204|P3|STARTED|Overall Study||27
23998|NCT02815982|54205|P2|STARTED|Overall Study||26
23999|NCT02815982|54206|P1|STARTED|Overall Study||27
24000|NCT02815735|54232|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
24001|NCT02815735|54233|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
24002|NCT02815735|54232|P2|COMPLETED|Second Intervention (4 Weeks)||37
24003|NCT02815735|54233|P1|COMPLETED|Second Intervention (4 Weeks)||33
24004|NCT02815735|54232|P2|STARTED|Second Intervention (4 Weeks)||37
24005|NCT02815735|54233|P1|STARTED|Second Intervention (4 Weeks)||34
24006|NCT02815735|54232|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
24007|NCT02815735|54233|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
24008|NCT02815735|54232|P2|COMPLETED|First Intervention (4 Weeks)||37
24009|NCT02815735|54233|P1|COMPLETED|First Intervention (4 Weeks)||34
24010|NCT02815735|54232|P2|STARTED|First Intervention (4 Weeks)||38
24011|NCT02815735|54233|P1|STARTED|First Intervention (4 Weeks)||36
24012|NCT02815644|54250|P2|NOT COMPLETED|Treatment Period 2||0
24013|NCT02815644|54251|P1|NOT COMPLETED|Treatment Period 2||0
24014|NCT02815644|54250|P2|COMPLETED|Treatment Period 2||11
24015|NCT02815644|54251|P1|COMPLETED|Treatment Period 2||11
24016|NCT02815644|54250|P2|STARTED|Treatment Period 2||11
24017|NCT02815644|54251|P1|STARTED|Treatment Period 2||11
24018|NCT02815644|54250|P2|NOT COMPLETED|Treatment Period 1 + Washout||0
24019|NCT02815644|54251|P1|NOT COMPLETED|Treatment Period 1 + Washout||0
24020|NCT02815644|54250|P2|COMPLETED|Treatment Period 1 + Washout||11
24021|NCT02815644|54251|P1|COMPLETED|Treatment Period 1 + Washout||11
24022|NCT02815644|54250|P2|STARTED|Treatment Period 1 + Washout||11
24023|NCT02815644|54251|P1|STARTED|Treatment Period 1 + Washout||11
24024|NCT02815397|54269|P1|NOT COMPLETED|Overall Study||2
24025|NCT02815397|54269|P1|COMPLETED|Overall Study||0
24026|NCT02815397|54269|P1|STARTED|Overall Study||2
24027|NCT02815293|54279|P3|NOT COMPLETED|Overall Study||18
24028|NCT02815293|54280|P2|NOT COMPLETED|Overall Study||8
24029|NCT02815293|54281|P1|NOT COMPLETED|Overall Study||10
24030|NCT02815293|54279|P3|COMPLETED|Overall Study||0
24031|NCT02815293|54280|P2|COMPLETED|Overall Study||0
24032|NCT02815293|54281|P1|COMPLETED|Overall Study||0
24033|NCT02815293|54279|P3|STARTED|Overall Study||18
24034|NCT02815293|54280|P2|STARTED|Overall Study||8
24035|NCT02815293|54281|P1|STARTED|Overall Study||10
24036|NCT02814656|54293|P4|NOT COMPLETED|Overall Study||0
24037|NCT02814656|54294|P3|NOT COMPLETED|Overall Study||0
24038|NCT02814656|54295|P2|NOT COMPLETED|Overall Study||0
24039|NCT02814656|54296|P1|NOT COMPLETED|Overall Study||0
24040|NCT02814656|54293|P4|COMPLETED|Overall Study||6
24041|NCT02814656|54294|P3|COMPLETED|Overall Study||6
24042|NCT02814656|54295|P2|COMPLETED|Overall Study||6
24043|NCT02814656|54296|P1|COMPLETED|Overall Study||6
24044|NCT02814656|54293|P4|STARTED|Overall Study||6
24045|NCT02814656|54294|P3|STARTED|Overall Study||6
24046|NCT02814656|54295|P2|STARTED|Overall Study||6
24047|NCT02814656|54296|P1|STARTED|Overall Study||6
24048|NCT02814643|54396|P2|NOT COMPLETED|Overall Study||3
24049|NCT02814643|54397|P1|NOT COMPLETED|Overall Study||1
24050|NCT02814643|54396|P2|COMPLETED|Overall Study||49
24051|NCT02814643|54397|P1|COMPLETED|Overall Study||50
24052|NCT02814643|54396|P2|STARTED|Overall Study||52
24053|NCT02814643|54397|P1|STARTED|Overall Study||51
24054|NCT02814565|54421|P2|NOT COMPLETED|Overall Study||2
24055|NCT02814565|54422|P1|NOT COMPLETED|Overall Study||1
24056|NCT02814565|54421|P2|COMPLETED|Overall Study||88
24057|NCT02814565|54422|P1|COMPLETED|Overall Study||89
24058|NCT02814565|54421|P2|STARTED|Overall Study||90
24059|NCT02814565|54422|P1|STARTED|Overall Study||90
24060|NCT02814448|54451|P5|NOT COMPLETED|Overall Study||2
24061|NCT02814448|54452|P4|NOT COMPLETED|Overall Study||0
24062|NCT02814448|54453|P3|NOT COMPLETED|Overall Study||1
24063|NCT02814448|54454|P2|NOT COMPLETED|Overall Study||0
24064|NCT02814448|54455|P1|NOT COMPLETED|Overall Study||0
24065|NCT02814448|54451|P5|COMPLETED|Overall Study||26
24066|NCT02814448|54452|P4|COMPLETED|Overall Study||25
24067|NCT02814448|54453|P3|COMPLETED|Overall Study||25
24068|NCT02814448|54454|P2|COMPLETED|Overall Study||24
24069|NCT02814448|54455|P1|COMPLETED|Overall Study||27
24070|NCT02814448|54451|P5|STARTED|Overall Study||28
24071|NCT02814448|54452|P4|STARTED|Overall Study||25
24072|NCT02814448|54453|P3|STARTED|Overall Study||26
24073|NCT02814448|54454|P2|STARTED|Overall Study||24
24074|NCT02814448|54455|P1|STARTED|Overall Study||27
24075|NCT02814279|54474|P2|NOT COMPLETED|Overall Study||0
24076|NCT02814279|54475|P1|NOT COMPLETED|Overall Study||0
24077|NCT02814279|54474|P2|COMPLETED|Overall Study||21
24078|NCT02814279|54475|P1|COMPLETED|Overall Study||21
24079|NCT02814279|54474|P2|STARTED|Overall Study||21
24080|NCT02814279|54475|P1|STARTED|Overall Study||21
24081|NCT02814227|54483|P1|NOT COMPLETED|Overall Study||0
24082|NCT02814227|54483|P1|COMPLETED|Overall Study||52
24083|NCT02814227|54483|P1|STARTED|Overall Study||52
24084|NCT02813694|54492|P2|NOT COMPLETED|Overall Study||14
24085|NCT02813694|54493|P1|NOT COMPLETED|Overall Study||17
24086|NCT02813694|54492|P2|COMPLETED|Overall Study|Completed Study (Late Follow Up Assessment)|354
24087|NCT02813694|54493|P1|COMPLETED|Overall Study||353
24088|NCT02813694|54492|P2|STARTED|Overall Study|Intent to Treat Analysis Set|368
24089|NCT02813694|54493|P1|STARTED|Overall Study|Intent to Treat Analysis Set|370
24090|NCT02813681|54506|P3|NOT COMPLETED|Overall Study||0
24091|NCT02813681|54507|P2|NOT COMPLETED|Overall Study||6
24092|NCT02813681|54508|P1|NOT COMPLETED|Overall Study||5
24093|NCT02813681|54506|P3|COMPLETED|Overall Study||19
24094|NCT02813681|54507|P2|COMPLETED|Overall Study||28
24095|NCT02813681|54508|P1|COMPLETED|Overall Study||22
24096|NCT02813681|54506|P3|STARTED|Overall Study||19
24097|NCT02813681|54507|P2|STARTED|Overall Study||34
24098|NCT02813681|54508|P1|STARTED|Overall Study||27
24099|NCT02813551|54531|P2|NOT COMPLETED|Overall Study||2
24100|NCT02813551|54532|P1|NOT COMPLETED|Overall Study||1
24101|NCT02813551|54531|P2|COMPLETED|Overall Study||57
24102|NCT02813551|54532|P1|COMPLETED|Overall Study||58
24103|NCT02813551|54531|P2|STARTED|Overall Study||59
24104|NCT02813551|54532|P1|STARTED|Overall Study||59
24105|NCT02813473|54558|P1|NOT COMPLETED|Overall Study||0
24106|NCT02813473|54558|P1|COMPLETED|Overall Study||223
24107|NCT02813473|54558|P1|STARTED|Overall Study||223
24108|NCT02813070|54565|P3|NOT COMPLETED|Overall Study||11
24109|NCT02813070|54566|P2|NOT COMPLETED|Overall Study||3
24110|NCT02813070|54567|P1|NOT COMPLETED|Overall Study||3
24111|NCT02813070|54565|P3|COMPLETED|Overall Study||25
24112|NCT02813070|54566|P2|COMPLETED|Overall Study||20
24113|NCT02813070|54567|P1|COMPLETED|Overall Study||25
24114|NCT02813070|54565|P3|Treated (Safety Population)|Overall Study||25
24115|NCT02813070|54566|P2|Treated (Safety Population)|Overall Study||20
24116|NCT02813070|54567|P1|Treated (Safety Population)|Overall Study||25
24117|NCT02813070|54565|P3|STARTED|Overall Study||36
24118|NCT02813070|54566|P2|STARTED|Overall Study||23
24119|NCT02813070|54567|P1|STARTED|Overall Study||28
24120|NCT02812342|54576|P1|NOT COMPLETED|Overall Study||0
24121|NCT02812342|54576|P1|COMPLETED|Overall Study||10
24122|NCT02812342|54576|P1|STARTED|Overall Study||10
24123|NCT02812238|54581|P2|NOT COMPLETED|Second Intervention||1
24124|NCT02812238|54582|P1|NOT COMPLETED|Second Intervention||0
24125|NCT02812238|54581|P2|COMPLETED|Second Intervention||18
24126|NCT02812238|54582|P1|COMPLETED|Second Intervention||18
24127|NCT02812238|54581|P2|STARTED|Second Intervention||19
24128|NCT02812238|54582|P1|STARTED|Second Intervention||18
24129|NCT02812238|54581|P2|NOT COMPLETED|First Intervention||0
24130|NCT02812238|54582|P1|NOT COMPLETED|First Intervention||1
24131|NCT02812238|54581|P2|COMPLETED|First Intervention||19
24132|NCT02812238|54582|P1|COMPLETED|First Intervention||18
24133|NCT02812238|54581|P2|STARTED|First Intervention||19
24134|NCT02812238|54582|P1|STARTED|First Intervention||19
24135|NCT02811965|54588|P1|NOT COMPLETED|Overall Study||0
24136|NCT02811965|54588|P1|COMPLETED|Overall Study||21
24137|NCT02811965|54588|P1|STARTED|Overall Study||21
24138|NCT02811419|54613|P2|NOT COMPLETED|Overall Study||13
24139|NCT02811419|54614|P1|NOT COMPLETED|Overall Study||12
24140|NCT02811419|54613|P2|COMPLETED|Overall Study||358
24141|NCT02811419|54614|P1|COMPLETED|Overall Study||357
24142|NCT02811419|54613|P2|STARTED|Overall Study||371
24143|NCT02811419|54614|P1|STARTED|Overall Study||369
24144|NCT02811302|54622|P1|NOT COMPLETED|Overall Study||213
24145|NCT02811302|54622|P1|COMPLETED|Overall Study||1282
24146|NCT02811302|54622|P1|STARTED|Overall Study||1495
24147|NCT02811159|54627|P1|NOT COMPLETED|Treatment Course 2||0
24148|NCT02811159|54627|P1|COMPLETED|Treatment Course 2||4
24149|NCT02811159|54627|P1|STARTED|Treatment Course 2|Not all participants who completed the Treatment Course 1 entered the Treatment Course 2.|4
24150|NCT02811159|54627|P1|NOT COMPLETED|Treatment Course 1||1
24151|NCT02811159|54627|P1|COMPLETED|Treatment Course 1||19
24152|NCT02811159|54627|P1|STARTED|Treatment Course 1||20
24153|NCT02810873|54644|P2|NOT COMPLETED|Overall Study||0
24154|NCT02810873|54645|P1|NOT COMPLETED|Overall Study||0
24155|NCT02810873|54644|P2|COMPLETED|Overall Study||13
24156|NCT02810873|54645|P1|COMPLETED|Overall Study||6
24157|NCT02810873|54644|P2|STARTED|Overall Study||13
24158|NCT02810873|54645|P1|STARTED|Overall Study||6
24159|NCT02810509|54655|P2|NOT COMPLETED|Overall Study||0
24160|NCT02810509|54656|P1|NOT COMPLETED|Overall Study||0
24161|NCT02810509|54655|P2|COMPLETED|Overall Study||1230
24162|NCT02810509|54656|P1|COMPLETED|Overall Study||584
24163|NCT02810509|54655|P2|STARTED|Overall Study||1230
24164|NCT02810509|54656|P1|STARTED|Overall Study||584
24165|NCT02810327|54666|P2|NOT COMPLETED|Overall Study||7
24166|NCT02810327|54667|P1|NOT COMPLETED|Overall Study||7
24167|NCT02810327|54666|P2|COMPLETED|Overall Study||34
24168|NCT02810327|54667|P1|COMPLETED|Overall Study||69
24169|NCT02810327|54666|P2|STARTED|Overall Study||41
24170|NCT02810327|54667|P1|STARTED|Overall Study||76
24171|NCT02809911|54675|P2|NOT COMPLETED|Overall Study||0
24172|NCT02809911|54676|P1|NOT COMPLETED|Overall Study||0
24173|NCT02809911|54675|P2|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|19
24174|NCT02809911|54676|P1|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|22
24175|NCT02809911|54675|P2|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|19
24176|NCT02809911|54676|P1|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|22
24177|NCT02809859|54684|P1|NOT COMPLETED|Overall Study||14
24178|NCT02809859|54684|P1|COMPLETED|Overall Study||125
24179|NCT02809859|54684|P1|STARTED|Overall Study||139
24180|NCT02809833|54692|P1|NOT COMPLETED|Overall Study||300
24181|NCT02809833|54692|P1|COMPLETED|Overall Study||550
24182|NCT02809833|54692|P1|STARTED|Overall Study||850
24183|NCT02808390|54769|P3|NOT COMPLETED|Overall Study||3
24184|NCT02808390|54770|P2|NOT COMPLETED|Overall Study||6
24185|NCT02808390|54771|P1|NOT COMPLETED|Overall Study||2
24186|NCT02808390|54769|P3|COMPLETED|Overall Study||4
24187|NCT02808390|54770|P2|COMPLETED|Overall Study||2
24188|NCT02808390|54771|P1|COMPLETED|Overall Study||2
24189|NCT02808390|54769|P3|STARTED|Overall Study||7
24190|NCT02808390|54770|P2|STARTED|Overall Study||8
24191|NCT02808390|54771|P1|STARTED|Overall Study||4
24192|NCT02808338|54779|P1|NOT COMPLETED|Take Home Period||0
24193|NCT02808338|54779|P1|COMPLETED|Take Home Period||13
24194|NCT02808338|54779|P1|STARTED|Take Home Period||13
24195|NCT02808338|54779|P1|NOT COMPLETED|Overnight In-lab Polysomonography||2
24196|NCT02808338|54779|P1|COMPLETED|Overnight In-lab Polysomonography||13
24197|NCT02808338|54779|P1|ResMed S9 VPAP Adapt|Overnight In-lab Polysomonography||12
24198|NCT02808338|54779|P1|Philips BiPAP AutoSV Advanced System One|Overnight In-lab Polysomonography||12
24199|NCT02808338|54779|P1|ResMed S7 VPAP Adapt|Overnight In-lab Polysomonography||13
24200|NCT02808338|54779|P1|Modified Philips BiPAP ASV|Overnight In-lab Polysomonography||13
24201|NCT02808338|54779|P1|STARTED|Overnight In-lab Polysomonography||15
24202|NCT02808338|54779|P1|NOT COMPLETED|Screening||10
24203|NCT02808338|54779|P1|COMPLETED|Screening||15
24204|NCT02808338|54779|P1|STARTED|Screening||25
24205|NCT02808130|54796|P6|NOT COMPLETED|Overall Study||0
24206|NCT02808130|54797|P5|NOT COMPLETED|Overall Study||0
24207|NCT02808130|54798|P4|NOT COMPLETED|Overall Study||0
24208|NCT02808130|54799|P3|NOT COMPLETED|Overall Study||0
24209|NCT02808130|54800|P2|NOT COMPLETED|Overall Study||0
24210|NCT02808130|54801|P1|NOT COMPLETED|Overall Study||0
24211|NCT02808130|54796|P6|COMPLETED|Overall Study||15
24212|NCT02808130|54797|P5|COMPLETED|Overall Study||15
24213|NCT02808130|54798|P4|COMPLETED|Overall Study||15
24214|NCT02808130|54799|P3|COMPLETED|Overall Study||15
24215|NCT02808130|54800|P2|COMPLETED|Overall Study||15
24216|NCT02808130|54801|P1|COMPLETED|Overall Study||15
24217|NCT02808130|54796|P6|STARTED|Overall Study||15
24218|NCT02808130|54797|P5|STARTED|Overall Study||15
24219|NCT02808130|54798|P4|STARTED|Overall Study||15
24220|NCT02808130|54799|P3|STARTED|Overall Study||15
24221|NCT02808130|54800|P2|STARTED|Overall Study||15
24222|NCT02808130|54801|P1|STARTED|Overall Study||15
24223|NCT02808052|54830|P3|NOT COMPLETED|Overall Study||0
24224|NCT02808052|54831|P2|NOT COMPLETED|Overall Study||0
24225|NCT02808052|54832|P1|NOT COMPLETED|Overall Study||0
24226|NCT02808052|54830|P3|COMPLETED|Overall Study||2
24227|NCT02808052|54831|P2|COMPLETED|Overall Study||3
24228|NCT02808052|54832|P1|COMPLETED|Overall Study||4
24229|NCT02808052|54830|P3|STARTED|Overall Study||2
24230|NCT02808052|54831|P2|STARTED|Overall Study||3
24231|NCT02808052|54832|P1|STARTED|Overall Study||4
24232|NCT02807948|54840|P2|NOT COMPLETED|Overall Study||0
24233|NCT02807948|54841|P1|NOT COMPLETED|Overall Study||1
24234|NCT02807948|54840|P2|COMPLETED|Overall Study||57
24235|NCT02807948|54841|P1|COMPLETED|Overall Study||131
24236|NCT02807948|54840|P2|STARTED|Overall Study||57
24237|NCT02807948|54841|P1|STARTED|Overall Study||132
24238|NCT02807402|54846|P1|NOT COMPLETED|Overall Study||6
24239|NCT02807402|54846|P1|COMPLETED|Overall Study||516
24240|NCT02807402|54846|P1|STARTED|Overall Study||522
24241|NCT02807376|54884|P2|NOT COMPLETED|Overall Study||1
24242|NCT02807376|54885|P1|NOT COMPLETED|Overall Study||3
24243|NCT02807376|54884|P2|COMPLETED|Overall Study||130
24244|NCT02807376|54885|P1|COMPLETED|Overall Study||136
24245|NCT02807376|54884|P2|STARTED|Overall Study||131
24246|NCT02807376|54885|P1|STARTED|Overall Study||139
24247|NCT02806973|54893|P4|NOT COMPLETED|Period 4||0
24248|NCT02806973|54894|P3|NOT COMPLETED|Period 4||0
24249|NCT02806973|54895|P2|NOT COMPLETED|Period 4||0
24250|NCT02806973|54896|P1|NOT COMPLETED|Period 4||0
24251|NCT02806973|54893|P4|COMPLETED|Period 4||3
24252|NCT02806973|54894|P3|COMPLETED|Period 4||6
24253|NCT02806973|54895|P2|COMPLETED|Period 4||6
24254|NCT02806973|54896|P1|COMPLETED|Period 4||8
24255|NCT02806973|54893|P4|STARTED|Period 4||3
24256|NCT02806973|54894|P3|STARTED|Period 4||6
24257|NCT02806973|54895|P2|STARTED|Period 4||6
24258|NCT02806973|54896|P1|STARTED|Period 4||8
24259|NCT02806973|54893|P4|NOT COMPLETED|Period 3||3
24260|NCT02806973|54894|P3|NOT COMPLETED|Period 3||1
24261|NCT02806973|54895|P2|NOT COMPLETED|Period 3||0
24262|NCT02806973|54896|P1|NOT COMPLETED|Period 3||0
24263|NCT02806973|54893|P4|COMPLETED|Period 3||3
24264|NCT02806973|54894|P3|COMPLETED|Period 3||6
24265|NCT02806973|54895|P2|COMPLETED|Period 3||6
24266|NCT02806973|54896|P1|COMPLETED|Period 3||8
24267|NCT02806973|54893|P4|STARTED|Period 3||6
24268|NCT02806973|54894|P3|STARTED|Period 3||7
24269|NCT02806973|54895|P2|STARTED|Period 3||6
24270|NCT02806973|54896|P1|STARTED|Period 3||8
24271|NCT02806973|54893|P4|NOT COMPLETED|Period 2||0
24272|NCT02806973|54894|P3|NOT COMPLETED|Period 2||0
24273|NCT02806973|54895|P2|NOT COMPLETED|Period 2||0
24274|NCT02806973|54896|P1|NOT COMPLETED|Period 2||0
24275|NCT02806973|54893|P4|COMPLETED|Period 2||6
24276|NCT02806973|54894|P3|COMPLETED|Period 2||7
24277|NCT02806973|54895|P2|COMPLETED|Period 2||6
24278|NCT02806973|54896|P1|COMPLETED|Period 2||8
24279|NCT02806973|54893|P4|STARTED|Period 2||6
24280|NCT02806973|54894|P3|STARTED|Period 2||7
24281|NCT02806973|54895|P2|STARTED|Period 2||6
24282|NCT02806973|54896|P1|STARTED|Period 2||8
24283|NCT02806973|54893|P4|NOT COMPLETED|Period 1||2
24284|NCT02806973|54894|P3|NOT COMPLETED|Period 1||1
24285|NCT02806973|54895|P2|NOT COMPLETED|Period 1||2
24286|NCT02806973|54896|P1|NOT COMPLETED|Period 1||0
24287|NCT02806973|54893|P4|COMPLETED|Period 1||6
24288|NCT02806973|54894|P3|COMPLETED|Period 1||7
24289|NCT02806973|54895|P2|COMPLETED|Period 1||6
24290|NCT02806973|54896|P1|COMPLETED|Period 1||8
24291|NCT02806973|54893|P4|STARTED|Period 1||8
24292|NCT02806973|54894|P3|STARTED|Period 1||8
24293|NCT02806973|54895|P2|STARTED|Period 1||8
24294|NCT02806973|54896|P1|STARTED|Period 1||8
24295|NCT02806869|54932|P2|NOT COMPLETED|Second Intervention (1 Day)||2
24296|NCT02806869|54933|P1|NOT COMPLETED|Second Intervention (1 Day)||0
24297|NCT02806869|54932|P2|COMPLETED|Second Intervention (1 Day)||5
24298|NCT02806869|54933|P1|COMPLETED|Second Intervention (1 Day)||7
24299|NCT02806869|54932|P2|STARTED|Second Intervention (1 Day)||7
24300|NCT02806869|54933|P1|STARTED|Second Intervention (1 Day)||7
24301|NCT02806869|54932|P2|NOT COMPLETED|Washout (7 Days)||0
24302|NCT02806869|54933|P1|NOT COMPLETED|Washout (7 Days)||0
24303|NCT02806869|54932|P2|COMPLETED|Washout (7 Days)||7
24304|NCT02806869|54933|P1|COMPLETED|Washout (7 Days)||7
24305|NCT02806869|54932|P2|STARTED|Washout (7 Days)||7
24306|NCT02806869|54933|P1|STARTED|Washout (7 Days)||7
24307|NCT02806869|54932|P2|NOT COMPLETED|First Intervention (1 Day)||12
24308|NCT02806869|54933|P1|NOT COMPLETED|First Intervention (1 Day)||11
24309|NCT02806869|54932|P2|COMPLETED|First Intervention (1 Day)||12
24310|NCT02806869|54933|P1|COMPLETED|First Intervention (1 Day)||13
24311|NCT02806869|54932|P2|STARTED|First Intervention (1 Day)||24
24312|NCT02806869|54933|P1|STARTED|First Intervention (1 Day)||24
24313|NCT02806726|54943|P1|NOT COMPLETED|Overall Study||1
24314|NCT02806726|54943|P1|COMPLETED|Overall Study|Subjects were treated contralaterally|6
24315|NCT02806726|54943|P1|STARTED|Overall Study|Subjects were treated contralaterally|7
24316|NCT02806713|54952|P2|NOT COMPLETED|Overall Study||2
24317|NCT02806713|54953|P1|NOT COMPLETED|Overall Study||2
24318|NCT02806713|54952|P2|COMPLETED|Overall Study||44
24319|NCT02806713|54953|P1|COMPLETED|Overall Study||44
24320|NCT02806713|54952|P2|STARTED|Overall Study||46
24321|NCT02806713|54953|P1|STARTED|Overall Study||46
24322|NCT02806544|54961|P1|NOT COMPLETED|Overall Study||4
24323|NCT02806544|54961|P1|COMPLETED|Overall Study||31
24324|NCT02806544|54961|P1|STARTED|Overall Study||35
24325|NCT02806505|54972|P2|NOT COMPLETED|Overall Study||11
24326|NCT02806505|54973|P1|NOT COMPLETED|Overall Study||10
24327|NCT02806505|54972|P2|COMPLETED|Overall Study||32
24328|NCT02806505|54973|P1|COMPLETED|Overall Study||28
24329|NCT02806505|54972|P2|STARTED|Overall Study||43
24330|NCT02806505|54973|P1|STARTED|Overall Study||38
24331|NCT02806232|54992|P9|NOT COMPLETED|Overall Study||0
24332|NCT02806232|54993|P8|NOT COMPLETED|Overall Study||0
24333|NCT02806232|54994|P7|NOT COMPLETED|Overall Study||0
24334|NCT02806232|54995|P6|NOT COMPLETED|Overall Study||2
24335|NCT02806232|54996|P5|NOT COMPLETED|Overall Study||2
24336|NCT02806232|54997|P4|NOT COMPLETED|Overall Study||0
24337|NCT02806232|54998|P3|NOT COMPLETED|Overall Study||1
24338|NCT02806232|54999|P2|NOT COMPLETED|Overall Study||4
24339|NCT02806232|55000|P1|NOT COMPLETED|Overall Study||1
24340|NCT02806232|54992|P9|COMPLETED|Overall Study||4
24341|NCT02806232|54993|P8|COMPLETED|Overall Study||20
24342|NCT02806232|54994|P7|COMPLETED|Overall Study||60
24343|NCT02806232|54995|P6|COMPLETED|Overall Study||58
24344|NCT02806232|54996|P5|COMPLETED|Overall Study||58
24345|NCT02806232|54997|P4|COMPLETED|Overall Study||60
24346|NCT02806232|54998|P3|COMPLETED|Overall Study||59
24347|NCT02806232|54999|P2|COMPLETED|Overall Study||56
24348|NCT02806232|55000|P1|COMPLETED|Overall Study||59
24349|NCT02806232|54992|P9|STARTED|Overall Study||4
24350|NCT02806232|54993|P8|STARTED|Overall Study||20
24351|NCT02806232|54994|P7|STARTED|Overall Study||60
24352|NCT02806232|54995|P6|STARTED|Overall Study||60
24353|NCT02806232|54996|P5|STARTED|Overall Study||60
24354|NCT02806232|54997|P4|STARTED|Overall Study||60
24355|NCT02806232|54998|P3|STARTED|Overall Study||60
24356|NCT02806232|54999|P2|STARTED|Overall Study||60
24357|NCT02806232|55000|P1|STARTED|Overall Study||60
24358|NCT02805907|55040|P2|NOT COMPLETED|Overall Study||3
24359|NCT02805907|55041|P1|NOT COMPLETED|Overall Study||3
24360|NCT02805907|55040|P2|COMPLETED|Overall Study||53
24361|NCT02805907|55041|P1|COMPLETED|Overall Study||53
24362|NCT02805907|55040|P2|STARTED|Overall Study||56
24363|NCT02805907|55041|P1|STARTED|Overall Study||56
24364|NCT02805647|55055|P2|NOT COMPLETED|Overall Study||0
24365|NCT02805647|55056|P1|NOT COMPLETED|Overall Study||0
24366|NCT02805647|55055|P2|COMPLETED|Overall Study|after laboratory tests|122
24367|NCT02805647|55056|P1|COMPLETED|Overall Study|after laboratory tests|100
24368|NCT02805647|55055|P2|STARTED|Overall Study|at the moment of submision|122
24369|NCT02805647|55056|P1|STARTED|Overall Study|at the moment of submision|100
24370|NCT02804750|55064|P2|NOT COMPLETED|Period 4||5
24371|NCT02804750|55065|P1|NOT COMPLETED|Period 4||0
24372|NCT02804750|55064|P2|COMPLETED|Period 4||7
24373|NCT02804750|55065|P1|COMPLETED|Period 4||0
24374|NCT02804750|55064|P2|STARTED|Period 4|One participant completed Period 3 but did not start Period 4 due to a pre-scheduled surgery.|12
24375|NCT02804750|55065|P1|STARTED|Period 4|Per-protocol, Group 1 did not participate in Period 4.|0
24376|NCT02804750|55064|P2|NOT COMPLETED|Period 3||2
24377|NCT02804750|55065|P1|NOT COMPLETED|Period 3||0
24378|NCT02804750|55064|P2|COMPLETED|Period 3||13
24379|NCT02804750|55065|P1|COMPLETED|Period 3||16
24380|NCT02804750|55064|P2|STARTED|Period 3||15
24381|NCT02804750|55065|P1|STARTED|Period 3||16
24382|NCT02804750|55064|P2|NOT COMPLETED|Period 2||0
24383|NCT02804750|55065|P1|NOT COMPLETED|Period 2||1
24384|NCT02804750|55064|P2|COMPLETED|Period 2||15
24385|NCT02804750|55065|P1|COMPLETED|Period 2||16
24386|NCT02804750|55064|P2|STARTED|Period 2||15
24387|NCT02804750|55065|P1|STARTED|Period 2||17
24388|NCT02804750|55064|P2|NOT COMPLETED|Period 1||3
24389|NCT02804750|55065|P1|NOT COMPLETED|Period 1||0
24390|NCT02804750|55064|P2|COMPLETED|Period 1||15
24391|NCT02804750|55065|P1|COMPLETED|Period 1||17
24392|NCT02804750|55064|P2|STARTED|Period 1||18
24393|NCT02804750|55065|P1|STARTED|Period 1||17
24394|NCT02804399|55079|P2|NOT COMPLETED|Period 2||1
24395|NCT02804399|55080|P1|NOT COMPLETED|Period 2||0
24396|NCT02804399|55079|P2|COMPLETED|Period 2||11
24397|NCT02804399|55080|P1|COMPLETED|Period 2||0
24398|NCT02804399|55079|P2|STARTED|Period 2||12
24399|NCT02804399|55080|P1|STARTED|Period 2||0
24400|NCT02804399|55079|P2|NOT COMPLETED|Washout Period at Least 10 Days||0
24401|NCT02804399|55080|P1|NOT COMPLETED|Washout Period at Least 10 Days||0
24402|NCT02804399|55079|P2|COMPLETED|Washout Period at Least 10 Days||0
24403|NCT02804399|55080|P1|COMPLETED|Washout Period at Least 10 Days||12
24404|NCT02804399|55079|P2|STARTED|Washout Period at Least 10 Days||0
24405|NCT02804399|55080|P1|STARTED|Washout Period at Least 10 Days||12
24406|NCT02804399|55079|P2|NOT COMPLETED|Period 1||0
24407|NCT02804399|55080|P1|NOT COMPLETED|Period 1||0
24408|NCT02804399|55079|P2|COMPLETED|Period 1||0
24409|NCT02804399|55080|P1|COMPLETED|Period 1||12
24410|NCT02804399|55079|P2|STARTED|Period 1||0
24411|NCT02804399|55080|P1|STARTED|Period 1||12
24412|NCT02803580|55129|P1|NOT COMPLETED|Overall Study||36
24413|NCT02803580|55129|P1|COMPLETED|Overall Study||173
24414|NCT02803580|55129|P1|STARTED|Overall Study||209
24415|NCT02803138|55168|P1|NOT COMPLETED|Overall Study||70
24416|NCT02803138|55168|P1|COMPLETED|Overall Study||166
24417|NCT02803138|55168|P1|STARTED|Overall Study||236
24418|NCT02802878|55184|P2|NOT COMPLETED|Overall Study||3
24419|NCT02802878|55185|P1|NOT COMPLETED|Overall Study||4
24420|NCT02802878|55184|P2|COMPLETED|Overall Study||18
24421|NCT02802878|55185|P1|COMPLETED|Overall Study||17
24422|NCT02802878|55184|P2|STARTED|Overall Study||21
24423|NCT02802878|55185|P1|STARTED|Overall Study||21
24424|NCT02802865|55201|P2|NOT COMPLETED|Overall Study||2
24425|NCT02802865|55202|P1|NOT COMPLETED|Overall Study||1
24426|NCT02802865|55201|P2|COMPLETED|Overall Study||33
24427|NCT02802865|55202|P1|COMPLETED|Overall Study||34
24428|NCT02802865|55201|P2|STARTED|Overall Study||35
24429|NCT02802865|55202|P1|STARTED|Overall Study||35
24430|NCT02802592|55224|P1|NOT COMPLETED|Overall Study||4
24431|NCT02802592|55224|P1|COMPLETED|Overall Study||0
24432|NCT02802592|55224|P1|STARTED|Overall Study||4
24433|NCT02802449|55237|P2|NOT COMPLETED|Overall Study||17
24434|NCT02802449|55238|P1|NOT COMPLETED|Overall Study||9
24435|NCT02802449|55237|P2|COMPLETED|Overall Study||202
24436|NCT02802449|55238|P1|COMPLETED|Overall Study||102
24437|NCT02802449|55237|P2|STARTED|Overall Study||219
24438|NCT02802449|55238|P1|STARTED|Overall Study||111
24439|NCT02802345|55256|P2|NOT COMPLETED|Overall Study||30
24440|NCT02802345|55257|P1|NOT COMPLETED|Overall Study||32
24441|NCT02802345|55256|P2|COMPLETED|Overall Study||108
24442|NCT02802345|55257|P1|COMPLETED|Overall Study||104
24443|NCT02802345|55256|P2|Treated|Overall Study||137
24444|NCT02802345|55257|P1|Treated|Overall Study||136
24445|NCT02802345|55256|P2|STARTED|Overall Study||138
24446|NCT02802345|55257|P1|STARTED|Overall Study||136
24447|NCT02802319|55273|P2|NOT COMPLETED|Overall Study||5
24448|NCT02802319|55274|P1|NOT COMPLETED|Overall Study||2
24449|NCT02802319|55273|P2|COMPLETED|Overall Study||17
24450|NCT02802319|55274|P1|COMPLETED|Overall Study||20
24451|NCT02802319|55273|P2|STARTED|Overall Study||22
24452|NCT02802319|55274|P1|STARTED|Overall Study||22
24453|NCT02801942|55284|P2|NOT COMPLETED|Overall Study||0
24454|NCT02801942|55285|P1|NOT COMPLETED|Overall Study||0
24455|NCT02801942|55284|P2|COMPLETED|Overall Study||10
24456|NCT02801942|55285|P1|COMPLETED|Overall Study||12
24457|NCT02801942|55284|P2|STARTED|Overall Study||10
24458|NCT02801942|55285|P1|STARTED|Overall Study||12
24459|NCT02801877|55409|P4|NOT COMPLETED|Overall Study||0
24460|NCT02801877|55410|P3|NOT COMPLETED|Overall Study||6
24461|NCT02801877|55411|P2|NOT COMPLETED|Overall Study||1
24462|NCT02801877|55412|P1|NOT COMPLETED|Overall Study||3
24463|NCT02801877|55409|P4|COMPLETED|Overall Study||76
24464|NCT02801877|55410|P3|COMPLETED|Overall Study||70
24465|NCT02801877|55411|P2|COMPLETED|Overall Study||74
24466|NCT02801877|55412|P1|COMPLETED|Overall Study||71
24467|NCT02801877|55409|P4|STARTED|Overall Study||76
24468|NCT02801877|55410|P3|STARTED|Overall Study||76
24469|NCT02801877|55411|P2|STARTED|Overall Study||75
24470|NCT02801877|55412|P1|STARTED|Overall Study||74
24471|NCT02801617|55432|P2|NOT COMPLETED|Overall Study||6
24472|NCT02801617|55433|P1|NOT COMPLETED|Overall Study||2
24473|NCT02801617|55432|P2|COMPLETED|Overall Study||50
24474|NCT02801617|55433|P1|COMPLETED|Overall Study||49
24475|NCT02801617|55432|P2|STARTED|Overall Study||56
24476|NCT02801617|55433|P1|STARTED|Overall Study||51
24477|NCT02801396|55451|P6|NOT COMPLETED|Period 3||0
24478|NCT02801396|55452|P5|NOT COMPLETED|Period 3||0
24479|NCT02801396|55453|P4|NOT COMPLETED|Period 3||0
24480|NCT02801396|55454|P3|NOT COMPLETED|Period 3||0
24481|NCT02801396|55455|P2|NOT COMPLETED|Period 3||0
24482|NCT02801396|55456|P1|NOT COMPLETED|Period 3||0
24483|NCT02801396|55451|P6|COMPLETED|Period 3||17
24484|NCT02801396|55452|P5|COMPLETED|Period 3||16
24485|NCT02801396|55453|P4|COMPLETED|Period 3||16
24486|NCT02801396|55454|P3|COMPLETED|Period 3||17
24487|NCT02801396|55455|P2|COMPLETED|Period 3||17
24488|NCT02801396|55456|P1|COMPLETED|Period 3||17
24489|NCT02801396|55451|P6|STARTED|Period 3||17
24490|NCT02801396|55452|P5|STARTED|Period 3||16
24491|NCT02801396|55453|P4|STARTED|Period 3||16
24492|NCT02801396|55454|P3|STARTED|Period 3||17
24493|NCT02801396|55455|P2|STARTED|Period 3||17
24494|NCT02801396|55456|P1|STARTED|Period 3||17
24495|NCT02801396|55451|P6|NOT COMPLETED|Period 2||0
24496|NCT02801396|55452|P5|NOT COMPLETED|Period 2||0
24497|NCT02801396|55453|P4|NOT COMPLETED|Period 2||0
24498|NCT02801396|55454|P3|NOT COMPLETED|Period 2||0
24499|NCT02801396|55455|P2|NOT COMPLETED|Period 2||0
24500|NCT02801396|55456|P1|NOT COMPLETED|Period 2||0
24501|NCT02801396|55451|P6|COMPLETED|Period 2||17
24502|NCT02801396|55452|P5|COMPLETED|Period 2||16
24503|NCT02801396|55453|P4|COMPLETED|Period 2||16
24504|NCT02801396|55454|P3|COMPLETED|Period 2||17
24505|NCT02801396|55455|P2|COMPLETED|Period 2||17
24506|NCT02801396|55456|P1|COMPLETED|Period 2||17
24507|NCT02801396|55451|P6|STARTED|Period 2||17
24508|NCT02801396|55452|P5|STARTED|Period 2||16
24509|NCT02801396|55453|P4|STARTED|Period 2||16
24510|NCT02801396|55454|P3|STARTED|Period 2||17
24511|NCT02801396|55455|P2|STARTED|Period 2||17
24512|NCT02801396|55456|P1|STARTED|Period 2||17
24513|NCT02801396|55451|P6|NOT COMPLETED|Period 1||0
24514|NCT02801396|55452|P5|NOT COMPLETED|Period 1||1
24515|NCT02801396|55453|P4|NOT COMPLETED|Period 1||0
24516|NCT02801396|55454|P3|NOT COMPLETED|Period 1||0
24517|NCT02801396|55455|P2|NOT COMPLETED|Period 1||0
24518|NCT02801396|55456|P1|NOT COMPLETED|Period 1||0
24519|NCT02801396|55451|P6|COMPLETED|Period 1||17
24520|NCT02801396|55452|P5|COMPLETED|Period 1||16
24521|NCT02801396|55453|P4|COMPLETED|Period 1||16
24522|NCT02801396|55454|P3|COMPLETED|Period 1||17
24523|NCT02801396|55455|P2|COMPLETED|Period 1||17
24524|NCT02801396|55456|P1|COMPLETED|Period 1||17
24525|NCT02801396|55451|P6|STARTED|Period 1||17
24526|NCT02801396|55452|P5|STARTED|Period 1||17
24527|NCT02801396|55453|P4|STARTED|Period 1||16
24528|NCT02801396|55454|P3|STARTED|Period 1||17
24529|NCT02801396|55455|P2|STARTED|Period 1||17
24530|NCT02801396|55456|P1|STARTED|Period 1||17
24531|NCT02801006|55473|P2|NOT COMPLETED|Lens 2||0
24532|NCT02801006|55474|P1|NOT COMPLETED|Lens 2||0
24533|NCT02801006|55473|P2|COMPLETED|Lens 2||19
24534|NCT02801006|55474|P1|COMPLETED|Lens 2||22
24535|NCT02801006|55473|P2|STARTED|Lens 2||19
24536|NCT02801006|55474|P1|STARTED|Lens 2||22
24537|NCT02801006|55473|P2|NOT COMPLETED|Lens 1||0
24538|NCT02801006|55474|P1|NOT COMPLETED|Lens 1||0
24539|NCT02801006|55473|P2|COMPLETED|Lens 1||19
24540|NCT02801006|55474|P1|COMPLETED|Lens 1||22
24541|NCT02801006|55473|P2|STARTED|Lens 1||19
24542|NCT02801006|55474|P1|STARTED|Lens 1||22
24543|NCT02800928|55490|P2|NOT COMPLETED|Overall Study||2
24544|NCT02800928|55491|P1|NOT COMPLETED|Overall Study||2
24545|NCT02800928|55490|P2|COMPLETED|Overall Study||6
24546|NCT02800928|55491|P1|COMPLETED|Overall Study||7
24547|NCT02800928|55490|P2|STARTED|Overall Study||8
24548|NCT02800928|55491|P1|STARTED|Overall Study||9
24549|NCT02800213|55501|P2|NOT COMPLETED|Second Intervention||0
24550|NCT02800213|55502|P1|NOT COMPLETED|Second Intervention||0
24551|NCT02800213|55501|P2|COMPLETED|Second Intervention||35
24552|NCT02800213|55502|P1|COMPLETED|Second Intervention||35
24553|NCT02800213|55501|P2|STARTED|Second Intervention||35
24554|NCT02800213|55502|P1|STARTED|Second Intervention||35
24555|NCT02800213|55501|P2|NOT COMPLETED|First Intervention||0
24556|NCT02800213|55502|P1|NOT COMPLETED|First Intervention||0
24557|NCT02800213|55501|P2|COMPLETED|First Intervention||35
24558|NCT02800213|55502|P1|COMPLETED|First Intervention||35
24559|NCT02800213|55501|P2|STARTED|First Intervention||35
24560|NCT02800213|55502|P1|STARTED|First Intervention||35
24561|NCT02799784|55508|P2|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||3
24562|NCT02799784|55509|P1|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||1
24563|NCT02799784|55508|P2|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||115
24564|NCT02799784|55509|P1|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||110
24565|NCT02799784|55508|P2|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||118
24566|NCT02799784|55509|P1|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||111
24567|NCT02799784|55508|P2|NOT COMPLETED|Washout Period (3 Weeks)||0
24568|NCT02799784|55509|P1|NOT COMPLETED|Washout Period (3 Weeks)||0
24569|NCT02799784|55508|P2|COMPLETED|Washout Period (3 Weeks)||118
24570|NCT02799784|55509|P1|COMPLETED|Washout Period (3 Weeks)||111
24571|NCT02799784|55508|P2|STARTED|Washout Period (3 Weeks)||118
24572|NCT02799784|55509|P1|STARTED|Washout Period (3 Weeks)||111
24573|NCT02799784|55508|P2|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||1
24574|NCT02799784|55509|P1|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||6
24575|NCT02799784|55508|P2|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||118
24576|NCT02799784|55509|P1|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||111
24577|NCT02799784|55508|P2|STARTED|Treatment Period 1 (TP1- 8 Weeks)||119
24578|NCT02799784|55509|P1|STARTED|Treatment Period 1 (TP1- 8 Weeks)||117
24579|NCT02799472|55517|P2|NOT COMPLETED|Overall Study||5
24580|NCT02799472|55518|P1|NOT COMPLETED|Overall Study||4
24581|NCT02799472|55517|P2|COMPLETED|Overall Study||23
24582|NCT02799472|55518|P1|COMPLETED|Overall Study||7
24583|NCT02799472|55517|P2|STARTED|Overall Study||28
24584|NCT02799472|55518|P1|STARTED|Overall Study||11
24585|NCT02799082|55578|P2|NOT COMPLETED|Overall Study||4
24586|NCT02799082|55579|P1|NOT COMPLETED|Overall Study||4
24587|NCT02799082|55578|P2|COMPLETED|Overall Study||77
24588|NCT02799082|55579|P1|COMPLETED|Overall Study||37
24589|NCT02799082|55578|P2|STARTED|Overall Study||81
24590|NCT02799082|55579|P1|STARTED|Overall Study||41
24591|NCT02799069|55616|P3|NOT COMPLETED|Overall Study||7
24592|NCT02799069|55617|P2|NOT COMPLETED|Overall Study||7
24593|NCT02799069|55618|P1|NOT COMPLETED|Overall Study||8
24594|NCT02799069|55616|P3|COMPLETED|Overall Study||240
24595|NCT02799069|55617|P2|COMPLETED|Overall Study||241
24596|NCT02799069|55618|P1|COMPLETED|Overall Study||68
24597|NCT02799069|55616|P3|ITT/Safety|Overall Study|1 subject received medication without Illumination and thus was excluded from ITT/safety population|246
24598|NCT02799069|55617|P2|ITT/Safety|Overall Study||248
24599|NCT02799069|55618|P1|ITT/Safety|Overall Study||76
24600|NCT02799069|55616|P3|STARTED|Overall Study||247
24601|NCT02799069|55617|P2|STARTED|Overall Study||248
24602|NCT02799069|55618|P1|STARTED|Overall Study||76
24603|NCT02798978|55735|P7|NOT COMPLETED|Part 2 (45 Days)||0
24604|NCT02798978|55736|P6|NOT COMPLETED|Part 2 (45 Days)||0
24605|NCT02798978|55737|P5|NOT COMPLETED|Part 2 (45 Days)||0
24606|NCT02798978|55738|P4|NOT COMPLETED|Part 2 (45 Days)||0
24607|NCT02798978|55739|P3|NOT COMPLETED|Part 2 (45 Days)||0
24608|NCT02798978|55740|P2|NOT COMPLETED|Part 2 (45 Days)||0
24609|NCT02798978|55741|P1|NOT COMPLETED|Part 2 (45 Days)||0
24610|NCT02798978|55735|P7|COMPLETED|Part 2 (45 Days)||0
24611|NCT02798978|55736|P6|COMPLETED|Part 2 (45 Days)||0
24612|NCT02798978|55737|P5|COMPLETED|Part 2 (45 Days)||0
24613|NCT02798978|55738|P4|COMPLETED|Part 2 (45 Days)||0
24614|NCT02798978|55739|P3|COMPLETED|Part 2 (45 Days)||0
24615|NCT02798978|55740|P2|COMPLETED|Part 2 (45 Days)||0
24616|NCT02798978|55741|P1|COMPLETED|Part 2 (45 Days)||0
24617|NCT02798978|55735|P7|STARTED|Part 2 (45 Days)||0
24618|NCT02798978|55736|P6|STARTED|Part 2 (45 Days)||0
24619|NCT02798978|55737|P5|STARTED|Part 2 (45 Days)||0
24620|NCT02798978|55738|P4|STARTED|Part 2 (45 Days)||0
24621|NCT02798978|55739|P3|STARTED|Part 2 (45 Days)||0
24622|NCT02798978|55740|P2|STARTED|Part 2 (45 Days)||0
24623|NCT02798978|55741|P1|STARTED|Part 2 (45 Days)||0
24624|NCT02798978|55735|P7|NOT COMPLETED|Part 1 (30 Days)||0
24625|NCT02798978|55736|P6|NOT COMPLETED|Part 1 (30 Days)||0
24626|NCT02798978|55737|P5|NOT COMPLETED|Part 1 (30 Days)||0
24627|NCT02798978|55738|P4|NOT COMPLETED|Part 1 (30 Days)||0
24628|NCT02798978|55739|P3|NOT COMPLETED|Part 1 (30 Days)||0
24629|NCT02798978|55740|P2|NOT COMPLETED|Part 1 (30 Days)||0
24630|NCT02798978|55741|P1|NOT COMPLETED|Part 1 (30 Days)||0
24631|NCT02798978|55735|P7|COMPLETED|Part 1 (30 Days)||0
24632|NCT02798978|55736|P6|COMPLETED|Part 1 (30 Days)||6
24633|NCT02798978|55737|P5|COMPLETED|Part 1 (30 Days)||6
24634|NCT02798978|55738|P4|COMPLETED|Part 1 (30 Days)||6
24635|NCT02798978|55739|P3|COMPLETED|Part 1 (30 Days)||6
24636|NCT02798978|55740|P2|COMPLETED|Part 1 (30 Days)||6
24637|NCT02798978|55741|P1|COMPLETED|Part 1 (30 Days)||10
24638|NCT02798978|55735|P7|STARTED|Part 1 (30 Days)||0
24639|NCT02798978|55736|P6|STARTED|Part 1 (30 Days)||6
24640|NCT02798978|55737|P5|STARTED|Part 1 (30 Days)||6
24641|NCT02798978|55738|P4|STARTED|Part 1 (30 Days)||6
24642|NCT02798978|55739|P3|STARTED|Part 1 (30 Days)||6
24643|NCT02798978|55740|P2|STARTED|Part 1 (30 Days)||6
24644|NCT02798978|55741|P1|STARTED|Part 1 (30 Days)||10
24645|NCT02798952|55944|P1|NOT COMPLETED|Overall Study||0
24646|NCT02798952|55944|P1|COMPLETED|Overall Study||302
24647|NCT02798952|55944|P1|STARTED|Overall Study||302
24648|NCT02798380|55956|P1|NOT COMPLETED|Overall Study||0
24649|NCT02798380|55956|P1|COMPLETED|Overall Study||30
24650|NCT02798380|55956|P1|STARTED|Overall Study||30
24651|NCT02798315|55960|P1|NOT COMPLETED|Overall Study||1
24652|NCT02798315|55960|P1|COMPLETED|Overall Study||39
24653|NCT02798315|55960|P1|STARTED|Overall Study||40
24654|NCT02798289|55974|P1|NOT COMPLETED|Overall Study||0
24655|NCT02798289|55974|P1|COMPLETED|Overall Study||55
24656|NCT02798289|55974|P1|STARTED|Overall Study||55
24657|NCT02797821|55981|P3|NOT COMPLETED|Overall Study||0
24658|NCT02797821|55982|P2|NOT COMPLETED|Overall Study||0
24659|NCT02797821|55983|P1|NOT COMPLETED|Overall Study||0
24660|NCT02797821|55981|P3|COMPLETED|Overall Study||9
24661|NCT02797821|55982|P2|COMPLETED|Overall Study||10
24662|NCT02797821|55983|P1|COMPLETED|Overall Study||8
24663|NCT02797821|55981|P3|Received at Least 1 Dose of Study Drug|Overall Study||9
24664|NCT02797821|55982|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
24665|NCT02797821|55983|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
24666|NCT02797821|55981|P3|STARTED|Overall Study||9
24667|NCT02797821|55982|P2|STARTED|Overall Study||10
24668|NCT02797821|55983|P1|STARTED|Overall Study||8
24669|NCT02797678|55994|P4|NOT COMPLETED|Sub-Study||0
24670|NCT02797678|55995|P3|NOT COMPLETED|Sub-Study||0
24671|NCT02797678|55996|P2|NOT COMPLETED|Sub-Study||0
24672|NCT02797678|55997|P1|NOT COMPLETED|Sub-Study||0
24673|NCT02797678|55994|P4|COMPLETED|Sub-Study||9
24674|NCT02797678|55995|P3|COMPLETED|Sub-Study||0
24675|NCT02797678|55996|P2|COMPLETED|Sub-Study||0
24676|NCT02797678|55997|P1|COMPLETED|Sub-Study||0
24677|NCT02797678|55994|P4|STARTED|Sub-Study||9
24678|NCT02797678|55995|P3|STARTED|Sub-Study||0
24679|NCT02797678|55996|P2|STARTED|Sub-Study||0
24680|NCT02797678|55997|P1|STARTED|Sub-Study||0
24681|NCT02797678|55994|P4|NOT COMPLETED|Second Intervention (5 Nights)||0
24682|NCT02797678|55995|P3|NOT COMPLETED|Second Intervention (5 Nights)||1
24683|NCT02797678|55996|P2|NOT COMPLETED|Second Intervention (5 Nights)||0
24684|NCT02797678|55997|P1|NOT COMPLETED|Second Intervention (5 Nights)||0
24685|NCT02797678|55994|P4|COMPLETED|Second Intervention (5 Nights)||0
24686|NCT02797678|55995|P3|COMPLETED|Second Intervention (5 Nights)||16
24687|NCT02797678|55996|P2|COMPLETED|Second Intervention (5 Nights)||19
24688|NCT02797678|55997|P1|COMPLETED|Second Intervention (5 Nights)||0
24689|NCT02797678|55994|P4|STARTED|Second Intervention (5 Nights)||0
24690|NCT02797678|55995|P3|STARTED|Second Intervention (5 Nights)||17
24691|NCT02797678|55996|P2|STARTED|Second Intervention (5 Nights)||19
24692|NCT02797678|55997|P1|STARTED|Second Intervention (5 Nights)||0
24693|NCT02797678|55994|P4|NOT COMPLETED|Washout||0
24694|NCT02797678|55995|P3|NOT COMPLETED|Washout||0
24695|NCT02797678|55996|P2|NOT COMPLETED|Washout||0
24696|NCT02797678|55997|P1|NOT COMPLETED|Washout||0
24697|NCT02797678|55994|P4|COMPLETED|Washout||0
24698|NCT02797678|55995|P3|COMPLETED|Washout||17
24699|NCT02797678|55996|P2|COMPLETED|Washout||19
24700|NCT02797678|55997|P1|COMPLETED|Washout||0
24701|NCT02797678|55994|P4|STARTED|Washout||0
24702|NCT02797678|55995|P3|STARTED|Washout||17
24703|NCT02797678|55996|P2|STARTED|Washout||19
24704|NCT02797678|55997|P1|STARTED|Washout||0
24705|NCT02797678|55994|P4|NOT COMPLETED|First Intervention (5 Nights)||0
24706|NCT02797678|55995|P3|NOT COMPLETED|First Intervention (5 Nights)||0
24707|NCT02797678|55996|P2|NOT COMPLETED|First Intervention (5 Nights)||1
24708|NCT02797678|55997|P1|NOT COMPLETED|First Intervention (5 Nights)||0
24709|NCT02797678|55994|P4|COMPLETED|First Intervention (5 Nights)||0
24710|NCT02797678|55995|P3|COMPLETED|First Intervention (5 Nights)||17
24711|NCT02797678|55996|P2|COMPLETED|First Intervention (5 Nights)||19
24712|NCT02797678|55997|P1|COMPLETED|First Intervention (5 Nights)||0
24713|NCT02797678|55994|P4|STARTED|First Intervention (5 Nights)||0
24714|NCT02797678|55995|P3|STARTED|First Intervention (5 Nights)||17
24715|NCT02797678|55996|P2|STARTED|First Intervention (5 Nights)||20
24716|NCT02797678|55997|P1|STARTED|First Intervention (5 Nights)||0
24717|NCT02797678|55994|P4|NOT COMPLETED|Screening Phase||0
24718|NCT02797678|55995|P3|NOT COMPLETED|Screening Phase||0
24719|NCT02797678|55996|P2|NOT COMPLETED|Screening Phase||0
24720|NCT02797678|55997|P1|NOT COMPLETED|Screening Phase||25
24721|NCT02797678|55994|P4|COMPLETED|Screening Phase||0
24722|NCT02797678|55995|P3|COMPLETED|Screening Phase||0
24723|NCT02797678|55996|P2|COMPLETED|Screening Phase||0
24724|NCT02797678|55997|P1|COMPLETED|Screening Phase||37
24725|NCT02797678|55994|P4|STARTED|Screening Phase||0
24726|NCT02797678|55995|P3|STARTED|Screening Phase||0
24727|NCT02797678|55996|P2|STARTED|Screening Phase||0
24728|NCT02797678|55997|P1|STARTED|Screening Phase||62
24729|NCT02797522|56023|P11|NOT COMPLETED|Overall Study||1
24730|NCT02797522|56024|P10|NOT COMPLETED|Overall Study||4
24731|NCT02797522|56025|P9|NOT COMPLETED|Overall Study||2
24732|NCT02797522|56026|P8|NOT COMPLETED|Overall Study||4
24733|NCT02797522|56027|P7|NOT COMPLETED|Overall Study||0
24734|NCT02797522|56028|P6|NOT COMPLETED|Overall Study||0
24735|NCT02797522|56029|P5|NOT COMPLETED|Overall Study||0
24736|NCT02797522|56030|P4|NOT COMPLETED|Overall Study||0
24737|NCT02797522|56031|P3|NOT COMPLETED|Overall Study||0
24738|NCT02797522|56032|P2|NOT COMPLETED|Overall Study||0
24739|NCT02797522|56033|P1|NOT COMPLETED|Overall Study||0
24740|NCT02797522|56023|P11|COMPLETED|Overall Study||0
24741|NCT02797522|56024|P10|COMPLETED|Overall Study||0
24742|NCT02797522|56025|P9|COMPLETED|Overall Study||0
24743|NCT02797522|56026|P8|COMPLETED|Overall Study||0
24744|NCT02797522|56027|P7|COMPLETED|Overall Study||12
24745|NCT02797522|56028|P6|COMPLETED|Overall Study||4
24746|NCT02797522|56029|P5|COMPLETED|Overall Study||4
24747|NCT02797522|56030|P4|COMPLETED|Overall Study||4
24748|NCT02797522|56031|P3|COMPLETED|Overall Study||4
24749|NCT02797522|56032|P2|COMPLETED|Overall Study||4
24750|NCT02797522|56033|P1|COMPLETED|Overall Study||4
24751|NCT02797522|56023|P11|STARTED|Overall Study||1
24752|NCT02797522|56024|P10|STARTED|Overall Study||4
24753|NCT02797522|56025|P9|STARTED|Overall Study||2
24754|NCT02797522|56026|P8|STARTED|Overall Study||4
24755|NCT02797522|56027|P7|STARTED|Overall Study||12
24756|NCT02797522|56028|P6|STARTED|Overall Study||4
24757|NCT02797522|56029|P5|STARTED|Overall Study||4
24758|NCT02797522|56030|P4|STARTED|Overall Study||4
24759|NCT02797522|56031|P3|STARTED|Overall Study||4
24760|NCT02797522|56032|P2|STARTED|Overall Study||4
24761|NCT02797522|56033|P1|STARTED|Overall Study||4
24762|NCT02797132|56139|P1|NOT COMPLETED|Part B (24 Weeks)||3
24763|NCT02797132|56139|P1|COMPLETED|Part B (24 Weeks)||57
24764|NCT02797132|56139|P1|Part B (>=14 kg Weight)|Part B (24 Weeks)||41
24765|NCT02797132|56139|P1|Part B (<14 kg Weight)|Part B (24 Weeks)||19
24766|NCT02797132|56139|P1|STARTED|Part B (24 Weeks)|Participants from Part A may have participated in Part B.|60
24767|NCT02797132|56139|P1|NOT COMPLETED|Part A (15 Days)||1
24768|NCT02797132|56139|P1|COMPLETED|Part A (15 Days)||11
24769|NCT02797132|56139|P1|Part A (>=14 kg Weight)|Part A (15 Days)||8
24770|NCT02797132|56139|P1|Part A (<14 kg Weight)|Part A (15 Days)||4
24771|NCT02797132|56139|P1|STARTED|Part A (15 Days)||12
24772|NCT02797080|56191|P1|NOT COMPLETED|Overall Study||2
24773|NCT02797080|56191|P1|COMPLETED|Overall Study||36
24774|NCT02797080|56191|P1|STARTED|Overall Study||38
24775|NCT02797054|56198|P3|NOT COMPLETED|Follow-up||285
24776|NCT02797054|56199|P2|NOT COMPLETED|Follow-up||228
24777|NCT02797054|56200|P1|NOT COMPLETED|Follow-up||209
24778|NCT02797054|56198|P3|COMPLETED|Follow-up||150
24779|NCT02797054|56199|P2|COMPLETED|Follow-up||155
24780|NCT02797054|56200|P1|COMPLETED|Follow-up||178
24781|NCT02797054|56198|P3|STARTED|Follow-up||435
24782|NCT02797054|56199|P2|STARTED|Follow-up||383
24783|NCT02797054|56200|P1|STARTED|Follow-up||387
24784|NCT02797054|56198|P3|NOT COMPLETED|Post-test||348
24785|NCT02797054|56199|P2|NOT COMPLETED|Post-test||11
24786|NCT02797054|56200|P1|NOT COMPLETED|Post-test||7
24787|NCT02797054|56198|P3|COMPLETED|Post-test||87
24788|NCT02797054|56199|P2|COMPLETED|Post-test||372
24789|NCT02797054|56200|P1|COMPLETED|Post-test||380
24790|NCT02797054|56198|P3|STARTED|Post-test||435
24791|NCT02797054|56199|P2|STARTED|Post-test||383
24792|NCT02797054|56200|P1|STARTED|Post-test||387
24793|NCT02796963|56233|P4|NOT COMPLETED|Overall Study||72
24794|NCT02796963|56234|P3|NOT COMPLETED|Overall Study||69
24795|NCT02796963|56235|P2|NOT COMPLETED|Overall Study||76
24796|NCT02796963|56236|P1|NOT COMPLETED|Overall Study||89
24797|NCT02796963|56233|P4|COMPLETED|Overall Study||282
24798|NCT02796963|56234|P3|COMPLETED|Overall Study||247
24799|NCT02796963|56235|P2|COMPLETED|Overall Study||252
24800|NCT02796963|56236|P1|COMPLETED|Overall Study||294
24801|NCT02796963|56233|P4|HIV Sero Converted|Overall Study||19
24802|NCT02796963|56234|P3|HIV Sero Converted|Overall Study||11
24803|NCT02796963|56235|P2|HIV Sero Converted|Overall Study||19
24804|NCT02796963|56236|P1|HIV Sero Converted|Overall Study||19
24805|NCT02796963|56233|P4|Fourth Follow up|Overall Study||263
24806|NCT02796963|56234|P3|Fourth Follow up|Overall Study||236
24807|NCT02796963|56235|P2|Fourth Follow up|Overall Study||233
24808|NCT02796963|56236|P1|Fourth Follow up|Overall Study||275
24809|NCT02796963|56233|P4|Third Follow up|Overall Study||286
24810|NCT02796963|56234|P3|Third Follow up|Overall Study||245
24811|NCT02796963|56235|P2|Third Follow up|Overall Study||237
24812|NCT02796963|56236|P1|Third Follow up|Overall Study||276
24813|NCT02796963|56233|P4|Second Follow up|Overall Study||293
24814|NCT02796963|56234|P3|Second Follow up|Overall Study||255
24815|NCT02796963|56235|P2|Second Follow up|Overall Study||260
24816|NCT02796963|56236|P1|Second Follow up|Overall Study||280
24817|NCT02796963|56233|P4|First Follow up|Overall Study||291
24818|NCT02796963|56234|P3|First Follow up|Overall Study||257
24819|NCT02796963|56235|P2|First Follow up|Overall Study||279
24820|NCT02796963|56236|P1|First Follow up|Overall Study||293
24821|NCT02796963|56233|P4|STARTED|Overall Study||354
24822|NCT02796963|56234|P3|STARTED|Overall Study||316
24823|NCT02796963|56235|P2|STARTED|Overall Study||328
24824|NCT02796963|56236|P1|STARTED|Overall Study||383
24825|NCT02796677|56302|P4|NOT COMPLETED|Overall Study||74
24826|NCT02796677|56303|P3|NOT COMPLETED|Overall Study||53
24827|NCT02796677|56304|P2|NOT COMPLETED|Overall Study||73
24828|NCT02796677|56305|P1|NOT COMPLETED|Overall Study||38
24829|NCT02796677|56302|P4|COMPLETED|Overall Study||405
24830|NCT02796677|56303|P3|COMPLETED|Overall Study||267
24831|NCT02796677|56304|P2|COMPLETED|Overall Study||405
24832|NCT02796677|56305|P1|COMPLETED|Overall Study||279
24833|NCT02796677|56302|P4|Completed Treatment and Follow-up|Overall Study||403
24834|NCT02796677|56303|P3|Completed Treatment and Follow-up|Overall Study||267
24835|NCT02796677|56304|P2|Completed Treatment and Follow-up|Overall Study||405
24836|NCT02796677|56305|P1|Completed Treatment and Follow-up|Overall Study||279
24837|NCT02796677|56302|P4|STARTED|Overall Study||479
24838|NCT02796677|56303|P3|STARTED|Overall Study||320
24839|NCT02796677|56304|P2|STARTED|Overall Study||478
24840|NCT02796677|56305|P1|STARTED|Overall Study||317
24841|NCT02796651|56329|P1|NOT COMPLETED|Overall Study||26
24842|NCT02796651|56329|P1|COMPLETED|Overall Study||106
24843|NCT02796651|56329|P1|Placebo (Lactose Monohydrate)|Overall Study||38
24844|NCT02796651|56329|P1|Perforomist 40 μg|Overall Study||108
24845|NCT02796651|56329|P1|Perforomist 20 μg|Overall Study||118
24846|NCT02796651|56329|P1|Formoterol Fumarate (FF) 24 μg|Overall Study||105
24847|NCT02796651|56329|P1|Formoterol Fumarate (FF) 12 μg|Overall Study||121
24848|NCT02796651|56329|P1|Formoterol Fumarate (FF) 6 μg|Overall Study||107
24849|NCT02796651|56329|P1|STARTED|Overall Study||132
24850|NCT02796352|56358|P1|NOT COMPLETED|Overall Study||0
24851|NCT02796352|56358|P1|COMPLETED|Overall Study||1
24852|NCT02796352|56358|P1|STARTED|Overall Study||1
24853|NCT02796092|56367|P2|NOT COMPLETED|Overall Study||0
24854|NCT02796092|56368|P1|NOT COMPLETED|Overall Study||0
24855|NCT02796092|56367|P2|COMPLETED|Overall Study||50
24856|NCT02796092|56368|P1|COMPLETED|Overall Study||50
24857|NCT02796092|56367|P2|STARTED|Overall Study||50
24858|NCT02796092|56368|P1|STARTED|Overall Study||50
24859|NCT02795832|56406|P6|NOT COMPLETED|Overall Study||3
24860|NCT02795832|56407|P5|NOT COMPLETED|Overall Study||0
24861|NCT02795832|56408|P4|NOT COMPLETED|Overall Study||0
24862|NCT02795832|56409|P3|NOT COMPLETED|Overall Study||0
24863|NCT02795832|56410|P2|NOT COMPLETED|Overall Study||0
24864|NCT02795832|56411|P1|NOT COMPLETED|Overall Study||0
24865|NCT02795832|56406|P6|COMPLETED|Overall Study||7
24866|NCT02795832|56407|P5|COMPLETED|Overall Study||20
24867|NCT02795832|56408|P4|COMPLETED|Overall Study||3
24868|NCT02795832|56409|P3|COMPLETED|Overall Study||8
24869|NCT02795832|56410|P2|COMPLETED|Overall Study||4
24870|NCT02795832|56411|P1|COMPLETED|Overall Study||8
24871|NCT02795832|56406|P6|STARTED|Overall Study||10
24872|NCT02795832|56407|P5|STARTED|Overall Study||20
24873|NCT02795832|56408|P4|STARTED|Overall Study||3
24874|NCT02795832|56409|P3|STARTED|Overall Study||8
24875|NCT02795832|56410|P2|STARTED|Overall Study||4
24876|NCT02795832|56411|P1|STARTED|Overall Study||8
24877|NCT02795819|56445|P7|NOT COMPLETED|Overall Study||0
24878|NCT02795819|56446|P6|NOT COMPLETED|Overall Study||0
24879|NCT02795819|56447|P5|NOT COMPLETED|Overall Study||0
24880|NCT02795819|56448|P4|NOT COMPLETED|Overall Study||0
24881|NCT02795819|56449|P3|NOT COMPLETED|Overall Study||0
24882|NCT02795819|56450|P2|NOT COMPLETED|Overall Study||0
24883|NCT02795819|56451|P1|NOT COMPLETED|Overall Study||0
24884|NCT02795819|56445|P7|COMPLETED|Overall Study||0
24885|NCT02795819|56446|P6|COMPLETED|Overall Study||0
24886|NCT02795819|56447|P5|COMPLETED|Overall Study||0
24887|NCT02795819|56448|P4|COMPLETED|Overall Study||0
24888|NCT02795819|56449|P3|COMPLETED|Overall Study||0
24889|NCT02795819|56450|P2|COMPLETED|Overall Study||6
24890|NCT02795819|56451|P1|COMPLETED|Overall Study||0
24891|NCT02795819|56445|P7|STARTED|Overall Study||0
24892|NCT02795819|56446|P6|STARTED|Overall Study||0
24893|NCT02795819|56447|P5|STARTED|Overall Study||0
24894|NCT02795819|56448|P4|STARTED|Overall Study||0
24895|NCT02795819|56449|P3|STARTED|Overall Study||0
24896|NCT02795819|56450|P2|STARTED|Overall Study||6
24897|NCT02795819|56451|P1|STARTED|Overall Study||0
24898|NCT02795767|56478|P3|NOT COMPLETED|Overall Study||10
24899|NCT02795767|56479|P2|NOT COMPLETED|Overall Study||10
24900|NCT02795767|56480|P1|NOT COMPLETED|Overall Study||68
24901|NCT02795767|56478|P3|COMPLETED|Overall Study||0
24902|NCT02795767|56479|P2|COMPLETED|Overall Study||0
24903|NCT02795767|56480|P1|COMPLETED|Overall Study||0
24904|NCT02795767|56478|P3|Discontinued From Study Treatment|Overall Study||1
24905|NCT02795767|56479|P2|Discontinued From Study Treatment|Overall Study||0
24906|NCT02795767|56480|P1|Discontinued From Study Treatment|Overall Study||2
24907|NCT02795767|56478|P3|Completed 52 Weeks in Study|Overall Study||0
24908|NCT02795767|56479|P2|Completed 52 Weeks in Study|Overall Study||0
24909|NCT02795767|56480|P1|Completed 52 Weeks in Study|Overall Study||59
24910|NCT02795767|56478|P3|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2
24911|NCT02795767|56479|P2|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
24912|NCT02795767|56480|P1|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
24913|NCT02795767|56478|P3|STARTED|Overall Study||10
24914|NCT02795767|56479|P2|STARTED|Overall Study||10
24915|NCT02795767|56480|P1|STARTED|Overall Study||68
24916|NCT02794974|56601|P2|NOT COMPLETED|Overall Study||1
24917|NCT02794974|56602|P1|NOT COMPLETED|Overall Study||0
24918|NCT02794974|56601|P2|COMPLETED|Overall Study||14
24919|NCT02794974|56602|P1|COMPLETED|Overall Study||14
24920|NCT02794974|56601|P2|STARTED|Overall Study||15
24921|NCT02794974|56602|P1|STARTED|Overall Study||14
24922|NCT02794870|56618|P2|NOT COMPLETED|Overall Study||0
24923|NCT02794870|56619|P1|NOT COMPLETED|Overall Study||2
24924|NCT02794870|56618|P2|COMPLETED|Overall Study||11
24925|NCT02794870|56619|P1|COMPLETED|Overall Study||20
24926|NCT02794870|56618|P2|Received Inoculation|Overall Study||11
24927|NCT02794870|56619|P1|Received Inoculation|Overall Study||21
24928|NCT02794870|56618|P2|STARTED|Overall Study||11
24929|NCT02794870|56619|P1|STARTED|Overall Study||22
24930|NCT02794844|56645|P1|NOT COMPLETED|Overall Study||5
24931|NCT02794844|56645|P1|COMPLETED|Overall Study||23
24932|NCT02794844|56645|P1|STARTED|Overall Study||28
24933|NCT02794480|56655|P4|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
24934|NCT02794480|56656|P3|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
24935|NCT02794480|56657|P2|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
24936|NCT02794480|56658|P1|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
24937|NCT02794480|56655|P4|COMPLETED|Period 2: Treatment Period 2 (28 Days)||77
24938|NCT02794480|56656|P3|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
24939|NCT02794480|56657|P2|COMPLETED|Period 2: Treatment Period 2 (28 Days)||80
24940|NCT02794480|56658|P1|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
24941|NCT02794480|56655|P4|STARTED|Period 2: Treatment Period 2 (28 Days)||78
24942|NCT02794480|56656|P3|STARTED|Period 2: Treatment Period 2 (28 Days)||79
24943|NCT02794480|56657|P2|STARTED|Period 2: Treatment Period 2 (28 Days)||80
24944|NCT02794480|56658|P1|STARTED|Period 2: Treatment Period 2 (28 Days)||80
24945|NCT02794480|56655|P4|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||3
24946|NCT02794480|56656|P3|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
24947|NCT02794480|56657|P2|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
24948|NCT02794480|56658|P1|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||0
24949|NCT02794480|56655|P4|COMPLETED|Period 1: Treatment Period 1 (28 Days)||78
24950|NCT02794480|56656|P3|COMPLETED|Period 1: Treatment Period 1 (28 Days)||79
24951|NCT02794480|56657|P2|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
24952|NCT02794480|56658|P1|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
24953|NCT02794480|56655|P4|STARTED|Period 1: Treatment Period 1 (28 Days)||81
24954|NCT02794480|56656|P3|STARTED|Period 1: Treatment Period 1 (28 Days)||81
24955|NCT02794480|56657|P2|STARTED|Period 1: Treatment Period 1 (28 Days)||82
24956|NCT02794480|56658|P1|STARTED|Period 1: Treatment Period 1 (28 Days)||80
24957|NCT02794103|56676|P1|NOT COMPLETED|Overall Study||3
24958|NCT02794103|56676|P1|COMPLETED|Overall Study||15
24959|NCT02794103|56676|P1|STARTED|Overall Study||18
24960|NCT02793947|56687|P2|NOT COMPLETED|Overall Study||5
24961|NCT02793947|56688|P1|NOT COMPLETED|Overall Study||2
24962|NCT02793947|56687|P2|COMPLETED|Overall Study||50
24963|NCT02793947|56688|P1|COMPLETED|Overall Study||45
24964|NCT02793947|56687|P2|STARTED|Overall Study||55
24965|NCT02793947|56688|P1|STARTED|Overall Study||47
24966|NCT02793817|56700|P2|NOT COMPLETED|Overall Study||5
24967|NCT02793817|56701|P1|NOT COMPLETED|Overall Study||3
24968|NCT02793817|56700|P2|COMPLETED|Overall Study||254
24969|NCT02793817|56701|P1|COMPLETED|Overall Study||258
24970|NCT02793817|56700|P2|STARTED|Overall Study||259
24971|NCT02793817|56701|P1|STARTED|Overall Study||261
24972|NCT02793674|56721|P2|NOT COMPLETED|Overall Study||0
24973|NCT02793674|56722|P1|NOT COMPLETED|Overall Study||0
24974|NCT02793674|56721|P2|COMPLETED|Overall Study||12
24975|NCT02793674|56722|P1|COMPLETED|Overall Study||9
24976|NCT02793674|56721|P2|STARTED|Overall Study||12
24977|NCT02793674|56722|P1|STARTED|Overall Study||9
24978|NCT02793232|56743|P9|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
24979|NCT02793232|56744|P8|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
24980|NCT02793232|56745|P7|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
24981|NCT02793232|56746|P6|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
24982|NCT02793232|56747|P5|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
24983|NCT02793232|56748|P4|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
24984|NCT02793232|56749|P3|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
24985|NCT02793232|56750|P2|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
24986|NCT02793232|56751|P1|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
24987|NCT02793232|56743|P9|COMPLETED|Period 4 (Part A: 5 Days)||0
24988|NCT02793232|56744|P8|COMPLETED|Period 4 (Part A: 5 Days)||0
24989|NCT02793232|56745|P7|COMPLETED|Period 4 (Part A: 5 Days)||0
24990|NCT02793232|56746|P6|COMPLETED|Period 4 (Part A: 5 Days)||0
24991|NCT02793232|56747|P5|COMPLETED|Period 4 (Part A: 5 Days)||0
24992|NCT02793232|56748|P4|COMPLETED|Period 4 (Part A: 5 Days)||2
24993|NCT02793232|56749|P3|COMPLETED|Period 4 (Part A: 5 Days)||2
24994|NCT02793232|56750|P2|COMPLETED|Period 4 (Part A: 5 Days)||2
24995|NCT02793232|56751|P1|COMPLETED|Period 4 (Part A: 5 Days)||2
24996|NCT02793232|56743|P9|STARTED|Period 4 (Part A: 5 Days)||0
24997|NCT02793232|56744|P8|STARTED|Period 4 (Part A: 5 Days)||0
24998|NCT02793232|56745|P7|STARTED|Period 4 (Part A: 5 Days)||0
24999|NCT02793232|56746|P6|STARTED|Period 4 (Part A: 5 Days)||0
25000|NCT02793232|56747|P5|STARTED|Period 4 (Part A: 5 Days)||0
25001|NCT02793232|56748|P4|STARTED|Period 4 (Part A: 5 Days)||2
25002|NCT02793232|56749|P3|STARTED|Period 4 (Part A: 5 Days)||2
25003|NCT02793232|56750|P2|STARTED|Period 4 (Part A: 5 Days)||2
25004|NCT02793232|56751|P1|STARTED|Period 4 (Part A: 5 Days)||2
25005|NCT02793232|56743|P9|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
25006|NCT02793232|56744|P8|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
25007|NCT02793232|56745|P7|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
25008|NCT02793232|56746|P6|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
25009|NCT02793232|56747|P5|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
25010|NCT02793232|56748|P4|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
25011|NCT02793232|56749|P3|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
25012|NCT02793232|56750|P2|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
25013|NCT02793232|56751|P1|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
25014|NCT02793232|56743|P9|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
25015|NCT02793232|56744|P8|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
25016|NCT02793232|56745|P7|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
25017|NCT02793232|56746|P6|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
25018|NCT02793232|56747|P5|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
25019|NCT02793232|56748|P4|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
25020|NCT02793232|56749|P3|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
25021|NCT02793232|56750|P2|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
25022|NCT02793232|56751|P1|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
25023|NCT02793232|56743|P9|STARTED|Washout Period 3(Part A:at Least 10days)||0
25024|NCT02793232|56744|P8|STARTED|Washout Period 3(Part A:at Least 10days)||0
25025|NCT02793232|56745|P7|STARTED|Washout Period 3(Part A:at Least 10days)||0
25026|NCT02793232|56746|P6|STARTED|Washout Period 3(Part A:at Least 10days)||0
25027|NCT02793232|56747|P5|STARTED|Washout Period 3(Part A:at Least 10days)||0
25028|NCT02793232|56748|P4|STARTED|Washout Period 3(Part A:at Least 10days)||2
25029|NCT02793232|56749|P3|STARTED|Washout Period 3(Part A:at Least 10days)||2
25030|NCT02793232|56750|P2|STARTED|Washout Period 3(Part A:at Least 10days)||2
25031|NCT02793232|56751|P1|STARTED|Washout Period 3(Part A:at Least 10days)||2
25032|NCT02793232|56743|P9|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
25033|NCT02793232|56744|P8|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
25034|NCT02793232|56745|P7|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
25035|NCT02793232|56746|P6|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
25036|NCT02793232|56747|P5|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
25037|NCT02793232|56748|P4|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
25038|NCT02793232|56749|P3|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
25039|NCT02793232|56750|P2|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
25040|NCT02793232|56751|P1|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
25041|NCT02793232|56743|P9|COMPLETED|Period 3 (Part A: 5 Days)||0
25042|NCT02793232|56744|P8|COMPLETED|Period 3 (Part A: 5 Days)||0
25043|NCT02793232|56745|P7|COMPLETED|Period 3 (Part A: 5 Days)||0
25044|NCT02793232|56746|P6|COMPLETED|Period 3 (Part A: 5 Days)||0
25045|NCT02793232|56747|P5|COMPLETED|Period 3 (Part A: 5 Days)||0
25046|NCT02793232|56748|P4|COMPLETED|Period 3 (Part A: 5 Days)||2
25047|NCT02793232|56749|P3|COMPLETED|Period 3 (Part A: 5 Days)||2
25048|NCT02793232|56750|P2|COMPLETED|Period 3 (Part A: 5 Days)||2
25049|NCT02793232|56751|P1|COMPLETED|Period 3 (Part A: 5 Days)||2
25050|NCT02793232|56743|P9|STARTED|Period 3 (Part A: 5 Days)||0
25051|NCT02793232|56744|P8|STARTED|Period 3 (Part A: 5 Days)||0
25052|NCT02793232|56745|P7|STARTED|Period 3 (Part A: 5 Days)||0
25053|NCT02793232|56746|P6|STARTED|Period 3 (Part A: 5 Days)||0
25054|NCT02793232|56747|P5|STARTED|Period 3 (Part A: 5 Days)||0
25055|NCT02793232|56748|P4|STARTED|Period 3 (Part A: 5 Days)||2
25056|NCT02793232|56749|P3|STARTED|Period 3 (Part A: 5 Days)||2
25057|NCT02793232|56750|P2|STARTED|Period 3 (Part A: 5 Days)||2
25058|NCT02793232|56751|P1|STARTED|Period 3 (Part A: 5 Days)||2
25059|NCT02793232|56743|P9|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
25060|NCT02793232|56744|P8|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
25061|NCT02793232|56745|P7|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
25062|NCT02793232|56746|P6|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
25063|NCT02793232|56747|P5|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
25064|NCT02793232|56748|P4|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
25065|NCT02793232|56749|P3|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
25066|NCT02793232|56750|P2|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
25067|NCT02793232|56751|P1|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
25068|NCT02793232|56743|P9|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
25069|NCT02793232|56744|P8|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
25070|NCT02793232|56745|P7|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
25071|NCT02793232|56746|P6|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
25072|NCT02793232|56747|P5|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
25073|NCT02793232|56748|P4|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
25074|NCT02793232|56749|P3|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
25075|NCT02793232|56750|P2|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
25076|NCT02793232|56751|P1|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
25077|NCT02793232|56743|P9|STARTED|Washout Period 2(Part A:at Least 10days)||0
25078|NCT02793232|56744|P8|STARTED|Washout Period 2(Part A:at Least 10days)||0
25079|NCT02793232|56745|P7|STARTED|Washout Period 2(Part A:at Least 10days)||0
25080|NCT02793232|56746|P6|STARTED|Washout Period 2(Part A:at Least 10days)||0
25081|NCT02793232|56747|P5|STARTED|Washout Period 2(Part A:at Least 10days)||0
25082|NCT02793232|56748|P4|STARTED|Washout Period 2(Part A:at Least 10days)||2
25083|NCT02793232|56749|P3|STARTED|Washout Period 2(Part A:at Least 10days)||2
25084|NCT02793232|56750|P2|STARTED|Washout Period 2(Part A:at Least 10days)||2
25085|NCT02793232|56751|P1|STARTED|Washout Period 2(Part A:at Least 10days)||2
25086|NCT02793232|56743|P9|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
25087|NCT02793232|56744|P8|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
25088|NCT02793232|56745|P7|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
25089|NCT02793232|56746|P6|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
25090|NCT02793232|56747|P5|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
25091|NCT02793232|56748|P4|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
25092|NCT02793232|56749|P3|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
25093|NCT02793232|56750|P2|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
25094|NCT02793232|56751|P1|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
25095|NCT02793232|56743|P9|COMPLETED|Period 2 (Part A: 5 Days)||0
25096|NCT02793232|56744|P8|COMPLETED|Period 2 (Part A: 5 Days)||0
25097|NCT02793232|56745|P7|COMPLETED|Period 2 (Part A: 5 Days)||0
25098|NCT02793232|56746|P6|COMPLETED|Period 2 (Part A: 5 Days)||0
25099|NCT02793232|56747|P5|COMPLETED|Period 2 (Part A: 5 Days)||0
25100|NCT02793232|56748|P4|COMPLETED|Period 2 (Part A: 5 Days)||2
25101|NCT02793232|56749|P3|COMPLETED|Period 2 (Part A: 5 Days)||2
25102|NCT02793232|56750|P2|COMPLETED|Period 2 (Part A: 5 Days)||2
25103|NCT02793232|56751|P1|COMPLETED|Period 2 (Part A: 5 Days)||2
25104|NCT02793232|56743|P9|STARTED|Period 2 (Part A: 5 Days)||0
25105|NCT02793232|56744|P8|STARTED|Period 2 (Part A: 5 Days)||0
25106|NCT02793232|56745|P7|STARTED|Period 2 (Part A: 5 Days)||0
25107|NCT02793232|56746|P6|STARTED|Period 2 (Part A: 5 Days)||0
25108|NCT02793232|56747|P5|STARTED|Period 2 (Part A: 5 Days)||0
25109|NCT02793232|56748|P4|STARTED|Period 2 (Part A: 5 Days)||2
25110|NCT02793232|56749|P3|STARTED|Period 2 (Part A: 5 Days)||2
25111|NCT02793232|56750|P2|STARTED|Period 2 (Part A: 5 Days)||2
25112|NCT02793232|56751|P1|STARTED|Period 2 (Part A: 5 Days)||2
25113|NCT02793232|56743|P9|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
25114|NCT02793232|56744|P8|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
25115|NCT02793232|56745|P7|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
25116|NCT02793232|56746|P6|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
25117|NCT02793232|56747|P5|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
25118|NCT02793232|56748|P4|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
25119|NCT02793232|56749|P3|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
25120|NCT02793232|56750|P2|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
25121|NCT02793232|56751|P1|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
25122|NCT02793232|56743|P9|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
25123|NCT02793232|56744|P8|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
25124|NCT02793232|56745|P7|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
25125|NCT02793232|56746|P6|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
25126|NCT02793232|56747|P5|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
25127|NCT02793232|56748|P4|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
25128|NCT02793232|56749|P3|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
25129|NCT02793232|56750|P2|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
25130|NCT02793232|56751|P1|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
25131|NCT02793232|56743|P9|STARTED|Washout Period 1(Part A:at Least 10days)||0
25132|NCT02793232|56744|P8|STARTED|Washout Period 1(Part A:at Least 10days)||0
25133|NCT02793232|56745|P7|STARTED|Washout Period 1(Part A:at Least 10days)||0
25134|NCT02793232|56746|P6|STARTED|Washout Period 1(Part A:at Least 10days)||0
25135|NCT02793232|56747|P5|STARTED|Washout Period 1(Part A:at Least 10days)||0
25136|NCT02793232|56748|P4|STARTED|Washout Period 1(Part A:at Least 10days)||2
25137|NCT02793232|56749|P3|STARTED|Washout Period 1(Part A:at Least 10days)||2
25138|NCT02793232|56750|P2|STARTED|Washout Period 1(Part A:at Least 10days)||2
25139|NCT02793232|56751|P1|STARTED|Washout Period 1(Part A:at Least 10days)||2
25140|NCT02793232|56743|P9|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
25141|NCT02793232|56744|P8|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
25142|NCT02793232|56745|P7|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1
25143|NCT02793232|56746|P6|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
25144|NCT02793232|56747|P5|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1
25145|NCT02793232|56748|P4|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
25146|NCT02793232|56749|P3|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
25147|NCT02793232|56750|P2|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
25148|NCT02793232|56751|P1|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
25149|NCT02793232|56743|P9|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8
25150|NCT02793232|56744|P8|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
25151|NCT02793232|56745|P7|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8
25152|NCT02793232|56746|P6|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||12
25153|NCT02793232|56747|P5|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||6
25154|NCT02793232|56748|P4|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
25155|NCT02793232|56749|P3|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
25156|NCT02793232|56750|P2|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
25157|NCT02793232|56751|P1|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
25158|NCT02793232|56743|P9|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||8
25159|NCT02793232|56744|P8|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
25160|NCT02793232|56745|P7|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||9
25161|NCT02793232|56746|P6|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||12
25162|NCT02793232|56747|P5|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||7
25163|NCT02793232|56748|P4|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
25164|NCT02793232|56749|P3|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
25165|NCT02793232|56750|P2|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
25166|NCT02793232|56751|P1|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
25167|NCT02793154|56936|P3|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
25168|NCT02793154|56937|P2|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
25169|NCT02793154|56938|P1|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
25170|NCT02793154|56936|P3|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
25171|NCT02793154|56937|P2|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
25172|NCT02793154|56938|P1|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
25173|NCT02793154|56936|P3|STARTED|Part B (Parallel Group-up to 84 Days)||0
25174|NCT02793154|56937|P2|STARTED|Part B (Parallel Group-up to 84 Days)||0
25175|NCT02793154|56938|P1|STARTED|Part B (Parallel Group-up to 84 Days)||0
25176|NCT02793154|56936|P3|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
25177|NCT02793154|56937|P2|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
25178|NCT02793154|56938|P1|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
25179|NCT02793154|56936|P3|COMPLETED|Part A (Single Group-up to 12 Days)||0
25180|NCT02793154|56937|P2|COMPLETED|Part A (Single Group-up to 12 Days)||0
25181|NCT02793154|56938|P1|COMPLETED|Part A (Single Group-up to 12 Days)||4
25182|NCT02793154|56936|P3|STARTED|Part A (Single Group-up to 12 Days)||0
25183|NCT02793154|56937|P2|STARTED|Part A (Single Group-up to 12 Days)||0
25184|NCT02793154|56938|P1|STARTED|Part A (Single Group-up to 12 Days)||4
25185|NCT02792829|57012|P8|NOT COMPLETED|Treatment Period 2||2
25186|NCT02792829|57013|P7|NOT COMPLETED|Treatment Period 2||1
25187|NCT02792829|57014|P6|NOT COMPLETED|Treatment Period 2||0
25188|NCT02792829|57015|P5|NOT COMPLETED|Treatment Period 2||1
25189|NCT02792829|57016|P4|NOT COMPLETED|Treatment Period 2||0
25190|NCT02792829|57017|P3|NOT COMPLETED|Treatment Period 2||0
25191|NCT02792829|57018|P2|NOT COMPLETED|Treatment Period 2||1
25192|NCT02792829|57019|P1|NOT COMPLETED|Treatment Period 2||0
25193|NCT02792829|57012|P8|COMPLETED|Treatment Period 2||8
25194|NCT02792829|57013|P7|COMPLETED|Treatment Period 2||9
25195|NCT02792829|57014|P6|COMPLETED|Treatment Period 2||5
25196|NCT02792829|57015|P5|COMPLETED|Treatment Period 2||4
25197|NCT02792829|57016|P4|COMPLETED|Treatment Period 2||5
25198|NCT02792829|57017|P3|COMPLETED|Treatment Period 2||5
25199|NCT02792829|57018|P2|COMPLETED|Treatment Period 2||9
25200|NCT02792829|57019|P1|COMPLETED|Treatment Period 2||10
25201|NCT02792829|57012|P8|STARTED|Treatment Period 2||10
25202|NCT02792829|57013|P7|STARTED|Treatment Period 2||10
25203|NCT02792829|57014|P6|STARTED|Treatment Period 2||5
25204|NCT02792829|57015|P5|STARTED|Treatment Period 2||5
25205|NCT02792829|57016|P4|STARTED|Treatment Period 2||5
25206|NCT02792829|57017|P3|STARTED|Treatment Period 2||5
25207|NCT02792829|57018|P2|STARTED|Treatment Period 2||10
25208|NCT02792829|57019|P1|STARTED|Treatment Period 2||10
25209|NCT02792829|57012|P8|NOT COMPLETED|Wash Out Period||0
25210|NCT02792829|57013|P7|NOT COMPLETED|Wash Out Period||0
25211|NCT02792829|57014|P6|NOT COMPLETED|Wash Out Period||0
25212|NCT02792829|57015|P5|NOT COMPLETED|Wash Out Period||0
25213|NCT02792829|57016|P4|NOT COMPLETED|Wash Out Period||0
25214|NCT02792829|57017|P3|NOT COMPLETED|Wash Out Period||0
25215|NCT02792829|57018|P2|NOT COMPLETED|Wash Out Period||0
25216|NCT02792829|57019|P1|NOT COMPLETED|Wash Out Period||0
25217|NCT02792829|57012|P8|COMPLETED|Wash Out Period||10
25218|NCT02792829|57013|P7|COMPLETED|Wash Out Period||10
25219|NCT02792829|57014|P6|COMPLETED|Wash Out Period||5
25220|NCT02792829|57015|P5|COMPLETED|Wash Out Period||5
25221|NCT02792829|57016|P4|COMPLETED|Wash Out Period||5
25222|NCT02792829|57017|P3|COMPLETED|Wash Out Period||5
25223|NCT02792829|57018|P2|COMPLETED|Wash Out Period||10
25224|NCT02792829|57019|P1|COMPLETED|Wash Out Period||10
25225|NCT02792829|57012|P8|STARTED|Wash Out Period||10
25226|NCT02792829|57013|P7|STARTED|Wash Out Period||10
25227|NCT02792829|57014|P6|STARTED|Wash Out Period||5
25228|NCT02792829|57015|P5|STARTED|Wash Out Period||5
25229|NCT02792829|57016|P4|STARTED|Wash Out Period||5
25230|NCT02792829|57017|P3|STARTED|Wash Out Period||5
25231|NCT02792829|57018|P2|STARTED|Wash Out Period||10
25232|NCT02792829|57019|P1|STARTED|Wash Out Period||10
25233|NCT02792829|57012|P8|NOT COMPLETED|Treatment Period 1||0
25234|NCT02792829|57013|P7|NOT COMPLETED|Treatment Period 1||0
25235|NCT02792829|57014|P6|NOT COMPLETED|Treatment Period 1||0
25236|NCT02792829|57015|P5|NOT COMPLETED|Treatment Period 1||0
25237|NCT02792829|57016|P4|NOT COMPLETED|Treatment Period 1||0
25238|NCT02792829|57017|P3|NOT COMPLETED|Treatment Period 1||0
25239|NCT02792829|57018|P2|NOT COMPLETED|Treatment Period 1||0
25240|NCT02792829|57019|P1|NOT COMPLETED|Treatment Period 1||0
25241|NCT02792829|57012|P8|COMPLETED|Treatment Period 1||10
25242|NCT02792829|57013|P7|COMPLETED|Treatment Period 1||10
25243|NCT02792829|57014|P6|COMPLETED|Treatment Period 1||5
25244|NCT02792829|57015|P5|COMPLETED|Treatment Period 1||5
25245|NCT02792829|57016|P4|COMPLETED|Treatment Period 1||5
25246|NCT02792829|57017|P3|COMPLETED|Treatment Period 1||5
25247|NCT02792829|57018|P2|COMPLETED|Treatment Period 1||10
25248|NCT02792829|57019|P1|COMPLETED|Treatment Period 1||10
25249|NCT02792829|57012|P8|STARTED|Treatment Period 1||10
25250|NCT02792829|57013|P7|STARTED|Treatment Period 1||10
25251|NCT02792829|57014|P6|STARTED|Treatment Period 1||5
25252|NCT02792829|57015|P5|STARTED|Treatment Period 1||5
25253|NCT02792829|57016|P4|STARTED|Treatment Period 1||5
25254|NCT02792829|57017|P3|STARTED|Treatment Period 1||5
25255|NCT02792829|57018|P2|STARTED|Treatment Period 1||10
25256|NCT02792829|57019|P1|STARTED|Treatment Period 1||10
25257|NCT02792777|57127|P2|NOT COMPLETED|Overall Study||0
25258|NCT02792777|57128|P1|NOT COMPLETED|Overall Study||7
25259|NCT02792777|57127|P2|COMPLETED|Overall Study||52
25260|NCT02792777|57128|P1|COMPLETED|Overall Study||89
25261|NCT02792777|57127|P2|STARTED|Overall Study||52
25262|NCT02792777|57128|P1|STARTED|Overall Study||96
25263|NCT02792699|57144|P3|NOT COMPLETED|Overall Study||10
25264|NCT02792699|57145|P2|NOT COMPLETED|Overall Study||10
25265|NCT02792699|57146|P1|NOT COMPLETED|Overall Study||9
25266|NCT02792699|57144|P3|COMPLETED|Overall Study||93
25267|NCT02792699|57145|P2|COMPLETED|Overall Study||94
25268|NCT02792699|57146|P1|COMPLETED|Overall Study||95
25269|NCT02792699|57144|P3|Received Second Infusion of Second Dose|Overall Study||93
25270|NCT02792699|57145|P2|Received Second Infusion of Second Dose|Overall Study||99
25271|NCT02792699|57146|P1|Received Second Infusion of Second Dose|Overall Study||97
25272|NCT02792699|57144|P3|Received First Infusion of Second Dose|Overall Study||95
25273|NCT02792699|57145|P2|Received First Infusion of Second Dose|Overall Study||99
25274|NCT02792699|57146|P1|Received First Infusion of Second Dose|Overall Study||97
25275|NCT02792699|57144|P3|Received Second Infusion of First Dose|Overall Study||99
25276|NCT02792699|57145|P2|Received Second Infusion of First Dose|Overall Study||103
25277|NCT02792699|57146|P1|Received Second Infusion of First Dose|Overall Study||102
25278|NCT02792699|57144|P3|Received First Infusion of First Dose|Overall Study||103
25279|NCT02792699|57145|P2|Received First Infusion of First Dose|Overall Study||104
25280|NCT02792699|57146|P1|Received First Infusion of First Dose|Overall Study||104
25281|NCT02792699|57144|P3|STARTED|Overall Study||103
25282|NCT02792699|57145|P2|STARTED|Overall Study||104
25283|NCT02792699|57146|P1|STARTED|Overall Study||104
25284|NCT02792517|57227|P1|NOT COMPLETED|Overall Study||20
25285|NCT02792517|57227|P1|COMPLETED|Overall Study||21
25286|NCT02792517|57227|P1|Received Erenumab|Overall Study||24
25287|NCT02792517|57227|P1|STARTED|Overall Study||41
25288|NCT02792062|57247|P6|NOT COMPLETED|Intervention Period 3 (6 Days)||0
25289|NCT02792062|57248|P5|NOT COMPLETED|Intervention Period 3 (6 Days)||0
25290|NCT02792062|57249|P4|NOT COMPLETED|Intervention Period 3 (6 Days)||0
25291|NCT02792062|57250|P3|NOT COMPLETED|Intervention Period 3 (6 Days)||0
25292|NCT02792062|57251|P2|NOT COMPLETED|Intervention Period 3 (6 Days)||0
25293|NCT02792062|57252|P1|NOT COMPLETED|Intervention Period 3 (6 Days)||0
25294|NCT02792062|57247|P6|COMPLETED|Intervention Period 3 (6 Days)||2
25295|NCT02792062|57248|P5|COMPLETED|Intervention Period 3 (6 Days)||2
25296|NCT02792062|57249|P4|COMPLETED|Intervention Period 3 (6 Days)||2
25297|NCT02792062|57250|P3|COMPLETED|Intervention Period 3 (6 Days)||2
25298|NCT02792062|57251|P2|COMPLETED|Intervention Period 3 (6 Days)||2
25299|NCT02792062|57252|P1|COMPLETED|Intervention Period 3 (6 Days)||1
25300|NCT02792062|57247|P6|STARTED|Intervention Period 3 (6 Days)||2
25301|NCT02792062|57248|P5|STARTED|Intervention Period 3 (6 Days)||2
25302|NCT02792062|57249|P4|STARTED|Intervention Period 3 (6 Days)||2
25303|NCT02792062|57250|P3|STARTED|Intervention Period 3 (6 Days)||2
25304|NCT02792062|57251|P2|STARTED|Intervention Period 3 (6 Days)||2
25305|NCT02792062|57252|P1|STARTED|Intervention Period 3 (6 Days)||1
25306|NCT02792062|57247|P6|NOT COMPLETED|Washout Period (at Least 14 Days)||0
25307|NCT02792062|57248|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||0
25308|NCT02792062|57249|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
25309|NCT02792062|57250|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
25310|NCT02792062|57251|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
25311|NCT02792062|57252|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||1
25312|NCT02792062|57247|P6|COMPLETED|Washout Period (at Least 14 Days)||2
25313|NCT02792062|57248|P5|COMPLETED|Washout Period (at Least 14 Days)||2
25314|NCT02792062|57249|P4|COMPLETED|Washout Period (at Least 14 Days)||2
25315|NCT02792062|57250|P3|COMPLETED|Washout Period (at Least 14 Days)||2
25316|NCT02792062|57251|P2|COMPLETED|Washout Period (at Least 14 Days)||2
25317|NCT02792062|57252|P1|COMPLETED|Washout Period (at Least 14 Days)||1
25318|NCT02792062|57247|P6|STARTED|Washout Period (at Least 14 Days)||2
25319|NCT02792062|57248|P5|STARTED|Washout Period (at Least 14 Days)||2
25320|NCT02792062|57249|P4|STARTED|Washout Period (at Least 14 Days)||2
25321|NCT02792062|57250|P3|STARTED|Washout Period (at Least 14 Days)||2
25322|NCT02792062|57251|P2|STARTED|Washout Period (at Least 14 Days)||2
25323|NCT02792062|57252|P1|STARTED|Washout Period (at Least 14 Days)||2
25324|NCT02792062|57247|P6|NOT COMPLETED|Intervention Period 2 (6 Days)||0
25325|NCT02792062|57248|P5|NOT COMPLETED|Intervention Period 2 (6 Days)||0
25326|NCT02792062|57249|P4|NOT COMPLETED|Intervention Period 2 (6 Days)||0
25327|NCT02792062|57250|P3|NOT COMPLETED|Intervention Period 2 (6 Days)||0
25328|NCT02792062|57251|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
25329|NCT02792062|57252|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
25330|NCT02792062|57247|P6|COMPLETED|Intervention Period 2 (6 Days)||2
25331|NCT02792062|57248|P5|COMPLETED|Intervention Period 2 (6 Days)||2
25332|NCT02792062|57249|P4|COMPLETED|Intervention Period 2 (6 Days)||2
25333|NCT02792062|57250|P3|COMPLETED|Intervention Period 2 (6 Days)||2
25334|NCT02792062|57251|P2|COMPLETED|Intervention Period 2 (6 Days)||2
25335|NCT02792062|57252|P1|COMPLETED|Intervention Period 2 (6 Days)||2
25336|NCT02792062|57247|P6|STARTED|Intervention Period 2 (6 Days)||2
25337|NCT02792062|57248|P5|STARTED|Intervention Period 2 (6 Days)||2
25338|NCT02792062|57249|P4|STARTED|Intervention Period 2 (6 Days)||2
25339|NCT02792062|57250|P3|STARTED|Intervention Period 2 (6 Days)||2
25340|NCT02792062|57251|P2|STARTED|Intervention Period 2 (6 Days)||2
25341|NCT02792062|57252|P1|STARTED|Intervention Period 2 (6 Days)||2
25342|NCT02792062|57247|P6|NOT COMPLETED|Washout Period (at Least 14 Days)||0
25343|NCT02792062|57248|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||0
25344|NCT02792062|57249|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
25345|NCT02792062|57250|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
25346|NCT02792062|57251|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
25347|NCT02792062|57252|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
25348|NCT02792062|57247|P6|COMPLETED|Washout Period (at Least 14 Days)||2
25349|NCT02792062|57248|P5|COMPLETED|Washout Period (at Least 14 Days)||2
25350|NCT02792062|57249|P4|COMPLETED|Washout Period (at Least 14 Days)||2
25351|NCT02792062|57250|P3|COMPLETED|Washout Period (at Least 14 Days)||2
25352|NCT02792062|57251|P2|COMPLETED|Washout Period (at Least 14 Days)||2
25353|NCT02792062|57252|P1|COMPLETED|Washout Period (at Least 14 Days)||2
25354|NCT02792062|57247|P6|STARTED|Washout Period (at Least 14 Days)||2
25355|NCT02792062|57248|P5|STARTED|Washout Period (at Least 14 Days)||2
25356|NCT02792062|57249|P4|STARTED|Washout Period (at Least 14 Days)||2
25357|NCT02792062|57250|P3|STARTED|Washout Period (at Least 14 Days)||2
25358|NCT02792062|57251|P2|STARTED|Washout Period (at Least 14 Days)||2
25359|NCT02792062|57252|P1|STARTED|Washout Period (at Least 14 Days)||2
25360|NCT02792062|57247|P6|NOT COMPLETED|Intervention Period 1 (6 Days)||0
25361|NCT02792062|57248|P5|NOT COMPLETED|Intervention Period 1 (6 Days)||0
25362|NCT02792062|57249|P4|NOT COMPLETED|Intervention Period 1 (6 Days)||0
25363|NCT02792062|57250|P3|NOT COMPLETED|Intervention Period 1 (6 Days)||0
25364|NCT02792062|57251|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
25365|NCT02792062|57252|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
25366|NCT02792062|57247|P6|COMPLETED|Intervention Period 1 (6 Days)||2
25367|NCT02792062|57248|P5|COMPLETED|Intervention Period 1 (6 Days)||2
25368|NCT02792062|57249|P4|COMPLETED|Intervention Period 1 (6 Days)||2
25369|NCT02792062|57250|P3|COMPLETED|Intervention Period 1 (6 Days)||2
25370|NCT02792062|57251|P2|COMPLETED|Intervention Period 1 (6 Days)||2
25371|NCT02792062|57252|P1|COMPLETED|Intervention Period 1 (6 Days)||2
25372|NCT02792062|57247|P6|STARTED|Intervention Period 1 (6 Days)||2
25373|NCT02792062|57248|P5|STARTED|Intervention Period 1 (6 Days)||2
25374|NCT02792062|57249|P4|STARTED|Intervention Period 1 (6 Days)||2
25375|NCT02792062|57250|P3|STARTED|Intervention Period 1 (6 Days)||2
25376|NCT02792062|57251|P2|STARTED|Intervention Period 1 (6 Days)||2
25377|NCT02792062|57252|P1|STARTED|Intervention Period 1 (6 Days)||2
25378|NCT02792049|57286|P2|NOT COMPLETED|Overall Study||0
25379|NCT02792049|57287|P1|NOT COMPLETED|Overall Study||0
25380|NCT02792049|57286|P2|COMPLETED|Overall Study||35
25381|NCT02792049|57287|P1|COMPLETED|Overall Study||35
25382|NCT02792049|57286|P2|STARTED|Overall Study||35
25383|NCT02792049|57287|P1|STARTED|Overall Study||35
25384|NCT02791763|57304|P3|NOT COMPLETED|Overall Study||13
25385|NCT02791763|57305|P2|NOT COMPLETED|Overall Study||37
25386|NCT02791763|57306|P1|NOT COMPLETED|Overall Study||38
25387|NCT02791763|57304|P3|COMPLETED|Overall Study||43
25388|NCT02791763|57305|P2|COMPLETED|Overall Study||113
25389|NCT02791763|57306|P1|COMPLETED|Overall Study||111
25390|NCT02791763|57304|P3|STARTED|Overall Study||56
25391|NCT02791763|57305|P2|STARTED|Overall Study||150
25392|NCT02791763|57306|P1|STARTED|Overall Study||149
25393|NCT02791659|57425|P2|NOT COMPLETED|Overall Study||1
25394|NCT02791659|57426|P1|NOT COMPLETED|Overall Study||0
25395|NCT02791659|57425|P2|COMPLETED|Overall Study||27
25396|NCT02791659|57426|P1|COMPLETED|Overall Study||27
25397|NCT02791659|57425|P2|STARTED|Overall Study||28
25398|NCT02791659|57426|P1|STARTED|Overall Study||27
25399|NCT02791516|57434|P2|NOT COMPLETED|Overall Study||1
25400|NCT02791516|57435|P1|NOT COMPLETED|Overall Study||1
25401|NCT02791516|57434|P2|COMPLETED|Overall Study||33
25402|NCT02791516|57435|P1|COMPLETED|Overall Study||32
25403|NCT02791516|57434|P2|Completed 6-month Treatment Period|Overall Study||33
25404|NCT02791516|57435|P1|Completed 6-month Treatment Period|Overall Study||33
25405|NCT02791516|57434|P2|STARTED|Overall Study||34
25406|NCT02791516|57435|P1|STARTED|Overall Study||33
25407|NCT02791490|57447|P2|NOT COMPLETED|Overall Study||8
25408|NCT02791490|57448|P1|NOT COMPLETED|Overall Study||3
25409|NCT02791490|57447|P2|COMPLETED|Overall Study||221
25410|NCT02791490|57448|P1|COMPLETED|Overall Study||226
25411|NCT02791490|57447|P2|STARTED|Overall Study||229
25412|NCT02791490|57448|P1|STARTED|Overall Study||229
25413|NCT02791269|57468|P2|NOT COMPLETED|Overall Study||1
25414|NCT02791269|57469|P1|NOT COMPLETED|Overall Study||0
25415|NCT02791269|57468|P2|COMPLETED|Overall Study||19
25416|NCT02791269|57469|P1|COMPLETED|Overall Study||4
25417|NCT02791269|57468|P2|STARTED|Overall Study||20
25418|NCT02791269|57469|P1|STARTED|Overall Study||4
25419|NCT02790788|57485|P2|NOT COMPLETED|Overall Study||0
25420|NCT02790788|57486|P1|NOT COMPLETED|Overall Study||0
25421|NCT02790788|57485|P2|COMPLETED|Overall Study||54
25422|NCT02790788|57486|P1|COMPLETED|Overall Study||46
25423|NCT02790788|57485|P2|STARTED|Overall Study||54
25424|NCT02790788|57486|P1|STARTED|Overall Study||46
25425|NCT02790736|57538|P2|NOT COMPLETED|Overall Study||0
25426|NCT02790736|57539|P1|NOT COMPLETED|Overall Study||0
25427|NCT02790736|57538|P2|COMPLETED|Overall Study||1
25428|NCT02790736|57539|P1|COMPLETED|Overall Study||5
25429|NCT02790736|57538|P2|STARTED|Overall Study||1
25430|NCT02790736|57539|P1|STARTED|Overall Study||5
25431|NCT02790606|57547|P1|NOT COMPLETED|Overall Study||8
25432|NCT02790606|57547|P1|COMPLETED|Overall Study||102
25433|NCT02790606|57547|P1|STARTED|Overall Study||110
25434|NCT02790463|57564|P2|NOT COMPLETED|Overall Study||309
25435|NCT02790463|57565|P1|NOT COMPLETED|Overall Study||0
25436|NCT02790463|57564|P2|COMPLETED|Overall Study||372
25437|NCT02790463|57565|P1|COMPLETED|Overall Study||782
25438|NCT02790463|57564|P2|STARTED|Overall Study||681
25439|NCT02790463|57565|P1|STARTED|Overall Study||782
25440|NCT02790281|57573|P1|NOT COMPLETED|Overall Study||0
25441|NCT02790281|57573|P1|COMPLETED|Overall Study||33
25442|NCT02790281|57573|P1|STARTED|Overall Study||33
25443|NCT02790073|57579|P1|NOT COMPLETED|Overall Study||3
25444|NCT02790073|57579|P1|COMPLETED|Overall Study||11
25445|NCT02790073|57579|P1|STARTED|Overall Study||14
25446|NCT02789410|57587|P2|NOT COMPLETED|Overall Study||0
25447|NCT02789410|57588|P1|NOT COMPLETED|Overall Study||0
25448|NCT02789410|57587|P2|COMPLETED|Overall Study||68
25449|NCT02789410|57588|P1|COMPLETED|Overall Study||66
25450|NCT02789410|57587|P2|STARTED|Overall Study||68
25451|NCT02789410|57588|P1|STARTED|Overall Study||66
25452|NCT02788474|57600|P2|NOT COMPLETED|Open Label Treatment Period||12
25453|NCT02788474|57601|P1|NOT COMPLETED|Open Label Treatment Period||32
25454|NCT02788474|57600|P2|COMPLETED|Open Label Treatment Period||100
25455|NCT02788474|57601|P1|COMPLETED|Open Label Treatment Period||189
25456|NCT02788474|57600|P2|STARTED|Open Label Treatment Period||112
25457|NCT02788474|57601|P1|STARTED|Open Label Treatment Period||221
25458|NCT02788474|57600|P2|NOT COMPLETED|Double Blind Treatment Period||4
25459|NCT02788474|57601|P1|NOT COMPLETED|Double Blind Treatment Period||10
25460|NCT02788474|57600|P2|COMPLETED|Double Blind Treatment Period||112
25461|NCT02788474|57601|P1|COMPLETED|Double Blind Treatment Period||221
25462|NCT02788474|57600|P2|Treated|Double Blind Treatment Period||116
25463|NCT02788474|57601|P1|Treated|Double Blind Treatment Period||230
25464|NCT02788474|57600|P2|STARTED|Double Blind Treatment Period||116
25465|NCT02788474|57601|P1|STARTED|Double Blind Treatment Period||231
25466|NCT02788357|57616|P2|NOT COMPLETED|Overall Study||0
25467|NCT02788357|57617|P1|NOT COMPLETED|Overall Study||3
25468|NCT02788357|57616|P2|COMPLETED|Overall Study||6
25469|NCT02788357|57617|P1|COMPLETED|Overall Study||3
25470|NCT02788357|57616|P2|STARTED|Overall Study||6
25471|NCT02788357|57617|P1|STARTED|Overall Study||6
25472|NCT02788279|57632|P3|NOT COMPLETED|Overall Study||90
25473|NCT02788279|57633|P2|NOT COMPLETED|Overall Study||183
25474|NCT02788279|57634|P1|NOT COMPLETED|Overall Study||90
25475|NCT02788279|57632|P3|COMPLETED|Overall Study||0
25476|NCT02788279|57633|P2|COMPLETED|Overall Study||0
25477|NCT02788279|57634|P1|COMPLETED|Overall Study||0
25478|NCT02788279|57632|P3|Modified ITT Population|Overall Study||61
25479|NCT02788279|57633|P2|Modified ITT Population|Overall Study||125
25480|NCT02788279|57634|P1|Modified ITT Population|Overall Study||57
25481|NCT02788279|57632|P3|Received Treatment (Safety Population)|Overall Study||90
25482|NCT02788279|57633|P2|Received Treatment (Safety Population)|Overall Study||179
25483|NCT02788279|57634|P1|Received Treatment (Safety Population)|Overall Study||80
25484|NCT02788279|57632|P3|STARTED|Overall Study||90
25485|NCT02788279|57633|P2|STARTED|Overall Study||183
25486|NCT02788279|57634|P1|STARTED|Overall Study||90
25487|NCT02788188|57658|P7|NOT COMPLETED|Overall Study||0
25488|NCT02788188|57659|P6|NOT COMPLETED|Overall Study||0
25489|NCT02788188|57660|P5|NOT COMPLETED|Overall Study||0
25490|NCT02788188|57661|P4|NOT COMPLETED|Overall Study||0
25491|NCT02788188|57662|P3|NOT COMPLETED|Overall Study||0
25492|NCT02788188|57663|P2|NOT COMPLETED|Overall Study||0
25493|NCT02788188|57664|P1|NOT COMPLETED|Overall Study||0
25494|NCT02788188|57658|P7|COMPLETED|Overall Study||10
25495|NCT02788188|57659|P6|COMPLETED|Overall Study||8
25496|NCT02788188|57660|P5|COMPLETED|Overall Study||8
25497|NCT02788188|57661|P4|COMPLETED|Overall Study||4
25498|NCT02788188|57662|P3|COMPLETED|Overall Study||4
25499|NCT02788188|57663|P2|COMPLETED|Overall Study||2
25500|NCT02788188|57664|P1|COMPLETED|Overall Study||2
25501|NCT02788188|57658|P7|STARTED|Overall Study||10
25502|NCT02788188|57659|P6|STARTED|Overall Study||8
25503|NCT02788188|57660|P5|STARTED|Overall Study||8
25504|NCT02788188|57661|P4|STARTED|Overall Study||4
25505|NCT02788188|57662|P3|STARTED|Overall Study||4
25506|NCT02788188|57663|P2|STARTED|Overall Study||2
25507|NCT02788188|57664|P1|STARTED|Overall Study||2
25508|NCT02788097|57682|P2|NOT COMPLETED|Overall Study||0
25509|NCT02788097|57683|P1|NOT COMPLETED|Overall Study||0
25510|NCT02788097|57682|P2|COMPLETED|Overall Study||69
25511|NCT02788097|57683|P1|COMPLETED|Overall Study||61
25512|NCT02788097|57682|P2|STARTED|Overall Study||69
25513|NCT02788097|57683|P1|STARTED|Overall Study||61
25514|NCT02787694|57689|P1|NOT COMPLETED|Overall Study||5
25515|NCT02787694|57689|P1|COMPLETED|Overall Study||17
25516|NCT02787694|57689|P1|STARTED|Overall Study||22
25517|NCT02787564|57695|P2|NOT COMPLETED|Overall Study||2
25518|NCT02787564|57696|P1|NOT COMPLETED|Overall Study||7
25519|NCT02787564|57695|P2|COMPLETED|Overall Study|n=12 food bank users; n=15 non-food bank users|27
25520|NCT02787564|57696|P1|COMPLETED|Overall Study|n=12 food bank users; n=13 non-food bank users|25
25521|NCT02787564|57695|P2|STARTED|Overall Study||29
25522|NCT02787564|57696|P1|STARTED|Overall Study||32
25523|NCT02787551|57714|P2|NOT COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||0
25524|NCT02787551|57715|P1|NOT COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||9
25525|NCT02787551|57714|P2|COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||0
25526|NCT02787551|57715|P1|COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||197
25527|NCT02787551|57714|P2|STARTED|Extension Period:26 Weeks(Upto 52 Weeks)||0
25528|NCT02787551|57715|P1|STARTED|Extension Period:26 Weeks(Upto 52 Weeks)|Participants who completed core period and met eligibility criteria for extension period.|206
25529|NCT02787551|57714|P2|NOT COMPLETED|Core Period: 26 Weeks||11
25530|NCT02787551|57715|P1|NOT COMPLETED|Core Period: 26 Weeks||27
25531|NCT02787551|57714|P2|COMPLETED|Core Period: 26 Weeks||246
25532|NCT02787551|57715|P1|COMPLETED|Core Period: 26 Weeks|Out of 230 participants, 206 participants entered in single arm extension period.|230
25533|NCT02787551|57714|P2|Treated|Core Period: 26 Weeks||256
25534|NCT02787551|57715|P1|Treated|Core Period: 26 Weeks||255
25535|NCT02787551|57714|P2|STARTED|Core Period: 26 Weeks||257
25536|NCT02787551|57715|P1|STARTED|Core Period: 26 Weeks||257
25537|NCT02787304|57751|P4|NOT COMPLETED|Overall Study||34
25538|NCT02787304|57752|P3|NOT COMPLETED|Overall Study||41
25539|NCT02787304|57753|P2|NOT COMPLETED|Overall Study||38
25540|NCT02787304|57754|P1|NOT COMPLETED|Overall Study||36
25541|NCT02787304|57751|P4|COMPLETED|Overall Study||15
25542|NCT02787304|57752|P3|COMPLETED|Overall Study||8
25543|NCT02787304|57753|P2|COMPLETED|Overall Study||12
25544|NCT02787304|57754|P1|COMPLETED|Overall Study||13
25545|NCT02787304|57751|P4|STARTED|Overall Study||49
25546|NCT02787304|57752|P3|STARTED|Overall Study||49
25547|NCT02787304|57753|P2|STARTED|Overall Study|One subject was randomized and received 1 dose of study drug but withdrew from the study.|50
25548|NCT02787304|57754|P1|STARTED|Overall Study||49
25549|NCT02786953|57802|P2|NOT COMPLETED|Overall Study||0
25550|NCT02786953|57803|P1|NOT COMPLETED|Overall Study||4
25551|NCT02786953|57802|P2|COMPLETED|Overall Study||20
25552|NCT02786953|57803|P1|COMPLETED|Overall Study||15
25553|NCT02786953|57802|P2|3 Month Parent Survey Completed|Overall Study||20
25554|NCT02786953|57803|P1|3 Month Parent Survey Completed|Overall Study||15
25555|NCT02786953|57802|P2|3 Month Teen Survey Completed|Overall Study||20
25556|NCT02786953|57803|P1|3 Month Teen Survey Completed|Overall Study||15
25557|NCT02786953|57802|P2|Session 3 Completed|Overall Study||0
25558|NCT02786953|57803|P1|Session 3 Completed|Overall Study||16
25559|NCT02786953|57802|P2|Session 2 Completed|Overall Study||0
25560|NCT02786953|57803|P1|Session 2 Completed|Overall Study||16
25561|NCT02786953|57802|P2|Session 1 Completed|Overall Study||0
25562|NCT02786953|57803|P1|Session 1 Completed|Overall Study||17
25563|NCT02786953|57802|P2|A1C Data Complete|Overall Study||19
25564|NCT02786953|57803|P1|A1C Data Complete|Overall Study||15
25565|NCT02786953|57802|P2|Actigraph Data Complete|Overall Study||12
25566|NCT02786953|57803|P1|Actigraph Data Complete|Overall Study||13
25567|NCT02786953|57802|P2|Baseline Parent Survey Completed|Overall Study||20
25568|NCT02786953|57803|P1|Baseline Parent Survey Completed|Overall Study||19
25569|NCT02786953|57802|P2|Baseline Teen Survey Data Completed|Overall Study||20
25570|NCT02786953|57803|P1|Baseline Teen Survey Data Completed|Overall Study||19
25571|NCT02786953|57802|P2|STARTED|Overall Study||20
25572|NCT02786953|57803|P1|STARTED|Overall Study||19
25573|NCT02786927|57825|P1|NOT COMPLETED|Overall Study||5
25574|NCT02786927|57825|P1|COMPLETED|Overall Study||207
25575|NCT02786927|57825|P1|STARTED|Overall Study||212
25576|NCT02786810|57832|P1|NOT COMPLETED|Overall Study||0
25577|NCT02786810|57832|P1|COMPLETED|Overall Study||10
25578|NCT02786810|57832|P1|STARTED|Overall Study||10
25579|NCT02786771|57839|P2|NOT COMPLETED|Overall Study||6
25580|NCT02786771|57840|P1|NOT COMPLETED|Overall Study||10
25581|NCT02786771|57839|P2|COMPLETED|Overall Study||56
25582|NCT02786771|57840|P1|COMPLETED|Overall Study||53
25583|NCT02786771|57839|P2|STARTED|Overall Study||62
25584|NCT02786771|57840|P1|STARTED|Overall Study||63
25585|NCT02786355|57846|P1|NOT COMPLETED|Overall Study||0
25586|NCT02786355|57846|P1|COMPLETED|Overall Study||35
25587|NCT02786355|57846|P1|STARTED|Overall Study||35
25588|NCT02786004|57855|P2|NOT COMPLETED|Overall Study||1
25589|NCT02786004|57856|P1|NOT COMPLETED|Overall Study||0
25590|NCT02786004|57855|P2|COMPLETED|Overall Study||9
25591|NCT02786004|57856|P1|COMPLETED|Overall Study||14
25592|NCT02786004|57855|P2|STARTED|Overall Study||10
25593|NCT02786004|57856|P1|STARTED|Overall Study||14
25594|NCT02785913|57864|P1|NOT COMPLETED|Overall Study||31
25595|NCT02785913|57864|P1|COMPLETED|Overall Study||0
25596|NCT02785913|57864|P1|Eligible and Began Protocol Therapy|Overall Study||26
25597|NCT02785913|57864|P1|Eligible|Overall Study||27
25598|NCT02785913|57864|P1|STARTED|Overall Study||31
25599|NCT02785900|57873|P2|NOT COMPLETED|Overall Study||123
25600|NCT02785900|57874|P1|NOT COMPLETED|Overall Study||117
25601|NCT02785900|57873|P2|COMPLETED|Overall Study||0
25602|NCT02785900|57874|P1|COMPLETED|Overall Study||0
25603|NCT02785900|57873|P2|STARTED|Overall Study||123
25604|NCT02785900|57874|P1|STARTED|Overall Study||117
25605|NCT02785770|57898|P4|NOT COMPLETED|Intervention Period 4 (1 Day)||0
25606|NCT02785770|57899|P3|NOT COMPLETED|Intervention Period 4 (1 Day)||0
25607|NCT02785770|57900|P2|NOT COMPLETED|Intervention Period 4 (1 Day)||0
25608|NCT02785770|57901|P1|NOT COMPLETED|Intervention Period 4 (1 Day)||0
25609|NCT02785770|57898|P4|COMPLETED|Intervention Period 4 (1 Day)||10
25610|NCT02785770|57899|P3|COMPLETED|Intervention Period 4 (1 Day)||10
25611|NCT02785770|57900|P2|COMPLETED|Intervention Period 4 (1 Day)||10
25612|NCT02785770|57901|P1|COMPLETED|Intervention Period 4 (1 Day)||11
25613|NCT02785770|57898|P4|STARTED|Intervention Period 4 (1 Day)||10
25614|NCT02785770|57899|P3|STARTED|Intervention Period 4 (1 Day)||10
25615|NCT02785770|57900|P2|STARTED|Intervention Period 4 (1 Day)||10
25616|NCT02785770|57901|P1|STARTED|Intervention Period 4 (1 Day)||11
25617|NCT02785770|57898|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
25618|NCT02785770|57899|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
25619|NCT02785770|57900|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
25620|NCT02785770|57901|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
25621|NCT02785770|57898|P4|COMPLETED|Washout Period 3 (7 Days)||10
25622|NCT02785770|57899|P3|COMPLETED|Washout Period 3 (7 Days)||10
25623|NCT02785770|57900|P2|COMPLETED|Washout Period 3 (7 Days)||10
25624|NCT02785770|57901|P1|COMPLETED|Washout Period 3 (7 Days)||11
25625|NCT02785770|57898|P4|STARTED|Washout Period 3 (7 Days)||10
25626|NCT02785770|57899|P3|STARTED|Washout Period 3 (7 Days)||10
25627|NCT02785770|57900|P2|STARTED|Washout Period 3 (7 Days)||10
25628|NCT02785770|57901|P1|STARTED|Washout Period 3 (7 Days)||11
25629|NCT02785770|57898|P4|NOT COMPLETED|Intervention Period 3 (1 Day)||1
25630|NCT02785770|57899|P3|NOT COMPLETED|Intervention Period 3 (1 Day)||0
25631|NCT02785770|57900|P2|NOT COMPLETED|Intervention Period 3 (1 Day)||0
25632|NCT02785770|57901|P1|NOT COMPLETED|Intervention Period 3 (1 Day)||0
25633|NCT02785770|57898|P4|COMPLETED|Intervention Period 3 (1 Day)||10
25634|NCT02785770|57899|P3|COMPLETED|Intervention Period 3 (1 Day)||10
25635|NCT02785770|57900|P2|COMPLETED|Intervention Period 3 (1 Day)||10
25636|NCT02785770|57901|P1|COMPLETED|Intervention Period 3 (1 Day)||11
25637|NCT02785770|57898|P4|STARTED|Intervention Period 3 (1 Day)||11
25638|NCT02785770|57899|P3|STARTED|Intervention Period 3 (1 Day)||10
25639|NCT02785770|57900|P2|STARTED|Intervention Period 3 (1 Day)||10
25640|NCT02785770|57901|P1|STARTED|Intervention Period 3 (1 Day)||11
25641|NCT02785770|57898|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
25642|NCT02785770|57899|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
25643|NCT02785770|57900|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
25644|NCT02785770|57901|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
25645|NCT02785770|57898|P4|COMPLETED|Washout Period 2 (7 Days)||11
25646|NCT02785770|57899|P3|COMPLETED|Washout Period 2 (7 Days)||10
25647|NCT02785770|57900|P2|COMPLETED|Washout Period 2 (7 Days)||10
25648|NCT02785770|57901|P1|COMPLETED|Washout Period 2 (7 Days)||11
25649|NCT02785770|57898|P4|STARTED|Washout Period 2 (7 Days)||11
25650|NCT02785770|57899|P3|STARTED|Washout Period 2 (7 Days)||10
25651|NCT02785770|57900|P2|STARTED|Washout Period 2 (7 Days)||10
25652|NCT02785770|57901|P1|STARTED|Washout Period 2 (7 Days)||11
25653|NCT02785770|57898|P4|NOT COMPLETED|Intervention Period 2 (1 Day)||0
25654|NCT02785770|57899|P3|NOT COMPLETED|Intervention Period 2 (1 Day)||1
25655|NCT02785770|57900|P2|NOT COMPLETED|Intervention Period 2 (1 Day)||1
25656|NCT02785770|57901|P1|NOT COMPLETED|Intervention Period 2 (1 Day)||0
25657|NCT02785770|57898|P4|COMPLETED|Intervention Period 2 (1 Day)||11
25658|NCT02785770|57899|P3|COMPLETED|Intervention Period 2 (1 Day)||10
25659|NCT02785770|57900|P2|COMPLETED|Intervention Period 2 (1 Day)||10
25660|NCT02785770|57901|P1|COMPLETED|Intervention Period 2 (1 Day)||11
25661|NCT02785770|57898|P4|STARTED|Intervention Period 2 (1 Day)||11
25662|NCT02785770|57899|P3|STARTED|Intervention Period 2 (1 Day)||11
25663|NCT02785770|57900|P2|STARTED|Intervention Period 2 (1 Day)||11
25664|NCT02785770|57901|P1|STARTED|Intervention Period 2 (1 Day)||11
25665|NCT02785770|57898|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
25666|NCT02785770|57899|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
25667|NCT02785770|57900|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
25668|NCT02785770|57901|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
25669|NCT02785770|57898|P4|COMPLETED|Washout Period 1 (7 Days)||11
25670|NCT02785770|57899|P3|COMPLETED|Washout Period 1 (7 Days)||11
25671|NCT02785770|57900|P2|COMPLETED|Washout Period 1 (7 Days)||11
25672|NCT02785770|57901|P1|COMPLETED|Washout Period 1 (7 Days)||11
25673|NCT02785770|57898|P4|STARTED|Washout Period 1 (7 Days)||11
25674|NCT02785770|57899|P3|STARTED|Washout Period 1 (7 Days)||11
25675|NCT02785770|57900|P2|STARTED|Washout Period 1 (7 Days)||11
25676|NCT02785770|57901|P1|STARTED|Washout Period 1 (7 Days)||11
25677|NCT02785770|57898|P4|NOT COMPLETED|Intervention Period 1 (1 Day)||0
25678|NCT02785770|57899|P3|NOT COMPLETED|Intervention Period 1 (1 Day)||0
25679|NCT02785770|57900|P2|NOT COMPLETED|Intervention Period 1 (1 Day)||0
25680|NCT02785770|57901|P1|NOT COMPLETED|Intervention Period 1 (1 Day)||0
25681|NCT02785770|57898|P4|COMPLETED|Intervention Period 1 (1 Day)||11
25682|NCT02785770|57899|P3|COMPLETED|Intervention Period 1 (1 Day)||11
25683|NCT02785770|57900|P2|COMPLETED|Intervention Period 1 (1 Day)||11
25684|NCT02785770|57901|P1|COMPLETED|Intervention Period 1 (1 Day)||11
25685|NCT02785770|57898|P4|STARTED|Intervention Period 1 (1 Day)||11
25686|NCT02785770|57899|P3|STARTED|Intervention Period 1 (1 Day)||11
25687|NCT02785770|57900|P2|STARTED|Intervention Period 1 (1 Day)||11
25688|NCT02785770|57901|P1|STARTED|Intervention Period 1 (1 Day)||11
25689|NCT02785588|57968|P1|NOT COMPLETED|Phase2 Controlled Image &Data Collection||0
25690|NCT02785588|57968|P1|COMPLETED|Phase2 Controlled Image &Data Collection||5
25691|NCT02785588|57968|P1|STARTED|Phase2 Controlled Image &Data Collection|Phase 2 participants represent newly enrolled participants.|5
25692|NCT02785588|57968|P1|NOT COMPLETED|Phase 1: Initial Feasibility Assessment||2
25693|NCT02785588|57968|P1|COMPLETED|Phase 1: Initial Feasibility Assessment||47
25694|NCT02785588|57968|P1|STARTED|Phase 1: Initial Feasibility Assessment||49
25695|NCT02785354|57985|P3|NOT COMPLETED|Overall Study||0
25696|NCT02785354|57986|P2|NOT COMPLETED|Overall Study||0
25697|NCT02785354|57987|P1|NOT COMPLETED|Overall Study||0
25698|NCT02785354|57985|P3|COMPLETED|Overall Study||44653
25699|NCT02785354|57986|P2|COMPLETED|Overall Study||31388
25700|NCT02785354|57987|P1|COMPLETED|Overall Study||27060
25701|NCT02785354|57985|P3|STARTED|Overall Study||44653
25702|NCT02785354|57986|P2|STARTED|Overall Study||31388
25703|NCT02785354|57987|P1|STARTED|Overall Study||27060
25704|NCT02784925|58016|P1|NOT COMPLETED|Overall Study||0
25705|NCT02784925|58016|P1|COMPLETED|Overall Study||30
25706|NCT02784925|58016|P1|STARTED|Overall Study||30
25707|NCT02784834|58020|P1|NOT COMPLETED|Overall Study||1
25708|NCT02784834|58020|P1|COMPLETED|Overall Study||1
25709|NCT02784834|58020|P1|STARTED|Overall Study||2
25710|NCT02784704|58026|P2|NOT COMPLETED|Overall Study||9
25711|NCT02784704|58027|P1|NOT COMPLETED|Overall Study||13
25712|NCT02784704|58026|P2|COMPLETED|Overall Study||241
25713|NCT02784704|58027|P1|COMPLETED|Overall Study||237
25714|NCT02784704|58026|P2|Treated|Overall Study||249
25715|NCT02784704|58027|P1|Treated|Overall Study||250
25716|NCT02784704|58026|P2|STARTED|Overall Study||250
25717|NCT02784704|58027|P1|STARTED|Overall Study||250
25718|NCT02784613|58037|P1|NOT COMPLETED|Overall Study||2
25719|NCT02784613|58037|P1|COMPLETED|Overall Study||8
25720|NCT02784613|58037|P1|STARTED|Overall Study||10
25721|NCT02784587|58043|P1|NOT COMPLETED|Overall Study||0
25722|NCT02784587|58043|P1|COMPLETED|Overall Study||25
25723|NCT02784587|58043|P1|STARTED|Overall Study||25
25724|NCT02784548|58047|P1|NOT COMPLETED|Overall Study||0
25725|NCT02784548|58047|P1|COMPLETED|Overall Study||15
25726|NCT02784548|58047|P1|STARTED|Overall Study||15
25727|NCT02784275|58056|P4|NOT COMPLETED|Overall Study||1
25728|NCT02784275|58057|P3|NOT COMPLETED|Overall Study||1
25729|NCT02784275|58058|P2|NOT COMPLETED|Overall Study||0
25730|NCT02784275|58059|P1|NOT COMPLETED|Overall Study||1
25731|NCT02784275|58056|P4|COMPLETED|Overall Study||14
25732|NCT02784275|58057|P3|COMPLETED|Overall Study||16
25733|NCT02784275|58058|P2|COMPLETED|Overall Study||16
25734|NCT02784275|58059|P1|COMPLETED|Overall Study||15
25735|NCT02784275|58056|P4|STARTED|Overall Study||15
25736|NCT02784275|58057|P3|STARTED|Overall Study||17
25737|NCT02784275|58058|P2|STARTED|Overall Study||16
25738|NCT02784275|58059|P1|STARTED|Overall Study||16
25739|NCT02784106|58103|P4|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||2
25740|NCT02784106|58104|P3|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||3
25741|NCT02784106|58105|P2|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
25742|NCT02784106|58106|P1|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
25743|NCT02784106|58103|P4|COMPLETED|Open-Label Extension Period (26 Weeks)||19
25744|NCT02784106|58104|P3|COMPLETED|Open-Label Extension Period (26 Weeks)||15
25745|NCT02784106|58105|P2|COMPLETED|Open-Label Extension Period (26 Weeks)||0
25746|NCT02784106|58106|P1|COMPLETED|Open-Label Extension Period (26 Weeks)||0
25747|NCT02784106|58103|P4|STARTED|Open-Label Extension Period (26 Weeks)||21
25748|NCT02784106|58104|P3|STARTED|Open-Label Extension Period (26 Weeks)||18
25749|NCT02784106|58105|P2|STARTED|Open-Label Extension Period (26 Weeks)||0
25750|NCT02784106|58106|P1|STARTED|Open-Label Extension Period (26 Weeks)||0
25751|NCT02784106|58103|P4|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
25752|NCT02784106|58104|P3|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
25753|NCT02784106|58105|P2|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||6
25754|NCT02784106|58106|P1|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||8
25755|NCT02784106|58103|P4|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
25756|NCT02784106|58104|P3|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
25757|NCT02784106|58105|P2|COMPLETED|Double-Blind Treatment Period (12 Weeks)||27
25758|NCT02784106|58106|P1|COMPLETED|Double-Blind Treatment Period (12 Weeks)||24
25759|NCT02784106|58103|P4|STARTED|Double-Blind Treatment Period (12 Weeks)||0
25760|NCT02784106|58104|P3|STARTED|Double-Blind Treatment Period (12 Weeks)||0
25761|NCT02784106|58105|P2|STARTED|Double-Blind Treatment Period (12 Weeks)||33
25762|NCT02784106|58106|P1|STARTED|Double-Blind Treatment Period (12 Weeks)||32
25763|NCT02783898|58169|P2|NOT COMPLETED|Overall Study||1
25764|NCT02783898|58170|P1|NOT COMPLETED|Overall Study||1
25765|NCT02783898|58169|P2|COMPLETED|Overall Study||116
25766|NCT02783898|58170|P1|COMPLETED|Overall Study||124
25767|NCT02783898|58169|P2|STARTED|Overall Study||117
25768|NCT02783898|58170|P1|STARTED|Overall Study||125
25769|NCT02783599|58190|P1|NOT COMPLETED|Overall Study||40
25770|NCT02783599|58190|P1|COMPLETED|Overall Study||11
25771|NCT02783599|58190|P1|Received At Least One Dose of Study Drug|Overall Study||51
25772|NCT02783599|58190|P1|STARTED|Overall Study||51
25773|NCT02783573|58206|P3|NOT COMPLETED|Delayed-Start Period||12
25774|NCT02783573|58207|P2|NOT COMPLETED|Delayed-Start Period||17
25775|NCT02783573|58208|P1|NOT COMPLETED|Delayed-Start Period||0
25776|NCT02783573|58206|P3|COMPLETED|Delayed-Start Period||0
25777|NCT02783573|58207|P2|COMPLETED|Delayed-Start Period||0
25778|NCT02783573|58208|P1|COMPLETED|Delayed-Start Period||0
25779|NCT02783573|58206|P3|Received at Least 1 Dose of Study Drug|Delayed-Start Period||12
25780|NCT02783573|58207|P2|Received at Least 1 Dose of Study Drug|Delayed-Start Period||14
25781|NCT02783573|58208|P1|Received at Least 1 Dose of Study Drug|Delayed-Start Period||0
25782|NCT02783573|58206|P3|STARTED|Delayed-Start Period|Participants completed period 1 may not have entered period 2 due to early termination of the study.|12
25783|NCT02783573|58207|P2|STARTED|Delayed-Start Period|Participants completed period 1 may not have entered period 2 due to early termination of the study.|17
25784|NCT02783573|58208|P1|STARTED|Delayed-Start Period|Participants from placebo group were randomized to Lanabecestat 20 mg and 50 mg.|0
25785|NCT02783573|58206|P3|NOT COMPLETED|Placebo-Controlled Treatment Period||548
25786|NCT02783573|58207|P2|NOT COMPLETED|Placebo-Controlled Treatment Period||562
25787|NCT02783573|58208|P1|NOT COMPLETED|Placebo-Controlled Treatment Period||536
25788|NCT02783573|58206|P3|COMPLETED|Placebo-Controlled Treatment Period||22
25789|NCT02783573|58207|P2|COMPLETED|Placebo-Controlled Treatment Period||28
25790|NCT02783573|58208|P1|COMPLETED|Placebo-Controlled Treatment Period||26
25791|NCT02783573|58206|P3|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||568
25792|NCT02783573|58207|P2|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||588
25793|NCT02783573|58208|P1|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||558
25794|NCT02783573|58206|P3|STARTED|Placebo-Controlled Treatment Period||570
25795|NCT02783573|58207|P2|STARTED|Placebo-Controlled Treatment Period||590
25796|NCT02783573|58208|P1|STARTED|Placebo-Controlled Treatment Period||562
25797|NCT02783443|58264|P2|NOT COMPLETED|Overall Study||0
25798|NCT02783443|58265|P1|NOT COMPLETED|Overall Study||0
25799|NCT02783443|58264|P2|COMPLETED|Overall Study||30
25800|NCT02783443|58265|P1|COMPLETED|Overall Study||30
25801|NCT02783443|58264|P2|STARTED|Overall Study||30
25802|NCT02783443|58265|P1|STARTED|Overall Study||30
25803|NCT02783170|58273|P2|NOT COMPLETED|Overall Study||0
25804|NCT02783170|58274|P1|NOT COMPLETED|Overall Study||1
25805|NCT02783170|58273|P2|COMPLETED|Overall Study||38
25806|NCT02783170|58274|P1|COMPLETED|Overall Study||42
25807|NCT02783170|58273|P2|Safety Population|Overall Study|Excluded sub. randomized but not vaccinated. Excluded sub. randomized to seq. but got simultaneous.|38
25808|NCT02783170|58274|P1|Safety Population|Overall Study|Added subject randomized to sequential but got simultaneous.|42
25809|NCT02783170|58273|P2|STARTED|Overall Study||38
25810|NCT02783170|58274|P1|STARTED|Overall Study||43
25811|NCT02782676|58315|P2|NOT COMPLETED|Overall Study||1
25812|NCT02782676|58316|P1|NOT COMPLETED|Overall Study||0
25813|NCT02782676|58315|P2|COMPLETED|Overall Study||209
25814|NCT02782676|58316|P1|COMPLETED|Overall Study||211
25815|NCT02782676|58315|P2|STARTED|Overall Study||210
25816|NCT02782676|58316|P1|STARTED|Overall Study||211
25817|NCT02782325|58346|P3|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||4
25818|NCT02782325|58347|P2|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
25819|NCT02782325|58348|P1|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
25820|NCT02782325|58346|P3|COMPLETED|Open Label FMT Period (up to 24 Weeks)||1
25821|NCT02782325|58347|P2|COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
25822|NCT02782325|58348|P1|COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
25823|NCT02782325|58346|P3|STARTED|Open Label FMT Period (up to 24 Weeks)|1 participant decided to not participate in the open label period|5
25824|NCT02782325|58347|P2|STARTED|Open Label FMT Period (up to 24 Weeks)||0
25825|NCT02782325|58348|P1|STARTED|Open Label FMT Period (up to 24 Weeks)||0
25826|NCT02782325|58346|P3|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
25827|NCT02782325|58347|P2|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||2
25828|NCT02782325|58348|P1|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||4
25829|NCT02782325|58346|P3|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
25830|NCT02782325|58347|P2|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
25831|NCT02782325|58348|P1|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
25832|NCT02782325|58346|P3|STARTED|Blinded FMT Treatment (up to 24 Weeks)||0
25833|NCT02782325|58347|P2|STARTED|Blinded FMT Treatment (up to 24 Weeks)||2
25834|NCT02782325|58348|P1|STARTED|Blinded FMT Treatment (up to 24 Weeks)||4
25835|NCT02782169|58376|P2|NOT COMPLETED|Overall Study||2
25836|NCT02782169|58377|P1|NOT COMPLETED|Overall Study||1
25837|NCT02782169|58376|P2|COMPLETED|Overall Study||52
25838|NCT02782169|58377|P1|COMPLETED|Overall Study||55
25839|NCT02782169|58376|P2|STARTED|Overall Study||54
25840|NCT02782169|58377|P1|STARTED|Overall Study||56
25841|NCT02781818|58394|P3|NOT COMPLETED|Overall Study||1
25842|NCT02781818|58395|P2|NOT COMPLETED|Overall Study||2
25843|NCT02781818|58396|P1|NOT COMPLETED|Overall Study||4
25844|NCT02781818|58394|P3|COMPLETED|Overall Study||16
25845|NCT02781818|58395|P2|COMPLETED|Overall Study||16
25846|NCT02781818|58396|P1|COMPLETED|Overall Study||16
25847|NCT02781818|58394|P3|STARTED|Overall Study||17
25848|NCT02781818|58395|P2|STARTED|Overall Study||18
25849|NCT02781818|58396|P1|STARTED|Overall Study||20
25850|NCT02781649|58413|P3|NOT COMPLETED|Overall Study||0
25851|NCT02781649|58414|P2|NOT COMPLETED|Overall Study||0
25852|NCT02781649|58415|P1|NOT COMPLETED|Overall Study||0
25853|NCT02781649|58413|P3|COMPLETED|Overall Study||3
25854|NCT02781649|58414|P2|COMPLETED|Overall Study||0
25855|NCT02781649|58415|P1|COMPLETED|Overall Study||7
25856|NCT02781649|58413|P3|STARTED|Overall Study||3
25857|NCT02781649|58414|P2|STARTED|Overall Study||0
25858|NCT02781649|58415|P1|STARTED|Overall Study|4 in this group had insufficient viral RNA for genotyping. They were treated as 1a|7
25859|NCT02781571|58441|P1|NOT COMPLETED|Overall Study||0
25860|NCT02781571|58441|P1|COMPLETED|Overall Study||79
25861|NCT02781571|58441|P1|STARTED|Overall Study||79
25862|NCT02781558|58462|P2|NOT COMPLETED|Overall Study||2
25863|NCT02781558|58463|P1|NOT COMPLETED|Overall Study||3
25864|NCT02781558|58462|P2|COMPLETED|Overall Study||101
25865|NCT02781558|58463|P1|COMPLETED|Overall Study||98
25866|NCT02781558|58462|P2|STARTED|Overall Study||103
25867|NCT02781558|58463|P1|STARTED|Overall Study||101
25868|NCT02781324|58501|P2|NOT COMPLETED|Overall Study||2
25869|NCT02781324|58502|P1|NOT COMPLETED|Overall Study||2
25870|NCT02781324|58501|P2|COMPLETED|Overall Study||31
25871|NCT02781324|58502|P1|COMPLETED|Overall Study||31
25872|NCT02781324|58501|P2|STARTED|Overall Study||33
25873|NCT02781324|58502|P1|STARTED|Overall Study||33
25874|NCT02781311|58511|P3|NOT COMPLETED|Overall Study||4
25875|NCT02781311|58512|P2|NOT COMPLETED|Overall Study||26
25876|NCT02781311|58513|P1|NOT COMPLETED|Overall Study||26
25877|NCT02781311|58511|P3|COMPLETED|Overall Study||8
25878|NCT02781311|58512|P2|COMPLETED|Overall Study||57
25879|NCT02781311|58513|P1|COMPLETED|Overall Study||48
25880|NCT02781311|58511|P3|mITT Population|Overall Study||11
25881|NCT02781311|58512|P2|mITT Population|Overall Study||78
25882|NCT02781311|58513|P1|mITT Population|Overall Study||70
25883|NCT02781311|58511|P3|Safety Population (Treated)|Overall Study||12
25884|NCT02781311|58512|P2|Safety Population (Treated)|Overall Study||81
25885|NCT02781311|58513|P1|Safety Population (Treated)|Overall Study||73
25886|NCT02781311|58511|P3|STARTED|Overall Study||12
25887|NCT02781311|58512|P2|STARTED|Overall Study||83
25888|NCT02781311|58513|P1|STARTED|Overall Study||74
25889|NCT02781051|58522|P1|NOT COMPLETED|Overall Study||2
25890|NCT02781051|58522|P1|COMPLETED|Overall Study||14
25891|NCT02781051|58522|P1|STARTED|Overall Study||16
25892|NCT02780869|58529|P2|NOT COMPLETED|Overall Study||9
25893|NCT02780869|58530|P1|NOT COMPLETED|Overall Study||13
25894|NCT02780869|58529|P2|COMPLETED|Overall Study||74
25895|NCT02780869|58530|P1|COMPLETED|Overall Study||162
25896|NCT02780869|58529|P2|STARTED|Overall Study||83
25897|NCT02780869|58530|P1|STARTED|Overall Study||175
25898|NCT02780856|58540|P1|NOT COMPLETED|Overall Study||1
25899|NCT02780856|58540|P1|COMPLETED|Overall Study||109
25900|NCT02780856|58540|P1|STARTED|Overall Study||110
25901|NCT02780765|58550|P2|NOT COMPLETED|Overall Study||0
25902|NCT02780765|58551|P1|NOT COMPLETED|Overall Study||0
25903|NCT02780765|58550|P2|COMPLETED|Overall Study||30
25904|NCT02780765|58551|P1|COMPLETED|Overall Study||30
25905|NCT02780765|58550|P2|STARTED|Overall Study||30
25906|NCT02780765|58551|P1|STARTED|Overall Study||30
25907|NCT02780700|58559|P1|NOT COMPLETED|Overall Study||1
25908|NCT02780700|58559|P1|COMPLETED|Overall Study||0
25909|NCT02780700|58559|P1|STARTED|Overall Study||1
25910|NCT02780661|58567|P2|NOT COMPLETED|Period 2||0
25911|NCT02780661|58568|P1|NOT COMPLETED|Period 2||0
25912|NCT02780661|58567|P2|COMPLETED|Period 2||9
25913|NCT02780661|58568|P1|COMPLETED|Period 2||10
25914|NCT02780661|58567|P2|STARTED|Period 2||9
25915|NCT02780661|58568|P1|STARTED|Period 2||10
25916|NCT02780661|58567|P2|NOT COMPLETED|Wash Out Period||0
25917|NCT02780661|58568|P1|NOT COMPLETED|Wash Out Period||0
25918|NCT02780661|58567|P2|COMPLETED|Wash Out Period||9
25919|NCT02780661|58568|P1|COMPLETED|Wash Out Period||10
25920|NCT02780661|58567|P2|STARTED|Wash Out Period||9
25921|NCT02780661|58568|P1|STARTED|Wash Out Period||10
25922|NCT02780661|58567|P2|NOT COMPLETED|Period 1||0
25923|NCT02780661|58568|P1|NOT COMPLETED|Period 1||0
25924|NCT02780661|58567|P2|COMPLETED|Period 1||9
25925|NCT02780661|58568|P1|COMPLETED|Period 1||10
25926|NCT02780661|58567|P2|STARTED|Period 1||9
25927|NCT02780661|58568|P1|STARTED|Period 1||10
25928|NCT02780622|58584|P2|NOT COMPLETED|Treatment Period 2||0
25929|NCT02780622|58585|P1|NOT COMPLETED|Treatment Period 2||0
25930|NCT02780622|58584|P2|COMPLETED|Treatment Period 2||10
25931|NCT02780622|58585|P1|COMPLETED|Treatment Period 2||10
25932|NCT02780622|58584|P2|STARTED|Treatment Period 2||10
25933|NCT02780622|58585|P1|STARTED|Treatment Period 2||10
25934|NCT02780622|58584|P2|NOT COMPLETED|Treatment Period 1||0
25935|NCT02780622|58585|P1|NOT COMPLETED|Treatment Period 1||0
25936|NCT02780622|58584|P2|COMPLETED|Treatment Period 1||10
25937|NCT02780622|58585|P1|COMPLETED|Treatment Period 1||10
25938|NCT02780622|58584|P2|STARTED|Treatment Period 1||10
25939|NCT02780622|58585|P1|STARTED|Treatment Period 1||10
25940|NCT02780388|58628|P5|NOT COMPLETED|Overall Study||0
25941|NCT02780388|58629|P4|NOT COMPLETED|Overall Study||0
25942|NCT02780388|58630|P3|NOT COMPLETED|Overall Study||0
25943|NCT02780388|58631|P2|NOT COMPLETED|Overall Study||2
25944|NCT02780388|58632|P1|NOT COMPLETED|Overall Study||1
25945|NCT02780388|58628|P5|COMPLETED|Overall Study||12
25946|NCT02780388|58629|P4|COMPLETED|Overall Study||12
25947|NCT02780388|58630|P3|COMPLETED|Overall Study||10
25948|NCT02780388|58631|P2|COMPLETED|Overall Study||6
25949|NCT02780388|58632|P1|COMPLETED|Overall Study||14
25950|NCT02780388|58628|P5|STARTED|Overall Study||12
25951|NCT02780388|58629|P4|STARTED|Overall Study||12
25952|NCT02780388|58630|P3|STARTED|Overall Study||10
25953|NCT02780388|58631|P2|STARTED|Overall Study||8
25954|NCT02780388|58632|P1|STARTED|Overall Study||15
25955|NCT02780349|58689|P1|NOT COMPLETED|Overall Study||2
25956|NCT02780349|58689|P1|COMPLETED|Overall Study||101
25957|NCT02780349|58689|P1|STARTED|Overall Study||103
25958|NCT02780167|58698|P5|NOT COMPLETED|Overall Study||17
25959|NCT02780167|58699|P4|NOT COMPLETED|Overall Study||19
25960|NCT02780167|58700|P3|NOT COMPLETED|Overall Study||24
25961|NCT02780167|58701|P2|NOT COMPLETED|Overall Study||22
25962|NCT02780167|58702|P1|NOT COMPLETED|Overall Study||28
25963|NCT02780167|58698|P5|COMPLETED|Overall Study||38
25964|NCT02780167|58699|P4|COMPLETED|Overall Study||37
25965|NCT02780167|58700|P3|COMPLETED|Overall Study||27
25966|NCT02780167|58701|P2|COMPLETED|Overall Study||27
25967|NCT02780167|58702|P1|COMPLETED|Overall Study||28
25968|NCT02780167|58698|P5|STARTED|Overall Study||55
25969|NCT02780167|58699|P4|STARTED|Overall Study||56
25970|NCT02780167|58700|P3|STARTED|Overall Study||51
25971|NCT02780167|58701|P2|STARTED|Overall Study||49
25972|NCT02780167|58702|P1|STARTED|Overall Study||56
25973|NCT02779543|58836|P2|NOT COMPLETED|Overall Study||0
25974|NCT02779543|58837|P1|NOT COMPLETED|Overall Study||0
25975|NCT02779543|58836|P2|COMPLETED|Overall Study||100
25976|NCT02779543|58837|P1|COMPLETED|Overall Study||100
25977|NCT02779543|58836|P2|STARTED|Overall Study||100
25978|NCT02779543|58837|P1|STARTED|Overall Study||100
25979|NCT02779491|58853|P4|NOT COMPLETED|Overall Study||2
25980|NCT02779491|58854|P3|NOT COMPLETED|Overall Study||1
25981|NCT02779491|58855|P2|NOT COMPLETED|Overall Study||1
25982|NCT02779491|58856|P1|NOT COMPLETED|Overall Study||0
25983|NCT02779491|58853|P4|COMPLETED|Overall Study||15
25984|NCT02779491|58854|P3|COMPLETED|Overall Study||17
25985|NCT02779491|58855|P2|COMPLETED|Overall Study||26
25986|NCT02779491|58856|P1|COMPLETED|Overall Study||32
25987|NCT02779491|58853|P4|STARTED|Overall Study||17
25988|NCT02779491|58854|P3|STARTED|Overall Study||18
25989|NCT02779491|58855|P2|STARTED|Overall Study||27
25990|NCT02779491|58856|P1|STARTED|Overall Study||32
25991|NCT02779166|58876|P2|NOT COMPLETED|Overall Study||0
25992|NCT02779166|58877|P1|NOT COMPLETED|Overall Study||0
25993|NCT02779166|58876|P2|COMPLETED|Overall Study||48
25994|NCT02779166|58877|P1|COMPLETED|Overall Study||50
25995|NCT02779166|58876|P2|STARTED|Overall Study||48
25996|NCT02779166|58877|P1|STARTED|Overall Study||50
25997|NCT02778555|58890|P3|NOT COMPLETED|Overall Study||107
25998|NCT02778555|58891|P2|NOT COMPLETED|Overall Study||32
25999|NCT02778555|58892|P1|NOT COMPLETED|Overall Study||55
26000|NCT02778555|58890|P3|COMPLETED|Overall Study||211
26001|NCT02778555|58891|P2|COMPLETED|Overall Study||177
26002|NCT02778555|58892|P1|COMPLETED|Overall Study||131
26003|NCT02778555|58890|P3|STARTED|Overall Study||318
26004|NCT02778555|58891|P2|STARTED|Overall Study||209
26005|NCT02778555|58892|P1|STARTED|Overall Study||186
26006|NCT02778152|58900|P1|NOT COMPLETED|Overall Study||0
26007|NCT02778152|58900|P1|COMPLETED|Overall Study||13
26008|NCT02778152|58900|P1|STARTED|Overall Study||13
26009|NCT02778113|58905|P4|NOT COMPLETED|Study Period Four||0
26010|NCT02778113|58906|P3|NOT COMPLETED|Study Period Four||0
26011|NCT02778113|58907|P2|NOT COMPLETED|Study Period Four||0
26012|NCT02778113|58908|P1|NOT COMPLETED|Study Period Four||0
26013|NCT02778113|58905|P4|COMPLETED|Study Period Four||4
26014|NCT02778113|58906|P3|COMPLETED|Study Period Four||2
26015|NCT02778113|58907|P2|COMPLETED|Study Period Four||4
26016|NCT02778113|58908|P1|COMPLETED|Study Period Four||3
26017|NCT02778113|58905|P4|Received Study Drug|Study Period Four||4
26018|NCT02778113|58906|P3|Received Study Drug|Study Period Four||2
26019|NCT02778113|58907|P2|Received Study Drug|Study Period Four||4
26020|NCT02778113|58908|P1|Received Study Drug|Study Period Four||3
26021|NCT02778113|58905|P4|STARTED|Study Period Four||4
26022|NCT02778113|58906|P3|STARTED|Study Period Four|One participant completed study period three, but did not enter study period four.|2
26023|NCT02778113|58907|P2|STARTED|Study Period Four||4
26024|NCT02778113|58908|P1|STARTED|Study Period Four|One participant completed study period three, but did not enter study period four.|3
26025|NCT02778113|58905|P4|NOT COMPLETED|Study Period Three||0
26026|NCT02778113|58906|P3|NOT COMPLETED|Study Period Three||0
26027|NCT02778113|58907|P2|NOT COMPLETED|Study Period Three||0
26028|NCT02778113|58908|P1|NOT COMPLETED|Study Period Three||0
26029|NCT02778113|58905|P4|COMPLETED|Study Period Three||4
26030|NCT02778113|58906|P3|COMPLETED|Study Period Three||3
26031|NCT02778113|58907|P2|COMPLETED|Study Period Three||4
26032|NCT02778113|58908|P1|COMPLETED|Study Period Three||4
26033|NCT02778113|58905|P4|Received Study Drug|Study Period Three||4
26034|NCT02778113|58906|P3|Received Study Drug|Study Period Three||3
26035|NCT02778113|58907|P2|Received Study Drug|Study Period Three||4
26036|NCT02778113|58908|P1|Received Study Drug|Study Period Three||4
26037|NCT02778113|58905|P4|STARTED|Study Period Three||4
26038|NCT02778113|58906|P3|STARTED|Study Period Three|One participant completed study period two, but did not enter study period three.|3
26039|NCT02778113|58907|P2|STARTED|Study Period Three||4
26040|NCT02778113|58908|P1|STARTED|Study Period Three||4
26041|NCT02778113|58905|P4|NOT COMPLETED|Study Period Two||0
26042|NCT02778113|58906|P3|NOT COMPLETED|Study Period Two||0
26043|NCT02778113|58907|P2|NOT COMPLETED|Study Period Two||0
26044|NCT02778113|58908|P1|NOT COMPLETED|Study Period Two||0
26045|NCT02778113|58905|P4|COMPLETED|Study Period Two||4
26046|NCT02778113|58906|P3|COMPLETED|Study Period Two||4
26047|NCT02778113|58907|P2|COMPLETED|Study Period Two||4
26048|NCT02778113|58908|P1|COMPLETED|Study Period Two||4
26049|NCT02778113|58905|P4|Received Study Drug|Study Period Two||4
26050|NCT02778113|58906|P3|Received Study Drug|Study Period Two||4
26051|NCT02778113|58907|P2|Received Study Drug|Study Period Two||4
26052|NCT02778113|58908|P1|Received Study Drug|Study Period Two||4
26053|NCT02778113|58905|P4|STARTED|Study Period Two||4
26054|NCT02778113|58906|P3|STARTED|Study Period Two||4
26055|NCT02778113|58907|P2|STARTED|Study Period Two||4
26056|NCT02778113|58908|P1|STARTED|Study Period Two||4
26057|NCT02778113|58905|P4|NOT COMPLETED|Study Period One||0
26058|NCT02778113|58906|P3|NOT COMPLETED|Study Period One||0
26059|NCT02778113|58907|P2|NOT COMPLETED|Study Period One||0
26060|NCT02778113|58908|P1|NOT COMPLETED|Study Period One||0
26061|NCT02778113|58905|P4|COMPLETED|Study Period One||4
26062|NCT02778113|58906|P3|COMPLETED|Study Period One||4
26063|NCT02778113|58907|P2|COMPLETED|Study Period One||4
26064|NCT02778113|58908|P1|COMPLETED|Study Period One||4
26065|NCT02778113|58905|P4|Received Study Drug|Study Period One||4
26066|NCT02778113|58906|P3|Received Study Drug|Study Period One||4
26067|NCT02778113|58907|P2|Received Study Drug|Study Period One||4
26068|NCT02778113|58908|P1|Received Study Drug|Study Period One||4
26069|NCT02778113|58905|P4|STARTED|Study Period One||4
26070|NCT02778113|58906|P3|STARTED|Study Period One||4
26071|NCT02778113|58907|P2|STARTED|Study Period One||4
26072|NCT02778113|58908|P1|STARTED|Study Period One||4
26073|NCT02778100|58948|P2|NOT COMPLETED|Period 2 (No Cold Symptoms)||0
26074|NCT02778100|58949|P1|NOT COMPLETED|Period 2 (No Cold Symptoms)||0
26075|NCT02778100|58948|P2|COMPLETED|Period 2 (No Cold Symptoms)||0
26076|NCT02778100|58949|P1|COMPLETED|Period 2 (No Cold Symptoms)||17
26077|NCT02778100|58948|P2|STARTED|Period 2 (No Cold Symptoms)|Cohort 2 only administered NG to participants with a common cold who are taking oxymetazoline.|0
26078|NCT02778100|58949|P1|STARTED|Period 2 (No Cold Symptoms)||17
26079|NCT02778100|58948|P2|NOT COMPLETED|Period 1 (Common Cold)||0
26080|NCT02778100|58949|P1|NOT COMPLETED|Period 1 (Common Cold)||1
26081|NCT02778100|58948|P2|COMPLETED|Period 1 (Common Cold)||18
26082|NCT02778100|58949|P1|COMPLETED|Period 1 (Common Cold)||17
26083|NCT02778100|58948|P2|STARTED|Period 1 (Common Cold)||18
26084|NCT02778100|58949|P1|STARTED|Period 1 (Common Cold)||18
26085|NCT02778074|58980|P2|NOT COMPLETED|Overall Study||10
26086|NCT02778074|58981|P1|NOT COMPLETED|Overall Study||7
26087|NCT02778074|58980|P2|COMPLETED|Overall Study||62
26088|NCT02778074|58981|P1|COMPLETED|Overall Study||65
26089|NCT02778074|58980|P2|STARTED|Overall Study||72
26090|NCT02778074|58981|P1|STARTED|Overall Study||72
26091|NCT02777944|58989|P2|NOT COMPLETED|Overall Study||0
26092|NCT02777944|58990|P1|NOT COMPLETED|Overall Study||0
26093|NCT02777944|58989|P2|COMPLETED|Overall Study||156
26094|NCT02777944|58990|P1|COMPLETED|Overall Study||157
26095|NCT02777944|58989|P2|STARTED|Overall Study||156
26096|NCT02777944|58990|P1|STARTED|Overall Study||157
26097|NCT02777931|59002|P2|NOT COMPLETED|Overall Study||13
26098|NCT02777931|59003|P1|NOT COMPLETED|Overall Study||12
26099|NCT02777931|59002|P2|COMPLETED|Overall Study||39
26100|NCT02777931|59003|P1|COMPLETED|Overall Study||37
26101|NCT02777931|59002|P2|Modified Intent to Treat Population|Overall Study||50
26102|NCT02777931|59003|P1|Modified Intent to Treat Population|Overall Study||46
26103|NCT02777931|59002|P2|Safety Population|Overall Study||50
26104|NCT02777931|59003|P1|Safety Population|Overall Study||47
26105|NCT02777931|59002|P2|STARTED|Overall Study||52
26106|NCT02777931|59003|P1|STARTED|Overall Study||49
26107|NCT02777918|59013|P2|NOT COMPLETED|Overall Study||4
26108|NCT02777918|59014|P1|NOT COMPLETED|Overall Study||3
26109|NCT02777918|59013|P2|COMPLETED|Overall Study||43
26110|NCT02777918|59014|P1|COMPLETED|Overall Study||50
26111|NCT02777918|59013|P2|STARTED|Overall Study||47
26112|NCT02777918|59014|P1|STARTED|Overall Study||53
26113|NCT02777827|59032|P6|NOT COMPLETED|Treatment Period 6||0
26114|NCT02777827|59033|P5|NOT COMPLETED|Treatment Period 6||0
26115|NCT02777827|59034|P4|NOT COMPLETED|Treatment Period 6||0
26116|NCT02777827|59035|P3|NOT COMPLETED|Treatment Period 6||0
26117|NCT02777827|59036|P2|NOT COMPLETED|Treatment Period 6||0
26118|NCT02777827|59037|P1|NOT COMPLETED|Treatment Period 6||0
26119|NCT02777827|59032|P6|COMPLETED|Treatment Period 6||6
26120|NCT02777827|59033|P5|COMPLETED|Treatment Period 6||4
26121|NCT02777827|59034|P4|COMPLETED|Treatment Period 6||5
26122|NCT02777827|59035|P3|COMPLETED|Treatment Period 6||4
26123|NCT02777827|59036|P2|COMPLETED|Treatment Period 6||5
26124|NCT02777827|59037|P1|COMPLETED|Treatment Period 6||5
26125|NCT02777827|59032|P6|STARTED|Treatment Period 6||6
26126|NCT02777827|59033|P5|STARTED|Treatment Period 6||4
26127|NCT02777827|59034|P4|STARTED|Treatment Period 6||5
26128|NCT02777827|59035|P3|STARTED|Treatment Period 6||4
26129|NCT02777827|59036|P2|STARTED|Treatment Period 6||5
26130|NCT02777827|59037|P1|STARTED|Treatment Period 6||5
26131|NCT02777827|59032|P6|NOT COMPLETED|Washout Between Periods 5 and 6||0
26132|NCT02777827|59033|P5|NOT COMPLETED|Washout Between Periods 5 and 6||0
26133|NCT02777827|59034|P4|NOT COMPLETED|Washout Between Periods 5 and 6||0
26134|NCT02777827|59035|P3|NOT COMPLETED|Washout Between Periods 5 and 6||0
26135|NCT02777827|59036|P2|NOT COMPLETED|Washout Between Periods 5 and 6||0
26136|NCT02777827|59037|P1|NOT COMPLETED|Washout Between Periods 5 and 6||0
26137|NCT02777827|59032|P6|COMPLETED|Washout Between Periods 5 and 6||6
26138|NCT02777827|59033|P5|COMPLETED|Washout Between Periods 5 and 6||4
26139|NCT02777827|59034|P4|COMPLETED|Washout Between Periods 5 and 6||5
26140|NCT02777827|59035|P3|COMPLETED|Washout Between Periods 5 and 6||4
26141|NCT02777827|59036|P2|COMPLETED|Washout Between Periods 5 and 6||5
26142|NCT02777827|59037|P1|COMPLETED|Washout Between Periods 5 and 6||5
26143|NCT02777827|59032|P6|STARTED|Washout Between Periods 5 and 6||6
26144|NCT02777827|59033|P5|STARTED|Washout Between Periods 5 and 6||4
26145|NCT02777827|59034|P4|STARTED|Washout Between Periods 5 and 6||5
26146|NCT02777827|59035|P3|STARTED|Washout Between Periods 5 and 6||4
26147|NCT02777827|59036|P2|STARTED|Washout Between Periods 5 and 6||5
26148|NCT02777827|59037|P1|STARTED|Washout Between Periods 5 and 6||5
26149|NCT02777827|59032|P6|NOT COMPLETED|Treatment Period 5||0
26150|NCT02777827|59033|P5|NOT COMPLETED|Treatment Period 5||0
26151|NCT02777827|59034|P4|NOT COMPLETED|Treatment Period 5||0
26152|NCT02777827|59035|P3|NOT COMPLETED|Treatment Period 5||0
26153|NCT02777827|59036|P2|NOT COMPLETED|Treatment Period 5||0
26154|NCT02777827|59037|P1|NOT COMPLETED|Treatment Period 5||0
26155|NCT02777827|59032|P6|COMPLETED|Treatment Period 5||6
26156|NCT02777827|59033|P5|COMPLETED|Treatment Period 5||4
26157|NCT02777827|59034|P4|COMPLETED|Treatment Period 5||5
26158|NCT02777827|59035|P3|COMPLETED|Treatment Period 5||4
26159|NCT02777827|59036|P2|COMPLETED|Treatment Period 5||5
26160|NCT02777827|59037|P1|COMPLETED|Treatment Period 5||5
26161|NCT02777827|59032|P6|STARTED|Treatment Period 5||6
26162|NCT02777827|59033|P5|STARTED|Treatment Period 5||4
26163|NCT02777827|59034|P4|STARTED|Treatment Period 5||5
26164|NCT02777827|59035|P3|STARTED|Treatment Period 5||4
26165|NCT02777827|59036|P2|STARTED|Treatment Period 5||5
26166|NCT02777827|59037|P1|STARTED|Treatment Period 5||5
26167|NCT02777827|59032|P6|NOT COMPLETED|Washout Between Periods 4 and 5||0
26168|NCT02777827|59033|P5|NOT COMPLETED|Washout Between Periods 4 and 5||0
26169|NCT02777827|59034|P4|NOT COMPLETED|Washout Between Periods 4 and 5||0
26170|NCT02777827|59035|P3|NOT COMPLETED|Washout Between Periods 4 and 5||0
26171|NCT02777827|59036|P2|NOT COMPLETED|Washout Between Periods 4 and 5||0
26172|NCT02777827|59037|P1|NOT COMPLETED|Washout Between Periods 4 and 5||0
26173|NCT02777827|59032|P6|COMPLETED|Washout Between Periods 4 and 5||6
26174|NCT02777827|59033|P5|COMPLETED|Washout Between Periods 4 and 5||4
26175|NCT02777827|59034|P4|COMPLETED|Washout Between Periods 4 and 5||5
26176|NCT02777827|59035|P3|COMPLETED|Washout Between Periods 4 and 5||4
26177|NCT02777827|59036|P2|COMPLETED|Washout Between Periods 4 and 5||5
26178|NCT02777827|59037|P1|COMPLETED|Washout Between Periods 4 and 5||5
26179|NCT02777827|59032|P6|STARTED|Washout Between Periods 4 and 5||6
26180|NCT02777827|59033|P5|STARTED|Washout Between Periods 4 and 5||4
26181|NCT02777827|59034|P4|STARTED|Washout Between Periods 4 and 5||5
26182|NCT02777827|59035|P3|STARTED|Washout Between Periods 4 and 5||4
26183|NCT02777827|59036|P2|STARTED|Washout Between Periods 4 and 5||5
26184|NCT02777827|59037|P1|STARTED|Washout Between Periods 4 and 5||5
26185|NCT02777827|59032|P6|NOT COMPLETED|Treatment Period 4||0
26186|NCT02777827|59033|P5|NOT COMPLETED|Treatment Period 4||0
26187|NCT02777827|59034|P4|NOT COMPLETED|Treatment Period 4||0
26188|NCT02777827|59035|P3|NOT COMPLETED|Treatment Period 4||0
26189|NCT02777827|59036|P2|NOT COMPLETED|Treatment Period 4||0
26190|NCT02777827|59037|P1|NOT COMPLETED|Treatment Period 4||0
26191|NCT02777827|59032|P6|COMPLETED|Treatment Period 4||6
26192|NCT02777827|59033|P5|COMPLETED|Treatment Period 4||4
26193|NCT02777827|59034|P4|COMPLETED|Treatment Period 4||5
26194|NCT02777827|59035|P3|COMPLETED|Treatment Period 4||4
26195|NCT02777827|59036|P2|COMPLETED|Treatment Period 4||5
26196|NCT02777827|59037|P1|COMPLETED|Treatment Period 4||5
26197|NCT02777827|59032|P6|STARTED|Treatment Period 4||6
26198|NCT02777827|59033|P5|STARTED|Treatment Period 4||4
26199|NCT02777827|59034|P4|STARTED|Treatment Period 4||5
26200|NCT02777827|59035|P3|STARTED|Treatment Period 4||4
26201|NCT02777827|59036|P2|STARTED|Treatment Period 4||5
26202|NCT02777827|59037|P1|STARTED|Treatment Period 4||5
26203|NCT02777827|59032|P6|NOT COMPLETED|Washout Between Periods 3 and 4||0
26204|NCT02777827|59033|P5|NOT COMPLETED|Washout Between Periods 3 and 4||0
26205|NCT02777827|59034|P4|NOT COMPLETED|Washout Between Periods 3 and 4||0
26206|NCT02777827|59035|P3|NOT COMPLETED|Washout Between Periods 3 and 4||1
26207|NCT02777827|59036|P2|NOT COMPLETED|Washout Between Periods 3 and 4||0
26208|NCT02777827|59037|P1|NOT COMPLETED|Washout Between Periods 3 and 4||0
26209|NCT02777827|59032|P6|COMPLETED|Washout Between Periods 3 and 4||6
26210|NCT02777827|59033|P5|COMPLETED|Washout Between Periods 3 and 4||4
26211|NCT02777827|59034|P4|COMPLETED|Washout Between Periods 3 and 4||5
26212|NCT02777827|59035|P3|COMPLETED|Washout Between Periods 3 and 4||4
26213|NCT02777827|59036|P2|COMPLETED|Washout Between Periods 3 and 4||5
26214|NCT02777827|59037|P1|COMPLETED|Washout Between Periods 3 and 4||5
26215|NCT02777827|59032|P6|STARTED|Washout Between Periods 3 and 4||6
26216|NCT02777827|59033|P5|STARTED|Washout Between Periods 3 and 4||4
26217|NCT02777827|59034|P4|STARTED|Washout Between Periods 3 and 4||5
26218|NCT02777827|59035|P3|STARTED|Washout Between Periods 3 and 4||5
26219|NCT02777827|59036|P2|STARTED|Washout Between Periods 3 and 4||5
26220|NCT02777827|59037|P1|STARTED|Washout Between Periods 3 and 4||5
26221|NCT02777827|59032|P6|NOT COMPLETED|Treatment Period 3||0
26222|NCT02777827|59033|P5|NOT COMPLETED|Treatment Period 3||0
26223|NCT02777827|59034|P4|NOT COMPLETED|Treatment Period 3||0
26224|NCT02777827|59035|P3|NOT COMPLETED|Treatment Period 3||0
26225|NCT02777827|59036|P2|NOT COMPLETED|Treatment Period 3||0
26226|NCT02777827|59037|P1|NOT COMPLETED|Treatment Period 3||0
26227|NCT02777827|59032|P6|COMPLETED|Treatment Period 3||6
26228|NCT02777827|59033|P5|COMPLETED|Treatment Period 3||4
26229|NCT02777827|59034|P4|COMPLETED|Treatment Period 3||5
26230|NCT02777827|59035|P3|COMPLETED|Treatment Period 3||5
26231|NCT02777827|59036|P2|COMPLETED|Treatment Period 3||5
26232|NCT02777827|59037|P1|COMPLETED|Treatment Period 3||5
26233|NCT02777827|59032|P6|STARTED|Treatment Period 3||6
26234|NCT02777827|59033|P5|STARTED|Treatment Period 3||4
26235|NCT02777827|59034|P4|STARTED|Treatment Period 3||5
26236|NCT02777827|59035|P3|STARTED|Treatment Period 3||5
26237|NCT02777827|59036|P2|STARTED|Treatment Period 3||5
26238|NCT02777827|59037|P1|STARTED|Treatment Period 3||5
26239|NCT02777827|59032|P6|NOT COMPLETED|Washout Between Periods 2 and 3||0
26240|NCT02777827|59033|P5|NOT COMPLETED|Washout Between Periods 2 and 3||0
26241|NCT02777827|59034|P4|NOT COMPLETED|Washout Between Periods 2 and 3||0
26242|NCT02777827|59035|P3|NOT COMPLETED|Washout Between Periods 2 and 3||0
26243|NCT02777827|59036|P2|NOT COMPLETED|Washout Between Periods 2 and 3||0
26244|NCT02777827|59037|P1|NOT COMPLETED|Washout Between Periods 2 and 3||0
26245|NCT02777827|59032|P6|COMPLETED|Washout Between Periods 2 and 3||6
26246|NCT02777827|59033|P5|COMPLETED|Washout Between Periods 2 and 3||4
26247|NCT02777827|59034|P4|COMPLETED|Washout Between Periods 2 and 3||5
26248|NCT02777827|59035|P3|COMPLETED|Washout Between Periods 2 and 3||5
26249|NCT02777827|59036|P2|COMPLETED|Washout Between Periods 2 and 3||5
26250|NCT02777827|59037|P1|COMPLETED|Washout Between Periods 2 and 3||5
26251|NCT02777827|59032|P6|STARTED|Washout Between Periods 2 and 3||6
26252|NCT02777827|59033|P5|STARTED|Washout Between Periods 2 and 3||4
26253|NCT02777827|59034|P4|STARTED|Washout Between Periods 2 and 3||5
26254|NCT02777827|59035|P3|STARTED|Washout Between Periods 2 and 3||5
26255|NCT02777827|59036|P2|STARTED|Washout Between Periods 2 and 3||5
26256|NCT02777827|59037|P1|STARTED|Washout Between Periods 2 and 3||5
26257|NCT02777827|59032|P6|NOT COMPLETED|Treatment Period 2||0
26258|NCT02777827|59033|P5|NOT COMPLETED|Treatment Period 2||0
26259|NCT02777827|59034|P4|NOT COMPLETED|Treatment Period 2||0
26260|NCT02777827|59035|P3|NOT COMPLETED|Treatment Period 2||0
26261|NCT02777827|59036|P2|NOT COMPLETED|Treatment Period 2||0
26262|NCT02777827|59037|P1|NOT COMPLETED|Treatment Period 2||0
26263|NCT02777827|59032|P6|COMPLETED|Treatment Period 2||6
26264|NCT02777827|59033|P5|COMPLETED|Treatment Period 2||4
26265|NCT02777827|59034|P4|COMPLETED|Treatment Period 2||5
26266|NCT02777827|59035|P3|COMPLETED|Treatment Period 2||5
26267|NCT02777827|59036|P2|COMPLETED|Treatment Period 2||5
26268|NCT02777827|59037|P1|COMPLETED|Treatment Period 2||5
26269|NCT02777827|59032|P6|STARTED|Treatment Period 2||6
26270|NCT02777827|59033|P5|STARTED|Treatment Period 2||4
26271|NCT02777827|59034|P4|STARTED|Treatment Period 2||5
26272|NCT02777827|59035|P3|STARTED|Treatment Period 2||5
26273|NCT02777827|59036|P2|STARTED|Treatment Period 2||5
26274|NCT02777827|59037|P1|STARTED|Treatment Period 2||5
26275|NCT02777827|59032|P6|NOT COMPLETED|Washout Between Periods 1 and 2||0
26276|NCT02777827|59033|P5|NOT COMPLETED|Washout Between Periods 1 and 2||0
26277|NCT02777827|59034|P4|NOT COMPLETED|Washout Between Periods 1 and 2||0
26278|NCT02777827|59035|P3|NOT COMPLETED|Washout Between Periods 1 and 2||0
26279|NCT02777827|59036|P2|NOT COMPLETED|Washout Between Periods 1 and 2||0
26280|NCT02777827|59037|P1|NOT COMPLETED|Washout Between Periods 1 and 2||0
26281|NCT02777827|59032|P6|COMPLETED|Washout Between Periods 1 and 2||6
26282|NCT02777827|59033|P5|COMPLETED|Washout Between Periods 1 and 2||4
26283|NCT02777827|59034|P4|COMPLETED|Washout Between Periods 1 and 2||5
26284|NCT02777827|59035|P3|COMPLETED|Washout Between Periods 1 and 2||5
26285|NCT02777827|59036|P2|COMPLETED|Washout Between Periods 1 and 2||5
26286|NCT02777827|59037|P1|COMPLETED|Washout Between Periods 1 and 2||5
26287|NCT02777827|59032|P6|STARTED|Washout Between Periods 1 and 2||6
26288|NCT02777827|59033|P5|STARTED|Washout Between Periods 1 and 2||4
26289|NCT02777827|59034|P4|STARTED|Washout Between Periods 1 and 2||5
26290|NCT02777827|59035|P3|STARTED|Washout Between Periods 1 and 2||5
26291|NCT02777827|59036|P2|STARTED|Washout Between Periods 1 and 2||5
26292|NCT02777827|59037|P1|STARTED|Washout Between Periods 1 and 2||5
26293|NCT02777827|59032|P6|NOT COMPLETED|Treatment Period 1||0
26294|NCT02777827|59033|P5|NOT COMPLETED|Treatment Period 1||0
26295|NCT02777827|59034|P4|NOT COMPLETED|Treatment Period 1||0
26296|NCT02777827|59035|P3|NOT COMPLETED|Treatment Period 1||0
26297|NCT02777827|59036|P2|NOT COMPLETED|Treatment Period 1||0
26298|NCT02777827|59037|P1|NOT COMPLETED|Treatment Period 1||0
26299|NCT02777827|59032|P6|COMPLETED|Treatment Period 1||6
26300|NCT02777827|59033|P5|COMPLETED|Treatment Period 1||4
26301|NCT02777827|59034|P4|COMPLETED|Treatment Period 1||5
26302|NCT02777827|59035|P3|COMPLETED|Treatment Period 1||5
26303|NCT02777827|59036|P2|COMPLETED|Treatment Period 1||5
26304|NCT02777827|59037|P1|COMPLETED|Treatment Period 1||5
26305|NCT02777827|59032|P6|STARTED|Treatment Period 1||6
26306|NCT02777827|59033|P5|STARTED|Treatment Period 1||4
26307|NCT02777827|59034|P4|STARTED|Treatment Period 1||5
26308|NCT02777827|59035|P3|STARTED|Treatment Period 1||5
26309|NCT02777827|59036|P2|STARTED|Treatment Period 1||5
26310|NCT02777827|59037|P1|STARTED|Treatment Period 1||5
26311|NCT02777749|59192|P3|NOT COMPLETED|Overall Study||0
26312|NCT02777749|59193|P2|NOT COMPLETED|Overall Study||0
26313|NCT02777749|59194|P1|NOT COMPLETED|Overall Study||0
26314|NCT02777749|59192|P3|COMPLETED|Overall Study||51
26315|NCT02777749|59193|P2|COMPLETED|Overall Study||51
26316|NCT02777749|59194|P1|COMPLETED|Overall Study||53
26317|NCT02777749|59192|P3|STARTED|Overall Study||51
26318|NCT02777749|59193|P2|STARTED|Overall Study||51
26319|NCT02777749|59194|P1|STARTED|Overall Study||53
26320|NCT02777268|59214|P1|NOT COMPLETED|Overall Study||0
26321|NCT02777268|59214|P1|COMPLETED|Overall Study||16
26322|NCT02777268|59214|P1|STARTED|Overall Study||16
26323|NCT02777242|59240|P1|NOT COMPLETED|Overall Study||6
26324|NCT02777242|59240|P1|COMPLETED|Overall Study||59
26325|NCT02777242|59240|P1|STARTED|Overall Study||65
26326|NCT02777125|59246|P2|NOT COMPLETED|Overall Study||47
26327|NCT02777125|59247|P1|NOT COMPLETED|Overall Study||43
26328|NCT02777125|59246|P2|COMPLETED|Overall Study||445
26329|NCT02777125|59247|P1|COMPLETED|Overall Study||445
26330|NCT02777125|59246|P2|STARTED|Overall Study||492
26331|NCT02777125|59247|P1|STARTED|Overall Study||488
26332|NCT02776774|59261|P1|NOT COMPLETED|Overall Study||0
26333|NCT02776774|59261|P1|COMPLETED|Overall Study|Total after data cleaning|91
26334|NCT02776774|59261|P1|STARTED|Overall Study||91
26335|NCT02776683|59266|P2|NOT COMPLETED|Post-switch Period||43
26336|NCT02776683|59267|P1|NOT COMPLETED|Post-switch Period||0
26337|NCT02776683|59266|P2|COMPLETED|Post-switch Period||0
26338|NCT02776683|59267|P1|COMPLETED|Post-switch Period||0
26339|NCT02776683|59266|P2|STARTED|Post-switch Period|Entered into Switch Set|43
26340|NCT02776683|59267|P1|STARTED|Post-switch Period||0
26341|NCT02776683|59266|P2|NOT COMPLETED|Pre-switch Period||0
26342|NCT02776683|59267|P1|NOT COMPLETED|Pre-switch Period||80
26343|NCT02776683|59266|P2|COMPLETED|Pre-switch Period||0
26344|NCT02776683|59267|P1|COMPLETED|Pre-switch Period|Entered into Switch Set|43
26345|NCT02776683|59266|P2|STARTED|Pre-switch Period||0
26346|NCT02776683|59267|P1|STARTED|Pre-switch Period|Assigned to trial medication or enrolled/treated|123
26347|NCT02776670|59278|P2|NOT COMPLETED|Overall Study||6
26348|NCT02776670|59279|P1|NOT COMPLETED|Overall Study||0
26349|NCT02776670|59278|P2|COMPLETED|Overall Study||108
26350|NCT02776670|59279|P1|COMPLETED|Overall Study||117
26351|NCT02776670|59278|P2|Safety Analysis Set|Overall Study||114
26352|NCT02776670|59279|P1|Safety Analysis Set|Overall Study||117
26353|NCT02776670|59278|P2|Per Protocol Analysis Set (PPS)|Overall Study||113
26354|NCT02776670|59279|P1|Per Protocol Analysis Set (PPS)|Overall Study||115
26355|NCT02776670|59278|P2|Full Analysis Set (FAS)|Overall Study||114
26356|NCT02776670|59279|P1|Full Analysis Set (FAS)|Overall Study||117
26357|NCT02776670|59278|P2|STARTED|Overall Study||114
26358|NCT02776670|59279|P1|STARTED|Overall Study||117
26359|NCT02776644|59293|P2|NOT COMPLETED|Overall Study||0
26360|NCT02776644|59294|P1|NOT COMPLETED|Overall Study||0
26361|NCT02776644|59293|P2|COMPLETED|Overall Study||126
26362|NCT02776644|59294|P1|COMPLETED|Overall Study||1223
26363|NCT02776644|59293|P2|STARTED|Overall Study||126
26364|NCT02776644|59294|P1|STARTED|Overall Study||1223
26365|NCT02776033|59337|P3|NOT COMPLETED|Overall Study||2
26366|NCT02776033|59338|P2|NOT COMPLETED|Overall Study||2
26367|NCT02776033|59339|P1|NOT COMPLETED|Overall Study||4
26368|NCT02776033|59337|P3|COMPLETED|Overall Study||22
26369|NCT02776033|59338|P2|COMPLETED|Overall Study||21
26370|NCT02776033|59339|P1|COMPLETED|Overall Study||14
26371|NCT02776033|59337|P3|STARTED|Overall Study||24
26372|NCT02776033|59338|P2|STARTED|Overall Study||23
26373|NCT02776033|59339|P1|STARTED|Overall Study||18
26374|NCT02775916|59404|P2|NOT COMPLETED|Overall Study||0
26375|NCT02775916|59405|P1|NOT COMPLETED|Overall Study||3
26376|NCT02775916|59404|P2|COMPLETED|Overall Study||10
26377|NCT02775916|59405|P1|COMPLETED|Overall Study||17
26378|NCT02775916|59404|P2|STARTED|Overall Study||10
26379|NCT02775916|59405|P1|STARTED|Overall Study||20
26380|NCT02775864|59427|P4|NOT COMPLETED|Overall Study||2084
26381|NCT02775864|59428|P3|NOT COMPLETED|Overall Study||1860
26382|NCT02775864|59429|P2|NOT COMPLETED|Overall Study||4899
26383|NCT02775864|59430|P1|NOT COMPLETED|Overall Study||3242
26384|NCT02775864|59427|P4|COMPLETED|Overall Study||10765
26385|NCT02775864|59428|P3|COMPLETED|Overall Study||10081
26386|NCT02775864|59429|P2|COMPLETED|Overall Study||26218
26387|NCT02775864|59430|P1|COMPLETED|Overall Study||22772
26388|NCT02775864|59427|P4|STARTED|Overall Study||12849
26389|NCT02775864|59428|P3|STARTED|Overall Study||11941
26390|NCT02775864|59429|P2|STARTED|Overall Study||31117
26391|NCT02775864|59430|P1|STARTED|Overall Study||26014
26392|NCT02775617|59450|P2|NOT COMPLETED|Overall Study||160
26393|NCT02775617|59451|P1|NOT COMPLETED|Overall Study||48
26394|NCT02775617|59450|P2|COMPLETED|Overall Study|Participants are seen at via a survey of the community. 76.2% of the resident population|478
26395|NCT02775617|59451|P1|COMPLETED|Overall Study|Participants are seen at via a survey of the community. 96.3% of the resident population|605
26396|NCT02775617|59450|P2|STARTED|Overall Study|Participants are seen at via a survey of the community. 88.9% of the resident population|638
26397|NCT02775617|59451|P1|STARTED|Overall Study|Participants are seen at via a survey of the community. 92.6% of the resident population|653
26398|NCT02775435|59463|P2|NOT COMPLETED|Overall Study||281
26399|NCT02775435|59464|P1|NOT COMPLETED|Overall Study||278
26400|NCT02775435|59463|P2|COMPLETED|Overall Study||0
26401|NCT02775435|59464|P1|COMPLETED|Overall Study||0
26402|NCT02775435|59463|P2|Switched to Pembrolizumab+Chemotherapy|Overall Study||75
26403|NCT02775435|59464|P1|Switched to Pembrolizumab+Chemotherapy|Overall Study||0
26404|NCT02775435|59463|P2|Treated|Overall Study||280
26405|NCT02775435|59464|P1|Treated|Overall Study||278
26406|NCT02775435|59463|P2|STARTED|Overall Study||281
26407|NCT02775435|59464|P1|STARTED|Overall Study||278
26408|NCT02775344|59482|P2|NOT COMPLETED|Overall Study||2
26409|NCT02775344|59483|P1|NOT COMPLETED|Overall Study||3
26410|NCT02775344|59482|P2|COMPLETED|Overall Study||38
26411|NCT02775344|59483|P1|COMPLETED|Overall Study||37
26412|NCT02775344|59482|P2|STARTED|Overall Study||40
26413|NCT02775344|59483|P1|STARTED|Overall Study||40
26414|NCT02775240|59501|P1|NOT COMPLETED|Overall Study||1
26415|NCT02775240|59501|P1|COMPLETED|Overall Study||17
26416|NCT02775240|59501|P1|Started Treatment B|Overall Study||17
26417|NCT02775240|59501|P1|Started Treatment A|Overall Study||18
26418|NCT02775240|59501|P1|STARTED|Overall Study||18
26419|NCT02774616|59567|P3|NOT COMPLETED|Overall Study||3
26420|NCT02774616|59568|P2|NOT COMPLETED|Overall Study||11
26421|NCT02774616|59569|P1|NOT COMPLETED|Overall Study||15
26422|NCT02774616|59567|P3|COMPLETED|Overall Study||13
26423|NCT02774616|59568|P2|COMPLETED|Overall Study||156
26424|NCT02774616|59569|P1|COMPLETED|Overall Study||80
26425|NCT02774616|59567|P3|Other|Overall Study||1
26426|NCT02774616|59568|P2|Other|Overall Study||4
26427|NCT02774616|59569|P1|Other|Overall Study||2
26428|NCT02774616|59567|P3|Device Explanted|Overall Study||1
26429|NCT02774616|59568|P2|Device Explanted|Overall Study||1
26430|NCT02774616|59569|P1|Device Explanted|Overall Study||2
26431|NCT02774616|59567|P3|Lost to FU|Overall Study||0
26432|NCT02774616|59568|P2|Lost to FU|Overall Study||0
26433|NCT02774616|59569|P1|Lost to FU|Overall Study||2
26434|NCT02774616|59567|P3|Withdrew Consent|Overall Study||0
26435|NCT02774616|59568|P2|Withdrew Consent|Overall Study||3
26436|NCT02774616|59569|P1|Withdrew Consent|Overall Study||3
26437|NCT02774616|59567|P3|Died|Overall Study||1
26438|NCT02774616|59568|P2|Died|Overall Study||3
26439|NCT02774616|59569|P1|Died|Overall Study||6
26440|NCT02774616|59567|P3|STARTED|Overall Study||16
26441|NCT02774616|59568|P2|STARTED|Overall Study||167
26442|NCT02774616|59569|P1|STARTED|Overall Study||95
26443|NCT02774343|59582|P2|NOT COMPLETED|Overall Study||3
26444|NCT02774343|59583|P1|NOT COMPLETED|Overall Study||6
26445|NCT02774343|59582|P2|COMPLETED|Overall Study||12
26446|NCT02774343|59583|P1|COMPLETED|Overall Study||9
26447|NCT02774343|59582|P2|Received at Least One Capsule|Overall Study||14
26448|NCT02774343|59583|P1|Received at Least One Capsule|Overall Study||12
26449|NCT02774343|59582|P2|STARTED|Overall Study||15
26450|NCT02774343|59583|P1|STARTED|Overall Study||15
26451|NCT02774278|59619|P1|NOT COMPLETED|Overall Study||264
26452|NCT02774278|59619|P1|COMPLETED|Overall Study||0
26453|NCT02774278|59619|P1|Safety Analysis Population (SAP)|Overall Study|SAP: all participants who received at least 1 dose of trial medication and had a safety follow-up.|261
26454|NCT02774278|59619|P1|STARTED|Overall Study||264
26455|NCT02774265|59629|P2|NOT COMPLETED|Overall Study||6
26456|NCT02774265|59630|P1|NOT COMPLETED|Overall Study||13
26457|NCT02774265|59629|P2|COMPLETED|Overall Study||159
26458|NCT02774265|59630|P1|COMPLETED|Overall Study||151
26459|NCT02774265|59629|P2|STARTED|Overall Study||165
26460|NCT02774265|59630|P1|STARTED|Overall Study||164
26461|NCT02774213|59640|P1|NOT COMPLETED|Overall Study||19
26462|NCT02774213|59640|P1|COMPLETED|Overall Study||55
26463|NCT02774213|59640|P1|STARTED|Overall Study||74
26464|NCT02774148|59653|P2|NOT COMPLETED|Overall Study||0
26465|NCT02774148|59654|P1|NOT COMPLETED|Overall Study||0
26466|NCT02774148|59653|P2|COMPLETED|Overall Study||0
26467|NCT02774148|59654|P1|COMPLETED|Overall Study||0
26468|NCT02774148|59653|P2|STARTED|Overall Study||0
26469|NCT02774148|59654|P1|STARTED|Overall Study||0
26470|NCT02773836|59674|P6|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
26471|NCT02773836|59675|P5|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
26472|NCT02773836|59676|P4|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
26473|NCT02773836|59677|P3|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
26474|NCT02773836|59678|P2|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
26475|NCT02773836|59679|P1|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
26476|NCT02773836|59674|P6|COMPLETED|Wave 2- Post-TPD Implementation||998
26477|NCT02773836|59675|P5|COMPLETED|Wave 2- Post-TPD Implementation||1002
26478|NCT02773836|59676|P4|COMPLETED|Wave 2- Post-TPD Implementation||1010
26479|NCT02773836|59677|P3|COMPLETED|Wave 2- Post-TPD Implementation||1003
26480|NCT02773836|59678|P2|COMPLETED|Wave 2- Post-TPD Implementation||1013
26481|NCT02773836|59679|P1|COMPLETED|Wave 2- Post-TPD Implementation||1010
26482|NCT02773836|59674|P6|STARTED|Wave 2- Post-TPD Implementation||998
26483|NCT02773836|59675|P5|STARTED|Wave 2- Post-TPD Implementation||1002
26484|NCT02773836|59676|P4|STARTED|Wave 2- Post-TPD Implementation||1010
26485|NCT02773836|59677|P3|STARTED|Wave 2- Post-TPD Implementation||1003
26486|NCT02773836|59678|P2|STARTED|Wave 2- Post-TPD Implementation||1013
26487|NCT02773836|59679|P1|STARTED|Wave 2- Post-TPD Implementation||1010
26488|NCT02773836|59674|P6|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
26489|NCT02773836|59675|P5|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
26490|NCT02773836|59676|P4|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
26491|NCT02773836|59677|P3|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
26492|NCT02773836|59678|P2|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
26493|NCT02773836|59679|P1|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
26494|NCT02773836|59674|P6|COMPLETED|Wave 1- Pre-TPD Implementation||1006
26495|NCT02773836|59675|P5|COMPLETED|Wave 1- Pre-TPD Implementation||1000
26496|NCT02773836|59676|P4|COMPLETED|Wave 1- Pre-TPD Implementation||1001
26497|NCT02773836|59677|P3|COMPLETED|Wave 1- Pre-TPD Implementation||1001
26498|NCT02773836|59678|P2|COMPLETED|Wave 1- Pre-TPD Implementation||1003
26499|NCT02773836|59679|P1|COMPLETED|Wave 1- Pre-TPD Implementation||1000
26500|NCT02773836|59674|P6|STARTED|Wave 1- Pre-TPD Implementation||1006
26501|NCT02773836|59675|P5|STARTED|Wave 1- Pre-TPD Implementation||1000
26502|NCT02773836|59676|P4|STARTED|Wave 1- Pre-TPD Implementation||1001
26503|NCT02773836|59677|P3|STARTED|Wave 1- Pre-TPD Implementation||1001
26504|NCT02773836|59678|P2|STARTED|Wave 1- Pre-TPD Implementation||1003
26505|NCT02773836|59679|P1|STARTED|Wave 1- Pre-TPD Implementation||1000
26506|NCT02773758|59767|P2|NOT COMPLETED|Overall Study||0
26507|NCT02773758|59768|P1|NOT COMPLETED|Overall Study||0
26508|NCT02773758|59767|P2|COMPLETED|Overall Study||70
26509|NCT02773758|59768|P1|COMPLETED|Overall Study||71
26510|NCT02773758|59767|P2|STARTED|Overall Study||70
26511|NCT02773758|59768|P1|STARTED|Overall Study||71
26512|NCT02773537|59781|P3|NOT COMPLETED|Overall Study||4
26513|NCT02773537|59782|P2|NOT COMPLETED|Overall Study||1
26514|NCT02773537|59783|P1|NOT COMPLETED|Overall Study||0
26515|NCT02773537|59781|P3|COMPLETED|Overall Study||21
26516|NCT02773537|59782|P2|COMPLETED|Overall Study||24
26517|NCT02773537|59783|P1|COMPLETED|Overall Study||25
26518|NCT02773537|59781|P3|STARTED|Overall Study||25
26519|NCT02773537|59782|P2|STARTED|Overall Study||25
26520|NCT02773537|59783|P1|STARTED|Overall Study||25
26521|NCT02773446|59818|P6|NOT COMPLETED|Second Admission||0
26522|NCT02773446|59819|P5|NOT COMPLETED|Second Admission||0
26523|NCT02773446|59820|P4|NOT COMPLETED|Second Admission||0
26524|NCT02773446|59821|P3|NOT COMPLETED|Second Admission||0
26525|NCT02773446|59822|P2|NOT COMPLETED|Second Admission||0
26526|NCT02773446|59823|P1|NOT COMPLETED|Second Admission||0
26527|NCT02773446|59818|P6|COMPLETED|Second Admission||19
26528|NCT02773446|59819|P5|COMPLETED|Second Admission||11
26529|NCT02773446|59820|P4|COMPLETED|Second Admission||0
26530|NCT02773446|59821|P3|COMPLETED|Second Admission||0
26531|NCT02773446|59822|P2|COMPLETED|Second Admission||0
26532|NCT02773446|59823|P1|COMPLETED|Second Admission||0
26533|NCT02773446|59818|P6|STARTED|Second Admission||19
26534|NCT02773446|59819|P5|STARTED|Second Admission||11
26535|NCT02773446|59820|P4|STARTED|Second Admission||0
26536|NCT02773446|59821|P3|STARTED|Second Admission||0
26537|NCT02773446|59822|P2|STARTED|Second Admission||0
26538|NCT02773446|59823|P1|STARTED|Second Admission||0
26539|NCT02773446|59818|P6|NOT COMPLETED|First Admission||0
26540|NCT02773446|59819|P5|NOT COMPLETED|First Admission||0
26541|NCT02773446|59820|P4|NOT COMPLETED|First Admission||1
26542|NCT02773446|59821|P3|NOT COMPLETED|First Admission||0
26543|NCT02773446|59822|P2|NOT COMPLETED|First Admission||0
26544|NCT02773446|59823|P1|NOT COMPLETED|First Admission||1
26545|NCT02773446|59818|P6|COMPLETED|First Admission||0
26546|NCT02773446|59819|P5|COMPLETED|First Admission||0
26547|NCT02773446|59820|P4|COMPLETED|First Admission||6
26548|NCT02773446|59821|P3|COMPLETED|First Admission||7
26549|NCT02773446|59822|P2|COMPLETED|First Admission||7
26550|NCT02773446|59823|P1|COMPLETED|First Admission||6
26551|NCT02773446|59818|P6|STARTED|First Admission||0
26552|NCT02773446|59819|P5|STARTED|First Admission||0
26553|NCT02773446|59820|P4|STARTED|First Admission||7
26554|NCT02773446|59821|P3|STARTED|First Admission||7
26555|NCT02773446|59822|P2|STARTED|First Admission||7
26556|NCT02773446|59823|P1|STARTED|First Admission||7
26557|NCT02773368|59864|P2|NOT COMPLETED|Overall Study||4
26558|NCT02773368|59865|P1|NOT COMPLETED|Overall Study||10
26559|NCT02773368|59864|P2|COMPLETED|Overall Study||206
26560|NCT02773368|59865|P1|COMPLETED|Overall Study||200
26561|NCT02773368|59864|P2|Exposed|Overall Study||210
26562|NCT02773368|59865|P1|Exposed|Overall Study||209
26563|NCT02773368|59864|P2|STARTED|Overall Study||210
26564|NCT02773368|59865|P1|STARTED|Overall Study||210
26565|NCT02772757|59938|P3|NOT COMPLETED|Overall Study||5
26566|NCT02772757|59939|P2|NOT COMPLETED|Overall Study||3
26567|NCT02772757|59940|P1|NOT COMPLETED|Overall Study||1
26568|NCT02772757|59938|P3|COMPLETED|Overall Study||21
26569|NCT02772757|59939|P2|COMPLETED|Overall Study||21
26570|NCT02772757|59940|P1|COMPLETED|Overall Study||21
26571|NCT02772757|59938|P3|STARTED|Overall Study||26
26572|NCT02772757|59939|P2|STARTED|Overall Study||24
26573|NCT02772757|59940|P1|STARTED|Overall Study||22
26574|NCT02772666|59957|P1|NOT COMPLETED|SFT Then O-Glass||0
26575|NCT02772666|59957|P1|COMPLETED|SFT Then O-Glass||44
26576|NCT02772666|59957|P1|STARTED|SFT Then O-Glass||44
26577|NCT02772666|59957|P1|NOT COMPLETED|O-Glas Then SFT||0
26578|NCT02772666|59957|P1|COMPLETED|O-Glas Then SFT||44
26579|NCT02772666|59957|P1|STARTED|O-Glas Then SFT||44
26580|NCT02772432|59964|P2|NOT COMPLETED|Overall Study||1
26581|NCT02772432|59965|P1|NOT COMPLETED|Overall Study||12
26582|NCT02772432|59964|P2|COMPLETED|Overall Study||21
26583|NCT02772432|59965|P1|COMPLETED|Overall Study||19
26584|NCT02772432|59964|P2|STARTED|Overall Study||22
26585|NCT02772432|59965|P1|STARTED|Overall Study||31
26586|NCT02771522|59975|P1|NOT COMPLETED|Overall Study||8
26587|NCT02771522|59975|P1|COMPLETED|Overall Study|87 teeth imaged with the Calcivis System fro 22 patients|22
26588|NCT02771522|59975|P1|STARTED|Overall Study|119 teeth imaged with the Calcivis System from 30 patients|30
26589|NCT02771366|59986|P2|NOT COMPLETED|Period 2 (Crossover)||0
26590|NCT02771366|59987|P1|NOT COMPLETED|Period 2 (Crossover)||2
26591|NCT02771366|59986|P2|COMPLETED|Period 2 (Crossover)||13
26592|NCT02771366|59987|P1|COMPLETED|Period 2 (Crossover)||13
26593|NCT02771366|59986|P2|STARTED|Period 2 (Crossover)||13
26594|NCT02771366|59987|P1|STARTED|Period 2 (Crossover)||15
26595|NCT02771366|59986|P2|NOT COMPLETED|Period 1||2
26596|NCT02771366|59987|P1|NOT COMPLETED|Period 1||0
26597|NCT02771366|59986|P2|COMPLETED|Period 1||13
26598|NCT02771366|59987|P1|COMPLETED|Period 1||15
26599|NCT02771366|59986|P2|STARTED|Period 1||15
26600|NCT02771366|59987|P1|STARTED|Period 1||15
26601|NCT02771275|59994|P1|NOT COMPLETED|Overall Study||13
26602|NCT02771275|59994|P1|COMPLETED|Overall Study||0
26603|NCT02771275|59994|P1|STARTED|Overall Study||13
26604|NCT02771145|60002|P1|NOT COMPLETED|Overall Study||4
26605|NCT02771145|60002|P1|COMPLETED|Overall Study||86
26606|NCT02771145|60002|P1|STARTED|Overall Study||90
26607|NCT02771093|60043|P2|NOT COMPLETED|Overall Study||0
26608|NCT02771093|60044|P1|NOT COMPLETED|Overall Study||0
26609|NCT02771093|60043|P2|COMPLETED|Overall Study||14
26610|NCT02771093|60044|P1|COMPLETED|Overall Study||13
26611|NCT02771093|60043|P2|STARTED|Overall Study||14
26612|NCT02771093|60044|P1|STARTED|Overall Study||13
26613|NCT02770625|60096|P1|NOT COMPLETED|Overall Study||0
26614|NCT02770625|60096|P1|COMPLETED|Overall Study||8
26615|NCT02770625|60096|P1|STARTED|Overall Study||8
26616|NCT02770612|60109|P1|NOT COMPLETED|Overall Study||1
26617|NCT02770612|60109|P1|COMPLETED|Overall Study||50
26618|NCT02770612|60109|P1|STARTED|Overall Study||51
26619|NCT02770248|60115|P2|NOT COMPLETED|Overall Study||2
26620|NCT02770248|60116|P1|NOT COMPLETED|Overall Study||0
26621|NCT02770248|60115|P2|COMPLETED|Overall Study||61
26622|NCT02770248|60116|P1|COMPLETED|Overall Study||62
26623|NCT02770248|60115|P2|STARTED|Overall Study||63
26624|NCT02770248|60116|P1|STARTED|Overall Study||62
26625|NCT02770014|60128|P1|NOT COMPLETED|EGFR Exon 19 Pos, Treated With Erlotinib||5
26626|NCT02770014|60128|P1|COMPLETED|EGFR Exon 19 Pos, Treated With Erlotinib|Of the 11 participants that had an activating EGFR mutation, 6 started erlotinib treatment.|6
26627|NCT02770014|60128|P1|STARTED|EGFR Exon 19 Pos, Treated With Erlotinib|A total of 11 participants were found to have an activating EGFR mutation (exon 19 del or L858R).|11
26628|NCT02770014|60128|P1|NOT COMPLETED|Plasma Genotyping||0
26629|NCT02770014|60128|P1|COMPLETED|Plasma Genotyping||43
26630|NCT02770014|60128|P1|STARTED|Plasma Genotyping||43
26631|NCT02769858|60134|P1|NOT COMPLETED|Overall Study||2
26632|NCT02769858|60134|P1|COMPLETED|Overall Study||8
26633|NCT02769858|60134|P1|STARTED|Overall Study||10
26634|NCT02769702|60140|P1|NOT COMPLETED|Overall Study||0
26635|NCT02769702|60140|P1|COMPLETED|Overall Study||2
26636|NCT02769702|60140|P1|STARTED|Overall Study||2
26637|NCT02769442|60147|P2|NOT COMPLETED|Overall Study||0
26638|NCT02769442|60148|P1|NOT COMPLETED|Overall Study||0
26639|NCT02769442|60147|P2|COMPLETED|Overall Study||291
26640|NCT02769442|60148|P1|COMPLETED|Overall Study||309
26641|NCT02769442|60147|P2|STARTED|Overall Study||291
26642|NCT02769442|60148|P1|STARTED|Overall Study||309
26643|NCT02769312|60158|P2|NOT COMPLETED|Follow-up||1
26644|NCT02769312|60159|P1|NOT COMPLETED|Follow-up||1
26645|NCT02769312|60158|P2|COMPLETED|Follow-up||23
26646|NCT02769312|60159|P1|COMPLETED|Follow-up||22
26647|NCT02769312|60158|P2|STARTED|Follow-up||24
26648|NCT02769312|60159|P1|STARTED|Follow-up||23
26649|NCT02769312|60158|P2|NOT COMPLETED|Unblinded (Optional 2-4 Weeks)||1
26650|NCT02769312|60159|P1|NOT COMPLETED|Unblinded (Optional 2-4 Weeks)||1
26651|NCT02769312|60158|P2|COMPLETED|Unblinded (Optional 2-4 Weeks)||23
26652|NCT02769312|60159|P1|COMPLETED|Unblinded (Optional 2-4 Weeks)||20
26653|NCT02769312|60158|P2|STARTED|Unblinded (Optional 2-4 Weeks)||24
26654|NCT02769312|60159|P1|STARTED|Unblinded (Optional 2-4 Weeks)|2 participants chose not to continue with the unblinded period.|21
26655|NCT02769312|60158|P2|NOT COMPLETED|Double-Blind (0-2 Weeks)||1
26656|NCT02769312|60159|P1|NOT COMPLETED|Double-Blind (0-2 Weeks)||2
26657|NCT02769312|60158|P2|COMPLETED|Double-Blind (0-2 Weeks)||24
26658|NCT02769312|60159|P1|COMPLETED|Double-Blind (0-2 Weeks)||23
26659|NCT02769312|60158|P2|STARTED|Double-Blind (0-2 Weeks)||25
26660|NCT02769312|60159|P1|STARTED|Double-Blind (0-2 Weeks)||25
26661|NCT02769247|60176|P4|NOT COMPLETED|Overall Study||1
26662|NCT02769247|60177|P3|NOT COMPLETED|Overall Study||1
26663|NCT02769247|60178|P2|NOT COMPLETED|Overall Study||0
26664|NCT02769247|60179|P1|NOT COMPLETED|Overall Study||2
26665|NCT02769247|60176|P4|COMPLETED|Overall Study|1 patient decided against study participation after enrollment/randomization|39
26666|NCT02769247|60177|P3|COMPLETED|Overall Study|1 took non-study med after enrollment/randomization, before IUD insertion (excluded from study)|39
26667|NCT02769247|60178|P2|COMPLETED|Overall Study||40
26668|NCT02769247|60179|P1|COMPLETED|Overall Study|unable to insert IUD in one patient; 1 pt decided against study participation after enrollment|38
26669|NCT02769247|60176|P4|STARTED|Overall Study||40
26670|NCT02769247|60177|P3|STARTED|Overall Study||40
26671|NCT02769247|60178|P2|STARTED|Overall Study||40
26672|NCT02769247|60179|P1|STARTED|Overall Study||40
26673|NCT02769065|60247|P30|NOT COMPLETED|Overall Study||0
26674|NCT02769065|60248|P29|NOT COMPLETED|Overall Study||0
26675|NCT02769065|60249|P28|NOT COMPLETED|Overall Study||0
26676|NCT02769065|60250|P27|NOT COMPLETED|Overall Study||0
26677|NCT02769065|60251|P26|NOT COMPLETED|Overall Study||0
26678|NCT02769065|60252|P25|NOT COMPLETED|Overall Study||0
26679|NCT02769065|60253|P24|NOT COMPLETED|Overall Study||0
26680|NCT02769065|60254|P23|NOT COMPLETED|Overall Study||0
26681|NCT02769065|60255|P22|NOT COMPLETED|Overall Study||0
26682|NCT02769065|60256|P21|NOT COMPLETED|Overall Study||0
26683|NCT02769065|60257|P20|NOT COMPLETED|Overall Study||0
26684|NCT02769065|60258|P19|NOT COMPLETED|Overall Study||0
26685|NCT02769065|60259|P18|NOT COMPLETED|Overall Study||0
26686|NCT02769065|60260|P17|NOT COMPLETED|Overall Study||0
26687|NCT02769065|60261|P16|NOT COMPLETED|Overall Study||0
26688|NCT02769065|60262|P15|NOT COMPLETED|Overall Study||0
26689|NCT02769065|60263|P14|NOT COMPLETED|Overall Study||0
26690|NCT02769065|60264|P13|NOT COMPLETED|Overall Study||0
26691|NCT02769065|60265|P12|NOT COMPLETED|Overall Study||0
26692|NCT02769065|60266|P11|NOT COMPLETED|Overall Study||1
26693|NCT02769065|60267|P10|NOT COMPLETED|Overall Study||0
26694|NCT02769065|60268|P9|NOT COMPLETED|Overall Study||0
26695|NCT02769065|60269|P8|NOT COMPLETED|Overall Study||0
26696|NCT02769065|60270|P7|NOT COMPLETED|Overall Study||1
26697|NCT02769065|60271|P6|NOT COMPLETED|Overall Study||0
26698|NCT02769065|60272|P5|NOT COMPLETED|Overall Study||0
26699|NCT02769065|60273|P4|NOT COMPLETED|Overall Study||0
26700|NCT02769065|60274|P3|NOT COMPLETED|Overall Study||0
26701|NCT02769065|60275|P2|NOT COMPLETED|Overall Study||0
26702|NCT02769065|60276|P1|NOT COMPLETED|Overall Study||1
26703|NCT02769065|60247|P30|COMPLETED|Overall Study||6
26704|NCT02769065|60248|P29|COMPLETED|Overall Study||6
26705|NCT02769065|60249|P28|COMPLETED|Overall Study||5
26706|NCT02769065|60250|P27|COMPLETED|Overall Study||9
26707|NCT02769065|60251|P26|COMPLETED|Overall Study||9
26708|NCT02769065|60252|P25|COMPLETED|Overall Study||6
26709|NCT02769065|60253|P24|COMPLETED|Overall Study||6
26710|NCT02769065|60254|P23|COMPLETED|Overall Study||4
26711|NCT02769065|60255|P22|COMPLETED|Overall Study||4
26712|NCT02769065|60256|P21|COMPLETED|Overall Study||4
26713|NCT02769065|60257|P20|COMPLETED|Overall Study||0
26714|NCT02769065|60258|P19|COMPLETED|Overall Study||5
26715|NCT02769065|60259|P18|COMPLETED|Overall Study||5
26716|NCT02769065|60260|P17|COMPLETED|Overall Study||5
26717|NCT02769065|60261|P16|COMPLETED|Overall Study||3
26718|NCT02769065|60262|P15|COMPLETED|Overall Study||6
26719|NCT02769065|60263|P14|COMPLETED|Overall Study||6
26720|NCT02769065|60264|P13|COMPLETED|Overall Study||6
26721|NCT02769065|60265|P12|COMPLETED|Overall Study||6
26722|NCT02769065|60266|P11|COMPLETED|Overall Study||5
26723|NCT02769065|60267|P10|COMPLETED|Overall Study||6
26724|NCT02769065|60268|P9|COMPLETED|Overall Study||6
26725|NCT02769065|60269|P8|COMPLETED|Overall Study||6
26726|NCT02769065|60270|P7|COMPLETED|Overall Study||6
26727|NCT02769065|60271|P6|COMPLETED|Overall Study||6
26728|NCT02769065|60272|P5|COMPLETED|Overall Study||6
26729|NCT02769065|60273|P4|COMPLETED|Overall Study||6
26730|NCT02769065|60274|P3|COMPLETED|Overall Study||6
26731|NCT02769065|60275|P2|COMPLETED|Overall Study||6
26732|NCT02769065|60276|P1|COMPLETED|Overall Study||16
26733|NCT02769065|60247|P30|STARTED|Overall Study||6
26734|NCT02769065|60248|P29|STARTED|Overall Study||6
26735|NCT02769065|60249|P28|STARTED|Overall Study||5
26736|NCT02769065|60250|P27|STARTED|Overall Study||9
26737|NCT02769065|60251|P26|STARTED|Overall Study||9
26738|NCT02769065|60252|P25|STARTED|Overall Study||6
26739|NCT02769065|60253|P24|STARTED|Overall Study||6
26740|NCT02769065|60254|P23|STARTED|Overall Study||4
26741|NCT02769065|60255|P22|STARTED|Overall Study||4
26742|NCT02769065|60256|P21|STARTED|Overall Study||4
26743|NCT02769065|60257|P20|STARTED|Overall Study||0
26744|NCT02769065|60258|P19|STARTED|Overall Study||5
26745|NCT02769065|60259|P18|STARTED|Overall Study||5
26746|NCT02769065|60260|P17|STARTED|Overall Study||5
26747|NCT02769065|60261|P16|STARTED|Overall Study||3
26748|NCT02769065|60262|P15|STARTED|Overall Study||6
26749|NCT02769065|60263|P14|STARTED|Overall Study||6
26750|NCT02769065|60264|P13|STARTED|Overall Study||6
26751|NCT02769065|60265|P12|STARTED|Overall Study||6
26752|NCT02769065|60266|P11|STARTED|Overall Study||6
26753|NCT02769065|60267|P10|STARTED|Overall Study||6
26754|NCT02769065|60268|P9|STARTED|Overall Study||6
26755|NCT02769065|60269|P8|STARTED|Overall Study||6
26756|NCT02769065|60270|P7|STARTED|Overall Study||7
26757|NCT02769065|60271|P6|STARTED|Overall Study||6
26758|NCT02769065|60272|P5|STARTED|Overall Study||6
26759|NCT02769065|60273|P4|STARTED|Overall Study||6
26760|NCT02769065|60274|P3|STARTED|Overall Study||6
26761|NCT02769065|60275|P2|STARTED|Overall Study||6
26762|NCT02769065|60276|P1|STARTED|Overall Study||17
26763|NCT02768870|60686|P1|NOT COMPLETED|Overall Study||26
26764|NCT02768870|60686|P1|COMPLETED|Overall Study||0
26765|NCT02768870|60686|P1|Implanted With Device|Overall Study||24
26766|NCT02768870|60686|P1|STARTED|Overall Study||26
26767|NCT02768753|60696|P2|NOT COMPLETED|Overall Study||0
26768|NCT02768753|60697|P1|NOT COMPLETED|Overall Study||0
26769|NCT02768753|60696|P2|COMPLETED|Overall Study||30
26770|NCT02768753|60697|P1|COMPLETED|Overall Study||30
26771|NCT02768753|60696|P2|STARTED|Overall Study||30
26772|NCT02768753|60697|P1|STARTED|Overall Study||30
26773|NCT02768194|60709|P6|NOT COMPLETED|Period 3||0
26774|NCT02768194|60710|P5|NOT COMPLETED|Period 3||0
26775|NCT02768194|60711|P4|NOT COMPLETED|Period 3||0
26776|NCT02768194|60712|P3|NOT COMPLETED|Period 3||0
26777|NCT02768194|60713|P2|NOT COMPLETED|Period 3||1
26778|NCT02768194|60714|P1|NOT COMPLETED|Period 3||0
26779|NCT02768194|60709|P6|COMPLETED|Period 3||4
26780|NCT02768194|60710|P5|COMPLETED|Period 3||4
26781|NCT02768194|60711|P4|COMPLETED|Period 3||3
26782|NCT02768194|60712|P3|COMPLETED|Period 3||4
26783|NCT02768194|60713|P2|COMPLETED|Period 3||3
26784|NCT02768194|60714|P1|COMPLETED|Period 3||3
26785|NCT02768194|60709|P6|STARTED|Period 3||4
26786|NCT02768194|60710|P5|STARTED|Period 3||4
26787|NCT02768194|60711|P4|STARTED|Period 3||3
26788|NCT02768194|60712|P3|STARTED|Period 3||4
26789|NCT02768194|60713|P2|STARTED|Period 3||4
26790|NCT02768194|60714|P1|STARTED|Period 3||3
26791|NCT02768194|60709|P6|NOT COMPLETED|Period 2||0
26792|NCT02768194|60710|P5|NOT COMPLETED|Period 2||0
26793|NCT02768194|60711|P4|NOT COMPLETED|Period 2||0
26794|NCT02768194|60712|P3|NOT COMPLETED|Period 2||0
26795|NCT02768194|60713|P2|NOT COMPLETED|Period 2||0
26796|NCT02768194|60714|P1|NOT COMPLETED|Period 2||1
26797|NCT02768194|60709|P6|COMPLETED|Period 2||4
26798|NCT02768194|60710|P5|COMPLETED|Period 2||4
26799|NCT02768194|60711|P4|COMPLETED|Period 2||3
26800|NCT02768194|60712|P3|COMPLETED|Period 2||4
26801|NCT02768194|60713|P2|COMPLETED|Period 2||4
26802|NCT02768194|60714|P1|COMPLETED|Period 2||3
26803|NCT02768194|60709|P6|STARTED|Period 2||4
26804|NCT02768194|60710|P5|STARTED|Period 2||4
26805|NCT02768194|60711|P4|STARTED|Period 2||3
26806|NCT02768194|60712|P3|STARTED|Period 2||4
26807|NCT02768194|60713|P2|STARTED|Period 2||4
26808|NCT02768194|60714|P1|STARTED|Period 2||4
26809|NCT02768194|60709|P6|NOT COMPLETED|Period 1||0
26810|NCT02768194|60710|P5|NOT COMPLETED|Period 1||0
26811|NCT02768194|60711|P4|NOT COMPLETED|Period 1||1
26812|NCT02768194|60712|P3|NOT COMPLETED|Period 1||0
26813|NCT02768194|60713|P2|NOT COMPLETED|Period 1||0
26814|NCT02768194|60714|P1|NOT COMPLETED|Period 1||0
26815|NCT02768194|60709|P6|COMPLETED|Period 1||4
26816|NCT02768194|60710|P5|COMPLETED|Period 1||4
26817|NCT02768194|60711|P4|COMPLETED|Period 1||3
26818|NCT02768194|60712|P3|COMPLETED|Period 1||4
26819|NCT02768194|60713|P2|COMPLETED|Period 1||4
26820|NCT02768194|60714|P1|COMPLETED|Period 1||4
26821|NCT02768194|60709|P6|STARTED|Period 1||4
26822|NCT02768194|60710|P5|STARTED|Period 1||4
26823|NCT02768194|60711|P4|STARTED|Period 1||4
26824|NCT02768194|60712|P3|STARTED|Period 1||4
26825|NCT02768194|60713|P2|STARTED|Period 1||4
26826|NCT02768194|60714|P1|STARTED|Period 1||4
26827|NCT02768129|60727|P2|NOT COMPLETED|Overall Study||0
26828|NCT02768129|60728|P1|NOT COMPLETED|Overall Study||0
26829|NCT02768129|60727|P2|COMPLETED|Overall Study||10
26830|NCT02768129|60728|P1|COMPLETED|Overall Study||11
26831|NCT02768129|60727|P2|STARTED|Overall Study||10
26832|NCT02768129|60728|P1|STARTED|Overall Study||11
26833|NCT02767947|60738|P2|NOT COMPLETED|Overall Study||0
26834|NCT02767947|60739|P1|NOT COMPLETED|Overall Study||0
26835|NCT02767947|60738|P2|COMPLETED|Overall Study||15
26836|NCT02767947|60739|P1|COMPLETED|Overall Study||60
26837|NCT02767947|60738|P2|Pharmacokinetic (PK) Population|Overall Study||3
26838|NCT02767947|60739|P1|Pharmacokinetic (PK) Population|Overall Study||12
26839|NCT02767947|60738|P2|Safety Population|Overall Study||15
26840|NCT02767947|60739|P1|Safety Population|Overall Study||60
26841|NCT02767947|60738|P2|STARTED|Overall Study||15
26842|NCT02767947|60739|P1|STARTED|Overall Study||60
26843|NCT02767843|60747|P1|NOT COMPLETED|Overall Study||0
26844|NCT02767843|60747|P1|COMPLETED|Overall Study||4
26845|NCT02767843|60747|P1|STARTED|Overall Study||4
26846|NCT02767765|60753|P1|NOT COMPLETED|Overall Study||11
26847|NCT02767765|60753|P1|COMPLETED|Overall Study||50
26848|NCT02767765|60753|P1|STARTED|Overall Study||61
26849|NCT02767609|60762|P1|NOT COMPLETED|Overall Study||0
26850|NCT02767609|60762|P1|COMPLETED|Overall Study||1
26851|NCT02767609|60762|P1|STARTED|Overall Study||1
26852|NCT02767531|60766|P2|NOT COMPLETED|Period 4||0
26853|NCT02767531|60767|P1|NOT COMPLETED|Period 4||0
26854|NCT02767531|60766|P2|COMPLETED|Period 4||1
26855|NCT02767531|60767|P1|COMPLETED|Period 4||1
26856|NCT02767531|60766|P2|STARTED|Period 4|Orlistat Therapy|1
26857|NCT02767531|60767|P1|STARTED|Period 4|Off Orlistat|1
26858|NCT02767531|60766|P2|NOT COMPLETED|Period 3||0
26859|NCT02767531|60767|P1|NOT COMPLETED|Period 3||0
26860|NCT02767531|60766|P2|COMPLETED|Period 3||1
26861|NCT02767531|60767|P1|COMPLETED|Period 3||1
26862|NCT02767531|60766|P2|STARTED|Period 3|Off Orlistat|1
26863|NCT02767531|60767|P1|STARTED|Period 3|Orlistat Therapy|1
26864|NCT02767531|60766|P2|NOT COMPLETED|Period 2||0
26865|NCT02767531|60767|P1|NOT COMPLETED|Period 2||0
26866|NCT02767531|60766|P2|COMPLETED|Period 2||1
26867|NCT02767531|60767|P1|COMPLETED|Period 2||1
26868|NCT02767531|60766|P2|STARTED|Period 2|Orlistat Therapy|1
26869|NCT02767531|60767|P1|STARTED|Period 2|Off Orlistat|1
26870|NCT02767531|60766|P2|NOT COMPLETED|Period 1||0
26871|NCT02767531|60767|P1|NOT COMPLETED|Period 1||0
26872|NCT02767531|60766|P2|COMPLETED|Period 1||1
26873|NCT02767531|60767|P1|COMPLETED|Period 1||1
26874|NCT02767531|60766|P2|STARTED|Period 1|Off Orlistat|1
26875|NCT02767531|60767|P1|STARTED|Period 1|Orlistat therapy|1
26876|NCT02767427|60775|P2|NOT COMPLETED|Overall Study||0
26877|NCT02767427|60776|P1|NOT COMPLETED|Overall Study||0
26878|NCT02767427|60775|P2|COMPLETED|Overall Study||19
26879|NCT02767427|60776|P1|COMPLETED|Overall Study||21
26880|NCT02767427|60775|P2|STARTED|Overall Study||19
26881|NCT02767427|60776|P1|STARTED|Overall Study||21
26882|NCT02767388|60785|P3|NOT COMPLETED|Overall Study||3
26883|NCT02767388|60786|P2|NOT COMPLETED|Overall Study||5
26884|NCT02767388|60787|P1|NOT COMPLETED|Overall Study||7
26885|NCT02767388|60785|P3|COMPLETED|Overall Study||12
26886|NCT02767388|60786|P2|COMPLETED|Overall Study||10
26887|NCT02767388|60787|P1|COMPLETED|Overall Study||8
26888|NCT02767388|60785|P3|STARTED|Overall Study||15
26889|NCT02767388|60786|P2|STARTED|Overall Study||15
26890|NCT02767388|60787|P1|STARTED|Overall Study||15
26891|NCT02767271|60806|P2|NOT COMPLETED|Overall Study||0
26892|NCT02767271|60807|P1|NOT COMPLETED|Overall Study||0
26893|NCT02767271|60806|P2|COMPLETED|Overall Study||15
26894|NCT02767271|60807|P1|COMPLETED|Overall Study||15
26895|NCT02767271|60806|P2|Pharmacokinetic Cruris (PKC) Population|Overall Study||15
26896|NCT02767271|60807|P1|Pharmacokinetic Cruris (PKC) Population|Overall Study||0
26897|NCT02767271|60806|P2|Pharmacokinetic Pedis (PKP) Population|Overall Study||0
26898|NCT02767271|60807|P1|Pharmacokinetic Pedis (PKP) Population|Overall Study||15
26899|NCT02767271|60806|P2|Safety Population|Overall Study||15
26900|NCT02767271|60807|P1|Safety Population|Overall Study||15
26901|NCT02767271|60806|P2|STARTED|Overall Study||15
26902|NCT02767271|60807|P1|STARTED|Overall Study||15
26903|NCT02767128|60817|P1|NOT COMPLETED|Overall Study||0
26904|NCT02767128|60817|P1|COMPLETED|Overall Study||14
26905|NCT02767128|60817|P1|Shohl's + Triferic Immediately|Overall Study||14
26906|NCT02767128|60817|P1|Shohl's + Triferic After 10 Min|Overall Study||14
26907|NCT02767128|60817|P1|Triferic|Overall Study||14
26908|NCT02767128|60817|P1|Shohl's + Fer-In-Sol|Overall Study||14
26909|NCT02767128|60817|P1|Fer-In-Sol|Overall Study||14
26910|NCT02767128|60817|P1|Baseline|Overall Study||14
26911|NCT02767128|60817|P1|STARTED|Overall Study||14
26912|NCT02767011|60845|P2|NOT COMPLETED|Overall Study||0
26913|NCT02767011|60846|P1|NOT COMPLETED|Overall Study||0
26914|NCT02767011|60845|P2|COMPLETED|Overall Study||14
26915|NCT02767011|60846|P1|COMPLETED|Overall Study||16
26916|NCT02767011|60845|P2|STARTED|Overall Study||14
26917|NCT02767011|60846|P1|STARTED|Overall Study||16
26918|NCT02766907|60870|P2|NOT COMPLETED|Overall Study||1
26919|NCT02766907|60871|P1|NOT COMPLETED|Overall Study||1
26920|NCT02766907|60870|P2|COMPLETED|Overall Study||9
26921|NCT02766907|60871|P1|COMPLETED|Overall Study||9
26922|NCT02766907|60870|P2|STARTED|Overall Study||10
26923|NCT02766907|60871|P1|STARTED|Overall Study||10
26924|NCT02766673|60879|P6|NOT COMPLETED|Overall Study||1
26925|NCT02766673|60880|P5|NOT COMPLETED|Overall Study||0
26926|NCT02766673|60881|P4|NOT COMPLETED|Overall Study||0
26927|NCT02766673|60882|P3|NOT COMPLETED|Overall Study||0
26928|NCT02766673|60883|P2|NOT COMPLETED|Overall Study||0
26929|NCT02766673|60884|P1|NOT COMPLETED|Overall Study||1
26930|NCT02766673|60879|P6|COMPLETED|Overall Study||3
26931|NCT02766673|60880|P5|COMPLETED|Overall Study||4
26932|NCT02766673|60881|P4|COMPLETED|Overall Study||4
26933|NCT02766673|60882|P3|COMPLETED|Overall Study||4
26934|NCT02766673|60883|P2|COMPLETED|Overall Study||4
26935|NCT02766673|60884|P1|COMPLETED|Overall Study||3
26936|NCT02766673|60879|P6|STARTED|Overall Study||4
26937|NCT02766673|60880|P5|STARTED|Overall Study||4
26938|NCT02766673|60881|P4|STARTED|Overall Study||4
26939|NCT02766673|60882|P3|STARTED|Overall Study||4
26940|NCT02766673|60883|P2|STARTED|Overall Study||4
26941|NCT02766673|60884|P1|STARTED|Overall Study||4
26942|NCT02766608|60900|P5|NOT COMPLETED|Overall Study||29
26943|NCT02766608|60901|P4|NOT COMPLETED|Overall Study||37
26944|NCT02766608|60902|P3|NOT COMPLETED|Overall Study||90
26945|NCT02766608|60903|P2|NOT COMPLETED|Overall Study||70
26946|NCT02766608|60904|P1|NOT COMPLETED|Overall Study||79
26947|NCT02766608|60900|P5|COMPLETED|Overall Study||190
26948|NCT02766608|60901|P4|COMPLETED|Overall Study||169
26949|NCT02766608|60902|P3|COMPLETED|Overall Study||554
26950|NCT02766608|60903|P2|COMPLETED|Overall Study||567
26951|NCT02766608|60904|P1|COMPLETED|Overall Study||576
26952|NCT02766608|60900|P5|STARTED|Overall Study||219
26953|NCT02766608|60901|P4|STARTED|Overall Study||206
26954|NCT02766608|60902|P3|STARTED|Overall Study||644
26955|NCT02766608|60903|P2|STARTED|Overall Study||637
26956|NCT02766608|60904|P1|STARTED|Overall Study||655
26957|NCT02766517|60981|P3|NOT COMPLETED|Overall Study||0
26958|NCT02766517|60982|P2|NOT COMPLETED|Overall Study||0
26959|NCT02766517|60983|P1|NOT COMPLETED|Overall Study||0
26960|NCT02766517|60981|P3|COMPLETED|Overall Study||9
26961|NCT02766517|60982|P2|COMPLETED|Overall Study||9
26962|NCT02766517|60983|P1|COMPLETED|Overall Study||19
26963|NCT02766517|60981|P3|STARTED|Overall Study||9
26964|NCT02766517|60982|P2|STARTED|Overall Study||9
26965|NCT02766517|60983|P1|STARTED|Overall Study||19
26966|NCT02766400|60996|P2|NOT COMPLETED|Overall Study||2
26967|NCT02766400|60997|P1|NOT COMPLETED|Overall Study||2
26968|NCT02766400|60996|P2|COMPLETED|Overall Study||20
26969|NCT02766400|60997|P1|COMPLETED|Overall Study||19
26970|NCT02766400|60996|P2|STARTED|Overall Study||22
26971|NCT02766400|60997|P1|STARTED|Overall Study||21
26972|NCT02766374|61005|P2|NOT COMPLETED|Overall Study||3
26973|NCT02766374|61006|P1|NOT COMPLETED|Overall Study||10
26974|NCT02766374|61005|P2|COMPLETED|Overall Study||30
26975|NCT02766374|61006|P1|COMPLETED|Overall Study||25
26976|NCT02766374|61005|P2|STARTED|Overall Study||33
26977|NCT02766374|61006|P1|STARTED|Overall Study||35
26978|NCT02766283|61012|P1|NOT COMPLETED|Overall Study||27
26979|NCT02766283|61012|P1|COMPLETED|Overall Study||816
26980|NCT02766283|61012|P1|STARTED|Overall Study||843
26981|NCT02766244|61036|P1|NOT COMPLETED|Overall Study||0
26982|NCT02766244|61036|P1|COMPLETED|Overall Study||3
26983|NCT02766244|61036|P1|STARTED|Overall Study||3
26984|NCT02765490|61047|P2|NOT COMPLETED|Overall Study||3
26985|NCT02765490|61048|P1|NOT COMPLETED|Overall Study||1
26986|NCT02765490|61047|P2|COMPLETED|Overall Study||179
26987|NCT02765490|61048|P1|COMPLETED|Overall Study||182
26988|NCT02765490|61047|P2|STARTED|Overall Study||182
26989|NCT02765490|61048|P1|STARTED|Overall Study||183
26990|NCT02765269|61066|P2|NOT COMPLETED|Overall Study||0
26991|NCT02765269|61067|P1|NOT COMPLETED|Overall Study||0
26992|NCT02765269|61066|P2|COMPLETED|Overall Study||21
26993|NCT02765269|61067|P1|COMPLETED|Overall Study||25
26994|NCT02765269|61066|P2|STARTED|Overall Study||21
26995|NCT02765269|61067|P1|STARTED|Overall Study||25
26996|NCT02764970|61081|P2|NOT COMPLETED|Overall Study||0
26997|NCT02764970|61082|P1|NOT COMPLETED|Overall Study||0
26998|NCT02764970|61081|P2|COMPLETED|Overall Study||47
26999|NCT02764970|61082|P1|COMPLETED|Overall Study||65
27000|NCT02764970|61081|P2|STARTED|Overall Study||47
27001|NCT02764970|61082|P1|STARTED|Overall Study||65
27002|NCT02764775|61094|P1|NOT COMPLETED|Overall Study||6
27003|NCT02764775|61094|P1|COMPLETED|Overall Study||8
27004|NCT02764775|61094|P1|STARTED|Overall Study|All 14 participants were assigned to the Headpod utilization group.|14
27005|NCT02764697|61098|P1|NOT COMPLETED|Overall Study||3
27006|NCT02764697|61098|P1|COMPLETED|Overall Study||2
27007|NCT02764697|61098|P1|STARTED|Overall Study||5
27008|NCT02764229|61103|P1|NOT COMPLETED|Overall Study||102
27009|NCT02764229|61103|P1|COMPLETED|Overall Study||10
27010|NCT02764229|61103|P1|STARTED|Overall Study||112
27011|NCT02764190|61109|P2|NOT COMPLETED|Overall Study||13
27012|NCT02764190|61110|P1|NOT COMPLETED|Overall Study||17
27013|NCT02764190|61109|P2|COMPLETED|Overall Study||122
27014|NCT02764190|61110|P1|COMPLETED|Overall Study||150
27015|NCT02764190|61109|P2|12 Month Follow-up|Overall Study||122
27016|NCT02764190|61110|P1|12 Month Follow-up|Overall Study||150
27017|NCT02764190|61109|P2|6 Month Follow-up|Overall Study||128
27018|NCT02764190|61110|P1|6 Month Follow-up|Overall Study||155
27019|NCT02764190|61109|P2|3 Month Follow-up|Overall Study||128
27020|NCT02764190|61110|P1|3 Month Follow-up|Overall Study||156
27021|NCT02764190|61109|P2|1 Day Follow-up|Overall Study||131
27022|NCT02764190|61110|P1|1 Day Follow-up|Overall Study||161
27023|NCT02764190|61109|P2|STARTED|Overall Study||135
27024|NCT02764190|61110|P1|STARTED|Overall Study||167
27025|NCT02763865|61156|P2|NOT COMPLETED|Overall Study||0
27026|NCT02763865|61157|P1|NOT COMPLETED|Overall Study||0
27027|NCT02763865|61156|P2|COMPLETED|Overall Study||5
27028|NCT02763865|61157|P1|COMPLETED|Overall Study||5
27029|NCT02763865|61156|P2|STARTED|Overall Study||5
27030|NCT02763865|61157|P1|STARTED|Overall Study||5
27031|NCT02763644|61171|P2|NOT COMPLETED|Overall Study||2
27032|NCT02763644|61172|P1|NOT COMPLETED|Overall Study||3
27033|NCT02763644|61171|P2|COMPLETED|Overall Study||2
27034|NCT02763644|61172|P1|COMPLETED|Overall Study||0
27035|NCT02763644|61171|P2|STARTED|Overall Study||4
27036|NCT02763644|61172|P1|STARTED|Overall Study||3
27037|NCT02763579|61192|P2|NOT COMPLETED|Overall Study||202
27038|NCT02763579|61193|P1|NOT COMPLETED|Overall Study||201
27039|NCT02763579|61192|P2|COMPLETED|Overall Study||0
27040|NCT02763579|61193|P1|COMPLETED|Overall Study||0
27041|NCT02763579|61192|P2|STARTED|Overall Study||202
27042|NCT02763579|61193|P1|STARTED|Overall Study||201
27043|NCT02763254|61201|P1|NOT COMPLETED|Overall Study||1
27044|NCT02763254|61201|P1|COMPLETED|Overall Study||0
27045|NCT02763254|61201|P1|STARTED|Overall Study||1
27046|NCT02763189|61208|P2|NOT COMPLETED|Overall Study||2
27047|NCT02763189|61209|P1|NOT COMPLETED|Overall Study||0
27048|NCT02763189|61208|P2|COMPLETED|Overall Study||2
27049|NCT02763189|61209|P1|COMPLETED|Overall Study||4
27050|NCT02763189|61208|P2|STARTED|Overall Study||4
27051|NCT02763189|61209|P1|STARTED|Overall Study||4
27052|NCT02763124|61217|P1|NOT COMPLETED|Overall Study||0
27053|NCT02763124|61217|P1|COMPLETED|Overall Study||18
27054|NCT02763124|61217|P1|STARTED|Overall Study||18
27055|NCT02762877|61226|P2|NOT COMPLETED|Overall Study||0
27056|NCT02762877|61227|P1|NOT COMPLETED|Overall Study||0
27057|NCT02762877|61226|P2|COMPLETED|Overall Study||19
27058|NCT02762877|61227|P1|COMPLETED|Overall Study||121
27059|NCT02762877|61226|P2|STARTED|Overall Study||19
27060|NCT02762877|61227|P1|STARTED|Overall Study||121
27061|NCT02762799|61238|P4|NOT COMPLETED|Overall Study||0
27062|NCT02762799|61239|P3|NOT COMPLETED|Overall Study||1
27063|NCT02762799|61240|P2|NOT COMPLETED|Overall Study||0
27064|NCT02762799|61241|P1|NOT COMPLETED|Overall Study||0
27065|NCT02762799|61238|P4|COMPLETED|Overall Study||12
27066|NCT02762799|61239|P3|COMPLETED|Overall Study||11
27067|NCT02762799|61240|P2|COMPLETED|Overall Study||18
27068|NCT02762799|61241|P1|COMPLETED|Overall Study||18
27069|NCT02762799|61238|P4|STARTED|Overall Study||12
27070|NCT02762799|61239|P3|STARTED|Overall Study||12
27071|NCT02762799|61240|P2|STARTED|Overall Study||18
27072|NCT02762799|61241|P1|STARTED|Overall Study||18
27073|NCT02762578|61313|P2|NOT COMPLETED|Overall Study||10
27074|NCT02762578|61314|P1|NOT COMPLETED|Overall Study||15
27075|NCT02762578|61313|P2|COMPLETED|Overall Study||172
27076|NCT02762578|61314|P1|COMPLETED|Overall Study||346
27077|NCT02762578|61313|P2|Exposed|Overall Study||181
27078|NCT02762578|61314|P1|Exposed|Overall Study||360
27079|NCT02762578|61313|P2|STARTED|Overall Study||182
27080|NCT02762578|61314|P1|STARTED|Overall Study||361
27081|NCT02762500|61416|P2|NOT COMPLETED|Overall Study||3
27082|NCT02762500|61417|P1|NOT COMPLETED|Overall Study||2
27083|NCT02762500|61416|P2|COMPLETED|Overall Study||59
27084|NCT02762500|61417|P1|COMPLETED|Overall Study||60
27085|NCT02762500|61416|P2|STARTED|Overall Study||62
27086|NCT02762500|61417|P1|STARTED|Overall Study||62
27087|NCT02762370|61437|P2|NOT COMPLETED|Overall Study||0
27088|NCT02762370|61438|P1|NOT COMPLETED|Overall Study||1
27089|NCT02762370|61437|P2|COMPLETED|Overall Study||15
27090|NCT02762370|61438|P1|COMPLETED|Overall Study||17
27091|NCT02762370|61437|P2|STARTED|Overall Study||15
27092|NCT02762370|61438|P1|STARTED|Overall Study||18
27093|NCT02762331|61458|P2|NOT COMPLETED|Overall Study||0
27094|NCT02762331|61459|P1|NOT COMPLETED|Overall Study||0
27095|NCT02762331|61458|P2|COMPLETED|Overall Study||2
27096|NCT02762331|61459|P1|COMPLETED|Overall Study||4
27097|NCT02762331|61458|P2|STARTED|Overall Study||2
27098|NCT02762331|61459|P1|STARTED|Overall Study||4
27099|NCT02762084|61478|P3|NOT COMPLETED|Overall Study||1
27100|NCT02762084|61479|P2|NOT COMPLETED|Overall Study||0
27101|NCT02762084|61480|P1|NOT COMPLETED|Overall Study||1
27102|NCT02762084|61478|P3|COMPLETED|Overall Study||4
27103|NCT02762084|61479|P2|COMPLETED|Overall Study||6
27104|NCT02762084|61480|P1|COMPLETED|Overall Study||5
27105|NCT02762084|61478|P3|By Tumor Per Protocol Population (PP)|Overall Study||4
27106|NCT02762084|61479|P2|By Tumor Per Protocol Population (PP)|Overall Study||6
27107|NCT02762084|61480|P1|By Tumor Per Protocol Population (PP)|Overall Study||6
27108|NCT02762084|61478|P3|Received at Least 1 Dose of Study Drug|Overall Study||5
27109|NCT02762084|61479|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
27110|NCT02762084|61480|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
27111|NCT02762084|61478|P3|STARTED|Overall Study||5
27112|NCT02762084|61479|P2|STARTED|Overall Study||6
27113|NCT02762084|61480|P1|STARTED|Overall Study||6
27114|NCT02761980|61522|P4|NOT COMPLETED|Overall Study||6
27115|NCT02761980|61523|P3|NOT COMPLETED|Overall Study||6
27116|NCT02761980|61524|P2|NOT COMPLETED|Overall Study||7
27117|NCT02761980|61525|P1|NOT COMPLETED|Overall Study||4
27118|NCT02761980|61522|P4|COMPLETED|Overall Study||81
27119|NCT02761980|61523|P3|COMPLETED|Overall Study||81
27120|NCT02761980|61524|P2|COMPLETED|Overall Study||80
27121|NCT02761980|61525|P1|COMPLETED|Overall Study||25
27122|NCT02761980|61522|P4|STARTED|Overall Study||87
27123|NCT02761980|61523|P3|STARTED|Overall Study||87
27124|NCT02761980|61524|P2|STARTED|Overall Study||87
27125|NCT02761980|61525|P1|STARTED|Overall Study||29
27126|NCT02761967|61557|P2|NOT COMPLETED|Overall Study||6
27127|NCT02761967|61558|P1|NOT COMPLETED|Overall Study||5
27128|NCT02761967|61557|P2|COMPLETED|Overall Study||64
27129|NCT02761967|61558|P1|COMPLETED|Overall Study||65
27130|NCT02761967|61557|P2|STARTED|Overall Study||70
27131|NCT02761967|61558|P1|STARTED|Overall Study||70
27132|NCT02761733|61572|P4|NOT COMPLETED|Overall Study||15
27133|NCT02761733|61573|P3|NOT COMPLETED|Overall Study||27
27134|NCT02761733|61574|P2|NOT COMPLETED|Overall Study||21
27135|NCT02761733|61575|P1|NOT COMPLETED|Overall Study||30
27136|NCT02761733|61572|P4|COMPLETED|Overall Study||45
27137|NCT02761733|61573|P3|COMPLETED|Overall Study||33
27138|NCT02761733|61574|P2|COMPLETED|Overall Study||39
27139|NCT02761733|61575|P1|COMPLETED|Overall Study||30
27140|NCT02761733|61572|P4|9/30/2015|Overall Study||50
27141|NCT02761733|61573|P3|9/30/2015|Overall Study||33
27142|NCT02761733|61574|P2|9/30/2015|Overall Study||44
27143|NCT02761733|61575|P1|9/30/2015|Overall Study||40
27144|NCT02761733|61572|P4|3/31/2015|Overall Study||50
27145|NCT02761733|61573|P3|3/31/2015|Overall Study||43
27146|NCT02761733|61574|P2|3/31/2015|Overall Study||47
27147|NCT02761733|61575|P1|3/31/2015|Overall Study||48
27148|NCT02761733|61572|P4|9/30/2014|Overall Study||55
27149|NCT02761733|61573|P3|9/30/2014|Overall Study||48
27150|NCT02761733|61574|P2|9/30/2014|Overall Study||56
27151|NCT02761733|61575|P1|9/30/2014|Overall Study||53
27152|NCT02761733|61572|P4|STARTED|Overall Study||60
27153|NCT02761733|61573|P3|STARTED|Overall Study||60
27154|NCT02761733|61574|P2|STARTED|Overall Study||60
27155|NCT02761733|61575|P1|STARTED|Overall Study||60
27156|NCT02761642|61605|P1|NOT COMPLETED|Overall Study||70
27157|NCT02761642|61605|P1|COMPLETED|Overall Study||130
27158|NCT02761642|61605|P1|Treated|Overall Study||197
27159|NCT02761642|61605|P1|STARTED|Overall Study||200
27160|NCT02761629|61618|P2|NOT COMPLETED|Overall Study||32
27161|NCT02761629|61619|P1|NOT COMPLETED|Overall Study||27
27162|NCT02761629|61618|P2|COMPLETED|Overall Study||58
27163|NCT02761629|61619|P1|COMPLETED|Overall Study||63
27164|NCT02761629|61618|P2|Treated|Overall Study||86
27165|NCT02761629|61619|P1|Treated|Overall Study||82
27166|NCT02761629|61618|P2|STARTED|Overall Study||90
27167|NCT02761629|61619|P1|STARTED|Overall Study||90
27168|NCT02761252|61642|P3|NOT COMPLETED|Overall Study||14
27169|NCT02761252|61643|P2|NOT COMPLETED|Overall Study||8
27170|NCT02761252|61644|P1|NOT COMPLETED|Overall Study||10
27171|NCT02761252|61642|P3|COMPLETED|Overall Study||123
27172|NCT02761252|61643|P2|COMPLETED|Overall Study||132
27173|NCT02761252|61644|P1|COMPLETED|Overall Study||133
27174|NCT02761252|61642|P3|STARTED|Overall Study||137
27175|NCT02761252|61643|P2|STARTED|Overall Study||140
27176|NCT02761252|61644|P1|STARTED|Overall Study||143
27177|NCT02760927|61666|P1|NOT COMPLETED|Overall Study||1
27178|NCT02760927|61666|P1|COMPLETED|Overall Study||3
27179|NCT02760927|61666|P1|STARTED|Overall Study||4
27180|NCT02760810|61674|P1|NOT COMPLETED|Overall Study||1
27181|NCT02760810|61674|P1|COMPLETED|Overall Study||29
27182|NCT02760810|61674|P1|STARTED|Overall Study||30
27183|NCT02760654|61682|P2|NOT COMPLETED|Overall Study||6
27184|NCT02760654|61683|P1|NOT COMPLETED|Overall Study||7
27185|NCT02760654|61682|P2|COMPLETED|Overall Study||24
27186|NCT02760654|61683|P1|COMPLETED|Overall Study||23
27187|NCT02760654|61682|P2|STARTED|Overall Study||30
27188|NCT02760654|61683|P1|STARTED|Overall Study||30
27189|NCT02760602|61709|P2|NOT COMPLETED|Overall Study||13
27190|NCT02760602|61710|P1|NOT COMPLETED|Overall Study||13
27191|NCT02760602|61709|P2|COMPLETED|Overall Study||0
27192|NCT02760602|61710|P1|COMPLETED|Overall Study||0
27193|NCT02760602|61709|P2|STARTED|Overall Study||13
27194|NCT02760602|61710|P1|STARTED|Overall Study||13
27195|NCT02760277|61752|P4|NOT COMPLETED|6.0 mg/kg/Day||0
27196|NCT02760277|61753|P3|NOT COMPLETED|6.0 mg/kg/Day||0
27197|NCT02760277|61754|P2|NOT COMPLETED|6.0 mg/kg/Day||0
27198|NCT02760277|61755|P1|NOT COMPLETED|6.0 mg/kg/Day||0
27199|NCT02760277|61752|P4|COMPLETED|6.0 mg/kg/Day||12
27200|NCT02760277|61753|P3|COMPLETED|6.0 mg/kg/Day||0
27201|NCT02760277|61754|P2|COMPLETED|6.0 mg/kg/Day||0
27202|NCT02760277|61755|P1|COMPLETED|6.0 mg/kg/Day||0
27203|NCT02760277|61752|P4|STARTED|6.0 mg/kg/Day||12
27204|NCT02760277|61753|P3|STARTED|6.0 mg/kg/Day||0
27205|NCT02760277|61754|P2|STARTED|6.0 mg/kg/Day||0
27206|NCT02760277|61755|P1|STARTED|6.0 mg/kg/Day||0
27207|NCT02760277|61752|P4|NOT COMPLETED|2.0 mg/kg/Day||0
27208|NCT02760277|61753|P3|NOT COMPLETED|2.0 mg/kg/Day||0
27209|NCT02760277|61754|P2|NOT COMPLETED|2.0 mg/kg/Day||0
27210|NCT02760277|61755|P1|NOT COMPLETED|2.0 mg/kg/Day||0
27211|NCT02760277|61752|P4|COMPLETED|2.0 mg/kg/Day||0
27212|NCT02760277|61753|P3|COMPLETED|2.0 mg/kg/Day||12
27213|NCT02760277|61754|P2|COMPLETED|2.0 mg/kg/Day||0
27214|NCT02760277|61755|P1|COMPLETED|2.0 mg/kg/Day||0
27215|NCT02760277|61752|P4|STARTED|2.0 mg/kg/Day||0
27216|NCT02760277|61753|P3|STARTED|2.0 mg/kg/Day||12
27217|NCT02760277|61754|P2|STARTED|2.0 mg/kg/Day||0
27218|NCT02760277|61755|P1|STARTED|2.0 mg/kg/Day||0
27219|NCT02760277|61752|P4|NOT COMPLETED|0.75 mg/kg/Day||0
27220|NCT02760277|61753|P3|NOT COMPLETED|0.75 mg/kg/Day||0
27221|NCT02760277|61754|P2|NOT COMPLETED|0.75 mg/kg/Day||0
27222|NCT02760277|61755|P1|NOT COMPLETED|0.75 mg/kg/Day||0
27223|NCT02760277|61752|P4|COMPLETED|0.75 mg/kg/Day||0
27224|NCT02760277|61753|P3|COMPLETED|0.75 mg/kg/Day||0
27225|NCT02760277|61754|P2|COMPLETED|0.75 mg/kg/Day||12
27226|NCT02760277|61755|P1|COMPLETED|0.75 mg/kg/Day||0
27227|NCT02760277|61752|P4|STARTED|0.75 mg/kg/Day||0
27228|NCT02760277|61753|P3|STARTED|0.75 mg/kg/Day||0
27229|NCT02760277|61754|P2|STARTED|0.75 mg/kg/Day||12
27230|NCT02760277|61755|P1|STARTED|0.75 mg/kg/Day||0
27231|NCT02760277|61752|P4|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
27232|NCT02760277|61753|P3|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
27233|NCT02760277|61754|P2|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
27234|NCT02760277|61755|P1|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
27235|NCT02760277|61752|P4|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
27236|NCT02760277|61753|P3|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
27237|NCT02760277|61754|P2|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
27238|NCT02760277|61755|P1|COMPLETED|Vamorolone 0.25 mg/kg/Day||12
27239|NCT02760277|61752|P4|STARTED|Vamorolone 0.25 mg/kg/Day||0
27240|NCT02760277|61753|P3|STARTED|Vamorolone 0.25 mg/kg/Day||0
27241|NCT02760277|61754|P2|STARTED|Vamorolone 0.25 mg/kg/Day||0
27242|NCT02760277|61755|P1|STARTED|Vamorolone 0.25 mg/kg/Day||12
27243|NCT02760264|61829|P4|NOT COMPLETED|6.0 mg/kg/Day||0
27244|NCT02760264|61830|P3|NOT COMPLETED|6.0 mg/kg/Day||0
27245|NCT02760264|61831|P2|NOT COMPLETED|6.0 mg/kg/Day||0
27246|NCT02760264|61832|P1|NOT COMPLETED|6.0 mg/kg/Day||0
27247|NCT02760264|61829|P4|COMPLETED|6.0 mg/kg/Day||12
27248|NCT02760264|61830|P3|COMPLETED|6.0 mg/kg/Day||0
27249|NCT02760264|61831|P2|COMPLETED|6.0 mg/kg/Day||0
27250|NCT02760264|61832|P1|COMPLETED|6.0 mg/kg/Day||0
27251|NCT02760264|61829|P4|STARTED|6.0 mg/kg/Day||12
27252|NCT02760264|61830|P3|STARTED|6.0 mg/kg/Day||0
27253|NCT02760264|61831|P2|STARTED|6.0 mg/kg/Day||0
27254|NCT02760264|61832|P1|STARTED|6.0 mg/kg/Day||0
27255|NCT02760264|61829|P4|NOT COMPLETED|2.0 mg/kg/Day||0
27256|NCT02760264|61830|P3|NOT COMPLETED|2.0 mg/kg/Day||0
27257|NCT02760264|61831|P2|NOT COMPLETED|2.0 mg/kg/Day||0
27258|NCT02760264|61832|P1|NOT COMPLETED|2.0 mg/kg/Day||0
27259|NCT02760264|61829|P4|COMPLETED|2.0 mg/kg/Day||0
27260|NCT02760264|61830|P3|COMPLETED|2.0 mg/kg/Day||12
27261|NCT02760264|61831|P2|COMPLETED|2.0 mg/kg/Day||0
27262|NCT02760264|61832|P1|COMPLETED|2.0 mg/kg/Day||0
27263|NCT02760264|61829|P4|STARTED|2.0 mg/kg/Day||0
27264|NCT02760264|61830|P3|STARTED|2.0 mg/kg/Day||12
27265|NCT02760264|61831|P2|STARTED|2.0 mg/kg/Day||0
27266|NCT02760264|61832|P1|STARTED|2.0 mg/kg/Day||0
27267|NCT02760264|61829|P4|NOT COMPLETED|0.75 mg/kg/Day||0
27268|NCT02760264|61830|P3|NOT COMPLETED|0.75 mg/kg/Day||0
27269|NCT02760264|61831|P2|NOT COMPLETED|0.75 mg/kg/Day||0
27270|NCT02760264|61832|P1|NOT COMPLETED|0.75 mg/kg/Day||0
27271|NCT02760264|61829|P4|COMPLETED|0.75 mg/kg/Day||0
27272|NCT02760264|61830|P3|COMPLETED|0.75 mg/kg/Day||0
27273|NCT02760264|61831|P2|COMPLETED|0.75 mg/kg/Day||12
27274|NCT02760264|61832|P1|COMPLETED|0.75 mg/kg/Day||0
27275|NCT02760264|61829|P4|STARTED|0.75 mg/kg/Day||0
27276|NCT02760264|61830|P3|STARTED|0.75 mg/kg/Day||0
27277|NCT02760264|61831|P2|STARTED|0.75 mg/kg/Day||12
27278|NCT02760264|61832|P1|STARTED|0.75 mg/kg/Day||0
27279|NCT02760264|61829|P4|NOT COMPLETED|0.25 mg/kg/Day||0
27280|NCT02760264|61830|P3|NOT COMPLETED|0.25 mg/kg/Day||0
27281|NCT02760264|61831|P2|NOT COMPLETED|0.25 mg/kg/Day||0
27282|NCT02760264|61832|P1|NOT COMPLETED|0.25 mg/kg/Day||0
27283|NCT02760264|61829|P4|COMPLETED|0.25 mg/kg/Day||0
27284|NCT02760264|61830|P3|COMPLETED|0.25 mg/kg/Day||0
27285|NCT02760264|61831|P2|COMPLETED|0.25 mg/kg/Day||0
27286|NCT02760264|61832|P1|COMPLETED|0.25 mg/kg/Day||12
27287|NCT02760264|61829|P4|STARTED|0.25 mg/kg/Day||0
27288|NCT02760264|61830|P3|STARTED|0.25 mg/kg/Day||0
27289|NCT02760264|61831|P2|STARTED|0.25 mg/kg/Day||0
27290|NCT02760264|61832|P1|STARTED|0.25 mg/kg/Day||12
27291|NCT02760056|61909|P2|NOT COMPLETED|Overall Study||0
27292|NCT02760056|61910|P1|NOT COMPLETED|Overall Study||0
27293|NCT02760056|61909|P2|COMPLETED|Overall Study||5
27294|NCT02760056|61910|P1|COMPLETED|Overall Study||10
27295|NCT02760056|61909|P2|STARTED|Overall Study||5
27296|NCT02760056|61910|P1|STARTED|Overall Study||10
27297|NCT02759939|61922|P4|NOT COMPLETED|Overall Study||1043
27298|NCT02759939|61923|P3|NOT COMPLETED|Overall Study||1154
27299|NCT02759939|61924|P2|NOT COMPLETED|Overall Study||972
27300|NCT02759939|61925|P1|NOT COMPLETED|Overall Study||1056
27301|NCT02759939|61922|P4|COMPLETED|Overall Study||203
27302|NCT02759939|61923|P3|COMPLETED|Overall Study||239
27303|NCT02759939|61924|P2|COMPLETED|Overall Study||171
27304|NCT02759939|61925|P1|COMPLETED|Overall Study||200
27305|NCT02759939|61922|P4|Consented to T2 and T3|Overall Study||564
27306|NCT02759939|61923|P3|Consented to T2 and T3|Overall Study||702
27307|NCT02759939|61924|P2|Consented to T2 and T3|Overall Study||626
27308|NCT02759939|61925|P1|Consented to T2 and T3|Overall Study||579
27309|NCT02759939|61922|P4|Analyzed at T2 and/or T3|Overall Study||304
27310|NCT02759939|61923|P3|Analyzed at T2 and/or T3|Overall Study||373
27311|NCT02759939|61924|P2|Analyzed at T2 and/or T3|Overall Study||278
27312|NCT02759939|61925|P1|Analyzed at T2 and/or T3|Overall Study||303
27313|NCT02759939|61922|P4|Eligible for T2 and T3|Overall Study||853
27314|NCT02759939|61923|P3|Eligible for T2 and T3|Overall Study||1022
27315|NCT02759939|61924|P2|Eligible for T2 and T3|Overall Study||962
27316|NCT02759939|61925|P1|Eligible for T2 and T3|Overall Study||935
27317|NCT02759939|61922|P4|Analyzed at T1|Overall Study||1244
27318|NCT02759939|61923|P3|Analyzed at T1|Overall Study||1388
27319|NCT02759939|61924|P2|Analyzed at T1|Overall Study||1141
27320|NCT02759939|61925|P1|Analyzed at T1|Overall Study||1245
27321|NCT02759939|61922|P4|STARTED|Overall Study||1246
27322|NCT02759939|61923|P3|STARTED|Overall Study||1393
27323|NCT02759939|61924|P2|STARTED|Overall Study||1143
27324|NCT02759939|61925|P1|STARTED|Overall Study||1256
27325|NCT02759692|61935|P2|NOT COMPLETED|Period 3||0
27326|NCT02759692|61936|P1|NOT COMPLETED|Period 3||0
27327|NCT02759692|61935|P2|COMPLETED|Period 3||139
27328|NCT02759692|61936|P1|COMPLETED|Period 3||137
27329|NCT02759692|61935|P2|STARTED|Period 3||139
27330|NCT02759692|61936|P1|STARTED|Period 3||137
27331|NCT02759692|61935|P2|NOT COMPLETED|Period 2||1
27332|NCT02759692|61936|P1|NOT COMPLETED|Period 2||1
27333|NCT02759692|61935|P2|COMPLETED|Period 2||139
27334|NCT02759692|61936|P1|COMPLETED|Period 2||137
27335|NCT02759692|61935|P2|STARTED|Period 2||140
27336|NCT02759692|61936|P1|STARTED|Period 2||138
27337|NCT02759692|61935|P2|NOT COMPLETED|Period 1||2
27338|NCT02759692|61936|P1|NOT COMPLETED|Period 1||3
27339|NCT02759692|61935|P2|COMPLETED|Period 1||140
27340|NCT02759692|61936|P1|COMPLETED|Period 1||138
27341|NCT02759692|61935|P2|STARTED|Period 1||142
27342|NCT02759692|61936|P1|STARTED|Period 1||141
27343|NCT02759562|61954|P2|NOT COMPLETED|Open-Label Treatment Period||2
27344|NCT02759562|61955|P1|NOT COMPLETED|Open-Label Treatment Period||2
27345|NCT02759562|61954|P2|COMPLETED|Open-Label Treatment Period||0
27346|NCT02759562|61955|P1|COMPLETED|Open-Label Treatment Period||0
27347|NCT02759562|61954|P2|STARTED|Open-Label Treatment Period||2
27348|NCT02759562|61955|P1|STARTED|Open-Label Treatment Period||2
27349|NCT02759562|61954|P2|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0
27350|NCT02759562|61955|P1|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0
27351|NCT02759562|61954|P2|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3
27352|NCT02759562|61955|P1|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3
27353|NCT02759562|61954|P2|STARTED|Double-Blind Treatment Period (8 Weeks)||3
27354|NCT02759562|61955|P1|STARTED|Double-Blind Treatment Period (8 Weeks)||3
27355|NCT02759471|61968|P1|NOT COMPLETED|Overall Study||2
27356|NCT02759471|61968|P1|COMPLETED|Overall Study||52
27357|NCT02759471|61968|P1|STARTED|Overall Study||54
27358|NCT02759354|61982|P4|NOT COMPLETED|Overall Study||0
27359|NCT02759354|61983|P3|NOT COMPLETED|Overall Study||0
27360|NCT02759354|61984|P2|NOT COMPLETED|Overall Study||0
27361|NCT02759354|61985|P1|NOT COMPLETED|Overall Study||0
27362|NCT02759354|61982|P4|COMPLETED|Overall Study||191
27363|NCT02759354|61983|P3|COMPLETED|Overall Study||181
27364|NCT02759354|61984|P2|COMPLETED|Overall Study||190
27365|NCT02759354|61985|P1|COMPLETED|Overall Study||192
27366|NCT02759354|61982|P4|STARTED|Overall Study||191
27367|NCT02759354|61983|P3|STARTED|Overall Study||181
27368|NCT02759354|61984|P2|STARTED|Overall Study||190
27369|NCT02759354|61985|P1|STARTED|Overall Study||192
27370|NCT02759315|62024|P5|NOT COMPLETED|Overall Study||1
27371|NCT02759315|62025|P4|NOT COMPLETED|Overall Study||1
27372|NCT02759315|62026|P3|NOT COMPLETED|Overall Study||10
27373|NCT02759315|62027|P2|NOT COMPLETED|Overall Study||1
27374|NCT02759315|62028|P1|NOT COMPLETED|Overall Study||4
27375|NCT02759315|62024|P5|COMPLETED|Overall Study||2
27376|NCT02759315|62025|P4|COMPLETED|Overall Study||19
27377|NCT02759315|62026|P3|COMPLETED|Overall Study||29
27378|NCT02759315|62027|P2|COMPLETED|Overall Study||28
27379|NCT02759315|62028|P1|COMPLETED|Overall Study||65
27380|NCT02759315|62024|P5|STARTED|Overall Study||3
27381|NCT02759315|62025|P4|STARTED|Overall Study||20
27382|NCT02759315|62026|P3|STARTED|Overall Study||39
27383|NCT02759315|62027|P2|STARTED|Overall Study||29
27384|NCT02759315|62028|P1|STARTED|Overall Study||69
27385|NCT02758613|62076|P4|NOT COMPLETED|Follow-up||0
27386|NCT02758613|62077|P3|NOT COMPLETED|Follow-up||0
27387|NCT02758613|62078|P2|NOT COMPLETED|Follow-up||0
27388|NCT02758613|62079|P1|NOT COMPLETED|Follow-up||0
27389|NCT02758613|62076|P4|COMPLETED|Follow-up||8
27390|NCT02758613|62077|P3|COMPLETED|Follow-up||8
27391|NCT02758613|62078|P2|COMPLETED|Follow-up||8
27392|NCT02758613|62079|P1|COMPLETED|Follow-up||6
27393|NCT02758613|62076|P4|STARTED|Follow-up||8
27394|NCT02758613|62077|P3|STARTED|Follow-up||8
27395|NCT02758613|62078|P2|STARTED|Follow-up||8
27396|NCT02758613|62079|P1|STARTED|Follow-up||6
27397|NCT02758613|62076|P4|NOT COMPLETED|Treatment||0
27398|NCT02758613|62077|P3|NOT COMPLETED|Treatment||1
27399|NCT02758613|62078|P2|NOT COMPLETED|Treatment||0
27400|NCT02758613|62079|P1|NOT COMPLETED|Treatment||2
27401|NCT02758613|62076|P4|COMPLETED|Treatment||8
27402|NCT02758613|62077|P3|COMPLETED|Treatment||8
27403|NCT02758613|62078|P2|COMPLETED|Treatment||8
27404|NCT02758613|62079|P1|COMPLETED|Treatment||6
27405|NCT02758613|62076|P4|Received at Least One Dose of Study Drug|Treatment||8
27406|NCT02758613|62077|P3|Received at Least One Dose of Study Drug|Treatment||9
27407|NCT02758613|62078|P2|Received at Least One Dose of Study Drug|Treatment||8
27408|NCT02758613|62079|P1|Received at Least One Dose of Study Drug|Treatment||8
27409|NCT02758613|62076|P4|STARTED|Treatment||8
27410|NCT02758613|62077|P3|STARTED|Treatment||9
27411|NCT02758613|62078|P2|STARTED|Treatment||8
27412|NCT02758613|62079|P1|STARTED|Treatment||8
27413|NCT02758301|62097|P2|NOT COMPLETED|Overall Study||8
27414|NCT02758301|62098|P1|NOT COMPLETED|Overall Study||34
27415|NCT02758301|62097|P2|COMPLETED|Overall Study||0
27416|NCT02758301|62098|P1|COMPLETED|Overall Study||70
27417|NCT02758301|62097|P2|STARTED|Overall Study||8
27418|NCT02758301|62098|P1|STARTED|Overall Study||104
27419|NCT02758210|62106|P1|NOT COMPLETED|Overall Study||0
27420|NCT02758210|62106|P1|COMPLETED|Overall Study||20
27421|NCT02758210|62106|P1|STARTED|Overall Study||20
27422|NCT02758171|62117|P2|NOT COMPLETED|Treatment Period 2||0
27423|NCT02758171|62118|P1|NOT COMPLETED|Treatment Period 2||0
27424|NCT02758171|62117|P2|COMPLETED|Treatment Period 2||28
27425|NCT02758171|62118|P1|COMPLETED|Treatment Period 2||26
27426|NCT02758171|62117|P2|STARTED|Treatment Period 2||28
27427|NCT02758171|62118|P1|STARTED|Treatment Period 2||26
27428|NCT02758171|62117|P2|NOT COMPLETED|Wash-out||0
27429|NCT02758171|62118|P1|NOT COMPLETED|Wash-out||2
27430|NCT02758171|62117|P2|COMPLETED|Wash-out||28
27431|NCT02758171|62118|P1|COMPLETED|Wash-out||26
27432|NCT02758171|62117|P2|STARTED|Wash-out||28
27433|NCT02758171|62118|P1|STARTED|Wash-out||28
27434|NCT02758171|62117|P2|NOT COMPLETED|Treatment Period 1||0
27435|NCT02758171|62118|P1|NOT COMPLETED|Treatment Period 1||0
27436|NCT02758171|62117|P2|COMPLETED|Treatment Period 1||28
27437|NCT02758171|62118|P1|COMPLETED|Treatment Period 1||28
27438|NCT02758171|62117|P2|STARTED|Treatment Period 1||28
27439|NCT02758171|62118|P1|STARTED|Treatment Period 1||28
27440|NCT02758132|62136|P2|NOT COMPLETED|Overall Study||1
27441|NCT02758132|62137|P1|NOT COMPLETED|Overall Study||0
27442|NCT02758132|62136|P2|COMPLETED|Overall Study||0
27443|NCT02758132|62137|P1|COMPLETED|Overall Study||0
27444|NCT02758132|62136|P2|STARTED|Overall Study||1
27445|NCT02758132|62137|P1|STARTED|Overall Study||0
27446|NCT02758119|62159|P2|NOT COMPLETED|Overall Study||1
27447|NCT02758119|62160|P1|NOT COMPLETED|Overall Study||2
27448|NCT02758119|62159|P2|COMPLETED|Overall Study||40
27449|NCT02758119|62160|P1|COMPLETED|Overall Study||39
27450|NCT02758119|62159|P2|STARTED|Overall Study||41
27451|NCT02758119|62160|P1|STARTED|Overall Study||41
27452|NCT02757963|62172|P1|NOT COMPLETED|Overall Study||1097
27453|NCT02757963|62172|P1|COMPLETED|Overall Study||561
27454|NCT02757963|62172|P1|STARTED|Overall Study||1658
27455|NCT02757950|62190|P2|NOT COMPLETED|Overall Study||11
27456|NCT02757950|62191|P1|NOT COMPLETED|Overall Study||4
27457|NCT02757950|62190|P2|COMPLETED|Overall Study||1248
27458|NCT02757950|62191|P1|COMPLETED|Overall Study||1199
27459|NCT02757950|62190|P2|STARTED|Overall Study||1259
27460|NCT02757950|62191|P1|STARTED|Overall Study||1203
27461|NCT02757768|62212|P2|NOT COMPLETED|Overall Study||28
27462|NCT02757768|62213|P1|NOT COMPLETED|Overall Study||33
27463|NCT02757768|62212|P2|COMPLETED|Overall Study||331
27464|NCT02757768|62213|P1|COMPLETED|Overall Study||323
27465|NCT02757768|62212|P2|Treated|Overall Study||354
27466|NCT02757768|62213|P1|Treated|Overall Study||352
27467|NCT02757768|62212|P2|STARTED|Overall Study||359
27468|NCT02757768|62213|P1|STARTED|Overall Study||356
27469|NCT02757625|62261|P4|NOT COMPLETED|Overall Study||0
27470|NCT02757625|62262|P3|NOT COMPLETED|Overall Study||2
27471|NCT02757625|62263|P2|NOT COMPLETED|Overall Study||0
27472|NCT02757625|62264|P1|NOT COMPLETED|Overall Study||0
27473|NCT02757625|62261|P4|COMPLETED|Overall Study||12
27474|NCT02757625|62262|P3|COMPLETED|Overall Study||17
27475|NCT02757625|62263|P2|COMPLETED|Overall Study||18
27476|NCT02757625|62264|P1|COMPLETED|Overall Study||14
27477|NCT02757625|62261|P4|STARTED|Overall Study||12
27478|NCT02757625|62262|P3|STARTED|Overall Study||19
27479|NCT02757625|62263|P2|STARTED|Overall Study||18
27480|NCT02757625|62264|P1|STARTED|Overall Study||14
27481|NCT02757547|62416|P1|NOT COMPLETED|Overall Study||0
27482|NCT02757547|62416|P1|COMPLETED|Overall Study||2
27483|NCT02757547|62416|P1|STARTED|Overall Study||2
27484|NCT02757521|62423|P2|NOT COMPLETED|Overall Study||0
27485|NCT02757521|62424|P1|NOT COMPLETED|Overall Study||1
27486|NCT02757521|62423|P2|COMPLETED|Overall Study||0
27487|NCT02757521|62424|P1|COMPLETED|Overall Study||0
27488|NCT02757521|62423|P2|STARTED|Overall Study||0
27489|NCT02757521|62424|P1|STARTED|Overall Study||1
27490|NCT02757430|62430|P1|NOT COMPLETED|Overall Study||12
27491|NCT02757430|62430|P1|COMPLETED|Overall Study|Subjects with pre-discharge visit were considered completed.|503
27492|NCT02757430|62430|P1|EP Mapping/Ablation Procedure|Overall Study||503
27493|NCT02757430|62430|P1|Baseline Visits|Overall Study||503
27494|NCT02757430|62430|P1|STARTED|Overall Study||515
27495|NCT02757105|62448|P2|NOT COMPLETED|Overall Study||11
27496|NCT02757105|62449|P1|NOT COMPLETED|Overall Study||12
27497|NCT02757105|62448|P2|COMPLETED|Overall Study||41
27498|NCT02757105|62449|P1|COMPLETED|Overall Study||63
27499|NCT02757105|62448|P2|Treated|Overall Study||51
27500|NCT02757105|62449|P1|Treated|Overall Study||75
27501|NCT02757105|62448|P2|STARTED|Overall Study||52
27502|NCT02757105|62449|P1|STARTED|Overall Study||75
27503|NCT02757053|62471|P2|NOT COMPLETED|Overall Study||5
27504|NCT02757053|62472|P1|NOT COMPLETED|Overall Study||3
27505|NCT02757053|62471|P2|COMPLETED|Overall Study||0
27506|NCT02757053|62472|P1|COMPLETED|Overall Study||0
27507|NCT02757053|62471|P2|STARTED|Overall Study||5
27508|NCT02757053|62472|P1|STARTED|Overall Study||3
27509|NCT02756949|62486|P2|NOT COMPLETED|Overall Study||8
27510|NCT02756949|62487|P1|NOT COMPLETED|Overall Study||0
27511|NCT02756949|62486|P2|COMPLETED|Overall Study||164
27512|NCT02756949|62487|P1|COMPLETED|Overall Study||181
27513|NCT02756949|62486|P2|STARTED|Overall Study||172
27514|NCT02756949|62487|P1|STARTED|Overall Study||181
27515|NCT02756832|62495|P1|NOT COMPLETED|Overall Study||53
27516|NCT02756832|62495|P1|COMPLETED|Overall Study||1356
27517|NCT02756832|62495|P1|Included in Efficacy and Safety Analysis|Overall Study||1399
27518|NCT02756832|62495|P1|Received Therapy|Overall Study||1393
27519|NCT02756832|62495|P1|STARTED|Overall Study||1409
27520|NCT02756819|62509|P1|NOT COMPLETED|Overall Study||52
27521|NCT02756819|62509|P1|COMPLETED|Overall Study||1893
27522|NCT02756819|62509|P1|Safety Analysis Set (SAS)|Overall Study|Participants who received at least one dose of Edarbi® therapy and had any follow-up data.|1934
27523|NCT02756819|62509|P1|Per-protocol Set (PPS)|Overall Study|Participants who were enrolled, received Edarbi® therapy and did not have major protocol deviations.|1724
27524|NCT02756819|62509|P1|STARTED|Overall Study||1945
27525|NCT02756689|62521|P2|NOT COMPLETED|Overall Study||0
27526|NCT02756689|62522|P1|NOT COMPLETED|Overall Study||0
27527|NCT02756689|62521|P2|COMPLETED|Overall Study||65
27528|NCT02756689|62522|P1|COMPLETED|Overall Study||64
27529|NCT02756689|62521|P2|STARTED|Overall Study||65
27530|NCT02756689|62522|P1|STARTED|Overall Study||64
27531|NCT02756637|62610|P2|NOT COMPLETED|Overall Study||54
27532|NCT02756637|62611|P1|NOT COMPLETED|Overall Study||87
27533|NCT02756637|62610|P2|COMPLETED|Overall Study||263
27534|NCT02756637|62611|P1|COMPLETED|Overall Study||230
27535|NCT02756637|62610|P2|Completed Curative Treatment|Overall Study||0
27536|NCT02756637|62611|P1|Completed Curative Treatment|Overall Study||230
27537|NCT02756637|62610|P2|Had NLR Value|Overall Study||263
27538|NCT02756637|62611|P1|Had NLR Value|Overall Study||263
27539|NCT02756637|62610|P2|Eligible for SWOG 8710|Overall Study||307
27540|NCT02756637|62611|P1|Eligible for SWOG 8710|Overall Study||307
27541|NCT02756637|62610|P2|STARTED|Overall Study||317
27542|NCT02756637|62611|P1|STARTED|Overall Study||317
27543|NCT02756624|62619|P2|NOT COMPLETED|Overall Study||7
27544|NCT02756624|62620|P1|NOT COMPLETED|Overall Study||16
27545|NCT02756624|62619|P2|COMPLETED|Overall Study||166
27546|NCT02756624|62620|P1|COMPLETED|Overall Study||327
27547|NCT02756624|62619|P2|STARTED|Overall Study||173
27548|NCT02756624|62620|P1|STARTED|Overall Study||343
27549|NCT02756351|62634|P2|NOT COMPLETED|Overall Study||0
27550|NCT02756351|62635|P1|NOT COMPLETED|Overall Study||0
27551|NCT02756351|62634|P2|COMPLETED|Overall Study||24
27552|NCT02756351|62635|P1|COMPLETED|Overall Study||24
27553|NCT02756351|62634|P2|STARTED|Overall Study||24
27554|NCT02756351|62635|P1|STARTED|Overall Study||24
27555|NCT02756338|62643|P1|NOT COMPLETED|Overall Study||5
27556|NCT02756338|62643|P1|COMPLETED|Overall Study||72
27557|NCT02756338|62643|P1|STARTED|Overall Study||77
27558|NCT02756182|62652|P1|NOT COMPLETED|Overall Study||0
27559|NCT02756182|62652|P1|COMPLETED|Overall Study||25
27560|NCT02756182|62652|P1|STARTED|Overall Study||25
27561|NCT02756078|62667|P2|NOT COMPLETED|Period 2||7
27562|NCT02756078|62668|P1|NOT COMPLETED|Period 2||6
27563|NCT02756078|62667|P2|COMPLETED|Period 2||57
27564|NCT02756078|62668|P1|COMPLETED|Period 2||70
27565|NCT02756078|62667|P2|STARTED|Period 2||64
27566|NCT02756078|62668|P1|STARTED|Period 2||76
27567|NCT02756078|62667|P2|NOT COMPLETED|Period 1||22
27568|NCT02756078|62668|P1|NOT COMPLETED|Period 1||9
27569|NCT02756078|62667|P2|COMPLETED|Period 1||64
27570|NCT02756078|62668|P1|COMPLETED|Period 1||76
27571|NCT02756078|62667|P2|STARTED|Period 1||86
27572|NCT02756078|62668|P1|STARTED|Period 1||85
27573|NCT02755935|62686|P1|NOT COMPLETED|Overall Study||2
27574|NCT02755935|62686|P1|COMPLETED|Overall Study||22
27575|NCT02755935|62686|P1|STARTED|Overall Study||24
27576|NCT02755831|62693|P2|NOT COMPLETED|Overall Study||3
27577|NCT02755831|62694|P1|NOT COMPLETED|Overall Study||3
27578|NCT02755831|62693|P2|COMPLETED|Overall Study||90
27579|NCT02755831|62694|P1|COMPLETED|Overall Study||97
27580|NCT02755831|62693|P2|STARTED|Overall Study||93
27581|NCT02755831|62694|P1|STARTED|Overall Study||100
27582|NCT02755818|62710|P4|NOT COMPLETED|Overall Study||3
27583|NCT02755818|62711|P3|NOT COMPLETED|Overall Study||1
27584|NCT02755818|62712|P2|NOT COMPLETED|Overall Study||0
27585|NCT02755818|62713|P1|NOT COMPLETED|Overall Study||0
27586|NCT02755818|62710|P4|COMPLETED|Overall Study||14
27587|NCT02755818|62711|P3|COMPLETED|Overall Study||1
27588|NCT02755818|62712|P2|COMPLETED|Overall Study||2
27589|NCT02755818|62713|P1|COMPLETED|Overall Study||30
27590|NCT02755818|62710|P4|STARTED|Overall Study||17
27591|NCT02755818|62711|P3|STARTED|Overall Study||2
27592|NCT02755818|62712|P2|STARTED|Overall Study||2
27593|NCT02755818|62713|P1|STARTED|Overall Study||30
27594|NCT02755805|62749|P2|NOT COMPLETED|Overall Study||4
27595|NCT02755805|62750|P1|NOT COMPLETED|Overall Study||2
27596|NCT02755805|62749|P2|COMPLETED|Overall Study||11
27597|NCT02755805|62750|P1|COMPLETED|Overall Study||13
27598|NCT02755805|62749|P2|STARTED|Overall Study||15
27599|NCT02755805|62750|P1|STARTED|Overall Study||15
27600|NCT02755090|62764|P2|NOT COMPLETED|Overall Study||0
27601|NCT02755090|62765|P1|NOT COMPLETED|Overall Study||1
27602|NCT02755090|62764|P2|COMPLETED|Overall Study||20
27603|NCT02755090|62765|P1|COMPLETED|Overall Study||18
27604|NCT02755090|62764|P2|STARTED|Overall Study||20
27605|NCT02755090|62765|P1|STARTED|Overall Study||19
27606|NCT02754661|62775|P2|NOT COMPLETED|Overall Study||19
27607|NCT02754661|62776|P1|NOT COMPLETED|Overall Study||15
27608|NCT02754661|62775|P2|COMPLETED|Overall Study||141
27609|NCT02754661|62776|P1|COMPLETED|Overall Study||145
27610|NCT02754661|62775|P2|STARTED|Overall Study||160
27611|NCT02754661|62776|P1|STARTED|Overall Study||160
27612|NCT02754570|62790|P1|NOT COMPLETED|Overall Study||0
27613|NCT02754570|62790|P1|COMPLETED|Overall Study||27
27614|NCT02754570|62790|P1|Visit 3 (PGA + Pilocarpine)|Overall Study||27
27615|NCT02754570|62790|P1|Visits 1 and 2 (PGA Only)|Overall Study||27
27616|NCT02754570|62790|P1|STARTED|Overall Study||27
27617|NCT02754492|62800|P4|NOT COMPLETED|Overall Study||23
27618|NCT02754492|62801|P3|NOT COMPLETED|Overall Study||2
27619|NCT02754492|62802|P2|NOT COMPLETED|Overall Study||2
27620|NCT02754492|62803|P1|NOT COMPLETED|Overall Study||4
27621|NCT02754492|62800|P4|COMPLETED|Overall Study||0
27622|NCT02754492|62801|P3|COMPLETED|Overall Study||93
27623|NCT02754492|62802|P2|COMPLETED|Overall Study||93
27624|NCT02754492|62803|P1|COMPLETED|Overall Study||93
27625|NCT02754492|62800|P4|STARTED|Overall Study||23
27626|NCT02754492|62801|P3|STARTED|Overall Study||95
27627|NCT02754492|62802|P2|STARTED|Overall Study||95
27628|NCT02754492|62803|P1|STARTED|Overall Study||97
27629|NCT02754440|62819|P4|NOT COMPLETED|Overall Study||35
27630|NCT02754440|62820|P3|NOT COMPLETED|Overall Study||7
27631|NCT02754440|62821|P2|NOT COMPLETED|Overall Study||8
27632|NCT02754440|62822|P1|NOT COMPLETED|Overall Study||6
27633|NCT02754440|62819|P4|COMPLETED|Overall Study||0
27634|NCT02754440|62820|P3|COMPLETED|Overall Study||93
27635|NCT02754440|62821|P2|COMPLETED|Overall Study||93
27636|NCT02754440|62822|P1|COMPLETED|Overall Study||93
27637|NCT02754440|62819|P4|STARTED|Overall Study||35
27638|NCT02754440|62820|P3|STARTED|Overall Study||100
27639|NCT02754440|62821|P2|STARTED|Overall Study||101
27640|NCT02754440|62822|P1|STARTED|Overall Study||99
27641|NCT02754427|62836|P2|NOT COMPLETED|Overall Study||1
27642|NCT02754427|62837|P1|NOT COMPLETED|Overall Study||0
27643|NCT02754427|62836|P2|COMPLETED|Overall Study||19
27644|NCT02754427|62837|P1|COMPLETED|Overall Study||21
27645|NCT02754427|62836|P2|STARTED|Overall Study||20
27646|NCT02754427|62837|P1|STARTED|Overall Study||21
27647|NCT02754310|62851|P2|NOT COMPLETED|Overall Study||0
27648|NCT02754310|62852|P1|NOT COMPLETED|Overall Study||0
27649|NCT02754310|62851|P2|COMPLETED|Overall Study||43
27650|NCT02754310|62852|P1|COMPLETED|Overall Study||42
27651|NCT02754310|62851|P2|STARTED|Overall Study||43
27652|NCT02754310|62852|P1|STARTED|Overall Study||42
27653|NCT02753946|62874|P2|NOT COMPLETED|Overall Study||9
27654|NCT02753946|62875|P1|NOT COMPLETED|Overall Study||14
27655|NCT02753946|62874|P2|COMPLETED|Overall Study||222
27656|NCT02753946|62875|P1|COMPLETED|Overall Study||219
27657|NCT02753946|62874|P2|STARTED|Overall Study||231
27658|NCT02753946|62875|P1|STARTED|Overall Study||233
27659|NCT02753920|62887|P2|NOT COMPLETED|Overall Study||0
27660|NCT02753920|62888|P1|NOT COMPLETED|Overall Study||0
27661|NCT02753920|62887|P2|COMPLETED|Overall Study||86
27662|NCT02753920|62888|P1|COMPLETED|Overall Study||87
27663|NCT02753920|62887|P2|STARTED|Overall Study||86
27664|NCT02753920|62888|P1|STARTED|Overall Study||87
27665|NCT02753699|62901|P3|NOT COMPLETED|Overall Study||23
27666|NCT02753699|62902|P2|NOT COMPLETED|Overall Study||43
27667|NCT02753699|62903|P1|NOT COMPLETED|Overall Study||14
27668|NCT02753699|62901|P3|COMPLETED|Overall Study||139
27669|NCT02753699|62902|P2|COMPLETED|Overall Study||354
27670|NCT02753699|62903|P1|COMPLETED|Overall Study||150
27671|NCT02753699|62901|P3|STARTED|Overall Study||162
27672|NCT02753699|62902|P2|STARTED|Overall Study||397
27673|NCT02753699|62903|P1|STARTED|Overall Study||164
27674|NCT02753413|62919|P2|NOT COMPLETED|Overall Study||0
27675|NCT02753413|62920|P1|NOT COMPLETED|Overall Study||0
27676|NCT02753413|62919|P2|COMPLETED|Overall Study||51
27677|NCT02753413|62920|P1|COMPLETED|Overall Study||49
27678|NCT02753413|62919|P2|STARTED|Overall Study||51
27679|NCT02753413|62920|P1|STARTED|Overall Study||49
27680|NCT02753075|62955|P3|NOT COMPLETED|Overall Study||3
27681|NCT02753075|62956|P2|NOT COMPLETED|Overall Study||3
27682|NCT02753075|62957|P1|NOT COMPLETED|Overall Study||8
27683|NCT02753075|62955|P3|COMPLETED|Overall Study||78
27684|NCT02753075|62956|P2|COMPLETED|Overall Study||77
27685|NCT02753075|62957|P1|COMPLETED|Overall Study||71
27686|NCT02753075|62955|P3|STARTED|Overall Study||81
27687|NCT02753075|62956|P2|STARTED|Overall Study||80
27688|NCT02753075|62957|P1|STARTED|Overall Study||79
27689|NCT02752958|62982|P1|NOT COMPLETED|Overall Study||9
27690|NCT02752958|62982|P1|COMPLETED|Overall Study||66
27691|NCT02752958|62982|P1|STARTED|Overall Study||75
27692|NCT02752880|63053|P2|NOT COMPLETED|Overall Study||3
27693|NCT02752880|63054|P1|NOT COMPLETED|Overall Study||2
27694|NCT02752880|63053|P2|COMPLETED|Overall Study||20
27695|NCT02752880|63054|P1|COMPLETED|Overall Study||21
27696|NCT02752880|63053|P2|STARTED|Overall Study||23
27697|NCT02752880|63054|P1|STARTED|Overall Study||23
27698|NCT02752802|63064|P2|NOT COMPLETED|Overall Study||0
27699|NCT02752802|63065|P1|NOT COMPLETED|Overall Study||1
27700|NCT02752802|63064|P2|COMPLETED|Overall Study||48
27701|NCT02752802|63065|P1|COMPLETED|Overall Study||47
27702|NCT02752802|63064|P2|STARTED|Overall Study||48
27703|NCT02752802|63065|P1|STARTED|Overall Study||48
27704|NCT02752776|63077|P3|NOT COMPLETED|Overall Study||48
27705|NCT02752776|63078|P2|NOT COMPLETED|Overall Study||76
27706|NCT02752776|63079|P1|NOT COMPLETED|Overall Study||52
27707|NCT02752776|63077|P3|COMPLETED|Overall Study||276
27708|NCT02752776|63078|P2|COMPLETED|Overall Study||597
27709|NCT02752776|63079|P1|COMPLETED|Overall Study||611
27710|NCT02752776|63077|P3|STARTED|Overall Study||324
27711|NCT02752776|63078|P2|STARTED|Overall Study||673
27712|NCT02752776|63079|P1|STARTED|Overall Study||663
27713|NCT02752633|63125|P1|NOT COMPLETED|Overall Study||1
27714|NCT02752633|63125|P1|COMPLETED|Overall Study||8
27715|NCT02752633|63125|P1|STARTED|Overall Study||9
27716|NCT02752490|63131|P2|NOT COMPLETED|Overall Study||0
27717|NCT02752490|63132|P1|NOT COMPLETED|Overall Study||0
27718|NCT02752490|63131|P2|COMPLETED|Overall Study||435
27719|NCT02752490|63132|P1|COMPLETED|Overall Study||409
27720|NCT02752490|63131|P2|STARTED|Overall Study||435
27721|NCT02752490|63132|P1|STARTED|Overall Study||409
27722|NCT02752256|63154|P2|NOT COMPLETED|Overall Study||0
27723|NCT02752256|63155|P1|NOT COMPLETED|Overall Study||0
27724|NCT02752256|63154|P2|COMPLETED|Overall Study||41
27725|NCT02752256|63155|P1|COMPLETED|Overall Study||35
27726|NCT02752256|63154|P2|STARTED|Overall Study||41
27727|NCT02752256|63155|P1|STARTED|Overall Study||35
27728|NCT02752074|63165|P2|NOT COMPLETED|Overall Study||352
27729|NCT02752074|63166|P1|NOT COMPLETED|Overall Study||354
27730|NCT02752074|63165|P2|COMPLETED|Overall Study||0
27731|NCT02752074|63166|P1|COMPLETED|Overall Study||0
27732|NCT02752074|63165|P2|Treated|Overall Study||352
27733|NCT02752074|63166|P1|Treated|Overall Study||353
27734|NCT02752074|63165|P2|STARTED|Overall Study||352
27735|NCT02752074|63166|P1|STARTED|Overall Study||354
27736|NCT02751983|63190|P2|NOT COMPLETED|Three-Month Follow-Up Assessments||16
27737|NCT02751983|63191|P1|NOT COMPLETED|Three-Month Follow-Up Assessments||12
27738|NCT02751983|63190|P2|COMPLETED|Three-Month Follow-Up Assessments||19
27739|NCT02751983|63191|P1|COMPLETED|Three-Month Follow-Up Assessments||23
27740|NCT02751983|63190|P2|STARTED|Three-Month Follow-Up Assessments||35
27741|NCT02751983|63191|P1|STARTED|Three-Month Follow-Up Assessments||35
27742|NCT02751983|63190|P2|NOT COMPLETED|One-Month Follow-Up Assessments||12
27743|NCT02751983|63191|P1|NOT COMPLETED|One-Month Follow-Up Assessments||14
27744|NCT02751983|63190|P2|COMPLETED|One-Month Follow-Up Assessments||23
27745|NCT02751983|63191|P1|COMPLETED|One-Month Follow-Up Assessments||21
27746|NCT02751983|63190|P2|STARTED|One-Month Follow-Up Assessments||35
27747|NCT02751983|63191|P1|STARTED|One-Month Follow-Up Assessments||35
27748|NCT02751983|63190|P2|NOT COMPLETED|Post-Treatment Assessment||0
27749|NCT02751983|63191|P1|NOT COMPLETED|Post-Treatment Assessment||5
27750|NCT02751983|63190|P2|COMPLETED|Post-Treatment Assessment||0
27751|NCT02751983|63191|P1|COMPLETED|Post-Treatment Assessment||30
27752|NCT02751983|63190|P2|STARTED|Post-Treatment Assessment||0
27753|NCT02751983|63191|P1|STARTED|Post-Treatment Assessment||35
27754|NCT02751983|63190|P2|NOT COMPLETED|Treatment||0
27755|NCT02751983|63191|P1|NOT COMPLETED|Treatment||4
27756|NCT02751983|63190|P2|COMPLETED|Treatment||35
27757|NCT02751983|63191|P1|COMPLETED|Treatment||31
27758|NCT02751983|63190|P2|STARTED|Treatment||35
27759|NCT02751983|63191|P1|STARTED|Treatment||35
27760|NCT02751983|63190|P2|NOT COMPLETED|Baseline and Randomization||0
27761|NCT02751983|63191|P1|NOT COMPLETED|Baseline and Randomization||0
27762|NCT02751983|63190|P2|COMPLETED|Baseline and Randomization||35
27763|NCT02751983|63191|P1|COMPLETED|Baseline and Randomization||35
27764|NCT02751983|63190|P2|STARTED|Baseline and Randomization||35
27765|NCT02751983|63191|P1|STARTED|Baseline and Randomization||35
27766|NCT02751879|63212|P2|NOT COMPLETED|Overall Study||0
27767|NCT02751879|63213|P1|NOT COMPLETED|Overall Study||0
27768|NCT02751879|63212|P2|COMPLETED|Overall Study||71
27769|NCT02751879|63213|P1|COMPLETED|Overall Study||157
27770|NCT02751879|63212|P2|On Treatment at Study Completion|Overall Study||41
27771|NCT02751879|63213|P1|On Treatment at Study Completion|Overall Study||81
27772|NCT02751879|63212|P2|STARTED|Overall Study||71
27773|NCT02751879|63213|P1|STARTED|Overall Study||157
27774|NCT02751450|63228|P2|NOT COMPLETED|Overall Study||0
27775|NCT02751450|63229|P1|NOT COMPLETED|Overall Study||1
27776|NCT02751450|63228|P2|COMPLETED|Overall Study||116
27777|NCT02751450|63229|P1|COMPLETED|Overall Study||116
27778|NCT02751450|63228|P2|STARTED|Overall Study||116
27779|NCT02751450|63229|P1|STARTED|Overall Study||117
27780|NCT02751424|63250|P9|NOT COMPLETED|Part 2||0
27781|NCT02751424|63251|P8|NOT COMPLETED|Part 2||5
27782|NCT02751424|63252|P7|NOT COMPLETED|Part 2||0
27783|NCT02751424|63253|P6|NOT COMPLETED|Part 2||0
27784|NCT02751424|63254|P5|NOT COMPLETED|Part 2||0
27785|NCT02751424|63255|P4|NOT COMPLETED|Part 2||0
27786|NCT02751424|63256|P3|NOT COMPLETED|Part 2||0
27787|NCT02751424|63257|P2|NOT COMPLETED|Part 2||0
27788|NCT02751424|63258|P1|NOT COMPLETED|Part 2||0
27789|NCT02751424|63250|P9|COMPLETED|Part 2||3
27790|NCT02751424|63251|P8|COMPLETED|Part 2||6
27791|NCT02751424|63252|P7|COMPLETED|Part 2||0
27792|NCT02751424|63253|P6|COMPLETED|Part 2||0
27793|NCT02751424|63254|P5|COMPLETED|Part 2||0
27794|NCT02751424|63255|P4|COMPLETED|Part 2||0
27795|NCT02751424|63256|P3|COMPLETED|Part 2||0
27796|NCT02751424|63257|P2|COMPLETED|Part 2||0
27797|NCT02751424|63258|P1|COMPLETED|Part 2||0
27798|NCT02751424|63250|P9|STARTED|Part 2||3
27799|NCT02751424|63251|P8|STARTED|Part 2||11
27800|NCT02751424|63252|P7|STARTED|Part 2||0
27801|NCT02751424|63253|P6|STARTED|Part 2||0
27802|NCT02751424|63254|P5|STARTED|Part 2||0
27803|NCT02751424|63255|P4|STARTED|Part 2||0
27804|NCT02751424|63256|P3|STARTED|Part 2||0
27805|NCT02751424|63257|P2|STARTED|Part 2||0
27806|NCT02751424|63258|P1|STARTED|Part 2||0
27807|NCT02751424|63250|P9|NOT COMPLETED|Part 1||0
27808|NCT02751424|63251|P8|NOT COMPLETED|Part 1||0
27809|NCT02751424|63252|P7|NOT COMPLETED|Part 1||0
27810|NCT02751424|63253|P6|NOT COMPLETED|Part 1||0
27811|NCT02751424|63254|P5|NOT COMPLETED|Part 1||0
27812|NCT02751424|63255|P4|NOT COMPLETED|Part 1||0
27813|NCT02751424|63256|P3|NOT COMPLETED|Part 1||0
27814|NCT02751424|63257|P2|NOT COMPLETED|Part 1||0
27815|NCT02751424|63258|P1|NOT COMPLETED|Part 1||0
27816|NCT02751424|63250|P9|COMPLETED|Part 1||0
27817|NCT02751424|63251|P8|COMPLETED|Part 1||0
27818|NCT02751424|63252|P7|COMPLETED|Part 1||12
27819|NCT02751424|63253|P6|COMPLETED|Part 1||6
27820|NCT02751424|63254|P5|COMPLETED|Part 1||6
27821|NCT02751424|63255|P4|COMPLETED|Part 1||6
27822|NCT02751424|63256|P3|COMPLETED|Part 1||6
27823|NCT02751424|63257|P2|COMPLETED|Part 1||6
27824|NCT02751424|63258|P1|COMPLETED|Part 1||6
27825|NCT02751424|63250|P9|STARTED|Part 1||0
27826|NCT02751424|63251|P8|STARTED|Part 1||0
27827|NCT02751424|63252|P7|STARTED|Part 1||12
27828|NCT02751424|63253|P6|STARTED|Part 1||6
27829|NCT02751424|63254|P5|STARTED|Part 1||6
27830|NCT02751424|63255|P4|STARTED|Part 1||6
27831|NCT02751424|63256|P3|STARTED|Part 1||6
27832|NCT02751424|63257|P2|STARTED|Part 1||6
27833|NCT02751424|63258|P1|STARTED|Part 1||6
27834|NCT02751385|63401|P2|NOT COMPLETED|Period 2||0
27835|NCT02751385|63402|P1|NOT COMPLETED|Period 2||0
27836|NCT02751385|63401|P2|COMPLETED|Period 2||2
27837|NCT02751385|63402|P1|COMPLETED|Period 2||0
27838|NCT02751385|63401|P2|STARTED|Period 2||2
27839|NCT02751385|63402|P1|STARTED|Period 2||0
27840|NCT02751385|63401|P2|NOT COMPLETED|Period 1||0
27841|NCT02751385|63402|P1|NOT COMPLETED|Period 1||0
27842|NCT02751385|63401|P2|COMPLETED|Period 1||0
27843|NCT02751385|63402|P1|COMPLETED|Period 1||2
27844|NCT02751385|63401|P2|STARTED|Period 1||0
27845|NCT02751385|63402|P1|STARTED|Period 1||2
27846|NCT02751320|63414|P1|NOT COMPLETED|Overall Study||3
27847|NCT02751320|63414|P1|COMPLETED|Overall Study||42
27848|NCT02751320|63414|P1|Received Reference Product 3|Overall Study||28
27849|NCT02751320|63414|P1|Received Reference Product 2|Overall Study||28
27850|NCT02751320|63414|P1|Received Reference Product 1|Overall Study||29
27851|NCT02751320|63414|P1|Received Test Prodcut 3|Overall Study||28
27852|NCT02751320|63414|P1|Received Test Prodcut 2|Overall Study||28
27853|NCT02751320|63414|P1|Received Test Product 1|Overall Study||29
27854|NCT02751320|63414|P1|STARTED|Overall Study||45
27855|NCT02750943|63452|P2|NOT COMPLETED|Overall Study||9
27856|NCT02750943|63453|P1|NOT COMPLETED|Overall Study||6
27857|NCT02750943|63452|P2|COMPLETED|Overall Study||119
27858|NCT02750943|63453|P1|COMPLETED|Overall Study||119
27859|NCT02750943|63452|P2|STARTED|Overall Study||128
27860|NCT02750943|63453|P1|STARTED|Overall Study||125
27861|NCT02750930|63467|P1|NOT COMPLETED|Overall Study||8
27862|NCT02750930|63467|P1|COMPLETED|Overall Study||0
27863|NCT02750930|63467|P1|STARTED|Overall Study||8
27864|NCT02750813|63479|P2|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
27865|NCT02750813|63480|P1|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
27866|NCT02750813|63479|P2|COMPLETED|Period 2, Second 14 Days of Wear||120
27867|NCT02750813|63480|P1|COMPLETED|Period 2, Second 14 Days of Wear||124
27868|NCT02750813|63479|P2|STARTED|Period 2, Second 14 Days of Wear||120
27869|NCT02750813|63480|P1|STARTED|Period 2, Second 14 Days of Wear||124
27870|NCT02750813|63479|P2|NOT COMPLETED|Period 1, First 14 Days of Wear||1
27871|NCT02750813|63480|P1|NOT COMPLETED|Period 1, First 14 Days of Wear||1
27872|NCT02750813|63479|P2|COMPLETED|Period 1, First 14 Days of Wear||120
27873|NCT02750813|63480|P1|COMPLETED|Period 1, First 14 Days of Wear||124
27874|NCT02750813|63479|P2|STARTED|Period 1, First 14 Days of Wear||121
27875|NCT02750813|63480|P1|STARTED|Period 1, First 14 Days of Wear||125
27876|NCT02750800|63495|P1|NOT COMPLETED|Overall Study||98
27877|NCT02750800|63495|P1|COMPLETED|Overall Study||314
27878|NCT02750800|63495|P1|STARTED|Overall Study||412
27879|NCT02750709|63594|P6|NOT COMPLETED|Treatment Period 3||0
27880|NCT02750709|63595|P5|NOT COMPLETED|Treatment Period 3||0
27881|NCT02750709|63596|P4|NOT COMPLETED|Treatment Period 3||0
27882|NCT02750709|63597|P3|NOT COMPLETED|Treatment Period 3||0
27883|NCT02750709|63598|P2|NOT COMPLETED|Treatment Period 3||0
27884|NCT02750709|63599|P1|NOT COMPLETED|Treatment Period 3||0
27885|NCT02750709|63594|P6|COMPLETED|Treatment Period 3||3
27886|NCT02750709|63595|P5|COMPLETED|Treatment Period 3||4
27887|NCT02750709|63596|P4|COMPLETED|Treatment Period 3||4
27888|NCT02750709|63597|P3|COMPLETED|Treatment Period 3||4
27889|NCT02750709|63598|P2|COMPLETED|Treatment Period 3||4
27890|NCT02750709|63599|P1|COMPLETED|Treatment Period 3||4
27891|NCT02750709|63594|P6|STARTED|Treatment Period 3||3
27892|NCT02750709|63595|P5|STARTED|Treatment Period 3||4
27893|NCT02750709|63596|P4|STARTED|Treatment Period 3||4
27894|NCT02750709|63597|P3|STARTED|Treatment Period 3||4
27895|NCT02750709|63598|P2|STARTED|Treatment Period 3||4
27896|NCT02750709|63599|P1|STARTED|Treatment Period 3||4
27897|NCT02750709|63594|P6|NOT COMPLETED|Treatment Period 2||0
27898|NCT02750709|63595|P5|NOT COMPLETED|Treatment Period 2||0
27899|NCT02750709|63596|P4|NOT COMPLETED|Treatment Period 2||0
27900|NCT02750709|63597|P3|NOT COMPLETED|Treatment Period 2||0
27901|NCT02750709|63598|P2|NOT COMPLETED|Treatment Period 2||0
27902|NCT02750709|63599|P1|NOT COMPLETED|Treatment Period 2||0
27903|NCT02750709|63594|P6|COMPLETED|Treatment Period 2||3
27904|NCT02750709|63595|P5|COMPLETED|Treatment Period 2||4
27905|NCT02750709|63596|P4|COMPLETED|Treatment Period 2||4
27906|NCT02750709|63597|P3|COMPLETED|Treatment Period 2||4
27907|NCT02750709|63598|P2|COMPLETED|Treatment Period 2||4
27908|NCT02750709|63599|P1|COMPLETED|Treatment Period 2||4
27909|NCT02750709|63594|P6|STARTED|Treatment Period 2||3
27910|NCT02750709|63595|P5|STARTED|Treatment Period 2||4
27911|NCT02750709|63596|P4|STARTED|Treatment Period 2||4
27912|NCT02750709|63597|P3|STARTED|Treatment Period 2||4
27913|NCT02750709|63598|P2|STARTED|Treatment Period 2||4
27914|NCT02750709|63599|P1|STARTED|Treatment Period 2||4
27915|NCT02750709|63594|P6|NOT COMPLETED|Treatment Period 1||1
27916|NCT02750709|63595|P5|NOT COMPLETED|Treatment Period 1||0
27917|NCT02750709|63596|P4|NOT COMPLETED|Treatment Period 1||0
27918|NCT02750709|63597|P3|NOT COMPLETED|Treatment Period 1||0
27919|NCT02750709|63598|P2|NOT COMPLETED|Treatment Period 1||0
27920|NCT02750709|63599|P1|NOT COMPLETED|Treatment Period 1||0
27921|NCT02750709|63594|P6|COMPLETED|Treatment Period 1||3
27922|NCT02750709|63595|P5|COMPLETED|Treatment Period 1||4
27923|NCT02750709|63596|P4|COMPLETED|Treatment Period 1||4
27924|NCT02750709|63597|P3|COMPLETED|Treatment Period 1||4
27925|NCT02750709|63598|P2|COMPLETED|Treatment Period 1||4
27926|NCT02750709|63599|P1|COMPLETED|Treatment Period 1||4
27927|NCT02750709|63594|P6|STARTED|Treatment Period 1||4
27928|NCT02750709|63595|P5|STARTED|Treatment Period 1||4
27929|NCT02750709|63596|P4|STARTED|Treatment Period 1||4
27930|NCT02750709|63597|P3|STARTED|Treatment Period 1||4
27931|NCT02750709|63598|P2|STARTED|Treatment Period 1||4
27932|NCT02750709|63599|P1|STARTED|Treatment Period 1||4
27933|NCT02750618|63625|P1|NOT COMPLETED|Overall Study||0
27934|NCT02750618|63625|P1|COMPLETED|Overall Study||13
27935|NCT02750618|63625|P1|STARTED|Overall Study||13
27936|NCT02750592|63641|P1|NOT COMPLETED|Overall Study||5
27937|NCT02750592|63641|P1|COMPLETED|Overall Study||25
27938|NCT02750592|63641|P1|STARTED|Overall Study||30
27939|NCT02750501|63660|P1|NOT COMPLETED|Overall Study||8
27940|NCT02750501|63660|P1|COMPLETED|Overall Study||36
27941|NCT02750501|63660|P1|Treated|Overall Study||39
27942|NCT02750501|63660|P1|Enrolled|Overall Study||44
27943|NCT02750501|63660|P1|STARTED|Overall Study||44
27944|NCT02750410|63674|P2|NOT COMPLETED|Open-Label Extension Period||6
27945|NCT02750410|63675|P1|NOT COMPLETED|Open-Label Extension Period||6
27946|NCT02750410|63674|P2|COMPLETED|Open-Label Extension Period||111
27947|NCT02750410|63675|P1|COMPLETED|Open-Label Extension Period||31
27948|NCT02750410|63674|P2|STARTED|Open-Label Extension Period||117
27949|NCT02750410|63675|P1|STARTED|Open-Label Extension Period||37
27950|NCT02750410|63674|P2|NOT COMPLETED|Double-Blind Treatment Period||3
27951|NCT02750410|63675|P1|NOT COMPLETED|Double-Blind Treatment Period||2
27952|NCT02750410|63674|P2|COMPLETED|Double-Blind Treatment Period||117
27953|NCT02750410|63675|P1|COMPLETED|Double-Blind Treatment Period||37
27954|NCT02750410|63674|P2|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||120
27955|NCT02750410|63675|P1|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||39
27956|NCT02750410|63674|P2|STARTED|Double-Blind Treatment Period||120
27957|NCT02750410|63675|P1|STARTED|Double-Blind Treatment Period||39
27958|NCT02750345|63693|P6|NOT COMPLETED|Intervention 3||0
27959|NCT02750345|63694|P5|NOT COMPLETED|Intervention 3||0
27960|NCT02750345|63695|P4|NOT COMPLETED|Intervention 3||0
27961|NCT02750345|63696|P3|NOT COMPLETED|Intervention 3||0
27962|NCT02750345|63697|P2|NOT COMPLETED|Intervention 3||0
27963|NCT02750345|63698|P1|NOT COMPLETED|Intervention 3||0
27964|NCT02750345|63693|P6|COMPLETED|Intervention 3||4
27965|NCT02750345|63694|P5|COMPLETED|Intervention 3||3
27966|NCT02750345|63695|P4|COMPLETED|Intervention 3||4
27967|NCT02750345|63696|P3|COMPLETED|Intervention 3||4
27968|NCT02750345|63697|P2|COMPLETED|Intervention 3||4
27969|NCT02750345|63698|P1|COMPLETED|Intervention 3||4
27970|NCT02750345|63693|P6|STARTED|Intervention 3||4
27971|NCT02750345|63694|P5|STARTED|Intervention 3||3
27972|NCT02750345|63695|P4|STARTED|Intervention 3||4
27973|NCT02750345|63696|P3|STARTED|Intervention 3||4
27974|NCT02750345|63697|P2|STARTED|Intervention 3||4
27975|NCT02750345|63698|P1|STARTED|Intervention 3||4
27976|NCT02750345|63693|P6|NOT COMPLETED|Intervention 2||0
27977|NCT02750345|63694|P5|NOT COMPLETED|Intervention 2||0
27978|NCT02750345|63695|P4|NOT COMPLETED|Intervention 2||0
27979|NCT02750345|63696|P3|NOT COMPLETED|Intervention 2||0
27980|NCT02750345|63697|P2|NOT COMPLETED|Intervention 2||0
27981|NCT02750345|63698|P1|NOT COMPLETED|Intervention 2||0
27982|NCT02750345|63693|P6|COMPLETED|Intervention 2||4
27983|NCT02750345|63694|P5|COMPLETED|Intervention 2||3
27984|NCT02750345|63695|P4|COMPLETED|Intervention 2||4
27985|NCT02750345|63696|P3|COMPLETED|Intervention 2||4
27986|NCT02750345|63697|P2|COMPLETED|Intervention 2||4
27987|NCT02750345|63698|P1|COMPLETED|Intervention 2||4
27988|NCT02750345|63693|P6|STARTED|Intervention 2||4
27989|NCT02750345|63694|P5|STARTED|Intervention 2||3
27990|NCT02750345|63695|P4|STARTED|Intervention 2||4
27991|NCT02750345|63696|P3|STARTED|Intervention 2||4
27992|NCT02750345|63697|P2|STARTED|Intervention 2||4
27993|NCT02750345|63698|P1|STARTED|Intervention 2||4
27994|NCT02750345|63693|P6|NOT COMPLETED|Intervention 1||0
27995|NCT02750345|63694|P5|NOT COMPLETED|Intervention 1||1
27996|NCT02750345|63695|P4|NOT COMPLETED|Intervention 1||0
27997|NCT02750345|63696|P3|NOT COMPLETED|Intervention 1||0
27998|NCT02750345|63697|P2|NOT COMPLETED|Intervention 1||0
27999|NCT02750345|63698|P1|NOT COMPLETED|Intervention 1||0
28000|NCT02750345|63693|P6|COMPLETED|Intervention 1||4
28001|NCT02750345|63694|P5|COMPLETED|Intervention 1||3
28002|NCT02750345|63695|P4|COMPLETED|Intervention 1||4
28003|NCT02750345|63696|P3|COMPLETED|Intervention 1||4
28004|NCT02750345|63697|P2|COMPLETED|Intervention 1||4
28005|NCT02750345|63698|P1|COMPLETED|Intervention 1||4
28006|NCT02750345|63693|P6|STARTED|Intervention 1||4
28007|NCT02750345|63694|P5|STARTED|Intervention 1||4
28008|NCT02750345|63695|P4|STARTED|Intervention 1||4
28009|NCT02750345|63696|P3|STARTED|Intervention 1||4
28010|NCT02750345|63697|P2|STARTED|Intervention 1||4
28011|NCT02750345|63698|P1|STARTED|Intervention 1||4
28012|NCT02750332|63724|P2|NOT COMPLETED|Treatment Period 2||0
28013|NCT02750332|63725|P1|NOT COMPLETED|Treatment Period 2||0
28014|NCT02750332|63724|P2|COMPLETED|Treatment Period 2||9
28015|NCT02750332|63725|P1|COMPLETED|Treatment Period 2||10
28016|NCT02750332|63724|P2|STARTED|Treatment Period 2||9
28017|NCT02750332|63725|P1|STARTED|Treatment Period 2||10
28018|NCT02750332|63724|P2|NOT COMPLETED|Treatment Period 1||1
28019|NCT02750332|63725|P1|NOT COMPLETED|Treatment Period 1||0
28020|NCT02750332|63724|P2|COMPLETED|Treatment Period 1||9
28021|NCT02750332|63725|P1|COMPLETED|Treatment Period 1||10
28022|NCT02750332|63724|P2|STARTED|Treatment Period 1||10
28023|NCT02750332|63725|P1|STARTED|Treatment Period 1||10
28024|NCT02750306|63745|P2|NOT COMPLETED|Overall Study||2
28025|NCT02750306|63746|P1|NOT COMPLETED|Overall Study||6
28026|NCT02750306|63745|P2|COMPLETED|Overall Study||141
28027|NCT02750306|63746|P1|COMPLETED|Overall Study||136
28028|NCT02750306|63745|P2|STARTED|Overall Study||143
28029|NCT02750306|63746|P1|STARTED|Overall Study||142
28030|NCT02750267|63760|P2|NOT COMPLETED|Overall Study||0
28031|NCT02750267|63761|P1|NOT COMPLETED|Overall Study||0
28032|NCT02750267|63760|P2|COMPLETED|Overall Study||6
28033|NCT02750267|63761|P1|COMPLETED|Overall Study||6
28034|NCT02750267|63760|P2|STARTED|Overall Study||6
28035|NCT02750267|63761|P1|STARTED|Overall Study||6
28036|NCT02749370|63799|P1|NOT COMPLETED|Overall Study||14
28037|NCT02749370|63799|P1|COMPLETED|Overall Study||66
28038|NCT02749370|63799|P1|STARTED|Overall Study||80
28039|NCT02748928|63826|P1|NOT COMPLETED|Overall Study||0
28040|NCT02748928|63826|P1|COMPLETED|Overall Study||62
28041|NCT02748928|63826|P1|STARTED|Overall Study||62
28042|NCT02748889|63837|P2|NOT COMPLETED|Overall Study||0
28043|NCT02748889|63838|P1|NOT COMPLETED|Overall Study||0
28044|NCT02748889|63837|P2|COMPLETED|Overall Study||1
28045|NCT02748889|63838|P1|COMPLETED|Overall Study||0
28046|NCT02748889|63837|P2|STARTED|Overall Study||1
28047|NCT02748889|63838|P1|STARTED|Overall Study||0
28048|NCT02748863|63845|P5|NOT COMPLETED|Treatment Period 2||1
28049|NCT02748863|63846|P4|NOT COMPLETED|Treatment Period 2||2
28050|NCT02748863|63847|P3|NOT COMPLETED|Treatment Period 2||0
28051|NCT02748863|63848|P2|NOT COMPLETED|Treatment Period 2||3
28052|NCT02748863|63849|P1|NOT COMPLETED|Treatment Period 2||5
28053|NCT02748863|63845|P5|COMPLETED|Treatment Period 2||33
28054|NCT02748863|63846|P4|COMPLETED|Treatment Period 2||32
28055|NCT02748863|63847|P3|COMPLETED|Treatment Period 2||0
28056|NCT02748863|63848|P2|COMPLETED|Treatment Period 2||66
28057|NCT02748863|63849|P1|COMPLETED|Treatment Period 2||67
28058|NCT02748863|63845|P5|STARTED|Treatment Period 2||34
28059|NCT02748863|63846|P4|STARTED|Treatment Period 2||34
28060|NCT02748863|63847|P3|STARTED|Treatment Period 2||0
28061|NCT02748863|63848|P2|STARTED|Treatment Period 2||69
28062|NCT02748863|63849|P1|STARTED|Treatment Period 2||72
28063|NCT02748863|63845|P5|NOT COMPLETED|Treatment Period 1||0
28064|NCT02748863|63846|P4|NOT COMPLETED|Treatment Period 1||0
28065|NCT02748863|63847|P3|NOT COMPLETED|Treatment Period 1||2
28066|NCT02748863|63848|P2|NOT COMPLETED|Treatment Period 1||2
28067|NCT02748863|63849|P1|NOT COMPLETED|Treatment Period 1||0
28068|NCT02748863|63845|P5|COMPLETED|Treatment Period 1||0
28069|NCT02748863|63846|P4|COMPLETED|Treatment Period 1||0
28070|NCT02748863|63847|P3|COMPLETED|Treatment Period 1||69
28071|NCT02748863|63848|P2|COMPLETED|Treatment Period 1||69
28072|NCT02748863|63849|P1|COMPLETED|Treatment Period 1||72
28073|NCT02748863|63845|P5|STARTED|Treatment Period 1|Not applicable for this period|0
28074|NCT02748863|63846|P4|STARTED|Treatment Period 1|Not applicable for this period|0
28075|NCT02748863|63847|P3|STARTED|Treatment Period 1||71
28076|NCT02748863|63848|P2|STARTED|Treatment Period 1||71
28077|NCT02748863|63849|P1|STARTED|Treatment Period 1||72
28078|NCT02748785|63875|P4|NOT COMPLETED|Visit 3- Visit 4||2
28079|NCT02748785|63876|P3|NOT COMPLETED|Visit 3- Visit 4||2
28080|NCT02748785|63877|P2|NOT COMPLETED|Visit 3- Visit 4||1
28081|NCT02748785|63878|P1|NOT COMPLETED|Visit 3- Visit 4||1
28082|NCT02748785|63875|P4|COMPLETED|Visit 3- Visit 4||50
28083|NCT02748785|63876|P3|COMPLETED|Visit 3- Visit 4||47
28084|NCT02748785|63877|P2|COMPLETED|Visit 3- Visit 4||43
28085|NCT02748785|63878|P1|COMPLETED|Visit 3- Visit 4||53
28086|NCT02748785|63875|P4|STARTED|Visit 3- Visit 4||52
28087|NCT02748785|63876|P3|STARTED|Visit 3- Visit 4||49
28088|NCT02748785|63877|P2|STARTED|Visit 3- Visit 4||44
28089|NCT02748785|63878|P1|STARTED|Visit 3- Visit 4||54
28090|NCT02748785|63875|P4|NOT COMPLETED|Visit 2-Visit 3||11
28091|NCT02748785|63876|P3|NOT COMPLETED|Visit 2-Visit 3||8
28092|NCT02748785|63877|P2|NOT COMPLETED|Visit 2-Visit 3||5
28093|NCT02748785|63878|P1|NOT COMPLETED|Visit 2-Visit 3||5
28094|NCT02748785|63875|P4|COMPLETED|Visit 2-Visit 3||52
28095|NCT02748785|63876|P3|COMPLETED|Visit 2-Visit 3||49
28096|NCT02748785|63877|P2|COMPLETED|Visit 2-Visit 3||44
28097|NCT02748785|63878|P1|COMPLETED|Visit 2-Visit 3||54
28098|NCT02748785|63875|P4|STARTED|Visit 2-Visit 3||63
28099|NCT02748785|63876|P3|STARTED|Visit 2-Visit 3||57
28100|NCT02748785|63877|P2|STARTED|Visit 2-Visit 3||49
28101|NCT02748785|63878|P1|STARTED|Visit 2-Visit 3||59
28102|NCT02748785|63875|P4|NOT COMPLETED|Visit 1- Visit 2||6
28103|NCT02748785|63876|P3|NOT COMPLETED|Visit 1- Visit 2||14
28104|NCT02748785|63877|P2|NOT COMPLETED|Visit 1- Visit 2||19
28105|NCT02748785|63878|P1|NOT COMPLETED|Visit 1- Visit 2||10
28106|NCT02748785|63875|P4|COMPLETED|Visit 1- Visit 2||63
28107|NCT02748785|63876|P3|COMPLETED|Visit 1- Visit 2||57
28108|NCT02748785|63877|P2|COMPLETED|Visit 1- Visit 2||49
28109|NCT02748785|63878|P1|COMPLETED|Visit 1- Visit 2||59
28110|NCT02748785|63875|P4|STARTED|Visit 1- Visit 2||69
28111|NCT02748785|63876|P3|STARTED|Visit 1- Visit 2||71
28112|NCT02748785|63877|P2|STARTED|Visit 1- Visit 2||68
28113|NCT02748785|63878|P1|STARTED|Visit 1- Visit 2||69
28114|NCT02748525|63924|P1|NOT COMPLETED|Overall Study||11
28115|NCT02748525|63924|P1|COMPLETED|Overall Study|Completed 6 months follow up|39
28116|NCT02748525|63924|P1|Completed Study Intervention|Overall Study||50
28117|NCT02748525|63924|P1|STARTED|Overall Study||50
28118|NCT02748213|63933|P2|NOT COMPLETED|Overall Study||112
28119|NCT02748213|63934|P1|NOT COMPLETED|Overall Study||113
28120|NCT02748213|63933|P2|COMPLETED|Overall Study||0
28121|NCT02748213|63934|P1|COMPLETED|Overall Study|"*The reason Refused Treatment also includes those who did not cooperate or withdrew consent."|0
28122|NCT02748213|63933|P2|Treated|Overall Study||110
28123|NCT02748213|63934|P1|Treated|Overall Study||112
28124|NCT02748213|63933|P2|STARTED|Overall Study||112
28125|NCT02748213|63934|P1|STARTED|Overall Study||113
28126|NCT02748057|63952|P2|NOT COMPLETED|Overall Study||2
28127|NCT02748057|63953|P1|NOT COMPLETED|Overall Study||5
28128|NCT02748057|63952|P2|COMPLETED|Overall Study||19
28129|NCT02748057|63953|P1|COMPLETED|Overall Study||109
28130|NCT02748057|63952|P2|STARTED|Overall Study||21
28131|NCT02748057|63953|P1|STARTED|Overall Study||114
28132|NCT02747186|63963|P2|NOT COMPLETED|Second Intervention||0
28133|NCT02747186|63964|P1|NOT COMPLETED|Second Intervention||0
28134|NCT02747186|63963|P2|COMPLETED|Second Intervention||12
28135|NCT02747186|63964|P1|COMPLETED|Second Intervention||12
28136|NCT02747186|63963|P2|STARTED|Second Intervention||12
28137|NCT02747186|63964|P1|STARTED|Second Intervention||12
28138|NCT02747186|63963|P2|NOT COMPLETED|Washout (1 Week)||0
28139|NCT02747186|63964|P1|NOT COMPLETED|Washout (1 Week)||0
28140|NCT02747186|63963|P2|COMPLETED|Washout (1 Week)||12
28141|NCT02747186|63964|P1|COMPLETED|Washout (1 Week)||12
28142|NCT02747186|63963|P2|STARTED|Washout (1 Week)||12
28143|NCT02747186|63964|P1|STARTED|Washout (1 Week)||12
28144|NCT02747186|63963|P2|NOT COMPLETED|First Intervention||0
28145|NCT02747186|63964|P1|NOT COMPLETED|First Intervention||0
28146|NCT02747186|63963|P2|COMPLETED|First Intervention||12
28147|NCT02747186|63964|P1|COMPLETED|First Intervention||12
28148|NCT02747186|63963|P2|STARTED|First Intervention||12
28149|NCT02747186|63964|P1|STARTED|First Intervention||12
28150|NCT02747004|63975|P3|NOT COMPLETED|Overall Study||47
28151|NCT02747004|63976|P2|NOT COMPLETED|Overall Study||49
28152|NCT02747004|63977|P1|NOT COMPLETED|Overall Study||57
28153|NCT02747004|63975|P3|COMPLETED|Overall Study||30
28154|NCT02747004|63976|P2|COMPLETED|Overall Study||30
28155|NCT02747004|63977|P1|COMPLETED|Overall Study||21
28156|NCT02747004|63975|P3|Received at Least One Dose of Study Drug|Overall Study||77
28157|NCT02747004|63976|P2|Received at Least One Dose of Study Drug|Overall Study||79
28158|NCT02747004|63977|P1|Received at Least One Dose of Study Drug|Overall Study||78
28159|NCT02747004|63975|P3|STARTED|Overall Study||77
28160|NCT02747004|63976|P2|STARTED|Overall Study||79
28161|NCT02747004|63977|P1|STARTED|Overall Study||78
28162|NCT02746809|64005|P1|NOT COMPLETED|Baseline-6 Months||5
28163|NCT02746809|64005|P1|COMPLETED|Baseline-6 Months||54
28164|NCT02746809|64005|P1|STARTED|Baseline-6 Months||59
28165|NCT02746809|64005|P1|NOT COMPLETED|Baseline- 30 Days||1
28166|NCT02746809|64005|P1|COMPLETED|Baseline- 30 Days||59
28167|NCT02746809|64005|P1|STARTED|Baseline- 30 Days||60
28168|NCT02746679|64025|P2|NOT COMPLETED|Overall Study||6
28169|NCT02746679|64026|P1|NOT COMPLETED|Overall Study||4
28170|NCT02746679|64025|P2|COMPLETED|Overall Study||75
28171|NCT02746679|64026|P1|COMPLETED|Overall Study||76
28172|NCT02746679|64025|P2|STARTED|Overall Study||81
28173|NCT02746679|64026|P1|STARTED|Overall Study||80
28174|NCT02746627|64059|P3|NOT COMPLETED|Overall Study||1
28175|NCT02746627|64060|P2|NOT COMPLETED|Overall Study||1
28176|NCT02746627|64061|P1|NOT COMPLETED|Overall Study||1
28177|NCT02746627|64059|P3|COMPLETED|Overall Study||29
28178|NCT02746627|64060|P2|COMPLETED|Overall Study||29
28179|NCT02746627|64061|P1|COMPLETED|Overall Study||59
28180|NCT02746627|64059|P3|STARTED|Overall Study||30
28181|NCT02746627|64060|P2|STARTED|Overall Study||30
28182|NCT02746627|64061|P1|STARTED|Overall Study||60
28183|NCT02746406|64084|P1|NOT COMPLETED|Overall Study||0
28184|NCT02746406|64084|P1|COMPLETED|Overall Study||5
28185|NCT02746406|64084|P1|STARTED|Overall Study||5
28186|NCT02746263|64090|P2|NOT COMPLETED|Overall Study||0
28187|NCT02746263|64091|P1|NOT COMPLETED|Overall Study||0
28188|NCT02746263|64090|P2|COMPLETED|Overall Study||1
28189|NCT02746263|64091|P1|COMPLETED|Overall Study||0
28190|NCT02746263|64090|P2|Per Protocol Analysis Set|Overall Study||0
28191|NCT02746263|64091|P1|Per Protocol Analysis Set|Overall Study||0
28192|NCT02746263|64090|P2|STARTED|Overall Study||1
28193|NCT02746263|64091|P1|STARTED|Overall Study||0
28194|NCT02746107|64097|P1|NOT COMPLETED|Overall Study||0
28195|NCT02746107|64097|P1|COMPLETED|Overall Study||968
28196|NCT02746107|64097|P1|CHA2DS2-VASC Score = 5|Overall Study||192
28197|NCT02746107|64097|P1|CHA2DS2-VASC Score = 4|Overall Study||197
28198|NCT02746107|64097|P1|CHA2DS2-VASC Score = 3|Overall Study||195
28199|NCT02746107|64097|P1|CHA2DS2-VASC Score = 2|Overall Study||189
28200|NCT02746107|64097|P1|CHA2DS2-VASC Score = 1|Overall Study||195
28201|NCT02746107|64097|P1|Target=Physician|Overall Study||482
28202|NCT02746107|64097|P1|Target=Patient|Overall Study||486
28203|NCT02746107|64097|P1|5year Risk Estimate|Overall Study||485
28204|NCT02746107|64097|P1|1year Risk Estimate|Overall Study||483
28205|NCT02746107|64097|P1|1 Diagram DA|Overall Study||486
28206|NCT02746107|64097|P1|2 Diagrams DA|Overall Study||482
28207|NCT02746107|64097|P1|STARTED|Overall Study||968
28208|NCT02745626|64115|P3|NOT COMPLETED|Overall Study||3
28209|NCT02745626|64116|P2|NOT COMPLETED|Overall Study||6
28210|NCT02745626|64117|P1|NOT COMPLETED|Overall Study||3
28211|NCT02745626|64115|P3|COMPLETED|Overall Study||19
28212|NCT02745626|64116|P2|COMPLETED|Overall Study||16
28213|NCT02745626|64117|P1|COMPLETED|Overall Study||21
28214|NCT02745626|64115|P3|STARTED|Overall Study||22
28215|NCT02745626|64116|P2|STARTED|Overall Study||22
28216|NCT02745626|64117|P1|STARTED|Overall Study||24
28217|NCT02745535|64143|P1|NOT COMPLETED|Overall Study||6
28218|NCT02745535|64143|P1|COMPLETED|Overall Study|Completed 12 weeks of study medication per protocol|71
28219|NCT02745535|64143|P1|Sustained Virologic Repsonse|Overall Study|Sustained Virologic response measured 24 weeks after completing study medication|70
28220|NCT02745535|64143|P1|STARTED|Overall Study||77
28221|NCT02745392|64155|P4|NOT COMPLETED|Overall Study||0
28222|NCT02745392|64156|P3|NOT COMPLETED|Overall Study||0
28223|NCT02745392|64157|P2|NOT COMPLETED|Overall Study||1
28224|NCT02745392|64158|P1|NOT COMPLETED|Overall Study||0
28225|NCT02745392|64155|P4|COMPLETED|Overall Study||92
28226|NCT02745392|64156|P3|COMPLETED|Overall Study||92
28227|NCT02745392|64157|P2|COMPLETED|Overall Study||89
28228|NCT02745392|64158|P1|COMPLETED|Overall Study||91
28229|NCT02745392|64155|P4|STARTED|Overall Study||92
28230|NCT02745392|64156|P3|STARTED|Overall Study||92
28231|NCT02745392|64157|P2|STARTED|Overall Study||90
28232|NCT02745392|64158|P1|STARTED|Overall Study||91
28233|NCT02745353|64174|P2|NOT COMPLETED|Second Intervention (2 Weeks)||1
28234|NCT02745353|64175|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
28235|NCT02745353|64174|P2|COMPLETED|Second Intervention (2 Weeks)||0
28236|NCT02745353|64175|P1|COMPLETED|Second Intervention (2 Weeks)||1
28237|NCT02745353|64174|P2|STARTED|Second Intervention (2 Weeks)||1
28238|NCT02745353|64175|P1|STARTED|Second Intervention (2 Weeks)||1
28239|NCT02745353|64174|P2|NOT COMPLETED|Washout (3 Days)||0
28240|NCT02745353|64175|P1|NOT COMPLETED|Washout (3 Days)||0
28241|NCT02745353|64174|P2|COMPLETED|Washout (3 Days)||1
28242|NCT02745353|64175|P1|COMPLETED|Washout (3 Days)||1
28243|NCT02745353|64174|P2|STARTED|Washout (3 Days)||1
28244|NCT02745353|64175|P1|STARTED|Washout (3 Days)||1
28245|NCT02745353|64174|P2|NOT COMPLETED|First Intervention (2 Weeks)||2
28246|NCT02745353|64175|P1|NOT COMPLETED|First Intervention (2 Weeks)||3
28247|NCT02745353|64174|P2|COMPLETED|First Intervention (2 Weeks)||1
28248|NCT02745353|64175|P1|COMPLETED|First Intervention (2 Weeks)||1
28249|NCT02745353|64174|P2|STARTED|First Intervention (2 Weeks)||3
28250|NCT02745353|64175|P1|STARTED|First Intervention (2 Weeks)||4
28251|NCT02745145|64184|P3|NOT COMPLETED|Overall Study||9
28252|NCT02745145|64185|P2|NOT COMPLETED|Overall Study||5
28253|NCT02745145|64186|P1|NOT COMPLETED|Overall Study||10
28254|NCT02745145|64184|P3|COMPLETED|Overall Study||0
28255|NCT02745145|64185|P2|COMPLETED|Overall Study||0
28256|NCT02745145|64186|P1|COMPLETED|Overall Study||0
28257|NCT02745145|64184|P3|STARTED|Overall Study||9
28258|NCT02745145|64185|P2|STARTED|Overall Study||5
28259|NCT02745145|64186|P1|STARTED|Overall Study||10
28260|NCT02745119|64225|P4|NOT COMPLETED|Overall Study||277
28261|NCT02745119|64226|P3|NOT COMPLETED|Overall Study||146
28262|NCT02745119|64227|P2|NOT COMPLETED|Overall Study||274
28263|NCT02745119|64228|P1|NOT COMPLETED|Overall Study||145
28264|NCT02745119|64225|P4|COMPLETED|Overall Study||0
28265|NCT02745119|64226|P3|COMPLETED|Overall Study||0
28266|NCT02745119|64227|P2|COMPLETED|Overall Study||0
28267|NCT02745119|64228|P1|COMPLETED|Overall Study||0
28268|NCT02745119|64225|P4|STARTED|Overall Study||277
28269|NCT02745119|64226|P3|STARTED|Overall Study||146
28270|NCT02745119|64227|P2|STARTED|Overall Study||274
28271|NCT02745119|64228|P1|STARTED|Overall Study||145
28272|NCT02744755|64252|P2|NOT COMPLETED|Study Period 2||8
28273|NCT02744755|64253|P1|NOT COMPLETED|Study Period 2||14
28274|NCT02744755|64252|P2|COMPLETED|Study Period 2||158
28275|NCT02744755|64253|P1|COMPLETED|Study Period 2||145
28276|NCT02744755|64252|P2|STARTED|Study Period 2||166
28277|NCT02744755|64253|P1|STARTED|Study Period 2||159
28278|NCT02744755|64252|P2|NOT COMPLETED|Study Period 1||8
28279|NCT02744755|64253|P1|NOT COMPLETED|Study Period 1||14
28280|NCT02744755|64252|P2|COMPLETED|Study Period 1||168
28281|NCT02744755|64253|P1|COMPLETED|Study Period 1||163
28282|NCT02744755|64252|P2|STARTED|Study Period 1||176
28283|NCT02744755|64253|P1|STARTED|Study Period 1||177
28284|NCT02744534|64307|P1|NOT COMPLETED|Overall Study||0
28285|NCT02744534|64307|P1|COMPLETED|Overall Study||21
28286|NCT02744534|64307|P1|STARTED|Overall Study||21
28287|NCT02744391|64313|P1|NOT COMPLETED|Overall Study||14
28288|NCT02744391|64313|P1|COMPLETED|Overall Study||33
28289|NCT02744391|64313|P1|STARTED|Overall Study||47
28290|NCT02744066|64337|P2|NOT COMPLETED|Overall Study||5
28291|NCT02744066|64338|P1|NOT COMPLETED|Overall Study||0
28292|NCT02744066|64337|P2|COMPLETED|Overall Study||25
28293|NCT02744066|64338|P1|COMPLETED|Overall Study||25
28294|NCT02744066|64337|P2|STARTED|Overall Study||30
28295|NCT02744066|64338|P1|STARTED|Overall Study||25
28296|NCT02743962|64348|P2|NOT COMPLETED|Overall Study||0
28297|NCT02743962|64349|P1|NOT COMPLETED|Overall Study||1
28298|NCT02743962|64348|P2|COMPLETED|Overall Study||5
28299|NCT02743962|64349|P1|COMPLETED|Overall Study||4
28300|NCT02743962|64348|P2|STARTED|Overall Study||5
28301|NCT02743962|64349|P1|STARTED|Overall Study||5
28302|NCT02743936|64370|P2|NOT COMPLETED|Overall Study||0
28303|NCT02743936|64371|P1|NOT COMPLETED|Overall Study||0
28304|NCT02743936|64370|P2|COMPLETED|Overall Study||32
28305|NCT02743936|64371|P1|COMPLETED|Overall Study||32
28306|NCT02743936|64370|P2|STARTED|Overall Study||32
28307|NCT02743936|64371|P1|STARTED|Overall Study||32
28308|NCT02743780|64384|P5|NOT COMPLETED|Part 3 (7 Days)||0
28309|NCT02743780|64385|P4|NOT COMPLETED|Part 3 (7 Days)||0
28310|NCT02743780|64386|P3|NOT COMPLETED|Part 3 (7 Days)||1
28311|NCT02743780|64387|P2|NOT COMPLETED|Part 3 (7 Days)||0
28312|NCT02743780|64388|P1|NOT COMPLETED|Part 3 (7 Days)||0
28313|NCT02743780|64384|P5|COMPLETED|Part 3 (7 Days)||25
28314|NCT02743780|64385|P4|COMPLETED|Part 3 (7 Days)||0
28315|NCT02743780|64386|P3|COMPLETED|Part 3 (7 Days)||24
28316|NCT02743780|64387|P2|COMPLETED|Part 3 (7 Days)||0
28317|NCT02743780|64388|P1|COMPLETED|Part 3 (7 Days)||0
28318|NCT02743780|64384|P5|STARTED|Part 3 (7 Days)||25
28319|NCT02743780|64385|P4|STARTED|Part 3 (7 Days)||0
28320|NCT02743780|64386|P3|STARTED|Part 3 (7 Days)||25
28321|NCT02743780|64387|P2|STARTED|Part 3 (7 Days)||0
28322|NCT02743780|64388|P1|STARTED|Part 3 (7 Days)||0
28323|NCT02743780|64384|P5|NOT COMPLETED|Part 2 (8 Days)||0
28324|NCT02743780|64385|P4|NOT COMPLETED|Part 2 (8 Days)||0
28325|NCT02743780|64386|P3|NOT COMPLETED|Part 2 (8 Days)||0
28326|NCT02743780|64387|P2|NOT COMPLETED|Part 2 (8 Days)||0
28327|NCT02743780|64388|P1|NOT COMPLETED|Part 2 (8 Days)||0
28328|NCT02743780|64384|P5|COMPLETED|Part 2 (8 Days)||4
28329|NCT02743780|64385|P4|COMPLETED|Part 2 (8 Days)||0
28330|NCT02743780|64386|P3|COMPLETED|Part 2 (8 Days)||6
28331|NCT02743780|64387|P2|COMPLETED|Part 2 (8 Days)||6
28332|NCT02743780|64388|P1|COMPLETED|Part 2 (8 Days)||0
28333|NCT02743780|64384|P5|STARTED|Part 2 (8 Days)||4
28334|NCT02743780|64385|P4|STARTED|Part 2 (8 Days)||0
28335|NCT02743780|64386|P3|STARTED|Part 2 (8 Days)||6
28336|NCT02743780|64387|P2|STARTED|Part 2 (8 Days)||6
28337|NCT02743780|64388|P1|STARTED|Part 2 (8 Days)||0
28338|NCT02743780|64384|P5|NOT COMPLETED|Part 1 (3 Days)||0
28339|NCT02743780|64385|P4|NOT COMPLETED|Part 1 (3 Days)||0
28340|NCT02743780|64386|P3|NOT COMPLETED|Part 1 (3 Days)||0
28341|NCT02743780|64387|P2|NOT COMPLETED|Part 1 (3 Days)||0
28342|NCT02743780|64388|P1|NOT COMPLETED|Part 1 (3 Days)||0
28343|NCT02743780|64384|P5|COMPLETED|Part 1 (3 Days)||8
28344|NCT02743780|64385|P4|COMPLETED|Part 1 (3 Days)||6
28345|NCT02743780|64386|P3|COMPLETED|Part 1 (3 Days)||6
28346|NCT02743780|64387|P2|COMPLETED|Part 1 (3 Days)||6
28347|NCT02743780|64388|P1|COMPLETED|Part 1 (3 Days)||6
28348|NCT02743780|64384|P5|STARTED|Part 1 (3 Days)||8
28349|NCT02743780|64385|P4|STARTED|Part 1 (3 Days)||6
28350|NCT02743780|64386|P3|STARTED|Part 1 (3 Days)||6
28351|NCT02743780|64387|P2|STARTED|Part 1 (3 Days)||6
28352|NCT02743780|64388|P1|STARTED|Part 1 (3 Days)||6
28353|NCT02743702|64435|P2|NOT COMPLETED|Overall Study||0
28354|NCT02743702|64436|P1|NOT COMPLETED|Overall Study||0
28355|NCT02743702|64435|P2|COMPLETED|Overall Study||10
28356|NCT02743702|64436|P1|COMPLETED|Overall Study||11
28357|NCT02743702|64435|P2|STARTED|Overall Study||10
28358|NCT02743702|64436|P1|STARTED|Overall Study||11
28359|NCT02743312|64444|P2|NOT COMPLETED|Overall Study||0
28360|NCT02743312|64445|P1|NOT COMPLETED|Overall Study||0
28361|NCT02743312|64444|P2|COMPLETED|Overall Study||2
28362|NCT02743312|64445|P1|COMPLETED|Overall Study||3
28363|NCT02743312|64444|P2|STARTED|Overall Study||2
28364|NCT02743312|64445|P1|STARTED|Overall Study||3
28365|NCT02743221|64478|P2|NOT COMPLETED|Overall Study||60
28366|NCT02743221|64479|P1|NOT COMPLETED|Overall Study||56
28367|NCT02743221|64478|P2|COMPLETED|Overall Study||17
28368|NCT02743221|64479|P1|COMPLETED|Overall Study||21
28369|NCT02743221|64478|P2|STARTED|Overall Study||77
28370|NCT02743221|64479|P1|STARTED|Overall Study||77
28371|NCT02743117|64495|P2|NOT COMPLETED|Overall Study||1
28372|NCT02743117|64496|P1|NOT COMPLETED|Overall Study||1
28373|NCT02743117|64495|P2|COMPLETED|Overall Study||240
28374|NCT02743117|64496|P1|COMPLETED|Overall Study||59
28375|NCT02743117|64495|P2|Treated|Overall Study||241
28376|NCT02743117|64496|P1|Treated|Overall Study||59
28377|NCT02743117|64495|P2|STARTED|Overall Study||241
28378|NCT02743117|64496|P1|STARTED|Overall Study||60
28379|NCT02742987|64512|P2|NOT COMPLETED|Overall Study||0
28380|NCT02742987|64513|P1|NOT COMPLETED|Overall Study||0
28381|NCT02742987|64512|P2|COMPLETED|Overall Study||21
28382|NCT02742987|64513|P1|COMPLETED|Overall Study||21
28383|NCT02742987|64512|P2|STARTED|Overall Study||21
28384|NCT02742987|64513|P1|STARTED|Overall Study||21
28385|NCT02742818|64521|P2|NOT COMPLETED|Overall Study||2
28386|NCT02742818|64522|P1|NOT COMPLETED|Overall Study||0
28387|NCT02742818|64521|P2|COMPLETED|Overall Study||23
28388|NCT02742818|64522|P1|COMPLETED|Overall Study||25
28389|NCT02742818|64521|P2|STARTED|Overall Study||25
28390|NCT02742818|64522|P1|STARTED|Overall Study||25
28391|NCT02742766|64555|P19|NOT COMPLETED|Part 3 (Up to 36 Days)||0
28392|NCT02742766|64556|P18|NOT COMPLETED|Part 3 (Up to 36 Days)||0
28393|NCT02742766|64557|P17|NOT COMPLETED|Part 3 (Up to 36 Days)||0
28394|NCT02742766|64558|P16|NOT COMPLETED|Part 3 (Up to 36 Days)||0
28395|NCT02742766|64559|P15|NOT COMPLETED|Part 3 (Up to 36 Days)||0
28396|NCT02742766|64560|P14|NOT COMPLETED|Part 3 (Up to 36 Days)||0
28397|NCT02742766|64561|P13|NOT COMPLETED|Part 3 (Up to 36 Days)||0
28398|NCT02742766|64562|P12|NOT COMPLETED|Part 3 (Up to 36 Days)||0
28399|NCT02742766|64563|P11|NOT COMPLETED|Part 3 (Up to 36 Days)||0
28400|NCT02742766|64564|P10|NOT COMPLETED|Part 3 (Up to 36 Days)||0
28401|NCT02742766|64565|P9|NOT COMPLETED|Part 3 (Up to 36 Days)||0
28402|NCT02742766|64566|P8|NOT COMPLETED|Part 3 (Up to 36 Days)||0
28403|NCT02742766|64567|P7|NOT COMPLETED|Part 3 (Up to 36 Days)||0
28404|NCT02742766|64568|P6|NOT COMPLETED|Part 3 (Up to 36 Days)||0
28405|NCT02742766|64569|P5|NOT COMPLETED|Part 3 (Up to 36 Days)||0
28406|NCT02742766|64570|P4|NOT COMPLETED|Part 3 (Up to 36 Days)||0
28407|NCT02742766|64571|P3|NOT COMPLETED|Part 3 (Up to 36 Days)||0
28408|NCT02742766|64572|P2|NOT COMPLETED|Part 3 (Up to 36 Days)||0
28409|NCT02742766|64573|P1|NOT COMPLETED|Part 3 (Up to 36 Days)||0
28410|NCT02742766|64555|P19|COMPLETED|Part 3 (Up to 36 Days)||0
28411|NCT02742766|64556|P18|COMPLETED|Part 3 (Up to 36 Days)||0
28412|NCT02742766|64557|P17|COMPLETED|Part 3 (Up to 36 Days)||0
28413|NCT02742766|64558|P16|COMPLETED|Part 3 (Up to 36 Days)||0
28414|NCT02742766|64559|P15|COMPLETED|Part 3 (Up to 36 Days)||0
28415|NCT02742766|64560|P14|COMPLETED|Part 3 (Up to 36 Days)||0
28416|NCT02742766|64561|P13|COMPLETED|Part 3 (Up to 36 Days)||0
28417|NCT02742766|64562|P12|COMPLETED|Part 3 (Up to 36 Days)||0
28418|NCT02742766|64563|P11|COMPLETED|Part 3 (Up to 36 Days)||0
28419|NCT02742766|64564|P10|COMPLETED|Part 3 (Up to 36 Days)||0
28420|NCT02742766|64565|P9|COMPLETED|Part 3 (Up to 36 Days)||0
28421|NCT02742766|64566|P8|COMPLETED|Part 3 (Up to 36 Days)||0
28422|NCT02742766|64567|P7|COMPLETED|Part 3 (Up to 36 Days)||0
28423|NCT02742766|64568|P6|COMPLETED|Part 3 (Up to 36 Days)||0
28424|NCT02742766|64569|P5|COMPLETED|Part 3 (Up to 36 Days)||0
28425|NCT02742766|64570|P4|COMPLETED|Part 3 (Up to 36 Days)||0
28426|NCT02742766|64571|P3|COMPLETED|Part 3 (Up to 36 Days)||0
28427|NCT02742766|64572|P2|COMPLETED|Part 3 (Up to 36 Days)||0
28428|NCT02742766|64573|P1|COMPLETED|Part 3 (Up to 36 Days)||0
28429|NCT02742766|64555|P19|STARTED|Part 3 (Up to 36 Days)||0
28430|NCT02742766|64556|P18|STARTED|Part 3 (Up to 36 Days)||0
28431|NCT02742766|64557|P17|STARTED|Part 3 (Up to 36 Days)||0
28432|NCT02742766|64558|P16|STARTED|Part 3 (Up to 36 Days)||0
28433|NCT02742766|64559|P15|STARTED|Part 3 (Up to 36 Days)||0
28434|NCT02742766|64560|P14|STARTED|Part 3 (Up to 36 Days)||0
28435|NCT02742766|64561|P13|STARTED|Part 3 (Up to 36 Days)||0
28436|NCT02742766|64562|P12|STARTED|Part 3 (Up to 36 Days)||0
28437|NCT02742766|64563|P11|STARTED|Part 3 (Up to 36 Days)||0
28438|NCT02742766|64564|P10|STARTED|Part 3 (Up to 36 Days)||0
28439|NCT02742766|64565|P9|STARTED|Part 3 (Up to 36 Days)||0
28440|NCT02742766|64566|P8|STARTED|Part 3 (Up to 36 Days)||0
28441|NCT02742766|64567|P7|STARTED|Part 3 (Up to 36 Days)||0
28442|NCT02742766|64568|P6|STARTED|Part 3 (Up to 36 Days)||0
28443|NCT02742766|64569|P5|STARTED|Part 3 (Up to 36 Days)||0
28444|NCT02742766|64570|P4|STARTED|Part 3 (Up to 36 Days)||0
28445|NCT02742766|64571|P3|STARTED|Part 3 (Up to 36 Days)||0
28446|NCT02742766|64572|P2|STARTED|Part 3 (Up to 36 Days)||0
28447|NCT02742766|64573|P1|STARTED|Part 3 (Up to 36 Days)||0
28448|NCT02742766|64555|P19|NOT COMPLETED|Part 2 (Up to 22 Days)||0
28449|NCT02742766|64556|P18|NOT COMPLETED|Part 2 (Up to 22 Days)||0
28450|NCT02742766|64557|P17|NOT COMPLETED|Part 2 (Up to 22 Days)||0
28451|NCT02742766|64558|P16|NOT COMPLETED|Part 2 (Up to 22 Days)||1
28452|NCT02742766|64559|P15|NOT COMPLETED|Part 2 (Up to 22 Days)||0
28453|NCT02742766|64560|P14|NOT COMPLETED|Part 2 (Up to 22 Days)||6
28454|NCT02742766|64561|P13|NOT COMPLETED|Part 2 (Up to 22 Days)||2
28455|NCT02742766|64562|P12|NOT COMPLETED|Part 2 (Up to 22 Days)||0
28456|NCT02742766|64563|P11|NOT COMPLETED|Part 2 (Up to 22 Days)||0
28457|NCT02742766|64564|P10|NOT COMPLETED|Part 2 (Up to 22 Days)||0
28458|NCT02742766|64565|P9|NOT COMPLETED|Part 2 (Up to 22 Days)||0
28459|NCT02742766|64566|P8|NOT COMPLETED|Part 2 (Up to 22 Days)||0
28460|NCT02742766|64567|P7|NOT COMPLETED|Part 2 (Up to 22 Days)||0
28461|NCT02742766|64568|P6|NOT COMPLETED|Part 2 (Up to 22 Days)||0
28462|NCT02742766|64569|P5|NOT COMPLETED|Part 2 (Up to 22 Days)||0
28463|NCT02742766|64570|P4|NOT COMPLETED|Part 2 (Up to 22 Days)||0
28464|NCT02742766|64571|P3|NOT COMPLETED|Part 2 (Up to 22 Days)||0
28465|NCT02742766|64572|P2|NOT COMPLETED|Part 2 (Up to 22 Days)||0
28466|NCT02742766|64573|P1|NOT COMPLETED|Part 2 (Up to 22 Days)||0
28467|NCT02742766|64555|P19|COMPLETED|Part 2 (Up to 22 Days)||0
28468|NCT02742766|64556|P18|COMPLETED|Part 2 (Up to 22 Days)||0
28469|NCT02742766|64557|P17|COMPLETED|Part 2 (Up to 22 Days)||0
28470|NCT02742766|64558|P16|COMPLETED|Part 2 (Up to 22 Days)|Day 4 study medication interrupted due to an AE and eventually withdrew from study on Day 5.|5
28471|NCT02742766|64559|P15|COMPLETED|Part 2 (Up to 22 Days)||6
28472|NCT02742766|64560|P14|COMPLETED|Part 2 (Up to 22 Days)||0
28473|NCT02742766|64561|P13|COMPLETED|Part 2 (Up to 22 Days)||4
28474|NCT02742766|64562|P12|COMPLETED|Part 2 (Up to 22 Days)||0
28475|NCT02742766|64563|P11|COMPLETED|Part 2 (Up to 22 Days)||0
28476|NCT02742766|64564|P10|COMPLETED|Part 2 (Up to 22 Days)||0
28477|NCT02742766|64565|P9|COMPLETED|Part 2 (Up to 22 Days)||0
28478|NCT02742766|64566|P8|COMPLETED|Part 2 (Up to 22 Days)||0
28479|NCT02742766|64567|P7|COMPLETED|Part 2 (Up to 22 Days)||0
28480|NCT02742766|64568|P6|COMPLETED|Part 2 (Up to 22 Days)||0
28481|NCT02742766|64569|P5|COMPLETED|Part 2 (Up to 22 Days)||0
28482|NCT02742766|64570|P4|COMPLETED|Part 2 (Up to 22 Days)||0
28483|NCT02742766|64571|P3|COMPLETED|Part 2 (Up to 22 Days)||0
28484|NCT02742766|64572|P2|COMPLETED|Part 2 (Up to 22 Days)||0
28485|NCT02742766|64573|P1|COMPLETED|Part 2 (Up to 22 Days)||0
28486|NCT02742766|64555|P19|STARTED|Part 2 (Up to 22 Days)||0
28487|NCT02742766|64556|P18|STARTED|Part 2 (Up to 22 Days)||0
28488|NCT02742766|64557|P17|STARTED|Part 2 (Up to 22 Days)||0
28489|NCT02742766|64558|P16|STARTED|Part 2 (Up to 22 Days)||6
28490|NCT02742766|64559|P15|STARTED|Part 2 (Up to 22 Days)||6
28491|NCT02742766|64560|P14|STARTED|Part 2 (Up to 22 Days)||6
28492|NCT02742766|64561|P13|STARTED|Part 2 (Up to 22 Days)||6
28493|NCT02742766|64562|P12|STARTED|Part 2 (Up to 22 Days)||0
28494|NCT02742766|64563|P11|STARTED|Part 2 (Up to 22 Days)||0
28495|NCT02742766|64564|P10|STARTED|Part 2 (Up to 22 Days)||0
28496|NCT02742766|64565|P9|STARTED|Part 2 (Up to 22 Days)||0
28497|NCT02742766|64566|P8|STARTED|Part 2 (Up to 22 Days)||0
28498|NCT02742766|64567|P7|STARTED|Part 2 (Up to 22 Days)||0
28499|NCT02742766|64568|P6|STARTED|Part 2 (Up to 22 Days)||0
28500|NCT02742766|64569|P5|STARTED|Part 2 (Up to 22 Days)||0
28501|NCT02742766|64570|P4|STARTED|Part 2 (Up to 22 Days)||0
28502|NCT02742766|64571|P3|STARTED|Part 2 (Up to 22 Days)||0
28503|NCT02742766|64572|P2|STARTED|Part 2 (Up to 22 Days)||0
28504|NCT02742766|64573|P1|STARTED|Part 2 (Up to 22 Days)||0
28505|NCT02742766|64555|P19|NOT COMPLETED|Part 1 (Up to 8 Days)||0
28506|NCT02742766|64556|P18|NOT COMPLETED|Part 1 (Up to 8 Days)||0
28507|NCT02742766|64557|P17|NOT COMPLETED|Part 1 (Up to 8 Days)||0
28508|NCT02742766|64558|P16|NOT COMPLETED|Part 1 (Up to 8 Days)||0
28509|NCT02742766|64559|P15|NOT COMPLETED|Part 1 (Up to 8 Days)||0
28510|NCT02742766|64560|P14|NOT COMPLETED|Part 1 (Up to 8 Days)||0
28511|NCT02742766|64561|P13|NOT COMPLETED|Part 1 (Up to 8 Days)||0
28512|NCT02742766|64562|P12|NOT COMPLETED|Part 1 (Up to 8 Days)||0
28513|NCT02742766|64563|P11|NOT COMPLETED|Part 1 (Up to 8 Days)||0
28514|NCT02742766|64564|P10|NOT COMPLETED|Part 1 (Up to 8 Days)||0
28515|NCT02742766|64565|P9|NOT COMPLETED|Part 1 (Up to 8 Days)||0
28516|NCT02742766|64566|P8|NOT COMPLETED|Part 1 (Up to 8 Days)||0
28517|NCT02742766|64567|P7|NOT COMPLETED|Part 1 (Up to 8 Days)||0
28518|NCT02742766|64568|P6|NOT COMPLETED|Part 1 (Up to 8 Days)||0
28519|NCT02742766|64569|P5|NOT COMPLETED|Part 1 (Up to 8 Days)||0
28520|NCT02742766|64570|P4|NOT COMPLETED|Part 1 (Up to 8 Days)||0
28521|NCT02742766|64571|P3|NOT COMPLETED|Part 1 (Up to 8 Days)||0
28522|NCT02742766|64572|P2|NOT COMPLETED|Part 1 (Up to 8 Days)||0
28523|NCT02742766|64573|P1|NOT COMPLETED|Part 1 (Up to 8 Days)||0
28524|NCT02742766|64555|P19|COMPLETED|Part 1 (Up to 8 Days)||0
28525|NCT02742766|64556|P18|COMPLETED|Part 1 (Up to 8 Days)||0
28526|NCT02742766|64557|P17|COMPLETED|Part 1 (Up to 8 Days)||0
28527|NCT02742766|64558|P16|COMPLETED|Part 1 (Up to 8 Days)||0
28528|NCT02742766|64559|P15|COMPLETED|Part 1 (Up to 8 Days)||0
28529|NCT02742766|64560|P14|COMPLETED|Part 1 (Up to 8 Days)||0
28530|NCT02742766|64561|P13|COMPLETED|Part 1 (Up to 8 Days)||0
28531|NCT02742766|64562|P12|COMPLETED|Part 1 (Up to 8 Days)||6
28532|NCT02742766|64563|P11|COMPLETED|Part 1 (Up to 8 Days)||6
28533|NCT02742766|64564|P10|COMPLETED|Part 1 (Up to 8 Days)||0
28534|NCT02742766|64565|P9|COMPLETED|Part 1 (Up to 8 Days)||6
28535|NCT02742766|64566|P8|COMPLETED|Part 1 (Up to 8 Days)||6
28536|NCT02742766|64567|P7|COMPLETED|Part 1 (Up to 8 Days)||6
28537|NCT02742766|64568|P6|COMPLETED|Part 1 (Up to 8 Days)||6
28538|NCT02742766|64569|P5|COMPLETED|Part 1 (Up to 8 Days)||6
28539|NCT02742766|64570|P4|COMPLETED|Part 1 (Up to 8 Days)||6
28540|NCT02742766|64571|P3|COMPLETED|Part 1 (Up to 8 Days)||6
28541|NCT02742766|64572|P2|COMPLETED|Part 1 (Up to 8 Days)||6
28542|NCT02742766|64573|P1|COMPLETED|Part 1 (Up to 8 Days)||20
28543|NCT02742766|64555|P19|STARTED|Part 1 (Up to 8 Days)||0
28544|NCT02742766|64556|P18|STARTED|Part 1 (Up to 8 Days)||0
28545|NCT02742766|64557|P17|STARTED|Part 1 (Up to 8 Days)||0
28546|NCT02742766|64558|P16|STARTED|Part 1 (Up to 8 Days)||0
28547|NCT02742766|64559|P15|STARTED|Part 1 (Up to 8 Days)||0
28548|NCT02742766|64560|P14|STARTED|Part 1 (Up to 8 Days)||0
28549|NCT02742766|64561|P13|STARTED|Part 1 (Up to 8 Days)||0
28550|NCT02742766|64562|P12|STARTED|Part 1 (Up to 8 Days)||6
28551|NCT02742766|64563|P11|STARTED|Part 1 (Up to 8 Days)||6
28552|NCT02742766|64564|P10|STARTED|Part 1 (Up to 8 Days)||0
28553|NCT02742766|64565|P9|STARTED|Part 1 (Up to 8 Days)||6
28554|NCT02742766|64566|P8|STARTED|Part 1 (Up to 8 Days)||6
28555|NCT02742766|64567|P7|STARTED|Part 1 (Up to 8 Days)||6
28556|NCT02742766|64568|P6|STARTED|Part 1 (Up to 8 Days)||6
28557|NCT02742766|64569|P5|STARTED|Part 1 (Up to 8 Days)||6
28558|NCT02742766|64570|P4|STARTED|Part 1 (Up to 8 Days)||6
28559|NCT02742766|64571|P3|STARTED|Part 1 (Up to 8 Days)||6
28560|NCT02742766|64572|P2|STARTED|Part 1 (Up to 8 Days)||6
28561|NCT02742766|64573|P1|STARTED|Part 1 (Up to 8 Days)||20
28562|NCT02742649|64833|P5|NOT COMPLETED|Open-Label Period||1
28563|NCT02742649|64834|P4|NOT COMPLETED|Open-Label Period||0
28564|NCT02742649|64835|P3|NOT COMPLETED|Open-Label Period||0
28565|NCT02742649|64836|P2|NOT COMPLETED|Open-Label Period||0
28566|NCT02742649|64837|P1|NOT COMPLETED|Open-Label Period||0
28567|NCT02742649|64833|P5|COMPLETED|Open-Label Period||48
28568|NCT02742649|64834|P4|COMPLETED|Open-Label Period||0
28569|NCT02742649|64835|P3|COMPLETED|Open-Label Period||0
28570|NCT02742649|64836|P2|COMPLETED|Open-Label Period||0
28571|NCT02742649|64837|P1|COMPLETED|Open-Label Period||0
28572|NCT02742649|64833|P5|STARTED|Open-Label Period||49
28573|NCT02742649|64834|P4|STARTED|Open-Label Period||0
28574|NCT02742649|64835|P3|STARTED|Open-Label Period||0
28575|NCT02742649|64836|P2|STARTED|Open-Label Period||0
28576|NCT02742649|64837|P1|STARTED|Open-Label Period||0
28577|NCT02742649|64833|P5|NOT COMPLETED|Double-Blind Treatment Period||0
28578|NCT02742649|64834|P4|NOT COMPLETED|Double-Blind Treatment Period||0
28579|NCT02742649|64835|P3|NOT COMPLETED|Double-Blind Treatment Period||0
28580|NCT02742649|64836|P2|NOT COMPLETED|Double-Blind Treatment Period||1
28581|NCT02742649|64837|P1|NOT COMPLETED|Double-Blind Treatment Period||0
28582|NCT02742649|64833|P5|COMPLETED|Double-Blind Treatment Period||0
28583|NCT02742649|64834|P4|COMPLETED|Double-Blind Treatment Period||16
28584|NCT02742649|64835|P3|COMPLETED|Double-Blind Treatment Period||17
28585|NCT02742649|64836|P2|COMPLETED|Double-Blind Treatment Period||16
28586|NCT02742649|64837|P1|COMPLETED|Double-Blind Treatment Period||0
28587|NCT02742649|64833|P5|STARTED|Double-Blind Treatment Period||0
28588|NCT02742649|64834|P4|STARTED|Double-Blind Treatment Period||16
28589|NCT02742649|64835|P3|STARTED|Double-Blind Treatment Period||17
28590|NCT02742649|64836|P2|STARTED|Double-Blind Treatment Period||17
28591|NCT02742649|64837|P1|STARTED|Double-Blind Treatment Period||0
28592|NCT02742649|64833|P5|NOT COMPLETED|Pre-Randomization Washout Period||0
28593|NCT02742649|64834|P4|NOT COMPLETED|Pre-Randomization Washout Period||0
28594|NCT02742649|64835|P3|NOT COMPLETED|Pre-Randomization Washout Period||0
28595|NCT02742649|64836|P2|NOT COMPLETED|Pre-Randomization Washout Period||0
28596|NCT02742649|64837|P1|NOT COMPLETED|Pre-Randomization Washout Period||5
28597|NCT02742649|64833|P5|COMPLETED|Pre-Randomization Washout Period||0
28598|NCT02742649|64834|P4|COMPLETED|Pre-Randomization Washout Period||0
28599|NCT02742649|64835|P3|COMPLETED|Pre-Randomization Washout Period||0
28600|NCT02742649|64836|P2|COMPLETED|Pre-Randomization Washout Period||0
28601|NCT02742649|64837|P1|COMPLETED|Pre-Randomization Washout Period||50
28602|NCT02742649|64833|P5|STARTED|Pre-Randomization Washout Period||0
28603|NCT02742649|64834|P4|STARTED|Pre-Randomization Washout Period||0
28604|NCT02742649|64835|P3|STARTED|Pre-Randomization Washout Period||0
28605|NCT02742649|64836|P2|STARTED|Pre-Randomization Washout Period||0
28606|NCT02742649|64837|P1|STARTED|Pre-Randomization Washout Period||55
28607|NCT02742519|64865|P3|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||10
28608|NCT02742519|64866|P2|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0
28609|NCT02742519|64867|P1|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0
28610|NCT02742519|64865|P3|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
28611|NCT02742519|64866|P2|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
28612|NCT02742519|64867|P1|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
28613|NCT02742519|64865|P3|STARTED|Part 2 Open Label Period (32 Weeks)|Of 12 participants who completed DB period, only 10 entered OL period & 2 opted for commercial drug.|10
28614|NCT02742519|64866|P2|STARTED|Part 2 Open Label Period (32 Weeks)||0
28615|NCT02742519|64867|P1|STARTED|Part 2 Open Label Period (32 Weeks)||0
28616|NCT02742519|64865|P3|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0
28617|NCT02742519|64866|P2|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1
28618|NCT02742519|64867|P1|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1
28619|NCT02742519|64865|P3|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0
28620|NCT02742519|64866|P2|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||5
28621|NCT02742519|64867|P1|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||7
28622|NCT02742519|64865|P3|STARTED|Part 1 Treatment Period 2 (8 Weeks)||0
28623|NCT02742519|64866|P2|STARTED|Part 1 Treatment Period 2 (8 Weeks)||6
28624|NCT02742519|64867|P1|STARTED|Part 1 Treatment Period 2 (8 Weeks)||8
28625|NCT02742519|64865|P3|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
28626|NCT02742519|64866|P2|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
28627|NCT02742519|64867|P1|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
28628|NCT02742519|64865|P3|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
28629|NCT02742519|64866|P2|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||6
28630|NCT02742519|64867|P1|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||8
28631|NCT02742519|64865|P3|STARTED|Part 1 Treatment Period 1 (8 Weeks)||0
28632|NCT02742519|64866|P2|STARTED|Part 1 Treatment Period 1 (8 Weeks)||6
28633|NCT02742519|64867|P1|STARTED|Part 1 Treatment Period 1 (8 Weeks)||8
28634|NCT02742441|64887|P2|NOT COMPLETED|Overall Study||8
28635|NCT02742441|64888|P1|NOT COMPLETED|Overall Study||6
28636|NCT02742441|64887|P2|COMPLETED|Overall Study||196
28637|NCT02742441|64888|P1|COMPLETED|Overall Study||199
28638|NCT02742441|64887|P2|STARTED|Overall Study||204
28639|NCT02742441|64888|P1|STARTED|Overall Study||205
28640|NCT02742129|64906|P2|NOT COMPLETED|Phase 2||2
28641|NCT02742129|64907|P1|NOT COMPLETED|Phase 2||1
28642|NCT02742129|64906|P2|COMPLETED|Phase 2||48
28643|NCT02742129|64907|P1|COMPLETED|Phase 2||50
28644|NCT02742129|64906|P2|STARTED|Phase 2||50
28645|NCT02742129|64907|P1|STARTED|Phase 2||51
28646|NCT02742129|64906|P2|NOT COMPLETED|Phase 1||2
28647|NCT02742129|64907|P1|NOT COMPLETED|Phase 1||2
28648|NCT02742129|64906|P2|COMPLETED|Phase 1||50
28649|NCT02742129|64907|P1|COMPLETED|Phase 1||51
28650|NCT02742129|64906|P2|STARTED|Phase 1||52
28651|NCT02742129|64907|P1|STARTED|Phase 1||53
28652|NCT02741713|64935|P2|NOT COMPLETED|Overall Study||1
28653|NCT02741713|64936|P1|NOT COMPLETED|Overall Study||2
28654|NCT02741713|64935|P2|COMPLETED|Overall Study||19
28655|NCT02741713|64936|P1|COMPLETED|Overall Study||18
28656|NCT02741713|64935|P2|STARTED|Overall Study||20
28657|NCT02741713|64936|P1|STARTED|Overall Study||20
28658|NCT02741687|64951|P2|NOT COMPLETED|Overall Study||0
28659|NCT02741687|64952|P1|NOT COMPLETED|Overall Study||0
28660|NCT02741687|64951|P2|COMPLETED|Overall Study||44
28661|NCT02741687|64952|P1|COMPLETED|Overall Study||36
28662|NCT02741687|64951|P2|STARTED|Overall Study||44
28663|NCT02741687|64952|P1|STARTED|Overall Study||36
28664|NCT02741310|64978|P2|NOT COMPLETED|Overall Study||2
28665|NCT02741310|64979|P1|NOT COMPLETED|Overall Study||2
28666|NCT02741310|64978|P2|COMPLETED|Overall Study||20
28667|NCT02741310|64979|P1|COMPLETED|Overall Study||10
28668|NCT02741310|64978|P2|STARTED|Overall Study||22
28669|NCT02741310|64979|P1|STARTED|Overall Study||12
28670|NCT02741284|65001|P2|NOT COMPLETED|Overall Study||9
28671|NCT02741284|65002|P1|NOT COMPLETED|Overall Study||6
28672|NCT02741284|65001|P2|COMPLETED|Overall Study||48
28673|NCT02741284|65002|P1|COMPLETED|Overall Study||51
28674|NCT02741284|65001|P2|STARTED|Overall Study||57
28675|NCT02741284|65002|P1|STARTED|Overall Study||57
28676|NCT02741271|65020|P2|NOT COMPLETED|Overall Study||2
28677|NCT02741271|65021|P1|NOT COMPLETED|Overall Study||2
28678|NCT02741271|65020|P2|COMPLETED|Overall Study||88
28679|NCT02741271|65021|P1|COMPLETED|Overall Study||89
28680|NCT02741271|65020|P2|STARTED|Overall Study||90
28681|NCT02741271|65021|P1|STARTED|Overall Study||91
28682|NCT02741245|65054|P5|NOT COMPLETED|Overall Study||2
28683|NCT02741245|65055|P4|NOT COMPLETED|Overall Study||4
28684|NCT02741245|65056|P3|NOT COMPLETED|Overall Study||0
28685|NCT02741245|65057|P2|NOT COMPLETED|Overall Study||1
28686|NCT02741245|65058|P1|NOT COMPLETED|Overall Study||0
28687|NCT02741245|65054|P5|COMPLETED|Overall Study||70
28688|NCT02741245|65055|P4|COMPLETED|Overall Study||67
28689|NCT02741245|65056|P3|COMPLETED|Overall Study||71
28690|NCT02741245|65057|P2|COMPLETED|Overall Study||71
28691|NCT02741245|65058|P1|COMPLETED|Overall Study||35
28692|NCT02741245|65054|P5|STARTED|Overall Study||72
28693|NCT02741245|65055|P4|STARTED|Overall Study||71
28694|NCT02741245|65056|P3|STARTED|Overall Study||71
28695|NCT02741245|65057|P2|STARTED|Overall Study||72
28696|NCT02741245|65058|P1|STARTED|Overall Study||35
28697|NCT02741076|65164|P4|NOT COMPLETED|Overall Study||2
28698|NCT02741076|65165|P3|NOT COMPLETED|Overall Study||2
28699|NCT02741076|65166|P2|NOT COMPLETED|Overall Study||5
28700|NCT02741076|65167|P1|NOT COMPLETED|Overall Study||3
28701|NCT02741076|65164|P4|COMPLETED|Overall Study||2
28702|NCT02741076|65165|P3|COMPLETED|Overall Study||1
28703|NCT02741076|65166|P2|COMPLETED|Overall Study||7
28704|NCT02741076|65167|P1|COMPLETED|Overall Study||10
28705|NCT02741076|65164|P4|STARTED|Overall Study||4
28706|NCT02741076|65165|P3|STARTED|Overall Study||3
28707|NCT02741076|65166|P2|STARTED|Overall Study||12
28708|NCT02741076|65167|P1|STARTED|Overall Study||13
28709|NCT02740920|65225|P1|NOT COMPLETED|Overall Study||0
28710|NCT02740920|65225|P1|COMPLETED|Overall Study||9
28711|NCT02740920|65225|P1|STARTED|Overall Study||9
28712|NCT02740660|65232|P2|NOT COMPLETED|Overall Study||0
28713|NCT02740660|65233|P1|NOT COMPLETED|Overall Study||0
28714|NCT02740660|65232|P2|COMPLETED|Overall Study||6
28715|NCT02740660|65233|P1|COMPLETED|Overall Study||6
28716|NCT02740660|65232|P2|STARTED|Overall Study||6
28717|NCT02740660|65233|P1|STARTED|Overall Study||6
28718|NCT02740413|65245|P1|NOT COMPLETED|Overall Study||0
28719|NCT02740413|65245|P1|COMPLETED|Overall Study||86
28720|NCT02740413|65245|P1|STARTED|Overall Study||86
28721|NCT02740049|65283|P1|NOT COMPLETED|Overall Study||1
28722|NCT02740049|65283|P1|COMPLETED|Overall Study||8
28723|NCT02740049|65283|P1|STARTED|Overall Study||9
28724|NCT02739997|65289|P1|NOT COMPLETED|Overall Study||2
28725|NCT02739997|65289|P1|COMPLETED|Overall Study||98
28726|NCT02739997|65289|P1|STARTED|Overall Study||100
28727|NCT02739984|65303|P2|NOT COMPLETED|Overall Study||2
28728|NCT02739984|65304|P1|NOT COMPLETED|Overall Study||5
28729|NCT02739984|65303|P2|COMPLETED|Overall Study||279
28730|NCT02739984|65304|P1|COMPLETED|Overall Study||138
28731|NCT02739984|65303|P2|Received Study Drug|Overall Study||280
28732|NCT02739984|65304|P1|Received Study Drug|Overall Study||141
28733|NCT02739984|65303|P2|STARTED|Overall Study||281
28734|NCT02739984|65304|P1|STARTED|Overall Study||143
28735|NCT02739828|65352|P1|NOT COMPLETED|Overall Study||5
28736|NCT02739828|65352|P1|COMPLETED|Overall Study||19
28737|NCT02739828|65352|P1|STARTED|Overall Study||24
28738|NCT02739698|65388|P2|NOT COMPLETED|Overall Study||5
28739|NCT02739698|65389|P1|NOT COMPLETED|Overall Study||6
28740|NCT02739698|65388|P2|COMPLETED|Overall Study||16
28741|NCT02739698|65389|P1|COMPLETED|Overall Study||16
28742|NCT02739698|65388|P2|STARTED|Overall Study||21
28743|NCT02739698|65389|P1|STARTED|Overall Study||22
28744|NCT02739594|65397|P2|NOT COMPLETED|Overall Study||28
28745|NCT02739594|65398|P1|NOT COMPLETED|Overall Study||25
28746|NCT02739594|65397|P2|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|15
28747|NCT02739594|65398|P1|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|21
28748|NCT02739594|65397|P2|Completed at Week 96|Overall Study||10
28749|NCT02739594|65398|P1|Completed at Week 96|Overall Study||10
28750|NCT02739594|65397|P2|Completed at Week 44|Overall Study||5
28751|NCT02739594|65398|P1|Completed at Week 44|Overall Study||11
28752|NCT02739594|65397|P2|STARTED|Overall Study||43
28753|NCT02739594|65398|P1|STARTED|Overall Study||46
28754|NCT02739360|65428|P1|NOT COMPLETED|Overall Study||3
28755|NCT02739360|65428|P1|COMPLETED|Overall Study||0
28756|NCT02739360|65428|P1|STARTED|Overall Study||3
28757|NCT02739321|65434|P2|NOT COMPLETED|Overall Study||4
28758|NCT02739321|65435|P1|NOT COMPLETED|Overall Study||3
28759|NCT02739321|65434|P2|COMPLETED|Overall Study||18
28760|NCT02739321|65435|P1|COMPLETED|Overall Study||20
28761|NCT02739321|65434|P2|STARTED|Overall Study||22
28762|NCT02739321|65435|P1|STARTED|Overall Study||23
28763|NCT02739269|65481|P2|NOT COMPLETED|Overall Study||4
28764|NCT02739269|65482|P1|NOT COMPLETED|Overall Study||7
28765|NCT02739269|65481|P2|COMPLETED|Overall Study||96
28766|NCT02739269|65482|P1|COMPLETED|Overall Study||93
28767|NCT02739269|65481|P2|STARTED|Overall Study||100
28768|NCT02739269|65482|P1|STARTED|Overall Study||100
28769|NCT02739100|65490|P1|NOT COMPLETED|Overall Study||0
28770|NCT02739100|65490|P1|COMPLETED|Overall Study||13
28771|NCT02739100|65490|P1|Triferic 6.6. mg IV Post-dialyzer|Overall Study||13
28772|NCT02739100|65490|P1|Triferic 6.6 mg IV Predialyzer|Overall Study||13
28773|NCT02739100|65490|P1|Triferic 2 Micromolar Via Hemodialysate|Overall Study||13
28774|NCT02739100|65490|P1|STARTED|Overall Study||13
28775|NCT02738879|65509|P2|NOT COMPLETED|Overall Study||25
28776|NCT02738879|65510|P1|NOT COMPLETED|Overall Study||13
28777|NCT02738879|65509|P2|COMPLETED|Overall Study||347
28778|NCT02738879|65510|P1|COMPLETED|Overall Study||361
28779|NCT02738879|65509|P2|Treated|Overall Study||370
28780|NCT02738879|65510|P1|Treated|Overall Study||373
28781|NCT02738879|65509|P2|STARTED|Overall Study||372
28782|NCT02738879|65510|P1|STARTED|Overall Study||374
28783|NCT02738853|65544|P1|NOT COMPLETED|30 Days- 6 Months||2
28784|NCT02738853|65544|P1|COMPLETED|30 Days- 6 Months||57
28785|NCT02738853|65544|P1|STARTED|30 Days- 6 Months||59
28786|NCT02738853|65544|P1|NOT COMPLETED|Baseline -30 Days||1
28787|NCT02738853|65544|P1|COMPLETED|Baseline -30 Days||59
28788|NCT02738853|65544|P1|STARTED|Baseline -30 Days||60
28789|NCT02738333|65563|P3|NOT COMPLETED|Overall Study||0
28790|NCT02738333|65564|P2|NOT COMPLETED|Overall Study||0
28791|NCT02738333|65565|P1|NOT COMPLETED|Overall Study||2
28792|NCT02738333|65563|P3|COMPLETED|Overall Study||25
28793|NCT02738333|65564|P2|COMPLETED|Overall Study||108
28794|NCT02738333|65565|P1|COMPLETED|Overall Study||104
28795|NCT02738333|65563|P3|STARTED|Overall Study||25
28796|NCT02738333|65564|P2|STARTED|Overall Study||108
28797|NCT02738333|65565|P1|STARTED|Overall Study||106
28798|NCT02738255|65641|P2|NOT COMPLETED|Overall Study||1
28799|NCT02738255|65642|P1|NOT COMPLETED|Overall Study||0
28800|NCT02738255|65641|P2|COMPLETED|Overall Study||14
28801|NCT02738255|65642|P1|COMPLETED|Overall Study||11
28802|NCT02738255|65641|P2|STARTED|Overall Study||15
28803|NCT02738255|65642|P1|STARTED|Overall Study||11
28804|NCT02738203|65654|P2|NOT COMPLETED|Overall Study||3
28805|NCT02738203|65655|P1|NOT COMPLETED|Overall Study||2
28806|NCT02738203|65654|P2|COMPLETED|Overall Study||107
28807|NCT02738203|65655|P1|COMPLETED|Overall Study||108
28808|NCT02738203|65654|P2|STARTED|Overall Study||110
28809|NCT02738203|65655|P1|STARTED|Overall Study||110
28810|NCT02738151|65671|P2|NOT COMPLETED|Overall Study||31
28811|NCT02738151|65672|P1|NOT COMPLETED|Overall Study||23
28812|NCT02738151|65671|P2|COMPLETED|Overall Study||432
28813|NCT02738151|65672|P1|COMPLETED|Overall Study||443
28814|NCT02738151|65671|P2|Treated|Overall Study||462
28815|NCT02738151|65672|P1|Treated|Overall Study||462
28816|NCT02738151|65671|P2|STARTED|Overall Study||463
28817|NCT02738151|65672|P1|STARTED|Overall Study||466
28818|NCT02738138|65716|P2|NOT COMPLETED|Overall Study||1
28819|NCT02738138|65717|P1|NOT COMPLETED|Overall Study||3
28820|NCT02738138|65716|P2|COMPLETED|Overall Study||15
28821|NCT02738138|65717|P1|COMPLETED|Overall Study||134
28822|NCT02738138|65716|P2|STARTED|Overall Study||16
28823|NCT02738138|65717|P1|STARTED|Overall Study||137
28824|NCT02738008|65727|P3|NOT COMPLETED|Overall Study||5
28825|NCT02738008|65728|P2|NOT COMPLETED|Overall Study||6
28826|NCT02738008|65729|P1|NOT COMPLETED|Overall Study||1
28827|NCT02738008|65727|P3|COMPLETED|Overall Study||0
28828|NCT02738008|65728|P2|COMPLETED|Overall Study||0
28829|NCT02738008|65729|P1|COMPLETED|Overall Study||0
28830|NCT02738008|65727|P3|STARTED|Overall Study||5
28831|NCT02738008|65728|P2|STARTED|Overall Study||6
28832|NCT02738008|65729|P1|STARTED|Overall Study||1
28833|NCT02737917|65745|P2|NOT COMPLETED|Overall Study||3
28834|NCT02737917|65746|P1|NOT COMPLETED|Overall Study||3
28835|NCT02737917|65745|P2|COMPLETED|Overall Study||100
28836|NCT02737917|65746|P1|COMPLETED|Overall Study||100
28837|NCT02737917|65745|P2|STARTED|Overall Study||103
28838|NCT02737917|65746|P1|STARTED|Overall Study||103
28839|NCT02737852|65754|P1|NOT COMPLETED|Overall Study||2
28840|NCT02737852|65754|P1|COMPLETED|Overall Study||30
28841|NCT02737852|65754|P1|STARTED|Overall Study||32
28842|NCT02737722|65763|P4|NOT COMPLETED|Overall Study||0
28843|NCT02737722|65764|P3|NOT COMPLETED|Overall Study||1
28844|NCT02737722|65765|P2|NOT COMPLETED|Overall Study||0
28845|NCT02737722|65766|P1|NOT COMPLETED|Overall Study||0
28846|NCT02737722|65763|P4|COMPLETED|Overall Study||6
28847|NCT02737722|65764|P3|COMPLETED|Overall Study||7
28848|NCT02737722|65765|P2|COMPLETED|Overall Study||8
28849|NCT02737722|65766|P1|COMPLETED|Overall Study||8
28850|NCT02737722|65763|P4|STARTED|Overall Study||6
28851|NCT02737722|65764|P3|STARTED|Overall Study||8
28852|NCT02737722|65765|P2|STARTED|Overall Study||8
28853|NCT02737722|65766|P1|STARTED|Overall Study||8
28854|NCT02737631|65812|P1|NOT COMPLETED|Overall Study||0
28855|NCT02737631|65812|P1|COMPLETED|Overall Study||222
28856|NCT02737631|65812|P1|STARTED|Overall Study||222
28857|NCT02737618|65817|P1|NOT COMPLETED|Overall Study||9
28858|NCT02737618|65817|P1|COMPLETED|Overall Study||34
28859|NCT02737618|65817|P1|STARTED|Overall Study||43
28860|NCT02737592|65822|P1|NOT COMPLETED|Overall Study||1
28861|NCT02737592|65822|P1|COMPLETED|Overall Study||33
28862|NCT02737592|65822|P1|STARTED|Overall Study||34
28863|NCT02737397|65827|P1|NOT COMPLETED|Overall Study||0
28864|NCT02737397|65827|P1|COMPLETED|Overall Study||13
28865|NCT02737397|65827|P1|Placebo|Overall Study||13
28866|NCT02737397|65827|P1|SJP-223|Overall Study||13
28867|NCT02737397|65827|P1|SJP-304|Overall Study||12
28868|NCT02737397|65827|P1|JMI-001|Overall Study||13
28869|NCT02737397|65827|P1|STARTED|Overall Study||13
28870|NCT02737163|65841|P1|NOT COMPLETED|Overall Study||0
28871|NCT02737163|65841|P1|COMPLETED|Overall Study||95
28872|NCT02737163|65841|P1|STARTED|Overall Study|114 encounter assessments were completed on 95 participants over 15 months|95
28873|NCT02737072|65851|P3|NOT COMPLETED|Overall Study||0
28874|NCT02737072|65852|P2|NOT COMPLETED|Overall Study||0
28875|NCT02737072|65853|P1|NOT COMPLETED|Overall Study||0
28876|NCT02737072|65851|P3|COMPLETED|Overall Study||3
28877|NCT02737072|65852|P2|COMPLETED|Overall Study||3
28878|NCT02737072|65853|P1|COMPLETED|Overall Study||3
28879|NCT02737072|65851|P3|Received at Least One Dose of Drug|Overall Study||3
28880|NCT02737072|65852|P2|Received at Least One Dose of Drug|Overall Study||3
28881|NCT02737072|65853|P1|Received at Least One Dose of Drug|Overall Study||3
28882|NCT02737072|65851|P3|STARTED|Overall Study||3
28883|NCT02737072|65852|P2|STARTED|Overall Study||3
28884|NCT02737072|65853|P1|STARTED|Overall Study||3
28885|NCT02736955|65877|P3|NOT COMPLETED|Overall Study||2
28886|NCT02736955|65878|P2|NOT COMPLETED|Overall Study||14
28887|NCT02736955|65879|P1|NOT COMPLETED|Overall Study||7
28888|NCT02736955|65877|P3|COMPLETED|Overall Study||6
28889|NCT02736955|65878|P2|COMPLETED|Overall Study||103
28890|NCT02736955|65879|P1|COMPLETED|Overall Study||29
28891|NCT02736955|65877|P3|STARTED|Overall Study||8
28892|NCT02736955|65878|P2|STARTED|Overall Study||117
28893|NCT02736955|65879|P1|STARTED|Overall Study||36
28894|NCT02736890|65895|P2|NOT COMPLETED|Crossover Next 12 Weeks||2
28895|NCT02736890|65896|P1|NOT COMPLETED|Crossover Next 12 Weeks||2
28896|NCT02736890|65895|P2|COMPLETED|Crossover Next 12 Weeks||1
28897|NCT02736890|65896|P1|COMPLETED|Crossover Next 12 Weeks||3
28898|NCT02736890|65895|P2|STARTED|Crossover Next 12 Weeks||3
28899|NCT02736890|65896|P1|STARTED|Crossover Next 12 Weeks||5
28900|NCT02736890|65895|P2|NOT COMPLETED|First 12 Weeks||0
28901|NCT02736890|65896|P1|NOT COMPLETED|First 12 Weeks||0
28902|NCT02736890|65895|P2|COMPLETED|First 12 Weeks||3
28903|NCT02736890|65896|P1|COMPLETED|First 12 Weeks||5
28904|NCT02736890|65895|P2|STARTED|First 12 Weeks||3
28905|NCT02736890|65896|P1|STARTED|First 12 Weeks||5
28906|NCT02736721|65916|P1|NOT COMPLETED|Overall Study||16
28907|NCT02736721|65916|P1|COMPLETED|Overall Study||25
28908|NCT02736721|65916|P1|STARTED|Overall Study||41
28909|NCT02736578|65927|P2|NOT COMPLETED|Overall Study||0
28910|NCT02736578|65928|P1|NOT COMPLETED|Overall Study||1
28911|NCT02736578|65927|P2|COMPLETED|Overall Study||2
28912|NCT02736578|65928|P1|COMPLETED|Overall Study||5
28913|NCT02736578|65927|P2|STARTED|Overall Study||2
28914|NCT02736578|65928|P1|STARTED|Overall Study||6
28915|NCT02736188|65946|P1|NOT COMPLETED|Overall Study||142
28916|NCT02736188|65946|P1|COMPLETED|Overall Study||0
28917|NCT02736188|65946|P1|STARTED|Overall Study||142
28918|NCT02736175|65972|P2|NOT COMPLETED|Overall Study||1
28919|NCT02736175|65973|P1|NOT COMPLETED|Overall Study||2
28920|NCT02736175|65972|P2|COMPLETED|Overall Study||221
28921|NCT02736175|65973|P1|COMPLETED|Overall Study||214
28922|NCT02736175|65972|P2|STARTED|Overall Study||222
28923|NCT02736175|65973|P1|STARTED|Overall Study||216
28924|NCT02735915|65981|P1|NOT COMPLETED|Revaccination Phase-TVc||3
28925|NCT02735915|65981|P1|COMPLETED|Revaccination Phase-TVc||59
28926|NCT02735915|65981|P1|STARTED|Revaccination Phase-TVc||62
28927|NCT02735915|65981|P1|NOT COMPLETED|Persistence Phase-Total Enrolled Cohort||8
28928|NCT02735915|65981|P1|COMPLETED|Persistence Phase-Total Enrolled Cohort|Represents number of subjects that started TVc|62
28929|NCT02735915|65981|P1|STARTED|Persistence Phase-Total Enrolled Cohort||70
28930|NCT02735551|66003|P3|NOT COMPLETED|Overall Study||0
28931|NCT02735551|66004|P2|NOT COMPLETED|Overall Study||0
28932|NCT02735551|66005|P1|NOT COMPLETED|Overall Study||0
28933|NCT02735551|66003|P3|COMPLETED|Overall Study||0
28934|NCT02735551|66004|P2|COMPLETED|Overall Study||0
28935|NCT02735551|66005|P1|COMPLETED|Overall Study||3
28936|NCT02735551|66003|P3|STARTED|Overall Study||0
28937|NCT02735551|66004|P2|STARTED|Overall Study||0
28938|NCT02735551|66005|P1|STARTED|Overall Study||3
28939|NCT02735421|66013|P1|NOT COMPLETED|Overall Study||13
28940|NCT02735421|66013|P1|COMPLETED|Overall Study||54
28941|NCT02735421|66013|P1|STARTED|Overall Study||67
28942|NCT02735382|66024|P4|NOT COMPLETED|Overall Study||0
28943|NCT02735382|66025|P3|NOT COMPLETED|Overall Study||0
28944|NCT02735382|66026|P2|NOT COMPLETED|Overall Study||0
28945|NCT02735382|66027|P1|NOT COMPLETED|Overall Study||0
28946|NCT02735382|66024|P4|COMPLETED|Overall Study||110
28947|NCT02735382|66025|P3|COMPLETED|Overall Study||184
28948|NCT02735382|66026|P2|COMPLETED|Overall Study||7155
28949|NCT02735382|66027|P1|COMPLETED|Overall Study||7481
28950|NCT02735382|66024|P4|STARTED|Overall Study||110
28951|NCT02735382|66025|P3|STARTED|Overall Study||184
28952|NCT02735382|66026|P2|STARTED|Overall Study||7155
28953|NCT02735382|66027|P1|STARTED|Overall Study||7481
28954|NCT02735200|66043|P2|NOT COMPLETED|Overall Study||5
28955|NCT02735200|66044|P1|NOT COMPLETED|Overall Study||8
28956|NCT02735200|66043|P2|COMPLETED|Overall Study||345
28957|NCT02735200|66044|P1|COMPLETED|Overall Study||192
28958|NCT02735200|66043|P2|STARTED|Overall Study||350
28959|NCT02735200|66044|P1|STARTED|Overall Study||200
28960|NCT02735187|66052|P2|NOT COMPLETED|Overall Study||1
28961|NCT02735187|66053|P1|NOT COMPLETED|Overall Study||4
28962|NCT02735187|66052|P2|COMPLETED|Overall Study||25
28963|NCT02735187|66053|P1|COMPLETED|Overall Study||21
28964|NCT02735187|66052|P2|STARTED|Overall Study||26
28965|NCT02735187|66053|P1|STARTED|Overall Study||25
28966|NCT02735096|66083|P1|NOT COMPLETED|Overall Study||1
28967|NCT02735096|66083|P1|COMPLETED|Overall Study||3
28968|NCT02735096|66083|P1|STARTED|Overall Study||4
28969|NCT02735044|66092|P2|NOT COMPLETED|Overall Study||23
28970|NCT02735044|66093|P1|NOT COMPLETED|Overall Study||16
28971|NCT02735044|66092|P2|COMPLETED|Overall Study||207
28972|NCT02735044|66093|P1|COMPLETED|Overall Study||217
28973|NCT02735044|66092|P2|Treated|Overall Study||228
28974|NCT02735044|66093|P1|Treated|Overall Study||233
28975|NCT02735044|66092|P2|STARTED|Overall Study||230
28976|NCT02735044|66093|P1|STARTED|Overall Study||233
28977|NCT02734953|66119|P1|NOT COMPLETED|Overall Study||0
28978|NCT02734953|66119|P1|COMPLETED|Overall Study||10
28979|NCT02734953|66119|P1|STARTED|Overall Study||10
28980|NCT02734940|66136|P2|NOT COMPLETED|Overall Study||0
28981|NCT02734940|66137|P1|NOT COMPLETED|Overall Study||0
28982|NCT02734940|66136|P2|COMPLETED|Overall Study||0
28983|NCT02734940|66137|P1|COMPLETED|Overall Study||0
28984|NCT02734940|66136|P2|STARTED|Overall Study||0
28985|NCT02734940|66137|P1|STARTED|Overall Study||0
28986|NCT02734810|66161|P2|NOT COMPLETED|Overall Study||0
28987|NCT02734810|66162|P1|NOT COMPLETED|Overall Study||2
28988|NCT02734810|66161|P2|COMPLETED|Overall Study||0
28989|NCT02734810|66162|P1|COMPLETED|Overall Study||13
28990|NCT02734810|66161|P2|STARTED|Overall Study||0
28991|NCT02734810|66162|P1|STARTED|Overall Study||15
28992|NCT02734498|66171|P3|NOT COMPLETED|Overall Study||0
28993|NCT02734498|66172|P2|NOT COMPLETED|Overall Study||0
28994|NCT02734498|66173|P1|NOT COMPLETED|Overall Study||0
28995|NCT02734498|66171|P3|COMPLETED|Overall Study||0
28996|NCT02734498|66172|P2|COMPLETED|Overall Study||0
28997|NCT02734498|66173|P1|COMPLETED|Overall Study||2
28998|NCT02734498|66171|P3|STARTED|Overall Study||0
28999|NCT02734498|66172|P2|STARTED|Overall Study||0
29000|NCT02734498|66173|P1|STARTED|Overall Study||2
29001|NCT02734355|66192|P2|NOT COMPLETED|Overall Study||0
29002|NCT02734355|66193|P1|NOT COMPLETED|Overall Study||0
29003|NCT02734355|66192|P2|COMPLETED|Overall Study||30
29004|NCT02734355|66193|P1|COMPLETED|Overall Study||34
29005|NCT02734355|66192|P2|STARTED|Overall Study||30
29006|NCT02734355|66193|P1|STARTED|Overall Study||34
29007|NCT02734238|66225|P2|NOT COMPLETED|Overall Study||0
29008|NCT02734238|66226|P1|NOT COMPLETED|Overall Study||0
29009|NCT02734238|66225|P2|COMPLETED|Overall Study||24
29010|NCT02734238|66226|P1|COMPLETED|Overall Study||26
29011|NCT02734238|66225|P2|STARTED|Overall Study||24
29012|NCT02734238|66226|P1|STARTED|Overall Study||26
29013|NCT02734212|66234|P2|NOT COMPLETED|Overall Study||10
29014|NCT02734212|66235|P1|NOT COMPLETED|Overall Study||5
29015|NCT02734212|66234|P2|COMPLETED|Overall Study||18
29016|NCT02734212|66235|P1|COMPLETED|Overall Study||24
29017|NCT02734212|66234|P2|STARTED|Overall Study||28
29018|NCT02734212|66235|P1|STARTED|Overall Study||29
29019|NCT02734056|66247|P2|NOT COMPLETED|Overall Study||1
29020|NCT02734056|66248|P1|NOT COMPLETED|Overall Study||0
29021|NCT02734056|66247|P2|COMPLETED|Overall Study||49
29022|NCT02734056|66248|P1|COMPLETED|Overall Study||50
29023|NCT02734056|66247|P2|STARTED|Overall Study||50
29024|NCT02734056|66248|P1|STARTED|Overall Study||50
29025|NCT02733991|66256|P2|NOT COMPLETED|Overall Study||5
29026|NCT02733991|66257|P1|NOT COMPLETED|Overall Study||1
29027|NCT02733991|66256|P2|COMPLETED|Overall Study||72
29028|NCT02733991|66257|P1|COMPLETED|Overall Study||75
29029|NCT02733991|66256|P2|STARTED|Overall Study||77
29030|NCT02733991|66257|P1|STARTED|Overall Study||76
29031|NCT02733653|66267|P1|NOT COMPLETED|Overall Study||1
29032|NCT02733653|66267|P1|COMPLETED|Overall Study||49
29033|NCT02733653|66267|P1|STARTED|Overall Study||50
29034|NCT02733588|66273|P1|NOT COMPLETED|Overall Study||0
29035|NCT02733588|66273|P1|COMPLETED|Overall Study||7
29036|NCT02733588|66273|P1|STARTED|Overall Study||7
29037|NCT02733367|66280|P1|NOT COMPLETED|Overall Study||6
29038|NCT02733367|66280|P1|COMPLETED|Overall Study||12
29039|NCT02733367|66280|P1|STARTED|Overall Study||18
29040|NCT02732951|66289|P2|NOT COMPLETED|Overall Study||6
29041|NCT02732951|66290|P1|NOT COMPLETED|Overall Study||5
29042|NCT02732951|66289|P2|COMPLETED|Overall Study||46
29043|NCT02732951|66290|P1|COMPLETED|Overall Study||48
29044|NCT02732951|66289|P2|STARTED|Overall Study||52
29045|NCT02732951|66290|P1|STARTED|Overall Study||53
29046|NCT02732938|66300|P3|NOT COMPLETED|Overall Study||0
29047|NCT02732938|66301|P2|NOT COMPLETED|Overall Study||18
29048|NCT02732938|66302|P1|NOT COMPLETED|Overall Study||4
29049|NCT02732938|66300|P3|COMPLETED|Overall Study||0
29050|NCT02732938|66301|P2|COMPLETED|Overall Study||0
29051|NCT02732938|66302|P1|COMPLETED|Overall Study||0
29052|NCT02732938|66300|P3|Received Treatment|Overall Study||0
29053|NCT02732938|66301|P2|Received Treatment|Overall Study||17
29054|NCT02732938|66302|P1|Received Treatment|Overall Study||4
29055|NCT02732938|66300|P3|STARTED|Overall Study||0
29056|NCT02732938|66301|P2|STARTED|Overall Study||18
29057|NCT02732938|66302|P1|STARTED|Overall Study||4
29058|NCT02732912|66348|P2|NOT COMPLETED|Overall Study||18
29059|NCT02732912|66349|P1|NOT COMPLETED|Overall Study||10
29060|NCT02732912|66348|P2|COMPLETED|Overall Study||91
29061|NCT02732912|66349|P1|COMPLETED|Overall Study||87
29062|NCT02732912|66348|P2|STARTED|Overall Study||109
29063|NCT02732912|66349|P1|STARTED|Overall Study||97
29064|NCT02732899|66365|P2|NOT COMPLETED|Overall Study||0
29065|NCT02732899|66366|P1|NOT COMPLETED|Overall Study||0
29066|NCT02732899|66365|P2|COMPLETED|Overall Study||10
29067|NCT02732899|66366|P1|COMPLETED|Overall Study||10
29068|NCT02732899|66365|P2|STARTED|Overall Study||10
29069|NCT02732899|66366|P1|STARTED|Overall Study||10
29070|NCT02732639|66374|P1|NOT COMPLETED|Overall Study||1
29071|NCT02732639|66374|P1|COMPLETED|Overall Study||30
29072|NCT02732639|66374|P1|STARTED|Overall Study||31
29073|NCT02732561|66387|P2|NOT COMPLETED|Overall Study||1
29074|NCT02732561|66388|P1|NOT COMPLETED|Overall Study||2
29075|NCT02732561|66387|P2|COMPLETED|Overall Study||4
29076|NCT02732561|66388|P1|COMPLETED|Overall Study||3
29077|NCT02732561|66387|P2|STARTED|Overall Study||5
29078|NCT02732561|66388|P1|STARTED|Overall Study||5
29079|NCT02732327|66398|P2|NOT COMPLETED|Overall Study||1
29080|NCT02732327|66399|P1|NOT COMPLETED|Overall Study||0
29081|NCT02732327|66398|P2|COMPLETED|Overall Study||1
29082|NCT02732327|66399|P1|COMPLETED|Overall Study||0
29083|NCT02732327|66398|P2|STARTED|Overall Study||2
29084|NCT02732327|66399|P1|STARTED|Overall Study||0
29085|NCT02732210|66407|P2|NOT COMPLETED|Overall Study||294
29086|NCT02732210|66408|P1|NOT COMPLETED|Overall Study||85
29087|NCT02732210|66407|P2|COMPLETED|Overall Study||338
29088|NCT02732210|66408|P1|COMPLETED|Overall Study||218
29089|NCT02732210|66407|P2|STARTED|Overall Study||632
29090|NCT02732210|66408|P1|STARTED|Overall Study||303
29091|NCT02732145|66428|P4|NOT COMPLETED|Overall Study||0
29092|NCT02732145|66429|P3|NOT COMPLETED|Overall Study||0
29093|NCT02732145|66430|P2|NOT COMPLETED|Overall Study||0
29094|NCT02732145|66431|P1|NOT COMPLETED|Overall Study||0
29095|NCT02732145|66428|P4|COMPLETED|Overall Study||82
29096|NCT02732145|66429|P3|COMPLETED|Overall Study||82
29097|NCT02732145|66430|P2|COMPLETED|Overall Study||82
29098|NCT02732145|66431|P1|COMPLETED|Overall Study||82
29099|NCT02732145|66428|P4|STARTED|Overall Study||82
29100|NCT02732145|66429|P3|STARTED|Overall Study||82
29101|NCT02732145|66430|P2|STARTED|Overall Study||82
29102|NCT02732145|66431|P1|STARTED|Overall Study||82
29103|NCT02731833|66559|P2|NOT COMPLETED|Overall Study||0
29104|NCT02731833|66560|P1|NOT COMPLETED|Overall Study||0
29105|NCT02731833|66559|P2|COMPLETED|Overall Study||111
29106|NCT02731833|66560|P1|COMPLETED|Overall Study||111
29107|NCT02731833|66559|P2|STARTED|Overall Study||111
29108|NCT02731833|66560|P1|STARTED|Overall Study||111
29109|NCT02731820|66574|P2|NOT COMPLETED|Overall Study||2
29110|NCT02731820|66575|P1|NOT COMPLETED|Overall Study||3
29111|NCT02731820|66574|P2|COMPLETED|Overall Study||18
29112|NCT02731820|66575|P1|COMPLETED|Overall Study||17
29113|NCT02731820|66574|P2|STARTED|Overall Study||20
29114|NCT02731820|66575|P1|STARTED|Overall Study||20
29115|NCT02731755|66587|P2|NOT COMPLETED|Second Intervention||0
29116|NCT02731755|66588|P1|NOT COMPLETED|Second Intervention||0
29117|NCT02731755|66587|P2|COMPLETED|Second Intervention||8
29118|NCT02731755|66588|P1|COMPLETED|Second Intervention||8
29119|NCT02731755|66587|P2|STARTED|Second Intervention||8
29120|NCT02731755|66588|P1|STARTED|Second Intervention||8
29121|NCT02731755|66587|P2|NOT COMPLETED|First Intervention||2
29122|NCT02731755|66588|P1|NOT COMPLETED|First Intervention||0
29123|NCT02731755|66587|P2|COMPLETED|First Intervention||8
29124|NCT02731755|66588|P1|COMPLETED|First Intervention||8
29125|NCT02731755|66587|P2|STARTED|First Intervention||10
29126|NCT02731755|66588|P1|STARTED|First Intervention||8
29127|NCT02731742|66612|P4|NOT COMPLETED|Overall Study||2
29128|NCT02731742|66613|P3|NOT COMPLETED|Overall Study||6
29129|NCT02731742|66614|P2|NOT COMPLETED|Overall Study||3
29130|NCT02731742|66615|P1|NOT COMPLETED|Overall Study||3
29131|NCT02731742|66612|P4|COMPLETED|Overall Study||0
29132|NCT02731742|66613|P3|COMPLETED|Overall Study||0
29133|NCT02731742|66614|P2|COMPLETED|Overall Study||0
29134|NCT02731742|66615|P1|COMPLETED|Overall Study||0
29135|NCT02731742|66612|P4|STARTED|Overall Study||2
29136|NCT02731742|66613|P3|STARTED|Overall Study||6
29137|NCT02731742|66614|P2|STARTED|Overall Study||3
29138|NCT02731742|66615|P1|STARTED|Overall Study||3
29139|NCT02731690|66633|P1|NOT COMPLETED|Overall Study||30
29140|NCT02731690|66633|P1|COMPLETED|Overall Study||12
29141|NCT02731690|66633|P1|STARTED|Overall Study||42
29142|NCT02731638|66653|P2|NOT COMPLETED|Overall Study||9
29143|NCT02731638|66654|P1|NOT COMPLETED|Overall Study||6
29144|NCT02731638|66653|P2|COMPLETED|Overall Study||26
29145|NCT02731638|66654|P1|COMPLETED|Overall Study||29
29146|NCT02731638|66653|P2|STARTED|Overall Study||35
29147|NCT02731638|66654|P1|STARTED|Overall Study||35
29148|NCT02731469|66679|P11|NOT COMPLETED|Overall Study||0
29149|NCT02731469|66680|P10|NOT COMPLETED|Overall Study||0
29150|NCT02731469|66681|P9|NOT COMPLETED|Overall Study||0
29151|NCT02731469|66682|P8|NOT COMPLETED|Overall Study||0
29152|NCT02731469|66683|P7|NOT COMPLETED|Overall Study||0
29153|NCT02731469|66684|P6|NOT COMPLETED|Overall Study||0
29154|NCT02731469|66685|P5|NOT COMPLETED|Overall Study||0
29155|NCT02731469|66686|P4|NOT COMPLETED|Overall Study||0
29156|NCT02731469|66687|P3|NOT COMPLETED|Overall Study||0
29157|NCT02731469|66688|P2|NOT COMPLETED|Overall Study||0
29158|NCT02731469|66689|P1|NOT COMPLETED|Overall Study||0
29159|NCT02731469|66679|P11|COMPLETED|Overall Study||6
29160|NCT02731469|66680|P10|COMPLETED|Overall Study||6
29161|NCT02731469|66681|P9|COMPLETED|Overall Study||6
29162|NCT02731469|66682|P8|COMPLETED|Overall Study||6
29163|NCT02731469|66683|P7|COMPLETED|Overall Study||3
29164|NCT02731469|66684|P6|COMPLETED|Overall Study||3
29165|NCT02731469|66685|P5|COMPLETED|Overall Study||3
29166|NCT02731469|66686|P4|COMPLETED|Overall Study||3
29167|NCT02731469|66687|P3|COMPLETED|Overall Study||3
29168|NCT02731469|66688|P2|COMPLETED|Overall Study||3
29169|NCT02731469|66689|P1|COMPLETED|Overall Study||3
29170|NCT02731469|66679|P11|STARTED|Overall Study||6
29171|NCT02731469|66680|P10|STARTED|Overall Study||6
29172|NCT02731469|66681|P9|STARTED|Overall Study||6
29173|NCT02731469|66682|P8|STARTED|Overall Study||6
29174|NCT02731469|66683|P7|STARTED|Overall Study||3
29175|NCT02731469|66684|P6|STARTED|Overall Study||3
29176|NCT02731469|66685|P5|STARTED|Overall Study||3
29177|NCT02731469|66686|P4|STARTED|Overall Study||3
29178|NCT02731469|66687|P3|STARTED|Overall Study||3
29179|NCT02731469|66688|P2|STARTED|Overall Study||3
29180|NCT02731469|66689|P1|STARTED|Overall Study||3
29181|NCT02731313|66878|P1|NOT COMPLETED|Overall Study||0
29182|NCT02731313|66878|P1|COMPLETED|Overall Study||367
29183|NCT02731313|66878|P1|STARTED|Overall Study||367
29184|NCT02731300|66888|P2|NOT COMPLETED|Overall Study||0
29185|NCT02731300|66889|P1|NOT COMPLETED|Overall Study||0
29186|NCT02731300|66888|P2|COMPLETED|Overall Study||7
29187|NCT02731300|66889|P1|COMPLETED|Overall Study||15
29188|NCT02731300|66888|P2|STARTED|Overall Study||7
29189|NCT02731300|66889|P1|STARTED|Overall Study||15
29190|NCT02731157|66897|P1|NOT COMPLETED|Third Standard RCE||0
29191|NCT02731157|66897|P1|COMPLETED|Third Standard RCE||3
29192|NCT02731157|66897|P1|STARTED|Third Standard RCE||3
29193|NCT02731157|66897|P1|NOT COMPLETED|Second Standard RCE||0
29194|NCT02731157|66897|P1|COMPLETED|Second Standard RCE||3
29195|NCT02731157|66897|P1|STARTED|Second Standard RCE||3
29196|NCT02731157|66897|P1|NOT COMPLETED|Third Rejuvenated RCE||0
29197|NCT02731157|66897|P1|COMPLETED|Third Rejuvenated RCE||3
29198|NCT02731157|66897|P1|STARTED|Third Rejuvenated RCE||3
29199|NCT02731157|66897|P1|NOT COMPLETED|Second Rejuvenated RCE||0
29200|NCT02731157|66897|P1|COMPLETED|Second Rejuvenated RCE||3
29201|NCT02731157|66897|P1|STARTED|Second Rejuvenated RCE||3
29202|NCT02731157|66897|P1|NOT COMPLETED|First Rejuvenated RCE||1
29203|NCT02731157|66897|P1|COMPLETED|First Rejuvenated RCE||3
29204|NCT02731157|66897|P1|STARTED|First Rejuvenated RCE||4
29205|NCT02731157|66897|P1|NOT COMPLETED|First Standard RCE||0
29206|NCT02731157|66897|P1|COMPLETED|First Standard RCE||4
29207|NCT02731157|66897|P1|STARTED|First Standard RCE||4
29208|NCT02731131|66915|P2|NOT COMPLETED|Overall Study||2
29209|NCT02731131|66916|P1|NOT COMPLETED|Overall Study||0
29210|NCT02731131|66915|P2|COMPLETED|Overall Study||4
29211|NCT02731131|66916|P1|COMPLETED|Overall Study||6
29212|NCT02731131|66915|P2|STARTED|Overall Study||6
29213|NCT02731131|66916|P1|STARTED|Overall Study||6
29214|NCT02730988|66934|P2|NOT COMPLETED|Overall Study||10
29215|NCT02730988|66935|P1|NOT COMPLETED|Overall Study||4
29216|NCT02730988|66934|P2|COMPLETED|Overall Study||39
29217|NCT02730988|66935|P1|COMPLETED|Overall Study||43
29218|NCT02730988|66934|P2|STARTED|Overall Study||49
29219|NCT02730988|66935|P1|STARTED|Overall Study||47
29220|NCT02730871|66945|P2|NOT COMPLETED|Overall Study||0
29221|NCT02730871|66946|P1|NOT COMPLETED|Overall Study||6
29222|NCT02730871|66945|P2|COMPLETED|Overall Study||67
29223|NCT02730871|66946|P1|COMPLETED|Overall Study||61
29224|NCT02730871|66945|P2|Safety Analysis Set|Overall Study||67
29225|NCT02730871|66946|P1|Safety Analysis Set|Overall Study||67
29226|NCT02730871|66945|P2|Full Analysis Set (FAS)|Overall Study||67
29227|NCT02730871|66946|P1|Full Analysis Set (FAS)|Overall Study||67
29228|NCT02730871|66945|P2|STARTED|Overall Study||67
29229|NCT02730871|66946|P1|STARTED|Overall Study||67
29230|NCT02730819|66960|P1|NOT COMPLETED|Overall Study||9
29231|NCT02730819|66960|P1|COMPLETED|Overall Study||10
29232|NCT02730819|66960|P1|Follow-up Week 20|Overall Study||10
29233|NCT02730819|66960|P1|Follow-up Week 16|Overall Study||11
29234|NCT02730819|66960|P1|Follow-up Week 12|Overall Study||11
29235|NCT02730819|66960|P1|Follow-up Week 8|Overall Study||14
29236|NCT02730819|66960|P1|Follow-up Week 4|Overall Study||16
29237|NCT02730819|66960|P1|Follow-up Week 2|Overall Study||15
29238|NCT02730819|66960|P1|STARTED|Overall Study||19
29239|NCT02730728|66969|P3|NOT COMPLETED|Overall Study||1
29240|NCT02730728|66970|P2|NOT COMPLETED|Overall Study||2
29241|NCT02730728|66971|P1|NOT COMPLETED|Overall Study||0
29242|NCT02730728|66969|P3|COMPLETED|Overall Study||52
29243|NCT02730728|66970|P2|COMPLETED|Overall Study||51
29244|NCT02730728|66971|P1|COMPLETED|Overall Study||53
29245|NCT02730728|66969|P3|STARTED|Overall Study||53
29246|NCT02730728|66970|P2|STARTED|Overall Study||53
29247|NCT02730728|66971|P1|STARTED|Overall Study||53
29248|NCT02730663|66988|P1|NOT COMPLETED|Overall Study||1
29249|NCT02730663|66988|P1|COMPLETED|Overall Study||35
29250|NCT02730663|66988|P1|STARTED|Overall Study||36
29251|NCT02730598|67000|P2|NOT COMPLETED|Overall Study||4
29252|NCT02730598|67001|P1|NOT COMPLETED|Overall Study||4
29253|NCT02730598|67000|P2|COMPLETED|Overall Study||10
29254|NCT02730598|67001|P1|COMPLETED|Overall Study||10
29255|NCT02730598|67000|P2|STARTED|Overall Study||14
29256|NCT02730598|67001|P1|STARTED|Overall Study||14
29257|NCT02730455|67024|P3|NOT COMPLETED|Overall Study||11
29258|NCT02730455|67025|P2|NOT COMPLETED|Overall Study||14
29259|NCT02730455|67026|P1|NOT COMPLETED|Overall Study||13
29260|NCT02730455|67024|P3|COMPLETED|Overall Study||81
29261|NCT02730455|67025|P2|COMPLETED|Overall Study||77
29262|NCT02730455|67026|P1|COMPLETED|Overall Study||81
29263|NCT02730455|67024|P3|Who Received Total Volume of Study Drug|Overall Study||89
29264|NCT02730455|67025|P2|Who Received Total Volume of Study Drug|Overall Study||88
29265|NCT02730455|67026|P1|Who Received Total Volume of Study Drug|Overall Study||90
29266|NCT02730455|67024|P3|Participants Dosed|Overall Study||91
29267|NCT02730455|67025|P2|Participants Dosed|Overall Study||88
29268|NCT02730455|67026|P1|Participants Dosed|Overall Study||91
29269|NCT02730455|67024|P3|Safety Population|Overall Study||89
29270|NCT02730455|67025|P2|Safety Population|Overall Study||90
29271|NCT02730455|67026|P1|Safety Population|Overall Study||91
29272|NCT02730455|67024|P3|STARTED|Overall Study||92
29273|NCT02730455|67025|P2|STARTED|Overall Study||91
29274|NCT02730455|67026|P1|STARTED|Overall Study||94
29275|NCT02730351|67058|P2|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
29276|NCT02730351|67059|P1|NOT COMPLETED|Treatment Period 2 (2 Weeks)||2
29277|NCT02730351|67058|P2|COMPLETED|Treatment Period 2 (2 Weeks)||36
29278|NCT02730351|67059|P1|COMPLETED|Treatment Period 2 (2 Weeks)||33
29279|NCT02730351|67058|P2|STARTED|Treatment Period 2 (2 Weeks)||36
29280|NCT02730351|67059|P1|STARTED|Treatment Period 2 (2 Weeks)||35
29281|NCT02730351|67058|P2|NOT COMPLETED|Wash-out Period (2 Weeks)||1
29282|NCT02730351|67059|P1|NOT COMPLETED|Wash-out Period (2 Weeks)||1
29283|NCT02730351|67058|P2|COMPLETED|Wash-out Period (2 Weeks)||36
29284|NCT02730351|67059|P1|COMPLETED|Wash-out Period (2 Weeks)||35
29285|NCT02730351|67058|P2|STARTED|Wash-out Period (2 Weeks)||37
29286|NCT02730351|67059|P1|STARTED|Wash-out Period (2 Weeks)||36
29287|NCT02730351|67058|P2|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
29288|NCT02730351|67059|P1|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
29289|NCT02730351|67058|P2|COMPLETED|Treatment Period 1 (2 Weeks)||37
29290|NCT02730351|67059|P1|COMPLETED|Treatment Period 1 (2 Weeks)||36
29291|NCT02730351|67058|P2|STARTED|Treatment Period 1 (2 Weeks)||37
29292|NCT02730351|67059|P1|STARTED|Treatment Period 1 (2 Weeks)||37
29293|NCT02730260|67073|P2|NOT COMPLETED|Overall Study||75
29294|NCT02730260|67074|P1|NOT COMPLETED|Overall Study||82
29295|NCT02730260|67073|P2|COMPLETED|Overall Study||185
29296|NCT02730260|67074|P1|COMPLETED|Overall Study||176
29297|NCT02730260|67073|P2|STARTED|Overall Study||260
29298|NCT02730260|67074|P1|STARTED|Overall Study||258
29299|NCT02730208|67082|P2|NOT COMPLETED|Overall Study||1
29300|NCT02730208|67083|P1|NOT COMPLETED|Overall Study||0
29301|NCT02730208|67082|P2|COMPLETED|Overall Study||20
29302|NCT02730208|67083|P1|COMPLETED|Overall Study||20
29303|NCT02730208|67082|P2|STARTED|Overall Study||21
29304|NCT02730208|67083|P1|STARTED|Overall Study||20
29305|NCT02730195|67091|P1|NOT COMPLETED|Overall Study||1
29306|NCT02730195|67091|P1|COMPLETED|Overall Study||8
29307|NCT02730195|67091|P1|STARTED|Overall Study||9
29308|NCT02730130|67097|P1|NOT COMPLETED|Overall Study||0
29309|NCT02730130|67097|P1|COMPLETED|Overall Study||17
29310|NCT02730130|67097|P1|STARTED|Overall Study||17
29311|NCT02729909|67105|P2|NOT COMPLETED|Overall Study||5
29312|NCT02729909|67106|P1|NOT COMPLETED|Overall Study||1
29313|NCT02729909|67105|P2|COMPLETED|Overall Study||101
29314|NCT02729909|67106|P1|COMPLETED|Overall Study||104
29315|NCT02729909|67105|P2|STARTED|Overall Study||106
29316|NCT02729909|67106|P1|STARTED|Overall Study||105
29317|NCT02729896|67125|P3|NOT COMPLETED|Overall Study||16
29318|NCT02729896|67126|P2|NOT COMPLETED|Overall Study||2
29319|NCT02729896|67127|P1|NOT COMPLETED|Overall Study||0
29320|NCT02729896|67125|P3|COMPLETED|Overall Study||7
29321|NCT02729896|67126|P2|COMPLETED|Overall Study||8
29322|NCT02729896|67127|P1|COMPLETED|Overall Study||3
29323|NCT02729896|67125|P3|STARTED|Overall Study||23
29324|NCT02729896|67126|P2|STARTED|Overall Study||10
29325|NCT02729896|67127|P1|STARTED|Overall Study||3
29326|NCT02729753|67146|P2|NOT COMPLETED|Overall Study||1
29327|NCT02729753|67147|P1|NOT COMPLETED|Overall Study||0
29328|NCT02729753|67146|P2|COMPLETED|Overall Study|Study Complete on 30 Oct 2016|6
29329|NCT02729753|67147|P1|COMPLETED|Overall Study|Study Complete on 30 Oct 2016|3
29330|NCT02729753|67146|P2|STARTED|Overall Study|First patient enrolled April 2016|7
29331|NCT02729753|67147|P1|STARTED|Overall Study|First patient enrolled April 2016|3
29332|NCT02729545|67161|P2|NOT COMPLETED|Overall Study||5
29333|NCT02729545|67162|P1|NOT COMPLETED|Overall Study||3
29334|NCT02729545|67161|P2|COMPLETED|Overall Study||25
29335|NCT02729545|67162|P1|COMPLETED|Overall Study||27
29336|NCT02729545|67161|P2|STARTED|Overall Study||30
29337|NCT02729545|67162|P1|STARTED|Overall Study||30
29338|NCT02729194|67184|P1|NOT COMPLETED|Overall Study||3
29339|NCT02729194|67184|P1|COMPLETED|Overall Study||13
29340|NCT02729194|67184|P1|STARTED|Overall Study||16
29341|NCT02729051|67196|P2|NOT COMPLETED|Overall Study||32
29342|NCT02729051|67197|P1|NOT COMPLETED|Overall Study||30
29343|NCT02729051|67196|P2|COMPLETED|Overall Study||496
29344|NCT02729051|67197|P1|COMPLETED|Overall Study||497
29345|NCT02729051|67196|P2|STARTED|Overall Study||528
29346|NCT02729051|67197|P1|STARTED|Overall Study||527
29347|NCT02729038|67217|P4|NOT COMPLETED|Part 2 (Up to 50 Days)||0
29348|NCT02729038|67218|P3|NOT COMPLETED|Part 2 (Up to 50 Days)||0
29349|NCT02729038|67219|P2|NOT COMPLETED|Part 2 (Up to 50 Days)||0
29350|NCT02729038|67220|P1|NOT COMPLETED|Part 2 (Up to 50 Days)||0
29351|NCT02729038|67217|P4|COMPLETED|Part 2 (Up to 50 Days)||8
29352|NCT02729038|67218|P3|COMPLETED|Part 2 (Up to 50 Days)||0
29353|NCT02729038|67219|P2|COMPLETED|Part 2 (Up to 50 Days)||0
29354|NCT02729038|67220|P1|COMPLETED|Part 2 (Up to 50 Days)||0
29355|NCT02729038|67217|P4|STARTED|Part 2 (Up to 50 Days)||8
29356|NCT02729038|67218|P3|STARTED|Part 2 (Up to 50 Days)||0
29357|NCT02729038|67219|P2|STARTED|Part 2 (Up to 50 Days)||0
29358|NCT02729038|67220|P1|STARTED|Part 2 (Up to 50 Days)||0
29359|NCT02729038|67217|P4|NOT COMPLETED|Part 1 (Up to 44 Days)||0
29360|NCT02729038|67218|P3|NOT COMPLETED|Part 1 (Up to 44 Days)||0
29361|NCT02729038|67219|P2|NOT COMPLETED|Part 1 (Up to 44 Days)||0
29362|NCT02729038|67220|P1|NOT COMPLETED|Part 1 (Up to 44 Days)||0
29363|NCT02729038|67217|P4|COMPLETED|Part 1 (Up to 44 Days)||0
29364|NCT02729038|67218|P3|COMPLETED|Part 1 (Up to 44 Days)||8
29365|NCT02729038|67219|P2|COMPLETED|Part 1 (Up to 44 Days)||8
29366|NCT02729038|67220|P1|COMPLETED|Part 1 (Up to 44 Days)||8
29367|NCT02729038|67217|P4|STARTED|Part 1 (Up to 44 Days)||0
29368|NCT02729038|67218|P3|STARTED|Part 1 (Up to 44 Days)||8
29369|NCT02729038|67219|P2|STARTED|Part 1 (Up to 44 Days)||8
29370|NCT02729038|67220|P1|STARTED|Part 1 (Up to 44 Days)||8
29371|NCT02729025|67341|P2|NOT COMPLETED|Overall Study||1
29372|NCT02729025|67342|P1|NOT COMPLETED|Overall Study||0
29373|NCT02729025|67341|P2|COMPLETED|Overall Study||64
29374|NCT02729025|67342|P1|COMPLETED|Overall Study||64
29375|NCT02729025|67341|P2|STARTED|Overall Study||65
29376|NCT02729025|67342|P1|STARTED|Overall Study||64
29377|NCT02728895|67356|P2|NOT COMPLETED|Overall Study||5
29378|NCT02728895|67357|P1|NOT COMPLETED|Overall Study||1
29379|NCT02728895|67356|P2|COMPLETED|Overall Study||16
29380|NCT02728895|67357|P1|COMPLETED|Overall Study||2
29381|NCT02728895|67356|P2|STARTED|Overall Study||21
29382|NCT02728895|67357|P1|STARTED|Overall Study||3
29383|NCT02728206|67377|P1|NOT COMPLETED|Overall Study||1
29384|NCT02728206|67377|P1|COMPLETED|Overall Study||8
29385|NCT02728206|67377|P1|STARTED|Overall Study||9
29386|NCT02728089|67385|P1|NOT COMPLETED|Overall Study||3
29387|NCT02728089|67385|P1|COMPLETED|Overall Study||112
29388|NCT02728089|67385|P1|Treated|Overall Study||114
29389|NCT02728089|67385|P1|STARTED|Overall Study||115
29390|NCT02727894|67402|P2|NOT COMPLETED|Overall Study||0
29391|NCT02727894|67403|P1|NOT COMPLETED|Overall Study||0
29392|NCT02727894|67402|P2|COMPLETED|Overall Study|September 2015|192
29393|NCT02727894|67403|P1|COMPLETED|Overall Study|September 2015|73
29394|NCT02727894|67402|P2|STARTED|Overall Study|March 2013|192
29395|NCT02727894|67403|P1|STARTED|Overall Study|March 2013|73
29396|NCT02727842|67419|P1|NOT COMPLETED|Overall Study||0
29397|NCT02727842|67419|P1|COMPLETED|Overall Study||30
29398|NCT02727842|67419|P1|STARTED|Overall Study||30
29399|NCT02727816|67423|P1|NOT COMPLETED|Overall Study||0
29400|NCT02727816|67423|P1|COMPLETED|Overall Study||35
29401|NCT02727816|67423|P1|STARTED|Overall Study||35
29402|NCT02727660|67473|P3|NOT COMPLETED|Overall Study||165
29403|NCT02727660|67474|P2|NOT COMPLETED|Overall Study||116
29404|NCT02727660|67475|P1|NOT COMPLETED|Overall Study||116
29405|NCT02727660|67473|P3|COMPLETED|Overall Study||442
29406|NCT02727660|67474|P2|COMPLETED|Overall Study||501
29407|NCT02727660|67475|P1|COMPLETED|Overall Study||503
29408|NCT02727660|67473|P3|STARTED|Overall Study||607
29409|NCT02727660|67474|P2|STARTED|Overall Study||617
29410|NCT02727660|67475|P1|STARTED|Overall Study||619
29411|NCT02727322|67494|P2|NOT COMPLETED|Overall Study||1
29412|NCT02727322|67495|P1|NOT COMPLETED|Overall Study||2
29413|NCT02727322|67494|P2|COMPLETED|Overall Study||76
29414|NCT02727322|67495|P1|COMPLETED|Overall Study||75
29415|NCT02727322|67494|P2|STARTED|Overall Study||77
29416|NCT02727322|67495|P1|STARTED|Overall Study||77
29417|NCT02726971|67507|P2|NOT COMPLETED|Overall Study||9
29418|NCT02726971|67508|P1|NOT COMPLETED|Overall Study||11
29419|NCT02726971|67507|P2|COMPLETED|Overall Study||62
29420|NCT02726971|67508|P1|COMPLETED|Overall Study||59
29421|NCT02726971|67507|P2|STARTED|Overall Study||71
29422|NCT02726971|67508|P1|STARTED|Overall Study||70
29423|NCT02726945|67521|P3|NOT COMPLETED|Overall Study||1
29424|NCT02726945|67522|P2|NOT COMPLETED|Overall Study||1
29425|NCT02726945|67523|P1|NOT COMPLETED|Overall Study||0
29426|NCT02726945|67521|P3|COMPLETED|Overall Study||12
29427|NCT02726945|67522|P2|COMPLETED|Overall Study||12
29428|NCT02726945|67523|P1|COMPLETED|Overall Study||13
29429|NCT02726945|67521|P3|STARTED|Overall Study||13
29430|NCT02726945|67522|P2|STARTED|Overall Study||13
29431|NCT02726945|67523|P1|STARTED|Overall Study||13
29432|NCT02726789|67534|P1|NOT COMPLETED|Overall Study||0
29433|NCT02726789|67534|P1|COMPLETED|Overall Study||5
29434|NCT02726789|67534|P1|STARTED|Overall Study||5
29435|NCT02726620|67543|P2|NOT COMPLETED|Through End of Study: All Interventions||0
29436|NCT02726620|67544|P1|NOT COMPLETED|Through End of Study: All Interventions||0
29437|NCT02726620|67543|P2|COMPLETED|Through End of Study: All Interventions||3234
29438|NCT02726620|67544|P1|COMPLETED|Through End of Study: All Interventions||0
29439|NCT02726620|67543|P2|Correct IOH Notifications|Through End of Study: All Interventions||2072
29440|NCT02726620|67544|P1|Correct IOH Notifications|Through End of Study: All Interventions||0
29441|NCT02726620|67543|P2|MAP < 65 mmHg: Primary Analysis|Through End of Study: All Interventions||2793
29442|NCT02726620|67544|P1|MAP < 65 mmHg: Primary Analysis|Through End of Study: All Interventions||0
29443|NCT02726620|67543|P2|STARTED|Through End of Study: All Interventions||3234
29444|NCT02726620|67544|P1|STARTED|Through End of Study: All Interventions||0
29445|NCT02726620|67543|P2|NOT COMPLETED|Months 2-3: In-room Providers Randomized||0
29446|NCT02726620|67544|P1|NOT COMPLETED|Months 2-3: In-room Providers Randomized||0
29447|NCT02726620|67543|P2|COMPLETED|Months 2-3: In-room Providers Randomized||1253
29448|NCT02726620|67544|P1|COMPLETED|Months 2-3: In-room Providers Randomized||0
29449|NCT02726620|67543|P2|Correct IOH Notifications|Months 2-3: In-room Providers Randomized||825
29450|NCT02726620|67544|P1|Correct IOH Notifications|Months 2-3: In-room Providers Randomized||0
29451|NCT02726620|67543|P2|MAP < 65 mmHg: Primary Analysis|Months 2-3: In-room Providers Randomized||1103
29452|NCT02726620|67544|P1|MAP < 65 mmHg: Primary Analysis|Months 2-3: In-room Providers Randomized||0
29453|NCT02726620|67543|P2|STARTED|Months 2-3: In-room Providers Randomized||1253
29454|NCT02726620|67544|P1|STARTED|Months 2-3: In-room Providers Randomized||0
29455|NCT02726620|67543|P2|NOT COMPLETED|Month 1: Attending Randomization||0
29456|NCT02726620|67544|P1|NOT COMPLETED|Month 1: Attending Randomization||0
29457|NCT02726620|67543|P2|COMPLETED|Month 1: Attending Randomization||485
29458|NCT02726620|67544|P1|COMPLETED|Month 1: Attending Randomization||0
29459|NCT02726620|67543|P2|Correct IOH Notifications|Month 1: Attending Randomization||313
29460|NCT02726620|67544|P1|Correct IOH Notifications|Month 1: Attending Randomization||0
29461|NCT02726620|67543|P2|MAP < 65 mmHg: Primary Analysis|Month 1: Attending Randomization||432
29462|NCT02726620|67544|P1|MAP < 65 mmHg: Primary Analysis|Month 1: Attending Randomization||0
29463|NCT02726620|67543|P2|STARTED|Month 1: Attending Randomization||485
29464|NCT02726620|67544|P1|STARTED|Month 1: Attending Randomization||0
29465|NCT02726620|67543|P2|NOT COMPLETED|Historic Cohort - Three Years||0
29466|NCT02726620|67544|P1|NOT COMPLETED|Historic Cohort - Three Years||0
29467|NCT02726620|67543|P2|COMPLETED|Historic Cohort - Three Years||0
29468|NCT02726620|67544|P1|COMPLETED|Historic Cohort - Three Years||17463
29469|NCT02726620|67543|P2|MAP < 65 mmHg: Primary Analysis|Historic Cohort - Three Years||0
29470|NCT02726620|67544|P1|MAP < 65 mmHg: Primary Analysis|Historic Cohort - Three Years||15624
29471|NCT02726620|67543|P2|STARTED|Historic Cohort - Three Years||0
29472|NCT02726620|67544|P1|STARTED|Historic Cohort - Three Years||17463
29473|NCT02726178|67642|P2|NOT COMPLETED|Overall Study||0
29474|NCT02726178|67643|P1|NOT COMPLETED|Overall Study||0
29475|NCT02726178|67642|P2|COMPLETED|Overall Study||28
29476|NCT02726178|67643|P1|COMPLETED|Overall Study||28
29477|NCT02726178|67642|P2|STARTED|Overall Study||28
29478|NCT02726178|67643|P1|STARTED|Overall Study||28
29479|NCT02726022|67651|P1|NOT COMPLETED|Overall Study||36
29480|NCT02726022|67651|P1|COMPLETED|Overall Study||78
29481|NCT02726022|67651|P1|STARTED|Overall Study||114
29482|NCT02725866|67660|P1|NOT COMPLETED|Overall Study||14
29483|NCT02725866|67660|P1|COMPLETED|Overall Study||202
29484|NCT02725866|67660|P1|STARTED|Overall Study||216
29485|NCT02725788|67673|P2|NOT COMPLETED|Overall Study||2
29486|NCT02725788|67674|P1|NOT COMPLETED|Overall Study||1
29487|NCT02725788|67673|P2|COMPLETED|Overall Study||122
29488|NCT02725788|67674|P1|COMPLETED|Overall Study||122
29489|NCT02725788|67673|P2|STARTED|Overall Study||124
29490|NCT02725788|67674|P1|STARTED|Overall Study||123
29491|NCT02725710|67682|P2|NOT COMPLETED|Overall Study||0
29492|NCT02725710|67683|P1|NOT COMPLETED|Overall Study||1
29493|NCT02725710|67682|P2|COMPLETED|Overall Study||47
29494|NCT02725710|67683|P1|COMPLETED|Overall Study||47
29495|NCT02725710|67682|P2|STARTED|Overall Study||47
29496|NCT02725710|67683|P1|STARTED|Overall Study||48
29497|NCT02725645|67711|P1|NOT COMPLETED|Overall Study||0
29498|NCT02725645|67711|P1|COMPLETED|Overall Study||14
29499|NCT02725645|67711|P1|STARTED|Overall Study||14
29500|NCT02725515|67717|P2|NOT COMPLETED|Overall Study||35
29501|NCT02725515|67718|P1|NOT COMPLETED|Overall Study||25
29502|NCT02725515|67717|P2|COMPLETED|Overall Study||17
29503|NCT02725515|67718|P1|COMPLETED|Overall Study||28
29504|NCT02725515|67717|P2|STARTED|Overall Study||52
29505|NCT02725515|67718|P1|STARTED|Overall Study||53
29506|NCT02725476|67730|P2|NOT COMPLETED|Overall Study||1
29507|NCT02725476|67731|P1|NOT COMPLETED|Overall Study||3
29508|NCT02725476|67730|P2|COMPLETED|Overall Study||4
29509|NCT02725476|67731|P1|COMPLETED|Overall Study||12
29510|NCT02725476|67730|P2|STARTED|Overall Study||5
29511|NCT02725476|67731|P1|STARTED|Overall Study||15
29512|NCT02725008|67741|P2|NOT COMPLETED|Overall Study||12
29513|NCT02725008|67742|P1|NOT COMPLETED|Overall Study||9
29514|NCT02725008|67741|P2|COMPLETED|Overall Study||39
29515|NCT02725008|67742|P1|COMPLETED|Overall Study||37
29516|NCT02725008|67741|P2|STARTED|Overall Study||51
29517|NCT02725008|67742|P1|STARTED|Overall Study||46
29518|NCT02724787|67750|P1|NOT COMPLETED|Overall Study||2
29519|NCT02724787|67750|P1|COMPLETED|Overall Study|22 completed treatment. 20 participants returned for post-treatment assessment.|22
29520|NCT02724787|67750|P1|STARTED|Overall Study||24
29521|NCT02724644|67760|P2|NOT COMPLETED|Overall Study||4
29522|NCT02724644|67761|P1|NOT COMPLETED|Overall Study||21
29523|NCT02724644|67760|P2|COMPLETED|Overall Study||182
29524|NCT02724644|67761|P1|COMPLETED|Overall Study||168
29525|NCT02724644|67760|P2|STARTED|Overall Study||186
29526|NCT02724644|67761|P1|STARTED|Overall Study||189
29527|NCT02724449|67789|P1|NOT COMPLETED|Overall Study||0
29528|NCT02724449|67789|P1|COMPLETED|Overall Study||16
29529|NCT02724449|67789|P1|STARTED|Overall Study||16
29530|NCT02724111|67795|P2|NOT COMPLETED|Overall Study||5
29531|NCT02724111|67796|P1|NOT COMPLETED|Overall Study||2
29532|NCT02724111|67795|P2|COMPLETED|Overall Study||40
29533|NCT02724111|67796|P1|COMPLETED|Overall Study||43
29534|NCT02724111|67795|P2|STARTED|Overall Study||45
29535|NCT02724111|67796|P1|STARTED|Overall Study||45
29536|NCT02723786|67816|P1|NOT COMPLETED|Overall Study||1
29537|NCT02723786|67816|P1|COMPLETED|Overall Study||6
29538|NCT02723786|67816|P1|STARTED|Overall Study||7
29539|NCT02723630|67844|P6|NOT COMPLETED|Intervention Period 3||0
29540|NCT02723630|67845|P5|NOT COMPLETED|Intervention Period 3||0
29541|NCT02723630|67846|P4|NOT COMPLETED|Intervention Period 3||0
29542|NCT02723630|67847|P3|NOT COMPLETED|Intervention Period 3||0
29543|NCT02723630|67848|P2|NOT COMPLETED|Intervention Period 3||1
29544|NCT02723630|67849|P1|NOT COMPLETED|Intervention Period 3||0
29545|NCT02723630|67844|P6|COMPLETED|Intervention Period 3||10
29546|NCT02723630|67845|P5|COMPLETED|Intervention Period 3||10
29547|NCT02723630|67846|P4|COMPLETED|Intervention Period 3||10
29548|NCT02723630|67847|P3|COMPLETED|Intervention Period 3||10
29549|NCT02723630|67848|P2|COMPLETED|Intervention Period 3||9
29550|NCT02723630|67849|P1|COMPLETED|Intervention Period 3||9
29551|NCT02723630|67844|P6|STARTED|Intervention Period 3||10
29552|NCT02723630|67845|P5|STARTED|Intervention Period 3||10
29553|NCT02723630|67846|P4|STARTED|Intervention Period 3||10
29554|NCT02723630|67847|P3|STARTED|Intervention Period 3||10
29555|NCT02723630|67848|P2|STARTED|Intervention Period 3||10
29556|NCT02723630|67849|P1|STARTED|Intervention Period 3||9
29557|NCT02723630|67844|P6|NOT COMPLETED|Intervention Period 2||0
29558|NCT02723630|67845|P5|NOT COMPLETED|Intervention Period 2||0
29559|NCT02723630|67846|P4|NOT COMPLETED|Intervention Period 2||0
29560|NCT02723630|67847|P3|NOT COMPLETED|Intervention Period 2||0
29561|NCT02723630|67848|P2|NOT COMPLETED|Intervention Period 2||0
29562|NCT02723630|67849|P1|NOT COMPLETED|Intervention Period 2||0
29563|NCT02723630|67844|P6|COMPLETED|Intervention Period 2||10
29564|NCT02723630|67845|P5|COMPLETED|Intervention Period 2||10
29565|NCT02723630|67846|P4|COMPLETED|Intervention Period 2||10
29566|NCT02723630|67847|P3|COMPLETED|Intervention Period 2||10
29567|NCT02723630|67848|P2|COMPLETED|Intervention Period 2||10
29568|NCT02723630|67849|P1|COMPLETED|Intervention Period 2||9
29569|NCT02723630|67844|P6|STARTED|Intervention Period 2||10
29570|NCT02723630|67845|P5|STARTED|Intervention Period 2||10
29571|NCT02723630|67846|P4|STARTED|Intervention Period 2||10
29572|NCT02723630|67847|P3|STARTED|Intervention Period 2||10
29573|NCT02723630|67848|P2|STARTED|Intervention Period 2||10
29574|NCT02723630|67849|P1|STARTED|Intervention Period 2||9
29575|NCT02723630|67844|P6|NOT COMPLETED|Intervention Period 1||0
29576|NCT02723630|67845|P5|NOT COMPLETED|Intervention Period 1||0
29577|NCT02723630|67846|P4|NOT COMPLETED|Intervention Period 1||0
29578|NCT02723630|67847|P3|NOT COMPLETED|Intervention Period 1||0
29579|NCT02723630|67848|P2|NOT COMPLETED|Intervention Period 1||0
29580|NCT02723630|67849|P1|NOT COMPLETED|Intervention Period 1||1
29581|NCT02723630|67844|P6|COMPLETED|Intervention Period 1||10
29582|NCT02723630|67845|P5|COMPLETED|Intervention Period 1||10
29583|NCT02723630|67846|P4|COMPLETED|Intervention Period 1||10
29584|NCT02723630|67847|P3|COMPLETED|Intervention Period 1||10
29585|NCT02723630|67848|P2|COMPLETED|Intervention Period 1||10
29586|NCT02723630|67849|P1|COMPLETED|Intervention Period 1||9
29587|NCT02723630|67844|P6|STARTED|Intervention Period 1||10
29588|NCT02723630|67845|P5|STARTED|Intervention Period 1||10
29589|NCT02723630|67846|P4|STARTED|Intervention Period 1||10
29590|NCT02723630|67847|P3|STARTED|Intervention Period 1||10
29591|NCT02723630|67848|P2|STARTED|Intervention Period 1||10
29592|NCT02723630|67849|P1|STARTED|Intervention Period 1||10
29593|NCT02723201|67881|P3|NOT COMPLETED|Fourth Intervention Period||0
29594|NCT02723201|67882|P2|NOT COMPLETED|Fourth Intervention Period||0
29595|NCT02723201|67883|P1|NOT COMPLETED|Fourth Intervention Period||0
29596|NCT02723201|67881|P3|COMPLETED|Fourth Intervention Period||0
29597|NCT02723201|67882|P2|COMPLETED|Fourth Intervention Period||0
29598|NCT02723201|67883|P1|COMPLETED|Fourth Intervention Period||9
29599|NCT02723201|67881|P3|STARTED|Fourth Intervention Period||0
29600|NCT02723201|67882|P2|STARTED|Fourth Intervention Period||0
29601|NCT02723201|67883|P1|STARTED|Fourth Intervention Period||9
29602|NCT02723201|67881|P3|NOT COMPLETED|Washout Period 3||0
29603|NCT02723201|67882|P2|NOT COMPLETED|Washout Period 3||0
29604|NCT02723201|67883|P1|NOT COMPLETED|Washout Period 3||0
29605|NCT02723201|67881|P3|COMPLETED|Washout Period 3||0
29606|NCT02723201|67882|P2|COMPLETED|Washout Period 3||0
29607|NCT02723201|67883|P1|COMPLETED|Washout Period 3||9
29608|NCT02723201|67881|P3|STARTED|Washout Period 3||0
29609|NCT02723201|67882|P2|STARTED|Washout Period 3||0
29610|NCT02723201|67883|P1|STARTED|Washout Period 3||9
29611|NCT02723201|67881|P3|NOT COMPLETED|Third Intervention Period||0
29612|NCT02723201|67882|P2|NOT COMPLETED|Third Intervention Period||0
29613|NCT02723201|67883|P1|NOT COMPLETED|Third Intervention Period||0
29614|NCT02723201|67881|P3|COMPLETED|Third Intervention Period||0
29615|NCT02723201|67882|P2|COMPLETED|Third Intervention Period||0
29616|NCT02723201|67883|P1|COMPLETED|Third Intervention Period||9
29617|NCT02723201|67881|P3|STARTED|Third Intervention Period||0
29618|NCT02723201|67882|P2|STARTED|Third Intervention Period||0
29619|NCT02723201|67883|P1|STARTED|Third Intervention Period||9
29620|NCT02723201|67881|P3|NOT COMPLETED|Washout Period 2||0
29621|NCT02723201|67882|P2|NOT COMPLETED|Washout Period 2||0
29622|NCT02723201|67883|P1|NOT COMPLETED|Washout Period 2||0
29623|NCT02723201|67881|P3|COMPLETED|Washout Period 2||0
29624|NCT02723201|67882|P2|COMPLETED|Washout Period 2||0
29625|NCT02723201|67883|P1|COMPLETED|Washout Period 2||9
29626|NCT02723201|67881|P3|STARTED|Washout Period 2||0
29627|NCT02723201|67882|P2|STARTED|Washout Period 2||0
29628|NCT02723201|67883|P1|STARTED|Washout Period 2||9
29629|NCT02723201|67881|P3|NOT COMPLETED|Second Intervention Period||0
29630|NCT02723201|67882|P2|NOT COMPLETED|Second Intervention Period||0
29631|NCT02723201|67883|P1|NOT COMPLETED|Second Intervention Period||2
29632|NCT02723201|67881|P3|COMPLETED|Second Intervention Period||7
29633|NCT02723201|67882|P2|COMPLETED|Second Intervention Period||7
29634|NCT02723201|67883|P1|COMPLETED|Second Intervention Period||9
29635|NCT02723201|67881|P3|STARTED|Second Intervention Period||7
29636|NCT02723201|67882|P2|STARTED|Second Intervention Period||7
29637|NCT02723201|67883|P1|STARTED|Second Intervention Period||11
29638|NCT02723201|67881|P3|NOT COMPLETED|Washout Period 1||0
29639|NCT02723201|67882|P2|NOT COMPLETED|Washout Period 1||0
29640|NCT02723201|67883|P1|NOT COMPLETED|Washout Period 1||0
29641|NCT02723201|67881|P3|COMPLETED|Washout Period 1||7
29642|NCT02723201|67882|P2|COMPLETED|Washout Period 1||7
29643|NCT02723201|67883|P1|COMPLETED|Washout Period 1||11
29644|NCT02723201|67881|P3|STARTED|Washout Period 1||7
29645|NCT02723201|67882|P2|STARTED|Washout Period 1||7
29646|NCT02723201|67883|P1|STARTED|Washout Period 1||11
29647|NCT02723201|67881|P3|NOT COMPLETED|First Intervention Period||0
29648|NCT02723201|67882|P2|NOT COMPLETED|First Intervention Period||0
29649|NCT02723201|67883|P1|NOT COMPLETED|First Intervention Period||0
29650|NCT02723201|67881|P3|COMPLETED|First Intervention Period||7
29651|NCT02723201|67882|P2|COMPLETED|First Intervention Period||7
29652|NCT02723201|67883|P1|COMPLETED|First Intervention Period||11
29653|NCT02723201|67881|P3|STARTED|First Intervention Period||7
29654|NCT02723201|67882|P2|STARTED|First Intervention Period||7
29655|NCT02723201|67883|P1|STARTED|First Intervention Period||11
29656|NCT02723188|67942|P3|NOT COMPLETED|Overall Study||0
29657|NCT02723188|67943|P2|NOT COMPLETED|Overall Study||0
29658|NCT02723188|67944|P1|NOT COMPLETED|Overall Study||1
29659|NCT02723188|67942|P3|COMPLETED|Overall Study||15
29660|NCT02723188|67943|P2|COMPLETED|Overall Study||15
29661|NCT02723188|67944|P1|COMPLETED|Overall Study||14
29662|NCT02723188|67942|P3|STARTED|Overall Study||15
29663|NCT02723188|67943|P2|STARTED|Overall Study||15
29664|NCT02723188|67944|P1|STARTED|Overall Study||15
29665|NCT02723175|67957|P2|NOT COMPLETED|Overall Study||3
29666|NCT02723175|67958|P1|NOT COMPLETED|Overall Study||4
29667|NCT02723175|67957|P2|COMPLETED|Overall Study||4
29668|NCT02723175|67958|P1|COMPLETED|Overall Study||4
29669|NCT02723175|67957|P2|STARTED|Overall Study||7
29670|NCT02723175|67958|P1|STARTED|Overall Study||8
29671|NCT02723084|68000|P2|NOT COMPLETED|Overall Study||1
29672|NCT02723084|68001|P1|NOT COMPLETED|Overall Study||4
29673|NCT02723084|68000|P2|COMPLETED|Overall Study||45
29674|NCT02723084|68001|P1|COMPLETED|Overall Study||86
29675|NCT02723084|68000|P2|STARTED|Overall Study||46
29676|NCT02723084|68001|P1|STARTED|Overall Study||90
29677|NCT02722967|68015|P3|NOT COMPLETED|Overall Study||4
29678|NCT02722967|68016|P2|NOT COMPLETED|Overall Study||2
29679|NCT02722967|68017|P1|NOT COMPLETED|Overall Study||5
29680|NCT02722967|68015|P3|COMPLETED|Overall Study||11
29681|NCT02722967|68016|P2|COMPLETED|Overall Study||10
29682|NCT02722967|68017|P1|COMPLETED|Overall Study||17
29683|NCT02722967|68015|P3|STARTED|Overall Study||15
29684|NCT02722967|68016|P2|STARTED|Overall Study||12
29685|NCT02722967|68017|P1|STARTED|Overall Study||22
29686|NCT02722928|68027|P2|NOT COMPLETED|Overall Study||20
29687|NCT02722928|68028|P1|NOT COMPLETED|Overall Study||10
29688|NCT02722928|68027|P2|COMPLETED|Overall Study||31
29689|NCT02722928|68028|P1|COMPLETED|Overall Study||39
29690|NCT02722928|68027|P2|STARTED|Overall Study||51
29691|NCT02722928|68028|P1|STARTED|Overall Study||49
29692|NCT02722837|68042|P1|NOT COMPLETED|Overall Study||0
29693|NCT02722837|68042|P1|COMPLETED|Overall Study||119
29694|NCT02722837|68042|P1|STARTED|Overall Study||119
29695|NCT02722577|68060|P1|NOT COMPLETED|Overall Study||0
29696|NCT02722577|68060|P1|COMPLETED|Overall Study||20
29697|NCT02722577|68060|P1|STARTED|Overall Study||20
29698|NCT02722564|68064|P1|NOT COMPLETED|Overall Study||0
29699|NCT02722564|68064|P1|COMPLETED|Overall Study||55
29700|NCT02722564|68064|P1|STARTED|Overall Study||55
29701|NCT02722330|68068|P1|NOT COMPLETED|Overall Study||0
29702|NCT02722330|68068|P1|COMPLETED|Overall Study||23
29703|NCT02722330|68068|P1|STARTED|Overall Study||23
29704|NCT02722304|68099|P5|NOT COMPLETED|Overall Study||2
29705|NCT02722304|68100|P4|NOT COMPLETED|Overall Study||2
29706|NCT02722304|68101|P3|NOT COMPLETED|Overall Study||2
29707|NCT02722304|68102|P2|NOT COMPLETED|Overall Study||0
29708|NCT02722304|68103|P1|NOT COMPLETED|Overall Study||1
29709|NCT02722304|68099|P5|COMPLETED|Overall Study||0
29710|NCT02722304|68100|P4|COMPLETED|Overall Study||0
29711|NCT02722304|68101|P3|COMPLETED|Overall Study||0
29712|NCT02722304|68102|P2|COMPLETED|Overall Study||0
29713|NCT02722304|68103|P1|COMPLETED|Overall Study||0
29714|NCT02722304|68099|P5|Treated|Overall Study||2
29715|NCT02722304|68100|P4|Treated|Overall Study||1
29716|NCT02722304|68101|P3|Treated|Overall Study||1
29717|NCT02722304|68102|P2|Treated|Overall Study||0
29718|NCT02722304|68103|P1|Treated|Overall Study||1
29719|NCT02722304|68099|P5|STARTED|Overall Study||2
29720|NCT02722304|68100|P4|STARTED|Overall Study||2
29721|NCT02722304|68101|P3|STARTED|Overall Study||2
29722|NCT02722304|68102|P2|STARTED|Overall Study||0
29723|NCT02722304|68103|P1|STARTED|Overall Study||1
29724|NCT02722278|68139|P2|NOT COMPLETED|Overall Study||7
29725|NCT02722278|68140|P1|NOT COMPLETED|Overall Study||12
29726|NCT02722278|68139|P2|COMPLETED|Overall Study||49
29727|NCT02722278|68140|P1|COMPLETED|Overall Study||154
29728|NCT02722278|68139|P2|STARTED|Overall Study||56
29729|NCT02722278|68140|P1|STARTED|Overall Study||166
29730|NCT02722239|68150|P2|NOT COMPLETED|Overall Study||0
29731|NCT02722239|68151|P1|NOT COMPLETED|Overall Study||0
29732|NCT02722239|68150|P2|COMPLETED|Overall Study||20
29733|NCT02722239|68151|P1|COMPLETED|Overall Study||20
29734|NCT02722239|68150|P2|Second Intervention (1 Day)|Overall Study||20
29735|NCT02722239|68151|P1|Second Intervention (1 Day)|Overall Study||20
29736|NCT02722239|68150|P2|Washout (7 Days)|Overall Study||20
29737|NCT02722239|68151|P1|Washout (7 Days)|Overall Study||20
29738|NCT02722239|68150|P2|First Intervention (1 Day)|Overall Study||20
29739|NCT02722239|68151|P1|First Intervention (1 Day)|Overall Study||20
29740|NCT02722239|68150|P2|STARTED|Overall Study||20
29741|NCT02722239|68151|P1|STARTED|Overall Study||20
29742|NCT02722148|68164|P1|NOT COMPLETED|Overall Study||5
29743|NCT02722148|68164|P1|COMPLETED|Overall Study||19
29744|NCT02722148|68164|P1|STARTED|Overall Study||24
29745|NCT02722044|68171|P1|NOT COMPLETED|Overall Study||5
29746|NCT02722044|68171|P1|COMPLETED|Overall Study||28
29747|NCT02722044|68171|P1|STARTED|Overall Study||33
29748|NCT02721875|68200|P2|NOT COMPLETED|Overall Study||0
29749|NCT02721875|68201|P1|NOT COMPLETED|Overall Study||1
29750|NCT02721875|68200|P2|COMPLETED|Overall Study||0
29751|NCT02721875|68201|P1|COMPLETED|Overall Study||0
29752|NCT02721875|68200|P2|STARTED|Overall Study||0
29753|NCT02721875|68201|P1|STARTED|Overall Study||1
29754|NCT02721641|68214|P1|NOT COMPLETED|Overall Study||0
29755|NCT02721641|68214|P1|COMPLETED|Overall Study|In this continued access study, all participants were considered to have completed per protocol.|69
29756|NCT02721641|68214|P1|STARTED|Overall Study||69
29757|NCT02721277|68220|P1|NOT COMPLETED|Overall Study||0
29758|NCT02721277|68220|P1|COMPLETED|Overall Study||2
29759|NCT02721277|68220|P1|STARTED|Overall Study||2
29760|NCT02721147|68252|P3|NOT COMPLETED|Overall Study||0
29761|NCT02721147|68253|P2|NOT COMPLETED|Overall Study||0
29762|NCT02721147|68254|P1|NOT COMPLETED|Overall Study||2
29763|NCT02721147|68252|P3|COMPLETED|Overall Study||31
29764|NCT02721147|68253|P2|COMPLETED|Overall Study||18
29765|NCT02721147|68254|P1|COMPLETED|Overall Study||38
29766|NCT02721147|68252|P3|STARTED|Overall Study||31
29767|NCT02721147|68253|P2|STARTED|Overall Study||18
29768|NCT02721147|68254|P1|STARTED|Overall Study||40
29769|NCT02720952|68289|P1|NOT COMPLETED|Overall Study||0
29770|NCT02720952|68289|P1|COMPLETED|Overall Study||24
29771|NCT02720952|68289|P1|STARTED|Overall Study||24
29772|NCT02720757|68298|P1|NOT COMPLETED|Overall Study||18
29773|NCT02720757|68298|P1|COMPLETED|Overall Study||114
29774|NCT02720757|68298|P1|STARTED|Overall Study||132
29775|NCT02720523|68311|P7|NOT COMPLETED|Period 2: Long-term Extension Period||60
29776|NCT02720523|68312|P6|NOT COMPLETED|Period 2: Long-term Extension Period||62
29777|NCT02720523|68313|P5|NOT COMPLETED|Period 2: Long-term Extension Period||65
29778|NCT02720523|68314|P4|NOT COMPLETED|Period 2: Long-term Extension Period||0
29779|NCT02720523|68315|P3|NOT COMPLETED|Period 2: Long-term Extension Period||0
29780|NCT02720523|68316|P2|NOT COMPLETED|Period 2: Long-term Extension Period||0
29781|NCT02720523|68317|P1|NOT COMPLETED|Period 2: Long-term Extension Period||0
29782|NCT02720523|68311|P7|COMPLETED|Period 2: Long-term Extension Period||0
29783|NCT02720523|68312|P6|COMPLETED|Period 2: Long-term Extension Period||0
29784|NCT02720523|68313|P5|COMPLETED|Period 2: Long-term Extension Period||0
29785|NCT02720523|68314|P4|COMPLETED|Period 2: Long-term Extension Period||0
29786|NCT02720523|68315|P3|COMPLETED|Period 2: Long-term Extension Period||0
29787|NCT02720523|68316|P2|COMPLETED|Period 2: Long-term Extension Period||0
29788|NCT02720523|68317|P1|COMPLETED|Period 2: Long-term Extension Period||0
29789|NCT02720523|68311|P7|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 30 mg|60
29790|NCT02720523|68312|P6|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 15 mg|62
29791|NCT02720523|68313|P5|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 7.5 mg|65
29792|NCT02720523|68314|P4|STARTED|Period 2: Long-term Extension Period||0
29793|NCT02720523|68315|P3|STARTED|Period 2: Long-term Extension Period||0
29794|NCT02720523|68316|P2|STARTED|Period 2: Long-term Extension Period||0
29795|NCT02720523|68317|P1|STARTED|Period 2: Long-term Extension Period||0
29796|NCT02720523|68311|P7|NOT COMPLETED|Period 1: Placebo-controlled Period||0
29797|NCT02720523|68312|P6|NOT COMPLETED|Period 1: Placebo-controlled Period||0
29798|NCT02720523|68313|P5|NOT COMPLETED|Period 1: Placebo-controlled Period||0
29799|NCT02720523|68314|P4|NOT COMPLETED|Period 1: Placebo-controlled Period||6
29800|NCT02720523|68315|P3|NOT COMPLETED|Period 1: Placebo-controlled Period||2
29801|NCT02720523|68316|P2|NOT COMPLETED|Period 1: Placebo-controlled Period||0
29802|NCT02720523|68317|P1|NOT COMPLETED|Period 1: Placebo-controlled Period||2
29803|NCT02720523|68311|P7|COMPLETED|Period 1: Placebo-controlled Period||0
29804|NCT02720523|68312|P6|COMPLETED|Period 1: Placebo-controlled Period||0
29805|NCT02720523|68313|P5|COMPLETED|Period 1: Placebo-controlled Period||0
29806|NCT02720523|68314|P4|COMPLETED|Period 1: Placebo-controlled Period||44
29807|NCT02720523|68315|P3|COMPLETED|Period 1: Placebo-controlled Period||47
29808|NCT02720523|68316|P2|COMPLETED|Period 1: Placebo-controlled Period||49
29809|NCT02720523|68317|P1|COMPLETED|Period 1: Placebo-controlled Period||47
29810|NCT02720523|68311|P7|STARTED|Period 1: Placebo-controlled Period||0
29811|NCT02720523|68312|P6|STARTED|Period 1: Placebo-controlled Period||0
29812|NCT02720523|68313|P5|STARTED|Period 1: Placebo-controlled Period||0
29813|NCT02720523|68314|P4|STARTED|Period 1: Placebo-controlled Period||50
29814|NCT02720523|68315|P3|STARTED|Period 1: Placebo-controlled Period||49
29815|NCT02720523|68316|P2|STARTED|Period 1: Placebo-controlled Period||49
29816|NCT02720523|68317|P1|STARTED|Period 1: Placebo-controlled Period||49
29817|NCT02720510|68376|P2|NOT COMPLETED|Overall Study||3
29818|NCT02720510|68377|P1|NOT COMPLETED|Overall Study||3
29819|NCT02720510|68376|P2|COMPLETED|Overall Study||0
29820|NCT02720510|68377|P1|COMPLETED|Overall Study||0
29821|NCT02720510|68376|P2|STARTED|Overall Study||3
29822|NCT02720510|68377|P1|STARTED|Overall Study||3
29823|NCT02720484|68395|P1|NOT COMPLETED|Follow Up for 2 Years||6
29824|NCT02720484|68395|P1|COMPLETED|Follow Up for 2 Years||1
29825|NCT02720484|68395|P1|STARTED|Follow Up for 2 Years|All patients that receive at least one treatment on study go into follow up.|7
29826|NCT02720484|68395|P1|NOT COMPLETED|Treatment on Study||6
29827|NCT02720484|68395|P1|COMPLETED|Treatment on Study||4
29828|NCT02720484|68395|P1|Treated Cycle 3|Treatment on Study||4
29829|NCT02720484|68395|P1|Reached 1st Response/2 Cycles|Treatment on Study||7
29830|NCT02720484|68395|P1|STARTED|Treatment on Study||10
29831|NCT02720224|68403|P1|NOT COMPLETED|Overall Study||0
29832|NCT02720224|68403|P1|COMPLETED|Overall Study||6
29833|NCT02720224|68403|P1|STARTED|Overall Study||6
29834|NCT02720198|68427|P2|NOT COMPLETED|Overall Study||1
29835|NCT02720198|68428|P1|NOT COMPLETED|Overall Study||0
29836|NCT02720198|68427|P2|COMPLETED|Overall Study||30
29837|NCT02720198|68428|P1|COMPLETED|Overall Study||29
29838|NCT02720198|68427|P2|STARTED|Overall Study||31
29839|NCT02720198|68428|P1|STARTED|Overall Study||29
29840|NCT02720107|68454|P1|NOT COMPLETED|Overall Study||0
29841|NCT02720107|68454|P1|COMPLETED|Overall Study||130
29842|NCT02720107|68454|P1|STARTED|Overall Study||130
29843|NCT02720081|68463|P2|NOT COMPLETED|Overall Study||4
29844|NCT02720081|68464|P1|NOT COMPLETED|Overall Study||4
29845|NCT02720081|68463|P2|COMPLETED|Overall Study||66
29846|NCT02720081|68464|P1|COMPLETED|Overall Study||68
29847|NCT02720081|68463|P2|Treated|Overall Study||69
29848|NCT02720081|68464|P1|Treated|Overall Study||70
29849|NCT02720081|68463|P2|STARTED|Overall Study||70
29850|NCT02720081|68464|P1|STARTED|Overall Study||72
29851|NCT02719938|68522|P2|NOT COMPLETED|Overall Study||1
29852|NCT02719938|68523|P1|NOT COMPLETED|Overall Study||4
29853|NCT02719938|68522|P2|COMPLETED|Overall Study||31
29854|NCT02719938|68523|P1|COMPLETED|Overall Study||26
29855|NCT02719938|68522|P2|STARTED|Overall Study||32
29856|NCT02719938|68523|P1|STARTED|Overall Study||30
29857|NCT02719743|68546|P5|NOT COMPLETED|Overall Study||2
29858|NCT02719743|68547|P4|NOT COMPLETED|Overall Study||1
29859|NCT02719743|68548|P3|NOT COMPLETED|Overall Study||0
29860|NCT02719743|68549|P2|NOT COMPLETED|Overall Study||3
29861|NCT02719743|68550|P1|NOT COMPLETED|Overall Study||1
29862|NCT02719743|68546|P5|COMPLETED|Overall Study||33
29863|NCT02719743|68547|P4|COMPLETED|Overall Study||36
29864|NCT02719743|68548|P3|COMPLETED|Overall Study||38
29865|NCT02719743|68549|P2|COMPLETED|Overall Study||34
29866|NCT02719743|68550|P1|COMPLETED|Overall Study||37
29867|NCT02719743|68546|P5|STARTED|Overall Study||35
29868|NCT02719743|68547|P4|STARTED|Overall Study||37
29869|NCT02719743|68548|P3|STARTED|Overall Study||38
29870|NCT02719743|68549|P2|STARTED|Overall Study||37
29871|NCT02719743|68550|P1|STARTED|Overall Study||38
29872|NCT02719639|68677|P1|NOT COMPLETED|Overall Study||0
29873|NCT02719639|68677|P1|COMPLETED|Overall Study||7443
29874|NCT02719639|68677|P1|STARTED|Overall Study||7443
29875|NCT02719171|68691|P5|NOT COMPLETED|Overall Study||2
29876|NCT02719171|68692|P4|NOT COMPLETED|Overall Study||2
29877|NCT02719171|68693|P3|NOT COMPLETED|Overall Study||3
29878|NCT02719171|68694|P2|NOT COMPLETED|Overall Study||4
29879|NCT02719171|68695|P1|NOT COMPLETED|Overall Study||1
29880|NCT02719171|68691|P5|COMPLETED|Overall Study||18
29881|NCT02719171|68692|P4|COMPLETED|Overall Study||37
29882|NCT02719171|68693|P3|COMPLETED|Overall Study||39
29883|NCT02719171|68694|P2|COMPLETED|Overall Study||38
29884|NCT02719171|68695|P1|COMPLETED|Overall Study||41
29885|NCT02719171|68691|P5|STARTED|Overall Study||20
29886|NCT02719171|68692|P4|STARTED|Overall Study||39
29887|NCT02719171|68693|P3|STARTED|Overall Study||42
29888|NCT02719171|68694|P2|STARTED|Overall Study||42
29889|NCT02719171|68695|P1|STARTED|Overall Study||42
29890|NCT02718898|68788|P7|NOT COMPLETED|Post Treatment Follow-up Period||5
29891|NCT02718898|68789|P6|NOT COMPLETED|Post Treatment Follow-up Period||11
29892|NCT02718898|68790|P5|NOT COMPLETED|Post Treatment Follow-up Period||1
29893|NCT02718898|68791|P4|NOT COMPLETED|Post Treatment Follow-up Period||0
29894|NCT02718898|68792|P3|NOT COMPLETED|Post Treatment Follow-up Period||0
29895|NCT02718898|68793|P2|NOT COMPLETED|Post Treatment Follow-up Period||0
29896|NCT02718898|68794|P1|NOT COMPLETED|Post Treatment Follow-up Period||0
29897|NCT02718898|68788|P7|COMPLETED|Post Treatment Follow-up Period||44
29898|NCT02718898|68789|P6|COMPLETED|Post Treatment Follow-up Period||67
29899|NCT02718898|68790|P5|COMPLETED|Post Treatment Follow-up Period||0
29900|NCT02718898|68791|P4|COMPLETED|Post Treatment Follow-up Period||0
29901|NCT02718898|68792|P3|COMPLETED|Post Treatment Follow-up Period||0
29902|NCT02718898|68793|P2|COMPLETED|Post Treatment Follow-up Period||0
29903|NCT02718898|68794|P1|COMPLETED|Post Treatment Follow-up Period||0
29904|NCT02718898|68788|P7|STARTED|Post Treatment Follow-up Period||49
29905|NCT02718898|68789|P6|STARTED|Post Treatment Follow-up Period||78
29906|NCT02718898|68790|P5|STARTED|Post Treatment Follow-up Period|One participant who discontinued from placebo blinded treatment had entered post-treatment follow-up|1
29907|NCT02718898|68791|P4|STARTED|Post Treatment Follow-up Period||0
29908|NCT02718898|68792|P3|STARTED|Post Treatment Follow-up Period||0
29909|NCT02718898|68793|P2|STARTED|Post Treatment Follow-up Period||0
29910|NCT02718898|68794|P1|STARTED|Post Treatment Follow-up Period||0
29911|NCT02718898|68788|P7|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
29912|NCT02718898|68789|P6|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
29913|NCT02718898|68790|P5|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
29914|NCT02718898|68791|P4|NOT COMPLETED|Open Label Treatment Period (OLTP)||10
29915|NCT02718898|68792|P3|NOT COMPLETED|Open Label Treatment Period (OLTP)||3
29916|NCT02718898|68793|P2|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
29917|NCT02718898|68794|P1|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
29918|NCT02718898|68788|P7|COMPLETED|Open Label Treatment Period (OLTP)||0
29919|NCT02718898|68789|P6|COMPLETED|Open Label Treatment Period (OLTP)||0
29920|NCT02718898|68790|P5|COMPLETED|Open Label Treatment Period (OLTP)||0
29921|NCT02718898|68791|P4|COMPLETED|Open Label Treatment Period (OLTP)||64
29922|NCT02718898|68792|P3|COMPLETED|Open Label Treatment Period (OLTP)||62
29923|NCT02718898|68793|P2|COMPLETED|Open Label Treatment Period (OLTP)||0
29924|NCT02718898|68794|P1|COMPLETED|Open Label Treatment Period (OLTP)||0
29925|NCT02718898|68788|P7|STARTED|Open Label Treatment Period (OLTP)||0
29926|NCT02718898|68789|P6|STARTED|Open Label Treatment Period (OLTP)||0
29927|NCT02718898|68790|P5|STARTED|Open Label Treatment Period (OLTP)||0
29928|NCT02718898|68791|P4|STARTED|Open Label Treatment Period (OLTP)||74
29929|NCT02718898|68792|P3|STARTED|Open Label Treatment Period (OLTP)||65
29930|NCT02718898|68793|P2|STARTED|Open Label Treatment Period (OLTP)||0
29931|NCT02718898|68794|P1|STARTED|Open Label Treatment Period (OLTP)||0
29932|NCT02718898|68788|P7|NOT COMPLETED|Blinded Treatment Period||0
29933|NCT02718898|68789|P6|NOT COMPLETED|Blinded Treatment Period||0
29934|NCT02718898|68790|P5|NOT COMPLETED|Blinded Treatment Period||0
29935|NCT02718898|68791|P4|NOT COMPLETED|Blinded Treatment Period||0
29936|NCT02718898|68792|P3|NOT COMPLETED|Blinded Treatment Period||0
29937|NCT02718898|68793|P2|NOT COMPLETED|Blinded Treatment Period||1
29938|NCT02718898|68794|P1|NOT COMPLETED|Blinded Treatment Period||9
29939|NCT02718898|68788|P7|COMPLETED|Blinded Treatment Period||0
29940|NCT02718898|68789|P6|COMPLETED|Blinded Treatment Period||0
29941|NCT02718898|68790|P5|COMPLETED|Blinded Treatment Period||0
29942|NCT02718898|68791|P4|COMPLETED|Blinded Treatment Period||0
29943|NCT02718898|68792|P3|COMPLETED|Blinded Treatment Period||0
29944|NCT02718898|68793|P2|COMPLETED|Blinded Treatment Period||74
29945|NCT02718898|68794|P1|COMPLETED|Blinded Treatment Period||65
29946|NCT02718898|68788|P7|STARTED|Blinded Treatment Period||0
29947|NCT02718898|68789|P6|STARTED|Blinded Treatment Period||0
29948|NCT02718898|68790|P5|STARTED|Blinded Treatment Period||0
29949|NCT02718898|68791|P4|STARTED|Blinded Treatment Period||0
29950|NCT02718898|68792|P3|STARTED|Blinded Treatment Period||0
29951|NCT02718898|68793|P2|STARTED|Blinded Treatment Period||75
29952|NCT02718898|68794|P1|STARTED|Blinded Treatment Period||74
29953|NCT02718326|68830|P3|NOT COMPLETED|Overall Study||10
29954|NCT02718326|68831|P2|NOT COMPLETED|Overall Study||13
29955|NCT02718326|68832|P1|NOT COMPLETED|Overall Study||24
29956|NCT02718326|68830|P3|COMPLETED|Overall Study||124
29957|NCT02718326|68831|P2|COMPLETED|Overall Study||122
29958|NCT02718326|68832|P1|COMPLETED|Overall Study||109
29959|NCT02718326|68830|P3|STARTED|Overall Study||134
29960|NCT02718326|68831|P2|STARTED|Overall Study||135
29961|NCT02718326|68832|P1|STARTED|Overall Study||133
29962|NCT02718248|68863|P1|NOT COMPLETED|Overall Study||0
29963|NCT02718248|68863|P1|COMPLETED|Overall Study||7
29964|NCT02718248|68863|P1|STARTED|Overall Study||7
29965|NCT02718157|68879|P1|NOT COMPLETED|Overall Study||162
29966|NCT02718157|68879|P1|COMPLETED|Overall Study||609
29967|NCT02718157|68879|P1|STARTED|Overall Study||771
29968|NCT02718118|68888|P2|NOT COMPLETED|Overall Study||1
29969|NCT02718118|68889|P1|NOT COMPLETED|Overall Study||2
29970|NCT02718118|68888|P2|COMPLETED|Overall Study||29
29971|NCT02718118|68889|P1|COMPLETED|Overall Study||28
29972|NCT02718118|68888|P2|STARTED|Overall Study||30
29973|NCT02718118|68889|P1|STARTED|Overall Study||30
29974|NCT02718040|68923|P1|NOT COMPLETED|Overall Study||0
29975|NCT02718040|68923|P1|COMPLETED|Overall Study||30
29976|NCT02718040|68923|P1|STARTED|Overall Study||30
29977|NCT02717949|68938|P2|NOT COMPLETED|Overall Study||0
29978|NCT02717949|68939|P1|NOT COMPLETED|Overall Study||0
29979|NCT02717949|68938|P2|COMPLETED|Overall Study||0
29980|NCT02717949|68939|P1|COMPLETED|Overall Study||0
29981|NCT02717949|68938|P2|STARTED|Overall Study||0
29982|NCT02717949|68939|P1|STARTED|Overall Study||0
29983|NCT02717754|68953|P6|NOT COMPLETED|Overall Study||20
29984|NCT02717754|68954|P5|NOT COMPLETED|Overall Study||20
29985|NCT02717754|68955|P4|NOT COMPLETED|Overall Study||10
29986|NCT02717754|68956|P3|NOT COMPLETED|Overall Study||0
29987|NCT02717754|68957|P2|NOT COMPLETED|Overall Study||0
29988|NCT02717754|68958|P1|NOT COMPLETED|Overall Study||0
29989|NCT02717754|68953|P6|COMPLETED|Overall Study||0
29990|NCT02717754|68954|P5|COMPLETED|Overall Study||0
29991|NCT02717754|68955|P4|COMPLETED|Overall Study||0
29992|NCT02717754|68956|P3|COMPLETED|Overall Study||20
29993|NCT02717754|68957|P2|COMPLETED|Overall Study||19
29994|NCT02717754|68958|P1|COMPLETED|Overall Study||10
29995|NCT02717754|68953|P6|STARTED|Overall Study||20
29996|NCT02717754|68954|P5|STARTED|Overall Study||20
29997|NCT02717754|68955|P4|STARTED|Overall Study||10
29998|NCT02717754|68956|P3|STARTED|Overall Study||20
29999|NCT02717754|68957|P2|STARTED|Overall Study||19
30000|NCT02717754|68958|P1|STARTED|Overall Study||10
30001|NCT02717273|68988|P2|NOT COMPLETED|Overall Study||2
30002|NCT02717273|68989|P1|NOT COMPLETED|Overall Study||3
30003|NCT02717273|68988|P2|COMPLETED|Overall Study||48
30004|NCT02717273|68989|P1|COMPLETED|Overall Study||49
30005|NCT02717273|68988|P2|STARTED|Overall Study||50
30006|NCT02717273|68989|P1|STARTED|Overall Study||52
30007|NCT02717195|69011|P5|NOT COMPLETED|Double-blind Treatment (DBT) Period||30
30008|NCT02717195|69012|P4|NOT COMPLETED|Double-blind Treatment (DBT) Period||44
30009|NCT02717195|69013|P3|NOT COMPLETED|Double-blind Treatment (DBT) Period||37
30010|NCT02717195|69014|P2|NOT COMPLETED|Double-blind Treatment (DBT) Period||0
30011|NCT02717195|69015|P1|NOT COMPLETED|Double-blind Treatment (DBT) Period||0
30012|NCT02717195|69011|P5|COMPLETED|Double-blind Treatment (DBT) Period||200
30013|NCT02717195|69012|P4|COMPLETED|Double-blind Treatment (DBT) Period||188
30014|NCT02717195|69013|P3|COMPLETED|Double-blind Treatment (DBT) Period||198
30015|NCT02717195|69014|P2|COMPLETED|Double-blind Treatment (DBT) Period||0
30016|NCT02717195|69015|P1|COMPLETED|Double-blind Treatment (DBT) Period||0
30017|NCT02717195|69011|P5|STARTED|Double-blind Treatment (DBT) Period||230
30018|NCT02717195|69012|P4|STARTED|Double-blind Treatment (DBT) Period||232
30019|NCT02717195|69013|P3|STARTED|Double-blind Treatment (DBT) Period||235
30020|NCT02717195|69014|P2|STARTED|Double-blind Treatment (DBT) Period||0
30021|NCT02717195|69015|P1|STARTED|Double-blind Treatment (DBT) Period||0
30022|NCT02717195|69011|P5|NOT COMPLETED|Prospective Confirmation (PC) Period||0
30023|NCT02717195|69012|P4|NOT COMPLETED|Prospective Confirmation (PC) Period||0
30024|NCT02717195|69013|P3|NOT COMPLETED|Prospective Confirmation (PC) Period||0
30025|NCT02717195|69014|P2|NOT COMPLETED|Prospective Confirmation (PC) Period||111
30026|NCT02717195|69015|P1|NOT COMPLETED|Prospective Confirmation (PC) Period||290
30027|NCT02717195|69011|P5|COMPLETED|Prospective Confirmation (PC) Period||0
30028|NCT02717195|69012|P4|COMPLETED|Prospective Confirmation (PC) Period||0
30029|NCT02717195|69013|P3|COMPLETED|Prospective Confirmation (PC) Period||0
30030|NCT02717195|69014|P2|COMPLETED|Prospective Confirmation (PC) Period||276
30031|NCT02717195|69015|P1|COMPLETED|Prospective Confirmation (PC) Period||421
30032|NCT02717195|69011|P5|STARTED|Prospective Confirmation (PC) Period||0
30033|NCT02717195|69012|P4|STARTED|Prospective Confirmation (PC) Period||0
30034|NCT02717195|69013|P3|STARTED|Prospective Confirmation (PC) Period||0
30035|NCT02717195|69014|P2|STARTED|Prospective Confirmation (PC) Period||387
30036|NCT02717195|69015|P1|STARTED|Prospective Confirmation (PC) Period||711
30037|NCT02716896|69048|P2|NOT COMPLETED|Overall Study||1
30038|NCT02716896|69049|P1|NOT COMPLETED|Overall Study||0
30039|NCT02716896|69048|P2|COMPLETED|Overall Study||0
30040|NCT02716896|69049|P1|COMPLETED|Overall Study||1
30041|NCT02716896|69048|P2|STARTED|Overall Study||1
30042|NCT02716896|69049|P1|STARTED|Overall Study||1
30043|NCT02716818|69069|P2|NOT COMPLETED|Overall Study||2
30044|NCT02716818|69070|P1|NOT COMPLETED|Overall Study||3
30045|NCT02716818|69069|P2|COMPLETED|Overall Study||59
30046|NCT02716818|69070|P1|COMPLETED|Overall Study||58
30047|NCT02716818|69069|P2|STARTED|Overall Study||61
30048|NCT02716818|69070|P1|STARTED|Overall Study||61
30049|NCT02716805|69100|P4|NOT COMPLETED|Overall Study||0
30050|NCT02716805|69101|P3|NOT COMPLETED|Overall Study||0
30051|NCT02716805|69102|P2|NOT COMPLETED|Overall Study||0
30052|NCT02716805|69103|P1|NOT COMPLETED|Overall Study||2
30053|NCT02716805|69100|P4|COMPLETED|Overall Study||0
30054|NCT02716805|69101|P3|COMPLETED|Overall Study||0
30055|NCT02716805|69102|P2|COMPLETED|Overall Study||0
30056|NCT02716805|69103|P1|COMPLETED|Overall Study||4
30057|NCT02716805|69100|P4|STARTED|Overall Study||0
30058|NCT02716805|69101|P3|STARTED|Overall Study||0
30059|NCT02716805|69102|P2|STARTED|Overall Study||0
30060|NCT02716805|69103|P1|STARTED|Overall Study||6
30061|NCT02716779|69111|P3|NOT COMPLETED|Combination Therapy||1
30062|NCT02716779|69112|P2|NOT COMPLETED|Combination Therapy||2
30063|NCT02716779|69113|P1|NOT COMPLETED|Combination Therapy||0
30064|NCT02716779|69111|P3|COMPLETED|Combination Therapy||25
30065|NCT02716779|69112|P2|COMPLETED|Combination Therapy||23
30066|NCT02716779|69113|P1|COMPLETED|Combination Therapy||14
30067|NCT02716779|69111|P3|STARTED|Combination Therapy||26
30068|NCT02716779|69112|P2|STARTED|Combination Therapy||25
30069|NCT02716779|69113|P1|STARTED|Combination Therapy||14
30070|NCT02716779|69111|P3|NOT COMPLETED|Monotherapy||1
30071|NCT02716779|69112|P2|NOT COMPLETED|Monotherapy||1
30072|NCT02716779|69113|P1|NOT COMPLETED|Monotherapy||0
30073|NCT02716779|69111|P3|COMPLETED|Monotherapy||26
30074|NCT02716779|69112|P2|COMPLETED|Monotherapy||25
30075|NCT02716779|69113|P1|COMPLETED|Monotherapy||14
30076|NCT02716779|69111|P3|STARTED|Monotherapy||27
30077|NCT02716779|69112|P2|STARTED|Monotherapy||26
30078|NCT02716779|69113|P1|STARTED|Monotherapy||14
30079|NCT02716714|69159|P2|NOT COMPLETED|Overall Study||2
30080|NCT02716714|69160|P1|NOT COMPLETED|Overall Study||12
30081|NCT02716714|69159|P2|COMPLETED|Overall Study||8
30082|NCT02716714|69160|P1|COMPLETED|Overall Study||55
30083|NCT02716714|69159|P2|STARTED|Overall Study||10
30084|NCT02716714|69160|P1|STARTED|Overall Study||67
30085|NCT02716584|69188|P2|NOT COMPLETED|Overall Study||5
30086|NCT02716584|69189|P1|NOT COMPLETED|Overall Study||8
30087|NCT02716584|69188|P2|COMPLETED|Overall Study||13
30088|NCT02716584|69189|P1|COMPLETED|Overall Study||27
30089|NCT02716584|69188|P2|STARTED|Overall Study||18
30090|NCT02716584|69189|P1|STARTED|Overall Study||35
30091|NCT02716506|69213|P1|NOT COMPLETED|Overall Study||1164
30092|NCT02716506|69213|P1|COMPLETED|Overall Study||2351
30093|NCT02716506|69213|P1|2 Years|Overall Study|Patients that completed the questionnaires two years after the operation.|2351
30094|NCT02716506|69213|P1|6 Months|Overall Study|Patients that completed the questionnaires six months after the operation.|2528
30095|NCT02716506|69213|P1|STARTED|Overall Study||3515
30096|NCT02716324|69220|P2|NOT COMPLETED|Overall Study||11
30097|NCT02716324|69221|P1|NOT COMPLETED|Overall Study||19
30098|NCT02716324|69220|P2|COMPLETED|Overall Study||143
30099|NCT02716324|69221|P1|COMPLETED|Overall Study||130
30100|NCT02716324|69220|P2|STARTED|Overall Study||154
30101|NCT02716324|69221|P1|STARTED|Overall Study||149
30102|NCT02716298|69245|P2|NOT COMPLETED|Second Intervention (1 Month)||0
30103|NCT02716298|69246|P1|NOT COMPLETED|Second Intervention (1 Month)||0
30104|NCT02716298|69245|P2|COMPLETED|Second Intervention (1 Month)||23
30105|NCT02716298|69246|P1|COMPLETED|Second Intervention (1 Month)||24
30106|NCT02716298|69245|P2|STARTED|Second Intervention (1 Month)||23
30107|NCT02716298|69246|P1|STARTED|Second Intervention (1 Month)||24
30108|NCT02716298|69245|P2|NOT COMPLETED|First Intervention (1 Month)||1
30109|NCT02716298|69246|P1|NOT COMPLETED|First Intervention (1 Month)||1
30110|NCT02716298|69245|P2|COMPLETED|First Intervention (1 Month)||23
30111|NCT02716298|69246|P1|COMPLETED|First Intervention (1 Month)||24
30112|NCT02716298|69245|P2|STARTED|First Intervention (1 Month)||24
30113|NCT02716298|69246|P1|STARTED|First Intervention (1 Month)||25
30114|NCT02716194|69264|P3|NOT COMPLETED|Period 2 - BAX 826||0
30115|NCT02716194|69265|P2|NOT COMPLETED|Period 2 - BAX 826||0
30116|NCT02716194|69266|P1|NOT COMPLETED|Period 2 - BAX 826||0
30117|NCT02716194|69264|P3|COMPLETED|Period 2 - BAX 826||13
30118|NCT02716194|69265|P2|COMPLETED|Period 2 - BAX 826||15
30119|NCT02716194|69266|P1|COMPLETED|Period 2 - BAX 826||10
30120|NCT02716194|69264|P3|STARTED|Period 2 - BAX 826||13
30121|NCT02716194|69265|P2|STARTED|Period 2 - BAX 826||15
30122|NCT02716194|69266|P1|STARTED|Period 2 - BAX 826||10
30123|NCT02716194|69264|P3|NOT COMPLETED|Period 1 - ADVATE||0
30124|NCT02716194|69265|P2|NOT COMPLETED|Period 1 - ADVATE||1
30125|NCT02716194|69266|P1|NOT COMPLETED|Period 1 - ADVATE||1
30126|NCT02716194|69264|P3|COMPLETED|Period 1 - ADVATE||13
30127|NCT02716194|69265|P2|COMPLETED|Period 1 - ADVATE||15
30128|NCT02716194|69266|P1|COMPLETED|Period 1 - ADVATE||10
30129|NCT02716194|69264|P3|STARTED|Period 1 - ADVATE||13
30130|NCT02716194|69265|P2|STARTED|Period 1 - ADVATE||16
30131|NCT02716194|69266|P1|STARTED|Period 1 - ADVATE||11
30132|NCT02715726|69346|P2|NOT COMPLETED|Overall Study||27
30133|NCT02715726|69347|P1|NOT COMPLETED|Overall Study||18
30134|NCT02715726|69346|P2|COMPLETED|Overall Study||380
30135|NCT02715726|69347|P1|COMPLETED|Overall Study||190
30136|NCT02715726|69346|P2|Safety Population|Overall Study||406
30137|NCT02715726|69347|P1|Safety Population|Overall Study||206
30138|NCT02715726|69346|P2|Treated|Overall Study||405
30139|NCT02715726|69347|P1|Treated|Overall Study||207
30140|NCT02715726|69346|P2|STARTED|Overall Study|Randomized|407
30141|NCT02715726|69347|P1|STARTED|Overall Study|Randomized|208
30142|NCT02715700|69395|P1|NOT COMPLETED|Overall Study||0
30143|NCT02715700|69395|P1|COMPLETED|Overall Study||14
30144|NCT02715700|69395|P1|STARTED|Overall Study||14
30145|NCT02714868|69427|P2|NOT COMPLETED|Overall Study||0
30146|NCT02714868|69428|P1|NOT COMPLETED|Overall Study||5
30147|NCT02714868|69427|P2|COMPLETED|Overall Study||35
30148|NCT02714868|69428|P1|COMPLETED|Overall Study||42
30149|NCT02714868|69427|P2|STARTED|Overall Study||35
30150|NCT02714868|69428|P1|STARTED|Overall Study||47
30151|NCT02714504|69446|P2|NOT COMPLETED|Overall Study||0
30152|NCT02714504|69447|P1|NOT COMPLETED|Overall Study||0
30153|NCT02714504|69446|P2|COMPLETED|Overall Study||178
30154|NCT02714504|69447|P1|COMPLETED|Overall Study||61
30155|NCT02714504|69446|P2|STARTED|Overall Study||178
30156|NCT02714504|69447|P1|STARTED|Overall Study||61
30157|NCT02714426|69455|P2|NOT COMPLETED|Overall Study||2
30158|NCT02714426|69456|P1|NOT COMPLETED|Overall Study||2
30159|NCT02714426|69455|P2|COMPLETED|Overall Study||19
30160|NCT02714426|69456|P1|COMPLETED|Overall Study||19
30161|NCT02714426|69455|P2|STARTED|Overall Study||21
30162|NCT02714426|69456|P1|STARTED|Overall Study||21
30163|NCT02714283|69474|P2|NOT COMPLETED|Overall Study||0
30164|NCT02714283|69475|P1|NOT COMPLETED|Overall Study||0
30165|NCT02714283|69474|P2|COMPLETED|Overall Study||6500
30166|NCT02714283|69475|P1|COMPLETED|Overall Study||83589
30167|NCT02714283|69474|P2|STARTED|Overall Study||6500
30168|NCT02714283|69475|P1|STARTED|Overall Study||83589
30169|NCT02714218|69502|P3|NOT COMPLETED|Overall Study||19
30170|NCT02714218|69503|P2|NOT COMPLETED|Overall Study||143
30171|NCT02714218|69504|P1|NOT COMPLETED|Overall Study||130
30172|NCT02714218|69502|P3|COMPLETED|Overall Study||8
30173|NCT02714218|69503|P2|COMPLETED|Overall Study||35
30174|NCT02714218|69504|P1|COMPLETED|Overall Study||50
30175|NCT02714218|69502|P3|STARTED|Overall Study||27
30176|NCT02714218|69503|P2|STARTED|Overall Study||178
30177|NCT02714218|69504|P1|STARTED|Overall Study||180
30178|NCT02714062|69554|P3|NOT COMPLETED|Overall Study||3
30179|NCT02714062|69555|P2|NOT COMPLETED|Overall Study||1
30180|NCT02714062|69556|P1|NOT COMPLETED|Overall Study||1
30181|NCT02714062|69554|P3|COMPLETED|Overall Study||10
30182|NCT02714062|69555|P2|COMPLETED|Overall Study||14
30183|NCT02714062|69556|P1|COMPLETED|Overall Study||13
30184|NCT02714062|69554|P3|STARTED|Overall Study||13
30185|NCT02714062|69555|P2|STARTED|Overall Study||15
30186|NCT02714062|69556|P1|STARTED|Overall Study||14
30187|NCT02713828|69602|P2|NOT COMPLETED|Overall Study||0
30188|NCT02713828|69603|P1|NOT COMPLETED|Overall Study||5
30189|NCT02713828|69602|P2|COMPLETED|Overall Study||0
30190|NCT02713828|69603|P1|COMPLETED|Overall Study||8
30191|NCT02713828|69602|P2|STARTED|Overall Study||0
30192|NCT02713828|69603|P1|STARTED|Overall Study||13
30193|NCT02713789|69615|P3|NOT COMPLETED|Overall Study||1
30194|NCT02713789|69616|P2|NOT COMPLETED|Overall Study||1
30195|NCT02713789|69617|P1|NOT COMPLETED|Overall Study||0
30196|NCT02713789|69615|P3|COMPLETED|Overall Study||7
30197|NCT02713789|69616|P2|COMPLETED|Overall Study||9
30198|NCT02713789|69617|P1|COMPLETED|Overall Study||8
30199|NCT02713789|69615|P3|STARTED|Overall Study||8
30200|NCT02713789|69616|P2|STARTED|Overall Study||10
30201|NCT02713789|69617|P1|STARTED|Overall Study||8
30202|NCT02713698|69655|P3|NOT COMPLETED|Overall Study||0
30203|NCT02713698|69656|P2|NOT COMPLETED|Overall Study||0
30204|NCT02713698|69657|P1|NOT COMPLETED|Overall Study||0
30205|NCT02713698|69655|P3|COMPLETED|Overall Study||20
30206|NCT02713698|69656|P2|COMPLETED|Overall Study||20
30207|NCT02713698|69657|P1|COMPLETED|Overall Study||20
30208|NCT02713698|69655|P3|STARTED|Overall Study||20
30209|NCT02713698|69656|P2|STARTED|Overall Study||20
30210|NCT02713698|69657|P1|STARTED|Overall Study||20
30211|NCT02713659|69667|P2|NOT COMPLETED|24 Month Study Visit||8
30212|NCT02713659|69668|P1|NOT COMPLETED|24 Month Study Visit||8
30213|NCT02713659|69667|P2|COMPLETED|24 Month Study Visit||44
30214|NCT02713659|69668|P1|COMPLETED|24 Month Study Visit||49
30215|NCT02713659|69667|P2|STARTED|24 Month Study Visit||52
30216|NCT02713659|69668|P1|STARTED|24 Month Study Visit||57
30217|NCT02713659|69667|P2|NOT COMPLETED|18 Month Study Visit||3
30218|NCT02713659|69668|P1|NOT COMPLETED|18 Month Study Visit||8
30219|NCT02713659|69667|P2|COMPLETED|18 Month Study Visit||50
30220|NCT02713659|69668|P1|COMPLETED|18 Month Study Visit||50
30221|NCT02713659|69667|P2|STARTED|18 Month Study Visit||53
30222|NCT02713659|69668|P1|STARTED|18 Month Study Visit||58
30223|NCT02713659|69667|P2|NOT COMPLETED|12 Month Study Visit||3
30224|NCT02713659|69668|P1|NOT COMPLETED|12 Month Study Visit||3
30225|NCT02713659|69667|P2|COMPLETED|12 Month Study Visit||52
30226|NCT02713659|69668|P1|COMPLETED|12 Month Study Visit||54
30227|NCT02713659|69667|P2|STARTED|12 Month Study Visit||55
30228|NCT02713659|69668|P1|STARTED|12 Month Study Visit||57
30229|NCT02713659|69667|P2|NOT COMPLETED|6 Month Study Visit||13
30230|NCT02713659|69668|P1|NOT COMPLETED|6 Month Study Visit||7
30231|NCT02713659|69667|P2|COMPLETED|6 Month Study Visit||47
30232|NCT02713659|69668|P1|COMPLETED|6 Month Study Visit||53
30233|NCT02713659|69667|P2|STARTED|6 Month Study Visit||60
30234|NCT02713659|69668|P1|STARTED|6 Month Study Visit||60
30235|NCT02713659|69667|P2|NOT COMPLETED|Baseline||0
30236|NCT02713659|69668|P1|NOT COMPLETED|Baseline||0
30237|NCT02713659|69667|P2|COMPLETED|Baseline||60
30238|NCT02713659|69668|P1|COMPLETED|Baseline||60
30239|NCT02713659|69667|P2|STARTED|Baseline||60
30240|NCT02713659|69668|P1|STARTED|Baseline||60
30241|NCT02713594|69680|P2|NOT COMPLETED|Overall Study||396
30242|NCT02713594|69681|P1|NOT COMPLETED|Overall Study||390
30243|NCT02713594|69680|P2|COMPLETED|Overall Study||552
30244|NCT02713594|69681|P1|COMPLETED|Overall Study||562
30245|NCT02713594|69680|P2|STARTED|Overall Study||948
30246|NCT02713594|69681|P1|STARTED|Overall Study||952
30247|NCT02713542|69693|P2|NOT COMPLETED|Overall Study||6
30248|NCT02713542|69694|P1|NOT COMPLETED|Overall Study||18
30249|NCT02713542|69693|P2|COMPLETED|Overall Study||24
30250|NCT02713542|69694|P1|COMPLETED|Overall Study||42
30251|NCT02713542|69693|P2|STARTED|Overall Study||30
30252|NCT02713542|69694|P1|STARTED|Overall Study||60
30253|NCT02713425|69700|P1|NOT COMPLETED|Overall Study||0
30254|NCT02713425|69700|P1|COMPLETED|Overall Study||20
30255|NCT02713425|69700|P1|STARTED|Overall Study||20
30256|NCT02713256|69705|P1|NOT COMPLETED|Overall Study||0
30257|NCT02713256|69705|P1|COMPLETED|Overall Study||15
30258|NCT02713256|69705|P1|STARTED|Overall Study||15
30259|NCT02713243|69713|P2|NOT COMPLETED|Overall Study||2
30260|NCT02713243|69714|P1|NOT COMPLETED|Overall Study||1
30261|NCT02713243|69713|P2|COMPLETED|Overall Study||8
30262|NCT02713243|69714|P1|COMPLETED|Overall Study||9
30263|NCT02713243|69713|P2|PK Analysis Set|Overall Study||9
30264|NCT02713243|69714|P1|PK Analysis Set|Overall Study||8
30265|NCT02713243|69713|P2|PD Analysis Set|Overall Study||10
30266|NCT02713243|69714|P1|PD Analysis Set|Overall Study||9
30267|NCT02713243|69713|P2|STARTED|Overall Study||10
30268|NCT02713243|69714|P1|STARTED|Overall Study||10
30269|NCT02713204|69732|P8|NOT COMPLETED|From Week 12 up to Week 36||4
30270|NCT02713204|69733|P7|NOT COMPLETED|From Week 12 up to Week 36||2
30271|NCT02713204|69734|P6|NOT COMPLETED|From Week 12 up to Week 36||1
30272|NCT02713204|69735|P5|NOT COMPLETED|From Week 12 up to Week 36||2
30273|NCT02713204|69736|P4|NOT COMPLETED|From Week 12 up to Week 36||4
30274|NCT02713204|69737|P3|NOT COMPLETED|From Week 12 up to Week 36||0
30275|NCT02713204|69738|P2|NOT COMPLETED|From Week 12 up to Week 36||0
30276|NCT02713204|69739|P1|NOT COMPLETED|From Week 12 up to Week 36||1
30277|NCT02713204|69732|P8|COMPLETED|From Week 12 up to Week 36||54
30278|NCT02713204|69733|P7|COMPLETED|From Week 12 up to Week 36||60
30279|NCT02713204|69734|P6|COMPLETED|From Week 12 up to Week 36||59
30280|NCT02713204|69735|P5|COMPLETED|From Week 12 up to Week 36||60
30281|NCT02713204|69736|P4|COMPLETED|From Week 12 up to Week 36||53
30282|NCT02713204|69737|P3|COMPLETED|From Week 12 up to Week 36||0
30283|NCT02713204|69738|P2|COMPLETED|From Week 12 up to Week 36||0
30284|NCT02713204|69739|P1|COMPLETED|From Week 12 up to Week 36||57
30285|NCT02713204|69732|P8|STARTED|From Week 12 up to Week 36||58
30286|NCT02713204|69733|P7|STARTED|From Week 12 up to Week 36||62
30287|NCT02713204|69734|P6|STARTED|From Week 12 up to Week 36||60
30288|NCT02713204|69735|P5|STARTED|From Week 12 up to Week 36||62
30289|NCT02713204|69736|P4|STARTED|From Week 12 up to Week 36||57
30290|NCT02713204|69737|P3|STARTED|From Week 12 up to Week 36||0
30291|NCT02713204|69738|P2|STARTED|From Week 12 up to Week 36||0
30292|NCT02713204|69739|P1|STARTED|From Week 12 up to Week 36||58
30293|NCT02713204|69732|P8|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
30294|NCT02713204|69733|P7|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
30295|NCT02713204|69734|P6|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
30296|NCT02713204|69735|P5|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
30297|NCT02713204|69736|P4|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
30298|NCT02713204|69737|P3|NOT COMPLETED|Baseline (Day 1) up to Week 12||2
30299|NCT02713204|69738|P2|NOT COMPLETED|Baseline (Day 1) up to Week 12||1
30300|NCT02713204|69739|P1|NOT COMPLETED|Baseline (Day 1) up to Week 12||1
30301|NCT02713204|69732|P8|COMPLETED|Baseline (Day 1) up to Week 12||0
30302|NCT02713204|69733|P7|COMPLETED|Baseline (Day 1) up to Week 12||0
30303|NCT02713204|69734|P6|COMPLETED|Baseline (Day 1) up to Week 12||0
30304|NCT02713204|69735|P5|COMPLETED|Baseline (Day 1) up to Week 12||0
30305|NCT02713204|69736|P4|COMPLETED|Baseline (Day 1) up to Week 12||0
30306|NCT02713204|69737|P3|COMPLETED|Baseline (Day 1) up to Week 12||181
30307|NCT02713204|69738|P2|COMPLETED|Baseline (Day 1) up to Week 12||121
30308|NCT02713204|69739|P1|COMPLETED|Baseline (Day 1) up to Week 12||59
30309|NCT02713204|69732|P8|STARTED|Baseline (Day 1) up to Week 12||0
30310|NCT02713204|69733|P7|STARTED|Baseline (Day 1) up to Week 12||0
30311|NCT02713204|69734|P6|STARTED|Baseline (Day 1) up to Week 12||0
30312|NCT02713204|69735|P5|STARTED|Baseline (Day 1) up to Week 12||0
30313|NCT02713204|69736|P4|STARTED|Baseline (Day 1) up to Week 12||0
30314|NCT02713204|69737|P3|STARTED|Baseline (Day 1) up to Week 12||183
30315|NCT02713204|69738|P2|STARTED|Baseline (Day 1) up to Week 12||122
30316|NCT02713204|69739|P1|STARTED|Baseline (Day 1) up to Week 12||60
30317|NCT02712788|69798|P2|NOT COMPLETED|Overall Study||0
30318|NCT02712788|69799|P1|NOT COMPLETED|Overall Study||2
30319|NCT02712788|69798|P2|COMPLETED|Overall Study||2
30320|NCT02712788|69799|P1|COMPLETED|Overall Study||0
30321|NCT02712788|69798|P2|STARTED|Overall Study||2
30322|NCT02712788|69799|P1|STARTED|Overall Study||2
30323|NCT02712554|69809|P2|NOT COMPLETED|Part B: Treatment Phase||3
30324|NCT02712554|69810|P1|NOT COMPLETED|Part B: Treatment Phase||0
30325|NCT02712554|69809|P2|COMPLETED|Part B: Treatment Phase||37
30326|NCT02712554|69810|P1|COMPLETED|Part B: Treatment Phase||0
30327|NCT02712554|69809|P2|STARTED|Part B: Treatment Phase||40
30328|NCT02712554|69810|P1|STARTED|Part B: Treatment Phase||0
30329|NCT02712554|69809|P2|NOT COMPLETED|Part B: Qualification Phase||21
30330|NCT02712554|69810|P1|NOT COMPLETED|Part B: Qualification Phase||0
30331|NCT02712554|69809|P2|COMPLETED|Part B: Qualification Phase||40
30332|NCT02712554|69810|P1|COMPLETED|Part B: Qualification Phase||0
30333|NCT02712554|69809|P2|STARTED|Part B: Qualification Phase||61
30334|NCT02712554|69810|P1|STARTED|Part B: Qualification Phase||0
30335|NCT02712554|69809|P2|NOT COMPLETED|Part A: Dose Selection Phase||0
30336|NCT02712554|69810|P1|NOT COMPLETED|Part A: Dose Selection Phase||0
30337|NCT02712554|69809|P2|COMPLETED|Part A: Dose Selection Phase|Subjects who participated in Dose Selection Phase were not eligible to participate in Part B.|0
30338|NCT02712554|69810|P1|COMPLETED|Part A: Dose Selection Phase||12
30339|NCT02712554|69809|P2|STARTED|Part A: Dose Selection Phase||0
30340|NCT02712554|69810|P1|STARTED|Part A: Dose Selection Phase||12
30341|NCT02712359|69932|P4|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
30342|NCT02712359|69933|P3|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
30343|NCT02712359|69934|P2|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
30344|NCT02712359|69935|P1|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
30345|NCT02712359|69932|P4|COMPLETED|Epoch 002: Persistence at Year 10||300
30346|NCT02712359|69933|P3|COMPLETED|Epoch 002: Persistence at Year 10||299
30347|NCT02712359|69934|P2|COMPLETED|Epoch 002: Persistence at Year 10||0
30348|NCT02712359|69935|P1|COMPLETED|Epoch 002: Persistence at Year 10||0
30349|NCT02712359|69932|P4|STARTED|Epoch 002: Persistence at Year 10||300
30350|NCT02712359|69933|P3|STARTED|Epoch 002: Persistence at Year 10||299
30351|NCT02712359|69934|P2|STARTED|Epoch 002: Persistence at Year 10||0
30352|NCT02712359|69935|P1|STARTED|Epoch 002: Persistence at Year 10||0
30353|NCT02712359|69932|P4|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
30354|NCT02712359|69933|P3|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
30355|NCT02712359|69934|P2|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
30356|NCT02712359|69935|P1|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
30357|NCT02712359|69932|P4|COMPLETED|Epoch 001: Persistence at Year 8||0
30358|NCT02712359|69933|P3|COMPLETED|Epoch 001: Persistence at Year 8||0
30359|NCT02712359|69934|P2|COMPLETED|Epoch 001: Persistence at Year 8||300
30360|NCT02712359|69935|P1|COMPLETED|Epoch 001: Persistence at Year 8||300
30361|NCT02712359|69932|P4|STARTED|Epoch 001: Persistence at Year 8||0
30362|NCT02712359|69933|P3|STARTED|Epoch 001: Persistence at Year 8||0
30363|NCT02712359|69934|P2|STARTED|Epoch 001: Persistence at Year 8||300
30364|NCT02712359|69935|P1|STARTED|Epoch 001: Persistence at Year 8||300
30365|NCT02712333|69955|P2|NOT COMPLETED|Second Period||0
30366|NCT02712333|69956|P1|NOT COMPLETED|Second Period||0
30367|NCT02712333|69955|P2|COMPLETED|Second Period||24
30368|NCT02712333|69956|P1|COMPLETED|Second Period||31
30369|NCT02712333|69955|P2|STARTED|Second Period||24
30370|NCT02712333|69956|P1|STARTED|Second Period||31
30371|NCT02712333|69955|P2|NOT COMPLETED|First Period||2
30372|NCT02712333|69956|P1|NOT COMPLETED|First Period||3
30373|NCT02712333|69955|P2|COMPLETED|First Period||24
30374|NCT02712333|69956|P1|COMPLETED|First Period||31
30375|NCT02712333|69955|P2|STARTED|First Period||26
30376|NCT02712333|69956|P1|STARTED|First Period||34
30377|NCT02712320|69974|P1|NOT COMPLETED|Overall Study||5
30378|NCT02712320|69974|P1|COMPLETED|Overall Study||25
30379|NCT02712320|69974|P1|STARTED|Overall Study||30
30380|NCT02712099|69984|P2|NOT COMPLETED|Overall Study||0
30381|NCT02712099|69985|P1|NOT COMPLETED|Overall Study||0
30382|NCT02712099|69984|P2|COMPLETED|Overall Study||20
30383|NCT02712099|69985|P1|COMPLETED|Overall Study||30
30384|NCT02712099|69984|P2|STARTED|Overall Study||20
30385|NCT02712099|69985|P1|STARTED|Overall Study||30
30386|NCT02712047|70001|P2|NOT COMPLETED|Treatment Period 2 (35 Days)||0
30387|NCT02712047|70002|P1|NOT COMPLETED|Treatment Period 2 (35 Days)||0
30388|NCT02712047|70001|P2|COMPLETED|Treatment Period 2 (35 Days)||13
30389|NCT02712047|70002|P1|COMPLETED|Treatment Period 2 (35 Days)||14
30390|NCT02712047|70001|P2|STARTED|Treatment Period 2 (35 Days)||13
30391|NCT02712047|70002|P1|STARTED|Treatment Period 2 (35 Days)||14
30392|NCT02712047|70001|P2|NOT COMPLETED|Washout Period (21 Days)||0
30393|NCT02712047|70002|P1|NOT COMPLETED|Washout Period (21 Days)||0
30394|NCT02712047|70001|P2|COMPLETED|Washout Period (21 Days)||13
30395|NCT02712047|70002|P1|COMPLETED|Washout Period (21 Days)||14
30396|NCT02712047|70001|P2|STARTED|Washout Period (21 Days)||13
30397|NCT02712047|70002|P1|STARTED|Washout Period (21 Days)||14
30398|NCT02712047|70001|P2|NOT COMPLETED|Treatment Period 1 (35 Days)||0
30399|NCT02712047|70002|P1|NOT COMPLETED|Treatment Period 1 (35 Days)||0
30400|NCT02712047|70001|P2|COMPLETED|Treatment Period 1 (35 Days)||13
30401|NCT02712047|70002|P1|COMPLETED|Treatment Period 1 (35 Days)||14
30402|NCT02712047|70001|P2|STARTED|Treatment Period 1 (35 Days)||13
30403|NCT02712047|70002|P1|STARTED|Treatment Period 1 (35 Days)||14
30404|NCT02712008|70017|P8|NOT COMPLETED|From Week 12 up to Week 36||4
30405|NCT02712008|70018|P7|NOT COMPLETED|From Week 12 up to Week 36||5
30406|NCT02712008|70019|P6|NOT COMPLETED|From Week 12 up to Week 36||0
30407|NCT02712008|70020|P5|NOT COMPLETED|From Week 12 up to Week 36||2
30408|NCT02712008|70021|P4|NOT COMPLETED|From Week 12 up to Week 36||2
30409|NCT02712008|70022|P3|NOT COMPLETED|From Week 12 up to Week 36||0
30410|NCT02712008|70023|P2|NOT COMPLETED|From Week 12 up to Week 36||0
30411|NCT02712008|70024|P1|NOT COMPLETED|From Week 12 up to Week 36||1
30412|NCT02712008|70017|P8|COMPLETED|From Week 12 up to Week 36||45
30413|NCT02712008|70018|P7|COMPLETED|From Week 12 up to Week 36||43
30414|NCT02712008|70019|P6|COMPLETED|From Week 12 up to Week 36||46
30415|NCT02712008|70020|P5|COMPLETED|From Week 12 up to Week 36||50
30416|NCT02712008|70021|P4|COMPLETED|From Week 12 up to Week 36||42
30417|NCT02712008|70022|P3|COMPLETED|From Week 12 up to Week 36||0
30418|NCT02712008|70023|P2|COMPLETED|From Week 12 up to Week 36||0
30419|NCT02712008|70024|P1|COMPLETED|From Week 12 up to Week 36||44
30420|NCT02712008|70017|P8|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 49 re-randomized from Aflibercept 2mg Q4 to REGN910-3 (6:2mg) Q8|49
30421|NCT02712008|70018|P7|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 48 re-randomized from Aflibercept 2mg Q4 to Aflibercept 2mg Q12|48
30422|NCT02712008|70019|P6|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 46 re-randomized from Aflibercept 2mg Q4 to Aflibercept 2mg Q8|46
30423|NCT02712008|70020|P5|STARTED|From Week 12 up to Week 36|Out of 96 that were re-randomized, 52 re-randomized from REGN910-3(6:2 mg)Q4 to REGN910-3(6:2 mg)Q12|52
30424|NCT02712008|70021|P4|STARTED|From Week 12 up to Week 36|Out of 96 that were re-randomized, 44 re-randomized from REGN910-3(6:2 mg)Q4 to REGN910-3(6:2 mg)Q8|44
30425|NCT02712008|70022|P3|STARTED|From Week 12 up to Week 36|Out of 148 that completed Week 12,143 re-randomized to Aflibercept 2mg Q8, Q12, REGN910-3 (6:2mg) Q8|0
30426|NCT02712008|70023|P2|STARTED|From Week 12 up to Week 36|Out of 97 participants that completed Week 12, 96 re-randomized to REGN910-3 (6:2mg) Q8 and Q12|0
30427|NCT02712008|70024|P1|STARTED|From Week 12 up to Week 36|Out of 46 participants that completed Week 12, 45 re-randomized for treatment from Week 12 to 36|45
30428|NCT02712008|70017|P8|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
30429|NCT02712008|70018|P7|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
30430|NCT02712008|70019|P6|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
30431|NCT02712008|70020|P5|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
30432|NCT02712008|70021|P4|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
30433|NCT02712008|70022|P3|NOT COMPLETED|Baseline (Day 1) up to Week 12||4
30434|NCT02712008|70023|P2|NOT COMPLETED|Baseline (Day 1) up to Week 12||3
30435|NCT02712008|70024|P1|NOT COMPLETED|Baseline (Day 1) up to Week 12||4
30436|NCT02712008|70017|P8|COMPLETED|Baseline (Day 1) up to Week 12||0
30437|NCT02712008|70018|P7|COMPLETED|Baseline (Day 1) up to Week 12||0
30438|NCT02712008|70019|P6|COMPLETED|Baseline (Day 1) up to Week 12||0
30439|NCT02712008|70020|P5|COMPLETED|Baseline (Day 1) up to Week 12||0
30440|NCT02712008|70021|P4|COMPLETED|Baseline (Day 1) up to Week 12||0
30441|NCT02712008|70022|P3|COMPLETED|Baseline (Day 1) up to Week 12||148
30442|NCT02712008|70023|P2|COMPLETED|Baseline (Day 1) up to Week 12||97
30443|NCT02712008|70024|P1|COMPLETED|Baseline (Day 1) up to Week 12||46
30444|NCT02712008|70017|P8|STARTED|Baseline (Day 1) up to Week 12||0
30445|NCT02712008|70018|P7|STARTED|Baseline (Day 1) up to Week 12||0
30446|NCT02712008|70019|P6|STARTED|Baseline (Day 1) up to Week 12||0
30447|NCT02712008|70020|P5|STARTED|Baseline (Day 1) up to Week 12||0
30448|NCT02712008|70021|P4|STARTED|Baseline (Day 1) up to Week 12||0
30449|NCT02712008|70022|P3|STARTED|Baseline (Day 1) up to Week 12||152
30450|NCT02712008|70023|P2|STARTED|Baseline (Day 1) up to Week 12||100
30451|NCT02712008|70024|P1|STARTED|Baseline (Day 1) up to Week 12||50
30452|NCT02711995|70056|P1|NOT COMPLETED|Second Intervention (30 Days)||0
30453|NCT02711995|70056|P1|COMPLETED|Second Intervention (30 Days)||7
30454|NCT02711995|70056|P1|STARTED|Second Intervention (30 Days)||7
30455|NCT02711995|70056|P1|NOT COMPLETED|Washout (90 Days)||1
30456|NCT02711995|70056|P1|COMPLETED|Washout (90 Days)||7
30457|NCT02711995|70056|P1|STARTED|Washout (90 Days)||8
30458|NCT02711995|70056|P1|NOT COMPLETED|First Intervention (30 Days)||0
30459|NCT02711995|70056|P1|COMPLETED|First Intervention (30 Days)||8
30460|NCT02711995|70056|P1|STARTED|First Intervention (30 Days)||8
30461|NCT02711839|70080|P2|NOT COMPLETED|Overall Study||10
30462|NCT02711839|70081|P1|NOT COMPLETED|Overall Study||4
30463|NCT02711839|70080|P2|COMPLETED|Overall Study||24
30464|NCT02711839|70081|P1|COMPLETED|Overall Study||16
30465|NCT02711839|70080|P2|STARTED|Overall Study||34
30466|NCT02711839|70081|P1|STARTED|Overall Study||20
30467|NCT02711800|70095|P1|NOT COMPLETED|Overall Study||2
30468|NCT02711800|70095|P1|COMPLETED|Overall Study||7
30469|NCT02711800|70095|P1|STARTED|Overall Study||9
30470|NCT02711345|70114|P10|NOT COMPLETED|Overall Study||12
30471|NCT02711345|70115|P9|NOT COMPLETED|Overall Study||6
30472|NCT02711345|70116|P8|NOT COMPLETED|Overall Study||6
30473|NCT02711345|70117|P7|NOT COMPLETED|Overall Study||12
30474|NCT02711345|70118|P6|NOT COMPLETED|Overall Study||6
30475|NCT02711345|70119|P5|NOT COMPLETED|Overall Study||8
30476|NCT02711345|70120|P4|NOT COMPLETED|Overall Study||4
30477|NCT02711345|70121|P3|NOT COMPLETED|Overall Study||6
30478|NCT02711345|70122|P2|NOT COMPLETED|Overall Study||3
30479|NCT02711345|70123|P1|NOT COMPLETED|Overall Study||2
30480|NCT02711345|70114|P10|COMPLETED|Overall Study||0
30481|NCT02711345|70115|P9|COMPLETED|Overall Study||0
30482|NCT02711345|70116|P8|COMPLETED|Overall Study||0
30483|NCT02711345|70117|P7|COMPLETED|Overall Study||0
30484|NCT02711345|70118|P6|COMPLETED|Overall Study||0
30485|NCT02711345|70119|P5|COMPLETED|Overall Study||0
30486|NCT02711345|70120|P4|COMPLETED|Overall Study||0
30487|NCT02711345|70121|P3|COMPLETED|Overall Study||0
30488|NCT02711345|70122|P2|COMPLETED|Overall Study||0
30489|NCT02711345|70123|P1|COMPLETED|Overall Study||0
30490|NCT02711345|70114|P10|STARTED|Overall Study||12
30491|NCT02711345|70115|P9|STARTED|Overall Study||6
30492|NCT02711345|70116|P8|STARTED|Overall Study||6
30493|NCT02711345|70117|P7|STARTED|Overall Study||12
30494|NCT02711345|70118|P6|STARTED|Overall Study||6
30495|NCT02711345|70119|P5|STARTED|Overall Study||8
30496|NCT02711345|70120|P4|STARTED|Overall Study||4
30497|NCT02711345|70121|P3|STARTED|Overall Study||6
30498|NCT02711345|70122|P2|STARTED|Overall Study||3
30499|NCT02711345|70123|P1|STARTED|Overall Study||2
30500|NCT02711306|70309|P2|NOT COMPLETED|Overall Study||2
30501|NCT02711306|70310|P1|NOT COMPLETED|Overall Study||2
30502|NCT02711306|70309|P2|COMPLETED|Overall Study||16
30503|NCT02711306|70310|P1|COMPLETED|Overall Study||16
30504|NCT02711306|70309|P2|STARTED|Overall Study||18
30505|NCT02711306|70310|P1|STARTED|Overall Study||18
30506|NCT02710630|70327|P5|NOT COMPLETED|Period 6||0
30507|NCT02710630|70328|P4|NOT COMPLETED|Period 6||0
30508|NCT02710630|70329|P3|NOT COMPLETED|Period 6||0
30509|NCT02710630|70330|P2|NOT COMPLETED|Period 6||0
30510|NCT02710630|70331|P1|NOT COMPLETED|Period 6||0
30511|NCT02710630|70327|P5|COMPLETED|Period 6||7
30512|NCT02710630|70328|P4|COMPLETED|Period 6||7
30513|NCT02710630|70329|P3|COMPLETED|Period 6||7
30514|NCT02710630|70330|P2|COMPLETED|Period 6||7
30515|NCT02710630|70331|P1|COMPLETED|Period 6||7
30516|NCT02710630|70327|P5|STARTED|Period 6||7
30517|NCT02710630|70328|P4|STARTED|Period 6||7
30518|NCT02710630|70329|P3|STARTED|Period 6||7
30519|NCT02710630|70330|P2|STARTED|Period 6||7
30520|NCT02710630|70331|P1|STARTED|Period 6||7
30521|NCT02710630|70327|P5|NOT COMPLETED|Period 5||0
30522|NCT02710630|70328|P4|NOT COMPLETED|Period 5||0
30523|NCT02710630|70329|P3|NOT COMPLETED|Period 5||0
30524|NCT02710630|70330|P2|NOT COMPLETED|Period 5||0
30525|NCT02710630|70331|P1|NOT COMPLETED|Period 5||0
30526|NCT02710630|70327|P5|COMPLETED|Period 5||7
30527|NCT02710630|70328|P4|COMPLETED|Period 5||7
30528|NCT02710630|70329|P3|COMPLETED|Period 5||7
30529|NCT02710630|70330|P2|COMPLETED|Period 5||7
30530|NCT02710630|70331|P1|COMPLETED|Period 5||7
30531|NCT02710630|70327|P5|STARTED|Period 5||7
30532|NCT02710630|70328|P4|STARTED|Period 5||7
30533|NCT02710630|70329|P3|STARTED|Period 5||7
30534|NCT02710630|70330|P2|STARTED|Period 5||7
30535|NCT02710630|70331|P1|STARTED|Period 5||7
30536|NCT02710630|70327|P5|NOT COMPLETED|Period 4||0
30537|NCT02710630|70328|P4|NOT COMPLETED|Period 4||0
30538|NCT02710630|70329|P3|NOT COMPLETED|Period 4||0
30539|NCT02710630|70330|P2|NOT COMPLETED|Period 4||0
30540|NCT02710630|70331|P1|NOT COMPLETED|Period 4||0
30541|NCT02710630|70327|P5|COMPLETED|Period 4||7
30542|NCT02710630|70328|P4|COMPLETED|Period 4||7
30543|NCT02710630|70329|P3|COMPLETED|Period 4||7
30544|NCT02710630|70330|P2|COMPLETED|Period 4||7
30545|NCT02710630|70331|P1|COMPLETED|Period 4||7
30546|NCT02710630|70327|P5|STARTED|Period 4||7
30547|NCT02710630|70328|P4|STARTED|Period 4||7
30548|NCT02710630|70329|P3|STARTED|Period 4||7
30549|NCT02710630|70330|P2|STARTED|Period 4||7
30550|NCT02710630|70331|P1|STARTED|Period 4||7
30551|NCT02710630|70327|P5|NOT COMPLETED|Period 3||0
30552|NCT02710630|70328|P4|NOT COMPLETED|Period 3||0
30553|NCT02710630|70329|P3|NOT COMPLETED|Period 3||0
30554|NCT02710630|70330|P2|NOT COMPLETED|Period 3||0
30555|NCT02710630|70331|P1|NOT COMPLETED|Period 3||0
30556|NCT02710630|70327|P5|COMPLETED|Period 3||7
30557|NCT02710630|70328|P4|COMPLETED|Period 3||7
30558|NCT02710630|70329|P3|COMPLETED|Period 3||7
30559|NCT02710630|70330|P2|COMPLETED|Period 3||7
30560|NCT02710630|70331|P1|COMPLETED|Period 3||7
30561|NCT02710630|70327|P5|STARTED|Period 3||7
30562|NCT02710630|70328|P4|STARTED|Period 3||7
30563|NCT02710630|70329|P3|STARTED|Period 3||7
30564|NCT02710630|70330|P2|STARTED|Period 3||7
30565|NCT02710630|70331|P1|STARTED|Period 3||7
30566|NCT02710630|70327|P5|NOT COMPLETED|Period 2||0
30567|NCT02710630|70328|P4|NOT COMPLETED|Period 2||0
30568|NCT02710630|70329|P3|NOT COMPLETED|Period 2||0
30569|NCT02710630|70330|P2|NOT COMPLETED|Period 2||0
30570|NCT02710630|70331|P1|NOT COMPLETED|Period 2||0
30571|NCT02710630|70327|P5|COMPLETED|Period 2||7
30572|NCT02710630|70328|P4|COMPLETED|Period 2||7
30573|NCT02710630|70329|P3|COMPLETED|Period 2||7
30574|NCT02710630|70330|P2|COMPLETED|Period 2||7
30575|NCT02710630|70331|P1|COMPLETED|Period 2||7
30576|NCT02710630|70327|P5|Not Treated|Period 2||0
30577|NCT02710630|70328|P4|Not Treated|Period 2||0
30578|NCT02710630|70329|P3|Not Treated|Period 2||0
30579|NCT02710630|70330|P2|Not Treated|Period 2||0
30580|NCT02710630|70331|P1|Not Treated|Period 2||1
30581|NCT02710630|70327|P5|STARTED|Period 2||7
30582|NCT02710630|70328|P4|STARTED|Period 2||7
30583|NCT02710630|70329|P3|STARTED|Period 2||7
30584|NCT02710630|70330|P2|STARTED|Period 2||7
30585|NCT02710630|70331|P1|STARTED|Period 2||7
30586|NCT02710630|70327|P5|NOT COMPLETED|Period 1||0
30587|NCT02710630|70328|P4|NOT COMPLETED|Period 1||0
30588|NCT02710630|70329|P3|NOT COMPLETED|Period 1||0
30589|NCT02710630|70330|P2|NOT COMPLETED|Period 1||0
30590|NCT02710630|70331|P1|NOT COMPLETED|Period 1||0
30591|NCT02710630|70327|P5|COMPLETED|Period 1||7
30592|NCT02710630|70328|P4|COMPLETED|Period 1||7
30593|NCT02710630|70329|P3|COMPLETED|Period 1||7
30594|NCT02710630|70330|P2|COMPLETED|Period 1||7
30595|NCT02710630|70331|P1|COMPLETED|Period 1||7
30596|NCT02710630|70327|P5|STARTED|Period 1||7
30597|NCT02710630|70328|P4|STARTED|Period 1||7
30598|NCT02710630|70329|P3|STARTED|Period 1||7
30599|NCT02710630|70330|P2|STARTED|Period 1||7
30600|NCT02710630|70331|P1|STARTED|Period 1||7
30601|NCT02710591|70379|P4|NOT COMPLETED|Overall Study||0
30602|NCT02710591|70380|P3|NOT COMPLETED|Overall Study||0
30603|NCT02710591|70381|P2|NOT COMPLETED|Overall Study||0
30604|NCT02710591|70382|P1|NOT COMPLETED|Overall Study||0
30605|NCT02710591|70379|P4|COMPLETED|Overall Study||5
30606|NCT02710591|70380|P3|COMPLETED|Overall Study||5
30607|NCT02710591|70381|P2|COMPLETED|Overall Study||5
30608|NCT02710591|70382|P1|COMPLETED|Overall Study||5
30609|NCT02710591|70379|P4|STARTED|Overall Study||5
30610|NCT02710591|70380|P3|STARTED|Overall Study||5
30611|NCT02710591|70381|P2|STARTED|Overall Study||5
30612|NCT02710591|70382|P1|STARTED|Overall Study||5
30613|NCT02710422|70398|P2|NOT COMPLETED|Overall Study||9
30614|NCT02710422|70399|P1|NOT COMPLETED|Overall Study||9
30615|NCT02710422|70398|P2|COMPLETED|Overall Study||3
30616|NCT02710422|70399|P1|COMPLETED|Overall Study||3
30617|NCT02710422|70398|P2|12 Month Visit|Overall Study||3
30618|NCT02710422|70399|P1|12 Month Visit|Overall Study||3
30619|NCT02710422|70398|P2|9 Month Visit|Overall Study||5
30620|NCT02710422|70399|P1|9 Month Visit|Overall Study||5
30621|NCT02710422|70398|P2|6 Month Visit|Overall Study||8
30622|NCT02710422|70399|P1|6 Month Visit|Overall Study||7
30623|NCT02710422|70398|P2|3 Month Visit|Overall Study||11
30624|NCT02710422|70399|P1|3 Month Visit|Overall Study||9
30625|NCT02710422|70398|P2|STARTED|Overall Study||12
30626|NCT02710422|70399|P1|STARTED|Overall Study||12
30627|NCT02710292|70415|P2|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
30628|NCT02710292|70416|P1|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
30629|NCT02710292|70415|P2|COMPLETED|Period 2, Second 10 Days of Wear||49
30630|NCT02710292|70416|P1|COMPLETED|Period 2, Second 10 Days of Wear||46
30631|NCT02710292|70415|P2|STARTED|Period 2, Second 10 Days of Wear||49
30632|NCT02710292|70416|P1|STARTED|Period 2, Second 10 Days of Wear||46
30633|NCT02710292|70415|P2|NOT COMPLETED|Period 1, First 10 Days of Wear||3
30634|NCT02710292|70416|P1|NOT COMPLETED|Period 1, First 10 Days of Wear||1
30635|NCT02710292|70415|P2|COMPLETED|Period 1, First 10 Days of Wear||49
30636|NCT02710292|70416|P1|COMPLETED|Period 1, First 10 Days of Wear||46
30637|NCT02710292|70415|P2|STARTED|Period 1, First 10 Days of Wear||52
30638|NCT02710292|70416|P1|STARTED|Period 1, First 10 Days of Wear||47
30639|NCT02710136|70425|P2|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
30640|NCT02710136|70426|P1|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
30641|NCT02710136|70425|P2|COMPLETED|Phase 2 [Refer to Arm/Group Description]||25
30642|NCT02710136|70426|P1|COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
30643|NCT02710136|70425|P2|STARTED|Phase 2 [Refer to Arm/Group Description]||25
30644|NCT02710136|70426|P1|STARTED|Phase 2 [Refer to Arm/Group Description]||0
30645|NCT02710136|70425|P2|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
30646|NCT02710136|70426|P1|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
30647|NCT02710136|70425|P2|COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
30648|NCT02710136|70426|P1|COMPLETED|Phase 1b[Refer to Arm/Group Description]||4
30649|NCT02710136|70425|P2|STARTED|Phase 1b[Refer to Arm/Group Description]||0
30650|NCT02710136|70426|P1|STARTED|Phase 1b[Refer to Arm/Group Description]||4
30651|NCT02710136|70425|P2|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||0
30652|NCT02710136|70426|P1|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||1
30653|NCT02710136|70425|P2|COMPLETED|Phase 1a[Refer to Arm/Group Description]||0
30654|NCT02710136|70426|P1|COMPLETED|Phase 1a[Refer to Arm/Group Description]||9
30655|NCT02710136|70425|P2|STARTED|Phase 1a[Refer to Arm/Group Description]||0
30656|NCT02710136|70426|P1|STARTED|Phase 1a[Refer to Arm/Group Description]||10
30657|NCT02710136|70425|P2|NOT COMPLETED|Study Enrollment||0
30658|NCT02710136|70426|P1|NOT COMPLETED|Study Enrollment||0
30659|NCT02710136|70425|P2|COMPLETED|Study Enrollment||25
30660|NCT02710136|70426|P1|COMPLETED|Study Enrollment||10
30661|NCT02710136|70425|P2|STARTED|Study Enrollment||25
30662|NCT02710136|70426|P1|STARTED|Study Enrollment||10
30663|NCT02710045|70452|P3|NOT COMPLETED|Overall Study||13
30664|NCT02710045|70453|P2|NOT COMPLETED|Overall Study||17
30665|NCT02710045|70454|P1|NOT COMPLETED|Overall Study||11
30666|NCT02710045|70452|P3|COMPLETED|Overall Study||68
30667|NCT02710045|70453|P2|COMPLETED|Overall Study||98
30668|NCT02710045|70454|P1|COMPLETED|Overall Study||95
30669|NCT02710045|70452|P3|STARTED|Overall Study||81
30670|NCT02710045|70453|P2|STARTED|Overall Study||115
30671|NCT02710045|70454|P1|STARTED|Overall Study||106
30672|NCT02709785|70483|P3|NOT COMPLETED|Overall Study||1
30673|NCT02709785|70484|P2|NOT COMPLETED|Overall Study||2
30674|NCT02709785|70485|P1|NOT COMPLETED|Overall Study||1
30675|NCT02709785|70483|P3|COMPLETED|Overall Study||27
30676|NCT02709785|70484|P2|COMPLETED|Overall Study||26
30677|NCT02709785|70485|P1|COMPLETED|Overall Study||23
30678|NCT02709785|70483|P3|6 Weeks|Overall Study||27
30679|NCT02709785|70484|P2|6 Weeks|Overall Study||26
30680|NCT02709785|70485|P1|6 Weeks|Overall Study||23
30681|NCT02709785|70483|P3|3 Weeks|Overall Study||27
30682|NCT02709785|70484|P2|3 Weeks|Overall Study||27
30683|NCT02709785|70485|P1|3 Weeks|Overall Study||23
30684|NCT02709785|70483|P3|STARTED|Overall Study||28
30685|NCT02709785|70484|P2|STARTED|Overall Study||28
30686|NCT02709785|70485|P1|STARTED|Overall Study||24
30687|NCT02709577|70507|P4|NOT COMPLETED|Overall Study||0
30688|NCT02709577|70508|P3|NOT COMPLETED|Overall Study||2
30689|NCT02709577|70509|P2|NOT COMPLETED|Overall Study||5
30690|NCT02709577|70510|P1|NOT COMPLETED|Overall Study||2
30691|NCT02709577|70507|P4|COMPLETED|Overall Study||5
30692|NCT02709577|70508|P3|COMPLETED|Overall Study||4
30693|NCT02709577|70509|P2|COMPLETED|Overall Study||8
30694|NCT02709577|70510|P1|COMPLETED|Overall Study||10
30695|NCT02709577|70507|P4|STARTED|Overall Study||5
30696|NCT02709577|70508|P3|STARTED|Overall Study||6
30697|NCT02709577|70509|P2|STARTED|Overall Study||13
30698|NCT02709577|70510|P1|STARTED|Overall Study||12
30699|NCT02709538|70525|P3|NOT COMPLETED|Overall Study||20
30700|NCT02709538|70526|P2|NOT COMPLETED|Overall Study||28
30701|NCT02709538|70527|P1|NOT COMPLETED|Overall Study||113
30702|NCT02709538|70525|P3|COMPLETED|Overall Study||81
30703|NCT02709538|70526|P2|COMPLETED|Overall Study||72
30704|NCT02709538|70527|P1|COMPLETED|Overall Study||287
30705|NCT02709538|70525|P3|STARTED|Overall Study||101
30706|NCT02709538|70526|P2|STARTED|Overall Study||100
30707|NCT02709538|70527|P1|STARTED|Overall Study||400
30708|NCT02709486|70538|P3|NOT COMPLETED|Overall Study||45
30709|NCT02709486|70539|P2|NOT COMPLETED|Overall Study||34
30710|NCT02709486|70540|P1|NOT COMPLETED|Overall Study||44
30711|NCT02709486|70538|P3|COMPLETED|Overall Study||239
30712|NCT02709486|70539|P2|COMPLETED|Overall Study||249
30713|NCT02709486|70540|P1|COMPLETED|Overall Study||238
30714|NCT02709486|70538|P3|STARTED|Overall Study||284
30715|NCT02709486|70539|P2|STARTED|Overall Study||283
30716|NCT02709486|70540|P1|STARTED|Overall Study||282
30717|NCT02709330|70731|P2|NOT COMPLETED|Overall Study||0
30718|NCT02709330|70732|P1|NOT COMPLETED|Overall Study||13
30719|NCT02709330|70731|P2|COMPLETED|Overall Study||10
30720|NCT02709330|70732|P1|COMPLETED|Overall Study||37
30721|NCT02709330|70731|P2|STARTED|Overall Study||10
30722|NCT02709330|70732|P1|STARTED|Overall Study||50
30723|NCT02709096|70746|P2|NOT COMPLETED|Overall Study||1
30724|NCT02709096|70747|P1|NOT COMPLETED|Overall Study||1
30725|NCT02709096|70746|P2|COMPLETED|Overall Study||10
30726|NCT02709096|70747|P1|COMPLETED|Overall Study||21
30727|NCT02709096|70746|P2|STARTED|Overall Study||11
30728|NCT02709096|70747|P1|STARTED|Overall Study||22
30729|NCT02709083|70753|P1|NOT COMPLETED|Overall Study||7
30730|NCT02709083|70753|P1|COMPLETED|Overall Study||0
30731|NCT02709083|70753|P1|STARTED|Overall Study||7
30732|NCT02709005|70766|P2|NOT COMPLETED|Overall Study||1
30733|NCT02709005|70767|P1|NOT COMPLETED|Overall Study||4
30734|NCT02709005|70766|P2|COMPLETED|Overall Study||35
30735|NCT02709005|70767|P1|COMPLETED|Overall Study||69
30736|NCT02709005|70766|P2|STARTED|Overall Study||36
30737|NCT02709005|70767|P1|STARTED|Overall Study||73
30738|NCT02708862|70795|P1|NOT COMPLETED|Overall Study||0
30739|NCT02708862|70795|P1|COMPLETED|Overall Study||26
30740|NCT02708862|70795|P1|STARTED|Overall Study||26
30741|NCT02708745|70806|P4|NOT COMPLETED|Overall Study||82
30742|NCT02708745|70807|P3|NOT COMPLETED|Overall Study||83
30743|NCT02708745|70808|P2|NOT COMPLETED|Overall Study||4
30744|NCT02708745|70809|P1|NOT COMPLETED|Overall Study||0
30745|NCT02708745|70806|P4|COMPLETED|Overall Study||116
30746|NCT02708745|70807|P3|COMPLETED|Overall Study||121
30747|NCT02708745|70808|P2|COMPLETED|Overall Study||65
30748|NCT02708745|70809|P1|COMPLETED|Overall Study||91
30749|NCT02708745|70806|P4|STARTED|Overall Study||198
30750|NCT02708745|70807|P3|STARTED|Overall Study||204
30751|NCT02708745|70808|P2|STARTED|Overall Study||69
30752|NCT02708745|70809|P1|STARTED|Overall Study||91
30753|NCT02708524|70825|P4|NOT COMPLETED|Overall Study||0
30754|NCT02708524|70826|P3|NOT COMPLETED|Overall Study||3
30755|NCT02708524|70827|P2|NOT COMPLETED|Overall Study||6
30756|NCT02708524|70828|P1|NOT COMPLETED|Overall Study||4
30757|NCT02708524|70825|P4|COMPLETED|Overall Study||136
30758|NCT02708524|70826|P3|COMPLETED|Overall Study||134
30759|NCT02708524|70827|P2|COMPLETED|Overall Study||130
30760|NCT02708524|70828|P1|COMPLETED|Overall Study||135
30761|NCT02708524|70825|P4|STARTED|Overall Study||136
30762|NCT02708524|70826|P3|STARTED|Overall Study||137
30763|NCT02708524|70827|P2|STARTED|Overall Study||136
30764|NCT02708524|70828|P1|STARTED|Overall Study||139
30765|NCT02708485|70876|P2|NOT COMPLETED|Overall Study||2
30766|NCT02708485|70877|P1|NOT COMPLETED|Overall Study||3
30767|NCT02708485|70876|P2|COMPLETED|Overall Study||10
30768|NCT02708485|70877|P1|COMPLETED|Overall Study||0
30769|NCT02708485|70876|P2|STARTED|Overall Study||12
30770|NCT02708485|70877|P1|STARTED|Overall Study||3
30771|NCT02708433|70885|P2|NOT COMPLETED|Second Intervention (Visit 2)||0
30772|NCT02708433|70886|P1|NOT COMPLETED|Second Intervention (Visit 2)||0
30773|NCT02708433|70885|P2|COMPLETED|Second Intervention (Visit 2)||11
30774|NCT02708433|70886|P1|COMPLETED|Second Intervention (Visit 2)||12
30775|NCT02708433|70885|P2|STARTED|Second Intervention (Visit 2)||11
30776|NCT02708433|70886|P1|STARTED|Second Intervention (Visit 2)||12
30777|NCT02708433|70885|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
30778|NCT02708433|70886|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
30779|NCT02708433|70885|P2|COMPLETED|Washout (at Least 1 Week)||11
30780|NCT02708433|70886|P1|COMPLETED|Washout (at Least 1 Week)||12
30781|NCT02708433|70885|P2|STARTED|Washout (at Least 1 Week)||11
30782|NCT02708433|70886|P1|STARTED|Washout (at Least 1 Week)||12
30783|NCT02708433|70885|P2|NOT COMPLETED|First Intervention (Visit 1)||0
30784|NCT02708433|70886|P1|NOT COMPLETED|First Intervention (Visit 1)||0
30785|NCT02708433|70885|P2|COMPLETED|First Intervention (Visit 1)||11
30786|NCT02708433|70886|P1|COMPLETED|First Intervention (Visit 1)||12
30787|NCT02708433|70885|P2|STARTED|First Intervention (Visit 1)||11
30788|NCT02708433|70886|P1|STARTED|First Intervention (Visit 1)||12
30789|NCT02708355|70897|P3|NOT COMPLETED|Overall Study||0
30790|NCT02708355|70898|P2|NOT COMPLETED|Overall Study||0
30791|NCT02708355|70899|P1|NOT COMPLETED|Overall Study||1
30792|NCT02708355|70897|P3|COMPLETED|Overall Study||12
30793|NCT02708355|70898|P2|COMPLETED|Overall Study||22
30794|NCT02708355|70899|P1|COMPLETED|Overall Study||20
30795|NCT02708355|70897|P3|STARTED|Overall Study||12
30796|NCT02708355|70898|P2|STARTED|Overall Study||22
30797|NCT02708355|70899|P1|STARTED|Overall Study||21
30798|NCT02708277|70912|P2|NOT COMPLETED|Overall Study||4
30799|NCT02708277|70913|P1|NOT COMPLETED|Overall Study||7
30800|NCT02708277|70912|P2|COMPLETED|Overall Study||39
30801|NCT02708277|70913|P1|COMPLETED|Overall Study||43
30802|NCT02708277|70912|P2|STARTED|Overall Study||43
30803|NCT02708277|70913|P1|STARTED|Overall Study||50
30804|NCT02708238|70928|P3|NOT COMPLETED|Overall Study||3
30805|NCT02708238|70929|P2|NOT COMPLETED|Overall Study||1
30806|NCT02708238|70930|P1|NOT COMPLETED|Overall Study||0
30807|NCT02708238|70928|P3|COMPLETED|Overall Study||57
30808|NCT02708238|70929|P2|COMPLETED|Overall Study||59
30809|NCT02708238|70930|P1|COMPLETED|Overall Study||60
30810|NCT02708238|70928|P3|STARTED|Overall Study||60
30811|NCT02708238|70929|P2|STARTED|Overall Study||60
30812|NCT02708238|70930|P1|STARTED|Overall Study||60
30813|NCT02708212|70943|P2|NOT COMPLETED|Overall Study||0
30814|NCT02708212|70944|P1|NOT COMPLETED|Overall Study||0
30815|NCT02708212|70943|P2|COMPLETED|Overall Study||60
30816|NCT02708212|70944|P1|COMPLETED|Overall Study||60
30817|NCT02708212|70943|P2|STARTED|Overall Study||60
30818|NCT02708212|70944|P1|STARTED|Overall Study||60
30819|NCT02708121|70956|P2|NOT COMPLETED|Overall Study||5
30820|NCT02708121|70957|P1|NOT COMPLETED|Overall Study||1
30821|NCT02708121|70956|P2|COMPLETED|Overall Study||26
30822|NCT02708121|70957|P1|COMPLETED|Overall Study||34
30823|NCT02708121|70956|P2|6 Month Weight Data Via EHR|Overall Study||13
30824|NCT02708121|70957|P1|6 Month Weight Data Via EHR|Overall Study||14
30825|NCT02708121|70956|P2|6 Month In-Person Follow Up Data|Overall Study||19
30826|NCT02708121|70957|P1|6 Month In-Person Follow Up Data|Overall Study||22
30827|NCT02708121|70956|P2|Treatment Program Use Data Available|Overall Study||24
30828|NCT02708121|70957|P1|Treatment Program Use Data Available|Overall Study||34
30829|NCT02708121|70956|P2|Provided Acceptability Data|Overall Study|This condition did not participate in acceptability survey|0
30830|NCT02708121|70957|P1|Provided Acceptability Data|Overall Study||20
30831|NCT02708121|70956|P2|STARTED|Overall Study||31
30832|NCT02708121|70957|P1|STARTED|Overall Study||35
30833|NCT02708095|70969|P3|NOT COMPLETED|Overall Study||18
30834|NCT02708095|70970|P2|NOT COMPLETED|Overall Study||19
30835|NCT02708095|70971|P1|NOT COMPLETED|Overall Study||22
30836|NCT02708095|70969|P3|COMPLETED|Overall Study||86
30837|NCT02708095|70970|P2|COMPLETED|Overall Study||86
30838|NCT02708095|70971|P1|COMPLETED|Overall Study||83
30839|NCT02708095|70969|P3|Received at Least 1 Dose of Study Drug|Overall Study||104
30840|NCT02708095|70970|P2|Received at Least 1 Dose of Study Drug|Overall Study||105
30841|NCT02708095|70971|P1|Received at Least 1 Dose of Study Drug|Overall Study||105
30842|NCT02708095|70969|P3|STARTED|Overall Study||104
30843|NCT02708095|70970|P2|STARTED|Overall Study||105
30844|NCT02708095|70971|P1|STARTED|Overall Study||105
30845|NCT02707991|70994|P2|NOT COMPLETED|Overall Study||1
30846|NCT02707991|70995|P1|NOT COMPLETED|Overall Study||1
30847|NCT02707991|70994|P2|COMPLETED|Overall Study||34
30848|NCT02707991|70995|P1|COMPLETED|Overall Study||32
30849|NCT02707991|70994|P2|Month 6 Data Collection|Overall Study||34
30850|NCT02707991|70995|P1|Month 6 Data Collection|Overall Study||32
30851|NCT02707991|70994|P2|Day 60 Data Collectio|Overall Study||34
30852|NCT02707991|70995|P1|Day 60 Data Collectio|Overall Study||32
30853|NCT02707991|70994|P2|STARTED|Overall Study||35
30854|NCT02707991|70995|P1|STARTED|Overall Study||33
30855|NCT02707952|71007|P4|NOT COMPLETED|Overall Study||0
30856|NCT02707952|71008|P3|NOT COMPLETED|Overall Study||2
30857|NCT02707952|71009|P2|NOT COMPLETED|Overall Study||1
30858|NCT02707952|71010|P1|NOT COMPLETED|Overall Study||2
30859|NCT02707952|71007|P4|COMPLETED|Overall Study||10
30860|NCT02707952|71008|P3|COMPLETED|Overall Study||101
30861|NCT02707952|71009|P2|COMPLETED|Overall Study||52
30862|NCT02707952|71010|P1|COMPLETED|Overall Study||127
30863|NCT02707952|71007|P4|Participants Who Received Study Drug|Overall Study||10
30864|NCT02707952|71008|P3|Participants Who Received Study Drug|Overall Study||103
30865|NCT02707952|71009|P2|Participants Who Received Study Drug|Overall Study||52
30866|NCT02707952|71010|P1|Participants Who Received Study Drug|Overall Study||129
30867|NCT02707952|71007|P4|STARTED|Overall Study||10
30868|NCT02707952|71008|P3|STARTED|Overall Study||103
30869|NCT02707952|71009|P2|STARTED|Overall Study||53
30870|NCT02707952|71010|P1|STARTED|Overall Study||129
30871|NCT02707640|71031|P2|NOT COMPLETED|Overall Study||7
30872|NCT02707640|71032|P1|NOT COMPLETED|Overall Study||9
30873|NCT02707640|71031|P2|COMPLETED|Overall Study||55
30874|NCT02707640|71032|P1|COMPLETED|Overall Study||52
30875|NCT02707640|71031|P2|STARTED|Overall Study||62
30876|NCT02707640|71032|P1|STARTED|Overall Study||61
30877|NCT02707601|71052|P2|NOT COMPLETED|Overall Study||4
30878|NCT02707601|71053|P1|NOT COMPLETED|Overall Study||4
30879|NCT02707601|71052|P2|COMPLETED|Overall Study||70
30880|NCT02707601|71053|P1|COMPLETED|Overall Study||72
30881|NCT02707601|71052|P2|STARTED|Overall Study||74
30882|NCT02707601|71053|P1|STARTED|Overall Study||76
30883|NCT02707172|71067|P1|NOT COMPLETED|2nd Set of Experiment||0
30884|NCT02707172|71067|P1|COMPLETED|2nd Set of Experiment||28
30885|NCT02707172|71067|P1|STARTED|2nd Set of Experiment||28
30886|NCT02707172|71067|P1|NOT COMPLETED|Wash Out||0
30887|NCT02707172|71067|P1|COMPLETED|Wash Out||28
30888|NCT02707172|71067|P1|STARTED|Wash Out||28
30889|NCT02707172|71067|P1|NOT COMPLETED|1st Set of Experiment||0
30890|NCT02707172|71067|P1|COMPLETED|1st Set of Experiment||28
30891|NCT02707172|71067|P1|STARTED|1st Set of Experiment||28
30892|NCT02707146|71074|P2|NOT COMPLETED|Overall Study||3
30893|NCT02707146|71075|P1|NOT COMPLETED|Overall Study||0
30894|NCT02707146|71074|P2|COMPLETED|Overall Study||388
30895|NCT02707146|71075|P1|COMPLETED|Overall Study||359
30896|NCT02707146|71074|P2|STARTED|Overall Study||391
30897|NCT02707146|71075|P1|STARTED|Overall Study||359
30898|NCT02706951|71086|P3|NOT COMPLETED|Overall Study||10
30899|NCT02706951|71087|P2|NOT COMPLETED|Overall Study||16
30900|NCT02706951|71088|P1|NOT COMPLETED|Overall Study||14
30901|NCT02706951|71086|P3|COMPLETED|Overall Study||205
30902|NCT02706951|71087|P2|COMPLETED|Overall Study||201
30903|NCT02706951|71088|P1|COMPLETED|Overall Study||202
30904|NCT02706951|71086|P3|STARTED|Overall Study||215
30905|NCT02706951|71087|P2|STARTED|Overall Study||217
30906|NCT02706951|71088|P1|STARTED|Overall Study||216
30907|NCT02706938|71122|P2|NOT COMPLETED|Second Period, 6 Weeks||10
30908|NCT02706938|71123|P1|NOT COMPLETED|Second Period, 6 Weeks||0
30909|NCT02706938|71122|P2|COMPLETED|Second Period, 6 Weeks|Only data from 19 patients were finally analyzed because of missing data.|21
30910|NCT02706938|71123|P1|COMPLETED|Second Period, 6 Weeks|Only data from 20 patients were finally analyzed because of missing data.|21
30911|NCT02706938|71122|P2|STARTED|Second Period, 6 Weeks||31
30912|NCT02706938|71123|P1|STARTED|Second Period, 6 Weeks||21
30913|NCT02706938|71122|P2|NOT COMPLETED|First Period, 6 Weeks||2
30914|NCT02706938|71123|P1|NOT COMPLETED|First Period, 6 Weeks||11
30915|NCT02706938|71122|P2|COMPLETED|First Period, 6 Weeks||31
30916|NCT02706938|71123|P1|COMPLETED|First Period, 6 Weeks||21
30917|NCT02706938|71122|P2|STARTED|First Period, 6 Weeks||33
30918|NCT02706938|71123|P1|STARTED|First Period, 6 Weeks||32
30919|NCT02706899|71134|P2|NOT COMPLETED|Overall Study||6
30920|NCT02706899|71135|P1|NOT COMPLETED|Overall Study||13
30921|NCT02706899|71134|P2|COMPLETED|Overall Study||0
30922|NCT02706899|71135|P1|COMPLETED|Overall Study||0
30923|NCT02706899|71134|P2|STARTED|Overall Study||6
30924|NCT02706899|71135|P1|STARTED|Overall Study||13
30925|NCT02706873|71161|P4|NOT COMPLETED|Overall Study||33
30926|NCT02706873|71162|P3|NOT COMPLETED|Overall Study||27
30927|NCT02706873|71163|P2|NOT COMPLETED|Overall Study||4
30928|NCT02706873|71164|P1|NOT COMPLETED|Overall Study||47
30929|NCT02706873|71161|P4|COMPLETED|Overall Study||282
30930|NCT02706873|71162|P3|COMPLETED|Overall Study||290
30931|NCT02706873|71163|P2|COMPLETED|Overall Study||51
30932|NCT02706873|71164|P1|COMPLETED|Overall Study||268
30933|NCT02706873|71161|P4|Japan Sub-study|Overall Study||28
30934|NCT02706873|71162|P3|Japan Sub-study|Overall Study||27
30935|NCT02706873|71163|P2|Japan Sub-study|Overall Study||55
30936|NCT02706873|71164|P1|Japan Sub-study|Overall Study||28
30937|NCT02706873|71161|P4|Global Analysis Population|Overall Study|Includes 28 participants in the Japan sub-study|314
30938|NCT02706873|71162|P3|Global Analysis Population|Overall Study|Includes 27 participants in the Japan sub-study|317
30939|NCT02706873|71163|P2|Global Analysis Population|Overall Study||0
30940|NCT02706873|71164|P1|Global Analysis Population|Overall Study|Includes 28 participants in the Japan sub-study|314
30941|NCT02706873|71161|P4|Received Study Drug|Overall Study||314
30942|NCT02706873|71162|P3|Received Study Drug|Overall Study||317
30943|NCT02706873|71163|P2|Received Study Drug|Overall Study||55
30944|NCT02706873|71164|P1|Received Study Drug|Overall Study||314
30945|NCT02706873|71161|P4|STARTED|Overall Study||315
30946|NCT02706873|71162|P3|STARTED|Overall Study||317
30947|NCT02706873|71163|P2|STARTED|Overall Study||55
30948|NCT02706873|71164|P1|STARTED|Overall Study||315
30949|NCT02706847|71264|P4|NOT COMPLETED|Week 12 to Week 24||14
30950|NCT02706847|71265|P3|NOT COMPLETED|Week 12 to Week 24||4
30951|NCT02706847|71266|P2|NOT COMPLETED|Week 12 to Week 24||2
30952|NCT02706847|71267|P1|NOT COMPLETED|Week 12 to Week 24||3
30953|NCT02706847|71264|P4|COMPLETED|Week 12 to Week 24||135
30954|NCT02706847|71265|P3|COMPLETED|Week 12 to Week 24||153
30955|NCT02706847|71266|P2|COMPLETED|Week 12 to Week 24||74
30956|NCT02706847|71267|P1|COMPLETED|Week 12 to Week 24||72
30957|NCT02706847|71264|P4|Received Study Treatment|Week 12 to Week 24||148
30958|NCT02706847|71265|P3|Received Study Treatment|Week 12 to Week 24||156
30959|NCT02706847|71266|P2|Received Study Treatment|Week 12 to Week 24||75
30960|NCT02706847|71267|P1|Received Study Treatment|Week 12 to Week 24||72
30961|NCT02706847|71264|P4|STARTED|Week 12 to Week 24||149
30962|NCT02706847|71265|P3|STARTED|Week 12 to Week 24||157
30963|NCT02706847|71266|P2|STARTED|Week 12 to Week 24||76
30964|NCT02706847|71267|P1|STARTED|Week 12 to Week 24||75
30965|NCT02706847|71264|P4|NOT COMPLETED|Day 1 to Week 12||16
30966|NCT02706847|71265|P3|NOT COMPLETED|Day 1 to Week 12||8
30967|NCT02706847|71266|P2|NOT COMPLETED|Day 1 to Week 12||8
30968|NCT02706847|71267|P1|NOT COMPLETED|Day 1 to Week 12||10
30969|NCT02706847|71264|P4|COMPLETED|Day 1 to Week 12||149
30970|NCT02706847|71265|P3|COMPLETED|Day 1 to Week 12||157
30971|NCT02706847|71266|P2|COMPLETED|Day 1 to Week 12||76
30972|NCT02706847|71267|P1|COMPLETED|Day 1 to Week 12||75
30973|NCT02706847|71264|P4|Received Study Treatment|Day 1 to Week 12||165
30974|NCT02706847|71265|P3|Received Study Treatment|Day 1 to Week 12||164
30975|NCT02706847|71266|P2|Received Study Treatment|Day 1 to Week 12||84
30976|NCT02706847|71267|P1|Received Study Treatment|Day 1 to Week 12||85
30977|NCT02706847|71264|P4|STARTED|Day 1 to Week 12||165
30978|NCT02706847|71265|P3|STARTED|Day 1 to Week 12||165
30979|NCT02706847|71266|P2|STARTED|Day 1 to Week 12||84
30980|NCT02706847|71267|P1|STARTED|Day 1 to Week 12||85
30981|NCT02706834|71309|P11|NOT COMPLETED|Overall Study||1
30982|NCT02706834|71310|P10|NOT COMPLETED|Overall Study||1
30983|NCT02706834|71311|P9|NOT COMPLETED|Overall Study||0
30984|NCT02706834|71312|P8|NOT COMPLETED|Overall Study||0
30985|NCT02706834|71313|P7|NOT COMPLETED|Overall Study||0
30986|NCT02706834|71314|P6|NOT COMPLETED|Overall Study||0
30987|NCT02706834|71315|P5|NOT COMPLETED|Overall Study||1
30988|NCT02706834|71316|P4|NOT COMPLETED|Overall Study||0
30989|NCT02706834|71317|P3|NOT COMPLETED|Overall Study||1
30990|NCT02706834|71318|P2|NOT COMPLETED|Overall Study||1
30991|NCT02706834|71319|P1|NOT COMPLETED|Overall Study||2
30992|NCT02706834|71309|P11|COMPLETED|Overall Study||3
30993|NCT02706834|71310|P10|COMPLETED|Overall Study||3
30994|NCT02706834|71311|P9|COMPLETED|Overall Study||4
30995|NCT02706834|71312|P8|COMPLETED|Overall Study||3
30996|NCT02706834|71313|P7|COMPLETED|Overall Study||3
30997|NCT02706834|71314|P6|COMPLETED|Overall Study||3
30998|NCT02706834|71315|P5|COMPLETED|Overall Study||2
30999|NCT02706834|71316|P4|COMPLETED|Overall Study||3
31000|NCT02706834|71317|P3|COMPLETED|Overall Study||2
31001|NCT02706834|71318|P2|COMPLETED|Overall Study||2
31002|NCT02706834|71319|P1|COMPLETED|Overall Study|Completed = completed study drug|1
31003|NCT02706834|71309|P11|STARTED|Overall Study||4
31004|NCT02706834|71310|P10|STARTED|Overall Study||4
31005|NCT02706834|71311|P9|STARTED|Overall Study||4
31006|NCT02706834|71312|P8|STARTED|Overall Study||3
31007|NCT02706834|71313|P7|STARTED|Overall Study||3
31008|NCT02706834|71314|P6|STARTED|Overall Study||3
31009|NCT02706834|71315|P5|STARTED|Overall Study||3
31010|NCT02706834|71316|P4|STARTED|Overall Study||3
31011|NCT02706834|71317|P3|STARTED|Overall Study||3
31012|NCT02706834|71318|P2|STARTED|Overall Study||3
31013|NCT02706834|71319|P1|STARTED|Overall Study||3
31014|NCT02706717|71463|P2|NOT COMPLETED|Overall Study||11
31015|NCT02706717|71464|P1|NOT COMPLETED|Overall Study||1
31016|NCT02706717|71463|P2|COMPLETED|Overall Study||35
31017|NCT02706717|71464|P1|COMPLETED|Overall Study||46
31018|NCT02706717|71463|P2|STARTED|Overall Study|3 placebo participants never initiated study treatment.|46
31019|NCT02706717|71464|P1|STARTED|Overall Study||47
31020|NCT02706691|71482|P1|NOT COMPLETED|Overall Study||1
31021|NCT02706691|71482|P1|COMPLETED|Overall Study||0
31022|NCT02706691|71482|P1|STARTED|Overall Study||1
31023|NCT02706327|71492|P3|NOT COMPLETED|Overall Study||2
31024|NCT02706327|71493|P2|NOT COMPLETED|Overall Study||1
31025|NCT02706327|71494|P1|NOT COMPLETED|Overall Study||1
31026|NCT02706327|71492|P3|COMPLETED|Overall Study||21
31027|NCT02706327|71493|P2|COMPLETED|Overall Study||21
31028|NCT02706327|71494|P1|COMPLETED|Overall Study||21
31029|NCT02706327|71492|P3|STARTED|Overall Study||23
31030|NCT02706327|71493|P2|STARTED|Overall Study||22
31031|NCT02706327|71494|P1|STARTED|Overall Study||22
31032|NCT02705807|71514|P1|NOT COMPLETED|Overall Study||0
31033|NCT02705807|71514|P1|COMPLETED|Overall Study||10
31034|NCT02705807|71514|P1|STARTED|Overall Study||10
31035|NCT02705716|71546|P2|NOT COMPLETED|Overall Study||2
31036|NCT02705716|71547|P1|NOT COMPLETED|Overall Study||4
31037|NCT02705716|71546|P2|COMPLETED|Overall Study||68
31038|NCT02705716|71547|P1|COMPLETED|Overall Study||68
31039|NCT02705716|71546|P2|STARTED|Overall Study||70
31040|NCT02705716|71547|P1|STARTED|Overall Study||72
31041|NCT02705625|71560|P3|NOT COMPLETED|Overall Study||11
31042|NCT02705625|71561|P2|NOT COMPLETED|Overall Study||10
31043|NCT02705625|71562|P1|NOT COMPLETED|Overall Study||8
31044|NCT02705625|71560|P3|COMPLETED|Overall Study||69
31045|NCT02705625|71561|P2|COMPLETED|Overall Study||72
31046|NCT02705625|71562|P1|COMPLETED|Overall Study||74
31047|NCT02705625|71560|P3|STARTED|Overall Study||80
31048|NCT02705625|71561|P2|STARTED|Overall Study||82
31049|NCT02705625|71562|P1|STARTED|Overall Study||82
31050|NCT02705586|71591|P1|NOT COMPLETED|Overall Study||8
31051|NCT02705586|71591|P1|COMPLETED|Overall Study||5
31052|NCT02705586|71591|P1|STARTED|Overall Study||13
31053|NCT02705365|71597|P2|NOT COMPLETED|Overall Study||0
31054|NCT02705365|71598|P1|NOT COMPLETED|Overall Study||0
31055|NCT02705365|71597|P2|COMPLETED|Overall Study||800
31056|NCT02705365|71598|P1|COMPLETED|Overall Study||400
31057|NCT02705365|71597|P2|STARTED|Overall Study||800
31058|NCT02705365|71598|P1|STARTED|Overall Study||400
31059|NCT02704702|71612|P6|NOT COMPLETED|Overall Study||2
31060|NCT02704702|71613|P5|NOT COMPLETED|Overall Study||2
31061|NCT02704702|71614|P4|NOT COMPLETED|Overall Study||1
31062|NCT02704702|71615|P3|NOT COMPLETED|Overall Study||0
31063|NCT02704702|71616|P2|NOT COMPLETED|Overall Study||0
31064|NCT02704702|71617|P1|NOT COMPLETED|Overall Study||1
31065|NCT02704702|71612|P6|COMPLETED|Overall Study||4
31066|NCT02704702|71613|P5|COMPLETED|Overall Study||4
31067|NCT02704702|71614|P4|COMPLETED|Overall Study||5
31068|NCT02704702|71615|P3|COMPLETED|Overall Study||6
31069|NCT02704702|71616|P2|COMPLETED|Overall Study||6
31070|NCT02704702|71617|P1|COMPLETED|Overall Study||5
31071|NCT02704702|71612|P6|STARTED|Overall Study||6
31072|NCT02704702|71613|P5|STARTED|Overall Study||6
31073|NCT02704702|71614|P4|STARTED|Overall Study||6
31074|NCT02704702|71615|P3|STARTED|Overall Study||6
31075|NCT02704702|71616|P2|STARTED|Overall Study||6
31076|NCT02704702|71617|P1|STARTED|Overall Study||6
31077|NCT02704689|71649|P1|NOT COMPLETED|Overall Study||3
31078|NCT02704689|71649|P1|COMPLETED|Overall Study||6
31079|NCT02704689|71649|P1|STARTED|Overall Study||9
31080|NCT02704104|71666|P1|NOT COMPLETED|Overall Study||0
31081|NCT02704104|71666|P1|COMPLETED|Overall Study||46
31082|NCT02704104|71666|P1|STARTED|Overall Study||46
31083|NCT02703948|71680|P1|NOT COMPLETED|Overall Study||3
31084|NCT02703948|71680|P1|COMPLETED|Overall Study||57
31085|NCT02703948|71680|P1|STARTED|Overall Study||60
31086|NCT02703909|71688|P4|NOT COMPLETED|Overall Study||0
31087|NCT02703909|71689|P3|NOT COMPLETED|Overall Study||0
31088|NCT02703909|71690|P2|NOT COMPLETED|Overall Study||0
31089|NCT02703909|71691|P1|NOT COMPLETED|Overall Study||0
31090|NCT02703909|71688|P4|COMPLETED|Overall Study||35
31091|NCT02703909|71689|P3|COMPLETED|Overall Study||36
31092|NCT02703909|71690|P2|COMPLETED|Overall Study||37
31093|NCT02703909|71691|P1|COMPLETED|Overall Study||36
31094|NCT02703909|71688|P4|STARTED|Overall Study||35
31095|NCT02703909|71689|P3|STARTED|Overall Study||36
31096|NCT02703909|71690|P2|STARTED|Overall Study||37
31097|NCT02703909|71691|P1|STARTED|Overall Study||36
31098|NCT02703636|71707|P1|NOT COMPLETED|Overall Study||16
31099|NCT02703636|71707|P1|COMPLETED|Overall Study||102
31100|NCT02703636|71707|P1|STARTED|Overall Study||118
31101|NCT02703467|71721|P3|NOT COMPLETED|Overall Study||0
31102|NCT02703467|71722|P2|NOT COMPLETED|Overall Study||0
31103|NCT02703467|71723|P1|NOT COMPLETED|Overall Study||0
31104|NCT02703467|71721|P3|COMPLETED|Overall Study||45
31105|NCT02703467|71722|P2|COMPLETED|Overall Study||5
31106|NCT02703467|71723|P1|COMPLETED|Overall Study||20
31107|NCT02703467|71721|P3|STARTED|Overall Study||45
31108|NCT02703467|71722|P2|STARTED|Overall Study||5
31109|NCT02703467|71723|P1|STARTED|Overall Study||20
31110|NCT02703454|71745|P2|NOT COMPLETED|Overall Study||16
31111|NCT02703454|71746|P1|NOT COMPLETED|Overall Study||11
31112|NCT02703454|71745|P2|COMPLETED|Overall Study||11
31113|NCT02703454|71746|P1|COMPLETED|Overall Study||13
31114|NCT02703454|71745|P2|Treated|Overall Study||24
31115|NCT02703454|71746|P1|Treated|Overall Study||23
31116|NCT02703454|71745|P2|STARTED|Overall Study||27
31117|NCT02703454|71746|P1|STARTED|Overall Study||24
31118|NCT02703259|71756|P2|NOT COMPLETED|2 Weeks Postoperative Assessment||10
31119|NCT02703259|71757|P1|NOT COMPLETED|2 Weeks Postoperative Assessment||10
31120|NCT02703259|71756|P2|COMPLETED|2 Weeks Postoperative Assessment||51
31121|NCT02703259|71757|P1|COMPLETED|2 Weeks Postoperative Assessment||58
31122|NCT02703259|71756|P2|STARTED|2 Weeks Postoperative Assessment||61
31123|NCT02703259|71757|P1|STARTED|2 Weeks Postoperative Assessment||68
31124|NCT02703259|71756|P2|NOT COMPLETED|24 Hours Postoperative Assessment||6
31125|NCT02703259|71757|P1|NOT COMPLETED|24 Hours Postoperative Assessment||2
31126|NCT02703259|71756|P2|COMPLETED|24 Hours Postoperative Assessment||61
31127|NCT02703259|71757|P1|COMPLETED|24 Hours Postoperative Assessment||68
31128|NCT02703259|71756|P2|STARTED|24 Hours Postoperative Assessment||67
31129|NCT02703259|71757|P1|STARTED|24 Hours Postoperative Assessment||70
31130|NCT02702999|71775|P2|NOT COMPLETED|Overall Study||0
31131|NCT02702999|71776|P1|NOT COMPLETED|Overall Study||0
31132|NCT02702999|71775|P2|COMPLETED|Overall Study||104
31133|NCT02702999|71776|P1|COMPLETED|Overall Study||102
31134|NCT02702999|71775|P2|STARTED|Overall Study||104
31135|NCT02702999|71776|P1|STARTED|Overall Study||102
31136|NCT02702921|71794|P2|NOT COMPLETED|Overall Study||8
31137|NCT02702921|71795|P1|NOT COMPLETED|Overall Study||14
31138|NCT02702921|71794|P2|COMPLETED|Overall Study||95
31139|NCT02702921|71795|P1|COMPLETED|Overall Study||84
31140|NCT02702921|71794|P2|STARTED|Overall Study||103
31141|NCT02702921|71795|P1|STARTED|Overall Study||98
31142|NCT02702193|71805|P2|NOT COMPLETED|12 Month Follow up||18
31143|NCT02702193|71806|P1|NOT COMPLETED|12 Month Follow up||17
31144|NCT02702193|71805|P2|COMPLETED|12 Month Follow up||69
31145|NCT02702193|71806|P1|COMPLETED|12 Month Follow up||69
31146|NCT02702193|71805|P2|STARTED|12 Month Follow up||87
31147|NCT02702193|71806|P1|STARTED|12 Month Follow up||86
31148|NCT02702193|71805|P2|NOT COMPLETED|8 Month Follow up||18
31149|NCT02702193|71806|P1|NOT COMPLETED|8 Month Follow up||15
31150|NCT02702193|71805|P2|COMPLETED|8 Month Follow up||69
31151|NCT02702193|71806|P1|COMPLETED|8 Month Follow up||71
31152|NCT02702193|71805|P2|STARTED|8 Month Follow up||87
31153|NCT02702193|71806|P1|STARTED|8 Month Follow up||86
31154|NCT02702193|71805|P2|NOT COMPLETED|4 Month Follow up||18
31155|NCT02702193|71806|P1|NOT COMPLETED|4 Month Follow up||18
31156|NCT02702193|71805|P2|COMPLETED|4 Month Follow up||69
31157|NCT02702193|71806|P1|COMPLETED|4 Month Follow up||68
31158|NCT02702193|71805|P2|STARTED|4 Month Follow up||87
31159|NCT02702193|71806|P1|STARTED|4 Month Follow up||86
31160|NCT02702193|71805|P2|NOT COMPLETED|Baseline Assessment/Randomization||0
31161|NCT02702193|71806|P1|NOT COMPLETED|Baseline Assessment/Randomization||1
31162|NCT02702193|71805|P2|COMPLETED|Baseline Assessment/Randomization||87
31163|NCT02702193|71806|P1|COMPLETED|Baseline Assessment/Randomization||85
31164|NCT02702193|71805|P2|STARTED|Baseline Assessment/Randomization||87
31165|NCT02702193|71806|P1|STARTED|Baseline Assessment/Randomization||86
31166|NCT02702011|71834|P4|NOT COMPLETED|Overall Study||0
31167|NCT02702011|71835|P3|NOT COMPLETED|Overall Study||0
31168|NCT02702011|71836|P2|NOT COMPLETED|Overall Study||1
31169|NCT02702011|71837|P1|NOT COMPLETED|Overall Study||0
31170|NCT02702011|71834|P4|COMPLETED|Overall Study||12
31171|NCT02702011|71835|P3|COMPLETED|Overall Study||12
31172|NCT02702011|71836|P2|COMPLETED|Overall Study||12
31173|NCT02702011|71837|P1|COMPLETED|Overall Study||11
31174|NCT02702011|71834|P4|STARTED|Overall Study|Started are the treated patients.|12
31175|NCT02702011|71835|P3|STARTED|Overall Study|Started are the treated patients.|12
31176|NCT02702011|71836|P2|STARTED|Overall Study|Started are the treated patients.|13
31177|NCT02702011|71837|P1|STARTED|Overall Study|Started are the treated patients.|11
31178|NCT02701985|71849|P2|NOT COMPLETED|Overall Study||6
31179|NCT02701985|71850|P1|NOT COMPLETED|Overall Study||3
31180|NCT02701985|71849|P2|COMPLETED|Overall Study||32
31181|NCT02701985|71850|P1|COMPLETED|Overall Study||34
31182|NCT02701985|71849|P2|STARTED|Overall Study||38
31183|NCT02701985|71850|P1|STARTED|Overall Study||37
31184|NCT02701764|71893|P2|NOT COMPLETED|Overall Study||1
31185|NCT02701764|71894|P1|NOT COMPLETED|Overall Study||0
31186|NCT02701764|71893|P2|COMPLETED|Overall Study||21
31187|NCT02701764|71894|P1|COMPLETED|Overall Study||21
31188|NCT02701764|71893|P2|STARTED|Overall Study||22
31189|NCT02701764|71894|P1|STARTED|Overall Study||21
31190|NCT02701647|71917|P3|NOT COMPLETED|Overall Study||1
31191|NCT02701647|71918|P2|NOT COMPLETED|Overall Study||0
31192|NCT02701647|71919|P1|NOT COMPLETED|Overall Study||0
31193|NCT02701647|71917|P3|COMPLETED|Overall Study|One participant from sham-TT withdraw due a back injury unrelated to study.|16
31194|NCT02701647|71918|P2|COMPLETED|Overall Study||17
31195|NCT02701647|71919|P1|COMPLETED|Overall Study||17
31196|NCT02701647|71917|P3|STARTED|Overall Study||17
31197|NCT02701647|71918|P2|STARTED|Overall Study||17
31198|NCT02701647|71919|P1|STARTED|Overall Study||17
31199|NCT02701634|71953|P2|NOT COMPLETED|Overall Study||31
31200|NCT02701634|71954|P1|NOT COMPLETED|Overall Study||32
31201|NCT02701634|71953|P2|COMPLETED|Overall Study||2
31202|NCT02701634|71954|P1|COMPLETED|Overall Study||1
31203|NCT02701634|71953|P2|STARTED|Overall Study||33
31204|NCT02701634|71954|P1|STARTED|Overall Study||33
31205|NCT02701582|71984|P2|NOT COMPLETED|Overall Study||0
31206|NCT02701582|71985|P1|NOT COMPLETED|Overall Study||2
31207|NCT02701582|71984|P2|COMPLETED|Overall Study||33
31208|NCT02701582|71985|P1|COMPLETED|Overall Study||33
31209|NCT02701582|71984|P2|STARTED|Overall Study||33
31210|NCT02701582|71985|P1|STARTED|Overall Study||35
31211|NCT02701556|72009|P2|NOT COMPLETED|Overall Study||20
31212|NCT02701556|72010|P1|NOT COMPLETED|Overall Study||23
31213|NCT02701556|72009|P2|COMPLETED|Overall Study||178
31214|NCT02701556|72010|P1|COMPLETED|Overall Study||175
31215|NCT02701556|72009|P2|STARTED|Overall Study||198
31216|NCT02701556|72010|P1|STARTED|Overall Study||198
31217|NCT02701387|72016|P1|NOT COMPLETED|Overall Study||0
31218|NCT02701387|72016|P1|COMPLETED|Overall Study||7
31219|NCT02701387|72016|P1|STARTED|Overall Study||7
31220|NCT02701361|72024|P3|NOT COMPLETED|Overall Study||2
31221|NCT02701361|72025|P2|NOT COMPLETED|Overall Study||3
31222|NCT02701361|72026|P1|NOT COMPLETED|Overall Study||9
31223|NCT02701361|72024|P3|COMPLETED|Overall Study||16
31224|NCT02701361|72025|P2|COMPLETED|Overall Study||28
31225|NCT02701361|72026|P1|COMPLETED|Overall Study||22
31226|NCT02701361|72024|P3|STARTED|Overall Study||18
31227|NCT02701361|72025|P2|STARTED|Overall Study||31
31228|NCT02701361|72026|P1|STARTED|Overall Study||31
31229|NCT02701296|72067|P2|NOT COMPLETED|Overall Study||2
31230|NCT02701296|72068|P1|NOT COMPLETED|Overall Study||0
31231|NCT02701296|72067|P2|COMPLETED|Overall Study|Data was incomplete for two participants their data was not included in the overall data analysis.|36
31232|NCT02701296|72068|P1|COMPLETED|Overall Study||42
31233|NCT02701296|72067|P2|STARTED|Overall Study||38
31234|NCT02701296|72068|P1|STARTED|Overall Study||42
31235|NCT02701270|72084|P4|NOT COMPLETED|Fourth Intervention at Visit 4||0
31236|NCT02701270|72085|P3|NOT COMPLETED|Fourth Intervention at Visit 4||0
31237|NCT02701270|72086|P2|NOT COMPLETED|Fourth Intervention at Visit 4||0
31238|NCT02701270|72087|P1|NOT COMPLETED|Fourth Intervention at Visit 4||0
31239|NCT02701270|72084|P4|COMPLETED|Fourth Intervention at Visit 4||3
31240|NCT02701270|72085|P3|COMPLETED|Fourth Intervention at Visit 4||3
31241|NCT02701270|72086|P2|COMPLETED|Fourth Intervention at Visit 4||3
31242|NCT02701270|72087|P1|COMPLETED|Fourth Intervention at Visit 4||2
31243|NCT02701270|72084|P4|STARTED|Fourth Intervention at Visit 4||3
31244|NCT02701270|72085|P3|STARTED|Fourth Intervention at Visit 4||3
31245|NCT02701270|72086|P2|STARTED|Fourth Intervention at Visit 4||3
31246|NCT02701270|72087|P1|STARTED|Fourth Intervention at Visit 4||2
31247|NCT02701270|72084|P4|NOT COMPLETED|Third Intervention at Visit 3||0
31248|NCT02701270|72085|P3|NOT COMPLETED|Third Intervention at Visit 3||0
31249|NCT02701270|72086|P2|NOT COMPLETED|Third Intervention at Visit 3||0
31250|NCT02701270|72087|P1|NOT COMPLETED|Third Intervention at Visit 3||0
31251|NCT02701270|72084|P4|COMPLETED|Third Intervention at Visit 3||3
31252|NCT02701270|72085|P3|COMPLETED|Third Intervention at Visit 3||3
31253|NCT02701270|72086|P2|COMPLETED|Third Intervention at Visit 3||3
31254|NCT02701270|72087|P1|COMPLETED|Third Intervention at Visit 3||2
31255|NCT02701270|72084|P4|STARTED|Third Intervention at Visit 3||3
31256|NCT02701270|72085|P3|STARTED|Third Intervention at Visit 3||3
31257|NCT02701270|72086|P2|STARTED|Third Intervention at Visit 3||3
31258|NCT02701270|72087|P1|STARTED|Third Intervention at Visit 3||2
31259|NCT02701270|72084|P4|NOT COMPLETED|Second Intervention at Visit 2||0
31260|NCT02701270|72085|P3|NOT COMPLETED|Second Intervention at Visit 2||0
31261|NCT02701270|72086|P2|NOT COMPLETED|Second Intervention at Visit 2||0
31262|NCT02701270|72087|P1|NOT COMPLETED|Second Intervention at Visit 2||0
31263|NCT02701270|72084|P4|COMPLETED|Second Intervention at Visit 2||3
31264|NCT02701270|72085|P3|COMPLETED|Second Intervention at Visit 2||3
31265|NCT02701270|72086|P2|COMPLETED|Second Intervention at Visit 2||3
31266|NCT02701270|72087|P1|COMPLETED|Second Intervention at Visit 2||2
31267|NCT02701270|72084|P4|STARTED|Second Intervention at Visit 2||3
31268|NCT02701270|72085|P3|STARTED|Second Intervention at Visit 2||3
31269|NCT02701270|72086|P2|STARTED|Second Intervention at Visit 2||3
31270|NCT02701270|72087|P1|STARTED|Second Intervention at Visit 2||2
31271|NCT02701270|72084|P4|NOT COMPLETED|First Intervention at Visit 1||0
31272|NCT02701270|72085|P3|NOT COMPLETED|First Intervention at Visit 1||0
31273|NCT02701270|72086|P2|NOT COMPLETED|First Intervention at Visit 1||0
31274|NCT02701270|72087|P1|NOT COMPLETED|First Intervention at Visit 1||0
31275|NCT02701270|72084|P4|COMPLETED|First Intervention at Visit 1||3
31276|NCT02701270|72085|P3|COMPLETED|First Intervention at Visit 1||3
31277|NCT02701270|72086|P2|COMPLETED|First Intervention at Visit 1||3
31278|NCT02701270|72087|P1|COMPLETED|First Intervention at Visit 1||2
31279|NCT02701270|72084|P4|STARTED|First Intervention at Visit 1||3
31280|NCT02701270|72085|P3|STARTED|First Intervention at Visit 1||3
31281|NCT02701270|72086|P2|STARTED|First Intervention at Visit 1||3
31282|NCT02701270|72087|P1|STARTED|First Intervention at Visit 1||2
31283|NCT02701257|72106|P5|NOT COMPLETED|Overall Study||3
31284|NCT02701257|72107|P4|NOT COMPLETED|Overall Study||1
31285|NCT02701257|72108|P3|NOT COMPLETED|Overall Study||0
31286|NCT02701257|72109|P2|NOT COMPLETED|Overall Study||3
31287|NCT02701257|72110|P1|NOT COMPLETED|Overall Study||0
31288|NCT02701257|72106|P5|COMPLETED|Overall Study||1
31289|NCT02701257|72107|P4|COMPLETED|Overall Study||3
31290|NCT02701257|72108|P3|COMPLETED|Overall Study||0
31291|NCT02701257|72109|P2|COMPLETED|Overall Study||3
31292|NCT02701257|72110|P1|COMPLETED|Overall Study||6
31293|NCT02701257|72106|P5|STARTED|Overall Study||4
31294|NCT02701257|72107|P4|STARTED|Overall Study||4
31295|NCT02701257|72108|P3|STARTED|Overall Study||0
31296|NCT02701257|72109|P2|STARTED|Overall Study||6
31297|NCT02701257|72110|P1|STARTED|Overall Study||6
31298|NCT02701049|72300|P3|NOT COMPLETED|Overall Study||0
31299|NCT02701049|72301|P2|NOT COMPLETED|Overall Study||0
31300|NCT02701049|72302|P1|NOT COMPLETED|Overall Study||0
31301|NCT02701049|72300|P3|COMPLETED|Overall Study|Total patients included in analysis|198
31302|NCT02701049|72301|P2|COMPLETED|Overall Study|Total patients included in analysis|342
31303|NCT02701049|72302|P1|COMPLETED|Overall Study|Total patients included in analysis|209
31304|NCT02701049|72300|P3|STARTED|Overall Study|Patients who completed a follow-up survey|198
31305|NCT02701049|72301|P2|STARTED|Overall Study|Patients who completed a follow-up survey|342
31306|NCT02701049|72302|P1|STARTED|Overall Study|Patients who completed a follow-up survey|209
31307|NCT02700997|72314|P1|NOT COMPLETED|Overall Study||2
31308|NCT02700997|72314|P1|COMPLETED|Overall Study||15
31309|NCT02700997|72314|P1|STARTED|Overall Study||17
31310|NCT02700984|72320|P2|NOT COMPLETED|Overall Study||14
31311|NCT02700984|72321|P1|NOT COMPLETED|Overall Study||15
31312|NCT02700984|72320|P2|COMPLETED|Overall Study||53
31313|NCT02700984|72321|P1|COMPLETED|Overall Study||200
31314|NCT02700984|72320|P2|STARTED|Overall Study||67
31315|NCT02700984|72321|P1|STARTED|Overall Study||215
31316|NCT02700815|72374|P4|NOT COMPLETED|Overall Study||7
31317|NCT02700815|72375|P3|NOT COMPLETED|Overall Study||4
31318|NCT02700815|72376|P2|NOT COMPLETED|Overall Study||7
31319|NCT02700815|72377|P1|NOT COMPLETED|Overall Study||1
31320|NCT02700815|72374|P4|COMPLETED|Overall Study||218
31321|NCT02700815|72375|P3|COMPLETED|Overall Study||219
31322|NCT02700815|72376|P2|COMPLETED|Overall Study||216
31323|NCT02700815|72377|P1|COMPLETED|Overall Study||74
31324|NCT02700815|72374|P4|STARTED|Overall Study||225
31325|NCT02700815|72375|P3|STARTED|Overall Study||223
31326|NCT02700815|72376|P2|STARTED|Overall Study||223
31327|NCT02700815|72377|P1|STARTED|Overall Study||75
31328|NCT02699983|72417|P2|NOT COMPLETED|Overall Study||0
31329|NCT02699983|72418|P1|NOT COMPLETED|Overall Study||1
31330|NCT02699983|72417|P2|COMPLETED|Overall Study||17
31331|NCT02699983|72418|P1|COMPLETED|Overall Study||17
31332|NCT02699983|72417|P2|STARTED|Overall Study||17
31333|NCT02699983|72418|P1|STARTED|Overall Study||18
31334|NCT02699970|72478|P1|NOT COMPLETED|Overall Study||0
31335|NCT02699970|72478|P1|COMPLETED|Overall Study||399
31336|NCT02699970|72478|P1|Inter-system|Overall Study||399
31337|NCT02699970|72478|P1|Intra-system|Overall Study||399
31338|NCT02699970|72478|P1|STARTED|Overall Study||399
31339|NCT02699892|72483|P1|NOT COMPLETED|Overall Study||36
31340|NCT02699892|72483|P1|COMPLETED|Overall Study||94
31341|NCT02699892|72483|P1|STARTED|Overall Study||130
31342|NCT02699684|72488|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
31343|NCT02699684|72489|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
31344|NCT02699684|72488|P2|COMPLETED|Period 2, Second 30 Days of Wear||38
31345|NCT02699684|72489|P1|COMPLETED|Period 2, Second 30 Days of Wear||36
31346|NCT02699684|72488|P2|STARTED|Period 2, Second 30 Days of Wear||38
31347|NCT02699684|72489|P1|STARTED|Period 2, Second 30 Days of Wear||37
31348|NCT02699684|72488|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||0
31349|NCT02699684|72489|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
31350|NCT02699684|72488|P2|COMPLETED|Period 1, First 30 Days of Wear||38
31351|NCT02699684|72489|P1|COMPLETED|Period 1, First 30 Days of Wear||37
31352|NCT02699684|72488|P2|STARTED|Period 1, First 30 Days of Wear||38
31353|NCT02699684|72489|P1|STARTED|Period 1, First 30 Days of Wear||37
31354|NCT02699632|72499|P1|NOT COMPLETED|Overall Study||2
31355|NCT02699632|72499|P1|COMPLETED|Overall Study||358
31356|NCT02699632|72499|P1|STARTED|Overall Study||360
31357|NCT02699593|72506|P2|NOT COMPLETED|Period 2||2
31358|NCT02699593|72507|P1|NOT COMPLETED|Period 2||2
31359|NCT02699593|72506|P2|COMPLETED|Period 2||60
31360|NCT02699593|72507|P1|COMPLETED|Period 2||65
31361|NCT02699593|72506|P2|STARTED|Period 2||62
31362|NCT02699593|72507|P1|STARTED|Period 2||67
31363|NCT02699593|72506|P2|NOT COMPLETED|Period 1||7
31364|NCT02699593|72507|P1|NOT COMPLETED|Period 1||5
31365|NCT02699593|72506|P2|COMPLETED|Period 1||62
31366|NCT02699593|72507|P1|COMPLETED|Period 1||67
31367|NCT02699593|72506|P2|STARTED|Period 1||69
31368|NCT02699593|72507|P1|STARTED|Period 1||72
31369|NCT02699099|72518|P3|NOT COMPLETED|Overall Study||3
31370|NCT02699099|72519|P2|NOT COMPLETED|Overall Study||2
31371|NCT02699099|72520|P1|NOT COMPLETED|Overall Study||7
31372|NCT02699099|72518|P3|COMPLETED|Overall Study||229
31373|NCT02699099|72519|P2|COMPLETED|Overall Study||234
31374|NCT02699099|72520|P1|COMPLETED|Overall Study||224
31375|NCT02699099|72518|P3|STARTED|Overall Study||232
31376|NCT02699099|72519|P2|STARTED|Overall Study||236
31377|NCT02699099|72520|P1|STARTED|Overall Study||231
31378|NCT02698800|72594|P2|NOT COMPLETED|Overall Study||0
31379|NCT02698800|72595|P1|NOT COMPLETED|Overall Study||1
31380|NCT02698800|72594|P2|COMPLETED|Overall Study||8
31381|NCT02698800|72595|P1|COMPLETED|Overall Study||6
31382|NCT02698800|72594|P2|STARTED|Overall Study||8
31383|NCT02698800|72595|P1|STARTED|Overall Study||7
31384|NCT02698735|72603|P1|NOT COMPLETED|Overall Study||0
31385|NCT02698735|72603|P1|COMPLETED|Overall Study|There are only 18 out of 20 samples because one patient declined intradermal injection intervention.|5
31386|NCT02698735|72603|P1|STARTED|Overall Study||5
31387|NCT02698566|72617|P2|NOT COMPLETED|Overall Study||0
31388|NCT02698566|72618|P1|NOT COMPLETED|Overall Study||0
31389|NCT02698566|72617|P2|COMPLETED|Overall Study||3
31390|NCT02698566|72618|P1|COMPLETED|Overall Study||35
31391|NCT02698566|72617|P2|STARTED|Overall Study||3
31392|NCT02698566|72618|P1|STARTED|Overall Study||35
31393|NCT02698436|72626|P2|NOT COMPLETED|Overall Study||7
31394|NCT02698436|72627|P1|NOT COMPLETED|Overall Study||7
31395|NCT02698436|72626|P2|COMPLETED|Overall Study||51
31396|NCT02698436|72627|P1|COMPLETED|Overall Study||52
31397|NCT02698436|72626|P2|STARTED|Overall Study||58
31398|NCT02698436|72627|P1|STARTED|Overall Study||59
31399|NCT02698423|72667|P2|NOT COMPLETED|Overall Study||24
31400|NCT02698423|72668|P1|NOT COMPLETED|Overall Study||19
31401|NCT02698423|72667|P2|COMPLETED|Overall Study||307
31402|NCT02698423|72668|P1|COMPLETED|Overall Study||317
31403|NCT02698423|72667|P2|STARTED|Overall Study||331
31404|NCT02698423|72668|P1|STARTED|Overall Study||336
31405|NCT02698371|72676|P1|NOT COMPLETED|ADU-SE (G6) Arm/Group Flow||2
31406|NCT02698371|72676|P1|COMPLETED|ADU-SE (G6) Arm/Group Flow||33
31407|NCT02698371|72676|P1|STARTED|ADU-SE (G6) Arm/Group Flow|Each participant received one NCCLs restoration with ADU-SE (G6 Arm/group)|35
31408|NCT02698371|72676|P1|NOT COMPLETED|ADU-ER (G5) Arm/Group Flow||3
31409|NCT02698371|72676|P1|COMPLETED|ADU-ER (G5) Arm/Group Flow||32
31410|NCT02698371|72676|P1|STARTED|ADU-ER (G5) Arm/Group Flow|Each participant received one NCCLs restoration with ADU-ER (G5 Arm/group)|35
31411|NCT02698371|72676|P1|NOT COMPLETED|FBU-SE (G4) Arm/Group Flow||3
31412|NCT02698371|72676|P1|COMPLETED|FBU-SE (G4) Arm/Group Flow||32
31413|NCT02698371|72676|P1|STARTED|FBU-SE (G4) Arm/Group Flow|Each participant received one NCCLs restoration with FBU-SE (G4 Arm/group)|35
31414|NCT02698371|72676|P1|NOT COMPLETED|FBU-ER (G3) Arm/Group Flow||3
31415|NCT02698371|72676|P1|COMPLETED|FBU-ER (G3) Arm/Group Flow||32
31416|NCT02698371|72676|P1|STARTED|FBU-ER (G3) Arm/Group Flow|Each participant received one NCCLs restoration with FBU-ER (G3 Arm/group)|35
31417|NCT02698371|72676|P1|NOT COMPLETED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||3
31418|NCT02698371|72676|P1|COMPLETED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||32
31419|NCT02698371|72676|P1|STARTED|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Each participant received one NCCLs restoration with FBDC-SE-EE (G2 control Arm/group)|35
31420|NCT02698371|72676|P1|NOT COMPLETED|FBDC-SE (G1; Control) Arm/Group Flow||3
31421|NCT02698371|72676|P1|COMPLETED|FBDC-SE (G1; Control) Arm/Group Flow||32
31422|NCT02698371|72676|P1|STARTED|FBDC-SE (G1; Control) Arm/Group Flow|Each participant received one NCCLs restoration with FBDC-SE (G1control Arm/Group).|35
31423|NCT02698371|72676|P1|NOT COMPLETED|All Participants Flow||3
31424|NCT02698371|72676|P1|COMPLETED|All Participants Flow||35
31425|NCT02698371|72676|P1|STARTED|All Participants Flow||38
31426|NCT02698189|72800|P2|NOT COMPLETED|Overall Study||6
31427|NCT02698189|72801|P1|NOT COMPLETED|Overall Study||3
31428|NCT02698189|72800|P2|COMPLETED|Overall Study||0
31429|NCT02698189|72801|P1|COMPLETED|Overall Study||0
31430|NCT02698189|72800|P2|STARTED|Overall Study||6
31431|NCT02698189|72801|P1|STARTED|Overall Study||3
31432|NCT02698176|72831|P4|NOT COMPLETED|Overall Study||0
31433|NCT02698176|72832|P3|NOT COMPLETED|Overall Study||1
31434|NCT02698176|72833|P2|NOT COMPLETED|Overall Study||3
31435|NCT02698176|72834|P1|NOT COMPLETED|Overall Study||9
31436|NCT02698176|72831|P4|COMPLETED|Overall Study||0
31437|NCT02698176|72832|P3|COMPLETED|Overall Study||0
31438|NCT02698176|72833|P2|COMPLETED|Overall Study||0
31439|NCT02698176|72834|P1|COMPLETED|Overall Study||0
31440|NCT02698176|72831|P4|STARTED|Overall Study|No participants were enrolled in Part B.|0
31441|NCT02698176|72832|P3|STARTED|Overall Study||1
31442|NCT02698176|72833|P2|STARTED|Overall Study||3
31443|NCT02698176|72834|P1|STARTED|Overall Study||9
31444|NCT02698033|72869|P1|NOT COMPLETED|Overall Study||1
31445|NCT02698033|72869|P1|COMPLETED|Overall Study||6
31446|NCT02698033|72869|P1|STARTED|Overall Study||7
31447|NCT02697890|72875|P2|NOT COMPLETED|Overall Study||0
31448|NCT02697890|72876|P1|NOT COMPLETED|Overall Study||0
31449|NCT02697890|72875|P2|COMPLETED|Overall Study||14
31450|NCT02697890|72876|P1|COMPLETED|Overall Study||14
31451|NCT02697890|72875|P2|STARTED|Overall Study||14
31452|NCT02697890|72876|P1|STARTED|Overall Study||14
31453|NCT02697773|72891|P3|NOT COMPLETED|Overall Study||40
31454|NCT02697773|72892|P2|NOT COMPLETED|Overall Study||38
31455|NCT02697773|72893|P1|NOT COMPLETED|Overall Study||38
31456|NCT02697773|72891|P3|COMPLETED|Overall Study||193
31457|NCT02697773|72892|P2|COMPLETED|Overall Study||194
31458|NCT02697773|72893|P1|COMPLETED|Overall Study||195
31459|NCT02697773|72891|P3|Treated|Overall Study||233
31460|NCT02697773|72892|P2|Treated|Overall Study||231
31461|NCT02697773|72893|P1|Treated|Overall Study||232
31462|NCT02697773|72891|P3|STARTED|Overall Study||233
31463|NCT02697773|72892|P2|STARTED|Overall Study||232
31464|NCT02697773|72893|P1|STARTED|Overall Study||233
31465|NCT02697435|73074|P2|NOT COMPLETED|Overall Study||4
31466|NCT02697435|73075|P1|NOT COMPLETED|Overall Study||1
31467|NCT02697435|73074|P2|COMPLETED|Overall Study||26
31468|NCT02697435|73075|P1|COMPLETED|Overall Study||24
31469|NCT02697435|73074|P2|STARTED|Overall Study||30
31470|NCT02697435|73075|P1|STARTED|Overall Study||25
31471|NCT02697240|73083|P1|NOT COMPLETED|Overall Study||0
31472|NCT02697240|73083|P1|COMPLETED|Overall Study||4
31473|NCT02697240|73083|P1|STARTED|Overall Study||4
31474|NCT02697214|73092|P6|NOT COMPLETED|Overall Study||0
31475|NCT02697214|73093|P5|NOT COMPLETED|Overall Study||0
31476|NCT02697214|73094|P4|NOT COMPLETED|Overall Study||0
31477|NCT02697214|73095|P3|NOT COMPLETED|Overall Study||0
31478|NCT02697214|73096|P2|NOT COMPLETED|Overall Study||0
31479|NCT02697214|73097|P1|NOT COMPLETED|Overall Study||0
31480|NCT02697214|73092|P6|COMPLETED|Overall Study||50
31481|NCT02697214|73093|P5|COMPLETED|Overall Study||50
31482|NCT02697214|73094|P4|COMPLETED|Overall Study||24
31483|NCT02697214|73095|P3|COMPLETED|Overall Study||25
31484|NCT02697214|73096|P2|COMPLETED|Overall Study||25
31485|NCT02697214|73097|P1|COMPLETED|Overall Study||26
31486|NCT02697214|73092|P6|Heart Rate at 6mph|Overall Study||50
31487|NCT02697214|73093|P5|Heart Rate at 6mph|Overall Study||50
31488|NCT02697214|73094|P4|Heart Rate at 6mph|Overall Study||24
31489|NCT02697214|73095|P3|Heart Rate at 6mph|Overall Study||25
31490|NCT02697214|73096|P2|Heart Rate at 6mph|Overall Study||25
31491|NCT02697214|73097|P1|Heart Rate at 6mph|Overall Study||26
31492|NCT02697214|73092|P6|Heart Rate at 4mph|Overall Study||50
31493|NCT02697214|73093|P5|Heart Rate at 4mph|Overall Study||50
31494|NCT02697214|73094|P4|Heart Rate at 4mph|Overall Study||24
31495|NCT02697214|73095|P3|Heart Rate at 4mph|Overall Study||25
31496|NCT02697214|73096|P2|Heart Rate at 4mph|Overall Study||25
31497|NCT02697214|73097|P1|Heart Rate at 4mph|Overall Study||26
31498|NCT02697214|73092|P6|Heart Rate at 3mph|Overall Study||50
31499|NCT02697214|73093|P5|Heart Rate at 3mph|Overall Study||50
31500|NCT02697214|73094|P4|Heart Rate at 3mph|Overall Study||24
31501|NCT02697214|73095|P3|Heart Rate at 3mph|Overall Study||25
31502|NCT02697214|73096|P2|Heart Rate at 3mph|Overall Study||25
31503|NCT02697214|73097|P1|Heart Rate at 3mph|Overall Study||26
31504|NCT02697214|73092|P6|Heart Rate at 2mph|Overall Study||50
31505|NCT02697214|73093|P5|Heart Rate at 2mph|Overall Study||50
31506|NCT02697214|73094|P4|Heart Rate at 2mph|Overall Study||24
31507|NCT02697214|73095|P3|Heart Rate at 2mph|Overall Study||25
31508|NCT02697214|73096|P2|Heart Rate at 2mph|Overall Study||25
31509|NCT02697214|73097|P1|Heart Rate at 2mph|Overall Study||26
31510|NCT02697214|73092|P6|STARTED|Overall Study||50
31511|NCT02697214|73093|P5|STARTED|Overall Study||50
31512|NCT02697214|73094|P4|STARTED|Overall Study||24
31513|NCT02697214|73095|P3|STARTED|Overall Study||25
31514|NCT02697214|73096|P2|STARTED|Overall Study||25
31515|NCT02697214|73097|P1|STARTED|Overall Study||26
31516|NCT02697188|73107|P1|NOT COMPLETED|TE Period 5 - 800 mg BID||0
31517|NCT02697188|73107|P1|COMPLETED|TE Period 5 - 800 mg BID||12
31518|NCT02697188|73107|P1|STARTED|TE Period 5 - 800 mg BID||12
31519|NCT02697188|73107|P1|NOT COMPLETED|TU Period 4 - 400 BID||0
31520|NCT02697188|73107|P1|COMPLETED|TU Period 4 - 400 BID||12
31521|NCT02697188|73107|P1|STARTED|TU Period 4 - 400 BID||12
31522|NCT02697188|73107|P1|NOT COMPLETED|TU Period 3 - 200 mg BID||0
31523|NCT02697188|73107|P1|COMPLETED|TU Period 3 - 200 mg BID||12
31524|NCT02697188|73107|P1|STARTED|TU Period 3 - 200 mg BID||12
31525|NCT02697188|73107|P1|NOT COMPLETED|TU Period 2 – 200 mg QD||0
31526|NCT02697188|73107|P1|COMPLETED|TU Period 2 – 200 mg QD||12
31527|NCT02697188|73107|P1|STARTED|TU Period 2 – 200 mg QD||12
31528|NCT02697188|73107|P1|NOT COMPLETED|TE Period 1 - 400 mg QD||0
31529|NCT02697188|73107|P1|COMPLETED|TE Period 1 - 400 mg QD||12
31530|NCT02697188|73107|P1|STARTED|TE Period 1 - 400 mg QD||12
31531|NCT02696850|73118|P2|NOT COMPLETED|Overall Study||8
31532|NCT02696850|73119|P1|NOT COMPLETED|Overall Study||11
31533|NCT02696850|73118|P2|COMPLETED|Overall Study||32
31534|NCT02696850|73119|P1|COMPLETED|Overall Study||29
31535|NCT02696850|73118|P2|STARTED|Overall Study||40
31536|NCT02696850|73119|P1|STARTED|Overall Study||40
31537|NCT02696798|73132|P3|NOT COMPLETED|Post-treatment Follow-up Period||19
31538|NCT02696798|73133|P2|NOT COMPLETED|Post-treatment Follow-up Period||26
31539|NCT02696798|73134|P1|NOT COMPLETED|Post-treatment Follow-up Period||5
31540|NCT02696798|73132|P3|COMPLETED|Post-treatment Follow-up Period||3
31541|NCT02696798|73133|P2|COMPLETED|Post-treatment Follow-up Period||8
31542|NCT02696798|73134|P1|COMPLETED|Post-treatment Follow-up Period||0
31543|NCT02696798|73132|P3|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|22
31544|NCT02696798|73133|P2|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|34
31545|NCT02696798|73134|P1|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|5
31546|NCT02696798|73132|P3|NOT COMPLETED|Extended Treatment Period||10
31547|NCT02696798|73133|P2|NOT COMPLETED|Extended Treatment Period||9
31548|NCT02696798|73134|P1|NOT COMPLETED|Extended Treatment Period||12
31549|NCT02696798|73132|P3|COMPLETED|Extended Treatment Period||80
31550|NCT02696798|73133|P2|COMPLETED|Extended Treatment Period||89
31551|NCT02696798|73134|P1|COMPLETED|Extended Treatment Period||81
31552|NCT02696798|73132|P3|STARTED|Extended Treatment Period||90
31553|NCT02696798|73133|P2|STARTED|Extended Treatment Period|1 participant completed blinded treatment period and entered post-treatment followup period directly|98
31554|NCT02696798|73134|P1|STARTED|Extended Treatment Period||93
31555|NCT02696798|73132|P3|NOT COMPLETED|Blinded Treatment Dosing Period||8
31556|NCT02696798|73133|P2|NOT COMPLETED|Blinded Treatment Dosing Period||15
31557|NCT02696798|73134|P1|NOT COMPLETED|Blinded Treatment Dosing Period||11
31558|NCT02696798|73132|P3|COMPLETED|Blinded Treatment Dosing Period||90
31559|NCT02696798|73133|P2|COMPLETED|Blinded Treatment Dosing Period||99
31560|NCT02696798|73134|P1|COMPLETED|Blinded Treatment Dosing Period||93
31561|NCT02696798|73132|P3|STARTED|Blinded Treatment Dosing Period||98
31562|NCT02696798|73133|P2|STARTED|Blinded Treatment Dosing Period||114
31563|NCT02696798|73134|P1|STARTED|Blinded Treatment Dosing Period||104
31564|NCT02696785|73231|P4|NOT COMPLETED|Follow-up Period||8
31565|NCT02696785|73232|P3|NOT COMPLETED|Follow-up Period||13
31566|NCT02696785|73233|P2|NOT COMPLETED|Follow-up Period||0
31567|NCT02696785|73234|P1|NOT COMPLETED|Follow-up Period||1
31568|NCT02696785|73231|P4|COMPLETED|Follow-up Period||8
31569|NCT02696785|73232|P3|COMPLETED|Follow-up Period||11
31570|NCT02696785|73233|P2|COMPLETED|Follow-up Period||0
31571|NCT02696785|73234|P1|COMPLETED|Follow-up Period||0
31572|NCT02696785|73231|P4|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|16
31573|NCT02696785|73232|P3|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|24
31574|NCT02696785|73233|P2|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|0
31661|NCT02696070|73442|P2|NOT COMPLETED|Overall Study||2
31575|NCT02696785|73234|P1|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|1
31576|NCT02696785|73231|P4|NOT COMPLETED|Extended Treatment Period||6
31577|NCT02696785|73232|P3|NOT COMPLETED|Extended Treatment Period||5
31578|NCT02696785|73233|P2|NOT COMPLETED|Extended Treatment Period||6
31579|NCT02696785|73234|P1|NOT COMPLETED|Extended Treatment Period||3
31580|NCT02696785|73231|P4|COMPLETED|Extended Treatment Period||72
31581|NCT02696785|73232|P3|COMPLETED|Extended Treatment Period||74
31582|NCT02696785|73233|P2|COMPLETED|Extended Treatment Period||80
31583|NCT02696785|73234|P1|COMPLETED|Extended Treatment Period||83
31584|NCT02696785|73231|P4|STARTED|Extended Treatment Period||78
31585|NCT02696785|73232|P3|STARTED|Extended Treatment Period||79
31586|NCT02696785|73233|P2|STARTED|Extended Treatment Period||86
31587|NCT02696785|73234|P1|STARTED|Extended Treatment Period||86
31588|NCT02696785|73231|P4|NOT COMPLETED|Washout Period||0
31589|NCT02696785|73232|P3|NOT COMPLETED|Washout Period||0
31590|NCT02696785|73233|P2|NOT COMPLETED|Washout Period||2
31591|NCT02696785|73234|P1|NOT COMPLETED|Washout Period||0
31592|NCT02696785|73231|P4|COMPLETED|Washout Period||0
31593|NCT02696785|73232|P3|COMPLETED|Washout Period||0
31594|NCT02696785|73233|P2|COMPLETED|Washout Period||86
31595|NCT02696785|73234|P1|COMPLETED|Washout Period||0
31596|NCT02696785|73231|P4|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
31597|NCT02696785|73232|P3|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
31598|NCT02696785|73233|P2|STARTED|Washout Period||88
31599|NCT02696785|73234|P1|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
31600|NCT02696785|73231|P4|NOT COMPLETED|Blinded Treatment Period||3
31601|NCT02696785|73232|P3|NOT COMPLETED|Blinded Treatment Period||4
31602|NCT02696785|73233|P2|NOT COMPLETED|Blinded Treatment Period||2
31603|NCT02696785|73234|P1|NOT COMPLETED|Blinded Treatment Period||1
31604|NCT02696785|73231|P4|COMPLETED|Blinded Treatment Period||78
31605|NCT02696785|73232|P3|COMPLETED|Blinded Treatment Period||79
31606|NCT02696785|73233|P2|COMPLETED|Blinded Treatment Period||88
31607|NCT02696785|73234|P1|COMPLETED|Blinded Treatment Period||86
31608|NCT02696785|73231|P4|Received at Least One Dose of Study Drug|Blinded Treatment Period||81
31609|NCT02696785|73232|P3|Received at Least One Dose of Study Drug|Blinded Treatment Period||83
31610|NCT02696785|73233|P2|Received at Least One Dose of Study Drug|Blinded Treatment Period||90
31611|NCT02696785|73234|P1|Received at Least One Dose of Study Drug|Blinded Treatment Period||86
31612|NCT02696785|73231|P4|STARTED|Blinded Treatment Period||81
31613|NCT02696785|73232|P3|STARTED|Blinded Treatment Period||83
31614|NCT02696785|73233|P2|STARTED|Blinded Treatment Period||90
31615|NCT02696785|73234|P1|STARTED|Blinded Treatment Period||87
31616|NCT02696434|73354|P2|NOT COMPLETED|Overall Study||18
31617|NCT02696434|73355|P1|NOT COMPLETED|Overall Study||22
31618|NCT02696434|73354|P2|COMPLETED|Overall Study||33
31619|NCT02696434|73355|P1|COMPLETED|Overall Study||28
31620|NCT02696434|73354|P2|STARTED|Overall Study||51
31621|NCT02696434|73355|P1|STARTED|Overall Study||50
31622|NCT02696317|73373|P2|NOT COMPLETED|Period 2, 10 Days of Wear||0
31623|NCT02696317|73374|P1|NOT COMPLETED|Period 2, 10 Days of Wear||1
31624|NCT02696317|73373|P2|COMPLETED|Period 2, 10 Days of Wear||36
31625|NCT02696317|73374|P1|COMPLETED|Period 2, 10 Days of Wear||39
31626|NCT02696317|73373|P2|STARTED|Period 2, 10 Days of Wear||36
31627|NCT02696317|73374|P1|STARTED|Period 2, 10 Days of Wear||40
31628|NCT02696317|73373|P2|NOT COMPLETED|Period 1, 10 Days of Wear||0
31629|NCT02696317|73374|P1|NOT COMPLETED|Period 1, 10 Days of Wear||0
31630|NCT02696317|73373|P2|COMPLETED|Period 1, 10 Days of Wear||36
31631|NCT02696317|73374|P1|COMPLETED|Period 1, 10 Days of Wear||40
31632|NCT02696317|73373|P2|STARTED|Period 1, 10 Days of Wear||36
31633|NCT02696317|73374|P1|STARTED|Period 1, 10 Days of Wear||40
31634|NCT02696317|73373|P2|NOT COMPLETED|Habitual, 10 Days of Wear||4
31635|NCT02696317|73374|P1|NOT COMPLETED|Habitual, 10 Days of Wear||2
31636|NCT02696317|73373|P2|COMPLETED|Habitual, 10 Days of Wear||36
31637|NCT02696317|73374|P1|COMPLETED|Habitual, 10 Days of Wear||40
31638|NCT02696317|73373|P2|STARTED|Habitual, 10 Days of Wear||40
31639|NCT02696317|73374|P1|STARTED|Habitual, 10 Days of Wear||42
31640|NCT02696291|73390|P2|NOT COMPLETED|Overall Study||0
31641|NCT02696291|73391|P1|NOT COMPLETED|Overall Study||0
31642|NCT02696291|73390|P2|COMPLETED|Overall Study||2
31643|NCT02696291|73391|P1|COMPLETED|Overall Study||5
31644|NCT02696291|73390|P2|STARTED|Overall Study||2
31645|NCT02696291|73391|P1|STARTED|Overall Study||5
31646|NCT02696226|73418|P4|NOT COMPLETED|Overall Study||0
31647|NCT02696226|73419|P3|NOT COMPLETED|Overall Study||2
31648|NCT02696226|73420|P2|NOT COMPLETED|Overall Study||0
31649|NCT02696226|73421|P1|NOT COMPLETED|Overall Study||1
31650|NCT02696226|73418|P4|COMPLETED|Overall Study||0
31651|NCT02696226|73419|P3|COMPLETED|Overall Study||0
31652|NCT02696226|73420|P2|COMPLETED|Overall Study||0
31653|NCT02696226|73421|P1|COMPLETED|Overall Study||0
31654|NCT02696226|73418|P4|STARTED|Overall Study||0
31655|NCT02696226|73419|P3|STARTED|Overall Study||2
31656|NCT02696226|73420|P2|STARTED|Overall Study||0
31657|NCT02696226|73421|P1|STARTED|Overall Study||1
31658|NCT02696083|73431|P1|NOT COMPLETED|Overall Study||6
31659|NCT02696083|73431|P1|COMPLETED|Overall Study||13
31660|NCT02696083|73431|P1|STARTED|Overall Study||19
31662|NCT02696070|73443|P1|NOT COMPLETED|Overall Study||1
31663|NCT02696070|73442|P2|COMPLETED|Overall Study||12
31664|NCT02696070|73443|P1|COMPLETED|Overall Study||7
31665|NCT02696070|73442|P2|STARTED|Overall Study||14
31666|NCT02696070|73443|P1|STARTED|Overall Study||8
31667|NCT02695719|73451|P2|NOT COMPLETED|Overall Study||10
31668|NCT02695719|73452|P1|NOT COMPLETED|Overall Study||3
31669|NCT02695719|73451|P2|COMPLETED|Overall Study||72
31670|NCT02695719|73452|P1|COMPLETED|Overall Study||71
31671|NCT02695719|73451|P2|STARTED|Overall Study||82
31672|NCT02695719|73452|P1|STARTED|Overall Study||74
31673|NCT02695628|73470|P1|NOT COMPLETED|Overall Study||1
31674|NCT02695628|73470|P1|COMPLETED|Overall Study||4
31675|NCT02695628|73470|P1|STARTED|Overall Study||5
31676|NCT02695524|73478|P2|NOT COMPLETED|Overall Study||3
31677|NCT02695524|73479|P1|NOT COMPLETED|Overall Study||3
31678|NCT02695524|73478|P2|COMPLETED|Overall Study||27
31679|NCT02695524|73479|P1|COMPLETED|Overall Study||27
31680|NCT02695524|73478|P2|STARTED|Overall Study||30
31681|NCT02695524|73479|P1|STARTED|Overall Study||30
31682|NCT02695446|73499|P1|NOT COMPLETED|Overall Study||0
31683|NCT02695446|73499|P1|COMPLETED|Overall Study||12
31684|NCT02695446|73499|P1|STARTED|Overall Study||12
31685|NCT02695329|73506|P2|NOT COMPLETED|Overall Study||5
31686|NCT02695329|73507|P1|NOT COMPLETED|Overall Study||5
31687|NCT02695329|73506|P2|COMPLETED|Overall Study||45
31688|NCT02695329|73507|P1|COMPLETED|Overall Study||45
31689|NCT02695329|73506|P2|STARTED|Overall Study||50
31690|NCT02695329|73507|P1|STARTED|Overall Study||50
31691|NCT02695290|73519|P1|NOT COMPLETED|Overall Study||0
31692|NCT02695290|73519|P1|COMPLETED|Overall Study||1
31693|NCT02695290|73519|P1|STARTED|Overall Study||1
31694|NCT02694978|73527|P2|NOT COMPLETED|Overall Study||60
31695|NCT02694978|73528|P1|NOT COMPLETED|Overall Study||71
31696|NCT02694978|73527|P2|COMPLETED|Overall Study||948
31697|NCT02694978|73528|P1|COMPLETED|Overall Study||935
31698|NCT02694978|73527|P2|Received at Least 1 Dose of Study Drug|Overall Study||1000
31699|NCT02694978|73528|P1|Received at Least 1 Dose of Study Drug|Overall Study||997
31700|NCT02694978|73527|P2|STARTED|Overall Study||1008
31701|NCT02694978|73528|P1|STARTED|Overall Study||1006
31702|NCT02694835|73542|P2|NOT COMPLETED|Overall Study||0
31703|NCT02694835|73543|P1|NOT COMPLETED|Overall Study||0
31704|NCT02694835|73542|P2|COMPLETED|Overall Study||39
31705|NCT02694835|73543|P1|COMPLETED|Overall Study||41
31706|NCT02694835|73542|P2|STARTED|Overall Study||39
31707|NCT02694835|73543|P1|STARTED|Overall Study||41
31708|NCT02694744|73551|P2|NOT COMPLETED|Overall Study||5
31709|NCT02694744|73552|P1|NOT COMPLETED|Overall Study||6
31710|NCT02694744|73551|P2|COMPLETED|Overall Study||52
31711|NCT02694744|73552|P1|COMPLETED|Overall Study||51
31712|NCT02694744|73551|P2|ITT|Overall Study||55
31713|NCT02694744|73552|P1|ITT|Overall Study||57
31714|NCT02694744|73551|P2|Safety Population|Overall Study||56
31715|NCT02694744|73552|P1|Safety Population|Overall Study||57
31716|NCT02694744|73551|P2|STARTED|Overall Study||57
31717|NCT02694744|73552|P1|STARTED|Overall Study||57
31718|NCT02694718|73560|P1|NOT COMPLETED|Overall Study||2
31719|NCT02694718|73560|P1|COMPLETED|Overall Study||58
31720|NCT02694718|73560|P1|STARTED|Overall Study||60
31721|NCT02694601|73570|P1|NOT COMPLETED|Overall Study||0
31722|NCT02694601|73570|P1|COMPLETED|Overall Study||10
31723|NCT02694601|73570|P1|STARTED|Overall Study||10
31724|NCT02694562|73578|P1|NOT COMPLETED|Overall Study||18
31725|NCT02694562|73578|P1|COMPLETED|Overall Study||2
31726|NCT02694562|73578|P1|STARTED|Overall Study||20
31727|NCT02694549|73587|P1|NOT COMPLETED|Overall Study||2
31728|NCT02694549|73587|P1|COMPLETED|Overall Study||10
31729|NCT02694549|73587|P1|STARTED|Overall Study||12
31730|NCT02694536|73593|P1|NOT COMPLETED|Overall Study||80
31731|NCT02694536|73593|P1|COMPLETED|Overall Study||0
31732|NCT02694536|73593|P1|STARTED|Overall Study||80
31733|NCT02694523|73604|P7|NOT COMPLETED|Part B||2
31734|NCT02694523|73605|P6|NOT COMPLETED|Part B||5
31735|NCT02694523|73606|P5|NOT COMPLETED|Part B||4
31736|NCT02694523|73607|P4|NOT COMPLETED|Part B||4
31737|NCT02694523|73608|P3|NOT COMPLETED|Part B||20
31738|NCT02694523|73609|P2|NOT COMPLETED|Part B||0
31739|NCT02694523|73610|P1|NOT COMPLETED|Part B||0
31740|NCT02694523|73604|P7|COMPLETED|Part B||51
31741|NCT02694523|73605|P6|COMPLETED|Part B||51
31742|NCT02694523|73606|P5|COMPLETED|Part B||34
31743|NCT02694523|73607|P4|COMPLETED|Part B||140
31744|NCT02694523|73608|P3|COMPLETED|Part B||274
31745|NCT02694523|73609|P2|COMPLETED|Part B||0
31746|NCT02694523|73610|P1|COMPLETED|Part B||0
31747|NCT02694523|73604|P7|STARTED|Part B|Adalimumab inadequate responders in Part A, rerandomized to risankizumab in Part B|53
31748|NCT02694523|73605|P6|STARTED|Part B|Adalimumab inadequate responders in Part A, rerandomized to adalimumab in Part B|56
31749|NCT02694523|73606|P5|STARTED|Part B|Adalimumab nonresponders in Part A switched to risankizumab in Part B|38
31750|NCT02694523|73607|P4|STARTED|Part B|Adalimumab responders in Part A continued to received adalimumab in Part B|144
31751|NCT02694523|73608|P3|STARTED|Part B|Participants who received risankizumab in Part A continued to received risankizumab in Part B|294
31752|NCT02694523|73609|P2|STARTED|Part B||0
31753|NCT02694523|73610|P1|STARTED|Part B||0
31754|NCT02694523|73604|P7|NOT COMPLETED|Part A||0
31755|NCT02694523|73605|P6|NOT COMPLETED|Part A||0
31756|NCT02694523|73606|P5|NOT COMPLETED|Part A||0
31757|NCT02694523|73607|P4|NOT COMPLETED|Part A||0
31758|NCT02694523|73608|P3|NOT COMPLETED|Part A||0
31759|NCT02694523|73609|P2|NOT COMPLETED|Part A||7
31760|NCT02694523|73610|P1|NOT COMPLETED|Part A||13
31761|NCT02694523|73604|P7|COMPLETED|Part A||0
31762|NCT02694523|73605|P6|COMPLETED|Part A||0
31763|NCT02694523|73606|P5|COMPLETED|Part A||0
31764|NCT02694523|73607|P4|COMPLETED|Part A||0
31765|NCT02694523|73608|P3|COMPLETED|Part A||0
31766|NCT02694523|73609|P2|COMPLETED|Part A||294
31767|NCT02694523|73610|P1|COMPLETED|Part A||291
31768|NCT02694523|73604|P7|STARTED|Part A||0
31769|NCT02694523|73605|P6|STARTED|Part A||0
31770|NCT02694523|73606|P5|STARTED|Part A||0
31771|NCT02694523|73607|P4|STARTED|Part A||0
31772|NCT02694523|73608|P3|STARTED|Part A||0
31773|NCT02694523|73609|P2|STARTED|Part A||301
31774|NCT02694523|73610|P1|STARTED|Part A||304
31775|NCT02694315|73634|P1|NOT COMPLETED|Overall Study||0
31776|NCT02694315|73634|P1|COMPLETED|Overall Study||200
31777|NCT02694315|73634|P1|STARTED|Overall Study||200
31778|NCT02694198|73639|P1|NOT COMPLETED|Overall Study||0
31779|NCT02694198|73639|P1|COMPLETED|Overall Study||135
31780|NCT02694198|73639|P1|STARTED|Overall Study||135
31781|NCT02693704|73648|P4|NOT COMPLETED|Overall Study||0
31782|NCT02693704|73649|P3|NOT COMPLETED|Overall Study||0
31783|NCT02693704|73650|P2|NOT COMPLETED|Overall Study||0
31784|NCT02693704|73651|P1|NOT COMPLETED|Overall Study||0
31785|NCT02693704|73648|P4|COMPLETED|Overall Study||10
31786|NCT02693704|73649|P3|COMPLETED|Overall Study||10
31787|NCT02693704|73650|P2|COMPLETED|Overall Study||10
31788|NCT02693704|73651|P1|COMPLETED|Overall Study||10
31789|NCT02693704|73648|P4|STARTED|Overall Study||10
31790|NCT02693704|73649|P3|STARTED|Overall Study||10
31791|NCT02693704|73650|P2|STARTED|Overall Study||10
31792|NCT02693704|73651|P1|STARTED|Overall Study||10
31793|NCT02693171|73669|P1|NOT COMPLETED|Overall Study||9
31794|NCT02693171|73669|P1|COMPLETED|Overall Study||3
31795|NCT02693171|73669|P1|STARTED|Overall Study|At study termination, 13 subjects had enrolled, 12 subjects received at least 1 dose of study drug.|12
31796|NCT02693132|73679|P3|NOT COMPLETED|Overall Study||1
31797|NCT02693132|73680|P2|NOT COMPLETED|Overall Study||1
31798|NCT02693132|73681|P1|NOT COMPLETED|Overall Study||1
31799|NCT02693132|73679|P3|COMPLETED|Overall Study||17
31800|NCT02693132|73680|P2|COMPLETED|Overall Study||16
31801|NCT02693132|73681|P1|COMPLETED|Overall Study||16
31802|NCT02693132|73679|P3|STARTED|Overall Study||18
31803|NCT02693132|73680|P2|STARTED|Overall Study||17
31804|NCT02693132|73681|P1|STARTED|Overall Study||17
31805|NCT02693002|73703|P2|NOT COMPLETED|Overall Study||0
31806|NCT02693002|73704|P1|NOT COMPLETED|Overall Study||1
31807|NCT02693002|73703|P2|COMPLETED|Overall Study||2
31808|NCT02693002|73704|P1|COMPLETED|Overall Study||1
31809|NCT02693002|73703|P2|STARTED|Overall Study||2
31810|NCT02693002|73704|P1|STARTED|Overall Study||2
31811|NCT02692859|73718|P2|NOT COMPLETED|Overall Study||95
31812|NCT02692859|73719|P1|NOT COMPLETED|Overall Study||84
31813|NCT02692859|73718|P2|COMPLETED|Overall Study||901
31814|NCT02692859|73719|P1|COMPLETED|Overall Study||912
31815|NCT02692859|73718|P2|STARTED|Overall Study||996
31816|NCT02692859|73719|P1|STARTED|Overall Study||996
31817|NCT02692703|73725|P1|NOT COMPLETED|Overall Study||2
31818|NCT02692703|73725|P1|COMPLETED|Overall Study||98
31819|NCT02692703|73725|P1|STARTED|Overall Study||100
31820|NCT02692560|73733|P2|NOT COMPLETED|Overall Study||6
31821|NCT02692560|73734|P1|NOT COMPLETED|Overall Study||0
31822|NCT02692560|73733|P2|COMPLETED|Overall Study||25
31823|NCT02692560|73734|P1|COMPLETED|Overall Study||29
31824|NCT02692560|73733|P2|STARTED|Overall Study||31
31825|NCT02692560|73734|P1|STARTED|Overall Study||29
31826|NCT02692495|73756|P2|NOT COMPLETED|Overall Study||0
31827|NCT02692495|73757|P1|NOT COMPLETED|Overall Study||0
31828|NCT02692495|73756|P2|COMPLETED|Overall Study||4
31829|NCT02692495|73757|P1|COMPLETED|Overall Study||12
31830|NCT02692495|73756|P2|STARTED|Overall Study||4
31831|NCT02692495|73757|P1|STARTED|Overall Study||12
31832|NCT02692482|73774|P2|NOT COMPLETED|Overall Study||4
31833|NCT02692482|73775|P1|NOT COMPLETED|Overall Study||3
31834|NCT02692482|73774|P2|COMPLETED|Overall Study||178
31835|NCT02692482|73775|P1|COMPLETED|Overall Study||174
31836|NCT02692482|73774|P2|STARTED|Overall Study||182
31837|NCT02692482|73775|P1|STARTED|Overall Study||177
31838|NCT02692417|73789|P2|NOT COMPLETED|Overall Study||1
31839|NCT02692417|73790|P1|NOT COMPLETED|Overall Study||6
31840|NCT02692417|73789|P2|COMPLETED|Overall Study||6
31841|NCT02692417|73790|P1|COMPLETED|Overall Study||3
31842|NCT02692417|73789|P2|STARTED|Overall Study||7
31843|NCT02692417|73790|P1|STARTED|Overall Study||9
31844|NCT02692235|73802|P2|NOT COMPLETED|Overall Study||3
31845|NCT02692235|73803|P1|NOT COMPLETED|Overall Study||3
31846|NCT02692235|73802|P2|COMPLETED|Overall Study||11
31847|NCT02692235|73803|P1|COMPLETED|Overall Study||11
31848|NCT02692235|73802|P2|STARTED|Overall Study||14
31849|NCT02692235|73803|P1|STARTED|Overall Study||14
31850|NCT02691936|73813|P2|NOT COMPLETED|Overall Study||5
31851|NCT02691936|73814|P1|NOT COMPLETED|Overall Study||2
31852|NCT02691936|73813|P2|COMPLETED|Overall Study||29
31853|NCT02691936|73814|P1|COMPLETED|Overall Study||33
31854|NCT02691936|73813|P2|STARTED|Overall Study||34
31855|NCT02691936|73814|P1|STARTED|Overall Study||35
31856|NCT02691741|73836|P2|NOT COMPLETED|Overall Study||7
31857|NCT02691741|73837|P1|NOT COMPLETED|Overall Study||1
31858|NCT02691741|73836|P2|COMPLETED|Overall Study||87
31859|NCT02691741|73837|P1|COMPLETED|Overall Study||93
31860|NCT02691741|73836|P2|Safety Analysis Set|Overall Study||89
31861|NCT02691741|73837|P1|Safety Analysis Set|Overall Study||93
31862|NCT02691741|73836|P2|Best-Case Analysis Set|Overall Study||85
31863|NCT02691741|73837|P1|Best-Case Analysis Set|Overall Study||86
31864|NCT02691741|73836|P2|All-Implanted Analysis Set|Overall Study||89
31865|NCT02691741|73837|P1|All-Implanted Analysis Set|Overall Study||93
31866|NCT02691741|73836|P2|STARTED|Overall Study||94
31867|NCT02691741|73837|P1|STARTED|Overall Study||94
31868|NCT02691702|73877|P11|NOT COMPLETED|Overall Study||2
31869|NCT02691702|73878|P10|NOT COMPLETED|Overall Study||2
31870|NCT02691702|73879|P9|NOT COMPLETED|Overall Study||2
31871|NCT02691702|73880|P8|NOT COMPLETED|Overall Study||0
31872|NCT02691702|73881|P7|NOT COMPLETED|Overall Study||3
31873|NCT02691702|73882|P6|NOT COMPLETED|Overall Study||3
31874|NCT02691702|73883|P5|NOT COMPLETED|Overall Study||0
31875|NCT02691702|73884|P4|NOT COMPLETED|Overall Study||0
31876|NCT02691702|73885|P3|NOT COMPLETED|Overall Study||1
31877|NCT02691702|73886|P2|NOT COMPLETED|Overall Study||1
31878|NCT02691702|73887|P1|NOT COMPLETED|Overall Study||2
31879|NCT02691702|73877|P11|COMPLETED|Overall Study||6
31880|NCT02691702|73878|P10|COMPLETED|Overall Study||6
31881|NCT02691702|73879|P9|COMPLETED|Overall Study||6
31882|NCT02691702|73880|P8|COMPLETED|Overall Study||12
31883|NCT02691702|73881|P7|COMPLETED|Overall Study||5
31884|NCT02691702|73882|P6|COMPLETED|Overall Study||5
31885|NCT02691702|73883|P5|COMPLETED|Overall Study||8
31886|NCT02691702|73884|P4|COMPLETED|Overall Study||8
31887|NCT02691702|73885|P3|COMPLETED|Overall Study||7
31888|NCT02691702|73886|P2|COMPLETED|Overall Study||10
31889|NCT02691702|73887|P1|COMPLETED|Overall Study||8
31890|NCT02691702|73877|P11|STARTED|Overall Study||8
31891|NCT02691702|73878|P10|STARTED|Overall Study||8
31892|NCT02691702|73879|P9|STARTED|Overall Study||8
31893|NCT02691702|73880|P8|STARTED|Overall Study||12
31894|NCT02691702|73881|P7|STARTED|Overall Study||8
31895|NCT02691702|73882|P6|STARTED|Overall Study||8
31896|NCT02691702|73883|P5|STARTED|Overall Study||8
31897|NCT02691702|73884|P4|STARTED|Overall Study||8
31898|NCT02691702|73885|P3|STARTED|Overall Study||8
31899|NCT02691702|73886|P2|STARTED|Overall Study||11
31900|NCT02691702|73887|P1|STARTED|Overall Study||10
31901|NCT02691572|74173|P2|NOT COMPLETED|Overall Study||1
31902|NCT02691572|74174|P1|NOT COMPLETED|Overall Study||1
31903|NCT02691572|74173|P2|COMPLETED|Overall Study||39
31904|NCT02691572|74174|P1|COMPLETED|Overall Study||39
31905|NCT02691572|74173|P2|STARTED|Overall Study||40
31906|NCT02691572|74174|P1|STARTED|Overall Study||40
31907|NCT02691507|74182|P2|NOT COMPLETED|Overall Study||1
31908|NCT02691507|74183|P1|NOT COMPLETED|Overall Study||0
31909|NCT02691507|74182|P2|COMPLETED|Overall Study||12
31910|NCT02691507|74183|P1|COMPLETED|Overall Study||40
31911|NCT02691507|74182|P2|STARTED|Overall Study||13
31912|NCT02691507|74183|P1|STARTED|Overall Study||40
31913|NCT02691416|74315|P2|NOT COMPLETED|Overall Study||0
31914|NCT02691416|74316|P1|NOT COMPLETED|Overall Study||0
31915|NCT02691416|74315|P2|COMPLETED|Overall Study||30
31916|NCT02691416|74316|P1|COMPLETED|Overall Study||30
31917|NCT02691416|74315|P2|STARTED|Overall Study||30
31918|NCT02691416|74316|P1|STARTED|Overall Study||30
31919|NCT02691260|74340|P4|NOT COMPLETED|Overall Study||3
31920|NCT02691260|74341|P3|NOT COMPLETED|Overall Study||2
31921|NCT02691260|74342|P2|NOT COMPLETED|Overall Study||2
31922|NCT02691260|74343|P1|NOT COMPLETED|Overall Study||2
31923|NCT02691260|74340|P4|COMPLETED|Overall Study||23
31924|NCT02691260|74341|P3|COMPLETED|Overall Study||25
31925|NCT02691260|74342|P2|COMPLETED|Overall Study||24
31926|NCT02691260|74343|P1|COMPLETED|Overall Study||24
31927|NCT02691260|74340|P4|STARTED|Overall Study||26
31928|NCT02691260|74341|P3|STARTED|Overall Study||27
31929|NCT02691260|74342|P2|STARTED|Overall Study||26
31930|NCT02691260|74343|P1|STARTED|Overall Study||26
31931|NCT02691143|74355|P2|NOT COMPLETED|Overall Study||0
31932|NCT02691143|74356|P1|NOT COMPLETED|Overall Study||0
31933|NCT02691143|74355|P2|COMPLETED|Overall Study||23
31934|NCT02691143|74356|P1|COMPLETED|Overall Study||27
31935|NCT02691143|74355|P2|STARTED|Overall Study||23
31936|NCT02691143|74356|P1|STARTED|Overall Study||27
31937|NCT02691013|74366|P2|NOT COMPLETED|Overall Study||0
31938|NCT02691013|74367|P1|NOT COMPLETED|Overall Study||3
31939|NCT02691013|74366|P2|COMPLETED|Overall Study||59
31940|NCT02691013|74367|P1|COMPLETED|Overall Study||58
31941|NCT02691013|74366|P2|STARTED|Overall Study||59
31942|NCT02691013|74367|P1|STARTED|Overall Study||61
31943|NCT02690974|74381|P1|NOT COMPLETED|Overall Study||40
31944|NCT02690974|74381|P1|COMPLETED|Overall Study||262
31945|NCT02690974|74381|P1|STARTED|Overall Study||302
31946|NCT02690948|74394|P2|NOT COMPLETED|Overall Study||0
31947|NCT02690948|74395|P1|NOT COMPLETED|Overall Study||0
31948|NCT02690948|74394|P2|COMPLETED|Overall Study||7
31949|NCT02690948|74395|P1|COMPLETED|Overall Study||9
31950|NCT02690948|74394|P2|STARTED|Overall Study||7
31951|NCT02690948|74395|P1|STARTED|Overall Study||9
31952|NCT02690935|74413|P2|NOT COMPLETED|Overall Study||0
31953|NCT02690935|74414|P1|NOT COMPLETED|Overall Study||0
31954|NCT02690935|74413|P2|COMPLETED|Overall Study|Count of participants|51
31955|NCT02690935|74414|P1|COMPLETED|Overall Study|Count of participants|51
31956|NCT02690935|74413|P2|STARTED|Overall Study|Count of participants|51
31957|NCT02690935|74414|P1|STARTED|Overall Study|Count of participants|51
31958|NCT02690727|74422|P2|NOT COMPLETED|Overall Study||2
31959|NCT02690727|74423|P1|NOT COMPLETED|Overall Study||2
31960|NCT02690727|74422|P2|COMPLETED|Overall Study||7
31961|NCT02690727|74423|P1|COMPLETED|Overall Study||7
31962|NCT02690727|74422|P2|STARTED|Overall Study||9
31963|NCT02690727|74423|P1|STARTED|Overall Study||9
31964|NCT02690701|74435|P2|NOT COMPLETED|Treatment Period 2||5
31965|NCT02690701|74436|P1|NOT COMPLETED|Treatment Period 2||3
31966|NCT02690701|74435|P2|COMPLETED|Treatment Period 2||37
31967|NCT02690701|74436|P1|COMPLETED|Treatment Period 2|Completed Treatment Period 2|41
31968|NCT02690701|74435|P2|STARTED|Treatment Period 2||42
31969|NCT02690701|74436|P1|STARTED|Treatment Period 2|Completed Treatment Period 1 and continued to Treatment Period 2|44
31970|NCT02690701|74435|P2|NOT COMPLETED|Treatment Period 1||3
31971|NCT02690701|74436|P1|NOT COMPLETED|Treatment Period 1||2
31972|NCT02690701|74435|P2|COMPLETED|Treatment Period 1||42
31973|NCT02690701|74436|P1|COMPLETED|Treatment Period 1||44
31974|NCT02690701|74435|P2|STARTED|Treatment Period 1||45
31975|NCT02690701|74436|P1|STARTED|Treatment Period 1||46
31976|NCT02690194|74504|P3|NOT COMPLETED|Overall Study||0
31977|NCT02690194|74505|P2|NOT COMPLETED|Overall Study||4
31978|NCT02690194|74506|P1|NOT COMPLETED|Overall Study||1
31979|NCT02690194|74504|P3|COMPLETED|Overall Study||19
31980|NCT02690194|74505|P2|COMPLETED|Overall Study||14
31981|NCT02690194|74506|P1|COMPLETED|Overall Study||16
31982|NCT02690194|74504|P3|STARTED|Overall Study||19
31983|NCT02690194|74505|P2|STARTED|Overall Study||18
31984|NCT02690194|74506|P1|STARTED|Overall Study||17
31985|NCT02690181|74555|P6|NOT COMPLETED|Overall Study||0
31986|NCT02690181|74556|P5|NOT COMPLETED|Overall Study||0
31987|NCT02690181|74557|P4|NOT COMPLETED|Overall Study||0
31988|NCT02690181|74558|P3|NOT COMPLETED|Overall Study||0
31989|NCT02690181|74559|P2|NOT COMPLETED|Overall Study||0
31990|NCT02690181|74560|P1|NOT COMPLETED|Overall Study||0
31991|NCT02690181|74555|P6|COMPLETED|Overall Study||21
31992|NCT02690181|74556|P5|COMPLETED|Overall Study||6
31993|NCT02690181|74557|P4|COMPLETED|Overall Study||10
31994|NCT02690181|74558|P3|COMPLETED|Overall Study||15
31995|NCT02690181|74559|P2|COMPLETED|Overall Study||14
31996|NCT02690181|74560|P1|COMPLETED|Overall Study||14
31997|NCT02690181|74555|P6|STARTED|Overall Study||21
31998|NCT02690181|74556|P5|STARTED|Overall Study||6
31999|NCT02690181|74557|P4|STARTED|Overall Study||10
32000|NCT02690181|74558|P3|STARTED|Overall Study||15
32001|NCT02690181|74559|P2|STARTED|Overall Study||14
32002|NCT02690181|74560|P1|STARTED|Overall Study||14
32003|NCT02689973|74686|P4|NOT COMPLETED|Overall Study||53
32004|NCT02689973|74687|P3|NOT COMPLETED|Overall Study||72
32005|NCT02689973|74688|P2|NOT COMPLETED|Overall Study||49
32006|NCT02689973|74689|P1|NOT COMPLETED|Overall Study||54
32007|NCT02689973|74686|P4|COMPLETED|Overall Study||232
32008|NCT02689973|74687|P3|COMPLETED|Overall Study||279
32009|NCT02689973|74688|P2|COMPLETED|Overall Study||221
32010|NCT02689973|74689|P1|COMPLETED|Overall Study||257
32011|NCT02689973|74686|P4|STARTED|Overall Study||285
32012|NCT02689973|74687|P3|STARTED|Overall Study||351
32013|NCT02689973|74688|P2|STARTED|Overall Study||270
32014|NCT02689973|74689|P1|STARTED|Overall Study||311
32015|NCT02689804|74713|P2|NOT COMPLETED|Overall Study||0
32016|NCT02689804|74714|P1|NOT COMPLETED|Overall Study||2
32017|NCT02689804|74713|P2|COMPLETED|Overall Study||16
32018|NCT02689804|74714|P1|COMPLETED|Overall Study||16
32019|NCT02689804|74713|P2|STARTED|Overall Study||16
32020|NCT02689804|74714|P1|STARTED|Overall Study||18
32021|NCT02689492|74740|P1|NOT COMPLETED|Overall Study||86
32022|NCT02689492|74740|P1|COMPLETED|Overall Study||315
32023|NCT02689492|74740|P1|STARTED|Overall Study||401
32024|NCT02689219|74756|P2|NOT COMPLETED|Overall Study||7
32025|NCT02689219|74757|P1|NOT COMPLETED|Overall Study||11
32026|NCT02689219|74756|P2|COMPLETED|Overall Study||0
32027|NCT02689219|74757|P1|COMPLETED|Overall Study||0
32028|NCT02689219|74756|P2|STARTED|Overall Study||7
32029|NCT02689219|74757|P1|STARTED|Overall Study||11
32030|NCT02689206|74774|P5|NOT COMPLETED|Overall Study||8
32031|NCT02689206|74775|P4|NOT COMPLETED|Overall Study||4
32032|NCT02689206|74776|P3|NOT COMPLETED|Overall Study||4
32033|NCT02689206|74777|P2|NOT COMPLETED|Overall Study||1
32034|NCT02689206|74778|P1|NOT COMPLETED|Overall Study||3
32035|NCT02689206|74774|P5|COMPLETED|Overall Study||14
32036|NCT02689206|74775|P4|COMPLETED|Overall Study||17
32037|NCT02689206|74776|P3|COMPLETED|Overall Study||16
32038|NCT02689206|74777|P2|COMPLETED|Overall Study||19
32039|NCT02689206|74778|P1|COMPLETED|Overall Study||17
32040|NCT02689206|74774|P5|STARTED|Overall Study||22
32041|NCT02689206|74775|P4|STARTED|Overall Study||21
32042|NCT02689206|74776|P3|STARTED|Overall Study||20
32043|NCT02689206|74777|P2|STARTED|Overall Study||20
32044|NCT02689206|74778|P1|STARTED|Overall Study||20
32045|NCT02689154|74982|P1|NOT COMPLETED|Overall Study||0
32046|NCT02689154|74982|P1|COMPLETED|Overall Study||18
32047|NCT02689154|74982|P1|STARTED|Overall Study||18
32048|NCT02688933|74991|P2|NOT COMPLETED|Overall Study||37
32049|NCT02688933|74992|P1|NOT COMPLETED|Overall Study||29
32050|NCT02688933|74991|P2|COMPLETED|Overall Study||281
32051|NCT02688933|74992|P1|COMPLETED|Overall Study||291
32052|NCT02688933|74991|P2|STARTED|Overall Study||318
32053|NCT02688933|74992|P1|STARTED|Overall Study||320
32054|NCT02688829|75012|P1|NOT COMPLETED|Overall Study||2
32055|NCT02688829|75012|P1|COMPLETED|Overall Study||19
32056|NCT02688829|75012|P1|STARTED|Overall Study||21
32057|NCT02688764|75024|P2|NOT COMPLETED|Overall Study||17
32058|NCT02688764|75025|P1|NOT COMPLETED|Overall Study||40
32059|NCT02688764|75024|P2|COMPLETED|Overall Study||2
32060|NCT02688764|75025|P1|COMPLETED|Overall Study||26
32061|NCT02688764|75024|P2|Treated in Stage 2|Overall Study||8
32062|NCT02688764|75025|P1|Treated in Stage 2|Overall Study||43
32063|NCT02688764|75024|P2|Treated in Stage 1|Overall Study||19
32064|NCT02688764|75025|P1|Treated in Stage 1|Overall Study||66
32065|NCT02688764|75024|P2|STARTED|Overall Study||19
32066|NCT02688764|75025|P1|STARTED|Overall Study||66
32067|NCT02688556|75075|P2|NOT COMPLETED|Overall Study||12
32068|NCT02688556|75076|P1|NOT COMPLETED|Overall Study||25
32069|NCT02688556|75075|P2|COMPLETED|Overall Study||361
32070|NCT02688556|75076|P1|COMPLETED|Overall Study||347
32071|NCT02688556|75075|P2|STARTED|Overall Study||373
32072|NCT02688556|75076|P1|STARTED|Overall Study||372
32073|NCT02688387|75092|P22|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32074|NCT02688387|75093|P21|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32075|NCT02688387|75094|P20|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32076|NCT02688387|75095|P19|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32077|NCT02688387|75096|P18|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32078|NCT02688387|75097|P17|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32079|NCT02688387|75098|P16|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32080|NCT02688387|75099|P15|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32081|NCT02688387|75100|P14|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32082|NCT02688387|75101|P13|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32083|NCT02688387|75102|P12|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32084|NCT02688387|75103|P11|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32085|NCT02688387|75104|P10|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32086|NCT02688387|75105|P9|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32087|NCT02688387|75106|P8|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32088|NCT02688387|75107|P7|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32089|NCT02688387|75108|P6|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32090|NCT02688387|75109|P5|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32091|NCT02688387|75110|P4|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32092|NCT02688387|75111|P3|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32093|NCT02688387|75112|P2|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32094|NCT02688387|75113|P1|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32095|NCT02688387|75092|P22|COMPLETED|Part 3B, Period 4 (up to 6 Days)||8
32096|NCT02688387|75093|P21|COMPLETED|Part 3B, Period 4 (up to 6 Days)||6
32097|NCT02688387|75094|P20|COMPLETED|Part 3B, Period 4 (up to 6 Days)||7
32098|NCT02688387|75095|P19|COMPLETED|Part 3B, Period 4 (up to 6 Days)||7
32099|NCT02688387|75096|P18|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32100|NCT02688387|75097|P17|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32101|NCT02688387|75098|P16|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32102|NCT02688387|75099|P15|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32103|NCT02688387|75100|P14|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32104|NCT02688387|75101|P13|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32105|NCT02688387|75102|P12|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32106|NCT02688387|75103|P11|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32107|NCT02688387|75104|P10|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32108|NCT02688387|75105|P9|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32109|NCT02688387|75106|P8|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32110|NCT02688387|75107|P7|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32111|NCT02688387|75108|P6|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32112|NCT02688387|75109|P5|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32113|NCT02688387|75110|P4|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32114|NCT02688387|75111|P3|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32115|NCT02688387|75112|P2|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32116|NCT02688387|75113|P1|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
32117|NCT02688387|75092|P22|STARTED|Part 3B, Period 4 (up to 6 Days)||8
32118|NCT02688387|75093|P21|STARTED|Part 3B, Period 4 (up to 6 Days)||6
32119|NCT02688387|75094|P20|STARTED|Part 3B, Period 4 (up to 6 Days)||7
32120|NCT02688387|75095|P19|STARTED|Part 3B, Period 4 (up to 6 Days)||7
32121|NCT02688387|75096|P18|STARTED|Part 3B, Period 4 (up to 6 Days)||0
32122|NCT02688387|75097|P17|STARTED|Part 3B, Period 4 (up to 6 Days)||0
32123|NCT02688387|75098|P16|STARTED|Part 3B, Period 4 (up to 6 Days)||0
32124|NCT02688387|75099|P15|STARTED|Part 3B, Period 4 (up to 6 Days)||0
32125|NCT02688387|75100|P14|STARTED|Part 3B, Period 4 (up to 6 Days)||0
32126|NCT02688387|75101|P13|STARTED|Part 3B, Period 4 (up to 6 Days)||0
32127|NCT02688387|75102|P12|STARTED|Part 3B, Period 4 (up to 6 Days)||0
32128|NCT02688387|75103|P11|STARTED|Part 3B, Period 4 (up to 6 Days)||0
32129|NCT02688387|75104|P10|STARTED|Part 3B, Period 4 (up to 6 Days)||0
32130|NCT02688387|75105|P9|STARTED|Part 3B, Period 4 (up to 6 Days)||0
32131|NCT02688387|75106|P8|STARTED|Part 3B, Period 4 (up to 6 Days)||0
32132|NCT02688387|75107|P7|STARTED|Part 3B, Period 4 (up to 6 Days)||0
32133|NCT02688387|75108|P6|STARTED|Part 3B, Period 4 (up to 6 Days)||0
32134|NCT02688387|75109|P5|STARTED|Part 3B, Period 4 (up to 6 Days)||0
32135|NCT02688387|75110|P4|STARTED|Part 3B, Period 4 (up to 6 Days)||0
32136|NCT02688387|75111|P3|STARTED|Part 3B, Period 4 (up to 6 Days)||0
32137|NCT02688387|75112|P2|STARTED|Part 3B, Period 4 (up to 6 Days)||0
32138|NCT02688387|75113|P1|STARTED|Part 3B, Period 4 (up to 6 Days)||0
32139|NCT02688387|75092|P22|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32140|NCT02688387|75093|P21|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
32141|NCT02688387|75094|P20|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
32142|NCT02688387|75095|P19|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
32143|NCT02688387|75096|P18|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32144|NCT02688387|75097|P17|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32145|NCT02688387|75098|P16|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32146|NCT02688387|75099|P15|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32147|NCT02688387|75100|P14|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32148|NCT02688387|75101|P13|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32149|NCT02688387|75102|P12|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32150|NCT02688387|75103|P11|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32151|NCT02688387|75104|P10|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32152|NCT02688387|75105|P9|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32153|NCT02688387|75106|P8|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32154|NCT02688387|75107|P7|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32155|NCT02688387|75108|P6|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32156|NCT02688387|75109|P5|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32157|NCT02688387|75110|P4|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32158|NCT02688387|75111|P3|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32159|NCT02688387|75112|P2|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32160|NCT02688387|75113|P1|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32161|NCT02688387|75092|P22|COMPLETED|Part 3B, Washout Period 3 (10 Days)||8
32162|NCT02688387|75093|P21|COMPLETED|Part 3B, Washout Period 3 (10 Days)||6
32163|NCT02688387|75094|P20|COMPLETED|Part 3B, Washout Period 3 (10 Days)||7
32164|NCT02688387|75095|P19|COMPLETED|Part 3B, Washout Period 3 (10 Days)||7
32165|NCT02688387|75096|P18|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32166|NCT02688387|75097|P17|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32167|NCT02688387|75098|P16|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32168|NCT02688387|75099|P15|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32169|NCT02688387|75100|P14|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32170|NCT02688387|75101|P13|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32171|NCT02688387|75102|P12|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32172|NCT02688387|75103|P11|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32173|NCT02688387|75104|P10|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32174|NCT02688387|75105|P9|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32175|NCT02688387|75106|P8|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32176|NCT02688387|75107|P7|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32177|NCT02688387|75108|P6|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32178|NCT02688387|75109|P5|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32179|NCT02688387|75110|P4|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32180|NCT02688387|75111|P3|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32181|NCT02688387|75112|P2|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32182|NCT02688387|75113|P1|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
32183|NCT02688387|75092|P22|STARTED|Part 3B, Washout Period 3 (10 Days)||8
32184|NCT02688387|75093|P21|STARTED|Part 3B, Washout Period 3 (10 Days)||7
32185|NCT02688387|75094|P20|STARTED|Part 3B, Washout Period 3 (10 Days)||8
32186|NCT02688387|75095|P19|STARTED|Part 3B, Washout Period 3 (10 Days)||8
32187|NCT02688387|75096|P18|STARTED|Part 3B, Washout Period 3 (10 Days)||0
32188|NCT02688387|75097|P17|STARTED|Part 3B, Washout Period 3 (10 Days)||0
32189|NCT02688387|75098|P16|STARTED|Part 3B, Washout Period 3 (10 Days)||0
32190|NCT02688387|75099|P15|STARTED|Part 3B, Washout Period 3 (10 Days)||0
32191|NCT02688387|75100|P14|STARTED|Part 3B, Washout Period 3 (10 Days)||0
32192|NCT02688387|75101|P13|STARTED|Part 3B, Washout Period 3 (10 Days)||0
32193|NCT02688387|75102|P12|STARTED|Part 3B, Washout Period 3 (10 Days)||0
32194|NCT02688387|75103|P11|STARTED|Part 3B, Washout Period 3 (10 Days)||0
32195|NCT02688387|75104|P10|STARTED|Part 3B, Washout Period 3 (10 Days)||0
32196|NCT02688387|75105|P9|STARTED|Part 3B, Washout Period 3 (10 Days)||0
32197|NCT02688387|75106|P8|STARTED|Part 3B, Washout Period 3 (10 Days)||0
32198|NCT02688387|75107|P7|STARTED|Part 3B, Washout Period 3 (10 Days)||0
32199|NCT02688387|75108|P6|STARTED|Part 3B, Washout Period 3 (10 Days)||0
32200|NCT02688387|75109|P5|STARTED|Part 3B, Washout Period 3 (10 Days)||0
32201|NCT02688387|75110|P4|STARTED|Part 3B, Washout Period 3 (10 Days)||0
32202|NCT02688387|75111|P3|STARTED|Part 3B, Washout Period 3 (10 Days)||0
32203|NCT02688387|75112|P2|STARTED|Part 3B, Washout Period 3 (10 Days)||0
32204|NCT02688387|75113|P1|STARTED|Part 3B, Washout Period 3 (10 Days)||0
32205|NCT02688387|75092|P22|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32206|NCT02688387|75093|P21|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||1
32207|NCT02688387|75094|P20|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32208|NCT02688387|75095|P19|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32209|NCT02688387|75096|P18|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32210|NCT02688387|75097|P17|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32211|NCT02688387|75098|P16|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32212|NCT02688387|75099|P15|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32213|NCT02688387|75100|P14|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32214|NCT02688387|75101|P13|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32215|NCT02688387|75102|P12|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32216|NCT02688387|75103|P11|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32217|NCT02688387|75104|P10|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32218|NCT02688387|75105|P9|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32219|NCT02688387|75106|P8|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32220|NCT02688387|75107|P7|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32221|NCT02688387|75108|P6|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32222|NCT02688387|75109|P5|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32223|NCT02688387|75110|P4|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32224|NCT02688387|75111|P3|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32225|NCT02688387|75112|P2|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32226|NCT02688387|75113|P1|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32227|NCT02688387|75092|P22|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
32228|NCT02688387|75093|P21|COMPLETED|Part 3B, Period 3 (up to 6 Days)||7
32229|NCT02688387|75094|P20|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
32230|NCT02688387|75095|P19|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
32231|NCT02688387|75096|P18|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32232|NCT02688387|75097|P17|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32233|NCT02688387|75098|P16|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32234|NCT02688387|75099|P15|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32235|NCT02688387|75100|P14|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32236|NCT02688387|75101|P13|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32237|NCT02688387|75102|P12|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32238|NCT02688387|75103|P11|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32239|NCT02688387|75104|P10|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32240|NCT02688387|75105|P9|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32241|NCT02688387|75106|P8|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32242|NCT02688387|75107|P7|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32243|NCT02688387|75108|P6|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32244|NCT02688387|75109|P5|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32245|NCT02688387|75110|P4|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32246|NCT02688387|75111|P3|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32247|NCT02688387|75112|P2|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32248|NCT02688387|75113|P1|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
32249|NCT02688387|75092|P22|STARTED|Part 3B, Period 3 (up to 6 Days)||8
32250|NCT02688387|75093|P21|STARTED|Part 3B, Period 3 (up to 6 Days)||8
32251|NCT02688387|75094|P20|STARTED|Part 3B, Period 3 (up to 6 Days)||8
32252|NCT02688387|75095|P19|STARTED|Part 3B, Period 3 (up to 6 Days)||8
32253|NCT02688387|75096|P18|STARTED|Part 3B, Period 3 (up to 6 Days)||0
32254|NCT02688387|75097|P17|STARTED|Part 3B, Period 3 (up to 6 Days)||0
32255|NCT02688387|75098|P16|STARTED|Part 3B, Period 3 (up to 6 Days)||0
32256|NCT02688387|75099|P15|STARTED|Part 3B, Period 3 (up to 6 Days)||0
32257|NCT02688387|75100|P14|STARTED|Part 3B, Period 3 (up to 6 Days)||0
32258|NCT02688387|75101|P13|STARTED|Part 3B, Period 3 (up to 6 Days)||0
32259|NCT02688387|75102|P12|STARTED|Part 3B, Period 3 (up to 6 Days)||0
32260|NCT02688387|75103|P11|STARTED|Part 3B, Period 3 (up to 6 Days)||0
32261|NCT02688387|75104|P10|STARTED|Part 3B, Period 3 (up to 6 Days)||0
32262|NCT02688387|75105|P9|STARTED|Part 3B, Period 3 (up to 6 Days)||0
32263|NCT02688387|75106|P8|STARTED|Part 3B, Period 3 (up to 6 Days)||0
32264|NCT02688387|75107|P7|STARTED|Part 3B, Period 3 (up to 6 Days)||0
32265|NCT02688387|75108|P6|STARTED|Part 3B, Period 3 (up to 6 Days)||0
32266|NCT02688387|75109|P5|STARTED|Part 3B, Period 3 (up to 6 Days)||0
32267|NCT02688387|75110|P4|STARTED|Part 3B, Period 3 (up to 6 Days)||0
32268|NCT02688387|75111|P3|STARTED|Part 3B, Period 3 (up to 6 Days)||0
32269|NCT02688387|75112|P2|STARTED|Part 3B, Period 3 (up to 6 Days)||0
32270|NCT02688387|75113|P1|STARTED|Part 3B, Period 3 (up to 6 Days)||0
32271|NCT02688387|75092|P22|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32272|NCT02688387|75093|P21|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32273|NCT02688387|75094|P20|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32274|NCT02688387|75095|P19|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32275|NCT02688387|75096|P18|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32276|NCT02688387|75097|P17|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32277|NCT02688387|75098|P16|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32278|NCT02688387|75099|P15|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32279|NCT02688387|75100|P14|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32280|NCT02688387|75101|P13|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32281|NCT02688387|75102|P12|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32282|NCT02688387|75103|P11|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32283|NCT02688387|75104|P10|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32284|NCT02688387|75105|P9|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32285|NCT02688387|75106|P8|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32286|NCT02688387|75107|P7|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32287|NCT02688387|75108|P6|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32288|NCT02688387|75109|P5|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32289|NCT02688387|75110|P4|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32290|NCT02688387|75111|P3|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32291|NCT02688387|75112|P2|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32292|NCT02688387|75113|P1|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32293|NCT02688387|75092|P22|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
32294|NCT02688387|75093|P21|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
32295|NCT02688387|75094|P20|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
32296|NCT02688387|75095|P19|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
32297|NCT02688387|75096|P18|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32298|NCT02688387|75097|P17|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32299|NCT02688387|75098|P16|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32300|NCT02688387|75099|P15|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32301|NCT02688387|75100|P14|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32302|NCT02688387|75101|P13|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32303|NCT02688387|75102|P12|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32304|NCT02688387|75103|P11|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32305|NCT02688387|75104|P10|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32306|NCT02688387|75105|P9|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32307|NCT02688387|75106|P8|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32308|NCT02688387|75107|P7|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32309|NCT02688387|75108|P6|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32310|NCT02688387|75109|P5|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32311|NCT02688387|75110|P4|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32312|NCT02688387|75111|P3|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32313|NCT02688387|75112|P2|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32314|NCT02688387|75113|P1|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
32315|NCT02688387|75092|P22|STARTED|Part 3B, Washout Period 2 (10 Days)||8
32316|NCT02688387|75093|P21|STARTED|Part 3B, Washout Period 2 (10 Days)||8
32317|NCT02688387|75094|P20|STARTED|Part 3B, Washout Period 2 (10 Days)||8
32318|NCT02688387|75095|P19|STARTED|Part 3B, Washout Period 2 (10 Days)||8
32319|NCT02688387|75096|P18|STARTED|Part 3B, Washout Period 2 (10 Days)||0
32320|NCT02688387|75097|P17|STARTED|Part 3B, Washout Period 2 (10 Days)||0
32321|NCT02688387|75098|P16|STARTED|Part 3B, Washout Period 2 (10 Days)||0
32322|NCT02688387|75099|P15|STARTED|Part 3B, Washout Period 2 (10 Days)||0
32323|NCT02688387|75100|P14|STARTED|Part 3B, Washout Period 2 (10 Days)||0
32324|NCT02688387|75101|P13|STARTED|Part 3B, Washout Period 2 (10 Days)||0
32325|NCT02688387|75102|P12|STARTED|Part 3B, Washout Period 2 (10 Days)||0
32326|NCT02688387|75103|P11|STARTED|Part 3B, Washout Period 2 (10 Days)||0
32327|NCT02688387|75104|P10|STARTED|Part 3B, Washout Period 2 (10 Days)||0
32328|NCT02688387|75105|P9|STARTED|Part 3B, Washout Period 2 (10 Days)||0
32329|NCT02688387|75106|P8|STARTED|Part 3B, Washout Period 2 (10 Days)||0
32330|NCT02688387|75107|P7|STARTED|Part 3B, Washout Period 2 (10 Days)||0
32331|NCT02688387|75108|P6|STARTED|Part 3B, Washout Period 2 (10 Days)||0
32332|NCT02688387|75109|P5|STARTED|Part 3B, Washout Period 2 (10 Days)||0
32333|NCT02688387|75110|P4|STARTED|Part 3B, Washout Period 2 (10 Days)||0
32334|NCT02688387|75111|P3|STARTED|Part 3B, Washout Period 2 (10 Days)||0
32335|NCT02688387|75112|P2|STARTED|Part 3B, Washout Period 2 (10 Days)||0
32336|NCT02688387|75113|P1|STARTED|Part 3B, Washout Period 2 (10 Days)||0
32337|NCT02688387|75092|P22|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32338|NCT02688387|75093|P21|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32339|NCT02688387|75094|P20|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32340|NCT02688387|75095|P19|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32341|NCT02688387|75096|P18|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32342|NCT02688387|75097|P17|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32343|NCT02688387|75098|P16|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32344|NCT02688387|75099|P15|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32345|NCT02688387|75100|P14|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32346|NCT02688387|75101|P13|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32347|NCT02688387|75102|P12|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32348|NCT02688387|75103|P11|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32349|NCT02688387|75104|P10|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32350|NCT02688387|75105|P9|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32351|NCT02688387|75106|P8|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32352|NCT02688387|75107|P7|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32353|NCT02688387|75108|P6|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32354|NCT02688387|75109|P5|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32355|NCT02688387|75110|P4|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32356|NCT02688387|75111|P3|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32357|NCT02688387|75112|P2|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32358|NCT02688387|75113|P1|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32359|NCT02688387|75092|P22|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
32360|NCT02688387|75093|P21|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
32361|NCT02688387|75094|P20|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
32362|NCT02688387|75095|P19|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
32363|NCT02688387|75096|P18|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32364|NCT02688387|75097|P17|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32365|NCT02688387|75098|P16|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32366|NCT02688387|75099|P15|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32367|NCT02688387|75100|P14|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32368|NCT02688387|75101|P13|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32369|NCT02688387|75102|P12|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32370|NCT02688387|75103|P11|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32371|NCT02688387|75104|P10|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32372|NCT02688387|75105|P9|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32373|NCT02688387|75106|P8|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32374|NCT02688387|75107|P7|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32375|NCT02688387|75108|P6|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32376|NCT02688387|75109|P5|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32377|NCT02688387|75110|P4|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32378|NCT02688387|75111|P3|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32379|NCT02688387|75112|P2|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32380|NCT02688387|75113|P1|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
32381|NCT02688387|75092|P22|STARTED|Part 3B, Period 2 (up to 6 Days)||8
32382|NCT02688387|75093|P21|STARTED|Part 3B, Period 2 (up to 6 Days)||8
32383|NCT02688387|75094|P20|STARTED|Part 3B, Period 2 (up to 6 Days)||8
32384|NCT02688387|75095|P19|STARTED|Part 3B, Period 2 (up to 6 Days)||8
32385|NCT02688387|75096|P18|STARTED|Part 3B, Period 2 (up to 6 Days)||0
32386|NCT02688387|75097|P17|STARTED|Part 3B, Period 2 (up to 6 Days)||0
32387|NCT02688387|75098|P16|STARTED|Part 3B, Period 2 (up to 6 Days)||0
32388|NCT02688387|75099|P15|STARTED|Part 3B, Period 2 (up to 6 Days)||0
32389|NCT02688387|75100|P14|STARTED|Part 3B, Period 2 (up to 6 Days)||0
32390|NCT02688387|75101|P13|STARTED|Part 3B, Period 2 (up to 6 Days)||0
32391|NCT02688387|75102|P12|STARTED|Part 3B, Period 2 (up to 6 Days)||0
32392|NCT02688387|75103|P11|STARTED|Part 3B, Period 2 (up to 6 Days)||0
32393|NCT02688387|75104|P10|STARTED|Part 3B, Period 2 (up to 6 Days)||0
32394|NCT02688387|75105|P9|STARTED|Part 3B, Period 2 (up to 6 Days)||0
32395|NCT02688387|75106|P8|STARTED|Part 3B, Period 2 (up to 6 Days)||0
32396|NCT02688387|75107|P7|STARTED|Part 3B, Period 2 (up to 6 Days)||0
32397|NCT02688387|75108|P6|STARTED|Part 3B, Period 2 (up to 6 Days)||0
32398|NCT02688387|75109|P5|STARTED|Part 3B, Period 2 (up to 6 Days)||0
32399|NCT02688387|75110|P4|STARTED|Part 3B, Period 2 (up to 6 Days)||0
32400|NCT02688387|75111|P3|STARTED|Part 3B, Period 2 (up to 6 Days)||0
32401|NCT02688387|75112|P2|STARTED|Part 3B, Period 2 (up to 6 Days)||0
32402|NCT02688387|75113|P1|STARTED|Part 3B, Period 2 (up to 6 Days)||0
32403|NCT02688387|75092|P22|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32404|NCT02688387|75093|P21|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32405|NCT02688387|75094|P20|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32406|NCT02688387|75095|P19|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32407|NCT02688387|75096|P18|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32408|NCT02688387|75097|P17|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32409|NCT02688387|75098|P16|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32410|NCT02688387|75099|P15|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32411|NCT02688387|75100|P14|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32412|NCT02688387|75101|P13|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32413|NCT02688387|75102|P12|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32414|NCT02688387|75103|P11|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32415|NCT02688387|75104|P10|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32416|NCT02688387|75105|P9|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32417|NCT02688387|75106|P8|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32418|NCT02688387|75107|P7|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32419|NCT02688387|75108|P6|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32420|NCT02688387|75109|P5|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32421|NCT02688387|75110|P4|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32422|NCT02688387|75111|P3|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32423|NCT02688387|75112|P2|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32424|NCT02688387|75113|P1|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32425|NCT02688387|75092|P22|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
32426|NCT02688387|75093|P21|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
32427|NCT02688387|75094|P20|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
32428|NCT02688387|75095|P19|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
32429|NCT02688387|75096|P18|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32430|NCT02688387|75097|P17|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32431|NCT02688387|75098|P16|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32432|NCT02688387|75099|P15|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32433|NCT02688387|75100|P14|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32434|NCT02688387|75101|P13|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32435|NCT02688387|75102|P12|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32436|NCT02688387|75103|P11|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32437|NCT02688387|75104|P10|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32438|NCT02688387|75105|P9|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32439|NCT02688387|75106|P8|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32440|NCT02688387|75107|P7|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32441|NCT02688387|75108|P6|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32442|NCT02688387|75109|P5|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32443|NCT02688387|75110|P4|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32444|NCT02688387|75111|P3|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32445|NCT02688387|75112|P2|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32446|NCT02688387|75113|P1|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
32447|NCT02688387|75092|P22|STARTED|Part 3B, Washout Period 1 (10 Days)||8
32448|NCT02688387|75093|P21|STARTED|Part 3B, Washout Period 1 (10 Days)||8
32449|NCT02688387|75094|P20|STARTED|Part 3B, Washout Period 1 (10 Days)||8
32450|NCT02688387|75095|P19|STARTED|Part 3B, Washout Period 1 (10 Days)||8
32451|NCT02688387|75096|P18|STARTED|Part 3B, Washout Period 1 (10 Days)||0
32452|NCT02688387|75097|P17|STARTED|Part 3B, Washout Period 1 (10 Days)||0
32453|NCT02688387|75098|P16|STARTED|Part 3B, Washout Period 1 (10 Days)||0
32454|NCT02688387|75099|P15|STARTED|Part 3B, Washout Period 1 (10 Days)||0
32455|NCT02688387|75100|P14|STARTED|Part 3B, Washout Period 1 (10 Days)||0
32456|NCT02688387|75101|P13|STARTED|Part 3B, Washout Period 1 (10 Days)||0
32457|NCT02688387|75102|P12|STARTED|Part 3B, Washout Period 1 (10 Days)||0
32458|NCT02688387|75103|P11|STARTED|Part 3B, Washout Period 1 (10 Days)||0
32459|NCT02688387|75104|P10|STARTED|Part 3B, Washout Period 1 (10 Days)||0
32460|NCT02688387|75105|P9|STARTED|Part 3B, Washout Period 1 (10 Days)||0
32461|NCT02688387|75106|P8|STARTED|Part 3B, Washout Period 1 (10 Days)||0
32462|NCT02688387|75107|P7|STARTED|Part 3B, Washout Period 1 (10 Days)||0
32463|NCT02688387|75108|P6|STARTED|Part 3B, Washout Period 1 (10 Days)||0
32464|NCT02688387|75109|P5|STARTED|Part 3B, Washout Period 1 (10 Days)||0
32465|NCT02688387|75110|P4|STARTED|Part 3B, Washout Period 1 (10 Days)||0
32466|NCT02688387|75111|P3|STARTED|Part 3B, Washout Period 1 (10 Days)||0
32467|NCT02688387|75112|P2|STARTED|Part 3B, Washout Period 1 (10 Days)||0
32468|NCT02688387|75113|P1|STARTED|Part 3B, Washout Period 1 (10 Days)||0
32469|NCT02688387|75092|P22|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32470|NCT02688387|75093|P21|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32471|NCT02688387|75094|P20|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32472|NCT02688387|75095|P19|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32473|NCT02688387|75096|P18|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32474|NCT02688387|75097|P17|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32475|NCT02688387|75098|P16|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32476|NCT02688387|75099|P15|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32477|NCT02688387|75100|P14|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32478|NCT02688387|75101|P13|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32479|NCT02688387|75102|P12|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32480|NCT02688387|75103|P11|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32481|NCT02688387|75104|P10|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32482|NCT02688387|75105|P9|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32483|NCT02688387|75106|P8|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32484|NCT02688387|75107|P7|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32485|NCT02688387|75108|P6|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32486|NCT02688387|75109|P5|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32487|NCT02688387|75110|P4|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32488|NCT02688387|75111|P3|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32489|NCT02688387|75112|P2|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32490|NCT02688387|75113|P1|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32491|NCT02688387|75092|P22|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
32492|NCT02688387|75093|P21|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
32493|NCT02688387|75094|P20|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
32494|NCT02688387|75095|P19|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
32495|NCT02688387|75096|P18|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32496|NCT02688387|75097|P17|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32497|NCT02688387|75098|P16|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32498|NCT02688387|75099|P15|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32499|NCT02688387|75100|P14|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32500|NCT02688387|75101|P13|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32501|NCT02688387|75102|P12|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32502|NCT02688387|75103|P11|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32503|NCT02688387|75104|P10|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32504|NCT02688387|75105|P9|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32505|NCT02688387|75106|P8|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32506|NCT02688387|75107|P7|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32507|NCT02688387|75108|P6|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32508|NCT02688387|75109|P5|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32509|NCT02688387|75110|P4|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32510|NCT02688387|75111|P3|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32511|NCT02688387|75112|P2|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32512|NCT02688387|75113|P1|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
32513|NCT02688387|75092|P22|STARTED|Part 3B, Period 1 (up to 6 Days)||8
32514|NCT02688387|75093|P21|STARTED|Part 3B, Period 1 (up to 6 Days)||8
32515|NCT02688387|75094|P20|STARTED|Part 3B, Period 1 (up to 6 Days)||8
32516|NCT02688387|75095|P19|STARTED|Part 3B, Period 1 (up to 6 Days)||8
32517|NCT02688387|75096|P18|STARTED|Part 3B, Period 1 (up to 6 Days)||0
32518|NCT02688387|75097|P17|STARTED|Part 3B, Period 1 (up to 6 Days)||0
32519|NCT02688387|75098|P16|STARTED|Part 3B, Period 1 (up to 6 Days)||0
32520|NCT02688387|75099|P15|STARTED|Part 3B, Period 1 (up to 6 Days)||0
32521|NCT02688387|75100|P14|STARTED|Part 3B, Period 1 (up to 6 Days)||0
32522|NCT02688387|75101|P13|STARTED|Part 3B, Period 1 (up to 6 Days)||0
32523|NCT02688387|75102|P12|STARTED|Part 3B, Period 1 (up to 6 Days)||0
32524|NCT02688387|75103|P11|STARTED|Part 3B, Period 1 (up to 6 Days)||0
32525|NCT02688387|75104|P10|STARTED|Part 3B, Period 1 (up to 6 Days)||0
32526|NCT02688387|75105|P9|STARTED|Part 3B, Period 1 (up to 6 Days)||0
32527|NCT02688387|75106|P8|STARTED|Part 3B, Period 1 (up to 6 Days)||0
32528|NCT02688387|75107|P7|STARTED|Part 3B, Period 1 (up to 6 Days)||0
32529|NCT02688387|75108|P6|STARTED|Part 3B, Period 1 (up to 6 Days)||0
32530|NCT02688387|75109|P5|STARTED|Part 3B, Period 1 (up to 6 Days)||0
32531|NCT02688387|75110|P4|STARTED|Part 3B, Period 1 (up to 6 Days)||0
32532|NCT02688387|75111|P3|STARTED|Part 3B, Period 1 (up to 6 Days)||0
32533|NCT02688387|75112|P2|STARTED|Part 3B, Period 1 (up to 6 Days)||0
32534|NCT02688387|75113|P1|STARTED|Part 3B, Period 1 (up to 6 Days)||0
32535|NCT02688387|75092|P22|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32536|NCT02688387|75093|P21|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32537|NCT02688387|75094|P20|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32538|NCT02688387|75095|P19|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32539|NCT02688387|75096|P18|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32540|NCT02688387|75097|P17|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32541|NCT02688387|75098|P16|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32542|NCT02688387|75099|P15|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32543|NCT02688387|75100|P14|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32544|NCT02688387|75101|P13|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32545|NCT02688387|75102|P12|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32546|NCT02688387|75103|P11|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32547|NCT02688387|75104|P10|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32548|NCT02688387|75105|P9|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32549|NCT02688387|75106|P8|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32550|NCT02688387|75107|P7|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32551|NCT02688387|75108|P6|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32552|NCT02688387|75109|P5|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32553|NCT02688387|75110|P4|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32554|NCT02688387|75111|P3|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32555|NCT02688387|75112|P2|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32556|NCT02688387|75113|P1|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32557|NCT02688387|75092|P22|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32558|NCT02688387|75093|P21|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32559|NCT02688387|75094|P20|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32560|NCT02688387|75095|P19|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32561|NCT02688387|75096|P18|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
32562|NCT02688387|75097|P17|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
32563|NCT02688387|75098|P16|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
32564|NCT02688387|75099|P15|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
32565|NCT02688387|75100|P14|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32566|NCT02688387|75101|P13|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32567|NCT02688387|75102|P12|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32568|NCT02688387|75103|P11|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32569|NCT02688387|75104|P10|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32570|NCT02688387|75105|P9|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32571|NCT02688387|75106|P8|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32572|NCT02688387|75107|P7|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32573|NCT02688387|75108|P6|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32574|NCT02688387|75109|P5|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32575|NCT02688387|75110|P4|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32576|NCT02688387|75111|P3|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32577|NCT02688387|75112|P2|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32578|NCT02688387|75113|P1|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
32579|NCT02688387|75092|P22|STARTED|Part 3A, Period 4 (up to 6 Days)||0
32580|NCT02688387|75093|P21|STARTED|Part 3A, Period 4 (up to 6 Days)||0
32581|NCT02688387|75094|P20|STARTED|Part 3A, Period 4 (up to 6 Days)||0
32582|NCT02688387|75095|P19|STARTED|Part 3A, Period 4 (up to 6 Days)||0
32583|NCT02688387|75096|P18|STARTED|Part 3A, Period 4 (up to 6 Days)||8
32584|NCT02688387|75097|P17|STARTED|Part 3A, Period 4 (up to 6 Days)||8
32585|NCT02688387|75098|P16|STARTED|Part 3A, Period 4 (up to 6 Days)||8
32586|NCT02688387|75099|P15|STARTED|Part 3A, Period 4 (up to 6 Days)||8
32587|NCT02688387|75100|P14|STARTED|Part 3A, Period 4 (up to 6 Days)||0
32588|NCT02688387|75101|P13|STARTED|Part 3A, Period 4 (up to 6 Days)||0
32589|NCT02688387|75102|P12|STARTED|Part 3A, Period 4 (up to 6 Days)||0
32590|NCT02688387|75103|P11|STARTED|Part 3A, Period 4 (up to 6 Days)||0
32591|NCT02688387|75104|P10|STARTED|Part 3A, Period 4 (up to 6 Days)||0
32592|NCT02688387|75105|P9|STARTED|Part 3A, Period 4 (up to 6 Days)||0
32593|NCT02688387|75106|P8|STARTED|Part 3A, Period 4 (up to 6 Days)||0
32594|NCT02688387|75107|P7|STARTED|Part 3A, Period 4 (up to 6 Days)||0
32595|NCT02688387|75108|P6|STARTED|Part 3A, Period 4 (up to 6 Days)||0
32596|NCT02688387|75109|P5|STARTED|Part 3A, Period 4 (up to 6 Days)||0
32597|NCT02688387|75110|P4|STARTED|Part 3A, Period 4 (up to 6 Days)||0
32598|NCT02688387|75111|P3|STARTED|Part 3A, Period 4 (up to 6 Days)||0
32599|NCT02688387|75112|P2|STARTED|Part 3A, Period 4 (up to 6 Days)||0
32600|NCT02688387|75113|P1|STARTED|Part 3A, Period 4 (up to 6 Days)||0
32601|NCT02688387|75092|P22|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32602|NCT02688387|75093|P21|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32603|NCT02688387|75094|P20|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32604|NCT02688387|75095|P19|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32605|NCT02688387|75096|P18|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32606|NCT02688387|75097|P17|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32607|NCT02688387|75098|P16|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32608|NCT02688387|75099|P15|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32609|NCT02688387|75100|P14|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32610|NCT02688387|75101|P13|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32611|NCT02688387|75102|P12|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32612|NCT02688387|75103|P11|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32613|NCT02688387|75104|P10|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32614|NCT02688387|75105|P9|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32615|NCT02688387|75106|P8|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32616|NCT02688387|75107|P7|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32617|NCT02688387|75108|P6|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32618|NCT02688387|75109|P5|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32619|NCT02688387|75110|P4|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32620|NCT02688387|75111|P3|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32621|NCT02688387|75112|P2|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32622|NCT02688387|75113|P1|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32623|NCT02688387|75092|P22|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32624|NCT02688387|75093|P21|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32625|NCT02688387|75094|P20|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32626|NCT02688387|75095|P19|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32627|NCT02688387|75096|P18|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
32628|NCT02688387|75097|P17|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
32629|NCT02688387|75098|P16|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
32630|NCT02688387|75099|P15|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
32631|NCT02688387|75100|P14|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32632|NCT02688387|75101|P13|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32633|NCT02688387|75102|P12|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32634|NCT02688387|75103|P11|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32635|NCT02688387|75104|P10|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32636|NCT02688387|75105|P9|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32637|NCT02688387|75106|P8|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32638|NCT02688387|75107|P7|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32639|NCT02688387|75108|P6|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32640|NCT02688387|75109|P5|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32641|NCT02688387|75110|P4|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32642|NCT02688387|75111|P3|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32643|NCT02688387|75112|P2|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32644|NCT02688387|75113|P1|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
32645|NCT02688387|75092|P22|STARTED|Part 3A, Washout Period 3 (10 Days)||0
32646|NCT02688387|75093|P21|STARTED|Part 3A, Washout Period 3 (10 Days)||0
32647|NCT02688387|75094|P20|STARTED|Part 3A, Washout Period 3 (10 Days)||0
32648|NCT02688387|75095|P19|STARTED|Part 3A, Washout Period 3 (10 Days)||0
32649|NCT02688387|75096|P18|STARTED|Part 3A, Washout Period 3 (10 Days)||8
32650|NCT02688387|75097|P17|STARTED|Part 3A, Washout Period 3 (10 Days)||8
32651|NCT02688387|75098|P16|STARTED|Part 3A, Washout Period 3 (10 Days)||8
32652|NCT02688387|75099|P15|STARTED|Part 3A, Washout Period 3 (10 Days)||8
32653|NCT02688387|75100|P14|STARTED|Part 3A, Washout Period 3 (10 Days)||0
32654|NCT02688387|75101|P13|STARTED|Part 3A, Washout Period 3 (10 Days)||0
32655|NCT02688387|75102|P12|STARTED|Part 3A, Washout Period 3 (10 Days)||0
32656|NCT02688387|75103|P11|STARTED|Part 3A, Washout Period 3 (10 Days)||0
32657|NCT02688387|75104|P10|STARTED|Part 3A, Washout Period 3 (10 Days)||0
32658|NCT02688387|75105|P9|STARTED|Part 3A, Washout Period 3 (10 Days)||0
32659|NCT02688387|75106|P8|STARTED|Part 3A, Washout Period 3 (10 Days)||0
32660|NCT02688387|75107|P7|STARTED|Part 3A, Washout Period 3 (10 Days)||0
32661|NCT02688387|75108|P6|STARTED|Part 3A, Washout Period 3 (10 Days)||0
32662|NCT02688387|75109|P5|STARTED|Part 3A, Washout Period 3 (10 Days)||0
32663|NCT02688387|75110|P4|STARTED|Part 3A, Washout Period 3 (10 Days)||0
32664|NCT02688387|75111|P3|STARTED|Part 3A, Washout Period 3 (10 Days)||0
32665|NCT02688387|75112|P2|STARTED|Part 3A, Washout Period 3 (10 Days)||0
32666|NCT02688387|75113|P1|STARTED|Part 3A, Washout Period 3 (10 Days)||0
32667|NCT02688387|75092|P22|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32668|NCT02688387|75093|P21|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32669|NCT02688387|75094|P20|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32670|NCT02688387|75095|P19|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32671|NCT02688387|75096|P18|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32672|NCT02688387|75097|P17|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32673|NCT02688387|75098|P16|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32674|NCT02688387|75099|P15|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32675|NCT02688387|75100|P14|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32676|NCT02688387|75101|P13|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32677|NCT02688387|75102|P12|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32678|NCT02688387|75103|P11|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32679|NCT02688387|75104|P10|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32680|NCT02688387|75105|P9|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32681|NCT02688387|75106|P8|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32682|NCT02688387|75107|P7|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32683|NCT02688387|75108|P6|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32684|NCT02688387|75109|P5|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32685|NCT02688387|75110|P4|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32686|NCT02688387|75111|P3|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32687|NCT02688387|75112|P2|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32688|NCT02688387|75113|P1|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32689|NCT02688387|75092|P22|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32690|NCT02688387|75093|P21|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32691|NCT02688387|75094|P20|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32692|NCT02688387|75095|P19|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32693|NCT02688387|75096|P18|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
32694|NCT02688387|75097|P17|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
32695|NCT02688387|75098|P16|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
32696|NCT02688387|75099|P15|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
32697|NCT02688387|75100|P14|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32698|NCT02688387|75101|P13|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32699|NCT02688387|75102|P12|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32700|NCT02688387|75103|P11|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32701|NCT02688387|75104|P10|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32702|NCT02688387|75105|P9|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32703|NCT02688387|75106|P8|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32704|NCT02688387|75107|P7|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32705|NCT02688387|75108|P6|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32706|NCT02688387|75109|P5|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32707|NCT02688387|75110|P4|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32708|NCT02688387|75111|P3|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32709|NCT02688387|75112|P2|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32710|NCT02688387|75113|P1|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
32711|NCT02688387|75092|P22|STARTED|Part 3A, Period 3 (up to 6 Days)||0
32712|NCT02688387|75093|P21|STARTED|Part 3A, Period 3 (up to 6 Days)||0
32713|NCT02688387|75094|P20|STARTED|Part 3A, Period 3 (up to 6 Days)||0
32714|NCT02688387|75095|P19|STARTED|Part 3A, Period 3 (up to 6 Days)||0
32715|NCT02688387|75096|P18|STARTED|Part 3A, Period 3 (up to 6 Days)||8
32716|NCT02688387|75097|P17|STARTED|Part 3A, Period 3 (up to 6 Days)||8
32717|NCT02688387|75098|P16|STARTED|Part 3A, Period 3 (up to 6 Days)||8
32718|NCT02688387|75099|P15|STARTED|Part 3A, Period 3 (up to 6 Days)||8
32719|NCT02688387|75100|P14|STARTED|Part 3A, Period 3 (up to 6 Days)||0
32720|NCT02688387|75101|P13|STARTED|Part 3A, Period 3 (up to 6 Days)||0
32721|NCT02688387|75102|P12|STARTED|Part 3A, Period 3 (up to 6 Days)||0
32722|NCT02688387|75103|P11|STARTED|Part 3A, Period 3 (up to 6 Days)||0
32723|NCT02688387|75104|P10|STARTED|Part 3A, Period 3 (up to 6 Days)||0
32724|NCT02688387|75105|P9|STARTED|Part 3A, Period 3 (up to 6 Days)||0
32725|NCT02688387|75106|P8|STARTED|Part 3A, Period 3 (up to 6 Days)||0
32726|NCT02688387|75107|P7|STARTED|Part 3A, Period 3 (up to 6 Days)||0
32727|NCT02688387|75108|P6|STARTED|Part 3A, Period 3 (up to 6 Days)||0
32728|NCT02688387|75109|P5|STARTED|Part 3A, Period 3 (up to 6 Days)||0
32729|NCT02688387|75110|P4|STARTED|Part 3A, Period 3 (up to 6 Days)||0
32730|NCT02688387|75111|P3|STARTED|Part 3A, Period 3 (up to 6 Days)||0
32731|NCT02688387|75112|P2|STARTED|Part 3A, Period 3 (up to 6 Days)||0
32732|NCT02688387|75113|P1|STARTED|Part 3A, Period 3 (up to 6 Days)||0
32733|NCT02688387|75092|P22|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32734|NCT02688387|75093|P21|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32735|NCT02688387|75094|P20|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32736|NCT02688387|75095|P19|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32737|NCT02688387|75096|P18|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32738|NCT02688387|75097|P17|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32739|NCT02688387|75098|P16|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32740|NCT02688387|75099|P15|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32741|NCT02688387|75100|P14|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32742|NCT02688387|75101|P13|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32743|NCT02688387|75102|P12|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32744|NCT02688387|75103|P11|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32745|NCT02688387|75104|P10|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32746|NCT02688387|75105|P9|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32747|NCT02688387|75106|P8|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32748|NCT02688387|75107|P7|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32749|NCT02688387|75108|P6|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32750|NCT02688387|75109|P5|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32751|NCT02688387|75110|P4|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32752|NCT02688387|75111|P3|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32753|NCT02688387|75112|P2|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32754|NCT02688387|75113|P1|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32755|NCT02688387|75092|P22|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32756|NCT02688387|75093|P21|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32757|NCT02688387|75094|P20|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32758|NCT02688387|75095|P19|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32759|NCT02688387|75096|P18|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
32760|NCT02688387|75097|P17|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
32761|NCT02688387|75098|P16|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
32762|NCT02688387|75099|P15|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
32763|NCT02688387|75100|P14|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32764|NCT02688387|75101|P13|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32765|NCT02688387|75102|P12|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32766|NCT02688387|75103|P11|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32767|NCT02688387|75104|P10|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32768|NCT02688387|75105|P9|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32769|NCT02688387|75106|P8|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32770|NCT02688387|75107|P7|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32771|NCT02688387|75108|P6|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32772|NCT02688387|75109|P5|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32773|NCT02688387|75110|P4|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32774|NCT02688387|75111|P3|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32775|NCT02688387|75112|P2|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32776|NCT02688387|75113|P1|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
32777|NCT02688387|75092|P22|STARTED|Part 3A, Washout Period 2 (10 Days)||0
32778|NCT02688387|75093|P21|STARTED|Part 3A, Washout Period 2 (10 Days)||0
32779|NCT02688387|75094|P20|STARTED|Part 3A, Washout Period 2 (10 Days)||0
32780|NCT02688387|75095|P19|STARTED|Part 3A, Washout Period 2 (10 Days)||0
32781|NCT02688387|75096|P18|STARTED|Part 3A, Washout Period 2 (10 Days)||8
32782|NCT02688387|75097|P17|STARTED|Part 3A, Washout Period 2 (10 Days)||8
32783|NCT02688387|75098|P16|STARTED|Part 3A, Washout Period 2 (10 Days)||8
32784|NCT02688387|75099|P15|STARTED|Part 3A, Washout Period 2 (10 Days)||8
32785|NCT02688387|75100|P14|STARTED|Part 3A, Washout Period 2 (10 Days)||0
32786|NCT02688387|75101|P13|STARTED|Part 3A, Washout Period 2 (10 Days)||0
32787|NCT02688387|75102|P12|STARTED|Part 3A, Washout Period 2 (10 Days)||0
32788|NCT02688387|75103|P11|STARTED|Part 3A, Washout Period 2 (10 Days)||0
32789|NCT02688387|75104|P10|STARTED|Part 3A, Washout Period 2 (10 Days)||0
32790|NCT02688387|75105|P9|STARTED|Part 3A, Washout Period 2 (10 Days)||0
32791|NCT02688387|75106|P8|STARTED|Part 3A, Washout Period 2 (10 Days)||0
32792|NCT02688387|75107|P7|STARTED|Part 3A, Washout Period 2 (10 Days)||0
32793|NCT02688387|75108|P6|STARTED|Part 3A, Washout Period 2 (10 Days)||0
32794|NCT02688387|75109|P5|STARTED|Part 3A, Washout Period 2 (10 Days)||0
32795|NCT02688387|75110|P4|STARTED|Part 3A, Washout Period 2 (10 Days)||0
32796|NCT02688387|75111|P3|STARTED|Part 3A, Washout Period 2 (10 Days)||0
32797|NCT02688387|75112|P2|STARTED|Part 3A, Washout Period 2 (10 Days)||0
32798|NCT02688387|75113|P1|STARTED|Part 3A, Washout Period 2 (10 Days)||0
32799|NCT02688387|75092|P22|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32800|NCT02688387|75093|P21|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32801|NCT02688387|75094|P20|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32802|NCT02688387|75095|P19|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32803|NCT02688387|75096|P18|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32804|NCT02688387|75097|P17|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32805|NCT02688387|75098|P16|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32806|NCT02688387|75099|P15|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32807|NCT02688387|75100|P14|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32808|NCT02688387|75101|P13|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32809|NCT02688387|75102|P12|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32810|NCT02688387|75103|P11|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32811|NCT02688387|75104|P10|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32812|NCT02688387|75105|P9|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32813|NCT02688387|75106|P8|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32814|NCT02688387|75107|P7|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32815|NCT02688387|75108|P6|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32816|NCT02688387|75109|P5|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32817|NCT02688387|75110|P4|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32818|NCT02688387|75111|P3|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32819|NCT02688387|75112|P2|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32820|NCT02688387|75113|P1|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32821|NCT02688387|75092|P22|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32822|NCT02688387|75093|P21|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32823|NCT02688387|75094|P20|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32824|NCT02688387|75095|P19|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32825|NCT02688387|75096|P18|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
32826|NCT02688387|75097|P17|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
32827|NCT02688387|75098|P16|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
32828|NCT02688387|75099|P15|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
32829|NCT02688387|75100|P14|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32830|NCT02688387|75101|P13|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32831|NCT02688387|75102|P12|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32832|NCT02688387|75103|P11|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32833|NCT02688387|75104|P10|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32834|NCT02688387|75105|P9|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32835|NCT02688387|75106|P8|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32836|NCT02688387|75107|P7|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32837|NCT02688387|75108|P6|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32838|NCT02688387|75109|P5|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32839|NCT02688387|75110|P4|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32840|NCT02688387|75111|P3|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32841|NCT02688387|75112|P2|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32842|NCT02688387|75113|P1|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
32843|NCT02688387|75092|P22|STARTED|Part 3A, Period 2 (up to 6 Days)||0
32844|NCT02688387|75093|P21|STARTED|Part 3A, Period 2 (up to 6 Days)||0
32845|NCT02688387|75094|P20|STARTED|Part 3A, Period 2 (up to 6 Days)||0
32846|NCT02688387|75095|P19|STARTED|Part 3A, Period 2 (up to 6 Days)||0
32847|NCT02688387|75096|P18|STARTED|Part 3A, Period 2 (up to 6 Days)||8
32848|NCT02688387|75097|P17|STARTED|Part 3A, Period 2 (up to 6 Days)||8
32849|NCT02688387|75098|P16|STARTED|Part 3A, Period 2 (up to 6 Days)||8
32850|NCT02688387|75099|P15|STARTED|Part 3A, Period 2 (up to 6 Days)||8
32851|NCT02688387|75100|P14|STARTED|Part 3A, Period 2 (up to 6 Days)||0
32852|NCT02688387|75101|P13|STARTED|Part 3A, Period 2 (up to 6 Days)||0
32853|NCT02688387|75102|P12|STARTED|Part 3A, Period 2 (up to 6 Days)||0
32854|NCT02688387|75103|P11|STARTED|Part 3A, Period 2 (up to 6 Days)||0
32855|NCT02688387|75104|P10|STARTED|Part 3A, Period 2 (up to 6 Days)||0
32856|NCT02688387|75105|P9|STARTED|Part 3A, Period 2 (up to 6 Days)||0
32857|NCT02688387|75106|P8|STARTED|Part 3A, Period 2 (up to 6 Days)||0
32858|NCT02688387|75107|P7|STARTED|Part 3A, Period 2 (up to 6 Days)||0
32859|NCT02688387|75108|P6|STARTED|Part 3A, Period 2 (up to 6 Days)||0
32860|NCT02688387|75109|P5|STARTED|Part 3A, Period 2 (up to 6 Days)||0
32861|NCT02688387|75110|P4|STARTED|Part 3A, Period 2 (up to 6 Days)||0
32862|NCT02688387|75111|P3|STARTED|Part 3A, Period 2 (up to 6 Days)||0
32863|NCT02688387|75112|P2|STARTED|Part 3A, Period 2 (up to 6 Days)||0
32864|NCT02688387|75113|P1|STARTED|Part 3A, Period 2 (up to 6 Days)||0
32865|NCT02688387|75092|P22|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32866|NCT02688387|75093|P21|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32867|NCT02688387|75094|P20|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32868|NCT02688387|75095|P19|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32869|NCT02688387|75096|P18|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32870|NCT02688387|75097|P17|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32871|NCT02688387|75098|P16|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32872|NCT02688387|75099|P15|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32873|NCT02688387|75100|P14|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32874|NCT02688387|75101|P13|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32875|NCT02688387|75102|P12|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32876|NCT02688387|75103|P11|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32877|NCT02688387|75104|P10|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32878|NCT02688387|75105|P9|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32879|NCT02688387|75106|P8|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32880|NCT02688387|75107|P7|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32881|NCT02688387|75108|P6|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32882|NCT02688387|75109|P5|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32883|NCT02688387|75110|P4|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32884|NCT02688387|75111|P3|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32885|NCT02688387|75112|P2|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32886|NCT02688387|75113|P1|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32887|NCT02688387|75092|P22|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32888|NCT02688387|75093|P21|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32889|NCT02688387|75094|P20|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32890|NCT02688387|75095|P19|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32891|NCT02688387|75096|P18|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
32892|NCT02688387|75097|P17|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
32893|NCT02688387|75098|P16|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
32894|NCT02688387|75099|P15|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
32895|NCT02688387|75100|P14|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32896|NCT02688387|75101|P13|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32897|NCT02688387|75102|P12|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32898|NCT02688387|75103|P11|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32899|NCT02688387|75104|P10|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32900|NCT02688387|75105|P9|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32901|NCT02688387|75106|P8|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32902|NCT02688387|75107|P7|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32903|NCT02688387|75108|P6|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32904|NCT02688387|75109|P5|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32905|NCT02688387|75110|P4|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32906|NCT02688387|75111|P3|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32907|NCT02688387|75112|P2|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32908|NCT02688387|75113|P1|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
32909|NCT02688387|75092|P22|STARTED|Part 3A, Washout Period 1 (10 Days)||0
32910|NCT02688387|75093|P21|STARTED|Part 3A, Washout Period 1 (10 Days)||0
32911|NCT02688387|75094|P20|STARTED|Part 3A, Washout Period 1 (10 Days)||0
32912|NCT02688387|75095|P19|STARTED|Part 3A, Washout Period 1 (10 Days)||0
32913|NCT02688387|75096|P18|STARTED|Part 3A, Washout Period 1 (10 Days)||8
32914|NCT02688387|75097|P17|STARTED|Part 3A, Washout Period 1 (10 Days)||8
32915|NCT02688387|75098|P16|STARTED|Part 3A, Washout Period 1 (10 Days)||8
32916|NCT02688387|75099|P15|STARTED|Part 3A, Washout Period 1 (10 Days)||8
32917|NCT02688387|75100|P14|STARTED|Part 3A, Washout Period 1 (10 Days)||0
32918|NCT02688387|75101|P13|STARTED|Part 3A, Washout Period 1 (10 Days)||0
32919|NCT02688387|75102|P12|STARTED|Part 3A, Washout Period 1 (10 Days)||0
32920|NCT02688387|75103|P11|STARTED|Part 3A, Washout Period 1 (10 Days)||0
32921|NCT02688387|75104|P10|STARTED|Part 3A, Washout Period 1 (10 Days)||0
32922|NCT02688387|75105|P9|STARTED|Part 3A, Washout Period 1 (10 Days)||0
32923|NCT02688387|75106|P8|STARTED|Part 3A, Washout Period 1 (10 Days)||0
32924|NCT02688387|75107|P7|STARTED|Part 3A, Washout Period 1 (10 Days)||0
32925|NCT02688387|75108|P6|STARTED|Part 3A, Washout Period 1 (10 Days)||0
32926|NCT02688387|75109|P5|STARTED|Part 3A, Washout Period 1 (10 Days)||0
32927|NCT02688387|75110|P4|STARTED|Part 3A, Washout Period 1 (10 Days)||0
32928|NCT02688387|75111|P3|STARTED|Part 3A, Washout Period 1 (10 Days)||0
32929|NCT02688387|75112|P2|STARTED|Part 3A, Washout Period 1 (10 Days)||0
32930|NCT02688387|75113|P1|STARTED|Part 3A, Washout Period 1 (10 Days)||0
32931|NCT02688387|75092|P22|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32932|NCT02688387|75093|P21|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32933|NCT02688387|75094|P20|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32934|NCT02688387|75095|P19|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32935|NCT02688387|75096|P18|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32936|NCT02688387|75097|P17|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32937|NCT02688387|75098|P16|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32938|NCT02688387|75099|P15|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||1
32939|NCT02688387|75100|P14|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32940|NCT02688387|75101|P13|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32941|NCT02688387|75102|P12|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32942|NCT02688387|75103|P11|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32943|NCT02688387|75104|P10|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32944|NCT02688387|75105|P9|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32945|NCT02688387|75106|P8|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32946|NCT02688387|75107|P7|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32947|NCT02688387|75108|P6|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32948|NCT02688387|75109|P5|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32949|NCT02688387|75110|P4|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32950|NCT02688387|75111|P3|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32951|NCT02688387|75112|P2|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32952|NCT02688387|75113|P1|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32953|NCT02688387|75092|P22|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32954|NCT02688387|75093|P21|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32955|NCT02688387|75094|P20|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32956|NCT02688387|75095|P19|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32957|NCT02688387|75096|P18|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
32958|NCT02688387|75097|P17|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
32959|NCT02688387|75098|P16|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
32960|NCT02688387|75099|P15|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
32961|NCT02688387|75100|P14|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32962|NCT02688387|75101|P13|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32963|NCT02688387|75102|P12|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32964|NCT02688387|75103|P11|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32965|NCT02688387|75104|P10|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32966|NCT02688387|75105|P9|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32967|NCT02688387|75106|P8|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32968|NCT02688387|75107|P7|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32969|NCT02688387|75108|P6|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32970|NCT02688387|75109|P5|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32971|NCT02688387|75110|P4|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32972|NCT02688387|75111|P3|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32973|NCT02688387|75112|P2|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32974|NCT02688387|75113|P1|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
32975|NCT02688387|75092|P22|STARTED|Part 3A, Period 1 (up to 6 Days)||0
32976|NCT02688387|75093|P21|STARTED|Part 3A, Period 1 (up to 6 Days)||0
32977|NCT02688387|75094|P20|STARTED|Part 3A, Period 1 (up to 6 Days)||0
32978|NCT02688387|75095|P19|STARTED|Part 3A, Period 1 (up to 6 Days)||0
32979|NCT02688387|75096|P18|STARTED|Part 3A, Period 1 (up to 6 Days)||8
32980|NCT02688387|75097|P17|STARTED|Part 3A, Period 1 (up to 6 Days)||8
32981|NCT02688387|75098|P16|STARTED|Part 3A, Period 1 (up to 6 Days)||8
32982|NCT02688387|75099|P15|STARTED|Part 3A, Period 1 (up to 6 Days)||9
32983|NCT02688387|75100|P14|STARTED|Part 3A, Period 1 (up to 6 Days)||0
32984|NCT02688387|75101|P13|STARTED|Part 3A, Period 1 (up to 6 Days)||0
32985|NCT02688387|75102|P12|STARTED|Part 3A, Period 1 (up to 6 Days)||0
32986|NCT02688387|75103|P11|STARTED|Part 3A, Period 1 (up to 6 Days)||0
32987|NCT02688387|75104|P10|STARTED|Part 3A, Period 1 (up to 6 Days)||0
32988|NCT02688387|75105|P9|STARTED|Part 3A, Period 1 (up to 6 Days)||0
32989|NCT02688387|75106|P8|STARTED|Part 3A, Period 1 (up to 6 Days)||0
32990|NCT02688387|75107|P7|STARTED|Part 3A, Period 1 (up to 6 Days)||0
32991|NCT02688387|75108|P6|STARTED|Part 3A, Period 1 (up to 6 Days)||0
32992|NCT02688387|75109|P5|STARTED|Part 3A, Period 1 (up to 6 Days)||0
32993|NCT02688387|75110|P4|STARTED|Part 3A, Period 1 (up to 6 Days)||0
32994|NCT02688387|75111|P3|STARTED|Part 3A, Period 1 (up to 6 Days)||0
32995|NCT02688387|75112|P2|STARTED|Part 3A, Period 1 (up to 6 Days)||0
32996|NCT02688387|75113|P1|STARTED|Part 3A, Period 1 (up to 6 Days)||0
32997|NCT02688387|75092|P22|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
32998|NCT02688387|75093|P21|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
32999|NCT02688387|75094|P20|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33000|NCT02688387|75095|P19|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33001|NCT02688387|75096|P18|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33002|NCT02688387|75097|P17|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33003|NCT02688387|75098|P16|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33004|NCT02688387|75099|P15|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33005|NCT02688387|75100|P14|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33006|NCT02688387|75101|P13|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33007|NCT02688387|75102|P12|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33008|NCT02688387|75103|P11|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33009|NCT02688387|75104|P10|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33010|NCT02688387|75105|P9|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33011|NCT02688387|75106|P8|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33012|NCT02688387|75107|P7|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33013|NCT02688387|75108|P6|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33014|NCT02688387|75109|P5|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33015|NCT02688387|75110|P4|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33016|NCT02688387|75111|P3|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33017|NCT02688387|75112|P2|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33018|NCT02688387|75113|P1|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33019|NCT02688387|75092|P22|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33020|NCT02688387|75093|P21|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33021|NCT02688387|75094|P20|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33022|NCT02688387|75095|P19|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33023|NCT02688387|75096|P18|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33024|NCT02688387|75097|P17|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33025|NCT02688387|75098|P16|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33026|NCT02688387|75099|P15|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33027|NCT02688387|75100|P14|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
33028|NCT02688387|75101|P13|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
33029|NCT02688387|75102|P12|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
33030|NCT02688387|75103|P11|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
33031|NCT02688387|75104|P10|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33032|NCT02688387|75105|P9|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33033|NCT02688387|75106|P8|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33034|NCT02688387|75107|P7|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33035|NCT02688387|75108|P6|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33036|NCT02688387|75109|P5|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33037|NCT02688387|75110|P4|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33038|NCT02688387|75111|P3|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33039|NCT02688387|75112|P2|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33040|NCT02688387|75113|P1|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
33041|NCT02688387|75092|P22|STARTED|Part 2, Period 4 (up to 6 Days)||0
33042|NCT02688387|75093|P21|STARTED|Part 2, Period 4 (up to 6 Days)||0
33043|NCT02688387|75094|P20|STARTED|Part 2, Period 4 (up to 6 Days)||0
33044|NCT02688387|75095|P19|STARTED|Part 2, Period 4 (up to 6 Days)||0
33045|NCT02688387|75096|P18|STARTED|Part 2, Period 4 (up to 6 Days)||0
33046|NCT02688387|75097|P17|STARTED|Part 2, Period 4 (up to 6 Days)||0
33047|NCT02688387|75098|P16|STARTED|Part 2, Period 4 (up to 6 Days)||0
33048|NCT02688387|75099|P15|STARTED|Part 2, Period 4 (up to 6 Days)||0
33049|NCT02688387|75100|P14|STARTED|Part 2, Period 4 (up to 6 Days)||5
33050|NCT02688387|75101|P13|STARTED|Part 2, Period 4 (up to 6 Days)||5
33051|NCT02688387|75102|P12|STARTED|Part 2, Period 4 (up to 6 Days)||5
33052|NCT02688387|75103|P11|STARTED|Part 2, Period 4 (up to 6 Days)||5
33053|NCT02688387|75104|P10|STARTED|Part 2, Period 4 (up to 6 Days)||0
33054|NCT02688387|75105|P9|STARTED|Part 2, Period 4 (up to 6 Days)||0
33055|NCT02688387|75106|P8|STARTED|Part 2, Period 4 (up to 6 Days)||0
33056|NCT02688387|75107|P7|STARTED|Part 2, Period 4 (up to 6 Days)||0
33057|NCT02688387|75108|P6|STARTED|Part 2, Period 4 (up to 6 Days)||0
33058|NCT02688387|75109|P5|STARTED|Part 2, Period 4 (up to 6 Days)||0
33059|NCT02688387|75110|P4|STARTED|Part 2, Period 4 (up to 6 Days)||0
33060|NCT02688387|75111|P3|STARTED|Part 2, Period 4 (up to 6 Days)||0
33061|NCT02688387|75112|P2|STARTED|Part 2, Period 4 (up to 6 Days)||0
33062|NCT02688387|75113|P1|STARTED|Part 2, Period 4 (up to 6 Days)||0
33063|NCT02688387|75092|P22|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33064|NCT02688387|75093|P21|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33065|NCT02688387|75094|P20|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33066|NCT02688387|75095|P19|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33067|NCT02688387|75096|P18|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33068|NCT02688387|75097|P17|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33069|NCT02688387|75098|P16|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33070|NCT02688387|75099|P15|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33071|NCT02688387|75100|P14|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33072|NCT02688387|75101|P13|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33073|NCT02688387|75102|P12|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33074|NCT02688387|75103|P11|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33075|NCT02688387|75104|P10|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33076|NCT02688387|75105|P9|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33077|NCT02688387|75106|P8|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33078|NCT02688387|75107|P7|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33079|NCT02688387|75108|P6|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33080|NCT02688387|75109|P5|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33081|NCT02688387|75110|P4|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33082|NCT02688387|75111|P3|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33083|NCT02688387|75112|P2|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33084|NCT02688387|75113|P1|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33085|NCT02688387|75092|P22|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33086|NCT02688387|75093|P21|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33087|NCT02688387|75094|P20|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33088|NCT02688387|75095|P19|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33089|NCT02688387|75096|P18|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33090|NCT02688387|75097|P17|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33091|NCT02688387|75098|P16|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33092|NCT02688387|75099|P15|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33093|NCT02688387|75100|P14|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
33094|NCT02688387|75101|P13|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
33095|NCT02688387|75102|P12|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
33096|NCT02688387|75103|P11|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
33097|NCT02688387|75104|P10|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33098|NCT02688387|75105|P9|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33099|NCT02688387|75106|P8|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33100|NCT02688387|75107|P7|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33101|NCT02688387|75108|P6|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33102|NCT02688387|75109|P5|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33103|NCT02688387|75110|P4|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33104|NCT02688387|75111|P3|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33105|NCT02688387|75112|P2|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33106|NCT02688387|75113|P1|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
33107|NCT02688387|75092|P22|STARTED|Part 2, Washout Period 3 (10 Days)||0
33108|NCT02688387|75093|P21|STARTED|Part 2, Washout Period 3 (10 Days)||0
33109|NCT02688387|75094|P20|STARTED|Part 2, Washout Period 3 (10 Days)||0
33110|NCT02688387|75095|P19|STARTED|Part 2, Washout Period 3 (10 Days)||0
33111|NCT02688387|75096|P18|STARTED|Part 2, Washout Period 3 (10 Days)||0
33112|NCT02688387|75097|P17|STARTED|Part 2, Washout Period 3 (10 Days)||0
33113|NCT02688387|75098|P16|STARTED|Part 2, Washout Period 3 (10 Days)||0
33114|NCT02688387|75099|P15|STARTED|Part 2, Washout Period 3 (10 Days)||0
33115|NCT02688387|75100|P14|STARTED|Part 2, Washout Period 3 (10 Days)||5
33116|NCT02688387|75101|P13|STARTED|Part 2, Washout Period 3 (10 Days)||5
33117|NCT02688387|75102|P12|STARTED|Part 2, Washout Period 3 (10 Days)||5
33118|NCT02688387|75103|P11|STARTED|Part 2, Washout Period 3 (10 Days)||5
33119|NCT02688387|75104|P10|STARTED|Part 2, Washout Period 3 (10 Days)||0
33120|NCT02688387|75105|P9|STARTED|Part 2, Washout Period 3 (10 Days)||0
33121|NCT02688387|75106|P8|STARTED|Part 2, Washout Period 3 (10 Days)||0
33122|NCT02688387|75107|P7|STARTED|Part 2, Washout Period 3 (10 Days)||0
33123|NCT02688387|75108|P6|STARTED|Part 2, Washout Period 3 (10 Days)||0
33124|NCT02688387|75109|P5|STARTED|Part 2, Washout Period 3 (10 Days)||0
33125|NCT02688387|75110|P4|STARTED|Part 2, Washout Period 3 (10 Days)||0
33126|NCT02688387|75111|P3|STARTED|Part 2, Washout Period 3 (10 Days)||0
33127|NCT02688387|75112|P2|STARTED|Part 2, Washout Period 3 (10 Days)||0
33128|NCT02688387|75113|P1|STARTED|Part 2, Washout Period 3 (10 Days)||0
33129|NCT02688387|75092|P22|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33130|NCT02688387|75093|P21|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33131|NCT02688387|75094|P20|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33132|NCT02688387|75095|P19|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33133|NCT02688387|75096|P18|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33134|NCT02688387|75097|P17|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33135|NCT02688387|75098|P16|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33136|NCT02688387|75099|P15|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33137|NCT02688387|75100|P14|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33138|NCT02688387|75101|P13|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33139|NCT02688387|75102|P12|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33140|NCT02688387|75103|P11|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33141|NCT02688387|75104|P10|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33142|NCT02688387|75105|P9|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33143|NCT02688387|75106|P8|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33144|NCT02688387|75107|P7|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33145|NCT02688387|75108|P6|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33146|NCT02688387|75109|P5|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33147|NCT02688387|75110|P4|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33148|NCT02688387|75111|P3|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33149|NCT02688387|75112|P2|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33150|NCT02688387|75113|P1|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33151|NCT02688387|75092|P22|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33152|NCT02688387|75093|P21|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33153|NCT02688387|75094|P20|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33154|NCT02688387|75095|P19|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33155|NCT02688387|75096|P18|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33156|NCT02688387|75097|P17|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33157|NCT02688387|75098|P16|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33158|NCT02688387|75099|P15|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33159|NCT02688387|75100|P14|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
33160|NCT02688387|75101|P13|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
33161|NCT02688387|75102|P12|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
33162|NCT02688387|75103|P11|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
33163|NCT02688387|75104|P10|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33164|NCT02688387|75105|P9|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33165|NCT02688387|75106|P8|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33166|NCT02688387|75107|P7|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33167|NCT02688387|75108|P6|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33168|NCT02688387|75109|P5|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33169|NCT02688387|75110|P4|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33170|NCT02688387|75111|P3|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33171|NCT02688387|75112|P2|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33172|NCT02688387|75113|P1|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
33173|NCT02688387|75092|P22|STARTED|Part 2, Period 3 (up to 6 Days)||0
33174|NCT02688387|75093|P21|STARTED|Part 2, Period 3 (up to 6 Days)||0
33175|NCT02688387|75094|P20|STARTED|Part 2, Period 3 (up to 6 Days)||0
33176|NCT02688387|75095|P19|STARTED|Part 2, Period 3 (up to 6 Days)||0
33177|NCT02688387|75096|P18|STARTED|Part 2, Period 3 (up to 6 Days)||0
33178|NCT02688387|75097|P17|STARTED|Part 2, Period 3 (up to 6 Days)||0
33179|NCT02688387|75098|P16|STARTED|Part 2, Period 3 (up to 6 Days)||0
33180|NCT02688387|75099|P15|STARTED|Part 2, Period 3 (up to 6 Days)||0
33181|NCT02688387|75100|P14|STARTED|Part 2, Period 3 (up to 6 Days)||5
33182|NCT02688387|75101|P13|STARTED|Part 2, Period 3 (up to 6 Days)||5
33183|NCT02688387|75102|P12|STARTED|Part 2, Period 3 (up to 6 Days)||5
33184|NCT02688387|75103|P11|STARTED|Part 2, Period 3 (up to 6 Days)||5
33185|NCT02688387|75104|P10|STARTED|Part 2, Period 3 (up to 6 Days)||0
33186|NCT02688387|75105|P9|STARTED|Part 2, Period 3 (up to 6 Days)||0
33187|NCT02688387|75106|P8|STARTED|Part 2, Period 3 (up to 6 Days)||0
33188|NCT02688387|75107|P7|STARTED|Part 2, Period 3 (up to 6 Days)||0
33189|NCT02688387|75108|P6|STARTED|Part 2, Period 3 (up to 6 Days)||0
33190|NCT02688387|75109|P5|STARTED|Part 2, Period 3 (up to 6 Days)||0
33191|NCT02688387|75110|P4|STARTED|Part 2, Period 3 (up to 6 Days)||0
33192|NCT02688387|75111|P3|STARTED|Part 2, Period 3 (up to 6 Days)||0
33193|NCT02688387|75112|P2|STARTED|Part 2, Period 3 (up to 6 Days)||0
33194|NCT02688387|75113|P1|STARTED|Part 2, Period 3 (up to 6 Days)||0
33195|NCT02688387|75092|P22|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33196|NCT02688387|75093|P21|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33197|NCT02688387|75094|P20|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33198|NCT02688387|75095|P19|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33199|NCT02688387|75096|P18|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33200|NCT02688387|75097|P17|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33201|NCT02688387|75098|P16|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33202|NCT02688387|75099|P15|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33203|NCT02688387|75100|P14|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33204|NCT02688387|75101|P13|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33205|NCT02688387|75102|P12|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33206|NCT02688387|75103|P11|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33207|NCT02688387|75104|P10|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33208|NCT02688387|75105|P9|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33209|NCT02688387|75106|P8|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33210|NCT02688387|75107|P7|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33211|NCT02688387|75108|P6|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33212|NCT02688387|75109|P5|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33213|NCT02688387|75110|P4|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33214|NCT02688387|75111|P3|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33215|NCT02688387|75112|P2|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33216|NCT02688387|75113|P1|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33217|NCT02688387|75092|P22|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33218|NCT02688387|75093|P21|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33219|NCT02688387|75094|P20|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33220|NCT02688387|75095|P19|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33221|NCT02688387|75096|P18|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33222|NCT02688387|75097|P17|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33223|NCT02688387|75098|P16|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33224|NCT02688387|75099|P15|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33225|NCT02688387|75100|P14|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
33226|NCT02688387|75101|P13|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
33227|NCT02688387|75102|P12|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
33228|NCT02688387|75103|P11|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
33229|NCT02688387|75104|P10|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33230|NCT02688387|75105|P9|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33231|NCT02688387|75106|P8|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33232|NCT02688387|75107|P7|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33233|NCT02688387|75108|P6|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33234|NCT02688387|75109|P5|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33235|NCT02688387|75110|P4|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33236|NCT02688387|75111|P3|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33237|NCT02688387|75112|P2|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33238|NCT02688387|75113|P1|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
33239|NCT02688387|75092|P22|STARTED|Part 2, Washout Period 2 (10 Days)||0
33240|NCT02688387|75093|P21|STARTED|Part 2, Washout Period 2 (10 Days)||0
33241|NCT02688387|75094|P20|STARTED|Part 2, Washout Period 2 (10 Days)||0
33242|NCT02688387|75095|P19|STARTED|Part 2, Washout Period 2 (10 Days)||0
33243|NCT02688387|75096|P18|STARTED|Part 2, Washout Period 2 (10 Days)||0
33244|NCT02688387|75097|P17|STARTED|Part 2, Washout Period 2 (10 Days)||0
33245|NCT02688387|75098|P16|STARTED|Part 2, Washout Period 2 (10 Days)||0
33246|NCT02688387|75099|P15|STARTED|Part 2, Washout Period 2 (10 Days)||0
33247|NCT02688387|75100|P14|STARTED|Part 2, Washout Period 2 (10 Days)||5
33248|NCT02688387|75101|P13|STARTED|Part 2, Washout Period 2 (10 Days)||5
33249|NCT02688387|75102|P12|STARTED|Part 2, Washout Period 2 (10 Days)||5
33250|NCT02688387|75103|P11|STARTED|Part 2, Washout Period 2 (10 Days)||5
33251|NCT02688387|75104|P10|STARTED|Part 2, Washout Period 2 (10 Days)||0
33252|NCT02688387|75105|P9|STARTED|Part 2, Washout Period 2 (10 Days)||0
33253|NCT02688387|75106|P8|STARTED|Part 2, Washout Period 2 (10 Days)||0
33254|NCT02688387|75107|P7|STARTED|Part 2, Washout Period 2 (10 Days)||0
33255|NCT02688387|75108|P6|STARTED|Part 2, Washout Period 2 (10 Days)||0
33256|NCT02688387|75109|P5|STARTED|Part 2, Washout Period 2 (10 Days)||0
33257|NCT02688387|75110|P4|STARTED|Part 2, Washout Period 2 (10 Days)||0
33258|NCT02688387|75111|P3|STARTED|Part 2, Washout Period 2 (10 Days)||0
33259|NCT02688387|75112|P2|STARTED|Part 2, Washout Period 2 (10 Days)||0
33260|NCT02688387|75113|P1|STARTED|Part 2, Washout Period 2 (10 Days)||0
33261|NCT02688387|75092|P22|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33262|NCT02688387|75093|P21|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33263|NCT02688387|75094|P20|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33264|NCT02688387|75095|P19|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33265|NCT02688387|75096|P18|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33266|NCT02688387|75097|P17|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33267|NCT02688387|75098|P16|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33268|NCT02688387|75099|P15|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33269|NCT02688387|75100|P14|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33270|NCT02688387|75101|P13|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33271|NCT02688387|75102|P12|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33272|NCT02688387|75103|P11|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33273|NCT02688387|75104|P10|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33274|NCT02688387|75105|P9|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33275|NCT02688387|75106|P8|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33276|NCT02688387|75107|P7|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33277|NCT02688387|75108|P6|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33278|NCT02688387|75109|P5|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33279|NCT02688387|75110|P4|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33280|NCT02688387|75111|P3|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33281|NCT02688387|75112|P2|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33282|NCT02688387|75113|P1|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33283|NCT02688387|75092|P22|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33284|NCT02688387|75093|P21|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33285|NCT02688387|75094|P20|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33286|NCT02688387|75095|P19|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33287|NCT02688387|75096|P18|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33288|NCT02688387|75097|P17|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33289|NCT02688387|75098|P16|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33290|NCT02688387|75099|P15|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33291|NCT02688387|75100|P14|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
33292|NCT02688387|75101|P13|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
33293|NCT02688387|75102|P12|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
33294|NCT02688387|75103|P11|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
33295|NCT02688387|75104|P10|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33296|NCT02688387|75105|P9|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33297|NCT02688387|75106|P8|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33298|NCT02688387|75107|P7|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33299|NCT02688387|75108|P6|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33300|NCT02688387|75109|P5|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33301|NCT02688387|75110|P4|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33302|NCT02688387|75111|P3|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33303|NCT02688387|75112|P2|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33304|NCT02688387|75113|P1|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
33305|NCT02688387|75092|P22|STARTED|Part 2, Period 2 (up to 6 Days)||0
33306|NCT02688387|75093|P21|STARTED|Part 2, Period 2 (up to 6 Days)||0
33307|NCT02688387|75094|P20|STARTED|Part 2, Period 2 (up to 6 Days)||0
33308|NCT02688387|75095|P19|STARTED|Part 2, Period 2 (up to 6 Days)||0
33309|NCT02688387|75096|P18|STARTED|Part 2, Period 2 (up to 6 Days)||0
33310|NCT02688387|75097|P17|STARTED|Part 2, Period 2 (up to 6 Days)||0
33311|NCT02688387|75098|P16|STARTED|Part 2, Period 2 (up to 6 Days)||0
33312|NCT02688387|75099|P15|STARTED|Part 2, Period 2 (up to 6 Days)||0
33313|NCT02688387|75100|P14|STARTED|Part 2, Period 2 (up to 6 Days)||5
33314|NCT02688387|75101|P13|STARTED|Part 2, Period 2 (up to 6 Days)||5
33315|NCT02688387|75102|P12|STARTED|Part 2, Period 2 (up to 6 Days)||5
33316|NCT02688387|75103|P11|STARTED|Part 2, Period 2 (up to 6 Days)||5
33317|NCT02688387|75104|P10|STARTED|Part 2, Period 2 (up to 6 Days)||0
33318|NCT02688387|75105|P9|STARTED|Part 2, Period 2 (up to 6 Days)||0
33319|NCT02688387|75106|P8|STARTED|Part 2, Period 2 (up to 6 Days)||0
33320|NCT02688387|75107|P7|STARTED|Part 2, Period 2 (up to 6 Days)||0
33321|NCT02688387|75108|P6|STARTED|Part 2, Period 2 (up to 6 Days)||0
33322|NCT02688387|75109|P5|STARTED|Part 2, Period 2 (up to 6 Days)||0
33323|NCT02688387|75110|P4|STARTED|Part 2, Period 2 (up to 6 Days)||0
33324|NCT02688387|75111|P3|STARTED|Part 2, Period 2 (up to 6 Days)||0
33325|NCT02688387|75112|P2|STARTED|Part 2, Period 2 (up to 6 Days)||0
33326|NCT02688387|75113|P1|STARTED|Part 2, Period 2 (up to 6 Days)||0
33327|NCT02688387|75092|P22|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33328|NCT02688387|75093|P21|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33329|NCT02688387|75094|P20|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33330|NCT02688387|75095|P19|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33331|NCT02688387|75096|P18|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33332|NCT02688387|75097|P17|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33333|NCT02688387|75098|P16|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33334|NCT02688387|75099|P15|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33335|NCT02688387|75100|P14|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33336|NCT02688387|75101|P13|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33337|NCT02688387|75102|P12|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33338|NCT02688387|75103|P11|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33339|NCT02688387|75104|P10|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33340|NCT02688387|75105|P9|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33341|NCT02688387|75106|P8|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33342|NCT02688387|75107|P7|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33343|NCT02688387|75108|P6|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33344|NCT02688387|75109|P5|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33345|NCT02688387|75110|P4|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33346|NCT02688387|75111|P3|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33347|NCT02688387|75112|P2|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33348|NCT02688387|75113|P1|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33349|NCT02688387|75092|P22|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33350|NCT02688387|75093|P21|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33351|NCT02688387|75094|P20|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33352|NCT02688387|75095|P19|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33353|NCT02688387|75096|P18|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33354|NCT02688387|75097|P17|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33355|NCT02688387|75098|P16|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33356|NCT02688387|75099|P15|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33357|NCT02688387|75100|P14|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
33358|NCT02688387|75101|P13|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
33359|NCT02688387|75102|P12|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
33360|NCT02688387|75103|P11|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
33361|NCT02688387|75104|P10|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33362|NCT02688387|75105|P9|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33363|NCT02688387|75106|P8|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33364|NCT02688387|75107|P7|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33365|NCT02688387|75108|P6|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33366|NCT02688387|75109|P5|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33367|NCT02688387|75110|P4|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33368|NCT02688387|75111|P3|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33369|NCT02688387|75112|P2|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33370|NCT02688387|75113|P1|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
33371|NCT02688387|75092|P22|STARTED|Part 2, Washout Period 1 (10 Days)||0
33372|NCT02688387|75093|P21|STARTED|Part 2, Washout Period 1 (10 Days)||0
33373|NCT02688387|75094|P20|STARTED|Part 2, Washout Period 1 (10 Days)||0
33374|NCT02688387|75095|P19|STARTED|Part 2, Washout Period 1 (10 Days)||0
33375|NCT02688387|75096|P18|STARTED|Part 2, Washout Period 1 (10 Days)||0
33376|NCT02688387|75097|P17|STARTED|Part 2, Washout Period 1 (10 Days)||0
33377|NCT02688387|75098|P16|STARTED|Part 2, Washout Period 1 (10 Days)||0
33378|NCT02688387|75099|P15|STARTED|Part 2, Washout Period 1 (10 Days)||0
33379|NCT02688387|75100|P14|STARTED|Part 2, Washout Period 1 (10 Days)||5
33380|NCT02688387|75101|P13|STARTED|Part 2, Washout Period 1 (10 Days)||5
33381|NCT02688387|75102|P12|STARTED|Part 2, Washout Period 1 (10 Days)||5
33382|NCT02688387|75103|P11|STARTED|Part 2, Washout Period 1 (10 Days)||5
33383|NCT02688387|75104|P10|STARTED|Part 2, Washout Period 1 (10 Days)||0
33384|NCT02688387|75105|P9|STARTED|Part 2, Washout Period 1 (10 Days)||0
33385|NCT02688387|75106|P8|STARTED|Part 2, Washout Period 1 (10 Days)||0
33386|NCT02688387|75107|P7|STARTED|Part 2, Washout Period 1 (10 Days)||0
33387|NCT02688387|75108|P6|STARTED|Part 2, Washout Period 1 (10 Days)||0
33388|NCT02688387|75109|P5|STARTED|Part 2, Washout Period 1 (10 Days)||0
33389|NCT02688387|75110|P4|STARTED|Part 2, Washout Period 1 (10 Days)||0
33390|NCT02688387|75111|P3|STARTED|Part 2, Washout Period 1 (10 Days)||0
33391|NCT02688387|75112|P2|STARTED|Part 2, Washout Period 1 (10 Days)||0
33392|NCT02688387|75113|P1|STARTED|Part 2, Washout Period 1 (10 Days)||0
33393|NCT02688387|75092|P22|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33394|NCT02688387|75093|P21|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33395|NCT02688387|75094|P20|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33396|NCT02688387|75095|P19|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33397|NCT02688387|75096|P18|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33398|NCT02688387|75097|P17|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33399|NCT02688387|75098|P16|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33400|NCT02688387|75099|P15|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33401|NCT02688387|75100|P14|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33402|NCT02688387|75101|P13|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33403|NCT02688387|75102|P12|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33404|NCT02688387|75103|P11|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||1
33405|NCT02688387|75104|P10|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33406|NCT02688387|75105|P9|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33407|NCT02688387|75106|P8|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33408|NCT02688387|75107|P7|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33409|NCT02688387|75108|P6|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33410|NCT02688387|75109|P5|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33411|NCT02688387|75110|P4|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33412|NCT02688387|75111|P3|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33413|NCT02688387|75112|P2|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33414|NCT02688387|75113|P1|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33415|NCT02688387|75092|P22|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33416|NCT02688387|75093|P21|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33417|NCT02688387|75094|P20|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33418|NCT02688387|75095|P19|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33419|NCT02688387|75096|P18|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33420|NCT02688387|75097|P17|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33421|NCT02688387|75098|P16|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33422|NCT02688387|75099|P15|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33423|NCT02688387|75100|P14|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
33424|NCT02688387|75101|P13|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
33425|NCT02688387|75102|P12|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
33426|NCT02688387|75103|P11|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
33427|NCT02688387|75104|P10|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33428|NCT02688387|75105|P9|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33429|NCT02688387|75106|P8|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33430|NCT02688387|75107|P7|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33431|NCT02688387|75108|P6|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33432|NCT02688387|75109|P5|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33433|NCT02688387|75110|P4|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33434|NCT02688387|75111|P3|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33435|NCT02688387|75112|P2|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33436|NCT02688387|75113|P1|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
33437|NCT02688387|75092|P22|STARTED|Part 2, Period 1 (up to 6 Days)||0
33438|NCT02688387|75093|P21|STARTED|Part 2, Period 1 (up to 6 Days)||0
33439|NCT02688387|75094|P20|STARTED|Part 2, Period 1 (up to 6 Days)||0
33440|NCT02688387|75095|P19|STARTED|Part 2, Period 1 (up to 6 Days)||0
33441|NCT02688387|75096|P18|STARTED|Part 2, Period 1 (up to 6 Days)||0
33442|NCT02688387|75097|P17|STARTED|Part 2, Period 1 (up to 6 Days)||0
33443|NCT02688387|75098|P16|STARTED|Part 2, Period 1 (up to 6 Days)||0
33444|NCT02688387|75099|P15|STARTED|Part 2, Period 1 (up to 6 Days)||0
33445|NCT02688387|75100|P14|STARTED|Part 2, Period 1 (up to 6 Days)||5
33446|NCT02688387|75101|P13|STARTED|Part 2, Period 1 (up to 6 Days)||5
33447|NCT02688387|75102|P12|STARTED|Part 2, Period 1 (up to 6 Days)||5
33448|NCT02688387|75103|P11|STARTED|Part 2, Period 1 (up to 6 Days)||6
33449|NCT02688387|75104|P10|STARTED|Part 2, Period 1 (up to 6 Days)||0
33450|NCT02688387|75105|P9|STARTED|Part 2, Period 1 (up to 6 Days)||0
33451|NCT02688387|75106|P8|STARTED|Part 2, Period 1 (up to 6 Days)||0
33452|NCT02688387|75107|P7|STARTED|Part 2, Period 1 (up to 6 Days)||0
33453|NCT02688387|75108|P6|STARTED|Part 2, Period 1 (up to 6 Days)||0
33454|NCT02688387|75109|P5|STARTED|Part 2, Period 1 (up to 6 Days)||0
33455|NCT02688387|75110|P4|STARTED|Part 2, Period 1 (up to 6 Days)||0
33456|NCT02688387|75111|P3|STARTED|Part 2, Period 1 (up to 6 Days)||0
33457|NCT02688387|75112|P2|STARTED|Part 2, Period 1 (up to 6 Days)||0
33458|NCT02688387|75113|P1|STARTED|Part 2, Period 1 (up to 6 Days)||0
33459|NCT02688387|75092|P22|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33460|NCT02688387|75093|P21|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33461|NCT02688387|75094|P20|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33462|NCT02688387|75095|P19|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33463|NCT02688387|75096|P18|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33464|NCT02688387|75097|P17|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33465|NCT02688387|75098|P16|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33466|NCT02688387|75099|P15|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33467|NCT02688387|75100|P14|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33468|NCT02688387|75101|P13|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33469|NCT02688387|75102|P12|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33470|NCT02688387|75103|P11|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33471|NCT02688387|75104|P10|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33472|NCT02688387|75105|P9|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33473|NCT02688387|75106|P8|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33474|NCT02688387|75107|P7|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33475|NCT02688387|75108|P6|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33476|NCT02688387|75109|P5|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33477|NCT02688387|75110|P4|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33478|NCT02688387|75111|P3|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33479|NCT02688387|75112|P2|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33480|NCT02688387|75113|P1|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33481|NCT02688387|75092|P22|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33482|NCT02688387|75093|P21|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33483|NCT02688387|75094|P20|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33484|NCT02688387|75095|P19|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33485|NCT02688387|75096|P18|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33486|NCT02688387|75097|P17|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33487|NCT02688387|75098|P16|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33488|NCT02688387|75099|P15|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33489|NCT02688387|75100|P14|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33490|NCT02688387|75101|P13|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33491|NCT02688387|75102|P12|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33492|NCT02688387|75103|P11|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
33493|NCT02688387|75104|P10|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
33494|NCT02688387|75105|P9|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
33495|NCT02688387|75106|P8|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
33496|NCT02688387|75107|P7|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
33497|NCT02688387|75108|P6|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
33498|NCT02688387|75109|P5|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
33499|NCT02688387|75110|P4|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
33500|NCT02688387|75111|P3|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
33501|NCT02688387|75112|P2|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
33502|NCT02688387|75113|P1|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
33503|NCT02688387|75092|P22|STARTED|Part 1, Period 5 (up to 6 Days)||0
33504|NCT02688387|75093|P21|STARTED|Part 1, Period 5 (up to 6 Days)||0
33505|NCT02688387|75094|P20|STARTED|Part 1, Period 5 (up to 6 Days)||0
33506|NCT02688387|75095|P19|STARTED|Part 1, Period 5 (up to 6 Days)||0
33507|NCT02688387|75096|P18|STARTED|Part 1, Period 5 (up to 6 Days)||0
33508|NCT02688387|75097|P17|STARTED|Part 1, Period 5 (up to 6 Days)||0
33509|NCT02688387|75098|P16|STARTED|Part 1, Period 5 (up to 6 Days)||0
33510|NCT02688387|75099|P15|STARTED|Part 1, Period 5 (up to 6 Days)||0
33511|NCT02688387|75100|P14|STARTED|Part 1, Period 5 (up to 6 Days)||0
33512|NCT02688387|75101|P13|STARTED|Part 1, Period 5 (up to 6 Days)||0
33513|NCT02688387|75102|P12|STARTED|Part 1, Period 5 (up to 6 Days)||0
33514|NCT02688387|75103|P11|STARTED|Part 1, Period 5 (up to 6 Days)||0
33515|NCT02688387|75104|P10|STARTED|Part 1, Period 5 (up to 6 Days)||2
33516|NCT02688387|75105|P9|STARTED|Part 1, Period 5 (up to 6 Days)||2
33517|NCT02688387|75106|P8|STARTED|Part 1, Period 5 (up to 6 Days)||2
33518|NCT02688387|75107|P7|STARTED|Part 1, Period 5 (up to 6 Days)||2
33519|NCT02688387|75108|P6|STARTED|Part 1, Period 5 (up to 6 Days)||2
33520|NCT02688387|75109|P5|STARTED|Part 1, Period 5 (up to 6 Days)||2
33521|NCT02688387|75110|P4|STARTED|Part 1, Period 5 (up to 6 Days)||2
33522|NCT02688387|75111|P3|STARTED|Part 1, Period 5 (up to 6 Days)||2
33523|NCT02688387|75112|P2|STARTED|Part 1, Period 5 (up to 6 Days)||2
33524|NCT02688387|75113|P1|STARTED|Part 1, Period 5 (up to 6 Days)||2
33525|NCT02688387|75092|P22|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33526|NCT02688387|75093|P21|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33527|NCT02688387|75094|P20|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33528|NCT02688387|75095|P19|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33529|NCT02688387|75096|P18|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33530|NCT02688387|75097|P17|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33531|NCT02688387|75098|P16|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33532|NCT02688387|75099|P15|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33533|NCT02688387|75100|P14|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33534|NCT02688387|75101|P13|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33535|NCT02688387|75102|P12|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33536|NCT02688387|75103|P11|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33537|NCT02688387|75104|P10|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33538|NCT02688387|75105|P9|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33539|NCT02688387|75106|P8|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33540|NCT02688387|75107|P7|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33541|NCT02688387|75108|P6|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33542|NCT02688387|75109|P5|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33543|NCT02688387|75110|P4|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33544|NCT02688387|75111|P3|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33545|NCT02688387|75112|P2|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33546|NCT02688387|75113|P1|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33547|NCT02688387|75092|P22|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33548|NCT02688387|75093|P21|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33549|NCT02688387|75094|P20|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33550|NCT02688387|75095|P19|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33551|NCT02688387|75096|P18|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33552|NCT02688387|75097|P17|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33553|NCT02688387|75098|P16|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33554|NCT02688387|75099|P15|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33555|NCT02688387|75100|P14|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33556|NCT02688387|75101|P13|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33557|NCT02688387|75102|P12|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33558|NCT02688387|75103|P11|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
33559|NCT02688387|75104|P10|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
33560|NCT02688387|75105|P9|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
33561|NCT02688387|75106|P8|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
33562|NCT02688387|75107|P7|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
33563|NCT02688387|75108|P6|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
33564|NCT02688387|75109|P5|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
33565|NCT02688387|75110|P4|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
33566|NCT02688387|75111|P3|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
33567|NCT02688387|75112|P2|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
33568|NCT02688387|75113|P1|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
33569|NCT02688387|75092|P22|STARTED|Part 1, Washout Period 4 (7 Days)||0
33570|NCT02688387|75093|P21|STARTED|Part 1, Washout Period 4 (7 Days)||0
33571|NCT02688387|75094|P20|STARTED|Part 1, Washout Period 4 (7 Days)||0
33572|NCT02688387|75095|P19|STARTED|Part 1, Washout Period 4 (7 Days)||0
33573|NCT02688387|75096|P18|STARTED|Part 1, Washout Period 4 (7 Days)||0
33574|NCT02688387|75097|P17|STARTED|Part 1, Washout Period 4 (7 Days)||0
33575|NCT02688387|75098|P16|STARTED|Part 1, Washout Period 4 (7 Days)||0
33576|NCT02688387|75099|P15|STARTED|Part 1, Washout Period 4 (7 Days)||0
33577|NCT02688387|75100|P14|STARTED|Part 1, Washout Period 4 (7 Days)||0
33578|NCT02688387|75101|P13|STARTED|Part 1, Washout Period 4 (7 Days)||0
33579|NCT02688387|75102|P12|STARTED|Part 1, Washout Period 4 (7 Days)||0
33580|NCT02688387|75103|P11|STARTED|Part 1, Washout Period 4 (7 Days)||0
33581|NCT02688387|75104|P10|STARTED|Part 1, Washout Period 4 (7 Days)||2
33582|NCT02688387|75105|P9|STARTED|Part 1, Washout Period 4 (7 Days)||2
33583|NCT02688387|75106|P8|STARTED|Part 1, Washout Period 4 (7 Days)||2
33584|NCT02688387|75107|P7|STARTED|Part 1, Washout Period 4 (7 Days)||2
33585|NCT02688387|75108|P6|STARTED|Part 1, Washout Period 4 (7 Days)||2
33586|NCT02688387|75109|P5|STARTED|Part 1, Washout Period 4 (7 Days)||2
33587|NCT02688387|75110|P4|STARTED|Part 1, Washout Period 4 (7 Days)||2
33588|NCT02688387|75111|P3|STARTED|Part 1, Washout Period 4 (7 Days)||2
33589|NCT02688387|75112|P2|STARTED|Part 1, Washout Period 4 (7 Days)||2
33590|NCT02688387|75113|P1|STARTED|Part 1, Washout Period 4 (7 Days)||2
33591|NCT02688387|75092|P22|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33592|NCT02688387|75093|P21|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33593|NCT02688387|75094|P20|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33594|NCT02688387|75095|P19|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33595|NCT02688387|75096|P18|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33596|NCT02688387|75097|P17|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33597|NCT02688387|75098|P16|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33598|NCT02688387|75099|P15|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33599|NCT02688387|75100|P14|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33600|NCT02688387|75101|P13|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33601|NCT02688387|75102|P12|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33602|NCT02688387|75103|P11|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33760|NCT02688387|75107|P7|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
33603|NCT02688387|75104|P10|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33604|NCT02688387|75105|P9|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33605|NCT02688387|75106|P8|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33606|NCT02688387|75107|P7|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33607|NCT02688387|75108|P6|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33608|NCT02688387|75109|P5|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33609|NCT02688387|75110|P4|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33610|NCT02688387|75111|P3|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33611|NCT02688387|75112|P2|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33612|NCT02688387|75113|P1|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33613|NCT02688387|75092|P22|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33614|NCT02688387|75093|P21|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33615|NCT02688387|75094|P20|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33616|NCT02688387|75095|P19|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33617|NCT02688387|75096|P18|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33618|NCT02688387|75097|P17|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33619|NCT02688387|75098|P16|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33620|NCT02688387|75099|P15|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33621|NCT02688387|75100|P14|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33622|NCT02688387|75101|P13|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33623|NCT02688387|75102|P12|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33624|NCT02688387|75103|P11|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
33625|NCT02688387|75104|P10|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
33626|NCT02688387|75105|P9|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
33627|NCT02688387|75106|P8|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
33628|NCT02688387|75107|P7|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
33629|NCT02688387|75108|P6|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
33630|NCT02688387|75109|P5|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
33631|NCT02688387|75110|P4|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
33632|NCT02688387|75111|P3|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
33633|NCT02688387|75112|P2|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
33634|NCT02688387|75113|P1|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
33635|NCT02688387|75092|P22|STARTED|Part 1, Period 4 (up to 6 Days)||0
33636|NCT02688387|75093|P21|STARTED|Part 1, Period 4 (up to 6 Days)||0
33637|NCT02688387|75094|P20|STARTED|Part 1, Period 4 (up to 6 Days)||0
33638|NCT02688387|75095|P19|STARTED|Part 1, Period 4 (up to 6 Days)||0
33639|NCT02688387|75096|P18|STARTED|Part 1, Period 4 (up to 6 Days)||0
33640|NCT02688387|75097|P17|STARTED|Part 1, Period 4 (up to 6 Days)||0
33641|NCT02688387|75098|P16|STARTED|Part 1, Period 4 (up to 6 Days)||0
33642|NCT02688387|75099|P15|STARTED|Part 1, Period 4 (up to 6 Days)||0
33643|NCT02688387|75100|P14|STARTED|Part 1, Period 4 (up to 6 Days)||0
33644|NCT02688387|75101|P13|STARTED|Part 1, Period 4 (up to 6 Days)||0
33645|NCT02688387|75102|P12|STARTED|Part 1, Period 4 (up to 6 Days)||0
33646|NCT02688387|75103|P11|STARTED|Part 1, Period 4 (up to 6 Days)||0
33647|NCT02688387|75104|P10|STARTED|Part 1, Period 4 (up to 6 Days)||2
33648|NCT02688387|75105|P9|STARTED|Part 1, Period 4 (up to 6 Days)||2
33649|NCT02688387|75106|P8|STARTED|Part 1, Period 4 (up to 6 Days)||2
33650|NCT02688387|75107|P7|STARTED|Part 1, Period 4 (up to 6 Days)||2
33651|NCT02688387|75108|P6|STARTED|Part 1, Period 4 (up to 6 Days)||2
33652|NCT02688387|75109|P5|STARTED|Part 1, Period 4 (up to 6 Days)||2
33653|NCT02688387|75110|P4|STARTED|Part 1, Period 4 (up to 6 Days)||2
33654|NCT02688387|75111|P3|STARTED|Part 1, Period 4 (up to 6 Days)||2
33655|NCT02688387|75112|P2|STARTED|Part 1, Period 4 (up to 6 Days)||2
33656|NCT02688387|75113|P1|STARTED|Part 1, Period 4 (up to 6 Days)||2
33657|NCT02688387|75092|P22|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33658|NCT02688387|75093|P21|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33659|NCT02688387|75094|P20|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33660|NCT02688387|75095|P19|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33661|NCT02688387|75096|P18|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33662|NCT02688387|75097|P17|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33663|NCT02688387|75098|P16|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33664|NCT02688387|75099|P15|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33665|NCT02688387|75100|P14|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33666|NCT02688387|75101|P13|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33667|NCT02688387|75102|P12|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33668|NCT02688387|75103|P11|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33669|NCT02688387|75104|P10|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33670|NCT02688387|75105|P9|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33671|NCT02688387|75106|P8|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33672|NCT02688387|75107|P7|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33673|NCT02688387|75108|P6|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33674|NCT02688387|75109|P5|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33675|NCT02688387|75110|P4|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33676|NCT02688387|75111|P3|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33677|NCT02688387|75112|P2|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33678|NCT02688387|75113|P1|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||1
33679|NCT02688387|75092|P22|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33680|NCT02688387|75093|P21|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33681|NCT02688387|75094|P20|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33682|NCT02688387|75095|P19|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33683|NCT02688387|75096|P18|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33684|NCT02688387|75097|P17|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33685|NCT02688387|75098|P16|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33686|NCT02688387|75099|P15|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33687|NCT02688387|75100|P14|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33688|NCT02688387|75101|P13|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33689|NCT02688387|75102|P12|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33690|NCT02688387|75103|P11|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
33691|NCT02688387|75104|P10|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
33692|NCT02688387|75105|P9|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
33693|NCT02688387|75106|P8|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
33694|NCT02688387|75107|P7|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
33695|NCT02688387|75108|P6|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
33696|NCT02688387|75109|P5|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
33697|NCT02688387|75110|P4|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
33698|NCT02688387|75111|P3|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
33699|NCT02688387|75112|P2|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
33700|NCT02688387|75113|P1|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
33701|NCT02688387|75092|P22|STARTED|Part 1, Washout Period 3 (7 Days)||0
33702|NCT02688387|75093|P21|STARTED|Part 1, Washout Period 3 (7 Days)||0
33703|NCT02688387|75094|P20|STARTED|Part 1, Washout Period 3 (7 Days)||0
33704|NCT02688387|75095|P19|STARTED|Part 1, Washout Period 3 (7 Days)||0
33705|NCT02688387|75096|P18|STARTED|Part 1, Washout Period 3 (7 Days)||0
33706|NCT02688387|75097|P17|STARTED|Part 1, Washout Period 3 (7 Days)||0
33707|NCT02688387|75098|P16|STARTED|Part 1, Washout Period 3 (7 Days)||0
33708|NCT02688387|75099|P15|STARTED|Part 1, Washout Period 3 (7 Days)||0
33709|NCT02688387|75100|P14|STARTED|Part 1, Washout Period 3 (7 Days)||0
33710|NCT02688387|75101|P13|STARTED|Part 1, Washout Period 3 (7 Days)||0
33711|NCT02688387|75102|P12|STARTED|Part 1, Washout Period 3 (7 Days)||0
33712|NCT02688387|75103|P11|STARTED|Part 1, Washout Period 3 (7 Days)||0
33713|NCT02688387|75104|P10|STARTED|Part 1, Washout Period 3 (7 Days)||2
33714|NCT02688387|75105|P9|STARTED|Part 1, Washout Period 3 (7 Days)||2
33715|NCT02688387|75106|P8|STARTED|Part 1, Washout Period 3 (7 Days)||2
33716|NCT02688387|75107|P7|STARTED|Part 1, Washout Period 3 (7 Days)||2
33717|NCT02688387|75108|P6|STARTED|Part 1, Washout Period 3 (7 Days)||2
33718|NCT02688387|75109|P5|STARTED|Part 1, Washout Period 3 (7 Days)||2
33719|NCT02688387|75110|P4|STARTED|Part 1, Washout Period 3 (7 Days)||2
33720|NCT02688387|75111|P3|STARTED|Part 1, Washout Period 3 (7 Days)||2
33721|NCT02688387|75112|P2|STARTED|Part 1, Washout Period 3 (7 Days)||2
33722|NCT02688387|75113|P1|STARTED|Part 1, Washout Period 3 (7 Days)||3
33723|NCT02688387|75092|P22|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33724|NCT02688387|75093|P21|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33725|NCT02688387|75094|P20|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33726|NCT02688387|75095|P19|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33727|NCT02688387|75096|P18|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33728|NCT02688387|75097|P17|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33729|NCT02688387|75098|P16|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33730|NCT02688387|75099|P15|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33731|NCT02688387|75100|P14|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33732|NCT02688387|75101|P13|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33733|NCT02688387|75102|P12|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33734|NCT02688387|75103|P11|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33735|NCT02688387|75104|P10|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33736|NCT02688387|75105|P9|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33737|NCT02688387|75106|P8|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33738|NCT02688387|75107|P7|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33739|NCT02688387|75108|P6|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33740|NCT02688387|75109|P5|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33741|NCT02688387|75110|P4|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33742|NCT02688387|75111|P3|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33743|NCT02688387|75112|P2|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33744|NCT02688387|75113|P1|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33745|NCT02688387|75092|P22|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33746|NCT02688387|75093|P21|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33747|NCT02688387|75094|P20|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33748|NCT02688387|75095|P19|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33749|NCT02688387|75096|P18|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33750|NCT02688387|75097|P17|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33751|NCT02688387|75098|P16|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33752|NCT02688387|75099|P15|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33753|NCT02688387|75100|P14|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33754|NCT02688387|75101|P13|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33755|NCT02688387|75102|P12|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33756|NCT02688387|75103|P11|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
33757|NCT02688387|75104|P10|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
33758|NCT02688387|75105|P9|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
33759|NCT02688387|75106|P8|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
33761|NCT02688387|75108|P6|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
33762|NCT02688387|75109|P5|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
33763|NCT02688387|75110|P4|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
33764|NCT02688387|75111|P3|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
33765|NCT02688387|75112|P2|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
33766|NCT02688387|75113|P1|COMPLETED|Part 1, Period 3 (up to 6 Days)||3
33767|NCT02688387|75092|P22|STARTED|Part 1, Period 3 (up to 6 Days)||0
33768|NCT02688387|75093|P21|STARTED|Part 1, Period 3 (up to 6 Days)||0
33769|NCT02688387|75094|P20|STARTED|Part 1, Period 3 (up to 6 Days)||0
33770|NCT02688387|75095|P19|STARTED|Part 1, Period 3 (up to 6 Days)||0
33771|NCT02688387|75096|P18|STARTED|Part 1, Period 3 (up to 6 Days)||0
33772|NCT02688387|75097|P17|STARTED|Part 1, Period 3 (up to 6 Days)||0
33773|NCT02688387|75098|P16|STARTED|Part 1, Period 3 (up to 6 Days)||0
33774|NCT02688387|75099|P15|STARTED|Part 1, Period 3 (up to 6 Days)||0
33775|NCT02688387|75100|P14|STARTED|Part 1, Period 3 (up to 6 Days)||0
33776|NCT02688387|75101|P13|STARTED|Part 1, Period 3 (up to 6 Days)||0
33777|NCT02688387|75102|P12|STARTED|Part 1, Period 3 (up to 6 Days)||0
33778|NCT02688387|75103|P11|STARTED|Part 1, Period 3 (up to 6 Days)||0
33779|NCT02688387|75104|P10|STARTED|Part 1, Period 3 (up to 6 Days)||2
33780|NCT02688387|75105|P9|STARTED|Part 1, Period 3 (up to 6 Days)||2
33781|NCT02688387|75106|P8|STARTED|Part 1, Period 3 (up to 6 Days)||2
33782|NCT02688387|75107|P7|STARTED|Part 1, Period 3 (up to 6 Days)||2
33783|NCT02688387|75108|P6|STARTED|Part 1, Period 3 (up to 6 Days)||2
33784|NCT02688387|75109|P5|STARTED|Part 1, Period 3 (up to 6 Days)||2
33785|NCT02688387|75110|P4|STARTED|Part 1, Period 3 (up to 6 Days)||2
33786|NCT02688387|75111|P3|STARTED|Part 1, Period 3 (up to 6 Days)||2
33787|NCT02688387|75112|P2|STARTED|Part 1, Period 3 (up to 6 Days)||2
33788|NCT02688387|75113|P1|STARTED|Part 1, Period 3 (up to 6 Days)||3
33789|NCT02688387|75092|P22|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33790|NCT02688387|75093|P21|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33791|NCT02688387|75094|P20|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33792|NCT02688387|75095|P19|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33793|NCT02688387|75096|P18|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33794|NCT02688387|75097|P17|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33795|NCT02688387|75098|P16|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33796|NCT02688387|75099|P15|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33797|NCT02688387|75100|P14|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33798|NCT02688387|75101|P13|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33799|NCT02688387|75102|P12|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33800|NCT02688387|75103|P11|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33801|NCT02688387|75104|P10|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33802|NCT02688387|75105|P9|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33803|NCT02688387|75106|P8|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33804|NCT02688387|75107|P7|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33805|NCT02688387|75108|P6|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33806|NCT02688387|75109|P5|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33807|NCT02688387|75110|P4|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33808|NCT02688387|75111|P3|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33809|NCT02688387|75112|P2|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33810|NCT02688387|75113|P1|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33811|NCT02688387|75092|P22|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33812|NCT02688387|75093|P21|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33813|NCT02688387|75094|P20|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33814|NCT02688387|75095|P19|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33815|NCT02688387|75096|P18|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33816|NCT02688387|75097|P17|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33817|NCT02688387|75098|P16|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33818|NCT02688387|75099|P15|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33819|NCT02688387|75100|P14|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33820|NCT02688387|75101|P13|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33821|NCT02688387|75102|P12|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33822|NCT02688387|75103|P11|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
33823|NCT02688387|75104|P10|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
33824|NCT02688387|75105|P9|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
33825|NCT02688387|75106|P8|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
33826|NCT02688387|75107|P7|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
33827|NCT02688387|75108|P6|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
33828|NCT02688387|75109|P5|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
33829|NCT02688387|75110|P4|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
33830|NCT02688387|75111|P3|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
33831|NCT02688387|75112|P2|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
33832|NCT02688387|75113|P1|COMPLETED|Part 1, Washout Period 2 (7 Days)||3
33833|NCT02688387|75092|P22|STARTED|Part 1, Washout Period 2 (7 Days)||0
33834|NCT02688387|75093|P21|STARTED|Part 1, Washout Period 2 (7 Days)||0
33835|NCT02688387|75094|P20|STARTED|Part 1, Washout Period 2 (7 Days)||0
33836|NCT02688387|75095|P19|STARTED|Part 1, Washout Period 2 (7 Days)||0
33837|NCT02688387|75096|P18|STARTED|Part 1, Washout Period 2 (7 Days)||0
33838|NCT02688387|75097|P17|STARTED|Part 1, Washout Period 2 (7 Days)||0
33839|NCT02688387|75098|P16|STARTED|Part 1, Washout Period 2 (7 Days)||0
33840|NCT02688387|75099|P15|STARTED|Part 1, Washout Period 2 (7 Days)||0
33841|NCT02688387|75100|P14|STARTED|Part 1, Washout Period 2 (7 Days)||0
33842|NCT02688387|75101|P13|STARTED|Part 1, Washout Period 2 (7 Days)||0
33843|NCT02688387|75102|P12|STARTED|Part 1, Washout Period 2 (7 Days)||0
33844|NCT02688387|75103|P11|STARTED|Part 1, Washout Period 2 (7 Days)||0
33845|NCT02688387|75104|P10|STARTED|Part 1, Washout Period 2 (7 Days)||2
33846|NCT02688387|75105|P9|STARTED|Part 1, Washout Period 2 (7 Days)||2
33847|NCT02688387|75106|P8|STARTED|Part 1, Washout Period 2 (7 Days)||2
33848|NCT02688387|75107|P7|STARTED|Part 1, Washout Period 2 (7 Days)||2
33849|NCT02688387|75108|P6|STARTED|Part 1, Washout Period 2 (7 Days)||2
33850|NCT02688387|75109|P5|STARTED|Part 1, Washout Period 2 (7 Days)||2
33851|NCT02688387|75110|P4|STARTED|Part 1, Washout Period 2 (7 Days)||2
33852|NCT02688387|75111|P3|STARTED|Part 1, Washout Period 2 (7 Days)||2
33853|NCT02688387|75112|P2|STARTED|Part 1, Washout Period 2 (7 Days)||2
33854|NCT02688387|75113|P1|STARTED|Part 1, Washout Period 2 (7 Days)||3
33855|NCT02688387|75092|P22|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
33856|NCT02688387|75093|P21|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
33857|NCT02688387|75094|P20|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
33858|NCT02688387|75095|P19|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
33859|NCT02688387|75096|P18|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
33860|NCT02688387|75097|P17|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
33861|NCT02688387|75098|P16|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
33862|NCT02688387|75099|P15|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
33863|NCT02688387|75100|P14|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
33864|NCT02688387|75101|P13|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
33865|NCT02688387|75102|P12|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
33866|NCT02688387|75103|P11|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
33867|NCT02688387|75104|P10|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
33868|NCT02688387|75105|P9|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
33869|NCT02688387|75106|P8|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
33870|NCT02688387|75107|P7|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
33871|NCT02688387|75108|P6|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
33872|NCT02688387|75109|P5|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||1
33873|NCT02688387|75110|P4|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
33874|NCT02688387|75111|P3|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||1
33875|NCT02688387|75112|P2|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
33876|NCT02688387|75113|P1|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
33877|NCT02688387|75092|P22|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
33878|NCT02688387|75093|P21|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
33879|NCT02688387|75094|P20|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
33880|NCT02688387|75095|P19|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
33881|NCT02688387|75096|P18|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
33882|NCT02688387|75097|P17|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
33883|NCT02688387|75098|P16|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
33884|NCT02688387|75099|P15|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
33885|NCT02688387|75100|P14|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
33886|NCT02688387|75101|P13|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
33887|NCT02688387|75102|P12|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
33888|NCT02688387|75103|P11|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
33889|NCT02688387|75104|P10|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
33890|NCT02688387|75105|P9|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
33891|NCT02688387|75106|P8|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
33892|NCT02688387|75107|P7|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
33893|NCT02688387|75108|P6|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
33894|NCT02688387|75109|P5|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
33895|NCT02688387|75110|P4|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
33896|NCT02688387|75111|P3|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
33897|NCT02688387|75112|P2|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
33898|NCT02688387|75113|P1|COMPLETED|Part 1, Period 2 (up to 6 Days)||3
33899|NCT02688387|75092|P22|STARTED|Part 1, Period 2 (up to 6 Days)||0
33900|NCT02688387|75093|P21|STARTED|Part 1, Period 2 (up to 6 Days)||0
33901|NCT02688387|75094|P20|STARTED|Part 1, Period 2 (up to 6 Days)||0
33902|NCT02688387|75095|P19|STARTED|Part 1, Period 2 (up to 6 Days)||0
33903|NCT02688387|75096|P18|STARTED|Part 1, Period 2 (up to 6 Days)||0
33904|NCT02688387|75097|P17|STARTED|Part 1, Period 2 (up to 6 Days)||0
33905|NCT02688387|75098|P16|STARTED|Part 1, Period 2 (up to 6 Days)||0
33906|NCT02688387|75099|P15|STARTED|Part 1, Period 2 (up to 6 Days)||0
33907|NCT02688387|75100|P14|STARTED|Part 1, Period 2 (up to 6 Days)||0
33908|NCT02688387|75101|P13|STARTED|Part 1, Period 2 (up to 6 Days)||0
33909|NCT02688387|75102|P12|STARTED|Part 1, Period 2 (up to 6 Days)||0
33910|NCT02688387|75103|P11|STARTED|Part 1, Period 2 (up to 6 Days)||0
33911|NCT02688387|75104|P10|STARTED|Part 1, Period 2 (up to 6 Days)||2
33912|NCT02688387|75105|P9|STARTED|Part 1, Period 2 (up to 6 Days)||2
33913|NCT02688387|75106|P8|STARTED|Part 1, Period 2 (up to 6 Days)||2
33914|NCT02688387|75107|P7|STARTED|Part 1, Period 2 (up to 6 Days)||2
33915|NCT02688387|75108|P6|STARTED|Part 1, Period 2 (up to 6 Days)||2
33916|NCT02688387|75109|P5|STARTED|Part 1, Period 2 (up to 6 Days)||3
33917|NCT02688387|75110|P4|STARTED|Part 1, Period 2 (up to 6 Days)||2
33918|NCT02688387|75111|P3|STARTED|Part 1, Period 2 (up to 6 Days)||3
33919|NCT02688387|75112|P2|STARTED|Part 1, Period 2 (up to 6 Days)||2
33920|NCT02688387|75113|P1|STARTED|Part 1, Period 2 (up to 6 Days)||3
33921|NCT02688387|75092|P22|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33922|NCT02688387|75093|P21|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33923|NCT02688387|75094|P20|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33924|NCT02688387|75095|P19|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33925|NCT02688387|75096|P18|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33926|NCT02688387|75097|P17|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33927|NCT02688387|75098|P16|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33928|NCT02688387|75099|P15|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33929|NCT02688387|75100|P14|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33930|NCT02688387|75101|P13|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33931|NCT02688387|75102|P12|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33932|NCT02688387|75103|P11|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33933|NCT02688387|75104|P10|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33934|NCT02688387|75105|P9|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33935|NCT02688387|75106|P8|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33936|NCT02688387|75107|P7|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33937|NCT02688387|75108|P6|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33938|NCT02688387|75109|P5|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33939|NCT02688387|75110|P4|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33940|NCT02688387|75111|P3|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33941|NCT02688387|75112|P2|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||1
33942|NCT02688387|75113|P1|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33943|NCT02688387|75092|P22|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33944|NCT02688387|75093|P21|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33945|NCT02688387|75094|P20|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33946|NCT02688387|75095|P19|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33947|NCT02688387|75096|P18|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33948|NCT02688387|75097|P17|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33949|NCT02688387|75098|P16|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33950|NCT02688387|75099|P15|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33951|NCT02688387|75100|P14|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33952|NCT02688387|75101|P13|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33953|NCT02688387|75102|P12|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33954|NCT02688387|75103|P11|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
33955|NCT02688387|75104|P10|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
33956|NCT02688387|75105|P9|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
33957|NCT02688387|75106|P8|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
33958|NCT02688387|75107|P7|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
33959|NCT02688387|75108|P6|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
33960|NCT02688387|75109|P5|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
33961|NCT02688387|75110|P4|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
33962|NCT02688387|75111|P3|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
33963|NCT02688387|75112|P2|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
33964|NCT02688387|75113|P1|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
33965|NCT02688387|75092|P22|STARTED|Part 1, Washout Period 1 (7 Days)||0
33966|NCT02688387|75093|P21|STARTED|Part 1, Washout Period 1 (7 Days)||0
33967|NCT02688387|75094|P20|STARTED|Part 1, Washout Period 1 (7 Days)||0
33968|NCT02688387|75095|P19|STARTED|Part 1, Washout Period 1 (7 Days)||0
33969|NCT02688387|75096|P18|STARTED|Part 1, Washout Period 1 (7 Days)||0
33970|NCT02688387|75097|P17|STARTED|Part 1, Washout Period 1 (7 Days)||0
33971|NCT02688387|75098|P16|STARTED|Part 1, Washout Period 1 (7 Days)||0
33972|NCT02688387|75099|P15|STARTED|Part 1, Washout Period 1 (7 Days)||0
33973|NCT02688387|75100|P14|STARTED|Part 1, Washout Period 1 (7 Days)||0
33974|NCT02688387|75101|P13|STARTED|Part 1, Washout Period 1 (7 Days)||0
33975|NCT02688387|75102|P12|STARTED|Part 1, Washout Period 1 (7 Days)||0
33976|NCT02688387|75103|P11|STARTED|Part 1, Washout Period 1 (7 Days)||0
33977|NCT02688387|75104|P10|STARTED|Part 1, Washout Period 1 (7 Days)||2
33978|NCT02688387|75105|P9|STARTED|Part 1, Washout Period 1 (7 Days)||2
33979|NCT02688387|75106|P8|STARTED|Part 1, Washout Period 1 (7 Days)||2
33980|NCT02688387|75107|P7|STARTED|Part 1, Washout Period 1 (7 Days)||2
33981|NCT02688387|75108|P6|STARTED|Part 1, Washout Period 1 (7 Days)||2
33982|NCT02688387|75109|P5|STARTED|Part 1, Washout Period 1 (7 Days)||3
33983|NCT02688387|75110|P4|STARTED|Part 1, Washout Period 1 (7 Days)||2
33984|NCT02688387|75111|P3|STARTED|Part 1, Washout Period 1 (7 Days)||3
33985|NCT02688387|75112|P2|STARTED|Part 1, Washout Period 1 (7 Days)||3
33986|NCT02688387|75113|P1|STARTED|Part 1, Washout Period 1 (7 Days)||3
33987|NCT02688387|75092|P22|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
33988|NCT02688387|75093|P21|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
33989|NCT02688387|75094|P20|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
33990|NCT02688387|75095|P19|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
33991|NCT02688387|75096|P18|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
33992|NCT02688387|75097|P17|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
33993|NCT02688387|75098|P16|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
33994|NCT02688387|75099|P15|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
33995|NCT02688387|75100|P14|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
33996|NCT02688387|75101|P13|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
33997|NCT02688387|75102|P12|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
33998|NCT02688387|75103|P11|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
33999|NCT02688387|75104|P10|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
34000|NCT02688387|75105|P9|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
34001|NCT02688387|75106|P8|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
34002|NCT02688387|75107|P7|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
34003|NCT02688387|75108|P6|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
34004|NCT02688387|75109|P5|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
34005|NCT02688387|75110|P4|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||1
34006|NCT02688387|75111|P3|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||1
34007|NCT02688387|75112|P2|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
34008|NCT02688387|75113|P1|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
34009|NCT02688387|75092|P22|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
34010|NCT02688387|75093|P21|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
34011|NCT02688387|75094|P20|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
34012|NCT02688387|75095|P19|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
34013|NCT02688387|75096|P18|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
34014|NCT02688387|75097|P17|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
34015|NCT02688387|75098|P16|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
34016|NCT02688387|75099|P15|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
34017|NCT02688387|75100|P14|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
34018|NCT02688387|75101|P13|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
34019|NCT02688387|75102|P12|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
34020|NCT02688387|75103|P11|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
34021|NCT02688387|75104|P10|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
34022|NCT02688387|75105|P9|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
34023|NCT02688387|75106|P8|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
34024|NCT02688387|75107|P7|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
34025|NCT02688387|75108|P6|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
34026|NCT02688387|75109|P5|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
34027|NCT02688387|75110|P4|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
34028|NCT02688387|75111|P3|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
34029|NCT02688387|75112|P2|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
34030|NCT02688387|75113|P1|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
34031|NCT02688387|75092|P22|STARTED|Part 1, Period 1 (up to 6 Days)||0
34032|NCT02688387|75093|P21|STARTED|Part 1, Period 1 (up to 6 Days)||0
34033|NCT02688387|75094|P20|STARTED|Part 1, Period 1 (up to 6 Days)||0
34034|NCT02688387|75095|P19|STARTED|Part 1, Period 1 (up to 6 Days)||0
34035|NCT02688387|75096|P18|STARTED|Part 1, Period 1 (up to 6 Days)||0
34036|NCT02688387|75097|P17|STARTED|Part 1, Period 1 (up to 6 Days)||0
34037|NCT02688387|75098|P16|STARTED|Part 1, Period 1 (up to 6 Days)||0
34038|NCT02688387|75099|P15|STARTED|Part 1, Period 1 (up to 6 Days)||0
34039|NCT02688387|75100|P14|STARTED|Part 1, Period 1 (up to 6 Days)||0
34040|NCT02688387|75101|P13|STARTED|Part 1, Period 1 (up to 6 Days)||0
34041|NCT02688387|75102|P12|STARTED|Part 1, Period 1 (up to 6 Days)||0
34042|NCT02688387|75103|P11|STARTED|Part 1, Period 1 (up to 6 Days)||0
34043|NCT02688387|75104|P10|STARTED|Part 1, Period 1 (up to 6 Days)||2
34044|NCT02688387|75105|P9|STARTED|Part 1, Period 1 (up to 6 Days)||2
34045|NCT02688387|75106|P8|STARTED|Part 1, Period 1 (up to 6 Days)||2
34046|NCT02688387|75107|P7|STARTED|Part 1, Period 1 (up to 6 Days)||2
34047|NCT02688387|75108|P6|STARTED|Part 1, Period 1 (up to 6 Days)||2
34048|NCT02688387|75109|P5|STARTED|Part 1, Period 1 (up to 6 Days)||3
34049|NCT02688387|75110|P4|STARTED|Part 1, Period 1 (up to 6 Days)||3
34050|NCT02688387|75111|P3|STARTED|Part 1, Period 1 (up to 6 Days)||4
34051|NCT02688387|75112|P2|STARTED|Part 1, Period 1 (up to 6 Days)||3
34052|NCT02688387|75113|P1|STARTED|Part 1, Period 1 (up to 6 Days)||3
34053|NCT02688218|75372|P2|NOT COMPLETED|Second Exercise Intervention (2 Hours)||0
34054|NCT02688218|75373|P1|NOT COMPLETED|Second Exercise Intervention (2 Hours)||0
34055|NCT02688218|75372|P2|COMPLETED|Second Exercise Intervention (2 Hours)||6
34056|NCT02688218|75373|P1|COMPLETED|Second Exercise Intervention (2 Hours)||24
34057|NCT02688218|75372|P2|STARTED|Second Exercise Intervention (2 Hours)||6
34058|NCT02688218|75373|P1|STARTED|Second Exercise Intervention (2 Hours)||24
34059|NCT02688218|75372|P2|NOT COMPLETED|Washout (30 Minutes)||0
34060|NCT02688218|75373|P1|NOT COMPLETED|Washout (30 Minutes)||0
34061|NCT02688218|75372|P2|COMPLETED|Washout (30 Minutes)||6
34062|NCT02688218|75373|P1|COMPLETED|Washout (30 Minutes)||24
34063|NCT02688218|75372|P2|STARTED|Washout (30 Minutes)||6
34064|NCT02688218|75373|P1|STARTED|Washout (30 Minutes)||24
34065|NCT02688218|75372|P2|NOT COMPLETED|First Exercise Intervention (2 Hours)||0
34066|NCT02688218|75373|P1|NOT COMPLETED|First Exercise Intervention (2 Hours)||0
34067|NCT02688218|75372|P2|COMPLETED|First Exercise Intervention (2 Hours)||6
34068|NCT02688218|75373|P1|COMPLETED|First Exercise Intervention (2 Hours)||24
34069|NCT02688218|75372|P2|STARTED|First Exercise Intervention (2 Hours)||6
34070|NCT02688218|75373|P1|STARTED|First Exercise Intervention (2 Hours)||24
34071|NCT02688153|75381|P2|NOT COMPLETED|Overall Study||7
34072|NCT02688153|75382|P1|NOT COMPLETED|Overall Study||15
34073|NCT02688153|75381|P2|COMPLETED|Overall Study||51
34074|NCT02688153|75382|P1|COMPLETED|Overall Study||47
34075|NCT02688153|75381|P2|Final Randomized Arm/Group|Overall Study||61
34076|NCT02688153|75382|P1|Final Randomized Arm/Group|Overall Study||59
34077|NCT02688153|75381|P2|STARTED|Overall Study||58
34078|NCT02688153|75382|P1|STARTED|Overall Study||62
34079|NCT02687919|75442|P2|NOT COMPLETED|Overall Study||6
34080|NCT02687919|75443|P1|NOT COMPLETED|Overall Study||8
34081|NCT02687919|75442|P2|COMPLETED|Overall Study||9
34082|NCT02687919|75443|P1|COMPLETED|Overall Study||8
34083|NCT02687919|75442|P2|STARTED|Overall Study||15
34084|NCT02687919|75443|P1|STARTED|Overall Study||16
34085|NCT02687542|75476|P5|NOT COMPLETED|Overall Study||20
34086|NCT02687542|75477|P4|NOT COMPLETED|Overall Study||10
34087|NCT02687542|75478|P3|NOT COMPLETED|Overall Study||14
34088|NCT02687542|75479|P2|NOT COMPLETED|Overall Study||12
34089|NCT02687542|75480|P1|NOT COMPLETED|Overall Study||8
34090|NCT02687542|75476|P5|COMPLETED|Overall Study||24
34091|NCT02687542|75477|P4|COMPLETED|Overall Study||3
34092|NCT02687542|75478|P3|COMPLETED|Overall Study||1
34093|NCT02687542|75479|P2|COMPLETED|Overall Study||1
34094|NCT02687542|75480|P1|COMPLETED|Overall Study||15
34095|NCT02687542|75476|P5|STARTED|Overall Study||44
34096|NCT02687542|75477|P4|STARTED|Overall Study||13
34097|NCT02687542|75478|P3|STARTED|Overall Study||15
34098|NCT02687542|75479|P2|STARTED|Overall Study||13
34099|NCT02687542|75480|P1|STARTED|Overall Study||23
34100|NCT02687529|75554|P2|NOT COMPLETED|Overall Study||0
34101|NCT02687529|75555|P1|NOT COMPLETED|Overall Study||0
34102|NCT02687529|75554|P2|COMPLETED|Overall Study||32
34103|NCT02687529|75555|P1|COMPLETED|Overall Study||34
34104|NCT02687529|75554|P2|STARTED|Overall Study||32
34105|NCT02687529|75555|P1|STARTED|Overall Study||34
34106|NCT02687412|75563|P2|NOT COMPLETED|Overall Study||0
34107|NCT02687412|75564|P1|NOT COMPLETED|Overall Study||0
34108|NCT02687412|75563|P2|COMPLETED|Overall Study||57
34109|NCT02687412|75564|P1|COMPLETED|Overall Study||50
34110|NCT02687412|75563|P2|STARTED|Overall Study||57
34111|NCT02687412|75564|P1|STARTED|Overall Study||50
34112|NCT02687217|75592|P2|NOT COMPLETED|Overall Study||0
34113|NCT02687217|75593|P1|NOT COMPLETED|Overall Study||0
34114|NCT02687217|75592|P2|COMPLETED|Overall Study||30
34115|NCT02687217|75593|P1|COMPLETED|Overall Study||30
34116|NCT02687217|75592|P2|STARTED|Overall Study||30
34117|NCT02687217|75593|P1|STARTED|Overall Study||30
34118|NCT02687191|75609|P6|NOT COMPLETED|Overall Study||1
34119|NCT02687191|75610|P5|NOT COMPLETED|Overall Study||1
34120|NCT02687191|75611|P4|NOT COMPLETED|Overall Study||1
34121|NCT02687191|75612|P3|NOT COMPLETED|Overall Study||1
34122|NCT02687191|75613|P2|NOT COMPLETED|Overall Study||1
34123|NCT02687191|75614|P1|NOT COMPLETED|Overall Study||0
34124|NCT02687191|75609|P6|COMPLETED|Overall Study||2
34125|NCT02687191|75610|P5|COMPLETED|Overall Study||2
34126|NCT02687191|75611|P4|COMPLETED|Overall Study||5
34127|NCT02687191|75612|P3|COMPLETED|Overall Study||2
34128|NCT02687191|75613|P2|COMPLETED|Overall Study||2
34129|NCT02687191|75614|P1|COMPLETED|Overall Study||3
34130|NCT02687191|75609|P6|STARTED|Overall Study||3
34131|NCT02687191|75610|P5|STARTED|Overall Study||3
34132|NCT02687191|75611|P4|STARTED|Overall Study||6
34133|NCT02687191|75612|P3|STARTED|Overall Study||3
34134|NCT02687191|75613|P2|STARTED|Overall Study||3
34135|NCT02687191|75614|P1|STARTED|Overall Study||3
34136|NCT02687126|75748|P1|NOT COMPLETED|Data Analysis||0
34137|NCT02687126|75748|P1|COMPLETED|Data Analysis||106
34138|NCT02687126|75748|P1|STARTED|Data Analysis||106
34139|NCT02687126|75748|P1|NOT COMPLETED|Data Collection||0
34140|NCT02687126|75748|P1|COMPLETED|Data Collection||106
34141|NCT02687126|75748|P1|STARTED|Data Collection||106
34142|NCT02686437|75757|P2|NOT COMPLETED|Overall Study||8
34143|NCT02686437|75758|P1|NOT COMPLETED|Overall Study||3
34144|NCT02686437|75757|P2|COMPLETED|Overall Study||12
34145|NCT02686437|75758|P1|COMPLETED|Overall Study||13
34146|NCT02686437|75757|P2|STARTED|Overall Study||20
34147|NCT02686437|75758|P1|STARTED|Overall Study||16
34148|NCT02686164|75766|P1|NOT COMPLETED|Overall Study||3
34149|NCT02686164|75766|P1|COMPLETED|Overall Study||27
34150|NCT02686164|75766|P1|STARTED|Overall Study||30
34151|NCT02686034|75778|P2|NOT COMPLETED|Open Label Period 3||1
34152|NCT02686034|75779|P1|NOT COMPLETED|Open Label Period 3||0
34153|NCT02686034|75778|P2|COMPLETED|Open Label Period 3||121
34154|NCT02686034|75779|P1|COMPLETED|Open Label Period 3||117
34155|NCT02686034|75778|P2|STARTED|Open Label Period 3||122
34156|NCT02686034|75779|P1|STARTED|Open Label Period 3||117
34157|NCT02686034|75778|P2|NOT COMPLETED|Randomized Controlled Period 2||4
34158|NCT02686034|75779|P1|NOT COMPLETED|Randomized Controlled Period 2||5
34159|NCT02686034|75778|P2|COMPLETED|Randomized Controlled Period 2||122
34160|NCT02686034|75779|P1|COMPLETED|Randomized Controlled Period 2||117
34161|NCT02686034|75778|P2|STARTED|Randomized Controlled Period 2||126
34162|NCT02686034|75779|P1|STARTED|Randomized Controlled Period 2||122
34163|NCT02686034|75778|P2|NOT COMPLETED|Run-In Period 1||17
34164|NCT02686034|75779|P1|NOT COMPLETED|Run-In Period 1||20
34165|NCT02686034|75778|P2|COMPLETED|Run-In Period 1||126
34166|NCT02686034|75779|P1|COMPLETED|Run-In Period 1||122
34167|NCT02686034|75778|P2|STARTED|Run-In Period 1||143
34168|NCT02686034|75779|P1|STARTED|Run-In Period 1||142
34169|NCT02685826|75818|P3|NOT COMPLETED|Overall Study||21
34170|NCT02685826|75819|P2|NOT COMPLETED|Overall Study||10
34171|NCT02685826|75820|P1|NOT COMPLETED|Overall Study||25
34172|NCT02685826|75818|P3|COMPLETED|Overall Study||0
34173|NCT02685826|75819|P2|COMPLETED|Overall Study||0
34174|NCT02685826|75820|P1|COMPLETED|Overall Study||0
34175|NCT02685826|75818|P3|STARTED|Overall Study||21
34176|NCT02685826|75819|P2|STARTED|Overall Study||10
34177|NCT02685826|75820|P1|STARTED|Overall Study||25
34178|NCT02685488|75905|P2|NOT COMPLETED|Overall Study||1
34179|NCT02685488|75906|P1|NOT COMPLETED|Overall Study||0
34180|NCT02685488|75905|P2|COMPLETED|Overall Study||13
34181|NCT02685488|75906|P1|COMPLETED|Overall Study||12
34182|NCT02685488|75905|P2|STARTED|Overall Study||14
34183|NCT02685488|75906|P1|STARTED|Overall Study||12
34184|NCT02685436|75920|P1|NOT COMPLETED|Overall Study||14
34185|NCT02685436|75920|P1|COMPLETED|Overall Study|GERD positive patients by either combined MII-pH or esophageal biopsy|38
34186|NCT02685436|75920|P1|STARTED|Overall Study|the overall studied group|52
34187|NCT02685293|75924|P2|NOT COMPLETED|Treatment Period 2||0
34188|NCT02685293|75925|P1|NOT COMPLETED|Treatment Period 2||0
34189|NCT02685293|75924|P2|COMPLETED|Treatment Period 2||3
34190|NCT02685293|75925|P1|COMPLETED|Treatment Period 2||1
34191|NCT02685293|75924|P2|STARTED|Treatment Period 2||3
34192|NCT02685293|75925|P1|STARTED|Treatment Period 2||1
34193|NCT02685293|75924|P2|NOT COMPLETED|Washout Period||0
34194|NCT02685293|75925|P1|NOT COMPLETED|Washout Period||0
34195|NCT02685293|75924|P2|COMPLETED|Washout Period||3
34196|NCT02685293|75925|P1|COMPLETED|Washout Period||1
34197|NCT02685293|75924|P2|STARTED|Washout Period||3
34198|NCT02685293|75925|P1|STARTED|Washout Period||1
34199|NCT02685293|75924|P2|NOT COMPLETED|Treatment Period 1||0
34200|NCT02685293|75925|P1|NOT COMPLETED|Treatment Period 1||0
34201|NCT02685293|75924|P2|COMPLETED|Treatment Period 1||3
34202|NCT02685293|75925|P1|COMPLETED|Treatment Period 1||1
34203|NCT02685293|75924|P2|STARTED|Treatment Period 1||3
34204|NCT02685293|75925|P1|STARTED|Treatment Period 1||1
34205|NCT02685202|75959|P1|NOT COMPLETED|Overall Study||9
34206|NCT02685202|75959|P1|COMPLETED|Overall Study||0
34207|NCT02685202|75959|P1|STARTED|Overall Study||9
34208|NCT02685072|75967|P2|NOT COMPLETED|3-Month Follow-Up||0
34209|NCT02685072|75968|P1|NOT COMPLETED|3-Month Follow-Up||0
34210|NCT02685072|75967|P2|COMPLETED|3-Month Follow-Up||22
34211|NCT02685072|75968|P1|COMPLETED|3-Month Follow-Up||19
34212|NCT02685072|75967|P2|STARTED|3-Month Follow-Up||22
34213|NCT02685072|75968|P1|STARTED|3-Month Follow-Up||19
34214|NCT02685072|75967|P2|NOT COMPLETED|1-Month Follow-Up||0
34215|NCT02685072|75968|P1|NOT COMPLETED|1-Month Follow-Up||1
34216|NCT02685072|75967|P2|COMPLETED|1-Month Follow-Up||22
34217|NCT02685072|75968|P1|COMPLETED|1-Month Follow-Up||19
34218|NCT02685072|75967|P2|STARTED|1-Month Follow-Up||22
34219|NCT02685072|75968|P1|STARTED|1-Month Follow-Up||20
34220|NCT02685072|75967|P2|NOT COMPLETED|Treatment Period||9
34221|NCT02685072|75968|P1|NOT COMPLETED|Treatment Period||13
34222|NCT02685072|75967|P2|COMPLETED|Treatment Period||22
34223|NCT02685072|75968|P1|COMPLETED|Treatment Period||20
34224|NCT02685072|75967|P2|Completed Week 8 Visit|Treatment Period|Week 8 data were collected at the 1-month follow-up for 1 participant|22
34225|NCT02685072|75968|P1|Completed Week 8 Visit|Treatment Period||20
34226|NCT02685072|75967|P2|Completed Week 7 Visit|Treatment Period||18
34227|NCT02685072|75968|P1|Completed Week 7 Visit|Treatment Period||17
34228|NCT02685072|75967|P2|Completed Week 6 Visit|Treatment Period||19
34229|NCT02685072|75968|P1|Completed Week 6 Visit|Treatment Period||18
34230|NCT02685072|75967|P2|Completed Week 5 Visit|Treatment Period||22
34231|NCT02685072|75968|P1|Completed Week 5 Visit|Treatment Period||19
34232|NCT02685072|75967|P2|Completed Week 4 Visit|Treatment Period||23
34233|NCT02685072|75968|P1|Completed Week 4 Visit|Treatment Period||19
34234|NCT02685072|75967|P2|Completed Week 3 Visit|Treatment Period||23
34235|NCT02685072|75968|P1|Completed Week 3 Visit|Treatment Period||20
34236|NCT02685072|75967|P2|Completed Week 2 Visit|Treatment Period||26
34237|NCT02685072|75968|P1|Completed Week 2 Visit|Treatment Period||23
34238|NCT02685072|75967|P2|STARTED|Treatment Period||31
34239|NCT02685072|75968|P1|STARTED|Treatment Period||33
34240|NCT02685033|76012|P2|NOT COMPLETED|Overall Study||2
34241|NCT02685033|76013|P1|NOT COMPLETED|Overall Study||3
34242|NCT02685033|76012|P2|COMPLETED|Overall Study||8
34243|NCT02685033|76013|P1|COMPLETED|Overall Study||67
34244|NCT02685033|76012|P2|STARTED|Overall Study||10
34245|NCT02685033|76013|P1|STARTED|Overall Study||70
34246|NCT02684981|76042|P3|NOT COMPLETED|Overall Study||127
34247|NCT02684981|76043|P2|NOT COMPLETED|Overall Study||210
34248|NCT02684981|76044|P1|NOT COMPLETED|Overall Study||240
34249|NCT02684981|76042|P3|COMPLETED|Overall Study||2059
34250|NCT02684981|76043|P2|COMPLETED|Overall Study||2969
34251|NCT02684981|76044|P1|COMPLETED|Overall Study||3860
34252|NCT02684981|76042|P3|STARTED|Overall Study||2186
34253|NCT02684981|76043|P2|STARTED|Overall Study||3179
34254|NCT02684981|76044|P1|STARTED|Overall Study||4100
34255|NCT02684942|76080|P6|NOT COMPLETED|Overall Study||0
34256|NCT02684942|76081|P5|NOT COMPLETED|Overall Study||0
34257|NCT02684942|76082|P4|NOT COMPLETED|Overall Study||0
34258|NCT02684942|76083|P3|NOT COMPLETED|Overall Study||0
34259|NCT02684942|76084|P2|NOT COMPLETED|Overall Study||0
34260|NCT02684942|76085|P1|NOT COMPLETED|Overall Study||0
34261|NCT02684942|76080|P6|COMPLETED|Overall Study||6
34262|NCT02684942|76081|P5|COMPLETED|Overall Study||6
34263|NCT02684942|76082|P4|COMPLETED|Overall Study||7
34264|NCT02684942|76083|P3|COMPLETED|Overall Study||7
34265|NCT02684942|76084|P2|COMPLETED|Overall Study||7
34266|NCT02684942|76085|P1|COMPLETED|Overall Study||7
34267|NCT02684942|76080|P6|STARTED|Overall Study||6
34268|NCT02684942|76081|P5|STARTED|Overall Study||6
34269|NCT02684942|76082|P4|STARTED|Overall Study||7
34270|NCT02684942|76083|P3|STARTED|Overall Study||7
34271|NCT02684942|76084|P2|STARTED|Overall Study||7
34272|NCT02684942|76085|P1|STARTED|Overall Study||7
34273|NCT02684630|76101|P2|NOT COMPLETED|Overall Study||3
34274|NCT02684630|76102|P1|NOT COMPLETED|Overall Study||5
34275|NCT02684630|76101|P2|COMPLETED|Overall Study||60
34276|NCT02684630|76102|P1|COMPLETED|Overall Study||60
34277|NCT02684630|76101|P2|STARTED|Overall Study||63
34278|NCT02684630|76102|P1|STARTED|Overall Study||65
34279|NCT02684604|76112|P2|NOT COMPLETED|Overall Study||0
34280|NCT02684604|76113|P1|NOT COMPLETED|Overall Study||0
34281|NCT02684604|76112|P2|COMPLETED|Overall Study||44
34282|NCT02684604|76113|P1|COMPLETED|Overall Study||44
34283|NCT02684604|76112|P2|STARTED|Overall Study||44
34284|NCT02684604|76113|P1|STARTED|Overall Study||44
34285|NCT02684591|76121|P2|NOT COMPLETED|Overall Study||3
34286|NCT02684591|76122|P1|NOT COMPLETED|Overall Study||1
34287|NCT02684591|76121|P2|COMPLETED|Overall Study||22
34288|NCT02684591|76122|P1|COMPLETED|Overall Study||24
34289|NCT02684591|76121|P2|STARTED|Overall Study||25
34290|NCT02684591|76122|P1|STARTED|Overall Study||25
34291|NCT02684435|76130|P1|NOT COMPLETED|Overall Study||0
34292|NCT02684435|76130|P1|COMPLETED|Overall Study||63
34293|NCT02684435|76130|P1|STARTED|Overall Study||63
34294|NCT02684396|76144|P6|NOT COMPLETED|Overall Study||0
34295|NCT02684396|76145|P5|NOT COMPLETED|Overall Study||0
34296|NCT02684396|76146|P4|NOT COMPLETED|Overall Study||0
34297|NCT02684396|76147|P3|NOT COMPLETED|Overall Study||0
34298|NCT02684396|76148|P2|NOT COMPLETED|Overall Study||0
34299|NCT02684396|76149|P1|NOT COMPLETED|Overall Study||0
34300|NCT02684396|76144|P6|COMPLETED|Overall Study||10
34301|NCT02684396|76145|P5|COMPLETED|Overall Study||5
34302|NCT02684396|76146|P4|COMPLETED|Overall Study||6
34303|NCT02684396|76147|P3|COMPLETED|Overall Study||6
34304|NCT02684396|76148|P2|COMPLETED|Overall Study||6
34305|NCT02684396|76149|P1|COMPLETED|Overall Study||6
34306|NCT02684396|76144|P6|STARTED|Overall Study||10
34307|NCT02684396|76145|P5|STARTED|Overall Study||5
34308|NCT02684396|76146|P4|STARTED|Overall Study||6
34309|NCT02684396|76147|P3|STARTED|Overall Study||6
34310|NCT02684396|76148|P2|STARTED|Overall Study||6
34311|NCT02684396|76149|P1|STARTED|Overall Study||6
34312|NCT02684370|76204|P6|NOT COMPLETED|Part B||8
34313|NCT02684370|76205|P5|NOT COMPLETED|Part B||5
34314|NCT02684370|76206|P4|NOT COMPLETED|Part B||2
34315|NCT02684370|76207|P3|NOT COMPLETED|Part B||0
34316|NCT02684370|76208|P2|NOT COMPLETED|Part B||0
34317|NCT02684370|76209|P1|NOT COMPLETED|Part B||0
34318|NCT02684370|76204|P6|COMPLETED|Part B||289
34319|NCT02684370|76205|P5|COMPLETED|Part B||94
34320|NCT02684370|76206|P4|COMPLETED|Part B||95
34321|NCT02684370|76207|P3|COMPLETED|Part B||0
34322|NCT02684370|76208|P2|COMPLETED|Part B||0
34323|NCT02684370|76209|P1|COMPLETED|Part B||0
34324|NCT02684370|76204|P6|STARTED|Part B|2 participants who received risankizumab in Part A did not receive a dose of study drug in Part B|297
34325|NCT02684370|76205|P5|STARTED|Part B|Participants who received ustekinumab in Part A received ustekinumab in Part B|99
34326|NCT02684370|76206|P4|STARTED|Part B|1 participant who received placebo in Part A did not receive a dose of study drug in Part B|97
34327|NCT02684370|76207|P3|STARTED|Part B||0
34328|NCT02684370|76208|P2|STARTED|Part B||0
34329|NCT02684370|76209|P1|STARTED|Part B||0
34330|NCT02684370|76204|P6|NOT COMPLETED|Part A||0
34331|NCT02684370|76205|P5|NOT COMPLETED|Part A||0
34332|NCT02684370|76206|P4|NOT COMPLETED|Part A||0
34333|NCT02684370|76207|P3|NOT COMPLETED|Part A||5
34334|NCT02684370|76208|P2|NOT COMPLETED|Part A||1
34335|NCT02684370|76209|P1|NOT COMPLETED|Part A||4
34336|NCT02684370|76204|P6|COMPLETED|Part A||0
34337|NCT02684370|76205|P5|COMPLETED|Part A||0
34338|NCT02684370|76206|P4|COMPLETED|Part A||0
34339|NCT02684370|76207|P3|COMPLETED|Part A||299
34340|NCT02684370|76208|P2|COMPLETED|Part A||99
34341|NCT02684370|76209|P1|COMPLETED|Part A||98
34342|NCT02684370|76204|P6|STARTED|Part A||0
34343|NCT02684370|76205|P5|STARTED|Part A||0
34344|NCT02684370|76206|P4|STARTED|Part A||0
34345|NCT02684370|76207|P3|STARTED|Part A||304
34346|NCT02684370|76208|P2|STARTED|Part A||100
34347|NCT02684370|76209|P1|STARTED|Part A||102
34348|NCT02684357|76254|P6|NOT COMPLETED|Part B||13
34349|NCT02684357|76255|P5|NOT COMPLETED|Part B||4
34350|NCT02684357|76256|P4|NOT COMPLETED|Part B||3
34351|NCT02684357|76257|P3|NOT COMPLETED|Part B||0
34352|NCT02684357|76258|P2|NOT COMPLETED|Part B||0
34353|NCT02684357|76259|P1|NOT COMPLETED|Part B||0
34354|NCT02684357|76254|P6|COMPLETED|Part B||278
34355|NCT02684357|76255|P5|COMPLETED|Part B||90
34356|NCT02684357|76256|P4|COMPLETED|Part B||91
34357|NCT02684357|76257|P3|COMPLETED|Part B||0
34358|NCT02684357|76258|P2|COMPLETED|Part B||0
34359|NCT02684357|76259|P1|COMPLETED|Part B||0
34360|NCT02684357|76254|P6|STARTED|Part B|1 participant who received risankizumab in Part A did not receive a dose of study drug in Part B|291
34361|NCT02684357|76255|P5|STARTED|Part B|2 participants who received ustekinumab in Part A did not receive a dose of study drug in Part B.|94
34362|NCT02684357|76256|P4|STARTED|Part B|Participants who received placebo in Part A received risankizumab in Part B|94
34363|NCT02684357|76257|P3|STARTED|Part B||0
34364|NCT02684357|76258|P2|STARTED|Part B||0
34365|NCT02684357|76259|P1|STARTED|Part B||0
34366|NCT02684357|76254|P6|NOT COMPLETED|Part A||0
34367|NCT02684357|76255|P5|NOT COMPLETED|Part A||0
34368|NCT02684357|76256|P4|NOT COMPLETED|Part A||0
34369|NCT02684357|76257|P3|NOT COMPLETED|Part A||2
34370|NCT02684357|76258|P2|NOT COMPLETED|Part A||3
34371|NCT02684357|76259|P1|NOT COMPLETED|Part A||4
34372|NCT02684357|76254|P6|COMPLETED|Part A||0
34373|NCT02684357|76255|P5|COMPLETED|Part A||0
34374|NCT02684357|76256|P4|COMPLETED|Part A||0
34375|NCT02684357|76257|P3|COMPLETED|Part A||292
34376|NCT02684357|76258|P2|COMPLETED|Part A||96
34377|NCT02684357|76259|P1|COMPLETED|Part A||94
34378|NCT02684357|76254|P6|STARTED|Part A||0
34379|NCT02684357|76255|P5|STARTED|Part A||0
34380|NCT02684357|76256|P4|STARTED|Part A||0
34381|NCT02684357|76257|P3|STARTED|Part A||294
34382|NCT02684357|76258|P2|STARTED|Part A||99
34383|NCT02684357|76259|P1|STARTED|Part A||98
34384|NCT02684344|76309|P2|NOT COMPLETED|Overall Study||1
34385|NCT02684344|76310|P1|NOT COMPLETED|Overall Study||0
34386|NCT02684344|76309|P2|COMPLETED|Overall Study||3
34387|NCT02684344|76310|P1|COMPLETED|Overall Study||1
34388|NCT02684344|76309|P2|STARTED|Overall Study||4
34389|NCT02684344|76310|P1|STARTED|Overall Study||1
34390|NCT02684188|76318|P2|NOT COMPLETED|Overall Study||3
34391|NCT02684188|76319|P1|NOT COMPLETED|Overall Study||2
34392|NCT02684188|76318|P2|COMPLETED|Overall Study||47
34393|NCT02684188|76319|P1|COMPLETED|Overall Study||75
34394|NCT02684188|76318|P2|STARTED|Overall Study||50
34395|NCT02684188|76319|P1|STARTED|Overall Study||77
34396|NCT02683954|76345|P2|NOT COMPLETED|Overall Study||0
34397|NCT02683954|76346|P1|NOT COMPLETED|Overall Study||0
34398|NCT02683954|76345|P2|COMPLETED|Overall Study||30
34399|NCT02683954|76346|P1|COMPLETED|Overall Study||30
34400|NCT02683954|76345|P2|STARTED|Overall Study||30
34401|NCT02683954|76346|P1|STARTED|Overall Study||30
34402|NCT02683785|76354|P2|NOT COMPLETED|Overall Study||4
34403|NCT02683785|76355|P1|NOT COMPLETED|Overall Study||1
34404|NCT02683785|76354|P2|COMPLETED|Overall Study||18
34405|NCT02683785|76355|P1|COMPLETED|Overall Study||21
34406|NCT02683785|76354|P2|STARTED|Overall Study||22
34407|NCT02683785|76355|P1|STARTED|Overall Study||22
34408|NCT02683772|76395|P2|NOT COMPLETED|Overall Study||0
34409|NCT02683772|76396|P1|NOT COMPLETED|Overall Study||0
34410|NCT02683772|76395|P2|COMPLETED|Overall Study||23
34411|NCT02683772|76396|P1|COMPLETED|Overall Study||15
34412|NCT02683772|76395|P2|STARTED|Overall Study||23
34413|NCT02683772|76396|P1|STARTED|Overall Study||15
34414|NCT02683746|76412|P2|NOT COMPLETED|Overall Study||14
34415|NCT02683746|76413|P1|NOT COMPLETED|Overall Study||16
34416|NCT02683746|76412|P2|COMPLETED|Overall Study||140
34417|NCT02683746|76413|P1|COMPLETED|Overall Study||138
34418|NCT02683746|76412|P2|STARTED|Overall Study||154
34419|NCT02683746|76413|P1|STARTED|Overall Study||154
34420|NCT02683707|76443|P2|NOT COMPLETED|Overall Study||0
34421|NCT02683707|76444|P1|NOT COMPLETED|Overall Study||0
34422|NCT02683707|76443|P2|COMPLETED|Overall Study||107
34423|NCT02683707|76444|P1|COMPLETED|Overall Study||105
34424|NCT02683707|76443|P2|STARTED|Overall Study||107
34425|NCT02683707|76444|P1|STARTED|Overall Study||105
34426|NCT02683668|76456|P3|NOT COMPLETED|Period 3||0
34427|NCT02683668|76457|P2|NOT COMPLETED|Period 3||0
34428|NCT02683668|76458|P1|NOT COMPLETED|Period 3||0
34429|NCT02683668|76456|P3|COMPLETED|Period 3||43
34430|NCT02683668|76457|P2|COMPLETED|Period 3||0
34431|NCT02683668|76458|P1|COMPLETED|Period 3||0
34432|NCT02683668|76456|P3|STARTED|Period 3||43
34433|NCT02683668|76457|P2|STARTED|Period 3||0
34434|NCT02683668|76458|P1|STARTED|Period 3||0
34435|NCT02683668|76456|P3|NOT COMPLETED|Period 2||0
34436|NCT02683668|76457|P2|NOT COMPLETED|Period 2||1
34437|NCT02683668|76458|P1|NOT COMPLETED|Period 2||0
34438|NCT02683668|76456|P3|COMPLETED|Period 2||0
34439|NCT02683668|76457|P2|COMPLETED|Period 2||43
34440|NCT02683668|76458|P1|COMPLETED|Period 2||0
34441|NCT02683668|76456|P3|STARTED|Period 2||0
34442|NCT02683668|76457|P2|STARTED|Period 2||44
34443|NCT02683668|76458|P1|STARTED|Period 2||0
34444|NCT02683668|76456|P3|NOT COMPLETED|Period 1||0
34445|NCT02683668|76457|P2|NOT COMPLETED|Period 1||0
34446|NCT02683668|76458|P1|NOT COMPLETED|Period 1||0
34447|NCT02683668|76456|P3|COMPLETED|Period 1||0
34448|NCT02683668|76457|P2|COMPLETED|Period 1||0
34449|NCT02683668|76458|P1|COMPLETED|Period 1||44
34450|NCT02683668|76456|P3|STARTED|Period 1||0
34451|NCT02683668|76457|P2|STARTED|Period 1||0
34452|NCT02683668|76458|P1|STARTED|Period 1||44
34453|NCT02683577|76476|P3|NOT COMPLETED|Overall Study||0
34454|NCT02683577|76477|P2|NOT COMPLETED|Overall Study||0
34455|NCT02683577|76478|P1|NOT COMPLETED|Overall Study||0
34456|NCT02683577|76476|P3|COMPLETED|Overall Study||8
34457|NCT02683577|76477|P2|COMPLETED|Overall Study||8
34458|NCT02683577|76478|P1|COMPLETED|Overall Study||8
34459|NCT02683577|76476|P3|STARTED|Overall Study||8
34460|NCT02683577|76477|P2|STARTED|Overall Study||8
34461|NCT02683577|76478|P1|STARTED|Overall Study||8
34462|NCT02683421|76528|P4|NOT COMPLETED|Overall Study||0
34463|NCT02683421|76529|P3|NOT COMPLETED|Overall Study||0
34464|NCT02683421|76530|P2|NOT COMPLETED|Overall Study||0
34465|NCT02683421|76531|P1|NOT COMPLETED|Overall Study||0
34466|NCT02683421|76528|P4|COMPLETED|Overall Study||5
34467|NCT02683421|76529|P3|COMPLETED|Overall Study||4
34468|NCT02683421|76530|P2|COMPLETED|Overall Study||4
34469|NCT02683421|76531|P1|COMPLETED|Overall Study||5
34470|NCT02683421|76528|P4|STARTED|Overall Study||5
34471|NCT02683421|76529|P3|STARTED|Overall Study||4
34472|NCT02683421|76530|P2|STARTED|Overall Study||4
34473|NCT02683421|76531|P1|STARTED|Overall Study||5
34474|NCT02683161|76549|P1|NOT COMPLETED|Overall Study||0
34475|NCT02683161|76549|P1|COMPLETED|Overall Study||5
34476|NCT02683161|76549|P1|STARTED|Overall Study||5
34477|NCT02683109|76555|P2|NOT COMPLETED|Overall Study||0
34478|NCT02683109|76556|P1|NOT COMPLETED|Overall Study||1
34479|NCT02683109|76555|P2|COMPLETED|Overall Study||111
34480|NCT02683109|76556|P1|COMPLETED|Overall Study||109
34481|NCT02683109|76555|P2|STARTED|Overall Study||111
34482|NCT02683109|76556|P1|STARTED|Overall Study||110
34483|NCT02683083|76567|P1|NOT COMPLETED|Overall Study||0
34484|NCT02683083|76567|P1|COMPLETED|Overall Study||9
34485|NCT02683083|76567|P1|STARTED|Overall Study||9
34486|NCT02682823|76577|P5|NOT COMPLETED|Overall Study||1
34487|NCT02682823|76578|P4|NOT COMPLETED|Overall Study||1
34488|NCT02682823|76579|P3|NOT COMPLETED|Overall Study||1
34489|NCT02682823|76580|P2|NOT COMPLETED|Overall Study||1
34490|NCT02682823|76581|P1|NOT COMPLETED|Overall Study||0
34491|NCT02682823|76577|P5|COMPLETED|Overall Study||18
34492|NCT02682823|76578|P4|COMPLETED|Overall Study||16
34493|NCT02682823|76579|P3|COMPLETED|Overall Study||18
34494|NCT02682823|76580|P2|COMPLETED|Overall Study||18
34495|NCT02682823|76581|P1|COMPLETED|Overall Study||17
34496|NCT02682823|76577|P5|Safety Population|Overall Study|All participants who received at least one dose of study drug.|19
34497|NCT02682823|76578|P4|Safety Population|Overall Study|All participants who received at least one dose of study drug.|17
34498|NCT02682823|76579|P3|Safety Population|Overall Study|All participants who received at least one dose of study drug.|18
34499|NCT02682823|76580|P2|Safety Population|Overall Study|All HCPs who administered at least one dose of study drug.|19
34500|NCT02682823|76581|P1|Safety Population|Overall Study|All CGs who administered at least one dose of study drug.|17
34501|NCT02682823|76577|P5|STARTED|Overall Study||19
34502|NCT02682823|76578|P4|STARTED|Overall Study||17
34503|NCT02682823|76579|P3|STARTED|Overall Study||19
34504|NCT02682823|76580|P2|STARTED|Overall Study||19
34505|NCT02682823|76581|P1|STARTED|Overall Study||17
34506|NCT02682602|76617|P2|NOT COMPLETED|Post-operative Fluoroscopy for Implanted||0
34507|NCT02682602|76618|P1|NOT COMPLETED|Post-operative Fluoroscopy for Implanted||3
34508|NCT02682602|76617|P2|COMPLETED|Post-operative Fluoroscopy for Implanted|Nonimplanted subjects were not analyzed again for the second period, because this would be redundant|0
34509|NCT02682602|76618|P1|COMPLETED|Post-operative Fluoroscopy for Implanted||7
34510|NCT02682602|76617|P2|STARTED|Post-operative Fluoroscopy for Implanted||0
34511|NCT02682602|76618|P1|STARTED|Post-operative Fluoroscopy for Implanted||10
34512|NCT02682602|76617|P2|NOT COMPLETED|Pre-operative Diseased & Normal Hips||0
34513|NCT02682602|76618|P1|NOT COMPLETED|Pre-operative Diseased & Normal Hips||1
34514|NCT02682602|76617|P2|COMPLETED|Pre-operative Diseased & Normal Hips||10
34515|NCT02682602|76618|P1|COMPLETED|Pre-operative Diseased & Normal Hips||10
34516|NCT02682602|76617|P2|STARTED|Pre-operative Diseased & Normal Hips||10
34517|NCT02682602|76618|P1|STARTED|Pre-operative Diseased & Normal Hips||11
34518|NCT02682498|76637|P2|NOT COMPLETED|Overall Study||0
34519|NCT02682498|76638|P1|NOT COMPLETED|Overall Study||0
34520|NCT02682498|76637|P2|COMPLETED|Overall Study||20
34521|NCT02682498|76638|P1|COMPLETED|Overall Study||18
34522|NCT02682498|76637|P2|STARTED|Overall Study||20
34523|NCT02682498|76638|P1|STARTED|Overall Study||18
34524|NCT02682381|76655|P3|NOT COMPLETED|Overall Study||0
34525|NCT02682381|76656|P2|NOT COMPLETED|Overall Study||0
34526|NCT02682381|76657|P1|NOT COMPLETED|Overall Study||0
34527|NCT02682381|76655|P3|COMPLETED|Overall Study||9
34528|NCT02682381|76656|P2|COMPLETED|Overall Study||26
34529|NCT02682381|76657|P1|COMPLETED|Overall Study||24
34530|NCT02682381|76655|P3|STARTED|Overall Study||9
34531|NCT02682381|76656|P2|STARTED|Overall Study||26
34532|NCT02682381|76657|P1|STARTED|Overall Study||24
34533|NCT02681510|76722|P1|NOT COMPLETED|Overall Study||10
34534|NCT02681510|76722|P1|COMPLETED|Overall Study||26
34535|NCT02681510|76722|P1|STARTED|Overall Study||36
34536|NCT02681458|76731|P2|NOT COMPLETED|Overall Study||656
34537|NCT02681458|76732|P1|NOT COMPLETED|Overall Study||645
34538|NCT02681458|76731|P2|COMPLETED|Overall Study||62
34539|NCT02681458|76732|P1|COMPLETED|Overall Study||73
34540|NCT02681458|76731|P2|STARTED|Overall Study||718
34541|NCT02681458|76732|P1|STARTED|Overall Study||718
34542|NCT02681172|76738|P1|NOT COMPLETED|Overall Study||13
34543|NCT02681172|76738|P1|COMPLETED|Overall Study||205
34544|NCT02681172|76738|P1|Per Protocol Set|Overall Study||205
34545|NCT02681172|76738|P1|Full Analysis Set|Overall Study||205
34546|NCT02681172|76738|P1|Safety Analysis Set|Overall Study||205
34547|NCT02681172|76738|P1|STARTED|Overall Study||218
34548|NCT02681094|76752|P3|NOT COMPLETED|2 - Enrolled Participants Set||54
34549|NCT02681094|76753|P2|NOT COMPLETED|2 - Enrolled Participants Set||41
34550|NCT02681094|76754|P1|NOT COMPLETED|2 - Enrolled Participants Set||40
34551|NCT02681094|76752|P3|COMPLETED|2 - Enrolled Participants Set||248
34552|NCT02681094|76753|P2|COMPLETED|2 - Enrolled Participants Set||261
34553|NCT02681094|76754|P1|COMPLETED|2 - Enrolled Participants Set||261
34554|NCT02681094|76752|P3|Participants Completed Treatment Period|2 - Enrolled Participants Set|A participant was randomized but did not receive treatment due to screen failure.|289
34555|NCT02681094|76753|P2|Participants Completed Treatment Period|2 - Enrolled Participants Set|A participant was randomized but did not receive treatment due to screen failure.|284
34556|NCT02681094|76754|P1|Participants Completed Treatment Period|2 - Enrolled Participants Set||281
34557|NCT02681094|76752|P3|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|302
34558|NCT02681094|76753|P2|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|302
34559|NCT02681094|76754|P1|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|301
34560|NCT02681094|76752|P3|NOT COMPLETED|1 -Modified Enrolled Participants Set||53
34561|NCT02681094|76753|P2|NOT COMPLETED|1 -Modified Enrolled Participants Set||39
34562|NCT02681094|76754|P1|NOT COMPLETED|1 -Modified Enrolled Participants Set||37
34563|NCT02681094|76752|P3|COMPLETED|1 -Modified Enrolled Participants Set||243
34564|NCT02681094|76753|P2|COMPLETED|1 -Modified Enrolled Participants Set||255
34565|NCT02681094|76754|P1|COMPLETED|1 -Modified Enrolled Participants Set||256
34566|NCT02681094|76752|P3|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||283
34567|NCT02681094|76753|P2|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||276
34568|NCT02681094|76754|P1|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||273
34569|NCT02681094|76752|P3|STARTED|1 -Modified Enrolled Participants Set|A participant was randomized but did not receive treatment|296
34570|NCT02681094|76753|P2|STARTED|1 -Modified Enrolled Participants Set|A participant was randomized but did not receive treatment|294
34571|NCT02681094|76754|P1|STARTED|1 -Modified Enrolled Participants Set||293
34572|NCT02680847|76773|P3|NOT COMPLETED|Overall Study||3
34573|NCT02680847|76774|P2|NOT COMPLETED|Overall Study||3
34574|NCT02680847|76775|P1|NOT COMPLETED|Overall Study||5
34575|NCT02680847|76773|P3|COMPLETED|Overall Study||4
34576|NCT02680847|76774|P2|COMPLETED|Overall Study||6
34577|NCT02680847|76775|P1|COMPLETED|Overall Study||11
34578|NCT02680847|76773|P3|STARTED|Overall Study||7
34579|NCT02680847|76774|P2|STARTED|Overall Study||9
34580|NCT02680847|76775|P1|STARTED|Overall Study||16
34581|NCT02680639|76810|P3|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
34582|NCT02680639|76811|P2|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
34583|NCT02680639|76812|P1|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
34584|NCT02680639|76810|P3|COMPLETED|High Frequency Oscillation (HFO) Therapy||1
34585|NCT02680639|76811|P2|COMPLETED|High Frequency Oscillation (HFO) Therapy||2
34586|NCT02680639|76812|P1|COMPLETED|High Frequency Oscillation (HFO) Therapy||0
34587|NCT02680639|76810|P3|STARTED|High Frequency Oscillation (HFO) Therapy||1
34588|NCT02680639|76811|P2|STARTED|High Frequency Oscillation (HFO) Therapy||2
34589|NCT02680639|76812|P1|STARTED|High Frequency Oscillation (HFO) Therapy||0
34590|NCT02680639|76810|P3|NOT COMPLETED|Screening Period||0
34591|NCT02680639|76811|P2|NOT COMPLETED|Screening Period||0
34592|NCT02680639|76812|P1|NOT COMPLETED|Screening Period||7
34593|NCT02680639|76810|P3|COMPLETED|Screening Period||0
34594|NCT02680639|76811|P2|COMPLETED|Screening Period||0
34595|NCT02680639|76812|P1|COMPLETED|Screening Period||3
34596|NCT02680639|76810|P3|STARTED|Screening Period||0
34597|NCT02680639|76811|P2|STARTED|Screening Period||0
34598|NCT02680639|76812|P1|STARTED|Screening Period||10
34599|NCT02680301|76835|P2|NOT COMPLETED|Overall Study||1
34600|NCT02680301|76836|P1|NOT COMPLETED|Overall Study||0
34601|NCT02680301|76835|P2|COMPLETED|Overall Study||17
34602|NCT02680301|76836|P1|COMPLETED|Overall Study||22
34603|NCT02680301|76835|P2|STARTED|Overall Study||18
34604|NCT02680301|76836|P1|STARTED|Overall Study||22
34605|NCT02680158|76844|P6|NOT COMPLETED|Overall Study||0
34606|NCT02680158|76845|P5|NOT COMPLETED|Overall Study||0
34607|NCT02680158|76846|P4|NOT COMPLETED|Overall Study||0
34608|NCT02680158|76847|P3|NOT COMPLETED|Overall Study||0
34609|NCT02680158|76848|P2|NOT COMPLETED|Overall Study||0
34610|NCT02680158|76849|P1|NOT COMPLETED|Overall Study||0
34611|NCT02680158|76844|P6|COMPLETED|Overall Study||8
34612|NCT02680158|76845|P5|COMPLETED|Overall Study||8
34613|NCT02680158|76846|P4|COMPLETED|Overall Study||8
34614|NCT02680158|76847|P3|COMPLETED|Overall Study||8
34615|NCT02680158|76848|P2|COMPLETED|Overall Study||8
34616|NCT02680158|76849|P1|COMPLETED|Overall Study||8
34617|NCT02680158|76844|P6|STARTED|Overall Study||8
34618|NCT02680158|76845|P5|STARTED|Overall Study||8
34619|NCT02680158|76846|P4|STARTED|Overall Study||8
34620|NCT02680158|76847|P3|STARTED|Overall Study||8
34621|NCT02680158|76848|P2|STARTED|Overall Study||8
34622|NCT02680158|76849|P1|STARTED|Overall Study||8
34623|NCT02680041|76860|P1|NOT COMPLETED|Overall Study||10
34624|NCT02680041|76860|P1|COMPLETED|Overall Study||211
34625|NCT02680041|76860|P1|Received 18F-fluciclovine|Overall Study||213
34626|NCT02680041|76860|P1|STARTED|Overall Study||221
34627|NCT02679976|76869|P1|NOT COMPLETED|Overall Study||0
34628|NCT02679976|76869|P1|COMPLETED|Overall Study||30
34629|NCT02679976|76869|P1|Myopes|Overall Study||14
34630|NCT02679976|76869|P1|Hyperopes|Overall Study||16
34631|NCT02679976|76869|P1|STARTED|Overall Study||30
34632|NCT02679911|76878|P1|NOT COMPLETED|Overall Study||0
34633|NCT02679911|76878|P1|COMPLETED|Overall Study||20
34634|NCT02679911|76878|P1|STARTED|Overall Study|Intra-individual study|20
34635|NCT02679729|76894|P9|NOT COMPLETED|Overall Study||0
34636|NCT02679729|76895|P8|NOT COMPLETED|Overall Study||0
34637|NCT02679729|76896|P7|NOT COMPLETED|Overall Study||1
34638|NCT02679729|76897|P6|NOT COMPLETED|Overall Study||0
34639|NCT02679729|76898|P5|NOT COMPLETED|Overall Study||1
34640|NCT02679729|76899|P4|NOT COMPLETED|Overall Study||0
34641|NCT02679729|76900|P3|NOT COMPLETED|Overall Study||0
34642|NCT02679729|76901|P2|NOT COMPLETED|Overall Study||2
34643|NCT02679729|76902|P1|NOT COMPLETED|Overall Study||0
34644|NCT02679729|76894|P9|COMPLETED|Overall Study||6
34645|NCT02679729|76895|P8|COMPLETED|Overall Study||14
34646|NCT02679729|76896|P7|COMPLETED|Overall Study||5
34647|NCT02679729|76897|P6|COMPLETED|Overall Study||6
34648|NCT02679729|76898|P5|COMPLETED|Overall Study||5
34649|NCT02679729|76899|P4|COMPLETED|Overall Study||6
34650|NCT02679729|76900|P3|COMPLETED|Overall Study||6
34651|NCT02679729|76901|P2|COMPLETED|Overall Study||5
34652|NCT02679729|76902|P1|COMPLETED|Overall Study||6
34653|NCT02679729|76894|P9|STARTED|Overall Study||6
34654|NCT02679729|76895|P8|STARTED|Overall Study||14
34655|NCT02679729|76896|P7|STARTED|Overall Study||6
34656|NCT02679729|76897|P6|STARTED|Overall Study||6
34657|NCT02679729|76898|P5|STARTED|Overall Study||6
34658|NCT02679729|76899|P4|STARTED|Overall Study||6
34659|NCT02679729|76900|P3|STARTED|Overall Study||6
34660|NCT02679729|76901|P2|STARTED|Overall Study||7
34661|NCT02679729|76902|P1|STARTED|Overall Study||6
34662|NCT02679690|77006|P1|NOT COMPLETED|Overall Study||1
34663|NCT02679690|77006|P1|COMPLETED|Overall Study||9
34664|NCT02679690|77006|P1|STARTED|Overall Study||10
34665|NCT02679469|77012|P1|NOT COMPLETED|Overall Study||0
34666|NCT02679469|77012|P1|COMPLETED|Overall Study||7
34667|NCT02679469|77012|P1|STARTED|Overall Study||7
34668|NCT02679274|77020|P2|NOT COMPLETED|Overall Study||0
34669|NCT02679274|77021|P1|NOT COMPLETED|Overall Study||1
34670|NCT02679274|77020|P2|COMPLETED|Overall Study||1
34671|NCT02679274|77021|P1|COMPLETED|Overall Study||1
34672|NCT02679274|77020|P2|STARTED|Overall Study||1
34673|NCT02679274|77021|P1|STARTED|Overall Study||2
34674|NCT02678923|77053|P2|NOT COMPLETED|Overall Study||5
34675|NCT02678923|77054|P1|NOT COMPLETED|Overall Study||6
34676|NCT02678923|77053|P2|COMPLETED|Overall Study||62
34677|NCT02678923|77054|P1|COMPLETED|Overall Study||53
34678|NCT02678923|77053|P2|mITT Population|Overall Study||61
34679|NCT02678923|77054|P1|mITT Population|Overall Study||52
34680|NCT02678923|77053|P2|Received at Least 1 Dose of Study Drug|Overall Study||64
34681|NCT02678923|77054|P1|Received at Least 1 Dose of Study Drug|Overall Study||58
34682|NCT02678923|77053|P2|STARTED|Overall Study||67
34683|NCT02678923|77054|P1|STARTED|Overall Study||59
34684|NCT02678676|77070|P2|NOT COMPLETED|Overall Study||872
34685|NCT02678676|77071|P1|NOT COMPLETED|Overall Study||888
34686|NCT02678676|77070|P2|COMPLETED|Overall Study||907
34687|NCT02678676|77071|P1|COMPLETED|Overall Study||932
34688|NCT02678676|77070|P2|STARTED|Overall Study||1779
34689|NCT02678676|77071|P1|STARTED|Overall Study||1820
34690|NCT02678286|77081|P2|NOT COMPLETED|Study Overall (28 Day Follow-Up)||4
34691|NCT02678286|77082|P1|NOT COMPLETED|Study Overall (28 Day Follow-Up)||6
34692|NCT02678286|77081|P2|COMPLETED|Study Overall (28 Day Follow-Up)||105
34693|NCT02678286|77082|P1|COMPLETED|Study Overall (28 Day Follow-Up)||104
34694|NCT02678286|77081|P2|STARTED|Study Overall (28 Day Follow-Up)||109
34695|NCT02678286|77082|P1|STARTED|Study Overall (28 Day Follow-Up)||110
34696|NCT02678286|77081|P2|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
34697|NCT02678286|77082|P1|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
34698|NCT02678286|77081|P2|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||107
34699|NCT02678286|77082|P1|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||108
34700|NCT02678286|77081|P2|STARTED|Treatment Phase (48 Hours Post-Dose 1)||109
34701|NCT02678286|77082|P1|STARTED|Treatment Phase (48 Hours Post-Dose 1)||110
34702|NCT02678039|77114|P2|NOT COMPLETED|Overall Study||0
34703|NCT02678039|77115|P1|NOT COMPLETED|Overall Study||0
34704|NCT02678039|77114|P2|COMPLETED|Overall Study||47
34705|NCT02678039|77115|P1|COMPLETED|Overall Study||53
34706|NCT02678039|77114|P2|STARTED|Overall Study||47
34707|NCT02678039|77115|P1|STARTED|Overall Study||53
34708|NCT02677844|77131|P7|NOT COMPLETED|Period 7||0
34709|NCT02677844|77132|P6|NOT COMPLETED|Period 7||0
34710|NCT02677844|77133|P5|NOT COMPLETED|Period 7||0
34711|NCT02677844|77134|P4|NOT COMPLETED|Period 7||0
34712|NCT02677844|77135|P3|NOT COMPLETED|Period 7||0
34713|NCT02677844|77136|P2|NOT COMPLETED|Period 7||0
34714|NCT02677844|77137|P1|NOT COMPLETED|Period 7||0
34715|NCT02677844|77131|P7|COMPLETED|Period 7||4
34716|NCT02677844|77132|P6|COMPLETED|Period 7||4
34717|NCT02677844|77133|P5|COMPLETED|Period 7||7
34718|NCT02677844|77134|P4|COMPLETED|Period 7||0
34719|NCT02677844|77135|P3|COMPLETED|Period 7||0
34720|NCT02677844|77136|P2|COMPLETED|Period 7||0
34721|NCT02677844|77137|P1|COMPLETED|Period 7||0
34722|NCT02677844|77131|P7|STARTED|Period 7||4
34723|NCT02677844|77132|P6|STARTED|Period 7||4
34724|NCT02677844|77133|P5|STARTED|Period 7||7
34725|NCT02677844|77134|P4|STARTED|Period 7||0
34726|NCT02677844|77135|P3|STARTED|Period 7||0
34727|NCT02677844|77136|P2|STARTED|Period 7||0
34728|NCT02677844|77137|P1|STARTED|Period 7||0
34729|NCT02677844|77131|P7|NOT COMPLETED|Period 6||0
34730|NCT02677844|77132|P6|NOT COMPLETED|Period 6||0
34731|NCT02677844|77133|P5|NOT COMPLETED|Period 6||0
34732|NCT02677844|77134|P4|NOT COMPLETED|Period 6||0
34733|NCT02677844|77135|P3|NOT COMPLETED|Period 6||0
34734|NCT02677844|77136|P2|NOT COMPLETED|Period 6||0
34735|NCT02677844|77137|P1|NOT COMPLETED|Period 6||0
34736|NCT02677844|77131|P7|COMPLETED|Period 6||4
34737|NCT02677844|77132|P6|COMPLETED|Period 6||4
34738|NCT02677844|77133|P5|COMPLETED|Period 6||7
34739|NCT02677844|77134|P4|COMPLETED|Period 6||0
34740|NCT02677844|77135|P3|COMPLETED|Period 6||0
34741|NCT02677844|77136|P2|COMPLETED|Period 6||0
34742|NCT02677844|77137|P1|COMPLETED|Period 6||0
34743|NCT02677844|77131|P7|STARTED|Period 6||4
34744|NCT02677844|77132|P6|STARTED|Period 6||4
34745|NCT02677844|77133|P5|STARTED|Period 6||7
34746|NCT02677844|77134|P4|STARTED|Period 6||0
34747|NCT02677844|77135|P3|STARTED|Period 6||0
34748|NCT02677844|77136|P2|STARTED|Period 6||0
34749|NCT02677844|77137|P1|STARTED|Period 6||0
34750|NCT02677844|77131|P7|NOT COMPLETED|Period 5||0
34751|NCT02677844|77132|P6|NOT COMPLETED|Period 5||0
34752|NCT02677844|77133|P5|NOT COMPLETED|Period 5||0
34753|NCT02677844|77134|P4|NOT COMPLETED|Period 5||0
34754|NCT02677844|77135|P3|NOT COMPLETED|Period 5||0
34755|NCT02677844|77136|P2|NOT COMPLETED|Period 5||0
34756|NCT02677844|77137|P1|NOT COMPLETED|Period 5||0
34757|NCT02677844|77131|P7|COMPLETED|Period 5||4
34758|NCT02677844|77132|P6|COMPLETED|Period 5||4
34759|NCT02677844|77133|P5|COMPLETED|Period 5||7
34760|NCT02677844|77134|P4|COMPLETED|Period 5||0
34761|NCT02677844|77135|P3|COMPLETED|Period 5||0
34762|NCT02677844|77136|P2|COMPLETED|Period 5||0
34763|NCT02677844|77137|P1|COMPLETED|Period 5||0
34764|NCT02677844|77131|P7|STARTED|Period 5||4
34765|NCT02677844|77132|P6|STARTED|Period 5||4
34766|NCT02677844|77133|P5|STARTED|Period 5||7
34767|NCT02677844|77134|P4|STARTED|Period 5||0
34768|NCT02677844|77135|P3|STARTED|Period 5||0
34769|NCT02677844|77136|P2|STARTED|Period 5||0
34770|NCT02677844|77137|P1|STARTED|Period 5||0
34771|NCT02677844|77131|P7|NOT COMPLETED|Period 4 (DDI)||0
34772|NCT02677844|77132|P6|NOT COMPLETED|Period 4 (DDI)||0
34773|NCT02677844|77133|P5|NOT COMPLETED|Period 4 (DDI)||0
34774|NCT02677844|77134|P4|NOT COMPLETED|Period 4 (DDI)||0
34775|NCT02677844|77135|P3|NOT COMPLETED|Period 4 (DDI)||0
34776|NCT02677844|77136|P2|NOT COMPLETED|Period 4 (DDI)||0
34777|NCT02677844|77137|P1|NOT COMPLETED|Period 4 (DDI)||0
34778|NCT02677844|77131|P7|COMPLETED|Period 4 (DDI)||4
34779|NCT02677844|77132|P6|COMPLETED|Period 4 (DDI)||4
34780|NCT02677844|77133|P5|COMPLETED|Period 4 (DDI)||7
34781|NCT02677844|77134|P4|COMPLETED|Period 4 (DDI)||0
34782|NCT02677844|77135|P3|COMPLETED|Period 4 (DDI)||0
34783|NCT02677844|77136|P2|COMPLETED|Period 4 (DDI)||0
34784|NCT02677844|77137|P1|COMPLETED|Period 4 (DDI)||0
34785|NCT02677844|77131|P7|STARTED|Period 4 (DDI)||4
34786|NCT02677844|77132|P6|STARTED|Period 4 (DDI)||4
34787|NCT02677844|77133|P5|STARTED|Period 4 (DDI)||7
34788|NCT02677844|77134|P4|STARTED|Period 4 (DDI)||0
34789|NCT02677844|77135|P3|STARTED|Period 4 (DDI)||0
34790|NCT02677844|77136|P2|STARTED|Period 4 (DDI)||0
34791|NCT02677844|77137|P1|STARTED|Period 4 (DDI)||0
34792|NCT02677844|77131|P7|NOT COMPLETED|Period 4||0
34793|NCT02677844|77132|P6|NOT COMPLETED|Period 4||0
34794|NCT02677844|77133|P5|NOT COMPLETED|Period 4||0
34795|NCT02677844|77134|P4|NOT COMPLETED|Period 4||0
34796|NCT02677844|77135|P3|NOT COMPLETED|Period 4||0
34797|NCT02677844|77136|P2|NOT COMPLETED|Period 4||0
34798|NCT02677844|77137|P1|NOT COMPLETED|Period 4||0
34799|NCT02677844|77131|P7|COMPLETED|Period 4||0
34800|NCT02677844|77132|P6|COMPLETED|Period 4||0
34801|NCT02677844|77133|P5|COMPLETED|Period 4||0
34802|NCT02677844|77134|P4|COMPLETED|Period 4||4
34803|NCT02677844|77135|P3|COMPLETED|Period 4||5
34804|NCT02677844|77136|P2|COMPLETED|Period 4||5
34805|NCT02677844|77137|P1|COMPLETED|Period 4||5
34806|NCT02677844|77131|P7|STARTED|Period 4||0
34807|NCT02677844|77132|P6|STARTED|Period 4||0
34808|NCT02677844|77133|P5|STARTED|Period 4||0
34809|NCT02677844|77134|P4|STARTED|Period 4||4
34810|NCT02677844|77135|P3|STARTED|Period 4||5
34811|NCT02677844|77136|P2|STARTED|Period 4||5
34812|NCT02677844|77137|P1|STARTED|Period 4||5
34813|NCT02677844|77131|P7|NOT COMPLETED|Period 3||0
34814|NCT02677844|77132|P6|NOT COMPLETED|Period 3||0
34815|NCT02677844|77133|P5|NOT COMPLETED|Period 3||0
34816|NCT02677844|77134|P4|NOT COMPLETED|Period 3||1
34817|NCT02677844|77135|P3|NOT COMPLETED|Period 3||0
34818|NCT02677844|77136|P2|NOT COMPLETED|Period 3||0
34819|NCT02677844|77137|P1|NOT COMPLETED|Period 3||0
34820|NCT02677844|77131|P7|COMPLETED|Period 3||0
34821|NCT02677844|77132|P6|COMPLETED|Period 3||0
34822|NCT02677844|77133|P5|COMPLETED|Period 3||0
34823|NCT02677844|77134|P4|COMPLETED|Period 3||4
34824|NCT02677844|77135|P3|COMPLETED|Period 3||5
34825|NCT02677844|77136|P2|COMPLETED|Period 3||5
34826|NCT02677844|77137|P1|COMPLETED|Period 3||5
34827|NCT02677844|77131|P7|STARTED|Period 3||0
34828|NCT02677844|77132|P6|STARTED|Period 3||0
34829|NCT02677844|77133|P5|STARTED|Period 3||0
34830|NCT02677844|77134|P4|STARTED|Period 3||5
34831|NCT02677844|77135|P3|STARTED|Period 3||5
34832|NCT02677844|77136|P2|STARTED|Period 3||5
34833|NCT02677844|77137|P1|STARTED|Period 3||5
34834|NCT02677844|77131|P7|NOT COMPLETED|Period 2||0
34835|NCT02677844|77132|P6|NOT COMPLETED|Period 2||0
34836|NCT02677844|77133|P5|NOT COMPLETED|Period 2||0
34837|NCT02677844|77134|P4|NOT COMPLETED|Period 2||0
34838|NCT02677844|77135|P3|NOT COMPLETED|Period 2||0
34839|NCT02677844|77136|P2|NOT COMPLETED|Period 2||0
34840|NCT02677844|77137|P1|NOT COMPLETED|Period 2||0
34841|NCT02677844|77131|P7|COMPLETED|Period 2||0
34842|NCT02677844|77132|P6|COMPLETED|Period 2||0
34843|NCT02677844|77133|P5|COMPLETED|Period 2||0
34844|NCT02677844|77134|P4|COMPLETED|Period 2||5
34845|NCT02677844|77135|P3|COMPLETED|Period 2||5
34846|NCT02677844|77136|P2|COMPLETED|Period 2||5
34847|NCT02677844|77137|P1|COMPLETED|Period 2||5
34848|NCT02677844|77131|P7|STARTED|Period 2||0
34849|NCT02677844|77132|P6|STARTED|Period 2||0
34850|NCT02677844|77133|P5|STARTED|Period 2||0
34851|NCT02677844|77134|P4|STARTED|Period 2||5
34852|NCT02677844|77135|P3|STARTED|Period 2||5
34853|NCT02677844|77136|P2|STARTED|Period 2||5
34854|NCT02677844|77137|P1|STARTED|Period 2||5
34855|NCT02677844|77131|P7|NOT COMPLETED|Period 1||0
34856|NCT02677844|77132|P6|NOT COMPLETED|Period 1||0
34857|NCT02677844|77133|P5|NOT COMPLETED|Period 1||0
34858|NCT02677844|77134|P4|NOT COMPLETED|Period 1||0
34859|NCT02677844|77135|P3|NOT COMPLETED|Period 1||0
34860|NCT02677844|77136|P2|NOT COMPLETED|Period 1||0
34861|NCT02677844|77137|P1|NOT COMPLETED|Period 1||0
34862|NCT02677844|77131|P7|COMPLETED|Period 1||0
34863|NCT02677844|77132|P6|COMPLETED|Period 1||0
34864|NCT02677844|77133|P5|COMPLETED|Period 1||0
34865|NCT02677844|77134|P4|COMPLETED|Period 1||5
34866|NCT02677844|77135|P3|COMPLETED|Period 1||5
34867|NCT02677844|77136|P2|COMPLETED|Period 1||5
34868|NCT02677844|77137|P1|COMPLETED|Period 1||5
34869|NCT02677844|77131|P7|STARTED|Period 1||0
34870|NCT02677844|77132|P6|STARTED|Period 1||0
34871|NCT02677844|77133|P5|STARTED|Period 1||0
34872|NCT02677844|77134|P4|STARTED|Period 1||5
34873|NCT02677844|77135|P3|STARTED|Period 1||5
34874|NCT02677844|77136|P2|STARTED|Period 1||5
34875|NCT02677844|77137|P1|STARTED|Period 1||5
34876|NCT02677779|77167|P2|NOT COMPLETED|Overall Study||0
34877|NCT02677779|77168|P1|NOT COMPLETED|Overall Study||0
34878|NCT02677779|77167|P2|COMPLETED|Overall Study||10
34879|NCT02677779|77168|P1|COMPLETED|Overall Study||10
34880|NCT02677779|77167|P2|STARTED|Overall Study||10
34881|NCT02677779|77168|P1|STARTED|Overall Study||10
34882|NCT02677766|77184|P2|NOT COMPLETED|Overall Study||3
34883|NCT02677766|77185|P1|NOT COMPLETED|Overall Study||5
34884|NCT02677766|77184|P2|COMPLETED|Overall Study||17
34885|NCT02677766|77185|P1|COMPLETED|Overall Study||15
34886|NCT02677766|77184|P2|STARTED|Overall Study||20
34887|NCT02677766|77185|P1|STARTED|Overall Study||20
34888|NCT02677740|77193|P2|NOT COMPLETED|Overall Study||0
34889|NCT02677740|77194|P1|NOT COMPLETED|Overall Study||0
34890|NCT02677740|77193|P2|COMPLETED|Overall Study||1
34891|NCT02677740|77194|P1|COMPLETED|Overall Study||7
34892|NCT02677740|77193|P2|STARTED|Overall Study||1
34893|NCT02677740|77194|P1|STARTED|Overall Study||7
34894|NCT02677623|77210|P4|NOT COMPLETED|Overall Study||0
34895|NCT02677623|77211|P3|NOT COMPLETED|Overall Study||0
34896|NCT02677623|77212|P2|NOT COMPLETED|Overall Study||0
34897|NCT02677623|77213|P1|NOT COMPLETED|Overall Study||0
34898|NCT02677623|77210|P4|COMPLETED|Overall Study||33
34899|NCT02677623|77211|P3|COMPLETED|Overall Study||32
34900|NCT02677623|77212|P2|COMPLETED|Overall Study||32
34901|NCT02677623|77213|P1|COMPLETED|Overall Study||33
34902|NCT02677623|77210|P4|STARTED|Overall Study||33
34903|NCT02677623|77211|P3|STARTED|Overall Study||32
34904|NCT02677623|77212|P2|STARTED|Overall Study||32
34905|NCT02677623|77213|P1|STARTED|Overall Study||33
34906|NCT02677493|77226|P3|NOT COMPLETED|Overall Study||3
34907|NCT02677493|77227|P2|NOT COMPLETED|Overall Study||2
34908|NCT02677493|77228|P1|NOT COMPLETED|Overall Study||11
34909|NCT02677493|77226|P3|COMPLETED|Overall Study||296
34910|NCT02677493|77227|P2|COMPLETED|Overall Study||296
34911|NCT02677493|77228|P1|COMPLETED|Overall Study||1186
34912|NCT02677493|77226|P3|STARTED|Overall Study||299
34913|NCT02677493|77227|P2|STARTED|Overall Study||298
34914|NCT02677493|77228|P1|STARTED|Overall Study||1197
34915|NCT02677220|77239|P1|NOT COMPLETED|Overall Study||1
34916|NCT02677220|77239|P1|COMPLETED|Overall Study||0
34917|NCT02677220|77239|P1|STARTED|Overall Study||1
34918|NCT02676895|77248|P3|NOT COMPLETED|Overall Study||3
34919|NCT02676895|77249|P2|NOT COMPLETED|Overall Study||3
34920|NCT02676895|77250|P1|NOT COMPLETED|Overall Study||2
34921|NCT02676895|77248|P3|COMPLETED|Overall Study||21
34922|NCT02676895|77249|P2|COMPLETED|Overall Study||23
34923|NCT02676895|77250|P1|COMPLETED|Overall Study||20
34924|NCT02676895|77248|P3|STARTED|Overall Study||24
34925|NCT02676895|77249|P2|STARTED|Overall Study||26
34926|NCT02676895|77250|P1|STARTED|Overall Study||22
34927|NCT02676882|77293|P2|NOT COMPLETED|Overall Study||2
34928|NCT02676882|77294|P1|NOT COMPLETED|Overall Study||3
34929|NCT02676882|77293|P2|COMPLETED|Overall Study||5
34930|NCT02676882|77294|P1|COMPLETED|Overall Study||10
34931|NCT02676882|77293|P2|Evaluable|Overall Study||6
34932|NCT02676882|77294|P1|Evaluable|Overall Study||11
34933|NCT02676882|77293|P2|STARTED|Overall Study||7
34934|NCT02676882|77294|P1|STARTED|Overall Study||13
34935|NCT02676466|77308|P8|NOT COMPLETED|Overall Study||1
34936|NCT02676466|77309|P7|NOT COMPLETED|Overall Study||1
34937|NCT02676466|77310|P6|NOT COMPLETED|Overall Study||1
34938|NCT02676466|77311|P5|NOT COMPLETED|Overall Study||3
34939|NCT02676466|77312|P4|NOT COMPLETED|Overall Study||0
34940|NCT02676466|77313|P3|NOT COMPLETED|Overall Study||2
34941|NCT02676466|77314|P2|NOT COMPLETED|Overall Study||5
34942|NCT02676466|77315|P1|NOT COMPLETED|Overall Study||4
34943|NCT02676466|77308|P8|COMPLETED|Overall Study||13
34944|NCT02676466|77309|P7|COMPLETED|Overall Study||12
34945|NCT02676466|77310|P6|COMPLETED|Overall Study||12
34946|NCT02676466|77311|P5|COMPLETED|Overall Study||23
34947|NCT02676466|77312|P4|COMPLETED|Overall Study||17
34948|NCT02676466|77313|P3|COMPLETED|Overall Study||24
34949|NCT02676466|77314|P2|COMPLETED|Overall Study||66
34950|NCT02676466|77315|P1|COMPLETED|Overall Study||105
34951|NCT02676466|77308|P8|STARTED|Overall Study||14
34952|NCT02676466|77309|P7|STARTED|Overall Study||13
34953|NCT02676466|77310|P6|STARTED|Overall Study||13
34954|NCT02676466|77311|P5|STARTED|Overall Study||26
34955|NCT02676466|77312|P4|STARTED|Overall Study||17
34956|NCT02676466|77313|P3|STARTED|Overall Study||26
34957|NCT02676466|77314|P2|STARTED|Overall Study||71
34958|NCT02676466|77315|P1|STARTED|Overall Study||109
34959|NCT02676375|77384|P3|NOT COMPLETED|Overall Study||3
34960|NCT02676375|77385|P2|NOT COMPLETED|Overall Study||4
34961|NCT02676375|77386|P1|NOT COMPLETED|Overall Study||1
34962|NCT02676375|77384|P3|COMPLETED|Overall Study||11
34963|NCT02676375|77385|P2|COMPLETED|Overall Study||10
34964|NCT02676375|77386|P1|COMPLETED|Overall Study||13
34965|NCT02676375|77384|P3|STARTED|Overall Study||14
34966|NCT02676375|77385|P2|STARTED|Overall Study||14
34967|NCT02676375|77386|P1|STARTED|Overall Study||14
34968|NCT02675907|77396|P2|NOT COMPLETED|Study Overall||4
34969|NCT02675907|77397|P1|NOT COMPLETED|Study Overall||3
34970|NCT02675907|77396|P2|COMPLETED|Study Overall||97
34971|NCT02675907|77397|P1|COMPLETED|Study Overall||97
34972|NCT02675907|77396|P2|STARTED|Study Overall||101
34973|NCT02675907|77397|P1|STARTED|Study Overall||100
34974|NCT02675907|77396|P2|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
34975|NCT02675907|77397|P1|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
34976|NCT02675907|77396|P2|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||96
34977|NCT02675907|77397|P1|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||95
34978|NCT02675907|77396|P2|STARTED|Treatment Phase (48 Hours Post-Dose 1)||101
34979|NCT02675907|77397|P1|STARTED|Treatment Phase (48 Hours Post-Dose 1)||100
34980|NCT02675764|77429|P2|NOT COMPLETED|Overall Study||0
34981|NCT02675764|77430|P1|NOT COMPLETED|Overall Study||0
34982|NCT02675764|77429|P2|COMPLETED|Overall Study||6
34983|NCT02675764|77430|P1|COMPLETED|Overall Study||6
34984|NCT02675764|77429|P2|STARTED|Overall Study||6
34985|NCT02675764|77430|P1|STARTED|Overall Study||6
34986|NCT02675751|77442|P1|NOT COMPLETED|Overall Study||16
34987|NCT02675751|77442|P1|COMPLETED|Overall Study||151
34988|NCT02675751|77442|P1|STARTED|Overall Study||167
34989|NCT02675634|77446|P6|NOT COMPLETED|Test Period 3||0
34990|NCT02675634|77447|P5|NOT COMPLETED|Test Period 3||0
34991|NCT02675634|77448|P4|NOT COMPLETED|Test Period 3||0
34992|NCT02675634|77449|P3|NOT COMPLETED|Test Period 3||0
34993|NCT02675634|77450|P2|NOT COMPLETED|Test Period 3||0
34994|NCT02675634|77451|P1|NOT COMPLETED|Test Period 3||0
34995|NCT02675634|77446|P6|COMPLETED|Test Period 3||8
34996|NCT02675634|77447|P5|COMPLETED|Test Period 3||10
34997|NCT02675634|77448|P4|COMPLETED|Test Period 3||8
34998|NCT02675634|77449|P3|COMPLETED|Test Period 3||8
34999|NCT02675634|77450|P2|COMPLETED|Test Period 3||7
35000|NCT02675634|77451|P1|COMPLETED|Test Period 3||9
35001|NCT02675634|77446|P6|STARTED|Test Period 3||8
35002|NCT02675634|77447|P5|STARTED|Test Period 3||10
35003|NCT02675634|77448|P4|STARTED|Test Period 3||8
35004|NCT02675634|77449|P3|STARTED|Test Period 3||8
35005|NCT02675634|77450|P2|STARTED|Test Period 3||7
35006|NCT02675634|77451|P1|STARTED|Test Period 3||9
35007|NCT02675634|77446|P6|NOT COMPLETED|Test Period 2||1
35008|NCT02675634|77447|P5|NOT COMPLETED|Test Period 2||0
35009|NCT02675634|77448|P4|NOT COMPLETED|Test Period 2||0
35010|NCT02675634|77449|P3|NOT COMPLETED|Test Period 2||0
35011|NCT02675634|77450|P2|NOT COMPLETED|Test Period 2||0
35012|NCT02675634|77451|P1|NOT COMPLETED|Test Period 2||1
35013|NCT02675634|77446|P6|COMPLETED|Test Period 2||8
35014|NCT02675634|77447|P5|COMPLETED|Test Period 2||10
35015|NCT02675634|77448|P4|COMPLETED|Test Period 2||8
35016|NCT02675634|77449|P3|COMPLETED|Test Period 2||8
35017|NCT02675634|77450|P2|COMPLETED|Test Period 2||7
35018|NCT02675634|77451|P1|COMPLETED|Test Period 2||9
35019|NCT02675634|77446|P6|STARTED|Test Period 2||9
35020|NCT02675634|77447|P5|STARTED|Test Period 2||10
35021|NCT02675634|77448|P4|STARTED|Test Period 2||8
35022|NCT02675634|77449|P3|STARTED|Test Period 2||8
35023|NCT02675634|77450|P2|STARTED|Test Period 2||7
35024|NCT02675634|77451|P1|STARTED|Test Period 2||10
35025|NCT02675634|77446|P6|NOT COMPLETED|Test Period 1||0
35026|NCT02675634|77447|P5|NOT COMPLETED|Test Period 1||0
35027|NCT02675634|77448|P4|NOT COMPLETED|Test Period 1||1
35028|NCT02675634|77449|P3|NOT COMPLETED|Test Period 1||1
35029|NCT02675634|77450|P2|NOT COMPLETED|Test Period 1||1
35030|NCT02675634|77451|P1|NOT COMPLETED|Test Period 1||0
35031|NCT02675634|77446|P6|COMPLETED|Test Period 1||9
35032|NCT02675634|77447|P5|COMPLETED|Test Period 1||10
35033|NCT02675634|77448|P4|COMPLETED|Test Period 1||8
35034|NCT02675634|77449|P3|COMPLETED|Test Period 1||8
35035|NCT02675634|77450|P2|COMPLETED|Test Period 1||7
35036|NCT02675634|77451|P1|COMPLETED|Test Period 1||10
35037|NCT02675634|77446|P6|STARTED|Test Period 1||9
35038|NCT02675634|77447|P5|STARTED|Test Period 1||10
35039|NCT02675634|77448|P4|STARTED|Test Period 1||9
35040|NCT02675634|77449|P3|STARTED|Test Period 1||9
35041|NCT02675634|77450|P2|STARTED|Test Period 1||8
35042|NCT02675634|77451|P1|STARTED|Test Period 1||10
35043|NCT02675543|77461|P2|NOT COMPLETED|Overall Study||0
35044|NCT02675543|77462|P1|NOT COMPLETED|Overall Study||0
35045|NCT02675543|77461|P2|COMPLETED|Overall Study||20
35046|NCT02675543|77462|P1|COMPLETED|Overall Study||15
35047|NCT02675543|77461|P2|STARTED|Overall Study||20
35048|NCT02675543|77462|P1|STARTED|Overall Study||15
35049|NCT02675517|77468|P1|NOT COMPLETED|Overall Study||159
35050|NCT02675517|77468|P1|COMPLETED|Overall Study||1578
35051|NCT02675517|77468|P1|STARTED|Overall Study||1737
35052|NCT02675426|77480|P3|NOT COMPLETED|Overall Study||18
35053|NCT02675426|77481|P2|NOT COMPLETED|Overall Study||8
35054|NCT02675426|77482|P1|NOT COMPLETED|Overall Study||13
35055|NCT02675426|77480|P3|COMPLETED|Overall Study||201
35056|NCT02675426|77481|P2|COMPLETED|Overall Study||213
35057|NCT02675426|77482|P1|COMPLETED|Overall Study||208
35058|NCT02675426|77480|P3|Treated|Overall Study||219
35059|NCT02675426|77481|P2|Treated|Overall Study||221
35060|NCT02675426|77482|P1|Treated|Overall Study||221
35061|NCT02675426|77480|P3|STARTED|Overall Study||219
35062|NCT02675426|77481|P2|STARTED|Overall Study||221
35063|NCT02675426|77482|P1|STARTED|Overall Study||221
35064|NCT02674854|77526|P3|NOT COMPLETED|Overall Study||14
35065|NCT02674854|77527|P2|NOT COMPLETED|Overall Study||27
35066|NCT02674854|77528|P1|NOT COMPLETED|Overall Study||24
35067|NCT02674854|77526|P3|COMPLETED|Overall Study||236
35068|NCT02674854|77527|P2|COMPLETED|Overall Study||228
35069|NCT02674854|77528|P1|COMPLETED|Overall Study||221
35070|NCT02674854|77526|P3|STARTED|Overall Study||250
35071|NCT02674854|77527|P2|STARTED|Overall Study||255
35072|NCT02674854|77528|P1|STARTED|Overall Study||245
35073|NCT02674568|77536|P1|NOT COMPLETED|Overall Study||339
35074|NCT02674568|77536|P1|COMPLETED|Overall Study||0
35075|NCT02674568|77536|P1|DLL3 Positive|Overall Study||287
35076|NCT02674568|77536|P1|Delta-like Protein 3 (DLL3) High|Overall Study||238
35077|NCT02674568|77536|P1|STARTED|Overall Study|Enrolled and dosed.|339
35078|NCT02674477|77561|P2|NOT COMPLETED|Overall Study||2
35079|NCT02674477|77562|P1|NOT COMPLETED|Overall Study||8
35080|NCT02674477|77561|P2|COMPLETED|Overall Study||45
35081|NCT02674477|77562|P1|COMPLETED|Overall Study||40
35082|NCT02674477|77561|P2|STARTED|Overall Study||47
35083|NCT02674477|77562|P1|STARTED|Overall Study||48
35084|NCT02674412|77572|P2|NOT COMPLETED|Overall Study||0
35085|NCT02674412|77573|P1|NOT COMPLETED|Overall Study||0
35086|NCT02674412|77572|P2|COMPLETED|Overall Study||5
35087|NCT02674412|77573|P1|COMPLETED|Overall Study||5
35088|NCT02674412|77572|P2|STARTED|Overall Study||5
35089|NCT02674412|77573|P1|STARTED|Overall Study||5
35090|NCT02674334|77585|P2|NOT COMPLETED|Overall Study||3
35091|NCT02674334|77586|P1|NOT COMPLETED|Overall Study||7
35092|NCT02674334|77585|P2|COMPLETED|Overall Study||40
35093|NCT02674334|77586|P1|COMPLETED|Overall Study||40
35094|NCT02674334|77585|P2|STARTED|Overall Study||43
35095|NCT02674334|77586|P1|STARTED|Overall Study||47
35096|NCT02674204|77596|P2|NOT COMPLETED|Overall Study||0
35097|NCT02674204|77597|P1|NOT COMPLETED|Overall Study||1
35098|NCT02674204|77596|P2|COMPLETED|Overall Study||1
35099|NCT02674204|77597|P1|COMPLETED|Overall Study||0
35100|NCT02674204|77596|P2|STARTED|Overall Study||1
35101|NCT02674204|77597|P1|STARTED|Overall Study||1
35102|NCT02673944|77631|P1|NOT COMPLETED|Overall Study||0
35103|NCT02673944|77631|P1|COMPLETED|Overall Study||10
35104|NCT02673944|77631|P1|STARTED|Overall Study||10
35105|NCT02673619|77640|P4|NOT COMPLETED|Overall Study||0
35106|NCT02673619|77641|P3|NOT COMPLETED|Overall Study||3
35107|NCT02673619|77642|P2|NOT COMPLETED|Overall Study||1
35108|NCT02673619|77643|P1|NOT COMPLETED|Overall Study||2
35109|NCT02673619|77640|P4|COMPLETED|Overall Study||7
35110|NCT02673619|77641|P3|COMPLETED|Overall Study||23
35111|NCT02673619|77642|P2|COMPLETED|Overall Study||4
35112|NCT02673619|77643|P1|COMPLETED|Overall Study||18
35113|NCT02673619|77640|P4|STARTED|Overall Study||7
35114|NCT02673619|77641|P3|STARTED|Overall Study||26
35115|NCT02673619|77642|P2|STARTED|Overall Study||5
35116|NCT02673619|77643|P1|STARTED|Overall Study||20
35117|NCT02673541|77735|P2|NOT COMPLETED|Overall Study||0
35118|NCT02673541|77736|P1|NOT COMPLETED|Overall Study||0
35119|NCT02673541|77735|P2|COMPLETED|Overall Study||2
35120|NCT02673541|77736|P1|COMPLETED|Overall Study||3
35121|NCT02673541|77735|P2|STARTED|Overall Study||2
35122|NCT02673541|77736|P1|STARTED|Overall Study||3
35123|NCT02673489|77754|P2|NOT COMPLETED|Follow Up Period||2
35124|NCT02673489|77755|P1|NOT COMPLETED|Follow Up Period||0
35125|NCT02673489|77754|P2|COMPLETED|Follow Up Period||21
35126|NCT02673489|77755|P1|COMPLETED|Follow Up Period||50
35127|NCT02673489|77754|P2|STARTED|Follow Up Period||23
35128|NCT02673489|77755|P1|STARTED|Follow Up Period||50
35129|NCT02673489|77754|P2|NOT COMPLETED|Treatment Period||3
35130|NCT02673489|77755|P1|NOT COMPLETED|Treatment Period||5
35131|NCT02673489|77754|P2|COMPLETED|Treatment Period||21
35132|NCT02673489|77755|P1|COMPLETED|Treatment Period||49
35133|NCT02673489|77754|P2|STARTED|Treatment Period||24
35134|NCT02673489|77755|P1|STARTED|Treatment Period||54
35135|NCT02673372|77770|P2|NOT COMPLETED|Overall Study||0
35136|NCT02673372|77771|P1|NOT COMPLETED|Overall Study||0
35137|NCT02673372|77770|P2|COMPLETED|Overall Study||30
35138|NCT02673372|77771|P1|COMPLETED|Overall Study||30
35139|NCT02673372|77770|P2|STARTED|Overall Study||30
35140|NCT02673372|77771|P1|STARTED|Overall Study||30
35141|NCT02673138|77777|P1|NOT COMPLETED|Overall Study||0
35142|NCT02673138|77777|P1|COMPLETED|Overall Study||10
35143|NCT02673138|77777|P1|STARTED|Overall Study||10
35144|NCT02672852|77791|P7|NOT COMPLETED|Part B||12
35145|NCT02672852|77792|P6|NOT COMPLETED|Part B||11
35146|NCT02672852|77793|P5|NOT COMPLETED|Part B||16
35147|NCT02672852|77794|P4|NOT COMPLETED|Part B||0
35148|NCT02672852|77795|P3|NOT COMPLETED|Part B||0
35149|NCT02672852|77796|P2|NOT COMPLETED|Part B||0
35150|NCT02672852|77797|P1|NOT COMPLETED|Part B||0
35151|NCT02672852|77791|P7|COMPLETED|Part B||51
35152|NCT02672852|77792|P6|COMPLETED|Part B||100
35153|NCT02672852|77793|P5|COMPLETED|Part B||209
35154|NCT02672852|77794|P4|COMPLETED|Part B||0
35155|NCT02672852|77795|P3|COMPLETED|Part B||0
35156|NCT02672852|77796|P2|COMPLETED|Part B||0
35157|NCT02672852|77797|P1|COMPLETED|Part B||0
35158|NCT02672852|77791|P7|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|63
35159|NCT02672852|77792|P6|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|111
35160|NCT02672852|77793|P5|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|225
35161|NCT02672852|77794|P4|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|0
35162|NCT02672852|77795|P3|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|0
35163|NCT02672852|77796|P2|STARTED|Part B||0
35164|NCT02672852|77797|P1|STARTED|Part B||0
35165|NCT02672852|77791|P7|NOT COMPLETED|Part A2||0
35166|NCT02672852|77792|P6|NOT COMPLETED|Part A2||0
35167|NCT02672852|77793|P5|NOT COMPLETED|Part A2||0
35168|NCT02672852|77794|P4|NOT COMPLETED|Part A2||4
35169|NCT02672852|77795|P3|NOT COMPLETED|Part A2||10
35170|NCT02672852|77796|P2|NOT COMPLETED|Part A2||0
35171|NCT02672852|77797|P1|NOT COMPLETED|Part A2||0
35172|NCT02672852|77791|P7|COMPLETED|Part A2||0
35173|NCT02672852|77792|P6|COMPLETED|Part A2||0
35174|NCT02672852|77793|P5|COMPLETED|Part A2||0
35175|NCT02672852|77794|P4|COMPLETED|Part A2||399
35176|NCT02672852|77795|P3|COMPLETED|Part A2||83
35177|NCT02672852|77796|P2|COMPLETED|Part A2||0
35178|NCT02672852|77797|P1|COMPLETED|Part A2||0
35179|NCT02672852|77791|P7|STARTED|Part A2||0
35180|NCT02672852|77792|P6|STARTED|Part A2||0
35181|NCT02672852|77793|P5|STARTED|Part A2||0
35182|NCT02672852|77794|P4|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|403
35183|NCT02672852|77795|P3|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|93
35184|NCT02672852|77796|P2|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|0
35185|NCT02672852|77797|P1|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|0
35186|NCT02672852|77791|P7|NOT COMPLETED|Part A1||0
35187|NCT02672852|77792|P6|NOT COMPLETED|Part A1||0
35188|NCT02672852|77793|P5|NOT COMPLETED|Part A1||0
35189|NCT02672852|77794|P4|NOT COMPLETED|Part A1||0
35190|NCT02672852|77795|P3|NOT COMPLETED|Part A1||0
35191|NCT02672852|77796|P2|NOT COMPLETED|Part A1||4
35192|NCT02672852|77797|P1|NOT COMPLETED|Part A1||3
35193|NCT02672852|77791|P7|COMPLETED|Part A1||0
35194|NCT02672852|77792|P6|COMPLETED|Part A1||0
35195|NCT02672852|77793|P5|COMPLETED|Part A1||0
35196|NCT02672852|77794|P4|COMPLETED|Part A1||0
35197|NCT02672852|77795|P3|COMPLETED|Part A1||0
35198|NCT02672852|77796|P2|COMPLETED|Part A1||403
35199|NCT02672852|77797|P1|COMPLETED|Part A1||97
35200|NCT02672852|77791|P7|STARTED|Part A1||0
35201|NCT02672852|77792|P6|STARTED|Part A1||0
35202|NCT02672852|77793|P5|STARTED|Part A1||0
35203|NCT02672852|77794|P4|STARTED|Part A1||0
35204|NCT02672852|77795|P3|STARTED|Part A1||0
35205|NCT02672852|77796|P2|STARTED|Part A1||407
35206|NCT02672852|77797|P1|STARTED|Part A1||100
35207|NCT02672553|77828|P2|NOT COMPLETED|Overall Study||8
35208|NCT02672553|77829|P1|NOT COMPLETED|Overall Study||12
35209|NCT02672553|77828|P2|COMPLETED|Overall Study||41
35210|NCT02672553|77829|P1|COMPLETED|Overall Study||39
35211|NCT02672553|77828|P2|As Intended (AI) Randomized Arm/Group|Overall Study||48
35212|NCT02672553|77829|P1|As Intended (AI) Randomized Arm/Group|Overall Study||46
35213|NCT02672553|77828|P2|As Treated (AT) Randomized Arm/Group|Overall Study||51
35214|NCT02672553|77829|P1|As Treated (AT) Randomized Arm/Group|Overall Study||46
35215|NCT02672553|77828|P2|Intent To Treated (ITT) Randomized Arm|Overall Study|One (1) subject randomized to Control arm/group withdrew prior to study procedure|48
35216|NCT02672553|77829|P1|Intent To Treated (ITT) Randomized Arm|Overall Study|Two (2) subjects randomized to Edwards INTUITY were intraoperative screen failures|49
35217|NCT02672553|77828|P2|STARTED|Overall Study||49
35218|NCT02672553|77829|P1|STARTED|Overall Study||51
35219|NCT02672514|77891|P2|NOT COMPLETED|Overall Study||0
35220|NCT02672514|77892|P1|NOT COMPLETED|Overall Study||0
35221|NCT02672514|77891|P2|COMPLETED|Overall Study||51
35222|NCT02672514|77892|P1|COMPLETED|Overall Study||53
35223|NCT02672514|77891|P2|STARTED|Overall Study||51
35224|NCT02672514|77892|P1|STARTED|Overall Study||53
35225|NCT02672423|77901|P10|NOT COMPLETED|Period 3||0
35226|NCT02672423|77902|P9|NOT COMPLETED|Period 3||0
35227|NCT02672423|77903|P8|NOT COMPLETED|Period 3||1
35228|NCT02672423|77904|P7|NOT COMPLETED|Period 3||0
35229|NCT02672423|77905|P6|NOT COMPLETED|Period 3||1
35230|NCT02672423|77906|P5|NOT COMPLETED|Period 3||0
35231|NCT02672423|77907|P4|NOT COMPLETED|Period 3||0
35232|NCT02672423|77908|P3|NOT COMPLETED|Period 3||0
35233|NCT02672423|77909|P2|NOT COMPLETED|Period 3||0
35234|NCT02672423|77910|P1|NOT COMPLETED|Period 3||0
35235|NCT02672423|77901|P10|COMPLETED|Period 3||0
35236|NCT02672423|77902|P9|COMPLETED|Period 3||0
35237|NCT02672423|77903|P8|COMPLETED|Period 3||14
35238|NCT02672423|77904|P7|COMPLETED|Period 3||15
35239|NCT02672423|77905|P6|COMPLETED|Period 3||14
35240|NCT02672423|77906|P5|COMPLETED|Period 3||14
35241|NCT02672423|77907|P4|COMPLETED|Period 3||15
35242|NCT02672423|77908|P3|COMPLETED|Period 3||13
35243|NCT02672423|77909|P2|COMPLETED|Period 3||0
35244|NCT02672423|77910|P1|COMPLETED|Period 3||0
35245|NCT02672423|77901|P10|STARTED|Period 3|Part C was a 2-period study design.|0
35246|NCT02672423|77902|P9|STARTED|Period 3|Part C was a 2-period study design.|0
35247|NCT02672423|77903|P8|STARTED|Period 3||15
35248|NCT02672423|77904|P7|STARTED|Period 3||15
35249|NCT02672423|77905|P6|STARTED|Period 3||15
35250|NCT02672423|77906|P5|STARTED|Period 3||14
35251|NCT02672423|77907|P4|STARTED|Period 3||15
35252|NCT02672423|77908|P3|STARTED|Period 3||13
35253|NCT02672423|77909|P2|STARTED|Period 3|Part A was a 2-period study design.|0
35254|NCT02672423|77910|P1|STARTED|Period 3|Part A was a 2-period study design.|0
35255|NCT02672423|77901|P10|NOT COMPLETED|Washout 2||0
35256|NCT02672423|77902|P9|NOT COMPLETED|Washout 2||0
35257|NCT02672423|77903|P8|NOT COMPLETED|Washout 2||0
35258|NCT02672423|77904|P7|NOT COMPLETED|Washout 2||0
35259|NCT02672423|77905|P6|NOT COMPLETED|Washout 2||0
35260|NCT02672423|77906|P5|NOT COMPLETED|Washout 2||0
35261|NCT02672423|77907|P4|NOT COMPLETED|Washout 2||0
35262|NCT02672423|77908|P3|NOT COMPLETED|Washout 2||0
35263|NCT02672423|77909|P2|NOT COMPLETED|Washout 2||0
35264|NCT02672423|77910|P1|NOT COMPLETED|Washout 2||0
35265|NCT02672423|77901|P10|COMPLETED|Washout 2||12
35266|NCT02672423|77902|P9|COMPLETED|Washout 2||12
35267|NCT02672423|77903|P8|COMPLETED|Washout 2||15
35268|NCT02672423|77904|P7|COMPLETED|Washout 2||15
35269|NCT02672423|77905|P6|COMPLETED|Washout 2||15
35270|NCT02672423|77906|P5|COMPLETED|Washout 2||14
35271|NCT02672423|77907|P4|COMPLETED|Washout 2||15
35272|NCT02672423|77908|P3|COMPLETED|Washout 2||13
35273|NCT02672423|77909|P2|COMPLETED|Washout 2||7
35274|NCT02672423|77910|P1|COMPLETED|Washout 2||7
35275|NCT02672423|77901|P10|STARTED|Washout 2||12
35276|NCT02672423|77902|P9|STARTED|Washout 2||12
35277|NCT02672423|77903|P8|STARTED|Washout 2||15
35278|NCT02672423|77904|P7|STARTED|Washout 2||15
35279|NCT02672423|77905|P6|STARTED|Washout 2||15
35280|NCT02672423|77906|P5|STARTED|Washout 2||14
35281|NCT02672423|77907|P4|STARTED|Washout 2||15
35282|NCT02672423|77908|P3|STARTED|Washout 2||13
35283|NCT02672423|77909|P2|STARTED|Washout 2||7
35284|NCT02672423|77910|P1|STARTED|Washout 2||7
35285|NCT02672423|77901|P10|NOT COMPLETED|Period 2||0
35286|NCT02672423|77902|P9|NOT COMPLETED|Period 2||0
35287|NCT02672423|77903|P8|NOT COMPLETED|Period 2||0
35288|NCT02672423|77904|P7|NOT COMPLETED|Period 2||0
35289|NCT02672423|77905|P6|NOT COMPLETED|Period 2||0
35290|NCT02672423|77906|P5|NOT COMPLETED|Period 2||0
35291|NCT02672423|77907|P4|NOT COMPLETED|Period 2||0
35292|NCT02672423|77908|P3|NOT COMPLETED|Period 2||1
35293|NCT02672423|77909|P2|NOT COMPLETED|Period 2||0
35294|NCT02672423|77910|P1|NOT COMPLETED|Period 2||0
35295|NCT02672423|77901|P10|COMPLETED|Period 2||12
35296|NCT02672423|77902|P9|COMPLETED|Period 2||12
35297|NCT02672423|77903|P8|COMPLETED|Period 2||15
35298|NCT02672423|77904|P7|COMPLETED|Period 2||15
35299|NCT02672423|77905|P6|COMPLETED|Period 2||15
35300|NCT02672423|77906|P5|COMPLETED|Period 2||14
35301|NCT02672423|77907|P4|COMPLETED|Period 2||15
35302|NCT02672423|77908|P3|COMPLETED|Period 2||13
35303|NCT02672423|77909|P2|COMPLETED|Period 2||7
35304|NCT02672423|77910|P1|COMPLETED|Period 2||7
35305|NCT02672423|77901|P10|STARTED|Period 2||12
35306|NCT02672423|77902|P9|STARTED|Period 2||12
35307|NCT02672423|77903|P8|STARTED|Period 2||15
35308|NCT02672423|77904|P7|STARTED|Period 2||15
35309|NCT02672423|77905|P6|STARTED|Period 2||15
35310|NCT02672423|77906|P5|STARTED|Period 2||14
35311|NCT02672423|77907|P4|STARTED|Period 2||15
35312|NCT02672423|77908|P3|STARTED|Period 2||14
35313|NCT02672423|77909|P2|STARTED|Period 2||7
35314|NCT02672423|77910|P1|STARTED|Period 2||7
35315|NCT02672423|77901|P10|NOT COMPLETED|Washout 1||0
35316|NCT02672423|77902|P9|NOT COMPLETED|Washout 1||0
35317|NCT02672423|77903|P8|NOT COMPLETED|Washout 1||0
35318|NCT02672423|77904|P7|NOT COMPLETED|Washout 1||0
35319|NCT02672423|77905|P6|NOT COMPLETED|Washout 1||0
35320|NCT02672423|77906|P5|NOT COMPLETED|Washout 1||0
35321|NCT02672423|77907|P4|NOT COMPLETED|Washout 1||0
35322|NCT02672423|77908|P3|NOT COMPLETED|Washout 1||0
35323|NCT02672423|77909|P2|NOT COMPLETED|Washout 1||0
35324|NCT02672423|77910|P1|NOT COMPLETED|Washout 1||0
35325|NCT02672423|77901|P10|COMPLETED|Washout 1||12
35326|NCT02672423|77902|P9|COMPLETED|Washout 1||12
35327|NCT02672423|77903|P8|COMPLETED|Washout 1||15
35328|NCT02672423|77904|P7|COMPLETED|Washout 1||15
35329|NCT02672423|77905|P6|COMPLETED|Washout 1||15
35330|NCT02672423|77906|P5|COMPLETED|Washout 1||14
35331|NCT02672423|77907|P4|COMPLETED|Washout 1||15
35332|NCT02672423|77908|P3|COMPLETED|Washout 1||14
35333|NCT02672423|77909|P2|COMPLETED|Washout 1||7
35334|NCT02672423|77910|P1|COMPLETED|Washout 1||7
35335|NCT02672423|77901|P10|STARTED|Washout 1||12
35336|NCT02672423|77902|P9|STARTED|Washout 1||12
35337|NCT02672423|77903|P8|STARTED|Washout 1||15
35338|NCT02672423|77904|P7|STARTED|Washout 1||15
35339|NCT02672423|77905|P6|STARTED|Washout 1||15
35340|NCT02672423|77906|P5|STARTED|Washout 1||14
35341|NCT02672423|77907|P4|STARTED|Washout 1||15
35342|NCT02672423|77908|P3|STARTED|Washout 1||14
35343|NCT02672423|77909|P2|STARTED|Washout 1||7
35344|NCT02672423|77910|P1|STARTED|Washout 1||7
35345|NCT02672423|77901|P10|NOT COMPLETED|Period 1||0
35346|NCT02672423|77902|P9|NOT COMPLETED|Period 1||0
35347|NCT02672423|77903|P8|NOT COMPLETED|Period 1||0
35348|NCT02672423|77904|P7|NOT COMPLETED|Period 1||0
35349|NCT02672423|77905|P6|NOT COMPLETED|Period 1||0
35350|NCT02672423|77906|P5|NOT COMPLETED|Period 1||1
35351|NCT02672423|77907|P4|NOT COMPLETED|Period 1||0
35352|NCT02672423|77908|P3|NOT COMPLETED|Period 1||0
35353|NCT02672423|77909|P2|NOT COMPLETED|Period 1||0
35354|NCT02672423|77910|P1|NOT COMPLETED|Period 1||0
35355|NCT02672423|77901|P10|COMPLETED|Period 1||12
35356|NCT02672423|77902|P9|COMPLETED|Period 1||12
35357|NCT02672423|77903|P8|COMPLETED|Period 1||15
35358|NCT02672423|77904|P7|COMPLETED|Period 1||15
35359|NCT02672423|77905|P6|COMPLETED|Period 1||15
35360|NCT02672423|77906|P5|COMPLETED|Period 1||14
35361|NCT02672423|77907|P4|COMPLETED|Period 1||15
35362|NCT02672423|77908|P3|COMPLETED|Period 1||14
35363|NCT02672423|77909|P2|COMPLETED|Period 1||7
35364|NCT02672423|77910|P1|COMPLETED|Period 1||7
35365|NCT02672423|77901|P10|Received at Least One Dose of Study Drug|Period 1||12
35366|NCT02672423|77902|P9|Received at Least One Dose of Study Drug|Period 1||12
35367|NCT02672423|77903|P8|Received at Least One Dose of Study Drug|Period 1||15
35368|NCT02672423|77904|P7|Received at Least One Dose of Study Drug|Period 1||15
35369|NCT02672423|77905|P6|Received at Least One Dose of Study Drug|Period 1||15
35370|NCT02672423|77906|P5|Received at Least One Dose of Study Drug|Period 1||15
35371|NCT02672423|77907|P4|Received at Least One Dose of Study Drug|Period 1||15
35372|NCT02672423|77908|P3|Received at Least One Dose of Study Drug|Period 1||14
35373|NCT02672423|77909|P2|Received at Least One Dose of Study Drug|Period 1||7
35374|NCT02672423|77910|P1|Received at Least One Dose of Study Drug|Period 1||7
35375|NCT02672423|77901|P10|STARTED|Period 1||12
35376|NCT02672423|77902|P9|STARTED|Period 1||12
35377|NCT02672423|77903|P8|STARTED|Period 1||15
35378|NCT02672423|77904|P7|STARTED|Period 1||15
35379|NCT02672423|77905|P6|STARTED|Period 1||15
35380|NCT02672423|77906|P5|STARTED|Period 1||15
35381|NCT02672423|77907|P4|STARTED|Period 1||15
35382|NCT02672423|77908|P3|STARTED|Period 1||14
35383|NCT02672423|77909|P2|STARTED|Period 1||7
35384|NCT02672423|77910|P1|STARTED|Period 1||7
35385|NCT02672176|77935|P2|NOT COMPLETED|Overall Study||26
35386|NCT02672176|77936|P1|NOT COMPLETED|Overall Study||6
35387|NCT02672176|77935|P2|COMPLETED|Overall Study||132
35388|NCT02672176|77936|P1|COMPLETED|Overall Study||155
35389|NCT02672176|77935|P2|STARTED|Overall Study||158
35390|NCT02672176|77936|P1|STARTED|Overall Study||161
35391|NCT02672111|77972|P2|NOT COMPLETED|Overall Study||12
35392|NCT02672111|77973|P1|NOT COMPLETED|Overall Study||58
35393|NCT02672111|77972|P2|COMPLETED|Overall Study||25
35394|NCT02672111|77973|P1|COMPLETED|Overall Study||132
35395|NCT02672111|77972|P2|Completed Treatment|Overall Study||29
35396|NCT02672111|77973|P1|Completed Treatment|Overall Study||138
35397|NCT02672111|77972|P2|STARTED|Overall Study||37
35398|NCT02672111|77973|P1|STARTED|Overall Study||190
35399|NCT02671760|77995|P3|NOT COMPLETED|Overall Study||0
35400|NCT02671760|77996|P2|NOT COMPLETED|Overall Study||1
35401|NCT02671760|77997|P1|NOT COMPLETED|Overall Study||0
35402|NCT02671760|77995|P3|COMPLETED|Overall Study||13
35403|NCT02671760|77996|P2|COMPLETED|Overall Study|1 Subject could not be contacted for f/u phone call. Data included in safety and efficacy analyses.|12
35404|NCT02671760|77997|P1|COMPLETED|Overall Study||13
35405|NCT02671760|77995|P3|STARTED|Overall Study||13
35406|NCT02671760|77996|P2|STARTED|Overall Study||13
35407|NCT02671760|77997|P1|STARTED|Overall Study||13
35408|NCT02671500|78023|P1|NOT COMPLETED|Overall Study||14
35409|NCT02671500|78023|P1|COMPLETED|Overall Study||361
35410|NCT02671500|78023|P1|STARTED|Overall Study||375
35411|NCT02671461|78038|P3|NOT COMPLETED|Follow-up||1
35412|NCT02671461|78039|P2|NOT COMPLETED|Follow-up||1
35413|NCT02671461|78040|P1|NOT COMPLETED|Follow-up||1
35414|NCT02671461|78038|P3|COMPLETED|Follow-up||6
35415|NCT02671461|78039|P2|COMPLETED|Follow-up||4
35416|NCT02671461|78040|P1|COMPLETED|Follow-up||1
35417|NCT02671461|78038|P3|STARTED|Follow-up||7
35418|NCT02671461|78039|P2|STARTED|Follow-up||5
35419|NCT02671461|78040|P1|STARTED|Follow-up||2
35420|NCT02671461|78038|P3|NOT COMPLETED|Treatment||5
35421|NCT02671461|78039|P2|NOT COMPLETED|Treatment||3
35422|NCT02671461|78040|P1|NOT COMPLETED|Treatment||2
35423|NCT02671461|78038|P3|COMPLETED|Treatment||2
35424|NCT02671461|78039|P2|COMPLETED|Treatment||2
35425|NCT02671461|78040|P1|COMPLETED|Treatment||1
35426|NCT02671461|78038|P3|STARTED|Treatment||7
35427|NCT02671461|78039|P2|STARTED|Treatment||5
35428|NCT02671461|78040|P1|STARTED|Treatment||3
35429|NCT02671266|78065|P2|NOT COMPLETED|Overall Study||1
35430|NCT02671266|78066|P1|NOT COMPLETED|Overall Study||1
35431|NCT02671266|78065|P2|COMPLETED|Overall Study||20
35432|NCT02671266|78066|P1|COMPLETED|Overall Study||19
35433|NCT02671266|78065|P2|Healthy Participants|Overall Study||8
35434|NCT02671266|78066|P1|Healthy Participants|Overall Study||8
35435|NCT02671266|78065|P2|OCD Participants|Overall Study||3
35436|NCT02671266|78066|P1|OCD Participants|Overall Study||2
35437|NCT02671266|78065|P2|BDD Participants|Overall Study||9
35438|NCT02671266|78066|P1|BDD Participants|Overall Study||9
35439|NCT02671266|78065|P2|STARTED|Overall Study||21
35440|NCT02671266|78066|P1|STARTED|Overall Study||20
35441|NCT02671136|78080|P2|NOT COMPLETED|Overall Study||0
35442|NCT02671136|78081|P1|NOT COMPLETED|Overall Study||0
35443|NCT02671136|78080|P2|COMPLETED|Overall Study||0
35444|NCT02671136|78081|P1|COMPLETED|Overall Study||3
35445|NCT02671136|78080|P2|STARTED|Overall Study||0
35446|NCT02671136|78081|P1|STARTED|Overall Study||3
35447|NCT02670928|78089|P2|NOT COMPLETED|Overall Study||1
35448|NCT02670928|78090|P1|NOT COMPLETED|Overall Study||10
35449|NCT02670928|78089|P2|COMPLETED|Overall Study||29
35450|NCT02670928|78090|P1|COMPLETED|Overall Study||90
35451|NCT02670928|78089|P2|STARTED|Overall Study||30
35452|NCT02670928|78090|P1|STARTED|Overall Study||100
35453|NCT02670915|78117|P3|NOT COMPLETED|Overall Study||5
35454|NCT02670915|78118|P2|NOT COMPLETED|Overall Study||8
35455|NCT02670915|78119|P1|NOT COMPLETED|Overall Study||4
35456|NCT02670915|78117|P3|COMPLETED|Overall Study||253
35457|NCT02670915|78118|P2|COMPLETED|Overall Study||251
35458|NCT02670915|78119|P1|COMPLETED|Overall Study||256
35459|NCT02670915|78117|P3|STARTED|Overall Study||258
35460|NCT02670915|78118|P2|STARTED|Overall Study||259
35461|NCT02670915|78119|P1|STARTED|Overall Study||260
35462|NCT02670811|78366|P2|NOT COMPLETED|Overall Study||0
35463|NCT02670811|78367|P1|NOT COMPLETED|Overall Study||1
35464|NCT02670811|78366|P2|COMPLETED|Overall Study||18
35465|NCT02670811|78367|P1|COMPLETED|Overall Study||17
35466|NCT02670811|78366|P2|STARTED|Overall Study||18
35467|NCT02670811|78367|P1|STARTED|Overall Study||18
35468|NCT02670629|78385|P2|NOT COMPLETED|Overall Study||0
35469|NCT02670629|78386|P1|NOT COMPLETED|Overall Study||0
35470|NCT02670629|78385|P2|COMPLETED|Overall Study||29
35471|NCT02670629|78386|P1|COMPLETED|Overall Study||29
35472|NCT02670629|78385|P2|STARTED|Overall Study||29
35473|NCT02670629|78386|P1|STARTED|Overall Study||29
35474|NCT02670551|78403|P3|NOT COMPLETED|Overall Study||31
35475|NCT02670551|78404|P2|NOT COMPLETED|Overall Study||26
35476|NCT02670551|78405|P1|NOT COMPLETED|Overall Study||28
35477|NCT02670551|78403|P3|COMPLETED|Overall Study||134
35478|NCT02670551|78404|P2|COMPLETED|Overall Study||134
35479|NCT02670551|78405|P1|COMPLETED|Overall Study||135
35480|NCT02670551|78403|P3|Received Treatment (Safety Population)|Overall Study||165
35481|NCT02670551|78404|P2|Received Treatment (Safety Population)|Overall Study||157
35482|NCT02670551|78405|P1|Received Treatment (Safety Population)|Overall Study||158
35483|NCT02670551|78403|P3|STARTED|Overall Study||165
35484|NCT02670551|78404|P2|STARTED|Overall Study||160
35485|NCT02670551|78405|P1|STARTED|Overall Study||163
35486|NCT02670538|78419|P3|NOT COMPLETED|Overall Study||30
35487|NCT02670538|78420|P2|NOT COMPLETED|Overall Study||32
35488|NCT02670538|78421|P1|NOT COMPLETED|Overall Study||32
35489|NCT02670538|78419|P3|COMPLETED|Overall Study||128
35490|NCT02670538|78420|P2|COMPLETED|Overall Study||136
35491|NCT02670538|78421|P1|COMPLETED|Overall Study||135
35492|NCT02670538|78419|P3|Intent-to-Treat Population|Overall Study||153
35493|NCT02670538|78420|P2|Intent-to-Treat Population|Overall Study||162
35494|NCT02670538|78421|P1|Intent-to-Treat Population|Overall Study||163
35495|NCT02670538|78419|P3|Safety Population : Received Study Drug|Overall Study||158
35496|NCT02670538|78420|P2|Safety Population : Received Study Drug|Overall Study||167
35497|NCT02670538|78421|P1|Safety Population : Received Study Drug|Overall Study||165
35498|NCT02670538|78419|P3|STARTED|Overall Study||158
35499|NCT02670538|78420|P2|STARTED|Overall Study||168
35500|NCT02670538|78421|P1|STARTED|Overall Study||167
35501|NCT02670473|78432|P1|NOT COMPLETED|Overall Study||1
35502|NCT02670473|78432|P1|COMPLETED|Overall Study||34
35503|NCT02670473|78432|P1|STARTED|Overall Study||35
35504|NCT02670343|78485|P1|NOT COMPLETED|Overall Study||0
35505|NCT02670343|78485|P1|COMPLETED|Overall Study||8
35506|NCT02670343|78485|P1|STARTED|Overall Study||8
35507|NCT02670330|78491|P2|NOT COMPLETED|Overall Study||77
35508|NCT02670330|78492|P1|NOT COMPLETED|Overall Study||75
35509|NCT02670330|78491|P2|COMPLETED|Overall Study||0
35510|NCT02670330|78492|P1|COMPLETED|Overall Study||0
35511|NCT02670330|78491|P2|Received At Least 1 Dose Of Study Drug|Overall Study||77
35512|NCT02670330|78492|P1|Received At Least 1 Dose Of Study Drug|Overall Study||75
35513|NCT02670330|78491|P2|STARTED|Overall Study||77
35514|NCT02670330|78492|P1|STARTED|Overall Study||75
35515|NCT02669940|78504|P2|NOT COMPLETED|Overall Study||3
35516|NCT02669940|78505|P1|NOT COMPLETED|Overall Study||1
35517|NCT02669940|78504|P2|COMPLETED|Overall Study||92
35518|NCT02669940|78505|P1|COMPLETED|Overall Study||62
35519|NCT02669940|78504|P2|STARTED|Overall Study||95
35520|NCT02669940|78505|P1|STARTED|Overall Study||63
35521|NCT02669914|78561|P3|NOT COMPLETED|Overall Study||0
35522|NCT02669914|78562|P2|NOT COMPLETED|Overall Study||0
35523|NCT02669914|78563|P1|NOT COMPLETED|Overall Study||0
35524|NCT02669914|78561|P3|COMPLETED|Overall Study||0
35525|NCT02669914|78562|P2|COMPLETED|Overall Study||0
35526|NCT02669914|78563|P1|COMPLETED|Overall Study||4
35527|NCT02669914|78561|P3|STARTED|Overall Study||0
35528|NCT02669914|78562|P2|STARTED|Overall Study||0
35529|NCT02669914|78563|P1|STARTED|Overall Study||4
35530|NCT02669862|78607|P3|NOT COMPLETED|Overall Study||5
35531|NCT02669862|78608|P2|NOT COMPLETED|Overall Study||5
35532|NCT02669862|78609|P1|NOT COMPLETED|Overall Study||2
35533|NCT02669862|78607|P3|COMPLETED|Overall Study||26
35534|NCT02669862|78608|P2|COMPLETED|Overall Study||29
35535|NCT02669862|78609|P1|COMPLETED|Overall Study||31
35536|NCT02669862|78607|P3|STARTED|Overall Study||31
35537|NCT02669862|78608|P2|STARTED|Overall Study||34
35538|NCT02669862|78609|P1|STARTED|Overall Study||33
35539|NCT02669784|78624|P2|NOT COMPLETED|Overall Study||0
35540|NCT02669784|78625|P1|NOT COMPLETED|Overall Study||0
35541|NCT02669784|78624|P2|COMPLETED|Overall Study||16
35542|NCT02669784|78625|P1|COMPLETED|Overall Study||18
35543|NCT02669784|78624|P2|STARTED|Overall Study||16
35544|NCT02669784|78625|P1|STARTED|Overall Study||18
35545|NCT02669758|78645|P1|NOT COMPLETED|Overall Study||94
35546|NCT02669758|78645|P1|COMPLETED|Overall Study||183
35547|NCT02669758|78645|P1|STARTED|Overall Study||277
35548|NCT02669667|78656|P7|NOT COMPLETED|Overall Study||0
35549|NCT02669667|78657|P6|NOT COMPLETED|Overall Study||1
35550|NCT02669667|78658|P5|NOT COMPLETED|Overall Study||0
35551|NCT02669667|78659|P4|NOT COMPLETED|Overall Study||0
35552|NCT02669667|78660|P3|NOT COMPLETED|Overall Study||0
35553|NCT02669667|78661|P2|NOT COMPLETED|Overall Study||0
35554|NCT02669667|78662|P1|NOT COMPLETED|Overall Study||0
35555|NCT02669667|78656|P7|COMPLETED|Overall Study||6
35556|NCT02669667|78657|P6|COMPLETED|Overall Study||5
35557|NCT02669667|78658|P5|COMPLETED|Overall Study||6
35558|NCT02669667|78659|P4|COMPLETED|Overall Study||6
35559|NCT02669667|78660|P3|COMPLETED|Overall Study||4
35560|NCT02669667|78661|P2|COMPLETED|Overall Study||4
35561|NCT02669667|78662|P1|COMPLETED|Overall Study||12
35562|NCT02669667|78656|P7|STARTED|Overall Study||6
35563|NCT02669667|78657|P6|STARTED|Overall Study||6
35564|NCT02669667|78658|P5|STARTED|Overall Study||6
35565|NCT02669667|78659|P4|STARTED|Overall Study||6
35566|NCT02669667|78660|P3|STARTED|Overall Study||4
35567|NCT02669667|78661|P2|STARTED|Overall Study||4
35568|NCT02669667|78662|P1|STARTED|Overall Study||12
35569|NCT02669615|78756|P1|NOT COMPLETED|Overall Study||0
35570|NCT02669615|78756|P1|COMPLETED|Overall Study||24
35571|NCT02669615|78756|P1|STARTED|Overall Study||24
35572|NCT02669433|78765|P3|NOT COMPLETED|Overall Study||15
35573|NCT02669433|78766|P2|NOT COMPLETED|Overall Study||14
35574|NCT02669433|78767|P1|NOT COMPLETED|Overall Study||15
35575|NCT02669433|78765|P3|COMPLETED|Overall Study||74
35576|NCT02669433|78766|P2|COMPLETED|Overall Study||75
35577|NCT02669433|78767|P1|COMPLETED|Overall Study||76
35578|NCT02669433|78765|P3|UPDRS Primary Population|Overall Study||84
35579|NCT02669433|78766|P2|UPDRS Primary Population|Overall Study||87
35580|NCT02669433|78767|P1|UPDRS Primary Population|Overall Study||87
35581|NCT02669433|78765|P3|Completers Population|Overall Study||69
35582|NCT02669433|78766|P2|Completers Population|Overall Study||72
35583|NCT02669433|78767|P1|Completers Population|Overall Study||73
35584|NCT02669433|78765|P3|Per-Protocol Population|Overall Study||82
35585|NCT02669433|78766|P2|Per-Protocol Population|Overall Study||79
35586|NCT02669433|78767|P1|Per-Protocol Population|Overall Study||78
35587|NCT02669433|78765|P3|Intent to Treat (ITT) Population|Overall Study||87
35588|NCT02669433|78766|P2|Intent to Treat (ITT) Population|Overall Study||89
35589|NCT02669433|78767|P1|Intent to Treat (ITT) Population|Overall Study||89
35590|NCT02669433|78765|P3|Safety Population|Overall Study||88
35591|NCT02669433|78766|P2|Safety Population|Overall Study||89
35592|NCT02669433|78767|P1|Safety Population|Overall Study||91
35593|NCT02669433|78765|P3|STARTED|Overall Study||89
35594|NCT02669433|78766|P2|STARTED|Overall Study||89
35595|NCT02669433|78767|P1|STARTED|Overall Study||91
35596|NCT02669264|78788|P7|NOT COMPLETED|Overall Study||5
35597|NCT02669264|78789|P6|NOT COMPLETED|Overall Study||6
35598|NCT02669264|78790|P5|NOT COMPLETED|Overall Study||5
35599|NCT02669264|78791|P4|NOT COMPLETED|Overall Study||3
35600|NCT02669264|78792|P3|NOT COMPLETED|Overall Study||3
35601|NCT02669264|78793|P2|NOT COMPLETED|Overall Study||6
35602|NCT02669264|78794|P1|NOT COMPLETED|Overall Study||5
35603|NCT02669264|78788|P7|COMPLETED|Overall Study||0
35604|NCT02669264|78789|P6|COMPLETED|Overall Study||0
35605|NCT02669264|78790|P5|COMPLETED|Overall Study||0
35606|NCT02669264|78791|P4|COMPLETED|Overall Study||1
35607|NCT02669264|78792|P3|COMPLETED|Overall Study||0
35608|NCT02669264|78793|P2|COMPLETED|Overall Study||1
35609|NCT02669264|78794|P1|COMPLETED|Overall Study||0
35610|NCT02669264|78788|P7|STARTED|Overall Study||5
35611|NCT02669264|78789|P6|STARTED|Overall Study||6
35612|NCT02669264|78790|P5|STARTED|Overall Study||5
35613|NCT02669264|78791|P4|STARTED|Overall Study||4
35614|NCT02669264|78792|P3|STARTED|Overall Study||3
35615|NCT02669264|78793|P2|STARTED|Overall Study||7
35616|NCT02669264|78794|P1|STARTED|Overall Study||5
35617|NCT02669095|78940|P2|NOT COMPLETED|Overall Study||3
35618|NCT02669095|78941|P1|NOT COMPLETED|Overall Study||1
35619|NCT02669095|78940|P2|COMPLETED|Overall Study||72
35620|NCT02669095|78941|P1|COMPLETED|Overall Study||74
35621|NCT02669095|78940|P2|STARTED|Overall Study||75
35622|NCT02669095|78941|P1|STARTED|Overall Study||75
35623|NCT02669082|78949|P1|NOT COMPLETED|Overall Study||1
35624|NCT02669082|78949|P1|COMPLETED|Overall Study||25
35625|NCT02669082|78949|P1|STARTED|Overall Study||26
35626|NCT02669043|78961|P1|NOT COMPLETED|Overall Study||4
35627|NCT02669043|78961|P1|COMPLETED|Overall Study||4
35628|NCT02669043|78961|P1|STARTED|Overall Study||8
35629|NCT02668952|78967|P2|NOT COMPLETED|Overall Study||0
35630|NCT02668952|78968|P1|NOT COMPLETED|Overall Study||0
35631|NCT02668952|78967|P2|COMPLETED|Overall Study||14
35632|NCT02668952|78968|P1|COMPLETED|Overall Study||16
35633|NCT02668952|78967|P2|STARTED|Overall Study||14
35634|NCT02668952|78968|P1|STARTED|Overall Study||16
35635|NCT02668822|78988|P2|NOT COMPLETED|Overall Study||9
35636|NCT02668822|78989|P1|NOT COMPLETED|Overall Study||9
35637|NCT02668822|78988|P2|COMPLETED|Overall Study||0
35638|NCT02668822|78989|P1|COMPLETED|Overall Study||0
35639|NCT02668822|78988|P2|STARTED|Overall Study||9
35640|NCT02668822|78989|P1|STARTED|Overall Study||9
35641|NCT02668783|79011|P2|NOT COMPLETED|Overall Study||12
35642|NCT02668783|79012|P1|NOT COMPLETED|Overall Study||13
35643|NCT02668783|79011|P2|COMPLETED|Overall Study||0
35644|NCT02668783|79012|P1|COMPLETED|Overall Study||0
35645|NCT02668783|79011|P2|Treated|Overall Study||11
35646|NCT02668783|79012|P1|Treated|Overall Study||13
35647|NCT02668783|79011|P2|STARTED|Overall Study||12
35648|NCT02668783|79012|P1|STARTED|Overall Study||13
35649|NCT02668640|79032|P1|NOT COMPLETED|Overall Study||14
35650|NCT02668640|79032|P1|COMPLETED|Overall Study||41
35651|NCT02668640|79032|P1|STARTED|Overall Study||55
35652|NCT02668432|79045|P2|NOT COMPLETED|Overall Study||0
35653|NCT02668432|79046|P1|NOT COMPLETED|Overall Study||0
35654|NCT02668432|79045|P2|COMPLETED|Overall Study||4
35655|NCT02668432|79046|P1|COMPLETED|Overall Study||5
35656|NCT02668432|79045|P2|STARTED|Overall Study||4
35657|NCT02668432|79046|P1|STARTED|Overall Study||5
35658|NCT02668302|79084|P2|NOT COMPLETED|Overall Study||0
35659|NCT02668302|79085|P1|NOT COMPLETED|Overall Study||1
35660|NCT02668302|79084|P2|COMPLETED|Overall Study||20
35661|NCT02668302|79085|P1|COMPLETED|Overall Study||19
35662|NCT02668302|79084|P2|STARTED|Overall Study||20
35663|NCT02668302|79085|P1|STARTED|Overall Study||20
35664|NCT02668198|79091|P1|NOT COMPLETED|Overall Study||0
35665|NCT02668198|79091|P1|COMPLETED|Overall Study||230
35666|NCT02668198|79091|P1|STARTED|Overall Study||230
35667|NCT02667912|79105|P2|NOT COMPLETED|Overall Study||3
35668|NCT02667912|79106|P1|NOT COMPLETED|Overall Study||5
35669|NCT02667912|79105|P2|COMPLETED|Overall Study||24
35670|NCT02667912|79106|P1|COMPLETED|Overall Study||23
35671|NCT02667912|79105|P2|Six Months|Overall Study||24
35672|NCT02667912|79106|P1|Six Months|Overall Study||27
35673|NCT02667912|79105|P2|STARTED|Overall Study||27
35674|NCT02667912|79106|P1|STARTED|Overall Study||28
35675|NCT02667821|79158|P1|NOT COMPLETED|Overall Study||0
35676|NCT02667821|79158|P1|COMPLETED|Overall Study||20
35677|NCT02667821|79158|P1|STARTED|Overall Study||20
35678|NCT02667704|79164|P1|NOT COMPLETED|Treatment Period 2||0
35679|NCT02667704|79164|P1|COMPLETED|Treatment Period 2||13
35680|NCT02667704|79164|P1|STARTED|Treatment Period 2||13
35681|NCT02667704|79164|P1|NOT COMPLETED|Treatment Period 1||0
35682|NCT02667704|79164|P1|COMPLETED|Treatment Period 1||13
35683|NCT02667704|79164|P1|STARTED|Treatment Period 1||13
35684|NCT02667639|79177|P2|NOT COMPLETED|Overall Study||0
35685|NCT02667639|79178|P1|NOT COMPLETED|Overall Study||0
35686|NCT02667639|79177|P2|COMPLETED|Overall Study||10
35687|NCT02667639|79178|P1|COMPLETED|Overall Study||25
35688|NCT02667639|79177|P2|STARTED|Overall Study||10
35689|NCT02667639|79178|P1|STARTED|Overall Study||25
35690|NCT02667288|79204|P1|NOT COMPLETED|Overall Study||13
35691|NCT02667288|79204|P1|COMPLETED|Overall Study||134
35692|NCT02667288|79204|P1|STARTED|Overall Study||147
35693|NCT02667275|79211|P2|NOT COMPLETED|Overall Study||15
35694|NCT02667275|79212|P1|NOT COMPLETED|Overall Study||11
35695|NCT02667275|79211|P2|COMPLETED|Overall Study||228
35696|NCT02667275|79212|P1|COMPLETED|Overall Study||233
35697|NCT02667275|79211|P2|STARTED|Overall Study||243
35698|NCT02667275|79212|P1|STARTED|Overall Study||244
35699|NCT02667236|79222|P2|NOT COMPLETED|Overall Study||1
35700|NCT02667236|79223|P1|NOT COMPLETED|Overall Study||3
35701|NCT02667236|79222|P2|COMPLETED|Overall Study||226
35702|NCT02667236|79223|P1|COMPLETED|Overall Study||220
35703|NCT02667236|79222|P2|STARTED|Overall Study||227
35704|NCT02667236|79223|P1|STARTED|Overall Study||223
35705|NCT02666950|79231|P1|NOT COMPLETED|Overall Study||0
35706|NCT02666950|79231|P1|COMPLETED|Overall Study||3
35707|NCT02666950|79231|P1|STARTED|Overall Study||3
35708|NCT02666560|79241|P2|NOT COMPLETED|Condition 2 (1 Day)||0
35709|NCT02666560|79242|P1|NOT COMPLETED|Condition 2 (1 Day)||0
35710|NCT02666560|79241|P2|COMPLETED|Condition 2 (1 Day)||11
35711|NCT02666560|79242|P1|COMPLETED|Condition 2 (1 Day)||8
35712|NCT02666560|79241|P2|STARTED|Condition 2 (1 Day)||11
35713|NCT02666560|79242|P1|STARTED|Condition 2 (1 Day)||8
35714|NCT02666560|79241|P2|NOT COMPLETED|Condition 1 (1 Day)||0
35715|NCT02666560|79242|P1|NOT COMPLETED|Condition 1 (1 Day)||0
35716|NCT02666560|79241|P2|COMPLETED|Condition 1 (1 Day)||11
35717|NCT02666560|79242|P1|COMPLETED|Condition 1 (1 Day)||8
35718|NCT02666560|79241|P2|STARTED|Condition 1 (1 Day)||11
35719|NCT02666560|79242|P1|STARTED|Condition 1 (1 Day)||8
35720|NCT02666352|79261|P3|NOT COMPLETED|Overall Study||0
35721|NCT02666352|79262|P2|NOT COMPLETED|Overall Study||0
35722|NCT02666352|79263|P1|NOT COMPLETED|Overall Study||0
35723|NCT02666352|79261|P3|COMPLETED|Overall Study||8
35724|NCT02666352|79262|P2|COMPLETED|Overall Study||8
35725|NCT02666352|79263|P1|COMPLETED|Overall Study||8
35726|NCT02666352|79261|P3|STARTED|Overall Study||8
35727|NCT02666352|79262|P2|STARTED|Overall Study||8
35728|NCT02666352|79263|P1|STARTED|Overall Study||8
35729|NCT02666222|79367|P1|NOT COMPLETED|Overall Study||2
35730|NCT02666222|79367|P1|COMPLETED|Overall Study||49
35731|NCT02666222|79367|P1|STARTED|Overall Study||51
35732|NCT02665689|79377|P2|NOT COMPLETED|Overall Study||2
35733|NCT02665689|79378|P1|NOT COMPLETED|Overall Study||2
35734|NCT02665689|79377|P2|COMPLETED|Overall Study||0
35735|NCT02665689|79378|P1|COMPLETED|Overall Study||0
35736|NCT02665689|79377|P2|STARTED|Overall Study||2
35737|NCT02665689|79378|P1|STARTED|Overall Study||2
35738|NCT02665468|79400|P2|NOT COMPLETED|Overall Study||0
35739|NCT02665468|79401|P1|NOT COMPLETED|Overall Study||0
35740|NCT02665468|79400|P2|COMPLETED|Overall Study||601
35741|NCT02665468|79401|P1|COMPLETED|Overall Study||595
35742|NCT02665468|79400|P2|STARTED|Overall Study||601
35743|NCT02665468|79401|P1|STARTED|Overall Study||595
35744|NCT02665455|79413|P1|NOT COMPLETED|Overall Study||9
35745|NCT02665455|79413|P1|COMPLETED|Overall Study||74
35746|NCT02665455|79413|P1|STARTED|Overall Study||83
35747|NCT02665286|79420|P3|NOT COMPLETED|Overall Study||1
35748|NCT02665286|79421|P2|NOT COMPLETED|Overall Study||2
35749|NCT02665286|79422|P1|NOT COMPLETED|Overall Study||3
35750|NCT02665286|79420|P3|COMPLETED|Overall Study||80
35751|NCT02665286|79421|P2|COMPLETED|Overall Study||78
35752|NCT02665286|79422|P1|COMPLETED|Overall Study||76
35753|NCT02665286|79420|P3|STARTED|Overall Study||81
35754|NCT02665286|79421|P2|STARTED|Overall Study||80
35755|NCT02665286|79422|P1|STARTED|Overall Study||79
35756|NCT02665260|79443|P4|NOT COMPLETED|Overall Study||1
35757|NCT02665260|79444|P3|NOT COMPLETED|Overall Study||4
35758|NCT02665260|79445|P2|NOT COMPLETED|Overall Study||1
35759|NCT02665260|79446|P1|NOT COMPLETED|Overall Study||2
35760|NCT02665260|79443|P4|COMPLETED|Overall Study||21
35761|NCT02665260|79444|P3|COMPLETED|Overall Study||21
35762|NCT02665260|79445|P2|COMPLETED|Overall Study||22
35763|NCT02665260|79446|P1|COMPLETED|Overall Study||22
35764|NCT02665260|79443|P4|STARTED|Overall Study||22
35765|NCT02665260|79444|P3|STARTED|Overall Study||25
35766|NCT02665260|79445|P2|STARTED|Overall Study||23
35767|NCT02665260|79446|P1|STARTED|Overall Study||24
35768|NCT02665221|79462|P2|NOT COMPLETED|Overall Study||15
35769|NCT02665221|79463|P1|NOT COMPLETED|Overall Study||15
35770|NCT02665221|79462|P2|COMPLETED|Overall Study||0
35771|NCT02665221|79463|P1|COMPLETED|Overall Study||0
35772|NCT02665221|79462|P2|STARTED|Overall Study||15
35773|NCT02665221|79463|P1|STARTED|Overall Study||15
35774|NCT02664987|79475|P1|NOT COMPLETED|Overall Study||0
35775|NCT02664987|79475|P1|COMPLETED|Overall Study||462
35776|NCT02664987|79475|P1|STARTED|Overall Study||462
35777|NCT02664961|79484|P1|NOT COMPLETED|Overall Study||0
35778|NCT02664961|79484|P1|COMPLETED|Overall Study||3
35779|NCT02664961|79484|P1|STARTED|Overall Study||3
35780|NCT02664610|79495|P2|NOT COMPLETED|Overall Study||7
35781|NCT02664610|79496|P1|NOT COMPLETED|Overall Study||14
35782|NCT02664610|79495|P2|COMPLETED|Overall Study||41
35783|NCT02664610|79496|P1|COMPLETED|Overall Study||32
35784|NCT02664610|79495|P2|STARTED|Overall Study||48
35785|NCT02664610|79496|P1|STARTED|Overall Study||46
35786|NCT02664532|79506|P2|NOT COMPLETED|Overall Study||0
35787|NCT02664532|79507|P1|NOT COMPLETED|Overall Study||0
35788|NCT02664532|79506|P2|COMPLETED|Overall Study||75
35789|NCT02664532|79507|P1|COMPLETED|Overall Study||75
35790|NCT02664532|79506|P2|STARTED|Overall Study||75
35791|NCT02664532|79507|P1|STARTED|Overall Study||75
35792|NCT02664415|79521|P2|NOT COMPLETED|Overall Study||0
35793|NCT02664415|79522|P1|NOT COMPLETED|Overall Study||1
35794|NCT02664415|79521|P2|COMPLETED|Overall Study||5
35795|NCT02664415|79522|P1|COMPLETED|Overall Study||13
35796|NCT02664415|79521|P2|STARTED|Overall Study||5
35797|NCT02664415|79522|P1|STARTED|Overall Study||14
35798|NCT02664311|79552|P2|NOT COMPLETED|Overall Study||0
35799|NCT02664311|79553|P1|NOT COMPLETED|Overall Study||0
35800|NCT02664311|79552|P2|COMPLETED|Overall Study||3
35801|NCT02664311|79553|P1|COMPLETED|Overall Study||6
35802|NCT02664311|79552|P2|STARTED|Overall Study||3
35803|NCT02664311|79553|P1|STARTED|Overall Study||6
35804|NCT02664272|79563|P1|NOT COMPLETED|Overall Study||2
35805|NCT02664272|79563|P1|COMPLETED|Overall Study||38
35806|NCT02664272|79563|P1|STARTED|Overall Study||40
35807|NCT02664220|79571|P2|NOT COMPLETED|Overall Study||0
35808|NCT02664220|79572|P1|NOT COMPLETED|Overall Study||0
35809|NCT02664220|79571|P2|COMPLETED|Overall Study||50
35810|NCT02664220|79572|P1|COMPLETED|Overall Study||50
35811|NCT02664220|79571|P2|STARTED|Overall Study||50
35812|NCT02664220|79572|P1|STARTED|Overall Study||50
35813|NCT02663752|79584|P1|NOT COMPLETED|Overall Study||0
35814|NCT02663752|79584|P1|COMPLETED|Overall Study||1
35815|NCT02663752|79584|P1|STARTED|Overall Study||1
35816|NCT02663687|79598|P5|NOT COMPLETED|Overall Study||0
35817|NCT02663687|79599|P4|NOT COMPLETED|Overall Study||0
35818|NCT02663687|79600|P3|NOT COMPLETED|Overall Study||1
35819|NCT02663687|79601|P2|NOT COMPLETED|Overall Study||0
35820|NCT02663687|79602|P1|NOT COMPLETED|Overall Study||2
35821|NCT02663687|79598|P5|COMPLETED|Overall Study||9
35822|NCT02663687|79599|P4|COMPLETED|Overall Study||9
35823|NCT02663687|79600|P3|COMPLETED|Overall Study||8
35824|NCT02663687|79601|P2|COMPLETED|Overall Study||9
35825|NCT02663687|79602|P1|COMPLETED|Overall Study||10
35826|NCT02663687|79598|P5|Treatment Period 2 (SC)|Overall Study||9
35827|NCT02663687|79599|P4|Treatment Period 2 (SC)|Overall Study||9
35828|NCT02663687|79600|P3|Treatment Period 2 (SC)|Overall Study||8
35829|NCT02663687|79601|P2|Treatment Period 2 (SC)|Overall Study||9
35830|NCT02663687|79602|P1|Treatment Period 2 (SC)|Overall Study||10
35831|NCT02663687|79598|P5|Treatment Period 1 (IV)|Overall Study||9
35832|NCT02663687|79599|P4|Treatment Period 1 (IV)|Overall Study||9
35833|NCT02663687|79600|P3|Treatment Period 1 (IV)|Overall Study||9
35834|NCT02663687|79601|P2|Treatment Period 1 (IV)|Overall Study||9
35835|NCT02663687|79602|P1|Treatment Period 1 (IV)|Overall Study||12
35836|NCT02663687|79598|P5|STARTED|Overall Study||9
35837|NCT02663687|79599|P4|STARTED|Overall Study||9
35838|NCT02663687|79600|P3|STARTED|Overall Study||9
35839|NCT02663687|79601|P2|STARTED|Overall Study||9
35840|NCT02663687|79602|P1|STARTED|Overall Study||12
35841|NCT02663674|79656|P2|NOT COMPLETED|Overall Study||10
35842|NCT02663674|79657|P1|NOT COMPLETED|Overall Study||7
35843|NCT02663674|79656|P2|COMPLETED|Overall Study||29
35844|NCT02663674|79657|P1|COMPLETED|Overall Study||26
35845|NCT02663674|79656|P2|STARTED|Overall Study||39
35846|NCT02663674|79657|P1|STARTED|Overall Study||33
35847|NCT02663453|79921|P2|NOT COMPLETED|Overall Study||4
35848|NCT02663453|79922|P1|NOT COMPLETED|Overall Study||5
35849|NCT02663453|79921|P2|COMPLETED|Overall Study||18
35850|NCT02663453|79922|P1|COMPLETED|Overall Study||17
35851|NCT02663453|79921|P2|STARTED|Overall Study||22
35852|NCT02663453|79922|P1|STARTED|Overall Study||22
35853|NCT02663232|79944|P1|NOT COMPLETED|Overall Study||0
35854|NCT02663232|79944|P1|COMPLETED|Overall Study||264
35855|NCT02663232|79944|P1|STARTED|Overall Study||264
35856|NCT02663128|79967|P6|NOT COMPLETED|Period 3||0
35857|NCT02663128|79968|P5|NOT COMPLETED|Period 3||0
35858|NCT02663128|79969|P4|NOT COMPLETED|Period 3||0
35859|NCT02663128|79970|P3|NOT COMPLETED|Period 3||0
35860|NCT02663128|79971|P2|NOT COMPLETED|Period 3||0
35861|NCT02663128|79972|P1|NOT COMPLETED|Period 3||0
35862|NCT02663128|79967|P6|COMPLETED|Period 3||3
35863|NCT02663128|79968|P5|COMPLETED|Period 3||2
35864|NCT02663128|79969|P4|COMPLETED|Period 3||3
35865|NCT02663128|79970|P3|COMPLETED|Period 3||3
35866|NCT02663128|79971|P2|COMPLETED|Period 3||3
35867|NCT02663128|79972|P1|COMPLETED|Period 3||3
35868|NCT02663128|79967|P6|STARTED|Period 3||3
35869|NCT02663128|79968|P5|STARTED|Period 3||2
35870|NCT02663128|79969|P4|STARTED|Period 3||3
35871|NCT02663128|79970|P3|STARTED|Period 3||3
35872|NCT02663128|79971|P2|STARTED|Period 3||3
35873|NCT02663128|79972|P1|STARTED|Period 3||3
35874|NCT02663128|79967|P6|NOT COMPLETED|Period 2||0
35875|NCT02663128|79968|P5|NOT COMPLETED|Period 2||1
35876|NCT02663128|79969|P4|NOT COMPLETED|Period 2||0
35877|NCT02663128|79970|P3|NOT COMPLETED|Period 2||0
35878|NCT02663128|79971|P2|NOT COMPLETED|Period 2||0
35879|NCT02663128|79972|P1|NOT COMPLETED|Period 2||0
35880|NCT02663128|79967|P6|COMPLETED|Period 2||3
35881|NCT02663128|79968|P5|COMPLETED|Period 2||2
35882|NCT02663128|79969|P4|COMPLETED|Period 2||3
35883|NCT02663128|79970|P3|COMPLETED|Period 2||3
35884|NCT02663128|79971|P2|COMPLETED|Period 2||3
35885|NCT02663128|79972|P1|COMPLETED|Period 2||3
35886|NCT02663128|79967|P6|STARTED|Period 2||3
35887|NCT02663128|79968|P5|STARTED|Period 2||3
35888|NCT02663128|79969|P4|STARTED|Period 2||3
35889|NCT02663128|79970|P3|STARTED|Period 2||3
35890|NCT02663128|79971|P2|STARTED|Period 2||3
35891|NCT02663128|79972|P1|STARTED|Period 2||3
35892|NCT02663128|79967|P6|NOT COMPLETED|Period 1||0
35893|NCT02663128|79968|P5|NOT COMPLETED|Period 1||0
35894|NCT02663128|79969|P4|NOT COMPLETED|Period 1||0
35895|NCT02663128|79970|P3|NOT COMPLETED|Period 1||0
35896|NCT02663128|79971|P2|NOT COMPLETED|Period 1||0
35897|NCT02663128|79972|P1|NOT COMPLETED|Period 1||0
35898|NCT02663128|79967|P6|COMPLETED|Period 1||3
35899|NCT02663128|79968|P5|COMPLETED|Period 1||3
35900|NCT02663128|79969|P4|COMPLETED|Period 1||3
35901|NCT02663128|79970|P3|COMPLETED|Period 1||3
35902|NCT02663128|79971|P2|COMPLETED|Period 1||3
35903|NCT02663128|79972|P1|COMPLETED|Period 1||3
35904|NCT02663128|79967|P6|Received at Least One Dose of Study Drug|Period 1||3
35905|NCT02663128|79968|P5|Received at Least One Dose of Study Drug|Period 1||3
35906|NCT02663128|79969|P4|Received at Least One Dose of Study Drug|Period 1||3
35907|NCT02663128|79970|P3|Received at Least One Dose of Study Drug|Period 1||3
35908|NCT02663128|79971|P2|Received at Least One Dose of Study Drug|Period 1||3
35909|NCT02663128|79972|P1|Received at Least One Dose of Study Drug|Period 1||3
35910|NCT02663128|79967|P6|STARTED|Period 1||3
35911|NCT02663128|79968|P5|STARTED|Period 1||3
35912|NCT02663128|79969|P4|STARTED|Period 1||3
35913|NCT02663128|79970|P3|STARTED|Period 1||3
35914|NCT02663128|79971|P2|STARTED|Period 1||3
35915|NCT02663128|79972|P1|STARTED|Period 1||3
35916|NCT02662764|79986|P1|NOT COMPLETED|Overall Study||30
35917|NCT02662764|79986|P1|COMPLETED|Overall Study|First 24-hours of study treatment|290
35918|NCT02662764|79986|P1|STARTED|Overall Study||320
35919|NCT02662608|80046|P1|NOT COMPLETED|Overall Study||0
35920|NCT02662608|80046|P1|COMPLETED|Overall Study||1
35921|NCT02662608|80046|P1|STARTED|Overall Study||1
35922|NCT02662569|80054|P4|NOT COMPLETED|Overall Study||4
35923|NCT02662569|80055|P3|NOT COMPLETED|Overall Study||6
35924|NCT02662569|80056|P2|NOT COMPLETED|Overall Study||1
35925|NCT02662569|80057|P1|NOT COMPLETED|Overall Study||7
35926|NCT02662569|80054|P4|COMPLETED|Overall Study||328
35927|NCT02662569|80055|P3|COMPLETED|Overall Study||321
35928|NCT02662569|80056|P2|COMPLETED|Overall Study||160
35929|NCT02662569|80057|P1|COMPLETED|Overall Study||159
35930|NCT02662569|80054|P4|Received Study Drug|Overall Study||332
35931|NCT02662569|80055|P3|Received Study Drug|Overall Study||325
35932|NCT02662569|80056|P2|Received Study Drug|Overall Study||160
35933|NCT02662569|80057|P1|Received Study Drug|Overall Study||164
35934|NCT02662569|80054|P4|STARTED|Overall Study||332
35935|NCT02662569|80055|P3|STARTED|Overall Study||327
35936|NCT02662569|80056|P2|STARTED|Overall Study||161
35937|NCT02662569|80057|P1|STARTED|Overall Study||166
35938|NCT02662556|80155|P1|NOT COMPLETED|Overall Study||8
35939|NCT02662556|80155|P1|COMPLETED|Overall Study||132
35940|NCT02662556|80155|P1|STARTED|Overall Study||140
35941|NCT02662387|80164|P2|NOT COMPLETED|Overall Study||0
35942|NCT02662387|80165|P1|NOT COMPLETED|Overall Study||0
35943|NCT02662387|80164|P2|COMPLETED|Overall Study||28
35944|NCT02662387|80165|P1|COMPLETED|Overall Study||27
35945|NCT02662387|80164|P2|STARTED|Overall Study||28
35946|NCT02662387|80165|P1|STARTED|Overall Study||27
35947|NCT02662244|80173|P1|NOT COMPLETED|Overall Study||2
35948|NCT02662244|80173|P1|COMPLETED|Overall Study||31
35949|NCT02662244|80173|P1|STARTED|Overall Study||33
35950|NCT02662036|80183|P2|NOT COMPLETED|Overall Study||13
35951|NCT02662036|80184|P1|NOT COMPLETED|Overall Study||13
35952|NCT02662036|80183|P2|COMPLETED|Overall Study||22
35953|NCT02662036|80184|P1|COMPLETED|Overall Study||22
35954|NCT02662036|80183|P2|STARTED|Overall Study||35
35955|NCT02662036|80184|P1|STARTED|Overall Study||35
35956|NCT02661828|80212|P2|NOT COMPLETED|Overall Study||0
35957|NCT02661828|80213|P1|NOT COMPLETED|Overall Study||0
35958|NCT02661828|80212|P2|COMPLETED|Overall Study||0
35959|NCT02661828|80213|P1|COMPLETED|Overall Study||1
35960|NCT02661828|80212|P2|STARTED|Overall Study||0
35961|NCT02661828|80213|P1|STARTED|Overall Study||1
35962|NCT02661815|80224|P4|NOT COMPLETED|Overall Study||0
35963|NCT02661815|80225|P3|NOT COMPLETED|Overall Study||0
35964|NCT02661815|80226|P2|NOT COMPLETED|Overall Study||0
35965|NCT02661815|80227|P1|NOT COMPLETED|Overall Study||1
35966|NCT02661815|80224|P4|COMPLETED|Overall Study||0
35967|NCT02661815|80225|P3|COMPLETED|Overall Study||0
35968|NCT02661815|80226|P2|COMPLETED|Overall Study||0
35969|NCT02661815|80227|P1|COMPLETED|Overall Study||5
35970|NCT02661815|80224|P4|STARTED|Overall Study||0
35971|NCT02661815|80225|P3|STARTED|Overall Study||0
35972|NCT02661815|80226|P2|STARTED|Overall Study||0
35973|NCT02661815|80227|P1|STARTED|Overall Study||6
35974|NCT02661737|80241|P1|NOT COMPLETED|Overall Study||34
35975|NCT02661737|80241|P1|COMPLETED|Overall Study||469
35976|NCT02661737|80241|P1|STARTED|Overall Study||503
35977|NCT02661594|80249|P4|NOT COMPLETED|Overall Study||0
35978|NCT02661594|80250|P3|NOT COMPLETED|Overall Study||1
35979|NCT02661594|80251|P2|NOT COMPLETED|Overall Study||0
35980|NCT02661594|80252|P1|NOT COMPLETED|Overall Study||1
35981|NCT02661594|80249|P4|COMPLETED|Overall Study||9
35982|NCT02661594|80250|P3|COMPLETED|Overall Study||9
35983|NCT02661594|80251|P2|COMPLETED|Overall Study||11
35984|NCT02661594|80252|P1|COMPLETED|Overall Study||9
35985|NCT02661594|80249|P4|STARTED|Overall Study||9
35986|NCT02661594|80250|P3|STARTED|Overall Study||10
35987|NCT02661594|80251|P2|STARTED|Overall Study||11
35988|NCT02661594|80252|P1|STARTED|Overall Study||10
35989|NCT02661256|80262|P1|NOT COMPLETED|Overall Study||0
35990|NCT02661256|80262|P1|COMPLETED|Overall Study||7
35991|NCT02661256|80262|P1|STARTED|Overall Study|Each participant went through arms in same order: on nCPAP then off nCPAP. 1 participant at a time.|7
35992|NCT02661126|80280|P2|NOT COMPLETED|Overall Study||0
35993|NCT02661126|80281|P1|NOT COMPLETED|Overall Study||0
35994|NCT02661126|80280|P2|COMPLETED|Overall Study||8
35995|NCT02661126|80281|P1|COMPLETED|Overall Study||8
35996|NCT02661126|80280|P2|STARTED|Overall Study||8
35997|NCT02661126|80281|P1|STARTED|Overall Study||8
35998|NCT02660983|80371|P2|NOT COMPLETED|Overall Study||26
35999|NCT02660983|80372|P1|NOT COMPLETED|Overall Study||24
36000|NCT02660983|80371|P2|COMPLETED|Overall Study||122
36001|NCT02660983|80372|P1|COMPLETED|Overall Study||130
36002|NCT02660983|80371|P2|Treated|Overall Study||147
36003|NCT02660983|80372|P1|Treated|Overall Study||153
36004|NCT02660983|80371|P2|STARTED|Overall Study||148
36005|NCT02660983|80372|P1|STARTED|Overall Study||154
36006|NCT02660918|80386|P2|NOT COMPLETED|Overall Study||1
36007|NCT02660918|80387|P1|NOT COMPLETED|Overall Study||1
36008|NCT02660918|80386|P2|COMPLETED|Overall Study|Age ineligible|41
36009|NCT02660918|80387|P1|COMPLETED|Overall Study|Age ineligible|41
36010|NCT02660918|80386|P2|STARTED|Overall Study||42
36011|NCT02660918|80387|P1|STARTED|Overall Study||42
36012|NCT02660853|80409|P1|NOT COMPLETED|Overall Study||0
36013|NCT02660853|80409|P1|COMPLETED|Overall Study||25
36014|NCT02660853|80409|P1|STARTED|Overall Study||25
36015|NCT02660827|80418|P1|NOT COMPLETED|Overall Study||0
36016|NCT02660827|80418|P1|COMPLETED|Overall Study||105
36017|NCT02660827|80418|P1|STARTED|Overall Study||105
36018|NCT02660801|80428|P2|NOT COMPLETED|Overall Study||0
36019|NCT02660801|80429|P1|NOT COMPLETED|Overall Study||0
36020|NCT02660801|80428|P2|COMPLETED|Overall Study||15
36021|NCT02660801|80429|P1|COMPLETED|Overall Study||11
36022|NCT02660801|80428|P2|STARTED|Overall Study||15
36023|NCT02660801|80429|P1|STARTED|Overall Study||11
36024|NCT02660580|80445|P5|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||11
36025|NCT02660580|80446|P4|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||11
36026|NCT02660580|80447|P3|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||18
36027|NCT02660580|80448|P2|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||0
36028|NCT02660580|80449|P1|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||0
36029|NCT02660580|80445|P5|COMPLETED|Extended Treatment Period(Week 16 to 52)||90
36030|NCT02660580|80446|P4|COMPLETED|Extended Treatment Period(Week 16 to 52)||90
36031|NCT02660580|80447|P3|COMPLETED|Extended Treatment Period(Week 16 to 52)||195
36032|NCT02660580|80448|P2|COMPLETED|Extended Treatment Period(Week 16 to 52)||0
36033|NCT02660580|80449|P1|COMPLETED|Extended Treatment Period(Week 16 to 52)||0
36034|NCT02660580|80445|P5|STARTED|Extended Treatment Period(Week 16 to 52)||101
36035|NCT02660580|80446|P4|STARTED|Extended Treatment Period(Week 16 to 52)||101
36036|NCT02660580|80447|P3|STARTED|Extended Treatment Period(Week 16 to 52)||213
36037|NCT02660580|80448|P2|STARTED|Extended Treatment Period(Week 16 to 52)||0
36038|NCT02660580|80449|P1|STARTED|Extended Treatment Period(Week 16 to 52)||0
36039|NCT02660580|80445|P5|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
36040|NCT02660580|80446|P4|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
36041|NCT02660580|80447|P3|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
36042|NCT02660580|80448|P2|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||19
36043|NCT02660580|80449|P1|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||9
36044|NCT02660580|80445|P5|COMPLETED|Core Treatment Period (Week 1 to 16)||0
36045|NCT02660580|80446|P4|COMPLETED|Core Treatment Period (Week 1 to 16)||0
36046|NCT02660580|80447|P3|COMPLETED|Core Treatment Period (Week 1 to 16)||0
36047|NCT02660580|80448|P2|COMPLETED|Core Treatment Period (Week 1 to 16)||202
36048|NCT02660580|80449|P1|COMPLETED|Core Treatment Period (Week 1 to 16)||213
36049|NCT02660580|80445|P5|Treated|Core Treatment Period (Week 1 to 16)||0
36050|NCT02660580|80446|P4|Treated|Core Treatment Period (Week 1 to 16)||0
36051|NCT02660580|80447|P3|Treated|Core Treatment Period (Week 1 to 16)||0
36052|NCT02660580|80448|P2|Treated|Core Treatment Period (Week 1 to 16)||220
36053|NCT02660580|80449|P1|Treated|Core Treatment Period (Week 1 to 16)||221
36054|NCT02660580|80445|P5|STARTED|Core Treatment Period (Week 1 to 16)||0
36055|NCT02660580|80446|P4|STARTED|Core Treatment Period (Week 1 to 16)||0
36056|NCT02660580|80447|P3|STARTED|Core Treatment Period (Week 1 to 16)||0
36057|NCT02660580|80448|P2|STARTED|Core Treatment Period (Week 1 to 16)||221
36058|NCT02660580|80449|P1|STARTED|Core Treatment Period (Week 1 to 16)||222
36059|NCT02660242|80558|P1|NOT COMPLETED|Glucagon Injection||1
36060|NCT02660242|80558|P1|COMPLETED|Glucagon Injection||15
36061|NCT02660242|80558|P1|STARTED|Glucagon Injection|16 participants were randomized but only 15 completed all 4 periods.|16
36062|NCT02660242|80558|P1|NOT COMPLETED|Glucose Tabs||1
36063|NCT02660242|80558|P1|COMPLETED|Glucose Tabs||15
36064|NCT02660242|80558|P1|STARTED|Glucose Tabs|16 participants were randomized but only 15 completed all 4 periods.|16
36065|NCT02660242|80558|P1|NOT COMPLETED|Basal Insulin Reduction||0
36066|NCT02660242|80558|P1|COMPLETED|Basal Insulin Reduction||16
36067|NCT02660242|80558|P1|STARTED|Basal Insulin Reduction||16
36068|NCT02660242|80558|P1|NOT COMPLETED|Control||0
36069|NCT02660242|80558|P1|COMPLETED|Control||16
36070|NCT02660242|80558|P1|STARTED|Control||16
36071|NCT02660229|80614|P2|NOT COMPLETED|Overall Study||1
36072|NCT02660229|80615|P1|NOT COMPLETED|Overall Study||2
36073|NCT02660229|80614|P2|COMPLETED|Overall Study||31
36074|NCT02660229|80615|P1|COMPLETED|Overall Study||32
36075|NCT02660229|80614|P2|Per Protocol Set|Overall Study|Withdrawal of ICF N=1, IC/EC deviation N=1, Prohibited medication N=1|29
36076|NCT02660229|80615|P1|Per Protocol Set|Overall Study|Adverse events N=1, Prohibited medication N=4|28
36077|NCT02660229|80614|P2|FAS Set|Overall Study||32
36078|NCT02660229|80615|P1|FAS Set|Overall Study|Oxycodone group: 1 patient was missed any efficacy assessment.|33
36079|NCT02660229|80614|P2|Safety Analysis Set|Overall Study||32
36080|NCT02660229|80615|P1|Safety Analysis Set|Overall Study||34
36081|NCT02660229|80614|P2|STARTED|Overall Study|Randomization|32
36082|NCT02660229|80615|P1|STARTED|Overall Study|Randomization|34
36083|NCT02659787|80627|P2|NOT COMPLETED|Second Intervention (1 Day)||0
36084|NCT02659787|80628|P1|NOT COMPLETED|Second Intervention (1 Day)||0
36085|NCT02659787|80627|P2|COMPLETED|Second Intervention (1 Day)||19
36086|NCT02659787|80628|P1|COMPLETED|Second Intervention (1 Day)||19
36087|NCT02659787|80627|P2|STARTED|Second Intervention (1 Day)||19
36088|NCT02659787|80628|P1|STARTED|Second Intervention (1 Day)||19
36089|NCT02659787|80627|P2|NOT COMPLETED|Washout (3 Days)||0
36090|NCT02659787|80628|P1|NOT COMPLETED|Washout (3 Days)||0
36091|NCT02659787|80627|P2|COMPLETED|Washout (3 Days)||19
36092|NCT02659787|80628|P1|COMPLETED|Washout (3 Days)||19
36093|NCT02659787|80627|P2|STARTED|Washout (3 Days)||19
36094|NCT02659787|80628|P1|STARTED|Washout (3 Days)||19
36095|NCT02659787|80627|P2|NOT COMPLETED|First Intervention (1 Day)||0
36096|NCT02659787|80628|P1|NOT COMPLETED|First Intervention (1 Day)||0
36097|NCT02659787|80627|P2|COMPLETED|First Intervention (1 Day)||19
36098|NCT02659787|80628|P1|COMPLETED|First Intervention (1 Day)||19
36099|NCT02659787|80627|P2|STARTED|First Intervention (1 Day)||19
36100|NCT02659787|80628|P1|STARTED|First Intervention (1 Day)||19
36101|NCT02659709|80634|P1|NOT COMPLETED|Overall Study||0
36102|NCT02659709|80634|P1|COMPLETED|Overall Study||50
36103|NCT02659709|80634|P1|STARTED|Overall Study||50
36104|NCT02659501|80643|P2|NOT COMPLETED|Overall Study||0
36105|NCT02659501|80644|P1|NOT COMPLETED|Overall Study||0
36106|NCT02659501|80643|P2|COMPLETED|Overall Study||12
36107|NCT02659501|80644|P1|COMPLETED|Overall Study||12
36108|NCT02659501|80643|P2|STARTED|Overall Study||12
36109|NCT02659501|80644|P1|STARTED|Overall Study||12
36110|NCT02658877|80660|P2|NOT COMPLETED|Overall Study||0
36111|NCT02658877|80661|P1|NOT COMPLETED|Overall Study||0
36112|NCT02658877|80660|P2|COMPLETED|Overall Study||0
36113|NCT02658877|80661|P1|COMPLETED|Overall Study||3
36114|NCT02658877|80660|P2|STARTED|Overall Study||0
36115|NCT02658877|80661|P1|STARTED|Overall Study||3
36116|NCT02658461|80690|P3|NOT COMPLETED|Overall Study||0
36117|NCT02658461|80691|P2|NOT COMPLETED|Overall Study||0
36118|NCT02658461|80692|P1|NOT COMPLETED|Overall Study||0
36119|NCT02658461|80690|P3|COMPLETED|Overall Study||12
36120|NCT02658461|80691|P2|COMPLETED|Overall Study||12
36121|NCT02658461|80692|P1|COMPLETED|Overall Study||12
36122|NCT02658461|80690|P3|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
36123|NCT02658461|80691|P2|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
36124|NCT02658461|80692|P1|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
36125|NCT02658240|80720|P2|NOT COMPLETED|Overall Study||0
36126|NCT02658240|80721|P1|NOT COMPLETED|Overall Study||0
36127|NCT02658240|80720|P2|COMPLETED|Overall Study||30
36128|NCT02658240|80721|P1|COMPLETED|Overall Study||30
36129|NCT02658240|80720|P2|STARTED|Overall Study||30
36130|NCT02658240|80721|P1|STARTED|Overall Study||30
36131|NCT02658149|80735|P2|NOT COMPLETED|Overall Study||0
36132|NCT02658149|80736|P1|NOT COMPLETED|Overall Study||1
36133|NCT02658149|80735|P2|COMPLETED|Overall Study||50
36134|NCT02658149|80736|P1|COMPLETED|Overall Study||49
36135|NCT02658149|80735|P2|STARTED|Overall Study||50
36136|NCT02658149|80736|P1|STARTED|Overall Study||50
36137|NCT02658084|80752|P2|NOT COMPLETED|Overall Study||0
36138|NCT02658084|80753|P1|NOT COMPLETED|Overall Study||2
36139|NCT02658084|80752|P2|COMPLETED|Overall Study||0
36140|NCT02658084|80753|P1|COMPLETED|Overall Study||0
36141|NCT02658084|80752|P2|STARTED|Overall Study||0
36142|NCT02658084|80753|P1|STARTED|Overall Study||2
36143|NCT02657928|80764|P2|NOT COMPLETED|Overall Study||0
36144|NCT02657928|80765|P1|NOT COMPLETED|Overall Study||0
36145|NCT02657928|80764|P2|COMPLETED|Overall Study||20
36146|NCT02657928|80765|P1|COMPLETED|Overall Study||20
36147|NCT02657928|80764|P2|STARTED|Overall Study||20
36148|NCT02657928|80765|P1|STARTED|Overall Study||20
36149|NCT02657915|80781|P2|NOT COMPLETED|Overall Study||0
36150|NCT02657915|80782|P1|NOT COMPLETED|Overall Study||0
36151|NCT02657915|80781|P2|COMPLETED|Overall Study||28
36152|NCT02657915|80782|P1|COMPLETED|Overall Study||24
36153|NCT02657915|80781|P2|Per-protocol Population|Overall Study||24
36154|NCT02657915|80782|P1|Per-protocol Population|Overall Study||23
36155|NCT02657915|80781|P2|Intent-to Treat (ITT) Population|Overall Study||28
36156|NCT02657915|80782|P1|Intent-to Treat (ITT) Population|Overall Study||24
36157|NCT02657915|80781|P2|STARTED|Overall Study||28
36158|NCT02657915|80782|P1|STARTED|Overall Study||24
36159|NCT02657629|80804|P2|NOT COMPLETED|Overall Study||0
36160|NCT02657629|80805|P1|NOT COMPLETED|Overall Study||2
36161|NCT02657629|80804|P2|COMPLETED|Overall Study||14
36162|NCT02657629|80805|P1|COMPLETED|Overall Study||12
36163|NCT02657629|80804|P2|STARTED|Overall Study||14
36164|NCT02657629|80805|P1|STARTED|Overall Study||14
36165|NCT02657564|80811|P1|NOT COMPLETED|Overall Study||74
36166|NCT02657564|80811|P1|COMPLETED|Overall Study||1163
36167|NCT02657564|80811|P1|STARTED|Overall Study||1237
36168|NCT02657538|80816|P1|NOT COMPLETED|Overall Study||4
36169|NCT02657538|80816|P1|COMPLETED|Overall Study||31
36170|NCT02657538|80816|P1|Received Visual Caries Detection + Bite|Overall Study||35
36171|NCT02657538|80816|P1|Received Near Infrared Transillumination|Overall Study||35
36172|NCT02657538|80816|P1|STARTED|Overall Study||35
36173|NCT02657408|80825|P2|NOT COMPLETED|Overall Study||7
36174|NCT02657408|80826|P1|NOT COMPLETED|Overall Study||3
36175|NCT02657408|80825|P2|COMPLETED|Overall Study||22
36176|NCT02657408|80826|P1|COMPLETED|Overall Study||25
36177|NCT02657408|80825|P2|STARTED|Overall Study||29
36178|NCT02657408|80826|P1|STARTED|Overall Study||28
36179|NCT02657369|80850|P1|NOT COMPLETED|Overall Study||34
36180|NCT02657369|80850|P1|COMPLETED|Overall Study||0
36181|NCT02657369|80850|P1|STARTED|Overall Study||34
36182|NCT02657252|80860|P2|NOT COMPLETED|Overall Study||7
36183|NCT02657252|80861|P1|NOT COMPLETED|Overall Study||10
36184|NCT02657252|80860|P2|COMPLETED|Overall Study||51
36185|NCT02657252|80861|P1|COMPLETED|Overall Study||47
36186|NCT02657252|80860|P2|STARTED|Overall Study||58
36187|NCT02657252|80861|P1|STARTED|Overall Study||57
36188|NCT02657226|80871|P1|NOT COMPLETED|Overall Study||0
36189|NCT02657226|80871|P1|COMPLETED|Overall Study||15724
36190|NCT02657226|80871|P1|STARTED|Overall Study||15724
36191|NCT02657031|80881|P2|NOT COMPLETED|Overall Study||2
36192|NCT02657031|80882|P1|NOT COMPLETED|Overall Study||1
36193|NCT02657031|80881|P2|COMPLETED|Overall Study||23
36194|NCT02657031|80882|P1|COMPLETED|Overall Study||28
36195|NCT02657031|80881|P2|STARTED|Overall Study||25
36196|NCT02657031|80882|P1|STARTED|Overall Study||29
36197|NCT02656745|80896|P1|NOT COMPLETED|Overall Study||0
36198|NCT02656745|80896|P1|COMPLETED|Overall Study||416
36199|NCT02656745|80896|P1|STARTED|Overall Study||416
36200|NCT02656693|80906|P3|NOT COMPLETED|Overall Study||3
36201|NCT02656693|80907|P2|NOT COMPLETED|Overall Study||2
36202|NCT02656693|80908|P1|NOT COMPLETED|Overall Study||1
36203|NCT02656693|80906|P3|COMPLETED|Overall Study||295
36204|NCT02656693|80907|P2|COMPLETED|Overall Study||214
36205|NCT02656693|80908|P1|COMPLETED|Overall Study||325
36206|NCT02656693|80906|P3|STARTED|Overall Study||298
36207|NCT02656693|80907|P2|STARTED|Overall Study||216
36208|NCT02656693|80908|P1|STARTED|Overall Study||326
36209|NCT02656485|80953|P4|NOT COMPLETED|Overall Study||2
36210|NCT02656485|80954|P3|NOT COMPLETED|Overall Study||2
36211|NCT02656485|80955|P2|NOT COMPLETED|Overall Study||3
36212|NCT02656485|80956|P1|NOT COMPLETED|Overall Study||2
36213|NCT02656485|80953|P4|COMPLETED|Overall Study||7
36214|NCT02656485|80954|P3|COMPLETED|Overall Study||7
36215|NCT02656485|80955|P2|COMPLETED|Overall Study||6
36216|NCT02656485|80956|P1|COMPLETED|Overall Study||7
36217|NCT02656485|80953|P4|STARTED|Overall Study||9
36218|NCT02656485|80954|P3|STARTED|Overall Study||9
36219|NCT02656485|80955|P2|STARTED|Overall Study||9
36220|NCT02656485|80956|P1|STARTED|Overall Study||9
36221|NCT02656420|80972|P4|NOT COMPLETED|Overall Study||0
36222|NCT02656420|80973|P3|NOT COMPLETED|Overall Study||0
36223|NCT02656420|80974|P2|NOT COMPLETED|Overall Study||1
36224|NCT02656420|80975|P1|NOT COMPLETED|Overall Study||0
36225|NCT02656420|80972|P4|COMPLETED|Overall Study||55
36226|NCT02656420|80973|P3|COMPLETED|Overall Study||35
36227|NCT02656420|80974|P2|COMPLETED|Overall Study||24
36228|NCT02656420|80975|P1|COMPLETED|Overall Study||55
36229|NCT02656420|80972|P4|STARTED|Overall Study||55
36230|NCT02656420|80973|P3|STARTED|Overall Study||35
36231|NCT02656420|80974|P2|STARTED|Overall Study||25
36232|NCT02656420|80975|P1|STARTED|Overall Study||55
36233|NCT02656329|80991|P2|NOT COMPLETED|Overall Study||157
36234|NCT02656329|80992|P1|NOT COMPLETED|Overall Study||164
36235|NCT02656329|80991|P2|COMPLETED|Overall Study||0
36236|NCT02656329|80992|P1|COMPLETED|Overall Study||0
36237|NCT02656329|80991|P2|STARTED|Overall Study||157
36238|NCT02656329|80992|P1|STARTED|Overall Study||164
36239|NCT02656173|81017|P2|NOT COMPLETED|Overall Study||11
36240|NCT02656173|81018|P1|NOT COMPLETED|Overall Study||13
36241|NCT02656173|81017|P2|COMPLETED|Overall Study||272
36242|NCT02656173|81018|P1|COMPLETED|Overall Study||272
36243|NCT02656173|81017|P2|Received Treatment|Overall Study||282
36244|NCT02656173|81018|P1|Received Treatment|Overall Study||284
36245|NCT02656173|81017|P2|STARTED|Overall Study||283
36246|NCT02656173|81018|P1|STARTED|Overall Study||285
36247|NCT02656160|81054|P2|NOT COMPLETED|Second Study Night||0
36248|NCT02656160|81055|P1|NOT COMPLETED|Second Study Night||0
36249|NCT02656160|81054|P2|COMPLETED|Second Study Night||6
36250|NCT02656160|81055|P1|COMPLETED|Second Study Night||4
36251|NCT02656160|81054|P2|STARTED|Second Study Night||6
36252|NCT02656160|81055|P1|STARTED|Second Study Night|3 subjects did not return for the second study night|4
36253|NCT02656160|81054|P2|NOT COMPLETED|First Study Night||0
36254|NCT02656160|81055|P1|NOT COMPLETED|First Study Night||0
36255|NCT02656160|81054|P2|COMPLETED|First Study Night||6
36256|NCT02656160|81055|P1|COMPLETED|First Study Night||7
36257|NCT02656160|81054|P2|STARTED|First Study Night||6
36258|NCT02656160|81055|P1|STARTED|First Study Night||7
36259|NCT02656069|81065|P2|NOT COMPLETED|Second Intervention||1
36260|NCT02656069|81066|P1|NOT COMPLETED|Second Intervention||1
36261|NCT02656069|81065|P2|COMPLETED|Second Intervention||35
36262|NCT02656069|81066|P1|COMPLETED|Second Intervention||43
36263|NCT02656069|81065|P2|STARTED|Second Intervention||36
36264|NCT02656069|81066|P1|STARTED|Second Intervention||44
36265|NCT02656069|81065|P2|NOT COMPLETED|First Intervention||0
36266|NCT02656069|81066|P1|NOT COMPLETED|First Intervention||0
36267|NCT02656069|81065|P2|COMPLETED|First Intervention||36
36268|NCT02656069|81066|P1|COMPLETED|First Intervention||44
36269|NCT02656069|81065|P2|STARTED|First Intervention||36
36270|NCT02656069|81066|P1|STARTED|First Intervention||44
36271|NCT02655887|81090|P1|NOT COMPLETED|Overall Study||14
36272|NCT02655887|81090|P1|COMPLETED|Overall Study|Completed 12-month follow-up.|156
36273|NCT02655887|81090|P1|STARTED|Overall Study|Intent to Treat (ITT) population.|170
36274|NCT02655679|81109|P5|NOT COMPLETED|Overall Study||1
36275|NCT02655679|81110|P4|NOT COMPLETED|Overall Study||4
36276|NCT02655679|81111|P3|NOT COMPLETED|Overall Study||1
36277|NCT02655679|81112|P2|NOT COMPLETED|Overall Study||3
36278|NCT02655679|81113|P1|NOT COMPLETED|Overall Study||3
36279|NCT02655679|81109|P5|COMPLETED|Overall Study||19
36280|NCT02655679|81110|P4|COMPLETED|Overall Study||20
36281|NCT02655679|81111|P3|COMPLETED|Overall Study||19
36282|NCT02655679|81112|P2|COMPLETED|Overall Study||16
36283|NCT02655679|81113|P1|COMPLETED|Overall Study||18
36284|NCT02655679|81109|P5|Received Study Drug (Safety Population)|Overall Study||20
36285|NCT02655679|81110|P4|Received Study Drug (Safety Population)|Overall Study||24
36286|NCT02655679|81111|P3|Received Study Drug (Safety Population)|Overall Study||20
36287|NCT02655679|81112|P2|Received Study Drug (Safety Population)|Overall Study||19
36288|NCT02655679|81113|P1|Received Study Drug (Safety Population)|Overall Study||20
36289|NCT02655679|81109|P5|STARTED|Overall Study||20
36290|NCT02655679|81110|P4|STARTED|Overall Study||24
36291|NCT02655679|81111|P3|STARTED|Overall Study||20
36292|NCT02655679|81112|P2|STARTED|Overall Study||19
36293|NCT02655679|81113|P1|STARTED|Overall Study||21
36294|NCT02655666|81185|P1|NOT COMPLETED|Overall Study||12
36295|NCT02655666|81185|P1|COMPLETED|Overall Study||4
36296|NCT02655666|81185|P1|STARTED|Overall Study||16
36297|NCT02655510|81202|P3|NOT COMPLETED|Overall Study||0
36298|NCT02655510|81203|P2|NOT COMPLETED|Overall Study||0
36299|NCT02655510|81204|P1|NOT COMPLETED|Overall Study||0
36300|NCT02655510|81202|P3|COMPLETED|Overall Study||6
36301|NCT02655510|81203|P2|COMPLETED|Overall Study||6
36302|NCT02655510|81204|P1|COMPLETED|Overall Study||6
36303|NCT02655510|81202|P3|STARTED|Overall Study||6
36304|NCT02655510|81203|P2|STARTED|Overall Study||6
36305|NCT02655510|81204|P1|STARTED|Overall Study||6
36306|NCT02655419|81214|P2|NOT COMPLETED|Overall Study||7
36307|NCT02655419|81215|P1|NOT COMPLETED|Overall Study||5
36308|NCT02655419|81214|P2|COMPLETED|Overall Study||16
36309|NCT02655419|81215|P1|COMPLETED|Overall Study||12
36310|NCT02655419|81214|P2|Treated|Overall Study||18
36311|NCT02655419|81215|P1|Treated|Overall Study||16
36312|NCT02655419|81214|P2|STARTED|Overall Study||23
36313|NCT02655419|81215|P1|STARTED|Overall Study||17
36314|NCT02655237|81335|P2|NOT COMPLETED|Overall Study||11
36315|NCT02655237|81336|P1|NOT COMPLETED|Overall Study||17
36316|NCT02655237|81335|P2|COMPLETED|Overall Study||131
36317|NCT02655237|81336|P1|COMPLETED|Overall Study||122
36318|NCT02655237|81335|P2|STARTED|Overall Study||142
36319|NCT02655237|81336|P1|STARTED|Overall Study||139
36320|NCT02655224|81376|P2|NOT COMPLETED|Overall Study||1
36321|NCT02655224|81377|P1|NOT COMPLETED|Overall Study||1
36322|NCT02655224|81376|P2|COMPLETED|Overall Study||31
36323|NCT02655224|81377|P1|COMPLETED|Overall Study||32
36324|NCT02655224|81376|P2|STARTED|Overall Study||32
36325|NCT02655224|81377|P1|STARTED|Overall Study||33
36326|NCT02654782|81409|P2|NOT COMPLETED|Overall Study||0
36327|NCT02654782|81410|P1|NOT COMPLETED|Overall Study||0
36328|NCT02654782|81409|P2|COMPLETED|Overall Study||5
36329|NCT02654782|81410|P1|COMPLETED|Overall Study||5
36330|NCT02654782|81409|P2|STARTED|Overall Study||5
36331|NCT02654782|81410|P1|STARTED|Overall Study||5
36332|NCT02654717|81420|P2|NOT COMPLETED|Overall Study||5
36333|NCT02654717|81421|P1|NOT COMPLETED|Overall Study||6
36334|NCT02654717|81420|P2|COMPLETED|Overall Study||50
36335|NCT02654717|81421|P1|COMPLETED|Overall Study||50
36336|NCT02654717|81420|P2|STARTED|Overall Study||55
36337|NCT02654717|81421|P1|STARTED|Overall Study||56
36338|NCT02654652|81429|P2|NOT COMPLETED|Overall Study||3
36339|NCT02654652|81430|P1|NOT COMPLETED|Overall Study||1
36340|NCT02654652|81429|P2|COMPLETED|Overall Study||18
36341|NCT02654652|81430|P1|COMPLETED|Overall Study||18
36342|NCT02654652|81429|P2|STARTED|Overall Study||21
36343|NCT02654652|81430|P1|STARTED|Overall Study||19
36344|NCT02654639|81438|P1|NOT COMPLETED|Overall Study||0
36345|NCT02654639|81438|P1|COMPLETED|Overall Study||4
36346|NCT02654639|81438|P1|STARTED|Overall Study||4
36347|NCT02654483|81444|P2|NOT COMPLETED|Open-label||0
36348|NCT02654483|81445|P1|NOT COMPLETED|Open-label||0
36349|NCT02654483|81444|P2|COMPLETED|Open-label||3
36350|NCT02654483|81445|P1|COMPLETED|Open-label||5
36351|NCT02654483|81444|P2|STARTED|Open-label|4 participants did not continue to open-label arm|3
36352|NCT02654483|81445|P1|STARTED|Open-label|2 participants did not proceed to open-label arm|5
36353|NCT02654483|81444|P2|NOT COMPLETED|Double-blind||0
36354|NCT02654483|81445|P1|NOT COMPLETED|Double-blind||0
36355|NCT02654483|81444|P2|COMPLETED|Double-blind||7
36356|NCT02654483|81445|P1|COMPLETED|Double-blind||7
36357|NCT02654483|81444|P2|STARTED|Double-blind||7
36358|NCT02654483|81445|P1|STARTED|Double-blind||7
36359|NCT02654314|81459|P2|NOT COMPLETED|Overall Study||0
36360|NCT02654314|81460|P1|NOT COMPLETED|Overall Study||0
36361|NCT02654314|81459|P2|COMPLETED|Overall Study||141
36362|NCT02654314|81460|P1|COMPLETED|Overall Study||136
36363|NCT02654314|81459|P2|STARTED|Overall Study||141
36364|NCT02654314|81460|P1|STARTED|Overall Study||136
36365|NCT02654145|81472|P1|NOT COMPLETED|Overall Study||7
36366|NCT02654145|81472|P1|COMPLETED|Overall Study||138
36367|NCT02654145|81472|P1|STARTED|Overall Study||145
36368|NCT02654132|81481|P2|NOT COMPLETED|Overall Study||46
36369|NCT02654132|81482|P1|NOT COMPLETED|Overall Study||36
36370|NCT02654132|81481|P2|COMPLETED|Overall Study||11
36371|NCT02654132|81482|P1|COMPLETED|Overall Study||24
36372|NCT02654132|81481|P2|STARTED|Overall Study||57
36373|NCT02654132|81482|P1|STARTED|Overall Study||60
36374|NCT02653872|81490|P1|NOT COMPLETED|Overall Study||0
36375|NCT02653872|81490|P1|COMPLETED|Overall Study||15
36376|NCT02653872|81490|P1|Treatment Period 3:|Overall Study|Participants received: itraconazole 200 mg + AZD7986.|15
36377|NCT02653872|81490|P1|Treatment Period 2:|Overall Study|Participants received Verapamil (240 mg; extended release formulation) + AZD7986 (25 mg).|15
36378|NCT02653872|81490|P1|Treatment Period 1:|Overall Study|Participants received single AZD7986 (25 mg).|15
36379|NCT02653872|81490|P1|STARTED|Overall Study||15
36380|NCT02653625|81525|P1|NOT COMPLETED|Overall Study||4
36381|NCT02653625|81525|P1|COMPLETED|Overall Study||20
36382|NCT02653625|81525|P1|STARTED|Overall Study||24
36383|NCT02653560|81534|P4|NOT COMPLETED|Placebo Phase||0
36384|NCT02653560|81535|P3|NOT COMPLETED|Placebo Phase||0
36385|NCT02653560|81536|P2|NOT COMPLETED|Placebo Phase||0
36386|NCT02653560|81537|P1|NOT COMPLETED|Placebo Phase||0
36387|NCT02653560|81534|P4|COMPLETED|Placebo Phase||30
36388|NCT02653560|81535|P3|COMPLETED|Placebo Phase||0
36389|NCT02653560|81536|P2|COMPLETED|Placebo Phase||0
36390|NCT02653560|81537|P1|COMPLETED|Placebo Phase||0
36391|NCT02653560|81534|P4|STARTED|Placebo Phase||30
36392|NCT02653560|81535|P3|STARTED|Placebo Phase||0
36393|NCT02653560|81536|P2|STARTED|Placebo Phase||0
36394|NCT02653560|81537|P1|STARTED|Placebo Phase||0
36395|NCT02653560|81534|P4|NOT COMPLETED|KCl Phase||0
36396|NCT02653560|81535|P3|NOT COMPLETED|KCl Phase||0
36397|NCT02653560|81536|P2|NOT COMPLETED|KCl Phase||0
36398|NCT02653560|81537|P1|NOT COMPLETED|KCl Phase||0
36399|NCT02653560|81534|P4|COMPLETED|KCl Phase||0
36400|NCT02653560|81535|P3|COMPLETED|KCl Phase||30
36401|NCT02653560|81536|P2|COMPLETED|KCl Phase||0
36402|NCT02653560|81537|P1|COMPLETED|KCl Phase||0
36403|NCT02653560|81534|P4|STARTED|KCl Phase||0
36404|NCT02653560|81535|P3|STARTED|KCl Phase||30
36405|NCT02653560|81536|P2|STARTED|KCl Phase||0
36406|NCT02653560|81537|P1|STARTED|KCl Phase||0
36407|NCT02653560|81534|P4|NOT COMPLETED|K Citrate Phase||0
36408|NCT02653560|81535|P3|NOT COMPLETED|K Citrate Phase||0
36409|NCT02653560|81536|P2|NOT COMPLETED|K Citrate Phase||0
36410|NCT02653560|81537|P1|NOT COMPLETED|K Citrate Phase||0
36411|NCT02653560|81534|P4|COMPLETED|K Citrate Phase||0
36412|NCT02653560|81535|P3|COMPLETED|K Citrate Phase||0
36413|NCT02653560|81536|P2|COMPLETED|K Citrate Phase||30
36414|NCT02653560|81537|P1|COMPLETED|K Citrate Phase||0
36415|NCT02653560|81534|P4|STARTED|K Citrate Phase||0
36416|NCT02653560|81535|P3|STARTED|K Citrate Phase||0
36417|NCT02653560|81536|P2|STARTED|K Citrate Phase||30
36418|NCT02653560|81537|P1|STARTED|K Citrate Phase||0
36419|NCT02653560|81534|P4|NOT COMPLETED|KMgCit Phase||0
36420|NCT02653560|81535|P3|NOT COMPLETED|KMgCit Phase||0
36421|NCT02653560|81536|P2|NOT COMPLETED|KMgCit Phase||0
36422|NCT02653560|81537|P1|NOT COMPLETED|KMgCit Phase||0
36423|NCT02653560|81534|P4|COMPLETED|KMgCit Phase||0
36424|NCT02653560|81535|P3|COMPLETED|KMgCit Phase||0
36425|NCT02653560|81536|P2|COMPLETED|KMgCit Phase||0
36426|NCT02653560|81537|P1|COMPLETED|KMgCit Phase||30
36427|NCT02653560|81534|P4|STARTED|KMgCit Phase||0
36428|NCT02653560|81535|P3|STARTED|KMgCit Phase||0
36429|NCT02653560|81536|P2|STARTED|KMgCit Phase||0
36430|NCT02653560|81537|P1|STARTED|KMgCit Phase||30
36431|NCT02653495|81549|P2|NOT COMPLETED|Overall Study||0
36432|NCT02653495|81550|P1|NOT COMPLETED|Overall Study||12
36433|NCT02653495|81549|P2|COMPLETED|Overall Study||2
36434|NCT02653495|81550|P1|COMPLETED|Overall Study||3
36435|NCT02653495|81549|P2|STARTED|Overall Study||2
36436|NCT02653495|81550|P1|STARTED|Overall Study||15
36437|NCT02653456|81564|P1|NOT COMPLETED|Overall Study||5
36438|NCT02653456|81564|P1|COMPLETED|Overall Study||59
36439|NCT02653456|81564|P1|STARTED|Overall Study||64
36440|NCT02653417|81575|P4|NOT COMPLETED|Overall Study||5
36441|NCT02653417|81576|P3|NOT COMPLETED|Overall Study||3
36442|NCT02653417|81577|P2|NOT COMPLETED|Overall Study||2
36443|NCT02653417|81578|P1|NOT COMPLETED|Overall Study||1
36444|NCT02653417|81575|P4|COMPLETED|Overall Study||33
36445|NCT02653417|81576|P3|COMPLETED|Overall Study||26
36446|NCT02653417|81577|P2|COMPLETED|Overall Study||32
36447|NCT02653417|81578|P1|COMPLETED|Overall Study||37
36448|NCT02653417|81575|P4|STARTED|Overall Study||38
36449|NCT02653417|81576|P3|STARTED|Overall Study||29
36450|NCT02653417|81577|P2|STARTED|Overall Study||34
36451|NCT02653417|81578|P1|STARTED|Overall Study||38
36452|NCT02653326|81602|P2|NOT COMPLETED|Overall Study||7
36453|NCT02653326|81603|P1|NOT COMPLETED|Overall Study||10
36454|NCT02653326|81602|P2|COMPLETED|Overall Study||27
36455|NCT02653326|81603|P1|COMPLETED|Overall Study||22
36456|NCT02653326|81602|P2|STARTED|Overall Study||34
36457|NCT02653326|81603|P1|STARTED|Overall Study||32
36458|NCT02653183|81617|P2|NOT COMPLETED|Overall Study||4
36459|NCT02653183|81618|P1|NOT COMPLETED|Overall Study||4
36460|NCT02653183|81617|P2|COMPLETED|Overall Study||46
36461|NCT02653183|81618|P1|COMPLETED|Overall Study||49
36462|NCT02653183|81617|P2|STARTED|Overall Study||50
36463|NCT02653183|81618|P1|STARTED|Overall Study||53
36464|NCT02653170|81641|P3|NOT COMPLETED|Overall Study||18
36465|NCT02653170|81642|P2|NOT COMPLETED|Overall Study||16
36466|NCT02653170|81643|P1|NOT COMPLETED|Overall Study||17
36467|NCT02653170|81641|P3|COMPLETED|Overall Study||72
36468|NCT02653170|81642|P2|COMPLETED|Overall Study||72
36469|NCT02653170|81643|P1|COMPLETED|Overall Study||70
36470|NCT02653170|81641|P3|STARTED|Overall Study||90
36471|NCT02653170|81642|P2|STARTED|Overall Study||88
36472|NCT02653170|81643|P1|STARTED|Overall Study||87
36473|NCT02652949|81663|P1|NOT COMPLETED|Overall Study||1
36474|NCT02652949|81663|P1|COMPLETED|Overall Study||86
36475|NCT02652949|81663|P1|30 Day Follow-Up (FU)|Overall Study||87
36476|NCT02652949|81663|P1|STARTED|Overall Study||87
36477|NCT02652624|81670|P2|NOT COMPLETED|Extension Phase||4
36478|NCT02652624|81671|P1|NOT COMPLETED|Extension Phase||4
36479|NCT02652624|81670|P2|COMPLETED|Extension Phase||224
36480|NCT02652624|81671|P1|COMPLETED|Extension Phase||227
36481|NCT02652624|81670|P2|STARTED|Extension Phase|3 participants completed the Randomized Phase, but did not enter the Extension Phase.|228
36482|NCT02652624|81671|P1|STARTED|Extension Phase||231
36483|NCT02652624|81670|P2|NOT COMPLETED|Randomized Phase||5
36484|NCT02652624|81671|P1|NOT COMPLETED|Randomized Phase||3
36485|NCT02652624|81670|P2|COMPLETED|Randomized Phase||231
36486|NCT02652624|81671|P1|COMPLETED|Randomized Phase||231
36487|NCT02652624|81670|P2|STARTED|Randomized Phase||236
36488|NCT02652624|81671|P1|STARTED|Randomized Phase||234
36489|NCT02652481|81683|P1|NOT COMPLETED|Phase 2||18
36490|NCT02652481|81683|P1|COMPLETED|Phase 2||243
36491|NCT02652481|81683|P1|STARTED|Phase 2||261
36492|NCT02652481|81683|P1|NOT COMPLETED|Phase 1||98
36493|NCT02652481|81683|P1|COMPLETED|Phase 1||141
36494|NCT02652481|81683|P1|STARTED|Phase 1||239
36495|NCT02652416|81695|P4|NOT COMPLETED|Overall Study||0
36496|NCT02652416|81696|P3|NOT COMPLETED|Overall Study||0
36497|NCT02652416|81697|P2|NOT COMPLETED|Overall Study||0
36498|NCT02652416|81698|P1|NOT COMPLETED|Overall Study||0
36499|NCT02652416|81695|P4|COMPLETED|Overall Study||18
36500|NCT02652416|81696|P3|COMPLETED|Overall Study||18
36501|NCT02652416|81697|P2|COMPLETED|Overall Study||18
36502|NCT02652416|81698|P1|COMPLETED|Overall Study||18
36503|NCT02652416|81695|P4|Subjects Who Participated in MD Part|Overall Study||18
36504|NCT02652416|81696|P3|Subjects Who Participated in MD Part|Overall Study||0
36505|NCT02652416|81697|P2|Subjects Who Participated in MD Part|Overall Study||0
36506|NCT02652416|81698|P1|Subjects Who Participated in MD Part|Overall Study||6
36507|NCT02652416|81695|P4|STARTED|Overall Study||18
36508|NCT02652416|81696|P3|STARTED|Overall Study||18
36509|NCT02652416|81697|P2|STARTED|Overall Study||18
36510|NCT02652416|81698|P1|STARTED|Overall Study||18
36511|NCT02652390|81729|P3|NOT COMPLETED|Overall Study||0
36512|NCT02652390|81730|P2|NOT COMPLETED|Overall Study||0
36513|NCT02652390|81731|P1|NOT COMPLETED|Overall Study||0
36514|NCT02652390|81729|P3|COMPLETED|Overall Study||37
36515|NCT02652390|81730|P2|COMPLETED|Overall Study||37
36516|NCT02652390|81731|P1|COMPLETED|Overall Study||37
36517|NCT02652390|81729|P3|STARTED|Overall Study||37
36518|NCT02652390|81730|P2|STARTED|Overall Study||37
36519|NCT02652390|81731|P1|STARTED|Overall Study||37
36520|NCT02652260|81755|P2|NOT COMPLETED|Overall Study||2
36521|NCT02652260|81756|P1|NOT COMPLETED|Overall Study||0
36522|NCT02652260|81755|P2|COMPLETED|Overall Study||41
36523|NCT02652260|81756|P1|COMPLETED|Overall Study||43
36524|NCT02652260|81755|P2|STARTED|Overall Study||43
36525|NCT02652260|81756|P1|STARTED|Overall Study||43
36526|NCT02652221|81792|P1|NOT COMPLETED|Overall Study||0
36527|NCT02652221|81792|P1|COMPLETED|Overall Study||55
36528|NCT02652221|81792|P1|STARTED|Overall Study||55
36529|NCT02652208|81801|P2|NOT COMPLETED|Overall Study||2
36530|NCT02652208|81802|P1|NOT COMPLETED|Overall Study||4
36531|NCT02652208|81801|P2|COMPLETED|Overall Study||15
36532|NCT02652208|81802|P1|COMPLETED|Overall Study||13
36533|NCT02652208|81801|P2|STARTED|Overall Study||17
36534|NCT02652208|81802|P1|STARTED|Overall Study||17
36535|NCT02652156|81815|P3|NOT COMPLETED|Overall Study||0
36536|NCT02652156|81816|P2|NOT COMPLETED|Overall Study||0
36537|NCT02652156|81817|P1|NOT COMPLETED|Overall Study||1
36538|NCT02652156|81815|P3|COMPLETED|Overall Study||4
36539|NCT02652156|81816|P2|COMPLETED|Overall Study||6
36540|NCT02652156|81817|P1|COMPLETED|Overall Study||3
36541|NCT02652156|81815|P3|STARTED|Overall Study||4
36542|NCT02652156|81816|P2|STARTED|Overall Study||6
36543|NCT02652156|81817|P1|STARTED|Overall Study||4
36544|NCT02651922|81843|P1|NOT COMPLETED|Overall Study||2
36545|NCT02651922|81843|P1|COMPLETED|Overall Study||154
36546|NCT02651922|81843|P1|STARTED|Overall Study||156
36547|NCT02651688|81863|P3|NOT COMPLETED|Overall Study||3
36548|NCT02651688|81864|P2|NOT COMPLETED|Overall Study||5
36549|NCT02651688|81865|P1|NOT COMPLETED|Overall Study||2
36550|NCT02651688|81863|P3|COMPLETED|Overall Study||12
36551|NCT02651688|81864|P2|COMPLETED|Overall Study||12
36552|NCT02651688|81865|P1|COMPLETED|Overall Study||16
36553|NCT02651688|81863|P3|STARTED|Overall Study||15
36554|NCT02651688|81864|P2|STARTED|Overall Study||17
36555|NCT02651688|81865|P1|STARTED|Overall Study||18
36556|NCT02651584|81932|P2|NOT COMPLETED|Overall Study||92
36557|NCT02651584|81933|P1|NOT COMPLETED|Overall Study||89
36558|NCT02651584|81932|P2|COMPLETED|Overall Study||121
36559|NCT02651584|81933|P1|COMPLETED|Overall Study||126
36560|NCT02651584|81932|P2|STARTED|Overall Study||213
36561|NCT02651584|81933|P1|STARTED|Overall Study||215
36562|NCT02651467|81948|P3|NOT COMPLETED|Overall Study||4
36563|NCT02651467|81949|P2|NOT COMPLETED|Overall Study||0
36564|NCT02651467|81950|P1|NOT COMPLETED|Overall Study||1
36565|NCT02651467|81948|P3|COMPLETED|Overall Study||69
36566|NCT02651467|81949|P2|COMPLETED|Overall Study||74
36567|NCT02651467|81950|P1|COMPLETED|Overall Study||73
36568|NCT02651467|81948|P3|STARTED|Overall Study||73
36569|NCT02651467|81949|P2|STARTED|Overall Study||74
36570|NCT02651467|81950|P1|STARTED|Overall Study||74
36571|NCT02651415|81969|P1|NOT COMPLETED|Overall Study||2
36572|NCT02651415|81969|P1|COMPLETED|Overall Study|10 patients were evaluable.|10
36573|NCT02651415|81969|P1|STARTED|Overall Study|12 patients were enrolled.|12
36574|NCT02651194|81978|P1|NOT COMPLETED|Overall Study||5
36575|NCT02651194|81978|P1|COMPLETED|Overall Study||99
36576|NCT02651194|81978|P1|STARTED|Overall Study||104
36577|NCT02651155|81986|P2|NOT COMPLETED|Overall Study||2
36578|NCT02651155|81987|P1|NOT COMPLETED|Overall Study||6
36579|NCT02651155|81986|P2|COMPLETED|Overall Study||103
36580|NCT02651155|81987|P1|COMPLETED|Overall Study||93
36581|NCT02651155|81986|P2|STARTED|Overall Study||105
36582|NCT02651155|81987|P1|STARTED|Overall Study||99
36583|NCT02651103|82003|P1|NOT COMPLETED|Overall Study||0
36584|NCT02651103|82003|P1|COMPLETED|Overall Study||30
36585|NCT02651103|82003|P1|STARTED|Overall Study||30
36586|NCT02650921|82007|P1|NOT COMPLETED|Overall Study||8
36587|NCT02650921|82007|P1|COMPLETED|Overall Study||84
36588|NCT02650921|82007|P1|STARTED|Overall Study||92
36589|NCT02650466|82055|P1|NOT COMPLETED|Overall Study||7
36590|NCT02650466|82055|P1|COMPLETED|Overall Study||17
36591|NCT02650466|82055|P1|STARTED|Overall Study||24
36592|NCT02650440|82063|P2|NOT COMPLETED|Overall Study||2
36593|NCT02650440|82064|P1|NOT COMPLETED|Overall Study||0
36594|NCT02650440|82063|P2|COMPLETED|Overall Study||8
36595|NCT02650440|82064|P1|COMPLETED|Overall Study||10
36596|NCT02650440|82063|P2|STARTED|Overall Study||10
36597|NCT02650440|82064|P1|STARTED|Overall Study||10
36598|NCT02650219|82082|P2|NOT COMPLETED|Overall Study||0
36599|NCT02650219|82083|P1|NOT COMPLETED|Overall Study||0
36600|NCT02650219|82082|P2|COMPLETED|Overall Study||20
36601|NCT02650219|82083|P1|COMPLETED|Overall Study||40
36602|NCT02650219|82082|P2|STARTED|Overall Study||20
36603|NCT02650219|82083|P1|STARTED|Overall Study||40
36604|NCT02650193|82096|P3|NOT COMPLETED|Overall Study||0
36605|NCT02650193|82097|P2|NOT COMPLETED|Overall Study||0
36606|NCT02650193|82098|P1|NOT COMPLETED|Overall Study||0
36607|NCT02650193|82096|P3|COMPLETED|Overall Study||13
36608|NCT02650193|82097|P2|COMPLETED|Overall Study||6
36609|NCT02650193|82098|P1|COMPLETED|Overall Study||6
36610|NCT02650193|82096|P3|STARTED|Overall Study||13
36611|NCT02650193|82097|P2|STARTED|Overall Study||6
36612|NCT02650193|82098|P1|STARTED|Overall Study||6
36613|NCT02650128|82185|P1|NOT COMPLETED|Overall Study||2
36614|NCT02650128|82185|P1|COMPLETED|Overall Study||58
36615|NCT02650128|82185|P1|30 Day Primary and Safety Endpoint|Overall Study||60
36616|NCT02650128|82185|P1|STARTED|Overall Study||60
36617|NCT02649946|82194|P2|NOT COMPLETED|Overall Study||15
36618|NCT02649946|82195|P1|NOT COMPLETED|Overall Study||12
36619|NCT02649946|82194|P2|COMPLETED|Overall Study||123
36620|NCT02649946|82195|P1|COMPLETED|Overall Study||130
36621|NCT02649946|82194|P2|STARTED|Overall Study||138
36622|NCT02649946|82195|P1|STARTED|Overall Study||142
36623|NCT02649634|82224|P2|NOT COMPLETED|Overall Study||6
36624|NCT02649634|82225|P1|NOT COMPLETED|Overall Study||3
36625|NCT02649634|82224|P2|COMPLETED|Overall Study||60
36626|NCT02649634|82225|P1|COMPLETED|Overall Study||66
36627|NCT02649634|82224|P2|STARTED|Overall Study||66
36628|NCT02649634|82225|P1|STARTED|Overall Study||69
36629|NCT02649192|82287|P6|NOT COMPLETED|Overall Study||0
36630|NCT02649192|82288|P5|NOT COMPLETED|Overall Study||1
36631|NCT02649192|82289|P4|NOT COMPLETED|Overall Study||2
36632|NCT02649192|82290|P3|NOT COMPLETED|Overall Study||1
36633|NCT02649192|82291|P2|NOT COMPLETED|Overall Study||0
36634|NCT02649192|82292|P1|NOT COMPLETED|Overall Study||0
36635|NCT02649192|82287|P6|COMPLETED|Overall Study||14
36636|NCT02649192|82288|P5|COMPLETED|Overall Study||11
36637|NCT02649192|82289|P4|COMPLETED|Overall Study||20
36638|NCT02649192|82290|P3|COMPLETED|Overall Study||21
36639|NCT02649192|82291|P2|COMPLETED|Overall Study||4
36640|NCT02649192|82292|P1|COMPLETED|Overall Study||5
36641|NCT02649192|82287|P6|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||6
36642|NCT02649192|82288|P5|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||5
36643|NCT02649192|82289|P4|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||10
36644|NCT02649192|82290|P3|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||11
36645|NCT02649192|82291|P2|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||2
36646|NCT02649192|82292|P1|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||3
36647|NCT02649192|82287|P6|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||8
36648|NCT02649192|82288|P5|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||7
36649|NCT02649192|82289|P4|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||12
36650|NCT02649192|82290|P3|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||11
36651|NCT02649192|82291|P2|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||2
36652|NCT02649192|82292|P1|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||2
36653|NCT02649192|82287|P6|STARTED|Overall Study||14
36654|NCT02649192|82288|P5|STARTED|Overall Study||12
36655|NCT02649192|82289|P4|STARTED|Overall Study||22
36656|NCT02649192|82290|P3|STARTED|Overall Study||22
36657|NCT02649192|82291|P2|STARTED|Overall Study||4
36658|NCT02649192|82292|P1|STARTED|Overall Study||5
36659|NCT02648646|82348|P1|NOT COMPLETED|Overall Study||2
36660|NCT02648646|82348|P1|COMPLETED|Overall Study||8
36661|NCT02648646|82348|P1|STARTED|Overall Study||10
36662|NCT02648438|82399|P3|NOT COMPLETED|Overall Study||0
36663|NCT02648438|82400|P2|NOT COMPLETED|Overall Study||3
36664|NCT02648438|82401|P1|NOT COMPLETED|Overall Study||3
36665|NCT02648438|82399|P3|COMPLETED|Overall Study||6
36666|NCT02648438|82400|P2|COMPLETED|Overall Study||9
36667|NCT02648438|82401|P1|COMPLETED|Overall Study||9
36668|NCT02648438|82399|P3|STARTED|Overall Study||6
36669|NCT02648438|82400|P2|STARTED|Overall Study||12
36670|NCT02648438|82401|P1|STARTED|Overall Study||12
36671|NCT02648230|82441|P1|NOT COMPLETED|Overall Study||0
36672|NCT02648230|82441|P1|COMPLETED|Overall Study||74
36673|NCT02648230|82441|P1|STARTED|Overall Study||74
36674|NCT02648217|82447|P2|NOT COMPLETED|Overall Study||5
36675|NCT02648217|82448|P1|NOT COMPLETED|Overall Study||10
36676|NCT02648217|82447|P2|COMPLETED|Overall Study||127
36677|NCT02648217|82448|P1|COMPLETED|Overall Study||121
36678|NCT02648217|82447|P2|Exposed|Overall Study||132
36679|NCT02648217|82448|P1|Exposed|Overall Study||130
36680|NCT02648217|82447|P2|STARTED|Overall Study||132
36681|NCT02648217|82448|P1|STARTED|Overall Study||131
36682|NCT02648204|82470|P4|NOT COMPLETED|Overall Study||16
36683|NCT02648204|82471|P3|NOT COMPLETED|Overall Study||13
36684|NCT02648204|82472|P2|NOT COMPLETED|Overall Study||21
36685|NCT02648204|82473|P1|NOT COMPLETED|Overall Study||22
36686|NCT02648204|82470|P4|COMPLETED|Overall Study||284
36687|NCT02648204|82471|P3|COMPLETED|Overall Study||287
36688|NCT02648204|82472|P2|COMPLETED|Overall Study||279
36689|NCT02648204|82473|P1|COMPLETED|Overall Study||279
36690|NCT02648204|82470|P4|Exposed|Overall Study||299
36691|NCT02648204|82471|P3|Exposed|Overall Study||299
36692|NCT02648204|82472|P2|Exposed|Overall Study||300
36693|NCT02648204|82473|P1|Exposed|Overall Study||301
36694|NCT02648204|82470|P4|STARTED|Overall Study||300
36695|NCT02648204|82471|P3|STARTED|Overall Study||300
36696|NCT02648204|82472|P2|STARTED|Overall Study||300
36697|NCT02648204|82473|P1|STARTED|Overall Study||301
36698|NCT02648178|82591|P1|NOT COMPLETED|Overall Study||9
36699|NCT02648178|82591|P1|COMPLETED|Overall Study||10
36700|NCT02648178|82591|P1|STARTED|Overall Study||19
36701|NCT02648022|82598|P2|NOT COMPLETED|Overall Study||0
36702|NCT02648022|82599|P1|NOT COMPLETED|Overall Study||0
36703|NCT02648022|82598|P2|COMPLETED|Overall Study||39
36704|NCT02648022|82599|P1|COMPLETED|Overall Study||40
36705|NCT02648022|82598|P2|STARTED|Overall Study||39
36706|NCT02648022|82599|P1|STARTED|Overall Study||40
36707|NCT02647944|82611|P2|NOT COMPLETED|Overall Study||3
36708|NCT02647944|82612|P1|NOT COMPLETED|Overall Study||2
36709|NCT02647944|82611|P2|COMPLETED|Overall Study||18
36710|NCT02647944|82612|P1|COMPLETED|Overall Study||17
36711|NCT02647944|82611|P2|STARTED|Overall Study||21
36712|NCT02647944|82612|P1|STARTED|Overall Study||19
36713|NCT02647905|82636|P1|NOT COMPLETED|Overall Study||3
36714|NCT02647905|82636|P1|COMPLETED|Overall Study||87
36715|NCT02647905|82636|P1|STARTED|Overall Study||90
36716|NCT02647788|82643|P2|NOT COMPLETED|Overall Study||13
36717|NCT02647788|82644|P1|NOT COMPLETED|Overall Study||16
36718|NCT02647788|82643|P2|COMPLETED|Overall Study||57
36719|NCT02647788|82644|P1|COMPLETED|Overall Study||54
36720|NCT02647788|82643|P2|STARTED|Overall Study||70
36721|NCT02647788|82644|P1|STARTED|Overall Study||70
36722|NCT02647645|82656|P2|NOT COMPLETED|Overall Study||1
36723|NCT02647645|82657|P1|NOT COMPLETED|Overall Study||2
36724|NCT02647645|82656|P2|COMPLETED|Overall Study||9
36725|NCT02647645|82657|P1|COMPLETED|Overall Study||9
36726|NCT02647645|82656|P2|STARTED|Overall Study||10
36727|NCT02647645|82657|P1|STARTED|Overall Study||11
36728|NCT02647320|82672|P5|NOT COMPLETED|Overall Study||17
36729|NCT02647320|82673|P4|NOT COMPLETED|Overall Study||10
36730|NCT02647320|82674|P3|NOT COMPLETED|Overall Study||15
36731|NCT02647320|82675|P2|NOT COMPLETED|Overall Study||11
36732|NCT02647320|82676|P1|NOT COMPLETED|Overall Study||12
36733|NCT02647320|82672|P5|COMPLETED|Overall Study||52
36734|NCT02647320|82673|P4|COMPLETED|Overall Study||58
36735|NCT02647320|82674|P3|COMPLETED|Overall Study||54
36736|NCT02647320|82675|P2|COMPLETED|Overall Study||35
36737|NCT02647320|82676|P1|COMPLETED|Overall Study||34
36738|NCT02647320|82672|P5|Modified Intent-to-Treat Set (mITT)|Overall Study||62
36739|NCT02647320|82673|P4|Modified Intent-to-Treat Set (mITT)|Overall Study||62
36740|NCT02647320|82674|P3|Modified Intent-to-Treat Set (mITT)|Overall Study||61
36741|NCT02647320|82675|P2|Modified Intent-to-Treat Set (mITT)|Overall Study||38
36742|NCT02647320|82676|P1|Modified Intent-to-Treat Set (mITT)|Overall Study||40
36743|NCT02647320|82672|P5|Safety Set|Overall Study||69
36744|NCT02647320|82673|P4|Safety Set|Overall Study||68
36745|NCT02647320|82674|P3|Safety Set|Overall Study||68
36746|NCT02647320|82675|P2|Safety Set|Overall Study||44
36747|NCT02647320|82676|P1|Safety Set|Overall Study||43
36748|NCT02647320|82672|P5|Inadvertently Randomized|Overall Study||0
36749|NCT02647320|82673|P4|Inadvertently Randomized|Overall Study||1
36750|NCT02647320|82674|P3|Inadvertently Randomized|Overall Study||0
36751|NCT02647320|82675|P2|Inadvertently Randomized|Overall Study||0
36752|NCT02647320|82676|P1|Inadvertently Randomized|Overall Study||0
36753|NCT02647320|82672|P5|STARTED|Overall Study||69
36754|NCT02647320|82673|P4|STARTED|Overall Study||68
36755|NCT02647320|82674|P3|STARTED|Overall Study||69
36756|NCT02647320|82675|P2|STARTED|Overall Study||46
36757|NCT02647320|82676|P1|STARTED|Overall Study||46
36758|NCT02647281|82767|P9|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||1
36759|NCT02647281|82768|P8|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
36760|NCT02647281|82769|P7|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
36761|NCT02647281|82770|P6|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
36762|NCT02647281|82771|P5|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
36763|NCT02647281|82772|P4|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
36764|NCT02647281|82773|P3|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
36765|NCT02647281|82774|P2|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
36766|NCT02647281|82775|P1|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
36767|NCT02647281|82767|P9|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||5
36768|NCT02647281|82768|P8|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
36769|NCT02647281|82769|P7|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
36770|NCT02647281|82770|P6|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
36771|NCT02647281|82771|P5|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
36772|NCT02647281|82772|P4|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
36773|NCT02647281|82773|P3|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
36774|NCT02647281|82774|P2|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
36775|NCT02647281|82775|P1|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
36776|NCT02647281|82767|P9|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
36777|NCT02647281|82768|P8|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
36778|NCT02647281|82769|P7|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
36779|NCT02647281|82770|P6|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
36780|NCT02647281|82771|P5|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
36781|NCT02647281|82772|P4|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
36782|NCT02647281|82773|P3|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
36783|NCT02647281|82774|P2|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
36784|NCT02647281|82775|P1|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
36785|NCT02647281|82767|P9|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
36786|NCT02647281|82768|P8|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
36787|NCT02647281|82769|P7|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
36788|NCT02647281|82770|P6|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
36789|NCT02647281|82771|P5|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
36790|NCT02647281|82772|P4|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
36791|NCT02647281|82773|P3|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
36792|NCT02647281|82774|P2|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
36793|NCT02647281|82775|P1|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
36794|NCT02647281|82767|P9|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
36795|NCT02647281|82768|P8|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
36796|NCT02647281|82769|P7|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
36797|NCT02647281|82770|P6|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
36798|NCT02647281|82771|P5|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
36799|NCT02647281|82772|P4|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
36800|NCT02647281|82773|P3|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
36801|NCT02647281|82774|P2|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
36802|NCT02647281|82775|P1|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||8
36803|NCT02647281|82767|P9|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
36804|NCT02647281|82768|P8|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
36805|NCT02647281|82769|P7|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
36806|NCT02647281|82770|P6|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
36807|NCT02647281|82771|P5|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
36808|NCT02647281|82772|P4|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
36809|NCT02647281|82773|P3|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
36810|NCT02647281|82774|P2|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
36811|NCT02647281|82775|P1|STARTED|Single-Ascending Dose(Part 1-62 Days)||8
36812|NCT02646826|82957|P4|NOT COMPLETED|Overall Study||1
36813|NCT02646826|82958|P3|NOT COMPLETED|Overall Study||1
36814|NCT02646826|82959|P2|NOT COMPLETED|Overall Study||0
36815|NCT02646826|82960|P1|NOT COMPLETED|Overall Study||2
36816|NCT02646826|82957|P4|COMPLETED|Overall Study||21
36817|NCT02646826|82958|P3|COMPLETED|Overall Study||20
36818|NCT02646826|82959|P2|COMPLETED|Overall Study||22
36819|NCT02646826|82960|P1|COMPLETED|Overall Study||19
36820|NCT02646826|82957|P4|STARTED|Overall Study||22
36821|NCT02646826|82958|P3|STARTED|Overall Study||21
36822|NCT02646826|82959|P2|STARTED|Overall Study||22
36823|NCT02646826|82960|P1|STARTED|Overall Study||21
36824|NCT02646761|82984|P2|NOT COMPLETED|Overall Study||10
36825|NCT02646761|82985|P1|NOT COMPLETED|Overall Study||8
36826|NCT02646761|82984|P2|COMPLETED|Overall Study||10
36827|NCT02646761|82985|P1|COMPLETED|Overall Study||10
36828|NCT02646761|82984|P2|5-week Assessment|Overall Study||10
36829|NCT02646761|82985|P1|5-week Assessment|Overall Study||12
36830|NCT02646761|82984|P2|Baseline Assessment|Overall Study||12
36831|NCT02646761|82985|P1|Baseline Assessment|Overall Study||13
36832|NCT02646761|82984|P2|Subject Withdrew Before Baseline|Overall Study||8
36833|NCT02646761|82985|P1|Subject Withdrew Before Baseline|Overall Study||5
36834|NCT02646761|82984|P2|STARTED|Overall Study||20
36835|NCT02646761|82985|P1|STARTED|Overall Study||18
36836|NCT02646566|83003|P3|NOT COMPLETED|Overall Study||5
36837|NCT02646566|83004|P2|NOT COMPLETED|Overall Study||4
36838|NCT02646566|83005|P1|NOT COMPLETED|Overall Study||6
36839|NCT02646566|83003|P3|COMPLETED|Overall Study||230
36840|NCT02646566|83004|P2|COMPLETED|Overall Study||226
36841|NCT02646566|83005|P1|COMPLETED|Overall Study||231
36842|NCT02646566|83003|P3|STARTED|Overall Study||235
36843|NCT02646566|83004|P2|STARTED|Overall Study||230
36844|NCT02646566|83005|P1|STARTED|Overall Study||237
36845|NCT02646449|83045|P2|NOT COMPLETED|Overall Study||0
36846|NCT02646449|83046|P1|NOT COMPLETED|Overall Study||0
36847|NCT02646449|83045|P2|COMPLETED|Overall Study||3
36848|NCT02646449|83046|P1|COMPLETED|Overall Study||4
36849|NCT02646449|83045|P2|STARTED|Overall Study||3
36850|NCT02646449|83046|P1|STARTED|Overall Study||4
36851|NCT02646124|83056|P2|NOT COMPLETED|Overall Study||2
36852|NCT02646124|83057|P1|NOT COMPLETED|Overall Study||0
36853|NCT02646124|83056|P2|COMPLETED|Overall Study||55
36854|NCT02646124|83057|P1|COMPLETED|Overall Study||57
36855|NCT02646124|83056|P2|STARTED|Overall Study||57
36856|NCT02646124|83057|P1|STARTED|Overall Study||57
36857|NCT02645760|83073|P2|NOT COMPLETED|Overall Study||0
36858|NCT02645760|83074|P1|NOT COMPLETED|Overall Study||0
36859|NCT02645760|83073|P2|COMPLETED|Overall Study||19
36860|NCT02645760|83074|P1|COMPLETED|Overall Study||19
36861|NCT02645760|83073|P2|STARTED|Overall Study||19
36862|NCT02645760|83074|P1|STARTED|Overall Study||19
36863|NCT02645253|83090|P4|NOT COMPLETED|Overall Study||0
36864|NCT02645253|83091|P3|NOT COMPLETED|Overall Study||0
36865|NCT02645253|83092|P2|NOT COMPLETED|Overall Study||0
36866|NCT02645253|83093|P1|NOT COMPLETED|Overall Study||0
36867|NCT02645253|83090|P4|COMPLETED|Overall Study||6
36868|NCT02645253|83091|P3|COMPLETED|Overall Study||7
36869|NCT02645253|83092|P2|COMPLETED|Overall Study||7
36870|NCT02645253|83093|P1|COMPLETED|Overall Study||7
36871|NCT02645253|83090|P4|STARTED|Overall Study||6
36872|NCT02645253|83091|P3|STARTED|Overall Study||7
36873|NCT02645253|83092|P2|STARTED|Overall Study||7
36874|NCT02645253|83093|P1|STARTED|Overall Study||7
36875|NCT02645123|83215|P3|NOT COMPLETED|Overall Study||0
36876|NCT02645123|83216|P2|NOT COMPLETED|Overall Study||0
36877|NCT02645123|83217|P1|NOT COMPLETED|Overall Study||0
36878|NCT02645123|83215|P3|COMPLETED|Overall Study||25
36879|NCT02645123|83216|P2|COMPLETED|Overall Study||25
36880|NCT02645123|83217|P1|COMPLETED|Overall Study||25
36881|NCT02645123|83215|P3|STARTED|Overall Study||25
36882|NCT02645123|83216|P2|STARTED|Overall Study||25
36883|NCT02645123|83217|P1|STARTED|Overall Study||25
36884|NCT02644356|83234|P1|NOT COMPLETED|Overall Study||2
36885|NCT02644356|83234|P1|COMPLETED|Overall Study|49 of the 51 consented subjects completed pre-post knowledge testing (96%)|49
36886|NCT02644356|83234|P1|STARTED|Overall Study||51
36887|NCT02644278|83248|P4|NOT COMPLETED|Overall Study||0
36888|NCT02644278|83249|P3|NOT COMPLETED|Overall Study||0
36889|NCT02644278|83250|P2|NOT COMPLETED|Overall Study||0
36890|NCT02644278|83251|P1|NOT COMPLETED|Overall Study||0
36891|NCT02644278|83248|P4|COMPLETED|Overall Study||3
36892|NCT02644278|83249|P3|COMPLETED|Overall Study||6
36893|NCT02644278|83250|P2|COMPLETED|Overall Study||3
36894|NCT02644278|83251|P1|COMPLETED|Overall Study||3
36895|NCT02644278|83248|P4|STARTED|Overall Study||3
36896|NCT02644278|83249|P3|STARTED|Overall Study||6
36897|NCT02644278|83250|P2|STARTED|Overall Study||3
36898|NCT02644278|83251|P1|STARTED|Overall Study||3
36899|NCT02644122|83317|P1|NOT COMPLETED|Overall Study||1
36900|NCT02644122|83317|P1|COMPLETED|Overall Study||0
36901|NCT02644122|83317|P1|STARTED|Overall Study||1
36902|NCT02644109|83327|P2|NOT COMPLETED|Overall Study||4
36903|NCT02644109|83328|P1|NOT COMPLETED|Overall Study||0
36904|NCT02644109|83327|P2|COMPLETED|Overall Study||24
36905|NCT02644109|83328|P1|COMPLETED|Overall Study||24
36906|NCT02644109|83327|P2|STARTED|Overall Study||28
36907|NCT02644109|83328|P1|STARTED|Overall Study||24
36908|NCT02644096|83336|P2|NOT COMPLETED|Overall Study||25
36909|NCT02644096|83337|P1|NOT COMPLETED|Overall Study||28
36910|NCT02644096|83336|P2|COMPLETED|Overall Study||57
36911|NCT02644096|83337|P1|COMPLETED|Overall Study||65
36912|NCT02644096|83336|P2|9 Month SF-36 Questionnaire|Overall Study||57
36913|NCT02644096|83337|P1|9 Month SF-36 Questionnaire|Overall Study||65
36914|NCT02644096|83336|P2|12 Week SF-36 Questionnaire|Overall Study||59
36915|NCT02644096|83337|P1|12 Week SF-36 Questionnaire|Overall Study||68
36916|NCT02644096|83336|P2|10 Week Interview|Overall Study||59
36917|NCT02644096|83337|P1|10 Week Interview|Overall Study|Not done in control group|0
36918|NCT02644096|83336|P2|2 Week Interview|Overall Study||68
36919|NCT02644096|83337|P1|2 Week Interview|Overall Study|Not done in control group|0
36920|NCT02644096|83336|P2|STARTED|Overall Study||82
36921|NCT02644096|83337|P1|STARTED|Overall Study||93
36922|NCT02643862|83345|P2|NOT COMPLETED|Overall Study||0
36923|NCT02643862|83346|P1|NOT COMPLETED|Overall Study||0
36924|NCT02643862|83345|P2|COMPLETED|Overall Study||12
36925|NCT02643862|83346|P1|COMPLETED|Overall Study||36
36926|NCT02643862|83345|P2|STARTED|Overall Study||12
36927|NCT02643862|83346|P1|STARTED|Overall Study||36
36928|NCT02643693|83354|P6|NOT COMPLETED|Overall Study||1
36929|NCT02643693|83355|P5|NOT COMPLETED|Overall Study||0
36930|NCT02643693|83356|P4|NOT COMPLETED|Overall Study||0
36931|NCT02643693|83357|P3|NOT COMPLETED|Overall Study||1
36932|NCT02643693|83358|P2|NOT COMPLETED|Overall Study||2
36933|NCT02643693|83359|P1|NOT COMPLETED|Overall Study||2
36934|NCT02643693|83354|P6|COMPLETED|Overall Study||3
36935|NCT02643693|83355|P5|COMPLETED|Overall Study||4
36936|NCT02643693|83356|P4|COMPLETED|Overall Study||4
36937|NCT02643693|83357|P3|COMPLETED|Overall Study||3
36938|NCT02643693|83358|P2|COMPLETED|Overall Study||2
36939|NCT02643693|83359|P1|COMPLETED|Overall Study||2
36940|NCT02643693|83354|P6|STARTED|Overall Study||4
36941|NCT02643693|83355|P5|STARTED|Overall Study||4
36942|NCT02643693|83356|P4|STARTED|Overall Study||4
36943|NCT02643693|83357|P3|STARTED|Overall Study||4
36944|NCT02643693|83358|P2|STARTED|Overall Study||4
36945|NCT02643693|83359|P1|STARTED|Overall Study||4
36946|NCT02643628|83372|P2|NOT COMPLETED|Overall Study||6
36947|NCT02643628|83373|P1|NOT COMPLETED|Overall Study||1
36948|NCT02643628|83372|P2|COMPLETED|Overall Study||17
36949|NCT02643628|83373|P1|COMPLETED|Overall Study||20
36950|NCT02643628|83372|P2|STARTED|Overall Study||23
36951|NCT02643628|83373|P1|STARTED|Overall Study||21
36952|NCT02643615|83389|P2|NOT COMPLETED|Overall Study||0
36953|NCT02643615|83390|P1|NOT COMPLETED|Overall Study||0
36954|NCT02643615|83389|P2|COMPLETED|Overall Study||11
36955|NCT02643615|83390|P1|COMPLETED|Overall Study||9
36956|NCT02643615|83389|P2|STARTED|Overall Study||11
36957|NCT02643615|83390|P1|STARTED|Overall Study||9
36958|NCT02643472|83404|P2|NOT COMPLETED|Overall Study||34
36959|NCT02643472|83405|P1|NOT COMPLETED|Overall Study||27
36960|NCT02643472|83404|P2|COMPLETED|Overall Study|One participant completed CESD-10 but not other measures at 12 months; n=115 for other measures.|116
36961|NCT02643472|83405|P1|COMPLETED|Overall Study||123
36962|NCT02643472|83404|P2|STARTED|Overall Study||150
36963|NCT02643472|83405|P1|STARTED|Overall Study||150
36964|NCT02643394|83431|P2|NOT COMPLETED|Overall Study||5
36965|NCT02643394|83432|P1|NOT COMPLETED|Overall Study||4
36966|NCT02643394|83431|P2|COMPLETED|Overall Study||50
36967|NCT02643394|83432|P1|COMPLETED|Overall Study||51
36968|NCT02643394|83431|P2|STARTED|Overall Study||55
36969|NCT02643394|83432|P1|STARTED|Overall Study||55
36970|NCT02643355|83442|P2|NOT COMPLETED|Overall Study||5
36971|NCT02643355|83443|P1|NOT COMPLETED|Overall Study||1
36972|NCT02643355|83442|P2|COMPLETED|Overall Study||30
36973|NCT02643355|83443|P1|COMPLETED|Overall Study||33
36974|NCT02643355|83442|P2|STARTED|Overall Study||35
36975|NCT02643355|83443|P1|STARTED|Overall Study||34
36976|NCT02643251|83457|P2|NOT COMPLETED|Overall Study||2
36977|NCT02643251|83458|P1|NOT COMPLETED|Overall Study||11
36978|NCT02643251|83457|P2|COMPLETED|Overall Study||67
36979|NCT02643251|83458|P1|COMPLETED|Overall Study||58
36980|NCT02643251|83457|P2|STARTED|Overall Study||69
36981|NCT02643251|83458|P1|STARTED|Overall Study||69
36982|NCT02643225|83468|P2|NOT COMPLETED|Overall Study||0
36983|NCT02643225|83469|P1|NOT COMPLETED|Overall Study||0
36984|NCT02643225|83468|P2|COMPLETED|Overall Study||40
36985|NCT02643225|83469|P1|COMPLETED|Overall Study||40
36986|NCT02643225|83468|P2|STARTED|Overall Study||40
36987|NCT02643225|83469|P1|STARTED|Overall Study||40
36988|NCT02643199|83481|P1|NOT COMPLETED|Overall Study||0
36989|NCT02643199|83481|P1|COMPLETED|Overall Study||90
36990|NCT02643199|83481|P1|STARTED|Overall Study||90
36991|NCT02643095|83486|P1|NOT COMPLETED|Overall Study||1
36992|NCT02643095|83486|P1|COMPLETED|Overall Study||21
36993|NCT02643095|83486|P1|STARTED|Overall Study||22
36994|NCT02643082|83490|P2|NOT COMPLETED|Period 2||0
36995|NCT02643082|83491|P1|NOT COMPLETED|Period 2||0
36996|NCT02643082|83490|P2|COMPLETED|Period 2||10
36997|NCT02643082|83491|P1|COMPLETED|Period 2||9
36998|NCT02643082|83490|P2|STARTED|Period 2||10
36999|NCT02643082|83491|P1|STARTED|Period 2||9
37000|NCT02643082|83490|P2|NOT COMPLETED|Washout||0
37001|NCT02643082|83491|P1|NOT COMPLETED|Washout||0
37002|NCT02643082|83490|P2|COMPLETED|Washout||10
37003|NCT02643082|83491|P1|COMPLETED|Washout||9
37004|NCT02643082|83490|P2|STARTED|Washout||10
37005|NCT02643082|83491|P1|STARTED|Washout||9
37006|NCT02643082|83490|P2|NOT COMPLETED|Period 1||0
37007|NCT02643082|83491|P1|NOT COMPLETED|Period 1||1
37008|NCT02643082|83490|P2|COMPLETED|Period 1||10
37009|NCT02643082|83491|P1|COMPLETED|Period 1||9
37010|NCT02643082|83490|P2|STARTED|Period 1||10
37011|NCT02643082|83491|P1|STARTED|Period 1||10
37012|NCT02643004|83508|P2|NOT COMPLETED|Second Intervention (One Week)||0
37013|NCT02643004|83509|P1|NOT COMPLETED|Second Intervention (One Week)||0
37014|NCT02643004|83508|P2|COMPLETED|Second Intervention (One Week)||35
37015|NCT02643004|83509|P1|COMPLETED|Second Intervention (One Week)||35
37016|NCT02643004|83508|P2|STARTED|Second Intervention (One Week)||35
37017|NCT02643004|83509|P1|STARTED|Second Intervention (One Week)||35
37018|NCT02643004|83508|P2|NOT COMPLETED|First Intervention (One Week)||0
37019|NCT02643004|83509|P1|NOT COMPLETED|First Intervention (One Week)||0
37020|NCT02643004|83508|P2|COMPLETED|First Intervention (One Week)||35
37021|NCT02643004|83509|P1|COMPLETED|First Intervention (One Week)||35
37022|NCT02643004|83508|P2|STARTED|First Intervention (One Week)||35
37023|NCT02643004|83509|P1|STARTED|First Intervention (One Week)||35
37024|NCT02642952|83551|P2|NOT COMPLETED|Overall Study||5
37025|NCT02642952|83552|P1|NOT COMPLETED|Overall Study||2
37026|NCT02642952|83551|P2|COMPLETED|Overall Study||25
37027|NCT02642952|83552|P1|COMPLETED|Overall Study||19
37028|NCT02642952|83551|P2|STARTED|Overall Study||30
37029|NCT02642952|83552|P1|STARTED|Overall Study||21
37030|NCT02642835|83566|P1|NOT COMPLETED|Overall Study||0
37031|NCT02642835|83566|P1|COMPLETED|Overall Study||48
37032|NCT02642835|83566|P1|STARTED|Overall Study||48
37033|NCT02642679|83579|P1|NOT COMPLETED|Overall Study||3
37034|NCT02642679|83579|P1|COMPLETED|Overall Study||16
37035|NCT02642679|83579|P1|STARTED|Overall Study||19
37036|NCT02642653|83587|P2|NOT COMPLETED|Overall Study||0
37037|NCT02642653|83588|P1|NOT COMPLETED|Overall Study||2
37038|NCT02642653|83587|P2|COMPLETED|Overall Study||16
37039|NCT02642653|83588|P1|COMPLETED|Overall Study||12
37040|NCT02642653|83587|P2|STARTED|Overall Study||16
37041|NCT02642653|83588|P1|STARTED|Overall Study||14
37042|NCT02642614|83624|P4|NOT COMPLETED|Overall Study||2
37043|NCT02642614|83625|P3|NOT COMPLETED|Overall Study||2
37044|NCT02642614|83626|P2|NOT COMPLETED|Overall Study||2
37045|NCT02642614|83627|P1|NOT COMPLETED|Overall Study||3
37046|NCT02642614|83624|P4|COMPLETED|Overall Study||28
37047|NCT02642614|83625|P3|COMPLETED|Overall Study||28
37048|NCT02642614|83626|P2|COMPLETED|Overall Study||28
37049|NCT02642614|83627|P1|COMPLETED|Overall Study||27
37050|NCT02642614|83624|P4|STARTED|Overall Study||30
37051|NCT02642614|83625|P3|STARTED|Overall Study||30
37052|NCT02642614|83626|P2|STARTED|Overall Study||30
37053|NCT02642614|83627|P1|STARTED|Overall Study||30
37054|NCT02642575|83659|P1|NOT COMPLETED|Overall Study||0
37055|NCT02642575|83659|P1|COMPLETED|Overall Study||67
37056|NCT02642575|83659|P1|STARTED|Overall Study||67
37057|NCT02642536|83667|P2|NOT COMPLETED|Overall Study||5
37058|NCT02642536|83668|P1|NOT COMPLETED|Overall Study||2
37059|NCT02642536|83667|P2|COMPLETED|Overall Study||18
37060|NCT02642536|83668|P1|COMPLETED|Overall Study||19
37061|NCT02642536|83667|P2|STARTED|Overall Study||23
37062|NCT02642536|83668|P1|STARTED|Overall Study||21
37063|NCT02642432|83694|P1|NOT COMPLETED|Overall Study||8
37064|NCT02642432|83694|P1|COMPLETED|Overall Study||138
37065|NCT02642432|83694|P1|STARTED|Overall Study||146
37066|NCT02642237|83702|P2|NOT COMPLETED|Overall Study||0
37067|NCT02642237|83703|P1|NOT COMPLETED|Overall Study||0
37068|NCT02642237|83702|P2|COMPLETED|Overall Study||15
37069|NCT02642237|83703|P1|COMPLETED|Overall Study||15
37070|NCT02642237|83702|P2|STARTED|Overall Study||15
37071|NCT02642237|83703|P1|STARTED|Overall Study||15
37072|NCT02642159|83711|P2|NOT COMPLETED|Overall Study||8
37073|NCT02642159|83712|P1|NOT COMPLETED|Overall Study||31
37074|NCT02642159|83711|P2|COMPLETED|Overall Study||129
37075|NCT02642159|83712|P1|COMPLETED|Overall Study||245
37076|NCT02642159|83711|P2|ITT: Intent to Prescribe Fenofibrate|Overall Study||24
37077|NCT02642159|83712|P1|ITT: Intent to Prescribe Fenofibrate|Overall Study|Fenofibrate was only ‘intended to prescribe’ in the Alirocumab arm but not actually administered.|47
37078|NCT02642159|83711|P2|ITT Population|Overall Study||136
37079|NCT02642159|83712|P1|ITT Population|Overall Study||273
37080|NCT02642159|83711|P2|Treated (Safety Population)|Overall Study||137
37081|NCT02642159|83712|P1|Treated (Safety Population)|Overall Study||275
37082|NCT02642159|83711|P2|STARTED|Overall Study|Randomized|137
37083|NCT02642159|83712|P1|STARTED|Overall Study|Randomized|276
37084|NCT02641912|83764|P2|NOT COMPLETED|Overall Study||0
37085|NCT02641912|83765|P1|NOT COMPLETED|Overall Study||0
37086|NCT02641912|83764|P2|COMPLETED|Overall Study||47
37087|NCT02641912|83765|P1|COMPLETED|Overall Study||53
37088|NCT02641912|83764|P2|STARTED|Overall Study||47
37089|NCT02641912|83765|P1|STARTED|Overall Study||53
37090|NCT02641730|83836|P5|NOT COMPLETED|Observational Period (Week 60 - Week 84)||1
37091|NCT02641730|83837|P4|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
37092|NCT02641730|83838|P3|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
37093|NCT02641730|83839|P2|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
37094|NCT02641730|83840|P1|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
37095|NCT02641730|83836|P5|COMPLETED|Observational Period (Week 60 - Week 84)||43
37096|NCT02641730|83837|P4|COMPLETED|Observational Period (Week 60 - Week 84)||45
37097|NCT02641730|83838|P3|COMPLETED|Observational Period (Week 60 - Week 84)||24
37098|NCT02641730|83839|P2|COMPLETED|Observational Period (Week 60 - Week 84)||21
37099|NCT02641730|83840|P1|COMPLETED|Observational Period (Week 60 - Week 84)||0
37100|NCT02641730|83836|P5|STARTED|Observational Period (Week 60 - Week 84)||44
37101|NCT02641730|83837|P4|STARTED|Observational Period (Week 60 - Week 84)||45
37102|NCT02641730|83838|P3|STARTED|Observational Period (Week 60 - Week 84)||24
37103|NCT02641730|83839|P2|STARTED|Observational Period (Week 60 - Week 84)||21
37104|NCT02641730|83840|P1|STARTED|Observational Period (Week 60 - Week 84)||0
37105|NCT02641730|83836|P5|NOT COMPLETED|After Controlled Period (Week 16 – 52)||6
37106|NCT02641730|83837|P4|NOT COMPLETED|After Controlled Period (Week 16 – 52)||8
37107|NCT02641730|83838|P3|NOT COMPLETED|After Controlled Period (Week 16 – 52)||2
37108|NCT02641730|83839|P2|NOT COMPLETED|After Controlled Period (Week 16 – 52)||4
37109|NCT02641730|83840|P1|NOT COMPLETED|After Controlled Period (Week 16 – 52)||0
37110|NCT02641730|83836|P5|COMPLETED|After Controlled Period (Week 16 – 52)||44
37111|NCT02641730|83837|P4|COMPLETED|After Controlled Period (Week 16 – 52)||45
37112|NCT02641730|83838|P3|COMPLETED|After Controlled Period (Week 16 – 52)||24
37113|NCT02641730|83839|P2|COMPLETED|After Controlled Period (Week 16 – 52)||21
37114|NCT02641730|83840|P1|COMPLETED|After Controlled Period (Week 16 – 52)||0
37115|NCT02641730|83836|P5|STARTED|After Controlled Period (Week 16 – 52)||50
37116|NCT02641730|83837|P4|STARTED|After Controlled Period (Week 16 – 52)||53
37117|NCT02641730|83838|P3|STARTED|After Controlled Period (Week 16 – 52)||26
37118|NCT02641730|83839|P2|STARTED|After Controlled Period (Week 16 – 52)||25
37119|NCT02641730|83840|P1|STARTED|After Controlled Period (Week 16 – 52)||0
37120|NCT02641730|83836|P5|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||2
37121|NCT02641730|83837|P4|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||1
37122|NCT02641730|83838|P3|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
37123|NCT02641730|83839|P2|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
37124|NCT02641730|83840|P1|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||2
37125|NCT02641730|83836|P5|COMPLETED|Placebo Controlled Period (Week 0 - 16)||50
37126|NCT02641730|83837|P4|COMPLETED|Placebo Controlled Period (Week 0 - 16)||53
37127|NCT02641730|83838|P3|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
37128|NCT02641730|83839|P2|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
37129|NCT02641730|83840|P1|COMPLETED|Placebo Controlled Period (Week 0 - 16)||51
37130|NCT02641730|83836|P5|STARTED|Placebo Controlled Period (Week 0 - 16)||52
37131|NCT02641730|83837|P4|STARTED|Placebo Controlled Period (Week 0 - 16)||54
37132|NCT02641730|83838|P3|STARTED|Placebo Controlled Period (Week 0 - 16)||0
37133|NCT02641730|83839|P2|STARTED|Placebo Controlled Period (Week 0 - 16)||0
37134|NCT02641730|83840|P1|STARTED|Placebo Controlled Period (Week 0 - 16)||53
37135|NCT02641587|83944|P2|NOT COMPLETED|Ambulatory Period||0
37136|NCT02641587|83945|P1|NOT COMPLETED|Ambulatory Period||1
37137|NCT02641587|83944|P2|COMPLETED|Ambulatory Period||39
37138|NCT02641587|83945|P1|COMPLETED|Ambulatory Period||76
37139|NCT02641587|83944|P2|STARTED|Ambulatory Period||39
37140|NCT02641587|83945|P1|STARTED|Ambulatory Period||77
37141|NCT02641587|83944|P2|NOT COMPLETED|Confinement Period||1
37142|NCT02641587|83945|P1|NOT COMPLETED|Confinement Period||3
37143|NCT02641587|83944|P2|COMPLETED|Confinement Period||39
37144|NCT02641587|83945|P1|COMPLETED|Confinement Period||77
37145|NCT02641587|83944|P2|STARTED|Confinement Period||40
37146|NCT02641587|83945|P1|STARTED|Confinement Period||80
37147|NCT02641561|83970|P4|NOT COMPLETED|Overall Study||0
37148|NCT02641561|83971|P3|NOT COMPLETED|Overall Study||0
37149|NCT02641561|83972|P2|NOT COMPLETED|Overall Study||0
37150|NCT02641561|83973|P1|NOT COMPLETED|Overall Study||0
37151|NCT02641561|83970|P4|COMPLETED|Overall Study||48
37152|NCT02641561|83971|P3|COMPLETED|Overall Study||48
37153|NCT02641561|83972|P2|COMPLETED|Overall Study||48
37154|NCT02641561|83973|P1|COMPLETED|Overall Study||48
37155|NCT02641561|83970|P4|STARTED|Overall Study||48
37156|NCT02641561|83971|P3|STARTED|Overall Study||48
37157|NCT02641561|83972|P2|STARTED|Overall Study||48
37158|NCT02641561|83973|P1|STARTED|Overall Study||48
37159|NCT02641522|84059|P1|NOT COMPLETED|Overall Study||0
37160|NCT02641522|84059|P1|COMPLETED|Overall Study||10
37161|NCT02641522|84059|P1|STARTED|Overall Study||10
37162|NCT02641392|84066|P3|NOT COMPLETED|Overall Study||293
37163|NCT02641392|84067|P2|NOT COMPLETED|Overall Study||13
37164|NCT02641392|84068|P1|NOT COMPLETED|Overall Study||4
37165|NCT02641392|84066|P3|COMPLETED|Overall Study||0
37166|NCT02641392|84067|P2|COMPLETED|Overall Study||0
37167|NCT02641392|84068|P1|COMPLETED|Overall Study||0
37168|NCT02641392|84066|P3|STARTED|Overall Study||293
37169|NCT02641392|84067|P2|STARTED|Overall Study||13
37170|NCT02641392|84068|P1|STARTED|Overall Study||4
37171|NCT02641379|84087|P11|NOT COMPLETED|Overall Study||8
37172|NCT02641379|84088|P10|NOT COMPLETED|Overall Study||9
37173|NCT02641379|84089|P9|NOT COMPLETED|Overall Study||6
37174|NCT02641379|84090|P8|NOT COMPLETED|Overall Study||19
37175|NCT02641379|84091|P7|NOT COMPLETED|Overall Study||13
37176|NCT02641379|84092|P6|NOT COMPLETED|Overall Study||16
37177|NCT02641379|84093|P5|NOT COMPLETED|Overall Study||17
37178|NCT02641379|84094|P4|NOT COMPLETED|Overall Study||17
37179|NCT02641379|84095|P3|NOT COMPLETED|Overall Study||71
37180|NCT02641379|84096|P2|NOT COMPLETED|Overall Study||51
37181|NCT02641379|84097|P1|NOT COMPLETED|Overall Study||35
37182|NCT02641379|84087|P11|COMPLETED|Overall Study||0
37183|NCT02641379|84088|P10|COMPLETED|Overall Study||36
37184|NCT02641379|84089|P9|COMPLETED|Overall Study||36
37185|NCT02641379|84090|P8|COMPLETED|Overall Study||1
37186|NCT02641379|84091|P7|COMPLETED|Overall Study||12
37187|NCT02641379|84092|P6|COMPLETED|Overall Study||20
37188|NCT02641379|84093|P5|COMPLETED|Overall Study||0
37189|NCT02641379|84094|P4|COMPLETED|Overall Study||139
37190|NCT02641379|84095|P3|COMPLETED|Overall Study||7
37191|NCT02641379|84096|P2|COMPLETED|Overall Study||101
37192|NCT02641379|84097|P1|COMPLETED|Overall Study||107
37193|NCT02641379|84087|P11|STARTED|Overall Study||8
37194|NCT02641379|84088|P10|STARTED|Overall Study||45
37195|NCT02641379|84089|P9|STARTED|Overall Study||42
37196|NCT02641379|84090|P8|STARTED|Overall Study||20
37197|NCT02641379|84091|P7|STARTED|Overall Study||25
37198|NCT02641379|84092|P6|STARTED|Overall Study||36
37199|NCT02641379|84093|P5|STARTED|Overall Study||17
37200|NCT02641379|84094|P4|STARTED|Overall Study||156
37201|NCT02641379|84095|P3|STARTED|Overall Study||78
37202|NCT02641379|84096|P2|STARTED|Overall Study||152
37203|NCT02641379|84097|P1|STARTED|Overall Study||142
37204|NCT02641249|84162|P1|NOT COMPLETED|Overall Study||4
37205|NCT02641249|84162|P1|COMPLETED|Overall Study||15
37206|NCT02641249|84162|P1|STARTED|Overall Study||19
37207|NCT02641067|84173|P2|NOT COMPLETED|Overall Study||0
37208|NCT02641067|84174|P1|NOT COMPLETED|Overall Study||0
37209|NCT02641067|84173|P2|COMPLETED|Overall Study||8
37210|NCT02641067|84174|P1|COMPLETED|Overall Study||8
37211|NCT02641067|84173|P2|STARTED|Overall Study||8
37212|NCT02641067|84174|P1|STARTED|Overall Study||8
37213|NCT02640755|84196|P2|NOT COMPLETED|Multiple Dose Period (Day 8 - EoS)||1
37214|NCT02640755|84197|P1|NOT COMPLETED|Multiple Dose Period (Day 8 - EoS)||2
37215|NCT02640755|84196|P2|COMPLETED|Multiple Dose Period (Day 8 - EoS)||0
37216|NCT02640755|84197|P1|COMPLETED|Multiple Dose Period (Day 8 - EoS)||1
37217|NCT02640755|84196|P2|STARTED|Multiple Dose Period (Day 8 - EoS)||1
37218|NCT02640755|84197|P1|STARTED|Multiple Dose Period (Day 8 - EoS)||3
37219|NCT02640755|84196|P2|NOT COMPLETED|Single Dose Period (Day 1 - 8)||0
37220|NCT02640755|84197|P1|NOT COMPLETED|Single Dose Period (Day 1 - 8)||0
37221|NCT02640755|84196|P2|COMPLETED|Single Dose Period (Day 1 - 8)||1
37222|NCT02640755|84197|P1|COMPLETED|Single Dose Period (Day 1 - 8)||3
37223|NCT02640755|84196|P2|STARTED|Single Dose Period (Day 1 - 8)||1
37224|NCT02640755|84197|P1|STARTED|Single Dose Period (Day 1 - 8)||3
37225|NCT02640612|84235|P3|NOT COMPLETED|Overall Study||6
37226|NCT02640612|84236|P2|NOT COMPLETED|Overall Study||14
37227|NCT02640612|84237|P1|NOT COMPLETED|Overall Study||22
37228|NCT02640612|84235|P3|COMPLETED|Overall Study||96
37229|NCT02640612|84236|P2|COMPLETED|Overall Study||89
37230|NCT02640612|84237|P1|COMPLETED|Overall Study||203
37231|NCT02640612|84235|P3|STARTED|Overall Study||102
37232|NCT02640612|84236|P2|STARTED|Overall Study||103
37233|NCT02640612|84237|P1|STARTED|Overall Study||225
37234|NCT02640547|84257|P1|NOT COMPLETED|Overall Study||11
37235|NCT02640547|84257|P1|COMPLETED|Overall Study||383
37236|NCT02640547|84257|P1|STARTED|Overall Study||394
37237|NCT02640482|84334|P2|NOT COMPLETED|Overall Study||0
37238|NCT02640482|84335|P1|NOT COMPLETED|Overall Study||3
37239|NCT02640482|84334|P2|COMPLETED|Overall Study||100
37240|NCT02640482|84335|P1|COMPLETED|Overall Study||199
37241|NCT02640482|84334|P2|STARTED|Overall Study||100
37242|NCT02640482|84335|P1|STARTED|Overall Study||202
37243|NCT02640404|84347|P2|NOT COMPLETED|Overall Study||0
37244|NCT02640404|84348|P1|NOT COMPLETED|Overall Study||2
37245|NCT02640404|84347|P2|COMPLETED|Overall Study||112
37246|NCT02640404|84348|P1|COMPLETED|Overall Study||110
37247|NCT02640404|84347|P2|STARTED|Overall Study||112
37248|NCT02640404|84348|P1|STARTED|Overall Study||112
37249|NCT02640157|84359|P3|NOT COMPLETED|Overall Study||10
37250|NCT02640157|84360|P2|NOT COMPLETED|Overall Study||5
37251|NCT02640157|84361|P1|NOT COMPLETED|Overall Study||13
37252|NCT02640157|84359|P3|COMPLETED|Overall Study||147
37253|NCT02640157|84360|P2|COMPLETED|Overall Study||111
37254|NCT02640157|84361|P1|COMPLETED|Overall Study||220
37255|NCT02640157|84359|P3|Discontinued Study Drug|Overall Study||3
37256|NCT02640157|84360|P2|Discontinued Study Drug|Overall Study||3
37257|NCT02640157|84361|P1|Discontinued Study Drug|Overall Study||8
37258|NCT02640157|84359|P3|Completed Study Drug|Overall Study||154
37259|NCT02640157|84360|P2|Completed Study Drug|Overall Study||112
37260|NCT02640157|84361|P1|Completed Study Drug|Overall Study||225
37261|NCT02640157|84359|P3|Received Study Drug|Overall Study||157
37262|NCT02640157|84360|P2|Received Study Drug|Overall Study|One participant in Arm B was randomized in error and never dispensed study drug.|115
37263|NCT02640157|84361|P1|Received Study Drug|Overall Study||233
37264|NCT02640157|84359|P3|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|157
37265|NCT02640157|84360|P2|STARTED|Overall Study||116
37266|NCT02640157|84361|P1|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|233
37267|NCT02640053|84380|P2|NOT COMPLETED|Overall Study||4
37268|NCT02640053|84381|P1|NOT COMPLETED|Overall Study||4
37269|NCT02640053|84380|P2|COMPLETED|Overall Study||17
37270|NCT02640053|84381|P1|COMPLETED|Overall Study||17
37271|NCT02640053|84380|P2|STARTED|Overall Study||21
37272|NCT02640053|84381|P1|STARTED|Overall Study||21
37273|NCT02639637|84404|P4|NOT COMPLETED|Overall Study||0
37274|NCT02639637|84405|P3|NOT COMPLETED|Overall Study||0
37275|NCT02639637|84406|P2|NOT COMPLETED|Overall Study||0
37276|NCT02639637|84407|P1|NOT COMPLETED|Overall Study||0
37277|NCT02639637|84404|P4|COMPLETED|Overall Study||3
37278|NCT02639637|84405|P3|COMPLETED|Overall Study||2
37279|NCT02639637|84406|P2|COMPLETED|Overall Study||6
37280|NCT02639637|84407|P1|COMPLETED|Overall Study||7
37281|NCT02639637|84404|P4|STARTED|Overall Study||3
37282|NCT02639637|84405|P3|STARTED|Overall Study||2
37283|NCT02639637|84406|P2|STARTED|Overall Study||6
37284|NCT02639637|84407|P1|STARTED|Overall Study||7
37285|NCT02639559|84471|P2|NOT COMPLETED|Overall Study||3
37286|NCT02639559|84472|P1|NOT COMPLETED|Overall Study||1
37287|NCT02639559|84471|P2|COMPLETED|Overall Study||22
37288|NCT02639559|84472|P1|COMPLETED|Overall Study||24
37289|NCT02639559|84471|P2|STARTED|Overall Study||25
37290|NCT02639559|84472|P1|STARTED|Overall Study||25
37291|NCT02639494|84488|P1|NOT COMPLETED|Overall Study||0
37292|NCT02639494|84488|P1|COMPLETED|Overall Study||20
37293|NCT02639494|84488|P1|STARTED|Overall Study||20
37294|NCT02639429|84505|P2|NOT COMPLETED|Overall Study||0
37295|NCT02639429|84506|P1|NOT COMPLETED|Overall Study||0
37296|NCT02639429|84505|P2|COMPLETED|Overall Study||123
37297|NCT02639429|84506|P1|COMPLETED|Overall Study||113
37298|NCT02639429|84505|P2|STARTED|Overall Study||123
37299|NCT02639429|84506|P1|STARTED|Overall Study||113
37300|NCT02639351|84545|P5|NOT COMPLETED|Overall Study||0
37301|NCT02639351|84546|P4|NOT COMPLETED|Overall Study||0
37302|NCT02639351|84547|P3|NOT COMPLETED|Overall Study||0
37303|NCT02639351|84548|P2|NOT COMPLETED|Overall Study||0
37304|NCT02639351|84549|P1|NOT COMPLETED|Overall Study||0
37305|NCT02639351|84545|P5|COMPLETED|Overall Study||16
37306|NCT02639351|84546|P4|COMPLETED|Overall Study||16
37307|NCT02639351|84547|P3|COMPLETED|Overall Study||16
37308|NCT02639351|84548|P2|COMPLETED|Overall Study||16
37309|NCT02639351|84549|P1|COMPLETED|Overall Study||16
37310|NCT02639351|84545|P5|STARTED|Overall Study||16
37311|NCT02639351|84546|P4|STARTED|Overall Study||16
37312|NCT02639351|84547|P3|STARTED|Overall Study||16
37313|NCT02639351|84548|P2|STARTED|Overall Study||16
37314|NCT02639351|84549|P1|STARTED|Overall Study||16
37315|NCT02639338|84898|P2|NOT COMPLETED|Overall Study||5
37316|NCT02639338|84899|P1|NOT COMPLETED|Overall Study||4
37317|NCT02639338|84898|P2|COMPLETED|Overall Study||105
37318|NCT02639338|84899|P1|COMPLETED|Overall Study||106
37319|NCT02639338|84898|P2|STARTED|Overall Study||110
37320|NCT02639338|84899|P1|STARTED|Overall Study||110
37321|NCT02639247|84917|P2|NOT COMPLETED|Overall Study||2
37322|NCT02639247|84918|P1|NOT COMPLETED|Overall Study||5
37323|NCT02639247|84917|P2|COMPLETED|Overall Study||149
37324|NCT02639247|84918|P1|COMPLETED|Overall Study||177
37325|NCT02639247|84917|P2|STARTED|Overall Study||151
37326|NCT02639247|84918|P1|STARTED|Overall Study||182
37327|NCT02639052|84934|P1|NOT COMPLETED|Overall Study||1
37328|NCT02639052|84934|P1|COMPLETED|Overall Study||34
37329|NCT02639052|84934|P1|Visit 4 (3-month Follow-up)|Overall Study||34
37330|NCT02639052|84934|P1|Visit 3 (1-month Follow-up)|Overall Study||35
37331|NCT02639052|84934|P1|Visit 2 (1-week Follow-up)|Overall Study||35
37332|NCT02639052|84934|P1|Visit 1 (Baseline)|Overall Study||35
37333|NCT02639052|84934|P1|STARTED|Overall Study||35
37334|NCT02638974|84950|P2|NOT COMPLETED|Overall Study||3
37335|NCT02638974|84951|P1|NOT COMPLETED|Overall Study||3
37336|NCT02638974|84950|P2|COMPLETED|Overall Study||22
37337|NCT02638974|84951|P1|COMPLETED|Overall Study||23
37338|NCT02638974|84950|P2|STARTED|Overall Study||25
37339|NCT02638974|84951|P1|STARTED|Overall Study||26
37340|NCT02638948|84971|P4|NOT COMPLETED|Overall Study||8
37341|NCT02638948|84972|P3|NOT COMPLETED|Overall Study||7
37342|NCT02638948|84973|P2|NOT COMPLETED|Overall Study||11
37343|NCT02638948|84974|P1|NOT COMPLETED|Overall Study||9
37344|NCT02638948|84971|P4|COMPLETED|Overall Study||18
37345|NCT02638948|84972|P3|COMPLETED|Overall Study||66
37346|NCT02638948|84973|P2|COMPLETED|Overall Study||62
37347|NCT02638948|84974|P1|COMPLETED|Overall Study||66
37348|NCT02638948|84971|P4|STARTED|Overall Study||26
37349|NCT02638948|84972|P3|STARTED|Overall Study||73
37350|NCT02638948|84973|P2|STARTED|Overall Study||73
37351|NCT02638948|84974|P1|STARTED|Overall Study||75
37352|NCT02638597|85061|P2|NOT COMPLETED|Overall Study||5
37353|NCT02638597|85062|P1|NOT COMPLETED|Overall Study||4
37354|NCT02638597|85061|P2|COMPLETED|Overall Study||3
37355|NCT02638597|85062|P1|COMPLETED|Overall Study||4
37356|NCT02638597|85061|P2|STARTED|Overall Study||8
37357|NCT02638597|85062|P1|STARTED|Overall Study||8
37358|NCT02638493|85073|P3|NOT COMPLETED|Overall Study||0
37359|NCT02638493|85074|P2|NOT COMPLETED|Overall Study||0
37360|NCT02638493|85075|P1|NOT COMPLETED|Overall Study||2
37361|NCT02638493|85073|P3|COMPLETED|Overall Study||8
37362|NCT02638493|85074|P2|COMPLETED|Overall Study||8
37363|NCT02638493|85075|P1|COMPLETED|Overall Study||8
37364|NCT02638493|85073|P3|STARTED|Overall Study||8
37365|NCT02638493|85074|P2|STARTED|Overall Study||8
37366|NCT02638493|85075|P1|STARTED|Overall Study|Two men were not able to provide semen samples, and thus were replaced|10
37367|NCT02638337|85106|P2|NOT COMPLETED|Overall Study||36
37368|NCT02638337|85107|P1|NOT COMPLETED|Overall Study||33
37369|NCT02638337|85106|P2|COMPLETED|Overall Study||279
37370|NCT02638337|85107|P1|COMPLETED|Overall Study||283
37371|NCT02638337|85106|P2|Received Treatment|Overall Study||315
37372|NCT02638337|85107|P1|Received Treatment|Overall Study||313
37373|NCT02638337|85106|P2|STARTED|Overall Study||315
37374|NCT02638337|85107|P1|STARTED|Overall Study||316
37375|NCT02638259|85191|P2|NOT COMPLETED|Treatment Period 2||11
37376|NCT02638259|85192|P1|NOT COMPLETED|Treatment Period 2||6
37377|NCT02638259|85191|P2|COMPLETED|Treatment Period 2||155
37378|NCT02638259|85192|P1|COMPLETED|Treatment Period 2||169
37379|NCT02638259|85191|P2|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (4 not eligible, 1 consent withdrawal, 1 adverse event).|166
37380|NCT02638259|85192|P1|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (3 not eligible, 2 consent withdrawal, 1 IP delay)|175
37381|NCT02638259|85191|P2|NOT COMPLETED|Treatment Period 1||18
37382|NCT02638259|85192|P1|NOT COMPLETED|Treatment Period 1||5
37383|NCT02638259|85191|P2|COMPLETED|Treatment Period 1||172
37384|NCT02638259|85192|P1|COMPLETED|Treatment Period 1||181
37385|NCT02638259|85191|P2|STARTED|Treatment Period 1||190
37386|NCT02638259|85192|P1|STARTED|Treatment Period 1||186
37387|NCT02638168|85266|P2|NOT COMPLETED|Overall Study||0
37388|NCT02638168|85267|P1|NOT COMPLETED|Overall Study||0
37389|NCT02638168|85266|P2|COMPLETED|Overall Study||0
37390|NCT02638168|85267|P1|COMPLETED|Overall Study||3
37391|NCT02638168|85266|P2|STARTED|Overall Study||0
37392|NCT02638168|85267|P1|STARTED|Overall Study||3
37393|NCT02638129|85284|P2|NOT COMPLETED|Overall Study||30
37394|NCT02638129|85285|P1|NOT COMPLETED|Overall Study||28
37395|NCT02638129|85284|P2|COMPLETED|Overall Study||0
37396|NCT02638129|85285|P1|COMPLETED|Overall Study||0
37397|NCT02638129|85284|P2|STARTED|Overall Study||30
37398|NCT02638129|85285|P1|STARTED|Overall Study||28
37399|NCT02638103|85301|P4|NOT COMPLETED|Overall Study||142
37400|NCT02638103|85302|P3|NOT COMPLETED|Overall Study||85
37401|NCT02638103|85303|P2|NOT COMPLETED|Overall Study||118
37402|NCT02638103|85304|P1|NOT COMPLETED|Overall Study||106
37403|NCT02638103|85301|P4|COMPLETED|Overall Study||383
37404|NCT02638103|85302|P3|COMPLETED|Overall Study||335
37405|NCT02638103|85303|P2|COMPLETED|Overall Study||408
37406|NCT02638103|85304|P1|COMPLETED|Overall Study||313
37407|NCT02638103|85301|P4|Full Analysis Set (FAS)|Overall Study||523
37408|NCT02638103|85302|P3|Full Analysis Set (FAS)|Overall Study||419
37409|NCT02638103|85303|P2|Full Analysis Set (FAS)|Overall Study||520
37410|NCT02638103|85304|P1|Full Analysis Set (FAS)|Overall Study||416
37411|NCT02638103|85301|P4|Safety Analysis Set|Overall Study||525
37412|NCT02638103|85302|P3|Safety Analysis Set|Overall Study||419
37413|NCT02638103|85303|P2|Safety Analysis Set|Overall Study||526
37414|NCT02638103|85304|P1|Safety Analysis Set|Overall Study||418
37415|NCT02638103|85301|P4|STARTED|Overall Study||525
37416|NCT02638103|85302|P3|STARTED|Overall Study||420
37417|NCT02638103|85303|P2|STARTED|Overall Study||526
37418|NCT02638103|85304|P1|STARTED|Overall Study||419
37419|NCT02638051|85380|P2|NOT COMPLETED|Overall Study||0
37420|NCT02638051|85381|P1|NOT COMPLETED|Overall Study||0
37421|NCT02638051|85380|P2|COMPLETED|Overall Study||130
37422|NCT02638051|85381|P1|COMPLETED|Overall Study||130
37423|NCT02638051|85380|P2|STARTED|Overall Study||130
37424|NCT02638051|85381|P1|STARTED|Overall Study||130
37425|NCT02637999|85394|P3|NOT COMPLETED|Overall Study||2
37426|NCT02637999|85395|P2|NOT COMPLETED|Overall Study||2
37427|NCT02637999|85396|P1|NOT COMPLETED|Overall Study||1
37428|NCT02637999|85394|P3|COMPLETED|Overall Study||6
37429|NCT02637999|85395|P2|COMPLETED|Overall Study||6
37430|NCT02637999|85396|P1|COMPLETED|Overall Study||7
37431|NCT02637999|85394|P3|STARTED|Overall Study||8
37432|NCT02637999|85395|P2|STARTED|Overall Study||8
37433|NCT02637999|85396|P1|STARTED|Overall Study||8
37434|NCT02637804|85430|P4|NOT COMPLETED|Second Intervention (1 Week)||0
37435|NCT02637804|85431|P3|NOT COMPLETED|Second Intervention (1 Week)||0
37436|NCT02637804|85432|P2|NOT COMPLETED|Second Intervention (1 Week)||0
37437|NCT02637804|85433|P1|NOT COMPLETED|Second Intervention (1 Week)||0
37438|NCT02637804|85430|P4|COMPLETED|Second Intervention (1 Week)||26
37439|NCT02637804|85431|P3|COMPLETED|Second Intervention (1 Week)||25
37440|NCT02637804|85432|P2|COMPLETED|Second Intervention (1 Week)||28
37441|NCT02637804|85433|P1|COMPLETED|Second Intervention (1 Week)||27
37442|NCT02637804|85430|P4|STARTED|Second Intervention (1 Week)||26
37443|NCT02637804|85431|P3|STARTED|Second Intervention (1 Week)||25
37444|NCT02637804|85432|P2|STARTED|Second Intervention (1 Week)||28
37445|NCT02637804|85433|P1|STARTED|Second Intervention (1 Week)||27
37446|NCT02637804|85430|P4|NOT COMPLETED|First Intervention (1 Week)||0
37447|NCT02637804|85431|P3|NOT COMPLETED|First Intervention (1 Week)||0
37448|NCT02637804|85432|P2|NOT COMPLETED|First Intervention (1 Week)||0
37449|NCT02637804|85433|P1|NOT COMPLETED|First Intervention (1 Week)||0
37450|NCT02637804|85430|P4|COMPLETED|First Intervention (1 Week)||26
37451|NCT02637804|85431|P3|COMPLETED|First Intervention (1 Week)||25
37452|NCT02637804|85432|P2|COMPLETED|First Intervention (1 Week)||28
37453|NCT02637804|85433|P1|COMPLETED|First Intervention (1 Week)||27
37454|NCT02637804|85430|P4|STARTED|First Intervention (1 Week)||26
37455|NCT02637804|85431|P3|STARTED|First Intervention (1 Week)||25
37456|NCT02637804|85432|P2|STARTED|First Intervention (1 Week)||28
37457|NCT02637804|85433|P1|STARTED|First Intervention (1 Week)||27
37458|NCT02637557|85541|P4|NOT COMPLETED|Overall Study||7
37459|NCT02637557|85542|P3|NOT COMPLETED|Overall Study||9
37460|NCT02637557|85543|P2|NOT COMPLETED|Overall Study||5
37461|NCT02637557|85544|P1|NOT COMPLETED|Overall Study||8
37462|NCT02637557|85541|P4|COMPLETED|Overall Study||62
37463|NCT02637557|85542|P3|COMPLETED|Overall Study||62
37464|NCT02637557|85543|P2|COMPLETED|Overall Study||66
37465|NCT02637557|85544|P1|COMPLETED|Overall Study||63
37466|NCT02637557|85541|P4|STARTED|Overall Study||69
37467|NCT02637557|85542|P3|STARTED|Overall Study||71
37468|NCT02637557|85543|P2|STARTED|Overall Study||71
37469|NCT02637557|85544|P1|STARTED|Overall Study||71
37470|NCT02637323|85636|P2|NOT COMPLETED|Overall Study||1
37471|NCT02637323|85637|P1|NOT COMPLETED|Overall Study||2
37472|NCT02637323|85636|P2|COMPLETED|Overall Study||17
37473|NCT02637323|85637|P1|COMPLETED|Overall Study||61
37474|NCT02637323|85636|P2|STARTED|Overall Study||18
37475|NCT02637323|85637|P1|STARTED|Overall Study||63
37476|NCT02637063|85648|P3|NOT COMPLETED|Overall Study||6
37477|NCT02637063|85649|P2|NOT COMPLETED|Overall Study||4
37478|NCT02637063|85650|P1|NOT COMPLETED|Overall Study||5
37479|NCT02637063|85648|P3|COMPLETED|Overall Study||62
37480|NCT02637063|85649|P2|COMPLETED|Overall Study||64
37481|NCT02637063|85650|P1|COMPLETED|Overall Study||62
37482|NCT02637063|85648|P3|STARTED|Overall Study||68
37483|NCT02637063|85649|P2|STARTED|Overall Study||68
37484|NCT02637063|85650|P1|STARTED|Overall Study||67
37485|NCT02637037|85678|P2|NOT COMPLETED|Overall Study||1
37486|NCT02637037|85679|P1|NOT COMPLETED|Overall Study||4
37487|NCT02637037|85678|P2|COMPLETED|Overall Study||39
37488|NCT02637037|85679|P1|COMPLETED|Overall Study||36
37489|NCT02637037|85678|P2|STARTED|Overall Study||40
37490|NCT02637037|85679|P1|STARTED|Overall Study||40
37491|NCT02636907|85745|P1|NOT COMPLETED|Extension Phase||10
37492|NCT02636907|85745|P1|COMPLETED|Extension Phase||62
37493|NCT02636907|85745|P1|STARTED|Extension Phase||72
37494|NCT02636907|85745|P1|NOT COMPLETED|Autoinjector Assessment Period||4
37495|NCT02636907|85745|P1|COMPLETED|Autoinjector Assessment Period|Completed autoinjector assessment period (Day 50).|73
37496|NCT02636907|85745|P1|STARTED|Autoinjector Assessment Period|Assigned to treatment.|77
37497|NCT02636608|85754|P1|NOT COMPLETED|Overall Study||11
37498|NCT02636608|85754|P1|COMPLETED|Overall Study||233
37499|NCT02636608|85754|P1|Received Treatment|Overall Study||243
37500|NCT02636608|85754|P1|STARTED|Overall Study||244
37501|NCT02636595|85782|P1|NOT COMPLETED|Overall Study||2
37502|NCT02636595|85782|P1|COMPLETED|Overall Study||119
37503|NCT02636595|85782|P1|STARTED|Overall Study||121
37504|NCT02636049|85788|P1|NOT COMPLETED|Overall Study||0
37505|NCT02636049|85788|P1|COMPLETED|Overall Study||12
37506|NCT02636049|85788|P1|Triferic 35 Micrograms/kg IV Push|Overall Study||12
37507|NCT02636049|85788|P1|Triferic 6 mg IV Over 3 Hours|Overall Study||12
37508|NCT02636049|85788|P1|STARTED|Overall Study||12
37509|NCT02635984|85802|P2|NOT COMPLETED|Overall Study||4
37510|NCT02635984|85803|P1|NOT COMPLETED|Overall Study||3
37511|NCT02635984|85802|P2|COMPLETED|Overall Study||51
37512|NCT02635984|85803|P1|COMPLETED|Overall Study||50
37513|NCT02635984|85802|P2|STARTED|Overall Study||55
37514|NCT02635984|85803|P1|STARTED|Overall Study||53
37515|NCT02635880|85823|P1|NOT COMPLETED|Overall Study||0
37516|NCT02635880|85823|P1|COMPLETED|Overall Study||32
37517|NCT02635880|85823|P1|STARTED|Overall Study||32
37518|NCT02635828|85828|P1|NOT COMPLETED|Overall Study||14
37519|NCT02635828|85828|P1|COMPLETED|Overall Study||40
37520|NCT02635828|85828|P1|STARTED|Overall Study||54
37521|NCT02635646|85835|P2|NOT COMPLETED|Overall Study||26
37522|NCT02635646|85836|P1|NOT COMPLETED|Overall Study||25
37523|NCT02635646|85835|P2|COMPLETED|Overall Study||39
37524|NCT02635646|85836|P1|COMPLETED|Overall Study||32
37525|NCT02635646|85835|P2|STARTED|Overall Study||65
37526|NCT02635646|85836|P1|STARTED|Overall Study||57
37527|NCT02635542|85852|P2|NOT COMPLETED|Overall Study||0
37528|NCT02635542|85853|P1|NOT COMPLETED|Overall Study||0
37529|NCT02635542|85852|P2|COMPLETED|Overall Study||50
37530|NCT02635542|85853|P1|COMPLETED|Overall Study||50
37531|NCT02635542|85852|P2|STARTED|Overall Study||50
37532|NCT02635542|85853|P1|STARTED|Overall Study||50
37533|NCT02635425|85863|P2|NOT COMPLETED|Overall Study||0
37534|NCT02635425|85864|P1|NOT COMPLETED|Overall Study||0
37535|NCT02635425|85863|P2|COMPLETED|Overall Study||15
37536|NCT02635425|85864|P1|COMPLETED|Overall Study||15
37537|NCT02635425|85863|P2|STARTED|Overall Study||15
37538|NCT02635425|85864|P1|STARTED|Overall Study||15
37539|NCT02635347|85872|P2|NOT COMPLETED|Overall Study||7
37540|NCT02635347|85873|P1|NOT COMPLETED|Overall Study||20
37541|NCT02635347|85872|P2|COMPLETED|Overall Study||63
37542|NCT02635347|85873|P1|COMPLETED|Overall Study||31
37543|NCT02635347|85872|P2|Analyses|Overall Study||63
37544|NCT02635347|85873|P1|Analyses|Overall Study||30
37545|NCT02635347|85872|P2|Follow up|Overall Study||63
37546|NCT02635347|85873|P1|Follow up|Overall Study||31
37547|NCT02635347|85872|P2|Protocol Completion|Overall Study||63
37548|NCT02635347|85873|P1|Protocol Completion|Overall Study||22
37549|NCT02635347|85872|P2|Enrollment|Overall Study||63
37550|NCT02635347|85873|P1|Enrollment|Overall Study||31
37551|NCT02635347|85872|P2|Screening|Overall Study||70
37552|NCT02635347|85873|P1|Screening|Overall Study||51
37553|NCT02635347|85872|P2|STARTED|Overall Study||70
37554|NCT02635347|85873|P1|STARTED|Overall Study||51
37555|NCT02635204|85904|P2|NOT COMPLETED|Overall Study||1
37556|NCT02635204|85905|P1|NOT COMPLETED|Overall Study||2
37557|NCT02635204|85904|P2|COMPLETED|Overall Study||88
37558|NCT02635204|85905|P1|COMPLETED|Overall Study||176
37559|NCT02635204|85904|P2|STARTED|Overall Study||89
37560|NCT02635204|85905|P1|STARTED|Overall Study||178
37561|NCT02634983|85915|P2|NOT COMPLETED|Period 2 (Second Treatment, 8-10 Days)||0
37562|NCT02634983|85916|P1|NOT COMPLETED|Period 2 (Second Treatment, 8-10 Days)||2
37563|NCT02634983|85915|P2|COMPLETED|Period 2 (Second Treatment, 8-10 Days)||15
37564|NCT02634983|85916|P1|COMPLETED|Period 2 (Second Treatment, 8-10 Days)||14
37565|NCT02634983|85915|P2|STARTED|Period 2 (Second Treatment, 8-10 Days)||15
37566|NCT02634983|85916|P1|STARTED|Period 2 (Second Treatment, 8-10 Days)||16
37567|NCT02634983|85915|P2|NOT COMPLETED|Washout (Approximately 7-14 Days)||0
37568|NCT02634983|85916|P1|NOT COMPLETED|Washout (Approximately 7-14 Days)||0
37569|NCT02634983|85915|P2|COMPLETED|Washout (Approximately 7-14 Days)||15
37570|NCT02634983|85916|P1|COMPLETED|Washout (Approximately 7-14 Days)||16
37571|NCT02634983|85915|P2|STARTED|Washout (Approximately 7-14 Days)||15
37572|NCT02634983|85916|P1|STARTED|Washout (Approximately 7-14 Days)||16
37573|NCT02634983|85915|P2|NOT COMPLETED|Period One (First Treatment, 8-10 Days)||0
37574|NCT02634983|85916|P1|NOT COMPLETED|Period One (First Treatment, 8-10 Days)||0
37575|NCT02634983|85915|P2|COMPLETED|Period One (First Treatment, 8-10 Days)||15
37576|NCT02634983|85916|P1|COMPLETED|Period One (First Treatment, 8-10 Days)||16
37577|NCT02634983|85915|P2|STARTED|Period One (First Treatment, 8-10 Days)||15
37578|NCT02634983|85916|P1|STARTED|Period One (First Treatment, 8-10 Days)||16
37579|NCT02634827|85936|P1|NOT COMPLETED|Overall Study||0
37580|NCT02634827|85936|P1|COMPLETED|Overall Study||1
37581|NCT02634827|85936|P1|STARTED|Overall Study||1
37582|NCT02634814|85950|P3|NOT COMPLETED|Overall Study||0
37583|NCT02634814|85951|P2|NOT COMPLETED|Overall Study||6
37584|NCT02634814|85952|P1|NOT COMPLETED|Overall Study||2
37585|NCT02634814|85950|P3|COMPLETED|Overall Study||29
37586|NCT02634814|85951|P2|COMPLETED|Overall Study||23
37587|NCT02634814|85952|P1|COMPLETED|Overall Study||30
37588|NCT02634814|85950|P3|STARTED|Overall Study||29
37589|NCT02634814|85951|P2|STARTED|Overall Study||29
37590|NCT02634814|85952|P1|STARTED|Overall Study||32
37591|NCT02634801|85975|P3|NOT COMPLETED|Follow-up Period||8
37592|NCT02634801|85976|P2|NOT COMPLETED|Follow-up Period||8
37593|NCT02634801|85977|P1|NOT COMPLETED|Follow-up Period||5
37594|NCT02634801|85975|P3|COMPLETED|Follow-up Period||38
37595|NCT02634801|85976|P2|COMPLETED|Follow-up Period||18
37596|NCT02634801|85977|P1|COMPLETED|Follow-up Period||36
37597|NCT02634801|85975|P3|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|46
37598|NCT02634801|85976|P2|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|26
37685|NCT02633800|86360|P1|NOT COMPLETED|Overall Study||44
37599|NCT02634801|85977|P1|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|41
37600|NCT02634801|85975|P3|NOT COMPLETED|Extension Period (Weeks 24 to 36)||2
37601|NCT02634801|85976|P2|NOT COMPLETED|Extension Period (Weeks 24 to 36)||1
37602|NCT02634801|85977|P1|NOT COMPLETED|Extension Period (Weeks 24 to 36)||3
37603|NCT02634801|85975|P3|COMPLETED|Extension Period (Weeks 24 to 36)||29
37604|NCT02634801|85976|P2|COMPLETED|Extension Period (Weeks 24 to 36)||18
37605|NCT02634801|85977|P1|COMPLETED|Extension Period (Weeks 24 to 36)||45
37606|NCT02634801|85975|P3|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|31
37607|NCT02634801|85976|P2|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|19
37608|NCT02634801|85977|P1|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|48
37609|NCT02634801|85975|P3|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||5
37610|NCT02634801|85976|P2|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||31
37611|NCT02634801|85977|P1|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||4
37612|NCT02634801|85975|P3|COMPLETED|Treatment Period (Weeks 0 to 24)||49
37613|NCT02634801|85976|P2|COMPLETED|Treatment Period (Weeks 0 to 24)||23
37614|NCT02634801|85977|P1|COMPLETED|Treatment Period (Weeks 0 to 24)||50
37615|NCT02634801|85975|P3|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52
37616|NCT02634801|85976|P2|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52
37617|NCT02634801|85977|P1|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||54
37618|NCT02634801|85975|P3|STARTED|Treatment Period (Weeks 0 to 24)||54
37619|NCT02634801|85976|P2|STARTED|Treatment Period (Weeks 0 to 24)||54
37620|NCT02634801|85977|P1|STARTED|Treatment Period (Weeks 0 to 24)||54
37621|NCT02634788|86077|P4|NOT COMPLETED|Overall Study||5
37622|NCT02634788|86078|P3|NOT COMPLETED|Overall Study||5
37623|NCT02634788|86079|P2|NOT COMPLETED|Overall Study||10
37624|NCT02634788|86080|P1|NOT COMPLETED|Overall Study||4
37625|NCT02634788|86077|P4|COMPLETED|Overall Study||77
37626|NCT02634788|86078|P3|COMPLETED|Overall Study||75
37627|NCT02634788|86079|P2|COMPLETED|Overall Study||71
37628|NCT02634788|86080|P1|COMPLETED|Overall Study||75
37629|NCT02634788|86077|P4|STARTED|Overall Study||82
37630|NCT02634788|86078|P3|STARTED|Overall Study||80
37631|NCT02634788|86079|P2|STARTED|Overall Study||81
37632|NCT02634788|86080|P1|STARTED|Overall Study||79
37633|NCT02634606|86146|P1|NOT COMPLETED|Overall Study||13
37634|NCT02634606|86146|P1|COMPLETED|Overall Study||0
37635|NCT02634606|86146|P1|STARTED|Overall Study||13
37636|NCT02634580|86158|P4|NOT COMPLETED|Overall Study||1
37637|NCT02634580|86159|P3|NOT COMPLETED|Overall Study||1
37638|NCT02634580|86160|P2|NOT COMPLETED|Overall Study||0
37639|NCT02634580|86161|P1|NOT COMPLETED|Overall Study||1
37640|NCT02634580|86158|P4|COMPLETED|Overall Study||20
37641|NCT02634580|86159|P3|COMPLETED|Overall Study||18
37642|NCT02634580|86160|P2|COMPLETED|Overall Study||11
37643|NCT02634580|86161|P1|COMPLETED|Overall Study||9
37644|NCT02634580|86158|P4|STARTED|Overall Study||21
37645|NCT02634580|86159|P3|STARTED|Overall Study||19
37646|NCT02634580|86160|P2|STARTED|Overall Study||11
37647|NCT02634580|86161|P1|STARTED|Overall Study||10
37648|NCT02634346|86218|P3|NOT COMPLETED|Overall Study||23
37649|NCT02634346|86219|P2|NOT COMPLETED|Overall Study||14
37650|NCT02634346|86220|P1|NOT COMPLETED|Overall Study||12
37651|NCT02634346|86218|P3|COMPLETED|Overall Study||111
37652|NCT02634346|86219|P2|COMPLETED|Overall Study||119
37653|NCT02634346|86220|P1|COMPLETED|Overall Study||122
37654|NCT02634346|86218|P3|STARTED|Overall Study||134
37655|NCT02634346|86219|P2|STARTED|Overall Study||133
37656|NCT02634346|86220|P1|STARTED|Overall Study||134
37657|NCT02634320|86234|P1|NOT COMPLETED|Overall Study||16
37658|NCT02634320|86234|P1|COMPLETED|Overall Study||35
37659|NCT02634320|86234|P1|STARTED|Overall Study||51
37660|NCT02634073|86243|P4|NOT COMPLETED|Overall Study||0
37661|NCT02634073|86244|P3|NOT COMPLETED|Overall Study||0
37662|NCT02634073|86245|P2|NOT COMPLETED|Overall Study||0
37663|NCT02634073|86246|P1|NOT COMPLETED|Overall Study||0
37664|NCT02634073|86243|P4|COMPLETED|Overall Study||4
37665|NCT02634073|86244|P3|COMPLETED|Overall Study||4
37666|NCT02634073|86245|P2|COMPLETED|Overall Study||4
37667|NCT02634073|86246|P1|COMPLETED|Overall Study||4
37668|NCT02634073|86243|P4|STARTED|Overall Study||4
37669|NCT02634073|86244|P3|STARTED|Overall Study||4
37670|NCT02634073|86245|P2|STARTED|Overall Study||4
37671|NCT02634073|86246|P1|STARTED|Overall Study||4
37672|NCT02633956|86336|P4|NOT COMPLETED|Overall Study||0
37673|NCT02633956|86337|P3|NOT COMPLETED|Overall Study||2
37674|NCT02633956|86338|P2|NOT COMPLETED|Overall Study||2
37675|NCT02633956|86339|P1|NOT COMPLETED|Overall Study||1
37676|NCT02633956|86336|P4|COMPLETED|Overall Study||21
37677|NCT02633956|86337|P3|COMPLETED|Overall Study||20
37678|NCT02633956|86338|P2|COMPLETED|Overall Study||19
37679|NCT02633956|86339|P1|COMPLETED|Overall Study||19
37680|NCT02633956|86336|P4|STARTED|Overall Study||21
37681|NCT02633956|86337|P3|STARTED|Overall Study||22
37682|NCT02633956|86338|P2|STARTED|Overall Study||21
37683|NCT02633956|86339|P1|STARTED|Overall Study||20
37684|NCT02633800|86359|P2|NOT COMPLETED|Overall Study||43
37686|NCT02633800|86359|P2|COMPLETED|Overall Study||0
37687|NCT02633800|86360|P1|COMPLETED|Overall Study||0
37688|NCT02633800|86359|P2|STARTED|Overall Study||43
37689|NCT02633800|86360|P1|STARTED|Overall Study||44
37690|NCT02633787|86370|P1|NOT COMPLETED|Overall Study||1
37691|NCT02633787|86370|P1|COMPLETED|Overall Study||109
37692|NCT02633787|86370|P1|STARTED|Overall Study||110
37693|NCT02633501|86382|P6|NOT COMPLETED|Overall Study||15
37694|NCT02633501|86383|P5|NOT COMPLETED|Overall Study||11
37695|NCT02633501|86384|P4|NOT COMPLETED|Overall Study||4
37696|NCT02633501|86385|P3|NOT COMPLETED|Overall Study||7
37697|NCT02633501|86386|P2|NOT COMPLETED|Overall Study||3
37698|NCT02633501|86387|P1|NOT COMPLETED|Overall Study||2
37699|NCT02633501|86382|P6|COMPLETED|Overall Study||48
37700|NCT02633501|86383|P5|COMPLETED|Overall Study||53
37701|NCT02633501|86384|P4|COMPLETED|Overall Study||59
37702|NCT02633501|86385|P3|COMPLETED|Overall Study||55
37703|NCT02633501|86386|P2|COMPLETED|Overall Study||11
37704|NCT02633501|86387|P1|COMPLETED|Overall Study||12
37705|NCT02633501|86382|P6|STARTED|Overall Study||63
37706|NCT02633501|86383|P5|STARTED|Overall Study||64
37707|NCT02633501|86384|P4|STARTED|Overall Study||63
37708|NCT02633501|86385|P3|STARTED|Overall Study||62
37709|NCT02633501|86386|P2|STARTED|Overall Study||14
37710|NCT02633501|86387|P1|STARTED|Overall Study||14
37711|NCT02633371|86406|P1|NOT COMPLETED|Overall Study||3
37712|NCT02633371|86406|P1|COMPLETED|Overall Study||7
37713|NCT02633371|86406|P1|STARTED|Overall Study||10
37714|NCT02633358|86412|P2|NOT COMPLETED|Overall Study||0
37715|NCT02633358|86413|P1|NOT COMPLETED|Overall Study||0
37716|NCT02633358|86412|P2|COMPLETED|Overall Study||54
37717|NCT02633358|86413|P1|COMPLETED|Overall Study||87
37718|NCT02633358|86412|P2|STARTED|Overall Study||54
37719|NCT02633358|86413|P1|STARTED|Overall Study||87
37720|NCT02633241|86427|P1|NOT COMPLETED|Overall Study||3
37721|NCT02633241|86427|P1|COMPLETED|Overall Study||27
37722|NCT02633241|86427|P1|STARTED|Overall Study||30
37723|NCT02633215|86440|P2|NOT COMPLETED|Overall Study||3
37724|NCT02633215|86441|P1|NOT COMPLETED|Overall Study||2
37725|NCT02633215|86440|P2|COMPLETED|Overall Study||15
37726|NCT02633215|86441|P1|COMPLETED|Overall Study||16
37727|NCT02633215|86440|P2|STARTED|Overall Study||18
37728|NCT02633215|86441|P1|STARTED|Overall Study||18
37729|NCT02632838|86453|P2|NOT COMPLETED|Overall Study||2
37730|NCT02632838|86454|P1|NOT COMPLETED|Overall Study||3
37731|NCT02632838|86453|P2|COMPLETED|Overall Study||13
37732|NCT02632838|86454|P1|COMPLETED|Overall Study||12
37733|NCT02632838|86453|P2|STARTED|Overall Study||15
37734|NCT02632838|86454|P1|STARTED|Overall Study||15
37735|NCT02632812|86470|P2|NOT COMPLETED|Overall Study||0
37736|NCT02632812|86471|P1|NOT COMPLETED|Overall Study||0
37737|NCT02632812|86470|P2|COMPLETED|Overall Study||12
37738|NCT02632812|86471|P1|COMPLETED|Overall Study||12
37739|NCT02632812|86470|P2|STARTED|Overall Study||12
37740|NCT02632812|86471|P1|STARTED|Overall Study||12
37741|NCT02632786|86491|P2|NOT COMPLETED|Overall Study||7
37742|NCT02632786|86492|P1|NOT COMPLETED|Overall Study||11
37743|NCT02632786|86491|P2|COMPLETED|Overall Study||56
37744|NCT02632786|86492|P1|COMPLETED|Overall Study||55
37745|NCT02632786|86491|P2|Randomized and Dosed|Overall Study||63
37746|NCT02632786|86492|P1|Randomized and Dosed|Overall Study||66
37747|NCT02632786|86491|P2|Informed Consent Obtained|Overall Study||63
37748|NCT02632786|86492|P1|Informed Consent Obtained|Overall Study||66
37749|NCT02632786|86491|P2|STARTED|Overall Study||63
37750|NCT02632786|86492|P1|STARTED|Overall Study||66
37751|NCT02632526|86516|P6|NOT COMPLETED|Overall Study||0
37752|NCT02632526|86517|P5|NOT COMPLETED|Overall Study||0
37753|NCT02632526|86518|P4|NOT COMPLETED|Overall Study||0
37754|NCT02632526|86519|P3|NOT COMPLETED|Overall Study||0
37755|NCT02632526|86520|P2|NOT COMPLETED|Overall Study||0
37756|NCT02632526|86521|P1|NOT COMPLETED|Overall Study||0
37757|NCT02632526|86516|P6|COMPLETED|Overall Study||8
37758|NCT02632526|86517|P5|COMPLETED|Overall Study||4
37759|NCT02632526|86518|P4|COMPLETED|Overall Study||12
37760|NCT02632526|86519|P3|COMPLETED|Overall Study||24
37761|NCT02632526|86520|P2|COMPLETED|Overall Study||12
37762|NCT02632526|86521|P1|COMPLETED|Overall Study||36
37763|NCT02632526|86516|P6|STARTED|Overall Study||8
37764|NCT02632526|86517|P5|STARTED|Overall Study||4
37765|NCT02632526|86518|P4|STARTED|Overall Study||12
37766|NCT02632526|86519|P3|STARTED|Overall Study||24
37767|NCT02632526|86520|P2|STARTED|Overall Study||12
37768|NCT02632526|86521|P1|STARTED|Overall Study||36
37769|NCT02632110|86702|P10|NOT COMPLETED|Overall Study||1
37770|NCT02632110|86703|P9|NOT COMPLETED|Overall Study||1
37771|NCT02632110|86704|P8|NOT COMPLETED|Overall Study||3
37772|NCT02632110|86705|P7|NOT COMPLETED|Overall Study||3
37773|NCT02632110|86706|P6|NOT COMPLETED|Overall Study||1
37774|NCT02632110|86707|P5|NOT COMPLETED|Overall Study||1
37775|NCT02632110|86708|P4|NOT COMPLETED|Overall Study||0
37776|NCT02632110|86709|P3|NOT COMPLETED|Overall Study||0
37777|NCT02632110|86710|P2|NOT COMPLETED|Overall Study||1
37778|NCT02632110|86711|P1|NOT COMPLETED|Overall Study||1
37779|NCT02632110|86702|P10|COMPLETED|Overall Study||29
37780|NCT02632110|86703|P9|COMPLETED|Overall Study||29
37781|NCT02632110|86704|P8|COMPLETED|Overall Study||23
37782|NCT02632110|86705|P7|COMPLETED|Overall Study||23
37783|NCT02632110|86706|P6|COMPLETED|Overall Study||28
37784|NCT02632110|86707|P5|COMPLETED|Overall Study||28
37785|NCT02632110|86708|P4|COMPLETED|Overall Study||27
37786|NCT02632110|86709|P3|COMPLETED|Overall Study||27
37787|NCT02632110|86710|P2|COMPLETED|Overall Study||24
37788|NCT02632110|86711|P1|COMPLETED|Overall Study||24
37789|NCT02632110|86702|P10|STARTED|Overall Study||30
37790|NCT02632110|86703|P9|STARTED|Overall Study||30
37791|NCT02632110|86704|P8|STARTED|Overall Study||26
37792|NCT02632110|86705|P7|STARTED|Overall Study||26
37793|NCT02632110|86706|P6|STARTED|Overall Study||29
37794|NCT02632110|86707|P5|STARTED|Overall Study||29
37795|NCT02632110|86708|P4|STARTED|Overall Study||27
37796|NCT02632110|86709|P3|STARTED|Overall Study||27
37797|NCT02632110|86710|P2|STARTED|Overall Study||25
37798|NCT02632110|86711|P1|STARTED|Overall Study||25
37799|NCT02631772|87180|P2|NOT COMPLETED|Overall Study||0
37800|NCT02631772|87181|P1|NOT COMPLETED|Overall Study||0
37801|NCT02631772|87180|P2|COMPLETED|Overall Study||16
37802|NCT02631772|87181|P1|COMPLETED|Overall Study||16
37803|NCT02631772|87180|P2|STARTED|Overall Study||16
37804|NCT02631772|87181|P1|STARTED|Overall Study||16
37805|NCT02631746|87191|P1|NOT COMPLETED|Overall Study||3
37806|NCT02631746|87191|P1|COMPLETED|Overall Study||0
37807|NCT02631746|87191|P1|STARTED|Overall Study||3
37808|NCT02631551|87206|P4|NOT COMPLETED|Overall Study||11
37809|NCT02631551|87207|P3|NOT COMPLETED|Overall Study||11
37810|NCT02631551|87208|P2|NOT COMPLETED|Overall Study||19
37811|NCT02631551|87209|P1|NOT COMPLETED|Overall Study||13
37812|NCT02631551|87206|P4|COMPLETED|Overall Study||276
37813|NCT02631551|87207|P3|COMPLETED|Overall Study||283
37814|NCT02631551|87208|P2|COMPLETED|Overall Study||278
37815|NCT02631551|87209|P1|COMPLETED|Overall Study||289
37816|NCT02631551|87206|P4|STARTED|Overall Study||287
37817|NCT02631551|87207|P3|STARTED|Overall Study||294
37818|NCT02631551|87208|P2|STARTED|Overall Study||297
37819|NCT02631551|87209|P1|STARTED|Overall Study||302
37820|NCT02631057|87221|P2|NOT COMPLETED|Overall Study||0
37821|NCT02631057|87222|P1|NOT COMPLETED|Overall Study||0
37822|NCT02631057|87221|P2|COMPLETED|Overall Study||3414
37823|NCT02631057|87222|P1|COMPLETED|Overall Study||899
37824|NCT02631057|87221|P2|STARTED|Overall Study||3414
37825|NCT02631057|87222|P1|STARTED|Overall Study||899
37826|NCT02630992|87228|P1|NOT COMPLETED|Overall Study||13
37827|NCT02630992|87228|P1|COMPLETED|Overall Study||99
37828|NCT02630992|87228|P1|STARTED|Overall Study||112
37829|NCT02630966|87247|P2|NOT COMPLETED|Overall Study||8
37830|NCT02630966|87248|P1|NOT COMPLETED|Overall Study||2
37831|NCT02630966|87247|P2|COMPLETED|Overall Study||10
37832|NCT02630966|87248|P1|COMPLETED|Overall Study||14
37833|NCT02630966|87247|P2|STARTED|Overall Study||18
37834|NCT02630966|87248|P1|STARTED|Overall Study||16
37835|NCT02630719|87266|P2|NOT COMPLETED|Overall Study||0
37836|NCT02630719|87267|P1|NOT COMPLETED|Overall Study||0
37837|NCT02630719|87266|P2|COMPLETED|Overall Study||6
37838|NCT02630719|87267|P1|COMPLETED|Overall Study||4
37839|NCT02630719|87266|P2|STARTED|Overall Study||6
37840|NCT02630719|87267|P1|STARTED|Overall Study||4
37841|NCT02630706|87276|P3|NOT COMPLETED|Overall Study||10
37842|NCT02630706|87277|P2|NOT COMPLETED|Overall Study||9
37843|NCT02630706|87278|P1|NOT COMPLETED|Overall Study||7
37844|NCT02630706|87276|P3|COMPLETED|Overall Study||157
37845|NCT02630706|87277|P2|COMPLETED|Overall Study||160
37846|NCT02630706|87278|P1|COMPLETED|Overall Study||163
37847|NCT02630706|87276|P3|Treated|Overall Study||167
37848|NCT02630706|87277|P2|Treated|Overall Study||169
37849|NCT02630706|87278|P1|Treated|Overall Study||170
37850|NCT02630706|87276|P3|STARTED|Overall Study||167
37851|NCT02630706|87277|P2|STARTED|Overall Study||169
37852|NCT02630706|87278|P1|STARTED|Overall Study||170
37853|NCT02630693|87387|P2|NOT COMPLETED|Overall Study||1
37854|NCT02630693|87388|P1|NOT COMPLETED|Overall Study||0
37855|NCT02630693|87387|P2|COMPLETED|Overall Study||89
37856|NCT02630693|87388|P1|COMPLETED|Overall Study||90
37857|NCT02630693|87387|P2|STARTED|Overall Study||90
37858|NCT02630693|87388|P1|STARTED|Overall Study||90
37859|NCT02630563|87400|P1|NOT COMPLETED|Overall Study||1
37860|NCT02630563|87400|P1|COMPLETED|Overall Study||8
37861|NCT02630563|87400|P1|STARTED|Overall Study||9
37862|NCT02630472|87411|P2|NOT COMPLETED|Overall Study||0
37863|NCT02630472|87412|P1|NOT COMPLETED|Overall Study||10
37864|NCT02630472|87411|P2|COMPLETED|Overall Study||0
37865|NCT02630472|87412|P1|COMPLETED|Overall Study||0
37866|NCT02630472|87411|P2|STARTED|Overall Study||0
37867|NCT02630472|87412|P1|STARTED|Overall Study||10
37868|NCT02630459|87430|P4|NOT COMPLETED|Overall Study||3
37869|NCT02630459|87431|P3|NOT COMPLETED|Overall Study||5
37870|NCT02630459|87432|P2|NOT COMPLETED|Overall Study||2
37871|NCT02630459|87433|P1|NOT COMPLETED|Overall Study||3
37872|NCT02630459|87430|P4|COMPLETED|Overall Study||134
37873|NCT02630459|87431|P3|COMPLETED|Overall Study||130
37874|NCT02630459|87432|P2|COMPLETED|Overall Study||65
37875|NCT02630459|87433|P1|COMPLETED|Overall Study||133
37876|NCT02630459|87430|P4|Received Investigational Product|Overall Study||137
37877|NCT02630459|87431|P3|Received Investigational Product|Overall Study||135
37878|NCT02630459|87432|P2|Received Investigational Product|Overall Study||66
37879|NCT02630459|87433|P1|Received Investigational Product|Overall Study||136
37880|NCT02630459|87430|P4|STARTED|Overall Study||137
37881|NCT02630459|87431|P3|STARTED|Overall Study||135
37882|NCT02630459|87432|P2|STARTED|Overall Study||67
37883|NCT02630459|87433|P1|STARTED|Overall Study||136
37884|NCT02630186|87451|P1|NOT COMPLETED|Overall Study||1
37885|NCT02630186|87451|P1|COMPLETED|Overall Study||2
37886|NCT02630186|87451|P1|STARTED|Overall Study||3
37887|NCT02629965|87467|P2|NOT COMPLETED|Period 2||0
37888|NCT02629965|87468|P1|NOT COMPLETED|Period 2||1
37889|NCT02629965|87467|P2|COMPLETED|Period 2||90
37890|NCT02629965|87468|P1|COMPLETED|Period 2||87
37891|NCT02629965|87467|P2|STARTED|Period 2||90
37892|NCT02629965|87468|P1|STARTED|Period 2||88
37893|NCT02629965|87467|P2|NOT COMPLETED|Period 1||2
37894|NCT02629965|87468|P1|NOT COMPLETED|Period 1||4
37895|NCT02629965|87467|P2|COMPLETED|Period 1||90
37896|NCT02629965|87468|P1|COMPLETED|Period 1||88
37897|NCT02629965|87467|P2|STARTED|Period 1||92
37898|NCT02629965|87468|P1|STARTED|Period 1||92
37899|NCT02629861|87507|P3|NOT COMPLETED|Overall Study||28
37900|NCT02629861|87508|P2|NOT COMPLETED|Overall Study||27
37901|NCT02629861|87509|P1|NOT COMPLETED|Overall Study||29
37902|NCT02629861|87507|P3|COMPLETED|Overall Study||262
37903|NCT02629861|87508|P2|COMPLETED|Overall Study||264
37904|NCT02629861|87509|P1|COMPLETED|Overall Study||265
37905|NCT02629861|87507|P3|Full Analysis Set|Overall Study||287
37906|NCT02629861|87508|P2|Full Analysis Set|Overall Study||288
37907|NCT02629861|87509|P1|Full Analysis Set|Overall Study||290
37908|NCT02629861|87507|P3|Safety Population|Overall Study||289
37909|NCT02629861|87508|P2|Safety Population|Overall Study||291
37910|NCT02629861|87509|P1|Safety Population|Overall Study||294
37911|NCT02629861|87507|P3|Intent to Treat (ITT)|Overall Study||290
37912|NCT02629861|87508|P2|Intent to Treat (ITT)|Overall Study||291
37913|NCT02629861|87509|P1|Intent to Treat (ITT)|Overall Study||294
37914|NCT02629861|87507|P3|STARTED|Overall Study||290
37915|NCT02629861|87508|P2|STARTED|Overall Study||291
37916|NCT02629861|87509|P1|STARTED|Overall Study||294
37917|NCT02629354|87558|P2|NOT COMPLETED|Follow-up||0
37918|NCT02629354|87559|P1|NOT COMPLETED|Follow-up||0
37919|NCT02629354|87558|P2|COMPLETED|Follow-up||18
37920|NCT02629354|87559|P1|COMPLETED|Follow-up||18
37921|NCT02629354|87558|P2|STARTED|Follow-up||18
37922|NCT02629354|87559|P1|STARTED|Follow-up||18
37923|NCT02629354|87558|P2|NOT COMPLETED|Period 2||0
37924|NCT02629354|87559|P1|NOT COMPLETED|Period 2||0
37925|NCT02629354|87558|P2|COMPLETED|Period 2||18
37926|NCT02629354|87559|P1|COMPLETED|Period 2||18
37927|NCT02629354|87558|P2|STARTED|Period 2||18
37928|NCT02629354|87559|P1|STARTED|Period 2||18
37929|NCT02629354|87558|P2|NOT COMPLETED|Washout Period||0
37930|NCT02629354|87559|P1|NOT COMPLETED|Washout Period||0
37931|NCT02629354|87558|P2|COMPLETED|Washout Period||18
37932|NCT02629354|87559|P1|COMPLETED|Washout Period||18
37933|NCT02629354|87558|P2|STARTED|Washout Period||18
37934|NCT02629354|87559|P1|STARTED|Washout Period||18
37935|NCT02629354|87558|P2|NOT COMPLETED|Period 1||0
37936|NCT02629354|87559|P1|NOT COMPLETED|Period 1||0
37937|NCT02629354|87558|P2|COMPLETED|Period 1||18
37938|NCT02629354|87559|P1|COMPLETED|Period 1||18
37939|NCT02629354|87558|P2|STARTED|Period 1||18
37940|NCT02629354|87559|P1|STARTED|Period 1||18
37941|NCT02629159|87584|P3|NOT COMPLETED|Overall Study||51
37942|NCT02629159|87585|P2|NOT COMPLETED|Overall Study||39
37943|NCT02629159|87586|P1|NOT COMPLETED|Overall Study||56
37944|NCT02629159|87584|P3|COMPLETED|Overall Study||600
37945|NCT02629159|87585|P2|COMPLETED|Overall Study||288
37946|NCT02629159|87586|P1|COMPLETED|Overall Study||595
37947|NCT02629159|87584|P3|Rescued at Week 22|Overall Study||18
37948|NCT02629159|87585|P2|Rescued at Week 22|Overall Study||7
37949|NCT02629159|87586|P1|Rescued at Week 22|Overall Study||26
37950|NCT02629159|87584|P3|Rescued at Week 18|Overall Study||29
37951|NCT02629159|87585|P2|Rescued at Week 18|Overall Study||14
37952|NCT02629159|87586|P1|Rescued at Week 18|Overall Study|One participant rescued at week 18 did not receive any dose of upadacitinib|48
37953|NCT02629159|87584|P3|Rescued at Week 14|Overall Study||78
37954|NCT02629159|87585|P2|Rescued at Week 14|Overall Study||56
37955|NCT02629159|87586|P1|Rescued at Week 14|Overall Study||231
37956|NCT02629159|87584|P3|Completed Week 14 on Study Drug|Overall Study||620
37957|NCT02629159|87585|P2|Completed Week 14 on Study Drug|Overall Study||300
37958|NCT02629159|87586|P1|Completed Week 14 on Study Drug|Overall Study||620
37959|NCT02629159|87584|P3|Received Assigned Study Drug|Overall Study|One participant received a placebo injection but no oral study drug before discontinuing the study|650
37960|NCT02629159|87585|P2|Received Assigned Study Drug|Overall Study||327
37961|NCT02629159|87586|P1|Received Assigned Study Drug|Overall Study||651
37962|NCT02629159|87584|P3|STARTED|Overall Study||651
37963|NCT02629159|87585|P2|STARTED|Overall Study||327
37964|NCT02629159|87586|P1|STARTED|Overall Study||651
37965|NCT02629094|87636|P1|NOT COMPLETED|Overall Study||0
37966|NCT02629094|87636|P1|COMPLETED|Overall Study||5
37967|NCT02629094|87636|P1|STARTED|Overall Study||5
37968|NCT02628938|87644|P3|NOT COMPLETED|Overall Study||4
37969|NCT02628938|87645|P2|NOT COMPLETED|Overall Study||2
37970|NCT02628938|87646|P1|NOT COMPLETED|Overall Study||5
37971|NCT02628938|87644|P3|COMPLETED|Overall Study||11
37972|NCT02628938|87645|P2|COMPLETED|Overall Study||13
37973|NCT02628938|87646|P1|COMPLETED|Overall Study||10
37974|NCT02628938|87644|P3|STARTED|Overall Study||15
37975|NCT02628938|87645|P2|STARTED|Overall Study||15
37976|NCT02628938|87646|P1|STARTED|Overall Study||15
37977|NCT02628743|87660|P1|NOT COMPLETED|Overall Study||131
37978|NCT02628743|87660|P1|COMPLETED|Overall Study||0
37979|NCT02628743|87660|P1|STARTED|Overall Study||131
37980|NCT02628600|87686|P2|NOT COMPLETED|Overall Study||32
37981|NCT02628600|87687|P1|NOT COMPLETED|Overall Study||24
37982|NCT02628600|87686|P2|COMPLETED|Overall Study||58
37983|NCT02628600|87687|P1|COMPLETED|Overall Study||49
37984|NCT02628600|87686|P2|Participant Discontinued the Study|Overall Study||32
37985|NCT02628600|87687|P1|Participant Discontinued the Study|Overall Study||24
37986|NCT02628600|87686|P2|STARTED|Overall Study||90
37987|NCT02628600|87687|P1|STARTED|Overall Study||73
37988|NCT02628418|87701|P2|NOT COMPLETED|Overall Study||2
37989|NCT02628418|87702|P1|NOT COMPLETED|Overall Study||1
37990|NCT02628418|87701|P2|COMPLETED|Overall Study||13
37991|NCT02628418|87702|P1|COMPLETED|Overall Study||14
37992|NCT02628418|87701|P2|STARTED|Overall Study||15
37993|NCT02628418|87702|P1|STARTED|Overall Study||15
37994|NCT02628236|87723|P1|NOT COMPLETED|Overall Study||0
37995|NCT02628236|87723|P1|COMPLETED|Overall Study||14
37996|NCT02628236|87723|P1|STARTED|Overall Study||14
37997|NCT02628106|87760|P1|NOT COMPLETED|Overall Study||0
37998|NCT02628106|87760|P1|COMPLETED|Overall Study||21
37999|NCT02628106|87760|P1|STARTED|Overall Study||21
38000|NCT02628028|87772|P8|NOT COMPLETED|Long-term Extension (LTE) Period||61
38001|NCT02628028|87773|P7|NOT COMPLETED|Long-term Extension (LTE) Period||58
38002|NCT02628028|87774|P6|NOT COMPLETED|Long-term Extension (LTE) Period||60
38003|NCT02628028|87775|P5|NOT COMPLETED|Long-term Extension (LTE) Period||0
38004|NCT02628028|87776|P4|NOT COMPLETED|Long-term Extension (LTE) Period||0
38005|NCT02628028|87777|P3|NOT COMPLETED|Long-term Extension (LTE) Period||0
38006|NCT02628028|87778|P2|NOT COMPLETED|Long-term Extension (LTE) Period||0
38007|NCT02628028|87779|P1|NOT COMPLETED|Long-term Extension (LTE) Period||0
38008|NCT02628028|87772|P8|COMPLETED|Long-term Extension (LTE) Period||0
38009|NCT02628028|87773|P7|COMPLETED|Long-term Extension (LTE) Period||0
38010|NCT02628028|87774|P6|COMPLETED|Long-term Extension (LTE) Period||1
38011|NCT02628028|87775|P5|COMPLETED|Long-term Extension (LTE) Period||0
38012|NCT02628028|87776|P4|COMPLETED|Long-term Extension (LTE) Period||0
38013|NCT02628028|87777|P3|COMPLETED|Long-term Extension (LTE) Period||0
38014|NCT02628028|87778|P2|COMPLETED|Long-term Extension (LTE) Period||0
38015|NCT02628028|87779|P1|COMPLETED|Long-term Extension (LTE) Period||0
38016|NCT02628028|87772|P8|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
38017|NCT02628028|87773|P7|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
38018|NCT02628028|87774|P6|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
38019|NCT02628028|87775|P5|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
38020|NCT02628028|87776|P4|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
38021|NCT02628028|87777|P3|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
38022|NCT02628028|87778|P2|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
38023|NCT02628028|87779|P1|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
38024|NCT02628028|87772|P8|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|61
38025|NCT02628028|87773|P7|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|58
38026|NCT02628028|87774|P6|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|61
38027|NCT02628028|87775|P5|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;42 participants completed part B placebo period,re-randomized to LTE period.|0
38028|NCT02628028|87776|P4|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
38029|NCT02628028|87777|P3|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
38030|NCT02628028|87778|P2|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
38031|NCT02628028|87779|P1|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
38032|NCT02628028|87772|P8|NOT COMPLETED|Dosing Period||15
38033|NCT02628028|87773|P7|NOT COMPLETED|Dosing Period||16
38034|NCT02628028|87774|P6|NOT COMPLETED|Dosing Period||14
38035|NCT02628028|87775|P5|NOT COMPLETED|Dosing Period||16
38036|NCT02628028|87776|P4|NOT COMPLETED|Dosing Period||0
38037|NCT02628028|87777|P3|NOT COMPLETED|Dosing Period||1
38038|NCT02628028|87778|P2|NOT COMPLETED|Dosing Period||0
38039|NCT02628028|87779|P1|NOT COMPLETED|Dosing Period||0
38040|NCT02628028|87772|P8|COMPLETED|Dosing Period||48
38041|NCT02628028|87773|P7|COMPLETED|Dosing Period||46
38042|NCT02628028|87774|P6|COMPLETED|Dosing Period||49
38043|NCT02628028|87775|P5|COMPLETED|Dosing Period||46
38044|NCT02628028|87776|P4|COMPLETED|Dosing Period||8
38045|NCT02628028|87777|P3|COMPLETED|Dosing Period||9
38046|NCT02628028|87778|P2|COMPLETED|Dosing Period||9
38047|NCT02628028|87779|P1|COMPLETED|Dosing Period||9
38048|NCT02628028|87772|P8|Received at Least 1dose of Study Drug|Dosing Period||63
38143|NCT02625922|88093|P2|Completed Treatment Period 1|Overall Study||10
38049|NCT02628028|87773|P7|Received at Least 1dose of Study Drug|Dosing Period||62
38050|NCT02628028|87774|P6|Received at Least 1dose of Study Drug|Dosing Period||63
38051|NCT02628028|87775|P5|Received at Least 1dose of Study Drug|Dosing Period||62
38052|NCT02628028|87776|P4|Received at Least 1dose of Study Drug|Dosing Period||8
38053|NCT02628028|87777|P3|Received at Least 1dose of Study Drug|Dosing Period||10
38054|NCT02628028|87778|P2|Received at Least 1dose of Study Drug|Dosing Period||9
38055|NCT02628028|87779|P1|Received at Least 1dose of Study Drug|Dosing Period||9
38056|NCT02628028|87772|P8|STARTED|Dosing Period||63
38057|NCT02628028|87773|P7|STARTED|Dosing Period||62
38058|NCT02628028|87774|P6|STARTED|Dosing Period||63
38059|NCT02628028|87775|P5|STARTED|Dosing Period||62
38060|NCT02628028|87776|P4|STARTED|Dosing Period||8
38061|NCT02628028|87777|P3|STARTED|Dosing Period||10
38062|NCT02628028|87778|P2|STARTED|Dosing Period||9
38063|NCT02628028|87779|P1|STARTED|Dosing Period||9
38064|NCT02627924|87821|P1|NOT COMPLETED|Overall Study||12
38065|NCT02627924|87821|P1|COMPLETED|Overall Study||79
38066|NCT02627924|87821|P1|STARTED|Overall Study||91
38067|NCT02627794|87838|P1|NOT COMPLETED|Overall Study||0
38068|NCT02627794|87838|P1|COMPLETED|Overall Study||3
38069|NCT02627794|87838|P1|STARTED|Overall Study||3
38070|NCT02627144|87851|P1|NOT COMPLETED|Overall Study||365
38071|NCT02627144|87851|P1|COMPLETED|Overall Study||0
38072|NCT02627144|87851|P1|Treated|Overall Study||359
38073|NCT02627144|87851|P1|STARTED|Overall Study||365
38074|NCT02627118|87859|P1|NOT COMPLETED|Overall Study||0
38075|NCT02627118|87859|P1|COMPLETED|Overall Study||10
38076|NCT02627118|87859|P1|STARTED|Overall Study||10
38077|NCT02627001|87866|P2|NOT COMPLETED|Overall Study||0
38078|NCT02627001|87867|P1|NOT COMPLETED|Overall Study||0
38079|NCT02627001|87866|P2|COMPLETED|Overall Study||14
38080|NCT02627001|87867|P1|COMPLETED|Overall Study||13
38081|NCT02627001|87866|P2|STARTED|Overall Study||14
38082|NCT02627001|87867|P1|STARTED|Overall Study||13
38083|NCT02626910|87877|P4|NOT COMPLETED|Overall Study||0
38084|NCT02626910|87878|P3|NOT COMPLETED|Overall Study||0
38085|NCT02626910|87879|P2|NOT COMPLETED|Overall Study||0
38086|NCT02626910|87880|P1|NOT COMPLETED|Overall Study||0
38087|NCT02626910|87877|P4|COMPLETED|Overall Study||10
38088|NCT02626910|87878|P3|COMPLETED|Overall Study||6
38089|NCT02626910|87879|P2|COMPLETED|Overall Study||10
38090|NCT02626910|87880|P1|COMPLETED|Overall Study||23
38091|NCT02626910|87877|P4|STARTED|Overall Study||10
38092|NCT02626910|87878|P3|STARTED|Overall Study||6
38093|NCT02626910|87879|P2|STARTED|Overall Study||10
38094|NCT02626910|87880|P1|STARTED|Overall Study||23
38095|NCT02626819|87892|P2|NOT COMPLETED|Overall Study||3
38096|NCT02626819|87893|P1|NOT COMPLETED|Overall Study||4
38097|NCT02626819|87892|P2|COMPLETED|Overall Study||20
38098|NCT02626819|87893|P1|COMPLETED|Overall Study||18
38099|NCT02626819|87892|P2|STARTED|Overall Study||23
38100|NCT02626819|87893|P1|STARTED|Overall Study||22
38101|NCT02626780|87913|P1|NOT COMPLETED|Overall Study||3
38102|NCT02626780|87913|P1|COMPLETED|Overall Study||4
38103|NCT02626780|87913|P1|Withdrew From Study|Overall Study||3
38104|NCT02626780|87913|P1|STARTED|Overall Study||7
38105|NCT02626611|87921|P3|NOT COMPLETED|Overall Study||3
38106|NCT02626611|87922|P2|NOT COMPLETED|Overall Study||1
38107|NCT02626611|87923|P1|NOT COMPLETED|Overall Study||4
38108|NCT02626611|87921|P3|COMPLETED|Overall Study||16
38109|NCT02626611|87922|P2|COMPLETED|Overall Study||20
38110|NCT02626611|87923|P1|COMPLETED|Overall Study||16
38111|NCT02626611|87921|P3|STARTED|Overall Study||19
38112|NCT02626611|87922|P2|STARTED|Overall Study||21
38113|NCT02626611|87923|P1|STARTED|Overall Study||20
38114|NCT02626520|87946|P2|NOT COMPLETED|Overall Study||10
38115|NCT02626520|87947|P1|NOT COMPLETED|Overall Study||1
38116|NCT02626520|87946|P2|COMPLETED|Overall Study||0
38117|NCT02626520|87947|P1|COMPLETED|Overall Study||0
38118|NCT02626520|87946|P2|STARTED|Overall Study||10
38119|NCT02626520|87947|P1|STARTED|Overall Study||1
38120|NCT02626182|87959|P2|NOT COMPLETED|Overall Study||0
38121|NCT02626182|87960|P1|NOT COMPLETED|Overall Study||2
38122|NCT02626182|87959|P2|COMPLETED|Overall Study||3
38123|NCT02626182|87960|P1|COMPLETED|Overall Study||9
38124|NCT02626182|87959|P2|STARTED|Overall Study||3
38125|NCT02626182|87960|P1|STARTED|Overall Study||11
38126|NCT02626000|87970|P1|NOT COMPLETED|Overall Study||36
38127|NCT02626000|87970|P1|COMPLETED|Overall Study||0
38128|NCT02626000|87970|P1|STARTED|Overall Study||36
38129|NCT02625974|87984|P2|NOT COMPLETED|Overall Study||6
38130|NCT02625974|87985|P1|NOT COMPLETED|Overall Study||16
38131|NCT02625974|87984|P2|COMPLETED|Overall Study||105
38132|NCT02625974|87985|P1|COMPLETED|Overall Study||203
38133|NCT02625974|87984|P2|Received Treatment|Overall Study||111
38134|NCT02625974|87985|P1|Received Treatment|Overall Study||219
38135|NCT02625974|87984|P2|STARTED|Overall Study||111
38136|NCT02625974|87985|P1|STARTED|Overall Study||219
38137|NCT02625922|88093|P2|NOT COMPLETED|Overall Study||2
38138|NCT02625922|88094|P1|NOT COMPLETED|Overall Study||2
38139|NCT02625922|88093|P2|COMPLETED|Overall Study||10
38140|NCT02625922|88094|P1|COMPLETED|Overall Study||12
38141|NCT02625922|88093|P2|Completed Treatment Period 2|Overall Study||8
38142|NCT02625922|88094|P1|Completed Treatment Period 2|Overall Study||11
38144|NCT02625922|88094|P1|Completed Treatment Period 1|Overall Study||12
38145|NCT02625922|88093|P2|STARTED|Overall Study||12
38146|NCT02625922|88094|P1|STARTED|Overall Study||14
38147|NCT02625844|88107|P1|NOT COMPLETED|Overall Study||0
38148|NCT02625844|88107|P1|COMPLETED|Overall Study||110
38149|NCT02625844|88107|P1|STARTED|Overall Study||110
38150|NCT02625623|88113|P2|NOT COMPLETED|Overall Study||35
38151|NCT02625623|88114|P1|NOT COMPLETED|Overall Study||49
38152|NCT02625623|88113|P2|COMPLETED|Overall Study||150
38153|NCT02625623|88114|P1|COMPLETED|Overall Study||137
38154|NCT02625623|88113|P2|Treated|Overall Study||184
38155|NCT02625623|88114|P1|Treated|Overall Study||177
38156|NCT02625623|88113|P2|STARTED|Overall Study||185
38157|NCT02625623|88114|P1|STARTED|Overall Study||186
38158|NCT02625571|88134|P1|NOT COMPLETED|Overall Study||3
38159|NCT02625571|88134|P1|COMPLETED|Overall Study||10
38160|NCT02625571|88134|P1|STARTED|Overall Study||13
38161|NCT02625545|88139|P1|NOT COMPLETED|Overall Study||0
38162|NCT02625545|88139|P1|COMPLETED|Overall Study||45
38163|NCT02625545|88139|P1|12 Month|Overall Study||45
38164|NCT02625545|88139|P1|6 Month|Overall Study||45
38165|NCT02625545|88139|P1|3 Month|Overall Study||45
38166|NCT02625545|88139|P1|STARTED|Overall Study||45
38167|NCT02625402|88155|P2|NOT COMPLETED|Overall Study||12
38168|NCT02625402|88156|P1|NOT COMPLETED|Overall Study||9
38169|NCT02625402|88155|P2|COMPLETED|Overall Study||25
38170|NCT02625402|88156|P1|COMPLETED|Overall Study||33
38171|NCT02625402|88155|P2|STARTED|Overall Study||37
38172|NCT02625402|88156|P1|STARTED|Overall Study||42
38173|NCT02625324|88166|P1|NOT COMPLETED|Overall Study||1
38174|NCT02625324|88166|P1|COMPLETED|Overall Study|Patients are in further follow up until study end at 60 months|86
38175|NCT02625324|88166|P1|30 Days Follow Up|Overall Study||87
38176|NCT02625324|88166|P1|STARTED|Overall Study||87
38177|NCT02625298|88173|P2|NOT COMPLETED|Overall Study||0
38178|NCT02625298|88174|P1|NOT COMPLETED|Overall Study||1
38179|NCT02625298|88173|P2|COMPLETED|Overall Study||13
38180|NCT02625298|88174|P1|COMPLETED|Overall Study||10
38181|NCT02625298|88173|P2|STARTED|Overall Study||13
38182|NCT02625298|88174|P1|STARTED|Overall Study||11
38183|NCT02625259|88187|P5|NOT COMPLETED|Second Intervention (Day 15)||0
38184|NCT02625259|88188|P4|NOT COMPLETED|Second Intervention (Day 15)||0
38185|NCT02625259|88189|P3|NOT COMPLETED|Second Intervention (Day 15)||0
38186|NCT02625259|88190|P2|NOT COMPLETED|Second Intervention (Day 15)||0
38187|NCT02625259|88191|P1|NOT COMPLETED|Second Intervention (Day 15)||0
38188|NCT02625259|88187|P5|COMPLETED|Second Intervention (Day 15)||0
38189|NCT02625259|88188|P4|COMPLETED|Second Intervention (Day 15)||9
38190|NCT02625259|88189|P3|COMPLETED|Second Intervention (Day 15)||7
38191|NCT02625259|88190|P2|COMPLETED|Second Intervention (Day 15)||8
38192|NCT02625259|88191|P1|COMPLETED|Second Intervention (Day 15)||9
38193|NCT02625259|88187|P5|STARTED|Second Intervention (Day 15)||0
38194|NCT02625259|88188|P4|STARTED|Second Intervention (Day 15)||9
38195|NCT02625259|88189|P3|STARTED|Second Intervention (Day 15)||7
38196|NCT02625259|88190|P2|STARTED|Second Intervention (Day 15)||8
38197|NCT02625259|88191|P1|STARTED|Second Intervention (Day 15)||9
38198|NCT02625259|88187|P5|NOT COMPLETED|Washout (Day 2 to Day 14)||0
38199|NCT02625259|88188|P4|NOT COMPLETED|Washout (Day 2 to Day 14)||0
38200|NCT02625259|88189|P3|NOT COMPLETED|Washout (Day 2 to Day 14)||0
38201|NCT02625259|88190|P2|NOT COMPLETED|Washout (Day 2 to Day 14)||0
38202|NCT02625259|88191|P1|NOT COMPLETED|Washout (Day 2 to Day 14)||0
38203|NCT02625259|88187|P5|COMPLETED|Washout (Day 2 to Day 14)||0
38204|NCT02625259|88188|P4|COMPLETED|Washout (Day 2 to Day 14)||9
38205|NCT02625259|88189|P3|COMPLETED|Washout (Day 2 to Day 14)||7
38206|NCT02625259|88190|P2|COMPLETED|Washout (Day 2 to Day 14)||8
38207|NCT02625259|88191|P1|COMPLETED|Washout (Day 2 to Day 14)||9
38208|NCT02625259|88187|P5|STARTED|Washout (Day 2 to Day 14)||0
38209|NCT02625259|88188|P4|STARTED|Washout (Day 2 to Day 14)||9
38210|NCT02625259|88189|P3|STARTED|Washout (Day 2 to Day 14)||7
38211|NCT02625259|88190|P2|STARTED|Washout (Day 2 to Day 14)||8
38212|NCT02625259|88191|P1|STARTED|Washout (Day 2 to Day 14)||9
38213|NCT02625259|88187|P5|NOT COMPLETED|First Intervention (Day 1)||0
38214|NCT02625259|88188|P4|NOT COMPLETED|First Intervention (Day 1)||1
38215|NCT02625259|88189|P3|NOT COMPLETED|First Intervention (Day 1)||1
38216|NCT02625259|88190|P2|NOT COMPLETED|First Intervention (Day 1)||1
38217|NCT02625259|88191|P1|NOT COMPLETED|First Intervention (Day 1)||2
38218|NCT02625259|88187|P5|COMPLETED|First Intervention (Day 1)||16
38219|NCT02625259|88188|P4|COMPLETED|First Intervention (Day 1)||9
38220|NCT02625259|88189|P3|COMPLETED|First Intervention (Day 1)||7
38221|NCT02625259|88190|P2|COMPLETED|First Intervention (Day 1)||8
38222|NCT02625259|88191|P1|COMPLETED|First Intervention (Day 1)||9
38223|NCT02625259|88187|P5|STARTED|First Intervention (Day 1)||16
38224|NCT02625259|88188|P4|STARTED|First Intervention (Day 1)||10
38225|NCT02625259|88189|P3|STARTED|First Intervention (Day 1)||8
38226|NCT02625259|88190|P2|STARTED|First Intervention (Day 1)||9
38227|NCT02625259|88191|P1|STARTED|First Intervention (Day 1)||11
38228|NCT02625233|88228|P2|NOT COMPLETED|Overall Study||0
38229|NCT02625233|88229|P1|NOT COMPLETED|Overall Study||2
38230|NCT02625233|88228|P2|COMPLETED|Overall Study||56
38231|NCT02625233|88229|P1|COMPLETED|Overall Study||47
38232|NCT02625233|88228|P2|STARTED|Overall Study||56
38233|NCT02625233|88229|P1|STARTED|Overall Study||49
38234|NCT02625220|88237|P1|NOT COMPLETED|Overall Study||7
38235|NCT02625220|88237|P1|COMPLETED|Overall Study||163
38236|NCT02625220|88237|P1|STARTED|Overall Study||170
38237|NCT02625207|88248|P4|NOT COMPLETED|Part 2 (11 Days)||0
38238|NCT02625207|88249|P3|NOT COMPLETED|Part 2 (11 Days)||0
38239|NCT02625207|88250|P2|NOT COMPLETED|Part 2 (11 Days)||0
38240|NCT02625207|88251|P1|NOT COMPLETED|Part 2 (11 Days)||0
38241|NCT02625207|88248|P4|COMPLETED|Part 2 (11 Days)||0
38242|NCT02625207|88249|P3|COMPLETED|Part 2 (11 Days)||12
38243|NCT02625207|88250|P2|COMPLETED|Part 2 (11 Days)||0
38244|NCT02625207|88251|P1|COMPLETED|Part 2 (11 Days)||11
38245|NCT02625207|88248|P4|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
38246|NCT02625207|88249|P3|STARTED|Part 2 (11 Days)||12
38247|NCT02625207|88250|P2|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
38248|NCT02625207|88251|P1|STARTED|Part 2 (11 Days)||11
38249|NCT02625207|88248|P4|NOT COMPLETED|Part 1 (6 Days)||0
38250|NCT02625207|88249|P3|NOT COMPLETED|Part 1 (6 Days)||0
38251|NCT02625207|88250|P2|NOT COMPLETED|Part 1 (6 Days)||0
38252|NCT02625207|88251|P1|NOT COMPLETED|Part 1 (6 Days)||0
38253|NCT02625207|88248|P4|COMPLETED|Part 1 (6 Days)||12
38254|NCT02625207|88249|P3|COMPLETED|Part 1 (6 Days)||12
38255|NCT02625207|88250|P2|COMPLETED|Part 1 (6 Days)||12
38256|NCT02625207|88251|P1|COMPLETED|Part 1 (6 Days)||11
38257|NCT02625207|88248|P4|STARTED|Part 1 (6 Days)||12
38258|NCT02625207|88249|P3|STARTED|Part 1 (6 Days)||12
38259|NCT02625207|88250|P2|STARTED|Part 1 (6 Days)||12
38260|NCT02625207|88251|P1|STARTED|Part 1 (6 Days)||11
38261|NCT02625181|88340|P3|NOT COMPLETED|Overall Study||0
38262|NCT02625181|88341|P2|NOT COMPLETED|Overall Study||0
38263|NCT02625181|88342|P1|NOT COMPLETED|Overall Study||0
38264|NCT02625181|88340|P3|COMPLETED|Overall Study||12707
38265|NCT02625181|88341|P2|COMPLETED|Overall Study||12809
38266|NCT02625181|88342|P1|COMPLETED|Overall Study||1518
38267|NCT02625181|88340|P3|STARTED|Overall Study||12707
38268|NCT02625181|88341|P2|STARTED|Overall Study||12809
38269|NCT02625181|88342|P1|STARTED|Overall Study||1518
38270|NCT02624791|88357|P6|NOT COMPLETED|Overall Study||0
38271|NCT02624791|88358|P5|NOT COMPLETED|Overall Study||0
38272|NCT02624791|88359|P4|NOT COMPLETED|Overall Study||0
38273|NCT02624791|88360|P3|NOT COMPLETED|Overall Study||0
38274|NCT02624791|88361|P2|NOT COMPLETED|Overall Study||0
38275|NCT02624791|88362|P1|NOT COMPLETED|Overall Study||2
38276|NCT02624791|88357|P6|COMPLETED|Overall Study||2
38277|NCT02624791|88358|P5|COMPLETED|Overall Study||2
38278|NCT02624791|88359|P4|COMPLETED|Overall Study||2
38279|NCT02624791|88360|P3|COMPLETED|Overall Study||2
38280|NCT02624791|88361|P2|COMPLETED|Overall Study||1
38281|NCT02624791|88362|P1|COMPLETED|Overall Study||0
38282|NCT02624791|88357|P6|STARTED|Overall Study||2
38283|NCT02624791|88358|P5|STARTED|Overall Study||2
38284|NCT02624791|88359|P4|STARTED|Overall Study||2
38285|NCT02624791|88360|P3|STARTED|Overall Study||2
38286|NCT02624791|88361|P2|STARTED|Overall Study||1
38287|NCT02624791|88362|P1|STARTED|Overall Study||2
38288|NCT02624687|88369|P2|NOT COMPLETED|Overall Study||2
38289|NCT02624687|88370|P1|NOT COMPLETED|Overall Study||1
38290|NCT02624687|88369|P2|COMPLETED|Overall Study||12
38291|NCT02624687|88370|P1|COMPLETED|Overall Study||12
38292|NCT02624687|88369|P2|STARTED|Overall Study||14
38293|NCT02624687|88370|P1|STARTED|Overall Study||13
38294|NCT02624492|88401|P3|NOT COMPLETED|Overall Study||5
38295|NCT02624492|88402|P2|NOT COMPLETED|Overall Study||4
38296|NCT02624492|88403|P1|NOT COMPLETED|Overall Study||2
38297|NCT02624492|88401|P3|COMPLETED|Overall Study||3
38298|NCT02624492|88402|P2|COMPLETED|Overall Study||4
38299|NCT02624492|88403|P1|COMPLETED|Overall Study||3
38300|NCT02624492|88401|P3|STARTED|Overall Study||8
38301|NCT02624492|88402|P2|STARTED|Overall Study||8
38302|NCT02624492|88403|P1|STARTED|Overall Study||5
38303|NCT02624284|88432|P3|NOT COMPLETED|Overall Study||11
38304|NCT02624284|88433|P2|NOT COMPLETED|Overall Study||18
38305|NCT02624284|88434|P1|NOT COMPLETED|Overall Study||14
38306|NCT02624284|88432|P3|COMPLETED|Overall Study||36
38307|NCT02624284|88433|P2|COMPLETED|Overall Study||35
38308|NCT02624284|88434|P1|COMPLETED|Overall Study||35
38309|NCT02624284|88432|P3|STARTED|Overall Study||47
38310|NCT02624284|88433|P2|STARTED|Overall Study||53
38311|NCT02624284|88434|P1|STARTED|Overall Study||49
38312|NCT02624050|88453|P2|NOT COMPLETED|Overall Study||0
38313|NCT02624050|88454|P1|NOT COMPLETED|Overall Study||6
38314|NCT02624050|88453|P2|COMPLETED|Overall Study||25
38315|NCT02624050|88454|P1|COMPLETED|Overall Study||20
38316|NCT02624050|88453|P2|STARTED|Overall Study||25
38317|NCT02624050|88454|P1|STARTED|Overall Study||26
38318|NCT02623959|88482|P2|NOT COMPLETED|Overall Study||1
38319|NCT02623959|88483|P1|NOT COMPLETED|Overall Study||0
38320|NCT02623959|88482|P2|COMPLETED|Overall Study|due to progression|0
38321|NCT02623959|88483|P1|COMPLETED|Overall Study||0
38322|NCT02623959|88482|P2|STARTED|Overall Study||1
38323|NCT02623959|88483|P1|STARTED|Overall Study||0
38324|NCT02623855|88493|P2|NOT COMPLETED|Overall Study||16
38325|NCT02623855|88494|P1|NOT COMPLETED|Overall Study||10
38326|NCT02623855|88493|P2|COMPLETED|Overall Study||84
38327|NCT02623855|88494|P1|COMPLETED|Overall Study||46
38328|NCT02623855|88493|P2|STARTED|Overall Study||100
38329|NCT02623855|88494|P1|STARTED|Overall Study||56
38330|NCT02623803|88516|P2|NOT COMPLETED|Overall Study||0
38331|NCT02623803|88517|P1|NOT COMPLETED|Overall Study||0
38332|NCT02623803|88516|P2|COMPLETED|Overall Study||23
38333|NCT02623803|88517|P1|COMPLETED|Overall Study||25
38334|NCT02623803|88516|P2|STARTED|Overall Study||23
38335|NCT02623803|88517|P1|STARTED|Overall Study||25
38336|NCT02623725|88563|P2|NOT COMPLETED|Overall Study||6
38337|NCT02623725|88564|P1|NOT COMPLETED|Overall Study||16
38338|NCT02623725|88563|P2|COMPLETED|Overall Study||58
38339|NCT02623725|88564|P1|COMPLETED|Overall Study||171
38340|NCT02623725|88563|P2|STARTED|Overall Study||64
38341|NCT02623725|88564|P1|STARTED|Overall Study||187
38342|NCT02623361|88598|P2|NOT COMPLETED|Overall Study||2
38343|NCT02623361|88599|P1|NOT COMPLETED|Overall Study||0
38344|NCT02623361|88598|P2|COMPLETED|Overall Study||38
38345|NCT02623361|88599|P1|COMPLETED|Overall Study||40
38346|NCT02623361|88598|P2|STARTED|Overall Study||40
38347|NCT02623361|88599|P1|STARTED|Overall Study||40
38348|NCT02623348|88611|P2|NOT COMPLETED|Overall Study||2
38349|NCT02623348|88612|P1|NOT COMPLETED|Overall Study||3
38350|NCT02623348|88611|P2|COMPLETED|Overall Study||28
38351|NCT02623348|88612|P1|COMPLETED|Overall Study||27
38352|NCT02623348|88611|P2|3-month Assessment|Overall Study||26
38353|NCT02623348|88612|P1|3-month Assessment|Overall Study||27
38354|NCT02623348|88611|P2|STARTED|Overall Study||30
38355|NCT02623348|88612|P1|STARTED|Overall Study||30
38356|NCT02623335|88638|P2|NOT COMPLETED|Overall Study||36
38357|NCT02623335|88639|P1|NOT COMPLETED|Overall Study||27
38358|NCT02623335|88638|P2|COMPLETED|Overall Study||187
38359|NCT02623335|88639|P1|COMPLETED|Overall Study||196
38360|NCT02623335|88638|P2|T3 Survey (12-14 Weeks)|Overall Study||187
38361|NCT02623335|88639|P1|T3 Survey (12-14 Weeks)|Overall Study||196
38362|NCT02623335|88638|P2|T2 Survey (6-8 Weeks)|Overall Study||192
38363|NCT02623335|88639|P1|T2 Survey (6-8 Weeks)|Overall Study||199
38364|NCT02623335|88638|P2|T1 Survey (24-48 Hours)|Overall Study||214
38365|NCT02623335|88639|P1|T1 Survey (24-48 Hours)|Overall Study||216
38366|NCT02623335|88638|P2|T0 Audio Recording (Day of Consultation)|Overall Study||222
38367|NCT02623335|88639|P1|T0 Audio Recording (Day of Consultation)|Overall Study||223
38368|NCT02623335|88638|P2|STARTED|Overall Study||223
38369|NCT02623335|88639|P1|STARTED|Overall Study||223
38370|NCT02623322|88666|P3|NOT COMPLETED|Overall Study||0
38371|NCT02623322|88667|P2|NOT COMPLETED|Overall Study||1
38372|NCT02623322|88668|P1|NOT COMPLETED|Overall Study||2
38373|NCT02623322|88666|P3|COMPLETED|Overall Study||40
38374|NCT02623322|88667|P2|COMPLETED|Overall Study||40
38375|NCT02623322|88668|P1|COMPLETED|Overall Study||41
38376|NCT02623322|88666|P3|STARTED|Overall Study||40
38377|NCT02623322|88667|P2|STARTED|Overall Study||41
38378|NCT02623322|88668|P1|STARTED|Overall Study||43
38379|NCT02622828|88701|P1|NOT COMPLETED|Overall Study||3
38380|NCT02622828|88701|P1|COMPLETED|Overall Study||1
38381|NCT02622828|88701|P1|STARTED|Overall Study||4
38382|NCT02622568|88708|P2|NOT COMPLETED|Overall Study||5
38383|NCT02622568|88709|P1|NOT COMPLETED|Overall Study||5
38384|NCT02622568|88708|P2|COMPLETED|Overall Study||9
38385|NCT02622568|88709|P1|COMPLETED|Overall Study||9
38386|NCT02622568|88708|P2|STARTED|Overall Study||14
38387|NCT02622568|88709|P1|STARTED|Overall Study||14
38388|NCT02622321|88719|P4|NOT COMPLETED|Overall Study||7
38389|NCT02622321|88720|P3|NOT COMPLETED|Overall Study||49
38390|NCT02622321|88721|P2|NOT COMPLETED|Overall Study||18
38391|NCT02622321|88722|P1|NOT COMPLETED|Overall Study||35
38392|NCT02622321|88719|P4|COMPLETED|Overall Study||0
38393|NCT02622321|88720|P3|COMPLETED|Overall Study||0
38394|NCT02622321|88721|P2|COMPLETED|Overall Study||0
38395|NCT02622321|88722|P1|COMPLETED|Overall Study||0
38396|NCT02622321|88719|P4|Treated|Overall Study||7
38397|NCT02622321|88720|P3|Treated|Overall Study||49
38398|NCT02622321|88721|P2|Treated|Overall Study||18
38399|NCT02622321|88722|P1|Treated|Overall Study||34
38400|NCT02622321|88719|P4|STARTED|Overall Study||7
38401|NCT02622321|88720|P3|STARTED|Overall Study||49
38402|NCT02622321|88721|P2|STARTED|Overall Study||18
38403|NCT02622321|88722|P1|STARTED|Overall Study||35
38404|NCT02622191|88767|P2|NOT COMPLETED|Overall Study||0
38405|NCT02622191|88768|P1|NOT COMPLETED|Overall Study||0
38406|NCT02622191|88767|P2|COMPLETED|Overall Study||14
38407|NCT02622191|88768|P1|COMPLETED|Overall Study||19
38408|NCT02622191|88767|P2|STARTED|Overall Study||14
38409|NCT02622191|88768|P1|STARTED|Overall Study||19
38410|NCT02622178|88778|P3|NOT COMPLETED|Overall Study||0
38411|NCT02622178|88779|P2|NOT COMPLETED|Overall Study||0
38412|NCT02622178|88780|P1|NOT COMPLETED|Overall Study||0
38413|NCT02622178|88778|P3|COMPLETED|Overall Study||49
38414|NCT02622178|88779|P2|COMPLETED|Overall Study||45
38415|NCT02622178|88780|P1|COMPLETED|Overall Study||42
38416|NCT02622178|88778|P3|STARTED|Overall Study||49
38417|NCT02622178|88779|P2|STARTED|Overall Study||45
38418|NCT02622178|88780|P1|STARTED|Overall Study||42
38419|NCT02622113|88793|P2|NOT COMPLETED|Overall Study||10
38420|NCT02622113|88794|P1|NOT COMPLETED|Overall Study||5
38421|NCT02622113|88793|P2|COMPLETED|Overall Study||66
38422|NCT02622113|88794|P1|COMPLETED|Overall Study||62
38423|NCT02622113|88793|P2|STARTED|Overall Study||76
38424|NCT02622113|88794|P1|STARTED|Overall Study||67
38425|NCT02622074|88812|P6|NOT COMPLETED|Overall Study||10
38426|NCT02622074|88813|P5|NOT COMPLETED|Overall Study||10
38427|NCT02622074|88814|P4|NOT COMPLETED|Overall Study||10
38428|NCT02622074|88815|P3|NOT COMPLETED|Overall Study||10
38429|NCT02622074|88816|P2|NOT COMPLETED|Overall Study||10
38430|NCT02622074|88817|P1|NOT COMPLETED|Overall Study||10
38431|NCT02622074|88812|P6|COMPLETED|Overall Study||0
38432|NCT02622074|88813|P5|COMPLETED|Overall Study||0
38433|NCT02622074|88814|P4|COMPLETED|Overall Study||0
38434|NCT02622074|88815|P3|COMPLETED|Overall Study||0
38435|NCT02622074|88816|P2|COMPLETED|Overall Study||0
38436|NCT02622074|88817|P1|COMPLETED|Overall Study||0
38437|NCT02622074|88812|P6|STARTED|Overall Study||10
38438|NCT02622074|88813|P5|STARTED|Overall Study||10
38439|NCT02622074|88814|P4|STARTED|Overall Study||10
38440|NCT02622074|88815|P3|STARTED|Overall Study||10
38441|NCT02622074|88816|P2|STARTED|Overall Study||10
38442|NCT02622074|88817|P1|STARTED|Overall Study||10
38443|NCT02621983|88893|P2|NOT COMPLETED|Overall Study||11
38444|NCT02621983|88894|P1|NOT COMPLETED|Overall Study||12
38445|NCT02621983|88893|P2|COMPLETED|Overall Study||6
38446|NCT02621983|88894|P1|COMPLETED|Overall Study||9
38447|NCT02621983|88893|P2|STARTED|Overall Study||17
38448|NCT02621983|88894|P1|STARTED|Overall Study||21
38449|NCT02621931|88909|P3|NOT COMPLETED|Overall Study||36
38450|NCT02621931|88910|P2|NOT COMPLETED|Overall Study||27
38451|NCT02621931|88911|P1|NOT COMPLETED|Overall Study||33
38452|NCT02621931|88909|P3|COMPLETED|Overall Study||343
38453|NCT02621931|88910|P2|COMPLETED|Overall Study||349
38454|NCT02621931|88911|P1|COMPLETED|Overall Study||342
38455|NCT02621931|88909|P3|Full Analysis Set|Overall Study||375
38456|NCT02621931|88910|P2|Full Analysis Set|Overall Study||375
38457|NCT02621931|88911|P1|Full Analysis Set|Overall Study||371
38458|NCT02621931|88909|P3|Safety and ITT Populations|Overall Study||379
38459|NCT02621931|88910|P2|Safety and ITT Populations|Overall Study||376
38460|NCT02621931|88911|P1|Safety and ITT Populations|Overall Study||375
38461|NCT02621931|88909|P3|STARTED|Overall Study||379
38462|NCT02621931|88910|P2|STARTED|Overall Study||376
38463|NCT02621931|88911|P1|STARTED|Overall Study||375
38464|NCT02621619|88962|P2|NOT COMPLETED|Overall Study||0
38465|NCT02621619|88963|P1|NOT COMPLETED|Overall Study||0
38466|NCT02621619|88962|P2|COMPLETED|Overall Study||79
38467|NCT02621619|88963|P1|COMPLETED|Overall Study||80
38468|NCT02621619|88962|P2|STARTED|Overall Study||79
38469|NCT02621619|88963|P1|STARTED|Overall Study||80
38470|NCT02621606|88974|P3|NOT COMPLETED|Overall Study||0
38471|NCT02621606|88975|P2|NOT COMPLETED|Overall Study||1
38472|NCT02621606|88976|P1|NOT COMPLETED|Overall Study||0
38473|NCT02621606|88974|P3|COMPLETED|Overall Study||10
38474|NCT02621606|88975|P2|COMPLETED|Overall Study||6
38475|NCT02621606|88976|P1|COMPLETED|Overall Study||3
38476|NCT02621606|88974|P3|Treated|Overall Study||10
38477|NCT02621606|88975|P2|Treated|Overall Study||7
38478|NCT02621606|88976|P1|Treated|Overall Study||3
38479|NCT02621606|88974|P3|STARTED|Overall Study||10
38480|NCT02621606|88975|P2|STARTED|Overall Study||7
38481|NCT02621606|88976|P1|STARTED|Overall Study||3
38482|NCT02621073|89004|P2|NOT COMPLETED|Overall Study||3
38483|NCT02621073|89005|P1|NOT COMPLETED|Overall Study||3
38484|NCT02621073|89004|P2|COMPLETED|Overall Study||0
38485|NCT02621073|89005|P1|COMPLETED|Overall Study||1
38486|NCT02621073|89004|P2|STARTED|Overall Study||3
38487|NCT02621073|89005|P1|STARTED|Overall Study||4
38488|NCT02621060|89015|P2|NOT COMPLETED|Overall Study||1
38489|NCT02621060|89016|P1|NOT COMPLETED|Overall Study||3
38490|NCT02621060|89015|P2|COMPLETED|Overall Study||14
38491|NCT02621060|89016|P1|COMPLETED|Overall Study||12
38492|NCT02621060|89015|P2|STARTED|Overall Study||15
38493|NCT02621060|89016|P1|STARTED|Overall Study||15
38494|NCT02621047|89067|P3|NOT COMPLETED|Overall Study||1
38495|NCT02621047|89068|P2|NOT COMPLETED|Overall Study||0
38496|NCT02621047|89069|P1|NOT COMPLETED|Overall Study||0
38497|NCT02621047|89067|P3|COMPLETED|Overall Study||11
38498|NCT02621047|89068|P2|COMPLETED|Overall Study||8
38499|NCT02621047|89069|P1|COMPLETED|Overall Study||8
38500|NCT02621047|89067|P3|STARTED|Overall Study||12
38501|NCT02621047|89068|P2|STARTED|Overall Study||8
38502|NCT02621047|89069|P1|STARTED|Overall Study||8
38503|NCT02621034|89185|P3|NOT COMPLETED|Overall Study||5
38504|NCT02621034|89186|P2|NOT COMPLETED|Overall Study||2
38505|NCT02621034|89187|P1|NOT COMPLETED|Overall Study||3
38506|NCT02621034|89185|P3|COMPLETED|Overall Study||50
38507|NCT02621034|89186|P2|COMPLETED|Overall Study||50
38508|NCT02621034|89187|P1|COMPLETED|Overall Study||50
38509|NCT02621034|89185|P3|STARTED|Overall Study||55
38510|NCT02621034|89186|P2|STARTED|Overall Study||52
38511|NCT02621034|89187|P1|STARTED|Overall Study||53
38512|NCT02620878|89200|P2|NOT COMPLETED|Overall Study||0
38513|NCT02620878|89201|P1|NOT COMPLETED|Overall Study||0
38514|NCT02620878|89200|P2|COMPLETED|Overall Study||16
38515|NCT02620878|89201|P1|COMPLETED|Overall Study||16
38516|NCT02620878|89200|P2|STARTED|Overall Study||16
38517|NCT02620878|89201|P1|STARTED|Overall Study||16
38518|NCT02620787|89212|P2|NOT COMPLETED|Overall Study||0
38519|NCT02620787|89213|P1|NOT COMPLETED|Overall Study||2
38520|NCT02620787|89212|P2|COMPLETED|Overall Study||6
38521|NCT02620787|89213|P1|COMPLETED|Overall Study||10
38522|NCT02620787|89212|P2|STARTED|Overall Study||6
38523|NCT02620787|89213|P1|STARTED|Overall Study||12
38524|NCT02620774|89225|P2|NOT COMPLETED|Overall Study||0
38525|NCT02620774|89226|P1|NOT COMPLETED|Overall Study||0
38526|NCT02620774|89225|P2|COMPLETED|Overall Study||6
38527|NCT02620774|89226|P1|COMPLETED|Overall Study||10
38528|NCT02620774|89225|P2|STARTED|Overall Study||6
38529|NCT02620774|89226|P1|STARTED|Overall Study||10
38530|NCT02620683|89244|P2|NOT COMPLETED|Second Intervention (Visit 2)||0
38531|NCT02620683|89245|P1|NOT COMPLETED|Second Intervention (Visit 2)||0
38532|NCT02620683|89244|P2|COMPLETED|Second Intervention (Visit 2)||11
38533|NCT02620683|89245|P1|COMPLETED|Second Intervention (Visit 2)||12
38534|NCT02620683|89244|P2|STARTED|Second Intervention (Visit 2)||11
38535|NCT02620683|89245|P1|STARTED|Second Intervention (Visit 2)||12
38536|NCT02620683|89244|P2|NOT COMPLETED|Washout (2 Weeks)||0
38537|NCT02620683|89245|P1|NOT COMPLETED|Washout (2 Weeks)||0
38538|NCT02620683|89244|P2|COMPLETED|Washout (2 Weeks)||11
38539|NCT02620683|89245|P1|COMPLETED|Washout (2 Weeks)||12
38540|NCT02620683|89244|P2|STARTED|Washout (2 Weeks)||11
38541|NCT02620683|89245|P1|STARTED|Washout (2 Weeks)||12
38542|NCT02620683|89244|P2|NOT COMPLETED|First Intervention (Visit 1)||0
38543|NCT02620683|89245|P1|NOT COMPLETED|First Intervention (Visit 1)||0
38544|NCT02620683|89244|P2|COMPLETED|First Intervention (Visit 1)||11
38545|NCT02620683|89245|P1|COMPLETED|First Intervention (Visit 1)||12
38546|NCT02620683|89244|P2|STARTED|First Intervention (Visit 1)||11
38547|NCT02620683|89245|P1|STARTED|First Intervention (Visit 1)||12
38548|NCT02620384|89255|P2|NOT COMPLETED|Overall Study||7
38549|NCT02620384|89256|P1|NOT COMPLETED|Overall Study||4
38550|NCT02620384|89255|P2|COMPLETED|Overall Study|Per protocol design patients must receive both doses of investigational product to be in analysis.|66
38551|NCT02620384|89256|P1|COMPLETED|Overall Study|Per protocol design patients must receive both doses of investigational product to be in analysis.|66
38552|NCT02620384|89255|P2|STARTED|Overall Study||73
38553|NCT02620384|89256|P1|STARTED|Overall Study||70
38554|NCT02620020|89288|P4|NOT COMPLETED|Overall Study||26
38555|NCT02620020|89289|P3|NOT COMPLETED|Overall Study||25
38556|NCT02620020|89290|P2|NOT COMPLETED|Overall Study||35
38557|NCT02620020|89291|P1|NOT COMPLETED|Overall Study||44
38558|NCT02620020|89288|P4|COMPLETED|Overall Study||115
38559|NCT02620020|89289|P3|COMPLETED|Overall Study||115
38560|NCT02620020|89290|P2|COMPLETED|Overall Study||106
38561|NCT02620020|89291|P1|COMPLETED|Overall Study||97
38562|NCT02620020|89288|P4|Modified Intent to Treat Set (mITT)|Overall Study||140
38563|NCT02620020|89289|P3|Modified Intent to Treat Set (mITT)|Overall Study||139
38564|NCT02620020|89290|P2|Modified Intent to Treat Set (mITT)|Overall Study||139
38565|NCT02620020|89291|P1|Modified Intent to Treat Set (mITT)|Overall Study||140
38566|NCT02620020|89288|P4|STARTED|Overall Study||141
38567|NCT02620020|89289|P3|STARTED|Overall Study||140
38568|NCT02620020|89290|P2|STARTED|Overall Study||141
38569|NCT02620020|89291|P1|STARTED|Overall Study||141
38570|NCT02619812|89317|P4|NOT COMPLETED|Overall Study||2
38571|NCT02619812|89318|P3|NOT COMPLETED|Overall Study||1
38572|NCT02619812|89319|P2|NOT COMPLETED|Overall Study||0
38573|NCT02619812|89320|P1|NOT COMPLETED|Overall Study||0
38574|NCT02619812|89317|P4|COMPLETED|Overall Study||0
38575|NCT02619812|89318|P3|COMPLETED|Overall Study||0
38576|NCT02619812|89319|P2|COMPLETED|Overall Study||0
38577|NCT02619812|89320|P1|COMPLETED|Overall Study||0
38578|NCT02619812|89317|P4|STARTED|Overall Study||2
38579|NCT02619812|89318|P3|STARTED|Overall Study||1
38580|NCT02619812|89319|P2|STARTED|Overall Study||0
38581|NCT02619812|89320|P1|STARTED|Overall Study||0
38582|NCT02619799|89336|P2|NOT COMPLETED|Overall Study||0
38583|NCT02619799|89337|P1|NOT COMPLETED|Overall Study||0
38584|NCT02619799|89336|P2|COMPLETED|Overall Study||25
38585|NCT02619799|89337|P1|COMPLETED|Overall Study||25
38586|NCT02619799|89336|P2|STARTED|Overall Study||25
38587|NCT02619799|89337|P1|STARTED|Overall Study||25
38588|NCT02619591|89355|P2|NOT COMPLETED|Overall Study||121
38589|NCT02619591|89356|P1|NOT COMPLETED|Overall Study||139
38590|NCT02619591|89355|P2|COMPLETED|Overall Study||0
38591|NCT02619591|89356|P1|COMPLETED|Overall Study||0
38592|NCT02619591|89355|P2|STARTED|Overall Study||121
38593|NCT02619591|89356|P1|STARTED|Overall Study||139
38594|NCT02619409|89367|P5|NOT COMPLETED|Overall Study||0
38595|NCT02619409|89368|P4|NOT COMPLETED|Overall Study||0
38596|NCT02619409|89369|P3|NOT COMPLETED|Overall Study||0
38597|NCT02619409|89370|P2|NOT COMPLETED|Overall Study||0
38598|NCT02619409|89371|P1|NOT COMPLETED|Overall Study||0
38599|NCT02619409|89367|P5|COMPLETED|Overall Study||6
38600|NCT02619409|89368|P4|COMPLETED|Overall Study||6
38601|NCT02619409|89369|P3|COMPLETED|Overall Study||6
38602|NCT02619409|89370|P2|COMPLETED|Overall Study||6
38603|NCT02619409|89371|P1|COMPLETED|Overall Study||6
38604|NCT02619409|89367|P5|STARTED|Overall Study||6
38605|NCT02619409|89368|P4|STARTED|Overall Study||6
38606|NCT02619409|89369|P3|STARTED|Overall Study||6
38607|NCT02619409|89370|P2|STARTED|Overall Study||6
38608|NCT02619409|89371|P1|STARTED|Overall Study||6
38609|NCT02619175|89390|P2|NOT COMPLETED|Overall Study||0
38610|NCT02619175|89391|P1|NOT COMPLETED|Overall Study||2
38611|NCT02619175|89390|P2|COMPLETED|Overall Study||16
38612|NCT02619175|89391|P1|COMPLETED|Overall Study||16
38613|NCT02619175|89390|P2|STARTED|Overall Study||16
38614|NCT02619175|89391|P1|STARTED|Overall Study||18
38615|NCT02618928|89405|P1|NOT COMPLETED|Overall Study||58
38616|NCT02618928|89405|P1|COMPLETED|Overall Study||677
38617|NCT02618928|89405|P1|Received Treatment|Overall Study||728
38618|NCT02618928|89405|P1|STARTED|Overall Study||735
38619|NCT02618915|89438|P2|NOT COMPLETED|Overall Study||0
38620|NCT02618915|89439|P1|NOT COMPLETED|Overall Study||0
38621|NCT02618915|89438|P2|COMPLETED|Overall Study||3
38622|NCT02618915|89439|P1|COMPLETED|Overall Study||3
38623|NCT02618915|89438|P2|STARTED|Overall Study||3
38624|NCT02618915|89439|P1|STARTED|Overall Study||3
38625|NCT02618772|89465|P2|NOT COMPLETED|Overall Study||0
38626|NCT02618772|89466|P1|NOT COMPLETED|Overall Study||1
38627|NCT02618772|89465|P2|COMPLETED|Overall Study||40
38628|NCT02618772|89466|P1|COMPLETED|Overall Study||38
38629|NCT02618772|89465|P2|Withdrawal by Subject|Overall Study||0
38630|NCT02618772|89466|P1|Withdrawal by Subject|Overall Study|The participant's family withdrew from the study after administration of the trial intervention.|1
38631|NCT02618772|89465|P2|STARTED|Overall Study||40
38632|NCT02618772|89466|P1|STARTED|Overall Study||39
38633|NCT02618759|89500|P2|NOT COMPLETED|Overall Study||5
38634|NCT02618759|89501|P1|NOT COMPLETED|Overall Study||2
38635|NCT02618759|89500|P2|COMPLETED|Overall Study||54
38636|NCT02618759|89501|P1|COMPLETED|Overall Study||58
38637|NCT02618759|89500|P2|STARTED|Overall Study||59
38638|NCT02618759|89501|P1|STARTED|Overall Study||60
38639|NCT02618512|89517|P1|NOT COMPLETED|Overall Study||0
38640|NCT02618512|89517|P1|COMPLETED|Overall Study||3
38641|NCT02618512|89517|P1|STARTED|Overall Study||3
38642|NCT02618187|89525|P4|NOT COMPLETED|Overall Study||5
38643|NCT02618187|89526|P3|NOT COMPLETED|Overall Study||4
38644|NCT02618187|89527|P2|NOT COMPLETED|Overall Study||2
38645|NCT02618187|89528|P1|NOT COMPLETED|Overall Study||2
38646|NCT02618187|89525|P4|COMPLETED|Overall Study||12
38647|NCT02618187|89526|P3|COMPLETED|Overall Study||11
38648|NCT02618187|89527|P2|COMPLETED|Overall Study||9
38649|NCT02618187|89528|P1|COMPLETED|Overall Study||13
38650|NCT02618187|89525|P4|Completed|Overall Study||13
38651|NCT02618187|89526|P3|Completed|Overall Study||13
38652|NCT02618187|89527|P2|Completed|Overall Study||10
38653|NCT02618187|89528|P1|Completed|Overall Study||13
38654|NCT02618187|89525|P4|STARTED|Overall Study||17
38655|NCT02618187|89526|P3|STARTED|Overall Study||15
38656|NCT02618187|89527|P2|STARTED|Overall Study||11
38657|NCT02618187|89528|P1|STARTED|Overall Study||15
38658|NCT02617901|89554|P1|NOT COMPLETED|Overall Study||0
38659|NCT02617901|89554|P1|COMPLETED|Overall Study||20
38660|NCT02617901|89554|P1|STARTED|Overall Study||20
38661|NCT02617888|89561|P3|NOT COMPLETED|Overall Study||0
38662|NCT02617888|89562|P2|NOT COMPLETED|Overall Study||7
38663|NCT02617888|89563|P1|NOT COMPLETED|Overall Study||1
38664|NCT02617888|89561|P3|COMPLETED|Overall Study||127
38665|NCT02617888|89562|P2|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break samples.|44
38666|NCT02617888|89563|P1|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break sample.|49
38667|NCT02617888|89561|P3|STARTED|Overall Study||127
38668|NCT02617888|89562|P2|STARTED|Overall Study||51
38669|NCT02617888|89563|P1|STARTED|Overall Study||50
38670|NCT02617784|89572|P2|NOT COMPLETED|Overall Study||0
38671|NCT02617784|89573|P1|NOT COMPLETED|Overall Study||0
38672|NCT02617784|89572|P2|COMPLETED|Overall Study||12
38673|NCT02617784|89573|P1|COMPLETED|Overall Study||12
38674|NCT02617784|89572|P2|Second Dose Assessment Period|Overall Study||12
38675|NCT02617784|89573|P1|Second Dose Assessment Period|Overall Study||11
38676|NCT02617784|89572|P2|First Dose Assessment Period|Overall Study||12
38677|NCT02617784|89573|P1|First Dose Assessment Period|Overall Study||12
38678|NCT02617784|89572|P2|STARTED|Overall Study||12
38679|NCT02617784|89573|P1|STARTED|Overall Study|None were prematurely withdrawn; 1 switched to CAPD mid-study and was excluded from second analysis.|12
38680|NCT02617667|89624|P4|NOT COMPLETED|Overall Study||1
38681|NCT02617667|89625|P3|NOT COMPLETED|Overall Study||4
38682|NCT02617667|89626|P2|NOT COMPLETED|Overall Study||1
38683|NCT02617667|89627|P1|NOT COMPLETED|Overall Study||1
38684|NCT02617667|89624|P4|COMPLETED|Overall Study||52
38685|NCT02617667|89625|P3|COMPLETED|Overall Study||48
38686|NCT02617667|89626|P2|COMPLETED|Overall Study||50
38687|NCT02617667|89627|P1|COMPLETED|Overall Study||50
38688|NCT02617667|89624|P4|STARTED|Overall Study||53
38689|NCT02617667|89625|P3|STARTED|Overall Study||52
38690|NCT02617667|89626|P2|STARTED|Overall Study||51
38691|NCT02617667|89627|P1|STARTED|Overall Study||51
38692|NCT02616900|89639|P1|NOT COMPLETED|Overall Study||23
38693|NCT02616900|89639|P1|COMPLETED|Overall Study|Six participants not included in study results because of incomplete data.|51
38694|NCT02616900|89639|P1|Completed 3mo Trial|Overall Study||57
38695|NCT02616900|89639|P1|STARTED|Overall Study||74
38696|NCT02616783|89647|P2|NOT COMPLETED|Overall Study||2
38697|NCT02616783|89648|P1|NOT COMPLETED|Overall Study||6
38698|NCT02616783|89647|P2|COMPLETED|Overall Study||54
38699|NCT02616783|89648|P1|COMPLETED|Overall Study||105
38700|NCT02616783|89647|P2|STARTED|Overall Study||56
38701|NCT02616783|89648|P1|STARTED|Overall Study||111
38702|NCT02616601|89671|P3|NOT COMPLETED|Overall Study||7
38703|NCT02616601|89672|P2|NOT COMPLETED|Overall Study||4
38704|NCT02616601|89673|P1|NOT COMPLETED|Overall Study||9
38705|NCT02616601|89671|P3|COMPLETED|Overall Study||135
38706|NCT02616601|89672|P2|COMPLETED|Overall Study||136
38707|NCT02616601|89673|P1|COMPLETED|Overall Study||131
38708|NCT02616601|89671|P3|PP Population|Overall Study||123
38709|NCT02616601|89672|P2|PP Population|Overall Study||121
38710|NCT02616601|89673|P1|PP Population|Overall Study||112
38711|NCT02616601|89671|P3|mITT Population|Overall Study||138
38712|NCT02616601|89672|P2|mITT Population|Overall Study||136
38713|NCT02616601|89673|P1|mITT Population|Overall Study||137
38714|NCT02616601|89671|P3|Safety Population|Overall Study||142
38715|NCT02616601|89672|P2|Safety Population|Overall Study||140
38716|NCT02616601|89673|P1|Safety Population|Overall Study||140
38717|NCT02616601|89671|P3|STARTED|Overall Study||142
38718|NCT02616601|89672|P2|STARTED|Overall Study||140
38719|NCT02616601|89673|P1|STARTED|Overall Study||140
38720|NCT02616523|89684|P3|NOT COMPLETED|Overall Study||0
38721|NCT02616523|89685|P2|NOT COMPLETED|Overall Study||0
38722|NCT02616523|89686|P1|NOT COMPLETED|Overall Study||1
38723|NCT02616523|89684|P3|COMPLETED|Overall Study|April 2015|20
38724|NCT02616523|89685|P2|COMPLETED|Overall Study|April 2015|20
38725|NCT02616523|89686|P1|COMPLETED|Overall Study|April 2015|19
38726|NCT02616523|89684|P3|STARTED|Overall Study|June 2014|20
38727|NCT02616523|89685|P2|STARTED|Overall Study|June 2014|20
38728|NCT02616523|89686|P1|STARTED|Overall Study|June 2014|20
38729|NCT02616380|89700|P1|NOT COMPLETED|Overall Study||3
38730|NCT02616380|89700|P1|COMPLETED|Overall Study||97
38731|NCT02616380|89700|P1|STARTED|Overall Study||100
38732|NCT02616250|89715|P2|NOT COMPLETED|Overall Study||9
38733|NCT02616250|89716|P1|NOT COMPLETED|Overall Study||10
38734|NCT02616250|89715|P2|COMPLETED|Overall Study||86
38735|NCT02616250|89716|P1|COMPLETED|Overall Study||85
38736|NCT02616250|89715|P2|STARTED|Overall Study||95
38737|NCT02616250|89716|P1|STARTED|Overall Study||95
38738|NCT02616146|89724|P2|NOT COMPLETED|Overall Study||504
38739|NCT02616146|89725|P1|NOT COMPLETED|Overall Study||1512
38740|NCT02616146|89724|P2|COMPLETED|Overall Study|Due to termination of study, LNG-EE reporting group received only up to 9 cycles of treatment.|0
38741|NCT02616146|89725|P1|COMPLETED|Overall Study|Due to termination of study, ENG-E2 reporting group received only up to 10 cycles of treatment.|0
38742|NCT02616146|89724|P2|STARTED|Overall Study||504
38743|NCT02616146|89725|P1|STARTED|Overall Study||1512
38744|NCT02616029|89741|P2|NOT COMPLETED|Overall Study||9
38745|NCT02616029|89742|P1|NOT COMPLETED|Overall Study||4
38746|NCT02616029|89741|P2|COMPLETED|Overall Study||19
38747|NCT02616029|89742|P1|COMPLETED|Overall Study||34
38748|NCT02616029|89741|P2|STARTED|Overall Study||28
38749|NCT02616029|89742|P1|STARTED|Overall Study||38
38750|NCT02615990|89765|P2|NOT COMPLETED|Overall Study||1
38751|NCT02615990|89766|P1|NOT COMPLETED|Overall Study||1
38752|NCT02615990|89765|P2|COMPLETED|Overall Study||0
38753|NCT02615990|89766|P1|COMPLETED|Overall Study||0
38754|NCT02615990|89765|P2|STARTED|Overall Study||1
38755|NCT02615990|89766|P1|STARTED|Overall Study||1
38756|NCT02615743|89812|P2|NOT COMPLETED|Overall Study||3
38757|NCT02615743|89813|P1|NOT COMPLETED|Overall Study||6
38758|NCT02615743|89812|P2|COMPLETED|Overall Study||17
38759|NCT02615743|89813|P1|COMPLETED|Overall Study||15
38760|NCT02615743|89812|P2|STARTED|Overall Study||20
38761|NCT02615743|89813|P1|STARTED|Overall Study||21
38762|NCT02615717|89827|P2|NOT COMPLETED|Overall Study||0
38763|NCT02615717|89828|P1|NOT COMPLETED|Overall Study||0
38764|NCT02615717|89827|P2|COMPLETED|Overall Study||3
38765|NCT02615717|89828|P1|COMPLETED|Overall Study||3
38766|NCT02615717|89827|P2|STARTED|Overall Study||3
38767|NCT02615717|89828|P1|STARTED|Overall Study||3
38768|NCT02615470|89842|P2|NOT COMPLETED|Overall Study||32
38769|NCT02615470|89843|P1|NOT COMPLETED|Overall Study||21
38770|NCT02615470|89842|P2|COMPLETED|Overall Study||30
38771|NCT02615470|89843|P1|COMPLETED|Overall Study||37
38772|NCT02615470|89842|P2|Completed the Baseline Surveys|Overall Study||47
38773|NCT02615470|89843|P1|Completed the Baseline Surveys|Overall Study||46
38774|NCT02615470|89842|P2|STARTED|Overall Study||62
38775|NCT02615470|89843|P1|STARTED|Overall Study||58
38776|NCT02615145|89856|P4|NOT COMPLETED|Overall Study||1
38777|NCT02615145|89857|P3|NOT COMPLETED|Overall Study||8
38778|NCT02615145|89858|P2|NOT COMPLETED|Overall Study||15
38779|NCT02615145|89859|P1|NOT COMPLETED|Overall Study||27
38780|NCT02615145|89856|P4|COMPLETED|Overall Study||0
38781|NCT02615145|89857|P3|COMPLETED|Overall Study||40
38782|NCT02615145|89858|P2|COMPLETED|Overall Study||263
38783|NCT02615145|89859|P1|COMPLETED|Overall Study||118
38784|NCT02615145|89856|P4|3DAA + RBV|Overall Study||0
38785|NCT02615145|89857|P3|3DAA + RBV|Overall Study||2
38786|NCT02615145|89858|P2|3DAA + RBV|Overall Study||17
38787|NCT02615145|89859|P1|3DAA + RBV|Overall Study||140
38788|NCT02615145|89856|P4|3DAA|Overall Study||0
38789|NCT02615145|89857|P3|3DAA|Overall Study||0
38790|NCT02615145|89858|P2|3DAA|Overall Study||261
38791|NCT02615145|89859|P1|3DAA|Overall Study||5
38792|NCT02615145|89856|P4|2 DAA + Ribavirin (RBV)|Overall Study||0
38793|NCT02615145|89857|P3|2 DAA + Ribavirin (RBV)|Overall Study||45
38794|NCT02615145|89858|P2|2 DAA + Ribavirin (RBV)|Overall Study||0
38795|NCT02615145|89859|P1|2 DAA + Ribavirin (RBV)|Overall Study||0
38796|NCT02615145|89856|P4|STARTED|Overall Study||1
38797|NCT02615145|89857|P3|STARTED|Overall Study||48
38798|NCT02615145|89858|P2|STARTED|Overall Study||278
38799|NCT02615145|89859|P1|STARTED|Overall Study||145
38800|NCT02614924|89935|P2|NOT COMPLETED|Overall Study||0
38801|NCT02614924|89936|P1|NOT COMPLETED|Overall Study||0
38802|NCT02614924|89935|P2|COMPLETED|Overall Study||20
38803|NCT02614924|89936|P1|COMPLETED|Overall Study||20
38804|NCT02614924|89935|P2|STARTED|Overall Study||20
38805|NCT02614924|89936|P1|STARTED|Overall Study||20
38806|NCT02614729|89946|P2|NOT COMPLETED|Overall Study||0
38807|NCT02614729|89947|P1|NOT COMPLETED|Overall Study||1
38808|NCT02614729|89946|P2|COMPLETED|Overall Study||17
38809|NCT02614729|89947|P1|COMPLETED|Overall Study||17
38810|NCT02614729|89946|P2|STARTED|Overall Study||17
38811|NCT02614729|89947|P1|STARTED|Overall Study||18
38812|NCT02614703|89967|P2|NOT COMPLETED|Overall Study||1
38813|NCT02614703|89968|P1|NOT COMPLETED|Overall Study||7
38814|NCT02614703|89967|P2|COMPLETED|Overall Study||28
38815|NCT02614703|89968|P1|COMPLETED|Overall Study||24
38816|NCT02614703|89967|P2|STARTED|Overall Study||29
38817|NCT02614703|89968|P1|STARTED|Overall Study||31
38818|NCT02614586|89974|P1|NOT COMPLETED|Overall Study||0
38819|NCT02614586|89974|P1|COMPLETED|Overall Study||11
38820|NCT02614586|89974|P1|STARTED|Overall Study||11
38821|NCT02614560|89981|P2|NOT COMPLETED|Overall Study||2
38822|NCT02614560|89982|P1|NOT COMPLETED|Overall Study||6
38823|NCT02614560|89981|P2|COMPLETED|Overall Study||6
38824|NCT02614560|89982|P1|COMPLETED|Overall Study||0
38825|NCT02614560|89981|P2|STARTED|Overall Study||8
38826|NCT02614560|89982|P1|STARTED|Overall Study||6
38827|NCT02614469|89999|P2|NOT COMPLETED|Period 2||0
38828|NCT02614469|90000|P1|NOT COMPLETED|Period 2||0
38829|NCT02614469|89999|P2|COMPLETED|Period 2||9
38830|NCT02614469|90000|P1|COMPLETED|Period 2||9
38831|NCT02614469|89999|P2|STARTED|Period 2||9
38832|NCT02614469|90000|P1|STARTED|Period 2||9
38833|NCT02614469|89999|P2|NOT COMPLETED|Period 1||0
38834|NCT02614469|90000|P1|NOT COMPLETED|Period 1||0
38835|NCT02614469|89999|P2|COMPLETED|Period 1||9
38836|NCT02614469|90000|P1|COMPLETED|Period 1||9
38837|NCT02614469|89999|P2|STARTED|Period 1||9
38838|NCT02614469|90000|P1|STARTED|Period 1||9
38839|NCT02614287|90030|P2|NOT COMPLETED|Post Treatment Follow-up Phase||5
38840|NCT02614287|90031|P1|NOT COMPLETED|Post Treatment Follow-up Phase||9
38841|NCT02614287|90030|P2|COMPLETED|Post Treatment Follow-up Phase||119
38842|NCT02614287|90031|P1|COMPLETED|Post Treatment Follow-up Phase||103
38843|NCT02614287|90030|P2|STARTED|Post Treatment Follow-up Phase|Follow-up period was optional, few participants who completed OL period didn't enter follow-up.|124
38844|NCT02614287|90031|P1|STARTED|Post Treatment Follow-up Phase|Follow-up period was optional, few participants who completed OL period didn't enter follow-up.|112
38845|NCT02614287|90030|P2|NOT COMPLETED|Open Label (OL) Treatment Phase||22
38846|NCT02614287|90031|P1|NOT COMPLETED|Open Label (OL) Treatment Phase||38
38847|NCT02614287|90030|P2|COMPLETED|Open Label (OL) Treatment Phase||113
38848|NCT02614287|90031|P1|COMPLETED|Open Label (OL) Treatment Phase||97
38849|NCT02614287|90030|P2|Received at Least One Dose of Study Drug|Open Label (OL) Treatment Phase||135
38850|NCT02614287|90031|P1|Received at Least One Dose of Study Drug|Open Label (OL) Treatment Phase||135
38851|NCT02614287|90030|P2|STARTED|Open Label (OL) Treatment Phase||135
38852|NCT02614287|90031|P1|STARTED|Open Label (OL) Treatment Phase||135
38853|NCT02614274|90065|P1|NOT COMPLETED|Overall Study||4
38854|NCT02614274|90065|P1|COMPLETED|Overall Study||5
38855|NCT02614274|90065|P1|STARTED|Overall Study||9
38856|NCT02614261|90077|P3|NOT COMPLETED|Overall Study||11
38857|NCT02614261|90078|P2|NOT COMPLETED|Overall Study||15
38858|NCT02614261|90079|P1|NOT COMPLETED|Overall Study||49
38859|NCT02614261|90077|P3|COMPLETED|Overall Study||266
38860|NCT02614261|90078|P2|COMPLETED|Overall Study||263
38861|NCT02614261|90079|P1|COMPLETED|Overall Study||509
38862|NCT02614261|90077|P3|Received at Least One Dose of Study Drug|Overall Study||277
38863|NCT02614261|90078|P2|Received at Least One Dose of Study Drug|Overall Study||278
38864|NCT02614261|90079|P1|Received at Least One Dose of Study Drug|Overall Study||558
38865|NCT02614261|90077|P3|STARTED|Overall Study||277
38866|NCT02614261|90078|P2|STARTED|Overall Study||278
38867|NCT02614261|90079|P1|STARTED|Overall Study||558
38868|NCT02614222|90118|P2|NOT COMPLETED|Overall Study||0
38869|NCT02614222|90119|P1|NOT COMPLETED|Overall Study||0
38870|NCT02614222|90118|P2|COMPLETED|Overall Study||14
38871|NCT02614222|90119|P1|COMPLETED|Overall Study||13
38872|NCT02614222|90118|P2|STARTED|Overall Study||14
38873|NCT02614222|90119|P1|STARTED|Overall Study||13
38874|NCT02614196|90145|P6|NOT COMPLETED|Post Treatment Follow-up Phase||0
38875|NCT02614196|90146|P5|NOT COMPLETED|Post Treatment Follow-up Phase||2
38876|NCT02614196|90147|P4|NOT COMPLETED|Post Treatment Follow-up Phase||1
38877|NCT02614196|90148|P3|NOT COMPLETED|Post Treatment Follow-up Phase||8
38878|NCT02614196|90149|P2|NOT COMPLETED|Post Treatment Follow-up Phase||5
38879|NCT02614196|90150|P1|NOT COMPLETED|Post Treatment Follow-up Phase||20
38880|NCT02614196|90145|P6|COMPLETED|Post Treatment Follow-up Phase||19
38881|NCT02614196|90146|P5|COMPLETED|Post Treatment Follow-up Phase||13
38882|NCT02614196|90147|P4|COMPLETED|Post Treatment Follow-up Phase||24
38883|NCT02614196|90148|P3|COMPLETED|Post Treatment Follow-up Phase||199
38884|NCT02614196|90149|P2|COMPLETED|Post Treatment Follow-up Phase||208
38885|NCT02614196|90150|P1|COMPLETED|Post Treatment Follow-up Phase||390
38886|NCT02614196|90145|P6|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|19
38887|NCT02614196|90146|P5|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|15
38888|NCT02614196|90147|P4|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|25
38889|NCT02614196|90148|P3|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|207
38890|NCT02614196|90149|P2|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|213
38891|NCT02614196|90150|P1|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|410
38892|NCT02614196|90145|P6|NOT COMPLETED|Double Blind Treatment Phase||0
38893|NCT02614196|90146|P5|NOT COMPLETED|Double Blind Treatment Phase||1
38894|NCT02614196|90147|P4|NOT COMPLETED|Double Blind Treatment Phase||4
38895|NCT02614196|90148|P3|NOT COMPLETED|Double Blind Treatment Phase||31
38896|NCT02614196|90149|P2|NOT COMPLETED|Double Blind Treatment Phase||30
38897|NCT02614196|90150|P1|NOT COMPLETED|Double Blind Treatment Phase||76
38898|NCT02614196|90145|P6|COMPLETED|Double Blind Treatment Phase||19
38899|NCT02614196|90146|P5|COMPLETED|Double Blind Treatment Phase||14
38900|NCT02614196|90147|P4|COMPLETED|Double Blind Treatment Phase||26
38901|NCT02614196|90148|P3|COMPLETED|Double Blind Treatment Phase||195
38902|NCT02614196|90149|P2|COMPLETED|Double Blind Treatment Phase||203
38903|NCT02614196|90150|P1|COMPLETED|Double Blind Treatment Phase||387
38904|NCT02614196|90145|P6|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||19
38905|NCT02614196|90146|P5|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||14
38906|NCT02614196|90147|P4|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||30
38907|NCT02614196|90148|P3|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||223
38908|NCT02614196|90149|P2|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||231
38909|NCT02614196|90150|P1|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||461
38910|NCT02614196|90145|P6|STARTED|Double Blind Treatment Phase||19
38911|NCT02614196|90146|P5|STARTED|Double Blind Treatment Phase||15
38912|NCT02614196|90147|P4|STARTED|Double Blind Treatment Phase||30
38913|NCT02614196|90148|P3|STARTED|Double Blind Treatment Phase||226
38914|NCT02614196|90149|P2|STARTED|Double Blind Treatment Phase||233
38915|NCT02614196|90150|P1|STARTED|Double Blind Treatment Phase||463
38916|NCT02614183|90196|P3|NOT COMPLETED|Post Treatment Follow-up Phase||12
38917|NCT02614183|90197|P2|NOT COMPLETED|Post Treatment Follow-up Phase||6
38918|NCT02614183|90198|P1|NOT COMPLETED|Post Treatment Follow-up Phase||18
38919|NCT02614183|90196|P3|COMPLETED|Post Treatment Follow-up Phase||171
38920|NCT02614183|90197|P2|COMPLETED|Post Treatment Follow-up Phase||179
38921|NCT02614183|90198|P1|COMPLETED|Post Treatment Follow-up Phase||354
38922|NCT02614183|90196|P3|Safety Population|Post Treatment Follow-up Phase|Two participants who received only 240mg loading dose prior to discontinuation moved to this group.|185
38923|NCT02614183|90197|P2|Safety Population|Post Treatment Follow-up Phase||183
38924|NCT02614183|90198|P1|Safety Population|Post Treatment Follow-up Phase||372
38925|NCT02614183|90196|P3|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|183
38926|NCT02614183|90197|P2|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|185
38927|NCT02614183|90198|P1|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|372
38928|NCT02614183|90196|P3|NOT COMPLETED|Double Blind Treatment Phase||39
38929|NCT02614183|90197|P2|NOT COMPLETED|Double Blind Treatment Phase||37
38930|NCT02614183|90198|P1|NOT COMPLETED|Double Blind Treatment Phase||83
38931|NCT02614183|90196|P3|COMPLETED|Double Blind Treatment Phase||175
38932|NCT02614183|90197|P2|COMPLETED|Double Blind Treatment Phase||177
38933|NCT02614183|90198|P1|COMPLETED|Double Blind Treatment Phase||351
38934|NCT02614183|90196|P3|Safety Population|Double Blind Treatment Phase|Eight pts discontinued after loading dose of 240mg galcanezumab in 120mg group moved to this group.|220
38935|NCT02614183|90197|P2|Safety Population|Double Blind Treatment Phase|One pt randomized to placebo received galcanezumab 120mg due to dosing error moved to this group.|206
38936|NCT02614183|90198|P1|Safety Population|Double Blind Treatment Phase||432
38937|NCT02614183|90196|P3|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||212
38938|NCT02614183|90197|P2|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||213
38939|NCT02614183|90198|P1|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||433
38940|NCT02614183|90196|P3|STARTED|Double Blind Treatment Phase||214
38941|NCT02614183|90197|P2|STARTED|Double Blind Treatment Phase||214
38942|NCT02614183|90198|P1|STARTED|Double Blind Treatment Phase||434
38943|NCT02614131|90242|P7|NOT COMPLETED|Overall Study||1
38944|NCT02614131|90243|P6|NOT COMPLETED|Overall Study||0
38945|NCT02614131|90244|P5|NOT COMPLETED|Overall Study||0
38946|NCT02614131|90245|P4|NOT COMPLETED|Overall Study||0
38947|NCT02614131|90246|P3|NOT COMPLETED|Overall Study||0
38948|NCT02614131|90247|P2|NOT COMPLETED|Overall Study||0
38949|NCT02614131|90248|P1|NOT COMPLETED|Overall Study||1
38950|NCT02614131|90242|P7|COMPLETED|Overall Study||4
38951|NCT02614131|90243|P6|COMPLETED|Overall Study||2
38952|NCT02614131|90244|P5|COMPLETED|Overall Study||8
38953|NCT02614131|90245|P4|COMPLETED|Overall Study||8
38954|NCT02614131|90246|P3|COMPLETED|Overall Study||8
38955|NCT02614131|90247|P2|COMPLETED|Overall Study||8
38956|NCT02614131|90248|P1|COMPLETED|Overall Study||10
38957|NCT02614131|90242|P7|Received at Least One Dose of Drug|Overall Study||5
38958|NCT02614131|90243|P6|Received at Least One Dose of Drug|Overall Study||2
38959|NCT02614131|90244|P5|Received at Least One Dose of Drug|Overall Study||8
38960|NCT02614131|90245|P4|Received at Least One Dose of Drug|Overall Study||8
38961|NCT02614131|90246|P3|Received at Least One Dose of Drug|Overall Study||8
38962|NCT02614131|90247|P2|Received at Least One Dose of Drug|Overall Study||8
38963|NCT02614131|90248|P1|Received at Least One Dose of Drug|Overall Study||11
38964|NCT02614131|90242|P7|STARTED|Overall Study||5
38965|NCT02614131|90243|P6|STARTED|Overall Study||2
38966|NCT02614131|90244|P5|STARTED|Overall Study||8
38967|NCT02614131|90245|P4|STARTED|Overall Study||8
38968|NCT02614131|90246|P3|STARTED|Overall Study||8
38969|NCT02614131|90247|P2|STARTED|Overall Study||8
38970|NCT02614131|90248|P1|STARTED|Overall Study||11
38971|NCT02614079|90279|P1|NOT COMPLETED|Overall Study||1
38972|NCT02614079|90279|P1|COMPLETED|Overall Study|1 participant withdrew from the study prior to completion of DSSEP testing|5
38973|NCT02614079|90279|P1|STARTED|Overall Study||6
38974|NCT02613910|90283|P1|NOT COMPLETED|Overall Study||1
38975|NCT02613910|90283|P1|COMPLETED|Overall Study||0
38976|NCT02613910|90283|P1|STARTED|Overall Study||1
38977|NCT02613897|90335|P3|NOT COMPLETED|Overall Study||0
38978|NCT02613897|90336|P2|NOT COMPLETED|Overall Study||0
38979|NCT02613897|90337|P1|NOT COMPLETED|Overall Study||0
38980|NCT02613897|90335|P3|COMPLETED|Overall Study||12
38981|NCT02613897|90336|P2|COMPLETED|Overall Study||22
38982|NCT02613897|90337|P1|COMPLETED|Overall Study||22
38983|NCT02613897|90335|P3|STARTED|Overall Study||12
38984|NCT02613897|90336|P2|STARTED|Overall Study||22
38985|NCT02613897|90337|P1|STARTED|Overall Study||22
38986|NCT02613871|90369|P1|NOT COMPLETED|Overall Study||3
38987|NCT02613871|90369|P1|COMPLETED|Overall Study||108
38988|NCT02613871|90369|P1|STARTED|Overall Study||111
38989|NCT02613507|90390|P2|NOT COMPLETED|Overall Study||164
38990|NCT02613507|90391|P1|NOT COMPLETED|Overall Study||288
38991|NCT02613507|90390|P2|COMPLETED|Overall Study||2
38992|NCT02613507|90391|P1|COMPLETED|Overall Study||50
38993|NCT02613507|90390|P2|STARTED|Overall Study||166
38994|NCT02613507|90391|P1|STARTED|Overall Study||338
38995|NCT02613481|90407|P1|NOT COMPLETED|Overall Study||9
38996|NCT02613481|90407|P1|COMPLETED|Overall Study||41
38997|NCT02613481|90407|P1|STARTED|Overall Study||50
38998|NCT02613403|90418|P5|NOT COMPLETED|Overall Study||0
38999|NCT02613403|90419|P4|NOT COMPLETED|Overall Study||0
39000|NCT02613403|90420|P3|NOT COMPLETED|Overall Study||0
39001|NCT02613403|90421|P2|NOT COMPLETED|Overall Study||1
39002|NCT02613403|90422|P1|NOT COMPLETED|Overall Study||2
39003|NCT02613403|90418|P5|COMPLETED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
39004|NCT02613403|90419|P4|COMPLETED|Overall Study||13
39005|NCT02613403|90420|P3|COMPLETED|Overall Study||9
39006|NCT02613403|90421|P2|COMPLETED|Overall Study||35
39007|NCT02613403|90422|P1|COMPLETED|Overall Study||34
39008|NCT02613403|90418|P5|Treated|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
39009|NCT02613403|90419|P4|Treated|Overall Study||13
39010|NCT02613403|90420|P3|Treated|Overall Study||9
39011|NCT02613403|90421|P2|Treated|Overall Study||36
39012|NCT02613403|90422|P1|Treated|Overall Study||35
39013|NCT02613403|90418|P5|STARTED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
39014|NCT02613403|90419|P4|STARTED|Overall Study||13
39015|NCT02613403|90420|P3|STARTED|Overall Study||9
39016|NCT02613403|90421|P2|STARTED|Overall Study||36
39017|NCT02613403|90422|P1|STARTED|Overall Study||36
39018|NCT02613338|90464|P1|NOT COMPLETED|Overall Study||0
39019|NCT02613338|90464|P1|COMPLETED|Overall Study||30
39020|NCT02613338|90464|P1|STARTED|Overall Study||30
39021|NCT02613221|90474|P1|NOT COMPLETED|Overall Study||55
39022|NCT02613221|90474|P1|COMPLETED|Overall Study||1
39023|NCT02613221|90474|P1|Safety Population: Received Study Drug|Overall Study||55
39024|NCT02613221|90474|P1|STARTED|Overall Study||56
39025|NCT02613182|90486|P1|NOT COMPLETED|Overall Study||34
39026|NCT02613182|90486|P1|COMPLETED|Overall Study||0
39027|NCT02613182|90486|P1|Number of Patients Dosed|Overall Study||34
39028|NCT02613182|90486|P1|STARTED|Overall Study||34
39029|NCT02612909|90495|P5|NOT COMPLETED|Phase 3||0
39030|NCT02612909|90496|P4|NOT COMPLETED|Phase 3||1
39031|NCT02612909|90497|P3|NOT COMPLETED|Phase 3||0
39032|NCT02612909|90498|P2|NOT COMPLETED|Phase 3||0
39033|NCT02612909|90499|P1|NOT COMPLETED|Phase 3||0
39034|NCT02612909|90495|P5|COMPLETED|Phase 3||525
39035|NCT02612909|90496|P4|COMPLETED|Phase 3||104
39036|NCT02612909|90497|P3|COMPLETED|Phase 3||0
39037|NCT02612909|90498|P2|COMPLETED|Phase 3||0
39038|NCT02612909|90499|P1|COMPLETED|Phase 3||0
39039|NCT02612909|90495|P5|Completed Day 43 Clinic Visit|Phase 3||524
39040|NCT02612909|90496|P4|Completed Day 43 Clinic Visit|Phase 3||104
39041|NCT02612909|90497|P3|Completed Day 43 Clinic Visit|Phase 3||0
39042|NCT02612909|90498|P2|Completed Day 43 Clinic Visit|Phase 3||0
39043|NCT02612909|90499|P1|Completed Day 43 Clinic Visit|Phase 3||0
39044|NCT02612909|90495|P5|Completed Day 29 Clinic Visit|Phase 3||525
39045|NCT02612909|90496|P4|Completed Day 29 Clinic Visit|Phase 3||104
39046|NCT02612909|90497|P3|Completed Day 29 Clinic Visit|Phase 3||0
39047|NCT02612909|90498|P2|Completed Day 29 Clinic Visit|Phase 3||0
39048|NCT02612909|90499|P1|Completed Day 29 Clinic Visit|Phase 3||0
39049|NCT02612909|90495|P5|Received Injection 2|Phase 3||520
39050|NCT02612909|90496|P4|Received Injection 2|Phase 3||103
39051|NCT02612909|90497|P3|Received Injection 2|Phase 3||0
39052|NCT02612909|90498|P2|Received Injection 2|Phase 3||0
39053|NCT02612909|90499|P1|Received Injection 2|Phase 3||0
39054|NCT02612909|90495|P5|Received Injection 1|Phase 3||525
39055|NCT02612909|90496|P4|Received Injection 1|Phase 3||105
39056|NCT02612909|90497|P3|Received Injection 1|Phase 3||0
39057|NCT02612909|90498|P2|Received Injection 1|Phase 3||0
39058|NCT02612909|90499|P1|Received Injection 1|Phase 3||0
39059|NCT02612909|90495|P5|STARTED|Phase 3||525
39060|NCT02612909|90496|P4|STARTED|Phase 3||105
39061|NCT02612909|90497|P3|STARTED|Phase 3||0
39062|NCT02612909|90498|P2|STARTED|Phase 3||0
39063|NCT02612909|90499|P1|STARTED|Phase 3||0
39064|NCT02612909|90495|P5|NOT COMPLETED|Phase 2||0
39065|NCT02612909|90496|P4|NOT COMPLETED|Phase 2||0
39066|NCT02612909|90497|P3|NOT COMPLETED|Phase 2||1
39067|NCT02612909|90498|P2|NOT COMPLETED|Phase 2||5
39068|NCT02612909|90499|P1|NOT COMPLETED|Phase 2||2
39069|NCT02612909|90495|P5|COMPLETED|Phase 2||0
39070|NCT02612909|90496|P4|COMPLETED|Phase 2||0
39071|NCT02612909|90497|P3|COMPLETED|Phase 2||99
39072|NCT02612909|90498|P2|COMPLETED|Phase 2||95
39073|NCT02612909|90499|P1|COMPLETED|Phase 2||98
39074|NCT02612909|90495|P5|Completed Day 43 Clinic Visit|Phase 2||0
39075|NCT02612909|90496|P4|Completed Day 43 Clinic Visit|Phase 2||0
39076|NCT02612909|90497|P3|Completed Day 43 Clinic Visit|Phase 2||99
39077|NCT02612909|90498|P2|Completed Day 43 Clinic Visit|Phase 2||94
39078|NCT02612909|90499|P1|Completed Day 43 Clinic Visit|Phase 2||97
39079|NCT02612909|90495|P5|Completed Day 29 Clinic Visit|Phase 2||0
39080|NCT02612909|90496|P4|Completed Day 29 Clinic Visit|Phase 2||0
39081|NCT02612909|90497|P3|Completed Day 29 Clinic Visit|Phase 2||99
39082|NCT02612909|90498|P2|Completed Day 29 Clinic Visit|Phase 2||95
39083|NCT02612909|90499|P1|Completed Day 29 Clinic Visit|Phase 2||98
39084|NCT02612909|90495|P5|Received Injection 2|Phase 2||0
39085|NCT02612909|90496|P4|Received Injection 2|Phase 2||0
39086|NCT02612909|90497|P3|Received Injection 2|Phase 2||99
39087|NCT02612909|90498|P2|Received Injection 2|Phase 2||95
39088|NCT02612909|90499|P1|Received Injection 2|Phase 2||98
39089|NCT02612909|90495|P5|Received Injection 1|Phase 2||0
39090|NCT02612909|90496|P4|Received Injection 1|Phase 2||0
39091|NCT02612909|90497|P3|Received Injection 1|Phase 2||100
39092|NCT02612909|90498|P2|Received Injection 1|Phase 2||100
39093|NCT02612909|90499|P1|Received Injection 1|Phase 2||100
39094|NCT02612909|90495|P5|STARTED|Phase 2||0
39095|NCT02612909|90496|P4|STARTED|Phase 2||0
39096|NCT02612909|90497|P3|STARTED|Phase 2||100
39097|NCT02612909|90498|P2|STARTED|Phase 2||100
39098|NCT02612909|90499|P1|STARTED|Phase 2||100
39099|NCT02612857|90567|P3|NOT COMPLETED|Overall Study||4
39100|NCT02612857|90568|P2|NOT COMPLETED|Overall Study||4
39101|NCT02612857|90569|P1|NOT COMPLETED|Overall Study||3
39102|NCT02612857|90567|P3|COMPLETED|Overall Study||6
39103|NCT02612857|90568|P2|COMPLETED|Overall Study||5
39104|NCT02612857|90569|P1|COMPLETED|Overall Study||8
39105|NCT02612857|90567|P3|STARTED|Overall Study||10
39106|NCT02612857|90568|P2|STARTED|Overall Study||9
39107|NCT02612857|90569|P1|STARTED|Overall Study||11
39108|NCT02612727|90582|P2|NOT COMPLETED|Overall Study||4
39109|NCT02612727|90583|P1|NOT COMPLETED|Overall Study||5
39110|NCT02612727|90582|P2|COMPLETED|Overall Study||83
39111|NCT02612727|90583|P1|COMPLETED|Overall Study||82
39112|NCT02612727|90582|P2|STARTED|Overall Study||87
39113|NCT02612727|90583|P1|STARTED|Overall Study||87
39114|NCT02612623|90595|P4|NOT COMPLETED|Overall Study||0
39115|NCT02612623|90596|P3|NOT COMPLETED|Overall Study||1
39116|NCT02612623|90597|P2|NOT COMPLETED|Overall Study||1
39117|NCT02612623|90598|P1|NOT COMPLETED|Overall Study||1
39118|NCT02612623|90595|P4|COMPLETED|Overall Study||4
39119|NCT02612623|90596|P3|COMPLETED|Overall Study||5
39120|NCT02612623|90597|P2|COMPLETED|Overall Study||5
39121|NCT02612623|90598|P1|COMPLETED|Overall Study||7
39122|NCT02612623|90595|P4|Treated|Overall Study||4
39123|NCT02612623|90596|P3|Treated|Overall Study||6
39124|NCT02612623|90597|P2|Treated|Overall Study||5
39125|NCT02612623|90598|P1|Treated|Overall Study||8
39126|NCT02612623|90595|P4|STARTED|Overall Study||4
39127|NCT02612623|90596|P3|STARTED|Overall Study||6
39128|NCT02612623|90597|P2|STARTED|Overall Study||6
39129|NCT02612623|90598|P1|STARTED|Overall Study||8
39130|NCT02612610|90612|P4|NOT COMPLETED|Overall Study||13
39131|NCT02612610|90613|P3|NOT COMPLETED|Overall Study||5
39132|NCT02612610|90614|P2|NOT COMPLETED|Overall Study||8
39133|NCT02612610|90615|P1|NOT COMPLETED|Overall Study||5
39134|NCT02612610|90612|P4|COMPLETED|Overall Study||50
39135|NCT02612610|90613|P3|COMPLETED|Overall Study||58
39136|NCT02612610|90614|P2|COMPLETED|Overall Study||56
39137|NCT02612610|90615|P1|COMPLETED|Overall Study||58
39138|NCT02612610|90612|P4|Treated|Overall Study||63
39139|NCT02612610|90613|P3|Treated|Overall Study||63
39140|NCT02612610|90614|P2|Treated|Overall Study||63
39141|NCT02612610|90615|P1|Treated|Overall Study||63
39142|NCT02612610|90612|P4|STARTED|Overall Study||63
39143|NCT02612610|90613|P3|STARTED|Overall Study||63
39144|NCT02612610|90614|P2|STARTED|Overall Study||64
39145|NCT02612610|90615|P1|STARTED|Overall Study||63
39146|NCT02612428|90859|P2|NOT COMPLETED|VTL-308E||7
39147|NCT02612428|90860|P1|NOT COMPLETED|VTL-308E||11
39148|NCT02612428|90859|P2|COMPLETED|VTL-308E||49
39149|NCT02612428|90860|P1|COMPLETED|VTL-308E||53
39150|NCT02612428|90859|P2|STARTED|VTL-308E||56
39151|NCT02612428|90860|P1|STARTED|VTL-308E||64
39152|NCT02612428|90859|P2|NOT COMPLETED|VTL-308||17
39153|NCT02612428|90860|P1|NOT COMPLETED|VTL-308||14
39154|NCT02612428|90859|P2|COMPLETED|VTL-308||56
39155|NCT02612428|90860|P1|COMPLETED|VTL-308||64
39156|NCT02612428|90859|P2|STARTED|VTL-308||73
39157|NCT02612428|90860|P1|STARTED|VTL-308||78
39158|NCT02612285|90870|P1|NOT COMPLETED|Overall Study||1
39159|NCT02612285|90870|P1|COMPLETED|Overall Study|Subject did not complete Cycle 1; no data points recorded|0
39160|NCT02612285|90870|P1|STARTED|Overall Study||1
39161|NCT02612077|90874|P1|NOT COMPLETED|Overall Study||466
39162|NCT02612077|90874|P1|COMPLETED|Overall Study||299
39163|NCT02612077|90874|P1|Efficacy Analysis Set|Overall Study||737
39164|NCT02612077|90874|P1|Safety Analysis Set|Overall Study||760
39165|NCT02612077|90874|P1|Did Not Receive Study Product|Overall Study||5
39166|NCT02612077|90874|P1|STARTED|Overall Study||765
39167|NCT02612064|90886|P2|NOT COMPLETED|Overall Study||3
39168|NCT02612064|90887|P1|NOT COMPLETED|Overall Study||1
39169|NCT02612064|90886|P2|COMPLETED|Overall Study||112
39170|NCT02612064|90887|P1|COMPLETED|Overall Study||114
39171|NCT02612064|90886|P2|STARTED|Overall Study||115
39172|NCT02612064|90887|P1|STARTED|Overall Study||115
39173|NCT02611765|90899|P2|NOT COMPLETED|Overall Study||6
39174|NCT02611765|90900|P1|NOT COMPLETED|Overall Study||2
39175|NCT02611765|90899|P2|COMPLETED|Overall Study||29
39176|NCT02611765|90900|P1|COMPLETED|Overall Study||27
39177|NCT02611765|90899|P2|STARTED|Overall Study||35
39178|NCT02611765|90900|P1|STARTED|Overall Study||29
39179|NCT02611752|90908|P2|NOT COMPLETED|Overall Study||1
39180|NCT02611752|90909|P1|NOT COMPLETED|Overall Study||0
39181|NCT02611752|90908|P2|COMPLETED|Overall Study||24
39182|NCT02611752|90909|P1|COMPLETED|Overall Study||22
39183|NCT02611752|90908|P2|Day11-13 Hydromorphone Challenge Injs|Overall Study||24
39184|NCT02611752|90909|P1|Day11-13 Hydromorphone Challenge Injs|Overall Study||22
39185|NCT02611752|90908|P2|Day 8-10 Hydromorphone Challenge Injs|Overall Study||24
39186|NCT02611752|90909|P1|Day 8-10 Hydromorphone Challenge Injs|Overall Study||22
39187|NCT02611752|90908|P2|Day 4-6 Hydromorphone Challenge Injs|Overall Study||24
39188|NCT02611752|90909|P1|Day 4-6 Hydromorphone Challenge Injs|Overall Study||22
39189|NCT02611752|90908|P2|Day 1-3 Hydromorphone Challenge Injs|Overall Study||25
39190|NCT02611752|90909|P1|Day 1-3 Hydromorphone Challenge Injs|Overall Study||22
39191|NCT02611752|90908|P2|STARTED|Overall Study||25
39192|NCT02611752|90909|P1|STARTED|Overall Study||22
39193|NCT02611479|90941|P1|NOT COMPLETED|Data Cleaning||2
39194|NCT02611479|90941|P1|COMPLETED|Data Cleaning||149
39195|NCT02611479|90941|P1|STARTED|Data Cleaning||151
39196|NCT02611479|90941|P1|NOT COMPLETED|Post-Surgery Follow-up at 1-Year||18
39197|NCT02611479|90941|P1|COMPLETED|Post-Surgery Follow-up at 1-Year||151
39198|NCT02611479|90941|P1|STARTED|Post-Surgery Follow-up at 1-Year||169
39199|NCT02611479|90941|P1|NOT COMPLETED|Post-Surgery Follow-up at 30-90 Days||2
39200|NCT02611479|90941|P1|COMPLETED|Post-Surgery Follow-up at 30-90 Days||169
39201|NCT02611479|90941|P1|STARTED|Post-Surgery Follow-up at 30-90 Days||171
39202|NCT02611479|90941|P1|NOT COMPLETED|Baseline Enrollment||13
39203|NCT02611479|90941|P1|COMPLETED|Baseline Enrollment||171
39204|NCT02611479|90941|P1|STARTED|Baseline Enrollment||184
39205|NCT02611154|90945|P1|NOT COMPLETED|Overall Study||0
39206|NCT02611154|90945|P1|COMPLETED|Overall Study||5
39207|NCT02611154|90945|P1|STARTED|Overall Study||5
39208|NCT02610972|90966|P2|NOT COMPLETED|Overall Study||0
39209|NCT02610972|90967|P1|NOT COMPLETED|Overall Study||0
39210|NCT02610972|90966|P2|COMPLETED|Overall Study||50
39211|NCT02610972|90967|P1|COMPLETED|Overall Study||100
39212|NCT02610972|90966|P2|STARTED|Overall Study||50
39213|NCT02610972|90967|P1|STARTED|Overall Study||100
39214|NCT02610868|90973|P1|NOT COMPLETED|MYOBLOC: Treatment Session 4||2
39215|NCT02610868|90973|P1|COMPLETED|MYOBLOC: Treatment Session 4||22
39216|NCT02610868|90973|P1|STARTED|MYOBLOC: Treatment Session 4||24
39217|NCT02610868|90973|P1|NOT COMPLETED|MYOBLOC: Treatment Session 3||7
39218|NCT02610868|90973|P1|COMPLETED|MYOBLOC: Treatment Session 3||43
39219|NCT02610868|90973|P1|STARTED|MYOBLOC: Treatment Session 3||50
39220|NCT02610868|90973|P1|NOT COMPLETED|MYOBLOC: Treatment Session 2||12
39221|NCT02610868|90973|P1|COMPLETED|MYOBLOC: Treatment Session 2||165
39222|NCT02610868|90973|P1|STARTED|MYOBLOC: Treatment Session 2||177
39223|NCT02610868|90973|P1|NOT COMPLETED|MYOBLOC: Treatment Session 1||7
39224|NCT02610868|90973|P1|COMPLETED|MYOBLOC: Treatment Session 1||180
39225|NCT02610868|90973|P1|STARTED|MYOBLOC: Treatment Session 1||187
39226|NCT02610842|91073|P1|NOT COMPLETED|Overall Study||5
39227|NCT02610842|91073|P1|COMPLETED|Overall Study||22
39228|NCT02610842|91073|P1|STARTED|Overall Study||27
39229|NCT02610816|91082|P4|NOT COMPLETED|Phase 2||6
39230|NCT02610816|91083|P3|NOT COMPLETED|Phase 2||11
39231|NCT02610816|91084|P2|NOT COMPLETED|Phase 2||0
39232|NCT02610816|91085|P1|NOT COMPLETED|Phase 2||0
39233|NCT02610816|91082|P4|COMPLETED|Phase 2||4
39234|NCT02610816|91083|P3|COMPLETED|Phase 2||8
39235|NCT02610816|91084|P2|COMPLETED|Phase 2||0
39236|NCT02610816|91085|P1|COMPLETED|Phase 2||0
39237|NCT02610816|91082|P4|STARTED|Phase 2||10
39238|NCT02610816|91083|P3|STARTED|Phase 2||19
39239|NCT02610816|91084|P2|STARTED|Phase 2||0
39240|NCT02610816|91085|P1|STARTED|Phase 2||0
39241|NCT02610816|91082|P4|NOT COMPLETED|Phase 1||0
39242|NCT02610816|91083|P3|NOT COMPLETED|Phase 1||0
39243|NCT02610816|91084|P2|NOT COMPLETED|Phase 1||8
39244|NCT02610816|91085|P1|NOT COMPLETED|Phase 1||4
39245|NCT02610816|91082|P4|COMPLETED|Phase 1||0
39246|NCT02610816|91083|P3|COMPLETED|Phase 1||0
39247|NCT02610816|91084|P2|COMPLETED|Phase 1||17
39248|NCT02610816|91085|P1|COMPLETED|Phase 1||34
39249|NCT02610816|91082|P4|STARTED|Phase 1||0
39250|NCT02610816|91083|P3|STARTED|Phase 1||0
39251|NCT02610816|91084|P2|STARTED|Phase 1||25
39252|NCT02610816|91085|P1|STARTED|Phase 1||38
39253|NCT02610725|91106|P1|NOT COMPLETED|Overall Study||206
39254|NCT02610725|91106|P1|COMPLETED|Overall Study||75
39255|NCT02610725|91106|P1|STARTED|Overall Study||281
39256|NCT02610634|91114|P2|NOT COMPLETED|Overall Study||0
39257|NCT02610634|91115|P1|NOT COMPLETED|Overall Study||0
39258|NCT02610634|91114|P2|COMPLETED|Overall Study||40
39259|NCT02610634|91115|P1|COMPLETED|Overall Study||60
39260|NCT02610634|91114|P2|STARTED|Overall Study||40
39261|NCT02610634|91115|P1|STARTED|Overall Study||60
39262|NCT02609841|91123|P1|NOT COMPLETED|Overall Study||28
39263|NCT02609841|91123|P1|COMPLETED|Overall Study||212
39264|NCT02609841|91123|P1|STARTED|Overall Study||240
39265|NCT02609672|91131|P2|NOT COMPLETED|Overall Study||1
39266|NCT02609672|91132|P1|NOT COMPLETED|Overall Study||3
39267|NCT02609672|91131|P2|COMPLETED|Overall Study||11
39268|NCT02609672|91132|P1|COMPLETED|Overall Study||9
39269|NCT02609672|91131|P2|STARTED|Overall Study||12
39270|NCT02609672|91132|P1|STARTED|Overall Study||12
39271|NCT02609659|91166|P1|NOT COMPLETED|Overall Study||8
39272|NCT02609659|91166|P1|COMPLETED|Overall Study||97
39273|NCT02609659|91166|P1|STARTED|Overall Study||105
39274|NCT02609633|91176|P2|NOT COMPLETED|Overall Study||2
39275|NCT02609633|91177|P1|NOT COMPLETED|Overall Study||5
39276|NCT02609633|91176|P2|COMPLETED|Overall Study||54
39277|NCT02609633|91177|P1|COMPLETED|Overall Study||37
39278|NCT02609633|91176|P2|Full Analysis Set (FAS)|Overall Study||46
39279|NCT02609633|91177|P1|Full Analysis Set (FAS)|Overall Study||32
39280|NCT02609633|91176|P2|STARTED|Overall Study||56
39281|NCT02609633|91177|P1|STARTED|Overall Study||42
39282|NCT02609399|91204|P2|NOT COMPLETED|Influenza Season 2016-2017||5
39283|NCT02609399|91205|P1|NOT COMPLETED|Influenza Season 2016-2017||9
39284|NCT02609399|91204|P2|COMPLETED|Influenza Season 2016-2017||59
39285|NCT02609399|91205|P1|COMPLETED|Influenza Season 2016-2017||49
39286|NCT02609399|91204|P2|STARTED|Influenza Season 2016-2017||64
39287|NCT02609399|91205|P1|STARTED|Influenza Season 2016-2017||58
39288|NCT02609399|91204|P2|NOT COMPLETED|Influenza Season 2015-2016||2
39289|NCT02609399|91205|P1|NOT COMPLETED|Influenza Season 2015-2016||3
39290|NCT02609399|91204|P2|COMPLETED|Influenza Season 2015-2016||29
39291|NCT02609399|91205|P1|COMPLETED|Influenza Season 2015-2016||24
39292|NCT02609399|91204|P2|STARTED|Influenza Season 2015-2016||31
39293|NCT02609399|91205|P1|STARTED|Influenza Season 2015-2016||27
39294|NCT02609308|91219|P2|NOT COMPLETED|Overall Study||0
39295|NCT02609308|91220|P1|NOT COMPLETED|Overall Study||0
39296|NCT02609308|91219|P2|COMPLETED|Overall Study||11
39297|NCT02609308|91220|P1|COMPLETED|Overall Study||10
39298|NCT02609308|91219|P2|STARTED|Overall Study||11
39299|NCT02609308|91220|P1|STARTED|Overall Study||10
39300|NCT02609204|91230|P1|NOT COMPLETED|Overall Study||0
39301|NCT02609204|91230|P1|COMPLETED|Overall Study||51
39302|NCT02609204|91230|P1|STARTED|Overall Study||51
39303|NCT02609178|91235|P6|NOT COMPLETED|Third Crown||0
39304|NCT02609178|91236|P5|NOT COMPLETED|Third Crown||0
39305|NCT02609178|91237|P4|NOT COMPLETED|Third Crown||0
39306|NCT02609178|91238|P3|NOT COMPLETED|Third Crown||0
39307|NCT02609178|91239|P2|NOT COMPLETED|Third Crown||0
39308|NCT02609178|91240|P1|NOT COMPLETED|Third Crown||0
39309|NCT02609178|91235|P6|COMPLETED|Third Crown||2
39310|NCT02609178|91236|P5|COMPLETED|Third Crown||0
39311|NCT02609178|91237|P4|COMPLETED|Third Crown||2
39312|NCT02609178|91238|P3|COMPLETED|Third Crown||5
39313|NCT02609178|91239|P2|COMPLETED|Third Crown||1
39314|NCT02609178|91240|P1|COMPLETED|Third Crown||0
39315|NCT02609178|91235|P6|STARTED|Third Crown||2
39316|NCT02609178|91236|P5|STARTED|Third Crown||0
39317|NCT02609178|91237|P4|STARTED|Third Crown||2
39318|NCT02609178|91238|P3|STARTED|Third Crown||5
39319|NCT02609178|91239|P2|STARTED|Third Crown||1
39320|NCT02609178|91240|P1|STARTED|Third Crown||0
39321|NCT02609178|91235|P6|NOT COMPLETED|5-minute Washout Time||0
39322|NCT02609178|91236|P5|NOT COMPLETED|5-minute Washout Time||0
39323|NCT02609178|91237|P4|NOT COMPLETED|5-minute Washout Time||0
39324|NCT02609178|91238|P3|NOT COMPLETED|5-minute Washout Time||0
39325|NCT02609178|91239|P2|NOT COMPLETED|5-minute Washout Time||0
39326|NCT02609178|91240|P1|NOT COMPLETED|5-minute Washout Time||0
39327|NCT02609178|91235|P6|COMPLETED|5-minute Washout Time||2
39328|NCT02609178|91236|P5|COMPLETED|5-minute Washout Time||0
39329|NCT02609178|91237|P4|COMPLETED|5-minute Washout Time||2
39330|NCT02609178|91238|P3|COMPLETED|5-minute Washout Time||5
39331|NCT02609178|91239|P2|COMPLETED|5-minute Washout Time||1
39332|NCT02609178|91240|P1|COMPLETED|5-minute Washout Time||0
39333|NCT02609178|91235|P6|STARTED|5-minute Washout Time||2
39334|NCT02609178|91236|P5|STARTED|5-minute Washout Time||0
39335|NCT02609178|91237|P4|STARTED|5-minute Washout Time||2
39336|NCT02609178|91238|P3|STARTED|5-minute Washout Time||5
39337|NCT02609178|91239|P2|STARTED|5-minute Washout Time||1
39338|NCT02609178|91240|P1|STARTED|5-minute Washout Time||0
39339|NCT02609178|91235|P6|NOT COMPLETED|Second Crown||0
39340|NCT02609178|91236|P5|NOT COMPLETED|Second Crown||0
39341|NCT02609178|91237|P4|NOT COMPLETED|Second Crown||0
39342|NCT02609178|91238|P3|NOT COMPLETED|Second Crown||0
39343|NCT02609178|91239|P2|NOT COMPLETED|Second Crown||0
39344|NCT02609178|91240|P1|NOT COMPLETED|Second Crown||0
39345|NCT02609178|91235|P6|COMPLETED|Second Crown||2
39346|NCT02609178|91236|P5|COMPLETED|Second Crown||0
39347|NCT02609178|91237|P4|COMPLETED|Second Crown||2
39348|NCT02609178|91238|P3|COMPLETED|Second Crown||5
39349|NCT02609178|91239|P2|COMPLETED|Second Crown||1
39350|NCT02609178|91240|P1|COMPLETED|Second Crown||0
39351|NCT02609178|91235|P6|STARTED|Second Crown||2
39352|NCT02609178|91236|P5|STARTED|Second Crown||0
39353|NCT02609178|91237|P4|STARTED|Second Crown||2
39354|NCT02609178|91238|P3|STARTED|Second Crown||5
39355|NCT02609178|91239|P2|STARTED|Second Crown||1
39356|NCT02609178|91240|P1|STARTED|Second Crown||0
39357|NCT02609178|91235|P6|NOT COMPLETED|5-minute Washout Time||0
39358|NCT02609178|91236|P5|NOT COMPLETED|5-minute Washout Time||0
39359|NCT02609178|91237|P4|NOT COMPLETED|5-minute Washout Time||0
39360|NCT02609178|91238|P3|NOT COMPLETED|5-minute Washout Time||0
39361|NCT02609178|91239|P2|NOT COMPLETED|5-minute Washout Time||0
39362|NCT02609178|91240|P1|NOT COMPLETED|5-minute Washout Time||0
39363|NCT02609178|91235|P6|COMPLETED|5-minute Washout Time||2
39364|NCT02609178|91236|P5|COMPLETED|5-minute Washout Time||0
39365|NCT02609178|91237|P4|COMPLETED|5-minute Washout Time||2
39366|NCT02609178|91238|P3|COMPLETED|5-minute Washout Time||5
39367|NCT02609178|91239|P2|COMPLETED|5-minute Washout Time||1
39368|NCT02609178|91240|P1|COMPLETED|5-minute Washout Time||0
39369|NCT02609178|91235|P6|STARTED|5-minute Washout Time||2
39370|NCT02609178|91236|P5|STARTED|5-minute Washout Time||0
39371|NCT02609178|91237|P4|STARTED|5-minute Washout Time||2
39372|NCT02609178|91238|P3|STARTED|5-minute Washout Time||5
39373|NCT02609178|91239|P2|STARTED|5-minute Washout Time||1
39374|NCT02609178|91240|P1|STARTED|5-minute Washout Time||0
39375|NCT02609178|91235|P6|NOT COMPLETED|First Crown||0
39376|NCT02609178|91236|P5|NOT COMPLETED|First Crown||0
39377|NCT02609178|91237|P4|NOT COMPLETED|First Crown||1
39378|NCT02609178|91238|P3|NOT COMPLETED|First Crown||1
39379|NCT02609178|91239|P2|NOT COMPLETED|First Crown||0
39380|NCT02609178|91240|P1|NOT COMPLETED|First Crown||0
39381|NCT02609178|91235|P6|COMPLETED|First Crown||2
39382|NCT02609178|91236|P5|COMPLETED|First Crown||0
39383|NCT02609178|91237|P4|COMPLETED|First Crown||2
39384|NCT02609178|91238|P3|COMPLETED|First Crown||5
39385|NCT02609178|91239|P2|COMPLETED|First Crown||1
39386|NCT02609178|91240|P1|COMPLETED|First Crown||0
39387|NCT02609178|91235|P6|STARTED|First Crown||2
39388|NCT02609178|91236|P5|STARTED|First Crown||0
39389|NCT02609178|91237|P4|STARTED|First Crown||3
39390|NCT02609178|91238|P3|STARTED|First Crown||6
39391|NCT02609178|91239|P2|STARTED|First Crown||1
39392|NCT02609178|91240|P1|STARTED|First Crown||0
39393|NCT02609113|91257|P2|NOT COMPLETED|Overall Study||2
39394|NCT02609113|91258|P1|NOT COMPLETED|Overall Study||2
39395|NCT02609113|91257|P2|COMPLETED|Overall Study||9
39396|NCT02609113|91258|P1|COMPLETED|Overall Study||9
39397|NCT02609113|91257|P2|STARTED|Overall Study||11
39398|NCT02609113|91258|P1|STARTED|Overall Study||11
39399|NCT02609100|91272|P2|NOT COMPLETED|Overall Study||0
39400|NCT02609100|91273|P1|NOT COMPLETED|Overall Study||0
39401|NCT02609100|91272|P2|COMPLETED|Overall Study||2
39402|NCT02609100|91273|P1|COMPLETED|Overall Study||2
39403|NCT02609100|91272|P2|STARTED|Overall Study||2
39404|NCT02609100|91273|P1|STARTED|Overall Study||2
39405|NCT02608892|91291|P2|NOT COMPLETED|Overall Study||0
39406|NCT02608892|91292|P1|NOT COMPLETED|Overall Study||1
39407|NCT02608892|91291|P2|COMPLETED|Overall Study||49
39408|NCT02608892|91292|P1|COMPLETED|Overall Study||50
39409|NCT02608892|91291|P2|STARTED|Overall Study||49
39410|NCT02608892|91292|P1|STARTED|Overall Study||51
39411|NCT02608489|91303|P2|NOT COMPLETED|Overall Study||10
39412|NCT02608489|91304|P1|NOT COMPLETED|Overall Study||13
39413|NCT02608489|91303|P2|COMPLETED|Overall Study||33
39414|NCT02608489|91304|P1|COMPLETED|Overall Study||30
39415|NCT02608489|91303|P2|STARTED|Overall Study||43
39416|NCT02608489|91304|P1|STARTED|Overall Study||43
39417|NCT02608177|91326|P2|NOT COMPLETED|Overall Study||0
39418|NCT02608177|91327|P1|NOT COMPLETED|Overall Study||0
39419|NCT02608177|91326|P2|COMPLETED|Overall Study||1
39420|NCT02608177|91327|P1|COMPLETED|Overall Study||2
39421|NCT02608177|91326|P2|STARTED|Overall Study||1
39422|NCT02608177|91327|P1|STARTED|Overall Study||2
39423|NCT02607956|91349|P2|NOT COMPLETED|Overall Study||330
39424|NCT02607956|91350|P1|NOT COMPLETED|Overall Study||327
39425|NCT02607956|91349|P2|COMPLETED|Overall Study||0
39426|NCT02607956|91350|P1|COMPLETED|Overall Study||0
39427|NCT02607956|91349|P2|STARTED|Overall Study||330
39428|NCT02607956|91350|P1|STARTED|Overall Study||327
39429|NCT02607930|91372|P2|NOT COMPLETED|Overall Study||315
39430|NCT02607930|91373|P1|NOT COMPLETED|Overall Study||316
39431|NCT02607930|91372|P2|COMPLETED|Overall Study||0
39432|NCT02607930|91373|P1|COMPLETED|Overall Study||0
39433|NCT02607930|91372|P2|STARTED|Overall Study||315
39434|NCT02607930|91373|P1|STARTED|Overall Study||316
39435|NCT02607800|91407|P2|NOT COMPLETED|Overall Study||11
39436|NCT02607800|91408|P1|NOT COMPLETED|Overall Study||10
39437|NCT02607800|91407|P2|COMPLETED|Overall Study||430
39438|NCT02607800|91408|P1|COMPLETED|Overall Study||492
39439|NCT02607800|91407|P2|STARTED|Overall Study||441
39440|NCT02607800|91408|P1|STARTED|Overall Study||502
39441|NCT02607735|91426|P3|NOT COMPLETED|Deferred Treatment Substudy||5
39442|NCT02607735|91427|P2|NOT COMPLETED|Deferred Treatment Substudy||0
39443|NCT02607735|91428|P1|NOT COMPLETED|Deferred Treatment Substudy||0
39444|NCT02607735|91426|P3|COMPLETED|Deferred Treatment Substudy||142
39445|NCT02607735|91427|P2|COMPLETED|Deferred Treatment Substudy||0
39446|NCT02607735|91428|P1|COMPLETED|Deferred Treatment Substudy||0
39447|NCT02607735|91426|P3|STARTED|Deferred Treatment Substudy||147
39448|NCT02607735|91427|P2|STARTED|Deferred Treatment Substudy||0
39449|NCT02607735|91428|P1|STARTED|Deferred Treatment Substudy||0
39450|NCT02607735|91426|P3|NOT COMPLETED|Primary Study||0
39451|NCT02607735|91427|P2|NOT COMPLETED|Primary Study||0
39452|NCT02607735|91428|P1|NOT COMPLETED|Primary Study||7
39453|NCT02607735|91426|P3|COMPLETED|Primary Study||0
39454|NCT02607735|91427|P2|COMPLETED|Primary Study||152
39455|NCT02607735|91428|P1|COMPLETED|Primary Study||257
39456|NCT02607735|91426|P3|STARTED|Primary Study||0
39457|NCT02607735|91427|P2|STARTED|Primary Study||152
39458|NCT02607735|91428|P1|STARTED|Primary Study||264
39459|NCT02607618|91450|P2|NOT COMPLETED|Overall Study||2
39460|NCT02607618|91451|P1|NOT COMPLETED|Overall Study||11
39461|NCT02607618|91450|P2|COMPLETED|Overall Study||305
39462|NCT02607618|91451|P1|COMPLETED|Overall Study||295
39463|NCT02607618|91450|P2|STARTED|Overall Study||307
39464|NCT02607618|91451|P1|STARTED|Overall Study||306
39465|NCT02607306|91462|P3|NOT COMPLETED|Overall Study||10
39466|NCT02607306|91463|P2|NOT COMPLETED|Overall Study||23
39467|NCT02607306|91464|P1|NOT COMPLETED|Overall Study||21
39468|NCT02607306|91462|P3|COMPLETED|Overall Study||263
39469|NCT02607306|91463|P2|COMPLETED|Overall Study||248
39470|NCT02607306|91464|P1|COMPLETED|Overall Study||254
39471|NCT02607306|91462|P3|STARTED|Overall Study||273
39472|NCT02607306|91463|P2|STARTED|Overall Study||271
39473|NCT02607306|91464|P1|STARTED|Overall Study||275
39474|NCT02607254|91587|P3|NOT COMPLETED|Overall Study||0
39475|NCT02607254|91588|P2|NOT COMPLETED|Overall Study||0
39476|NCT02607254|91589|P1|NOT COMPLETED|Overall Study||0
39477|NCT02607254|91587|P3|COMPLETED|Overall Study||5
39478|NCT02607254|91588|P2|COMPLETED|Overall Study||3
39479|NCT02607254|91589|P1|COMPLETED|Overall Study||3
39480|NCT02607254|91587|P3|STARTED|Overall Study||5
39481|NCT02607254|91588|P2|STARTED|Overall Study||3
39482|NCT02607254|91589|P1|STARTED|Overall Study||3
39483|NCT02606903|91608|P2|NOT COMPLETED|Overall Study||0
39484|NCT02606903|91609|P1|NOT COMPLETED|Overall Study||0
39485|NCT02606903|91608|P2|COMPLETED|Overall Study||36
39486|NCT02606903|91609|P1|COMPLETED|Overall Study||35
39487|NCT02606903|91608|P2|STARTED|Overall Study||36
39488|NCT02606903|91609|P1|STARTED|Overall Study||35
39489|NCT02606877|91623|P2|NOT COMPLETED|Overall Study||1
39490|NCT02606877|91624|P1|NOT COMPLETED|Overall Study||4
39491|NCT02606877|91623|P2|COMPLETED|Overall Study||16
39492|NCT02606877|91624|P1|COMPLETED|Overall Study||16
39493|NCT02606877|91623|P2|STARTED|Overall Study||17
39494|NCT02606877|91624|P1|STARTED|Overall Study||20
39495|NCT02606838|91638|P1|NOT COMPLETED|Overall Study||0
39496|NCT02606838|91638|P1|COMPLETED|Overall Study||119
39497|NCT02606838|91638|P1|STARTED|Overall Study||119
39498|NCT02606734|91646|P1|NOT COMPLETED|Overall Study||0
39499|NCT02606734|91646|P1|COMPLETED|Overall Study||44
39500|NCT02606734|91646|P1|STARTED|Overall Study||44
39501|NCT02606643|91652|P2|NOT COMPLETED|Overall Study||3
39502|NCT02606643|91653|P1|NOT COMPLETED|Overall Study||1
39503|NCT02606643|91652|P2|COMPLETED|Overall Study||73
39504|NCT02606643|91653|P1|COMPLETED|Overall Study||67
39505|NCT02606643|91652|P2|STARTED|Overall Study||76
39506|NCT02606643|91653|P1|STARTED|Overall Study||68
39507|NCT02606604|91665|P2|NOT COMPLETED|Overall Study||0
39508|NCT02606604|91666|P1|NOT COMPLETED|Overall Study||1
39509|NCT02606604|91665|P2|COMPLETED|Overall Study||7
39510|NCT02606604|91666|P1|COMPLETED|Overall Study||7
39511|NCT02606604|91665|P2|STARTED|Overall Study||7
39512|NCT02606604|91666|P1|STARTED|Overall Study||8
39513|NCT02606500|91692|P2|NOT COMPLETED|Overall Study||0
39514|NCT02606500|91693|P1|NOT COMPLETED|Overall Study||0
39515|NCT02606500|91692|P2|COMPLETED|Overall Study||35
39516|NCT02606500|91693|P1|COMPLETED|Overall Study||35
39517|NCT02606500|91692|P2|STARTED|Overall Study||35
39518|NCT02606500|91693|P1|STARTED|Overall Study||35
39519|NCT02606279|91711|P2|NOT COMPLETED|Overall Study||1
39520|NCT02606279|91712|P1|NOT COMPLETED|Overall Study||0
39521|NCT02606279|91711|P2|COMPLETED|Overall Study||0
39522|NCT02606279|91712|P1|COMPLETED|Overall Study||0
39523|NCT02606279|91711|P2|STARTED|Overall Study||1
39524|NCT02606279|91712|P1|STARTED|Overall Study||0
39525|NCT02606253|91727|P3|NOT COMPLETED|Overall Study||0
39526|NCT02606253|91728|P2|NOT COMPLETED|Overall Study||2
39527|NCT02606253|91729|P1|NOT COMPLETED|Overall Study||5
39528|NCT02606253|91727|P3|COMPLETED|Overall Study||20
39529|NCT02606253|91728|P2|COMPLETED|Overall Study||18
39530|NCT02606253|91729|P1|COMPLETED|Overall Study||15
39531|NCT02606253|91727|P3|STARTED|Overall Study||20
39532|NCT02606253|91728|P2|STARTED|Overall Study||20
39533|NCT02606253|91729|P1|STARTED|Overall Study||20
39534|NCT02605993|91792|P4|NOT COMPLETED|Extension Period||7
39535|NCT02605993|91793|P3|NOT COMPLETED|Extension Period||7
39536|NCT02605993|91794|P2|NOT COMPLETED|Extension Period||6
39537|NCT02605993|91795|P1|NOT COMPLETED|Extension Period||6
39538|NCT02605993|91792|P4|COMPLETED|Extension Period||0
39539|NCT02605993|91793|P3|COMPLETED|Extension Period||0
39540|NCT02605993|91794|P2|COMPLETED|Extension Period||0
39541|NCT02605993|91795|P1|COMPLETED|Extension Period||0
39542|NCT02605993|91792|P4|STARTED|Extension Period||7
39543|NCT02605993|91793|P3|STARTED|Extension Period||7
39544|NCT02605993|91794|P2|STARTED|Extension Period||6
39545|NCT02605993|91795|P1|STARTED|Extension Period||6
39546|NCT02605993|91792|P4|NOT COMPLETED|Treatment Period||0
39547|NCT02605993|91793|P3|NOT COMPLETED|Treatment Period||0
39548|NCT02605993|91794|P2|NOT COMPLETED|Treatment Period||0
39549|NCT02605993|91795|P1|NOT COMPLETED|Treatment Period||0
39550|NCT02605993|91792|P4|COMPLETED|Treatment Period||7
39551|NCT02605993|91793|P3|COMPLETED|Treatment Period||7
39552|NCT02605993|91794|P2|COMPLETED|Treatment Period||6
39553|NCT02605993|91795|P1|COMPLETED|Treatment Period||6
39554|NCT02605993|91792|P4|Received at Least 1 Dose of Study Drug|Treatment Period||7
39555|NCT02605993|91793|P3|Received at Least 1 Dose of Study Drug|Treatment Period||7
39556|NCT02605993|91794|P2|Received at Least 1 Dose of Study Drug|Treatment Period||6
39557|NCT02605993|91795|P1|Received at Least 1 Dose of Study Drug|Treatment Period||6
39558|NCT02605993|91792|P4|STARTED|Treatment Period||7
39559|NCT02605993|91793|P3|STARTED|Treatment Period||7
39560|NCT02605993|91794|P2|STARTED|Treatment Period||6
39561|NCT02605993|91795|P1|STARTED|Treatment Period||6
39562|NCT02605954|91831|P2|NOT COMPLETED|Overall Study||4
39563|NCT02605954|91832|P1|NOT COMPLETED|Overall Study||12
39564|NCT02605954|91831|P2|COMPLETED|Overall Study||88
39565|NCT02605954|91832|P1|COMPLETED|Overall Study||171
39566|NCT02605954|91831|P2|STARTED|Overall Study||92
39567|NCT02605954|91832|P1|STARTED|Overall Study||183
39568|NCT02605928|91849|P1|NOT COMPLETED|Overall Study||33
39569|NCT02605928|91849|P1|COMPLETED|Overall Study||46
39570|NCT02605928|91849|P1|Pivotal Phase, Statistical Phase|Overall Study||51
39571|NCT02605928|91849|P1|STARTED|Overall Study||79
39572|NCT02605876|91856|P3|NOT COMPLETED|Overall Study||0
39573|NCT02605876|91857|P2|NOT COMPLETED|Overall Study||0
39574|NCT02605876|91858|P1|NOT COMPLETED|Overall Study||0
39575|NCT02605876|91856|P3|COMPLETED|Overall Study||25
39576|NCT02605876|91857|P2|COMPLETED|Overall Study||25
39577|NCT02605876|91858|P1|COMPLETED|Overall Study||25
39578|NCT02605876|91856|P3|STARTED|Overall Study||25
39579|NCT02605876|91857|P2|STARTED|Overall Study||25
39580|NCT02605876|91858|P1|STARTED|Overall Study||25
39581|NCT02605863|91883|P2|NOT COMPLETED|Overall Study||0
39582|NCT02605863|91884|P1|NOT COMPLETED|Overall Study||0
39583|NCT02605863|91883|P2|COMPLETED|Overall Study||0
39584|NCT02605863|91884|P1|COMPLETED|Overall Study||1
39585|NCT02605863|91883|P2|STARTED|Overall Study||0
39586|NCT02605863|91884|P1|STARTED|Overall Study||1
39587|NCT02605824|91892|P2|NOT COMPLETED|Overall Study||0
39588|NCT02605824|91893|P1|NOT COMPLETED|Overall Study||1
39589|NCT02605824|91892|P2|COMPLETED|Overall Study||0
39590|NCT02605824|91893|P1|COMPLETED|Overall Study||0
39591|NCT02605824|91892|P2|STARTED|Overall Study||0
39592|NCT02605824|91893|P1|STARTED|Overall Study||1
39593|NCT02605395|91901|P2|NOT COMPLETED|Period 2, Day 8||0
39594|NCT02605395|91902|P1|NOT COMPLETED|Period 2, Day 8||0
39595|NCT02605395|91901|P2|COMPLETED|Period 2, Day 8||35
39596|NCT02605395|91902|P1|COMPLETED|Period 2, Day 8||35
39597|NCT02605395|91901|P2|STARTED|Period 2, Day 8||35
39598|NCT02605395|91902|P1|STARTED|Period 2, Day 8||35
39599|NCT02605395|91901|P2|NOT COMPLETED|Washout Period, Day 2 to Day 7||0
39600|NCT02605395|91902|P1|NOT COMPLETED|Washout Period, Day 2 to Day 7||0
39601|NCT02605395|91901|P2|COMPLETED|Washout Period, Day 2 to Day 7||35
39602|NCT02605395|91902|P1|COMPLETED|Washout Period, Day 2 to Day 7||35
39603|NCT02605395|91901|P2|STARTED|Washout Period, Day 2 to Day 7||35
39604|NCT02605395|91902|P1|STARTED|Washout Period, Day 2 to Day 7||35
39605|NCT02605395|91901|P2|NOT COMPLETED|Period 1, Day 1||0
39606|NCT02605395|91902|P1|NOT COMPLETED|Period 1, Day 1||0
39607|NCT02605395|91901|P2|COMPLETED|Period 1, Day 1||35
39608|NCT02605395|91902|P1|COMPLETED|Period 1, Day 1||35
39609|NCT02605395|91901|P2|STARTED|Period 1, Day 1||35
39610|NCT02605395|91902|P1|STARTED|Period 1, Day 1||35
39611|NCT02605304|91920|P2|NOT COMPLETED|Overall Study||0
39612|NCT02605304|91921|P1|NOT COMPLETED|Overall Study||0
39613|NCT02605304|91920|P2|COMPLETED|Overall Study||3
39614|NCT02605304|91921|P1|COMPLETED|Overall Study||4
39615|NCT02605304|91920|P2|STARTED|Overall Study||3
39616|NCT02605304|91921|P1|STARTED|Overall Study||4
39617|NCT02605187|91945|P4|NOT COMPLETED|Overall Study||1
39618|NCT02605187|91946|P3|NOT COMPLETED|Overall Study||11
39619|NCT02605187|91947|P2|NOT COMPLETED|Overall Study||2
39620|NCT02605187|91948|P1|NOT COMPLETED|Overall Study||8
39621|NCT02605187|91945|P4|COMPLETED|Overall Study||15
39622|NCT02605187|91946|P3|COMPLETED|Overall Study||72
39623|NCT02605187|91947|P2|COMPLETED|Overall Study||19
39624|NCT02605187|91948|P1|COMPLETED|Overall Study||32
39625|NCT02605187|91945|P4|STARTED|Overall Study||16
39626|NCT02605187|91946|P3|STARTED|Overall Study||83
39627|NCT02605187|91947|P2|STARTED|Overall Study||21
39628|NCT02605187|91948|P1|STARTED|Overall Study||40
39629|NCT02605174|92006|P7|NOT COMPLETED|Overall Study||89
39630|NCT02605174|92007|P6|NOT COMPLETED|Overall Study||32
39631|NCT02605174|92008|P5|NOT COMPLETED|Overall Study||53
39632|NCT02605174|92009|P4|NOT COMPLETED|Overall Study||36
39633|NCT02605174|92010|P3|NOT COMPLETED|Overall Study||76
39634|NCT02605174|92011|P2|NOT COMPLETED|Overall Study||23
39635|NCT02605174|92012|P1|NOT COMPLETED|Overall Study||64
39636|NCT02605174|92006|P7|COMPLETED|Overall Study||662
39637|NCT02605174|92007|P6|COMPLETED|Overall Study||217
39638|NCT02605174|92008|P5|COMPLETED|Overall Study||448
39639|NCT02605174|92009|P4|COMPLETED|Overall Study||216
39640|NCT02605174|92010|P3|COMPLETED|Overall Study||426
39641|NCT02605174|92011|P2|COMPLETED|Overall Study||226
39642|NCT02605174|92012|P1|COMPLETED|Overall Study||437
39643|NCT02605174|92006|P7|Received Optional 2nd Dose|Overall Study||361
39644|NCT02605174|92007|P6|Received Optional 2nd Dose|Overall Study||74
39645|NCT02605174|92008|P5|Received Optional 2nd Dose|Overall Study||144
39646|NCT02605174|92009|P4|Received Optional 2nd Dose|Overall Study||83
39647|NCT02605174|92010|P3|Received Optional 2nd Dose|Overall Study||177
39648|NCT02605174|92011|P2|Received Optional 2nd Dose|Overall Study||96
39649|NCT02605174|92012|P1|Received Optional 2nd Dose|Overall Study||206
39650|NCT02605174|92006|P7|Received at Least 1 Dose of Study Drug|Overall Study||645
39651|NCT02605174|92007|P6|Received at Least 1 Dose of Study Drug|Overall Study||215
39652|NCT02605174|92008|P5|Received at Least 1 Dose of Study Drug|Overall Study||434
39653|NCT02605174|92009|P4|Received at Least 1 Dose of Study Drug|Overall Study||212
39654|NCT02605174|92010|P3|Received at Least 1 Dose of Study Drug|Overall Study||423
39655|NCT02605174|92011|P2|Received at Least 1 Dose of Study Drug|Overall Study||225
39656|NCT02605174|92012|P1|Received at Least 1 Dose of Study Drug|Overall Study||429
39657|NCT02605174|92006|P7|STARTED|Overall Study||751
39658|NCT02605174|92007|P6|STARTED|Overall Study||249
39659|NCT02605174|92008|P5|STARTED|Overall Study||501
39660|NCT02605174|92009|P4|STARTED|Overall Study||252
39661|NCT02605174|92010|P3|STARTED|Overall Study||502
39662|NCT02605174|92011|P2|STARTED|Overall Study||249
39663|NCT02605174|92012|P1|STARTED|Overall Study||501
39664|NCT02605122|92074|P2|NOT COMPLETED|Overall Study||2
39665|NCT02605122|92075|P1|NOT COMPLETED|Overall Study||5
39666|NCT02605122|92074|P2|COMPLETED|Overall Study||22
39667|NCT02605122|92075|P1|COMPLETED|Overall Study||68
39668|NCT02605122|92074|P2|Received Study Drug|Overall Study||24
39669|NCT02605122|92075|P1|Received Study Drug|Overall Study||70
39670|NCT02605122|92074|P2|STARTED|Overall Study||24
39671|NCT02605122|92075|P1|STARTED|Overall Study||73
39672|NCT02604810|92087|P1|NOT COMPLETED|IGSC 20%, 24 Weeks||7
39673|NCT02604810|92087|P1|COMPLETED|IGSC 20%, 24 Weeks||42
39674|NCT02604810|92087|P1|STARTED|IGSC 20%, 24 Weeks||49
39675|NCT02604810|92087|P1|NOT COMPLETED|IGIV-C 10%, 4-5 Weeks||3
39676|NCT02604810|92087|P1|COMPLETED|IGIV-C 10%, 4-5 Weeks||49
39677|NCT02604810|92087|P1|STARTED|IGIV-C 10%, 4-5 Weeks||52
39678|NCT02604589|92098|P3|NOT COMPLETED|Overall Study||1
39679|NCT02604589|92099|P2|NOT COMPLETED|Overall Study||0
39680|NCT02604589|92100|P1|NOT COMPLETED|Overall Study||0
39681|NCT02604589|92098|P3|COMPLETED|Overall Study||1
39682|NCT02604589|92099|P2|COMPLETED|Overall Study||5
39683|NCT02604589|92100|P1|COMPLETED|Overall Study||3
39684|NCT02604589|92098|P3|STARTED|Overall Study||2
39685|NCT02604589|92099|P2|STARTED|Overall Study||5
39686|NCT02604589|92100|P1|STARTED|Overall Study||3
39687|NCT02604550|92128|P2|NOT COMPLETED|Overall Study||26
39688|NCT02604550|92129|P1|NOT COMPLETED|Overall Study||25
39689|NCT02604550|92128|P2|COMPLETED|Overall Study||33
39690|NCT02604550|92129|P1|COMPLETED|Overall Study||31
39691|NCT02604550|92128|P2|STARTED|Overall Study||59
39692|NCT02604550|92129|P1|STARTED|Overall Study||56
39693|NCT02604407|92156|P3|NOT COMPLETED|Overall Study||16
39694|NCT02604407|92157|P2|NOT COMPLETED|Overall Study||12
39695|NCT02604407|92158|P1|NOT COMPLETED|Overall Study||11
39696|NCT02604407|92156|P3|COMPLETED|Overall Study||76
39697|NCT02604407|92157|P2|COMPLETED|Overall Study||80
39698|NCT02604407|92158|P1|COMPLETED|Overall Study||80
39699|NCT02604407|92156|P3|TREATED|Overall Study||90
39700|NCT02604407|92157|P2|TREATED|Overall Study||92
39701|NCT02604407|92158|P1|TREATED|Overall Study||89
39702|NCT02604407|92156|P3|STARTED|Overall Study||92
39703|NCT02604407|92157|P2|STARTED|Overall Study||92
39704|NCT02604407|92158|P1|STARTED|Overall Study||91
39705|NCT02604342|92171|P2|NOT COMPLETED|Overall Study||23
39706|NCT02604342|92172|P1|NOT COMPLETED|Overall Study||43
39707|NCT02604342|92171|P2|COMPLETED|Overall Study||17
39708|NCT02604342|92172|P1|COMPLETED|Overall Study||36
39709|NCT02604342|92171|P2|STARTED|Overall Study||40
39710|NCT02604342|92172|P1|STARTED|Overall Study||79
39711|NCT02604264|92224|P2|NOT COMPLETED|Intervention||242
39712|NCT02604264|92225|P1|NOT COMPLETED|Intervention||200
39713|NCT02604264|92224|P2|COMPLETED|Intervention||1225
39714|NCT02604264|92225|P1|COMPLETED|Intervention||1245
39715|NCT02604264|92224|P2|STARTED|Intervention||1467
39716|NCT02604264|92225|P1|STARTED|Intervention||1445
39717|NCT02604264|92224|P2|NOT COMPLETED|Run-In||0
39718|NCT02604264|92225|P1|NOT COMPLETED|Run-In||0
39719|NCT02604264|92224|P2|COMPLETED|Run-In||611
39720|NCT02604264|92225|P1|COMPLETED|Run-In||618
39721|NCT02604264|92224|P2|STARTED|Run-In|The 1-mo run-in period data was used to determine pre-study demographics and PBC rate.|611
39722|NCT02604264|92225|P1|STARTED|Run-In||618
39723|NCT02604212|92235|P4|NOT COMPLETED|Overall Study||3
39724|NCT02604212|92236|P3|NOT COMPLETED|Overall Study||4
39725|NCT02604212|92237|P2|NOT COMPLETED|Overall Study||1
39726|NCT02604212|92238|P1|NOT COMPLETED|Overall Study||2
39727|NCT02604212|92235|P4|COMPLETED|Overall Study||8
39728|NCT02604212|92236|P3|COMPLETED|Overall Study||6
39729|NCT02604212|92237|P2|COMPLETED|Overall Study||4
39730|NCT02604212|92238|P1|COMPLETED|Overall Study||4
39731|NCT02604212|92235|P4|STARTED|Overall Study||11
39732|NCT02604212|92236|P3|STARTED|Overall Study||10
39733|NCT02604212|92237|P2|STARTED|Overall Study||5
39734|NCT02604212|92238|P1|STARTED|Overall Study||6
39735|NCT02604199|92306|P4|NOT COMPLETED|Overall Study||3
39736|NCT02604199|92307|P3|NOT COMPLETED|Overall Study||0
39737|NCT02604199|92308|P2|NOT COMPLETED|Overall Study||3
39738|NCT02604199|92309|P1|NOT COMPLETED|Overall Study||0
39739|NCT02604199|92306|P4|COMPLETED|Overall Study||18
39740|NCT02604199|92307|P3|COMPLETED|Overall Study||17
39741|NCT02604199|92308|P2|COMPLETED|Overall Study||8
39742|NCT02604199|92309|P1|COMPLETED|Overall Study||9
39743|NCT02604199|92306|P4|STARTED|Overall Study||21
39744|NCT02604199|92307|P3|STARTED|Overall Study||17
39745|NCT02604199|92308|P2|STARTED|Overall Study||11
39746|NCT02604199|92309|P1|STARTED|Overall Study||9
39747|NCT02604173|92360|P3|NOT COMPLETED|Overall Study||0
39748|NCT02604173|92361|P2|NOT COMPLETED|Overall Study||0
39749|NCT02604173|92362|P1|NOT COMPLETED|Overall Study||0
39750|NCT02604173|92360|P3|COMPLETED|Overall Study||35
39751|NCT02604173|92361|P2|COMPLETED|Overall Study||35
39752|NCT02604173|92362|P1|COMPLETED|Overall Study||33
39753|NCT02604173|92360|P3|STARTED|Overall Study||35
39754|NCT02604173|92361|P2|STARTED|Overall Study||35
39755|NCT02604173|92362|P1|STARTED|Overall Study||33
39756|NCT02604160|92378|P2|NOT COMPLETED|Overall Study||2
39757|NCT02604160|92379|P1|NOT COMPLETED|Overall Study||0
39758|NCT02604160|92378|P2|COMPLETED|Overall Study||3
39759|NCT02604160|92379|P1|COMPLETED|Overall Study||2
39760|NCT02604160|92378|P2|Received at Least One Dose of Study Drug|Overall Study||5
39761|NCT02604160|92379|P1|Received at Least One Dose of Study Drug|Overall Study||2
39762|NCT02604160|92378|P2|STARTED|Overall Study||5
39763|NCT02604160|92379|P1|STARTED|Overall Study||2
39764|NCT02604017|92393|P2|NOT COMPLETED|Overall Study||8
39765|NCT02604017|92394|P1|NOT COMPLETED|Overall Study||6
39766|NCT02604017|92393|P2|COMPLETED|Overall Study||343
39767|NCT02604017|92394|P1|COMPLETED|Overall Study||346
39768|NCT02604017|92393|P2|STARTED|Overall Study||351
39769|NCT02604017|92394|P1|STARTED|Overall Study||352
39770|NCT02603952|92423|P4|NOT COMPLETED|Overall Study||1
39771|NCT02603952|92424|P3|NOT COMPLETED|Overall Study||0
39772|NCT02603952|92425|P2|NOT COMPLETED|Overall Study||0
39773|NCT02603952|92426|P1|NOT COMPLETED|Overall Study||1
39774|NCT02603952|92423|P4|COMPLETED|Overall Study||31
39775|NCT02603952|92424|P3|COMPLETED|Overall Study||31
39776|NCT02603952|92425|P2|COMPLETED|Overall Study||31
39777|NCT02603952|92426|P1|COMPLETED|Overall Study||31
39778|NCT02603952|92423|P4|Treated|Overall Study||31
39779|NCT02603952|92424|P3|Treated|Overall Study||31
39780|NCT02603952|92425|P2|Treated|Overall Study||31
39781|NCT02603952|92426|P1|Treated|Overall Study||32
39782|NCT02603952|92423|P4|STARTED|Overall Study||32
39783|NCT02603952|92424|P3|STARTED|Overall Study||31
39784|NCT02603952|92425|P2|STARTED|Overall Study||31
39785|NCT02603952|92426|P1|STARTED|Overall Study||32
39786|NCT02603926|92467|P1|NOT COMPLETED|Overall Study||0
39787|NCT02603926|92467|P1|COMPLETED|Overall Study||6
39788|NCT02603926|92467|P1|STARTED|Overall Study||6
39789|NCT02603666|92474|P1|NOT COMPLETED|Overall Study||0
39790|NCT02603666|92474|P1|COMPLETED|Overall Study||130
39791|NCT02603666|92474|P1|STARTED|Overall Study||130
39792|NCT02603393|92480|P2|NOT COMPLETED|Overall Study||54
39793|NCT02603393|92481|P1|NOT COMPLETED|Overall Study||71
39794|NCT02603393|92480|P2|COMPLETED|Overall Study||472
39795|NCT02603393|92481|P1|COMPLETED|Overall Study||456
39796|NCT02603393|92480|P2|STARTED|Overall Study||526
39797|NCT02603393|92481|P1|STARTED|Overall Study||527
39798|NCT02603211|92507|P1|NOT COMPLETED|Overall Study||0
39799|NCT02603211|92507|P1|COMPLETED|Overall Study||20
39800|NCT02603211|92507|P1|STARTED|Overall Study||20
39801|NCT02603172|92520|P8|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
39802|NCT02603172|92521|P7|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
39803|NCT02603172|92522|P6|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
39804|NCT02603172|92523|P5|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
39805|NCT02603172|92524|P4|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
39806|NCT02603172|92525|P3|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
39807|NCT02603172|92526|P2|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
39808|NCT02603172|92527|P1|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
39809|NCT02603172|92520|P8|COMPLETED|Part C (Approximately 13 Weeks)||0
39810|NCT02603172|92521|P7|COMPLETED|Part C (Approximately 13 Weeks)||0
39811|NCT02603172|92522|P6|COMPLETED|Part C (Approximately 13 Weeks)||0
39812|NCT02603172|92523|P5|COMPLETED|Part C (Approximately 13 Weeks)||0
39813|NCT02603172|92524|P4|COMPLETED|Part C (Approximately 13 Weeks)||0
39814|NCT02603172|92525|P3|COMPLETED|Part C (Approximately 13 Weeks)||0
39815|NCT02603172|92526|P2|COMPLETED|Part C (Approximately 13 Weeks)||0
39816|NCT02603172|92527|P1|COMPLETED|Part C (Approximately 13 Weeks)||0
39817|NCT02603172|92520|P8|STARTED|Part C (Approximately 13 Weeks)||0
39818|NCT02603172|92521|P7|STARTED|Part C (Approximately 13 Weeks)||0
39819|NCT02603172|92522|P6|STARTED|Part C (Approximately 13 Weeks)||0
39820|NCT02603172|92523|P5|STARTED|Part C (Approximately 13 Weeks)||0
39821|NCT02603172|92524|P4|STARTED|Part C (Approximately 13 Weeks)||0
39822|NCT02603172|92525|P3|STARTED|Part C (Approximately 13 Weeks)||0
39823|NCT02603172|92526|P2|STARTED|Part C (Approximately 13 Weeks)||0
39824|NCT02603172|92527|P1|STARTED|Part C (Approximately 13 Weeks)||0
39825|NCT02603172|92520|P8|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
39826|NCT02603172|92521|P7|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
39827|NCT02603172|92522|P6|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
39828|NCT02603172|92523|P5|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
39829|NCT02603172|92524|P4|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
39830|NCT02603172|92525|P3|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
39831|NCT02603172|92526|P2|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
39832|NCT02603172|92527|P1|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
39833|NCT02603172|92520|P8|COMPLETED|Part B (Approximately 7 Weeks)||0
39834|NCT02603172|92521|P7|COMPLETED|Part B (Approximately 7 Weeks)||0
39835|NCT02603172|92522|P6|COMPLETED|Part B (Approximately 7 Weeks)||0
39836|NCT02603172|92523|P5|COMPLETED|Part B (Approximately 7 Weeks)||6
39837|NCT02603172|92524|P4|COMPLETED|Part B (Approximately 7 Weeks)||1
39838|NCT02603172|92525|P3|COMPLETED|Part B (Approximately 7 Weeks)||0
39839|NCT02603172|92526|P2|COMPLETED|Part B (Approximately 7 Weeks)||1
39840|NCT02603172|92527|P1|COMPLETED|Part B (Approximately 7 Weeks)||0
39841|NCT02603172|92520|P8|STARTED|Part B (Approximately 7 Weeks)||0
39842|NCT02603172|92521|P7|STARTED|Part B (Approximately 7 Weeks)||0
39843|NCT02603172|92522|P6|STARTED|Part B (Approximately 7 Weeks)||0
39844|NCT02603172|92523|P5|STARTED|Part B (Approximately 7 Weeks)||6
39845|NCT02603172|92524|P4|STARTED|Part B (Approximately 7 Weeks)||1
39846|NCT02603172|92525|P3|STARTED|Part B (Approximately 7 Weeks)||0
39847|NCT02603172|92526|P2|STARTED|Part B (Approximately 7 Weeks)||1
39848|NCT02603172|92527|P1|STARTED|Part B (Approximately 7 Weeks)||0
39849|NCT02603172|92520|P8|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
39850|NCT02603172|92521|P7|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
39851|NCT02603172|92522|P6|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
39852|NCT02603172|92523|P5|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
39853|NCT02603172|92524|P4|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
39854|NCT02603172|92525|P3|NOT COMPLETED|Part A (Approximately 16 Weeks)||1
39855|NCT02603172|92526|P2|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
39856|NCT02603172|92527|P1|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
39857|NCT02603172|92520|P8|COMPLETED|Part A (Approximately 16 Weeks)||0
39858|NCT02603172|92521|P7|COMPLETED|Part A (Approximately 16 Weeks)||0
39859|NCT02603172|92522|P6|COMPLETED|Part A (Approximately 16 Weeks)||0
39860|NCT02603172|92523|P5|COMPLETED|Part A (Approximately 16 Weeks)||0
39861|NCT02603172|92524|P4|COMPLETED|Part A (Approximately 16 Weeks)||1
39862|NCT02603172|92525|P3|COMPLETED|Part A (Approximately 16 Weeks)||7
39863|NCT02603172|92526|P2|COMPLETED|Part A (Approximately 16 Weeks)||1
39864|NCT02603172|92527|P1|COMPLETED|Part A (Approximately 16 Weeks)||7
39865|NCT02603172|92520|P8|STARTED|Part A (Approximately 16 Weeks)||0
39866|NCT02603172|92521|P7|STARTED|Part A (Approximately 16 Weeks)||0
39867|NCT02603172|92522|P6|STARTED|Part A (Approximately 16 Weeks)||0
39868|NCT02603172|92523|P5|STARTED|Part A (Approximately 16 Weeks)||0
39869|NCT02603172|92524|P4|STARTED|Part A (Approximately 16 Weeks)||1
39870|NCT02603172|92525|P3|STARTED|Part A (Approximately 16 Weeks)||8
39871|NCT02603172|92526|P2|STARTED|Part A (Approximately 16 Weeks)||1
39872|NCT02603172|92527|P1|STARTED|Part A (Approximately 16 Weeks)||7
39873|NCT02603120|92655|P2|NOT COMPLETED|Overall Study||283
39874|NCT02603120|92656|P1|NOT COMPLETED|Overall Study||284
39875|NCT02603120|92655|P2|COMPLETED|Overall Study||0
39876|NCT02603120|92656|P1|COMPLETED|Overall Study||0
39877|NCT02603120|92655|P2|STARTED|Overall Study||283
39878|NCT02603120|92656|P1|STARTED|Overall Study||284
39879|NCT02603107|92676|P2|NOT COMPLETED|Optional Extension Phase||213
39880|NCT02603107|92677|P1|NOT COMPLETED|Optional Extension Phase||241
39881|NCT02603107|92676|P2|COMPLETED|Optional Extension Phase||0
39882|NCT02603107|92677|P1|COMPLETED|Optional Extension Phase||0
39883|NCT02603107|92676|P2|STARTED|Optional Extension Phase|27 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|213
39884|NCT02603107|92677|P1|STARTED|Optional Extension Phase|4 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|241
39885|NCT02603107|92676|P2|NOT COMPLETED|Randomized Phase||48
39886|NCT02603107|92677|P1|NOT COMPLETED|Randomized Phase||45
39887|NCT02603107|92676|P2|COMPLETED|Randomized Phase||240
39888|NCT02603107|92677|P1|COMPLETED|Randomized Phase||245
39889|NCT02603107|92676|P2|STARTED|Randomized Phase||288
39890|NCT02603107|92677|P1|STARTED|Randomized Phase||290
39891|NCT02602496|92690|P3|NOT COMPLETED|Overall Study||0
39892|NCT02602496|92691|P2|NOT COMPLETED|Overall Study||2
39893|NCT02602496|92692|P1|NOT COMPLETED|Overall Study||1
39894|NCT02602496|92690|P3|COMPLETED|Overall Study||17
39895|NCT02602496|92691|P2|COMPLETED|Overall Study||18
39896|NCT02602496|92692|P1|COMPLETED|Overall Study||14
39897|NCT02602496|92690|P3|STARTED|Overall Study||17
39898|NCT02602496|92691|P2|STARTED|Overall Study||20
39899|NCT02602496|92692|P1|STARTED|Overall Study||15
39900|NCT02602223|92721|P1|NOT COMPLETED|Overall Study||0
39901|NCT02602223|92721|P1|COMPLETED|Overall Study||9
39902|NCT02602223|92721|P1|STARTED|Overall Study||9
39903|NCT02602080|92740|P3|NOT COMPLETED|Overall Study||3
39904|NCT02602080|92741|P2|NOT COMPLETED|Overall Study||1
39905|NCT02602080|92742|P1|NOT COMPLETED|Overall Study||6
39906|NCT02602080|92740|P3|COMPLETED|Overall Study||15
39907|NCT02602080|92741|P2|COMPLETED|Overall Study||15
39908|NCT02602080|92742|P1|COMPLETED|Overall Study||15
39909|NCT02602080|92740|P3|STARTED|Overall Study||18
39910|NCT02602080|92741|P2|STARTED|Overall Study||16
39911|NCT02602080|92742|P1|STARTED|Overall Study||21
39912|NCT02601976|92777|P1|NOT COMPLETED|Overall Study||0
39913|NCT02601976|92777|P1|COMPLETED|Overall Study||64
39914|NCT02601976|92777|P1|STARTED|Overall Study||64
39915|NCT02601820|92785|P1|NOT COMPLETED|1-Yr Post-Treatment (T5)||88
39916|NCT02601820|92785|P1|COMPLETED|1-Yr Post-Treatment (T5)|Of 1528, 88 were excluded for a missing T5 record. 1440 provided data at T5. Some outcomes missing.|1440
39917|NCT02601820|92785|P1|STARTED|1-Yr Post-Treatment (T5)|Of 1601, 73 were excluded at T5 due to death, withdrawal, other reason. 1528 remained in the study.|1528
39918|NCT02601820|92785|P1|NOT COMPLETED|12 Weeks Post-Treatment (T4)||3
39919|NCT02601820|92785|P1|COMPLETED|12 Weeks Post-Treatment (T4)|Of 1564, 3 were excluded for a missing T4 record. 1561 provided data at T4. Some outcomes missing.|1561
39920|NCT02601820|92785|P1|STARTED|12 Weeks Post-Treatment (T4)|Of 1601, 37 were excluded at T4 due to death, withdrawal, other reason. 1564 remained in the study.|1564
39921|NCT02601820|92785|P1|NOT COMPLETED|Late On-Treatment (T3)||49
39922|NCT02601820|92785|P1|COMPLETED|Late On-Treatment (T3)|Of 1573, 49 were excluded for a missing T3 record. 1524 provided data at T3. Some outcomes missing.|1524
39923|NCT02601820|92785|P1|STARTED|Late On-Treatment (T3)|Of 1601, 28 were excluded at T3 due to death, withdrawal, other reason. 1573 remained in the study.|1573
39924|NCT02601820|92785|P1|NOT COMPLETED|Early On-Treatment (T2)||51
39925|NCT02601820|92785|P1|COMPLETED|Early On-Treatment (T2)|Of 1584, 51 were excluded for a missing T2 record. 1533 provided data at T2. Some outcomes missing.|1533
39926|NCT02601820|92785|P1|STARTED|Early On-Treatment (T2)|Of 1601, 17 were excluded at T2 due to death, withdrawal, other reason. 1584 remained in the study.|1584
39927|NCT02601820|92785|P1|NOT COMPLETED|Pre-Treatment (T1)||0
39928|NCT02601820|92785|P1|COMPLETED|Pre-Treatment (T1)||1601
39929|NCT02601820|92785|P1|STARTED|Pre-Treatment (T1)|1601 patients were enrolled and completed Baseline PROs (T1).|1601
39930|NCT02601625|92814|P4|NOT COMPLETED|Overall Study||1
39931|NCT02601625|92815|P3|NOT COMPLETED|Overall Study||1
39932|NCT02601625|92816|P2|NOT COMPLETED|Overall Study||0
39933|NCT02601625|92817|P1|NOT COMPLETED|Overall Study||0
39934|NCT02601625|92814|P4|COMPLETED|Overall Study||11
39935|NCT02601625|92815|P3|COMPLETED|Overall Study||5
39936|NCT02601625|92816|P2|COMPLETED|Overall Study||6
39937|NCT02601625|92817|P1|COMPLETED|Overall Study||6
39938|NCT02601625|92814|P4|STARTED|Overall Study||12
39939|NCT02601625|92815|P3|STARTED|Overall Study||6
39940|NCT02601625|92816|P2|STARTED|Overall Study||6
39941|NCT02601625|92817|P1|STARTED|Overall Study||6
39942|NCT02601573|92870|P5|NOT COMPLETED|Overall Study||2
39943|NCT02601573|92871|P4|NOT COMPLETED|Overall Study||1
39944|NCT02601573|92872|P3|NOT COMPLETED|Overall Study||1
39945|NCT02601573|92873|P2|NOT COMPLETED|Overall Study||4
39946|NCT02601573|92874|P1|NOT COMPLETED|Overall Study||0
39947|NCT02601573|92870|P5|COMPLETED|Overall Study||16
39948|NCT02601573|92871|P4|COMPLETED|Overall Study||17
39949|NCT02601573|92872|P3|COMPLETED|Overall Study||16
39950|NCT02601573|92873|P2|COMPLETED|Overall Study||20
39951|NCT02601573|92874|P1|COMPLETED|Overall Study||23
39952|NCT02601573|92870|P5|STARTED|Overall Study|Number randomized and treated.|18
39953|NCT02601573|92871|P4|STARTED|Overall Study|Number randomized and treated.|18
39954|NCT02601573|92872|P3|STARTED|Overall Study|Number randomized and treated.|17
39955|NCT02601573|92873|P2|STARTED|Overall Study|Number randomized and treated.|24
39956|NCT02601573|92874|P1|STARTED|Overall Study|Number randomized and treated.|23
39957|NCT02601560|92909|P8|NOT COMPLETED|Overall Study||0
39958|NCT02601560|92910|P7|NOT COMPLETED|Overall Study||1
39959|NCT02601560|92911|P6|NOT COMPLETED|Overall Study||0
39960|NCT02601560|92912|P5|NOT COMPLETED|Overall Study||0
39961|NCT02601560|92913|P4|NOT COMPLETED|Overall Study||0
39962|NCT02601560|92914|P3|NOT COMPLETED|Overall Study||0
39963|NCT02601560|92915|P2|NOT COMPLETED|Overall Study||0
39964|NCT02601560|92916|P1|NOT COMPLETED|Overall Study||0
39965|NCT02601560|92909|P8|COMPLETED|Overall Study||6
39966|NCT02601560|92910|P7|COMPLETED|Overall Study||5
39967|NCT02601560|92911|P6|COMPLETED|Overall Study||4
39968|NCT02601560|92912|P5|COMPLETED|Overall Study||6
39969|NCT02601560|92913|P4|COMPLETED|Overall Study||6
39970|NCT02601560|92914|P3|COMPLETED|Overall Study||6
39971|NCT02601560|92915|P2|COMPLETED|Overall Study||6
39972|NCT02601560|92916|P1|COMPLETED|Overall Study||8
39973|NCT02601560|92909|P8|STARTED|Overall Study||6
39974|NCT02601560|92910|P7|STARTED|Overall Study||6
39975|NCT02601560|92911|P6|STARTED|Overall Study||4
39976|NCT02601560|92912|P5|STARTED|Overall Study||6
39977|NCT02601560|92913|P4|STARTED|Overall Study||6
39978|NCT02601560|92914|P3|STARTED|Overall Study||6
39979|NCT02601560|92915|P2|STARTED|Overall Study||6
39980|NCT02601560|92916|P1|STARTED|Overall Study||8
39981|NCT02601469|93100|P2|NOT COMPLETED|Overall Study||0
39982|NCT02601469|93101|P1|NOT COMPLETED|Overall Study||1
39983|NCT02601469|93100|P2|COMPLETED|Overall Study||1
39984|NCT02601469|93101|P1|COMPLETED|Overall Study||24
39985|NCT02601469|93100|P2|STARTED|Overall Study||1
39986|NCT02601469|93101|P1|STARTED|Overall Study||25
39987|NCT02601300|93107|P1|NOT COMPLETED|Extension Phase||17
39988|NCT02601300|93107|P1|COMPLETED|Extension Phase||18
39989|NCT02601300|93107|P1|Treated With IP|Extension Phase||34
39990|NCT02601300|93107|P1|STARTED|Extension Phase|3 completed induction phase; did not enter extension due to withdrawal and lack of efficacy|35
39991|NCT02601300|93107|P1|NOT COMPLETED|Induction Phase||3
39992|NCT02601300|93107|P1|COMPLETED|Induction Phase||38
39993|NCT02601300|93107|P1|STARTED|Induction Phase||41
39994|NCT02600871|93122|P2|NOT COMPLETED|Overall Study||10
39995|NCT02600871|93123|P1|NOT COMPLETED|Overall Study||13
39996|NCT02600871|93122|P2|COMPLETED|Overall Study|45 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
39997|NCT02600871|93123|P1|COMPLETED|Overall Study|51 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
39998|NCT02600871|93122|P2|STARTED|Overall Study||49
39999|NCT02600871|93123|P1|STARTED|Overall Study||52
40000|NCT02600845|93133|P1|NOT COMPLETED|Overall Study||18
40001|NCT02600845|93133|P1|COMPLETED|Overall Study||104
40002|NCT02600845|93133|P1|STARTED|Overall Study||122
40003|NCT02600819|93148|P2|NOT COMPLETED|Open-Label Extension (OLE) (B/F/TAF)||7
40004|NCT02600819|93149|P1|NOT COMPLETED|Open-Label Extension (OLE) (B/F/TAF)||0
40005|NCT02600819|93148|P2|COMPLETED|Open-Label Extension (OLE) (B/F/TAF)||0
40006|NCT02600819|93149|P1|COMPLETED|Open-Label Extension (OLE) (B/F/TAF)||0
40007|NCT02600819|93148|P2|STARTED|Open-Label Extension (OLE) (B/F/TAF)|Only US participants were eligible to roll over into the Extension Phase per the study protocol.|7
40008|NCT02600819|93149|P1|STARTED|Open-Label Extension (OLE) (B/F/TAF)|Only US participants were eligible to roll over into the Extension Phase per the study protocol.|0
40009|NCT02600819|93148|P2|NOT COMPLETED|Main Study (E/C/F/TAF)||0
40010|NCT02600819|93149|P1|NOT COMPLETED|Main Study (E/C/F/TAF)||19
40011|NCT02600819|93148|P2|COMPLETED|Main Study (E/C/F/TAF)||0
40012|NCT02600819|93149|P1|COMPLETED|Main Study (E/C/F/TAF)||36
40013|NCT02600819|93148|P2|STARTED|Main Study (E/C/F/TAF)||0
40014|NCT02600819|93149|P1|STARTED|Main Study (E/C/F/TAF)||55
40015|NCT02600767|93161|P1|NOT COMPLETED|Overall Study||5
40016|NCT02600767|93161|P1|COMPLETED|Overall Study||74
40017|NCT02600767|93161|P1|STARTED|Overall Study||79
40018|NCT02600715|93167|P2|NOT COMPLETED|Overall Study||0
40019|NCT02600715|93168|P1|NOT COMPLETED|Overall Study||0
40020|NCT02600715|93167|P2|COMPLETED|Overall Study||13
40021|NCT02600715|93168|P1|COMPLETED|Overall Study||13
40022|NCT02600715|93167|P2|Completed 2-week Follow-up Appointment|Overall Study||12
40023|NCT02600715|93168|P1|Completed 2-week Follow-up Appointment|Overall Study||13
40024|NCT02600715|93167|P2|Received Treatment and Suppository|Overall Study||13
40025|NCT02600715|93168|P1|Received Treatment and Suppository|Overall Study||13
40026|NCT02600715|93167|P2|Allocated to Randomization|Overall Study||13
40027|NCT02600715|93168|P1|Allocated to Randomization|Overall Study||13
40028|NCT02600715|93167|P2|STARTED|Overall Study||13
40029|NCT02600715|93168|P1|STARTED|Overall Study||13
40030|NCT02600637|93199|P2|NOT COMPLETED|Overall Study||5
40031|NCT02600637|93200|P1|NOT COMPLETED|Overall Study||5
40032|NCT02600637|93199|P2|COMPLETED|Overall Study||13
40033|NCT02600637|93200|P1|COMPLETED|Overall Study||14
40034|NCT02600637|93199|P2|STARTED|Overall Study||18
40035|NCT02600637|93200|P1|STARTED|Overall Study||19
40036|NCT02600611|93212|P2|NOT COMPLETED|Overall Study||0
40037|NCT02600611|93213|P1|NOT COMPLETED|Overall Study||2
40038|NCT02600611|93212|P2|COMPLETED|Overall Study||300
40039|NCT02600611|93213|P1|COMPLETED|Overall Study||298
40040|NCT02600611|93212|P2|STARTED|Overall Study||300
40041|NCT02600611|93213|P1|STARTED|Overall Study||300
40042|NCT02600403|93224|P3|NOT COMPLETED|Overall Study||0
40043|NCT02600403|93225|P2|NOT COMPLETED|Overall Study||0
40044|NCT02600403|93226|P1|NOT COMPLETED|Overall Study||0
40045|NCT02600403|93224|P3|COMPLETED|Overall Study||11
40046|NCT02600403|93225|P2|COMPLETED|Overall Study||6
40047|NCT02600403|93226|P1|COMPLETED|Overall Study||44
40048|NCT02600403|93224|P3|STARTED|Overall Study||11
40049|NCT02600403|93225|P2|STARTED|Overall Study||6
40050|NCT02600403|93226|P1|STARTED|Overall Study||44
40051|NCT02600351|93253|P4|NOT COMPLETED|Overall Study||5
40052|NCT02600351|93254|P3|NOT COMPLETED|Overall Study||6
40053|NCT02600351|93255|P2|NOT COMPLETED|Overall Study||0
40054|NCT02600351|93256|P1|NOT COMPLETED|Overall Study||5
40055|NCT02600351|93253|P4|COMPLETED|Overall Study||22
40056|NCT02600351|93254|P3|COMPLETED|Overall Study||20
40057|NCT02600351|93255|P2|COMPLETED|Overall Study||17
40058|NCT02600351|93256|P1|COMPLETED|Overall Study||12
40059|NCT02600351|93253|P4|STARTED|Overall Study||27
40060|NCT02600351|93254|P3|STARTED|Overall Study||26
40061|NCT02600351|93255|P2|STARTED|Overall Study||17
40062|NCT02600351|93256|P1|STARTED|Overall Study||17
40063|NCT02600325|93286|P1|NOT COMPLETED|Overall Study||0
40064|NCT02600325|93286|P1|COMPLETED|Overall Study||80
40065|NCT02600325|93286|P1|STARTED|Overall Study||80
40066|NCT02599766|93291|P1|NOT COMPLETED|Overall Study||3
40067|NCT02599766|93291|P1|COMPLETED|Overall Study||19
40068|NCT02599766|93291|P1|STARTED|Overall Study||22
40069|NCT02599441|93323|P1|NOT COMPLETED|Overall Study||0
40070|NCT02599441|93323|P1|COMPLETED|Overall Study||9
40071|NCT02599441|93323|P1|STARTED|Overall Study||9
40072|NCT02599194|93329|P1|NOT COMPLETED|Overall Study||0
40073|NCT02599194|93329|P1|COMPLETED|Overall Study||7
40074|NCT02599194|93329|P1|STARTED|Overall Study||7
40075|NCT02599129|93338|P2|NOT COMPLETED|Overall Study||3
40076|NCT02599129|93339|P1|NOT COMPLETED|Overall Study||5
40077|NCT02599129|93338|P2|COMPLETED|Overall Study||1
40078|NCT02599129|93339|P1|COMPLETED|Overall Study||2
40079|NCT02599129|93338|P2|STARTED|Overall Study||4
40080|NCT02599129|93339|P1|STARTED|Overall Study||7
40081|NCT02598934|93355|P2|NOT COMPLETED|Overall Study||22
40082|NCT02598934|93356|P1|NOT COMPLETED|Overall Study||19
40083|NCT02598934|93355|P2|COMPLETED|Overall Study||132
40084|NCT02598934|93356|P1|COMPLETED|Overall Study||135
40085|NCT02598934|93355|P2|STARTED|Overall Study||154
40086|NCT02598934|93356|P1|STARTED|Overall Study||154
40087|NCT02598622|93368|P2|NOT COMPLETED|Overall Study||0
40088|NCT02598622|93369|P1|NOT COMPLETED|Overall Study||6
40089|NCT02598622|93368|P2|COMPLETED|Overall Study||0
40090|NCT02598622|93369|P1|COMPLETED|Overall Study||2
40091|NCT02598622|93368|P2|STARTED|Overall Study|Study terminated prior to randomization phase. No enrollment in this arm.|0
40092|NCT02598622|93369|P1|STARTED|Overall Study||8
40093|NCT02598583|93377|P2|NOT COMPLETED|Overall Study||0
40094|NCT02598583|93378|P1|NOT COMPLETED|Overall Study||0
40095|NCT02598583|93377|P2|COMPLETED|Overall Study||7
40096|NCT02598583|93378|P1|COMPLETED|Overall Study||6
40097|NCT02598583|93377|P2|STARTED|Overall Study||7
40098|NCT02598583|93378|P1|STARTED|Overall Study||6
40099|NCT02598297|93398|P2|NOT COMPLETED|Overall Study||24
40100|NCT02598297|93399|P1|NOT COMPLETED|Overall Study||25
40101|NCT02598297|93398|P2|COMPLETED|Overall Study||0
40102|NCT02598297|93399|P1|COMPLETED|Overall Study||0
40103|NCT02598297|93398|P2|Subjects Followed for Survival|Overall Study||0
40104|NCT02598297|93399|P1|Subjects Followed for Survival|Overall Study||1
40105|NCT02598297|93398|P2|Not Treted Wit Study Drug|Overall Study||0
40106|NCT02598297|93399|P1|Not Treted Wit Study Drug|Overall Study||1
40107|NCT02598297|93398|P2|STARTED|Overall Study||24
40108|NCT02598297|93399|P1|STARTED|Overall Study|One subject in the ruxolitinib arm was not treated with the study drug|25
40109|NCT02598193|93425|P1|NOT COMPLETED|Overall Study||16
40110|NCT02598193|93425|P1|COMPLETED|Overall Study||73
40111|NCT02598193|93425|P1|STARTED|Overall Study||89
40112|NCT02598128|93433|P4|NOT COMPLETED|Period C: Days 12 to 20||0
40113|NCT02598128|93434|P3|NOT COMPLETED|Period C: Days 12 to 20||0
40114|NCT02598128|93435|P2|NOT COMPLETED|Period C: Days 12 to 20||0
40115|NCT02598128|93436|P1|NOT COMPLETED|Period C: Days 12 to 20||0
40116|NCT02598128|93433|P4|COMPLETED|Period C: Days 12 to 20||33
40117|NCT02598128|93434|P3|COMPLETED|Period C: Days 12 to 20||0
40118|NCT02598128|93435|P2|COMPLETED|Period C: Days 12 to 20||0
40119|NCT02598128|93436|P1|COMPLETED|Period C: Days 12 to 20||0
40120|NCT02598128|93433|P4|STARTED|Period C: Days 12 to 20||33
40121|NCT02598128|93434|P3|STARTED|Period C: Days 12 to 20||0
40122|NCT02598128|93435|P2|STARTED|Period C: Days 12 to 20||0
40123|NCT02598128|93436|P1|STARTED|Period C: Days 12 to 20||0
40124|NCT02598128|93433|P4|NOT COMPLETED|Period B: Days 1 to 11||0
40125|NCT02598128|93434|P3|NOT COMPLETED|Period B: Days 1 to 11||0
40126|NCT02598128|93435|P2|NOT COMPLETED|Period B: Days 1 to 11||0
40127|NCT02598128|93436|P1|NOT COMPLETED|Period B: Days 1 to 11||0
40128|NCT02598128|93433|P4|COMPLETED|Period B: Days 1 to 11||0
40129|NCT02598128|93434|P3|COMPLETED|Period B: Days 1 to 11||16
40130|NCT02598128|93435|P2|COMPLETED|Period B: Days 1 to 11||17
40131|NCT02598128|93436|P1|COMPLETED|Period B: Days 1 to 11||0
40132|NCT02598128|93433|P4|STARTED|Period B: Days 1 to 11||0
40133|NCT02598128|93434|P3|STARTED|Period B: Days 1 to 11||16
40134|NCT02598128|93435|P2|STARTED|Period B: Days 1 to 11||17
40135|NCT02598128|93436|P1|STARTED|Period B: Days 1 to 11||0
40136|NCT02598128|93433|P4|NOT COMPLETED|Period A: Days -7 to -1||0
40137|NCT02598128|93434|P3|NOT COMPLETED|Period A: Days -7 to -1||0
40138|NCT02598128|93435|P2|NOT COMPLETED|Period A: Days -7 to -1||0
40139|NCT02598128|93436|P1|NOT COMPLETED|Period A: Days -7 to -1||1
40140|NCT02598128|93433|P4|COMPLETED|Period A: Days -7 to -1||0
40141|NCT02598128|93434|P3|COMPLETED|Period A: Days -7 to -1||0
40142|NCT02598128|93435|P2|COMPLETED|Period A: Days -7 to -1||0
40143|NCT02598128|93436|P1|COMPLETED|Period A: Days -7 to -1||33
40144|NCT02598128|93433|P4|STARTED|Period A: Days -7 to -1||0
40145|NCT02598128|93434|P3|STARTED|Period A: Days -7 to -1||0
40146|NCT02598128|93435|P2|STARTED|Period A: Days -7 to -1||0
40147|NCT02598128|93436|P1|STARTED|Period A: Days -7 to -1||34
40148|NCT02598089|93450|P2|NOT COMPLETED|Overall Study||0
40149|NCT02598089|93451|P1|NOT COMPLETED|Overall Study||0
40150|NCT02598089|93450|P2|COMPLETED|Overall Study||30
40151|NCT02598089|93451|P1|COMPLETED|Overall Study||30
40152|NCT02598089|93450|P2|STARTED|Overall Study||30
40153|NCT02598089|93451|P1|STARTED|Overall Study||30
40154|NCT02598076|93479|P2|NOT COMPLETED|Overall Study||3
40155|NCT02598076|93480|P1|NOT COMPLETED|Overall Study||2
40156|NCT02598076|93479|P2|COMPLETED|Overall Study||26
40157|NCT02598076|93480|P1|COMPLETED|Overall Study||29
40158|NCT02598076|93479|P2|STARTED|Overall Study||29
40159|NCT02598076|93480|P1|STARTED|Overall Study||31
40160|NCT02597946|93494|P1|NOT COMPLETED|Overall Study||18
40161|NCT02597946|93494|P1|COMPLETED|Overall Study||0
40162|NCT02597946|93494|P1|STARTED|Overall Study||18
40163|NCT02597920|93506|P3|NOT COMPLETED|Overall Study||6
40164|NCT02597920|93507|P2|NOT COMPLETED|Overall Study||84
40165|NCT02597920|93508|P1|NOT COMPLETED|Overall Study||41
40166|NCT02597920|93506|P3|COMPLETED|Overall Study||72
40167|NCT02597920|93507|P2|COMPLETED|Overall Study||1075
40168|NCT02597920|93508|P1|COMPLETED|Overall Study||544
40169|NCT02597920|93506|P3|STARTED|Overall Study||78
40170|NCT02597920|93507|P2|STARTED|Overall Study||1159
40171|NCT02597920|93508|P1|STARTED|Overall Study|Information about study termination is not available for 1 subject.|585
40172|NCT02597907|93533|P2|NOT COMPLETED|Overall Study||0
40173|NCT02597907|93534|P1|NOT COMPLETED|Overall Study||0
40174|NCT02597907|93533|P2|COMPLETED|Overall Study||44
40175|NCT02597907|93534|P1|COMPLETED|Overall Study||44
40176|NCT02597907|93533|P2|STARTED|Overall Study||44
40177|NCT02597907|93534|P1|STARTED|Overall Study||44
40178|NCT02597855|93542|P2|NOT COMPLETED|Overall Study||1
40179|NCT02597855|93543|P1|NOT COMPLETED|Overall Study||2
40180|NCT02597855|93542|P2|COMPLETED|Overall Study||13
40181|NCT02597855|93543|P1|COMPLETED|Overall Study||16
40182|NCT02597855|93542|P2|STARTED|Overall Study||14
40183|NCT02597855|93543|P1|STARTED|Overall Study||18
40184|NCT02597582|93553|P2|NOT COMPLETED|Overall Study||0
40185|NCT02597582|93554|P1|NOT COMPLETED|Overall Study||0
40186|NCT02597582|93553|P2|COMPLETED|Overall Study||20
40187|NCT02597582|93554|P1|COMPLETED|Overall Study||21
40188|NCT02597582|93553|P2|STARTED|Overall Study||20
40189|NCT02597582|93554|P1|STARTED|Overall Study||21
40190|NCT02597543|93572|P2|NOT COMPLETED|Overall Study||0
40191|NCT02597543|93573|P1|NOT COMPLETED|Overall Study||0
40192|NCT02597543|93572|P2|COMPLETED|Overall Study||8
40193|NCT02597543|93573|P1|COMPLETED|Overall Study||6
40194|NCT02597543|93572|P2|STARTED|Overall Study||8
40195|NCT02597543|93573|P1|STARTED|Overall Study||6
40196|NCT02597127|93597|P8|NOT COMPLETED|Overall Study||2
40197|NCT02597127|93598|P7|NOT COMPLETED|Overall Study||4
40198|NCT02597127|93599|P6|NOT COMPLETED|Overall Study||4
40199|NCT02597127|93600|P5|NOT COMPLETED|Overall Study||5
40200|NCT02597127|93601|P4|NOT COMPLETED|Overall Study||5
40201|NCT02597127|93602|P3|NOT COMPLETED|Overall Study||8
40202|NCT02597127|93603|P2|NOT COMPLETED|Overall Study||3
40203|NCT02597127|93604|P1|NOT COMPLETED|Overall Study||1
40204|NCT02597127|93597|P8|COMPLETED|Overall Study||60
40205|NCT02597127|93598|P7|COMPLETED|Overall Study||57
40206|NCT02597127|93599|P6|COMPLETED|Overall Study||59
40207|NCT02597127|93600|P5|COMPLETED|Overall Study||57
40208|NCT02597127|93601|P4|COMPLETED|Overall Study||60
40209|NCT02597127|93602|P3|COMPLETED|Overall Study||58
40210|NCT02597127|93603|P2|COMPLETED|Overall Study||59
40211|NCT02597127|93604|P1|COMPLETED|Overall Study||59
40212|NCT02597127|93597|P8|Treated|Overall Study||62
40213|NCT02597127|93598|P7|Treated|Overall Study||61
40214|NCT02597127|93599|P6|Treated|Overall Study||62
40215|NCT02597127|93600|P5|Treated|Overall Study||61
40216|NCT02597127|93601|P4|Treated|Overall Study||65
40217|NCT02597127|93602|P3|Treated|Overall Study||65
40218|NCT02597127|93603|P2|Treated|Overall Study||61
40219|NCT02597127|93604|P1|Treated|Overall Study||60
40220|NCT02597127|93597|P8|STARTED|Overall Study||62
40221|NCT02597127|93598|P7|STARTED|Overall Study||61
40222|NCT02597127|93599|P6|STARTED|Overall Study||63
40223|NCT02597127|93600|P5|STARTED|Overall Study||62
40224|NCT02597127|93601|P4|STARTED|Overall Study||65
40225|NCT02597127|93602|P3|STARTED|Overall Study||66
40226|NCT02597127|93603|P2|STARTED|Overall Study||62
40227|NCT02597127|93604|P1|STARTED|Overall Study||60
40228|NCT02597049|93694|P3|NOT COMPLETED|Overall Study||3
40229|NCT02597049|93695|P2|NOT COMPLETED|Overall Study||5
40230|NCT02597049|93696|P1|NOT COMPLETED|Overall Study||7
40231|NCT02597049|93694|P3|COMPLETED|Overall Study||137
40232|NCT02597049|93695|P2|COMPLETED|Overall Study||137
40233|NCT02597049|93696|P1|COMPLETED|Overall Study||135
40234|NCT02597049|93694|P3|Received at Least One Dose of Study Drug|Overall Study||140
40235|NCT02597049|93695|P2|Received at Least One Dose of Study Drug|Overall Study||141
40236|NCT02597049|93696|P1|Received at Least One Dose of Study Drug|Overall Study||142
40237|NCT02597049|93694|P3|STARTED|Overall Study||140
40238|NCT02597049|93695|P2|STARTED|Overall Study||142
40239|NCT02597049|93696|P1|STARTED|Overall Study||142
40240|NCT02596971|93737|P3|NOT COMPLETED|Overall Study||42
40241|NCT02596971|93738|P2|NOT COMPLETED|Overall Study||7
40242|NCT02596971|93739|P1|NOT COMPLETED|Overall Study||42
40243|NCT02596971|93737|P3|COMPLETED|Overall Study||0
40244|NCT02596971|93738|P2|COMPLETED|Overall Study||0
40245|NCT02596971|93739|P1|COMPLETED|Overall Study||0
40246|NCT02596971|93737|P3|STARTED|Overall Study||42
40247|NCT02596971|93738|P2|STARTED|Overall Study||7
40248|NCT02596971|93739|P1|STARTED|Overall Study||42
40249|NCT02596958|93768|P1|NOT COMPLETED|Overall Study||996
40250|NCT02596958|93768|P1|COMPLETED|Overall Study||0
40251|NCT02596958|93768|P1|STARTED|Overall Study||996
40252|NCT02596945|93780|P1|NOT COMPLETED|Overall Study||56
40253|NCT02596945|93780|P1|COMPLETED|Overall Study||167
40254|NCT02596945|93780|P1|Treated|Overall Study||220
40255|NCT02596945|93780|P1|STARTED|Overall Study||223
40256|NCT02596893|93790|P4|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
40257|NCT02596893|93791|P3|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
40258|NCT02596893|93792|P2|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
40259|NCT02596893|93793|P1|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
40260|NCT02596893|93790|P4|COMPLETED|Follow-Up Period Weeks 0 to 52||47
40261|NCT02596893|93791|P3|COMPLETED|Follow-Up Period Weeks 0 to 52||56
40262|NCT02596893|93792|P2|COMPLETED|Follow-Up Period Weeks 0 to 52||51
40263|NCT02596893|93793|P1|COMPLETED|Follow-Up Period Weeks 0 to 52||57
40264|NCT02596893|93790|P4|STARTED|Follow-Up Period Weeks 0 to 52||47
40265|NCT02596893|93791|P3|STARTED|Follow-Up Period Weeks 0 to 52||56
40266|NCT02596893|93792|P2|STARTED|Follow-Up Period Weeks 0 to 52||51
40267|NCT02596893|93793|P1|STARTED|Follow-Up Period Weeks 0 to 52||57
40268|NCT02596893|93790|P4|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||166
40269|NCT02596893|93791|P3|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||162
40270|NCT02596893|93792|P2|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||168
40271|NCT02596893|93793|P1|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||164
40272|NCT02596893|93790|P4|COMPLETED|Overall Double-Blind Period Weeks 0-52||9
40273|NCT02596893|93791|P3|COMPLETED|Overall Double-Blind Period Weeks 0-52||14
40274|NCT02596893|93792|P2|COMPLETED|Overall Double-Blind Period Weeks 0-52||8
40275|NCT02596893|93793|P1|COMPLETED|Overall Double-Blind Period Weeks 0-52||10
40276|NCT02596893|93790|P4|STARTED|Overall Double-Blind Period Weeks 0-52||175
40277|NCT02596893|93791|P3|STARTED|Overall Double-Blind Period Weeks 0-52||176
40278|NCT02596893|93792|P2|STARTED|Overall Double-Blind Period Weeks 0-52||176
40279|NCT02596893|93793|P1|STARTED|Overall Double-Blind Period Weeks 0-52||174
40280|NCT02596867|93847|P1|NOT COMPLETED|Overall Study||0
40281|NCT02596867|93847|P1|COMPLETED|Overall Study||2
40282|NCT02596867|93847|P1|2 Patients Prospectively Recruited|Overall Study||2
40283|NCT02596867|93847|P1|STARTED|Overall Study||2
40284|NCT02596854|93852|P1|NOT COMPLETED|Overall Study||8
40285|NCT02596854|93852|P1|COMPLETED|Overall Study||109
40286|NCT02596854|93852|P1|STARTED|Overall Study||117
40287|NCT02596750|93858|P2|NOT COMPLETED|30 Minutes||0
40288|NCT02596750|93859|P1|NOT COMPLETED|30 Minutes||0
40289|NCT02596750|93858|P2|COMPLETED|30 Minutes||21
40290|NCT02596750|93859|P1|COMPLETED|30 Minutes||21
40291|NCT02596750|93858|P2|STARTED|30 Minutes||21
40292|NCT02596750|93859|P1|STARTED|30 Minutes||21
40293|NCT02596750|93858|P2|NOT COMPLETED|10 Minutes||0
40294|NCT02596750|93859|P1|NOT COMPLETED|10 Minutes||0
40295|NCT02596750|93858|P2|COMPLETED|10 Minutes||21
40296|NCT02596750|93859|P1|COMPLETED|10 Minutes||21
40297|NCT02596750|93858|P2|STARTED|10 Minutes||21
40298|NCT02596750|93859|P1|STARTED|10 Minutes||21
40299|NCT02596750|93858|P2|NOT COMPLETED|5 Minutes||0
40300|NCT02596750|93859|P1|NOT COMPLETED|5 Minutes||0
40301|NCT02596750|93858|P2|COMPLETED|5 Minutes||21
40302|NCT02596750|93859|P1|COMPLETED|5 Minutes||21
40303|NCT02596750|93858|P2|STARTED|5 Minutes||21
40304|NCT02596750|93859|P1|STARTED|5 Minutes||21
40305|NCT02596750|93858|P2|NOT COMPLETED|2 Minutes||0
40306|NCT02596750|93859|P1|NOT COMPLETED|2 Minutes||0
40307|NCT02596750|93858|P2|COMPLETED|2 Minutes||21
40308|NCT02596750|93859|P1|COMPLETED|2 Minutes||21
40309|NCT02596750|93858|P2|STARTED|2 Minutes||21
40310|NCT02596750|93859|P1|STARTED|2 Minutes||21
40311|NCT02596750|93858|P2|NOT COMPLETED|Baseline||0
40312|NCT02596750|93859|P1|NOT COMPLETED|Baseline||0
40313|NCT02596750|93858|P2|COMPLETED|Baseline||21
40314|NCT02596750|93859|P1|COMPLETED|Baseline||21
40315|NCT02596750|93858|P2|STARTED|Baseline||21
40316|NCT02596750|93859|P1|STARTED|Baseline||21
40317|NCT02596620|93873|P2|NOT COMPLETED|Overall Study||1
40318|NCT02596620|93874|P1|NOT COMPLETED|Overall Study||1
40319|NCT02596620|93873|P2|COMPLETED|Overall Study|Completed on 30th September 2015|81
40320|NCT02596620|93874|P1|COMPLETED|Overall Study|Completed on 30th September 2015|81
40321|NCT02596620|93873|P2|STARTED|Overall Study|Started from 1st October 2013|82
40322|NCT02596620|93874|P1|STARTED|Overall Study|Started from 1st October 2013|82
40323|NCT02596451|93883|P3|NOT COMPLETED|Overall Study||14
40324|NCT02596451|93884|P2|NOT COMPLETED|Overall Study||18
40325|NCT02596451|93885|P1|NOT COMPLETED|Overall Study||4
40326|NCT02596451|93883|P3|COMPLETED|Overall Study||373
40327|NCT02596451|93884|P2|COMPLETED|Overall Study||374
40328|NCT02596451|93885|P1|COMPLETED|Overall Study||381
40329|NCT02596451|93883|P3|STARTED|Overall Study||387
40330|NCT02596451|93884|P2|STARTED|Overall Study||392
40331|NCT02596451|93885|P1|STARTED|Overall Study||385
40332|NCT02596321|93894|P2|NOT COMPLETED|Overall Study||0
40333|NCT02596321|93895|P1|NOT COMPLETED|Overall Study||3
40334|NCT02596321|93894|P2|COMPLETED|Overall Study||56
40335|NCT02596321|93895|P1|COMPLETED|Overall Study||53
40336|NCT02596321|93894|P2|STARTED|Overall Study||56
40337|NCT02596321|93895|P1|STARTED|Overall Study||56
40338|NCT02596035|93910|P3|NOT COMPLETED|Overall Study||1
40339|NCT02596035|93911|P2|NOT COMPLETED|Overall Study||44
40340|NCT02596035|93912|P1|NOT COMPLETED|Overall Study||86
40341|NCT02596035|93910|P3|COMPLETED|Overall Study||0
40342|NCT02596035|93911|P2|COMPLETED|Overall Study||0
40343|NCT02596035|93912|P1|COMPLETED|Overall Study||11
40344|NCT02596035|93910|P3|STARTED|Overall Study||1
40345|NCT02596035|93911|P2|STARTED|Overall Study||44
40346|NCT02596035|93912|P1|STARTED|Overall Study||97
40347|NCT02596022|93941|P2|NOT COMPLETED|Overall Study||0
40348|NCT02596022|93942|P1|NOT COMPLETED|Overall Study||0
40349|NCT02596022|93941|P2|COMPLETED|Overall Study||8
40350|NCT02596022|93942|P1|COMPLETED|Overall Study||10
40351|NCT02596022|93941|P2|STARTED|Overall Study||8
40352|NCT02596022|93942|P1|STARTED|Overall Study||10
40353|NCT02596009|93948|P6|NOT COMPLETED|Overall Study||0
40354|NCT02596009|93949|P5|NOT COMPLETED|Overall Study||0
40355|NCT02596009|93950|P4|NOT COMPLETED|Overall Study||0
40356|NCT02596009|93951|P3|NOT COMPLETED|Overall Study||0
40357|NCT02596009|93952|P2|NOT COMPLETED|Overall Study||1
40358|NCT02596009|93953|P1|NOT COMPLETED|Overall Study||0
40359|NCT02596009|93948|P6|COMPLETED|Overall Study||17
40360|NCT02596009|93949|P5|COMPLETED|Overall Study||18
40361|NCT02596009|93950|P4|COMPLETED|Overall Study||16
40362|NCT02596009|93951|P3|COMPLETED|Overall Study||16
40363|NCT02596009|93952|P2|COMPLETED|Overall Study||15
40364|NCT02596009|93953|P1|COMPLETED|Overall Study||14
40365|NCT02596009|93948|P6|STARTED|Overall Study||17
40366|NCT02596009|93949|P5|STARTED|Overall Study||18
40367|NCT02596009|93950|P4|STARTED|Overall Study||16
40368|NCT02596009|93951|P3|STARTED|Overall Study||16
40369|NCT02596009|93952|P2|STARTED|Overall Study||16
40370|NCT02596009|93953|P1|STARTED|Overall Study||14
40371|NCT02595983|93962|P1|NOT COMPLETED|Overall Study||4
40372|NCT02595983|93962|P1|COMPLETED|Overall Study||8
40373|NCT02595983|93962|P1|STARTED|Overall Study||12
40374|NCT02595970|93970|P1|NOT COMPLETED|Overall Study||20
40375|NCT02595970|93970|P1|COMPLETED|Overall Study|Out of 100 patients who completed treatment period 2, 20 patients completed the extension period.|100
40376|NCT02595970|93970|P1|STARTED|Overall Study||120
40377|NCT02595723|93987|P3|NOT COMPLETED|Third Intervention (4 Days)||0
40378|NCT02595723|93988|P2|NOT COMPLETED|Third Intervention (4 Days)||0
40379|NCT02595723|93989|P1|NOT COMPLETED|Third Intervention (4 Days)||0
40380|NCT02595723|93987|P3|COMPLETED|Third Intervention (4 Days)||7
40381|NCT02595723|93988|P2|COMPLETED|Third Intervention (4 Days)||5
40382|NCT02595723|93989|P1|COMPLETED|Third Intervention (4 Days)||6
40383|NCT02595723|93987|P3|STARTED|Third Intervention (4 Days)||7
40384|NCT02595723|93988|P2|STARTED|Third Intervention (4 Days)||5
40385|NCT02595723|93989|P1|STARTED|Third Intervention (4 Days)||6
40386|NCT02595723|93987|P3|NOT COMPLETED|Second Washout (21 Days)||0
40387|NCT02595723|93988|P2|NOT COMPLETED|Second Washout (21 Days)||1
40388|NCT02595723|93989|P1|NOT COMPLETED|Second Washout (21 Days)||0
40389|NCT02595723|93987|P3|COMPLETED|Second Washout (21 Days)||7
40390|NCT02595723|93988|P2|COMPLETED|Second Washout (21 Days)||5
40391|NCT02595723|93989|P1|COMPLETED|Second Washout (21 Days)||6
40392|NCT02595723|93987|P3|STARTED|Second Washout (21 Days)||7
40393|NCT02595723|93988|P2|STARTED|Second Washout (21 Days)||6
40394|NCT02595723|93989|P1|STARTED|Second Washout (21 Days)||6
40395|NCT02595723|93987|P3|NOT COMPLETED|Second Intervention (4 Days)||0
40396|NCT02595723|93988|P2|NOT COMPLETED|Second Intervention (4 Days)||0
40397|NCT02595723|93989|P1|NOT COMPLETED|Second Intervention (4 Days)||0
40398|NCT02595723|93987|P3|COMPLETED|Second Intervention (4 Days)||7
40399|NCT02595723|93988|P2|COMPLETED|Second Intervention (4 Days)||6
40400|NCT02595723|93989|P1|COMPLETED|Second Intervention (4 Days)||6
40401|NCT02595723|93987|P3|STARTED|Second Intervention (4 Days)||7
40402|NCT02595723|93988|P2|STARTED|Second Intervention (4 Days)||6
40403|NCT02595723|93989|P1|STARTED|Second Intervention (4 Days)||6
40404|NCT02595723|93987|P3|NOT COMPLETED|First Washout (21 Days)||0
40405|NCT02595723|93988|P2|NOT COMPLETED|First Washout (21 Days)||0
40406|NCT02595723|93989|P1|NOT COMPLETED|First Washout (21 Days)||2
40407|NCT02595723|93987|P3|COMPLETED|First Washout (21 Days)||7
40408|NCT02595723|93988|P2|COMPLETED|First Washout (21 Days)||6
40409|NCT02595723|93989|P1|COMPLETED|First Washout (21 Days)||6
40410|NCT02595723|93987|P3|STARTED|First Washout (21 Days)||7
40411|NCT02595723|93988|P2|STARTED|First Washout (21 Days)||6
40412|NCT02595723|93989|P1|STARTED|First Washout (21 Days)||8
40413|NCT02595723|93987|P3|NOT COMPLETED|First Intervention (4 Days)||0
40414|NCT02595723|93988|P2|NOT COMPLETED|First Intervention (4 Days)||0
40415|NCT02595723|93989|P1|NOT COMPLETED|First Intervention (4 Days)||0
40416|NCT02595723|93987|P3|COMPLETED|First Intervention (4 Days)||7
40417|NCT02595723|93988|P2|COMPLETED|First Intervention (4 Days)||6
40418|NCT02595723|93989|P1|COMPLETED|First Intervention (4 Days)||8
40419|NCT02595723|93987|P3|STARTED|First Intervention (4 Days)||7
40420|NCT02595723|93988|P2|STARTED|First Intervention (4 Days)||6
40421|NCT02595723|93989|P1|STARTED|First Intervention (4 Days)||8
40422|NCT02595567|93997|P1|NOT COMPLETED|Overall Study||0
40423|NCT02595567|93997|P1|COMPLETED|Overall Study||25
40424|NCT02595567|93997|P1|STARTED|Overall Study||25
40425|NCT02595502|94001|P2|NOT COMPLETED|Period 3||2
40426|NCT02595502|94002|P1|NOT COMPLETED|Period 3||1
40427|NCT02595502|94001|P2|COMPLETED|Period 3||136
40428|NCT02595502|94002|P1|COMPLETED|Period 3||140
40429|NCT02595502|94001|P2|STARTED|Period 3||138
40430|NCT02595502|94002|P1|STARTED|Period 3||141
40431|NCT02595502|94001|P2|NOT COMPLETED|Period 2||2
40432|NCT02595502|94002|P1|NOT COMPLETED|Period 2||1
40433|NCT02595502|94001|P2|COMPLETED|Period 2||138
40434|NCT02595502|94002|P1|COMPLETED|Period 2||141
40435|NCT02595502|94001|P2|STARTED|Period 2||140
40436|NCT02595502|94002|P1|STARTED|Period 2||142
40437|NCT02595502|94001|P2|NOT COMPLETED|Period 1||2
40438|NCT02595502|94002|P1|NOT COMPLETED|Period 1||1
40439|NCT02595502|94001|P2|COMPLETED|Period 1||140
40440|NCT02595502|94002|P1|COMPLETED|Period 1||142
40441|NCT02595502|94001|P2|STARTED|Period 1||142
40442|NCT02595502|94002|P1|STARTED|Period 1||143
40443|NCT02595450|94008|P1|NOT COMPLETED|Overall Study||81
40444|NCT02595450|94008|P1|COMPLETED|Overall Study||218
40445|NCT02595450|94008|P1|Treated|Overall Study||291
40446|NCT02595450|94008|P1|STARTED|Overall Study||299
40447|NCT02595437|94014|P1|NOT COMPLETED|Triferic Via Hemodialysate||0
40448|NCT02595437|94014|P1|COMPLETED|Triferic Via Hemodialysate||21
40449|NCT02595437|94014|P1|STARTED|Triferic Via Hemodialysate||21
40450|NCT02595437|94014|P1|NOT COMPLETED|Triferic Via IV||1
40451|NCT02595437|94014|P1|COMPLETED|Triferic Via IV||21
40452|NCT02595437|94014|P1|STARTED|Triferic Via IV||22
40453|NCT02595073|94034|P2|NOT COMPLETED|Overall Study||1
40454|NCT02595073|94035|P1|NOT COMPLETED|Overall Study||2
40455|NCT02595073|94034|P2|COMPLETED|Overall Study||62
40456|NCT02595073|94035|P1|COMPLETED|Overall Study||59
40457|NCT02595073|94034|P2|STARTED|Overall Study||63
40458|NCT02595073|94035|P1|STARTED|Overall Study||61
40459|NCT02595008|94045|P2|NOT COMPLETED|Overall Study||0
40460|NCT02595008|94046|P1|NOT COMPLETED|Overall Study||1
40461|NCT02595008|94045|P2|COMPLETED|Overall Study||4
40462|NCT02595008|94046|P1|COMPLETED|Overall Study||19
40463|NCT02595008|94045|P2|STARTED|Overall Study||4
40464|NCT02595008|94046|P1|STARTED|Overall Study||20
40465|NCT02594826|94054|P2|NOT COMPLETED|Overall Study||60
40466|NCT02594826|94055|P1|NOT COMPLETED|Overall Study||57
40467|NCT02594826|94054|P2|COMPLETED|Overall Study||298
40468|NCT02594826|94055|P1|COMPLETED|Overall Study||290
40469|NCT02594826|94054|P2|STARTED|Overall Study||358
40470|NCT02594826|94055|P1|STARTED|Overall Study||347
40471|NCT02594644|94065|P2|NOT COMPLETED|Overall Study||1
40472|NCT02594644|94066|P1|NOT COMPLETED|Overall Study||0
40473|NCT02594644|94065|P2|COMPLETED|Overall Study||15
40474|NCT02594644|94066|P1|COMPLETED|Overall Study||16
40475|NCT02594644|94065|P2|STARTED|Overall Study||16
40476|NCT02594644|94066|P1|STARTED|Overall Study||16
40477|NCT02594163|94084|P2|NOT COMPLETED|Follow-up Period||12
40478|NCT02594163|94085|P1|NOT COMPLETED|Follow-up Period||11
40479|NCT02594163|94084|P2|COMPLETED|Follow-up Period||1
40480|NCT02594163|94085|P1|COMPLETED|Follow-up Period||1
40481|NCT02594163|94084|P2|STARTED|Follow-up Period|All participants were to be followed after treatment|13
40482|NCT02594163|94085|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|12
40483|NCT02594163|94084|P2|NOT COMPLETED|Treatment Period||12
40484|NCT02594163|94085|P1|NOT COMPLETED|Treatment Period||7
40485|NCT02594163|94084|P2|COMPLETED|Treatment Period||1
40486|NCT02594163|94085|P1|COMPLETED|Treatment Period||5
40487|NCT02594163|94084|P2|STARTED|Treatment Period||13
40488|NCT02594163|94085|P1|STARTED|Treatment Period||12
40489|NCT02594098|94103|P2|NOT COMPLETED|Overall Study||13
40490|NCT02594098|94104|P1|NOT COMPLETED|Overall Study||26
40491|NCT02594098|94103|P2|COMPLETED|Overall Study||1
40492|NCT02594098|94104|P1|COMPLETED|Overall Study||1
40493|NCT02594098|94103|P2|STARTED|Overall Study||14
40494|NCT02594098|94104|P1|STARTED|Overall Study||27
40495|NCT02593903|94166|P2|NOT COMPLETED|Overall Study||1
40496|NCT02593903|94167|P1|NOT COMPLETED|Overall Study||0
40497|NCT02593903|94166|P2|COMPLETED|Overall Study||31
40498|NCT02593903|94167|P1|COMPLETED|Overall Study||35
40499|NCT02593903|94166|P2|STARTED|Overall Study||32
40500|NCT02593903|94167|P1|STARTED|Overall Study||35
40501|NCT02593864|94173|P1|NOT COMPLETED|Overall Study||6
40502|NCT02593864|94173|P1|COMPLETED|Overall Study||19
40503|NCT02593864|94173|P1|STARTED|Overall Study||25
40504|NCT02593773|94178|P1|NOT COMPLETED|Overall Study||35
40505|NCT02593773|94178|P1|COMPLETED|Overall Study||51
40506|NCT02593773|94178|P1|STARTED|Overall Study||86
40507|NCT02593630|94188|P1|NOT COMPLETED|Overall Study||1
40508|NCT02593630|94188|P1|COMPLETED|Overall Study||53
40509|NCT02593630|94188|P1|STARTED|Overall Study||54
40510|NCT02593396|94196|P2|NOT COMPLETED|Overall Study||14
40511|NCT02593396|94197|P1|NOT COMPLETED|Overall Study||15
40512|NCT02593396|94196|P2|COMPLETED|Overall Study||26
40513|NCT02593396|94197|P1|COMPLETED|Overall Study||25
40514|NCT02593396|94196|P2|At Least Done One Efficacy Assessment|Overall Study||36
40515|NCT02593396|94197|P1|At Least Done One Efficacy Assessment|Overall Study||36
40516|NCT02593396|94196|P2|STARTED|Overall Study||40
40517|NCT02593396|94197|P1|STARTED|Overall Study||40
40518|NCT02593305|94210|P3|NOT COMPLETED|Post 2||0
40519|NCT02593305|94211|P2|NOT COMPLETED|Post 2||0
40520|NCT02593305|94212|P1|NOT COMPLETED|Post 2||0
40521|NCT02593305|94210|P3|COMPLETED|Post 2||0
40522|NCT02593305|94211|P2|COMPLETED|Post 2||6
40523|NCT02593305|94212|P1|COMPLETED|Post 2||7
40524|NCT02593305|94210|P3|STARTED|Post 2||0
40525|NCT02593305|94211|P2|STARTED|Post 2||6
40526|NCT02593305|94212|P1|STARTED|Post 2||7
40527|NCT02593305|94210|P3|NOT COMPLETED|Baseline 2||0
40528|NCT02593305|94211|P2|NOT COMPLETED|Baseline 2||0
40529|NCT02593305|94212|P1|NOT COMPLETED|Baseline 2||0
40530|NCT02593305|94210|P3|COMPLETED|Baseline 2||0
40531|NCT02593305|94211|P2|COMPLETED|Baseline 2||6
40532|NCT02593305|94212|P1|COMPLETED|Baseline 2||7
40533|NCT02593305|94210|P3|STARTED|Baseline 2||0
40534|NCT02593305|94211|P2|STARTED|Baseline 2||6
40535|NCT02593305|94212|P1|STARTED|Baseline 2||7
40536|NCT02593305|94210|P3|NOT COMPLETED|Post 1||10
40537|NCT02593305|94211|P2|NOT COMPLETED|Post 1||0
40538|NCT02593305|94212|P1|NOT COMPLETED|Post 1||0
40539|NCT02593305|94210|P3|COMPLETED|Post 1||0
40540|NCT02593305|94211|P2|COMPLETED|Post 1||6
40541|NCT02593305|94212|P1|COMPLETED|Post 1||7
40542|NCT02593305|94210|P3|STARTED|Post 1||10
40543|NCT02593305|94211|P2|STARTED|Post 1||6
40544|NCT02593305|94212|P1|STARTED|Post 1||7
40545|NCT02593305|94210|P3|NOT COMPLETED|Baseline 1||0
40546|NCT02593305|94211|P2|NOT COMPLETED|Baseline 1||0
40547|NCT02593305|94212|P1|NOT COMPLETED|Baseline 1||0
40548|NCT02593305|94210|P3|COMPLETED|Baseline 1||10
40549|NCT02593305|94211|P2|COMPLETED|Baseline 1||6
40550|NCT02593305|94212|P1|COMPLETED|Baseline 1||7
40551|NCT02593305|94210|P3|STARTED|Baseline 1||10
40552|NCT02593305|94211|P2|STARTED|Baseline 1||6
40553|NCT02593305|94212|P1|STARTED|Baseline 1||7
40554|NCT02593149|94227|P2|NOT COMPLETED|Intervention||115
40555|NCT02593149|94228|P1|NOT COMPLETED|Intervention||116
40556|NCT02593149|94227|P2|COMPLETED|Intervention||845
40557|NCT02593149|94228|P1|COMPLETED|Intervention||826
40558|NCT02593149|94227|P2|STARTED|Intervention||960
40559|NCT02593149|94228|P1|STARTED|Intervention||942
40560|NCT02593149|94227|P2|NOT COMPLETED|Run-In||38
40561|NCT02593149|94228|P1|NOT COMPLETED|Run-In||36
40562|NCT02593149|94227|P2|COMPLETED|Run-In||323
40563|NCT02593149|94228|P1|COMPLETED|Run-In||304
40564|NCT02593149|94227|P2|STARTED|Run-In||361
40565|NCT02593149|94228|P1|STARTED|Run-In||340
40566|NCT02592876|94236|P2|NOT COMPLETED|Overall Study||40
40567|NCT02592876|94237|P1|NOT COMPLETED|Overall Study||41
40568|NCT02592876|94236|P2|COMPLETED|Overall Study||0
40569|NCT02592876|94237|P1|COMPLETED|Overall Study||0
40570|NCT02592876|94236|P2|Completed Treatment|Overall Study||32
40571|NCT02592876|94237|P1|Completed Treatment|Overall Study||34
40572|NCT02592876|94236|P2|Received Study Drug|Overall Study||40
40573|NCT02592876|94237|P1|Received Study Drug|Overall Study||40
40574|NCT02592876|94236|P2|STARTED|Overall Study||40
40575|NCT02592876|94237|P1|STARTED|Overall Study||41
40576|NCT02592655|94263|P1|NOT COMPLETED|Fourth Tourniquet Right Thigh.||0
40577|NCT02592655|94263|P1|COMPLETED|Fourth Tourniquet Right Thigh.||4
40578|NCT02592655|94263|P1|Tourniquet Tape 5 cm Width|Fourth Tourniquet Right Thigh.||0
40579|NCT02592655|94263|P1|Tourniquet Tape 10 cm Width|Fourth Tourniquet Right Thigh.||3
40580|NCT02592655|94263|P1|Windlass Tourniquet|Fourth Tourniquet Right Thigh.||0
40581|NCT02592655|94263|P1|ATS (Pneumatic)|Fourth Tourniquet Right Thigh.||1
40582|NCT02592655|94263|P1|STARTED|Fourth Tourniquet Right Thigh.|Only the first 4 participants received all four interventions.|4
40583|NCT02592655|94263|P1|NOT COMPLETED|Third Tourniquet, Left Thigh.||0
40584|NCT02592655|94263|P1|COMPLETED|Third Tourniquet, Left Thigh.||19
40585|NCT02592655|94263|P1|Tourniquet Tape 5 cm Width|Third Tourniquet, Left Thigh.||1
40586|NCT02592655|94263|P1|Tourniquet Tape 10 cm Width|Third Tourniquet, Left Thigh.||6
40587|NCT02592655|94263|P1|Windlass Tourniquet|Third Tourniquet, Left Thigh.||4
40753|NCT02590354|94528|P1|NOT COMPLETED|Phase 1||98
40588|NCT02592655|94263|P1|ATS (Pneumatic)|Third Tourniquet, Left Thigh.||8
40589|NCT02592655|94263|P1|STARTED|Third Tourniquet, Left Thigh.||19
40590|NCT02592655|94263|P1|NOT COMPLETED|Second Tourniquet Right Thigh.||0
40591|NCT02592655|94263|P1|COMPLETED|Second Tourniquet Right Thigh.||19
40592|NCT02592655|94263|P1|Tourniquet Tape 5 cm Width|Second Tourniquet Right Thigh.||1
40593|NCT02592655|94263|P1|Tourniquet Tape 10 cm Width|Second Tourniquet Right Thigh.||5
40594|NCT02592655|94263|P1|Windlass Tourniquet|Second Tourniquet Right Thigh.||8
40595|NCT02592655|94263|P1|ATS (Pneumatic)|Second Tourniquet Right Thigh.||5
40596|NCT02592655|94263|P1|STARTED|Second Tourniquet Right Thigh.||19
40597|NCT02592655|94263|P1|NOT COMPLETED|First Tourniquet, Left Thigh.||0
40598|NCT02592655|94263|P1|COMPLETED|First Tourniquet, Left Thigh.||19
40599|NCT02592655|94263|P1|Tourniquet Tape 5 cm Width|First Tourniquet, Left Thigh.||2
40600|NCT02592655|94263|P1|Tourniquet Tape 10 cm Width|First Tourniquet, Left Thigh.||5
40601|NCT02592655|94263|P1|Windlass Tourniquet|First Tourniquet, Left Thigh.||7
40602|NCT02592655|94263|P1|ATS (Pneumatic)|First Tourniquet, Left Thigh.||5
40603|NCT02592655|94263|P1|STARTED|First Tourniquet, Left Thigh.||19
40604|NCT02592629|94281|P3|NOT COMPLETED|Overall Study||0
40605|NCT02592629|94282|P2|NOT COMPLETED|Overall Study||0
40606|NCT02592629|94283|P1|NOT COMPLETED|Overall Study||0
40607|NCT02592629|94281|P3|COMPLETED|Overall Study||5
40608|NCT02592629|94282|P2|COMPLETED|Overall Study||9
40609|NCT02592629|94283|P1|COMPLETED|Overall Study||5
40610|NCT02592629|94281|P3|STARTED|Overall Study||5
40611|NCT02592629|94282|P2|STARTED|Overall Study||9
40612|NCT02592629|94283|P1|STARTED|Overall Study||5
40613|NCT02592486|94293|P2|NOT COMPLETED|Overall Study||5
40614|NCT02592486|94294|P1|NOT COMPLETED|Overall Study||0
40615|NCT02592486|94293|P2|COMPLETED|Overall Study||76
40616|NCT02592486|94294|P1|COMPLETED|Overall Study||81
40617|NCT02592486|94293|P2|STARTED|Overall Study||81
40618|NCT02592486|94294|P1|STARTED|Overall Study||81
40619|NCT02592447|94308|P2|NOT COMPLETED|Overall Study||1
40620|NCT02592447|94309|P1|NOT COMPLETED|Overall Study||2
40621|NCT02592447|94308|P2|COMPLETED|Overall Study||14
40622|NCT02592447|94309|P1|COMPLETED|Overall Study||27
40623|NCT02592447|94308|P2|STARTED|Overall Study||15
40624|NCT02592447|94309|P1|STARTED|Overall Study||29
40625|NCT02591537|94319|P2|NOT COMPLETED|Overall Study||0
40626|NCT02591537|94320|P1|NOT COMPLETED|Overall Study||0
40627|NCT02591537|94319|P2|COMPLETED|Overall Study||8
40628|NCT02591537|94320|P1|COMPLETED|Overall Study||8
40629|NCT02591537|94319|P2|STARTED|Overall Study||8
40630|NCT02591537|94320|P1|STARTED|Overall Study||8
40631|NCT02591511|94342|P2|NOT COMPLETED|Overall Study||0
40632|NCT02591511|94343|P1|NOT COMPLETED|Overall Study||0
40633|NCT02591511|94342|P2|COMPLETED|Overall Study||33
40634|NCT02591511|94343|P1|COMPLETED|Overall Study||30
40635|NCT02591511|94342|P2|STARTED|Overall Study||33
40636|NCT02591511|94343|P1|STARTED|Overall Study||30
40637|NCT02591290|94349|P1|NOT COMPLETED|Overall Study||2
40638|NCT02591290|94349|P1|COMPLETED|Overall Study||58
40639|NCT02591290|94349|P1|Vaccinated Dose 2|Overall Study||58
40640|NCT02591290|94349|P1|Vaccinated Dose 1|Overall Study||60
40641|NCT02591290|94349|P1|STARTED|Overall Study||60
40642|NCT02591238|94359|P4|NOT COMPLETED|Overall Study||3
40643|NCT02591238|94360|P3|NOT COMPLETED|Overall Study||0
40644|NCT02591238|94361|P2|NOT COMPLETED|Overall Study||1
40645|NCT02591238|94362|P1|NOT COMPLETED|Overall Study||1
40646|NCT02591238|94359|P4|COMPLETED|Overall Study||15
40647|NCT02591238|94360|P3|COMPLETED|Overall Study||17
40648|NCT02591238|94361|P2|COMPLETED|Overall Study||16
40649|NCT02591238|94362|P1|COMPLETED|Overall Study||15
40650|NCT02591238|94359|P4|STARTED|Overall Study||18
40651|NCT02591238|94360|P3|STARTED|Overall Study||17
40652|NCT02591238|94361|P2|STARTED|Overall Study||17
40653|NCT02591238|94362|P1|STARTED|Overall Study||16
40654|NCT02591056|94392|P1|NOT COMPLETED|Overall Study||0
40655|NCT02591056|94392|P1|COMPLETED|Overall Study||27
40656|NCT02591056|94392|P1|STARTED|Overall Study||27
40657|NCT02590939|94398|P2|NOT COMPLETED|Overall Study||2
40658|NCT02590939|94399|P1|NOT COMPLETED|Overall Study||5
40659|NCT02590939|94398|P2|COMPLETED|Overall Study||52
40660|NCT02590939|94399|P1|COMPLETED|Overall Study||47
40661|NCT02590939|94398|P2|STARTED|Overall Study||54
40662|NCT02590939|94399|P1|STARTED|Overall Study||52
40663|NCT02590588|94419|P1|NOT COMPLETED|Overall Study||1
40664|NCT02590588|94419|P1|COMPLETED|Overall Study||0
40665|NCT02590588|94419|P1|STARTED|Overall Study||1
40666|NCT02590562|94427|P1|NOT COMPLETED|Overall Study||6
40667|NCT02590562|94427|P1|COMPLETED|Overall Study||802
40668|NCT02590562|94427|P1|STARTED|Overall Study||808
40669|NCT02590432|94486|P9|NOT COMPLETED|Dose-reduced Open Label Treatment Period||18
40670|NCT02590432|94487|P8|NOT COMPLETED|Dose-reduced Open Label Treatment Period||18
40671|NCT02590432|94488|P7|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
40672|NCT02590432|94489|P6|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
40673|NCT02590432|94490|P5|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
40674|NCT02590432|94491|P4|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
40675|NCT02590432|94492|P3|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
40676|NCT02590432|94493|P2|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
40677|NCT02590432|94494|P1|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
40678|NCT02590432|94486|P9|COMPLETED|Dose-reduced Open Label Treatment Period||8
40679|NCT02590432|94487|P8|COMPLETED|Dose-reduced Open Label Treatment Period||13
40680|NCT02590432|94488|P7|COMPLETED|Dose-reduced Open Label Treatment Period||0
40681|NCT02590432|94489|P6|COMPLETED|Dose-reduced Open Label Treatment Period||0
40682|NCT02590432|94490|P5|COMPLETED|Dose-reduced Open Label Treatment Period||0
40683|NCT02590432|94491|P4|COMPLETED|Dose-reduced Open Label Treatment Period||0
40684|NCT02590432|94492|P3|COMPLETED|Dose-reduced Open Label Treatment Period||0
40685|NCT02590432|94493|P2|COMPLETED|Dose-reduced Open Label Treatment Period||0
40686|NCT02590432|94494|P1|COMPLETED|Dose-reduced Open Label Treatment Period||0
40687|NCT02590432|94486|P9|STARTED|Dose-reduced Open Label Treatment Period||26
40688|NCT02590432|94487|P8|STARTED|Dose-reduced Open Label Treatment Period||31
40689|NCT02590432|94488|P7|STARTED|Dose-reduced Open Label Treatment Period||0
40690|NCT02590432|94489|P6|STARTED|Dose-reduced Open Label Treatment Period||0
40691|NCT02590432|94490|P5|STARTED|Dose-reduced Open Label Treatment Period||0
40692|NCT02590432|94491|P4|STARTED|Dose-reduced Open Label Treatment Period||0
40693|NCT02590432|94492|P3|STARTED|Dose-reduced Open Label Treatment Period||0
40694|NCT02590432|94493|P2|STARTED|Dose-reduced Open Label Treatment Period||0
40695|NCT02590432|94494|P1|STARTED|Dose-reduced Open Label Treatment Period||0
40696|NCT02590432|94486|P9|NOT COMPLETED|Double-blind Treatment Period||0
40697|NCT02590432|94487|P8|NOT COMPLETED|Double-blind Treatment Period||0
40698|NCT02590432|94488|P7|NOT COMPLETED|Double-blind Treatment Period||21
40699|NCT02590432|94489|P6|NOT COMPLETED|Double-blind Treatment Period||26
40700|NCT02590432|94490|P5|NOT COMPLETED|Double-blind Treatment Period||9
40701|NCT02590432|94491|P4|NOT COMPLETED|Double-blind Treatment Period||15
40702|NCT02590432|94492|P3|NOT COMPLETED|Double-blind Treatment Period||17
40703|NCT02590432|94493|P2|NOT COMPLETED|Double-blind Treatment Period||0
40704|NCT02590432|94494|P1|NOT COMPLETED|Double-blind Treatment Period||0
40705|NCT02590432|94486|P9|COMPLETED|Double-blind Treatment Period||0
40706|NCT02590432|94487|P8|COMPLETED|Double-blind Treatment Period||0
40707|NCT02590432|94488|P7|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|9
40708|NCT02590432|94489|P6|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|6
40709|NCT02590432|94490|P5|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|7
40710|NCT02590432|94491|P4|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|3
40711|NCT02590432|94492|P3|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|1
40712|NCT02590432|94493|P2|COMPLETED|Double-blind Treatment Period||0
40713|NCT02590432|94494|P1|COMPLETED|Double-blind Treatment Period||0
40714|NCT02590432|94486|P9|STARTED|Double-blind Treatment Period||0
40715|NCT02590432|94487|P8|STARTED|Double-blind Treatment Period||0
40716|NCT02590432|94488|P7|STARTED|Double-blind Treatment Period||30
40717|NCT02590432|94489|P6|STARTED|Double-blind Treatment Period||32
40718|NCT02590432|94490|P5|STARTED|Double-blind Treatment Period||16
40719|NCT02590432|94491|P4|STARTED|Double-blind Treatment Period||18
40720|NCT02590432|94492|P3|STARTED|Double-blind Treatment Period||18
40721|NCT02590432|94493|P2|STARTED|Double-blind Treatment Period||0
40722|NCT02590432|94494|P1|STARTED|Double-blind Treatment Period||0
40723|NCT02590432|94486|P9|NOT COMPLETED|Open-label Treatment Period||0
40724|NCT02590432|94487|P8|NOT COMPLETED|Open-label Treatment Period||0
40725|NCT02590432|94488|P7|NOT COMPLETED|Open-label Treatment Period||0
40726|NCT02590432|94489|P6|NOT COMPLETED|Open-label Treatment Period||0
40727|NCT02590432|94490|P5|NOT COMPLETED|Open-label Treatment Period||0
40728|NCT02590432|94491|P4|NOT COMPLETED|Open-label Treatment Period||0
40729|NCT02590432|94492|P3|NOT COMPLETED|Open-label Treatment Period||0
40730|NCT02590432|94493|P2|NOT COMPLETED|Open-label Treatment Period||152
40731|NCT02590432|94494|P1|NOT COMPLETED|Open-label Treatment Period||232
40732|NCT02590432|94486|P9|COMPLETED|Open-label Treatment Period||0
40733|NCT02590432|94487|P8|COMPLETED|Open-label Treatment Period||0
40734|NCT02590432|94488|P7|COMPLETED|Open-label Treatment Period||0
40735|NCT02590432|94489|P6|COMPLETED|Open-label Treatment Period||0
40736|NCT02590432|94490|P5|COMPLETED|Open-label Treatment Period||0
40737|NCT02590432|94491|P4|COMPLETED|Open-label Treatment Period||0
40738|NCT02590432|94492|P3|COMPLETED|Open-label Treatment Period||0
40739|NCT02590432|94493|P2|COMPLETED|Open-label Treatment Period|Participants were not randomized to Double-blind Treatment Period.|166
40740|NCT02590432|94494|P1|COMPLETED|Open-label Treatment Period|Participants were not randomized to Double-blind Treatment Period.|276
40741|NCT02590432|94486|P9|STARTED|Open-label Treatment Period||0
40742|NCT02590432|94487|P8|STARTED|Open-label Treatment Period||0
40743|NCT02590432|94488|P7|STARTED|Open-label Treatment Period||0
40744|NCT02590432|94489|P6|STARTED|Open-label Treatment Period||0
40745|NCT02590432|94490|P5|STARTED|Open-label Treatment Period||0
40746|NCT02590432|94491|P4|STARTED|Open-label Treatment Period||0
40747|NCT02590432|94492|P3|STARTED|Open-label Treatment Period||0
40748|NCT02590432|94493|P2|STARTED|Open-label Treatment Period||318
40749|NCT02590432|94494|P1|STARTED|Open-label Treatment Period||508
40750|NCT02590354|94528|P1|NOT COMPLETED|Phase 2 - Treatment Interruption||2
40751|NCT02590354|94528|P1|COMPLETED|Phase 2 - Treatment Interruption||14
40752|NCT02590354|94528|P1|STARTED|Phase 2 - Treatment Interruption||16
40754|NCT02590354|94528|P1|COMPLETED|Phase 1||16
40755|NCT02590354|94528|P1|STARTED|Phase 1||114
40756|NCT02590003|94538|P2|NOT COMPLETED|Overall Study||2
40757|NCT02590003|94539|P1|NOT COMPLETED|Overall Study||1
40758|NCT02590003|94538|P2|COMPLETED|Overall Study||0
40759|NCT02590003|94539|P1|COMPLETED|Overall Study||0
40760|NCT02590003|94538|P2|STARTED|Overall Study||2
40761|NCT02590003|94539|P1|STARTED|Overall Study||1
40762|NCT02589808|94559|P1|NOT COMPLETED|Overall Study||0
40763|NCT02589808|94559|P1|COMPLETED|Overall Study||76
40764|NCT02589808|94559|P1|STARTED|Overall Study||76
40765|NCT02589639|94566|P3|NOT COMPLETED|Overall Study||4
40766|NCT02589639|94567|P2|NOT COMPLETED|Overall Study||10
40767|NCT02589639|94568|P1|NOT COMPLETED|Overall Study||10
40768|NCT02589639|94566|P3|COMPLETED|Overall Study||86
40769|NCT02589639|94567|P2|COMPLETED|Overall Study||79
40770|NCT02589639|94568|P1|COMPLETED|Overall Study||80
40771|NCT02589639|94566|P3|Treated|Overall Study||90
40772|NCT02589639|94567|P2|Treated|Overall Study||86
40773|NCT02589639|94568|P1|Treated|Overall Study||90
40774|NCT02589639|94566|P3|STARTED|Overall Study||90
40775|NCT02589639|94567|P2|STARTED|Overall Study||89
40776|NCT02589639|94568|P1|STARTED|Overall Study||90
40777|NCT02589626|94581|P2|NOT COMPLETED|Overall Study||2
40778|NCT02589626|94582|P1|NOT COMPLETED|Overall Study||3
40779|NCT02589626|94581|P2|COMPLETED|Overall Study||31
40780|NCT02589626|94582|P1|COMPLETED|Overall Study||29
40781|NCT02589626|94581|P2|STARTED|Overall Study|Entered are treated patients|33
40782|NCT02589626|94582|P1|STARTED|Overall Study|Entered are treated patients|32
40783|NCT02589405|94590|P1|NOT COMPLETED|Overall Study||4
40784|NCT02589405|94590|P1|COMPLETED|Overall Study||46
40785|NCT02589405|94590|P1|STARTED|Overall Study||50
40786|NCT02589171|94596|P2|NOT COMPLETED|Overall Study||5
40787|NCT02589171|94597|P1|NOT COMPLETED|Overall Study||7
40788|NCT02589171|94596|P2|COMPLETED|Overall Study||30
40789|NCT02589171|94597|P1|COMPLETED|Overall Study||28
40790|NCT02589171|94596|P2|Week 6 Follow up|Overall Study||30
40791|NCT02589171|94597|P1|Week 6 Follow up|Overall Study||28
40792|NCT02589171|94596|P2|Week 1 Follow up|Overall Study||34
40793|NCT02589171|94597|P1|Week 1 Follow up|Overall Study||35
40794|NCT02589171|94596|P2|Day 1 Follow up|Overall Study||35
40795|NCT02589171|94597|P1|Day 1 Follow up|Overall Study||35
40796|NCT02589171|94596|P2|STARTED|Overall Study||35
40797|NCT02589171|94597|P1|STARTED|Overall Study||35
40798|NCT02588976|94637|P1|NOT COMPLETED|Overall Study||0
40799|NCT02588976|94637|P1|COMPLETED|Overall Study||30
40800|NCT02588976|94637|P1|STARTED|Overall Study||30
40801|NCT02588872|94644|P2|NOT COMPLETED|Overall Study||0
40802|NCT02588872|94645|P1|NOT COMPLETED|Overall Study||0
40803|NCT02588872|94644|P2|COMPLETED|Overall Study||52
40804|NCT02588872|94645|P1|COMPLETED|Overall Study||59
40805|NCT02588872|94644|P2|STARTED|Overall Study||52
40806|NCT02588872|94645|P1|STARTED|Overall Study||59
40807|NCT02588599|94659|P1|NOT COMPLETED|Overall Study||0
40808|NCT02588599|94659|P1|COMPLETED|Overall Study||54
40809|NCT02588599|94659|P1|STARTED|Overall Study||54
40810|NCT02588573|94666|P2|NOT COMPLETED|Overall Study||0
40811|NCT02588573|94667|P1|NOT COMPLETED|Overall Study||0
40812|NCT02588573|94666|P2|COMPLETED|Overall Study||45
40813|NCT02588573|94667|P1|COMPLETED|Overall Study||45
40814|NCT02588573|94666|P2|Randomized Eye Somofilcon A|Overall Study||45
40815|NCT02588573|94667|P1|Randomized Eye Somofilcon A|Overall Study||45
40816|NCT02588573|94666|P2|Randomized Eye Etafilcon A|Overall Study||45
40817|NCT02588573|94667|P1|Randomized Eye Etafilcon A|Overall Study||45
40818|NCT02588573|94666|P2|STARTED|Overall Study||45
40819|NCT02588573|94667|P1|STARTED|Overall Study||45
40820|NCT02588261|94699|P2|NOT COMPLETED|Overall Study||263
40821|NCT02588261|94700|P1|NOT COMPLETED|Overall Study||267
40822|NCT02588261|94699|P2|COMPLETED|Overall Study||0
40823|NCT02588261|94700|P1|COMPLETED|Overall Study||0
40824|NCT02588261|94699|P2|Treated|Overall Study||262
40825|NCT02588261|94700|P1|Treated|Overall Study||265
40826|NCT02588261|94699|P2|STARTED|Overall Study||263
40827|NCT02588261|94700|P1|STARTED|Overall Study||267
40828|NCT02587819|94726|P1|NOT COMPLETED|Overall Study||2
40829|NCT02587819|94726|P1|COMPLETED|Overall Study||19
40830|NCT02587819|94726|P1|Exposed|Overall Study||21
40831|NCT02587819|94726|P1|STARTED|Overall Study||21
40832|NCT02587234|94735|P2|NOT COMPLETED|Overall Study||3
40833|NCT02587234|94736|P1|NOT COMPLETED|Overall Study||1
40834|NCT02587234|94735|P2|COMPLETED|Overall Study||7
40835|NCT02587234|94736|P1|COMPLETED|Overall Study||10
40836|NCT02587234|94735|P2|STARTED|Overall Study||10
40837|NCT02587234|94736|P1|STARTED|Overall Study||11
40838|NCT02587117|94748|P2|NOT COMPLETED|Overall Study||0
40839|NCT02587117|94749|P1|NOT COMPLETED|Overall Study||0
40840|NCT02587117|94748|P2|COMPLETED|Overall Study||15
40841|NCT02587117|94749|P1|COMPLETED|Overall Study||13
40842|NCT02587117|94748|P2|STARTED|Overall Study||15
40843|NCT02587117|94749|P1|STARTED|Overall Study||13
40844|NCT02586805|94761|P4|NOT COMPLETED|Overall Study||2
40845|NCT02586805|94762|P3|NOT COMPLETED|Overall Study||3
40846|NCT02586805|94763|P2|NOT COMPLETED|Overall Study||1
40847|NCT02586805|94764|P1|NOT COMPLETED|Overall Study||6
40848|NCT02586805|94761|P4|COMPLETED|Overall Study||25
40849|NCT02586805|94762|P3|COMPLETED|Overall Study||26
40850|NCT02586805|94763|P2|COMPLETED|Overall Study||27
40851|NCT02586805|94764|P1|COMPLETED|Overall Study||35
40852|NCT02586805|94761|P4|STARTED|Overall Study||27
40853|NCT02586805|94762|P3|STARTED|Overall Study||29
40854|NCT02586805|94763|P2|STARTED|Overall Study||28
40855|NCT02586805|94764|P1|STARTED|Overall Study||41
40856|NCT02586675|94786|P1|NOT COMPLETED|Overall Study||0
40857|NCT02586675|94786|P1|COMPLETED|Overall Study||7
40858|NCT02586675|94786|P1|STARTED|Overall Study||7
40859|NCT02586506|94792|P1|NOT COMPLETED|Overall Study||9
40860|NCT02586506|94792|P1|COMPLETED|Overall Study||250
40861|NCT02586506|94792|P1|STARTED|Overall Study||259
40862|NCT02586493|94798|P1|NOT COMPLETED|Overall Study||12
40863|NCT02586493|94798|P1|COMPLETED|Overall Study||266
40864|NCT02586493|94798|P1|STARTED|Overall Study||278
40865|NCT02586415|94806|P2|NOT COMPLETED|Overall Study||25
40866|NCT02586415|94807|P1|NOT COMPLETED|Overall Study||14
40867|NCT02586415|94806|P2|COMPLETED|Overall Study||65
40868|NCT02586415|94807|P1|COMPLETED|Overall Study||78
40869|NCT02586415|94806|P2|Day 90 Assessment|Overall Study||65
40870|NCT02586415|94807|P1|Day 90 Assessment|Overall Study||78
40871|NCT02586415|94806|P2|Day 30 Assessment|Overall Study||70
40872|NCT02586415|94807|P1|Day 30 Assessment|Overall Study||81
40873|NCT02586415|94806|P2|24 Hour Assessment|Overall Study||90
40874|NCT02586415|94807|P1|24 Hour Assessment|Overall Study||91
40875|NCT02586415|94806|P2|STARTED|Overall Study||90
40876|NCT02586415|94807|P1|STARTED|Overall Study||92
40877|NCT02586025|94819|P2|NOT COMPLETED|Treatment-Free Follow-Up||35
40878|NCT02586025|94820|P1|NOT COMPLETED|Treatment-Free Follow-Up||56
40879|NCT02586025|94819|P2|COMPLETED|Treatment-Free Follow-Up||3
40880|NCT02586025|94820|P1|COMPLETED|Treatment-Free Follow-Up||3
40881|NCT02586025|94819|P2|STARTED|Treatment-Free Follow-Up||38
40882|NCT02586025|94820|P1|STARTED|Treatment-Free Follow-Up||59
40883|NCT02586025|94819|P2|NOT COMPLETED|Adjuvant Treatment||69
40884|NCT02586025|94820|P1|NOT COMPLETED|Adjuvant Treatment||139
40885|NCT02586025|94819|P2|COMPLETED|Adjuvant Treatment||34
40886|NCT02586025|94820|P1|COMPLETED|Adjuvant Treatment||69
40887|NCT02586025|94819|P2|Started Adjuvant HER2 Treatment|Adjuvant Treatment||99
40888|NCT02586025|94820|P1|Started Adjuvant HER2 Treatment|Adjuvant Treatment||204
40889|NCT02586025|94819|P2|Started Adjuvant FEC Treatment|Adjuvant Treatment||103
40890|NCT02586025|94820|P1|Started Adjuvant FEC Treatment|Adjuvant Treatment||208
40891|NCT02586025|94819|P2|STARTED|Adjuvant Treatment||103
40892|NCT02586025|94820|P1|STARTED|Adjuvant Treatment||208
40893|NCT02586025|94819|P2|NOT COMPLETED|Neoadjuvant Treatment||7
40894|NCT02586025|94820|P1|NOT COMPLETED|Neoadjuvant Treatment||11
40895|NCT02586025|94819|P2|COMPLETED|Neoadjuvant Treatment||103
40896|NCT02586025|94820|P1|COMPLETED|Neoadjuvant Treatment||208
40897|NCT02586025|94819|P2|Underwent Surgery|Neoadjuvant Treatment||105
40898|NCT02586025|94820|P1|Underwent Surgery|Neoadjuvant Treatment||210
40899|NCT02586025|94819|P2|Completed Neoadjuvant Treatment|Neoadjuvant Treatment||108
40900|NCT02586025|94820|P1|Completed Neoadjuvant Treatment|Neoadjuvant Treatment||214
40901|NCT02586025|94819|P2|Received at Least One Dose of Study Drug|Neoadjuvant Treatment||110
40902|NCT02586025|94820|P1|Received at Least One Dose of Study Drug|Neoadjuvant Treatment||218
40903|NCT02586025|94819|P2|STARTED|Neoadjuvant Treatment||110
40904|NCT02586025|94820|P1|STARTED|Neoadjuvant Treatment||219
40905|NCT02585999|94856|P1|NOT COMPLETED|Overall Study||2
40906|NCT02585999|94856|P1|COMPLETED|Overall Study|28 participants enrolled; 2 withdrew prior to starting, leaving 26 to complete study activity.|26
40907|NCT02585999|94856|P1|STARTED|Overall Study||28
40908|NCT02585960|94864|P3|NOT COMPLETED|Prophylactic Treatment Period||0
40909|NCT02585960|94865|P2|NOT COMPLETED|Prophylactic Treatment Period||5
40910|NCT02585960|94866|P1|NOT COMPLETED|Prophylactic Treatment Period||0
40911|NCT02585960|94864|P3|COMPLETED|Prophylactic Treatment Period||0
40912|NCT02585960|94865|P2|COMPLETED|Prophylactic Treatment Period||43
40913|NCT02585960|94866|P1|COMPLETED|Prophylactic Treatment Period||52
40914|NCT02585960|94864|P3|STARTED|Prophylactic Treatment Period||0
40915|NCT02585960|94865|P2|STARTED|Prophylactic Treatment Period||48
40916|NCT02585960|94866|P1|STARTED|Prophylactic Treatment Period||52
40917|NCT02585960|94864|P3|NOT COMPLETED|PK/Safety Assessment Period||6
40918|NCT02585960|94865|P2|NOT COMPLETED|PK/Safety Assessment Period||10
40919|NCT02585960|94866|P1|NOT COMPLETED|PK/Safety Assessment Period||5
40920|NCT02585960|94864|P3|COMPLETED|PK/Safety Assessment Period||0
40921|NCT02585960|94865|P2|COMPLETED|PK/Safety Assessment Period||48
40922|NCT02585960|94866|P1|COMPLETED|PK/Safety Assessment Period||52
40923|NCT02585960|94864|P3|Completed 2nd 6 Month Period|PK/Safety Assessment Period||0
40924|NCT02585960|94865|P2|Completed 2nd 6 Month Period|PK/Safety Assessment Period||48
40925|NCT02585960|94866|P1|Completed 2nd 6 Month Period|PK/Safety Assessment Period||52
40926|NCT02585960|94864|P3|Completed 1st 6 Month Period|PK/Safety Assessment Period||0
40927|NCT02585960|94865|P2|Completed 1st 6 Month Period|PK/Safety Assessment Period||53
40928|NCT02585960|94866|P1|Completed 1st 6 Month Period|PK/Safety Assessment Period||57
40929|NCT02585960|94864|P3|STARTED|PK/Safety Assessment Period||6
40930|NCT02585960|94865|P2|STARTED|PK/Safety Assessment Period||58
40931|NCT02585960|94866|P1|STARTED|PK/Safety Assessment Period||57
40932|NCT02585934|94936|P2|NOT COMPLETED|Overall Study||73
40933|NCT02585934|94937|P1|NOT COMPLETED|Overall Study||69
40934|NCT02585934|94936|P2|COMPLETED|Overall Study||581
40935|NCT02585934|94937|P1|COMPLETED|Overall Study||592
40936|NCT02585934|94936|P2|Per Protocol (PP)|Overall Study||582
40937|NCT02585934|94937|P1|Per Protocol (PP)|Overall Study||603
40938|NCT02585934|94936|P2|Intent to Treat (ITT)|Overall Study||633
40939|NCT02585934|94937|P1|Intent to Treat (ITT)|Overall Study||643
40940|NCT02585934|94936|P2|Safety Population|Overall Study||651
40941|NCT02585934|94937|P1|Safety Population|Overall Study||656
40942|NCT02585934|94936|P2|STARTED|Overall Study||654
40943|NCT02585934|94937|P1|STARTED|Overall Study||661
40944|NCT02585895|94960|P2|NOT COMPLETED|Post-primary Period||0
40945|NCT02585895|94961|P1|NOT COMPLETED|Post-primary Period||0
40946|NCT02585895|94960|P2|COMPLETED|Post-primary Period||19
40947|NCT02585895|94961|P1|COMPLETED|Post-primary Period||20
40948|NCT02585895|94960|P2|STARTED|Post-primary Period||19
40949|NCT02585895|94961|P1|STARTED|Post-primary Period||20
40950|NCT02585895|94960|P2|NOT COMPLETED|Primary Period||0
40951|NCT02585895|94961|P1|NOT COMPLETED|Primary Period||0
40952|NCT02585895|94960|P2|COMPLETED|Primary Period||19
40953|NCT02585895|94961|P1|COMPLETED|Primary Period||20
40954|NCT02585895|94960|P2|STARTED|Primary Period||19
40955|NCT02585895|94961|P1|STARTED|Primary Period||20
40956|NCT02585843|94978|P2|NOT COMPLETED|Overall Study||0
40957|NCT02585843|94979|P1|NOT COMPLETED|Overall Study||1
40958|NCT02585843|94978|P2|COMPLETED|Overall Study||10
40959|NCT02585843|94979|P1|COMPLETED|Overall Study||9
40960|NCT02585843|94978|P2|STARTED|Overall Study||10
40961|NCT02585843|94979|P1|STARTED|Overall Study||10
40962|NCT02585778|94997|P2|NOT COMPLETED|Overall Study||15
40963|NCT02585778|94998|P1|NOT COMPLETED|Overall Study||33
40964|NCT02585778|94997|P2|COMPLETED|Overall Study||157
40965|NCT02585778|94998|P1|COMPLETED|Overall Study||312
40966|NCT02585778|94997|P2|T2DM Participants|Overall Study||147
40967|NCT02585778|94998|P1|T2DM Participants|Overall Study||294
40968|NCT02585778|94997|P2|T1DM Participants|Overall Study||25
40969|NCT02585778|94998|P1|T1DM Participants|Overall Study||51
40970|NCT02585778|94997|P2|mITT Population|Overall Study||164
40971|NCT02585778|94998|P1|mITT Population|Overall Study||333
40972|NCT02585778|94997|P2|ITT Population|Overall Study||167
40973|NCT02585778|94998|P1|ITT Population|Overall Study||336
40974|NCT02585778|94997|P2|Treated (Safety Population)|Overall Study||170
40975|NCT02585778|94998|P1|Treated (Safety Population)|Overall Study||344
40976|NCT02585778|94997|P2|STARTED|Overall Study|Randomized|172
40977|NCT02585778|94998|P1|STARTED|Overall Study|Randomized|345
40978|NCT02585700|95114|P2|NOT COMPLETED|Overall Study||0
40979|NCT02585700|95115|P1|NOT COMPLETED|Overall Study||0
40980|NCT02585700|95114|P2|COMPLETED|Overall Study||30
40981|NCT02585700|95115|P1|COMPLETED|Overall Study||30
40982|NCT02585700|95114|P2|STARTED|Overall Study||30
40983|NCT02585700|95115|P1|STARTED|Overall Study||30
40984|NCT02585245|95141|P1|NOT COMPLETED|Overall Study||13
40985|NCT02585245|95141|P1|COMPLETED|Overall Study||594
40986|NCT02585245|95141|P1|STARTED|Overall Study||607
40987|NCT02584998|95149|P3|NOT COMPLETED|Overall Study||0
40988|NCT02584998|95150|P2|NOT COMPLETED|Overall Study||0
40989|NCT02584998|95151|P1|NOT COMPLETED|Overall Study||0
40990|NCT02584998|95149|P3|COMPLETED|Overall Study||261
40991|NCT02584998|95150|P2|COMPLETED|Overall Study||261
40992|NCT02584998|95151|P1|COMPLETED|Overall Study||260
40993|NCT02584998|95149|P3|STARTED|Overall Study||261
40994|NCT02584998|95150|P2|STARTED|Overall Study||261
40995|NCT02584998|95151|P1|STARTED|Overall Study||260
40996|NCT02584959|95165|P3|NOT COMPLETED|Period 2||2
40997|NCT02584959|95166|P2|NOT COMPLETED|Period 2||1
40998|NCT02584959|95167|P1|NOT COMPLETED|Period 2||6
40999|NCT02584959|95165|P3|COMPLETED|Period 2||13
41000|NCT02584959|95166|P2|COMPLETED|Period 2||24
41001|NCT02584959|95167|P1|COMPLETED|Period 2||22
41002|NCT02584959|95165|P3|STARTED|Period 2||15
41003|NCT02584959|95166|P2|STARTED|Period 2||25
41004|NCT02584959|95167|P1|STARTED|Period 2||28
41005|NCT02584959|95165|P3|NOT COMPLETED|Period 1||0
41006|NCT02584959|95166|P2|NOT COMPLETED|Period 1||4
41007|NCT02584959|95167|P1|NOT COMPLETED|Period 1||3
41008|NCT02584959|95165|P3|COMPLETED|Period 1||15
41009|NCT02584959|95166|P2|COMPLETED|Period 1||25
41010|NCT02584959|95167|P1|COMPLETED|Period 1||28
41011|NCT02584959|95165|P3|STARTED|Period 1||15
41012|NCT02584959|95166|P2|STARTED|Period 1||29
41013|NCT02584959|95167|P1|STARTED|Period 1||31
41014|NCT02584855|95222|P6|NOT COMPLETED|Post Treatment Follow-up Period||0
41015|NCT02584855|95223|P5|NOT COMPLETED|Post Treatment Follow-up Period||8
41016|NCT02584855|95224|P4|NOT COMPLETED|Post Treatment Follow-up Period||0
41017|NCT02584855|95225|P3|NOT COMPLETED|Post Treatment Follow-up Period||0
41018|NCT02584855|95226|P2|NOT COMPLETED|Post Treatment Follow-up Period||0
41019|NCT02584855|95227|P1|NOT COMPLETED|Post Treatment Follow-up Period||0
41020|NCT02584855|95222|P6|COMPLETED|Post Treatment Follow-up Period||12
41021|NCT02584855|95223|P5|COMPLETED|Post Treatment Follow-up Period||347
41022|NCT02584855|95224|P4|COMPLETED|Post Treatment Follow-up Period||0
41023|NCT02584855|95225|P3|COMPLETED|Post Treatment Follow-up Period||0
41024|NCT02584855|95226|P2|COMPLETED|Post Treatment Follow-up Period||0
41025|NCT02584855|95227|P1|COMPLETED|Post Treatment Follow-up Period||0
41026|NCT02584855|95222|P6|STARTED|Post Treatment Follow-up Period||12
41027|NCT02584855|95223|P5|STARTED|Post Treatment Follow-up Period||355
41028|NCT02584855|95224|P4|STARTED|Post Treatment Follow-up Period||0
41029|NCT02584855|95225|P3|STARTED|Post Treatment Follow-up Period||0
41030|NCT02584855|95226|P2|STARTED|Post Treatment Follow-up Period||0
41031|NCT02584855|95227|P1|STARTED|Post Treatment Follow-up Period||0
41032|NCT02584855|95222|P6|NOT COMPLETED|Double-Blind Withdrawal Period||0
41033|NCT02584855|95223|P5|NOT COMPLETED|Double-Blind Withdrawal Period||0
41034|NCT02584855|95224|P4|NOT COMPLETED|Double-Blind Withdrawal Period||1
41035|NCT02584855|95225|P3|NOT COMPLETED|Double-Blind Withdrawal Period||2
41036|NCT02584855|95226|P2|NOT COMPLETED|Double-Blind Withdrawal Period||15
41037|NCT02584855|95227|P1|NOT COMPLETED|Double-Blind Withdrawal Period||0
41038|NCT02584855|95222|P6|COMPLETED|Double-Blind Withdrawal Period||0
41039|NCT02584855|95223|P5|COMPLETED|Double-Blind Withdrawal Period||0
41040|NCT02584855|95224|P4|COMPLETED|Double-Blind Withdrawal Period||78
41041|NCT02584855|95225|P3|COMPLETED|Double-Blind Withdrawal Period||77
41042|NCT02584855|95226|P2|COMPLETED|Double-Blind Withdrawal Period||118
41043|NCT02584855|95227|P1|COMPLETED|Double-Blind Withdrawal Period||0
41044|NCT02584855|95222|P6|Relapsed|Double-Blind Withdrawal Period||0
41045|NCT02584855|95223|P5|Relapsed|Double-Blind Withdrawal Period||0
41046|NCT02584855|95224|P4|Relapsed|Double-Blind Withdrawal Period||30
41047|NCT02584855|95225|P3|Relapsed|Double-Blind Withdrawal Period||67
41048|NCT02584855|95226|P2|Relapsed|Double-Blind Withdrawal Period||0
41049|NCT02584855|95227|P1|Relapsed|Double-Blind Withdrawal Period||0
41050|NCT02584855|95222|P6|STARTED|Double-Blind Withdrawal Period||0
41051|NCT02584855|95223|P5|STARTED|Double-Blind Withdrawal Period||0
41052|NCT02584855|95224|P4|STARTED|Double-Blind Withdrawal Period|Participants completed open label and met criteria for double-blind withdrawal period.|79
41053|NCT02584855|95225|P3|STARTED|Double-Blind Withdrawal Period|Participants completed open label and met criteria for double-blind withdrawal period.|79
41054|NCT02584855|95226|P2|STARTED|Double-Blind Withdrawal Period|Participants completed open label but did not meet criteria for double-blind withdrawal period.|133
41055|NCT02584855|95227|P1|STARTED|Double-Blind Withdrawal Period||0
41056|NCT02584855|95222|P6|NOT COMPLETED|Open-Label Treatment Period||0
41057|NCT02584855|95223|P5|NOT COMPLETED|Open-Label Treatment Period||0
41058|NCT02584855|95224|P4|NOT COMPLETED|Open-Label Treatment Period||0
41059|NCT02584855|95225|P3|NOT COMPLETED|Open-Label Treatment Period||0
41060|NCT02584855|95226|P2|NOT COMPLETED|Open-Label Treatment Period||0
41061|NCT02584855|95227|P1|NOT COMPLETED|Open-Label Treatment Period||103
41062|NCT02584855|95222|P6|COMPLETED|Open-Label Treatment Period||0
41063|NCT02584855|95223|P5|COMPLETED|Open-Label Treatment Period||0
41064|NCT02584855|95224|P4|COMPLETED|Open-Label Treatment Period||0
41065|NCT02584855|95225|P3|COMPLETED|Open-Label Treatment Period||0
41066|NCT02584855|95226|P2|COMPLETED|Open-Label Treatment Period||0
41067|NCT02584855|95227|P1|COMPLETED|Open-Label Treatment Period||291
41068|NCT02584855|95222|P6|Non-randomized|Open-Label Treatment Period||0
41069|NCT02584855|95223|P5|Non-randomized|Open-Label Treatment Period||0
41070|NCT02584855|95224|P4|Non-randomized|Open-Label Treatment Period||0
41071|NCT02584855|95225|P3|Non-randomized|Open-Label Treatment Period||0
41072|NCT02584855|95226|P2|Non-randomized|Open-Label Treatment Period||0
41073|NCT02584855|95227|P1|Non-randomized|Open-Label Treatment Period||133
41074|NCT02584855|95222|P6|Met Randomization Criteria|Open-Label Treatment Period||0
41075|NCT02584855|95223|P5|Met Randomization Criteria|Open-Label Treatment Period||0
41076|NCT02584855|95224|P4|Met Randomization Criteria|Open-Label Treatment Period||0
41077|NCT02584855|95225|P3|Met Randomization Criteria|Open-Label Treatment Period||0
41078|NCT02584855|95226|P2|Met Randomization Criteria|Open-Label Treatment Period||0
41079|NCT02584855|95227|P1|Met Randomization Criteria|Open-Label Treatment Period||158
41080|NCT02584855|95222|P6|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
41081|NCT02584855|95223|P5|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
41082|NCT02584855|95224|P4|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
41083|NCT02584855|95225|P3|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
41084|NCT02584855|95226|P2|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
41085|NCT02584855|95227|P1|Received at Least One Dose of Study Drug|Open-Label Treatment Period||394
41086|NCT02584855|95222|P6|STARTED|Open-Label Treatment Period||0
41087|NCT02584855|95223|P5|STARTED|Open-Label Treatment Period||0
41088|NCT02584855|95224|P4|STARTED|Open-Label Treatment Period|Participants were randomized to this arm during double-blind withdrawal period.|0
41089|NCT02584855|95225|P3|STARTED|Open-Label Treatment Period|Participants were randomized to this arm during double-blind withdrawal period.|0
41090|NCT02584855|95226|P2|STARTED|Open-Label Treatment Period|Participants completed Open-Label Treatment Period.|0
41091|NCT02584855|95227|P1|STARTED|Open-Label Treatment Period||394
41092|NCT02584790|95261|P1|NOT COMPLETED|Overall Study||15
41093|NCT02584790|95261|P1|COMPLETED|Overall Study||40
41094|NCT02584790|95261|P1|STARTED|Overall Study||55
41095|NCT02584686|95269|P2|NOT COMPLETED|Overall Study||0
41096|NCT02584686|95270|P1|NOT COMPLETED|Overall Study||0
41097|NCT02584686|95269|P2|COMPLETED|Overall Study||12
41098|NCT02584686|95270|P1|COMPLETED|Overall Study||12
41099|NCT02584686|95269|P2|STARTED|Overall Study||12
41100|NCT02584686|95270|P1|STARTED|Overall Study||12
41101|NCT02584673|95298|P2|NOT COMPLETED|Overall Study||0
41102|NCT02584673|95299|P1|NOT COMPLETED|Overall Study||0
41103|NCT02584673|95298|P2|COMPLETED|Overall Study||15
41104|NCT02584673|95299|P1|COMPLETED|Overall Study||15
41105|NCT02584673|95298|P2|STARTED|Overall Study||15
41106|NCT02584673|95299|P1|STARTED|Overall Study||15
41107|NCT02584660|95313|P2|NOT COMPLETED|Overall Study||8
41108|NCT02584660|95314|P1|NOT COMPLETED|Overall Study||7
41109|NCT02584660|95313|P2|COMPLETED|Overall Study||55
41110|NCT02584660|95314|P1|COMPLETED|Overall Study||44
41111|NCT02584660|95313|P2|Treated|Overall Study||63
41112|NCT02584660|95314|P1|Treated|Overall Study||49
41113|NCT02584660|95313|P2|STARTED|Overall Study||63
41114|NCT02584660|95314|P1|STARTED|Overall Study||51
41115|NCT02584504|95333|P3|NOT COMPLETED|Open-label Treatment||8
41116|NCT02584504|95334|P2|NOT COMPLETED|Open-label Treatment||4
41117|NCT02584504|95335|P1|NOT COMPLETED|Open-label Treatment||2
41118|NCT02584504|95333|P3|COMPLETED|Open-label Treatment||47
41119|NCT02584504|95334|P2|COMPLETED|Open-label Treatment||47
41120|NCT02584504|95335|P1|COMPLETED|Open-label Treatment||52
41121|NCT02584504|95333|P3|Treated|Open-label Treatment||54
41122|NCT02584504|95334|P2|Treated|Open-label Treatment||50
41123|NCT02584504|95335|P1|Treated|Open-label Treatment||54
41124|NCT02584504|95333|P3|STARTED|Open-label Treatment||55
41125|NCT02584504|95334|P2|STARTED|Open-label Treatment||51
41126|NCT02584504|95335|P1|STARTED|Open-label Treatment||54
41127|NCT02584504|95333|P3|NOT COMPLETED|Double-blind Treatment||1
41128|NCT02584504|95334|P2|NOT COMPLETED|Double-blind Treatment||2
41129|NCT02584504|95335|P1|NOT COMPLETED|Double-blind Treatment||0
41130|NCT02584504|95333|P3|COMPLETED|Double-blind Treatment||55
41131|NCT02584504|95334|P2|COMPLETED|Double-blind Treatment||51
41132|NCT02584504|95335|P1|COMPLETED|Double-blind Treatment||54
41133|NCT02584504|95333|P3|Safety Population|Double-blind Treatment||56
41134|NCT02584504|95334|P2|Safety Population|Double-blind Treatment||53
41135|NCT02584504|95335|P1|Safety Population|Double-blind Treatment||54
41136|NCT02584504|95333|P3|mITT Population|Double-blind Treatment||56
41137|NCT02584504|95334|P2|mITT Population|Double-blind Treatment||53
41138|NCT02584504|95335|P1|mITT Population|Double-blind Treatment||54
41139|NCT02584504|95333|P3|ITT Population|Double-blind Treatment||56
41140|NCT02584504|95334|P2|ITT Population|Double-blind Treatment||53
41141|NCT02584504|95335|P1|ITT Population|Double-blind Treatment||54
41142|NCT02584504|95333|P3|STARTED|Double-blind Treatment|Randomized|56
41143|NCT02584504|95334|P2|STARTED|Double-blind Treatment|Randomized|53
41144|NCT02584504|95335|P1|STARTED|Double-blind Treatment|Randomized|54
41145|NCT02584452|95391|P2|NOT COMPLETED|Overall Study||2
41146|NCT02584452|95392|P1|NOT COMPLETED|Overall Study||2
41147|NCT02584452|95391|P2|COMPLETED|Overall Study||21
41148|NCT02584452|95392|P1|COMPLETED|Overall Study||32
41149|NCT02584452|95391|P2|STARTED|Overall Study||23
41150|NCT02584452|95392|P1|STARTED|Overall Study||34
41151|NCT02583477|95422|P2|NOT COMPLETED|Overall Study||20
41152|NCT02583477|95423|P1|NOT COMPLETED|Overall Study||3
41153|NCT02583477|95422|P2|COMPLETED|Overall Study||0
41154|NCT02583477|95423|P1|COMPLETED|Overall Study||0
41155|NCT02583477|95422|P2|Completed Treatment|Overall Study||0
41156|NCT02583477|95423|P1|Completed Treatment|Overall Study||0
41157|NCT02583477|95422|P2|Received Treatment|Overall Study||20
41158|NCT02583477|95423|P1|Received Treatment|Overall Study||3
41159|NCT02583477|95422|P2|STARTED|Overall Study||20
41160|NCT02583477|95423|P1|STARTED|Overall Study||3
41161|NCT02583425|95443|P1|NOT COMPLETED|Treatment Period||1
41162|NCT02583425|95443|P1|COMPLETED|Treatment Period||9
41163|NCT02583425|95443|P1|STARTED|Treatment Period||10
41164|NCT02583425|95443|P1|NOT COMPLETED|Baseline||5
41165|NCT02583425|95443|P1|COMPLETED|Baseline||10
41166|NCT02583425|95443|P1|STARTED|Baseline||15
41167|NCT02583425|95443|P1|NOT COMPLETED|Screening||12
41168|NCT02583425|95443|P1|COMPLETED|Screening||15
41169|NCT02583425|95443|P1|STARTED|Screening||27
41170|NCT02583269|95453|P5|NOT COMPLETED|Overall Study||0
41171|NCT02583269|95454|P4|NOT COMPLETED|Overall Study||0
41172|NCT02583269|95455|P3|NOT COMPLETED|Overall Study||0
41173|NCT02583269|95456|P2|NOT COMPLETED|Overall Study||0
41174|NCT02583269|95457|P1|NOT COMPLETED|Overall Study||1
41175|NCT02583269|95453|P5|COMPLETED|Overall Study||6
41176|NCT02583269|95454|P4|COMPLETED|Overall Study||5
41177|NCT02583269|95455|P3|COMPLETED|Overall Study||3
41178|NCT02583269|95456|P2|COMPLETED|Overall Study||7
41179|NCT02583269|95457|P1|COMPLETED|Overall Study||2
41180|NCT02583269|95453|P5|STARTED|Overall Study||6
41181|NCT02583269|95454|P4|STARTED|Overall Study||5
41182|NCT02583269|95455|P3|STARTED|Overall Study||3
41183|NCT02583269|95456|P2|STARTED|Overall Study||7
41184|NCT02583269|95457|P1|STARTED|Overall Study||3
41185|NCT02583256|95484|P4|NOT COMPLETED|Overall Study||3
41186|NCT02583256|95485|P3|NOT COMPLETED|Overall Study||2
41187|NCT02583256|95486|P2|NOT COMPLETED|Overall Study||2
41188|NCT02583256|95487|P1|NOT COMPLETED|Overall Study||3
41189|NCT02583256|95484|P4|COMPLETED|Overall Study||390
41190|NCT02583256|95485|P3|COMPLETED|Overall Study||400
41191|NCT02583256|95486|P2|COMPLETED|Overall Study||401
41192|NCT02583256|95487|P1|COMPLETED|Overall Study||400
41193|NCT02583256|95484|P4|Exposed|Overall Study||393
41194|NCT02583256|95485|P3|Exposed|Overall Study||402
41195|NCT02583256|95486|P2|Exposed|Overall Study||403
41196|NCT02583256|95487|P1|Exposed|Overall Study||403
41197|NCT02583256|95484|P4|STARTED|Overall Study||393
41198|NCT02583256|95485|P3|STARTED|Overall Study||402
41199|NCT02583256|95486|P2|STARTED|Overall Study||403
41200|NCT02583256|95487|P1|STARTED|Overall Study||403
41201|NCT02583230|95575|P1|NOT COMPLETED|Overall Study||0
41202|NCT02583230|95575|P1|COMPLETED|Overall Study||11
41203|NCT02583230|95575|P1|STARTED|Overall Study||11
41204|NCT02582983|95581|P1|NOT COMPLETED|Overall Study||6
41205|NCT02582983|95581|P1|COMPLETED|Overall Study||17
41206|NCT02582983|95581|P1|STARTED|Overall Study||23
41207|NCT02582970|95586|P1|NOT COMPLETED|Overall Study||0
41208|NCT02582970|95586|P1|COMPLETED|Overall Study||40
41209|NCT02582970|95586|P1|STARTED|Overall Study||40
41210|NCT02582840|95599|P3|NOT COMPLETED|Overall Study||0
41211|NCT02582840|95600|P2|NOT COMPLETED|Overall Study||0
41212|NCT02582840|95601|P1|NOT COMPLETED|Overall Study||0
41213|NCT02582840|95599|P3|COMPLETED|Overall Study||14
41214|NCT02582840|95600|P2|COMPLETED|Overall Study||14
41215|NCT02582840|95601|P1|COMPLETED|Overall Study||14
41216|NCT02582840|95599|P3|STARTED|Overall Study||14
41217|NCT02582840|95600|P2|STARTED|Overall Study||14
41218|NCT02582840|95601|P1|STARTED|Overall Study||14
41219|NCT02582814|95644|P2|NOT COMPLETED|Overall Study||7
41220|NCT02582814|95645|P1|NOT COMPLETED|Overall Study||9
41221|NCT02582814|95644|P2|COMPLETED|Overall Study||68
41222|NCT02582814|95645|P1|COMPLETED|Overall Study||67
41223|NCT02582814|95644|P2|STARTED|Overall Study||75
41224|NCT02582814|95645|P1|STARTED|Overall Study||76
41225|NCT02582749|95685|P2|NOT COMPLETED|Overall Study||11
41226|NCT02582749|95686|P1|NOT COMPLETED|Overall Study||5
41227|NCT02582749|95685|P2|COMPLETED|Overall Study||0
41228|NCT02582749|95686|P1|COMPLETED|Overall Study||0
41229|NCT02582749|95685|P2|STARTED|Overall Study||11
41230|NCT02582749|95686|P1|STARTED|Overall Study||5
41231|NCT02582684|95716|P1|NOT COMPLETED|Overall Study||17
41232|NCT02582684|95716|P1|COMPLETED|Overall Study||105
41233|NCT02582684|95716|P1|STARTED|Overall Study||122
41234|NCT02582671|95735|P1|NOT COMPLETED|Overall Study||2
41235|NCT02582671|95735|P1|COMPLETED|Overall Study||99
41236|NCT02582671|95735|P1|STARTED|Overall Study||101
41237|NCT02582658|95747|P1|NOT COMPLETED|Overall Study||25
41238|NCT02582658|95747|P1|COMPLETED|Overall Study||146
41239|NCT02582658|95747|P1|STARTED|Overall Study||171
41240|NCT02582632|95765|P1|NOT COMPLETED|Overall Study||1
41241|NCT02582632|95765|P1|COMPLETED|Overall Study||165
41242|NCT02582632|95765|P1|STARTED|Overall Study||166
41243|NCT02582515|95780|P2|NOT COMPLETED|Overall Study||1
41244|NCT02582515|95781|P1|NOT COMPLETED|Overall Study||0
41245|NCT02582515|95780|P2|COMPLETED|Overall Study||10
41246|NCT02582515|95781|P1|COMPLETED|Overall Study||9
41247|NCT02582515|95780|P2|Received Study Intervention|Overall Study||10
41248|NCT02582515|95781|P1|Received Study Intervention|Overall Study||9
41249|NCT02582515|95780|P2|STARTED|Overall Study||11
41250|NCT02582515|95781|P1|STARTED|Overall Study||9
41251|NCT02582242|95789|P2|NOT COMPLETED|Overall Study||17
41252|NCT02582242|95790|P1|NOT COMPLETED|Overall Study||20
41253|NCT02582242|95789|P2|COMPLETED|Overall Study||200
41254|NCT02582242|95790|P1|COMPLETED|Overall Study||200
41255|NCT02582242|95789|P2|STARTED|Overall Study||217
41256|NCT02582242|95790|P1|STARTED|Overall Study||220
41257|NCT02581995|95830|P1|NOT COMPLETED|Overall Study||31
41258|NCT02581995|95830|P1|COMPLETED|Overall Study||529
41259|NCT02581995|95830|P1|Treated|Overall Study||560
41260|NCT02581995|95830|P1|STARTED|Overall Study||560
41261|NCT02581930|95844|P1|NOT COMPLETED|Overall Study||2
41262|NCT02581930|95844|P1|COMPLETED|Overall Study||16
41263|NCT02581930|95844|P1|STARTED|Overall Study||18
41264|NCT02581488|95852|P2|NOT COMPLETED|Overall Study||11
41265|NCT02581488|95853|P1|NOT COMPLETED|Overall Study||9
41266|NCT02581488|95852|P2|COMPLETED|Overall Study||40
41267|NCT02581488|95853|P1|COMPLETED|Overall Study||42
41268|NCT02581488|95852|P2|STARTED|Overall Study||51
41269|NCT02581488|95853|P1|STARTED|Overall Study||51
41270|NCT02581475|95869|P2|NOT COMPLETED|Overall Study||15
41271|NCT02581475|95870|P1|NOT COMPLETED|Overall Study||11
41272|NCT02581475|95869|P2|COMPLETED|Overall Study||178
41273|NCT02581475|95870|P1|COMPLETED|Overall Study||182
41274|NCT02581475|95869|P2|STARTED|Overall Study||193
41275|NCT02581475|95870|P1|STARTED|Overall Study||193
41276|NCT02581410|95884|P2|NOT COMPLETED|End of Study Phase||11
41277|NCT02581410|95885|P1|NOT COMPLETED|End of Study Phase||5
41278|NCT02581410|95884|P2|COMPLETED|End of Study Phase||204
41279|NCT02581410|95885|P1|COMPLETED|End of Study Phase||210
41280|NCT02581410|95884|P2|STARTED|End of Study Phase||215
41281|NCT02581410|95885|P1|STARTED|End of Study Phase||215
41282|NCT02581410|95884|P2|NOT COMPLETED|Vaccination Phase||3
41283|NCT02581410|95885|P1|NOT COMPLETED|Vaccination Phase||2
41284|NCT02581410|95884|P2|COMPLETED|Vaccination Phase||212
41285|NCT02581410|95885|P1|COMPLETED|Vaccination Phase||213
41286|NCT02581410|95884|P2|STARTED|Vaccination Phase||215
41287|NCT02581410|95885|P1|STARTED|Vaccination Phase||215
41288|NCT02581345|95915|P4|NOT COMPLETED|Part 2: Week 17 to Week 47||12
41289|NCT02581345|95916|P3|NOT COMPLETED|Part 2: Week 17 to Week 47||15
41290|NCT02581345|95917|P2|NOT COMPLETED|Part 2: Week 17 to Week 47||0
41291|NCT02581345|95918|P1|NOT COMPLETED|Part 2: Week 17 to Week 47||29
41292|NCT02581345|95915|P4|COMPLETED|Part 2: Week 17 to Week 47||119
41293|NCT02581345|95916|P3|COMPLETED|Part 2: Week 17 to Week 47||117
41294|NCT02581345|95917|P2|COMPLETED|Part 2: Week 17 to Week 47||0
41295|NCT02581345|95918|P1|COMPLETED|Part 2: Week 17 to Week 47||242
41296|NCT02581345|95915|P4|STARTED|Part 2: Week 17 to Week 47||131
41297|NCT02581345|95916|P3|STARTED|Part 2: Week 17 to Week 47||132
41298|NCT02581345|95917|P2|STARTED|Part 2: Week 17 to Week 47||0
41299|NCT02581345|95918|P1|STARTED|Part 2: Week 17 to Week 47||271
41300|NCT02581345|95915|P4|NOT COMPLETED|Part 1: up to Week 16||0
41301|NCT02581345|95916|P3|NOT COMPLETED|Part 1: up to Week 16||0
41302|NCT02581345|95917|P2|NOT COMPLETED|Part 1: up to Week 16||23
41303|NCT02581345|95918|P1|NOT COMPLETED|Part 1: up to Week 16||15
41304|NCT02581345|95915|P4|COMPLETED|Part 1: up to Week 16||0
41305|NCT02581345|95916|P3|COMPLETED|Part 1: up to Week 16||0
41306|NCT02581345|95917|P2|COMPLETED|Part 1: up to Week 16||263
41307|NCT02581345|95918|P1|COMPLETED|Part 1: up to Week 16||271
41308|NCT02581345|95915|P4|STARTED|Part 1: up to Week 16||0
41309|NCT02581345|95916|P3|STARTED|Part 1: up to Week 16||0
41310|NCT02581345|95917|P2|STARTED|Part 1: up to Week 16||286
41311|NCT02581345|95918|P1|STARTED|Part 1: up to Week 16||286
41312|NCT02581202|96020|P1|NOT COMPLETED|Overall Study||14
41313|NCT02581202|96020|P1|COMPLETED|Overall Study||202
41314|NCT02581202|96020|P1|STARTED|Overall Study||216
41315|NCT02581189|96059|P1|NOT COMPLETED|Overall Study||53
41316|NCT02581189|96059|P1|COMPLETED|Overall Study||481
41317|NCT02581189|96059|P1|STARTED|Overall Study||534
41318|NCT02581163|96073|P1|NOT COMPLETED|Overall Study||29
41319|NCT02581163|96073|P1|COMPLETED|Overall Study||282
41320|NCT02581163|96073|P1|STARTED|Overall Study||311
41321|NCT02581137|96087|P1|NOT COMPLETED|Overall Study||4
41322|NCT02581137|96087|P1|COMPLETED|Overall Study||22
41323|NCT02581137|96087|P1|STARTED|Overall Study||26
41324|NCT02581111|96094|P2|NOT COMPLETED|Overall Study||7
41325|NCT02581111|96095|P1|NOT COMPLETED|Overall Study||2
41326|NCT02581111|96094|P2|COMPLETED|Overall Study||94
41327|NCT02581111|96095|P1|COMPLETED|Overall Study||96
41328|NCT02581111|96094|P2|STARTED|Overall Study||101
41329|NCT02581111|96095|P1|STARTED|Overall Study||98
41330|NCT02580799|96105|P1|NOT COMPLETED|Overall Study||0
41331|NCT02580799|96105|P1|COMPLETED|Overall Study||30
41332|NCT02580799|96105|P1|STARTED|Overall Study||30
41333|NCT02580591|96131|P4|NOT COMPLETED|Overall Study||12
41334|NCT02580591|96132|P3|NOT COMPLETED|Overall Study||13
41335|NCT02580591|96133|P2|NOT COMPLETED|Overall Study||10
41336|NCT02580591|96134|P1|NOT COMPLETED|Overall Study||18
41337|NCT02580591|96131|P4|COMPLETED|Overall Study||233
41338|NCT02580591|96132|P3|COMPLETED|Overall Study||235
41339|NCT02580591|96133|P2|COMPLETED|Overall Study||232
41340|NCT02580591|96134|P1|COMPLETED|Overall Study||224
41341|NCT02580591|96131|P4|Treated|Overall Study||245
41342|NCT02580591|96132|P3|Treated|Overall Study||248
41343|NCT02580591|96133|P2|Treated|Overall Study||241
41344|NCT02580591|96134|P1|Treated|Overall Study||241
41345|NCT02580591|96131|P4|STARTED|Overall Study||245
41346|NCT02580591|96132|P3|STARTED|Overall Study||248
41347|NCT02580591|96133|P2|STARTED|Overall Study||242
41348|NCT02580591|96134|P1|STARTED|Overall Study||242
41349|NCT02580357|96167|P3|NOT COMPLETED|Overall Study||0
41350|NCT02580357|96168|P2|NOT COMPLETED|Overall Study||0
41351|NCT02580357|96169|P1|NOT COMPLETED|Overall Study||3
41352|NCT02580357|96167|P3|COMPLETED|Overall Study||18
41353|NCT02580357|96168|P2|COMPLETED|Overall Study||18
41354|NCT02580357|96169|P1|COMPLETED|Overall Study||15
41355|NCT02580357|96167|P3|STARTED|Overall Study||18
41356|NCT02580357|96168|P2|STARTED|Overall Study||18
41357|NCT02580357|96169|P1|STARTED|Overall Study||18
41358|NCT02580318|96180|P1|NOT COMPLETED|Overall Study||0
41359|NCT02580318|96180|P1|COMPLETED|Overall Study||54
41360|NCT02580318|96180|P1|Drinking Water (5 Minutes)|Overall Study||54
41361|NCT02580318|96180|P1|Drinking Water (Immediate)|Overall Study||51
41362|NCT02580318|96180|P1|Hyperventilation (10 Minutes)|Overall Study||54
41363|NCT02580318|96180|P1|Hyperventilation (5 Minutes)|Overall Study||54
41364|NCT02580318|96180|P1|Hyperventilation (Immediate)|Overall Study||54
41365|NCT02580318|96180|P1|Poor Effort|Overall Study||53
41366|NCT02580318|96180|P1|STARTED|Overall Study||54
41367|NCT02580240|96186|P2|NOT COMPLETED|Overall Study||0
41368|NCT02580240|96187|P1|NOT COMPLETED|Overall Study||2
41369|NCT02580240|96186|P2|COMPLETED|Overall Study||58
41370|NCT02580240|96187|P1|COMPLETED|Overall Study||60
41371|NCT02580240|96186|P2|STARTED|Overall Study||58
41372|NCT02580240|96187|P1|STARTED|Overall Study||62
41373|NCT02580188|96197|P2|NOT COMPLETED|Overall Study||3
41374|NCT02580188|96198|P1|NOT COMPLETED|Overall Study||3
41375|NCT02580188|96197|P2|COMPLETED|Overall Study||32
41376|NCT02580188|96198|P1|COMPLETED|Overall Study||32
41377|NCT02580188|96197|P2|STARTED|Overall Study||35
41378|NCT02580188|96198|P1|STARTED|Overall Study||35
41379|NCT02580058|96211|P3|NOT COMPLETED|Overall Study||86
41380|NCT02580058|96212|P2|NOT COMPLETED|Overall Study||86
41381|NCT02580058|96213|P1|NOT COMPLETED|Overall Study||79
41382|NCT02580058|96211|P3|COMPLETED|Overall Study||104
41383|NCT02580058|96212|P2|COMPLETED|Overall Study||102
41384|NCT02580058|96213|P1|COMPLETED|Overall Study||109
41385|NCT02580058|96211|P3|Treated|Overall Study||177
41386|NCT02580058|96212|P2|Treated|Overall Study||182
41387|NCT02580058|96213|P1|Treated|Overall Study||187
41388|NCT02580058|96211|P3|STARTED|Overall Study||190
41389|NCT02580058|96212|P2|STARTED|Overall Study||188
41390|NCT02580058|96213|P1|STARTED|Overall Study||188
41391|NCT02579876|96280|P2|NOT COMPLETED|Overall Study||0
41392|NCT02579876|96281|P1|NOT COMPLETED|Overall Study||1
41393|NCT02579876|96280|P2|COMPLETED|Overall Study||5
41394|NCT02579876|96281|P1|COMPLETED|Overall Study||14
41395|NCT02579876|96280|P2|STARTED|Overall Study||5
41396|NCT02579876|96281|P1|STARTED|Overall Study||15
41397|NCT02579863|96303|P2|NOT COMPLETED|Overall Study||154
41398|NCT02579863|96304|P1|NOT COMPLETED|Overall Study||156
41399|NCT02579863|96303|P2|COMPLETED|Overall Study||0
41400|NCT02579863|96304|P1|COMPLETED|Overall Study||0
41401|NCT02579863|96303|P2|Treated|Overall Study||148
41402|NCT02579863|96304|P1|Treated|Overall Study||154
41403|NCT02579863|96303|P2|STARTED|Overall Study||154
41404|NCT02579863|96304|P1|STARTED|Overall Study||156
41405|NCT02579772|96324|P2|NOT COMPLETED|Overall Study||2
41406|NCT02579772|96325|P1|NOT COMPLETED|Overall Study||2
41407|NCT02579772|96324|P2|COMPLETED|Overall Study||3
41408|NCT02579772|96325|P1|COMPLETED|Overall Study||6
41409|NCT02579772|96324|P2|STARTED|Overall Study||5
41410|NCT02579772|96325|P1|STARTED|Overall Study||8
41411|NCT02579603|96345|P2|NOT COMPLETED|Overall Study||2
41412|NCT02579603|96346|P1|NOT COMPLETED|Overall Study||4
41413|NCT02579603|96345|P2|COMPLETED|Overall Study||51
41414|NCT02579603|96346|P1|COMPLETED|Overall Study||48
41415|NCT02579603|96345|P2|Number of Patients Treated|Overall Study||53
41416|NCT02579603|96346|P1|Number of Patients Treated|Overall Study||51
41417|NCT02579603|96345|P2|STARTED|Overall Study|Started are the randomised patients|53
41418|NCT02579603|96346|P1|STARTED|Overall Study|Started are the randomised patients|52
41419|NCT02579421|96359|P4|NOT COMPLETED|Overall Study||3
41420|NCT02579421|96360|P3|NOT COMPLETED|Overall Study||1
41421|NCT02579421|96361|P2|NOT COMPLETED|Overall Study||5
41422|NCT02579421|96362|P1|NOT COMPLETED|Overall Study||6
41423|NCT02579421|96359|P4|COMPLETED|Overall Study||3
41424|NCT02579421|96360|P3|COMPLETED|Overall Study||5
41425|NCT02579421|96361|P2|COMPLETED|Overall Study||18
41426|NCT02579421|96362|P1|COMPLETED|Overall Study||17
41427|NCT02579421|96359|P4|STARTED|Overall Study||6
41428|NCT02579421|96360|P3|STARTED|Overall Study||6
41429|NCT02579421|96361|P2|STARTED|Overall Study||23
41430|NCT02579421|96362|P1|STARTED|Overall Study||23
41431|NCT02579135|96374|P2|NOT COMPLETED|Overall Study||9
41432|NCT02579135|96375|P1|NOT COMPLETED|Overall Study||2
41433|NCT02579135|96374|P2|COMPLETED|Overall Study||106
41434|NCT02579135|96375|P1|COMPLETED|Overall Study||105
41435|NCT02579135|96374|P2|STARTED|Overall Study||115
41436|NCT02579135|96375|P1|STARTED|Overall Study||107
41437|NCT02579057|96386|P2|NOT COMPLETED|Overall Study||0
41438|NCT02579057|96387|P1|NOT COMPLETED|Overall Study||0
41439|NCT02579057|96386|P2|COMPLETED|Overall Study||21
41440|NCT02579057|96387|P1|COMPLETED|Overall Study||19
41441|NCT02579057|96386|P2|STARTED|Overall Study||21
41442|NCT02579057|96387|P1|STARTED|Overall Study||19
41443|NCT02578992|96401|P2|NOT COMPLETED|Overall Study||3
41444|NCT02578992|96402|P1|NOT COMPLETED|Overall Study||3
41445|NCT02578992|96401|P2|COMPLETED|Overall Study|October 2015|62
41446|NCT02578992|96402|P1|COMPLETED|Overall Study|October 2015|62
41447|NCT02578992|96401|P2|STARTED|Overall Study|November 2014|65
41448|NCT02578992|96402|P1|STARTED|Overall Study|November 2014|65
41449|NCT02578940|96414|P1|NOT COMPLETED|Overall Study||6
41450|NCT02578940|96414|P1|COMPLETED|Overall Study||103
41451|NCT02578940|96414|P1|Received 18F-fluciclovine|Overall Study||104
41452|NCT02578940|96414|P1|STARTED|Overall Study||109
41453|NCT02578862|96423|P2|NOT COMPLETED|Overall Study||2
41454|NCT02578862|96424|P1|NOT COMPLETED|Overall Study||0
41455|NCT02578862|96423|P2|COMPLETED|Overall Study||33
41456|NCT02578862|96424|P1|COMPLETED|Overall Study||37
41457|NCT02578862|96423|P2|STARTED|Overall Study||35
41458|NCT02578862|96424|P1|STARTED|Overall Study||37
41459|NCT02578745|96442|P2|NOT COMPLETED|Overall Study||0
41460|NCT02578745|96443|P1|NOT COMPLETED|Overall Study||0
41461|NCT02578745|96442|P2|COMPLETED|Overall Study||60
41462|NCT02578745|96443|P1|COMPLETED|Overall Study||60
41463|NCT02578745|96442|P2|STARTED|Overall Study||60
41464|NCT02578745|96443|P1|STARTED|Overall Study||60
41465|NCT02578706|96462|P3|NOT COMPLETED|Overall Study||0
41466|NCT02578706|96463|P2|NOT COMPLETED|Overall Study||5
41467|NCT02578706|96464|P1|NOT COMPLETED|Overall Study||1
41468|NCT02578706|96462|P3|COMPLETED|Overall Study||8
41469|NCT02578706|96463|P2|COMPLETED|Overall Study||5
41470|NCT02578706|96464|P1|COMPLETED|Overall Study||8
41471|NCT02578706|96462|P3|STARTED|Overall Study||8
41472|NCT02578706|96463|P2|STARTED|Overall Study||10
41473|NCT02578706|96464|P1|STARTED|Overall Study||9
41474|NCT02578680|96543|P2|NOT COMPLETED|Overall Study||206
41475|NCT02578680|96544|P1|NOT COMPLETED|Overall Study||410
41476|NCT02578680|96543|P2|COMPLETED|Overall Study||0
41477|NCT02578680|96544|P1|COMPLETED|Overall Study||0
41478|NCT02578680|96543|P2|Switched to Pembrolizumab|Overall Study||67
41479|NCT02578680|96544|P1|Switched to Pembrolizumab|Overall Study||0
41480|NCT02578680|96543|P2|Treated|Overall Study||202
41481|NCT02578680|96544|P1|Treated|Overall Study||405
41482|NCT02578680|96543|P2|STARTED|Overall Study||206
41483|NCT02578680|96544|P1|STARTED|Overall Study||410
41484|NCT02578316|96560|P1|NOT COMPLETED|Extension Phase||6
41485|NCT02578316|96560|P1|COMPLETED|Extension Phase||0
41486|NCT02578316|96560|P1|STARTED|Extension Phase||6
41487|NCT02578316|96560|P1|NOT COMPLETED|Study Phase||0
41488|NCT02578316|96560|P1|COMPLETED|Study Phase||6
41489|NCT02578316|96560|P1|STARTED|Study Phase||6
41490|NCT02578238|96584|P1|NOT COMPLETED|Overall Study||0
41491|NCT02578238|96584|P1|COMPLETED|Overall Study||143
41492|NCT02578238|96584|P1|STARTED|Overall Study||143
41493|NCT02578199|96588|P1|NOT COMPLETED|Overall Study||4
41494|NCT02578199|96588|P1|COMPLETED|Overall Study||27
41495|NCT02578199|96588|P1|STARTED|Overall Study||31
41496|NCT02578186|96593|P2|NOT COMPLETED|Period 2 (Second of Crossover)||0
41497|NCT02578186|96594|P1|NOT COMPLETED|Period 2 (Second of Crossover)||0
41498|NCT02578186|96593|P2|COMPLETED|Period 2 (Second of Crossover)||13
41499|NCT02578186|96594|P1|COMPLETED|Period 2 (Second of Crossover)||12
41500|NCT02578186|96593|P2|STARTED|Period 2 (Second of Crossover)||13
41501|NCT02578186|96594|P1|STARTED|Period 2 (Second of Crossover)||12
41502|NCT02578186|96593|P2|NOT COMPLETED|Period 1 (First of Crossover)||5
41503|NCT02578186|96594|P1|NOT COMPLETED|Period 1 (First of Crossover)||5
41504|NCT02578186|96593|P2|COMPLETED|Period 1 (First of Crossover)||13
41505|NCT02578186|96594|P1|COMPLETED|Period 1 (First of Crossover)||12
41506|NCT02578186|96593|P2|STARTED|Period 1 (First of Crossover)||18
41507|NCT02578186|96594|P1|STARTED|Period 1 (First of Crossover)||17
41508|NCT02577991|96603|P3|NOT COMPLETED|Overall Study||0
41509|NCT02577991|96604|P2|NOT COMPLETED|Overall Study||2
41510|NCT02577991|96605|P1|NOT COMPLETED|Overall Study||3
41511|NCT02577991|96603|P3|COMPLETED|Overall Study||29
41512|NCT02577991|96604|P2|COMPLETED|Overall Study||25
41513|NCT02577991|96605|P1|COMPLETED|Overall Study||21
41514|NCT02577991|96603|P3|STARTED|Overall Study||29
41515|NCT02577991|96604|P2|STARTED|Overall Study||27
41516|NCT02577991|96605|P1|STARTED|Overall Study||24
41517|NCT02577978|96627|P2|NOT COMPLETED|Overall Study||4
41518|NCT02577978|96628|P1|NOT COMPLETED|Overall Study||7
41519|NCT02577978|96627|P2|COMPLETED|Overall Study||25
41520|NCT02577978|96628|P1|COMPLETED|Overall Study||25
41521|NCT02577978|96627|P2|STARTED|Overall Study||29
41522|NCT02577978|96628|P1|STARTED|Overall Study||32
41523|NCT02577900|96661|P3|NOT COMPLETED|Overall Study||0
41524|NCT02577900|96662|P2|NOT COMPLETED|Overall Study||0
41525|NCT02577900|96663|P1|NOT COMPLETED|Overall Study||0
41526|NCT02577900|96661|P3|COMPLETED|Overall Study||10
41527|NCT02577900|96662|P2|COMPLETED|Overall Study||10
41528|NCT02577900|96663|P1|COMPLETED|Overall Study||11
41529|NCT02577900|96661|P3|STARTED|Overall Study||10
41530|NCT02577900|96662|P2|STARTED|Overall Study||10
41531|NCT02577900|96663|P1|STARTED|Overall Study||11
41532|NCT02577887|96683|P1|NOT COMPLETED|Overall Study||298
41533|NCT02577887|96683|P1|COMPLETED|Overall Study||1803
41534|NCT02577887|96683|P1|6 Month Follow-up|Overall Study||1938
41535|NCT02577887|96683|P1|STARTED|Overall Study||2101
41536|NCT02577822|96692|P2|NOT COMPLETED|Overall Study||13
41537|NCT02577822|96693|P1|NOT COMPLETED|Overall Study||6
41538|NCT02577822|96692|P2|COMPLETED|Overall Study||20
41539|NCT02577822|96693|P1|COMPLETED|Overall Study||21
41540|NCT02577822|96692|P2|STARTED|Overall Study||33
41541|NCT02577822|96693|P1|STARTED|Overall Study||27
41542|NCT02577718|96709|P1|NOT COMPLETED|Overall Study||8
41543|NCT02577718|96709|P1|COMPLETED|Overall Study||52
41544|NCT02577718|96709|P1|STARTED|Overall Study||60
41545|NCT02577601|96715|P1|NOT COMPLETED|UPA+COC (1 Month)||0
41546|NCT02577601|96715|P1|COMPLETED|UPA+COC (1 Month)||33
41547|NCT02577601|96715|P1|STARTED|UPA+COC (1 Month)||33
41548|NCT02577601|96715|P1|NOT COMPLETED|Washout (1 Month)||0
41549|NCT02577601|96715|P1|COMPLETED|Washout (1 Month)||33
41550|NCT02577601|96715|P1|STARTED|Washout (1 Month)||33
41551|NCT02577601|96715|P1|NOT COMPLETED|UPA Only (1 Month)||0
41552|NCT02577601|96715|P1|COMPLETED|UPA Only (1 Month)||36
41553|NCT02577601|96715|P1|STARTED|UPA Only (1 Month)||36
41554|NCT02577510|96722|P2|NOT COMPLETED|Overall Study||0
41555|NCT02577510|96723|P1|NOT COMPLETED|Overall Study||0
41556|NCT02577510|96722|P2|COMPLETED|Overall Study||21
41557|NCT02577510|96723|P1|COMPLETED|Overall Study||21
41558|NCT02577510|96722|P2|STARTED|Overall Study||21
41559|NCT02577510|96723|P1|STARTED|Overall Study||21
41560|NCT02577445|96737|P2|NOT COMPLETED|Overall Study||17
41561|NCT02577445|96738|P1|NOT COMPLETED|Overall Study||14
41562|NCT02577445|96737|P2|COMPLETED|Overall Study|study terminated prematurely|0
41563|NCT02577445|96738|P1|COMPLETED|Overall Study|study terminated prematurely|0
41564|NCT02577445|96737|P2|STARTED|Overall Study||17
41565|NCT02577445|96738|P1|STARTED|Overall Study||14
41566|NCT02577315|96751|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
41567|NCT02577315|96752|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
41568|NCT02577315|96751|P2|COMPLETED|Treatment Period 2 (4 Days)||12
41569|NCT02577315|96752|P1|COMPLETED|Treatment Period 2 (4 Days)||12
41570|NCT02577315|96751|P2|STARTED|Treatment Period 2 (4 Days)||12
41571|NCT02577315|96752|P1|STARTED|Treatment Period 2 (4 Days)||12
41572|NCT02577315|96751|P2|NOT COMPLETED|Washout Period (5 Days)||0
41573|NCT02577315|96752|P1|NOT COMPLETED|Washout Period (5 Days)||0
41574|NCT02577315|96751|P2|COMPLETED|Washout Period (5 Days)||12
41575|NCT02577315|96752|P1|COMPLETED|Washout Period (5 Days)||12
41576|NCT02577315|96751|P2|STARTED|Washout Period (5 Days)||12
41577|NCT02577315|96752|P1|STARTED|Washout Period (5 Days)||12
41578|NCT02577315|96751|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||1
41579|NCT02577315|96752|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
41580|NCT02577315|96751|P2|COMPLETED|Treatment Period 1 (4 Days)||12
41581|NCT02577315|96752|P1|COMPLETED|Treatment Period 1 (4 Days)||12
41582|NCT02577315|96751|P2|STARTED|Treatment Period 1 (4 Days)||13
41583|NCT02577315|96752|P1|STARTED|Treatment Period 1 (4 Days)||12
41584|NCT02577146|96768|P1|NOT COMPLETED|Overall Study||28
41585|NCT02577146|96768|P1|COMPLETED|Overall Study||46
41586|NCT02577146|96768|P1|STARTED|Overall Study||74
41587|NCT02577107|96775|P2|NOT COMPLETED|Overall Study||1
41588|NCT02577107|96776|P1|NOT COMPLETED|Overall Study||0
41589|NCT02577107|96775|P2|COMPLETED|Overall Study||5
41590|NCT02577107|96776|P1|COMPLETED|Overall Study||6
41591|NCT02577107|96775|P2|STARTED|Overall Study||6
41592|NCT02577107|96776|P1|STARTED|Overall Study||6
41593|NCT02577029|96796|P8|NOT COMPLETED|Overall Study||12
41594|NCT02577029|96797|P7|NOT COMPLETED|Overall Study||12
41595|NCT02577029|96798|P6|NOT COMPLETED|Overall Study||13
41596|NCT02577029|96799|P5|NOT COMPLETED|Overall Study||11
41597|NCT02577029|96800|P4|NOT COMPLETED|Overall Study||12
41598|NCT02577029|96801|P3|NOT COMPLETED|Overall Study||7
41599|NCT02577029|96802|P2|NOT COMPLETED|Overall Study||2
41600|NCT02577029|96803|P1|NOT COMPLETED|Overall Study||10
41601|NCT02577029|96796|P8|COMPLETED|Overall Study||0
41602|NCT02577029|96797|P7|COMPLETED|Overall Study||0
41603|NCT02577029|96798|P6|COMPLETED|Overall Study||0
41604|NCT02577029|96799|P5|COMPLETED|Overall Study||0
41605|NCT02577029|96800|P4|COMPLETED|Overall Study||0
41606|NCT02577029|96801|P3|COMPLETED|Overall Study||0
41607|NCT02577029|96802|P2|COMPLETED|Overall Study||0
41608|NCT02577029|96803|P1|COMPLETED|Overall Study||0
41609|NCT02577029|96796|P8|STARTED|Overall Study||12
41610|NCT02577029|96797|P7|STARTED|Overall Study||12
41611|NCT02577029|96798|P6|STARTED|Overall Study||13
41612|NCT02577029|96799|P5|STARTED|Overall Study||11
41613|NCT02577029|96800|P4|STARTED|Overall Study||12
41614|NCT02577029|96801|P3|STARTED|Overall Study||7
41615|NCT02577029|96802|P2|STARTED|Overall Study||2
41616|NCT02577029|96803|P1|STARTED|Overall Study||10
41617|NCT02577016|96911|P2|NOT COMPLETED|Overall Study||2
41618|NCT02577016|96912|P1|NOT COMPLETED|Overall Study||2
41619|NCT02577016|96911|P2|COMPLETED|Overall Study||69
41620|NCT02577016|96912|P1|COMPLETED|Overall Study||68
41621|NCT02577016|96911|P2|STARTED|Overall Study||71
41622|NCT02577016|96912|P1|STARTED|Overall Study||70
41623|NCT02577003|96930|P2|NOT COMPLETED|Overall Study||5
41624|NCT02577003|96931|P1|NOT COMPLETED|Overall Study||2
41625|NCT02577003|96930|P2|COMPLETED|Overall Study||65
41626|NCT02577003|96931|P1|COMPLETED|Overall Study||71
41627|NCT02577003|96930|P2|STARTED|Overall Study||70
41628|NCT02577003|96931|P1|STARTED|Overall Study||73
41629|NCT02576977|96951|P2|NOT COMPLETED|Overall Study||125
41630|NCT02576977|96952|P1|NOT COMPLETED|Overall Study||126
41631|NCT02576977|96951|P2|COMPLETED|Overall Study||0
41632|NCT02576977|96952|P1|COMPLETED|Overall Study||0
41633|NCT02576977|96951|P2|Treated|Overall Study||123
41634|NCT02576977|96952|P1|Treated|Overall Study||122
41635|NCT02576977|96951|P2|STARTED|Overall Study||125
41636|NCT02576977|96952|P1|STARTED|Overall Study||126
41637|NCT02576951|96974|P4|NOT COMPLETED|Overall Study||5
41638|NCT02576951|96975|P3|NOT COMPLETED|Overall Study||2
41639|NCT02576951|96976|P2|NOT COMPLETED|Overall Study||0
41640|NCT02576951|96977|P1|NOT COMPLETED|Overall Study||1
41641|NCT02576951|96974|P4|COMPLETED|Overall Study||75
41642|NCT02576951|96975|P3|COMPLETED|Overall Study||78
41643|NCT02576951|96976|P2|COMPLETED|Overall Study||3
41644|NCT02576951|96977|P1|COMPLETED|Overall Study||14
41645|NCT02576951|96974|P4|Received at Least One Dose of Study Drug|Overall Study||80
41646|NCT02576951|96975|P3|Received at Least One Dose of Study Drug|Overall Study||80
41647|NCT02576951|96976|P2|Received at Least One Dose of Study Drug|Overall Study||3
41648|NCT02576951|96977|P1|Received at Least One Dose of Study Drug|Overall Study||15
41649|NCT02576951|96974|P4|STARTED|Overall Study||80
41650|NCT02576951|96975|P3|STARTED|Overall Study||80
41651|NCT02576951|96976|P2|STARTED|Overall Study||3
41652|NCT02576951|96977|P1|STARTED|Overall Study||15
41653|NCT02576938|97001|P3|NOT COMPLETED|Overall Study||12
41654|NCT02576938|97002|P2|NOT COMPLETED|Overall Study||12
41655|NCT02576938|97003|P1|NOT COMPLETED|Overall Study||20
41656|NCT02576938|97001|P3|COMPLETED|Overall Study||26
41657|NCT02576938|97002|P2|COMPLETED|Overall Study||25
41658|NCT02576938|97003|P1|COMPLETED|Overall Study||29
41659|NCT02576938|97001|P3|Received at Least One Dose of Study Drug|Overall Study||38
41660|NCT02576938|97002|P2|Received at Least One Dose of Study Drug|Overall Study||37
41661|NCT02576938|97003|P1|Received at Least One Dose of Study Drug|Overall Study||49
41662|NCT02576938|97001|P3|STARTED|Overall Study||38
41663|NCT02576938|97002|P2|STARTED|Overall Study||37
41664|NCT02576938|97003|P1|STARTED|Overall Study||49
41665|NCT02576678|97034|P3|NOT COMPLETED|Overall Study||15
41666|NCT02576678|97035|P2|NOT COMPLETED|Overall Study||1
41667|NCT02576678|97036|P1|NOT COMPLETED|Overall Study||5
41668|NCT02576678|97034|P3|COMPLETED|Overall Study||6
41669|NCT02576678|97035|P2|COMPLETED|Overall Study||7
41670|NCT02576678|97036|P1|COMPLETED|Overall Study||8
41671|NCT02576678|97034|P3|Pharmacokinetic (PK) Population|Overall Study||18
41672|NCT02576678|97035|P2|Pharmacokinetic (PK) Population|Overall Study||8
41673|NCT02576678|97036|P1|Pharmacokinetic (PK) Population|Overall Study||12
41674|NCT02576678|97034|P3|STARTED|Overall Study||21
41675|NCT02576678|97035|P2|STARTED|Overall Study||8
41676|NCT02576678|97036|P1|STARTED|Overall Study||13
41677|NCT02576652|97068|P1|NOT COMPLETED|Overall Study||2
41678|NCT02576652|97068|P1|COMPLETED|Overall Study||4
41679|NCT02576652|97068|P1|STARTED|Overall Study||6
41680|NCT02576639|97080|P5|NOT COMPLETED|Overall Study||4
41681|NCT02576639|97081|P4|NOT COMPLETED|Overall Study||1
41682|NCT02576639|97082|P3|NOT COMPLETED|Overall Study||2
41683|NCT02576639|97083|P2|NOT COMPLETED|Overall Study||2
41684|NCT02576639|97084|P1|NOT COMPLETED|Overall Study||2
41685|NCT02576639|97080|P5|COMPLETED|Overall Study||20
41686|NCT02576639|97081|P4|COMPLETED|Overall Study||25
41687|NCT02576639|97082|P3|COMPLETED|Overall Study||23
41688|NCT02576639|97083|P2|COMPLETED|Overall Study||23
41689|NCT02576639|97084|P1|COMPLETED|Overall Study||22
41690|NCT02576639|97080|P5|Safety Analysis Set|Overall Study||24
41691|NCT02576639|97081|P4|Safety Analysis Set|Overall Study||26
41692|NCT02576639|97082|P3|Safety Analysis Set|Overall Study||25
41693|NCT02576639|97083|P2|Safety Analysis Set|Overall Study||25
41694|NCT02576639|97084|P1|Safety Analysis Set|Overall Study||24
41695|NCT02576639|97080|P5|Pharmacokinetic Analysis Set|Overall Study||24
41696|NCT02576639|97081|P4|Pharmacokinetic Analysis Set|Overall Study||26
41697|NCT02576639|97082|P3|Pharmacokinetic Analysis Set|Overall Study||25
41698|NCT02576639|97083|P2|Pharmacokinetic Analysis Set|Overall Study||25
41699|NCT02576639|97084|P1|Pharmacokinetic Analysis Set|Overall Study||0
41700|NCT02576639|97080|P5|Pharmacodynamic Analysis Set|Overall Study||25
41701|NCT02576639|97081|P4|Pharmacodynamic Analysis Set|Overall Study||25
41702|NCT02576639|97082|P3|Pharmacodynamic Analysis Set|Overall Study||25
41703|NCT02576639|97083|P2|Pharmacodynamic Analysis Set|Overall Study||24
41704|NCT02576639|97084|P1|Pharmacodynamic Analysis Set|Overall Study||24
41705|NCT02576639|97080|P5|STARTED|Overall Study||24
41706|NCT02576639|97081|P4|STARTED|Overall Study||26
41707|NCT02576639|97082|P3|STARTED|Overall Study||25
41708|NCT02576639|97083|P2|STARTED|Overall Study||25
41709|NCT02576639|97084|P1|STARTED|Overall Study||24
41710|NCT02576587|97143|P2|NOT COMPLETED|Follow up Period (Case Only)||155
41711|NCT02576587|97144|P1|NOT COMPLETED|Follow up Period (Case Only)||117
41712|NCT02576587|97143|P2|COMPLETED|Follow up Period (Case Only)||0
41713|NCT02576587|97144|P1|COMPLETED|Follow up Period (Case Only)||44
41714|NCT02576587|97143|P2|Selected for Follow up|Follow up Period (Case Only)||0
41715|NCT02576587|97144|P1|Selected for Follow up|Follow up Period (Case Only)||61
41716|NCT02576587|97143|P2|STARTED|Follow up Period (Case Only)|Controls not eligible for follow-up|155
41717|NCT02576587|97144|P1|STARTED|Follow up Period (Case Only)|Completed baseline.|161
41718|NCT02576587|97143|P2|NOT COMPLETED|Baseline||1
41719|NCT02576587|97144|P1|NOT COMPLETED|Baseline||0
41720|NCT02576587|97143|P2|COMPLETED|Baseline|Baseline visit completed|155
41721|NCT02576587|97144|P1|COMPLETED|Baseline|Baseline visit completed|161
41722|NCT02576587|97143|P2|STARTED|Baseline|Total controls baseline visit|156
41723|NCT02576587|97144|P1|STARTED|Baseline|Total cases baseline visit|161
41724|NCT02576535|97162|P1|NOT COMPLETED|Overall Study||2
41725|NCT02576535|97162|P1|COMPLETED|Overall Study||16
41726|NCT02576535|97162|P1|STARTED|Overall Study||18
41727|NCT02576249|97173|P2|NOT COMPLETED|Overall Study||0
41728|NCT02576249|97174|P1|NOT COMPLETED|Overall Study||0
41729|NCT02576249|97173|P2|COMPLETED|Overall Study||14
41730|NCT02576249|97174|P1|COMPLETED|Overall Study||15
41731|NCT02576249|97173|P2|STARTED|Overall Study||14
41732|NCT02576249|97174|P1|STARTED|Overall Study||15
41733|NCT02576145|97186|P2|NOT COMPLETED|Overall Study||1
41734|NCT02576145|97187|P1|NOT COMPLETED|Overall Study||3
41735|NCT02576145|97186|P2|COMPLETED|Overall Study||4
41736|NCT02576145|97187|P1|COMPLETED|Overall Study||3
41737|NCT02576145|97186|P2|STARTED|Overall Study||5
41738|NCT02576145|97187|P1|STARTED|Overall Study||6
41739|NCT02576054|97223|P1|NOT COMPLETED|Overall Study||1
41740|NCT02576054|97223|P1|COMPLETED|Overall Study||100
41741|NCT02576054|97223|P1|Vaccination 3|Overall Study||100
41742|NCT02576054|97223|P1|Vaccination 2|Overall Study||100
41743|NCT02576054|97223|P1|Vaccination 1|Overall Study||100
41744|NCT02576054|97223|P1|STARTED|Overall Study||101
41745|NCT02576041|97238|P1|NOT COMPLETED|Bilastine (Active Treatement)||0
41746|NCT02576041|97238|P1|COMPLETED|Bilastine (Active Treatement)||18
41747|NCT02576041|97238|P1|STARTED|Bilastine (Active Treatement)||18
41748|NCT02576041|97238|P1|NOT COMPLETED|Placebo (run-in)||0
41749|NCT02576041|97238|P1|COMPLETED|Placebo (run-in)||18
41750|NCT02576041|97238|P1|STARTED|Placebo (run-in)||18
41751|NCT02575950|97244|P4|NOT COMPLETED|Overall Study||5
41752|NCT02575950|97245|P3|NOT COMPLETED|Overall Study||0
41753|NCT02575950|97246|P2|NOT COMPLETED|Overall Study||1
41754|NCT02575950|97247|P1|NOT COMPLETED|Overall Study||0
41755|NCT02575950|97244|P4|COMPLETED|Overall Study||20
41756|NCT02575950|97245|P3|COMPLETED|Overall Study||6
41757|NCT02575950|97246|P2|COMPLETED|Overall Study||5
41758|NCT02575950|97247|P1|COMPLETED|Overall Study||3
41759|NCT02575950|97244|P4|STARTED|Overall Study||25
41760|NCT02575950|97245|P3|STARTED|Overall Study||6
41761|NCT02575950|97246|P2|STARTED|Overall Study||6
41762|NCT02575950|97247|P1|STARTED|Overall Study||3
41763|NCT02575911|97276|P1|NOT COMPLETED|Overall Study||1
41764|NCT02575911|97276|P1|COMPLETED|Overall Study||29
41765|NCT02575911|97276|P1|STARTED|Overall Study||30
41766|NCT02575833|97296|P2|NOT COMPLETED|Overall Study||1
41767|NCT02575833|97297|P1|NOT COMPLETED|Overall Study||1
41768|NCT02575833|97296|P2|COMPLETED|Overall Study||44
41769|NCT02575833|97297|P1|COMPLETED|Overall Study||43
41770|NCT02575833|97296|P2|Received Study Drug|Overall Study||44
41771|NCT02575833|97297|P1|Received Study Drug|Overall Study||44
41772|NCT02575833|97296|P2|STARTED|Overall Study||45
41773|NCT02575833|97297|P1|STARTED|Overall Study||44
41774|NCT02575807|97312|P5|NOT COMPLETED|Overall Study||4
41775|NCT02575807|97313|P4|NOT COMPLETED|Overall Study||2
41776|NCT02575807|97314|P3|NOT COMPLETED|Overall Study||16
41777|NCT02575807|97315|P2|NOT COMPLETED|Overall Study||4
41778|NCT02575807|97316|P1|NOT COMPLETED|Overall Study||9
41779|NCT02575807|97312|P5|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
41780|NCT02575807|97313|P4|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
41781|NCT02575807|97314|P3|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
41782|NCT02575807|97315|P2|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
41783|NCT02575807|97316|P1|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
41784|NCT02575807|97312|P5|Treated|Overall Study||3
41785|NCT02575807|97313|P4|Treated|Overall Study||1
41786|NCT02575807|97314|P3|Treated|Overall Study||16
41787|NCT02575807|97315|P2|Treated|Overall Study||4
41788|NCT02575807|97316|P1|Treated|Overall Study||8
41789|NCT02575807|97312|P5|STARTED|Overall Study||4
41790|NCT02575807|97313|P4|STARTED|Overall Study||2
41791|NCT02575807|97314|P3|STARTED|Overall Study||16
41792|NCT02575807|97315|P2|STARTED|Overall Study||4
41793|NCT02575807|97316|P1|STARTED|Overall Study||9
41794|NCT02575365|97356|P1|NOT COMPLETED|Overall Study||4
41795|NCT02575365|97356|P1|COMPLETED|Overall Study||0
41796|NCT02575365|97356|P1|STARTED|Overall Study||4
41797|NCT02575300|97366|P1|NOT COMPLETED|Overall Study||0
41798|NCT02575300|97366|P1|COMPLETED|Overall Study||20
41799|NCT02575300|97366|P1|STARTED|Overall Study||20
41800|NCT02575079|97376|P2|NOT COMPLETED|Overall Study||0
41801|NCT02575079|97377|P1|NOT COMPLETED|Overall Study||6
41802|NCT02575079|97376|P2|COMPLETED|Overall Study||71
41803|NCT02575079|97377|P1|COMPLETED|Overall Study||42
41804|NCT02575079|97376|P2|STARTED|Overall Study||71
41805|NCT02575079|97377|P1|STARTED|Overall Study||48
41806|NCT02574858|97391|P1|NOT COMPLETED|Overall Study||0
41807|NCT02574858|97391|P1|COMPLETED|Overall Study||25
41808|NCT02574858|97391|P1|STARTED|Overall Study||25
41809|NCT02574845|97402|P6|NOT COMPLETED|Overall Study||1
41810|NCT02574845|97403|P5|NOT COMPLETED|Overall Study||1
41811|NCT02574845|97404|P4|NOT COMPLETED|Overall Study||0
41812|NCT02574845|97405|P3|NOT COMPLETED|Overall Study||0
41813|NCT02574845|97406|P2|NOT COMPLETED|Overall Study||1
41814|NCT02574845|97407|P1|NOT COMPLETED|Overall Study||0
41815|NCT02574845|97402|P6|COMPLETED|Overall Study||2
41816|NCT02574845|97403|P5|COMPLETED|Overall Study||2
41817|NCT02574845|97404|P4|COMPLETED|Overall Study||3
41818|NCT02574845|97405|P3|COMPLETED|Overall Study||3
41819|NCT02574845|97406|P2|COMPLETED|Overall Study||2
41820|NCT02574845|97407|P1|COMPLETED|Overall Study||3
41821|NCT02574845|97402|P6|Received R|Overall Study||3
41822|NCT02574845|97403|P5|Received R|Overall Study||2
41823|NCT02574845|97404|P4|Received R|Overall Study||3
41824|NCT02574845|97405|P3|Received R|Overall Study||3
41825|NCT02574845|97406|P2|Received R|Overall Study||2
41826|NCT02574845|97407|P1|Received R|Overall Study||3
41827|NCT02574845|97402|P6|Received T5|Overall Study||2
41828|NCT02574845|97403|P5|Received T5|Overall Study||3
41829|NCT02574845|97404|P4|Received T5|Overall Study||3
41830|NCT02574845|97405|P3|Received T5|Overall Study||3
41831|NCT02574845|97406|P2|Received T5|Overall Study||2
41832|NCT02574845|97407|P1|Received T5|Overall Study||3
41833|NCT02574845|97402|P6|Received T4|Overall Study||2
41834|NCT02574845|97403|P5|Received T4|Overall Study||2
41835|NCT02574845|97404|P4|Received T4|Overall Study||3
41836|NCT02574845|97405|P3|Received T4|Overall Study||3
41837|NCT02574845|97406|P2|Received T4|Overall Study||2
41838|NCT02574845|97407|P1|Received T4|Overall Study||3
41839|NCT02574845|97402|P6|Received T3|Overall Study||3
41840|NCT02574845|97403|P5|Received T3|Overall Study||2
41841|NCT02574845|97404|P4|Received T3|Overall Study||3
41842|NCT02574845|97405|P3|Received T3|Overall Study||3
41843|NCT02574845|97406|P2|Received T3|Overall Study||2
41844|NCT02574845|97407|P1|Received T3|Overall Study|one subject missed treatment period 2|2
41845|NCT02574845|97402|P6|Received T2|Overall Study||3
41846|NCT02574845|97403|P5|Received T2|Overall Study||2
41847|NCT02574845|97404|P4|Received T2|Overall Study||3
41848|NCT02574845|97405|P3|Received T2|Overall Study||3
41849|NCT02574845|97406|P2|Received T2|Overall Study||3
41850|NCT02574845|97407|P1|Received T2|Overall Study||3
41851|NCT02574845|97402|P6|Received T1|Overall Study|one subject missed treatment period 2|2
41852|NCT02574845|97403|P5|Received T1|Overall Study||2
41853|NCT02574845|97404|P4|Received T1|Overall Study||3
41854|NCT02574845|97405|P3|Received T1|Overall Study||3
41855|NCT02574845|97406|P2|Received T1|Overall Study||2
41856|NCT02574845|97407|P1|Received T1|Overall Study||3
41857|NCT02574845|97402|P6|STARTED|Overall Study||3
41858|NCT02574845|97403|P5|STARTED|Overall Study||3
41859|NCT02574845|97404|P4|STARTED|Overall Study||3
41860|NCT02574845|97405|P3|STARTED|Overall Study||3
41861|NCT02574845|97406|P2|STARTED|Overall Study||3
41862|NCT02574845|97407|P1|STARTED|Overall Study||3
41863|NCT02574832|97433|P1|NOT COMPLETED|Overall Study||0
41864|NCT02574832|97433|P1|COMPLETED|Overall Study||2
41865|NCT02574832|97433|P1|STARTED|Overall Study||2
41866|NCT02574481|97441|P4|NOT COMPLETED|Overall Study||0
41867|NCT02574481|97442|P3|NOT COMPLETED|Overall Study||3
41868|NCT02574481|97443|P2|NOT COMPLETED|Overall Study||14
41869|NCT02574481|97444|P1|NOT COMPLETED|Overall Study||27
41870|NCT02574481|97441|P4|COMPLETED|Overall Study||13
41871|NCT02574481|97442|P3|COMPLETED|Overall Study||47
41872|NCT02574481|97443|P2|COMPLETED|Overall Study||142
41873|NCT02574481|97444|P1|COMPLETED|Overall Study||282
41874|NCT02574481|97441|P4|STARTED|Overall Study||13
41875|NCT02574481|97442|P3|STARTED|Overall Study||50
41876|NCT02574481|97443|P2|STARTED|Overall Study||156
41877|NCT02574481|97444|P1|STARTED|Overall Study||309
41878|NCT02574260|97482|P1|NOT COMPLETED|Overall Study||1
41879|NCT02574260|97482|P1|COMPLETED|Overall Study||2
41880|NCT02574260|97482|P1|STARTED|Overall Study||3
41881|NCT02574247|97491|P3|NOT COMPLETED|Overall Study||5
41882|NCT02574247|97492|P2|NOT COMPLETED|Overall Study||3
41883|NCT02574247|97493|P1|NOT COMPLETED|Overall Study||5
41884|NCT02574247|97491|P3|COMPLETED|Overall Study||5
41885|NCT02574247|97492|P2|COMPLETED|Overall Study||5
41886|NCT02574247|97493|P1|COMPLETED|Overall Study||5
41887|NCT02574247|97491|P3|STARTED|Overall Study||10
41888|NCT02574247|97492|P2|STARTED|Overall Study||8
41889|NCT02574247|97493|P1|STARTED|Overall Study||10
41890|NCT02573948|97505|P1|NOT COMPLETED|Longitudinal Cohort||56
41891|NCT02573948|97505|P1|COMPLETED|Longitudinal Cohort||194
41892|NCT02573948|97505|P1|STARTED|Longitudinal Cohort|Not on ART a/o MMT. MSM and FSW were prioritized for enrolling,|250
41893|NCT02573948|97505|P1|NOT COMPLETED|RDS||0
41894|NCT02573948|97505|P1|COMPLETED|RDS||603
41895|NCT02573948|97505|P1|STARTED|RDS||603
41896|NCT02573870|97515|P2|NOT COMPLETED|Overall Study||7
41897|NCT02573870|97516|P1|NOT COMPLETED|Overall Study||0
41898|NCT02573870|97515|P2|COMPLETED|Overall Study||35
41899|NCT02573870|97516|P1|COMPLETED|Overall Study||20
41900|NCT02573870|97515|P2|STARTED|Overall Study||42
41901|NCT02573870|97516|P1|STARTED|Overall Study||20
41902|NCT02573467|97526|P4|NOT COMPLETED|Post-treatment Follow up Epoch||3
41903|NCT02573467|97527|P3|NOT COMPLETED|Post-treatment Follow up Epoch||10
41904|NCT02573467|97528|P2|NOT COMPLETED|Post-treatment Follow up Epoch||5
41905|NCT02573467|97529|P1|NOT COMPLETED|Post-treatment Follow up Epoch||6
41906|NCT02573467|97526|P4|COMPLETED|Post-treatment Follow up Epoch||44
41907|NCT02573467|97527|P3|COMPLETED|Post-treatment Follow up Epoch||34
41908|NCT02573467|97528|P2|COMPLETED|Post-treatment Follow up Epoch||41
41909|NCT02573467|97529|P1|COMPLETED|Post-treatment Follow up Epoch||35
41910|NCT02573467|97526|P4|STARTED|Post-treatment Follow up Epoch||47
41911|NCT02573467|97527|P3|STARTED|Post-treatment Follow up Epoch||44
41912|NCT02573467|97528|P2|STARTED|Post-treatment Follow up Epoch||46
41913|NCT02573467|97529|P1|STARTED|Post-treatment Follow up Epoch||41
41914|NCT02573467|97526|P4|NOT COMPLETED|Double-blind Treatment Epoch||55
41915|NCT02573467|97527|P3|NOT COMPLETED|Double-blind Treatment Epoch||51
41916|NCT02573467|97528|P2|NOT COMPLETED|Double-blind Treatment Epoch||52
41917|NCT02573467|97529|P1|NOT COMPLETED|Double-blind Treatment Epoch||53
41918|NCT02573467|97526|P4|COMPLETED|Double-blind Treatment Epoch||0
41919|NCT02573467|97527|P3|COMPLETED|Double-blind Treatment Epoch||0
41920|NCT02573467|97528|P2|COMPLETED|Double-blind Treatment Epoch||0
41921|NCT02573467|97529|P1|COMPLETED|Double-blind Treatment Epoch||0
41922|NCT02573467|97526|P4|Full Analysis Set|Double-blind Treatment Epoch||55
41923|NCT02573467|97527|P3|Full Analysis Set|Double-blind Treatment Epoch||51
41924|NCT02573467|97528|P2|Full Analysis Set|Double-blind Treatment Epoch||52
41925|NCT02573467|97529|P1|Full Analysis Set|Double-blind Treatment Epoch||53
41926|NCT02573467|97526|P4|STARTED|Double-blind Treatment Epoch||55
41927|NCT02573467|97527|P3|STARTED|Double-blind Treatment Epoch||51
41928|NCT02573467|97528|P2|STARTED|Double-blind Treatment Epoch||52
41929|NCT02573467|97529|P1|STARTED|Double-blind Treatment Epoch||53
41930|NCT02573402|97570|P2|NOT COMPLETED|Overall Study||0
41931|NCT02573402|97571|P1|NOT COMPLETED|Overall Study||0
41932|NCT02573402|97570|P2|COMPLETED|Overall Study||7
41933|NCT02573402|97571|P1|COMPLETED|Overall Study||12
41934|NCT02573402|97570|P2|STARTED|Overall Study||7
41935|NCT02573402|97571|P1|STARTED|Overall Study||12
41936|NCT02573233|97593|P2|NOT COMPLETED|Overall Study||0
41937|NCT02573233|97594|P1|NOT COMPLETED|Overall Study||0
41938|NCT02573233|97593|P2|COMPLETED|Overall Study||20
41939|NCT02573233|97594|P1|COMPLETED|Overall Study||22
41940|NCT02573233|97593|P2|STARTED|Overall Study||20
41941|NCT02573233|97594|P1|STARTED|Overall Study||22
41942|NCT02573181|97621|P2|NOT COMPLETED|Overall Study||0
41943|NCT02573181|97622|P1|NOT COMPLETED|Overall Study||0
41944|NCT02573181|97621|P2|COMPLETED|Overall Study||126
41945|NCT02573181|97622|P1|COMPLETED|Overall Study||127
41946|NCT02573181|97621|P2|Vaccinated|Overall Study||126
41947|NCT02573181|97622|P1|Vaccinated|Overall Study||127
41948|NCT02573181|97621|P2|STARTED|Overall Study||126
41949|NCT02573181|97622|P1|STARTED|Overall Study||127
41950|NCT02573155|97646|P2|NOT COMPLETED|Period 5||0
41951|NCT02573155|97647|P1|NOT COMPLETED|Period 5||0
41952|NCT02573155|97646|P2|COMPLETED|Period 5||28
41953|NCT02573155|97647|P1|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
41954|NCT02573155|97646|P2|STARTED|Period 5||28
41955|NCT02573155|97647|P1|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
41956|NCT02573155|97646|P2|NOT COMPLETED|Washout Between Treatment Period 4 and 5||1
41957|NCT02573155|97647|P1|NOT COMPLETED|Washout Between Treatment Period 4 and 5||0
41958|NCT02573155|97646|P2|COMPLETED|Washout Between Treatment Period 4 and 5||28
41959|NCT02573155|97647|P1|COMPLETED|Washout Between Treatment Period 4 and 5|Part 1 comprised 3 treatment periods only|0
41960|NCT02573155|97646|P2|STARTED|Washout Between Treatment Period 4 and 5||29
41961|NCT02573155|97647|P1|STARTED|Washout Between Treatment Period 4 and 5|Part 1 comprised 3 treatment periods only|0
41962|NCT02573155|97646|P2|NOT COMPLETED|Period 4||0
41963|NCT02573155|97647|P1|NOT COMPLETED|Period 4||0
41964|NCT02573155|97646|P2|COMPLETED|Period 4||29
41965|NCT02573155|97647|P1|COMPLETED|Period 4|Part 1 comprised 3 treatment periods only|0
41966|NCT02573155|97646|P2|STARTED|Period 4||29
41967|NCT02573155|97647|P1|STARTED|Period 4|Part 1 comprised 3 treatment periods only|0
41968|NCT02573155|97646|P2|NOT COMPLETED|Washout Between Treatment Period 3 and 4||2
41969|NCT02573155|97647|P1|NOT COMPLETED|Washout Between Treatment Period 3 and 4||0
41970|NCT02573155|97646|P2|COMPLETED|Washout Between Treatment Period 3 and 4||29
41971|NCT02573155|97647|P1|COMPLETED|Washout Between Treatment Period 3 and 4|Part 1 comprised 3 treatment periods only|0
41972|NCT02573155|97646|P2|STARTED|Washout Between Treatment Period 3 and 4||31
41973|NCT02573155|97647|P1|STARTED|Washout Between Treatment Period 3 and 4|Part 1 comprised 3 treatment periods only|0
41974|NCT02573155|97646|P2|NOT COMPLETED|Period 3||0
41975|NCT02573155|97647|P1|NOT COMPLETED|Period 3||0
41976|NCT02573155|97646|P2|COMPLETED|Period 3||31
41977|NCT02573155|97647|P1|COMPLETED|Period 3||15
41978|NCT02573155|97646|P2|STARTED|Period 3||31
41979|NCT02573155|97647|P1|STARTED|Period 3||15
41980|NCT02573155|97646|P2|NOT COMPLETED|Washout Between Treatment Period 2 and 3||2
41981|NCT02573155|97647|P1|NOT COMPLETED|Washout Between Treatment Period 2 and 3||1
41982|NCT02573155|97646|P2|COMPLETED|Washout Between Treatment Period 2 and 3||31
41983|NCT02573155|97647|P1|COMPLETED|Washout Between Treatment Period 2 and 3||15
41984|NCT02573155|97646|P2|STARTED|Washout Between Treatment Period 2 and 3||33
41985|NCT02573155|97647|P1|STARTED|Washout Between Treatment Period 2 and 3||16
41986|NCT02573155|97646|P2|NOT COMPLETED|Period 2||0
41987|NCT02573155|97647|P1|NOT COMPLETED|Period 2||0
41988|NCT02573155|97646|P2|COMPLETED|Period 2||33
41989|NCT02573155|97647|P1|COMPLETED|Period 2||16
41990|NCT02573155|97646|P2|STARTED|Period 2||33
41991|NCT02573155|97647|P1|STARTED|Period 2||16
41992|NCT02573155|97646|P2|NOT COMPLETED|Washout Between Treatment Period 1 and 2||5
41993|NCT02573155|97647|P1|NOT COMPLETED|Washout Between Treatment Period 1 and 2||0
41994|NCT02573155|97646|P2|COMPLETED|Washout Between Treatment Period 1 and 2||33
41995|NCT02573155|97647|P1|COMPLETED|Washout Between Treatment Period 1 and 2||16
41996|NCT02573155|97646|P2|STARTED|Washout Between Treatment Period 1 and 2||38
41997|NCT02573155|97647|P1|STARTED|Washout Between Treatment Period 1 and 2||16
41998|NCT02573155|97646|P2|NOT COMPLETED|Treatment Period 1||0
41999|NCT02573155|97647|P1|NOT COMPLETED|Treatment Period 1||0
42000|NCT02573155|97646|P2|COMPLETED|Treatment Period 1||38
42001|NCT02573155|97647|P1|COMPLETED|Treatment Period 1||16
42002|NCT02573155|97646|P2|STARTED|Treatment Period 1||38
42003|NCT02573155|97647|P1|STARTED|Treatment Period 1||16
42004|NCT02573012|97795|P2|NOT COMPLETED|Overall Study||15
42005|NCT02573012|97796|P1|NOT COMPLETED|Overall Study||15
42006|NCT02573012|97795|P2|COMPLETED|Overall Study||113
42007|NCT02573012|97796|P1|COMPLETED|Overall Study||116
42008|NCT02573012|97795|P2|STARTED|Overall Study||128
42009|NCT02573012|97796|P1|STARTED|Overall Study||131
42010|NCT02572817|97848|P2|NOT COMPLETED|Overall Study||6
42011|NCT02572817|97849|P1|NOT COMPLETED|Overall Study||9
42012|NCT02572817|97848|P2|COMPLETED|Overall Study||41
42013|NCT02572817|97849|P1|COMPLETED|Overall Study||82
42014|NCT02572817|97848|P2|STARTED|Overall Study||47
42015|NCT02572817|97849|P1|STARTED|Overall Study||91
42016|NCT02572752|97916|P3|NOT COMPLETED|Period 3 Including Washout||0
42017|NCT02572752|97917|P2|NOT COMPLETED|Period 3 Including Washout||0
42018|NCT02572752|97918|P1|NOT COMPLETED|Period 3 Including Washout||0
42019|NCT02572752|97916|P3|COMPLETED|Period 3 Including Washout||24
42020|NCT02572752|97917|P2|COMPLETED|Period 3 Including Washout||23
42021|NCT02572752|97918|P1|COMPLETED|Period 3 Including Washout||23
42022|NCT02572752|97916|P3|STARTED|Period 3 Including Washout||24
42023|NCT02572752|97917|P2|STARTED|Period 3 Including Washout||23
42024|NCT02572752|97918|P1|STARTED|Period 3 Including Washout||23
42025|NCT02572752|97916|P3|NOT COMPLETED|Period 2 Including Washout||0
42026|NCT02572752|97917|P2|NOT COMPLETED|Period 2 Including Washout||0
42027|NCT02572752|97918|P1|NOT COMPLETED|Period 2 Including Washout||0
42028|NCT02572752|97916|P3|COMPLETED|Period 2 Including Washout||24
42029|NCT02572752|97917|P2|COMPLETED|Period 2 Including Washout||23
42030|NCT02572752|97918|P1|COMPLETED|Period 2 Including Washout||23
42031|NCT02572752|97916|P3|STARTED|Period 2 Including Washout||24
42032|NCT02572752|97917|P2|STARTED|Period 2 Including Washout||23
42033|NCT02572752|97918|P1|STARTED|Period 2 Including Washout||23
42034|NCT02572752|97916|P3|NOT COMPLETED|Period 1 Including Washout||0
42035|NCT02572752|97917|P2|NOT COMPLETED|Period 1 Including Washout||0
42036|NCT02572752|97918|P1|NOT COMPLETED|Period 1 Including Washout||0
42037|NCT02572752|97916|P3|COMPLETED|Period 1 Including Washout||24
42038|NCT02572752|97917|P2|COMPLETED|Period 1 Including Washout||23
42039|NCT02572752|97918|P1|COMPLETED|Period 1 Including Washout||23
42040|NCT02572752|97916|P3|STARTED|Period 1 Including Washout||24
42041|NCT02572752|97917|P2|STARTED|Period 1 Including Washout||23
42042|NCT02572752|97918|P1|STARTED|Period 1 Including Washout||23
42043|NCT02572609|97933|P2|NOT COMPLETED|Period 2: Treatment Period 2||0
42044|NCT02572609|97934|P1|NOT COMPLETED|Period 2: Treatment Period 2||0
42045|NCT02572609|97933|P2|COMPLETED|Period 2: Treatment Period 2||18
42046|NCT02572609|97934|P1|COMPLETED|Period 2: Treatment Period 2||18
42047|NCT02572609|97933|P2|STARTED|Period 2: Treatment Period 2||18
42048|NCT02572609|97934|P1|STARTED|Period 2: Treatment Period 2||18
42049|NCT02572609|97933|P2|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
42050|NCT02572609|97934|P1|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
42051|NCT02572609|97933|P2|COMPLETED|Period 1: Treatment Period 1 + Washout||18
42052|NCT02572609|97934|P1|COMPLETED|Period 1: Treatment Period 1 + Washout||18
42053|NCT02572609|97933|P2|STARTED|Period 1: Treatment Period 1 + Washout||18
42054|NCT02572609|97934|P1|STARTED|Period 1: Treatment Period 1 + Washout||18
42055|NCT02572427|97944|P2|NOT COMPLETED|Overall Study||9
42056|NCT02572427|97945|P1|NOT COMPLETED|Overall Study||6
42057|NCT02572427|97944|P2|COMPLETED|Overall Study||36
42058|NCT02572427|97945|P1|COMPLETED|Overall Study||31
42059|NCT02572427|97944|P2|STARTED|Overall Study||45
42060|NCT02572427|97945|P1|STARTED|Overall Study||37
42061|NCT02572401|97957|P4|NOT COMPLETED|Overall Study||10
42062|NCT02572401|97958|P3|NOT COMPLETED|Overall Study||9
42063|NCT02572401|97959|P2|NOT COMPLETED|Overall Study||8
42064|NCT02572401|97960|P1|NOT COMPLETED|Overall Study||5
42065|NCT02572401|97957|P4|COMPLETED|Overall Study||88
42066|NCT02572401|97958|P3|COMPLETED|Overall Study||89
42067|NCT02572401|97959|P2|COMPLETED|Overall Study||90
42068|NCT02572401|97960|P1|COMPLETED|Overall Study||92
42069|NCT02572401|97957|P4|STARTED|Overall Study||98
42070|NCT02572401|97958|P3|STARTED|Overall Study||98
42071|NCT02572401|97959|P2|STARTED|Overall Study||98
42072|NCT02572401|97960|P1|STARTED|Overall Study||97
42073|NCT02572388|97990|P4|NOT COMPLETED|Overall Study||2
42074|NCT02572388|97991|P3|NOT COMPLETED|Overall Study||2
42075|NCT02572388|97992|P2|NOT COMPLETED|Overall Study||1
42076|NCT02572388|97993|P1|NOT COMPLETED|Overall Study||1
42077|NCT02572388|97990|P4|COMPLETED|Overall Study||4
42078|NCT02572388|97991|P3|COMPLETED|Overall Study||8
42079|NCT02572388|97992|P2|COMPLETED|Overall Study||3
42080|NCT02572388|97993|P1|COMPLETED|Overall Study||10
42081|NCT02572388|97990|P4|STARTED|Overall Study||6
42082|NCT02572388|97991|P3|STARTED|Overall Study||10
42083|NCT02572388|97992|P2|STARTED|Overall Study||4
42084|NCT02572388|97993|P1|STARTED|Overall Study||11
42085|NCT02572167|98018|P3|NOT COMPLETED|Overall Study||31
42086|NCT02572167|98019|P2|NOT COMPLETED|Overall Study||56
42087|NCT02572167|98020|P1|NOT COMPLETED|Overall Study||6
42088|NCT02572167|98018|P3|COMPLETED|Overall Study||0
42089|NCT02572167|98019|P2|COMPLETED|Overall Study||0
42090|NCT02572167|98020|P1|COMPLETED|Overall Study||0
42091|NCT02572167|98018|P3|STARTED|Overall Study||31
42092|NCT02572167|98019|P2|STARTED|Overall Study||56
42093|NCT02572167|98020|P1|STARTED|Overall Study||6
42094|NCT02572076|98034|P1|NOT COMPLETED|Overall Study||1
42095|NCT02572076|98034|P1|COMPLETED|Overall Study||9
42096|NCT02572076|98034|P1|STARTED|Overall Study||10
42097|NCT02571634|98038|P1|NOT COMPLETED|Overall Study||0
42098|NCT02571634|98038|P1|COMPLETED|Overall Study|The final subject was enrolled on this date.|23
42099|NCT02571634|98038|P1|STARTED|Overall Study|First subject wasn't enrolled until July related to receipt of medications from sponsor.|23
42100|NCT02571439|98048|P2|NOT COMPLETED|Overall Study||0
42101|NCT02571439|98049|P1|NOT COMPLETED|Overall Study||0
42102|NCT02571439|98048|P2|COMPLETED|Overall Study||21
42103|NCT02571439|98049|P1|COMPLETED|Overall Study||20
42104|NCT02571439|98048|P2|STARTED|Overall Study||21
42105|NCT02571439|98049|P1|STARTED|Overall Study||20
42106|NCT02571244|98075|P2|NOT COMPLETED|Overall Study||1
42107|NCT02571244|98076|P1|NOT COMPLETED|Overall Study||3
42108|NCT02571244|98075|P2|COMPLETED|Overall Study||21
42109|NCT02571244|98076|P1|COMPLETED|Overall Study||41
42110|NCT02571244|98075|P2|STARTED|Overall Study||22
42111|NCT02571244|98076|P1|STARTED|Overall Study||44
42112|NCT02571218|98092|P2|NOT COMPLETED|Overall Study||0
42113|NCT02571218|98093|P1|NOT COMPLETED|Overall Study||0
42114|NCT02571218|98092|P2|COMPLETED|Overall Study||41
42115|NCT02571218|98093|P1|COMPLETED|Overall Study||40
42116|NCT02571218|98092|P2|STARTED|Overall Study||41
42117|NCT02571218|98093|P1|STARTED|Overall Study||40
42118|NCT02571153|98104|P3|NOT COMPLETED|Overall Study||2
42119|NCT02571153|98105|P2|NOT COMPLETED|Overall Study||8
42120|NCT02571153|98106|P1|NOT COMPLETED|Overall Study||6
42121|NCT02571153|98104|P3|COMPLETED|Overall Study||43
42122|NCT02571153|98105|P2|COMPLETED|Overall Study||37
42123|NCT02571153|98106|P1|COMPLETED|Overall Study||39
42124|NCT02571153|98104|P3|STARTED|Overall Study||45
42125|NCT02571153|98105|P2|STARTED|Overall Study||45
42126|NCT02571153|98106|P1|STARTED|Overall Study||45
42127|NCT02571075|98134|P2|NOT COMPLETED|Overall Study||24
42128|NCT02571075|98135|P1|NOT COMPLETED|Overall Study||20
42129|NCT02571075|98134|P2|COMPLETED|Overall Study||26
42130|NCT02571075|98135|P1|COMPLETED|Overall Study||25
42131|NCT02571075|98134|P2|STARTED|Overall Study||50
42132|NCT02571075|98135|P1|STARTED|Overall Study||45
42133|NCT02571049|98149|P2|NOT COMPLETED|Randomization||2
42134|NCT02571049|98150|P1|NOT COMPLETED|Randomization||0
42135|NCT02571049|98149|P2|COMPLETED|Randomization||10
42136|NCT02571049|98150|P1|COMPLETED|Randomization||8
42137|NCT02571049|98149|P2|STARTED|Randomization||12
42138|NCT02571049|98150|P1|STARTED|Randomization||8
42139|NCT02571049|98149|P2|NOT COMPLETED|Screening||2
42140|NCT02571049|98150|P1|NOT COMPLETED|Screening||2
42141|NCT02571049|98149|P2|COMPLETED|Screening||12
42142|NCT02571049|98150|P1|COMPLETED|Screening||8
42143|NCT02571049|98149|P2|STARTED|Screening||14
42144|NCT02571049|98150|P1|STARTED|Screening||10
42145|NCT02570750|98158|P2|NOT COMPLETED|Overall Study||5
42146|NCT02570750|98159|P1|NOT COMPLETED|Overall Study||14
42147|NCT02570750|98158|P2|COMPLETED|Overall Study||68
42148|NCT02570750|98159|P1|COMPLETED|Overall Study||96
42149|NCT02570750|98158|P2|STARTED|Overall Study||73
42150|NCT02570750|98159|P1|STARTED|Overall Study||110
42151|NCT02570711|98177|P2|NOT COMPLETED|Overall Study||2
42152|NCT02570711|98178|P1|NOT COMPLETED|Overall Study||1
42153|NCT02570711|98177|P2|COMPLETED|Overall Study||0
42154|NCT02570711|98178|P1|COMPLETED|Overall Study||0
42155|NCT02570711|98177|P2|STARTED|Overall Study||2
42156|NCT02570711|98178|P1|STARTED|Overall Study||1
42157|NCT02570425|98186|P2|NOT COMPLETED|Visit 3||0
42158|NCT02570425|98187|P1|NOT COMPLETED|Visit 3||0
42159|NCT02570425|98186|P2|COMPLETED|Visit 3||231
42160|NCT02570425|98187|P1|COMPLETED|Visit 3||229
42161|NCT02570425|98186|P2|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|231
42162|NCT02570425|98187|P1|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|229
42163|NCT02570425|98186|P2|NOT COMPLETED|Visit 2||0
42164|NCT02570425|98187|P1|NOT COMPLETED|Visit 2||0
42165|NCT02570425|98186|P2|COMPLETED|Visit 2||247
42166|NCT02570425|98187|P1|COMPLETED|Visit 2||251
42167|NCT02570425|98186|P2|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|247
42168|NCT02570425|98187|P1|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|251
42169|NCT02570425|98186|P2|NOT COMPLETED|Visit 1||0
42170|NCT02570425|98187|P1|NOT COMPLETED|Visit 1||0
42171|NCT02570425|98186|P2|COMPLETED|Visit 1||242
42172|NCT02570425|98187|P1|COMPLETED|Visit 1||274
42173|NCT02570425|98186|P2|STARTED|Visit 1||242
42174|NCT02570425|98187|P1|STARTED|Visit 1||274
42175|NCT02570295|98236|P2|NOT COMPLETED|Overall Study||58
42176|NCT02570295|98237|P1|NOT COMPLETED|Overall Study||11
42177|NCT02570295|98236|P2|COMPLETED|Overall Study||289
42178|NCT02570295|98237|P1|COMPLETED|Overall Study||364
42179|NCT02570295|98236|P2|STARTED|Overall Study||347
42180|NCT02570295|98237|P1|STARTED|Overall Study||375
42181|NCT02570165|98266|P7|NOT COMPLETED|Overall Study||0
42182|NCT02570165|98267|P6|NOT COMPLETED|Overall Study||2
42183|NCT02570165|98268|P5|NOT COMPLETED|Overall Study||6
42184|NCT02570165|98269|P4|NOT COMPLETED|Overall Study||5
42185|NCT02570165|98270|P3|NOT COMPLETED|Overall Study||5
42186|NCT02570165|98271|P2|NOT COMPLETED|Overall Study||3
42187|NCT02570165|98272|P1|NOT COMPLETED|Overall Study||2
42188|NCT02570165|98266|P7|COMPLETED|Overall Study||47
42189|NCT02570165|98267|P6|COMPLETED|Overall Study||44
42190|NCT02570165|98268|P5|COMPLETED|Overall Study||41
42191|NCT02570165|98269|P4|COMPLETED|Overall Study||40
42192|NCT02570165|98270|P3|COMPLETED|Overall Study||41
42193|NCT02570165|98271|P2|COMPLETED|Overall Study||43
42194|NCT02570165|98272|P1|COMPLETED|Overall Study||44
42195|NCT02570165|98266|P7|STARTED|Overall Study||47
42196|NCT02570165|98267|P6|STARTED|Overall Study||46
42197|NCT02570165|98268|P5|STARTED|Overall Study||47
42198|NCT02570165|98269|P4|STARTED|Overall Study||45
42199|NCT02570165|98270|P3|STARTED|Overall Study||46
42200|NCT02570165|98271|P2|STARTED|Overall Study||46
42201|NCT02570165|98272|P1|STARTED|Overall Study||46
42202|NCT02570139|98297|P2|NOT COMPLETED|Overall Study||0
42203|NCT02570139|98298|P1|NOT COMPLETED|Overall Study||0
42204|NCT02570139|98297|P2|COMPLETED|Overall Study||21
42205|NCT02570139|98298|P1|COMPLETED|Overall Study||24
42206|NCT02570139|98297|P2|STARTED|Overall Study|21 subjects treated with SensiCare Protective Barrier|21
42207|NCT02570139|98298|P1|STARTED|Overall Study|24 subjects were treated w/ Cavilon Advanced Skin Protectant. Study terminated due to low enrollment|24
42208|NCT02570126|98312|P2|NOT COMPLETED|Overall Study||9
42209|NCT02570126|98313|P1|NOT COMPLETED|Overall Study||6
42210|NCT02570126|98312|P2|COMPLETED|Overall Study||607
42211|NCT02570126|98313|P1|COMPLETED|Overall Study||609
42212|NCT02570126|98312|P2|STARTED|Overall Study||616
42213|NCT02570126|98313|P1|STARTED|Overall Study||615
42214|NCT02570074|98339|P2|NOT COMPLETED|Period 2 (Second Dosing Regimen)||0
42215|NCT02570074|98340|P1|NOT COMPLETED|Period 2 (Second Dosing Regimen)||1
42216|NCT02570074|98339|P2|COMPLETED|Period 2 (Second Dosing Regimen)||10
42217|NCT02570074|98340|P1|COMPLETED|Period 2 (Second Dosing Regimen)||8
42218|NCT02570074|98339|P2|STARTED|Period 2 (Second Dosing Regimen)||10
42219|NCT02570074|98340|P1|STARTED|Period 2 (Second Dosing Regimen)||9
42220|NCT02570074|98339|P2|NOT COMPLETED|Period 1 (First Dosing Regimen)||0
42221|NCT02570074|98340|P1|NOT COMPLETED|Period 1 (First Dosing Regimen)||0
42222|NCT02570074|98339|P2|COMPLETED|Period 1 (First Dosing Regimen)||10
42223|NCT02570074|98340|P1|COMPLETED|Period 1 (First Dosing Regimen)||9
42224|NCT02570074|98339|P2|STARTED|Period 1 (First Dosing Regimen)||10
42225|NCT02570074|98340|P1|STARTED|Period 1 (First Dosing Regimen)||9
42226|NCT02570022|98400|P2|NOT COMPLETED|Overall Study||0
42227|NCT02570022|98401|P1|NOT COMPLETED|Overall Study||0
42228|NCT02570022|98400|P2|COMPLETED|Overall Study||31
42229|NCT02570022|98401|P1|COMPLETED|Overall Study||26
42230|NCT02570022|98400|P2|STARTED|Overall Study||31
42231|NCT02570022|98401|P1|STARTED|Overall Study||26
42232|NCT02569996|98409|P1|NOT COMPLETED|Overall Study||55
42233|NCT02569996|98409|P1|COMPLETED|Overall Study||69
42234|NCT02569996|98409|P1|STARTED|Overall Study||124
42235|NCT02569957|98421|P2|NOT COMPLETED|Overall Study||1
42236|NCT02569957|98422|P1|NOT COMPLETED|Overall Study||0
42237|NCT02569957|98421|P2|COMPLETED|Overall Study||0
42238|NCT02569957|98422|P1|COMPLETED|Overall Study||0
42239|NCT02569957|98421|P2|STARTED|Overall Study||1
42240|NCT02569957|98422|P1|STARTED|Overall Study||0
42241|NCT02569853|98454|P2|NOT COMPLETED|Overall Study||14
42242|NCT02569853|98455|P1|NOT COMPLETED|Overall Study||20
42243|NCT02569853|98454|P2|COMPLETED|Overall Study||123
42244|NCT02569853|98455|P1|COMPLETED|Overall Study||111
42245|NCT02569853|98454|P2|STARTED|Overall Study||137
42246|NCT02569853|98455|P1|STARTED|Overall Study||131
42247|NCT02569710|98473|P10|NOT COMPLETED|Overall Study||0
42248|NCT02569710|98474|P9|NOT COMPLETED|Overall Study||1
42249|NCT02569710|98475|P8|NOT COMPLETED|Overall Study||0
42250|NCT02569710|98476|P7|NOT COMPLETED|Overall Study||2
42251|NCT02569710|98477|P6|NOT COMPLETED|Overall Study||1
42252|NCT02569710|98478|P5|NOT COMPLETED|Overall Study||1
42253|NCT02569710|98479|P4|NOT COMPLETED|Overall Study||0
42254|NCT02569710|98480|P3|NOT COMPLETED|Overall Study||0
42255|NCT02569710|98481|P2|NOT COMPLETED|Overall Study||0
42256|NCT02569710|98482|P1|NOT COMPLETED|Overall Study||1
42257|NCT02569710|98473|P10|COMPLETED|Overall Study||4
42258|NCT02569710|98474|P9|COMPLETED|Overall Study||14
42259|NCT02569710|98475|P8|COMPLETED|Overall Study||30
42260|NCT02569710|98476|P7|COMPLETED|Overall Study||12
42261|NCT02569710|98477|P6|COMPLETED|Overall Study||4
42262|NCT02569710|98478|P5|COMPLETED|Overall Study||7
42263|NCT02569710|98479|P4|COMPLETED|Overall Study||20
42264|NCT02569710|98480|P3|COMPLETED|Overall Study||20
42265|NCT02569710|98481|P2|COMPLETED|Overall Study||25
42266|NCT02569710|98482|P1|COMPLETED|Overall Study||19
42267|NCT02569710|98473|P10|STARTED|Overall Study||4
42268|NCT02569710|98474|P9|STARTED|Overall Study||15
42269|NCT02569710|98475|P8|STARTED|Overall Study||30
42270|NCT02569710|98476|P7|STARTED|Overall Study||14
42271|NCT02569710|98477|P6|STARTED|Overall Study||5
42272|NCT02569710|98478|P5|STARTED|Overall Study||8
42273|NCT02569710|98479|P4|STARTED|Overall Study||20
42274|NCT02569710|98480|P3|STARTED|Overall Study||20
42275|NCT02569710|98481|P2|STARTED|Overall Study||25
42276|NCT02569710|98482|P1|STARTED|Overall Study||20
42277|NCT02569658|98792|P2|NOT COMPLETED|Overall Study||1
42278|NCT02569658|98793|P1|NOT COMPLETED|Overall Study||1
42279|NCT02569658|98792|P2|COMPLETED|Overall Study||56
42280|NCT02569658|98793|P1|COMPLETED|Overall Study||52
42281|NCT02569658|98792|P2|STARTED|Overall Study||57
42282|NCT02569658|98793|P1|STARTED|Overall Study||53
42283|NCT02569437|98811|P2|NOT COMPLETED|Overall Study||14
42284|NCT02569437|98812|P1|NOT COMPLETED|Overall Study||12
42285|NCT02569437|98811|P2|COMPLETED|Overall Study||11
42286|NCT02569437|98812|P1|COMPLETED|Overall Study||12
42287|NCT02569437|98811|P2|STARTED|Overall Study||25
42288|NCT02569437|98812|P1|STARTED|Overall Study||24
42289|NCT02569112|98826|P2|NOT COMPLETED|Overall Study||0
42290|NCT02569112|98827|P1|NOT COMPLETED|Overall Study||0
42387|NCT02568046|98945|P2|NOT COMPLETED|Overall Study||3
42291|NCT02569112|98826|P2|COMPLETED|Overall Study|Each subject received multipolar RF with varipulse technology to only one side of their body.|10
42292|NCT02569112|98827|P1|COMPLETED|Overall Study||10
42293|NCT02569112|98826|P2|STARTED|Overall Study||10
42294|NCT02569112|98827|P1|STARTED|Overall Study||10
42295|NCT02569086|98832|P1|NOT COMPLETED|Overall Study||0
42296|NCT02569086|98832|P1|COMPLETED|Overall Study||22
42297|NCT02569086|98832|P1|STARTED|Overall Study||22
42298|NCT02568852|98839|P2|NOT COMPLETED|Overall Study||0
42299|NCT02568852|98840|P1|NOT COMPLETED|Overall Study||0
42300|NCT02568852|98839|P2|COMPLETED|Overall Study||25
42301|NCT02568852|98840|P1|COMPLETED|Overall Study||25
42302|NCT02568852|98839|P2|STARTED|Overall Study||25
42303|NCT02568852|98840|P1|STARTED|Overall Study||25
42304|NCT02568683|98878|P2|NOT COMPLETED|Overall Study||4
42305|NCT02568683|98879|P1|NOT COMPLETED|Overall Study||6
42306|NCT02568683|98878|P2|COMPLETED|Overall Study||0
42307|NCT02568683|98879|P1|COMPLETED|Overall Study||0
42308|NCT02568683|98878|P2|STARTED|Overall Study||4
42309|NCT02568683|98879|P1|STARTED|Overall Study||6
42310|NCT02568397|98891|P2|NOT COMPLETED|Period 2||2
42311|NCT02568397|98892|P1|NOT COMPLETED|Period 2||0
42312|NCT02568397|98891|P2|COMPLETED|Period 2||58
42313|NCT02568397|98892|P1|COMPLETED|Period 2||0
42314|NCT02568397|98891|P2|STARTED|Period 2|Daily doses of 50 mg LY3314814 were administered daily on Days 3 to 21 of Period 2.|60
42315|NCT02568397|98892|P1|STARTED|Period 2|A single oral dose of 150 mg dabigatran etexilate was administered on Day 1 of Period 1.|0
42316|NCT02568397|98891|P2|NOT COMPLETED|Period 1||0
42317|NCT02568397|98892|P1|NOT COMPLETED|Period 1||0
42318|NCT02568397|98891|P2|COMPLETED|Period 1||0
42319|NCT02568397|98892|P1|COMPLETED|Period 1||60
42320|NCT02568397|98891|P2|Received at Least 1 Dose of Study Drug|Period 1||0
42321|NCT02568397|98892|P1|Received at Least 1 Dose of Study Drug|Period 1||60
42322|NCT02568397|98891|P2|STARTED|Period 1||0
42323|NCT02568397|98892|P1|STARTED|Period 1||60
42324|NCT02568384|98916|P1|NOT COMPLETED|Overall Study||2
42325|NCT02568384|98916|P1|COMPLETED|Overall Study||43
42326|NCT02568384|98916|P1|STARTED|Overall Study||45
42327|NCT02568345|98926|P1|NOT COMPLETED|Overall Study||0
42328|NCT02568345|98926|P1|COMPLETED|Overall Study||31
42329|NCT02568345|98926|P1|Treated at 2.6 mg/kg|Overall Study|Patients: 8th-10th|3
42330|NCT02568345|98926|P1|Treated at 2.4 mg/kg|Overall Study|Patients: 1st-5th; 7th; 11th-15th; 21st-25th; 27th-31st|25
42331|NCT02568345|98926|P1|Treated at 2.2 mg/kg|Overall Study|patients: 6th, 20th, 26th|3
42332|NCT02568345|98926|P1|STARTED|Overall Study||31
42333|NCT02568254|98930|P6|NOT COMPLETED|Period 3||0
42334|NCT02568254|98931|P5|NOT COMPLETED|Period 3||1
42335|NCT02568254|98932|P4|NOT COMPLETED|Period 3||0
42336|NCT02568254|98933|P3|NOT COMPLETED|Period 3||0
42337|NCT02568254|98934|P2|NOT COMPLETED|Period 3||0
42338|NCT02568254|98935|P1|NOT COMPLETED|Period 3||0
42339|NCT02568254|98930|P6|COMPLETED|Period 3||12
42340|NCT02568254|98931|P5|COMPLETED|Period 3||11
42341|NCT02568254|98932|P4|COMPLETED|Period 3||12
42342|NCT02568254|98933|P3|COMPLETED|Period 3||12
42343|NCT02568254|98934|P2|COMPLETED|Period 3||12
42344|NCT02568254|98935|P1|COMPLETED|Period 3||13
42345|NCT02568254|98930|P6|STARTED|Period 3||12
42346|NCT02568254|98931|P5|STARTED|Period 3||12
42347|NCT02568254|98932|P4|STARTED|Period 3||12
42348|NCT02568254|98933|P3|STARTED|Period 3||12
42349|NCT02568254|98934|P2|STARTED|Period 3||12
42350|NCT02568254|98935|P1|STARTED|Period 3||13
42351|NCT02568254|98930|P6|NOT COMPLETED|Period 2||0
42352|NCT02568254|98931|P5|NOT COMPLETED|Period 2||0
42353|NCT02568254|98932|P4|NOT COMPLETED|Period 2||0
42354|NCT02568254|98933|P3|NOT COMPLETED|Period 2||1
42355|NCT02568254|98934|P2|NOT COMPLETED|Period 2||0
42356|NCT02568254|98935|P1|NOT COMPLETED|Period 2||0
42357|NCT02568254|98930|P6|COMPLETED|Period 2||12
42358|NCT02568254|98931|P5|COMPLETED|Period 2||12
42359|NCT02568254|98932|P4|COMPLETED|Period 2||12
42360|NCT02568254|98933|P3|COMPLETED|Period 2||12
42361|NCT02568254|98934|P2|COMPLETED|Period 2||12
42362|NCT02568254|98935|P1|COMPLETED|Period 2||13
42363|NCT02568254|98930|P6|STARTED|Period 2||12
42364|NCT02568254|98931|P5|STARTED|Period 2||12
42365|NCT02568254|98932|P4|STARTED|Period 2||12
42366|NCT02568254|98933|P3|STARTED|Period 2||13
42367|NCT02568254|98934|P2|STARTED|Period 2||12
42368|NCT02568254|98935|P1|STARTED|Period 2||13
42369|NCT02568254|98930|P6|NOT COMPLETED|Period 1||0
42370|NCT02568254|98931|P5|NOT COMPLETED|Period 1||0
42371|NCT02568254|98932|P4|NOT COMPLETED|Period 1||0
42372|NCT02568254|98933|P3|NOT COMPLETED|Period 1||0
42373|NCT02568254|98934|P2|NOT COMPLETED|Period 1||0
42374|NCT02568254|98935|P1|NOT COMPLETED|Period 1||0
42375|NCT02568254|98930|P6|COMPLETED|Period 1||12
42376|NCT02568254|98931|P5|COMPLETED|Period 1||12
42377|NCT02568254|98932|P4|COMPLETED|Period 1||12
42378|NCT02568254|98933|P3|COMPLETED|Period 1||13
42379|NCT02568254|98934|P2|COMPLETED|Period 1||12
42380|NCT02568254|98935|P1|COMPLETED|Period 1||13
42381|NCT02568254|98930|P6|STARTED|Period 1||12
42382|NCT02568254|98931|P5|STARTED|Period 1||12
42383|NCT02568254|98932|P4|STARTED|Period 1||12
42384|NCT02568254|98933|P3|STARTED|Period 1||13
42385|NCT02568254|98934|P2|STARTED|Period 1||12
42386|NCT02568254|98935|P1|STARTED|Period 1||13
42388|NCT02568046|98946|P1|NOT COMPLETED|Overall Study||5
42389|NCT02568046|98945|P2|COMPLETED|Overall Study||2
42390|NCT02568046|98946|P1|COMPLETED|Overall Study||0
42391|NCT02568046|98945|P2|STARTED|Overall Study||5
42392|NCT02568046|98946|P1|STARTED|Overall Study||5
42393|NCT02567968|98952|P2|NOT COMPLETED|Second Intervention||0
42394|NCT02567968|98953|P1|NOT COMPLETED|Second Intervention||0
42395|NCT02567968|98952|P2|COMPLETED|Second Intervention||4
42396|NCT02567968|98953|P1|COMPLETED|Second Intervention||4
42397|NCT02567968|98952|P2|STARTED|Second Intervention||4
42398|NCT02567968|98953|P1|STARTED|Second Intervention||4
42399|NCT02567968|98952|P2|NOT COMPLETED|Washout (2 Weeks)||0
42400|NCT02567968|98953|P1|NOT COMPLETED|Washout (2 Weeks)||0
42401|NCT02567968|98952|P2|COMPLETED|Washout (2 Weeks)||4
42402|NCT02567968|98953|P1|COMPLETED|Washout (2 Weeks)||4
42403|NCT02567968|98952|P2|STARTED|Washout (2 Weeks)||4
42404|NCT02567968|98953|P1|STARTED|Washout (2 Weeks)||4
42405|NCT02567968|98952|P2|NOT COMPLETED|First Intervention||0
42406|NCT02567968|98953|P1|NOT COMPLETED|First Intervention||0
42407|NCT02567968|98952|P2|COMPLETED|First Intervention||4
42408|NCT02567968|98953|P1|COMPLETED|First Intervention||4
42409|NCT02567968|98952|P2|STARTED|First Intervention||4
42410|NCT02567968|98953|P1|STARTED|First Intervention||4
42411|NCT02567708|98975|P2|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||3
42412|NCT02567708|98976|P1|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
42413|NCT02567708|98975|P2|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||20
42414|NCT02567708|98976|P1|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||22
42415|NCT02567708|98975|P2|STARTED|Treatment Period 2 (Up to 4 Weeks)||23
42416|NCT02567708|98976|P1|STARTED|Treatment Period 2 (Up to 4 Weeks)||22
42417|NCT02567708|98975|P2|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
42418|NCT02567708|98976|P1|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
42419|NCT02567708|98975|P2|COMPLETED|Washout Period (Up to 4 Weeks)||23
42420|NCT02567708|98976|P1|COMPLETED|Washout Period (Up to 4 Weeks)||22
42421|NCT02567708|98975|P2|STARTED|Washout Period (Up to 4 Weeks)||23
42422|NCT02567708|98976|P1|STARTED|Washout Period (Up to 4 Weeks)||22
42423|NCT02567708|98975|P2|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||3
42424|NCT02567708|98976|P1|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||2
42425|NCT02567708|98975|P2|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||23
42426|NCT02567708|98976|P1|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||22
42427|NCT02567708|98975|P2|STARTED|Treatment Period 1 (Up to 4 Weeks)||26
42428|NCT02567708|98976|P1|STARTED|Treatment Period 1 (Up to 4 Weeks)||24
42429|NCT02567552|99017|P2|NOT COMPLETED|Overall Study||1
42430|NCT02567552|99018|P1|NOT COMPLETED|Overall Study||0
42431|NCT02567552|99017|P2|COMPLETED|Overall Study|dropout by pain in the puncture site|11
42432|NCT02567552|99018|P1|COMPLETED|Overall Study||12
42433|NCT02567552|99017|P2|STARTED|Overall Study||12
42434|NCT02567552|99018|P1|STARTED|Overall Study||12
42435|NCT02567188|99048|P1|NOT COMPLETED|Overall Study||35
42436|NCT02567188|99048|P1|COMPLETED|Overall Study||109
42437|NCT02567188|99048|P1|STARTED|Overall Study||144
42438|NCT02566785|99079|P2|NOT COMPLETED|Overall Study||3
42439|NCT02566785|99080|P1|NOT COMPLETED|Overall Study||1
42440|NCT02566785|99079|P2|COMPLETED|Overall Study||15
42441|NCT02566785|99080|P1|COMPLETED|Overall Study||14
42442|NCT02566785|99079|P2|STARTED|Overall Study||18
42443|NCT02566785|99080|P1|STARTED|Overall Study||15
42444|NCT02566759|99107|P17|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42445|NCT02566759|99108|P16|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42446|NCT02566759|99109|P15|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42447|NCT02566759|99110|P14|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42448|NCT02566759|99111|P13|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42449|NCT02566759|99112|P12|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42450|NCT02566759|99113|P11|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42451|NCT02566759|99114|P10|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42452|NCT02566759|99115|P9|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42453|NCT02566759|99116|P8|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42454|NCT02566759|99117|P7|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42455|NCT02566759|99118|P6|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42456|NCT02566759|99119|P5|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42457|NCT02566759|99120|P4|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42458|NCT02566759|99121|P3|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42459|NCT02566759|99122|P2|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42460|NCT02566759|99123|P1|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42461|NCT02566759|99107|P17|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
42462|NCT02566759|99108|P16|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
42463|NCT02566759|99109|P15|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
42464|NCT02566759|99110|P14|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42465|NCT02566759|99111|P13|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42466|NCT02566759|99112|P12|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42467|NCT02566759|99113|P11|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42468|NCT02566759|99114|P10|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42469|NCT02566759|99115|P9|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42470|NCT02566759|99116|P8|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42471|NCT02566759|99117|P7|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42472|NCT02566759|99118|P6|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42473|NCT02566759|99119|P5|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42474|NCT02566759|99120|P4|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42475|NCT02566759|99121|P3|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42476|NCT02566759|99122|P2|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42477|NCT02566759|99123|P1|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42478|NCT02566759|99107|P17|STARTED|Crossover Treatment (Part 4: 1 Day)||7
42479|NCT02566759|99108|P16|STARTED|Crossover Treatment (Part 4: 1 Day)||8
42480|NCT02566759|99109|P15|STARTED|Crossover Treatment (Part 4: 1 Day)||8
42481|NCT02566759|99110|P14|STARTED|Crossover Treatment (Part 4: 1 Day)||0
42482|NCT02566759|99111|P13|STARTED|Crossover Treatment (Part 4: 1 Day)||0
42483|NCT02566759|99112|P12|STARTED|Crossover Treatment (Part 4: 1 Day)||0
42484|NCT02566759|99113|P11|STARTED|Crossover Treatment (Part 4: 1 Day)||0
42485|NCT02566759|99114|P10|STARTED|Crossover Treatment (Part 4: 1 Day)||0
42486|NCT02566759|99115|P9|STARTED|Crossover Treatment (Part 4: 1 Day)||0
42487|NCT02566759|99116|P8|STARTED|Crossover Treatment (Part 4: 1 Day)||0
42488|NCT02566759|99117|P7|STARTED|Crossover Treatment (Part 4: 1 Day)||0
42489|NCT02566759|99118|P6|STARTED|Crossover Treatment (Part 4: 1 Day)||0
42490|NCT02566759|99119|P5|STARTED|Crossover Treatment (Part 4: 1 Day)||0
42491|NCT02566759|99120|P4|STARTED|Crossover Treatment (Part 4: 1 Day)||0
42492|NCT02566759|99121|P3|STARTED|Crossover Treatment (Part 4: 1 Day)||0
42493|NCT02566759|99122|P2|STARTED|Crossover Treatment (Part 4: 1 Day)||0
42494|NCT02566759|99123|P1|STARTED|Crossover Treatment (Part 4: 1 Day)||0
42495|NCT02566759|99107|P17|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42496|NCT02566759|99108|P16|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42497|NCT02566759|99109|P15|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42498|NCT02566759|99110|P14|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42499|NCT02566759|99111|P13|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42500|NCT02566759|99112|P12|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42501|NCT02566759|99113|P11|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42502|NCT02566759|99114|P10|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42503|NCT02566759|99115|P9|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42504|NCT02566759|99116|P8|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42505|NCT02566759|99117|P7|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42506|NCT02566759|99118|P6|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42507|NCT02566759|99119|P5|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42508|NCT02566759|99120|P4|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42509|NCT02566759|99121|P3|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42510|NCT02566759|99122|P2|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42511|NCT02566759|99123|P1|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42512|NCT02566759|99107|P17|COMPLETED|Washout Crossover Period (Part 4:5 Days)||7
42513|NCT02566759|99108|P16|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
42514|NCT02566759|99109|P15|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
42515|NCT02566759|99110|P14|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42516|NCT02566759|99111|P13|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42517|NCT02566759|99112|P12|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42518|NCT02566759|99113|P11|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42519|NCT02566759|99114|P10|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42520|NCT02566759|99115|P9|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42521|NCT02566759|99116|P8|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42522|NCT02566759|99117|P7|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42523|NCT02566759|99118|P6|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42524|NCT02566759|99119|P5|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42525|NCT02566759|99120|P4|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42526|NCT02566759|99121|P3|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42527|NCT02566759|99122|P2|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42528|NCT02566759|99123|P1|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42529|NCT02566759|99107|P17|STARTED|Washout Crossover Period (Part 4:5 Days)||7
42530|NCT02566759|99108|P16|STARTED|Washout Crossover Period (Part 4:5 Days)||8
42531|NCT02566759|99109|P15|STARTED|Washout Crossover Period (Part 4:5 Days)||8
42532|NCT02566759|99110|P14|STARTED|Washout Crossover Period (Part 4:5 Days)||0
42533|NCT02566759|99111|P13|STARTED|Washout Crossover Period (Part 4:5 Days)||0
42534|NCT02566759|99112|P12|STARTED|Washout Crossover Period (Part 4:5 Days)||0
42535|NCT02566759|99113|P11|STARTED|Washout Crossover Period (Part 4:5 Days)||0
42536|NCT02566759|99114|P10|STARTED|Washout Crossover Period (Part 4:5 Days)||0
42537|NCT02566759|99115|P9|STARTED|Washout Crossover Period (Part 4:5 Days)||0
42538|NCT02566759|99116|P8|STARTED|Washout Crossover Period (Part 4:5 Days)||0
42539|NCT02566759|99117|P7|STARTED|Washout Crossover Period (Part 4:5 Days)||0
42540|NCT02566759|99118|P6|STARTED|Washout Crossover Period (Part 4:5 Days)||0
42541|NCT02566759|99119|P5|STARTED|Washout Crossover Period (Part 4:5 Days)||0
42542|NCT02566759|99120|P4|STARTED|Washout Crossover Period (Part 4:5 Days)||0
42543|NCT02566759|99121|P3|STARTED|Washout Crossover Period (Part 4:5 Days)||0
42544|NCT02566759|99122|P2|STARTED|Washout Crossover Period (Part 4:5 Days)||0
42545|NCT02566759|99123|P1|STARTED|Washout Crossover Period (Part 4:5 Days)||0
42546|NCT02566759|99107|P17|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||1
42547|NCT02566759|99108|P16|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42548|NCT02566759|99109|P15|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42549|NCT02566759|99110|P14|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42550|NCT02566759|99111|P13|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42551|NCT02566759|99112|P12|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42552|NCT02566759|99113|P11|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42553|NCT02566759|99114|P10|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42554|NCT02566759|99115|P9|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42555|NCT02566759|99116|P8|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42556|NCT02566759|99117|P7|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42557|NCT02566759|99118|P6|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42558|NCT02566759|99119|P5|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42559|NCT02566759|99120|P4|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42560|NCT02566759|99121|P3|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42561|NCT02566759|99122|P2|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42562|NCT02566759|99123|P1|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42563|NCT02566759|99107|P17|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
42564|NCT02566759|99108|P16|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
42565|NCT02566759|99109|P15|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
42566|NCT02566759|99110|P14|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42567|NCT02566759|99111|P13|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42568|NCT02566759|99112|P12|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42569|NCT02566759|99113|P11|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42570|NCT02566759|99114|P10|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42571|NCT02566759|99115|P9|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42572|NCT02566759|99116|P8|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42573|NCT02566759|99117|P7|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42574|NCT02566759|99118|P6|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42575|NCT02566759|99119|P5|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42576|NCT02566759|99120|P4|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42577|NCT02566759|99121|P3|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42578|NCT02566759|99122|P2|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42579|NCT02566759|99123|P1|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
42580|NCT02566759|99107|P17|STARTED|Crossover Treatment (Part 4: 1 Day)||8
42581|NCT02566759|99108|P16|STARTED|Crossover Treatment (Part 4: 1 Day)||8
42582|NCT02566759|99109|P15|STARTED|Crossover Treatment (Part 4: 1 Day)||8
42583|NCT02566759|99110|P14|STARTED|Crossover Treatment (Part 4: 1 Day)||0
42584|NCT02566759|99111|P13|STARTED|Crossover Treatment (Part 4: 1 Day)||0
42585|NCT02566759|99112|P12|STARTED|Crossover Treatment (Part 4: 1 Day)||0
42586|NCT02566759|99113|P11|STARTED|Crossover Treatment (Part 4: 1 Day)||0
42587|NCT02566759|99114|P10|STARTED|Crossover Treatment (Part 4: 1 Day)||0
42588|NCT02566759|99115|P9|STARTED|Crossover Treatment (Part 4: 1 Day)||0
42589|NCT02566759|99116|P8|STARTED|Crossover Treatment (Part 4: 1 Day)||0
42590|NCT02566759|99117|P7|STARTED|Crossover Treatment (Part 4: 1 Day)||0
42591|NCT02566759|99118|P6|STARTED|Crossover Treatment (Part 4: 1 Day)||0
42592|NCT02566759|99119|P5|STARTED|Crossover Treatment (Part 4: 1 Day)||0
42593|NCT02566759|99120|P4|STARTED|Crossover Treatment (Part 4: 1 Day)||0
42594|NCT02566759|99121|P3|STARTED|Crossover Treatment (Part 4: 1 Day)||0
42595|NCT02566759|99122|P2|STARTED|Crossover Treatment (Part 4: 1 Day)||0
42596|NCT02566759|99123|P1|STARTED|Crossover Treatment (Part 4: 1 Day)||0
42597|NCT02566759|99107|P17|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42598|NCT02566759|99108|P16|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42599|NCT02566759|99109|P15|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42600|NCT02566759|99110|P14|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42601|NCT02566759|99111|P13|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42602|NCT02566759|99112|P12|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42603|NCT02566759|99113|P11|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42604|NCT02566759|99114|P10|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42605|NCT02566759|99115|P9|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42606|NCT02566759|99116|P8|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42607|NCT02566759|99117|P7|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42608|NCT02566759|99118|P6|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42609|NCT02566759|99119|P5|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42610|NCT02566759|99120|P4|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42611|NCT02566759|99121|P3|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42612|NCT02566759|99122|P2|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42613|NCT02566759|99123|P1|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42614|NCT02566759|99107|P17|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
42615|NCT02566759|99108|P16|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
42616|NCT02566759|99109|P15|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
42617|NCT02566759|99110|P14|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42618|NCT02566759|99111|P13|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42619|NCT02566759|99112|P12|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42620|NCT02566759|99113|P11|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42621|NCT02566759|99114|P10|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42622|NCT02566759|99115|P9|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42623|NCT02566759|99116|P8|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42624|NCT02566759|99117|P7|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42625|NCT02566759|99118|P6|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42626|NCT02566759|99119|P5|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42627|NCT02566759|99120|P4|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42628|NCT02566759|99121|P3|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42629|NCT02566759|99122|P2|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42630|NCT02566759|99123|P1|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
42631|NCT02566759|99107|P17|STARTED|Washout Crossover Period (Part 4:5 Days)||8
42632|NCT02566759|99108|P16|STARTED|Washout Crossover Period (Part 4:5 Days)||8
42633|NCT02566759|99109|P15|STARTED|Washout Crossover Period (Part 4:5 Days)||8
42634|NCT02566759|99110|P14|STARTED|Washout Crossover Period (Part 4:5 Days)||0
42635|NCT02566759|99111|P13|STARTED|Washout Crossover Period (Part 4:5 Days)||0
42636|NCT02566759|99112|P12|STARTED|Washout Crossover Period (Part 4:5 Days)||0
42637|NCT02566759|99113|P11|STARTED|Washout Crossover Period (Part 4:5 Days)||0
42638|NCT02566759|99114|P10|STARTED|Washout Crossover Period (Part 4:5 Days)||0
42639|NCT02566759|99115|P9|STARTED|Washout Crossover Period (Part 4:5 Days)||0
42640|NCT02566759|99116|P8|STARTED|Washout Crossover Period (Part 4:5 Days)||0
42641|NCT02566759|99117|P7|STARTED|Washout Crossover Period (Part 4:5 Days)||0
42642|NCT02566759|99118|P6|STARTED|Washout Crossover Period (Part 4:5 Days)||0
42643|NCT02566759|99119|P5|STARTED|Washout Crossover Period (Part 4:5 Days)||0
42644|NCT02566759|99120|P4|STARTED|Washout Crossover Period (Part 4:5 Days)||0
42645|NCT02566759|99121|P3|STARTED|Washout Crossover Period (Part 4:5 Days)||0
42646|NCT02566759|99122|P2|STARTED|Washout Crossover Period (Part 4:5 Days)||0
42647|NCT02566759|99123|P1|STARTED|Washout Crossover Period (Part 4:5 Days)||0
42648|NCT02566759|99107|P17|NOT COMPLETED|All Parts||0
42649|NCT02566759|99108|P16|NOT COMPLETED|All Parts||0
42650|NCT02566759|99109|P15|NOT COMPLETED|All Parts||0
42651|NCT02566759|99110|P14|NOT COMPLETED|All Parts||5
42652|NCT02566759|99111|P13|NOT COMPLETED|All Parts||1
42653|NCT02566759|99112|P12|NOT COMPLETED|All Parts||0
42654|NCT02566759|99113|P11|NOT COMPLETED|All Parts||0
42655|NCT02566759|99114|P10|NOT COMPLETED|All Parts||0
42656|NCT02566759|99115|P9|NOT COMPLETED|All Parts||0
42657|NCT02566759|99116|P8|NOT COMPLETED|All Parts||0
42658|NCT02566759|99117|P7|NOT COMPLETED|All Parts||0
42659|NCT02566759|99118|P6|NOT COMPLETED|All Parts||0
42660|NCT02566759|99119|P5|NOT COMPLETED|All Parts||0
42661|NCT02566759|99120|P4|NOT COMPLETED|All Parts||0
42662|NCT02566759|99121|P3|NOT COMPLETED|All Parts||0
42663|NCT02566759|99122|P2|NOT COMPLETED|All Parts||1
42664|NCT02566759|99123|P1|NOT COMPLETED|All Parts||0
42665|NCT02566759|99107|P17|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
42666|NCT02566759|99108|P16|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
42667|NCT02566759|99109|P15|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
42668|NCT02566759|99110|P14|COMPLETED|All Parts||0
42669|NCT02566759|99111|P13|COMPLETED|All Parts||0
42670|NCT02566759|99112|P12|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
42671|NCT02566759|99113|P11|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
42672|NCT02566759|99114|P10|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
42673|NCT02566759|99115|P9|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
42674|NCT02566759|99116|P8|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|8
42675|NCT02566759|99117|P7|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
42676|NCT02566759|99118|P6|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
42677|NCT02566759|99119|P5|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
42678|NCT02566759|99120|P4|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
42679|NCT02566759|99121|P3|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
42680|NCT02566759|99122|P2|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|5
42681|NCT02566759|99123|P1|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|12
42682|NCT02566759|99107|P17|STARTED|All Parts||8
42683|NCT02566759|99108|P16|STARTED|All Parts||8
42684|NCT02566759|99109|P15|STARTED|All Parts||8
42685|NCT02566759|99110|P14|STARTED|All Parts||5
42686|NCT02566759|99111|P13|STARTED|All Parts||1
42687|NCT02566759|99112|P12|STARTED|All Parts||6
42688|NCT02566759|99113|P11|STARTED|All Parts||6
42689|NCT02566759|99114|P10|STARTED|All Parts||6
42690|NCT02566759|99115|P9|STARTED|All Parts||6
42691|NCT02566759|99116|P8|STARTED|All Parts||8
42692|NCT02566759|99117|P7|STARTED|All Parts||6
42693|NCT02566759|99118|P6|STARTED|All Parts||6
42694|NCT02566759|99119|P5|STARTED|All Parts||6
42695|NCT02566759|99120|P4|STARTED|All Parts||6
42696|NCT02566759|99121|P3|STARTED|All Parts||6
42697|NCT02566759|99122|P2|STARTED|All Parts||6
42698|NCT02566759|99123|P1|STARTED|All Parts||12
42699|NCT02566590|99276|P2|NOT COMPLETED|Overall Study||0
42700|NCT02566590|99277|P1|NOT COMPLETED|Overall Study||0
42701|NCT02566590|99276|P2|COMPLETED|Overall Study||10
42702|NCT02566590|99277|P1|COMPLETED|Overall Study||10
42703|NCT02566590|99276|P2|STARTED|Overall Study||10
42704|NCT02566590|99277|P1|STARTED|Overall Study||10
42705|NCT02566577|99285|P2|NOT COMPLETED|Overall Study||2
42706|NCT02566577|99286|P1|NOT COMPLETED|Overall Study||3
42707|NCT02566577|99285|P2|COMPLETED|Overall Study||4
42708|NCT02566577|99286|P1|COMPLETED|Overall Study||6
42709|NCT02566577|99285|P2|STARTED|Overall Study||6
42710|NCT02566577|99286|P1|STARTED|Overall Study||9
42711|NCT02566369|99314|P2|NOT COMPLETED|Overall Study||61
42712|NCT02566369|99315|P1|NOT COMPLETED|Overall Study||72
42713|NCT02566369|99314|P2|COMPLETED|Overall Study||535
42714|NCT02566369|99315|P1|COMPLETED|Overall Study||540
42715|NCT02566369|99314|P2|STARTED|Overall Study||596
42716|NCT02566369|99315|P1|STARTED|Overall Study||612
42717|NCT02566317|99323|P2|NOT COMPLETED|Overall Study||62
42718|NCT02566317|99324|P1|NOT COMPLETED|Overall Study||29
42719|NCT02566317|99323|P2|COMPLETED|Overall Study||292
42720|NCT02566317|99324|P1|COMPLETED|Overall Study||247
42721|NCT02566317|99323|P2|STARTED|Overall Study||354
42722|NCT02566317|99324|P1|STARTED|Overall Study||276
42723|NCT02566265|99336|P2|NOT COMPLETED|Overall Study||6
42724|NCT02566265|99337|P1|NOT COMPLETED|Overall Study||9
42725|NCT02566265|99336|P2|COMPLETED|Overall Study||35
42726|NCT02566265|99337|P1|COMPLETED|Overall Study||72
42727|NCT02566265|99336|P2|End of Study Visit (Optional)|Overall Study||18
42728|NCT02566265|99337|P1|End of Study Visit (Optional)|Overall Study||38
42729|NCT02566265|99336|P2|30 Days Following 2nd Vaccine|Overall Study||35
42730|NCT02566265|99337|P1|30 Days Following 2nd Vaccine|Overall Study||72
42731|NCT02566265|99336|P2|Day of Second Vaccine|Overall Study||41
42732|NCT02566265|99337|P1|Day of Second Vaccine|Overall Study||74
42733|NCT02566265|99336|P2|Day 7 (+/- 2 Days) (Optional)|Overall Study||12
42734|NCT02566265|99337|P1|Day 7 (+/- 2 Days) (Optional)|Overall Study||19
42735|NCT02566265|99336|P2|STARTED|Overall Study||41
42736|NCT02566265|99337|P1|STARTED|Overall Study||81
42737|NCT02566135|99345|P2|NOT COMPLETED|Overall Study||0
42738|NCT02566135|99346|P1|NOT COMPLETED|Overall Study||0
42739|NCT02566135|99345|P2|COMPLETED|Overall Study||29
42740|NCT02566135|99346|P1|COMPLETED|Overall Study||29
42741|NCT02566135|99345|P2|STARTED|Overall Study||29
42742|NCT02566135|99346|P1|STARTED|Overall Study||29
42743|NCT02566109|99366|P1|NOT COMPLETED|Overall Study||1
42744|NCT02566109|99366|P1|COMPLETED|Overall Study||5
42745|NCT02566109|99366|P1|STARTED|Overall Study||6
42746|NCT02566044|99379|P3|NOT COMPLETED|Overall Study||0
42747|NCT02566044|99380|P2|NOT COMPLETED|Overall Study||0
42748|NCT02566044|99381|P1|NOT COMPLETED|Overall Study||0
42749|NCT02566044|99379|P3|COMPLETED|Overall Study||4
42750|NCT02566044|99380|P2|COMPLETED|Overall Study||6
42751|NCT02566044|99381|P1|COMPLETED|Overall Study||6
42752|NCT02566044|99379|P3|STARTED|Overall Study||4
42753|NCT02566044|99380|P2|STARTED|Overall Study||6
42754|NCT02566044|99381|P1|STARTED|Overall Study||6
42755|NCT02566031|99421|P2|NOT COMPLETED|Overall Study||12
42756|NCT02566031|99422|P1|NOT COMPLETED|Overall Study||20
42757|NCT02566031|99421|P2|COMPLETED|Overall Study||178
42758|NCT02566031|99422|P1|COMPLETED|Overall Study||169
42759|NCT02566031|99421|P2|STARTED|Overall Study||190
42760|NCT02566031|99422|P1|STARTED|Overall Study||189
42761|NCT02566005|99439|P2|NOT COMPLETED|Overall Study||6
42762|NCT02566005|99440|P1|NOT COMPLETED|Overall Study||8
42763|NCT02566005|99439|P2|COMPLETED|Overall Study||94
42764|NCT02566005|99440|P1|COMPLETED|Overall Study||92
42765|NCT02566005|99439|P2|STARTED|Overall Study||100
42766|NCT02566005|99440|P1|STARTED|Overall Study||100
42767|NCT02565810|99468|P1|NOT COMPLETED|Overall Study||1
42768|NCT02565810|99468|P1|COMPLETED|Overall Study||48
42769|NCT02565810|99468|P1|STARTED|Overall Study||49
42770|NCT02565784|99477|P1|NOT COMPLETED|Second Treatment||2
42771|NCT02565784|99477|P1|COMPLETED|Second Treatment||96
42772|NCT02565784|99477|P1|12 Months Follow-up|Second Treatment||96
42773|NCT02565784|99477|P1|6 Months Follow-up|Second Treatment||97
42774|NCT02565784|99477|P1|STARTED|Second Treatment||98
42775|NCT02565784|99477|P1|NOT COMPLETED|First Treatment||2
42776|NCT02565784|99477|P1|COMPLETED|First Treatment||98
42777|NCT02565784|99477|P1|12 Months Follow-up|First Treatment||98
42778|NCT02565784|99477|P1|6 Months Follow-up|First Treatment||99
42779|NCT02565784|99477|P1|STARTED|First Treatment||100
42780|NCT02565706|99489|P4|NOT COMPLETED|Overall Study||85
42781|NCT02565706|99490|P3|NOT COMPLETED|Overall Study||89
42782|NCT02565706|99491|P2|NOT COMPLETED|Overall Study||82
42783|NCT02565706|99492|P1|NOT COMPLETED|Overall Study||77
42784|NCT02565706|99489|P4|COMPLETED|Overall Study||116
42785|NCT02565706|99490|P3|COMPLETED|Overall Study||104
42786|NCT02565706|99491|P2|COMPLETED|Overall Study||90
42787|NCT02565706|99492|P1|COMPLETED|Overall Study||101
42788|NCT02565706|99489|P4|STARTED|Overall Study||201
42789|NCT02565706|99490|P3|STARTED|Overall Study||193
42790|NCT02565706|99491|P2|STARTED|Overall Study||172
42791|NCT02565706|99492|P1|STARTED|Overall Study||178
42792|NCT02565628|99564|P2|NOT COMPLETED|Overall Study||0
42793|NCT02565628|99565|P1|NOT COMPLETED|Overall Study||0
42794|NCT02565628|99564|P2|COMPLETED|Overall Study||9
42795|NCT02565628|99565|P1|COMPLETED|Overall Study||10
42796|NCT02565628|99564|P2|Received Treatment|Overall Study||9
42797|NCT02565628|99565|P1|Received Treatment|Overall Study||10
42798|NCT02565628|99564|P2|STARTED|Overall Study||9
42799|NCT02565628|99565|P1|STARTED|Overall Study||10
42800|NCT02565615|99598|P5|NOT COMPLETED|Overall Study||1601
42801|NCT02565615|99599|P4|NOT COMPLETED|Overall Study||3
42802|NCT02565615|99600|P3|NOT COMPLETED|Overall Study||0
42803|NCT02565615|99601|P2|NOT COMPLETED|Overall Study||36
42804|NCT02565615|99602|P1|NOT COMPLETED|Overall Study||3
42805|NCT02565615|99598|P5|COMPLETED|Overall Study||21
42806|NCT02565615|99599|P4|COMPLETED|Overall Study||98
42807|NCT02565615|99600|P3|COMPLETED|Overall Study||21
42808|NCT02565615|99601|P2|COMPLETED|Overall Study||3044
42809|NCT02565615|99602|P1|COMPLETED|Overall Study||288
42810|NCT02565615|99598|P5|Treated|Overall Study||1055
42811|NCT02565615|99599|P4|Treated|Overall Study||101
42812|NCT02565615|99600|P3|Treated|Overall Study||21
42813|NCT02565615|99601|P2|Treated|Overall Study||3080
42814|NCT02565615|99602|P1|Treated|Overall Study||291
42815|NCT02565615|99598|P5|STARTED|Overall Study||1622
42816|NCT02565615|99599|P4|STARTED|Overall Study||101
42817|NCT02565615|99600|P3|STARTED|Overall Study||21
42818|NCT02565615|99601|P2|STARTED|Overall Study||3080
42819|NCT02565615|99602|P1|STARTED|Overall Study||291
42820|NCT02565576|99716|P2|NOT COMPLETED|Overall Study||5
42821|NCT02565576|99717|P1|NOT COMPLETED|Overall Study||5
42822|NCT02565576|99716|P2|COMPLETED|Overall Study||17
42823|NCT02565576|99717|P1|COMPLETED|Overall Study||17
42824|NCT02565576|99716|P2|STARTED|Overall Study||22
42825|NCT02565576|99717|P1|STARTED|Overall Study||22
42826|NCT02565485|99744|P2|NOT COMPLETED|Overall Study||0
42827|NCT02565485|99745|P1|NOT COMPLETED|Overall Study||0
42828|NCT02565485|99744|P2|COMPLETED|Overall Study||137
42829|NCT02565485|99745|P1|COMPLETED|Overall Study||139
42830|NCT02565485|99744|P2|STARTED|Overall Study||137
42831|NCT02565485|99745|P1|STARTED|Overall Study||139
42832|NCT02565381|99760|P3|NOT COMPLETED|Overall Study||1
42833|NCT02565381|99761|P2|NOT COMPLETED|Overall Study||0
42834|NCT02565381|99762|P1|NOT COMPLETED|Overall Study||1
42835|NCT02565381|99760|P3|COMPLETED|Overall Study||24
42836|NCT02565381|99761|P2|COMPLETED|Overall Study||25
42837|NCT02565381|99762|P1|COMPLETED|Overall Study||24
42838|NCT02565381|99760|P3|STARTED|Overall Study||25
42839|NCT02565381|99761|P2|STARTED|Overall Study||25
42840|NCT02565381|99762|P1|STARTED|Overall Study||25
42841|NCT02565147|99802|P2|NOT COMPLETED|Overall Study||3
42842|NCT02565147|99803|P1|NOT COMPLETED|Overall Study||6
42843|NCT02565147|99802|P2|COMPLETED|Overall Study||37
42844|NCT02565147|99803|P1|COMPLETED|Overall Study||32
42845|NCT02565147|99802|P2|Per-Protocol Population|Overall Study||36
42846|NCT02565147|99803|P1|Per-Protocol Population|Overall Study||28
42847|NCT02565147|99802|P2|Received Study Drug|Overall Study||40
42848|NCT02565147|99803|P1|Received Study Drug|Overall Study||38
42849|NCT02565147|99802|P2|STARTED|Overall Study||40
42850|NCT02565147|99803|P1|STARTED|Overall Study||38
42851|NCT02565108|99827|P2|NOT COMPLETED|Overall Study||0
42852|NCT02565108|99828|P1|NOT COMPLETED|Overall Study||2
42853|NCT02565108|99827|P2|COMPLETED|Overall Study||4
42854|NCT02565108|99828|P1|COMPLETED|Overall Study||14
42855|NCT02565108|99827|P2|Pharmacokinetic (PK) Set|Overall Study||3
42856|NCT02565108|99828|P1|Pharmacokinetic (PK) Set|Overall Study||10
42857|NCT02565108|99827|P2|Safety Set|Overall Study||4
42858|NCT02565108|99828|P1|Safety Set|Overall Study||16
42859|NCT02565108|99827|P2|STARTED|Overall Study||4
42860|NCT02565108|99828|P1|STARTED|Overall Study||16
42861|NCT02564952|99844|P1|NOT COMPLETED|Overall Study||11
42862|NCT02564952|99844|P1|COMPLETED|Overall Study||7
42863|NCT02564952|99844|P1|Completed OLE Titration Period|Overall Study||16
42864|NCT02564952|99844|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
42865|NCT02564952|99844|P1|STARTED|Overall Study||18
42866|NCT02564926|99850|P2|NOT COMPLETED|Overall Study||7
42867|NCT02564926|99851|P1|NOT COMPLETED|Overall Study||8
42868|NCT02564926|99850|P2|COMPLETED|Overall Study||54
42869|NCT02564926|99851|P1|COMPLETED|Overall Study||52
42870|NCT02564926|99850|P2|STARTED|Overall Study||61
42871|NCT02564926|99851|P1|STARTED|Overall Study||60
42872|NCT02564718|99889|P2|NOT COMPLETED|Overall Study||1
42873|NCT02564718|99890|P1|NOT COMPLETED|Overall Study||0
42874|NCT02564718|99889|P2|COMPLETED|Overall Study||4
42875|NCT02564718|99890|P1|COMPLETED|Overall Study||5
42876|NCT02564718|99889|P2|STARTED|Overall Study||5
42877|NCT02564718|99890|P1|STARTED|Overall Study||5
42878|NCT02564497|99920|P2|NOT COMPLETED|Overall Study||0
42879|NCT02564497|99921|P1|NOT COMPLETED|Overall Study||0
42880|NCT02564497|99920|P2|COMPLETED|Overall Study||72
42881|NCT02564497|99921|P1|COMPLETED|Overall Study||74
42882|NCT02564497|99920|P2|STARTED|Overall Study||72
42883|NCT02564497|99921|P1|STARTED|Overall Study||74
42884|NCT02564263|99941|P2|NOT COMPLETED|Overall Study||314
42885|NCT02564263|99942|P1|NOT COMPLETED|Overall Study||314
42886|NCT02564263|99941|P2|COMPLETED|Overall Study||0
42887|NCT02564263|99942|P1|COMPLETED|Overall Study||0
42888|NCT02564263|99941|P2|Treated|Overall Study||296
42889|NCT02564263|99942|P1|Treated|Overall Study||314
42890|NCT02564263|99941|P2|STARTED|Overall Study||314
42891|NCT02564263|99942|P1|STARTED|Overall Study||314
42892|NCT02564211|99964|P1|NOT COMPLETED|Overall Study||4
42893|NCT02564211|99964|P1|COMPLETED|Overall Study||73
42894|NCT02564211|99964|P1|STARTED|Overall Study||77
42895|NCT02564055|99976|P6|NOT COMPLETED|Overall Study||12
42896|NCT02564055|99977|P5|NOT COMPLETED|Overall Study||15
42897|NCT02564055|99978|P4|NOT COMPLETED|Overall Study||6
42898|NCT02564055|99979|P3|NOT COMPLETED|Overall Study||12
42899|NCT02564055|99980|P2|NOT COMPLETED|Overall Study||5
42900|NCT02564055|99981|P1|NOT COMPLETED|Overall Study||6
42901|NCT02564055|99976|P6|COMPLETED|Overall Study||28
42902|NCT02564055|99977|P5|COMPLETED|Overall Study||27
42903|NCT02564055|99978|P4|COMPLETED|Overall Study||35
42904|NCT02564055|99979|P3|COMPLETED|Overall Study||31
42905|NCT02564055|99980|P2|COMPLETED|Overall Study||36
42906|NCT02564055|99981|P1|COMPLETED|Overall Study||34
42907|NCT02564055|99976|P6|STARTED|Overall Study||40
42908|NCT02564055|99977|P5|STARTED|Overall Study||42
42909|NCT02564055|99978|P4|STARTED|Overall Study||41
42910|NCT02564055|99979|P3|STARTED|Overall Study||43
42911|NCT02564055|99980|P2|STARTED|Overall Study||41
42912|NCT02564055|99981|P1|STARTED|Overall Study||40
42913|NCT02564042|100235|P6|NOT COMPLETED|Overall Study||14
42914|NCT02564042|100236|P5|NOT COMPLETED|Overall Study||11
42915|NCT02564042|100237|P4|NOT COMPLETED|Overall Study||3
42916|NCT02564042|100238|P3|NOT COMPLETED|Overall Study||6
42917|NCT02564042|100239|P2|NOT COMPLETED|Overall Study||8
42918|NCT02564042|100240|P1|NOT COMPLETED|Overall Study||11
42919|NCT02564042|100235|P6|COMPLETED|Overall Study||24
42920|NCT02564042|100236|P5|COMPLETED|Overall Study||26
42921|NCT02564042|100237|P4|COMPLETED|Overall Study||35
42922|NCT02564042|100238|P3|COMPLETED|Overall Study||32
42923|NCT02564042|100239|P2|COMPLETED|Overall Study||30
42924|NCT02564042|100240|P1|COMPLETED|Overall Study||27
42925|NCT02564042|100235|P6|STARTED|Overall Study||38
42926|NCT02564042|100236|P5|STARTED|Overall Study||37
42927|NCT02564042|100237|P4|STARTED|Overall Study||38
42928|NCT02564042|100238|P3|STARTED|Overall Study||38
42929|NCT02564042|100239|P2|STARTED|Overall Study||38
42930|NCT02564042|100240|P1|STARTED|Overall Study||38
42931|NCT02564029|100452|P1|NOT COMPLETED|Overall Study||0
42932|NCT02564029|100452|P1|COMPLETED|Overall Study||7
42933|NCT02564029|100452|P1|STARTED|Overall Study||7
42934|NCT02564016|100495|P2|NOT COMPLETED|Overall Study||10
42935|NCT02564016|100496|P1|NOT COMPLETED|Overall Study||18
42936|NCT02564016|100495|P2|COMPLETED|Overall Study||4
42937|NCT02564016|100496|P1|COMPLETED|Overall Study||4
42938|NCT02564016|100495|P2|STARTED|Overall Study||14
42939|NCT02564016|100496|P1|STARTED|Overall Study||22
42940|NCT02563899|100510|P4|NOT COMPLETED|Overall Study||0
42941|NCT02563899|100511|P3|NOT COMPLETED|Overall Study||1
42942|NCT02563899|100512|P2|NOT COMPLETED|Overall Study||0
42943|NCT02563899|100513|P1|NOT COMPLETED|Overall Study||1
42944|NCT02563899|100510|P4|COMPLETED|Overall Study||6
42945|NCT02563899|100511|P3|COMPLETED|Overall Study||9
42946|NCT02563899|100512|P2|COMPLETED|Overall Study||5
42947|NCT02563899|100513|P1|COMPLETED|Overall Study||17
42948|NCT02563899|100510|P4|STARTED|Overall Study||6
42949|NCT02563899|100511|P3|STARTED|Overall Study||10
42950|NCT02563899|100512|P2|STARTED|Overall Study||5
42951|NCT02563899|100513|P1|STARTED|Overall Study||18
42952|NCT02563860|100554|P1|NOT COMPLETED|Overall Study||1
42953|NCT02563860|100554|P1|COMPLETED|Overall Study||19
42954|NCT02563860|100554|P1|STARTED|Overall Study||20
42955|NCT02563834|100561|P2|NOT COMPLETED|Insulin Infusion (*Day 2)||0
42956|NCT02563834|100562|P1|NOT COMPLETED|Insulin Infusion (*Day 2)||0
42957|NCT02563834|100561|P2|COMPLETED|Insulin Infusion (*Day 2)||8
42958|NCT02563834|100562|P1|COMPLETED|Insulin Infusion (*Day 2)||10
42959|NCT02563834|100561|P2|STARTED|Insulin Infusion (*Day 2)||8
42960|NCT02563834|100562|P1|STARTED|Insulin Infusion (*Day 2)||10
42961|NCT02563834|100561|P2|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
42962|NCT02563834|100562|P1|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
42963|NCT02563834|100561|P2|COMPLETED|Control (Saline) Infusion (*Day 1)||8
42964|NCT02563834|100562|P1|COMPLETED|Control (Saline) Infusion (*Day 1)||10
42965|NCT02563834|100561|P2|STARTED|Control (Saline) Infusion (*Day 1)||8
42966|NCT02563834|100562|P1|STARTED|Control (Saline) Infusion (*Day 1)||10
42967|NCT02563808|100580|P2|NOT COMPLETED|Overall Study||0
42968|NCT02563808|100581|P1|NOT COMPLETED|Overall Study||0
42969|NCT02563808|100580|P2|COMPLETED|Overall Study||88
42970|NCT02563808|100581|P1|COMPLETED|Overall Study||96
42971|NCT02563808|100580|P2|STARTED|Overall Study|A total of 5 participants enrolled were not included in final data due to data collection error|88
42972|NCT02563808|100581|P1|STARTED|Overall Study||96
42973|NCT02563106|100589|P2|NOT COMPLETED|Overall Study||29
42974|NCT02563106|100590|P1|NOT COMPLETED|Overall Study||34
42975|NCT02563106|100589|P2|COMPLETED|Overall Study||178
42976|NCT02563106|100590|P1|COMPLETED|Overall Study||172
42977|NCT02563106|100589|P2|STARTED|Overall Study||207
42978|NCT02563106|100590|P1|STARTED|Overall Study||206
42979|NCT02563093|100600|P4|NOT COMPLETED|Overall Study||0
42980|NCT02563093|100601|P3|NOT COMPLETED|Overall Study||0
42981|NCT02563093|100602|P2|NOT COMPLETED|Overall Study||0
42982|NCT02563093|100603|P1|NOT COMPLETED|Overall Study||0
42983|NCT02563093|100600|P4|COMPLETED|Overall Study||51
42984|NCT02563093|100601|P3|COMPLETED|Overall Study||53
42985|NCT02563093|100602|P2|COMPLETED|Overall Study||52
42986|NCT02563093|100603|P1|COMPLETED|Overall Study||52
42987|NCT02563093|100600|P4|STARTED|Overall Study||51
42988|NCT02563093|100601|P3|STARTED|Overall Study||53
42989|NCT02563093|100602|P2|STARTED|Overall Study||52
42990|NCT02563093|100603|P1|STARTED|Overall Study||52
42991|NCT02563028|100629|P1|NOT COMPLETED|Overall Study||2
42992|NCT02563028|100629|P1|COMPLETED|Overall Study||18
42993|NCT02563028|100629|P1|STARTED|Overall Study||20
42994|NCT02562989|100639|P3|NOT COMPLETED|Overall Study||0
42995|NCT02562989|100640|P2|NOT COMPLETED|Overall Study||0
42996|NCT02562989|100641|P1|NOT COMPLETED|Overall Study||0
42997|NCT02562989|100639|P3|COMPLETED|Overall Study||6
42998|NCT02562989|100640|P2|COMPLETED|Overall Study||4
42999|NCT02562989|100641|P1|COMPLETED|Overall Study||3
43000|NCT02562989|100639|P3|STARTED|Overall Study||6
43001|NCT02562989|100640|P2|STARTED|Overall Study||4
43002|NCT02562989|100641|P1|STARTED|Overall Study||3
43003|NCT02562924|100667|P3|NOT COMPLETED|Overall Study||4
43004|NCT02562924|100668|P2|NOT COMPLETED|Overall Study||11
43005|NCT02562924|100669|P1|NOT COMPLETED|Overall Study||1
43006|NCT02562924|100667|P3|COMPLETED|Overall Study||8
43007|NCT02562924|100668|P2|COMPLETED|Overall Study||1
43008|NCT02562924|100669|P1|COMPLETED|Overall Study||12
43009|NCT02562924|100667|P3|STARTED|Overall Study||12
43010|NCT02562924|100668|P2|STARTED|Overall Study||12
43011|NCT02562924|100669|P1|STARTED|Overall Study||13
43012|NCT02562521|100688|P2|NOT COMPLETED|Overall Study||0
43013|NCT02562521|100689|P1|NOT COMPLETED|Overall Study||0
43014|NCT02562521|100688|P2|COMPLETED|Overall Study||7
43015|NCT02562521|100689|P1|COMPLETED|Overall Study||18
43016|NCT02562521|100688|P2|STARTED|Overall Study||7
43017|NCT02562521|100689|P1|STARTED|Overall Study||18
43018|NCT02562482|100705|P2|NOT COMPLETED|Overall Study||16
43019|NCT02562482|100706|P1|NOT COMPLETED|Overall Study||21
43020|NCT02562482|100705|P2|COMPLETED|Overall Study||183
43021|NCT02562482|100706|P1|COMPLETED|Overall Study||180
43022|NCT02562482|100705|P2|Received 2nd Injection|Overall Study||192
43023|NCT02562482|100706|P1|Received 2nd Injection|Overall Study||192
43024|NCT02562482|100705|P2|Received 1st Injection|Overall Study||199
43025|NCT02562482|100706|P1|Received 1st Injection|Overall Study||197
43026|NCT02562482|100705|P2|STARTED|Overall Study||199
43027|NCT02562482|100706|P1|STARTED|Overall Study||201
43028|NCT02561832|100730|P2|NOT COMPLETED|Overall Study||4
43029|NCT02561832|100731|P1|NOT COMPLETED|Overall Study||7
43030|NCT02561832|100730|P2|COMPLETED|Overall Study||3
43031|NCT02561832|100731|P1|COMPLETED|Overall Study||1
43032|NCT02561832|100730|P2|INFORMED CONSENT OBTAINED|Overall Study||7
43033|NCT02561832|100731|P1|INFORMED CONSENT OBTAINED|Overall Study||8
43034|NCT02561832|100730|P2|STARTED|Overall Study||7
43035|NCT02561832|100731|P1|STARTED|Overall Study||8
43036|NCT02561806|100739|P2|NOT COMPLETED|Post-Treatment Follow-up||1
43037|NCT02561806|100740|P1|NOT COMPLETED|Post-Treatment Follow-up||2
43038|NCT02561806|100739|P2|COMPLETED|Post-Treatment Follow-up||59
43039|NCT02561806|100740|P1|COMPLETED|Post-Treatment Follow-up||155
43040|NCT02561806|100739|P2|STARTED|Post-Treatment Follow-up|Participants who discontinued previous periods had option to enter post treatment follow-up period.|60
43041|NCT02561806|100740|P1|STARTED|Post-Treatment Follow-up|Participants who discontinued previous periods had option to enter post treatment follow-up period.|157
43042|NCT02561806|100739|P2|NOT COMPLETED|Maintenance Period||8
43043|NCT02561806|100740|P1|NOT COMPLETED|Maintenance Period||13
43044|NCT02561806|100739|P2|COMPLETED|Maintenance Period||123
43045|NCT02561806|100740|P1|COMPLETED|Maintenance Period||151
43046|NCT02561806|100739|P2|STARTED|Maintenance Period||131
43047|NCT02561806|100740|P1|STARTED|Maintenance Period||164
43048|NCT02561806|100739|P2|NOT COMPLETED|Induction Period||5
43049|NCT02561806|100740|P1|NOT COMPLETED|Induction Period||2
43050|NCT02561806|100739|P2|COMPLETED|Induction Period||131
43051|NCT02561806|100740|P1|COMPLETED|Induction Period||164
43052|NCT02561806|100739|P2|Received At Least One Dose of Study Drug|Induction Period||135
43053|NCT02561806|100740|P1|Received At Least One Dose of Study Drug|Induction Period||166
43054|NCT02561806|100739|P2|STARTED|Induction Period||136
43055|NCT02561806|100740|P1|STARTED|Induction Period||166
43056|NCT02561702|100796|P2|NOT COMPLETED|Second Intervention||0
43057|NCT02561702|100797|P1|NOT COMPLETED|Second Intervention||0
43058|NCT02561702|100796|P2|COMPLETED|Second Intervention||2
43059|NCT02561702|100797|P1|COMPLETED|Second Intervention||2
43060|NCT02561702|100796|P2|STARTED|Second Intervention||2
43061|NCT02561702|100797|P1|STARTED|Second Intervention||2
43062|NCT02561702|100796|P2|NOT COMPLETED|Washout||0
43063|NCT02561702|100797|P1|NOT COMPLETED|Washout||0
43064|NCT02561702|100796|P2|COMPLETED|Washout||2
43065|NCT02561702|100797|P1|COMPLETED|Washout||2
43066|NCT02561702|100796|P2|STARTED|Washout||2
43067|NCT02561702|100797|P1|STARTED|Washout||2
43068|NCT02561702|100796|P2|NOT COMPLETED|First Intervention||0
43069|NCT02561702|100797|P1|NOT COMPLETED|First Intervention||0
43070|NCT02561702|100796|P2|COMPLETED|First Intervention||2
43071|NCT02561702|100797|P1|COMPLETED|First Intervention||2
43072|NCT02561702|100796|P2|STARTED|First Intervention||2
43073|NCT02561702|100797|P1|STARTED|First Intervention||2
43074|NCT02561585|100807|P2|NOT COMPLETED|Overall Study||5
43075|NCT02561585|100808|P1|NOT COMPLETED|Overall Study||3
43076|NCT02561585|100807|P2|COMPLETED|Overall Study||6
43077|NCT02561585|100808|P1|COMPLETED|Overall Study||17
43078|NCT02561585|100807|P2|STARTED|Overall Study||11
43079|NCT02561585|100808|P1|STARTED|Overall Study||20
43080|NCT02561572|100844|P2|NOT COMPLETED|Overall Study||2
43081|NCT02561572|100845|P1|NOT COMPLETED|Overall Study||2
43082|NCT02561572|100844|P2|COMPLETED|Overall Study||62
43083|NCT02561572|100845|P1|COMPLETED|Overall Study||62
43084|NCT02561572|100844|P2|STARTED|Overall Study||64
43085|NCT02561572|100845|P1|STARTED|Overall Study||64
43086|NCT02561195|100867|P6|NOT COMPLETED|Overall Study||10
43087|NCT02561195|100868|P5|NOT COMPLETED|Overall Study||28
43088|NCT02561195|100869|P4|NOT COMPLETED|Overall Study||26
43089|NCT02561195|100870|P3|NOT COMPLETED|Overall Study||6
43090|NCT02561195|100871|P2|NOT COMPLETED|Overall Study||22
43091|NCT02561195|100872|P1|NOT COMPLETED|Overall Study||23
43092|NCT02561195|100867|P6|COMPLETED|Overall Study||51
43093|NCT02561195|100868|P5|COMPLETED|Overall Study||155
43094|NCT02561195|100869|P4|COMPLETED|Overall Study||157
43095|NCT02561195|100870|P3|COMPLETED|Overall Study||55
43096|NCT02561195|100871|P2|COMPLETED|Overall Study||162
43097|NCT02561195|100872|P1|COMPLETED|Overall Study||160
43098|NCT02561195|100867|P6|Treated|Overall Study||61
43099|NCT02561195|100868|P5|Treated|Overall Study||183
43100|NCT02561195|100869|P4|Treated|Overall Study||183
43101|NCT02561195|100870|P3|Treated|Overall Study||61
43102|NCT02561195|100871|P2|Treated|Overall Study||184
43103|NCT02561195|100872|P1|Treated|Overall Study||182
43104|NCT02561195|100867|P6|STARTED|Overall Study||61
43105|NCT02561195|100868|P5|STARTED|Overall Study||183
43106|NCT02561195|100869|P4|STARTED|Overall Study||183
43107|NCT02561195|100870|P3|STARTED|Overall Study||61
43108|NCT02561195|100871|P2|STARTED|Overall Study||184
43109|NCT02561195|100872|P1|STARTED|Overall Study||183
43110|NCT02561156|101033|P13|NOT COMPLETED|Part 2||0
43111|NCT02561156|101034|P12|NOT COMPLETED|Part 2||1
43112|NCT02561156|101035|P11|NOT COMPLETED|Part 2||0
43113|NCT02561156|101036|P10|NOT COMPLETED|Part 2||0
43114|NCT02561156|101037|P9|NOT COMPLETED|Part 2||0
43115|NCT02561156|101038|P8|NOT COMPLETED|Part 2||0
43116|NCT02561156|101039|P7|NOT COMPLETED|Part 2||0
43117|NCT02561156|101040|P6|NOT COMPLETED|Part 2||0
43118|NCT02561156|101041|P5|NOT COMPLETED|Part 2||0
43119|NCT02561156|101042|P4|NOT COMPLETED|Part 2||0
43120|NCT02561156|101043|P3|NOT COMPLETED|Part 2||0
43121|NCT02561156|101044|P2|NOT COMPLETED|Part 2||0
43122|NCT02561156|101045|P1|NOT COMPLETED|Part 2||0
43123|NCT02561156|101033|P13|COMPLETED|Part 2||6
43124|NCT02561156|101034|P12|COMPLETED|Part 2||5
43125|NCT02561156|101035|P11|COMPLETED|Part 2||6
43126|NCT02561156|101036|P10|COMPLETED|Part 2||6
43127|NCT02561156|101037|P9|COMPLETED|Part 2||6
43128|NCT02561156|101038|P8|COMPLETED|Part 2||10
43129|NCT02561156|101039|P7|COMPLETED|Part 2||0
43130|NCT02561156|101040|P6|COMPLETED|Part 2||0
43131|NCT02561156|101041|P5|COMPLETED|Part 2||0
43132|NCT02561156|101042|P4|COMPLETED|Part 2||0
43133|NCT02561156|101043|P3|COMPLETED|Part 2||0
43134|NCT02561156|101044|P2|COMPLETED|Part 2||0
43135|NCT02561156|101045|P1|COMPLETED|Part 2||0
43136|NCT02561156|101033|P13|STARTED|Part 2||6
43137|NCT02561156|101034|P12|STARTED|Part 2||6
43138|NCT02561156|101035|P11|STARTED|Part 2||6
43139|NCT02561156|101036|P10|STARTED|Part 2||6
43140|NCT02561156|101037|P9|STARTED|Part 2||6
43141|NCT02561156|101038|P8|STARTED|Part 2||10
43142|NCT02561156|101039|P7|STARTED|Part 2||0
43143|NCT02561156|101040|P6|STARTED|Part 2||0
43144|NCT02561156|101041|P5|STARTED|Part 2||0
43145|NCT02561156|101042|P4|STARTED|Part 2||0
43146|NCT02561156|101043|P3|STARTED|Part 2||0
43147|NCT02561156|101044|P2|STARTED|Part 2||0
43148|NCT02561156|101045|P1|STARTED|Part 2||0
43149|NCT02561156|101033|P13|NOT COMPLETED|Part 1||0
43150|NCT02561156|101034|P12|NOT COMPLETED|Part 1||0
43151|NCT02561156|101035|P11|NOT COMPLETED|Part 1||0
43152|NCT02561156|101036|P10|NOT COMPLETED|Part 1||0
43153|NCT02561156|101037|P9|NOT COMPLETED|Part 1||0
43154|NCT02561156|101038|P8|NOT COMPLETED|Part 1||0
43155|NCT02561156|101039|P7|NOT COMPLETED|Part 1||0
43156|NCT02561156|101040|P6|NOT COMPLETED|Part 1||0
43157|NCT02561156|101041|P5|NOT COMPLETED|Part 1||0
43158|NCT02561156|101042|P4|NOT COMPLETED|Part 1||0
43159|NCT02561156|101043|P3|NOT COMPLETED|Part 1||0
43160|NCT02561156|101044|P2|NOT COMPLETED|Part 1||0
43161|NCT02561156|101045|P1|NOT COMPLETED|Part 1||0
43162|NCT02561156|101033|P13|COMPLETED|Part 1||0
43163|NCT02561156|101034|P12|COMPLETED|Part 1||0
43164|NCT02561156|101035|P11|COMPLETED|Part 1||0
43165|NCT02561156|101036|P10|COMPLETED|Part 1||0
43166|NCT02561156|101037|P9|COMPLETED|Part 1||0
43167|NCT02561156|101038|P8|COMPLETED|Part 1||0
43168|NCT02561156|101039|P7|COMPLETED|Part 1||6
43169|NCT02561156|101040|P6|COMPLETED|Part 1||6
43170|NCT02561156|101041|P5|COMPLETED|Part 1||6
43171|NCT02561156|101042|P4|COMPLETED|Part 1||6
43172|NCT02561156|101043|P3|COMPLETED|Part 1||6
43173|NCT02561156|101044|P2|COMPLETED|Part 1||6
43174|NCT02561156|101045|P1|COMPLETED|Part 1||12
43175|NCT02561156|101033|P13|STARTED|Part 1||0
43176|NCT02561156|101034|P12|STARTED|Part 1||0
43177|NCT02561156|101035|P11|STARTED|Part 1||0
43178|NCT02561156|101036|P10|STARTED|Part 1||0
43179|NCT02561156|101037|P9|STARTED|Part 1||0
43180|NCT02561156|101038|P8|STARTED|Part 1||0
43181|NCT02561156|101039|P7|STARTED|Part 1||6
43182|NCT02561156|101040|P6|STARTED|Part 1||6
43183|NCT02561156|101041|P5|STARTED|Part 1||6
43184|NCT02561156|101042|P4|STARTED|Part 1||6
43185|NCT02561156|101043|P3|STARTED|Part 1||6
43186|NCT02561156|101044|P2|STARTED|Part 1||6
43187|NCT02561156|101045|P1|STARTED|Part 1||12
43188|NCT02560922|101217|P2|NOT COMPLETED|Overall Study||12
43189|NCT02560922|101218|P1|NOT COMPLETED|Overall Study||26
43190|NCT02560922|101217|P2|COMPLETED|Overall Study||112
43191|NCT02560922|101218|P1|COMPLETED|Overall Study||98
43192|NCT02560922|101217|P2|STARTED|Overall Study||124
43193|NCT02560922|101218|P1|STARTED|Overall Study||124
43194|NCT02560753|101246|P4|NOT COMPLETED|Overall Study||0
43195|NCT02560753|101247|P3|NOT COMPLETED|Overall Study||1
43196|NCT02560753|101248|P2|NOT COMPLETED|Overall Study||0
43197|NCT02560753|101249|P1|NOT COMPLETED|Overall Study||1
43198|NCT02560753|101246|P4|COMPLETED|Overall Study||8
43199|NCT02560753|101247|P3|COMPLETED|Overall Study||9
43200|NCT02560753|101248|P2|COMPLETED|Overall Study||9
43201|NCT02560753|101249|P1|COMPLETED|Overall Study||8
43202|NCT02560753|101246|P4|STARTED|Overall Study||8
43203|NCT02560753|101247|P3|STARTED|Overall Study||10
43204|NCT02560753|101248|P2|STARTED|Overall Study||9
43205|NCT02560753|101249|P1|STARTED|Overall Study||9
43206|NCT02560701|101277|P2|NOT COMPLETED|Overall Study||51466
43207|NCT02560701|101278|P1|NOT COMPLETED|Overall Study||4543
43208|NCT02560701|101277|P2|COMPLETED|Overall Study||37776
43209|NCT02560701|101278|P1|COMPLETED|Overall Study||3517
43210|NCT02560701|101277|P2|Matched Cohort|Overall Study||37776
43211|NCT02560701|101278|P1|Matched Cohort|Overall Study||3517
43212|NCT02560701|101277|P2|Bipolar Diagnosis Time Constraints|Overall Study||39427
43213|NCT02560701|101278|P1|Bipolar Diagnosis Time Constraints|Overall Study||3533
43214|NCT02560701|101277|P2|Restrict to Patients Between 12 and 64|Overall Study||82367
43215|NCT02560701|101278|P1|Restrict to Patients Between 12 and 64|Overall Study||7598
43216|NCT02560701|101277|P2|Carve Out|Overall Study||88729
43217|NCT02560701|101278|P1|Carve Out|Overall Study||8060
43218|NCT02560701|101277|P2|STARTED|Overall Study||89242
43219|NCT02560701|101278|P1|STARTED|Overall Study||8060
43220|NCT02560584|101294|P1|NOT COMPLETED|Overall Study||0
43221|NCT02560584|101294|P1|COMPLETED|Overall Study||304
43222|NCT02560584|101294|P1|STARTED|Overall Study||304
43223|NCT02560493|101303|P2|NOT COMPLETED|Overall Study||0
43224|NCT02560493|101304|P1|NOT COMPLETED|Overall Study||1
43225|NCT02560493|101303|P2|COMPLETED|Overall Study||23
43226|NCT02560493|101304|P1|COMPLETED|Overall Study||22
43227|NCT02560493|101303|P2|STARTED|Overall Study||23
43228|NCT02560493|101304|P1|STARTED|Overall Study||23
43229|NCT02560389|101327|P3|NOT COMPLETED|Overall Study||2
43230|NCT02560389|101328|P2|NOT COMPLETED|Overall Study||3
43231|NCT02560389|101329|P1|NOT COMPLETED|Overall Study||1
43232|NCT02560389|101327|P3|COMPLETED|Overall Study||27
43233|NCT02560389|101328|P2|COMPLETED|Overall Study||25
43234|NCT02560389|101329|P1|COMPLETED|Overall Study||33
43235|NCT02560389|101327|P3|STARTED|Overall Study||29
43236|NCT02560389|101328|P2|STARTED|Overall Study||28
43237|NCT02560389|101329|P1|STARTED|Overall Study||34
43238|NCT02560324|101345|P2|NOT COMPLETED|Period 2 (2 Weeks)||2
43239|NCT02560324|101346|P1|NOT COMPLETED|Period 2 (2 Weeks)||1
43240|NCT02560324|101345|P2|COMPLETED|Period 2 (2 Weeks)||21
43241|NCT02560324|101346|P1|COMPLETED|Period 2 (2 Weeks)||22
43242|NCT02560324|101345|P2|STARTED|Period 2 (2 Weeks)||23
43243|NCT02560324|101346|P1|STARTED|Period 2 (2 Weeks)||23
43244|NCT02560324|101345|P2|NOT COMPLETED|Washout (2 Weeks)||2
43245|NCT02560324|101346|P1|NOT COMPLETED|Washout (2 Weeks)||0
43246|NCT02560324|101345|P2|COMPLETED|Washout (2 Weeks)||23
43247|NCT02560324|101346|P1|COMPLETED|Washout (2 Weeks)||23
43248|NCT02560324|101345|P2|STARTED|Washout (2 Weeks)||25
43249|NCT02560324|101346|P1|STARTED|Washout (2 Weeks)||23
43250|NCT02560324|101345|P2|NOT COMPLETED|Period 1 (2 Weeks)||9
43251|NCT02560324|101346|P1|NOT COMPLETED|Period 1 (2 Weeks)||12
43252|NCT02560324|101345|P2|COMPLETED|Period 1 (2 Weeks)||25
43253|NCT02560324|101346|P1|COMPLETED|Period 1 (2 Weeks)||23
43254|NCT02560324|101345|P2|STARTED|Period 1 (2 Weeks)||34
43255|NCT02560324|101346|P1|STARTED|Period 1 (2 Weeks)||35
43256|NCT02560051|101363|P3|NOT COMPLETED|Overall Study||1
43257|NCT02560051|101364|P2|NOT COMPLETED|Overall Study||4
43258|NCT02560051|101365|P1|NOT COMPLETED|Overall Study||3
43259|NCT02560051|101363|P3|COMPLETED|Overall Study||4
43260|NCT02560051|101364|P2|COMPLETED|Overall Study||4
43261|NCT02560051|101365|P1|COMPLETED|Overall Study||3
43262|NCT02560051|101363|P3|STARTED|Overall Study||5
43263|NCT02560051|101364|P2|STARTED|Overall Study||8
43264|NCT02560051|101365|P1|STARTED|Overall Study||6
43265|NCT02560038|101421|P1|NOT COMPLETED|Overall Study||2
43266|NCT02560038|101421|P1|COMPLETED|Overall Study||1
43267|NCT02560038|101421|P1|STARTED|Overall Study||3
43268|NCT02560025|101427|P1|NOT COMPLETED|Overall Study||3
43269|NCT02560025|101427|P1|COMPLETED|Overall Study||39
43270|NCT02560025|101427|P1|STARTED|Overall Study||42
43271|NCT02560012|101433|P1|NOT COMPLETED|Overall Study||2
43272|NCT02560012|101433|P1|COMPLETED|Overall Study||1
43273|NCT02560012|101433|P1|STARTED|Overall Study||3
43274|NCT02559687|101437|P1|NOT COMPLETED|Overall Study||121
43275|NCT02559687|101437|P1|COMPLETED|Overall Study||0
43276|NCT02559687|101437|P1|STARTED|Overall Study||121
43277|NCT02559622|101450|P4|NOT COMPLETED|Overall Study||3
43278|NCT02559622|101451|P3|NOT COMPLETED|Overall Study||2
43279|NCT02559622|101452|P2|NOT COMPLETED|Overall Study||5
43280|NCT02559622|101453|P1|NOT COMPLETED|Overall Study||1
43281|NCT02559622|101450|P4|COMPLETED|Overall Study||20
43282|NCT02559622|101451|P3|COMPLETED|Overall Study||24
43283|NCT02559622|101452|P2|COMPLETED|Overall Study||49
43284|NCT02559622|101453|P1|COMPLETED|Overall Study||47
43285|NCT02559622|101450|P4|STARTED|Overall Study||23
43286|NCT02559622|101451|P3|STARTED|Overall Study||26
43287|NCT02559622|101452|P2|STARTED|Overall Study||54
43288|NCT02559622|101453|P1|STARTED|Overall Study||48
43289|NCT02559570|101537|P5|NOT COMPLETED|Overall Study||2
43290|NCT02559570|101538|P4|NOT COMPLETED|Overall Study||3
43291|NCT02559570|101539|P3|NOT COMPLETED|Overall Study||2
43292|NCT02559570|101540|P2|NOT COMPLETED|Overall Study||2
43293|NCT02559570|101541|P1|NOT COMPLETED|Overall Study||2
43294|NCT02559570|101537|P5|COMPLETED|Overall Study||14
43295|NCT02559570|101538|P4|COMPLETED|Overall Study||36
43296|NCT02559570|101539|P3|COMPLETED|Overall Study||39
43297|NCT02559570|101540|P2|COMPLETED|Overall Study||34
43298|NCT02559570|101541|P1|COMPLETED|Overall Study||39
43299|NCT02559570|101537|P5|STARTED|Overall Study||16
43300|NCT02559570|101538|P4|STARTED|Overall Study||39
43301|NCT02559570|101539|P3|STARTED|Overall Study||41
43302|NCT02559570|101540|P2|STARTED|Overall Study||36
43303|NCT02559570|101541|P1|STARTED|Overall Study||41
43304|NCT02559414|101579|P3|NOT COMPLETED|Overall Study||2
43305|NCT02559414|101580|P2|NOT COMPLETED|Overall Study||2
43306|NCT02559414|101581|P1|NOT COMPLETED|Overall Study||1
43307|NCT02559414|101579|P3|COMPLETED|Overall Study||20
43308|NCT02559414|101580|P2|COMPLETED|Overall Study||20
43309|NCT02559414|101581|P1|COMPLETED|Overall Study||10
43310|NCT02559414|101579|P3|STARTED|Overall Study||22
43311|NCT02559414|101580|P2|STARTED|Overall Study||22
43312|NCT02559414|101581|P1|STARTED|Overall Study||11
43313|NCT02559310|101621|P2|NOT COMPLETED|Overall Study||19
43314|NCT02559310|101622|P1|NOT COMPLETED|Overall Study||27
43315|NCT02559310|101621|P2|COMPLETED|Overall Study||256
43316|NCT02559310|101622|P1|COMPLETED|Overall Study||249
43317|NCT02559310|101621|P2|STARTED|Overall Study||275
43318|NCT02559310|101622|P1|STARTED|Overall Study||276
43319|NCT02558894|101634|P2|NOT COMPLETED|Overall Study||33
43320|NCT02558894|101635|P1|NOT COMPLETED|Overall Study||32
43321|NCT02558894|101634|P2|COMPLETED|Overall Study||0
43322|NCT02558894|101635|P1|COMPLETED|Overall Study||0
43323|NCT02558894|101634|P2|Patients Who Received IP|Overall Study||32
43324|NCT02558894|101635|P1|Patients Who Received IP|Overall Study||32
43325|NCT02558894|101634|P2|STARTED|Overall Study||33
43326|NCT02558894|101635|P1|STARTED|Overall Study||32
43327|NCT02558829|101663|P8|NOT COMPLETED|Overall Study||3
43328|NCT02558829|101664|P7|NOT COMPLETED|Overall Study||1
43329|NCT02558829|101665|P6|NOT COMPLETED|Overall Study||2
43330|NCT02558829|101666|P5|NOT COMPLETED|Overall Study||2
43331|NCT02558829|101667|P4|NOT COMPLETED|Overall Study||2
43332|NCT02558829|101668|P3|NOT COMPLETED|Overall Study||3
43333|NCT02558829|101669|P2|NOT COMPLETED|Overall Study||3
43334|NCT02558829|101670|P1|NOT COMPLETED|Overall Study||1
43335|NCT02558829|101663|P8|COMPLETED|Overall Study||8
43336|NCT02558829|101664|P7|COMPLETED|Overall Study||17
43337|NCT02558829|101665|P6|COMPLETED|Overall Study||24
43338|NCT02558829|101666|P5|COMPLETED|Overall Study||16
43339|NCT02558829|101667|P4|COMPLETED|Overall Study||16
43340|NCT02558829|101668|P3|COMPLETED|Overall Study||21
43341|NCT02558829|101669|P2|COMPLETED|Overall Study||18
43342|NCT02558829|101670|P1|COMPLETED|Overall Study||20
43343|NCT02558829|101663|P8|STARTED|Overall Study||11
43344|NCT02558829|101664|P7|STARTED|Overall Study||18
43345|NCT02558829|101665|P6|STARTED|Overall Study||26
43346|NCT02558829|101666|P5|STARTED|Overall Study||18
43347|NCT02558829|101667|P4|STARTED|Overall Study||18
43348|NCT02558829|101668|P3|STARTED|Overall Study||24
43349|NCT02558829|101669|P2|STARTED|Overall Study||21
43350|NCT02558829|101670|P1|STARTED|Overall Study||21
43351|NCT02558790|101696|P1|NOT COMPLETED|Overall Study||7
43352|NCT02558790|101696|P1|COMPLETED|Overall Study||13
43353|NCT02558790|101696|P1|Treated|Overall Study||15
43354|NCT02558790|101696|P1|STARTED|Overall Study|20 subjects signed consent to participate in the study. 15 subjects began taking L-TAMS.|20
43355|NCT02558400|101703|P3|NOT COMPLETED|Overall Study||33
43356|NCT02558400|101704|P2|NOT COMPLETED|Overall Study||96
43357|NCT02558400|101705|P1|NOT COMPLETED|Overall Study||79
43358|NCT02558400|101703|P3|COMPLETED|Overall Study||203
43359|NCT02558400|101704|P2|COMPLETED|Overall Study||148
43360|NCT02558400|101705|P1|COMPLETED|Overall Study||159
43361|NCT02558400|101703|P3|STARTED|Overall Study||236
43362|NCT02558400|101704|P2|STARTED|Overall Study||244
43363|NCT02558400|101705|P1|STARTED|Overall Study||238
43364|NCT02558374|101718|P2|NOT COMPLETED|Overall Study||43
43365|NCT02558374|101719|P1|NOT COMPLETED|Overall Study||108
43366|NCT02558374|101718|P2|COMPLETED|Overall Study||314
43367|NCT02558374|101719|P1|COMPLETED|Overall Study||243
43368|NCT02558374|101718|P2|STARTED|Overall Study||357
43369|NCT02558374|101719|P1|STARTED|Overall Study||351
43370|NCT02557698|101729|P2|NOT COMPLETED|Overall Study||0
43371|NCT02557698|101730|P1|NOT COMPLETED|Overall Study||0
43372|NCT02557698|101729|P2|COMPLETED|Overall Study||30
43373|NCT02557698|101730|P1|COMPLETED|Overall Study||30
43374|NCT02557698|101729|P2|STARTED|Overall Study||30
43375|NCT02557698|101730|P1|STARTED|Overall Study||30
43376|NCT02557646|101794|P1|NOT COMPLETED|Overall Study||276
43377|NCT02557646|101794|P1|COMPLETED|Overall Study||417
43378|NCT02557646|101794|P1|STARTED|Overall Study||693
43379|NCT02557555|101812|P1|NOT COMPLETED|Overall Study||0
43380|NCT02557555|101812|P1|COMPLETED|Overall Study||100
43381|NCT02557555|101812|P1|STARTED|Overall Study||100
43382|NCT02557399|101819|P2|NOT COMPLETED|Overall Study||8
43383|NCT02557399|101820|P1|NOT COMPLETED|Overall Study||7
43384|NCT02557399|101819|P2|COMPLETED|Overall Study||169
43385|NCT02557399|101820|P1|COMPLETED|Overall Study||165
43386|NCT02557399|101819|P2|STARTED|Overall Study||177
43387|NCT02557399|101820|P1|STARTED|Overall Study||172
43388|NCT02557035|101854|P2|NOT COMPLETED|Overall Study||9
43389|NCT02557035|101855|P1|NOT COMPLETED|Overall Study||7
43390|NCT02557035|101854|P2|COMPLETED|Overall Study||206
43391|NCT02557035|101855|P1|COMPLETED|Overall Study||218
43392|NCT02557035|101854|P2|STARTED|Overall Study||215
43393|NCT02557035|101855|P1|STARTED|Overall Study||225
43394|NCT02556801|101881|P4|NOT COMPLETED|Overall Study||5
43395|NCT02556801|101882|P3|NOT COMPLETED|Overall Study||4
43396|NCT02556801|101883|P2|NOT COMPLETED|Overall Study||7
43397|NCT02556801|101884|P1|NOT COMPLETED|Overall Study||2
43398|NCT02556801|101881|P4|COMPLETED|Overall Study||37
43399|NCT02556801|101882|P3|COMPLETED|Overall Study||38
43400|NCT02556801|101883|P2|COMPLETED|Overall Study||35
43401|NCT02556801|101884|P1|COMPLETED|Overall Study||40
43402|NCT02556801|101881|P4|STARTED|Overall Study||42
43403|NCT02556801|101882|P3|STARTED|Overall Study||42
43404|NCT02556801|101883|P2|STARTED|Overall Study||42
43405|NCT02556801|101884|P1|STARTED|Overall Study||42
43406|NCT02556788|101936|P2|NOT COMPLETED|Overall Study||37
43407|NCT02556788|101937|P1|NOT COMPLETED|Overall Study||44
43408|NCT02556788|101936|P2|COMPLETED|Overall Study||573
43409|NCT02556788|101937|P1|COMPLETED|Overall Study||558
43410|NCT02556788|101936|P2|STARTED|Overall Study||610
43411|NCT02556788|101937|P1|STARTED|Overall Study||602
43412|NCT02556632|101946|P3|NOT COMPLETED|Overall Study||9
43413|NCT02556632|101947|P2|NOT COMPLETED|Overall Study||6
43414|NCT02556632|101948|P1|NOT COMPLETED|Overall Study||5
43415|NCT02556632|101946|P3|COMPLETED|Overall Study||53
43416|NCT02556632|101947|P2|COMPLETED|Overall Study||59
43417|NCT02556632|101948|P1|COMPLETED|Overall Study||59
43418|NCT02556632|101946|P3|STARTED|Overall Study||62
43419|NCT02556632|101947|P2|STARTED|Overall Study||65
43420|NCT02556632|101948|P1|STARTED|Overall Study||64
43421|NCT02556333|101962|P1|NOT COMPLETED|Overall Study||0
43422|NCT02556333|101962|P1|COMPLETED|Overall Study||1
43423|NCT02556333|101962|P1|STARTED|Overall Study||1
43424|NCT02556307|101966|P1|NOT COMPLETED|Overall Study||53
43425|NCT02556307|101966|P1|COMPLETED|Overall Study||217
43426|NCT02556307|101966|P1|Treated|Overall Study||268
43427|NCT02556307|101966|P1|STARTED|Overall Study||270
43428|NCT02556255|101976|P1|NOT COMPLETED|Overall Study||4
43429|NCT02556255|101976|P1|COMPLETED|Overall Study||46
43430|NCT02556255|101976|P1|STARTED|Overall Study||50
43431|NCT02556177|101991|P2|NOT COMPLETED|Overall Study||61
43432|NCT02556177|101992|P1|NOT COMPLETED|Overall Study||283
43433|NCT02556177|101991|P2|COMPLETED|Overall Study||91
43434|NCT02556177|101992|P1|COMPLETED|Overall Study||42
43435|NCT02556177|101991|P2|STARTED|Overall Study||152
43436|NCT02556177|101992|P1|STARTED|Overall Study||325
43437|NCT02556138|102000|P1|NOT COMPLETED|Overall Study||1
43438|NCT02556138|102000|P1|COMPLETED|Overall Study|One patient withdrew from the study due to intolerance of the balloon after 1 month.|7
43439|NCT02556138|102000|P1|STARTED|Overall Study||8
43440|NCT02555878|102008|P2|NOT COMPLETED|Overall Study||150
43441|NCT02555878|102009|P1|NOT COMPLETED|Overall Study||166
43442|NCT02555878|102008|P2|COMPLETED|Overall Study||270
43443|NCT02555878|102009|P1|COMPLETED|Overall Study||255
43444|NCT02555878|102008|P2|Treated|Overall Study||405
43445|NCT02555878|102009|P1|Treated|Overall Study||404
43446|NCT02555878|102008|P2|STARTED|Overall Study||420
43447|NCT02555878|102009|P1|STARTED|Overall Study||421
43448|NCT02555722|102041|P2|NOT COMPLETED|Month 3||0
43449|NCT02555722|102042|P1|NOT COMPLETED|Month 3||0
43450|NCT02555722|102041|P2|COMPLETED|Month 3||29
43451|NCT02555722|102042|P1|COMPLETED|Month 3||54
43452|NCT02555722|102041|P2|STARTED|Month 3||29
43453|NCT02555722|102042|P1|STARTED|Month 3||54
43454|NCT02555722|102041|P2|NOT COMPLETED|Month 2||0
43455|NCT02555722|102042|P1|NOT COMPLETED|Month 2||4
43456|NCT02555722|102041|P2|COMPLETED|Month 2||29
43457|NCT02555722|102042|P1|COMPLETED|Month 2||54
43458|NCT02555722|102041|P2|STARTED|Month 2||29
43459|NCT02555722|102042|P1|STARTED|Month 2||58
43460|NCT02555722|102041|P2|NOT COMPLETED|Month 1||0
43461|NCT02555722|102042|P1|NOT COMPLETED|Month 1||1
43462|NCT02555722|102041|P2|COMPLETED|Month 1||29
43463|NCT02555722|102042|P1|COMPLETED|Month 1||58
43464|NCT02555722|102041|P2|STARTED|Month 1||29
43465|NCT02555722|102042|P1|STARTED|Month 1||59
43466|NCT02555722|102041|P2|NOT COMPLETED|Week 2||1
43467|NCT02555722|102042|P1|NOT COMPLETED|Week 2||1
43468|NCT02555722|102041|P2|COMPLETED|Week 2||29
43469|NCT02555722|102042|P1|COMPLETED|Week 2||59
43470|NCT02555722|102041|P2|STARTED|Week 2||30
43471|NCT02555722|102042|P1|STARTED|Week 2||60
43472|NCT02555722|102041|P2|NOT COMPLETED|Week 1||0
43473|NCT02555722|102042|P1|NOT COMPLETED|Week 1||0
43474|NCT02555722|102041|P2|COMPLETED|Week 1||30
43475|NCT02555722|102042|P1|COMPLETED|Week 1||60
43476|NCT02555722|102041|P2|STARTED|Week 1||30
43477|NCT02555722|102042|P1|STARTED|Week 1||60
43478|NCT02555722|102041|P2|NOT COMPLETED|Lens Dispensed||0
43479|NCT02555722|102042|P1|NOT COMPLETED|Lens Dispensed||0
43480|NCT02555722|102041|P2|COMPLETED|Lens Dispensed||30
43481|NCT02555722|102042|P1|COMPLETED|Lens Dispensed||60
43482|NCT02555722|102041|P2|STARTED|Lens Dispensed||30
43483|NCT02555722|102042|P1|STARTED|Lens Dispensed||60
43484|NCT02555631|102224|P1|NOT COMPLETED|Overall Study||4
43485|NCT02555631|102224|P1|COMPLETED|Overall Study||25
43486|NCT02555631|102224|P1|STARTED|Overall Study||29
43487|NCT02555618|102233|P2|NOT COMPLETED|Overall Study||0
43488|NCT02555618|102234|P1|NOT COMPLETED|Overall Study||1
43489|NCT02555618|102233|P2|COMPLETED|Overall Study||200
43490|NCT02555618|102234|P1|COMPLETED|Overall Study||199
43491|NCT02555618|102233|P2|STARTED|Overall Study||200
43492|NCT02555618|102234|P1|STARTED|Overall Study||200
43493|NCT02555228|102278|P2|NOT COMPLETED|Overall Study||0
43494|NCT02555228|102279|P1|NOT COMPLETED|Overall Study||0
43495|NCT02555228|102278|P2|COMPLETED|Overall Study|29th October 2015|27
43496|NCT02555228|102279|P1|COMPLETED|Overall Study|19th November 2015|27
43497|NCT02555228|102278|P2|STARTED|Overall Study|14th August 2015|27
43498|NCT02555228|102279|P1|STARTED|Overall Study|20th August 2015|27
43499|NCT02555215|102291|P1|NOT COMPLETED|Overall Study||3
43500|NCT02555215|102291|P1|COMPLETED|Overall Study||17
43501|NCT02555215|102291|P1|STARTED|Overall Study||20
43502|NCT02554981|102302|P1|NOT COMPLETED|Overall Study||5
43503|NCT02554981|102302|P1|COMPLETED|Overall Study||46
43504|NCT02554981|102302|P1|STARTED|Overall Study||51
43505|NCT02554929|102328|P2|NOT COMPLETED|Overall Study||12
43506|NCT02554929|102329|P1|NOT COMPLETED|Overall Study||6
43507|NCT02554929|102328|P2|COMPLETED|Overall Study||32
43508|NCT02554929|102329|P1|COMPLETED|Overall Study||40
43509|NCT02554929|102328|P2|Per Protocol 6 Month Follow-up|Overall Study||32
43510|NCT02554929|102329|P1|Per Protocol 6 Month Follow-up|Overall Study||40
43511|NCT02554929|102328|P2|Per Protocol Post-Intervention|Overall Study||36
43512|NCT02554929|102329|P1|Per Protocol Post-Intervention|Overall Study||42
43513|NCT02554929|102328|P2|Per Protocol Received Intervention|Overall Study||36
43514|NCT02554929|102329|P1|Per Protocol Received Intervention|Overall Study||44
43515|NCT02554929|102328|P2|STARTED|Overall Study||44
43516|NCT02554929|102329|P1|STARTED|Overall Study||46
43517|NCT02554890|102347|P2|NOT COMPLETED|Open-label||52
43518|NCT02554890|102348|P1|NOT COMPLETED|Open-label||0
43519|NCT02554890|102347|P2|COMPLETED|Open-label||835
43520|NCT02554890|102348|P1|COMPLETED|Open-label||0
43521|NCT02554890|102347|P2|STARTED|Open-label||887
43522|NCT02554890|102348|P1|STARTED|Open-label||0
43523|NCT02554890|102347|P2|NOT COMPLETED|Double-blind||91
43524|NCT02554890|102348|P1|NOT COMPLETED|Double-blind||96
43525|NCT02554890|102347|P2|COMPLETED|Double-blind||352
43526|NCT02554890|102348|P1|COMPLETED|Double-blind||348
43527|NCT02554890|102347|P2|Treated Patients|Double-blind||439
43528|NCT02554890|102348|P1|Treated Patients|Double-blind||436
43529|NCT02554890|102347|P2|STARTED|Double-blind||443
43530|NCT02554890|102348|P1|STARTED|Double-blind||444
43531|NCT02554877|102376|P4|NOT COMPLETED|Overall Study||7
43532|NCT02554877|102377|P3|NOT COMPLETED|Overall Study||6
43533|NCT02554877|102378|P2|NOT COMPLETED|Overall Study||7
43534|NCT02554877|102379|P1|NOT COMPLETED|Overall Study||12
43535|NCT02554877|102376|P4|COMPLETED|Overall Study||45
43536|NCT02554877|102377|P3|COMPLETED|Overall Study||46
43537|NCT02554877|102378|P2|COMPLETED|Overall Study||44
43538|NCT02554877|102379|P1|COMPLETED|Overall Study||39
43539|NCT02554877|102376|P4|STARTED|Overall Study||52
43540|NCT02554877|102377|P3|STARTED|Overall Study||52
43541|NCT02554877|102378|P2|STARTED|Overall Study||51
43542|NCT02554877|102379|P1|STARTED|Overall Study||51
43543|NCT02554799|102443|P2|NOT COMPLETED|Overall Study||0
43544|NCT02554799|102444|P1|NOT COMPLETED|Overall Study||0
43545|NCT02554799|102443|P2|COMPLETED|Overall Study||9
43546|NCT02554799|102444|P1|COMPLETED|Overall Study||9
43547|NCT02554799|102443|P2|STARTED|Overall Study||9
43548|NCT02554799|102444|P1|STARTED|Overall Study||9
43549|NCT02554682|102472|P10|NOT COMPLETED|Overall Study||2
43550|NCT02554682|102473|P9|NOT COMPLETED|Overall Study||2
43551|NCT02554682|102474|P8|NOT COMPLETED|Overall Study||6
43552|NCT02554682|102475|P7|NOT COMPLETED|Overall Study||6
43553|NCT02554682|102476|P6|NOT COMPLETED|Overall Study||1
43554|NCT02554682|102477|P5|NOT COMPLETED|Overall Study||2
43555|NCT02554682|102478|P4|NOT COMPLETED|Overall Study||3
43556|NCT02554682|102479|P3|NOT COMPLETED|Overall Study||4
43557|NCT02554682|102480|P2|NOT COMPLETED|Overall Study||12
43558|NCT02554682|102481|P1|NOT COMPLETED|Overall Study||15
43559|NCT02554682|102472|P10|COMPLETED|Overall Study||24
43560|NCT02554682|102473|P9|COMPLETED|Overall Study||24
43561|NCT02554682|102474|P8|COMPLETED|Overall Study||22
43562|NCT02554682|102475|P7|COMPLETED|Overall Study||22
43563|NCT02554682|102476|P6|COMPLETED|Overall Study||39
43564|NCT02554682|102477|P5|COMPLETED|Overall Study||38
43565|NCT02554682|102478|P4|COMPLETED|Overall Study||37
43566|NCT02554682|102479|P3|COMPLETED|Overall Study||36
43567|NCT02554682|102480|P2|COMPLETED|Overall Study||28
43568|NCT02554682|102481|P1|COMPLETED|Overall Study||25
43569|NCT02554682|102472|P10|STARTED|Overall Study||26
43570|NCT02554682|102473|P9|STARTED|Overall Study||26
43571|NCT02554682|102474|P8|STARTED|Overall Study||28
43572|NCT02554682|102475|P7|STARTED|Overall Study||28
43573|NCT02554682|102476|P6|STARTED|Overall Study||40
43574|NCT02554682|102477|P5|STARTED|Overall Study||40
43575|NCT02554682|102478|P4|STARTED|Overall Study||40
43576|NCT02554682|102479|P3|STARTED|Overall Study||40
43577|NCT02554682|102480|P2|STARTED|Overall Study||40
43578|NCT02554682|102481|P1|STARTED|Overall Study||40
43579|NCT02554656|102530|P1|NOT COMPLETED|Overall Study||3
43580|NCT02554656|102530|P1|COMPLETED|Overall Study||86
43581|NCT02554656|102530|P1|STARTED|Overall Study||89
43582|NCT02554435|102540|P2|NOT COMPLETED|Overall Study||1
43583|NCT02554435|102541|P1|NOT COMPLETED|Overall Study||6
43584|NCT02554435|102540|P2|COMPLETED|Overall Study||19
43585|NCT02554435|102541|P1|COMPLETED|Overall Study||14
43586|NCT02554435|102540|P2|STARTED|Overall Study||20
43587|NCT02554435|102541|P1|STARTED|Overall Study||20
43588|NCT02554279|102575|P2|NOT COMPLETED|Overall Study||18
43589|NCT02554279|102576|P1|NOT COMPLETED|Overall Study||32
43590|NCT02554279|102575|P2|COMPLETED|Overall Study||291
43591|NCT02554279|102576|P1|COMPLETED|Overall Study||279
43592|NCT02554279|102575|P2|Completed Fresh Blastocyst Transfer|Overall Study||191
43593|NCT02554279|102576|P1|Completed Fresh Blastocyst Transfer|Overall Study||201
43594|NCT02554279|102575|P2|Completed Oocyte Retrieval|Overall Study||306
43595|NCT02554279|102576|P1|Completed Oocyte Retrieval|Overall Study||292
43596|NCT02554279|102575|P2|Received Trigger|Overall Study||307
43597|NCT02554279|102576|P1|Received Trigger|Overall Study||293
43598|NCT02554279|102575|P2|Completed Day 6 of Stimulation|Overall Study||309
43599|NCT02554279|102576|P1|Completed Day 6 of Stimulation|Overall Study||308
43600|NCT02554279|102575|P2|Treated|Overall Study||309
43601|NCT02554279|102576|P1|Treated|Overall Study||310
43602|NCT02554279|102575|P2|STARTED|Overall Study||309
43603|NCT02554279|102576|P1|STARTED|Overall Study||311
43604|NCT02553928|102610|P2|NOT COMPLETED|Overall Study||3
43605|NCT02553928|102611|P1|NOT COMPLETED|Overall Study||2
43606|NCT02553928|102610|P2|COMPLETED|Overall Study||29
43607|NCT02553928|102611|P1|COMPLETED|Overall Study||28
43608|NCT02553928|102610|P2|STARTED|Overall Study||32
43609|NCT02553928|102611|P1|STARTED|Overall Study||30
43610|NCT02553915|102623|P4|NOT COMPLETED|Overall Study||3
43611|NCT02553915|102624|P3|NOT COMPLETED|Overall Study||3
43612|NCT02553915|102625|P2|NOT COMPLETED|Overall Study||1
43613|NCT02553915|102626|P1|NOT COMPLETED|Overall Study||4
43614|NCT02553915|102623|P4|COMPLETED|Overall Study||13
43615|NCT02553915|102624|P3|COMPLETED|Overall Study||12
43616|NCT02553915|102625|P2|COMPLETED|Overall Study||14
43617|NCT02553915|102626|P1|COMPLETED|Overall Study||11
43618|NCT02553915|102623|P4|STARTED|Overall Study||16
43619|NCT02553915|102624|P3|STARTED|Overall Study||15
43620|NCT02553915|102625|P2|STARTED|Overall Study||15
43621|NCT02553915|102626|P1|STARTED|Overall Study||15
43622|NCT02553798|102656|P1|NOT COMPLETED|Overall Study||338
43623|NCT02553798|102656|P1|COMPLETED|Overall Study||226
43624|NCT02553798|102656|P1|STARTED|Overall Study||564
43625|NCT02553772|102665|P2|NOT COMPLETED|Overall Study||6
43626|NCT02553772|102666|P1|NOT COMPLETED|Overall Study||6
43627|NCT02553772|102665|P2|COMPLETED|Overall Study||116
43628|NCT02553772|102666|P1|COMPLETED|Overall Study||114
43629|NCT02553772|102665|P2|STARTED|Overall Study||122
43630|NCT02553772|102666|P1|STARTED|Overall Study||120
43631|NCT02553746|102682|P2|NOT COMPLETED|Overall Study||2
43632|NCT02553746|102683|P1|NOT COMPLETED|Overall Study||3
43633|NCT02553746|102682|P2|COMPLETED|Overall Study||64
43634|NCT02553746|102683|P1|COMPLETED|Overall Study||77
43635|NCT02553746|102682|P2|STARTED|Overall Study||66
43636|NCT02553746|102683|P1|STARTED|Overall Study||80
43637|NCT02553629|102711|P2|NOT COMPLETED|Overall Study||6
43638|NCT02553629|102712|P1|NOT COMPLETED|Overall Study||3
43639|NCT02553629|102711|P2|COMPLETED|Overall Study||50
43640|NCT02553629|102712|P1|COMPLETED|Overall Study||50
43641|NCT02553629|102711|P2|STARTED|Overall Study||56
43642|NCT02553629|102712|P1|STARTED|Overall Study||53
43643|NCT02553538|102728|P2|NOT COMPLETED|Overall Study||56
43644|NCT02553538|102729|P1|NOT COMPLETED|Overall Study||187
43645|NCT02553538|102728|P2|COMPLETED|Overall Study||764
43646|NCT02553538|102729|P1|COMPLETED|Overall Study||605
43647|NCT02553538|102728|P2|STARTED|Overall Study||820
43648|NCT02553538|102729|P1|STARTED|Overall Study||792
43649|NCT02553512|102741|P1|NOT COMPLETED|Overall Study||23
43650|NCT02553512|102741|P1|COMPLETED|Overall Study||144
43651|NCT02553512|102741|P1|STARTED|Overall Study||167
43652|NCT02553499|102763|P14|NOT COMPLETED|Overall Study||2
43653|NCT02553499|102764|P13|NOT COMPLETED|Overall Study||3
43654|NCT02553499|102765|P12|NOT COMPLETED|Overall Study||3
43655|NCT02553499|102766|P11|NOT COMPLETED|Overall Study||3
43656|NCT02553499|102767|P10|NOT COMPLETED|Overall Study||3
43657|NCT02553499|102768|P9|NOT COMPLETED|Overall Study||3
43658|NCT02553499|102769|P8|NOT COMPLETED|Overall Study||3
43659|NCT02553499|102770|P7|NOT COMPLETED|Overall Study||3
43660|NCT02553499|102771|P6|NOT COMPLETED|Overall Study||3
43661|NCT02553499|102772|P5|NOT COMPLETED|Overall Study||3
43662|NCT02553499|102773|P4|NOT COMPLETED|Overall Study||2
43663|NCT02553499|102774|P3|NOT COMPLETED|Overall Study||2
43664|NCT02553499|102775|P2|NOT COMPLETED|Overall Study||2
43665|NCT02553499|102776|P1|NOT COMPLETED|Overall Study||2
43666|NCT02553499|102763|P14|COMPLETED|Overall Study||0
43667|NCT02553499|102764|P13|COMPLETED|Overall Study||0
43668|NCT02553499|102765|P12|COMPLETED|Overall Study||0
43669|NCT02553499|102766|P11|COMPLETED|Overall Study||0
43670|NCT02553499|102767|P10|COMPLETED|Overall Study||0
43671|NCT02553499|102768|P9|COMPLETED|Overall Study||0
43672|NCT02553499|102769|P8|COMPLETED|Overall Study||0
43673|NCT02553499|102770|P7|COMPLETED|Overall Study||0
43674|NCT02553499|102771|P6|COMPLETED|Overall Study||0
43675|NCT02553499|102772|P5|COMPLETED|Overall Study||0
43676|NCT02553499|102773|P4|COMPLETED|Overall Study||0
43677|NCT02553499|102774|P3|COMPLETED|Overall Study||0
43678|NCT02553499|102775|P2|COMPLETED|Overall Study||0
43679|NCT02553499|102776|P1|COMPLETED|Overall Study||0
43680|NCT02553499|102763|P14|STARTED|Overall Study||2
43681|NCT02553499|102764|P13|STARTED|Overall Study||3
43682|NCT02553499|102765|P12|STARTED|Overall Study||3
43683|NCT02553499|102766|P11|STARTED|Overall Study||3
43684|NCT02553499|102767|P10|STARTED|Overall Study||3
43685|NCT02553499|102768|P9|STARTED|Overall Study||3
43686|NCT02553499|102769|P8|STARTED|Overall Study||3
43687|NCT02553499|102770|P7|STARTED|Overall Study||3
43688|NCT02553499|102771|P6|STARTED|Overall Study||3
43689|NCT02553499|102772|P5|STARTED|Overall Study||3
43690|NCT02553499|102773|P4|STARTED|Overall Study||2
43691|NCT02553499|102774|P3|STARTED|Overall Study||2
43692|NCT02553499|102775|P2|STARTED|Overall Study||2
43693|NCT02553499|102776|P1|STARTED|Overall Study||2
43694|NCT02553421|102878|P2|NOT COMPLETED|Overall Study||1
43695|NCT02553421|102879|P1|NOT COMPLETED|Overall Study||29
43696|NCT02553421|102878|P2|COMPLETED|Overall Study||57
43697|NCT02553421|102879|P1|COMPLETED|Overall Study||156
43698|NCT02553421|102878|P2|STARTED|Overall Study||58
43699|NCT02553421|102879|P1|STARTED|Overall Study||185
43700|NCT02553317|102889|P2|NOT COMPLETED|Open-label (OL) Treatment Period||4
43701|NCT02553317|102890|P1|NOT COMPLETED|Open-label (OL) Treatment Period||0
43702|NCT02553317|102889|P2|COMPLETED|Open-label (OL) Treatment Period||22
43703|NCT02553317|102890|P1|COMPLETED|Open-label (OL) Treatment Period||2
43704|NCT02553317|102889|P2|STARTED|Open-label (OL) Treatment Period|26 patients on placebo had a recurrence of TTP during the DB period and started OL treatment.|26
43705|NCT02553317|102890|P1|STARTED|Open-label (OL) Treatment Period|2 patients on caplacizumab had a recurrence of TTP during the DB period and started OL treatment.|2
43706|NCT02553317|102889|P2|NOT COMPLETED|Double-blind (DB) Treatment Period||8
43707|NCT02553317|102890|P1|NOT COMPLETED|Double-blind (DB) Treatment Period||3
43708|NCT02553317|102889|P2|COMPLETED|Double-blind (DB) Treatment Period||65
43709|NCT02553317|102890|P1|COMPLETED|Double-blind (DB) Treatment Period||68
43710|NCT02553317|102889|P2|STARTED|Double-blind (DB) Treatment Period||73
43711|NCT02553317|102890|P1|STARTED|Double-blind (DB) Treatment Period|One patient withdrew consent prior to first dosing and did not start the DB treatment period.|71
43712|NCT02553317|102889|P2|NOT COMPLETED|Overall Treatment Period + Follow-up||23
43713|NCT02553317|102890|P1|NOT COMPLETED|Overall Treatment Period + Follow-up||14
43714|NCT02553317|102889|P2|COMPLETED|Overall Treatment Period + Follow-up||50
43715|NCT02553317|102890|P1|COMPLETED|Overall Treatment Period + Follow-up||58
43716|NCT02553317|102889|P2|Received Study Drug|Overall Treatment Period + Follow-up||73
43717|NCT02553317|102890|P1|Received Study Drug|Overall Treatment Period + Follow-up||71
43718|NCT02553317|102889|P2|STARTED|Overall Treatment Period + Follow-up||73
43719|NCT02553317|102890|P1|STARTED|Overall Treatment Period + Follow-up||72
43720|NCT02553135|102913|P1|NOT COMPLETED|Overall Study||0
43721|NCT02553135|102913|P1|COMPLETED|Overall Study||6
43722|NCT02553135|102913|P1|STARTED|Overall Study||6
43723|NCT02552810|102922|P2|NOT COMPLETED|Overall Study||0
43724|NCT02552810|102923|P1|NOT COMPLETED|Overall Study||0
43725|NCT02552810|102922|P2|COMPLETED|Overall Study||15
43726|NCT02552810|102923|P1|COMPLETED|Overall Study||15
43727|NCT02552810|102922|P2|STARTED|Overall Study||15
43728|NCT02552810|102923|P1|STARTED|Overall Study||15
43729|NCT02552368|102939|P1|NOT COMPLETED|Overall Study||13
43730|NCT02552368|102939|P1|COMPLETED|Overall Study||10
43731|NCT02552368|102939|P1|STARTED|Overall Study||23
43732|NCT02552355|102948|P4|NOT COMPLETED|Overall Study||1
43733|NCT02552355|102949|P3|NOT COMPLETED|Overall Study||2
43734|NCT02552355|102950|P2|NOT COMPLETED|Overall Study||2
43735|NCT02552355|102951|P1|NOT COMPLETED|Overall Study||0
43736|NCT02552355|102948|P4|COMPLETED|Overall Study||14
43737|NCT02552355|102949|P3|COMPLETED|Overall Study||12
43738|NCT02552355|102950|P2|COMPLETED|Overall Study||11
43739|NCT02552355|102951|P1|COMPLETED|Overall Study||14
43740|NCT02552355|102948|P4|STARTED|Overall Study||15
43741|NCT02552355|102949|P3|STARTED|Overall Study||14
43742|NCT02552355|102950|P2|STARTED|Overall Study||13
43743|NCT02552355|102951|P1|STARTED|Overall Study||14
43744|NCT02552303|102997|P4|NOT COMPLETED|Follow-Up||0
43745|NCT02552303|102998|P3|NOT COMPLETED|Follow-Up||1
43746|NCT02552303|102999|P2|NOT COMPLETED|Follow-Up||2
43747|NCT02552303|103000|P1|NOT COMPLETED|Follow-Up||0
43748|NCT02552303|102997|P4|COMPLETED|Follow-Up||10
43749|NCT02552303|102998|P3|COMPLETED|Follow-Up||6
43750|NCT02552303|102999|P2|COMPLETED|Follow-Up||6
43751|NCT02552303|103000|P1|COMPLETED|Follow-Up||7
43752|NCT02552303|102997|P4|STARTED|Follow-Up||10
43753|NCT02552303|102998|P3|STARTED|Follow-Up||7
43754|NCT02552303|102999|P2|STARTED|Follow-Up||8
43755|NCT02552303|103000|P1|STARTED|Follow-Up||7
43756|NCT02552303|102997|P4|NOT COMPLETED|Allocation||1
43757|NCT02552303|102998|P3|NOT COMPLETED|Allocation||1
43758|NCT02552303|102999|P2|NOT COMPLETED|Allocation||2
43759|NCT02552303|103000|P1|NOT COMPLETED|Allocation||3
43760|NCT02552303|102997|P4|COMPLETED|Allocation||10
43761|NCT02552303|102998|P3|COMPLETED|Allocation||7
43762|NCT02552303|102999|P2|COMPLETED|Allocation||8
43763|NCT02552303|103000|P1|COMPLETED|Allocation||7
43764|NCT02552303|102997|P4|STARTED|Allocation||11
43765|NCT02552303|102998|P3|STARTED|Allocation||8
43766|NCT02552303|102999|P2|STARTED|Allocation||10
43767|NCT02552303|103000|P1|STARTED|Allocation||10
43768|NCT02552147|103014|P2|NOT COMPLETED|Second Intervention (7 Days)||0
43769|NCT02552147|103015|P1|NOT COMPLETED|Second Intervention (7 Days)||2
43770|NCT02552147|103014|P2|COMPLETED|Second Intervention (7 Days)||4
43771|NCT02552147|103015|P1|COMPLETED|Second Intervention (7 Days)||1
43772|NCT02552147|103014|P2|STARTED|Second Intervention (7 Days)||4
43773|NCT02552147|103015|P1|STARTED|Second Intervention (7 Days)||3
43774|NCT02552147|103014|P2|NOT COMPLETED|Washout (7 Days)||0
43775|NCT02552147|103015|P1|NOT COMPLETED|Washout (7 Days)||0
43776|NCT02552147|103014|P2|COMPLETED|Washout (7 Days)||4
43777|NCT02552147|103015|P1|COMPLETED|Washout (7 Days)||3
43778|NCT02552147|103014|P2|STARTED|Washout (7 Days)||4
43779|NCT02552147|103015|P1|STARTED|Washout (7 Days)||3
43780|NCT02552147|103014|P2|NOT COMPLETED|First Intervention (7 Days)||0
43781|NCT02552147|103015|P1|NOT COMPLETED|First Intervention (7 Days)||1
43782|NCT02552147|103014|P2|COMPLETED|First Intervention (7 Days)||4
43783|NCT02552147|103015|P1|COMPLETED|First Intervention (7 Days)||3
43784|NCT02552147|103014|P2|STARTED|First Intervention (7 Days)||4
43785|NCT02552147|103015|P1|STARTED|First Intervention (7 Days)||4
43786|NCT02552121|103049|P8|NOT COMPLETED|Part 2: Cohort Expansion||3
43787|NCT02552121|103050|P7|NOT COMPLETED|Part 2: Cohort Expansion||1
43788|NCT02552121|103051|P6|NOT COMPLETED|Part 2: Cohort Expansion||4
43789|NCT02552121|103052|P5|NOT COMPLETED|Part 2: Cohort Expansion||1
43790|NCT02552121|103053|P4|NOT COMPLETED|Part 2: Cohort Expansion||3
43791|NCT02552121|103054|P3|NOT COMPLETED|Part 2: Cohort Expansion||11
43792|NCT02552121|103055|P2|NOT COMPLETED|Part 2: Cohort Expansion||0
43793|NCT02552121|103056|P1|NOT COMPLETED|Part 2: Cohort Expansion||0
43794|NCT02552121|103049|P8|COMPLETED|Part 2: Cohort Expansion||0
43795|NCT02552121|103050|P7|COMPLETED|Part 2: Cohort Expansion||0
43796|NCT02552121|103051|P6|COMPLETED|Part 2: Cohort Expansion||1
43797|NCT02552121|103052|P5|COMPLETED|Part 2: Cohort Expansion||0
43798|NCT02552121|103053|P4|COMPLETED|Part 2: Cohort Expansion||0
43799|NCT02552121|103054|P3|COMPLETED|Part 2: Cohort Expansion||0
43800|NCT02552121|103055|P2|COMPLETED|Part 2: Cohort Expansion||0
43801|NCT02552121|103056|P1|COMPLETED|Part 2: Cohort Expansion||0
43802|NCT02552121|103049|P8|STARTED|Part 2: Cohort Expansion||3
43803|NCT02552121|103050|P7|STARTED|Part 2: Cohort Expansion||1
43804|NCT02552121|103051|P6|STARTED|Part 2: Cohort Expansion||5
43805|NCT02552121|103052|P5|STARTED|Part 2: Cohort Expansion||1
43806|NCT02552121|103053|P4|STARTED|Part 2: Cohort Expansion||3
43807|NCT02552121|103054|P3|STARTED|Part 2: Cohort Expansion||11
43808|NCT02552121|103055|P2|STARTED|Part 2: Cohort Expansion||0
43809|NCT02552121|103056|P1|STARTED|Part 2: Cohort Expansion||0
43810|NCT02552121|103049|P8|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
43811|NCT02552121|103050|P7|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
43812|NCT02552121|103051|P6|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
43813|NCT02552121|103052|P5|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
43814|NCT02552121|103053|P4|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
43815|NCT02552121|103054|P3|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
43816|NCT02552121|103055|P2|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||6
43817|NCT02552121|103056|P1|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
43818|NCT02552121|103049|P8|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
43819|NCT02552121|103050|P7|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
43820|NCT02552121|103051|P6|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
43821|NCT02552121|103052|P5|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
43822|NCT02552121|103053|P4|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
43823|NCT02552121|103054|P3|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
43824|NCT02552121|103055|P2|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
43825|NCT02552121|103056|P1|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
43826|NCT02552121|103049|P8|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
43827|NCT02552121|103050|P7|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
43828|NCT02552121|103051|P6|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
43829|NCT02552121|103052|P5|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
43830|NCT02552121|103053|P4|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
43831|NCT02552121|103054|P3|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
43832|NCT02552121|103055|P2|STARTED|Part 1: Dose Level 2 (Week 17-48)||6
43833|NCT02552121|103056|P1|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
43834|NCT02552121|103049|P8|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
43835|NCT02552121|103050|P7|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
43836|NCT02552121|103051|P6|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
43837|NCT02552121|103052|P5|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
43838|NCT02552121|103053|P4|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
43839|NCT02552121|103054|P3|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
43840|NCT02552121|103055|P2|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
43841|NCT02552121|103056|P1|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||3
43842|NCT02552121|103049|P8|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
43843|NCT02552121|103050|P7|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
43844|NCT02552121|103051|P6|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
43845|NCT02552121|103052|P5|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
43846|NCT02552121|103053|P4|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
43847|NCT02552121|103054|P3|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
43848|NCT02552121|103055|P2|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
43849|NCT02552121|103056|P1|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
43850|NCT02552121|103049|P8|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
43851|NCT02552121|103050|P7|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
43852|NCT02552121|103051|P6|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
43853|NCT02552121|103052|P5|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
43854|NCT02552121|103053|P4|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
43855|NCT02552121|103054|P3|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
43856|NCT02552121|103055|P2|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
43857|NCT02552121|103056|P1|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||3
43858|NCT02551887|103302|P3|NOT COMPLETED|Overall Study||0
43859|NCT02551887|103303|P2|NOT COMPLETED|Overall Study||0
43860|NCT02551887|103304|P1|NOT COMPLETED|Overall Study||0
43861|NCT02551887|103302|P3|COMPLETED|Overall Study||222
43862|NCT02551887|103303|P2|COMPLETED|Overall Study||124
43863|NCT02551887|103304|P1|COMPLETED|Overall Study||301
43864|NCT02551887|103302|P3|STARTED|Overall Study||222
43865|NCT02551887|103303|P2|STARTED|Overall Study||124
43866|NCT02551887|103304|P1|STARTED|Overall Study||301
43867|NCT02551874|103317|P2|NOT COMPLETED|Overall Study||39
43868|NCT02551874|103318|P1|NOT COMPLETED|Overall Study||28
43869|NCT02551874|103317|P2|COMPLETED|Overall Study||287
43870|NCT02551874|103318|P1|COMPLETED|Overall Study||296
43871|NCT02551874|103317|P2|Received Treatment in Long-term Study|Overall Study||284
43872|NCT02551874|103318|P1|Received Treatment in Long-term Study|Overall Study||295
43873|NCT02551874|103317|P2|Entered Long-term Study|Overall Study||294
43874|NCT02551874|103318|P1|Entered Long-term Study|Overall Study||306
43875|NCT02551874|103317|P2|Received Treatment in Short-term Study|Overall Study||319
43876|NCT02551874|103318|P1|Received Treatment in Short-term Study|Overall Study||324
43877|NCT02551874|103317|P2|STARTED|Overall Study||326
43878|NCT02551874|103318|P1|STARTED|Overall Study||324
43879|NCT02551822|103336|P2|NOT COMPLETED|Overall Study||2
43880|NCT02551822|103337|P1|NOT COMPLETED|Overall Study||2
43881|NCT02551822|103336|P2|COMPLETED|Overall Study||10
43882|NCT02551822|103337|P1|COMPLETED|Overall Study||9
43883|NCT02551822|103336|P2|STARTED|Overall Study||12
43884|NCT02551822|103337|P1|STARTED|Overall Study||11
43885|NCT02551770|103347|P2|NOT COMPLETED|Overall Study||3
43886|NCT02551770|103348|P1|NOT COMPLETED|Overall Study||3
43887|NCT02551770|103347|P2|COMPLETED|Overall Study||48
43888|NCT02551770|103348|P1|COMPLETED|Overall Study||48
43889|NCT02551770|103347|P2|STARTED|Overall Study||51
43890|NCT02551770|103348|P1|STARTED|Overall Study||51
43891|NCT02551744|103367|P2|NOT COMPLETED|Overall Study||0
43892|NCT02551744|103368|P1|NOT COMPLETED|Overall Study||0
43893|NCT02551744|103367|P2|COMPLETED|Overall Study||51
43894|NCT02551744|103368|P1|COMPLETED|Overall Study||50
43895|NCT02551744|103367|P2|STARTED|Overall Study||51
43896|NCT02551744|103368|P1|STARTED|Overall Study||50
43897|NCT02551731|103374|P1|NOT COMPLETED|Overall Study||2
43898|NCT02551731|103374|P1|COMPLETED|Overall Study||7
43899|NCT02551731|103374|P1|STARTED|Overall Study||9
43900|NCT02551653|103393|P2|NOT COMPLETED|Overall Study||0
43901|NCT02551653|103394|P1|NOT COMPLETED|Overall Study||0
43902|NCT02551653|103393|P2|COMPLETED|Overall Study||5
43903|NCT02551653|103394|P1|COMPLETED|Overall Study||5
43904|NCT02551653|103393|P2|STARTED|Overall Study||5
43905|NCT02551653|103394|P1|STARTED|Overall Study||5
43906|NCT02551224|103402|P2|NOT COMPLETED|Second Intervention (5 Min After First )||0
43907|NCT02551224|103403|P1|NOT COMPLETED|Second Intervention (5 Min After First )||0
43908|NCT02551224|103402|P2|COMPLETED|Second Intervention (5 Min After First )||50
43909|NCT02551224|103403|P1|COMPLETED|Second Intervention (5 Min After First )||50
43910|NCT02551224|103402|P2|STARTED|Second Intervention (5 Min After First )||50
43911|NCT02551224|103403|P1|STARTED|Second Intervention (5 Min After First )||50
43912|NCT02551224|103402|P2|NOT COMPLETED|First Intervention||0
43913|NCT02551224|103403|P1|NOT COMPLETED|First Intervention||0
43914|NCT02551224|103402|P2|COMPLETED|First Intervention||50
43915|NCT02551224|103403|P1|COMPLETED|First Intervention||50
43916|NCT02551224|103402|P2|STARTED|First Intervention||50
43917|NCT02551224|103403|P1|STARTED|First Intervention||50
43918|NCT02551055|103418|P8|NOT COMPLETED|Overall Study||0
43919|NCT02551055|103419|P7|NOT COMPLETED|Overall Study||3
43920|NCT02551055|103420|P6|NOT COMPLETED|Overall Study||1
43921|NCT02551055|103421|P5|NOT COMPLETED|Overall Study||7
43922|NCT02551055|103422|P4|NOT COMPLETED|Overall Study||5
43923|NCT02551055|103423|P3|NOT COMPLETED|Overall Study||2
43924|NCT02551055|103424|P2|NOT COMPLETED|Overall Study||6
43925|NCT02551055|103425|P1|NOT COMPLETED|Overall Study||4
43926|NCT02551055|103418|P8|COMPLETED|Overall Study||0
43927|NCT02551055|103419|P7|COMPLETED|Overall Study||1
43928|NCT02551055|103420|P6|COMPLETED|Overall Study||1
43929|NCT02551055|103421|P5|COMPLETED|Overall Study||0
43930|NCT02551055|103422|P4|COMPLETED|Overall Study||1
43931|NCT02551055|103423|P3|COMPLETED|Overall Study||1
43932|NCT02551055|103424|P2|COMPLETED|Overall Study||0
43933|NCT02551055|103425|P1|COMPLETED|Overall Study||0
43934|NCT02551055|103418|P8|STARTED|Overall Study||0
43935|NCT02551055|103419|P7|STARTED|Overall Study||4
43936|NCT02551055|103420|P6|STARTED|Overall Study||2
43937|NCT02551055|103421|P5|STARTED|Overall Study||7
43938|NCT02551055|103422|P4|STARTED|Overall Study||6
43939|NCT02551055|103423|P3|STARTED|Overall Study||3
43940|NCT02551055|103424|P2|STARTED|Overall Study||6
43941|NCT02551055|103425|P1|STARTED|Overall Study||4
43942|NCT02550873|103500|P3|NOT COMPLETED|Open Label Extension||111
43943|NCT02550873|103501|P2|NOT COMPLETED|Open Label Extension||0
43944|NCT02550873|103502|P1|NOT COMPLETED|Open Label Extension||0
43945|NCT02550873|103500|P3|COMPLETED|Open Label Extension|Open Label extension is ongoing|0
43946|NCT02550873|103501|P2|COMPLETED|Open Label Extension||0
43947|NCT02550873|103502|P1|COMPLETED|Open Label Extension||0
43948|NCT02550873|103500|P3|STARTED|Open Label Extension||111
43949|NCT02550873|103501|P2|STARTED|Open Label Extension||0
43950|NCT02550873|103502|P1|STARTED|Open Label Extension||0
43951|NCT02550873|103500|P3|NOT COMPLETED|Randomized Double Blind||0
43952|NCT02550873|103501|P2|NOT COMPLETED|Randomized Double Blind||2
43953|NCT02550873|103502|P1|NOT COMPLETED|Randomized Double Blind||4
43954|NCT02550873|103500|P3|COMPLETED|Randomized Double Blind||0
43955|NCT02550873|103501|P2|COMPLETED|Randomized Double Blind||37
43956|NCT02550873|103502|P1|COMPLETED|Randomized Double Blind||74
43957|NCT02550873|103500|P3|Continue to Open Label Extension|Randomized Double Blind||0
43958|NCT02550873|103501|P2|Continue to Open Label Extension|Randomized Double Blind||37
43959|NCT02550873|103502|P1|Continue to Open Label Extension|Randomized Double Blind||74
43960|NCT02550873|103500|P3|Received Treatment|Randomized Double Blind||0
43961|NCT02550873|103501|P2|Received Treatment|Randomized Double Blind||39
43962|NCT02550873|103502|P1|Received Treatment|Randomized Double Blind||77
43963|NCT02550873|103500|P3|STARTED|Randomized Double Blind||0
43964|NCT02550873|103501|P2|STARTED|Randomized Double Blind||39
43965|NCT02550873|103502|P1|STARTED|Randomized Double Blind||78
43966|NCT02550288|103585|P5|NOT COMPLETED|Overall Study||3
43967|NCT02550288|103586|P4|NOT COMPLETED|Overall Study||3
43968|NCT02550288|103587|P3|NOT COMPLETED|Overall Study||1
43969|NCT02550288|103588|P2|NOT COMPLETED|Overall Study||3
43970|NCT02550288|103589|P1|NOT COMPLETED|Overall Study||2
43971|NCT02550288|103585|P5|COMPLETED|Overall Study||66
43972|NCT02550288|103586|P4|COMPLETED|Overall Study||65
43973|NCT02550288|103587|P3|COMPLETED|Overall Study||68
43974|NCT02550288|103588|P2|COMPLETED|Overall Study||65
43975|NCT02550288|103589|P1|COMPLETED|Overall Study||33
43976|NCT02550288|103585|P5|STARTED|Overall Study||69
43977|NCT02550288|103586|P4|STARTED|Overall Study||68
43978|NCT02550288|103587|P3|STARTED|Overall Study||69
43979|NCT02550288|103588|P2|STARTED|Overall Study||68
43980|NCT02550288|103589|P1|STARTED|Overall Study||35
43981|NCT02550210|103686|P1|NOT COMPLETED|Overall Study||4
43982|NCT02550210|103686|P1|COMPLETED|Overall Study||19
43983|NCT02550210|103686|P1|STARTED|Overall Study||23
43984|NCT02550197|103695|P2|NOT COMPLETED|Overall Study||0
43985|NCT02550197|103696|P1|NOT COMPLETED|Overall Study||0
43986|NCT02550197|103695|P2|COMPLETED|Overall Study||100
43987|NCT02550197|103696|P1|COMPLETED|Overall Study||200
43988|NCT02550197|103695|P2|STARTED|Overall Study||100
43989|NCT02550197|103696|P1|STARTED|Overall Study||200
43990|NCT02550132|103714|P1|NOT COMPLETED|Overall Study||0
43991|NCT02550132|103714|P1|COMPLETED|Overall Study||25
43992|NCT02550132|103714|P1|STARTED|Overall Study||25
43993|NCT02549755|103745|P1|NOT COMPLETED|Overall Study||1
43994|NCT02549755|103745|P1|COMPLETED|Overall Study||0
43995|NCT02549755|103745|P1|STARTED|Overall Study||1
43996|NCT02549716|103751|P2|NOT COMPLETED|Overall Study||0
43997|NCT02549716|103752|P1|NOT COMPLETED|Overall Study||0
43998|NCT02549716|103751|P2|COMPLETED|Overall Study||2
43999|NCT02549716|103752|P1|COMPLETED|Overall Study||1
44000|NCT02549716|103751|P2|STARTED|Overall Study||2
44001|NCT02549716|103752|P1|STARTED|Overall Study||1
44002|NCT02549573|103766|P2|NOT COMPLETED|Overall Study||3
44003|NCT02549573|103767|P1|NOT COMPLETED|Overall Study||0
44004|NCT02549573|103766|P2|COMPLETED|Overall Study||4
44005|NCT02549573|103767|P1|COMPLETED|Overall Study||6
44006|NCT02549573|103766|P2|STARTED|Overall Study||7
44007|NCT02549573|103767|P1|STARTED|Overall Study||6
44008|NCT02549365|103811|P2|NOT COMPLETED|Overall Study||0
44009|NCT02549365|103812|P1|NOT COMPLETED|Overall Study||0
44010|NCT02549365|103811|P2|COMPLETED|Overall Study||112
44011|NCT02549365|103812|P1|COMPLETED|Overall Study||164
44012|NCT02549365|103811|P2|STARTED|Overall Study||112
44013|NCT02549365|103812|P1|STARTED|Overall Study||164
44014|NCT02549352|103821|P2|NOT COMPLETED|12-month Follow-up||12
44015|NCT02549352|103822|P1|NOT COMPLETED|12-month Follow-up||8
44016|NCT02549352|103821|P2|COMPLETED|12-month Follow-up||81
44017|NCT02549352|103822|P1|COMPLETED|12-month Follow-up||199
44018|NCT02549352|103821|P2|STARTED|12-month Follow-up||93
44019|NCT02549352|103822|P1|STARTED|12-month Follow-up||207
44020|NCT02549352|103821|P2|NOT COMPLETED|3-day Treatment and 8-week Follow-up||6
44021|NCT02549352|103822|P1|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2
44022|NCT02549352|103821|P2|COMPLETED|3-day Treatment and 8-week Follow-up||96
44023|NCT02549352|103822|P1|COMPLETED|3-day Treatment and 8-week Follow-up||207
44024|NCT02549352|103821|P2|Treated|3-day Treatment and 8-week Follow-up|1 participant was included in 0.037% in the safety analysis set as they received both IMPs in error|101
44025|NCT02549352|103822|P1|Treated|3-day Treatment and 8-week Follow-up||209
44026|NCT02549352|103821|P2|STARTED|3-day Treatment and 8-week Follow-up||102
44027|NCT02549352|103822|P1|STARTED|3-day Treatment and 8-week Follow-up||209
44028|NCT02549339|103838|P2|NOT COMPLETED|12-month Follow-up||11
44029|NCT02549339|103839|P1|NOT COMPLETED|12-month Follow-up||9
44030|NCT02549339|103838|P2|COMPLETED|12-month Follow-up||87
44031|NCT02549339|103839|P1|COMPLETED|12-month Follow-up||192
44032|NCT02549339|103838|P2|STARTED|12-month Follow-up||98
44033|NCT02549339|103839|P1|STARTED|12-month Follow-up||201
44034|NCT02549339|103838|P2|NOT COMPLETED|3-day Treatment and 8-week Follow-up||5
44035|NCT02549339|103839|P1|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4
44036|NCT02549339|103838|P2|COMPLETED|3-day Treatment and 8-week Follow-up||99
44037|NCT02549339|103839|P1|COMPLETED|3-day Treatment and 8-week Follow-up||201
44038|NCT02549339|103838|P2|Treated|3-day Treatment and 8-week Follow-up||104
44039|NCT02549339|103839|P1|Treated|3-day Treatment and 8-week Follow-up||202
44040|NCT02549339|103838|P2|STARTED|3-day Treatment and 8-week Follow-up||104
44041|NCT02549339|103839|P1|STARTED|3-day Treatment and 8-week Follow-up||205
44042|NCT02549196|103857|P4|NOT COMPLETED|Overall Study||1
44043|NCT02549196|103858|P3|NOT COMPLETED|Overall Study||1
44044|NCT02549196|103859|P2|NOT COMPLETED|Overall Study||0
44045|NCT02549196|103860|P1|NOT COMPLETED|Overall Study||1
44046|NCT02549196|103857|P4|COMPLETED|Overall Study||12
44047|NCT02549196|103858|P3|COMPLETED|Overall Study||5
44048|NCT02549196|103859|P2|COMPLETED|Overall Study||1
44049|NCT02549196|103860|P1|COMPLETED|Overall Study||7
44050|NCT02549196|103857|P4|STARTED|Overall Study||13
44051|NCT02549196|103858|P3|STARTED|Overall Study||6
44052|NCT02549196|103859|P2|STARTED|Overall Study||1
44053|NCT02549196|103860|P1|STARTED|Overall Study||8
44054|NCT02549040|103874|P1|NOT COMPLETED|Period 5||0
44055|NCT02549040|103874|P1|COMPLETED|Period 5||16
44056|NCT02549040|103874|P1|STARTED|Period 5||16
44057|NCT02549040|103874|P1|NOT COMPLETED|Period 4||0
44058|NCT02549040|103874|P1|COMPLETED|Period 4||16
44059|NCT02549040|103874|P1|STARTED|Period 4||16
44060|NCT02549040|103874|P1|NOT COMPLETED|Period 3||0
44061|NCT02549040|103874|P1|COMPLETED|Period 3||16
44062|NCT02549040|103874|P1|STARTED|Period 3||16
44063|NCT02549040|103874|P1|NOT COMPLETED|Period 2||0
44064|NCT02549040|103874|P1|COMPLETED|Period 2||16
44065|NCT02549040|103874|P1|STARTED|Period 2||16
44066|NCT02549040|103874|P1|NOT COMPLETED|Period 1||0
44067|NCT02549040|103874|P1|COMPLETED|Period 1||16
44068|NCT02549040|103874|P1|STARTED|Period 1||16
44069|NCT02549027|103916|P6|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
44070|NCT02549027|103917|P5|NOT COMPLETED|Period 5 - MK-6096 or Placebo||2
44071|NCT02549027|103918|P4|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
44072|NCT02549027|103919|P3|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
44073|NCT02549027|103920|P2|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
44074|NCT02549027|103921|P1|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
44075|NCT02549027|103916|P6|COMPLETED|Period 5 - MK-6096 or Placebo||1
44076|NCT02549027|103917|P5|COMPLETED|Period 5 - MK-6096 or Placebo|The 2 participants who did not complete Period 5 did not receive study drug in Period 5|14
44077|NCT02549027|103918|P4|COMPLETED|Period 5 - MK-6096 or Placebo||0
44078|NCT02549027|103919|P3|COMPLETED|Period 5 - MK-6096 or Placebo||0
44079|NCT02549027|103920|P2|COMPLETED|Period 5 - MK-6096 or Placebo||0
44080|NCT02549027|103921|P1|COMPLETED|Period 5 - MK-6096 or Placebo||0
44081|NCT02549027|103916|P6|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|1
44082|NCT02549027|103917|P5|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|16
44083|NCT02549027|103918|P4|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
44084|NCT02549027|103919|P3|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
44085|NCT02549027|103920|P2|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
44086|NCT02549027|103921|P1|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg/Placebo (Period 5) arms|0
44087|NCT02549027|103916|P6|NOT COMPLETED|Washout After Period 4||0
44088|NCT02549027|103917|P5|NOT COMPLETED|Washout After Period 4||0
44089|NCT02549027|103918|P4|NOT COMPLETED|Washout After Period 4||1
44090|NCT02549027|103919|P3|NOT COMPLETED|Washout After Period 4||1
44091|NCT02549027|103920|P2|NOT COMPLETED|Washout After Period 4||1
44092|NCT02549027|103921|P1|NOT COMPLETED|Washout After Period 4||0
44093|NCT02549027|103916|P6|COMPLETED|Washout After Period 4||0
44094|NCT02549027|103917|P5|COMPLETED|Washout After Period 4||0
44095|NCT02549027|103918|P4|COMPLETED|Washout After Period 4||4
44096|NCT02549027|103919|P3|COMPLETED|Washout After Period 4||4
44097|NCT02549027|103920|P2|COMPLETED|Washout After Period 4||4
44098|NCT02549027|103921|P1|COMPLETED|Washout After Period 4||5
44099|NCT02549027|103916|P6|STARTED|Washout After Period 4||0
44100|NCT02549027|103917|P5|STARTED|Washout After Period 4||0
44101|NCT02549027|103918|P4|STARTED|Washout After Period 4||5
44102|NCT02549027|103919|P3|STARTED|Washout After Period 4||5
44103|NCT02549027|103920|P2|STARTED|Washout After Period 4||5
44104|NCT02549027|103921|P1|STARTED|Washout After Period 4||5
44105|NCT02549027|103916|P6|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
44106|NCT02549027|103917|P5|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
44107|NCT02549027|103918|P4|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
44108|NCT02549027|103919|P3|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
44109|NCT02549027|103920|P2|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
44110|NCT02549027|103921|P1|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
44111|NCT02549027|103916|P6|COMPLETED|Period 4 - MK-1064 or Placebo||0
44112|NCT02549027|103917|P5|COMPLETED|Period 4 - MK-1064 or Placebo||0
44113|NCT02549027|103918|P4|COMPLETED|Period 4 - MK-1064 or Placebo||5
44114|NCT02549027|103919|P3|COMPLETED|Period 4 - MK-1064 or Placebo||5
44115|NCT02549027|103920|P2|COMPLETED|Period 4 - MK-1064 or Placebo||5
44116|NCT02549027|103921|P1|COMPLETED|Period 4 - MK-1064 or Placebo||5
44117|NCT02549027|103916|P6|STARTED|Period 4 - MK-1064 or Placebo||0
44118|NCT02549027|103917|P5|STARTED|Period 4 - MK-1064 or Placebo||0
44119|NCT02549027|103918|P4|STARTED|Period 4 - MK-1064 or Placebo||5
44120|NCT02549027|103919|P3|STARTED|Period 4 - MK-1064 or Placebo||5
44121|NCT02549027|103920|P2|STARTED|Period 4 - MK-1064 or Placebo||5
44122|NCT02549027|103921|P1|STARTED|Period 4 - MK-1064 or Placebo||5
44123|NCT02549027|103916|P6|NOT COMPLETED|Washout After Period 3||0
44124|NCT02549027|103917|P5|NOT COMPLETED|Washout After Period 3||0
44125|NCT02549027|103918|P4|NOT COMPLETED|Washout After Period 3||0
44126|NCT02549027|103919|P3|NOT COMPLETED|Washout After Period 3||0
44127|NCT02549027|103920|P2|NOT COMPLETED|Washout After Period 3||0
44128|NCT02549027|103921|P1|NOT COMPLETED|Washout After Period 3||0
44129|NCT02549027|103916|P6|COMPLETED|Washout After Period 3||0
44130|NCT02549027|103917|P5|COMPLETED|Washout After Period 3||0
44131|NCT02549027|103918|P4|COMPLETED|Washout After Period 3||5
44132|NCT02549027|103919|P3|COMPLETED|Washout After Period 3||5
44133|NCT02549027|103920|P2|COMPLETED|Washout After Period 3||5
44134|NCT02549027|103921|P1|COMPLETED|Washout After Period 3||5
44135|NCT02549027|103916|P6|STARTED|Washout After Period 3||0
44136|NCT02549027|103917|P5|STARTED|Washout After Period 3||0
44137|NCT02549027|103918|P4|STARTED|Washout After Period 3||5
44138|NCT02549027|103919|P3|STARTED|Washout After Period 3||5
44139|NCT02549027|103920|P2|STARTED|Washout After Period 3||5
44140|NCT02549027|103921|P1|STARTED|Washout After Period 3||5
44141|NCT02549027|103916|P6|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
44142|NCT02549027|103917|P5|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
44143|NCT02549027|103918|P4|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
44144|NCT02549027|103919|P3|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
44145|NCT02549027|103920|P2|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
44146|NCT02549027|103921|P1|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
44147|NCT02549027|103916|P6|COMPLETED|Period 3 - MK-1064 or Placebo||0
44148|NCT02549027|103917|P5|COMPLETED|Period 3 - MK-1064 or Placebo||0
44149|NCT02549027|103918|P4|COMPLETED|Period 3 - MK-1064 or Placebo||5
44150|NCT02549027|103919|P3|COMPLETED|Period 3 - MK-1064 or Placebo||5
44151|NCT02549027|103920|P2|COMPLETED|Period 3 - MK-1064 or Placebo||5
44152|NCT02549027|103921|P1|COMPLETED|Period 3 - MK-1064 or Placebo||5
44153|NCT02549027|103916|P6|STARTED|Period 3 - MK-1064 or Placebo||0
44154|NCT02549027|103917|P5|STARTED|Period 3 - MK-1064 or Placebo||0
44155|NCT02549027|103918|P4|STARTED|Period 3 - MK-1064 or Placebo||5
44156|NCT02549027|103919|P3|STARTED|Period 3 - MK-1064 or Placebo||5
44157|NCT02549027|103920|P2|STARTED|Period 3 - MK-1064 or Placebo||5
44158|NCT02549027|103921|P1|STARTED|Period 3 - MK-1064 or Placebo||5
44159|NCT02549027|103916|P6|NOT COMPLETED|Washout After Period 2||0
44160|NCT02549027|103917|P5|NOT COMPLETED|Washout After Period 2||0
44161|NCT02549027|103918|P4|NOT COMPLETED|Washout After Period 2||0
44162|NCT02549027|103919|P3|NOT COMPLETED|Washout After Period 2||0
44163|NCT02549027|103920|P2|NOT COMPLETED|Washout After Period 2||0
44164|NCT02549027|103921|P1|NOT COMPLETED|Washout After Period 2||0
44165|NCT02549027|103916|P6|COMPLETED|Washout After Period 2||0
44166|NCT02549027|103917|P5|COMPLETED|Washout After Period 2||0
44167|NCT02549027|103918|P4|COMPLETED|Washout After Period 2||5
44168|NCT02549027|103919|P3|COMPLETED|Washout After Period 2||5
44169|NCT02549027|103920|P2|COMPLETED|Washout After Period 2||5
44170|NCT02549027|103921|P1|COMPLETED|Washout After Period 2||5
44171|NCT02549027|103916|P6|STARTED|Washout After Period 2||0
44172|NCT02549027|103917|P5|STARTED|Washout After Period 2||0
44173|NCT02549027|103918|P4|STARTED|Washout After Period 2||5
44174|NCT02549027|103919|P3|STARTED|Washout After Period 2||5
44175|NCT02549027|103920|P2|STARTED|Washout After Period 2||5
44176|NCT02549027|103921|P1|STARTED|Washout After Period 2||5
44177|NCT02549027|103916|P6|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
44178|NCT02549027|103917|P5|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
44179|NCT02549027|103918|P4|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
44180|NCT02549027|103919|P3|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
44181|NCT02549027|103920|P2|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
44182|NCT02549027|103921|P1|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
44183|NCT02549027|103916|P6|COMPLETED|Period 2 - MK-1064 or Placebo||0
44184|NCT02549027|103917|P5|COMPLETED|Period 2 - MK-1064 or Placebo||0
44185|NCT02549027|103918|P4|COMPLETED|Period 2 - MK-1064 or Placebo||5
44186|NCT02549027|103919|P3|COMPLETED|Period 2 - MK-1064 or Placebo||5
44187|NCT02549027|103920|P2|COMPLETED|Period 2 - MK-1064 or Placebo||5
44188|NCT02549027|103921|P1|COMPLETED|Period 2 - MK-1064 or Placebo||5
44189|NCT02549027|103916|P6|STARTED|Period 2 - MK-1064 or Placebo||0
44190|NCT02549027|103917|P5|STARTED|Period 2 - MK-1064 or Placebo||0
44191|NCT02549027|103918|P4|STARTED|Period 2 - MK-1064 or Placebo||5
44192|NCT02549027|103919|P3|STARTED|Period 2 - MK-1064 or Placebo||5
44193|NCT02549027|103920|P2|STARTED|Period 2 - MK-1064 or Placebo||5
44194|NCT02549027|103921|P1|STARTED|Period 2 - MK-1064 or Placebo||5
44195|NCT02549027|103916|P6|NOT COMPLETED|Washout After Period 1||0
44196|NCT02549027|103917|P5|NOT COMPLETED|Washout After Period 1||0
44197|NCT02549027|103918|P4|NOT COMPLETED|Washout After Period 1||0
44198|NCT02549027|103919|P3|NOT COMPLETED|Washout After Period 1||0
44199|NCT02549027|103920|P2|NOT COMPLETED|Washout After Period 1||0
44200|NCT02549027|103921|P1|NOT COMPLETED|Washout After Period 1||0
44201|NCT02549027|103916|P6|COMPLETED|Washout After Period 1||0
44202|NCT02549027|103917|P5|COMPLETED|Washout After Period 1||0
44203|NCT02549027|103918|P4|COMPLETED|Washout After Period 1||5
44204|NCT02549027|103919|P3|COMPLETED|Washout After Period 1||5
44205|NCT02549027|103920|P2|COMPLETED|Washout After Period 1||5
44206|NCT02549027|103921|P1|COMPLETED|Washout After Period 1||5
44207|NCT02549027|103916|P6|STARTED|Washout After Period 1||0
44208|NCT02549027|103917|P5|STARTED|Washout After Period 1||0
44209|NCT02549027|103918|P4|STARTED|Washout After Period 1||5
44210|NCT02549027|103919|P3|STARTED|Washout After Period 1||5
44211|NCT02549027|103920|P2|STARTED|Washout After Period 1||5
44212|NCT02549027|103921|P1|STARTED|Washout After Period 1||5
44213|NCT02549027|103916|P6|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
44214|NCT02549027|103917|P5|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
44215|NCT02549027|103918|P4|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
44216|NCT02549027|103919|P3|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
44217|NCT02549027|103920|P2|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
44218|NCT02549027|103921|P1|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
44219|NCT02549027|103916|P6|COMPLETED|Period 1 - MK-1064 or Placebo||0
44220|NCT02549027|103917|P5|COMPLETED|Period 1 - MK-1064 or Placebo||0
44221|NCT02549027|103918|P4|COMPLETED|Period 1 - MK-1064 or Placebo||5
44222|NCT02549027|103919|P3|COMPLETED|Period 1 - MK-1064 or Placebo||5
44223|NCT02549027|103920|P2|COMPLETED|Period 1 - MK-1064 or Placebo||5
44224|NCT02549027|103921|P1|COMPLETED|Period 1 - MK-1064 or Placebo||5
44225|NCT02549027|103916|P6|STARTED|Period 1 - MK-1064 or Placebo||0
44226|NCT02549027|103917|P5|STARTED|Period 1 - MK-1064 or Placebo||0
44227|NCT02549027|103918|P4|STARTED|Period 1 - MK-1064 or Placebo||5
44228|NCT02549027|103919|P3|STARTED|Period 1 - MK-1064 or Placebo||5
44229|NCT02549027|103920|P2|STARTED|Period 1 - MK-1064 or Placebo||5
44230|NCT02549027|103921|P1|STARTED|Period 1 - MK-1064 or Placebo||5
44231|NCT02549014|103958|P2|NOT COMPLETED|Overall Study||0
44232|NCT02549014|103959|P1|NOT COMPLETED|Overall Study||0
44233|NCT02549014|103958|P2|COMPLETED|Overall Study||8
44234|NCT02549014|103959|P1|COMPLETED|Overall Study||8
44235|NCT02549014|103958|P2|STARTED|Overall Study||8
44236|NCT02549014|103959|P1|STARTED|Overall Study||8
44237|NCT02548962|104051|P2|NOT COMPLETED|Overall Study||0
44238|NCT02548962|104052|P1|NOT COMPLETED|Overall Study||1
44239|NCT02548962|104051|P2|COMPLETED|Overall Study||3
44240|NCT02548962|104052|P1|COMPLETED|Overall Study||7
44241|NCT02548962|104051|P2|STARTED|Overall Study||3
44242|NCT02548962|104052|P1|STARTED|Overall Study||8
44243|NCT02548845|104062|P1|NOT COMPLETED|Overall Study||0
44244|NCT02548845|104062|P1|COMPLETED|Overall Study||70
44245|NCT02548845|104062|P1|STARTED|Overall Study||70
44246|NCT02548728|104076|P2|NOT COMPLETED|Overall Study||0
44247|NCT02548728|104077|P1|NOT COMPLETED|Overall Study||0
44248|NCT02548728|104076|P2|COMPLETED|Overall Study||6
44249|NCT02548728|104077|P1|COMPLETED|Overall Study||6
44250|NCT02548728|104076|P2|STARTED|Overall Study||6
44251|NCT02548728|104077|P1|STARTED|Overall Study||6
44252|NCT02548585|104096|P7|NOT COMPLETED|Overall Study||1
44253|NCT02548585|104097|P6|NOT COMPLETED|Overall Study||2
44254|NCT02548585|104098|P5|NOT COMPLETED|Overall Study||3
44255|NCT02548585|104099|P4|NOT COMPLETED|Overall Study||2
44256|NCT02548585|104100|P3|NOT COMPLETED|Overall Study||0
44257|NCT02548585|104101|P2|NOT COMPLETED|Overall Study||0
44258|NCT02548585|104102|P1|NOT COMPLETED|Overall Study||2
44259|NCT02548585|104096|P7|COMPLETED|Overall Study||11
44260|NCT02548585|104097|P6|COMPLETED|Overall Study||10
44261|NCT02548585|104098|P5|COMPLETED|Overall Study||22
44262|NCT02548585|104099|P4|COMPLETED|Overall Study||5
44263|NCT02548585|104100|P3|COMPLETED|Overall Study||6
44264|NCT02548585|104101|P2|COMPLETED|Overall Study||6
44265|NCT02548585|104102|P1|COMPLETED|Overall Study||43
44266|NCT02548585|104096|P7|Treated|Overall Study||12
44267|NCT02548585|104097|P6|Treated|Overall Study||11
44268|NCT02548585|104098|P5|Treated|Overall Study||25
44269|NCT02548585|104099|P4|Treated|Overall Study||7
44270|NCT02548585|104100|P3|Treated|Overall Study||6
44271|NCT02548585|104101|P2|Treated|Overall Study||6
44272|NCT02548585|104102|P1|Treated|Overall Study||45
44273|NCT02548585|104096|P7|STARTED|Overall Study||12
44274|NCT02548585|104097|P6|STARTED|Overall Study||12
44275|NCT02548585|104098|P5|STARTED|Overall Study||25
44276|NCT02548585|104099|P4|STARTED|Overall Study||7
44277|NCT02548585|104100|P3|STARTED|Overall Study||6
44278|NCT02548585|104101|P2|STARTED|Overall Study||6
44279|NCT02548585|104102|P1|STARTED|Overall Study||45
44280|NCT02548455|104320|P1|NOT COMPLETED|Overall Study||240
44281|NCT02548455|104320|P1|COMPLETED|Overall Study|Completed 6-Month Follow-up|259
44282|NCT02548455|104320|P1|Completed 12-Month Follow-up|Overall Study|Study completed prior to all subjects reaching the 6- and 12-month visits.|61
44283|NCT02548455|104320|P1|Completed 6-Month Follow-up|Overall Study||259
44284|NCT02548455|104320|P1|Completed Pre-Discharge|Overall Study||484
44285|NCT02548455|104320|P1|STARTED|Overall Study|A total of 499 subjects were enrolled at 31 investigational sites.|499
44286|NCT02548312|104332|P8|NOT COMPLETED|Overall Study||42
44287|NCT02548312|104333|P7|NOT COMPLETED|Overall Study||40
44288|NCT02548312|104334|P6|NOT COMPLETED|Overall Study||40
44289|NCT02548312|104335|P5|NOT COMPLETED|Overall Study||34
44290|NCT02548312|104336|P4|NOT COMPLETED|Overall Study||46
44291|NCT02548312|104337|P3|NOT COMPLETED|Overall Study||38
44292|NCT02548312|104338|P2|NOT COMPLETED|Overall Study||43
44293|NCT02548312|104339|P1|NOT COMPLETED|Overall Study||33
44294|NCT02548312|104332|P8|COMPLETED|Overall Study||91
44295|NCT02548312|104333|P7|COMPLETED|Overall Study||93
44296|NCT02548312|104334|P6|COMPLETED|Overall Study||93
44297|NCT02548312|104335|P5|COMPLETED|Overall Study||99
44298|NCT02548312|104336|P4|COMPLETED|Overall Study||87
44299|NCT02548312|104337|P3|COMPLETED|Overall Study||96
44300|NCT02548312|104338|P2|COMPLETED|Overall Study||90
44301|NCT02548312|104339|P1|COMPLETED|Overall Study||100
44302|NCT02548312|104332|P8|STARTED|Overall Study||133
44303|NCT02548312|104333|P7|STARTED|Overall Study||133
44304|NCT02548312|104334|P6|STARTED|Overall Study||133
44305|NCT02548312|104335|P5|STARTED|Overall Study||133
44306|NCT02548312|104336|P4|STARTED|Overall Study||133
44307|NCT02548312|104337|P3|STARTED|Overall Study||134
44308|NCT02548312|104338|P2|STARTED|Overall Study||133
44309|NCT02548312|104339|P1|STARTED|Overall Study||133
44310|NCT02548156|104381|P6|NOT COMPLETED|Period 3||0
44311|NCT02548156|104382|P5|NOT COMPLETED|Period 3||0
44312|NCT02548156|104383|P4|NOT COMPLETED|Period 3||0
44313|NCT02548156|104384|P3|NOT COMPLETED|Period 3||0
44314|NCT02548156|104385|P2|NOT COMPLETED|Period 3||0
44315|NCT02548156|104386|P1|NOT COMPLETED|Period 3||0
44316|NCT02548156|104381|P6|COMPLETED|Period 3||5
44317|NCT02548156|104382|P5|COMPLETED|Period 3||4
44318|NCT02548156|104383|P4|COMPLETED|Period 3||5
44319|NCT02548156|104384|P3|COMPLETED|Period 3||4
44320|NCT02548156|104385|P2|COMPLETED|Period 3||5
44321|NCT02548156|104386|P1|COMPLETED|Period 3||5
44322|NCT02548156|104381|P6|STARTED|Period 3||5
44323|NCT02548156|104382|P5|STARTED|Period 3||4
44324|NCT02548156|104383|P4|STARTED|Period 3||5
44325|NCT02548156|104384|P3|STARTED|Period 3||4
44326|NCT02548156|104385|P2|STARTED|Period 3||5
44327|NCT02548156|104386|P1|STARTED|Period 3||5
44328|NCT02548156|104381|P6|NOT COMPLETED|Washout Period 2||0
44329|NCT02548156|104382|P5|NOT COMPLETED|Washout Period 2||0
44330|NCT02548156|104383|P4|NOT COMPLETED|Washout Period 2||0
44331|NCT02548156|104384|P3|NOT COMPLETED|Washout Period 2||0
44332|NCT02548156|104385|P2|NOT COMPLETED|Washout Period 2||0
44333|NCT02548156|104386|P1|NOT COMPLETED|Washout Period 2||0
44334|NCT02548156|104381|P6|COMPLETED|Washout Period 2||5
44335|NCT02548156|104382|P5|COMPLETED|Washout Period 2||4
44336|NCT02548156|104383|P4|COMPLETED|Washout Period 2||5
44337|NCT02548156|104384|P3|COMPLETED|Washout Period 2||4
44338|NCT02548156|104385|P2|COMPLETED|Washout Period 2||5
44339|NCT02548156|104386|P1|COMPLETED|Washout Period 2||5
44340|NCT02548156|104381|P6|STARTED|Washout Period 2||5
44341|NCT02548156|104382|P5|STARTED|Washout Period 2||4
44342|NCT02548156|104383|P4|STARTED|Washout Period 2||5
44343|NCT02548156|104384|P3|STARTED|Washout Period 2||4
44344|NCT02548156|104385|P2|STARTED|Washout Period 2||5
44345|NCT02548156|104386|P1|STARTED|Washout Period 2||5
44346|NCT02548156|104381|P6|NOT COMPLETED|Period 2||0
44347|NCT02548156|104382|P5|NOT COMPLETED|Period 2||0
44348|NCT02548156|104383|P4|NOT COMPLETED|Period 2||0
44349|NCT02548156|104384|P3|NOT COMPLETED|Period 2||0
44350|NCT02548156|104385|P2|NOT COMPLETED|Period 2||0
44351|NCT02548156|104386|P1|NOT COMPLETED|Period 2||0
44352|NCT02548156|104381|P6|COMPLETED|Period 2||5
44353|NCT02548156|104382|P5|COMPLETED|Period 2||4
44354|NCT02548156|104383|P4|COMPLETED|Period 2||5
44355|NCT02548156|104384|P3|COMPLETED|Period 2||4
44356|NCT02548156|104385|P2|COMPLETED|Period 2||5
44357|NCT02548156|104386|P1|COMPLETED|Period 2||5
44358|NCT02548156|104381|P6|STARTED|Period 2||5
44359|NCT02548156|104382|P5|STARTED|Period 2||4
44360|NCT02548156|104383|P4|STARTED|Period 2||5
44361|NCT02548156|104384|P3|STARTED|Period 2||4
44362|NCT02548156|104385|P2|STARTED|Period 2||5
44363|NCT02548156|104386|P1|STARTED|Period 2||5
44364|NCT02548156|104381|P6|NOT COMPLETED|Washout Period 1||0
44365|NCT02548156|104382|P5|NOT COMPLETED|Washout Period 1||1
44366|NCT02548156|104383|P4|NOT COMPLETED|Washout Period 1||0
44367|NCT02548156|104384|P3|NOT COMPLETED|Washout Period 1||0
44368|NCT02548156|104385|P2|NOT COMPLETED|Washout Period 1||0
44369|NCT02548156|104386|P1|NOT COMPLETED|Washout Period 1||0
44370|NCT02548156|104381|P6|COMPLETED|Washout Period 1||5
44371|NCT02548156|104382|P5|COMPLETED|Washout Period 1||4
44372|NCT02548156|104383|P4|COMPLETED|Washout Period 1||5
44373|NCT02548156|104384|P3|COMPLETED|Washout Period 1||4
44374|NCT02548156|104385|P2|COMPLETED|Washout Period 1||5
44375|NCT02548156|104386|P1|COMPLETED|Washout Period 1||5
44376|NCT02548156|104381|P6|STARTED|Washout Period 1||5
44377|NCT02548156|104382|P5|STARTED|Washout Period 1||5
44378|NCT02548156|104383|P4|STARTED|Washout Period 1||5
44379|NCT02548156|104384|P3|STARTED|Washout Period 1||4
44380|NCT02548156|104385|P2|STARTED|Washout Period 1||5
44381|NCT02548156|104386|P1|STARTED|Washout Period 1||5
44382|NCT02548156|104381|P6|NOT COMPLETED|Period 1||0
44383|NCT02548156|104382|P5|NOT COMPLETED|Period 1||0
44384|NCT02548156|104383|P4|NOT COMPLETED|Period 1||0
44385|NCT02548156|104384|P3|NOT COMPLETED|Period 1||0
44386|NCT02548156|104385|P2|NOT COMPLETED|Period 1||0
44387|NCT02548156|104386|P1|NOT COMPLETED|Period 1||0
44388|NCT02548156|104381|P6|COMPLETED|Period 1||5
44389|NCT02548156|104382|P5|COMPLETED|Period 1||5
44390|NCT02548156|104383|P4|COMPLETED|Period 1||5
44391|NCT02548156|104384|P3|COMPLETED|Period 1||4
44392|NCT02548156|104385|P2|COMPLETED|Period 1||5
44393|NCT02548156|104386|P1|COMPLETED|Period 1||5
44394|NCT02548156|104381|P6|STARTED|Period 1||5
44395|NCT02548156|104382|P5|STARTED|Period 1||5
44396|NCT02548156|104383|P4|STARTED|Period 1||5
44397|NCT02548156|104384|P3|STARTED|Period 1||4
44398|NCT02548156|104385|P2|STARTED|Period 1||5
44399|NCT02548156|104386|P1|STARTED|Period 1||5
44400|NCT02548143|104405|P2|NOT COMPLETED|Overall Study||1
44401|NCT02548143|104406|P1|NOT COMPLETED|Overall Study||1
44402|NCT02548143|104405|P2|COMPLETED|Overall Study||5
44403|NCT02548143|104406|P1|COMPLETED|Overall Study||5
44404|NCT02548143|104405|P2|STARTED|Overall Study||6
44405|NCT02548143|104406|P1|STARTED|Overall Study||6
44406|NCT02548078|104418|P2|NOT COMPLETED|Overall Study||6
44407|NCT02548078|104419|P1|NOT COMPLETED|Overall Study||5
44408|NCT02548078|104418|P2|COMPLETED|Overall Study||294
44409|NCT02548078|104419|P1|COMPLETED|Overall Study||295
44410|NCT02548078|104418|P2|STARTED|Overall Study||300
44411|NCT02548078|104419|P1|STARTED|Overall Study||300
44412|NCT02547987|104607|P1|NOT COMPLETED|Overall Study||3
44413|NCT02547987|104607|P1|COMPLETED|Overall Study||22
44414|NCT02547987|104607|P1|STARTED|Overall Study||25
44415|NCT02547974|104615|P4|NOT COMPLETED|Overall Study||0
44416|NCT02547974|104616|P3|NOT COMPLETED|Overall Study||0
44417|NCT02547974|104617|P2|NOT COMPLETED|Overall Study||0
44418|NCT02547974|104618|P1|NOT COMPLETED|Overall Study||1
44419|NCT02547974|104615|P4|COMPLETED|Overall Study||44
44420|NCT02547974|104616|P3|COMPLETED|Overall Study||30
44421|NCT02547974|104617|P2|COMPLETED|Overall Study||31
44422|NCT02547974|104618|P1|COMPLETED|Overall Study||14
44423|NCT02547974|104615|P4|STARTED|Overall Study||44
44424|NCT02547974|104616|P3|STARTED|Overall Study||30
44425|NCT02547974|104617|P2|STARTED|Overall Study||31
44426|NCT02547974|104618|P1|STARTED|Overall Study||15
44427|NCT02547935|104705|P3|NOT COMPLETED|Overall Study||5
44428|NCT02547935|104706|P2|NOT COMPLETED|Overall Study||8
44429|NCT02547935|104707|P1|NOT COMPLETED|Overall Study||5
44430|NCT02547935|104705|P3|COMPLETED|Overall Study||143
44431|NCT02547935|104706|P2|COMPLETED|Overall Study||137
44432|NCT02547935|104707|P1|COMPLETED|Overall Study||150
44433|NCT02547935|104705|P3|Safety Analysis Set|Overall Study||148
44434|NCT02547935|104706|P2|Safety Analysis Set|Overall Study||145
44435|NCT02547935|104707|P1|Safety Analysis Set|Overall Study||152
44436|NCT02547935|104705|P3|Full Analysis Set|Overall Study||148
44437|NCT02547935|104706|P2|Full Analysis Set|Overall Study||144
44438|NCT02547935|104707|P1|Full Analysis Set|Overall Study||152
44439|NCT02547935|104705|P3|Received Treatment|Overall Study||148
44440|NCT02547935|104706|P2|Received Treatment|Overall Study||145
44441|NCT02547935|104707|P1|Received Treatment|Overall Study||152
44442|NCT02547935|104705|P3|STARTED|Overall Study||148
44443|NCT02547935|104706|P2|STARTED|Overall Study||145
44444|NCT02547935|104707|P1|STARTED|Overall Study||155
44445|NCT02547779|104736|P2|NOT COMPLETED|Overall Study||0
44446|NCT02547779|104737|P1|NOT COMPLETED|Overall Study||0
44447|NCT02547779|104736|P2|COMPLETED|Overall Study||5207
44448|NCT02547779|104737|P1|COMPLETED|Overall Study||5214
44449|NCT02547779|104736|P2|STARTED|Overall Study||5207
44450|NCT02547779|104737|P1|STARTED|Overall Study||5214
44451|NCT02547714|104745|P1|NOT COMPLETED|Overall Study||0
44452|NCT02547714|104745|P1|COMPLETED|Overall Study||34
44453|NCT02547714|104745|P1|STARTED|Overall Study||34
44454|NCT02547649|104758|P3|NOT COMPLETED|Overall Study||4
44455|NCT02547649|104759|P2|NOT COMPLETED|Overall Study||5
44456|NCT02547649|104760|P1|NOT COMPLETED|Overall Study||3
44457|NCT02547649|104758|P3|COMPLETED|Overall Study||224
44458|NCT02547649|104759|P2|COMPLETED|Overall Study||226
44459|NCT02547649|104760|P1|COMPLETED|Overall Study||228
44460|NCT02547649|104758|P3|Vaccinated|Overall Study||227
44461|NCT02547649|104759|P2|Vaccinated|Overall Study||231
44462|NCT02547649|104760|P1|Vaccinated|Overall Study||231
44463|NCT02547649|104758|P3|STARTED|Overall Study||228
44464|NCT02547649|104759|P2|STARTED|Overall Study||231
44465|NCT02547649|104760|P1|STARTED|Overall Study||231
44466|NCT02547623|104794|P2|NOT COMPLETED|Overall Study||3
44467|NCT02547623|104795|P1|NOT COMPLETED|Overall Study||4
44468|NCT02547623|104794|P2|COMPLETED|Overall Study||52
44469|NCT02547623|104795|P1|COMPLETED|Overall Study||122
44470|NCT02547623|104794|P2|STARTED|Overall Study||55
44471|NCT02547623|104795|P1|STARTED|Overall Study||126
44472|NCT02547454|104825|P1|NOT COMPLETED|Overall Study||172
44473|NCT02547454|104825|P1|COMPLETED|Overall Study||221
44474|NCT02547454|104825|P1|STARTED|Overall Study||393
44475|NCT02547363|104855|P2|NOT COMPLETED|12-month Follow-up||5
44476|NCT02547363|104856|P1|NOT COMPLETED|12-month Follow-up||10
44477|NCT02547363|104855|P2|COMPLETED|12-month Follow-up||81
44478|NCT02547363|104856|P1|COMPLETED|12-month Follow-up||194
44479|NCT02547363|104855|P2|STARTED|12-month Follow-up||86
44480|NCT02547363|104856|P1|STARTED|12-month Follow-up||204
44481|NCT02547363|104855|P2|NOT COMPLETED|3-day Treatment and 8-week Follow-up||11
44482|NCT02547363|104856|P1|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4
44483|NCT02547363|104855|P2|COMPLETED|3-day Treatment and 8-week Follow-up||94
44484|NCT02547363|104856|P1|COMPLETED|3-day Treatment and 8-week Follow-up||207
44485|NCT02547363|104855|P2|Treated|3-day Treatment and 8-week Follow-up||104
44486|NCT02547363|104856|P1|Treated|3-day Treatment and 8-week Follow-up||209
44487|NCT02547363|104855|P2|STARTED|3-day Treatment and 8-week Follow-up||105
44488|NCT02547363|104856|P1|STARTED|3-day Treatment and 8-week Follow-up||211
44489|NCT02547233|104872|P2|NOT COMPLETED|12-month Follow-up||17
44490|NCT02547233|104873|P1|NOT COMPLETED|12-month Follow-up||14
44491|NCT02547233|104872|P2|COMPLETED|12-month Follow-up||67
44492|NCT02547233|104873|P1|COMPLETED|12-month Follow-up||185
44493|NCT02547233|104872|P2|STARTED|12-month Follow-up||84
44494|NCT02547233|104873|P1|STARTED|12-month Follow-up||199
44495|NCT02547233|104872|P2|NOT COMPLETED|3-day Treatment and 8-week Follow-up||10
44496|NCT02547233|104873|P1|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2
44497|NCT02547233|104872|P2|COMPLETED|3-day Treatment and 8-week Follow-up||92
44498|NCT02547233|104873|P1|COMPLETED|3-day Treatment and 8-week Follow-up||203
44499|NCT02547233|104872|P2|Treated|3-day Treatment and 8-week Follow-up||100
44500|NCT02547233|104873|P1|Treated|3-day Treatment and 8-week Follow-up||205
44501|NCT02547233|104872|P2|STARTED|3-day Treatment and 8-week Follow-up||102
44502|NCT02547233|104873|P1|STARTED|3-day Treatment and 8-week Follow-up||205
44503|NCT02547129|104889|P2|NOT COMPLETED|Overall Study||0
44504|NCT02547129|104890|P1|NOT COMPLETED|Overall Study||1
44505|NCT02547129|104889|P2|COMPLETED|Overall Study||2
44506|NCT02547129|104890|P1|COMPLETED|Overall Study||1
44507|NCT02547129|104889|P2|STARTED|Overall Study||2
44508|NCT02547129|104890|P1|STARTED|Overall Study||2
44509|NCT02547064|104904|P2|NOT COMPLETED|Overall Study||2
44510|NCT02547064|104905|P1|NOT COMPLETED|Overall Study||3
44511|NCT02547064|104904|P2|COMPLETED|Overall Study||79
44512|NCT02547064|104905|P1|COMPLETED|Overall Study||78
44513|NCT02547064|104904|P2|STARTED|Overall Study||81
44514|NCT02547064|104905|P1|STARTED|Overall Study||81
44515|NCT02547038|104933|P2|NOT COMPLETED|Overall Study||2
44516|NCT02547038|104934|P1|NOT COMPLETED|Overall Study||3
44517|NCT02547038|104933|P2|COMPLETED|Overall Study||174
44518|NCT02547038|104934|P1|COMPLETED|Overall Study||173
44519|NCT02547038|104933|P2|STARTED|Overall Study||176
44520|NCT02547038|104934|P1|STARTED|Overall Study||176
44521|NCT02547012|104942|P2|NOT COMPLETED|Overall Study||0
44522|NCT02547012|104943|P1|NOT COMPLETED|Overall Study||0
44523|NCT02547012|104942|P2|COMPLETED|Overall Study||27
44524|NCT02547012|104943|P1|COMPLETED|Overall Study||24
44525|NCT02547012|104942|P2|STARTED|Overall Study||27
44526|NCT02547012|104943|P1|STARTED|Overall Study||24
44527|NCT02546986|104951|P2|NOT COMPLETED|Survival Follow-Up Phase||35
44528|NCT02546986|104952|P1|NOT COMPLETED|Survival Follow-Up Phase||36
44529|NCT02546986|104951|P2|COMPLETED|Survival Follow-Up Phase||0
44530|NCT02546986|104952|P1|COMPLETED|Survival Follow-Up Phase||0
44531|NCT02546986|104951|P2|STARTED|Survival Follow-Up Phase||35
44532|NCT02546986|104952|P1|STARTED|Survival Follow-Up Phase||36
44533|NCT02546986|104951|P2|NOT COMPLETED|Treatment Period||49
44534|NCT02546986|104952|P1|NOT COMPLETED|Treatment Period||51
44535|NCT02546986|104951|P2|COMPLETED|Treatment Period||0
44536|NCT02546986|104952|P1|COMPLETED|Treatment Period||0
44537|NCT02546986|104951|P2|STARTED|Treatment Period||49
44538|NCT02546986|104952|P1|STARTED|Treatment Period||51
44539|NCT02546609|104978|P3|NOT COMPLETED|Overall Study||7
44540|NCT02546609|104979|P2|NOT COMPLETED|Overall Study||11
44541|NCT02546609|104980|P1|NOT COMPLETED|Overall Study||2
44542|NCT02546609|104978|P3|COMPLETED|Overall Study||25
44543|NCT02546609|104979|P2|COMPLETED|Overall Study||24
44544|NCT02546609|104980|P1|COMPLETED|Overall Study||22
44545|NCT02546609|104978|P3|STARTED|Overall Study||32
44546|NCT02546609|104979|P2|STARTED|Overall Study||35
44547|NCT02546609|104980|P1|STARTED|Overall Study||24
44548|NCT02546544|105021|P1|NOT COMPLETED|Overall Study||16
44549|NCT02546544|105021|P1|COMPLETED|Overall Study||0
44550|NCT02546544|105021|P1|Received Allocated Intervention|Overall Study||16
44551|NCT02546544|105021|P1|STARTED|Overall Study||16
44552|NCT02546375|105030|P1|NOT COMPLETED|Overall Study||0
44553|NCT02546375|105030|P1|COMPLETED|Overall Study||87
44554|NCT02546375|105030|P1|STARTED|Overall Study||87
44555|NCT02546362|105052|P1|NOT COMPLETED|12-week Treatment Period||9
44556|NCT02546362|105052|P1|COMPLETED|12-week Treatment Period||38
44557|NCT02546362|105052|P1|STARTED|12-week Treatment Period||47
44558|NCT02546362|105052|P1|NOT COMPLETED|4-week Treatment Period||3
44559|NCT02546362|105052|P1|COMPLETED|4-week Treatment Period||47
44560|NCT02546362|105052|P1|STARTED|4-week Treatment Period||50
44561|NCT02546193|105073|P4|NOT COMPLETED|Overall Study||0
44562|NCT02546193|105074|P3|NOT COMPLETED|Overall Study||2
44563|NCT02546193|105075|P2|NOT COMPLETED|Overall Study||6
44564|NCT02546193|105076|P1|NOT COMPLETED|Overall Study||6
44565|NCT02546193|105073|P4|COMPLETED|Overall Study||0
44566|NCT02546193|105074|P3|COMPLETED|Overall Study||0
44567|NCT02546193|105075|P2|COMPLETED|Overall Study||4
44568|NCT02546193|105076|P1|COMPLETED|Overall Study||4
44569|NCT02546193|105073|P4|STARTED|Overall Study||0
44570|NCT02546193|105074|P3|STARTED|Overall Study|Enrolled independently (Prospective study). Not counted in Outpatient Foley Catheter Arm.|2
44571|NCT02546193|105075|P2|STARTED|Overall Study||10
44572|NCT02546193|105076|P1|STARTED|Overall Study||10
44573|NCT02545868|105113|P3|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||34
44574|NCT02545868|105114|P2|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||35
44575|NCT02545868|105115|P1|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||33
44576|NCT02545868|105113|P3|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
44577|NCT02545868|105114|P2|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
44578|NCT02545868|105115|P1|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
44579|NCT02545868|105113|P3|STARTED|Optional Ocrelizumab Ext (OOE) Period||34
44580|NCT02545868|105114|P2|STARTED|Optional Ocrelizumab Ext (OOE) Period||35
44581|NCT02545868|105115|P1|STARTED|Optional Ocrelizumab Ext (OOE) Period||33
44582|NCT02545868|105113|P3|NOT COMPLETED|Immunization Study Period (ISP)||0
44583|NCT02545868|105114|P2|NOT COMPLETED|Immunization Study Period (ISP)||0
44584|NCT02545868|105115|P1|NOT COMPLETED|Immunization Study Period (ISP)||0
44585|NCT02545868|105113|P3|COMPLETED|Immunization Study Period (ISP)||34
44586|NCT02545868|105114|P2|COMPLETED|Immunization Study Period (ISP)||35
44587|NCT02545868|105115|P1|COMPLETED|Immunization Study Period (ISP)||33
44588|NCT02545868|105113|P3|STARTED|Immunization Study Period (ISP)||34
44589|NCT02545868|105114|P2|STARTED|Immunization Study Period (ISP)||35
44590|NCT02545868|105115|P1|STARTED|Immunization Study Period (ISP)||33
44591|NCT02545608|105188|P2|NOT COMPLETED|Overall Study||7
44592|NCT02545608|105189|P1|NOT COMPLETED|Overall Study||0
44593|NCT02545608|105188|P2|COMPLETED|Overall Study||93
44594|NCT02545608|105189|P1|COMPLETED|Overall Study||9
44595|NCT02545608|105188|P2|STARTED|Overall Study|Split hand study design. Total no. of subjects in Randomised group and No-treatment control is 100.|100
44596|NCT02545608|105189|P1|STARTED|Overall Study||9
44597|NCT02545543|105198|P2|NOT COMPLETED|Overall Study||34
44598|NCT02545543|105199|P1|NOT COMPLETED|Overall Study||81
44599|NCT02545543|105198|P2|COMPLETED|Overall Study||535
44600|NCT02545543|105199|P1|COMPLETED|Overall Study||1628
44601|NCT02545543|105198|P2|STARTED|Overall Study||569
44602|NCT02545543|105199|P1|STARTED|Overall Study||1709
44603|NCT02545322|105223|P1|NOT COMPLETED|Overall Study||3
44604|NCT02545322|105223|P1|COMPLETED|Overall Study||15
44605|NCT02545322|105223|P1|STARTED|Overall Study||18
44606|NCT02545270|105231|P3|NOT COMPLETED|Overall Study||2
44607|NCT02545270|105232|P2|NOT COMPLETED|Overall Study||1
44608|NCT02545270|105233|P1|NOT COMPLETED|Overall Study||0
44609|NCT02545270|105231|P3|COMPLETED|Overall Study||3
44610|NCT02545270|105232|P2|COMPLETED|Overall Study||4
44611|NCT02545270|105233|P1|COMPLETED|Overall Study||6
44612|NCT02545270|105231|P3|STARTED|Overall Study||5
44613|NCT02545270|105232|P2|STARTED|Overall Study||5
44614|NCT02545270|105233|P1|STARTED|Overall Study||6
44615|NCT02545101|105243|P1|NOT COMPLETED|Overall Study||0
44616|NCT02545101|105243|P1|COMPLETED|Overall Study||100
44617|NCT02545101|105243|P1|STARTED|Overall Study||100
44618|NCT02544984|105262|P2|NOT COMPLETED|Overall Study||2
44619|NCT02544984|105263|P1|NOT COMPLETED|Overall Study||2
44620|NCT02544984|105262|P2|COMPLETED|Overall Study||28
44621|NCT02544984|105263|P1|COMPLETED|Overall Study||28
44622|NCT02544984|105262|P2|STARTED|Overall Study||30
44623|NCT02544984|105263|P1|STARTED|Overall Study||30
44624|NCT02544633|105277|P4|NOT COMPLETED|Survival Follow-up Period||12
44625|NCT02544633|105278|P3|NOT COMPLETED|Survival Follow-up Period||7
44626|NCT02544633|105279|P2|NOT COMPLETED|Survival Follow-up Period||19
44627|NCT02544633|105280|P1|NOT COMPLETED|Survival Follow-up Period||28
44628|NCT02544633|105277|P4|COMPLETED|Survival Follow-up Period||0
44629|NCT02544633|105278|P3|COMPLETED|Survival Follow-up Period||0
44630|NCT02544633|105279|P2|COMPLETED|Survival Follow-up Period||0
44631|NCT02544633|105280|P1|COMPLETED|Survival Follow-up Period||0
44632|NCT02544633|105277|P4|STARTED|Survival Follow-up Period||12
44633|NCT02544633|105278|P3|STARTED|Survival Follow-up Period||7
44634|NCT02544633|105279|P2|STARTED|Survival Follow-up Period||19
44635|NCT02544633|105280|P1|STARTED|Survival Follow-up Period||28
44636|NCT02544633|105277|P4|NOT COMPLETED|Treatment Period||12
44637|NCT02544633|105278|P3|NOT COMPLETED|Treatment Period||8
44638|NCT02544633|105279|P2|NOT COMPLETED|Treatment Period||20
44639|NCT02544633|105280|P1|NOT COMPLETED|Treatment Period||28
44640|NCT02544633|105277|P4|COMPLETED|Treatment Period||0
44641|NCT02544633|105278|P3|COMPLETED|Treatment Period||0
44642|NCT02544633|105279|P2|COMPLETED|Treatment Period||0
44643|NCT02544633|105280|P1|COMPLETED|Treatment Period||0
44644|NCT02544633|105277|P4|STARTED|Treatment Period||12
44645|NCT02544633|105278|P3|STARTED|Treatment Period||8
44646|NCT02544633|105279|P2|STARTED|Treatment Period||20
44647|NCT02544633|105280|P1|STARTED|Treatment Period||28
44648|NCT02544607|105311|P1|NOT COMPLETED|Overall Study||0
44649|NCT02544607|105311|P1|COMPLETED|Overall Study||16
44650|NCT02544607|105311|P1|STARTED|Overall Study||16
44651|NCT02544451|105322|P3|NOT COMPLETED|Overall Study||1
44652|NCT02544451|105323|P2|NOT COMPLETED|Overall Study||12
44653|NCT02544451|105324|P1|NOT COMPLETED|Overall Study||14
44654|NCT02544451|105322|P3|COMPLETED|Overall Study||5
44655|NCT02544451|105323|P2|COMPLETED|Overall Study||84
44656|NCT02544451|105324|P1|COMPLETED|Overall Study||129
44657|NCT02544451|105322|P3|STARTED|Overall Study||6
44658|NCT02544451|105323|P2|STARTED|Overall Study||96
44659|NCT02544451|105324|P1|STARTED|Overall Study||143
44660|NCT02544074|105388|P21|NOT COMPLETED|Overall Study||0
44661|NCT02544074|105389|P20|NOT COMPLETED|Overall Study||0
44662|NCT02544074|105390|P19|NOT COMPLETED|Overall Study||0
44663|NCT02544074|105391|P18|NOT COMPLETED|Overall Study||0
44664|NCT02544074|105392|P17|NOT COMPLETED|Overall Study||0
44665|NCT02544074|105393|P16|NOT COMPLETED|Overall Study||0
44666|NCT02544074|105394|P15|NOT COMPLETED|Overall Study||0
44667|NCT02544074|105395|P14|NOT COMPLETED|Overall Study||0
44668|NCT02544074|105396|P13|NOT COMPLETED|Overall Study||0
44669|NCT02544074|105397|P12|NOT COMPLETED|Overall Study||0
44670|NCT02544074|105398|P11|NOT COMPLETED|Overall Study||0
44671|NCT02544074|105399|P10|NOT COMPLETED|Overall Study||1
44672|NCT02544074|105400|P9|NOT COMPLETED|Overall Study||0
44673|NCT02544074|105401|P8|NOT COMPLETED|Overall Study||0
44674|NCT02544074|105402|P7|NOT COMPLETED|Overall Study||0
44675|NCT02544074|105403|P6|NOT COMPLETED|Overall Study||1
44676|NCT02544074|105404|P5|NOT COMPLETED|Overall Study||0
44677|NCT02544074|105405|P4|NOT COMPLETED|Overall Study||0
44678|NCT02544074|105406|P3|NOT COMPLETED|Overall Study||0
44679|NCT02544074|105407|P2|NOT COMPLETED|Overall Study||1
44680|NCT02544074|105408|P1|NOT COMPLETED|Overall Study||0
44681|NCT02544074|105388|P21|COMPLETED|Overall Study||3
44682|NCT02544074|105389|P20|COMPLETED|Overall Study||3
44683|NCT02544074|105390|P19|COMPLETED|Overall Study||4
44684|NCT02544074|105391|P18|COMPLETED|Overall Study||3
44685|NCT02544074|105392|P17|COMPLETED|Overall Study||6
44686|NCT02544074|105393|P16|COMPLETED|Overall Study||8
44687|NCT02544074|105394|P15|COMPLETED|Overall Study||5
44688|NCT02544074|105395|P14|COMPLETED|Overall Study||5
44689|NCT02544074|105396|P13|COMPLETED|Overall Study||4
44690|NCT02544074|105397|P12|COMPLETED|Overall Study||3
44691|NCT02544074|105398|P11|COMPLETED|Overall Study||2
44692|NCT02544074|105399|P10|COMPLETED|Overall Study||1
44693|NCT02544074|105400|P9|COMPLETED|Overall Study||6
44694|NCT02544074|105401|P8|COMPLETED|Overall Study||4
44695|NCT02544074|105402|P7|COMPLETED|Overall Study||2
44696|NCT02544074|105403|P6|COMPLETED|Overall Study||0
44697|NCT02544074|105404|P5|COMPLETED|Overall Study||4
44698|NCT02544074|105405|P4|COMPLETED|Overall Study||1
44699|NCT02544074|105406|P3|COMPLETED|Overall Study||1
44700|NCT02544074|105407|P2|COMPLETED|Overall Study||0
44701|NCT02544074|105408|P1|COMPLETED|Overall Study||1
44702|NCT02544074|105388|P21|STARTED|Overall Study||3
44703|NCT02544074|105389|P20|STARTED|Overall Study||3
44704|NCT02544074|105390|P19|STARTED|Overall Study||4
44705|NCT02544074|105391|P18|STARTED|Overall Study||3
44706|NCT02544074|105392|P17|STARTED|Overall Study||6
44707|NCT02544074|105393|P16|STARTED|Overall Study||8
44708|NCT02544074|105394|P15|STARTED|Overall Study||5
44709|NCT02544074|105395|P14|STARTED|Overall Study||5
44710|NCT02544074|105396|P13|STARTED|Overall Study||4
44711|NCT02544074|105397|P12|STARTED|Overall Study||3
44712|NCT02544074|105398|P11|STARTED|Overall Study||2
44713|NCT02544074|105399|P10|STARTED|Overall Study||2
44714|NCT02544074|105400|P9|STARTED|Overall Study||6
44715|NCT02544074|105401|P8|STARTED|Overall Study||4
44716|NCT02544074|105402|P7|STARTED|Overall Study||2
44717|NCT02544074|105403|P6|STARTED|Overall Study||1
44718|NCT02544074|105404|P5|STARTED|Overall Study||4
44719|NCT02544074|105405|P4|STARTED|Overall Study||1
44720|NCT02544074|105406|P3|STARTED|Overall Study||1
44721|NCT02544074|105407|P2|STARTED|Overall Study||1
44722|NCT02544074|105408|P1|STARTED|Overall Study||1
44723|NCT02543918|105444|P2|NOT COMPLETED|Overall Study||4
44724|NCT02543918|105445|P1|NOT COMPLETED|Overall Study||3
44725|NCT02543918|105444|P2|COMPLETED|Overall Study||39
44726|NCT02543918|105445|P1|COMPLETED|Overall Study||38
44727|NCT02543918|105444|P2|Received at Least 1 Dose of Study Drug|Overall Study||42
44728|NCT02543918|105445|P1|Received at Least 1 Dose of Study Drug|Overall Study||41
44729|NCT02543918|105444|P2|STARTED|Overall Study||43
44730|NCT02543918|105445|P1|STARTED|Overall Study||41
44731|NCT02543892|105459|P8|NOT COMPLETED|Had Immunology Data||0
44732|NCT02543892|105460|P7|NOT COMPLETED|Had Immunology Data||1
44733|NCT02543892|105461|P6|NOT COMPLETED|Had Immunology Data||0
44734|NCT02543892|105462|P5|NOT COMPLETED|Had Immunology Data||0
44735|NCT02543892|105463|P4|NOT COMPLETED|Had Immunology Data||0
44736|NCT02543892|105464|P3|NOT COMPLETED|Had Immunology Data||0
44737|NCT02543892|105465|P2|NOT COMPLETED|Had Immunology Data||0
44738|NCT02543892|105466|P1|NOT COMPLETED|Had Immunology Data||0
44739|NCT02543892|105459|P8|COMPLETED|Had Immunology Data||49
44740|NCT02543892|105460|P7|COMPLETED|Had Immunology Data|Subject received both vaccinations and attended last visit, but withdrew consent afterwards.|49
44741|NCT02543892|105461|P6|COMPLETED|Had Immunology Data||49
44742|NCT02543892|105462|P5|COMPLETED|Had Immunology Data||50
44743|NCT02543892|105463|P4|COMPLETED|Had Immunology Data||12
44744|NCT02543892|105464|P3|COMPLETED|Had Immunology Data||12
44745|NCT02543892|105465|P2|COMPLETED|Had Immunology Data||11
44746|NCT02543892|105466|P1|COMPLETED|Had Immunology Data||11
44747|NCT02543892|105459|P8|STARTED|Had Immunology Data||49
44748|NCT02543892|105460|P7|STARTED|Had Immunology Data||50
44749|NCT02543892|105461|P6|STARTED|Had Immunology Data||49
44750|NCT02543892|105462|P5|STARTED|Had Immunology Data||50
44751|NCT02543892|105463|P4|STARTED|Had Immunology Data||12
44752|NCT02543892|105464|P3|STARTED|Had Immunology Data||12
44753|NCT02543892|105465|P2|STARTED|Had Immunology Data||11
44754|NCT02543892|105466|P1|STARTED|Had Immunology Data||11
44755|NCT02543892|105459|P8|NOT COMPLETED|Received Vaccination 2||1
44756|NCT02543892|105460|P7|NOT COMPLETED|Received Vaccination 2||0
44757|NCT02543892|105461|P6|NOT COMPLETED|Received Vaccination 2||1
44758|NCT02543892|105462|P5|NOT COMPLETED|Received Vaccination 2||0
44759|NCT02543892|105463|P4|NOT COMPLETED|Received Vaccination 2||0
44760|NCT02543892|105464|P3|NOT COMPLETED|Received Vaccination 2||0
44761|NCT02543892|105465|P2|NOT COMPLETED|Received Vaccination 2||1
44762|NCT02543892|105466|P1|NOT COMPLETED|Received Vaccination 2||1
44763|NCT02543892|105459|P8|COMPLETED|Received Vaccination 2||49
44764|NCT02543892|105460|P7|COMPLETED|Received Vaccination 2||50
44765|NCT02543892|105461|P6|COMPLETED|Received Vaccination 2||49
44766|NCT02543892|105462|P5|COMPLETED|Received Vaccination 2||50
44767|NCT02543892|105463|P4|COMPLETED|Received Vaccination 2||12
44768|NCT02543892|105464|P3|COMPLETED|Received Vaccination 2||12
44769|NCT02543892|105465|P2|COMPLETED|Received Vaccination 2||11
44770|NCT02543892|105466|P1|COMPLETED|Received Vaccination 2||11
44771|NCT02543892|105459|P8|STARTED|Received Vaccination 2||50
44772|NCT02543892|105460|P7|STARTED|Received Vaccination 2||50
44773|NCT02543892|105461|P6|STARTED|Received Vaccination 2||50
44774|NCT02543892|105462|P5|STARTED|Received Vaccination 2||50
44775|NCT02543892|105463|P4|STARTED|Received Vaccination 2||12
44776|NCT02543892|105464|P3|STARTED|Received Vaccination 2||12
44777|NCT02543892|105465|P2|STARTED|Received Vaccination 2||12
44778|NCT02543892|105466|P1|STARTED|Received Vaccination 2||12
44779|NCT02543892|105459|P8|NOT COMPLETED|Received Vaccination 1||0
44780|NCT02543892|105460|P7|NOT COMPLETED|Received Vaccination 1||0
44781|NCT02543892|105461|P6|NOT COMPLETED|Received Vaccination 1||0
44782|NCT02543892|105462|P5|NOT COMPLETED|Received Vaccination 1||0
44783|NCT02543892|105463|P4|NOT COMPLETED|Received Vaccination 1||0
44784|NCT02543892|105464|P3|NOT COMPLETED|Received Vaccination 1||0
44785|NCT02543892|105465|P2|NOT COMPLETED|Received Vaccination 1||0
44786|NCT02543892|105466|P1|NOT COMPLETED|Received Vaccination 1||0
44787|NCT02543892|105459|P8|COMPLETED|Received Vaccination 1||50
44788|NCT02543892|105460|P7|COMPLETED|Received Vaccination 1||50
44789|NCT02543892|105461|P6|COMPLETED|Received Vaccination 1||50
44790|NCT02543892|105462|P5|COMPLETED|Received Vaccination 1||50
44791|NCT02543892|105463|P4|COMPLETED|Received Vaccination 1||12
44792|NCT02543892|105464|P3|COMPLETED|Received Vaccination 1||12
44793|NCT02543892|105465|P2|COMPLETED|Received Vaccination 1||12
44794|NCT02543892|105466|P1|COMPLETED|Received Vaccination 1||12
44795|NCT02543892|105459|P8|STARTED|Received Vaccination 1||50
44796|NCT02543892|105460|P7|STARTED|Received Vaccination 1||50
44797|NCT02543892|105461|P6|STARTED|Received Vaccination 1||50
44798|NCT02543892|105462|P5|STARTED|Received Vaccination 1||50
44799|NCT02543892|105463|P4|STARTED|Received Vaccination 1||12
44800|NCT02543892|105464|P3|STARTED|Received Vaccination 1||12
44801|NCT02543892|105465|P2|STARTED|Received Vaccination 1||12
44802|NCT02543892|105466|P1|STARTED|Received Vaccination 1||12
44803|NCT02543801|105516|P4|NOT COMPLETED|Overall Study||0
44804|NCT02543801|105517|P3|NOT COMPLETED|Overall Study||0
44805|NCT02543801|105518|P2|NOT COMPLETED|Overall Study||2
44806|NCT02543801|105519|P1|NOT COMPLETED|Overall Study||1
44807|NCT02543801|105516|P4|COMPLETED|Overall Study||59
44808|NCT02543801|105517|P3|COMPLETED|Overall Study||59
44809|NCT02543801|105518|P2|COMPLETED|Overall Study||58
44810|NCT02543801|105519|P1|COMPLETED|Overall Study||60
44811|NCT02543801|105516|P4|STARTED|Overall Study||59
44812|NCT02543801|105517|P3|STARTED|Overall Study||59
44813|NCT02543801|105518|P2|STARTED|Overall Study||60
44814|NCT02543801|105519|P1|STARTED|Overall Study||61
44815|NCT02543554|105539|P2|NOT COMPLETED|Overall Study||0
44816|NCT02543554|105540|P1|NOT COMPLETED|Overall Study||0
44817|NCT02543554|105539|P2|COMPLETED|Overall Study||513
44818|NCT02543554|105540|P1|COMPLETED|Overall Study||1192
44819|NCT02543554|105539|P2|STARTED|Overall Study||513
44820|NCT02543554|105540|P1|STARTED|Overall Study||1192
44821|NCT02543528|105548|P5|NOT COMPLETED|Extended Wear Period||0
44822|NCT02543528|105549|P4|NOT COMPLETED|Extended Wear Period||12
44823|NCT02543528|105550|P3|NOT COMPLETED|Extended Wear Period||23
44824|NCT02543528|105551|P2|NOT COMPLETED|Extended Wear Period||21
44825|NCT02543528|105552|P1|NOT COMPLETED|Extended Wear Period||28
44826|NCT02543528|105548|P5|COMPLETED|Extended Wear Period||0
44827|NCT02543528|105549|P4|COMPLETED|Extended Wear Period||23
44828|NCT02543528|105550|P3|COMPLETED|Extended Wear Period||13
44829|NCT02543528|105551|P2|COMPLETED|Extended Wear Period||14
44830|NCT02543528|105552|P1|COMPLETED|Extended Wear Period||8
44831|NCT02543528|105548|P5|STARTED|Extended Wear Period||0
44832|NCT02543528|105549|P4|STARTED|Extended Wear Period||35
44833|NCT02543528|105550|P3|STARTED|Extended Wear Period||36
44834|NCT02543528|105551|P2|STARTED|Extended Wear Period||35
44835|NCT02543528|105552|P1|STARTED|Extended Wear Period||36
44836|NCT02543528|105548|P5|NOT COMPLETED|Adaptation Period||26
44837|NCT02543528|105549|P4|NOT COMPLETED|Adaptation Period||0
44838|NCT02543528|105550|P3|NOT COMPLETED|Adaptation Period||0
44839|NCT02543528|105551|P2|NOT COMPLETED|Adaptation Period||0
44840|NCT02543528|105552|P1|NOT COMPLETED|Adaptation Period||0
44841|NCT02543528|105548|P5|COMPLETED|Adaptation Period||142
44842|NCT02543528|105549|P4|COMPLETED|Adaptation Period||0
44843|NCT02543528|105550|P3|COMPLETED|Adaptation Period||0
44844|NCT02543528|105551|P2|COMPLETED|Adaptation Period||0
44845|NCT02543528|105552|P1|COMPLETED|Adaptation Period||0
44846|NCT02543528|105548|P5|STARTED|Adaptation Period||168
44847|NCT02543528|105549|P4|STARTED|Adaptation Period||0
44848|NCT02543528|105550|P3|STARTED|Adaptation Period||0
44849|NCT02543528|105551|P2|STARTED|Adaptation Period||0
44850|NCT02543528|105552|P1|STARTED|Adaptation Period||0
44851|NCT02543437|105571|P1|NOT COMPLETED|Overall Study||0
44852|NCT02543437|105571|P1|COMPLETED|Overall Study||117
44853|NCT02543437|105571|P1|STARTED|Overall Study||117
44854|NCT02543398|105578|P2|NOT COMPLETED|Overall Study||0
44855|NCT02543398|105579|P1|NOT COMPLETED|Overall Study||0
44856|NCT02543398|105578|P2|COMPLETED|Overall Study||20
44857|NCT02543398|105579|P1|COMPLETED|Overall Study||20
44858|NCT02543398|105578|P2|STARTED|Overall Study||20
44859|NCT02543398|105579|P1|STARTED|Overall Study||20
44860|NCT02543346|105585|P4|NOT COMPLETED|Second Treatment Visit||0
44861|NCT02543346|105586|P3|NOT COMPLETED|Second Treatment Visit||0
44862|NCT02543346|105587|P2|NOT COMPLETED|Second Treatment Visit||0
44863|NCT02543346|105588|P1|NOT COMPLETED|Second Treatment Visit||0
44864|NCT02543346|105585|P4|COMPLETED|Second Treatment Visit||21
44865|NCT02543346|105586|P3|COMPLETED|Second Treatment Visit||22
44866|NCT02543346|105587|P2|COMPLETED|Second Treatment Visit||23
44867|NCT02543346|105588|P1|COMPLETED|Second Treatment Visit||25
44868|NCT02543346|105585|P4|STARTED|Second Treatment Visit||21
44869|NCT02543346|105586|P3|STARTED|Second Treatment Visit||22
44870|NCT02543346|105587|P2|STARTED|Second Treatment Visit||23
44871|NCT02543346|105588|P1|STARTED|Second Treatment Visit||25
44872|NCT02543346|105585|P4|NOT COMPLETED|Second Priming Visit||2
44873|NCT02543346|105586|P3|NOT COMPLETED|Second Priming Visit||2
44874|NCT02543346|105587|P2|NOT COMPLETED|Second Priming Visit||2
44875|NCT02543346|105588|P1|NOT COMPLETED|Second Priming Visit||1
44876|NCT02543346|105585|P4|COMPLETED|Second Priming Visit||21
44877|NCT02543346|105586|P3|COMPLETED|Second Priming Visit||22
44878|NCT02543346|105587|P2|COMPLETED|Second Priming Visit||23
44879|NCT02543346|105588|P1|COMPLETED|Second Priming Visit||25
44880|NCT02543346|105585|P4|STARTED|Second Priming Visit||23
44881|NCT02543346|105586|P3|STARTED|Second Priming Visit||24
44882|NCT02543346|105587|P2|STARTED|Second Priming Visit||25
44883|NCT02543346|105588|P1|STARTED|Second Priming Visit||26
44884|NCT02543346|105585|P4|NOT COMPLETED|Washout (at Least 14 Days)||0
44885|NCT02543346|105586|P3|NOT COMPLETED|Washout (at Least 14 Days)||0
44886|NCT02543346|105587|P2|NOT COMPLETED|Washout (at Least 14 Days)||0
44887|NCT02543346|105588|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
44888|NCT02543346|105585|P4|COMPLETED|Washout (at Least 14 Days)||23
44889|NCT02543346|105586|P3|COMPLETED|Washout (at Least 14 Days)||24
44890|NCT02543346|105587|P2|COMPLETED|Washout (at Least 14 Days)||25
44891|NCT02543346|105588|P1|COMPLETED|Washout (at Least 14 Days)||26
44892|NCT02543346|105585|P4|STARTED|Washout (at Least 14 Days)||23
44893|NCT02543346|105586|P3|STARTED|Washout (at Least 14 Days)||24
44894|NCT02543346|105587|P2|STARTED|Washout (at Least 14 Days)||25
44895|NCT02543346|105588|P1|STARTED|Washout (at Least 14 Days)||26
44896|NCT02543346|105585|P4|NOT COMPLETED|First Treatment Visit||0
44897|NCT02543346|105586|P3|NOT COMPLETED|First Treatment Visit||0
44898|NCT02543346|105587|P2|NOT COMPLETED|First Treatment Visit||0
44899|NCT02543346|105588|P1|NOT COMPLETED|First Treatment Visit||0
44900|NCT02543346|105585|P4|COMPLETED|First Treatment Visit||23
44901|NCT02543346|105586|P3|COMPLETED|First Treatment Visit||24
44902|NCT02543346|105587|P2|COMPLETED|First Treatment Visit||25
44903|NCT02543346|105588|P1|COMPLETED|First Treatment Visit||26
44904|NCT02543346|105585|P4|STARTED|First Treatment Visit||23
44905|NCT02543346|105586|P3|STARTED|First Treatment Visit||24
44906|NCT02543346|105587|P2|STARTED|First Treatment Visit||25
44907|NCT02543346|105588|P1|STARTED|First Treatment Visit||26
44908|NCT02543346|105585|P4|NOT COMPLETED|First Priming Visit||0
44909|NCT02543346|105586|P3|NOT COMPLETED|First Priming Visit||0
44910|NCT02543346|105587|P2|NOT COMPLETED|First Priming Visit||0
44911|NCT02543346|105588|P1|NOT COMPLETED|First Priming Visit||0
44912|NCT02543346|105585|P4|COMPLETED|First Priming Visit||23
44913|NCT02543346|105586|P3|COMPLETED|First Priming Visit||24
44914|NCT02543346|105587|P2|COMPLETED|First Priming Visit||25
44915|NCT02543346|105588|P1|COMPLETED|First Priming Visit||26
44916|NCT02543346|105585|P4|STARTED|First Priming Visit||23
44917|NCT02543346|105586|P3|STARTED|First Priming Visit||24
44918|NCT02543346|105587|P2|STARTED|First Priming Visit||25
44919|NCT02543346|105588|P1|STARTED|First Priming Visit||26
44920|NCT02542943|105617|P3|NOT COMPLETED|Overall Study||0
44921|NCT02542943|105618|P2|NOT COMPLETED|Overall Study||1
44922|NCT02542943|105619|P1|NOT COMPLETED|Overall Study||1
44923|NCT02542943|105617|P3|COMPLETED|Overall Study||81
44924|NCT02542943|105618|P2|COMPLETED|Overall Study||79
44925|NCT02542943|105619|P1|COMPLETED|Overall Study||78
44926|NCT02542943|105617|P3|STARTED|Overall Study||81
44927|NCT02542943|105618|P2|STARTED|Overall Study||80
44928|NCT02542943|105619|P1|STARTED|Overall Study||79
44929|NCT02542761|105644|P2|NOT COMPLETED|Second Intervention||0
44930|NCT02542761|105645|P1|NOT COMPLETED|Second Intervention||0
44931|NCT02542761|105644|P2|COMPLETED|Second Intervention||5
44932|NCT02542761|105645|P1|COMPLETED|Second Intervention||5
44933|NCT02542761|105644|P2|STARTED|Second Intervention||5
44934|NCT02542761|105645|P1|STARTED|Second Intervention||5
44935|NCT02542761|105644|P2|NOT COMPLETED|Acclimation Period 2||0
44936|NCT02542761|105645|P1|NOT COMPLETED|Acclimation Period 2||0
44937|NCT02542761|105644|P2|COMPLETED|Acclimation Period 2||5
44938|NCT02542761|105645|P1|COMPLETED|Acclimation Period 2||5
44939|NCT02542761|105644|P2|STARTED|Acclimation Period 2||5
44940|NCT02542761|105645|P1|STARTED|Acclimation Period 2||5
44941|NCT02542761|105644|P2|NOT COMPLETED|First Intervention||0
44942|NCT02542761|105645|P1|NOT COMPLETED|First Intervention||0
44943|NCT02542761|105644|P2|COMPLETED|First Intervention||5
44944|NCT02542761|105645|P1|COMPLETED|First Intervention||5
44945|NCT02542761|105644|P2|STARTED|First Intervention||5
44946|NCT02542761|105645|P1|STARTED|First Intervention||5
44947|NCT02542761|105644|P2|NOT COMPLETED|Acclimation Period 1||0
44948|NCT02542761|105645|P1|NOT COMPLETED|Acclimation Period 1||0
44949|NCT02542761|105644|P2|COMPLETED|Acclimation Period 1||5
44950|NCT02542761|105645|P1|COMPLETED|Acclimation Period 1||5
44951|NCT02542761|105644|P2|STARTED|Acclimation Period 1||5
44952|NCT02542761|105645|P1|STARTED|Acclimation Period 1||5
44953|NCT02542631|105663|P2|NOT COMPLETED|Overall Study||31
44954|NCT02542631|105664|P1|NOT COMPLETED|Overall Study||31
44955|NCT02542631|105663|P2|COMPLETED|Overall Study||108
44956|NCT02542631|105664|P1|COMPLETED|Overall Study||108
44957|NCT02542631|105663|P2|STARTED|Overall Study||139
44958|NCT02542631|105664|P1|STARTED|Overall Study||139
44959|NCT02542605|105686|P3|NOT COMPLETED|Part B: Randomization Phase||1
44960|NCT02542605|105687|P2|NOT COMPLETED|Part B: Randomization Phase||0
44961|NCT02542605|105688|P1|NOT COMPLETED|Part B: Randomization Phase||0
44962|NCT02542605|105686|P3|COMPLETED|Part B: Randomization Phase||7
44963|NCT02542605|105687|P2|COMPLETED|Part B: Randomization Phase||9
44964|NCT02542605|105688|P1|COMPLETED|Part B: Randomization Phase||0
44965|NCT02542605|105686|P3|Received Placebo/Erenumab|Part B: Randomization Phase||7
44966|NCT02542605|105687|P2|Received Placebo/Erenumab|Part B: Randomization Phase||9
44967|NCT02542605|105688|P1|Received Placebo/Erenumab|Part B: Randomization Phase||0
44968|NCT02542605|105686|P3|PACAP-38 naïve Participants|Part B: Randomization Phase||8
44969|NCT02542605|105687|P2|PACAP-38 naïve Participants|Part B: Randomization Phase||7
44970|NCT02542605|105688|P1|PACAP-38 naïve Participants|Part B: Randomization Phase||0
44971|NCT02542605|105686|P3|Not PACAP-38 naïve Participants|Part B: Randomization Phase||0
44972|NCT02542605|105687|P2|Not PACAP-38 naïve Participants|Part B: Randomization Phase||2
44973|NCT02542605|105688|P1|Not PACAP-38 naïve Participants|Part B: Randomization Phase||0
44974|NCT02542605|105686|P3|STARTED|Part B: Randomization Phase||8
44975|NCT02542605|105687|P2|STARTED|Part B: Randomization Phase||9
44976|NCT02542605|105688|P1|STARTED|Part B: Randomization Phase||0
44977|NCT02542605|105686|P3|NOT COMPLETED|Part B: Challenge Phase||0
44978|NCT02542605|105687|P2|NOT COMPLETED|Part B: Challenge Phase||0
44979|NCT02542605|105688|P1|NOT COMPLETED|Part B: Challenge Phase||1
44980|NCT02542605|105686|P3|COMPLETED|Part B: Challenge Phase||0
44981|NCT02542605|105687|P2|COMPLETED|Part B: Challenge Phase||0
44982|NCT02542605|105688|P1|COMPLETED|Part B: Challenge Phase||22
44983|NCT02542605|105686|P3|Proceeded to Randomization Phase|Part B: Challenge Phase||0
44984|NCT02542605|105687|P2|Proceeded to Randomization Phase|Part B: Challenge Phase||0
44985|NCT02542605|105688|P1|Proceeded to Randomization Phase|Part B: Challenge Phase||15
44986|NCT02542605|105686|P3|Received PACAP-38|Part B: Challenge Phase||0
44987|NCT02542605|105687|P2|Received PACAP-38|Part B: Challenge Phase||0
44988|NCT02542605|105688|P1|Received PACAP-38|Part B: Challenge Phase||23
44989|NCT02542605|105686|P3|STARTED|Part B: Challenge Phase||0
44990|NCT02542605|105687|P2|STARTED|Part B: Challenge Phase||0
44991|NCT02542605|105688|P1|STARTED|Part B: Challenge Phase||23
44992|NCT02542605|105686|P3|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
44993|NCT02542605|105687|P2|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
44994|NCT02542605|105688|P1|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
44995|NCT02542605|105686|P3|COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
44996|NCT02542605|105687|P2|COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
44997|NCT02542605|105688|P1|COMPLETED|Part A: PACAP-38 Dose Selection Phase||12
44998|NCT02542605|105686|P3|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||0
44999|NCT02542605|105687|P2|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||0
45000|NCT02542605|105688|P1|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||2
45001|NCT02542605|105686|P3|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||0
45002|NCT02542605|105687|P2|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||0
45003|NCT02542605|105688|P1|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||12
45004|NCT02542605|105686|P3|STARTED|Part A: PACAP-38 Dose Selection Phase||0
45005|NCT02542605|105687|P2|STARTED|Part A: PACAP-38 Dose Selection Phase||0
45006|NCT02542605|105688|P1|STARTED|Part A: PACAP-38 Dose Selection Phase||12
45007|NCT02542462|105739|P4|NOT COMPLETED|Overall Study||1
45008|NCT02542462|105740|P3|NOT COMPLETED|Overall Study||0
45009|NCT02542462|105741|P2|NOT COMPLETED|Overall Study||0
45010|NCT02542462|105742|P1|NOT COMPLETED|Overall Study||0
45011|NCT02542462|105739|P4|COMPLETED|Overall Study||25
45012|NCT02542462|105740|P3|COMPLETED|Overall Study||25
45013|NCT02542462|105741|P2|COMPLETED|Overall Study||25
45014|NCT02542462|105742|P1|COMPLETED|Overall Study||25
45015|NCT02542462|105739|P4|STARTED|Overall Study||26
45016|NCT02542462|105740|P3|STARTED|Overall Study||25
45017|NCT02542462|105741|P2|STARTED|Overall Study||25
45018|NCT02542462|105742|P1|STARTED|Overall Study||25
45019|NCT02542280|105756|P2|NOT COMPLETED|Overall Study||8
45020|NCT02542280|105757|P1|NOT COMPLETED|Overall Study||12
45021|NCT02542280|105756|P2|COMPLETED|Overall Study||167
45022|NCT02542280|105757|P1|COMPLETED|Overall Study||162
45023|NCT02542280|105756|P2|STARTED|Overall Study||175
45024|NCT02542280|105757|P1|STARTED|Overall Study||174
45025|NCT02542072|105767|P2|NOT COMPLETED|Second Intervention (1 Month)||0
45026|NCT02542072|105768|P1|NOT COMPLETED|Second Intervention (1 Month)||2
45027|NCT02542072|105767|P2|COMPLETED|Second Intervention (1 Month)||43
45028|NCT02542072|105768|P1|COMPLETED|Second Intervention (1 Month)||37
45029|NCT02542072|105767|P2|STARTED|Second Intervention (1 Month)||43
45030|NCT02542072|105768|P1|STARTED|Second Intervention (1 Month)||39
45031|NCT02542072|105767|P2|NOT COMPLETED|First Intervention (1 Month)||3
45032|NCT02542072|105768|P1|NOT COMPLETED|First Intervention (1 Month)||5
45033|NCT02542072|105767|P2|COMPLETED|First Intervention (1 Month)||43
45034|NCT02542072|105768|P1|COMPLETED|First Intervention (1 Month)||39
45035|NCT02542072|105767|P2|STARTED|First Intervention (1 Month)||46
45036|NCT02542072|105768|P1|STARTED|First Intervention (1 Month)||44
45037|NCT02542046|105871|P3|NOT COMPLETED|Overall Study||0
45038|NCT02542046|105872|P2|NOT COMPLETED|Overall Study||0
45039|NCT02542046|105873|P1|NOT COMPLETED|Overall Study||0
45040|NCT02542046|105871|P3|COMPLETED|Overall Study||300
45041|NCT02542046|105872|P2|COMPLETED|Overall Study||300
45042|NCT02542046|105873|P1|COMPLETED|Overall Study||300
45043|NCT02542046|105871|P3|STARTED|Overall Study||300
45044|NCT02542046|105872|P2|STARTED|Overall Study||300
45045|NCT02542046|105873|P1|STARTED|Overall Study||300
45046|NCT02541942|105887|P1|NOT COMPLETED|Overall Study||0
45047|NCT02541942|105887|P1|COMPLETED|Overall Study||19
45048|NCT02541942|105887|P1|STARTED|Overall Study||19
45049|NCT02541864|105894|P2|NOT COMPLETED|Overall Study||0
45050|NCT02541864|105895|P1|NOT COMPLETED|Overall Study||0
45051|NCT02541864|105894|P2|COMPLETED|Overall Study||166
45052|NCT02541864|105895|P1|COMPLETED|Overall Study||164
45053|NCT02541864|105894|P2|STARTED|Overall Study||166
45054|NCT02541864|105895|P1|STARTED|Overall Study||164
45055|NCT02541422|105901|P2|NOT COMPLETED|Second Intervention||0
45056|NCT02541422|105902|P1|NOT COMPLETED|Second Intervention||0
45057|NCT02541422|105901|P2|COMPLETED|Second Intervention||26
45058|NCT02541422|105902|P1|COMPLETED|Second Intervention||23
45059|NCT02541422|105901|P2|STARTED|Second Intervention||26
45060|NCT02541422|105902|P1|STARTED|Second Intervention||23
45061|NCT02541422|105901|P2|NOT COMPLETED|First Intervention||0
45062|NCT02541422|105902|P1|NOT COMPLETED|First Intervention||0
45063|NCT02541422|105901|P2|COMPLETED|First Intervention||26
45064|NCT02541422|105902|P1|COMPLETED|First Intervention||23
45065|NCT02541422|105901|P2|STARTED|First Intervention||26
45066|NCT02541422|105902|P1|STARTED|First Intervention||23
45067|NCT02540850|105911|P3|NOT COMPLETED|Overall Study||34
45068|NCT02540850|105912|P2|NOT COMPLETED|Overall Study||66
45069|NCT02540850|105913|P1|NOT COMPLETED|Overall Study||69
45070|NCT02540850|105911|P3|COMPLETED|Overall Study||410
45071|NCT02540850|105912|P2|COMPLETED|Overall Study||330
45072|NCT02540850|105913|P1|COMPLETED|Overall Study||291
45073|NCT02540850|105911|P3|STARTED|Overall Study||444
45074|NCT02540850|105912|P2|STARTED|Overall Study||396
45075|NCT02540850|105913|P1|STARTED|Overall Study||360
45076|NCT02540772|105941|P2|NOT COMPLETED|Overall Study||0
45077|NCT02540772|105942|P1|NOT COMPLETED|Overall Study||0
45078|NCT02540772|105941|P2|COMPLETED|Overall Study||10
45079|NCT02540772|105942|P1|COMPLETED|Overall Study||10
45080|NCT02540772|105941|P2|STARTED|Overall Study||10
45081|NCT02540772|105942|P1|STARTED|Overall Study||10
45082|NCT02540668|105954|P2|NOT COMPLETED|Period 2 - LY3314814 and Warfarin||1
45083|NCT02540668|105955|P1|NOT COMPLETED|Period 2 - LY3314814 and Warfarin||0
45084|NCT02540668|105954|P2|COMPLETED|Period 2 - LY3314814 and Warfarin||14
45085|NCT02540668|105955|P1|COMPLETED|Period 2 - LY3314814 and Warfarin||0
45086|NCT02540668|105954|P2|STARTED|Period 2 - LY3314814 and Warfarin|Warfarin was co-administered with LY3314814 only in Period 2.|15
45087|NCT02540668|105955|P1|STARTED|Period 2 - LY3314814 and Warfarin|Warfarin was administered alone only in Period 1.|0
45088|NCT02540668|105954|P2|NOT COMPLETED|Period 1 - Warfarin Single Dose||0
45089|NCT02540668|105955|P1|NOT COMPLETED|Period 1 - Warfarin Single Dose||0
45090|NCT02540668|105954|P2|COMPLETED|Period 1 - Warfarin Single Dose||0
45091|NCT02540668|105955|P1|COMPLETED|Period 1 - Warfarin Single Dose||15
45092|NCT02540668|105954|P2|Received at Least One Dose of Study Drug|Period 1 - Warfarin Single Dose||0
45093|NCT02540668|105955|P1|Received at Least One Dose of Study Drug|Period 1 - Warfarin Single Dose||15
45094|NCT02540668|105954|P2|STARTED|Period 1 - Warfarin Single Dose||0
45095|NCT02540668|105955|P1|STARTED|Period 1 - Warfarin Single Dose||15
45096|NCT02540538|105975|P3|NOT COMPLETED|Overall Study||0
45097|NCT02540538|105976|P2|NOT COMPLETED|Overall Study||1
45098|NCT02540538|105977|P1|NOT COMPLETED|Overall Study||0
45099|NCT02540538|105975|P3|COMPLETED|Overall Study||10
45100|NCT02540538|105976|P2|COMPLETED|Overall Study||11
45101|NCT02540538|105977|P1|COMPLETED|Overall Study||12
45102|NCT02540538|105975|P3|STARTED|Overall Study||10
45103|NCT02540538|105976|P2|STARTED|Overall Study||12
45104|NCT02540538|105977|P1|STARTED|Overall Study||12
45105|NCT02540447|105993|P2|NOT COMPLETED|Overall Study||0
45106|NCT02540447|105994|P1|NOT COMPLETED|Overall Study||0
45107|NCT02540447|105993|P2|COMPLETED|Overall Study||40
45108|NCT02540447|105994|P1|COMPLETED|Overall Study||40
45109|NCT02540447|105993|P2|STARTED|Overall Study||40
45110|NCT02540447|105994|P1|STARTED|Overall Study||40
45111|NCT02540434|106010|P2|NOT COMPLETED|Overall Study||0
45112|NCT02540434|106011|P1|NOT COMPLETED|Overall Study||0
45113|NCT02540434|106010|P2|COMPLETED|Overall Study||1
45114|NCT02540434|106011|P1|COMPLETED|Overall Study||1
45115|NCT02540434|106010|P2|STARTED|Overall Study||1
45116|NCT02540434|106011|P1|STARTED|Overall Study||1
45117|NCT02540356|106045|P2|NOT COMPLETED|Overall Study||0
45118|NCT02540356|106046|P1|NOT COMPLETED|Overall Study||1
45119|NCT02540356|106045|P2|COMPLETED|Overall Study||0
45120|NCT02540356|106046|P1|COMPLETED|Overall Study||0
45121|NCT02540356|106045|P2|STARTED|Overall Study||0
45122|NCT02540356|106046|P1|STARTED|Overall Study||1
45123|NCT02540265|106080|P3|NOT COMPLETED|Overall Study||1
45124|NCT02540265|106081|P2|NOT COMPLETED|Overall Study||0
45125|NCT02540265|106082|P1|NOT COMPLETED|Overall Study||0
45126|NCT02540265|106080|P3|COMPLETED|Overall Study||18
45127|NCT02540265|106081|P2|COMPLETED|Overall Study||20
45128|NCT02540265|106082|P1|COMPLETED|Overall Study||20
45129|NCT02540265|106080|P3|Treatment Completion|Overall Study||18
45130|NCT02540265|106081|P2|Treatment Completion|Overall Study||19
45131|NCT02540265|106082|P1|Treatment Completion|Overall Study||20
45132|NCT02540265|106080|P3|STARTED|Overall Study||19
45133|NCT02540265|106081|P2|STARTED|Overall Study||20
45134|NCT02540265|106082|P1|STARTED|Overall Study||20
45135|NCT02540213|106102|P1|NOT COMPLETED|Overall Study||39
45136|NCT02540213|106102|P1|COMPLETED|Overall Study||201
45137|NCT02540213|106102|P1|STARTED|Overall Study||240
45138|NCT02540083|106123|P1|NOT COMPLETED|Overall Study||16
45139|NCT02540083|106123|P1|COMPLETED|Overall Study||78
45140|NCT02540083|106123|P1|STARTED|Overall Study||94
45141|NCT02539992|106136|P3|NOT COMPLETED|Overall Study||4
45142|NCT02539992|106137|P2|NOT COMPLETED|Overall Study||4
45143|NCT02539992|106138|P1|NOT COMPLETED|Overall Study||0
45144|NCT02539992|106136|P3|COMPLETED|Overall Study||14
45145|NCT02539992|106137|P2|COMPLETED|Overall Study||7
45146|NCT02539992|106138|P1|COMPLETED|Overall Study||15
45147|NCT02539992|106136|P3|STARTED|Overall Study||18
45148|NCT02539992|106137|P2|STARTED|Overall Study||11
45149|NCT02539992|106138|P1|STARTED|Overall Study||15
45150|NCT02539797|106164|P3|NOT COMPLETED|Overall Study||0
45151|NCT02539797|106165|P2|NOT COMPLETED|Overall Study||1
45152|NCT02539797|106166|P1|NOT COMPLETED|Overall Study||0
45153|NCT02539797|106164|P3|COMPLETED|Overall Study||13
45154|NCT02539797|106165|P2|COMPLETED|Overall Study||12
45155|NCT02539797|106166|P1|COMPLETED|Overall Study||12
45156|NCT02539797|106164|P3|STARTED|Overall Study||13
45157|NCT02539797|106165|P2|STARTED|Overall Study||13
45158|NCT02539797|106166|P1|STARTED|Overall Study||12
45159|NCT02539654|106177|P1|NOT COMPLETED|Overall Study||0
45160|NCT02539654|106177|P1|COMPLETED|Overall Study||14
45161|NCT02539654|106177|P1|STARTED|Overall Study||14
45162|NCT02539563|106189|P2|NOT COMPLETED|Overall Study||14
45163|NCT02539563|106190|P1|NOT COMPLETED|Overall Study||6
45164|NCT02539563|106189|P2|COMPLETED|Overall Study||42
45165|NCT02539563|106190|P1|COMPLETED|Overall Study||39
45166|NCT02539563|106189|P2|STARTED|Overall Study||56
45167|NCT02539563|106190|P1|STARTED|Overall Study||45
45168|NCT02539511|106206|P2|NOT COMPLETED|Overall Study||0
45169|NCT02539511|106207|P1|NOT COMPLETED|Overall Study||6
45170|NCT02539511|106206|P2|COMPLETED|Overall Study||17
45171|NCT02539511|106207|P1|COMPLETED|Overall Study||17
45172|NCT02539511|106206|P2|STARTED|Overall Study||17
45173|NCT02539511|106207|P1|STARTED|Overall Study||23
45174|NCT02539342|106215|P2|NOT COMPLETED|Overall Study||0
45175|NCT02539342|106216|P1|NOT COMPLETED|Overall Study||0
45176|NCT02539342|106215|P2|COMPLETED|Overall Study||0
45177|NCT02539342|106216|P1|COMPLETED|Overall Study||1
45178|NCT02539342|106215|P2|STARTED|Overall Study||0
45179|NCT02539342|106216|P1|STARTED|Overall Study||1
45180|NCT02539225|106226|P2|NOT COMPLETED|Part B||20
45181|NCT02539225|106227|P1|NOT COMPLETED|Part B||13
45182|NCT02539225|106226|P2|COMPLETED|Part B||41
45183|NCT02539225|106227|P1|COMPLETED|Part B||44
45184|NCT02539225|106226|P2|STARTED|Part B||61
45185|NCT02539225|106227|P1|STARTED|Part B||57
45186|NCT02539225|106226|P2|NOT COMPLETED|Pre Treatment for Part B||3
45187|NCT02539225|106227|P1|NOT COMPLETED|Pre Treatment for Part B||5
45188|NCT02539225|106226|P2|COMPLETED|Pre Treatment for Part B||61
45189|NCT02539225|106227|P1|COMPLETED|Pre Treatment for Part B||57
45190|NCT02539225|106226|P2|STARTED|Pre Treatment for Part B||64
45191|NCT02539225|106227|P1|STARTED|Pre Treatment for Part B||62
45192|NCT02539225|106226|P2|NOT COMPLETED|Part A||22
45193|NCT02539225|106227|P1|NOT COMPLETED|Part A||24
45194|NCT02539225|106226|P2|COMPLETED|Part A||72
45195|NCT02539225|106227|P1|COMPLETED|Part A||73
45196|NCT02539225|106226|P2|Received Any Quantity of Study Drug|Part A||93
45197|NCT02539225|106227|P1|Received Any Quantity of Study Drug|Part A||96
45198|NCT02539225|106226|P2|STARTED|Part A||94
45199|NCT02539225|106227|P1|STARTED|Part A||97
45200|NCT02539134|106247|P6|NOT COMPLETED|Overall Study||0
45201|NCT02539134|106248|P5|NOT COMPLETED|Overall Study||0
45202|NCT02539134|106249|P4|NOT COMPLETED|Overall Study||0
45203|NCT02539134|106250|P3|NOT COMPLETED|Overall Study||0
45204|NCT02539134|106251|P2|NOT COMPLETED|Overall Study||0
45205|NCT02539134|106252|P1|NOT COMPLETED|Overall Study||1
45206|NCT02539134|106247|P6|COMPLETED|Overall Study||6
45207|NCT02539134|106248|P5|COMPLETED|Overall Study||6
45208|NCT02539134|106249|P4|COMPLETED|Overall Study||6
45209|NCT02539134|106250|P3|COMPLETED|Overall Study||6
45210|NCT02539134|106251|P2|COMPLETED|Overall Study||6
45211|NCT02539134|106252|P1|COMPLETED|Overall Study||9
45212|NCT02539134|106247|P6|STARTED|Overall Study||6
45213|NCT02539134|106248|P5|STARTED|Overall Study||6
45214|NCT02539134|106249|P4|STARTED|Overall Study||6
45215|NCT02539134|106250|P3|STARTED|Overall Study||6
45216|NCT02539134|106251|P2|STARTED|Overall Study||6
45217|NCT02539134|106252|P1|STARTED|Overall Study||10
45218|NCT02539108|106306|P2|NOT COMPLETED|Overall Study||0
45219|NCT02539108|106307|P1|NOT COMPLETED|Overall Study||0
45220|NCT02539108|106306|P2|COMPLETED|Overall Study||30
45221|NCT02539108|106307|P1|COMPLETED|Overall Study||30
45222|NCT02539108|106306|P2|STARTED|Overall Study||30
45223|NCT02539108|106307|P1|STARTED|Overall Study||30
45224|NCT02538965|106321|P1|NOT COMPLETED|Follow-Up Period||15
45225|NCT02538965|106321|P1|COMPLETED|Follow-Up Period||2
45226|NCT02538965|106321|P1|STARTED|Follow-Up Period||17
45227|NCT02538965|106321|P1|NOT COMPLETED|Treatment Period||17
45228|NCT02538965|106321|P1|COMPLETED|Treatment Period||0
45229|NCT02538965|106321|P1|STARTED|Treatment Period||17
45230|NCT02538783|106342|P2|NOT COMPLETED|Overall Study||1
45231|NCT02538783|106343|P1|NOT COMPLETED|Overall Study||0
45232|NCT02538783|106342|P2|COMPLETED|Overall Study||128
45233|NCT02538783|106343|P1|COMPLETED|Overall Study||130
45234|NCT02538783|106342|P2|STARTED|Overall Study||129
45235|NCT02538783|106343|P1|STARTED|Overall Study||130
45236|NCT02538679|106354|P3|NOT COMPLETED|Overall Study||8
45237|NCT02538679|106355|P2|NOT COMPLETED|Overall Study||9
45238|NCT02538679|106356|P1|NOT COMPLETED|Overall Study||3
45239|NCT02538679|106354|P3|COMPLETED|Overall Study||41
45240|NCT02538679|106355|P2|COMPLETED|Overall Study||45
45241|NCT02538679|106356|P1|COMPLETED|Overall Study||21
45242|NCT02538679|106354|P3|STARTED|Overall Study||49
45243|NCT02538679|106355|P2|STARTED|Overall Study||54
45244|NCT02538679|106356|P1|STARTED|Overall Study||24
45245|NCT02538666|106367|P3|NOT COMPLETED|Overall Study||1
45246|NCT02538666|106368|P2|NOT COMPLETED|Overall Study||1
45247|NCT02538666|106369|P1|NOT COMPLETED|Overall Study||2
45248|NCT02538666|106367|P3|COMPLETED|Overall Study||278
45249|NCT02538666|106368|P2|COMPLETED|Overall Study||279
45250|NCT02538666|106369|P1|COMPLETED|Overall Study||273
45251|NCT02538666|106367|P3|STARTED|Overall Study||279
45252|NCT02538666|106368|P2|STARTED|Overall Study||280
45253|NCT02538666|106369|P1|STARTED|Overall Study||275
45254|NCT02538419|106390|P2|NOT COMPLETED|Overall Study||0
45255|NCT02538419|106391|P1|NOT COMPLETED|Overall Study||0
45256|NCT02538419|106390|P2|COMPLETED|Overall Study||20
45257|NCT02538419|106391|P1|COMPLETED|Overall Study||20
45258|NCT02538419|106390|P2|STARTED|Overall Study||20
45259|NCT02538419|106391|P1|STARTED|Overall Study||20
45260|NCT02538107|106407|P1|NOT COMPLETED|Overall Study||110
45261|NCT02538107|106407|P1|COMPLETED|Overall Study||180
45262|NCT02538107|106407|P1|STARTED|Overall Study||290
45263|NCT02538042|106429|P2|NOT COMPLETED|Overall Study||11
45264|NCT02538042|106430|P1|NOT COMPLETED|Overall Study||11
45265|NCT02538042|106429|P2|COMPLETED|Overall Study||6
45266|NCT02538042|106430|P1|COMPLETED|Overall Study||6
45267|NCT02538042|106429|P2|Completed All Post-Quit Visits|Overall Study||12
45268|NCT02538042|106430|P1|Completed All Post-Quit Visits|Overall Study||12
45269|NCT02538042|106429|P2|Attended Post-Quit Visit|Overall Study||14
45270|NCT02538042|106430|P1|Attended Post-Quit Visit|Overall Study||15
45271|NCT02538042|106429|P2|Completed All MCE Sessions|Overall Study||15
45272|NCT02538042|106430|P1|Completed All MCE Sessions|Overall Study||15
45273|NCT02538042|106429|P2|STARTED|Overall Study||17
45274|NCT02538042|106430|P1|STARTED|Overall Study||17
45275|NCT02538029|106449|P3|NOT COMPLETED|Overall Study||1
45276|NCT02538029|106450|P2|NOT COMPLETED|Overall Study||0
45277|NCT02538029|106451|P1|NOT COMPLETED|Overall Study||1
45278|NCT02538029|106449|P3|COMPLETED|Overall Study||10
45279|NCT02538029|106450|P2|COMPLETED|Overall Study||10
45280|NCT02538029|106451|P1|COMPLETED|Overall Study||23
45281|NCT02538029|106449|P3|STARTED|Overall Study||11
45282|NCT02538029|106450|P2|STARTED|Overall Study||10
45283|NCT02538029|106451|P1|STARTED|Overall Study||24
45284|NCT02537951|106473|P1|NOT COMPLETED|Overall Study||0
45285|NCT02537951|106473|P1|COMPLETED|Overall Study||10
45286|NCT02537951|106473|P1|STARTED|Overall Study||10
45287|NCT02537730|106481|P2|NOT COMPLETED|Second Intervention (7 Days)||0
45288|NCT02537730|106482|P1|NOT COMPLETED|Second Intervention (7 Days)||0
45289|NCT02537730|106481|P2|COMPLETED|Second Intervention (7 Days)||16
45290|NCT02537730|106482|P1|COMPLETED|Second Intervention (7 Days)||17
45291|NCT02537730|106481|P2|STARTED|Second Intervention (7 Days)||16
45292|NCT02537730|106482|P1|STARTED|Second Intervention (7 Days)||17
45293|NCT02537730|106481|P2|NOT COMPLETED|First Intervention (7 Days)||0
45294|NCT02537730|106482|P1|NOT COMPLETED|First Intervention (7 Days)||0
45295|NCT02537730|106481|P2|COMPLETED|First Intervention (7 Days)||16
45296|NCT02537730|106482|P1|COMPLETED|First Intervention (7 Days)||17
45297|NCT02537730|106481|P2|STARTED|First Intervention (7 Days)||16
45298|NCT02537730|106482|P1|STARTED|First Intervention (7 Days)||17
45299|NCT02537574|106497|P3|NOT COMPLETED|Overall Study||108
45300|NCT02537574|106498|P2|NOT COMPLETED|Overall Study||103
45301|NCT02537574|106499|P1|NOT COMPLETED|Overall Study||99
45302|NCT02537574|106497|P3|COMPLETED|Overall Study||18
45303|NCT02537574|106498|P2|COMPLETED|Overall Study||23
45304|NCT02537574|106499|P1|COMPLETED|Overall Study||27
45305|NCT02537574|106497|P3|STARTED|Overall Study||126
45306|NCT02537574|106498|P2|STARTED|Overall Study||126
45307|NCT02537574|106499|P1|STARTED|Overall Study||126
45308|NCT02537522|106525|P4|NOT COMPLETED|Phase II - Period 2 Bilateral||0
45309|NCT02537522|106526|P3|NOT COMPLETED|Phase II - Period 2 Bilateral||0
45310|NCT02537522|106527|P2|NOT COMPLETED|Phase II - Period 2 Bilateral||0
45311|NCT02537522|106528|P1|NOT COMPLETED|Phase II - Period 2 Bilateral||0
45312|NCT02537522|106525|P4|COMPLETED|Phase II - Period 2 Bilateral||22
45313|NCT02537522|106526|P3|COMPLETED|Phase II - Period 2 Bilateral||23
45314|NCT02537522|106527|P2|COMPLETED|Phase II - Period 2 Bilateral||0
45315|NCT02537522|106528|P1|COMPLETED|Phase II - Period 2 Bilateral||0
45316|NCT02537522|106525|P4|STARTED|Phase II - Period 2 Bilateral||22
45317|NCT02537522|106526|P3|STARTED|Phase II - Period 2 Bilateral||23
45318|NCT02537522|106527|P2|STARTED|Phase II - Period 2 Bilateral||0
45319|NCT02537522|106528|P1|STARTED|Phase II - Period 2 Bilateral||0
45320|NCT02537522|106525|P4|NOT COMPLETED|Phase II - Period 1 Bilateral||1
45321|NCT02537522|106526|P3|NOT COMPLETED|Phase II - Period 1 Bilateral||0
45322|NCT02537522|106527|P2|NOT COMPLETED|Phase II - Period 1 Bilateral||0
45323|NCT02537522|106528|P1|NOT COMPLETED|Phase II - Period 1 Bilateral||0
45324|NCT02537522|106525|P4|COMPLETED|Phase II - Period 1 Bilateral||22
45325|NCT02537522|106526|P3|COMPLETED|Phase II - Period 1 Bilateral||23
45326|NCT02537522|106527|P2|COMPLETED|Phase II - Period 1 Bilateral||0
45327|NCT02537522|106528|P1|COMPLETED|Phase II - Period 1 Bilateral||0
45328|NCT02537522|106525|P4|STARTED|Phase II - Period 1 Bilateral||23
45329|NCT02537522|106526|P3|STARTED|Phase II - Period 1 Bilateral||23
45330|NCT02537522|106527|P2|STARTED|Phase II - Period 1 Bilateral||0
45331|NCT02537522|106528|P1|STARTED|Phase II - Period 1 Bilateral||0
45332|NCT02537522|106525|P4|NOT COMPLETED|Phase I - Contralateral||0
45333|NCT02537522|106526|P3|NOT COMPLETED|Phase I - Contralateral||0
45334|NCT02537522|106527|P2|NOT COMPLETED|Phase I - Contralateral||10
45335|NCT02537522|106528|P1|NOT COMPLETED|Phase I - Contralateral||15
45336|NCT02537522|106525|P4|COMPLETED|Phase I - Contralateral||0
45337|NCT02537522|106526|P3|COMPLETED|Phase I - Contralateral||0
45338|NCT02537522|106527|P2|COMPLETED|Phase I - Contralateral||27
45339|NCT02537522|106528|P1|COMPLETED|Phase I - Contralateral||19
45340|NCT02537522|106525|P4|STARTED|Phase I - Contralateral||0
45341|NCT02537522|106526|P3|STARTED|Phase I - Contralateral||0
45342|NCT02537522|106527|P2|STARTED|Phase I - Contralateral||37
45343|NCT02537522|106528|P1|STARTED|Phase I - Contralateral||34
45344|NCT02537444|106538|P2|NOT COMPLETED|Overall Study||39
45345|NCT02537444|106539|P1|NOT COMPLETED|Overall Study||39
45346|NCT02537444|106538|P2|COMPLETED|Overall Study||0
45347|NCT02537444|106539|P1|COMPLETED|Overall Study||0
45348|NCT02537444|106538|P2|Discontinued Study|Overall Study||39
45349|NCT02537444|106539|P1|Discontinued Study|Overall Study||39
45350|NCT02537444|106538|P2|Received Study Medication|Overall Study||39
45351|NCT02537444|106539|P1|Received Study Medication|Overall Study||38
45352|NCT02537444|106538|P2|Enrolled|Overall Study||39
45353|NCT02537444|106539|P1|Enrolled|Overall Study||39
45354|NCT02537444|106538|P2|STARTED|Overall Study||39
45355|NCT02537444|106539|P1|STARTED|Overall Study||39
45356|NCT02537431|106545|P1|NOT COMPLETED|Overall Study||1
45357|NCT02537431|106545|P1|COMPLETED|Overall Study|Completed Open-Label Period (Week 0 - Week 48)|13
45358|NCT02537431|106545|P1|STARTED|Overall Study|Screened and received at least 1 dose of study drug.|14
45359|NCT02537015|106574|P1|NOT COMPLETED|Overall Study||6
45360|NCT02537015|106574|P1|COMPLETED|Overall Study||75
45361|NCT02537015|106574|P1|STARTED|Overall Study||81
45362|NCT02536976|106580|P2|NOT COMPLETED|Overall Study||1
45363|NCT02536976|106581|P1|NOT COMPLETED|Overall Study||0
45364|NCT02536976|106580|P2|COMPLETED|Overall Study||1
45365|NCT02536976|106581|P1|COMPLETED|Overall Study||3
45366|NCT02536976|106580|P2|Washout|Overall Study||1
45367|NCT02536976|106581|P1|Washout|Overall Study||3
45368|NCT02536976|106580|P2|Dose Escalation and Maintenance|Overall Study|10 weeks double blind placebo matching mirabegron|1
45369|NCT02536976|106581|P1|Dose Escalation and Maintenance|Overall Study|10 weeks double blind mirabegron|3
45370|NCT02536976|106580|P2|Randomization|Overall Study|2 weeks double blind placebo matching mirabegron|1
45371|NCT02536976|106581|P1|Randomization|Overall Study|2 weeks double blind mirabegron|3
45372|NCT02536976|106580|P2|STARTED|Overall Study|2 weeks single blind placebo run-in. 1 participant terminated due to unrelated failing health|2
45373|NCT02536976|106581|P1|STARTED|Overall Study|2 weeks single blind placebo run-in|3
45374|NCT02536781|106593|P2|NOT COMPLETED|Overall Study||0
45375|NCT02536781|106594|P1|NOT COMPLETED|Overall Study||2
45376|NCT02536781|106593|P2|COMPLETED|Overall Study||34
45377|NCT02536781|106594|P1|COMPLETED|Overall Study||34
45378|NCT02536781|106593|P2|STARTED|Overall Study||34
45379|NCT02536781|106594|P1|STARTED|Overall Study||36
45380|NCT02536664|106604|P2|NOT COMPLETED|Overall Study||80
45381|NCT02536664|106605|P1|NOT COMPLETED|Overall Study||107
45382|NCT02536664|106604|P2|COMPLETED|Overall Study||97
45383|NCT02536664|106605|P1|COMPLETED|Overall Study||205
45384|NCT02536664|106604|P2|STARTED|Overall Study||177
45385|NCT02536664|106605|P1|STARTED|Overall Study||312
45386|NCT02536313|106625|P2|NOT COMPLETED|Overall Study||1
45387|NCT02536313|106626|P1|NOT COMPLETED|Overall Study||0
45388|NCT02536313|106625|P2|COMPLETED|Overall Study||24
45389|NCT02536313|106626|P1|COMPLETED|Overall Study||24
45390|NCT02536313|106625|P2|STARTED|Overall Study||25
45391|NCT02536313|106626|P1|STARTED|Overall Study||24
45392|NCT02535806|106642|P1|NOT COMPLETED|Overall Study||0
45393|NCT02535806|106642|P1|COMPLETED|Overall Study||2
45394|NCT02535806|106642|P1|STARTED|Overall Study||2
45395|NCT02535741|106649|P1|NOT COMPLETED|Overall Study||32
45396|NCT02535741|106649|P1|COMPLETED|Overall Study|Completed cases at 2 years follow-up|136
45397|NCT02535741|106649|P1|STARTED|Overall Study||168
45398|NCT02535715|106657|P3|NOT COMPLETED|Overall Study||1
45399|NCT02535715|106658|P2|NOT COMPLETED|Overall Study||0
45400|NCT02535715|106659|P1|NOT COMPLETED|Overall Study||0
45401|NCT02535715|106657|P3|COMPLETED|Overall Study||2
45402|NCT02535715|106658|P2|COMPLETED|Overall Study||4
45403|NCT02535715|106659|P1|COMPLETED|Overall Study||4
45404|NCT02535715|106657|P3|STARTED|Overall Study||3
45405|NCT02535715|106658|P2|STARTED|Overall Study||4
45406|NCT02535715|106659|P1|STARTED|Overall Study||4
45407|NCT02535416|106688|P9|NOT COMPLETED|Overall Study||0
45408|NCT02535416|106689|P8|NOT COMPLETED|Overall Study||0
45409|NCT02535416|106690|P7|NOT COMPLETED|Overall Study||0
45410|NCT02535416|106691|P6|NOT COMPLETED|Overall Study||0
45411|NCT02535416|106692|P5|NOT COMPLETED|Overall Study||0
45412|NCT02535416|106693|P4|NOT COMPLETED|Overall Study||0
45413|NCT02535416|106694|P3|NOT COMPLETED|Overall Study||0
45414|NCT02535416|106695|P2|NOT COMPLETED|Overall Study||0
45415|NCT02535416|106696|P1|NOT COMPLETED|Overall Study||1
45416|NCT02535416|106688|P9|COMPLETED|Overall Study||6
45417|NCT02535416|106689|P8|COMPLETED|Overall Study||6
45418|NCT02535416|106690|P7|COMPLETED|Overall Study||6
45419|NCT02535416|106691|P6|COMPLETED|Overall Study||4
45420|NCT02535416|106692|P5|COMPLETED|Overall Study||4
45421|NCT02535416|106693|P4|COMPLETED|Overall Study||4
45422|NCT02535416|106694|P3|COMPLETED|Overall Study||4
45423|NCT02535416|106695|P2|COMPLETED|Overall Study||2
45424|NCT02535416|106696|P1|COMPLETED|Overall Study||3
45425|NCT02535416|106688|P9|STARTED|Overall Study||6
45426|NCT02535416|106689|P8|STARTED|Overall Study||6
45427|NCT02535416|106690|P7|STARTED|Overall Study||6
45428|NCT02535416|106691|P6|STARTED|Overall Study||4
45429|NCT02535416|106692|P5|STARTED|Overall Study||4
45430|NCT02535416|106693|P4|STARTED|Overall Study||4
45431|NCT02535416|106694|P3|STARTED|Overall Study||4
45432|NCT02535416|106695|P2|STARTED|Overall Study||2
45433|NCT02535416|106696|P1|STARTED|Overall Study||4
45434|NCT02535364|106748|P1|NOT COMPLETED|12-Month Follow-up Period||35
45435|NCT02535364|106748|P1|COMPLETED|12-Month Follow-up Period||3
45436|NCT02535364|106748|P1|STARTED|12-Month Follow-up Period||38
45437|NCT02535364|106748|P1|NOT COMPLETED|Study Treatment||2
45438|NCT02535364|106748|P1|COMPLETED|Study Treatment||38
45439|NCT02535364|106748|P1|STARTED|Study Treatment||40
45440|NCT02535364|106748|P1|NOT COMPLETED|Part B Screening||17
45441|NCT02535364|106748|P1|COMPLETED|Part B Screening||40
45442|NCT02535364|106748|P1|STARTED|Part B Screening||57
45443|NCT02535364|106748|P1|NOT COMPLETED|Part A Screening Through Leukapheresis||25
45444|NCT02535364|106748|P1|COMPLETED|Part A Screening Through Leukapheresis||57
45445|NCT02535364|106748|P1|STARTED|Part A Screening Through Leukapheresis||82
45446|NCT02535065|106773|P1|NOT COMPLETED|Overall Study||62
45447|NCT02535065|106773|P1|COMPLETED|Overall Study||0
45448|NCT02535065|106773|P1|12-Month Follow-up|Overall Study||61
45449|NCT02535065|106773|P1|1-Month Follow-up|Overall Study||62
45450|NCT02535065|106773|P1|STARTED|Overall Study||62
45451|NCT02535026|106778|P1|NOT COMPLETED|Overall Study||0
45452|NCT02535026|106778|P1|COMPLETED|Overall Study||580
45453|NCT02535026|106778|P1|STARTED|Overall Study||580
45454|NCT02534935|106833|P3|NOT COMPLETED|Overall Study||5
45455|NCT02534935|106834|P2|NOT COMPLETED|Overall Study||10
45456|NCT02534935|106835|P1|NOT COMPLETED|Overall Study||0
45457|NCT02534935|106833|P3|COMPLETED|Overall Study||127
45458|NCT02534935|106834|P2|COMPLETED|Overall Study||210
45459|NCT02534935|106835|P1|COMPLETED|Overall Study||44
45460|NCT02534935|106833|P3|STARTED|Overall Study||132
45461|NCT02534935|106834|P2|STARTED|Overall Study||220
45462|NCT02534935|106835|P1|STARTED|Overall Study||44
45463|NCT02534896|106996|P3|NOT COMPLETED|Overall Study||1
45464|NCT02534896|106997|P2|NOT COMPLETED|Overall Study||1
45465|NCT02534896|106998|P1|NOT COMPLETED|Overall Study||4
45466|NCT02534896|106996|P3|COMPLETED|Overall Study||48
45467|NCT02534896|106997|P2|COMPLETED|Overall Study||51
45468|NCT02534896|106998|P1|COMPLETED|Overall Study||45
45469|NCT02534896|106996|P3|STARTED|Overall Study||49
45470|NCT02534896|106997|P2|STARTED|Overall Study||52
45471|NCT02534896|106998|P1|STARTED|Overall Study||49
45472|NCT02534883|107017|P2|NOT COMPLETED|Overall Study||3
45473|NCT02534883|107018|P1|NOT COMPLETED|Overall Study||8
45474|NCT02534883|107017|P2|COMPLETED|Overall Study||0
45475|NCT02534883|107018|P1|COMPLETED|Overall Study||0
45476|NCT02534883|107017|P2|STARTED|Overall Study||3
45477|NCT02534883|107018|P1|STARTED|Overall Study||8
45478|NCT02534493|107034|P1|NOT COMPLETED|Overall Study||2
45479|NCT02534493|107034|P1|COMPLETED|Overall Study||11
45480|NCT02534493|107034|P1|STARTED|Overall Study||13
45481|NCT02534350|107045|P2|NOT COMPLETED|Overall Study||0
45482|NCT02534350|107046|P1|NOT COMPLETED|Overall Study||4
45483|NCT02534350|107045|P2|COMPLETED|Overall Study||20
45484|NCT02534350|107046|P1|COMPLETED|Overall Study||37
45485|NCT02534350|107045|P2|STARTED|Overall Study||20
45486|NCT02534350|107046|P1|STARTED|Overall Study||41
45487|NCT02534324|107060|P2|NOT COMPLETED|Overall Study||8
45488|NCT02534324|107061|P1|NOT COMPLETED|Overall Study||25
45489|NCT02534324|107060|P2|COMPLETED|Overall Study||40
45490|NCT02534324|107061|P1|COMPLETED|Overall Study||73
45491|NCT02534324|107060|P2|STARTED|Overall Study||48
45492|NCT02534324|107061|P1|STARTED|Overall Study||98
45493|NCT02534129|107071|P2|NOT COMPLETED|Overall Study||0
45494|NCT02534129|107072|P1|NOT COMPLETED|Overall Study||0
45495|NCT02534129|107071|P2|COMPLETED|Overall Study||13
45496|NCT02534129|107072|P1|COMPLETED|Overall Study||13
45497|NCT02534129|107071|P2|STARTED|Overall Study||13
45498|NCT02534129|107072|P1|STARTED|Overall Study||13
45499|NCT02533999|107080|P2|NOT COMPLETED|Overall Study||7
45500|NCT02533999|107081|P1|NOT COMPLETED|Overall Study||6
45501|NCT02533999|107080|P2|COMPLETED|Overall Study||30
45502|NCT02533999|107081|P1|COMPLETED|Overall Study||32
45503|NCT02533999|107080|P2|STARTED|Overall Study||37
45504|NCT02533999|107081|P1|STARTED|Overall Study||38
45505|NCT02533726|107101|P2|NOT COMPLETED|Treatment||0
45506|NCT02533726|107102|P1|NOT COMPLETED|Treatment||0
45507|NCT02533726|107101|P2|COMPLETED|Treatment||603
45508|NCT02533726|107102|P1|COMPLETED|Treatment||709
45509|NCT02533726|107101|P2|Per Protocol Population|Treatment||555
45510|NCT02533726|107102|P1|Per Protocol Population|Treatment||671
45511|NCT02533726|107101|P2|STARTED|Treatment|4 participants allocated to Optimal Turning actually received Standard Care|603
45512|NCT02533726|107102|P1|STARTED|Treatment|54 participants allocated to Standard Care actually received Optimal Turning|709
45513|NCT02533726|107101|P2|NOT COMPLETED|Initial Allocation||0
45514|NCT02533726|107102|P1|NOT COMPLETED|Initial Allocation||0
45515|NCT02533726|107101|P2|COMPLETED|Initial Allocation||653
45516|NCT02533726|107102|P1|COMPLETED|Initial Allocation||659
45517|NCT02533726|107101|P2|STARTED|Initial Allocation||653
45518|NCT02533726|107102|P1|STARTED|Initial Allocation||659
45519|NCT02533570|107113|P3|NOT COMPLETED|Overall Study||1
45520|NCT02533570|107114|P2|NOT COMPLETED|Overall Study||1
45521|NCT02533570|107115|P1|NOT COMPLETED|Overall Study||0
45522|NCT02533570|107113|P3|COMPLETED|Overall Study||7
45523|NCT02533570|107114|P2|COMPLETED|Overall Study||7
45524|NCT02533570|107115|P1|COMPLETED|Overall Study||4
45525|NCT02533570|107113|P3|STARTED|Overall Study||8
45526|NCT02533570|107114|P2|STARTED|Overall Study||8
45527|NCT02533570|107115|P1|STARTED|Overall Study||4
45528|NCT02533531|107126|P1|NOT COMPLETED|Overall Study||1
45529|NCT02533531|107126|P1|COMPLETED|Overall Study||0
45530|NCT02533531|107126|P1|STARTED|Overall Study||1
45531|NCT02533505|107131|P2|NOT COMPLETED|Overall Study||1
45532|NCT02533505|107132|P1|NOT COMPLETED|Overall Study||3
45533|NCT02533505|107131|P2|COMPLETED|Overall Study||24
45534|NCT02533505|107132|P1|COMPLETED|Overall Study||23
45535|NCT02533505|107131|P2|STARTED|Overall Study||25
45536|NCT02533505|107132|P1|STARTED|Overall Study||26
45537|NCT02533466|107164|P2|NOT COMPLETED|Overall Study||0
45538|NCT02533466|107165|P1|NOT COMPLETED|Overall Study||0
45539|NCT02533466|107164|P2|COMPLETED|Overall Study||14
45540|NCT02533466|107165|P1|COMPLETED|Overall Study||16
45541|NCT02533466|107164|P2|STARTED|Overall Study||14
45542|NCT02533466|107165|P1|STARTED|Overall Study||16
45543|NCT02533453|107189|P1|NOT COMPLETED|Overall Study||9
45544|NCT02533453|107189|P1|COMPLETED|Overall Study||101
45545|NCT02533453|107189|P1|STARTED|Overall Study||110
45546|NCT02533401|107198|P1|NOT COMPLETED|Overall Study||11
45547|NCT02533401|107198|P1|COMPLETED|Overall Study||23
45548|NCT02533401|107198|P1|STARTED|Overall Study||34
45549|NCT02533375|107206|P1|NOT COMPLETED|Overall Study||5
45550|NCT02533375|107206|P1|COMPLETED|Overall Study||5
45551|NCT02533375|107206|P1|STARTED|Overall Study||10
45552|NCT02533258|107238|P1|NOT COMPLETED|Overall Study||8
45553|NCT02533258|107238|P1|COMPLETED|Overall Study||5
45554|NCT02533258|107238|P1|STARTED|Overall Study||13
45555|NCT02533167|107250|P1|NOT COMPLETED|Overall Study||15
45556|NCT02533167|107250|P1|COMPLETED|Overall Study||55
45557|NCT02533167|107250|P1|STARTED|Overall Study||70
45558|NCT02533063|107261|P2|NOT COMPLETED|Intervention 2 (8 Weeks)||0
45559|NCT02533063|107262|P1|NOT COMPLETED|Intervention 2 (8 Weeks)||0
45560|NCT02533063|107261|P2|COMPLETED|Intervention 2 (8 Weeks)||11
45561|NCT02533063|107262|P1|COMPLETED|Intervention 2 (8 Weeks)||14
45562|NCT02533063|107261|P2|STARTED|Intervention 2 (8 Weeks)||11
45563|NCT02533063|107262|P1|STARTED|Intervention 2 (8 Weeks)||14
45564|NCT02533063|107261|P2|NOT COMPLETED|Washout (4 Weeks)||0
45565|NCT02533063|107262|P1|NOT COMPLETED|Washout (4 Weeks)||0
45566|NCT02533063|107261|P2|COMPLETED|Washout (4 Weeks)||11
45567|NCT02533063|107262|P1|COMPLETED|Washout (4 Weeks)||14
45568|NCT02533063|107261|P2|STARTED|Washout (4 Weeks)||11
45569|NCT02533063|107262|P1|STARTED|Washout (4 Weeks)||14
45570|NCT02533063|107261|P2|NOT COMPLETED|Intervention 1 (8 Weeks)||5
45571|NCT02533063|107262|P1|NOT COMPLETED|Intervention 1 (8 Weeks)||2
45572|NCT02533063|107261|P2|COMPLETED|Intervention 1 (8 Weeks)||11
45573|NCT02533063|107262|P1|COMPLETED|Intervention 1 (8 Weeks)||14
45574|NCT02533063|107261|P2|STARTED|Intervention 1 (8 Weeks)||16
45575|NCT02533063|107262|P1|STARTED|Intervention 1 (8 Weeks)||16
45576|NCT02532998|107284|P1|NOT COMPLETED|Overall Study||0
45577|NCT02532998|107284|P1|COMPLETED|Overall Study||23
45578|NCT02532998|107284|P1|STARTED|Overall Study||23
45579|NCT02532933|107368|P2|NOT COMPLETED|Overall Study||6
45580|NCT02532933|107369|P1|NOT COMPLETED|Overall Study||6
45581|NCT02532933|107368|P2|COMPLETED|Overall Study||16
45582|NCT02532933|107369|P1|COMPLETED|Overall Study||16
45583|NCT02532933|107368|P2|STARTED|Overall Study||22
45584|NCT02532933|107369|P1|STARTED|Overall Study||22
45585|NCT02532855|107377|P2|NOT COMPLETED|Overall Study||11
45586|NCT02532855|107378|P1|NOT COMPLETED|Overall Study||8
45587|NCT02532855|107377|P2|COMPLETED|Overall Study||296
45588|NCT02532855|107378|P1|COMPLETED|Overall Study||299
45589|NCT02532855|107377|P2|Treated|Overall Study|One participant had a protocol violation, was randomized but did not take study medication.|306
45590|NCT02532855|107378|P1|Treated|Overall Study||307
45591|NCT02532855|107377|P2|STARTED|Overall Study||307
45592|NCT02532855|107378|P1|STARTED|Overall Study||307
45593|NCT02532764|107412|P10|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
45594|NCT02532764|107413|P9|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
45595|NCT02532764|107414|P8|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
45596|NCT02532764|107415|P7|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
45597|NCT02532764|107416|P6|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
45598|NCT02532764|107417|P5|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
45599|NCT02532764|107418|P4|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
45600|NCT02532764|107419|P3|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
45601|NCT02532764|107420|P2|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
45602|NCT02532764|107421|P1|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
45603|NCT02532764|107412|P10|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||8
45604|NCT02532764|107413|P9|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||5
45605|NCT02532764|107414|P8|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
45606|NCT02532764|107415|P7|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
45607|NCT02532764|107416|P6|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
45608|NCT02532764|107417|P5|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
45609|NCT02532764|107418|P4|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
45610|NCT02532764|107419|P3|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
45611|NCT02532764|107420|P2|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
45612|NCT02532764|107421|P1|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
45613|NCT02532764|107412|P10|STARTED|Multiple Ascending Dose (MAD) Cohorst||9
45614|NCT02532764|107413|P9|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
45615|NCT02532764|107414|P8|STARTED|Multiple Ascending Dose (MAD) Cohorst||7
45616|NCT02532764|107415|P7|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
45617|NCT02532764|107416|P6|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
45618|NCT02532764|107417|P5|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
45619|NCT02532764|107418|P4|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
45620|NCT02532764|107419|P3|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
45621|NCT02532764|107420|P2|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
45622|NCT02532764|107421|P1|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
45623|NCT02532764|107412|P10|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
45624|NCT02532764|107413|P9|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
45625|NCT02532764|107414|P8|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
45626|NCT02532764|107415|P7|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
45627|NCT02532764|107416|P6|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
45628|NCT02532764|107417|P5|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
45629|NCT02532764|107418|P4|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
45630|NCT02532764|107419|P3|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
45631|NCT02532764|107420|P2|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
45632|NCT02532764|107421|P1|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
45633|NCT02532764|107412|P10|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
45634|NCT02532764|107413|P9|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
45635|NCT02532764|107414|P8|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
45636|NCT02532764|107415|P7|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
45637|NCT02532764|107416|P6|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
45638|NCT02532764|107417|P5|COMPLETED|Single Ascending Dose (SAD) Cohorts||9
45639|NCT02532764|107418|P4|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
45640|NCT02532764|107419|P3|COMPLETED|Single Ascending Dose (SAD) Cohorts||9
45641|NCT02532764|107420|P2|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
45642|NCT02532764|107421|P1|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
45643|NCT02532764|107412|P10|STARTED|Single Ascending Dose (SAD) Cohorts||0
45644|NCT02532764|107413|P9|STARTED|Single Ascending Dose (SAD) Cohorts||0
45645|NCT02532764|107414|P8|STARTED|Single Ascending Dose (SAD) Cohorts||0
45646|NCT02532764|107415|P7|STARTED|Single Ascending Dose (SAD) Cohorts||0
45647|NCT02532764|107416|P6|STARTED|Single Ascending Dose (SAD) Cohorts||0
45648|NCT02532764|107417|P5|STARTED|Single Ascending Dose (SAD) Cohorts||9
45649|NCT02532764|107418|P4|STARTED|Single Ascending Dose (SAD) Cohorts||6
45650|NCT02532764|107419|P3|STARTED|Single Ascending Dose (SAD) Cohorts||9
45651|NCT02532764|107420|P2|STARTED|Single Ascending Dose (SAD) Cohorts||6
45652|NCT02532764|107421|P1|STARTED|Single Ascending Dose (SAD) Cohorts||6
45653|NCT02532647|107572|P3|NOT COMPLETED|Overall Study||1
45654|NCT02532647|107573|P2|NOT COMPLETED|Overall Study||0
45655|NCT02532647|107574|P1|NOT COMPLETED|Overall Study||1
45656|NCT02532647|107572|P3|COMPLETED|Overall Study||30
45657|NCT02532647|107573|P2|COMPLETED|Overall Study||16
45658|NCT02532647|107574|P1|COMPLETED|Overall Study||31
45659|NCT02532647|107572|P3|Safety Population|Overall Study||30
45660|NCT02532647|107573|P2|Safety Population|Overall Study||16
45661|NCT02532647|107574|P1|Safety Population|Overall Study||31
45662|NCT02532647|107572|P3|STARTED|Overall Study||31
45663|NCT02532647|107573|P2|STARTED|Overall Study||16
45664|NCT02532647|107574|P1|STARTED|Overall Study||32
45665|NCT02532465|107590|P2|NOT COMPLETED|Overall Study||1
45666|NCT02532465|107591|P1|NOT COMPLETED|Overall Study||1
45667|NCT02532465|107590|P2|COMPLETED|Overall Study||24
45668|NCT02532465|107591|P1|COMPLETED|Overall Study||24
45669|NCT02532465|107590|P2|STARTED|Overall Study||25
45670|NCT02532465|107591|P1|STARTED|Overall Study||25
45671|NCT02532374|107601|P1|NOT COMPLETED|Overall Study||2
45672|NCT02532374|107601|P1|COMPLETED|Overall Study||14
45673|NCT02532374|107601|P1|P3L150 μg/Puff (Visit 6)|Overall Study||14
45674|NCT02532374|107601|P1|P3L 80 μg/Puff (Visit 5)|Overall Study||14
45675|NCT02532374|107601|P1|P3L 50 μg/Puff (Visit 4)|Overall Study||15
45676|NCT02532374|107601|P1|Nicorette Inhalator (Visit 3)|Overall Study||15
45677|NCT02532374|107601|P1|STARTED|Overall Study||16
45678|NCT02532179|107625|P1|NOT COMPLETED|Overall Study||3
45679|NCT02532179|107625|P1|COMPLETED|Overall Study||9
45680|NCT02532179|107625|P1|STARTED|Overall Study||12
45681|NCT02532010|107636|P2|NOT COMPLETED|Overall Study||4
45682|NCT02532010|107637|P1|NOT COMPLETED|Overall Study||9
45683|NCT02532010|107636|P2|COMPLETED|Overall Study||0
45684|NCT02532010|107637|P1|COMPLETED|Overall Study||0
45685|NCT02532010|107636|P2|STARTED|Overall Study||4
45686|NCT02532010|107637|P1|STARTED|Overall Study||9
45687|NCT02531867|107655|P1|NOT COMPLETED|Overall Study||0
45688|NCT02531867|107655|P1|COMPLETED|Overall Study||13
45689|NCT02531867|107655|P1|STARTED|Overall Study||13
45690|NCT02531802|107680|P21|NOT COMPLETED|Received Vaccination 2||1
45691|NCT02531802|107681|P20|NOT COMPLETED|Received Vaccination 2||1
45692|NCT02531802|107682|P19|NOT COMPLETED|Received Vaccination 2||3
45693|NCT02531802|107683|P18|NOT COMPLETED|Received Vaccination 2||4
45694|NCT02531802|107684|P17|NOT COMPLETED|Received Vaccination 2||0
45695|NCT02531802|107685|P16|NOT COMPLETED|Received Vaccination 2||0
45696|NCT02531802|107686|P15|NOT COMPLETED|Received Vaccination 2||1
45697|NCT02531802|107687|P14|NOT COMPLETED|Received Vaccination 2||2
45698|NCT02531802|107688|P13|NOT COMPLETED|Received Vaccination 2||2
45699|NCT02531802|107689|P12|NOT COMPLETED|Received Vaccination 2||0
45700|NCT02531802|107690|P11|NOT COMPLETED|Received Vaccination 2||2
45701|NCT02531802|107691|P10|NOT COMPLETED|Received Vaccination 2||3
45702|NCT02531802|107692|P9|NOT COMPLETED|Received Vaccination 2||0
45703|NCT02531802|107693|P8|NOT COMPLETED|Received Vaccination 2||0
45704|NCT02531802|107694|P7|NOT COMPLETED|Received Vaccination 2||0
45705|NCT02531802|107695|P6|NOT COMPLETED|Received Vaccination 2||3
45706|NCT02531802|107696|P5|NOT COMPLETED|Received Vaccination 2||0
45707|NCT02531802|107697|P4|NOT COMPLETED|Received Vaccination 2||0
45708|NCT02531802|107698|P3|NOT COMPLETED|Received Vaccination 2||1
45709|NCT02531802|107699|P2|NOT COMPLETED|Received Vaccination 2||0
45710|NCT02531802|107700|P1|NOT COMPLETED|Received Vaccination 2||0
45711|NCT02531802|107680|P21|COMPLETED|Received Vaccination 2||49
45712|NCT02531802|107681|P20|COMPLETED|Received Vaccination 2||29
45713|NCT02531802|107682|P19|COMPLETED|Received Vaccination 2||27
45714|NCT02531802|107683|P18|COMPLETED|Received Vaccination 2||26
45715|NCT02531802|107684|P17|COMPLETED|Received Vaccination 2||30
45716|NCT02531802|107685|P16|COMPLETED|Received Vaccination 2||30
45717|NCT02531802|107686|P15|COMPLETED|Received Vaccination 2||39
45718|NCT02531802|107687|P14|COMPLETED|Received Vaccination 2||13
45719|NCT02531802|107688|P13|COMPLETED|Received Vaccination 2||13
45720|NCT02531802|107689|P12|COMPLETED|Received Vaccination 2||15
45721|NCT02531802|107690|P11|COMPLETED|Received Vaccination 2||13
45722|NCT02531802|107691|P10|COMPLETED|Received Vaccination 2||49
45723|NCT02531802|107692|P9|COMPLETED|Received Vaccination 2||15
45724|NCT02531802|107693|P8|COMPLETED|Received Vaccination 2||15
45725|NCT02531802|107694|P7|COMPLETED|Received Vaccination 2||15
45726|NCT02531802|107695|P6|COMPLETED|Received Vaccination 2||0
45727|NCT02531802|107696|P5|COMPLETED|Received Vaccination 2||15
45728|NCT02531802|107697|P4|COMPLETED|Received Vaccination 2||15
45729|NCT02531802|107698|P3|COMPLETED|Received Vaccination 2||14
45730|NCT02531802|107699|P2|COMPLETED|Received Vaccination 2||15
45731|NCT02531802|107700|P1|COMPLETED|Received Vaccination 2||15
45732|NCT02531802|107680|P21|STARTED|Received Vaccination 2||50
45733|NCT02531802|107681|P20|STARTED|Received Vaccination 2||30
45734|NCT02531802|107682|P19|STARTED|Received Vaccination 2||30
45735|NCT02531802|107683|P18|STARTED|Received Vaccination 2||30
45736|NCT02531802|107684|P17|STARTED|Received Vaccination 2||30
45737|NCT02531802|107685|P16|STARTED|Received Vaccination 2||30
45738|NCT02531802|107686|P15|STARTED|Received Vaccination 2||40
45739|NCT02531802|107687|P14|STARTED|Received Vaccination 2||15
45740|NCT02531802|107688|P13|STARTED|Received Vaccination 2||15
45741|NCT02531802|107689|P12|STARTED|Received Vaccination 2||15
45742|NCT02531802|107690|P11|STARTED|Received Vaccination 2||15
45743|NCT02531802|107691|P10|STARTED|Received Vaccination 2||52
45744|NCT02531802|107692|P9|STARTED|Received Vaccination 2||15
45745|NCT02531802|107693|P8|STARTED|Received Vaccination 2||15
45746|NCT02531802|107694|P7|STARTED|Received Vaccination 2||15
45747|NCT02531802|107695|P6|STARTED|Received Vaccination 2||3
45748|NCT02531802|107696|P5|STARTED|Received Vaccination 2||15
45749|NCT02531802|107697|P4|STARTED|Received Vaccination 2||15
45750|NCT02531802|107698|P3|STARTED|Received Vaccination 2||15
45751|NCT02531802|107699|P2|STARTED|Received Vaccination 2||15
45752|NCT02531802|107700|P1|STARTED|Received Vaccination 2||15
45753|NCT02531802|107680|P21|NOT COMPLETED|Received Vaccination 1||0
45754|NCT02531802|107681|P20|NOT COMPLETED|Received Vaccination 1||0
45755|NCT02531802|107682|P19|NOT COMPLETED|Received Vaccination 1||0
45756|NCT02531802|107683|P18|NOT COMPLETED|Received Vaccination 1||0
45757|NCT02531802|107684|P17|NOT COMPLETED|Received Vaccination 1||0
45758|NCT02531802|107685|P16|NOT COMPLETED|Received Vaccination 1||0
45759|NCT02531802|107686|P15|NOT COMPLETED|Received Vaccination 1||0
45760|NCT02531802|107687|P14|NOT COMPLETED|Received Vaccination 1||0
45761|NCT02531802|107688|P13|NOT COMPLETED|Received Vaccination 1||0
45762|NCT02531802|107689|P12|NOT COMPLETED|Received Vaccination 1||0
45763|NCT02531802|107690|P11|NOT COMPLETED|Received Vaccination 1||0
45764|NCT02531802|107691|P10|NOT COMPLETED|Received Vaccination 1||0
45765|NCT02531802|107692|P9|NOT COMPLETED|Received Vaccination 1||0
45766|NCT02531802|107693|P8|NOT COMPLETED|Received Vaccination 1||0
45767|NCT02531802|107694|P7|NOT COMPLETED|Received Vaccination 1||0
45768|NCT02531802|107695|P6|NOT COMPLETED|Received Vaccination 1||0
45769|NCT02531802|107696|P5|NOT COMPLETED|Received Vaccination 1||0
45770|NCT02531802|107697|P4|NOT COMPLETED|Received Vaccination 1||0
45771|NCT02531802|107698|P3|NOT COMPLETED|Received Vaccination 1||0
45772|NCT02531802|107699|P2|NOT COMPLETED|Received Vaccination 1||0
45773|NCT02531802|107700|P1|NOT COMPLETED|Received Vaccination 1||0
45774|NCT02531802|107680|P21|COMPLETED|Received Vaccination 1||50
45775|NCT02531802|107681|P20|COMPLETED|Received Vaccination 1||30
45776|NCT02531802|107682|P19|COMPLETED|Received Vaccination 1||30
45777|NCT02531802|107683|P18|COMPLETED|Received Vaccination 1||30
45778|NCT02531802|107684|P17|COMPLETED|Received Vaccination 1||30
45779|NCT02531802|107685|P16|COMPLETED|Received Vaccination 1||30
45780|NCT02531802|107686|P15|COMPLETED|Received Vaccination 1||40
45781|NCT02531802|107687|P14|COMPLETED|Received Vaccination 1||15
45782|NCT02531802|107688|P13|COMPLETED|Received Vaccination 1||15
45783|NCT02531802|107689|P12|COMPLETED|Received Vaccination 1||15
45784|NCT02531802|107690|P11|COMPLETED|Received Vaccination 1||15
45785|NCT02531802|107691|P10|COMPLETED|Received Vaccination 1||52
45786|NCT02531802|107692|P9|COMPLETED|Received Vaccination 1||15
45787|NCT02531802|107693|P8|COMPLETED|Received Vaccination 1||15
45788|NCT02531802|107694|P7|COMPLETED|Received Vaccination 1||15
45789|NCT02531802|107695|P6|COMPLETED|Received Vaccination 1||3
45790|NCT02531802|107696|P5|COMPLETED|Received Vaccination 1||15
45791|NCT02531802|107697|P4|COMPLETED|Received Vaccination 1||15
45792|NCT02531802|107698|P3|COMPLETED|Received Vaccination 1||15
45793|NCT02531802|107699|P2|COMPLETED|Received Vaccination 1||15
45794|NCT02531802|107700|P1|COMPLETED|Received Vaccination 1||15
45795|NCT02531802|107680|P21|STARTED|Received Vaccination 1||50
45796|NCT02531802|107681|P20|STARTED|Received Vaccination 1||30
45797|NCT02531802|107682|P19|STARTED|Received Vaccination 1||30
45798|NCT02531802|107683|P18|STARTED|Received Vaccination 1||30
45799|NCT02531802|107684|P17|STARTED|Received Vaccination 1||30
45800|NCT02531802|107685|P16|STARTED|Received Vaccination 1||30
45801|NCT02531802|107686|P15|STARTED|Received Vaccination 1||40
45802|NCT02531802|107687|P14|STARTED|Received Vaccination 1||15
45803|NCT02531802|107688|P13|STARTED|Received Vaccination 1||15
45804|NCT02531802|107689|P12|STARTED|Received Vaccination 1||15
45805|NCT02531802|107690|P11|STARTED|Received Vaccination 1||15
45806|NCT02531802|107691|P10|STARTED|Received Vaccination 1||52
45807|NCT02531802|107692|P9|STARTED|Received Vaccination 1||15
45808|NCT02531802|107693|P8|STARTED|Received Vaccination 1||15
45809|NCT02531802|107694|P7|STARTED|Received Vaccination 1||15
45810|NCT02531802|107695|P6|STARTED|Received Vaccination 1||3
45811|NCT02531802|107696|P5|STARTED|Received Vaccination 1||15
45812|NCT02531802|107697|P4|STARTED|Received Vaccination 1||15
45813|NCT02531802|107698|P3|STARTED|Received Vaccination 1||15
45814|NCT02531802|107699|P2|STARTED|Received Vaccination 1||15
45815|NCT02531802|107700|P1|STARTED|Received Vaccination 1||15
45816|NCT02531698|108132|P2|NOT COMPLETED|Overall Study||2
45817|NCT02531698|108133|P1|NOT COMPLETED|Overall Study||11
45818|NCT02531698|108132|P2|COMPLETED|Overall Study||104
45819|NCT02531698|108133|P1|COMPLETED|Overall Study||283
45820|NCT02531698|108132|P2|STARTED|Overall Study||106
45821|NCT02531698|108133|P1|STARTED|Overall Study||294
45822|NCT02531646|108380|P3|NOT COMPLETED|Overall Study||0
45823|NCT02531646|108381|P2|NOT COMPLETED|Overall Study||1
45824|NCT02531646|108382|P1|NOT COMPLETED|Overall Study||5
45825|NCT02531646|108380|P3|COMPLETED|Overall Study||11
45826|NCT02531646|108381|P2|COMPLETED|Overall Study||17
45827|NCT02531646|108382|P1|COMPLETED|Overall Study||32
45828|NCT02531646|108380|P3|STARTED|Overall Study||11
45829|NCT02531646|108381|P2|STARTED|Overall Study||18
45830|NCT02531646|108382|P1|STARTED|Overall Study||37
45831|NCT02531633|108401|P10|NOT COMPLETED|Part B (104 Weeks)||4
45832|NCT02531633|108402|P9|NOT COMPLETED|Part B (104 Weeks)||5
45833|NCT02531633|108403|P8|NOT COMPLETED|Part B (104 Weeks)||4
45834|NCT02531633|108404|P7|NOT COMPLETED|Part B (104 Weeks)||5
45835|NCT02531633|108405|P6|NOT COMPLETED|Part B (104 Weeks)||8
45836|NCT02531633|108406|P5|NOT COMPLETED|Part B (104 Weeks)||0
45837|NCT02531633|108407|P4|NOT COMPLETED|Part B (104 Weeks)||0
45838|NCT02531633|108408|P3|NOT COMPLETED|Part B (104 Weeks)||0
45839|NCT02531633|108409|P2|NOT COMPLETED|Part B (104 Weeks)||0
45840|NCT02531633|108410|P1|NOT COMPLETED|Part B (104 Weeks)||0
45841|NCT02531633|108401|P10|COMPLETED|Part B (104 Weeks)||0
45842|NCT02531633|108402|P9|COMPLETED|Part B (104 Weeks)||0
45843|NCT02531633|108403|P8|COMPLETED|Part B (104 Weeks)||0
45844|NCT02531633|108404|P7|COMPLETED|Part B (104 Weeks)||0
45845|NCT02531633|108405|P6|COMPLETED|Part B (104 Weeks)||0
45846|NCT02531633|108406|P5|COMPLETED|Part B (104 Weeks)||0
45847|NCT02531633|108407|P4|COMPLETED|Part B (104 Weeks)||0
45848|NCT02531633|108408|P3|COMPLETED|Part B (104 Weeks)||0
45849|NCT02531633|108409|P2|COMPLETED|Part B (104 Weeks)||0
45850|NCT02531633|108410|P1|COMPLETED|Part B (104 Weeks)||0
45851|NCT02531633|108401|P10|STARTED|Part B (104 Weeks)||4
45852|NCT02531633|108402|P9|STARTED|Part B (104 Weeks)||5
45853|NCT02531633|108403|P8|STARTED|Part B (104 Weeks)||4
45854|NCT02531633|108404|P7|STARTED|Part B (104 Weeks)||5
45855|NCT02531633|108405|P6|STARTED|Part B (104 Weeks)||8
45856|NCT02531633|108406|P5|STARTED|Part B (104 Weeks)||0
45857|NCT02531633|108407|P4|STARTED|Part B (104 Weeks)||0
45858|NCT02531633|108408|P3|STARTED|Part B (104 Weeks)||0
45859|NCT02531633|108409|P2|STARTED|Part B (104 Weeks)||0
45860|NCT02531633|108410|P1|STARTED|Part B (104 Weeks)||0
45861|NCT02531633|108401|P10|NOT COMPLETED|Part A (52 Weeks)||0
45862|NCT02531633|108402|P9|NOT COMPLETED|Part A (52 Weeks)||0
45863|NCT02531633|108403|P8|NOT COMPLETED|Part A (52 Weeks)||0
45864|NCT02531633|108404|P7|NOT COMPLETED|Part A (52 Weeks)||0
45865|NCT02531633|108405|P6|NOT COMPLETED|Part A (52 Weeks)||0
45866|NCT02531633|108406|P5|NOT COMPLETED|Part A (52 Weeks)||23
45867|NCT02531633|108407|P4|NOT COMPLETED|Part A (52 Weeks)||22
45868|NCT02531633|108408|P3|NOT COMPLETED|Part A (52 Weeks)||22
45869|NCT02531633|108409|P2|NOT COMPLETED|Part A (52 Weeks)||34
45870|NCT02531633|108410|P1|NOT COMPLETED|Part A (52 Weeks)||34
45871|NCT02531633|108401|P10|COMPLETED|Part A (52 Weeks)||0
45872|NCT02531633|108402|P9|COMPLETED|Part A (52 Weeks)||0
45873|NCT02531633|108403|P8|COMPLETED|Part A (52 Weeks)||0
45874|NCT02531633|108404|P7|COMPLETED|Part A (52 Weeks)||0
45875|NCT02531633|108405|P6|COMPLETED|Part A (52 Weeks)||0
45876|NCT02531633|108406|P5|COMPLETED|Part A (52 Weeks)||4
45877|NCT02531633|108407|P4|COMPLETED|Part A (52 Weeks)||5
45878|NCT02531633|108408|P3|COMPLETED|Part A (52 Weeks)||4
45879|NCT02531633|108409|P2|COMPLETED|Part A (52 Weeks)||5
45880|NCT02531633|108410|P1|COMPLETED|Part A (52 Weeks)||8
45881|NCT02531633|108401|P10|Completed Part A and Didn’t Enter Part B|Part A (52 Weeks)||0
45882|NCT02531633|108402|P9|Completed Part A and Didn’t Enter Part B|Part A (52 Weeks)||0
45883|NCT02531633|108403|P8|Completed Part A and Didn’t Enter Part B|Part A (52 Weeks)||0
45884|NCT02531633|108404|P7|Completed Part A and Didn’t Enter Part B|Part A (52 Weeks)||0
45885|NCT02531633|108405|P6|Completed Part A and Didn’t Enter Part B|Part A (52 Weeks)||0
45886|NCT02531633|108406|P5|Completed Part A and Didn’t Enter Part B|Part A (52 Weeks)||0
45887|NCT02531633|108407|P4|Completed Part A and Didn’t Enter Part B|Part A (52 Weeks)||0
45888|NCT02531633|108408|P3|Completed Part A and Didn’t Enter Part B|Part A (52 Weeks)||1
45889|NCT02531633|108409|P2|Completed Part A and Didn’t Enter Part B|Part A (52 Weeks)||0
45890|NCT02531633|108410|P1|Completed Part A and Didn’t Enter Part B|Part A (52 Weeks)||1
45891|NCT02531633|108401|P10|STARTED|Part A (52 Weeks)||0
45892|NCT02531633|108402|P9|STARTED|Part A (52 Weeks)||0
45893|NCT02531633|108403|P8|STARTED|Part A (52 Weeks)||0
45894|NCT02531633|108404|P7|STARTED|Part A (52 Weeks)||0
45895|NCT02531633|108405|P6|STARTED|Part A (52 Weeks)||0
45896|NCT02531633|108406|P5|STARTED|Part A (52 Weeks)||27
45897|NCT02531633|108407|P4|STARTED|Part A (52 Weeks)||27
45898|NCT02531633|108408|P3|STARTED|Part A (52 Weeks)||26
45899|NCT02531633|108409|P2|STARTED|Part A (52 Weeks)||39
45900|NCT02531633|108410|P1|STARTED|Part A (52 Weeks)||42
45901|NCT02531438|108889|P2|NOT COMPLETED|Overall Study||26
45902|NCT02531438|108890|P1|NOT COMPLETED|Overall Study||30
45903|NCT02531438|108889|P2|COMPLETED|Overall Study||362
45904|NCT02531438|108890|P1|COMPLETED|Overall Study||356
45905|NCT02531438|108889|P2|STARTED|Overall Study||388
45906|NCT02531438|108890|P1|STARTED|Overall Study||386
45907|NCT02531373|108909|P9|NOT COMPLETED|Overall Study||9
45908|NCT02531373|108910|P8|NOT COMPLETED|Overall Study||9
45909|NCT02531373|108911|P7|NOT COMPLETED|Overall Study||11
45910|NCT02531373|108912|P6|NOT COMPLETED|Overall Study||9
45911|NCT02531373|108913|P5|NOT COMPLETED|Overall Study||8
45912|NCT02531373|108914|P4|NOT COMPLETED|Overall Study||0
45913|NCT02531373|108915|P3|NOT COMPLETED|Overall Study||0
45914|NCT02531373|108916|P2|NOT COMPLETED|Overall Study||0
45915|NCT02531373|108917|P1|NOT COMPLETED|Overall Study||0
45916|NCT02531373|108909|P9|COMPLETED|Overall Study||43
45917|NCT02531373|108910|P8|COMPLETED|Overall Study||43
45918|NCT02531373|108911|P7|COMPLETED|Overall Study||41
45919|NCT02531373|108912|P6|COMPLETED|Overall Study||42
45920|NCT02531373|108913|P5|COMPLETED|Overall Study||43
45921|NCT02531373|108914|P4|COMPLETED|Overall Study||20
45922|NCT02531373|108915|P3|COMPLETED|Overall Study||20
45923|NCT02531373|108916|P2|COMPLETED|Overall Study||20
45924|NCT02531373|108917|P1|COMPLETED|Overall Study||20
45925|NCT02531373|108909|P9|Vaccination 4|Overall Study||43
45926|NCT02531373|108910|P8|Vaccination 4|Overall Study||43
45927|NCT02531373|108911|P7|Vaccination 4|Overall Study||43
45928|NCT02531373|108912|P6|Vaccination 4|Overall Study||43
45929|NCT02531373|108913|P5|Vaccination 4|Overall Study||44
45930|NCT02531373|108914|P4|Vaccination 4|Overall Study||0
45931|NCT02531373|108915|P3|Vaccination 4|Overall Study||0
45932|NCT02531373|108916|P2|Vaccination 4|Overall Study||0
45933|NCT02531373|108917|P1|Vaccination 4|Overall Study||0
45934|NCT02531373|108909|P9|Vaccination 3|Overall Study||49
45935|NCT02531373|108910|P8|Vaccination 3|Overall Study||51
45936|NCT02531373|108911|P7|Vaccination 3|Overall Study||49
45937|NCT02531373|108912|P6|Vaccination 3|Overall Study||47
45938|NCT02531373|108913|P5|Vaccination 3|Overall Study||48
45939|NCT02531373|108914|P4|Vaccination 3|Overall Study||0
45940|NCT02531373|108915|P3|Vaccination 3|Overall Study||0
45941|NCT02531373|108916|P2|Vaccination 3|Overall Study||0
45942|NCT02531373|108917|P1|Vaccination 3|Overall Study||0
45943|NCT02531373|108909|P9|Vaccination 2|Overall Study||51
45944|NCT02531373|108910|P8|Vaccination 2|Overall Study||51
45945|NCT02531373|108911|P7|Vaccination 2|Overall Study||50
45946|NCT02531373|108912|P6|Vaccination 2|Overall Study||48
45947|NCT02531373|108913|P5|Vaccination 2|Overall Study||49
45948|NCT02531373|108914|P4|Vaccination 2|Overall Study||0
45949|NCT02531373|108915|P3|Vaccination 2|Overall Study||0
45950|NCT02531373|108916|P2|Vaccination 2|Overall Study||0
45951|NCT02531373|108917|P1|Vaccination 2|Overall Study||0
45952|NCT02531373|108909|P9|Vaccination 1|Overall Study||52
45953|NCT02531373|108910|P8|Vaccination 1|Overall Study||52
45954|NCT02531373|108911|P7|Vaccination 1|Overall Study||52
45955|NCT02531373|108912|P6|Vaccination 1|Overall Study||50
45956|NCT02531373|108913|P5|Vaccination 1|Overall Study||50
45957|NCT02531373|108914|P4|Vaccination 1|Overall Study||20
45958|NCT02531373|108915|P3|Vaccination 1|Overall Study||20
45959|NCT02531373|108916|P2|Vaccination 1|Overall Study||20
45960|NCT02531373|108917|P1|Vaccination 1|Overall Study||20
45961|NCT02531373|108909|P9|STARTED|Overall Study||52
45962|NCT02531373|108910|P8|STARTED|Overall Study||52
45963|NCT02531373|108911|P7|STARTED|Overall Study||52
45964|NCT02531373|108912|P6|STARTED|Overall Study||51
45965|NCT02531373|108913|P5|STARTED|Overall Study||51
45966|NCT02531373|108914|P4|STARTED|Overall Study||20
45967|NCT02531373|108915|P3|STARTED|Overall Study||20
45968|NCT02531373|108916|P2|STARTED|Overall Study||20
45969|NCT02531373|108917|P1|STARTED|Overall Study||20
45970|NCT02531321|108976|P2|NOT COMPLETED|Overall Study||0
45971|NCT02531321|108977|P1|NOT COMPLETED|Overall Study||2
45972|NCT02531321|108976|P2|COMPLETED|Overall Study||10
45973|NCT02531321|108977|P1|COMPLETED|Overall Study||5
45974|NCT02531321|108976|P2|STARTED|Overall Study||10
45975|NCT02531321|108977|P1|STARTED|Overall Study||7
45976|NCT02531308|108985|P1|NOT COMPLETED|Overall Study||3
45977|NCT02531308|108985|P1|COMPLETED|Overall Study||2
45978|NCT02531308|108985|P1|STARTED|Overall Study||5
45979|NCT02531035|108991|P2|NOT COMPLETED|Overall Study||95
45980|NCT02531035|108992|P1|NOT COMPLETED|Overall Study||81
45981|NCT02531035|108991|P2|COMPLETED|Overall Study||605
45982|NCT02531035|108992|P1|COMPLETED|Overall Study||624
45983|NCT02531035|108991|P2|Treated|Overall Study||699
45984|NCT02531035|108992|P1|Treated|Overall Study||703
45985|NCT02531035|108991|P2|STARTED|Overall Study||700
45986|NCT02531035|108992|P1|STARTED|Overall Study||705
45987|NCT02531022|109008|P2|NOT COMPLETED|Overall Study||2
45988|NCT02531022|109009|P1|NOT COMPLETED|Overall Study||0
45989|NCT02531022|109008|P2|COMPLETED|Overall Study||48
45990|NCT02531022|109009|P1|COMPLETED|Overall Study||55
45991|NCT02531022|109008|P2|STARTED|Overall Study||50
45992|NCT02531022|109009|P1|STARTED|Overall Study||55
45993|NCT02530671|109019|P2|NOT COMPLETED|Overall Study||0
45994|NCT02530671|109020|P1|NOT COMPLETED|Overall Study||3
45995|NCT02530671|109019|P2|COMPLETED|Overall Study||55
45996|NCT02530671|109020|P1|COMPLETED|Overall Study||52
45997|NCT02530671|109019|P2|STARTED|Overall Study||55
45998|NCT02530671|109020|P1|STARTED|Overall Study||55
45999|NCT02530515|109039|P3|NOT COMPLETED|Overall Study||0
46000|NCT02530515|109040|P2|NOT COMPLETED|Overall Study||0
46001|NCT02530515|109041|P1|NOT COMPLETED|Overall Study||0
46002|NCT02530515|109039|P3|COMPLETED|Overall Study||8
46003|NCT02530515|109040|P2|COMPLETED|Overall Study||0
46004|NCT02530515|109041|P1|COMPLETED|Overall Study||0
46005|NCT02530515|109039|P3|STARTED|Overall Study||8
46006|NCT02530515|109040|P2|STARTED|Overall Study||0
46007|NCT02530515|109041|P1|STARTED|Overall Study||0
46008|NCT02530450|109060|P2|NOT COMPLETED|Overall Study||5
46009|NCT02530450|109061|P1|NOT COMPLETED|Overall Study||6
46010|NCT02530450|109060|P2|COMPLETED|Overall Study||9
46011|NCT02530450|109061|P1|COMPLETED|Overall Study||10
46012|NCT02530450|109060|P2|STARTED|Overall Study||14
46013|NCT02530450|109061|P1|STARTED|Overall Study||16
46014|NCT02530385|109069|P2|NOT COMPLETED|Overall Study||1
46015|NCT02530385|109070|P1|NOT COMPLETED|Overall Study||0
46016|NCT02530385|109069|P2|COMPLETED|Overall Study||11
46017|NCT02530385|109070|P1|COMPLETED|Overall Study||12
46018|NCT02530385|109069|P2|STARTED|Overall Study||12
46019|NCT02530385|109070|P1|STARTED|Overall Study||12
46020|NCT02530294|109086|P2|NOT COMPLETED|Overall Study||6
46021|NCT02530294|109087|P1|NOT COMPLETED|Overall Study||16
46022|NCT02530294|109086|P2|COMPLETED|Overall Study||113
46023|NCT02530294|109087|P1|COMPLETED|Overall Study||218
46024|NCT02530294|109086|P2|STARTED|Overall Study||119
46025|NCT02530294|109087|P1|STARTED|Overall Study||234
46026|NCT02530281|109103|P2|NOT COMPLETED|Overall Study||3
46027|NCT02530281|109104|P1|NOT COMPLETED|Overall Study||21
46028|NCT02530281|109103|P2|COMPLETED|Overall Study||112
46029|NCT02530281|109104|P1|COMPLETED|Overall Study||208
46030|NCT02530281|109103|P2|STARTED|Overall Study||115
46031|NCT02530281|109104|P1|STARTED|Overall Study||229
46032|NCT02530151|109122|P2|NOT COMPLETED|Overall Study||16
46033|NCT02530151|109123|P1|NOT COMPLETED|Overall Study||21
46034|NCT02530151|109122|P2|COMPLETED|Overall Study||17
46035|NCT02530151|109123|P1|COMPLETED|Overall Study||16
46036|NCT02530151|109122|P2|STARTED|Overall Study||33
46037|NCT02530151|109123|P1|STARTED|Overall Study||37
46038|NCT02530125|109133|P1|NOT COMPLETED|Followed for Survival for 2 Years||3
46039|NCT02530125|109133|P1|COMPLETED|Followed for Survival for 2 Years||0
46040|NCT02530125|109133|P1|STARTED|Followed for Survival for 2 Years||3
46041|NCT02530125|109133|P1|NOT COMPLETED|Completed Treatment||1
46042|NCT02530125|109133|P1|COMPLETED|Completed Treatment||3
46043|NCT02530125|109133|P1|STARTED|Completed Treatment||4
46044|NCT02529995|109147|P2|NOT COMPLETED|Part B||12
46045|NCT02529995|109148|P1|NOT COMPLETED|Part B||6
46046|NCT02529995|109147|P2|COMPLETED|Part B||4
46047|NCT02529995|109148|P1|COMPLETED|Part B||9
46048|NCT02529995|109147|P2|STARTED|Part B||16
46049|NCT02529995|109148|P1|STARTED|Part B||15
46050|NCT02529995|109147|P2|NOT COMPLETED|Part A||16
46051|NCT02529995|109148|P1|NOT COMPLETED|Part A||15
46052|NCT02529995|109147|P2|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
46053|NCT02529995|109148|P1|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
46054|NCT02529995|109147|P2|STARTED|Part A||16
46055|NCT02529995|109148|P1|STARTED|Part A||15
46056|NCT02529488|109182|P1|NOT COMPLETED|Overall Study||4
46057|NCT02529488|109182|P1|COMPLETED|Overall Study||145
46058|NCT02529488|109182|P1|STARTED|Overall Study||149
46059|NCT02529137|109190|P1|NOT COMPLETED|Overall Study||8
46060|NCT02529137|109190|P1|COMPLETED|Overall Study||1992
46061|NCT02529137|109190|P1|STARTED|Overall Study||2000
46062|NCT02528786|109195|P1|NOT COMPLETED|Overall Study||0
46063|NCT02528786|109195|P1|COMPLETED|Overall Study||8
46064|NCT02528786|109195|P1|STARTED|Overall Study||8
46065|NCT02528721|109201|P2|NOT COMPLETED|Overall Study||3
46066|NCT02528721|109202|P1|NOT COMPLETED|Overall Study||7
46067|NCT02528721|109201|P2|COMPLETED|Overall Study||76
46068|NCT02528721|109202|P1|COMPLETED|Overall Study||196
46069|NCT02528721|109201|P2|STARTED|Overall Study||79
46070|NCT02528721|109202|P1|STARTED|Overall Study||203
46071|NCT02528643|109214|P2|NOT COMPLETED|Overall Study||85
46072|NCT02528643|109215|P1|NOT COMPLETED|Overall Study||39
46073|NCT02528643|109214|P2|COMPLETED|Overall Study||25
46074|NCT02528643|109215|P1|COMPLETED|Overall Study||16
46075|NCT02528643|109214|P2|Treated|Overall Study||107
46076|NCT02528643|109215|P1|Treated|Overall Study||55
46077|NCT02528643|109214|P2|STARTED|Overall Study||110
46078|NCT02528643|109215|P1|STARTED|Overall Study||55
46079|NCT02528500|109228|P1|NOT COMPLETED|Overall Study||0
46080|NCT02528500|109228|P1|COMPLETED|Overall Study||10
46081|NCT02528500|109228|P1|STARTED|Overall Study||10
46082|NCT02528331|109232|P1|NOT COMPLETED|Overall Study||2
46083|NCT02528331|109232|P1|COMPLETED|Overall Study||0
46084|NCT02528331|109232|P1|STARTED|Overall Study||2
46085|NCT02528318|109244|P5|NOT COMPLETED|Overall Study||0
46086|NCT02528318|109245|P4|NOT COMPLETED|Overall Study||0
46087|NCT02528318|109246|P3|NOT COMPLETED|Overall Study||0
46088|NCT02528318|109247|P2|NOT COMPLETED|Overall Study||0
46089|NCT02528318|109248|P1|NOT COMPLETED|Overall Study||0
46090|NCT02528318|109244|P5|COMPLETED|Overall Study||24
46091|NCT02528318|109245|P4|COMPLETED|Overall Study||0
46092|NCT02528318|109246|P3|COMPLETED|Overall Study||8
46093|NCT02528318|109247|P2|COMPLETED|Overall Study||8
46094|NCT02528318|109248|P1|COMPLETED|Overall Study||8
46095|NCT02528318|109244|P5|STARTED|Overall Study||24
46096|NCT02528318|109245|P4|STARTED|Overall Study|Study was terminated prior to initiation of this intervention|0
46097|NCT02528318|109246|P3|STARTED|Overall Study||8
46098|NCT02528318|109247|P2|STARTED|Overall Study||8
46099|NCT02528318|109248|P1|STARTED|Overall Study||8
46100|NCT02528305|109300|P1|NOT COMPLETED|Overall Study||3
46101|NCT02528305|109300|P1|COMPLETED|Overall Study||9
46102|NCT02528305|109300|P1|End of Intervention Period Assessment|Overall Study||9
46103|NCT02528305|109300|P1|End of Control Period Assessment|Overall Study||11
46104|NCT02528305|109300|P1|STARTED|Overall Study||12
46105|NCT02528214|109344|P2|NOT COMPLETED|Overall Study||3
46106|NCT02528214|109345|P1|NOT COMPLETED|Overall Study||0
46107|NCT02528214|109344|P2|COMPLETED|Overall Study||100
46108|NCT02528214|109345|P1|COMPLETED|Overall Study||107
46109|NCT02528214|109344|P2|Treated|Overall Study||103
46110|NCT02528214|109345|P1|Treated|Overall Study||107
46111|NCT02528214|109344|P2|STARTED|Overall Study||103
46112|NCT02528214|109345|P1|STARTED|Overall Study||107
46113|NCT02528097|109379|P2|NOT COMPLETED|Overall Study||0
46114|NCT02528097|109380|P1|NOT COMPLETED|Overall Study||0
46115|NCT02528097|109379|P2|COMPLETED|Overall Study||1
46116|NCT02528097|109380|P1|COMPLETED|Overall Study||1
46117|NCT02528097|109379|P2|STARTED|Overall Study||1
46118|NCT02528097|109380|P1|STARTED|Overall Study||1
46119|NCT02527694|109390|P2|NOT COMPLETED|Overall Study||8
46120|NCT02527694|109391|P1|NOT COMPLETED|Overall Study||10
46121|NCT02527694|109390|P2|COMPLETED|Overall Study||21
46122|NCT02527694|109391|P1|COMPLETED|Overall Study||10
46123|NCT02527694|109390|P2|STARTED|Overall Study||29
46124|NCT02527694|109391|P1|STARTED|Overall Study||20
46125|NCT02527434|109402|P3|NOT COMPLETED|Overall Study||20
46126|NCT02527434|109403|P2|NOT COMPLETED|Overall Study||11
46127|NCT02527434|109404|P1|NOT COMPLETED|Overall Study||28
46128|NCT02527434|109402|P3|COMPLETED|Overall Study||0
46129|NCT02527434|109403|P2|COMPLETED|Overall Study||1
46130|NCT02527434|109404|P1|COMPLETED|Overall Study||4
46131|NCT02527434|109402|P3|Started Retreatment Phase (MEDI)|Overall Study||1
46132|NCT02527434|109403|P2|Started Retreatment Phase (MEDI)|Overall Study||0
46133|NCT02527434|109404|P1|Started Retreatment Phase (MEDI)|Overall Study||4
46134|NCT02527434|109402|P3|Started Retreatment Phase (COMBO)|Overall Study||4
46135|NCT02527434|109403|P2|Started Retreatment Phase (COMBO)|Overall Study||5
46136|NCT02527434|109404|P1|Started Retreatment Phase (COMBO)|Overall Study||7
46137|NCT02527434|109402|P3|STARTED|Overall Study||20
46138|NCT02527434|109403|P2|STARTED|Overall Study||12
46139|NCT02527434|109404|P1|STARTED|Overall Study||32
46140|NCT02527161|109462|P1|NOT COMPLETED|Overall Study||62
46141|NCT02527161|109462|P1|COMPLETED|Overall Study|Completed/Not completed counts are for knees at the 6 mo primary outcome interval.|96
46142|NCT02527161|109462|P1|STARTED|Overall Study|All results are reported by knee throughout record. Participant=knee.|158
46143|NCT02527148|109481|P2|NOT COMPLETED|Overall Study||0
46144|NCT02527148|109482|P1|NOT COMPLETED|Overall Study||1
46145|NCT02527148|109481|P2|COMPLETED|Overall Study||50
46146|NCT02527148|109482|P1|COMPLETED|Overall Study||49
46147|NCT02527148|109481|P2|STARTED|Overall Study||50
46148|NCT02527148|109482|P1|STARTED|Overall Study||50
46149|NCT02526693|109502|P2|NOT COMPLETED|Overall Study||1
46150|NCT02526693|109503|P1|NOT COMPLETED|Overall Study||3
46151|NCT02526693|109502|P2|COMPLETED|Overall Study||50
46152|NCT02526693|109503|P1|COMPLETED|Overall Study||50
46153|NCT02526693|109502|P2|STARTED|Overall Study||51
46154|NCT02526693|109503|P1|STARTED|Overall Study||53
46155|NCT02526680|109513|P1|NOT COMPLETED|Overall Study||0
46156|NCT02526680|109513|P1|COMPLETED|Overall Study||27
46157|NCT02526680|109513|P1|STARTED|Overall Study||27
46158|NCT02526654|109522|P2|NOT COMPLETED|Overall Study||0
46159|NCT02526654|109523|P1|NOT COMPLETED|Overall Study||0
46160|NCT02526654|109522|P2|COMPLETED|Overall Study||36
46161|NCT02526654|109523|P1|COMPLETED|Overall Study||79
46162|NCT02526654|109522|P2|STARTED|Overall Study||36
46163|NCT02526654|109523|P1|STARTED|Overall Study||79
46164|NCT02526550|109532|P1|NOT COMPLETED|Overall Study||1
46165|NCT02526550|109532|P1|COMPLETED|Overall Study||49
46166|NCT02526550|109532|P1|STARTED|Overall Study||50
46167|NCT02526524|109544|P6|NOT COMPLETED|Overall Study||21
46168|NCT02526524|109545|P5|NOT COMPLETED|Overall Study||24
46169|NCT02526524|109546|P4|NOT COMPLETED|Overall Study||7
46170|NCT02526524|109547|P3|NOT COMPLETED|Overall Study||26
46171|NCT02526524|109548|P2|NOT COMPLETED|Overall Study||9
46172|NCT02526524|109549|P1|NOT COMPLETED|Overall Study||12
46173|NCT02526524|109544|P6|COMPLETED|Overall Study||73
46174|NCT02526524|109545|P5|COMPLETED|Overall Study||72
46175|NCT02526524|109546|P4|COMPLETED|Overall Study||89
46176|NCT02526524|109547|P3|COMPLETED|Overall Study||70
46177|NCT02526524|109548|P2|COMPLETED|Overall Study||86
46178|NCT02526524|109549|P1|COMPLETED|Overall Study||82
46179|NCT02526524|109544|P6|STARTED|Overall Study||94
46180|NCT02526524|109545|P5|STARTED|Overall Study||96
46181|NCT02526524|109546|P4|STARTED|Overall Study||96
46182|NCT02526524|109547|P3|STARTED|Overall Study||96
46183|NCT02526524|109548|P2|STARTED|Overall Study||95
46184|NCT02526524|109549|P1|STARTED|Overall Study||94
46185|NCT02526290|109563|P1|NOT COMPLETED|Overall Study||8
46186|NCT02526290|109563|P1|COMPLETED|Overall Study||89
46187|NCT02526290|109563|P1|STARTED|Overall Study||97
46188|NCT02525874|109570|P1|NOT COMPLETED|Overall Study||60
46189|NCT02525874|109570|P1|COMPLETED|Overall Study||158
46190|NCT02525874|109570|P1|STARTED|Overall Study||218
46191|NCT02525718|109585|P2|NOT COMPLETED|Overall Study||1
46192|NCT02525718|109586|P1|NOT COMPLETED|Overall Study||1
46193|NCT02525718|109585|P2|COMPLETED|Overall Study||23
46194|NCT02525718|109586|P1|COMPLETED|Overall Study||22
46195|NCT02525718|109585|P2|STARTED|Overall Study||24
46196|NCT02525718|109586|P1|STARTED|Overall Study||23
46197|NCT02525627|109600|P2|NOT COMPLETED|Overall Study||13
46198|NCT02525627|109601|P1|NOT COMPLETED|Overall Study||14
46199|NCT02525627|109600|P2|COMPLETED|Overall Study||5
46200|NCT02525627|109601|P1|COMPLETED|Overall Study||2
46201|NCT02525627|109600|P2|STARTED|Overall Study||18
46202|NCT02525627|109601|P1|STARTED|Overall Study||16
46203|NCT02525575|109611|P1|NOT COMPLETED|Overall Study||15
46204|NCT02525575|109611|P1|COMPLETED|Overall Study||22
46205|NCT02525575|109611|P1|STARTED|Overall Study||37
46206|NCT02525536|109621|P3|NOT COMPLETED|Overall Study||0
46207|NCT02525536|109622|P2|NOT COMPLETED|Overall Study||0
46208|NCT02525536|109623|P1|NOT COMPLETED|Overall Study||0
46209|NCT02525536|109621|P3|COMPLETED|Overall Study||6
46210|NCT02525536|109622|P2|COMPLETED|Overall Study||6
46211|NCT02525536|109623|P1|COMPLETED|Overall Study||6
46212|NCT02525536|109621|P3|STARTED|Overall Study||6
46213|NCT02525536|109622|P2|STARTED|Overall Study||6
46214|NCT02525536|109623|P1|STARTED|Overall Study||6
46215|NCT02525094|109696|P2|NOT COMPLETED|Overall Study||8
46216|NCT02525094|109697|P1|NOT COMPLETED|Overall Study||8
46217|NCT02525094|109696|P2|COMPLETED|Overall Study||48
46218|NCT02525094|109697|P1|COMPLETED|Overall Study||49
46219|NCT02525094|109696|P2|Treated|Overall Study||55
46220|NCT02525094|109697|P1|Treated|Overall Study||56
46221|NCT02525094|109696|P2|STARTED|Overall Study||56
46222|NCT02525094|109697|P1|STARTED|Overall Study||57
46223|NCT02524977|109726|P2|NOT COMPLETED|Overall Study||45
46224|NCT02524977|109727|P1|NOT COMPLETED|Overall Study||46
46225|NCT02524977|109726|P2|COMPLETED|Overall Study||801
46226|NCT02524977|109727|P1|COMPLETED|Overall Study||692
46227|NCT02524977|109726|P2|STARTED|Overall Study||846
46228|NCT02524977|109727|P1|STARTED|Overall Study||738
46229|NCT02524665|109735|P1|NOT COMPLETED|Overall Study||1
46230|NCT02524665|109735|P1|COMPLETED|Overall Study||19
46231|NCT02524665|109735|P1|STARTED|Overall Study||20
46232|NCT02524561|109753|P3|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
46233|NCT02524561|109754|P2|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
46234|NCT02524561|109755|P1|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
46235|NCT02524561|109753|P3|COMPLETED|Final: Year 3 or 4 Post-randomization||187
46236|NCT02524561|109754|P2|COMPLETED|Final: Year 3 or 4 Post-randomization||162
46237|NCT02524561|109755|P1|COMPLETED|Final: Year 3 or 4 Post-randomization||168
46238|NCT02524561|109753|P3|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||151
46239|NCT02524561|109754|P2|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||139
46240|NCT02524561|109755|P1|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||143
46241|NCT02524561|109753|P3|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|187
46242|NCT02524561|109754|P2|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|162
46243|NCT02524561|109755|P1|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|168
46244|NCT02524561|109753|P3|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
46245|NCT02524561|109754|P2|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
46246|NCT02524561|109755|P1|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
46247|NCT02524561|109753|P3|COMPLETED|Year 1: Post Randomization Mammograms||187
46248|NCT02524561|109754|P2|COMPLETED|Year 1: Post Randomization Mammograms||162
46249|NCT02524561|109755|P1|COMPLETED|Year 1: Post Randomization Mammograms||168
46250|NCT02524561|109753|P3|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|148
46251|NCT02524561|109754|P2|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|123
46252|NCT02524561|109755|P1|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post-randomization mammogram|136
46253|NCT02524561|109753|P3|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|187
46254|NCT02524561|109754|P2|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|162
46255|NCT02524561|109755|P1|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|168
46256|NCT02524561|109753|P3|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
46257|NCT02524561|109754|P2|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
46258|NCT02524561|109755|P1|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
46259|NCT02524561|109753|P3|COMPLETED|Baseline: Pre-randomization Mammogram||187
46260|NCT02524561|109754|P2|COMPLETED|Baseline: Pre-randomization Mammogram||162
46261|NCT02524561|109755|P1|COMPLETED|Baseline: Pre-randomization Mammogram||168
46262|NCT02524561|109753|P3|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||151
46263|NCT02524561|109754|P2|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||133
46264|NCT02524561|109755|P1|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||137
46265|NCT02524561|109753|P3|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS.|187
46266|NCT02524561|109754|P2|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|162
46267|NCT02524561|109755|P1|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|168
46268|NCT02524418|109772|P1|NOT COMPLETED|Overall Study||13
46269|NCT02524418|109772|P1|COMPLETED|Overall Study||75
46270|NCT02524418|109772|P1|STARTED|Overall Study||88
46271|NCT02524288|109786|P1|NOT COMPLETED|Overall Study||1941
46272|NCT02524288|109786|P1|COMPLETED|Overall Study||0
46273|NCT02524288|109786|P1|Treated|Overall Study||1936
46274|NCT02524288|109786|P1|STARTED|Overall Study||1941
46275|NCT02524158|109796|P2|NOT COMPLETED|6-month Assessment||21
46276|NCT02524158|109797|P1|NOT COMPLETED|6-month Assessment||22
46277|NCT02524158|109796|P2|COMPLETED|6-month Assessment||55
46278|NCT02524158|109797|P1|COMPLETED|6-month Assessment||54
46279|NCT02524158|109796|P2|STARTED|6-month Assessment||76
46280|NCT02524158|109797|P1|STARTED|6-month Assessment||76
46281|NCT02524158|109796|P2|NOT COMPLETED|12-weeks Assessment||13
46282|NCT02524158|109797|P1|NOT COMPLETED|12-weeks Assessment||19
46283|NCT02524158|109796|P2|COMPLETED|12-weeks Assessment||63
46284|NCT02524158|109797|P1|COMPLETED|12-weeks Assessment||57
46285|NCT02524158|109796|P2|STARTED|12-weeks Assessment||76
46286|NCT02524158|109797|P1|STARTED|12-weeks Assessment||76
46287|NCT02524145|109839|P3|NOT COMPLETED|Overall Study||3
46288|NCT02524145|109840|P2|NOT COMPLETED|Overall Study||2
46289|NCT02524145|109841|P1|NOT COMPLETED|Overall Study||2
46290|NCT02524145|109839|P3|COMPLETED|Overall Study||7
46291|NCT02524145|109840|P2|COMPLETED|Overall Study||13
46292|NCT02524145|109841|P1|COMPLETED|Overall Study||13
46293|NCT02524145|109839|P3|STARTED|Overall Study||10
46294|NCT02524145|109840|P2|STARTED|Overall Study||15
46295|NCT02524145|109841|P1|STARTED|Overall Study||15
46296|NCT02524106|109853|P2|NOT COMPLETED|Overall Study||0
46297|NCT02524106|109854|P1|NOT COMPLETED|Overall Study||0
46298|NCT02524106|109853|P2|COMPLETED|Overall Study||5
46299|NCT02524106|109854|P1|COMPLETED|Overall Study||6
46300|NCT02524106|109853|P2|STARTED|Overall Study||5
46301|NCT02524106|109854|P1|STARTED|Overall Study||6
46302|NCT02524054|109864|P3|NOT COMPLETED|Overall Study||0
46303|NCT02524054|109865|P2|NOT COMPLETED|Overall Study||0
46304|NCT02524054|109866|P1|NOT COMPLETED|Overall Study||0
46305|NCT02524054|109864|P3|COMPLETED|Overall Study||8
46306|NCT02524054|109865|P2|COMPLETED|Overall Study||9
46307|NCT02524054|109866|P1|COMPLETED|Overall Study||7
46308|NCT02524054|109864|P3|STARTED|Overall Study||8
46309|NCT02524054|109865|P2|STARTED|Overall Study||9
46310|NCT02524054|109866|P1|STARTED|Overall Study||7
46311|NCT02523586|109877|P1|NOT COMPLETED|Overall Study||4
46312|NCT02523586|109877|P1|COMPLETED|Overall Study||10
46313|NCT02523586|109877|P1|STARTED|Overall Study||14
46314|NCT02523235|109890|P2|NOT COMPLETED|Overall Study||0
46315|NCT02523235|109891|P1|NOT COMPLETED|Overall Study||0
46316|NCT02523235|109890|P2|COMPLETED|Overall Study||58
46317|NCT02523235|109891|P1|COMPLETED|Overall Study||56
46318|NCT02523235|109890|P2|STARTED|Overall Study||58
46319|NCT02523235|109891|P1|STARTED|Overall Study||56
46320|NCT02522728|109913|P2|NOT COMPLETED|Overall Study||11
46321|NCT02522728|109914|P1|NOT COMPLETED|Overall Study||12
46322|NCT02522728|109913|P2|COMPLETED|Overall Study||19
46323|NCT02522728|109914|P1|COMPLETED|Overall Study||16
46324|NCT02522728|109913|P2|STARTED|Overall Study||30
46325|NCT02522728|109914|P1|STARTED|Overall Study||28
46326|NCT02522624|109930|P2|NOT COMPLETED|Overall Study||0
46327|NCT02522624|109931|P1|NOT COMPLETED|Overall Study||1
46328|NCT02522624|109930|P2|COMPLETED|Overall Study||163
46329|NCT02522624|109931|P1|COMPLETED|Overall Study|Discontinued intervention due to technical failure (n=1)|164
46330|NCT02522624|109930|P2|STARTED|Overall Study||163
46331|NCT02522624|109931|P1|STARTED|Overall Study||165
46332|NCT02522442|109949|P2|NOT COMPLETED|Overall Study||0
46333|NCT02522442|109950|P1|NOT COMPLETED|Overall Study||0
46334|NCT02522442|109949|P2|COMPLETED|Overall Study||22
46335|NCT02522442|109950|P1|COMPLETED|Overall Study||26
46336|NCT02522442|109949|P2|STARTED|Overall Study||22
46337|NCT02522442|109950|P1|STARTED|Overall Study||26
46338|NCT02522403|109966|P2|NOT COMPLETED|Overall Study||6
46339|NCT02522403|109967|P1|NOT COMPLETED|Overall Study||4
46340|NCT02522403|109966|P2|COMPLETED|Overall Study||13
46341|NCT02522403|109967|P1|COMPLETED|Overall Study||13
46342|NCT02522403|109966|P2|STARTED|Overall Study||19
46343|NCT02522403|109967|P1|STARTED|Overall Study||17
46344|NCT02522377|109979|P2|NOT COMPLETED|Overall Study||0
46345|NCT02522377|109980|P1|NOT COMPLETED|Overall Study||4
46346|NCT02522377|109979|P2|COMPLETED|Overall Study||5
46347|NCT02522377|109980|P1|COMPLETED|Overall Study||3
46348|NCT02522377|109979|P2|STARTED|Overall Study||5
46349|NCT02522377|109980|P1|STARTED|Overall Study||7
46350|NCT02522325|109996|P2|NOT COMPLETED|Overall Study||1
46351|NCT02522325|109997|P1|NOT COMPLETED|Overall Study||0
46352|NCT02522325|109996|P2|COMPLETED|Overall Study||14
46353|NCT02522325|109997|P1|COMPLETED|Overall Study||15
46354|NCT02522325|109996|P2|STARTED|Overall Study||15
46355|NCT02522325|109997|P1|STARTED|Overall Study||15
46356|NCT02522299|110005|P2|NOT COMPLETED|Overall Study||1
46357|NCT02522299|110006|P1|NOT COMPLETED|Overall Study||4
46358|NCT02522299|110005|P2|COMPLETED|Overall Study||21
46359|NCT02522299|110006|P1|COMPLETED|Overall Study||18
46360|NCT02522299|110005|P2|STARTED|Overall Study||22
46361|NCT02522299|110006|P1|STARTED|Overall Study||22
46362|NCT02522286|110089|P4|NOT COMPLETED|Overall Study||3
46363|NCT02522286|110090|P3|NOT COMPLETED|Overall Study||0
46364|NCT02522286|110091|P2|NOT COMPLETED|Overall Study||0
46365|NCT02522286|110092|P1|NOT COMPLETED|Overall Study||3
46366|NCT02522286|110089|P4|COMPLETED|Overall Study||75
46367|NCT02522286|110090|P3|COMPLETED|Overall Study||75
46368|NCT02522286|110091|P2|COMPLETED|Overall Study||75
46369|NCT02522286|110092|P1|COMPLETED|Overall Study||75
46370|NCT02522286|110089|P4|STARTED|Overall Study||78
46371|NCT02522286|110090|P3|STARTED|Overall Study||75
46372|NCT02522286|110091|P2|STARTED|Overall Study||75
46373|NCT02522286|110092|P1|STARTED|Overall Study||78
46374|NCT02521948|110118|P1|NOT COMPLETED|Overall Study||13
46375|NCT02521948|110118|P1|COMPLETED|Overall Study||37
46376|NCT02521948|110118|P1|STARTED|Overall Study||50
46377|NCT02521376|110131|P4|NOT COMPLETED|Overall Study||0
46378|NCT02521376|110132|P3|NOT COMPLETED|Overall Study||0
46379|NCT02521376|110133|P2|NOT COMPLETED|Overall Study||0
46380|NCT02521376|110134|P1|NOT COMPLETED|Overall Study||1
46381|NCT02521376|110131|P4|COMPLETED|Overall Study||20
46382|NCT02521376|110132|P3|COMPLETED|Overall Study||10
46383|NCT02521376|110133|P2|COMPLETED|Overall Study||18
46384|NCT02521376|110134|P1|COMPLETED|Overall Study||7
46385|NCT02521376|110131|P4|STARTED|Overall Study||20
46386|NCT02521376|110132|P3|STARTED|Overall Study||10
46387|NCT02521376|110133|P2|STARTED|Overall Study||18
46388|NCT02521376|110134|P1|STARTED|Overall Study||8
46389|NCT02521259|110166|P2|NOT COMPLETED|Overall Study||5
46390|NCT02521259|110167|P1|NOT COMPLETED|Overall Study||1
46391|NCT02521259|110166|P2|COMPLETED|Overall Study||28
46392|NCT02521259|110167|P1|COMPLETED|Overall Study||34
46393|NCT02521259|110166|P2|STARTED|Overall Study||33
46394|NCT02521259|110167|P1|STARTED|Overall Study||35
46395|NCT02520726|110175|P2|NOT COMPLETED|Overall Study||2
46396|NCT02520726|110176|P1|NOT COMPLETED|Overall Study||3
46397|NCT02520726|110175|P2|COMPLETED|Overall Study||0
46398|NCT02520726|110176|P1|COMPLETED|Overall Study||0
46399|NCT02520726|110175|P2|STARTED|Overall Study||2
46400|NCT02520726|110176|P1|STARTED|Overall Study||3
46401|NCT02520531|110186|P2|NOT COMPLETED|Overall Study||6
46402|NCT02520531|110187|P1|NOT COMPLETED|Overall Study||6
46403|NCT02520531|110186|P2|COMPLETED|Overall Study||36
46404|NCT02520531|110187|P1|COMPLETED|Overall Study||36
46405|NCT02520531|110186|P2|STARTED|Overall Study||42
46406|NCT02520531|110187|P1|STARTED|Overall Study||42
46407|NCT02520518|110205|P4|NOT COMPLETED|Overall Study||1
46408|NCT02520518|110206|P3|NOT COMPLETED|Overall Study||2
46409|NCT02520518|110207|P2|NOT COMPLETED|Overall Study||0
46410|NCT02520518|110208|P1|NOT COMPLETED|Overall Study||0
46411|NCT02520518|110205|P4|COMPLETED|Overall Study||1
46412|NCT02520518|110206|P3|COMPLETED|Overall Study||1
46413|NCT02520518|110207|P2|COMPLETED|Overall Study||1
46414|NCT02520518|110208|P1|COMPLETED|Overall Study||3
46415|NCT02520518|110205|P4|STARTED|Overall Study||2
46416|NCT02520518|110206|P3|STARTED|Overall Study||3
46417|NCT02520518|110207|P2|STARTED|Overall Study||1
46418|NCT02520518|110208|P1|STARTED|Overall Study||3
46419|NCT02520414|110266|P1|NOT COMPLETED|Overall Study||0
46420|NCT02520414|110266|P1|COMPLETED|Overall Study||10
46421|NCT02520414|110266|P1|STARTED|Overall Study||10
46422|NCT02520388|110272|P2|NOT COMPLETED|Overall Study||16
46423|NCT02520388|110273|P1|NOT COMPLETED|Overall Study||9
46424|NCT02520388|110272|P2|COMPLETED|Overall Study||65
46425|NCT02520388|110273|P1|COMPLETED|Overall Study||73
46426|NCT02520388|110272|P2|Treated|Overall Study||80
46427|NCT02520388|110273|P1|Treated|Overall Study||81
46428|NCT02520388|110272|P2|STARTED|Overall Study||81
46429|NCT02520388|110273|P1|STARTED|Overall Study||82
46430|NCT02520310|110281|P1|NOT COMPLETED|At 1 Year Clinical Follow-up||1
46431|NCT02520310|110281|P1|COMPLETED|At 1 Year Clinical Follow-up||28
46432|NCT02520310|110281|P1|STARTED|At 1 Year Clinical Follow-up||29
46433|NCT02520310|110281|P1|NOT COMPLETED|At 6 Months Clinical Follow-up||1
46434|NCT02520310|110281|P1|COMPLETED|At 6 Months Clinical Follow-up||29
46435|NCT02520310|110281|P1|STARTED|At 6 Months Clinical Follow-up||30
46436|NCT02520310|110281|P1|NOT COMPLETED|At 30 Days Clinical Follow-up||0
46437|NCT02520310|110281|P1|COMPLETED|At 30 Days Clinical Follow-up||30
46438|NCT02520310|110281|P1|STARTED|At 30 Days Clinical Follow-up||30
46439|NCT02520284|110416|P3|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||34
46440|NCT02520284|110417|P2|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||35
46441|NCT02520284|110418|P1|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||32
46442|NCT02520284|110416|P3|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
46443|NCT02520284|110417|P2|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
46444|NCT02520284|110418|P1|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
46445|NCT02520284|110416|P3|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|34
46446|NCT02520284|110417|P2|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|35
46447|NCT02520284|110418|P1|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|32
46448|NCT02520284|110416|P3|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||18
46449|NCT02520284|110417|P2|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||16
46450|NCT02520284|110418|P1|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||20
46451|NCT02520284|110416|P3|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
46452|NCT02520284|110417|P2|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
46453|NCT02520284|110418|P1|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
46454|NCT02520284|110416|P3|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|18
46455|NCT02520284|110417|P2|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|16
46456|NCT02520284|110418|P1|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|20
46457|NCT02520284|110416|P3|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||2
46458|NCT02520284|110417|P2|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||4
46459|NCT02520284|110418|P1|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||2
46460|NCT02520284|110416|P3|COMPLETED|Blinded Induction Phase: Up to Week 8|1 Participant completed Blinded Induction Phase but did not continue further in study.|53
46461|NCT02520284|110417|P2|COMPLETED|Blinded Induction Phase: Up to Week 8|1 Participant completed Blinded Induction Phase but did not continue further in study.|52
46462|NCT02520284|110418|P1|COMPLETED|Blinded Induction Phase: Up to Week 8||52
46463|NCT02520284|110416|P3|STARTED|Blinded Induction Phase: Up to Week 8||55
46464|NCT02520284|110417|P2|STARTED|Blinded Induction Phase: Up to Week 8||56
46465|NCT02520284|110418|P1|STARTED|Blinded Induction Phase: Up to Week 8||54
46466|NCT02520089|110452|P2|NOT COMPLETED|Overall Study||4
46467|NCT02520089|110453|P1|NOT COMPLETED|Overall Study||3
46468|NCT02520089|110452|P2|COMPLETED|Overall Study||7
46469|NCT02520089|110453|P1|COMPLETED|Overall Study||9
46470|NCT02520089|110452|P2|STARTED|Overall Study||11
46471|NCT02520089|110453|P1|STARTED|Overall Study||12
46472|NCT02519855|110463|P2|NOT COMPLETED|Overall Study||4
46473|NCT02519855|110464|P1|NOT COMPLETED|Overall Study||3
46474|NCT02519855|110463|P2|COMPLETED|Overall Study||437
46475|NCT02519855|110464|P1|COMPLETED|Overall Study||438
46476|NCT02519855|110463|P2|Vaccinated at Week 4|Overall Study||424
46477|NCT02519855|110464|P1|Vaccinated at Week 4|Overall Study||432
46478|NCT02519855|110463|P2|Vaccinated on Day 1|Overall Study||441
46479|NCT02519855|110464|P1|Vaccinated on Day 1|Overall Study||440
46480|NCT02519855|110463|P2|STARTED|Overall Study|Participants are included as treated|441
46481|NCT02519855|110464|P1|STARTED|Overall Study|Participants are included as treated|441
46482|NCT02519842|110482|P3|NOT COMPLETED|Optional Extension: Cycles 2-6||29
46483|NCT02519842|110483|P2|NOT COMPLETED|Optional Extension: Cycles 2-6||0
46484|NCT02519842|110484|P1|NOT COMPLETED|Optional Extension: Cycles 2-6||0
46485|NCT02519842|110482|P3|COMPLETED|Optional Extension: Cycles 2-6||26
46486|NCT02519842|110483|P2|COMPLETED|Optional Extension: Cycles 2-6||0
46487|NCT02519842|110484|P1|COMPLETED|Optional Extension: Cycles 2-6||0
46488|NCT02519842|110482|P3|Treated|Optional Extension: Cycles 2-6||55
46489|NCT02519842|110483|P2|Treated|Optional Extension: Cycles 2-6||0
46490|NCT02519842|110484|P1|Treated|Optional Extension: Cycles 2-6||0
46491|NCT02519842|110482|P3|STARTED|Optional Extension: Cycles 2-6|Enrollment in Cycles 2-6 was optional.|55
46492|NCT02519842|110483|P2|STARTED|Optional Extension: Cycles 2-6|28 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
46493|NCT02519842|110484|P1|STARTED|Optional Extension: Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
46494|NCT02519842|110482|P3|NOT COMPLETED|Base Study: Cycle 1||0
46495|NCT02519842|110483|P2|NOT COMPLETED|Base Study: Cycle 1||3
46496|NCT02519842|110484|P1|NOT COMPLETED|Base Study: Cycle 1||2
46497|NCT02519842|110482|P3|COMPLETED|Base Study: Cycle 1||0
46498|NCT02519842|110483|P2|COMPLETED|Base Study: Cycle 1||34
46499|NCT02519842|110484|P1|COMPLETED|Base Study: Cycle 1||36
46500|NCT02519842|110482|P3|Treated|Base Study: Cycle 1||0
46501|NCT02519842|110483|P2|Treated|Base Study: Cycle 1||34
46502|NCT02519842|110484|P1|Treated|Base Study: Cycle 1||37
46503|NCT02519842|110482|P3|STARTED|Base Study: Cycle 1||0
46504|NCT02519842|110483|P2|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|37
46505|NCT02519842|110484|P1|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|38
46506|NCT02519712|110503|P1|NOT COMPLETED|Overall Study||4
46507|NCT02519712|110503|P1|COMPLETED|Overall Study||0
46508|NCT02519712|110503|P1|STARTED|Overall Study||4
46509|NCT02519595|110510|P3|NOT COMPLETED|Overall Study||16
46510|NCT02519595|110511|P2|NOT COMPLETED|Overall Study||22
46511|NCT02519595|110512|P1|NOT COMPLETED|Overall Study||8
46512|NCT02519595|110510|P3|COMPLETED|Overall Study||40
46513|NCT02519595|110511|P2|COMPLETED|Overall Study||35
46514|NCT02519595|110512|P1|COMPLETED|Overall Study||50
46515|NCT02519595|110510|P3|STARTED|Overall Study||56
46516|NCT02519595|110511|P2|STARTED|Overall Study||57
46517|NCT02519595|110512|P1|STARTED|Overall Study||58
46518|NCT02519504|110537|P2|NOT COMPLETED|Overall Study||103
46519|NCT02519504|110538|P1|NOT COMPLETED|Overall Study||113
46520|NCT02519504|110537|P2|COMPLETED|Overall Study||144
46521|NCT02519504|110538|P1|COMPLETED|Overall Study||206
46522|NCT02519504|110537|P2|Attended Direct Testing|Overall Study||149
46523|NCT02519504|110538|P1|Attended Direct Testing|Overall Study||212
46524|NCT02519504|110537|P2|STARTED|Overall Study||247
46525|NCT02519504|110538|P1|STARTED|Overall Study||319
46526|NCT02519387|110598|P1|NOT COMPLETED|Overall Study||22
46527|NCT02519387|110598|P1|COMPLETED|Overall Study||56
46528|NCT02519387|110598|P1|STARTED|Overall Study||78
46529|NCT02519244|110606|P1|NOT COMPLETED|Overall Study||0
46530|NCT02519244|110606|P1|COMPLETED|Overall Study||10
46531|NCT02519244|110606|P1|STARTED|Overall Study||10
46532|NCT02519036|110641|P6|NOT COMPLETED|Overall Study||0
46533|NCT02519036|110642|P5|NOT COMPLETED|Overall Study||0
46534|NCT02519036|110643|P4|NOT COMPLETED|Overall Study||0
46535|NCT02519036|110644|P3|NOT COMPLETED|Overall Study||0
46536|NCT02519036|110645|P2|NOT COMPLETED|Overall Study||0
46537|NCT02519036|110646|P1|NOT COMPLETED|Overall Study||0
46538|NCT02519036|110641|P6|COMPLETED|Overall Study||10
46539|NCT02519036|110642|P5|COMPLETED|Overall Study||9
46540|NCT02519036|110643|P4|COMPLETED|Overall Study||6
46541|NCT02519036|110644|P3|COMPLETED|Overall Study||6
46542|NCT02519036|110645|P2|COMPLETED|Overall Study||3
46543|NCT02519036|110646|P1|COMPLETED|Overall Study||12
46544|NCT02519036|110641|P6|STARTED|Overall Study||10
46545|NCT02519036|110642|P5|STARTED|Overall Study||9
46546|NCT02519036|110643|P4|STARTED|Overall Study||6
46547|NCT02519036|110644|P3|STARTED|Overall Study||6
46548|NCT02519036|110645|P2|STARTED|Overall Study||3
46549|NCT02519036|110646|P1|STARTED|Overall Study||12
46550|NCT02519023|110701|P2|NOT COMPLETED|Overall Study||7
46551|NCT02519023|110702|P1|NOT COMPLETED|Overall Study||18
46552|NCT02519023|110701|P2|COMPLETED|Overall Study||31
46553|NCT02519023|110702|P1|COMPLETED|Overall Study||31
46554|NCT02519023|110701|P2|STARTED|Overall Study||38
46555|NCT02519023|110702|P1|STARTED|Overall Study||49
46556|NCT02518971|110736|P2|NOT COMPLETED|Overall Study||20
46557|NCT02518971|110737|P1|NOT COMPLETED|Overall Study||23
46558|NCT02518971|110736|P2|COMPLETED|Overall Study||67
46559|NCT02518971|110737|P1|COMPLETED|Overall Study||64
46560|NCT02518971|110736|P2|STARTED|Overall Study||87
46561|NCT02518971|110737|P1|STARTED|Overall Study||87
46562|NCT02518919|110757|P3|NOT COMPLETED|Overall Study||2
46563|NCT02518919|110758|P2|NOT COMPLETED|Overall Study||1
46564|NCT02518919|110759|P1|NOT COMPLETED|Overall Study||1
46565|NCT02518919|110757|P3|COMPLETED|Overall Study||19
46566|NCT02518919|110758|P2|COMPLETED|Overall Study||20
46567|NCT02518919|110759|P1|COMPLETED|Overall Study||20
46568|NCT02518919|110757|P3|STARTED|Overall Study||21
46569|NCT02518919|110758|P2|STARTED|Overall Study||21
46570|NCT02518919|110759|P1|STARTED|Overall Study||21
46571|NCT02518750|110779|P1|NOT COMPLETED|Overall Study||2
46572|NCT02518750|110779|P1|COMPLETED|Overall Study||1
46573|NCT02518750|110779|P1|STARTED|Overall Study||3
46574|NCT02518685|110789|P2|NOT COMPLETED|Overall Study||10
46575|NCT02518685|110790|P1|NOT COMPLETED|Overall Study||49
46576|NCT02518685|110789|P2|COMPLETED|Overall Study||79
46577|NCT02518685|110790|P1|COMPLETED|Overall Study|Randomized Completers (139) plus Open-Label Completers (25)|164
46578|NCT02518685|110789|P2|Per Protocol Analysis|Overall Study||89
46579|NCT02518685|110790|P1|Per Protocol Analysis|Overall Study|Three TPS-treated subjects were inadvertently unblinded, excluding them from efficacy analyses.|168
46580|NCT02518685|110789|P2|Enrolled|Overall Study||89
46581|NCT02518685|110790|P1|Enrolled|Overall Study|Includes 171 Successful device deployments, 10 unsuccessful delivery attempts and 32 Open-Label|213
46582|NCT02518685|110789|P2|Randomized Cohort|Overall Study||89
46583|NCT02518685|110790|P1|Randomized Cohort|Overall Study||181
46584|NCT02518685|110789|P2|Safety Cohort|Overall Study||89
46585|NCT02518685|110790|P1|Safety Cohort|Overall Study|Randomized to and successfully received TPS (171) + Open-Label TPS-treated Subjects (32)|203
46586|NCT02518685|110789|P2|STARTED|Overall Study||89
46587|NCT02518685|110790|P1|STARTED|Overall Study||213
46588|NCT02518620|110799|P2|NOT COMPLETED|Overall Study||26
46589|NCT02518620|110800|P1|NOT COMPLETED|Overall Study||52
46590|NCT02518620|110799|P2|COMPLETED|Overall Study||123
46591|NCT02518620|110800|P1|COMPLETED|Overall Study||205
46592|NCT02518620|110799|P2|STARTED|Overall Study||149
46593|NCT02518620|110800|P1|STARTED|Overall Study||257
46594|NCT02518464|110823|P1|NOT COMPLETED|Overall Study||2
46595|NCT02518464|110823|P1|COMPLETED|Overall Study||38
46596|NCT02518464|110823|P1|STARTED|Overall Study||40
46597|NCT02518139|110830|P3|NOT COMPLETED|Overall Study||94
46598|NCT02518139|110831|P2|NOT COMPLETED|Overall Study||144
46599|NCT02518139|110832|P1|NOT COMPLETED|Overall Study||145
46600|NCT02518139|110830|P3|COMPLETED|Overall Study||262
46601|NCT02518139|110831|P2|COMPLETED|Overall Study||191
46602|NCT02518139|110832|P1|COMPLETED|Overall Study||219
46603|NCT02518139|110830|P3|STARTED|Overall Study||356
46604|NCT02518139|110831|P2|STARTED|Overall Study||335
46605|NCT02518139|110832|P1|STARTED|Overall Study||364
46606|NCT02518113|110844|P4|NOT COMPLETED|Overall Study||0
46607|NCT02518113|110845|P3|NOT COMPLETED|Overall Study||4
46608|NCT02518113|110846|P2|NOT COMPLETED|Overall Study||5
46609|NCT02518113|110847|P1|NOT COMPLETED|Overall Study||3
46610|NCT02518113|110844|P4|COMPLETED|Overall Study||3
46611|NCT02518113|110845|P3|COMPLETED|Overall Study||11
46612|NCT02518113|110846|P2|COMPLETED|Overall Study||7
46613|NCT02518113|110847|P1|COMPLETED|Overall Study||3
46614|NCT02518113|110844|P4|STARTED|Overall Study||3
46615|NCT02518113|110845|P3|STARTED|Overall Study||15
46616|NCT02518113|110846|P2|STARTED|Overall Study||12
46617|NCT02518113|110847|P1|STARTED|Overall Study||6
46618|NCT02518048|110888|P1|NOT COMPLETED|Overall Study||1
46619|NCT02518048|110888|P1|COMPLETED|Overall Study||34
46620|NCT02518048|110888|P1|STARTED|Overall Study||35
46621|NCT02517996|110901|P2|NOT COMPLETED|Overall Study||0
46622|NCT02517996|110902|P1|NOT COMPLETED|Overall Study||0
46623|NCT02517996|110901|P2|COMPLETED|Overall Study||9
46624|NCT02517996|110902|P1|COMPLETED|Overall Study||8
46625|NCT02517996|110901|P2|STARTED|Overall Study||9
46626|NCT02517996|110902|P1|STARTED|Overall Study||8
46627|NCT02517866|110914|P3|NOT COMPLETED|Overall Study||0
46628|NCT02517866|110915|P2|NOT COMPLETED|Overall Study||6
46629|NCT02517866|110916|P1|NOT COMPLETED|Overall Study||20
46630|NCT02517866|110914|P3|COMPLETED|Overall Study||1
46631|NCT02517866|110915|P2|COMPLETED|Overall Study||84
46632|NCT02517866|110916|P1|COMPLETED|Overall Study||269
46633|NCT02517866|110914|P3|STARTED|Overall Study||1
46634|NCT02517866|110915|P2|STARTED|Overall Study||90
46635|NCT02517866|110916|P1|STARTED|Overall Study||289
46636|NCT02517658|110961|P3|NOT COMPLETED|Overall Study||0
46637|NCT02517658|110962|P2|NOT COMPLETED|Overall Study||0
46638|NCT02517658|110963|P1|NOT COMPLETED|Overall Study||0
46639|NCT02517658|110961|P3|COMPLETED|Overall Study||33
46640|NCT02517658|110962|P2|COMPLETED|Overall Study||33
46641|NCT02517658|110963|P1|COMPLETED|Overall Study||33
46642|NCT02517658|110961|P3|STARTED|Overall Study||33
46643|NCT02517658|110962|P2|STARTED|Overall Study||33
46644|NCT02517658|110963|P1|STARTED|Overall Study||33
46645|NCT02517580|110971|P1|NOT COMPLETED|Overall Study||4
46646|NCT02517580|110971|P1|COMPLETED|Overall Study||56
46647|NCT02517580|110971|P1|STARTED|Overall Study||60
46648|NCT02517567|110975|P4|NOT COMPLETED|Fourth Exposure (8 Hours)||0
46649|NCT02517567|110976|P3|NOT COMPLETED|Fourth Exposure (8 Hours)||0
46650|NCT02517567|110977|P2|NOT COMPLETED|Fourth Exposure (8 Hours)||0
46651|NCT02517567|110978|P1|NOT COMPLETED|Fourth Exposure (8 Hours)||0
46652|NCT02517567|110975|P4|COMPLETED|Fourth Exposure (8 Hours)||8
46653|NCT02517567|110976|P3|COMPLETED|Fourth Exposure (8 Hours)||6
46654|NCT02517567|110977|P2|COMPLETED|Fourth Exposure (8 Hours)||8
46655|NCT02517567|110978|P1|COMPLETED|Fourth Exposure (8 Hours)||6
46656|NCT02517567|110975|P4|STARTED|Fourth Exposure (8 Hours)||8
46657|NCT02517567|110976|P3|STARTED|Fourth Exposure (8 Hours)|One subject discontinued between Period 3 and Period 4 (withdrawal by subject)|6
46658|NCT02517567|110977|P2|STARTED|Fourth Exposure (8 Hours)||8
46659|NCT02517567|110978|P1|STARTED|Fourth Exposure (8 Hours)||6
46660|NCT02517567|110975|P4|NOT COMPLETED|Third Exposure (8 Hours)||0
46661|NCT02517567|110976|P3|NOT COMPLETED|Third Exposure (8 Hours)||0
46662|NCT02517567|110977|P2|NOT COMPLETED|Third Exposure (8 Hours)||0
46663|NCT02517567|110978|P1|NOT COMPLETED|Third Exposure (8 Hours)||0
46664|NCT02517567|110975|P4|COMPLETED|Third Exposure (8 Hours)||8
46665|NCT02517567|110976|P3|COMPLETED|Third Exposure (8 Hours)||7
46666|NCT02517567|110977|P2|COMPLETED|Third Exposure (8 Hours)||8
46667|NCT02517567|110978|P1|COMPLETED|Third Exposure (8 Hours)||6
46668|NCT02517567|110975|P4|STARTED|Third Exposure (8 Hours)||8
46669|NCT02517567|110976|P3|STARTED|Third Exposure (8 Hours)||7
46670|NCT02517567|110977|P2|STARTED|Third Exposure (8 Hours)||8
46671|NCT02517567|110978|P1|STARTED|Third Exposure (8 Hours)||6
46672|NCT02517567|110975|P4|NOT COMPLETED|Second Exposure (8 Hours)||0
46673|NCT02517567|110976|P3|NOT COMPLETED|Second Exposure (8 Hours)||0
46674|NCT02517567|110977|P2|NOT COMPLETED|Second Exposure (8 Hours)||0
46675|NCT02517567|110978|P1|NOT COMPLETED|Second Exposure (8 Hours)||0
46676|NCT02517567|110975|P4|COMPLETED|Second Exposure (8 Hours)||8
46677|NCT02517567|110976|P3|COMPLETED|Second Exposure (8 Hours)||7
46678|NCT02517567|110977|P2|COMPLETED|Second Exposure (8 Hours)||8
46679|NCT02517567|110978|P1|COMPLETED|Second Exposure (8 Hours)||6
46680|NCT02517567|110975|P4|STARTED|Second Exposure (8 Hours)||8
46681|NCT02517567|110976|P3|STARTED|Second Exposure (8 Hours)||7
46682|NCT02517567|110977|P2|STARTED|Second Exposure (8 Hours)||8
46683|NCT02517567|110978|P1|STARTED|Second Exposure (8 Hours)||6
46684|NCT02517567|110975|P4|NOT COMPLETED|First Exposure (8 Hours)||0
46685|NCT02517567|110976|P3|NOT COMPLETED|First Exposure (8 Hours)||0
46686|NCT02517567|110977|P2|NOT COMPLETED|First Exposure (8 Hours)||0
46687|NCT02517567|110978|P1|NOT COMPLETED|First Exposure (8 Hours)||0
46688|NCT02517567|110975|P4|COMPLETED|First Exposure (8 Hours)||8
46689|NCT02517567|110976|P3|COMPLETED|First Exposure (8 Hours)||7
46690|NCT02517567|110977|P2|COMPLETED|First Exposure (8 Hours)||8
46691|NCT02517567|110978|P1|COMPLETED|First Exposure (8 Hours)||6
46692|NCT02517567|110975|P4|STARTED|First Exposure (8 Hours)||8
46693|NCT02517567|110976|P3|STARTED|First Exposure (8 Hours)||7
46694|NCT02517567|110977|P2|STARTED|First Exposure (8 Hours)||8
46695|NCT02517567|110978|P1|STARTED|First Exposure (8 Hours)||6
46696|NCT02517541|110987|P1|NOT COMPLETED|Test Period (SenSura Mio Convex Soft)||12
46697|NCT02517541|110987|P1|COMPLETED|Test Period (SenSura Mio Convex Soft)||61
46698|NCT02517541|110987|P1|STARTED|Test Period (SenSura Mio Convex Soft)||73
46699|NCT02517541|110987|P1|NOT COMPLETED|Baseline Period (Own Product)||1
46700|NCT02517541|110987|P1|COMPLETED|Baseline Period (Own Product)||73
46701|NCT02517541|110987|P1|STARTED|Baseline Period (Own Product)||74
46702|NCT02517528|110993|P1|NOT COMPLETED|Overall Study||1
46703|NCT02517528|110993|P1|COMPLETED|Overall Study||103
46704|NCT02517528|110993|P1|STARTED|Overall Study||104
46705|NCT02517515|111003|P2|NOT COMPLETED|Overall Study||2
46706|NCT02517515|111004|P1|NOT COMPLETED|Overall Study||2
46707|NCT02517515|111003|P2|COMPLETED|Overall Study||323
46708|NCT02517515|111004|P1|COMPLETED|Overall Study||323
46709|NCT02517515|111003|P2|STARTED|Overall Study||325
46710|NCT02517515|111004|P1|STARTED|Overall Study||325
46711|NCT02517463|111021|P2|NOT COMPLETED|Overall Study||2
46712|NCT02517463|111022|P1|NOT COMPLETED|Overall Study||5
46713|NCT02517463|111021|P2|COMPLETED|Overall Study||329
46714|NCT02517463|111022|P1|COMPLETED|Overall Study||364
46715|NCT02517463|111021|P2|STARTED|Overall Study||331
46716|NCT02517463|111022|P1|STARTED|Overall Study||369
46717|NCT02517047|111032|P1|NOT COMPLETED|Overall Study||2
46718|NCT02517047|111032|P1|COMPLETED|Overall Study||24
46719|NCT02517047|111032|P1|STARTED|Overall Study||26
46720|NCT02517021|111041|P2|NOT COMPLETED|Overall Study||85
46721|NCT02517021|111042|P1|NOT COMPLETED|Overall Study||83
46722|NCT02517021|111041|P2|COMPLETED|Overall Study||117
46723|NCT02517021|111042|P1|COMPLETED|Overall Study||120
46724|NCT02517021|111041|P2|STARTED|Overall Study||202
46725|NCT02517021|111042|P1|STARTED|Overall Study||203
46726|NCT02516982|111070|P4|NOT COMPLETED|Overall Study||50
46727|NCT02516982|111071|P3|NOT COMPLETED|Overall Study||48
46728|NCT02516982|111072|P2|NOT COMPLETED|Overall Study||35
46729|NCT02516982|111073|P1|NOT COMPLETED|Overall Study||32
46730|NCT02516982|111070|P4|COMPLETED|Overall Study||125
46731|NCT02516982|111071|P3|COMPLETED|Overall Study||126
46732|NCT02516982|111072|P2|COMPLETED|Overall Study||257
46733|NCT02516982|111073|P1|COMPLETED|Overall Study||273
46734|NCT02516982|111070|P4|STARTED|Overall Study||175
46735|NCT02516982|111071|P3|STARTED|Overall Study||174
46736|NCT02516982|111072|P2|STARTED|Overall Study||292
46737|NCT02516982|111073|P1|STARTED|Overall Study||305
46738|NCT02516605|111100|P5|NOT COMPLETED|Overall Study||1
46739|NCT02516605|111101|P4|NOT COMPLETED|Overall Study||1
46740|NCT02516605|111102|P3|NOT COMPLETED|Overall Study||0
46741|NCT02516605|111103|P2|NOT COMPLETED|Overall Study||0
46742|NCT02516605|111104|P1|NOT COMPLETED|Overall Study||0
46743|NCT02516605|111100|P5|COMPLETED|Overall Study||20
46744|NCT02516605|111101|P4|COMPLETED|Overall Study||7
46745|NCT02516605|111102|P3|COMPLETED|Overall Study||12
46746|NCT02516605|111103|P2|COMPLETED|Overall Study||9
46747|NCT02516605|111104|P1|COMPLETED|Overall Study||11
46748|NCT02516605|111100|P5|STARTED|Overall Study||21
46749|NCT02516605|111101|P4|STARTED|Overall Study||8
46750|NCT02516605|111102|P3|STARTED|Overall Study||12
46751|NCT02516605|111103|P2|STARTED|Overall Study||9
46752|NCT02516605|111104|P1|STARTED|Overall Study||11
46753|NCT02516592|111175|P2|NOT COMPLETED|Overall Study||13
46754|NCT02516592|111176|P1|NOT COMPLETED|Overall Study||16
46755|NCT02516592|111175|P2|COMPLETED|Overall Study||238
46756|NCT02516592|111176|P1|COMPLETED|Overall Study||235
46757|NCT02516592|111175|P2|Full Analysis Set|Overall Study||250
46758|NCT02516592|111176|P1|Full Analysis Set|Overall Study||248
46759|NCT02516592|111175|P2|STARTED|Overall Study||251
46760|NCT02516592|111176|P1|STARTED|Overall Study||251
46761|NCT02516410|111192|P2|NOT COMPLETED|Overall Study||2
46762|NCT02516410|111193|P1|NOT COMPLETED|Overall Study||0
46763|NCT02516410|111192|P2|COMPLETED|Overall Study||81
46764|NCT02516410|111193|P1|COMPLETED|Overall Study||85
46765|NCT02516410|111192|P2|STARTED|Overall Study||83
46766|NCT02516410|111193|P1|STARTED|Overall Study||85
46767|NCT02516306|111222|P2|NOT COMPLETED|Period 2: Day 8 - 91||2
46768|NCT02516306|111223|P1|NOT COMPLETED|Period 2: Day 8 - 91||1
46769|NCT02516306|111222|P2|COMPLETED|Period 2: Day 8 - 91||23
46770|NCT02516306|111223|P1|COMPLETED|Period 2: Day 8 - 91||49
46771|NCT02516306|111222|P2|STARTED|Period 2: Day 8 - 91||25
46772|NCT02516306|111223|P1|STARTED|Period 2: Day 8 - 91||50
46773|NCT02516306|111222|P2|NOT COMPLETED|Period 1: Day 1 - 7||0
46774|NCT02516306|111223|P1|NOT COMPLETED|Period 1: Day 1 - 7||0
46775|NCT02516306|111222|P2|COMPLETED|Period 1: Day 1 - 7||25
46776|NCT02516306|111223|P1|COMPLETED|Period 1: Day 1 - 7||50
46777|NCT02516306|111222|P2|STARTED|Period 1: Day 1 - 7||25
46778|NCT02516306|111223|P1|STARTED|Period 1: Day 1 - 7||50
46779|NCT02516202|111232|P3|NOT COMPLETED|Overall Study||3
46780|NCT02516202|111233|P2|NOT COMPLETED|Overall Study||1
46781|NCT02516202|111234|P1|NOT COMPLETED|Overall Study||2
46782|NCT02516202|111232|P3|COMPLETED|Overall Study||97
46783|NCT02516202|111233|P2|COMPLETED|Overall Study||99
46784|NCT02516202|111234|P1|COMPLETED|Overall Study||100
46785|NCT02516202|111232|P3|STARTED|Overall Study||100
46786|NCT02516202|111233|P2|STARTED|Overall Study||100
46787|NCT02516202|111234|P1|STARTED|Overall Study||102
46788|NCT02516163|111260|P1|NOT COMPLETED|Overall Study||28
46789|NCT02516163|111260|P1|COMPLETED|Overall Study||24
46790|NCT02516163|111260|P1|STARTED|Overall Study||52
46791|NCT02516150|111264|P1|NOT COMPLETED|Overall Study||0
46792|NCT02516150|111264|P1|COMPLETED|Overall Study||15
46793|NCT02516150|111264|P1|STARTED|Overall Study||15
46794|NCT02516098|111274|P2|NOT COMPLETED|Washout After Period 2||0
46795|NCT02516098|111275|P1|NOT COMPLETED|Washout After Period 2||0
46796|NCT02516098|111274|P2|COMPLETED|Washout After Period 2||26
46797|NCT02516098|111275|P1|COMPLETED|Washout After Period 2||27
46798|NCT02516098|111274|P2|STARTED|Washout After Period 2||26
46799|NCT02516098|111275|P1|STARTED|Washout After Period 2||27
46800|NCT02516098|111274|P2|NOT COMPLETED|Period 2||1
46801|NCT02516098|111275|P1|NOT COMPLETED|Period 2||0
46802|NCT02516098|111274|P2|COMPLETED|Period 2||26
46803|NCT02516098|111275|P1|COMPLETED|Period 2||27
46804|NCT02516098|111274|P2|STARTED|Period 2||27
46805|NCT02516098|111275|P1|STARTED|Period 2||27
46806|NCT02516098|111274|P2|NOT COMPLETED|Washout After Period 1||1
46807|NCT02516098|111275|P1|NOT COMPLETED|Washout After Period 1||0
46808|NCT02516098|111274|P2|COMPLETED|Washout After Period 1||27
46809|NCT02516098|111275|P1|COMPLETED|Washout After Period 1||27
46810|NCT02516098|111274|P2|STARTED|Washout After Period 1||28
46811|NCT02516098|111275|P1|STARTED|Washout After Period 1||27
46812|NCT02516098|111274|P2|NOT COMPLETED|Period 1||0
46813|NCT02516098|111275|P1|NOT COMPLETED|Period 1||1
46814|NCT02516098|111274|P2|COMPLETED|Period 1||28
46815|NCT02516098|111275|P1|COMPLETED|Period 1||27
46816|NCT02516098|111274|P2|STARTED|Period 1||28
46817|NCT02516098|111275|P1|STARTED|Period 1||28
46818|NCT02515994|111289|P2|NOT COMPLETED|Overall Study||7
46819|NCT02515994|111290|P1|NOT COMPLETED|Overall Study||10
46820|NCT02515994|111289|P2|COMPLETED|Overall Study||105
46821|NCT02515994|111290|P1|COMPLETED|Overall Study||99
46822|NCT02515994|111289|P2|STARTED|Overall Study||112
46823|NCT02515994|111290|P1|STARTED|Overall Study||109
46824|NCT02515942|111305|P3|NOT COMPLETED|Overall Study||4
46825|NCT02515942|111306|P2|NOT COMPLETED|Overall Study||3
46826|NCT02515942|111307|P1|NOT COMPLETED|Overall Study||7
46827|NCT02515942|111305|P3|COMPLETED|Overall Study||35
46828|NCT02515942|111306|P2|COMPLETED|Overall Study||36
46829|NCT02515942|111307|P1|COMPLETED|Overall Study||29
46830|NCT02515942|111305|P3|Completed Day 337|Overall Study||35
46831|NCT02515942|111306|P2|Completed Day 337|Overall Study||36
46832|NCT02515942|111307|P1|Completed Day 337|Overall Study||30
46833|NCT02515942|111305|P3|Completed Day 253|Overall Study||36
46834|NCT02515942|111306|P2|Completed Day 253|Overall Study||37
46835|NCT02515942|111307|P1|Completed Day 253|Overall Study|One subject missed Day 253 visit|29
46836|NCT02515942|111305|P3|Completed Day 169|Overall Study||37
46837|NCT02515942|111306|P2|Completed Day 169|Overall Study||37
46838|NCT02515942|111307|P1|Completed Day 169|Overall Study||32
46839|NCT02515942|111305|P3|Completed Day 85|Overall Study||37
46840|NCT02515942|111306|P2|Completed Day 85|Overall Study||38
46841|NCT02515942|111307|P1|Completed Day 85|Overall Study||35
46842|NCT02515942|111305|P3|Pharmacokinetics (PK) Analysis Set|Overall Study||0
46843|NCT02515942|111306|P2|Pharmacokinetics (PK) Analysis Set|Overall Study||39
46844|NCT02515942|111307|P1|Pharmacokinetics (PK) Analysis Set|Overall Study||36
46845|NCT02515942|111305|P3|Per Protocol Analysis Set (PPS)|Overall Study||34
46846|NCT02515942|111306|P2|Per Protocol Analysis Set (PPS)|Overall Study||35
46847|NCT02515942|111307|P1|Per Protocol Analysis Set (PPS)|Overall Study||30
46848|NCT02515942|111305|P3|Full Analysis Set (FAS)|Overall Study||38
46849|NCT02515942|111306|P2|Full Analysis Set (FAS)|Overall Study||37
46850|NCT02515942|111307|P1|Full Analysis Set (FAS)|Overall Study||35
46851|NCT02515942|111305|P3|Safety Analysis Set|Overall Study||39
46852|NCT02515942|111306|P2|Safety Analysis Set|Overall Study||39
46853|NCT02515942|111307|P1|Safety Analysis Set|Overall Study||36
46854|NCT02515942|111305|P3|STARTED|Overall Study||39
46855|NCT02515942|111306|P2|STARTED|Overall Study||39
46856|NCT02515942|111307|P1|STARTED|Overall Study||36
46857|NCT02515851|111356|P2|NOT COMPLETED|Overall Study||0
46858|NCT02515851|111357|P1|NOT COMPLETED|Overall Study||0
46859|NCT02515851|111356|P2|COMPLETED|Overall Study||15
46860|NCT02515851|111357|P1|COMPLETED|Overall Study||15
46861|NCT02515851|111356|P2|STARTED|Overall Study||15
46862|NCT02515851|111357|P1|STARTED|Overall Study||15
46863|NCT02515669|111373|P4|NOT COMPLETED|48 Week Open-Label Phase||0
46864|NCT02515669|111374|P3|NOT COMPLETED|48 Week Open-Label Phase||1
46865|NCT02515669|111375|P2|NOT COMPLETED|48 Week Open-Label Phase||0
46866|NCT02515669|111376|P1|NOT COMPLETED|48 Week Open-Label Phase||0
46867|NCT02515669|111373|P4|COMPLETED|48 Week Open-Label Phase||26
46868|NCT02515669|111374|P3|COMPLETED|48 Week Open-Label Phase||7
46869|NCT02515669|111375|P2|COMPLETED|48 Week Open-Label Phase||9
46870|NCT02515669|111376|P1|COMPLETED|48 Week Open-Label Phase||0
46871|NCT02515669|111373|P4|STARTED|48 Week Open-Label Phase|7 DB placebo participants switched to the Panel 3/Expansion RO cohort for the open-label phase.|26
46872|NCT02515669|111374|P3|STARTED|48 Week Open-Label Phase|2 DB placebo participants switched to the Panel 2 RO cohort for the open-label phase.|8
46873|NCT02515669|111375|P2|STARTED|48 Week Open-Label Phase|2 DB placebo participants switched to the Panel 1 RO cohort for the open-label phase.|9
46874|NCT02515669|111376|P1|STARTED|48 Week Open-Label Phase|Double-blind (DB) placebo participants switched to RO7239361 (RO) for the open label phase.|0
46875|NCT02515669|111373|P4|NOT COMPLETED|24 Week Double-Blind Phase||0
46876|NCT02515669|111374|P3|NOT COMPLETED|24 Week Double-Blind Phase||0
46877|NCT02515669|111375|P2|NOT COMPLETED|24 Week Double-Blind Phase||0
46878|NCT02515669|111376|P1|NOT COMPLETED|24 Week Double-Blind Phase||0
46879|NCT02515669|111373|P4|COMPLETED|24 Week Double-Blind Phase||19
46880|NCT02515669|111374|P3|COMPLETED|24 Week Double-Blind Phase||6
46881|NCT02515669|111375|P2|COMPLETED|24 Week Double-Blind Phase||7
46882|NCT02515669|111376|P1|COMPLETED|24 Week Double-Blind Phase||11
46883|NCT02515669|111373|P4|STARTED|24 Week Double-Blind Phase||19
46884|NCT02515669|111374|P3|STARTED|24 Week Double-Blind Phase||6
46885|NCT02515669|111375|P2|STARTED|24 Week Double-Blind Phase||7
46886|NCT02515669|111376|P1|STARTED|24 Week Double-Blind Phase||11
46887|NCT02515656|111441|P2|NOT COMPLETED|Overall Study||71
46888|NCT02515656|111442|P1|NOT COMPLETED|Overall Study||56
46889|NCT02515656|111441|P2|COMPLETED|Overall Study||261
46890|NCT02515656|111442|P1|COMPLETED|Overall Study||270
46891|NCT02515656|111441|P2|Safety Population|Overall Study||328
46892|NCT02515656|111442|P1|Safety Population|Overall Study||325
46893|NCT02515656|111441|P2|Per Protocol Set (PPS)|Overall Study||275
46894|NCT02515656|111442|P1|Per Protocol Set (PPS)|Overall Study||277
46895|NCT02515656|111441|P2|Full Analysis Set (FAS)|Overall Study||309
46896|NCT02515656|111442|P1|Full Analysis Set (FAS)|Overall Study||302
46897|NCT02515656|111441|P2|STARTED|Overall Study||332
46898|NCT02515656|111442|P1|STARTED|Overall Study||326
46899|NCT02515331|111461|P3|NOT COMPLETED|Overall Study||4
46900|NCT02515331|111462|P2|NOT COMPLETED|Overall Study||0
46901|NCT02515331|111463|P1|NOT COMPLETED|Overall Study||2
46902|NCT02515331|111461|P3|COMPLETED|Overall Study||28
46903|NCT02515331|111462|P2|COMPLETED|Overall Study||15
46904|NCT02515331|111463|P1|COMPLETED|Overall Study||15
46905|NCT02515331|111461|P3|Pharmacokinetic (PK) Analysis Set|Overall Study||0
46906|NCT02515331|111462|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||15
46907|NCT02515331|111463|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||17
46908|NCT02515331|111461|P3|Primary Pharmacodynamic Analysis Set|Overall Study||29
46909|NCT02515331|111462|P2|Primary Pharmacodynamic Analysis Set|Overall Study||14
46910|NCT02515331|111463|P1|Primary Pharmacodynamic Analysis Set|Overall Study||15
46911|NCT02515331|111461|P3|STARTED|Overall Study||32
46912|NCT02515331|111462|P2|STARTED|Overall Study||15
46913|NCT02515331|111463|P1|STARTED|Overall Study||17
46914|NCT02515279|111484|P1|NOT COMPLETED|Overall Study||104
46915|NCT02515279|111484|P1|COMPLETED|Overall Study||359
46916|NCT02515279|111484|P1|STARTED|Overall Study||463
46917|NCT02515253|111492|P2|NOT COMPLETED|Overall Study||8
46918|NCT02515253|111493|P1|NOT COMPLETED|Overall Study||7
46919|NCT02515253|111492|P2|COMPLETED|Overall Study||8
46920|NCT02515253|111493|P1|COMPLETED|Overall Study||10
46921|NCT02515253|111492|P2|STARTED|Overall Study||16
46922|NCT02515253|111493|P1|STARTED|Overall Study||17
46923|NCT02515058|111503|P2|NOT COMPLETED|Overall Study||2
46924|NCT02515058|111504|P1|NOT COMPLETED|Overall Study||3
46925|NCT02515058|111503|P2|COMPLETED|Overall Study||20
46926|NCT02515058|111504|P1|COMPLETED|Overall Study||18
46927|NCT02515058|111503|P2|STARTED|Overall Study||22
46928|NCT02515058|111504|P1|STARTED|Overall Study||21
46929|NCT02515045|111514|P3|NOT COMPLETED|Overall Study||4
46930|NCT02515045|111515|P2|NOT COMPLETED|Overall Study||4
46931|NCT02515045|111516|P1|NOT COMPLETED|Overall Study||0
46932|NCT02515045|111514|P3|COMPLETED|Overall Study||55
46933|NCT02515045|111515|P2|COMPLETED|Overall Study||26
46934|NCT02515045|111516|P1|COMPLETED|Overall Study||29
46935|NCT02515045|111514|P3|STARTED|Overall Study||59
46936|NCT02515045|111515|P2|STARTED|Overall Study||30
46937|NCT02515045|111516|P1|STARTED|Overall Study||29
46938|NCT02514889|111532|P2|NOT COMPLETED|Follow-up Assessment Participation||12
46939|NCT02514889|111533|P1|NOT COMPLETED|Follow-up Assessment Participation||10
46940|NCT02514889|111532|P2|COMPLETED|Follow-up Assessment Participation||86
46941|NCT02514889|111533|P1|COMPLETED|Follow-up Assessment Participation||92
46942|NCT02514889|111532|P2|STARTED|Follow-up Assessment Participation||98
46943|NCT02514889|111533|P1|STARTED|Follow-up Assessment Participation||102
46944|NCT02514889|111532|P2|NOT COMPLETED|Intervention Participation||8
46945|NCT02514889|111533|P1|NOT COMPLETED|Intervention Participation||9
46946|NCT02514889|111532|P2|COMPLETED|Intervention Participation||98
46947|NCT02514889|111533|P1|COMPLETED|Intervention Participation||102
46948|NCT02514889|111532|P2|STARTED|Intervention Participation||106
46949|NCT02514889|111533|P1|STARTED|Intervention Participation||111
46950|NCT02514889|111532|P2|NOT COMPLETED|Randomization/Allocation to Condition||24
46951|NCT02514889|111533|P1|NOT COMPLETED|Randomization/Allocation to Condition||20
46952|NCT02514889|111532|P2|COMPLETED|Randomization/Allocation to Condition||106
46953|NCT02514889|111533|P1|COMPLETED|Randomization/Allocation to Condition||111
46954|NCT02514889|111532|P2|STARTED|Randomization/Allocation to Condition||130
46955|NCT02514889|111533|P1|STARTED|Randomization/Allocation to Condition||131
46956|NCT02514772|111553|P2|NOT COMPLETED|Overall Study||2
46957|NCT02514772|111554|P1|NOT COMPLETED|Overall Study||3
46958|NCT02514772|111553|P2|COMPLETED|Overall Study||52
46959|NCT02514772|111554|P1|COMPLETED|Overall Study||50
46960|NCT02514772|111553|P2|STARTED|Overall Study||54
46961|NCT02514772|111554|P1|STARTED|Overall Study||53
46962|NCT02514551|111568|P2|NOT COMPLETED|Overall Study||9
46963|NCT02514551|111569|P1|NOT COMPLETED|Overall Study||5
46964|NCT02514551|111568|P2|COMPLETED|Overall Study||113
46965|NCT02514551|111569|P1|COMPLETED|Overall Study||118
46966|NCT02514551|111568|P2|Received at Least One Dose of Study Drug|Overall Study||120
46967|NCT02514551|111569|P1|Received at Least One Dose of Study Drug|Overall Study||123
46968|NCT02514551|111568|P2|STARTED|Overall Study||122
46969|NCT02514551|111569|P1|STARTED|Overall Study||123
46970|NCT02514473|111586|P2|NOT COMPLETED|Overall Study||5
46971|NCT02514473|111587|P1|NOT COMPLETED|Overall Study||3
46972|NCT02514473|111586|P2|COMPLETED|Overall Study||98
46973|NCT02514473|111587|P1|COMPLETED|Overall Study||98
46974|NCT02514473|111586|P2|STARTED|Overall Study||103
46975|NCT02514473|111587|P1|STARTED|Overall Study||101
46976|NCT02514122|111630|P2|NOT COMPLETED|Overall Study||0
46977|NCT02514122|111631|P1|NOT COMPLETED|Overall Study||2
46978|NCT02514122|111630|P2|COMPLETED|Overall Study||29
46979|NCT02514122|111631|P1|COMPLETED|Overall Study|one participant dropped out for religious reasons; one for needle phobia|30
46980|NCT02514122|111630|P2|STARTED|Overall Study||29
46981|NCT02514122|111631|P1|STARTED|Overall Study||32
46982|NCT02514044|111639|P1|NOT COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||0
46983|NCT02514044|111639|P1|COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||10
46984|NCT02514044|111639|P1|STARTED|Placebo+tDCS+Speech Therapy (1 Day)||10
46985|NCT02514044|111639|P1|NOT COMPLETED|Washout (1 Week)||0
46986|NCT02514044|111639|P1|COMPLETED|Washout (1 Week)||10
46987|NCT02514044|111639|P1|STARTED|Washout (1 Week)||10
46988|NCT02514044|111639|P1|NOT COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||0
46989|NCT02514044|111639|P1|COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||10
46990|NCT02514044|111639|P1|STARTED|Dexedrine+tDCS+Speech Therapy (1 Day)||10
46991|NCT02513940|111653|P6|NOT COMPLETED|Overall Study||0
46992|NCT02513940|111654|P5|NOT COMPLETED|Overall Study||0
46993|NCT02513940|111655|P4|NOT COMPLETED|Overall Study||0
46994|NCT02513940|111656|P3|NOT COMPLETED|Overall Study||0
46995|NCT02513940|111657|P2|NOT COMPLETED|Overall Study||0
46996|NCT02513940|111658|P1|NOT COMPLETED|Overall Study||0
46997|NCT02513940|111653|P6|COMPLETED|Overall Study||3
46998|NCT02513940|111654|P5|COMPLETED|Overall Study||2
46999|NCT02513940|111655|P4|COMPLETED|Overall Study||2
47000|NCT02513940|111656|P3|COMPLETED|Overall Study||2
47001|NCT02513940|111657|P2|COMPLETED|Overall Study||3
47002|NCT02513940|111658|P1|COMPLETED|Overall Study||2
47003|NCT02513940|111653|P6|STARTED|Overall Study||3
47004|NCT02513940|111654|P5|STARTED|Overall Study||2
47005|NCT02513940|111655|P4|STARTED|Overall Study||2
47006|NCT02513940|111656|P3|STARTED|Overall Study||2
47007|NCT02513940|111657|P2|STARTED|Overall Study||3
47008|NCT02513940|111658|P1|STARTED|Overall Study|This was a crossover study, with a total n=14. All 14 subjects completed each phase of the study|2
47009|NCT02513823|111678|P1|NOT COMPLETED|Overall Study||5
47010|NCT02513823|111678|P1|COMPLETED|Overall Study||22
47011|NCT02513823|111678|P1|STARTED|Overall Study||27
47012|NCT02513771|111685|P2|NOT COMPLETED|Overall Study||1
47013|NCT02513771|111686|P1|NOT COMPLETED|Overall Study||2
47014|NCT02513771|111685|P2|COMPLETED|Overall Study||44
47015|NCT02513771|111686|P1|COMPLETED|Overall Study||43
47016|NCT02513771|111685|P2|STARTED|Overall Study||45
47017|NCT02513771|111686|P1|STARTED|Overall Study||45
47018|NCT02513745|111724|P2|NOT COMPLETED|Overall Study||3
47019|NCT02513745|111725|P1|NOT COMPLETED|Overall Study||3
47020|NCT02513745|111724|P2|COMPLETED|Overall Study||39
47021|NCT02513745|111725|P1|COMPLETED|Overall Study||39
47022|NCT02513745|111724|P2|STARTED|Overall Study||42
47023|NCT02513745|111725|P1|STARTED|Overall Study||42
47024|NCT02513732|111735|P1|NOT COMPLETED|Overall Study||0
47025|NCT02513732|111735|P1|COMPLETED|Overall Study||100
47026|NCT02513732|111735|P1|STARTED|Overall Study||100
47027|NCT02513719|111847|P1|NOT COMPLETED|At 5 Years Clinical Follow-up||234
47028|NCT02513719|111847|P1|COMPLETED|At 5 Years Clinical Follow-up||39
47029|NCT02513719|111847|P1|STARTED|At 5 Years Clinical Follow-up||273
47030|NCT02513719|111847|P1|NOT COMPLETED|At 4 Years Clinical Follow-up||16
47031|NCT02513719|111847|P1|COMPLETED|At 4 Years Clinical Follow-up||273
47032|NCT02513719|111847|P1|STARTED|At 4 Years Clinical Follow-up||289
47033|NCT02513719|111847|P1|NOT COMPLETED|At 3 Years Clinical Follow-up||11
47034|NCT02513719|111847|P1|COMPLETED|At 3 Years Clinical Follow-up||289
47035|NCT02513719|111847|P1|STARTED|At 3 Years Clinical Follow-up||300
47036|NCT02513719|111847|P1|NOT COMPLETED|At 2 Years Clinical Follow-up||5
47037|NCT02513719|111847|P1|COMPLETED|At 2 Years Clinical Follow-up||300
47038|NCT02513719|111847|P1|STARTED|At 2 Years Clinical Follow-up||305
47039|NCT02513719|111847|P1|NOT COMPLETED|At 1 Year Clinical Follow-up||7
47040|NCT02513719|111847|P1|COMPLETED|At 1 Year Clinical Follow-up||305
47041|NCT02513719|111847|P1|STARTED|At 1 Year Clinical Follow-up||312
47042|NCT02513719|111847|P1|NOT COMPLETED|At 8 Months Clinical Follow-up||0
47043|NCT02513719|111847|P1|COMPLETED|At 8 Months Clinical Follow-up||312
47044|NCT02513719|111847|P1|STARTED|At 8 Months Clinical Follow-up||312
47045|NCT02513641|111932|P1|NOT COMPLETED|Overall Study||0
47046|NCT02513641|111932|P1|COMPLETED|Overall Study||8
47047|NCT02513641|111932|P1|STARTED|Overall Study||8
47048|NCT02513550|111946|P6|NOT COMPLETED|Post-Treatment Follow-up Period||0
47049|NCT02513550|111947|P5|NOT COMPLETED|Post-Treatment Follow-up Period||0
47050|NCT02513550|111948|P4|NOT COMPLETED|Post-Treatment Follow-up Period||0
47051|NCT02513550|111949|P3|NOT COMPLETED|Post-Treatment Follow-up Period||63
47052|NCT02513550|111950|P2|NOT COMPLETED|Post-Treatment Follow-up Period||39
47053|NCT02513550|111951|P1|NOT COMPLETED|Post-Treatment Follow-up Period||31
47054|NCT02513550|111946|P6|COMPLETED|Post-Treatment Follow-up Period||15
47055|NCT02513550|111947|P5|COMPLETED|Post-Treatment Follow-up Period||4
47056|NCT02513550|111948|P4|COMPLETED|Post-Treatment Follow-up Period||9
47057|NCT02513550|111949|P3|COMPLETED|Post-Treatment Follow-up Period||496
47058|NCT02513550|111950|P2|COMPLETED|Post-Treatment Follow-up Period||244
47059|NCT02513550|111951|P1|COMPLETED|Post-Treatment Follow-up Period||254
47060|NCT02513550|111946|P6|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|15
47061|NCT02513550|111947|P5|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|4
47062|NCT02513550|111948|P4|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|9
47063|NCT02513550|111949|P3|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|559
47064|NCT02513550|111950|P2|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|283
47065|NCT02513550|111951|P1|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|285
47066|NCT02513550|111946|P6|NOT COMPLETED|Double Blind Treatment Period||1
47067|NCT02513550|111947|P5|NOT COMPLETED|Double Blind Treatment Period||1
47068|NCT02513550|111948|P4|NOT COMPLETED|Double Blind Treatment Period||0
47069|NCT02513550|111949|P3|NOT COMPLETED|Double Blind Treatment Period||74
47070|NCT02513550|111950|P2|NOT COMPLETED|Double Blind Treatment Period||38
47071|NCT02513550|111951|P1|NOT COMPLETED|Double Blind Treatment Period||36
47072|NCT02513550|111946|P6|COMPLETED|Double Blind Treatment Period||15
47073|NCT02513550|111947|P5|COMPLETED|Double Blind Treatment Period||4
47074|NCT02513550|111948|P4|COMPLETED|Double Blind Treatment Period||9
47075|NCT02513550|111949|P3|COMPLETED|Double Blind Treatment Period||537
47076|NCT02513550|111950|P2|COMPLETED|Double Blind Treatment Period||268
47077|NCT02513550|111951|P1|COMPLETED|Double Blind Treatment Period||274
47078|NCT02513550|111946|P6|Received at Least One Dose of Study Drug|Double Blind Treatment Period||16
47079|NCT02513550|111947|P5|Received at Least One Dose of Study Drug|Double Blind Treatment Period||5
47080|NCT02513550|111948|P4|Received at Least One Dose of Study Drug|Double Blind Treatment Period||9
47081|NCT02513550|111949|P3|Received at Least One Dose of Study Drug|Double Blind Treatment Period||609
47082|NCT02513550|111950|P2|Received at Least One Dose of Study Drug|Double Blind Treatment Period||306
47083|NCT02513550|111951|P1|Received at Least One Dose of Study Drug|Double Blind Treatment Period||310
47084|NCT02513550|111946|P6|STARTED|Double Blind Treatment Period||16
47085|NCT02513550|111947|P5|STARTED|Double Blind Treatment Period||5
47086|NCT02513550|111948|P4|STARTED|Double Blind Treatment Period||9
47087|NCT02513550|111949|P3|STARTED|Double Blind Treatment Period||611
47088|NCT02513550|111950|P2|STARTED|Double Blind Treatment Period||306
47089|NCT02513550|111951|P1|STARTED|Double Blind Treatment Period||310
47090|NCT02513498|112023|P1|NOT COMPLETED|Overall Study||24
47091|NCT02513498|112023|P1|COMPLETED|Overall Study||26
47092|NCT02513498|112023|P1|STARTED|Overall Study||50
47093|NCT02513446|112045|P2|NOT COMPLETED|Period 2||0
47094|NCT02513446|112046|P1|NOT COMPLETED|Period 2||0
47095|NCT02513446|112045|P2|COMPLETED|Period 2||8
47096|NCT02513446|112046|P1|COMPLETED|Period 2||8
47097|NCT02513446|112045|P2|STARTED|Period 2||8
47098|NCT02513446|112046|P1|STARTED|Period 2||8
47099|NCT02513446|112045|P2|NOT COMPLETED|Washout Period of 10 Days||0
47100|NCT02513446|112046|P1|NOT COMPLETED|Washout Period of 10 Days||0
47101|NCT02513446|112045|P2|COMPLETED|Washout Period of 10 Days||8
47102|NCT02513446|112046|P1|COMPLETED|Washout Period of 10 Days||8
47103|NCT02513446|112045|P2|STARTED|Washout Period of 10 Days||8
47104|NCT02513446|112046|P1|STARTED|Washout Period of 10 Days||8
47105|NCT02513446|112045|P2|NOT COMPLETED|Period 1||0
47106|NCT02513446|112046|P1|NOT COMPLETED|Period 1||0
47107|NCT02513446|112045|P2|COMPLETED|Period 1||8
47108|NCT02513446|112046|P1|COMPLETED|Period 1||8
47109|NCT02513446|112045|P2|STARTED|Period 1||8
47110|NCT02513446|112046|P1|STARTED|Period 1||8
47111|NCT02513160|112061|P4|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||2
47112|NCT02513160|112062|P3|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||1
47113|NCT02513160|112063|P2|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||4
47114|NCT02513160|112064|P1|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||6
47115|NCT02513160|112061|P4|COMPLETED|Treatment Period (Day 0 to Week 6)||103
47116|NCT02513160|112062|P3|COMPLETED|Treatment Period (Day 0 to Week 6)||104
47117|NCT02513160|112063|P2|COMPLETED|Treatment Period (Day 0 to Week 6)||104
47118|NCT02513160|112064|P1|COMPLETED|Treatment Period (Day 0 to Week 6)||101
47119|NCT02513160|112061|P4|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
47120|NCT02513160|112062|P3|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
47121|NCT02513160|112063|P2|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|108
47122|NCT02513160|112064|P1|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|107
47123|NCT02513160|112061|P4|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
47124|NCT02513160|112062|P3|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
47125|NCT02513160|112063|P2|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
47126|NCT02513160|112064|P1|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||288
47127|NCT02513160|112061|P4|COMPLETED|Run-In Period (Days -14 to Day -1)||0
47128|NCT02513160|112062|P3|COMPLETED|Run-In Period (Days -14 to Day -1)||0
47129|NCT02513160|112063|P2|COMPLETED|Run-In Period (Days -14 to Day -1)||0
47130|NCT02513160|112064|P1|COMPLETED|Run-In Period (Days -14 to Day -1)||425
47131|NCT02513160|112061|P4|STARTED|Run-In Period (Days -14 to Day -1)||0
47132|NCT02513160|112062|P3|STARTED|Run-In Period (Days -14 to Day -1)||0
47133|NCT02513160|112063|P2|STARTED|Run-In Period (Days -14 to Day -1)||0
47134|NCT02513160|112064|P1|STARTED|Run-In Period (Days -14 to Day -1)|Enrolled|713
47135|NCT02513095|112101|P2|NOT COMPLETED|Overall Study||16
47136|NCT02513095|112102|P1|NOT COMPLETED|Overall Study||14
47137|NCT02513095|112101|P2|COMPLETED|Overall Study||1
47138|NCT02513095|112102|P1|COMPLETED|Overall Study||3
47139|NCT02513095|112101|P2|STARTED|Overall Study||17
47140|NCT02513095|112102|P1|STARTED|Overall Study||17
47141|NCT02512900|112110|P2|NOT COMPLETED|Overall Study||0
47142|NCT02512900|112111|P1|NOT COMPLETED|Overall Study||0
47143|NCT02512900|112110|P2|COMPLETED|Overall Study||10
47144|NCT02512900|112111|P1|COMPLETED|Overall Study||11
47145|NCT02512900|112110|P2|STARTED|Overall Study||10
47146|NCT02512900|112111|P1|STARTED|Overall Study||11
47147|NCT02512874|112142|P1|NOT COMPLETED|Overall Study||2
47148|NCT02512874|112142|P1|COMPLETED|Overall Study||63
47149|NCT02512874|112142|P1|STARTED|Overall Study||65
47150|NCT02512861|112148|P2|NOT COMPLETED|Overall Study||9
47151|NCT02512861|112149|P1|NOT COMPLETED|Overall Study||6
47152|NCT02512861|112148|P2|COMPLETED|Overall Study||40
47153|NCT02512861|112149|P1|COMPLETED|Overall Study||38
47154|NCT02512861|112148|P2|STARTED|Overall Study||49
47155|NCT02512861|112149|P1|STARTED|Overall Study||44
47156|NCT02512809|112170|P1|NOT COMPLETED|Overall Study||0
47157|NCT02512809|112170|P1|COMPLETED|Overall Study||25
47158|NCT02512809|112170|P1|STARTED|Overall Study||25
47159|NCT02512783|112176|P2|NOT COMPLETED|Overall Study||0
47160|NCT02512783|112177|P1|NOT COMPLETED|Overall Study||0
47161|NCT02512783|112176|P2|COMPLETED|Overall Study||75
47162|NCT02512783|112177|P1|COMPLETED|Overall Study||96
47163|NCT02512783|112176|P2|STARTED|Overall Study||75
47164|NCT02512783|112177|P1|STARTED|Overall Study||96
47165|NCT02512679|112185|P2|NOT COMPLETED|Overall Study||0
47166|NCT02512679|112186|P1|NOT COMPLETED|Overall Study||0
47167|NCT02512679|112185|P2|COMPLETED|Overall Study||0
47168|NCT02512679|112186|P1|COMPLETED|Overall Study||20
47169|NCT02512679|112185|P2|STARTED|Overall Study||0
47170|NCT02512679|112186|P1|STARTED|Overall Study||20
47171|NCT02512575|112204|P10|NOT COMPLETED|Overall Study||0
47172|NCT02512575|112205|P9|NOT COMPLETED|Overall Study||0
47173|NCT02512575|112206|P8|NOT COMPLETED|Overall Study||0
47174|NCT02512575|112207|P7|NOT COMPLETED|Overall Study||0
47175|NCT02512575|112208|P6|NOT COMPLETED|Overall Study||0
47176|NCT02512575|112209|P5|NOT COMPLETED|Overall Study||0
47177|NCT02512575|112210|P4|NOT COMPLETED|Overall Study||0
47178|NCT02512575|112211|P3|NOT COMPLETED|Overall Study||0
47179|NCT02512575|112212|P2|NOT COMPLETED|Overall Study||0
47180|NCT02512575|112213|P1|NOT COMPLETED|Overall Study||0
47181|NCT02512575|112204|P10|COMPLETED|Overall Study||18
47182|NCT02512575|112205|P9|COMPLETED|Overall Study||6
47183|NCT02512575|112206|P8|COMPLETED|Overall Study||6
47184|NCT02512575|112207|P7|COMPLETED|Overall Study||6
47185|NCT02512575|112208|P6|COMPLETED|Overall Study||6
47186|NCT02512575|112209|P5|COMPLETED|Overall Study||6
47187|NCT02512575|112210|P4|COMPLETED|Overall Study||6
47188|NCT02512575|112211|P3|COMPLETED|Overall Study||6
47189|NCT02512575|112212|P2|COMPLETED|Overall Study||6
47190|NCT02512575|112213|P1|COMPLETED|Overall Study||6
47191|NCT02512575|112204|P10|STARTED|Overall Study||18
47192|NCT02512575|112205|P9|STARTED|Overall Study||6
47193|NCT02512575|112206|P8|STARTED|Overall Study||6
47194|NCT02512575|112207|P7|STARTED|Overall Study||6
47195|NCT02512575|112208|P6|STARTED|Overall Study||6
47196|NCT02512575|112209|P5|STARTED|Overall Study||6
47197|NCT02512575|112210|P4|STARTED|Overall Study||6
47198|NCT02512575|112211|P3|STARTED|Overall Study||6
47199|NCT02512575|112212|P2|STARTED|Overall Study||6
47200|NCT02512575|112213|P1|STARTED|Overall Study||6
47201|NCT02512510|112308|P3|NOT COMPLETED|Overall Study||52
47202|NCT02512510|112309|P2|NOT COMPLETED|Overall Study||35
47203|NCT02512510|112310|P1|NOT COMPLETED|Overall Study||42
47204|NCT02512510|112308|P3|COMPLETED|Overall Study||157
47205|NCT02512510|112309|P2|COMPLETED|Overall Study||162
47206|NCT02512510|112310|P1|COMPLETED|Overall Study||163
47207|NCT02512510|112308|P3|STARTED|Overall Study||209
47208|NCT02512510|112309|P2|STARTED|Overall Study||197
47209|NCT02512510|112310|P1|STARTED|Overall Study||205
47210|NCT02512419|112335|P2|NOT COMPLETED|Overall Study||0
47211|NCT02512419|112336|P1|NOT COMPLETED|Overall Study||2
47212|NCT02512419|112335|P2|COMPLETED|Overall Study||24
47213|NCT02512419|112336|P1|COMPLETED|Overall Study|2 participants became ineligible after enrolling therefore were not included in analysis.|22
47214|NCT02512419|112335|P2|STARTED|Overall Study||24
47215|NCT02512419|112336|P1|STARTED|Overall Study||24
47216|NCT02512393|112346|P2|NOT COMPLETED|Overall Study||0
47217|NCT02512393|112347|P1|NOT COMPLETED|Overall Study||1
47218|NCT02512393|112346|P2|COMPLETED|Overall Study||20
47219|NCT02512393|112347|P1|COMPLETED|Overall Study||20
47220|NCT02512393|112346|P2|STARTED|Overall Study||20
47221|NCT02512393|112347|P1|STARTED|Overall Study||21
47222|NCT02512302|112427|P10|NOT COMPLETED|Period 5||0
47223|NCT02512302|112428|P9|NOT COMPLETED|Period 5||0
47224|NCT02512302|112429|P8|NOT COMPLETED|Period 5||0
47225|NCT02512302|112430|P7|NOT COMPLETED|Period 5||0
47226|NCT02512302|112431|P6|NOT COMPLETED|Period 5||0
47227|NCT02512302|112432|P5|NOT COMPLETED|Period 5||0
47228|NCT02512302|112433|P4|NOT COMPLETED|Period 5||0
47229|NCT02512302|112434|P3|NOT COMPLETED|Period 5||0
47230|NCT02512302|112435|P2|NOT COMPLETED|Period 5||0
47231|NCT02512302|112436|P1|NOT COMPLETED|Period 5||0
47232|NCT02512302|112427|P10|COMPLETED|Period 5||2
47233|NCT02512302|112428|P9|COMPLETED|Period 5||3
47234|NCT02512302|112429|P8|COMPLETED|Period 5||3
47235|NCT02512302|112430|P7|COMPLETED|Period 5||1
47236|NCT02512302|112431|P6|COMPLETED|Period 5||3
47237|NCT02512302|112432|P5|COMPLETED|Period 5||3
47238|NCT02512302|112433|P4|COMPLETED|Period 5||3
47239|NCT02512302|112434|P3|COMPLETED|Period 5||3
47240|NCT02512302|112435|P2|COMPLETED|Period 5||2
47241|NCT02512302|112436|P1|COMPLETED|Period 5||3
47242|NCT02512302|112427|P10|STARTED|Period 5||2
47243|NCT02512302|112428|P9|STARTED|Period 5||3
47244|NCT02512302|112429|P8|STARTED|Period 5||3
47245|NCT02512302|112430|P7|STARTED|Period 5||1
47246|NCT02512302|112431|P6|STARTED|Period 5||3
47247|NCT02512302|112432|P5|STARTED|Period 5||3
47248|NCT02512302|112433|P4|STARTED|Period 5||3
47249|NCT02512302|112434|P3|STARTED|Period 5||3
47250|NCT02512302|112435|P2|STARTED|Period 5||2
47251|NCT02512302|112436|P1|STARTED|Period 5||3
47252|NCT02512302|112427|P10|NOT COMPLETED|Period 4||0
47253|NCT02512302|112428|P9|NOT COMPLETED|Period 4||0
47254|NCT02512302|112429|P8|NOT COMPLETED|Period 4||0
47255|NCT02512302|112430|P7|NOT COMPLETED|Period 4||1
47256|NCT02512302|112431|P6|NOT COMPLETED|Period 4||0
47257|NCT02512302|112432|P5|NOT COMPLETED|Period 4||0
47258|NCT02512302|112433|P4|NOT COMPLETED|Period 4||0
47259|NCT02512302|112434|P3|NOT COMPLETED|Period 4||0
47260|NCT02512302|112435|P2|NOT COMPLETED|Period 4||0
47261|NCT02512302|112436|P1|NOT COMPLETED|Period 4||0
47262|NCT02512302|112427|P10|COMPLETED|Period 4||2
47263|NCT02512302|112428|P9|COMPLETED|Period 4||3
47264|NCT02512302|112429|P8|COMPLETED|Period 4||3
47265|NCT02512302|112430|P7|COMPLETED|Period 4||1
47266|NCT02512302|112431|P6|COMPLETED|Period 4||3
47267|NCT02512302|112432|P5|COMPLETED|Period 4||3
47268|NCT02512302|112433|P4|COMPLETED|Period 4||3
47269|NCT02512302|112434|P3|COMPLETED|Period 4||3
47270|NCT02512302|112435|P2|COMPLETED|Period 4||2
47271|NCT02512302|112436|P1|COMPLETED|Period 4||3
47272|NCT02512302|112427|P10|STARTED|Period 4||2
47273|NCT02512302|112428|P9|STARTED|Period 4||3
47274|NCT02512302|112429|P8|STARTED|Period 4||3
47275|NCT02512302|112430|P7|STARTED|Period 4||2
47276|NCT02512302|112431|P6|STARTED|Period 4||3
47277|NCT02512302|112432|P5|STARTED|Period 4||3
47278|NCT02512302|112433|P4|STARTED|Period 4||3
47279|NCT02512302|112434|P3|STARTED|Period 4||3
47280|NCT02512302|112435|P2|STARTED|Period 4||2
47281|NCT02512302|112436|P1|STARTED|Period 4||3
47282|NCT02512302|112427|P10|NOT COMPLETED|Period 3||0
47283|NCT02512302|112428|P9|NOT COMPLETED|Period 3||0
47284|NCT02512302|112429|P8|NOT COMPLETED|Period 3||0
47285|NCT02512302|112430|P7|NOT COMPLETED|Period 3||0
47286|NCT02512302|112431|P6|NOT COMPLETED|Period 3||0
47287|NCT02512302|112432|P5|NOT COMPLETED|Period 3||0
47288|NCT02512302|112433|P4|NOT COMPLETED|Period 3||0
47289|NCT02512302|112434|P3|NOT COMPLETED|Period 3||1
47290|NCT02512302|112435|P2|NOT COMPLETED|Period 3||0
47291|NCT02512302|112436|P1|NOT COMPLETED|Period 3||0
47292|NCT02512302|112427|P10|COMPLETED|Period 3||2
47293|NCT02512302|112428|P9|COMPLETED|Period 3||3
47294|NCT02512302|112429|P8|COMPLETED|Period 3||3
47295|NCT02512302|112430|P7|COMPLETED|Period 3||2
47296|NCT02512302|112431|P6|COMPLETED|Period 3||3
47297|NCT02512302|112432|P5|COMPLETED|Period 3||3
47298|NCT02512302|112433|P4|COMPLETED|Period 3||3
47299|NCT02512302|112434|P3|COMPLETED|Period 3||3
47300|NCT02512302|112435|P2|COMPLETED|Period 3||2
47301|NCT02512302|112436|P1|COMPLETED|Period 3||3
47302|NCT02512302|112427|P10|STARTED|Period 3||2
47303|NCT02512302|112428|P9|STARTED|Period 3||3
47304|NCT02512302|112429|P8|STARTED|Period 3||3
47305|NCT02512302|112430|P7|STARTED|Period 3||2
47306|NCT02512302|112431|P6|STARTED|Period 3||3
47307|NCT02512302|112432|P5|STARTED|Period 3||3
47308|NCT02512302|112433|P4|STARTED|Period 3||3
47309|NCT02512302|112434|P3|STARTED|Period 3||4
47310|NCT02512302|112435|P2|STARTED|Period 3||2
47311|NCT02512302|112436|P1|STARTED|Period 3||3
47312|NCT02512302|112427|P10|NOT COMPLETED|Period 2||1
47313|NCT02512302|112428|P9|NOT COMPLETED|Period 2||0
47314|NCT02512302|112429|P8|NOT COMPLETED|Period 2||0
47315|NCT02512302|112430|P7|NOT COMPLETED|Period 2||0
47316|NCT02512302|112431|P6|NOT COMPLETED|Period 2||0
47317|NCT02512302|112432|P5|NOT COMPLETED|Period 2||0
47318|NCT02512302|112433|P4|NOT COMPLETED|Period 2||0
47319|NCT02512302|112434|P3|NOT COMPLETED|Period 2||0
47320|NCT02512302|112435|P2|NOT COMPLETED|Period 2||0
47321|NCT02512302|112436|P1|NOT COMPLETED|Period 2||0
47322|NCT02512302|112427|P10|COMPLETED|Period 2||2
47323|NCT02512302|112428|P9|COMPLETED|Period 2||3
47324|NCT02512302|112429|P8|COMPLETED|Period 2||3
47325|NCT02512302|112430|P7|COMPLETED|Period 2||2
47326|NCT02512302|112431|P6|COMPLETED|Period 2||3
47327|NCT02512302|112432|P5|COMPLETED|Period 2||3
47328|NCT02512302|112433|P4|COMPLETED|Period 2||3
47329|NCT02512302|112434|P3|COMPLETED|Period 2||4
47330|NCT02512302|112435|P2|COMPLETED|Period 2||2
47331|NCT02512302|112436|P1|COMPLETED|Period 2||3
47332|NCT02512302|112427|P10|STARTED|Period 2||3
47333|NCT02512302|112428|P9|STARTED|Period 2||3
47334|NCT02512302|112429|P8|STARTED|Period 2||3
47335|NCT02512302|112430|P7|STARTED|Period 2||2
47336|NCT02512302|112431|P6|STARTED|Period 2||3
47337|NCT02512302|112432|P5|STARTED|Period 2||3
47338|NCT02512302|112433|P4|STARTED|Period 2||3
47339|NCT02512302|112434|P3|STARTED|Period 2||4
47340|NCT02512302|112435|P2|STARTED|Period 2||2
47341|NCT02512302|112436|P1|STARTED|Period 2||3
47342|NCT02512302|112427|P10|NOT COMPLETED|Period 1||0
47343|NCT02512302|112428|P9|NOT COMPLETED|Period 1||0
47344|NCT02512302|112429|P8|NOT COMPLETED|Period 1||0
47345|NCT02512302|112430|P7|NOT COMPLETED|Period 1||0
47346|NCT02512302|112431|P6|NOT COMPLETED|Period 1||0
47347|NCT02512302|112432|P5|NOT COMPLETED|Period 1||0
47348|NCT02512302|112433|P4|NOT COMPLETED|Period 1||0
47349|NCT02512302|112434|P3|NOT COMPLETED|Period 1||0
47350|NCT02512302|112435|P2|NOT COMPLETED|Period 1||1
47351|NCT02512302|112436|P1|NOT COMPLETED|Period 1||0
47352|NCT02512302|112427|P10|COMPLETED|Period 1||3
47353|NCT02512302|112428|P9|COMPLETED|Period 1||3
47354|NCT02512302|112429|P8|COMPLETED|Period 1||3
47355|NCT02512302|112430|P7|COMPLETED|Period 1||2
47356|NCT02512302|112431|P6|COMPLETED|Period 1||3
47357|NCT02512302|112432|P5|COMPLETED|Period 1||3
47358|NCT02512302|112433|P4|COMPLETED|Period 1||3
47359|NCT02512302|112434|P3|COMPLETED|Period 1||4
47360|NCT02512302|112435|P2|COMPLETED|Period 1||2
47361|NCT02512302|112436|P1|COMPLETED|Period 1||3
47362|NCT02512302|112427|P10|STARTED|Period 1||3
47363|NCT02512302|112428|P9|STARTED|Period 1||3
47364|NCT02512302|112429|P8|STARTED|Period 1||3
47365|NCT02512302|112430|P7|STARTED|Period 1||2
47366|NCT02512302|112431|P6|STARTED|Period 1||3
47367|NCT02512302|112432|P5|STARTED|Period 1||3
47368|NCT02512302|112433|P4|STARTED|Period 1||3
47369|NCT02512302|112434|P3|STARTED|Period 1||4
47370|NCT02512302|112435|P2|STARTED|Period 1||3
47371|NCT02512302|112436|P1|STARTED|Period 1||3
47372|NCT02512276|112510|P2|NOT COMPLETED|Overall Study||11
47373|NCT02512276|112511|P1|NOT COMPLETED|Overall Study||8
47374|NCT02512276|112510|P2|COMPLETED|Overall Study||2029
47375|NCT02512276|112511|P1|COMPLETED|Overall Study||2030
47376|NCT02512276|112510|P2|STARTED|Overall Study||2040
47377|NCT02512276|112511|P1|STARTED|Overall Study||2038
47378|NCT02512224|112529|P2|NOT COMPLETED|Overall Study||0
47379|NCT02512224|112530|P1|NOT COMPLETED|Overall Study||0
47380|NCT02512224|112529|P2|COMPLETED|Overall Study||2912
47381|NCT02512224|112530|P1|COMPLETED|Overall Study||2912
47382|NCT02512224|112529|P2|STARTED|Overall Study||2912
47383|NCT02512224|112530|P1|STARTED|Overall Study||2912
47384|NCT02512094|112546|P1|NOT COMPLETED|Overall Study||0
47385|NCT02512094|112546|P1|COMPLETED|Overall Study||53
47386|NCT02512094|112546|P1|STARTED|Overall Study||53
47387|NCT02512068|112552|P2|NOT COMPLETED|Overall Study||13
47388|NCT02512068|112553|P1|NOT COMPLETED|Overall Study||12
47389|NCT02512068|112552|P2|COMPLETED|Overall Study||39
47390|NCT02512068|112553|P1|COMPLETED|Overall Study||43
47391|NCT02512068|112552|P2|STARTED|Overall Study||52
47392|NCT02512068|112553|P1|STARTED|Overall Study||55
47393|NCT02511782|112580|P3|NOT COMPLETED|Overall Study||0
47394|NCT02511782|112581|P2|NOT COMPLETED|Overall Study||0
47395|NCT02511782|112582|P1|NOT COMPLETED|Overall Study||1
47396|NCT02511782|112580|P3|COMPLETED|Overall Study||10
47397|NCT02511782|112581|P2|COMPLETED|Overall Study||2
47398|NCT02511782|112582|P1|COMPLETED|Overall Study||50
47399|NCT02511782|112580|P3|STARTED|Overall Study||10
47400|NCT02511782|112581|P2|STARTED|Overall Study||2
47401|NCT02511782|112582|P1|STARTED|Overall Study||51
47402|NCT02511717|112594|P2|NOT COMPLETED|Overall Study||0
47403|NCT02511717|112595|P1|NOT COMPLETED|Overall Study||2
47404|NCT02511717|112594|P2|COMPLETED|Overall Study||10
47405|NCT02511717|112595|P1|COMPLETED|Overall Study||8
47406|NCT02511717|112594|P2|STARTED|Overall Study||10
47407|NCT02511717|112595|P1|STARTED|Overall Study||10
47408|NCT02511678|112601|P1|NOT COMPLETED|Overall Study||36
47409|NCT02511678|112601|P1|COMPLETED|Overall Study||37
47410|NCT02511678|112601|P1|Safety Population|Overall Study|Participants for whom received the complete study cryoablation procedure.|65
47411|NCT02511678|112601|P1|Participants Discontinued Pre-Treatment|Overall Study||7
47412|NCT02511678|112601|P1|Intent-to-Treat (ITT) Population|Overall Study|Participants for whom cryoablation via Galil Medical cryoablation system was attempted or performed.|66
47413|NCT02511678|112601|P1|STARTED|Overall Study||73
47414|NCT02511587|112616|P2|NOT COMPLETED|Overall Study||0
47415|NCT02511587|112617|P1|NOT COMPLETED|Overall Study||0
47416|NCT02511587|112616|P2|COMPLETED|Overall Study||58
47417|NCT02511587|112617|P1|COMPLETED|Overall Study||58
47418|NCT02511587|112616|P2|STARTED|Overall Study||58
47419|NCT02511587|112617|P1|STARTED|Overall Study||58
47420|NCT02511535|112630|P3|NOT COMPLETED|Overall Study||0
47421|NCT02511535|112631|P2|NOT COMPLETED|Overall Study||0
47422|NCT02511535|112632|P1|NOT COMPLETED|Overall Study||0
47423|NCT02511535|112630|P3|COMPLETED|Overall Study||49
47424|NCT02511535|112631|P2|COMPLETED|Overall Study||21
47425|NCT02511535|112632|P1|COMPLETED|Overall Study||49
47426|NCT02511535|112630|P3|STARTED|Overall Study||49
47427|NCT02511535|112631|P2|STARTED|Overall Study||21
47428|NCT02511535|112632|P1|STARTED|Overall Study||49
47429|NCT02511431|112655|P6|NOT COMPLETED|Post-treatment Follow-up||0
47430|NCT02511431|112656|P5|NOT COMPLETED|Post-treatment Follow-up||0
47431|NCT02511431|112657|P4|NOT COMPLETED|Post-treatment Follow-up||0
47432|NCT02511431|112658|P3|NOT COMPLETED|Post-treatment Follow-up||0
47433|NCT02511431|112659|P2|NOT COMPLETED|Post-treatment Follow-up||0
47434|NCT02511431|112660|P1|NOT COMPLETED|Post-treatment Follow-up||0
47435|NCT02511431|112655|P6|COMPLETED|Post-treatment Follow-up||2
47436|NCT02511431|112656|P5|COMPLETED|Post-treatment Follow-up||3
47437|NCT02511431|112657|P4|COMPLETED|Post-treatment Follow-up||3
47438|NCT02511431|112658|P3|COMPLETED|Post-treatment Follow-up||3
47439|NCT02511431|112659|P2|COMPLETED|Post-treatment Follow-up||4
47440|NCT02511431|112660|P1|COMPLETED|Post-treatment Follow-up||4
47441|NCT02511431|112655|P6|STARTED|Post-treatment Follow-up||2
47442|NCT02511431|112656|P5|STARTED|Post-treatment Follow-up||3
47443|NCT02511431|112657|P4|STARTED|Post-treatment Follow-up||3
47444|NCT02511431|112658|P3|STARTED|Post-treatment Follow-up||3
47445|NCT02511431|112659|P2|STARTED|Post-treatment Follow-up||4
47446|NCT02511431|112660|P1|STARTED|Post-treatment Follow-up||4
47447|NCT02511431|112655|P6|NOT COMPLETED|Treatment||1
47448|NCT02511431|112656|P5|NOT COMPLETED|Treatment||0
47449|NCT02511431|112657|P4|NOT COMPLETED|Treatment||0
47450|NCT02511431|112658|P3|NOT COMPLETED|Treatment||1
47451|NCT02511431|112659|P2|NOT COMPLETED|Treatment||0
47452|NCT02511431|112660|P1|NOT COMPLETED|Treatment||0
47453|NCT02511431|112655|P6|COMPLETED|Treatment||2
47454|NCT02511431|112656|P5|COMPLETED|Treatment||3
47455|NCT02511431|112657|P4|COMPLETED|Treatment||3
47456|NCT02511431|112658|P3|COMPLETED|Treatment||3
47457|NCT02511431|112659|P2|COMPLETED|Treatment||4
47458|NCT02511431|112660|P1|COMPLETED|Treatment||4
47459|NCT02511431|112655|P6|STARTED|Treatment||3
47460|NCT02511431|112656|P5|STARTED|Treatment||3
47461|NCT02511431|112657|P4|STARTED|Treatment||3
47462|NCT02511431|112658|P3|STARTED|Treatment||4
47463|NCT02511431|112659|P2|STARTED|Treatment||4
47464|NCT02511431|112660|P1|STARTED|Treatment||4
47465|NCT02511379|112681|P1|NOT COMPLETED|Overall Study||0
47466|NCT02511379|112681|P1|COMPLETED|Overall Study||14
47467|NCT02511379|112681|P1|STARTED|Overall Study||14
47468|NCT02511184|112687|P2|NOT COMPLETED|Overall Study||7
47469|NCT02511184|112688|P1|NOT COMPLETED|Overall Study||2
47470|NCT02511184|112687|P2|COMPLETED|Overall Study||0
47471|NCT02511184|112688|P1|COMPLETED|Overall Study||0
47472|NCT02511184|112687|P2|STARTED|Overall Study||7
47473|NCT02511184|112688|P1|STARTED|Overall Study||2
47474|NCT02510820|112738|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
47475|NCT02510820|112739|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
47476|NCT02510820|112738|P2|COMPLETED|Second Intervention (4 Weeks)||26
47477|NCT02510820|112739|P1|COMPLETED|Second Intervention (4 Weeks)||20
47478|NCT02510820|112738|P2|STARTED|Second Intervention (4 Weeks)||26
47479|NCT02510820|112739|P1|STARTED|Second Intervention (4 Weeks)||21
47480|NCT02510820|112738|P2|NOT COMPLETED|Washout (1 Week)||0
47481|NCT02510820|112739|P1|NOT COMPLETED|Washout (1 Week)||0
47482|NCT02510820|112738|P2|COMPLETED|Washout (1 Week)||26
47483|NCT02510820|112739|P1|COMPLETED|Washout (1 Week)||21
47484|NCT02510820|112738|P2|STARTED|Washout (1 Week)||26
47485|NCT02510820|112739|P1|STARTED|Washout (1 Week)||21
47486|NCT02510820|112738|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
47487|NCT02510820|112739|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
47488|NCT02510820|112738|P2|COMPLETED|First Intervention (4 Weeks)||26
47489|NCT02510820|112739|P1|COMPLETED|First Intervention (4 Weeks)||21
47490|NCT02510820|112738|P2|STARTED|First Intervention (4 Weeks)||27
47491|NCT02510820|112739|P1|STARTED|First Intervention (4 Weeks)||21
47492|NCT02510014|112779|P2|NOT COMPLETED|Treatment Period||57
47493|NCT02510014|112780|P1|NOT COMPLETED|Treatment Period||206
47494|NCT02510014|112779|P2|COMPLETED|Treatment Period||200
47495|NCT02510014|112780|P1|COMPLETED|Treatment Period||206
47496|NCT02510014|112779|P2|STARTED|Treatment Period||257
47497|NCT02510014|112780|P1|STARTED|Treatment Period||412
47498|NCT02510014|112779|P2|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||10
47499|NCT02510014|112780|P1|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||96
47500|NCT02510014|112779|P2|COMPLETED|Run-In Period (Days -14 to Day -1)||257
47501|NCT02510014|112780|P1|COMPLETED|Run-In Period (Days -14 to Day -1)||412
47502|NCT02510014|112779|P2|STARTED|Run-In Period (Days -14 to Day -1)||267
47503|NCT02510014|112780|P1|STARTED|Run-In Period (Days -14 to Day -1)||508
47504|NCT02509936|112802|P2|NOT COMPLETED|Overall Study||16
47505|NCT02509936|112803|P1|NOT COMPLETED|Overall Study||12
47506|NCT02509936|112802|P2|COMPLETED|Overall Study||145
47507|NCT02509936|112803|P1|COMPLETED|Overall Study||151
47508|NCT02509936|112802|P2|STARTED|Overall Study||161
47509|NCT02509936|112803|P1|STARTED|Overall Study||163
47510|NCT02509767|112829|P2|NOT COMPLETED|Overall Study||41
47511|NCT02509767|112830|P1|NOT COMPLETED|Overall Study||44
47512|NCT02509767|112829|P2|COMPLETED|Overall Study||159
47513|NCT02509767|112830|P1|COMPLETED|Overall Study||157
47514|NCT02509767|112829|P2|STARTED|Overall Study||200
47515|NCT02509767|112830|P1|STARTED|Overall Study||201
47516|NCT02509585|112841|P1|NOT COMPLETED|Overall Study||0
47517|NCT02509585|112841|P1|COMPLETED|Overall Study||18
47518|NCT02509585|112841|P1|STARTED|Overall Study||18
47519|NCT02509481|112856|P2|NOT COMPLETED|Overall Study||0
47520|NCT02509481|112857|P1|NOT COMPLETED|Overall Study||0
47521|NCT02509481|112856|P2|COMPLETED|Overall Study||1447
47522|NCT02509481|112857|P1|COMPLETED|Overall Study||1265
47523|NCT02509481|112856|P2|STARTED|Overall Study||1447
47524|NCT02509481|112857|P1|STARTED|Overall Study||1265
47525|NCT02509117|112883|P10|NOT COMPLETED|Period 4 -Part A: 4 Days||0
47526|NCT02509117|112884|P9|NOT COMPLETED|Period 4 -Part A: 4 Days||0
47527|NCT02509117|112885|P8|NOT COMPLETED|Period 4 -Part A: 4 Days||0
47528|NCT02509117|112886|P7|NOT COMPLETED|Period 4 -Part A: 4 Days||0
47529|NCT02509117|112887|P6|NOT COMPLETED|Period 4 -Part A: 4 Days||0
47530|NCT02509117|112888|P5|NOT COMPLETED|Period 4 -Part A: 4 Days||0
47531|NCT02509117|112889|P4|NOT COMPLETED|Period 4 -Part A: 4 Days||0
47532|NCT02509117|112890|P3|NOT COMPLETED|Period 4 -Part A: 4 Days||0
47533|NCT02509117|112891|P2|NOT COMPLETED|Period 4 -Part A: 4 Days||0
47534|NCT02509117|112892|P1|NOT COMPLETED|Period 4 -Part A: 4 Days||0
47535|NCT02509117|112883|P10|COMPLETED|Period 4 -Part A: 4 Days||0
47536|NCT02509117|112884|P9|COMPLETED|Period 4 -Part A: 4 Days||0
47537|NCT02509117|112885|P8|COMPLETED|Period 4 -Part A: 4 Days||0
47538|NCT02509117|112886|P7|COMPLETED|Period 4 -Part A: 4 Days||0
47539|NCT02509117|112887|P6|COMPLETED|Period 4 -Part A: 4 Days||0
47540|NCT02509117|112888|P5|COMPLETED|Period 4 -Part A: 4 Days||0
47541|NCT02509117|112889|P4|COMPLETED|Period 4 -Part A: 4 Days||2
47542|NCT02509117|112890|P3|COMPLETED|Period 4 -Part A: 4 Days||2
47543|NCT02509117|112891|P2|COMPLETED|Period 4 -Part A: 4 Days||2
47544|NCT02509117|112892|P1|COMPLETED|Period 4 -Part A: 4 Days||2
47545|NCT02509117|112883|P10|STARTED|Period 4 -Part A: 4 Days||0
47546|NCT02509117|112884|P9|STARTED|Period 4 -Part A: 4 Days||0
47547|NCT02509117|112885|P8|STARTED|Period 4 -Part A: 4 Days||0
47548|NCT02509117|112886|P7|STARTED|Period 4 -Part A: 4 Days||0
47549|NCT02509117|112887|P6|STARTED|Period 4 -Part A: 4 Days||0
47550|NCT02509117|112888|P5|STARTED|Period 4 -Part A: 4 Days||0
47551|NCT02509117|112889|P4|STARTED|Period 4 -Part A: 4 Days||2
47552|NCT02509117|112890|P3|STARTED|Period 4 -Part A: 4 Days||2
47553|NCT02509117|112891|P2|STARTED|Period 4 -Part A: 4 Days||2
47554|NCT02509117|112892|P1|STARTED|Period 4 -Part A: 4 Days||2
47555|NCT02509117|112883|P10|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
47556|NCT02509117|112884|P9|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
47557|NCT02509117|112885|P8|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
47558|NCT02509117|112886|P7|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
47559|NCT02509117|112887|P6|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
47560|NCT02509117|112888|P5|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
47561|NCT02509117|112889|P4|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
47562|NCT02509117|112890|P3|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
47563|NCT02509117|112891|P2|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
47564|NCT02509117|112892|P1|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
47565|NCT02509117|112883|P10|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
47566|NCT02509117|112884|P9|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
47567|NCT02509117|112885|P8|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
47568|NCT02509117|112886|P7|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
47569|NCT02509117|112887|P6|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
47570|NCT02509117|112888|P5|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
47571|NCT02509117|112889|P4|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
47572|NCT02509117|112890|P3|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
47573|NCT02509117|112891|P2|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
47574|NCT02509117|112892|P1|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
47575|NCT02509117|112883|P10|STARTED|Washout Period 3 (Part A: 7 Days)||0
47576|NCT02509117|112884|P9|STARTED|Washout Period 3 (Part A: 7 Days)||0
47577|NCT02509117|112885|P8|STARTED|Washout Period 3 (Part A: 7 Days)||0
47578|NCT02509117|112886|P7|STARTED|Washout Period 3 (Part A: 7 Days)||0
47579|NCT02509117|112887|P6|STARTED|Washout Period 3 (Part A: 7 Days)||0
47580|NCT02509117|112888|P5|STARTED|Washout Period 3 (Part A: 7 Days)||0
47581|NCT02509117|112889|P4|STARTED|Washout Period 3 (Part A: 7 Days)||2
47582|NCT02509117|112890|P3|STARTED|Washout Period 3 (Part A: 7 Days)||2
47583|NCT02509117|112891|P2|STARTED|Washout Period 3 (Part A: 7 Days)||2
47584|NCT02509117|112892|P1|STARTED|Washout Period 3 (Part A: 7 Days)||2
47585|NCT02509117|112883|P10|NOT COMPLETED|Period 3 -Part A: 4 Days||0
47586|NCT02509117|112884|P9|NOT COMPLETED|Period 3 -Part A: 4 Days||0
47587|NCT02509117|112885|P8|NOT COMPLETED|Period 3 -Part A: 4 Days||0
47588|NCT02509117|112886|P7|NOT COMPLETED|Period 3 -Part A: 4 Days||0
47589|NCT02509117|112887|P6|NOT COMPLETED|Period 3 -Part A: 4 Days||0
47590|NCT02509117|112888|P5|NOT COMPLETED|Period 3 -Part A: 4 Days||0
47591|NCT02509117|112889|P4|NOT COMPLETED|Period 3 -Part A: 4 Days||0
47592|NCT02509117|112890|P3|NOT COMPLETED|Period 3 -Part A: 4 Days||0
47593|NCT02509117|112891|P2|NOT COMPLETED|Period 3 -Part A: 4 Days||0
47594|NCT02509117|112892|P1|NOT COMPLETED|Period 3 -Part A: 4 Days||0
47595|NCT02509117|112883|P10|COMPLETED|Period 3 -Part A: 4 Days||0
47596|NCT02509117|112884|P9|COMPLETED|Period 3 -Part A: 4 Days||0
47597|NCT02509117|112885|P8|COMPLETED|Period 3 -Part A: 4 Days||0
47598|NCT02509117|112886|P7|COMPLETED|Period 3 -Part A: 4 Days||0
47599|NCT02509117|112887|P6|COMPLETED|Period 3 -Part A: 4 Days||0
47600|NCT02509117|112888|P5|COMPLETED|Period 3 -Part A: 4 Days||0
47601|NCT02509117|112889|P4|COMPLETED|Period 3 -Part A: 4 Days||2
47602|NCT02509117|112890|P3|COMPLETED|Period 3 -Part A: 4 Days||2
47603|NCT02509117|112891|P2|COMPLETED|Period 3 -Part A: 4 Days||2
47604|NCT02509117|112892|P1|COMPLETED|Period 3 -Part A: 4 Days||2
47605|NCT02509117|112883|P10|STARTED|Period 3 -Part A: 4 Days||0
47606|NCT02509117|112884|P9|STARTED|Period 3 -Part A: 4 Days||0
47607|NCT02509117|112885|P8|STARTED|Period 3 -Part A: 4 Days||0
47608|NCT02509117|112886|P7|STARTED|Period 3 -Part A: 4 Days||0
47609|NCT02509117|112887|P6|STARTED|Period 3 -Part A: 4 Days||0
47610|NCT02509117|112888|P5|STARTED|Period 3 -Part A: 4 Days||0
47611|NCT02509117|112889|P4|STARTED|Period 3 -Part A: 4 Days||2
47612|NCT02509117|112890|P3|STARTED|Period 3 -Part A: 4 Days||2
47613|NCT02509117|112891|P2|STARTED|Period 3 -Part A: 4 Days||2
47614|NCT02509117|112892|P1|STARTED|Period 3 -Part A: 4 Days||2
47615|NCT02509117|112883|P10|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
47616|NCT02509117|112884|P9|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
47617|NCT02509117|112885|P8|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
47618|NCT02509117|112886|P7|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
47619|NCT02509117|112887|P6|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
47620|NCT02509117|112888|P5|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
47621|NCT02509117|112889|P4|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
47622|NCT02509117|112890|P3|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
47623|NCT02509117|112891|P2|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
47624|NCT02509117|112892|P1|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
47625|NCT02509117|112883|P10|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
47626|NCT02509117|112884|P9|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
47627|NCT02509117|112885|P8|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
47628|NCT02509117|112886|P7|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
47629|NCT02509117|112887|P6|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
47630|NCT02509117|112888|P5|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
47631|NCT02509117|112889|P4|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
47632|NCT02509117|112890|P3|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
47633|NCT02509117|112891|P2|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
47634|NCT02509117|112892|P1|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
47635|NCT02509117|112883|P10|STARTED|Washout Period 2 (Part A: 7 Days)||0
47636|NCT02509117|112884|P9|STARTED|Washout Period 2 (Part A: 7 Days)||0
47637|NCT02509117|112885|P8|STARTED|Washout Period 2 (Part A: 7 Days)||0
47638|NCT02509117|112886|P7|STARTED|Washout Period 2 (Part A: 7 Days)||0
47639|NCT02509117|112887|P6|STARTED|Washout Period 2 (Part A: 7 Days)||0
47640|NCT02509117|112888|P5|STARTED|Washout Period 2 (Part A: 7 Days)||0
47641|NCT02509117|112889|P4|STARTED|Washout Period 2 (Part A: 7 Days)||2
47642|NCT02509117|112890|P3|STARTED|Washout Period 2 (Part A: 7 Days)||2
47643|NCT02509117|112891|P2|STARTED|Washout Period 2 (Part A: 7 Days)||2
47644|NCT02509117|112892|P1|STARTED|Washout Period 2 (Part A: 7 Days)||2
47645|NCT02509117|112883|P10|NOT COMPLETED|Period 2 -Part A: 4 Days||0
47646|NCT02509117|112884|P9|NOT COMPLETED|Period 2 -Part A: 4 Days||0
47647|NCT02509117|112885|P8|NOT COMPLETED|Period 2 -Part A: 4 Days||0
47648|NCT02509117|112886|P7|NOT COMPLETED|Period 2 -Part A: 4 Days||0
47649|NCT02509117|112887|P6|NOT COMPLETED|Period 2 -Part A: 4 Days||0
47650|NCT02509117|112888|P5|NOT COMPLETED|Period 2 -Part A: 4 Days||0
47651|NCT02509117|112889|P4|NOT COMPLETED|Period 2 -Part A: 4 Days||0
47652|NCT02509117|112890|P3|NOT COMPLETED|Period 2 -Part A: 4 Days||0
47653|NCT02509117|112891|P2|NOT COMPLETED|Period 2 -Part A: 4 Days||0
47654|NCT02509117|112892|P1|NOT COMPLETED|Period 2 -Part A: 4 Days||0
47655|NCT02509117|112883|P10|COMPLETED|Period 2 -Part A: 4 Days||0
47656|NCT02509117|112884|P9|COMPLETED|Period 2 -Part A: 4 Days||0
47657|NCT02509117|112885|P8|COMPLETED|Period 2 -Part A: 4 Days||0
47658|NCT02509117|112886|P7|COMPLETED|Period 2 -Part A: 4 Days||0
47659|NCT02509117|112887|P6|COMPLETED|Period 2 -Part A: 4 Days||0
47660|NCT02509117|112888|P5|COMPLETED|Period 2 -Part A: 4 Days||0
47661|NCT02509117|112889|P4|COMPLETED|Period 2 -Part A: 4 Days||2
47662|NCT02509117|112890|P3|COMPLETED|Period 2 -Part A: 4 Days||2
47663|NCT02509117|112891|P2|COMPLETED|Period 2 -Part A: 4 Days||2
47664|NCT02509117|112892|P1|COMPLETED|Period 2 -Part A: 4 Days||2
47665|NCT02509117|112883|P10|Treated|Period 2 -Part A: 4 Days||0
47666|NCT02509117|112884|P9|Treated|Period 2 -Part A: 4 Days||0
47667|NCT02509117|112885|P8|Treated|Period 2 -Part A: 4 Days||0
47668|NCT02509117|112886|P7|Treated|Period 2 -Part A: 4 Days||0
47669|NCT02509117|112887|P6|Treated|Period 2 -Part A: 4 Days||0
47670|NCT02509117|112888|P5|Treated|Period 2 -Part A: 4 Days||0
47671|NCT02509117|112889|P4|Treated|Period 2 -Part A: 4 Days||2
47672|NCT02509117|112890|P3|Treated|Period 2 -Part A: 4 Days||2
47673|NCT02509117|112891|P2|Treated|Period 2 -Part A: 4 Days||2
47674|NCT02509117|112892|P1|Treated|Period 2 -Part A: 4 Days||2
47675|NCT02509117|112883|P10|STARTED|Period 2 -Part A: 4 Days||0
47676|NCT02509117|112884|P9|STARTED|Period 2 -Part A: 4 Days||0
47677|NCT02509117|112885|P8|STARTED|Period 2 -Part A: 4 Days||0
47678|NCT02509117|112886|P7|STARTED|Period 2 -Part A: 4 Days||0
47679|NCT02509117|112887|P6|STARTED|Period 2 -Part A: 4 Days||0
47680|NCT02509117|112888|P5|STARTED|Period 2 -Part A: 4 Days||0
47681|NCT02509117|112889|P4|STARTED|Period 2 -Part A: 4 Days||2
47682|NCT02509117|112890|P3|STARTED|Period 2 -Part A: 4 Days||2
47683|NCT02509117|112891|P2|STARTED|Period 2 -Part A: 4 Days|1 participant was added in intervention period 2|2
47684|NCT02509117|112892|P1|STARTED|Period 2 -Part A: 4 Days||2
47685|NCT02509117|112883|P10|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
47686|NCT02509117|112884|P9|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
47687|NCT02509117|112885|P8|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
47688|NCT02509117|112886|P7|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
47689|NCT02509117|112887|P6|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
47690|NCT02509117|112888|P5|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
47691|NCT02509117|112889|P4|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
47692|NCT02509117|112890|P3|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
47693|NCT02509117|112891|P2|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
47694|NCT02509117|112892|P1|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
47695|NCT02509117|112883|P10|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
47696|NCT02509117|112884|P9|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
47697|NCT02509117|112885|P8|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
47698|NCT02509117|112886|P7|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
47699|NCT02509117|112887|P6|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
47700|NCT02509117|112888|P5|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
47701|NCT02509117|112889|P4|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
47702|NCT02509117|112890|P3|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
47703|NCT02509117|112891|P2|COMPLETED|Washout Period 1 (Part A: 7 Days)||1
47704|NCT02509117|112892|P1|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
47705|NCT02509117|112883|P10|STARTED|Washout Period 1 (Part A: 7 Days)||0
47706|NCT02509117|112884|P9|STARTED|Washout Period 1 (Part A: 7 Days)||0
47707|NCT02509117|112885|P8|STARTED|Washout Period 1 (Part A: 7 Days)||0
47708|NCT02509117|112886|P7|STARTED|Washout Period 1 (Part A: 7 Days)||0
47709|NCT02509117|112887|P6|STARTED|Washout Period 1 (Part A: 7 Days)||0
47710|NCT02509117|112888|P5|STARTED|Washout Period 1 (Part A: 7 Days)||0
47711|NCT02509117|112889|P4|STARTED|Washout Period 1 (Part A: 7 Days)||2
47712|NCT02509117|112890|P3|STARTED|Washout Period 1 (Part A: 7 Days)||2
47713|NCT02509117|112891|P2|STARTED|Washout Period 1 (Part A: 7 Days)||1
47714|NCT02509117|112892|P1|STARTED|Washout Period 1 (Part A: 7 Days)||2
47715|NCT02509117|112883|P10|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
47716|NCT02509117|112884|P9|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
47717|NCT02509117|112885|P8|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
47718|NCT02509117|112886|P7|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
47719|NCT02509117|112887|P6|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
47720|NCT02509117|112888|P5|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
47721|NCT02509117|112889|P4|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
47722|NCT02509117|112890|P3|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
47723|NCT02509117|112891|P2|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1
47724|NCT02509117|112892|P1|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
47725|NCT02509117|112883|P10|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
47726|NCT02509117|112884|P9|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||4
47727|NCT02509117|112885|P8|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
47728|NCT02509117|112886|P7|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
47729|NCT02509117|112887|P6|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
47730|NCT02509117|112888|P5|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
47731|NCT02509117|112889|P4|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
47732|NCT02509117|112890|P3|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
47733|NCT02509117|112891|P2|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1
47734|NCT02509117|112892|P1|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
47735|NCT02509117|112883|P10|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||10
47736|NCT02509117|112884|P9|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||4
47737|NCT02509117|112885|P8|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
47738|NCT02509117|112886|P7|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
47739|NCT02509117|112887|P6|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
47740|NCT02509117|112888|P5|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
47741|NCT02509117|112889|P4|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
47742|NCT02509117|112890|P3|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
47743|NCT02509117|112891|P2|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||1
47744|NCT02509117|112892|P1|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
47745|NCT02509117|112883|P10|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||10
47746|NCT02509117|112884|P9|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||4
47747|NCT02509117|112885|P8|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
47748|NCT02509117|112886|P7|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
47749|NCT02509117|112887|P6|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
47750|NCT02509117|112888|P5|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
47751|NCT02509117|112889|P4|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
47752|NCT02509117|112890|P3|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
47753|NCT02509117|112891|P2|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
47754|NCT02509117|112892|P1|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
47755|NCT02509078|113103|P2|NOT COMPLETED|Overall Study||1
47756|NCT02509078|113104|P1|NOT COMPLETED|Overall Study||1
47757|NCT02509078|113103|P2|COMPLETED|Overall Study||505
47758|NCT02509078|113104|P1|COMPLETED|Overall Study||501
47759|NCT02509078|113103|P2|STARTED|Overall Study||506
47760|NCT02509078|113104|P1|STARTED|Overall Study||502
47761|NCT02509065|113140|P23|NOT COMPLETED|Overall Study||0
47762|NCT02509065|113141|P22|NOT COMPLETED|Overall Study||0
47763|NCT02509065|113142|P21|NOT COMPLETED|Overall Study||0
47764|NCT02509065|113143|P20|NOT COMPLETED|Overall Study||0
47765|NCT02509065|113144|P19|NOT COMPLETED|Overall Study||0
47766|NCT02509065|113145|P18|NOT COMPLETED|Overall Study||0
47767|NCT02509065|113146|P17|NOT COMPLETED|Overall Study||0
47768|NCT02509065|113147|P16|NOT COMPLETED|Overall Study||0
47769|NCT02509065|113148|P15|NOT COMPLETED|Overall Study||0
47770|NCT02509065|113149|P14|NOT COMPLETED|Overall Study||0
47771|NCT02509065|113150|P13|NOT COMPLETED|Overall Study||0
47772|NCT02509065|113151|P12|NOT COMPLETED|Overall Study||0
47773|NCT02509065|113152|P11|NOT COMPLETED|Overall Study||0
47774|NCT02509065|113153|P10|NOT COMPLETED|Overall Study||0
47775|NCT02509065|113154|P9|NOT COMPLETED|Overall Study||0
47776|NCT02509065|113155|P8|NOT COMPLETED|Overall Study||0
47777|NCT02509065|113156|P7|NOT COMPLETED|Overall Study||0
47778|NCT02509065|113157|P6|NOT COMPLETED|Overall Study||0
47779|NCT02509065|113158|P5|NOT COMPLETED|Overall Study||0
47780|NCT02509065|113159|P4|NOT COMPLETED|Overall Study||0
47781|NCT02509065|113160|P3|NOT COMPLETED|Overall Study||0
47782|NCT02509065|113161|P2|NOT COMPLETED|Overall Study||0
47783|NCT02509065|113162|P1|NOT COMPLETED|Overall Study||0
47784|NCT02509065|113140|P23|COMPLETED|Overall Study||1
47785|NCT02509065|113141|P22|COMPLETED|Overall Study||1
47786|NCT02509065|113142|P21|COMPLETED|Overall Study||1
47787|NCT02509065|113143|P20|COMPLETED|Overall Study||1
47788|NCT02509065|113144|P19|COMPLETED|Overall Study||1
47789|NCT02509065|113145|P18|COMPLETED|Overall Study||1
47790|NCT02509065|113146|P17|COMPLETED|Overall Study||1
47791|NCT02509065|113147|P16|COMPLETED|Overall Study||1
47792|NCT02509065|113148|P15|COMPLETED|Overall Study||1
47793|NCT02509065|113149|P14|COMPLETED|Overall Study||1
47794|NCT02509065|113150|P13|COMPLETED|Overall Study||1
47795|NCT02509065|113151|P12|COMPLETED|Overall Study||1
47796|NCT02509065|113152|P11|COMPLETED|Overall Study||1
47797|NCT02509065|113153|P10|COMPLETED|Overall Study||1
47798|NCT02509065|113154|P9|COMPLETED|Overall Study||1
47799|NCT02509065|113155|P8|COMPLETED|Overall Study||1
47800|NCT02509065|113156|P7|COMPLETED|Overall Study||1
47801|NCT02509065|113157|P6|COMPLETED|Overall Study||1
47802|NCT02509065|113158|P5|COMPLETED|Overall Study||1
47803|NCT02509065|113159|P4|COMPLETED|Overall Study||1
47804|NCT02509065|113160|P3|COMPLETED|Overall Study||2
47805|NCT02509065|113161|P2|COMPLETED|Overall Study||1
47806|NCT02509065|113162|P1|COMPLETED|Overall Study||1
47807|NCT02509065|113140|P23|STARTED|Overall Study||1
47808|NCT02509065|113141|P22|STARTED|Overall Study||1
47809|NCT02509065|113142|P21|STARTED|Overall Study||1
47810|NCT02509065|113143|P20|STARTED|Overall Study||1
47811|NCT02509065|113144|P19|STARTED|Overall Study||1
47812|NCT02509065|113145|P18|STARTED|Overall Study||1
47813|NCT02509065|113146|P17|STARTED|Overall Study||1
47814|NCT02509065|113147|P16|STARTED|Overall Study||1
47815|NCT02509065|113148|P15|STARTED|Overall Study||1
47816|NCT02509065|113149|P14|STARTED|Overall Study||1
47817|NCT02509065|113150|P13|STARTED|Overall Study||1
47818|NCT02509065|113151|P12|STARTED|Overall Study||1
47819|NCT02509065|113152|P11|STARTED|Overall Study||1
47820|NCT02509065|113153|P10|STARTED|Overall Study||1
47821|NCT02509065|113154|P9|STARTED|Overall Study||1
47822|NCT02509065|113155|P8|STARTED|Overall Study||1
47823|NCT02509065|113156|P7|STARTED|Overall Study||1
47824|NCT02509065|113157|P6|STARTED|Overall Study||1
47825|NCT02509065|113158|P5|STARTED|Overall Study||1
47826|NCT02509065|113159|P4|STARTED|Overall Study||1
47827|NCT02509065|113160|P3|STARTED|Overall Study||2
47828|NCT02509065|113161|P2|STARTED|Overall Study||1
47829|NCT02509065|113162|P1|STARTED|Overall Study||1
47830|NCT02508701|113251|P4|NOT COMPLETED|Overall Study||3
47831|NCT02508701|113252|P3|NOT COMPLETED|Overall Study||5
47832|NCT02508701|113253|P2|NOT COMPLETED|Overall Study||5
47833|NCT02508701|113254|P1|NOT COMPLETED|Overall Study||9
47834|NCT02508701|113251|P4|COMPLETED|Overall Study||1
47835|NCT02508701|113252|P3|COMPLETED|Overall Study||0
47836|NCT02508701|113253|P2|COMPLETED|Overall Study||1
47837|NCT02508701|113254|P1|COMPLETED|Overall Study||0
47838|NCT02508701|113251|P4|STARTED|Overall Study||4
47839|NCT02508701|113252|P3|STARTED|Overall Study||5
47840|NCT02508701|113253|P2|STARTED|Overall Study||6
47841|NCT02508701|113254|P1|STARTED|Overall Study||9
47842|NCT02508259|113278|P2|NOT COMPLETED|Overall Study||0
47843|NCT02508259|113279|P1|NOT COMPLETED|Overall Study||0
47844|NCT02508259|113278|P2|COMPLETED|Overall Study||5
47845|NCT02508259|113279|P1|COMPLETED|Overall Study||5
47846|NCT02508259|113278|P2|STARTED|Overall Study||5
47847|NCT02508259|113279|P1|STARTED|Overall Study||5
47848|NCT02508207|113297|P2|NOT COMPLETED|Overall Study||0
47849|NCT02508207|113298|P1|NOT COMPLETED|Overall Study||0
47850|NCT02508207|113297|P2|COMPLETED|Overall Study||27
47851|NCT02508207|113298|P1|COMPLETED|Overall Study||7
47852|NCT02508207|113297|P2|STARTED|Overall Study||27
47853|NCT02508207|113298|P1|STARTED|Overall Study||7
47854|NCT02508194|113314|P2|NOT COMPLETED|Overall Study||44
47855|NCT02508194|113315|P1|NOT COMPLETED|Overall Study||52
47856|NCT02508194|113314|P2|COMPLETED|Overall Study||907
47857|NCT02508194|113315|P1|COMPLETED|Overall Study||897
47858|NCT02508194|113314|P2|STARTED|Overall Study||951
47859|NCT02508194|113315|P1|STARTED|Overall Study||949
47860|NCT02508116|113355|P2|NOT COMPLETED|Overall Study||7
47861|NCT02508116|113356|P1|NOT COMPLETED|Overall Study||8
47862|NCT02508116|113355|P2|COMPLETED|Overall Study||250
47863|NCT02508116|113356|P1|COMPLETED|Overall Study||244
47864|NCT02508116|113355|P2|Received Intervention as Randomized|Overall Study||255
47865|NCT02508116|113356|P1|Received Intervention as Randomized|Overall Study||249
47866|NCT02508116|113355|P2|STARTED|Overall Study||257
47867|NCT02508116|113356|P1|STARTED|Overall Study||252
47868|NCT02508103|113370|P2|NOT COMPLETED|Overall Study||0
47869|NCT02508103|113371|P1|NOT COMPLETED|Overall Study||0
47870|NCT02508103|113370|P2|COMPLETED|Overall Study||5
47871|NCT02508103|113371|P1|COMPLETED|Overall Study||5
47872|NCT02508103|113370|P2|STARTED|Overall Study||5
47873|NCT02508103|113371|P1|STARTED|Overall Study||5
47874|NCT02508077|113379|P1|NOT COMPLETED|Overall Study||0
47875|NCT02508077|113379|P1|COMPLETED|Overall Study||1
47876|NCT02508077|113379|P1|STARTED|Overall Study||1
47877|NCT02507752|113383|P1|NOT COMPLETED|Overall Study||17
47878|NCT02507752|113383|P1|COMPLETED|Overall Study||55
47879|NCT02507752|113383|P1|STARTED|Overall Study||72
47880|NCT02507388|113403|P2|NOT COMPLETED|Overall Study||0
47881|NCT02507388|113404|P1|NOT COMPLETED|Overall Study||0
47882|NCT02507388|113403|P2|COMPLETED|Overall Study||25
47883|NCT02507388|113404|P1|COMPLETED|Overall Study||25
47884|NCT02507388|113403|P2|STARTED|Overall Study||25
47885|NCT02507388|113404|P1|STARTED|Overall Study||25
47886|NCT02507375|113427|P2|NOT COMPLETED|Overall Study||8
47887|NCT02507375|113428|P1|NOT COMPLETED|Overall Study||4
47888|NCT02507375|113427|P2|COMPLETED|Overall Study||1
47889|NCT02507375|113428|P1|COMPLETED|Overall Study||2
47890|NCT02507375|113427|P2|Extension Period|Overall Study||1
47891|NCT02507375|113428|P1|Extension Period|Overall Study||2
47892|NCT02507375|113427|P2|Cycle 6|Overall Study||1
47893|NCT02507375|113428|P1|Cycle 6|Overall Study||3
47894|NCT02507375|113427|P2|Cycle 5|Overall Study||1
47895|NCT02507375|113428|P1|Cycle 5|Overall Study||3
47896|NCT02507375|113427|P2|Cycle 4|Overall Study||2
47897|NCT02507375|113428|P1|Cycle 4|Overall Study||4
47898|NCT02507375|113427|P2|Cycle 3|Overall Study||5
47899|NCT02507375|113428|P1|Cycle 3|Overall Study||4
47900|NCT02507375|113427|P2|Cycle 2|Overall Study||5
47901|NCT02507375|113428|P1|Cycle 2|Overall Study||5
47902|NCT02507375|113427|P2|Received Pertuzumab|Overall Study||6
47903|NCT02507375|113428|P1|Received Pertuzumab|Overall Study||6
47904|NCT02507375|113427|P2|Cycle 1|Overall Study||9
47905|NCT02507375|113428|P1|Cycle 1|Overall Study||6
47906|NCT02507375|113427|P2|STARTED|Overall Study|Two patients in cohort 2 did not begin treatment in Cycle 1 so were not included in the analysis set|9
47907|NCT02507375|113428|P1|STARTED|Overall Study||6
47908|NCT02507349|113447|P2|NOT COMPLETED|Overall Study||161
47909|NCT02507349|113448|P1|NOT COMPLETED|Overall Study||187
47910|NCT02507349|113447|P2|COMPLETED|Overall Study||1050
47911|NCT02507349|113448|P1|COMPLETED|Overall Study||1045
47912|NCT02507349|113447|P2|STARTED|Overall Study||1211
47913|NCT02507349|113448|P1|STARTED|Overall Study||1232
47914|NCT02507219|113472|P6|NOT COMPLETED|Overall Study||0
47915|NCT02507219|113473|P5|NOT COMPLETED|Overall Study||1
47916|NCT02507219|113474|P4|NOT COMPLETED|Overall Study||0
47917|NCT02507219|113475|P3|NOT COMPLETED|Overall Study||0
47918|NCT02507219|113476|P2|NOT COMPLETED|Overall Study||0
47919|NCT02507219|113477|P1|NOT COMPLETED|Overall Study||1
47920|NCT02507219|113472|P6|COMPLETED|Overall Study||3
47921|NCT02507219|113473|P5|COMPLETED|Overall Study||3
47922|NCT02507219|113474|P4|COMPLETED|Overall Study||3
47923|NCT02507219|113475|P3|COMPLETED|Overall Study||3
47924|NCT02507219|113476|P2|COMPLETED|Overall Study||4
47925|NCT02507219|113477|P1|COMPLETED|Overall Study||4
47926|NCT02507219|113472|P6|STARTED|Overall Study||3
47927|NCT02507219|113473|P5|STARTED|Overall Study||4
47928|NCT02507219|113474|P4|STARTED|Overall Study||3
47929|NCT02507219|113475|P3|STARTED|Overall Study||3
47930|NCT02507219|113476|P2|STARTED|Overall Study||4
47931|NCT02507219|113477|P1|STARTED|Overall Study||5
47932|NCT02506985|113487|P2|NOT COMPLETED|Overall Study||0
47933|NCT02506985|113488|P1|NOT COMPLETED|Overall Study||0
47934|NCT02506985|113487|P2|COMPLETED|Overall Study||6
47935|NCT02506985|113488|P1|COMPLETED|Overall Study||4
47936|NCT02506985|113487|P2|STARTED|Overall Study||6
47937|NCT02506985|113488|P1|STARTED|Overall Study||4
47938|NCT02506881|113506|P4|NOT COMPLETED|Second Intervention (Day 1)||0
47939|NCT02506881|113507|P3|NOT COMPLETED|Second Intervention (Day 1)||0
47940|NCT02506881|113508|P2|NOT COMPLETED|Second Intervention (Day 1)||0
47941|NCT02506881|113509|P1|NOT COMPLETED|Second Intervention (Day 1)||0
47942|NCT02506881|113506|P4|COMPLETED|Second Intervention (Day 1)||12
47943|NCT02506881|113507|P3|COMPLETED|Second Intervention (Day 1)||12
47944|NCT02506881|113508|P2|COMPLETED|Second Intervention (Day 1)||12
47945|NCT02506881|113509|P1|COMPLETED|Second Intervention (Day 1)||12
47946|NCT02506881|113506|P4|STARTED|Second Intervention (Day 1)||12
47947|NCT02506881|113507|P3|STARTED|Second Intervention (Day 1)||12
47948|NCT02506881|113508|P2|STARTED|Second Intervention (Day 1)||12
47949|NCT02506881|113509|P1|STARTED|Second Intervention (Day 1)||12
47950|NCT02506881|113506|P4|NOT COMPLETED|Washout (at Least 25 Days)||0
47951|NCT02506881|113507|P3|NOT COMPLETED|Washout (at Least 25 Days)||0
47952|NCT02506881|113508|P2|NOT COMPLETED|Washout (at Least 25 Days)||0
47953|NCT02506881|113509|P1|NOT COMPLETED|Washout (at Least 25 Days)||0
47954|NCT02506881|113506|P4|COMPLETED|Washout (at Least 25 Days)||12
47955|NCT02506881|113507|P3|COMPLETED|Washout (at Least 25 Days)||12
47956|NCT02506881|113508|P2|COMPLETED|Washout (at Least 25 Days)||12
47957|NCT02506881|113509|P1|COMPLETED|Washout (at Least 25 Days)||12
47958|NCT02506881|113506|P4|STARTED|Washout (at Least 25 Days)||12
47959|NCT02506881|113507|P3|STARTED|Washout (at Least 25 Days)||12
47960|NCT02506881|113508|P2|STARTED|Washout (at Least 25 Days)||12
47961|NCT02506881|113509|P1|STARTED|Washout (at Least 25 Days)||12
47962|NCT02506881|113506|P4|NOT COMPLETED|First Intervention (Day 1)||12
47963|NCT02506881|113507|P3|NOT COMPLETED|First Intervention (Day 1)||13
47964|NCT02506881|113508|P2|NOT COMPLETED|First Intervention (Day 1)||0
47965|NCT02506881|113509|P1|NOT COMPLETED|First Intervention (Day 1)||1
47966|NCT02506881|113506|P4|COMPLETED|First Intervention (Day 1)||12
47967|NCT02506881|113507|P3|COMPLETED|First Intervention (Day 1)||12
47968|NCT02506881|113508|P2|COMPLETED|First Intervention (Day 1)||12
47969|NCT02506881|113509|P1|COMPLETED|First Intervention (Day 1)||12
47970|NCT02506881|113506|P4|STARTED|First Intervention (Day 1)||24
47971|NCT02506881|113507|P3|STARTED|First Intervention (Day 1)||25
47972|NCT02506881|113508|P2|STARTED|First Intervention (Day 1)||12
47973|NCT02506881|113509|P1|STARTED|First Intervention (Day 1)||13
47974|NCT02506868|113545|P2|NOT COMPLETED|Additional Period of Study (Until 52W)||5
47975|NCT02506868|113546|P1|NOT COMPLETED|Additional Period of Study (Until 52W)||3
47976|NCT02506868|113545|P2|COMPLETED|Additional Period of Study (Until 52W)||85
47977|NCT02506868|113546|P1|COMPLETED|Additional Period of Study (Until 52W)||83
47978|NCT02506868|113545|P2|STARTED|Additional Period of Study (Until 52W)||90
47979|NCT02506868|113546|P1|STARTED|Additional Period of Study (Until 52W)||86
47980|NCT02506868|113545|P2|NOT COMPLETED|Main Period of Study (24 Weeks)||8
47981|NCT02506868|113546|P1|NOT COMPLETED|Main Period of Study (24 Weeks)||12
47982|NCT02506868|113545|P2|COMPLETED|Main Period of Study (24 Weeks)||90
47983|NCT02506868|113546|P1|COMPLETED|Main Period of Study (24 Weeks)||86
47984|NCT02506868|113545|P2|Per Protocol Population|Main Period of Study (24 Weeks)||90
47985|NCT02506868|113546|P1|Per Protocol Population|Main Period of Study (24 Weeks)||86
47986|NCT02506868|113545|P2|mITT Population|Main Period of Study (24 Weeks)|One patient from Aranesp group was excluded prior to the first administration|97
47987|NCT02506868|113546|P1|mITT Population|Main Period of Study (24 Weeks)||98
47988|NCT02506868|113545|P2|STARTED|Main Period of Study (24 Weeks)||98
47989|NCT02506868|113546|P1|STARTED|Main Period of Study (24 Weeks)||98
47990|NCT02506816|113582|P1|NOT COMPLETED|Overall Study||3
47991|NCT02506816|113582|P1|COMPLETED|Overall Study||33
47992|NCT02506816|113582|P1|Samples Availability|Overall Study|31 of 36 patients had valid samples for analysis of biomarkers (primary and secondary analysis)|31
47993|NCT02506816|113582|P1|STARTED|Overall Study||36
47994|NCT02506660|113591|P2|NOT COMPLETED|Overall Study||1
47995|NCT02506660|113592|P1|NOT COMPLETED|Overall Study||2
47996|NCT02506660|113591|P2|COMPLETED|Overall Study||63
47997|NCT02506660|113592|P1|COMPLETED|Overall Study||62
47998|NCT02506660|113591|P2|STARTED|Overall Study||64
47999|NCT02506660|113592|P1|STARTED|Overall Study||64
48000|NCT02506309|113612|P2|NOT COMPLETED|Overall Study||1
48001|NCT02506309|113613|P1|NOT COMPLETED|Overall Study||2
48002|NCT02506309|113612|P2|COMPLETED|Overall Study||44
48003|NCT02506309|113613|P1|COMPLETED|Overall Study||46
48004|NCT02506309|113612|P2|STARTED|Overall Study||45
48005|NCT02506309|113613|P1|STARTED|Overall Study||48
48006|NCT02506257|113629|P4|NOT COMPLETED|Overall Study||0
48007|NCT02506257|113630|P3|NOT COMPLETED|Overall Study||4
48008|NCT02506257|113631|P2|NOT COMPLETED|Overall Study||2
48009|NCT02506257|113632|P1|NOT COMPLETED|Overall Study||0
48010|NCT02506257|113629|P4|COMPLETED|Overall Study||9
48011|NCT02506257|113630|P3|COMPLETED|Overall Study||23
48012|NCT02506257|113631|P2|COMPLETED|Overall Study||26
48013|NCT02506257|113632|P1|COMPLETED|Overall Study||26
48014|NCT02506257|113629|P4|STARTED|Overall Study||9
48015|NCT02506257|113630|P3|STARTED|Overall Study||27
48016|NCT02506257|113631|P2|STARTED|Overall Study||28
48017|NCT02506257|113632|P1|STARTED|Overall Study||26
48018|NCT02506101|113664|P2|NOT COMPLETED|Overall Study||0
48019|NCT02506101|113665|P1|NOT COMPLETED|Overall Study||2
48020|NCT02506101|113664|P2|COMPLETED|Overall Study||0
48021|NCT02506101|113665|P1|COMPLETED|Overall Study||0
48022|NCT02506101|113664|P2|STARTED|Overall Study||0
48023|NCT02506101|113665|P1|STARTED|Overall Study||2
48024|NCT02506036|113681|P2|NOT COMPLETED|Second Intervention (4-6 Weeks)||0
48025|NCT02506036|113682|P1|NOT COMPLETED|Second Intervention (4-6 Weeks)||0
48026|NCT02506036|113681|P2|COMPLETED|Second Intervention (4-6 Weeks)||1
48027|NCT02506036|113682|P1|COMPLETED|Second Intervention (4-6 Weeks)||2
48028|NCT02506036|113681|P2|STARTED|Second Intervention (4-6 Weeks)||1
48029|NCT02506036|113682|P1|STARTED|Second Intervention (4-6 Weeks)||2
48030|NCT02506036|113681|P2|NOT COMPLETED|Washout (1-2 Weeks)||0
48031|NCT02506036|113682|P1|NOT COMPLETED|Washout (1-2 Weeks)||0
48032|NCT02506036|113681|P2|COMPLETED|Washout (1-2 Weeks)||1
48033|NCT02506036|113682|P1|COMPLETED|Washout (1-2 Weeks)||2
48034|NCT02506036|113681|P2|STARTED|Washout (1-2 Weeks)||1
48035|NCT02506036|113682|P1|STARTED|Washout (1-2 Weeks)||2
48036|NCT02506036|113681|P2|NOT COMPLETED|First Intervention (4-6 Weeks)||2
48037|NCT02506036|113682|P1|NOT COMPLETED|First Intervention (4-6 Weeks)||1
48038|NCT02506036|113681|P2|COMPLETED|First Intervention (4-6 Weeks)||1
48039|NCT02506036|113682|P1|COMPLETED|First Intervention (4-6 Weeks)||2
48040|NCT02506036|113681|P2|STARTED|First Intervention (4-6 Weeks)||3
48041|NCT02506036|113682|P1|STARTED|First Intervention (4-6 Weeks)||3
48042|NCT02505945|113690|P2|NOT COMPLETED|Overall Study||4
48043|NCT02505945|113691|P1|NOT COMPLETED|Overall Study||22
48044|NCT02505945|113690|P2|COMPLETED|Overall Study||46
48045|NCT02505945|113691|P1|COMPLETED|Overall Study||80
48046|NCT02505945|113690|P2|STARTED|Overall Study||50
48047|NCT02505945|113691|P1|STARTED|Overall Study||102
48048|NCT02505867|113701|P2|NOT COMPLETED|Overall Study||6
48049|NCT02505867|113702|P1|NOT COMPLETED|Overall Study||6
48050|NCT02505867|113701|P2|COMPLETED|Overall Study||0
48051|NCT02505867|113702|P1|COMPLETED|Overall Study||0
48052|NCT02505867|113701|P2|STARTED|Overall Study||6
48053|NCT02505867|113702|P1|STARTED|Overall Study||6
48054|NCT02505334|113710|P2|NOT COMPLETED|Extension Treatment Period||0
48055|NCT02505334|113711|P1|NOT COMPLETED|Extension Treatment Period||18
48056|NCT02505334|113710|P2|COMPLETED|Extension Treatment Period||0
48057|NCT02505334|113711|P1|COMPLETED|Extension Treatment Period||194
48058|NCT02505334|113710|P2|STARTED|Extension Treatment Period|This treatment arm is not considered for this period as the subjects were treated for 26 weeks|0
48059|NCT02505334|113711|P1|STARTED|Extension Treatment Period|6 subjects withdrew from the trial after the main period and prior to entering the extension period|212
48060|NCT02505334|113710|P2|NOT COMPLETED|Main Treatment Period||39
48061|NCT02505334|113711|P1|NOT COMPLETED|Main Treatment Period||15
48062|NCT02505334|113710|P2|COMPLETED|Main Treatment Period||194
48063|NCT02505334|113711|P1|COMPLETED|Main Treatment Period||218
48064|NCT02505334|113710|P2|STARTED|Main Treatment Period||233
48065|NCT02505334|113711|P1|STARTED|Main Treatment Period||233
48066|NCT02504931|113838|P2|NOT COMPLETED|Overall Study||10
48067|NCT02504931|113839|P1|NOT COMPLETED|Overall Study||12
48068|NCT02504931|113838|P2|COMPLETED|Overall Study||13
48069|NCT02504931|113839|P1|COMPLETED|Overall Study||14
48070|NCT02504931|113838|P2|STARTED|Overall Study||23
48071|NCT02504931|113839|P1|STARTED|Overall Study||26
48072|NCT02504892|113847|P1|NOT COMPLETED|Overall Study||2
48073|NCT02504892|113847|P1|COMPLETED|Overall Study||1
48074|NCT02504892|113847|P1|STARTED|Overall Study||3
48075|NCT02504827|113854|P1|NOT COMPLETED|Overall Study||1
48076|NCT02504827|113854|P1|COMPLETED|Overall Study||11
48077|NCT02504827|113854|P1|STARTED|Overall Study||12
48078|NCT02504775|113859|P2|NOT COMPLETED|Period 2||0
48079|NCT02504775|113860|P1|NOT COMPLETED|Period 2||0
48080|NCT02504775|113859|P2|COMPLETED|Period 2||14
48081|NCT02504775|113860|P1|COMPLETED|Period 2||14
48082|NCT02504775|113859|P2|STARTED|Period 2||14
48083|NCT02504775|113860|P1|STARTED|Period 2||14
48084|NCT02504775|113859|P2|NOT COMPLETED|Washout||0
48085|NCT02504775|113860|P1|NOT COMPLETED|Washout||0
48086|NCT02504775|113859|P2|COMPLETED|Washout||14
48087|NCT02504775|113860|P1|COMPLETED|Washout||14
48088|NCT02504775|113859|P2|STARTED|Washout||14
48089|NCT02504775|113860|P1|STARTED|Washout||14
48090|NCT02504775|113859|P2|NOT COMPLETED|Period 1||0
48091|NCT02504775|113860|P1|NOT COMPLETED|Period 1||0
48092|NCT02504775|113859|P2|COMPLETED|Period 1||14
48093|NCT02504775|113860|P1|COMPLETED|Period 1||14
48094|NCT02504775|113859|P2|STARTED|Period 1||14
48095|NCT02504775|113860|P1|STARTED|Period 1||14
48096|NCT02504723|113874|P2|NOT COMPLETED|Overall Study||0
48097|NCT02504723|113875|P1|NOT COMPLETED|Overall Study||0
48098|NCT02504723|113874|P2|COMPLETED|Overall Study||61
48099|NCT02504723|113875|P1|COMPLETED|Overall Study||60
48100|NCT02504723|113874|P2|STARTED|Overall Study||61
48101|NCT02504723|113875|P1|STARTED|Overall Study||60
48102|NCT02504671|113893|P6|NOT COMPLETED|Overall Study||14
48103|NCT02504671|113894|P5|NOT COMPLETED|Overall Study||12
48104|NCT02504671|113895|P4|NOT COMPLETED|Overall Study||10
48105|NCT02504671|113896|P3|NOT COMPLETED|Overall Study||10
48106|NCT02504671|113897|P2|NOT COMPLETED|Overall Study||14
48107|NCT02504671|113898|P1|NOT COMPLETED|Overall Study||12
48108|NCT02504671|113893|P6|COMPLETED|Overall Study||23
48109|NCT02504671|113894|P5|COMPLETED|Overall Study||25
48110|NCT02504671|113895|P4|COMPLETED|Overall Study||27
48111|NCT02504671|113896|P3|COMPLETED|Overall Study||27
48112|NCT02504671|113897|P2|COMPLETED|Overall Study||23
48113|NCT02504671|113898|P1|COMPLETED|Overall Study||25
48114|NCT02504671|113893|P6|STARTED|Overall Study||37
48115|NCT02504671|113894|P5|STARTED|Overall Study||37
48116|NCT02504671|113895|P4|STARTED|Overall Study||37
48117|NCT02504671|113896|P3|STARTED|Overall Study||37
48118|NCT02504671|113897|P2|STARTED|Overall Study||37
48119|NCT02504671|113898|P1|STARTED|Overall Study||37
48120|NCT02504645|114040|P2|NOT COMPLETED|Overall Study||25
48121|NCT02504645|114041|P1|NOT COMPLETED|Overall Study||24
48122|NCT02504645|114040|P2|COMPLETED|Overall Study||76
48123|NCT02504645|114041|P1|COMPLETED|Overall Study||77
48124|NCT02504645|114040|P2|STARTED|Overall Study||101
48125|NCT02504645|114041|P1|STARTED|Overall Study||101
48126|NCT02504619|114049|P1|NOT COMPLETED|Overall Study||0
48127|NCT02504619|114049|P1|COMPLETED|Overall Study||1
48128|NCT02504619|114049|P1|STARTED|Overall Study||1
48129|NCT02504541|114055|P1|NOT COMPLETED|Overall Study||20
48130|NCT02504541|114055|P1|COMPLETED|Overall Study||113
48131|NCT02504541|114055|P1|STARTED|Overall Study||133
48132|NCT02504502|114061|P2|NOT COMPLETED|Crossover to Enhanced Report||0
48133|NCT02504502|114062|P1|NOT COMPLETED|Crossover to Enhanced Report||5
48134|NCT02504502|114061|P2|COMPLETED|Crossover to Enhanced Report|the enhanced report arm was completed in first period and does not carry forward to period 2|0
48135|NCT02504502|114062|P1|COMPLETED|Crossover to Enhanced Report||15
48136|NCT02504502|114061|P2|STARTED|Crossover to Enhanced Report|The enhanced report arm was completed in first period and does not carry forward to period 2.|0
48137|NCT02504502|114062|P1|STARTED|Crossover to Enhanced Report||20
48138|NCT02504502|114061|P2|NOT COMPLETED|Routine Care vs. Enhanced Report||7
48139|NCT02504502|114062|P1|NOT COMPLETED|Routine Care vs. Enhanced Report||4
48140|NCT02504502|114061|P2|COMPLETED|Routine Care vs. Enhanced Report||21
48141|NCT02504502|114062|P1|COMPLETED|Routine Care vs. Enhanced Report||20
48142|NCT02504502|114061|P2|STARTED|Routine Care vs. Enhanced Report||28
48143|NCT02504502|114062|P1|STARTED|Routine Care vs. Enhanced Report||24
48144|NCT02504424|114068|P1|NOT COMPLETED|Overall Study||2
48145|NCT02504424|114068|P1|COMPLETED|Overall Study||48
48146|NCT02504424|114068|P1|STARTED|Overall Study||50
48147|NCT02504320|114077|P4|NOT COMPLETED|Treatment Period 4||0
48148|NCT02504320|114078|P3|NOT COMPLETED|Treatment Period 4||0
48149|NCT02504320|114079|P2|NOT COMPLETED|Treatment Period 4||0
48150|NCT02504320|114080|P1|NOT COMPLETED|Treatment Period 4||0
48151|NCT02504320|114077|P4|COMPLETED|Treatment Period 4||19
48152|NCT02504320|114078|P3|COMPLETED|Treatment Period 4||18
48153|NCT02504320|114079|P2|COMPLETED|Treatment Period 4||18
48154|NCT02504320|114080|P1|COMPLETED|Treatment Period 4||19
48155|NCT02504320|114077|P4|STARTED|Treatment Period 4||19
48156|NCT02504320|114078|P3|STARTED|Treatment Period 4||18
48157|NCT02504320|114079|P2|STARTED|Treatment Period 4||18
48158|NCT02504320|114080|P1|STARTED|Treatment Period 4||19
48159|NCT02504320|114077|P4|NOT COMPLETED|Treatment Period 3||1
48160|NCT02504320|114078|P3|NOT COMPLETED|Treatment Period 3||1
48161|NCT02504320|114079|P2|NOT COMPLETED|Treatment Period 3||0
48162|NCT02504320|114080|P1|NOT COMPLETED|Treatment Period 3||0
48163|NCT02504320|114077|P4|COMPLETED|Treatment Period 3||19
48164|NCT02504320|114078|P3|COMPLETED|Treatment Period 3||18
48165|NCT02504320|114079|P2|COMPLETED|Treatment Period 3||18
48166|NCT02504320|114080|P1|COMPLETED|Treatment Period 3||19
48167|NCT02504320|114077|P4|STARTED|Treatment Period 3||20
48168|NCT02504320|114078|P3|STARTED|Treatment Period 3||19
48169|NCT02504320|114079|P2|STARTED|Treatment Period 3||18
48170|NCT02504320|114080|P1|STARTED|Treatment Period 3||19
48171|NCT02504320|114077|P4|NOT COMPLETED|Treatment Period 2||0
48172|NCT02504320|114078|P3|NOT COMPLETED|Treatment Period 2||0
48173|NCT02504320|114079|P2|NOT COMPLETED|Treatment Period 2||1
48174|NCT02504320|114080|P1|NOT COMPLETED|Treatment Period 2||0
48175|NCT02504320|114077|P4|COMPLETED|Treatment Period 2||20
48176|NCT02504320|114078|P3|COMPLETED|Treatment Period 2||19
48177|NCT02504320|114079|P2|COMPLETED|Treatment Period 2||18
48178|NCT02504320|114080|P1|COMPLETED|Treatment Period 2||19
48179|NCT02504320|114077|P4|STARTED|Treatment Period 2||20
48180|NCT02504320|114078|P3|STARTED|Treatment Period 2||19
48181|NCT02504320|114079|P2|STARTED|Treatment Period 2||19
48182|NCT02504320|114080|P1|STARTED|Treatment Period 2||19
48183|NCT02504320|114077|P4|NOT COMPLETED|Treatment Period 1||0
48184|NCT02504320|114078|P3|NOT COMPLETED|Treatment Period 1||1
48185|NCT02504320|114079|P2|NOT COMPLETED|Treatment Period 1||0
48186|NCT02504320|114080|P1|NOT COMPLETED|Treatment Period 1||0
48187|NCT02504320|114077|P4|COMPLETED|Treatment Period 1||20
48188|NCT02504320|114078|P3|COMPLETED|Treatment Period 1||19
48189|NCT02504320|114079|P2|COMPLETED|Treatment Period 1||19
48190|NCT02504320|114080|P1|COMPLETED|Treatment Period 1||19
48191|NCT02504320|114077|P4|STARTED|Treatment Period 1||20
48192|NCT02504320|114078|P3|STARTED|Treatment Period 1||20
48193|NCT02504320|114079|P2|STARTED|Treatment Period 1||19
48194|NCT02504320|114080|P1|STARTED|Treatment Period 1||19
48195|NCT02504294|114100|P2|NOT COMPLETED|Overall Study||48
48196|NCT02504294|114101|P1|NOT COMPLETED|Overall Study||56
48197|NCT02504294|114100|P2|COMPLETED|Overall Study||158
48198|NCT02504294|114101|P1|COMPLETED|Overall Study||156
48199|NCT02504294|114100|P2|STARTED|Overall Study||206
48200|NCT02504294|114101|P1|STARTED|Overall Study||212
48201|NCT02504268|114111|P2|NOT COMPLETED|Overall Study||68
48202|NCT02504268|114112|P1|NOT COMPLETED|Overall Study||63
48203|NCT02504268|114111|P2|COMPLETED|Overall Study||233
48204|NCT02504268|114112|P1|COMPLETED|Overall Study||388
48205|NCT02504268|114111|P2|STARTED|Overall Study||301
48206|NCT02504268|114112|P1|STARTED|Overall Study||451
48207|NCT02504099|114126|P1|NOT COMPLETED|Overall Study||0
48208|NCT02504099|114126|P1|COMPLETED|Overall Study||3
48209|NCT02504099|114126|P1|STARTED|Overall Study||3
48210|NCT02504073|114134|P1|NOT COMPLETED|Overall Study||0
48211|NCT02504073|114134|P1|COMPLETED|Overall Study||54
48212|NCT02504073|114134|P1|STARTED|Overall Study||54
48213|NCT02503982|114140|P1|NOT COMPLETED|Overall Study||0
48214|NCT02503982|114140|P1|COMPLETED|Overall Study||13
48215|NCT02503982|114140|P1|STARTED|Overall Study||13
48216|NCT02503865|114147|P3|NOT COMPLETED|Overall Study||2
48217|NCT02503865|114148|P2|NOT COMPLETED|Overall Study||47
48218|NCT02503865|114149|P1|NOT COMPLETED|Overall Study||5
48219|NCT02503865|114147|P3|COMPLETED|Overall Study||64
48220|NCT02503865|114148|P2|COMPLETED|Overall Study||222
48221|NCT02503865|114149|P1|COMPLETED|Overall Study||65
48222|NCT02503865|114147|P3|STARTED|Overall Study||66
48223|NCT02503865|114148|P2|STARTED|Overall Study||269
48224|NCT02503865|114149|P1|STARTED|Overall Study||70
48225|NCT02503787|114169|P1|NOT COMPLETED|Implant to 3 Month Endpoint||3
48226|NCT02503787|114169|P1|COMPLETED|Implant to 3 Month Endpoint||29
48227|NCT02503787|114169|P1|STARTED|Implant to 3 Month Endpoint||32
48228|NCT02503787|114169|P1|NOT COMPLETED|Successful Trial (≥50% Pain Relief)||5
48229|NCT02503787|114169|P1|COMPLETED|Successful Trial (≥50% Pain Relief)||32
48230|NCT02503787|114169|P1|STARTED|Successful Trial (≥50% Pain Relief)||37
48231|NCT02503787|114169|P1|NOT COMPLETED|Device Trial (HD Programming Trial)||7
48232|NCT02503787|114169|P1|COMPLETED|Device Trial (HD Programming Trial)||37
48233|NCT02503787|114169|P1|STARTED|Device Trial (HD Programming Trial)||44
48234|NCT02503787|114169|P1|NOT COMPLETED|Enrollment||20
48235|NCT02503787|114169|P1|COMPLETED|Enrollment||44
48236|NCT02503787|114169|P1|STARTED|Enrollment||64
48237|NCT02503410|114178|P2|NOT COMPLETED|Overall Study||0
48238|NCT02503410|114179|P1|NOT COMPLETED|Overall Study||0
48239|NCT02503410|114178|P2|COMPLETED|Overall Study||3
48240|NCT02503410|114179|P1|COMPLETED|Overall Study||4
48241|NCT02503410|114178|P2|STARTED|Overall Study||3
48242|NCT02503410|114179|P1|STARTED|Overall Study||4
48243|NCT02503254|114201|P2|NOT COMPLETED|Overall Study||0
48244|NCT02503254|114202|P1|NOT COMPLETED|Overall Study||0
48245|NCT02503254|114201|P2|COMPLETED|Overall Study||39
48246|NCT02503254|114202|P1|COMPLETED|Overall Study||41
48247|NCT02503254|114201|P2|STARTED|Overall Study||39
48248|NCT02503254|114202|P1|STARTED|Overall Study||41
48249|NCT02503215|114215|P1|NOT COMPLETED|Overall Study||3
48250|NCT02503215|114215|P1|COMPLETED|Overall Study||14
48251|NCT02503215|114215|P1|STARTED|Overall Study||17
48252|NCT02503202|114226|P5|NOT COMPLETED|Extension: Month 6 to 24||1
48253|NCT02503202|114227|P4|NOT COMPLETED|Extension: Month 6 to 24||18
48254|NCT02503202|114228|P3|NOT COMPLETED|Extension: Month 6 to 24||9
48255|NCT02503202|114229|P2|NOT COMPLETED|Extension: Month 6 to 24||16
48256|NCT02503202|114230|P1|NOT COMPLETED|Extension: Month 6 to 24||11
48257|NCT02503202|114226|P5|COMPLETED|Extension: Month 6 to 24||67
48258|NCT02503202|114227|P4|COMPLETED|Extension: Month 6 to 24||119
48259|NCT02503202|114228|P3|COMPLETED|Extension: Month 6 to 24||103
48260|NCT02503202|114229|P2|COMPLETED|Extension: Month 6 to 24||114
48261|NCT02503202|114230|P1|COMPLETED|Extension: Month 6 to 24||108
48262|NCT02503202|114226|P5|STARTED|Extension: Month 6 to 24||68
48263|NCT02503202|114227|P4|STARTED|Extension: Month 6 to 24||137
48264|NCT02503202|114228|P3|STARTED|Extension: Month 6 to 24||112
48265|NCT02503202|114229|P2|STARTED|Extension: Month 6 to 24||130
48266|NCT02503202|114230|P1|STARTED|Extension: Month 6 to 24||119
48267|NCT02503202|114226|P5|NOT COMPLETED|Base Study: Up to Month 6||3
48268|NCT02503202|114227|P4|NOT COMPLETED|Base Study: Up to Month 6||11
48269|NCT02503202|114228|P3|NOT COMPLETED|Base Study: Up to Month 6||15
48270|NCT02503202|114229|P2|NOT COMPLETED|Base Study: Up to Month 6||12
48271|NCT02503202|114230|P1|NOT COMPLETED|Base Study: Up to Month 6||18
48272|NCT02503202|114226|P5|COMPLETED|Base Study: Up to Month 6||130
48273|NCT02503202|114227|P4|COMPLETED|Base Study: Up to Month 6||255
48274|NCT02503202|114228|P3|COMPLETED|Base Study: Up to Month 6||252
48275|NCT02503202|114229|P2|COMPLETED|Base Study: Up to Month 6||253
48276|NCT02503202|114230|P1|COMPLETED|Base Study: Up to Month 6||248
48277|NCT02503202|114226|P5|Vaccinated|Base Study: Up to Month 6||133
48278|NCT02503202|114227|P4|Vaccinated|Base Study: Up to Month 6||264
48279|NCT02503202|114228|P3|Vaccinated|Base Study: Up to Month 6||266
48280|NCT02503202|114229|P2|Vaccinated|Base Study: Up to Month 6||265
48281|NCT02503202|114230|P1|Vaccinated|Base Study: Up to Month 6||266
48282|NCT02503202|114226|P5|STARTED|Base Study: Up to Month 6||133
48283|NCT02503202|114227|P4|STARTED|Base Study: Up to Month 6||266
48284|NCT02503202|114228|P3|STARTED|Base Study: Up to Month 6||267
48285|NCT02503202|114229|P2|STARTED|Base Study: Up to Month 6||265
48286|NCT02503202|114230|P1|STARTED|Base Study: Up to Month 6||266
48287|NCT02503085|114272|P4|NOT COMPLETED|Period 4||0
48288|NCT02503085|114273|P3|NOT COMPLETED|Period 4||0
48289|NCT02503085|114274|P2|NOT COMPLETED|Period 4||0
48290|NCT02503085|114275|P1|NOT COMPLETED|Period 4||0
48291|NCT02503085|114272|P4|COMPLETED|Period 4||7
48292|NCT02503085|114273|P3|COMPLETED|Period 4||6
48293|NCT02503085|114274|P2|COMPLETED|Period 4||7
48294|NCT02503085|114275|P1|COMPLETED|Period 4||6
48295|NCT02503085|114272|P4|STARTED|Period 4||7
48296|NCT02503085|114273|P3|STARTED|Period 4||6
48297|NCT02503085|114274|P2|STARTED|Period 4||7
48298|NCT02503085|114275|P1|STARTED|Period 4||6
48299|NCT02503085|114272|P4|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
48300|NCT02503085|114273|P3|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
48301|NCT02503085|114274|P2|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
48302|NCT02503085|114275|P1|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
48303|NCT02503085|114272|P4|COMPLETED|Period 3: Washout (3 to 7 Days)||7
48304|NCT02503085|114273|P3|COMPLETED|Period 3: Washout (3 to 7 Days)||6
48305|NCT02503085|114274|P2|COMPLETED|Period 3: Washout (3 to 7 Days)||7
48306|NCT02503085|114275|P1|COMPLETED|Period 3: Washout (3 to 7 Days)||6
48307|NCT02503085|114272|P4|STARTED|Period 3: Washout (3 to 7 Days)||7
48308|NCT02503085|114273|P3|STARTED|Period 3: Washout (3 to 7 Days)||6
48309|NCT02503085|114274|P2|STARTED|Period 3: Washout (3 to 7 Days)||7
48310|NCT02503085|114275|P1|STARTED|Period 3: Washout (3 to 7 Days)||6
48311|NCT02503085|114272|P4|NOT COMPLETED|Period 3||0
48312|NCT02503085|114273|P3|NOT COMPLETED|Period 3||0
48313|NCT02503085|114274|P2|NOT COMPLETED|Period 3||0
48314|NCT02503085|114275|P1|NOT COMPLETED|Period 3||0
48315|NCT02503085|114272|P4|COMPLETED|Period 3||7
48316|NCT02503085|114273|P3|COMPLETED|Period 3||6
48317|NCT02503085|114274|P2|COMPLETED|Period 3||7
48318|NCT02503085|114275|P1|COMPLETED|Period 3||6
48319|NCT02503085|114272|P4|STARTED|Period 3||7
48320|NCT02503085|114273|P3|STARTED|Period 3||6
48321|NCT02503085|114274|P2|STARTED|Period 3||7
48322|NCT02503085|114275|P1|STARTED|Period 3||6
48323|NCT02503085|114272|P4|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
48324|NCT02503085|114273|P3|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
48325|NCT02503085|114274|P2|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
48326|NCT02503085|114275|P1|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
48327|NCT02503085|114272|P4|COMPLETED|Period 2: Washout (3 to 7 Days)||7
48328|NCT02503085|114273|P3|COMPLETED|Period 2: Washout (3 to 7 Days)||6
48329|NCT02503085|114274|P2|COMPLETED|Period 2: Washout (3 to 7 Days)||7
48330|NCT02503085|114275|P1|COMPLETED|Period 2: Washout (3 to 7 Days)||6
48331|NCT02503085|114272|P4|STARTED|Period 2: Washout (3 to 7 Days)||7
48332|NCT02503085|114273|P3|STARTED|Period 2: Washout (3 to 7 Days)||7
48333|NCT02503085|114274|P2|STARTED|Period 2: Washout (3 to 7 Days)||7
48334|NCT02503085|114275|P1|STARTED|Period 2: Washout (3 to 7 Days)||7
48335|NCT02503085|114272|P4|NOT COMPLETED|Period 2||0
48336|NCT02503085|114273|P3|NOT COMPLETED|Period 2||0
48337|NCT02503085|114274|P2|NOT COMPLETED|Period 2||0
48338|NCT02503085|114275|P1|NOT COMPLETED|Period 2||0
48339|NCT02503085|114272|P4|COMPLETED|Period 2||7
48340|NCT02503085|114273|P3|COMPLETED|Period 2||7
48341|NCT02503085|114274|P2|COMPLETED|Period 2||7
48342|NCT02503085|114275|P1|COMPLETED|Period 2||7
48343|NCT02503085|114272|P4|STARTED|Period 2||7
48344|NCT02503085|114273|P3|STARTED|Period 2||7
48345|NCT02503085|114274|P2|STARTED|Period 2||7
48346|NCT02503085|114275|P1|STARTED|Period 2||7
48347|NCT02503085|114272|P4|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
48348|NCT02503085|114273|P3|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
48349|NCT02503085|114274|P2|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
48350|NCT02503085|114275|P1|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
48351|NCT02503085|114272|P4|COMPLETED|Period 1: Washout (3 to 7 Days)||7
48352|NCT02503085|114273|P3|COMPLETED|Period 1: Washout (3 to 7 Days)||7
48353|NCT02503085|114274|P2|COMPLETED|Period 1: Washout (3 to 7 Days)||7
48354|NCT02503085|114275|P1|COMPLETED|Period 1: Washout (3 to 7 Days)||7
48355|NCT02503085|114272|P4|STARTED|Period 1: Washout (3 to 7 Days)||7
48356|NCT02503085|114273|P3|STARTED|Period 1: Washout (3 to 7 Days)||7
48357|NCT02503085|114274|P2|STARTED|Period 1: Washout (3 to 7 Days)||7
48358|NCT02503085|114275|P1|STARTED|Period 1: Washout (3 to 7 Days)||7
48359|NCT02503085|114272|P4|NOT COMPLETED|Period 1||0
48360|NCT02503085|114273|P3|NOT COMPLETED|Period 1||0
48361|NCT02503085|114274|P2|NOT COMPLETED|Period 1||0
48362|NCT02503085|114275|P1|NOT COMPLETED|Period 1||0
48363|NCT02503085|114272|P4|COMPLETED|Period 1||7
48364|NCT02503085|114273|P3|COMPLETED|Period 1||7
48365|NCT02503085|114274|P2|COMPLETED|Period 1||7
48366|NCT02503085|114275|P1|COMPLETED|Period 1||7
48367|NCT02503085|114272|P4|STARTED|Period 1||7
48368|NCT02503085|114273|P3|STARTED|Period 1||7
48369|NCT02503085|114274|P2|STARTED|Period 1||7
48370|NCT02503085|114275|P1|STARTED|Period 1||7
48371|NCT02502864|114314|P1|NOT COMPLETED|Overall Study||1
48372|NCT02502864|114314|P1|COMPLETED|Overall Study||8
48373|NCT02502864|114314|P1|STARTED|Overall Study||9
48374|NCT02502734|114323|P2|NOT COMPLETED|Double-blind Treatment Period 2||0
48375|NCT02502734|114324|P1|NOT COMPLETED|Double-blind Treatment Period 2||0
48376|NCT02502734|114323|P2|COMPLETED|Double-blind Treatment Period 2||30
48377|NCT02502734|114324|P1|COMPLETED|Double-blind Treatment Period 2||28
48378|NCT02502734|114323|P2|STARTED|Double-blind Treatment Period 2||30
48379|NCT02502734|114324|P1|STARTED|Double-blind Treatment Period 2||28
48380|NCT02502734|114323|P2|NOT COMPLETED|Washout Period||0
48381|NCT02502734|114324|P1|NOT COMPLETED|Washout Period||1
48382|NCT02502734|114323|P2|COMPLETED|Washout Period||30
48383|NCT02502734|114324|P1|COMPLETED|Washout Period||28
48384|NCT02502734|114323|P2|STARTED|Washout Period||30
48385|NCT02502734|114324|P1|STARTED|Washout Period||29
48386|NCT02502734|114323|P2|NOT COMPLETED|Double-blind Treatment Period 1||0
48387|NCT02502734|114324|P1|NOT COMPLETED|Double-blind Treatment Period 1||1
48388|NCT02502734|114323|P2|COMPLETED|Double-blind Treatment Period 1||30
48389|NCT02502734|114324|P1|COMPLETED|Double-blind Treatment Period 1||29
48390|NCT02502734|114323|P2|STARTED|Double-blind Treatment Period 1||30
48391|NCT02502734|114324|P1|STARTED|Double-blind Treatment Period 1||30
48392|NCT02502526|114335|P3|NOT COMPLETED|Overall Study||6
48393|NCT02502526|114336|P2|NOT COMPLETED|Overall Study||4
48394|NCT02502526|114337|P1|NOT COMPLETED|Overall Study||6
48395|NCT02502526|114335|P3|COMPLETED|Overall Study||55
48396|NCT02502526|114336|P2|COMPLETED|Overall Study||55
48397|NCT02502526|114337|P1|COMPLETED|Overall Study||56
48398|NCT02502526|114335|P3|Intent-to-Treat (ITT)|Overall Study||59
48399|NCT02502526|114336|P2|Intent-to-Treat (ITT)|Overall Study||57
48400|NCT02502526|114337|P1|Intent-to-Treat (ITT)|Overall Study||57
48401|NCT02502526|114335|P3|STARTED|Overall Study||61
48402|NCT02502526|114336|P2|STARTED|Overall Study||59
48403|NCT02502526|114337|P1|STARTED|Overall Study||62
48404|NCT02502487|114353|P3|NOT COMPLETED|Overall Study||0
48405|NCT02502487|114354|P2|NOT COMPLETED|Overall Study||0
48406|NCT02502487|114355|P1|NOT COMPLETED|Overall Study||0
48407|NCT02502487|114353|P3|COMPLETED|Overall Study||86
48408|NCT02502487|114354|P2|COMPLETED|Overall Study||86
48409|NCT02502487|114355|P1|COMPLETED|Overall Study||86
48410|NCT02502487|114353|P3|STARTED|Overall Study||86
48411|NCT02502487|114354|P2|STARTED|Overall Study||86
48412|NCT02502487|114355|P1|STARTED|Overall Study||86
48413|NCT02502461|114425|P2|NOT COMPLETED|Overall Study||0
48414|NCT02502461|114426|P1|NOT COMPLETED|Overall Study||0
48415|NCT02502461|114425|P2|COMPLETED|Overall Study||44
48416|NCT02502461|114426|P1|COMPLETED|Overall Study||46
48417|NCT02502461|114425|P2|STARTED|Overall Study||44
48418|NCT02502461|114426|P1|STARTED|Overall Study||46
48419|NCT02502149|114434|P5|NOT COMPLETED|Treatment Period||0
48420|NCT02502149|114435|P4|NOT COMPLETED|Treatment Period||0
48421|NCT02502149|114436|P3|NOT COMPLETED|Treatment Period||0
48422|NCT02502149|114437|P2|NOT COMPLETED|Treatment Period||0
48423|NCT02502149|114438|P1|NOT COMPLETED|Treatment Period||0
48424|NCT02502149|114434|P5|COMPLETED|Treatment Period||12
48425|NCT02502149|114435|P4|COMPLETED|Treatment Period||11
48426|NCT02502149|114436|P3|COMPLETED|Treatment Period||0
48427|NCT02502149|114437|P2|COMPLETED|Treatment Period||0
48428|NCT02502149|114438|P1|COMPLETED|Treatment Period||0
48429|NCT02502149|114434|P5|STARTED|Treatment Period||12
48430|NCT02502149|114435|P4|STARTED|Treatment Period||11
48431|NCT02502149|114436|P3|STARTED|Treatment Period||0
48432|NCT02502149|114437|P2|STARTED|Treatment Period||0
48433|NCT02502149|114438|P1|STARTED|Treatment Period||0
48434|NCT02502149|114434|P5|NOT COMPLETED|PK2 Assessment Period||0
48435|NCT02502149|114435|P4|NOT COMPLETED|PK2 Assessment Period||0
48436|NCT02502149|114436|P3|NOT COMPLETED|PK2 Assessment Period||0
48437|NCT02502149|114437|P2|NOT COMPLETED|PK2 Assessment Period||0
48438|NCT02502149|114438|P1|NOT COMPLETED|PK2 Assessment Period||0
48439|NCT02502149|114434|P5|COMPLETED|PK2 Assessment Period||0
48440|NCT02502149|114435|P4|COMPLETED|PK2 Assessment Period||0
48441|NCT02502149|114436|P3|COMPLETED|PK2 Assessment Period||12
48442|NCT02502149|114437|P2|COMPLETED|PK2 Assessment Period||11
48443|NCT02502149|114438|P1|COMPLETED|PK2 Assessment Period||0
48444|NCT02502149|114434|P5|STARTED|PK2 Assessment Period||0
48445|NCT02502149|114435|P4|STARTED|PK2 Assessment Period||0
48446|NCT02502149|114436|P3|STARTED|PK2 Assessment Period||12
48447|NCT02502149|114437|P2|STARTED|PK2 Assessment Period||11
48448|NCT02502149|114438|P1|STARTED|PK2 Assessment Period||0
48449|NCT02502149|114434|P5|NOT COMPLETED|Intermediate||0
48450|NCT02502149|114435|P4|NOT COMPLETED|Intermediate||0
48451|NCT02502149|114436|P3|NOT COMPLETED|Intermediate||0
48452|NCT02502149|114437|P2|NOT COMPLETED|Intermediate||0
48453|NCT02502149|114438|P1|NOT COMPLETED|Intermediate||1
48454|NCT02502149|114434|P5|COMPLETED|Intermediate||0
48455|NCT02502149|114435|P4|COMPLETED|Intermediate||0
48456|NCT02502149|114436|P3|COMPLETED|Intermediate||0
48457|NCT02502149|114437|P2|COMPLETED|Intermediate||0
48458|NCT02502149|114438|P1|COMPLETED|Intermediate||23
48459|NCT02502149|114434|P5|STARTED|Intermediate||0
48460|NCT02502149|114435|P4|STARTED|Intermediate||0
48461|NCT02502149|114436|P3|STARTED|Intermediate||0
48462|NCT02502149|114437|P2|STARTED|Intermediate||0
48463|NCT02502149|114438|P1|STARTED|Intermediate||24
48464|NCT02502149|114434|P5|NOT COMPLETED|PK1 Assessment Period||0
48465|NCT02502149|114435|P4|NOT COMPLETED|PK1 Assessment Period||0
48466|NCT02502149|114436|P3|NOT COMPLETED|PK1 Assessment Period||0
48467|NCT02502149|114437|P2|NOT COMPLETED|PK1 Assessment Period||0
48468|NCT02502149|114438|P1|NOT COMPLETED|PK1 Assessment Period||0
48469|NCT02502149|114434|P5|COMPLETED|PK1 Assessment Period||0
48470|NCT02502149|114435|P4|COMPLETED|PK1 Assessment Period||0
48471|NCT02502149|114436|P3|COMPLETED|PK1 Assessment Period||0
48472|NCT02502149|114437|P2|COMPLETED|PK1 Assessment Period||0
48473|NCT02502149|114438|P1|COMPLETED|PK1 Assessment Period||24
48474|NCT02502149|114434|P5|STARTED|PK1 Assessment Period||0
48475|NCT02502149|114435|P4|STARTED|PK1 Assessment Period||0
48476|NCT02502149|114436|P3|STARTED|PK1 Assessment Period||0
48477|NCT02502149|114437|P2|STARTED|PK1 Assessment Period||0
48478|NCT02502149|114438|P1|STARTED|PK1 Assessment Period||24
48479|NCT02502071|114557|P1|NOT COMPLETED|Overall Study||0
48480|NCT02502071|114557|P1|COMPLETED|Overall Study||45
48481|NCT02502071|114557|P1|STARTED|Overall Study||45
48482|NCT02502019|114562|P1|NOT COMPLETED|Overall Study||0
48483|NCT02502019|114562|P1|COMPLETED|Overall Study||27
48484|NCT02502019|114562|P1|STARTED|Overall Study||27
48485|NCT02501759|114570|P1|NOT COMPLETED|Overall Study||1
48486|NCT02501759|114570|P1|COMPLETED|Overall Study||1
48487|NCT02501759|114570|P1|STARTED|Overall Study||2
48488|NCT02501629|114578|P2|NOT COMPLETED|Overall Study||7
48489|NCT02501629|114579|P1|NOT COMPLETED|Overall Study||5
48490|NCT02501629|114578|P2|COMPLETED|Overall Study||81
48491|NCT02501629|114579|P1|COMPLETED|Overall Study||84
48492|NCT02501629|114578|P2|STARTED|Overall Study||88
48493|NCT02501629|114579|P1|STARTED|Overall Study||89
48494|NCT02501590|114603|P2|NOT COMPLETED|Overall Study||0
48495|NCT02501590|114604|P1|NOT COMPLETED|Overall Study||0
48496|NCT02501590|114603|P2|COMPLETED|Overall Study||35
48497|NCT02501590|114604|P1|COMPLETED|Overall Study||13
48498|NCT02501590|114603|P2|STARTED|Overall Study||35
48499|NCT02501590|114604|P1|STARTED|Overall Study||13
48500|NCT02501161|114612|P2|NOT COMPLETED|Overall Study||25
48501|NCT02501161|114613|P1|NOT COMPLETED|Overall Study||22
48502|NCT02501161|114612|P2|COMPLETED|Overall Study||481
48503|NCT02501161|114613|P1|COMPLETED|Overall Study||484
48504|NCT02501161|114612|P2|Exposed|Overall Study||504
48505|NCT02501161|114613|P1|Exposed|Overall Study||506
48506|NCT02501161|114612|P2|STARTED|Overall Study||506
48507|NCT02501161|114613|P1|STARTED|Overall Study||506
48508|NCT02501135|114725|P1|NOT COMPLETED|Overall Study||0
48509|NCT02501135|114725|P1|COMPLETED|Overall Study||281
48510|NCT02501135|114725|P1|STARTED|Overall Study||281
48511|NCT02500979|114737|P2|NOT COMPLETED|Period 2||0
48512|NCT02500979|114738|P1|NOT COMPLETED|Period 2||1
48513|NCT02500979|114737|P2|COMPLETED|Period 2||16
48514|NCT02500979|114738|P1|COMPLETED|Period 2||11
48515|NCT02500979|114737|P2|STARTED|Period 2||16
48516|NCT02500979|114738|P1|STARTED|Period 2||12
48517|NCT02500979|114737|P2|NOT COMPLETED|Period 1||1
48518|NCT02500979|114738|P1|NOT COMPLETED|Period 1||4
48519|NCT02500979|114737|P2|COMPLETED|Period 1||16
48520|NCT02500979|114738|P1|COMPLETED|Period 1||12
48521|NCT02500979|114737|P2|STARTED|Period 1||17
48522|NCT02500979|114738|P1|STARTED|Period 1||16
48523|NCT02500901|114772|P1|NOT COMPLETED|Overall Study||2
48524|NCT02500901|114772|P1|COMPLETED|Overall Study||0
48525|NCT02500901|114772|P1|STARTED|Overall Study||2
48526|NCT02500836|114781|P3|NOT COMPLETED|Overall Study||1
48527|NCT02500836|114782|P2|NOT COMPLETED|Overall Study||5
48528|NCT02500836|114783|P1|NOT COMPLETED|Overall Study||3
48529|NCT02500836|114781|P3|COMPLETED|Overall Study||127
48530|NCT02500836|114782|P2|COMPLETED|Overall Study||254
48531|NCT02500836|114783|P1|COMPLETED|Overall Study||256
48532|NCT02500836|114781|P3|STARTED|Overall Study||128
48533|NCT02500836|114782|P2|STARTED|Overall Study||259
48534|NCT02500836|114783|P1|STARTED|Overall Study||259
48535|NCT02500758|114794|P2|NOT COMPLETED|Second Intervention (2 Minutes)||2
48536|NCT02500758|114795|P1|NOT COMPLETED|Second Intervention (2 Minutes)||3
48537|NCT02500758|114794|P2|COMPLETED|Second Intervention (2 Minutes)||10
48538|NCT02500758|114795|P1|COMPLETED|Second Intervention (2 Minutes)||10
48539|NCT02500758|114794|P2|STARTED|Second Intervention (2 Minutes)||12
48540|NCT02500758|114795|P1|STARTED|Second Intervention (2 Minutes)||13
48541|NCT02500758|114794|P2|NOT COMPLETED|Washout (1 Week)||2
48542|NCT02500758|114795|P1|NOT COMPLETED|Washout (1 Week)||2
48543|NCT02500758|114794|P2|COMPLETED|Washout (1 Week)||12
48544|NCT02500758|114795|P1|COMPLETED|Washout (1 Week)||13
48545|NCT02500758|114794|P2|STARTED|Washout (1 Week)||14
48546|NCT02500758|114795|P1|STARTED|Washout (1 Week)||15
48547|NCT02500758|114794|P2|NOT COMPLETED|First Intervention (2 Minutes)||1
48548|NCT02500758|114795|P1|NOT COMPLETED|First Intervention (2 Minutes)||0
48549|NCT02500758|114794|P2|COMPLETED|First Intervention (2 Minutes)||14
48550|NCT02500758|114795|P1|COMPLETED|First Intervention (2 Minutes)||15
48551|NCT02500758|114794|P2|STARTED|First Intervention (2 Minutes)||15
48552|NCT02500758|114795|P1|STARTED|First Intervention (2 Minutes)||15
48553|NCT02500706|114806|P3|NOT COMPLETED|Overall Study||7
48554|NCT02500706|114807|P2|NOT COMPLETED|Overall Study||7
48555|NCT02500706|114808|P1|NOT COMPLETED|Overall Study||4
48556|NCT02500706|114806|P3|COMPLETED|Overall Study||335
48557|NCT02500706|114807|P2|COMPLETED|Overall Study||334
48558|NCT02500706|114808|P1|COMPLETED|Overall Study||338
48559|NCT02500706|114806|P3|Exposed|Overall Study||342
48560|NCT02500706|114807|P2|Exposed|Overall Study||341
48561|NCT02500706|114808|P1|Exposed|Overall Study||342
48562|NCT02500706|114806|P3|STARTED|Overall Study||342
48563|NCT02500706|114807|P2|STARTED|Overall Study||341
48564|NCT02500706|114808|P1|STARTED|Overall Study||342
48565|NCT02500641|114962|P2|NOT COMPLETED|Overall Study||12
48566|NCT02500641|114963|P1|NOT COMPLETED|Overall Study||10
48567|NCT02500641|114962|P2|COMPLETED|Overall Study||86
48568|NCT02500641|114963|P1|COMPLETED|Overall Study||88
48569|NCT02500641|114962|P2|STARTED|Overall Study||98
48570|NCT02500641|114963|P1|STARTED|Overall Study||98
48571|NCT02500628|114971|P2|NOT COMPLETED|Overall Study||0
48572|NCT02500628|114972|P1|NOT COMPLETED|Overall Study||0
48573|NCT02500628|114971|P2|COMPLETED|Overall Study||23
48574|NCT02500628|114972|P1|COMPLETED|Overall Study||38
48575|NCT02500628|114971|P2|STARTED|Overall Study||23
48576|NCT02500628|114972|P1|STARTED|Overall Study||38
48577|NCT02500537|114984|P2|NOT COMPLETED|Overall Study||1
48578|NCT02500537|114985|P1|NOT COMPLETED|Overall Study||3
48579|NCT02500537|114984|P2|COMPLETED|Overall Study||39
48580|NCT02500537|114985|P1|COMPLETED|Overall Study||57
48581|NCT02500537|114984|P2|STARTED|Overall Study||40
48582|NCT02500537|114985|P1|STARTED|Overall Study||60
48583|NCT02500368|115003|P2|NOT COMPLETED|Second Intervention (1 Week)||0
48584|NCT02500368|115004|P1|NOT COMPLETED|Second Intervention (1 Week)||0
48585|NCT02500368|115003|P2|COMPLETED|Second Intervention (1 Week)||20
48586|NCT02500368|115004|P1|COMPLETED|Second Intervention (1 Week)||20
48587|NCT02500368|115003|P2|STARTED|Second Intervention (1 Week)||20
48588|NCT02500368|115004|P1|STARTED|Second Intervention (1 Week)||20
48589|NCT02500368|115003|P2|NOT COMPLETED|First Intervention (1 Week)||0
48590|NCT02500368|115004|P1|NOT COMPLETED|First Intervention (1 Week)||0
48591|NCT02500368|115003|P2|COMPLETED|First Intervention (1 Week)||20
48592|NCT02500368|115004|P1|COMPLETED|First Intervention (1 Week)||20
48593|NCT02500368|115003|P2|STARTED|First Intervention (1 Week)||20
48594|NCT02500368|115004|P1|STARTED|First Intervention (1 Week)||20
48595|NCT02500056|115054|P2|NOT COMPLETED|Overall Study||8
48596|NCT02500056|115055|P1|NOT COMPLETED|Overall Study||7
48597|NCT02500056|115054|P2|COMPLETED|Overall Study||65
48598|NCT02500056|115055|P1|COMPLETED|Overall Study||63
48599|NCT02500056|115054|P2|STARTED|Overall Study||73
48600|NCT02500056|115055|P1|STARTED|Overall Study||70
48601|NCT02499952|115065|P1|NOT COMPLETED|Overall Study||10
48602|NCT02499952|115065|P1|COMPLETED|Overall Study||2
48603|NCT02499952|115065|P1|STARTED|Overall Study||12
48604|NCT02499900|115074|P2|NOT COMPLETED|Extension Study Period||20
48605|NCT02499900|115075|P1|NOT COMPLETED|Extension Study Period||12
48606|NCT02499900|115074|P2|COMPLETED|Extension Study Period||377
48607|NCT02499900|115075|P1|COMPLETED|Extension Study Period||380
48608|NCT02499900|115074|P2|Safety Analysis Set|Extension Study Period|One participant was not treated in the Extension Study Period|396
48609|NCT02499900|115075|P1|Safety Analysis Set|Extension Study Period||392
48610|NCT02499900|115074|P2|STARTED|Extension Study Period||397
48611|NCT02499900|115075|P1|STARTED|Extension Study Period||392
48612|NCT02499900|115074|P2|NOT COMPLETED|Completed Core, Continued Into Extension||2
48613|NCT02499900|115075|P1|NOT COMPLETED|Completed Core, Continued Into Extension||3
48614|NCT02499900|115074|P2|COMPLETED|Completed Core, Continued Into Extension||397
48615|NCT02499900|115075|P1|COMPLETED|Completed Core, Continued Into Extension||392
48616|NCT02499900|115074|P2|STARTED|Completed Core, Continued Into Extension||399
48617|NCT02499900|115075|P1|STARTED|Completed Core, Continued Into Extension||395
48618|NCT02499900|115074|P2|NOT COMPLETED|Core Study Period||32
48619|NCT02499900|115075|P1|NOT COMPLETED|Core Study Period||35
48620|NCT02499900|115074|P2|COMPLETED|Core Study Period||399
48621|NCT02499900|115075|P1|COMPLETED|Core Study Period||395
48622|NCT02499900|115074|P2|Safety Analysis Set|Core Study Period||430
48623|NCT02499900|115075|P1|Safety Analysis Set|Core Study Period||427
48624|NCT02499900|115074|P2|STARTED|Core Study Period||431
48625|NCT02499900|115075|P1|STARTED|Core Study Period||430
48626|NCT02499887|115097|P2|NOT COMPLETED|Overall Study||0
48627|NCT02499887|115098|P1|NOT COMPLETED|Overall Study||0
48628|NCT02499887|115097|P2|COMPLETED|Overall Study||3
48629|NCT02499887|115098|P1|COMPLETED|Overall Study||3
48630|NCT02499887|115097|P2|STARTED|Overall Study||3
48631|NCT02499887|115098|P1|STARTED|Overall Study||3
48632|NCT02499783|115106|P3|NOT COMPLETED|Open Label Period: Weeks 8 to 26||29
48633|NCT02499783|115107|P2|NOT COMPLETED|Open Label Period: Weeks 8 to 26||0
48634|NCT02499783|115108|P1|NOT COMPLETED|Open Label Period: Weeks 8 to 26||0
48635|NCT02499783|115106|P3|COMPLETED|Open Label Period: Weeks 8 to 26||159
48636|NCT02499783|115107|P2|COMPLETED|Open Label Period: Weeks 8 to 26||0
48637|NCT02499783|115108|P1|COMPLETED|Open Label Period: Weeks 8 to 26||0
48638|NCT02499783|115106|P3|STARTED|Open Label Period: Weeks 8 to 26||188
48639|NCT02499783|115107|P2|STARTED|Open Label Period: Weeks 8 to 26||0
48640|NCT02499783|115108|P1|STARTED|Open Label Period: Weeks 8 to 26||0
48641|NCT02499783|115106|P3|NOT COMPLETED|DB Period: Weeks 0-8||0
48642|NCT02499783|115107|P2|NOT COMPLETED|DB Period: Weeks 0-8||7
48643|NCT02499783|115108|P1|NOT COMPLETED|DB Period: Weeks 0-8||10
48644|NCT02499783|115106|P3|COMPLETED|DB Period: Weeks 0-8||0
48645|NCT02499783|115107|P2|COMPLETED|DB Period: Weeks 0-8||96
48646|NCT02499783|115108|P1|COMPLETED|DB Period: Weeks 0-8||92
48647|NCT02499783|115106|P3|STARTED|DB Period: Weeks 0-8||0
48648|NCT02499783|115107|P2|STARTED|DB Period: Weeks 0-8||103
48649|NCT02499783|115108|P1|STARTED|DB Period: Weeks 0-8||102
48650|NCT02499783|115106|P3|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||0
48651|NCT02499783|115107|P2|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||5
48652|NCT02499783|115108|P1|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||4
48653|NCT02499783|115106|P3|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||0
48654|NCT02499783|115107|P2|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||98
48655|NCT02499783|115108|P1|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||98
48656|NCT02499783|115106|P3|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||0
48657|NCT02499783|115107|P2|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||103
48658|NCT02499783|115108|P1|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||102
48659|NCT02499692|115155|P1|NOT COMPLETED|Overall Study||0
48660|NCT02499692|115155|P1|COMPLETED|Overall Study||103
48661|NCT02499692|115155|P1|STARTED|Overall Study||103
48662|NCT02499575|115166|P2|NOT COMPLETED|Overall Study||1
48663|NCT02499575|115167|P1|NOT COMPLETED|Overall Study||0
48664|NCT02499575|115166|P2|COMPLETED|Overall Study||0
48665|NCT02499575|115167|P1|COMPLETED|Overall Study||1
48666|NCT02499575|115166|P2|STARTED|Overall Study||1
48667|NCT02499575|115167|P1|STARTED|Overall Study||1
48668|NCT02499380|115177|P1|NOT COMPLETED|Overall Study||3
48669|NCT02499380|115177|P1|COMPLETED|Overall Study||17
48670|NCT02499380|115177|P1|STARTED|Overall Study||20
48671|NCT02499263|115182|P1|NOT COMPLETED|Overall Study||62
48672|NCT02499263|115182|P1|COMPLETED|Overall Study||84
48673|NCT02499263|115182|P1|STARTED|Overall Study||146
48674|NCT02499172|115219|P4|NOT COMPLETED|Overall Study||436
48675|NCT02499172|115220|P3|NOT COMPLETED|Overall Study||523
48676|NCT02499172|115221|P2|NOT COMPLETED|Overall Study||64
48677|NCT02499172|115222|P1|NOT COMPLETED|Overall Study||65
48678|NCT02499172|115219|P4|COMPLETED|Overall Study||0
48679|NCT02499172|115220|P3|COMPLETED|Overall Study||0
48680|NCT02499172|115221|P2|COMPLETED|Overall Study||835
48681|NCT02499172|115222|P1|COMPLETED|Overall Study||835
48682|NCT02499172|115219|P4|STARTED|Overall Study||436
48683|NCT02499172|115220|P3|STARTED|Overall Study||523
48684|NCT02499172|115221|P2|STARTED|Overall Study||899
48685|NCT02499172|115222|P1|STARTED|Overall Study||900
48686|NCT02499159|115234|P2|NOT COMPLETED|30-Day Follow-Up Phone Call||2
48687|NCT02499159|115235|P1|NOT COMPLETED|30-Day Follow-Up Phone Call||7
48688|NCT02499159|115234|P2|COMPLETED|30-Day Follow-Up Phone Call||47
48689|NCT02499159|115235|P1|COMPLETED|30-Day Follow-Up Phone Call||42
48690|NCT02499159|115234|P2|STARTED|30-Day Follow-Up Phone Call||49
48691|NCT02499159|115235|P1|STARTED|30-Day Follow-Up Phone Call||49
48692|NCT02499159|115234|P2|NOT COMPLETED|Randomization||1
48693|NCT02499159|115235|P1|NOT COMPLETED|Randomization||1
48694|NCT02499159|115234|P2|COMPLETED|Randomization||49
48695|NCT02499159|115235|P1|COMPLETED|Randomization||49
48696|NCT02499159|115234|P2|STARTED|Randomization||50
48697|NCT02499159|115235|P1|STARTED|Randomization||50
48698|NCT02499146|115259|P1|NOT COMPLETED|Overall Study||26
48699|NCT02499146|115259|P1|COMPLETED|Overall Study||0
48700|NCT02499146|115259|P1|STARTED|Overall Study||26
48701|NCT02499120|115299|P2|NOT COMPLETED|Overall Study||60
48702|NCT02499120|115300|P1|NOT COMPLETED|Overall Study||65
48703|NCT02499120|115299|P2|COMPLETED|Overall Study||0
48704|NCT02499120|115300|P1|COMPLETED|Overall Study||0
48705|NCT02499120|115299|P2|Received Treatment|Overall Study||60
48706|NCT02499120|115300|P1|Received Treatment|Overall Study||64
48707|NCT02499120|115299|P2|STARTED|Overall Study||60
48708|NCT02499120|115300|P1|STARTED|Overall Study||65
48709|NCT02499029|115331|P2|NOT COMPLETED|Overall Study||3
48710|NCT02499029|115332|P1|NOT COMPLETED|Overall Study||5
48711|NCT02499029|115331|P2|COMPLETED|Overall Study||14
48712|NCT02499029|115332|P1|COMPLETED|Overall Study||13
48713|NCT02499029|115331|P2|STARTED|Overall Study||17
48714|NCT02499029|115332|P1|STARTED|Overall Study||18
48715|NCT02498834|115346|P2|NOT COMPLETED|Overall Study||10
48716|NCT02498834|115347|P1|NOT COMPLETED|Overall Study||10
48717|NCT02498834|115346|P2|COMPLETED|Overall Study||164
48718|NCT02498834|115347|P1|COMPLETED|Overall Study||175
48719|NCT02498834|115346|P2|STARTED|Overall Study||174
48720|NCT02498834|115347|P1|STARTED|Overall Study||185
48721|NCT02498821|115359|P2|NOT COMPLETED|Overall Study||5
48722|NCT02498821|115360|P1|NOT COMPLETED|Overall Study||3
48723|NCT02498821|115359|P2|COMPLETED|Overall Study||60
48724|NCT02498821|115360|P1|COMPLETED|Overall Study||60
48725|NCT02498821|115359|P2|STARTED|Overall Study||65
48726|NCT02498821|115360|P1|STARTED|Overall Study||63
48727|NCT02498769|115389|P2|NOT COMPLETED|Overall Study||0
48728|NCT02498769|115390|P1|NOT COMPLETED|Overall Study||0
48729|NCT02498769|115389|P2|COMPLETED|Overall Study||67
48730|NCT02498769|115390|P1|COMPLETED|Overall Study||63
48731|NCT02498769|115389|P2|STARTED|Overall Study||67
48732|NCT02498769|115390|P1|STARTED|Overall Study||63
48733|NCT02498678|115404|P2|NOT COMPLETED|Overall Study||2
48734|NCT02498678|115405|P1|NOT COMPLETED|Overall Study||0
48735|NCT02498678|115404|P2|COMPLETED|Overall Study||23
48736|NCT02498678|115405|P1|COMPLETED|Overall Study||25
48737|NCT02498678|115404|P2|STARTED|Overall Study||25
48738|NCT02498678|115405|P1|STARTED|Overall Study||25
48739|NCT02498652|115421|P2|NOT COMPLETED|Overall Study||1
48740|NCT02498652|115422|P1|NOT COMPLETED|Overall Study||0
48741|NCT02498652|115421|P2|COMPLETED|Overall Study|One subject was withdrawn due to noncompliance/protocol violation|20
48742|NCT02498652|115422|P1|COMPLETED|Overall Study||20
48743|NCT02498652|115421|P2|STARTED|Overall Study||21
48744|NCT02498652|115422|P1|STARTED|Overall Study||20
48745|NCT02498522|115523|P2|NOT COMPLETED|Overall Study||2
48746|NCT02498522|115524|P1|NOT COMPLETED|Overall Study||2
48747|NCT02498522|115523|P2|COMPLETED|Overall Study||83
48748|NCT02498522|115524|P1|COMPLETED|Overall Study||83
48749|NCT02498522|115523|P2|STARTED|Overall Study||85
48750|NCT02498522|115524|P1|STARTED|Overall Study||85
48751|NCT02498483|115532|P2|NOT COMPLETED|Overall Study||0
48752|NCT02498483|115533|P1|NOT COMPLETED|Overall Study||0
48753|NCT02498483|115532|P2|COMPLETED|Overall Study||5
48754|NCT02498483|115533|P1|COMPLETED|Overall Study||6
48755|NCT02498483|115532|P2|STARTED|Overall Study||5
48756|NCT02498483|115533|P1|STARTED|Overall Study||6
48757|NCT02498236|115555|P8|NOT COMPLETED|Overall Study||1
48758|NCT02498236|115556|P7|NOT COMPLETED|Overall Study||1
48759|NCT02498236|115557|P6|NOT COMPLETED|Overall Study||0
48760|NCT02498236|115558|P5|NOT COMPLETED|Overall Study||1
48761|NCT02498236|115559|P4|NOT COMPLETED|Overall Study||0
48762|NCT02498236|115560|P3|NOT COMPLETED|Overall Study||0
48763|NCT02498236|115561|P2|NOT COMPLETED|Overall Study||0
48764|NCT02498236|115562|P1|NOT COMPLETED|Overall Study||1
48765|NCT02498236|115555|P8|COMPLETED|Overall Study||6
48766|NCT02498236|115556|P7|COMPLETED|Overall Study||6
48767|NCT02498236|115557|P6|COMPLETED|Overall Study||6
48768|NCT02498236|115558|P5|COMPLETED|Overall Study||6
48769|NCT02498236|115559|P4|COMPLETED|Overall Study||6
48770|NCT02498236|115560|P3|COMPLETED|Overall Study||6
48771|NCT02498236|115561|P2|COMPLETED|Overall Study||6
48772|NCT02498236|115562|P1|COMPLETED|Overall Study||5
48773|NCT02498236|115555|P8|Randomized|Overall Study||7
48774|NCT02498236|115556|P7|Randomized|Overall Study||7
48775|NCT02498236|115557|P6|Randomized|Overall Study||6
48776|NCT02498236|115558|P5|Randomized|Overall Study||7
48777|NCT02498236|115559|P4|Randomized|Overall Study||6
48778|NCT02498236|115560|P3|Randomized|Overall Study||6
48779|NCT02498236|115561|P2|Randomized|Overall Study||6
48780|NCT02498236|115562|P1|Randomized|Overall Study||6
48781|NCT02498236|115555|P8|STARTED|Overall Study||7
48782|NCT02498236|115556|P7|STARTED|Overall Study||7
48783|NCT02498236|115557|P6|STARTED|Overall Study||6
48784|NCT02498236|115558|P5|STARTED|Overall Study||7
48785|NCT02498236|115559|P4|STARTED|Overall Study||6
48786|NCT02498236|115560|P3|STARTED|Overall Study||6
48787|NCT02498236|115561|P2|STARTED|Overall Study||6
48788|NCT02498236|115562|P1|STARTED|Overall Study||6
48789|NCT02497976|115593|P2|NOT COMPLETED|Overall Study||1
48790|NCT02497976|115594|P1|NOT COMPLETED|Overall Study||2
48791|NCT02497976|115593|P2|COMPLETED|Overall Study||13
48792|NCT02497976|115594|P1|COMPLETED|Overall Study||26
48793|NCT02497976|115593|P2|STARTED|Overall Study||14
48794|NCT02497976|115594|P1|STARTED|Overall Study||28
48795|NCT02497937|115610|P2|NOT COMPLETED|Period 2 (Up to 7 Days)||0
48796|NCT02497937|115611|P1|NOT COMPLETED|Period 2 (Up to 7 Days)||0
48797|NCT02497937|115610|P2|COMPLETED|Period 2 (Up to 7 Days)||5
48798|NCT02497937|115611|P1|COMPLETED|Period 2 (Up to 7 Days)||6
48799|NCT02497937|115610|P2|STARTED|Period 2 (Up to 7 Days)||5
48800|NCT02497937|115611|P1|STARTED|Period 2 (Up to 7 Days)||6
48801|NCT02497937|115610|P2|NOT COMPLETED|Washout Period (Up to 14 Days)||0
48802|NCT02497937|115611|P1|NOT COMPLETED|Washout Period (Up to 14 Days)||0
48803|NCT02497937|115610|P2|COMPLETED|Washout Period (Up to 14 Days)||5
48804|NCT02497937|115611|P1|COMPLETED|Washout Period (Up to 14 Days)||6
48805|NCT02497937|115610|P2|STARTED|Washout Period (Up to 14 Days)||5
48806|NCT02497937|115611|P1|STARTED|Washout Period (Up to 14 Days)||6
48807|NCT02497937|115610|P2|NOT COMPLETED|Period 1 (Up to 7 Days)||0
48808|NCT02497937|115611|P1|NOT COMPLETED|Period 1 (Up to 7 Days)||0
48809|NCT02497937|115610|P2|COMPLETED|Period 1 (Up to 7 Days)||5
48810|NCT02497937|115611|P1|COMPLETED|Period 1 (Up to 7 Days)||6
48811|NCT02497937|115610|P2|STARTED|Period 1 (Up to 7 Days)||5
48812|NCT02497937|115611|P1|STARTED|Period 1 (Up to 7 Days)||6
48813|NCT02497781|115689|P2|NOT COMPLETED|Overall Study||3
48814|NCT02497781|115690|P1|NOT COMPLETED|Overall Study||4
48815|NCT02497781|115689|P2|COMPLETED|Overall Study||26
48816|NCT02497781|115690|P1|COMPLETED|Overall Study||64
48817|NCT02497781|115689|P2|Treated|Overall Study||28
48818|NCT02497781|115690|P1|Treated|Overall Study||67
48819|NCT02497781|115689|P2|STARTED|Overall Study||29
48820|NCT02497781|115690|P1|STARTED|Overall Study||68
48821|NCT02497755|115753|P2|NOT COMPLETED|Overall Study||0
48822|NCT02497755|115754|P1|NOT COMPLETED|Overall Study||1
48823|NCT02497755|115753|P2|COMPLETED|Overall Study||1
48824|NCT02497755|115754|P1|COMPLETED|Overall Study||17
48825|NCT02497755|115753|P2|STARTED|Overall Study||1
48826|NCT02497755|115754|P1|STARTED|Overall Study||18
48827|NCT02497469|115769|P2|NOT COMPLETED|Overall Study||115
48828|NCT02497469|115770|P1|NOT COMPLETED|Overall Study||169
48829|NCT02497469|115769|P2|COMPLETED|Overall Study||270
48830|NCT02497469|115770|P1|COMPLETED|Overall Study||217
48831|NCT02497469|115769|P2|Safety Analysis Set|Overall Study||383
48832|NCT02497469|115770|P1|Safety Analysis Set|Overall Study||386
48833|NCT02497469|115769|P2|STARTED|Overall Study||385
48834|NCT02497469|115770|P1|STARTED|Overall Study||386
48835|NCT02497391|115780|P6|NOT COMPLETED|Period 3 (14 Days)||0
48836|NCT02497391|115781|P5|NOT COMPLETED|Period 3 (14 Days)||1
48837|NCT02497391|115782|P4|NOT COMPLETED|Period 3 (14 Days)||0
48838|NCT02497391|115783|P3|NOT COMPLETED|Period 3 (14 Days)||1
48839|NCT02497391|115784|P2|NOT COMPLETED|Period 3 (14 Days)||1
48840|NCT02497391|115785|P1|NOT COMPLETED|Period 3 (14 Days)||0
48841|NCT02497391|115780|P6|COMPLETED|Period 3 (14 Days)||13
48842|NCT02497391|115781|P5|COMPLETED|Period 3 (14 Days)||13
48843|NCT02497391|115782|P4|COMPLETED|Period 3 (14 Days)||13
48844|NCT02497391|115783|P3|COMPLETED|Period 3 (14 Days)||12
48845|NCT02497391|115784|P2|COMPLETED|Period 3 (14 Days)||13
48846|NCT02497391|115785|P1|COMPLETED|Period 3 (14 Days)||12
48847|NCT02497391|115780|P6|STARTED|Period 3 (14 Days)||13
48848|NCT02497391|115781|P5|STARTED|Period 3 (14 Days)||14
48849|NCT02497391|115782|P4|STARTED|Period 3 (14 Days)||13
48850|NCT02497391|115783|P3|STARTED|Period 3 (14 Days)||13
48851|NCT02497391|115784|P2|STARTED|Period 3 (14 Days)||14
48852|NCT02497391|115785|P1|STARTED|Period 3 (14 Days)||12
48853|NCT02497391|115780|P6|NOT COMPLETED|Period 2 (14 Days)||3
48854|NCT02497391|115781|P5|NOT COMPLETED|Period 2 (14 Days)||2
48855|NCT02497391|115782|P4|NOT COMPLETED|Period 2 (14 Days)||3
48856|NCT02497391|115783|P3|NOT COMPLETED|Period 2 (14 Days)||3
48857|NCT02497391|115784|P2|NOT COMPLETED|Period 2 (14 Days)||1
48858|NCT02497391|115785|P1|NOT COMPLETED|Period 2 (14 Days)||4
48859|NCT02497391|115780|P6|COMPLETED|Period 2 (14 Days)||13
48860|NCT02497391|115781|P5|COMPLETED|Period 2 (14 Days)||14
48861|NCT02497391|115782|P4|COMPLETED|Period 2 (14 Days)||13
48862|NCT02497391|115783|P3|COMPLETED|Period 2 (14 Days)||13
48863|NCT02497391|115784|P2|COMPLETED|Period 2 (14 Days)||14
48864|NCT02497391|115785|P1|COMPLETED|Period 2 (14 Days)||12
48865|NCT02497391|115780|P6|STARTED|Period 2 (14 Days)||16
48866|NCT02497391|115781|P5|STARTED|Period 2 (14 Days)||16
48867|NCT02497391|115782|P4|STARTED|Period 2 (14 Days)||16
48868|NCT02497391|115783|P3|STARTED|Period 2 (14 Days)||16
48869|NCT02497391|115784|P2|STARTED|Period 2 (14 Days)||15
48870|NCT02497391|115785|P1|STARTED|Period 2 (14 Days)||16
48871|NCT02497391|115780|P6|NOT COMPLETED|Period 1 (14 Days)||0
48872|NCT02497391|115781|P5|NOT COMPLETED|Period 1 (14 Days)||0
48873|NCT02497391|115782|P4|NOT COMPLETED|Period 1 (14 Days)||0
48874|NCT02497391|115783|P3|NOT COMPLETED|Period 1 (14 Days)||0
48875|NCT02497391|115784|P2|NOT COMPLETED|Period 1 (14 Days)||0
48876|NCT02497391|115785|P1|NOT COMPLETED|Period 1 (14 Days)||0
48877|NCT02497391|115780|P6|COMPLETED|Period 1 (14 Days)||16
48878|NCT02497391|115781|P5|COMPLETED|Period 1 (14 Days)||16
48879|NCT02497391|115782|P4|COMPLETED|Period 1 (14 Days)||16
48880|NCT02497391|115783|P3|COMPLETED|Period 1 (14 Days)||16
48881|NCT02497391|115784|P2|COMPLETED|Period 1 (14 Days)||15
48882|NCT02497391|115785|P1|COMPLETED|Period 1 (14 Days)||16
48883|NCT02497391|115780|P6|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
48884|NCT02497391|115781|P5|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
48885|NCT02497391|115782|P4|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
48886|NCT02497391|115783|P3|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
48887|NCT02497391|115784|P2|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||15
48888|NCT02497391|115785|P1|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
48889|NCT02497391|115780|P6|STARTED|Period 1 (14 Days)||16
48890|NCT02497391|115781|P5|STARTED|Period 1 (14 Days)||16
48891|NCT02497391|115782|P4|STARTED|Period 1 (14 Days)||16
48892|NCT02497391|115783|P3|STARTED|Period 1 (14 Days)||16
48893|NCT02497391|115784|P2|STARTED|Period 1 (14 Days)||15
48894|NCT02497391|115785|P1|STARTED|Period 1 (14 Days)||16
48895|NCT02497287|115796|P1|NOT COMPLETED|Follow-up Phase (4 Week)||31
48896|NCT02497287|115796|P1|COMPLETED|Follow-up Phase (4 Week)||326
48897|NCT02497287|115796|P1|STARTED|Follow-up Phase (4 Week)|Included non-responders (IND phase) or discontinued treatment phase or completed OP/MA phase.|357
48898|NCT02497287|115796|P1|NOT COMPLETED|Optimization/Maintenance (48 Weeks)||453
48899|NCT02497287|115796|P1|COMPLETED|Optimization/Maintenance (48 Weeks)||150
48900|NCT02497287|115796|P1|STARTED|Optimization/Maintenance (48 Weeks)|Included who completed IND phase (580) + responders from TRD3005 (23).|603
48901|NCT02497287|115796|P1|NOT COMPLETED|Induction Phase (4 Weeks)||199
48902|NCT02497287|115796|P1|COMPLETED|Induction Phase (4 Weeks)||580
48903|NCT02497287|115796|P1|STARTED|Induction Phase (4 Weeks)|Included DE participants (691) and non-responders from TRD3005 (88).|779
48904|NCT02497235|115840|P5|NOT COMPLETED|Overall Study||0
48905|NCT02497235|115841|P4|NOT COMPLETED|Overall Study||0
48906|NCT02497235|115842|P3|NOT COMPLETED|Overall Study||0
48907|NCT02497235|115843|P2|NOT COMPLETED|Overall Study||0
48908|NCT02497235|115844|P1|NOT COMPLETED|Overall Study||0
48909|NCT02497235|115840|P5|COMPLETED|Overall Study||3
48910|NCT02497235|115841|P4|COMPLETED|Overall Study||2
48911|NCT02497235|115842|P3|COMPLETED|Overall Study||2
48912|NCT02497235|115843|P2|COMPLETED|Overall Study||2
48913|NCT02497235|115844|P1|COMPLETED|Overall Study||2
48914|NCT02497235|115840|P5|STARTED|Overall Study||3
48915|NCT02497235|115841|P4|STARTED|Overall Study||2
48916|NCT02497235|115842|P3|STARTED|Overall Study||2
48917|NCT02497235|115843|P2|STARTED|Overall Study||2
48918|NCT02497235|115844|P1|STARTED|Overall Study||2
48919|NCT02497040|115877|P3|NOT COMPLETED|Overall Study||0
48920|NCT02497040|115878|P2|NOT COMPLETED|Overall Study||0
48921|NCT02497040|115879|P1|NOT COMPLETED|Overall Study||0
48922|NCT02497040|115877|P3|COMPLETED|Overall Study||30
48923|NCT02497040|115878|P2|COMPLETED|Overall Study||30
48924|NCT02497040|115879|P1|COMPLETED|Overall Study||30
48925|NCT02497040|115877|P3|STARTED|Overall Study||30
48926|NCT02497040|115878|P2|STARTED|Overall Study||30
48927|NCT02497040|115879|P1|STARTED|Overall Study||30
48928|NCT02496702|115889|P2|NOT COMPLETED|Overall Study||8
48929|NCT02496702|115890|P1|NOT COMPLETED|Overall Study||8
48930|NCT02496702|115889|P2|COMPLETED|Overall Study||22
48931|NCT02496702|115890|P1|COMPLETED|Overall Study||22
48932|NCT02496702|115889|P2|Did Not Receive Allocated Intervention|Overall Study||0
48933|NCT02496702|115890|P1|Did Not Receive Allocated Intervention|Overall Study||9
48934|NCT02496702|115889|P2|Received Allocated Intervention|Overall Study||0
48935|NCT02496702|115890|P1|Received Allocated Intervention|Overall Study||21
48936|NCT02496702|115889|P2|STARTED|Overall Study||30
48937|NCT02496702|115890|P1|STARTED|Overall Study||30
48938|NCT02496533|115912|P2|NOT COMPLETED|Overall Study||6
48939|NCT02496533|115913|P1|NOT COMPLETED|Overall Study||3
48940|NCT02496533|115912|P2|COMPLETED|Overall Study||106
48941|NCT02496533|115913|P1|COMPLETED|Overall Study||102
48942|NCT02496533|115912|P2|STARTED|Overall Study||112
48943|NCT02496533|115913|P1|STARTED|Overall Study||105
48944|NCT02496221|115925|P2|NOT COMPLETED|Treatment Period 2 - 4 Days||1
48945|NCT02496221|115926|P1|NOT COMPLETED|Treatment Period 2 - 4 Days||2
48946|NCT02496221|115925|P2|COMPLETED|Treatment Period 2 - 4 Days||9
48947|NCT02496221|115926|P1|COMPLETED|Treatment Period 2 - 4 Days||8
48948|NCT02496221|115925|P2|STARTED|Treatment Period 2 - 4 Days||10
48949|NCT02496221|115926|P1|STARTED|Treatment Period 2 - 4 Days||10
48950|NCT02496221|115925|P2|NOT COMPLETED|Treatment Period 1 - 4 Days||0
48951|NCT02496221|115926|P1|NOT COMPLETED|Treatment Period 1 - 4 Days||0
48952|NCT02496221|115925|P2|COMPLETED|Treatment Period 1 - 4 Days||10
48953|NCT02496221|115926|P1|COMPLETED|Treatment Period 1 - 4 Days||10
48954|NCT02496221|115925|P2|STARTED|Treatment Period 1 - 4 Days||10
48955|NCT02496221|115926|P1|STARTED|Treatment Period 1 - 4 Days||10
48956|NCT02496039|115960|P1|NOT COMPLETED|Overall Study||4
48957|NCT02496039|115960|P1|COMPLETED|Overall Study||1
48958|NCT02496039|115960|P1|STARTED|Overall Study||5
48959|NCT02496000|115975|P3|NOT COMPLETED|Overall Study||2
48960|NCT02496000|115976|P2|NOT COMPLETED|Overall Study||5
48961|NCT02496000|115977|P1|NOT COMPLETED|Overall Study||2
48962|NCT02496000|115975|P3|COMPLETED|Overall Study||61
48963|NCT02496000|115976|P2|COMPLETED|Overall Study||56
48964|NCT02496000|115977|P1|COMPLETED|Overall Study||62
48965|NCT02496000|115975|P3|STARTED|Overall Study||63
48966|NCT02496000|115976|P2|STARTED|Overall Study||61
48967|NCT02496000|115977|P1|STARTED|Overall Study||64
48968|NCT02495948|115998|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
48969|NCT02495948|115999|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
48970|NCT02495948|115998|P2|COMPLETED|Period 2, Second 30 Days of Wear||82
48971|NCT02495948|115999|P1|COMPLETED|Period 2, Second 30 Days of Wear||82
48972|NCT02495948|115998|P2|STARTED|Period 2, Second 30 Days of Wear||83
48973|NCT02495948|115999|P1|STARTED|Period 2, Second 30 Days of Wear||83
48974|NCT02495948|115998|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||1
48975|NCT02495948|115999|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
48976|NCT02495948|115998|P2|COMPLETED|Period 1, First 30 Days of Wear||83
48977|NCT02495948|115999|P1|COMPLETED|Period 1, First 30 Days of Wear||83
48978|NCT02495948|115998|P2|STARTED|Period 1, First 30 Days of Wear||84
48979|NCT02495948|115999|P1|STARTED|Period 1, First 30 Days of Wear||83
48980|NCT02495844|116008|P2|NOT COMPLETED|Overall Study||4
48981|NCT02495844|116009|P1|NOT COMPLETED|Overall Study||1
48982|NCT02495844|116008|P2|COMPLETED|Overall Study||24
48983|NCT02495844|116009|P1|COMPLETED|Overall Study||26
48984|NCT02495844|116008|P2|STARTED|Overall Study||28
48985|NCT02495844|116009|P1|STARTED|Overall Study||27
48986|NCT02495831|116039|P2|NOT COMPLETED|Second Intervention||0
48987|NCT02495831|116040|P1|NOT COMPLETED|Second Intervention||0
48988|NCT02495831|116039|P2|COMPLETED|Second Intervention||10
48989|NCT02495831|116040|P1|COMPLETED|Second Intervention||12
48990|NCT02495831|116039|P2|STARTED|Second Intervention||10
48991|NCT02495831|116040|P1|STARTED|Second Intervention|One participant withdrew at the end of period 1|12
48992|NCT02495831|116039|P2|NOT COMPLETED|First Intervention||0
48993|NCT02495831|116040|P1|NOT COMPLETED|First Intervention||0
48994|NCT02495831|116039|P2|COMPLETED|First Intervention||10
48995|NCT02495831|116040|P1|COMPLETED|First Intervention||13
48996|NCT02495831|116039|P2|STARTED|First Intervention||10
48997|NCT02495831|116040|P1|STARTED|First Intervention||13
48998|NCT02495779|116054|P1|NOT COMPLETED|Overall Study||6
48999|NCT02495779|116054|P1|COMPLETED|Overall Study||48
49000|NCT02495779|116054|P1|STARTED|Overall Study||54
49001|NCT02495623|116061|P3|NOT COMPLETED|Overall Study||8
49002|NCT02495623|116062|P2|NOT COMPLETED|Overall Study||9
49003|NCT02495623|116063|P1|NOT COMPLETED|Overall Study||5
49004|NCT02495623|116061|P3|COMPLETED|Overall Study||20
49005|NCT02495623|116062|P2|COMPLETED|Overall Study||17
49006|NCT02495623|116063|P1|COMPLETED|Overall Study||20
49007|NCT02495623|116061|P3|Dosed|Overall Study||22
49008|NCT02495623|116062|P2|Dosed|Overall Study||19
49009|NCT02495623|116063|P1|Dosed|Overall Study||22
49010|NCT02495623|116061|P3|STARTED|Overall Study||28
49011|NCT02495623|116062|P2|STARTED|Overall Study||26
49012|NCT02495623|116063|P1|STARTED|Overall Study||25
49013|NCT02495259|116074|P3|NOT COMPLETED|Overall Study||0
49014|NCT02495259|116075|P2|NOT COMPLETED|Overall Study||1
49015|NCT02495259|116076|P1|NOT COMPLETED|Overall Study||0
49016|NCT02495259|116074|P3|COMPLETED|Overall Study||8
49017|NCT02495259|116075|P2|COMPLETED|Overall Study||3
49018|NCT02495259|116076|P1|COMPLETED|Overall Study||7
49019|NCT02495259|116074|P3|STARTED|Overall Study||8
49020|NCT02495259|116075|P2|STARTED|Overall Study||4
49021|NCT02495259|116076|P1|STARTED|Overall Study||7
49022|NCT02495233|116101|P2|NOT COMPLETED|Overall Study||1
49023|NCT02495233|116102|P1|NOT COMPLETED|Overall Study||0
49024|NCT02495233|116101|P2|COMPLETED|Overall Study||6
49025|NCT02495233|116102|P1|COMPLETED|Overall Study||3
49026|NCT02495233|116101|P2|STARTED|Overall Study||7
49027|NCT02495233|116102|P1|STARTED|Overall Study||3
49028|NCT02495168|116131|P3|NOT COMPLETED|Overall Study||17
49029|NCT02495168|116132|P2|NOT COMPLETED|Overall Study||54
49030|NCT02495168|116133|P1|NOT COMPLETED|Overall Study||38
49031|NCT02495168|116131|P3|COMPLETED|Overall Study||110
49032|NCT02495168|116132|P2|COMPLETED|Overall Study||462
49033|NCT02495168|116133|P1|COMPLETED|Overall Study||466
49034|NCT02495168|116131|P3|Day 42 (D42PPS) Population|Overall Study||88
49035|NCT02495168|116132|P2|Day 42 (D42PPS) Population|Overall Study||383
49036|NCT02495168|116133|P1|Day 42 (D42PPS) Population|Overall Study||382
49037|NCT02495168|116131|P3|Day1 Per-protocol Set (D1PPS) Population|Overall Study||99
49038|NCT02495168|116132|P2|Day1 Per-protocol Set (D1PPS) Population|Overall Study||437
49039|NCT02495168|116133|P1|Day1 Per-protocol Set (D1PPS) Population|Overall Study||437
49040|NCT02495168|116131|P3|Modified Intent-to-Treat Population|Overall Study||111
49041|NCT02495168|116132|P2|Modified Intent-to-Treat Population|Overall Study||478
49042|NCT02495168|116133|P1|Modified Intent-to-Treat Population|Overall Study||468
49043|NCT02495168|116131|P3|Safety Population|Overall Study||126
49044|NCT02495168|116132|P2|Safety Population|Overall Study||514
49045|NCT02495168|116133|P1|Safety Population|Overall Study||501
49046|NCT02495168|116131|P3|STARTED|Overall Study||127
49047|NCT02495168|116132|P2|STARTED|Overall Study||516
49048|NCT02495168|116133|P1|STARTED|Overall Study||504
49049|NCT02495038|116153|P3|NOT COMPLETED|Overall Study||0
49050|NCT02495038|116154|P2|NOT COMPLETED|Overall Study||0
49051|NCT02495038|116155|P1|NOT COMPLETED|Overall Study||0
49052|NCT02495038|116153|P3|COMPLETED|Overall Study||27
49053|NCT02495038|116154|P2|COMPLETED|Overall Study||27
49054|NCT02495038|116155|P1|COMPLETED|Overall Study||27
49055|NCT02495038|116153|P3|STARTED|Overall Study||27
49056|NCT02495038|116154|P2|STARTED|Overall Study||27
49057|NCT02495038|116155|P1|STARTED|Overall Study||27
49058|NCT02495025|116192|P2|NOT COMPLETED|Overall Study||14
49059|NCT02495025|116193|P1|NOT COMPLETED|Overall Study||26
49060|NCT02495025|116192|P2|COMPLETED|Overall Study||61
49061|NCT02495025|116193|P1|COMPLETED|Overall Study||51
49062|NCT02495025|116192|P2|STARTED|Overall Study||75
49063|NCT02495025|116193|P1|STARTED|Overall Study||77
49064|NCT02494817|116207|P2|NOT COMPLETED|Overall Study||49
49065|NCT02494817|116208|P1|NOT COMPLETED|Overall Study||55
49066|NCT02494817|116207|P2|COMPLETED|Overall Study|41 couples and 5 partnered men completed all 3 assessments (baseline, 3- and 6-month)|87
49067|NCT02494817|116208|P1|COMPLETED|Overall Study|49 couples and 9 partnered men completed all 3 assessments (baseline, 3- and 6-month)|107
49068|NCT02494817|116207|P2|6 Month Assessment|Overall Study|represents 45 couples and 8 partnered men|98
49069|NCT02494817|116208|P1|6 Month Assessment|Overall Study|represents 52 couples and 11 partnered men|115
49070|NCT02494817|116207|P2|3 Month Assessment|Overall Study|represents 44 couples and 4 partnered men|92
49071|NCT02494817|116208|P1|3 Month Assessment|Overall Study|represents 59 couples and 7 partnered men|125
49072|NCT02494817|116207|P2|STARTED|Overall Study|representing 68 couples|136
49073|NCT02494817|116208|P1|STARTED|Overall Study|representing 81 couples|162
49074|NCT02494713|116228|P1|NOT COMPLETED|Overall Study||0
49075|NCT02494713|116228|P1|COMPLETED|Overall Study||4
49076|NCT02494713|116228|P1|STARTED|Overall Study||4
49077|NCT02494596|116245|P3|NOT COMPLETED|Overall Study||1
49078|NCT02494596|116246|P2|NOT COMPLETED|Overall Study||5
49079|NCT02494596|116247|P1|NOT COMPLETED|Overall Study||3
49080|NCT02494596|116245|P3|COMPLETED|Overall Study||6
49081|NCT02494596|116246|P2|COMPLETED|Overall Study||2
49082|NCT02494596|116247|P1|COMPLETED|Overall Study||2
49083|NCT02494596|116245|P3|STARTED|Overall Study||7
49084|NCT02494596|116246|P2|STARTED|Overall Study||7
49085|NCT02494596|116247|P1|STARTED|Overall Study||5
49086|NCT02494518|116275|P3|NOT COMPLETED|Overall Study||3
49087|NCT02494518|116276|P2|NOT COMPLETED|Overall Study||2
49088|NCT02494518|116277|P1|NOT COMPLETED|Overall Study||1
49089|NCT02494518|116275|P3|COMPLETED|Overall Study||8
49090|NCT02494518|116276|P2|COMPLETED|Overall Study||10
49091|NCT02494518|116277|P1|COMPLETED|Overall Study||10
49092|NCT02494518|116275|P3|STARTED|Overall Study||11
49093|NCT02494518|116276|P2|STARTED|Overall Study||12
49094|NCT02494518|116277|P1|STARTED|Overall Study||11
49095|NCT02494440|116309|P1|NOT COMPLETED|Overall Study||0
49096|NCT02494440|116309|P1|COMPLETED|Overall Study||90
49097|NCT02494440|116309|P1|STARTED|Overall Study||90
49098|NCT02494401|116317|P2|NOT COMPLETED|Overall Study||27
49099|NCT02494401|116318|P1|NOT COMPLETED|Overall Study||25
49100|NCT02494401|116317|P2|COMPLETED|Overall Study||106
49101|NCT02494401|116318|P1|COMPLETED|Overall Study||109
49102|NCT02494401|116317|P2|6 Month Follow up|Overall Study||106
49103|NCT02494401|116318|P1|6 Month Follow up|Overall Study||109
49104|NCT02494401|116317|P2|Week 16|Overall Study||124
49105|NCT02494401|116318|P1|Week 16|Overall Study||123
49106|NCT02494401|116317|P2|STARTED|Overall Study||133
49107|NCT02494401|116318|P1|STARTED|Overall Study||134
49108|NCT02494323|116356|P1|NOT COMPLETED|Overall Study||0
49109|NCT02494323|116356|P1|COMPLETED|Overall Study||70
49110|NCT02494323|116356|P1|STARTED|Overall Study||70
49111|NCT02494206|116361|P1|NOT COMPLETED|Overall Study||2
49112|NCT02494206|116361|P1|COMPLETED|Overall Study||7
49113|NCT02494206|116361|P1|STARTED|Overall Study||9
49114|NCT02494180|116367|P2|NOT COMPLETED|Overall Study||0
49115|NCT02494180|116368|P1|NOT COMPLETED|Overall Study||0
49116|NCT02494180|116367|P2|COMPLETED|Overall Study||85
49117|NCT02494180|116368|P1|COMPLETED|Overall Study||85
49118|NCT02494180|116367|P2|STARTED|Overall Study||85
49119|NCT02494180|116368|P1|STARTED|Overall Study||85
49120|NCT02494102|116390|P2|NOT COMPLETED|Overall Study||0
49121|NCT02494102|116391|P1|NOT COMPLETED|Overall Study||0
49122|NCT02494102|116390|P2|COMPLETED|Overall Study||47
49123|NCT02494102|116391|P1|COMPLETED|Overall Study||42
49124|NCT02494102|116390|P2|STARTED|Overall Study||47
49125|NCT02494102|116391|P1|STARTED|Overall Study||42
49126|NCT02494076|116401|P2|NOT COMPLETED|Overall Study||0
49127|NCT02494076|116402|P1|NOT COMPLETED|Overall Study||0
49128|NCT02494076|116401|P2|COMPLETED|Overall Study||26
49129|NCT02494076|116402|P1|COMPLETED|Overall Study||26
49130|NCT02494076|116401|P2|STARTED|Overall Study||26
49131|NCT02494076|116402|P1|STARTED|Overall Study||26
49132|NCT02493946|116415|P3|NOT COMPLETED|Open Label Period||86
49133|NCT02493946|116416|P2|NOT COMPLETED|Open Label Period||0
49134|NCT02493946|116417|P1|NOT COMPLETED|Open Label Period||0
49135|NCT02493946|116415|P3|COMPLETED|Open Label Period||509
49136|NCT02493946|116416|P2|COMPLETED|Open Label Period||0
49137|NCT02493946|116417|P1|COMPLETED|Open Label Period||0
49138|NCT02493946|116415|P3|STARTED|Open Label Period|The previous period relates to DB period only, this period relates to OL treatment only.|595
49139|NCT02493946|116416|P2|STARTED|Open Label Period|Only the BTX-A-HAC Solution 50 U - LT Analyses arm is applicable for this period.|0
49140|NCT02493946|116417|P1|STARTED|Open Label Period|Only the BTX-A-HAC Solution 50 U - LT Analyses arm is applicable for this period.|0
49141|NCT02493946|116415|P3|NOT COMPLETED|DB Period||0
49142|NCT02493946|116416|P2|NOT COMPLETED|DB Period||5
49143|NCT02493946|116417|P1|NOT COMPLETED|DB Period||8
49144|NCT02493946|116415|P3|COMPLETED|DB Period||0
49145|NCT02493946|116416|P2|COMPLETED|DB Period||59
49146|NCT02493946|116417|P1|COMPLETED|DB Period||118
49147|NCT02493946|116415|P3|STARTED|DB Period||0
49148|NCT02493946|116416|P2|STARTED|DB Period||64
49149|NCT02493946|116417|P1|STARTED|DB Period||126
49150|NCT02493868|116450|P2|NOT COMPLETED|Follow-up Phase||2
49151|NCT02493868|116451|P1|NOT COMPLETED|Follow-up Phase||11
49152|NCT02493868|116450|P2|COMPLETED|Follow-up Phase||62
49153|NCT02493868|116451|P1|COMPLETED|Follow-up Phase||470
49154|NCT02493868|116450|P2|STARTED|Follow-up Phase||64
49155|NCT02493868|116451|P1|STARTED|Follow-up Phase||481
49156|NCT02493868|116450|P2|NOT COMPLETED|Maintenance Phase: DE+TE Participants||22
49157|NCT02493868|116451|P1|NOT COMPLETED|Maintenance Phase: DE+TE Participants||13
49158|NCT02493868|116450|P2|COMPLETED|Maintenance Phase: DE+TE Participants||177
49159|NCT02493868|116451|P1|COMPLETED|Maintenance Phase: DE+TE Participants||139
49160|NCT02493868|116450|P2|Stable Responders|Maintenance Phase: DE+TE Participants||59
49161|NCT02493868|116451|P1|Stable Responders|Maintenance Phase: DE+TE Participants||62
49162|NCT02493868|116450|P2|Stable Remitters|Maintenance Phase: DE+TE Participants||86
49163|NCT02493868|116451|P1|Stable Remitters|Maintenance Phase: DE+TE Participants||90
49164|NCT02493868|116450|P2|STARTED|Maintenance Phase: DE+TE Participants|145 participants randomized from intranasal esketamine arm after OP phase+54 continued from OP phase|199
49165|NCT02493868|116451|P1|STARTED|Maintenance Phase: DE+TE Participants|152 participants randomized from intranasal esketamine arm after OP phase: DE (90) + TE (62)|152
49166|NCT02493868|116450|P2|NOT COMPLETED|Optimization Phase: DE+TE Participants||32
49167|NCT02493868|116451|P1|NOT COMPLETED|Optimization Phase: DE+TE Participants||158
49168|NCT02493868|116450|P2|COMPLETED|Optimization Phase: DE+TE Participants|Participants who completed and met predefined remission/response criteria continued to MA phase.|54
49169|NCT02493868|116451|P1|COMPLETED|Optimization Phase: DE+TE Participants|Participants who completed and met predefined remission/response criteria randomized to MA phase|297
49170|NCT02493868|116450|P2|STARTED|Optimization Phase: DE+TE Participants|Placebo treated transferred-entry participant.|86
49171|NCT02493868|116451|P1|STARTED|Optimization Phase: DE+TE Participants|Total participants: direct-entry (273) + esketamine-treated transferred-entry participants (182).|455
49172|NCT02493868|116450|P2|NOT COMPLETED|Induction Phase: DE Participants||0
49173|NCT02493868|116451|P1|NOT COMPLETED|Induction Phase: DE Participants||164
49174|NCT02493868|116450|P2|COMPLETED|Induction Phase: DE Participants||0
49175|NCT02493868|116451|P1|COMPLETED|Induction Phase: DE Participants|Participants who completed and met predefined response criteria continued to OP phase.|273
49176|NCT02493868|116450|P2|STARTED|Induction Phase: DE Participants||0
49177|NCT02493868|116451|P1|STARTED|Induction Phase: DE Participants||437
49178|NCT02493855|116500|P3|NOT COMPLETED|Overall Study||0
49179|NCT02493855|116501|P2|NOT COMPLETED|Overall Study||1
49180|NCT02493855|116502|P1|NOT COMPLETED|Overall Study||2
49181|NCT02493855|116500|P3|COMPLETED|Overall Study||6
49182|NCT02493855|116501|P2|COMPLETED|Overall Study||18
49183|NCT02493855|116502|P1|COMPLETED|Overall Study||19
49184|NCT02493855|116500|P3|STARTED|Overall Study||6
49185|NCT02493855|116501|P2|STARTED|Overall Study||19
49186|NCT02493855|116502|P1|STARTED|Overall Study||21
49187|NCT02493777|116512|P2|NOT COMPLETED|Overall Study||1
49188|NCT02493777|116513|P1|NOT COMPLETED|Overall Study||0
49189|NCT02493777|116512|P2|COMPLETED|Overall Study||53
49190|NCT02493777|116513|P1|COMPLETED|Overall Study||65
49191|NCT02493777|116512|P2|STARTED|Overall Study||54
49192|NCT02493777|116513|P1|STARTED|Overall Study||65
49193|NCT02493751|116523|P2|NOT COMPLETED|Overall Study||29
49194|NCT02493751|116524|P1|NOT COMPLETED|Overall Study||13
49195|NCT02493751|116523|P2|COMPLETED|Overall Study|Participants who died were considered as completed.|10
49196|NCT02493751|116524|P1|COMPLETED|Overall Study|Participants who died were considered as completed.|3
49197|NCT02493751|116523|P2|STARTED|Overall Study||39
49198|NCT02493751|116524|P1|STARTED|Overall Study||16
49199|NCT02493621|116531|P2|NOT COMPLETED|Overall Study||0
49200|NCT02493621|116532|P1|NOT COMPLETED|Overall Study||0
49201|NCT02493621|116531|P2|COMPLETED|Overall Study||58
49202|NCT02493621|116532|P1|COMPLETED|Overall Study||58
49203|NCT02493621|116531|P2|STARTED|Overall Study||58
49204|NCT02493621|116532|P1|STARTED|Overall Study||58
49205|NCT02493517|116542|P2|NOT COMPLETED|Overall Study||7
49206|NCT02493517|116543|P1|NOT COMPLETED|Overall Study||2
49207|NCT02493517|116542|P2|COMPLETED|Overall Study||57
49208|NCT02493517|116543|P1|COMPLETED|Overall Study||62
49209|NCT02493517|116542|P2|STARTED|Overall Study||64
49210|NCT02493517|116543|P1|STARTED|Overall Study||64
49211|NCT02493452|116568|P3|NOT COMPLETED|Overall Study||54
49212|NCT02493452|116569|P2|NOT COMPLETED|Overall Study||49
49213|NCT02493452|116570|P1|NOT COMPLETED|Overall Study||50
49214|NCT02493452|116568|P3|COMPLETED|Overall Study||325
49215|NCT02493452|116569|P2|COMPLETED|Overall Study||328
49216|NCT02493452|116570|P1|COMPLETED|Overall Study||329
49217|NCT02493452|116568|P3|STARTED|Overall Study||379
49218|NCT02493452|116569|P2|STARTED|Overall Study||377
49219|NCT02493452|116570|P1|STARTED|Overall Study||379
49220|NCT02493361|116602|P1|NOT COMPLETED|Overall Study||14
49221|NCT02493361|116602|P1|COMPLETED|Overall Study||10
49222|NCT02493361|116602|P1|STARTED|Overall Study||24
49223|NCT02493127|116608|P2|NOT COMPLETED|Overall Study||1
49224|NCT02493127|116609|P1|NOT COMPLETED|Overall Study||1
49225|NCT02493127|116608|P2|COMPLETED|Overall Study||60
49226|NCT02493127|116609|P1|COMPLETED|Overall Study||60
49227|NCT02493127|116608|P2|STARTED|Overall Study||61
49228|NCT02493127|116609|P1|STARTED|Overall Study||61
49229|NCT02493088|116621|P1|NOT COMPLETED|Overall Study||0
49230|NCT02493088|116621|P1|COMPLETED|Overall Study||11
49231|NCT02493088|116621|P1|STARTED|Overall Study||11
49232|NCT02493062|116627|P1|NOT COMPLETED|Overall Study||12
49233|NCT02493062|116627|P1|COMPLETED|Overall Study||23
49234|NCT02493062|116627|P1|STARTED|Overall Study||35
49235|NCT02493036|116638|P3|NOT COMPLETED|Overall Study||2
49236|NCT02493036|116639|P2|NOT COMPLETED|Overall Study||2
49237|NCT02493036|116640|P1|NOT COMPLETED|Overall Study||1
49238|NCT02493036|116638|P3|COMPLETED|Overall Study||15
49239|NCT02493036|116639|P2|COMPLETED|Overall Study||18
49240|NCT02493036|116640|P1|COMPLETED|Overall Study||16
49241|NCT02493036|116638|P3|STARTED|Overall Study||17
49242|NCT02493036|116639|P2|STARTED|Overall Study||20
49243|NCT02493036|116640|P1|STARTED|Overall Study||17
49244|NCT02492984|116650|P2|NOT COMPLETED|Overall Study||0
49245|NCT02492984|116651|P1|NOT COMPLETED|Overall Study||3
49246|NCT02492984|116650|P2|COMPLETED|Overall Study||14
49247|NCT02492984|116651|P1|COMPLETED|Overall Study||70
49248|NCT02492984|116650|P2|STARTED|Overall Study||14
49249|NCT02492984|116651|P1|STARTED|Overall Study||73
49250|NCT02492958|116675|P4|NOT COMPLETED|Overall Study||0
49251|NCT02492958|116676|P3|NOT COMPLETED|Overall Study||2
49252|NCT02492958|116677|P2|NOT COMPLETED|Overall Study||0
49253|NCT02492958|116678|P1|NOT COMPLETED|Overall Study||1
49254|NCT02492958|116675|P4|COMPLETED|Overall Study||34
49255|NCT02492958|116676|P3|COMPLETED|Overall Study||32
49256|NCT02492958|116677|P2|COMPLETED|Overall Study||34
49257|NCT02492958|116678|P1|COMPLETED|Overall Study||33
49258|NCT02492958|116675|P4|STARTED|Overall Study||34
49259|NCT02492958|116676|P3|STARTED|Overall Study||34
49260|NCT02492958|116677|P2|STARTED|Overall Study||34
49261|NCT02492958|116678|P1|STARTED|Overall Study||34
49262|NCT02492880|116764|P1|NOT COMPLETED|Overall Study||2
49263|NCT02492880|116764|P1|COMPLETED|Overall Study||13
49264|NCT02492880|116764|P1|STARTED|Overall Study||15
49265|NCT02492841|116771|P3|NOT COMPLETED|Overall Study||35
49266|NCT02492841|116772|P2|NOT COMPLETED|Overall Study||31
49267|NCT02492841|116773|P1|NOT COMPLETED|Overall Study||34
49268|NCT02492841|116771|P3|COMPLETED|Overall Study||25
49269|NCT02492841|116772|P2|COMPLETED|Overall Study||22
49270|NCT02492841|116773|P1|COMPLETED|Overall Study||22
49271|NCT02492841|116771|P3|STARTED|Overall Study||60
49272|NCT02492841|116772|P2|STARTED|Overall Study||53
49273|NCT02492841|116773|P1|STARTED|Overall Study||56
49274|NCT02492802|116784|P1|NOT COMPLETED|Overall Study||0
49275|NCT02492802|116784|P1|COMPLETED|Overall Study||64
49276|NCT02492802|116784|P1|STARTED|Overall Study||64
49277|NCT02492763|116792|P4|NOT COMPLETED|Overall Study||13
49278|NCT02492763|116793|P3|NOT COMPLETED|Overall Study||10
49279|NCT02492763|116794|P2|NOT COMPLETED|Overall Study||15
49280|NCT02492763|116795|P1|NOT COMPLETED|Overall Study||16
49281|NCT02492763|116792|P4|COMPLETED|Overall Study||30
49282|NCT02492763|116793|P3|COMPLETED|Overall Study||33
49283|NCT02492763|116794|P2|COMPLETED|Overall Study||29
49284|NCT02492763|116795|P1|COMPLETED|Overall Study||30
49285|NCT02492763|116792|P4|Treated|Overall Study||42
49286|NCT02492763|116793|P3|Treated|Overall Study||43
49287|NCT02492763|116794|P2|Treated|Overall Study||44
49288|NCT02492763|116795|P1|Treated|Overall Study||46
49289|NCT02492763|116792|P4|STARTED|Overall Study||43
49290|NCT02492763|116793|P3|STARTED|Overall Study||43
49291|NCT02492763|116794|P2|STARTED|Overall Study||44
49292|NCT02492763|116795|P1|STARTED|Overall Study||46
49293|NCT02492451|116852|P3|NOT COMPLETED|Overall Study||0
49294|NCT02492451|116853|P2|NOT COMPLETED|Overall Study||0
49295|NCT02492451|116854|P1|NOT COMPLETED|Overall Study||0
49296|NCT02492451|116852|P3|COMPLETED|Overall Study||39
49297|NCT02492451|116853|P2|COMPLETED|Overall Study||39
49298|NCT02492451|116854|P1|COMPLETED|Overall Study||40
49299|NCT02492451|116852|P3|STARTED|Overall Study||39
49300|NCT02492451|116853|P2|STARTED|Overall Study||39
49301|NCT02492451|116854|P1|STARTED|Overall Study||40
49302|NCT02492165|116866|P4|NOT COMPLETED|Overall Study||0
49303|NCT02492165|116867|P3|NOT COMPLETED|Overall Study||0
49304|NCT02492165|116868|P2|NOT COMPLETED|Overall Study||1
49305|NCT02492165|116869|P1|NOT COMPLETED|Overall Study||0
49306|NCT02492165|116866|P4|COMPLETED|Overall Study||30
49307|NCT02492165|116867|P3|COMPLETED|Overall Study||60
49308|NCT02492165|116868|P2|COMPLETED|Overall Study||59
49309|NCT02492165|116869|P1|COMPLETED|Overall Study||100
49310|NCT02492165|116866|P4|STARTED|Overall Study||30
49311|NCT02492165|116867|P3|STARTED|Overall Study||60
49312|NCT02492165|116868|P2|STARTED|Overall Study||60
49313|NCT02492165|116869|P1|STARTED|Overall Study||100
49314|NCT02492100|116891|P1|NOT COMPLETED|Overall Study||1
49315|NCT02492100|116891|P1|COMPLETED|Overall Study||46
49316|NCT02492100|116891|P1|STARTED|Overall Study||47
49317|NCT02491944|116898|P1|NOT COMPLETED|Overall Study||0
49318|NCT02491944|116898|P1|COMPLETED|Overall Study||10
49319|NCT02491944|116898|P1|STARTED|Overall Study||10
49320|NCT02491892|116920|P2|NOT COMPLETED|Overall Study||38
49321|NCT02491892|116921|P1|NOT COMPLETED|Overall Study||41
49322|NCT02491892|116920|P2|COMPLETED|Overall Study||0
49323|NCT02491892|116921|P1|COMPLETED|Overall Study||0
49324|NCT02491892|116920|P2|Treated|Overall Study|One participant was randomized but died before receiving study medication.|37
49325|NCT02491892|116921|P1|Treated|Overall Study||41
49326|NCT02491892|116920|P2|STARTED|Overall Study||38
49327|NCT02491892|116921|P1|STARTED|Overall Study||41
49328|NCT02491684|116967|P2|NOT COMPLETED|Treatment Phase||3
49329|NCT02491684|116968|P1|NOT COMPLETED|Treatment Phase||3
49330|NCT02491684|116967|P2|COMPLETED|Treatment Phase||57
49331|NCT02491684|116968|P1|COMPLETED|Treatment Phase||58
49332|NCT02491684|116967|P2|STARTED|Treatment Phase||60
49333|NCT02491684|116968|P1|STARTED|Treatment Phase||61
49334|NCT02491684|116967|P2|NOT COMPLETED|Pre-treatment Phase||0
49335|NCT02491684|116968|P1|NOT COMPLETED|Pre-treatment Phase||0
49336|NCT02491684|116967|P2|COMPLETED|Pre-treatment Phase||60
49337|NCT02491684|116968|P1|COMPLETED|Pre-treatment Phase||61
49338|NCT02491684|116967|P2|STARTED|Pre-treatment Phase||60
49339|NCT02491684|116968|P1|STARTED|Pre-treatment Phase||61
49340|NCT02491463|117006|P4|NOT COMPLETED|Overall Study||1
49341|NCT02491463|117007|P3|NOT COMPLETED|Overall Study||4
49342|NCT02491463|117008|P2|NOT COMPLETED|Overall Study||10
49343|NCT02491463|117009|P1|NOT COMPLETED|Overall Study||2
49344|NCT02491463|117006|P4|COMPLETED|Overall Study||14
49345|NCT02491463|117007|P3|COMPLETED|Overall Study||15
49346|NCT02491463|117008|P2|COMPLETED|Overall Study||21
49347|NCT02491463|117009|P1|COMPLETED|Overall Study||5
49348|NCT02491463|117006|P4|STARTED|Overall Study||15
49349|NCT02491463|117007|P3|STARTED|Overall Study||19
49350|NCT02491463|117008|P2|STARTED|Overall Study||31
49351|NCT02491463|117009|P1|STARTED|Overall Study||7
49352|NCT02491437|117097|P2|NOT COMPLETED|Overall Study||357
49353|NCT02491437|117098|P1|NOT COMPLETED|Overall Study||352
49354|NCT02491437|117097|P2|COMPLETED|Overall Study||157
49355|NCT02491437|117098|P1|COMPLETED|Overall Study||168
49356|NCT02491437|117097|P2|Full Analysis Sample|Overall Study||489
49357|NCT02491437|117098|P1|Full Analysis Sample|Overall Study||494
49358|NCT02491437|117097|P2|Safety Sample|Overall Study||512
49359|NCT02491437|117098|P1|Safety Sample|Overall Study||518
49360|NCT02491437|117097|P2|STARTED|Overall Study||514
49361|NCT02491437|117098|P1|STARTED|Overall Study||520
49362|NCT02491411|117112|P1|NOT COMPLETED|Overall Study||4
49363|NCT02491411|117112|P1|COMPLETED|Overall Study||0
49364|NCT02491411|117112|P1|STARTED|Overall Study||4
49365|NCT02491359|117122|P1|NOT COMPLETED|Overall Study||16
49366|NCT02491359|117122|P1|COMPLETED|Overall Study||4
49367|NCT02491359|117122|P1|STARTED|Overall Study||20
49368|NCT02491073|117143|P2|NOT COMPLETED|Overall Study||0
49369|NCT02491073|117144|P1|NOT COMPLETED|Overall Study||1
49370|NCT02491073|117143|P2|COMPLETED|Overall Study||34
49371|NCT02491073|117144|P1|COMPLETED|Overall Study||36
49372|NCT02491073|117143|P2|STARTED|Overall Study||34
49373|NCT02491073|117144|P1|STARTED|Overall Study||37
49374|NCT02490670|117172|P2|NOT COMPLETED|Period 2 (19 Days)||0
49375|NCT02490670|117173|P1|NOT COMPLETED|Period 2 (19 Days)||0
49376|NCT02490670|117172|P2|COMPLETED|Period 2 (19 Days)||14
49377|NCT02490670|117173|P1|COMPLETED|Period 2 (19 Days)||14
49378|NCT02490670|117172|P2|STARTED|Period 2 (19 Days)||14
49379|NCT02490670|117173|P1|STARTED|Period 2 (19 Days)||14
49380|NCT02490670|117172|P2|NOT COMPLETED|Washout Period (7 Days)||0
49381|NCT02490670|117173|P1|NOT COMPLETED|Washout Period (7 Days)||0
49382|NCT02490670|117172|P2|COMPLETED|Washout Period (7 Days)||14
49383|NCT02490670|117173|P1|COMPLETED|Washout Period (7 Days)||14
49384|NCT02490670|117172|P2|STARTED|Washout Period (7 Days)||14
49385|NCT02490670|117173|P1|STARTED|Washout Period (7 Days)||14
49386|NCT02490670|117172|P2|NOT COMPLETED|Period 1 (19 Days)||0
49387|NCT02490670|117173|P1|NOT COMPLETED|Period 1 (19 Days)||0
49388|NCT02490670|117172|P2|COMPLETED|Period 1 (19 Days)||14
49389|NCT02490670|117173|P1|COMPLETED|Period 1 (19 Days)||14
49390|NCT02490670|117172|P2|STARTED|Period 1 (19 Days)||14
49391|NCT02490670|117173|P1|STARTED|Period 1 (19 Days)||14
49392|NCT02490475|117185|P4|NOT COMPLETED|Period 2: Extension Phase||1
49393|NCT02490475|117186|P3|NOT COMPLETED|Period 2: Extension Phase||3
49394|NCT02490475|117187|P2|NOT COMPLETED|Period 2: Extension Phase||0
49395|NCT02490475|117188|P1|NOT COMPLETED|Period 2: Extension Phase||1
49396|NCT02490475|117185|P4|COMPLETED|Period 2: Extension Phase||0
49397|NCT02490475|117186|P3|COMPLETED|Period 2: Extension Phase||0
49398|NCT02490475|117187|P2|COMPLETED|Period 2: Extension Phase||0
49399|NCT02490475|117188|P1|COMPLETED|Period 2: Extension Phase||0
49400|NCT02490475|117185|P4|STARTED|Period 2: Extension Phase||1
49401|NCT02490475|117186|P3|STARTED|Period 2: Extension Phase||3
49402|NCT02490475|117187|P2|STARTED|Period 2: Extension Phase||0
49403|NCT02490475|117188|P1|STARTED|Period 2: Extension Phase||1
49404|NCT02490475|117185|P4|NOT COMPLETED|Period 1: First 6 Cycles||5
49405|NCT02490475|117186|P3|NOT COMPLETED|Period 1: First 6 Cycles||6
49406|NCT02490475|117187|P2|NOT COMPLETED|Period 1: First 6 Cycles||2
49407|NCT02490475|117188|P1|NOT COMPLETED|Period 1: First 6 Cycles||6
49408|NCT02490475|117185|P4|COMPLETED|Period 1: First 6 Cycles||0
49409|NCT02490475|117186|P3|COMPLETED|Period 1: First 6 Cycles||0
49410|NCT02490475|117187|P2|COMPLETED|Period 1: First 6 Cycles||0
49411|NCT02490475|117188|P1|COMPLETED|Period 1: First 6 Cycles||0
49412|NCT02490475|117185|P4|STARTED|Period 1: First 6 Cycles||5
49413|NCT02490475|117186|P3|STARTED|Period 1: First 6 Cycles||6
49414|NCT02490475|117187|P2|STARTED|Period 1: First 6 Cycles||2
49415|NCT02490475|117188|P1|STARTED|Period 1: First 6 Cycles||6
49416|NCT02490371|117266|P2|NOT COMPLETED|Overall Study||1
49417|NCT02490371|117267|P1|NOT COMPLETED|Overall Study||1
49418|NCT02490371|117266|P2|COMPLETED|Overall Study||11
49419|NCT02490371|117267|P1|COMPLETED|Overall Study||11
49420|NCT02490371|117266|P2|STARTED|Overall Study||12
49421|NCT02490371|117267|P1|STARTED|Overall Study||12
49422|NCT02490293|117285|P2|NOT COMPLETED|Overall Study||3
49423|NCT02490293|117286|P1|NOT COMPLETED|Overall Study||2
49424|NCT02490293|117285|P2|COMPLETED|Overall Study||99
49425|NCT02490293|117286|P1|COMPLETED|Overall Study||94
49426|NCT02490293|117285|P2|STARTED|Overall Study||102
49427|NCT02490293|117286|P1|STARTED|Overall Study||96
49428|NCT02489981|117294|P1|NOT COMPLETED|Overall Study||127
49429|NCT02489981|117294|P1|COMPLETED|Overall Study||213
49430|NCT02489981|117294|P1|STARTED|Overall Study||340
49431|NCT02489968|117301|P6|NOT COMPLETED|Double-blind Treatment Period||8
49432|NCT02489968|117302|P5|NOT COMPLETED|Double-blind Treatment Period||6
49433|NCT02489968|117303|P4|NOT COMPLETED|Double-blind Treatment Period||8
49434|NCT02489968|117304|P3|NOT COMPLETED|Double-blind Treatment Period||2
49435|NCT02489968|117305|P2|NOT COMPLETED|Double-blind Treatment Period||0
49436|NCT02489968|117306|P1|NOT COMPLETED|Double-blind Treatment Period||0
49437|NCT02489968|117301|P6|COMPLETED|Double-blind Treatment Period||108
49438|NCT02489968|117302|P5|COMPLETED|Double-blind Treatment Period||110
49439|NCT02489968|117303|P4|COMPLETED|Double-blind Treatment Period||100
49440|NCT02489968|117304|P3|COMPLETED|Double-blind Treatment Period||105
49441|NCT02489968|117305|P2|COMPLETED|Double-blind Treatment Period||0
49442|NCT02489968|117306|P1|COMPLETED|Double-blind Treatment Period||0
49443|NCT02489968|117301|P6|STARTED|Double-blind Treatment Period||116
49444|NCT02489968|117302|P5|STARTED|Double-blind Treatment Period||116
49445|NCT02489968|117303|P4|STARTED|Double-blind Treatment Period||108
49446|NCT02489968|117304|P3|STARTED|Double-blind Treatment Period||107
49447|NCT02489968|117305|P2|STARTED|Double-blind Treatment Period||0
49448|NCT02489968|117306|P1|STARTED|Double-blind Treatment Period||0
49449|NCT02489968|117301|P6|NOT COMPLETED|Open-label Treatment Period||0
49450|NCT02489968|117302|P5|NOT COMPLETED|Open-label Treatment Period||0
49451|NCT02489968|117303|P4|NOT COMPLETED|Open-label Treatment Period||0
49452|NCT02489968|117304|P3|NOT COMPLETED|Open-label Treatment Period||0
49453|NCT02489968|117305|P2|NOT COMPLETED|Open-label Treatment Period||208
49454|NCT02489968|117306|P1|NOT COMPLETED|Open-label Treatment Period||224
49455|NCT02489968|117301|P6|COMPLETED|Open-label Treatment Period||0
49456|NCT02489968|117302|P5|COMPLETED|Open-label Treatment Period||0
49457|NCT02489968|117303|P4|COMPLETED|Open-label Treatment Period||0
49458|NCT02489968|117304|P3|COMPLETED|Open-label Treatment Period||0
49459|NCT02489968|117305|P2|COMPLETED|Open-label Treatment Period||232
49460|NCT02489968|117306|P1|COMPLETED|Open-label Treatment Period||215
49461|NCT02489968|117301|P6|STARTED|Open-label Treatment Period||0
49462|NCT02489968|117302|P5|STARTED|Open-label Treatment Period||0
49463|NCT02489968|117303|P4|STARTED|Open-label Treatment Period||0
49464|NCT02489968|117304|P3|STARTED|Open-label Treatment Period||0
49465|NCT02489968|117305|P2|STARTED|Open-label Treatment Period|1 subject did not receive treatment and hence excluded. Started represents treated numbers.|440
49466|NCT02489968|117306|P1|STARTED|Open-label Treatment Period||439
49467|NCT02489799|117320|P2|NOT COMPLETED|Overall Study||9
49468|NCT02489799|117321|P1|NOT COMPLETED|Overall Study||9
49469|NCT02489799|117320|P2|COMPLETED|Overall Study||38
49470|NCT02489799|117321|P1|COMPLETED|Overall Study||36
49471|NCT02489799|117320|P2|Postsurgical One Week Visit (V3)|Overall Study||39
49472|NCT02489799|117321|P1|Postsurgical One Week Visit (V3)|Overall Study||40
49473|NCT02489799|117320|P2|Presurgical Consent Visit (V2)|Overall Study||39
49474|NCT02489799|117321|P1|Presurgical Consent Visit (V2)|Overall Study||40
49475|NCT02489799|117320|P2|STARTED|Overall Study||47
49476|NCT02489799|117321|P1|STARTED|Overall Study||45
49477|NCT02489773|117347|P2|NOT COMPLETED|Overall Study||2
49478|NCT02489773|117348|P1|NOT COMPLETED|Overall Study||7
49479|NCT02489773|117347|P2|COMPLETED|Overall Study||50
49480|NCT02489773|117348|P1|COMPLETED|Overall Study||91
49481|NCT02489773|117347|P2|STARTED|Overall Study||52
49482|NCT02489773|117348|P1|STARTED|Overall Study||98
49483|NCT02489500|117358|P2|NOT COMPLETED|Overall Study||1
49484|NCT02489500|117359|P1|NOT COMPLETED|Overall Study||1
49485|NCT02489500|117358|P2|COMPLETED|Overall Study||0
49486|NCT02489500|117359|P1|COMPLETED|Overall Study||1
49487|NCT02489500|117358|P2|STARTED|Overall Study||1
49488|NCT02489500|117359|P1|STARTED|Overall Study||2
49489|NCT02489357|117371|P1|NOT COMPLETED|Overall Study||0
49490|NCT02489357|117371|P1|COMPLETED|Overall Study||12
49491|NCT02489357|117371|P1|STARTED|Overall Study||12
49492|NCT02489279|117379|P2|NOT COMPLETED|Overall Study||10
49493|NCT02489279|117380|P1|NOT COMPLETED|Overall Study||12
49494|NCT02489279|117379|P2|COMPLETED|Overall Study||31
49495|NCT02489279|117380|P1|COMPLETED|Overall Study||32
49496|NCT02489279|117379|P2|STARTED|Overall Study||41
49497|NCT02489279|117380|P1|STARTED|Overall Study||44
49498|NCT02489227|117395|P3|NOT COMPLETED|Overall Study||19
49499|NCT02489227|117396|P2|NOT COMPLETED|Overall Study||34
49500|NCT02489227|117397|P1|NOT COMPLETED|Overall Study||54
49501|NCT02489227|117395|P3|COMPLETED|Overall Study||117
49502|NCT02489227|117396|P2|COMPLETED|Overall Study||101
49503|NCT02489227|117397|P1|COMPLETED|Overall Study||220
49504|NCT02489227|117395|P3|STARTED|Overall Study||136
49505|NCT02489227|117396|P2|STARTED|Overall Study||135
49506|NCT02489227|117397|P1|STARTED|Overall Study||274
49507|NCT02489110|117409|P2|NOT COMPLETED|Overall Study||25
49508|NCT02489110|117410|P1|NOT COMPLETED|Overall Study||27
49509|NCT02489110|117409|P2|COMPLETED|Overall Study||50
49510|NCT02489110|117410|P1|COMPLETED|Overall Study||48
49511|NCT02489110|117409|P2|STARTED|Overall Study||75
49512|NCT02489110|117410|P1|STARTED|Overall Study||75
49513|NCT02488980|117421|P3|NOT COMPLETED|Overall Study||2
49514|NCT02488980|117422|P2|NOT COMPLETED|Overall Study||2
49515|NCT02488980|117423|P1|NOT COMPLETED|Overall Study||2
49516|NCT02488980|117421|P3|COMPLETED|Overall Study||99
49517|NCT02488980|117422|P2|COMPLETED|Overall Study||99
49518|NCT02488980|117423|P1|COMPLETED|Overall Study||102
49519|NCT02488980|117421|P3|STARTED|Overall Study||101
49520|NCT02488980|117422|P2|STARTED|Overall Study||101
49521|NCT02488980|117423|P1|STARTED|Overall Study||104
49522|NCT02488915|117440|P1|NOT COMPLETED|Overall Study||26
49523|NCT02488915|117440|P1|COMPLETED|Overall Study||202
49524|NCT02488915|117440|P1|STARTED|Overall Study||228
49525|NCT02488824|117458|P2|NOT COMPLETED|Overall Study||1
49526|NCT02488824|117459|P1|NOT COMPLETED|Overall Study||1
49527|NCT02488824|117458|P2|COMPLETED|Overall Study||19
49528|NCT02488824|117459|P1|COMPLETED|Overall Study||20
49529|NCT02488824|117458|P2|STARTED|Overall Study||20
49530|NCT02488824|117459|P1|STARTED|Overall Study||21
49531|NCT02488681|117473|P1|NOT COMPLETED|Overall Study||7
49532|NCT02488681|117473|P1|COMPLETED|Overall Study|Patients successfully implanted with Micra|269
49533|NCT02488681|117473|P1|STARTED|Overall Study|Patients with Micra implant attempt|276
49534|NCT02488330|117477|P1|NOT COMPLETED|Overall Study||12
49535|NCT02488330|117477|P1|COMPLETED|Overall Study||0
49536|NCT02488330|117477|P1|STARTED|Overall Study||12
49537|NCT02488317|117483|P2|NOT COMPLETED|Overall Study||47
49538|NCT02488317|117484|P1|NOT COMPLETED|Overall Study||54
49539|NCT02488317|117483|P2|COMPLETED|Overall Study||70
49540|NCT02488317|117484|P1|COMPLETED|Overall Study||63
49541|NCT02488317|117483|P2|STARTED|Overall Study||117
49542|NCT02488317|117484|P1|STARTED|Overall Study||117
49543|NCT02488239|117498|P1|NOT COMPLETED|Overall Study||10
49544|NCT02488239|117498|P1|COMPLETED|Overall Study||54
49545|NCT02488239|117498|P1|STARTED|Overall Study||64
49546|NCT02488070|117503|P1|NOT COMPLETED|Overall Study||0
49547|NCT02488070|117503|P1|COMPLETED|Overall Study||10
49548|NCT02488070|117503|P1|STARTED|Overall Study||10
49549|NCT02488018|117511|P1|NOT COMPLETED|Overall Study||0
49550|NCT02488018|117511|P1|COMPLETED|Overall Study||10
49551|NCT02488018|117511|P1|STARTED|Overall Study||10
49552|NCT02488005|117515|P1|NOT COMPLETED|Overall Study||2
49553|NCT02488005|117515|P1|COMPLETED|Overall Study||13
49554|NCT02488005|117515|P1|STARTED|Overall Study||15
49555|NCT02487979|117525|P1|NOT COMPLETED|Overall Study||21
49556|NCT02487979|117525|P1|COMPLETED|Overall Study||1
49557|NCT02487979|117525|P1|STARTED|Overall Study||22
49558|NCT02487810|117537|P2|NOT COMPLETED|Overall Study||0
49559|NCT02487810|117538|P1|NOT COMPLETED|Overall Study||1
49560|NCT02487810|117537|P2|COMPLETED|Overall Study||102
49561|NCT02487810|117538|P1|COMPLETED|Overall Study||97
49562|NCT02487810|117537|P2|STARTED|Overall Study||102
49563|NCT02487810|117538|P1|STARTED|Overall Study||98
49564|NCT02487771|117570|P2|NOT COMPLETED|Overall Study||14
49565|NCT02487771|117571|P1|NOT COMPLETED|Overall Study||10
49566|NCT02487771|117570|P2|COMPLETED|Overall Study||85
49567|NCT02487771|117571|P1|COMPLETED|Overall Study||81
49568|NCT02487771|117570|P2|STARTED|Overall Study||99
49569|NCT02487771|117571|P1|STARTED|Overall Study||91
49570|NCT02487498|117721|P2|NOT COMPLETED|Period: Period 2||5
49571|NCT02487498|117722|P1|NOT COMPLETED|Period: Period 2||6
49572|NCT02487498|117721|P2|COMPLETED|Period: Period 2||154
49573|NCT02487498|117722|P1|COMPLETED|Period: Period 2||164
49574|NCT02487498|117721|P2|STARTED|Period: Period 2||159
49575|NCT02487498|117722|P1|STARTED|Period: Period 2||170
49576|NCT02487498|117721|P2|NOT COMPLETED|Period: Washout||7
49577|NCT02487498|117722|P1|NOT COMPLETED|Period: Washout||2
49578|NCT02487498|117721|P2|COMPLETED|Period: Washout||159
49579|NCT02487498|117722|P1|COMPLETED|Period: Washout||170
49580|NCT02487498|117721|P2|STARTED|Period: Washout||166
49581|NCT02487498|117722|P1|STARTED|Period: Washout||172
49582|NCT02487498|117721|P2|NOT COMPLETED|Period: Period 1||11
49583|NCT02487498|117722|P1|NOT COMPLETED|Period: Period 1||6
49584|NCT02487498|117721|P2|COMPLETED|Period: Period 1||166
49585|NCT02487498|117722|P1|COMPLETED|Period: Period 1||172
49586|NCT02487498|117721|P2|STARTED|Period: Period 1||177
49587|NCT02487498|117722|P1|STARTED|Period: Period 1||178
49588|NCT02487472|117745|P1|NOT COMPLETED|Overall Study||11
49589|NCT02487472|117745|P1|COMPLETED|Overall Study||90
49590|NCT02487472|117745|P1|STARTED|Overall Study||101
49591|NCT02487446|117761|P2|NOT COMPLETED|Period 2||5
49592|NCT02487446|117762|P1|NOT COMPLETED|Period 2||8
49593|NCT02487446|117761|P2|COMPLETED|Period 2||158
49594|NCT02487446|117762|P1|COMPLETED|Period 2||154
49595|NCT02487446|117761|P2|STARTED|Period 2||163
49596|NCT02487446|117762|P1|STARTED|Period 2||162
49597|NCT02487446|117761|P2|NOT COMPLETED|Washout||8
49598|NCT02487446|117762|P1|NOT COMPLETED|Washout||3
49599|NCT02487446|117761|P2|COMPLETED|Washout||163
49600|NCT02487446|117762|P1|COMPLETED|Washout||162
49601|NCT02487446|117761|P2|STARTED|Washout||171
49602|NCT02487446|117762|P1|STARTED|Washout||165
49603|NCT02487446|117761|P2|NOT COMPLETED|Period 1||8
49604|NCT02487446|117762|P1|NOT COMPLETED|Period 1||13
49605|NCT02487446|117761|P2|COMPLETED|Period 1||171
49606|NCT02487446|117762|P1|COMPLETED|Period 1||165
49607|NCT02487446|117761|P2|STARTED|Period 1||179
49608|NCT02487446|117762|P1|STARTED|Period 1||178
49609|NCT02487303|117788|P3|NOT COMPLETED|Overall Study||1
49610|NCT02487303|117789|P2|NOT COMPLETED|Overall Study||4
49611|NCT02487303|117790|P1|NOT COMPLETED|Overall Study||2
49612|NCT02487303|117788|P3|COMPLETED|Overall Study||47
49613|NCT02487303|117789|P2|COMPLETED|Overall Study||47
49614|NCT02487303|117790|P1|COMPLETED|Overall Study||47
49615|NCT02487303|117788|P3|STARTED|Overall Study||48
49616|NCT02487303|117789|P2|STARTED|Overall Study||51
49617|NCT02487303|117790|P1|STARTED|Overall Study||49
49618|NCT02487225|117809|P2|NOT COMPLETED|Overall Study||30
49619|NCT02487225|117810|P1|NOT COMPLETED|Overall Study||27
49620|NCT02487225|117809|P2|COMPLETED|Overall Study||8
49621|NCT02487225|117810|P1|COMPLETED|Overall Study||18
49622|NCT02487225|117809|P2|STARTED|Overall Study||38
49623|NCT02487225|117810|P1|STARTED|Overall Study||45
49624|NCT02487199|117824|P2|NOT COMPLETED|Overall Study||1
49625|NCT02487199|117825|P1|NOT COMPLETED|Overall Study||0
49626|NCT02487199|117824|P2|COMPLETED|Overall Study||4
49627|NCT02487199|117825|P1|COMPLETED|Overall Study||13
49628|NCT02487199|117824|P2|STARTED|Overall Study||5
49629|NCT02487199|117825|P1|STARTED|Overall Study||13
49630|NCT02487030|117844|P7|NOT COMPLETED|Overall Study||0
49631|NCT02487030|117845|P6|NOT COMPLETED|Overall Study||1
49632|NCT02487030|117846|P5|NOT COMPLETED|Overall Study||2
49633|NCT02487030|117847|P4|NOT COMPLETED|Overall Study||2
49634|NCT02487030|117848|P3|NOT COMPLETED|Overall Study||2
49635|NCT02487030|117849|P2|NOT COMPLETED|Overall Study||4
49636|NCT02487030|117850|P1|NOT COMPLETED|Overall Study||2
49637|NCT02487030|117844|P7|COMPLETED|Overall Study||11
49638|NCT02487030|117845|P6|COMPLETED|Overall Study||37
49639|NCT02487030|117846|P5|COMPLETED|Overall Study||34
49640|NCT02487030|117847|P4|COMPLETED|Overall Study||40
49641|NCT02487030|117848|P3|COMPLETED|Overall Study||41
49642|NCT02487030|117849|P2|COMPLETED|Overall Study||38
49643|NCT02487030|117850|P1|COMPLETED|Overall Study||41
49644|NCT02487030|117844|P7|STARTED|Overall Study||11
49645|NCT02487030|117845|P6|STARTED|Overall Study||38
49646|NCT02487030|117846|P5|STARTED|Overall Study||36
49647|NCT02487030|117847|P4|STARTED|Overall Study||42
49648|NCT02487030|117848|P3|STARTED|Overall Study||43
49649|NCT02487030|117849|P2|STARTED|Overall Study||42
49650|NCT02487030|117850|P1|STARTED|Overall Study||43
49651|NCT02486952|117881|P1|NOT COMPLETED|Overall Study||50
49652|NCT02486952|117881|P1|COMPLETED|Overall Study||104
49653|NCT02486952|117881|P1|Started Induction Therapy|Overall Study||151
49654|NCT02486952|117881|P1|STARTED|Overall Study||154
49655|NCT02486939|117888|P2|NOT COMPLETED|Overall Study||2
49656|NCT02486939|117889|P1|NOT COMPLETED|Overall Study||1
49657|NCT02486939|117888|P2|COMPLETED|Overall Study||132
49658|NCT02486939|117889|P1|COMPLETED|Overall Study||224
49659|NCT02486939|117888|P2|STARTED|Overall Study||134
49660|NCT02486939|117889|P1|STARTED|Overall Study||225
49661|NCT02486796|117899|P2|NOT COMPLETED|Overall Study||1
49662|NCT02486796|117900|P1|NOT COMPLETED|Overall Study||2
49663|NCT02486796|117899|P2|COMPLETED|Overall Study||1
49664|NCT02486796|117900|P1|COMPLETED|Overall Study||1
49665|NCT02486796|117899|P2|STARTED|Overall Study||2
49666|NCT02486796|117900|P1|STARTED|Overall Study||3
49667|NCT02486757|117912|P1|NOT COMPLETED|Overall Study||1
49668|NCT02486757|117912|P1|COMPLETED|Overall Study||5
49669|NCT02486757|117912|P1|STARTED|Overall Study||6
49670|NCT02486692|117918|P2|NOT COMPLETED|Overall Study||7
49671|NCT02486692|117919|P1|NOT COMPLETED|Overall Study||4
49672|NCT02486692|117918|P2|COMPLETED|Overall Study||23
49673|NCT02486692|117919|P1|COMPLETED|Overall Study||26
49674|NCT02486692|117918|P2|STARTED|Overall Study||30
49675|NCT02486692|117919|P1|STARTED|Overall Study||30
49676|NCT02486653|117931|P2|NOT COMPLETED|Overall Study||4
49677|NCT02486653|117932|P1|NOT COMPLETED|Overall Study||6
49678|NCT02486653|117931|P2|COMPLETED|Overall Study||71
49679|NCT02486653|117932|P1|COMPLETED|Overall Study||70
49680|NCT02486653|117931|P2|STARTED|Overall Study||75
49681|NCT02486653|117932|P1|STARTED|Overall Study||76
49682|NCT02486627|117956|P2|NOT COMPLETED|Overall Study||9
49683|NCT02486627|117957|P1|NOT COMPLETED|Overall Study||7
49684|NCT02486627|117956|P2|COMPLETED|Overall Study||294
49685|NCT02486627|117957|P1|COMPLETED|Overall Study||299
49686|NCT02486627|117956|P2|STARTED|Overall Study||303
49687|NCT02486627|117957|P1|STARTED|Overall Study||306
49688|NCT02486302|117974|P1|NOT COMPLETED|Overall Study||676
49689|NCT02486302|117974|P1|COMPLETED|Overall Study||858
49690|NCT02486302|117974|P1|Treated|Overall Study||1523
49691|NCT02486302|117974|P1|STARTED|Overall Study||1534
49692|NCT02486016|118029|P1|NOT COMPLETED|Overall Study||0
49693|NCT02486016|118029|P1|COMPLETED|Overall Study||10
49694|NCT02486016|118029|P1|STARTED|Overall Study|Same 10 volunteers completed Apotex, Duragesic and Mylan arms of the study; crossover study.|10
49695|NCT02485925|118037|P1|NOT COMPLETED|Overall Study||15
49696|NCT02485925|118037|P1|COMPLETED|Overall Study||185
49697|NCT02485925|118037|P1|Per-Protocol Population|Overall Study||166
49698|NCT02485925|118037|P1|Intent to Treat (ITT) Population|Overall Study||193
49699|NCT02485925|118037|P1|Safety Population|Overall Study||200
49700|NCT02485925|118037|P1|STARTED|Overall Study||200
49701|NCT02485912|118047|P2|NOT COMPLETED|Overall Study||0
49702|NCT02485912|118048|P1|NOT COMPLETED|Overall Study||0
49703|NCT02485912|118047|P2|COMPLETED|Overall Study||20
49704|NCT02485912|118048|P1|COMPLETED|Overall Study||20
49705|NCT02485912|118047|P2|STARTED|Overall Study||20
49706|NCT02485912|118048|P1|STARTED|Overall Study||20
49707|NCT02485834|118056|P2|NOT COMPLETED|Overall Study||0
49708|NCT02485834|118057|P1|NOT COMPLETED|Overall Study||0
49709|NCT02485834|118056|P2|COMPLETED|Overall Study||2
49710|NCT02485834|118057|P1|COMPLETED|Overall Study||3
49711|NCT02485834|118056|P2|STARTED|Overall Study||2
49712|NCT02485834|118057|P1|STARTED|Overall Study||3
49713|NCT02485717|118069|P3|NOT COMPLETED|Overall Study||1
49714|NCT02485717|118070|P2|NOT COMPLETED|Overall Study||2
49715|NCT02485717|118071|P1|NOT COMPLETED|Overall Study||6
49716|NCT02485717|118069|P3|COMPLETED|Overall Study||27
49717|NCT02485717|118070|P2|COMPLETED|Overall Study||158
49718|NCT02485717|118071|P1|COMPLETED|Overall Study||170
49719|NCT02485717|118069|P3|STARTED|Overall Study||28
49720|NCT02485717|118070|P2|STARTED|Overall Study||160
49721|NCT02485717|118071|P1|STARTED|Overall Study||176
49722|NCT02485704|118086|P2|NOT COMPLETED|Overall Study||8
49723|NCT02485704|118087|P1|NOT COMPLETED|Overall Study||5
49724|NCT02485704|118086|P2|COMPLETED|Overall Study||118
49725|NCT02485704|118087|P1|COMPLETED|Overall Study||149
49726|NCT02485704|118086|P2|STARTED|Overall Study||126
49727|NCT02485704|118087|P1|STARTED|Overall Study||154
49728|NCT02485561|118096|P3|NOT COMPLETED|Overall Study||23
49729|NCT02485561|118097|P2|NOT COMPLETED|Overall Study||39
49730|NCT02485561|118098|P1|NOT COMPLETED|Overall Study||28
49731|NCT02485561|118096|P3|COMPLETED|Overall Study||136
49732|NCT02485561|118097|P2|COMPLETED|Overall Study||118
49733|NCT02485561|118098|P1|COMPLETED|Overall Study||133
49734|NCT02485561|118096|P3|Completed 1 mo Survey|Overall Study||144
49735|NCT02485561|118097|P2|Completed 1 mo Survey|Overall Study||138
49736|NCT02485561|118098|P1|Completed 1 mo Survey|Overall Study||145
49737|NCT02485561|118096|P3|STARTED|Overall Study||159
49738|NCT02485561|118097|P2|STARTED|Overall Study||157
49739|NCT02485561|118098|P1|STARTED|Overall Study||161
49740|NCT02485483|118135|P2|NOT COMPLETED|Overall Study||0
49741|NCT02485483|118136|P1|NOT COMPLETED|Overall Study||54
49742|NCT02485483|118135|P2|COMPLETED|Overall Study||1015
49743|NCT02485483|118136|P1|COMPLETED|Overall Study||223
49744|NCT02485483|118135|P2|STARTED|Overall Study||1015
49745|NCT02485483|118136|P1|STARTED|Overall Study||277
49746|NCT02485353|118151|P1|NOT COMPLETED|Overall Study||2
49747|NCT02485353|118151|P1|COMPLETED|Overall Study||0
49748|NCT02485353|118151|P1|STARTED|Overall Study||2
49749|NCT02485301|118158|P2|NOT COMPLETED|Overall Study||49
49750|NCT02485301|118159|P1|NOT COMPLETED|Overall Study||38
49751|NCT02485301|118158|P2|COMPLETED|Overall Study||1455
49752|NCT02485301|118159|P1|COMPLETED|Overall Study||1471
49753|NCT02485301|118158|P2|STARTED|Overall Study||1504
49754|NCT02485301|118159|P1|STARTED|Overall Study||1509
49755|NCT02485158|118209|P1|NOT COMPLETED|Overall Study||4
49756|NCT02485158|118209|P1|COMPLETED|Overall Study||24
49757|NCT02485158|118209|P1|STARTED|Overall Study||28
49758|NCT02484911|118298|P2|NOT COMPLETED|Overall Study||2
49759|NCT02484911|118299|P1|NOT COMPLETED|Overall Study||4
49760|NCT02484911|118298|P2|COMPLETED|Overall Study||58
49761|NCT02484911|118299|P1|COMPLETED|Overall Study||56
49762|NCT02484911|118298|P2|STARTED|Overall Study||60
49763|NCT02484911|118299|P1|STARTED|Overall Study||60
49764|NCT02484898|118327|P1|NOT COMPLETED|Overall Study||18
49765|NCT02484898|118327|P1|COMPLETED|Overall Study||182
49766|NCT02484898|118327|P1|STARTED|Overall Study||200
49767|NCT02484859|118333|P2|NOT COMPLETED|Overall Study||0
49768|NCT02484859|118334|P1|NOT COMPLETED|Overall Study||0
49769|NCT02484859|118333|P2|COMPLETED|Overall Study||44
49770|NCT02484859|118334|P1|COMPLETED|Overall Study||44
49771|NCT02484859|118333|P2|STARTED|Overall Study||44
49772|NCT02484859|118334|P1|STARTED|Overall Study||44
49773|NCT02484729|118358|P10|NOT COMPLETED|Overall Study||1
49774|NCT02484729|118359|P9|NOT COMPLETED|Overall Study||0
49775|NCT02484729|118360|P8|NOT COMPLETED|Overall Study||0
49776|NCT02484729|118361|P7|NOT COMPLETED|Overall Study||0
49777|NCT02484729|118362|P6|NOT COMPLETED|Overall Study||0
49778|NCT02484729|118363|P5|NOT COMPLETED|Overall Study||0
49779|NCT02484729|118364|P4|NOT COMPLETED|Overall Study||0
49780|NCT02484729|118365|P3|NOT COMPLETED|Overall Study||0
49781|NCT02484729|118366|P2|NOT COMPLETED|Overall Study||0
49782|NCT02484729|118367|P1|NOT COMPLETED|Overall Study||0
49783|NCT02484729|118358|P10|COMPLETED|Overall Study||7
49784|NCT02484729|118359|P9|COMPLETED|Overall Study||6
49785|NCT02484729|118360|P8|COMPLETED|Overall Study||6
49786|NCT02484729|118361|P7|COMPLETED|Overall Study||5
49787|NCT02484729|118362|P6|COMPLETED|Overall Study||6
49788|NCT02484729|118363|P5|COMPLETED|Overall Study||5
49789|NCT02484729|118364|P4|COMPLETED|Overall Study||6
49790|NCT02484729|118365|P3|COMPLETED|Overall Study||6
49791|NCT02484729|118366|P2|COMPLETED|Overall Study||6
49792|NCT02484729|118367|P1|COMPLETED|Overall Study||16
49793|NCT02484729|118358|P10|STARTED|Overall Study||8
49794|NCT02484729|118359|P9|STARTED|Overall Study||6
49795|NCT02484729|118360|P8|STARTED|Overall Study||6
49796|NCT02484729|118361|P7|STARTED|Overall Study||5
49797|NCT02484729|118362|P6|STARTED|Overall Study||6
49798|NCT02484729|118363|P5|STARTED|Overall Study||5
49799|NCT02484729|118364|P4|STARTED|Overall Study||6
49800|NCT02484729|118365|P3|STARTED|Overall Study||6
49801|NCT02484729|118366|P2|STARTED|Overall Study||6
49802|NCT02484729|118367|P1|STARTED|Overall Study||16
49803|NCT02484651|118565|P2|NOT COMPLETED|Overall Study||4
49804|NCT02484651|118566|P1|NOT COMPLETED|Overall Study||3
49805|NCT02484651|118565|P2|COMPLETED|Overall Study||31
49806|NCT02484651|118566|P1|COMPLETED|Overall Study||32
49807|NCT02484651|118565|P2|Data Analysis|Overall Study||31
49808|NCT02484651|118566|P1|Data Analysis|Overall Study||32
49809|NCT02484651|118565|P2|End of Clinical Study|Overall Study||35
49810|NCT02484651|118566|P1|End of Clinical Study|Overall Study||35
49811|NCT02484651|118565|P2|STARTED|Overall Study|35 patients were randomized|35
49812|NCT02484651|118566|P1|STARTED|Overall Study|35 patients were randomized|35
49813|NCT02484222|118578|P1|NOT COMPLETED|Overall Study||3
49814|NCT02484222|118578|P1|COMPLETED|Overall Study||77
49815|NCT02484222|118578|P1|STARTED|Overall Study||80
49816|NCT02483975|118587|P2|NOT COMPLETED|Overall Study||2
49817|NCT02483975|118588|P1|NOT COMPLETED|Overall Study||2
49818|NCT02483975|118587|P2|COMPLETED|Overall Study|Subject reported as not completed due to AE was discontinued due to exacerbation, was not an AE/SAE|53
49819|NCT02483975|118588|P1|COMPLETED|Overall Study||54
49820|NCT02483975|118587|P2|STARTED|Overall Study||55
49821|NCT02483975|118588|P1|STARTED|Overall Study||56
49822|NCT02483611|118605|P3|NOT COMPLETED|Overall Study||1
49823|NCT02483611|118606|P2|NOT COMPLETED|Overall Study||0
49824|NCT02483611|118607|P1|NOT COMPLETED|Overall Study||0
49825|NCT02483611|118605|P3|COMPLETED|Overall Study|One patient required decurarization|15
49826|NCT02483611|118606|P2|COMPLETED|Overall Study||16
49827|NCT02483611|118607|P1|COMPLETED|Overall Study||16
49828|NCT02483611|118605|P3|STARTED|Overall Study||16
49829|NCT02483611|118606|P2|STARTED|Overall Study||16
49830|NCT02483611|118607|P1|STARTED|Overall Study||16
49831|NCT02483585|118704|P2|NOT COMPLETED|Open-label Treatment Phase||25
49832|NCT02483585|118705|P1|NOT COMPLETED|Open-label Treatment Phase||27
49833|NCT02483585|118704|P2|COMPLETED|Open-label Treatment Phase||243
49834|NCT02483585|118705|P1|COMPLETED|Open-label Treatment Phase||243
49835|NCT02483585|118704|P2|STARTED|Open-label Treatment Phase|Three participants who completed the double-blind phase did not enter the open-label treatment phase|268
49836|NCT02483585|118705|P1|STARTED|Open-label Treatment Phase|Five participants who completed the double-blind phase did not enter the open-label treatment phase|270
49837|NCT02483585|118704|P2|NOT COMPLETED|Double-blind Treatment Phase||15
49838|NCT02483585|118705|P1|NOT COMPLETED|Double-blind Treatment Phase||16
49839|NCT02483585|118704|P2|COMPLETED|Double-blind Treatment Phase||271
49840|NCT02483585|118705|P1|COMPLETED|Double-blind Treatment Phase||275
49841|NCT02483585|118704|P2|Received Treatment|Double-blind Treatment Phase||283
49842|NCT02483585|118705|P1|Received Treatment|Double-blind Treatment Phase||289
49843|NCT02483585|118704|P2|STARTED|Double-blind Treatment Phase||286
49844|NCT02483585|118705|P1|STARTED|Double-blind Treatment Phase||291
49845|NCT02483572|118727|P2|NOT COMPLETED|Overall Study||1
49846|NCT02483572|118728|P1|NOT COMPLETED|Overall Study||2
49847|NCT02483572|118727|P2|COMPLETED|Overall Study||1
49848|NCT02483572|118728|P1|COMPLETED|Overall Study||0
49849|NCT02483572|118727|P2|STARTED|Overall Study||2
49850|NCT02483572|118728|P1|STARTED|Overall Study||2
49851|NCT02483416|118742|P2|NOT COMPLETED|Overall Study||1
49852|NCT02483416|118743|P1|NOT COMPLETED|Overall Study||3
49853|NCT02483416|118742|P2|COMPLETED|Overall Study||6
49854|NCT02483416|118743|P1|COMPLETED|Overall Study||18
49855|NCT02483416|118742|P2|STARTED|Overall Study||7
49856|NCT02483416|118743|P1|STARTED|Overall Study||21
49857|NCT02482935|118798|P2|NOT COMPLETED|Period 2||0
49858|NCT02482935|118799|P1|NOT COMPLETED|Period 2||0
49859|NCT02482935|118798|P2|COMPLETED|Period 2||15
49860|NCT02482935|118799|P1|COMPLETED|Period 2||14
49861|NCT02482935|118798|P2|Follow-up|Period 2||15
49862|NCT02482935|118799|P1|Follow-up|Period 2||14
49863|NCT02482935|118798|P2|Received Abemaciclib|Period 2||15
49864|NCT02482935|118799|P1|Received Abemaciclib|Period 2||14
49865|NCT02482935|118798|P2|STARTED|Period 2||15
49866|NCT02482935|118799|P1|STARTED|Period 2||14
49867|NCT02482935|118798|P2|NOT COMPLETED|Period 1||0
49868|NCT02482935|118799|P1|NOT COMPLETED|Period 1||1
49869|NCT02482935|118798|P2|COMPLETED|Period 1||15
49870|NCT02482935|118799|P1|COMPLETED|Period 1||14
49871|NCT02482935|118798|P2|Washout|Period 1||15
49872|NCT02482935|118799|P1|Washout|Period 1||15
49873|NCT02482935|118798|P2|Received Abemaciclib|Period 1||15
49874|NCT02482935|118799|P1|Received Abemaciclib|Period 1||15
49875|NCT02482935|118798|P2|STARTED|Period 1||15
49876|NCT02482935|118799|P1|STARTED|Period 1||15
49877|NCT02482870|118809|P2|NOT COMPLETED|Period 2 - Rest of the Study||0
49878|NCT02482870|118810|P1|NOT COMPLETED|Period 2 - Rest of the Study||0
49879|NCT02482870|118809|P2|COMPLETED|Period 2 - Rest of the Study||202
49880|NCT02482870|118810|P1|COMPLETED|Period 2 - Rest of the Study||186
49881|NCT02482870|118809|P2|STARTED|Period 2 - Rest of the Study||202
49882|NCT02482870|118810|P1|STARTED|Period 2 - Rest of the Study||186
49883|NCT02482870|118809|P2|NOT COMPLETED|Period 1 - First 60 Patients||0
49884|NCT02482870|118810|P1|NOT COMPLETED|Period 1 - First 60 Patients||0
49885|NCT02482870|118809|P2|COMPLETED|Period 1 - First 60 Patients||30
49886|NCT02482870|118810|P1|COMPLETED|Period 1 - First 60 Patients||30
49887|NCT02482870|118809|P2|STARTED|Period 1 - First 60 Patients||30
49888|NCT02482870|118810|P1|STARTED|Period 1 - First 60 Patients||30
49889|NCT02482805|118827|P3|NOT COMPLETED|Overall Study||0
49890|NCT02482805|118828|P2|NOT COMPLETED|Overall Study||4
49891|NCT02482805|118829|P1|NOT COMPLETED|Overall Study||4
49892|NCT02482805|118827|P3|COMPLETED|Overall Study||20
49893|NCT02482805|118828|P2|COMPLETED|Overall Study||23
49894|NCT02482805|118829|P1|COMPLETED|Overall Study||22
49895|NCT02482805|118827|P3|STARTED|Overall Study||20
49896|NCT02482805|118828|P2|STARTED|Overall Study||27
49897|NCT02482805|118829|P1|STARTED|Overall Study||26
49898|NCT02482675|118843|P23|NOT COMPLETED|Overall Study||0
49899|NCT02482675|118844|P22|NOT COMPLETED|Overall Study||0
49900|NCT02482675|118845|P21|NOT COMPLETED|Overall Study||0
49901|NCT02482675|118846|P20|NOT COMPLETED|Overall Study||0
49902|NCT02482675|118847|P19|NOT COMPLETED|Overall Study||0
49903|NCT02482675|118848|P18|NOT COMPLETED|Overall Study||0
49904|NCT02482675|118849|P17|NOT COMPLETED|Overall Study||0
49905|NCT02482675|118850|P16|NOT COMPLETED|Overall Study||0
49906|NCT02482675|118851|P15|NOT COMPLETED|Overall Study||0
49907|NCT02482675|118852|P14|NOT COMPLETED|Overall Study||0
49908|NCT02482675|118853|P13|NOT COMPLETED|Overall Study||0
49909|NCT02482675|118854|P12|NOT COMPLETED|Overall Study||0
49910|NCT02482675|118855|P11|NOT COMPLETED|Overall Study||0
49911|NCT02482675|118856|P10|NOT COMPLETED|Overall Study||0
49912|NCT02482675|118857|P9|NOT COMPLETED|Overall Study||0
49913|NCT02482675|118858|P8|NOT COMPLETED|Overall Study||0
49914|NCT02482675|118859|P7|NOT COMPLETED|Overall Study||0
49915|NCT02482675|118860|P6|NOT COMPLETED|Overall Study||0
49916|NCT02482675|118861|P5|NOT COMPLETED|Overall Study||0
49917|NCT02482675|118862|P4|NOT COMPLETED|Overall Study||0
49918|NCT02482675|118863|P3|NOT COMPLETED|Overall Study||0
49919|NCT02482675|118864|P2|NOT COMPLETED|Overall Study||0
49920|NCT02482675|118865|P1|NOT COMPLETED|Overall Study||0
49921|NCT02482675|118843|P23|COMPLETED|Overall Study||1
49922|NCT02482675|118844|P22|COMPLETED|Overall Study||1
49923|NCT02482675|118845|P21|COMPLETED|Overall Study||1
49924|NCT02482675|118846|P20|COMPLETED|Overall Study||1
49925|NCT02482675|118847|P19|COMPLETED|Overall Study||1
49926|NCT02482675|118848|P18|COMPLETED|Overall Study||1
49927|NCT02482675|118849|P17|COMPLETED|Overall Study||1
49928|NCT02482675|118850|P16|COMPLETED|Overall Study||1
49929|NCT02482675|118851|P15|COMPLETED|Overall Study||1
49930|NCT02482675|118852|P14|COMPLETED|Overall Study||1
49931|NCT02482675|118853|P13|COMPLETED|Overall Study||1
49932|NCT02482675|118854|P12|COMPLETED|Overall Study||1
49933|NCT02482675|118855|P11|COMPLETED|Overall Study||1
49934|NCT02482675|118856|P10|COMPLETED|Overall Study||1
49935|NCT02482675|118857|P9|COMPLETED|Overall Study||1
49936|NCT02482675|118858|P8|COMPLETED|Overall Study||1
49937|NCT02482675|118859|P7|COMPLETED|Overall Study||1
49938|NCT02482675|118860|P6|COMPLETED|Overall Study||1
49939|NCT02482675|118861|P5|COMPLETED|Overall Study||1
49940|NCT02482675|118862|P4|COMPLETED|Overall Study||1
49941|NCT02482675|118863|P3|COMPLETED|Overall Study||1
49942|NCT02482675|118864|P2|COMPLETED|Overall Study||1
49943|NCT02482675|118865|P1|COMPLETED|Overall Study||1
49944|NCT02482675|118843|P23|STARTED|Overall Study||1
49945|NCT02482675|118844|P22|STARTED|Overall Study||1
49946|NCT02482675|118845|P21|STARTED|Overall Study||1
49947|NCT02482675|118846|P20|STARTED|Overall Study||1
49948|NCT02482675|118847|P19|STARTED|Overall Study||1
49949|NCT02482675|118848|P18|STARTED|Overall Study||1
49950|NCT02482675|118849|P17|STARTED|Overall Study||1
49951|NCT02482675|118850|P16|STARTED|Overall Study||1
49952|NCT02482675|118851|P15|STARTED|Overall Study||1
49953|NCT02482675|118852|P14|STARTED|Overall Study||1
49954|NCT02482675|118853|P13|STARTED|Overall Study||1
49955|NCT02482675|118854|P12|STARTED|Overall Study||1
49956|NCT02482675|118855|P11|STARTED|Overall Study||1
49957|NCT02482675|118856|P10|STARTED|Overall Study||1
49958|NCT02482675|118857|P9|STARTED|Overall Study||1
49959|NCT02482675|118858|P8|STARTED|Overall Study||1
49960|NCT02482675|118859|P7|STARTED|Overall Study||1
49961|NCT02482675|118860|P6|STARTED|Overall Study||1
49962|NCT02482675|118861|P5|STARTED|Overall Study||1
49963|NCT02482675|118862|P4|STARTED|Overall Study||1
49964|NCT02482675|118863|P3|STARTED|Overall Study||1
49965|NCT02482675|118864|P2|STARTED|Overall Study||1
49966|NCT02482675|118865|P1|STARTED|Overall Study||1
49967|NCT02482610|118923|P6|NOT COMPLETED|Overall Study||0
49968|NCT02482610|118924|P5|NOT COMPLETED|Overall Study||0
49969|NCT02482610|118925|P4|NOT COMPLETED|Overall Study||0
49970|NCT02482610|118926|P3|NOT COMPLETED|Overall Study||0
49971|NCT02482610|118927|P2|NOT COMPLETED|Overall Study||0
49972|NCT02482610|118928|P1|NOT COMPLETED|Overall Study||0
49973|NCT02482610|118923|P6|COMPLETED|Overall Study||5
49974|NCT02482610|118924|P5|COMPLETED|Overall Study||3
49975|NCT02482610|118925|P4|COMPLETED|Overall Study||3
49976|NCT02482610|118926|P3|COMPLETED|Overall Study||2
49977|NCT02482610|118927|P2|COMPLETED|Overall Study||5
49978|NCT02482610|118928|P1|COMPLETED|Overall Study||4
49979|NCT02482610|118923|P6|STARTED|Overall Study||5
49980|NCT02482610|118924|P5|STARTED|Overall Study||3
49981|NCT02482610|118925|P4|STARTED|Overall Study||3
49982|NCT02482610|118926|P3|STARTED|Overall Study||2
49983|NCT02482610|118927|P2|STARTED|Overall Study||5
49984|NCT02482610|118928|P1|STARTED|Overall Study||4
49985|NCT02482571|118948|P1|NOT COMPLETED|Overall Study||8
49986|NCT02482571|118948|P1|COMPLETED|Overall Study||17
49987|NCT02482571|118948|P1|STARTED|Overall Study||25
49988|NCT02482428|118960|P5|NOT COMPLETED|Overall Study||7
49989|NCT02482428|118961|P4|NOT COMPLETED|Overall Study||2
49990|NCT02482428|118962|P3|NOT COMPLETED|Overall Study||1
49991|NCT02482428|118963|P2|NOT COMPLETED|Overall Study||12
49992|NCT02482428|118964|P1|NOT COMPLETED|Overall Study||9
49993|NCT02482428|118960|P5|COMPLETED|Overall Study||15
49994|NCT02482428|118961|P4|COMPLETED|Overall Study||8
49995|NCT02482428|118962|P3|COMPLETED|Overall Study||9
49996|NCT02482428|118963|P2|COMPLETED|Overall Study||10
49997|NCT02482428|118964|P1|COMPLETED|Overall Study||15
49998|NCT02482428|118960|P5|STARTED|Overall Study||22
49999|NCT02482428|118961|P4|STARTED|Overall Study||10
50000|NCT02482428|118962|P3|STARTED|Overall Study||10
50001|NCT02482428|118963|P2|STARTED|Overall Study||22
50002|NCT02482428|118964|P1|STARTED|Overall Study||24
50003|NCT02482298|118987|P3|NOT COMPLETED|Overall Study||3
50004|NCT02482298|118988|P2|NOT COMPLETED|Overall Study||3
50005|NCT02482298|118989|P1|NOT COMPLETED|Overall Study||2
50006|NCT02482298|118987|P3|COMPLETED|Overall Study||27
50007|NCT02482298|118988|P2|COMPLETED|Overall Study||24
50008|NCT02482298|118989|P1|COMPLETED|Overall Study||28
50009|NCT02482298|118987|P3|STARTED|Overall Study||30
50010|NCT02482298|118988|P2|STARTED|Overall Study||27
50011|NCT02482298|118989|P1|STARTED|Overall Study||30
50012|NCT02482233|119011|P2|NOT COMPLETED|Overall Study||1
50013|NCT02482233|119012|P1|NOT COMPLETED|Overall Study||1
50014|NCT02482233|119011|P2|COMPLETED|Overall Study||19
50015|NCT02482233|119012|P1|COMPLETED|Overall Study||9
50016|NCT02482233|119011|P2|STARTED|Overall Study||20
50017|NCT02482233|119012|P1|STARTED|Overall Study||10
50018|NCT02482129|119048|P2|NOT COMPLETED|Overall Study||2
50019|NCT02482129|119049|P1|NOT COMPLETED|Overall Study||6
50020|NCT02482129|119048|P2|COMPLETED|Overall Study||9
50021|NCT02482129|119049|P1|COMPLETED|Overall Study||26
50022|NCT02482129|119048|P2|Treated, as Randomized|Overall Study||9
50023|NCT02482129|119049|P1|Treated, as Randomized|Overall Study||30
50024|NCT02482129|119048|P2|STARTED|Overall Study||11
50025|NCT02482129|119049|P1|STARTED|Overall Study||32
50026|NCT02481934|119076|P1|NOT COMPLETED|Overall Study||2
50027|NCT02481934|119076|P1|COMPLETED|Overall Study||3
50028|NCT02481934|119076|P1|STARTED|Overall Study||5
50029|NCT02481596|119084|P3|NOT COMPLETED|Overall Study||8
50030|NCT02481596|119085|P2|NOT COMPLETED|Overall Study||1
50031|NCT02481596|119086|P1|NOT COMPLETED|Overall Study||3
50032|NCT02481596|119084|P3|COMPLETED|Overall Study||245
50033|NCT02481596|119085|P2|COMPLETED|Overall Study||126
50034|NCT02481596|119086|P1|COMPLETED|Overall Study||123
50035|NCT02481596|119084|P3|STARTED|Overall Study||253
50036|NCT02481596|119085|P2|STARTED|Overall Study||127
50037|NCT02481596|119086|P1|STARTED|Overall Study||126
50038|NCT02481557|119111|P2|NOT COMPLETED|Overall Study||0
50039|NCT02481557|119112|P1|NOT COMPLETED|Overall Study||0
50040|NCT02481557|119111|P2|COMPLETED|Overall Study||19
50041|NCT02481557|119112|P1|COMPLETED|Overall Study||17
50042|NCT02481557|119111|P2|STARTED|Overall Study||19
50043|NCT02481557|119112|P1|STARTED|Overall Study||17
50044|NCT02481375|119124|P4|NOT COMPLETED|Overall Study||14
50045|NCT02481375|119125|P3|NOT COMPLETED|Overall Study||10
50046|NCT02481375|119126|P2|NOT COMPLETED|Overall Study||11
50047|NCT02481375|119127|P1|NOT COMPLETED|Overall Study||14
50048|NCT02481375|119124|P4|COMPLETED|Overall Study||186
50049|NCT02481375|119125|P3|COMPLETED|Overall Study||191
50050|NCT02481375|119126|P2|COMPLETED|Overall Study||191
50051|NCT02481375|119127|P1|COMPLETED|Overall Study||192
50052|NCT02481375|119124|P4|STARTED|Overall Study||200
50053|NCT02481375|119125|P3|STARTED|Overall Study||201
50054|NCT02481375|119126|P2|STARTED|Overall Study||202
50055|NCT02481375|119127|P1|STARTED|Overall Study||206
50056|NCT02481219|119139|P2|NOT COMPLETED|Overall Study||1
50057|NCT02481219|119140|P1|NOT COMPLETED|Overall Study||2
50058|NCT02481219|119139|P2|COMPLETED|Overall Study||61
50059|NCT02481219|119140|P1|COMPLETED|Overall Study||58
50060|NCT02481219|119139|P2|STARTED|Overall Study||62
50061|NCT02481219|119140|P1|STARTED|Overall Study||60
50062|NCT02481141|119158|P2|NOT COMPLETED|Overall Study||5
50063|NCT02481141|119159|P1|NOT COMPLETED|Overall Study||9
50064|NCT02481141|119158|P2|COMPLETED|Overall Study||13
50065|NCT02481141|119159|P1|COMPLETED|Overall Study||26
50066|NCT02481141|119158|P2|STARTED|Overall Study||18
50067|NCT02481141|119159|P1|STARTED|Overall Study||35
50068|NCT02481050|119211|P1|NOT COMPLETED|Overall Study||58
50069|NCT02481050|119211|P1|COMPLETED|Overall Study||0
50070|NCT02481050|119211|P1|STARTED|Overall Study||58
50071|NCT02480998|119222|P2|NOT COMPLETED|Overall Study||0
50072|NCT02480998|119223|P1|NOT COMPLETED|Overall Study||0
50073|NCT02480998|119222|P2|COMPLETED|Overall Study||28
50074|NCT02480998|119223|P1|COMPLETED|Overall Study||56
50075|NCT02480998|119222|P2|STARTED|Overall Study||28
50076|NCT02480998|119223|P1|STARTED|Overall Study||56
50077|NCT02480920|119231|P1|NOT COMPLETED|Overall Study||0
50078|NCT02480920|119231|P1|COMPLETED|Overall Study||2738
50079|NCT02480920|119231|P1|STARTED|Overall Study||2738
50080|NCT02480764|119238|P3|NOT COMPLETED|Overall Study||21
50081|NCT02480764|119239|P2|NOT COMPLETED|Overall Study||20
50082|NCT02480764|119240|P1|NOT COMPLETED|Overall Study||10
50083|NCT02480764|119238|P3|COMPLETED|Overall Study||183
50084|NCT02480764|119239|P2|COMPLETED|Overall Study||189
50085|NCT02480764|119240|P1|COMPLETED|Overall Study||189
50086|NCT02480764|119238|P3|STARTED|Overall Study||204
50087|NCT02480764|119239|P2|STARTED|Overall Study||209
50088|NCT02480764|119240|P1|STARTED|Overall Study||199
50089|NCT02480712|119266|P1|NOT COMPLETED|Overall Study||11
50090|NCT02480712|119266|P1|COMPLETED|Overall Study||96
50091|NCT02480712|119266|P1|STARTED|Overall Study||107
50092|NCT02480621|119285|P2|NOT COMPLETED|Follow Up||2
50093|NCT02480621|119286|P1|NOT COMPLETED|Follow Up||4
50094|NCT02480621|119285|P2|COMPLETED|Follow Up||37
50095|NCT02480621|119286|P1|COMPLETED|Follow Up||39
50096|NCT02480621|119285|P2|STARTED|Follow Up||39
50097|NCT02480621|119286|P1|STARTED|Follow Up||43
50098|NCT02480621|119285|P2|NOT COMPLETED|Randomization||1
50099|NCT02480621|119286|P1|NOT COMPLETED|Randomization||1
50100|NCT02480621|119285|P2|COMPLETED|Randomization||39
50101|NCT02480621|119286|P1|COMPLETED|Randomization||43
50102|NCT02480621|119285|P2|STARTED|Randomization||40
50103|NCT02480621|119286|P1|STARTED|Randomization||44
50104|NCT02480582|119292|P6|NOT COMPLETED|Overall Study||0
50105|NCT02480582|119293|P5|NOT COMPLETED|Overall Study||0
50106|NCT02480582|119294|P4|NOT COMPLETED|Overall Study||0
50107|NCT02480582|119295|P3|NOT COMPLETED|Overall Study||0
50108|NCT02480582|119296|P2|NOT COMPLETED|Overall Study||0
50109|NCT02480582|119297|P1|NOT COMPLETED|Overall Study||0
50110|NCT02480582|119292|P6|COMPLETED|Overall Study||7
50111|NCT02480582|119293|P5|COMPLETED|Overall Study||7
50112|NCT02480582|119294|P4|COMPLETED|Overall Study||7
50113|NCT02480582|119295|P3|COMPLETED|Overall Study||7
50114|NCT02480582|119296|P2|COMPLETED|Overall Study||7
50115|NCT02480582|119297|P1|COMPLETED|Overall Study||7
50116|NCT02480582|119292|P6|STARTED|Overall Study||7
50117|NCT02480582|119293|P5|STARTED|Overall Study||7
50118|NCT02480582|119294|P4|STARTED|Overall Study||7
50119|NCT02480582|119295|P3|STARTED|Overall Study||7
50120|NCT02480582|119296|P2|STARTED|Overall Study||7
50121|NCT02480582|119297|P1|STARTED|Overall Study||7
50122|NCT02480439|119320|P3|NOT COMPLETED|Treatment Period 3||0
50123|NCT02480439|119321|P2|NOT COMPLETED|Treatment Period 3||0
50124|NCT02480439|119322|P1|NOT COMPLETED|Treatment Period 3||0
50125|NCT02480439|119320|P3|COMPLETED|Treatment Period 3||7
50126|NCT02480439|119321|P2|COMPLETED|Treatment Period 3||7
50127|NCT02480439|119322|P1|COMPLETED|Treatment Period 3||8
50128|NCT02480439|119320|P3|STARTED|Treatment Period 3|1 Participant was withdrawn due to an Adverse Event after completing Period 2.|7
50129|NCT02480439|119321|P2|STARTED|Treatment Period 3||7
50130|NCT02480439|119322|P1|STARTED|Treatment Period 3||8
50131|NCT02480439|119320|P3|NOT COMPLETED|Treatment Period 2||0
50132|NCT02480439|119321|P2|NOT COMPLETED|Treatment Period 2||0
50133|NCT02480439|119322|P1|NOT COMPLETED|Treatment Period 2||0
50134|NCT02480439|119320|P3|COMPLETED|Treatment Period 2||8
50135|NCT02480439|119321|P2|COMPLETED|Treatment Period 2||7
50136|NCT02480439|119322|P1|COMPLETED|Treatment Period 2||8
50137|NCT02480439|119320|P3|STARTED|Treatment Period 2||8
50138|NCT02480439|119321|P2|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|7
50139|NCT02480439|119322|P1|STARTED|Treatment Period 2||8
50140|NCT02480439|119320|P3|NOT COMPLETED|Treatment Period 1||0
50141|NCT02480439|119321|P2|NOT COMPLETED|Treatment Period 1||0
50142|NCT02480439|119322|P1|NOT COMPLETED|Treatment Period 1||0
50143|NCT02480439|119320|P3|COMPLETED|Treatment Period 1||8
50144|NCT02480439|119321|P2|COMPLETED|Treatment Period 1||8
50145|NCT02480439|119322|P1|COMPLETED|Treatment Period 1||8
50146|NCT02480439|119320|P3|STARTED|Treatment Period 1||8
50147|NCT02480439|119321|P2|STARTED|Treatment Period 1||8
50148|NCT02480439|119322|P1|STARTED|Treatment Period 1||8
50149|NCT02480166|119348|P3|NOT COMPLETED|Overall Study||0
50150|NCT02480166|119349|P2|NOT COMPLETED|Overall Study||0
50151|NCT02480166|119350|P1|NOT COMPLETED|Overall Study||0
50152|NCT02480166|119348|P3|COMPLETED|Overall Study||4
50153|NCT02480166|119349|P2|COMPLETED|Overall Study||36
50154|NCT02480166|119350|P1|COMPLETED|Overall Study||20
50155|NCT02480166|119348|P3|STARTED|Overall Study||4
50156|NCT02480166|119349|P2|STARTED|Overall Study||36
50157|NCT02480166|119350|P1|STARTED|Overall Study||20
50158|NCT02480153|119363|P3|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||4
50159|NCT02480153|119364|P2|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||3
50160|NCT02480153|119365|P1|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||7
50161|NCT02480153|119363|P3|COMPLETED|Period 3: Week 52 Dosing to Week 78||123
50162|NCT02480153|119364|P2|COMPLETED|Period 3: Week 52 Dosing to Week 78||118
50163|NCT02480153|119365|P1|COMPLETED|Period 3: Week 52 Dosing to Week 78||252
50164|NCT02480153|119363|P3|Received Treatment|Period 3: Week 52 Dosing to Week 78||127
50165|NCT02480153|119364|P2|Received Treatment|Period 3: Week 52 Dosing to Week 78||120
50166|NCT02480153|119365|P1|Received Treatment|Period 3: Week 52 Dosing to Week 78||258
50167|NCT02480153|119363|P3|STARTED|Period 3: Week 52 Dosing to Week 78||127
50168|NCT02480153|119364|P2|STARTED|Period 3: Week 52 Dosing to Week 78||121
50169|NCT02480153|119365|P1|STARTED|Period 3: Week 52 Dosing to Week 78||259
50170|NCT02480153|119363|P3|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||7
50171|NCT02480153|119364|P2|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||13
50172|NCT02480153|119365|P1|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||20
50173|NCT02480153|119363|P3|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||127
50174|NCT02480153|119364|P2|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||122
50175|NCT02480153|119365|P1|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||263
50176|NCT02480153|119363|P3|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||133
50177|NCT02480153|119364|P2|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||135
50178|NCT02480153|119365|P1|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||283
50179|NCT02480153|119363|P3|STARTED|Period 2: Week 26 to Week 52 Pre-dose||134
50180|NCT02480153|119364|P2|STARTED|Period 2: Week 26 to Week 52 Pre-dose||135
50181|NCT02480153|119365|P1|STARTED|Period 2: Week 26 to Week 52 Pre-dose||283
50182|NCT02480153|119363|P3|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||0
50183|NCT02480153|119364|P2|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||16
50184|NCT02480153|119365|P1|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||4
50185|NCT02480153|119363|P3|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||0
50186|NCT02480153|119364|P2|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||284
50187|NCT02480153|119365|P1|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||293
50188|NCT02480153|119363|P3|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||0
50189|NCT02480153|119364|P2|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||299
50190|NCT02480153|119365|P1|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||297
50191|NCT02480153|119363|P3|STARTED|Period 1: First Dose to Week 26 Pre-dose||0
50192|NCT02480153|119364|P2|STARTED|Period 1: First Dose to Week 26 Pre-dose||300
50193|NCT02480153|119365|P1|STARTED|Period 1: First Dose to Week 26 Pre-dose||297
50194|NCT02480010|119542|P2|NOT COMPLETED|Overall Study||33
50195|NCT02480010|119543|P1|NOT COMPLETED|Overall Study||35
50196|NCT02480010|119542|P2|COMPLETED|Overall Study||0
50197|NCT02480010|119543|P1|COMPLETED|Overall Study||0
50198|NCT02480010|119542|P2|STARTED|Overall Study||33
50199|NCT02480010|119543|P1|STARTED|Overall Study||35
50200|NCT02479880|119589|P2|NOT COMPLETED|Overall Study||13
50201|NCT02479880|119590|P1|NOT COMPLETED|Overall Study||13
50202|NCT02479880|119589|P2|COMPLETED|Overall Study||2
50203|NCT02479880|119590|P1|COMPLETED|Overall Study||2
50204|NCT02479880|119589|P2|STARTED|Overall Study||15
50205|NCT02479880|119590|P1|STARTED|Overall Study||15
50206|NCT02479763|119598|P2|NOT COMPLETED|Overall Study||3
50207|NCT02479763|119599|P1|NOT COMPLETED|Overall Study||3
50208|NCT02479763|119598|P2|COMPLETED|Overall Study||50
50209|NCT02479763|119599|P1|COMPLETED|Overall Study||50
50210|NCT02479763|119598|P2|STARTED|Overall Study||53
50211|NCT02479763|119599|P1|STARTED|Overall Study||53
50212|NCT02479412|119614|P9|NOT COMPLETED|Overall Study||1
50213|NCT02479412|119615|P8|NOT COMPLETED|Overall Study||1
50214|NCT02479412|119616|P7|NOT COMPLETED|Overall Study||0
50215|NCT02479412|119617|P6|NOT COMPLETED|Overall Study||0
50216|NCT02479412|119618|P5|NOT COMPLETED|Overall Study||1
50217|NCT02479412|119619|P4|NOT COMPLETED|Overall Study||1
50218|NCT02479412|119620|P3|NOT COMPLETED|Overall Study||2
50219|NCT02479412|119621|P2|NOT COMPLETED|Overall Study||0
50220|NCT02479412|119622|P1|NOT COMPLETED|Overall Study||0
50221|NCT02479412|119614|P9|COMPLETED|Overall Study||6
50222|NCT02479412|119615|P8|COMPLETED|Overall Study||4
50223|NCT02479412|119616|P7|COMPLETED|Overall Study||6
50224|NCT02479412|119617|P6|COMPLETED|Overall Study||5
50225|NCT02479412|119618|P5|COMPLETED|Overall Study||5
50226|NCT02479412|119619|P4|COMPLETED|Overall Study||6
50227|NCT02479412|119620|P3|COMPLETED|Overall Study||4
50228|NCT02479412|119621|P2|COMPLETED|Overall Study||6
50229|NCT02479412|119622|P1|COMPLETED|Overall Study||6
50230|NCT02479412|119614|P9|STARTED|Overall Study||7
50231|NCT02479412|119615|P8|STARTED|Overall Study||5
50232|NCT02479412|119616|P7|STARTED|Overall Study||6
50233|NCT02479412|119617|P6|STARTED|Overall Study||5
50234|NCT02479412|119618|P5|STARTED|Overall Study||6
50235|NCT02479412|119619|P4|STARTED|Overall Study||7
50236|NCT02479412|119620|P3|STARTED|Overall Study||6
50237|NCT02479412|119621|P2|STARTED|Overall Study||6
50238|NCT02479412|119622|P1|STARTED|Overall Study||6
50239|NCT02479139|119699|P6|NOT COMPLETED|Overall Study||6
50240|NCT02479139|119700|P5|NOT COMPLETED|Overall Study||5
50241|NCT02479139|119701|P4|NOT COMPLETED|Overall Study||7
50242|NCT02479139|119702|P3|NOT COMPLETED|Overall Study||7
50243|NCT02479139|119703|P2|NOT COMPLETED|Overall Study||10
50244|NCT02479139|119704|P1|NOT COMPLETED|Overall Study||8
50245|NCT02479139|119699|P6|COMPLETED|Overall Study||19
50246|NCT02479139|119700|P5|COMPLETED|Overall Study||17
50247|NCT02479139|119701|P4|COMPLETED|Overall Study||14
50248|NCT02479139|119702|P3|COMPLETED|Overall Study||21
50249|NCT02479139|119703|P2|COMPLETED|Overall Study||12
50250|NCT02479139|119704|P1|COMPLETED|Overall Study||19
50251|NCT02479139|119699|P6|STARTED|Overall Study||25
50252|NCT02479139|119700|P5|STARTED|Overall Study||22
50253|NCT02479139|119701|P4|STARTED|Overall Study||21
50254|NCT02479139|119702|P3|STARTED|Overall Study||28
50255|NCT02479139|119703|P2|STARTED|Overall Study||22
50256|NCT02479139|119704|P1|STARTED|Overall Study||27
50257|NCT02478671|119730|P1|NOT COMPLETED|Overall Study||0
50258|NCT02478671|119730|P1|COMPLETED|Overall Study||4
50259|NCT02478671|119730|P1|STARTED|Overall Study||4
50260|NCT02478632|119737|P2|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||4
50261|NCT02478632|119738|P1|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||7
50262|NCT02478632|119737|P2|COMPLETED|Late Switch Phase (Week 52 to Week 148)||40
50263|NCT02478632|119738|P1|COMPLETED|Late Switch Phase (Week 52 to Week 148)||42
50264|NCT02478632|119737|P2|STARTED|Late Switch Phase (Week 52 to Week 148)||44
50265|NCT02478632|119738|P1|STARTED|Late Switch Phase (Week 52 to Week 148)||49
50266|NCT02478632|119737|P2|NOT COMPLETED|Early Switch Phase (Up to Week 52)||5
50267|NCT02478632|119738|P1|NOT COMPLETED|Early Switch Phase (Up to Week 52)||4
50268|NCT02478632|119737|P2|COMPLETED|Early Switch Phase (Up to Week 52)||44
50269|NCT02478632|119738|P1|COMPLETED|Early Switch Phase (Up to Week 52)||49
50270|NCT02478632|119737|P2|STARTED|Early Switch Phase (Up to Week 52)||49
50271|NCT02478632|119738|P1|STARTED|Early Switch Phase (Up to Week 52)||53
50272|NCT02478580|119764|P2|NOT COMPLETED|Overall Study||0
50273|NCT02478580|119765|P1|NOT COMPLETED|Overall Study||0
50274|NCT02478580|119764|P2|COMPLETED|Overall Study||33
50275|NCT02478580|119765|P1|COMPLETED|Overall Study||34
50276|NCT02478580|119764|P2|STARTED|Overall Study||33
50277|NCT02478580|119765|P1|STARTED|Overall Study||34
50278|NCT02478398|119775|P2|NOT COMPLETED|Overall Study||21
50279|NCT02478398|119776|P1|NOT COMPLETED|Overall Study||52
50280|NCT02478398|119775|P2|COMPLETED|Overall Study||491
50281|NCT02478398|119776|P1|COMPLETED|Overall Study||461
50282|NCT02478398|119775|P2|Treated|Overall Study||510
50283|NCT02478398|119776|P1|Treated|Overall Study||512
50284|NCT02478398|119775|P2|STARTED|Overall Study||512
50285|NCT02478398|119776|P1|STARTED|Overall Study||513
50286|NCT02478372|119796|P2|NOT COMPLETED|Overall Study||14
50287|NCT02478372|119797|P1|NOT COMPLETED|Overall Study||13
50288|NCT02478372|119796|P2|COMPLETED|Overall Study||107
50289|NCT02478372|119797|P1|COMPLETED|Overall Study||108
50290|NCT02478372|119796|P2|Reviewed at One Year|Overall Study|Routine folow up at one year - four patients did not attend, two patients died|107
50291|NCT02478372|119797|P1|Reviewed at One Year|Overall Study|Routine follow up at one year|108
50383|NCT02476578|120098|P1|Left Before End of Trial|Overall Study||6
50292|NCT02478372|119796|P2|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks|113
50293|NCT02478372|119797|P1|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks - one patient refused to attend|108
50294|NCT02478372|119796|P2|Recieved Allocation Intervention|Overall Study||113
50295|NCT02478372|119797|P1|Recieved Allocation Intervention|Overall Study||109
50296|NCT02478372|119796|P2|STARTED|Overall Study||121
50297|NCT02478372|119797|P1|STARTED|Overall Study||121
50298|NCT02478164|119819|P1|NOT COMPLETED|Overall Study||15
50299|NCT02478164|119819|P1|COMPLETED|Overall Study||0
50300|NCT02478164|119819|P1|STARTED|Overall Study|17 participants enrolled. 15 of 17 received ponatinib as 2 participants withdrew prior to ponatinib.|15
50301|NCT02477709|119826|P1|NOT COMPLETED|Overall Study||0
50302|NCT02477709|119826|P1|COMPLETED|Overall Study||6
50303|NCT02477709|119826|P1|STARTED|Overall Study||6
50304|NCT02477618|119832|P2|NOT COMPLETED|Overall Study||14
50305|NCT02477618|119833|P1|NOT COMPLETED|Overall Study||15
50306|NCT02477618|119832|P2|COMPLETED|Overall Study||53
50307|NCT02477618|119833|P1|COMPLETED|Overall Study||50
50308|NCT02477618|119832|P2|Intent-to-Treat Analysis Set|Overall Study||66
50309|NCT02477618|119833|P1|Intent-to-Treat Analysis Set|Overall Study||66
50310|NCT02477618|119832|P2|STARTED|Overall Study||67
50311|NCT02477618|119833|P1|STARTED|Overall Study||65
50312|NCT02477605|119857|P2|NOT COMPLETED|Overall Study||4
50313|NCT02477605|119858|P1|NOT COMPLETED|Overall Study||1
50314|NCT02477605|119857|P2|COMPLETED|Overall Study||64
50315|NCT02477605|119858|P1|COMPLETED|Overall Study||67
50316|NCT02477605|119857|P2|Randomized and Treated|Overall Study||68
50317|NCT02477605|119858|P1|Randomized and Treated|Overall Study||67
50318|NCT02477605|119857|P2|STARTED|Overall Study||68
50319|NCT02477605|119858|P1|STARTED|Overall Study||68
50320|NCT02477553|119874|P2|NOT COMPLETED|Overall Study||20
50321|NCT02477553|119875|P1|NOT COMPLETED|Overall Study||20
50322|NCT02477553|119874|P2|COMPLETED|Overall Study||344
50323|NCT02477553|119875|P1|COMPLETED|Overall Study||344
50324|NCT02477553|119874|P2|STARTED|Overall Study||364
50325|NCT02477553|119875|P1|STARTED|Overall Study||364
50326|NCT02477527|119895|P1|NOT COMPLETED|Overall Study||6
50327|NCT02477527|119895|P1|COMPLETED|Overall Study||21
50328|NCT02477527|119895|P1|STARTED|Overall Study||27
50329|NCT02477332|119909|P6|NOT COMPLETED|Overall Study||5
50330|NCT02477332|119910|P5|NOT COMPLETED|Overall Study||4
50331|NCT02477332|119911|P4|NOT COMPLETED|Overall Study||13
50332|NCT02477332|119912|P3|NOT COMPLETED|Overall Study||12
50333|NCT02477332|119913|P2|NOT COMPLETED|Overall Study||7
50334|NCT02477332|119914|P1|NOT COMPLETED|Overall Study||3
50335|NCT02477332|119909|P6|COMPLETED|Overall Study||37
50336|NCT02477332|119910|P5|COMPLETED|Overall Study||39
50337|NCT02477332|119911|P4|COMPLETED|Overall Study||72
50338|NCT02477332|119912|P3|COMPLETED|Overall Study||73
50339|NCT02477332|119913|P2|COMPLETED|Overall Study||77
50340|NCT02477332|119914|P1|COMPLETED|Overall Study||40
50341|NCT02477332|119909|P6|STARTED|Overall Study||42
50342|NCT02477332|119910|P5|STARTED|Overall Study||43
50343|NCT02477332|119911|P4|STARTED|Overall Study||85
50344|NCT02477332|119912|P3|STARTED|Overall Study||85
50345|NCT02477332|119913|P2|STARTED|Overall Study||84
50346|NCT02477332|119914|P1|STARTED|Overall Study||43
50347|NCT02477020|119990|P2|NOT COMPLETED|Overall Study||28
50348|NCT02477020|119991|P1|NOT COMPLETED|Overall Study||30
50349|NCT02477020|119990|P2|COMPLETED|Overall Study|Completed = participants who completed study treatment.|55
50350|NCT02477020|119991|P1|COMPLETED|Overall Study|Completed = participants who completed study treatment.|51
50351|NCT02477020|119990|P2|STARTED|Overall Study||83
50352|NCT02477020|119991|P1|STARTED|Overall Study||81
50353|NCT02476994|120021|P2|NOT COMPLETED|Overall Study||0
50354|NCT02476994|120022|P1|NOT COMPLETED|Overall Study||1
50355|NCT02476994|120021|P2|COMPLETED|Overall Study||0
50356|NCT02476994|120022|P1|COMPLETED|Overall Study||0
50357|NCT02476994|120021|P2|STARTED|Overall Study||0
50358|NCT02476994|120022|P1|STARTED|Overall Study||1
50359|NCT02476890|120052|P4|NOT COMPLETED|Overall Study||0
50360|NCT02476890|120053|P3|NOT COMPLETED|Overall Study||0
50361|NCT02476890|120054|P2|NOT COMPLETED|Overall Study||0
50362|NCT02476890|120055|P1|NOT COMPLETED|Overall Study||0
50363|NCT02476890|120052|P4|COMPLETED|Overall Study||12
50364|NCT02476890|120053|P3|COMPLETED|Overall Study||12
50365|NCT02476890|120054|P2|COMPLETED|Overall Study||6
50366|NCT02476890|120055|P1|COMPLETED|Overall Study||6
50367|NCT02476890|120052|P4|Washout|Overall Study||12
50368|NCT02476890|120053|P3|Washout|Overall Study||12
50369|NCT02476890|120054|P2|Washout|Overall Study||6
50370|NCT02476890|120055|P1|Washout|Overall Study||6
50371|NCT02476890|120052|P4|STARTED|Overall Study|Crossover study|12
50372|NCT02476890|120053|P3|STARTED|Overall Study|Crossover study|12
50373|NCT02476890|120054|P2|STARTED|Overall Study|Crossover study|6
50374|NCT02476890|120055|P1|STARTED|Overall Study|Crossover study|6
50375|NCT02476617|120091|P1|NOT COMPLETED|Overall Study||2
50376|NCT02476617|120091|P1|COMPLETED|Overall Study||23
50377|NCT02476617|120091|P1|STARTED|Overall Study||25
50378|NCT02476578|120097|P2|NOT COMPLETED|Overall Study||56
50379|NCT02476578|120098|P1|NOT COMPLETED|Overall Study||41
50380|NCT02476578|120097|P2|COMPLETED|Overall Study||4218
50381|NCT02476578|120098|P1|COMPLETED|Overall Study||4269
50382|NCT02476578|120097|P2|Left Before End of Trial|Overall Study||13
50384|NCT02476578|120097|P2|Died Before Email Was Sent|Overall Study||43
50385|NCT02476578|120098|P1|Died Before Email Was Sent|Overall Study||35
50386|NCT02476578|120097|P2|STARTED|Overall Study||4274
50387|NCT02476578|120098|P1|STARTED|Overall Study||4310
50388|NCT02476565|120112|P2|NOT COMPLETED|Overall Study||0
50389|NCT02476565|120113|P1|NOT COMPLETED|Overall Study||0
50390|NCT02476565|120112|P2|COMPLETED|Overall Study||19
50391|NCT02476565|120113|P1|COMPLETED|Overall Study||20
50392|NCT02476565|120112|P2|STARTED|Overall Study||19
50393|NCT02476565|120113|P1|STARTED|Overall Study||20
50394|NCT02476448|120137|P4|NOT COMPLETED|Overall Study||0
50395|NCT02476448|120138|P3|NOT COMPLETED|Overall Study||0
50396|NCT02476448|120139|P2|NOT COMPLETED|Overall Study||0
50397|NCT02476448|120140|P1|NOT COMPLETED|Overall Study||0
50398|NCT02476448|120137|P4|COMPLETED|Overall Study||44
50399|NCT02476448|120138|P3|COMPLETED|Overall Study||44
50400|NCT02476448|120139|P2|COMPLETED|Overall Study||44
50401|NCT02476448|120140|P1|COMPLETED|Overall Study||44
50402|NCT02476448|120137|P4|STARTED|Overall Study||44
50403|NCT02476448|120138|P3|STARTED|Overall Study||44
50404|NCT02476448|120139|P2|STARTED|Overall Study||44
50405|NCT02476448|120140|P1|STARTED|Overall Study|one given phenazopyridine pre-op and was analyzed in her randomization group per intention to treat|44
50406|NCT02476422|120160|P2|NOT COMPLETED|Overall Study||1
50407|NCT02476422|120161|P1|NOT COMPLETED|Overall Study||0
50408|NCT02476422|120160|P2|COMPLETED|Overall Study||161
50409|NCT02476422|120161|P1|COMPLETED|Overall Study||166
50410|NCT02476422|120160|P2|STARTED|Overall Study||162
50411|NCT02476422|120161|P1|STARTED|Overall Study|"started = Randomized Set/Full analysis set/Safety set"|166
50412|NCT02476175|120191|P1|NOT COMPLETED|Overall Study||2
50413|NCT02476175|120191|P1|COMPLETED|Overall Study||33
50414|NCT02476175|120191|P1|STARTED|Overall Study||35
50415|NCT02476032|120202|P3|NOT COMPLETED|Overall Study||1
50416|NCT02476032|120203|P2|NOT COMPLETED|Overall Study||1
50417|NCT02476032|120204|P1|NOT COMPLETED|Overall Study||0
50418|NCT02476032|120202|P3|COMPLETED|Overall Study||19
50419|NCT02476032|120203|P2|COMPLETED|Overall Study||19
50420|NCT02476032|120204|P1|COMPLETED|Overall Study||20
50421|NCT02476032|120202|P3|STARTED|Overall Study||20
50422|NCT02476032|120203|P2|STARTED|Overall Study||20
50423|NCT02476032|120204|P1|STARTED|Overall Study||20
50424|NCT02475980|120215|P1|NOT COMPLETED|Overall Study||5
50425|NCT02475980|120215|P1|COMPLETED|Overall Study||8
50426|NCT02475980|120215|P1|STARTED|Overall Study||13
50427|NCT02475837|120226|P2|NOT COMPLETED|Overall Study||0
50428|NCT02475837|120227|P1|NOT COMPLETED|Overall Study||0
50429|NCT02475837|120226|P2|COMPLETED|Overall Study||7
50430|NCT02475837|120227|P1|COMPLETED|Overall Study||6
50431|NCT02475837|120226|P2|STARTED|Overall Study||7
50432|NCT02475837|120227|P1|STARTED|Overall Study||6
50433|NCT02475733|120241|P2|NOT COMPLETED|Overall Study||0
50434|NCT02475733|120242|P1|NOT COMPLETED|Overall Study||2
50435|NCT02475733|120241|P2|COMPLETED|Overall Study||22
50436|NCT02475733|120242|P1|COMPLETED|Overall Study||59
50437|NCT02475733|120241|P2|STARTED|Overall Study||22
50438|NCT02475733|120242|P1|STARTED|Overall Study||61
50439|NCT02475655|120299|P2|NOT COMPLETED|Overall Study||1
50440|NCT02475655|120300|P1|NOT COMPLETED|Overall Study||0
50441|NCT02475655|120299|P2|COMPLETED|Overall Study||19
50442|NCT02475655|120300|P1|COMPLETED|Overall Study||40
50443|NCT02475655|120299|P2|STARTED|Overall Study||20
50444|NCT02475655|120300|P1|STARTED|Overall Study||40
50445|NCT02475564|120361|P2|NOT COMPLETED|Overall Study||1
50446|NCT02475564|120362|P1|NOT COMPLETED|Overall Study||4
50447|NCT02475564|120361|P2|COMPLETED|Overall Study||21
50448|NCT02475564|120362|P1|COMPLETED|Overall Study||18
50449|NCT02475564|120361|P2|STARTED|Overall Study||22
50450|NCT02475564|120362|P1|STARTED|Overall Study||22
50451|NCT02475395|120374|P2|NOT COMPLETED|Overall Study||3
50452|NCT02475395|120375|P1|NOT COMPLETED|Overall Study||30
50453|NCT02475395|120374|P2|COMPLETED|Overall Study||11
50454|NCT02475395|120375|P1|COMPLETED|Overall Study||228
50455|NCT02475395|120374|P2|STARTED|Overall Study||14
50456|NCT02475395|120375|P1|STARTED|Overall Study||258
50457|NCT02475278|120385|P1|NOT COMPLETED|Overall Study||2
50458|NCT02475278|120385|P1|COMPLETED|Overall Study||48
50459|NCT02475278|120385|P1|STARTED|Overall Study||50
50460|NCT02475265|120396|P1|NOT COMPLETED|Overall Study||3
50461|NCT02475265|120396|P1|COMPLETED|Overall Study||8
50462|NCT02475265|120396|P1|STARTED|Overall Study||11
50463|NCT02475070|120402|P2|NOT COMPLETED|Overall Study||0
50464|NCT02475070|120403|P1|NOT COMPLETED|Overall Study||0
50465|NCT02475070|120402|P2|COMPLETED|Overall Study||11
50466|NCT02475070|120403|P1|COMPLETED|Overall Study||17
50467|NCT02475070|120402|P2|STARTED|Overall Study||11
50468|NCT02475070|120403|P1|STARTED|Overall Study||17
50469|NCT02475031|120413|P2|NOT COMPLETED|Overall Study||0
50470|NCT02475031|120414|P1|NOT COMPLETED|Overall Study||0
50471|NCT02475031|120413|P2|COMPLETED|Overall Study||35
50472|NCT02475031|120414|P1|COMPLETED|Overall Study||35
50473|NCT02475031|120413|P2|STARTED|Overall Study||35
50474|NCT02475031|120414|P1|STARTED|Overall Study||35
50475|NCT02474901|120430|P2|NOT COMPLETED|Overall Study||0
50476|NCT02474901|120431|P1|NOT COMPLETED|Overall Study||1
50477|NCT02474901|120430|P2|COMPLETED|Overall Study||56
50478|NCT02474901|120431|P1|COMPLETED|Overall Study||44
50479|NCT02474901|120430|P2|STARTED|Overall Study||56
50480|NCT02474901|120431|P1|STARTED|Overall Study||45
50481|NCT02474589|120447|P2|NOT COMPLETED|Overall Study||5
50482|NCT02474589|120448|P1|NOT COMPLETED|Overall Study||25
50483|NCT02474589|120447|P2|COMPLETED|Overall Study||85
50484|NCT02474589|120448|P1|COMPLETED|Overall Study||334
50485|NCT02474589|120447|P2|STARTED|Overall Study||90
50486|NCT02474589|120448|P1|STARTED|Overall Study||359
50487|NCT02474498|120457|P3|NOT COMPLETED|Overall Study||0
50488|NCT02474498|120458|P2|NOT COMPLETED|Overall Study||0
50489|NCT02474498|120459|P1|NOT COMPLETED|Overall Study||0
50490|NCT02474498|120457|P3|COMPLETED|Overall Study||14
50491|NCT02474498|120458|P2|COMPLETED|Overall Study||14
50492|NCT02474498|120459|P1|COMPLETED|Overall Study||13
50493|NCT02474498|120457|P3|STARTED|Overall Study||14
50494|NCT02474498|120458|P2|STARTED|Overall Study||14
50495|NCT02474498|120459|P1|STARTED|Overall Study||13
50496|NCT02474407|120476|P2|NOT COMPLETED|Second Intervention (14 Days)||0
50497|NCT02474407|120477|P1|NOT COMPLETED|Second Intervention (14 Days)||0
50498|NCT02474407|120476|P2|COMPLETED|Second Intervention (14 Days)||39
50499|NCT02474407|120477|P1|COMPLETED|Second Intervention (14 Days)||39
50500|NCT02474407|120476|P2|STARTED|Second Intervention (14 Days)||39
50501|NCT02474407|120477|P1|STARTED|Second Intervention (14 Days)||39
50502|NCT02474407|120476|P2|NOT COMPLETED|Washout (14 Days)||0
50503|NCT02474407|120477|P1|NOT COMPLETED|Washout (14 Days)||0
50504|NCT02474407|120476|P2|COMPLETED|Washout (14 Days)||39
50505|NCT02474407|120477|P1|COMPLETED|Washout (14 Days)||39
50506|NCT02474407|120476|P2|STARTED|Washout (14 Days)||39
50507|NCT02474407|120477|P1|STARTED|Washout (14 Days)||39
50508|NCT02474407|120476|P2|NOT COMPLETED|First Intervention (14 Days)||0
50509|NCT02474407|120477|P1|NOT COMPLETED|First Intervention (14 Days)||0
50510|NCT02474407|120476|P2|COMPLETED|First Intervention (14 Days)||39
50511|NCT02474407|120477|P1|COMPLETED|First Intervention (14 Days)||39
50512|NCT02474407|120476|P2|STARTED|First Intervention (14 Days)||39
50513|NCT02474407|120477|P1|STARTED|First Intervention (14 Days)||39
50514|NCT02474082|120507|P2|NOT COMPLETED|Overall Study||54
50515|NCT02474082|120508|P1|NOT COMPLETED|Overall Study||6
50516|NCT02474082|120507|P2|COMPLETED|Overall Study||43
50517|NCT02474082|120508|P1|COMPLETED|Overall Study||99
50518|NCT02474082|120507|P2|Full Analysis Set (FAS)|Overall Study||95
50519|NCT02474082|120508|P1|Full Analysis Set (FAS)|Overall Study||105
50520|NCT02474082|120507|P2|STARTED|Overall Study||97
50521|NCT02474082|120508|P1|STARTED|Overall Study||105
50522|NCT02474069|120542|P3|NOT COMPLETED|Comparative Dosing Phase (CDP)||6
50523|NCT02474069|120543|P2|NOT COMPLETED|Comparative Dosing Phase (CDP)||9
50524|NCT02474069|120544|P1|NOT COMPLETED|Comparative Dosing Phase (CDP)||0
50525|NCT02474069|120542|P3|COMPLETED|Comparative Dosing Phase (CDP)||157
50526|NCT02474069|120543|P2|COMPLETED|Comparative Dosing Phase (CDP)||153
50527|NCT02474069|120544|P1|COMPLETED|Comparative Dosing Phase (CDP)||0
50528|NCT02474069|120542|P3|STARTED|Comparative Dosing Phase (CDP)||163
50529|NCT02474069|120543|P2|STARTED|Comparative Dosing Phase (CDP)||162
50530|NCT02474069|120544|P1|STARTED|Comparative Dosing Phase (CDP)||0
50531|NCT02474069|120542|P3|NOT COMPLETED|Selection Phase (SP)||0
50532|NCT02474069|120543|P2|NOT COMPLETED|Selection Phase (SP)||0
50533|NCT02474069|120544|P1|NOT COMPLETED|Selection Phase (SP)||23
50534|NCT02474069|120542|P3|COMPLETED|Selection Phase (SP)||0
50535|NCT02474069|120543|P2|COMPLETED|Selection Phase (SP)||0
50536|NCT02474069|120544|P1|COMPLETED|Selection Phase (SP)||749
50537|NCT02474069|120542|P3|STARTED|Selection Phase (SP)||0
50538|NCT02474069|120543|P2|STARTED|Selection Phase (SP)||0
50539|NCT02474069|120544|P1|STARTED|Selection Phase (SP)||772
50540|NCT02473991|120569|P1|NOT COMPLETED|Overall Study||0
50541|NCT02473991|120569|P1|COMPLETED|Overall Study||395
50542|NCT02473991|120569|P1|STARTED|Overall Study||395
50543|NCT02473952|120577|P2|NOT COMPLETED|Overall Study||8
50544|NCT02473952|120578|P1|NOT COMPLETED|Overall Study||2
50545|NCT02473952|120577|P2|COMPLETED|Overall Study||24
50546|NCT02473952|120578|P1|COMPLETED|Overall Study||28
50547|NCT02473952|120577|P2|STARTED|Overall Study||32
50548|NCT02473952|120578|P1|STARTED|Overall Study||30
50549|NCT02473783|120586|P2|NOT COMPLETED|Overall Study||0
50550|NCT02473783|120587|P1|NOT COMPLETED|Overall Study||0
50551|NCT02473783|120586|P2|COMPLETED|Overall Study||17
50552|NCT02473783|120587|P1|COMPLETED|Overall Study||20
50553|NCT02473783|120586|P2|STARTED|Overall Study||17
50554|NCT02473783|120587|P1|STARTED|Overall Study||20
50555|NCT02473718|120597|P2|NOT COMPLETED|Overall Study||0
50556|NCT02473718|120598|P1|NOT COMPLETED|Overall Study||0
50557|NCT02473718|120597|P2|COMPLETED|Overall Study||41
50558|NCT02473718|120598|P1|COMPLETED|Overall Study||41
50559|NCT02473718|120597|P2|STARTED|Overall Study||41
50560|NCT02473718|120598|P1|STARTED|Overall Study||41
50561|NCT02473640|120618|P1|NOT COMPLETED|Treatment Period 2||0
50562|NCT02473640|120618|P1|COMPLETED|Treatment Period 2||14
50563|NCT02473640|120618|P1|STARTED|Treatment Period 2||14
50564|NCT02473640|120618|P1|NOT COMPLETED|Run-in Phase||0
50565|NCT02473640|120618|P1|COMPLETED|Run-in Phase||14
50566|NCT02473640|120618|P1|STARTED|Run-in Phase||14
50567|NCT02473640|120618|P1|NOT COMPLETED|Treatment Period 1||1
50568|NCT02473640|120618|P1|COMPLETED|Treatment Period 1||14
50569|NCT02473640|120618|P1|STARTED|Treatment Period 1||15
50570|NCT02473523|120627|P1|NOT COMPLETED|Overall Study||2
50571|NCT02473523|120627|P1|COMPLETED|Overall Study||0
50572|NCT02473523|120627|P1|STARTED|Overall Study||2
50573|NCT02473510|120648|P2|NOT COMPLETED|Overall Study||2
50574|NCT02473510|120649|P1|NOT COMPLETED|Overall Study||1
50575|NCT02473510|120648|P2|COMPLETED|Overall Study||238
50576|NCT02473510|120649|P1|COMPLETED|Overall Study||59
50577|NCT02473510|120648|P2|STARTED|Overall Study||240
50578|NCT02473510|120649|P1|STARTED|Overall Study||60
50579|NCT02473471|120663|P1|NOT COMPLETED|Overall Study||3
50580|NCT02473471|120663|P1|COMPLETED|Overall Study||32
50581|NCT02473471|120663|P1|Randomized Not Treated|Overall Study||2
50582|NCT02473471|120663|P1|Received Allocated Intervention|Overall Study||33
50583|NCT02473471|120663|P1|STARTED|Overall Study||35
50584|NCT02473445|120694|P1|NOT COMPLETED|Overall Study||22
50585|NCT02473445|120694|P1|COMPLETED|Overall Study||0
50586|NCT02473445|120694|P1|STARTED|Overall Study||22
50587|NCT02473367|120700|P1|NOT COMPLETED|Period 4||1
50588|NCT02473367|120700|P1|COMPLETED|Period 4||18
50589|NCT02473367|120700|P1|STARTED|Period 4||19
50590|NCT02473367|120700|P1|NOT COMPLETED|Wait 3||0
50591|NCT02473367|120700|P1|COMPLETED|Wait 3||19
50592|NCT02473367|120700|P1|STARTED|Wait 3||19
50593|NCT02473367|120700|P1|NOT COMPLETED|Period 3||0
50594|NCT02473367|120700|P1|COMPLETED|Period 3||19
50595|NCT02473367|120700|P1|STARTED|Period 3||19
50596|NCT02473367|120700|P1|NOT COMPLETED|Wait 2||0
50597|NCT02473367|120700|P1|COMPLETED|Wait 2||19
50598|NCT02473367|120700|P1|STARTED|Wait 2||19
50599|NCT02473367|120700|P1|NOT COMPLETED|Period 2||0
50600|NCT02473367|120700|P1|COMPLETED|Period 2||19
50601|NCT02473367|120700|P1|STARTED|Period 2||19
50602|NCT02473367|120700|P1|NOT COMPLETED|Wait 1||1
50603|NCT02473367|120700|P1|COMPLETED|Wait 1||19
50604|NCT02473367|120700|P1|STARTED|Wait 1||20
50605|NCT02473367|120700|P1|NOT COMPLETED|Period 1||0
50606|NCT02473367|120700|P1|COMPLETED|Period 1||20
50607|NCT02473367|120700|P1|STARTED|Period 1||20
50608|NCT02473289|120720|P2|NOT COMPLETED|Overall Study||13
50609|NCT02473289|120721|P1|NOT COMPLETED|Overall Study||11
50610|NCT02473289|120720|P2|COMPLETED|Overall Study||81
50611|NCT02473289|120721|P1|COMPLETED|Overall Study||88
50612|NCT02473289|120720|P2|STARTED|Overall Study||94
50613|NCT02473289|120721|P1|STARTED|Overall Study||99
50614|NCT02472977|120746|P3|NOT COMPLETED|Overall Study||8
50615|NCT02472977|120747|P2|NOT COMPLETED|Overall Study||27
50616|NCT02472977|120748|P1|NOT COMPLETED|Overall Study||6
50617|NCT02472977|120746|P3|COMPLETED|Overall Study||0
50618|NCT02472977|120747|P2|COMPLETED|Overall Study||0
50619|NCT02472977|120748|P1|COMPLETED|Overall Study||0
50620|NCT02472977|120746|P3|STARTED|Overall Study||8
50621|NCT02472977|120747|P2|STARTED|Overall Study||27
50622|NCT02472977|120748|P1|STARTED|Overall Study||6
50623|NCT02472964|120773|P2|NOT COMPLETED|Part 2 (Week 24-week 48)||63
50624|NCT02472964|120774|P1|NOT COMPLETED|Part 2 (Week 24-week 48)||65
50625|NCT02472964|120773|P2|COMPLETED|Part 2 (Week 24-week 48)||116
50626|NCT02472964|120774|P1|COMPLETED|Part 2 (Week 24-week 48)||98
50627|NCT02472964|120773|P2|STARTED|Part 2 (Week 24-week 48)||179
50628|NCT02472964|120774|P1|STARTED|Part 2 (Week 24-week 48)||163
50629|NCT02472964|120773|P2|NOT COMPLETED|Part 1 (up to Week 24)||62
50630|NCT02472964|120774|P1|NOT COMPLETED|Part 1 (up to Week 24)||75
50631|NCT02472964|120773|P2|COMPLETED|Part 1 (up to Week 24)||185
50632|NCT02472964|120774|P1|COMPLETED|Part 1 (up to Week 24)||171
50633|NCT02472964|120773|P2|STARTED|Part 1 (up to Week 24)||247
50634|NCT02472964|120774|P1|STARTED|Part 1 (up to Week 24)||246
50635|NCT02472886|120783|P3|NOT COMPLETED|Overall Study||1
50636|NCT02472886|120784|P2|NOT COMPLETED|Overall Study||2
50637|NCT02472886|120785|P1|NOT COMPLETED|Overall Study||0
50638|NCT02472886|120783|P3|COMPLETED|Overall Study||26
50639|NCT02472886|120784|P2|COMPLETED|Overall Study||57
50640|NCT02472886|120785|P1|COMPLETED|Overall Study||67
50641|NCT02472886|120783|P3|STARTED|Overall Study||27
50642|NCT02472886|120784|P2|STARTED|Overall Study||59
50643|NCT02472886|120785|P1|STARTED|Overall Study||67
50644|NCT02472847|120813|P2|NOT COMPLETED|Overall Study||5
50645|NCT02472847|120814|P1|NOT COMPLETED|Overall Study||1
50646|NCT02472847|120813|P2|COMPLETED|Overall Study||21
50647|NCT02472847|120814|P1|COMPLETED|Overall Study||23
50648|NCT02472847|120813|P2|STARTED|Overall Study||26
50649|NCT02472847|120814|P1|STARTED|Overall Study||24
50650|NCT02472756|120820|P1|NOT COMPLETED|Maintenance (Approximately 2 Years)||10
50651|NCT02472756|120820|P1|COMPLETED|Maintenance (Approximately 2 Years)||10
50652|NCT02472756|120820|P1|STARTED|Maintenance (Approximately 2 Years)|Out of 39 participants who completed induction period, 19 did not continue in maintenance period.|20
50653|NCT02472756|120820|P1|NOT COMPLETED|Induction (Approximately 6 Months)||2
50654|NCT02472756|120820|P1|COMPLETED|Induction (Approximately 6 Months)||39
50655|NCT02472756|120820|P1|Treated|Induction (Approximately 6 Months)||40
50656|NCT02472756|120820|P1|STARTED|Induction (Approximately 6 Months)||41
50657|NCT02472652|120826|P1|NOT COMPLETED|Overall Study||1
50658|NCT02472652|120826|P1|COMPLETED|Overall Study||1
50659|NCT02472652|120826|P1|STARTED|Overall Study||2
50660|NCT02472639|120833|P2|NOT COMPLETED|Overall Study||3
50661|NCT02472639|120834|P1|NOT COMPLETED|Overall Study||4
50662|NCT02472639|120833|P2|COMPLETED|Overall Study||0
50663|NCT02472639|120834|P1|COMPLETED|Overall Study||0
50664|NCT02472639|120833|P2|STARTED|Overall Study||3
50665|NCT02472639|120834|P1|STARTED|Overall Study||4
50666|NCT02472522|120850|P2|NOT COMPLETED|Overall Study||0
50667|NCT02472522|120851|P1|NOT COMPLETED|Overall Study||0
50668|NCT02472522|120850|P2|COMPLETED|Overall Study||50
50669|NCT02472522|120851|P1|COMPLETED|Overall Study||50
50670|NCT02472522|120850|P2|STARTED|Overall Study||50
50671|NCT02472522|120851|P1|STARTED|Overall Study||50
50672|NCT02472405|120881|P1|NOT COMPLETED|Overall Study||10
50673|NCT02472405|120881|P1|COMPLETED|Overall Study||8
50674|NCT02472405|120881|P1|STARTED|Overall Study||18
50675|NCT02472366|120889|P2|NOT COMPLETED|Overall Study||0
50676|NCT02472366|120890|P1|NOT COMPLETED|Overall Study||1
50677|NCT02472366|120889|P2|COMPLETED|Overall Study||10
50678|NCT02472366|120890|P1|COMPLETED|Overall Study||5
50679|NCT02472366|120889|P2|STARTED|Overall Study||10
50680|NCT02472366|120890|P1|STARTED|Overall Study|6 subjects receiving ILUVIEN, 7 eyes receiving ILUVIEN|6
50681|NCT02472353|120906|P2|NOT COMPLETED|Overall Study||6
50682|NCT02472353|120907|P1|NOT COMPLETED|Overall Study||4
50683|NCT02472353|120906|P2|COMPLETED|Overall Study||10
50684|NCT02472353|120907|P1|COMPLETED|Overall Study||10
50685|NCT02472353|120906|P2|STARTED|Overall Study||16
50686|NCT02472353|120907|P1|STARTED|Overall Study||14
50687|NCT02472314|120915|P2|NOT COMPLETED|Overall Study||0
50688|NCT02472314|120916|P1|NOT COMPLETED|Overall Study||0
50689|NCT02472314|120915|P2|COMPLETED|Overall Study||36
50690|NCT02472314|120916|P1|COMPLETED|Overall Study||34
50691|NCT02472314|120915|P2|STARTED|Overall Study||36
50692|NCT02472314|120916|P1|STARTED|Overall Study||34
50693|NCT02472262|120931|P3|NOT COMPLETED|Overall Study||25
50694|NCT02472262|120932|P2|NOT COMPLETED|Overall Study||21
50695|NCT02472262|120933|P1|NOT COMPLETED|Overall Study||18
50696|NCT02472262|120931|P3|COMPLETED|Overall Study||93
50697|NCT02472262|120932|P2|COMPLETED|Overall Study||99
50698|NCT02472262|120933|P1|COMPLETED|Overall Study||99
50699|NCT02472262|120931|P3|STARTED|Overall Study||118
50700|NCT02472262|120932|P2|STARTED|Overall Study||120
50701|NCT02472262|120933|P1|STARTED|Overall Study||117
50702|NCT02472145|120944|P3|NOT COMPLETED|Overall Study||157
50703|NCT02472145|120945|P2|NOT COMPLETED|Overall Study||159
50704|NCT02472145|120946|P1|NOT COMPLETED|Overall Study||10
50705|NCT02472145|120944|P3|COMPLETED|Overall Study||0
50706|NCT02472145|120945|P2|COMPLETED|Overall Study||0
50707|NCT02472145|120946|P1|COMPLETED|Overall Study||0
50708|NCT02472145|120944|P3|Safety|Overall Study|1 participant who was not treated and 9 participants who received only decitabine were excluded.|147
50709|NCT02472145|120945|P2|Safety|Overall Study|9 participants who received decitabine,not JNJ-56022473 included,3 untreated participant excluded.|165
50710|NCT02472145|120946|P1|Safety|Overall Study||10
50711|NCT02472145|120944|P3|Treated|Overall Study||156
50712|NCT02472145|120945|P2|Treated|Overall Study||156
50713|NCT02472145|120946|P1|Treated|Overall Study||10
50714|NCT02472145|120944|P3|STARTED|Overall Study||157
50715|NCT02472145|120945|P2|STARTED|Overall Study||159
50716|NCT02472145|120946|P1|STARTED|Overall Study||10
50717|NCT02471755|120967|P2|NOT COMPLETED|Overall Study||1
50718|NCT02471755|120968|P1|NOT COMPLETED|Overall Study||1
50719|NCT02471755|120967|P2|COMPLETED|Overall Study||44
50720|NCT02471755|120968|P1|COMPLETED|Overall Study||44
50721|NCT02471755|120967|P2|STARTED|Overall Study||45
50722|NCT02471755|120968|P1|STARTED|Overall Study||45
50723|NCT02471651|120986|P2|NOT COMPLETED|Overall Study||5
50724|NCT02471651|120987|P1|NOT COMPLETED|Overall Study||5
50725|NCT02471651|120986|P2|COMPLETED|Overall Study||15
50726|NCT02471651|120987|P1|COMPLETED|Overall Study||15
50727|NCT02471651|120986|P2|STARTED|Overall Study||20
50728|NCT02471651|120987|P1|STARTED|Overall Study||20
50729|NCT02471612|120997|P1|NOT COMPLETED|Overall Study||2
50730|NCT02471612|120997|P1|COMPLETED|Overall Study||157
50731|NCT02471612|120997|P1|STARTED|Overall Study||159
50732|NCT02471521|121016|P2|NOT COMPLETED|Overall Study||8
50733|NCT02471521|121017|P1|NOT COMPLETED|Overall Study||0
50734|NCT02471521|121016|P2|COMPLETED|Overall Study||52
50735|NCT02471521|121017|P1|COMPLETED|Overall Study||60
50736|NCT02471521|121016|P2|STARTED|Overall Study||60
50737|NCT02471521|121017|P1|STARTED|Overall Study||60
50738|NCT02471404|121028|P3|NOT COMPLETED|Overall Study||25
50739|NCT02471404|121029|P2|NOT COMPLETED|Overall Study||14
50740|NCT02471404|121030|P1|NOT COMPLETED|Overall Study||33
50741|NCT02471404|121028|P3|COMPLETED|Overall Study||288
50742|NCT02471404|121029|P2|COMPLETED|Overall Study||298
50743|NCT02471404|121030|P1|COMPLETED|Overall Study||281
50744|NCT02471404|121028|P3|STARTED|Overall Study||313
50745|NCT02471404|121029|P2|STARTED|Overall Study||312
50746|NCT02471404|121030|P1|STARTED|Overall Study||314
50747|NCT02471326|121053|P1|NOT COMPLETED|Overall Study||1
50748|NCT02471326|121053|P1|COMPLETED|Overall Study||9
50749|NCT02471326|121053|P1|STARTED|Overall Study||10
50750|NCT02471313|121058|P1|NOT COMPLETED|Overall Study||0
50751|NCT02471313|121058|P1|COMPLETED|Overall Study||3
50752|NCT02471313|121058|P1|STARTED|Overall Study||3
50753|NCT02471183|121062|P1|NOT COMPLETED|Extended Treatment Period||1
50754|NCT02471183|121062|P1|COMPLETED|Extended Treatment Period||31
50755|NCT02471183|121062|P1|STARTED|Extended Treatment Period||32
50756|NCT02471183|121062|P1|NOT COMPLETED|Main Treatment Period||2
50757|NCT02471183|121062|P1|COMPLETED|Main Treatment Period||32
50758|NCT02471183|121062|P1|STARTED|Main Treatment Period||34
50759|NCT02470949|121077|P2|NOT COMPLETED|Second Intervention||0
50760|NCT02470949|121078|P1|NOT COMPLETED|Second Intervention||0
50761|NCT02470949|121077|P2|COMPLETED|Second Intervention||2
50762|NCT02470949|121078|P1|COMPLETED|Second Intervention||4
50763|NCT02470949|121077|P2|STARTED|Second Intervention||2
50764|NCT02470949|121078|P1|STARTED|Second Intervention||4
50765|NCT02470949|121077|P2|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
50766|NCT02470949|121078|P1|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
50767|NCT02470949|121077|P2|COMPLETED|Washout Period for a Minimum of 4 Weeks||5
50768|NCT02470949|121078|P1|COMPLETED|Washout Period for a Minimum of 4 Weeks||4
50769|NCT02470949|121077|P2|STARTED|Washout Period for a Minimum of 4 Weeks||5
50770|NCT02470949|121078|P1|STARTED|Washout Period for a Minimum of 4 Weeks||4
50771|NCT02470949|121077|P2|NOT COMPLETED|First Intervention||0
50772|NCT02470949|121078|P1|NOT COMPLETED|First Intervention||0
50773|NCT02470949|121077|P2|COMPLETED|First Intervention||5
50774|NCT02470949|121078|P1|COMPLETED|First Intervention||4
50775|NCT02470949|121077|P2|STARTED|First Intervention||5
50776|NCT02470949|121078|P1|STARTED|First Intervention||4
50777|NCT02470910|121088|P1|NOT COMPLETED|Overall Study||0
50778|NCT02470910|121088|P1|COMPLETED|Overall Study||15
50779|NCT02470910|121088|P1|STARTED|Overall Study||15
50780|NCT02470754|121095|P2|NOT COMPLETED|Overall Study||0
50781|NCT02470754|121096|P1|NOT COMPLETED|Overall Study||2
50782|NCT02470754|121095|P2|COMPLETED|Overall Study||19
50783|NCT02470754|121096|P1|COMPLETED|Overall Study||17
50784|NCT02470754|121095|P2|STARTED|Overall Study||19
50785|NCT02470754|121096|P1|STARTED|Overall Study||19
50786|NCT02470741|121124|P2|NOT COMPLETED|Overall Study||2
50787|NCT02470741|121125|P1|NOT COMPLETED|Overall Study||3
50788|NCT02470741|121124|P2|COMPLETED|Overall Study||4
50789|NCT02470741|121125|P1|COMPLETED|Overall Study||3
50790|NCT02470741|121124|P2|STARTED|Overall Study||6
50791|NCT02470741|121125|P1|STARTED|Overall Study||6
50792|NCT02470494|121131|P1|NOT COMPLETED|Overall Study||5
50793|NCT02470494|121131|P1|COMPLETED|Overall Study||41
50794|NCT02470494|121131|P1|STARTED|Overall Study||46
50795|NCT02470429|121141|P2|NOT COMPLETED|Overall Study||0
50796|NCT02470429|121142|P1|NOT COMPLETED|Overall Study||2
50797|NCT02470429|121141|P2|COMPLETED|Overall Study||49
50798|NCT02470429|121142|P1|COMPLETED|Overall Study||48
50799|NCT02470429|121141|P2|STARTED|Overall Study||49
50800|NCT02470429|121142|P1|STARTED|Overall Study||50
50801|NCT02470403|121160|P5|NOT COMPLETED|Overall Study||0
50802|NCT02470403|121161|P4|NOT COMPLETED|Overall Study||4
50803|NCT02470403|121162|P3|NOT COMPLETED|Overall Study||0
50804|NCT02470403|121163|P2|NOT COMPLETED|Overall Study||1
50805|NCT02470403|121164|P1|NOT COMPLETED|Overall Study||2
50806|NCT02470403|121160|P5|COMPLETED|Overall Study||10
50807|NCT02470403|121161|P4|COMPLETED|Overall Study||39
50808|NCT02470403|121162|P3|COMPLETED|Overall Study||40
50809|NCT02470403|121163|P2|COMPLETED|Overall Study||43
50810|NCT02470403|121164|P1|COMPLETED|Overall Study||42
50811|NCT02470403|121160|P5|Normoglycemic|Overall Study||5
50812|NCT02470403|121161|P4|Normoglycemic|Overall Study||23
50813|NCT02470403|121162|P3|Normoglycemic|Overall Study||20
50814|NCT02470403|121163|P2|Normoglycemic|Overall Study||20
50815|NCT02470403|121164|P1|Normoglycemic|Overall Study||20
50816|NCT02470403|121160|P5|Dysglycemic|Overall Study||5
50817|NCT02470403|121161|P4|Dysglycemic|Overall Study||20
50818|NCT02470403|121162|P3|Dysglycemic|Overall Study||20
50819|NCT02470403|121163|P2|Dysglycemic|Overall Study||24
50820|NCT02470403|121164|P1|Dysglycemic|Overall Study||24
50821|NCT02470403|121160|P5|STARTED|Overall Study||10
50822|NCT02470403|121161|P4|STARTED|Overall Study||43
50823|NCT02470403|121162|P3|STARTED|Overall Study||40
50824|NCT02470403|121163|P2|STARTED|Overall Study||44
50825|NCT02470403|121164|P1|STARTED|Overall Study||44
50826|NCT02470390|121204|P2|NOT COMPLETED|Overall Study||1
50827|NCT02470390|121205|P1|NOT COMPLETED|Overall Study||0
50828|NCT02470390|121204|P2|COMPLETED|Overall Study||6
50829|NCT02470390|121205|P1|COMPLETED|Overall Study||6
50830|NCT02470390|121204|P2|STARTED|Overall Study||7
50831|NCT02470390|121205|P1|STARTED|Overall Study||6
50832|NCT02470312|121233|P2|NOT COMPLETED|Overall Study||12
50833|NCT02470312|121234|P1|NOT COMPLETED|Overall Study||5
50834|NCT02470312|121233|P2|COMPLETED|Overall Study||419
50835|NCT02470312|121234|P1|COMPLETED|Overall Study||142
50836|NCT02470312|121233|P2|STARTED|Overall Study||431
50837|NCT02470312|121234|P1|STARTED|Overall Study||147
50838|NCT02469961|121244|P2|NOT COMPLETED|Overall Study||1
50839|NCT02469961|121245|P1|NOT COMPLETED|Overall Study||4
50840|NCT02469961|121244|P2|COMPLETED|Overall Study||24
50841|NCT02469961|121245|P1|COMPLETED|Overall Study||21
50842|NCT02469961|121244|P2|STARTED|Overall Study||25
50843|NCT02469961|121245|P1|STARTED|Overall Study||25
50844|NCT02469714|121259|P2|NOT COMPLETED|Overall Study||5
50845|NCT02469714|121260|P1|NOT COMPLETED|Overall Study||8
50846|NCT02469714|121259|P2|COMPLETED|Overall Study||50
50847|NCT02469714|121260|P1|COMPLETED|Overall Study||47
50848|NCT02469714|121259|P2|8 Month Follow-Up|Overall Study||50
50849|NCT02469714|121260|P1|8 Month Follow-Up|Overall Study||49
50850|NCT02469714|121259|P2|4 Month Follow-Up|Overall Study||51
50851|NCT02469714|121260|P1|4 Month Follow-Up|Overall Study||50
50852|NCT02469714|121259|P2|STARTED|Overall Study||55
50853|NCT02469714|121260|P1|STARTED|Overall Study||55
50854|NCT02469701|121280|P1|NOT COMPLETED|Overall Study||0
50855|NCT02469701|121280|P1|COMPLETED|Overall Study||10
50856|NCT02469701|121280|P1|STARTED|Overall Study||10
50857|NCT02469623|121284|P1|NOT COMPLETED|Overall Study||13
50858|NCT02469623|121284|P1|COMPLETED|Overall Study||72
50859|NCT02469623|121284|P1|STARTED|Overall Study||85
50860|NCT02469610|121291|P2|NOT COMPLETED|Overall Study||1
50861|NCT02469610|121292|P1|NOT COMPLETED|Overall Study||4
50862|NCT02469610|121291|P2|COMPLETED|Overall Study||30
50863|NCT02469610|121292|P1|COMPLETED|Overall Study||30
50864|NCT02469610|121291|P2|STARTED|Overall Study||31
50865|NCT02469610|121292|P1|STARTED|Overall Study||34
50866|NCT02469597|121302|P2|NOT COMPLETED|Overall Study||0
50867|NCT02469597|121303|P1|NOT COMPLETED|Overall Study||0
50868|NCT02469597|121302|P2|COMPLETED|Overall Study||24
50869|NCT02469597|121303|P1|COMPLETED|Overall Study||22
50870|NCT02469597|121302|P2|STARTED|Overall Study||24
50871|NCT02469597|121303|P1|STARTED|Overall Study||22
50872|NCT02469415|121319|P1|NOT COMPLETED|Overall Study||3
50873|NCT02469415|121319|P1|COMPLETED|Overall Study||0
50874|NCT02469415|121319|P1|STARTED|Overall Study||3
50875|NCT02469298|121327|P4|NOT COMPLETED|Overall Study||2
50876|NCT02469298|121328|P3|NOT COMPLETED|Overall Study||2
50877|NCT02469298|121329|P2|NOT COMPLETED|Overall Study||1
50878|NCT02469298|121330|P1|NOT COMPLETED|Overall Study||1
50879|NCT02469298|121327|P4|COMPLETED|Overall Study||5
50880|NCT02469298|121328|P3|COMPLETED|Overall Study||14
50881|NCT02469298|121329|P2|COMPLETED|Overall Study||6
50882|NCT02469298|121330|P1|COMPLETED|Overall Study||14
50883|NCT02469298|121327|P4|STARTED|Overall Study||7
50884|NCT02469298|121328|P3|STARTED|Overall Study||16
50885|NCT02469298|121329|P2|STARTED|Overall Study||7
50886|NCT02469298|121330|P1|STARTED|Overall Study||15
50887|NCT02469246|121470|P2|NOT COMPLETED|Open-Label Extension (OLE)||0
50888|NCT02469246|121471|P1|NOT COMPLETED|Open-Label Extension (OLE)||0
50889|NCT02469246|121470|P2|COMPLETED|Open-Label Extension (OLE)||5
50890|NCT02469246|121471|P1|COMPLETED|Open-Label Extension (OLE)||6
50891|NCT02469246|121470|P2|STARTED|Open-Label Extension (OLE)|Only participants in countries where F/TAF was not commercially available were eligible for the OLE.|5
50892|NCT02469246|121471|P1|STARTED|Open-Label Extension (OLE)|Only participants in countries where F/TAF was not commercially available were eligible for the OLE.|6
50893|NCT02469246|121470|P2|NOT COMPLETED|Double-Blind Phase||56
50894|NCT02469246|121471|P1|NOT COMPLETED|Double-Blind Phase||67
50895|NCT02469246|121470|P2|COMPLETED|Double-Blind Phase||226
50896|NCT02469246|121471|P1|COMPLETED|Double-Blind Phase||218
50897|NCT02469246|121470|P2|STARTED|Double-Blind Phase||282
50898|NCT02469246|121471|P1|STARTED|Double-Blind Phase||285
50899|NCT02469168|121503|P2|NOT COMPLETED|Overall Study||0
50900|NCT02469168|121504|P1|NOT COMPLETED|Overall Study||1
50901|NCT02469168|121503|P2|COMPLETED|Overall Study||0
50902|NCT02469168|121504|P1|COMPLETED|Overall Study||0
50903|NCT02469168|121503|P2|STARTED|Overall Study||0
50904|NCT02469168|121504|P1|STARTED|Overall Study||1
50905|NCT02469116|121512|P1|NOT COMPLETED|Overall Study||0
50906|NCT02469116|121512|P1|COMPLETED|Overall Study||18
50907|NCT02469116|121512|P1|STARTED|Overall Study||18
50908|NCT02469064|121524|P2|NOT COMPLETED|Overall Study||3
50909|NCT02469064|121525|P1|NOT COMPLETED|Overall Study||1
50910|NCT02469064|121524|P2|COMPLETED|Overall Study||59
50911|NCT02469064|121525|P1|COMPLETED|Overall Study||63
50912|NCT02469064|121524|P2|STARTED|Overall Study||62
50913|NCT02469064|121525|P1|STARTED|Overall Study||64
50914|NCT02468934|121533|P1|NOT COMPLETED|Overall Study||7
50915|NCT02468934|121533|P1|COMPLETED|Overall Study||20
50916|NCT02468934|121533|P1|Underwent Total Knee Arthroplasty|Overall Study||20
50917|NCT02468934|121533|P1|Enrolled/Received Leads|Overall Study||24
50918|NCT02468934|121533|P1|STARTED|Overall Study||27
50919|NCT02468830|121552|P1|NOT COMPLETED|Overall Study||3
50920|NCT02468830|121552|P1|COMPLETED|Overall Study||55
50921|NCT02468830|121552|P1|STARTED|Overall Study||58
50922|NCT02468700|121562|P2|NOT COMPLETED|Overall Study||2
50923|NCT02468700|121563|P1|NOT COMPLETED|Overall Study||2
50924|NCT02468700|121562|P2|COMPLETED|Overall Study||19
50925|NCT02468700|121563|P1|COMPLETED|Overall Study||20
50926|NCT02468700|121562|P2|STARTED|Overall Study||21
50927|NCT02468700|121563|P1|STARTED|Overall Study||22
50928|NCT02468583|121577|P2|NOT COMPLETED|Overall Study||0
50929|NCT02468583|121578|P1|NOT COMPLETED|Overall Study||0
50930|NCT02468583|121577|P2|COMPLETED|Overall Study||3
50931|NCT02468583|121578|P1|COMPLETED|Overall Study||3
50932|NCT02468583|121577|P2|STARTED|Overall Study||3
50933|NCT02468583|121578|P1|STARTED|Overall Study||3
50934|NCT02468414|121616|P2|NOT COMPLETED|Overall Study||0
50935|NCT02468414|121617|P1|NOT COMPLETED|Overall Study||3
50936|NCT02468414|121616|P2|COMPLETED|Overall Study||0
50937|NCT02468414|121617|P1|COMPLETED|Overall Study||0
50938|NCT02468414|121616|P2|Safety Follow-up|Overall Study||0
50939|NCT02468414|121617|P1|Safety Follow-up|Overall Study||0
50940|NCT02468414|121616|P2|Implantation|Overall Study||0
50941|NCT02468414|121617|P1|Implantation|Overall Study||1
50942|NCT02468414|121616|P2|Harvesting|Overall Study||0
50943|NCT02468414|121617|P1|Harvesting|Overall Study||1
50944|NCT02468414|121616|P2|Successfully Screened|Overall Study||0
50945|NCT02468414|121617|P1|Successfully Screened|Overall Study||2
50946|NCT02468414|121616|P2|STARTED|Overall Study||0
50947|NCT02468414|121617|P1|STARTED|Overall Study||3
50948|NCT02468154|121625|P2|NOT COMPLETED|Overall Study||0
50949|NCT02468154|121626|P1|NOT COMPLETED|Overall Study||0
50950|NCT02468154|121625|P2|COMPLETED|Overall Study||28
50951|NCT02468154|121626|P1|COMPLETED|Overall Study||29
50952|NCT02468154|121625|P2|STARTED|Overall Study||28
50953|NCT02468154|121626|P1|STARTED|Overall Study||29
50954|NCT02467777|121640|P2|NOT COMPLETED|Overall Study||0
50955|NCT02467777|121641|P1|NOT COMPLETED|Overall Study||0
50956|NCT02467777|121640|P2|COMPLETED|Overall Study||27
50957|NCT02467777|121641|P1|COMPLETED|Overall Study||23
50958|NCT02467777|121640|P2|STARTED|Overall Study||27
50959|NCT02467777|121641|P1|STARTED|Overall Study||23
50960|NCT02467621|121649|P2|NOT COMPLETED|Overall Study||6
50961|NCT02467621|121650|P1|NOT COMPLETED|Overall Study||1
50962|NCT02467621|121649|P2|COMPLETED|Overall Study||1647
50963|NCT02467621|121650|P1|COMPLETED|Overall Study||1644
50964|NCT02467621|121649|P2|STARTED|Overall Study||1653
50965|NCT02467621|121650|P1|STARTED|Overall Study||1645
50966|NCT02467504|121670|P2|NOT COMPLETED|Overall Study||1
50967|NCT02467504|121671|P1|NOT COMPLETED|Overall Study||6
50968|NCT02467504|121670|P2|COMPLETED|Overall Study||23
50969|NCT02467504|121671|P1|COMPLETED|Overall Study||17
50970|NCT02467504|121670|P2|STARTED|Overall Study||24
50971|NCT02467504|121671|P1|STARTED|Overall Study||23
50972|NCT02467491|121715|P1|NOT COMPLETED|Overall Study||0
50973|NCT02467491|121715|P1|COMPLETED|Overall Study||12
50974|NCT02467491|121715|P1|STARTED|Overall Study||12
50975|NCT02467179|121726|P2|NOT COMPLETED|Overall Study||0
50976|NCT02467179|121727|P1|NOT COMPLETED|Overall Study||0
50977|NCT02467179|121726|P2|COMPLETED|Overall Study||25
50978|NCT02467179|121727|P1|COMPLETED|Overall Study||25
50979|NCT02467179|121726|P2|STARTED|Overall Study||25
50980|NCT02467179|121727|P1|STARTED|Overall Study||25
50981|NCT02467075|121737|P2|NOT COMPLETED|30 Day Follow-up||0
50982|NCT02467075|121738|P1|NOT COMPLETED|30 Day Follow-up||0
50983|NCT02467075|121737|P2|COMPLETED|30 Day Follow-up||1
50984|NCT02467075|121738|P1|COMPLETED|30 Day Follow-up||0
50985|NCT02467075|121737|P2|STARTED|30 Day Follow-up||1
50986|NCT02467075|121738|P1|STARTED|30 Day Follow-up||0
50987|NCT02467075|121737|P2|NOT COMPLETED|72 Hour Follow-up||0
50988|NCT02467075|121738|P1|NOT COMPLETED|72 Hour Follow-up||0
50989|NCT02467075|121737|P2|COMPLETED|72 Hour Follow-up||1
50990|NCT02467075|121738|P1|COMPLETED|72 Hour Follow-up||0
50991|NCT02467075|121737|P2|STARTED|72 Hour Follow-up||1
50992|NCT02467075|121738|P1|STARTED|72 Hour Follow-up||0
50993|NCT02467075|121737|P2|NOT COMPLETED|48 Hour Follow-up||0
50994|NCT02467075|121738|P1|NOT COMPLETED|48 Hour Follow-up||0
50995|NCT02467075|121737|P2|COMPLETED|48 Hour Follow-up||1
50996|NCT02467075|121738|P1|COMPLETED|48 Hour Follow-up||0
50997|NCT02467075|121737|P2|STARTED|48 Hour Follow-up||1
50998|NCT02467075|121738|P1|STARTED|48 Hour Follow-up||0
50999|NCT02467075|121737|P2|NOT COMPLETED|Initial CT Scan||0
51000|NCT02467075|121738|P1|NOT COMPLETED|Initial CT Scan||0
51001|NCT02467075|121737|P2|COMPLETED|Initial CT Scan||1
51002|NCT02467075|121738|P1|COMPLETED|Initial CT Scan||0
51003|NCT02467075|121737|P2|STARTED|Initial CT Scan||1
51004|NCT02467075|121738|P1|STARTED|Initial CT Scan||0
51005|NCT02466958|121756|P2|NOT COMPLETED|Overall Study||3
51006|NCT02466958|121757|P1|NOT COMPLETED|Overall Study||10
51007|NCT02466958|121756|P2|COMPLETED|Overall Study||9
51008|NCT02466958|121757|P1|COMPLETED|Overall Study||7
51009|NCT02466958|121756|P2|STARTED|Overall Study||12
51010|NCT02466958|121757|P1|STARTED|Overall Study||17
51011|NCT02466659|121769|P2|NOT COMPLETED|Overall Study||2
51012|NCT02466659|121770|P1|NOT COMPLETED|Overall Study||5
51013|NCT02466659|121769|P2|COMPLETED|Overall Study||1
51014|NCT02466659|121770|P1|COMPLETED|Overall Study||0
51015|NCT02466659|121769|P2|STARTED|Overall Study||3
51016|NCT02466659|121770|P1|STARTED|Overall Study||5
51017|NCT02466555|121778|P1|NOT COMPLETED|Overall Study||2
51018|NCT02466555|121778|P1|COMPLETED|Overall Study||28
51019|NCT02466555|121778|P1|STARTED|Overall Study||30
51020|NCT02466516|121790|P5|NOT COMPLETED|Overall Study||0
51021|NCT02466516|121791|P4|NOT COMPLETED|Overall Study||0
51022|NCT02466516|121792|P3|NOT COMPLETED|Overall Study||1
51023|NCT02466516|121793|P2|NOT COMPLETED|Overall Study||1
51024|NCT02466516|121794|P1|NOT COMPLETED|Overall Study||4
51025|NCT02466516|121790|P5|COMPLETED|Overall Study||10
51026|NCT02466516|121791|P4|COMPLETED|Overall Study||10
51027|NCT02466516|121792|P3|COMPLETED|Overall Study||9
51028|NCT02466516|121793|P2|COMPLETED|Overall Study||21
51029|NCT02466516|121794|P1|COMPLETED|Overall Study||16
51030|NCT02466516|121790|P5|STARTED|Overall Study||10
51031|NCT02466516|121791|P4|STARTED|Overall Study||10
51032|NCT02466516|121792|P3|STARTED|Overall Study||10
51033|NCT02466516|121793|P2|STARTED|Overall Study||22
51034|NCT02466516|121794|P1|STARTED|Overall Study||20
51035|NCT02466425|121813|P2|NOT COMPLETED|Overall Study||16
51036|NCT02466425|121814|P1|NOT COMPLETED|Overall Study||14
51037|NCT02466425|121813|P2|COMPLETED|Overall Study||116
51038|NCT02466425|121814|P1|COMPLETED|Overall Study||118
51039|NCT02466425|121813|P2|Treated|Overall Study||132
51040|NCT02466425|121814|P1|Treated|Overall Study||131
51041|NCT02466425|121813|P2|STARTED|Overall Study||132
51042|NCT02466425|121814|P1|STARTED|Overall Study||132
51043|NCT02466412|121824|P2|NOT COMPLETED|Second Intervention (Day 3)||0
51044|NCT02466412|121825|P1|NOT COMPLETED|Second Intervention (Day 3)||0
51045|NCT02466412|121824|P2|COMPLETED|Second Intervention (Day 3)||24
51046|NCT02466412|121825|P1|COMPLETED|Second Intervention (Day 3)||24
51047|NCT02466412|121824|P2|STARTED|Second Intervention (Day 3)||24
51048|NCT02466412|121825|P1|STARTED|Second Intervention (Day 3)||24
51049|NCT02466412|121824|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
51050|NCT02466412|121825|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
51051|NCT02466412|121824|P2|COMPLETED|Washout Period of 1 Day (Day 2)||24
51052|NCT02466412|121825|P1|COMPLETED|Washout Period of 1 Day (Day 2)||24
51053|NCT02466412|121824|P2|STARTED|Washout Period of 1 Day (Day 2)||24
51054|NCT02466412|121825|P1|STARTED|Washout Period of 1 Day (Day 2)||24
51055|NCT02466412|121824|P2|NOT COMPLETED|First Intervention (Day 1)||0
51056|NCT02466412|121825|P1|NOT COMPLETED|First Intervention (Day 1)||0
51057|NCT02466412|121824|P2|COMPLETED|First Intervention (Day 1)||24
51058|NCT02466412|121825|P1|COMPLETED|First Intervention (Day 1)||24
51059|NCT02466412|121824|P2|STARTED|First Intervention (Day 1)||24
51060|NCT02466412|121825|P1|STARTED|First Intervention (Day 1)||24
51061|NCT02466412|121824|P2|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
51062|NCT02466412|121825|P1|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
51063|NCT02466412|121824|P2|COMPLETED|Washout Period of 1 Day (Day -1)||24
51064|NCT02466412|121825|P1|COMPLETED|Washout Period of 1 Day (Day -1)||24
51065|NCT02466412|121824|P2|STARTED|Washout Period of 1 Day (Day -1)||24
51066|NCT02466412|121825|P1|STARTED|Washout Period of 1 Day (Day -1)||24
51067|NCT02466230|121834|P1|NOT COMPLETED|Overall Study||0
51068|NCT02466230|121834|P1|COMPLETED|Overall Study||28
51069|NCT02466230|121834|P1|STARTED|Overall Study||28
51070|NCT02466087|121839|P2|NOT COMPLETED|Second Intervention: Weeks 7-12||0
51071|NCT02466087|121840|P1|NOT COMPLETED|Second Intervention: Weeks 7-12||0
51072|NCT02466087|121839|P2|COMPLETED|Second Intervention: Weeks 7-12||57
51073|NCT02466087|121840|P1|COMPLETED|Second Intervention: Weeks 7-12||55
51074|NCT02466087|121839|P2|STARTED|Second Intervention: Weeks 7-12||57
51075|NCT02466087|121840|P1|STARTED|Second Intervention: Weeks 7-12||55
51076|NCT02466087|121839|P2|NOT COMPLETED|First Intervention: Weeks 1-6||7
51077|NCT02466087|121840|P1|NOT COMPLETED|First Intervention: Weeks 1-6||7
51078|NCT02466087|121839|P2|COMPLETED|First Intervention: Weeks 1-6||57
51079|NCT02466087|121840|P1|COMPLETED|First Intervention: Weeks 1-6||55
51080|NCT02466087|121839|P2|STARTED|First Intervention: Weeks 1-6||64
51081|NCT02466087|121840|P1|STARTED|First Intervention: Weeks 1-6||62
51082|NCT02465931|121852|P2|NOT COMPLETED|Overall Study||11
51083|NCT02465931|121853|P1|NOT COMPLETED|Overall Study||11
51084|NCT02465931|121852|P2|COMPLETED|Overall Study||45
51085|NCT02465931|121853|P1|COMPLETED|Overall Study||44
51086|NCT02465931|121852|P2|STARTED|Overall Study||56
51087|NCT02465931|121853|P1|STARTED|Overall Study||55
51088|NCT02465866|121859|P4|NOT COMPLETED|Period 4: Washout (14 Days)||0
51089|NCT02465866|121860|P3|NOT COMPLETED|Period 4: Washout (14 Days)||0
51090|NCT02465866|121861|P2|NOT COMPLETED|Period 4: Washout (14 Days)||0
51091|NCT02465866|121862|P1|NOT COMPLETED|Period 4: Washout (14 Days)||0
51092|NCT02465866|121859|P4|COMPLETED|Period 4: Washout (14 Days)||5
51093|NCT02465866|121860|P3|COMPLETED|Period 4: Washout (14 Days)||5
51094|NCT02465866|121861|P2|COMPLETED|Period 4: Washout (14 Days)||4
51095|NCT02465866|121862|P1|COMPLETED|Period 4: Washout (14 Days)||5
51096|NCT02465866|121859|P4|STARTED|Period 4: Washout (14 Days)||5
51097|NCT02465866|121860|P3|STARTED|Period 4: Washout (14 Days)||5
51098|NCT02465866|121861|P2|STARTED|Period 4: Washout (14 Days)||4
51099|NCT02465866|121862|P1|STARTED|Period 4: Washout (14 Days)||5
51100|NCT02465866|121859|P4|NOT COMPLETED|Period 4||0
51101|NCT02465866|121860|P3|NOT COMPLETED|Period 4||0
51102|NCT02465866|121861|P2|NOT COMPLETED|Period 4||0
51103|NCT02465866|121862|P1|NOT COMPLETED|Period 4||0
51104|NCT02465866|121859|P4|COMPLETED|Period 4||5
51105|NCT02465866|121860|P3|COMPLETED|Period 4||5
51106|NCT02465866|121861|P2|COMPLETED|Period 4||4
51107|NCT02465866|121862|P1|COMPLETED|Period 4||5
51108|NCT02465866|121859|P4|STARTED|Period 4||5
51109|NCT02465866|121860|P3|STARTED|Period 4||5
51110|NCT02465866|121861|P2|STARTED|Period 4||4
51111|NCT02465866|121862|P1|STARTED|Period 4||5
51112|NCT02465866|121859|P4|NOT COMPLETED|Period 3: Washout (14 Days)||0
51113|NCT02465866|121860|P3|NOT COMPLETED|Period 3: Washout (14 Days)||0
51114|NCT02465866|121861|P2|NOT COMPLETED|Period 3: Washout (14 Days)||0
51115|NCT02465866|121862|P1|NOT COMPLETED|Period 3: Washout (14 Days)||0
51116|NCT02465866|121859|P4|COMPLETED|Period 3: Washout (14 Days)||5
51117|NCT02465866|121860|P3|COMPLETED|Period 3: Washout (14 Days)||5
51118|NCT02465866|121861|P2|COMPLETED|Period 3: Washout (14 Days)||4
51119|NCT02465866|121862|P1|COMPLETED|Period 3: Washout (14 Days)||5
51120|NCT02465866|121859|P4|STARTED|Period 3: Washout (14 Days)||5
51121|NCT02465866|121860|P3|STARTED|Period 3: Washout (14 Days)||5
51122|NCT02465866|121861|P2|STARTED|Period 3: Washout (14 Days)||4
51123|NCT02465866|121862|P1|STARTED|Period 3: Washout (14 Days)||5
51124|NCT02465866|121859|P4|NOT COMPLETED|Period 3||0
51125|NCT02465866|121860|P3|NOT COMPLETED|Period 3||0
51126|NCT02465866|121861|P2|NOT COMPLETED|Period 3||1
51127|NCT02465866|121862|P1|NOT COMPLETED|Period 3||0
51128|NCT02465866|121859|P4|COMPLETED|Period 3||5
51129|NCT02465866|121860|P3|COMPLETED|Period 3||5
51130|NCT02465866|121861|P2|COMPLETED|Period 3||4
51131|NCT02465866|121862|P1|COMPLETED|Period 3||5
51132|NCT02465866|121859|P4|STARTED|Period 3||5
51133|NCT02465866|121860|P3|STARTED|Period 3||5
51134|NCT02465866|121861|P2|STARTED|Period 3||5
51135|NCT02465866|121862|P1|STARTED|Period 3||5
51136|NCT02465866|121859|P4|NOT COMPLETED|Period 2: Washout (14 Days)||0
51137|NCT02465866|121860|P3|NOT COMPLETED|Period 2: Washout (14 Days)||0
51138|NCT02465866|121861|P2|NOT COMPLETED|Period 2: Washout (14 Days)||0
51139|NCT02465866|121862|P1|NOT COMPLETED|Period 2: Washout (14 Days)||0
51140|NCT02465866|121859|P4|COMPLETED|Period 2: Washout (14 Days)||5
51141|NCT02465866|121860|P3|COMPLETED|Period 2: Washout (14 Days)||5
51142|NCT02465866|121861|P2|COMPLETED|Period 2: Washout (14 Days)||5
51143|NCT02465866|121862|P1|COMPLETED|Period 2: Washout (14 Days)||5
51144|NCT02465866|121859|P4|STARTED|Period 2: Washout (14 Days)||5
51145|NCT02465866|121860|P3|STARTED|Period 2: Washout (14 Days)||5
51146|NCT02465866|121861|P2|STARTED|Period 2: Washout (14 Days)||5
51147|NCT02465866|121862|P1|STARTED|Period 2: Washout (14 Days)||5
51148|NCT02465866|121859|P4|NOT COMPLETED|Period 2||0
51149|NCT02465866|121860|P3|NOT COMPLETED|Period 2||0
51150|NCT02465866|121861|P2|NOT COMPLETED|Period 2||0
51151|NCT02465866|121862|P1|NOT COMPLETED|Period 2||0
51152|NCT02465866|121859|P4|COMPLETED|Period 2||5
51153|NCT02465866|121860|P3|COMPLETED|Period 2||5
51154|NCT02465866|121861|P2|COMPLETED|Period 2||5
51155|NCT02465866|121862|P1|COMPLETED|Period 2||5
51156|NCT02465866|121859|P4|STARTED|Period 2||5
51157|NCT02465866|121860|P3|STARTED|Period 2||5
51158|NCT02465866|121861|P2|STARTED|Period 2||5
51159|NCT02465866|121862|P1|STARTED|Period 2||5
51160|NCT02465866|121859|P4|NOT COMPLETED|Period 1: Washout (14 Days)||0
51161|NCT02465866|121860|P3|NOT COMPLETED|Period 1: Washout (14 Days)||0
51162|NCT02465866|121861|P2|NOT COMPLETED|Period 1: Washout (14 Days)||0
51163|NCT02465866|121862|P1|NOT COMPLETED|Period 1: Washout (14 Days)||0
51164|NCT02465866|121859|P4|COMPLETED|Period 1: Washout (14 Days)||5
51165|NCT02465866|121860|P3|COMPLETED|Period 1: Washout (14 Days)||5
51166|NCT02465866|121861|P2|COMPLETED|Period 1: Washout (14 Days)||5
51167|NCT02465866|121862|P1|COMPLETED|Period 1: Washout (14 Days)||5
51168|NCT02465866|121859|P4|STARTED|Period 1: Washout (14 Days)||5
51169|NCT02465866|121860|P3|STARTED|Period 1: Washout (14 Days)||5
51170|NCT02465866|121861|P2|STARTED|Period 1: Washout (14 Days)||5
51171|NCT02465866|121862|P1|STARTED|Period 1: Washout (14 Days)||5
51172|NCT02465866|121859|P4|NOT COMPLETED|Period 1||0
51173|NCT02465866|121860|P3|NOT COMPLETED|Period 1||0
51174|NCT02465866|121861|P2|NOT COMPLETED|Period 1||0
51175|NCT02465866|121862|P1|NOT COMPLETED|Period 1||0
51176|NCT02465866|121859|P4|COMPLETED|Period 1||5
51177|NCT02465866|121860|P3|COMPLETED|Period 1||5
51178|NCT02465866|121861|P2|COMPLETED|Period 1||5
51179|NCT02465866|121862|P1|COMPLETED|Period 1||5
51180|NCT02465866|121859|P4|STARTED|Period 1||5
51181|NCT02465866|121860|P3|STARTED|Period 1||5
51182|NCT02465866|121861|P2|STARTED|Period 1||5
51183|NCT02465866|121862|P1|STARTED|Period 1||5
51184|NCT02465632|121935|P3|NOT COMPLETED|Overall Study||17
51185|NCT02465632|121936|P2|NOT COMPLETED|Overall Study||23
51186|NCT02465632|121937|P1|NOT COMPLETED|Overall Study||31
51187|NCT02465632|121935|P3|COMPLETED|Overall Study||203
51188|NCT02465632|121936|P2|COMPLETED|Overall Study||417
51189|NCT02465632|121937|P1|COMPLETED|Overall Study||409
51190|NCT02465632|121935|P3|STARTED|Overall Study||220
51191|NCT02465632|121936|P2|STARTED|Overall Study||440
51192|NCT02465632|121937|P1|STARTED|Overall Study||440
51193|NCT02465528|121952|P4|NOT COMPLETED|Overall Study||5
51194|NCT02465528|121953|P3|NOT COMPLETED|Overall Study||12
51195|NCT02465528|121954|P2|NOT COMPLETED|Overall Study||4
51196|NCT02465528|121955|P1|NOT COMPLETED|Overall Study||1
51197|NCT02465528|121952|P4|COMPLETED|Overall Study||0
51198|NCT02465528|121953|P3|COMPLETED|Overall Study||0
51199|NCT02465528|121954|P2|COMPLETED|Overall Study||0
51200|NCT02465528|121955|P1|COMPLETED|Overall Study||0
51201|NCT02465528|121952|P4|STARTED|Overall Study||5
51202|NCT02465528|121953|P3|STARTED|Overall Study||12
51203|NCT02465528|121954|P2|STARTED|Overall Study||4
51204|NCT02465528|121955|P1|STARTED|Overall Study||1
51205|NCT02465515|121988|P2|NOT COMPLETED|Overall Study||111
51206|NCT02465515|121989|P1|NOT COMPLETED|Overall Study||154
51207|NCT02465515|121988|P2|COMPLETED|Overall Study||4620
51208|NCT02465515|121989|P1|COMPLETED|Overall Study||4578
51209|NCT02465515|121988|P2|STARTED|Overall Study||4731
51210|NCT02465515|121989|P1|STARTED|Overall Study||4732
51211|NCT02465489|122035|P1|NOT COMPLETED|Overall Study||5
51212|NCT02465489|122035|P1|COMPLETED|Overall Study||15
51213|NCT02465489|122035|P1|STARTED|Overall Study||20
51214|NCT02465463|122064|P2|NOT COMPLETED|Overall Study||1
51215|NCT02465463|122065|P1|NOT COMPLETED|Overall Study||4
51216|NCT02465463|122064|P2|COMPLETED|Overall Study||4
51217|NCT02465463|122065|P1|COMPLETED|Overall Study||4
51218|NCT02465463|122064|P2|STARTED|Overall Study||5
51219|NCT02465463|122065|P1|STARTED|Overall Study||8
51220|NCT02465450|122084|P6|NOT COMPLETED|Treatment Period 2||0
51221|NCT02465450|122085|P5|NOT COMPLETED|Treatment Period 2||4
51222|NCT02465450|122086|P4|NOT COMPLETED|Treatment Period 2||3
51223|NCT02465450|122087|P3|NOT COMPLETED|Treatment Period 2||0
51224|NCT02465450|122088|P2|NOT COMPLETED|Treatment Period 2||0
51225|NCT02465450|122089|P1|NOT COMPLETED|Treatment Period 2||0
51226|NCT02465450|122084|P6|COMPLETED|Treatment Period 2||23
51227|NCT02465450|122085|P5|COMPLETED|Treatment Period 2||24
51228|NCT02465450|122086|P4|COMPLETED|Treatment Period 2||27
51229|NCT02465450|122087|P3|COMPLETED|Treatment Period 2||0
51230|NCT02465450|122088|P2|COMPLETED|Treatment Period 2||0
51231|NCT02465450|122089|P1|COMPLETED|Treatment Period 2||0
51232|NCT02465450|122084|P6|STARTED|Treatment Period 2||23
51233|NCT02465450|122085|P5|STARTED|Treatment Period 2||28
51234|NCT02465450|122086|P4|STARTED|Treatment Period 2||30
51235|NCT02465450|122087|P3|STARTED|Treatment Period 2||0
51236|NCT02465450|122088|P2|STARTED|Treatment Period 2||0
51237|NCT02465450|122089|P1|STARTED|Treatment Period 2||0
51238|NCT02465450|122084|P6|NOT COMPLETED|Treatment Period 1||0
51239|NCT02465450|122085|P5|NOT COMPLETED|Treatment Period 1||0
51240|NCT02465450|122086|P4|NOT COMPLETED|Treatment Period 1||0
51241|NCT02465450|122087|P3|NOT COMPLETED|Treatment Period 1||1
51242|NCT02465450|122088|P2|NOT COMPLETED|Treatment Period 1||1
51243|NCT02465450|122089|P1|NOT COMPLETED|Treatment Period 1||2
51244|NCT02465450|122084|P6|COMPLETED|Treatment Period 1||0
51245|NCT02465450|122085|P5|COMPLETED|Treatment Period 1||0
51246|NCT02465450|122086|P4|COMPLETED|Treatment Period 1||0
51247|NCT02465450|122087|P3|COMPLETED|Treatment Period 1||34
51248|NCT02465450|122088|P2|COMPLETED|Treatment Period 1||23
51249|NCT02465450|122089|P1|COMPLETED|Treatment Period 1||24
51250|NCT02465450|122084|P6|STARTED|Treatment Period 1||0
51251|NCT02465450|122085|P5|STARTED|Treatment Period 1||0
51252|NCT02465450|122086|P4|STARTED|Treatment Period 1||0
51253|NCT02465450|122087|P3|STARTED|Treatment Period 1||35
51254|NCT02465450|122088|P2|STARTED|Treatment Period 1||24
51255|NCT02465450|122089|P1|STARTED|Treatment Period 1||26
51256|NCT02465437|122113|P4|NOT COMPLETED|Overall Study||1
51257|NCT02465437|122114|P3|NOT COMPLETED|Overall Study||1
51258|NCT02465437|122115|P2|NOT COMPLETED|Overall Study||1
51259|NCT02465437|122116|P1|NOT COMPLETED|Overall Study||1
51260|NCT02465437|122113|P4|COMPLETED|Overall Study||14
51261|NCT02465437|122114|P3|COMPLETED|Overall Study||8
51262|NCT02465437|122115|P2|COMPLETED|Overall Study||8
51263|NCT02465437|122116|P1|COMPLETED|Overall Study||8
51264|NCT02465437|122113|P4|STARTED|Overall Study||15
51265|NCT02465437|122114|P3|STARTED|Overall Study||9
51266|NCT02465437|122115|P2|STARTED|Overall Study||9
51267|NCT02465437|122116|P1|STARTED|Overall Study||9
51268|NCT02465372|122136|P2|NOT COMPLETED|Overall Study||97
51269|NCT02465372|122137|P1|NOT COMPLETED|Overall Study||122
51270|NCT02465372|122136|P2|COMPLETED|Overall Study||153
51271|NCT02465372|122137|P1|COMPLETED|Overall Study||227
51272|NCT02465372|122136|P2|STARTED|Overall Study||250
51273|NCT02465372|122137|P1|STARTED|Overall Study||349
51274|NCT02465216|122152|P5|NOT COMPLETED|Overall Study||3
51275|NCT02465216|122153|P4|NOT COMPLETED|Overall Study||2
51276|NCT02465216|122154|P3|NOT COMPLETED|Overall Study||1
51277|NCT02465216|122155|P2|NOT COMPLETED|Overall Study||0
51278|NCT02465216|122156|P1|NOT COMPLETED|Overall Study||3
51279|NCT02465216|122152|P5|COMPLETED|Overall Study||9
51280|NCT02465216|122153|P4|COMPLETED|Overall Study||12
51281|NCT02465216|122154|P3|COMPLETED|Overall Study||13
51282|NCT02465216|122155|P2|COMPLETED|Overall Study||5
51283|NCT02465216|122156|P1|COMPLETED|Overall Study||12
51284|NCT02465216|122152|P5|STARTED|Overall Study||12
51285|NCT02465216|122153|P4|STARTED|Overall Study||14
51286|NCT02465216|122154|P3|STARTED|Overall Study||14
51287|NCT02465216|122155|P2|STARTED|Overall Study||5
51288|NCT02465216|122156|P1|STARTED|Overall Study||15
51289|NCT02465203|122176|P3|NOT COMPLETED|Overall Study||13
51290|NCT02465203|122177|P2|NOT COMPLETED|Overall Study||36
51291|NCT02465203|122178|P1|NOT COMPLETED|Overall Study||56
51292|NCT02465203|122176|P3|COMPLETED|Overall Study||0
51293|NCT02465203|122177|P2|COMPLETED|Overall Study||0
51294|NCT02465203|122178|P1|COMPLETED|Overall Study||0
51295|NCT02465203|122176|P3|STARTED|Overall Study||13
51296|NCT02465203|122177|P2|STARTED|Overall Study||36
51297|NCT02465203|122178|P1|STARTED|Overall Study||56
51298|NCT02465099|122191|P2|NOT COMPLETED|Overall Study||0
51299|NCT02465099|122192|P1|NOT COMPLETED|Overall Study||0
51300|NCT02465099|122191|P2|COMPLETED|Overall Study||19
51301|NCT02465099|122192|P1|COMPLETED|Overall Study||45
51302|NCT02465099|122191|P2|STARTED|Overall Study||19
51303|NCT02465099|122192|P1|STARTED|Overall Study||45
51304|NCT02465073|122201|P3|NOT COMPLETED|Overall Study||1
51305|NCT02465073|122202|P2|NOT COMPLETED|Overall Study||1
51306|NCT02465073|122203|P1|NOT COMPLETED|Overall Study||2
51307|NCT02465073|122201|P3|COMPLETED|Overall Study||15
51308|NCT02465073|122202|P2|COMPLETED|Overall Study||15
51309|NCT02465073|122203|P1|COMPLETED|Overall Study||15
51310|NCT02465073|122201|P3|STARTED|Overall Study||16
51311|NCT02465073|122202|P2|STARTED|Overall Study||16
51312|NCT02465073|122203|P1|STARTED|Overall Study||17
51313|NCT02464917|122213|P2|NOT COMPLETED|Overall Study||0
51314|NCT02464917|122214|P1|NOT COMPLETED|Overall Study||0
51315|NCT02464917|122213|P2|COMPLETED|Overall Study||35
51316|NCT02464917|122214|P1|COMPLETED|Overall Study||35
51317|NCT02464917|122213|P2|STARTED|Overall Study||35
51318|NCT02464917|122214|P1|STARTED|Overall Study||35
51319|NCT02464176|122243|P3|NOT COMPLETED|Overall Study||0
51320|NCT02464176|122244|P2|NOT COMPLETED|Overall Study||0
51321|NCT02464176|122245|P1|NOT COMPLETED|Overall Study||0
51322|NCT02464176|122243|P3|COMPLETED|Overall Study||15
51323|NCT02464176|122244|P2|COMPLETED|Overall Study||50
51324|NCT02464176|122245|P1|COMPLETED|Overall Study||50
51325|NCT02464176|122243|P3|STARTED|Overall Study||15
51326|NCT02464176|122244|P2|STARTED|Overall Study||50
51327|NCT02464176|122245|P1|STARTED|Overall Study||50
51328|NCT02464163|122266|P4|NOT COMPLETED|Overall Study||5
51329|NCT02464163|122267|P3|NOT COMPLETED|Overall Study||5
51330|NCT02464163|122268|P2|NOT COMPLETED|Overall Study||8
51331|NCT02464163|122269|P1|NOT COMPLETED|Overall Study||3
51332|NCT02464163|122266|P4|COMPLETED|Overall Study||96
51333|NCT02464163|122267|P3|COMPLETED|Overall Study||97
51334|NCT02464163|122268|P2|COMPLETED|Overall Study||94
51335|NCT02464163|122269|P1|COMPLETED|Overall Study||99
51336|NCT02464163|122266|P4|STARTED|Overall Study||101
51337|NCT02464163|122267|P3|STARTED|Overall Study||102
51338|NCT02464163|122268|P2|STARTED|Overall Study||102
51339|NCT02464163|122269|P1|STARTED|Overall Study||102
51340|NCT02464033|122291|P1|NOT COMPLETED|Overall Study||0
51341|NCT02464033|122291|P1|COMPLETED|Overall Study||20
51342|NCT02464033|122291|P1|STARTED|Overall Study||20
51343|NCT02463981|122322|P2|NOT COMPLETED|Overall Study||2
51344|NCT02463981|122323|P1|NOT COMPLETED|Overall Study||3
51345|NCT02463981|122322|P2|COMPLETED|Overall Study||14
51346|NCT02463981|122323|P1|COMPLETED|Overall Study||18
51347|NCT02463981|122322|P2|STARTED|Overall Study||16
51348|NCT02463981|122323|P1|STARTED|Overall Study||21
51349|NCT02463409|122331|P1|NOT COMPLETED|Overall Study||2
51350|NCT02463409|122331|P1|COMPLETED|Overall Study||4
51351|NCT02463409|122331|P1|STARTED|Overall Study||6
51352|NCT02463331|122339|P2|NOT COMPLETED|Overall Study||6
51353|NCT02463331|122340|P1|NOT COMPLETED|Overall Study||16
51354|NCT02463331|122339|P2|COMPLETED|Overall Study||25
51355|NCT02463331|122340|P1|COMPLETED|Overall Study||10
51356|NCT02463331|122339|P2|STARTED|Overall Study||31
51357|NCT02463331|122340|P1|STARTED|Overall Study||26
51358|NCT02463227|122348|P1|NOT COMPLETED|Overall Study||0
51359|NCT02463227|122348|P1|COMPLETED|Overall Study||14
51360|NCT02463227|122348|P1|STARTED|Overall Study||14
51361|NCT02463097|122356|P1|NOT COMPLETED|Overall Study||1
51362|NCT02463097|122356|P1|COMPLETED|Overall Study||123
51363|NCT02463097|122356|P1|STARTED|Overall Study||124
51364|NCT02463071|122365|P3|NOT COMPLETED|Overall Study||6
51365|NCT02463071|122366|P2|NOT COMPLETED|Overall Study||16
51366|NCT02463071|122367|P1|NOT COMPLETED|Overall Study||12
51367|NCT02463071|122365|P3|COMPLETED|Overall Study||71
51368|NCT02463071|122366|P2|COMPLETED|Overall Study||138
51369|NCT02463071|122367|P1|COMPLETED|Overall Study||140
51370|NCT02463071|122365|P3|STARTED|Overall Study||77
51371|NCT02463071|122366|P2|STARTED|Overall Study||154
51372|NCT02463071|122367|P1|STARTED|Overall Study||152
51373|NCT02462720|122393|P2|NOT COMPLETED|Part 2||1
51374|NCT02462720|122394|P1|NOT COMPLETED|Part 2||1
51375|NCT02462720|122393|P2|COMPLETED|Part 2||16
51376|NCT02462720|122394|P1|COMPLETED|Part 2||17
51377|NCT02462720|122393|P2|STARTED|Part 2||17
51378|NCT02462720|122394|P1|STARTED|Part 2||18
51379|NCT02462720|122393|P2|NOT COMPLETED|Part 1||0
51380|NCT02462720|122394|P1|NOT COMPLETED|Part 1||0
51381|NCT02462720|122393|P2|COMPLETED|Part 1||17
51382|NCT02462720|122394|P1|COMPLETED|Part 1||18
51383|NCT02462720|122393|P2|STARTED|Part 1||17
51384|NCT02462720|122394|P1|STARTED|Part 1||18
51385|NCT02462473|122404|P1|NOT COMPLETED|Overall Study||4
51386|NCT02462473|122404|P1|COMPLETED|Overall Study||5
51387|NCT02462473|122404|P1|STARTED|Overall Study||9
51388|NCT02462291|122417|P2|NOT COMPLETED|Overall Study||6
51389|NCT02462291|122418|P1|NOT COMPLETED|Overall Study||5
51390|NCT02462291|122417|P2|COMPLETED|Overall Study||75
51391|NCT02462291|122418|P1|COMPLETED|Overall Study||77
51392|NCT02462291|122417|P2|STARTED|Overall Study||81
51393|NCT02462291|122418|P1|STARTED|Overall Study||82
51394|NCT02462148|122459|P3|NOT COMPLETED|Overall Study||0
51395|NCT02462148|122460|P2|NOT COMPLETED|Overall Study||0
51396|NCT02462148|122461|P1|NOT COMPLETED|Overall Study||1
51397|NCT02462148|122459|P3|COMPLETED|Overall Study||12
51398|NCT02462148|122460|P2|COMPLETED|Overall Study||36
51399|NCT02462148|122461|P1|COMPLETED|Overall Study||36
51400|NCT02462148|122459|P3|STARTED|Overall Study||12
51401|NCT02462148|122460|P2|STARTED|Overall Study||36
51402|NCT02462148|122461|P1|STARTED|Overall Study||37
51403|NCT02462057|122489|P5|NOT COMPLETED|Overall Study||50
51404|NCT02462057|122490|P4|NOT COMPLETED|Overall Study||51
51405|NCT02462057|122491|P3|NOT COMPLETED|Overall Study||46
51406|NCT02462057|122492|P2|NOT COMPLETED|Overall Study||40
51407|NCT02462057|122493|P1|NOT COMPLETED|Overall Study||54
51408|NCT02462057|122489|P5|COMPLETED|Overall Study||708
51409|NCT02462057|122490|P4|COMPLETED|Overall Study||701
51410|NCT02462057|122491|P3|COMPLETED|Overall Study||766
51411|NCT02462057|122492|P2|COMPLETED|Overall Study||753
51412|NCT02462057|122493|P1|COMPLETED|Overall Study||737
51413|NCT02462057|122489|P5|STARTED|Overall Study||758
51414|NCT02462057|122490|P4|STARTED|Overall Study||752
51415|NCT02462057|122491|P3|STARTED|Overall Study||812
51416|NCT02462057|122492|P2|STARTED|Overall Study||793
51417|NCT02462057|122493|P1|STARTED|Overall Study||791
51418|NCT02461992|122505|P1|NOT COMPLETED|Overall Study||0
51419|NCT02461992|122505|P1|COMPLETED|Overall Study||13
51420|NCT02461992|122505|P1|STARTED|Overall Study||13
51421|NCT02461966|122525|P3|NOT COMPLETED|Overall Study||0
51422|NCT02461966|122526|P2|NOT COMPLETED|Overall Study||0
51423|NCT02461966|122527|P1|NOT COMPLETED|Overall Study||0
51424|NCT02461966|122525|P3|COMPLETED|Overall Study||60
51425|NCT02461966|122526|P2|COMPLETED|Overall Study||80
51426|NCT02461966|122527|P1|COMPLETED|Overall Study||160
51427|NCT02461966|122525|P3|STARTED|Overall Study||60
51428|NCT02461966|122526|P2|STARTED|Overall Study||80
51429|NCT02461966|122527|P1|STARTED|Overall Study||160
51430|NCT02461758|122539|P4|NOT COMPLETED|Overall Study||0
51431|NCT02461758|122540|P3|NOT COMPLETED|Overall Study||1
51432|NCT02461758|122541|P2|NOT COMPLETED|Overall Study||1
51433|NCT02461758|122542|P1|NOT COMPLETED|Overall Study||0
51434|NCT02461758|122539|P4|COMPLETED|Overall Study||15
51435|NCT02461758|122540|P3|COMPLETED|Overall Study||25
51436|NCT02461758|122541|P2|COMPLETED|Overall Study||19
51437|NCT02461758|122542|P1|COMPLETED|Overall Study||20
51438|NCT02461758|122539|P4|STARTED|Overall Study||15
51439|NCT02461758|122540|P3|STARTED|Overall Study||26
51440|NCT02461758|122541|P2|STARTED|Overall Study||20
51441|NCT02461758|122542|P1|STARTED|Overall Study||20
51442|NCT02461693|122568|P2|NOT COMPLETED|Overall Study||0
51443|NCT02461693|122569|P1|NOT COMPLETED|Overall Study||0
51444|NCT02461693|122568|P2|COMPLETED|Overall Study||102
51445|NCT02461693|122569|P1|COMPLETED|Overall Study||103
51446|NCT02461693|122568|P2|STARTED|Overall Study||102
51447|NCT02461693|122569|P1|STARTED|Overall Study||103
51448|NCT02461628|122583|P2|NOT COMPLETED|Overall Study||7
51449|NCT02461628|122584|P1|NOT COMPLETED|Overall Study||4
51450|NCT02461628|122583|P2|COMPLETED|Overall Study||3625
51451|NCT02461628|122584|P1|COMPLETED|Overall Study||3729
51452|NCT02461628|122583|P2|18 Month Survey|Overall Study||905
51453|NCT02461628|122584|P1|18 Month Survey|Overall Study||995
51454|NCT02461628|122583|P2|12 Month Survey|Overall Study||914
51455|NCT02461628|122584|P1|12 Month Survey|Overall Study||882
51456|NCT02461628|122583|P2|6 Month Survey|Overall Study||832
51457|NCT02461628|122584|P1|6 Month Survey|Overall Study||814
51458|NCT02461628|122583|P2|Baseline Survey|Overall Study||974
51459|NCT02461628|122584|P1|Baseline Survey|Overall Study||1038
51460|NCT02461628|122583|P2|STARTED|Overall Study||3632
51461|NCT02461628|122584|P1|STARTED|Overall Study||3733
51462|NCT02461589|122608|P10|NOT COMPLETED|Overall Study||5
51463|NCT02461589|122609|P9|NOT COMPLETED|Overall Study||6
51464|NCT02461589|122610|P8|NOT COMPLETED|Overall Study||5
51465|NCT02461589|122611|P7|NOT COMPLETED|Overall Study||6
51466|NCT02461589|122612|P6|NOT COMPLETED|Overall Study||3
51467|NCT02461589|122613|P5|NOT COMPLETED|Overall Study||2
51468|NCT02461589|122614|P4|NOT COMPLETED|Overall Study||5
51469|NCT02461589|122615|P3|NOT COMPLETED|Overall Study||5
51470|NCT02461589|122616|P2|NOT COMPLETED|Overall Study||2
51471|NCT02461589|122617|P1|NOT COMPLETED|Overall Study||6
51472|NCT02461589|122608|P10|COMPLETED|Overall Study||60
51473|NCT02461589|122609|P9|COMPLETED|Overall Study||123
51474|NCT02461589|122610|P8|COMPLETED|Overall Study||60
51475|NCT02461589|122611|P7|COMPLETED|Overall Study||58
51476|NCT02461589|122612|P6|COMPLETED|Overall Study||61
51477|NCT02461589|122613|P5|COMPLETED|Overall Study||62
51478|NCT02461589|122614|P4|COMPLETED|Overall Study||58
51479|NCT02461589|122615|P3|COMPLETED|Overall Study||60
51480|NCT02461589|122616|P2|COMPLETED|Overall Study||61
51481|NCT02461589|122617|P1|COMPLETED|Overall Study||58
51482|NCT02461589|122608|P10|Exposed|Overall Study||64
51483|NCT02461589|122609|P9|Exposed|Overall Study||129
51484|NCT02461589|122610|P8|Exposed|Overall Study||65
51485|NCT02461589|122611|P7|Exposed|Overall Study||64
51486|NCT02461589|122612|P6|Exposed|Overall Study||64
51487|NCT02461589|122613|P5|Exposed|Overall Study||64
51488|NCT02461589|122614|P4|Exposed|Overall Study||63
51489|NCT02461589|122615|P3|Exposed|Overall Study||65
51490|NCT02461589|122616|P2|Exposed|Overall Study||63
51491|NCT02461589|122617|P1|Exposed|Overall Study||64
51492|NCT02461589|122608|P10|STARTED|Overall Study||65
51493|NCT02461589|122609|P9|STARTED|Overall Study||129
51494|NCT02461589|122610|P8|STARTED|Overall Study||65
51495|NCT02461589|122611|P7|STARTED|Overall Study||64
51496|NCT02461589|122612|P6|STARTED|Overall Study||64
51497|NCT02461589|122613|P5|STARTED|Overall Study||64
51498|NCT02461589|122614|P4|STARTED|Overall Study||63
51499|NCT02461589|122615|P3|STARTED|Overall Study||65
51500|NCT02461589|122616|P2|STARTED|Overall Study||63
51501|NCT02461589|122617|P1|STARTED|Overall Study||64
51502|NCT02461563|122673|P4|NOT COMPLETED|Overall Study||0
51503|NCT02461563|122674|P3|NOT COMPLETED|Overall Study||0
51504|NCT02461563|122675|P2|NOT COMPLETED|Overall Study||0
51505|NCT02461563|122676|P1|NOT COMPLETED|Overall Study||0
51506|NCT02461563|122673|P4|COMPLETED|Overall Study||3
51507|NCT02461563|122674|P3|COMPLETED|Overall Study||3
51508|NCT02461563|122675|P2|COMPLETED|Overall Study||3
51509|NCT02461563|122676|P1|COMPLETED|Overall Study||3
51510|NCT02461563|122673|P4|STARTED|Overall Study||3
51511|NCT02461563|122674|P3|STARTED|Overall Study||3
51512|NCT02461563|122675|P2|STARTED|Overall Study||3
51513|NCT02461563|122676|P1|STARTED|Overall Study||3
51514|NCT02461550|122710|P1|NOT COMPLETED|Overall Study||0
51515|NCT02461550|122710|P1|COMPLETED|Overall Study||2
51516|NCT02461550|122710|P1|STARTED|Overall Study||2
51517|NCT02461433|122716|P2|NOT COMPLETED|Overall Study||0
51518|NCT02461433|122717|P1|NOT COMPLETED|Overall Study||0
51519|NCT02461433|122716|P2|COMPLETED|Overall Study||1
51520|NCT02461433|122717|P1|COMPLETED|Overall Study||1
51521|NCT02461433|122716|P2|STARTED|Overall Study||1
51522|NCT02461433|122717|P1|STARTED|Overall Study||1
51523|NCT02461355|122743|P1|NOT COMPLETED|Overall Study||0
51524|NCT02461355|122743|P1|COMPLETED|Overall Study||2
51525|NCT02461355|122743|P1|STARTED|Overall Study||2
51526|NCT02461290|122750|P1|NOT COMPLETED|Overall Study||10
51527|NCT02461290|122750|P1|COMPLETED|Overall Study||89
51528|NCT02461290|122750|P1|STARTED|Overall Study||99
51529|NCT02461160|122770|P13|NOT COMPLETED|Overall Study||0
51530|NCT02461160|122771|P12|NOT COMPLETED|Overall Study||0
51531|NCT02461160|122772|P11|NOT COMPLETED|Overall Study||0
51532|NCT02461160|122773|P10|NOT COMPLETED|Overall Study||0
51533|NCT02461160|122774|P9|NOT COMPLETED|Overall Study||0
51534|NCT02461160|122775|P8|NOT COMPLETED|Overall Study||1
51535|NCT02461160|122776|P7|NOT COMPLETED|Overall Study||0
51536|NCT02461160|122777|P6|NOT COMPLETED|Overall Study||0
51537|NCT02461160|122778|P5|NOT COMPLETED|Overall Study||0
51538|NCT02461160|122779|P4|NOT COMPLETED|Overall Study||0
51539|NCT02461160|122780|P3|NOT COMPLETED|Overall Study||0
51540|NCT02461160|122781|P2|NOT COMPLETED|Overall Study||0
51541|NCT02461160|122782|P1|NOT COMPLETED|Overall Study||0
51542|NCT02461160|122770|P13|COMPLETED|Overall Study||8
51543|NCT02461160|122771|P12|COMPLETED|Overall Study||4
51544|NCT02461160|122772|P11|COMPLETED|Overall Study||4
51545|NCT02461160|122773|P10|COMPLETED|Overall Study||4
51546|NCT02461160|122774|P9|COMPLETED|Overall Study||12
51547|NCT02461160|122775|P8|COMPLETED|Overall Study||5
51548|NCT02461160|122776|P7|COMPLETED|Overall Study||6
51549|NCT02461160|122777|P6|COMPLETED|Overall Study||6
51550|NCT02461160|122778|P5|COMPLETED|Overall Study||6
51551|NCT02461160|122779|P4|COMPLETED|Overall Study||12
51552|NCT02461160|122780|P3|COMPLETED|Overall Study||6
51553|NCT02461160|122781|P2|COMPLETED|Overall Study||6
51554|NCT02461160|122782|P1|COMPLETED|Overall Study||8
51555|NCT02461160|122770|P13|STARTED|Overall Study||8
51556|NCT02461160|122771|P12|STARTED|Overall Study||4
51557|NCT02461160|122772|P11|STARTED|Overall Study||4
51558|NCT02461160|122773|P10|STARTED|Overall Study||4
51559|NCT02461160|122774|P9|STARTED|Overall Study||12
51560|NCT02461160|122775|P8|STARTED|Overall Study||6
51561|NCT02461160|122776|P7|STARTED|Overall Study||6
51562|NCT02461160|122777|P6|STARTED|Overall Study||6
51563|NCT02461160|122778|P5|STARTED|Overall Study||6
51564|NCT02461160|122779|P4|STARTED|Overall Study||12
51565|NCT02461160|122780|P3|STARTED|Overall Study||6
51566|NCT02461160|122781|P2|STARTED|Overall Study||6
51567|NCT02461160|122782|P1|STARTED|Overall Study||8
51568|NCT02461134|122993|P1|NOT COMPLETED|Overall Study||1
51569|NCT02461134|122993|P1|COMPLETED|Overall Study||0
51570|NCT02461134|122993|P1|STARTED|Overall Study||1
51571|NCT02460991|123001|P2|NOT COMPLETED|Overall Study||2
51572|NCT02460991|123002|P1|NOT COMPLETED|Overall Study||0
51573|NCT02460991|123001|P2|COMPLETED|Overall Study||0
51574|NCT02460991|123002|P1|COMPLETED|Overall Study||0
51575|NCT02460991|123001|P2|STARTED|Overall Study||2
51576|NCT02460991|123002|P1|STARTED|Overall Study||0
51577|NCT02460978|123019|P3|NOT COMPLETED|Overall Study||33
51578|NCT02460978|123020|P2|NOT COMPLETED|Overall Study||25
51579|NCT02460978|123021|P1|NOT COMPLETED|Overall Study||27
51580|NCT02460978|123019|P3|COMPLETED|Overall Study||239
51581|NCT02460978|123020|P2|COMPLETED|Overall Study||245
51582|NCT02460978|123021|P1|COMPLETED|Overall Study||244
51583|NCT02460978|123019|P3|STARTED|Overall Study||272
51584|NCT02460978|123020|P2|STARTED|Overall Study||270
51585|NCT02460978|123021|P1|STARTED|Overall Study||271
51586|NCT02460822|123047|P1|NOT COMPLETED|Overall Study||1
51587|NCT02460822|123047|P1|COMPLETED|Overall Study||15
51588|NCT02460822|123047|P1|STARTED|Overall Study||16
51589|NCT02460562|123058|P2|NOT COMPLETED|Overall Study||16
51590|NCT02460562|123059|P1|NOT COMPLETED|Overall Study||15
51591|NCT02460562|123058|P2|COMPLETED|Overall Study||60
51592|NCT02460562|123059|P1|COMPLETED|Overall Study||59
51593|NCT02460562|123058|P2|STARTED|Overall Study||76
51594|NCT02460562|123059|P1|STARTED|Overall Study||74
51595|NCT02460458|123067|P1|NOT COMPLETED|Prospective Phase||0
51596|NCT02460458|123067|P1|COMPLETED|Prospective Phase|Information not yet available.|0
51597|NCT02460458|123067|P1|STARTED|Prospective Phase|Information not yet available.|0
51598|NCT02460458|123067|P1|NOT COMPLETED|Confirmatory Phase||266
51599|NCT02460458|123067|P1|COMPLETED|Confirmatory Phase|Information not yet available.|0
51600|NCT02460458|123067|P1|STARTED|Confirmatory Phase||266
51601|NCT02460458|123067|P1|NOT COMPLETED|Retrospective Phase||0
51602|NCT02460458|123067|P1|COMPLETED|Retrospective Phase||266
51603|NCT02460458|123067|P1|STARTED|Retrospective Phase||266
51604|NCT02460380|123075|P2|NOT COMPLETED|Overall Study||5
51605|NCT02460380|123076|P1|NOT COMPLETED|Overall Study||10
51606|NCT02460380|123075|P2|COMPLETED|Overall Study||18
51607|NCT02460380|123076|P1|COMPLETED|Overall Study||35
51608|NCT02460380|123075|P2|STARTED|Overall Study||23
51609|NCT02460380|123076|P1|STARTED|Overall Study||45
51610|NCT02460172|123096|P1|NOT COMPLETED|Overall Study||0
51611|NCT02460172|123096|P1|COMPLETED|Overall Study||25
51612|NCT02460172|123096|P1|STARTED|Overall Study||25
51613|NCT02460159|123112|P2|NOT COMPLETED|Overall Study||1
51614|NCT02460159|123113|P1|NOT COMPLETED|Overall Study||6
51615|NCT02460159|123112|P2|COMPLETED|Overall Study||17
51616|NCT02460159|123113|P1|COMPLETED|Overall Study||111
51617|NCT02460159|123112|P2|STARTED|Overall Study||18
51618|NCT02460159|123113|P1|STARTED|Overall Study||117
51619|NCT02459951|123141|P1|NOT COMPLETED|Overall Study||1
51620|NCT02459951|123141|P1|COMPLETED|Overall Study||9
51621|NCT02459951|123141|P1|STARTED|Overall Study||10
51622|NCT02459899|123152|P4|NOT COMPLETED|Overall Study||2
51623|NCT02459899|123153|P3|NOT COMPLETED|Overall Study||0
51624|NCT02459899|123154|P2|NOT COMPLETED|Overall Study||6
51625|NCT02459899|123155|P1|NOT COMPLETED|Overall Study||3
51626|NCT02459899|123152|P4|COMPLETED|Overall Study||33
51627|NCT02459899|123153|P3|COMPLETED|Overall Study||35
51628|NCT02459899|123154|P2|COMPLETED|Overall Study||29
51629|NCT02459899|123155|P1|COMPLETED|Overall Study||33
51630|NCT02459899|123152|P4|STARTED|Overall Study||35
51631|NCT02459899|123153|P3|STARTED|Overall Study||35
51632|NCT02459899|123154|P2|STARTED|Overall Study||35
51633|NCT02459899|123155|P1|STARTED|Overall Study||36
51634|NCT02459665|123189|P4|NOT COMPLETED|Overall Study||2
51635|NCT02459665|123190|P3|NOT COMPLETED|Overall Study||1
51636|NCT02459665|123191|P2|NOT COMPLETED|Overall Study||1
51637|NCT02459665|123192|P1|NOT COMPLETED|Overall Study||0
51638|NCT02459665|123189|P4|COMPLETED|Overall Study||15
51639|NCT02459665|123190|P3|COMPLETED|Overall Study||16
51640|NCT02459665|123191|P2|COMPLETED|Overall Study||16
51641|NCT02459665|123192|P1|COMPLETED|Overall Study||17
51642|NCT02459665|123189|P4|Month 6 Visit|Overall Study||15
51643|NCT02459665|123190|P3|Month 6 Visit|Overall Study||16
51644|NCT02459665|123191|P2|Month 6 Visit|Overall Study||16
51645|NCT02459665|123192|P1|Month 6 Visit|Overall Study||17
51646|NCT02459665|123189|P4|Month 2 Visit|Overall Study||16
51647|NCT02459665|123190|P3|Month 2 Visit|Overall Study||17
51648|NCT02459665|123191|P2|Month 2 Visit|Overall Study||16
51649|NCT02459665|123192|P1|Month 2 Visit|Overall Study||17
51650|NCT02459665|123189|P4|Month 1 Visit|Overall Study||16
51651|NCT02459665|123190|P3|Month 1 Visit|Overall Study||17
51652|NCT02459665|123191|P2|Month 1 Visit|Overall Study||17
51653|NCT02459665|123192|P1|Month 1 Visit|Overall Study||17
51654|NCT02459665|123189|P4|Day 7 Visit|Overall Study||16
51655|NCT02459665|123190|P3|Day 7 Visit|Overall Study||17
51656|NCT02459665|123191|P2|Day 7 Visit|Overall Study||17
51657|NCT02459665|123192|P1|Day 7 Visit|Overall Study||17
51658|NCT02459665|123189|P4|STARTED|Overall Study||17
51659|NCT02459665|123190|P3|STARTED|Overall Study||17
51660|NCT02459665|123191|P2|STARTED|Overall Study||17
51661|NCT02459665|123192|P1|STARTED|Overall Study||17
51662|NCT02459418|123223|P2|NOT COMPLETED|Overall Study||6
51663|NCT02459418|123224|P1|NOT COMPLETED|Overall Study||8
51664|NCT02459418|123223|P2|COMPLETED|Overall Study||15
51665|NCT02459418|123224|P1|COMPLETED|Overall Study||13
51666|NCT02459418|123223|P2|Received Second Treatment|Overall Study||15
51667|NCT02459418|123224|P1|Received Second Treatment|Overall Study||13
51668|NCT02459418|123223|P2|Received First Treatment|Overall Study||21
51669|NCT02459418|123224|P1|Received First Treatment|Overall Study||21
51670|NCT02459418|123223|P2|STARTED|Overall Study||21
51671|NCT02459418|123224|P1|STARTED|Overall Study||21
51672|NCT02459197|123246|P2|NOT COMPLETED|Overall Study||1
51673|NCT02459197|123247|P1|NOT COMPLETED|Overall Study||0
51674|NCT02459197|123246|P2|COMPLETED|Overall Study||55
51675|NCT02459197|123247|P1|COMPLETED|Overall Study||58
51676|NCT02459197|123246|P2|STARTED|Overall Study||56
51677|NCT02459197|123247|P1|STARTED|Overall Study||58
51678|NCT02459093|123263|P2|NOT COMPLETED|Overall Study||18
51679|NCT02459093|123264|P1|NOT COMPLETED|Overall Study||12
51680|NCT02459093|123263|P2|COMPLETED|Overall Study||257
51681|NCT02459093|123264|P1|COMPLETED|Overall Study||263
51682|NCT02459093|123263|P2|STARTED|Overall Study||275
51683|NCT02459093|123264|P1|STARTED|Overall Study||275
51684|NCT02459080|123275|P3|NOT COMPLETED|Overall Study||58
51685|NCT02459080|123276|P2|NOT COMPLETED|Overall Study||40
51686|NCT02459080|123277|P1|NOT COMPLETED|Overall Study||44
51687|NCT02459080|123275|P3|COMPLETED|Overall Study||151
51688|NCT02459080|123276|P2|COMPLETED|Overall Study||158
51689|NCT02459080|123277|P1|COMPLETED|Overall Study||168
51690|NCT02459080|123275|P3|STARTED|Overall Study||209
51691|NCT02459080|123276|P2|STARTED|Overall Study||198
51692|NCT02459080|123277|P1|STARTED|Overall Study||212
51693|NCT02458768|123302|P2|NOT COMPLETED|Overall Study||5
51694|NCT02458768|123303|P1|NOT COMPLETED|Overall Study||7
51695|NCT02458768|123302|P2|COMPLETED|Overall Study||50
51696|NCT02458768|123303|P1|COMPLETED|Overall Study||50
51697|NCT02458768|123302|P2|STARTED|Overall Study||55
51698|NCT02458768|123303|P1|STARTED|Overall Study||57
51699|NCT02458365|123311|P2|NOT COMPLETED|Overall Study||294
51700|NCT02458365|123312|P1|NOT COMPLETED|Overall Study||277
51701|NCT02458365|123311|P2|COMPLETED|Overall Study||1607
51702|NCT02458365|123312|P1|COMPLETED|Overall Study||1723
51703|NCT02458365|123311|P2|STARTED|Overall Study||1901
51704|NCT02458365|123312|P1|STARTED|Overall Study||2000
51705|NCT02458352|123332|P1|NOT COMPLETED|Overall Study||0
51706|NCT02458352|123332|P1|COMPLETED|Overall Study||105
51707|NCT02458352|123332|P1|STARTED|Overall Study||105
51708|NCT02458287|123344|P4|NOT COMPLETED|Overall Study||3
51709|NCT02458287|123345|P3|NOT COMPLETED|Overall Study||3
51710|NCT02458287|123346|P2|NOT COMPLETED|Overall Study||4
51711|NCT02458287|123347|P1|NOT COMPLETED|Overall Study||0
51712|NCT02458287|123344|P4|COMPLETED|Overall Study||97
51713|NCT02458287|123345|P3|COMPLETED|Overall Study||46
51714|NCT02458287|123346|P2|COMPLETED|Overall Study||96
51715|NCT02458287|123347|P1|COMPLETED|Overall Study||50
51716|NCT02458287|123344|P4|STARTED|Overall Study||100
51717|NCT02458287|123345|P3|STARTED|Overall Study||49
51718|NCT02458287|123346|P2|STARTED|Overall Study||100
51719|NCT02458287|123347|P1|STARTED|Overall Study||50
51720|NCT02457793|123398|P6|NOT COMPLETED|Overall Study||6
51721|NCT02457793|123399|P5|NOT COMPLETED|Overall Study||4
51722|NCT02457793|123400|P4|NOT COMPLETED|Overall Study||5
51723|NCT02457793|123401|P3|NOT COMPLETED|Overall Study||3
51724|NCT02457793|123402|P2|NOT COMPLETED|Overall Study||4
51725|NCT02457793|123403|P1|NOT COMPLETED|Overall Study||1
51726|NCT02457793|123398|P6|COMPLETED|Overall Study||0
51727|NCT02457793|123399|P5|COMPLETED|Overall Study||0
51728|NCT02457793|123400|P4|COMPLETED|Overall Study||0
51729|NCT02457793|123401|P3|COMPLETED|Overall Study||0
51730|NCT02457793|123402|P2|COMPLETED|Overall Study||1
51731|NCT02457793|123403|P1|COMPLETED|Overall Study||0
51732|NCT02457793|123398|P6|STARTED|Overall Study||6
51733|NCT02457793|123399|P5|STARTED|Overall Study||4
51734|NCT02457793|123400|P4|STARTED|Overall Study||5
51735|NCT02457793|123401|P3|STARTED|Overall Study||3
51736|NCT02457793|123402|P2|STARTED|Overall Study||5
51737|NCT02457793|123403|P1|STARTED|Overall Study||1
51738|NCT02457728|123543|P1|NOT COMPLETED|Overall Study||0
51739|NCT02457728|123543|P1|COMPLETED|Overall Study||34
51740|NCT02457728|123543|P1|STARTED|Overall Study||34
51741|NCT02457611|123547|P1|NOT COMPLETED|Overall Study||3
51742|NCT02457611|123547|P1|COMPLETED|Overall Study||23
51743|NCT02457611|123547|P1|STARTED|Overall Study||26
51744|NCT02457546|123561|P2|NOT COMPLETED|Overall Study||4
51745|NCT02457546|123562|P1|NOT COMPLETED|Overall Study||9
51746|NCT02457546|123561|P2|COMPLETED|Overall Study||116
51747|NCT02457546|123562|P1|COMPLETED|Overall Study||105
51748|NCT02457546|123561|P2|STARTED|Overall Study||120
51749|NCT02457546|123562|P1|STARTED|Overall Study||114
51750|NCT02457260|123573|P3|NOT COMPLETED|Overall Study||1
51751|NCT02457260|123574|P2|NOT COMPLETED|Overall Study||3
51752|NCT02457260|123575|P1|NOT COMPLETED|Overall Study||2
51753|NCT02457260|123573|P3|COMPLETED|Overall Study||1
51754|NCT02457260|123574|P2|COMPLETED|Overall Study||4
51755|NCT02457260|123575|P1|COMPLETED|Overall Study||10
51756|NCT02457260|123573|P3|STARTED|Overall Study||2
51757|NCT02457260|123574|P2|STARTED|Overall Study||7
51758|NCT02457260|123575|P1|STARTED|Overall Study||12
51759|NCT02457247|123617|P4|NOT COMPLETED|Period 2||0
51760|NCT02457247|123618|P3|NOT COMPLETED|Period 2||0
51761|NCT02457247|123619|P2|NOT COMPLETED|Period 2||3
51762|NCT02457247|123620|P1|NOT COMPLETED|Period 2||2
51763|NCT02457247|123617|P4|COMPLETED|Period 2||70
51764|NCT02457247|123618|P3|COMPLETED|Period 2||68
51765|NCT02457247|123619|P2|COMPLETED|Period 2||65
51766|NCT02457247|123620|P1|COMPLETED|Period 2||64
51767|NCT02457247|123617|P4|STARTED|Period 2||70
51768|NCT02457247|123618|P3|STARTED|Period 2||68
51769|NCT02457247|123619|P2|STARTED|Period 2||68
51770|NCT02457247|123620|P1|STARTED|Period 2||66
51771|NCT02457247|123617|P4|NOT COMPLETED|Period 1||0
51772|NCT02457247|123618|P3|NOT COMPLETED|Period 1||0
51773|NCT02457247|123619|P2|NOT COMPLETED|Period 1||2
51774|NCT02457247|123620|P1|NOT COMPLETED|Period 1||2
51775|NCT02457247|123617|P4|COMPLETED|Period 1||70
51776|NCT02457247|123618|P3|COMPLETED|Period 1||68
51777|NCT02457247|123619|P2|COMPLETED|Period 1||68
51778|NCT02457247|123620|P1|COMPLETED|Period 1||66
51779|NCT02457247|123617|P4|STARTED|Period 1||70
51780|NCT02457247|123618|P3|STARTED|Period 1||68
51781|NCT02457247|123619|P2|STARTED|Period 1||70
51782|NCT02457247|123620|P1|STARTED|Period 1||68
51783|NCT02457195|123640|P1|NOT COMPLETED|Overall Study||9
51784|NCT02457195|123640|P1|COMPLETED|Overall Study||41
51785|NCT02457195|123640|P1|STARTED|Overall Study||50
51786|NCT02457182|123646|P2|NOT COMPLETED|Overall Study||0
51787|NCT02457182|123647|P1|NOT COMPLETED|Overall Study||1
51788|NCT02457182|123646|P2|COMPLETED|Overall Study||11
51789|NCT02457182|123647|P1|COMPLETED|Overall Study||8
51790|NCT02457182|123646|P2|STARTED|Overall Study||11
51791|NCT02457182|123647|P1|STARTED|Overall Study||9
51792|NCT02457065|123665|P2|NOT COMPLETED|Overall Study||11
51793|NCT02457065|123666|P1|NOT COMPLETED|Overall Study||9
51794|NCT02457065|123665|P2|COMPLETED|Overall Study||16
51795|NCT02457065|123666|P1|COMPLETED|Overall Study||18
51796|NCT02457065|123665|P2|STARTED|Overall Study||27
51797|NCT02457065|123666|P1|STARTED|Overall Study||27
51798|NCT02456896|123676|P2|NOT COMPLETED|Overall Study||4
51799|NCT02456896|123677|P1|NOT COMPLETED|Overall Study||6
51800|NCT02456896|123676|P2|COMPLETED|Overall Study||21
51801|NCT02456896|123677|P1|COMPLETED|Overall Study||19
51802|NCT02456896|123676|P2|STARTED|Overall Study||25
51803|NCT02456896|123677|P1|STARTED|Overall Study||25
51804|NCT02456740|123688|P9|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||18
51805|NCT02456740|123689|P8|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12
51806|NCT02456740|123690|P7|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||9
51807|NCT02456740|123691|P6|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||13
51808|NCT02456740|123692|P5|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||17
51809|NCT02456740|123693|P4|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||14
51810|NCT02456740|123694|P3|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
51811|NCT02456740|123695|P2|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
51812|NCT02456740|123696|P1|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
51813|NCT02456740|123688|P9|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||126
51814|NCT02456740|123689|P8|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||128
51815|NCT02456740|123690|P7|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||131
51816|NCT02456740|123691|P6|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||130
51817|NCT02456740|123692|P5|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||123
51818|NCT02456740|123693|P4|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||124
51819|NCT02456740|123694|P3|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
51820|NCT02456740|123695|P2|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
51821|NCT02456740|123696|P1|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
51822|NCT02456740|123688|P9|STARTED|Active Treatment Phase (Weeks 24 - 52)||144
51823|NCT02456740|123689|P8|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
51824|NCT02456740|123690|P7|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
51825|NCT02456740|123691|P6|STARTED|Active Treatment Phase (Weeks 24 - 52)||143
51826|NCT02456740|123692|P5|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
51827|NCT02456740|123693|P4|STARTED|Active Treatment Phase (Weeks 24 - 52)||138
51828|NCT02456740|123694|P3|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
51829|NCT02456740|123695|P2|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
51830|NCT02456740|123696|P1|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
51831|NCT02456740|123688|P9|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
51832|NCT02456740|123689|P8|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
51833|NCT02456740|123690|P7|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
51834|NCT02456740|123691|P6|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
51835|NCT02456740|123692|P5|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
51836|NCT02456740|123693|P4|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
51837|NCT02456740|123694|P3|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||27
51838|NCT02456740|123695|P2|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||33
51839|NCT02456740|123696|P1|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||37
51840|NCT02456740|123688|P9|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
51841|NCT02456740|123689|P8|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
51842|NCT02456740|123690|P7|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
51843|NCT02456740|123691|P6|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
51844|NCT02456740|123692|P5|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
51845|NCT02456740|123693|P4|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
51846|NCT02456740|123694|P3|COMPLETED|Double-blind Treatment Phase (24 Weeks)||292
51847|NCT02456740|123695|P2|COMPLETED|Double-blind Treatment Phase (24 Weeks)||284
51848|NCT02456740|123696|P1|COMPLETED|Double-blind Treatment Phase (24 Weeks)||282
51849|NCT02456740|123688|P9|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
51850|NCT02456740|123689|P8|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
51851|NCT02456740|123690|P7|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
51852|NCT02456740|123691|P6|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
51853|NCT02456740|123692|P5|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
51854|NCT02456740|123693|P4|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
51855|NCT02456740|123694|P3|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319
51856|NCT02456740|123695|P2|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||314
51857|NCT02456740|123696|P1|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319
51858|NCT02456740|123688|P9|STARTED|Double-blind Treatment Phase (24 Weeks)||0
51859|NCT02456740|123689|P8|STARTED|Double-blind Treatment Phase (24 Weeks)||0
51860|NCT02456740|123690|P7|STARTED|Double-blind Treatment Phase (24 Weeks)||0
51861|NCT02456740|123691|P6|STARTED|Double-blind Treatment Phase (24 Weeks)||0
51862|NCT02456740|123692|P5|STARTED|Double-blind Treatment Phase (24 Weeks)||0
51863|NCT02456740|123693|P4|STARTED|Double-blind Treatment Phase (24 Weeks)||0
51864|NCT02456740|123694|P3|STARTED|Double-blind Treatment Phase (24 Weeks)||319
51865|NCT02456740|123695|P2|STARTED|Double-blind Treatment Phase (24 Weeks)||317
51866|NCT02456740|123696|P1|STARTED|Double-blind Treatment Phase (24 Weeks)||319
51867|NCT02455518|123722|P4|NOT COMPLETED|Overall Study||3
51868|NCT02455518|123723|P3|NOT COMPLETED|Overall Study||1
51869|NCT02455518|123724|P2|NOT COMPLETED|Overall Study||1
51870|NCT02455518|123725|P1|NOT COMPLETED|Overall Study||0
51871|NCT02455518|123722|P4|COMPLETED|Overall Study||101
51872|NCT02455518|123723|P3|COMPLETED|Overall Study||103
51873|NCT02455518|123724|P2|COMPLETED|Overall Study||103
51874|NCT02455518|123725|P1|COMPLETED|Overall Study||104
51875|NCT02455518|123722|P4|STARTED|Overall Study||104
51876|NCT02455518|123723|P3|STARTED|Overall Study||104
51877|NCT02455518|123724|P2|STARTED|Overall Study||104
51878|NCT02455518|123725|P1|STARTED|Overall Study||104
51879|NCT02455388|123741|P3|NOT COMPLETED|Overall Study||11
51880|NCT02455388|123742|P2|NOT COMPLETED|Overall Study||0
51881|NCT02455388|123743|P1|NOT COMPLETED|Overall Study||1
51882|NCT02455388|123741|P3|COMPLETED|Overall Study||326
51883|NCT02455388|123742|P2|COMPLETED|Overall Study||15
51884|NCT02455388|123743|P1|COMPLETED|Overall Study||17
51885|NCT02455388|123741|P3|STARTED|Overall Study||337
51886|NCT02455388|123742|P2|STARTED|Overall Study||15
51887|NCT02455388|123743|P1|STARTED|Overall Study||18
51888|NCT02455336|123754|P2|NOT COMPLETED|Overall Study||2
51889|NCT02455336|123755|P1|NOT COMPLETED|Overall Study||5
51890|NCT02455336|123754|P2|COMPLETED|Overall Study||6
51891|NCT02455336|123755|P1|COMPLETED|Overall Study||10
51892|NCT02455336|123754|P2|STARTED|Overall Study||8
51893|NCT02455336|123755|P1|STARTED|Overall Study||15
51894|NCT02455076|123770|P5|NOT COMPLETED|Outpatient||12
51895|NCT02455076|123771|P4|NOT COMPLETED|Outpatient||6
51896|NCT02455076|123772|P3|NOT COMPLETED|Outpatient||0
51897|NCT02455076|123773|P2|NOT COMPLETED|Outpatient||0
51898|NCT02455076|123774|P1|NOT COMPLETED|Outpatient||0
51899|NCT02455076|123770|P5|COMPLETED|Outpatient||43
51900|NCT02455076|123771|P4|COMPLETED|Outpatient||42
51901|NCT02455076|123772|P3|COMPLETED|Outpatient||0
51902|NCT02455076|123773|P2|COMPLETED|Outpatient||0
51903|NCT02455076|123774|P1|COMPLETED|Outpatient||0
51904|NCT02455076|123770|P5|STARTED|Outpatient||55
51905|NCT02455076|123771|P4|STARTED|Outpatient||48
51906|NCT02455076|123772|P3|STARTED|Outpatient||0
51907|NCT02455076|123773|P2|STARTED|Outpatient||0
51908|NCT02455076|123774|P1|STARTED|Outpatient||0
51909|NCT02455076|123770|P5|NOT COMPLETED|Inpatient||0
51910|NCT02455076|123771|P4|NOT COMPLETED|Inpatient||0
51911|NCT02455076|123772|P3|NOT COMPLETED|Inpatient||0
51912|NCT02455076|123773|P2|NOT COMPLETED|Inpatient||1
51913|NCT02455076|123774|P1|NOT COMPLETED|Inpatient||4
51914|NCT02455076|123770|P5|COMPLETED|Inpatient||0
51915|NCT02455076|123771|P4|COMPLETED|Inpatient||0
51916|NCT02455076|123772|P3|COMPLETED|Inpatient||52
51917|NCT02455076|123773|P2|COMPLETED|Inpatient||50
51918|NCT02455076|123774|P1|COMPLETED|Inpatient||43
51919|NCT02455076|123770|P5|STARTED|Inpatient||0
51920|NCT02455076|123771|P4|STARTED|Inpatient||0
51921|NCT02455076|123772|P3|STARTED|Inpatient||52
51922|NCT02455076|123773|P2|STARTED|Inpatient||51
51923|NCT02455076|123774|P1|STARTED|Inpatient||47
51924|NCT02455050|123860|P4|NOT COMPLETED|Treatment Period 2||1
51925|NCT02455050|123861|P3|NOT COMPLETED|Treatment Period 2||2
51926|NCT02455050|123862|P2|NOT COMPLETED|Treatment Period 2||0
51927|NCT02455050|123863|P1|NOT COMPLETED|Treatment Period 2||1
51928|NCT02455050|123860|P4|COMPLETED|Treatment Period 2||17
51929|NCT02455050|123861|P3|COMPLETED|Treatment Period 2||17
51930|NCT02455050|123862|P2|COMPLETED|Treatment Period 2||18
51931|NCT02455050|123863|P1|COMPLETED|Treatment Period 2||18
51932|NCT02455050|123860|P4|STARTED|Treatment Period 2||18
51933|NCT02455050|123861|P3|STARTED|Treatment Period 2||19
51934|NCT02455050|123862|P2|STARTED|Treatment Period 2||18
51935|NCT02455050|123863|P1|STARTED|Treatment Period 2||19
51936|NCT02455050|123860|P4|NOT COMPLETED|Treatment Period 1||2
51937|NCT02455050|123861|P3|NOT COMPLETED|Treatment Period 1||1
51938|NCT02455050|123862|P2|NOT COMPLETED|Treatment Period 1||1
51939|NCT02455050|123863|P1|NOT COMPLETED|Treatment Period 1||1
51940|NCT02455050|123860|P4|COMPLETED|Treatment Period 1||18
51941|NCT02455050|123861|P3|COMPLETED|Treatment Period 1||19
51942|NCT02455050|123862|P2|COMPLETED|Treatment Period 1||18
51943|NCT02455050|123863|P1|COMPLETED|Treatment Period 1||19
51944|NCT02455050|123860|P4|STARTED|Treatment Period 1||20
51945|NCT02455050|123861|P3|STARTED|Treatment Period 1||20
51946|NCT02455050|123862|P2|STARTED|Treatment Period 1||19
51947|NCT02455050|123863|P1|STARTED|Treatment Period 1||20
51948|NCT02454959|123927|P1|NOT COMPLETED|Overall Study||9
51949|NCT02454959|123927|P1|COMPLETED|Overall Study||70
51950|NCT02454959|123927|P1|GFF MDI (PT003) Without Aerochamber|Overall Study||77
51951|NCT02454959|123927|P1|GFF MDI (PT003) With Aerochamber|Overall Study||73
51952|NCT02454959|123927|P1|STARTED|Overall Study||79
51953|NCT02454933|123947|P2|NOT COMPLETED|Overall Study||8
51954|NCT02454933|123948|P1|NOT COMPLETED|Overall Study||8
51955|NCT02454933|123947|P2|COMPLETED|Overall Study||4
51956|NCT02454933|123948|P1|COMPLETED|Overall Study||9
51957|NCT02454933|123947|P2|Treatment Group Randomised to|Overall Study||14
51958|NCT02454933|123948|P1|Treatment Group Randomised to|Overall Study||15
51959|NCT02454933|123947|P2|STARTED|Overall Study|2 subjects switched to osimertinib monotherapy Cycle 1 Day 1|12
51960|NCT02454933|123948|P1|STARTED|Overall Study||17
51961|NCT02454608|123956|P3|NOT COMPLETED|Open Label Period||19
51962|NCT02454608|123957|P2|NOT COMPLETED|Open Label Period||0
51963|NCT02454608|123958|P1|NOT COMPLETED|Open Label Period||0
51964|NCT02454608|123956|P3|COMPLETED|Open Label Period||10
51965|NCT02454608|123957|P2|COMPLETED|Open Label Period|This arm is not part of this period of the study|0
51966|NCT02454608|123958|P1|COMPLETED|Open Label Period|This arm is not part of this period of the study|0
51967|NCT02454608|123956|P3|STARTED|Open Label Period||29
51968|NCT02454608|123957|P2|STARTED|Open Label Period|This arm is not part of this period of the study|0
51969|NCT02454608|123958|P1|STARTED|Open Label Period|This arm is not part of this period of the study|0
51970|NCT02454608|123956|P3|NOT COMPLETED|Double-Blind Period||0
51971|NCT02454608|123957|P2|NOT COMPLETED|Double-Blind Period||2
51972|NCT02454608|123958|P1|NOT COMPLETED|Double-Blind Period||0
51973|NCT02454608|123956|P3|COMPLETED|Double-Blind Period|This arm is not part of this period of the study|0
51974|NCT02454608|123957|P2|COMPLETED|Double-Blind Period||12
51975|NCT02454608|123958|P1|COMPLETED|Double-Blind Period||15
51976|NCT02454608|123956|P3|STARTED|Double-Blind Period|This arm is not part of this period of the study|0
51977|NCT02454608|123957|P2|STARTED|Double-Blind Period||14
51978|NCT02454608|123958|P1|STARTED|Double-Blind Period||15
51979|NCT02454530|123981|P2|NOT COMPLETED|Overall Study||127
51980|NCT02454530|123982|P1|NOT COMPLETED|Overall Study||70
51981|NCT02454530|123981|P2|COMPLETED|Overall Study||481
51982|NCT02454530|123982|P1|COMPLETED|Overall Study||482
51983|NCT02454530|123981|P2|STARTED|Overall Study||608
51984|NCT02454530|123982|P1|STARTED|Overall Study||552
51985|NCT02454478|124019|P1|NOT COMPLETED|Overall Study||1
51986|NCT02454478|124019|P1|COMPLETED|Overall Study||6
51987|NCT02454478|124019|P1|STARTED|Overall Study||7
51988|NCT02454296|124035|P2|NOT COMPLETED|Overall Study||0
51989|NCT02454296|124036|P1|NOT COMPLETED|Overall Study||0
51990|NCT02454296|124035|P2|COMPLETED|Overall Study||21
51991|NCT02454296|124036|P1|COMPLETED|Overall Study||20
51992|NCT02454296|124035|P2|STARTED|Overall Study||21
51993|NCT02454296|124036|P1|STARTED|Overall Study||20
51994|NCT02454283|124048|P2|NOT COMPLETED|Overall Study||0
51995|NCT02454283|124049|P1|NOT COMPLETED|Overall Study||0
51996|NCT02454283|124048|P2|COMPLETED|Overall Study||15
51997|NCT02454283|124049|P1|COMPLETED|Overall Study||26
51998|NCT02454283|124048|P2|STARTED|Overall Study||15
51999|NCT02454283|124049|P1|STARTED|Overall Study||26
52000|NCT02454179|124059|P2|NOT COMPLETED|Overall Study||39
52001|NCT02454179|124060|P1|NOT COMPLETED|Overall Study||39
52002|NCT02454179|124059|P2|COMPLETED|Overall Study||0
52003|NCT02454179|124060|P1|COMPLETED|Overall Study||0
52004|NCT02454179|124059|P2|Discontinue Study|Overall Study||39
52005|NCT02454179|124060|P1|Discontinue Study|Overall Study||39
52006|NCT02454179|124059|P2|Received Study Medication|Overall Study||37
52007|NCT02454179|124060|P1|Received Study Medication|Overall Study||39
52008|NCT02454179|124059|P2|Enrolled|Overall Study||39
52009|NCT02454179|124060|P1|Enrolled|Overall Study||39
52010|NCT02454179|124059|P2|STARTED|Overall Study||39
52011|NCT02454179|124060|P1|STARTED|Overall Study||39
52012|NCT02454127|124070|P4|NOT COMPLETED|Overall Study||20
52013|NCT02454127|124071|P3|NOT COMPLETED|Overall Study||14
52014|NCT02454127|124072|P2|NOT COMPLETED|Overall Study||14
52015|NCT02454127|124073|P1|NOT COMPLETED|Overall Study||19
52016|NCT02454127|124070|P4|COMPLETED|Overall Study||20
52017|NCT02454127|124071|P3|COMPLETED|Overall Study||26
52018|NCT02454127|124072|P2|COMPLETED|Overall Study||26
52019|NCT02454127|124073|P1|COMPLETED|Overall Study||21
52020|NCT02454127|124070|P4|STARTED|Overall Study||40
52021|NCT02454127|124071|P3|STARTED|Overall Study||40
52022|NCT02454127|124072|P2|STARTED|Overall Study||40
52023|NCT02454127|124073|P1|STARTED|Overall Study||40
52024|NCT02454101|124113|P2|NOT COMPLETED|Overall Study||7
52025|NCT02454101|124114|P1|NOT COMPLETED|Overall Study||5
52026|NCT02454101|124113|P2|COMPLETED|Overall Study||143
52027|NCT02454101|124114|P1|COMPLETED|Overall Study||145
52028|NCT02454101|124113|P2|STARTED|Overall Study||150
52029|NCT02454101|124114|P1|STARTED|Overall Study||150
52030|NCT02453841|124136|P1|NOT COMPLETED|Overall Study||3
52031|NCT02453841|124136|P1|COMPLETED|Overall Study||27
52032|NCT02453841|124136|P1|STARTED|Overall Study||30
52033|NCT02453750|124143|P1|NOT COMPLETED|Overall Study||0
52034|NCT02453750|124143|P1|COMPLETED|Overall Study||21
52035|NCT02453750|124143|P1|STARTED|Overall Study||21
52036|NCT02453685|124152|P2|NOT COMPLETED|Overall Study||12
52037|NCT02453685|124153|P1|NOT COMPLETED|Overall Study||19
52038|NCT02453685|124152|P2|COMPLETED|Overall Study||155
52039|NCT02453685|124153|P1|COMPLETED|Overall Study||149
52040|NCT02453685|124152|P2|Exposed|Overall Study||166
52041|NCT02453685|124153|P1|Exposed|Overall Study||166
52042|NCT02453685|124152|P2|STARTED|Overall Study||167
52043|NCT02453685|124153|P1|STARTED|Overall Study||168
52044|NCT02453672|124168|P3|NOT COMPLETED|Overall Study||1
52045|NCT02453672|124169|P2|NOT COMPLETED|Overall Study||2
52046|NCT02453672|124170|P1|NOT COMPLETED|Overall Study||3
52047|NCT02453672|124168|P3|COMPLETED|Overall Study||38
52048|NCT02453672|124169|P2|COMPLETED|Overall Study||38
52049|NCT02453672|124170|P1|COMPLETED|Overall Study||37
52050|NCT02453672|124168|P3|STARTED|Overall Study||39
52051|NCT02453672|124169|P2|STARTED|Overall Study||40
52052|NCT02453672|124170|P1|STARTED|Overall Study||40
52053|NCT02453581|124187|P3|NOT COMPLETED|Overall Study||0
52054|NCT02453581|124188|P2|NOT COMPLETED|Overall Study||0
52055|NCT02453581|124189|P1|NOT COMPLETED|Overall Study||0
52056|NCT02453581|124187|P3|COMPLETED|Overall Study||8
52057|NCT02453581|124188|P2|COMPLETED|Overall Study||8
52058|NCT02453581|124189|P1|COMPLETED|Overall Study||8
52059|NCT02453581|124187|P3|STARTED|Overall Study||8
52060|NCT02453581|124188|P2|STARTED|Overall Study||8
52061|NCT02453581|124189|P1|STARTED|Overall Study||8
52062|NCT02453555|124211|P6|NOT COMPLETED|Extension Period||1
52063|NCT02453555|124212|P5|NOT COMPLETED|Extension Period||1
52064|NCT02453555|124213|P4|NOT COMPLETED|Extension Period||2
52065|NCT02453555|124214|P3|NOT COMPLETED|Extension Period||3
52066|NCT02453555|124215|P2|NOT COMPLETED|Extension Period||0
52067|NCT02453555|124216|P1|NOT COMPLETED|Extension Period||0
52068|NCT02453555|124211|P6|COMPLETED|Extension Period||5
52069|NCT02453555|124212|P5|COMPLETED|Extension Period||79
52070|NCT02453555|124213|P4|COMPLETED|Extension Period||49
52071|NCT02453555|124214|P3|COMPLETED|Extension Period||123
52072|NCT02453555|124215|P2|COMPLETED|Extension Period||0
52073|NCT02453555|124216|P1|COMPLETED|Extension Period||0
52074|NCT02453555|124211|P6|STARTED|Extension Period||6
52075|NCT02453555|124212|P5|STARTED|Extension Period||80
52076|NCT02453555|124213|P4|STARTED|Extension Period||51
52077|NCT02453555|124214|P3|STARTED|Extension Period||126
52078|NCT02453555|124215|P2|STARTED|Extension Period|This reporting group is not applicable in this period.|0
52079|NCT02453555|124216|P1|STARTED|Extension Period|This reporting group is not applicable in this period.|0
52080|NCT02453555|124211|P6|NOT COMPLETED|24-week Double-blind Treatment Period||0
52081|NCT02453555|124212|P5|NOT COMPLETED|24-week Double-blind Treatment Period||0
52082|NCT02453555|124213|P4|NOT COMPLETED|24-week Double-blind Treatment Period||0
52083|NCT02453555|124214|P3|NOT COMPLETED|24-week Double-blind Treatment Period||0
52084|NCT02453555|124215|P2|NOT COMPLETED|24-week Double-blind Treatment Period||7
52085|NCT02453555|124216|P1|NOT COMPLETED|24-week Double-blind Treatment Period||5
52086|NCT02453555|124211|P6|COMPLETED|24-week Double-blind Treatment Period||0
52087|NCT02453555|124212|P5|COMPLETED|24-week Double-blind Treatment Period||0
52088|NCT02453555|124213|P4|COMPLETED|24-week Double-blind Treatment Period||0
52089|NCT02453555|124214|P3|COMPLETED|24-week Double-blind Treatment Period||0
52090|NCT02453555|124215|P2|COMPLETED|24-week Double-blind Treatment Period||86
52091|NCT02453555|124216|P1|COMPLETED|24-week Double-blind Treatment Period||177
52092|NCT02453555|124211|P6|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
52093|NCT02453555|124212|P5|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
52094|NCT02453555|124213|P4|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
52095|NCT02453555|124214|P3|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
52096|NCT02453555|124215|P2|STARTED|24-week Double-blind Treatment Period|Started are treated subjects.|93
52097|NCT02453555|124216|P1|STARTED|24-week Double-blind Treatment Period|Started are treated subjects.|182
52098|NCT02453386|124232|P3|NOT COMPLETED|Overall Study||41
52099|NCT02453386|124233|P2|NOT COMPLETED|Overall Study||49
52100|NCT02453386|124234|P1|NOT COMPLETED|Overall Study||49
52101|NCT02453386|124232|P3|COMPLETED|Overall Study||108
52102|NCT02453386|124233|P2|COMPLETED|Overall Study||100
52103|NCT02453386|124234|P1|COMPLETED|Overall Study||102
52104|NCT02453386|124232|P3|STARTED|Overall Study||149
52105|NCT02453386|124233|P2|STARTED|Overall Study||149
52106|NCT02453386|124234|P1|STARTED|Overall Study||151
52107|NCT02453360|124260|P3|NOT COMPLETED|Overall Study||0
52108|NCT02453360|124261|P2|NOT COMPLETED|Overall Study||0
52109|NCT02453360|124262|P1|NOT COMPLETED|Overall Study||0
52110|NCT02453360|124260|P3|COMPLETED|Overall Study||20
52111|NCT02453360|124261|P2|COMPLETED|Overall Study||20
52112|NCT02453360|124262|P1|COMPLETED|Overall Study||20
52113|NCT02453360|124260|P3|STARTED|Overall Study||20
52114|NCT02453360|124261|P2|STARTED|Overall Study||20
52115|NCT02453360|124262|P1|STARTED|Overall Study||20
52116|NCT02453347|124282|P1|NOT COMPLETED|Overall Study||0
52117|NCT02453347|124282|P1|COMPLETED|Overall Study||6
52118|NCT02453347|124282|P1|STARTED|Overall Study||6
52119|NCT02453321|124298|P3|NOT COMPLETED|Overall Study||2
52120|NCT02453321|124299|P2|NOT COMPLETED|Overall Study||2
52121|NCT02453321|124300|P1|NOT COMPLETED|Overall Study||1
52122|NCT02453321|124298|P3|COMPLETED|Overall Study||19
52123|NCT02453321|124299|P2|COMPLETED|Overall Study||19
52124|NCT02453321|124300|P1|COMPLETED|Overall Study||19
52125|NCT02453321|124298|P3|STARTED|Overall Study||21
52126|NCT02453321|124299|P2|STARTED|Overall Study||21
52127|NCT02453321|124300|P1|STARTED|Overall Study||20
52128|NCT02453282|124320|P3|NOT COMPLETED|Overall Study||372
52129|NCT02453282|124321|P2|NOT COMPLETED|Overall Study||372
52130|NCT02453282|124322|P1|NOT COMPLETED|Overall Study||374
52131|NCT02453282|124320|P3|COMPLETED|Overall Study||0
52132|NCT02453282|124321|P2|COMPLETED|Overall Study||0
52133|NCT02453282|124322|P1|COMPLETED|Overall Study||0
52134|NCT02453282|124320|P3|Received Treatment|Overall Study||352
52135|NCT02453282|124321|P2|Received Treatment|Overall Study||371
52136|NCT02453282|124322|P1|Received Treatment|Overall Study||369
52137|NCT02453282|124320|P3|STARTED|Overall Study||372
52138|NCT02453282|124321|P2|STARTED|Overall Study||372
52139|NCT02453282|124322|P1|STARTED|Overall Study||374
52140|NCT02453256|124403|P2|NOT COMPLETED|Overall Study||9
52141|NCT02453256|124404|P1|NOT COMPLETED|Overall Study||13
52142|NCT02453256|124403|P2|COMPLETED|Overall Study||95
52143|NCT02453256|124404|P1|COMPLETED|Overall Study||93
52144|NCT02453256|124403|P2|STARTED|Overall Study||104
52145|NCT02453256|124404|P1|STARTED|Overall Study||106
52146|NCT02452944|124490|P2|NOT COMPLETED|Overall Study||0
52147|NCT02452944|124491|P1|NOT COMPLETED|Overall Study||0
52148|NCT02452944|124490|P2|COMPLETED|Overall Study||31
52149|NCT02452944|124491|P1|COMPLETED|Overall Study||31
52150|NCT02452944|124490|P2|STARTED|Overall Study||31
52151|NCT02452944|124491|P1|STARTED|Overall Study||31
52152|NCT02452892|124503|P4|NOT COMPLETED|Follow-up||1
52153|NCT02452892|124504|P3|NOT COMPLETED|Follow-up||0
52154|NCT02452892|124505|P2|NOT COMPLETED|Follow-up||0
52155|NCT02452892|124506|P1|NOT COMPLETED|Follow-up||1
52156|NCT02452892|124503|P4|COMPLETED|Follow-up||38
52157|NCT02452892|124504|P3|COMPLETED|Follow-up||7
52158|NCT02452892|124505|P2|COMPLETED|Follow-up||7
52159|NCT02452892|124506|P1|COMPLETED|Follow-up||62
52160|NCT02452892|124503|P4|STARTED|Follow-up||39
52161|NCT02452892|124504|P3|STARTED|Follow-up||7
52162|NCT02452892|124505|P2|STARTED|Follow-up||7
52163|NCT02452892|124506|P1|STARTED|Follow-up||63
52164|NCT02452892|124503|P4|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
52165|NCT02452892|124504|P3|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
52166|NCT02452892|124505|P2|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
52167|NCT02452892|124506|P1|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
52168|NCT02452892|124503|P4|COMPLETED|Week 2 Stratification & Re-Randomization||39
52169|NCT02452892|124504|P3|COMPLETED|Week 2 Stratification & Re-Randomization||7
52170|NCT02452892|124505|P2|COMPLETED|Week 2 Stratification & Re-Randomization||7
52171|NCT02452892|124506|P1|COMPLETED|Week 2 Stratification & Re-Randomization||63
52172|NCT02452892|124503|P4|Responders|Week 2 Stratification & Re-Randomization||0
52173|NCT02452892|124504|P3|Responders|Week 2 Stratification & Re-Randomization||7
52174|NCT02452892|124505|P2|Responders|Week 2 Stratification & Re-Randomization||7
52175|NCT02452892|124506|P1|Responders|Week 2 Stratification & Re-Randomization||27
52176|NCT02452892|124503|P4|Non-reponders|Week 2 Stratification & Re-Randomization||41
52177|NCT02452892|124504|P3|Non-reponders|Week 2 Stratification & Re-Randomization||0
52178|NCT02452892|124505|P2|Non-reponders|Week 2 Stratification & Re-Randomization||0
52179|NCT02452892|124506|P1|Non-reponders|Week 2 Stratification & Re-Randomization||38
52180|NCT02452892|124503|P4|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (13), LFMS 20min (14), and LFMS 60 min (14).|41
52181|NCT02452892|124504|P3|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0),LFMS 20min (0), LFMS 60min (7)|7
52182|NCT02452892|124505|P2|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0), LFMS 20min (7), and LFMS 60min(0).|7
52183|NCT02452892|124506|P1|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that started LFMS sham (27), LFMS 20min (19), and LFMS 60min (19)|65
52184|NCT02452892|124503|P4|NOT COMPLETED|Week 1 Initial Randommization||0
52185|NCT02452892|124504|P3|NOT COMPLETED|Week 1 Initial Randommization||1
52186|NCT02452892|124505|P2|NOT COMPLETED|Week 1 Initial Randommization||0
52187|NCT02452892|124506|P1|NOT COMPLETED|Week 1 Initial Randommization||1
52188|NCT02452892|124503|P4|COMPLETED|Week 1 Initial Randommization||0
52189|NCT02452892|124504|P3|COMPLETED|Week 1 Initial Randommization||40
52190|NCT02452892|124505|P2|COMPLETED|Week 1 Initial Randommization||40
52191|NCT02452892|124506|P1|COMPLETED|Week 1 Initial Randommization||40
52192|NCT02452892|124503|P4|STARTED|Week 1 Initial Randommization||0
52193|NCT02452892|124504|P3|STARTED|Week 1 Initial Randommization||41
52194|NCT02452892|124505|P2|STARTED|Week 1 Initial Randommization||40
52195|NCT02452892|124506|P1|STARTED|Week 1 Initial Randommization||41
52196|NCT02452554|124541|P6|NOT COMPLETED|Overall Study||9
52197|NCT02452554|124542|P5|NOT COMPLETED|Overall Study||5
52198|NCT02452554|124543|P4|NOT COMPLETED|Overall Study||1
52199|NCT02452554|124544|P3|NOT COMPLETED|Overall Study||11
52200|NCT02452554|124545|P2|NOT COMPLETED|Overall Study||17
52201|NCT02452554|124546|P1|NOT COMPLETED|Overall Study||17
52202|NCT02452554|124541|P6|COMPLETED|Overall Study||1
52203|NCT02452554|124542|P5|COMPLETED|Overall Study||0
52204|NCT02452554|124543|P4|COMPLETED|Overall Study||0
52205|NCT02452554|124544|P3|COMPLETED|Overall Study||1
52206|NCT02452554|124545|P2|COMPLETED|Overall Study||0
52207|NCT02452554|124546|P1|COMPLETED|Overall Study||0
52208|NCT02452554|124541|P6|STARTED|Overall Study||10
52209|NCT02452554|124542|P5|STARTED|Overall Study||5
52210|NCT02452554|124543|P4|STARTED|Overall Study||1
52211|NCT02452554|124544|P3|STARTED|Overall Study||12
52212|NCT02452554|124545|P2|STARTED|Overall Study||17
52213|NCT02452554|124546|P1|STARTED|Overall Study||17
52214|NCT02452528|124563|P2|NOT COMPLETED|Overall Study||1
52215|NCT02452528|124564|P1|NOT COMPLETED|Overall Study||1
52216|NCT02452528|124563|P2|COMPLETED|Overall Study||1
52217|NCT02452528|124564|P1|COMPLETED|Overall Study||1
52218|NCT02452528|124563|P2|STARTED|Overall Study||2
52219|NCT02452528|124564|P1|STARTED|Overall Study||2
52220|NCT02452424|124607|P11|NOT COMPLETED|Overall Study||2
52221|NCT02452424|124608|P10|NOT COMPLETED|Overall Study||2
52222|NCT02452424|124609|P9|NOT COMPLETED|Overall Study||6
52223|NCT02452424|124610|P8|NOT COMPLETED|Overall Study||4
52224|NCT02452424|124611|P7|NOT COMPLETED|Overall Study||10
52225|NCT02452424|124612|P6|NOT COMPLETED|Overall Study||1
52226|NCT02452424|124613|P5|NOT COMPLETED|Overall Study||2
52227|NCT02452424|124614|P4|NOT COMPLETED|Overall Study||8
52228|NCT02452424|124615|P3|NOT COMPLETED|Overall Study||7
52229|NCT02452424|124616|P2|NOT COMPLETED|Overall Study||3
52230|NCT02452424|124617|P1|NOT COMPLETED|Overall Study||2
52231|NCT02452424|124607|P11|COMPLETED|Overall Study||4
52232|NCT02452424|124608|P10|COMPLETED|Overall Study||1
52233|NCT02452424|124609|P9|COMPLETED|Overall Study||9
52234|NCT02452424|124610|P8|COMPLETED|Overall Study||4
52235|NCT02452424|124611|P7|COMPLETED|Overall Study||3
52236|NCT02452424|124612|P6|COMPLETED|Overall Study||5
52237|NCT02452424|124613|P5|COMPLETED|Overall Study||2
52238|NCT02452424|124614|P4|COMPLETED|Overall Study||1
52239|NCT02452424|124615|P3|COMPLETED|Overall Study||0
52240|NCT02452424|124616|P2|COMPLETED|Overall Study||0
52241|NCT02452424|124617|P1|COMPLETED|Overall Study||2
52242|NCT02452424|124607|P11|STARTED|Overall Study||6
52243|NCT02452424|124608|P10|STARTED|Overall Study||3
52244|NCT02452424|124609|P9|STARTED|Overall Study||15
52245|NCT02452424|124610|P8|STARTED|Overall Study||8
52246|NCT02452424|124611|P7|STARTED|Overall Study||13
52247|NCT02452424|124612|P6|STARTED|Overall Study||6
52248|NCT02452424|124613|P5|STARTED|Overall Study||4
52249|NCT02452424|124614|P4|STARTED|Overall Study||9
52250|NCT02452424|124615|P3|STARTED|Overall Study||7
52251|NCT02452424|124616|P2|STARTED|Overall Study||3
52252|NCT02452424|124617|P1|STARTED|Overall Study||4
52253|NCT02452346|124652|P1|NOT COMPLETED|Overall Study||9
52254|NCT02452346|124652|P1|COMPLETED|Overall Study||3
52255|NCT02452346|124652|P1|STARTED|Overall Study||12
52256|NCT02452320|124660|P2|NOT COMPLETED|Overall Study||1
52257|NCT02452320|124661|P1|NOT COMPLETED|Overall Study||0
52258|NCT02452320|124660|P2|COMPLETED|Overall Study||63
52259|NCT02452320|124661|P1|COMPLETED|Overall Study||64
52260|NCT02452320|124660|P2|STARTED|Overall Study||64
52261|NCT02452320|124661|P1|STARTED|Overall Study||64
52262|NCT02452190|124673|P2|NOT COMPLETED|Overall Study||24
52263|NCT02452190|124674|P1|NOT COMPLETED|Overall Study||35
52264|NCT02452190|124673|P2|COMPLETED|Overall Study||212
52265|NCT02452190|124674|P1|COMPLETED|Overall Study||197
52266|NCT02452190|124673|P2|Safety Population|Overall Study||237
52267|NCT02452190|124674|P1|Safety Population|Overall Study||231
52268|NCT02452190|124673|P2|Intent to Treat (ITT) Population|Overall Study||234
52269|NCT02452190|124674|P1|Intent to Treat (ITT) Population|Overall Study||230
52270|NCT02452190|124673|P2|STARTED|Overall Study||236
52271|NCT02452190|124674|P1|STARTED|Overall Study||232
52272|NCT02452047|124701|P3|NOT COMPLETED|Overall Study||2
52273|NCT02452047|124702|P2|NOT COMPLETED|Overall Study||5
52274|NCT02452047|124703|P1|NOT COMPLETED|Overall Study||4
52275|NCT02452047|124701|P3|COMPLETED|Overall Study||1
52276|NCT02452047|124702|P2|COMPLETED|Overall Study||11
52277|NCT02452047|124703|P1|COMPLETED|Overall Study||27
52278|NCT02452047|124701|P3|STARTED|Overall Study||3
52279|NCT02452047|124702|P2|STARTED|Overall Study||16
52280|NCT02452047|124703|P1|STARTED|Overall Study||31
52281|NCT02452034|124768|P6|NOT COMPLETED|Overall Study||3
52282|NCT02452034|124769|P5|NOT COMPLETED|Overall Study||1
52283|NCT02452034|124770|P4|NOT COMPLETED|Overall Study||1
52284|NCT02452034|124771|P3|NOT COMPLETED|Overall Study||1
52285|NCT02452034|124772|P2|NOT COMPLETED|Overall Study||1
52286|NCT02452034|124773|P1|NOT COMPLETED|Overall Study||2
52287|NCT02452034|124768|P6|COMPLETED|Overall Study||26
52288|NCT02452034|124769|P5|COMPLETED|Overall Study||19
52289|NCT02452034|124770|P4|COMPLETED|Overall Study||16
52290|NCT02452034|124771|P3|COMPLETED|Overall Study||14
52291|NCT02452034|124772|P2|COMPLETED|Overall Study||20
52292|NCT02452034|124773|P1|COMPLETED|Overall Study||14
52293|NCT02452034|124768|P6|Treated|Overall Study||29
52294|NCT02452034|124769|P5|Treated|Overall Study||20
52295|NCT02452034|124770|P4|Treated|Overall Study||16
52296|NCT02452034|124771|P3|Treated|Overall Study||15
52297|NCT02452034|124772|P2|Treated|Overall Study||21
52298|NCT02452034|124773|P1|Treated|Overall Study||14
52299|NCT02452034|124768|P6|STARTED|Overall Study||29
52300|NCT02452034|124769|P5|STARTED|Overall Study||20
52301|NCT02452034|124770|P4|STARTED|Overall Study||17
52302|NCT02452034|124771|P3|STARTED|Overall Study||15
52303|NCT02452034|124772|P2|STARTED|Overall Study||21
52304|NCT02452034|124773|P1|STARTED|Overall Study||16
52305|NCT02451995|124837|P2|NOT COMPLETED|Overall Study||0
52306|NCT02451995|124838|P1|NOT COMPLETED|Overall Study||0
52307|NCT02451995|124837|P2|COMPLETED|Overall Study||41
52308|NCT02451995|124838|P1|COMPLETED|Overall Study||42
52309|NCT02451995|124837|P2|STARTED|Overall Study||41
52310|NCT02451995|124838|P1|STARTED|Overall Study||42
52311|NCT02451917|124846|P2|NOT COMPLETED|Second Intervention (24 Weeks)||0
52312|NCT02451917|124847|P1|NOT COMPLETED|Second Intervention (24 Weeks)||0
52313|NCT02451917|124846|P2|COMPLETED|Second Intervention (24 Weeks)||15
52314|NCT02451917|124847|P1|COMPLETED|Second Intervention (24 Weeks)||14
52315|NCT02451917|124846|P2|STARTED|Second Intervention (24 Weeks)||15
52316|NCT02451917|124847|P1|STARTED|Second Intervention (24 Weeks)||14
52317|NCT02451917|124846|P2|NOT COMPLETED|First Intervention (24 Weeks)||3
52318|NCT02451917|124847|P1|NOT COMPLETED|First Intervention (24 Weeks)||2
52319|NCT02451917|124846|P2|COMPLETED|First Intervention (24 Weeks)||15
52320|NCT02451917|124847|P1|COMPLETED|First Intervention (24 Weeks)||14
52321|NCT02451917|124846|P2|STARTED|First Intervention (24 Weeks)||18
52322|NCT02451917|124847|P1|STARTED|First Intervention (24 Weeks)||16
52323|NCT02451839|124865|P3|NOT COMPLETED|Overall Study||7
52324|NCT02451839|124866|P2|NOT COMPLETED|Overall Study||19
52325|NCT02451839|124867|P1|NOT COMPLETED|Overall Study||28
52326|NCT02451839|124865|P3|COMPLETED|Overall Study||30
52327|NCT02451839|124866|P2|COMPLETED|Overall Study||40
52328|NCT02451839|124867|P1|COMPLETED|Overall Study||44
52329|NCT02451839|124865|P3|Baseline WHODAS Data Recorded|Overall Study||37
52330|NCT02451839|124866|P2|Baseline WHODAS Data Recorded|Overall Study||57
52331|NCT02451839|124867|P1|Baseline WHODAS Data Recorded|Overall Study||70
52332|NCT02451839|124865|P3|STARTED|Overall Study||37
52333|NCT02451839|124866|P2|STARTED|Overall Study||59
52334|NCT02451839|124867|P1|STARTED|Overall Study||72
52335|NCT02451670|124889|P2|NOT COMPLETED|Overall Study||696
52336|NCT02451670|124890|P1|NOT COMPLETED|Overall Study||714
52337|NCT02451670|124889|P2|COMPLETED|Overall Study||4387
52338|NCT02451670|124890|P1|COMPLETED|Overall Study||4550
52339|NCT02451670|124889|P2|STARTED|Overall Study||5083
52340|NCT02451670|124890|P1|STARTED|Overall Study||5264
52341|NCT02451358|124900|P4|NOT COMPLETED|Overall Study||0
52342|NCT02451358|124901|P3|NOT COMPLETED|Overall Study||1
52343|NCT02451358|124902|P2|NOT COMPLETED|Overall Study||2
52344|NCT02451358|124903|P1|NOT COMPLETED|Overall Study||1
52345|NCT02451358|124900|P4|COMPLETED|Overall Study||100
52346|NCT02451358|124901|P3|COMPLETED|Overall Study||99
52347|NCT02451358|124902|P2|COMPLETED|Overall Study||98
52348|NCT02451358|124903|P1|COMPLETED|Overall Study||99
52349|NCT02451358|124900|P4|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
52350|NCT02451358|124901|P3|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
52351|NCT02451358|124902|P2|Vaccinated at Day 28|Overall Study||98
52352|NCT02451358|124903|P1|Vaccinated at Day 28|Overall Study||99
52353|NCT02451358|124900|P4|Vaccinated at Day 0|Overall Study||100
52354|NCT02451358|124901|P3|Vaccinated at Day 0|Overall Study||100
52355|NCT02451358|124902|P2|Vaccinated at Day 0|Overall Study||100
52356|NCT02451358|124903|P1|Vaccinated at Day 0|Overall Study||100
52357|NCT02451358|124900|P4|STARTED|Overall Study||100
52358|NCT02451358|124901|P3|STARTED|Overall Study||100
52359|NCT02451358|124902|P2|STARTED|Overall Study||100
52360|NCT02451358|124903|P1|STARTED|Overall Study||100
52361|NCT02451150|124927|P2|NOT COMPLETED|Overall Study||0
52362|NCT02451150|124928|P1|NOT COMPLETED|Overall Study||0
52363|NCT02451150|124927|P2|COMPLETED|Overall Study||3
52364|NCT02451150|124928|P1|COMPLETED|Overall Study||3
52365|NCT02451150|124927|P2|STARTED|Overall Study||3
52366|NCT02451150|124928|P1|STARTED|Overall Study||3
52367|NCT02451137|124980|P2|NOT COMPLETED|Overall Study||298
52368|NCT02451137|124981|P1|NOT COMPLETED|Overall Study||246
52369|NCT02451137|124980|P2|COMPLETED|Overall Study||1355
52370|NCT02451137|124981|P1|COMPLETED|Overall Study||1405
52371|NCT02451137|124980|P2|Safety Population|Overall Study|9 participants received Toujeo instead of Standard of Care.|1621
52372|NCT02451137|124981|P1|Safety Population|Overall Study|4 participants received Standard of Care instead of Toujeo.|1637
52373|NCT02451137|124980|P2|Treated|Overall Study||1626
52374|NCT02451137|124981|P1|Treated|Overall Study||1632
52375|NCT02451137|124980|P2|STARTED|Overall Study||1653
52376|NCT02451137|124981|P1|STARTED|Overall Study||1651
52377|NCT02451124|125011|P1|NOT COMPLETED|Overall Study||1
52378|NCT02451124|125011|P1|COMPLETED|Overall Study||155
52379|NCT02451124|125011|P1|STARTED|Overall Study||156
52380|NCT02451007|125022|P1|NOT COMPLETED|Overall Study||7
52381|NCT02451007|125022|P1|COMPLETED|Overall Study||32
52382|NCT02451007|125022|P1|STARTED|Overall Study||39
52383|NCT02450799|125032|P3|NOT COMPLETED|Overall Study||0
52384|NCT02450799|125033|P2|NOT COMPLETED|Overall Study||0
52385|NCT02450799|125034|P1|NOT COMPLETED|Overall Study||0
52386|NCT02450799|125032|P3|COMPLETED|Overall Study||30
52387|NCT02450799|125033|P2|COMPLETED|Overall Study||37
52388|NCT02450799|125034|P1|COMPLETED|Overall Study||31
52389|NCT02450799|125032|P3|STARTED|Overall Study||30
52390|NCT02450799|125033|P2|STARTED|Overall Study||37
52391|NCT02450799|125034|P1|STARTED|Overall Study||31
52392|NCT02450747|125045|P1|NOT COMPLETED|Overall Study||0
52393|NCT02450747|125045|P1|COMPLETED|Overall Study||39
52394|NCT02450747|125045|P1|STARTED|Overall Study||39
52395|NCT02450591|125054|P1|NOT COMPLETED|Overall Study||0
52396|NCT02450591|125054|P1|COMPLETED|Overall Study||4
52397|NCT02450591|125054|P1|STARTED|Overall Study||4
52398|NCT02450552|125061|P3|NOT COMPLETED|Overall Study||5
52399|NCT02450552|125062|P2|NOT COMPLETED|Overall Study||0
52400|NCT02450552|125063|P1|NOT COMPLETED|Overall Study||5
52401|NCT02450552|125061|P3|COMPLETED|Overall Study||18
52402|NCT02450552|125062|P2|COMPLETED|Overall Study||23
52403|NCT02450552|125063|P1|COMPLETED|Overall Study||14
52404|NCT02450552|125061|P3|STARTED|Overall Study||23
52405|NCT02450552|125062|P2|STARTED|Overall Study||23
52406|NCT02450552|125063|P1|STARTED|Overall Study||19
52407|NCT02450539|125106|P2|NOT COMPLETED|Overall Study||33
52408|NCT02450539|125107|P1|NOT COMPLETED|Overall Study||50
52409|NCT02450539|125106|P2|COMPLETED|Overall Study||20
52410|NCT02450539|125107|P1|COMPLETED|Overall Study||56
52411|NCT02450539|125106|P2|Death|Overall Study||20
52412|NCT02450539|125107|P1|Death|Overall Study||56
52413|NCT02450539|125106|P2|Received at Least One Dose of Study Drug|Overall Study||52
52414|NCT02450539|125107|P1|Received at Least One Dose of Study Drug|Overall Study||106
52415|NCT02450539|125106|P2|STARTED|Overall Study||53
52416|NCT02450539|125107|P1|STARTED|Overall Study||106
52417|NCT02450526|125131|P5|NOT COMPLETED|OL Period (Cycles 2-5)||41
52418|NCT02450526|125132|P4|NOT COMPLETED|OL Period (Cycles 2-5)||0
52419|NCT02450526|125133|P3|NOT COMPLETED|OL Period (Cycles 2-5)||0
52420|NCT02450526|125134|P2|NOT COMPLETED|OL Period (Cycles 2-5)||0
52421|NCT02450526|125135|P1|NOT COMPLETED|OL Period (Cycles 2-5)||0
52422|NCT02450526|125131|P5|COMPLETED|OL Period (Cycles 2-5)||424
52423|NCT02450526|125132|P4|COMPLETED|OL Period (Cycles 2-5)||0
52424|NCT02450526|125133|P3|COMPLETED|OL Period (Cycles 2-5)||0
52425|NCT02450526|125134|P2|COMPLETED|OL Period (Cycles 2-5)||0
52426|NCT02450526|125135|P1|COMPLETED|OL Period (Cycles 2-5)||0
52427|NCT02450526|125131|P5|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
52428|NCT02450526|125132|P4|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
52429|NCT02450526|125133|P3|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
52430|NCT02450526|125134|P2|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
52431|NCT02450526|125135|P1|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
52432|NCT02450526|125131|P5|Discontinued During Cycle 4|OL Period (Cycles 2-5)||2
52433|NCT02450526|125132|P4|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
52434|NCT02450526|125133|P3|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
52435|NCT02450526|125134|P2|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
52436|NCT02450526|125135|P1|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
52437|NCT02450526|125131|P5|Discontinued During Cycle 3|OL Period (Cycles 2-5)||11
52438|NCT02450526|125132|P4|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
52439|NCT02450526|125133|P3|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
52440|NCT02450526|125134|P2|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
52441|NCT02450526|125135|P1|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
52442|NCT02450526|125131|P5|Discontinued During Cycle 2|OL Period (Cycles 2-5)||28
52443|NCT02450526|125132|P4|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
52444|NCT02450526|125133|P3|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
52445|NCT02450526|125134|P2|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
52446|NCT02450526|125135|P1|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
52447|NCT02450526|125131|P5|Safety Population|OL Period (Cycles 2-5)||465
52448|NCT02450526|125132|P4|Safety Population|OL Period (Cycles 2-5)||0
52449|NCT02450526|125133|P3|Safety Population|OL Period (Cycles 2-5)||0
52450|NCT02450526|125134|P2|Safety Population|OL Period (Cycles 2-5)||0
52451|NCT02450526|125135|P1|Safety Population|OL Period (Cycles 2-5)||0
52452|NCT02450526|125131|P5|STARTED|OL Period (Cycles 2-5)|Nine subjects completed the DB Period but were not eligible for retreatment in the OL Period.|465
52453|NCT02450526|125132|P4|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
52454|NCT02450526|125133|P3|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
52455|NCT02450526|125134|P2|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
52456|NCT02450526|125135|P1|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
52457|NCT02450526|125131|P5|NOT COMPLETED|DB Period (Cycle 1)||0
52458|NCT02450526|125132|P4|NOT COMPLETED|DB Period (Cycle 1)||2
52459|NCT02450526|125133|P3|NOT COMPLETED|DB Period (Cycle 1)||10
52460|NCT02450526|125134|P2|NOT COMPLETED|DB Period (Cycle 1)||3
52461|NCT02450526|125135|P1|NOT COMPLETED|DB Period (Cycle 1)||31
52462|NCT02450526|125131|P5|COMPLETED|DB Period (Cycle 1)|This arm was not included in DB Period (Cycle 1).|0
52463|NCT02450526|125132|P4|COMPLETED|DB Period (Cycle 1)||20
52464|NCT02450526|125133|P3|COMPLETED|DB Period (Cycle 1)||97
52465|NCT02450526|125134|P2|COMPLETED|DB Period (Cycle 1)||63
52466|NCT02450526|125135|P1|COMPLETED|DB Period (Cycle 1)||294
52467|NCT02450526|125131|P5|Safety Population|DB Period (Cycle 1)||0
52468|NCT02450526|125132|P4|Safety Population|DB Period (Cycle 1)||21
52469|NCT02450526|125133|P3|Safety Population|DB Period (Cycle 1)||107
52470|NCT02450526|125134|P2|Safety Population|DB Period (Cycle 1)||66
52471|NCT02450526|125135|P1|Safety Population|DB Period (Cycle 1)||326
52472|NCT02450526|125131|P5|STARTED|DB Period (Cycle 1)|This arm was not included in DB Period (Cycle 1).|0
52473|NCT02450526|125132|P4|STARTED|DB Period (Cycle 1)||22
52474|NCT02450526|125133|P3|STARTED|DB Period (Cycle 1)||107
52475|NCT02450526|125134|P2|STARTED|DB Period (Cycle 1)||66
52476|NCT02450526|125135|P1|STARTED|DB Period (Cycle 1)||325
52477|NCT02450383|125222|P2|NOT COMPLETED|Overall Study||0
52478|NCT02450383|125223|P1|NOT COMPLETED|Overall Study||0
52479|NCT02450383|125222|P2|COMPLETED|Overall Study||10
52480|NCT02450383|125223|P1|COMPLETED|Overall Study||10
52481|NCT02450383|125222|P2|STARTED|Overall Study||10
52482|NCT02450383|125223|P1|STARTED|Overall Study||10
52483|NCT02449915|125237|P2|NOT COMPLETED|Overall Study||4
52484|NCT02449915|125238|P1|NOT COMPLETED|Overall Study||2
52485|NCT02449915|125237|P2|COMPLETED|Overall Study||31
52486|NCT02449915|125238|P1|COMPLETED|Overall Study||33
52487|NCT02449915|125237|P2|STARTED|Overall Study||35
52488|NCT02449915|125238|P1|STARTED|Overall Study||35
52489|NCT02449902|125246|P2|NOT COMPLETED|Overall Study||2
52490|NCT02449902|125247|P1|NOT COMPLETED|Overall Study||0
52491|NCT02449902|125246|P2|COMPLETED|Overall Study||24
52492|NCT02449902|125247|P1|COMPLETED|Overall Study||24
52493|NCT02449902|125246|P2|STARTED|Overall Study||26
52494|NCT02449902|125247|P1|STARTED|Overall Study||24
52495|NCT02449889|125274|P3|NOT COMPLETED|Overall Study||1
52496|NCT02449889|125275|P2|NOT COMPLETED|Overall Study||6
52497|NCT02449889|125276|P1|NOT COMPLETED|Overall Study||1
52498|NCT02449889|125274|P3|COMPLETED|Overall Study||59
52499|NCT02449889|125275|P2|COMPLETED|Overall Study||52
52500|NCT02449889|125276|P1|COMPLETED|Overall Study||57
52501|NCT02449889|125274|P3|STARTED|Overall Study||60
52502|NCT02449889|125275|P2|STARTED|Overall Study||58
52503|NCT02449889|125276|P1|STARTED|Overall Study||58
52504|NCT02449798|125302|P1|NOT COMPLETED|Overall Study||0
52505|NCT02449798|125302|P1|COMPLETED|Overall Study||120
52506|NCT02449798|125302|P1|STARTED|Overall Study||120
52507|NCT02449473|125316|P2|NOT COMPLETED|Overall Study||0
52508|NCT02449473|125317|P1|NOT COMPLETED|Overall Study||0
52509|NCT02449473|125316|P2|COMPLETED|Overall Study||40
52510|NCT02449473|125317|P1|COMPLETED|Overall Study||39
52511|NCT02449473|125316|P2|STARTED|Overall Study||40
52512|NCT02449473|125317|P1|STARTED|Overall Study||39
52513|NCT02449356|125333|P2|NOT COMPLETED|Overall Study||0
52514|NCT02449356|125334|P1|NOT COMPLETED|Overall Study||0
52515|NCT02449356|125333|P2|COMPLETED|Overall Study||30
52516|NCT02449356|125334|P1|COMPLETED|Overall Study||30
52517|NCT02449356|125333|P2|STARTED|Overall Study||30
52518|NCT02449356|125334|P1|STARTED|Overall Study||30
52519|NCT02449291|125353|P3|NOT COMPLETED|Overall Study||1
52520|NCT02449291|125354|P2|NOT COMPLETED|Overall Study||2
52521|NCT02449291|125355|P1|NOT COMPLETED|Overall Study||5
52522|NCT02449291|125353|P3|COMPLETED|Overall Study||180
52523|NCT02449291|125354|P2|COMPLETED|Overall Study||186
52524|NCT02449291|125355|P1|COMPLETED|Overall Study||186
52525|NCT02449291|125353|P3|STARTED|Overall Study||181
52526|NCT02449291|125354|P2|STARTED|Overall Study||188
52527|NCT02449291|125355|P1|STARTED|Overall Study||191
52528|NCT02449174|125392|P2|NOT COMPLETED|Overall Study||0
52529|NCT02449174|125393|P1|NOT COMPLETED|Overall Study||0
52530|NCT02449174|125392|P2|COMPLETED|Overall Study||32
52531|NCT02449174|125393|P1|COMPLETED|Overall Study||36
52532|NCT02449174|125392|P2|STARTED|Overall Study||32
52533|NCT02449174|125393|P1|STARTED|Overall Study||36
52534|NCT02449044|125401|P1|NOT COMPLETED|Overall Study||64
52535|NCT02449044|125401|P1|COMPLETED|Overall Study|Participants who completed Weeks 58, 106 and 216 visit.|47
52536|NCT02449044|125401|P1|STARTED|Overall Study||111
52537|NCT02449018|125422|P2|NOT COMPLETED|Overall Study||2
52538|NCT02449018|125423|P1|NOT COMPLETED|Overall Study||12
52539|NCT02449018|125422|P2|COMPLETED|Overall Study||26
52540|NCT02449018|125423|P1|COMPLETED|Overall Study||52
52541|NCT02449018|125422|P2|STARTED|Overall Study||28
52542|NCT02449018|125423|P1|STARTED|Overall Study||64
52543|NCT02448914|125450|P2|NOT COMPLETED|Second Intervention (1 Day)||0
52544|NCT02448914|125451|P1|NOT COMPLETED|Second Intervention (1 Day)||0
52545|NCT02448914|125450|P2|COMPLETED|Second Intervention (1 Day)||5
52546|NCT02448914|125451|P1|COMPLETED|Second Intervention (1 Day)||6
52547|NCT02448914|125450|P2|STARTED|Second Intervention (1 Day)||5
52548|NCT02448914|125451|P1|STARTED|Second Intervention (1 Day)||6
52549|NCT02448914|125450|P2|NOT COMPLETED|First Intervention (1 Day)||0
52550|NCT02448914|125451|P1|NOT COMPLETED|First Intervention (1 Day)||0
52551|NCT02448914|125450|P2|COMPLETED|First Intervention (1 Day)||5
52552|NCT02448914|125451|P1|COMPLETED|First Intervention (1 Day)||6
52553|NCT02448914|125450|P2|STARTED|First Intervention (1 Day)||5
52554|NCT02448914|125451|P1|STARTED|First Intervention (1 Day)||6
52555|NCT02448875|125470|P3|NOT COMPLETED|Overall Study||1
52556|NCT02448875|125471|P2|NOT COMPLETED|Overall Study||1
52557|NCT02448875|125472|P1|NOT COMPLETED|Overall Study||7
52558|NCT02448875|125470|P3|COMPLETED|Overall Study||60
52559|NCT02448875|125471|P2|COMPLETED|Overall Study||20
52560|NCT02448875|125472|P1|COMPLETED|Overall Study||53
52561|NCT02448875|125470|P3|Safety Analysis Set|Overall Study||61
52562|NCT02448875|125471|P2|Safety Analysis Set|Overall Study||21
52563|NCT02448875|125472|P1|Safety Analysis Set|Overall Study||60
52564|NCT02448875|125470|P3|Full Analysis Set|Overall Study||61
52565|NCT02448875|125471|P2|Full Analysis Set|Overall Study||21
52566|NCT02448875|125472|P1|Full Analysis Set|Overall Study||60
52567|NCT02448875|125470|P3|Completed Dose Selection Phase|Overall Study||20
52568|NCT02448875|125471|P2|Completed Dose Selection Phase|Overall Study||21
52569|NCT02448875|125472|P1|Completed Dose Selection Phase|Overall Study||20
52570|NCT02448875|125470|P3|STARTED|Overall Study||61
52571|NCT02448875|125471|P2|STARTED|Overall Study||21
52572|NCT02448875|125472|P1|STARTED|Overall Study||60
52573|NCT02448862|125497|P2|NOT COMPLETED|Overall Study||0
52574|NCT02448862|125498|P1|NOT COMPLETED|Overall Study||0
52575|NCT02448862|125497|P2|COMPLETED|Overall Study||6050
52576|NCT02448862|125498|P1|COMPLETED|Overall Study||4525
52577|NCT02448862|125497|P2|STARTED|Overall Study||6050
52578|NCT02448862|125498|P1|STARTED|Overall Study||4525
52579|NCT02448810|125520|P8|NOT COMPLETED|Overall Study||8
52580|NCT02448810|125521|P7|NOT COMPLETED|Overall Study||18
52581|NCT02448810|125522|P6|NOT COMPLETED|Overall Study||16
52582|NCT02448810|125523|P5|NOT COMPLETED|Overall Study||31
52583|NCT02448810|125524|P4|NOT COMPLETED|Overall Study||3
52584|NCT02448810|125525|P3|NOT COMPLETED|Overall Study||3
52585|NCT02448810|125526|P2|NOT COMPLETED|Overall Study||3
52586|NCT02448810|125527|P1|NOT COMPLETED|Overall Study||3
52587|NCT02448810|125520|P8|COMPLETED|Overall Study||0
52588|NCT02448810|125521|P7|COMPLETED|Overall Study||0
52589|NCT02448810|125522|P6|COMPLETED|Overall Study||0
52590|NCT02448810|125523|P5|COMPLETED|Overall Study||0
52591|NCT02448810|125524|P4|COMPLETED|Overall Study||0
52592|NCT02448810|125525|P3|COMPLETED|Overall Study||0
52593|NCT02448810|125526|P2|COMPLETED|Overall Study||0
52594|NCT02448810|125527|P1|COMPLETED|Overall Study||0
52595|NCT02448810|125520|P8|Treated|Overall Study||7
52596|NCT02448810|125521|P7|Treated|Overall Study||18
52597|NCT02448810|125522|P6|Treated|Overall Study||13
52598|NCT02448810|125523|P5|Treated|Overall Study||29
52599|NCT02448810|125524|P4|Treated|Overall Study||3
52600|NCT02448810|125525|P3|Treated|Overall Study||3
52601|NCT02448810|125526|P2|Treated|Overall Study||3
52602|NCT02448810|125527|P1|Treated|Overall Study||3
52603|NCT02448810|125520|P8|STARTED|Overall Study||8
52604|NCT02448810|125521|P7|STARTED|Overall Study||18
52605|NCT02448810|125522|P6|STARTED|Overall Study||16
52606|NCT02448810|125523|P5|STARTED|Overall Study||31
52607|NCT02448810|125524|P4|STARTED|Overall Study||3
52608|NCT02448810|125525|P3|STARTED|Overall Study||3
52609|NCT02448810|125526|P2|STARTED|Overall Study||3
52610|NCT02448810|125527|P1|STARTED|Overall Study||3
52611|NCT02448719|125604|P11|NOT COMPLETED|Overall Study||0
52612|NCT02448719|125605|P10|NOT COMPLETED|Overall Study||0
52613|NCT02448719|125606|P9|NOT COMPLETED|Overall Study||0
52614|NCT02448719|125607|P8|NOT COMPLETED|Overall Study||0
52615|NCT02448719|125608|P7|NOT COMPLETED|Overall Study||0
52616|NCT02448719|125609|P6|NOT COMPLETED|Overall Study||0
52617|NCT02448719|125610|P5|NOT COMPLETED|Overall Study||1
52618|NCT02448719|125611|P4|NOT COMPLETED|Overall Study||0
52619|NCT02448719|125612|P3|NOT COMPLETED|Overall Study||0
52620|NCT02448719|125613|P2|NOT COMPLETED|Overall Study||0
52621|NCT02448719|125614|P1|NOT COMPLETED|Overall Study||0
52622|NCT02448719|125604|P11|COMPLETED|Overall Study||6
52623|NCT02448719|125605|P10|COMPLETED|Overall Study||6
52624|NCT02448719|125606|P9|COMPLETED|Overall Study||6
52625|NCT02448719|125607|P8|COMPLETED|Overall Study||6
52626|NCT02448719|125608|P7|COMPLETED|Overall Study||6
52627|NCT02448719|125609|P6|COMPLETED|Overall Study||6
52628|NCT02448719|125610|P5|COMPLETED|Overall Study||5
52629|NCT02448719|125611|P4|COMPLETED|Overall Study||6
52630|NCT02448719|125612|P3|COMPLETED|Overall Study||6
52631|NCT02448719|125613|P2|COMPLETED|Overall Study||6
52632|NCT02448719|125614|P1|COMPLETED|Overall Study||12
52633|NCT02448719|125604|P11|STARTED|Overall Study||6
52634|NCT02448719|125605|P10|STARTED|Overall Study||6
52635|NCT02448719|125606|P9|STARTED|Overall Study||6
52636|NCT02448719|125607|P8|STARTED|Overall Study||6
52637|NCT02448719|125608|P7|STARTED|Overall Study||6
52638|NCT02448719|125609|P6|STARTED|Overall Study||6
52639|NCT02448719|125610|P5|STARTED|Overall Study||6
52640|NCT02448719|125611|P4|STARTED|Overall Study||6
52641|NCT02448719|125612|P3|STARTED|Overall Study||6
52642|NCT02448719|125613|P2|STARTED|Overall Study||6
52643|NCT02448719|125614|P1|STARTED|Overall Study||12
52644|NCT02448563|125842|P2|NOT COMPLETED|Overall Study||11
52645|NCT02448563|125843|P1|NOT COMPLETED|Overall Study||16
52646|NCT02448563|125842|P2|COMPLETED|Overall Study||19
52647|NCT02448563|125843|P1|COMPLETED|Overall Study||16
52648|NCT02448563|125842|P2|STARTED|Overall Study|Randomized after completing Visit 2|30
52649|NCT02448563|125843|P1|STARTED|Overall Study|Randomized after completing Visit 2|32
52650|NCT02448537|125865|P3|NOT COMPLETED|Overall Study||1
52651|NCT02448537|125866|P2|NOT COMPLETED|Overall Study||1
52652|NCT02448537|125867|P1|NOT COMPLETED|Overall Study||1
52653|NCT02448537|125865|P3|COMPLETED|Overall Study||11
52654|NCT02448537|125866|P2|COMPLETED|Overall Study||9
52655|NCT02448537|125867|P1|COMPLETED|Overall Study||19
52656|NCT02448537|125865|P3|STARTED|Overall Study||12
52657|NCT02448537|125866|P2|STARTED|Overall Study||10
52658|NCT02448537|125867|P1|STARTED|Overall Study||20
52659|NCT02448368|125883|P13|NOT COMPLETED|Overall Study||0
52660|NCT02448368|125884|P12|NOT COMPLETED|Overall Study||0
52661|NCT02448368|125885|P11|NOT COMPLETED|Overall Study||0
52662|NCT02448368|125886|P10|NOT COMPLETED|Overall Study||0
52663|NCT02448368|125887|P9|NOT COMPLETED|Overall Study||0
52664|NCT02448368|125888|P8|NOT COMPLETED|Overall Study||0
52665|NCT02448368|125889|P7|NOT COMPLETED|Overall Study||0
52666|NCT02448368|125890|P6|NOT COMPLETED|Overall Study||0
52667|NCT02448368|125891|P5|NOT COMPLETED|Overall Study||0
52668|NCT02448368|125892|P4|NOT COMPLETED|Overall Study||0
52669|NCT02448368|125893|P3|NOT COMPLETED|Overall Study||0
52670|NCT02448368|125894|P2|NOT COMPLETED|Overall Study||0
52671|NCT02448368|125895|P1|NOT COMPLETED|Overall Study||0
52672|NCT02448368|125883|P13|COMPLETED|Overall Study||5
52673|NCT02448368|125884|P12|COMPLETED|Overall Study||5
52674|NCT02448368|125885|P11|COMPLETED|Overall Study||5
52675|NCT02448368|125886|P10|COMPLETED|Overall Study||2
52676|NCT02448368|125887|P9|COMPLETED|Overall Study||2
52677|NCT02448368|125888|P8|COMPLETED|Overall Study||2
52678|NCT02448368|125889|P7|COMPLETED|Overall Study||2
52679|NCT02448368|125890|P6|COMPLETED|Overall Study||2
52680|NCT02448368|125891|P5|COMPLETED|Overall Study||2
52681|NCT02448368|125892|P4|COMPLETED|Overall Study||2
52682|NCT02448368|125893|P3|COMPLETED|Overall Study||2
52683|NCT02448368|125894|P2|COMPLETED|Overall Study||2
52684|NCT02448368|125895|P1|COMPLETED|Overall Study||2
52685|NCT02448368|125883|P13|STARTED|Overall Study||5
52686|NCT02448368|125884|P12|STARTED|Overall Study||5
52687|NCT02448368|125885|P11|STARTED|Overall Study||5
52688|NCT02448368|125886|P10|STARTED|Overall Study||2
52689|NCT02448368|125887|P9|STARTED|Overall Study||2
52690|NCT02448368|125888|P8|STARTED|Overall Study||2
52691|NCT02448368|125889|P7|STARTED|Overall Study||2
52692|NCT02448368|125890|P6|STARTED|Overall Study||2
52693|NCT02448368|125891|P5|STARTED|Overall Study||2
52694|NCT02448368|125892|P4|STARTED|Overall Study||2
52695|NCT02448368|125893|P3|STARTED|Overall Study||2
52696|NCT02448368|125894|P2|STARTED|Overall Study||2
52697|NCT02448368|125895|P1|STARTED|Overall Study||2
52698|NCT02448303|125972|P2|NOT COMPLETED|Overall Study||36
52699|NCT02448303|125973|P1|NOT COMPLETED|Overall Study||38
52700|NCT02448303|125972|P2|COMPLETED|Overall Study||0
52701|NCT02448303|125973|P1|COMPLETED|Overall Study||0
52702|NCT02448303|125972|P2|Discontinued Study|Overall Study||36
52703|NCT02448303|125973|P1|Discontinued Study|Overall Study||38
52704|NCT02448303|125972|P2|Received Study Medication|Overall Study||35
52705|NCT02448303|125973|P1|Received Study Medication|Overall Study||33
52706|NCT02448303|125972|P2|Enrolled|Overall Study||36
52707|NCT02448303|125973|P1|Enrolled|Overall Study||38
52708|NCT02448303|125972|P2|STARTED|Overall Study||36
52709|NCT02448303|125973|P1|STARTED|Overall Study||38
52710|NCT02447952|125979|P1|NOT COMPLETED|Overall Study||7
52711|NCT02447952|125979|P1|COMPLETED|Overall Study||18
52712|NCT02447952|125979|P1|STARTED|Overall Study||25
52713|NCT02447926|126031|P1|NOT COMPLETED|Overall Study||0
52714|NCT02447926|126031|P1|COMPLETED|Overall Study||1
52715|NCT02447926|126031|P1|STARTED|Overall Study||1
52716|NCT02447887|126036|P1|NOT COMPLETED|Overall Study||3
52717|NCT02447887|126036|P1|COMPLETED|Overall Study||0
52718|NCT02447887|126036|P1|STARTED|Overall Study||3
52719|NCT02447848|126049|P1|NOT COMPLETED|Overall Study||11
52720|NCT02447848|126049|P1|COMPLETED|Overall Study||65
52721|NCT02447848|126049|P1|STARTED|Overall Study||76
52722|NCT02447458|126061|P6|NOT COMPLETED|Overall Study||0
52723|NCT02447458|126062|P5|NOT COMPLETED|Overall Study||0
52724|NCT02447458|126063|P4|NOT COMPLETED|Overall Study||0
52725|NCT02447458|126064|P3|NOT COMPLETED|Overall Study||1
52726|NCT02447458|126065|P2|NOT COMPLETED|Overall Study||0
52727|NCT02447458|126066|P1|NOT COMPLETED|Overall Study||0
52728|NCT02447458|126061|P6|COMPLETED|Overall Study||10
52729|NCT02447458|126062|P5|COMPLETED|Overall Study||6
52730|NCT02447458|126063|P4|COMPLETED|Overall Study||6
52731|NCT02447458|126064|P3|COMPLETED|Overall Study||5
52732|NCT02447458|126065|P2|COMPLETED|Overall Study||6
52733|NCT02447458|126066|P1|COMPLETED|Overall Study||5
52734|NCT02447458|126061|P6|STARTED|Overall Study||10
52735|NCT02447458|126062|P5|STARTED|Overall Study||6
52736|NCT02447458|126063|P4|STARTED|Overall Study||6
52737|NCT02447458|126064|P3|STARTED|Overall Study||6
52738|NCT02447458|126065|P2|STARTED|Overall Study||6
52739|NCT02447458|126066|P1|STARTED|Overall Study||5
52740|NCT02447432|126164|P2|NOT COMPLETED|Epoch 002||0
52741|NCT02447432|126165|P1|NOT COMPLETED|Epoch 002||0
52742|NCT02447432|126164|P2|COMPLETED|Epoch 002||145
52743|NCT02447432|126165|P1|COMPLETED|Epoch 002||152
52744|NCT02447432|126164|P2|STARTED|Epoch 002||145
52745|NCT02447432|126165|P1|STARTED|Epoch 002||152
52746|NCT02447432|126164|P2|NOT COMPLETED|Epoch 001||13
52747|NCT02447432|126165|P1|NOT COMPLETED|Epoch 001||5
52748|NCT02447432|126164|P2|COMPLETED|Epoch 001||147
52749|NCT02447432|126165|P1|COMPLETED|Epoch 001||155
52750|NCT02447432|126164|P2|STARTED|Epoch 001||160
52751|NCT02447432|126165|P1|STARTED|Epoch 001||160
52752|NCT02447328|126197|P1|NOT COMPLETED|Overall Study||1
52753|NCT02447328|126197|P1|COMPLETED|Overall Study||82
52754|NCT02447328|126197|P1|STARTED|Overall Study|Enrolment 85 Screening Failure 2 starting study drug 83|83
52755|NCT02447250|126201|P1|NOT COMPLETED|Third Dose (360 mcg Albuterol)||5
52756|NCT02447250|126201|P1|COMPLETED|Third Dose (360 mcg Albuterol)||8
52757|NCT02447250|126201|P1|STARTED|Third Dose (360 mcg Albuterol)||13
52758|NCT02447250|126201|P1|NOT COMPLETED|Second Dose (270 mcg Albuterol)||1
52759|NCT02447250|126201|P1|COMPLETED|Second Dose (270 mcg Albuterol)||13
52760|NCT02447250|126201|P1|STARTED|Second Dose (270 mcg Albuterol)||14
52761|NCT02447250|126201|P1|NOT COMPLETED|First Dose (180 mcg Albuterol)||0
52762|NCT02447250|126201|P1|COMPLETED|First Dose (180 mcg Albuterol)||14
52763|NCT02447250|126201|P1|STARTED|First Dose (180 mcg Albuterol)||14
52764|NCT02447133|126212|P1|NOT COMPLETED|Overall Study||0
52765|NCT02447133|126212|P1|COMPLETED|Overall Study||12
52766|NCT02447133|126212|P1|STARTED|Overall Study||12
52767|NCT02447029|126220|P2|NOT COMPLETED|Overall Study||2
52768|NCT02447029|126221|P1|NOT COMPLETED|Overall Study||3
52769|NCT02447029|126220|P2|COMPLETED|Overall Study||68
52770|NCT02447029|126221|P1|COMPLETED|Overall Study||69
52771|NCT02447029|126220|P2|Treated|Overall Study||68
52772|NCT02447029|126221|P1|Treated|Overall Study||69
52773|NCT02447029|126220|P2|STARTED|Overall Study||70
52774|NCT02447029|126221|P1|STARTED|Overall Study||72
52775|NCT02446990|126241|P2|NOT COMPLETED|Overall Study||658
52776|NCT02446990|126242|P1|NOT COMPLETED|Overall Study||720
52777|NCT02446990|126241|P2|COMPLETED|Overall Study||8894
52778|NCT02446990|126242|P1|COMPLETED|Overall Study||8830
52779|NCT02446990|126241|P2|STARTED|Overall Study||9552
52780|NCT02446990|126242|P1|STARTED|Overall Study||9550
52781|NCT02446769|126274|P3|NOT COMPLETED|Study Period||0
52782|NCT02446769|126275|P2|NOT COMPLETED|Study Period||2
52783|NCT02446769|126276|P1|NOT COMPLETED|Study Period||0
52784|NCT02446769|126274|P3|COMPLETED|Study Period||3
52785|NCT02446769|126275|P2|COMPLETED|Study Period||2
52786|NCT02446769|126276|P1|COMPLETED|Study Period||0
52787|NCT02446769|126274|P3|STARTED|Study Period||3
52788|NCT02446769|126275|P2|STARTED|Study Period||4
52789|NCT02446769|126276|P1|STARTED|Study Period||0
52790|NCT02446769|126274|P3|NOT COMPLETED|Screening Period||0
52791|NCT02446769|126275|P2|NOT COMPLETED|Screening Period||0
52792|NCT02446769|126276|P1|NOT COMPLETED|Screening Period||11
52793|NCT02446769|126274|P3|COMPLETED|Screening Period||0
52794|NCT02446769|126275|P2|COMPLETED|Screening Period||0
52795|NCT02446769|126276|P1|COMPLETED|Screening Period||7
52796|NCT02446769|126274|P3|STARTED|Screening Period||0
52797|NCT02446769|126275|P2|STARTED|Screening Period||0
52798|NCT02446769|126276|P1|STARTED|Screening Period||18
52799|NCT02446743|126297|P2|NOT COMPLETED|Overall Study||5
52800|NCT02446743|126298|P1|NOT COMPLETED|Overall Study||5
52801|NCT02446743|126297|P2|COMPLETED|Overall Study||250
52802|NCT02446743|126298|P1|COMPLETED|Overall Study||271
52803|NCT02446743|126297|P2|STARTED|Overall Study||255
52804|NCT02446743|126298|P1|STARTED|Overall Study||276
52805|NCT02446717|126453|P5|NOT COMPLETED|Overall Study||1
52806|NCT02446717|126454|P4|NOT COMPLETED|Overall Study||1
52807|NCT02446717|126455|P3|NOT COMPLETED|Overall Study||2
52808|NCT02446717|126456|P2|NOT COMPLETED|Overall Study||1
52809|NCT02446717|126457|P1|NOT COMPLETED|Overall Study||0
52810|NCT02446717|126453|P5|COMPLETED|Overall Study||46
52811|NCT02446717|126454|P4|COMPLETED|Overall Study||43
52812|NCT02446717|126455|P3|COMPLETED|Overall Study||20
52813|NCT02446717|126456|P2|COMPLETED|Overall Study||21
52814|NCT02446717|126457|P1|COMPLETED|Overall Study||6
52815|NCT02446717|126453|P5|STARTED|Overall Study||47
52816|NCT02446717|126454|P4|STARTED|Overall Study||44
52817|NCT02446717|126455|P3|STARTED|Overall Study||22
52818|NCT02446717|126456|P2|STARTED|Overall Study||22
52819|NCT02446717|126457|P1|STARTED|Overall Study||6
52820|NCT02446691|126484|P1|NOT COMPLETED|Overall Study||11
52821|NCT02446691|126484|P1|COMPLETED|Overall Study||117
52822|NCT02446691|126484|P1|STARTED|Overall Study||128
52823|NCT02446613|126504|P2|NOT COMPLETED|Overall Study||0
52824|NCT02446613|126505|P1|NOT COMPLETED|Overall Study||0
52825|NCT02446613|126504|P2|COMPLETED|Overall Study||10
52826|NCT02446613|126505|P1|COMPLETED|Overall Study||6
52827|NCT02446613|126504|P2|STARTED|Overall Study||10
52828|NCT02446613|126505|P1|STARTED|Overall Study||6
52829|NCT02446496|126527|P1|NOT COMPLETED|Overall Study||0
52830|NCT02446496|126527|P1|COMPLETED|Overall Study||24
52831|NCT02446496|126527|P1|STARTED|Overall Study||24
52832|NCT02446483|126539|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
52833|NCT02446483|126540|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
52834|NCT02446483|126539|P2|COMPLETED|Period 3: Intervention Period 2||30
52835|NCT02446483|126540|P1|COMPLETED|Period 3: Intervention Period 2||30
52836|NCT02446483|126539|P2|STARTED|Period 3: Intervention Period 2||30
52837|NCT02446483|126540|P1|STARTED|Period 3: Intervention Period 2||30
52838|NCT02446483|126539|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
52839|NCT02446483|126540|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
52840|NCT02446483|126539|P2|COMPLETED|Period 2: Washout Period (7 Days)||30
52841|NCT02446483|126540|P1|COMPLETED|Period 2: Washout Period (7 Days)||30
52842|NCT02446483|126539|P2|STARTED|Period 2: Washout Period (7 Days)||30
52843|NCT02446483|126540|P1|STARTED|Period 2: Washout Period (7 Days)||30
52844|NCT02446483|126539|P2|NOT COMPLETED|Period 1: Intervention Period 1||0
52845|NCT02446483|126540|P1|NOT COMPLETED|Period 1: Intervention Period 1||0
52846|NCT02446483|126539|P2|COMPLETED|Period 1: Intervention Period 1||30
52847|NCT02446483|126540|P1|COMPLETED|Period 1: Intervention Period 1||30
52848|NCT02446483|126539|P2|STARTED|Period 1: Intervention Period 1||30
52849|NCT02446483|126540|P1|STARTED|Period 1: Intervention Period 1||30
52850|NCT02446418|126554|P2|NOT COMPLETED|Overall Study||16
52851|NCT02446418|126555|P1|NOT COMPLETED|Overall Study||18
52852|NCT02446418|126554|P2|COMPLETED|Overall Study||194
52853|NCT02446418|126555|P1|COMPLETED|Overall Study||192
52854|NCT02446418|126554|P2|STARTED|Overall Study||210
52855|NCT02446418|126555|P1|STARTED|Overall Study||210
52856|NCT02446314|126569|P4|NOT COMPLETED|Thirteen to Twenty Four Weeks||1
52857|NCT02446314|126570|P3|NOT COMPLETED|Thirteen to Twenty Four Weeks||2
52858|NCT02446314|126571|P2|NOT COMPLETED|Thirteen to Twenty Four Weeks||1
52859|NCT02446314|126572|P1|NOT COMPLETED|Thirteen to Twenty Four Weeks||0
52860|NCT02446314|126569|P4|COMPLETED|Thirteen to Twenty Four Weeks||28
52861|NCT02446314|126570|P3|COMPLETED|Thirteen to Twenty Four Weeks||29
52862|NCT02446314|126571|P2|COMPLETED|Thirteen to Twenty Four Weeks||28
52863|NCT02446314|126572|P1|COMPLETED|Thirteen to Twenty Four Weeks||27
52864|NCT02446314|126569|P4|STARTED|Thirteen to Twenty Four Weeks||29
52865|NCT02446314|126570|P3|STARTED|Thirteen to Twenty Four Weeks||31
52866|NCT02446314|126571|P2|STARTED|Thirteen to Twenty Four Weeks||29
52867|NCT02446314|126572|P1|STARTED|Thirteen to Twenty Four Weeks||27
52868|NCT02446314|126569|P4|NOT COMPLETED|Zero to Twelve Weeks.||2
52869|NCT02446314|126570|P3|NOT COMPLETED|Zero to Twelve Weeks.||0
52870|NCT02446314|126571|P2|NOT COMPLETED|Zero to Twelve Weeks.||1
52871|NCT02446314|126572|P1|NOT COMPLETED|Zero to Twelve Weeks.||3
52872|NCT02446314|126569|P4|COMPLETED|Zero to Twelve Weeks.||29
52873|NCT02446314|126570|P3|COMPLETED|Zero to Twelve Weeks.||31
52874|NCT02446314|126571|P2|COMPLETED|Zero to Twelve Weeks.||29
52875|NCT02446314|126572|P1|COMPLETED|Zero to Twelve Weeks.||27
52876|NCT02446314|126569|P4|STARTED|Zero to Twelve Weeks.||31
52877|NCT02446314|126570|P3|STARTED|Zero to Twelve Weeks.||31
52878|NCT02446314|126571|P2|STARTED|Zero to Twelve Weeks.||30
52879|NCT02446314|126572|P1|STARTED|Zero to Twelve Weeks.||30
52880|NCT02446223|126618|P1|NOT COMPLETED|Overall Study||1
52881|NCT02446223|126618|P1|COMPLETED|Overall Study||20
52882|NCT02446223|126618|P1|STARTED|Overall Study||21
52883|NCT02446171|126626|P4|NOT COMPLETED|Overall Study||0
52884|NCT02446171|126627|P3|NOT COMPLETED|Overall Study||2
52885|NCT02446171|126628|P2|NOT COMPLETED|Overall Study||0
52886|NCT02446171|126629|P1|NOT COMPLETED|Overall Study||0
52887|NCT02446171|126626|P4|COMPLETED|Overall Study||11
52888|NCT02446171|126627|P3|COMPLETED|Overall Study||9
52889|NCT02446171|126628|P2|COMPLETED|Overall Study||11
52890|NCT02446171|126629|P1|COMPLETED|Overall Study||11
52891|NCT02446171|126626|P4|STARTED|Overall Study||11
52892|NCT02446171|126627|P3|STARTED|Overall Study||11
52893|NCT02446171|126628|P2|STARTED|Overall Study||11
52894|NCT02446171|126629|P1|STARTED|Overall Study||11
52895|NCT02446015|126700|P2|NOT COMPLETED|Overall Study||1
52896|NCT02446015|126701|P1|NOT COMPLETED|Overall Study||1
52897|NCT02446015|126700|P2|COMPLETED|Overall Study||62
52898|NCT02446015|126701|P1|COMPLETED|Overall Study||33
52899|NCT02446015|126700|P2|STARTED|Overall Study||63
52900|NCT02446015|126701|P1|STARTED|Overall Study||34
52901|NCT02445911|126716|P4|NOT COMPLETED|Overall Study||0
52902|NCT02445911|126717|P3|NOT COMPLETED|Overall Study||0
52903|NCT02445911|126718|P2|NOT COMPLETED|Overall Study||0
52904|NCT02445911|126719|P1|NOT COMPLETED|Overall Study||0
52905|NCT02445911|126716|P4|COMPLETED|Overall Study||20
52906|NCT02445911|126717|P3|COMPLETED|Overall Study||21
52907|NCT02445911|126718|P2|COMPLETED|Overall Study||20
52908|NCT02445911|126719|P1|COMPLETED|Overall Study||20
52909|NCT02445911|126716|P4|STARTED|Overall Study||20
52910|NCT02445911|126717|P3|STARTED|Overall Study||21
52911|NCT02445911|126718|P2|STARTED|Overall Study||20
52912|NCT02445911|126719|P1|STARTED|Overall Study||20
52913|NCT02445859|126791|P2|NOT COMPLETED|Overall Study||3
52914|NCT02445859|126792|P1|NOT COMPLETED|Overall Study||2
52915|NCT02445859|126791|P2|COMPLETED|Overall Study||42
52916|NCT02445859|126792|P1|COMPLETED|Overall Study||43
52917|NCT02445859|126791|P2|STARTED|Overall Study||45
52918|NCT02445859|126792|P1|STARTED|Overall Study||45
52919|NCT02445807|126800|P2|NOT COMPLETED|Overall Study||0
52920|NCT02445807|126801|P1|NOT COMPLETED|Overall Study||0
52921|NCT02445807|126800|P2|COMPLETED|Overall Study||89
52922|NCT02445807|126801|P1|COMPLETED|Overall Study||176
52923|NCT02445807|126800|P2|STARTED|Overall Study||89
52924|NCT02445807|126801|P1|STARTED|Overall Study||176
52925|NCT02445755|126811|P1|NOT COMPLETED|Overall Study||13
52926|NCT02445755|126811|P1|COMPLETED|Overall Study||100
52927|NCT02445755|126811|P1|STARTED|Overall Study|Neonates will be tested with 3 transcutaneous (TcB) devices +/-30 minutes of routine bilirubin labs|113
52928|NCT02445625|126818|P1|NOT COMPLETED|Overall Study||0
52929|NCT02445625|126818|P1|COMPLETED|Overall Study||15
52930|NCT02445625|126818|P1|STARTED|Overall Study||15
52931|NCT02445586|126825|P1|NOT COMPLETED|Overall Study||39
52932|NCT02445586|126825|P1|COMPLETED|Overall Study||13
52933|NCT02445586|126825|P1|Received at Least One Dose of Study Drug|Overall Study||52
52934|NCT02445586|126825|P1|STARTED|Overall Study||52
52935|NCT02445573|126865|P2|NOT COMPLETED|Overall Study||2
52936|NCT02445573|126866|P1|NOT COMPLETED|Overall Study||1
52937|NCT02445573|126865|P2|COMPLETED|Overall Study||38
52938|NCT02445573|126866|P1|COMPLETED|Overall Study||39
52939|NCT02445573|126865|P2|STARTED|Overall Study||40
52940|NCT02445573|126866|P1|STARTED|Overall Study||40
52941|NCT02445326|126882|P2|NOT COMPLETED|Overall Study||1
52942|NCT02445326|126883|P1|NOT COMPLETED|Overall Study||2
52943|NCT02445326|126882|P2|COMPLETED|Overall Study||37
52944|NCT02445326|126883|P1|COMPLETED|Overall Study||33
52945|NCT02445326|126882|P2|STARTED|Overall Study||38
52946|NCT02445326|126883|P1|STARTED|Overall Study||35
52947|NCT02445287|126901|P2|NOT COMPLETED|Overall Study||0
52948|NCT02445287|126902|P1|NOT COMPLETED|Overall Study||0
52949|NCT02445287|126901|P2|COMPLETED|Overall Study||13
52950|NCT02445287|126902|P1|COMPLETED|Overall Study||35
52951|NCT02445287|126901|P2|STARTED|Overall Study||13
52952|NCT02445287|126902|P1|STARTED|Overall Study||35
52953|NCT02445196|126917|P2|NOT COMPLETED|Overall Study||6
52954|NCT02445196|126918|P1|NOT COMPLETED|Overall Study||11
52955|NCT02445196|126917|P2|COMPLETED|Overall Study||52
52956|NCT02445196|126918|P1|COMPLETED|Overall Study||51
52957|NCT02445196|126917|P2|STARTED|Overall Study||58
52958|NCT02445196|126918|P1|STARTED|Overall Study||62
52959|NCT02445014|126931|P1|NOT COMPLETED|Overall Study||0
52960|NCT02445014|126931|P1|COMPLETED|Overall Study||3
52961|NCT02445014|126931|P1|STARTED|Overall Study||3
52962|NCT02444988|126937|P2|NOT COMPLETED|Overall Study||0
52963|NCT02444988|126938|P1|NOT COMPLETED|Overall Study||0
52964|NCT02444988|126937|P2|COMPLETED|Overall Study||2735
52965|NCT02444988|126938|P1|COMPLETED|Overall Study||2646
52966|NCT02444988|126937|P2|STARTED|Overall Study||2735
52967|NCT02444988|126938|P1|STARTED|Overall Study||2646
52968|NCT02444936|126948|P2|NOT COMPLETED|Overall Study||0
52969|NCT02444936|126949|P1|NOT COMPLETED|Overall Study||0
52970|NCT02444936|126948|P2|COMPLETED|Overall Study||12
52971|NCT02444936|126949|P1|COMPLETED|Overall Study||10
52972|NCT02444936|126948|P2|STARTED|Overall Study||12
52973|NCT02444936|126949|P1|STARTED|Overall Study||10
52974|NCT02444793|126959|P4|NOT COMPLETED|Overall Study||3
52975|NCT02444793|126960|P3|NOT COMPLETED|Overall Study||4
52976|NCT02444793|126961|P2|NOT COMPLETED|Overall Study||6
52977|NCT02444793|126962|P1|NOT COMPLETED|Overall Study||11
52978|NCT02444793|126959|P4|COMPLETED|Overall Study||0
52979|NCT02444793|126960|P3|COMPLETED|Overall Study||0
52980|NCT02444793|126961|P2|COMPLETED|Overall Study||0
52981|NCT02444793|126962|P1|COMPLETED|Overall Study||0
52982|NCT02444793|126959|P4|STARTED|Overall Study||3
52983|NCT02444793|126960|P3|STARTED|Overall Study||4
52984|NCT02444793|126961|P2|STARTED|Overall Study||6
52985|NCT02444793|126962|P1|STARTED|Overall Study||11
52986|NCT02444715|127089|P2|NOT COMPLETED|Overall Study||16
52987|NCT02444715|127090|P1|NOT COMPLETED|Overall Study||10
52988|NCT02444715|127089|P2|COMPLETED|Overall Study||32
52989|NCT02444715|127090|P1|COMPLETED|Overall Study||36
52990|NCT02444715|127089|P2|STARTED|Overall Study||48
52991|NCT02444715|127090|P1|STARTED|Overall Study||46
52992|NCT02444533|127121|P2|NOT COMPLETED|Overall Study||4
52993|NCT02444533|127122|P1|NOT COMPLETED|Overall Study||2
52994|NCT02444533|127121|P2|COMPLETED|Overall Study||18
52995|NCT02444533|127122|P1|COMPLETED|Overall Study||15
52996|NCT02444533|127121|P2|STARTED|Overall Study||22
52997|NCT02444533|127122|P1|STARTED|Overall Study||17
52998|NCT02444234|127136|P2|NOT COMPLETED|Second Intervention (3 Days)||0
52999|NCT02444234|127137|P1|NOT COMPLETED|Second Intervention (3 Days)||0
53000|NCT02444234|127136|P2|COMPLETED|Second Intervention (3 Days)||5
53001|NCT02444234|127137|P1|COMPLETED|Second Intervention (3 Days)||6
53002|NCT02444234|127136|P2|STARTED|Second Intervention (3 Days)||5
53003|NCT02444234|127137|P1|STARTED|Second Intervention (3 Days)||6
53004|NCT02444234|127136|P2|NOT COMPLETED|Washout (2 Day Minimum)||0
53005|NCT02444234|127137|P1|NOT COMPLETED|Washout (2 Day Minimum)||0
53006|NCT02444234|127136|P2|COMPLETED|Washout (2 Day Minimum)||5
53007|NCT02444234|127137|P1|COMPLETED|Washout (2 Day Minimum)||6
53008|NCT02444234|127136|P2|STARTED|Washout (2 Day Minimum)||5
53009|NCT02444234|127137|P1|STARTED|Washout (2 Day Minimum)||6
53010|NCT02444234|127136|P2|NOT COMPLETED|First Intervention (3 Days)||0
53011|NCT02444234|127137|P1|NOT COMPLETED|First Intervention (3 Days)||0
53012|NCT02444234|127136|P2|COMPLETED|First Intervention (3 Days)||5
53013|NCT02444234|127137|P1|COMPLETED|First Intervention (3 Days)||6
53014|NCT02444234|127136|P2|STARTED|First Intervention (3 Days)||5
53015|NCT02444234|127137|P1|STARTED|First Intervention (3 Days)||6
53016|NCT02444182|127155|P2|NOT COMPLETED|Overall Study||5
53017|NCT02444182|127156|P1|NOT COMPLETED|Overall Study||2
53018|NCT02444182|127155|P2|COMPLETED|Overall Study||49
53019|NCT02444182|127156|P1|COMPLETED|Overall Study||52
53020|NCT02444182|127155|P2|STARTED|Overall Study||54
53021|NCT02444182|127156|P1|STARTED|Overall Study||54
53022|NCT02444143|127166|P2|NOT COMPLETED|Overall Study||1
53023|NCT02444143|127167|P1|NOT COMPLETED|Overall Study||0
53024|NCT02444143|127166|P2|COMPLETED|Overall Study|1 patient withdrawal|9
53025|NCT02444143|127167|P1|COMPLETED|Overall Study||10
53026|NCT02444143|127166|P2|STARTED|Overall Study||10
53027|NCT02444143|127167|P1|STARTED|Overall Study||10
53028|NCT02443883|127179|P4|NOT COMPLETED|Overall Study||7
53029|NCT02443883|127180|P3|NOT COMPLETED|Overall Study||4
53030|NCT02443883|127181|P2|NOT COMPLETED|Overall Study||5
53031|NCT02443883|127182|P1|NOT COMPLETED|Overall Study||6
53032|NCT02443883|127179|P4|COMPLETED|Overall Study||34
53033|NCT02443883|127180|P3|COMPLETED|Overall Study||37
53034|NCT02443883|127181|P2|COMPLETED|Overall Study||37
53035|NCT02443883|127182|P1|COMPLETED|Overall Study||34
53036|NCT02443883|127179|P4|Received at Least One Dose of Study Drug|Overall Study||40
53037|NCT02443883|127180|P3|Received at Least One Dose of Study Drug|Overall Study||41
53038|NCT02443883|127181|P2|Received at Least One Dose of Study Drug|Overall Study||42
53039|NCT02443883|127182|P1|Received at Least One Dose of Study Drug|Overall Study||38
53040|NCT02443883|127179|P4|STARTED|Overall Study||41
53041|NCT02443883|127180|P3|STARTED|Overall Study||41
53042|NCT02443883|127181|P2|STARTED|Overall Study||42
53043|NCT02443883|127182|P1|STARTED|Overall Study||40
53044|NCT02443805|127202|P2|NOT COMPLETED|Overall Study||127
53045|NCT02443805|127203|P1|NOT COMPLETED|Overall Study||213
53046|NCT02443805|127202|P2|COMPLETED|Overall Study||678
53047|NCT02443805|127203|P1|COMPLETED|Overall Study||589
53048|NCT02443805|127202|P2|STARTED|Overall Study||805
53049|NCT02443805|127203|P1|STARTED|Overall Study||802
53050|NCT02443792|127215|P2|NOT COMPLETED|Overall Study||2
53051|NCT02443792|127216|P1|NOT COMPLETED|Overall Study||7
53052|NCT02443792|127215|P2|COMPLETED|Overall Study||23
53053|NCT02443792|127216|P1|COMPLETED|Overall Study||43
53054|NCT02443792|127215|P2|STARTED|Overall Study||25
53055|NCT02443792|127216|P1|STARTED|Overall Study||50
53056|NCT02443740|127234|P11|NOT COMPLETED|Intervention Period 4 (3 Days)||0
53057|NCT02443740|127235|P10|NOT COMPLETED|Intervention Period 4 (3 Days)||0
53058|NCT02443740|127236|P9|NOT COMPLETED|Intervention Period 4 (3 Days)||0
53059|NCT02443740|127237|P8|NOT COMPLETED|Intervention Period 4 (3 Days)||0
53060|NCT02443740|127238|P7|NOT COMPLETED|Intervention Period 4 (3 Days)||0
53061|NCT02443740|127239|P6|NOT COMPLETED|Intervention Period 4 (3 Days)||0
53062|NCT02443740|127240|P5|NOT COMPLETED|Intervention Period 4 (3 Days)||0
53063|NCT02443740|127241|P4|NOT COMPLETED|Intervention Period 4 (3 Days)||0
53064|NCT02443740|127242|P3|NOT COMPLETED|Intervention Period 4 (3 Days)||0
53065|NCT02443740|127243|P2|NOT COMPLETED|Intervention Period 4 (3 Days)||0
53066|NCT02443740|127244|P1|NOT COMPLETED|Intervention Period 4 (3 Days)||0
53067|NCT02443740|127234|P11|COMPLETED|Intervention Period 4 (3 Days)||0
53068|NCT02443740|127235|P10|COMPLETED|Intervention Period 4 (3 Days)||0
53069|NCT02443740|127236|P9|COMPLETED|Intervention Period 4 (3 Days)||0
53070|NCT02443740|127237|P8|COMPLETED|Intervention Period 4 (3 Days)||2
53071|NCT02443740|127238|P7|COMPLETED|Intervention Period 4 (3 Days)||2
53072|NCT02443740|127239|P6|COMPLETED|Intervention Period 4 (3 Days)||2
53073|NCT02443740|127240|P5|COMPLETED|Intervention Period 4 (3 Days)||2
53074|NCT02443740|127241|P4|COMPLETED|Intervention Period 4 (3 Days)||3
53075|NCT02443740|127242|P3|COMPLETED|Intervention Period 4 (3 Days)||2
53076|NCT02443740|127243|P2|COMPLETED|Intervention Period 4 (3 Days)||2
53077|NCT02443740|127244|P1|COMPLETED|Intervention Period 4 (3 Days)||1
53078|NCT02443740|127234|P11|STARTED|Intervention Period 4 (3 Days)||0
53079|NCT02443740|127235|P10|STARTED|Intervention Period 4 (3 Days)||0
53080|NCT02443740|127236|P9|STARTED|Intervention Period 4 (3 Days)||0
53081|NCT02443740|127237|P8|STARTED|Intervention Period 4 (3 Days)||2
53082|NCT02443740|127238|P7|STARTED|Intervention Period 4 (3 Days)||2
53083|NCT02443740|127239|P6|STARTED|Intervention Period 4 (3 Days)||2
53084|NCT02443740|127240|P5|STARTED|Intervention Period 4 (3 Days)||2
53085|NCT02443740|127241|P4|STARTED|Intervention Period 4 (3 Days)||3
53086|NCT02443740|127242|P3|STARTED|Intervention Period 4 (3 Days)||2
53087|NCT02443740|127243|P2|STARTED|Intervention Period 4 (3 Days)||2
53088|NCT02443740|127244|P1|STARTED|Intervention Period 4 (3 Days)||1
53089|NCT02443740|127234|P11|NOT COMPLETED|Washout Period 3 (7 Days)||0
53090|NCT02443740|127235|P10|NOT COMPLETED|Washout Period 3 (7 Days)||0
53091|NCT02443740|127236|P9|NOT COMPLETED|Washout Period 3 (7 Days)||0
53092|NCT02443740|127237|P8|NOT COMPLETED|Washout Period 3 (7 Days)||0
53093|NCT02443740|127238|P7|NOT COMPLETED|Washout Period 3 (7 Days)||0
53094|NCT02443740|127239|P6|NOT COMPLETED|Washout Period 3 (7 Days)||0
53095|NCT02443740|127240|P5|NOT COMPLETED|Washout Period 3 (7 Days)||0
53096|NCT02443740|127241|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
53097|NCT02443740|127242|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
53098|NCT02443740|127243|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
53099|NCT02443740|127244|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
53100|NCT02443740|127234|P11|COMPLETED|Washout Period 3 (7 Days)||0
53101|NCT02443740|127235|P10|COMPLETED|Washout Period 3 (7 Days)||0
53102|NCT02443740|127236|P9|COMPLETED|Washout Period 3 (7 Days)||0
53103|NCT02443740|127237|P8|COMPLETED|Washout Period 3 (7 Days)||2
53104|NCT02443740|127238|P7|COMPLETED|Washout Period 3 (7 Days)||2
53105|NCT02443740|127239|P6|COMPLETED|Washout Period 3 (7 Days)||2
53106|NCT02443740|127240|P5|COMPLETED|Washout Period 3 (7 Days)||2
53107|NCT02443740|127241|P4|COMPLETED|Washout Period 3 (7 Days)||3
53108|NCT02443740|127242|P3|COMPLETED|Washout Period 3 (7 Days)||2
53109|NCT02443740|127243|P2|COMPLETED|Washout Period 3 (7 Days)||2
53110|NCT02443740|127244|P1|COMPLETED|Washout Period 3 (7 Days)||1
53111|NCT02443740|127234|P11|STARTED|Washout Period 3 (7 Days)||0
53112|NCT02443740|127235|P10|STARTED|Washout Period 3 (7 Days)||0
53113|NCT02443740|127236|P9|STARTED|Washout Period 3 (7 Days)||0
53114|NCT02443740|127237|P8|STARTED|Washout Period 3 (7 Days)||2
53115|NCT02443740|127238|P7|STARTED|Washout Period 3 (7 Days)||2
53116|NCT02443740|127239|P6|STARTED|Washout Period 3 (7 Days)||2
53117|NCT02443740|127240|P5|STARTED|Washout Period 3 (7 Days)||2
53118|NCT02443740|127241|P4|STARTED|Washout Period 3 (7 Days)||3
53119|NCT02443740|127242|P3|STARTED|Washout Period 3 (7 Days)||2
53120|NCT02443740|127243|P2|STARTED|Washout Period 3 (7 Days)||2
53121|NCT02443740|127244|P1|STARTED|Washout Period 3 (7 Days)||1
53122|NCT02443740|127234|P11|NOT COMPLETED|Intervention Period 3 (3 Days)||0
53123|NCT02443740|127235|P10|NOT COMPLETED|Intervention Period 3 (3 Days)||0
53124|NCT02443740|127236|P9|NOT COMPLETED|Intervention Period 3 (3 Days)||0
53125|NCT02443740|127237|P8|NOT COMPLETED|Intervention Period 3 (3 Days)||0
53126|NCT02443740|127238|P7|NOT COMPLETED|Intervention Period 3 (3 Days)||0
53127|NCT02443740|127239|P6|NOT COMPLETED|Intervention Period 3 (3 Days)||0
53128|NCT02443740|127240|P5|NOT COMPLETED|Intervention Period 3 (3 Days)||0
53129|NCT02443740|127241|P4|NOT COMPLETED|Intervention Period 3 (3 Days)||0
53130|NCT02443740|127242|P3|NOT COMPLETED|Intervention Period 3 (3 Days)||0
53131|NCT02443740|127243|P2|NOT COMPLETED|Intervention Period 3 (3 Days)||0
53132|NCT02443740|127244|P1|NOT COMPLETED|Intervention Period 3 (3 Days)||0
53133|NCT02443740|127234|P11|COMPLETED|Intervention Period 3 (3 Days)||0
53134|NCT02443740|127235|P10|COMPLETED|Intervention Period 3 (3 Days)||0
53135|NCT02443740|127236|P9|COMPLETED|Intervention Period 3 (3 Days)||0
53136|NCT02443740|127237|P8|COMPLETED|Intervention Period 3 (3 Days)||2
53137|NCT02443740|127238|P7|COMPLETED|Intervention Period 3 (3 Days)||2
53138|NCT02443740|127239|P6|COMPLETED|Intervention Period 3 (3 Days)||2
53139|NCT02443740|127240|P5|COMPLETED|Intervention Period 3 (3 Days)||2
53140|NCT02443740|127241|P4|COMPLETED|Intervention Period 3 (3 Days)||3
53141|NCT02443740|127242|P3|COMPLETED|Intervention Period 3 (3 Days)||2
53142|NCT02443740|127243|P2|COMPLETED|Intervention Period 3 (3 Days)||2
53143|NCT02443740|127244|P1|COMPLETED|Intervention Period 3 (3 Days)||1
53144|NCT02443740|127234|P11|STARTED|Intervention Period 3 (3 Days)||0
53145|NCT02443740|127235|P10|STARTED|Intervention Period 3 (3 Days)||0
53146|NCT02443740|127236|P9|STARTED|Intervention Period 3 (3 Days)||0
53147|NCT02443740|127237|P8|STARTED|Intervention Period 3 (3 Days)||2
53148|NCT02443740|127238|P7|STARTED|Intervention Period 3 (3 Days)||2
53149|NCT02443740|127239|P6|STARTED|Intervention Period 3 (3 Days)||2
53150|NCT02443740|127240|P5|STARTED|Intervention Period 3 (3 Days)||2
53151|NCT02443740|127241|P4|STARTED|Intervention Period 3 (3 Days)||3
53152|NCT02443740|127242|P3|STARTED|Intervention Period 3 (3 Days)||2
53153|NCT02443740|127243|P2|STARTED|Intervention Period 3 (3 Days)||2
53154|NCT02443740|127244|P1|STARTED|Intervention Period 3 (3 Days)||1
53155|NCT02443740|127234|P11|NOT COMPLETED|Washout Period 2 (7 Days)||0
53156|NCT02443740|127235|P10|NOT COMPLETED|Washout Period 2 (7 Days)||0
53157|NCT02443740|127236|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
53158|NCT02443740|127237|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
53159|NCT02443740|127238|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
53160|NCT02443740|127239|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
53161|NCT02443740|127240|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
53162|NCT02443740|127241|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
53163|NCT02443740|127242|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
53164|NCT02443740|127243|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
53165|NCT02443740|127244|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
53166|NCT02443740|127234|P11|COMPLETED|Washout Period 2 (7 Days)||0
53167|NCT02443740|127235|P10|COMPLETED|Washout Period 2 (7 Days)||0
53168|NCT02443740|127236|P9|COMPLETED|Washout Period 2 (7 Days)||0
53169|NCT02443740|127237|P8|COMPLETED|Washout Period 2 (7 Days)||2
53170|NCT02443740|127238|P7|COMPLETED|Washout Period 2 (7 Days)||2
53171|NCT02443740|127239|P6|COMPLETED|Washout Period 2 (7 Days)||2
53172|NCT02443740|127240|P5|COMPLETED|Washout Period 2 (7 Days)||2
53173|NCT02443740|127241|P4|COMPLETED|Washout Period 2 (7 Days)||3
53174|NCT02443740|127242|P3|COMPLETED|Washout Period 2 (7 Days)||2
53175|NCT02443740|127243|P2|COMPLETED|Washout Period 2 (7 Days)||2
53176|NCT02443740|127244|P1|COMPLETED|Washout Period 2 (7 Days)||1
53177|NCT02443740|127234|P11|STARTED|Washout Period 2 (7 Days)||0
53178|NCT02443740|127235|P10|STARTED|Washout Period 2 (7 Days)||0
53179|NCT02443740|127236|P9|STARTED|Washout Period 2 (7 Days)||0
53180|NCT02443740|127237|P8|STARTED|Washout Period 2 (7 Days)||2
53181|NCT02443740|127238|P7|STARTED|Washout Period 2 (7 Days)||2
53182|NCT02443740|127239|P6|STARTED|Washout Period 2 (7 Days)||2
53183|NCT02443740|127240|P5|STARTED|Washout Period 2 (7 Days)||2
53184|NCT02443740|127241|P4|STARTED|Washout Period 2 (7 Days)||3
53185|NCT02443740|127242|P3|STARTED|Washout Period 2 (7 Days)||2
53186|NCT02443740|127243|P2|STARTED|Washout Period 2 (7 Days)||2
53187|NCT02443740|127244|P1|STARTED|Washout Period 2 (7 Days)||1
53188|NCT02443740|127234|P11|NOT COMPLETED|Intervention Period 2 (3 Days)||0
53189|NCT02443740|127235|P10|NOT COMPLETED|Intervention Period 2 (3 Days)||0
53190|NCT02443740|127236|P9|NOT COMPLETED|Intervention Period 2 (3 Days)||0
53191|NCT02443740|127237|P8|NOT COMPLETED|Intervention Period 2 (3 Days)||0
53192|NCT02443740|127238|P7|NOT COMPLETED|Intervention Period 2 (3 Days)||0
53193|NCT02443740|127239|P6|NOT COMPLETED|Intervention Period 2 (3 Days)||0
53194|NCT02443740|127240|P5|NOT COMPLETED|Intervention Period 2 (3 Days)||0
53195|NCT02443740|127241|P4|NOT COMPLETED|Intervention Period 2 (3 Days)||0
53196|NCT02443740|127242|P3|NOT COMPLETED|Intervention Period 2 (3 Days)||0
53197|NCT02443740|127243|P2|NOT COMPLETED|Intervention Period 2 (3 Days)||0
53198|NCT02443740|127244|P1|NOT COMPLETED|Intervention Period 2 (3 Days)||0
53199|NCT02443740|127234|P11|COMPLETED|Intervention Period 2 (3 Days)||3
53200|NCT02443740|127235|P10|COMPLETED|Intervention Period 2 (3 Days)||3
53201|NCT02443740|127236|P9|COMPLETED|Intervention Period 2 (3 Days)||0
53202|NCT02443740|127237|P8|COMPLETED|Intervention Period 2 (3 Days)||2
53203|NCT02443740|127238|P7|COMPLETED|Intervention Period 2 (3 Days)||2
53204|NCT02443740|127239|P6|COMPLETED|Intervention Period 2 (3 Days)||2
53205|NCT02443740|127240|P5|COMPLETED|Intervention Period 2 (3 Days)||2
53206|NCT02443740|127241|P4|COMPLETED|Intervention Period 2 (3 Days)||3
53207|NCT02443740|127242|P3|COMPLETED|Intervention Period 2 (3 Days)||2
53208|NCT02443740|127243|P2|COMPLETED|Intervention Period 2 (3 Days)||2
53209|NCT02443740|127244|P1|COMPLETED|Intervention Period 2 (3 Days)||1
53210|NCT02443740|127234|P11|STARTED|Intervention Period 2 (3 Days)||3
53211|NCT02443740|127235|P10|STARTED|Intervention Period 2 (3 Days)||3
53212|NCT02443740|127236|P9|STARTED|Intervention Period 2 (3 Days)||0
53213|NCT02443740|127237|P8|STARTED|Intervention Period 2 (3 Days)||2
53214|NCT02443740|127238|P7|STARTED|Intervention Period 2 (3 Days)||2
53215|NCT02443740|127239|P6|STARTED|Intervention Period 2 (3 Days)||2
53216|NCT02443740|127240|P5|STARTED|Intervention Period 2 (3 Days)||2
53217|NCT02443740|127241|P4|STARTED|Intervention Period 2 (3 Days)||3
53218|NCT02443740|127242|P3|STARTED|Intervention Period 2 (3 Days)||2
53219|NCT02443740|127243|P2|STARTED|Intervention Period 2 (3 Days)||2
53220|NCT02443740|127244|P1|STARTED|Intervention Period 2 (3 Days)||1
53221|NCT02443740|127234|P11|NOT COMPLETED|Washout Period 1 (7 Days)||0
53222|NCT02443740|127235|P10|NOT COMPLETED|Washout Period 1 (7 Days)||0
53223|NCT02443740|127236|P9|NOT COMPLETED|Washout Period 1 (7 Days)||0
53224|NCT02443740|127237|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
53225|NCT02443740|127238|P7|NOT COMPLETED|Washout Period 1 (7 Days)||0
53226|NCT02443740|127239|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
53227|NCT02443740|127240|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
53228|NCT02443740|127241|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
53229|NCT02443740|127242|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
53230|NCT02443740|127243|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
53231|NCT02443740|127244|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
53232|NCT02443740|127234|P11|COMPLETED|Washout Period 1 (7 Days)||3
53233|NCT02443740|127235|P10|COMPLETED|Washout Period 1 (7 Days)||3
53234|NCT02443740|127236|P9|COMPLETED|Washout Period 1 (7 Days)||0
53235|NCT02443740|127237|P8|COMPLETED|Washout Period 1 (7 Days)||2
53236|NCT02443740|127238|P7|COMPLETED|Washout Period 1 (7 Days)||2
53237|NCT02443740|127239|P6|COMPLETED|Washout Period 1 (7 Days)||2
53238|NCT02443740|127240|P5|COMPLETED|Washout Period 1 (7 Days)||2
53239|NCT02443740|127241|P4|COMPLETED|Washout Period 1 (7 Days)||3
53240|NCT02443740|127242|P3|COMPLETED|Washout Period 1 (7 Days)||2
53241|NCT02443740|127243|P2|COMPLETED|Washout Period 1 (7 Days)||2
53242|NCT02443740|127244|P1|COMPLETED|Washout Period 1 (7 Days)||1
53243|NCT02443740|127234|P11|STARTED|Washout Period 1 (7 Days)||3
53244|NCT02443740|127235|P10|STARTED|Washout Period 1 (7 Days)||3
53245|NCT02443740|127236|P9|STARTED|Washout Period 1 (7 Days)||0
53246|NCT02443740|127237|P8|STARTED|Washout Period 1 (7 Days)||2
53247|NCT02443740|127238|P7|STARTED|Washout Period 1 (7 Days)||2
53248|NCT02443740|127239|P6|STARTED|Washout Period 1 (7 Days)||2
53249|NCT02443740|127240|P5|STARTED|Washout Period 1 (7 Days)||2
53250|NCT02443740|127241|P4|STARTED|Washout Period 1 (7 Days)||3
53251|NCT02443740|127242|P3|STARTED|Washout Period 1 (7 Days)||2
53252|NCT02443740|127243|P2|STARTED|Washout Period 1 (7 Days)||2
53253|NCT02443740|127244|P1|STARTED|Washout Period 1 (7 Days)||1
53254|NCT02443740|127234|P11|NOT COMPLETED|Intervention Period 1 (3 Days)||0
53255|NCT02443740|127235|P10|NOT COMPLETED|Intervention Period 1 (3 Days)||0
53256|NCT02443740|127236|P9|NOT COMPLETED|Intervention Period 1 (3 Days)||0
53257|NCT02443740|127237|P8|NOT COMPLETED|Intervention Period 1 (3 Days)||0
53258|NCT02443740|127238|P7|NOT COMPLETED|Intervention Period 1 (3 Days)||1
53259|NCT02443740|127239|P6|NOT COMPLETED|Intervention Period 1 (3 Days)||2
53260|NCT02443740|127240|P5|NOT COMPLETED|Intervention Period 1 (3 Days)||0
53261|NCT02443740|127241|P4|NOT COMPLETED|Intervention Period 1 (3 Days)||0
53262|NCT02443740|127242|P3|NOT COMPLETED|Intervention Period 1 (3 Days)||0
53263|NCT02443740|127243|P2|NOT COMPLETED|Intervention Period 1 (3 Days)||0
53264|NCT02443740|127244|P1|NOT COMPLETED|Intervention Period 1 (3 Days)||1
53265|NCT02443740|127234|P11|COMPLETED|Intervention Period 1 (3 Days)||3
53266|NCT02443740|127235|P10|COMPLETED|Intervention Period 1 (3 Days)||3
53267|NCT02443740|127236|P9|COMPLETED|Intervention Period 1 (3 Days)||6
53268|NCT02443740|127237|P8|COMPLETED|Intervention Period 1 (3 Days)||2
53269|NCT02443740|127238|P7|COMPLETED|Intervention Period 1 (3 Days)||2
53270|NCT02443740|127239|P6|COMPLETED|Intervention Period 1 (3 Days)||2
53271|NCT02443740|127240|P5|COMPLETED|Intervention Period 1 (3 Days)||2
53272|NCT02443740|127241|P4|COMPLETED|Intervention Period 1 (3 Days)||3
53273|NCT02443740|127242|P3|COMPLETED|Intervention Period 1 (3 Days)||2
53274|NCT02443740|127243|P2|COMPLETED|Intervention Period 1 (3 Days)||2
53275|NCT02443740|127244|P1|COMPLETED|Intervention Period 1 (3 Days)||1
53276|NCT02443740|127234|P11|STARTED|Intervention Period 1 (3 Days)||3
53277|NCT02443740|127235|P10|STARTED|Intervention Period 1 (3 Days)||3
53278|NCT02443740|127236|P9|STARTED|Intervention Period 1 (3 Days)||6
53279|NCT02443740|127237|P8|STARTED|Intervention Period 1 (3 Days)||2
53280|NCT02443740|127238|P7|STARTED|Intervention Period 1 (3 Days)||3
53281|NCT02443740|127239|P6|STARTED|Intervention Period 1 (3 Days)||4
53282|NCT02443740|127240|P5|STARTED|Intervention Period 1 (3 Days)||2
53283|NCT02443740|127241|P4|STARTED|Intervention Period 1 (3 Days)||3
53284|NCT02443740|127242|P3|STARTED|Intervention Period 1 (3 Days)||2
53285|NCT02443740|127243|P2|STARTED|Intervention Period 1 (3 Days)||2
53286|NCT02443740|127244|P1|STARTED|Intervention Period 1 (3 Days)||2
53287|NCT02443688|127426|P3|NOT COMPLETED|Overall Study||12
53288|NCT02443688|127427|P2|NOT COMPLETED|Overall Study||9
53289|NCT02443688|127428|P1|NOT COMPLETED|Overall Study||12
53290|NCT02443688|127426|P3|COMPLETED|Overall Study||55
53291|NCT02443688|127427|P2|COMPLETED|Overall Study||58
53292|NCT02443688|127428|P1|COMPLETED|Overall Study||54
53293|NCT02443688|127426|P3|STARTED|Overall Study||67
53294|NCT02443688|127427|P2|STARTED|Overall Study||67
53295|NCT02443688|127428|P1|STARTED|Overall Study||66
53296|NCT02443571|127493|P3|NOT COMPLETED|Overall Study||0
53297|NCT02443571|127494|P2|NOT COMPLETED|Overall Study||0
53298|NCT02443571|127495|P1|NOT COMPLETED|Overall Study||0
53299|NCT02443571|127493|P3|COMPLETED|Overall Study||23
53300|NCT02443571|127494|P2|COMPLETED|Overall Study||95
53301|NCT02443571|127495|P1|COMPLETED|Overall Study||596
53302|NCT02443571|127493|P3|STARTED|Overall Study||23
53303|NCT02443571|127494|P2|STARTED|Overall Study||95
53304|NCT02443571|127495|P1|STARTED|Overall Study||596
53305|NCT02443402|127507|P2|NOT COMPLETED|Overall Study||3
53306|NCT02443402|127508|P1|NOT COMPLETED|Overall Study||4
53307|NCT02443402|127507|P2|COMPLETED|Overall Study||28
53308|NCT02443402|127508|P1|COMPLETED|Overall Study||32
53309|NCT02443402|127507|P2|STARTED|Overall Study||31
53310|NCT02443402|127508|P1|STARTED|Overall Study||36
53311|NCT02443298|127570|P2|NOT COMPLETED|Overall Study||5
53312|NCT02443298|127571|P1|NOT COMPLETED|Overall Study||4
53313|NCT02443298|127570|P2|COMPLETED|Overall Study||104
53314|NCT02443298|127571|P1|COMPLETED|Overall Study||101
53315|NCT02443298|127570|P2|STARTED|Overall Study||109
53316|NCT02443298|127571|P1|STARTED|Overall Study||105
53317|NCT02443103|127591|P1|NOT COMPLETED|Overall Study||3
53318|NCT02443103|127591|P1|COMPLETED|Overall Study||1
53319|NCT02443103|127591|P1|STARTED|Overall Study||4
53320|NCT02442830|127598|P2|NOT COMPLETED|Overall Study||1
53321|NCT02442830|127599|P1|NOT COMPLETED|Overall Study||0
53322|NCT02442830|127598|P2|COMPLETED|Overall Study||44
53323|NCT02442830|127599|P1|COMPLETED|Overall Study||42
53324|NCT02442830|127598|P2|STARTED|Overall Study||45
53325|NCT02442830|127599|P1|STARTED|Overall Study||42
53326|NCT02442804|127609|P2|NOT COMPLETED|Overall Study||1
53327|NCT02442804|127610|P1|NOT COMPLETED|Overall Study||1
53328|NCT02442804|127609|P2|COMPLETED|Overall Study||7
53329|NCT02442804|127610|P1|COMPLETED|Overall Study||7
53330|NCT02442804|127609|P2|STARTED|Overall Study||8
53331|NCT02442804|127610|P1|STARTED|Overall Study||8
53332|NCT02442700|127640|P2|NOT COMPLETED|Later 12 Weeks||0
53333|NCT02442700|127641|P1|NOT COMPLETED|Later 12 Weeks||0
53334|NCT02442700|127640|P2|COMPLETED|Later 12 Weeks||12
53335|NCT02442700|127641|P1|COMPLETED|Later 12 Weeks||12
53336|NCT02442700|127640|P2|STARTED|Later 12 Weeks||12
53337|NCT02442700|127641|P1|STARTED|Later 12 Weeks||12
53338|NCT02442700|127640|P2|NOT COMPLETED|First 12 Weeks||0
53339|NCT02442700|127641|P1|NOT COMPLETED|First 12 Weeks||0
53340|NCT02442700|127640|P2|COMPLETED|First 12 Weeks||12
53341|NCT02442700|127641|P1|COMPLETED|First 12 Weeks||12
53342|NCT02442700|127640|P2|STARTED|First 12 Weeks||12
53343|NCT02442700|127641|P1|STARTED|First 12 Weeks||12
53344|NCT02442687|127652|P3|NOT COMPLETED|Overall Study||3
53345|NCT02442687|127653|P2|NOT COMPLETED|Overall Study||11
53346|NCT02442687|127654|P1|NOT COMPLETED|Overall Study||8
53347|NCT02442687|127652|P3|COMPLETED|Overall Study||19
53348|NCT02442687|127653|P2|COMPLETED|Overall Study||11
53349|NCT02442687|127654|P1|COMPLETED|Overall Study||13
53350|NCT02442687|127652|P3|STARTED|Overall Study||22
53351|NCT02442687|127653|P2|STARTED|Overall Study||22
53352|NCT02442687|127654|P1|STARTED|Overall Study||21
53353|NCT02442349|127715|P1|NOT COMPLETED|Overall Study||171
53354|NCT02442349|127715|P1|COMPLETED|Overall Study||0
53355|NCT02442349|127715|P1|STARTED|Overall Study||171
53356|NCT02442310|127720|P1|NOT COMPLETED|Overall Study||3
53357|NCT02442310|127720|P1|COMPLETED|Overall Study||17
53358|NCT02442310|127720|P1|STARTED|Overall Study||20
53359|NCT02442284|127742|P1|NOT COMPLETED|Overall Study||7
53360|NCT02442284|127742|P1|COMPLETED|Overall Study||92
53361|NCT02442284|127742|P1|STARTED|Overall Study||99
53362|NCT02442271|127749|P1|NOT COMPLETED|Overall Study||4
53363|NCT02442271|127749|P1|COMPLETED|Overall Study||218
53364|NCT02442271|127749|P1|STARTED|Overall Study||222
53365|NCT02442206|127775|P2|NOT COMPLETED|Period 2||0
53366|NCT02442206|127776|P1|NOT COMPLETED|Period 2||1
53367|NCT02442206|127775|P2|COMPLETED|Period 2||29
53368|NCT02442206|127776|P1|COMPLETED|Period 2||28
53369|NCT02442206|127775|P2|STARTED|Period 2||29
53370|NCT02442206|127776|P1|STARTED|Period 2||29
53371|NCT02442206|127775|P2|NOT COMPLETED|Period 1||3
53372|NCT02442206|127776|P1|NOT COMPLETED|Period 1||1
53373|NCT02442206|127775|P2|COMPLETED|Period 1||29
53374|NCT02442206|127776|P1|COMPLETED|Period 1||29
53375|NCT02442206|127775|P2|STARTED|Period 1||32
53376|NCT02442206|127776|P1|STARTED|Period 1||30
53377|NCT02441946|127808|P3|NOT COMPLETED|Extension Period (8 Weeks)||0
53378|NCT02441946|127809|P2|NOT COMPLETED|Extension Period (8 Weeks)||0
53379|NCT02441946|127810|P1|NOT COMPLETED|Extension Period (8 Weeks)||2
53380|NCT02441946|127808|P3|COMPLETED|Extension Period (8 Weeks)||0
53381|NCT02441946|127809|P2|COMPLETED|Extension Period (8 Weeks)||0
53382|NCT02441946|127810|P1|COMPLETED|Extension Period (8 Weeks)||40
53383|NCT02441946|127808|P3|STARTED|Extension Period (8 Weeks)||0
53384|NCT02441946|127809|P2|STARTED|Extension Period (8 Weeks)||0
53385|NCT02441946|127810|P1|STARTED|Extension Period (8 Weeks)|All participants who did not discontinue continued to the extension period.|42
53386|NCT02441946|127808|P3|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
53387|NCT02441946|127809|P2|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
53388|NCT02441946|127810|P1|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||27
53389|NCT02441946|127808|P3|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
53390|NCT02441946|127809|P2|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
53391|NCT02441946|127810|P1|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||190
53392|NCT02441946|127808|P3|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||0
53393|NCT02441946|127809|P2|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||0
53394|NCT02441946|127810|P1|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||5
53395|NCT02441946|127808|P3|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
53396|NCT02441946|127809|P2|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
53397|NCT02441946|127810|P1|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||217
53398|NCT02441946|127808|P3|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
53399|NCT02441946|127809|P2|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
53400|NCT02441946|127810|P1|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned to abemaciclib + anastrozole post cycle 1.|217
53401|NCT02441946|127808|P3|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
53402|NCT02441946|127809|P2|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
53403|NCT02441946|127810|P1|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||2
53404|NCT02441946|127808|P3|COMPLETED|Cycle 1 Period 1 (2 Weeks)||74
53405|NCT02441946|127809|P2|COMPLETED|Cycle 1 Period 1 (2 Weeks)||71
53406|NCT02441946|127810|P1|COMPLETED|Cycle 1 Period 1 (2 Weeks)||72
53407|NCT02441946|127808|P3|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
53408|NCT02441946|127809|P2|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)|1 participant did not receive drug due to an error in randomization.|75
53409|NCT02441946|127810|P1|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
53410|NCT02441946|127808|P3|STARTED|Cycle 1 Period 1 (2 Weeks)||74
53411|NCT02441946|127809|P2|STARTED|Cycle 1 Period 1 (2 Weeks)||76
53412|NCT02441946|127810|P1|STARTED|Cycle 1 Period 1 (2 Weeks)||74
53413|NCT02441517|127831|P1|NOT COMPLETED|Overall Study||4
53414|NCT02441517|127831|P1|COMPLETED|Overall Study||0
53415|NCT02441517|127831|P1|Received Treatment|Overall Study||4
53416|NCT02441517|127831|P1|STARTED|Overall Study||4
53417|NCT02441309|127844|P3|NOT COMPLETED|Overall Study||3
53418|NCT02441309|127845|P2|NOT COMPLETED|Overall Study||2
53419|NCT02441309|127846|P1|NOT COMPLETED|Overall Study||3
53420|NCT02441309|127844|P3|COMPLETED|Overall Study||0
53421|NCT02441309|127845|P2|COMPLETED|Overall Study||0
53422|NCT02441309|127846|P1|COMPLETED|Overall Study||0
53423|NCT02441309|127844|P3|Received Allocated Intervention|Overall Study||3
53424|NCT02441309|127845|P2|Received Allocated Intervention|Overall Study||2
53425|NCT02441309|127846|P1|Received Allocated Intervention|Overall Study||1
53426|NCT02441309|127844|P3|STARTED|Overall Study||3
53427|NCT02441309|127845|P2|STARTED|Overall Study||2
53428|NCT02441309|127846|P1|STARTED|Overall Study||3
53429|NCT02441218|127877|P2|NOT COMPLETED|Overall Study||612
53430|NCT02441218|127878|P1|NOT COMPLETED|Overall Study||578
53431|NCT02441218|127877|P2|COMPLETED|Overall Study||2652
53432|NCT02441218|127878|P1|COMPLETED|Overall Study||2663
53433|NCT02441218|127877|P2|STARTED|Overall Study||3264
53434|NCT02441218|127878|P1|STARTED|Overall Study||3241
53435|NCT02441179|127904|P2|NOT COMPLETED|Overall Study||1
53436|NCT02441179|127905|P1|NOT COMPLETED|Overall Study||1
53437|NCT02441179|127904|P2|COMPLETED|Overall Study||16
53438|NCT02441179|127905|P1|COMPLETED|Overall Study||17
53439|NCT02441179|127904|P2|STARTED|Overall Study||17
53440|NCT02441179|127905|P1|STARTED|Overall Study||18
53441|NCT02441114|127923|P1|NOT COMPLETED|Period3||0
53442|NCT02441114|127923|P1|COMPLETED|Period3||6
53443|NCT02441114|127923|P1|STARTED|Period3||6
53444|NCT02441114|127923|P1|NOT COMPLETED|Washout2||4
53445|NCT02441114|127923|P1|COMPLETED|Washout2||6
53446|NCT02441114|127923|P1|STARTED|Washout2||10
53447|NCT02441114|127923|P1|NOT COMPLETED|Period2||0
53448|NCT02441114|127923|P1|COMPLETED|Period2||10
53449|NCT02441114|127923|P1|STARTED|Period2||10
53450|NCT02441114|127923|P1|NOT COMPLETED|Washout1||0
53451|NCT02441114|127923|P1|COMPLETED|Washout1||10
53452|NCT02441114|127923|P1|STARTED|Washout1||10
53453|NCT02441114|127923|P1|NOT COMPLETED|Period1||0
53454|NCT02441114|127923|P1|COMPLETED|Period1||10
53455|NCT02441114|127923|P1|STARTED|Period1||10
53456|NCT02441036|127934|P5|NOT COMPLETED|Overall Study||0
53457|NCT02441036|127935|P4|NOT COMPLETED|Overall Study||1
53458|NCT02441036|127936|P3|NOT COMPLETED|Overall Study||0
53459|NCT02441036|127937|P2|NOT COMPLETED|Overall Study||1
53460|NCT02441036|127938|P1|NOT COMPLETED|Overall Study||0
53461|NCT02441036|127934|P5|COMPLETED|Overall Study||1
53462|NCT02441036|127935|P4|COMPLETED|Overall Study||3
53463|NCT02441036|127936|P3|COMPLETED|Overall Study||3
53464|NCT02441036|127937|P2|COMPLETED|Overall Study||4
53465|NCT02441036|127938|P1|COMPLETED|Overall Study||3
53466|NCT02441036|127934|P5|Tissue Resected|Overall Study||1
53467|NCT02441036|127935|P4|Tissue Resected|Overall Study||3
53468|NCT02441036|127936|P3|Tissue Resected|Overall Study||3
53469|NCT02441036|127937|P2|Tissue Resected|Overall Study||4
53470|NCT02441036|127938|P1|Tissue Resected|Overall Study||3
53471|NCT02441036|127934|P5|Treated|Overall Study||1
53472|NCT02441036|127935|P4|Treated|Overall Study||4
53473|NCT02441036|127936|P3|Treated|Overall Study||3
53474|NCT02441036|127937|P2|Treated|Overall Study||5
53475|NCT02441036|127938|P1|Treated|Overall Study||3
53476|NCT02441036|127934|P5|STARTED|Overall Study||1
53477|NCT02441036|127935|P4|STARTED|Overall Study||4
53478|NCT02441036|127936|P3|STARTED|Overall Study||3
53479|NCT02441036|127937|P2|STARTED|Overall Study||5
53480|NCT02441036|127938|P1|STARTED|Overall Study||3
53481|NCT02440659|127967|P2|NOT COMPLETED|Overall Study||335
53482|NCT02440659|127968|P1|NOT COMPLETED|Overall Study||651
53483|NCT02440659|127967|P2|COMPLETED|Overall Study||614
53484|NCT02440659|127968|P1|COMPLETED|Overall Study||1346
53485|NCT02440659|127967|P2|STARTED|Overall Study||949
53486|NCT02440659|127968|P1|STARTED|Overall Study||1997
53487|NCT02440633|127974|P1|NOT COMPLETED|Overall Study||0
53488|NCT02440633|127974|P1|COMPLETED|Overall Study||8
53489|NCT02440633|127974|P1|STARTED|Overall Study||8
53490|NCT02440594|127991|P8|NOT COMPLETED|Overall Study||56
53491|NCT02440594|127992|P7|NOT COMPLETED|Overall Study||37
53492|NCT02440594|127993|P6|NOT COMPLETED|Overall Study||7
53493|NCT02440594|127994|P5|NOT COMPLETED|Overall Study||9
53494|NCT02440594|127995|P4|NOT COMPLETED|Overall Study||89
53495|NCT02440594|127996|P3|NOT COMPLETED|Overall Study||117
53496|NCT02440594|127997|P2|NOT COMPLETED|Overall Study||108
53497|NCT02440594|127998|P1|NOT COMPLETED|Overall Study||132
53498|NCT02440594|127991|P8|COMPLETED|Overall Study||234
53499|NCT02440594|127992|P7|COMPLETED|Overall Study||113
53500|NCT02440594|127993|P6|COMPLETED|Overall Study||47
53501|NCT02440594|127994|P5|COMPLETED|Overall Study||46
53502|NCT02440594|127995|P4|COMPLETED|Overall Study||340
53503|NCT02440594|127996|P3|COMPLETED|Overall Study||319
53504|NCT02440594|127997|P2|COMPLETED|Overall Study||401
53505|NCT02440594|127998|P1|COMPLETED|Overall Study||377
53506|NCT02440594|127991|P8|STARTED|Overall Study||290
53507|NCT02440594|127992|P7|STARTED|Overall Study||150
53508|NCT02440594|127993|P6|STARTED|Overall Study||54
53509|NCT02440594|127994|P5|STARTED|Overall Study||55
53510|NCT02440594|127995|P4|STARTED|Overall Study||429
53511|NCT02440594|127996|P3|STARTED|Overall Study||436
53512|NCT02440594|127997|P2|STARTED|Overall Study||509
53513|NCT02440594|127998|P1|STARTED|Overall Study||509
53514|NCT02440451|128030|P1|NOT COMPLETED|Overall Study||0
53515|NCT02440451|128030|P1|COMPLETED|Overall Study||15
53516|NCT02440451|128030|P1|STARTED|Overall Study||15
53517|NCT02440334|128036|P1|NOT COMPLETED|Overall Study||0
53518|NCT02440334|128036|P1|COMPLETED|Overall Study||53
53519|NCT02440334|128036|P1|STARTED|Overall Study||53
53520|NCT02440308|128040|P1|NOT COMPLETED|Overall Study||0
53521|NCT02440308|128040|P1|COMPLETED|Overall Study||10
53522|NCT02440308|128040|P1|STARTED|Overall Study||10
53523|NCT02440204|128048|P3|NOT COMPLETED|Overall Study||0
53524|NCT02440204|128049|P2|NOT COMPLETED|Overall Study||0
53525|NCT02440204|128050|P1|NOT COMPLETED|Overall Study||0
53526|NCT02440204|128048|P3|COMPLETED|Overall Study||22
53527|NCT02440204|128049|P2|COMPLETED|Overall Study||24
53528|NCT02440204|128050|P1|COMPLETED|Overall Study||22
53529|NCT02440204|128048|P3|STARTED|Overall Study||22
53530|NCT02440204|128049|P2|STARTED|Overall Study||24
53531|NCT02440204|128050|P1|STARTED|Overall Study||22
53532|NCT02439879|128063|P2|NOT COMPLETED|Overall Study||0
53533|NCT02439879|128064|P1|NOT COMPLETED|Overall Study||0
53534|NCT02439879|128063|P2|COMPLETED|Overall Study||17
53535|NCT02439879|128064|P1|COMPLETED|Overall Study||16
53536|NCT02439879|128063|P2|STARTED|Overall Study||17
53537|NCT02439879|128064|P1|STARTED|Overall Study||16
53538|NCT02439814|128072|P2|NOT COMPLETED|Overall Study||0
53539|NCT02439814|128073|P1|NOT COMPLETED|Overall Study||0
53540|NCT02439814|128072|P2|COMPLETED|Overall Study||10
53541|NCT02439814|128073|P1|COMPLETED|Overall Study||11
53542|NCT02439814|128072|P2|STARTED|Overall Study||10
53543|NCT02439814|128073|P1|STARTED|Overall Study||11
53544|NCT02439710|128079|P1|NOT COMPLETED|Overall Study||0
53545|NCT02439710|128079|P1|COMPLETED|Overall Study||656
53546|NCT02439710|128079|P1|STARTED|Overall Study||656
53547|NCT02439320|128088|P3|NOT COMPLETED|Overall Study||99
53548|NCT02439320|128089|P2|NOT COMPLETED|Overall Study||114
53549|NCT02439320|128090|P1|NOT COMPLETED|Overall Study||96
53550|NCT02439320|128088|P3|COMPLETED|Overall Study||643
53551|NCT02439320|128089|P2|COMPLETED|Overall Study||631
53552|NCT02439320|128090|P1|COMPLETED|Overall Study||648
53553|NCT02439320|128088|P3|2nd Dose (After 2 Hour Assessment)|Overall Study||401
53554|NCT02439320|128089|P2|2nd Dose (After 2 Hour Assessment)|Overall Study||238
53555|NCT02439320|128090|P1|2nd Dose (After 2 Hour Assessment)|Overall Study||289
53556|NCT02439320|128088|P3|1st Dose (by 4 Hours Migraine Onset)|Overall Study||617
53557|NCT02439320|128089|P2|1st Dose (by 4 Hours Migraine Onset)|Overall Study||609
53558|NCT02439320|128090|P1|1st Dose (by 4 Hours Migraine Onset)|Overall Study||630
53559|NCT02439320|128088|P3|Confirmed Eligibility|Overall Study||705
53560|NCT02439320|128089|P2|Confirmed Eligibility|Overall Study||695
53561|NCT02439320|128090|P1|Confirmed Eligibility|Overall Study||710
53562|NCT02439320|128088|P3|STARTED|Overall Study||742
53563|NCT02439320|128089|P2|STARTED|Overall Study||745
53564|NCT02439320|128090|P1|STARTED|Overall Study||744
53565|NCT02439281|128135|P2|NOT COMPLETED|Overall Study||0
53566|NCT02439281|128136|P1|NOT COMPLETED|Overall Study||0
53567|NCT02439281|128135|P2|COMPLETED|Overall Study||26
53568|NCT02439281|128136|P1|COMPLETED|Overall Study||24
53569|NCT02439281|128135|P2|STARTED|Overall Study||26
53570|NCT02439281|128136|P1|STARTED|Overall Study||24
53571|NCT02439164|128156|P2|NOT COMPLETED|Overall Study||0
53572|NCT02439164|128157|P1|NOT COMPLETED|Overall Study||0
53573|NCT02439164|128156|P2|COMPLETED|Overall Study||18
53574|NCT02439164|128157|P1|COMPLETED|Overall Study||18
53575|NCT02439164|128156|P2|STARTED|Overall Study||18
53576|NCT02439164|128157|P1|STARTED|Overall Study||18
53577|NCT02439138|128170|P1|NOT COMPLETED|Overall Study||3
53578|NCT02439138|128170|P1|COMPLETED|Overall Study||2
53579|NCT02439138|128170|P1|STARTED|Overall Study||5
53580|NCT02438826|128183|P2|NOT COMPLETED|Overall Study||4
53581|NCT02438826|128184|P1|NOT COMPLETED|Overall Study||6
53582|NCT02438826|128183|P2|COMPLETED|Overall Study||113
53583|NCT02438826|128184|P1|COMPLETED|Overall Study||117
53584|NCT02438826|128183|P2|Received at Least 1 Dose of Study Drug|Overall Study||117
53585|NCT02438826|128184|P1|Received at Least 1 Dose of Study Drug|Overall Study||120
53586|NCT02438826|128183|P2|STARTED|Overall Study||117
53587|NCT02438826|128184|P1|STARTED|Overall Study||123
53588|NCT02438813|128212|P1|NOT COMPLETED|Overall Study||525
53589|NCT02438813|128212|P1|COMPLETED|Overall Study||504
53590|NCT02438813|128212|P1|Did Not ReceiveTreatment for SMF|Overall Study||353
53591|NCT02438813|128212|P1|Received Treatment for SMF|Overall Study||676
53592|NCT02438813|128212|P1|STARTED|Overall Study||1029
53593|NCT02438787|128264|P3|NOT COMPLETED|Overall Study||83
53594|NCT02438787|128265|P2|NOT COMPLETED|Overall Study||83
53595|NCT02438787|128266|P1|NOT COMPLETED|Overall Study||81
53596|NCT02438787|128264|P3|COMPLETED|Overall Study||22
53597|NCT02438787|128265|P2|COMPLETED|Overall Study||23
53598|NCT02438787|128266|P1|COMPLETED|Overall Study||23
53599|NCT02438787|128264|P3|Cross Over at Week 24|Overall Study||0
53600|NCT02438787|128265|P2|Cross Over at Week 24|Overall Study||0
53601|NCT02438787|128266|P1|Cross Over at Week 24|Overall Study|Out of 43: crossed over to Ustekinumab 45 mg (n=21) and Ustekinumab 90 mg (n=22)|43
53602|NCT02438787|128264|P3|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|20
53603|NCT02438787|128265|P2|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
53604|NCT02438787|128266|P1|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
53605|NCT02438787|128264|P3|STARTED|Overall Study||105
53606|NCT02438787|128265|P2|STARTED|Overall Study||106
53607|NCT02438787|128266|P1|STARTED|Overall Study||104
53608|NCT02438540|128311|P2|NOT COMPLETED|Overall Study||0
53609|NCT02438540|128312|P1|NOT COMPLETED|Overall Study||0
53610|NCT02438540|128311|P2|COMPLETED|Overall Study||20
53611|NCT02438540|128312|P1|COMPLETED|Overall Study||19
53612|NCT02438540|128311|P2|STARTED|Overall Study||20
53613|NCT02438540|128312|P1|STARTED|Overall Study||19
53614|NCT02438423|128356|P4|NOT COMPLETED|Overall Study||0
53615|NCT02438423|128357|P3|NOT COMPLETED|Overall Study||0
53616|NCT02438423|128358|P2|NOT COMPLETED|Overall Study||0
53617|NCT02438423|128359|P1|NOT COMPLETED|Overall Study||0
53618|NCT02438423|128356|P4|COMPLETED|Overall Study||25
53619|NCT02438423|128357|P3|COMPLETED|Overall Study||25
53620|NCT02438423|128358|P2|COMPLETED|Overall Study||25
53621|NCT02438423|128359|P1|COMPLETED|Overall Study||25
53622|NCT02438423|128356|P4|STARTED|Overall Study||25
53623|NCT02438423|128357|P3|STARTED|Overall Study||25
53624|NCT02438423|128358|P2|STARTED|Overall Study||25
53625|NCT02438423|128359|P1|STARTED|Overall Study||25
53626|NCT02438280|128385|P2|NOT COMPLETED|Overall Study||0
53627|NCT02438280|128386|P1|NOT COMPLETED|Overall Study||1
53628|NCT02438280|128385|P2|COMPLETED|Overall Study||13
53629|NCT02438280|128386|P1|COMPLETED|Overall Study||13
53630|NCT02438280|128385|P2|STARTED|Overall Study||13
53631|NCT02438280|128386|P1|STARTED|Overall Study||14
53632|NCT02438137|128396|P2|NOT COMPLETED|Overall Study||6
53633|NCT02438137|128397|P1|NOT COMPLETED|Overall Study||8
53634|NCT02438137|128396|P2|COMPLETED|Overall Study||15
53635|NCT02438137|128397|P1|COMPLETED|Overall Study||36
53636|NCT02438137|128396|P2|STARTED|Overall Study||21
53637|NCT02438137|128397|P1|STARTED|Overall Study||44
53638|NCT02437903|128405|P1|NOT COMPLETED|Overall Study||5
53639|NCT02437903|128405|P1|COMPLETED|Overall Study||25
53640|NCT02437903|128405|P1|STARTED|Overall Study||30
53641|NCT02437890|128418|P5|NOT COMPLETED|Overall Study||16
53642|NCT02437890|128419|P4|NOT COMPLETED|Overall Study||22
53643|NCT02437890|128420|P3|NOT COMPLETED|Overall Study||15
53644|NCT02437890|128421|P2|NOT COMPLETED|Overall Study||16
53645|NCT02437890|128422|P1|NOT COMPLETED|Overall Study||8
53646|NCT02437890|128418|P5|COMPLETED|Overall Study||46
53647|NCT02437890|128419|P4|COMPLETED|Overall Study||40
53648|NCT02437890|128420|P3|COMPLETED|Overall Study||47
53649|NCT02437890|128421|P2|COMPLETED|Overall Study||48
53650|NCT02437890|128422|P1|COMPLETED|Overall Study||54
53651|NCT02437890|128418|P5|STARTED|Overall Study||62
53652|NCT02437890|128419|P4|STARTED|Overall Study||62
53653|NCT02437890|128420|P3|STARTED|Overall Study||62
53654|NCT02437890|128421|P2|STARTED|Overall Study||64
53655|NCT02437890|128422|P1|STARTED|Overall Study||62
53656|NCT02437864|128635|P2|NOT COMPLETED|Overall Study||0
53657|NCT02437864|128636|P1|NOT COMPLETED|Overall Study||4
53658|NCT02437864|128635|P2|COMPLETED|Overall Study||160
53659|NCT02437864|128636|P1|COMPLETED|Overall Study||196
53660|NCT02437864|128635|P2|STARTED|Overall Study||160
53661|NCT02437864|128636|P1|STARTED|Overall Study||200
53662|NCT02437669|128650|P1|NOT COMPLETED|Overall Study||0
53663|NCT02437669|128650|P1|COMPLETED|Overall Study||35
53664|NCT02437669|128650|P1|STARTED|Overall Study||35
53665|NCT02437513|128657|P1|NOT COMPLETED|Overall Study||2
53666|NCT02437513|128657|P1|COMPLETED|Overall Study||0
53667|NCT02437513|128657|P1|STARTED|Overall Study||2
53668|NCT02437487|128667|P2|NOT COMPLETED|Overall Study||14
53669|NCT02437487|128668|P1|NOT COMPLETED|Overall Study||27
53670|NCT02437487|128667|P2|COMPLETED|Overall Study||16
53671|NCT02437487|128668|P1|COMPLETED|Overall Study||32
53672|NCT02437487|128667|P2|Intention-to-Treat Population|Overall Study||30
53673|NCT02437487|128668|P1|Intention-to-Treat Population|Overall Study||59
53674|NCT02437487|128667|P2|Actual Treatment Received|Overall Study||29
53675|NCT02437487|128668|P1|Actual Treatment Received|Overall Study||60
53676|NCT02437487|128667|P2|STARTED|Overall Study||30
53677|NCT02437487|128668|P1|STARTED|Overall Study||59
53678|NCT02437409|128682|P1|NOT COMPLETED|Overall Study||15
53679|NCT02437409|128682|P1|COMPLETED|Overall Study|In total 100 patients fulfilled the in-and exclusion criteria,15 patients were excluded/discontinued|100
53680|NCT02437409|128682|P1|STARTED|Overall Study|Eventually 100 evaluable patients, attrition rate of 15%|115
53681|NCT02437383|128693|P2|NOT COMPLETED|Overall Study||13
53682|NCT02437383|128694|P1|NOT COMPLETED|Overall Study||13
53683|NCT02437383|128693|P2|COMPLETED|Overall Study||87
53684|NCT02437383|128694|P1|COMPLETED|Overall Study||87
53685|NCT02437383|128693|P2|STARTED|Overall Study||100
53686|NCT02437383|128694|P1|STARTED|Overall Study||100
53687|NCT02437344|128768|P1|NOT COMPLETED|Overall Study||1
53688|NCT02437344|128768|P1|COMPLETED|Overall Study||15
53689|NCT02437344|128768|P1|STARTED|Overall Study||16
53690|NCT02437318|128775|P2|NOT COMPLETED|Overall Study||242
53691|NCT02437318|128776|P1|NOT COMPLETED|Overall Study||229
53692|NCT02437318|128775|P2|COMPLETED|Overall Study||46
53693|NCT02437318|128776|P1|COMPLETED|Overall Study||55
53694|NCT02437318|128775|P2|Untreated (Protocol Deviation)|Overall Study||1
53695|NCT02437318|128776|P1|Untreated (Protocol Deviation)|Overall Study||0
53696|NCT02437318|128775|P2|End of Treatment (Didn't Complete)|Overall Study||241
53697|NCT02437318|128776|P1|End of Treatment (Didn't Complete)|Overall Study||229
53698|NCT02437318|128775|P2|STARTED|Overall Study||288
53699|NCT02437318|128776|P1|STARTED|Overall Study||284
53700|NCT02437305|128784|P2|NOT COMPLETED|Overall Study||12
53701|NCT02437305|128785|P1|NOT COMPLETED|Overall Study||18
53702|NCT02437305|128784|P2|COMPLETED|Overall Study||38
53703|NCT02437305|128785|P1|COMPLETED|Overall Study||32
53704|NCT02437305|128784|P2|STARTED|Overall Study||50
53705|NCT02437305|128785|P1|STARTED|Overall Study||50
53706|NCT02437253|128795|P2|NOT COMPLETED|Overall Study||0
53707|NCT02437253|128796|P1|NOT COMPLETED|Overall Study||0
53708|NCT02437253|128795|P2|COMPLETED|Overall Study||1
53709|NCT02437253|128796|P1|COMPLETED|Overall Study||1
53710|NCT02437253|128795|P2|STARTED|Overall Study||1
53711|NCT02437253|128796|P1|STARTED|Overall Study||1
53712|NCT02437188|128812|P2|NOT COMPLETED|Overall Study||9
53713|NCT02437188|128813|P1|NOT COMPLETED|Overall Study||4
53714|NCT02437188|128812|P2|COMPLETED|Overall Study||35
53715|NCT02437188|128813|P1|COMPLETED|Overall Study||40
53716|NCT02437188|128812|P2|STARTED|Overall Study||44
53717|NCT02437188|128813|P1|STARTED|Overall Study||44
53718|NCT02437162|128830|P3|NOT COMPLETED|Overall Study||109
53719|NCT02437162|128831|P2|NOT COMPLETED|Overall Study||108
53720|NCT02437162|128832|P1|NOT COMPLETED|Overall Study||107
53721|NCT02437162|128830|P3|COMPLETED|Overall Study||6
53722|NCT02437162|128831|P2|COMPLETED|Overall Study||8
53723|NCT02437162|128832|P1|COMPLETED|Overall Study||9
53724|NCT02437162|128830|P3|Cross Over at Week 24|Overall Study||0
53725|NCT02437162|128831|P2|Cross Over at Week 24|Overall Study||0
53726|NCT02437162|128832|P1|Cross Over at Week 24|Overall Study|Out of 87: crossed over to Ustekinumab 45 mg (n=44) and Ustekinumab 90 mg (n=43)|87
53727|NCT02437162|128830|P3|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|14
53728|NCT02437162|128831|P2|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
53729|NCT02437162|128832|P1|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|26
53730|NCT02437162|128830|P3|Treated|Overall Study||114
53731|NCT02437162|128831|P2|Treated|Overall Study||116
53732|NCT02437162|128832|P1|Treated|Overall Study||116
53733|NCT02437162|128830|P3|STARTED|Overall Study||115
53734|NCT02437162|128831|P2|STARTED|Overall Study||116
53735|NCT02437162|128832|P1|STARTED|Overall Study||116
53736|NCT02436915|128952|P2|NOT COMPLETED|Overall Study||1
53737|NCT02436915|128953|P1|NOT COMPLETED|Overall Study||0
53738|NCT02436915|128952|P2|COMPLETED|Overall Study||9
53739|NCT02436915|128953|P1|COMPLETED|Overall Study||9
53740|NCT02436915|128952|P2|STARTED|Overall Study||10
53741|NCT02436915|128953|P1|STARTED|Overall Study||9
53742|NCT02436889|128975|P2|NOT COMPLETED|Overall Study||1
53743|NCT02436889|128976|P1|NOT COMPLETED|Overall Study||1
53744|NCT02436889|128975|P2|COMPLETED|Overall Study||10
53745|NCT02436889|128976|P1|COMPLETED|Overall Study||11
53746|NCT02436889|128975|P2|STARTED|Overall Study||11
53747|NCT02436889|128976|P1|STARTED|Overall Study||12
53748|NCT02436811|128995|P3|NOT COMPLETED|Overall Study||7
53749|NCT02436811|128996|P2|NOT COMPLETED|Overall Study||9
53750|NCT02436811|128997|P1|NOT COMPLETED|Overall Study||2
53751|NCT02436811|128995|P3|COMPLETED|Overall Study||53
53752|NCT02436811|128996|P2|COMPLETED|Overall Study||51
53753|NCT02436811|128997|P1|COMPLETED|Overall Study||58
53754|NCT02436811|128995|P3|STARTED|Overall Study||60
53755|NCT02436811|128996|P2|STARTED|Overall Study||60
53756|NCT02436811|128997|P1|STARTED|Overall Study||60
53757|NCT02436681|129005|P1|NOT COMPLETED|Overall Study||14
53758|NCT02436681|129005|P1|COMPLETED|Overall Study||27
53759|NCT02436681|129005|P1|STARTED|Overall Study||41
53760|NCT02436577|129022|P6|NOT COMPLETED|Overall Study||0
53761|NCT02436577|129023|P5|NOT COMPLETED|Overall Study||0
53762|NCT02436577|129024|P4|NOT COMPLETED|Overall Study||0
53763|NCT02436577|129025|P3|NOT COMPLETED|Overall Study||0
53764|NCT02436577|129026|P2|NOT COMPLETED|Overall Study||1
53765|NCT02436577|129027|P1|NOT COMPLETED|Overall Study||0
53766|NCT02436577|129022|P6|COMPLETED|Overall Study||7
53767|NCT02436577|129023|P5|COMPLETED|Overall Study||7
53768|NCT02436577|129024|P4|COMPLETED|Overall Study||7
53769|NCT02436577|129025|P3|COMPLETED|Overall Study||7
53770|NCT02436577|129026|P2|COMPLETED|Overall Study||6
53771|NCT02436577|129027|P1|COMPLETED|Overall Study||7
53772|NCT02436577|129022|P6|STARTED|Overall Study||7
53773|NCT02436577|129023|P5|STARTED|Overall Study||7
53774|NCT02436577|129024|P4|STARTED|Overall Study||7
53775|NCT02436577|129025|P3|STARTED|Overall Study||7
53776|NCT02436577|129026|P2|STARTED|Overall Study||7
53777|NCT02436577|129027|P1|STARTED|Overall Study||7
53778|NCT02436330|129082|P2|NOT COMPLETED|Cohort 6||1
53779|NCT02436330|129083|P1|NOT COMPLETED|Cohort 6||3
53780|NCT02436330|129082|P2|COMPLETED|Cohort 6||4
53781|NCT02436330|129083|P1|COMPLETED|Cohort 6||1
53782|NCT02436330|129082|P2|STARTED|Cohort 6||5
53783|NCT02436330|129083|P1|STARTED|Cohort 6||4
53784|NCT02436330|129082|P2|NOT COMPLETED|Cohort 5||4
53785|NCT02436330|129083|P1|NOT COMPLETED|Cohort 5||6
53786|NCT02436330|129082|P2|COMPLETED|Cohort 5||1
53787|NCT02436330|129083|P1|COMPLETED|Cohort 5||4
53788|NCT02436330|129082|P2|STARTED|Cohort 5||5
53789|NCT02436330|129083|P1|STARTED|Cohort 5||10
53790|NCT02436330|129082|P2|NOT COMPLETED|Cohort 4||0
53791|NCT02436330|129083|P1|NOT COMPLETED|Cohort 4||2
53792|NCT02436330|129082|P2|COMPLETED|Cohort 4||0
53793|NCT02436330|129083|P1|COMPLETED|Cohort 4||4
53794|NCT02436330|129082|P2|STARTED|Cohort 4|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
53795|NCT02436330|129083|P1|STARTED|Cohort 4||6
53796|NCT02436330|129082|P2|NOT COMPLETED|Cohort 3||0
53797|NCT02436330|129083|P1|NOT COMPLETED|Cohort 3||5
53798|NCT02436330|129082|P2|COMPLETED|Cohort 3||0
53799|NCT02436330|129083|P1|COMPLETED|Cohort 3||7
53800|NCT02436330|129082|P2|STARTED|Cohort 3|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
53801|NCT02436330|129083|P1|STARTED|Cohort 3||12
53802|NCT02436330|129082|P2|NOT COMPLETED|Cohort 2||3
53803|NCT02436330|129083|P1|NOT COMPLETED|Cohort 2||4
53804|NCT02436330|129082|P2|COMPLETED|Cohort 2||7
53805|NCT02436330|129083|P1|COMPLETED|Cohort 2||10
53806|NCT02436330|129082|P2|STARTED|Cohort 2||10
53807|NCT02436330|129083|P1|STARTED|Cohort 2||14
53808|NCT02436330|129082|P2|NOT COMPLETED|Cohort 1||3
53809|NCT02436330|129083|P1|NOT COMPLETED|Cohort 1||5
53810|NCT02436330|129082|P2|COMPLETED|Cohort 1||1
53811|NCT02436330|129083|P1|COMPLETED|Cohort 1||9
53812|NCT02436330|129082|P2|STARTED|Cohort 1||4
53813|NCT02436330|129083|P1|STARTED|Cohort 1||14
53814|NCT02436304|129128|P3|NOT COMPLETED|Overall Study||1
53815|NCT02436304|129129|P2|NOT COMPLETED|Overall Study||2
53816|NCT02436304|129130|P1|NOT COMPLETED|Overall Study||0
53817|NCT02436304|129128|P3|COMPLETED|Overall Study||100
53818|NCT02436304|129129|P2|COMPLETED|Overall Study||100
53819|NCT02436304|129130|P1|COMPLETED|Overall Study||153
53820|NCT02436304|129128|P3|STARTED|Overall Study||101
53821|NCT02436304|129129|P2|STARTED|Overall Study||102
53822|NCT02436304|129130|P1|STARTED|Overall Study||153
53823|NCT02436239|129149|P4|NOT COMPLETED|Down-Taper Period||2
53824|NCT02436239|129150|P3|NOT COMPLETED|Down-Taper Period||1
53825|NCT02436239|129151|P2|NOT COMPLETED|Down-Taper Period||4
53826|NCT02436239|129152|P1|NOT COMPLETED|Down-Taper Period||4
53827|NCT02436239|129149|P4|COMPLETED|Down-Taper Period||4
53828|NCT02436239|129150|P3|COMPLETED|Down-Taper Period||43
53829|NCT02436239|129151|P2|COMPLETED|Down-Taper Period||99
53830|NCT02436239|129152|P1|COMPLETED|Down-Taper Period||86
53831|NCT02436239|129149|P4|STARTED|Down-Taper Period|One participant who completed the open-label treatment period did not enter the down-taper period.|6
53832|NCT02436239|129150|P3|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|44
53833|NCT02436239|129151|P2|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|103
53834|NCT02436239|129152|P1|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|90
53835|NCT02436239|129149|P4|NOT COMPLETED|Open-Lable Treatment Period||5
53836|NCT02436239|129150|P3|NOT COMPLETED|Open-Lable Treatment Period||27
53837|NCT02436239|129151|P2|NOT COMPLETED|Open-Lable Treatment Period||34
53838|NCT02436239|129152|P1|NOT COMPLETED|Open-Lable Treatment Period||33
53839|NCT02436239|129149|P4|COMPLETED|Open-Lable Treatment Period||7
53840|NCT02436239|129150|P3|COMPLETED|Open-Lable Treatment Period||38
53841|NCT02436239|129151|P2|COMPLETED|Open-Lable Treatment Period||97
53842|NCT02436239|129152|P1|COMPLETED|Open-Lable Treatment Period||89
53843|NCT02436239|129149|P4|STARTED|Open-Lable Treatment Period||12
53844|NCT02436239|129150|P3|STARTED|Open-Lable Treatment Period||65
53845|NCT02436239|129151|P2|STARTED|Open-Lable Treatment Period||131
53846|NCT02436239|129152|P1|STARTED|Open-Lable Treatment Period||122
53847|NCT02436200|129174|P1|NOT COMPLETED|Overall Study||1
53848|NCT02436200|129174|P1|COMPLETED|Overall Study||20
53849|NCT02436200|129174|P1|STARTED|Overall Study||21
53850|NCT02436031|129179|P2|NOT COMPLETED|Second Study Night||0
53851|NCT02436031|129180|P1|NOT COMPLETED|Second Study Night||0
53852|NCT02436031|129179|P2|COMPLETED|Second Study Night||8
53853|NCT02436031|129180|P1|COMPLETED|Second Study Night||7
53854|NCT02436031|129179|P2|STARTED|Second Study Night||8
53855|NCT02436031|129180|P1|STARTED|Second Study Night|1 participant did not tolerate the study setup so did not participate in the second study night|7
53856|NCT02436031|129179|P2|NOT COMPLETED|First Study Night||0
53857|NCT02436031|129180|P1|NOT COMPLETED|First Study Night||0
53858|NCT02436031|129179|P2|COMPLETED|First Study Night||8
53859|NCT02436031|129180|P1|COMPLETED|First Study Night||8
53860|NCT02436031|129179|P2|STARTED|First Study Night||8
53861|NCT02436031|129180|P1|STARTED|First Study Night||8
53862|NCT02435966|129193|P3|NOT COMPLETED|Overall Study||0
53863|NCT02435966|129194|P2|NOT COMPLETED|Overall Study||1
53864|NCT02435966|129195|P1|NOT COMPLETED|Overall Study||0
53865|NCT02435966|129193|P3|COMPLETED|Overall Study||30
53866|NCT02435966|129194|P2|COMPLETED|Overall Study||53
53867|NCT02435966|129195|P1|COMPLETED|Overall Study||47
53868|NCT02435966|129193|P3|Follow-up|Overall Study||30
53869|NCT02435966|129194|P2|Follow-up|Overall Study||53
53870|NCT02435966|129195|P1|Follow-up|Overall Study||47
53871|NCT02435966|129193|P3|Second Intervention|Overall Study||30
53872|NCT02435966|129194|P2|Second Intervention|Overall Study||53
53873|NCT02435966|129195|P1|Second Intervention|Overall Study||47
53874|NCT02435966|129193|P3|First Intervention|Overall Study||30
53875|NCT02435966|129194|P2|First Intervention|Overall Study||54
53876|NCT02435966|129195|P1|First Intervention|Overall Study||47
53877|NCT02435966|129193|P3|STARTED|Overall Study||30
53878|NCT02435966|129194|P2|STARTED|Overall Study||54
53879|NCT02435966|129195|P1|STARTED|Overall Study||47
53880|NCT02435914|129207|P4|NOT COMPLETED|Overall Study||0
53881|NCT02435914|129208|P3|NOT COMPLETED|Overall Study||1
53882|NCT02435914|129209|P2|NOT COMPLETED|Overall Study||1
53883|NCT02435914|129210|P1|NOT COMPLETED|Overall Study||1
53884|NCT02435914|129207|P4|COMPLETED|Overall Study||59
53885|NCT02435914|129208|P3|COMPLETED|Overall Study||59
53886|NCT02435914|129209|P2|COMPLETED|Overall Study||58
53887|NCT02435914|129210|P1|COMPLETED|Overall Study||57
53888|NCT02435914|129207|P4|STARTED|Overall Study||59
53889|NCT02435914|129208|P3|STARTED|Overall Study||60
53890|NCT02435914|129209|P2|STARTED|Overall Study||59
53891|NCT02435914|129210|P1|STARTED|Overall Study||58
53892|NCT02435836|129232|P1|NOT COMPLETED|Overall Study||631
53893|NCT02435836|129232|P1|COMPLETED|Overall Study||0
53894|NCT02435836|129232|P1|STARTED|Overall Study||631
53895|NCT02435706|129250|P2|NOT COMPLETED|Overall Study||1
53896|NCT02435706|129251|P1|NOT COMPLETED|Overall Study||2
53897|NCT02435706|129250|P2|COMPLETED|Overall Study||20
53898|NCT02435706|129251|P1|COMPLETED|Overall Study||16
53899|NCT02435706|129250|P2|STARTED|Overall Study||21
53900|NCT02435706|129251|P1|STARTED|Overall Study||18
53901|NCT02435524|129265|P2|NOT COMPLETED|Endline Survey||0
53902|NCT02435524|129266|P1|NOT COMPLETED|Endline Survey||0
53903|NCT02435524|129265|P2|COMPLETED|Endline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1161
53904|NCT02435524|129266|P1|COMPLETED|Endline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1092
53905|NCT02435524|129265|P2|STARTED|Endline Survey||1161
53906|NCT02435524|129266|P1|STARTED|Endline Survey||1092
53907|NCT02435524|129265|P2|NOT COMPLETED|Baseline Survey||0
53908|NCT02435524|129266|P1|NOT COMPLETED|Baseline Survey||0
53909|NCT02435524|129265|P2|COMPLETED|Baseline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1177
53910|NCT02435524|129266|P1|COMPLETED|Baseline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1111
53911|NCT02435524|129265|P2|STARTED|Baseline Survey||1177
53912|NCT02435524|129266|P1|STARTED|Baseline Survey||1111
53913|NCT02435511|129274|P2|NOT COMPLETED|Overall Study||35
53914|NCT02435511|129275|P1|NOT COMPLETED|Overall Study||44
53915|NCT02435511|129274|P2|COMPLETED|Overall Study|Defined as completing the 3 month follow-up; not necessarily all time points|174
53916|NCT02435511|129275|P1|COMPLETED|Overall Study|Defined as completing the 3 month follow-up, not necessarily all time points|158
53917|NCT02435511|129274|P2|STARTED|Overall Study|Defined as enrolled and completed baseline|209
53918|NCT02435511|129275|P1|STARTED|Overall Study|Defined as enrolled and completed baseline|202
53919|NCT02435433|129291|P5|NOT COMPLETED|Overall Study||0
53920|NCT02435433|129292|P4|NOT COMPLETED|Overall Study||0
53921|NCT02435433|129293|P3|NOT COMPLETED|Overall Study||0
53922|NCT02435433|129294|P2|NOT COMPLETED|Overall Study||5
53923|NCT02435433|129295|P1|NOT COMPLETED|Overall Study||15
53924|NCT02435433|129291|P5|COMPLETED|Overall Study||0
53925|NCT02435433|129292|P4|COMPLETED|Overall Study||0
53926|NCT02435433|129293|P3|COMPLETED|Overall Study||0
53927|NCT02435433|129294|P2|COMPLETED|Overall Study||90
53928|NCT02435433|129295|P1|COMPLETED|Overall Study||182
53929|NCT02435433|129291|P5|Participants Who Received Study Drug|Overall Study||0
53930|NCT02435433|129292|P4|Participants Who Received Study Drug|Overall Study||0
53931|NCT02435433|129293|P3|Participants Who Received Study Drug|Overall Study||0
53932|NCT02435433|129294|P2|Participants Who Received Study Drug|Overall Study||95
53933|NCT02435433|129295|P1|Participants Who Received Study Drug|Overall Study||197
53934|NCT02435433|129291|P5|STARTED|Overall Study||0
53935|NCT02435433|129292|P4|STARTED|Overall Study||0
53936|NCT02435433|129293|P3|STARTED|Overall Study||0
53937|NCT02435433|129294|P2|STARTED|Overall Study||95
53938|NCT02435433|129295|P1|STARTED|Overall Study||197
53939|NCT02435277|129321|P4|NOT COMPLETED|Overall Study||0
53940|NCT02435277|129322|P3|NOT COMPLETED|Overall Study||0
53941|NCT02435277|129323|P2|NOT COMPLETED|Overall Study||1
53942|NCT02435277|129324|P1|NOT COMPLETED|Overall Study||2
53943|NCT02435277|129321|P4|COMPLETED|Overall Study||11
53944|NCT02435277|129322|P3|COMPLETED|Overall Study||11
53945|NCT02435277|129323|P2|COMPLETED|Overall Study||15
53946|NCT02435277|129324|P1|COMPLETED|Overall Study||10
53947|NCT02435277|129321|P4|STARTED|Overall Study||11
53948|NCT02435277|129322|P3|STARTED|Overall Study||11
53949|NCT02435277|129323|P2|STARTED|Overall Study||16
53950|NCT02435277|129324|P1|STARTED|Overall Study||12
53951|NCT02435147|129338|P1|NOT COMPLETED|Overall Study||11
53952|NCT02435147|129338|P1|COMPLETED|Overall Study||75
53953|NCT02435147|129338|P1|STARTED|Overall Study||86
53954|NCT02435069|129343|P5|NOT COMPLETED|Effectiveness - Second Intervention||1
53955|NCT02435069|129344|P4|NOT COMPLETED|Effectiveness - Second Intervention||0
53956|NCT02435069|129345|P3|NOT COMPLETED|Effectiveness - Second Intervention||0
53957|NCT02435069|129346|P2|NOT COMPLETED|Effectiveness - Second Intervention||0
53958|NCT02435069|129347|P1|NOT COMPLETED|Effectiveness - Second Intervention||0
53959|NCT02435069|129343|P5|COMPLETED|Effectiveness - Second Intervention||0
53960|NCT02435069|129344|P4|COMPLETED|Effectiveness - Second Intervention||1
53961|NCT02435069|129345|P3|COMPLETED|Effectiveness - Second Intervention||0
53962|NCT02435069|129346|P2|COMPLETED|Effectiveness - Second Intervention||0
53963|NCT02435069|129347|P1|COMPLETED|Effectiveness - Second Intervention||0
53964|NCT02435069|129343|P5|STARTED|Effectiveness - Second Intervention||1
53965|NCT02435069|129344|P4|STARTED|Effectiveness - Second Intervention||1
53966|NCT02435069|129345|P3|STARTED|Effectiveness - Second Intervention||0
53967|NCT02435069|129346|P2|STARTED|Effectiveness - Second Intervention||0
53968|NCT02435069|129347|P1|STARTED|Effectiveness - Second Intervention||0
53969|NCT02435069|129343|P5|NOT COMPLETED|Dose Response - First Intervention||0
53970|NCT02435069|129344|P4|NOT COMPLETED|Dose Response - First Intervention||0
53971|NCT02435069|129345|P3|NOT COMPLETED|Dose Response - First Intervention||1
53972|NCT02435069|129346|P2|NOT COMPLETED|Dose Response - First Intervention||1
53973|NCT02435069|129347|P1|NOT COMPLETED|Dose Response - First Intervention||0
53974|NCT02435069|129343|P5|COMPLETED|Dose Response - First Intervention||0
53975|NCT02435069|129344|P4|COMPLETED|Dose Response - First Intervention||0
53976|NCT02435069|129345|P3|COMPLETED|Dose Response - First Intervention||1
53977|NCT02435069|129346|P2|COMPLETED|Dose Response - First Intervention||2
53978|NCT02435069|129347|P1|COMPLETED|Dose Response - First Intervention||0
53979|NCT02435069|129343|P5|STARTED|Dose Response - First Intervention||0
53980|NCT02435069|129344|P4|STARTED|Dose Response - First Intervention||0
53981|NCT02435069|129345|P3|STARTED|Dose Response - First Intervention||2
53982|NCT02435069|129346|P2|STARTED|Dose Response - First Intervention||3
53983|NCT02435069|129347|P1|STARTED|Dose Response - First Intervention||0
53984|NCT02435069|129343|P5|NOT COMPLETED|Preoperative Baseline Phase||0
53985|NCT02435069|129344|P4|NOT COMPLETED|Preoperative Baseline Phase||0
53986|NCT02435069|129345|P3|NOT COMPLETED|Preoperative Baseline Phase||0
53987|NCT02435069|129346|P2|NOT COMPLETED|Preoperative Baseline Phase||0
53988|NCT02435069|129347|P1|NOT COMPLETED|Preoperative Baseline Phase||0
53989|NCT02435069|129343|P5|COMPLETED|Preoperative Baseline Phase||0
53990|NCT02435069|129344|P4|COMPLETED|Preoperative Baseline Phase||0
53991|NCT02435069|129345|P3|COMPLETED|Preoperative Baseline Phase||0
53992|NCT02435069|129346|P2|COMPLETED|Preoperative Baseline Phase||0
53993|NCT02435069|129347|P1|COMPLETED|Preoperative Baseline Phase||5
53994|NCT02435069|129343|P5|STARTED|Preoperative Baseline Phase||0
53995|NCT02435069|129344|P4|STARTED|Preoperative Baseline Phase||0
53996|NCT02435069|129345|P3|STARTED|Preoperative Baseline Phase||0
53997|NCT02435069|129346|P2|STARTED|Preoperative Baseline Phase||0
53998|NCT02435069|129347|P1|STARTED|Preoperative Baseline Phase||5
53999|NCT02434939|129369|P2|NOT COMPLETED|Overall Study||49
54000|NCT02434939|129370|P1|NOT COMPLETED|Overall Study||37
54001|NCT02434939|129369|P2|COMPLETED|Overall Study||71
54002|NCT02434939|129370|P1|COMPLETED|Overall Study||83
54003|NCT02434939|129369|P2|STARTED|Overall Study||120
54004|NCT02434939|129370|P1|STARTED|Overall Study||120
54005|NCT02434523|129384|P2|NOT COMPLETED|Overall Study||6
54006|NCT02434523|129385|P1|NOT COMPLETED|Overall Study||5
54007|NCT02434523|129384|P2|COMPLETED|Overall Study||9
54008|NCT02434523|129385|P1|COMPLETED|Overall Study||10
54009|NCT02434523|129384|P2|STARTED|Overall Study||15
54010|NCT02434523|129385|P1|STARTED|Overall Study||15
54011|NCT02434497|129397|P1|NOT COMPLETED|Overall Study||5
54012|NCT02434497|129397|P1|COMPLETED|Overall Study||4
54013|NCT02434497|129397|P1|STARTED|Overall Study||9
54014|NCT02434471|129497|P1|NOT COMPLETED|Overall Study||9
54015|NCT02434471|129497|P1|COMPLETED|Overall Study||25
54016|NCT02434471|129497|P1|STARTED|Overall Study||34
54017|NCT02434328|129506|P2|NOT COMPLETED|Overall Study||42
54018|NCT02434328|129507|P1|NOT COMPLETED|Overall Study||30
54019|NCT02434328|129506|P2|COMPLETED|Overall Study||329
54020|NCT02434328|129507|P1|COMPLETED|Overall Study||342
54021|NCT02434328|129506|P2|Randomized and Treated|Overall Study||369
54022|NCT02434328|129507|P1|Randomized and Treated|Overall Study||370
54023|NCT02434328|129506|P2|STARTED|Overall Study||371
54024|NCT02434328|129507|P1|STARTED|Overall Study||372
54025|NCT02434146|129570|P1|NOT COMPLETED|Overall Study||0
54026|NCT02434146|129570|P1|COMPLETED|Overall Study||3
54027|NCT02434146|129570|P1|STARTED|Overall Study||3
54028|NCT02433834|129582|P1|NOT COMPLETED|Overall Study||37
54029|NCT02433834|129582|P1|COMPLETED|Overall Study|Subject PT001101-040014 did not complete Period 4 but completed the study. CSR states 210 completed.|211
54030|NCT02433834|129582|P1|SAL 50 µg|Overall Study||167
54031|NCT02433834|129582|P1|Placebo MDI|Overall Study||174
54032|NCT02433834|129582|P1|GP MDI 1.9 µg|Overall Study||107
54033|NCT02433834|129582|P1|GP MDI 3.6 µg|Overall Study||118
54034|NCT02433834|129582|P1|GP MDI 7.2 µg|Overall Study||228
54035|NCT02433834|129582|P1|GP MDI 14.4 µg|Overall Study||230
54036|NCT02433834|129582|P1|GP MDI 28.8 µg|Overall Study||112
54037|NCT02433834|129582|P1|STARTED|Overall Study||248
54038|NCT02433678|129642|P2|NOT COMPLETED|Overall Study||2
54039|NCT02433678|129643|P1|NOT COMPLETED|Overall Study||1
54040|NCT02433678|129642|P2|COMPLETED|Overall Study||24
54041|NCT02433678|129643|P1|COMPLETED|Overall Study||25
54042|NCT02433678|129642|P2|STARTED|Overall Study||26
54043|NCT02433678|129643|P1|STARTED|Overall Study||26
54044|NCT02433496|129678|P3|NOT COMPLETED|Overall Study||0
54045|NCT02433496|129679|P2|NOT COMPLETED|Overall Study||0
54046|NCT02433496|129680|P1|NOT COMPLETED|Overall Study||0
54047|NCT02433496|129678|P3|COMPLETED|Overall Study|This includes patients (9813) and providers (20).|9833
54048|NCT02433496|129679|P2|COMPLETED|Overall Study|This includes patients (13296) and providers (13).|13309
54049|NCT02433496|129680|P1|COMPLETED|Overall Study|This includes patients (29956) and providers (34).|29990
54050|NCT02433496|129678|P3|STARTED|Overall Study|This includes patients (9813) and providers (20).|9833
54051|NCT02433496|129679|P2|STARTED|Overall Study|This includes patients (13296) and providers (13).|13309
54052|NCT02433496|129680|P1|STARTED|Overall Study|This includes patients (29956) and providers (34).|29990
54053|NCT02433483|129710|P1|NOT COMPLETED|Overall Study||2
54054|NCT02433483|129710|P1|COMPLETED|Overall Study||0
54055|NCT02433483|129710|P1|STARTED|Overall Study||2
54056|NCT02433366|129724|P2|NOT COMPLETED|Overall Study||0
54057|NCT02433366|129725|P1|NOT COMPLETED|Overall Study||0
54058|NCT02433366|129724|P2|COMPLETED|Overall Study||802
54059|NCT02433366|129725|P1|COMPLETED|Overall Study||411
54060|NCT02433366|129724|P2|STARTED|Overall Study||802
54061|NCT02433366|129725|P1|STARTED|Overall Study||411
54062|NCT02433340|129737|P4|NOT COMPLETED|Overall Study||2
54063|NCT02433340|129738|P3|NOT COMPLETED|Overall Study||2
54064|NCT02433340|129739|P2|NOT COMPLETED|Overall Study||2
54065|NCT02433340|129740|P1|NOT COMPLETED|Overall Study||2
54066|NCT02433340|129737|P4|COMPLETED|Overall Study||38
54067|NCT02433340|129738|P3|COMPLETED|Overall Study||37
54068|NCT02433340|129739|P2|COMPLETED|Overall Study||35
54069|NCT02433340|129740|P1|COMPLETED|Overall Study||40
54070|NCT02433340|129737|P4|STARTED|Overall Study||40
54071|NCT02433340|129738|P3|STARTED|Overall Study||39
54072|NCT02433340|129739|P2|STARTED|Overall Study||37
54073|NCT02433340|129740|P1|STARTED|Overall Study||42
54074|NCT02433288|130634|P2|NOT COMPLETED|Overall Study||126
54075|NCT02433288|130635|P1|NOT COMPLETED|Overall Study||123
54076|NCT02433288|130634|P2|COMPLETED|Overall Study||316
54077|NCT02433288|130635|P1|COMPLETED|Overall Study||320
54078|NCT02433288|130634|P2|STARTED|Overall Study||442
54079|NCT02433288|130635|P1|STARTED|Overall Study||443
54080|NCT02432729|130649|P1|NOT COMPLETED|Month 12 Visit||196
54081|NCT02432729|130649|P1|COMPLETED|Month 12 Visit||436
54082|NCT02432729|130649|P1|STARTED|Month 12 Visit||632
54083|NCT02432729|130649|P1|NOT COMPLETED|Month 6 Visit||86
54084|NCT02432729|130649|P1|COMPLETED|Month 6 Visit||632
54085|NCT02432729|130649|P1|STARTED|Month 6 Visit||718
54086|NCT02432729|130649|P1|NOT COMPLETED|Month 3 Visit||2
54087|NCT02432729|130649|P1|COMPLETED|Month 3 Visit||718
54088|NCT02432729|130649|P1|STARTED|Month 3 Visit||720
54089|NCT02432300|130677|P1|NOT COMPLETED|Overall Study||4
54090|NCT02432300|130677|P1|COMPLETED|Overall Study||13
54091|NCT02432300|130677|P1|STARTED|Overall Study||17
54092|NCT02432287|130686|P2|NOT COMPLETED|Second Intervention||0
54093|NCT02432287|130687|P1|NOT COMPLETED|Second Intervention||0
54094|NCT02432287|130686|P2|COMPLETED|Second Intervention||7
54095|NCT02432287|130687|P1|COMPLETED|Second Intervention||7
54096|NCT02432287|130686|P2|STARTED|Second Intervention||7
54097|NCT02432287|130687|P1|STARTED|Second Intervention||7
54098|NCT02432287|130686|P2|NOT COMPLETED|Washout Period||0
54099|NCT02432287|130687|P1|NOT COMPLETED|Washout Period||0
54100|NCT02432287|130686|P2|COMPLETED|Washout Period||7
54101|NCT02432287|130687|P1|COMPLETED|Washout Period||7
54102|NCT02432287|130686|P2|STARTED|Washout Period||7
54103|NCT02432287|130687|P1|STARTED|Washout Period||7
54104|NCT02432287|130686|P2|NOT COMPLETED|First Intervention||1
54105|NCT02432287|130687|P1|NOT COMPLETED|First Intervention||0
54106|NCT02432287|130686|P2|COMPLETED|First Intervention||7
54107|NCT02432287|130687|P1|COMPLETED|First Intervention||8
54108|NCT02432287|130686|P2|STARTED|First Intervention||8
54109|NCT02432287|130687|P1|STARTED|First Intervention||8
54110|NCT02432196|130695|P1|NOT COMPLETED|Overall Study||26
54111|NCT02432196|130695|P1|COMPLETED|Overall Study||0
54112|NCT02432196|130695|P1|Implanted With Device|Overall Study||25
54113|NCT02432196|130695|P1|STARTED|Overall Study||26
54114|NCT02432144|130703|P1|NOT COMPLETED|Overall Study||1
54115|NCT02432144|130703|P1|COMPLETED|Overall Study||11
54116|NCT02432144|130703|P1|STARTED|Overall Study||12
54117|NCT02432105|130711|P3|NOT COMPLETED|Overall Study||3
54118|NCT02432105|130712|P2|NOT COMPLETED|Overall Study||2
54119|NCT02432105|130713|P1|NOT COMPLETED|Overall Study||2
54120|NCT02432105|130711|P3|COMPLETED|Overall Study||108
54121|NCT02432105|130712|P2|COMPLETED|Overall Study||108
54122|NCT02432105|130713|P1|COMPLETED|Overall Study||162
54123|NCT02432105|130711|P3|STARTED|Overall Study||111
54124|NCT02432105|130712|P2|STARTED|Overall Study||110
54125|NCT02432105|130713|P1|STARTED|Overall Study||164
54126|NCT02432040|130730|P2|NOT COMPLETED|Overall Study||6
54127|NCT02432040|130731|P1|NOT COMPLETED|Overall Study||8
54128|NCT02432040|130730|P2|COMPLETED|Overall Study||8
54129|NCT02432040|130731|P1|COMPLETED|Overall Study||6
54130|NCT02432040|130730|P2|STARTED|Overall Study||14
54131|NCT02432040|130731|P1|STARTED|Overall Study||14
54132|NCT02431793|130754|P3|NOT COMPLETED|Overall Study||117
54133|NCT02431793|130755|P2|NOT COMPLETED|Overall Study||134
54134|NCT02431793|130756|P1|NOT COMPLETED|Overall Study||119
54135|NCT02431793|130754|P3|COMPLETED|Overall Study||90
54136|NCT02431793|130755|P2|COMPLETED|Overall Study||109
54137|NCT02431793|130756|P1|COMPLETED|Overall Study||83
54138|NCT02431793|130754|P3|Completed T3 (30 Days Post Enrollment)|Overall Study||93
54139|NCT02431793|130755|P2|Completed T3 (30 Days Post Enrollment)|Overall Study||113
54140|NCT02431793|130756|P1|Completed T3 (30 Days Post Enrollment)|Overall Study||85
54141|NCT02431793|130754|P3|Completed T2 (7-14 Days Post Enrollment)|Overall Study||107
54142|NCT02431793|130755|P2|Completed T2 (7-14 Days Post Enrollment)|Overall Study||141
54143|NCT02431793|130756|P1|Completed T2 (7-14 Days Post Enrollment)|Overall Study||95
54144|NCT02431793|130754|P3|Completed T1 (3-5 Days Post Enrollment)|Overall Study||143
54145|NCT02431793|130755|P2|Completed T1 (3-5 Days Post Enrollment)|Overall Study||180
54146|NCT02431793|130756|P1|Completed T1 (3-5 Days Post Enrollment)|Overall Study||136
54147|NCT02431793|130754|P3|STARTED|Overall Study||207
54148|NCT02431793|130755|P2|STARTED|Overall Study||243
54149|NCT02431793|130756|P1|STARTED|Overall Study||202
54150|NCT02431754|130778|P2|NOT COMPLETED|Period 2 (8 Weeks)||4
54151|NCT02431754|130779|P1|NOT COMPLETED|Period 2 (8 Weeks)||1
54152|NCT02431754|130778|P2|COMPLETED|Period 2 (8 Weeks)||78
54153|NCT02431754|130779|P1|COMPLETED|Period 2 (8 Weeks)||74
54154|NCT02431754|130778|P2|STARTED|Period 2 (8 Weeks)||82
54155|NCT02431754|130779|P1|STARTED|Period 2 (8 Weeks)||75
54156|NCT02431754|130778|P2|NOT COMPLETED|Wash-out Period (4 Weeks)||0
54157|NCT02431754|130779|P1|NOT COMPLETED|Wash-out Period (4 Weeks)||4
54158|NCT02431754|130778|P2|COMPLETED|Wash-out Period (4 Weeks)||82
54159|NCT02431754|130779|P1|COMPLETED|Wash-out Period (4 Weeks)||75
54160|NCT02431754|130778|P2|STARTED|Wash-out Period (4 Weeks)||82
54161|NCT02431754|130779|P1|STARTED|Wash-out Period (4 Weeks)||79
54162|NCT02431754|130778|P2|NOT COMPLETED|Period 1 (8 Weeks)||4
54163|NCT02431754|130779|P1|NOT COMPLETED|Period 1 (8 Weeks)||6
54164|NCT02431754|130778|P2|COMPLETED|Period 1 (8 Weeks)||82
54165|NCT02431754|130779|P1|COMPLETED|Period 1 (8 Weeks)||79
54166|NCT02431754|130778|P2|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||86
54167|NCT02431754|130779|P1|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||85
54168|NCT02431754|130778|P2|STARTED|Period 1 (8 Weeks)||86
54169|NCT02431754|130779|P1|STARTED|Period 1 (8 Weeks)||85
54170|NCT02431741|130797|P1|NOT COMPLETED|Overall Study||0
54171|NCT02431741|130797|P1|COMPLETED|Overall Study||14
54172|NCT02431741|130797|P1|STARTED|Overall Study||14
54173|NCT02431598|130801|P6|NOT COMPLETED|Overall Study||0
54174|NCT02431598|130802|P5|NOT COMPLETED|Overall Study||0
54175|NCT02431598|130803|P4|NOT COMPLETED|Overall Study||0
54176|NCT02431598|130804|P3|NOT COMPLETED|Overall Study||0
54177|NCT02431598|130805|P2|NOT COMPLETED|Overall Study||0
54178|NCT02431598|130806|P1|NOT COMPLETED|Overall Study||0
54179|NCT02431598|130801|P6|COMPLETED|Overall Study||6
54180|NCT02431598|130802|P5|COMPLETED|Overall Study||7
54181|NCT02431598|130803|P4|COMPLETED|Overall Study||7
54182|NCT02431598|130804|P3|COMPLETED|Overall Study||9
54183|NCT02431598|130805|P2|COMPLETED|Overall Study||9
54184|NCT02431598|130806|P1|COMPLETED|Overall Study||6
54185|NCT02431598|130801|P6|STARTED|Overall Study||6
54186|NCT02431598|130802|P5|STARTED|Overall Study||7
54187|NCT02431598|130803|P4|STARTED|Overall Study||7
54188|NCT02431598|130804|P3|STARTED|Overall Study||9
54189|NCT02431598|130805|P2|STARTED|Overall Study||9
54190|NCT02431598|130806|P1|STARTED|Overall Study||6
54191|NCT02431559|130834|P4|NOT COMPLETED|Overall Study||31
54192|NCT02431559|130835|P3|NOT COMPLETED|Overall Study||4
54193|NCT02431559|130836|P2|NOT COMPLETED|Overall Study||3
54194|NCT02431559|130837|P1|NOT COMPLETED|Overall Study||2
54195|NCT02431559|130834|P4|COMPLETED|Overall Study||9
54196|NCT02431559|130835|P3|COMPLETED|Overall Study||2
54197|NCT02431559|130836|P2|COMPLETED|Overall Study||1
54198|NCT02431559|130837|P1|COMPLETED|Overall Study||1
54199|NCT02431559|130834|P4|STARTED|Overall Study||40
54200|NCT02431559|130835|P3|STARTED|Overall Study||6
54201|NCT02431559|130836|P2|STARTED|Overall Study||4
54202|NCT02431559|130837|P1|STARTED|Overall Study||3
54203|NCT02431533|130861|P2|NOT COMPLETED|Overall Study||3
54204|NCT02431533|130862|P1|NOT COMPLETED|Overall Study||2
54205|NCT02431533|130861|P2|COMPLETED|Overall Study||22
54206|NCT02431533|130862|P1|COMPLETED|Overall Study||23
54207|NCT02431533|130861|P2|STARTED|Overall Study||25
54208|NCT02431533|130862|P1|STARTED|Overall Study||25
54209|NCT02431468|130897|P3|NOT COMPLETED|Overall Study||9
54210|NCT02431468|130898|P2|NOT COMPLETED|Overall Study||18
54211|NCT02431468|130899|P1|NOT COMPLETED|Overall Study||8
54212|NCT02431468|130897|P3|COMPLETED|Overall Study||39
54213|NCT02431468|130898|P2|COMPLETED|Overall Study||29
54214|NCT02431468|130899|P1|COMPLETED|Overall Study||38
54215|NCT02431468|130897|P3|STARTED|Overall Study||48
54216|NCT02431468|130898|P2|STARTED|Overall Study||47
54217|NCT02431468|130899|P1|STARTED|Overall Study||46
54218|NCT02431455|130921|P2|NOT COMPLETED|Overall Study||0
54219|NCT02431455|130922|P1|NOT COMPLETED|Overall Study||0
54220|NCT02431455|130921|P2|COMPLETED|Overall Study||112
54221|NCT02431455|130922|P1|COMPLETED|Overall Study||112
54222|NCT02431455|130921|P2|STARTED|Overall Study||112
54223|NCT02431455|130922|P1|STARTED|Overall Study||112
54224|NCT02431299|130936|P2|NOT COMPLETED|Overall Study||1
54225|NCT02431299|130937|P1|NOT COMPLETED|Overall Study||53
54226|NCT02431299|130936|P2|COMPLETED|Overall Study||62
54227|NCT02431299|130937|P1|COMPLETED|Overall Study||183
54228|NCT02431299|130936|P2|STARTED|Overall Study||63
54229|NCT02431299|130937|P1|STARTED|Overall Study||236
54230|NCT02431273|130950|P1|NOT COMPLETED|TDF-FTC-MVC (Triple IVR)||0
54231|NCT02431273|130950|P1|COMPLETED|TDF-FTC-MVC (Triple IVR)||6
54232|NCT02431273|130950|P1|STARTED|TDF-FTC-MVC (Triple IVR)||6
54233|NCT02431273|130950|P1|NOT COMPLETED|TDF-FTC (Dual IVR)||0
54234|NCT02431273|130950|P1|COMPLETED|TDF-FTC (Dual IVR)||6
54235|NCT02431273|130950|P1|STARTED|TDF-FTC (Dual IVR)||6
54236|NCT02431273|130950|P1|NOT COMPLETED|TDF (Single IVR)||0
54237|NCT02431273|130950|P1|COMPLETED|TDF (Single IVR)||6
54238|NCT02431273|130950|P1|STARTED|TDF (Single IVR)||6
54239|NCT02431260|130990|P14|NOT COMPLETED|Overall Study||1
54240|NCT02431260|130991|P13|NOT COMPLETED|Overall Study||10
54241|NCT02431260|130992|P12|NOT COMPLETED|Overall Study||4
54242|NCT02431260|130993|P11|NOT COMPLETED|Overall Study||4
54243|NCT02431260|130994|P10|NOT COMPLETED|Overall Study||8
54244|NCT02431260|130995|P9|NOT COMPLETED|Overall Study||8
54245|NCT02431260|130996|P8|NOT COMPLETED|Overall Study||3
54246|NCT02431260|130997|P7|NOT COMPLETED|Overall Study||4
54247|NCT02431260|130998|P6|NOT COMPLETED|Overall Study||4
54248|NCT02431260|130999|P5|NOT COMPLETED|Overall Study||3
54249|NCT02431260|131000|P4|NOT COMPLETED|Overall Study||5
54250|NCT02431260|131001|P3|NOT COMPLETED|Overall Study||6
54251|NCT02431260|131002|P2|NOT COMPLETED|Overall Study||5
54252|NCT02431260|131003|P1|NOT COMPLETED|Overall Study||4
54253|NCT02431260|130990|P14|COMPLETED|Overall Study||0
54254|NCT02431260|130991|P13|COMPLETED|Overall Study||0
54255|NCT02431260|130992|P12|COMPLETED|Overall Study||0
54256|NCT02431260|130993|P11|COMPLETED|Overall Study||0
54257|NCT02431260|130994|P10|COMPLETED|Overall Study||0
54258|NCT02431260|130995|P9|COMPLETED|Overall Study||0
54259|NCT02431260|130996|P8|COMPLETED|Overall Study||0
54260|NCT02431260|130997|P7|COMPLETED|Overall Study||0
54261|NCT02431260|130998|P6|COMPLETED|Overall Study||0
54262|NCT02431260|130999|P5|COMPLETED|Overall Study||0
54263|NCT02431260|131000|P4|COMPLETED|Overall Study||0
54264|NCT02431260|131001|P3|COMPLETED|Overall Study||0
54265|NCT02431260|131002|P2|COMPLETED|Overall Study||0
54266|NCT02431260|131003|P1|COMPLETED|Overall Study||0
54267|NCT02431260|130990|P14|STARTED|Overall Study||1
54268|NCT02431260|130991|P13|STARTED|Overall Study||10
54269|NCT02431260|130992|P12|STARTED|Overall Study||4
54270|NCT02431260|130993|P11|STARTED|Overall Study||4
54271|NCT02431260|130994|P10|STARTED|Overall Study||8
54272|NCT02431260|130995|P9|STARTED|Overall Study||8
54273|NCT02431260|130996|P8|STARTED|Overall Study||3
54274|NCT02431260|130997|P7|STARTED|Overall Study||4
54275|NCT02431260|130998|P6|STARTED|Overall Study||4
54276|NCT02431260|130999|P5|STARTED|Overall Study||3
54277|NCT02431260|131000|P4|STARTED|Overall Study||5
54278|NCT02431260|131001|P3|STARTED|Overall Study||6
54279|NCT02431260|131002|P2|STARTED|Overall Study||5
54280|NCT02431260|131003|P1|STARTED|Overall Study||4
54281|NCT02431247|131096|P2|NOT COMPLETED|Overall Study||363
54282|NCT02431247|131097|P1|NOT COMPLETED|Overall Study||362
54283|NCT02431247|131096|P2|COMPLETED|Overall Study||0
54284|NCT02431247|131097|P1|COMPLETED|Overall Study||0
54285|NCT02431247|131096|P2|STARTED|Overall Study||363
54286|NCT02431247|131097|P1|STARTED|Overall Study||362
54287|NCT02431052|131156|P5|NOT COMPLETED|Overall Study||15
54288|NCT02431052|131157|P4|NOT COMPLETED|Overall Study||16
54289|NCT02431052|131158|P3|NOT COMPLETED|Overall Study||12
54290|NCT02431052|131159|P2|NOT COMPLETED|Overall Study||4
54291|NCT02431052|131160|P1|NOT COMPLETED|Overall Study||11
54292|NCT02431052|131156|P5|COMPLETED|Overall Study||86
54293|NCT02431052|131157|P4|COMPLETED|Overall Study||94
54294|NCT02431052|131158|P3|COMPLETED|Overall Study||94
54295|NCT02431052|131159|P2|COMPLETED|Overall Study||46
54296|NCT02431052|131160|P1|COMPLETED|Overall Study||42
54297|NCT02431052|131156|P5|STARTED|Overall Study||101
54298|NCT02431052|131157|P4|STARTED|Overall Study||110
54299|NCT02431052|131158|P3|STARTED|Overall Study||106
54300|NCT02431052|131159|P2|STARTED|Overall Study||50
54301|NCT02431052|131160|P1|STARTED|Overall Study||53
54302|NCT02430870|131190|P8|NOT COMPLETED|Part 2||1
54303|NCT02430870|131191|P7|NOT COMPLETED|Part 2||1
54304|NCT02430870|131192|P6|NOT COMPLETED|Part 2||0
54305|NCT02430870|131193|P5|NOT COMPLETED|Part 2||0
54306|NCT02430870|131194|P4|NOT COMPLETED|Part 2||0
54307|NCT02430870|131195|P3|NOT COMPLETED|Part 2||0
54308|NCT02430870|131196|P2|NOT COMPLETED|Part 2||0
54309|NCT02430870|131197|P1|NOT COMPLETED|Part 2||0
54310|NCT02430870|131190|P8|COMPLETED|Part 2||7
54311|NCT02430870|131191|P7|COMPLETED|Part 2||5
54312|NCT02430870|131192|P6|COMPLETED|Part 2||6
54313|NCT02430870|131193|P5|COMPLETED|Part 2||6
54314|NCT02430870|131194|P4|COMPLETED|Part 2||6
54315|NCT02430870|131195|P3|COMPLETED|Part 2||0
54316|NCT02430870|131196|P2|COMPLETED|Part 2||0
54317|NCT02430870|131197|P1|COMPLETED|Part 2||0
54318|NCT02430870|131190|P8|STARTED|Part 2||8
54319|NCT02430870|131191|P7|STARTED|Part 2||6
54320|NCT02430870|131192|P6|STARTED|Part 2||6
54321|NCT02430870|131193|P5|STARTED|Part 2||6
54322|NCT02430870|131194|P4|STARTED|Part 2||6
54323|NCT02430870|131195|P3|STARTED|Part 2||0
54324|NCT02430870|131196|P2|STARTED|Part 2||0
54325|NCT02430870|131197|P1|STARTED|Part 2||0
54326|NCT02430870|131190|P8|NOT COMPLETED|Part 1||0
54327|NCT02430870|131191|P7|NOT COMPLETED|Part 1||0
54328|NCT02430870|131192|P6|NOT COMPLETED|Part 1||0
54329|NCT02430870|131193|P5|NOT COMPLETED|Part 1||0
54330|NCT02430870|131194|P4|NOT COMPLETED|Part 1||0
54331|NCT02430870|131195|P3|NOT COMPLETED|Part 1||0
54332|NCT02430870|131196|P2|NOT COMPLETED|Part 1||0
54333|NCT02430870|131197|P1|NOT COMPLETED|Part 1||0
54334|NCT02430870|131190|P8|COMPLETED|Part 1||0
54335|NCT02430870|131191|P7|COMPLETED|Part 1||0
54336|NCT02430870|131192|P6|COMPLETED|Part 1||0
54337|NCT02430870|131193|P5|COMPLETED|Part 1||0
54338|NCT02430870|131194|P4|COMPLETED|Part 1||0
54339|NCT02430870|131195|P3|COMPLETED|Part 1||4
54340|NCT02430870|131196|P2|COMPLETED|Part 1||6
54341|NCT02430870|131197|P1|COMPLETED|Part 1||6
54342|NCT02430870|131190|P8|STARTED|Part 1||0
54343|NCT02430870|131191|P7|STARTED|Part 1||0
54344|NCT02430870|131192|P6|STARTED|Part 1||0
54345|NCT02430870|131193|P5|STARTED|Part 1||0
54346|NCT02430870|131194|P4|STARTED|Part 1||0
54347|NCT02430870|131195|P3|STARTED|Part 1||4
54348|NCT02430870|131196|P2|STARTED|Part 1||6
54349|NCT02430870|131197|P1|STARTED|Part 1||6
54350|NCT02430818|131271|P2|NOT COMPLETED|Overall Study||0
54351|NCT02430818|131272|P1|NOT COMPLETED|Overall Study||0
54352|NCT02430818|131271|P2|COMPLETED|Overall Study||6
54353|NCT02430818|131272|P1|COMPLETED|Overall Study||7
54354|NCT02430818|131271|P2|STARTED|Overall Study||6
54355|NCT02430818|131272|P1|STARTED|Overall Study||7
54356|NCT02430532|131284|P2|NOT COMPLETED|Overall Study||28
54357|NCT02430532|131285|P1|NOT COMPLETED|Overall Study||30
54358|NCT02430532|131284|P2|COMPLETED|Overall Study||0
54359|NCT02430532|131285|P1|COMPLETED|Overall Study||0
54360|NCT02430532|131284|P2|STARTED|Overall Study||28
54361|NCT02430532|131285|P1|STARTED|Overall Study||30
54362|NCT02430389|131301|P2|NOT COMPLETED|Overall Study||0
54363|NCT02430389|131302|P1|NOT COMPLETED|Overall Study||0
54364|NCT02430389|131301|P2|COMPLETED|Overall Study||10
54365|NCT02430389|131302|P1|COMPLETED|Overall Study||10
54366|NCT02430389|131301|P2|STARTED|Overall Study||10
54367|NCT02430389|131302|P1|STARTED|Overall Study||10
54368|NCT02430311|131312|P2|NOT COMPLETED|Part B||8
54369|NCT02430311|131313|P1|NOT COMPLETED|Part B||10
54370|NCT02430311|131312|P2|COMPLETED|Part B||7
54371|NCT02430311|131313|P1|COMPLETED|Part B||9
54372|NCT02430311|131312|P2|Received Paclitaxel|Part B||14
54373|NCT02430311|131313|P1|Received Paclitaxel|Part B|Cohort 1 patients are planned to receive olaparib monotherapy|0
54374|NCT02430311|131312|P2|Received Olaparib|Part B||15
54375|NCT02430311|131313|P1|Received Olaparib|Part B||19
54376|NCT02430311|131312|P2|STARTED|Part B||15
54377|NCT02430311|131313|P1|STARTED|Part B||19
54378|NCT02430311|131312|P2|NOT COMPLETED|Part A||1
54379|NCT02430311|131313|P1|NOT COMPLETED|Part A||1
54380|NCT02430311|131312|P2|COMPLETED|Part A||15
54381|NCT02430311|131313|P1|COMPLETED|Part A||19
54382|NCT02430311|131312|P2|Received Paclitaxel|Part A||16
54383|NCT02430311|131313|P1|Received Paclitaxel|Part A|Cohort 1 patients are planned to receive olaparib monotherapy|0
54384|NCT02430311|131312|P2|Received Olaparib|Part A||16
54385|NCT02430311|131313|P1|Received Olaparib|Part A||20
54386|NCT02430311|131312|P2|STARTED|Part A||16
54387|NCT02430311|131313|P1|STARTED|Part A||20
54388|NCT02430090|131349|P3|NOT COMPLETED|Overall Study||0
54389|NCT02430090|131350|P2|NOT COMPLETED|Overall Study||0
54390|NCT02430090|131351|P1|NOT COMPLETED|Overall Study||0
54391|NCT02430090|131349|P3|COMPLETED|Overall Study||15
54392|NCT02430090|131350|P2|COMPLETED|Overall Study||15
54393|NCT02430090|131351|P1|COMPLETED|Overall Study||15
54394|NCT02430090|131349|P3|STARTED|Overall Study||15
54395|NCT02430090|131350|P2|STARTED|Overall Study||15
54396|NCT02430090|131351|P1|STARTED|Overall Study||15
54397|NCT02429869|131359|P1|NOT COMPLETED|Overall Study||0
54398|NCT02429869|131359|P1|COMPLETED|Overall Study||10
54399|NCT02429869|131359|P1|STARTED|Overall Study||10
54400|NCT02429856|131367|P2|NOT COMPLETED|Overall Study||19
54401|NCT02429856|131368|P1|NOT COMPLETED|Overall Study||19
54402|NCT02429856|131367|P2|COMPLETED|Overall Study||32
54403|NCT02429856|131368|P1|COMPLETED|Overall Study||30
54404|NCT02429856|131367|P2|STARTED|Overall Study||51
54405|NCT02429856|131368|P1|STARTED|Overall Study||49
54406|NCT02429791|131386|P2|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||28
54407|NCT02429791|131387|P1|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||25
54408|NCT02429791|131386|P2|COMPLETED|Late Switch Phase (Week 52 to Week 148)||210
54409|NCT02429791|131387|P1|COMPLETED|Late Switch Phase (Week 52 to Week 148)||214
54410|NCT02429791|131386|P2|STARTED|Late Switch Phase (Week 52 to Week 148)||238
54411|NCT02429791|131387|P1|STARTED|Late Switch Phase (Week 52 to Week 148)||239
54412|NCT02429791|131386|P2|NOT COMPLETED|Early Switch Phase (Up to Week 52)||18
54413|NCT02429791|131387|P1|NOT COMPLETED|Early Switch Phase (Up to Week 52)||13
54414|NCT02429791|131386|P2|COMPLETED|Early Switch Phase (Up to Week 52)||238
54415|NCT02429791|131387|P1|COMPLETED|Early Switch Phase (Up to Week 52)||239
54416|NCT02429791|131386|P2|STARTED|Early Switch Phase (Up to Week 52)||256
54417|NCT02429791|131387|P1|STARTED|Early Switch Phase (Up to Week 52)||252
54418|NCT02429310|131475|P2|NOT COMPLETED|Overall Study||3
54419|NCT02429310|131476|P1|NOT COMPLETED|Overall Study||2
54420|NCT02429310|131475|P2|COMPLETED|Overall Study||17
54421|NCT02429310|131476|P1|COMPLETED|Overall Study||20
54422|NCT02429310|131475|P2|STARTED|Overall Study||20
54423|NCT02429310|131476|P1|STARTED|Overall Study||22
54424|NCT02429258|131486|P2|NOT COMPLETED|Overall Study||1
54425|NCT02429258|131487|P1|NOT COMPLETED|Overall Study||2
54426|NCT02429258|131486|P2|COMPLETED|Overall Study||49
54427|NCT02429258|131487|P1|COMPLETED|Overall Study||48
54428|NCT02429258|131486|P2|STARTED|Overall Study||50
54429|NCT02429258|131487|P1|STARTED|Overall Study||50
54430|NCT02428699|131513|P2|NOT COMPLETED|Period 2||0
54431|NCT02428699|131514|P1|NOT COMPLETED|Period 2||0
54432|NCT02428699|131513|P2|COMPLETED|Period 2||23
54433|NCT02428699|131514|P1|COMPLETED|Period 2||24
54434|NCT02428699|131513|P2|STARTED|Period 2||23
54435|NCT02428699|131514|P1|STARTED|Period 2||24
54436|NCT02428699|131513|P2|NOT COMPLETED|Washout Period 1||2
54437|NCT02428699|131514|P1|NOT COMPLETED|Washout Period 1||1
54438|NCT02428699|131513|P2|COMPLETED|Washout Period 1||23
54439|NCT02428699|131514|P1|COMPLETED|Washout Period 1||24
54440|NCT02428699|131513|P2|STARTED|Washout Period 1||25
54441|NCT02428699|131514|P1|STARTED|Washout Period 1||25
54442|NCT02428699|131513|P2|NOT COMPLETED|Period 1||0
54443|NCT02428699|131514|P1|NOT COMPLETED|Period 1||0
54444|NCT02428699|131513|P2|COMPLETED|Period 1||25
54445|NCT02428699|131514|P1|COMPLETED|Period 1||25
54446|NCT02428699|131513|P2|STARTED|Period 1||25
54447|NCT02428699|131514|P1|STARTED|Period 1||25
54448|NCT02428608|131542|P1|NOT COMPLETED|Overall Study||83
54449|NCT02428608|131542|P1|COMPLETED|Overall Study||487
54450|NCT02428608|131542|P1|STARTED|Overall Study||570
54451|NCT02428595|131547|P1|NOT COMPLETED|Treatment||19
54452|NCT02428595|131547|P1|COMPLETED|Treatment||54
54453|NCT02428595|131547|P1|STARTED|Treatment||73
54454|NCT02428595|131547|P1|NOT COMPLETED|Fitting||64
54455|NCT02428595|131547|P1|COMPLETED|Fitting||73
54456|NCT02428595|131547|P1|STARTED|Fitting||137
54457|NCT02428478|131563|P2|NOT COMPLETED|Second Study Night||0
54458|NCT02428478|131564|P1|NOT COMPLETED|Second Study Night||0
54459|NCT02428478|131563|P2|COMPLETED|Second Study Night||6
54460|NCT02428478|131564|P1|COMPLETED|Second Study Night||8
54461|NCT02428478|131563|P2|STARTED|Second Study Night|2 participants did not return for the second study night|6
54462|NCT02428478|131564|P1|STARTED|Second Study Night|1 participant did not return for the second study night|8
54463|NCT02428478|131563|P2|NOT COMPLETED|First Study Night||0
54464|NCT02428478|131564|P1|NOT COMPLETED|First Study Night||0
54465|NCT02428478|131563|P2|COMPLETED|First Study Night||8
54466|NCT02428478|131564|P1|COMPLETED|First Study Night||9
54467|NCT02428478|131563|P2|STARTED|First Study Night||8
54468|NCT02428478|131564|P1|STARTED|First Study Night||9
54469|NCT02428413|131574|P2|NOT COMPLETED|Overall Study||9
54470|NCT02428413|131575|P1|NOT COMPLETED|Overall Study||8
54471|NCT02428413|131574|P2|COMPLETED|Overall Study||52
54472|NCT02428413|131575|P1|COMPLETED|Overall Study||56
54473|NCT02428413|131574|P2|STARTED|Overall Study||61
54474|NCT02428413|131575|P1|STARTED|Overall Study||64
54475|NCT02428309|131587|P1|NOT COMPLETED|Overall Study||0
54476|NCT02428309|131587|P1|COMPLETED|Overall Study|The enrolled participant completed treatment and was followed through week 152, per protocol.|1
54477|NCT02428309|131587|P1|STARTED|Overall Study||1
54478|NCT02428231|131612|P2|NOT COMPLETED|Overall Study||17
54479|NCT02428231|131613|P1|NOT COMPLETED|Overall Study||13
54480|NCT02428231|131612|P2|COMPLETED|Overall Study||15
54481|NCT02428231|131613|P1|COMPLETED|Overall Study||17
54482|NCT02428231|131612|P2|STARTED|Overall Study||32
54483|NCT02428231|131613|P1|STARTED|Overall Study||30
54484|NCT02427984|131630|P3|NOT COMPLETED|Overall Study||18
54485|NCT02427984|131631|P2|NOT COMPLETED|Overall Study||5
54486|NCT02427984|131632|P1|NOT COMPLETED|Overall Study||13
54487|NCT02427984|131630|P3|COMPLETED|Overall Study||32
54488|NCT02427984|131631|P2|COMPLETED|Overall Study||40
54489|NCT02427984|131632|P1|COMPLETED|Overall Study||40
54490|NCT02427984|131630|P3|STARTED|Overall Study||50
54491|NCT02427984|131631|P2|STARTED|Overall Study||45
54492|NCT02427984|131632|P1|STARTED|Overall Study||53
54493|NCT02427958|131646|P1|NOT COMPLETED|Overall Study||24
54494|NCT02427958|131646|P1|COMPLETED|Overall Study||283
54495|NCT02427958|131646|P1|STARTED|Overall Study||307
54496|NCT02427750|131653|P2|NOT COMPLETED|Overall Study||0
54497|NCT02427750|131654|P1|NOT COMPLETED|Overall Study||0
54498|NCT02427750|131653|P2|COMPLETED|Overall Study||63
54499|NCT02427750|131654|P1|COMPLETED|Overall Study||63
54500|NCT02427750|131653|P2|STARTED|Overall Study||63
54501|NCT02427750|131654|P1|STARTED|Overall Study||63
54502|NCT02427737|131679|P2|NOT COMPLETED|Duke Pre- and Post-Training Groups||395
54503|NCT02427737|131680|P1|NOT COMPLETED|Duke Pre- and Post-Training Groups||779
54504|NCT02427737|131679|P2|COMPLETED|Duke Pre- and Post-Training Groups||4051
54505|NCT02427737|131680|P1|COMPLETED|Duke Pre- and Post-Training Groups||8879
54506|NCT02427737|131679|P2|STARTED|Duke Pre- and Post-Training Groups|Note Control=Baseline|4446
54507|NCT02427737|131680|P1|STARTED|Duke Pre- and Post-Training Groups|Note this is a pre-training to post-training comparison.|9658
54508|NCT02427737|131679|P2|NOT COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||215
54509|NCT02427737|131680|P1|NOT COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||220
54510|NCT02427737|131679|P2|COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||2716
54511|NCT02427737|131680|P1|COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||3928
54512|NCT02427737|131679|P2|STARTED|OSU Q3FY16 (Third Post Training Quarter)||2931
54513|NCT02427737|131680|P1|STARTED|OSU Q3FY16 (Third Post Training Quarter)||4148
54514|NCT02427737|131679|P2|NOT COMPLETED|OSU Q2FY16(Second Post Training Quarter)||213
54515|NCT02427737|131680|P1|NOT COMPLETED|OSU Q2FY16(Second Post Training Quarter)||214
54516|NCT02427737|131679|P2|COMPLETED|OSU Q2FY16(Second Post Training Quarter)||2857
54517|NCT02427737|131680|P1|COMPLETED|OSU Q2FY16(Second Post Training Quarter)||3907
54518|NCT02427737|131679|P2|STARTED|OSU Q2FY16(Second Post Training Quarter)||3070
54519|NCT02427737|131680|P1|STARTED|OSU Q2FY16(Second Post Training Quarter)||4121
54520|NCT02427737|131679|P2|NOT COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||214
54521|NCT02427737|131680|P1|NOT COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||215
54522|NCT02427737|131679|P2|COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||3032
54523|NCT02427737|131680|P1|COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||3815
54524|NCT02427737|131679|P2|STARTED|OSU Q1FY16 (First Post-Training Quarter)||3246
54525|NCT02427737|131680|P1|STARTED|OSU Q1FY16 (First Post-Training Quarter)||4030
54526|NCT02427737|131679|P2|NOT COMPLETED|OSU Baseline Q4FY15||216
54527|NCT02427737|131680|P1|NOT COMPLETED|OSU Baseline Q4FY15||218
54528|NCT02427737|131679|P2|COMPLETED|OSU Baseline Q4FY15||3230
54529|NCT02427737|131680|P1|COMPLETED|OSU Baseline Q4FY15||3940
54530|NCT02427737|131679|P2|STARTED|OSU Baseline Q4FY15||3446
54531|NCT02427737|131680|P1|STARTED|OSU Baseline Q4FY15||4158
54532|NCT02427672|131728|P2|NOT COMPLETED|Overall Study||2
54533|NCT02427672|131729|P1|NOT COMPLETED|Overall Study||1
54534|NCT02427672|131728|P2|COMPLETED|Overall Study||42
54535|NCT02427672|131729|P1|COMPLETED|Overall Study||39
54536|NCT02427672|131728|P2|STARTED|Overall Study||44
54537|NCT02427672|131729|P1|STARTED|Overall Study||40
54538|NCT02427646|131739|P2|NOT COMPLETED|Overall Study||14
54539|NCT02427646|131740|P1|NOT COMPLETED|Overall Study||8
54540|NCT02427646|131739|P2|COMPLETED|Overall Study||14
54541|NCT02427646|131740|P1|COMPLETED|Overall Study||16
54542|NCT02427646|131739|P2|STARTED|Overall Study||28
54543|NCT02427646|131740|P1|STARTED|Overall Study||24
54544|NCT02427607|131748|P1|NOT COMPLETED|Overall Study||1
54545|NCT02427607|131748|P1|COMPLETED|Overall Study||6
54546|NCT02427607|131748|P1|STARTED|Overall Study||7
54547|NCT02427477|131754|P2|NOT COMPLETED|Period 3||0
54548|NCT02427477|131755|P1|NOT COMPLETED|Period 3||0
54549|NCT02427477|131754|P2|COMPLETED|Period 3||60
54550|NCT02427477|131755|P1|COMPLETED|Period 3||59
54551|NCT02427477|131754|P2|STARTED|Period 3||60
54552|NCT02427477|131755|P1|STARTED|Period 3||59
54553|NCT02427477|131754|P2|NOT COMPLETED|Period 2||0
54554|NCT02427477|131755|P1|NOT COMPLETED|Period 2||0
54555|NCT02427477|131754|P2|COMPLETED|Period 2||60
54556|NCT02427477|131755|P1|COMPLETED|Period 2||59
54557|NCT02427477|131754|P2|STARTED|Period 2||60
54558|NCT02427477|131755|P1|STARTED|Period 2||59
54559|NCT02427477|131754|P2|NOT COMPLETED|Period 1||0
54560|NCT02427477|131755|P1|NOT COMPLETED|Period 1||1
54561|NCT02427477|131754|P2|COMPLETED|Period 1||60
54562|NCT02427477|131755|P1|COMPLETED|Period 1||59
54563|NCT02427477|131754|P2|STARTED|Period 1||60
54564|NCT02427477|131755|P1|STARTED|Period 1||60
54565|NCT02427399|131768|P5|NOT COMPLETED|Overall Study||15
54566|NCT02427399|131769|P4|NOT COMPLETED|Overall Study||18
54567|NCT02427399|131770|P3|NOT COMPLETED|Overall Study||12
54568|NCT02427399|131771|P2|NOT COMPLETED|Overall Study||16
54569|NCT02427399|131772|P1|NOT COMPLETED|Overall Study||14
54570|NCT02427399|131768|P5|COMPLETED|Overall Study||205
54571|NCT02427399|131769|P4|COMPLETED|Overall Study||202
54572|NCT02427399|131770|P3|COMPLETED|Overall Study||208
54573|NCT02427399|131771|P2|COMPLETED|Overall Study||204
54574|NCT02427399|131772|P1|COMPLETED|Overall Study||206
54575|NCT02427399|131768|P5|STARTED|Overall Study||220
54576|NCT02427399|131769|P4|STARTED|Overall Study||220
54577|NCT02427399|131770|P3|STARTED|Overall Study||220
54578|NCT02427399|131771|P2|STARTED|Overall Study||220
54579|NCT02427399|131772|P1|STARTED|Overall Study||220
54580|NCT02427100|131796|P2|NOT COMPLETED|Overall Study||2
54581|NCT02427100|131797|P1|NOT COMPLETED|Overall Study||0
54582|NCT02427100|131796|P2|COMPLETED|Overall Study||15
54583|NCT02427100|131797|P1|COMPLETED|Overall Study||15
54584|NCT02427100|131796|P2|STARTED|Overall Study||17
54585|NCT02427100|131797|P1|STARTED|Overall Study||15
54586|NCT02426918|131808|P3|NOT COMPLETED|Overall Study||14
54587|NCT02426918|131809|P2|NOT COMPLETED|Overall Study||19
54588|NCT02426918|131810|P1|NOT COMPLETED|Overall Study||17
54589|NCT02426918|131808|P3|COMPLETED|Overall Study||97
54590|NCT02426918|131809|P2|COMPLETED|Overall Study||90
54591|NCT02426918|131810|P1|COMPLETED|Overall Study||93
54592|NCT02426918|131808|P3|Safety Population|Overall Study||107
54593|NCT02426918|131809|P2|Safety Population|Overall Study||107
54594|NCT02426918|131810|P1|Safety Population|Overall Study||110
54595|NCT02426918|131808|P3|STARTED|Overall Study||111
54596|NCT02426918|131809|P2|STARTED|Overall Study||109
54597|NCT02426918|131810|P1|STARTED|Overall Study||110
54598|NCT02426580|131832|P2|NOT COMPLETED|Overall Study||16
54599|NCT02426580|131833|P1|NOT COMPLETED|Overall Study||11
54600|NCT02426580|131832|P2|COMPLETED|Overall Study|the last patient in this group enrolled in April 2017|54
54601|NCT02426580|131833|P1|COMPLETED|Overall Study|the last patient enrolled in this group in April 2017|59
54602|NCT02426580|131832|P2|STARTED|Overall Study|January 2014|70
54603|NCT02426580|131833|P1|STARTED|Overall Study|April 2015|70
54604|NCT02426541|131841|P2|NOT COMPLETED|Overall Study||0
54605|NCT02426541|131842|P1|NOT COMPLETED|Overall Study||1
54606|NCT02426541|131841|P2|COMPLETED|Overall Study||16
54607|NCT02426541|131842|P1|COMPLETED|Overall Study||15
54608|NCT02426541|131841|P2|STARTED|Overall Study||16
54609|NCT02426541|131842|P1|STARTED|Overall Study||16
54610|NCT02426138|131854|P2|NOT COMPLETED|Intent to Treat Population Milestone||0
54611|NCT02426138|131855|P1|NOT COMPLETED|Intent to Treat Population Milestone||0
54612|NCT02426138|131854|P2|COMPLETED|Intent to Treat Population Milestone||22
54613|NCT02426138|131855|P1|COMPLETED|Intent to Treat Population Milestone||20
54614|NCT02426138|131854|P2|STARTED|Intent to Treat Population Milestone||22
54615|NCT02426138|131855|P1|STARTED|Intent to Treat Population Milestone||20
54616|NCT02426138|131854|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
54617|NCT02426138|131855|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
54618|NCT02426138|131854|P2|COMPLETED|Second Intervention (12 Weeks)||22
54619|NCT02426138|131855|P1|COMPLETED|Second Intervention (12 Weeks)||20
54620|NCT02426138|131854|P2|STARTED|Second Intervention (12 Weeks)||22
54621|NCT02426138|131855|P1|STARTED|Second Intervention (12 Weeks)||20
54622|NCT02426138|131854|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
54623|NCT02426138|131855|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
54624|NCT02426138|131854|P2|COMPLETED|First Intervention (12 Weeks)||22
54625|NCT02426138|131855|P1|COMPLETED|First Intervention (12 Weeks)||20
54626|NCT02426138|131854|P2|STARTED|First Intervention (12 Weeks)||23
54627|NCT02426138|131855|P1|STARTED|First Intervention (12 Weeks)||21
54628|NCT02426125|131895|P2|NOT COMPLETED|Overall Study||26
54629|NCT02426125|131896|P1|NOT COMPLETED|Overall Study||29
54630|NCT02426125|131895|P2|COMPLETED|Overall Study||241
54631|NCT02426125|131896|P1|COMPLETED|Overall Study||234
54632|NCT02426125|131895|P2|First Randomized Participants|Overall Study||221
54633|NCT02426125|131896|P1|First Randomized Participants|Overall Study||216
54634|NCT02426125|131895|P2|Received at Least One Dose of Study Drug|Overall Study||265
54635|NCT02426125|131896|P1|Received at Least One Dose of Study Drug|Overall Study||258
54636|NCT02426125|131895|P2|STARTED|Overall Study||267
54637|NCT02426125|131896|P1|STARTED|Overall Study||263
54638|NCT02425956|131920|P1|NOT COMPLETED|Overall Study||0
54639|NCT02425956|131920|P1|COMPLETED|Overall Study||21
54640|NCT02425956|131920|P1|STARTED|Overall Study||21
54641|NCT02425826|131927|P3|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
54642|NCT02425826|131928|P2|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
54643|NCT02425826|131929|P1|NOT COMPLETED|Post-Treatment Observational Follow-Up||1
54644|NCT02425826|131927|P3|COMPLETED|Post-Treatment Observational Follow-Up||49
54645|NCT02425826|131928|P2|COMPLETED|Post-Treatment Observational Follow-Up||0
54646|NCT02425826|131929|P1|COMPLETED|Post-Treatment Observational Follow-Up||80
54647|NCT02425826|131927|P3|STARTED|Post-Treatment Observational Follow-Up||49
54648|NCT02425826|131928|P2|STARTED|Post-Treatment Observational Follow-Up||0
54649|NCT02425826|131929|P1|STARTED|Post-Treatment Observational Follow-Up||81
54650|NCT02425826|131927|P3|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||14
54651|NCT02425826|131928|P2|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
54652|NCT02425826|131929|P1|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||35
54653|NCT02425826|131927|P3|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||50
54654|NCT02425826|131928|P2|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
54655|NCT02425826|131929|P1|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||86
54656|NCT02425826|131927|P3|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||64
54657|NCT02425826|131928|P2|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||0
54658|NCT02425826|131929|P1|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||121
54659|NCT02425826|131927|P3|STARTED|Apremilast Extension Phase (Weeks 16-52)||64
54660|NCT02425826|131928|P2|STARTED|Apremilast Extension Phase (Weeks 16-52)||0
54661|NCT02425826|131929|P1|STARTED|Apremilast Extension Phase (Weeks 16-52)||121
54662|NCT02425826|131927|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
54663|NCT02425826|131928|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||9
54664|NCT02425826|131929|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||27
54665|NCT02425826|131927|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
54666|NCT02425826|131928|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|64
54667|NCT02425826|131929|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|121
54668|NCT02425826|131927|P3|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)||0
54669|NCT02425826|131928|P2|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|73
54670|NCT02425826|131929|P1|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|147
54671|NCT02425826|131927|P3|STARTED|Placebo-controlled Phase (Week 0 - 16)||0
54672|NCT02425826|131928|P2|STARTED|Placebo-controlled Phase (Week 0 - 16)||73
54673|NCT02425826|131929|P1|STARTED|Placebo-controlled Phase (Week 0 - 16)||148
54674|NCT02425449|131967|P5|NOT COMPLETED|Overall Study||0
54675|NCT02425449|131968|P4|NOT COMPLETED|Overall Study||0
54676|NCT02425449|131969|P3|NOT COMPLETED|Overall Study||0
54677|NCT02425449|131970|P2|NOT COMPLETED|Overall Study||0
54678|NCT02425449|131971|P1|NOT COMPLETED|Overall Study||0
54679|NCT02425449|131967|P5|COMPLETED|Overall Study||5
54680|NCT02425449|131968|P4|COMPLETED|Overall Study||5
54681|NCT02425449|131969|P3|COMPLETED|Overall Study||5
54682|NCT02425449|131970|P2|COMPLETED|Overall Study||4
54683|NCT02425449|131971|P1|COMPLETED|Overall Study||0
54684|NCT02425449|131967|P5|STARTED|Overall Study||5
54685|NCT02425449|131968|P4|STARTED|Overall Study||5
54686|NCT02425449|131969|P3|STARTED|Overall Study||5
54687|NCT02425449|131970|P2|STARTED|Overall Study||4
54688|NCT02425449|131971|P1|STARTED|Overall Study||0
54689|NCT02425111|131983|P1|NOT COMPLETED|Part B: Treatment Extension Period||10
54690|NCT02425111|131983|P1|COMPLETED|Part B: Treatment Extension Period||46
54691|NCT02425111|131983|P1|STARTED|Part B: Treatment Extension Period||56
54692|NCT02425111|131983|P1|NOT COMPLETED|Part A: Treatment Period||23
54693|NCT02425111|131983|P1|COMPLETED|Part A: Treatment Period||78
54694|NCT02425111|131983|P1|STARTED|Part A: Treatment Period||101
54695|NCT02425098|132004|P2|NOT COMPLETED|Overall Study||16
54696|NCT02425098|132005|P1|NOT COMPLETED|Overall Study||13
54697|NCT02425098|132004|P2|COMPLETED|Overall Study||159
54698|NCT02425098|132005|P1|COMPLETED|Overall Study||163
54699|NCT02425098|132004|P2|STARTED|Overall Study||175
54700|NCT02425098|132005|P1|STARTED|Overall Study||176
54701|NCT02424799|132053|P6|NOT COMPLETED|Part C (Up to Day 23)||0
54702|NCT02424799|132054|P5|NOT COMPLETED|Part C (Up to Day 23)||0
54703|NCT02424799|132055|P4|NOT COMPLETED|Part C (Up to Day 23)||0
54704|NCT02424799|132056|P3|NOT COMPLETED|Part C (Up to Day 23)||0
54705|NCT02424799|132057|P2|NOT COMPLETED|Part C (Up to Day 23)||0
54706|NCT02424799|132058|P1|NOT COMPLETED|Part C (Up to Day 23)||0
54707|NCT02424799|132053|P6|COMPLETED|Part C (Up to Day 23)||4
54708|NCT02424799|132054|P5|COMPLETED|Part C (Up to Day 23)||1
54709|NCT02424799|132055|P4|COMPLETED|Part C (Up to Day 23)||0
54710|NCT02424799|132056|P3|COMPLETED|Part C (Up to Day 23)||0
54711|NCT02424799|132057|P2|COMPLETED|Part C (Up to Day 23)||0
54712|NCT02424799|132058|P1|COMPLETED|Part C (Up to Day 23)||0
54713|NCT02424799|132053|P6|STARTED|Part C (Up to Day 23)||4
54714|NCT02424799|132054|P5|STARTED|Part C (Up to Day 23)||1
54715|NCT02424799|132055|P4|STARTED|Part C (Up to Day 23)||0
54716|NCT02424799|132056|P3|STARTED|Part C (Up to Day 23)||0
54717|NCT02424799|132057|P2|STARTED|Part C (Up to Day 23)||0
54718|NCT02424799|132058|P1|STARTED|Part C (Up to Day 23)||0
54719|NCT02424799|132053|P6|NOT COMPLETED|Part B (Up to Day 19)||0
54720|NCT02424799|132054|P5|NOT COMPLETED|Part B (Up to Day 19)||0
54721|NCT02424799|132055|P4|NOT COMPLETED|Part B (Up to Day 19)||0
54722|NCT02424799|132056|P3|NOT COMPLETED|Part B (Up to Day 19)||0
54723|NCT02424799|132057|P2|NOT COMPLETED|Part B (Up to Day 19)||0
54724|NCT02424799|132058|P1|NOT COMPLETED|Part B (Up to Day 19)||0
54725|NCT02424799|132053|P6|COMPLETED|Part B (Up to Day 19)||0
54726|NCT02424799|132054|P5|COMPLETED|Part B (Up to Day 19)||0
54727|NCT02424799|132055|P4|COMPLETED|Part B (Up to Day 19)||9
54728|NCT02424799|132056|P3|COMPLETED|Part B (Up to Day 19)||3
54729|NCT02424799|132057|P2|COMPLETED|Part B (Up to Day 19)||0
54730|NCT02424799|132058|P1|COMPLETED|Part B (Up to Day 19)||0
54731|NCT02424799|132053|P6|STARTED|Part B (Up to Day 19)||0
54732|NCT02424799|132054|P5|STARTED|Part B (Up to Day 19)||0
54733|NCT02424799|132055|P4|STARTED|Part B (Up to Day 19)||9
54734|NCT02424799|132056|P3|STARTED|Part B (Up to Day 19)||3
54735|NCT02424799|132057|P2|STARTED|Part B (Up to Day 19)||0
54736|NCT02424799|132058|P1|STARTED|Part B (Up to Day 19)||0
54737|NCT02424799|132053|P6|NOT COMPLETED|Part A (Up to Day 11)||0
54738|NCT02424799|132054|P5|NOT COMPLETED|Part A (Up to Day 11)||0
54739|NCT02424799|132055|P4|NOT COMPLETED|Part A (Up to Day 11)||0
54740|NCT02424799|132056|P3|NOT COMPLETED|Part A (Up to Day 11)||0
54741|NCT02424799|132057|P2|NOT COMPLETED|Part A (Up to Day 11)||0
54742|NCT02424799|132058|P1|NOT COMPLETED|Part A (Up to Day 11)||0
54743|NCT02424799|132053|P6|COMPLETED|Part A (Up to Day 11)||0
54744|NCT02424799|132054|P5|COMPLETED|Part A (Up to Day 11)||0
54745|NCT02424799|132055|P4|COMPLETED|Part A (Up to Day 11)||0
54746|NCT02424799|132056|P3|COMPLETED|Part A (Up to Day 11)||0
54747|NCT02424799|132057|P2|COMPLETED|Part A (Up to Day 11)||8
54748|NCT02424799|132058|P1|COMPLETED|Part A (Up to Day 11)||9
54749|NCT02424799|132053|P6|STARTED|Part A (Up to Day 11)||0
54750|NCT02424799|132054|P5|STARTED|Part A (Up to Day 11)||0
54751|NCT02424799|132055|P4|STARTED|Part A (Up to Day 11)||0
54752|NCT02424799|132056|P3|STARTED|Part A (Up to Day 11)||0
54753|NCT02424799|132057|P2|STARTED|Part A (Up to Day 11)||8
54754|NCT02424799|132058|P1|STARTED|Part A (Up to Day 11)||9
54755|NCT02424734|132157|P3|NOT COMPLETED|Overall Study||0
54756|NCT02424734|132158|P2|NOT COMPLETED|Overall Study||2
54757|NCT02424734|132159|P1|NOT COMPLETED|Overall Study||2
54758|NCT02424734|132157|P3|COMPLETED|Overall Study||2
54759|NCT02424734|132158|P2|COMPLETED|Overall Study||3
54760|NCT02424734|132159|P1|COMPLETED|Overall Study||2
54761|NCT02424734|132157|P3|Treated|Overall Study||2
54762|NCT02424734|132158|P2|Treated|Overall Study||5
54763|NCT02424734|132159|P1|Treated|Overall Study||4
54764|NCT02424734|132157|P3|STARTED|Overall Study||2
54765|NCT02424734|132158|P2|STARTED|Overall Study||5
54766|NCT02424734|132159|P1|STARTED|Overall Study||4
54767|NCT02424591|132178|P2|NOT COMPLETED|Overall Study||3
54768|NCT02424591|132179|P1|NOT COMPLETED|Overall Study||2
54769|NCT02424591|132178|P2|COMPLETED|Overall Study||20
54770|NCT02424591|132179|P1|COMPLETED|Overall Study||20
54771|NCT02424591|132178|P2|STARTED|Overall Study||23
54772|NCT02424591|132179|P1|STARTED|Overall Study||22
54773|NCT02424578|132191|P2|NOT COMPLETED|Overall Study||1
54774|NCT02424578|132192|P1|NOT COMPLETED|Overall Study||0
54775|NCT02424578|132191|P2|COMPLETED|Overall Study||14
54776|NCT02424578|132192|P1|COMPLETED|Overall Study||15
54777|NCT02424578|132191|P2|STARTED|Overall Study||15
54778|NCT02424578|132192|P1|STARTED|Overall Study||15
54779|NCT02424565|132198|P2|NOT COMPLETED|Period 2 (D3)||0
54780|NCT02424565|132199|P1|NOT COMPLETED|Period 2 (D3)||0
54781|NCT02424565|132198|P2|COMPLETED|Period 2 (D3)||6
54782|NCT02424565|132199|P1|COMPLETED|Period 2 (D3)||8
54783|NCT02424565|132198|P2|STARTED|Period 2 (D3)||6
54784|NCT02424565|132199|P1|STARTED|Period 2 (D3)||8
54785|NCT02424565|132198|P2|NOT COMPLETED|Washout Period||0
54786|NCT02424565|132199|P1|NOT COMPLETED|Washout Period||0
54787|NCT02424565|132198|P2|COMPLETED|Washout Period||6
54788|NCT02424565|132199|P1|COMPLETED|Washout Period||8
54789|NCT02424565|132198|P2|STARTED|Washout Period||6
54790|NCT02424565|132199|P1|STARTED|Washout Period||8
54791|NCT02424565|132198|P2|NOT COMPLETED|Period 1 (D0)||1
54792|NCT02424565|132199|P1|NOT COMPLETED|Period 1 (D0)||0
54793|NCT02424565|132198|P2|COMPLETED|Period 1 (D0)||6
54794|NCT02424565|132199|P1|COMPLETED|Period 1 (D0)||8
54795|NCT02424565|132198|P2|STARTED|Period 1 (D0)||7
54796|NCT02424565|132199|P1|STARTED|Period 1 (D0)||8
54797|NCT02424539|132208|P3|NOT COMPLETED|Overall Study||8
54798|NCT02424539|132209|P2|NOT COMPLETED|Overall Study||8
54799|NCT02424539|132210|P1|NOT COMPLETED|Overall Study||14
54800|NCT02424539|132208|P3|COMPLETED|Overall Study||111
54801|NCT02424539|132209|P2|COMPLETED|Overall Study||111
54802|NCT02424539|132210|P1|COMPLETED|Overall Study||106
54803|NCT02424539|132208|P3|STARTED|Overall Study||119
54804|NCT02424539|132209|P2|STARTED|Overall Study||119
54805|NCT02424539|132210|P1|STARTED|Overall Study||120
54806|NCT02424357|132274|P2|NOT COMPLETED|Overall Study||0
54807|NCT02424357|132275|P1|NOT COMPLETED|Overall Study||0
54808|NCT02424357|132274|P2|COMPLETED|Overall Study||30
54809|NCT02424357|132275|P1|COMPLETED|Overall Study||35
54810|NCT02424357|132274|P2|STARTED|Overall Study||30
54811|NCT02424357|132275|P1|STARTED|Overall Study||35
54812|NCT02424344|132285|P2|NOT COMPLETED|Overall Study||10
54813|NCT02424344|132286|P1|NOT COMPLETED|Overall Study||7
54814|NCT02424344|132285|P2|COMPLETED|Overall Study||123
54815|NCT02424344|132286|P1|COMPLETED|Overall Study||127
54816|NCT02424344|132285|P2|STARTED|Overall Study||133
54817|NCT02424344|132286|P1|STARTED|Overall Study||134
54818|NCT02424175|132296|P1|NOT COMPLETED|Overall Study||0
54819|NCT02424175|132296|P1|COMPLETED|Overall Study||10
54820|NCT02424175|132296|P1|STARTED|Overall Study||10
54821|NCT02424149|132304|P2|NOT COMPLETED|Overall Study||1
54822|NCT02424149|132305|P1|NOT COMPLETED|Overall Study||2
54823|NCT02424149|132304|P2|COMPLETED|Overall Study||52
54824|NCT02424149|132305|P1|COMPLETED|Overall Study||52
54825|NCT02424149|132304|P2|STARTED|Overall Study||53
54826|NCT02424149|132305|P1|STARTED|Overall Study||54
54827|NCT02424097|132321|P2|NOT COMPLETED|Overall Study||2
54828|NCT02424097|132322|P1|NOT COMPLETED|Overall Study||1
54829|NCT02424097|132321|P2|COMPLETED|Overall Study||18
54830|NCT02424097|132322|P1|COMPLETED|Overall Study||19
54831|NCT02424097|132321|P2|STARTED|Overall Study||20
54832|NCT02424097|132322|P1|STARTED|Overall Study||20
54833|NCT02423993|132334|P4|NOT COMPLETED|Overall Study||0
54834|NCT02423993|132335|P3|NOT COMPLETED|Overall Study||0
54835|NCT02423993|132336|P2|NOT COMPLETED|Overall Study||0
54836|NCT02423993|132337|P1|NOT COMPLETED|Overall Study||0
54837|NCT02423993|132334|P4|COMPLETED|Overall Study||19
54838|NCT02423993|132335|P3|COMPLETED|Overall Study||23
54839|NCT02423993|132336|P2|COMPLETED|Overall Study||16
54840|NCT02423993|132337|P1|COMPLETED|Overall Study||19
54841|NCT02423993|132334|P4|STARTED|Overall Study||19
54842|NCT02423993|132335|P3|STARTED|Overall Study||23
54843|NCT02423993|132336|P2|STARTED|Overall Study||16
54844|NCT02423993|132337|P1|STARTED|Overall Study||19
54845|NCT02423980|132367|P1|NOT COMPLETED|Overall Study||0
54846|NCT02423980|132367|P1|COMPLETED|Overall Study||7
54847|NCT02423980|132367|P1|STARTED|Overall Study||7
54848|NCT02423798|132377|P1|NOT COMPLETED|Overall Study||3
54849|NCT02423798|132377|P1|COMPLETED|Overall Study||21
54850|NCT02423798|132377|P1|STARTED|Overall Study||24
54851|NCT02423577|132385|P2|NOT COMPLETED|Overall Study||0
54852|NCT02423577|132386|P1|NOT COMPLETED|Overall Study||0
54853|NCT02423577|132385|P2|COMPLETED|Overall Study||26
54854|NCT02423577|132386|P1|COMPLETED|Overall Study||53
54855|NCT02423577|132385|P2|STARTED|Overall Study||26
54856|NCT02423577|132386|P1|STARTED|Overall Study||53
54857|NCT02423447|132392|P2|NOT COMPLETED|Overall Study||0
54858|NCT02423447|132393|P1|NOT COMPLETED|Overall Study||0
54859|NCT02423447|132392|P2|COMPLETED|Overall Study||12
54860|NCT02423447|132393|P1|COMPLETED|Overall Study||13
54861|NCT02423447|132392|P2|STARTED|Overall Study||12
54862|NCT02423447|132393|P1|STARTED|Overall Study||13
54863|NCT02423408|132409|P2|NOT COMPLETED|Overall Study||2
54864|NCT02423408|132410|P1|NOT COMPLETED|Overall Study||1
54865|NCT02423408|132409|P2|COMPLETED|Overall Study||80
54866|NCT02423408|132410|P1|COMPLETED|Overall Study||82
54867|NCT02423408|132409|P2|STARTED|Overall Study||82
54868|NCT02423408|132410|P1|STARTED|Overall Study||83
54869|NCT02423317|132424|P2|NOT COMPLETED|Overall Study||0
54870|NCT02423317|132425|P1|NOT COMPLETED|Overall Study||0
54871|NCT02423317|132424|P2|COMPLETED|Overall Study||30
54872|NCT02423317|132425|P1|COMPLETED|Overall Study||30
54873|NCT02423317|132424|P2|STARTED|Overall Study||30
54874|NCT02423317|132425|P1|STARTED|Overall Study||30
54875|NCT02423291|132443|P1|NOT COMPLETED|Overall Study||15
54876|NCT02423291|132443|P1|COMPLETED|Overall Study|Patients that have completed therapy|0
54877|NCT02423291|132443|P1|STARTED|Overall Study|Patients enrolled|15
54878|NCT02423200|132449|P2|NOT COMPLETED|Overall Study||0
54879|NCT02423200|132450|P1|NOT COMPLETED|Overall Study||1
54880|NCT02423200|132449|P2|COMPLETED|Overall Study||1
54881|NCT02423200|132450|P1|COMPLETED|Overall Study||7
54882|NCT02423200|132449|P2|STARTED|Overall Study||1
54883|NCT02423200|132450|P1|STARTED|Overall Study||8
54884|NCT02423122|132460|P2|NOT COMPLETED|Overall Study||0
54885|NCT02423122|132461|P1|NOT COMPLETED|Overall Study||0
54886|NCT02423122|132460|P2|COMPLETED|Overall Study||7
54887|NCT02423122|132461|P1|COMPLETED|Overall Study||9
54888|NCT02423122|132460|P2|STARTED|Overall Study||7
54889|NCT02423122|132461|P1|STARTED|Overall Study||9
54890|NCT02423109|132473|P2|NOT COMPLETED|Lens 2||0
54891|NCT02423109|132474|P1|NOT COMPLETED|Lens 2||0
54892|NCT02423109|132473|P2|COMPLETED|Lens 2||14
54893|NCT02423109|132474|P1|COMPLETED|Lens 2||18
54894|NCT02423109|132473|P2|STARTED|Lens 2||14
54895|NCT02423109|132474|P1|STARTED|Lens 2||18
54896|NCT02423109|132473|P2|NOT COMPLETED|Lens 1||0
54897|NCT02423109|132474|P1|NOT COMPLETED|Lens 1||1
54898|NCT02423109|132473|P2|COMPLETED|Lens 1||14
54899|NCT02423109|132474|P1|COMPLETED|Lens 1||18
54900|NCT02423109|132473|P2|STARTED|Lens 1||14
54901|NCT02423109|132474|P1|STARTED|Lens 1||19
54902|NCT02422940|132484|P2|NOT COMPLETED|Overall Study||121
54903|NCT02422940|132485|P1|NOT COMPLETED|Overall Study||121
54904|NCT02422940|132484|P2|COMPLETED|Overall Study||21
54905|NCT02422940|132485|P1|COMPLETED|Overall Study||31
54906|NCT02422940|132484|P2|STARTED|Overall Study||142
54907|NCT02422940|132485|P1|STARTED|Overall Study||152
54908|NCT02422797|132507|P2|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||18
54909|NCT02422797|132508|P1|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||23
54910|NCT02422797|132507|P2|COMPLETED|Late Switch Phase (Week 52 to Week 148)||221
54911|NCT02422797|132508|P1|COMPLETED|Late Switch Phase (Week 52 to Week 148)||222
54912|NCT02422797|132507|P2|STARTED|Late Switch Phase (Week 52 to Week 148)||239
54913|NCT02422797|132508|P1|STARTED|Late Switch Phase (Week 52 to Week 148)||245
54914|NCT02422797|132507|P2|NOT COMPLETED|Early Switch Phase (Up to Week 52)||16
54915|NCT02422797|132508|P1|NOT COMPLETED|Early Switch Phase (Up to Week 52)||16
54916|NCT02422797|132507|P2|COMPLETED|Early Switch Phase (Up to Week 52)||239
54917|NCT02422797|132508|P1|COMPLETED|Early Switch Phase (Up to Week 52)||245
54918|NCT02422797|132507|P2|STARTED|Early Switch Phase (Up to Week 52)||255
54919|NCT02422797|132508|P1|STARTED|Early Switch Phase (Up to Week 52)||261
54920|NCT02422615|132596|P2|NOT COMPLETED|Overall Study||166
54921|NCT02422615|132597|P1|NOT COMPLETED|Overall Study||280
54922|NCT02422615|132596|P2|COMPLETED|Overall Study||76
54923|NCT02422615|132597|P1|COMPLETED|Overall Study||204
54924|NCT02422615|132596|P2|Untreated|Overall Study||1
54925|NCT02422615|132597|P1|Untreated|Overall Study||1
54926|NCT02422615|132596|P2|STARTED|Overall Study||242
54927|NCT02422615|132597|P1|STARTED|Overall Study||484
54928|NCT02422446|132605|P2|NOT COMPLETED|Overall Study||0
54929|NCT02422446|132606|P1|NOT COMPLETED|Overall Study||0
54930|NCT02422446|132605|P2|COMPLETED|Overall Study||1
54931|NCT02422446|132606|P1|COMPLETED|Overall Study||1
54932|NCT02422446|132605|P2|STARTED|Overall Study||1
54933|NCT02422446|132606|P1|STARTED|Overall Study||1
54934|NCT02422303|132614|P2|NOT COMPLETED|Overall Study||1
54935|NCT02422303|132615|P1|NOT COMPLETED|Overall Study||1
54936|NCT02422303|132614|P2|COMPLETED|Overall Study||5
54937|NCT02422303|132615|P1|COMPLETED|Overall Study||5
54938|NCT02422303|132614|P2|STARTED|Overall Study||6
54939|NCT02422303|132615|P1|STARTED|Overall Study||6
54940|NCT02422264|132623|P2|NOT COMPLETED|Overall Study||4
54941|NCT02422264|132624|P1|NOT COMPLETED|Overall Study||5
54942|NCT02422264|132623|P2|COMPLETED|Overall Study||301
54943|NCT02422264|132624|P1|COMPLETED|Overall Study||291
54944|NCT02422264|132623|P2|STARTED|Overall Study||305
54945|NCT02422264|132624|P1|STARTED|Overall Study||296
54946|NCT02422186|132670|P2|NOT COMPLETED|Follow-up Phase (2 Weeks)||0
54947|NCT02422186|132671|P1|NOT COMPLETED|Follow-up Phase (2 Weeks)||4
54948|NCT02422186|132670|P2|COMPLETED|Follow-up Phase (2 Weeks)||3
54949|NCT02422186|132671|P1|COMPLETED|Follow-up Phase (2 Weeks)||8
54950|NCT02422186|132670|P2|STARTED|Follow-up Phase (2 Weeks)||3
54951|NCT02422186|132671|P1|STARTED|Follow-up Phase (2 Weeks)||12
54952|NCT02422186|132670|P2|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
54953|NCT02422186|132671|P1|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||10
54954|NCT02422186|132670|P2|COMPLETED|Double-blind Induction Phase (4 Weeks)||60
54955|NCT02422186|132671|P1|COMPLETED|Double-blind Induction Phase (4 Weeks)||62
54956|NCT02422186|132670|P2|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||65
54957|NCT02422186|132671|P1|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||72
54958|NCT02422186|132670|P2|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||65
54959|NCT02422186|132671|P1|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||72
54960|NCT02422186|132670|P2|STARTED|Double-blind Induction Phase (4 Weeks)||66
54961|NCT02422186|132671|P1|STARTED|Double-blind Induction Phase (4 Weeks)||72
54962|NCT02421939|132695|P2|NOT COMPLETED|Overall Study||124
54963|NCT02421939|132696|P1|NOT COMPLETED|Overall Study||209
54964|NCT02421939|132695|P2|COMPLETED|Overall Study||0
54965|NCT02421939|132696|P1|COMPLETED|Overall Study||38
54966|NCT02421939|132695|P2|Treated|Overall Study||109
54967|NCT02421939|132696|P1|Treated|Overall Study||246
54968|NCT02421939|132695|P2|STARTED|Overall Study||124
54969|NCT02421939|132696|P1|STARTED|Overall Study||247
54970|NCT02421887|132724|P2|NOT COMPLETED|Overall Study||9
54971|NCT02421887|132725|P1|NOT COMPLETED|Overall Study||17
54972|NCT02421887|132724|P2|COMPLETED|Overall Study||77
54973|NCT02421887|132725|P1|COMPLETED|Overall Study||68
54974|NCT02421887|132724|P2|STARTED|Overall Study||86
54975|NCT02421887|132725|P1|STARTED|Overall Study||85
54976|NCT02421510|132752|P3|NOT COMPLETED|Overall Study||36
54977|NCT02421510|132753|P2|NOT COMPLETED|Overall Study||35
54978|NCT02421510|132754|P1|NOT COMPLETED|Overall Study||33
54979|NCT02421510|132752|P3|COMPLETED|Overall Study||227
54980|NCT02421510|132753|P2|COMPLETED|Overall Study||226
54981|NCT02421510|132754|P1|COMPLETED|Overall Study||225
54982|NCT02421510|132752|P3|Completed the 24 Week Treatment Period|Overall Study||240
54983|NCT02421510|132753|P2|Completed the 24 Week Treatment Period|Overall Study||239
54984|NCT02421510|132754|P1|Completed the 24 Week Treatment Period|Overall Study||236
54985|NCT02421510|132752|P3|STARTED|Overall Study||263
54986|NCT02421510|132753|P2|STARTED|Overall Study||261
54987|NCT02421510|132754|P1|STARTED|Overall Study||258
54988|NCT02421419|132786|P3|NOT COMPLETED|Overall Study||1
54989|NCT02421419|132787|P2|NOT COMPLETED|Overall Study||0
54990|NCT02421419|132788|P1|NOT COMPLETED|Overall Study||0
54991|NCT02421419|132786|P3|COMPLETED|Overall Study||8
54992|NCT02421419|132787|P2|COMPLETED|Overall Study||11
54993|NCT02421419|132788|P1|COMPLETED|Overall Study||6
54994|NCT02421419|132786|P3|STARTED|Overall Study||9
54995|NCT02421419|132787|P2|STARTED|Overall Study||11
54996|NCT02421419|132788|P1|STARTED|Overall Study||6
54997|NCT02421354|132805|P1|NOT COMPLETED|Overall Study||0
54998|NCT02421354|132805|P1|COMPLETED|Overall Study||8
54999|NCT02421354|132805|P1|STARTED|Overall Study||8
55000|NCT02421211|132811|P2|NOT COMPLETED|Overall Study||0
55001|NCT02421211|132812|P1|NOT COMPLETED|Overall Study||0
55002|NCT02421211|132811|P2|COMPLETED|Overall Study||20
55003|NCT02421211|132812|P1|COMPLETED|Overall Study||20
55004|NCT02421211|132811|P2|STARTED|Overall Study||20
55005|NCT02421211|132812|P1|STARTED|Overall Study||20
55006|NCT02421172|132858|P5|NOT COMPLETED|Period 2||1
55007|NCT02421172|132859|P4|NOT COMPLETED|Period 2||3
55008|NCT02421172|132860|P3|NOT COMPLETED|Period 2||7
55009|NCT02421172|132861|P2|NOT COMPLETED|Period 2||0
55010|NCT02421172|132862|P1|NOT COMPLETED|Period 2||0
55011|NCT02421172|132858|P5|COMPLETED|Period 2||14
55012|NCT02421172|132859|P4|COMPLETED|Period 2||13
55013|NCT02421172|132860|P3|COMPLETED|Period 2||22
55014|NCT02421172|132861|P2|COMPLETED|Period 2||0
55015|NCT02421172|132862|P1|COMPLETED|Period 2||0
55016|NCT02421172|132858|P5|STARTED|Period 2||15
55017|NCT02421172|132859|P4|STARTED|Period 2||16
55018|NCT02421172|132860|P3|STARTED|Period 2||29
55019|NCT02421172|132861|P2|STARTED|Period 2||0
55020|NCT02421172|132862|P1|STARTED|Period 2||0
55021|NCT02421172|132858|P5|NOT COMPLETED|Period 1||0
55022|NCT02421172|132859|P4|NOT COMPLETED|Period 1||0
55023|NCT02421172|132860|P3|NOT COMPLETED|Period 1||0
55024|NCT02421172|132861|P2|NOT COMPLETED|Period 1||2
55025|NCT02421172|132862|P1|NOT COMPLETED|Period 1||4
55026|NCT02421172|132858|P5|COMPLETED|Period 1||0
55027|NCT02421172|132859|P4|COMPLETED|Period 1||0
55028|NCT02421172|132860|P3|COMPLETED|Period 1||0
55029|NCT02421172|132861|P2|COMPLETED|Period 1||31
55030|NCT02421172|132862|P1|COMPLETED|Period 1||29
55031|NCT02421172|132858|P5|PK Analysis Set Period 1|Period 1||0
55032|NCT02421172|132859|P4|PK Analysis Set Period 1|Period 1||0
55033|NCT02421172|132860|P3|PK Analysis Set Period 1|Period 1||0
55034|NCT02421172|132861|P2|PK Analysis Set Period 1|Period 1||0
55035|NCT02421172|132862|P1|PK Analysis Set Period 1|Period 1||33
55036|NCT02421172|132858|P5|PD Analysis Set Period 1|Period 1||0
55037|NCT02421172|132859|P4|PD Analysis Set Period 1|Period 1||0
55038|NCT02421172|132860|P3|PD Analysis Set Period 1|Period 1||0
55039|NCT02421172|132861|P2|PD Analysis Set Period 1|Period 1||33
55040|NCT02421172|132862|P1|PD Analysis Set Period 1|Period 1||31
55041|NCT02421172|132858|P5|STARTED|Period 1||0
55042|NCT02421172|132859|P4|STARTED|Period 1||0
55043|NCT02421172|132860|P3|STARTED|Period 1||0
55044|NCT02421172|132861|P2|STARTED|Period 1||33
55045|NCT02421172|132862|P1|STARTED|Period 1||33
55046|NCT02421146|132889|P4|NOT COMPLETED|Overall Study||0
55047|NCT02421146|132890|P3|NOT COMPLETED|Overall Study||0
55048|NCT02421146|132891|P2|NOT COMPLETED|Overall Study||0
55049|NCT02421146|132892|P1|NOT COMPLETED|Overall Study||0
55050|NCT02421146|132889|P4|COMPLETED|Overall Study||3
55051|NCT02421146|132890|P3|COMPLETED|Overall Study||3
55052|NCT02421146|132891|P2|COMPLETED|Overall Study||4
55053|NCT02421146|132892|P1|COMPLETED|Overall Study||2
55054|NCT02421146|132889|P4|STARTED|Overall Study||3
55055|NCT02421146|132890|P3|STARTED|Overall Study||3
55056|NCT02421146|132891|P2|STARTED|Overall Study||4
55057|NCT02421146|132892|P1|STARTED|Overall Study||2
55058|NCT02421120|132906|P1|NOT COMPLETED|Overall Study||1
55059|NCT02421120|132906|P1|COMPLETED|Overall Study||20
55060|NCT02421120|132906|P1|STARTED|Overall Study||21
55061|NCT02420951|132916|P2|NOT COMPLETED|Overall Study||0
55062|NCT02420951|132917|P1|NOT COMPLETED|Overall Study||0
55063|NCT02420951|132916|P2|COMPLETED|Overall Study||25
55064|NCT02420951|132917|P1|COMPLETED|Overall Study||25
55065|NCT02420951|132916|P2|STARTED|Overall Study||25
55066|NCT02420951|132917|P1|STARTED|Overall Study||25
55067|NCT02420873|132936|P3|NOT COMPLETED|Overall Study||0
55068|NCT02420873|132937|P2|NOT COMPLETED|Overall Study||0
55069|NCT02420873|132938|P1|NOT COMPLETED|Overall Study||0
55070|NCT02420873|132936|P3|COMPLETED|Overall Study||0
55071|NCT02420873|132937|P2|COMPLETED|Overall Study||0
55072|NCT02420873|132938|P1|COMPLETED|Overall Study||9
55073|NCT02420873|132936|P3|STARTED|Overall Study||0
55074|NCT02420873|132937|P2|STARTED|Overall Study||0
55075|NCT02420873|132938|P1|STARTED|Overall Study||9
55076|NCT02420821|132948|P2|NOT COMPLETED|Overall Study||137
55077|NCT02420821|132949|P1|NOT COMPLETED|Overall Study||168
55078|NCT02420821|132948|P2|COMPLETED|Overall Study||317
55079|NCT02420821|132949|P1|COMPLETED|Overall Study||293
55080|NCT02420821|132948|P2|STARTED|Overall Study||454
55081|NCT02420821|132949|P1|STARTED|Overall Study||461
55082|NCT02420327|133017|P1|NOT COMPLETED|Overall Study||16
55083|NCT02420327|133017|P1|COMPLETED|Overall Study||27
55084|NCT02420327|133017|P1|STARTED|Overall Study||43
55085|NCT02420262|133053|P2|NOT COMPLETED|Overall Study||5
55086|NCT02420262|133054|P1|NOT COMPLETED|Overall Study||2
55087|NCT02420262|133053|P2|COMPLETED|Overall Study||249
55088|NCT02420262|133054|P1|COMPLETED|Overall Study||250
55089|NCT02420262|133053|P2|Exposed|Overall Study|One subject withdrew consent before exposure to trial product due to personal reasons.|253
55090|NCT02420262|133054|P1|Exposed|Overall Study||252
55091|NCT02420262|133053|P2|STARTED|Overall Study||254
55092|NCT02420262|133054|P1|STARTED|Overall Study||252
55093|NCT02420210|133068|P1|NOT COMPLETED|Overall Study||0
55094|NCT02420210|133068|P1|COMPLETED|Overall Study||2
55095|NCT02420210|133068|P1|STARTED|Overall Study||2
55096|NCT02420093|133080|P2|NOT COMPLETED|Overall Study||1
55097|NCT02420093|133081|P1|NOT COMPLETED|Overall Study||1
55098|NCT02420093|133080|P2|COMPLETED|Overall Study||7
55099|NCT02420093|133081|P1|COMPLETED|Overall Study||8
55100|NCT02420093|133080|P2|STARTED|Overall Study||8
55101|NCT02420093|133081|P1|STARTED|Overall Study||9
55102|NCT02420041|133097|P2|NOT COMPLETED|Overall Study||0
55103|NCT02420041|133098|P1|NOT COMPLETED|Overall Study||0
55104|NCT02420041|133097|P2|COMPLETED|Overall Study||14
55105|NCT02420041|133098|P1|COMPLETED|Overall Study||14
55106|NCT02420041|133097|P2|STARTED|Overall Study||14
55107|NCT02420041|133098|P1|STARTED|Overall Study||14
55108|NCT02420015|133124|P2|NOT COMPLETED|Overall Study||0
55109|NCT02420015|133125|P1|NOT COMPLETED|Overall Study||0
55110|NCT02420015|133124|P2|COMPLETED|Overall Study||13
55111|NCT02420015|133125|P1|COMPLETED|Overall Study||21
55112|NCT02420015|133124|P2|STARTED|Overall Study||13
55113|NCT02420015|133125|P1|STARTED|Overall Study||21
55114|NCT02419937|133143|P2|NOT COMPLETED|Overall Study||0
55115|NCT02419937|133144|P1|NOT COMPLETED|Overall Study||1
55116|NCT02419937|133143|P2|COMPLETED|Overall Study||16
55117|NCT02419937|133144|P1|COMPLETED|Overall Study||11
55118|NCT02419937|133143|P2|STARTED|Overall Study||16
55119|NCT02419937|133144|P1|STARTED|Overall Study||12
55120|NCT02419755|133152|P2|NOT COMPLETED|Overall Study||4
55121|NCT02419755|133153|P1|NOT COMPLETED|Overall Study||3
55122|NCT02419755|133152|P2|COMPLETED|Overall Study||2
55123|NCT02419755|133153|P1|COMPLETED|Overall Study||3
55124|NCT02419755|133152|P2|STARTED|Overall Study||6
55125|NCT02419755|133153|P1|STARTED|Overall Study||6
55126|NCT02419612|133179|P2|NOT COMPLETED|Overall Study||23
55127|NCT02419612|133180|P1|NOT COMPLETED|Overall Study||17
55128|NCT02419612|133179|P2|COMPLETED|Overall Study||194
55129|NCT02419612|133180|P1|COMPLETED|Overall Study||210
55130|NCT02419612|133179|P2|STARTED|Overall Study||217
55131|NCT02419612|133180|P1|STARTED|Overall Study||227
55132|NCT02419573|133196|P2|NOT COMPLETED|Overall Study||0
55133|NCT02419573|133197|P1|NOT COMPLETED|Overall Study||4
55134|NCT02419573|133196|P2|COMPLETED|Overall Study||1505
55135|NCT02419573|133197|P1|COMPLETED|Overall Study||1495
55136|NCT02419573|133196|P2|STARTED|Overall Study||1505
55137|NCT02419573|133197|P1|STARTED|Overall Study||1499
55138|NCT02419547|133209|P1|NOT COMPLETED|Overall Study||0
55139|NCT02419547|133209|P1|COMPLETED|Overall Study||11
55140|NCT02419547|133209|P1|STARTED|Overall Study||11
55141|NCT02419521|133213|P1|NOT COMPLETED|Overall Study||1
55142|NCT02419521|133213|P1|COMPLETED|Overall Study||74
55143|NCT02419521|133213|P1|STARTED|Overall Study||75
55144|NCT02419508|133227|P2|NOT COMPLETED|Overall Study||4
55145|NCT02419508|133228|P1|NOT COMPLETED|Overall Study||10
55146|NCT02419508|133227|P2|COMPLETED|Overall Study||88
55147|NCT02419508|133228|P1|COMPLETED|Overall Study||86
55148|NCT02419508|133227|P2|Safety Analysis Set|Overall Study||92
55149|NCT02419508|133228|P1|Safety Analysis Set|Overall Study||95
55150|NCT02419508|133227|P2|Full Analysis Set|Overall Study||92
55151|NCT02419508|133228|P1|Full Analysis Set|Overall Study||95
55152|NCT02419508|133227|P2|STARTED|Overall Study||92
55153|NCT02419508|133228|P1|STARTED|Overall Study||96
55154|NCT02419469|133246|P1|NOT COMPLETED|Overall Study||1
55155|NCT02419469|133246|P1|COMPLETED|Overall Study||0
55156|NCT02419469|133246|P1|STARTED|Overall Study||1
55157|NCT02419313|133250|P2|NOT COMPLETED|Second Intervention||0
55158|NCT02419313|133251|P1|NOT COMPLETED|Second Intervention||1
55159|NCT02419313|133250|P2|COMPLETED|Second Intervention||15
55160|NCT02419313|133251|P1|COMPLETED|Second Intervention||15
55161|NCT02419313|133250|P2|STARTED|Second Intervention||15
55162|NCT02419313|133251|P1|STARTED|Second Intervention||16
55163|NCT02419313|133250|P2|NOT COMPLETED|First Intervention||0
55164|NCT02419313|133251|P1|NOT COMPLETED|First Intervention||2
55165|NCT02419313|133250|P2|COMPLETED|First Intervention||15
55166|NCT02419313|133251|P1|COMPLETED|First Intervention||16
55167|NCT02419313|133250|P2|STARTED|First Intervention||15
55168|NCT02419313|133251|P1|STARTED|First Intervention||18
55169|NCT02419001|133263|P2|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
55170|NCT02419001|133264|P1|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
55171|NCT02419001|133263|P2|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
55172|NCT02419001|133264|P1|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
55173|NCT02419001|133263|P2|STARTED|Period 2- Ceftriaxone With SYN-004||5
55174|NCT02419001|133264|P1|STARTED|Period 2- Ceftriaxone With SYN-004||5
55175|NCT02419001|133263|P2|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||0
55176|NCT02419001|133264|P1|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||1
55177|NCT02419001|133263|P2|COMPLETED|Period 1- Ceftriaxone Without SYN-004||5
55178|NCT02419001|133264|P1|COMPLETED|Period 1- Ceftriaxone Without SYN-004|The Adverse Event (AE) was with ceftriaxone, not with Investigational Product (IP)|5
55179|NCT02419001|133263|P2|STARTED|Period 1- Ceftriaxone Without SYN-004||5
55180|NCT02419001|133264|P1|STARTED|Period 1- Ceftriaxone Without SYN-004||6
55181|NCT02418910|133274|P1|NOT COMPLETED|Overall Study||7
55182|NCT02418910|133274|P1|COMPLETED|Overall Study||43
55183|NCT02418910|133274|P1|STARTED|Overall Study||50
55184|NCT02418819|133282|P4|NOT COMPLETED|Overall Study||1
55185|NCT02418819|133283|P3|NOT COMPLETED|Overall Study||4
55186|NCT02418819|133284|P2|NOT COMPLETED|Overall Study||0
55187|NCT02418819|133285|P1|NOT COMPLETED|Overall Study||1
55188|NCT02418819|133282|P4|COMPLETED|Overall Study||28
55189|NCT02418819|133283|P3|COMPLETED|Overall Study||29
55190|NCT02418819|133284|P2|COMPLETED|Overall Study||16
55191|NCT02418819|133285|P1|COMPLETED|Overall Study||21
55192|NCT02418819|133282|P4|STARTED|Overall Study||29
55193|NCT02418819|133283|P3|STARTED|Overall Study||33
55194|NCT02418819|133284|P2|STARTED|Overall Study||16
55195|NCT02418819|133285|P1|STARTED|Overall Study||22
55196|NCT02418676|133328|P3|NOT COMPLETED|Overall Study||0
55197|NCT02418676|133329|P2|NOT COMPLETED|Overall Study||0
55198|NCT02418676|133330|P1|NOT COMPLETED|Overall Study||0
55199|NCT02418676|133328|P3|COMPLETED|Overall Study||5
55200|NCT02418676|133329|P2|COMPLETED|Overall Study||5
55201|NCT02418676|133330|P1|COMPLETED|Overall Study||5
55202|NCT02418676|133328|P3|STARTED|Overall Study||5
55203|NCT02418676|133329|P2|STARTED|Overall Study||5
55204|NCT02418676|133330|P1|STARTED|Overall Study||5
55205|NCT02418585|133343|P2|NOT COMPLETED|Follow-up Phase (24 Weeks)||25
55206|NCT02418585|133344|P1|NOT COMPLETED|Follow-up Phase (24 Weeks)||18
55207|NCT02418585|133343|P2|COMPLETED|Follow-up Phase (24 Weeks)||27
55208|NCT02418585|133344|P1|COMPLETED|Follow-up Phase (24 Weeks)||16
55209|NCT02418585|133343|P2|STARTED|Follow-up Phase (24 Weeks)||52
55210|NCT02418585|133344|P1|STARTED|Follow-up Phase (24 Weeks)||34
55211|NCT02418585|133343|P2|NOT COMPLETED|Double Blind (DB) Phase (4 Weeks)||12
55212|NCT02418585|133344|P1|NOT COMPLETED|Double Blind (DB) Phase (4 Weeks)||18
55213|NCT02418585|133343|P2|COMPLETED|Double Blind (DB) Phase (4 Weeks)||99
55214|NCT02418585|133344|P1|COMPLETED|Double Blind (DB) Phase (4 Weeks)||98
55215|NCT02418585|133343|P2|Full Analysis Set|Double Blind (DB) Phase (4 Weeks)||109
55216|NCT02418585|133344|P1|Full Analysis Set|Double Blind (DB) Phase (4 Weeks)||114
55217|NCT02418585|133343|P2|Safety Analysis Set|Double Blind (DB) Phase (4 Weeks)||109
55218|NCT02418585|133344|P1|Safety Analysis Set|Double Blind (DB) Phase (4 Weeks)||115
55219|NCT02418585|133343|P2|STARTED|Double Blind (DB) Phase (4 Weeks)||111
55220|NCT02418585|133344|P1|STARTED|Double Blind (DB) Phase (4 Weeks)||116
55221|NCT02418468|133384|P2|NOT COMPLETED|Overall Study||1
55222|NCT02418468|133385|P1|NOT COMPLETED|Overall Study||2
55223|NCT02418468|133384|P2|COMPLETED|Overall Study||10
55224|NCT02418468|133385|P1|COMPLETED|Overall Study||11
55225|NCT02418468|133384|P2|STARTED|Overall Study||11
55226|NCT02418468|133385|P1|STARTED|Overall Study||13
55227|NCT02418455|133391|P1|NOT COMPLETED|Continuation Period||7
55228|NCT02418455|133391|P1|COMPLETED|Continuation Period||0
55229|NCT02418455|133391|P1|STARTED|Continuation Period||7
55230|NCT02418455|133391|P1|NOT COMPLETED|48-Week Treatment Period||1
55231|NCT02418455|133391|P1|COMPLETED|48-Week Treatment Period||7
55232|NCT02418455|133391|P1|Emergency IND (eIND)|48-Week Treatment Period||1
55233|NCT02418455|133391|P1|STARTED|48-Week Treatment Period||8
55234|NCT02418312|133414|P2|NOT COMPLETED|Overall Study||0
55235|NCT02418312|133415|P1|NOT COMPLETED|Overall Study||0
55236|NCT02418312|133414|P2|COMPLETED|Overall Study||114
55237|NCT02418312|133415|P1|COMPLETED|Overall Study||114
55238|NCT02418312|133414|P2|STARTED|Overall Study||114
55239|NCT02418312|133415|P1|STARTED|Overall Study||114
55240|NCT02418234|133421|P1|NOT COMPLETED|Overall Study||0
55241|NCT02418234|133421|P1|COMPLETED|Overall Study||314
55242|NCT02418234|133421|P1|STARTED|Overall Study||314
55243|NCT02418026|133434|P2|NOT COMPLETED|Overall Study||0
55244|NCT02418026|133435|P1|NOT COMPLETED|Overall Study||0
55245|NCT02418026|133434|P2|COMPLETED|Overall Study||35
55246|NCT02418026|133435|P1|COMPLETED|Overall Study||44
55247|NCT02418026|133434|P2|STARTED|Overall Study||35
55248|NCT02418026|133435|P1|STARTED|Overall Study||44
55249|NCT02418000|133470|P5|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||4
55250|NCT02418000|133471|P4|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
55251|NCT02418000|133472|P3|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
55252|NCT02418000|133473|P2|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
55253|NCT02418000|133474|P1|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
55254|NCT02418000|133470|P5|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
55255|NCT02418000|133471|P4|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
55256|NCT02418000|133472|P3|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
55257|NCT02418000|133473|P2|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
55258|NCT02418000|133474|P1|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
55259|NCT02418000|133470|P5|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||4
55260|NCT02418000|133471|P4|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
55261|NCT02418000|133472|P3|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
55262|NCT02418000|133473|P2|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
55263|NCT02418000|133474|P1|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
55264|NCT02418000|133470|P5|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
55265|NCT02418000|133471|P4|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||3
55266|NCT02418000|133472|P3|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
55267|NCT02418000|133473|P2|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
55268|NCT02418000|133474|P1|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
55269|NCT02418000|133470|P5|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
55270|NCT02418000|133471|P4|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
55271|NCT02418000|133472|P3|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
55272|NCT02418000|133473|P2|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
55273|NCT02418000|133474|P1|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
55274|NCT02418000|133470|P5|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
55275|NCT02418000|133471|P4|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||3
55276|NCT02418000|133472|P3|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
55277|NCT02418000|133473|P2|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
55278|NCT02418000|133474|P1|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
55279|NCT02418000|133470|P5|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
55280|NCT02418000|133471|P4|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
55281|NCT02418000|133472|P3|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||3
55282|NCT02418000|133473|P2|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
55283|NCT02418000|133474|P1|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
55284|NCT02418000|133470|P5|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
55285|NCT02418000|133471|P4|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
55286|NCT02418000|133472|P3|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
55287|NCT02418000|133473|P2|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
55288|NCT02418000|133474|P1|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
55289|NCT02418000|133470|P5|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
55290|NCT02418000|133471|P4|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
55291|NCT02418000|133472|P3|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||3
55292|NCT02418000|133473|P2|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
55293|NCT02418000|133474|P1|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
55294|NCT02418000|133470|P5|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
55295|NCT02418000|133471|P4|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
55296|NCT02418000|133472|P3|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
55297|NCT02418000|133473|P2|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||10
55298|NCT02418000|133474|P1|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
55299|NCT02418000|133470|P5|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
55300|NCT02418000|133471|P4|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
55301|NCT02418000|133472|P3|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
55302|NCT02418000|133473|P2|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
55303|NCT02418000|133474|P1|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
55304|NCT02418000|133470|P5|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
55305|NCT02418000|133471|P4|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
55306|NCT02418000|133472|P3|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
55307|NCT02418000|133473|P2|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||10
55308|NCT02418000|133474|P1|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
55309|NCT02418000|133470|P5|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
55310|NCT02418000|133471|P4|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
55311|NCT02418000|133472|P3|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
55312|NCT02418000|133473|P2|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
55313|NCT02418000|133474|P1|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||7
55314|NCT02418000|133470|P5|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
55315|NCT02418000|133471|P4|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
55316|NCT02418000|133472|P3|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
55317|NCT02418000|133473|P2|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
55318|NCT02418000|133474|P1|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
55319|NCT02418000|133470|P5|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
55320|NCT02418000|133471|P4|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
55321|NCT02418000|133472|P3|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
55322|NCT02418000|133473|P2|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
55323|NCT02418000|133474|P1|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||7
55324|NCT02417961|133592|P1|NOT COMPLETED|Overall Study||4
55325|NCT02417961|133592|P1|COMPLETED|Overall Study||112
55326|NCT02417961|133592|P1|STARTED|Overall Study||116
55327|NCT02417935|133604|P2|NOT COMPLETED|Tapering Period||0
55328|NCT02417935|133605|P1|NOT COMPLETED|Tapering Period||0
55329|NCT02417935|133604|P2|COMPLETED|Tapering Period||142
55330|NCT02417935|133605|P1|COMPLETED|Tapering Period||134
55331|NCT02417935|133604|P2|STARTED|Tapering Period|Participants who discontinued treatment period had an option to enter the taper period|142
55332|NCT02417935|133605|P1|STARTED|Tapering Period|Participants who discontinued treatment period had an option to enter the taper period|134
55333|NCT02417935|133604|P2|NOT COMPLETED|Treatment Period||16
55334|NCT02417935|133605|P1|NOT COMPLETED|Treatment Period||21
55335|NCT02417935|133604|P2|COMPLETED|Treatment Period||137
55336|NCT02417935|133605|P1|COMPLETED|Treatment Period||130
55337|NCT02417935|133604|P2|Received at Least One Dose of Study Drug|Treatment Period||152
55338|NCT02417935|133605|P1|Received at Least One Dose of Study Drug|Treatment Period||151
55339|NCT02417935|133604|P2|STARTED|Treatment Period||153
55340|NCT02417935|133605|P1|STARTED|Treatment Period||151
55341|NCT02417753|133629|P1|NOT COMPLETED|Overall Study||1
55342|NCT02417753|133629|P1|COMPLETED|Overall Study||0
55343|NCT02417753|133629|P1|STARTED|Overall Study||1
55344|NCT02417532|133639|P1|NOT COMPLETED|Overall Study||0
55345|NCT02417532|133639|P1|COMPLETED|Overall Study||56
55346|NCT02417532|133639|P1|STARTED|Overall Study||56
55347|NCT02417441|133649|P2|NOT COMPLETED|Overall Study||19
55348|NCT02417441|133650|P1|NOT COMPLETED|Overall Study||52
55349|NCT02417441|133649|P2|COMPLETED|Overall Study||306
55350|NCT02417441|133650|P1|COMPLETED|Overall Study||593
55351|NCT02417441|133649|P2|STARTED|Overall Study||325
55352|NCT02417441|133650|P1|STARTED|Overall Study||645
55353|NCT02417376|133671|P2|NOT COMPLETED|Overall Study||10
55354|NCT02417376|133672|P1|NOT COMPLETED|Overall Study||5
55355|NCT02417376|133671|P2|COMPLETED|Overall Study||25
55356|NCT02417376|133672|P1|COMPLETED|Overall Study||30
55357|NCT02417376|133671|P2|STARTED|Overall Study||35
55358|NCT02417376|133672|P1|STARTED|Overall Study||35
55359|NCT02417246|133718|P2|NOT COMPLETED|Phase 4 2nd Generic Administered||0
55360|NCT02417246|133719|P1|NOT COMPLETED|Phase 4 2nd Generic Administered||0
55361|NCT02417246|133718|P2|COMPLETED|Phase 4 2nd Generic Administered||20
55362|NCT02417246|133719|P1|COMPLETED|Phase 4 2nd Generic Administered||18
55363|NCT02417246|133718|P2|STARTED|Phase 4 2nd Generic Administered||20
55364|NCT02417246|133719|P1|STARTED|Phase 4 2nd Generic Administered||18
55365|NCT02417246|133718|P2|NOT COMPLETED|Phase 3 Brand Name Metoprolol ER #2||0
55366|NCT02417246|133719|P1|NOT COMPLETED|Phase 3 Brand Name Metoprolol ER #2||1
55367|NCT02417246|133718|P2|COMPLETED|Phase 3 Brand Name Metoprolol ER #2||20
55368|NCT02417246|133719|P1|COMPLETED|Phase 3 Brand Name Metoprolol ER #2||18
55369|NCT02417246|133718|P2|STARTED|Phase 3 Brand Name Metoprolol ER #2||20
55370|NCT02417246|133719|P1|STARTED|Phase 3 Brand Name Metoprolol ER #2||19
55371|NCT02417246|133718|P2|NOT COMPLETED|Phase 2 1st Generic Administered||0
55372|NCT02417246|133719|P1|NOT COMPLETED|Phase 2 1st Generic Administered||1
55373|NCT02417246|133718|P2|COMPLETED|Phase 2 1st Generic Administered||20
55374|NCT02417246|133719|P1|COMPLETED|Phase 2 1st Generic Administered||19
55375|NCT02417246|133718|P2|STARTED|Phase 2 1st Generic Administered||20
55376|NCT02417246|133719|P1|STARTED|Phase 2 1st Generic Administered||20
55377|NCT02417246|133718|P2|NOT COMPLETED|Phase 1 Brand Name Metoprolol ER||4
55378|NCT02417246|133719|P1|NOT COMPLETED|Phase 1 Brand Name Metoprolol ER||4
55379|NCT02417246|133718|P2|COMPLETED|Phase 1 Brand Name Metoprolol ER||20
55380|NCT02417246|133719|P1|COMPLETED|Phase 1 Brand Name Metoprolol ER||20
55381|NCT02417246|133718|P2|STARTED|Phase 1 Brand Name Metoprolol ER||24
55382|NCT02417246|133719|P1|STARTED|Phase 1 Brand Name Metoprolol ER||24
55383|NCT02417233|133742|P3|NOT COMPLETED|Overall Study||59
55384|NCT02417233|133743|P2|NOT COMPLETED|Overall Study||51
55385|NCT02417233|133744|P1|NOT COMPLETED|Overall Study||36
55386|NCT02417233|133742|P3|COMPLETED|Overall Study||239
55387|NCT02417233|133743|P2|COMPLETED|Overall Study||238
55388|NCT02417233|133744|P1|COMPLETED|Overall Study||133
55389|NCT02417233|133742|P3|STARTED|Overall Study||298
55390|NCT02417233|133743|P2|STARTED|Overall Study||289
55391|NCT02417233|133744|P1|STARTED|Overall Study||169
55392|NCT02417129|133767|P2|NOT COMPLETED|Overall Study||0
55393|NCT02417129|133768|P1|NOT COMPLETED|Overall Study||0
55394|NCT02417129|133767|P2|COMPLETED|Overall Study||0
55395|NCT02417129|133768|P1|COMPLETED|Overall Study||2
55396|NCT02417129|133767|P2|STARTED|Overall Study||0
55397|NCT02417129|133768|P1|STARTED|Overall Study||2
55398|NCT02417064|133781|P3|NOT COMPLETED|Follow-up Phase (24 Weeks)||51
55399|NCT02417064|133782|P2|NOT COMPLETED|Follow-up Phase (24 Weeks)||42
55400|NCT02417064|133783|P1|NOT COMPLETED|Follow-up Phase (24 Weeks)||39
55401|NCT02417064|133781|P3|COMPLETED|Follow-up Phase (24 Weeks)||18
55402|NCT02417064|133782|P2|COMPLETED|Follow-up Phase (24 Weeks)||10
55403|NCT02417064|133783|P1|COMPLETED|Follow-up Phase (24 Weeks)||8
55404|NCT02417064|133781|P3|STARTED|Follow-up Phase (24 Weeks)||69
55405|NCT02417064|133782|P2|STARTED|Follow-up Phase (24 Weeks)||52
55406|NCT02417064|133783|P1|STARTED|Follow-up Phase (24 Weeks)||47
55407|NCT02417064|133781|P3|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
55408|NCT02417064|133782|P2|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||19
55409|NCT02417064|133783|P1|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
55410|NCT02417064|133781|P3|COMPLETED|Double-blind Induction Phase (4 Weeks)||107
55411|NCT02417064|133782|P2|COMPLETED|Double-blind Induction Phase (4 Weeks)||97
55412|NCT02417064|133783|P1|COMPLETED|Double-blind Induction Phase (4 Weeks)||111
55413|NCT02417064|133781|P3|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||113
55414|NCT02417064|133782|P2|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||116
55415|NCT02417064|133783|P1|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||115
55416|NCT02417064|133781|P3|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||113
55417|NCT02417064|133782|P2|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||114
55418|NCT02417064|133783|P1|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||115
55419|NCT02417064|133781|P3|STARTED|Double-blind Induction Phase (4 Weeks)||113
55420|NCT02417064|133782|P2|STARTED|Double-blind Induction Phase (4 Weeks)||116
55421|NCT02417064|133783|P1|STARTED|Double-blind Induction Phase (4 Weeks)||117
55422|NCT02416973|133842|P3|NOT COMPLETED|Overall Study||1
55423|NCT02416973|133843|P2|NOT COMPLETED|Overall Study||3
55424|NCT02416973|133844|P1|NOT COMPLETED|Overall Study||1
55425|NCT02416973|133842|P3|COMPLETED|Overall Study||13
55426|NCT02416973|133843|P2|COMPLETED|Overall Study||10
55427|NCT02416973|133844|P1|COMPLETED|Overall Study||13
55428|NCT02416973|133842|P3|STARTED|Overall Study||14
55429|NCT02416973|133843|P2|STARTED|Overall Study||13
55430|NCT02416973|133844|P1|STARTED|Overall Study||14
55431|NCT02416934|133854|P2|NOT COMPLETED|Overall Study||7
55432|NCT02416934|133855|P1|NOT COMPLETED|Overall Study||3
55433|NCT02416934|133854|P2|COMPLETED|Overall Study||31
55434|NCT02416934|133855|P1|COMPLETED|Overall Study||33
55435|NCT02416934|133854|P2|Last Participant Completed 1 yr|Overall Study||31
55436|NCT02416934|133855|P1|Last Participant Completed 1 yr|Overall Study||33
55437|NCT02416934|133854|P2|Double Blind (0-52 Weeks)|Overall Study||38
55438|NCT02416934|133855|P1|Double Blind (0-52 Weeks)|Overall Study||36
55439|NCT02416934|133854|P2|STARTED|Overall Study||38
55440|NCT02416934|133855|P1|STARTED|Overall Study||36
55441|NCT02416713|133871|P4|NOT COMPLETED|Overall Study||0
55442|NCT02416713|133872|P3|NOT COMPLETED|Overall Study||0
55443|NCT02416713|133873|P2|NOT COMPLETED|Overall Study||0
55444|NCT02416713|133874|P1|NOT COMPLETED|Overall Study||0
55445|NCT02416713|133871|P4|COMPLETED|Overall Study||10
55446|NCT02416713|133872|P3|COMPLETED|Overall Study||8
55447|NCT02416713|133873|P2|COMPLETED|Overall Study||9
55448|NCT02416713|133874|P1|COMPLETED|Overall Study||8
55449|NCT02416713|133871|P4|STARTED|Overall Study||10
55450|NCT02416713|133872|P3|STARTED|Overall Study||8
55451|NCT02416713|133873|P2|STARTED|Overall Study||9
55452|NCT02416713|133874|P1|STARTED|Overall Study||8
55453|NCT02416180|133884|P1|NOT COMPLETED|Overall Study||1
55454|NCT02416180|133884|P1|COMPLETED|Overall Study||110
55455|NCT02416180|133884|P1|STARTED|Overall Study||111
55456|NCT02415959|133896|P5|NOT COMPLETED|Overall Study||0
55457|NCT02415959|133897|P4|NOT COMPLETED|Overall Study||1
55458|NCT02415959|133898|P3|NOT COMPLETED|Overall Study||0
55459|NCT02415959|133899|P2|NOT COMPLETED|Overall Study||1
55460|NCT02415959|133900|P1|NOT COMPLETED|Overall Study||0
55461|NCT02415959|133896|P5|COMPLETED|Overall Study||14
55462|NCT02415959|133897|P4|COMPLETED|Overall Study||13
55463|NCT02415959|133898|P3|COMPLETED|Overall Study||14
55464|NCT02415959|133899|P2|COMPLETED|Overall Study||13
55465|NCT02415959|133900|P1|COMPLETED|Overall Study||14
55466|NCT02415959|133896|P5|STARTED|Overall Study||14
55467|NCT02415959|133897|P4|STARTED|Overall Study||14
55468|NCT02415959|133898|P3|STARTED|Overall Study||14
55469|NCT02415959|133899|P2|STARTED|Overall Study||14
55470|NCT02415959|133900|P1|STARTED|Overall Study||14
55471|NCT02415842|133945|P13|NOT COMPLETED|Overall Study||0
55472|NCT02415842|133946|P12|NOT COMPLETED|Overall Study||0
55473|NCT02415842|133947|P11|NOT COMPLETED|Overall Study||0
55474|NCT02415842|133948|P10|NOT COMPLETED|Overall Study||0
55475|NCT02415842|133949|P9|NOT COMPLETED|Overall Study||0
55476|NCT02415842|133950|P8|NOT COMPLETED|Overall Study||0
55477|NCT02415842|133951|P7|NOT COMPLETED|Overall Study||0
55478|NCT02415842|133952|P6|NOT COMPLETED|Overall Study||0
55479|NCT02415842|133953|P5|NOT COMPLETED|Overall Study||0
55480|NCT02415842|133954|P4|NOT COMPLETED|Overall Study||0
55481|NCT02415842|133955|P3|NOT COMPLETED|Overall Study||0
55482|NCT02415842|133956|P2|NOT COMPLETED|Overall Study||0
55483|NCT02415842|133957|P1|NOT COMPLETED|Overall Study||0
55484|NCT02415842|133945|P13|COMPLETED|Overall Study||20
55485|NCT02415842|133946|P12|COMPLETED|Overall Study||33
55486|NCT02415842|133947|P11|COMPLETED|Overall Study||49
55487|NCT02415842|133948|P10|COMPLETED|Overall Study||53
55488|NCT02415842|133949|P9|COMPLETED|Overall Study||29
55489|NCT02415842|133950|P8|COMPLETED|Overall Study||26
55490|NCT02415842|133951|P7|COMPLETED|Overall Study||30
55491|NCT02415842|133952|P6|COMPLETED|Overall Study||30
55492|NCT02415842|133953|P5|COMPLETED|Overall Study||30
55493|NCT02415842|133954|P4|COMPLETED|Overall Study||27
55494|NCT02415842|133955|P3|COMPLETED|Overall Study||29
55495|NCT02415842|133956|P2|COMPLETED|Overall Study||29
55496|NCT02415842|133957|P1|COMPLETED|Overall Study||29
55497|NCT02415842|133945|P13|STARTED|Overall Study||20
55498|NCT02415842|133946|P12|STARTED|Overall Study||33
55499|NCT02415842|133947|P11|STARTED|Overall Study||49
55500|NCT02415842|133948|P10|STARTED|Overall Study||53
55501|NCT02415842|133949|P9|STARTED|Overall Study||29
55502|NCT02415842|133950|P8|STARTED|Overall Study||26
55503|NCT02415842|133951|P7|STARTED|Overall Study||30
55504|NCT02415842|133952|P6|STARTED|Overall Study||30
55505|NCT02415842|133953|P5|STARTED|Overall Study||30
55506|NCT02415842|133954|P4|STARTED|Overall Study||27
55507|NCT02415842|133955|P3|STARTED|Overall Study||29
55508|NCT02415842|133956|P2|STARTED|Overall Study||29
55509|NCT02415842|133957|P1|STARTED|Overall Study||29
55510|NCT02415608|134298|P2|NOT COMPLETED|Overall Study||0
55511|NCT02415608|134299|P1|NOT COMPLETED|Overall Study||0
55512|NCT02415608|134298|P2|COMPLETED|Overall Study||1
55513|NCT02415608|134299|P1|COMPLETED|Overall Study||3
55514|NCT02415608|134298|P2|STARTED|Overall Study||1
55515|NCT02415608|134299|P1|STARTED|Overall Study||3
55516|NCT02415595|134329|P4|NOT COMPLETED|Overall Study||53
55517|NCT02415595|134330|P3|NOT COMPLETED|Overall Study||51
55518|NCT02415595|134331|P2|NOT COMPLETED|Overall Study||52
55519|NCT02415595|134332|P1|NOT COMPLETED|Overall Study||50
55520|NCT02415595|134329|P4|COMPLETED|Overall Study||0
55521|NCT02415595|134330|P3|COMPLETED|Overall Study||0
55522|NCT02415595|134331|P2|COMPLETED|Overall Study||0
55523|NCT02415595|134332|P1|COMPLETED|Overall Study||0
55524|NCT02415595|134329|P4|STARTED|Overall Study||53
55525|NCT02415595|134330|P3|STARTED|Overall Study||51
55526|NCT02415595|134331|P2|STARTED|Overall Study||52
55527|NCT02415595|134332|P1|STARTED|Overall Study||50
55528|NCT02415439|134404|P13|NOT COMPLETED|Overall Study||0
55529|NCT02415439|134405|P12|NOT COMPLETED|Overall Study||0
55530|NCT02415439|134406|P11|NOT COMPLETED|Overall Study||0
55531|NCT02415439|134407|P10|NOT COMPLETED|Overall Study||0
55532|NCT02415439|134408|P9|NOT COMPLETED|Overall Study||1
55533|NCT02415439|134409|P8|NOT COMPLETED|Overall Study||0
55534|NCT02415439|134410|P7|NOT COMPLETED|Overall Study||0
55535|NCT02415439|134411|P6|NOT COMPLETED|Overall Study||0
55536|NCT02415439|134412|P5|NOT COMPLETED|Overall Study||0
55537|NCT02415439|134413|P4|NOT COMPLETED|Overall Study||0
55538|NCT02415439|134414|P3|NOT COMPLETED|Overall Study||0
55539|NCT02415439|134415|P2|NOT COMPLETED|Overall Study||0
55540|NCT02415439|134416|P1|NOT COMPLETED|Overall Study||0
55541|NCT02415439|134404|P13|COMPLETED|Overall Study||8
55542|NCT02415439|134405|P12|COMPLETED|Overall Study||6
55543|NCT02415439|134406|P11|COMPLETED|Overall Study||6
55544|NCT02415439|134407|P10|COMPLETED|Overall Study||6
55545|NCT02415439|134408|P9|COMPLETED|Overall Study||5
55546|NCT02415439|134409|P8|COMPLETED|Overall Study||12
55547|NCT02415439|134410|P7|COMPLETED|Overall Study||6
55548|NCT02415439|134411|P6|COMPLETED|Overall Study||6
55549|NCT02415439|134412|P5|COMPLETED|Overall Study||6
55550|NCT02415439|134413|P4|COMPLETED|Overall Study||6
55551|NCT02415439|134414|P3|COMPLETED|Overall Study||6
55552|NCT02415439|134415|P2|COMPLETED|Overall Study||6
55553|NCT02415439|134416|P1|COMPLETED|Overall Study||6
55554|NCT02415439|134404|P13|STARTED|Overall Study||8
55555|NCT02415439|134405|P12|STARTED|Overall Study||6
55556|NCT02415439|134406|P11|STARTED|Overall Study||6
55557|NCT02415439|134407|P10|STARTED|Overall Study||6
55558|NCT02415439|134408|P9|STARTED|Overall Study||6
55559|NCT02415439|134409|P8|STARTED|Overall Study||12
55560|NCT02415439|134410|P7|STARTED|Overall Study||6
55561|NCT02415439|134411|P6|STARTED|Overall Study||6
55562|NCT02415439|134412|P5|STARTED|Overall Study||6
55563|NCT02415439|134413|P4|STARTED|Overall Study||6
55564|NCT02415439|134414|P3|STARTED|Overall Study||6
55565|NCT02415439|134415|P2|STARTED|Overall Study||6
55566|NCT02415439|134416|P1|STARTED|Overall Study||6
55567|NCT02415244|134472|P2|NOT COMPLETED|Overall Study||0
55568|NCT02415244|134473|P1|NOT COMPLETED|Overall Study||0
55569|NCT02415244|134472|P2|COMPLETED|Overall Study||25
55570|NCT02415244|134473|P1|COMPLETED|Overall Study||50
55571|NCT02415244|134472|P2|STARTED|Overall Study||25
55572|NCT02415244|134473|P1|STARTED|Overall Study||50
55573|NCT02415166|134483|P4|NOT COMPLETED|Overall Study||0
55574|NCT02415166|134484|P3|NOT COMPLETED|Overall Study||0
55575|NCT02415166|134485|P2|NOT COMPLETED|Overall Study||0
55576|NCT02415166|134486|P1|NOT COMPLETED|Overall Study||0
55577|NCT02415166|134483|P4|COMPLETED|Overall Study||0
55578|NCT02415166|134484|P3|COMPLETED|Overall Study||0
55579|NCT02415166|134485|P2|COMPLETED|Overall Study||0
55580|NCT02415166|134486|P1|COMPLETED|Overall Study||6
55581|NCT02415166|134483|P4|STARTED|Overall Study||0
55582|NCT02415166|134484|P3|STARTED|Overall Study||0
55583|NCT02415166|134485|P2|STARTED|Overall Study||0
55584|NCT02415166|134486|P1|STARTED|Overall Study||6
55585|NCT02415127|134514|P2|NOT COMPLETED|Overall Study||0
55586|NCT02415127|134515|P1|NOT COMPLETED|Overall Study||1
55587|NCT02415127|134514|P2|COMPLETED|Overall Study||45
55588|NCT02415127|134515|P1|COMPLETED|Overall Study||46
55589|NCT02415127|134514|P2|STARTED|Overall Study||45
55590|NCT02415127|134515|P1|STARTED|Overall Study||47
55591|NCT02414958|134532|P3|NOT COMPLETED|Overall Study||14
55592|NCT02414958|134533|P2|NOT COMPLETED|Overall Study||20
55593|NCT02414958|134534|P1|NOT COMPLETED|Overall Study||32
55594|NCT02414958|134532|P3|COMPLETED|Overall Study||230
55595|NCT02414958|134533|P2|COMPLETED|Overall Study||223
55596|NCT02414958|134534|P1|COMPLETED|Overall Study||211
55597|NCT02414958|134532|P3|STARTED|Overall Study||244
55598|NCT02414958|134533|P2|STARTED|Overall Study||243
55599|NCT02414958|134534|P1|STARTED|Overall Study||243
55600|NCT02414854|134567|P4|NOT COMPLETED|Overall Study||51
55601|NCT02414854|134568|P3|NOT COMPLETED|Overall Study||20
55602|NCT02414854|134569|P2|NOT COMPLETED|Overall Study||45
55603|NCT02414854|134570|P1|NOT COMPLETED|Overall Study||22
55604|NCT02414854|134567|P4|COMPLETED|Overall Study||582
55605|NCT02414854|134568|P3|COMPLETED|Overall Study||301
55606|NCT02414854|134569|P2|COMPLETED|Overall Study||586
55607|NCT02414854|134570|P1|COMPLETED|Overall Study||295
55608|NCT02414854|134567|P4|Treated|Overall Study|1 got other treatment (dupilumab 200) than assigned + was allocated to that in AE table|632
55609|NCT02414854|134568|P3|Treated|Overall Study||321
55610|NCT02414854|134569|P2|Treated|Overall Study||629
55611|NCT02414854|134570|P1|Treated|Overall Study|2 got other treatment (1 each dupilumab 200+300) than assigned + were allocated to those in AE table|315
55612|NCT02414854|134567|P4|STARTED|Overall Study||633
55613|NCT02414854|134568|P3|STARTED|Overall Study||321
55614|NCT02414854|134569|P2|STARTED|Overall Study||631
55615|NCT02414854|134570|P1|STARTED|Overall Study||317
55616|NCT02414841|134734|P2|NOT COMPLETED|Overall Study||33
55617|NCT02414841|134735|P1|NOT COMPLETED|Overall Study||56
55618|NCT02414841|134734|P2|COMPLETED|Overall Study||175
55619|NCT02414841|134735|P1|COMPLETED|Overall Study||349
55620|NCT02414841|134734|P2|STARTED|Overall Study||208
55621|NCT02414841|134735|P1|STARTED|Overall Study||405
55622|NCT02414828|134747|P4|NOT COMPLETED|Overall Study||2
55623|NCT02414828|134748|P3|NOT COMPLETED|Overall Study||1
55624|NCT02414828|134749|P2|NOT COMPLETED|Overall Study||1
55625|NCT02414828|134750|P1|NOT COMPLETED|Overall Study||0
55626|NCT02414828|134747|P4|COMPLETED|Overall Study||29
55627|NCT02414828|134748|P3|COMPLETED|Overall Study||19
55628|NCT02414828|134749|P2|COMPLETED|Overall Study||9
55629|NCT02414828|134750|P1|COMPLETED|Overall Study||11
55630|NCT02414828|134747|P4|STARTED|Overall Study||31
55631|NCT02414828|134748|P3|STARTED|Overall Study||20
55632|NCT02414828|134749|P2|STARTED|Overall Study||10
55633|NCT02414828|134750|P1|STARTED|Overall Study||11
55634|NCT02414633|134788|P1|NOT COMPLETED|Overall Study||0
55635|NCT02414633|134788|P1|COMPLETED|Overall Study||148
55636|NCT02414633|134788|P1|STARTED|Overall Study||148
55637|NCT02414204|134811|P2|NOT COMPLETED|Overall Study||0
55638|NCT02414204|134812|P1|NOT COMPLETED|Overall Study||0
55639|NCT02414204|134811|P2|COMPLETED|Overall Study||2
55640|NCT02414204|134812|P1|COMPLETED|Overall Study||2
55641|NCT02414204|134811|P2|STARTED|Overall Study||2
55642|NCT02414204|134812|P1|STARTED|Overall Study||2
55643|NCT02414152|134820|P1|NOT COMPLETED|Overall Study||2
55644|NCT02414152|134820|P1|COMPLETED|Overall Study|Both subjects completed 56 days of anakinra but did not complete all visits in observational period|0
55645|NCT02414152|134820|P1|STARTED|Overall Study||2
55646|NCT02413918|134824|P1|NOT COMPLETED|Overall Study||25
55647|NCT02413918|134824|P1|COMPLETED|Overall Study||16
55648|NCT02413918|134824|P1|STARTED|Overall Study||41
55649|NCT02413879|134831|P1|NOT COMPLETED|Overall Study||0
55650|NCT02413879|134831|P1|COMPLETED|Overall Study||86
55651|NCT02413879|134831|P1|STARTED|Overall Study||86
55652|NCT02413684|134837|P1|NOT COMPLETED|Overall Study||13
55653|NCT02413684|134837|P1|COMPLETED|Overall Study||40
55654|NCT02413684|134837|P1|STARTED|Overall Study||53
55655|NCT02413593|134847|P1|NOT COMPLETED|Overall Study||4
55656|NCT02413593|134847|P1|COMPLETED|Overall Study||107
55657|NCT02413593|134847|P1|STARTED|Overall Study||111
55658|NCT02413489|134859|P3|NOT COMPLETED|Overall Study||5
55659|NCT02413489|134860|P2|NOT COMPLETED|Overall Study||16
55660|NCT02413489|134861|P1|NOT COMPLETED|Overall Study||15
55661|NCT02413489|134859|P3|COMPLETED|Overall Study||0
55662|NCT02413489|134860|P2|COMPLETED|Overall Study||0
55663|NCT02413489|134861|P1|COMPLETED|Overall Study||0
55664|NCT02413489|134859|P3|STARTED|Overall Study||5
55665|NCT02413489|134860|P2|STARTED|Overall Study||16
55666|NCT02413489|134861|P1|STARTED|Overall Study||15
55667|NCT02413463|134883|P2|NOT COMPLETED|Overall Study||2
55668|NCT02413463|134884|P1|NOT COMPLETED|Overall Study||5
55669|NCT02413463|134883|P2|COMPLETED|Overall Study||28
55670|NCT02413463|134884|P1|COMPLETED|Overall Study||25
55671|NCT02413463|134883|P2|STARTED|Overall Study||30
55672|NCT02413463|134884|P1|STARTED|Overall Study||30
55673|NCT02413398|134902|P2|NOT COMPLETED|Overall Study||7
55674|NCT02413398|134903|P1|NOT COMPLETED|Overall Study||4
55675|NCT02413398|134902|P2|COMPLETED|Overall Study||154
55676|NCT02413398|134903|P1|COMPLETED|Overall Study||156
55677|NCT02413398|134902|P2|STARTED|Overall Study||161
55678|NCT02413398|134903|P1|STARTED|Overall Study||160
55679|NCT02413346|134917|P2|NOT COMPLETED|Overall Study||70
55680|NCT02413346|134918|P1|NOT COMPLETED|Overall Study||59
55681|NCT02413346|134917|P2|COMPLETED|Overall Study||177
55682|NCT02413346|134918|P1|COMPLETED|Overall Study||177
55683|NCT02413346|134917|P2|STARTED|Overall Study||247
55684|NCT02413346|134918|P1|STARTED|Overall Study||236
55685|NCT02413333|134928|P2|NOT COMPLETED|Period 2||0
55686|NCT02413333|134929|P1|NOT COMPLETED|Period 2||1
55687|NCT02413333|134928|P2|COMPLETED|Period 2||65
55688|NCT02413333|134929|P1|COMPLETED|Period 2||64
55689|NCT02413333|134928|P2|STARTED|Period 2||65
55690|NCT02413333|134929|P1|STARTED|Period 2||65
55691|NCT02413333|134928|P2|NOT COMPLETED|Period 1||1
55692|NCT02413333|134929|P1|NOT COMPLETED|Period 1||1
55693|NCT02413333|134928|P2|COMPLETED|Period 1||65
55694|NCT02413333|134929|P1|COMPLETED|Period 1||65
55695|NCT02413333|134928|P2|Randomized and Treated|Period 1||66
55696|NCT02413333|134929|P1|Randomized and Treated|Period 1||66
55697|NCT02413333|134928|P2|STARTED|Period 1||66
55698|NCT02413333|134929|P1|STARTED|Period 1||66
55699|NCT02413294|134937|P1|NOT COMPLETED|Overall Study||1
55700|NCT02413294|134937|P1|COMPLETED|Overall Study||11
55701|NCT02413294|134937|P1|STARTED|Overall Study||12
55702|NCT02413255|134972|P17|NOT COMPLETED|Overall Study||0
55703|NCT02413255|134973|P16|NOT COMPLETED|Overall Study||0
55704|NCT02413255|134974|P15|NOT COMPLETED|Overall Study||1
55705|NCT02413255|134975|P14|NOT COMPLETED|Overall Study||0
55706|NCT02413255|134976|P13|NOT COMPLETED|Overall Study||0
55707|NCT02413255|134977|P12|NOT COMPLETED|Overall Study||0
55708|NCT02413255|134978|P11|NOT COMPLETED|Overall Study||0
55709|NCT02413255|134979|P10|NOT COMPLETED|Overall Study||0
55710|NCT02413255|134980|P9|NOT COMPLETED|Overall Study||0
55711|NCT02413255|134981|P8|NOT COMPLETED|Overall Study||0
55712|NCT02413255|134982|P7|NOT COMPLETED|Overall Study||0
55713|NCT02413255|134983|P6|NOT COMPLETED|Overall Study||0
55714|NCT02413255|134984|P5|NOT COMPLETED|Overall Study||0
55715|NCT02413255|134985|P4|NOT COMPLETED|Overall Study||0
55716|NCT02413255|134986|P3|NOT COMPLETED|Overall Study||0
55717|NCT02413255|134987|P2|NOT COMPLETED|Overall Study||0
55718|NCT02413255|134988|P1|NOT COMPLETED|Overall Study||0
55719|NCT02413255|134972|P17|COMPLETED|Overall Study||6
55720|NCT02413255|134973|P16|COMPLETED|Overall Study||6
55721|NCT02413255|134974|P15|COMPLETED|Overall Study||5
55722|NCT02413255|134975|P14|COMPLETED|Overall Study||6
55723|NCT02413255|134976|P13|COMPLETED|Overall Study||6
55724|NCT02413255|134977|P12|COMPLETED|Overall Study||6
55725|NCT02413255|134978|P11|COMPLETED|Overall Study||12
55726|NCT02413255|134979|P10|COMPLETED|Overall Study||6
55727|NCT02413255|134980|P9|COMPLETED|Overall Study||6
55728|NCT02413255|134981|P8|COMPLETED|Overall Study||6
55729|NCT02413255|134982|P7|COMPLETED|Overall Study||6
55730|NCT02413255|134983|P6|COMPLETED|Overall Study||6
55731|NCT02413255|134984|P5|COMPLETED|Overall Study||6
55732|NCT02413255|134985|P4|COMPLETED|Overall Study||6
55733|NCT02413255|134986|P3|COMPLETED|Overall Study||6
55734|NCT02413255|134987|P2|COMPLETED|Overall Study||6
55735|NCT02413255|134988|P1|COMPLETED|Overall Study||18
55736|NCT02413255|134972|P17|STARTED|Overall Study||6
55737|NCT02413255|134973|P16|STARTED|Overall Study||6
55738|NCT02413255|134974|P15|STARTED|Overall Study||6
55739|NCT02413255|134975|P14|STARTED|Overall Study||6
55740|NCT02413255|134976|P13|STARTED|Overall Study||6
55741|NCT02413255|134977|P12|STARTED|Overall Study||6
55742|NCT02413255|134978|P11|STARTED|Overall Study||12
55743|NCT02413255|134979|P10|STARTED|Overall Study||6
55744|NCT02413255|134980|P9|STARTED|Overall Study||6
55745|NCT02413255|134981|P8|STARTED|Overall Study||6
55746|NCT02413255|134982|P7|STARTED|Overall Study||6
55747|NCT02413255|134983|P6|STARTED|Overall Study||6
55748|NCT02413255|134984|P5|STARTED|Overall Study||6
55749|NCT02413255|134985|P4|STARTED|Overall Study||6
55750|NCT02413255|134986|P3|STARTED|Overall Study||6
55751|NCT02413255|134987|P2|STARTED|Overall Study||6
55752|NCT02413255|134988|P1|STARTED|Overall Study||18
55753|NCT02413229|135344|P8|NOT COMPLETED|Overall Study||4
55754|NCT02413229|135345|P7|NOT COMPLETED|Overall Study||0
55755|NCT02413229|135346|P6|NOT COMPLETED|Overall Study||0
55756|NCT02413229|135347|P5|NOT COMPLETED|Overall Study||3
55757|NCT02413229|135348|P4|NOT COMPLETED|Overall Study||1
55758|NCT02413229|135349|P3|NOT COMPLETED|Overall Study||1
55759|NCT02413229|135350|P2|NOT COMPLETED|Overall Study||1
55760|NCT02413229|135351|P1|NOT COMPLETED|Overall Study||1
55761|NCT02413229|135344|P8|COMPLETED|Overall Study||11
55762|NCT02413229|135345|P7|COMPLETED|Overall Study||25
55763|NCT02413229|135346|P6|COMPLETED|Overall Study||12
55764|NCT02413229|135347|P5|COMPLETED|Overall Study||21
55765|NCT02413229|135348|P4|COMPLETED|Overall Study||11
55766|NCT02413229|135349|P3|COMPLETED|Overall Study||25
55767|NCT02413229|135350|P2|COMPLETED|Overall Study||11
55768|NCT02413229|135351|P1|COMPLETED|Overall Study||24
55769|NCT02413229|135344|P8|STARTED|Overall Study||15
55770|NCT02413229|135345|P7|STARTED|Overall Study||25
55771|NCT02413229|135346|P6|STARTED|Overall Study||12
55772|NCT02413229|135347|P5|STARTED|Overall Study||24
55773|NCT02413229|135348|P4|STARTED|Overall Study||12
55774|NCT02413229|135349|P3|STARTED|Overall Study||26
55775|NCT02413229|135350|P2|STARTED|Overall Study||12
55776|NCT02413229|135351|P1|STARTED|Overall Study||25
55777|NCT02413203|135371|P2|NOT COMPLETED|Overall Study||0
55778|NCT02413203|135372|P1|NOT COMPLETED|Overall Study||0
55779|NCT02413203|135371|P2|COMPLETED|Overall Study||10
55780|NCT02413203|135372|P1|COMPLETED|Overall Study||10
55781|NCT02413203|135371|P2|STARTED|Overall Study||10
55782|NCT02413203|135372|P1|STARTED|Overall Study||10
55783|NCT02413190|135392|P1|NOT COMPLETED|Overall Study||0
55784|NCT02413190|135392|P1|COMPLETED|Overall Study||94
55785|NCT02413190|135392|P1|STARTED|Overall Study||94
55786|NCT02413151|135398|P2|NOT COMPLETED|Overall Study||2
55787|NCT02413151|135399|P1|NOT COMPLETED|Overall Study||10
55788|NCT02413151|135398|P2|COMPLETED|Overall Study||28
55789|NCT02413151|135399|P1|COMPLETED|Overall Study||22
55790|NCT02413151|135398|P2|STARTED|Overall Study||30
55791|NCT02413151|135399|P1|STARTED|Overall Study||32
55792|NCT02413047|135427|P1|NOT COMPLETED|Overall Study||0
55793|NCT02413047|135427|P1|COMPLETED|Overall Study||3
55794|NCT02413047|135427|P1|Participants on Adalimumab|Overall Study||1
55795|NCT02413047|135427|P1|Participants on Infliximab|Overall Study||2
55796|NCT02413047|135427|P1|STARTED|Overall Study||3
55797|NCT02413034|135440|P2|NOT COMPLETED|Overall Study||0
55798|NCT02413034|135441|P1|NOT COMPLETED|Overall Study||0
55799|NCT02413034|135440|P2|COMPLETED|Overall Study||14
55800|NCT02413034|135441|P1|COMPLETED|Overall Study||14
55801|NCT02413034|135440|P2|STARTED|Overall Study||14
55802|NCT02413034|135441|P1|STARTED|Overall Study||14
55803|NCT02413008|135451|P2|NOT COMPLETED|Overall Study||2
55804|NCT02413008|135452|P1|NOT COMPLETED|Overall Study||7
55805|NCT02413008|135451|P2|COMPLETED|Overall Study||9
55806|NCT02413008|135452|P1|COMPLETED|Overall Study||43
55807|NCT02413008|135451|P2|STARTED|Overall Study||11
55808|NCT02413008|135452|P1|STARTED|Overall Study||50
55809|NCT02412878|135490|P2|NOT COMPLETED|Overall Study||183
55810|NCT02412878|135491|P1|NOT COMPLETED|Overall Study||174
55811|NCT02412878|135490|P2|COMPLETED|Overall Study||57
55812|NCT02412878|135491|P1|COMPLETED|Overall Study||64
55813|NCT02412878|135490|P2|Received Carfilzomib|Overall Study||238
55814|NCT02412878|135491|P1|Received Carfilzomib|Overall Study||235
55815|NCT02412878|135490|P2|STARTED|Overall Study||240
55816|NCT02412878|135491|P1|STARTED|Overall Study||238
55817|NCT02412761|135505|P6|NOT COMPLETED|Third Intervention (2 Weeks)||0
55818|NCT02412761|135506|P5|NOT COMPLETED|Third Intervention (2 Weeks)||0
55819|NCT02412761|135507|P4|NOT COMPLETED|Third Intervention (2 Weeks)||0
55820|NCT02412761|135508|P3|NOT COMPLETED|Third Intervention (2 Weeks)||0
55821|NCT02412761|135509|P2|NOT COMPLETED|Third Intervention (2 Weeks)||0
55822|NCT02412761|135510|P1|NOT COMPLETED|Third Intervention (2 Weeks)||0
55823|NCT02412761|135505|P6|COMPLETED|Third Intervention (2 Weeks)||6
55824|NCT02412761|135506|P5|COMPLETED|Third Intervention (2 Weeks)||4
55825|NCT02412761|135507|P4|COMPLETED|Third Intervention (2 Weeks)||8
55826|NCT02412761|135508|P3|COMPLETED|Third Intervention (2 Weeks)||4
55827|NCT02412761|135509|P2|COMPLETED|Third Intervention (2 Weeks)||5
55828|NCT02412761|135510|P1|COMPLETED|Third Intervention (2 Weeks)||5
55829|NCT02412761|135505|P6|STARTED|Third Intervention (2 Weeks)||6
55830|NCT02412761|135506|P5|STARTED|Third Intervention (2 Weeks)||4
55831|NCT02412761|135507|P4|STARTED|Third Intervention (2 Weeks)||8
55832|NCT02412761|135508|P3|STARTED|Third Intervention (2 Weeks)||4
55833|NCT02412761|135509|P2|STARTED|Third Intervention (2 Weeks)||5
55834|NCT02412761|135510|P1|STARTED|Third Intervention (2 Weeks)||5
55835|NCT02412761|135505|P6|NOT COMPLETED|Second Intervention (2 Weeks)||0
55836|NCT02412761|135506|P5|NOT COMPLETED|Second Intervention (2 Weeks)||0
55837|NCT02412761|135507|P4|NOT COMPLETED|Second Intervention (2 Weeks)||0
55838|NCT02412761|135508|P3|NOT COMPLETED|Second Intervention (2 Weeks)||0
55839|NCT02412761|135509|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
55840|NCT02412761|135510|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
55841|NCT02412761|135505|P6|COMPLETED|Second Intervention (2 Weeks)||6
55842|NCT02412761|135506|P5|COMPLETED|Second Intervention (2 Weeks)||4
55843|NCT02412761|135507|P4|COMPLETED|Second Intervention (2 Weeks)||8
55844|NCT02412761|135508|P3|COMPLETED|Second Intervention (2 Weeks)||4
55845|NCT02412761|135509|P2|COMPLETED|Second Intervention (2 Weeks)||5
55846|NCT02412761|135510|P1|COMPLETED|Second Intervention (2 Weeks)||5
55847|NCT02412761|135505|P6|STARTED|Second Intervention (2 Weeks)||6
55848|NCT02412761|135506|P5|STARTED|Second Intervention (2 Weeks)||4
55849|NCT02412761|135507|P4|STARTED|Second Intervention (2 Weeks)||8
55850|NCT02412761|135508|P3|STARTED|Second Intervention (2 Weeks)||4
55851|NCT02412761|135509|P2|STARTED|Second Intervention (2 Weeks)||5
55852|NCT02412761|135510|P1|STARTED|Second Intervention (2 Weeks)||5
55853|NCT02412761|135505|P6|NOT COMPLETED|First Intervention (2 Weeks)||1
55854|NCT02412761|135506|P5|NOT COMPLETED|First Intervention (2 Weeks)||0
55855|NCT02412761|135507|P4|NOT COMPLETED|First Intervention (2 Weeks)||0
55856|NCT02412761|135508|P3|NOT COMPLETED|First Intervention (2 Weeks)||1
55857|NCT02412761|135509|P2|NOT COMPLETED|First Intervention (2 Weeks)||1
55858|NCT02412761|135510|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
55859|NCT02412761|135505|P6|COMPLETED|First Intervention (2 Weeks)||6
55860|NCT02412761|135506|P5|COMPLETED|First Intervention (2 Weeks)||4
55861|NCT02412761|135507|P4|COMPLETED|First Intervention (2 Weeks)||8
55862|NCT02412761|135508|P3|COMPLETED|First Intervention (2 Weeks)||4
55863|NCT02412761|135509|P2|COMPLETED|First Intervention (2 Weeks)||5
55864|NCT02412761|135510|P1|COMPLETED|First Intervention (2 Weeks)||5
55865|NCT02412761|135505|P6|STARTED|First Intervention (2 Weeks)||7
55866|NCT02412761|135506|P5|STARTED|First Intervention (2 Weeks)||4
55867|NCT02412761|135507|P4|STARTED|First Intervention (2 Weeks)||8
55868|NCT02412761|135508|P3|STARTED|First Intervention (2 Weeks)||5
55869|NCT02412761|135509|P2|STARTED|First Intervention (2 Weeks)||6
55870|NCT02412761|135510|P1|STARTED|First Intervention (2 Weeks)||5
55871|NCT02412657|135521|P3|NOT COMPLETED|Overall Study||3
55872|NCT02412657|135522|P2|NOT COMPLETED|Overall Study||2
55873|NCT02412657|135523|P1|NOT COMPLETED|Overall Study||1
55874|NCT02412657|135521|P3|COMPLETED|Overall Study||22
55875|NCT02412657|135522|P2|COMPLETED|Overall Study||23
55876|NCT02412657|135523|P1|COMPLETED|Overall Study||24
55877|NCT02412657|135521|P3|STARTED|Overall Study||25
55878|NCT02412657|135522|P2|STARTED|Overall Study||25
55879|NCT02412657|135523|P1|STARTED|Overall Study||25
55880|NCT02412644|135533|P2|NOT COMPLETED|Overall Study||4
55881|NCT02412644|135534|P1|NOT COMPLETED|Overall Study||15
55882|NCT02412644|135533|P2|COMPLETED|Overall Study||4
55883|NCT02412644|135534|P1|COMPLETED|Overall Study||6
55884|NCT02412644|135533|P2|STARTED|Overall Study||8
55885|NCT02412644|135534|P1|STARTED|Overall Study||21
55886|NCT02412501|135546|P1|NOT COMPLETED|Overall Study||0
55887|NCT02412501|135546|P1|COMPLETED|Overall Study||101
55888|NCT02412501|135546|P1|STARTED|Overall Study||101
55889|NCT02412488|135567|P1|NOT COMPLETED|Overall Study||18
55890|NCT02412488|135567|P1|COMPLETED|Overall Study||174
55891|NCT02412488|135567|P1|Reveal LINQ Implanted|Overall Study||191
55892|NCT02412488|135567|P1|STARTED|Overall Study||192
55893|NCT02412436|135571|P1|NOT COMPLETED|Overall Study||18
55894|NCT02412436|135571|P1|COMPLETED|Overall Study||44
55895|NCT02412436|135571|P1|STARTED|Overall Study||62
55896|NCT02412111|135587|P3|NOT COMPLETED|Active Comparator Period (8 Weeks)||6
55897|NCT02412111|135588|P2|NOT COMPLETED|Active Comparator Period (8 Weeks)||1
55898|NCT02412111|135589|P1|NOT COMPLETED|Active Comparator Period (8 Weeks)||0
55899|NCT02412111|135587|P3|COMPLETED|Active Comparator Period (8 Weeks)||69
55900|NCT02412111|135588|P2|COMPLETED|Active Comparator Period (8 Weeks)||75
55901|NCT02412111|135589|P1|COMPLETED|Active Comparator Period (8 Weeks)||0
55902|NCT02412111|135587|P3|Full Analysis Set|Active Comparator Period (8 Weeks)||74
55903|NCT02412111|135588|P2|Full Analysis Set|Active Comparator Period (8 Weeks)||76
55904|NCT02412111|135589|P1|Full Analysis Set|Active Comparator Period (8 Weeks)||0
55905|NCT02412111|135587|P3|STARTED|Active Comparator Period (8 Weeks)||75
55906|NCT02412111|135588|P2|STARTED|Active Comparator Period (8 Weeks)||76
55907|NCT02412111|135589|P1|STARTED|Active Comparator Period (8 Weeks)||0
55908|NCT02412111|135587|P3|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
55909|NCT02412111|135588|P2|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
55910|NCT02412111|135589|P1|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||3
55911|NCT02412111|135587|P3|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
55912|NCT02412111|135588|P2|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
55913|NCT02412111|135589|P1|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||153
55914|NCT02412111|135587|P3|STARTED|Ivacaftor Run-in Period (4 Weeks)||0
55915|NCT02412111|135588|P2|STARTED|Ivacaftor Run-in Period (4 Weeks)||0
55916|NCT02412111|135589|P1|STARTED|Ivacaftor Run-in Period (4 Weeks)||156
55917|NCT02412098|135611|P3|NOT COMPLETED|Overall Study||0
55918|NCT02412098|135612|P2|NOT COMPLETED|Overall Study||0
55919|NCT02412098|135613|P1|NOT COMPLETED|Overall Study||0
55920|NCT02412098|135611|P3|COMPLETED|Overall Study||21
55921|NCT02412098|135612|P2|COMPLETED|Overall Study||14
55922|NCT02412098|135613|P1|COMPLETED|Overall Study||14
55923|NCT02412098|135611|P3|STARTED|Overall Study||21
55924|NCT02412098|135612|P2|STARTED|Overall Study||14
55925|NCT02412098|135613|P1|STARTED|Overall Study||14
55926|NCT02411929|135640|P1|NOT COMPLETED|Period 2||0
55927|NCT02411929|135640|P1|COMPLETED|Period 2||8
55928|NCT02411929|135640|P1|STARTED|Period 2||8
55929|NCT02411929|135640|P1|NOT COMPLETED|Washout Period||0
55930|NCT02411929|135640|P1|COMPLETED|Washout Period||8
55931|NCT02411929|135640|P1|STARTED|Washout Period||8
55932|NCT02411929|135640|P1|NOT COMPLETED|Period 1||0
55933|NCT02411929|135640|P1|COMPLETED|Period 1||8
55934|NCT02411929|135640|P1|STARTED|Period 1||8
55935|NCT02411747|135672|P2|NOT COMPLETED|Overall Study||4
55936|NCT02411747|135673|P1|NOT COMPLETED|Overall Study||3
55937|NCT02411747|135672|P2|COMPLETED|Overall Study||12
55938|NCT02411747|135673|P1|COMPLETED|Overall Study||13
55939|NCT02411747|135672|P2|Simulation Training Completed|Overall Study||16
55940|NCT02411747|135673|P1|Simulation Training Completed|Overall Study||16
55941|NCT02411747|135672|P2|STARTED|Overall Study||16
55942|NCT02411747|135673|P1|STARTED|Overall Study||16
55943|NCT02411643|135679|P1|NOT COMPLETED|Overall Study||0
55944|NCT02411643|135679|P1|COMPLETED|Overall Study||2
55945|NCT02411643|135679|P1|STARTED|Overall Study||2
55946|NCT02411578|135688|P2|NOT COMPLETED|Extension Phase||0
55947|NCT02411578|135689|P1|NOT COMPLETED|Extension Phase||0
55948|NCT02411578|135688|P2|COMPLETED|Extension Phase||9
55949|NCT02411578|135689|P1|COMPLETED|Extension Phase||8
55950|NCT02411578|135688|P2|STARTED|Extension Phase|2 Crossover Trial participants could not continue due to study syringes expiration|9
55951|NCT02411578|135689|P1|STARTED|Extension Phase||8
55952|NCT02411578|135688|P2|NOT COMPLETED|Crossover Trial Phase||1
55953|NCT02411578|135689|P1|NOT COMPLETED|Crossover Trial Phase||0
55954|NCT02411578|135688|P2|COMPLETED|Crossover Trial Phase||11
55955|NCT02411578|135689|P1|COMPLETED|Crossover Trial Phase||8
55956|NCT02411578|135688|P2|STARTED|Crossover Trial Phase||12
55957|NCT02411578|135689|P1|STARTED|Crossover Trial Phase||8
55958|NCT02411565|135731|P2|NOT COMPLETED|Overall Study||0
55959|NCT02411565|135732|P1|NOT COMPLETED|Overall Study||0
55960|NCT02411565|135731|P2|COMPLETED|Overall Study||2
55961|NCT02411565|135732|P1|COMPLETED|Overall Study||1
55962|NCT02411565|135731|P2|STARTED|Overall Study||2
55963|NCT02411565|135732|P1|STARTED|Overall Study||1
55964|NCT02411539|135746|P2|NOT COMPLETED|Overall Study||1
55965|NCT02411539|135747|P1|NOT COMPLETED|Overall Study||2
55966|NCT02411539|135746|P2|COMPLETED|Overall Study||19
55967|NCT02411539|135747|P1|COMPLETED|Overall Study||18
55968|NCT02411539|135746|P2|STARTED|Overall Study||20
55969|NCT02411539|135747|P1|STARTED|Overall Study||20
55970|NCT02411461|135825|P3|NOT COMPLETED|Overall Study||0
55971|NCT02411461|135826|P2|NOT COMPLETED|Overall Study||0
55972|NCT02411461|135827|P1|NOT COMPLETED|Overall Study||0
55973|NCT02411461|135825|P3|COMPLETED|Overall Study||15
55974|NCT02411461|135826|P2|COMPLETED|Overall Study||8
55975|NCT02411461|135827|P1|COMPLETED|Overall Study||16
55976|NCT02411461|135825|P3|STARTED|Overall Study||15
55977|NCT02411461|135826|P2|STARTED|Overall Study||8
55978|NCT02411461|135827|P1|STARTED|Overall Study||16
55979|NCT02411396|135835|P1|NOT COMPLETED|Overall Study||41
55980|NCT02411396|135835|P1|COMPLETED|Overall Study||442
55981|NCT02411396|135835|P1|STARTED|Overall Study||483
55982|NCT02411292|135848|P1|NOT COMPLETED|Overall Study||21
55983|NCT02411292|135848|P1|COMPLETED|Overall Study||89
55984|NCT02411292|135848|P1|STARTED|Overall Study||110
55985|NCT02411201|135854|P1|NOT COMPLETED|Overall Study||6
55986|NCT02411201|135854|P1|COMPLETED|Overall Study||45
55987|NCT02411201|135854|P1|STARTED|Overall Study||51
55988|NCT02411110|135867|P2|NOT COMPLETED|Treatment Period 2||4
55989|NCT02411110|135868|P1|NOT COMPLETED|Treatment Period 2||1
55990|NCT02411110|135867|P2|COMPLETED|Treatment Period 2||44
55991|NCT02411110|135868|P1|COMPLETED|Treatment Period 2||49
55992|NCT02411110|135867|P2|STARTED|Treatment Period 2|Period 2 was optional.|48
55993|NCT02411110|135868|P1|STARTED|Treatment Period 2|Period 2 was optional.|50
55994|NCT02411110|135867|P2|NOT COMPLETED|Treatment Period 1||7
55995|NCT02411110|135868|P1|NOT COMPLETED|Treatment Period 1||9
55996|NCT02411110|135867|P2|COMPLETED|Treatment Period 1||59
55997|NCT02411110|135868|P1|COMPLETED|Treatment Period 1||56
55998|NCT02411110|135867|P2|STARTED|Treatment Period 1||66
55999|NCT02411110|135868|P1|STARTED|Treatment Period 1||65
56000|NCT02410967|135878|P2|NOT COMPLETED|Follow-up Phase (8 Weeks)||6
56001|NCT02410967|135879|P1|NOT COMPLETED|Follow-up Phase (8 Weeks)||4
56002|NCT02410967|135878|P2|COMPLETED|Follow-up Phase (8 Weeks)||16
56003|NCT02410967|135879|P1|COMPLETED|Follow-up Phase (8 Weeks)||22
56004|NCT02410967|135878|P2|STARTED|Follow-up Phase (8 Weeks)||22
56005|NCT02410967|135879|P1|STARTED|Follow-up Phase (8 Weeks)||26
56006|NCT02410967|135878|P2|NOT COMPLETED|Treatment Phase (4 Weeks)||4
56007|NCT02410967|135879|P1|NOT COMPLETED|Treatment Phase (4 Weeks)||1
56008|NCT02410967|135878|P2|COMPLETED|Treatment Phase (4 Weeks)||22
56009|NCT02410967|135879|P1|COMPLETED|Treatment Phase (4 Weeks)||26
56010|NCT02410967|135878|P2|STARTED|Treatment Phase (4 Weeks)||26
56011|NCT02410967|135879|P1|STARTED|Treatment Phase (4 Weeks)||27
56012|NCT02410824|135895|P2|NOT COMPLETED|Second Intervention (One Week)||0
56013|NCT02410824|135896|P1|NOT COMPLETED|Second Intervention (One Week)||0
56014|NCT02410824|135895|P2|COMPLETED|Second Intervention (One Week)||22
56015|NCT02410824|135896|P1|COMPLETED|Second Intervention (One Week)||22
56016|NCT02410824|135895|P2|STARTED|Second Intervention (One Week)||22
56017|NCT02410824|135896|P1|STARTED|Second Intervention (One Week)||22
56018|NCT02410824|135895|P2|NOT COMPLETED|First Intervention (One Week)||1
56019|NCT02410824|135896|P1|NOT COMPLETED|First Intervention (One Week)||0
56020|NCT02410824|135895|P2|COMPLETED|First Intervention (One Week)||22
56021|NCT02410824|135896|P1|COMPLETED|First Intervention (One Week)||22
56022|NCT02410824|135895|P2|STARTED|First Intervention (One Week)||23
56023|NCT02410824|135896|P1|STARTED|First Intervention (One Week)||22
56024|NCT02410577|135928|P1|NOT COMPLETED|Overall Study||0
56025|NCT02410577|135928|P1|COMPLETED|Overall Study||2
56026|NCT02410577|135928|P1|STARTED|Overall Study||2
56027|NCT02410551|135932|P1|NOT COMPLETED|Overall Study||4
56028|NCT02410551|135932|P1|COMPLETED|Overall Study||0
56029|NCT02410551|135932|P1|STARTED|Overall Study||4
56030|NCT02410382|135939|P2|NOT COMPLETED|Overall Study||0
56031|NCT02410382|135940|P1|NOT COMPLETED|Overall Study||0
56032|NCT02410382|135939|P2|COMPLETED|Overall Study||0
56033|NCT02410382|135940|P1|COMPLETED|Overall Study|Study was terminated by IRB - attempts made to obtain info were unsuccessful.|0
56034|NCT02410382|135939|P2|STARTED|Overall Study||0
56035|NCT02410382|135940|P1|STARTED|Overall Study||0
56036|NCT02410343|135950|P2|NOT COMPLETED|Extension Period (12 Months)||1
56037|NCT02410343|135951|P1|NOT COMPLETED|Extension Period (12 Months)||1
56038|NCT02410343|135950|P2|COMPLETED|Extension Period (12 Months)||0
56039|NCT02410343|135951|P1|COMPLETED|Extension Period (12 Months)||0
56040|NCT02410343|135950|P2|STARTED|Extension Period (12 Months)||1
56041|NCT02410343|135951|P1|STARTED|Extension Period (12 Months)||1
56042|NCT02410343|135950|P2|NOT COMPLETED|Core Period (24 Weeks)||7
56043|NCT02410343|135951|P1|NOT COMPLETED|Core Period (24 Weeks)||5
56044|NCT02410343|135950|P2|COMPLETED|Core Period (24 Weeks)||1
56045|NCT02410343|135951|P1|COMPLETED|Core Period (24 Weeks)||1
56046|NCT02410343|135950|P2|STARTED|Core Period (24 Weeks)||8
56047|NCT02410343|135951|P1|STARTED|Core Period (24 Weeks)||6
56048|NCT02410291|135988|P2|NOT COMPLETED|Overall Study||0
56049|NCT02410291|135989|P1|NOT COMPLETED|Overall Study||0
56050|NCT02410291|135988|P2|COMPLETED|Overall Study||29
56051|NCT02410291|135989|P1|COMPLETED|Overall Study||29
56052|NCT02410291|135988|P2|STARTED|Overall Study||29
56053|NCT02410291|135989|P1|STARTED|Overall Study||29
56054|NCT02410278|135997|P3|NOT COMPLETED|Study Treatment Period||4
56055|NCT02410278|135998|P2|NOT COMPLETED|Study Treatment Period||11
56056|NCT02410278|135999|P1|NOT COMPLETED|Study Treatment Period||0
56057|NCT02410278|135997|P3|COMPLETED|Study Treatment Period||29
56058|NCT02410278|135998|P2|COMPLETED|Study Treatment Period||20
56059|NCT02410278|135999|P1|COMPLETED|Study Treatment Period||0
56060|NCT02410278|135997|P3|Completed Randomized Study Treatment|Study Treatment Period||29
56061|NCT02410278|135998|P2|Completed Randomized Study Treatment|Study Treatment Period||20
56062|NCT02410278|135999|P1|Completed Randomized Study Treatment|Study Treatment Period||0
56063|NCT02410278|135997|P3|Modified Intent-to Treat(mITT)Population|Study Treatment Period||33
56064|NCT02410278|135998|P2|Modified Intent-to Treat(mITT)Population|Study Treatment Period||30
56065|NCT02410278|135999|P1|Modified Intent-to Treat(mITT)Population|Study Treatment Period||0
56066|NCT02410278|135997|P3|STARTED|Study Treatment Period||33
56067|NCT02410278|135998|P2|STARTED|Study Treatment Period||31
56068|NCT02410278|135999|P1|STARTED|Study Treatment Period||0
56069|NCT02410278|135997|P3|NOT COMPLETED|Run-in Period||0
56070|NCT02410278|135998|P2|NOT COMPLETED|Run-in Period||0
56071|NCT02410278|135999|P1|NOT COMPLETED|Run-in Period||38
56072|NCT02410278|135997|P3|COMPLETED|Run-in Period||0
56073|NCT02410278|135998|P2|COMPLETED|Run-in Period||0
56074|NCT02410278|135999|P1|COMPLETED|Run-in Period||64
56075|NCT02410278|135997|P3|Received at Least 1 Dose of DMF|Run-in Period||0
56076|NCT02410278|135998|P2|Received at Least 1 Dose of DMF|Run-in Period||0
56077|NCT02410278|135999|P1|Received at Least 1 Dose of DMF|Run-in Period||98
56078|NCT02410278|135997|P3|STARTED|Run-in Period||0
56079|NCT02410278|135998|P2|STARTED|Run-in Period||0
56080|NCT02410278|135999|P1|STARTED|Run-in Period||102
56081|NCT02410252|136024|P1|NOT COMPLETED|Overall Study||6
56082|NCT02410252|136024|P1|COMPLETED|Overall Study||19
56083|NCT02410252|136024|P1|STARTED|Overall Study||25
56084|NCT02410213|136030|P2|NOT COMPLETED|Overall Study||0
56085|NCT02410213|136031|P1|NOT COMPLETED|Overall Study||0
56086|NCT02410213|136030|P2|COMPLETED|Overall Study||19
56087|NCT02410213|136031|P1|COMPLETED|Overall Study||16
56088|NCT02410213|136030|P2|STARTED|Overall Study||19
56089|NCT02410213|136031|P1|STARTED|Overall Study||16
56090|NCT02410200|136037|P1|NOT COMPLETED|Overall Study||2
56091|NCT02410200|136037|P1|COMPLETED|Overall Study||20
56092|NCT02410200|136037|P1|STARTED|Overall Study||22
56093|NCT02410161|136050|P2|NOT COMPLETED|Overall Study||0
56094|NCT02410161|136051|P1|NOT COMPLETED|Overall Study||0
56095|NCT02410161|136050|P2|COMPLETED|Overall Study||10
56096|NCT02410161|136051|P1|COMPLETED|Overall Study||10
56097|NCT02410161|136050|P2|STARTED|Overall Study||10
56098|NCT02410161|136051|P1|STARTED|Overall Study||10
56099|NCT02410018|136067|P2|NOT COMPLETED|Overall Study||0
56100|NCT02410018|136068|P1|NOT COMPLETED|Overall Study||0
56101|NCT02410018|136067|P2|COMPLETED|Overall Study||1
56102|NCT02410018|136068|P1|COMPLETED|Overall Study||2
56103|NCT02410018|136067|P2|STARTED|Overall Study||1
56104|NCT02410018|136068|P1|STARTED|Overall Study||2
56105|NCT02409927|136088|P1|NOT COMPLETED|Overall Study||0
56106|NCT02409927|136088|P1|COMPLETED|Overall Study||10
56107|NCT02409927|136088|P1|STARTED|Overall Study||10
56108|NCT02409914|136096|P1|NOT COMPLETED|Overall Study||0
56109|NCT02409914|136096|P1|COMPLETED|Overall Study||7
56110|NCT02409914|136096|P1|STARTED|Overall Study||7
56111|NCT02409784|136102|P1|NOT COMPLETED|Overall Study||0
56112|NCT02409784|136102|P1|COMPLETED|Overall Study||10
56113|NCT02409784|136102|P1|STARTED|Overall Study||10
56114|NCT02409732|136107|P1|NOT COMPLETED|Overall Study||6
56115|NCT02409732|136107|P1|COMPLETED|Overall Study||14
56116|NCT02409732|136107|P1|STARTED|Overall Study|First patient consented on 4/23/15|20
56117|NCT02409667|136115|P5|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||3
56118|NCT02409667|136116|P4|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||8
56119|NCT02409667|136117|P3|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||21
56120|NCT02409667|136118|P2|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||23
56121|NCT02409667|136119|P1|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||0
56122|NCT02409667|136115|P5|COMPLETED|Treatment Period 2, Week 24 to Week 52)||90
56123|NCT02409667|136116|P4|COMPLETED|Treatment Period 2, Week 24 to Week 52)||106
56124|NCT02409667|136117|P3|COMPLETED|Treatment Period 2, Week 24 to Week 52)||641
56125|NCT02409667|136118|P2|COMPLETED|Treatment Period 2, Week 24 to Week 52)||621
56126|NCT02409667|136119|P1|COMPLETED|Treatment Period 2, Week 24 to Week 52)||0
56127|NCT02409667|136115|P5|STARTED|Treatment Period 2, Week 24 to Week 52)||93
56128|NCT02409667|136116|P4|STARTED|Treatment Period 2, Week 24 to Week 52)||114
56129|NCT02409667|136117|P3|STARTED|Treatment Period 2, Week 24 to Week 52)||662
56130|NCT02409667|136118|P2|STARTED|Treatment Period 2, Week 24 to Week 52)||644
56131|NCT02409667|136119|P1|STARTED|Treatment Period 2, Week 24 to Week 52)||0
56132|NCT02409667|136115|P5|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
56133|NCT02409667|136116|P4|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
56134|NCT02409667|136117|P3|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
56135|NCT02409667|136118|P2|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
56136|NCT02409667|136119|P1|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||121
56137|NCT02409667|136115|P5|COMPLETED|Treatment Period 1, Baseline to Week 24||0
56138|NCT02409667|136116|P4|COMPLETED|Treatment Period 1, Baseline to Week 24||0
56139|NCT02409667|136117|P3|COMPLETED|Treatment Period 1, Baseline to Week 24||0
56140|NCT02409667|136118|P2|COMPLETED|Treatment Period 1, Baseline to Week 24||0
56141|NCT02409667|136119|P1|COMPLETED|Treatment Period 1, Baseline to Week 24||1526
56142|NCT02409667|136115|P5|STARTED|Treatment Period 1, Baseline to Week 24||0
56143|NCT02409667|136116|P4|STARTED|Treatment Period 1, Baseline to Week 24||0
56144|NCT02409667|136117|P3|STARTED|Treatment Period 1, Baseline to Week 24||0
56145|NCT02409667|136118|P2|STARTED|Treatment Period 1, Baseline to Week 24||0
56146|NCT02409667|136119|P1|STARTED|Treatment Period 1, Baseline to Week 24||1647
56147|NCT02409459|136160|P2|NOT COMPLETED|Overall Study||1
56148|NCT02409459|136161|P1|NOT COMPLETED|Overall Study||1
56149|NCT02409459|136160|P2|COMPLETED|Overall Study||39
56150|NCT02409459|136161|P1|COMPLETED|Overall Study||40
56151|NCT02409459|136160|P2|STARTED|Overall Study||40
56152|NCT02409459|136161|P1|STARTED|Overall Study||41
56153|NCT02409355|136181|P2|NOT COMPLETED|Overall Study||4
56154|NCT02409355|136182|P1|NOT COMPLETED|Overall Study||4
56155|NCT02409355|136181|P2|COMPLETED|Overall Study||0
56156|NCT02409355|136182|P1|COMPLETED|Overall Study||0
56157|NCT02409355|136181|P2|STARTED|Overall Study||4
56158|NCT02409355|136182|P1|STARTED|Overall Study||4
56159|NCT02408965|136190|P2|NOT COMPLETED|Overall Study||0
56160|NCT02408965|136191|P1|NOT COMPLETED|Overall Study||0
56161|NCT02408965|136190|P2|COMPLETED|Overall Study||144
56162|NCT02408965|136191|P1|COMPLETED|Overall Study||140
56163|NCT02408965|136190|P2|STARTED|Overall Study||144
56164|NCT02408965|136191|P1|STARTED|Overall Study||140
56165|NCT02408692|136216|P3|NOT COMPLETED|Overall Study||0
56166|NCT02408692|136217|P2|NOT COMPLETED|Overall Study||0
56167|NCT02408692|136218|P1|NOT COMPLETED|Overall Study||0
56168|NCT02408692|136216|P3|COMPLETED|Overall Study||5
56169|NCT02408692|136217|P2|COMPLETED|Overall Study||5
56170|NCT02408692|136218|P1|COMPLETED|Overall Study||5
56171|NCT02408692|136216|P3|STARTED|Overall Study||5
56172|NCT02408692|136217|P2|STARTED|Overall Study||5
56173|NCT02408692|136218|P1|STARTED|Overall Study||5
56174|NCT02408315|136231|P2|NOT COMPLETED|Overall Study||0
56175|NCT02408315|136232|P1|NOT COMPLETED|Overall Study||0
56176|NCT02408315|136231|P2|COMPLETED|Overall Study||152
56177|NCT02408315|136232|P1|COMPLETED|Overall Study||148
56178|NCT02408315|136231|P2|STARTED|Overall Study||152
56179|NCT02408315|136232|P1|STARTED|Overall Study||148
56180|NCT02408263|136254|P2|NOT COMPLETED|Overall Study||0
56181|NCT02408263|136255|P1|NOT COMPLETED|Overall Study||0
56182|NCT02408263|136254|P2|COMPLETED|Overall Study||25
56183|NCT02408263|136255|P1|COMPLETED|Overall Study||25
56184|NCT02408263|136254|P2|STARTED|Overall Study||25
56185|NCT02408263|136255|P1|STARTED|Overall Study||25
56186|NCT02408068|136261|P6|NOT COMPLETED|Treatment 3 (1.5 Days)||0
56187|NCT02408068|136262|P5|NOT COMPLETED|Treatment 3 (1.5 Days)||0
56188|NCT02408068|136263|P4|NOT COMPLETED|Treatment 3 (1.5 Days)||0
56189|NCT02408068|136264|P3|NOT COMPLETED|Treatment 3 (1.5 Days)||1
56190|NCT02408068|136265|P2|NOT COMPLETED|Treatment 3 (1.5 Days)||0
56191|NCT02408068|136266|P1|NOT COMPLETED|Treatment 3 (1.5 Days)||0
56192|NCT02408068|136261|P6|COMPLETED|Treatment 3 (1.5 Days)||3
56193|NCT02408068|136262|P5|COMPLETED|Treatment 3 (1.5 Days)||3
56194|NCT02408068|136263|P4|COMPLETED|Treatment 3 (1.5 Days)||3
56195|NCT02408068|136264|P3|COMPLETED|Treatment 3 (1.5 Days)||2
56196|NCT02408068|136265|P2|COMPLETED|Treatment 3 (1.5 Days)||3
56197|NCT02408068|136266|P1|COMPLETED|Treatment 3 (1.5 Days)||3
56198|NCT02408068|136261|P6|STARTED|Treatment 3 (1.5 Days)||3
56199|NCT02408068|136262|P5|STARTED|Treatment 3 (1.5 Days)||3
56200|NCT02408068|136263|P4|STARTED|Treatment 3 (1.5 Days)||3
56201|NCT02408068|136264|P3|STARTED|Treatment 3 (1.5 Days)||3
56202|NCT02408068|136265|P2|STARTED|Treatment 3 (1.5 Days)||3
56203|NCT02408068|136266|P1|STARTED|Treatment 3 (1.5 Days)||3
56204|NCT02408068|136261|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
56205|NCT02408068|136262|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
56206|NCT02408068|136263|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
56207|NCT02408068|136264|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
56208|NCT02408068|136265|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
56209|NCT02408068|136266|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
56210|NCT02408068|136261|P6|COMPLETED|Washout Period 2 (7 Days)||3
56211|NCT02408068|136262|P5|COMPLETED|Washout Period 2 (7 Days)||3
56212|NCT02408068|136263|P4|COMPLETED|Washout Period 2 (7 Days)||3
56213|NCT02408068|136264|P3|COMPLETED|Washout Period 2 (7 Days)||3
56214|NCT02408068|136265|P2|COMPLETED|Washout Period 2 (7 Days)||3
56215|NCT02408068|136266|P1|COMPLETED|Washout Period 2 (7 Days)||3
56216|NCT02408068|136261|P6|STARTED|Washout Period 2 (7 Days)||3
56217|NCT02408068|136262|P5|STARTED|Washout Period 2 (7 Days)||3
56218|NCT02408068|136263|P4|STARTED|Washout Period 2 (7 Days)||3
56219|NCT02408068|136264|P3|STARTED|Washout Period 2 (7 Days)||3
56220|NCT02408068|136265|P2|STARTED|Washout Period 2 (7 Days)||3
56221|NCT02408068|136266|P1|STARTED|Washout Period 2 (7 Days)||3
56222|NCT02408068|136261|P6|NOT COMPLETED|Treatment 2 (1.5 Days)||0
56223|NCT02408068|136262|P5|NOT COMPLETED|Treatment 2 (1.5 Days)||0
56224|NCT02408068|136263|P4|NOT COMPLETED|Treatment 2 (1.5 Days)||0
56225|NCT02408068|136264|P3|NOT COMPLETED|Treatment 2 (1.5 Days)||0
56226|NCT02408068|136265|P2|NOT COMPLETED|Treatment 2 (1.5 Days)||0
56227|NCT02408068|136266|P1|NOT COMPLETED|Treatment 2 (1.5 Days)||0
56228|NCT02408068|136261|P6|COMPLETED|Treatment 2 (1.5 Days)||3
56229|NCT02408068|136262|P5|COMPLETED|Treatment 2 (1.5 Days)||3
56230|NCT02408068|136263|P4|COMPLETED|Treatment 2 (1.5 Days)||3
56231|NCT02408068|136264|P3|COMPLETED|Treatment 2 (1.5 Days)||3
56232|NCT02408068|136265|P2|COMPLETED|Treatment 2 (1.5 Days)||3
56233|NCT02408068|136266|P1|COMPLETED|Treatment 2 (1.5 Days)||3
56234|NCT02408068|136261|P6|STARTED|Treatment 2 (1.5 Days)||3
56235|NCT02408068|136262|P5|STARTED|Treatment 2 (1.5 Days)||3
56236|NCT02408068|136263|P4|STARTED|Treatment 2 (1.5 Days)||3
56237|NCT02408068|136264|P3|STARTED|Treatment 2 (1.5 Days)||3
56238|NCT02408068|136265|P2|STARTED|Treatment 2 (1.5 Days)||3
56239|NCT02408068|136266|P1|STARTED|Treatment 2 (1.5 Days)||3
56240|NCT02408068|136261|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
56241|NCT02408068|136262|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
56242|NCT02408068|136263|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
56243|NCT02408068|136264|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
56244|NCT02408068|136265|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
56245|NCT02408068|136266|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
56246|NCT02408068|136261|P6|COMPLETED|Washout Period 1 (7 Days)||3
56247|NCT02408068|136262|P5|COMPLETED|Washout Period 1 (7 Days)||3
56248|NCT02408068|136263|P4|COMPLETED|Washout Period 1 (7 Days)||3
56249|NCT02408068|136264|P3|COMPLETED|Washout Period 1 (7 Days)||3
56250|NCT02408068|136265|P2|COMPLETED|Washout Period 1 (7 Days)||3
56251|NCT02408068|136266|P1|COMPLETED|Washout Period 1 (7 Days)||3
56252|NCT02408068|136261|P6|STARTED|Washout Period 1 (7 Days)||3
56253|NCT02408068|136262|P5|STARTED|Washout Period 1 (7 Days)||3
56254|NCT02408068|136263|P4|STARTED|Washout Period 1 (7 Days)||3
56255|NCT02408068|136264|P3|STARTED|Washout Period 1 (7 Days)||3
56256|NCT02408068|136265|P2|STARTED|Washout Period 1 (7 Days)||3
56257|NCT02408068|136266|P1|STARTED|Washout Period 1 (7 Days)||3
56258|NCT02408068|136261|P6|NOT COMPLETED|Treatment 1 (1.5 Days)||0
56259|NCT02408068|136262|P5|NOT COMPLETED|Treatment 1 (1.5 Days)||0
56260|NCT02408068|136263|P4|NOT COMPLETED|Treatment 1 (1.5 Days)||0
56261|NCT02408068|136264|P3|NOT COMPLETED|Treatment 1 (1.5 Days)||0
56262|NCT02408068|136265|P2|NOT COMPLETED|Treatment 1 (1.5 Days)||0
56263|NCT02408068|136266|P1|NOT COMPLETED|Treatment 1 (1.5 Days)||0
56264|NCT02408068|136261|P6|COMPLETED|Treatment 1 (1.5 Days)||3
56265|NCT02408068|136262|P5|COMPLETED|Treatment 1 (1.5 Days)||3
56266|NCT02408068|136263|P4|COMPLETED|Treatment 1 (1.5 Days)||3
56267|NCT02408068|136264|P3|COMPLETED|Treatment 1 (1.5 Days)||3
56268|NCT02408068|136265|P2|COMPLETED|Treatment 1 (1.5 Days)||3
56269|NCT02408068|136266|P1|COMPLETED|Treatment 1 (1.5 Days)||3
56270|NCT02408068|136261|P6|STARTED|Treatment 1 (1.5 Days)||3
56271|NCT02408068|136262|P5|STARTED|Treatment 1 (1.5 Days)||3
56272|NCT02408068|136263|P4|STARTED|Treatment 1 (1.5 Days)||3
56273|NCT02408068|136264|P3|STARTED|Treatment 1 (1.5 Days)||3
56274|NCT02408068|136265|P2|STARTED|Treatment 1 (1.5 Days)||3
56275|NCT02408068|136266|P1|STARTED|Treatment 1 (1.5 Days)||3
56276|NCT02407704|136293|P4|NOT COMPLETED|Overall Study||3
56277|NCT02407704|136294|P3|NOT COMPLETED|Overall Study||1
56278|NCT02407704|136295|P2|NOT COMPLETED|Overall Study||0
56279|NCT02407704|136296|P1|NOT COMPLETED|Overall Study||0
56280|NCT02407704|136293|P4|COMPLETED|Overall Study||2
56281|NCT02407704|136294|P3|COMPLETED|Overall Study||4
56282|NCT02407704|136295|P2|COMPLETED|Overall Study||3
56283|NCT02407704|136296|P1|COMPLETED|Overall Study||2
56284|NCT02407704|136293|P4|STARTED|Overall Study||5
56285|NCT02407704|136294|P3|STARTED|Overall Study||5
56286|NCT02407704|136295|P2|STARTED|Overall Study||3
56287|NCT02407704|136296|P1|STARTED|Overall Study||2
56288|NCT02407249|136330|P1|NOT COMPLETED|Overall Study||26
56289|NCT02407249|136330|P1|COMPLETED|Overall Study||47
56290|NCT02407249|136330|P1|Treated|Overall Study||60
56291|NCT02407249|136330|P1|STARTED|Overall Study||73
56292|NCT02407223|136341|P3|NOT COMPLETED|Overall Study||122
56293|NCT02407223|136342|P2|NOT COMPLETED|Overall Study||118
56294|NCT02407223|136343|P1|NOT COMPLETED|Overall Study||116
56295|NCT02407223|136341|P3|COMPLETED|Overall Study||0
56296|NCT02407223|136342|P2|COMPLETED|Overall Study||0
56297|NCT02407223|136343|P1|COMPLETED|Overall Study||0
56298|NCT02407223|136341|P3|Qualified Re-randomization at Week 52|Overall Study||2
56299|NCT02407223|136342|P2|Qualified Re-randomization at Week 52|Overall Study||3
56300|NCT02407223|136343|P1|Qualified Re-randomization at Week 52|Overall Study||0
56301|NCT02407223|136341|P3|Cross Over at Week 24|Overall Study||0
56302|NCT02407223|136342|P2|Cross Over at Week 24|Overall Study||0
56303|NCT02407223|136343|P1|Cross Over at Week 24|Overall Study|Study discontinuation/completion reported under randomization group|60
56304|NCT02407223|136341|P3|Early Escape at Week 16|Overall Study||0
56305|NCT02407223|136342|P2|Early Escape at Week 16|Overall Study||0
56306|NCT02407223|136343|P1|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|22
56307|NCT02407223|136341|P3|STARTED|Overall Study||122
56308|NCT02407223|136342|P2|STARTED|Overall Study||118
56309|NCT02407223|136343|P1|STARTED|Overall Study||116
56310|NCT02407132|136388|P2|NOT COMPLETED|12 Months Post-intervention||2
56311|NCT02407132|136389|P1|NOT COMPLETED|12 Months Post-intervention||13
56312|NCT02407132|136388|P2|COMPLETED|12 Months Post-intervention||90
56313|NCT02407132|136389|P1|COMPLETED|12 Months Post-intervention||83
56314|NCT02407132|136388|P2|STARTED|12 Months Post-intervention||92
56315|NCT02407132|136389|P1|STARTED|12 Months Post-intervention||96
56316|NCT02407132|136388|P2|NOT COMPLETED|6 Months Post-intervention||9
56317|NCT02407132|136389|P1|NOT COMPLETED|6 Months Post-intervention||11
56318|NCT02407132|136388|P2|COMPLETED|6 Months Post-intervention||92
56319|NCT02407132|136389|P1|COMPLETED|6 Months Post-intervention||96
56320|NCT02407132|136388|P2|STARTED|6 Months Post-intervention||101
56321|NCT02407132|136389|P1|STARTED|6 Months Post-intervention||107
56322|NCT02407132|136388|P2|NOT COMPLETED|Immediate Post-intervention||10
56323|NCT02407132|136389|P1|NOT COMPLETED|Immediate Post-intervention||3
56324|NCT02407132|136388|P2|COMPLETED|Immediate Post-intervention||101
56325|NCT02407132|136389|P1|COMPLETED|Immediate Post-intervention||107
56326|NCT02407132|136388|P2|STARTED|Immediate Post-intervention||111
56327|NCT02407132|136389|P1|STARTED|Immediate Post-intervention||110
56328|NCT02406937|136416|P3|NOT COMPLETED|Overall Study||2
56329|NCT02406937|136417|P2|NOT COMPLETED|Overall Study||1
56330|NCT02406937|136418|P1|NOT COMPLETED|Overall Study||1
56331|NCT02406937|136416|P3|COMPLETED|Overall Study||58
56332|NCT02406937|136417|P2|COMPLETED|Overall Study||59
56333|NCT02406937|136418|P1|COMPLETED|Overall Study||59
56334|NCT02406937|136416|P3|STARTED|Overall Study||60
56335|NCT02406937|136417|P2|STARTED|Overall Study||60
56336|NCT02406937|136418|P1|STARTED|Overall Study||60
56337|NCT02406677|136476|P2|NOT COMPLETED|Overall Study||598
56338|NCT02406677|136477|P1|NOT COMPLETED|Overall Study||301
56339|NCT02406677|136476|P2|COMPLETED|Overall Study||3967
56340|NCT02406677|136477|P1|COMPLETED|Overall Study||6135
56341|NCT02406677|136476|P2|STARTED|Overall Study||4565
56342|NCT02406677|136477|P1|STARTED|Overall Study||6436
56343|NCT02406612|136491|P2|NOT COMPLETED|Overall Study||4
56344|NCT02406612|136492|P1|NOT COMPLETED|Overall Study||4
56345|NCT02406612|136491|P2|COMPLETED|Overall Study||17
56346|NCT02406612|136492|P1|COMPLETED|Overall Study||22
56347|NCT02406612|136491|P2|STARTED|Overall Study||21
56348|NCT02406612|136492|P1|STARTED|Overall Study||26
56349|NCT02406586|136507|P3|NOT COMPLETED|Overall Study||2
56350|NCT02406586|136508|P2|NOT COMPLETED|Overall Study||4
56351|NCT02406586|136509|P1|NOT COMPLETED|Overall Study||1
56352|NCT02406586|136507|P3|COMPLETED|Overall Study||10
56353|NCT02406586|136508|P2|COMPLETED|Overall Study||8
56354|NCT02406586|136509|P1|COMPLETED|Overall Study||11
56355|NCT02406586|136507|P3|STARTED|Overall Study||12
56356|NCT02406586|136508|P2|STARTED|Overall Study||12
56357|NCT02406586|136509|P1|STARTED|Overall Study||12
56358|NCT02406573|136583|P1|NOT COMPLETED|Overall Study||0
56359|NCT02406573|136583|P1|COMPLETED|Overall Study||30
56360|NCT02406573|136583|P1|STARTED|Overall Study||30
56361|NCT02406495|136589|P1|NOT COMPLETED|Overall Study||0
56362|NCT02406495|136589|P1|COMPLETED|Overall Study||40
56363|NCT02406495|136589|P1|STARTED|Overall Study||40
56364|NCT02406443|136630|P2|NOT COMPLETED|Overall Study||2
56365|NCT02406443|136631|P1|NOT COMPLETED|Overall Study||2
56366|NCT02406443|136630|P2|COMPLETED|Overall Study||16
56367|NCT02406443|136631|P1|COMPLETED|Overall Study||16
56368|NCT02406443|136630|P2|STARTED|Overall Study||18
56369|NCT02406443|136631|P1|STARTED|Overall Study||18
56370|NCT02406261|136651|P2|NOT COMPLETED|Period 2||3
56371|NCT02406261|136652|P1|NOT COMPLETED|Period 2||0
56372|NCT02406261|136651|P2|COMPLETED|Period 2||29
56373|NCT02406261|136652|P1|COMPLETED|Period 2||0
56374|NCT02406261|136651|P2|STARTED|Period 2||32
56375|NCT02406261|136652|P1|STARTED|Period 2|Cohort A participated in Period 1 only|0
56376|NCT02406261|136651|P2|NOT COMPLETED|Period 1||0
56377|NCT02406261|136652|P1|NOT COMPLETED|Period 1||3
56378|NCT02406261|136651|P2|COMPLETED|Period 1||32
56379|NCT02406261|136652|P1|COMPLETED|Period 1||47
56380|NCT02406261|136651|P2|Received at Least One Dose of Study Drug|Period 1||32
56381|NCT02406261|136652|P1|Received at Least One Dose of Study Drug|Period 1||50
56382|NCT02406261|136651|P2|STARTED|Period 1||32
56383|NCT02406261|136652|P1|STARTED|Period 1||50
56384|NCT02406248|136664|P1|NOT COMPLETED|Overall Study||9
56385|NCT02406248|136664|P1|COMPLETED|Overall Study||99
56386|NCT02406248|136664|P1|STARTED|Overall Study||108
56387|NCT02406027|136675|P7|NOT COMPLETED|Open-label Phase (Period 2)||22
56388|NCT02406027|136676|P6|NOT COMPLETED|Open-label Phase (Period 2)||26
56389|NCT02406027|136677|P5|NOT COMPLETED|Open-label Phase (Period 2)||14
56390|NCT02406027|136678|P4|NOT COMPLETED|Open-label Phase (Period 2)||15
56391|NCT02406027|136679|P3|NOT COMPLETED|Open-label Phase (Period 2)||0
56392|NCT02406027|136680|P2|NOT COMPLETED|Open-label Phase (Period 2)||0
56393|NCT02406027|136681|P1|NOT COMPLETED|Open-label Phase (Period 2)||0
56394|NCT02406027|136675|P7|COMPLETED|Open-label Phase (Period 2)||0
56395|NCT02406027|136676|P6|COMPLETED|Open-label Phase (Period 2)||0
56396|NCT02406027|136677|P5|COMPLETED|Open-label Phase (Period 2)||0
56397|NCT02406027|136678|P4|COMPLETED|Open-label Phase (Period 2)||0
56398|NCT02406027|136679|P3|COMPLETED|Open-label Phase (Period 2)||0
56399|NCT02406027|136680|P2|COMPLETED|Open-label Phase (Period 2)||0
56400|NCT02406027|136681|P1|COMPLETED|Open-label Phase (Period 2)||0
56401|NCT02406027|136675|P7|STARTED|Open-label Phase (Period 2)||22
56402|NCT02406027|136676|P6|STARTED|Open-label Phase (Period 2)||26
56403|NCT02406027|136677|P5|STARTED|Open-label Phase (Period 2)||14
56404|NCT02406027|136678|P4|STARTED|Open-label Phase (Period 2)||15
56405|NCT02406027|136679|P3|STARTED|Open-label Phase (Period 2)||0
56406|NCT02406027|136680|P2|STARTED|Open-label Phase (Period 2)||0
56407|NCT02406027|136681|P1|STARTED|Open-label Phase (Period 2)||0
56408|NCT02406027|136675|P7|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
56409|NCT02406027|136676|P6|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
56410|NCT02406027|136677|P5|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
56411|NCT02406027|136678|P4|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
56412|NCT02406027|136679|P3|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||4
56413|NCT02406027|136680|P2|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||3
56414|NCT02406027|136681|P1|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||6
56415|NCT02406027|136675|P7|COMPLETED|Double-blind Treatment Phase (Period 1)||0
56416|NCT02406027|136676|P6|COMPLETED|Double-blind Treatment Phase (Period 1)||0
56417|NCT02406027|136677|P5|COMPLETED|Double-blind Treatment Phase (Period 1)||0
56418|NCT02406027|136678|P4|COMPLETED|Double-blind Treatment Phase (Period 1)||0
56419|NCT02406027|136679|P3|COMPLETED|Double-blind Treatment Phase (Period 1)||22
56420|NCT02406027|136680|P2|COMPLETED|Double-blind Treatment Phase (Period 1)||26
56421|NCT02406027|136681|P1|COMPLETED|Double-blind Treatment Phase (Period 1)||29
56422|NCT02406027|136675|P7|Prodromal|Double-blind Treatment Phase (Period 1)||0
56423|NCT02406027|136676|P6|Prodromal|Double-blind Treatment Phase (Period 1)||0
56424|NCT02406027|136677|P5|Prodromal|Double-blind Treatment Phase (Period 1)||0
56425|NCT02406027|136678|P4|Prodromal|Double-blind Treatment Phase (Period 1)||0
56426|NCT02406027|136679|P3|Prodromal|Double-blind Treatment Phase (Period 1)||20
56427|NCT02406027|136680|P2|Prodromal|Double-blind Treatment Phase (Period 1)||21
56428|NCT02406027|136681|P1|Prodromal|Double-blind Treatment Phase (Period 1)||29
56429|NCT02406027|136675|P7|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
56430|NCT02406027|136676|P6|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
56431|NCT02406027|136677|P5|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
56432|NCT02406027|136678|P4|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
56433|NCT02406027|136679|P3|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||6
56434|NCT02406027|136680|P2|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||8
56435|NCT02406027|136681|P1|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||6
56436|NCT02406027|136675|P7|STARTED|Double-blind Treatment Phase (Period 1)||0
56437|NCT02406027|136676|P6|STARTED|Double-blind Treatment Phase (Period 1)||0
56438|NCT02406027|136677|P5|STARTED|Double-blind Treatment Phase (Period 1)||0
56439|NCT02406027|136678|P4|STARTED|Double-blind Treatment Phase (Period 1)||0
56440|NCT02406027|136679|P3|STARTED|Double-blind Treatment Phase (Period 1)||26
56441|NCT02406027|136680|P2|STARTED|Double-blind Treatment Phase (Period 1)||29
56442|NCT02406027|136681|P1|STARTED|Double-blind Treatment Phase (Period 1)||35
56443|NCT02405962|136711|P2|NOT COMPLETED|Overall Study||5
56444|NCT02405962|136712|P1|NOT COMPLETED|Overall Study||1
56445|NCT02405962|136711|P2|COMPLETED|Overall Study||79
56446|NCT02405962|136712|P1|COMPLETED|Overall Study||83
56447|NCT02405962|136711|P2|3 Months After the Intervention|Overall Study||79
56448|NCT02405962|136712|P1|3 Months After the Intervention|Overall Study||80
56449|NCT02405962|136711|P2|Post-intervention|Overall Study||81
56450|NCT02405962|136712|P1|Post-intervention|Overall Study||80
56451|NCT02405962|136711|P2|STARTED|Overall Study||84
56452|NCT02405962|136712|P1|STARTED|Overall Study||84
56453|NCT02405780|136750|P4|NOT COMPLETED|Period II||18
56454|NCT02405780|136751|P3|NOT COMPLETED|Period II||12
56455|NCT02405780|136752|P2|NOT COMPLETED|Period II||12
56456|NCT02405780|136753|P1|NOT COMPLETED|Period II||15
56457|NCT02405780|136750|P4|COMPLETED|Period II||172
56458|NCT02405780|136751|P3|COMPLETED|Period II||81
56459|NCT02405780|136752|P2|COMPLETED|Period II||88
56460|NCT02405780|136753|P1|COMPLETED|Period II||174
56461|NCT02405780|136750|P4|STARTED|Period II||190
56462|NCT02405780|136751|P3|STARTED|Period II||93
56463|NCT02405780|136752|P2|STARTED|Period II||100
56464|NCT02405780|136753|P1|STARTED|Period II||189
56465|NCT02405780|136750|P4|NOT COMPLETED|Period I||23
56466|NCT02405780|136751|P3|NOT COMPLETED|Period I||15
56467|NCT02405780|136752|P2|NOT COMPLETED|Period I||8
56468|NCT02405780|136753|P1|NOT COMPLETED|Period I||27
56469|NCT02405780|136750|P4|COMPLETED|Period I||190
56470|NCT02405780|136751|P3|COMPLETED|Period I||93
56471|NCT02405780|136752|P2|COMPLETED|Period I||100
56472|NCT02405780|136753|P1|COMPLETED|Period I||189
56473|NCT02405780|136750|P4|STARTED|Period I||213
56474|NCT02405780|136751|P3|STARTED|Period I||108
56475|NCT02405780|136752|P2|STARTED|Period I||108
56476|NCT02405780|136753|P1|STARTED|Period I||216
56477|NCT02405442|136816|P4|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
56478|NCT02405442|136817|P3|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
56479|NCT02405442|136818|P2|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
56480|NCT02405442|136819|P1|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||3
56481|NCT02405442|136816|P4|COMPLETED|Extended Treatment Phase(up to Week 208)||0
56482|NCT02405442|136817|P3|COMPLETED|Extended Treatment Phase(up to Week 208)||0
56483|NCT02405442|136818|P2|COMPLETED|Extended Treatment Phase(up to Week 208)||0
56484|NCT02405442|136819|P1|COMPLETED|Extended Treatment Phase(up to Week 208)||0
56485|NCT02405442|136816|P4|STARTED|Extended Treatment Phase(up to Week 208)||2
56486|NCT02405442|136817|P3|STARTED|Extended Treatment Phase(up to Week 208)||2
56487|NCT02405442|136818|P2|STARTED|Extended Treatment Phase(up to Week 208)|1 participant completed Open-Label Phase, but did not continue in Extended Treatment Phase.|2
56488|NCT02405442|136819|P1|STARTED|Extended Treatment Phase(up to Week 208)|1 participant completed Open-Label Phase, but did not continue in Extended Treatment Phase.|3
56489|NCT02405442|136816|P4|NOT COMPLETED|Open-Label Phase (up to Week 52)||24
56490|NCT02405442|136817|P3|NOT COMPLETED|Open-Label Phase (up to Week 52)||45
56491|NCT02405442|136818|P2|NOT COMPLETED|Open-Label Phase (up to Week 52)||45
56492|NCT02405442|136819|P1|NOT COMPLETED|Open-Label Phase (up to Week 52)||48
56493|NCT02405442|136816|P4|COMPLETED|Open-Label Phase (up to Week 52)||2
56494|NCT02405442|136817|P3|COMPLETED|Open-Label Phase (up to Week 52)||2
56495|NCT02405442|136818|P2|COMPLETED|Open-Label Phase (up to Week 52)||3
56496|NCT02405442|136819|P1|COMPLETED|Open-Label Phase (up to Week 52)||4
56497|NCT02405442|136816|P4|STARTED|Open-Label Phase (up to Week 52)|1 participant completed Double-Blind Phase, but did not continue in Open-Label Phase.|26
56498|NCT02405442|136817|P3|STARTED|Open-Label Phase (up to Week 52)||47
56499|NCT02405442|136818|P2|STARTED|Open-Label Phase (up to Week 52)||48
56500|NCT02405442|136819|P1|STARTED|Open-Label Phase (up to Week 52)||52
56501|NCT02405442|136816|P4|NOT COMPLETED|Double-Blind Phase (up to Week 8)||1
56502|NCT02405442|136817|P3|NOT COMPLETED|Double-Blind Phase (up to Week 8)||6
56503|NCT02405442|136818|P2|NOT COMPLETED|Double-Blind Phase (up to Week 8)||5
56504|NCT02405442|136819|P1|NOT COMPLETED|Double-Blind Phase (up to Week 8)||1
56505|NCT02405442|136816|P4|COMPLETED|Double-Blind Phase (up to Week 8)||27
56506|NCT02405442|136817|P3|COMPLETED|Double-Blind Phase (up to Week 8)||47
56507|NCT02405442|136818|P2|COMPLETED|Double-Blind Phase (up to Week 8)||48
56508|NCT02405442|136819|P1|COMPLETED|Double-Blind Phase (up to Week 8)||52
56509|NCT02405442|136816|P4|STARTED|Double-Blind Phase (up to Week 8)||28
56510|NCT02405442|136817|P3|STARTED|Double-Blind Phase (up to Week 8)||53
56511|NCT02405442|136818|P2|STARTED|Double-Blind Phase (up to Week 8)||53
56512|NCT02405442|136819|P1|STARTED|Double-Blind Phase (up to Week 8)||53
56513|NCT02405429|136845|P1|NOT COMPLETED|Overall Study||0
56514|NCT02405429|136845|P1|COMPLETED|Overall Study||49
56515|NCT02405429|136845|P1|STARTED|Overall Study||49
56516|NCT02405390|136855|P2|NOT COMPLETED|Overall Study||0
56517|NCT02405390|136856|P1|NOT COMPLETED|Overall Study||0
56518|NCT02405390|136855|P2|COMPLETED|Overall Study||46
56519|NCT02405390|136856|P1|COMPLETED|Overall Study||46
56520|NCT02405390|136855|P2|STARTED|Overall Study||46
56521|NCT02405390|136856|P1|STARTED|Overall Study||46
56522|NCT02405195|136864|P1|NOT COMPLETED|Overall Study||0
56523|NCT02405195|136864|P1|COMPLETED|Overall Study||18
56524|NCT02405195|136864|P1|STARTED|Overall Study||18
56525|NCT02405091|136873|P3|NOT COMPLETED|Overall Study||2
56526|NCT02405091|136874|P2|NOT COMPLETED|Overall Study||33
56527|NCT02405091|136875|P1|NOT COMPLETED|Overall Study||29
56528|NCT02405091|136873|P3|COMPLETED|Overall Study||9
56529|NCT02405091|136874|P2|COMPLETED|Overall Study||74
56530|NCT02405091|136875|P1|COMPLETED|Overall Study||20
56531|NCT02405091|136873|P3|STARTED|Overall Study||11
56532|NCT02405091|136874|P2|STARTED|Overall Study||107
56533|NCT02405091|136875|P1|STARTED|Overall Study||49
56534|NCT02404792|136898|P2|NOT COMPLETED|Overall Study||8
56535|NCT02404792|136899|P1|NOT COMPLETED|Overall Study||5
56536|NCT02404792|136898|P2|COMPLETED|Overall Study||29
56537|NCT02404792|136899|P1|COMPLETED|Overall Study||27
56538|NCT02404792|136898|P2|STARTED|Overall Study||37
56539|NCT02404792|136899|P1|STARTED|Overall Study||32
56540|NCT02404649|136911|P2|NOT COMPLETED|Overall Study||2
56541|NCT02404649|136912|P1|NOT COMPLETED|Overall Study||1
56542|NCT02404649|136911|P2|COMPLETED|Overall Study||14
56543|NCT02404649|136912|P1|COMPLETED|Overall Study||16
56544|NCT02404649|136911|P2|STARTED|Overall Study||16
56545|NCT02404649|136912|P1|STARTED|Overall Study||17
56546|NCT02404610|136920|P2|NOT COMPLETED|Overall Study||0
56547|NCT02404610|136921|P1|NOT COMPLETED|Overall Study||0
56548|NCT02404610|136920|P2|COMPLETED|Overall Study||53
56549|NCT02404610|136921|P1|COMPLETED|Overall Study||54
56550|NCT02404610|136920|P2|STARTED|Overall Study||53
56551|NCT02404610|136921|P1|STARTED|Overall Study||54
56552|NCT02404545|136929|P2|NOT COMPLETED|Overall Study||6
56553|NCT02404545|136930|P1|NOT COMPLETED|Overall Study||6
56554|NCT02404545|136929|P2|COMPLETED|Overall Study||0
56555|NCT02404545|136930|P1|COMPLETED|Overall Study||0
56556|NCT02404545|136929|P2|STARTED|Overall Study||6
56557|NCT02404545|136930|P1|STARTED|Overall Study||6
56558|NCT02404532|136937|P1|NOT COMPLETED|Overall Study||0
56559|NCT02404532|136937|P1|COMPLETED|Overall Study||29
56560|NCT02404532|136937|P1|STARTED|Overall Study||29
56561|NCT02404493|136949|P2|NOT COMPLETED|Overall Study||1
56562|NCT02404493|136950|P1|NOT COMPLETED|Overall Study||1
56563|NCT02404493|136949|P2|COMPLETED|Overall Study||5
56564|NCT02404493|136950|P1|COMPLETED|Overall Study||16
56565|NCT02404493|136949|P2|STARTED|Overall Study||6
56566|NCT02404493|136950|P1|STARTED|Overall Study||17
56567|NCT02404389|137195|P5|NOT COMPLETED|Overall Study||3
56568|NCT02404389|137196|P4|NOT COMPLETED|Overall Study||1
56569|NCT02404389|137197|P3|NOT COMPLETED|Overall Study||1
56570|NCT02404389|137198|P2|NOT COMPLETED|Overall Study||0
56571|NCT02404389|137199|P1|NOT COMPLETED|Overall Study||2
56572|NCT02404389|137195|P5|COMPLETED|Overall Study||18
56573|NCT02404389|137196|P4|COMPLETED|Overall Study||9
56574|NCT02404389|137197|P3|COMPLETED|Overall Study||10
56575|NCT02404389|137198|P2|COMPLETED|Overall Study||20
56576|NCT02404389|137199|P1|COMPLETED|Overall Study||18
56577|NCT02404389|137195|P5|STARTED|Overall Study||21
56578|NCT02404389|137196|P4|STARTED|Overall Study||10
56579|NCT02404389|137197|P3|STARTED|Overall Study||11
56580|NCT02404389|137198|P2|STARTED|Overall Study||20
56581|NCT02404389|137199|P1|STARTED|Overall Study||20
56582|NCT02404350|137239|P4|NOT COMPLETED|Overall Study||37
56583|NCT02404350|137240|P3|NOT COMPLETED|Overall Study||6
56584|NCT02404350|137241|P2|NOT COMPLETED|Overall Study||6
56585|NCT02404350|137242|P1|NOT COMPLETED|Overall Study||15
56586|NCT02404350|137239|P4|COMPLETED|Overall Study||295
56587|NCT02404350|137240|P3|COMPLETED|Overall Study||216
56588|NCT02404350|137241|P2|COMPLETED|Overall Study||214
56589|NCT02404350|137242|P1|COMPLETED|Overall Study||207
56590|NCT02404350|137239|P4|STARTED|Overall Study||332
56591|NCT02404350|137240|P3|STARTED|Overall Study||222
56592|NCT02404350|137241|P2|STARTED|Overall Study||220
56593|NCT02404350|137242|P1|STARTED|Overall Study||222
56594|NCT02404285|137259|P2|NOT COMPLETED|Overall Study||2
56595|NCT02404285|137260|P1|NOT COMPLETED|Overall Study||2
56596|NCT02404285|137259|P2|COMPLETED|Overall Study||33
56597|NCT02404285|137260|P1|COMPLETED|Overall Study||31
56598|NCT02404285|137259|P2|STARTED|Overall Study||35
56599|NCT02404285|137260|P1|STARTED|Overall Study||33
56600|NCT02404168|137292|P1|NOT COMPLETED|Overall Study||0
56601|NCT02404168|137292|P1|COMPLETED|Overall Study||4
56602|NCT02404168|137292|P1|STARTED|Overall Study||4
56603|NCT02404103|137302|P2|NOT COMPLETED|Overall Study||3
56604|NCT02404103|137303|P1|NOT COMPLETED|Overall Study||4
56605|NCT02404103|137302|P2|COMPLETED|Overall Study||9
56606|NCT02404103|137303|P1|COMPLETED|Overall Study||10
56607|NCT02404103|137302|P2|STARTED|Overall Study||12
56608|NCT02404103|137303|P1|STARTED|Overall Study||14
56609|NCT02404025|137323|P1|NOT COMPLETED|Overall Study||4
56610|NCT02404025|137323|P1|COMPLETED|Overall Study||6
56611|NCT02404025|137323|P1|STARTED|Overall Study||10
56612|NCT02403999|137355|P3|NOT COMPLETED|Overall Study||0
56613|NCT02403999|137356|P2|NOT COMPLETED|Overall Study||0
56614|NCT02403999|137357|P1|NOT COMPLETED|Overall Study||0
56615|NCT02403999|137355|P3|COMPLETED|Overall Study||11
56616|NCT02403999|137356|P2|COMPLETED|Overall Study||10
56617|NCT02403999|137357|P1|COMPLETED|Overall Study||10
56618|NCT02403999|137355|P3|STARTED|Overall Study||11
56619|NCT02403999|137356|P2|STARTED|Overall Study||10
56620|NCT02403999|137357|P1|STARTED|Overall Study||10
56621|NCT02403986|137370|P2|NOT COMPLETED|Overall Study||4
56622|NCT02403986|137371|P1|NOT COMPLETED|Overall Study||5
56623|NCT02403986|137370|P2|COMPLETED|Overall Study||23
56624|NCT02403986|137371|P1|COMPLETED|Overall Study||21
56625|NCT02403986|137370|P2|STARTED|Overall Study||27
56626|NCT02403986|137371|P1|STARTED|Overall Study||26
56627|NCT02403895|137379|P1|NOT COMPLETED|Overall Study||0
56628|NCT02403895|137379|P1|COMPLETED|Overall Study||11
56629|NCT02403895|137379|P1|STARTED|Overall Study||11
56630|NCT02403830|137392|P2|NOT COMPLETED|Visit 2||0
56631|NCT02403830|137393|P1|NOT COMPLETED|Visit 2||0
56632|NCT02403830|137392|P2|COMPLETED|Visit 2||15
56633|NCT02403830|137393|P1|COMPLETED|Visit 2||14
56634|NCT02403830|137392|P2|STARTED|Visit 2||15
56635|NCT02403830|137393|P1|STARTED|Visit 2|One subject completed visit 1 and then withdrew from the study for an adverse event (nausea).|14
56636|NCT02403830|137392|P2|NOT COMPLETED|Visit 1||0
56637|NCT02403830|137393|P1|NOT COMPLETED|Visit 1||0
56638|NCT02403830|137392|P2|COMPLETED|Visit 1||15
56639|NCT02403830|137393|P1|COMPLETED|Visit 1||15
56640|NCT02403830|137392|P2|STARTED|Visit 1||15
56641|NCT02403830|137393|P1|STARTED|Visit 1||15
56642|NCT02403778|137405|P2|NOT COMPLETED|Overall Study||0
56643|NCT02403778|137406|P1|NOT COMPLETED|Overall Study||0
56644|NCT02403778|137405|P2|COMPLETED|Overall Study||4
56645|NCT02403778|137406|P1|COMPLETED|Overall Study||6
56646|NCT02403778|137405|P2|STARTED|Overall Study||4
56647|NCT02403778|137406|P1|STARTED|Overall Study||6
56648|NCT02403674|137422|P2|NOT COMPLETED|Overall Study||63
56649|NCT02403674|137423|P1|NOT COMPLETED|Overall Study||55
56650|NCT02403674|137422|P2|COMPLETED|Overall Study||303
56651|NCT02403674|137423|P1|COMPLETED|Overall Study||313
56652|NCT02403674|137422|P2|Treated|Overall Study||364
56653|NCT02403674|137423|P1|Treated|Overall Study||364
56654|NCT02403674|137422|P2|STARTED|Overall Study||366
56655|NCT02403674|137423|P1|STARTED|Overall Study||368
56656|NCT02403635|137462|P1|NOT COMPLETED|Overall Study||9
56657|NCT02403635|137462|P1|COMPLETED|Overall Study||18
56658|NCT02403635|137462|P1|Received the First Dose|Overall Study||18
56659|NCT02403635|137462|P1|Screening (28 Days)|Overall Study||27
56660|NCT02403635|137462|P1|STARTED|Overall Study||27
56661|NCT02403479|137530|P2|NOT COMPLETED|Overall Study||0
56662|NCT02403479|137531|P1|NOT COMPLETED|Overall Study||2
56663|NCT02403479|137530|P2|COMPLETED|Overall Study||12
56664|NCT02403479|137531|P1|COMPLETED|Overall Study||8
56665|NCT02403479|137530|P2|STARTED|Overall Study||12
56666|NCT02403479|137531|P1|STARTED|Overall Study||10
56667|NCT02403271|137539|P2|NOT COMPLETED|Period 2||124
56668|NCT02403271|137540|P1|NOT COMPLETED|Period 2||0
56669|NCT02403271|137539|P2|COMPLETED|Period 2||0
56670|NCT02403271|137540|P1|COMPLETED|Period 2||0
56671|NCT02403271|137539|P2|STARTED|Period 2|Phase 2 includes all subjects who participated in Phase 1b.|124
56672|NCT02403271|137540|P1|STARTED|Period 2||0
56673|NCT02403271|137539|P2|NOT COMPLETED|Period 1||0
56674|NCT02403271|137540|P1|NOT COMPLETED|Period 1||1
56675|NCT02403271|137539|P2|COMPLETED|Period 1||0
56676|NCT02403271|137540|P1|COMPLETED|Period 1||6
56677|NCT02403271|137539|P2|STARTED|Period 1||0
56678|NCT02403271|137540|P1|STARTED|Period 1|All Phase 1b participants went on to participate in Phase 2.|7
56679|NCT02403206|137554|P2|NOT COMPLETED|Overall Study||10
56680|NCT02403206|137555|P1|NOT COMPLETED|Overall Study||11
56681|NCT02403206|137554|P2|COMPLETED|Overall Study||186
56682|NCT02403206|137555|P1|COMPLETED|Overall Study||183
56683|NCT02403206|137554|P2|Randomized and Treated|Overall Study||190
56684|NCT02403206|137555|P1|Randomized and Treated|Overall Study||188
56685|NCT02403206|137554|P2|Treated Prior to Randomization|Overall Study||1
56686|NCT02403206|137555|P1|Treated Prior to Randomization|Overall Study||0
56687|NCT02403206|137554|P2|STARTED|Overall Study||196
56688|NCT02403206|137555|P1|STARTED|Overall Study||194
56689|NCT02403180|137566|P2|NOT COMPLETED|Period 2 (5 Days)||1
56690|NCT02403180|137567|P1|NOT COMPLETED|Period 2 (5 Days)||0
56691|NCT02403180|137566|P2|COMPLETED|Period 2 (5 Days)||32
56692|NCT02403180|137567|P1|COMPLETED|Period 2 (5 Days)||36
56693|NCT02403180|137566|P2|STARTED|Period 2 (5 Days)||33
56694|NCT02403180|137567|P1|STARTED|Period 2 (5 Days)||36
56695|NCT02403180|137566|P2|NOT COMPLETED|Period 1 (5 Days)||0
56696|NCT02403180|137567|P1|NOT COMPLETED|Period 1 (5 Days)||0
56697|NCT02403180|137566|P2|COMPLETED|Period 1 (5 Days)||33
56698|NCT02403180|137567|P1|COMPLETED|Period 1 (5 Days)||36
56699|NCT02403180|137566|P2|Randomized|Period 1 (5 Days)||33
56700|NCT02403180|137567|P1|Randomized|Period 1 (5 Days)||36
56701|NCT02403180|137566|P2|STARTED|Period 1 (5 Days)||33
56702|NCT02403180|137567|P1|STARTED|Period 1 (5 Days)||36
56703|NCT02403180|137566|P2|NOT COMPLETED|Pre-Treatment Period||1
56704|NCT02403180|137567|P1|NOT COMPLETED|Pre-Treatment Period||0
56705|NCT02403180|137566|P2|COMPLETED|Pre-Treatment Period||33
56706|NCT02403180|137567|P1|COMPLETED|Pre-Treatment Period||36
56707|NCT02403180|137566|P2|STARTED|Pre-Treatment Period||34
56708|NCT02403180|137567|P1|STARTED|Pre-Treatment Period||36
56709|NCT02403154|137579|P4|NOT COMPLETED|Overall Study||1
56710|NCT02403154|137580|P3|NOT COMPLETED|Overall Study||1
56711|NCT02403154|137581|P2|NOT COMPLETED|Overall Study||0
56712|NCT02403154|137582|P1|NOT COMPLETED|Overall Study||2
56713|NCT02403154|137579|P4|COMPLETED|Overall Study||0
56714|NCT02403154|137580|P3|COMPLETED|Overall Study||0
56715|NCT02403154|137581|P2|COMPLETED|Overall Study||0
56716|NCT02403154|137582|P1|COMPLETED|Overall Study||0
56717|NCT02403154|137579|P4|STARTED|Overall Study||1
56718|NCT02403154|137580|P3|STARTED|Overall Study||1
56719|NCT02403154|137581|P2|STARTED|Overall Study||0
56720|NCT02403154|137582|P1|STARTED|Overall Study||2
56721|NCT02402933|137596|P1|NOT COMPLETED|Overall Study||14
56722|NCT02402933|137596|P1|COMPLETED|Overall Study||12
56723|NCT02402933|137596|P1|Received at Least One Dose of Study Drug|Overall Study||22
56724|NCT02402933|137596|P1|STARTED|Overall Study||26
56725|NCT02402764|137603|P1|NOT COMPLETED|Overall Study||0
56726|NCT02402764|137603|P1|COMPLETED|Overall Study||10
56727|NCT02402764|137603|P1|STARTED|Overall Study||10
56728|NCT02402322|137614|P3|NOT COMPLETED|Follow-up||24
56729|NCT02402322|137615|P2|NOT COMPLETED|Follow-up||3
56730|NCT02402322|137616|P1|NOT COMPLETED|Follow-up||6
56731|NCT02402322|137614|P3|COMPLETED|Follow-up||0
56732|NCT02402322|137615|P2|COMPLETED|Follow-up||21
56733|NCT02402322|137616|P1|COMPLETED|Follow-up||18
56734|NCT02402322|137614|P3|STARTED|Follow-up|These individuals were not evaluated at this follow-up as they started an alternative treatment.|24
56735|NCT02402322|137615|P2|STARTED|Follow-up||24
56736|NCT02402322|137616|P1|STARTED|Follow-up||24
56737|NCT02402322|137614|P3|NOT COMPLETED|Pretreatment||1
56738|NCT02402322|137615|P2|NOT COMPLETED|Pretreatment||1
56739|NCT02402322|137616|P1|NOT COMPLETED|Pretreatment||3
56740|NCT02402322|137614|P3|COMPLETED|Pretreatment||24
56741|NCT02402322|137615|P2|COMPLETED|Pretreatment||24
56742|NCT02402322|137616|P1|COMPLETED|Pretreatment||24
56743|NCT02402322|137614|P3|Posttreatment Measures|Pretreatment||24
56744|NCT02402322|137615|P2|Posttreatment Measures|Pretreatment||24
56745|NCT02402322|137616|P1|Posttreatment Measures|Pretreatment||24
56746|NCT02402322|137614|P3|STARTED|Pretreatment||25
56747|NCT02402322|137615|P2|STARTED|Pretreatment||25
56748|NCT02402322|137616|P1|STARTED|Pretreatment||27
56749|NCT02402296|137650|P2|NOT COMPLETED|Overall Study||0
56750|NCT02402296|137651|P1|NOT COMPLETED|Overall Study||0
56751|NCT02402296|137650|P2|COMPLETED|Overall Study||15
56752|NCT02402296|137651|P1|COMPLETED|Overall Study||15
56753|NCT02402296|137650|P2|STARTED|Overall Study||15
56754|NCT02402296|137651|P1|STARTED|Overall Study||15
56755|NCT02402218|137666|P3|NOT COMPLETED|Overall Study||17
56756|NCT02402218|137667|P2|NOT COMPLETED|Overall Study||13
56757|NCT02402218|137668|P1|NOT COMPLETED|Overall Study||14
56758|NCT02402218|137666|P3|COMPLETED|Overall Study||37
56759|NCT02402218|137667|P2|COMPLETED|Overall Study||41
56760|NCT02402218|137668|P1|COMPLETED|Overall Study||22
56761|NCT02402218|137666|P3|Achieved Sustained Virologic Response|Overall Study||37
56762|NCT02402218|137667|P2|Achieved Sustained Virologic Response|Overall Study||41
56763|NCT02402218|137668|P1|Achieved Sustained Virologic Response|Overall Study||22
56764|NCT02402218|137666|P3|Completed Treatment With LDV/SOF|Overall Study||39
56765|NCT02402218|137667|P2|Completed Treatment With LDV/SOF|Overall Study||42
56766|NCT02402218|137668|P1|Completed Treatment With LDV/SOF|Overall Study||23
56767|NCT02402218|137666|P3|Initiated Treatment With LDV/SOF|Overall Study||41
56768|NCT02402218|137667|P2|Initiated Treatment With LDV/SOF|Overall Study||45
56769|NCT02402218|137668|P1|Initiated Treatment With LDV/SOF|Overall Study||24
56770|NCT02402218|137666|P3|STARTED|Overall Study||54
56771|NCT02402218|137667|P2|STARTED|Overall Study||54
56772|NCT02402218|137668|P1|STARTED|Overall Study||36
56773|NCT02402166|137691|P1|NOT COMPLETED|Overall Study||5
56774|NCT02402166|137691|P1|COMPLETED|Overall Study||19
56775|NCT02402166|137691|P1|STARTED|Overall Study||24
56776|NCT02402153|137712|P1|NOT COMPLETED|Overall Study||0
56777|NCT02402153|137712|P1|COMPLETED|Overall Study||18
56778|NCT02402153|137712|P1|STARTED|Overall Study||18
56779|NCT02402127|137728|P6|NOT COMPLETED|Third Wear Period (1 Day)||0
56780|NCT02402127|137729|P5|NOT COMPLETED|Third Wear Period (1 Day)||0
56781|NCT02402127|137730|P4|NOT COMPLETED|Third Wear Period (1 Day)||0
56782|NCT02402127|137731|P3|NOT COMPLETED|Third Wear Period (1 Day)||0
56783|NCT02402127|137732|P2|NOT COMPLETED|Third Wear Period (1 Day)||0
56784|NCT02402127|137733|P1|NOT COMPLETED|Third Wear Period (1 Day)||0
56785|NCT02402127|137728|P6|COMPLETED|Third Wear Period (1 Day)||4
56786|NCT02402127|137729|P5|COMPLETED|Third Wear Period (1 Day)||4
56787|NCT02402127|137730|P4|COMPLETED|Third Wear Period (1 Day)||4
56788|NCT02402127|137731|P3|COMPLETED|Third Wear Period (1 Day)||4
56789|NCT02402127|137732|P2|COMPLETED|Third Wear Period (1 Day)||4
56790|NCT02402127|137733|P1|COMPLETED|Third Wear Period (1 Day)||4
56791|NCT02402127|137728|P6|STARTED|Third Wear Period (1 Day)||4
56792|NCT02402127|137729|P5|STARTED|Third Wear Period (1 Day)||4
56793|NCT02402127|137730|P4|STARTED|Third Wear Period (1 Day)||4
56794|NCT02402127|137731|P3|STARTED|Third Wear Period (1 Day)||4
56795|NCT02402127|137732|P2|STARTED|Third Wear Period (1 Day)||4
56796|NCT02402127|137733|P1|STARTED|Third Wear Period (1 Day)||4
56797|NCT02402127|137728|P6|NOT COMPLETED|Second Wear Period (1 Day)||0
56798|NCT02402127|137729|P5|NOT COMPLETED|Second Wear Period (1 Day)||0
56799|NCT02402127|137730|P4|NOT COMPLETED|Second Wear Period (1 Day)||0
56800|NCT02402127|137731|P3|NOT COMPLETED|Second Wear Period (1 Day)||0
56801|NCT02402127|137732|P2|NOT COMPLETED|Second Wear Period (1 Day)||0
56802|NCT02402127|137733|P1|NOT COMPLETED|Second Wear Period (1 Day)||0
56803|NCT02402127|137728|P6|COMPLETED|Second Wear Period (1 Day)||4
56804|NCT02402127|137729|P5|COMPLETED|Second Wear Period (1 Day)||4
56805|NCT02402127|137730|P4|COMPLETED|Second Wear Period (1 Day)||4
56806|NCT02402127|137731|P3|COMPLETED|Second Wear Period (1 Day)||4
56807|NCT02402127|137732|P2|COMPLETED|Second Wear Period (1 Day)||4
56808|NCT02402127|137733|P1|COMPLETED|Second Wear Period (1 Day)||4
56809|NCT02402127|137728|P6|STARTED|Second Wear Period (1 Day)||4
56810|NCT02402127|137729|P5|STARTED|Second Wear Period (1 Day)||4
56811|NCT02402127|137730|P4|STARTED|Second Wear Period (1 Day)||4
56812|NCT02402127|137731|P3|STARTED|Second Wear Period (1 Day)||4
56813|NCT02402127|137732|P2|STARTED|Second Wear Period (1 Day)||4
56814|NCT02402127|137733|P1|STARTED|Second Wear Period (1 Day)||4
56815|NCT02402127|137728|P6|NOT COMPLETED|First Wear Period (1 Day)||0
56816|NCT02402127|137729|P5|NOT COMPLETED|First Wear Period (1 Day)||0
56817|NCT02402127|137730|P4|NOT COMPLETED|First Wear Period (1 Day)||0
56818|NCT02402127|137731|P3|NOT COMPLETED|First Wear Period (1 Day)||0
56819|NCT02402127|137732|P2|NOT COMPLETED|First Wear Period (1 Day)||0
56820|NCT02402127|137733|P1|NOT COMPLETED|First Wear Period (1 Day)||0
56821|NCT02402127|137728|P6|COMPLETED|First Wear Period (1 Day)||4
56822|NCT02402127|137729|P5|COMPLETED|First Wear Period (1 Day)||4
56823|NCT02402127|137730|P4|COMPLETED|First Wear Period (1 Day)||4
56824|NCT02402127|137731|P3|COMPLETED|First Wear Period (1 Day)||4
56825|NCT02402127|137732|P2|COMPLETED|First Wear Period (1 Day)||4
56826|NCT02402127|137733|P1|COMPLETED|First Wear Period (1 Day)||4
56827|NCT02402127|137728|P6|Randomized and Treated|First Wear Period (1 Day)||4
56828|NCT02402127|137729|P5|Randomized and Treated|First Wear Period (1 Day)||4
56829|NCT02402127|137730|P4|Randomized and Treated|First Wear Period (1 Day)||4
56830|NCT02402127|137731|P3|Randomized and Treated|First Wear Period (1 Day)||4
56831|NCT02402127|137732|P2|Randomized and Treated|First Wear Period (1 Day)||4
56832|NCT02402127|137733|P1|Randomized and Treated|First Wear Period (1 Day)||4
56833|NCT02402127|137728|P6|STARTED|First Wear Period (1 Day)||4
56834|NCT02402127|137729|P5|STARTED|First Wear Period (1 Day)||4
56835|NCT02402127|137730|P4|STARTED|First Wear Period (1 Day)||4
56836|NCT02402127|137731|P3|STARTED|First Wear Period (1 Day)||4
56837|NCT02402127|137732|P2|STARTED|First Wear Period (1 Day)||4
56838|NCT02402127|137733|P1|STARTED|First Wear Period (1 Day)||4
56839|NCT02402036|137744|P1|NOT COMPLETED|Overall Study||0
56840|NCT02402036|137744|P1|COMPLETED|Overall Study||10
56841|NCT02402036|137744|P1|STARTED|Overall Study||10
56842|NCT02401867|137748|P1|NOT COMPLETED|Analysis||9
56843|NCT02401867|137748|P1|COMPLETED|Analysis|Comparative analysis of vaginal HPV DNA results and cervical HPV DNA results|131
56844|NCT02401867|137748|P1|STARTED|Analysis||140
56845|NCT02401867|137748|P1|NOT COMPLETED|Specimen Collection||10
56846|NCT02401867|137748|P1|COMPLETED|Specimen Collection|Completed both vaginal self-swab and provider-collected cervical swab|140
56847|NCT02401867|137748|P1|STARTED|Specimen Collection||150
56848|NCT02401867|137748|P1|NOT COMPLETED|Enrolled||0
56849|NCT02401867|137748|P1|COMPLETED|Enrolled||150
56850|NCT02401867|137748|P1|STARTED|Enrolled||150
56851|NCT02401555|137756|P3|NOT COMPLETED|Overall Study||0
56852|NCT02401555|137757|P2|NOT COMPLETED|Overall Study||0
56853|NCT02401555|137758|P1|NOT COMPLETED|Overall Study||0
56854|NCT02401555|137756|P3|COMPLETED|Overall Study||120
56855|NCT02401555|137757|P2|COMPLETED|Overall Study||212
56856|NCT02401555|137758|P1|COMPLETED|Overall Study||87
56857|NCT02401555|137756|P3|STARTED|Overall Study||120
56858|NCT02401555|137757|P2|STARTED|Overall Study||212
56859|NCT02401555|137758|P1|STARTED|Overall Study||87
56860|NCT02401529|137768|P2|NOT COMPLETED|Overall Study||7
56861|NCT02401529|137769|P1|NOT COMPLETED|Overall Study||9
56862|NCT02401529|137768|P2|COMPLETED|Overall Study||50
56863|NCT02401529|137769|P1|COMPLETED|Overall Study||50
56864|NCT02401529|137768|P2|STARTED|Overall Study||57
56865|NCT02401529|137769|P1|STARTED|Overall Study||59
56866|NCT02401464|137797|P4|NOT COMPLETED|Intervention Period 2 (6 Days)||0
56867|NCT02401464|137798|P3|NOT COMPLETED|Intervention Period 2 (6 Days)||0
56868|NCT02401464|137799|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
56869|NCT02401464|137800|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
56870|NCT02401464|137797|P4|COMPLETED|Intervention Period 2 (6 Days)||13
56871|NCT02401464|137798|P3|COMPLETED|Intervention Period 2 (6 Days)||13
56872|NCT02401464|137799|P2|COMPLETED|Intervention Period 2 (6 Days)||13
56873|NCT02401464|137800|P1|COMPLETED|Intervention Period 2 (6 Days)||13
56874|NCT02401464|137797|P4|STARTED|Intervention Period 2 (6 Days)||13
56875|NCT02401464|137798|P3|STARTED|Intervention Period 2 (6 Days)||13
56876|NCT02401464|137799|P2|STARTED|Intervention Period 2 (6 Days)||13
56877|NCT02401464|137800|P1|STARTED|Intervention Period 2 (6 Days)||13
56878|NCT02401464|137797|P4|NOT COMPLETED|Washout Period (At Least 6 Days)||0
56879|NCT02401464|137798|P3|NOT COMPLETED|Washout Period (At Least 6 Days)||0
56880|NCT02401464|137799|P2|NOT COMPLETED|Washout Period (At Least 6 Days)||0
56881|NCT02401464|137800|P1|NOT COMPLETED|Washout Period (At Least 6 Days)||0
56882|NCT02401464|137797|P4|COMPLETED|Washout Period (At Least 6 Days)||13
56883|NCT02401464|137798|P3|COMPLETED|Washout Period (At Least 6 Days)||13
56884|NCT02401464|137799|P2|COMPLETED|Washout Period (At Least 6 Days)||13
56885|NCT02401464|137800|P1|COMPLETED|Washout Period (At Least 6 Days)||13
56886|NCT02401464|137797|P4|STARTED|Washout Period (At Least 6 Days)||13
56887|NCT02401464|137798|P3|STARTED|Washout Period (At Least 6 Days)||13
56888|NCT02401464|137799|P2|STARTED|Washout Period (At Least 6 Days)||13
56889|NCT02401464|137800|P1|STARTED|Washout Period (At Least 6 Days)||13
56890|NCT02401464|137797|P4|NOT COMPLETED|Intervention Period 1 (6 Days)||0
56891|NCT02401464|137798|P3|NOT COMPLETED|Intervention Period 1 (6 Days)||0
56892|NCT02401464|137799|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
56893|NCT02401464|137800|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
56894|NCT02401464|137797|P4|COMPLETED|Intervention Period 1 (6 Days)||13
56895|NCT02401464|137798|P3|COMPLETED|Intervention Period 1 (6 Days)||13
56896|NCT02401464|137799|P2|COMPLETED|Intervention Period 1 (6 Days)||13
56897|NCT02401464|137800|P1|COMPLETED|Intervention Period 1 (6 Days)||13
56898|NCT02401464|137797|P4|STARTED|Intervention Period 1 (6 Days)||13
56899|NCT02401464|137798|P3|STARTED|Intervention Period 1 (6 Days)||13
56900|NCT02401464|137799|P2|STARTED|Intervention Period 1 (6 Days)||13
56901|NCT02401464|137800|P1|STARTED|Intervention Period 1 (6 Days)||13
56902|NCT02401412|137836|P2|NOT COMPLETED|Overall Study||32
56903|NCT02401412|137837|P1|NOT COMPLETED|Overall Study||30
56904|NCT02401412|137836|P2|COMPLETED|Overall Study||49
56905|NCT02401412|137837|P1|COMPLETED|Overall Study||59
56906|NCT02401412|137836|P2|Received Study Device|Overall Study||80
56907|NCT02401412|137837|P1|Received Study Device|Overall Study||89
56908|NCT02401412|137836|P2|STARTED|Overall Study||81
56909|NCT02401412|137837|P1|STARTED|Overall Study||89
56910|NCT02401256|137845|P1|NOT COMPLETED|Overall Study||17
56911|NCT02401256|137845|P1|COMPLETED|Overall Study||53
56912|NCT02401256|137845|P1|Analysed|Overall Study|Volunteers that completed at least until Phase 2 inpatient visit (Volunteers with Efavirenz PK data)|61
56913|NCT02401256|137845|P1|Finished Phase 3|Overall Study||53
56914|NCT02401256|137845|P1|Finished Phase 2|Overall Study||58
56915|NCT02401256|137845|P1|Finished Phase 1|Overall Study||64
56916|NCT02401256|137845|P1|STARTED|Overall Study||70
56917|NCT02401230|137854|P3|NOT COMPLETED|Overall Study||4
56918|NCT02401230|137855|P2|NOT COMPLETED|Overall Study||6
56919|NCT02401230|137856|P1|NOT COMPLETED|Overall Study||6
56920|NCT02401230|137854|P3|COMPLETED|Overall Study||21
56921|NCT02401230|137855|P2|COMPLETED|Overall Study||19
56922|NCT02401230|137856|P1|COMPLETED|Overall Study||20
56923|NCT02401230|137854|P3|STARTED|Overall Study||25
56924|NCT02401230|137855|P2|STARTED|Overall Study||25
56925|NCT02401230|137856|P1|STARTED|Overall Study||26
56926|NCT02401048|137891|P2|NOT COMPLETED|Overall Study||30
56927|NCT02401048|137892|P1|NOT COMPLETED|Overall Study||22
56928|NCT02401048|137891|P2|COMPLETED|Overall Study||4
56929|NCT02401048|137892|P1|COMPLETED|Overall Study||5
56930|NCT02401048|137891|P2|STARTED|Overall Study||34
56931|NCT02401048|137892|P1|STARTED|Overall Study||27
56932|NCT02401022|137924|P2|NOT COMPLETED|Overall Study||20
56933|NCT02401022|137925|P1|NOT COMPLETED|Overall Study||15
56934|NCT02401022|137924|P2|COMPLETED|Overall Study||90
56935|NCT02401022|137925|P1|COMPLETED|Overall Study||89
56936|NCT02401022|137924|P2|STARTED|Overall Study||110
56937|NCT02401022|137925|P1|STARTED|Overall Study||104
56938|NCT02400996|137931|P1|NOT COMPLETED|Overall Study||0
56939|NCT02400996|137931|P1|COMPLETED|Overall Study||40
56940|NCT02400996|137931|P1|STARTED|Overall Study||40
56941|NCT02400905|137935|P1|NOT COMPLETED|Overall Study||271
56942|NCT02400905|137935|P1|COMPLETED|Overall Study||0
56943|NCT02400905|137935|P1|12-month Follow-up|Overall Study||256
56944|NCT02400905|137935|P1|STARTED|Overall Study||271
56945|NCT02400749|137945|P2|NOT COMPLETED|Week 17 - 32||3
56946|NCT02400749|137946|P1|NOT COMPLETED|Week 17 - 32||5
56947|NCT02400749|137945|P2|COMPLETED|Week 17 - 32||41
56948|NCT02400749|137946|P1|COMPLETED|Week 17 - 32||34
56949|NCT02400749|137945|P2|STARTED|Week 17 - 32||44
56950|NCT02400749|137946|P1|STARTED|Week 17 - 32||39
56951|NCT02400749|137945|P2|NOT COMPLETED|Week 0 -16||6
56952|NCT02400749|137946|P1|NOT COMPLETED|Week 0 -16||11
56953|NCT02400749|137945|P2|COMPLETED|Week 0 -16||44
56954|NCT02400749|137946|P1|COMPLETED|Week 0 -16||39
56955|NCT02400749|137945|P2|STARTED|Week 0 -16||50
56956|NCT02400749|137946|P1|STARTED|Week 0 -16||50
56957|NCT02400710|137962|P2|NOT COMPLETED|Overall Study||0
56958|NCT02400710|137963|P1|NOT COMPLETED|Overall Study||0
56959|NCT02400710|137962|P2|COMPLETED|Overall Study||10
56960|NCT02400710|137963|P1|COMPLETED|Overall Study||10
56961|NCT02400710|137962|P2|STARTED|Overall Study||10
56962|NCT02400710|137963|P1|STARTED|Overall Study||10
56963|NCT02400580|137973|P2|NOT COMPLETED|Overall Study||1
56964|NCT02400580|137974|P1|NOT COMPLETED|Overall Study||2
56965|NCT02400580|137973|P2|COMPLETED|Overall Study||91
56966|NCT02400580|137974|P1|COMPLETED|Overall Study||89
56967|NCT02400580|137973|P2|STARTED|Overall Study||92
56968|NCT02400580|137974|P1|STARTED|Overall Study||91
56969|NCT02400346|137990|P1|NOT COMPLETED|Overall Study||44
56970|NCT02400346|137990|P1|COMPLETED|Overall Study||88
56971|NCT02400346|137990|P1|STARTED|Overall Study||132
56972|NCT02400333|137998|P4|NOT COMPLETED|Overall Study||2
56973|NCT02400333|137999|P3|NOT COMPLETED|Overall Study||2
56974|NCT02400333|138000|P2|NOT COMPLETED|Overall Study||1
56975|NCT02400333|138001|P1|NOT COMPLETED|Overall Study||1
56976|NCT02400333|137998|P4|COMPLETED|Overall Study||7
56977|NCT02400333|137999|P3|COMPLETED|Overall Study||7
56978|NCT02400333|138000|P2|COMPLETED|Overall Study||8
56979|NCT02400333|138001|P1|COMPLETED|Overall Study||8
56980|NCT02400333|137998|P4|STARTED|Overall Study||9
56981|NCT02400333|137999|P3|STARTED|Overall Study||9
56982|NCT02400333|138000|P2|STARTED|Overall Study||9
56983|NCT02400333|138001|P1|STARTED|Overall Study||9
56984|NCT02400307|138061|P2|NOT COMPLETED|Overall Study||0
56985|NCT02400307|138062|P1|NOT COMPLETED|Overall Study||1
56986|NCT02400307|138061|P2|COMPLETED|Overall Study||8
56987|NCT02400307|138062|P1|COMPLETED|Overall Study||10
56988|NCT02400307|138061|P2|STARTED|Overall Study||8
56989|NCT02400307|138062|P1|STARTED|Overall Study||11
56990|NCT02400073|138082|P1|NOT COMPLETED|Overall Study||11
56991|NCT02400073|138082|P1|COMPLETED|Overall Study||111
56992|NCT02400073|138082|P1|STARTED|Overall Study||122
56993|NCT02399917|138090|P3|NOT COMPLETED|Overall Study||0
56994|NCT02399917|138091|P2|NOT COMPLETED|Overall Study||0
56995|NCT02399917|138092|P1|NOT COMPLETED|Overall Study||0
56996|NCT02399917|138090|P3|COMPLETED|Overall Study||24
56997|NCT02399917|138091|P2|COMPLETED|Overall Study||6
56998|NCT02399917|138092|P1|COMPLETED|Overall Study||6
56999|NCT02399917|138090|P3|STARTED|Overall Study||24
57000|NCT02399917|138091|P2|STARTED|Overall Study||6
57001|NCT02399917|138092|P1|STARTED|Overall Study||6
57002|NCT02399345|138110|P1|NOT COMPLETED|Overall Study||0
57003|NCT02399345|138110|P1|COMPLETED|Overall Study||10
57004|NCT02399345|138110|P1|STARTED|Overall Study||10
57005|NCT02399254|138116|P1|NOT COMPLETED|Overall Study||2
57006|NCT02399254|138116|P1|COMPLETED|Overall Study||19
57007|NCT02399254|138116|P1|STARTED|Overall Study||21
57008|NCT02399163|138123|P1|NOT COMPLETED|Overall Study||9
57009|NCT02399163|138123|P1|COMPLETED|Overall Study||53
57010|NCT02399163|138123|P1|STARTED|Overall Study||62
57011|NCT02399111|138151|P4|NOT COMPLETED|Overall Study||0
57012|NCT02399111|138152|P3|NOT COMPLETED|Overall Study||0
57013|NCT02399111|138153|P2|NOT COMPLETED|Overall Study||0
57014|NCT02399111|138154|P1|NOT COMPLETED|Overall Study||0
57015|NCT02399111|138151|P4|COMPLETED|Overall Study||0
57016|NCT02399111|138152|P3|COMPLETED|Overall Study||4
57017|NCT02399111|138153|P2|COMPLETED|Overall Study||1
57018|NCT02399111|138154|P1|COMPLETED|Overall Study||4
57019|NCT02399111|138151|P4|STARTED|Overall Study||0
57020|NCT02399111|138152|P3|STARTED|Overall Study||4
57021|NCT02399111|138153|P2|STARTED|Overall Study||1
57022|NCT02399111|138154|P1|STARTED|Overall Study||4
57023|NCT02398227|138170|P2|NOT COMPLETED|Overall Study||18
57024|NCT02398227|138171|P1|NOT COMPLETED|Overall Study||27
57025|NCT02398227|138170|P2|COMPLETED|Overall Study||71
57026|NCT02398227|138171|P1|COMPLETED|Overall Study||56
57027|NCT02398227|138170|P2|STARTED|Overall Study||89
57028|NCT02398227|138171|P1|STARTED|Overall Study||83
57029|NCT02398188|138181|P2|NOT COMPLETED|Overall Study||34
57030|NCT02398188|138182|P1|NOT COMPLETED|Overall Study||27
57031|NCT02398188|138181|P2|COMPLETED|Overall Study||361
57032|NCT02398188|138182|P1|COMPLETED|Overall Study||371
57033|NCT02398188|138181|P2|STARTED|Overall Study||395
57034|NCT02398188|138182|P1|STARTED|Overall Study||398
57035|NCT02397954|138192|P1|NOT COMPLETED|Overall Study||0
57036|NCT02397954|138192|P1|COMPLETED|Overall Study||4
57037|NCT02397954|138192|P1|STARTED|Overall Study||4
57038|NCT02397915|138200|P4|NOT COMPLETED|Period 2||0
57039|NCT02397915|138201|P3|NOT COMPLETED|Period 2||0
57040|NCT02397915|138202|P2|NOT COMPLETED|Period 2||0
57041|NCT02397915|138203|P1|NOT COMPLETED|Period 2||0
57042|NCT02397915|138200|P4|COMPLETED|Period 2||149
57043|NCT02397915|138201|P3|COMPLETED|Period 2||149
57044|NCT02397915|138202|P2|COMPLETED|Period 2||0
57045|NCT02397915|138203|P1|COMPLETED|Period 2||0
57046|NCT02397915|138200|P4|STARTED|Period 2||149
57047|NCT02397915|138201|P3|STARTED|Period 2||149
57048|NCT02397915|138202|P2|STARTED|Period 2||0
57049|NCT02397915|138203|P1|STARTED|Period 2||0
57050|NCT02397915|138200|P4|NOT COMPLETED|Period 1||0
57051|NCT02397915|138201|P3|NOT COMPLETED|Period 1||0
57052|NCT02397915|138202|P2|NOT COMPLETED|Period 1||1
57053|NCT02397915|138203|P1|NOT COMPLETED|Period 1||1
57054|NCT02397915|138200|P4|COMPLETED|Period 1||0
57055|NCT02397915|138201|P3|COMPLETED|Period 1||0
57056|NCT02397915|138202|P2|COMPLETED|Period 1||149
57057|NCT02397915|138203|P1|COMPLETED|Period 1||149
57058|NCT02397915|138200|P4|STARTED|Period 1||0
57059|NCT02397915|138201|P3|STARTED|Period 1||0
57060|NCT02397915|138202|P2|STARTED|Period 1||150
57061|NCT02397915|138203|P1|STARTED|Period 1||150
57062|NCT02397785|138255|P2|NOT COMPLETED|Overall Study||9
57063|NCT02397785|138256|P1|NOT COMPLETED|Overall Study||2
57064|NCT02397785|138255|P2|COMPLETED|Overall Study||25
57065|NCT02397785|138256|P1|COMPLETED|Overall Study||22
57066|NCT02397785|138255|P2|STARTED|Overall Study||34
57067|NCT02397785|138256|P1|STARTED|Overall Study||24
57068|NCT02397694|138302|P2|NOT COMPLETED|Open Label Extension Phase||30
57069|NCT02397694|138303|P1|NOT COMPLETED|Open Label Extension Phase||62
57070|NCT02397694|138302|P2|COMPLETED|Open Label Extension Phase||0
57071|NCT02397694|138303|P1|COMPLETED|Open Label Extension Phase||0
57072|NCT02397694|138302|P2|STARTED|Open Label Extension Phase||30
57073|NCT02397694|138303|P1|STARTED|Open Label Extension Phase||62
57074|NCT02397694|138302|P2|NOT COMPLETED|Double-Blinded Phase||3
57075|NCT02397694|138303|P1|NOT COMPLETED|Double-Blinded Phase||3
57076|NCT02397694|138302|P2|COMPLETED|Double-Blinded Phase||30
57077|NCT02397694|138303|P1|COMPLETED|Double-Blinded Phase||62
57078|NCT02397694|138302|P2|STARTED|Double-Blinded Phase||33
57079|NCT02397694|138303|P1|STARTED|Double-Blinded Phase||65
57080|NCT02397655|138341|P1|NOT COMPLETED|Overall Study||1301
57081|NCT02397655|138341|P1|COMPLETED|Overall Study||10711
57082|NCT02397655|138341|P1|STARTED|Overall Study||12012
57083|NCT02397564|138345|P1|NOT COMPLETED|Overall Study||4
57084|NCT02397564|138345|P1|COMPLETED|Overall Study||16
57085|NCT02397564|138345|P1|STARTED|Overall Study||20
57086|NCT02397473|138352|P2|NOT COMPLETED|Post Treatment Follow-up Phase||2
57087|NCT02397473|138353|P1|NOT COMPLETED|Post Treatment Follow-up Phase||3
57088|NCT02397473|138352|P2|COMPLETED|Post Treatment Follow-up Phase||45
57089|NCT02397473|138353|P1|COMPLETED|Post Treatment Follow-up Phase||47
57090|NCT02397473|138352|P2|STARTED|Post Treatment Follow-up Phase||47
57091|NCT02397473|138353|P1|STARTED|Post Treatment Follow-up Phase|Participants who discontinued treatment period had an option to enter post treatment phase.|50
57092|NCT02397473|138352|P2|NOT COMPLETED|Treatment Phase||7
57093|NCT02397473|138353|P1|NOT COMPLETED|Treatment Phase||12
57094|NCT02397473|138352|P2|COMPLETED|Treatment Phase||45
57095|NCT02397473|138353|P1|COMPLETED|Treatment Phase||45
57096|NCT02397473|138352|P2|Received at Least One Dose of Study Drug|Treatment Phase||49
57097|NCT02397473|138353|P1|Received at Least One Dose of Study Drug|Treatment Phase||57
57098|NCT02397473|138352|P2|STARTED|Treatment Phase||52
57099|NCT02397473|138353|P1|STARTED|Treatment Phase||57
57100|NCT02397265|138381|P3|NOT COMPLETED|Third Intervention of Three||0
57101|NCT02397265|138382|P2|NOT COMPLETED|Third Intervention of Three||0
57102|NCT02397265|138383|P1|NOT COMPLETED|Third Intervention of Three||0
57103|NCT02397265|138381|P3|COMPLETED|Third Intervention of Three||2
57104|NCT02397265|138382|P2|COMPLETED|Third Intervention of Three||2
57105|NCT02397265|138383|P1|COMPLETED|Third Intervention of Three||2
57106|NCT02397265|138381|P3|STARTED|Third Intervention of Three||2
57107|NCT02397265|138382|P2|STARTED|Third Intervention of Three||2
57108|NCT02397265|138383|P1|STARTED|Third Intervention of Three||2
57109|NCT02397265|138381|P3|NOT COMPLETED|Second Intervention of Three||0
57110|NCT02397265|138382|P2|NOT COMPLETED|Second Intervention of Three||0
57111|NCT02397265|138383|P1|NOT COMPLETED|Second Intervention of Three||0
57112|NCT02397265|138381|P3|COMPLETED|Second Intervention of Three||2
57113|NCT02397265|138382|P2|COMPLETED|Second Intervention of Three||2
57114|NCT02397265|138383|P1|COMPLETED|Second Intervention of Three||2
57115|NCT02397265|138381|P3|STARTED|Second Intervention of Three||2
57116|NCT02397265|138382|P2|STARTED|Second Intervention of Three||2
57117|NCT02397265|138383|P1|STARTED|Second Intervention of Three||2
57118|NCT02397265|138381|P3|NOT COMPLETED|First Intervention of Three||0
57119|NCT02397265|138382|P2|NOT COMPLETED|First Intervention of Three||0
57120|NCT02397265|138383|P1|NOT COMPLETED|First Intervention of Three||0
57121|NCT02397265|138381|P3|COMPLETED|First Intervention of Three||2
57122|NCT02397265|138382|P2|COMPLETED|First Intervention of Three||2
57123|NCT02397265|138383|P1|COMPLETED|First Intervention of Three||2
57124|NCT02397265|138381|P3|STARTED|First Intervention of Three||2
57125|NCT02397265|138382|P2|STARTED|First Intervention of Three||2
57126|NCT02397265|138383|P1|STARTED|First Intervention of Three||2
57127|NCT02397122|138393|P2|NOT COMPLETED|Overall Study||0
57128|NCT02397122|138394|P1|NOT COMPLETED|Overall Study||0
57129|NCT02397122|138393|P2|COMPLETED|Overall Study||20
57130|NCT02397122|138394|P1|COMPLETED|Overall Study||20
57131|NCT02397122|138393|P2|STARTED|Overall Study||20
57132|NCT02397122|138394|P1|STARTED|Overall Study||20
57133|NCT02397096|138412|P2|NOT COMPLETED|Study Extensions||202
57134|NCT02397096|138413|P1|NOT COMPLETED|Study Extensions||399
57135|NCT02397096|138412|P2|COMPLETED|Study Extensions|The extension study is ongoing.|0
57136|NCT02397096|138413|P1|COMPLETED|Study Extensions|The extension study is ongoing.|0
57137|NCT02397096|138412|P2|STARTED|Study Extensions|The extension study is optional; not all eligible participants enrolled.|202
57138|NCT02397096|138413|P1|STARTED|Study Extensions|The extension study is optional; not all eligible participants enrolled.|399
57139|NCT02397096|138412|P2|NOT COMPLETED|Week 24 to Week 48||7
57140|NCT02397096|138413|P1|NOT COMPLETED|Week 24 to Week 48||20
57141|NCT02397096|138412|P2|COMPLETED|Week 24 to Week 48||202
57142|NCT02397096|138413|P1|COMPLETED|Week 24 to Week 48||407
57143|NCT02397096|138412|P2|STARTED|Week 24 to Week 48||209
57144|NCT02397096|138413|P1|STARTED|Week 24 to Week 48||427
57145|NCT02397096|138412|P2|NOT COMPLETED|Day 1 to Week 24||14
57146|NCT02397096|138413|P1|NOT COMPLETED|Day 1 to Week 24||20
57147|NCT02397096|138412|P2|COMPLETED|Day 1 to Week 24||209
57148|NCT02397096|138413|P1|COMPLETED|Day 1 to Week 24||427
57149|NCT02397096|138412|P2|STARTED|Day 1 to Week 24||223
57150|NCT02397096|138413|P1|STARTED|Day 1 to Week 24||447
57151|NCT02396953|138446|P3|NOT COMPLETED|Overall Study||3
57152|NCT02396953|138447|P2|NOT COMPLETED|Overall Study||3
57153|NCT02396953|138448|P1|NOT COMPLETED|Overall Study||4
57154|NCT02396953|138446|P3|COMPLETED|Overall Study||7
57155|NCT02396953|138447|P2|COMPLETED|Overall Study||6
57156|NCT02396953|138448|P1|COMPLETED|Overall Study||5
57157|NCT02396953|138446|P3|STARTED|Overall Study||10
57158|NCT02396953|138447|P2|STARTED|Overall Study||9
57159|NCT02396953|138448|P1|STARTED|Overall Study||9
57160|NCT02396745|138498|P1|NOT COMPLETED|Overall Study||0
57161|NCT02396745|138498|P1|COMPLETED|Overall Study||1
57162|NCT02396745|138498|P1|STARTED|Overall Study||1
57163|NCT02396732|138510|P2|NOT COMPLETED|Overall Study||0
57164|NCT02396732|138511|P1|NOT COMPLETED|Overall Study||0
57165|NCT02396732|138510|P2|COMPLETED|Overall Study||17
57166|NCT02396732|138511|P1|COMPLETED|Overall Study||14
57167|NCT02396732|138510|P2|STARTED|Overall Study||17
57168|NCT02396732|138511|P1|STARTED|Overall Study||14
57169|NCT02396537|138523|P2|NOT COMPLETED|Overall Study||1
57170|NCT02396537|138524|P1|NOT COMPLETED|Overall Study||0
57171|NCT02396537|138523|P2|COMPLETED|Overall Study||36
57172|NCT02396537|138524|P1|COMPLETED|Overall Study||40
57173|NCT02396537|138523|P2|STARTED|Overall Study||37
57174|NCT02396537|138524|P1|STARTED|Overall Study||40
57175|NCT02396511|138530|P1|NOT COMPLETED|Overall Study||0
57176|NCT02396511|138530|P1|COMPLETED|Overall Study||2
57177|NCT02396511|138530|P1|STARTED|Overall Study||2
57178|NCT02396420|138536|P1|NOT COMPLETED|Overall Study||1
57179|NCT02396420|138536|P1|COMPLETED|Overall Study||1
57180|NCT02396420|138536|P1|6 Months Post PAE|Overall Study||2
57181|NCT02396420|138536|P1|3 Months Post PAE|Overall Study||2
57182|NCT02396420|138536|P1|1 Month Post PAE|Overall Study||2
57183|NCT02396420|138536|P1|STARTED|Overall Study||2
57184|NCT02396381|138560|P2|NOT COMPLETED|Overall Study||74
57185|NCT02396381|138561|P1|NOT COMPLETED|Overall Study||107
57186|NCT02396381|138560|P2|COMPLETED|Overall Study||422
57187|NCT02396381|138561|P1|COMPLETED|Overall Study||381
57188|NCT02396381|138560|P2|Full Analysis Set - As Exposed (FAS-EX)|Overall Study||443
57189|NCT02396381|138561|P1|Full Analysis Set - As Exposed (FAS-EX)|Overall Study||414
57190|NCT02396381|138560|P2|STARTED|Overall Study||496
57191|NCT02396381|138561|P1|STARTED|Overall Study||488
57192|NCT02396316|138600|P2|NOT COMPLETED|Overall Study||5
57193|NCT02396316|138601|P1|NOT COMPLETED|Overall Study||7
57194|NCT02396316|138600|P2|COMPLETED|Overall Study||22
57195|NCT02396316|138601|P1|COMPLETED|Overall Study||20
57196|NCT02396316|138600|P2|Received Active Injection at Week 9|Overall Study||1
57197|NCT02396316|138601|P1|Received Active Injection at Week 9|Overall Study||2
57198|NCT02396316|138600|P2|Received Active Injection at Week 5|Overall Study||4
57199|NCT02396316|138601|P1|Received Active Injection at Week 5|Overall Study||4
57200|NCT02396316|138600|P2|Received AFL Injection at Week 1|Overall Study||22
57201|NCT02396316|138601|P1|Received AFL Injection at Week 1|Overall Study||0
57202|NCT02396316|138600|P2|Received Sham Injection at Week 1|Overall Study||0
57203|NCT02396316|138601|P1|Received Sham Injection at Week 1|Overall Study||10
57204|NCT02396316|138600|P2|Treated|Overall Study||27
57205|NCT02396316|138601|P1|Treated|Overall Study||27
57206|NCT02396316|138600|P2|STARTED|Overall Study||27
57207|NCT02396316|138601|P1|STARTED|Overall Study||27
57208|NCT02396251|138613|P2|NOT COMPLETED|Overall Study||5
57209|NCT02396251|138614|P1|NOT COMPLETED|Overall Study||13
57210|NCT02396251|138613|P2|COMPLETED|Overall Study||7
57211|NCT02396251|138614|P1|COMPLETED|Overall Study||23
57212|NCT02396251|138613|P2|STARTED|Overall Study||12
57213|NCT02396251|138614|P1|STARTED|Overall Study||36
57214|NCT02396212|138620|P1|NOT COMPLETED|Overall Study||3
57215|NCT02396212|138620|P1|COMPLETED|Overall Study||16
57216|NCT02396212|138620|P1|STARTED|Overall Study||19
57217|NCT02396160|138641|P2|NOT COMPLETED|Overall Study||2
57218|NCT02396160|138642|P1|NOT COMPLETED|Overall Study||6
57219|NCT02396160|138641|P2|COMPLETED|Overall Study||73
57220|NCT02396160|138642|P1|COMPLETED|Overall Study||69
57221|NCT02396160|138641|P2|STARTED|Overall Study||75
57222|NCT02396160|138642|P1|STARTED|Overall Study||75
57223|NCT02396147|138658|P2|NOT COMPLETED|Period 3||0
57224|NCT02396147|138659|P1|NOT COMPLETED|Period 3||0
57225|NCT02396147|138658|P2|COMPLETED|Period 3||27
57226|NCT02396147|138659|P1|COMPLETED|Period 3||27
57227|NCT02396147|138658|P2|STARTED|Period 3||27
57228|NCT02396147|138659|P1|STARTED|Period 3||27
57229|NCT02396147|138658|P2|NOT COMPLETED|Period 2||0
57230|NCT02396147|138659|P1|NOT COMPLETED|Period 2||0
57231|NCT02396147|138658|P2|COMPLETED|Period 2||27
57232|NCT02396147|138659|P1|COMPLETED|Period 2||27
57233|NCT02396147|138658|P2|STARTED|Period 2||27
57234|NCT02396147|138659|P1|STARTED|Period 2||27
57235|NCT02396147|138658|P2|NOT COMPLETED|Period 1||0
57236|NCT02396147|138659|P1|NOT COMPLETED|Period 1||0
57237|NCT02396147|138658|P2|COMPLETED|Period 1||27
57238|NCT02396147|138659|P1|COMPLETED|Period 1||27
57239|NCT02396147|138658|P2|STARTED|Period 1||27
57240|NCT02396147|138659|P1|STARTED|Period 1||27
57241|NCT02395822|138727|P1|NOT COMPLETED|Overall Study||2
57242|NCT02395822|138727|P1|COMPLETED|Overall Study||15
57243|NCT02395822|138727|P1|STARTED|Overall Study||17
57244|NCT02395692|138735|P2|NOT COMPLETED|Overall Study||0
57245|NCT02395692|138736|P1|NOT COMPLETED|Overall Study||0
57246|NCT02395692|138735|P2|COMPLETED|Overall Study||0
57247|NCT02395692|138736|P1|COMPLETED|Overall Study||19
57248|NCT02395692|138735|P2|STARTED|Overall Study||0
57249|NCT02395692|138736|P1|STARTED|Overall Study||19
57250|NCT02395653|138746|P1|NOT COMPLETED|Overall Study||12
57251|NCT02395653|138746|P1|COMPLETED|Overall Study||59
57252|NCT02395653|138746|P1|Received at Least 1 Dose of Study Drug|Overall Study||61
57253|NCT02395653|138746|P1|STARTED|Overall Study||71
57254|NCT02395536|138755|P2|NOT COMPLETED|Overall Study||30
57255|NCT02395536|138756|P1|NOT COMPLETED|Overall Study||20
57256|NCT02395536|138755|P2|COMPLETED|Overall Study||227
57257|NCT02395536|138756|P1|COMPLETED|Overall Study||244
57258|NCT02395536|138755|P2|REVEAL LINQ Insertion|Overall Study||231
57259|NCT02395536|138756|P1|REVEAL LINQ Insertion|Overall Study||251
57260|NCT02395536|138755|P2|STARTED|Overall Study||257
57261|NCT02395536|138756|P1|STARTED|Overall Study||264
57262|NCT02395471|138764|P2|NOT COMPLETED|Overall Study||3
57263|NCT02395471|138765|P1|NOT COMPLETED|Overall Study||7
57264|NCT02395471|138764|P2|COMPLETED|Overall Study||59
57265|NCT02395471|138765|P1|COMPLETED|Overall Study||122
57266|NCT02395471|138764|P2|STARTED|Overall Study||62
57267|NCT02395471|138765|P1|STARTED|Overall Study||129
57268|NCT02395302|138780|P1|NOT COMPLETED|Overall Study||14
57269|NCT02395302|138780|P1|COMPLETED|Overall Study||14
57270|NCT02395302|138780|P1|STARTED|Overall Study||28
57271|NCT02395185|138784|P1|NOT COMPLETED|Overall Study||0
57272|NCT02395185|138784|P1|COMPLETED|Overall Study||33
57273|NCT02395185|138784|P1|Sequence 18 (m,w,m,s,w,s)|Overall Study||1
57274|NCT02395185|138784|P1|Sequence 17 (w,m,s,w,s,m)|Overall Study||1
57275|NCT02395185|138784|P1|Sequence 16 (m,s,w,s,m,w)|Overall Study||1
57276|NCT02395185|138784|P1|Sequence 15 (s,w,s,m,w,m)|Overall Study||2
57277|NCT02395185|138784|P1|Sequence 14 (w,s,m,w,m,s)|Overall Study||2
57278|NCT02395185|138784|P1|Sequence 13 (s,m,w,m,s,w)|Overall Study||2
57279|NCT02395185|138784|P1|Sequence 12 (s,w,w,m,m,s)|Overall Study||2
57280|NCT02395185|138784|P1|Sequence 11 (w,w,m,m,s,s)|Overall Study||2
57281|NCT02395185|138784|P1|Sequence 10 (w,m,m,s,s,w)|Overall Study||2
57282|NCT02395185|138784|P1|Sequence 9 (m,m,s,s,w,w)|Overall Study||2
57283|NCT02395185|138784|P1|Sequence 8 (m,s,s,w,w,m)|Overall Study||2
57284|NCT02395185|138784|P1|Sequence 7 (s,s,w,w,m,m)|Overall Study||2
57285|NCT02395185|138784|P1|Sequence 6 (s,m,m,w,w,s)|Overall Study||2
57286|NCT02395185|138784|P1|Sequence 5 (m,m,w,w,s,s)|Overall Study||2
57287|NCT02395185|138784|P1|Sequence 4 (m,w,w,s,s,m)|Overall Study||2
57288|NCT02395185|138784|P1|Sequence 3 (w,w,s,s,m,m)|Overall Study||2
57289|NCT02395185|138784|P1|Sequence 2 (w,s,s,m,m,w)|Overall Study||2
57290|NCT02395185|138784|P1|Sequence 1 (s,s,m,m,w,w)|Overall Study|one of the participants in this milestone did not have a guardian enrolled due to age.|2
57291|NCT02395185|138784|P1|STARTED|Overall Study|32 guardians participated with these infants. one infant did not have a guardian participate.|33
57292|NCT02395172|138800|P2|NOT COMPLETED|Overall Study||36
57293|NCT02395172|138801|P1|NOT COMPLETED|Overall Study||52
57294|NCT02395172|138800|P2|COMPLETED|Overall Study||360
57295|NCT02395172|138801|P1|COMPLETED|Overall Study||344
57296|NCT02395172|138800|P2|Treated|Overall Study||365
57297|NCT02395172|138801|P1|Treated|Overall Study||393
57298|NCT02395172|138800|P2|STARTED|Overall Study||396
57299|NCT02395172|138801|P1|STARTED|Overall Study||396
57300|NCT02395133|138840|P4|NOT COMPLETED|Overall Study||14
57301|NCT02395133|138841|P3|NOT COMPLETED|Overall Study||10
57302|NCT02395133|138842|P2|NOT COMPLETED|Overall Study||9
57303|NCT02395133|138843|P1|NOT COMPLETED|Overall Study||14
57304|NCT02395133|138840|P4|COMPLETED|Overall Study||155
57305|NCT02395133|138841|P3|COMPLETED|Overall Study||76
57306|NCT02395133|138842|P2|COMPLETED|Overall Study||75
57307|NCT02395133|138843|P1|COMPLETED|Overall Study||69
57308|NCT02395133|138840|P4|STARTED|Overall Study||169
57309|NCT02395133|138841|P3|STARTED|Overall Study||86
57310|NCT02395133|138842|P2|STARTED|Overall Study||84
57311|NCT02395133|138843|P1|STARTED|Overall Study||83
57312|NCT02395055|138931|P2|NOT COMPLETED|Overall Study||3
57313|NCT02395055|138932|P1|NOT COMPLETED|Overall Study||7
57314|NCT02395055|138931|P2|COMPLETED|Overall Study||44
57315|NCT02395055|138932|P1|COMPLETED|Overall Study||40
57316|NCT02395055|138931|P2|STARTED|Overall Study||47
57317|NCT02395055|138932|P1|STARTED|Overall Study||47
57318|NCT02395042|138945|P3|NOT COMPLETED|Treatment 2 Period||0
57319|NCT02395042|138946|P2|NOT COMPLETED|Treatment 2 Period||1
57320|NCT02395042|138947|P1|NOT COMPLETED|Treatment 2 Period||1
57321|NCT02395042|138945|P3|COMPLETED|Treatment 2 Period||13
57322|NCT02395042|138946|P2|COMPLETED|Treatment 2 Period||23
57323|NCT02395042|138947|P1|COMPLETED|Treatment 2 Period||9
57324|NCT02395042|138945|P3|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|13
57325|NCT02395042|138946|P2|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|24
57326|NCT02395042|138947|P1|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|10
57327|NCT02395042|138945|P3|NOT COMPLETED|Treatment 1 Period||2
57328|NCT02395042|138946|P2|NOT COMPLETED|Treatment 1 Period||6
57329|NCT02395042|138947|P1|NOT COMPLETED|Treatment 1 Period||3
57330|NCT02395042|138945|P3|COMPLETED|Treatment 1 Period||14
57331|NCT02395042|138946|P2|COMPLETED|Treatment 1 Period||25
57332|NCT02395042|138947|P1|COMPLETED|Treatment 1 Period||9
57333|NCT02395042|138945|P3|STARTED|Treatment 1 Period||16
57334|NCT02395042|138946|P2|STARTED|Treatment 1 Period||31
57335|NCT02395042|138947|P1|STARTED|Treatment 1 Period||12
57336|NCT02394951|138966|P2|NOT COMPLETED|Period II||4
57337|NCT02394951|138967|P1|NOT COMPLETED|Period II||0
57338|NCT02394951|138966|P2|COMPLETED|Period II||9
57339|NCT02394951|138967|P1|COMPLETED|Period II||11
57340|NCT02394951|138966|P2|STARTED|Period II||13
57341|NCT02394951|138967|P1|STARTED|Period II||11
57342|NCT02394951|138966|P2|NOT COMPLETED|Period I||1
57343|NCT02394951|138967|P1|NOT COMPLETED|Period I||1
57344|NCT02394951|138966|P2|COMPLETED|Period I||13
57345|NCT02394951|138967|P1|COMPLETED|Period I||11
57346|NCT02394951|138966|P2|STARTED|Period I||14
57347|NCT02394951|138967|P1|STARTED|Period I||12
57348|NCT02394925|138985|P1|NOT COMPLETED|Overall Study||29
57349|NCT02394925|138985|P1|COMPLETED|Overall Study||79
57350|NCT02394925|138985|P1|STARTED|Overall Study||108
57351|NCT02394912|138989|P1|NOT COMPLETED|Overall Study||0
57352|NCT02394912|138989|P1|COMPLETED|Overall Study||21
57353|NCT02394912|138989|P1|STARTED|Overall Study||21
57354|NCT02394808|138995|P2|NOT COMPLETED|Period 2||0
57355|NCT02394808|138996|P1|NOT COMPLETED|Period 2||1
57356|NCT02394808|138995|P2|COMPLETED|Period 2||28
57357|NCT02394808|138996|P1|COMPLETED|Period 2||24
57358|NCT02394808|138995|P2|STARTED|Period 2||28
57359|NCT02394808|138996|P1|STARTED|Period 2||25
57360|NCT02394808|138995|P2|NOT COMPLETED|Period 1||1
57361|NCT02394808|138996|P1|NOT COMPLETED|Period 1||0
57362|NCT02394808|138995|P2|COMPLETED|Period 1||28
57363|NCT02394808|138996|P1|COMPLETED|Period 1||25
57364|NCT02394808|138995|P2|STARTED|Period 1||29
57365|NCT02394808|138996|P1|STARTED|Period 1||25
57366|NCT02394756|139004|P6|NOT COMPLETED|Period 3||0
57367|NCT02394756|139005|P5|NOT COMPLETED|Period 3||0
57368|NCT02394756|139006|P4|NOT COMPLETED|Period 3||0
57369|NCT02394756|139007|P3|NOT COMPLETED|Period 3||0
57370|NCT02394756|139008|P2|NOT COMPLETED|Period 3||0
57371|NCT02394756|139009|P1|NOT COMPLETED|Period 3||0
57372|NCT02394756|139004|P6|COMPLETED|Period 3||6
57373|NCT02394756|139005|P5|COMPLETED|Period 3||6
57374|NCT02394756|139006|P4|COMPLETED|Period 3||6
57375|NCT02394756|139007|P3|COMPLETED|Period 3||6
57376|NCT02394756|139008|P2|COMPLETED|Period 3||6
57377|NCT02394756|139009|P1|COMPLETED|Period 3||7
57378|NCT02394756|139004|P6|STARTED|Period 3||6
57379|NCT02394756|139005|P5|STARTED|Period 3||6
57380|NCT02394756|139006|P4|STARTED|Period 3||6
57381|NCT02394756|139007|P3|STARTED|Period 3||6
57382|NCT02394756|139008|P2|STARTED|Period 3||6
57383|NCT02394756|139009|P1|STARTED|Period 3||7
57384|NCT02394756|139004|P6|NOT COMPLETED|Period 2||0
57385|NCT02394756|139005|P5|NOT COMPLETED|Period 2||1
57386|NCT02394756|139006|P4|NOT COMPLETED|Period 2||0
57387|NCT02394756|139007|P3|NOT COMPLETED|Period 2||0
57388|NCT02394756|139008|P2|NOT COMPLETED|Period 2||0
57389|NCT02394756|139009|P1|NOT COMPLETED|Period 2||0
57390|NCT02394756|139004|P6|COMPLETED|Period 2||6
57391|NCT02394756|139005|P5|COMPLETED|Period 2||6
57392|NCT02394756|139006|P4|COMPLETED|Period 2||6
57393|NCT02394756|139007|P3|COMPLETED|Period 2||6
57394|NCT02394756|139008|P2|COMPLETED|Period 2||6
57395|NCT02394756|139009|P1|COMPLETED|Period 2||7
57396|NCT02394756|139004|P6|STARTED|Period 2||6
57397|NCT02394756|139005|P5|STARTED|Period 2||7
57398|NCT02394756|139006|P4|STARTED|Period 2||6
57399|NCT02394756|139007|P3|STARTED|Period 2||6
57400|NCT02394756|139008|P2|STARTED|Period 2||6
57401|NCT02394756|139009|P1|STARTED|Period 2||7
57402|NCT02394756|139004|P6|NOT COMPLETED|Period 1||1
57403|NCT02394756|139005|P5|NOT COMPLETED|Period 1||0
57404|NCT02394756|139006|P4|NOT COMPLETED|Period 1||1
57405|NCT02394756|139007|P3|NOT COMPLETED|Period 1||1
57406|NCT02394756|139008|P2|NOT COMPLETED|Period 1||1
57407|NCT02394756|139009|P1|NOT COMPLETED|Period 1||0
57408|NCT02394756|139004|P6|COMPLETED|Period 1||6
57409|NCT02394756|139005|P5|COMPLETED|Period 1||7
57410|NCT02394756|139006|P4|COMPLETED|Period 1||6
57411|NCT02394756|139007|P3|COMPLETED|Period 1||6
57412|NCT02394756|139008|P2|COMPLETED|Period 1||6
57413|NCT02394756|139009|P1|COMPLETED|Period 1||7
57414|NCT02394756|139004|P6|STARTED|Period 1||7
57415|NCT02394756|139005|P5|STARTED|Period 1||7
57416|NCT02394756|139006|P4|STARTED|Period 1||7
57417|NCT02394756|139007|P3|STARTED|Period 1||7
57418|NCT02394756|139008|P2|STARTED|Period 1||7
57419|NCT02394756|139009|P1|STARTED|Period 1||7
57420|NCT02394730|139022|P2|NOT COMPLETED|Overall Study||1
57421|NCT02394730|139023|P1|NOT COMPLETED|Overall Study||1
57422|NCT02394730|139022|P2|COMPLETED|Overall Study||30
57423|NCT02394730|139023|P1|COMPLETED|Overall Study||33
57424|NCT02394730|139022|P2|STARTED|Overall Study||31
57425|NCT02394730|139023|P1|STARTED|Overall Study||34
57426|NCT02394665|139060|P3|NOT COMPLETED|Overall Study||0
57427|NCT02394665|139061|P2|NOT COMPLETED|Overall Study||0
57428|NCT02394665|139062|P1|NOT COMPLETED|Overall Study||1
57429|NCT02394665|139060|P3|COMPLETED|Overall Study||0
57430|NCT02394665|139061|P2|COMPLETED|Overall Study||0
57431|NCT02394665|139062|P1|COMPLETED|Overall Study||0
57432|NCT02394665|139060|P3|STARTED|Overall Study||0
57433|NCT02394665|139061|P2|STARTED|Overall Study||0
57434|NCT02394665|139062|P1|STARTED|Overall Study||1
57435|NCT02394600|139084|P2|NOT COMPLETED|Overall Study||2
57436|NCT02394600|139085|P1|NOT COMPLETED|Overall Study||4
57437|NCT02394600|139084|P2|COMPLETED|Overall Study||44
57438|NCT02394600|139085|P1|COMPLETED|Overall Study||43
57439|NCT02394600|139084|P2|STARTED|Overall Study||46
57440|NCT02394600|139085|P1|STARTED|Overall Study||47
57441|NCT02394561|139095|P2|NOT COMPLETED|Extension Phase||12
57442|NCT02394561|139096|P1|NOT COMPLETED|Extension Phase||11
57443|NCT02394561|139095|P2|COMPLETED|Extension Phase||207
57444|NCT02394561|139096|P1|COMPLETED|Extension Phase||151
57445|NCT02394561|139095|P2|STARTED|Extension Phase||219
57446|NCT02394561|139096|P1|STARTED|Extension Phase||162
57447|NCT02394561|139095|P2|NOT COMPLETED|CORE Phase||19
57448|NCT02394561|139096|P1|NOT COMPLETED|CORE Phase||13
57449|NCT02394561|139095|P2|COMPLETED|CORE Phase||227
57450|NCT02394561|139096|P1|COMPLETED|CORE Phase||172
57451|NCT02394561|139095|P2|ITT Set|CORE Phase||246
57452|NCT02394561|139096|P1|ITT Set|CORE Phase||184
57453|NCT02394561|139095|P2|Safety Set|CORE Phase||246
57454|NCT02394561|139096|P1|Safety Set|CORE Phase||185
57455|NCT02394561|139095|P2|Full Analysis Set|CORE Phase||246
57456|NCT02394561|139096|P1|Full Analysis Set|CORE Phase||185
57457|NCT02394561|139095|P2|STARTED|CORE Phase||246
57458|NCT02394561|139096|P1|STARTED|CORE Phase||185
57459|NCT02394457|139120|P2|NOT COMPLETED|Overall Study||0
57460|NCT02394457|139121|P1|NOT COMPLETED|Overall Study||0
57461|NCT02394457|139120|P2|COMPLETED|Overall Study||13
57462|NCT02394457|139121|P1|COMPLETED|Overall Study||15
57463|NCT02394457|139120|P2|STARTED|Overall Study||13
57464|NCT02394457|139121|P1|STARTED|Overall Study||15
57465|NCT02394340|139137|P1|NOT COMPLETED|Overall Study||2
57466|NCT02394340|139137|P1|COMPLETED|Overall Study||18
57467|NCT02394340|139137|P1|Received at Least 1 Dose of Study Drug|Overall Study||20
57468|NCT02394340|139137|P1|STARTED|Overall Study||20
57469|NCT02393950|139144|P2|NOT COMPLETED|Overall Study||1
57470|NCT02393950|139145|P1|NOT COMPLETED|Overall Study||1
57471|NCT02393950|139144|P2|COMPLETED|Overall Study||8
57472|NCT02393950|139145|P1|COMPLETED|Overall Study||8
57473|NCT02393950|139144|P2|Period 4|Overall Study|6 subjects ODM-106 Capsule A 100 mg (10 x 10mg) and 2 subjects on placebo|8
57474|NCT02393950|139145|P1|Period 4|Overall Study|6 subjects ODM-106 Capsule B 50 mg and 2 subjects on placebo|8
57475|NCT02393950|139144|P2|Period 3|Overall Study|6 subjects ODM-106 Capsule B 200 mg (20 x 10mg) and 2 subjects on placebo|8
57476|NCT02393950|139145|P1|Period 3|Overall Study|6 subjects ODM-106 Capsule B 25 mg and 2 subjects on placebo|8
57477|NCT02393950|139144|P2|Period 2|Overall Study|6 subjects ODM-106 Capsule B 100 mg (10 x 10mg) and 2 subjects on placebo|8
57478|NCT02393950|139145|P1|Period 2|Overall Study|6 subjects ODM-106 Capsule B 10 mg and 2 subjects on placebo|8
57479|NCT02393950|139144|P2|Period 1|Overall Study|6 subjects ODM-106 Capsule B 100 mg (1 x 100mg) and 2 subjects on placebo|8
57480|NCT02393950|139145|P1|Period 1|Overall Study|6 subjects ODM-106 Capsule B 2 mg and 2 subjects on placebo|8
57481|NCT02393950|139144|P2|STARTED|Overall Study||9
57482|NCT02393950|139145|P1|STARTED|Overall Study||9
57483|NCT02393677|139212|P2|NOT COMPLETED|Overall Study||0
57484|NCT02393677|139213|P1|NOT COMPLETED|Overall Study||0
57485|NCT02393677|139212|P2|COMPLETED|Overall Study||40
57486|NCT02393677|139213|P1|COMPLETED|Overall Study||40
57487|NCT02393677|139212|P2|STARTED|Overall Study||40
57488|NCT02393677|139213|P1|STARTED|Overall Study||40
57489|NCT02393547|139219|P1|NOT COMPLETED|Overall Study||6
57490|NCT02393547|139219|P1|COMPLETED|Overall Study||14
57491|NCT02393547|139219|P1|STARTED|Overall Study||20
57492|NCT02393417|139230|P4|NOT COMPLETED|Overall Study||12
57493|NCT02393417|139231|P3|NOT COMPLETED|Overall Study||10
57494|NCT02393417|139232|P2|NOT COMPLETED|Overall Study||13
57495|NCT02393417|139233|P1|NOT COMPLETED|Overall Study||15
57496|NCT02393417|139230|P4|COMPLETED|Overall Study||29
57497|NCT02393417|139231|P3|COMPLETED|Overall Study||30
57498|NCT02393417|139232|P2|COMPLETED|Overall Study||32
57499|NCT02393417|139233|P1|COMPLETED|Overall Study||28
57500|NCT02393417|139230|P4|Completed Treatment|Overall Study||30
57501|NCT02393417|139231|P3|Completed Treatment|Overall Study||32
57502|NCT02393417|139232|P2|Completed Treatment|Overall Study||34
57503|NCT02393417|139233|P1|Completed Treatment|Overall Study||30
57504|NCT02393417|139230|P4|STARTED|Overall Study||41
57505|NCT02393417|139231|P3|STARTED|Overall Study||40
57506|NCT02393417|139232|P2|STARTED|Overall Study||45
57507|NCT02393417|139233|P1|STARTED|Overall Study||43
57508|NCT02393378|139291|P2|NOT COMPLETED|Overall Study||0
57509|NCT02393378|139292|P1|NOT COMPLETED|Overall Study||0
57510|NCT02393378|139291|P2|COMPLETED|Overall Study||4
57511|NCT02393378|139292|P1|COMPLETED|Overall Study||3
57512|NCT02393378|139291|P2|STARTED|Overall Study||4
57513|NCT02393378|139292|P1|STARTED|Overall Study||3
57514|NCT02393209|139310|P4|NOT COMPLETED|Overall Study||0
57515|NCT02393209|139311|P3|NOT COMPLETED|Overall Study||0
57516|NCT02393209|139312|P2|NOT COMPLETED|Overall Study||8
57517|NCT02393209|139313|P1|NOT COMPLETED|Overall Study||6
57518|NCT02393209|139310|P4|COMPLETED|Overall Study||0
57519|NCT02393209|139311|P3|COMPLETED|Overall Study||0
57520|NCT02393209|139312|P2|COMPLETED|Overall Study||0
57521|NCT02393209|139313|P1|COMPLETED|Overall Study||0
57522|NCT02393209|139310|P4|STARTED|Overall Study||0
57523|NCT02393209|139311|P3|STARTED|Overall Study||0
57524|NCT02393209|139312|P2|STARTED|Overall Study||8
57525|NCT02393209|139313|P1|STARTED|Overall Study||6
57526|NCT02392806|139371|P2|NOT COMPLETED|Overall Study||0
57527|NCT02392806|139372|P1|NOT COMPLETED|Overall Study||0
57528|NCT02392806|139371|P2|COMPLETED|Overall Study||21
57529|NCT02392806|139372|P1|COMPLETED|Overall Study||22
57530|NCT02392806|139371|P2|STARTED|Overall Study||21
57531|NCT02392806|139372|P1|STARTED|Overall Study||22
57532|NCT02392767|139382|P2|NOT COMPLETED|Overall Study||0
57533|NCT02392767|139383|P1|NOT COMPLETED|Overall Study||0
57534|NCT02392767|139382|P2|COMPLETED|Overall Study||13
57535|NCT02392767|139383|P1|COMPLETED|Overall Study||12
57536|NCT02392767|139382|P2|STARTED|Overall Study||13
57537|NCT02392767|139383|P1|STARTED|Overall Study||12
57538|NCT02392624|139402|P3|NOT COMPLETED|Overall Study||13
57539|NCT02392624|139403|P2|NOT COMPLETED|Overall Study||15
57540|NCT02392624|139404|P1|NOT COMPLETED|Overall Study||71
57541|NCT02392624|139402|P3|COMPLETED|Overall Study||40
57542|NCT02392624|139403|P2|COMPLETED|Overall Study||66
57543|NCT02392624|139404|P1|COMPLETED|Overall Study||0
57544|NCT02392624|139402|P3|STARTED|Overall Study||53
57545|NCT02392624|139403|P2|STARTED|Overall Study||81
57546|NCT02392624|139404|P1|STARTED|Overall Study||71
57547|NCT02392507|139417|P1|NOT COMPLETED|Maintenance Regimen||12
57548|NCT02392507|139417|P1|COMPLETED|Maintenance Regimen||22
57549|NCT02392507|139417|P1|STARTED|Maintenance Regimen|After induction regimen participants with disease response are eligible for maintenance regimen.|34
57550|NCT02392507|139417|P1|NOT COMPLETED|Induction Regimen||17
57551|NCT02392507|139417|P1|COMPLETED|Induction Regimen||37
57552|NCT02392507|139417|P1|Received at Least 1 Dose of Study Drug|Induction Regimen||54
57553|NCT02392507|139417|P1|STARTED|Induction Regimen||54
57554|NCT02392494|139435|P4|NOT COMPLETED|Overall Study||0
57555|NCT02392494|139436|P3|NOT COMPLETED|Overall Study||0
57556|NCT02392494|139437|P2|NOT COMPLETED|Overall Study||0
57557|NCT02392494|139438|P1|NOT COMPLETED|Overall Study||0
57558|NCT02392494|139435|P4|COMPLETED|Overall Study||0
57559|NCT02392494|139436|P3|COMPLETED|Overall Study||3
57560|NCT02392494|139437|P2|COMPLETED|Overall Study||3
57561|NCT02392494|139438|P1|COMPLETED|Overall Study||3
57562|NCT02392494|139435|P4|STARTED|Overall Study||0
57563|NCT02392494|139436|P3|STARTED|Overall Study||3
57564|NCT02392494|139437|P2|STARTED|Overall Study||3
57565|NCT02392494|139438|P1|STARTED|Overall Study||3
57566|NCT02392481|139456|P4|NOT COMPLETED|Overall Study||2
57567|NCT02392481|139457|P3|NOT COMPLETED|Overall Study||2
57568|NCT02392481|139458|P2|NOT COMPLETED|Overall Study||0
57569|NCT02392481|139459|P1|NOT COMPLETED|Overall Study||0
57570|NCT02392481|139456|P4|COMPLETED|Overall Study||25
57571|NCT02392481|139457|P3|COMPLETED|Overall Study||18
57572|NCT02392481|139458|P2|COMPLETED|Overall Study||12
57573|NCT02392481|139459|P1|COMPLETED|Overall Study||10
57574|NCT02392481|139456|P4|STARTED|Overall Study||27
57575|NCT02392481|139457|P3|STARTED|Overall Study||20
57576|NCT02392481|139458|P2|STARTED|Overall Study||12
57577|NCT02392481|139459|P1|STARTED|Overall Study||10
57578|NCT02392403|139481|P1|NOT COMPLETED|Overall Study||3
57579|NCT02392403|139481|P1|COMPLETED|Overall Study||42
57580|NCT02392403|139481|P1|STARTED|Overall Study||45
57581|NCT02392377|139495|P2|NOT COMPLETED|Overall Study||1
57582|NCT02392377|139496|P1|NOT COMPLETED|Overall Study||0
57583|NCT02392377|139495|P2|COMPLETED|Overall Study||0
57584|NCT02392377|139496|P1|COMPLETED|Overall Study||0
57585|NCT02392377|139495|P2|STARTED|Overall Study||1
57586|NCT02392377|139496|P1|STARTED|Overall Study||0
57587|NCT02392351|139522|P2|NOT COMPLETED|Overall Study||17
57588|NCT02392351|139523|P1|NOT COMPLETED|Overall Study||34
57589|NCT02392351|139522|P2|COMPLETED|Overall Study|Primary endpoint: only observational results available.|0
57590|NCT02392351|139523|P1|COMPLETED|Overall Study|Primary endpoint: only observational results available.|0
57591|NCT02392351|139522|P2|STARTED|Overall Study||17
57592|NCT02392351|139523|P1|STARTED|Overall Study||34
57593|NCT02392247|139547|P1|NOT COMPLETED|Overall Study||2
57594|NCT02392247|139547|P1|COMPLETED|Overall Study||50
57595|NCT02392247|139547|P1|STARTED|Overall Study||52
57596|NCT02392234|139558|P6|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
57597|NCT02392234|139559|P5|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
57598|NCT02392234|139560|P4|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
57599|NCT02392234|139561|P3|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
57600|NCT02392234|139562|P2|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
57601|NCT02392234|139563|P1|NOT COMPLETED|Treatment Period 2 (8 Weeks)||1
57602|NCT02392234|139558|P6|COMPLETED|Treatment Period 2 (8 Weeks)||38
57603|NCT02392234|139559|P5|COMPLETED|Treatment Period 2 (8 Weeks)||37
57604|NCT02392234|139560|P4|COMPLETED|Treatment Period 2 (8 Weeks)||41
57605|NCT02392234|139561|P3|COMPLETED|Treatment Period 2 (8 Weeks)||38
57606|NCT02392234|139562|P2|COMPLETED|Treatment Period 2 (8 Weeks)||43
57607|NCT02392234|139563|P1|COMPLETED|Treatment Period 2 (8 Weeks)||37
57608|NCT02392234|139558|P6|STARTED|Treatment Period 2 (8 Weeks)||38
57609|NCT02392234|139559|P5|STARTED|Treatment Period 2 (8 Weeks)||37
57610|NCT02392234|139560|P4|STARTED|Treatment Period 2 (8 Weeks)||41
57611|NCT02392234|139561|P3|STARTED|Treatment Period 2 (8 Weeks)||38
57612|NCT02392234|139562|P2|STARTED|Treatment Period 2 (8 Weeks)||43
57613|NCT02392234|139563|P1|STARTED|Treatment Period 2 (8 Weeks)||38
57614|NCT02392234|139558|P6|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3
57615|NCT02392234|139559|P5|NOT COMPLETED|Treatment Period 1 (8 Weeks)||4
57616|NCT02392234|139560|P4|NOT COMPLETED|Treatment Period 1 (8 Weeks)||1
57617|NCT02392234|139561|P3|NOT COMPLETED|Treatment Period 1 (8 Weeks)||2
57618|NCT02392234|139562|P2|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
57619|NCT02392234|139563|P1|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3
57620|NCT02392234|139558|P6|COMPLETED|Treatment Period 1 (8 Weeks)||38
57621|NCT02392234|139559|P5|COMPLETED|Treatment Period 1 (8 Weeks)||37
57622|NCT02392234|139560|P4|COMPLETED|Treatment Period 1 (8 Weeks)||41
57623|NCT02392234|139561|P3|COMPLETED|Treatment Period 1 (8 Weeks)||38
57624|NCT02392234|139562|P2|COMPLETED|Treatment Period 1 (8 Weeks)||43
57625|NCT02392234|139563|P1|COMPLETED|Treatment Period 1 (8 Weeks)||38
57626|NCT02392234|139558|P6|Treated|Treatment Period 1 (8 Weeks)||41
57627|NCT02392234|139559|P5|Treated|Treatment Period 1 (8 Weeks)||40
57628|NCT02392234|139560|P4|Treated|Treatment Period 1 (8 Weeks)||42
57629|NCT02392234|139561|P3|Treated|Treatment Period 1 (8 Weeks)||39
57630|NCT02392234|139562|P2|Treated|Treatment Period 1 (8 Weeks)||43
57631|NCT02392234|139563|P1|Treated|Treatment Period 1 (8 Weeks)||41
57632|NCT02392234|139558|P6|STARTED|Treatment Period 1 (8 Weeks)||41
57633|NCT02392234|139559|P5|STARTED|Treatment Period 1 (8 Weeks)||41
57634|NCT02392234|139560|P4|STARTED|Treatment Period 1 (8 Weeks)||42
57635|NCT02392234|139561|P3|STARTED|Treatment Period 1 (8 Weeks)||40
57636|NCT02392234|139562|P2|STARTED|Treatment Period 1 (8 Weeks)||43
57637|NCT02392234|139563|P1|STARTED|Treatment Period 1 (8 Weeks)||41
57638|NCT02392208|139585|P1|NOT COMPLETED|Telavancin After Hemodialysis||0
57639|NCT02392208|139585|P1|COMPLETED|Telavancin After Hemodialysis||8
57640|NCT02392208|139585|P1|STARTED|Telavancin After Hemodialysis||8
57641|NCT02392208|139585|P1|NOT COMPLETED|Telavancin Before Hemodialysis||0
57642|NCT02392208|139585|P1|COMPLETED|Telavancin Before Hemodialysis||8
57643|NCT02392208|139585|P1|STARTED|Telavancin Before Hemodialysis||8
57644|NCT02392000|139595|P1|NOT COMPLETED|Overall Study||27
57645|NCT02392000|139595|P1|COMPLETED|Overall Study||11
57646|NCT02392000|139595|P1|STARTED|Overall Study||38
57647|NCT02391948|139608|P5|NOT COMPLETED|24-month Assessment||10
57648|NCT02391948|139609|P4|NOT COMPLETED|24-month Assessment||9
57649|NCT02391948|139610|P3|NOT COMPLETED|24-month Assessment||3
57650|NCT02391948|139611|P2|NOT COMPLETED|24-month Assessment||10
57651|NCT02391948|139612|P1|NOT COMPLETED|24-month Assessment||14
57652|NCT02391948|139608|P5|COMPLETED|24-month Assessment||69
57653|NCT02391948|139609|P4|COMPLETED|24-month Assessment||75
57654|NCT02391948|139610|P3|COMPLETED|24-month Assessment||48
57655|NCT02391948|139611|P2|COMPLETED|24-month Assessment||97
57656|NCT02391948|139612|P1|COMPLETED|24-month Assessment||135
57657|NCT02391948|139608|P5|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 4 of the Not Completed remained active.|79
57658|NCT02391948|139609|P4|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 1 of the Not Completed remained active.|84
57659|NCT02391948|139610|P3|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 3 of the Not Completed remained active.|51
57660|NCT02391948|139611|P2|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 6 of the Not Completed remained active.|107
57661|NCT02391948|139612|P1|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 2 of the Not Completed remained active.|149
57662|NCT02391948|139608|P5|NOT COMPLETED|18-month Assessment||30
57663|NCT02391948|139609|P4|NOT COMPLETED|18-month Assessment||36
57664|NCT02391948|139610|P3|NOT COMPLETED|18-month Assessment||26
57665|NCT02391948|139611|P2|NOT COMPLETED|18-month Assessment||50
57666|NCT02391948|139612|P1|NOT COMPLETED|18-month Assessment||72
57667|NCT02391948|139608|P5|COMPLETED|18-month Assessment||75
57668|NCT02391948|139609|P4|COMPLETED|18-month Assessment||83
57669|NCT02391948|139610|P3|COMPLETED|18-month Assessment||48
57670|NCT02391948|139611|P2|COMPLETED|18-month Assessment||101
57671|NCT02391948|139612|P1|COMPLETED|18-month Assessment||147
57672|NCT02391948|139608|P5|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 2 of the Not Completed remained active.|105
57673|NCT02391948|139609|P4|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 3 of the Not Completed remained active.|119
57674|NCT02391948|139610|P3|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 1 of the Not Completed remained active.|74
57675|NCT02391948|139611|P2|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 4 of the Not Completed remained active.|151
57676|NCT02391948|139612|P1|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 2 of the Not Completed remained active.|219
57677|NCT02391948|139608|P5|NOT COMPLETED|12-month Assessment||6
57678|NCT02391948|139609|P4|NOT COMPLETED|12-month Assessment||9
57679|NCT02391948|139610|P3|NOT COMPLETED|12-month Assessment||4
57680|NCT02391948|139611|P2|NOT COMPLETED|12-month Assessment||9
57681|NCT02391948|139612|P1|NOT COMPLETED|12-month Assessment||8
57682|NCT02391948|139608|P5|COMPLETED|12-month Assessment||103
57683|NCT02391948|139609|P4|COMPLETED|12-month Assessment||116
57684|NCT02391948|139610|P3|COMPLETED|12-month Assessment||73
57685|NCT02391948|139611|P2|COMPLETED|12-month Assessment||147
57686|NCT02391948|139612|P1|COMPLETED|12-month Assessment||217
57687|NCT02391948|139608|P5|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 24 of the Not Completed remained active.|109
57688|NCT02391948|139609|P4|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 41 of the Not Completed remained active.|125
57689|NCT02391948|139610|P3|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 28 of the Not Completed remained active.|77
57690|NCT02391948|139611|P2|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 51 of the Not Completed remained active.|156
57691|NCT02391948|139612|P1|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 77 of the Not Completed remained active.|225
57692|NCT02391948|139608|P5|NOT COMPLETED|6-month Assessment||26
57693|NCT02391948|139609|P4|NOT COMPLETED|6-month Assessment||45
57694|NCT02391948|139610|P3|NOT COMPLETED|6-month Assessment||31
57695|NCT02391948|139611|P2|NOT COMPLETED|6-month Assessment||56
57696|NCT02391948|139612|P1|NOT COMPLETED|6-month Assessment||79
57697|NCT02391948|139608|P5|COMPLETED|6-month Assessment||85
57698|NCT02391948|139609|P4|COMPLETED|6-month Assessment||84
57699|NCT02391948|139610|P3|COMPLETED|6-month Assessment||49
57700|NCT02391948|139611|P2|COMPLETED|6-month Assessment||105
57701|NCT02391948|139612|P1|COMPLETED|6-month Assessment||148
57702|NCT02391948|139608|P5|STARTED|6-month Assessment||111
57703|NCT02391948|139609|P4|STARTED|6-month Assessment||129
57704|NCT02391948|139610|P3|STARTED|6-month Assessment||80
57705|NCT02391948|139611|P2|STARTED|6-month Assessment||161
57706|NCT02391948|139612|P1|STARTED|6-month Assessment||227
57707|NCT02391948|139608|P5|NOT COMPLETED|Baseline||0
57708|NCT02391948|139609|P4|NOT COMPLETED|Baseline||0
57709|NCT02391948|139610|P3|NOT COMPLETED|Baseline||0
57710|NCT02391948|139611|P2|NOT COMPLETED|Baseline||0
57711|NCT02391948|139612|P1|NOT COMPLETED|Baseline||0
57712|NCT02391948|139608|P5|COMPLETED|Baseline||111
57713|NCT02391948|139609|P4|COMPLETED|Baseline||129
57714|NCT02391948|139610|P3|COMPLETED|Baseline||80
57715|NCT02391948|139611|P2|COMPLETED|Baseline||161
57716|NCT02391948|139612|P1|COMPLETED|Baseline||227
57717|NCT02391948|139608|P5|STARTED|Baseline||111
57718|NCT02391948|139609|P4|STARTED|Baseline||129
57719|NCT02391948|139610|P3|STARTED|Baseline||80
57720|NCT02391948|139611|P2|STARTED|Baseline||161
57721|NCT02391948|139612|P1|STARTED|Baseline||227
57722|NCT02391714|139706|P2|NOT COMPLETED|Overall Study||0
57723|NCT02391714|139707|P1|NOT COMPLETED|Overall Study||0
57724|NCT02391714|139706|P2|COMPLETED|Overall Study||40
57725|NCT02391714|139707|P1|COMPLETED|Overall Study||40
57726|NCT02391714|139706|P2|STARTED|Overall Study||40
57727|NCT02391714|139707|P1|STARTED|Overall Study||40
57728|NCT02391584|139719|P2|NOT COMPLETED|12 Month (End of Study)||0
57729|NCT02391584|139720|P1|NOT COMPLETED|12 Month (End of Study)||2
57730|NCT02391584|139719|P2|COMPLETED|12 Month (End of Study)||0
57731|NCT02391584|139720|P1|COMPLETED|12 Month (End of Study)||49
57732|NCT02391584|139719|P2|STARTED|12 Month (End of Study)||0
57733|NCT02391584|139720|P1|STARTED|12 Month (End of Study)||51
57734|NCT02391584|139719|P2|NOT COMPLETED|6 Month||0
57735|NCT02391584|139720|P1|NOT COMPLETED|6 Month||1
57736|NCT02391584|139719|P2|COMPLETED|6 Month||0
57737|NCT02391584|139720|P1|COMPLETED|6 Month||51
57738|NCT02391584|139719|P2|STARTED|6 Month||0
57739|NCT02391584|139720|P1|STARTED|6 Month||52
57740|NCT02391584|139719|P2|NOT COMPLETED|3 Month||0
57741|NCT02391584|139720|P1|NOT COMPLETED|3 Month||1
57742|NCT02391584|139719|P2|COMPLETED|3 Month||0
57743|NCT02391584|139720|P1|COMPLETED|3 Month||52
57744|NCT02391584|139719|P2|STARTED|3 Month|23 Crossover participants are included in balloon dilation arm for remainder of study visits.|0
57745|NCT02391584|139720|P1|STARTED|3 Month|Includes 30 balloon dilation and 23 crossover participants|53
57746|NCT02391584|139719|P2|NOT COMPLETED|Primary Endpoint (6-weeks)||2
57747|NCT02391584|139720|P1|NOT COMPLETED|Primary Endpoint (6-weeks)||2
57748|NCT02391584|139719|P2|COMPLETED|Primary Endpoint (6-weeks)||27
57749|NCT02391584|139720|P1|COMPLETED|Primary Endpoint (6-weeks)||29
57750|NCT02391584|139719|P2|STARTED|Primary Endpoint (6-weeks)||29
57751|NCT02391584|139720|P1|STARTED|Primary Endpoint (6-weeks)||31
57752|NCT02391545|139737|P2|NOT COMPLETED|Overall Study||28
57753|NCT02391545|139738|P1|NOT COMPLETED|Overall Study||26
57754|NCT02391545|139737|P2|COMPLETED|Overall Study||0
57755|NCT02391545|139738|P1|COMPLETED|Overall Study||1
57756|NCT02391545|139737|P2|STARTED|Overall Study||28
57757|NCT02391545|139738|P1|STARTED|Overall Study||27
57758|NCT02391363|139758|P2|NOT COMPLETED|Overall Study||8
57759|NCT02391363|139759|P1|NOT COMPLETED|Overall Study||11
57760|NCT02391363|139758|P2|COMPLETED|Overall Study||56
57761|NCT02391363|139759|P1|COMPLETED|Overall Study||59
57762|NCT02391363|139758|P2|STARTED|Overall Study||64
57763|NCT02391363|139759|P1|STARTED|Overall Study||70
57764|NCT02391311|139825|P2|NOT COMPLETED|Overall Study||2
57765|NCT02391311|139826|P1|NOT COMPLETED|Overall Study||3
57766|NCT02391311|139825|P2|COMPLETED|Overall Study||19
57767|NCT02391311|139826|P1|COMPLETED|Overall Study||18
57768|NCT02391311|139825|P2|STARTED|Overall Study||21
57769|NCT02391311|139826|P1|STARTED|Overall Study||21
57770|NCT02391116|139834|P1|NOT COMPLETED|Survival Follow-up||4
57771|NCT02391116|139834|P1|COMPLETED|Survival Follow-up|Reason for completed in this period included death (35) and clinical endpoint reached (7)|42
57772|NCT02391116|139834|P1|STARTED|Survival Follow-up|21 participants discontinued from treatment didn't enter due to withdrawal by subject (3) and death|46
57773|NCT02391116|139834|P1|NOT COMPLETED|Active Follow-up||3
57774|NCT02391116|139834|P1|COMPLETED|Active Follow-up|Reasons for completion in this period included death (2) and PD (4)|6
57775|NCT02391116|139834|P1|STARTED|Active Follow-up|This period incorporates safety follow-up with radiological|9
57776|NCT02391116|139834|P1|NOT COMPLETED|Safety Follow-up||13
57777|NCT02391116|139834|P1|COMPLETED|Safety Follow-up|14 participants were considered completed due to death|43
57778|NCT02391116|139834|P1|STARTED|Safety Follow-up|This period excludes 2 deaths on treatment and 9 participants entering active follow-up|56
57779|NCT02391116|139834|P1|NOT COMPLETED|Treatment||14
57780|NCT02391116|139834|P1|COMPLETED|Treatment|Reasons for completion in this period included death (2), PD (50) and lack of efficacy (1)|53
57781|NCT02391116|139834|P1|Included in Per Protocol Set|Treatment||40
57782|NCT02391116|139834|P1|STARTED|Treatment||67
57783|NCT02391038|139888|P3|NOT COMPLETED|Overall Study||6
57784|NCT02391038|139889|P2|NOT COMPLETED|Overall Study||3
57785|NCT02391038|139890|P1|NOT COMPLETED|Overall Study||3
57786|NCT02391038|139888|P3|COMPLETED|Overall Study||0
57787|NCT02391038|139889|P2|COMPLETED|Overall Study||0
57788|NCT02391038|139890|P1|COMPLETED|Overall Study||0
57789|NCT02391038|139888|P3|STARTED|Overall Study||6
57790|NCT02391038|139889|P2|STARTED|Overall Study||3
57791|NCT02391038|139890|P1|STARTED|Overall Study||3
57792|NCT02390791|140006|P2|NOT COMPLETED|Overall Study||0
57793|NCT02390791|140007|P1|NOT COMPLETED|Overall Study||0
57794|NCT02390791|140006|P2|COMPLETED|Overall Study||45
57795|NCT02390791|140007|P1|COMPLETED|Overall Study||40
57796|NCT02390791|140006|P2|STARTED|Overall Study||45
57797|NCT02390791|140007|P1|STARTED|Overall Study||40
57798|NCT02390557|140034|P3|NOT COMPLETED|Wave 2||23
57799|NCT02390557|140035|P2|NOT COMPLETED|Wave 2||41
57800|NCT02390557|140036|P1|NOT COMPLETED|Wave 2||72
57801|NCT02390557|140034|P3|COMPLETED|Wave 2||112
57802|NCT02390557|140035|P2|COMPLETED|Wave 2||115
57803|NCT02390557|140036|P1|COMPLETED|Wave 2||88
57804|NCT02390557|140034|P3|STARTED|Wave 2||135
57805|NCT02390557|140035|P2|STARTED|Wave 2||156
57806|NCT02390557|140036|P1|STARTED|Wave 2||160
57807|NCT02390557|140034|P3|NOT COMPLETED|Wave 1||0
57808|NCT02390557|140035|P2|NOT COMPLETED|Wave 1||0
57809|NCT02390557|140036|P1|NOT COMPLETED|Wave 1||0
57810|NCT02390557|140034|P3|COMPLETED|Wave 1||135
57811|NCT02390557|140035|P2|COMPLETED|Wave 1||156
57812|NCT02390557|140036|P1|COMPLETED|Wave 1||160
57813|NCT02390557|140034|P3|STARTED|Wave 1||135
57814|NCT02390557|140035|P2|STARTED|Wave 1||156
57815|NCT02390557|140036|P1|STARTED|Wave 1||160
57816|NCT02390362|140046|P2|NOT COMPLETED|Overall Study||1
57817|NCT02390362|140047|P1|NOT COMPLETED|Overall Study||0
57818|NCT02390362|140046|P2|COMPLETED|Overall Study||1
57819|NCT02390362|140047|P1|COMPLETED|Overall Study||1
57820|NCT02390362|140046|P2|STARTED|Overall Study||2
57821|NCT02390362|140047|P1|STARTED|Overall Study|1 subject enrolled in this arm. completed 2 doses of Rituximab.|1
57822|NCT02390219|140055|P1|NOT COMPLETED|Overall Study||13
57823|NCT02390219|140055|P1|COMPLETED|Overall Study||33
57824|NCT02390219|140055|P1|STARTED|Overall Study||46
57825|NCT02390167|140065|P1|NOT COMPLETED|Overall Study||1
57826|NCT02390167|140065|P1|COMPLETED|Overall Study||375
57827|NCT02390167|140065|P1|Without Diabetes|Overall Study||43
57828|NCT02390167|140065|P1|With Diabetes|Overall Study||333
57829|NCT02390167|140065|P1|STARTED|Overall Study||376
57830|NCT02390076|140087|P3|NOT COMPLETED|Overall Study||4
57831|NCT02390076|140088|P2|NOT COMPLETED|Overall Study||1
57832|NCT02390076|140089|P1|NOT COMPLETED|Overall Study||2
57833|NCT02390076|140087|P3|COMPLETED|Overall Study||11
57834|NCT02390076|140088|P2|COMPLETED|Overall Study||17
57835|NCT02390076|140089|P1|COMPLETED|Overall Study||16
57836|NCT02390076|140087|P3|STARTED|Overall Study||15
57837|NCT02390076|140088|P2|STARTED|Overall Study||18
57838|NCT02390076|140089|P1|STARTED|Overall Study||18
57839|NCT02389946|140102|P2|NOT COMPLETED|Overall Study||15
57840|NCT02389946|140103|P1|NOT COMPLETED|Overall Study||24
57841|NCT02389946|140102|P2|COMPLETED|Overall Study||435
57842|NCT02389946|140103|P1|COMPLETED|Overall Study||860
57843|NCT02389946|140102|P2|STARTED|Overall Study||450
57844|NCT02389946|140103|P1|STARTED|Overall Study||884
57845|NCT02389894|140118|P3|NOT COMPLETED|Overall Study||9
57846|NCT02389894|140119|P2|NOT COMPLETED|Overall Study||10
57847|NCT02389894|140120|P1|NOT COMPLETED|Overall Study||8
57848|NCT02389894|140118|P3|COMPLETED|Overall Study||123
57849|NCT02389894|140119|P2|COMPLETED|Overall Study||108
57850|NCT02389894|140120|P1|COMPLETED|Overall Study||125
57851|NCT02389894|140118|P3|STARTED|Overall Study||132
57852|NCT02389894|140119|P2|STARTED|Overall Study||118
57853|NCT02389894|140120|P1|STARTED|Overall Study||133
57854|NCT02389881|140195|P7|NOT COMPLETED|Overall Study||0
57855|NCT02389881|140196|P6|NOT COMPLETED|Overall Study||0
57856|NCT02389881|140197|P5|NOT COMPLETED|Overall Study||0
57857|NCT02389881|140198|P4|NOT COMPLETED|Overall Study||0
57858|NCT02389881|140199|P3|NOT COMPLETED|Overall Study||0
57859|NCT02389881|140200|P2|NOT COMPLETED|Overall Study||0
57860|NCT02389881|140201|P1|NOT COMPLETED|Overall Study||0
57861|NCT02389881|140195|P7|COMPLETED|Overall Study||2
57862|NCT02389881|140196|P6|COMPLETED|Overall Study||8
57863|NCT02389881|140197|P5|COMPLETED|Overall Study||6
57864|NCT02389881|140198|P4|COMPLETED|Overall Study||6
57865|NCT02389881|140199|P3|COMPLETED|Overall Study||6
57866|NCT02389881|140200|P2|COMPLETED|Overall Study||6
57867|NCT02389881|140201|P1|COMPLETED|Overall Study||6
57868|NCT02389881|140195|P7|STARTED|Overall Study||2
57869|NCT02389881|140196|P6|STARTED|Overall Study||8
57870|NCT02389881|140197|P5|STARTED|Overall Study||6
57871|NCT02389881|140198|P4|STARTED|Overall Study||6
57872|NCT02389881|140199|P3|STARTED|Overall Study||6
57873|NCT02389881|140200|P2|STARTED|Overall Study||6
57874|NCT02389881|140201|P1|STARTED|Overall Study||6
57875|NCT02389829|140252|P2|NOT COMPLETED|Overall Study||1
57876|NCT02389829|140253|P1|NOT COMPLETED|Overall Study||0
57877|NCT02389829|140252|P2|COMPLETED|Overall Study||62
57878|NCT02389829|140253|P1|COMPLETED|Overall Study||64
57879|NCT02389829|140252|P2|STARTED|Overall Study||63
57880|NCT02389829|140253|P1|STARTED|Overall Study||64
57881|NCT02389816|140268|P3|NOT COMPLETED|Overall Study||12
57882|NCT02389816|140269|P2|NOT COMPLETED|Overall Study||13
57883|NCT02389816|140270|P1|NOT COMPLETED|Overall Study||15
57884|NCT02389816|140268|P3|COMPLETED|Overall Study||152
57885|NCT02389816|140269|P2|COMPLETED|Overall Study||152
57886|NCT02389816|140270|P1|COMPLETED|Overall Study||149
57887|NCT02389816|140268|P3|STARTED|Overall Study||164
57888|NCT02389816|140269|P2|STARTED|Overall Study||165
57889|NCT02389816|140270|P1|STARTED|Overall Study||164
57890|NCT02389764|140302|P1|NOT COMPLETED|Overall Study||9
57891|NCT02389764|140302|P1|COMPLETED|Overall Study||0
57892|NCT02389764|140302|P1|STARTED|Overall Study||9
57893|NCT02389738|140307|P1|NOT COMPLETED|Overall Study||1
57894|NCT02389738|140307|P1|COMPLETED|Overall Study||5
57895|NCT02389738|140307|P1|STARTED|Overall Study||6
57896|NCT02389725|140313|P2|NOT COMPLETED|Overall Study||0
57897|NCT02389725|140314|P1|NOT COMPLETED|Overall Study||0
57898|NCT02389725|140313|P2|COMPLETED|Overall Study||60
57899|NCT02389725|140314|P1|COMPLETED|Overall Study||59
57900|NCT02389725|140313|P2|STARTED|Overall Study||60
57901|NCT02389725|140314|P1|STARTED|Overall Study||59
57902|NCT02389712|140328|P2|NOT COMPLETED|Overall Study||0
57903|NCT02389712|140329|P1|NOT COMPLETED|Overall Study||0
57904|NCT02389712|140328|P2|COMPLETED|Overall Study||1
57905|NCT02389712|140329|P1|COMPLETED|Overall Study||1
57906|NCT02389712|140328|P2|STARTED|Overall Study||1
57907|NCT02389712|140329|P1|STARTED|Overall Study||1
57908|NCT02389621|140337|P2|NOT COMPLETED|Posttreatment Period||4
57909|NCT02389621|140338|P1|NOT COMPLETED|Posttreatment Period||9
57910|NCT02389621|140337|P2|COMPLETED|Posttreatment Period||102
57911|NCT02389621|140338|P1|COMPLETED|Posttreatment Period||98
57912|NCT02389621|140337|P2|STARTED|Posttreatment Period||106
57913|NCT02389621|140338|P1|STARTED|Posttreatment Period||107
57914|NCT02389621|140337|P2|NOT COMPLETED|Treatment Period||1
57915|NCT02389621|140338|P1|NOT COMPLETED|Treatment Period||1
57916|NCT02389621|140337|P2|COMPLETED|Treatment Period||106
57917|NCT02389621|140338|P1|COMPLETED|Treatment Period||107
57918|NCT02389621|140337|P2|Received Study Drug|Treatment Period||107
57919|NCT02389621|140338|P1|Received Study Drug|Treatment Period||107
57920|NCT02389621|140337|P2|STARTED|Treatment Period||107
57921|NCT02389621|140338|P1|STARTED|Treatment Period||108
57922|NCT02389452|140368|P1|NOT COMPLETED|Overall Study||25
57923|NCT02389452|140368|P1|COMPLETED|Overall Study||369
57924|NCT02389452|140368|P1|Participants Received Repeat Injection|Overall Study|Repeat injection based on physician's assessment of efficacy and safety at Week 26, 39 or 52.|11
57925|NCT02389452|140368|P1|STARTED|Overall Study||394
57926|NCT02389374|140389|P3|NOT COMPLETED|Overall Study||1
57927|NCT02389374|140390|P2|NOT COMPLETED|Overall Study||28
57928|NCT02389374|140391|P1|NOT COMPLETED|Overall Study||9
57929|NCT02389374|140389|P3|COMPLETED|Overall Study||10
57930|NCT02389374|140390|P2|COMPLETED|Overall Study||87
57931|NCT02389374|140391|P1|COMPLETED|Overall Study||46
57932|NCT02389374|140389|P3|STARTED|Overall Study||11
57933|NCT02389374|140390|P2|STARTED|Overall Study||115
57934|NCT02389374|140391|P1|STARTED|Overall Study||55
57935|NCT02389361|140423|P2|NOT COMPLETED|Overall Study||0
57936|NCT02389361|140424|P1|NOT COMPLETED|Overall Study||0
57937|NCT02389361|140423|P2|COMPLETED|Overall Study||27
57938|NCT02389361|140424|P1|COMPLETED|Overall Study||24
57939|NCT02389361|140423|P2|STARTED|Overall Study||27
57940|NCT02389361|140424|P1|STARTED|Overall Study||24
57941|NCT02389101|140430|P1|NOT COMPLETED|Overall Study||0
57942|NCT02389101|140430|P1|COMPLETED|Overall Study||21
57943|NCT02389101|140430|P1|STARTED|Overall Study||21
57944|NCT02389088|140434|P1|NOT COMPLETED|Phase II - All Study Participants||0
57945|NCT02389088|140434|P1|COMPLETED|Phase II - All Study Participants||9
57946|NCT02389088|140434|P1|STARTED|Phase II - All Study Participants||9
57947|NCT02389088|140434|P1|NOT COMPLETED|Overall Study - Phase I||0
57948|NCT02389088|140434|P1|COMPLETED|Overall Study - Phase I||9
57949|NCT02389088|140434|P1|STARTED|Overall Study - Phase I||9
57950|NCT02388997|140480|P2|NOT COMPLETED|Overall Study||6
57951|NCT02388997|140481|P1|NOT COMPLETED|Overall Study||3
57952|NCT02388997|140480|P2|COMPLETED|Overall Study||10
57953|NCT02388997|140481|P1|COMPLETED|Overall Study||12
57954|NCT02388997|140480|P2|STARTED|Overall Study||16
57955|NCT02388997|140481|P1|STARTED|Overall Study||15
57956|NCT02388932|140499|P1|NOT COMPLETED|Overall Study||1
57957|NCT02388932|140499|P1|COMPLETED|Overall Study||2
57958|NCT02388932|140499|P1|STARTED|Overall Study||3
57959|NCT02388880|140509|P1|NOT COMPLETED|Overall Study||0
57960|NCT02388880|140509|P1|COMPLETED|Overall Study||3
57961|NCT02388880|140509|P1|STARTED|Overall Study||3
57962|NCT02388815|140516|P1|NOT COMPLETED|Overall Study||4
57963|NCT02388815|140516|P1|COMPLETED|Overall Study||85
57964|NCT02388815|140516|P1|STARTED|Overall Study||89
57965|NCT02388776|140520|P1|NOT COMPLETED|Overall Study||2
57966|NCT02388776|140520|P1|COMPLETED|Overall Study||0
57967|NCT02388776|140520|P1|STARTED|Overall Study||2
57968|NCT02388763|140525|P2|NOT COMPLETED|Period 2, 10 Days of Wear||0
57969|NCT02388763|140526|P1|NOT COMPLETED|Period 2, 10 Days of Wear||0
57970|NCT02388763|140525|P2|COMPLETED|Period 2, 10 Days of Wear||30
57971|NCT02388763|140526|P1|COMPLETED|Period 2, 10 Days of Wear||30
57972|NCT02388763|140525|P2|STARTED|Period 2, 10 Days of Wear||30
57973|NCT02388763|140526|P1|STARTED|Period 2, 10 Days of Wear||30
57974|NCT02388763|140525|P2|NOT COMPLETED|Period 1, 10 Days of Wear||1
57975|NCT02388763|140526|P1|NOT COMPLETED|Period 1, 10 Days of Wear||1
57976|NCT02388763|140525|P2|COMPLETED|Period 1, 10 Days of Wear||30
57977|NCT02388763|140526|P1|COMPLETED|Period 1, 10 Days of Wear||30
57978|NCT02388763|140525|P2|STARTED|Period 1, 10 Days of Wear||31
57979|NCT02388763|140526|P1|STARTED|Period 1, 10 Days of Wear||31
57980|NCT02388763|140525|P2|NOT COMPLETED|Habitual, 10 Days of Wear||1
57981|NCT02388763|140526|P1|NOT COMPLETED|Habitual, 10 Days of Wear||1
57982|NCT02388763|140525|P2|COMPLETED|Habitual, 10 Days of Wear||31
57983|NCT02388763|140526|P1|COMPLETED|Habitual, 10 Days of Wear||31
57984|NCT02388763|140525|P2|STARTED|Habitual, 10 Days of Wear||32
57985|NCT02388763|140526|P1|STARTED|Habitual, 10 Days of Wear||32
57986|NCT02388724|140539|P2|NOT COMPLETED|Overall Study||13
57987|NCT02388724|140540|P1|NOT COMPLETED|Overall Study||12
57988|NCT02388724|140539|P2|COMPLETED|Overall Study||224
57989|NCT02388724|140540|P1|COMPLETED|Overall Study||232
57990|NCT02388724|140539|P2|Safety Set: Randomized But Not Treated|Overall Study||2
57991|NCT02388724|140540|P1|Safety Set: Randomized But Not Treated|Overall Study||0
57992|NCT02388724|140539|P2|STARTED|Overall Study||237
57993|NCT02388724|140540|P1|STARTED|Overall Study||244
57994|NCT02388568|140564|P2|NOT COMPLETED|Overall Study||15
57995|NCT02388568|140565|P1|NOT COMPLETED|Overall Study||10
57996|NCT02388568|140564|P2|COMPLETED|Overall Study||53
57997|NCT02388568|140565|P1|COMPLETED|Overall Study||59
57998|NCT02388568|140564|P2|STARTED|Overall Study||68
57999|NCT02388568|140565|P1|STARTED|Overall Study||69
58000|NCT02388347|140586|P5|NOT COMPLETED|Overall Study||0
58001|NCT02388347|140587|P4|NOT COMPLETED|Overall Study||0
58002|NCT02388347|140588|P3|NOT COMPLETED|Overall Study||1
58003|NCT02388347|140589|P2|NOT COMPLETED|Overall Study||0
58004|NCT02388347|140590|P1|NOT COMPLETED|Overall Study||0
58005|NCT02388347|140586|P5|COMPLETED|Overall Study||6
58006|NCT02388347|140587|P4|COMPLETED|Overall Study||6
58007|NCT02388347|140588|P3|COMPLETED|Overall Study||5
58008|NCT02388347|140589|P2|COMPLETED|Overall Study||6
58009|NCT02388347|140590|P1|COMPLETED|Overall Study||8
58010|NCT02388347|140586|P5|STARTED|Overall Study||6
58011|NCT02388347|140587|P4|STARTED|Overall Study||6
58012|NCT02388347|140588|P3|STARTED|Overall Study||6
58013|NCT02388347|140589|P2|STARTED|Overall Study||6
58014|NCT02388347|140590|P1|STARTED|Overall Study||8
58015|NCT02388321|140657|P2|NOT COMPLETED|Overall Study||0
58016|NCT02388321|140658|P1|NOT COMPLETED|Overall Study||0
58017|NCT02388321|140657|P2|COMPLETED|Overall Study||11
58018|NCT02388321|140658|P1|COMPLETED|Overall Study||11
58019|NCT02388321|140657|P2|STARTED|Overall Study||11
58020|NCT02388321|140658|P1|STARTED|Overall Study||11
58021|NCT02388295|140669|P3|NOT COMPLETED|Treatment Weeks 3 to 12||0
58022|NCT02388295|140670|P2|NOT COMPLETED|Treatment Weeks 3 to 12||1
58023|NCT02388295|140671|P1|NOT COMPLETED|Treatment Weeks 3 to 12||1
58024|NCT02388295|140669|P3|COMPLETED|Treatment Weeks 3 to 12||17
58025|NCT02388295|140670|P2|COMPLETED|Treatment Weeks 3 to 12||13
58026|NCT02388295|140671|P1|COMPLETED|Treatment Weeks 3 to 12||15
58027|NCT02388295|140669|P3|STARTED|Treatment Weeks 3 to 12||17
58028|NCT02388295|140670|P2|STARTED|Treatment Weeks 3 to 12||14
58029|NCT02388295|140671|P1|STARTED|Treatment Weeks 3 to 12||16
58030|NCT02388295|140669|P3|NOT COMPLETED|Dose Escalation Week 2||1
58031|NCT02388295|140670|P2|NOT COMPLETED|Dose Escalation Week 2||2
58032|NCT02388295|140671|P1|NOT COMPLETED|Dose Escalation Week 2||1
58033|NCT02388295|140669|P3|COMPLETED|Dose Escalation Week 2||17
58034|NCT02388295|140670|P2|COMPLETED|Dose Escalation Week 2||14
58035|NCT02388295|140671|P1|COMPLETED|Dose Escalation Week 2||16
58036|NCT02388295|140669|P3|STARTED|Dose Escalation Week 2||18
58037|NCT02388295|140670|P2|STARTED|Dose Escalation Week 2||16
58038|NCT02388295|140671|P1|STARTED|Dose Escalation Week 2||17
58039|NCT02388295|140669|P3|NOT COMPLETED|Dose Escalation Week 1||2
58040|NCT02388295|140670|P2|NOT COMPLETED|Dose Escalation Week 1||3
58041|NCT02388295|140671|P1|NOT COMPLETED|Dose Escalation Week 1||2
58042|NCT02388295|140669|P3|COMPLETED|Dose Escalation Week 1||18
58043|NCT02388295|140670|P2|COMPLETED|Dose Escalation Week 1||16
58044|NCT02388295|140671|P1|COMPLETED|Dose Escalation Week 1||17
58045|NCT02388295|140669|P3|STARTED|Dose Escalation Week 1|Number randomized to treatment|20
58046|NCT02388295|140670|P2|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
58047|NCT02388295|140671|P1|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
58048|NCT02388269|140689|P3|NOT COMPLETED|Overall Study||10
58049|NCT02388269|140690|P2|NOT COMPLETED|Overall Study||2
58050|NCT02388269|140691|P1|NOT COMPLETED|Overall Study||9
58051|NCT02388269|140689|P3|COMPLETED|Overall Study||0
58052|NCT02388269|140690|P2|COMPLETED|Overall Study||38
58053|NCT02388269|140691|P1|COMPLETED|Overall Study||32
58054|NCT02388269|140689|P3|Open Label|Overall Study||0
58055|NCT02388269|140690|P2|Open Label|Overall Study||38
58056|NCT02388269|140691|P1|Open Label|Overall Study||37
58057|NCT02388269|140689|P3|Randomised Period|Overall Study||0
58058|NCT02388269|140690|P2|Randomised Period|Overall Study||40
58059|NCT02388269|140691|P1|Randomised Period|Overall Study||41
58060|NCT02388269|140689|P3|STARTED|Overall Study||10
58061|NCT02388269|140690|P2|STARTED|Overall Study||40
58062|NCT02388269|140691|P1|STARTED|Overall Study||41
58063|NCT02388191|140723|P2|NOT COMPLETED|Overall Study||0
58064|NCT02388191|140724|P1|NOT COMPLETED|Overall Study||1
58065|NCT02388191|140723|P2|COMPLETED|Overall Study||60
58066|NCT02388191|140724|P1|COMPLETED|Overall Study||58
58067|NCT02388191|140723|P2|STARTED|Overall Study||60
58068|NCT02388191|140724|P1|STARTED|Overall Study||59
58069|NCT02388074|140738|P1|NOT COMPLETED|Overall Study||3
58070|NCT02388074|140738|P1|COMPLETED|Overall Study||22
58071|NCT02388074|140738|P1|STARTED|Overall Study||25
58072|NCT02387996|140742|P1|NOT COMPLETED|Overall Study||204
58073|NCT02387996|140742|P1|COMPLETED|Overall Study|Completed equals continuing in the Treatment Period|66
58074|NCT02387996|140742|P1|STARTED|Overall Study||270
58075|NCT02387983|140753|P1|NOT COMPLETED|Overall Study||7
58076|NCT02387983|140753|P1|COMPLETED|Overall Study||58
58077|NCT02387983|140753|P1|STARTED|Overall Study||65
58078|NCT02387957|140768|P3|NOT COMPLETED|Overall Study||20
58079|NCT02387957|140769|P2|NOT COMPLETED|Overall Study||21
58080|NCT02387957|140770|P1|NOT COMPLETED|Overall Study||21
58081|NCT02387957|140768|P3|COMPLETED|Overall Study|The study was discontinued|1
58082|NCT02387957|140769|P2|COMPLETED|Overall Study|The study was discontinued|0
58083|NCT02387957|140770|P1|COMPLETED|Overall Study|The study was discontinued|0
58084|NCT02387957|140768|P3|STARTED|Overall Study||21
58085|NCT02387957|140769|P2|STARTED|Overall Study||21
58086|NCT02387957|140770|P1|STARTED|Overall Study||21
58087|NCT02387853|140781|P1|NOT COMPLETED|Overall Study||3
58088|NCT02387853|140781|P1|COMPLETED|Overall Study||103
58089|NCT02387853|140781|P1|STARTED|Overall Study||106
58090|NCT02387814|140801|P4|NOT COMPLETED|Overall Study||0
58091|NCT02387814|140802|P3|NOT COMPLETED|Overall Study||0
58092|NCT02387814|140803|P2|NOT COMPLETED|Overall Study||0
58093|NCT02387814|140804|P1|NOT COMPLETED|Overall Study||0
58094|NCT02387814|140801|P4|COMPLETED|Overall Study||6
58095|NCT02387814|140802|P3|COMPLETED|Overall Study||10
58096|NCT02387814|140803|P2|COMPLETED|Overall Study||9
58097|NCT02387814|140804|P1|COMPLETED|Overall Study||10
58098|NCT02387814|140801|P4|Received Abemaciclib|Overall Study||6
58099|NCT02387814|140802|P3|Received Abemaciclib|Overall Study||10
58100|NCT02387814|140803|P2|Received Abemaciclib|Overall Study||9
58101|NCT02387814|140804|P1|Received Abemaciclib|Overall Study||10
58102|NCT02387814|140801|P4|STARTED|Overall Study||6
58103|NCT02387814|140802|P3|STARTED|Overall Study||10
58104|NCT02387814|140803|P2|STARTED|Overall Study||9
58105|NCT02387814|140804|P1|STARTED|Overall Study||10
58106|NCT02387801|140820|P2|NOT COMPLETED|Post-Treatment Follow-up||0
58107|NCT02387801|140821|P1|NOT COMPLETED|Post-Treatment Follow-up||0
58108|NCT02387801|140820|P2|COMPLETED|Post-Treatment Follow-up||12
58109|NCT02387801|140821|P1|COMPLETED|Post-Treatment Follow-up||0
58110|NCT02387801|140820|P2|STARTED|Post-Treatment Follow-up||12
58111|NCT02387801|140821|P1|STARTED|Post-Treatment Follow-up||0
58112|NCT02387801|140820|P2|NOT COMPLETED|Maintenance Dosing Period||0
58113|NCT02387801|140821|P1|NOT COMPLETED|Maintenance Dosing Period||0
58114|NCT02387801|140820|P2|COMPLETED|Maintenance Dosing Period||12
58115|NCT02387801|140821|P1|COMPLETED|Maintenance Dosing Period||0
58116|NCT02387801|140820|P2|STARTED|Maintenance Dosing Period||12
58117|NCT02387801|140821|P1|STARTED|Maintenance Dosing Period|All participants from Induction Dosing Period went to ixe Q4W arm during Maintenance Dosing Period.|0
58118|NCT02387801|140820|P2|NOT COMPLETED|Induction Dosing Period||0
58119|NCT02387801|140821|P1|NOT COMPLETED|Induction Dosing Period||0
58120|NCT02387801|140820|P2|COMPLETED|Induction Dosing Period||6
58121|NCT02387801|140821|P1|COMPLETED|Induction Dosing Period||6
58122|NCT02387801|140820|P2|STARTED|Induction Dosing Period||6
58123|NCT02387801|140821|P1|STARTED|Induction Dosing Period||6
58124|NCT02387762|140841|P2|NOT COMPLETED|Overall Study||0
58125|NCT02387762|140842|P1|NOT COMPLETED|Overall Study||1
58126|NCT02387762|140841|P2|COMPLETED|Overall Study||15
58127|NCT02387762|140842|P1|COMPLETED|Overall Study||15
58128|NCT02387762|140841|P2|STARTED|Overall Study||15
58129|NCT02387762|140842|P1|STARTED|Overall Study||16
58130|NCT02387749|140848|P1|NOT COMPLETED|Overall Study||0
58131|NCT02387749|140848|P1|COMPLETED|Overall Study||10
58132|NCT02387749|140848|P1|STARTED|Overall Study||10
58133|NCT02387710|140857|P2|NOT COMPLETED|Second Study Night||0
58134|NCT02387710|140858|P1|NOT COMPLETED|Second Study Night||0
58135|NCT02387710|140857|P2|COMPLETED|Second Study Night||7
58136|NCT02387710|140858|P1|COMPLETED|Second Study Night||9
58137|NCT02387710|140857|P2|STARTED|Second Study Night|2 patients did not come back for excessive sleep disruption due to the equipment|7
58138|NCT02387710|140858|P1|STARTED|Second Study Night||9
58139|NCT02387710|140857|P2|NOT COMPLETED|First Study Night||0
58140|NCT02387710|140858|P1|NOT COMPLETED|First Study Night||0
58141|NCT02387710|140857|P2|COMPLETED|First Study Night||9
58142|NCT02387710|140858|P1|COMPLETED|First Study Night||9
58143|NCT02387710|140857|P2|STARTED|First Study Night||9
58144|NCT02387710|140858|P1|STARTED|First Study Night||9
58145|NCT02387580|140874|P6|NOT COMPLETED|Overall Study||0
58146|NCT02387580|140875|P5|NOT COMPLETED|Overall Study||0
58147|NCT02387580|140876|P4|NOT COMPLETED|Overall Study||1
58148|NCT02387580|140877|P3|NOT COMPLETED|Overall Study||0
58149|NCT02387580|140878|P2|NOT COMPLETED|Overall Study||0
58150|NCT02387580|140879|P1|NOT COMPLETED|Overall Study||0
58151|NCT02387580|140874|P6|COMPLETED|Overall Study||8
58152|NCT02387580|140875|P5|COMPLETED|Overall Study||8
58153|NCT02387580|140876|P4|COMPLETED|Overall Study||7
58154|NCT02387580|140877|P3|COMPLETED|Overall Study||8
58155|NCT02387580|140878|P2|COMPLETED|Overall Study||8
58156|NCT02387580|140879|P1|COMPLETED|Overall Study||8
58157|NCT02387580|140874|P6|STARTED|Overall Study||8
58158|NCT02387580|140875|P5|STARTED|Overall Study||8
58159|NCT02387580|140876|P4|STARTED|Overall Study||8
58160|NCT02387580|140877|P3|STARTED|Overall Study||8
58161|NCT02387580|140878|P2|STARTED|Overall Study||8
58162|NCT02387580|140879|P1|STARTED|Overall Study||8
58163|NCT02387554|140915|P4|NOT COMPLETED|Overall Study||2
58164|NCT02387554|140916|P3|NOT COMPLETED|Overall Study||2
58165|NCT02387554|140917|P2|NOT COMPLETED|Overall Study||0
58166|NCT02387554|140918|P1|NOT COMPLETED|Overall Study||3
58167|NCT02387554|140915|P4|COMPLETED|Overall Study||6
58168|NCT02387554|140916|P3|COMPLETED|Overall Study||6
58169|NCT02387554|140917|P2|COMPLETED|Overall Study||7
58170|NCT02387554|140918|P1|COMPLETED|Overall Study||7
58171|NCT02387554|140915|P4|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
58172|NCT02387554|140916|P3|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
58173|NCT02387554|140917|P2|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|7
58174|NCT02387554|140918|P1|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|10
58175|NCT02387502|140931|P3|NOT COMPLETED|Overall Study||0
58176|NCT02387502|140932|P2|NOT COMPLETED|Overall Study||0
58177|NCT02387502|140933|P1|NOT COMPLETED|Overall Study||0
58178|NCT02387502|140931|P3|COMPLETED|Overall Study||40
58179|NCT02387502|140932|P2|COMPLETED|Overall Study||40
58180|NCT02387502|140933|P1|COMPLETED|Overall Study||40
58181|NCT02387502|140931|P3|STARTED|Overall Study||40
58182|NCT02387502|140932|P2|STARTED|Overall Study||40
58183|NCT02387502|140933|P1|STARTED|Overall Study||40
58184|NCT02387476|140943|P2|NOT COMPLETED|Overall Study||5
58185|NCT02387476|140944|P1|NOT COMPLETED|Overall Study||6
58186|NCT02387476|140943|P2|COMPLETED|Overall Study||17
58187|NCT02387476|140944|P1|COMPLETED|Overall Study||19
58188|NCT02387476|140943|P2|STARTED|Overall Study||22
58189|NCT02387476|140944|P1|STARTED|Overall Study||25
58190|NCT02387372|140972|P2|NOT COMPLETED|Overall Study||0
58191|NCT02387372|140973|P1|NOT COMPLETED|Overall Study||1
58192|NCT02387372|140972|P2|COMPLETED|Overall Study||10
58193|NCT02387372|140973|P1|COMPLETED|Overall Study||26
58194|NCT02387372|140972|P2|Treated|Overall Study||10
58195|NCT02387372|140973|P1|Treated|Overall Study||26
58196|NCT02387372|140972|P2|STARTED|Overall Study||10
58197|NCT02387372|140973|P1|STARTED|Overall Study||27
58198|NCT02387359|141022|P3|NOT COMPLETED|Overall Study||56
58199|NCT02387359|141023|P2|NOT COMPLETED|Overall Study||42
58200|NCT02387359|141024|P1|NOT COMPLETED|Overall Study||59
58201|NCT02387359|141022|P3|COMPLETED|Overall Study||293
58202|NCT02387359|141023|P2|COMPLETED|Overall Study||309
58203|NCT02387359|141024|P1|COMPLETED|Overall Study||295
58204|NCT02387359|141022|P3|STARTED|Overall Study||349
58205|NCT02387359|141023|P2|STARTED|Overall Study||351
58206|NCT02387359|141024|P1|STARTED|Overall Study||354
58207|NCT02387268|141056|P1|NOT COMPLETED|Overall Study||1
58208|NCT02387268|141056|P1|COMPLETED|Overall Study||9
58209|NCT02387268|141056|P1|STARTED|Overall Study||10
58210|NCT02387008|141064|P3|NOT COMPLETED|Overall Study||0
58211|NCT02387008|141065|P2|NOT COMPLETED|Overall Study||0
58212|NCT02387008|141066|P1|NOT COMPLETED|Overall Study||0
58213|NCT02387008|141064|P3|COMPLETED|Overall Study||4
58214|NCT02387008|141065|P2|COMPLETED|Overall Study||0
58215|NCT02387008|141066|P1|COMPLETED|Overall Study||2
58216|NCT02387008|141064|P3|STARTED|Overall Study||4
58217|NCT02387008|141065|P2|STARTED|Overall Study||0
58218|NCT02387008|141066|P1|STARTED|Overall Study||2
58219|NCT02386345|141083|P1|NOT COMPLETED|Overall Study||102
58220|NCT02386345|141083|P1|COMPLETED|Overall Study||197
58221|NCT02386345|141083|P1|STARTED|Overall Study||299
58222|NCT02386189|141093|P2|NOT COMPLETED|Overall Study||3
58223|NCT02386189|141094|P1|NOT COMPLETED|Overall Study||4
58224|NCT02386189|141093|P2|COMPLETED|Overall Study||30
58225|NCT02386189|141094|P1|COMPLETED|Overall Study||26
58226|NCT02386189|141093|P2|STARTED|Overall Study||33
58227|NCT02386189|141094|P1|STARTED|Overall Study||30
58228|NCT02386098|141117|P5|NOT COMPLETED|Stage 2 (96 Weeks)||0
58229|NCT02386098|141118|P4|NOT COMPLETED|Stage 2 (96 Weeks)||0
58230|NCT02386098|141119|P3|NOT COMPLETED|Stage 2 (96 Weeks)||0
58231|NCT02386098|141120|P2|NOT COMPLETED|Stage 2 (96 Weeks)||0
58232|NCT02386098|141121|P1|NOT COMPLETED|Stage 2 (96 Weeks)||0
58233|NCT02386098|141117|P5|COMPLETED|Stage 2 (96 Weeks)||0
58234|NCT02386098|141118|P4|COMPLETED|Stage 2 (96 Weeks)||0
58235|NCT02386098|141119|P3|COMPLETED|Stage 2 (96 Weeks)||0
58236|NCT02386098|141120|P2|COMPLETED|Stage 2 (96 Weeks)||0
58237|NCT02386098|141121|P1|COMPLETED|Stage 2 (96 Weeks)||0
58238|NCT02386098|141117|P5|STARTED|Stage 2 (96 Weeks)||0
58239|NCT02386098|141118|P4|STARTED|Stage 2 (96 Weeks)||0
58240|NCT02386098|141119|P3|STARTED|Stage 2 (96 Weeks)||0
58241|NCT02386098|141120|P2|STARTED|Stage 2 (96 Weeks)||0
58242|NCT02386098|141121|P1|STARTED|Stage 2 (96 Weeks)||0
58243|NCT02386098|141117|P5|NOT COMPLETED|Stage 1 (96 Weeks)||0
58244|NCT02386098|141118|P4|NOT COMPLETED|Stage 1 (96 Weeks)||0
58245|NCT02386098|141119|P3|NOT COMPLETED|Stage 1 (96 Weeks)||0
58246|NCT02386098|141120|P2|NOT COMPLETED|Stage 1 (96 Weeks)||43
58247|NCT02386098|141121|P1|NOT COMPLETED|Stage 1 (96 Weeks)||43
58248|NCT02386098|141117|P5|COMPLETED|Stage 1 (96 Weeks)||0
58249|NCT02386098|141118|P4|COMPLETED|Stage 1 (96 Weeks)||0
58250|NCT02386098|141119|P3|COMPLETED|Stage 1 (96 Weeks)||0
58251|NCT02386098|141120|P2|COMPLETED|Stage 1 (96 Weeks)||0
58252|NCT02386098|141121|P1|COMPLETED|Stage 1 (96 Weeks)||0
58253|NCT02386098|141117|P5|STARTED|Stage 1 (96 Weeks)||0
58254|NCT02386098|141118|P4|STARTED|Stage 1 (96 Weeks)||0
58255|NCT02386098|141119|P3|STARTED|Stage 1 (96 Weeks)||0
58256|NCT02386098|141120|P2|STARTED|Stage 1 (96 Weeks)||43
58257|NCT02386098|141121|P1|STARTED|Stage 1 (96 Weeks)||43
58258|NCT02385799|141200|P2|NOT COMPLETED|Overall Study||8
58259|NCT02385799|141201|P1|NOT COMPLETED|Overall Study||5
58260|NCT02385799|141200|P2|COMPLETED|Overall Study||24
58261|NCT02385799|141201|P1|COMPLETED|Overall Study||21
58262|NCT02385799|141200|P2|Completed End-of-Treatment Visit|Overall Study||26
58263|NCT02385799|141201|P1|Completed End-of-Treatment Visit|Overall Study||21
58264|NCT02385799|141200|P2|STARTED|Overall Study||32
58265|NCT02385799|141201|P1|STARTED|Overall Study||26
58266|NCT02385721|141235|P1|NOT COMPLETED|Overall Study||230
58267|NCT02385721|141235|P1|COMPLETED|Overall Study||371
58268|NCT02385721|141235|P1|STARTED|Overall Study||601
58269|NCT02385708|141242|P2|NOT COMPLETED|Overall Study||15
58270|NCT02385708|141243|P1|NOT COMPLETED|Overall Study||8
58271|NCT02385708|141242|P2|COMPLETED|Overall Study||67
58272|NCT02385708|141243|P1|COMPLETED|Overall Study||73
58273|NCT02385708|141242|P2|Intervention Started|Overall Study||82
58274|NCT02385708|141243|P1|Intervention Started|Overall Study||81
58275|NCT02385708|141242|P2|STARTED|Overall Study||82
58276|NCT02385708|141243|P1|STARTED|Overall Study||81
58277|NCT02385669|141249|P1|NOT COMPLETED|Overall Study||2
58278|NCT02385669|141249|P1|COMPLETED|Overall Study||1
58279|NCT02385669|141249|P1|STARTED|Overall Study||3
58280|NCT02385526|141257|P3|NOT COMPLETED|Overall Study||0
58281|NCT02385526|141258|P2|NOT COMPLETED|Overall Study||3
58282|NCT02385526|141259|P1|NOT COMPLETED|Overall Study||2
58283|NCT02385526|141257|P3|COMPLETED|Overall Study||20
58284|NCT02385526|141258|P2|COMPLETED|Overall Study||17
58285|NCT02385526|141259|P1|COMPLETED|Overall Study||20
58286|NCT02385526|141257|P3|STARTED|Overall Study||20
58287|NCT02385526|141258|P2|STARTED|Overall Study||20
58288|NCT02385526|141259|P1|STARTED|Overall Study||22
58289|NCT02385084|141267|P6|NOT COMPLETED|Period 3||0
58290|NCT02385084|141268|P5|NOT COMPLETED|Period 3||0
58291|NCT02385084|141269|P4|NOT COMPLETED|Period 3||0
58292|NCT02385084|141270|P3|NOT COMPLETED|Period 3||0
58293|NCT02385084|141271|P2|NOT COMPLETED|Period 3||0
58294|NCT02385084|141272|P1|NOT COMPLETED|Period 3||0
58295|NCT02385084|141267|P6|COMPLETED|Period 3||3
58296|NCT02385084|141268|P5|COMPLETED|Period 3||2
58297|NCT02385084|141269|P4|COMPLETED|Period 3||3
58298|NCT02385084|141270|P3|COMPLETED|Period 3||1
58299|NCT02385084|141271|P2|COMPLETED|Period 3||3
58300|NCT02385084|141272|P1|COMPLETED|Period 3||2
58301|NCT02385084|141267|P6|Washout|Period 3||3
58302|NCT02385084|141268|P5|Washout|Period 3||2
58303|NCT02385084|141269|P4|Washout|Period 3||3
58304|NCT02385084|141270|P3|Washout|Period 3||1
58305|NCT02385084|141271|P2|Washout|Period 3||3
58306|NCT02385084|141272|P1|Washout|Period 3||2
58307|NCT02385084|141267|P6|Received LY2409021|Period 3||3
58308|NCT02385084|141268|P5|Received LY2409021|Period 3||2
58309|NCT02385084|141269|P4|Received LY2409021|Period 3||3
58310|NCT02385084|141270|P3|Received LY2409021|Period 3||1
58311|NCT02385084|141271|P2|Received LY2409021|Period 3||3
58312|NCT02385084|141272|P1|Received LY2409021|Period 3||2
58313|NCT02385084|141267|P6|STARTED|Period 3||3
58314|NCT02385084|141268|P5|STARTED|Period 3|1 participant discontinued after Period 2 - adverse event. Did not enter Period 3.|2
58315|NCT02385084|141269|P4|STARTED|Period 3||3
58316|NCT02385084|141270|P3|STARTED|Period 3|1 participant discontinued after Period 2 - adverse event. Did not enter Period 3.|1
58317|NCT02385084|141271|P2|STARTED|Period 3||3
58318|NCT02385084|141272|P1|STARTED|Period 3||2
58319|NCT02385084|141267|P6|NOT COMPLETED|Period 2||0
58320|NCT02385084|141268|P5|NOT COMPLETED|Period 2||0
58321|NCT02385084|141269|P4|NOT COMPLETED|Period 2||0
58322|NCT02385084|141270|P3|NOT COMPLETED|Period 2||1
58323|NCT02385084|141271|P2|NOT COMPLETED|Period 2||0
58324|NCT02385084|141272|P1|NOT COMPLETED|Period 2||0
58325|NCT02385084|141267|P6|COMPLETED|Period 2||3
58326|NCT02385084|141268|P5|COMPLETED|Period 2||3
58327|NCT02385084|141269|P4|COMPLETED|Period 2||3
58328|NCT02385084|141270|P3|COMPLETED|Period 2||2
58329|NCT02385084|141271|P2|COMPLETED|Period 2||3
58330|NCT02385084|141272|P1|COMPLETED|Period 2||2
58331|NCT02385084|141267|P6|Washout|Period 2||3
58332|NCT02385084|141268|P5|Washout|Period 2||3
58333|NCT02385084|141269|P4|Washout|Period 2||3
58334|NCT02385084|141270|P3|Washout|Period 2||3
58335|NCT02385084|141271|P2|Washout|Period 2||3
58336|NCT02385084|141272|P1|Washout|Period 2||2
58337|NCT02385084|141267|P6|Received LY2409021|Period 2||3
58338|NCT02385084|141268|P5|Received LY2409021|Period 2||3
58339|NCT02385084|141269|P4|Received LY2409021|Period 2||3
58340|NCT02385084|141270|P3|Received LY2409021|Period 2||3
58341|NCT02385084|141271|P2|Received LY2409021|Period 2||3
58342|NCT02385084|141272|P1|Received LY2409021|Period 2||2
58343|NCT02385084|141267|P6|STARTED|Period 2||3
58344|NCT02385084|141268|P5|STARTED|Period 2||3
58345|NCT02385084|141269|P4|STARTED|Period 2||3
58346|NCT02385084|141270|P3|STARTED|Period 2||3
58347|NCT02385084|141271|P2|STARTED|Period 2||3
58348|NCT02385084|141272|P1|STARTED|Period 2|1 participant discontinued after Period 1 - physician decision. Did not enter Period 2.|2
58349|NCT02385084|141267|P6|NOT COMPLETED|Period 1||0
58350|NCT02385084|141268|P5|NOT COMPLETED|Period 1||0
58351|NCT02385084|141269|P4|NOT COMPLETED|Period 1||0
58352|NCT02385084|141270|P3|NOT COMPLETED|Period 1||0
58353|NCT02385084|141271|P2|NOT COMPLETED|Period 1||0
58354|NCT02385084|141272|P1|NOT COMPLETED|Period 1||0
58355|NCT02385084|141267|P6|COMPLETED|Period 1||3
58356|NCT02385084|141268|P5|COMPLETED|Period 1||3
58357|NCT02385084|141269|P4|COMPLETED|Period 1||3
58358|NCT02385084|141270|P3|COMPLETED|Period 1||3
58359|NCT02385084|141271|P2|COMPLETED|Period 1||3
58360|NCT02385084|141272|P1|COMPLETED|Period 1||3
58361|NCT02385084|141267|P6|Washout|Period 1||3
58362|NCT02385084|141268|P5|Washout|Period 1||3
58363|NCT02385084|141269|P4|Washout|Period 1||3
58364|NCT02385084|141270|P3|Washout|Period 1||3
58365|NCT02385084|141271|P2|Washout|Period 1||3
58366|NCT02385084|141272|P1|Washout|Period 1||3
58367|NCT02385084|141267|P6|Received LY2409021|Period 1||3
58368|NCT02385084|141268|P5|Received LY2409021|Period 1||3
58369|NCT02385084|141269|P4|Received LY2409021|Period 1||3
58370|NCT02385084|141270|P3|Received LY2409021|Period 1||3
58371|NCT02385084|141271|P2|Received LY2409021|Period 1||3
58372|NCT02385084|141272|P1|Received LY2409021|Period 1||3
58373|NCT02385084|141267|P6|STARTED|Period 1||3
58374|NCT02385084|141268|P5|STARTED|Period 1||3
58375|NCT02385084|141269|P4|STARTED|Period 1||3
58376|NCT02385084|141270|P3|STARTED|Period 1||3
58377|NCT02385084|141271|P2|STARTED|Period 1||3
58378|NCT02385084|141272|P1|STARTED|Period 1||3
58379|NCT02384941|141286|P3|NOT COMPLETED|Overall Study||41
58380|NCT02384941|141287|P2|NOT COMPLETED|Overall Study||35
58381|NCT02384941|141288|P1|NOT COMPLETED|Overall Study||50
58382|NCT02384941|141286|P3|COMPLETED|Overall Study||221
58383|NCT02384941|141287|P2|COMPLETED|Overall Study||228
58384|NCT02384941|141288|P1|COMPLETED|Overall Study||218
58385|NCT02384941|141286|P3|STARTED|Overall Study||262
58386|NCT02384941|141287|P2|STARTED|Overall Study||263
58387|NCT02384941|141288|P1|STARTED|Overall Study||268
58388|NCT02384538|141319|P2|NOT COMPLETED|Overall Study||15
58389|NCT02384538|141320|P1|NOT COMPLETED|Overall Study||6
58390|NCT02384538|141319|P2|COMPLETED|Overall Study||49
58391|NCT02384538|141320|P1|COMPLETED|Overall Study||61
58392|NCT02384538|141319|P2|STARTED|Overall Study||64
58393|NCT02384538|141320|P1|STARTED|Overall Study||67
58394|NCT02384460|141340|P2|NOT COMPLETED|Overall Study||7
58395|NCT02384460|141341|P1|NOT COMPLETED|Overall Study||7
58396|NCT02384460|141340|P2|COMPLETED|Overall Study||80
58397|NCT02384460|141341|P1|COMPLETED|Overall Study||75
58398|NCT02384460|141340|P2|Received at Least 1 Dose of Study Drug|Overall Study||87
58399|NCT02384460|141341|P1|Received at Least 1 Dose of Study Drug|Overall Study||82
58400|NCT02384460|141340|P2|STARTED|Overall Study||87
58401|NCT02384460|141341|P1|STARTED|Overall Study||82
58402|NCT02384200|141361|P2|NOT COMPLETED|Overall Study||0
58403|NCT02384200|141362|P1|NOT COMPLETED|Overall Study||0
58404|NCT02384200|141361|P2|COMPLETED|Overall Study||43
58405|NCT02384200|141362|P1|COMPLETED|Overall Study||43
58406|NCT02384200|141361|P2|STARTED|Overall Study||43
58407|NCT02384200|141362|P1|STARTED|Overall Study||43
58408|NCT02384096|141388|P2|NOT COMPLETED|Second Intervention (7 Days)||1
58409|NCT02384096|141389|P1|NOT COMPLETED|Second Intervention (7 Days)||0
58410|NCT02384096|141388|P2|COMPLETED|Second Intervention (7 Days)||6
58411|NCT02384096|141389|P1|COMPLETED|Second Intervention (7 Days)||4
58412|NCT02384096|141388|P2|STARTED|Second Intervention (7 Days)||7
58413|NCT02384096|141389|P1|STARTED|Second Intervention (7 Days)||4
58414|NCT02384096|141388|P2|NOT COMPLETED|First Intervention (7 Days)||0
58415|NCT02384096|141389|P1|NOT COMPLETED|First Intervention (7 Days)||1
58416|NCT02384096|141388|P2|COMPLETED|First Intervention (7 Days)||7
58417|NCT02384096|141389|P1|COMPLETED|First Intervention (7 Days)||4
58418|NCT02384096|141388|P2|STARTED|First Intervention (7 Days)||7
58419|NCT02384096|141389|P1|STARTED|First Intervention (7 Days)||5
58420|NCT02384070|141397|P3|NOT COMPLETED|Overall Study||0
58421|NCT02384070|141398|P2|NOT COMPLETED|Overall Study||0
58422|NCT02384070|141399|P1|NOT COMPLETED|Overall Study||0
58423|NCT02384070|141397|P3|COMPLETED|Overall Study||100
58424|NCT02384070|141398|P2|COMPLETED|Overall Study||100
58425|NCT02384070|141399|P1|COMPLETED|Overall Study||100
58426|NCT02384070|141397|P3|STARTED|Overall Study||100
58427|NCT02384070|141398|P2|STARTED|Overall Study||100
58428|NCT02384070|141399|P1|STARTED|Overall Study||100
58429|NCT02384044|141415|P2|NOT COMPLETED|Overall Study||0
58430|NCT02384044|141416|P1|NOT COMPLETED|Overall Study||0
58431|NCT02384044|141415|P2|COMPLETED|Overall Study||15
58432|NCT02384044|141416|P1|COMPLETED|Overall Study||15
58433|NCT02384044|141415|P2|STARTED|Overall Study||15
58434|NCT02384044|141416|P1|STARTED|Overall Study||15
58435|NCT02383966|141426|P2|NOT COMPLETED|Overall Study||7
58436|NCT02383966|141427|P1|NOT COMPLETED|Overall Study||26
58437|NCT02383966|141426|P2|COMPLETED|Overall Study||72
58438|NCT02383966|141427|P1|COMPLETED|Overall Study||138
58439|NCT02383966|141426|P2|STARTED|Overall Study||79
58440|NCT02383966|141427|P1|STARTED|Overall Study||164
58441|NCT02383940|141447|P2|NOT COMPLETED|Overall Study||3
58442|NCT02383940|141448|P1|NOT COMPLETED|Overall Study||9
58443|NCT02383940|141447|P2|COMPLETED|Overall Study||40
58444|NCT02383940|141448|P1|COMPLETED|Overall Study||35
58445|NCT02383940|141447|P2|Treated|Overall Study||43
58446|NCT02383940|141448|P1|Treated|Overall Study||42
58447|NCT02383940|141447|P2|STARTED|Overall Study||43
58448|NCT02383940|141448|P1|STARTED|Overall Study||44
58449|NCT02383862|141464|P2|NOT COMPLETED|3 Month Follow up||21
58450|NCT02383862|141465|P1|NOT COMPLETED|3 Month Follow up||23
58451|NCT02383862|141464|P2|COMPLETED|3 Month Follow up||128
58452|NCT02383862|141465|P1|COMPLETED|3 Month Follow up||128
58453|NCT02383862|141464|P2|STARTED|3 Month Follow up||149
58454|NCT02383862|141465|P1|STARTED|3 Month Follow up||151
58455|NCT02383862|141464|P2|NOT COMPLETED|Baseline||0
58456|NCT02383862|141465|P1|NOT COMPLETED|Baseline||0
58457|NCT02383862|141464|P2|COMPLETED|Baseline||149
58458|NCT02383862|141465|P1|COMPLETED|Baseline||151
58459|NCT02383862|141464|P2|STARTED|Baseline||149
58460|NCT02383862|141465|P1|STARTED|Baseline||151
58461|NCT02383758|141498|P2|NOT COMPLETED|Overall Study||2
58462|NCT02383758|141499|P1|NOT COMPLETED|Overall Study||0
58463|NCT02383758|141498|P2|COMPLETED|Overall Study||8
58464|NCT02383758|141499|P1|COMPLETED|Overall Study||10
58465|NCT02383758|141498|P2|STARTED|Overall Study||10
58466|NCT02383758|141499|P1|STARTED|Overall Study||10
58467|NCT02383719|141511|P1|NOT COMPLETED|Overall Study||0
58468|NCT02383719|141511|P1|COMPLETED|Overall Study||18
58469|NCT02383719|141511|P1|STARTED|Overall Study||18
58470|NCT02383706|141515|P1|NOT COMPLETED|Overall Study||28
58471|NCT02383706|141515|P1|COMPLETED|Overall Study||80
58472|NCT02383706|141515|P1|STARTED|Overall Study||108
58473|NCT02383667|141521|P1|NOT COMPLETED|Overall Study||0
58474|NCT02383667|141521|P1|COMPLETED|Overall Study||20
58475|NCT02383667|141521|P1|STARTED|Overall Study||20
58476|NCT02383576|141527|P2|NOT COMPLETED|Overall Study||45
58477|NCT02383576|141528|P1|NOT COMPLETED|Overall Study||63
58478|NCT02383576|141527|P2|COMPLETED|Overall Study||46
58479|NCT02383576|141528|P1|COMPLETED|Overall Study||31
58480|NCT02383576|141527|P2|STARTED|Overall Study||91
58481|NCT02383576|141528|P1|STARTED|Overall Study||94
58482|NCT02383472|141544|P2|NOT COMPLETED|Overall Study||1
58483|NCT02383472|141545|P1|NOT COMPLETED|Overall Study||1
58484|NCT02383472|141544|P2|COMPLETED|Overall Study||29
58485|NCT02383472|141545|P1|COMPLETED|Overall Study||22
58486|NCT02383472|141544|P2|STARTED|Overall Study||30
58487|NCT02383472|141545|P1|STARTED|Overall Study||23
58488|NCT02383433|141559|P1|NOT COMPLETED|Overall Study||2
58489|NCT02383433|141559|P1|COMPLETED|Overall Study||0
58490|NCT02383433|141559|P1|STARTED|Overall Study||2
58491|NCT02383420|141566|P3|NOT COMPLETED|Overall Study||0
58492|NCT02383420|141567|P2|NOT COMPLETED|Overall Study||0
58493|NCT02383420|141568|P1|NOT COMPLETED|Overall Study||2
58494|NCT02383420|141566|P3|COMPLETED|Overall Study||3
58495|NCT02383420|141567|P2|COMPLETED|Overall Study||10
58496|NCT02383420|141568|P1|COMPLETED|Overall Study||8
58497|NCT02383420|141566|P3|STARTED|Overall Study||3
58498|NCT02383420|141567|P2|STARTED|Overall Study||10
58499|NCT02383420|141568|P1|STARTED|Overall Study||10
58500|NCT02383355|141578|P2|NOT COMPLETED|Overall Study||0
58501|NCT02383355|141579|P1|NOT COMPLETED|Overall Study||2
58502|NCT02383355|141578|P2|COMPLETED|Overall Study||21
58503|NCT02383355|141579|P1|COMPLETED|Overall Study||17
58504|NCT02383355|141578|P2|STARTED|Overall Study||21
58505|NCT02383355|141579|P1|STARTED|Overall Study||19
58506|NCT02383056|141595|P2|NOT COMPLETED|Overall Study||2
58507|NCT02383056|141596|P1|NOT COMPLETED|Overall Study||1
58508|NCT02383056|141595|P2|COMPLETED|Overall Study||5
58509|NCT02383056|141596|P1|COMPLETED|Overall Study||6
58510|NCT02383056|141595|P2|STARTED|Overall Study||7
58511|NCT02383056|141596|P1|STARTED|Overall Study||7
58512|NCT02383043|141609|P3|NOT COMPLETED|Overall Study||0
58513|NCT02383043|141610|P2|NOT COMPLETED|Overall Study||0
58514|NCT02383043|141611|P1|NOT COMPLETED|Overall Study||2
58515|NCT02383043|141609|P3|COMPLETED|Overall Study||4
58516|NCT02383043|141610|P2|COMPLETED|Overall Study||5
58517|NCT02383043|141611|P1|COMPLETED|Overall Study||7
58518|NCT02383043|141609|P3|STARTED|Overall Study||4
58519|NCT02383043|141610|P2|STARTED|Overall Study||5
58520|NCT02383043|141611|P1|STARTED|Overall Study||9
58521|NCT02382991|141622|P2|NOT COMPLETED|Overall Study||3
58522|NCT02382991|141623|P1|NOT COMPLETED|Overall Study||2
58523|NCT02382991|141622|P2|COMPLETED|Overall Study||15
58524|NCT02382991|141623|P1|COMPLETED|Overall Study||15
58525|NCT02382991|141622|P2|STARTED|Overall Study||18
58526|NCT02382991|141623|P1|STARTED|Overall Study||17
58527|NCT02382913|141643|P10|NOT COMPLETED|Overall Study||0
58528|NCT02382913|141644|P9|NOT COMPLETED|Overall Study||0
58529|NCT02382913|141645|P8|NOT COMPLETED|Overall Study||0
58530|NCT02382913|141646|P7|NOT COMPLETED|Overall Study||0
58531|NCT02382913|141647|P6|NOT COMPLETED|Overall Study||0
58532|NCT02382913|141648|P5|NOT COMPLETED|Overall Study||0
58533|NCT02382913|141649|P4|NOT COMPLETED|Overall Study||0
58534|NCT02382913|141650|P3|NOT COMPLETED|Overall Study||0
58535|NCT02382913|141651|P2|NOT COMPLETED|Overall Study||0
58536|NCT02382913|141652|P1|NOT COMPLETED|Overall Study||0
58537|NCT02382913|141643|P10|COMPLETED|Overall Study||33
58538|NCT02382913|141644|P9|COMPLETED|Overall Study||30
58539|NCT02382913|141645|P8|COMPLETED|Overall Study||30
58540|NCT02382913|141646|P7|COMPLETED|Overall Study||37
58541|NCT02382913|141647|P6|COMPLETED|Overall Study||30
58542|NCT02382913|141648|P5|COMPLETED|Overall Study||33
58543|NCT02382913|141649|P4|COMPLETED|Overall Study||27
58544|NCT02382913|141650|P3|COMPLETED|Overall Study||32
58545|NCT02382913|141651|P2|COMPLETED|Overall Study||36
58546|NCT02382913|141652|P1|COMPLETED|Overall Study||27
58547|NCT02382913|141643|P10|STARTED|Overall Study||33
58548|NCT02382913|141644|P9|STARTED|Overall Study||30
58549|NCT02382913|141645|P8|STARTED|Overall Study||30
58550|NCT02382913|141646|P7|STARTED|Overall Study||37
58551|NCT02382913|141647|P6|STARTED|Overall Study||30
58552|NCT02382913|141648|P5|STARTED|Overall Study||33
58553|NCT02382913|141649|P4|STARTED|Overall Study||27
58554|NCT02382913|141650|P3|STARTED|Overall Study||32
58555|NCT02382913|141651|P2|STARTED|Overall Study||36
58556|NCT02382913|141652|P1|STARTED|Overall Study||27
58557|NCT02382848|141688|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
58558|NCT02382848|141689|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
58559|NCT02382848|141688|P2|COMPLETED|Second Intervention (3 Weeks)||5
58560|NCT02382848|141689|P1|COMPLETED|Second Intervention (3 Weeks)||3
58561|NCT02382848|141688|P2|STARTED|Second Intervention (3 Weeks)||5
58562|NCT02382848|141689|P1|STARTED|Second Intervention (3 Weeks)||3
58563|NCT02382848|141688|P2|NOT COMPLETED|Washout (1 Week)||0
58564|NCT02382848|141689|P1|NOT COMPLETED|Washout (1 Week)||0
58565|NCT02382848|141688|P2|COMPLETED|Washout (1 Week)||5
58566|NCT02382848|141689|P1|COMPLETED|Washout (1 Week)||3
58567|NCT02382848|141688|P2|STARTED|Washout (1 Week)||5
58568|NCT02382848|141689|P1|STARTED|Washout (1 Week)||3
58569|NCT02382848|141688|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
58570|NCT02382848|141689|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
58571|NCT02382848|141688|P2|COMPLETED|First Intervention (3 Weeks)||5
58572|NCT02382848|141689|P1|COMPLETED|First Intervention (3 Weeks)||3
58573|NCT02382848|141688|P2|STARTED|First Intervention (3 Weeks)||5
58574|NCT02382848|141689|P1|STARTED|First Intervention (3 Weeks)||3
58575|NCT02382744|141707|P2|NOT COMPLETED|Overall Study||0
58576|NCT02382744|141708|P1|NOT COMPLETED|Overall Study||0
58577|NCT02382744|141707|P2|COMPLETED|Overall Study||40
58578|NCT02382744|141708|P1|COMPLETED|Overall Study||40
58579|NCT02382744|141707|P2|Analyzed|Overall Study||40
58580|NCT02382744|141708|P1|Analyzed|Overall Study||40
58581|NCT02382744|141707|P2|Allocated|Overall Study||40
58582|NCT02382744|141708|P1|Allocated|Overall Study||40
58583|NCT02382744|141707|P2|STARTED|Overall Study||40
58584|NCT02382744|141708|P1|STARTED|Overall Study||40
58585|NCT02382705|141739|P1|NOT COMPLETED|Overall Study||24
58586|NCT02382705|141739|P1|COMPLETED|Overall Study||33
58587|NCT02382705|141739|P1|STARTED|Overall Study||57
58588|NCT02382640|141750|P4|NOT COMPLETED|Intervention Period 4 (3 Days)||0
58589|NCT02382640|141751|P3|NOT COMPLETED|Intervention Period 4 (3 Days)||0
58590|NCT02382640|141752|P2|NOT COMPLETED|Intervention Period 4 (3 Days)||0
58591|NCT02382640|141753|P1|NOT COMPLETED|Intervention Period 4 (3 Days)||1
58592|NCT02382640|141750|P4|COMPLETED|Intervention Period 4 (3 Days)||9
58593|NCT02382640|141751|P3|COMPLETED|Intervention Period 4 (3 Days)||9
58594|NCT02382640|141752|P2|COMPLETED|Intervention Period 4 (3 Days)||9
58595|NCT02382640|141753|P1|COMPLETED|Intervention Period 4 (3 Days)||8
58596|NCT02382640|141750|P4|STARTED|Intervention Period 4 (3 Days)||9
58597|NCT02382640|141751|P3|STARTED|Intervention Period 4 (3 Days)||9
58598|NCT02382640|141752|P2|STARTED|Intervention Period 4 (3 Days)||9
58599|NCT02382640|141753|P1|STARTED|Intervention Period 4 (3 Days)||9
58600|NCT02382640|141750|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
58601|NCT02382640|141751|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
58602|NCT02382640|141752|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
58603|NCT02382640|141753|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
58604|NCT02382640|141750|P4|COMPLETED|Washout Period 3 (7 Days)||9
58605|NCT02382640|141751|P3|COMPLETED|Washout Period 3 (7 Days)||9
58606|NCT02382640|141752|P2|COMPLETED|Washout Period 3 (7 Days)||9
58607|NCT02382640|141753|P1|COMPLETED|Washout Period 3 (7 Days)||9
58608|NCT02382640|141750|P4|STARTED|Washout Period 3 (7 Days)||9
58609|NCT02382640|141751|P3|STARTED|Washout Period 3 (7 Days)||9
58610|NCT02382640|141752|P2|STARTED|Washout Period 3 (7 Days)||9
58611|NCT02382640|141753|P1|STARTED|Washout Period 3 (7 Days)||9
58612|NCT02382640|141750|P4|NOT COMPLETED|Intervention Period 3 (3 Days)||0
58613|NCT02382640|141751|P3|NOT COMPLETED|Intervention Period 3 (3 Days)||0
58614|NCT02382640|141752|P2|NOT COMPLETED|Intervention Period 3 (3 Days)||0
58615|NCT02382640|141753|P1|NOT COMPLETED|Intervention Period 3 (3 Days)||0
58616|NCT02382640|141750|P4|COMPLETED|Intervention Period 3 (3 Days)||9
58617|NCT02382640|141751|P3|COMPLETED|Intervention Period 3 (3 Days)||9
58618|NCT02382640|141752|P2|COMPLETED|Intervention Period 3 (3 Days)||9
58619|NCT02382640|141753|P1|COMPLETED|Intervention Period 3 (3 Days)||9
58620|NCT02382640|141750|P4|STARTED|Intervention Period 3 (3 Days)||9
58621|NCT02382640|141751|P3|STARTED|Intervention Period 3 (3 Days)||9
58622|NCT02382640|141752|P2|STARTED|Intervention Period 3 (3 Days)||9
58623|NCT02382640|141753|P1|STARTED|Intervention Period 3 (3 Days)||9
58624|NCT02382640|141750|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
58625|NCT02382640|141751|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
58626|NCT02382640|141752|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
58627|NCT02382640|141753|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
58628|NCT02382640|141750|P4|COMPLETED|Washout Period 2 (7 Days)||9
58629|NCT02382640|141751|P3|COMPLETED|Washout Period 2 (7 Days)||9
58630|NCT02382640|141752|P2|COMPLETED|Washout Period 2 (7 Days)||9
58631|NCT02382640|141753|P1|COMPLETED|Washout Period 2 (7 Days)||9
58632|NCT02382640|141750|P4|STARTED|Washout Period 2 (7 Days)||9
58633|NCT02382640|141751|P3|STARTED|Washout Period 2 (7 Days)||9
58634|NCT02382640|141752|P2|STARTED|Washout Period 2 (7 Days)||9
58635|NCT02382640|141753|P1|STARTED|Washout Period 2 (7 Days)||9
58636|NCT02382640|141750|P4|NOT COMPLETED|Intervention Period 2 (3 Days)||0
58637|NCT02382640|141751|P3|NOT COMPLETED|Intervention Period 2 (3 Days)||0
58638|NCT02382640|141752|P2|NOT COMPLETED|Intervention Period 2 (3 Days)||0
58639|NCT02382640|141753|P1|NOT COMPLETED|Intervention Period 2 (3 Days)||0
58640|NCT02382640|141750|P4|COMPLETED|Intervention Period 2 (3 Days)||9
58641|NCT02382640|141751|P3|COMPLETED|Intervention Period 2 (3 Days)||9
58642|NCT02382640|141752|P2|COMPLETED|Intervention Period 2 (3 Days)||9
58643|NCT02382640|141753|P1|COMPLETED|Intervention Period 2 (3 Days)||9
58644|NCT02382640|141750|P4|STARTED|Intervention Period 2 (3 Days)||9
58645|NCT02382640|141751|P3|STARTED|Intervention Period 2 (3 Days)||9
58646|NCT02382640|141752|P2|STARTED|Intervention Period 2 (3 Days)||9
58647|NCT02382640|141753|P1|STARTED|Intervention Period 2 (3 Days)||9
58648|NCT02382640|141750|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
58649|NCT02382640|141751|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
58650|NCT02382640|141752|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
58651|NCT02382640|141753|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
58652|NCT02382640|141750|P4|COMPLETED|Washout Period 1 (7 Days)||9
58653|NCT02382640|141751|P3|COMPLETED|Washout Period 1 (7 Days)||9
58654|NCT02382640|141752|P2|COMPLETED|Washout Period 1 (7 Days)||9
58655|NCT02382640|141753|P1|COMPLETED|Washout Period 1 (7 Days)||9
58656|NCT02382640|141750|P4|STARTED|Washout Period 1 (7 Days)||9
58657|NCT02382640|141751|P3|STARTED|Washout Period 1 (7 Days)||9
58658|NCT02382640|141752|P2|STARTED|Washout Period 1 (7 Days)||9
58659|NCT02382640|141753|P1|STARTED|Washout Period 1 (7 Days)||9
58660|NCT02382640|141750|P4|NOT COMPLETED|Intervention Period 1 (3 Days)||0
58661|NCT02382640|141751|P3|NOT COMPLETED|Intervention Period 1 (3 Days)||0
58662|NCT02382640|141752|P2|NOT COMPLETED|Intervention Period 1 (3 Days)||0
58663|NCT02382640|141753|P1|NOT COMPLETED|Intervention Period 1 (3 Days)||0
58664|NCT02382640|141750|P4|COMPLETED|Intervention Period 1 (3 Days)||9
58665|NCT02382640|141751|P3|COMPLETED|Intervention Period 1 (3 Days)||9
58666|NCT02382640|141752|P2|COMPLETED|Intervention Period 1 (3 Days)||9
58667|NCT02382640|141753|P1|COMPLETED|Intervention Period 1 (3 Days)||9
58668|NCT02382640|141750|P4|STARTED|Intervention Period 1 (3 Days)||9
58669|NCT02382640|141751|P3|STARTED|Intervention Period 1 (3 Days)||9
58670|NCT02382640|141752|P2|STARTED|Intervention Period 1 (3 Days)||9
58671|NCT02382640|141753|P1|STARTED|Intervention Period 1 (3 Days)||9
58672|NCT02382133|141791|P1|NOT COMPLETED|Overall Study||33
58673|NCT02382133|141791|P1|COMPLETED|Overall Study||10
58674|NCT02382133|141791|P1|STARTED|Overall Study||43
58675|NCT02382016|141798|P2|NOT COMPLETED|OL Extension Period||0
58676|NCT02382016|141799|P1|NOT COMPLETED|OL Extension Period||6
58677|NCT02382016|141798|P2|COMPLETED|OL Extension Period||0
58678|NCT02382016|141799|P1|COMPLETED|OL Extension Period||27
58679|NCT02382016|141798|P2|STARTED|OL Extension Period||0
58680|NCT02382016|141799|P1|STARTED|OL Extension Period|Participants(French site) who completed DB,OL periods, consented receiving macitentan in OLE period.|33
58681|NCT02382016|141798|P2|NOT COMPLETED|Open-label (OL) Treatment Period||0
58682|NCT02382016|141799|P1|NOT COMPLETED|Open-label (OL) Treatment Period||9
58683|NCT02382016|141798|P2|COMPLETED|Open-label (OL) Treatment Period||0
58684|NCT02382016|141799|P1|COMPLETED|Open-label (OL) Treatment Period||71
58685|NCT02382016|141798|P2|STARTED|Open-label (OL) Treatment Period||0
58686|NCT02382016|141799|P1|STARTED|Open-label (OL) Treatment Period||80
58687|NCT02382016|141798|P2|NOT COMPLETED|Double-blind (DB) Treatment Period||1
58688|NCT02382016|141799|P1|NOT COMPLETED|Double-blind (DB) Treatment Period||4
58689|NCT02382016|141798|P2|COMPLETED|Double-blind (DB) Treatment Period||41
58690|NCT02382016|141799|P1|COMPLETED|Double-blind (DB) Treatment Period||39
58691|NCT02382016|141798|P2|STARTED|Double-blind (DB) Treatment Period||42
58692|NCT02382016|141799|P1|STARTED|Double-blind (DB) Treatment Period||43
58693|NCT02381795|141823|P1|NOT COMPLETED|Overall Study||3
58694|NCT02381795|141823|P1|COMPLETED|Overall Study||7
58695|NCT02381795|141823|P1|STARTED|Overall Study||10
58696|NCT02381678|141827|P3|NOT COMPLETED|Overall Study||0
58697|NCT02381678|141828|P2|NOT COMPLETED|Overall Study||0
58698|NCT02381678|141829|P1|NOT COMPLETED|Overall Study||0
58699|NCT02381678|141827|P3|COMPLETED|Overall Study||32
58700|NCT02381678|141828|P2|COMPLETED|Overall Study||139
58701|NCT02381678|141829|P1|COMPLETED|Overall Study||54
58702|NCT02381678|141827|P3|STARTED|Overall Study||32
58703|NCT02381678|141828|P2|STARTED|Overall Study||139
58704|NCT02381678|141829|P1|STARTED|Overall Study||54
58705|NCT02381418|141835|P1|NOT COMPLETED|Overall Study||0
58706|NCT02381418|141835|P1|COMPLETED|Overall Study||120
58707|NCT02381418|141835|P1|STARTED|Overall Study||120
58708|NCT02381392|141843|P2|NOT COMPLETED|Overall Study||0
58709|NCT02381392|141844|P1|NOT COMPLETED|Overall Study||0
58710|NCT02381392|141843|P2|COMPLETED|Overall Study||12
58711|NCT02381392|141844|P1|COMPLETED|Overall Study||11
58712|NCT02381392|141843|P2|STARTED|Overall Study||12
58713|NCT02381392|141844|P1|STARTED|Overall Study||11
58714|NCT02381288|141862|P4|NOT COMPLETED|Overall Study||0
58715|NCT02381288|141863|P3|NOT COMPLETED|Overall Study||0
58716|NCT02381288|141864|P2|NOT COMPLETED|Overall Study||0
58717|NCT02381288|141865|P1|NOT COMPLETED|Overall Study||0
58718|NCT02381288|141862|P4|COMPLETED|Overall Study||5
58719|NCT02381288|141863|P3|COMPLETED|Overall Study||5
58720|NCT02381288|141864|P2|COMPLETED|Overall Study||2
58721|NCT02381288|141865|P1|COMPLETED|Overall Study||5
58722|NCT02381288|141862|P4|STARTED|Overall Study||5
58723|NCT02381288|141863|P3|STARTED|Overall Study||5
58724|NCT02381288|141864|P2|STARTED|Overall Study||2
58725|NCT02381288|141865|P1|STARTED|Overall Study||5
58726|NCT02381015|141896|P4|NOT COMPLETED|Year 3 Chart Review||51
58727|NCT02381015|141897|P3|NOT COMPLETED|Year 3 Chart Review||58
58728|NCT02381015|141898|P2|NOT COMPLETED|Year 3 Chart Review||34
58729|NCT02381015|141899|P1|NOT COMPLETED|Year 3 Chart Review||47
58730|NCT02381015|141896|P4|COMPLETED|Year 3 Chart Review||118
58731|NCT02381015|141897|P3|COMPLETED|Year 3 Chart Review||115
58732|NCT02381015|141898|P2|COMPLETED|Year 3 Chart Review||134
58733|NCT02381015|141899|P1|COMPLETED|Year 3 Chart Review||125
58734|NCT02381015|141896|P4|STARTED|Year 3 Chart Review||169
58735|NCT02381015|141897|P3|STARTED|Year 3 Chart Review||173
58736|NCT02381015|141898|P2|STARTED|Year 3 Chart Review||168
58737|NCT02381015|141899|P1|STARTED|Year 3 Chart Review||172
58738|NCT02381015|141896|P4|NOT COMPLETED|Visit 3 - 3 Months Followup||0
58739|NCT02381015|141897|P3|NOT COMPLETED|Visit 3 - 3 Months Followup||0
58740|NCT02381015|141898|P2|NOT COMPLETED|Visit 3 - 3 Months Followup||0
58741|NCT02381015|141899|P1|NOT COMPLETED|Visit 3 - 3 Months Followup||0
58742|NCT02381015|141896|P4|COMPLETED|Visit 3 - 3 Months Followup||169
58743|NCT02381015|141897|P3|COMPLETED|Visit 3 - 3 Months Followup||173
58744|NCT02381015|141898|P2|COMPLETED|Visit 3 - 3 Months Followup||168
58745|NCT02381015|141899|P1|COMPLETED|Visit 3 - 3 Months Followup||172
58746|NCT02381015|141896|P4|STARTED|Visit 3 - 3 Months Followup||169
58747|NCT02381015|141897|P3|STARTED|Visit 3 - 3 Months Followup||173
58748|NCT02381015|141898|P2|STARTED|Visit 3 - 3 Months Followup||168
58749|NCT02381015|141899|P1|STARTED|Visit 3 - 3 Months Followup||172
58750|NCT02381015|141896|P4|NOT COMPLETED|Visit 2 - Results DIsclosure||3
58751|NCT02381015|141897|P3|NOT COMPLETED|Visit 2 - Results DIsclosure||2
58752|NCT02381015|141898|P2|NOT COMPLETED|Visit 2 - Results DIsclosure||5
58753|NCT02381015|141899|P1|NOT COMPLETED|Visit 2 - Results DIsclosure||3
58754|NCT02381015|141896|P4|COMPLETED|Visit 2 - Results DIsclosure||169
58755|NCT02381015|141897|P3|COMPLETED|Visit 2 - Results DIsclosure||173
58756|NCT02381015|141898|P2|COMPLETED|Visit 2 - Results DIsclosure||168
58757|NCT02381015|141899|P1|COMPLETED|Visit 2 - Results DIsclosure||172
58758|NCT02381015|141896|P4|STARTED|Visit 2 - Results DIsclosure||172
58759|NCT02381015|141897|P3|STARTED|Visit 2 - Results DIsclosure||175
58760|NCT02381015|141898|P2|STARTED|Visit 2 - Results DIsclosure||173
58761|NCT02381015|141899|P1|STARTED|Visit 2 - Results DIsclosure||175
58762|NCT02381015|141896|P4|NOT COMPLETED|Visit 1 - Enrollment||3
58763|NCT02381015|141897|P3|NOT COMPLETED|Visit 1 - Enrollment||0
58764|NCT02381015|141898|P2|NOT COMPLETED|Visit 1 - Enrollment||2
58765|NCT02381015|141899|P1|NOT COMPLETED|Visit 1 - Enrollment||0
58766|NCT02381015|141896|P4|COMPLETED|Visit 1 - Enrollment||172
58767|NCT02381015|141897|P3|COMPLETED|Visit 1 - Enrollment||175
58768|NCT02381015|141898|P2|COMPLETED|Visit 1 - Enrollment||173
58769|NCT02381015|141899|P1|COMPLETED|Visit 1 - Enrollment||175
58770|NCT02381015|141896|P4|STARTED|Visit 1 - Enrollment||175
58771|NCT02381015|141897|P3|STARTED|Visit 1 - Enrollment||175
58772|NCT02381015|141898|P2|STARTED|Visit 1 - Enrollment||175
58773|NCT02381015|141899|P1|STARTED|Visit 1 - Enrollment||175
58774|NCT02380859|141931|P2|NOT COMPLETED|Overall Study||0
58775|NCT02380859|141932|P1|NOT COMPLETED|Overall Study||2
58776|NCT02380859|141931|P2|COMPLETED|Overall Study||13
58777|NCT02380859|141932|P1|COMPLETED|Overall Study||17
58778|NCT02380859|141931|P2|STARTED|Overall Study||13
58779|NCT02380859|141932|P1|STARTED|Overall Study||19
58780|NCT02380742|141968|P2|NOT COMPLETED|Overall Study||0
58781|NCT02380742|141969|P1|NOT COMPLETED|Overall Study||1
58782|NCT02380742|141968|P2|COMPLETED|Overall Study||26
58783|NCT02380742|141969|P1|COMPLETED|Overall Study||27
58784|NCT02380742|141968|P2|STARTED|Overall Study||26
58785|NCT02380742|141969|P1|STARTED|Overall Study||28
58786|NCT02380287|141989|P8|NOT COMPLETED|Overall Study||0
58787|NCT02380287|141990|P7|NOT COMPLETED|Overall Study||0
58788|NCT02380287|141991|P6|NOT COMPLETED|Overall Study||0
58789|NCT02380287|141992|P5|NOT COMPLETED|Overall Study||0
58790|NCT02380287|141993|P4|NOT COMPLETED|Overall Study||0
58791|NCT02380287|141994|P3|NOT COMPLETED|Overall Study||1
58792|NCT02380287|141995|P2|NOT COMPLETED|Overall Study||0
58793|NCT02380287|141996|P1|NOT COMPLETED|Overall Study||0
58794|NCT02380287|141989|P8|COMPLETED|Overall Study||3
58795|NCT02380287|141990|P7|COMPLETED|Overall Study||3
58796|NCT02380287|141991|P6|COMPLETED|Overall Study||3
58797|NCT02380287|141992|P5|COMPLETED|Overall Study||3
58798|NCT02380287|141993|P4|COMPLETED|Overall Study||3
58799|NCT02380287|141994|P3|COMPLETED|Overall Study||2
58800|NCT02380287|141995|P2|COMPLETED|Overall Study||3
58801|NCT02380287|141996|P1|COMPLETED|Overall Study||1
58802|NCT02380287|141989|P8|STARTED|Overall Study||3
58803|NCT02380287|141990|P7|STARTED|Overall Study||3
58804|NCT02380287|141991|P6|STARTED|Overall Study||3
58805|NCT02380287|141992|P5|STARTED|Overall Study||3
58806|NCT02380287|141993|P4|STARTED|Overall Study||3
58807|NCT02380287|141994|P3|STARTED|Overall Study||3
58808|NCT02380287|141995|P2|STARTED|Overall Study||3
58809|NCT02380287|141996|P1|STARTED|Overall Study||1
58810|NCT02380261|142007|P1|NOT COMPLETED|Overall Study||0
58811|NCT02380261|142007|P1|COMPLETED|Overall Study||35
58812|NCT02380261|142007|P1|STARTED|Overall Study||35
58813|NCT02380248|142012|P1|NOT COMPLETED|Overall Study||14
58814|NCT02380248|142012|P1|COMPLETED|Overall Study||186
58815|NCT02380248|142012|P1|STARTED|Overall Study||200
58816|NCT02380183|142019|P2|NOT COMPLETED|Overall Study||0
58817|NCT02380183|142020|P1|NOT COMPLETED|Overall Study||0
58818|NCT02380183|142019|P2|COMPLETED|Overall Study||34
58819|NCT02380183|142020|P1|COMPLETED|Overall Study||36
58820|NCT02380183|142019|P2|STARTED|Overall Study||34
58821|NCT02380183|142020|P1|STARTED|Overall Study||36
58822|NCT02379923|142028|P1|NOT COMPLETED|Overall Study||5
58823|NCT02379923|142028|P1|COMPLETED|Overall Study||158
58824|NCT02379923|142028|P1|STARTED|Overall Study||163
58825|NCT02379858|142044|P2|NOT COMPLETED|Overall Study||0
58826|NCT02379858|142045|P1|NOT COMPLETED|Overall Study||0
58827|NCT02379858|142044|P2|COMPLETED|Overall Study||4
58828|NCT02379858|142045|P1|COMPLETED|Overall Study||6
58829|NCT02379858|142044|P2|STARTED|Overall Study||4
58830|NCT02379858|142045|P1|STARTED|Overall Study||6
58831|NCT02379637|142057|P2|NOT COMPLETED|Overall Study||1
58832|NCT02379637|142058|P1|NOT COMPLETED|Overall Study||2
58833|NCT02379637|142057|P2|COMPLETED|Overall Study||34
58834|NCT02379637|142058|P1|COMPLETED|Overall Study||33
58835|NCT02379637|142057|P2|STARTED|Overall Study||35
58836|NCT02379637|142058|P1|STARTED|Overall Study||35
58837|NCT02379585|142068|P2|NOT COMPLETED|Overall Study||5
58838|NCT02379585|142069|P1|NOT COMPLETED|Overall Study||3
58839|NCT02379585|142068|P2|COMPLETED|Overall Study||0
58840|NCT02379585|142069|P1|COMPLETED|Overall Study||0
58841|NCT02379585|142068|P2|STARTED|Overall Study||5
58842|NCT02379585|142069|P1|STARTED|Overall Study||3
58843|NCT02379442|142091|P1|NOT COMPLETED|Overall Study||0
58844|NCT02379442|142091|P1|COMPLETED|Overall Study||1
58845|NCT02379442|142091|P1|STARTED|Overall Study||1
58846|NCT02379390|142097|P2|NOT COMPLETED|Overall Study||2
58847|NCT02379390|142098|P1|NOT COMPLETED|Overall Study||2
58848|NCT02379390|142097|P2|COMPLETED|Overall Study||2
58849|NCT02379390|142098|P1|COMPLETED|Overall Study||2
58850|NCT02379390|142097|P2|STARTED|Overall Study||4
58851|NCT02379390|142098|P1|STARTED|Overall Study||4
58852|NCT02379221|142126|P1|NOT COMPLETED|Overall Study||1
58853|NCT02379221|142126|P1|COMPLETED|Overall Study||48
58854|NCT02379221|142126|P1|STARTED|Overall Study||49
58855|NCT02379117|142143|P2|NOT COMPLETED|Overall Study||0
58856|NCT02379117|142144|P1|NOT COMPLETED|Overall Study||0
58857|NCT02379117|142143|P2|COMPLETED|Overall Study||31
58858|NCT02379117|142144|P1|COMPLETED|Overall Study||30
58859|NCT02379117|142143|P2|STARTED|Overall Study||31
58860|NCT02379117|142144|P1|STARTED|Overall Study||30
58861|NCT02379091|142154|P4|NOT COMPLETED|Overall Study||14
58862|NCT02379091|142155|P3|NOT COMPLETED|Overall Study||7
58863|NCT02379091|142156|P2|NOT COMPLETED|Overall Study||10
58864|NCT02379091|142157|P1|NOT COMPLETED|Overall Study||12
58865|NCT02379091|142154|P4|COMPLETED|Overall Study||14
58866|NCT02379091|142155|P3|COMPLETED|Overall Study||18
58867|NCT02379091|142156|P2|COMPLETED|Overall Study||18
58868|NCT02379091|142157|P1|COMPLETED|Overall Study||15
58869|NCT02379091|142154|P4|Full Analysis Set|Overall Study||28
58870|NCT02379091|142155|P3|Full Analysis Set|Overall Study|One participant was excluded because of data collection issues.|24
58871|NCT02379091|142156|P2|Full Analysis Set|Overall Study||28
58872|NCT02379091|142157|P1|Full Analysis Set|Overall Study|One participant was excluded because of data collection issues.|26
58873|NCT02379091|142154|P4|STARTED|Overall Study||28
58874|NCT02379091|142155|P3|STARTED|Overall Study||25
58875|NCT02379091|142156|P2|STARTED|Overall Study||28
58876|NCT02379091|142157|P1|STARTED|Overall Study||27
58877|NCT02378961|142197|P4|NOT COMPLETED|Overall Study||1
58878|NCT02378961|142198|P3|NOT COMPLETED|Overall Study||1
58879|NCT02378961|142199|P2|NOT COMPLETED|Overall Study||2
58880|NCT02378961|142200|P1|NOT COMPLETED|Overall Study||4
58881|NCT02378961|142197|P4|COMPLETED|Overall Study||28
58882|NCT02378961|142198|P3|COMPLETED|Overall Study||35
58883|NCT02378961|142199|P2|COMPLETED|Overall Study||28
58884|NCT02378961|142200|P1|COMPLETED|Overall Study||29
58885|NCT02378961|142197|P4|STARTED|Overall Study||29
58886|NCT02378961|142198|P3|STARTED|Overall Study||36
58887|NCT02378961|142199|P2|STARTED|Overall Study||30
58888|NCT02378961|142200|P1|STARTED|Overall Study||33
58889|NCT02378935|142237|P7|NOT COMPLETED|Overall Study||0
58890|NCT02378935|142238|P6|NOT COMPLETED|Overall Study||0
58891|NCT02378935|142239|P5|NOT COMPLETED|Overall Study||0
58892|NCT02378935|142240|P4|NOT COMPLETED|Overall Study||6
58893|NCT02378935|142241|P3|NOT COMPLETED|Overall Study||3
58894|NCT02378935|142242|P2|NOT COMPLETED|Overall Study||0
58895|NCT02378935|142243|P1|NOT COMPLETED|Overall Study||10
58896|NCT02378935|142237|P7|COMPLETED|Overall Study||8
58897|NCT02378935|142238|P6|COMPLETED|Overall Study||32
58898|NCT02378935|142239|P5|COMPLETED|Overall Study||31
58899|NCT02378935|142240|P4|COMPLETED|Overall Study||25
58900|NCT02378935|142241|P3|COMPLETED|Overall Study||30
58901|NCT02378935|142242|P2|COMPLETED|Overall Study||36
58902|NCT02378935|142243|P1|COMPLETED|Overall Study||24
58903|NCT02378935|142237|P7|STARTED|Overall Study||8
58904|NCT02378935|142238|P6|STARTED|Overall Study||32
58905|NCT02378935|142239|P5|STARTED|Overall Study||31
58906|NCT02378935|142240|P4|STARTED|Overall Study||31
58907|NCT02378935|142241|P3|STARTED|Overall Study||33
58908|NCT02378935|142242|P2|STARTED|Overall Study||36
58909|NCT02378935|142243|P1|STARTED|Overall Study||34
58910|NCT02378883|142294|P1|NOT COMPLETED|12 Months Follow-Up||5
58911|NCT02378883|142294|P1|COMPLETED|12 Months Follow-Up||41
58912|NCT02378883|142294|P1|STARTED|12 Months Follow-Up|Two deaths occurred between 30 day FU and prior to 12 month FU.|46
58913|NCT02378883|142294|P1|NOT COMPLETED|30 Day Follow-Up||6
58914|NCT02378883|142294|P1|COMPLETED|30 Day Follow-Up||106
58915|NCT02378883|142294|P1|STARTED|30 Day Follow-Up||112
58916|NCT02378883|142294|P1|NOT COMPLETED|Discharge||0
58917|NCT02378883|142294|P1|COMPLETED|Discharge||112
58918|NCT02378883|142294|P1|STARTED|Discharge||112
58919|NCT02378883|142294|P1|NOT COMPLETED|Enrollment||9
58920|NCT02378883|142294|P1|COMPLETED|Enrollment|Attempted with study device - intent to treat population|112
58921|NCT02378883|142294|P1|STARTED|Enrollment|Participants consented and assessed for eligibility|121
58922|NCT02378844|142307|P3|NOT COMPLETED|Open Label Period||0
58923|NCT02378844|142308|P2|NOT COMPLETED|Open Label Period||48
58924|NCT02378844|142309|P1|NOT COMPLETED|Open Label Period||43
58925|NCT02378844|142307|P3|COMPLETED|Open Label Period||0
58926|NCT02378844|142308|P2|COMPLETED|Open Label Period||87
58927|NCT02378844|142309|P1|COMPLETED|Open Label Period||99
58928|NCT02378844|142307|P3|STARTED|Open Label Period||0
58929|NCT02378844|142308|P2|STARTED|Open Label Period||135
58930|NCT02378844|142309|P1|STARTED|Open Label Period||142
58931|NCT02378844|142307|P3|NOT COMPLETED|Randomized Period (Double Blind)||0
58932|NCT02378844|142308|P2|NOT COMPLETED|Randomized Period (Double Blind)||32
58933|NCT02378844|142309|P1|NOT COMPLETED|Randomized Period (Double Blind)||23
58934|NCT02378844|142307|P3|COMPLETED|Randomized Period (Double Blind)||0
58935|NCT02378844|142308|P2|COMPLETED|Randomized Period (Double Blind)||135
58936|NCT02378844|142309|P1|COMPLETED|Randomized Period (Double Blind)||142
58937|NCT02378844|142307|P3|STARTED|Randomized Period (Double Blind)||0
58938|NCT02378844|142308|P2|STARTED|Randomized Period (Double Blind)||167
58939|NCT02378844|142309|P1|STARTED|Randomized Period (Double Blind)||165
58940|NCT02378844|142307|P3|NOT COMPLETED|Run-in Period||136
58941|NCT02378844|142308|P2|NOT COMPLETED|Run-in Period||5
58942|NCT02378844|142309|P1|NOT COMPLETED|Run-in Period||4
58943|NCT02378844|142307|P3|COMPLETED|Run-in Period||0
58944|NCT02378844|142308|P2|COMPLETED|Run-in Period||167
58945|NCT02378844|142309|P1|COMPLETED|Run-in Period||165
58946|NCT02378844|142307|P3|STARTED|Run-in Period||136
58947|NCT02378844|142308|P2|STARTED|Run-in Period||172
58948|NCT02378844|142309|P1|STARTED|Run-in Period||169
58949|NCT02378753|142339|P2|NOT COMPLETED|Overall Study||695
58950|NCT02378753|142340|P1|NOT COMPLETED|Overall Study||218
58951|NCT02378753|142339|P2|COMPLETED|Overall Study||3637
58952|NCT02378753|142340|P1|COMPLETED|Overall Study||4101
58953|NCT02378753|142339|P2|STARTED|Overall Study||4332
58954|NCT02378753|142340|P1|STARTED|Overall Study||4319
58955|NCT02378662|142360|P2|NOT COMPLETED|Overall Study||0
58956|NCT02378662|142361|P1|NOT COMPLETED|Overall Study||2
58957|NCT02378662|142360|P2|COMPLETED|Overall Study||0
58958|NCT02378662|142361|P1|COMPLETED|Overall Study||0
58959|NCT02378662|142360|P2|Implantation|Overall Study||0
58960|NCT02378662|142361|P1|Implantation|Overall Study||2
58961|NCT02378662|142360|P2|Harvesting|Overall Study||0
58962|NCT02378662|142361|P1|Harvesting|Overall Study||2
58963|NCT02378662|142360|P2|STARTED|Overall Study||0
58964|NCT02378662|142361|P1|STARTED|Overall Study||2
58965|NCT02378506|142367|P1|NOT COMPLETED|Overall Study||25
58966|NCT02378506|142367|P1|COMPLETED|Overall Study||163
58967|NCT02378506|142367|P1|Treated|Overall Study||187
58968|NCT02378506|142367|P1|STARTED|Overall Study||188
58969|NCT02378480|142386|P2|NOT COMPLETED|Overall Study||32
58970|NCT02378480|142387|P1|NOT COMPLETED|Overall Study||28
58971|NCT02378480|142386|P2|COMPLETED|Overall Study||294
58972|NCT02378480|142387|P1|COMPLETED|Overall Study||301
58973|NCT02378480|142386|P2|STARTED|Overall Study||326
58974|NCT02378480|142387|P1|STARTED|Overall Study||329
58975|NCT02378402|142402|P3|NOT COMPLETED|Overall Study||0
58976|NCT02378402|142403|P2|NOT COMPLETED|Overall Study||2
58977|NCT02378402|142404|P1|NOT COMPLETED|Overall Study||0
58978|NCT02378402|142402|P3|COMPLETED|Overall Study||21
58979|NCT02378402|142403|P2|COMPLETED|Overall Study||23
58980|NCT02378402|142404|P1|COMPLETED|Overall Study||25
58981|NCT02378402|142402|P3|STARTED|Overall Study||21
58982|NCT02378402|142403|P2|STARTED|Overall Study||25
58983|NCT02378402|142404|P1|STARTED|Overall Study||25
58984|NCT02378220|142414|P2|NOT COMPLETED|Overall Study||1
58985|NCT02378220|142415|P1|NOT COMPLETED|Overall Study||6
58986|NCT02378220|142414|P2|COMPLETED|Overall Study||56
58987|NCT02378220|142415|P1|COMPLETED|Overall Study||47
58988|NCT02378220|142414|P2|STARTED|Overall Study||57
58989|NCT02378220|142415|P1|STARTED|Overall Study||53
58990|NCT02378207|142449|P4|NOT COMPLETED|Overall Study||1
58991|NCT02378207|142450|P3|NOT COMPLETED|Overall Study||2
58992|NCT02378207|142451|P2|NOT COMPLETED|Overall Study||3
58993|NCT02378207|142452|P1|NOT COMPLETED|Overall Study||0
58994|NCT02378207|142449|P4|COMPLETED|Overall Study||11
58995|NCT02378207|142450|P3|COMPLETED|Overall Study||22
58996|NCT02378207|142451|P2|COMPLETED|Overall Study||21
58997|NCT02378207|142452|P1|COMPLETED|Overall Study||24
58998|NCT02378207|142449|P4|STARTED|Overall Study||12
58999|NCT02378207|142450|P3|STARTED|Overall Study||24
59000|NCT02378207|142451|P2|STARTED|Overall Study||24
59001|NCT02378207|142452|P1|STARTED|Overall Study||24
59002|NCT02377921|142468|P2|NOT COMPLETED|Overall Study||1
59003|NCT02377921|142469|P1|NOT COMPLETED|Overall Study||1
59004|NCT02377921|142468|P2|COMPLETED|Overall Study||43
59005|NCT02377921|142469|P1|COMPLETED|Overall Study||44
59006|NCT02377921|142468|P2|STARTED|Overall Study||44
59007|NCT02377921|142469|P1|STARTED|Overall Study||45
59008|NCT02377466|142493|P2|NOT COMPLETED|Overall Study||2
59009|NCT02377466|142494|P1|NOT COMPLETED|Overall Study||0
59010|NCT02377466|142493|P2|COMPLETED|Overall Study||10
59011|NCT02377466|142494|P1|COMPLETED|Overall Study||13
59012|NCT02377466|142493|P2|Treated|Overall Study||10
59013|NCT02377466|142494|P1|Treated|Overall Study||13
59014|NCT02377466|142493|P2|STARTED|Overall Study||12
59015|NCT02377466|142494|P1|STARTED|Overall Study||13
59016|NCT02377427|142612|P5|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
59017|NCT02377427|142613|P4|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
59018|NCT02377427|142614|P3|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||1
59019|NCT02377427|142615|P2|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
59020|NCT02377427|142616|P1|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
59021|NCT02377427|142612|P5|COMPLETED|Part B (From Week 20 and up to Week 80)||4
59022|NCT02377427|142613|P4|COMPLETED|Part B (From Week 20 and up to Week 80)||10
59023|NCT02377427|142614|P3|COMPLETED|Part B (From Week 20 and up to Week 80)||15
59024|NCT02377427|142615|P2|COMPLETED|Part B (From Week 20 and up to Week 80)||0
59025|NCT02377427|142616|P1|COMPLETED|Part B (From Week 20 and up to Week 80)||0
59026|NCT02377427|142612|P5|STARTED|Part B (From Week 20 and up to Week 80)||4
59027|NCT02377427|142613|P4|STARTED|Part B (From Week 20 and up to Week 80)||10
59028|NCT02377427|142614|P3|STARTED|Part B (From Week 20 and up to Week 80)|Two participants of PartA chose not to continue in PartB;4 shifted to PartB Mepolizumab 40/100mg arm|16
59029|NCT02377427|142615|P2|STARTED|Part B (From Week 20 and up to Week 80)||0
59030|NCT02377427|142616|P1|STARTED|Part B (From Week 20 and up to Week 80)||0
59031|NCT02377427|142612|P5|NOT COMPLETED|Part A (Up to Week 20)||0
59032|NCT02377427|142613|P4|NOT COMPLETED|Part A (Up to Week 20)||0
59033|NCT02377427|142614|P3|NOT COMPLETED|Part A (Up to Week 20)||0
59034|NCT02377427|142615|P2|NOT COMPLETED|Part A (Up to Week 20)||0
59035|NCT02377427|142616|P1|NOT COMPLETED|Part A (Up to Week 20)||4
59036|NCT02377427|142612|P5|COMPLETED|Part A (Up to Week 20)||0
59037|NCT02377427|142613|P4|COMPLETED|Part A (Up to Week 20)||0
59038|NCT02377427|142614|P3|COMPLETED|Part A (Up to Week 20)||0
59039|NCT02377427|142615|P2|COMPLETED|Part A (Up to Week 20)||10
59040|NCT02377427|142616|P1|COMPLETED|Part A (Up to Week 20)||22
59041|NCT02377427|142612|P5|STARTED|Part A (Up to Week 20)||0
59042|NCT02377427|142613|P4|STARTED|Part A (Up to Week 20)||0
59043|NCT02377427|142614|P3|STARTED|Part A (Up to Week 20)||0
59044|NCT02377427|142615|P2|STARTED|Part A (Up to Week 20)||10
59045|NCT02377427|142616|P1|STARTED|Part A (Up to Week 20)||26
59046|NCT02377362|142689|P13|NOT COMPLETED|Part B Overall||0
59047|NCT02377362|142690|P12|NOT COMPLETED|Part B Overall||1
59048|NCT02377362|142691|P11|NOT COMPLETED|Part B Overall||0
59049|NCT02377362|142692|P10|NOT COMPLETED|Part B Overall||1
59050|NCT02377362|142693|P9|NOT COMPLETED|Part B Overall||0
59051|NCT02377362|142694|P8|NOT COMPLETED|Part B Overall||1
59052|NCT02377362|142695|P7|NOT COMPLETED|Part B Overall||2
59053|NCT02377362|142696|P6|NOT COMPLETED|Part B Overall||0
59054|NCT02377362|142697|P5|NOT COMPLETED|Part B Overall||0
59055|NCT02377362|142698|P4|NOT COMPLETED|Part B Overall||0
59056|NCT02377362|142699|P3|NOT COMPLETED|Part B Overall||0
59057|NCT02377362|142700|P2|NOT COMPLETED|Part B Overall||0
59058|NCT02377362|142701|P1|NOT COMPLETED|Part B Overall||0
59059|NCT02377362|142689|P13|COMPLETED|Part B Overall||12
59060|NCT02377362|142690|P12|COMPLETED|Part B Overall||6
59061|NCT02377362|142691|P11|COMPLETED|Part B Overall||6
59062|NCT02377362|142692|P10|COMPLETED|Part B Overall||6
59063|NCT02377362|142693|P9|COMPLETED|Part B Overall||6
59064|NCT02377362|142694|P8|COMPLETED|Part B Overall||5
59065|NCT02377362|142695|P7|COMPLETED|Part B Overall||4
59066|NCT02377362|142696|P6|COMPLETED|Part B Overall||0
59067|NCT02377362|142697|P5|COMPLETED|Part B Overall||0
59068|NCT02377362|142698|P4|COMPLETED|Part B Overall||0
59069|NCT02377362|142699|P3|COMPLETED|Part B Overall||0
59070|NCT02377362|142700|P2|COMPLETED|Part B Overall||0
59071|NCT02377362|142701|P1|COMPLETED|Part B Overall||0
59072|NCT02377362|142689|P13|STARTED|Part B Overall||12
59073|NCT02377362|142690|P12|STARTED|Part B Overall||7
59074|NCT02377362|142691|P11|STARTED|Part B Overall||6
59075|NCT02377362|142692|P10|STARTED|Part B Overall||7
59076|NCT02377362|142693|P9|STARTED|Part B Overall||6
59077|NCT02377362|142694|P8|STARTED|Part B Overall||6
59078|NCT02377362|142695|P7|STARTED|Part B Overall||6
59079|NCT02377362|142696|P6|STARTED|Part B Overall||0
59080|NCT02377362|142697|P5|STARTED|Part B Overall||0
59081|NCT02377362|142698|P4|STARTED|Part B Overall||0
59082|NCT02377362|142699|P3|STARTED|Part B Overall||0
59083|NCT02377362|142700|P2|STARTED|Part B Overall||0
59084|NCT02377362|142701|P1|STARTED|Part B Overall||0
59085|NCT02377362|142689|P13|NOT COMPLETED|Part A Third Treatment||0
59086|NCT02377362|142690|P12|NOT COMPLETED|Part A Third Treatment||0
59087|NCT02377362|142691|P11|NOT COMPLETED|Part A Third Treatment||0
59088|NCT02377362|142692|P10|NOT COMPLETED|Part A Third Treatment||0
59089|NCT02377362|142693|P9|NOT COMPLETED|Part A Third Treatment||0
59090|NCT02377362|142694|P8|NOT COMPLETED|Part A Third Treatment||0
59091|NCT02377362|142695|P7|NOT COMPLETED|Part A Third Treatment||0
59092|NCT02377362|142696|P6|NOT COMPLETED|Part A Third Treatment||4
59093|NCT02377362|142697|P5|NOT COMPLETED|Part A Third Treatment||3
59094|NCT02377362|142698|P4|NOT COMPLETED|Part A Third Treatment||4
59095|NCT02377362|142699|P3|NOT COMPLETED|Part A Third Treatment||0
59096|NCT02377362|142700|P2|NOT COMPLETED|Part A Third Treatment||0
59097|NCT02377362|142701|P1|NOT COMPLETED|Part A Third Treatment||0
59098|NCT02377362|142689|P13|COMPLETED|Part A Third Treatment||0
59099|NCT02377362|142690|P12|COMPLETED|Part A Third Treatment||0
59100|NCT02377362|142691|P11|COMPLETED|Part A Third Treatment||0
59101|NCT02377362|142692|P10|COMPLETED|Part A Third Treatment||0
59102|NCT02377362|142693|P9|COMPLETED|Part A Third Treatment||0
59103|NCT02377362|142694|P8|COMPLETED|Part A Third Treatment||0
59104|NCT02377362|142695|P7|COMPLETED|Part A Third Treatment||0
59105|NCT02377362|142696|P6|COMPLETED|Part A Third Treatment||0
59106|NCT02377362|142697|P5|COMPLETED|Part A Third Treatment||0
59107|NCT02377362|142698|P4|COMPLETED|Part A Third Treatment||0
59108|NCT02377362|142699|P3|COMPLETED|Part A Third Treatment||4
59109|NCT02377362|142700|P2|COMPLETED|Part A Third Treatment||4
59110|NCT02377362|142701|P1|COMPLETED|Part A Third Treatment||4
59111|NCT02377362|142689|P13|STARTED|Part A Third Treatment||0
59112|NCT02377362|142690|P12|STARTED|Part A Third Treatment||0
59113|NCT02377362|142691|P11|STARTED|Part A Third Treatment||0
59114|NCT02377362|142692|P10|STARTED|Part A Third Treatment||0
59115|NCT02377362|142693|P9|STARTED|Part A Third Treatment||0
59116|NCT02377362|142694|P8|STARTED|Part A Third Treatment||0
59117|NCT02377362|142695|P7|STARTED|Part A Third Treatment||0
59118|NCT02377362|142696|P6|STARTED|Part A Third Treatment||4
59119|NCT02377362|142697|P5|STARTED|Part A Third Treatment||3
59120|NCT02377362|142698|P4|STARTED|Part A Third Treatment||4
59121|NCT02377362|142699|P3|STARTED|Part A Third Treatment||4
59122|NCT02377362|142700|P2|STARTED|Part A Third Treatment||4
59123|NCT02377362|142701|P1|STARTED|Part A Third Treatment||4
59124|NCT02377362|142689|P13|NOT COMPLETED|Part A Second Treatment||0
59125|NCT02377362|142690|P12|NOT COMPLETED|Part A Second Treatment||0
59126|NCT02377362|142691|P11|NOT COMPLETED|Part A Second Treatment||0
59127|NCT02377362|142692|P10|NOT COMPLETED|Part A Second Treatment||0
59128|NCT02377362|142693|P9|NOT COMPLETED|Part A Second Treatment||0
59129|NCT02377362|142694|P8|NOT COMPLETED|Part A Second Treatment||0
59130|NCT02377362|142695|P7|NOT COMPLETED|Part A Second Treatment||0
59131|NCT02377362|142696|P6|NOT COMPLETED|Part A Second Treatment||0
59132|NCT02377362|142697|P5|NOT COMPLETED|Part A Second Treatment||1
59133|NCT02377362|142698|P4|NOT COMPLETED|Part A Second Treatment||0
59134|NCT02377362|142699|P3|NOT COMPLETED|Part A Second Treatment||0
59135|NCT02377362|142700|P2|NOT COMPLETED|Part A Second Treatment||0
59136|NCT02377362|142701|P1|NOT COMPLETED|Part A Second Treatment||0
59137|NCT02377362|142689|P13|COMPLETED|Part A Second Treatment||0
59138|NCT02377362|142690|P12|COMPLETED|Part A Second Treatment||0
59139|NCT02377362|142691|P11|COMPLETED|Part A Second Treatment||0
59140|NCT02377362|142692|P10|COMPLETED|Part A Second Treatment||0
59141|NCT02377362|142693|P9|COMPLETED|Part A Second Treatment||0
59142|NCT02377362|142694|P8|COMPLETED|Part A Second Treatment||0
59143|NCT02377362|142695|P7|COMPLETED|Part A Second Treatment||0
59144|NCT02377362|142696|P6|COMPLETED|Part A Second Treatment||4
59145|NCT02377362|142697|P5|COMPLETED|Part A Second Treatment||3
59146|NCT02377362|142698|P4|COMPLETED|Part A Second Treatment||4
59147|NCT02377362|142699|P3|COMPLETED|Part A Second Treatment||4
59148|NCT02377362|142700|P2|COMPLETED|Part A Second Treatment||4
59149|NCT02377362|142701|P1|COMPLETED|Part A Second Treatment||4
59150|NCT02377362|142689|P13|STARTED|Part A Second Treatment||0
59151|NCT02377362|142690|P12|STARTED|Part A Second Treatment||0
59152|NCT02377362|142691|P11|STARTED|Part A Second Treatment||0
59153|NCT02377362|142692|P10|STARTED|Part A Second Treatment||0
59154|NCT02377362|142693|P9|STARTED|Part A Second Treatment||0
59155|NCT02377362|142694|P8|STARTED|Part A Second Treatment||0
59156|NCT02377362|142695|P7|STARTED|Part A Second Treatment||0
59157|NCT02377362|142696|P6|STARTED|Part A Second Treatment||4
59158|NCT02377362|142697|P5|STARTED|Part A Second Treatment||4
59159|NCT02377362|142698|P4|STARTED|Part A Second Treatment||4
59160|NCT02377362|142699|P3|STARTED|Part A Second Treatment||4
59161|NCT02377362|142700|P2|STARTED|Part A Second Treatment||4
59162|NCT02377362|142701|P1|STARTED|Part A Second Treatment||4
59163|NCT02377362|142689|P13|NOT COMPLETED|Part A First Treatment||0
59164|NCT02377362|142690|P12|NOT COMPLETED|Part A First Treatment||0
59165|NCT02377362|142691|P11|NOT COMPLETED|Part A First Treatment||0
59166|NCT02377362|142692|P10|NOT COMPLETED|Part A First Treatment||0
59167|NCT02377362|142693|P9|NOT COMPLETED|Part A First Treatment||0
59168|NCT02377362|142694|P8|NOT COMPLETED|Part A First Treatment||0
59169|NCT02377362|142695|P7|NOT COMPLETED|Part A First Treatment||0
59170|NCT02377362|142696|P6|NOT COMPLETED|Part A First Treatment||0
59171|NCT02377362|142697|P5|NOT COMPLETED|Part A First Treatment||0
59172|NCT02377362|142698|P4|NOT COMPLETED|Part A First Treatment||0
59173|NCT02377362|142699|P3|NOT COMPLETED|Part A First Treatment||0
59174|NCT02377362|142700|P2|NOT COMPLETED|Part A First Treatment||0
59175|NCT02377362|142701|P1|NOT COMPLETED|Part A First Treatment||0
59176|NCT02377362|142689|P13|COMPLETED|Part A First Treatment||0
59177|NCT02377362|142690|P12|COMPLETED|Part A First Treatment||0
59178|NCT02377362|142691|P11|COMPLETED|Part A First Treatment||0
59179|NCT02377362|142692|P10|COMPLETED|Part A First Treatment||0
59180|NCT02377362|142693|P9|COMPLETED|Part A First Treatment||0
59181|NCT02377362|142694|P8|COMPLETED|Part A First Treatment||0
59182|NCT02377362|142695|P7|COMPLETED|Part A First Treatment||0
59183|NCT02377362|142696|P6|COMPLETED|Part A First Treatment||4
59184|NCT02377362|142697|P5|COMPLETED|Part A First Treatment||4
59185|NCT02377362|142698|P4|COMPLETED|Part A First Treatment||4
59186|NCT02377362|142699|P3|COMPLETED|Part A First Treatment||4
59187|NCT02377362|142700|P2|COMPLETED|Part A First Treatment||4
59188|NCT02377362|142701|P1|COMPLETED|Part A First Treatment||4
59189|NCT02377362|142689|P13|STARTED|Part A First Treatment||0
59190|NCT02377362|142690|P12|STARTED|Part A First Treatment||0
59191|NCT02377362|142691|P11|STARTED|Part A First Treatment||0
59192|NCT02377362|142692|P10|STARTED|Part A First Treatment||0
59193|NCT02377362|142693|P9|STARTED|Part A First Treatment||0
59194|NCT02377362|142694|P8|STARTED|Part A First Treatment||0
59195|NCT02377362|142695|P7|STARTED|Part A First Treatment||0
59196|NCT02377362|142696|P6|STARTED|Part A First Treatment||4
59197|NCT02377362|142697|P5|STARTED|Part A First Treatment||4
59198|NCT02377362|142698|P4|STARTED|Part A First Treatment||4
59199|NCT02377362|142699|P3|STARTED|Part A First Treatment||4
59200|NCT02377362|142700|P2|STARTED|Part A First Treatment||4
59201|NCT02377362|142701|P1|STARTED|Part A First Treatment||4
59202|NCT02377349|142910|P2|NOT COMPLETED|Overall Study||11
59203|NCT02377349|142911|P1|NOT COMPLETED|Overall Study||16
59204|NCT02377349|142910|P2|COMPLETED|Overall Study||335
59205|NCT02377349|142911|P1|COMPLETED|Overall Study||325
59206|NCT02377349|142910|P2|STARTED|Overall Study||346
59207|NCT02377349|142911|P1|STARTED|Overall Study||341
59208|NCT02377063|142949|P1|NOT COMPLETED|Overall Study||5
59209|NCT02377063|142949|P1|COMPLETED|Overall Study||20
59210|NCT02377063|142949|P1|STARTED|Overall Study||25
59211|NCT02376998|142953|P1|NOT COMPLETED|Overall Study||9
59212|NCT02376998|142953|P1|COMPLETED|Overall Study||11
59213|NCT02376998|142953|P1|STARTED|Overall Study||20
59214|NCT02376933|142957|P1|NOT COMPLETED|Overall Study||2
59215|NCT02376933|142957|P1|COMPLETED|Overall Study||8
59216|NCT02376933|142957|P1|STARTED|Overall Study||10
59217|NCT02376790|142967|P3|NOT COMPLETED|Overall Study||53
59218|NCT02376790|142968|P2|NOT COMPLETED|Overall Study||47
59219|NCT02376790|142969|P1|NOT COMPLETED|Overall Study||60
59220|NCT02376790|142967|P3|COMPLETED|Overall Study||230
59221|NCT02376790|142968|P2|COMPLETED|Overall Study||237
59222|NCT02376790|142969|P1|COMPLETED|Overall Study||224
59223|NCT02376790|142967|P3|Received Treatment|Overall Study||282
59224|NCT02376790|142968|P2|Received Treatment|Overall Study||284
59225|NCT02376790|142969|P1|Received Treatment|Overall Study||282
59226|NCT02376790|142967|P3|STARTED|Overall Study||283
59227|NCT02376790|142968|P2|STARTED|Overall Study||284
59228|NCT02376790|142969|P1|STARTED|Overall Study||284
59229|NCT02376530|143089|P4|NOT COMPLETED|Overall Study||0
59230|NCT02376530|143090|P3|NOT COMPLETED|Overall Study||0
59231|NCT02376530|143091|P2|NOT COMPLETED|Overall Study||0
59232|NCT02376530|143092|P1|NOT COMPLETED|Overall Study||0
59233|NCT02376530|143089|P4|COMPLETED|Overall Study||197
59234|NCT02376530|143090|P3|COMPLETED|Overall Study||197
59235|NCT02376530|143091|P2|COMPLETED|Overall Study||198
59236|NCT02376530|143092|P1|COMPLETED|Overall Study||196
59237|NCT02376530|143089|P4|STARTED|Overall Study||197
59238|NCT02376530|143090|P3|STARTED|Overall Study||197
59239|NCT02376530|143091|P2|STARTED|Overall Study||198
59240|NCT02376530|143092|P1|STARTED|Overall Study||196
59241|NCT02376283|143105|P3|NOT COMPLETED|Overall Study||0
59242|NCT02376283|143106|P2|NOT COMPLETED|Overall Study||0
59243|NCT02376283|143107|P1|NOT COMPLETED|Overall Study||0
59244|NCT02376283|143105|P3|COMPLETED|Overall Study||30
59245|NCT02376283|143106|P2|COMPLETED|Overall Study||30
59246|NCT02376283|143107|P1|COMPLETED|Overall Study||27
59247|NCT02376283|143105|P3|STARTED|Overall Study||30
59248|NCT02376283|143106|P2|STARTED|Overall Study||30
59249|NCT02376283|143107|P1|STARTED|Overall Study||27
59250|NCT02376257|143125|P3|NOT COMPLETED|Overall Study||0
59251|NCT02376257|143126|P2|NOT COMPLETED|Overall Study||0
59252|NCT02376257|143127|P1|NOT COMPLETED|Overall Study||0
59253|NCT02376257|143125|P3|COMPLETED|Overall Study||11
59254|NCT02376257|143126|P2|COMPLETED|Overall Study||12
59255|NCT02376257|143127|P1|COMPLETED|Overall Study||13
59256|NCT02376257|143125|P3|STARTED|Overall Study||11
59257|NCT02376257|143126|P2|STARTED|Overall Study||12
59258|NCT02376257|143127|P1|STARTED|Overall Study||13
59259|NCT02376179|143156|P1|NOT COMPLETED|Overall Study||0
59260|NCT02376179|143156|P1|COMPLETED|Overall Study||84
59261|NCT02376179|143156|P1|STARTED|Overall Study||84
59262|NCT02376166|143160|P1|NOT COMPLETED|Overall Study||3
59263|NCT02376166|143160|P1|COMPLETED|Overall Study||12
59264|NCT02376166|143160|P1|STARTED|Overall Study||15
59265|NCT02375971|143188|P3|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5
59266|NCT02375971|143189|P2|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5
59267|NCT02375971|143190|P1|NOT COMPLETED|Follow-Up Phase (up to Day 169)||7
59268|NCT02375971|143188|P3|COMPLETED|Follow-Up Phase (up to Day 169)||64
59269|NCT02375971|143189|P2|COMPLETED|Follow-Up Phase (up to Day 169)||71
59270|NCT02375971|143190|P1|COMPLETED|Follow-Up Phase (up to Day 169)||66
59271|NCT02375971|143188|P3|STARTED|Follow-Up Phase (up to Day 169)||69
59272|NCT02375971|143189|P2|STARTED|Follow-Up Phase (up to Day 169)||76
59273|NCT02375971|143190|P1|STARTED|Follow-Up Phase (up to Day 169)||73
59274|NCT02375971|143188|P3|NOT COMPLETED|Treatment (Day 1 - Baseline)||5
59275|NCT02375971|143189|P2|NOT COMPLETED|Treatment (Day 1 - Baseline)||1
59276|NCT02375971|143190|P1|NOT COMPLETED|Treatment (Day 1 - Baseline)||1
59277|NCT02375971|143188|P3|COMPLETED|Treatment (Day 1 - Baseline)||69
59278|NCT02375971|143189|P2|COMPLETED|Treatment (Day 1 - Baseline)||76
59279|NCT02375971|143190|P1|COMPLETED|Treatment (Day 1 - Baseline)||73
59280|NCT02375971|143188|P3|PK Set|Treatment (Day 1 - Baseline)||0
59281|NCT02375971|143189|P2|PK Set|Treatment (Day 1 - Baseline)||46
59282|NCT02375971|143190|P1|PK Set|Treatment (Day 1 - Baseline)||49
59283|NCT02375971|143188|P3|VEGF Set|Treatment (Day 1 - Baseline)||51
59284|NCT02375971|143189|P2|VEGF Set|Treatment (Day 1 - Baseline)||26
59285|NCT02375971|143190|P1|VEGF Set|Treatment (Day 1 - Baseline)||19
59286|NCT02375971|143188|P3|Safety Set|Treatment (Day 1 - Baseline)||69
59287|NCT02375971|143189|P2|Safety Set|Treatment (Day 1 - Baseline)||76
59288|NCT02375971|143190|P1|Safety Set|Treatment (Day 1 - Baseline)||73
59289|NCT02375971|143188|P3|STARTED|Treatment (Day 1 - Baseline)||74
59290|NCT02375971|143189|P2|STARTED|Treatment (Day 1 - Baseline)||77
59291|NCT02375971|143190|P1|STARTED|Treatment (Day 1 - Baseline)||74
59292|NCT02375724|143232|P2|NOT COMPLETED|Overall Study||6
59293|NCT02375724|143233|P1|NOT COMPLETED|Overall Study||6
59294|NCT02375724|143232|P2|COMPLETED|Overall Study||128
59295|NCT02375724|143233|P1|COMPLETED|Overall Study||129
59296|NCT02375724|143232|P2|STARTED|Overall Study||134
59297|NCT02375724|143233|P1|STARTED|Overall Study||135
59298|NCT02375698|143245|P2|NOT COMPLETED|Overall Study||2
59299|NCT02375698|143246|P1|NOT COMPLETED|Overall Study||2
59300|NCT02375698|143245|P2|COMPLETED|Overall Study||4
59301|NCT02375698|143246|P1|COMPLETED|Overall Study||14
59302|NCT02375698|143245|P2|STARTED|Overall Study||6
59303|NCT02375698|143246|P1|STARTED|Overall Study||16
59304|NCT02375373|143254|P1|NOT COMPLETED|Overall Study||11
59305|NCT02375373|143254|P1|COMPLETED|Overall Study||1
59306|NCT02375373|143254|P1|STARTED|Overall Study||12
59307|NCT02375347|143258|P1|NOT COMPLETED|Overall Study||1
59308|NCT02375347|143258|P1|COMPLETED|Overall Study||12
59309|NCT02375347|143258|P1|STARTED|Overall Study||13
59310|NCT02374957|143264|P2|NOT COMPLETED|Overall Study||0
59311|NCT02374957|143265|P1|NOT COMPLETED|Overall Study||1
59312|NCT02374957|143264|P2|COMPLETED|Overall Study||9
59313|NCT02374957|143265|P1|COMPLETED|Overall Study||10
59314|NCT02374957|143264|P2|STARTED|Overall Study||9
59315|NCT02374957|143265|P1|STARTED|Overall Study||11
59316|NCT02374593|143293|P2|NOT COMPLETED|Overall Study||0
59317|NCT02374593|143294|P1|NOT COMPLETED|Overall Study||2
59318|NCT02374593|143293|P2|COMPLETED|Overall Study||44
59319|NCT02374593|143294|P1|COMPLETED|Overall Study||22
59320|NCT02374593|143293|P2|STARTED|Overall Study||44
59321|NCT02374593|143294|P1|STARTED|Overall Study||24
59322|NCT02374398|143308|P4|NOT COMPLETED|Overall Study||0
59323|NCT02374398|143309|P3|NOT COMPLETED|Overall Study||3
59324|NCT02374398|143310|P2|NOT COMPLETED|Overall Study||1
59325|NCT02374398|143311|P1|NOT COMPLETED|Overall Study||2
59326|NCT02374398|143308|P4|COMPLETED|Overall Study||32
59327|NCT02374398|143309|P3|COMPLETED|Overall Study||29
59328|NCT02374398|143310|P2|COMPLETED|Overall Study||31
59329|NCT02374398|143311|P1|COMPLETED|Overall Study||29
59330|NCT02374398|143308|P4|STARTED|Overall Study||32
59331|NCT02374398|143309|P3|STARTED|Overall Study||32
59332|NCT02374398|143310|P2|STARTED|Overall Study||32
59333|NCT02374398|143311|P1|STARTED|Overall Study||31
59334|NCT02374346|143337|P1|NOT COMPLETED|Overall Study||48
59335|NCT02374346|143337|P1|COMPLETED|Overall Study||446
59336|NCT02374346|143337|P1|STARTED|Overall Study||494
59337|NCT02374307|143345|P2|NOT COMPLETED|6-months Follow-up||6
59338|NCT02374307|143346|P1|NOT COMPLETED|6-months Follow-up||3
59339|NCT02374307|143345|P2|COMPLETED|6-months Follow-up||64
59340|NCT02374307|143346|P1|COMPLETED|6-months Follow-up||71
59341|NCT02374307|143345|P2|STARTED|6-months Follow-up|1 subject missed the first follow-up, but continued the study and was assessed at 6 months.|70
59342|NCT02374307|143346|P1|STARTED|6-months Follow-up|5 subjects missed the first follow-up, but continued the study and were assessed at 6 months.|74
59343|NCT02374307|143345|P2|NOT COMPLETED|3-months Follow-up||9
59344|NCT02374307|143346|P1|NOT COMPLETED|3-months Follow-up||8
59345|NCT02374307|143345|P2|COMPLETED|3-months Follow-up||69
59346|NCT02374307|143346|P1|COMPLETED|3-months Follow-up||69
59347|NCT02374307|143345|P2|STARTED|3-months Follow-up||78
59348|NCT02374307|143346|P1|STARTED|3-months Follow-up||77
59349|NCT02374255|143377|P4|NOT COMPLETED|Overall Study||0
59350|NCT02374255|143378|P3|NOT COMPLETED|Overall Study||0
59351|NCT02374255|143379|P2|NOT COMPLETED|Overall Study||0
59352|NCT02374255|143380|P1|NOT COMPLETED|Overall Study||2
59353|NCT02374255|143377|P4|COMPLETED|Overall Study||11
59354|NCT02374255|143378|P3|COMPLETED|Overall Study||11
59355|NCT02374255|143379|P2|COMPLETED|Overall Study||110
59356|NCT02374255|143380|P1|COMPLETED|Overall Study||153
59357|NCT02374255|143377|P4|STARTED|Overall Study||11
59358|NCT02374255|143378|P3|STARTED|Overall Study||11
59359|NCT02374255|143379|P2|STARTED|Overall Study||110
59360|NCT02374255|143380|P1|STARTED|Overall Study||155
59361|NCT02374164|143401|P3|NOT COMPLETED|Treatment Period 3||0
59362|NCT02374164|143402|P2|NOT COMPLETED|Treatment Period 3||0
59363|NCT02374164|143403|P1|NOT COMPLETED|Treatment Period 3||0
59364|NCT02374164|143401|P3|COMPLETED|Treatment Period 3||12
59365|NCT02374164|143402|P2|COMPLETED|Treatment Period 3||11
59366|NCT02374164|143403|P1|COMPLETED|Treatment Period 3||12
59367|NCT02374164|143401|P3|STARTED|Treatment Period 3||12
59368|NCT02374164|143402|P2|STARTED|Treatment Period 3|One participant was Lost-to-Follow-Up prior to treatment A.|11
59369|NCT02374164|143403|P1|STARTED|Treatment Period 3||12
59370|NCT02374164|143401|P3|NOT COMPLETED|Treatment Period 2||0
59371|NCT02374164|143402|P2|NOT COMPLETED|Treatment Period 2||0
59372|NCT02374164|143403|P1|NOT COMPLETED|Treatment Period 2||0
59373|NCT02374164|143401|P3|COMPLETED|Treatment Period 2||12
59374|NCT02374164|143402|P2|COMPLETED|Treatment Period 2||12
59375|NCT02374164|143403|P1|COMPLETED|Treatment Period 2||12
59376|NCT02374164|143401|P3|STARTED|Treatment Period 2||12
59377|NCT02374164|143402|P2|STARTED|Treatment Period 2||12
59378|NCT02374164|143403|P1|STARTED|Treatment Period 2||12
59379|NCT02374164|143401|P3|NOT COMPLETED|Treatment Period 1||0
59380|NCT02374164|143402|P2|NOT COMPLETED|Treatment Period 1||0
59381|NCT02374164|143403|P1|NOT COMPLETED|Treatment Period 1||0
59382|NCT02374164|143401|P3|COMPLETED|Treatment Period 1||12
59383|NCT02374164|143402|P2|COMPLETED|Treatment Period 1||12
59384|NCT02374164|143403|P1|COMPLETED|Treatment Period 1||12
59385|NCT02374164|143401|P3|STARTED|Treatment Period 1||12
59386|NCT02374164|143402|P2|STARTED|Treatment Period 1||12
59387|NCT02374164|143403|P1|STARTED|Treatment Period 1||12
59388|NCT02374138|143422|P2|NOT COMPLETED|Twelve Month FollowUp||12
59389|NCT02374138|143423|P1|NOT COMPLETED|Twelve Month FollowUp||9
59390|NCT02374138|143422|P2|COMPLETED|Twelve Month FollowUp||95
59391|NCT02374138|143423|P1|COMPLETED|Twelve Month FollowUp||101
59392|NCT02374138|143422|P2|STARTED|Twelve Month FollowUp||107
59393|NCT02374138|143423|P1|STARTED|Twelve Month FollowUp||110
59394|NCT02374138|143422|P2|NOT COMPLETED|Six Month Follow Up||14
59395|NCT02374138|143423|P1|NOT COMPLETED|Six Month Follow Up||8
59396|NCT02374138|143422|P2|COMPLETED|Six Month Follow Up|6 Month Follow Up|93
59397|NCT02374138|143423|P1|COMPLETED|Six Month Follow Up|6 Month Follow Up|102
59398|NCT02374138|143422|P2|STARTED|Six Month Follow Up||107
59399|NCT02374138|143423|P1|STARTED|Six Month Follow Up||110
59400|NCT02374099|143481|P2|NOT COMPLETED|Overall Study||49
59401|NCT02374099|143482|P1|NOT COMPLETED|Overall Study||48
59402|NCT02374099|143481|P2|COMPLETED|Overall Study||0
59403|NCT02374099|143482|P1|COMPLETED|Overall Study||0
59404|NCT02374099|143481|P2|Participants Treated|Overall Study|1 participant randomized, but not treated|48
59405|NCT02374099|143482|P1|Participants Treated|Overall Study|2 participants randomized, but not treated|46
59406|NCT02374099|143481|P2|STARTED|Overall Study||49
59407|NCT02374099|143482|P1|STARTED|Overall Study||48
59408|NCT02374060|143501|P3|NOT COMPLETED|Overall Study||3
59409|NCT02374060|143502|P2|NOT COMPLETED|Overall Study||1
59410|NCT02374060|143503|P1|NOT COMPLETED|Overall Study||2
59411|NCT02374060|143501|P3|COMPLETED|Overall Study||61
59412|NCT02374060|143502|P2|COMPLETED|Overall Study||62
59413|NCT02374060|143503|P1|COMPLETED|Overall Study||63
59414|NCT02374060|143501|P3|STARTED|Overall Study||64
59415|NCT02374060|143502|P2|STARTED|Overall Study||63
59416|NCT02374060|143503|P1|STARTED|Overall Study||65
59417|NCT02373865|143555|P2|NOT COMPLETED|Overall Study||0
59418|NCT02373865|143556|P1|NOT COMPLETED|Overall Study||0
59419|NCT02373865|143555|P2|COMPLETED|Overall Study||2
59420|NCT02373865|143556|P1|COMPLETED|Overall Study||2
59421|NCT02373865|143555|P2|STARTED|Overall Study||2
59422|NCT02373865|143556|P1|STARTED|Overall Study||2
59423|NCT02373852|143566|P1|NOT COMPLETED|Overall Study||1
59424|NCT02373852|143566|P1|COMPLETED|Overall Study||11
59425|NCT02373852|143566|P1|STARTED|Overall Study|Includes patients from a previous retrospective study NCT01042444|12
59426|NCT02373371|143573|P2|NOT COMPLETED|Overall Study||0
59427|NCT02373371|143574|P1|NOT COMPLETED|Overall Study||0
59428|NCT02373371|143573|P2|COMPLETED|Overall Study||13
59429|NCT02373371|143574|P1|COMPLETED|Overall Study||13
59430|NCT02373371|143573|P2|STARTED|Overall Study||13
59431|NCT02373371|143574|P1|STARTED|Overall Study||13
59432|NCT02373202|143590|P4|NOT COMPLETED|Overall Study||1
59433|NCT02373202|143591|P3|NOT COMPLETED|Overall Study||3
59434|NCT02373202|143592|P2|NOT COMPLETED|Overall Study||6
59435|NCT02373202|143593|P1|NOT COMPLETED|Overall Study||2
59436|NCT02373202|143590|P4|COMPLETED|Overall Study||30
59437|NCT02373202|143591|P3|COMPLETED|Overall Study||27
59438|NCT02373202|143592|P2|COMPLETED|Overall Study||9
59439|NCT02373202|143593|P1|COMPLETED|Overall Study||13
59440|NCT02373202|143590|P4|STARTED|Overall Study||31
59441|NCT02373202|143591|P3|STARTED|Overall Study||30
59442|NCT02373202|143592|P2|STARTED|Overall Study||15
59443|NCT02373202|143593|P1|STARTED|Overall Study||15
59444|NCT02373137|143645|P2|NOT COMPLETED|Overall Study||1
59445|NCT02373137|143646|P1|NOT COMPLETED|Overall Study||1
59446|NCT02373137|143645|P2|COMPLETED|Overall Study||18
59447|NCT02373137|143646|P1|COMPLETED|Overall Study||18
59448|NCT02373137|143645|P2|12-Month Follow-Up|Overall Study||19
59449|NCT02373137|143646|P1|12-Month Follow-Up|Overall Study||19
59450|NCT02373137|143645|P2|6-Month Follow-Up|Overall Study||18
59451|NCT02373137|143646|P1|6-Month Follow-Up|Overall Study||19
59452|NCT02373137|143645|P2|3-Month Follow-Up|Overall Study||19
59453|NCT02373137|143646|P1|3-Month Follow-Up|Overall Study||19
59454|NCT02373137|143645|P2|STARTED|Overall Study||19
59455|NCT02373137|143646|P1|STARTED|Overall Study||19
59456|NCT02373124|143662|P1|NOT COMPLETED|Overall Study||1
59457|NCT02373124|143662|P1|COMPLETED|Overall Study||3
59458|NCT02373124|143662|P1|STARTED|Overall Study||4
59459|NCT02373098|143668|P2|NOT COMPLETED|Overall Study||0
59460|NCT02373098|143669|P1|NOT COMPLETED|Overall Study||12
59461|NCT02373098|143668|P2|COMPLETED|Overall Study||60
59462|NCT02373098|143669|P1|COMPLETED|Overall Study||54
59463|NCT02373098|143668|P2|STARTED|Overall Study||60
59464|NCT02373098|143669|P1|STARTED|Overall Study||66
59465|NCT02372799|143697|P3|NOT COMPLETED|Down-taper Period||2
59466|NCT02372799|143698|P2|NOT COMPLETED|Down-taper Period||2
59467|NCT02372799|143699|P1|NOT COMPLETED|Down-taper Period||1
59468|NCT02372799|143697|P3|COMPLETED|Down-taper Period||80
59469|NCT02372799|143698|P2|COMPLETED|Down-taper Period||157
59470|NCT02372799|143699|P1|COMPLETED|Down-taper Period||151
59471|NCT02372799|143697|P3|STARTED|Down-taper Period||82
59472|NCT02372799|143698|P2|STARTED|Down-taper Period||159
59473|NCT02372799|143699|P1|STARTED|Down-taper Period||152
59474|NCT02372799|143697|P3|NOT COMPLETED|Treatment Period||15
59475|NCT02372799|143698|P2|NOT COMPLETED|Treatment Period||32
59476|NCT02372799|143699|P1|NOT COMPLETED|Treatment Period||34
59477|NCT02372799|143697|P3|COMPLETED|Treatment Period||82
59478|NCT02372799|143698|P2|COMPLETED|Treatment Period||155
59479|NCT02372799|143699|P1|COMPLETED|Treatment Period||152
59480|NCT02372799|143697|P3|STARTED|Treatment Period||97
59481|NCT02372799|143698|P2|STARTED|Treatment Period||187
59482|NCT02372799|143699|P1|STARTED|Treatment Period||186
59483|NCT02372682|143712|P2|NOT COMPLETED|Overall Study||14
59484|NCT02372682|143713|P1|NOT COMPLETED|Overall Study||8
59485|NCT02372682|143712|P2|COMPLETED|Overall Study||79
59486|NCT02372682|143713|P1|COMPLETED|Overall Study||70
59487|NCT02372682|143712|P2|STARTED|Overall Study||93
59488|NCT02372682|143713|P1|STARTED|Overall Study||78
59489|NCT02372396|143728|P2|NOT COMPLETED|Overall Study||9
59490|NCT02372396|143729|P1|NOT COMPLETED|Overall Study||7
59491|NCT02372396|143728|P2|COMPLETED|Overall Study||11
59492|NCT02372396|143729|P1|COMPLETED|Overall Study||10
59493|NCT02372396|143728|P2|Began Intervention|Overall Study||14
59494|NCT02372396|143729|P1|Began Intervention|Overall Study||14
59495|NCT02372396|143728|P2|STARTED|Overall Study||20
59496|NCT02372396|143729|P1|STARTED|Overall Study||17
59497|NCT02372344|143735|P3|NOT COMPLETED|Period 3 (Visit 4)||0
59498|NCT02372344|143736|P2|NOT COMPLETED|Period 3 (Visit 4)||0
59499|NCT02372344|143737|P1|NOT COMPLETED|Period 3 (Visit 4)||0
59500|NCT02372344|143735|P3|COMPLETED|Period 3 (Visit 4)||14
59501|NCT02372344|143736|P2|COMPLETED|Period 3 (Visit 4)||14
59502|NCT02372344|143737|P1|COMPLETED|Period 3 (Visit 4)||14
59503|NCT02372344|143735|P3|STARTED|Period 3 (Visit 4)||14
59504|NCT02372344|143736|P2|STARTED|Period 3 (Visit 4)||14
59505|NCT02372344|143737|P1|STARTED|Period 3 (Visit 4)||14
59506|NCT02372344|143735|P3|NOT COMPLETED|Period 2 (Visit 3)||0
59507|NCT02372344|143736|P2|NOT COMPLETED|Period 2 (Visit 3)||0
59508|NCT02372344|143737|P1|NOT COMPLETED|Period 2 (Visit 3)||0
59509|NCT02372344|143735|P3|COMPLETED|Period 2 (Visit 3)||14
59510|NCT02372344|143736|P2|COMPLETED|Period 2 (Visit 3)||14
59511|NCT02372344|143737|P1|COMPLETED|Period 2 (Visit 3)||14
59512|NCT02372344|143735|P3|STARTED|Period 2 (Visit 3)||14
59513|NCT02372344|143736|P2|STARTED|Period 2 (Visit 3)||14
59514|NCT02372344|143737|P1|STARTED|Period 2 (Visit 3)||14
59515|NCT02372344|143735|P3|NOT COMPLETED|Period 1 (Visit 2)||0
59516|NCT02372344|143736|P2|NOT COMPLETED|Period 1 (Visit 2)||0
59517|NCT02372344|143737|P1|NOT COMPLETED|Period 1 (Visit 2)||0
59518|NCT02372344|143735|P3|COMPLETED|Period 1 (Visit 2)||14
59519|NCT02372344|143736|P2|COMPLETED|Period 1 (Visit 2)||14
59520|NCT02372344|143737|P1|COMPLETED|Period 1 (Visit 2)||14
59521|NCT02372344|143735|P3|STARTED|Period 1 (Visit 2)||14
59522|NCT02372344|143736|P2|STARTED|Period 1 (Visit 2)||14
59523|NCT02372344|143737|P1|STARTED|Period 1 (Visit 2)||14
59524|NCT02372253|143753|P2|NOT COMPLETED|Overall Study||0
59525|NCT02372253|143754|P1|NOT COMPLETED|Overall Study||2
59526|NCT02372253|143753|P2|COMPLETED|Overall Study||13
59527|NCT02372253|143754|P1|COMPLETED|Overall Study||11
59528|NCT02372253|143753|P2|STARTED|Overall Study||13
59529|NCT02372253|143754|P1|STARTED|Overall Study||13
59530|NCT02372097|143772|P2|NOT COMPLETED|Second Intervention Period (8 Days)||0
59531|NCT02372097|143773|P1|NOT COMPLETED|Second Intervention Period (8 Days)||0
59532|NCT02372097|143772|P2|COMPLETED|Second Intervention Period (8 Days)||12
59533|NCT02372097|143773|P1|COMPLETED|Second Intervention Period (8 Days)||12
59534|NCT02372097|143772|P2|STARTED|Second Intervention Period (8 Days)||12
59535|NCT02372097|143773|P1|STARTED|Second Intervention Period (8 Days)||12
59536|NCT02372097|143772|P2|NOT COMPLETED|Wash Out Period (13 Days)||0
59537|NCT02372097|143773|P1|NOT COMPLETED|Wash Out Period (13 Days)||0
59538|NCT02372097|143772|P2|COMPLETED|Wash Out Period (13 Days)||12
59539|NCT02372097|143773|P1|COMPLETED|Wash Out Period (13 Days)||12
59540|NCT02372097|143772|P2|STARTED|Wash Out Period (13 Days)||12
59541|NCT02372097|143773|P1|STARTED|Wash Out Period (13 Days)||12
59542|NCT02372097|143772|P2|NOT COMPLETED|First Intervention Period (8 Days)||0
59543|NCT02372097|143773|P1|NOT COMPLETED|First Intervention Period (8 Days)||0
59544|NCT02372097|143772|P2|COMPLETED|First Intervention Period (8 Days)||12
59545|NCT02372097|143773|P1|COMPLETED|First Intervention Period (8 Days)||12
59546|NCT02372097|143772|P2|STARTED|First Intervention Period (8 Days)||12
59547|NCT02372097|143773|P1|STARTED|First Intervention Period (8 Days)||12
59548|NCT02372071|143799|P1|NOT COMPLETED|Overall Study||18
59549|NCT02372071|143799|P1|COMPLETED|Overall Study||93
59550|NCT02372071|143799|P1|STARTED|Overall Study||111
59551|NCT02372058|143804|P1|NOT COMPLETED|Overall Study||3
59552|NCT02372058|143804|P1|COMPLETED|Overall Study||100
59553|NCT02372058|143804|P1|STARTED|Overall Study||103
59554|NCT02371876|143810|P1|NOT COMPLETED|Overall Study||0
59555|NCT02371876|143810|P1|COMPLETED|Overall Study||134
59556|NCT02371876|143810|P1|STARTED|Overall Study||134
59557|NCT02371850|143820|P1|NOT COMPLETED|Overall Study||0
59558|NCT02371850|143820|P1|COMPLETED|Overall Study||10
59559|NCT02371850|143820|P1|STARTED|Overall Study||10
59560|NCT02371785|143825|P1|NOT COMPLETED|Overall Study||0
59561|NCT02371785|143825|P1|COMPLETED|Overall Study||20
59562|NCT02371785|143825|P1|STARTED|Overall Study||20
59563|NCT02371759|143843|P8|NOT COMPLETED|Overall Study||4
59564|NCT02371759|143844|P7|NOT COMPLETED|Overall Study||0
59565|NCT02371759|143845|P6|NOT COMPLETED|Overall Study||1
59566|NCT02371759|143846|P5|NOT COMPLETED|Overall Study||3
59567|NCT02371759|143847|P4|NOT COMPLETED|Overall Study||0
59568|NCT02371759|143848|P3|NOT COMPLETED|Overall Study||1
59569|NCT02371759|143849|P2|NOT COMPLETED|Overall Study||1
59570|NCT02371759|143850|P1|NOT COMPLETED|Overall Study||3
59571|NCT02371759|143843|P8|COMPLETED|Overall Study||24
59572|NCT02371759|143844|P7|COMPLETED|Overall Study||25
59573|NCT02371759|143845|P6|COMPLETED|Overall Study||25
59574|NCT02371759|143846|P5|COMPLETED|Overall Study||24
59575|NCT02371759|143847|P4|COMPLETED|Overall Study||31
59576|NCT02371759|143848|P3|COMPLETED|Overall Study||32
59577|NCT02371759|143849|P2|COMPLETED|Overall Study||30
59578|NCT02371759|143850|P1|COMPLETED|Overall Study||29
59579|NCT02371759|143843|P8|STARTED|Overall Study||28
59580|NCT02371759|143844|P7|STARTED|Overall Study||25
59581|NCT02371759|143845|P6|STARTED|Overall Study||26
59582|NCT02371759|143846|P5|STARTED|Overall Study||27
59583|NCT02371759|143847|P4|STARTED|Overall Study||31
59584|NCT02371759|143848|P3|STARTED|Overall Study||33
59585|NCT02371759|143849|P2|STARTED|Overall Study||31
59586|NCT02371759|143850|P1|STARTED|Overall Study||32
59587|NCT02371746|144067|P7|NOT COMPLETED|Overall Study||1
59588|NCT02371746|144068|P6|NOT COMPLETED|Overall Study||0
59589|NCT02371746|144069|P5|NOT COMPLETED|Overall Study||0
59590|NCT02371746|144070|P4|NOT COMPLETED|Overall Study||0
59591|NCT02371746|144071|P3|NOT COMPLETED|Overall Study||0
59592|NCT02371746|144072|P2|NOT COMPLETED|Overall Study||0
59593|NCT02371746|144073|P1|NOT COMPLETED|Overall Study||0
59594|NCT02371746|144067|P7|COMPLETED|Overall Study||8
59595|NCT02371746|144068|P6|COMPLETED|Overall Study||6
59596|NCT02371746|144069|P5|COMPLETED|Overall Study||5
59597|NCT02371746|144070|P4|COMPLETED|Overall Study||2
59598|NCT02371746|144071|P3|COMPLETED|Overall Study||2
59599|NCT02371746|144072|P2|COMPLETED|Overall Study||10
59600|NCT02371746|144073|P1|COMPLETED|Overall Study||7
59601|NCT02371746|144067|P7|STARTED|Overall Study||9
59602|NCT02371746|144068|P6|STARTED|Overall Study||6
59603|NCT02371746|144069|P5|STARTED|Overall Study||5
59604|NCT02371746|144070|P4|STARTED|Overall Study||2
59605|NCT02371746|144071|P3|STARTED|Overall Study||2
59606|NCT02371746|144072|P2|STARTED|Overall Study||10
59607|NCT02371746|144073|P1|STARTED|Overall Study||7
59608|NCT02371629|144091|P2|NOT COMPLETED|Overall Study||25
59609|NCT02371629|144092|P1|NOT COMPLETED|Overall Study||26
59610|NCT02371629|144091|P2|COMPLETED|Overall Study||363
59611|NCT02371629|144092|P1|COMPLETED|Overall Study||362
59612|NCT02371629|144091|P2|STARTED|Overall Study||388
59613|NCT02371629|144092|P1|STARTED|Overall Study||388
59614|NCT02371616|144128|P2|NOT COMPLETED|Overall Study||7
59615|NCT02371616|144129|P1|NOT COMPLETED|Overall Study||4
59616|NCT02371616|144128|P2|COMPLETED|Overall Study||147
59617|NCT02371616|144129|P1|COMPLETED|Overall Study||146
59618|NCT02371616|144128|P2|STARTED|Overall Study||154
59619|NCT02371616|144129|P1|STARTED|Overall Study||150
59620|NCT02371395|144141|P1|NOT COMPLETED|Overall Study||0
59621|NCT02371395|144141|P1|COMPLETED|Overall Study||1000
59622|NCT02371395|144141|P1|STARTED|Overall Study||1000
59623|NCT02371187|144147|P2|NOT COMPLETED|Overall Study||4
59624|NCT02371187|144148|P1|NOT COMPLETED|Overall Study||3
59625|NCT02371187|144147|P2|COMPLETED|Overall Study||15
59626|NCT02371187|144148|P1|COMPLETED|Overall Study||15
59627|NCT02371187|144147|P2|STARTED|Overall Study||19
59628|NCT02371187|144148|P1|STARTED|Overall Study||18
59629|NCT02370914|144162|P1|NOT COMPLETED|Overall Study||2
59630|NCT02370914|144162|P1|COMPLETED|Overall Study||82
59631|NCT02370914|144162|P1|STARTED|Overall Study||84
59632|NCT02370667|144169|P3|NOT COMPLETED|Overall Study||0
59633|NCT02370667|144170|P2|NOT COMPLETED|Overall Study||1
59634|NCT02370667|144171|P1|NOT COMPLETED|Overall Study||0
59635|NCT02370667|144169|P3|COMPLETED|Overall Study||10
59636|NCT02370667|144170|P2|COMPLETED|Overall Study||10
59637|NCT02370667|144171|P1|COMPLETED|Overall Study||10
59638|NCT02370667|144169|P3|STARTED|Overall Study||10
59639|NCT02370667|144170|P2|STARTED|Overall Study||11
59640|NCT02370667|144171|P1|STARTED|Overall Study||10
59641|NCT02370641|144235|P2|NOT COMPLETED|Overall Study||2
59642|NCT02370641|144236|P1|NOT COMPLETED|Overall Study||4
59643|NCT02370641|144235|P2|COMPLETED|Overall Study||6
59644|NCT02370641|144236|P1|COMPLETED|Overall Study||14
59645|NCT02370641|144235|P2|STARTED|Overall Study||8
59646|NCT02370641|144236|P1|STARTED|Overall Study||18
59647|NCT02370615|144244|P2|NOT COMPLETED|Overall Study||0
59648|NCT02370615|144245|P1|NOT COMPLETED|Overall Study||1
59649|NCT02370615|144244|P2|COMPLETED|Overall Study||18
59650|NCT02370615|144245|P1|COMPLETED|Overall Study||15
59651|NCT02370615|144244|P2|STARTED|Overall Study||18
59652|NCT02370615|144245|P1|STARTED|Overall Study||16
59653|NCT02370602|144288|P6|NOT COMPLETED|Overall Study||0
59654|NCT02370602|144289|P5|NOT COMPLETED|Overall Study||0
59655|NCT02370602|144290|P4|NOT COMPLETED|Overall Study||0
59656|NCT02370602|144291|P3|NOT COMPLETED|Overall Study||0
59657|NCT02370602|144292|P2|NOT COMPLETED|Overall Study||0
59658|NCT02370602|144293|P1|NOT COMPLETED|Overall Study||1
59659|NCT02370602|144288|P6|COMPLETED|Overall Study||2
59660|NCT02370602|144289|P5|COMPLETED|Overall Study||3
59661|NCT02370602|144290|P4|COMPLETED|Overall Study||3
59662|NCT02370602|144291|P3|COMPLETED|Overall Study||2
59663|NCT02370602|144292|P2|COMPLETED|Overall Study||2
59664|NCT02370602|144293|P1|COMPLETED|Overall Study||0
59665|NCT02370602|144288|P6|STARTED|Overall Study||2
59666|NCT02370602|144289|P5|STARTED|Overall Study||3
59667|NCT02370602|144290|P4|STARTED|Overall Study||3
59668|NCT02370602|144291|P3|STARTED|Overall Study||2
59669|NCT02370602|144292|P2|STARTED|Overall Study||2
59670|NCT02370602|144293|P1|STARTED|Overall Study||1
59671|NCT02370537|144387|P3|NOT COMPLETED|Part B||259
59672|NCT02370537|144388|P2|NOT COMPLETED|Part B||3
59673|NCT02370537|144389|P1|NOT COMPLETED|Part B||1
59674|NCT02370537|144387|P3|COMPLETED|Part B||23
59675|NCT02370537|144388|P2|COMPLETED|Part B||12
59676|NCT02370537|144389|P1|COMPLETED|Part B||15
59677|NCT02370537|144387|P3|Period 2 Sequence BA|Part B||12
59678|NCT02370537|144388|P2|Period 2 Sequence BA|Part B||7
59679|NCT02370537|144389|P1|Period 2 Sequence BA|Part B||7
59680|NCT02370537|144387|P3|Period 2 Sequence AB|Part B||11
59681|NCT02370537|144388|P2|Period 2 Sequence AB|Part B||5
59682|NCT02370537|144389|P1|Period 2 Sequence AB|Part B||8
59683|NCT02370537|144387|P3|Period 1 Sequence BA|Part B||12
59684|NCT02370537|144388|P2|Period 1 Sequence BA|Part B||7
59685|NCT02370537|144389|P1|Period 1 Sequence BA|Part B||7
59686|NCT02370537|144387|P3|Period 1 Sequence AB|Part B||11
59687|NCT02370537|144388|P2|Period 1 Sequence AB|Part B||6
59688|NCT02370537|144389|P1|Period 1 Sequence AB|Part B||8
59689|NCT02370537|144387|P3|Eligible for Randomisation|Part B||23
59690|NCT02370537|144388|P2|Eligible for Randomisation|Part B||13
59691|NCT02370537|144389|P1|Eligible for Randomisation|Part B||15
59692|NCT02370537|144387|P3|STARTED|Part B||282
59693|NCT02370537|144388|P2|STARTED|Part B||15
59694|NCT02370537|144389|P1|STARTED|Part B||16
59695|NCT02370537|144387|P3|NOT COMPLETED|Part A (Open-label Recruitment)||1
59696|NCT02370537|144388|P2|NOT COMPLETED|Part A (Open-label Recruitment)||1
59697|NCT02370537|144389|P1|NOT COMPLETED|Part A (Open-label Recruitment)||0
59698|NCT02370537|144387|P3|COMPLETED|Part A (Open-label Recruitment)||282
59699|NCT02370537|144388|P2|COMPLETED|Part A (Open-label Recruitment)||15
59700|NCT02370537|144389|P1|COMPLETED|Part A (Open-label Recruitment)||16
59701|NCT02370537|144387|P3|STARTED|Part A (Open-label Recruitment)||283
59702|NCT02370537|144388|P2|STARTED|Part A (Open-label Recruitment)||16
59703|NCT02370537|144389|P1|STARTED|Part A (Open-label Recruitment)||16
59704|NCT02370498|144438|P2|NOT COMPLETED|Overall Study||296
59705|NCT02370498|144439|P1|NOT COMPLETED|Overall Study||296
59706|NCT02370498|144438|P2|COMPLETED|Overall Study||0
59707|NCT02370498|144439|P1|COMPLETED|Overall Study||0
59708|NCT02370498|144438|P2|PD-L1 Positive Participants|Overall Study||199
59709|NCT02370498|144439|P1|PD-L1 Positive Participants|Overall Study||196
59710|NCT02370498|144438|P2|Treated|Overall Study||276
59711|NCT02370498|144439|P1|Treated|Overall Study||294
59712|NCT02370498|144438|P2|STARTED|Overall Study||296
59713|NCT02370498|144439|P1|STARTED|Overall Study||296
59714|NCT02370420|144493|P2|NOT COMPLETED|Overall Study||12
59715|NCT02370420|144494|P1|NOT COMPLETED|Overall Study||14
59716|NCT02370420|144493|P2|COMPLETED|Overall Study||15
59717|NCT02370420|144494|P1|COMPLETED|Overall Study||15
59718|NCT02370420|144493|P2|STARTED|Overall Study||27
59719|NCT02370420|144494|P1|STARTED|Overall Study||29
59720|NCT02370407|144506|P2|NOT COMPLETED|Overall Study||0
59721|NCT02370407|144507|P1|NOT COMPLETED|Overall Study||0
59722|NCT02370407|144506|P2|COMPLETED|Overall Study||20
59723|NCT02370407|144507|P1|COMPLETED|Overall Study||20
59724|NCT02370407|144506|P2|STARTED|Overall Study||20
59725|NCT02370407|144507|P1|STARTED|Overall Study||20
59726|NCT02370394|144531|P2|NOT COMPLETED|Overall Study||2
59727|NCT02370394|144532|P1|NOT COMPLETED|Overall Study||2
59728|NCT02370394|144531|P2|COMPLETED|Overall Study||23
59729|NCT02370394|144532|P1|COMPLETED|Overall Study||26
59730|NCT02370394|144531|P2|STARTED|Overall Study||25
59731|NCT02370394|144532|P1|STARTED|Overall Study||28
59732|NCT02370251|144546|P1|NOT COMPLETED|Overall Study||11
59733|NCT02370251|144546|P1|COMPLETED|Overall Study||52
59734|NCT02370251|144546|P1|STARTED|Overall Study||63
59735|NCT02370121|144554|P2|NOT COMPLETED|Overall Study||1
59736|NCT02370121|144555|P1|NOT COMPLETED|Overall Study||1
59737|NCT02370121|144554|P2|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
59738|NCT02370121|144555|P1|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
59739|NCT02370121|144554|P2|STARTED|Overall Study||12
59740|NCT02370121|144555|P1|STARTED|Overall Study||12
59741|NCT02370095|144595|P2|NOT COMPLETED|Overall Study||1
59742|NCT02370095|144596|P1|NOT COMPLETED|Overall Study||0
59743|NCT02370095|144595|P2|COMPLETED|Overall Study||3
59744|NCT02370095|144596|P1|COMPLETED|Overall Study||10
59745|NCT02370095|144595|P2|STARTED|Overall Study||4
59746|NCT02370095|144596|P1|STARTED|Overall Study||10
59747|NCT02370043|144626|P6|NOT COMPLETED|Overall Study||1
59748|NCT02370043|144627|P5|NOT COMPLETED|Overall Study||1
59749|NCT02370043|144628|P4|NOT COMPLETED|Overall Study||0
59750|NCT02370043|144629|P3|NOT COMPLETED|Overall Study||0
59751|NCT02370043|144630|P2|NOT COMPLETED|Overall Study||0
59752|NCT02370043|144631|P1|NOT COMPLETED|Overall Study||0
59753|NCT02370043|144626|P6|COMPLETED|Overall Study||3
59754|NCT02370043|144627|P5|COMPLETED|Overall Study||2
59755|NCT02370043|144628|P4|COMPLETED|Overall Study||3
59756|NCT02370043|144629|P3|COMPLETED|Overall Study||3
59757|NCT02370043|144630|P2|COMPLETED|Overall Study||3
59758|NCT02370043|144631|P1|COMPLETED|Overall Study||3
59759|NCT02370043|144626|P6|STARTED|Overall Study||4
59760|NCT02370043|144627|P5|STARTED|Overall Study||3
59761|NCT02370043|144628|P4|STARTED|Overall Study||3
59762|NCT02370043|144629|P3|STARTED|Overall Study||3
59763|NCT02370043|144630|P2|STARTED|Overall Study||3
59764|NCT02370043|144631|P1|STARTED|Overall Study||3
59765|NCT02369874|144763|P3|NOT COMPLETED|Overall Study||61
59766|NCT02369874|144764|P2|NOT COMPLETED|Overall Study||57
59767|NCT02369874|144765|P1|NOT COMPLETED|Overall Study||44
59768|NCT02369874|144763|P3|COMPLETED|Overall Study||188
59769|NCT02369874|144764|P2|COMPLETED|Overall Study||183
59770|NCT02369874|144765|P1|COMPLETED|Overall Study||203
59771|NCT02369874|144763|P3|Received Treatment|Overall Study||240
59772|NCT02369874|144764|P2|Received Treatment|Overall Study||237
59773|NCT02369874|144765|P1|Received Treatment|Overall Study||246
59774|NCT02369874|144763|P3|STARTED|Overall Study||249
59775|NCT02369874|144764|P2|STARTED|Overall Study||240
59776|NCT02369874|144765|P1|STARTED|Overall Study||247
59777|NCT02369848|144812|P1|NOT COMPLETED|Overall Study||4
59778|NCT02369848|144812|P1|COMPLETED|Overall Study||56
59779|NCT02369848|144812|P1|12 Month Primary Endpoint|Overall Study||30
59780|NCT02369848|144812|P1|30 Day Primary Safety Endpoint|Overall Study||58
59781|NCT02369848|144812|P1|STARTED|Overall Study||60
59782|NCT02369835|144828|P2|NOT COMPLETED|Overall Study||13
59783|NCT02369835|144829|P1|NOT COMPLETED|Overall Study||11
59784|NCT02369835|144828|P2|COMPLETED|Overall Study|Reasons that participants did not complete for the Primary Outcome are not available.|55
59785|NCT02369835|144829|P1|COMPLETED|Overall Study|Reasons that participants did not complete for the Primary Outcome are not available.|53
59786|NCT02369835|144828|P2|STARTED|Overall Study||68
59787|NCT02369835|144829|P1|STARTED|Overall Study||64
59788|NCT02369796|144844|P5|NOT COMPLETED|Overall Study||0
59789|NCT02369796|144845|P4|NOT COMPLETED|Overall Study||0
59790|NCT02369796|144846|P3|NOT COMPLETED|Overall Study||0
59791|NCT02369796|144847|P2|NOT COMPLETED|Overall Study||0
59792|NCT02369796|144848|P1|NOT COMPLETED|Overall Study||0
59793|NCT02369796|144844|P5|COMPLETED|Overall Study||3
59794|NCT02369796|144845|P4|COMPLETED|Overall Study||3
59795|NCT02369796|144846|P3|COMPLETED|Overall Study||3
59796|NCT02369796|144847|P2|COMPLETED|Overall Study||3
59797|NCT02369796|144848|P1|COMPLETED|Overall Study||3
59798|NCT02369796|144844|P5|STARTED|Overall Study||3
59799|NCT02369796|144845|P4|STARTED|Overall Study||3
59800|NCT02369796|144846|P3|STARTED|Overall Study||3
59801|NCT02369796|144847|P2|STARTED|Overall Study||3
59802|NCT02369796|144848|P1|STARTED|Overall Study||3
59803|NCT02369510|144890|P3|NOT COMPLETED|Overall Study||6
59804|NCT02369510|144891|P2|NOT COMPLETED|Overall Study||3
59805|NCT02369510|144892|P1|NOT COMPLETED|Overall Study||2
59806|NCT02369510|144890|P3|COMPLETED|Overall Study||17
59807|NCT02369510|144891|P2|COMPLETED|Overall Study||19
59808|NCT02369510|144892|P1|COMPLETED|Overall Study||21
59809|NCT02369510|144890|P3|STARTED|Overall Study||23
59810|NCT02369510|144891|P2|STARTED|Overall Study||22
59811|NCT02369510|144892|P1|STARTED|Overall Study||23
59812|NCT02369484|144921|P1|NOT COMPLETED|Overall Study||0
59813|NCT02369484|144921|P1|COMPLETED|Overall Study||13
59814|NCT02369484|144921|P1|STARTED|Overall Study||13
59815|NCT02369341|144931|P2|NOT COMPLETED|Overall Study||0
59816|NCT02369341|144932|P1|NOT COMPLETED|Overall Study||1
59817|NCT02369341|144931|P2|COMPLETED|Overall Study||57
59818|NCT02369341|144932|P1|COMPLETED|Overall Study||62
59819|NCT02369341|144931|P2|STARTED|Overall Study||57
59820|NCT02369341|144932|P1|STARTED|Overall Study||63
59821|NCT02369211|144988|P2|NOT COMPLETED|Overall Study||2
59822|NCT02369211|144989|P1|NOT COMPLETED|Overall Study||0
59823|NCT02369211|144988|P2|COMPLETED|Overall Study||41
59824|NCT02369211|144989|P1|COMPLETED|Overall Study||43
59825|NCT02369211|144988|P2|STARTED|Overall Study||43
59826|NCT02369211|144989|P1|STARTED|Overall Study||43
59827|NCT02369172|145001|P1|NOT COMPLETED|Overall Study||0
59828|NCT02369172|145001|P1|COMPLETED|Overall Study||24
59829|NCT02369172|145001|P1|STARTED|Overall Study||24
59830|NCT02369068|145075|P2|NOT COMPLETED|6 Months||1
59831|NCT02369068|145076|P1|NOT COMPLETED|6 Months||0
59832|NCT02369068|145075|P2|COMPLETED|6 Months||7
59833|NCT02369068|145076|P1|COMPLETED|6 Months||9
59834|NCT02369068|145075|P2|STARTED|6 Months||8
59835|NCT02369068|145076|P1|STARTED|6 Months||9
59836|NCT02369068|145075|P2|NOT COMPLETED|3 Months||2
59837|NCT02369068|145076|P1|NOT COMPLETED|3 Months||0
59838|NCT02369068|145075|P2|COMPLETED|3 Months||8
59839|NCT02369068|145076|P1|COMPLETED|3 Months||9
59840|NCT02369068|145075|P2|STARTED|3 Months||10
59841|NCT02369068|145076|P1|STARTED|3 Months||9
59842|NCT02369068|145075|P2|NOT COMPLETED|1 Month||1
59843|NCT02369068|145076|P1|NOT COMPLETED|1 Month||1
59844|NCT02369068|145075|P2|COMPLETED|1 Month||10
59845|NCT02369068|145076|P1|COMPLETED|1 Month||9
59846|NCT02369068|145075|P2|STARTED|1 Month||11
59847|NCT02369068|145076|P1|STARTED|1 Month||10
59848|NCT02368886|145108|P4|NOT COMPLETED|Overall Study||4
59849|NCT02368886|145109|P3|NOT COMPLETED|Overall Study||1
59850|NCT02368886|145110|P2|NOT COMPLETED|Overall Study||1
59851|NCT02368886|145111|P1|NOT COMPLETED|Overall Study||1
59852|NCT02368886|145108|P4|COMPLETED|Overall Study||29
59853|NCT02368886|145109|P3|COMPLETED|Overall Study||33
59854|NCT02368886|145110|P2|COMPLETED|Overall Study||26
59855|NCT02368886|145111|P1|COMPLETED|Overall Study||28
59856|NCT02368886|145108|P4|STARTED|Overall Study||33
59857|NCT02368886|145109|P3|STARTED|Overall Study||34
59858|NCT02368886|145110|P2|STARTED|Overall Study||27
59859|NCT02368886|145111|P1|STARTED|Overall Study||29
59860|NCT02368457|145131|P2|NOT COMPLETED|Overall Study||0
59861|NCT02368457|145132|P1|NOT COMPLETED|Overall Study||0
59862|NCT02368457|145131|P2|COMPLETED|Overall Study||12
59863|NCT02368457|145132|P1|COMPLETED|Overall Study||12
59864|NCT02368457|145131|P2|STARTED|Overall Study||12
59865|NCT02368457|145132|P1|STARTED|Overall Study||12
59866|NCT02368314|145142|P2|NOT COMPLETED|Overall Study||3
59867|NCT02368314|145143|P1|NOT COMPLETED|Overall Study||3
59868|NCT02368314|145142|P2|COMPLETED|Overall Study||57
59869|NCT02368314|145143|P1|COMPLETED|Overall Study||61
59870|NCT02368314|145142|P2|STARTED|Overall Study||60
59871|NCT02368314|145143|P1|STARTED|Overall Study||64
59872|NCT02368210|145155|P2|NOT COMPLETED|Overall Study||1
59873|NCT02368210|145156|P1|NOT COMPLETED|Overall Study||1
59874|NCT02368210|145155|P2|COMPLETED|Overall Study||75
59875|NCT02368210|145156|P1|COMPLETED|Overall Study||74
59876|NCT02368210|145155|P2|STARTED|Overall Study||76
59877|NCT02368210|145156|P1|STARTED|Overall Study||75
59878|NCT02368093|145174|P2|NOT COMPLETED|Overall Study||0
59879|NCT02368093|145175|P1|NOT COMPLETED|Overall Study||0
59880|NCT02368093|145174|P2|COMPLETED|Overall Study||24
59881|NCT02368093|145175|P1|COMPLETED|Overall Study||24
59882|NCT02368093|145174|P2|STARTED|Overall Study||24
59883|NCT02368093|145175|P1|STARTED|Overall Study||24
59884|NCT02367911|145183|P2|NOT COMPLETED|Overall Study||4
59885|NCT02367911|145184|P1|NOT COMPLETED|Overall Study||5
59886|NCT02367911|145183|P2|COMPLETED|Overall Study||69
59887|NCT02367911|145184|P1|COMPLETED|Overall Study||66
59888|NCT02367911|145183|P2|STARTED|Overall Study||73
59889|NCT02367911|145184|P1|STARTED|Overall Study||71
59890|NCT02367885|145195|P3|NOT COMPLETED|Overall Study||0
59891|NCT02367885|145196|P2|NOT COMPLETED|Overall Study||0
59892|NCT02367885|145197|P1|NOT COMPLETED|Overall Study||2
59893|NCT02367885|145195|P3|COMPLETED|Overall Study||33
59894|NCT02367885|145196|P2|COMPLETED|Overall Study||33
59895|NCT02367885|145197|P1|COMPLETED|Overall Study||31
59896|NCT02367885|145195|P3|STARTED|Overall Study||33
59897|NCT02367885|145196|P2|STARTED|Overall Study||33
59898|NCT02367885|145197|P1|STARTED|Overall Study||33
59899|NCT02367872|145270|P8|NOT COMPLETED|Overall Study||0
59900|NCT02367872|145271|P7|NOT COMPLETED|Overall Study||0
59901|NCT02367872|145272|P6|NOT COMPLETED|Overall Study||0
59902|NCT02367872|145273|P5|NOT COMPLETED|Overall Study||0
59903|NCT02367872|145274|P4|NOT COMPLETED|Overall Study||0
59904|NCT02367872|145275|P3|NOT COMPLETED|Overall Study||0
59905|NCT02367872|145276|P2|NOT COMPLETED|Overall Study||0
59906|NCT02367872|145277|P1|NOT COMPLETED|Overall Study||0
59907|NCT02367872|145270|P8|COMPLETED|Overall Study||6
59908|NCT02367872|145271|P7|COMPLETED|Overall Study||6
59909|NCT02367872|145272|P6|COMPLETED|Overall Study||6
59910|NCT02367872|145273|P5|COMPLETED|Overall Study||6
59911|NCT02367872|145274|P4|COMPLETED|Overall Study||6
59912|NCT02367872|145275|P3|COMPLETED|Overall Study||6
59913|NCT02367872|145276|P2|COMPLETED|Overall Study||6
59914|NCT02367872|145277|P1|COMPLETED|Overall Study||6
59915|NCT02367872|145270|P8|STARTED|Overall Study||6
59916|NCT02367872|145271|P7|STARTED|Overall Study||6
59917|NCT02367872|145272|P6|STARTED|Overall Study||6
59918|NCT02367872|145273|P5|STARTED|Overall Study||6
59919|NCT02367872|145274|P4|STARTED|Overall Study||6
59920|NCT02367872|145275|P3|STARTED|Overall Study||6
59921|NCT02367872|145276|P2|STARTED|Overall Study||6
59922|NCT02367872|145277|P1|STARTED|Overall Study||6
59923|NCT02367833|145433|P3|NOT COMPLETED|Overall Study||0
59924|NCT02367833|145434|P2|NOT COMPLETED|Overall Study||1
59925|NCT02367833|145435|P1|NOT COMPLETED|Overall Study||1
59926|NCT02367833|145433|P3|COMPLETED|Overall Study||8
59927|NCT02367833|145434|P2|COMPLETED|Overall Study||8
59928|NCT02367833|145435|P1|COMPLETED|Overall Study||8
59929|NCT02367833|145433|P3|STARTED|Overall Study||8
59930|NCT02367833|145434|P2|STARTED|Overall Study||9
59931|NCT02367833|145435|P1|STARTED|Overall Study||9
59932|NCT02367794|145449|P3|NOT COMPLETED|Overall Study||249
59933|NCT02367794|145450|P2|NOT COMPLETED|Overall Study||240
59934|NCT02367794|145451|P1|NOT COMPLETED|Overall Study||258
59935|NCT02367794|145449|P3|COMPLETED|Overall Study||89
59936|NCT02367794|145450|P2|COMPLETED|Overall Study||103
59937|NCT02367794|145451|P1|COMPLETED|Overall Study||82
59938|NCT02367794|145449|P3|STARTED|Overall Study||338
59939|NCT02367794|145450|P2|STARTED|Overall Study||343
59940|NCT02367794|145451|P1|STARTED|Overall Study||340
59941|NCT02367781|145464|P2|NOT COMPLETED|Overall Study||240
59942|NCT02367781|145465|P1|NOT COMPLETED|Overall Study||483
59943|NCT02367781|145464|P2|COMPLETED|Overall Study||0
59944|NCT02367781|145465|P1|COMPLETED|Overall Study||0
59945|NCT02367781|145464|P2|STARTED|Overall Study||240
59946|NCT02367781|145465|P1|STARTED|Overall Study||483
59947|NCT02367729|145475|P2|NOT COMPLETED|Overall Study||8
59948|NCT02367729|145476|P1|NOT COMPLETED|Overall Study||3
59949|NCT02367729|145475|P2|COMPLETED|Overall Study||47
59950|NCT02367729|145476|P1|COMPLETED|Overall Study||57
59951|NCT02367729|145475|P2|STARTED|Overall Study||55
59952|NCT02367729|145476|P1|STARTED|Overall Study||60
59953|NCT02367521|145494|P2|NOT COMPLETED|Overall Study||0
59954|NCT02367521|145495|P1|NOT COMPLETED|Overall Study||4
59955|NCT02367521|145494|P2|COMPLETED|Overall Study||17
59956|NCT02367521|145495|P1|COMPLETED|Overall Study||13
59957|NCT02367521|145494|P2|STARTED|Overall Study||17
59958|NCT02367521|145495|P1|STARTED|Overall Study||17
59959|NCT02367391|145549|P2|NOT COMPLETED|Overall Study||0
59960|NCT02367391|145550|P1|NOT COMPLETED|Overall Study||2
59961|NCT02367391|145549|P2|COMPLETED|Overall Study||76
59962|NCT02367391|145550|P1|COMPLETED|Overall Study||74
59963|NCT02367391|145549|P2|STARTED|Overall Study||76
59964|NCT02367391|145550|P1|STARTED|Overall Study||76
59965|NCT02367352|145568|P3|NOT COMPLETED|Overall Study||0
59966|NCT02367352|145569|P2|NOT COMPLETED|Overall Study||0
59967|NCT02367352|145570|P1|NOT COMPLETED|Overall Study||9
59968|NCT02367352|145568|P3|COMPLETED|Overall Study||0
59969|NCT02367352|145569|P2|COMPLETED|Overall Study||0
59970|NCT02367352|145570|P1|COMPLETED|Overall Study||0
59971|NCT02367352|145568|P3|STARTED|Overall Study||0
59972|NCT02367352|145569|P2|STARTED|Overall Study||0
59973|NCT02367352|145570|P1|STARTED|Overall Study||9
59974|NCT02367170|145609|P2|NOT COMPLETED|Overall Study||0
59975|NCT02367170|145610|P1|NOT COMPLETED|Overall Study||0
59976|NCT02367170|145609|P2|COMPLETED|Overall Study||0
59977|NCT02367170|145610|P1|COMPLETED|Overall Study||1
59978|NCT02367170|145609|P2|STARTED|Overall Study||0
59979|NCT02367170|145610|P1|STARTED|Overall Study||1
59980|NCT02367131|145620|P1|NOT COMPLETED|Overall Study||222
59981|NCT02367131|145620|P1|COMPLETED|Overall Study||201
59982|NCT02367131|145620|P1|STARTED|Overall Study|Started are the treated patients|423
59983|NCT02367066|145628|P2|NOT COMPLETED|Overall Study||0
59984|NCT02367066|145629|P1|NOT COMPLETED|Overall Study||0
59985|NCT02367066|145628|P2|COMPLETED|Overall Study||10
59986|NCT02367066|145629|P1|COMPLETED|Overall Study||10
59987|NCT02367066|145628|P2|STARTED|Overall Study||10
59988|NCT02367066|145629|P1|STARTED|Overall Study||10
59989|NCT02366936|145687|P1|NOT COMPLETED|Overall Study||8
59990|NCT02366936|145687|P1|COMPLETED|Overall Study||24
59991|NCT02366936|145687|P1|STARTED|Overall Study||32
59992|NCT02366923|145692|P1|NOT COMPLETED|Overall Study||6
59993|NCT02366923|145692|P1|COMPLETED|Overall Study||22
59994|NCT02366923|145692|P1|STARTED|Overall Study||28
59995|NCT02366910|145705|P1|NOT COMPLETED|Overall Study||5
59996|NCT02366910|145705|P1|COMPLETED|Overall Study||21
59997|NCT02366910|145705|P1|STARTED|Overall Study||26
59998|NCT02366845|145719|P2|NOT COMPLETED|Overall Study||0
59999|NCT02366845|145720|P1|NOT COMPLETED|Overall Study||0
60000|NCT02366845|145719|P2|COMPLETED|Overall Study||25
60001|NCT02366845|145720|P1|COMPLETED|Overall Study||25
60002|NCT02366845|145719|P2|STARTED|Overall Study||25
60003|NCT02366845|145720|P1|STARTED|Overall Study||25
60004|NCT02366767|145734|P2|NOT COMPLETED|Overall Study||0
60005|NCT02366767|145735|P1|NOT COMPLETED|Overall Study||1
60006|NCT02366767|145734|P2|COMPLETED|Overall Study||10
60007|NCT02366767|145735|P1|COMPLETED|Overall Study||10
60008|NCT02366767|145734|P2|STARTED|Overall Study||10
60009|NCT02366767|145735|P1|STARTED|Overall Study||11
60010|NCT02366689|145748|P3|NOT COMPLETED|Overall Study||2
60011|NCT02366689|145749|P2|NOT COMPLETED|Overall Study||3
60012|NCT02366689|145750|P1|NOT COMPLETED|Overall Study||4
60013|NCT02366689|145748|P3|COMPLETED|Overall Study||59
60014|NCT02366689|145749|P2|COMPLETED|Overall Study||55
60015|NCT02366689|145750|P1|COMPLETED|Overall Study||56
60016|NCT02366689|145748|P3|STARTED|Overall Study||61
60017|NCT02366689|145749|P2|STARTED|Overall Study||58
60018|NCT02366689|145750|P1|STARTED|Overall Study||60
60019|NCT02366663|145775|P2|NOT COMPLETED|Overall Study||0
60020|NCT02366663|145776|P1|NOT COMPLETED|Overall Study||0
60021|NCT02366663|145775|P2|COMPLETED|Overall Study||1
60022|NCT02366663|145776|P1|COMPLETED|Overall Study||2
60023|NCT02366663|145775|P2|STARTED|Overall Study||1
60024|NCT02366663|145776|P1|STARTED|Overall Study||2
60025|NCT02366637|145802|P2|NOT COMPLETED|Second Intervention Period||1
60026|NCT02366637|145803|P1|NOT COMPLETED|Second Intervention Period||1
60027|NCT02366637|145802|P2|COMPLETED|Second Intervention Period||0
60028|NCT02366637|145803|P1|COMPLETED|Second Intervention Period||0
60029|NCT02366637|145802|P2|STARTED|Second Intervention Period||1
60030|NCT02366637|145803|P1|STARTED|Second Intervention Period||1
60031|NCT02366637|145802|P2|NOT COMPLETED|Washout Period 28 to 49 Days||0
60032|NCT02366637|145803|P1|NOT COMPLETED|Washout Period 28 to 49 Days||0
60033|NCT02366637|145802|P2|COMPLETED|Washout Period 28 to 49 Days||1
60034|NCT02366637|145803|P1|COMPLETED|Washout Period 28 to 49 Days||1
60035|NCT02366637|145802|P2|STARTED|Washout Period 28 to 49 Days||1
60036|NCT02366637|145803|P1|STARTED|Washout Period 28 to 49 Days||1
60037|NCT02366637|145802|P2|NOT COMPLETED|First Intervention Period||5
60038|NCT02366637|145803|P1|NOT COMPLETED|First Intervention Period||6
60039|NCT02366637|145802|P2|COMPLETED|First Intervention Period||1
60040|NCT02366637|145803|P1|COMPLETED|First Intervention Period||1
60041|NCT02366637|145802|P2|STARTED|First Intervention Period||6
60042|NCT02366637|145803|P1|STARTED|First Intervention Period||7
60043|NCT02366468|145829|P2|NOT COMPLETED|Overall Study||9
60044|NCT02366468|145830|P1|NOT COMPLETED|Overall Study||6
60045|NCT02366468|145829|P2|COMPLETED|Overall Study||58
60046|NCT02366468|145830|P1|COMPLETED|Overall Study||62
60047|NCT02366468|145829|P2|Per Protocol Set (PPS)|Overall Study||61
60048|NCT02366468|145830|P1|Per Protocol Set (PPS)|Overall Study||62
60049|NCT02366468|145829|P2|Full Analysis Set (FAS)|Overall Study||66
60050|NCT02366468|145830|P1|Full Analysis Set (FAS)|Overall Study||67
60051|NCT02366468|145829|P2|STARTED|Overall Study||67
60052|NCT02366468|145830|P1|STARTED|Overall Study||68
60053|NCT02366338|145851|P3|NOT COMPLETED|Overall Study||0
60054|NCT02366338|145852|P2|NOT COMPLETED|Overall Study||0
60055|NCT02366338|145853|P1|NOT COMPLETED|Overall Study||0
60056|NCT02366338|145851|P3|COMPLETED|Overall Study||36
60057|NCT02366338|145852|P2|COMPLETED|Overall Study||39
60058|NCT02366338|145853|P1|COMPLETED|Overall Study||73
60059|NCT02366338|145851|P3|STARTED|Overall Study||36
60060|NCT02366338|145852|P2|STARTED|Overall Study||39
60061|NCT02366338|145853|P1|STARTED|Overall Study||73
60062|NCT02366195|145861|P1|NOT COMPLETED|Overall Study||112
60063|NCT02366195|145861|P1|COMPLETED|Overall Study||0
60064|NCT02366195|145861|P1|Received Study Drug|Overall Study||111
60065|NCT02366195|145861|P1|STARTED|Overall Study||112
60066|NCT02365961|145881|P2|NOT COMPLETED|Overall Study||0
60067|NCT02365961|145882|P1|NOT COMPLETED|Overall Study||0
60068|NCT02365961|145881|P2|COMPLETED|Overall Study||43
60069|NCT02365961|145882|P1|COMPLETED|Overall Study||41
60070|NCT02365961|145881|P2|STARTED|Overall Study||43
60071|NCT02365961|145882|P1|STARTED|Overall Study||41
60072|NCT02365714|145896|P1|NOT COMPLETED|Overall Study||0
60073|NCT02365714|145896|P1|COMPLETED|Overall Study||2
60074|NCT02365714|145896|P1|STARTED|Overall Study||2
60075|NCT02365688|145902|P1|NOT COMPLETED|Overall Study||0
60076|NCT02365688|145902|P1|COMPLETED|Overall Study|All subjects consented to an change in standard infusion volume pre-incision|18
60077|NCT02365688|145902|P1|STARTED|Overall Study|All subjects received a bolus of 500cc before first incision|18
60078|NCT02365636|145909|P3|NOT COMPLETED|Overall Study||3
60079|NCT02365636|145910|P2|NOT COMPLETED|Overall Study||7
60080|NCT02365636|145911|P1|NOT COMPLETED|Overall Study||6
60081|NCT02365636|145909|P3|COMPLETED|Overall Study||97
60082|NCT02365636|145910|P2|COMPLETED|Overall Study||93
60083|NCT02365636|145911|P1|COMPLETED|Overall Study||94
60084|NCT02365636|145909|P3|Full Analysis Set|Overall Study||100
60085|NCT02365636|145910|P2|Full Analysis Set|Overall Study||98
60086|NCT02365636|145911|P1|Full Analysis Set|Overall Study||100
60087|NCT02365636|145909|P3|Safety Population|Overall Study||100
60088|NCT02365636|145910|P2|Safety Population|Overall Study|2 terminated prior to treatment due to 1) prohibited concomitant medication 2) exclusion criteria|98
60089|NCT02365636|145911|P1|Safety Population|Overall Study||100
60090|NCT02365636|145909|P3|STARTED|Overall Study||100
60091|NCT02365636|145910|P2|STARTED|Overall Study||100
60092|NCT02365636|145911|P1|STARTED|Overall Study||100
60093|NCT02365584|145957|P2|NOT COMPLETED|Overall Study||14
60094|NCT02365584|145958|P1|NOT COMPLETED|Overall Study||12
60095|NCT02365584|145957|P2|COMPLETED|Overall Study||8
60096|NCT02365584|145958|P1|COMPLETED|Overall Study||9
60097|NCT02365584|145957|P2|STARTED|Overall Study||22
60098|NCT02365584|145958|P1|STARTED|Overall Study||21
60099|NCT02365558|145982|P2|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||1
60100|NCT02365558|145983|P1|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||0
60101|NCT02365558|145982|P2|COMPLETED|Period 2 (Day 8 Through Day 20)||32
60102|NCT02365558|145983|P1|COMPLETED|Period 2 (Day 8 Through Day 20)||0
60103|NCT02365558|145982|P2|STARTED|Period 2 (Day 8 Through Day 20)|Participants completed Period 1 and entered Evacetrapib + Omeprazole for Period 2.|33
60104|NCT02365558|145983|P1|STARTED|Period 2 (Day 8 Through Day 20)|Participants move to Evacetrapib + Omeprazole for Period 2.|0
60105|NCT02365558|145982|P2|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||0
60106|NCT02365558|145983|P1|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||1
60107|NCT02365558|145982|P2|COMPLETED|Period 1 (Day 1 Through Day 7)||0
60108|NCT02365558|145983|P1|COMPLETED|Period 1 (Day 1 Through Day 7)||33
60109|NCT02365558|145982|P2|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||0
60110|NCT02365558|145983|P1|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||34
60111|NCT02365558|145982|P2|STARTED|Period 1 (Day 1 Through Day 7)||0
60112|NCT02365558|145983|P1|STARTED|Period 1 (Day 1 Through Day 7)||34
60113|NCT02365519|145996|P3|NOT COMPLETED|Randomized and Treated||1
60114|NCT02365519|145997|P2|NOT COMPLETED|Randomized and Treated||2
60115|NCT02365519|145998|P1|NOT COMPLETED|Randomized and Treated||0
60116|NCT02365519|145996|P3|COMPLETED|Randomized and Treated||64
60117|NCT02365519|145997|P2|COMPLETED|Randomized and Treated||67
60118|NCT02365519|145998|P1|COMPLETED|Randomized and Treated||0
60119|NCT02365519|145996|P3|STARTED|Randomized and Treated||65
60120|NCT02365519|145997|P2|STARTED|Randomized and Treated||69
60121|NCT02365519|145998|P1|STARTED|Randomized and Treated||0
60122|NCT02365519|145996|P3|NOT COMPLETED|Vehicle Run-In||0
60123|NCT02365519|145997|P2|NOT COMPLETED|Vehicle Run-In||0
60124|NCT02365519|145998|P1|NOT COMPLETED|Vehicle Run-In||79
60125|NCT02365519|145996|P3|COMPLETED|Vehicle Run-In||0
60126|NCT02365519|145997|P2|COMPLETED|Vehicle Run-In||0
60127|NCT02365519|145998|P1|COMPLETED|Vehicle Run-In||134
60128|NCT02365519|145996|P3|STARTED|Vehicle Run-In||0
60129|NCT02365519|145997|P2|STARTED|Vehicle Run-In||0
60130|NCT02365519|145998|P1|STARTED|Vehicle Run-In||213
60131|NCT02365298|146019|P2|NOT COMPLETED|Period 2||2
60132|NCT02365298|146020|P1|NOT COMPLETED|Period 2||2
60133|NCT02365298|146019|P2|COMPLETED|Period 2||12
60134|NCT02365298|146020|P1|COMPLETED|Period 2||12
60135|NCT02365298|146019|P2|STARTED|Period 2||14
60136|NCT02365298|146020|P1|STARTED|Period 2||14
60137|NCT02365298|146019|P2|NOT COMPLETED|Period 1||0
60138|NCT02365298|146020|P1|NOT COMPLETED|Period 1||0
60139|NCT02365298|146019|P2|COMPLETED|Period 1||14
60140|NCT02365298|146020|P1|COMPLETED|Period 1||14
60141|NCT02365298|146019|P2|STARTED|Period 1||14
60142|NCT02365298|146020|P1|STARTED|Period 1||14
60143|NCT02365285|146040|P4|NOT COMPLETED|Overall Study||2
60144|NCT02365285|146041|P3|NOT COMPLETED|Overall Study||1
60145|NCT02365285|146042|P2|NOT COMPLETED|Overall Study||1
60146|NCT02365285|146043|P1|NOT COMPLETED|Overall Study||0
60147|NCT02365285|146040|P4|COMPLETED|Overall Study||1
60148|NCT02365285|146041|P3|COMPLETED|Overall Study||6
60149|NCT02365285|146042|P2|COMPLETED|Overall Study||5
60150|NCT02365285|146043|P1|COMPLETED|Overall Study||7
60151|NCT02365285|146040|P4|STARTED|Overall Study||3
60152|NCT02365285|146041|P3|STARTED|Overall Study||7
60153|NCT02365285|146042|P2|STARTED|Overall Study||6
60154|NCT02365285|146043|P1|STARTED|Overall Study||7
60155|NCT02365233|146060|P3|NOT COMPLETED|Overall Study||2
60156|NCT02365233|146061|P2|NOT COMPLETED|Overall Study||2
60157|NCT02365233|146062|P1|NOT COMPLETED|Overall Study||1
60158|NCT02365233|146060|P3|COMPLETED|Overall Study||0
60159|NCT02365233|146061|P2|COMPLETED|Overall Study||0
60160|NCT02365233|146062|P1|COMPLETED|Overall Study||0
60161|NCT02365233|146060|P3|STARTED|Overall Study||2
60162|NCT02365233|146061|P2|STARTED|Overall Study||2
60163|NCT02365233|146062|P1|STARTED|Overall Study||1
60164|NCT02365207|146070|P1|NOT COMPLETED|Overall Study||2
60165|NCT02365207|146070|P1|COMPLETED|Overall Study||4
60166|NCT02365207|146070|P1|STARTED|Overall Study||6
60167|NCT02364999|146076|P2|NOT COMPLETED|Overall Study||173
60168|NCT02364999|146077|P1|NOT COMPLETED|Overall Study||165
60169|NCT02364999|146076|P2|COMPLETED|Overall Study||188
60170|NCT02364999|146077|P1|COMPLETED|Overall Study||193
60171|NCT02364999|146076|P2|Received Treatment|Overall Study||358
60172|NCT02364999|146077|P1|Received Treatment|Overall Study||356
60173|NCT02364999|146076|P2|STARTED|Overall Study||361
60174|NCT02364999|146077|P1|STARTED|Overall Study||358
60175|NCT02364947|146103|P3|NOT COMPLETED|Overall Study||26
60176|NCT02364947|146104|P2|NOT COMPLETED|Overall Study||45
60177|NCT02364947|146105|P1|NOT COMPLETED|Overall Study||59
60178|NCT02364947|146103|P3|COMPLETED|Overall Study||219
60179|NCT02364947|146104|P2|COMPLETED|Overall Study||139
60180|NCT02364947|146105|P1|COMPLETED|Overall Study||189
60181|NCT02364947|146103|P3|STARTED|Overall Study||245
60182|NCT02364947|146104|P2|STARTED|Overall Study||184
60183|NCT02364947|146105|P1|STARTED|Overall Study||248
60184|NCT02364778|146172|P1|NOT COMPLETED|Overall Study||0
60185|NCT02364778|146172|P1|COMPLETED|Overall Study||30
60186|NCT02364778|146172|P1|STARTED|Overall Study||30
60187|NCT02364700|146184|P1|NOT COMPLETED|Overall Study||0
60188|NCT02364700|146184|P1|COMPLETED|Overall Study||12
60189|NCT02364700|146184|P1|STARTED|Overall Study||12
60190|NCT02364570|146193|P16|NOT COMPLETED|Overall Study||0
60191|NCT02364570|146194|P15|NOT COMPLETED|Overall Study||0
60192|NCT02364570|146195|P14|NOT COMPLETED|Overall Study||0
60193|NCT02364570|146196|P13|NOT COMPLETED|Overall Study||0
60194|NCT02364570|146197|P12|NOT COMPLETED|Overall Study||0
60195|NCT02364570|146198|P11|NOT COMPLETED|Overall Study||0
60196|NCT02364570|146199|P10|NOT COMPLETED|Overall Study||0
60197|NCT02364570|146200|P9|NOT COMPLETED|Overall Study||0
60198|NCT02364570|146201|P8|NOT COMPLETED|Overall Study||0
60199|NCT02364570|146202|P7|NOT COMPLETED|Overall Study||0
60200|NCT02364570|146203|P6|NOT COMPLETED|Overall Study||0
60201|NCT02364570|146204|P5|NOT COMPLETED|Overall Study||0
60202|NCT02364570|146205|P4|NOT COMPLETED|Overall Study||0
60203|NCT02364570|146206|P3|NOT COMPLETED|Overall Study||0
60204|NCT02364570|146207|P2|NOT COMPLETED|Overall Study||0
60205|NCT02364570|146208|P1|NOT COMPLETED|Overall Study||0
60206|NCT02364570|146193|P16|COMPLETED|Overall Study||1
60207|NCT02364570|146194|P15|COMPLETED|Overall Study||1
60208|NCT02364570|146195|P14|COMPLETED|Overall Study||2
60209|NCT02364570|146196|P13|COMPLETED|Overall Study||1
60210|NCT02364570|146197|P12|COMPLETED|Overall Study||1
60211|NCT02364570|146198|P11|COMPLETED|Overall Study||1
60212|NCT02364570|146199|P10|COMPLETED|Overall Study||1
60213|NCT02364570|146200|P9|COMPLETED|Overall Study||2
60214|NCT02364570|146201|P8|COMPLETED|Overall Study||1
60215|NCT02364570|146202|P7|COMPLETED|Overall Study||2
60216|NCT02364570|146203|P6|COMPLETED|Overall Study||1
60217|NCT02364570|146204|P5|COMPLETED|Overall Study||1
60218|NCT02364570|146205|P4|COMPLETED|Overall Study||1
60219|NCT02364570|146206|P3|COMPLETED|Overall Study||2
60220|NCT02364570|146207|P2|COMPLETED|Overall Study||1
60221|NCT02364570|146208|P1|COMPLETED|Overall Study||1
60222|NCT02364570|146193|P16|STARTED|Overall Study||1
60223|NCT02364570|146194|P15|STARTED|Overall Study||1
60224|NCT02364570|146195|P14|STARTED|Overall Study||2
60225|NCT02364570|146196|P13|STARTED|Overall Study||1
60226|NCT02364570|146197|P12|STARTED|Overall Study||1
60227|NCT02364570|146198|P11|STARTED|Overall Study||1
60228|NCT02364570|146199|P10|STARTED|Overall Study||1
60229|NCT02364570|146200|P9|STARTED|Overall Study||2
60230|NCT02364570|146201|P8|STARTED|Overall Study||1
60231|NCT02364570|146202|P7|STARTED|Overall Study||2
60232|NCT02364570|146203|P6|STARTED|Overall Study||1
60233|NCT02364570|146204|P5|STARTED|Overall Study||1
60234|NCT02364570|146205|P4|STARTED|Overall Study||1
60235|NCT02364570|146206|P3|STARTED|Overall Study||2
60236|NCT02364570|146207|P2|STARTED|Overall Study||1
60237|NCT02364570|146208|P1|STARTED|Overall Study||1
60238|NCT02364336|146276|P2|NOT COMPLETED|Overall Study||1
60239|NCT02364336|146277|P1|NOT COMPLETED|Overall Study||0
60240|NCT02364336|146276|P2|COMPLETED|Overall Study||11
60241|NCT02364336|146277|P1|COMPLETED|Overall Study||1
60242|NCT02364336|146276|P2|48 Weeks After End of Peginterferon|Overall Study||10
60243|NCT02364336|146277|P1|48 Weeks After End of Peginterferon|Overall Study||1
60244|NCT02364336|146276|P2|24 Weeks After End of Peginterferon|Overall Study||11
60245|NCT02364336|146277|P1|24 Weeks After End of Peginterferon|Overall Study||1
60246|NCT02364336|146276|P2|End of Peginterferon Treatment|Overall Study||11
60247|NCT02364336|146277|P1|End of Peginterferon Treatment|Overall Study||1
60248|NCT02364336|146276|P2|6 Hours Post First Peginterferon Inject|Overall Study||12
60249|NCT02364336|146277|P1|6 Hours Post First Peginterferon Inject|Overall Study||1
60250|NCT02364336|146276|P2|STARTED|Overall Study||12
60251|NCT02364336|146277|P1|STARTED|Overall Study||1
60252|NCT02364180|146290|P1|NOT COMPLETED|Overall Study||1
60253|NCT02364180|146290|P1|COMPLETED|Overall Study||10
60254|NCT02364180|146290|P1|STARTED|Overall Study||11
60255|NCT02364037|146296|P2|NOT COMPLETED|Overall Study||53
60256|NCT02364037|146297|P1|NOT COMPLETED|Overall Study||44
60257|NCT02364037|146296|P2|COMPLETED|Overall Study||453
60258|NCT02364037|146297|P1|COMPLETED|Overall Study||458
60259|NCT02364037|146296|P2|STARTED|Overall Study||506
60260|NCT02364037|146297|P1|STARTED|Overall Study||502
60261|NCT02363959|146311|P2|NOT COMPLETED|Overall Study||0
60262|NCT02363959|146312|P1|NOT COMPLETED|Overall Study||1
60263|NCT02363959|146311|P2|COMPLETED|Overall Study||10
60264|NCT02363959|146312|P1|COMPLETED|Overall Study||9
60265|NCT02363959|146311|P2|STARTED|Overall Study||10
60266|NCT02363959|146312|P1|STARTED|Overall Study||10
60267|NCT02363946|146341|P13|NOT COMPLETED|Overall Study||0
60268|NCT02363946|146342|P12|NOT COMPLETED|Overall Study||0
60269|NCT02363946|146343|P11|NOT COMPLETED|Overall Study||0
60270|NCT02363946|146344|P10|NOT COMPLETED|Overall Study||0
60271|NCT02363946|146345|P9|NOT COMPLETED|Overall Study||0
60272|NCT02363946|146346|P8|NOT COMPLETED|Overall Study||1
60273|NCT02363946|146347|P7|NOT COMPLETED|Overall Study||0
60274|NCT02363946|146348|P6|NOT COMPLETED|Overall Study||0
60275|NCT02363946|146349|P5|NOT COMPLETED|Overall Study||0
60276|NCT02363946|146350|P4|NOT COMPLETED|Overall Study||0
60277|NCT02363946|146351|P3|NOT COMPLETED|Overall Study||0
60278|NCT02363946|146352|P2|NOT COMPLETED|Overall Study||0
60279|NCT02363946|146353|P1|NOT COMPLETED|Overall Study||0
60280|NCT02363946|146341|P13|COMPLETED|Overall Study||4
60281|NCT02363946|146342|P12|COMPLETED|Overall Study||3
60282|NCT02363946|146343|P11|COMPLETED|Overall Study||4
60283|NCT02363946|146344|P10|COMPLETED|Overall Study||18
60284|NCT02363946|146345|P9|COMPLETED|Overall Study||4
60285|NCT02363946|146346|P8|COMPLETED|Overall Study||3
60286|NCT02363946|146347|P7|COMPLETED|Overall Study||4
60287|NCT02363946|146348|P6|COMPLETED|Overall Study||4
60288|NCT02363946|146349|P5|COMPLETED|Overall Study||4
60289|NCT02363946|146350|P4|COMPLETED|Overall Study||4
60290|NCT02363946|146351|P3|COMPLETED|Overall Study||4
60291|NCT02363946|146352|P2|COMPLETED|Overall Study||4
60292|NCT02363946|146353|P1|COMPLETED|Overall Study||4
60293|NCT02363946|146341|P13|STARTED|Overall Study||4
60294|NCT02363946|146342|P12|STARTED|Overall Study||3
60295|NCT02363946|146343|P11|STARTED|Overall Study||4
60296|NCT02363946|146344|P10|STARTED|Overall Study||18
60297|NCT02363946|146345|P9|STARTED|Overall Study||4
60298|NCT02363946|146346|P8|STARTED|Overall Study||4
60299|NCT02363946|146347|P7|STARTED|Overall Study||4
60300|NCT02363946|146348|P6|STARTED|Overall Study||4
60301|NCT02363946|146349|P5|STARTED|Overall Study||4
60302|NCT02363946|146350|P4|STARTED|Overall Study||4
60303|NCT02363946|146351|P3|STARTED|Overall Study||4
60304|NCT02363946|146352|P2|STARTED|Overall Study||4
60305|NCT02363946|146353|P1|STARTED|Overall Study||4
60306|NCT02363933|146539|P1|NOT COMPLETED|Overall Study||6
60307|NCT02363933|146539|P1|COMPLETED|Overall Study||2
60308|NCT02363933|146539|P1|STARTED|Overall Study||8
60309|NCT02363907|146544|P1|NOT COMPLETED|Overall Study||0
60310|NCT02363907|146544|P1|COMPLETED|Overall Study||30
60311|NCT02363907|146544|P1|STARTED|Overall Study||30
60312|NCT02363803|146550|P2|NOT COMPLETED|Period 2||0
60313|NCT02363803|146551|P1|NOT COMPLETED|Period 2||0
60314|NCT02363803|146550|P2|COMPLETED|Period 2||16
60315|NCT02363803|146551|P1|COMPLETED|Period 2||17
60316|NCT02363803|146550|P2|STARTED|Period 2|One participant did not return for Period 2 treatment|16
60317|NCT02363803|146551|P1|STARTED|Period 2||17
60318|NCT02363803|146550|P2|NOT COMPLETED|Period 1||0
60319|NCT02363803|146551|P1|NOT COMPLETED|Period 1||0
60320|NCT02363803|146550|P2|COMPLETED|Period 1||17
60321|NCT02363803|146551|P1|COMPLETED|Period 1||17
60322|NCT02363803|146550|P2|STARTED|Period 1||17
60323|NCT02363803|146551|P1|STARTED|Period 1||17
60324|NCT02363621|146571|P2|NOT COMPLETED|Overall Study||0
60325|NCT02363621|146572|P1|NOT COMPLETED|Overall Study||1
60326|NCT02363621|146571|P2|COMPLETED|Overall Study||50
60327|NCT02363621|146572|P1|COMPLETED|Overall Study||50
60328|NCT02363621|146571|P2|STARTED|Overall Study||50
60329|NCT02363621|146572|P1|STARTED|Overall Study||51
60330|NCT02363478|146582|P1|NOT COMPLETED|Overall Study||8
60331|NCT02363478|146582|P1|COMPLETED|Overall Study||22
60332|NCT02363478|146582|P1|STARTED|Overall Study||30
60333|NCT02363439|146589|P1|NOT COMPLETED|Overall Study||4
60334|NCT02363439|146589|P1|COMPLETED|Overall Study||1
60335|NCT02363439|146589|P1|STARTED|Overall Study||5
60336|NCT02363322|146595|P2|NOT COMPLETED|Overall Study||0
60337|NCT02363322|146596|P1|NOT COMPLETED|Overall Study||1
60338|NCT02363322|146595|P2|COMPLETED|Overall Study||36
60339|NCT02363322|146596|P1|COMPLETED|Overall Study||35
60340|NCT02363322|146595|P2|STARTED|Overall Study||36
60341|NCT02363322|146596|P1|STARTED|Overall Study||36
60342|NCT02363270|146608|P2|NOT COMPLETED|Overall Study||0
60343|NCT02363270|146609|P1|NOT COMPLETED|Overall Study||0
60344|NCT02363270|146608|P2|COMPLETED|Overall Study||24
60345|NCT02363270|146609|P1|COMPLETED|Overall Study||24
60346|NCT02363270|146608|P2|STARTED|Overall Study||24
60347|NCT02363270|146609|P1|STARTED|Overall Study||24
60348|NCT02362789|146617|P3|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||12
60349|NCT02362789|146618|P2|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||4
60350|NCT02362789|146619|P1|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0
60351|NCT02362789|146617|P3|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||26
60352|NCT02362789|146618|P2|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||38
60353|NCT02362789|146619|P1|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0
60354|NCT02362789|146617|P3|STARTED|Randomized Withdrawal (Wk 16 to 32)|Subjects achieving PASI reduction by 98-100% vs. baseline during Run-In|38
60355|NCT02362789|146618|P2|STARTED|Randomized Withdrawal (Wk 16 to 32)|Subjects achieving PASI reduction by 98-100% vs. baseline during Run-In|42
60356|NCT02362789|146619|P1|STARTED|Randomized Withdrawal (Wk 16 to 32)|N/A. Run-in phase completed.|0
60357|NCT02362789|146617|P3|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0
60358|NCT02362789|146618|P2|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0
60359|NCT02362789|146619|P1|NOT COMPLETED|Run-in Phase (Week 0 to 16)||2
60360|NCT02362789|146617|P3|COMPLETED|Run-in Phase (Week 0 to 16)||0
60361|NCT02362789|146618|P2|COMPLETED|Run-in Phase (Week 0 to 16)||0
60362|NCT02362789|146619|P1|COMPLETED|Run-in Phase (Week 0 to 16)||128
60363|NCT02362789|146617|P3|STARTED|Run-in Phase (Week 0 to 16)||0
60364|NCT02362789|146618|P2|STARTED|Run-in Phase (Week 0 to 16)||0
60365|NCT02362789|146619|P1|STARTED|Run-in Phase (Week 0 to 16)||130
60366|NCT02362646|146628|P2|NOT COMPLETED|Overall Study||24
60367|NCT02362646|146629|P1|NOT COMPLETED|Overall Study||38
60368|NCT02362646|146628|P2|COMPLETED|Overall Study||29
60369|NCT02362646|146629|P1|COMPLETED|Overall Study||68
60370|NCT02362646|146628|P2|STARTED|Overall Study||53
60371|NCT02362646|146629|P1|STARTED|Overall Study||106
60372|NCT02362594|146639|P2|NOT COMPLETED|Overall Study||225
60373|NCT02362594|146640|P1|NOT COMPLETED|Overall Study||250
60374|NCT02362594|146639|P2|COMPLETED|Overall Study||280
60375|NCT02362594|146640|P1|COMPLETED|Overall Study||264
60376|NCT02362594|146639|P2|Continuing Part 1 Adjuvant Therapy|Overall Study||21
60377|NCT02362594|146640|P1|Continuing Part 1 Adjuvant Therapy|Overall Study||41
60378|NCT02362594|146639|P2|Treated|Overall Study||502
60379|NCT02362594|146640|P1|Treated|Overall Study||509
60380|NCT02362594|146639|P2|STARTED|Overall Study||505
60381|NCT02362594|146640|P1|STARTED|Overall Study||514
60382|NCT02362503|146661|P3|NOT COMPLETED|Open Label Period-Up to Atleast 96 Weeks||99
60383|NCT02362503|146662|P2|NOT COMPLETED|Open Label Period-Up to Atleast 96 Weeks||198
60384|NCT02362503|146663|P1|NOT COMPLETED|Open Label Period-Up to Atleast 96 Weeks||68
60385|NCT02362503|146661|P3|COMPLETED|Open Label Period-Up to Atleast 96 Weeks||0
60386|NCT02362503|146662|P2|COMPLETED|Open Label Period-Up to Atleast 96 Weeks||0
60387|NCT02362503|146663|P1|COMPLETED|Open Label Period-Up to Atleast 96 Weeks||0
60388|NCT02362503|146661|P3|STARTED|Open Label Period-Up to Atleast 96 Weeks||99
60389|NCT02362503|146662|P2|STARTED|Open Label Period-Up to Atleast 96 Weeks|Subject withdrawn due to progression of disease died during study due to squamous cell carcinoma.|198
60390|NCT02362503|146663|P1|STARTED|Open Label Period-Up to Atleast 96 Weeks||68
60391|NCT02362503|146661|P3|NOT COMPLETED|Double-blind Period-Up to 8 Days||0
60392|NCT02362503|146662|P2|NOT COMPLETED|Double-blind Period-Up to 8 Days||5
60393|NCT02362503|146663|P1|NOT COMPLETED|Double-blind Period-Up to 8 Days||1
60394|NCT02362503|146661|P3|COMPLETED|Double-blind Period-Up to 8 Days||0
60395|NCT02362503|146662|P2|COMPLETED|Double-blind Period-Up to 8 Days||198
60396|NCT02362503|146663|P1|COMPLETED|Double-blind Period-Up to 8 Days||68
60397|NCT02362503|146661|P3|STARTED|Double-blind Period-Up to 8 Days||0
60398|NCT02362503|146662|P2|STARTED|Double-blind Period-Up to 8 Days||203
60399|NCT02362503|146663|P1|STARTED|Double-blind Period-Up to 8 Days||69
60400|NCT02362412|146688|P2|NOT COMPLETED|Treatment Period III||1
60401|NCT02362412|146689|P1|NOT COMPLETED|Treatment Period III||0
60402|NCT02362412|146688|P2|COMPLETED|Treatment Period III||10
60403|NCT02362412|146689|P1|COMPLETED|Treatment Period III||9
60404|NCT02362412|146688|P2|TREATED|Treatment Period III||11
60405|NCT02362412|146689|P1|TREATED|Treatment Period III||9
60406|NCT02362412|146688|P2|STARTED|Treatment Period III||11
60407|NCT02362412|146689|P1|STARTED|Treatment Period III||9
60408|NCT02362412|146688|P2|NOT COMPLETED|Treatment Period II||0
60409|NCT02362412|146689|P1|NOT COMPLETED|Treatment Period II||0
60410|NCT02362412|146688|P2|COMPLETED|Treatment Period II||11
60411|NCT02362412|146689|P1|COMPLETED|Treatment Period II||9
60412|NCT02362412|146688|P2|TREATED|Treatment Period II||11
60413|NCT02362412|146689|P1|TREATED|Treatment Period II||9
60414|NCT02362412|146688|P2|STARTED|Treatment Period II||11
60415|NCT02362412|146689|P1|STARTED|Treatment Period II||9
60416|NCT02362373|146715|P1|NOT COMPLETED|Overall Study||0
60417|NCT02362373|146715|P1|COMPLETED|Overall Study||20
60418|NCT02362373|146715|P1|STARTED|Overall Study||20
60419|NCT02362360|146723|P2|NOT COMPLETED|Period 2||0
60420|NCT02362360|146724|P1|NOT COMPLETED|Period 2||0
60421|NCT02362360|146723|P2|COMPLETED|Period 2||25
60422|NCT02362360|146724|P1|COMPLETED|Period 2||23
60423|NCT02362360|146723|P2|STARTED|Period 2||25
60424|NCT02362360|146724|P1|STARTED|Period 2||23
60425|NCT02362360|146723|P2|NOT COMPLETED|Period 1||1
60426|NCT02362360|146724|P1|NOT COMPLETED|Period 1||3
60427|NCT02362360|146723|P2|COMPLETED|Period 1||25
60428|NCT02362360|146724|P1|COMPLETED|Period 1||23
60429|NCT02362360|146723|P2|STARTED|Period 1||26
60430|NCT02362360|146724|P1|STARTED|Period 1||26
60431|NCT02362321|146732|P2|NOT COMPLETED|Overall Study||0
60432|NCT02362321|146733|P1|NOT COMPLETED|Overall Study||4
60433|NCT02362321|146732|P2|COMPLETED|Overall Study||10
60434|NCT02362321|146733|P1|COMPLETED|Overall Study||6
60435|NCT02362321|146732|P2|STARTED|Overall Study||10
60436|NCT02362321|146733|P1|STARTED|Overall Study||10
60437|NCT02362282|146741|P2|NOT COMPLETED|Overall Study||0
60438|NCT02362282|146742|P1|NOT COMPLETED|Overall Study||1
60439|NCT02362282|146741|P2|COMPLETED|Overall Study||7
60440|NCT02362282|146742|P1|COMPLETED|Overall Study||4
60441|NCT02362282|146741|P2|STARTED|Overall Study||7
60442|NCT02362282|146742|P1|STARTED|Overall Study||5
60443|NCT02362048|146750|P2|NOT COMPLETED|Overall Study||40
60444|NCT02362048|146751|P1|NOT COMPLETED|Overall Study||37
60445|NCT02362048|146750|P2|COMPLETED|Overall Study||0
60446|NCT02362048|146751|P1|COMPLETED|Overall Study||0
60447|NCT02362048|146750|P2|Discontinued Study|Overall Study||40
60448|NCT02362048|146751|P1|Discontinued Study|Overall Study||37
60449|NCT02362048|146750|P2|Received Study Medication|Overall Study||38
60450|NCT02362048|146751|P1|Received Study Medication|Overall Study||35
60451|NCT02362048|146750|P2|Enrolled|Overall Study||40
60452|NCT02362048|146751|P1|Enrolled|Overall Study||37
60453|NCT02362048|146750|P2|STARTED|Overall Study|40 enrolled but only 38 received study medication.|40
60454|NCT02362048|146751|P1|STARTED|Overall Study|37 enrolled but only 35 received study medication.|37
60455|NCT02361762|146759|P2|NOT COMPLETED|Overall Study||2
60456|NCT02361762|146760|P1|NOT COMPLETED|Overall Study||0
60457|NCT02361762|146759|P2|COMPLETED|Overall Study||33
60458|NCT02361762|146760|P1|COMPLETED|Overall Study||35
60459|NCT02361762|146759|P2|STARTED|Overall Study||35
60460|NCT02361762|146760|P1|STARTED|Overall Study||35
60461|NCT02361736|146790|P2|NOT COMPLETED|Overall Study||1
60462|NCT02361736|146791|P1|NOT COMPLETED|Overall Study||1
60463|NCT02361736|146790|P2|COMPLETED|Overall Study||59
60464|NCT02361736|146791|P1|COMPLETED|Overall Study||59
60465|NCT02361736|146790|P2|STARTED|Overall Study||60
60466|NCT02361736|146791|P1|STARTED|Overall Study||60
60467|NCT02361580|146811|P2|NOT COMPLETED|Overall Study||3
60468|NCT02361580|146812|P1|NOT COMPLETED|Overall Study||6
60469|NCT02361580|146811|P2|COMPLETED|Overall Study||0
60470|NCT02361580|146812|P1|COMPLETED|Overall Study||0
60471|NCT02361580|146811|P2|STARTED|Overall Study||3
60472|NCT02361580|146812|P1|STARTED|Overall Study||6
60473|NCT02361476|146824|P2|NOT COMPLETED|Overall Study||0
60474|NCT02361476|146825|P1|NOT COMPLETED|Overall Study||0
60475|NCT02361476|146824|P2|COMPLETED|Overall Study||188
60476|NCT02361476|146825|P1|COMPLETED|Overall Study||191
60477|NCT02361476|146824|P2|STARTED|Overall Study||188
60478|NCT02361476|146825|P1|STARTED|Overall Study||191
60479|NCT02361216|146841|P2|NOT COMPLETED|12-month Follow-up||27
60480|NCT02361216|146842|P1|NOT COMPLETED|12-month Follow-up||52
60481|NCT02361216|146841|P2|COMPLETED|12-month Follow-up||130
60482|NCT02361216|146842|P1|COMPLETED|12-month Follow-up||489
60483|NCT02361216|146841|P2|STARTED|12-month Follow-up|1 of the 158 subjects did not receive treatment and was also excluded from the 12-month follow-up.|157
60484|NCT02361216|146842|P1|STARTED|12-month Follow-up||541
60485|NCT02361216|146841|P2|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||19
60486|NCT02361216|146842|P1|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||11
60487|NCT02361216|146841|P2|COMPLETED|3 Day Treatment and 8 Week Follow/up||158
60488|NCT02361216|146842|P1|COMPLETED|3 Day Treatment and 8 Week Follow/up||541
60489|NCT02361216|146841|P2|STARTED|3 Day Treatment and 8 Week Follow/up||177
60490|NCT02361216|146842|P1|STARTED|3 Day Treatment and 8 Week Follow/up||552
60491|NCT02360995|146857|P3|NOT COMPLETED|Overall Study||2
60492|NCT02360995|146858|P2|NOT COMPLETED|Overall Study||1
60493|NCT02360995|146859|P1|NOT COMPLETED|Overall Study||2
60494|NCT02360995|146857|P3|COMPLETED|Overall Study||41
60495|NCT02360995|146858|P2|COMPLETED|Overall Study||42
60496|NCT02360995|146859|P1|COMPLETED|Overall Study||41
60497|NCT02360995|146857|P3|STARTED|Overall Study||43
60498|NCT02360995|146858|P2|STARTED|Overall Study||43
60499|NCT02360995|146859|P1|STARTED|Overall Study||43
60500|NCT02360774|146884|P2|NOT COMPLETED|Overall Study||2
60501|NCT02360774|146885|P1|NOT COMPLETED|Overall Study||3
60502|NCT02360774|146884|P2|COMPLETED|Overall Study||13
60503|NCT02360774|146885|P1|COMPLETED|Overall Study||12
60504|NCT02360774|146884|P2|STARTED|Overall Study||15
60505|NCT02360774|146885|P1|STARTED|Overall Study||15
60506|NCT02360631|146899|P2|NOT COMPLETED|Overall Study||26
60507|NCT02360631|146900|P1|NOT COMPLETED|Overall Study||33
60508|NCT02360631|146899|P2|COMPLETED|Overall Study||174
60509|NCT02360631|146900|P1|COMPLETED|Overall Study||267
60510|NCT02360631|146899|P2|Week 12|Overall Study||165
60511|NCT02360631|146900|P1|Week 12|Overall Study||249
60512|NCT02360631|146899|P2|STARTED|Overall Study||200
60513|NCT02360631|146900|P1|STARTED|Overall Study||300
60514|NCT02360475|146914|P4|NOT COMPLETED|Overall Study||5
60515|NCT02360475|146915|P3|NOT COMPLETED|Overall Study||8
60516|NCT02360475|146916|P2|NOT COMPLETED|Overall Study||13
60517|NCT02360475|146917|P1|NOT COMPLETED|Overall Study||4
60518|NCT02360475|146914|P4|COMPLETED|Overall Study||120
60519|NCT02360475|146915|P3|COMPLETED|Overall Study||117
60520|NCT02360475|146916|P2|COMPLETED|Overall Study||111
60521|NCT02360475|146917|P1|COMPLETED|Overall Study||122
60522|NCT02360475|146914|P4|STARTED|Overall Study||125
60523|NCT02360475|146915|P3|STARTED|Overall Study||125
60524|NCT02360475|146916|P2|STARTED|Overall Study||124
60525|NCT02360475|146917|P1|STARTED|Overall Study||126
60526|NCT02360228|146978|P3|NOT COMPLETED|Overall Study||1
60527|NCT02360228|146979|P2|NOT COMPLETED|Overall Study||1
60528|NCT02360228|146980|P1|NOT COMPLETED|Overall Study||1
60529|NCT02360228|146978|P3|COMPLETED|Overall Study||7
60530|NCT02360228|146979|P2|COMPLETED|Overall Study||7
60531|NCT02360228|146980|P1|COMPLETED|Overall Study||8
60532|NCT02360228|146978|P3|STARTED|Overall Study||8
60533|NCT02360228|146979|P2|STARTED|Overall Study||8
60534|NCT02360228|146980|P1|STARTED|Overall Study||9
60535|NCT02360124|147009|P3|NOT COMPLETED|Overall Study||26
60536|NCT02360124|147010|P2|NOT COMPLETED|Overall Study||12
60537|NCT02360124|147011|P1|NOT COMPLETED|Overall Study||28
60538|NCT02360124|147009|P3|COMPLETED|Overall Study||82
60539|NCT02360124|147010|P2|COMPLETED|Overall Study||95
60540|NCT02360124|147011|P1|COMPLETED|Overall Study||80
60541|NCT02360124|147009|P3|STARTED|Overall Study||108
60542|NCT02360124|147010|P2|STARTED|Overall Study||107
60543|NCT02360124|147011|P1|STARTED|Overall Study||108
60544|NCT02360111|147022|P1|NOT COMPLETED|Overall Study||2
60545|NCT02360111|147022|P1|COMPLETED|Overall Study||1
60546|NCT02360111|147022|P1|STARTED|Overall Study||3
60547|NCT02360059|147032|P2|NOT COMPLETED|Overall Study||0
60548|NCT02360059|147033|P1|NOT COMPLETED|Overall Study||0
60549|NCT02360059|147032|P2|COMPLETED|Overall Study||0
60550|NCT02360059|147033|P1|COMPLETED|Overall Study||1
60551|NCT02360059|147032|P2|STARTED|Overall Study||0
60552|NCT02360059|147033|P1|STARTED|Overall Study||1
60553|NCT02359955|147041|P2|NOT COMPLETED|Overall Study||0
60554|NCT02359955|147042|P1|NOT COMPLETED|Overall Study||0
60555|NCT02359955|147041|P2|COMPLETED|Overall Study||10
60556|NCT02359955|147042|P1|COMPLETED|Overall Study||10
60557|NCT02359955|147041|P2|STARTED|Overall Study||10
60558|NCT02359955|147042|P1|STARTED|Overall Study||10
60559|NCT02359916|147065|P7|NOT COMPLETED|Overall Study||0
60560|NCT02359916|147066|P6|NOT COMPLETED|Overall Study||0
60561|NCT02359916|147067|P5|NOT COMPLETED|Overall Study||0
60562|NCT02359916|147068|P4|NOT COMPLETED|Overall Study||0
60563|NCT02359916|147069|P3|NOT COMPLETED|Overall Study||0
60564|NCT02359916|147070|P2|NOT COMPLETED|Overall Study||0
60565|NCT02359916|147071|P1|NOT COMPLETED|Overall Study||0
60566|NCT02359916|147065|P7|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
60567|NCT02359916|147066|P6|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
60568|NCT02359916|147067|P5|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
60569|NCT02359916|147068|P4|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
60570|NCT02359916|147069|P3|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
60571|NCT02359916|147070|P2|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
60572|NCT02359916|147071|P1|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
60573|NCT02359916|147065|P7|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
60574|NCT02359916|147066|P6|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
60575|NCT02359916|147067|P5|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
60576|NCT02359916|147068|P4|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
60577|NCT02359916|147069|P3|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
60578|NCT02359916|147070|P2|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
60579|NCT02359916|147071|P1|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
60580|NCT02359903|147093|P2|NOT COMPLETED|Overall Study||2
60581|NCT02359903|147094|P1|NOT COMPLETED|Overall Study||0
60582|NCT02359903|147093|P2|COMPLETED|Overall Study||43
60583|NCT02359903|147094|P1|COMPLETED|Overall Study||45
60584|NCT02359903|147093|P2|STARTED|Overall Study||45
60585|NCT02359903|147094|P1|STARTED|Overall Study||45
60586|NCT02359890|147102|P1|NOT COMPLETED|Overall Study||10
60587|NCT02359890|147102|P1|COMPLETED|Overall Study||155
60588|NCT02359890|147102|P1|Per-Protocol (PP) Population|Overall Study|Subjects part of mITT population who had undergone RF ablation.|155
60589|NCT02359890|147102|P1|mITT Population|Overall Study|Enrolled subjects who met the inclusion/exclusion criteria and had the study catheter inserted|155
60590|NCT02359890|147102|P1|Safety Population|Overall Study|Enrolled subjects who had the study catheter inserted|159
60591|NCT02359890|147102|P1|STARTED|Overall Study|Patients who enrolled in the study are those who signed informed consent forms.|165
60592|NCT02359877|147113|P4|NOT COMPLETED|Overall Study||3
60593|NCT02359877|147114|P3|NOT COMPLETED|Overall Study||0
60594|NCT02359877|147115|P2|NOT COMPLETED|Overall Study||0
60595|NCT02359877|147116|P1|NOT COMPLETED|Overall Study||1
60596|NCT02359877|147113|P4|COMPLETED|Overall Study||11
60597|NCT02359877|147114|P3|COMPLETED|Overall Study||6
60598|NCT02359877|147115|P2|COMPLETED|Overall Study||6
60599|NCT02359877|147116|P1|COMPLETED|Overall Study||33
60600|NCT02359877|147113|P4|STARTED|Overall Study||14
60601|NCT02359877|147114|P3|STARTED|Overall Study||6
60602|NCT02359877|147115|P2|STARTED|Overall Study||6
60603|NCT02359877|147116|P1|STARTED|Overall Study||34
60604|NCT02359851|147166|P1|NOT COMPLETED|Overall Study||2
60605|NCT02359851|147166|P1|COMPLETED|Overall Study||3
60606|NCT02359851|147166|P1|STARTED|Overall Study||5
60607|NCT02359435|147176|P2|NOT COMPLETED|Overall Study||4
60608|NCT02359435|147177|P1|NOT COMPLETED|Overall Study||4
60609|NCT02359435|147176|P2|COMPLETED|Overall Study||216
60610|NCT02359435|147177|P1|COMPLETED|Overall Study||216
60611|NCT02359435|147176|P2|STARTED|Overall Study||220
60612|NCT02359435|147177|P1|STARTED|Overall Study||220
60613|NCT02359305|147185|P2|NOT COMPLETED|Overall Study||0
60614|NCT02359305|147186|P1|NOT COMPLETED|Overall Study||0
60615|NCT02359305|147185|P2|COMPLETED|Overall Study||34
60616|NCT02359305|147186|P1|COMPLETED|Overall Study||34
60617|NCT02359305|147185|P2|STARTED|Overall Study||34
60618|NCT02359305|147186|P1|STARTED|Overall Study||34
60619|NCT02359110|147198|P2|NOT COMPLETED|Overall Study||0
60620|NCT02359110|147199|P1|NOT COMPLETED|Overall Study||0
60621|NCT02359110|147198|P2|COMPLETED|Overall Study||54
60622|NCT02359110|147199|P1|COMPLETED|Overall Study||55
60623|NCT02359110|147198|P2|STARTED|Overall Study||54
60624|NCT02359110|147199|P1|STARTED|Overall Study||55
60625|NCT02359058|147212|P3|NOT COMPLETED|Overall Study||0
60626|NCT02359058|147213|P2|NOT COMPLETED|Overall Study||0
60627|NCT02359058|147214|P1|NOT COMPLETED|Overall Study||0
60628|NCT02359058|147212|P3|COMPLETED|Overall Study||6
60629|NCT02359058|147213|P2|COMPLETED|Overall Study||6
60630|NCT02359058|147214|P1|COMPLETED|Overall Study||6
60631|NCT02359058|147212|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
60632|NCT02359058|147213|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
60633|NCT02359058|147214|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
60634|NCT02359058|147212|P3|STARTED|Overall Study||6
60635|NCT02359058|147213|P2|STARTED|Overall Study||6
60636|NCT02359058|147214|P1|STARTED|Overall Study||6
60637|NCT02359045|147237|P2|NOT COMPLETED|Overall Study||3
60638|NCT02359045|147238|P1|NOT COMPLETED|Overall Study||4
60639|NCT02359045|147237|P2|COMPLETED|Overall Study||39
60640|NCT02359045|147238|P1|COMPLETED|Overall Study||36
60641|NCT02359045|147237|P2|STARTED|Overall Study||42
60642|NCT02359045|147238|P1|STARTED|Overall Study||40
60643|NCT02359006|147473|P2|NOT COMPLETED|Overall Study||3
60644|NCT02359006|147474|P1|NOT COMPLETED|Overall Study||4
60645|NCT02359006|147473|P2|COMPLETED|Overall Study||10
60646|NCT02359006|147474|P1|COMPLETED|Overall Study||10
60647|NCT02359006|147473|P2|STARTED|Overall Study||13
60648|NCT02359006|147474|P1|STARTED|Overall Study||14
60649|NCT02358876|147514|P1|NOT COMPLETED|Overall Study||2
60650|NCT02358876|147514|P1|COMPLETED|Overall Study|All 32 participants completed the in-clinic portion and 30 out of the 32 completed the home portion.|30
60651|NCT02358876|147514|P1|STARTED|Overall Study||32
60652|NCT02358863|147518|P1|NOT COMPLETED|Overall Study||3
60653|NCT02358863|147518|P1|COMPLETED|Overall Study||10
60654|NCT02358863|147518|P1|STARTED|Overall Study||13
60655|NCT02358668|147525|P3|NOT COMPLETED|Overall Study||0
60656|NCT02358668|147526|P2|NOT COMPLETED|Overall Study||1
60657|NCT02358668|147527|P1|NOT COMPLETED|Overall Study||2
60658|NCT02358668|147525|P3|COMPLETED|Overall Study||12
60659|NCT02358668|147526|P2|COMPLETED|Overall Study||23
60660|NCT02358668|147527|P1|COMPLETED|Overall Study||22
60661|NCT02358668|147525|P3|STARTED|Overall Study||12
60662|NCT02358668|147526|P2|STARTED|Overall Study||24
60663|NCT02358668|147527|P1|STARTED|Overall Study||24
60664|NCT02358473|147667|P1|NOT COMPLETED|Overall Study||13
60665|NCT02358473|147667|P1|COMPLETED|Overall Study||0
60666|NCT02358473|147667|P1|STARTED|Overall Study||13
60667|NCT02358343|147681|P5|NOT COMPLETED|Comparative Efficacy Trial / Observation||2
60668|NCT02358343|147682|P4|NOT COMPLETED|Comparative Efficacy Trial / Observation||2
60669|NCT02358343|147683|P3|NOT COMPLETED|Comparative Efficacy Trial / Observation||5
60670|NCT02358343|147684|P2|NOT COMPLETED|Comparative Efficacy Trial / Observation||0
60671|NCT02358343|147685|P1|NOT COMPLETED|Comparative Efficacy Trial / Observation||0
60672|NCT02358343|147681|P5|COMPLETED|Comparative Efficacy Trial / Observation||18
60673|NCT02358343|147682|P4|COMPLETED|Comparative Efficacy Trial / Observation||58
60674|NCT02358343|147683|P3|COMPLETED|Comparative Efficacy Trial / Observation||55
60675|NCT02358343|147684|P2|COMPLETED|Comparative Efficacy Trial / Observation||0
60676|NCT02358343|147685|P1|COMPLETED|Comparative Efficacy Trial / Observation||0
60677|NCT02358343|147681|P5|STARTED|Comparative Efficacy Trial / Observation||20
60678|NCT02358343|147682|P4|STARTED|Comparative Efficacy Trial / Observation|47 completed treatment|60
60679|NCT02358343|147683|P3|STARTED|Comparative Efficacy Trial / Observation|44 completed treatment|60
60680|NCT02358343|147684|P2|STARTED|Comparative Efficacy Trial / Observation|Participants enrolled in screening intervention enrolled in comparative efficacy trial|0
60681|NCT02358343|147685|P1|STARTED|Comparative Efficacy Trial / Observation|Participants enrolled in screening intervention enrolled in comparative efficacy trial|0
60682|NCT02358343|147681|P5|NOT COMPLETED|Screening Intervention||0
60683|NCT02358343|147682|P4|NOT COMPLETED|Screening Intervention||0
60684|NCT02358343|147683|P3|NOT COMPLETED|Screening Intervention||0
60685|NCT02358343|147684|P2|NOT COMPLETED|Screening Intervention||8
60686|NCT02358343|147685|P1|NOT COMPLETED|Screening Intervention||6
60687|NCT02358343|147681|P5|COMPLETED|Screening Intervention||0
60688|NCT02358343|147682|P4|COMPLETED|Screening Intervention||0
60689|NCT02358343|147683|P3|COMPLETED|Screening Intervention||0
60690|NCT02358343|147684|P2|COMPLETED|Screening Intervention||84
60691|NCT02358343|147685|P1|COMPLETED|Screening Intervention||86
60692|NCT02358343|147681|P5|STARTED|Screening Intervention||0
60693|NCT02358343|147682|P4|STARTED|Screening Intervention||0
60694|NCT02358343|147683|P3|STARTED|Screening Intervention||0
60695|NCT02358343|147684|P2|STARTED|Screening Intervention|89 completed control visit|92
60696|NCT02358343|147685|P1|STARTED|Screening Intervention|90 completed engagement interview|92
60697|NCT02358135|147722|P2|NOT COMPLETED|Overall Study||19
60698|NCT02358135|147723|P1|NOT COMPLETED|Overall Study||15
60699|NCT02358135|147722|P2|COMPLETED|Overall Study||131
60700|NCT02358135|147723|P1|COMPLETED|Overall Study||135
60701|NCT02358135|147722|P2|Randomized|Overall Study||148
60702|NCT02358135|147723|P1|Randomized|Overall Study||148
60703|NCT02358135|147722|P2|STARTED|Overall Study||150
60704|NCT02358135|147723|P1|STARTED|Overall Study||150
60705|NCT02358044|147741|P2|NOT COMPLETED|Overall Study||7
60706|NCT02358044|147742|P1|NOT COMPLETED|Overall Study||2
60707|NCT02358044|147741|P2|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|121
60708|NCT02358044|147742|P1|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|127
60709|NCT02358044|147741|P2|Treated|Overall Study||126
60710|NCT02358044|147742|P1|Treated|Overall Study||129
60711|NCT02358044|147741|P2|STARTED|Overall Study||128
60712|NCT02358044|147742|P1|STARTED|Overall Study||129
60713|NCT02357940|147760|P2|NOT COMPLETED|Overall Study||2
60714|NCT02357940|147761|P1|NOT COMPLETED|Overall Study||0
60715|NCT02357940|147760|P2|COMPLETED|Overall Study||30
60716|NCT02357940|147761|P1|COMPLETED|Overall Study||9
60717|NCT02357940|147760|P2|STARTED|Overall Study||32
60718|NCT02357940|147761|P1|STARTED|Overall Study||9
60719|NCT02357901|147888|P4|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||66
60720|NCT02357901|147889|P3|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||72
60898|NCT02355691|148374|P2|2nd Postop Visit|Overall Study||9
60721|NCT02357901|147890|P2|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||78
60722|NCT02357901|147891|P1|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||0
60723|NCT02357901|147888|P4|COMPLETED|Treatment Period (Day 1 to Week 24)||34
60724|NCT02357901|147889|P3|COMPLETED|Treatment Period (Day 1 to Week 24)||129
60725|NCT02357901|147890|P2|COMPLETED|Treatment Period (Day 1 to Week 24)||125
60726|NCT02357901|147891|P1|COMPLETED|Treatment Period (Day 1 to Week 24)||0
60727|NCT02357901|147888|P4|Full Analysis Set|Treatment Period (Day 1 to Week 24)||99
60728|NCT02357901|147889|P3|Full Analysis Set|Treatment Period (Day 1 to Week 24)||196
60729|NCT02357901|147890|P2|Full Analysis Set|Treatment Period (Day 1 to Week 24)||194
60730|NCT02357901|147891|P1|Full Analysis Set|Treatment Period (Day 1 to Week 24)||0
60731|NCT02357901|147888|P4|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||100
60732|NCT02357901|147889|P3|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||201
60733|NCT02357901|147890|P2|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||203
60734|NCT02357901|147891|P1|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||0
60735|NCT02357901|147888|P4|STARTED|Treatment Period (Day 1 to Week 24)||100
60736|NCT02357901|147889|P3|STARTED|Treatment Period (Day 1 to Week 24)||201
60737|NCT02357901|147890|P2|STARTED|Treatment Period (Day 1 to Week 24)||203
60738|NCT02357901|147891|P1|STARTED|Treatment Period (Day 1 to Week 24)||0
60739|NCT02357901|147888|P4|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
60740|NCT02357901|147889|P3|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
60741|NCT02357901|147890|P2|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
60742|NCT02357901|147891|P1|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||161
60743|NCT02357901|147888|P4|COMPLETED|Run-In Period (Days -14 to Day -1)||0
60744|NCT02357901|147889|P3|COMPLETED|Run-In Period (Days -14 to Day -1)||0
60745|NCT02357901|147890|P2|COMPLETED|Run-In Period (Days -14 to Day -1)||0
60746|NCT02357901|147891|P1|COMPLETED|Run-In Period (Days -14 to Day -1)||504
60747|NCT02357901|147888|P4|STARTED|Run-In Period (Days -14 to Day -1)||0
60748|NCT02357901|147889|P3|STARTED|Run-In Period (Days -14 to Day -1)||0
60749|NCT02357901|147890|P2|STARTED|Run-In Period (Days -14 to Day -1)||0
60750|NCT02357901|147891|P1|STARTED|Run-In Period (Days -14 to Day -1)|Received at least one dose of SUBOXONE sublingual film.|665
60751|NCT02357758|147944|P3|NOT COMPLETED|Overall Study||7
60752|NCT02357758|147945|P2|NOT COMPLETED|Overall Study||0
60753|NCT02357758|147946|P1|NOT COMPLETED|Overall Study||16
60754|NCT02357758|147944|P3|COMPLETED|Overall Study||5
60755|NCT02357758|147945|P2|COMPLETED|Overall Study||20
60756|NCT02357758|147946|P1|COMPLETED|Overall Study||9
60757|NCT02357758|147944|P3|STARTED|Overall Study||12
60758|NCT02357758|147945|P2|STARTED|Overall Study||20
60759|NCT02357758|147946|P1|STARTED|Overall Study||25
60760|NCT02357485|147954|P1|NOT COMPLETED|Overall Study||0
60761|NCT02357485|147954|P1|COMPLETED|Overall Study||6
60762|NCT02357485|147954|P1|STARTED|Overall Study|6 subjects, 8 knees ( 2 bilateral & 4 unilateral)|6
60763|NCT02357459|147965|P3|NOT COMPLETED|Overall Study||12
60764|NCT02357459|147966|P2|NOT COMPLETED|Overall Study||14
60765|NCT02357459|147967|P1|NOT COMPLETED|Overall Study||17
60766|NCT02357459|147965|P3|COMPLETED|Overall Study||150
60767|NCT02357459|147966|P2|COMPLETED|Overall Study||149
60768|NCT02357459|147967|P1|COMPLETED|Overall Study||144
60769|NCT02357459|147965|P3|STARTED|Overall Study||162
60770|NCT02357459|147966|P2|STARTED|Overall Study||163
60771|NCT02357459|147967|P1|STARTED|Overall Study||161
60772|NCT02357420|148013|P4|NOT COMPLETED|Overall Study||19
60773|NCT02357420|148014|P3|NOT COMPLETED|Overall Study||16
60774|NCT02357420|148015|P2|NOT COMPLETED|Overall Study||12
60775|NCT02357420|148016|P1|NOT COMPLETED|Overall Study||12
60776|NCT02357420|148013|P4|COMPLETED|Overall Study||63
60777|NCT02357420|148014|P3|COMPLETED|Overall Study|1 participant who discontinued prematurely was included in completed as he/she fulfilled Visit 8.|93
60778|NCT02357420|148015|P2|COMPLETED|Overall Study|1 participant who discontinued prematurely was included in completed as he/she fulfilled Visit 8.|86
60779|NCT02357420|148016|P1|COMPLETED|Overall Study|3 participants who discontinued prematurely were included in completed as they fulfilled Visit 8.|92
60780|NCT02357420|148013|P4|Full Analysis Set (FAS)|Overall Study|1 participant from safety set did not enter FAS.|81
60781|NCT02357420|148014|P3|Full Analysis Set (FAS)|Overall Study||109
60782|NCT02357420|148015|P2|Full Analysis Set (FAS)|Overall Study||98
60783|NCT02357420|148016|P1|Full Analysis Set (FAS)|Overall Study||104
60784|NCT02357420|148013|P4|STARTED|Overall Study||82
60785|NCT02357420|148014|P3|STARTED|Overall Study||109
60786|NCT02357420|148015|P2|STARTED|Overall Study||98
60787|NCT02357420|148016|P1|STARTED|Overall Study||104
60788|NCT02357394|148036|P2|NOT COMPLETED|Overall Study||0
60789|NCT02357394|148037|P1|NOT COMPLETED|Overall Study||0
60790|NCT02357394|148036|P2|COMPLETED|Overall Study||3
60791|NCT02357394|148037|P1|COMPLETED|Overall Study||4
60792|NCT02357394|148036|P2|STARTED|Overall Study||3
60793|NCT02357394|148037|P1|STARTED|Overall Study||4
60794|NCT02357342|148077|P2|NOT COMPLETED|Extension Study||0
60795|NCT02357342|148078|P1|NOT COMPLETED|Extension Study||0
60796|NCT02357342|148077|P2|COMPLETED|Extension Study||9
60797|NCT02357342|148078|P1|COMPLETED|Extension Study||4
60798|NCT02357342|148077|P2|STARTED|Extension Study||9
60799|NCT02357342|148078|P1|STARTED|Extension Study||4
60800|NCT02357342|148077|P2|NOT COMPLETED|First 6 Months||0
60801|NCT02357342|148078|P1|NOT COMPLETED|First 6 Months||2
60802|NCT02357342|148077|P2|COMPLETED|First 6 Months||20
60803|NCT02357342|148078|P1|COMPLETED|First 6 Months|2 patients died. Neither deaths were study drug related.|18
60804|NCT02357342|148077|P2|STARTED|First 6 Months||20
60805|NCT02357342|148078|P1|STARTED|First 6 Months||20
60806|NCT02357290|148088|P1|NOT COMPLETED|Overall Study||26
60807|NCT02357290|148088|P1|COMPLETED|Overall Study||14
60808|NCT02357290|148088|P1|Exposed|Overall Study||26
60809|NCT02357290|148088|P1|STARTED|Overall Study||40
60810|NCT02357264|148095|P2|NOT COMPLETED|Overall Study||0
60811|NCT02357264|148096|P1|NOT COMPLETED|Overall Study||0
60812|NCT02357264|148095|P2|COMPLETED|Overall Study||130
60813|NCT02357264|148096|P1|COMPLETED|Overall Study||56
60814|NCT02357264|148095|P2|STARTED|Overall Study||130
60815|NCT02357264|148096|P1|STARTED|Overall Study||56
60816|NCT02357173|148105|P3|NOT COMPLETED|Overall Study||6
60817|NCT02357173|148106|P2|NOT COMPLETED|Overall Study||6
60818|NCT02357173|148107|P1|NOT COMPLETED|Overall Study||6
60819|NCT02357173|148105|P3|COMPLETED|Overall Study||16
60820|NCT02357173|148106|P2|COMPLETED|Overall Study||15
60821|NCT02357173|148107|P1|COMPLETED|Overall Study||19
60822|NCT02357173|148105|P3|STARTED|Overall Study||22
60823|NCT02357173|148106|P2|STARTED|Overall Study||21
60824|NCT02357173|148107|P1|STARTED|Overall Study||25
60825|NCT02356900|148126|P2|NOT COMPLETED|Overall Study||0
60826|NCT02356900|148127|P1|NOT COMPLETED|Overall Study||0
60827|NCT02356900|148126|P2|COMPLETED|Overall Study||10
60828|NCT02356900|148127|P1|COMPLETED|Overall Study||11
60829|NCT02356900|148126|P2|STARTED|Overall Study||10
60830|NCT02356900|148127|P1|STARTED|Overall Study||11
60831|NCT02356783|148147|P2|NOT COMPLETED|Overall Study||3
60832|NCT02356783|148148|P1|NOT COMPLETED|Overall Study||1
60833|NCT02356783|148147|P2|COMPLETED|Overall Study||14
60834|NCT02356783|148148|P1|COMPLETED|Overall Study||15
60835|NCT02356783|148147|P2|STARTED|Overall Study||17
60836|NCT02356783|148148|P1|STARTED|Overall Study||16
60837|NCT02356588|148158|P2|NOT COMPLETED|Overall Study||13
60838|NCT02356588|148159|P1|NOT COMPLETED|Overall Study||5
60839|NCT02356588|148158|P2|COMPLETED|Overall Study||41
60840|NCT02356588|148159|P1|COMPLETED|Overall Study||102
60841|NCT02356588|148158|P2|STARTED|Overall Study||54
60842|NCT02356588|148159|P1|STARTED|Overall Study||107
60843|NCT02356575|148193|P2|NOT COMPLETED|Overall Study||0
60844|NCT02356575|148194|P1|NOT COMPLETED|Overall Study||0
60845|NCT02356575|148193|P2|COMPLETED|Overall Study||80
60846|NCT02356575|148194|P1|COMPLETED|Overall Study||80
60847|NCT02356575|148193|P2|STARTED|Overall Study||80
60848|NCT02356575|148194|P1|STARTED|Overall Study||80
60849|NCT02356562|148276|P2|NOT COMPLETED|Overall Study||1
60850|NCT02356562|148277|P1|NOT COMPLETED|Overall Study||2
60851|NCT02356562|148276|P2|COMPLETED|Overall Study||6
60852|NCT02356562|148277|P1|COMPLETED|Overall Study||20
60853|NCT02356562|148276|P2|STARTED|Overall Study||7
60854|NCT02356562|148277|P1|STARTED|Overall Study||22
60855|NCT02356471|148287|P1|NOT COMPLETED|Overall Study||6
60856|NCT02356471|148287|P1|COMPLETED|Overall Study||28
60857|NCT02356471|148287|P1|STARTED|Overall Study||34
60858|NCT02356211|148303|P3|NOT COMPLETED|Overall Study||0
60859|NCT02356211|148304|P2|NOT COMPLETED|Overall Study||5
60860|NCT02356211|148305|P1|NOT COMPLETED|Overall Study||0
60861|NCT02356211|148303|P3|COMPLETED|Overall Study||51
60862|NCT02356211|148304|P2|COMPLETED|Overall Study|For 18 patients, phone call follow-up or EMR provided sufficient follow-up information.|18
60863|NCT02356211|148305|P1|COMPLETED|Overall Study||55
60864|NCT02356211|148303|P3|STARTED|Overall Study||51
60865|NCT02356211|148304|P2|STARTED|Overall Study||23
60866|NCT02356211|148305|P1|STARTED|Overall Study||55
60867|NCT02356198|148315|P2|NOT COMPLETED|Overall Study||7
60868|NCT02356198|148316|P1|NOT COMPLETED|Overall Study||2
60869|NCT02356198|148315|P2|COMPLETED|Overall Study||98
60870|NCT02356198|148316|P1|COMPLETED|Overall Study||102
60871|NCT02356198|148315|P2|STARTED|Overall Study||105
60872|NCT02356198|148316|P1|STARTED|Overall Study||104
60873|NCT02356107|148330|P1|NOT COMPLETED|Overall Study||3
60874|NCT02356107|148330|P1|COMPLETED|Overall Study||12
60875|NCT02356107|148330|P1|STARTED|Overall Study||15
60876|NCT02355977|148337|P3|NOT COMPLETED|Overall Study||0
60877|NCT02355977|148338|P2|NOT COMPLETED|Overall Study||0
60878|NCT02355977|148339|P1|NOT COMPLETED|Overall Study||0
60879|NCT02355977|148337|P3|COMPLETED|Overall Study||23
60880|NCT02355977|148338|P2|COMPLETED|Overall Study||26
60881|NCT02355977|148339|P1|COMPLETED|Overall Study||21
60882|NCT02355977|148337|P3|STARTED|Overall Study||23
60883|NCT02355977|148338|P2|STARTED|Overall Study||26
60884|NCT02355977|148339|P1|STARTED|Overall Study||21
60885|NCT02355886|148355|P2|NOT COMPLETED|Overall Study||0
60886|NCT02355886|148356|P1|NOT COMPLETED|Overall Study||0
60887|NCT02355886|148355|P2|COMPLETED|Overall Study||12
60888|NCT02355886|148356|P1|COMPLETED|Overall Study||13
60889|NCT02355886|148355|P2|STARTED|Overall Study||12
60890|NCT02355886|148356|P1|STARTED|Overall Study||13
60891|NCT02355743|148366|P1|NOT COMPLETED|Overall Study||2
60892|NCT02355743|148366|P1|COMPLETED|Overall Study||6
60893|NCT02355743|148366|P1|STARTED|Overall Study||8
60894|NCT02355691|148374|P2|NOT COMPLETED|Overall Study||9
60895|NCT02355691|148375|P1|NOT COMPLETED|Overall Study||7
60896|NCT02355691|148374|P2|COMPLETED|Overall Study||0
60897|NCT02355691|148375|P1|COMPLETED|Overall Study||0
60899|NCT02355691|148375|P1|2nd Postop Visit|Overall Study||7
60900|NCT02355691|148374|P2|1st Postop Visit|Overall Study||9
60901|NCT02355691|148375|P1|1st Postop Visit|Overall Study||7
60902|NCT02355691|148374|P2|STARTED|Overall Study||9
60903|NCT02355691|148375|P1|STARTED|Overall Study||7
60904|NCT02355665|148385|P2|NOT COMPLETED|Overall Study||232
60905|NCT02355665|148386|P1|NOT COMPLETED|Overall Study||249
60906|NCT02355665|148385|P2|COMPLETED|Overall Study||365
60907|NCT02355665|148386|P1|COMPLETED|Overall Study||352
60908|NCT02355665|148385|P2|STARTED|Overall Study||597
60909|NCT02355665|148386|P1|STARTED|Overall Study||601
60910|NCT02355275|148818|P1|NOT COMPLETED|Overall Study||8
60911|NCT02355275|148818|P1|COMPLETED|Overall Study||14
60912|NCT02355275|148818|P1|STARTED|Overall Study||22
60913|NCT02355158|148823|P1|NOT COMPLETED|Overall Study||150
60914|NCT02355158|148823|P1|COMPLETED|Overall Study||47
60915|NCT02355158|148823|P1|STARTED|Overall Study||197
60916|NCT02355067|148829|P2|NOT COMPLETED|Overall Study||8
60917|NCT02355067|148830|P1|NOT COMPLETED|Overall Study||8
60918|NCT02355067|148829|P2|COMPLETED|Overall Study||12
60919|NCT02355067|148830|P1|COMPLETED|Overall Study||12
60920|NCT02355067|148829|P2|STARTED|Overall Study||20
60921|NCT02355067|148830|P1|STARTED|Overall Study||20
60922|NCT02355028|148844|P2|NOT COMPLETED|Overall Study||5
60923|NCT02355028|148845|P1|NOT COMPLETED|Overall Study||11
60924|NCT02355028|148844|P2|COMPLETED|Overall Study||41
60925|NCT02355028|148845|P1|COMPLETED|Overall Study||36
60926|NCT02355028|148844|P2|Treated|Overall Study||45
60927|NCT02355028|148845|P1|Treated|Overall Study||46
60928|NCT02355028|148844|P2|STARTED|Overall Study||46
60929|NCT02355028|148845|P1|STARTED|Overall Study||47
60930|NCT02354976|148881|P3|NOT COMPLETED|Overall Study||3
60931|NCT02354976|148882|P2|NOT COMPLETED|Overall Study||1
60932|NCT02354976|148883|P1|NOT COMPLETED|Overall Study||2
60933|NCT02354976|148881|P3|COMPLETED|Overall Study||23
60934|NCT02354976|148882|P2|COMPLETED|Overall Study||26
60935|NCT02354976|148883|P1|COMPLETED|Overall Study||23
60936|NCT02354976|148881|P3|STARTED|Overall Study||26
60937|NCT02354976|148882|P2|STARTED|Overall Study||27
60938|NCT02354976|148883|P1|STARTED|Overall Study||25
60939|NCT02354924|148894|P2|NOT COMPLETED|Overall Study||0
60940|NCT02354924|148895|P1|NOT COMPLETED|Overall Study||0
60941|NCT02354924|148894|P2|COMPLETED|Overall Study||20
60942|NCT02354924|148895|P1|COMPLETED|Overall Study||40
60943|NCT02354924|148894|P2|STARTED|Overall Study||20
60944|NCT02354924|148895|P1|STARTED|Overall Study||40
60945|NCT02354859|148907|P2|NOT COMPLETED|Overall Study||2
60946|NCT02354859|148908|P1|NOT COMPLETED|Overall Study||0
60947|NCT02354859|148907|P2|COMPLETED|Overall Study||57
60948|NCT02354859|148908|P1|COMPLETED|Overall Study||60
60949|NCT02354859|148907|P2|STARTED|Overall Study||59
60950|NCT02354859|148908|P1|STARTED|Overall Study||60
60951|NCT02354833|148926|P2|NOT COMPLETED|Overall Study||0
60952|NCT02354833|148927|P1|NOT COMPLETED|Overall Study||0
60953|NCT02354833|148926|P2|COMPLETED|Overall Study||43
60954|NCT02354833|148927|P1|COMPLETED|Overall Study||38
60955|NCT02354833|148926|P2|STARTED|Overall Study||43
60956|NCT02354833|148927|P1|STARTED|Overall Study||38
60957|NCT02354599|148945|P6|NOT COMPLETED|Overall Study||1
60958|NCT02354599|148946|P5|NOT COMPLETED|Overall Study||0
60959|NCT02354599|148947|P4|NOT COMPLETED|Overall Study||0
60960|NCT02354599|148948|P3|NOT COMPLETED|Overall Study||0
60961|NCT02354599|148949|P2|NOT COMPLETED|Overall Study||1
60962|NCT02354599|148950|P1|NOT COMPLETED|Overall Study||1
60963|NCT02354599|148945|P6|COMPLETED|Overall Study||5
60964|NCT02354599|148946|P5|COMPLETED|Overall Study||2
60965|NCT02354599|148947|P4|COMPLETED|Overall Study||6
60966|NCT02354599|148948|P3|COMPLETED|Overall Study||6
60967|NCT02354599|148949|P2|COMPLETED|Overall Study||5
60968|NCT02354599|148950|P1|COMPLETED|Overall Study||5
60969|NCT02354599|148945|P6|STARTED|Overall Study||6
60970|NCT02354599|148946|P5|STARTED|Overall Study||2
60971|NCT02354599|148947|P4|STARTED|Overall Study||6
60972|NCT02354599|148948|P3|STARTED|Overall Study||6
60973|NCT02354599|148949|P2|STARTED|Overall Study||6
60974|NCT02354599|148950|P1|STARTED|Overall Study||6
60975|NCT02354482|149020|P1|NOT COMPLETED|Reference||0
60976|NCT02354482|149020|P1|COMPLETED|Reference||2042
60977|NCT02354482|149020|P1|STARTED|Reference||2042
60978|NCT02354482|149020|P1|NOT COMPLETED|Assessment and Teach Back||0
60979|NCT02354482|149020|P1|COMPLETED|Assessment and Teach Back||508
60980|NCT02354482|149020|P1|STARTED|Assessment and Teach Back||508
60981|NCT02354482|149020|P1|NOT COMPLETED|Patient/Family Caregiver Assessment||0
60982|NCT02354482|149020|P1|COMPLETED|Patient/Family Caregiver Assessment||3093
60983|NCT02354482|149020|P1|STARTED|Patient/Family Caregiver Assessment||3093
60984|NCT02354482|149020|P1|NOT COMPLETED|Hospital-Based Trust and Plain Language||0
60985|NCT02354482|149020|P1|COMPLETED|Hospital-Based Trust and Plain Language||2090
60986|NCT02354482|149020|P1|STARTED|Hospital-Based Trust and Plain Language||2090
60987|NCT02354482|149020|P1|NOT COMPLETED|Home-Based Trust and Plain Language||0
60988|NCT02354482|149020|P1|COMPLETED|Home-Based Trust and Plain Language||1979
60989|NCT02354482|149020|P1|STARTED|Home-Based Trust and Plain Language||1979
60990|NCT02354482|149020|P1|NOT COMPLETED|Patient Communication and Care||0
60991|NCT02354482|149020|P1|COMPLETED|Patient Communication and Care||2158
60992|NCT02354482|149020|P1|STARTED|Patient Communication and Care||2158
60993|NCT02354443|149040|P1|NOT COMPLETED|Overall Study||0
60994|NCT02354443|149040|P1|COMPLETED|Overall Study||1
60995|NCT02354443|149040|P1|STARTED|Overall Study||1
60996|NCT02354417|149044|P1|NOT COMPLETED|Overall Study||1
60997|NCT02354417|149044|P1|COMPLETED|Overall Study||2
60998|NCT02354417|149044|P1|STARTED|Overall Study||3
60999|NCT02354378|149050|P2|NOT COMPLETED|Overall Study||4
61000|NCT02354378|149051|P1|NOT COMPLETED|Overall Study||34
61001|NCT02354378|149050|P2|COMPLETED|Overall Study||16
61002|NCT02354378|149051|P1|COMPLETED|Overall Study||30
61003|NCT02354378|149050|P2|STARTED|Overall Study||20
61004|NCT02354378|149051|P1|STARTED|Overall Study||64
61005|NCT02354352|149061|P2|NOT COMPLETED|Overall Study||3
61006|NCT02354352|149062|P1|NOT COMPLETED|Overall Study||3
61007|NCT02354352|149061|P2|COMPLETED|Overall Study||23
61008|NCT02354352|149062|P1|COMPLETED|Overall Study||23
61009|NCT02354352|149061|P2|9 Months|Overall Study||23
61010|NCT02354352|149062|P1|9 Months|Overall Study||25
61011|NCT02354352|149061|P2|6 Months|Overall Study||23
61012|NCT02354352|149062|P1|6 Months|Overall Study||25
61013|NCT02354352|149061|P2|3 Months|Overall Study||23
61014|NCT02354352|149062|P1|3 Months|Overall Study||25
61015|NCT02354352|149061|P2|2 Months|Overall Study||22
61016|NCT02354352|149062|P1|2 Months|Overall Study||24
61017|NCT02354352|149061|P2|1 Month|Overall Study||23
61018|NCT02354352|149062|P1|1 Month|Overall Study||24
61019|NCT02354352|149061|P2|2 Weeks|Overall Study||25
61020|NCT02354352|149062|P1|2 Weeks|Overall Study||26
61021|NCT02354352|149061|P2|STARTED|Overall Study||26
61022|NCT02354352|149062|P1|STARTED|Overall Study||26
61023|NCT02354235|149070|P2|NOT COMPLETED|Overall Study||7
61024|NCT02354235|149071|P1|NOT COMPLETED|Overall Study||3
61025|NCT02354235|149070|P2|COMPLETED|Overall Study||61
61026|NCT02354235|149071|P1|COMPLETED|Overall Study||67
61027|NCT02354235|149070|P2|STARTED|Overall Study||68
61028|NCT02354235|149071|P1|STARTED|Overall Study||70
61029|NCT02354222|149087|P2|NOT COMPLETED|Overall Study||11
61030|NCT02354222|149088|P1|NOT COMPLETED|Overall Study||4
61031|NCT02354222|149087|P2|COMPLETED|Overall Study||66
61032|NCT02354222|149088|P1|COMPLETED|Overall Study||73
61033|NCT02354222|149087|P2|STARTED|Overall Study||77
61034|NCT02354222|149088|P1|STARTED|Overall Study||77
61035|NCT02354092|149104|P2|NOT COMPLETED|Overall Study||0
61036|NCT02354092|149105|P1|NOT COMPLETED|Overall Study||0
61037|NCT02354092|149104|P2|COMPLETED|Overall Study||7
61038|NCT02354092|149105|P1|COMPLETED|Overall Study||7
61039|NCT02354092|149104|P2|STARTED|Overall Study||7
61040|NCT02354092|149105|P1|STARTED|Overall Study||7
61041|NCT02353871|149119|P2|NOT COMPLETED|Overall Study||9
61042|NCT02353871|149120|P1|NOT COMPLETED|Overall Study||3
61043|NCT02353871|149119|P2|COMPLETED|Overall Study||51
61044|NCT02353871|149120|P1|COMPLETED|Overall Study||122
61045|NCT02353871|149119|P2|STARTED|Overall Study|Randomised. Included a subject who was randomised by mistake (excluded from mITT population).|60
61046|NCT02353871|149120|P1|STARTED|Overall Study|Randomised.|125
61047|NCT02353832|149140|P1|NOT COMPLETED|Overall Study||0
61048|NCT02353832|149140|P1|COMPLETED|Overall Study||44
61049|NCT02353832|149140|P1|STARTED|Overall Study||44
61050|NCT02353806|149145|P1|NOT COMPLETED|Overall Study||10
61051|NCT02353806|149145|P1|COMPLETED|Overall Study||6
61052|NCT02353806|149145|P1|STARTED|Overall Study||16
61053|NCT02353754|149162|P2|NOT COMPLETED|Overall Study||0
61054|NCT02353754|149163|P1|NOT COMPLETED|Overall Study||2
61055|NCT02353754|149162|P2|COMPLETED|Overall Study||0
61056|NCT02353754|149163|P1|COMPLETED|Overall Study||10
61057|NCT02353754|149162|P2|STARTED|Overall Study||0
61058|NCT02353754|149163|P1|STARTED|Overall Study||12
61059|NCT02353572|149173|P1|NOT COMPLETED|Overall Study||3
61060|NCT02353572|149173|P1|COMPLETED|Overall Study||0
61061|NCT02353572|149173|P1|STARTED|Overall Study||3
61062|NCT02353468|149177|P1|NOT COMPLETED|Overall Study||3
61063|NCT02353468|149177|P1|COMPLETED|Overall Study||0
61064|NCT02353468|149177|P1|STARTED|Overall Study||3
61065|NCT02353442|149183|P2|NOT COMPLETED|Overall Study||4
61066|NCT02353442|149184|P1|NOT COMPLETED|Overall Study||3
61067|NCT02353442|149183|P2|COMPLETED|Overall Study||27
61068|NCT02353442|149184|P1|COMPLETED|Overall Study||25
61069|NCT02353442|149183|P2|STARTED|Overall Study||31
61070|NCT02353442|149184|P1|STARTED|Overall Study||28
61071|NCT02353299|149198|P4|NOT COMPLETED|Fourth Intervention (1 Night)||0
61072|NCT02353299|149199|P3|NOT COMPLETED|Fourth Intervention (1 Night)||0
61073|NCT02353299|149200|P2|NOT COMPLETED|Fourth Intervention (1 Night)||0
61074|NCT02353299|149201|P1|NOT COMPLETED|Fourth Intervention (1 Night)||0
61075|NCT02353299|149198|P4|COMPLETED|Fourth Intervention (1 Night)||13
61076|NCT02353299|149199|P3|COMPLETED|Fourth Intervention (1 Night)||13
61077|NCT02353299|149200|P2|COMPLETED|Fourth Intervention (1 Night)||12
61078|NCT02353299|149201|P1|COMPLETED|Fourth Intervention (1 Night)||13
61079|NCT02353299|149198|P4|STARTED|Fourth Intervention (1 Night)||13
61080|NCT02353299|149199|P3|STARTED|Fourth Intervention (1 Night)||13
61081|NCT02353299|149200|P2|STARTED|Fourth Intervention (1 Night)|One patient withdrawn from study prior to start of fourth intervention.|12
61082|NCT02353299|149201|P1|STARTED|Fourth Intervention (1 Night)||13
61083|NCT02353299|149198|P4|NOT COMPLETED|Third Intervention (1 Night)||0
61084|NCT02353299|149199|P3|NOT COMPLETED|Third Intervention (1 Night)||0
61085|NCT02353299|149200|P2|NOT COMPLETED|Third Intervention (1 Night)||0
61086|NCT02353299|149201|P1|NOT COMPLETED|Third Intervention (1 Night)||0
61087|NCT02353299|149198|P4|COMPLETED|Third Intervention (1 Night)||13
61088|NCT02353299|149199|P3|COMPLETED|Third Intervention (1 Night)||13
61089|NCT02353299|149200|P2|COMPLETED|Third Intervention (1 Night)||13
61090|NCT02353299|149201|P1|COMPLETED|Third Intervention (1 Night)||13
61091|NCT02353299|149198|P4|STARTED|Third Intervention (1 Night)||13
61092|NCT02353299|149199|P3|STARTED|Third Intervention (1 Night)||13
61093|NCT02353299|149200|P2|STARTED|Third Intervention (1 Night)||13
61094|NCT02353299|149201|P1|STARTED|Third Intervention (1 Night)||13
61095|NCT02353299|149198|P4|NOT COMPLETED|Second Intervention (1 Night)||0
61096|NCT02353299|149199|P3|NOT COMPLETED|Second Intervention (1 Night)||0
61097|NCT02353299|149200|P2|NOT COMPLETED|Second Intervention (1 Night)||0
61098|NCT02353299|149201|P1|NOT COMPLETED|Second Intervention (1 Night)||0
61099|NCT02353299|149198|P4|COMPLETED|Second Intervention (1 Night)||13
61100|NCT02353299|149199|P3|COMPLETED|Second Intervention (1 Night)||13
61101|NCT02353299|149200|P2|COMPLETED|Second Intervention (1 Night)||13
61102|NCT02353299|149201|P1|COMPLETED|Second Intervention (1 Night)||13
61103|NCT02353299|149198|P4|STARTED|Second Intervention (1 Night)||13
61104|NCT02353299|149199|P3|STARTED|Second Intervention (1 Night)||13
61105|NCT02353299|149200|P2|STARTED|Second Intervention (1 Night)||13
61106|NCT02353299|149201|P1|STARTED|Second Intervention (1 Night)||13
61107|NCT02353299|149198|P4|NOT COMPLETED|First Intervention (1 Night)||0
61108|NCT02353299|149199|P3|NOT COMPLETED|First Intervention (1 Night)||0
61109|NCT02353299|149200|P2|NOT COMPLETED|First Intervention (1 Night)||0
61110|NCT02353299|149201|P1|NOT COMPLETED|First Intervention (1 Night)||0
61111|NCT02353299|149198|P4|COMPLETED|First Intervention (1 Night)||13
61112|NCT02353299|149199|P3|COMPLETED|First Intervention (1 Night)||13
61113|NCT02353299|149200|P2|COMPLETED|First Intervention (1 Night)||13
61114|NCT02353299|149201|P1|COMPLETED|First Intervention (1 Night)||13
61115|NCT02353299|149198|P4|STARTED|First Intervention (1 Night)||13
61116|NCT02353299|149199|P3|STARTED|First Intervention (1 Night)||13
61117|NCT02353299|149200|P2|STARTED|First Intervention (1 Night)||13
61118|NCT02353299|149201|P1|STARTED|First Intervention (1 Night)||13
61119|NCT02353169|149239|P4|NOT COMPLETED|Overall Study||3
61120|NCT02353169|149240|P3|NOT COMPLETED|Overall Study||4
61121|NCT02353169|149241|P2|NOT COMPLETED|Overall Study||6
61122|NCT02353169|149242|P1|NOT COMPLETED|Overall Study||3
61123|NCT02353169|149239|P4|COMPLETED|Overall Study||12
61124|NCT02353169|149240|P3|COMPLETED|Overall Study||12
61125|NCT02353169|149241|P2|COMPLETED|Overall Study||12
61126|NCT02353169|149242|P1|COMPLETED|Overall Study||12
61127|NCT02353169|149239|P4|STARTED|Overall Study||15
61128|NCT02353169|149240|P3|STARTED|Overall Study||16
61129|NCT02353169|149241|P2|STARTED|Overall Study||18
61130|NCT02353169|149242|P1|STARTED|Overall Study||15
61131|NCT02352948|149266|P6|NOT COMPLETED|Overall Study||49
61132|NCT02352948|149267|P5|NOT COMPLETED|Overall Study||88
61133|NCT02352948|149268|P4|NOT COMPLETED|Overall Study||99
61134|NCT02352948|149269|P3|NOT COMPLETED|Overall Study||129
61135|NCT02352948|149270|P2|NOT COMPLETED|Overall Study||59
61136|NCT02352948|149271|P1|NOT COMPLETED|Overall Study||49
61137|NCT02352948|149266|P6|COMPLETED|Overall Study||11
61138|NCT02352948|149267|P5|COMPLETED|Overall Study||29
61139|NCT02352948|149268|P4|COMPLETED|Overall Study||19
61140|NCT02352948|149269|P3|COMPLETED|Overall Study||45
61141|NCT02352948|149270|P2|COMPLETED|Overall Study||5
61142|NCT02352948|149271|P1|COMPLETED|Overall Study||13
61143|NCT02352948|149266|P6|Completed Study Treatment|Overall Study||4
61144|NCT02352948|149267|P5|Completed Study Treatment|Overall Study||23
61145|NCT02352948|149268|P4|Completed Study Treatment|Overall Study||0
61146|NCT02352948|149269|P3|Completed Study Treatment|Overall Study||36
61147|NCT02352948|149270|P2|Completed Study Treatment|Overall Study||0
61148|NCT02352948|149271|P1|Completed Study Treatment|Overall Study||15
61149|NCT02352948|149266|P6|Received Treatment|Overall Study||60
61150|NCT02352948|149267|P5|Received Treatment|Overall Study||117
61151|NCT02352948|149268|P4|Received Treatment|Overall Study||110
61152|NCT02352948|149269|P3|Received Treatment|Overall Study||173
61153|NCT02352948|149270|P2|Received Treatment|Overall Study||63
61154|NCT02352948|149271|P1|Received Treatment|Overall Study||62
61155|NCT02352948|149266|P6|STARTED|Overall Study||60
61156|NCT02352948|149267|P5|STARTED|Overall Study||117
61157|NCT02352948|149268|P4|STARTED|Overall Study||118
61158|NCT02352948|149269|P3|STARTED|Overall Study||174
61159|NCT02352948|149270|P2|STARTED|Overall Study||64
61160|NCT02352948|149271|P1|STARTED|Overall Study||62
61161|NCT02352844|149327|P1|NOT COMPLETED|Overall Study||0
61162|NCT02352844|149327|P1|COMPLETED|Overall Study||12
61163|NCT02352844|149327|P1|STARTED|Overall Study||12
61164|NCT02352831|149335|P2|NOT COMPLETED|Overall Study||0
61165|NCT02352831|149336|P1|NOT COMPLETED|Overall Study||0
61166|NCT02352831|149335|P2|COMPLETED|Overall Study||10
61167|NCT02352831|149336|P1|COMPLETED|Overall Study||6
61168|NCT02352831|149335|P2|STARTED|Overall Study||10
61169|NCT02352831|149336|P1|STARTED|Overall Study||6
61170|NCT02352779|149359|P3|NOT COMPLETED|Overall Study||2
61171|NCT02352779|149360|P2|NOT COMPLETED|Overall Study||1
61172|NCT02352779|149361|P1|NOT COMPLETED|Overall Study||8
61173|NCT02352779|149359|P3|COMPLETED|Overall Study||33
61174|NCT02352779|149360|P2|COMPLETED|Overall Study||35
61175|NCT02352779|149361|P1|COMPLETED|Overall Study||29
61176|NCT02352779|149359|P3|STARTED|Overall Study||35
61177|NCT02352779|149360|P2|STARTED|Overall Study||36
61178|NCT02352779|149361|P1|STARTED|Overall Study||37
61179|NCT02352363|149371|P2|NOT COMPLETED|Overall Study||3
61180|NCT02352363|149372|P1|NOT COMPLETED|Overall Study||7
61181|NCT02352363|149371|P2|COMPLETED|Overall Study||127
61182|NCT02352363|149372|P1|COMPLETED|Overall Study||271
61183|NCT02352363|149371|P2|STARTED|Overall Study||130
61184|NCT02352363|149372|P1|STARTED|Overall Study||278
61185|NCT02352298|149384|P1|NOT COMPLETED|Overall Study||0
61186|NCT02352298|149384|P1|COMPLETED|Overall Study||52
61187|NCT02352298|149384|P1|STARTED|Overall Study||52
61188|NCT02352103|149391|P2|NOT COMPLETED|Overall Study||1
61189|NCT02352103|149392|P1|NOT COMPLETED|Overall Study||0
61190|NCT02352103|149391|P2|COMPLETED|Overall Study||59
61191|NCT02352103|149392|P1|COMPLETED|Overall Study||60
61192|NCT02352103|149391|P2|STARTED|Overall Study||60
61193|NCT02352103|149392|P1|STARTED|Overall Study||60
61194|NCT02351960|149414|P2|NOT COMPLETED|Overall Study||12
61195|NCT02351960|149415|P1|NOT COMPLETED|Overall Study||11
61196|NCT02351960|149414|P2|COMPLETED|Overall Study||76
61197|NCT02351960|149415|P1|COMPLETED|Overall Study||197
61198|NCT02351960|149414|P2|STARTED|Overall Study||88
61199|NCT02351960|149415|P1|STARTED|Overall Study||208
61200|NCT02351934|149436|P2|NOT COMPLETED|Follow-Up||10
61201|NCT02351934|149437|P1|NOT COMPLETED|Follow-Up||12
61202|NCT02351934|149436|P2|COMPLETED|Follow-Up||51
61203|NCT02351934|149437|P1|COMPLETED|Follow-Up||44
61204|NCT02351934|149436|P2|STARTED|Follow-Up||61
61205|NCT02351934|149437|P1|STARTED|Follow-Up||56
61206|NCT02351934|149436|P2|NOT COMPLETED|Allocation||0
61207|NCT02351934|149437|P1|NOT COMPLETED|Allocation||6
61208|NCT02351934|149436|P2|COMPLETED|Allocation||61
61209|NCT02351934|149437|P1|COMPLETED|Allocation||56
61210|NCT02351934|149436|P2|Received Allocation|Allocation||61
61211|NCT02351934|149437|P1|Received Allocation|Allocation||56
61212|NCT02351934|149436|P2|STARTED|Allocation||61
61213|NCT02351934|149437|P1|STARTED|Allocation||62
61214|NCT02351817|149453|P2|NOT COMPLETED|Period 2||2
61215|NCT02351817|149454|P1|NOT COMPLETED|Period 2||1
61216|NCT02351817|149453|P2|COMPLETED|Period 2||3
61217|NCT02351817|149454|P1|COMPLETED|Period 2||4
61218|NCT02351817|149453|P2|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
61219|NCT02351817|149454|P1|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
61220|NCT02351817|149453|P2|NOT COMPLETED|Period 1||3
61221|NCT02351817|149454|P1|NOT COMPLETED|Period 1||1
61222|NCT02351817|149453|P2|COMPLETED|Period 1||2
61223|NCT02351817|149454|P1|COMPLETED|Period 1||4
61224|NCT02351817|149453|P2|STARTED|Period 1||5
61225|NCT02351817|149454|P1|STARTED|Period 1||5
61226|NCT02351817|149453|P2|NOT COMPLETED|Baseline Period||0
61227|NCT02351817|149454|P1|NOT COMPLETED|Baseline Period||0
61228|NCT02351817|149453|P2|COMPLETED|Baseline Period||5
61229|NCT02351817|149454|P1|COMPLETED|Baseline Period||5
61230|NCT02351817|149453|P2|STARTED|Baseline Period||5
61231|NCT02351817|149454|P1|STARTED|Baseline Period||5
61232|NCT02351739|149463|P2|NOT COMPLETED|Overall Study||40
61233|NCT02351739|149464|P1|NOT COMPLETED|Overall Study||38
61234|NCT02351739|149463|P2|COMPLETED|Overall Study||0
61235|NCT02351739|149464|P1|COMPLETED|Overall Study||0
61236|NCT02351739|149463|P2|Discontinued Study|Overall Study||40
61237|NCT02351739|149464|P1|Discontinued Study|Overall Study||38
61238|NCT02351739|149463|P2|Received Study Medication|Overall Study||40
61239|NCT02351739|149464|P1|Received Study Medication|Overall Study||35
61240|NCT02351739|149463|P2|Enrolled|Overall Study||40
61241|NCT02351739|149464|P1|Enrolled|Overall Study||38
61242|NCT02351739|149463|P2|STARTED|Overall Study||40
61243|NCT02351739|149464|P1|STARTED|Overall Study||38
61244|NCT02351505|149470|P1|NOT COMPLETED|Overall Study||0
61245|NCT02351505|149470|P1|COMPLETED|Overall Study||1
61246|NCT02351505|149470|P1|STARTED|Overall Study||1
61247|NCT02351271|149483|P2|NOT COMPLETED|Overall Study||0
61248|NCT02351271|149484|P1|NOT COMPLETED|Overall Study||0
61249|NCT02351271|149483|P2|COMPLETED|Overall Study||62
61250|NCT02351271|149484|P1|COMPLETED|Overall Study||68
61251|NCT02351271|149483|P2|STARTED|Overall Study||62
61252|NCT02351271|149484|P1|STARTED|Overall Study||68
61253|NCT02351063|149496|P1|NOT COMPLETED|Overall Study||0
61254|NCT02351063|149496|P1|COMPLETED|Overall Study|Study terminated. No study data collected.|1
61255|NCT02351063|149496|P1|STARTED|Overall Study||1
61256|NCT02351037|149503|P3|NOT COMPLETED|Overall Study||0
61257|NCT02351037|149504|P2|NOT COMPLETED|Overall Study||0
61258|NCT02351037|149505|P1|NOT COMPLETED|Overall Study||0
61259|NCT02351037|149503|P3|COMPLETED|Overall Study||8
61260|NCT02351037|149504|P2|COMPLETED|Overall Study||21
61261|NCT02351037|149505|P1|COMPLETED|Overall Study||7
61262|NCT02351037|149503|P3|STARTED|Overall Study||8
61263|NCT02351037|149504|P2|STARTED|Overall Study||21
61264|NCT02351037|149505|P1|STARTED|Overall Study||7
61265|NCT02350881|149513|P1|NOT COMPLETED|Overall Study||0
61266|NCT02350881|149513|P1|COMPLETED|Overall Study|64 patients were completed (6 bilateral)|64
61267|NCT02350881|149513|P1|STARTED|Overall Study|64 patients were included (6 bilateral)|64
61268|NCT02350777|149543|P2|NOT COMPLETED|Overall Study||0
61269|NCT02350777|149544|P1|NOT COMPLETED|Overall Study||0
61270|NCT02350777|149543|P2|COMPLETED|Overall Study||2
61271|NCT02350777|149544|P1|COMPLETED|Overall Study||2
61272|NCT02350777|149543|P2|STARTED|Overall Study||2
61273|NCT02350777|149544|P1|STARTED|Overall Study||2
61274|NCT02350569|149550|P1|NOT COMPLETED|Retreatment (LDV/SOF 12 Weeks)||0
61275|NCT02350569|149550|P1|COMPLETED|Retreatment (LDV/SOF 12 Weeks)||1
61276|NCT02350569|149550|P1|STARTED|Retreatment (LDV/SOF 12 Weeks)|1 completed treatment (Main Study), experienced virologic failure, and entered Retreatment Phase|1
61277|NCT02350569|149550|P1|NOT COMPLETED|Main Study (LDV/SOF 4 Weeks)||0
61278|NCT02350569|149550|P1|COMPLETED|Main Study (LDV/SOF 4 Weeks)|1 participant discontinued treatment, but completed follow-up visits and study.|16
61279|NCT02350569|149550|P1|STARTED|Main Study (LDV/SOF 4 Weeks)||16
61280|NCT02349789|149560|P1|NOT COMPLETED|Overall Study||2
61281|NCT02349789|149560|P1|COMPLETED|Overall Study||9
61282|NCT02349789|149560|P1|STARTED|Overall Study||11
61283|NCT02349711|149571|P2|NOT COMPLETED|Overall Study||2
61284|NCT02349711|149572|P1|NOT COMPLETED|Overall Study||3
61285|NCT02349711|149571|P2|COMPLETED|Overall Study||84
61286|NCT02349711|149572|P1|COMPLETED|Overall Study||84
61287|NCT02349711|149571|P2|STARTED|Overall Study||86
61288|NCT02349711|149572|P1|STARTED|Overall Study||87
61289|NCT02349685|149587|P3|NOT COMPLETED|Overall Study||4
61290|NCT02349685|149588|P2|NOT COMPLETED|Overall Study||2
61291|NCT02349685|149589|P1|NOT COMPLETED|Overall Study||5
61292|NCT02349685|149587|P3|COMPLETED|Overall Study||37
61293|NCT02349685|149588|P2|COMPLETED|Overall Study||87
61294|NCT02349685|149589|P1|COMPLETED|Overall Study||84
61295|NCT02349685|149587|P3|STARTED|Overall Study||41
61296|NCT02349685|149588|P2|STARTED|Overall Study||89
61297|NCT02349685|149589|P1|STARTED|Overall Study||89
61298|NCT02349646|149600|P1|NOT COMPLETED|Overall Study||17
61299|NCT02349646|149600|P1|COMPLETED|Overall Study||16
61300|NCT02349646|149600|P1|Receive Permanent System|Overall Study||27
61301|NCT02349646|149600|P1|Received Trial System|Overall Study||24
61302|NCT02349646|149600|P1|STARTED|Overall Study||33
61303|NCT02349542|149605|P1|NOT COMPLETED|Overall Study||5
61304|NCT02349542|149605|P1|COMPLETED|Overall Study||15
61305|NCT02349542|149605|P1|STARTED|Overall Study||20
61306|NCT02349477|149612|P2|NOT COMPLETED|Overall Study||18
61307|NCT02349477|149613|P1|NOT COMPLETED|Overall Study||13
61308|NCT02349477|149612|P2|COMPLETED|Overall Study||28
61309|NCT02349477|149613|P1|COMPLETED|Overall Study||31
61310|NCT02349477|149612|P2|STARTED|Overall Study||46
61311|NCT02349477|149613|P1|STARTED|Overall Study||44
61312|NCT02349451|149629|P4|NOT COMPLETED|Overall Study||1
61313|NCT02349451|149630|P3|NOT COMPLETED|Overall Study||2
61314|NCT02349451|149631|P2|NOT COMPLETED|Overall Study||1
61315|NCT02349451|149632|P1|NOT COMPLETED|Overall Study||0
61316|NCT02349451|149629|P4|COMPLETED|Overall Study||72
61317|NCT02349451|149630|P3|COMPLETED|Overall Study||69
61318|NCT02349451|149631|P2|COMPLETED|Overall Study||71
61319|NCT02349451|149632|P1|COMPLETED|Overall Study||24
61320|NCT02349451|149629|P4|STARTED|Overall Study||73
61321|NCT02349451|149630|P3|STARTED|Overall Study||71
61322|NCT02349451|149631|P2|STARTED|Overall Study||72
61323|NCT02349451|149632|P1|STARTED|Overall Study||24
61324|NCT02349438|149668|P2|NOT COMPLETED|Period 2||0
61325|NCT02349438|149669|P1|NOT COMPLETED|Period 2||0
61326|NCT02349438|149668|P2|COMPLETED|Period 2||10
61327|NCT02349438|149669|P1|COMPLETED|Period 2||11
61328|NCT02349438|149668|P2|STARTED|Period 2||10
61329|NCT02349438|149669|P1|STARTED|Period 2||11
61330|NCT02349438|149668|P2|NOT COMPLETED|Period 1||0
61331|NCT02349438|149669|P1|NOT COMPLETED|Period 1||0
61332|NCT02349438|149668|P2|COMPLETED|Period 1||10
61333|NCT02349438|149669|P1|COMPLETED|Period 1||11
61334|NCT02349438|149668|P2|STARTED|Period 1||10
61335|NCT02349438|149669|P1|STARTED|Period 1||11
61336|NCT02349412|149681|P2|NOT COMPLETED|Overall Study||7
61337|NCT02349412|149682|P1|NOT COMPLETED|Overall Study||7
61338|NCT02349412|149681|P2|COMPLETED|Overall Study||196
61339|NCT02349412|149682|P1|COMPLETED|Overall Study||195
61340|NCT02349412|149681|P2|Completed Week-24 QOL Assessment Measure|Overall Study||80
61341|NCT02349412|149682|P1|Completed Week-24 QOL Assessment Measure|Overall Study||68
61342|NCT02349412|149681|P2|Completed Week-12 QOL Assessment Measure|Overall Study||101
61343|NCT02349412|149682|P1|Completed Week-12 QOL Assessment Measure|Overall Study||92
61344|NCT02349412|149681|P2|STARTED|Overall Study||203
61345|NCT02349412|149682|P1|STARTED|Overall Study||202
61346|NCT02349360|149698|P2|NOT COMPLETED|Overall Study||1
61347|NCT02349360|149699|P1|NOT COMPLETED|Overall Study||0
61348|NCT02349360|149698|P2|COMPLETED|Overall Study||20
61349|NCT02349360|149699|P1|COMPLETED|Overall Study||21
61350|NCT02349360|149698|P2|STARTED|Overall Study||21
61351|NCT02349360|149699|P1|STARTED|Overall Study||21
61352|NCT02349295|149710|P5|NOT COMPLETED|IR (Week 16-24)||1
61353|NCT02349295|149711|P4|NOT COMPLETED|IR (Week 16-24)||0
61354|NCT02349295|149712|P3|NOT COMPLETED|IR (Week 16-24)||0
61355|NCT02349295|149713|P2|NOT COMPLETED|IR (Week 16-24)||0
61356|NCT02349295|149714|P1|NOT COMPLETED|IR (Week 16-24)||0
61357|NCT02349295|149710|P5|COMPLETED|IR (Week 16-24)||32
61358|NCT02349295|149711|P4|COMPLETED|IR (Week 16-24)||31
61359|NCT02349295|149712|P3|COMPLETED|IR (Week 16-24)||0
61360|NCT02349295|149713|P2|COMPLETED|IR (Week 16-24)||0
61361|NCT02349295|149714|P1|COMPLETED|IR (Week 16-24)||0
61362|NCT02349295|149710|P5|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q2W and IR from ixekizumab 80 mg Q2W.|33
61363|NCT02349295|149711|P4|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q4W and IR from ixekizumab 80 mg Q4W.|31
61364|NCT02349295|149712|P3|STARTED|IR (Week 16-24)|Only IR participants were included.|0
61365|NCT02349295|149713|P2|STARTED|IR (Week 16-24)|Only IR participants were included.|0
61366|NCT02349295|149714|P1|STARTED|IR (Week 16-24)|Only IR participants were included.|0
61367|NCT02349295|149710|P5|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
61368|NCT02349295|149711|P4|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
61369|NCT02349295|149712|P3|NOT COMPLETED|Double Blind Treatment (Week 0-24)||14
61370|NCT02349295|149713|P2|NOT COMPLETED|Double Blind Treatment (Week 0-24)||11
61371|NCT02349295|149714|P1|NOT COMPLETED|Double Blind Treatment (Week 0-24)||24
61372|NCT02349295|149710|P5|COMPLETED|Double Blind Treatment (Week 0-24)||0
61373|NCT02349295|149711|P4|COMPLETED|Double Blind Treatment (Week 0-24)||0
61374|NCT02349295|149712|P3|COMPLETED|Double Blind Treatment (Week 0-24)||109
61375|NCT02349295|149713|P2|COMPLETED|Double Blind Treatment (Week 0-24)||111
61376|NCT02349295|149714|P1|COMPLETED|Double Blind Treatment (Week 0-24)||94
61377|NCT02349295|149710|P5|STARTED|Double Blind Treatment (Week 0-24)||0
61378|NCT02349295|149711|P4|STARTED|Double Blind Treatment (Week 0-24)||0
61379|NCT02349295|149712|P3|STARTED|Double Blind Treatment (Week 0-24)||123
61380|NCT02349295|149713|P2|STARTED|Double Blind Treatment (Week 0-24)||122
61381|NCT02349295|149714|P1|STARTED|Double Blind Treatment (Week 0-24)||118
61382|NCT02349178|149788|P1|NOT COMPLETED|Overall Study||0
61383|NCT02349178|149788|P1|COMPLETED|Overall Study||6
61384|NCT02349178|149788|P1|STARTED|Overall Study||6
61385|NCT02349152|149794|P2|NOT COMPLETED|Overall Study||4
61386|NCT02349152|149795|P1|NOT COMPLETED|Overall Study||6
61387|NCT02349152|149794|P2|COMPLETED|Overall Study||52
61388|NCT02349152|149795|P1|COMPLETED|Overall Study||54
61389|NCT02349152|149794|P2|STARTED|Overall Study||56
61390|NCT02349152|149795|P1|STARTED|Overall Study||60
61391|NCT02349061|149831|P2|NOT COMPLETED|Overall Study||4
61392|NCT02349061|149832|P1|NOT COMPLETED|Overall Study||9
61393|NCT02349061|149831|P2|COMPLETED|Overall Study||56
61394|NCT02349061|149832|P1|COMPLETED|Overall Study||33
61395|NCT02349061|149831|P2|STARTED|Overall Study||60
61396|NCT02349061|149832|P1|STARTED|Overall Study||42
61397|NCT02349048|149840|P2|NOT COMPLETED|Overall Study||0
61398|NCT02349048|149841|P1|NOT COMPLETED|Overall Study||5
61399|NCT02349048|149840|P2|COMPLETED|Overall Study||9
61400|NCT02349048|149841|P1|COMPLETED|Overall Study||54
61401|NCT02349048|149840|P2|STARTED|Overall Study||9
61402|NCT02349048|149841|P1|STARTED|Overall Study||59
61403|NCT02348918|149870|P9|NOT COMPLETED|Overall Study||0
61404|NCT02348918|149871|P8|NOT COMPLETED|Overall Study||0
61405|NCT02348918|149872|P7|NOT COMPLETED|Overall Study||0
61406|NCT02348918|149873|P6|NOT COMPLETED|Overall Study||0
61407|NCT02348918|149874|P5|NOT COMPLETED|Overall Study||0
61408|NCT02348918|149875|P4|NOT COMPLETED|Overall Study||0
61409|NCT02348918|149876|P3|NOT COMPLETED|Overall Study||0
61410|NCT02348918|149877|P2|NOT COMPLETED|Overall Study||0
61411|NCT02348918|149878|P1|NOT COMPLETED|Overall Study||0
61412|NCT02348918|149870|P9|COMPLETED|Overall Study||15
61413|NCT02348918|149871|P8|COMPLETED|Overall Study||16
61414|NCT02348918|149872|P7|COMPLETED|Overall Study||13
61415|NCT02348918|149873|P6|COMPLETED|Overall Study||17
61416|NCT02348918|149874|P5|COMPLETED|Overall Study||19
61417|NCT02348918|149875|P4|COMPLETED|Overall Study||24
61418|NCT02348918|149876|P3|COMPLETED|Overall Study||42
61419|NCT02348918|149877|P2|COMPLETED|Overall Study||33
61420|NCT02348918|149878|P1|COMPLETED|Overall Study||39
61421|NCT02348918|149870|P9|STARTED|Overall Study||15
61422|NCT02348918|149871|P8|STARTED|Overall Study||16
61423|NCT02348918|149872|P7|STARTED|Overall Study||13
61424|NCT02348918|149873|P6|STARTED|Overall Study||17
61425|NCT02348918|149874|P5|STARTED|Overall Study||19
61426|NCT02348918|149875|P4|STARTED|Overall Study||24
61427|NCT02348918|149876|P3|STARTED|Overall Study||42
61428|NCT02348918|149877|P2|STARTED|Overall Study||33
61429|NCT02348918|149878|P1|STARTED|Overall Study||39
61430|NCT02348840|149902|P4|NOT COMPLETED|Overall Study||0
61431|NCT02348840|149903|P3|NOT COMPLETED|Overall Study||0
61432|NCT02348840|149904|P2|NOT COMPLETED|Overall Study||1
61433|NCT02348840|149905|P1|NOT COMPLETED|Overall Study||2
61434|NCT02348840|149902|P4|COMPLETED|Overall Study||374
61435|NCT02348840|149903|P3|COMPLETED|Overall Study||425
61436|NCT02348840|149904|P2|COMPLETED|Overall Study||20
61437|NCT02348840|149905|P1|COMPLETED|Overall Study||21
61438|NCT02348840|149902|P4|STARTED|Overall Study||374
61439|NCT02348840|149903|P3|STARTED|Overall Study||425
61440|NCT02348840|149904|P2|STARTED|Overall Study||21
61441|NCT02348840|149905|P1|STARTED|Overall Study||23
61442|NCT02348723|149919|P2|NOT COMPLETED|Overall Study||26
61443|NCT02348723|149920|P1|NOT COMPLETED|Overall Study||28
61444|NCT02348723|149919|P2|COMPLETED|Overall Study||312
61445|NCT02348723|149920|P1|COMPLETED|Overall Study||310
61446|NCT02348723|149919|P2|STARTED|Overall Study||338
61447|NCT02348723|149920|P1|STARTED|Overall Study||338
61448|NCT02348684|149932|P1|NOT COMPLETED|Overall Study||0
61449|NCT02348684|149932|P1|COMPLETED|Overall Study||20
61450|NCT02348684|149932|P1|STARTED|Overall Study||20
61451|NCT02348658|149936|P2|NOT COMPLETED|Period 2 (7 Days)||0
61452|NCT02348658|149937|P1|NOT COMPLETED|Period 2 (7 Days)||0
61453|NCT02348658|149936|P2|COMPLETED|Period 2 (7 Days)||6
61454|NCT02348658|149937|P1|COMPLETED|Period 2 (7 Days)||6
61455|NCT02348658|149936|P2|STARTED|Period 2 (7 Days)||6
61456|NCT02348658|149937|P1|STARTED|Period 2 (7 Days)||6
61457|NCT02348658|149936|P2|NOT COMPLETED|Washout Period (22 Days)||0
61458|NCT02348658|149937|P1|NOT COMPLETED|Washout Period (22 Days)||0
61459|NCT02348658|149936|P2|COMPLETED|Washout Period (22 Days)||6
61460|NCT02348658|149937|P1|COMPLETED|Washout Period (22 Days)||6
61461|NCT02348658|149936|P2|STARTED|Washout Period (22 Days)||6
61462|NCT02348658|149937|P1|STARTED|Washout Period (22 Days)||6
61463|NCT02348658|149936|P2|NOT COMPLETED|Period 1 (7 Days)||0
61464|NCT02348658|149937|P1|NOT COMPLETED|Period 1 (7 Days)||0
61465|NCT02348658|149936|P2|COMPLETED|Period 1 (7 Days)||6
61466|NCT02348658|149937|P1|COMPLETED|Period 1 (7 Days)||6
61467|NCT02348658|149936|P2|STARTED|Period 1 (7 Days)||6
61468|NCT02348658|149937|P1|STARTED|Period 1 (7 Days)||6
61469|NCT02348632|149971|P2|NOT COMPLETED|Randomized Withdrawal Period||1
61470|NCT02348632|149972|P1|NOT COMPLETED|Randomized Withdrawal Period||3
61471|NCT02348632|149971|P2|COMPLETED|Randomized Withdrawal Period||141
61472|NCT02348632|149972|P1|COMPLETED|Randomized Withdrawal Period||137
61473|NCT02348632|149971|P2|STARTED|Randomized Withdrawal Period||142
61474|NCT02348632|149972|P1|STARTED|Randomized Withdrawal Period||140
61475|NCT02348632|149971|P2|NOT COMPLETED|Open-label Period||0
61476|NCT02348632|149972|P1|NOT COMPLETED|Open-label Period||185
61477|NCT02348632|149971|P2|COMPLETED|Open-label Period||0
61478|NCT02348632|149972|P1|COMPLETED|Open-label Period||458
61479|NCT02348632|149971|P2|STARTED|Open-label Period||0
61480|NCT02348632|149972|P1|STARTED|Open-label Period||643
61481|NCT02348619|149982|P2|NOT COMPLETED|Double-Blind Withdrawal Phase||0
61482|NCT02348619|149983|P1|NOT COMPLETED|Double-Blind Withdrawal Phase||2
61483|NCT02348619|149982|P2|COMPLETED|Double-Blind Withdrawal Phase||62
61484|NCT02348619|149983|P1|COMPLETED|Double-Blind Withdrawal Phase||60
61485|NCT02348619|149982|P2|STARTED|Double-Blind Withdrawal Phase||62
61486|NCT02348619|149983|P1|STARTED|Double-Blind Withdrawal Phase||62
61487|NCT02348619|149982|P2|NOT COMPLETED|Stable-Dose Phase||0
61488|NCT02348619|149983|P1|NOT COMPLETED|Stable-Dose Phase||33
61489|NCT02348619|149982|P2|COMPLETED|Stable-Dose Phase||0
61490|NCT02348619|149983|P1|COMPLETED|Stable-Dose Phase||124
61491|NCT02348619|149982|P2|STARTED|Stable-Dose Phase||0
61492|NCT02348619|149983|P1|STARTED|Stable-Dose Phase||157
61493|NCT02348619|149982|P2|NOT COMPLETED|Titration Phase||0
61494|NCT02348619|149983|P1|NOT COMPLETED|Titration Phase||17
61495|NCT02348619|149982|P2|COMPLETED|Titration Phase||0
61496|NCT02348619|149983|P1|COMPLETED|Titration Phase||157
61497|NCT02348619|149982|P2|STARTED|Titration Phase||0
61498|NCT02348619|149983|P1|STARTED|Titration Phase||174
61499|NCT02348606|150002|P5|NOT COMPLETED|Overall Study||18
61500|NCT02348606|150003|P4|NOT COMPLETED|Overall Study||24
61501|NCT02348606|150004|P3|NOT COMPLETED|Overall Study||11
61502|NCT02348606|150005|P2|NOT COMPLETED|Overall Study||8
61503|NCT02348606|150006|P1|NOT COMPLETED|Overall Study||9
61504|NCT02348606|150002|P5|COMPLETED|Overall Study||101
61505|NCT02348606|150003|P4|COMPLETED|Overall Study||94
61506|NCT02348606|150004|P3|COMPLETED|Overall Study||106
61507|NCT02348606|150005|P2|COMPLETED|Overall Study||54
61508|NCT02348606|150006|P1|COMPLETED|Overall Study||49
61509|NCT02348606|150002|P5|STARTED|Overall Study||119
61510|NCT02348606|150003|P4|STARTED|Overall Study||118
61511|NCT02348606|150004|P3|STARTED|Overall Study||117
61512|NCT02348606|150005|P2|STARTED|Overall Study||62
61513|NCT02348606|150006|P1|STARTED|Overall Study||58
61514|NCT02348593|150062|P4|NOT COMPLETED|Overall Study||7
61515|NCT02348593|150063|P3|NOT COMPLETED|Overall Study||16
61516|NCT02348593|150064|P2|NOT COMPLETED|Overall Study||8
61517|NCT02348593|150065|P1|NOT COMPLETED|Overall Study||10
61518|NCT02348593|150062|P4|COMPLETED|Overall Study||52
61519|NCT02348593|150063|P3|COMPLETED|Overall Study||43
61520|NCT02348593|150064|P2|COMPLETED|Overall Study||51
61521|NCT02348593|150065|P1|COMPLETED|Overall Study||49
61522|NCT02348593|150062|P4|STARTED|Overall Study||59
61523|NCT02348593|150063|P3|STARTED|Overall Study||59
61524|NCT02348593|150064|P2|STARTED|Overall Study||59
61525|NCT02348593|150065|P1|STARTED|Overall Study||59
61526|NCT02348359|150111|P4|NOT COMPLETED|Overall Study||12
61527|NCT02348359|150112|P3|NOT COMPLETED|Overall Study||14
61528|NCT02348359|150113|P2|NOT COMPLETED|Overall Study||17
61529|NCT02348359|150114|P1|NOT COMPLETED|Overall Study||11
61530|NCT02348359|150111|P4|COMPLETED|Overall Study||27
61531|NCT02348359|150112|P3|COMPLETED|Overall Study||25
61532|NCT02348359|150113|P2|COMPLETED|Overall Study||22
61533|NCT02348359|150114|P1|COMPLETED|Overall Study||29
61534|NCT02348359|150111|P4|STARTED|Overall Study||39
61535|NCT02348359|150112|P3|STARTED|Overall Study||39
61536|NCT02348359|150113|P2|STARTED|Overall Study||39
61537|NCT02348359|150114|P1|STARTED|Overall Study||40
61538|NCT02347943|150127|P3|NOT COMPLETED|Overall Study||45
61539|NCT02347943|150128|P2|NOT COMPLETED|Overall Study||67
61540|NCT02347943|150129|P1|NOT COMPLETED|Overall Study||140
61541|NCT02347943|150127|P3|COMPLETED|Overall Study||0
61542|NCT02347943|150128|P2|COMPLETED|Overall Study||0
61543|NCT02347943|150129|P1|COMPLETED|Overall Study||0
61544|NCT02347943|150127|P3|STARTED|Overall Study||45
61545|NCT02347943|150128|P2|STARTED|Overall Study||67
61546|NCT02347943|150129|P1|STARTED|Overall Study||140
61547|NCT02347787|150139|P2|NOT COMPLETED|9 Month Follow-Up||71
61548|NCT02347787|150140|P1|NOT COMPLETED|9 Month Follow-Up||61
61549|NCT02347787|150139|P2|COMPLETED|9 Month Follow-Up||233
61550|NCT02347787|150140|P1|COMPLETED|9 Month Follow-Up||227
61551|NCT02347787|150139|P2|STARTED|9 Month Follow-Up||304
61552|NCT02347787|150140|P1|STARTED|9 Month Follow-Up||288
61553|NCT02347787|150139|P2|NOT COMPLETED|6 Month Follow-Up||56
61554|NCT02347787|150140|P1|NOT COMPLETED|6 Month Follow-Up||66
61555|NCT02347787|150139|P2|COMPLETED|6 Month Follow-Up||248
61556|NCT02347787|150140|P1|COMPLETED|6 Month Follow-Up||222
61557|NCT02347787|150139|P2|STARTED|6 Month Follow-Up||304
61558|NCT02347787|150140|P1|STARTED|6 Month Follow-Up||288
61559|NCT02347774|150202|P3|NOT COMPLETED|On Study Treatment||36
61560|NCT02347774|150203|P2|NOT COMPLETED|On Study Treatment||31
61561|NCT02347774|150204|P1|NOT COMPLETED|On Study Treatment||24
61562|NCT02347774|150202|P3|COMPLETED|On Study Treatment||177
61563|NCT02347774|150203|P2|COMPLETED|On Study Treatment||183
61564|NCT02347774|150204|P1|COMPLETED|On Study Treatment||190
61565|NCT02347774|150202|P3|STARTED|On Study Treatment|One subject randomized in error to the placebo arm was never dosed .|213
61566|NCT02347774|150203|P2|STARTED|On Study Treatment||214
61567|NCT02347774|150204|P1|STARTED|On Study Treatment||214
61568|NCT02347774|150202|P3|NOT COMPLETED|Study Participation||25
61569|NCT02347774|150203|P2|NOT COMPLETED|Study Participation||21
61570|NCT02347774|150204|P1|NOT COMPLETED|Study Participation||15
61571|NCT02347774|150202|P3|COMPLETED|Study Participation||188
61572|NCT02347774|150203|P2|COMPLETED|Study Participation||193
61573|NCT02347774|150204|P1|COMPLETED|Study Participation||199
61574|NCT02347774|150202|P3|STARTED|Study Participation|One subject randomized in error to the placebo arm was never dosed .|213
61575|NCT02347774|150203|P2|STARTED|Study Participation||214
61576|NCT02347774|150204|P1|STARTED|Study Participation||214
61577|NCT02347761|150260|P3|NOT COMPLETED|On Study Treatment||42
61578|NCT02347761|150261|P2|NOT COMPLETED|On Study Treatment||23
61579|NCT02347761|150262|P1|NOT COMPLETED|On Study Treatment||27
61580|NCT02347761|150260|P3|COMPLETED|On Study Treatment||176
61581|NCT02347761|150261|P2|COMPLETED|On Study Treatment||194
61582|NCT02347761|150262|P1|COMPLETED|On Study Treatment||191
61583|NCT02347761|150260|P3|STARTED|On Study Treatment||218
61584|NCT02347761|150261|P2|STARTED|On Study Treatment||217
61585|NCT02347761|150262|P1|STARTED|On Study Treatment||218
61586|NCT02347761|150260|P3|NOT COMPLETED|All Collected||27
61587|NCT02347761|150261|P2|NOT COMPLETED|All Collected||14
61588|NCT02347761|150262|P1|NOT COMPLETED|All Collected||17
61589|NCT02347761|150260|P3|COMPLETED|All Collected||191
61590|NCT02347761|150261|P2|COMPLETED|All Collected||203
61591|NCT02347761|150262|P1|COMPLETED|All Collected||201
61592|NCT02347761|150260|P3|STARTED|All Collected||218
61593|NCT02347761|150261|P2|STARTED|All Collected||217
61594|NCT02347761|150262|P1|STARTED|All Collected||218
61595|NCT02347657|150323|P2|NOT COMPLETED|Overall Study||15
61596|NCT02347657|150324|P1|NOT COMPLETED|Overall Study||18
61597|NCT02347657|150323|P2|COMPLETED|Overall Study||236
61598|NCT02347657|150324|P1|COMPLETED|Overall Study||241
61599|NCT02347657|150323|P2|Treated|Overall Study||251
61600|NCT02347657|150324|P1|Treated|Overall Study||258
61601|NCT02347657|150323|P2|STARTED|Overall Study||251
61602|NCT02347657|150324|P1|STARTED|Overall Study||259
61603|NCT02347605|150355|P6|NOT COMPLETED|Overall Study||2
61604|NCT02347605|150356|P5|NOT COMPLETED|Overall Study||3
61605|NCT02347605|150357|P4|NOT COMPLETED|Overall Study||4
61606|NCT02347605|150358|P3|NOT COMPLETED|Overall Study||1
61607|NCT02347605|150359|P2|NOT COMPLETED|Overall Study||3
61608|NCT02347605|150360|P1|NOT COMPLETED|Overall Study||3
61609|NCT02347605|150355|P6|COMPLETED|Overall Study||7
61610|NCT02347605|150356|P5|COMPLETED|Overall Study||6
61611|NCT02347605|150357|P4|COMPLETED|Overall Study||6
61612|NCT02347605|150358|P3|COMPLETED|Overall Study||7
61613|NCT02347605|150359|P2|COMPLETED|Overall Study||7
61614|NCT02347605|150360|P1|COMPLETED|Overall Study||7
61615|NCT02347605|150355|P6|Completed Lab 2|Overall Study||8
61616|NCT02347605|150356|P5|Completed Lab 2|Overall Study||6
61617|NCT02347605|150357|P4|Completed Lab 2|Overall Study||7
61618|NCT02347605|150358|P3|Completed Lab 2|Overall Study||7
61619|NCT02347605|150359|P2|Completed Lab 2|Overall Study||7
61620|NCT02347605|150360|P1|Completed Lab 2|Overall Study||7
61621|NCT02347605|150355|P6|Completed Lab 1|Overall Study||9
61622|NCT02347605|150356|P5|Completed Lab 1|Overall Study||8
61623|NCT02347605|150357|P4|Completed Lab 1|Overall Study||10
61624|NCT02347605|150358|P3|Completed Lab 1|Overall Study||8
61625|NCT02347605|150359|P2|Completed Lab 1|Overall Study||10
61626|NCT02347605|150360|P1|Completed Lab 1|Overall Study||10
61627|NCT02347605|150355|P6|STARTED|Overall Study||9
61628|NCT02347605|150356|P5|STARTED|Overall Study||9
61629|NCT02347605|150357|P4|STARTED|Overall Study||10
61630|NCT02347605|150358|P3|STARTED|Overall Study||8
61631|NCT02347605|150359|P2|STARTED|Overall Study||10
61632|NCT02347605|150360|P1|STARTED|Overall Study||10
61633|NCT02347488|150371|P1|NOT COMPLETED|Overall Study||0
61634|NCT02347488|150371|P1|COMPLETED|Overall Study||30
61635|NCT02347488|150371|P1|STARTED|Overall Study||30
61636|NCT02347345|150384|P3|NOT COMPLETED|Overall Study||0
61637|NCT02347345|150385|P2|NOT COMPLETED|Overall Study||0
61638|NCT02347345|150386|P1|NOT COMPLETED|Overall Study||0
61639|NCT02347345|150384|P3|COMPLETED|Overall Study||12
61640|NCT02347345|150385|P2|COMPLETED|Overall Study||12
61641|NCT02347345|150386|P1|COMPLETED|Overall Study||10
61642|NCT02347345|150384|P3|STARTED|Overall Study||12
61643|NCT02347345|150385|P2|STARTED|Overall Study||12
61644|NCT02347345|150386|P1|STARTED|Overall Study||10
61645|NCT02347332|150402|P2|NOT COMPLETED|Overall Study||229
61646|NCT02347332|150403|P1|NOT COMPLETED|Overall Study||230
61647|NCT02347332|150402|P2|COMPLETED|Overall Study|6 patients: unknown cause(2home), PDsuspect(1home+1hosp), sudden death(1home), hypercapnie(1hosp).|0
61648|NCT02347332|150403|P1|COMPLETED|Overall Study|6 patients: suicide(1), unknown cause(5 - 4 at home +1 in city hospital).|0
61649|NCT02347332|150402|P2|STARTED|Overall Study||229
61650|NCT02347332|150403|P1|STARTED|Overall Study||230
61651|NCT02347189|150417|P1|NOT COMPLETED|Overall Study||11
61652|NCT02347189|150417|P1|COMPLETED|Overall Study||28
61653|NCT02347189|150417|P1|Implanted > 24 Hours|Overall Study||30
61654|NCT02347189|150417|P1|Implanted|Overall Study||30
61655|NCT02347189|150417|P1|Catheterized|Overall Study||39
61656|NCT02347189|150417|P1|STARTED|Overall Study||39
61657|NCT02347176|150436|P4|NOT COMPLETED|Overall Study||4
61658|NCT02347176|150437|P3|NOT COMPLETED|Overall Study||8
61659|NCT02347176|150438|P2|NOT COMPLETED|Overall Study||10
61660|NCT02347176|150439|P1|NOT COMPLETED|Overall Study||12
61661|NCT02347176|150436|P4|COMPLETED|Overall Study||48
61662|NCT02347176|150437|P3|COMPLETED|Overall Study||43
61663|NCT02347176|150438|P2|COMPLETED|Overall Study||40
61664|NCT02347176|150439|P1|COMPLETED|Overall Study||39
61665|NCT02347176|150436|P4|STARTED|Overall Study||52
61666|NCT02347176|150437|P3|STARTED|Overall Study||51
61667|NCT02347176|150438|P2|STARTED|Overall Study||50
61668|NCT02347176|150439|P1|STARTED|Overall Study||51
61669|NCT02347124|150487|P2|NOT COMPLETED|Overall Study||99
61670|NCT02347124|150488|P1|NOT COMPLETED|Overall Study||93
61671|NCT02347124|150487|P2|COMPLETED|Overall Study||259
61672|NCT02347124|150488|P1|COMPLETED|Overall Study||267
61673|NCT02347124|150487|P2|2 Month Follow-up|Overall Study||275
61674|NCT02347124|150488|P1|2 Month Follow-up|Overall Study||298
61675|NCT02347124|150487|P2|STARTED|Overall Study||358
61676|NCT02347124|150488|P1|STARTED|Overall Study||360
61677|NCT02347098|150524|P2|NOT COMPLETED|Overall Study||8
61678|NCT02347098|150525|P1|NOT COMPLETED|Overall Study||7
61679|NCT02347098|150524|P2|COMPLETED|Overall Study||58
61680|NCT02347098|150525|P1|COMPLETED|Overall Study||56
61681|NCT02347098|150524|P2|STARTED|Overall Study||66
61682|NCT02347098|150525|P1|STARTED|Overall Study||63
61683|NCT02347085|150537|P1|NOT COMPLETED|Overall Study||10
61684|NCT02347085|150537|P1|COMPLETED|Overall Study||33
61685|NCT02347085|150537|P1|Placebo MDI|Overall Study||40
61686|NCT02347085|150537|P1|GFF MDI 14.4/9.6 µg|Overall Study||40
61687|NCT02347085|150537|P1|STARTED|Overall Study||43
61688|NCT02347072|150559|P1|NOT COMPLETED|Overall Study||18
61689|NCT02347072|150559|P1|COMPLETED|Overall Study||62
61690|NCT02347072|150559|P1|Spiriva Respimat 5 µg|Overall Study||73
61691|NCT02347072|150559|P1|Placebo MDI|Overall Study||72
61692|NCT02347072|150559|P1|GFF MDI 14.4/9.6 µg|Overall Study||75
61693|NCT02347072|150559|P1|STARTED|Overall Study||80
61694|NCT02346877|150593|P2|NOT COMPLETED|Overall Study||0
61695|NCT02346877|150594|P1|NOT COMPLETED|Overall Study||19
61696|NCT02346877|150593|P2|COMPLETED|Overall Study||0
61697|NCT02346877|150594|P1|COMPLETED|Overall Study||0
61698|NCT02346877|150593|P2|STARTED|Overall Study||0
61699|NCT02346877|150594|P1|STARTED|Overall Study||19
61700|NCT02346721|150604|P1|NOT COMPLETED|Overall Study||4
61701|NCT02346721|150604|P1|COMPLETED|Overall Study||107
61702|NCT02346721|150604|P1|STARTED|Overall Study||111
61703|NCT02346643|150613|P1|NOT COMPLETED|Overall Study||35
61704|NCT02346643|150613|P1|COMPLETED|Overall Study||6
61705|NCT02346643|150613|P1|Received Permanent System|Overall Study||31
61706|NCT02346643|150613|P1|Received Trial System|Overall Study||29
61707|NCT02346643|150613|P1|STARTED|Overall Study||41
61708|NCT02346461|150620|P2|NOT COMPLETED|Overall Study||0
61709|NCT02346461|150621|P1|NOT COMPLETED|Overall Study||0
61710|NCT02346461|150620|P2|COMPLETED|Overall Study||6
61711|NCT02346461|150621|P1|COMPLETED|Overall Study||6
61712|NCT02346461|150620|P2|STARTED|Overall Study||6
61713|NCT02346461|150621|P1|STARTED|Overall Study||6
61714|NCT02346370|150643|P3|NOT COMPLETED|Overall Study||4
61715|NCT02346370|150644|P2|NOT COMPLETED|Overall Study||4
61716|NCT02346370|150645|P1|NOT COMPLETED|Overall Study||8
61717|NCT02346370|150643|P3|COMPLETED|Overall Study||0
61718|NCT02346370|150644|P2|COMPLETED|Overall Study||0
61719|NCT02346370|150645|P1|COMPLETED|Overall Study||0
61720|NCT02346370|150643|P3|STARTED|Overall Study||4
61721|NCT02346370|150644|P2|STARTED|Overall Study||4
61722|NCT02346370|150645|P1|STARTED|Overall Study||8
61723|NCT02346240|150694|P17|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||6
61724|NCT02346240|150695|P16|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||13
61725|NCT02346240|150696|P15|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||14
61726|NCT02346240|150697|P14|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||7
61727|NCT02346240|150698|P13|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||0
61728|NCT02346240|150699|P12|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||3
61729|NCT02346240|150700|P11|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||2
61730|NCT02346240|150701|P10|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||1
61731|NCT02346240|150702|P9|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||4
61732|NCT02346240|150703|P8|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||2
61733|NCT02346240|150704|P7|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||2
61734|NCT02346240|150705|P6|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||1
61735|NCT02346240|150706|P5|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||0
61736|NCT02346240|150707|P4|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||0
61737|NCT02346240|150708|P3|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||0
61738|NCT02346240|150709|P2|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||0
61739|NCT02346240|150710|P1|NOT COMPLETED|Finished Wk16 Entered Maintenance Period||0
61740|NCT02346240|150694|P17|COMPLETED|Finished Wk16 Entered Maintenance Period||30
61741|NCT02346240|150695|P16|COMPLETED|Finished Wk16 Entered Maintenance Period||36
61742|NCT02346240|150696|P15|COMPLETED|Finished Wk16 Entered Maintenance Period||71
61743|NCT02346240|150697|P14|COMPLETED|Finished Wk16 Entered Maintenance Period||46
61744|NCT02346240|150698|P13|COMPLETED|Finished Wk16 Entered Maintenance Period||49
61745|NCT02346240|150699|P12|COMPLETED|Finished Wk16 Entered Maintenance Period||47
61746|NCT02346240|150700|P11|COMPLETED|Finished Wk16 Entered Maintenance Period||23
61747|NCT02346240|150701|P10|COMPLETED|Finished Wk16 Entered Maintenance Period||43
61748|NCT02346240|150702|P9|COMPLETED|Finished Wk16 Entered Maintenance Period||40
61749|NCT02346240|150703|P8|COMPLETED|Finished Wk16 Entered Maintenance Period||20
61750|NCT02346240|150704|P7|COMPLETED|Finished Wk16 Entered Maintenance Period||48
61751|NCT02346240|150705|P6|COMPLETED|Finished Wk16 Entered Maintenance Period||23
61752|NCT02346240|150706|P5|COMPLETED|Finished Wk16 Entered Maintenance Period||2
61753|NCT02346240|150707|P4|COMPLETED|Finished Wk16 Entered Maintenance Period||0
61754|NCT02346240|150708|P3|COMPLETED|Finished Wk16 Entered Maintenance Period||0
61755|NCT02346240|150709|P2|COMPLETED|Finished Wk16 Entered Maintenance Period||0
61756|NCT02346240|150710|P1|COMPLETED|Finished Wk16 Entered Maintenance Period||0
61757|NCT02346240|150694|P17|STARTED|Finished Wk16 Entered Maintenance Period||36
61758|NCT02346240|150695|P16|STARTED|Finished Wk16 Entered Maintenance Period||49
61759|NCT02346240|150696|P15|STARTED|Finished Wk16 Entered Maintenance Period||85
61760|NCT02346240|150697|P14|STARTED|Finished Wk16 Entered Maintenance Period||53
61761|NCT02346240|150698|P13|STARTED|Finished Wk16 Entered Maintenance Period||49
61762|NCT02346240|150699|P12|STARTED|Finished Wk16 Entered Maintenance Period||50
61763|NCT02346240|150700|P11|STARTED|Finished Wk16 Entered Maintenance Period||25
61764|NCT02346240|150701|P10|STARTED|Finished Wk16 Entered Maintenance Period||44
61765|NCT02346240|150702|P9|STARTED|Finished Wk16 Entered Maintenance Period||44
61766|NCT02346240|150703|P8|STARTED|Finished Wk16 Entered Maintenance Period||22
61767|NCT02346240|150704|P7|STARTED|Finished Wk16 Entered Maintenance Period||50
61768|NCT02346240|150705|P6|STARTED|Finished Wk16 Entered Maintenance Period||24
61769|NCT02346240|150706|P5|STARTED|Finished Wk16 Entered Maintenance Period||2
61770|NCT02346240|150707|P4|STARTED|Finished Wk16 Entered Maintenance Period||0
61771|NCT02346240|150708|P3|STARTED|Finished Wk16 Entered Maintenance Period||0
61772|NCT02346240|150709|P2|STARTED|Finished Wk16 Entered Maintenance Period||0
61773|NCT02346240|150710|P1|STARTED|Finished Wk16 Entered Maintenance Period||0
61774|NCT02346240|150694|P17|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
61775|NCT02346240|150695|P16|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
61776|NCT02346240|150696|P15|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
61777|NCT02346240|150697|P14|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
61778|NCT02346240|150698|P13|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
61779|NCT02346240|150699|P12|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
61780|NCT02346240|150700|P11|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
61781|NCT02346240|150701|P10|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
61782|NCT02346240|150702|P9|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
61783|NCT02346240|150703|P8|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
61784|NCT02346240|150704|P7|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
61785|NCT02346240|150705|P6|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
61786|NCT02346240|150706|P5|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
61787|NCT02346240|150707|P4|NOT COMPLETED|Initial Period (Baseline to Week 16)||7
61788|NCT02346240|150708|P3|NOT COMPLETED|Initial Period (Baseline to Week 16)||6
61789|NCT02346240|150709|P2|NOT COMPLETED|Initial Period (Baseline to Week 16)||11
61790|NCT02346240|150710|P1|NOT COMPLETED|Initial Period (Baseline to Week 16)||2
61791|NCT02346240|150694|P17|COMPLETED|Initial Period (Baseline to Week 16)||0
61792|NCT02346240|150695|P16|COMPLETED|Initial Period (Baseline to Week 16)||0
61793|NCT02346240|150696|P15|COMPLETED|Initial Period (Baseline to Week 16)||0
61794|NCT02346240|150697|P14|COMPLETED|Initial Period (Baseline to Week 16)||0
61795|NCT02346240|150698|P13|COMPLETED|Initial Period (Baseline to Week 16)||0
61796|NCT02346240|150699|P12|COMPLETED|Initial Period (Baseline to Week 16)||0
61797|NCT02346240|150700|P11|COMPLETED|Initial Period (Baseline to Week 16)||0
61798|NCT02346240|150701|P10|COMPLETED|Initial Period (Baseline to Week 16)||0
61799|NCT02346240|150702|P9|COMPLETED|Initial Period (Baseline to Week 16)||0
61800|NCT02346240|150703|P8|COMPLETED|Initial Period (Baseline to Week 16)||0
61801|NCT02346240|150704|P7|COMPLETED|Initial Period (Baseline to Week 16)||0
61802|NCT02346240|150705|P6|COMPLETED|Initial Period (Baseline to Week 16)||0
61803|NCT02346240|150706|P5|COMPLETED|Initial Period (Baseline to Week 16)||0
61804|NCT02346240|150707|P4|COMPLETED|Initial Period (Baseline to Week 16)||160
61805|NCT02346240|150708|P3|COMPLETED|Initial Period (Baseline to Week 16)||159
61806|NCT02346240|150709|P2|COMPLETED|Initial Period (Baseline to Week 16)||159
61807|NCT02346240|150710|P1|COMPLETED|Initial Period (Baseline to Week 16)||55
61808|NCT02346240|150694|P17|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
61809|NCT02346240|150695|P16|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
61810|NCT02346240|150696|P15|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
61811|NCT02346240|150697|P14|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
61812|NCT02346240|150698|P13|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
61813|NCT02346240|150699|P12|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
61814|NCT02346240|150700|P11|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
61815|NCT02346240|150701|P10|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
61816|NCT02346240|150702|P9|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
61817|NCT02346240|150703|P8|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
61818|NCT02346240|150704|P7|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
61819|NCT02346240|150705|P6|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
61820|NCT02346240|150706|P5|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
61821|NCT02346240|150707|P4|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||160
61822|NCT02346240|150708|P3|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159
61823|NCT02346240|150709|P2|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159
61824|NCT02346240|150710|P1|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||55
61825|NCT02346240|150694|P17|Completed Week 16|Initial Period (Baseline to Week 16)||0
61826|NCT02346240|150695|P16|Completed Week 16|Initial Period (Baseline to Week 16)||0
61827|NCT02346240|150696|P15|Completed Week 16|Initial Period (Baseline to Week 16)||0
61828|NCT02346240|150697|P14|Completed Week 16|Initial Period (Baseline to Week 16)||0
61829|NCT02346240|150698|P13|Completed Week 16|Initial Period (Baseline to Week 16)||0
61830|NCT02346240|150699|P12|Completed Week 16|Initial Period (Baseline to Week 16)||0
61831|NCT02346240|150700|P11|Completed Week 16|Initial Period (Baseline to Week 16)||0
61832|NCT02346240|150701|P10|Completed Week 16|Initial Period (Baseline to Week 16)||0
61833|NCT02346240|150702|P9|Completed Week 16|Initial Period (Baseline to Week 16)||0
61834|NCT02346240|150703|P8|Completed Week 16|Initial Period (Baseline to Week 16)||0
61835|NCT02346240|150704|P7|Completed Week 16|Initial Period (Baseline to Week 16)||0
61836|NCT02346240|150705|P6|Completed Week 16|Initial Period (Baseline to Week 16)||0
61837|NCT02346240|150706|P5|Completed Week 16|Initial Period (Baseline to Week 16)||0
61838|NCT02346240|150707|P4|Completed Week 16|Initial Period (Baseline to Week 16)||162
61839|NCT02346240|150708|P3|Completed Week 16|Initial Period (Baseline to Week 16)||159
61840|NCT02346240|150709|P2|Completed Week 16|Initial Period (Baseline to Week 16)||159
61841|NCT02346240|150710|P1|Completed Week 16|Initial Period (Baseline to Week 16)||55
61842|NCT02346240|150694|P17|STARTED|Initial Period (Baseline to Week 16)||0
61843|NCT02346240|150695|P16|STARTED|Initial Period (Baseline to Week 16)||0
61844|NCT02346240|150696|P15|STARTED|Initial Period (Baseline to Week 16)||0
61845|NCT02346240|150697|P14|STARTED|Initial Period (Baseline to Week 16)||0
61846|NCT02346240|150698|P13|STARTED|Initial Period (Baseline to Week 16)||0
61847|NCT02346240|150699|P12|STARTED|Initial Period (Baseline to Week 16)||0
61848|NCT02346240|150700|P11|STARTED|Initial Period (Baseline to Week 16)||0
61849|NCT02346240|150701|P10|STARTED|Initial Period (Baseline to Week 16)||0
61850|NCT02346240|150702|P9|STARTED|Initial Period (Baseline to Week 16)||0
61851|NCT02346240|150703|P8|STARTED|Initial Period (Baseline to Week 16)||0
61852|NCT02346240|150704|P7|STARTED|Initial Period (Baseline to Week 16)||0
61853|NCT02346240|150705|P6|STARTED|Initial Period (Baseline to Week 16)||0
61854|NCT02346240|150706|P5|STARTED|Initial Period (Baseline to Week 16)||0
61855|NCT02346240|150707|P4|STARTED|Initial Period (Baseline to Week 16)||167
61856|NCT02346240|150708|P3|STARTED|Initial Period (Baseline to Week 16)||165
61857|NCT02346240|150709|P2|STARTED|Initial Period (Baseline to Week 16)||170
61858|NCT02346240|150710|P1|STARTED|Initial Period (Baseline to Week 16)||57
61859|NCT02345889|150748|P4|NOT COMPLETED|Overall Study||16
61860|NCT02345889|150749|P3|NOT COMPLETED|Overall Study||20
61861|NCT02345889|150750|P2|NOT COMPLETED|Overall Study||17
61862|NCT02345889|150751|P1|NOT COMPLETED|Overall Study||21
61863|NCT02345889|150748|P4|COMPLETED|Overall Study||299
61864|NCT02345889|150749|P3|COMPLETED|Overall Study||295
61865|NCT02345889|150750|P2|COMPLETED|Overall Study||299
61866|NCT02345889|150751|P1|COMPLETED|Overall Study||295
61867|NCT02345889|150748|P4|STARTED|Overall Study||315
61868|NCT02345889|150749|P3|STARTED|Overall Study||315
61869|NCT02345889|150750|P2|STARTED|Overall Study||316
61870|NCT02345889|150751|P1|STARTED|Overall Study||316
61871|NCT02345772|150817|P1|NOT COMPLETED|Overall Study||4
61872|NCT02345772|150817|P1|COMPLETED|Overall Study||0
61873|NCT02345772|150817|P1|STARTED|Overall Study||4
61874|NCT02345720|150823|P1|NOT COMPLETED|Overall Study||0
61875|NCT02345720|150823|P1|COMPLETED|Overall Study||20
61876|NCT02345720|150823|P1|STARTED|Overall Study||20
61877|NCT02345642|150831|P2|NOT COMPLETED|Overall Study||0
61878|NCT02345642|150832|P1|NOT COMPLETED|Overall Study||0
61879|NCT02345642|150831|P2|COMPLETED|Overall Study||10
61880|NCT02345642|150832|P1|COMPLETED|Overall Study||10
61881|NCT02345642|150831|P2|STARTED|Overall Study||10
61882|NCT02345642|150832|P1|STARTED|Overall Study||10
61883|NCT02345486|150840|P2|NOT COMPLETED|Overall Study||0
61884|NCT02345486|150841|P1|NOT COMPLETED|Overall Study||0
61885|NCT02345486|150840|P2|COMPLETED|Overall Study||520
61886|NCT02345486|150841|P1|COMPLETED|Overall Study||454
61887|NCT02345486|150840|P2|STARTED|Overall Study||520
61888|NCT02345486|150841|P1|STARTED|Overall Study||454
61889|NCT02345460|150889|P1|NOT COMPLETED|Overall Study||0
61890|NCT02345460|150889|P1|COMPLETED|Overall Study||1
61891|NCT02345460|150889|P1|STARTED|Overall Study||1
61892|NCT02345369|150902|P2|NOT COMPLETED|Overall Study||0
61893|NCT02345369|150903|P1|NOT COMPLETED|Overall Study||0
61894|NCT02345369|150902|P2|COMPLETED|Overall Study||0
61895|NCT02345369|150903|P1|COMPLETED|Overall Study||0
61896|NCT02345369|150902|P2|STARTED|Overall Study||0
61897|NCT02345369|150903|P1|STARTED|Overall Study||0
61898|NCT02345330|150913|P1|NOT COMPLETED|Overall Study||3
61899|NCT02345330|150913|P1|COMPLETED|Overall Study||1
61900|NCT02345330|150913|P1|STARTED|Overall Study||4
61901|NCT02345252|150925|P2|NOT COMPLETED|Overall Study||316
61902|NCT02345252|150926|P1|NOT COMPLETED|Overall Study||316
61903|NCT02345252|150925|P2|COMPLETED|Overall Study||0
61904|NCT02345252|150926|P1|COMPLETED|Overall Study||0
61905|NCT02345252|150925|P2|STARTED|Overall Study||316
61906|NCT02345252|150926|P1|STARTED|Overall Study||316
61907|NCT02345226|150942|P2|NOT COMPLETED|Overall Study||441
61908|NCT02345226|150943|P1|NOT COMPLETED|Overall Study||440
61909|NCT02345226|150942|P2|COMPLETED|Overall Study||0
61910|NCT02345226|150943|P1|COMPLETED|Overall Study||0
61911|NCT02345226|150942|P2|STARTED|Overall Study||441
61912|NCT02345226|150943|P1|STARTED|Overall Study||440
61913|NCT02345161|150961|P2|NOT COMPLETED|Overall Study||57
61914|NCT02345161|150962|P1|NOT COMPLETED|Overall Study||45
61915|NCT02345161|150961|P2|COMPLETED|Overall Study||842
61916|NCT02345161|150962|P1|COMPLETED|Overall Study||866
61917|NCT02345161|150961|P2|STARTED|Overall Study||899
61918|NCT02345161|150962|P1|STARTED|Overall Study||911
61919|NCT02345031|151066|P2|NOT COMPLETED|Overall Study||1
61920|NCT02345031|151067|P1|NOT COMPLETED|Overall Study||1
61921|NCT02345031|151066|P2|COMPLETED|Overall Study||39
61922|NCT02345031|151067|P1|COMPLETED|Overall Study||37
61923|NCT02345031|151066|P2|STARTED|Overall Study||40
61924|NCT02345031|151067|P1|STARTED|Overall Study||38
61925|NCT02344745|151083|P2|NOT COMPLETED|Overall Study||0
61926|NCT02344745|151084|P1|NOT COMPLETED|Overall Study||2
61927|NCT02344745|151083|P2|COMPLETED|Overall Study||40
61928|NCT02344745|151084|P1|COMPLETED|Overall Study||38
61929|NCT02344745|151083|P2|STARTED|Overall Study||40
61930|NCT02344745|151084|P1|STARTED|Overall Study||40
61931|NCT02344628|151098|P2|NOT COMPLETED|Overall Study||86
61932|NCT02344628|151099|P1|NOT COMPLETED|Overall Study||91
61933|NCT02344628|151098|P2|COMPLETED|Overall Study|4/52 clinical data was available for 286. Serological data 6/12 for 218. Both were available for 206|206
61934|NCT02344628|151099|P1|COMPLETED|Overall Study|4/52 clinical data was available for 283. Serological data 6/12 for 212. Both were available for 200|200
61935|NCT02344628|151098|P2|STARTED|Overall Study||292
61936|NCT02344628|151099|P1|STARTED|Overall Study||291
61937|NCT02344407|151112|P3|NOT COMPLETED|Overall Study||6
61938|NCT02344407|151113|P2|NOT COMPLETED|Overall Study||9
61939|NCT02344407|151114|P1|NOT COMPLETED|Overall Study||8
61940|NCT02344407|151112|P3|COMPLETED|Overall Study||494
61941|NCT02344407|151113|P2|COMPLETED|Overall Study||491
61942|NCT02344407|151114|P1|COMPLETED|Overall Study||492
61943|NCT02344407|151112|P3|STARTED|Overall Study||500
61944|NCT02344407|151113|P2|STARTED|Overall Study||500
61945|NCT02344407|151114|P1|STARTED|Overall Study||500
61946|NCT02344342|151129|P4|NOT COMPLETED|Overall Study||10
61947|NCT02344342|151130|P3|NOT COMPLETED|Overall Study||14
61948|NCT02344342|151131|P2|NOT COMPLETED|Overall Study||9
61949|NCT02344342|151132|P1|NOT COMPLETED|Overall Study||11
61950|NCT02344342|151129|P4|COMPLETED|Overall Study||3
61951|NCT02344342|151130|P3|COMPLETED|Overall Study||0
61952|NCT02344342|151131|P2|COMPLETED|Overall Study||2
61953|NCT02344342|151132|P1|COMPLETED|Overall Study||2
61954|NCT02344342|151129|P4|STARTED|Overall Study||13
61955|NCT02344342|151130|P3|STARTED|Overall Study||14
61956|NCT02344342|151131|P2|STARTED|Overall Study||11
61957|NCT02344342|151132|P1|STARTED|Overall Study||13
61958|NCT02344251|151156|P2|NOT COMPLETED|Overall Study||0
61959|NCT02344251|151157|P1|NOT COMPLETED|Overall Study||0
61960|NCT02344251|151156|P2|COMPLETED|Overall Study||20
61961|NCT02344251|151157|P1|COMPLETED|Overall Study||20
61962|NCT02344251|151156|P2|STARTED|Overall Study||20
61963|NCT02344251|151157|P1|STARTED|Overall Study||20
61964|NCT02344238|151168|P3|NOT COMPLETED|Overall Study||0
61965|NCT02344238|151169|P2|NOT COMPLETED|Overall Study||0
61966|NCT02344238|151170|P1|NOT COMPLETED|Overall Study||0
61967|NCT02344238|151168|P3|COMPLETED|Overall Study||20
61968|NCT02344238|151169|P2|COMPLETED|Overall Study||20
61969|NCT02344238|151170|P1|COMPLETED|Overall Study||20
61970|NCT02344238|151168|P3|STARTED|Overall Study||20
61971|NCT02344238|151169|P2|STARTED|Overall Study||20
61972|NCT02344238|151170|P1|STARTED|Overall Study||20
61973|NCT02344173|151179|P1|NOT COMPLETED|12-month Visit||96
61974|NCT02344173|151179|P1|COMPLETED|12-month Visit||1932
61975|NCT02344173|151179|P1|STARTED|12-month Visit||2028
61976|NCT02344173|151179|P1|NOT COMPLETED|Procedure||7
61977|NCT02344173|151179|P1|COMPLETED|Procedure||2028
61978|NCT02344173|151179|P1|STARTED|Procedure||2035
61979|NCT02344173|151179|P1|NOT COMPLETED|Enrollment||0
61980|NCT02344173|151179|P1|COMPLETED|Enrollment||2035
61981|NCT02344173|151179|P1|STARTED|Enrollment||2035
61982|NCT02344004|151187|P2|NOT COMPLETED|Overall Study||36
61983|NCT02344004|151188|P1|NOT COMPLETED|Overall Study||154
61984|NCT02344004|151187|P2|COMPLETED|Overall Study|As of the data cutoff date of 07 July 2017.|76
61985|NCT02344004|151188|P1|COMPLETED|Overall Study|As of the data cutoff date of 07 July 2017.|70
61986|NCT02344004|151187|P2|Subjects Discontinued the Study|Overall Study||10
61987|NCT02344004|151188|P1|Subjects Discontinued the Study|Overall Study||44
61988|NCT02344004|151187|P2|STARTED|Overall Study||112
61989|NCT02344004|151188|P1|STARTED|Overall Study||224
61990|NCT02343939|151209|P9|NOT COMPLETED|Overall Study||7
61991|NCT02343939|151210|P8|NOT COMPLETED|Overall Study||37
61992|NCT02343939|151211|P7|NOT COMPLETED|Overall Study||15
61993|NCT02343939|151212|P6|NOT COMPLETED|Overall Study||17
61994|NCT02343939|151213|P5|NOT COMPLETED|Overall Study||8
61995|NCT02343939|151214|P4|NOT COMPLETED|Overall Study||6
61996|NCT02343939|151215|P3|NOT COMPLETED|Overall Study||5
61997|NCT02343939|151216|P2|NOT COMPLETED|Overall Study||48
61998|NCT02343939|151217|P1|NOT COMPLETED|Overall Study||3
61999|NCT02343939|151209|P9|COMPLETED|Overall Study||0
62000|NCT02343939|151210|P8|COMPLETED|Overall Study||0
62001|NCT02343939|151211|P7|COMPLETED|Overall Study||0
62002|NCT02343939|151212|P6|COMPLETED|Overall Study||0
62003|NCT02343939|151213|P5|COMPLETED|Overall Study||0
62004|NCT02343939|151214|P4|COMPLETED|Overall Study||0
62005|NCT02343939|151215|P3|COMPLETED|Overall Study||0
62006|NCT02343939|151216|P2|COMPLETED|Overall Study||2
62007|NCT02343939|151217|P1|COMPLETED|Overall Study||0
62008|NCT02343939|151209|P9|STARTED|Overall Study||7
62009|NCT02343939|151210|P8|STARTED|Overall Study||37
62010|NCT02343939|151211|P7|STARTED|Overall Study||15
62011|NCT02343939|151212|P6|STARTED|Overall Study||17
62012|NCT02343939|151213|P5|STARTED|Overall Study||8
62013|NCT02343939|151214|P4|STARTED|Overall Study||6
62014|NCT02343939|151215|P3|STARTED|Overall Study||5
62015|NCT02343939|151216|P2|STARTED|Overall Study||50
62016|NCT02343939|151217|P1|STARTED|Overall Study||3
62017|NCT02343627|151329|P2|NOT COMPLETED|Overall Study||1
62018|NCT02343627|151330|P1|NOT COMPLETED|Overall Study||12
62019|NCT02343627|151329|P2|COMPLETED|Overall Study||11
62020|NCT02343627|151330|P1|COMPLETED|Overall Study||23
62021|NCT02343627|151329|P2|STARTED|Overall Study||12
62022|NCT02343627|151330|P1|STARTED|Overall Study||35
62023|NCT02343575|151338|P2|NOT COMPLETED|Overall Study||0
62024|NCT02343575|151339|P1|NOT COMPLETED|Overall Study||0
62025|NCT02343575|151338|P2|COMPLETED|Overall Study||2
62026|NCT02343575|151339|P1|COMPLETED|Overall Study||1
62027|NCT02343575|151338|P2|STARTED|Overall Study||2
62028|NCT02343575|151339|P1|STARTED|Overall Study||1
62029|NCT02343458|151359|P4|NOT COMPLETED|Overall Study||38
62030|NCT02343458|151360|P3|NOT COMPLETED|Overall Study||63
62031|NCT02343458|151361|P2|NOT COMPLETED|Overall Study||66
62032|NCT02343458|151362|P1|NOT COMPLETED|Overall Study||61
62033|NCT02343458|151359|P4|COMPLETED|Overall Study||200
62034|NCT02343458|151360|P3|COMPLETED|Overall Study||417
62035|NCT02343458|151361|P2|COMPLETED|Overall Study||417
62036|NCT02343458|151362|P1|COMPLETED|Overall Study||494
62037|NCT02343458|151359|P4|STARTED|Overall Study||238
62038|NCT02343458|151360|P3|STARTED|Overall Study||480
62039|NCT02343458|151361|P2|STARTED|Overall Study||483
62040|NCT02343458|151362|P1|STARTED|Overall Study||555
62041|NCT02343380|151438|P2|NOT COMPLETED|Overall Study||0
62042|NCT02343380|151439|P1|NOT COMPLETED|Overall Study||0
62043|NCT02343380|151438|P2|COMPLETED|Overall Study|Morning test (second week)|10
62044|NCT02343380|151439|P1|COMPLETED|Overall Study|Evening test (second week)|10
62045|NCT02343380|151438|P2|STARTED|Overall Study|Evening test (first week)|10
62046|NCT02343380|151439|P1|STARTED|Overall Study|Morning test (first week)|10
62047|NCT02343276|151457|P2|NOT COMPLETED|Overall Study||0
62048|NCT02343276|151458|P1|NOT COMPLETED|Overall Study||0
62049|NCT02343276|151457|P2|COMPLETED|Overall Study||164
62050|NCT02343276|151458|P1|COMPLETED|Overall Study||164
62051|NCT02343276|151457|P2|STARTED|Overall Study||164
62052|NCT02343276|151458|P1|STARTED|Overall Study||164
62053|NCT02343263|151471|P3|NOT COMPLETED|Overall Study||1
62054|NCT02343263|151472|P2|NOT COMPLETED|Overall Study||3
62055|NCT02343263|151473|P1|NOT COMPLETED|Overall Study||5
62056|NCT02343263|151471|P3|COMPLETED|Overall Study||0
62057|NCT02343263|151472|P2|COMPLETED|Overall Study||0
62058|NCT02343263|151473|P1|COMPLETED|Overall Study|Study closed due for administrative reasons|0
62059|NCT02343263|151471|P3|STARTED|Overall Study||1
62060|NCT02343263|151472|P2|STARTED|Overall Study||3
62061|NCT02343263|151473|P1|STARTED|Overall Study|Study closed due for administrative reasons|5
62062|NCT02343159|151502|P3|NOT COMPLETED|Overall Study||30
62063|NCT02343159|151503|P2|NOT COMPLETED|Overall Study||26
62064|NCT02343159|151504|P1|NOT COMPLETED|Overall Study||26
62065|NCT02343159|151502|P3|COMPLETED|Overall Study||0
62066|NCT02343159|151503|P2|COMPLETED|Overall Study||1
62067|NCT02343159|151504|P1|COMPLETED|Overall Study||1
62068|NCT02343159|151502|P3|STARTED|Overall Study||30
62069|NCT02343159|151503|P2|STARTED|Overall Study||27
62070|NCT02343159|151504|P1|STARTED|Overall Study||27
62071|NCT02343081|151531|P2|NOT COMPLETED|Second Intervention (Day 4)||0
62072|NCT02343081|151532|P1|NOT COMPLETED|Second Intervention (Day 4)||0
62073|NCT02343081|151531|P2|COMPLETED|Second Intervention (Day 4)||8
62074|NCT02343081|151532|P1|COMPLETED|Second Intervention (Day 4)||8
62075|NCT02343081|151531|P2|Received Intervention|Second Intervention (Day 4)||8
62076|NCT02343081|151532|P1|Received Intervention|Second Intervention (Day 4)||8
62077|NCT02343081|151531|P2|STARTED|Second Intervention (Day 4)||8
62078|NCT02343081|151532|P1|STARTED|Second Intervention (Day 4)||8
62079|NCT02343081|151531|P2|NOT COMPLETED|Washout (10 Hours)||0
62080|NCT02343081|151532|P1|NOT COMPLETED|Washout (10 Hours)||0
62081|NCT02343081|151531|P2|COMPLETED|Washout (10 Hours)||8
62082|NCT02343081|151532|P1|COMPLETED|Washout (10 Hours)||8
62083|NCT02343081|151531|P2|STARTED|Washout (10 Hours)||8
62084|NCT02343081|151532|P1|STARTED|Washout (10 Hours)||8
62085|NCT02343081|151531|P2|NOT COMPLETED|First Intervention (Day 3)||0
62086|NCT02343081|151532|P1|NOT COMPLETED|First Intervention (Day 3)||0
62087|NCT02343081|151531|P2|COMPLETED|First Intervention (Day 3)||8
62088|NCT02343081|151532|P1|COMPLETED|First Intervention (Day 3)||8
62089|NCT02343081|151531|P2|Received Intervention|First Intervention (Day 3)||8
62090|NCT02343081|151532|P1|Received Intervention|First Intervention (Day 3)||8
62091|NCT02343081|151531|P2|STARTED|First Intervention (Day 3)||8
62092|NCT02343081|151532|P1|STARTED|First Intervention (Day 3)||8
62093|NCT02343003|151548|P2|NOT COMPLETED|Overall Study||7
62094|NCT02343003|151549|P1|NOT COMPLETED|Overall Study||18
62095|NCT02343003|151548|P2|COMPLETED|Overall Study||68
62096|NCT02343003|151549|P1|COMPLETED|Overall Study||58
62097|NCT02343003|151548|P2|STARTED|Overall Study||75
62098|NCT02343003|151549|P1|STARTED|Overall Study||76
62099|NCT02342886|151570|P5|NOT COMPLETED|Overall Study||3
62100|NCT02342886|151571|P4|NOT COMPLETED|Overall Study||9
62101|NCT02342886|151572|P3|NOT COMPLETED|Overall Study||15
62102|NCT02342886|151573|P2|NOT COMPLETED|Overall Study||8
62103|NCT02342886|151574|P1|NOT COMPLETED|Overall Study||8
62104|NCT02342886|151570|P5|COMPLETED|Overall Study||10
62105|NCT02342886|151571|P4|COMPLETED|Overall Study||59
62106|NCT02342886|151572|P3|COMPLETED|Overall Study||52
62107|NCT02342886|151573|P2|COMPLETED|Overall Study||63
62108|NCT02342886|151574|P1|COMPLETED|Overall Study||57
62109|NCT02342886|151570|P5|Completed Month 24 Follow-Up|Overall Study||10
62110|NCT02342886|151571|P4|Completed Month 24 Follow-Up|Overall Study||53
62111|NCT02342886|151572|P3|Completed Month 24 Follow-Up|Overall Study||46
62112|NCT02342886|151573|P2|Completed Month 24 Follow-Up|Overall Study||47
62113|NCT02342886|151574|P1|Completed Month 24 Follow-Up|Overall Study||40
62114|NCT02342886|151570|P5|Completed Month 12 Follow-Up|Overall Study||10
62115|NCT02342886|151571|P4|Completed Month 12 Follow-Up|Overall Study||57
62116|NCT02342886|151572|P3|Completed Month 12 Follow-Up|Overall Study||49
62117|NCT02342886|151573|P2|Completed Month 12 Follow-Up|Overall Study||52
62118|NCT02342886|151574|P1|Completed Month 12 Follow-Up|Overall Study||43
62119|NCT02342886|151570|P5|STARTED|Overall Study||13
62120|NCT02342886|151571|P4|STARTED|Overall Study||68
62121|NCT02342886|151572|P3|STARTED|Overall Study||67
62122|NCT02342886|151573|P2|STARTED|Overall Study||71
62123|NCT02342886|151574|P1|STARTED|Overall Study||65
62124|NCT02342743|151591|P1|NOT COMPLETED|Treatment Period||11
62125|NCT02342743|151591|P1|COMPLETED|Treatment Period||47
62126|NCT02342743|151591|P1|STARTED|Treatment Period|7 patients didn't meet inclusion criteria for treatment period, evaluated at the end of the baseline|58
62127|NCT02342743|151591|P1|NOT COMPLETED|Baseline Period||15
62128|NCT02342743|151591|P1|COMPLETED|Baseline Period||58
62129|NCT02342743|151591|P1|STARTED|Baseline Period||73
62130|NCT02342704|151604|P2|NOT COMPLETED|Overall Study||51
62131|NCT02342704|151605|P1|NOT COMPLETED|Overall Study||53
62132|NCT02342704|151604|P2|COMPLETED|Overall Study||3
62133|NCT02342704|151605|P1|COMPLETED|Overall Study||1
62134|NCT02342704|151604|P2|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
62135|NCT02342704|151605|P1|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
62136|NCT02342678|151633|P2|NOT COMPLETED|Overall Study||5
62137|NCT02342678|151634|P1|NOT COMPLETED|Overall Study||1
62138|NCT02342678|151633|P2|COMPLETED|Overall Study||23
62139|NCT02342678|151634|P1|COMPLETED|Overall Study||27
62140|NCT02342678|151633|P2|STARTED|Overall Study||28
62141|NCT02342678|151634|P1|STARTED|Overall Study||28
62142|NCT02342561|151654|P1|NOT COMPLETED|Overall Study||0
62143|NCT02342561|151654|P1|COMPLETED|Overall Study||20
62144|NCT02342561|151654|P1|STARTED|Overall Study||20
62145|NCT02342548|151665|P3|NOT COMPLETED|Overall Study||43
62146|NCT02342548|151666|P2|NOT COMPLETED|Overall Study||62
62147|NCT02342548|151667|P1|NOT COMPLETED|Overall Study||34
62148|NCT02342548|151665|P3|COMPLETED|Overall Study||23
62149|NCT02342548|151666|P2|COMPLETED|Overall Study||9
62150|NCT02342548|151667|P1|COMPLETED|Overall Study||17
62151|NCT02342548|151665|P3|STARTED|Overall Study||66
62152|NCT02342548|151666|P2|STARTED|Overall Study||71
62153|NCT02342548|151667|P1|STARTED|Overall Study||51
62154|NCT02342535|151705|P1|NOT COMPLETED|Overall Study||0
62155|NCT02342535|151705|P1|COMPLETED|Overall Study|30 women in aerobic class and 38 kids in kids exercise class|68
62156|NCT02342535|151705|P1|STARTED|Overall Study|30 women who participated in the aerobic exercise class and 38 children.|68
62157|NCT02342418|151711|P2|NOT COMPLETED|Overall Study||1
62158|NCT02342418|151712|P1|NOT COMPLETED|Overall Study||0
62159|NCT02342418|151711|P2|COMPLETED|Overall Study||9
62160|NCT02342418|151712|P1|COMPLETED|Overall Study||9
62161|NCT02342418|151711|P2|STARTED|Overall Study||10
62162|NCT02342418|151712|P1|STARTED|Overall Study||9
62163|NCT02342314|151722|P17|NOT COMPLETED|Part B||0
62164|NCT02342314|151723|P16|NOT COMPLETED|Part B||0
62165|NCT02342314|151724|P15|NOT COMPLETED|Part B||0
62166|NCT02342314|151725|P14|NOT COMPLETED|Part B||0
62167|NCT02342314|151726|P13|NOT COMPLETED|Part B||0
62168|NCT02342314|151727|P12|NOT COMPLETED|Part B||0
62169|NCT02342314|151728|P11|NOT COMPLETED|Part B||0
62170|NCT02342314|151729|P10|NOT COMPLETED|Part B||0
62171|NCT02342314|151730|P9|NOT COMPLETED|Part B||0
62172|NCT02342314|151731|P8|NOT COMPLETED|Part B||0
62173|NCT02342314|151732|P7|NOT COMPLETED|Part B||0
62174|NCT02342314|151733|P6|NOT COMPLETED|Part B||0
62175|NCT02342314|151734|P5|NOT COMPLETED|Part B||0
62176|NCT02342314|151735|P4|NOT COMPLETED|Part B||0
62177|NCT02342314|151736|P3|NOT COMPLETED|Part B||0
62178|NCT02342314|151737|P2|NOT COMPLETED|Part B||0
62179|NCT02342314|151738|P1|NOT COMPLETED|Part B||0
62180|NCT02342314|151722|P17|COMPLETED|Part B||6
62181|NCT02342314|151723|P16|COMPLETED|Part B||3
62182|NCT02342314|151724|P15|COMPLETED|Part B||3
62183|NCT02342314|151725|P14|COMPLETED|Part B||3
62184|NCT02342314|151726|P13|COMPLETED|Part B||3
62185|NCT02342314|151727|P12|COMPLETED|Part B||3
62186|NCT02342314|151728|P11|COMPLETED|Part B||3
62187|NCT02342314|151729|P10|COMPLETED|Part B||3
62188|NCT02342314|151730|P9|COMPLETED|Part B||3
62189|NCT02342314|151731|P8|COMPLETED|Part B||3
62190|NCT02342314|151732|P7|COMPLETED|Part B||11
62191|NCT02342314|151733|P6|COMPLETED|Part B||0
62192|NCT02342314|151734|P5|COMPLETED|Part B||0
62193|NCT02342314|151735|P4|COMPLETED|Part B||0
62194|NCT02342314|151736|P3|COMPLETED|Part B||0
62195|NCT02342314|151737|P2|COMPLETED|Part B||0
62196|NCT02342314|151738|P1|COMPLETED|Part B||0
62197|NCT02342314|151722|P17|STARTED|Part B|Participants received rGlucagon in Part B.|6
62198|NCT02342314|151723|P16|STARTED|Part B|Participants received LY3185643 in Part B.|3
62199|NCT02342314|151724|P15|STARTED|Part B|Participants received LY3185643 in Part B.|3
62200|NCT02342314|151725|P14|STARTED|Part B|Participants received LY3185643 in Part B.|3
62201|NCT02342314|151726|P13|STARTED|Part B|Participants received LY3185643 in Part B.|3
62202|NCT02342314|151727|P12|STARTED|Part B|Participants received LY3185643 in Part B.|3
62203|NCT02342314|151728|P11|STARTED|Part B|Participants received LY3185643 in Part B.|3
62204|NCT02342314|151729|P10|STARTED|Part B|Participants received LY3185643 in Part B.|3
62205|NCT02342314|151730|P9|STARTED|Part B|Participants received LY3185643 in Part B.|3
62206|NCT02342314|151731|P8|STARTED|Part B|Participants received LY3185643 in Part B.|3
62207|NCT02342314|151732|P7|STARTED|Part B|Participants received placebo in Part B.|11
62208|NCT02342314|151733|P6|STARTED|Part B|Participants received LY3143753 in Part A.|0
62209|NCT02342314|151734|P5|STARTED|Part B|Participants received LY3143753 in Part A.|0
62210|NCT02342314|151735|P4|STARTED|Part B|Participants received LY3143753 in Part A.|0
62211|NCT02342314|151736|P3|STARTED|Part B|Participants received LY3143753 in Part A.|0
62212|NCT02342314|151737|P2|STARTED|Part B|Participants received LY3143753 in Part A.|0
62213|NCT02342314|151738|P1|STARTED|Part B|Participants received placebo in Part A.|0
62214|NCT02342314|151722|P17|NOT COMPLETED|Part A||0
62215|NCT02342314|151723|P16|NOT COMPLETED|Part A||0
62216|NCT02342314|151724|P15|NOT COMPLETED|Part A||0
62217|NCT02342314|151725|P14|NOT COMPLETED|Part A||0
62218|NCT02342314|151726|P13|NOT COMPLETED|Part A||0
62219|NCT02342314|151727|P12|NOT COMPLETED|Part A||0
62220|NCT02342314|151728|P11|NOT COMPLETED|Part A||0
62221|NCT02342314|151729|P10|NOT COMPLETED|Part A||0
62222|NCT02342314|151730|P9|NOT COMPLETED|Part A||0
62223|NCT02342314|151731|P8|NOT COMPLETED|Part A||0
62224|NCT02342314|151732|P7|NOT COMPLETED|Part A||0
62225|NCT02342314|151733|P6|NOT COMPLETED|Part A||0
62226|NCT02342314|151734|P5|NOT COMPLETED|Part A||0
62227|NCT02342314|151735|P4|NOT COMPLETED|Part A||0
62228|NCT02342314|151736|P3|NOT COMPLETED|Part A||0
62229|NCT02342314|151737|P2|NOT COMPLETED|Part A||0
62230|NCT02342314|151738|P1|NOT COMPLETED|Part A||0
62231|NCT02342314|151722|P17|COMPLETED|Part A||0
62232|NCT02342314|151723|P16|COMPLETED|Part A||0
62233|NCT02342314|151724|P15|COMPLETED|Part A||0
62234|NCT02342314|151725|P14|COMPLETED|Part A||0
62235|NCT02342314|151726|P13|COMPLETED|Part A||0
62236|NCT02342314|151727|P12|COMPLETED|Part A||0
62237|NCT02342314|151728|P11|COMPLETED|Part A||0
62238|NCT02342314|151729|P10|COMPLETED|Part A||0
62239|NCT02342314|151730|P9|COMPLETED|Part A||0
62240|NCT02342314|151731|P8|COMPLETED|Part A||0
62241|NCT02342314|151732|P7|COMPLETED|Part A||0
62242|NCT02342314|151733|P6|COMPLETED|Part A||3
62243|NCT02342314|151734|P5|COMPLETED|Part A||6
62244|NCT02342314|151735|P4|COMPLETED|Part A||3
62245|NCT02342314|151736|P3|COMPLETED|Part A||3
62246|NCT02342314|151737|P2|COMPLETED|Part A||3
62247|NCT02342314|151738|P1|COMPLETED|Part A||6
62248|NCT02342314|151722|P17|STARTED|Part A||0
62249|NCT02342314|151723|P16|STARTED|Part A||0
62250|NCT02342314|151724|P15|STARTED|Part A||0
62251|NCT02342314|151725|P14|STARTED|Part A||0
62252|NCT02342314|151726|P13|STARTED|Part A||0
62253|NCT02342314|151727|P12|STARTED|Part A||0
62254|NCT02342314|151728|P11|STARTED|Part A||0
62255|NCT02342314|151729|P10|STARTED|Part A||0
62256|NCT02342314|151730|P9|STARTED|Part A||0
62257|NCT02342314|151731|P8|STARTED|Part A||0
62258|NCT02342314|151732|P7|STARTED|Part A||0
62259|NCT02342314|151733|P6|STARTED|Part A||3
62260|NCT02342314|151734|P5|STARTED|Part A||6
62261|NCT02342314|151735|P4|STARTED|Part A||3
62262|NCT02342314|151736|P3|STARTED|Part A||3
62263|NCT02342314|151737|P2|STARTED|Part A||3
62264|NCT02342314|151738|P1|STARTED|Part A||6
62265|NCT02342288|151886|P2|NOT COMPLETED|Overall Study||6
62266|NCT02342288|151887|P1|NOT COMPLETED|Overall Study||5
62267|NCT02342288|151886|P2|COMPLETED|Overall Study||27
62268|NCT02342288|151887|P1|COMPLETED|Overall Study||25
62269|NCT02342288|151886|P2|STARTED|Overall Study|various issues listed below caused removal of subjects|33
62270|NCT02342288|151887|P1|STARTED|Overall Study|16 patients were not randomized to either arm.|30
62271|NCT02342223|151893|P1|NOT COMPLETED|Overall Study||1
62272|NCT02342223|151893|P1|COMPLETED|Overall Study||19
62273|NCT02342223|151893|P1|STARTED|Overall Study||20
62274|NCT02342197|151904|P2|NOT COMPLETED|Overall Study||2
62275|NCT02342197|151905|P1|NOT COMPLETED|Overall Study||3
62276|NCT02342197|151904|P2|COMPLETED|Overall Study||28
62277|NCT02342197|151905|P1|COMPLETED|Overall Study||27
62278|NCT02342197|151904|P2|STARTED|Overall Study||30
62279|NCT02342197|151905|P1|STARTED|Overall Study||30
62280|NCT02342171|151913|P2|NOT COMPLETED|Overall Study||89
62281|NCT02342171|151914|P1|NOT COMPLETED|Overall Study||15
62282|NCT02342171|151913|P2|COMPLETED|Overall Study||418
62283|NCT02342171|151914|P1|COMPLETED|Overall Study||84
62284|NCT02342171|151913|P2|STARTED|Overall Study||507
62285|NCT02342171|151914|P1|STARTED|Overall Study||99
62286|NCT02341859|151930|P2|NOT COMPLETED|Second Intervention (1 Day)||0
62287|NCT02341859|151931|P1|NOT COMPLETED|Second Intervention (1 Day)||0
62288|NCT02341859|151930|P2|COMPLETED|Second Intervention (1 Day)||9
62289|NCT02341859|151931|P1|COMPLETED|Second Intervention (1 Day)||10
62290|NCT02341859|151930|P2|STARTED|Second Intervention (1 Day)||9
62291|NCT02341859|151931|P1|STARTED|Second Intervention (1 Day)||10
62292|NCT02341859|151930|P2|NOT COMPLETED|First Intervention (1 Day)||0
62293|NCT02341859|151931|P1|NOT COMPLETED|First Intervention (1 Day)||0
62294|NCT02341859|151930|P2|COMPLETED|First Intervention (1 Day)||9
62295|NCT02341859|151931|P1|COMPLETED|First Intervention (1 Day)||10
62296|NCT02341859|151930|P2|STARTED|First Intervention (1 Day)||9
62297|NCT02341859|151931|P1|STARTED|First Intervention (1 Day)||10
62298|NCT02341599|152089|P5|NOT COMPLETED|Overall Study||0
62299|NCT02341599|152090|P4|NOT COMPLETED|Overall Study||0
62300|NCT02341599|152091|P3|NOT COMPLETED|Overall Study||0
62301|NCT02341599|152092|P2|NOT COMPLETED|Overall Study||0
62302|NCT02341599|152093|P1|NOT COMPLETED|Overall Study||0
62303|NCT02341599|152089|P5|COMPLETED|Overall Study||8
62304|NCT02341599|152090|P4|COMPLETED|Overall Study||8
62305|NCT02341599|152091|P3|COMPLETED|Overall Study||8
62306|NCT02341599|152092|P2|COMPLETED|Overall Study||8
62307|NCT02341599|152093|P1|COMPLETED|Overall Study||8
62308|NCT02341599|152089|P5|STARTED|Overall Study||8
62309|NCT02341599|152090|P4|STARTED|Overall Study||8
62310|NCT02341599|152091|P3|STARTED|Overall Study||8
62311|NCT02341599|152092|P2|STARTED|Overall Study||8
62312|NCT02341599|152093|P1|STARTED|Overall Study||8
62313|NCT02341482|152161|P1|NOT COMPLETED|Overall Study||1
62314|NCT02341482|152161|P1|COMPLETED|Overall Study||12
62315|NCT02341482|152161|P1|STARTED|Overall Study||13
62316|NCT02341456|152190|P3|NOT COMPLETED|Overall Study||4
62317|NCT02341456|152191|P2|NOT COMPLETED|Overall Study||6
62318|NCT02341456|152192|P1|NOT COMPLETED|Overall Study||4
62319|NCT02341456|152190|P3|COMPLETED|Overall Study||2
62320|NCT02341456|152191|P2|COMPLETED|Overall Study||0
62321|NCT02341456|152192|P1|COMPLETED|Overall Study||3
62322|NCT02341456|152190|P3|STARTED|Overall Study||6
62323|NCT02341456|152191|P2|STARTED|Overall Study||6
62324|NCT02341456|152192|P1|STARTED|Overall Study||7
62325|NCT02341417|152317|P3|NOT COMPLETED|Overall Study||1
62326|NCT02341417|152318|P2|NOT COMPLETED|Overall Study||2
62327|NCT02341417|152319|P1|NOT COMPLETED|Overall Study||2
62328|NCT02341417|152317|P3|COMPLETED|Overall Study||0
62329|NCT02341417|152318|P2|COMPLETED|Overall Study||12
62330|NCT02341417|152319|P1|COMPLETED|Overall Study||11
62331|NCT02341417|152317|P3|STARTED|Overall Study||1
62332|NCT02341417|152318|P2|STARTED|Overall Study||14
62333|NCT02341417|152319|P1|STARTED|Overall Study||13
62334|NCT02341144|152363|P2|NOT COMPLETED|Overall Study||1
62335|NCT02341144|152364|P1|NOT COMPLETED|Overall Study||2
62336|NCT02341144|152363|P2|COMPLETED|Overall Study||30
62337|NCT02341144|152364|P1|COMPLETED|Overall Study||28
62338|NCT02341144|152363|P2|STARTED|Overall Study||31
62339|NCT02341144|152364|P1|STARTED|Overall Study||30
62340|NCT02340962|152380|P2|NOT COMPLETED|Overall Study||0
62341|NCT02340962|152381|P1|NOT COMPLETED|Overall Study||1
62342|NCT02340962|152380|P2|COMPLETED|Overall Study||12
62343|NCT02340962|152381|P1|COMPLETED|Overall Study||12
62344|NCT02340962|152380|P2|STARTED|Overall Study||12
62345|NCT02340962|152381|P1|STARTED|Overall Study||13
62346|NCT02340819|152401|P1|NOT COMPLETED|Overall Study||4
62347|NCT02340819|152401|P1|COMPLETED|Overall Study||7
62348|NCT02340819|152401|P1|Completed Stage 4|Overall Study||7
62349|NCT02340819|152401|P1|Started Stage 4|Overall Study||7
62350|NCT02340819|152401|P1|Completed Stage 3|Overall Study||7
62351|NCT02340819|152401|P1|Started Stage 3|Overall Study||8
62352|NCT02340819|152401|P1|Completed Stage 2|Overall Study||9
62353|NCT02340819|152401|P1|Started Stage 2|Overall Study||11
62354|NCT02340819|152401|P1|STARTED|Overall Study||11
62355|NCT02340806|152430|P2|NOT COMPLETED|Overall Study||4
62356|NCT02340806|152431|P1|NOT COMPLETED|Overall Study||6
62357|NCT02340806|152430|P2|COMPLETED|Overall Study||108
62358|NCT02340806|152431|P1|COMPLETED|Overall Study||102
62359|NCT02340806|152430|P2|STARTED|Overall Study||112
62360|NCT02340806|152431|P1|STARTED|Overall Study||108
62361|NCT02340780|152457|P1|NOT COMPLETED|Overall Study||1
62362|NCT02340780|152457|P1|COMPLETED|Overall Study||13
62363|NCT02340780|152457|P1|STARTED|Overall Study||14
62364|NCT02340767|152471|P9|NOT COMPLETED|Overall Study||0
62365|NCT02340767|152472|P8|NOT COMPLETED|Overall Study||0
62366|NCT02340767|152473|P7|NOT COMPLETED|Overall Study||0
62367|NCT02340767|152474|P6|NOT COMPLETED|Overall Study||0
62368|NCT02340767|152475|P5|NOT COMPLETED|Overall Study||0
62369|NCT02340767|152476|P4|NOT COMPLETED|Overall Study||0
62370|NCT02340767|152477|P3|NOT COMPLETED|Overall Study||0
62371|NCT02340767|152478|P2|NOT COMPLETED|Overall Study||0
62372|NCT02340767|152479|P1|NOT COMPLETED|Overall Study||0
62373|NCT02340767|152471|P9|COMPLETED|Overall Study||531
62374|NCT02340767|152472|P8|COMPLETED|Overall Study||444
62375|NCT02340767|152473|P7|COMPLETED|Overall Study||525
62376|NCT02340767|152474|P6|COMPLETED|Overall Study||526
62377|NCT02340767|152475|P5|COMPLETED|Overall Study||474
62378|NCT02340767|152476|P4|COMPLETED|Overall Study||500
62379|NCT02340767|152477|P3|COMPLETED|Overall Study||29
62380|NCT02340767|152478|P2|COMPLETED|Overall Study||28
62381|NCT02340767|152479|P1|COMPLETED|Overall Study||28
62382|NCT02340767|152471|P9|STARTED|Overall Study||531
62383|NCT02340767|152472|P8|STARTED|Overall Study||444
62384|NCT02340767|152473|P7|STARTED|Overall Study||525
62385|NCT02340767|152474|P6|STARTED|Overall Study||526
62386|NCT02340767|152475|P5|STARTED|Overall Study||474
62387|NCT02340767|152476|P4|STARTED|Overall Study||500
62388|NCT02340767|152477|P3|STARTED|Overall Study||29
62389|NCT02340767|152478|P2|STARTED|Overall Study||28
62390|NCT02340767|152479|P1|STARTED|Overall Study||28
62391|NCT02340715|152495|P1|NOT COMPLETED|Overall Study||0
62392|NCT02340715|152495|P1|COMPLETED|Overall Study|158|158
62393|NCT02340715|152495|P1|STARTED|Overall Study|158|158
62394|NCT02340676|152499|P1|NOT COMPLETED|Overall Study||0
62395|NCT02340676|152499|P1|COMPLETED|Overall Study||25
62396|NCT02340676|152499|P1|STARTED|Overall Study||25
62397|NCT02340663|152512|P2|NOT COMPLETED|Overall Study||1
62398|NCT02340663|152513|P1|NOT COMPLETED|Overall Study||5
62399|NCT02340663|152512|P2|COMPLETED|Overall Study||31
62400|NCT02340663|152513|P1|COMPLETED|Overall Study||30
62401|NCT02340663|152512|P2|4 Month Follow-up, Assessments|Overall Study||31
62402|NCT02340663|152513|P1|4 Month Follow-up, Assessments|Overall Study||30
62403|NCT02340663|152512|P2|1 Week Follow-up, Assessments|Overall Study||31
62404|NCT02340663|152513|P1|1 Week Follow-up, Assessments|Overall Study||33
62405|NCT02340663|152512|P2|Splint Delivery, Assessments|Overall Study||31
62406|NCT02340663|152513|P1|Splint Delivery, Assessments|Overall Study||33
62407|NCT02340663|152512|P2|Clinical Exam, Impressions|Overall Study||32
62408|NCT02340663|152513|P1|Clinical Exam, Impressions|Overall Study||35
62409|NCT02340663|152512|P2|STARTED|Overall Study||32
62410|NCT02340663|152513|P1|STARTED|Overall Study||35
62411|NCT02340520|152569|P1|NOT COMPLETED|Overall Study||3
62412|NCT02340520|152569|P1|COMPLETED|Overall Study||8
62413|NCT02340520|152569|P1|STARTED|Overall Study||11
62414|NCT02340338|152581|P7|NOT COMPLETED|Overall Study||0
62415|NCT02340338|152582|P6|NOT COMPLETED|Overall Study||0
62416|NCT02340338|152583|P5|NOT COMPLETED|Overall Study||0
62417|NCT02340338|152584|P4|NOT COMPLETED|Overall Study||0
62418|NCT02340338|152585|P3|NOT COMPLETED|Overall Study||0
62419|NCT02340338|152586|P2|NOT COMPLETED|Overall Study||0
62420|NCT02340338|152587|P1|NOT COMPLETED|Overall Study||0
62421|NCT02340338|152581|P7|COMPLETED|Overall Study||12
62422|NCT02340338|152582|P6|COMPLETED|Overall Study|1 withdrew voluntarily after the first immunization; safety and serum assessment completed.|9
62423|NCT02340338|152583|P5|COMPLETED|Overall Study||9
62424|NCT02340338|152584|P4|COMPLETED|Overall Study||9
62425|NCT02340338|152585|P3|COMPLETED|Overall Study||3
62426|NCT02340338|152586|P2|COMPLETED|Overall Study||2
62427|NCT02340338|152587|P1|COMPLETED|Overall Study||2
62428|NCT02340338|152581|P7|STARTED|Overall Study|Placebos were randomly assigned to dose groups 1-6, included in the 46 participants.|12
62429|NCT02340338|152582|P6|STARTED|Overall Study|9 vaccine + 3 placebo|9
62430|NCT02340338|152583|P5|STARTED|Overall Study|9 vaccine + 3 placebo|9
62431|NCT02340338|152584|P4|STARTED|Overall Study|9 vaccine + 3 placebo|9
62432|NCT02340338|152585|P3|STARTED|Overall Study|3 vaccine + 1 placebo|3
62433|NCT02340338|152586|P2|STARTED|Overall Study|2 vaccine + 1 placebo|2
62434|NCT02340338|152587|P1|STARTED|Overall Study|2 vaccine + 1 placebo|2
62435|NCT02340221|152612|P2|NOT COMPLETED|Overall Study||417
62436|NCT02340221|152613|P1|NOT COMPLETED|Overall Study||214
62437|NCT02340221|152612|P2|COMPLETED|Overall Study||0
62438|NCT02340221|152613|P1|COMPLETED|Overall Study||0
62439|NCT02340221|152612|P2|STARTED|Overall Study||417
62440|NCT02340221|152613|P1|STARTED|Overall Study||214
62441|NCT02340104|152637|P1|NOT COMPLETED|Overall Study||0
62442|NCT02340104|152637|P1|COMPLETED|Overall Study||8
62443|NCT02340104|152637|P1|STARTED|Overall Study||8
62444|NCT02340091|152642|P1|NOT COMPLETED|Overall Study||2
62445|NCT02340091|152642|P1|COMPLETED|Overall Study||60
62446|NCT02340091|152642|P1|STARTED|Overall Study|All Study Participants|62
62447|NCT02340078|152647|P1|NOT COMPLETED|Overall Study||1
62448|NCT02340078|152647|P1|COMPLETED|Overall Study||61
62449|NCT02340078|152647|P1|STARTED|Overall Study||62
62450|NCT02340000|152654|P2|NOT COMPLETED|Time Period 2||15
62451|NCT02340000|152655|P1|NOT COMPLETED|Time Period 2||19
62452|NCT02340000|152654|P2|COMPLETED|Time Period 2||52
62453|NCT02340000|152655|P1|COMPLETED|Time Period 2||50
62454|NCT02340000|152654|P2|STARTED|Time Period 2||67
62455|NCT02340000|152655|P1|STARTED|Time Period 2||69
62456|NCT02340000|152654|P2|NOT COMPLETED|Time Period 1||15
62457|NCT02340000|152655|P1|NOT COMPLETED|Time Period 1||12
62458|NCT02340000|152654|P2|COMPLETED|Time Period 1||74
62459|NCT02340000|152655|P1|COMPLETED|Time Period 1||78
62460|NCT02340000|152654|P2|STARTED|Time Period 1||89
62461|NCT02340000|152655|P1|STARTED|Time Period 1||90
62462|NCT02339909|152685|P3|NOT COMPLETED|Overall Study||71
62463|NCT02339909|152686|P2|NOT COMPLETED|Overall Study||63
62464|NCT02339909|152687|P1|NOT COMPLETED|Overall Study||89
62465|NCT02339909|152685|P3|COMPLETED|Overall Study||304
62466|NCT02339909|152686|P2|COMPLETED|Overall Study||312
62467|NCT02339909|152687|P1|COMPLETED|Overall Study||435
62468|NCT02339909|152685|P3|STARTED|Overall Study||375
62469|NCT02339909|152686|P2|STARTED|Overall Study||375
62470|NCT02339909|152687|P1|STARTED|Overall Study||524
62471|NCT02339831|152700|P2|NOT COMPLETED|Overall Study||7
62472|NCT02339831|152701|P1|NOT COMPLETED|Overall Study||20
62473|NCT02339831|152700|P2|COMPLETED|Overall Study||45
62474|NCT02339831|152701|P1|COMPLETED|Overall Study||38
62475|NCT02339831|152700|P2|Lost to Follow Up|Overall Study||7
62476|NCT02339831|152701|P1|Lost to Follow Up|Overall Study||20
62477|NCT02339831|152700|P2|STARTED|Overall Study||52
62478|NCT02339831|152701|P1|STARTED|Overall Study||58
62479|NCT02339584|152725|P2|NOT COMPLETED|Overall Study||15
62480|NCT02339584|152726|P1|NOT COMPLETED|Overall Study||15
62481|NCT02339584|152725|P2|COMPLETED|Overall Study||176
62482|NCT02339584|152726|P1|COMPLETED|Overall Study||173
62483|NCT02339584|152725|P2|STARTED|Overall Study||191
62484|NCT02339584|152726|P1|STARTED|Overall Study||188
62485|NCT02339558|152732|P1|NOT COMPLETED|Overall Study||0
62486|NCT02339558|152732|P1|COMPLETED|Overall Study||45
62487|NCT02339558|152732|P1|STARTED|Overall Study||45
62488|NCT02339545|152741|P1|NOT COMPLETED|Overall Study||0
62489|NCT02339545|152741|P1|COMPLETED|Overall Study||15
62490|NCT02339545|152741|P1|STARTED|Overall Study||15
62491|NCT02339506|152746|P2|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
62492|NCT02339506|152747|P1|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
62493|NCT02339506|152746|P2|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
62494|NCT02339506|152747|P1|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
62495|NCT02339506|152746|P2|STARTED|Period 3 (Placebo or Cosyntropin)||10
62496|NCT02339506|152747|P1|STARTED|Period 3 (Placebo or Cosyntropin)||10
62497|NCT02339506|152746|P2|NOT COMPLETED|Washout (Period 2)||0
62498|NCT02339506|152747|P1|NOT COMPLETED|Washout (Period 2)||2
62499|NCT02339506|152746|P2|COMPLETED|Washout (Period 2)||10
62500|NCT02339506|152747|P1|COMPLETED|Washout (Period 2)||10
62501|NCT02339506|152746|P2|STARTED|Washout (Period 2)||10
62502|NCT02339506|152747|P1|STARTED|Washout (Period 2)||12
62503|NCT02339506|152746|P2|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||1
62504|NCT02339506|152747|P1|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||0
62505|NCT02339506|152746|P2|COMPLETED|Period 1 (Placebo or Cosyntropin)||10
62506|NCT02339506|152747|P1|COMPLETED|Period 1 (Placebo or Cosyntropin)||12
62507|NCT02339506|152746|P2|STARTED|Period 1 (Placebo or Cosyntropin)||11
62508|NCT02339506|152747|P1|STARTED|Period 1 (Placebo or Cosyntropin)||12
62509|NCT02339415|152755|P2|NOT COMPLETED|Second Period||2
62510|NCT02339415|152756|P1|NOT COMPLETED|Second Period||1
62511|NCT02339415|152755|P2|COMPLETED|Second Period||18
62512|NCT02339415|152756|P1|COMPLETED|Second Period||19
62513|NCT02339415|152755|P2|STARTED|Second Period||20
62514|NCT02339415|152756|P1|STARTED|Second Period||20
62515|NCT02339415|152755|P2|NOT COMPLETED|Washout||0
62516|NCT02339415|152756|P1|NOT COMPLETED|Washout||0
62517|NCT02339415|152755|P2|COMPLETED|Washout||20
62518|NCT02339415|152756|P1|COMPLETED|Washout||20
62519|NCT02339415|152755|P2|STARTED|Washout||20
62520|NCT02339415|152756|P1|STARTED|Washout||20
62521|NCT02339415|152755|P2|NOT COMPLETED|First Period||2
62522|NCT02339415|152756|P1|NOT COMPLETED|First Period||2
62523|NCT02339415|152755|P2|COMPLETED|First Period||20
62524|NCT02339415|152756|P1|COMPLETED|First Period||20
62525|NCT02339415|152755|P2|Received at Least One Dose|First Period||20
62526|NCT02339415|152756|P1|Received at Least One Dose|First Period||21
62527|NCT02339415|152755|P2|STARTED|First Period||22
62528|NCT02339415|152756|P1|STARTED|First Period||22
62529|NCT02339389|152766|P1|NOT COMPLETED|Overall Study||16
62530|NCT02339389|152766|P1|COMPLETED|Overall Study||41
62531|NCT02339389|152766|P1|STARTED|Overall Study||57
62532|NCT02339285|152774|P3|NOT COMPLETED|Overall Study||2
62533|NCT02339285|152775|P2|NOT COMPLETED|Overall Study||3
62534|NCT02339285|152776|P1|NOT COMPLETED|Overall Study||1
62535|NCT02339285|152774|P3|COMPLETED|Overall Study||9
62536|NCT02339285|152775|P2|COMPLETED|Overall Study||8
62537|NCT02339285|152776|P1|COMPLETED|Overall Study||9
62538|NCT02339285|152774|P3|4 Week Follow-up Visit|Overall Study||9
62539|NCT02339285|152775|P2|4 Week Follow-up Visit|Overall Study||8
62540|NCT02339285|152776|P1|4 Week Follow-up Visit|Overall Study||9
62541|NCT02339285|152774|P3|2 Week Follow-up|Overall Study||10
62542|NCT02339285|152775|P2|2 Week Follow-up|Overall Study||10
62543|NCT02339285|152776|P1|2 Week Follow-up|Overall Study||9
62544|NCT02339285|152774|P3|Completed Intervention|Overall Study||10
62545|NCT02339285|152775|P2|Completed Intervention|Overall Study||10
62546|NCT02339285|152776|P1|Completed Intervention|Overall Study||10
62547|NCT02339285|152774|P3|STARTED|Overall Study||11
62548|NCT02339285|152775|P2|STARTED|Overall Study||11
62549|NCT02339285|152776|P1|STARTED|Overall Study||10
62550|NCT02339246|152804|P3|NOT COMPLETED|Third Period (7 Days)||0
62551|NCT02339246|152805|P2|NOT COMPLETED|Third Period (7 Days)||0
62552|NCT02339246|152806|P1|NOT COMPLETED|Third Period (7 Days)||0
62553|NCT02339246|152804|P3|COMPLETED|Third Period (7 Days)||0
62554|NCT02339246|152805|P2|COMPLETED|Third Period (7 Days)||16
62555|NCT02339246|152806|P1|COMPLETED|Third Period (7 Days)||15
62556|NCT02339246|152804|P3|STARTED|Third Period (7 Days)||0
62557|NCT02339246|152805|P2|STARTED|Third Period (7 Days)||16
62558|NCT02339246|152806|P1|STARTED|Third Period (7 Days)||15
62559|NCT02339246|152804|P3|NOT COMPLETED|Second Intervention (7 Days)||0
62560|NCT02339246|152805|P2|NOT COMPLETED|Second Intervention (7 Days)||0
62561|NCT02339246|152806|P1|NOT COMPLETED|Second Intervention (7 Days)||0
62562|NCT02339246|152804|P3|COMPLETED|Second Intervention (7 Days)||0
62563|NCT02339246|152805|P2|COMPLETED|Second Intervention (7 Days)||15
62564|NCT02339246|152806|P1|COMPLETED|Second Intervention (7 Days)||16
62565|NCT02339246|152804|P3|STARTED|Second Intervention (7 Days)||0
62566|NCT02339246|152805|P2|STARTED|Second Intervention (7 Days)||15
62567|NCT02339246|152806|P1|STARTED|Second Intervention (7 Days)||16
62568|NCT02339246|152804|P3|NOT COMPLETED|First Intervention (7 Days)||0
62569|NCT02339246|152805|P2|NOT COMPLETED|First Intervention (7 Days)||0
62570|NCT02339246|152806|P1|NOT COMPLETED|First Intervention (7 Days)||0
62571|NCT02339246|152804|P3|COMPLETED|First Intervention (7 Days)||31
62572|NCT02339246|152805|P2|COMPLETED|First Intervention (7 Days)||0
62573|NCT02339246|152806|P1|COMPLETED|First Intervention (7 Days)||0
62574|NCT02339246|152804|P3|STARTED|First Intervention (7 Days)||31
62575|NCT02339246|152805|P2|STARTED|First Intervention (7 Days)||0
62576|NCT02339246|152806|P1|STARTED|First Intervention (7 Days)||0
62577|NCT02339155|152822|P2|NOT COMPLETED|Overall Study||21
62578|NCT02339155|152823|P1|NOT COMPLETED|Overall Study||15
62579|NCT02339155|152822|P2|COMPLETED|Overall Study||266
62580|NCT02339155|152823|P1|COMPLETED|Overall Study||271
62581|NCT02339155|152822|P2|Received Study Treatment|Overall Study||281
62582|NCT02339155|152823|P1|Received Study Treatment|Overall Study||285
62583|NCT02339155|152822|P2|STARTED|Overall Study||287
62584|NCT02339155|152823|P1|STARTED|Overall Study||286
62585|NCT02339038|152849|P1|NOT COMPLETED|Overall Study||600
62586|NCT02339038|152849|P1|COMPLETED|Overall Study||0
62587|NCT02339038|152849|P1|STARTED|Overall Study||600
62588|NCT02338973|152853|P1|NOT COMPLETED|Overall Study||0
62589|NCT02338973|152853|P1|COMPLETED|Overall Study||4
62590|NCT02338973|152853|P1|Enhanced S-Cone Syndrome (ESCS)|Overall Study||2
62591|NCT02338973|152853|P1|Rod-cone Dystrophy (RCD)|Overall Study||2
62592|NCT02338973|152853|P1|STARTED|Overall Study||4
62593|NCT02338882|153029|P2|NOT COMPLETED|Overall Study||3
62594|NCT02338882|153030|P1|NOT COMPLETED|Overall Study||7
62595|NCT02338882|153029|P2|COMPLETED|Overall Study||47
62596|NCT02338882|153030|P1|COMPLETED|Overall Study||43
62597|NCT02338882|153029|P2|STARTED|Overall Study||50
62598|NCT02338882|153030|P1|STARTED|Overall Study||50
62599|NCT02338843|153068|P2|NOT COMPLETED|Overall Study||58
62600|NCT02338843|153069|P1|NOT COMPLETED|Overall Study||44
62601|NCT02338843|153068|P2|COMPLETED|Overall Study||100
62602|NCT02338843|153069|P1|COMPLETED|Overall Study||119
62603|NCT02338843|153068|P2|STARTED|Overall Study||158
62604|NCT02338843|153069|P1|STARTED|Overall Study||163
62605|NCT02338713|153075|P1|NOT COMPLETED|Overall Study||0
62606|NCT02338713|153075|P1|COMPLETED|Overall Study||27
62607|NCT02338713|153075|P1|STARTED|Overall Study||27
62608|NCT02338492|153097|P1|NOT COMPLETED|Overall Study||45
62609|NCT02338492|153097|P1|COMPLETED|Overall Study||36
62610|NCT02338492|153097|P1|Treatment Failure|Overall Study||2
62611|NCT02338492|153097|P1|Device Implanted|Overall Study||79
62612|NCT02338492|153097|P1|Enrolled|Overall Study||81
62613|NCT02338492|153097|P1|STARTED|Overall Study||81
62614|NCT02338362|153113|P2|NOT COMPLETED|Overall Study||1
62615|NCT02338362|153114|P1|NOT COMPLETED|Overall Study||1
62616|NCT02338362|153113|P2|COMPLETED|Overall Study||10
62617|NCT02338362|153114|P1|COMPLETED|Overall Study||10
62618|NCT02338362|153113|P2|STARTED|Overall Study||11
62619|NCT02338362|153114|P1|STARTED|Overall Study||11
62620|NCT02338336|153130|P4|NOT COMPLETED|Overall Study||0
62621|NCT02338336|153131|P3|NOT COMPLETED|Overall Study||0
62622|NCT02338336|153132|P2|NOT COMPLETED|Overall Study||0
62623|NCT02338336|153133|P1|NOT COMPLETED|Overall Study||2
62624|NCT02338336|153130|P4|COMPLETED|Overall Study||4
62625|NCT02338336|153131|P3|COMPLETED|Overall Study||7
62626|NCT02338336|153132|P2|COMPLETED|Overall Study||17
62627|NCT02338336|153133|P1|COMPLETED|Overall Study||24
62628|NCT02338336|153130|P4|STARTED|Overall Study||4
62629|NCT02338336|153131|P3|STARTED|Overall Study||7
62630|NCT02338336|153132|P2|STARTED|Overall Study||17
62631|NCT02338336|153133|P1|STARTED|Overall Study||26
62632|NCT02338193|153144|P3|NOT COMPLETED|Overall Study||10
62633|NCT02338193|153145|P2|NOT COMPLETED|Overall Study||4
62634|NCT02338193|153146|P1|NOT COMPLETED|Overall Study||3
62635|NCT02338193|153144|P3|COMPLETED|Overall Study||15
62636|NCT02338193|153145|P2|COMPLETED|Overall Study||17
62637|NCT02338193|153146|P1|COMPLETED|Overall Study||17
62638|NCT02338193|153144|P3|STARTED|Overall Study||25
62639|NCT02338193|153145|P2|STARTED|Overall Study||21
62640|NCT02338193|153146|P1|STARTED|Overall Study||20
62641|NCT02338154|153199|P1|NOT COMPLETED|Overall Study||143
62642|NCT02338154|153199|P1|COMPLETED|Overall Study||373
62643|NCT02338154|153199|P1|INTUITY (Study Valve Cohort)|Overall Study||493
62644|NCT02338154|153199|P1|Enrolled Cohort (Intent to Treat)|Overall Study||516
62645|NCT02338154|153199|P1|STARTED|Overall Study||516
62646|NCT02338076|153295|P1|NOT COMPLETED|Overall Study||0
62647|NCT02338076|153295|P1|COMPLETED|Overall Study||20
62648|NCT02338076|153295|P1|STARTED|Overall Study||20
62649|NCT02337959|153313|P3|NOT COMPLETED|Overall Study||0
62650|NCT02337959|153314|P2|NOT COMPLETED|Overall Study||3
62651|NCT02337959|153315|P1|NOT COMPLETED|Overall Study||0
62652|NCT02337959|153313|P3|COMPLETED|Overall Study||7
62653|NCT02337959|153314|P2|COMPLETED|Overall Study||7
62654|NCT02337959|153315|P1|COMPLETED|Overall Study||10
62655|NCT02337959|153313|P3|STARTED|Overall Study||7
62656|NCT02337959|153314|P2|STARTED|Overall Study||10
62657|NCT02337959|153315|P1|STARTED|Overall Study||10
62658|NCT02337946|153323|P3|NOT COMPLETED|Protocol Treatment 2 Period||50
62659|NCT02337946|153324|P2|NOT COMPLETED|Protocol Treatment 2 Period||51
62660|NCT02337946|153325|P1|NOT COMPLETED|Protocol Treatment 2 Period||0
62661|NCT02337946|153323|P3|COMPLETED|Protocol Treatment 2 Period||7
62662|NCT02337946|153324|P2|COMPLETED|Protocol Treatment 2 Period||5
62663|NCT02337946|153325|P1|COMPLETED|Protocol Treatment 2 Period||0
62664|NCT02337946|153323|P3|Safety Population|Protocol Treatment 2 Period||54
62665|NCT02337946|153324|P2|Safety Population|Protocol Treatment 2 Period||56
62666|NCT02337946|153325|P1|Safety Population|Protocol Treatment 2 Period||0
62667|NCT02337946|153323|P3|STARTED|Protocol Treatment 2 Period||57
62668|NCT02337946|153324|P2|STARTED|Protocol Treatment 2 Period||56
62669|NCT02337946|153325|P1|STARTED|Protocol Treatment 2 Period||0
62670|NCT02337946|153323|P3|NOT COMPLETED|In-between Period||0
62671|NCT02337946|153324|P2|NOT COMPLETED|In-between Period||0
62672|NCT02337946|153325|P1|NOT COMPLETED|In-between Period||1
62673|NCT02337946|153323|P3|COMPLETED|In-between Period||0
62674|NCT02337946|153324|P2|COMPLETED|In-between Period||0
62675|NCT02337946|153325|P1|COMPLETED|In-between Period||113
62676|NCT02337946|153323|P3|STARTED|In-between Period||0
62677|NCT02337946|153324|P2|STARTED|In-between Period||0
62678|NCT02337946|153325|P1|STARTED|In-between Period||114
62679|NCT02337946|153323|P3|NOT COMPLETED|Protocol Treatment 1 Period||0
62680|NCT02337946|153324|P2|NOT COMPLETED|Protocol Treatment 1 Period||0
62681|NCT02337946|153325|P1|NOT COMPLETED|Protocol Treatment 1 Period||50
62682|NCT02337946|153323|P3|COMPLETED|Protocol Treatment 1 Period||0
62683|NCT02337946|153324|P2|COMPLETED|Protocol Treatment 1 Period||0
62684|NCT02337946|153325|P1|COMPLETED|Protocol Treatment 1 Period||114
62685|NCT02337946|153323|P3|STARTED|Protocol Treatment 1 Period||0
62686|NCT02337946|153324|P2|STARTED|Protocol Treatment 1 Period||0
62687|NCT02337946|153325|P1|STARTED|Protocol Treatment 1 Period||164
62688|NCT02337907|153353|P6|NOT COMPLETED|Overall Study||1
62689|NCT02337907|153354|P5|NOT COMPLETED|Overall Study||10
62690|NCT02337907|153355|P4|NOT COMPLETED|Overall Study||4
62691|NCT02337907|153356|P3|NOT COMPLETED|Overall Study||1
62692|NCT02337907|153357|P2|NOT COMPLETED|Overall Study||4
62693|NCT02337907|153358|P1|NOT COMPLETED|Overall Study||4
62694|NCT02337907|153353|P6|COMPLETED|Overall Study||4
62695|NCT02337907|153354|P5|COMPLETED|Overall Study||96
62696|NCT02337907|153355|P4|COMPLETED|Overall Study||51
62697|NCT02337907|153356|P3|COMPLETED|Overall Study||54
62698|NCT02337907|153357|P2|COMPLETED|Overall Study||49
62699|NCT02337907|153358|P1|COMPLETED|Overall Study||51
62700|NCT02337907|153353|P6|STARTED|Overall Study||5
62701|NCT02337907|153354|P5|STARTED|Overall Study||106
62702|NCT02337907|153355|P4|STARTED|Overall Study||55
62703|NCT02337907|153356|P3|STARTED|Overall Study||55
62704|NCT02337907|153357|P2|STARTED|Overall Study||53
62705|NCT02337907|153358|P1|STARTED|Overall Study||55
62706|NCT02337764|153393|P1|NOT COMPLETED|Overall Study||60
62707|NCT02337764|153393|P1|COMPLETED|Overall Study||162
62708|NCT02337764|153393|P1|STARTED|Overall Study||222
62709|NCT02337751|153406|P2|NOT COMPLETED|Overall Study||16
62710|NCT02337751|153407|P1|NOT COMPLETED|Overall Study||11
62711|NCT02337751|153406|P2|COMPLETED|Overall Study||87
62712|NCT02337751|153407|P1|COMPLETED|Overall Study||84
62713|NCT02337751|153406|P2|STARTED|Overall Study||103
62714|NCT02337751|153407|P1|STARTED|Overall Study||95
62715|NCT02337738|153426|P3|NOT COMPLETED|Overall Study||26
62716|NCT02337738|153427|P2|NOT COMPLETED|Overall Study||30
62717|NCT02337738|153428|P1|NOT COMPLETED|Overall Study||22
62718|NCT02337738|153426|P3|COMPLETED|Overall Study||103
62719|NCT02337738|153427|P2|COMPLETED|Overall Study||104
62720|NCT02337738|153428|P1|COMPLETED|Overall Study||119
62721|NCT02337738|153426|P3|STARTED|Overall Study||129
62722|NCT02337738|153427|P2|STARTED|Overall Study||134
62723|NCT02337738|153428|P1|STARTED|Overall Study||141
62724|NCT02337725|153468|P2|NOT COMPLETED|Overall Study||8
62725|NCT02337725|153469|P1|NOT COMPLETED|Overall Study||26
62726|NCT02337725|153468|P2|COMPLETED|Overall Study||110
62727|NCT02337725|153469|P1|COMPLETED|Overall Study||100
62728|NCT02337725|153468|P2|STARTED|Overall Study||118
62729|NCT02337725|153469|P1|STARTED|Overall Study||126
62730|NCT02337491|153493|P2|NOT COMPLETED|Overall Study||30
62731|NCT02337491|153494|P1|NOT COMPLETED|Overall Study||50
62732|NCT02337491|153493|P2|COMPLETED|Overall Study||0
62733|NCT02337491|153494|P1|COMPLETED|Overall Study||0
62734|NCT02337491|153493|P2|STARTED|Overall Study||30
62735|NCT02337491|153494|P1|STARTED|Overall Study||50
62736|NCT02337478|153508|P1|NOT COMPLETED|Overall Study||5
62737|NCT02337478|153508|P1|COMPLETED|Overall Study||0
62738|NCT02337478|153508|P1|STARTED|Overall Study||5
62739|NCT02337387|153518|P4|NOT COMPLETED|Overall Study||3
62740|NCT02337387|153519|P3|NOT COMPLETED|Overall Study||3
62741|NCT02337387|153520|P2|NOT COMPLETED|Overall Study||8
62742|NCT02337387|153521|P1|NOT COMPLETED|Overall Study||14
62743|NCT02337387|153518|P4|COMPLETED|Overall Study||0
62744|NCT02337387|153519|P3|COMPLETED|Overall Study||0
62745|NCT02337387|153520|P2|COMPLETED|Overall Study||0
62746|NCT02337387|153521|P1|COMPLETED|Overall Study||0
62747|NCT02337387|153518|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
62748|NCT02337387|153519|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
62749|NCT02337387|153520|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
62750|NCT02337387|153521|P1|Received at Least 1 Dose of Study Drug|Overall Study||14
62751|NCT02337387|153518|P4|STARTED|Overall Study||3
62752|NCT02337387|153519|P3|STARTED|Overall Study||3
62753|NCT02337387|153520|P2|STARTED|Overall Study||8
62754|NCT02337387|153521|P1|STARTED|Overall Study||14
62755|NCT02337361|153539|P2|NOT COMPLETED|6-month Follow-up||4
62756|NCT02337361|153540|P1|NOT COMPLETED|6-month Follow-up||2
62757|NCT02337361|153539|P2|COMPLETED|6-month Follow-up||68
62758|NCT02337361|153540|P1|COMPLETED|6-month Follow-up||78
62759|NCT02337361|153539|P2|STARTED|6-month Follow-up||72
62760|NCT02337361|153540|P1|STARTED|6-month Follow-up||80
62761|NCT02337361|153539|P2|NOT COMPLETED|3-month Follow-up||14
62762|NCT02337361|153540|P1|NOT COMPLETED|3-month Follow-up||19
62763|NCT02337361|153539|P2|COMPLETED|3-month Follow-up||72
62764|NCT02337361|153540|P1|COMPLETED|3-month Follow-up||80
62765|NCT02337361|153539|P2|STARTED|3-month Follow-up||86
62766|NCT02337361|153540|P1|STARTED|3-month Follow-up||99
62767|NCT02337361|153539|P2|NOT COMPLETED|Baseline Assessment||0
62768|NCT02337361|153540|P1|NOT COMPLETED|Baseline Assessment||0
62769|NCT02337361|153539|P2|COMPLETED|Baseline Assessment||86
62770|NCT02337361|153540|P1|COMPLETED|Baseline Assessment||99
62771|NCT02337361|153539|P2|STARTED|Baseline Assessment||86
62772|NCT02337361|153540|P1|STARTED|Baseline Assessment||99
62773|NCT02337062|153560|P2|NOT COMPLETED|Overall Study||19
62774|NCT02337062|153561|P1|NOT COMPLETED|Overall Study||17
62775|NCT02337062|153560|P2|COMPLETED|Overall Study||556
62776|NCT02337062|153561|P1|COMPLETED|Overall Study||555
62777|NCT02337062|153560|P2|STARTED|Overall Study||575
62778|NCT02337062|153561|P1|STARTED|Overall Study||572
62779|NCT02336958|153579|P2|NOT COMPLETED|Overall Study||0
62780|NCT02336958|153580|P1|NOT COMPLETED|Overall Study||0
62781|NCT02336958|153579|P2|COMPLETED|Overall Study||20
62782|NCT02336958|153580|P1|COMPLETED|Overall Study||20
62783|NCT02336958|153579|P2|STARTED|Overall Study||20
62784|NCT02336958|153580|P1|STARTED|Overall Study||20
62785|NCT02336763|153588|P1|NOT COMPLETED|Overall Study||0
62786|NCT02336763|153588|P1|COMPLETED|Overall Study||2
62787|NCT02336763|153588|P1|STARTED|Overall Study||2
62788|NCT02336607|153602|P4|NOT COMPLETED|Overall Study||87
62789|NCT02336607|153603|P3|NOT COMPLETED|Overall Study||6
62790|NCT02336607|153604|P2|NOT COMPLETED|Overall Study||10
62791|NCT02336607|153605|P1|NOT COMPLETED|Overall Study||4
62792|NCT02336607|153602|P4|COMPLETED|Overall Study||180
62793|NCT02336607|153603|P3|COMPLETED|Overall Study||86
62794|NCT02336607|153604|P2|COMPLETED|Overall Study||75
62795|NCT02336607|153605|P1|COMPLETED|Overall Study||81
62796|NCT02336607|153602|P4|Patients Included in Safety Population|Overall Study||260
62797|NCT02336607|153603|P3|Patients Included in Safety Population|Overall Study||92
62798|NCT02336607|153604|P2|Patients Included in Safety Population|Overall Study||85
62799|NCT02336607|153605|P1|Patients Included in Safety Population|Overall Study||85
62800|NCT02336607|153602|P4|Patients Included in PP Population|Overall Study||162
62801|NCT02336607|153603|P3|Patients Included in PP Population|Overall Study||75
62802|NCT02336607|153604|P2|Patients Included in PP Population|Overall Study||75
62803|NCT02336607|153605|P1|Patients Included in PP Population|Overall Study||78
62804|NCT02336607|153602|P4|Patients Included in ITT Population|Overall Study||222
62805|NCT02336607|153603|P3|Patients Included in ITT Population|Overall Study||91
62806|NCT02336607|153604|P2|Patients Included in ITT Population|Overall Study||84
62807|NCT02336607|153605|P1|Patients Included in ITT Population|Overall Study||84
62808|NCT02336607|153602|P4|STARTED|Overall Study||267
62809|NCT02336607|153603|P3|STARTED|Overall Study||92
62810|NCT02336607|153604|P2|STARTED|Overall Study||85
62811|NCT02336607|153605|P1|STARTED|Overall Study||85
62812|NCT02336594|153663|P4|NOT COMPLETED|Overall Study||0
62813|NCT02336594|153664|P3|NOT COMPLETED|Overall Study||0
62814|NCT02336594|153665|P2|NOT COMPLETED|Overall Study||0
62815|NCT02336594|153666|P1|NOT COMPLETED|Overall Study||0
62816|NCT02336594|153663|P4|COMPLETED|Overall Study||4
62817|NCT02336594|153664|P3|COMPLETED|Overall Study||4
62818|NCT02336594|153665|P2|COMPLETED|Overall Study||4
62819|NCT02336594|153666|P1|COMPLETED|Overall Study||3
62820|NCT02336594|153663|P4|STARTED|Overall Study||4
62821|NCT02336594|153664|P3|STARTED|Overall Study||4
62822|NCT02336594|153665|P2|STARTED|Overall Study||4
62823|NCT02336594|153666|P1|STARTED|Overall Study||3
62824|NCT02336438|153706|P1|NOT COMPLETED|Overall Study||1
62825|NCT02336438|153706|P1|COMPLETED|Overall Study||10
62826|NCT02336438|153706|P1|STARTED|Overall Study||11
62827|NCT02336425|153719|P4|NOT COMPLETED|Overall Study||3
62828|NCT02336425|153720|P3|NOT COMPLETED|Overall Study||3
62829|NCT02336425|153721|P2|NOT COMPLETED|Overall Study||2
62830|NCT02336425|153722|P1|NOT COMPLETED|Overall Study||2
62831|NCT02336425|153719|P4|COMPLETED|Overall Study||0
62832|NCT02336425|153720|P3|COMPLETED|Overall Study||0
62833|NCT02336425|153721|P2|COMPLETED|Overall Study||0
62834|NCT02336425|153722|P1|COMPLETED|Overall Study||0
62835|NCT02336425|153719|P4|STARTED|Overall Study||3
62836|NCT02336425|153720|P3|STARTED|Overall Study||3
62837|NCT02336425|153721|P2|STARTED|Overall Study||2
62838|NCT02336425|153722|P1|STARTED|Overall Study||2
62839|NCT02336282|153772|P1|NOT COMPLETED|Overall Study||5
62840|NCT02336282|153772|P1|COMPLETED|Overall Study||28
62841|NCT02336282|153772|P1|STARTED|Overall Study||33
62842|NCT02336178|153796|P1|NOT COMPLETED|Overall Study||4
62843|NCT02336178|153796|P1|COMPLETED|Overall Study||66
62844|NCT02336178|153796|P1|STARTED|Overall Study||70
62845|NCT02336165|153887|P5|NOT COMPLETED|Overall Study||22
62846|NCT02336165|153888|P4|NOT COMPLETED|Overall Study||31
62847|NCT02336165|153889|P3|NOT COMPLETED|Overall Study||31
62848|NCT02336165|153890|P2|NOT COMPLETED|Overall Study||25
62849|NCT02336165|153891|P1|NOT COMPLETED|Overall Study||34
62850|NCT02336165|153887|P5|COMPLETED|Overall Study||0
62851|NCT02336165|153888|P4|COMPLETED|Overall Study||2
62852|NCT02336165|153889|P3|COMPLETED|Overall Study||2
62853|NCT02336165|153890|P2|COMPLETED|Overall Study||6
62854|NCT02336165|153891|P1|COMPLETED|Overall Study||6
62855|NCT02336165|153887|P5|STARTED|Overall Study||22
62856|NCT02336165|153888|P4|STARTED|Overall Study||33
62857|NCT02336165|153889|P3|STARTED|Overall Study||33
62858|NCT02336165|153890|P2|STARTED|Overall Study||31
62859|NCT02336165|153891|P1|STARTED|Overall Study||40
62860|NCT02336074|153921|P2|NOT COMPLETED|Overall Study||2
62861|NCT02336074|153922|P1|NOT COMPLETED|Overall Study||0
62862|NCT02336074|153921|P2|COMPLETED|Overall Study||28
62863|NCT02336074|153922|P1|COMPLETED|Overall Study||30
62864|NCT02336074|153921|P2|STARTED|Overall Study||30
62865|NCT02336074|153922|P1|STARTED|Overall Study||30
62866|NCT02335710|153941|P2|NOT COMPLETED|Overall Study||0
62867|NCT02335710|153942|P1|NOT COMPLETED|Overall Study||0
62868|NCT02335710|153941|P2|COMPLETED|Overall Study||10
62869|NCT02335710|153942|P1|COMPLETED|Overall Study||40
62870|NCT02335710|153941|P2|STARTED|Overall Study||10
62871|NCT02335710|153942|P1|STARTED|Overall Study||40
62872|NCT02335502|153962|P1|NOT COMPLETED|Overall Study||17
62873|NCT02335502|153962|P1|COMPLETED|Overall Study||49
62874|NCT02335502|153962|P1|Receiving Permanent System|Overall Study||56
62875|NCT02335502|153962|P1|Received Trial System|Overall Study||65
62876|NCT02335502|153962|P1|STARTED|Overall Study||66
62877|NCT02335489|153967|P1|NOT COMPLETED|Overall Study||10
62878|NCT02335489|153967|P1|COMPLETED|Overall Study||0
62879|NCT02335489|153967|P1|Receiving Permanent System|Overall Study||8
62880|NCT02335489|153967|P1|Received Trial System|Overall Study||9
62881|NCT02335489|153967|P1|STARTED|Overall Study||10
62882|NCT02335424|153971|P1|NOT COMPLETED|Overall Study||374
62883|NCT02335424|153971|P1|COMPLETED|Overall Study||0
62884|NCT02335424|153971|P1|Treated|Overall Study||370
62885|NCT02335424|153971|P1|STARTED|Overall Study||374
62886|NCT02335346|154004|P1|NOT COMPLETED|Overall Study||12
62887|NCT02335346|154004|P1|COMPLETED|Overall Study||81
62888|NCT02335346|154004|P1|Received At Least 1 Dose of Study Drug|Overall Study||93
62889|NCT02335346|154004|P1|STARTED|Overall Study||93
62890|NCT02335229|154016|P1|NOT COMPLETED|Overall Study||7
62891|NCT02335229|154016|P1|COMPLETED|Overall Study||23
62892|NCT02335229|154016|P1|Received Permanent System|Overall Study||26
62893|NCT02335229|154016|P1|Received Trial System|Overall Study||10
62894|NCT02335229|154016|P1|STARTED|Overall Study||30
62895|NCT02335216|154021|P1|NOT COMPLETED|Overall Study||13
62896|NCT02335216|154021|P1|COMPLETED|Overall Study||9
62897|NCT02335216|154021|P1|Received Permanent System|Overall Study||13
62898|NCT02335216|154021|P1|Received Trial System|Overall Study||16
62899|NCT02335216|154021|P1|STARTED|Overall Study||22
62900|NCT02334982|154033|P7|NOT COMPLETED|Overall Study||0
62901|NCT02334982|154034|P6|NOT COMPLETED|Overall Study||0
62902|NCT02334982|154035|P5|NOT COMPLETED|Overall Study||0
62903|NCT02334982|154036|P4|NOT COMPLETED|Overall Study||0
62904|NCT02334982|154037|P3|NOT COMPLETED|Overall Study||0
62905|NCT02334982|154038|P2|NOT COMPLETED|Overall Study||0
62906|NCT02334982|154039|P1|NOT COMPLETED|Overall Study||0
62907|NCT02334982|154033|P7|COMPLETED|Overall Study||12
62908|NCT02334982|154034|P6|COMPLETED|Overall Study||6
62909|NCT02334982|154035|P5|COMPLETED|Overall Study||6
62910|NCT02334982|154036|P4|COMPLETED|Overall Study||6
62911|NCT02334982|154037|P3|COMPLETED|Overall Study||6
62912|NCT02334982|154038|P2|COMPLETED|Overall Study||5
62913|NCT02334982|154039|P1|COMPLETED|Overall Study||6
62914|NCT02334982|154033|P7|STARTED|Overall Study||12
62915|NCT02334982|154034|P6|STARTED|Overall Study||6
62916|NCT02334982|154035|P5|STARTED|Overall Study||6
62917|NCT02334982|154036|P4|STARTED|Overall Study||6
62918|NCT02334982|154037|P3|STARTED|Overall Study||6
62919|NCT02334982|154038|P2|STARTED|Overall Study||5
62920|NCT02334982|154039|P1|STARTED|Overall Study||6
62921|NCT02334813|154145|P2|NOT COMPLETED|Overall Study||1
62922|NCT02334813|154146|P1|NOT COMPLETED|Overall Study||3
62923|NCT02334813|154145|P2|COMPLETED|Overall Study||13
62924|NCT02334813|154146|P1|COMPLETED|Overall Study||9
62925|NCT02334813|154145|P2|STARTED|Overall Study||14
62926|NCT02334813|154146|P1|STARTED|Overall Study||12
62927|NCT02334800|154156|P4|NOT COMPLETED|Overall Study||0
62928|NCT02334800|154157|P3|NOT COMPLETED|Overall Study||0
62929|NCT02334800|154158|P2|NOT COMPLETED|Overall Study||0
62930|NCT02334800|154159|P1|NOT COMPLETED|Overall Study||0
62931|NCT02334800|154156|P4|COMPLETED|Overall Study||7
62932|NCT02334800|154157|P3|COMPLETED|Overall Study||7
62933|NCT02334800|154158|P2|COMPLETED|Overall Study||7
62934|NCT02334800|154159|P1|COMPLETED|Overall Study||7
62935|NCT02334800|154156|P4|Received Treatment|Overall Study||7
62936|NCT02334800|154157|P3|Received Treatment|Overall Study||7
62937|NCT02334800|154158|P2|Received Treatment|Overall Study||7
62938|NCT02334800|154159|P1|Received Treatment|Overall Study||7
62939|NCT02334800|154156|P4|STARTED|Overall Study||7
62940|NCT02334800|154157|P3|STARTED|Overall Study||7
62941|NCT02334800|154158|P2|STARTED|Overall Study||7
62942|NCT02334800|154159|P1|STARTED|Overall Study||7
62943|NCT02334787|154253|P4|NOT COMPLETED|Overall Study||0
62944|NCT02334787|154254|P3|NOT COMPLETED|Overall Study||0
62945|NCT02334787|154255|P2|NOT COMPLETED|Overall Study||0
62946|NCT02334787|154256|P1|NOT COMPLETED|Overall Study||0
62947|NCT02334787|154253|P4|COMPLETED|Overall Study||8
62948|NCT02334787|154254|P3|COMPLETED|Overall Study||8
62949|NCT02334787|154255|P2|COMPLETED|Overall Study||8
62950|NCT02334787|154256|P1|COMPLETED|Overall Study||8
62951|NCT02334787|154253|P4|STARTED|Overall Study||8
62952|NCT02334787|154254|P3|STARTED|Overall Study||8
62953|NCT02334787|154255|P2|STARTED|Overall Study||8
62954|NCT02334787|154256|P1|STARTED|Overall Study||8
62955|NCT02334527|154278|P1|NOT COMPLETED|Overall Study||0
62956|NCT02334527|154278|P1|COMPLETED|Overall Study||12
62957|NCT02334527|154278|P1|STARTED|Overall Study||12
62958|NCT02334436|154289|P2|NOT COMPLETED|Overall Study||1
62959|NCT02334436|154290|P1|NOT COMPLETED|Overall Study||9
62960|NCT02334436|154289|P2|COMPLETED|Overall Study||77
62961|NCT02334436|154290|P1|COMPLETED|Overall Study||237
62962|NCT02334436|154289|P2|STARTED|Overall Study||78
62963|NCT02334436|154290|P1|STARTED|Overall Study||246
62964|NCT02334423|154304|P2|NOT COMPLETED|Overall Study||3
62965|NCT02334423|154305|P1|NOT COMPLETED|Overall Study||10
62966|NCT02334423|154304|P2|COMPLETED|Overall Study||81
62967|NCT02334423|154305|P1|COMPLETED|Overall Study||236
62968|NCT02334423|154304|P2|STARTED|Overall Study||84
62969|NCT02334423|154305|P1|STARTED|Overall Study||246
62970|NCT02334384|154319|P2|NOT COMPLETED|Overall Study||1
62971|NCT02334384|154320|P1|NOT COMPLETED|Overall Study||1
62972|NCT02334384|154319|P2|COMPLETED|Overall Study||1
62973|NCT02334384|154320|P1|COMPLETED|Overall Study||3
62974|NCT02334384|154319|P2|STARTED|Overall Study||2
62975|NCT02334384|154320|P1|STARTED|Overall Study||4
62976|NCT02334358|154326|P1|NOT COMPLETED|Overall Study||9
62977|NCT02334358|154326|P1|COMPLETED|Overall Study||494
62978|NCT02334358|154326|P1|STARTED|Overall Study||503
62979|NCT02334306|154332|P2|NOT COMPLETED|Open-label Period||0
62980|NCT02334306|154333|P1|NOT COMPLETED|Open-label Period||0
62981|NCT02334306|154332|P2|COMPLETED|Open-label Period||14
62982|NCT02334306|154333|P1|COMPLETED|Open-label Period||15
62983|NCT02334306|154332|P2|STARTED|Open-label Period||14
62984|NCT02334306|154333|P1|STARTED|Open-label Period||15
62985|NCT02334306|154332|P2|NOT COMPLETED|Double-blind Period||2
62986|NCT02334306|154333|P1|NOT COMPLETED|Double-blind Period||1
62987|NCT02334306|154332|P2|COMPLETED|Double-blind Period||14
62988|NCT02334306|154333|P1|COMPLETED|Double-blind Period||15
62989|NCT02334306|154332|P2|STARTED|Double-blind Period||16
62990|NCT02334306|154333|P1|STARTED|Double-blind Period||16
62991|NCT02334267|154355|P2|NOT COMPLETED|Overall Study||0
62992|NCT02334267|154356|P1|NOT COMPLETED|Overall Study||1
62993|NCT02334267|154355|P2|COMPLETED|Overall Study||5
62994|NCT02334267|154356|P1|COMPLETED|Overall Study||5
62995|NCT02334267|154355|P2|STARTED|Overall Study||5
62996|NCT02334267|154356|P1|STARTED|Overall Study||6
62997|NCT02334059|154371|P3|NOT COMPLETED|Overall Study||0
62998|NCT02334059|154372|P2|NOT COMPLETED|Overall Study||0
62999|NCT02334059|154373|P1|NOT COMPLETED|Overall Study||0
63000|NCT02334059|154371|P3|COMPLETED|Overall Study||37
63001|NCT02334059|154372|P2|COMPLETED|Overall Study||34
63002|NCT02334059|154373|P1|COMPLETED|Overall Study||37
63003|NCT02334059|154371|P3|STARTED|Overall Study||37
63004|NCT02334059|154372|P2|STARTED|Overall Study||34
63005|NCT02334059|154373|P1|STARTED|Overall Study||37
63006|NCT02333383|154387|P1|NOT COMPLETED|Overall Study||41
63007|NCT02333383|154387|P1|COMPLETED|Overall Study||160
63008|NCT02333383|154387|P1|STARTED|Overall Study||201
63009|NCT02333331|154401|P4|NOT COMPLETED|Overall Study||3
63010|NCT02333331|154402|P3|NOT COMPLETED|Overall Study||18
63011|NCT02333331|154403|P2|NOT COMPLETED|Overall Study||6
63012|NCT02333331|154404|P1|NOT COMPLETED|Overall Study||2
63013|NCT02333331|154401|P4|COMPLETED|Overall Study||64
63014|NCT02333331|154402|P3|COMPLETED|Overall Study||95
63015|NCT02333331|154403|P2|COMPLETED|Overall Study||12
63016|NCT02333331|154404|P1|COMPLETED|Overall Study||17
63017|NCT02333331|154401|P4|STARTED|Overall Study||67
63018|NCT02333331|154402|P3|STARTED|Overall Study||113
63019|NCT02333331|154403|P2|STARTED|Overall Study||18
63020|NCT02333331|154404|P1|STARTED|Overall Study||19
63021|NCT02333045|154432|P2|NOT COMPLETED|Overall Study||0
63022|NCT02333045|154433|P1|NOT COMPLETED|Overall Study||0
63023|NCT02333045|154432|P2|COMPLETED|Overall Study||3
63024|NCT02333045|154433|P1|COMPLETED|Overall Study||1
63025|NCT02333045|154432|P2|STARTED|Overall Study||3
63026|NCT02333045|154433|P1|STARTED|Overall Study||1
63027|NCT02332902|154443|P1|NOT COMPLETED|Overall Study||7
63028|NCT02332902|154443|P1|COMPLETED|Overall Study||17
63029|NCT02332902|154443|P1|STARTED|Overall Study||24
63030|NCT02332889|154448|P1|NOT COMPLETED|Overall Study||1
63031|NCT02332889|154448|P1|COMPLETED|Overall Study||0
63032|NCT02332889|154448|P1|STARTED|Overall Study||1
63033|NCT02332876|154454|P2|NOT COMPLETED|Overall Study||1
63034|NCT02332876|154455|P1|NOT COMPLETED|Overall Study||1
63035|NCT02332876|154454|P2|COMPLETED|Overall Study||43
63036|NCT02332876|154455|P1|COMPLETED|Overall Study||42
63037|NCT02332876|154454|P2|STARTED|Overall Study||44
63038|NCT02332876|154455|P1|STARTED|Overall Study||43
63039|NCT02332824|154467|P6|NOT COMPLETED|Overall Study||1
63040|NCT02332824|154468|P5|NOT COMPLETED|Overall Study||4
63041|NCT02332824|154469|P4|NOT COMPLETED|Overall Study||2
63042|NCT02332824|154470|P3|NOT COMPLETED|Overall Study||2
63043|NCT02332824|154471|P2|NOT COMPLETED|Overall Study||1
63044|NCT02332824|154472|P1|NOT COMPLETED|Overall Study||6
63045|NCT02332824|154467|P6|COMPLETED|Overall Study||69
63046|NCT02332824|154468|P5|COMPLETED|Overall Study||65
63047|NCT02332824|154469|P4|COMPLETED|Overall Study||66
63048|NCT02332824|154470|P3|COMPLETED|Overall Study||72
63049|NCT02332824|154471|P2|COMPLETED|Overall Study||66
63050|NCT02332824|154472|P1|COMPLETED|Overall Study||61
63051|NCT02332824|154467|P6|STARTED|Overall Study||70
63052|NCT02332824|154468|P5|STARTED|Overall Study||69
63053|NCT02332824|154469|P4|STARTED|Overall Study||68
63054|NCT02332824|154470|P3|STARTED|Overall Study||74
63055|NCT02332824|154471|P2|STARTED|Overall Study||67
63056|NCT02332824|154472|P1|STARTED|Overall Study||67
63057|NCT02332798|154513|P3|NOT COMPLETED|Overall Study||1
63058|NCT02332798|154514|P2|NOT COMPLETED|Overall Study||2
63059|NCT02332798|154515|P1|NOT COMPLETED|Overall Study||1
63060|NCT02332798|154513|P3|COMPLETED|Overall Study||11
63061|NCT02332798|154514|P2|COMPLETED|Overall Study||12
63062|NCT02332798|154515|P1|COMPLETED|Overall Study||12
63063|NCT02332798|154513|P3|STARTED|Overall Study||12
63064|NCT02332798|154514|P2|STARTED|Overall Study||14
63065|NCT02332798|154515|P1|STARTED|Overall Study||13
63066|NCT02332720|154588|P23|NOT COMPLETED|Part C||0
63067|NCT02332720|154589|P22|NOT COMPLETED|Part C||0
63068|NCT02332720|154590|P21|NOT COMPLETED|Part C||0
63069|NCT02332720|154591|P20|NOT COMPLETED|Part C||0
63070|NCT02332720|154592|P19|NOT COMPLETED|Part C||0
63071|NCT02332720|154593|P18|NOT COMPLETED|Part C||0
63072|NCT02332720|154594|P17|NOT COMPLETED|Part C||0
63073|NCT02332720|154595|P16|NOT COMPLETED|Part C||0
63074|NCT02332720|154596|P15|NOT COMPLETED|Part C||0
63075|NCT02332720|154597|P14|NOT COMPLETED|Part C||0
63076|NCT02332720|154598|P13|NOT COMPLETED|Part C||0
63077|NCT02332720|154599|P12|NOT COMPLETED|Part C||0
63078|NCT02332720|154600|P11|NOT COMPLETED|Part C||0
63079|NCT02332720|154601|P10|NOT COMPLETED|Part C||0
63080|NCT02332720|154602|P9|NOT COMPLETED|Part C||0
63081|NCT02332720|154603|P8|NOT COMPLETED|Part C||0
63082|NCT02332720|154604|P7|NOT COMPLETED|Part C||0
63083|NCT02332720|154605|P6|NOT COMPLETED|Part C||0
63084|NCT02332720|154606|P5|NOT COMPLETED|Part C||0
63085|NCT02332720|154607|P4|NOT COMPLETED|Part C||0
63086|NCT02332720|154608|P3|NOT COMPLETED|Part C||0
63087|NCT02332720|154609|P2|NOT COMPLETED|Part C||0
63088|NCT02332720|154610|P1|NOT COMPLETED|Part C||0
63089|NCT02332720|154588|P23|COMPLETED|Part C||0
63090|NCT02332720|154589|P22|COMPLETED|Part C||0
63091|NCT02332720|154590|P21|COMPLETED|Part C||0
63092|NCT02332720|154591|P20|COMPLETED|Part C||0
63093|NCT02332720|154592|P19|COMPLETED|Part C||0
63094|NCT02332720|154593|P18|COMPLETED|Part C||0
63095|NCT02332720|154594|P17|COMPLETED|Part C||0
63096|NCT02332720|154595|P16|COMPLETED|Part C||0
63097|NCT02332720|154596|P15|COMPLETED|Part C||0
63098|NCT02332720|154597|P14|COMPLETED|Part C||0
63099|NCT02332720|154598|P13|COMPLETED|Part C||0
63100|NCT02332720|154599|P12|COMPLETED|Part C||0
63101|NCT02332720|154600|P11|COMPLETED|Part C||0
63102|NCT02332720|154601|P10|COMPLETED|Part C||0
63103|NCT02332720|154602|P9|COMPLETED|Part C||0
63104|NCT02332720|154603|P8|COMPLETED|Part C||0
63105|NCT02332720|154604|P7|COMPLETED|Part C||0
63106|NCT02332720|154605|P6|COMPLETED|Part C||0
63107|NCT02332720|154606|P5|COMPLETED|Part C||0
63108|NCT02332720|154607|P4|COMPLETED|Part C||2
63109|NCT02332720|154608|P3|COMPLETED|Part C||3
63110|NCT02332720|154609|P2|COMPLETED|Part C||1
63111|NCT02332720|154610|P1|COMPLETED|Part C||2
63112|NCT02332720|154588|P23|STARTED|Part C|Part B participants were not included in Part C.|0
63113|NCT02332720|154589|P22|STARTED|Part C||0
63114|NCT02332720|154590|P21|STARTED|Part C|Part B participants were not included in Part C.|0
63115|NCT02332720|154591|P20|STARTED|Part C|Part B participants were not included in Part C.|0
63116|NCT02332720|154592|P19|STARTED|Part C|Part B participants were not included in Part C.|0
63117|NCT02332720|154593|P18|STARTED|Part C|Part B participants were not included in Part C.|0
63118|NCT02332720|154594|P17|STARTED|Part C|Part B participants were not included in Part C.|0
63119|NCT02332720|154595|P16|STARTED|Part C|Part B participants were not included in Part C.|0
63120|NCT02332720|154596|P15|STARTED|Part C|Part B participants were not included in Part C.|0
63121|NCT02332720|154597|P14|STARTED|Part C|Part B participants were not included in Part C.|0
63122|NCT02332720|154598|P13|STARTED|Part C|Part B participants were not included in Part C.|0
63123|NCT02332720|154599|P12|STARTED|Part C|Part B participants were not included in Part C.|0
63124|NCT02332720|154600|P11|STARTED|Part C|Part B participants were not included in Part C.|0
63125|NCT02332720|154601|P10|STARTED|Part C|Part B participants were not included in Part C.|0
63126|NCT02332720|154602|P9|STARTED|Part C|Part B participants were not included in Part C.|0
63127|NCT02332720|154603|P8|STARTED|Part C|Part B participants were not included in Part C.|0
63128|NCT02332720|154604|P7|STARTED|Part C|Part B participants were not included in Part C.|0
63129|NCT02332720|154605|P6|STARTED|Part C|Part B participants were not included in Part C.|0
63130|NCT02332720|154606|P5|STARTED|Part C|Part B participants were not included in Part C.|0
63131|NCT02332720|154607|P4|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|2
63132|NCT02332720|154608|P3|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|3
63133|NCT02332720|154609|P2|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|1
63134|NCT02332720|154610|P1|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|2
63135|NCT02332720|154588|P23|NOT COMPLETED|Part A and Part B||0
63136|NCT02332720|154589|P22|NOT COMPLETED|Part A and Part B||0
63137|NCT02332720|154590|P21|NOT COMPLETED|Part A and Part B||0
63138|NCT02332720|154591|P20|NOT COMPLETED|Part A and Part B||1
63139|NCT02332720|154592|P19|NOT COMPLETED|Part A and Part B||1
63140|NCT02332720|154593|P18|NOT COMPLETED|Part A and Part B||1
63141|NCT02332720|154594|P17|NOT COMPLETED|Part A and Part B||0
63142|NCT02332720|154595|P16|NOT COMPLETED|Part A and Part B||1
63143|NCT02332720|154596|P15|NOT COMPLETED|Part A and Part B||0
63144|NCT02332720|154597|P14|NOT COMPLETED|Part A and Part B||0
63145|NCT02332720|154598|P13|NOT COMPLETED|Part A and Part B||0
63146|NCT02332720|154599|P12|NOT COMPLETED|Part A and Part B||0
63147|NCT02332720|154600|P11|NOT COMPLETED|Part A and Part B||0
63148|NCT02332720|154601|P10|NOT COMPLETED|Part A and Part B||0
63149|NCT02332720|154602|P9|NOT COMPLETED|Part A and Part B||0
63150|NCT02332720|154603|P8|NOT COMPLETED|Part A and Part B||1
63151|NCT02332720|154604|P7|NOT COMPLETED|Part A and Part B||1
63152|NCT02332720|154605|P6|NOT COMPLETED|Part A and Part B||3
63153|NCT02332720|154606|P5|NOT COMPLETED|Part A and Part B||0
63154|NCT02332720|154607|P4|NOT COMPLETED|Part A and Part B||0
63155|NCT02332720|154608|P3|NOT COMPLETED|Part A and Part B||0
63156|NCT02332720|154609|P2|NOT COMPLETED|Part A and Part B||0
63157|NCT02332720|154610|P1|NOT COMPLETED|Part A and Part B||1
63158|NCT02332720|154588|P23|COMPLETED|Part A and Part B||4
63159|NCT02332720|154589|P22|COMPLETED|Part A and Part B||0
63160|NCT02332720|154590|P21|COMPLETED|Part A and Part B||7
63161|NCT02332720|154591|P20|COMPLETED|Part A and Part B||24
63162|NCT02332720|154592|P19|COMPLETED|Part A and Part B||20
63163|NCT02332720|154593|P18|COMPLETED|Part A and Part B||13
63164|NCT02332720|154594|P17|COMPLETED|Part A and Part B||15
63165|NCT02332720|154595|P16|COMPLETED|Part A and Part B||13
63166|NCT02332720|154596|P15|COMPLETED|Part A and Part B||16
63167|NCT02332720|154597|P14|COMPLETED|Part A and Part B||13
63168|NCT02332720|154598|P13|COMPLETED|Part A and Part B||16
63169|NCT02332720|154599|P12|COMPLETED|Part A and Part B||15
63170|NCT02332720|154600|P11|COMPLETED|Part A and Part B||14
63171|NCT02332720|154601|P10|COMPLETED|Part A and Part B||14
63172|NCT02332720|154602|P9|COMPLETED|Part A and Part B||15
63173|NCT02332720|154603|P8|COMPLETED|Part A and Part B||34
63174|NCT02332720|154604|P7|COMPLETED|Part A and Part B||36
63175|NCT02332720|154605|P6|COMPLETED|Part A and Part B||33
63176|NCT02332720|154606|P5|COMPLETED|Part A and Part B||16
63177|NCT02332720|154607|P4|COMPLETED|Part A and Part B||22
63178|NCT02332720|154608|P3|COMPLETED|Part A and Part B||22
63179|NCT02332720|154609|P2|COMPLETED|Part A and Part B||21
63180|NCT02332720|154610|P1|COMPLETED|Part A and Part B||20
63181|NCT02332720|154588|P23|Treated|Part A and Part B||4
63182|NCT02332720|154589|P22|Treated|Part A and Part B||0
63183|NCT02332720|154590|P21|Treated|Part A and Part B||7
63184|NCT02332720|154591|P20|Treated|Part A and Part B||25
63185|NCT02332720|154592|P19|Treated|Part A and Part B||20
63186|NCT02332720|154593|P18|Treated|Part A and Part B||14
63187|NCT02332720|154594|P17|Treated|Part A and Part B||15
63188|NCT02332720|154595|P16|Treated|Part A and Part B||14
63189|NCT02332720|154596|P15|Treated|Part A and Part B||16
63190|NCT02332720|154597|P14|Treated|Part A and Part B||13
63191|NCT02332720|154598|P13|Treated|Part A and Part B||16
63192|NCT02332720|154599|P12|Treated|Part A and Part B||15
63193|NCT02332720|154600|P11|Treated|Part A and Part B||14
63194|NCT02332720|154601|P10|Treated|Part A and Part B||14
63195|NCT02332720|154602|P9|Treated|Part A and Part B||15
63196|NCT02332720|154603|P8|Treated|Part A and Part B||35
63197|NCT02332720|154604|P7|Treated|Part A and Part B||37
63198|NCT02332720|154605|P6|Treated|Part A and Part B||36
63199|NCT02332720|154606|P5|Treated|Part A and Part B||16
63200|NCT02332720|154607|P4|Treated|Part A and Part B||22
63201|NCT02332720|154608|P3|Treated|Part A and Part B||22
63202|NCT02332720|154609|P2|Treated|Part A and Part B||21
63203|NCT02332720|154610|P1|Treated|Part A and Part B||21
63204|NCT02332720|154588|P23|STARTED|Part A and Part B||4
63205|NCT02332720|154589|P22|STARTED|Part A and Part B||0
63206|NCT02332720|154590|P21|STARTED|Part A and Part B||7
63207|NCT02332720|154591|P20|STARTED|Part A and Part B||25
63208|NCT02332720|154592|P19|STARTED|Part A and Part B||21
63209|NCT02332720|154593|P18|STARTED|Part A and Part B||14
63210|NCT02332720|154594|P17|STARTED|Part A and Part B||15
63211|NCT02332720|154595|P16|STARTED|Part A and Part B||14
63212|NCT02332720|154596|P15|STARTED|Part A and Part B||16
63213|NCT02332720|154597|P14|STARTED|Part A and Part B||13
63214|NCT02332720|154598|P13|STARTED|Part A and Part B||16
63215|NCT02332720|154599|P12|STARTED|Part A and Part B||15
63216|NCT02332720|154600|P11|STARTED|Part A and Part B||14
63217|NCT02332720|154601|P10|STARTED|Part A and Part B||14
63218|NCT02332720|154602|P9|STARTED|Part A and Part B||15
63219|NCT02332720|154603|P8|STARTED|Part A and Part B||35
63220|NCT02332720|154604|P7|STARTED|Part A and Part B||37
63221|NCT02332720|154605|P6|STARTED|Part A and Part B||36
63222|NCT02332720|154606|P5|STARTED|Part A and Part B||16
63223|NCT02332720|154607|P4|STARTED|Part A and Part B||22
63224|NCT02332720|154608|P3|STARTED|Part A and Part B||22
63225|NCT02332720|154609|P2|STARTED|Part A and Part B||21
63226|NCT02332720|154610|P1|STARTED|Part A and Part B||21
63227|NCT02332707|154746|P18|NOT COMPLETED|Overall Study||0
63228|NCT02332707|154747|P17|NOT COMPLETED|Overall Study||0
63229|NCT02332707|154748|P16|NOT COMPLETED|Overall Study||0
63230|NCT02332707|154749|P15|NOT COMPLETED|Overall Study||0
63231|NCT02332707|154750|P14|NOT COMPLETED|Overall Study||0
63232|NCT02332707|154751|P13|NOT COMPLETED|Overall Study||5
63233|NCT02332707|154752|P12|NOT COMPLETED|Overall Study||0
63234|NCT02332707|154753|P11|NOT COMPLETED|Overall Study||2
63235|NCT02332707|154754|P10|NOT COMPLETED|Overall Study||3
63236|NCT02332707|154755|P9|NOT COMPLETED|Overall Study||0
63237|NCT02332707|154756|P8|NOT COMPLETED|Overall Study||0
63238|NCT02332707|154757|P7|NOT COMPLETED|Overall Study||0
63239|NCT02332707|154758|P6|NOT COMPLETED|Overall Study||1
63240|NCT02332707|154759|P5|NOT COMPLETED|Overall Study||0
63241|NCT02332707|154760|P4|NOT COMPLETED|Overall Study||1
63242|NCT02332707|154761|P3|NOT COMPLETED|Overall Study||1
63243|NCT02332707|154762|P2|NOT COMPLETED|Overall Study||0
63244|NCT02332707|154763|P1|NOT COMPLETED|Overall Study||0
63245|NCT02332707|154746|P18|COMPLETED|Overall Study||16
63246|NCT02332707|154747|P17|COMPLETED|Overall Study||30
63247|NCT02332707|154748|P16|COMPLETED|Overall Study||26
63248|NCT02332707|154749|P15|COMPLETED|Overall Study||16
63249|NCT02332707|154750|P14|COMPLETED|Overall Study||15
63250|NCT02332707|154751|P13|COMPLETED|Overall Study||35
63251|NCT02332707|154752|P12|COMPLETED|Overall Study||35
63252|NCT02332707|154753|P11|COMPLETED|Overall Study||29
63253|NCT02332707|154754|P10|COMPLETED|Overall Study||28
63254|NCT02332707|154755|P9|COMPLETED|Overall Study||48
63255|NCT02332707|154756|P8|COMPLETED|Overall Study||16
63256|NCT02332707|154757|P7|COMPLETED|Overall Study||15
63257|NCT02332707|154758|P6|COMPLETED|Overall Study||22
63258|NCT02332707|154759|P5|COMPLETED|Overall Study||23
63259|NCT02332707|154760|P4|COMPLETED|Overall Study||13
63260|NCT02332707|154761|P3|COMPLETED|Overall Study||15
63261|NCT02332707|154762|P2|COMPLETED|Overall Study||24
63262|NCT02332707|154763|P1|COMPLETED|Overall Study||23
63263|NCT02332707|154746|P18|STARTED|Overall Study||16
63264|NCT02332707|154747|P17|STARTED|Overall Study||30
63265|NCT02332707|154748|P16|STARTED|Overall Study||26
63266|NCT02332707|154749|P15|STARTED|Overall Study||16
63267|NCT02332707|154750|P14|STARTED|Overall Study||15
63268|NCT02332707|154751|P13|STARTED|Overall Study||40
63269|NCT02332707|154752|P12|STARTED|Overall Study||35
63270|NCT02332707|154753|P11|STARTED|Overall Study||31
63271|NCT02332707|154754|P10|STARTED|Overall Study||31
63272|NCT02332707|154755|P9|STARTED|Overall Study||48
63273|NCT02332707|154756|P8|STARTED|Overall Study||16
63274|NCT02332707|154757|P7|STARTED|Overall Study||15
63275|NCT02332707|154758|P6|STARTED|Overall Study||23
63276|NCT02332707|154759|P5|STARTED|Overall Study||23
63277|NCT02332707|154760|P4|STARTED|Overall Study||14
63278|NCT02332707|154761|P3|STARTED|Overall Study||16
63279|NCT02332707|154762|P2|STARTED|Overall Study||24
63280|NCT02332707|154763|P1|STARTED|Overall Study||23
63281|NCT02332590|154857|P2|NOT COMPLETED|Overall Study||19
63282|NCT02332590|154858|P1|NOT COMPLETED|Overall Study||29
63283|NCT02332590|154857|P2|COMPLETED|Overall Study|All 165 participants entered open-label treatment period.|165
63284|NCT02332590|154858|P1|COMPLETED|Overall Study|155 participants entered open-label treatment period and 1 did not enroll.|156
63285|NCT02332590|154857|P2|Treated|Overall Study||184
63286|NCT02332590|154858|P1|Treated|Overall Study||184
63287|NCT02332590|154857|P2|STARTED|Overall Study||184
63288|NCT02332590|154858|P1|STARTED|Overall Study||185
63289|NCT02332239|154922|P2|NOT COMPLETED|Overall Study||6
63290|NCT02332239|154923|P1|NOT COMPLETED|Overall Study||4
63291|NCT02332239|154922|P2|COMPLETED|Overall Study||52
63292|NCT02332239|154923|P1|COMPLETED|Overall Study||54
63293|NCT02332239|154922|P2|STARTED|Overall Study||58
63294|NCT02332239|154923|P1|STARTED|Overall Study||58
63295|NCT02331992|154936|P1|NOT COMPLETED|Overall Study||0
63296|NCT02331992|154936|P1|COMPLETED|Overall Study||34
63297|NCT02331992|154936|P1|STARTED|Overall Study||34
63298|NCT02331940|154943|P2|NOT COMPLETED|Overall Study||5
63299|NCT02331940|154944|P1|NOT COMPLETED|Overall Study||7
63300|NCT02331940|154943|P2|COMPLETED|Overall Study||95
63301|NCT02331940|154944|P1|COMPLETED|Overall Study||93
63302|NCT02331940|154943|P2|STARTED|Overall Study||100
63303|NCT02331940|154944|P1|STARTED|Overall Study||100
63304|NCT02331680|154959|P3|NOT COMPLETED|Overall Study||15
63305|NCT02331680|154960|P2|NOT COMPLETED|Overall Study||4
63306|NCT02331680|154961|P1|NOT COMPLETED|Overall Study||6
63307|NCT02331680|154959|P3|COMPLETED|Overall Study||29
63308|NCT02331680|154960|P2|COMPLETED|Overall Study||36
63309|NCT02331680|154961|P1|COMPLETED|Overall Study||34
63310|NCT02331680|154959|P3|STARTED|Overall Study||44
63311|NCT02331680|154960|P2|STARTED|Overall Study||40
63312|NCT02331680|154961|P1|STARTED|Overall Study||40
63313|NCT02331589|154974|P2|NOT COMPLETED|Overall Study||5
63314|NCT02331589|154975|P1|NOT COMPLETED|Overall Study||5
63315|NCT02331589|154974|P2|COMPLETED|Overall Study||31
63316|NCT02331589|154975|P1|COMPLETED|Overall Study||34
63317|NCT02331589|154974|P2|STARTED|Overall Study||36
63318|NCT02331589|154975|P1|STARTED|Overall Study||39
63319|NCT02331446|154991|P4|NOT COMPLETED|Overall Study||3
63320|NCT02331446|154992|P3|NOT COMPLETED|Overall Study||3
63321|NCT02331446|154993|P2|NOT COMPLETED|Overall Study||5
63322|NCT02331446|154994|P1|NOT COMPLETED|Overall Study||4
63323|NCT02331446|154991|P4|COMPLETED|Overall Study||8
63324|NCT02331446|154992|P3|COMPLETED|Overall Study||8
63325|NCT02331446|154993|P2|COMPLETED|Overall Study||6
63326|NCT02331446|154994|P1|COMPLETED|Overall Study||5
63327|NCT02331446|154991|P4|STARTED|Overall Study||11
63328|NCT02331446|154992|P3|STARTED|Overall Study||11
63329|NCT02331446|154993|P2|STARTED|Overall Study||11
63330|NCT02331446|154994|P1|STARTED|Overall Study||9
63331|NCT02331407|155064|P1|NOT COMPLETED|Overall Study||0
63332|NCT02331407|155064|P1|COMPLETED|Overall Study||9
63333|NCT02331407|155064|P1|STARTED|Overall Study||9
63334|NCT02331368|155070|P1|NOT COMPLETED|Overall Study||3
63335|NCT02331368|155070|P1|COMPLETED|Overall Study||29
63336|NCT02331368|155070|P1|STARTED|Overall Study||32
63337|NCT02331108|155082|P6|NOT COMPLETED|Overall Study||2
63338|NCT02331108|155083|P5|NOT COMPLETED|Overall Study||2
63339|NCT02331108|155084|P4|NOT COMPLETED|Overall Study||1
63340|NCT02331108|155085|P3|NOT COMPLETED|Overall Study||1
63341|NCT02331108|155086|P2|NOT COMPLETED|Overall Study||2
63342|NCT02331108|155087|P1|NOT COMPLETED|Overall Study||1
63343|NCT02331108|155082|P6|COMPLETED|Overall Study||50
63344|NCT02331108|155083|P5|COMPLETED|Overall Study||50
63345|NCT02331108|155084|P4|COMPLETED|Overall Study||50
63346|NCT02331108|155085|P3|COMPLETED|Overall Study||50
63347|NCT02331108|155086|P2|COMPLETED|Overall Study||50
63348|NCT02331108|155087|P1|COMPLETED|Overall Study||50
63349|NCT02331108|155082|P6|STARTED|Overall Study||52
63350|NCT02331108|155083|P5|STARTED|Overall Study||52
63351|NCT02331108|155084|P4|STARTED|Overall Study||51
63352|NCT02331108|155085|P3|STARTED|Overall Study||51
63353|NCT02331108|155086|P2|STARTED|Overall Study||52
63354|NCT02331108|155087|P1|STARTED|Overall Study||51
63355|NCT02330978|155109|P1|NOT COMPLETED|The Second Patient Included at Study||0
63356|NCT02330978|155109|P1|COMPLETED|The Second Patient Included at Study||1
63357|NCT02330978|155109|P1|STARTED|The Second Patient Included at Study||1
63358|NCT02330978|155109|P1|NOT COMPLETED|The First Patient Included at Study||0
63359|NCT02330978|155109|P1|COMPLETED|The First Patient Included at Study||1
63360|NCT02330978|155109|P1|STARTED|The First Patient Included at Study||1
63361|NCT02330588|155118|P5|NOT COMPLETED|Overall Study||19
63362|NCT02330588|155119|P4|NOT COMPLETED|Overall Study||22
63363|NCT02330588|155120|P3|NOT COMPLETED|Overall Study||15
63364|NCT02330588|155121|P2|NOT COMPLETED|Overall Study||18
63365|NCT02330588|155122|P1|NOT COMPLETED|Overall Study||16
63366|NCT02330588|155118|P5|COMPLETED|Overall Study||28
63367|NCT02330588|155119|P4|COMPLETED|Overall Study||24
63368|NCT02330588|155120|P3|COMPLETED|Overall Study||31
63369|NCT02330588|155121|P2|COMPLETED|Overall Study||25
63370|NCT02330588|155122|P1|COMPLETED|Overall Study||28
63371|NCT02330588|155118|P5|STARTED|Overall Study||47
63372|NCT02330588|155119|P4|STARTED|Overall Study||46
63373|NCT02330588|155120|P3|STARTED|Overall Study||46
63374|NCT02330588|155121|P2|STARTED|Overall Study||43
63375|NCT02330588|155122|P1|STARTED|Overall Study||44
63376|NCT02330549|155149|P2|NOT COMPLETED|Overall Study||1
63377|NCT02330549|155150|P1|NOT COMPLETED|Overall Study||4
63378|NCT02330549|155149|P2|COMPLETED|Overall Study||24
63379|NCT02330549|155150|P1|COMPLETED|Overall Study||16
63380|NCT02330549|155149|P2|STARTED|Overall Study||25
63381|NCT02330549|155150|P1|STARTED|Overall Study||20
63382|NCT02330523|155265|P2|NOT COMPLETED|Overall Study||0
63383|NCT02330523|155266|P1|NOT COMPLETED|Overall Study||0
63384|NCT02330523|155265|P2|COMPLETED|Overall Study||19
63385|NCT02330523|155266|P1|COMPLETED|Overall Study||21
63386|NCT02330523|155265|P2|STARTED|Overall Study||19
63387|NCT02330523|155266|P1|STARTED|Overall Study||21
63388|NCT02330276|155279|P3|NOT COMPLETED|Overall Study||0
63389|NCT02330276|155280|P2|NOT COMPLETED|Overall Study||0
63390|NCT02330276|155281|P1|NOT COMPLETED|Overall Study||0
63391|NCT02330276|155279|P3|COMPLETED|Overall Study||4
63392|NCT02330276|155280|P2|COMPLETED|Overall Study||4
63393|NCT02330276|155281|P1|COMPLETED|Overall Study||4
63394|NCT02330276|155279|P3|STARTED|Overall Study||4
63395|NCT02330276|155280|P2|STARTED|Overall Study||4
63396|NCT02330276|155281|P1|STARTED|Overall Study||4
63397|NCT02330172|155303|P2|NOT COMPLETED|Overall Study||1
63398|NCT02330172|155304|P1|NOT COMPLETED|Overall Study||3
63399|NCT02330172|155303|P2|COMPLETED|Overall Study||21
63400|NCT02330172|155304|P1|COMPLETED|Overall Study||19
63401|NCT02330172|155303|P2|STARTED|Overall Study||22
63402|NCT02330172|155304|P1|STARTED|Overall Study||22
63403|NCT02330094|155314|P2|NOT COMPLETED|Overall Study||0
63404|NCT02330094|155315|P1|NOT COMPLETED|Overall Study||0
63405|NCT02330094|155314|P2|COMPLETED|Overall Study||8
63406|NCT02330094|155315|P1|COMPLETED|Overall Study||8
63407|NCT02330094|155314|P2|STARTED|Overall Study||8
63408|NCT02330094|155315|P1|STARTED|Overall Study||8
63409|NCT02330081|155325|P1|NOT COMPLETED|Overall Study||8
63410|NCT02330081|155325|P1|COMPLETED|Overall Study||14
63411|NCT02330081|155325|P1|STARTED|Overall Study||22
63412|NCT02330055|155346|P2|NOT COMPLETED|Overall Study||9
63413|NCT02330055|155347|P1|NOT COMPLETED|Overall Study||10
63414|NCT02330055|155346|P2|COMPLETED|Overall Study||40
63415|NCT02330055|155347|P1|COMPLETED|Overall Study||40
63416|NCT02330055|155346|P2|STARTED|Overall Study||49
63417|NCT02330055|155347|P1|STARTED|Overall Study||50
63418|NCT02329964|155367|P2|NOT COMPLETED|Overall Study||0
63419|NCT02329964|155368|P1|NOT COMPLETED|Overall Study||0
63420|NCT02329964|155367|P2|COMPLETED|Overall Study||40
63421|NCT02329964|155368|P1|COMPLETED|Overall Study||40
63422|NCT02329964|155367|P2|STARTED|Overall Study||40
63423|NCT02329964|155368|P1|STARTED|Overall Study||40
63424|NCT02329743|155393|P3|NOT COMPLETED|Overall Study||8
63425|NCT02329743|155394|P2|NOT COMPLETED|Overall Study||7
63426|NCT02329743|155395|P1|NOT COMPLETED|Overall Study||6
63427|NCT02329743|155393|P3|COMPLETED|Overall Study||77
63428|NCT02329743|155394|P2|COMPLETED|Overall Study||80
63429|NCT02329743|155395|P1|COMPLETED|Overall Study||78
63430|NCT02329743|155393|P3|STARTED|Overall Study||85
63431|NCT02329743|155394|P2|STARTED|Overall Study||87
63432|NCT02329743|155395|P1|STARTED|Overall Study||84
63433|NCT02329730|155410|P12|NOT COMPLETED|Overall Study||0
63434|NCT02329730|155411|P11|NOT COMPLETED|Overall Study||0
63435|NCT02329730|155412|P10|NOT COMPLETED|Overall Study||1
63436|NCT02329730|155413|P9|NOT COMPLETED|Overall Study||1
63437|NCT02329730|155414|P8|NOT COMPLETED|Overall Study||1
63438|NCT02329730|155415|P7|NOT COMPLETED|Overall Study||1
63439|NCT02329730|155416|P6|NOT COMPLETED|Overall Study||2
63440|NCT02329730|155417|P5|NOT COMPLETED|Overall Study||3
63441|NCT02329730|155418|P4|NOT COMPLETED|Overall Study||0
63442|NCT02329730|155419|P3|NOT COMPLETED|Overall Study||0
63443|NCT02329730|155420|P2|NOT COMPLETED|Overall Study||0
63444|NCT02329730|155421|P1|NOT COMPLETED|Overall Study||0
63445|NCT02329730|155410|P12|COMPLETED|Overall Study||8
63446|NCT02329730|155411|P11|COMPLETED|Overall Study||8
63447|NCT02329730|155412|P10|COMPLETED|Overall Study||7
63448|NCT02329730|155413|P9|COMPLETED|Overall Study||7
63449|NCT02329730|155414|P8|COMPLETED|Overall Study||13
63450|NCT02329730|155415|P7|COMPLETED|Overall Study||13
63451|NCT02329730|155416|P6|COMPLETED|Overall Study||12
63452|NCT02329730|155417|P5|COMPLETED|Overall Study||11
63453|NCT02329730|155418|P4|COMPLETED|Overall Study||14
63454|NCT02329730|155419|P3|COMPLETED|Overall Study||14
63455|NCT02329730|155420|P2|COMPLETED|Overall Study||14
63456|NCT02329730|155421|P1|COMPLETED|Overall Study||14
63457|NCT02329730|155410|P12|STARTED|Overall Study||8
63458|NCT02329730|155411|P11|STARTED|Overall Study||8
63459|NCT02329730|155412|P10|STARTED|Overall Study||8
63460|NCT02329730|155413|P9|STARTED|Overall Study||8
63461|NCT02329730|155414|P8|STARTED|Overall Study||14
63462|NCT02329730|155415|P7|STARTED|Overall Study||14
63463|NCT02329730|155416|P6|STARTED|Overall Study||14
63464|NCT02329730|155417|P5|STARTED|Overall Study||14
63465|NCT02329730|155418|P4|STARTED|Overall Study||14
63466|NCT02329730|155419|P3|STARTED|Overall Study||14
63467|NCT02329730|155420|P2|STARTED|Overall Study||14
63468|NCT02329730|155421|P1|STARTED|Overall Study||14
63469|NCT02329600|155498|P3|NOT COMPLETED|Overall Study||0
63470|NCT02329600|155499|P2|NOT COMPLETED|Overall Study||0
63471|NCT02329600|155500|P1|NOT COMPLETED|Overall Study||0
63472|NCT02329600|155498|P3|COMPLETED|Overall Study||15
63473|NCT02329600|155499|P2|COMPLETED|Overall Study||15
63474|NCT02329600|155500|P1|COMPLETED|Overall Study||10
63475|NCT02329600|155498|P3|STARTED|Overall Study||15
63476|NCT02329600|155499|P2|STARTED|Overall Study||15
63477|NCT02329600|155500|P1|STARTED|Overall Study||10
63478|NCT02329587|155513|P2|NOT COMPLETED|1-month Follow-up||1
63479|NCT02329587|155514|P1|NOT COMPLETED|1-month Follow-up||0
63480|NCT02329587|155513|P2|COMPLETED|1-month Follow-up||5
63481|NCT02329587|155514|P1|COMPLETED|1-month Follow-up||4
63482|NCT02329587|155513|P2|STARTED|1-month Follow-up||6
63483|NCT02329587|155514|P1|STARTED|1-month Follow-up||4
63484|NCT02329587|155513|P2|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
63485|NCT02329587|155514|P1|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
63486|NCT02329587|155513|P2|COMPLETED|Baseline Thru Post-treatment Assessment||6
63487|NCT02329587|155514|P1|COMPLETED|Baseline Thru Post-treatment Assessment||4
63488|NCT02329587|155513|P2|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||4
63489|NCT02329587|155514|P1|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||3
63490|NCT02329587|155513|P2|STARTED|Baseline Thru Post-treatment Assessment||7
63491|NCT02329587|155514|P1|STARTED|Baseline Thru Post-treatment Assessment||5
63492|NCT02329431|155532|P2|NOT COMPLETED|Overall Study||13
63493|NCT02329431|155533|P1|NOT COMPLETED|Overall Study||20
63494|NCT02329431|155532|P2|COMPLETED|Overall Study||76
63495|NCT02329431|155533|P1|COMPLETED|Overall Study||72
63496|NCT02329431|155532|P2|Baseline Interview|Overall Study||85
63497|NCT02329431|155533|P1|Baseline Interview|Overall Study||87
63498|NCT02329431|155532|P2|STARTED|Overall Study||89
63499|NCT02329431|155533|P1|STARTED|Overall Study||92
63500|NCT02329223|155552|P3|NOT COMPLETED|Overall Study||6
63501|NCT02329223|155553|P2|NOT COMPLETED|Overall Study||3
63502|NCT02329223|155554|P1|NOT COMPLETED|Overall Study||1
63503|NCT02329223|155552|P3|COMPLETED|Overall Study||68
63504|NCT02329223|155553|P2|COMPLETED|Overall Study||68
63505|NCT02329223|155554|P1|COMPLETED|Overall Study||72
63506|NCT02329223|155552|P3|Safety Set|Overall Study||74
63507|NCT02329223|155553|P2|Safety Set|Overall Study||71
63508|NCT02329223|155554|P1|Safety Set|Overall Study||73
63509|NCT02329223|155552|P3|Full Analysis Set|Overall Study||74
63510|NCT02329223|155553|P2|Full Analysis Set|Overall Study||70
63511|NCT02329223|155554|P1|Full Analysis Set|Overall Study||73
63512|NCT02329223|155552|P3|STARTED|Overall Study||74
63513|NCT02329223|155553|P2|STARTED|Overall Study||71
63514|NCT02329223|155554|P1|STARTED|Overall Study||73
63515|NCT02329015|155587|P2|NOT COMPLETED|Overall Study||0
63516|NCT02329015|155588|P1|NOT COMPLETED|Overall Study||0
63517|NCT02329015|155587|P2|COMPLETED|Overall Study||64
63518|NCT02329015|155588|P1|COMPLETED|Overall Study||48
63519|NCT02329015|155587|P2|STARTED|Overall Study||64
63520|NCT02329015|155588|P1|STARTED|Overall Study||48
63521|NCT02328937|155604|P6|NOT COMPLETED|Period 3||0
63522|NCT02328937|155605|P5|NOT COMPLETED|Period 3||0
63523|NCT02328937|155606|P4|NOT COMPLETED|Period 3||0
63524|NCT02328937|155607|P3|NOT COMPLETED|Period 3||0
63525|NCT02328937|155608|P2|NOT COMPLETED|Period 3||0
63526|NCT02328937|155609|P1|NOT COMPLETED|Period 3||0
63527|NCT02328937|155604|P6|COMPLETED|Period 3||6
63528|NCT02328937|155605|P5|COMPLETED|Period 3||6
63529|NCT02328937|155606|P4|COMPLETED|Period 3||5
63530|NCT02328937|155607|P3|COMPLETED|Period 3||6
63531|NCT02328937|155608|P2|COMPLETED|Period 3||6
63532|NCT02328937|155609|P1|COMPLETED|Period 3||7
63533|NCT02328937|155604|P6|STARTED|Period 3||6
63534|NCT02328937|155605|P5|STARTED|Period 3||6
63535|NCT02328937|155606|P4|STARTED|Period 3||5
63536|NCT02328937|155607|P3|STARTED|Period 3||6
63537|NCT02328937|155608|P2|STARTED|Period 3||6
63538|NCT02328937|155609|P1|STARTED|Period 3||7
63539|NCT02328937|155604|P6|NOT COMPLETED|Period 2||0
63540|NCT02328937|155605|P5|NOT COMPLETED|Period 2||0
63541|NCT02328937|155606|P4|NOT COMPLETED|Period 2||0
63542|NCT02328937|155607|P3|NOT COMPLETED|Period 2||1
63543|NCT02328937|155608|P2|NOT COMPLETED|Period 2||0
63544|NCT02328937|155609|P1|NOT COMPLETED|Period 2||0
63545|NCT02328937|155604|P6|COMPLETED|Period 2||6
63546|NCT02328937|155605|P5|COMPLETED|Period 2||6
63547|NCT02328937|155606|P4|COMPLETED|Period 2||5
63548|NCT02328937|155607|P3|COMPLETED|Period 2||6
63549|NCT02328937|155608|P2|COMPLETED|Period 2||6
63550|NCT02328937|155609|P1|COMPLETED|Period 2||7
63551|NCT02328937|155604|P6|STARTED|Period 2||6
63552|NCT02328937|155605|P5|STARTED|Period 2||6
63553|NCT02328937|155606|P4|STARTED|Period 2||5
63554|NCT02328937|155607|P3|STARTED|Period 2||7
63555|NCT02328937|155608|P2|STARTED|Period 2||6
63556|NCT02328937|155609|P1|STARTED|Period 2||7
63557|NCT02328937|155604|P6|NOT COMPLETED|Period 1||0
63558|NCT02328937|155605|P5|NOT COMPLETED|Period 1||0
63559|NCT02328937|155606|P4|NOT COMPLETED|Period 1||1
63560|NCT02328937|155607|P3|NOT COMPLETED|Period 1||0
63561|NCT02328937|155608|P2|NOT COMPLETED|Period 1||0
63562|NCT02328937|155609|P1|NOT COMPLETED|Period 1||0
63563|NCT02328937|155604|P6|COMPLETED|Period 1||6
63564|NCT02328937|155605|P5|COMPLETED|Period 1||6
63565|NCT02328937|155606|P4|COMPLETED|Period 1||5
63566|NCT02328937|155607|P3|COMPLETED|Period 1||7
63567|NCT02328937|155608|P2|COMPLETED|Period 1||6
63568|NCT02328937|155609|P1|COMPLETED|Period 1||7
63569|NCT02328937|155604|P6|STARTED|Period 1||6
63570|NCT02328937|155605|P5|STARTED|Period 1||6
63571|NCT02328937|155606|P4|STARTED|Period 1||6
63572|NCT02328937|155607|P3|STARTED|Period 1||7
63573|NCT02328937|155608|P2|STARTED|Period 1||6
63574|NCT02328937|155609|P1|STARTED|Period 1||7
63575|NCT02328807|155620|P1|NOT COMPLETED|Overall Study||0
63576|NCT02328807|155620|P1|COMPLETED|Overall Study||6
63577|NCT02328807|155620|P1|STARTED|Overall Study||6
63578|NCT02328547|155629|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
63579|NCT02328547|155630|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
63580|NCT02328547|155629|P2|COMPLETED|Second Intervention (12 Weeks)||23
63581|NCT02328547|155630|P1|COMPLETED|Second Intervention (12 Weeks)||22
63582|NCT02328547|155629|P2|STARTED|Second Intervention (12 Weeks)||23
63583|NCT02328547|155630|P1|STARTED|Second Intervention (12 Weeks)||22
63584|NCT02328547|155629|P2|NOT COMPLETED|First Intervention (12 Weeks)||0
63585|NCT02328547|155630|P1|NOT COMPLETED|First Intervention (12 Weeks)||3
63586|NCT02328547|155629|P2|COMPLETED|First Intervention (12 Weeks)||23
63587|NCT02328547|155630|P1|COMPLETED|First Intervention (12 Weeks)||22
63588|NCT02328547|155629|P2|STARTED|First Intervention (12 Weeks)||23
63589|NCT02328547|155630|P1|STARTED|First Intervention (12 Weeks)||25
63590|NCT02328404|155670|P2|NOT COMPLETED|Overall Study||1
63591|NCT02328404|155671|P1|NOT COMPLETED|Overall Study||1
63592|NCT02328404|155670|P2|COMPLETED|Overall Study||29
63593|NCT02328404|155671|P1|COMPLETED|Overall Study||29
63594|NCT02328404|155670|P2|STARTED|Overall Study||30
63595|NCT02328404|155671|P1|STARTED|Overall Study||30
63596|NCT02328105|155705|P1|NOT COMPLETED|Overall Study||11
63597|NCT02328105|155705|P1|COMPLETED|Overall Study||0
63598|NCT02328105|155705|P1|STARTED|Overall Study||11
63599|NCT02328040|155710|P2|NOT COMPLETED|Second Intervention (2 Days)||0
63600|NCT02328040|155711|P1|NOT COMPLETED|Second Intervention (2 Days)||0
63601|NCT02328040|155710|P2|COMPLETED|Second Intervention (2 Days)||8
63602|NCT02328040|155711|P1|COMPLETED|Second Intervention (2 Days)||7
63603|NCT02328040|155710|P2|STARTED|Second Intervention (2 Days)||8
63604|NCT02328040|155711|P1|STARTED|Second Intervention (2 Days)||7
63605|NCT02328040|155710|P2|NOT COMPLETED|First Intervention (2 Days)||1
63606|NCT02328040|155711|P1|NOT COMPLETED|First Intervention (2 Days)||1
63607|NCT02328040|155710|P2|COMPLETED|First Intervention (2 Days)||8
63608|NCT02328040|155711|P1|COMPLETED|First Intervention (2 Days)||7
63609|NCT02328040|155710|P2|STARTED|First Intervention (2 Days)||9
63610|NCT02328040|155711|P1|STARTED|First Intervention (2 Days)||8
63611|NCT02327429|155719|P1|NOT COMPLETED|Overall Study||2
63612|NCT02327429|155719|P1|COMPLETED|Overall Study||17
63613|NCT02327429|155719|P1|STARTED|Overall Study||19
63614|NCT02327325|155742|P3|NOT COMPLETED|Overall Study||5
63615|NCT02327325|155743|P2|NOT COMPLETED|Overall Study||4
63616|NCT02327325|155744|P1|NOT COMPLETED|Overall Study||1
63617|NCT02327325|155742|P3|COMPLETED|Overall Study||15
63618|NCT02327325|155743|P2|COMPLETED|Overall Study||16
63619|NCT02327325|155744|P1|COMPLETED|Overall Study||19
63620|NCT02327325|155742|P3|STARTED|Overall Study||20
63621|NCT02327325|155743|P2|STARTED|Overall Study||20
63622|NCT02327325|155744|P1|STARTED|Overall Study||20
63623|NCT02327260|155767|P3|NOT COMPLETED|Overall Study||2
63624|NCT02327260|155768|P2|NOT COMPLETED|Overall Study||4
63625|NCT02327260|155769|P1|NOT COMPLETED|Overall Study||6
63626|NCT02327260|155767|P3|COMPLETED|Overall Study||15
63627|NCT02327260|155768|P2|COMPLETED|Overall Study||20
63628|NCT02327260|155769|P1|COMPLETED|Overall Study||14
63629|NCT02327260|155767|P3|STARTED|Overall Study||17
63630|NCT02327260|155768|P2|STARTED|Overall Study||24
63631|NCT02327260|155769|P1|STARTED|Overall Study||20
63632|NCT02327143|155801|P2|NOT COMPLETED|Day 1: Time 6 Hrs – to Day 9||0
63633|NCT02327143|155802|P1|NOT COMPLETED|Day 1: Time 6 Hrs – to Day 9||0
63634|NCT02327143|155801|P2|COMPLETED|Day 1: Time 6 Hrs – to Day 9||11
63635|NCT02327143|155802|P1|COMPLETED|Day 1: Time 6 Hrs – to Day 9||0
63636|NCT02327143|155801|P2|STARTED|Day 1: Time 6 Hrs – to Day 9||11
63637|NCT02327143|155802|P1|STARTED|Day 1: Time 6 Hrs – to Day 9||0
63638|NCT02327143|155801|P2|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
63639|NCT02327143|155802|P1|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
63640|NCT02327143|155801|P2|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
63641|NCT02327143|155802|P1|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||11
63642|NCT02327143|155801|P2|STARTED|Day 1: Time 0 Hrs to 6 Hrs||0
63643|NCT02327143|155802|P1|STARTED|Day 1: Time 0 Hrs to 6 Hrs||11
63644|NCT02327130|155810|P1|NOT COMPLETED|Overall Study||12
63645|NCT02327130|155810|P1|COMPLETED|Overall Study||20
63646|NCT02327130|155810|P1|STARTED|Overall Study||32
63647|NCT02327117|155819|P2|NOT COMPLETED|Overall Study||0
63648|NCT02327117|155820|P1|NOT COMPLETED|Overall Study||0
63649|NCT02327117|155819|P2|COMPLETED|Overall Study||45
63650|NCT02327117|155820|P1|COMPLETED|Overall Study||45
63651|NCT02327117|155819|P2|STARTED|Overall Study||45
63652|NCT02327117|155820|P1|STARTED|Overall Study||45
63653|NCT02327013|155829|P5|NOT COMPLETED|Overall Study||4
63654|NCT02327013|155830|P4|NOT COMPLETED|Overall Study||1
63655|NCT02327013|155831|P3|NOT COMPLETED|Overall Study||42
63656|NCT02327013|155832|P2|NOT COMPLETED|Overall Study||16
63657|NCT02327013|155833|P1|NOT COMPLETED|Overall Study||13
63658|NCT02327013|155829|P5|COMPLETED|Overall Study||12
63659|NCT02327013|155830|P4|COMPLETED|Overall Study||20
63660|NCT02327013|155831|P3|COMPLETED|Overall Study||54
63661|NCT02327013|155832|P2|COMPLETED|Overall Study||29
63662|NCT02327013|155833|P1|COMPLETED|Overall Study||36
63663|NCT02327013|155829|P5|STARTED|Overall Study||16
63664|NCT02327013|155830|P4|STARTED|Overall Study||21
63665|NCT02327013|155831|P3|STARTED|Overall Study||96
63666|NCT02327013|155832|P2|STARTED|Overall Study||45
63667|NCT02327013|155833|P1|STARTED|Overall Study||49
63668|NCT02326844|156006|P1|NOT COMPLETED|Overall Study||0
63669|NCT02326844|156006|P1|COMPLETED|Overall Study||3
63670|NCT02326844|156006|P1|STARTED|Overall Study||3
63671|NCT02326649|156013|P1|NOT COMPLETED|Overall Study||12
63672|NCT02326649|156013|P1|COMPLETED|Overall Study||21
63673|NCT02326649|156013|P1|STARTED|Overall Study||33
63674|NCT02326597|156019|P2|NOT COMPLETED|Overall Study||32
63675|NCT02326597|156020|P1|NOT COMPLETED|Overall Study||42
63676|NCT02326597|156019|P2|COMPLETED|Overall Study||28
63677|NCT02326597|156020|P1|COMPLETED|Overall Study||18
63678|NCT02326597|156019|P2|STARTED|Overall Study||60
63679|NCT02326597|156020|P1|STARTED|Overall Study||60
63680|NCT02326298|156041|P14|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||9
63681|NCT02326298|156042|P13|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||19
63682|NCT02326298|156043|P12|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||20
63683|NCT02326298|156044|P11|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
63684|NCT02326298|156045|P10|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
63685|NCT02326298|156046|P9|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
63686|NCT02326298|156047|P8|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
63687|NCT02326298|156048|P7|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
63688|NCT02326298|156049|P6|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
63689|NCT02326298|156050|P5|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
63690|NCT02326298|156051|P4|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
63691|NCT02326298|156052|P3|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
63692|NCT02326298|156053|P2|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
63693|NCT02326298|156054|P1|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
63694|NCT02326298|156041|P14|COMPLETED|Open-label Period (Week 48 to Week 144)||44
63695|NCT02326298|156042|P13|COMPLETED|Open-label Period (Week 48 to Week 144)||51
63696|NCT02326298|156043|P12|COMPLETED|Open-label Period (Week 48 to Week 144)||54
63697|NCT02326298|156044|P11|COMPLETED|Open-label Period (Week 48 to Week 144)||3
63698|NCT02326298|156045|P10|COMPLETED|Open-label Period (Week 48 to Week 144)||0
63699|NCT02326298|156046|P9|COMPLETED|Open-label Period (Week 48 to Week 144)||0
63700|NCT02326298|156047|P8|COMPLETED|Open-label Period (Week 48 to Week 144)||0
63701|NCT02326298|156048|P7|COMPLETED|Open-label Period (Week 48 to Week 144)||0
63702|NCT02326298|156049|P6|COMPLETED|Open-label Period (Week 48 to Week 144)||0
63703|NCT02326298|156050|P5|COMPLETED|Open-label Period (Week 48 to Week 144)||0
63704|NCT02326298|156051|P4|COMPLETED|Open-label Period (Week 48 to Week 144)||0
63705|NCT02326298|156052|P3|COMPLETED|Open-label Period (Week 48 to Week 144)||0
63706|NCT02326298|156053|P2|COMPLETED|Open-label Period (Week 48 to Week 144)||0
63707|NCT02326298|156054|P1|COMPLETED|Open-label Period (Week 48 to Week 144)||0
63708|NCT02326298|156041|P14|STARTED|Open-label Period (Week 48 to Week 144)||53
63709|NCT02326298|156042|P13|STARTED|Open-label Period (Week 48 to Week 144)||70
63710|NCT02326298|156043|P12|STARTED|Open-label Period (Week 48 to Week 144)||74
63711|NCT02326298|156044|P11|STARTED|Open-label Period (Week 48 to Week 144)||3
63712|NCT02326298|156045|P10|STARTED|Open-label Period (Week 48 to Week 144)||0
63713|NCT02326298|156046|P9|STARTED|Open-label Period (Week 48 to Week 144)||0
63714|NCT02326298|156047|P8|STARTED|Open-label Period (Week 48 to Week 144)||0
63715|NCT02326298|156048|P7|STARTED|Open-label Period (Week 48 to Week 144)||0
63716|NCT02326298|156049|P6|STARTED|Open-label Period (Week 48 to Week 144)||0
63717|NCT02326298|156050|P5|STARTED|Open-label Period (Week 48 to Week 144)||0
63718|NCT02326298|156051|P4|STARTED|Open-label Period (Week 48 to Week 144)||0
63719|NCT02326298|156052|P3|STARTED|Open-label Period (Week 48 to Week 144)||0
63720|NCT02326298|156053|P2|STARTED|Open-label Period (Week 48 to Week 144)||0
63721|NCT02326298|156054|P1|STARTED|Open-label Period (Week 48 to Week 144)||0
63722|NCT02326298|156041|P14|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
63723|NCT02326298|156042|P13|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
63724|NCT02326298|156043|P12|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
63725|NCT02326298|156044|P11|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
63726|NCT02326298|156045|P10|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
63727|NCT02326298|156046|P9|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
63728|NCT02326298|156047|P8|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
63729|NCT02326298|156048|P7|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
63730|NCT02326298|156049|P6|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
63731|NCT02326298|156050|P5|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
63732|NCT02326298|156051|P4|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
63733|NCT02326298|156052|P3|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
63734|NCT02326298|156053|P2|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
63735|NCT02326298|156054|P1|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
63736|NCT02326298|156041|P14|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
63737|NCT02326298|156042|P13|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
63738|NCT02326298|156043|P12|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
63739|NCT02326298|156044|P11|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
63740|NCT02326298|156045|P10|COMPLETED|Maintenance Period (Week 16 to Week 48)||7
63741|NCT02326298|156046|P9|COMPLETED|Maintenance Period (Week 16 to Week 48)||13
63742|NCT02326298|156047|P8|COMPLETED|Maintenance Period (Week 16 to Week 48)||33
63743|NCT02326298|156048|P7|COMPLETED|Maintenance Period (Week 16 to Week 48)||70
63744|NCT02326298|156049|P6|COMPLETED|Maintenance Period (Week 16 to Week 48)||69
63745|NCT02326298|156050|P5|COMPLETED|Maintenance Period (Week 16 to Week 48)||5
63746|NCT02326298|156051|P4|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
63747|NCT02326298|156052|P3|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
63748|NCT02326298|156053|P2|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
63749|NCT02326298|156054|P1|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
63750|NCT02326298|156041|P14|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
63751|NCT02326298|156042|P13|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
63752|NCT02326298|156043|P12|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
63753|NCT02326298|156044|P11|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
63754|NCT02326298|156045|P10|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||7
63755|NCT02326298|156046|P9|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||13
63756|NCT02326298|156047|P8|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||33
63757|NCT02326298|156048|P7|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||70
63758|NCT02326298|156049|P6|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||69
63759|NCT02326298|156050|P5|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||5
63760|NCT02326298|156051|P4|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
63761|NCT02326298|156052|P3|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
63762|NCT02326298|156053|P2|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
63763|NCT02326298|156054|P1|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
63764|NCT02326298|156041|P14|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
63765|NCT02326298|156042|P13|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
63766|NCT02326298|156043|P12|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
63767|NCT02326298|156044|P11|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
63768|NCT02326298|156045|P10|Completed Week 48|Maintenance Period (Week 16 to Week 48)||7
63769|NCT02326298|156046|P9|Completed Week 48|Maintenance Period (Week 16 to Week 48)||13
63770|NCT02326298|156047|P8|Completed Week 48|Maintenance Period (Week 16 to Week 48)||33
63771|NCT02326298|156048|P7|Completed Week 48|Maintenance Period (Week 16 to Week 48)||70
63772|NCT02326298|156049|P6|Completed Week 48|Maintenance Period (Week 16 to Week 48)||71
63773|NCT02326298|156050|P5|Completed Week 48|Maintenance Period (Week 16 to Week 48)||5
63774|NCT02326298|156051|P4|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
63775|NCT02326298|156052|P3|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
63776|NCT02326298|156053|P2|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
63777|NCT02326298|156054|P1|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
63778|NCT02326298|156041|P14|STARTED|Maintenance Period (Week 16 to Week 48)||0
63779|NCT02326298|156042|P13|STARTED|Maintenance Period (Week 16 to Week 48)||0
63780|NCT02326298|156043|P12|STARTED|Maintenance Period (Week 16 to Week 48)||0
63781|NCT02326298|156044|P11|STARTED|Maintenance Period (Week 16 to Week 48)||0
63782|NCT02326298|156045|P10|STARTED|Maintenance Period (Week 16 to Week 48)||8
63783|NCT02326298|156046|P9|STARTED|Maintenance Period (Week 16 to Week 48)||18
63784|NCT02326298|156047|P8|STARTED|Maintenance Period (Week 16 to Week 48)||38
63785|NCT02326298|156048|P7|STARTED|Maintenance Period (Week 16 to Week 48)||77
63786|NCT02326298|156049|P6|STARTED|Maintenance Period (Week 16 to Week 48)||74
63787|NCT02326298|156050|P5|STARTED|Maintenance Period (Week 16 to Week 48)||5
63788|NCT02326298|156051|P4|STARTED|Maintenance Period (Week 16 to Week 48)||3
63789|NCT02326298|156052|P3|STARTED|Maintenance Period (Week 16 to Week 48)||0
63790|NCT02326298|156053|P2|STARTED|Maintenance Period (Week 16 to Week 48)||0
63791|NCT02326298|156054|P1|STARTED|Maintenance Period (Week 16 to Week 48)||0
63792|NCT02326298|156041|P14|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
63793|NCT02326298|156042|P13|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
63794|NCT02326298|156043|P12|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
63795|NCT02326298|156044|P11|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
63796|NCT02326298|156045|P10|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
63797|NCT02326298|156046|P9|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
63798|NCT02326298|156047|P8|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
63799|NCT02326298|156048|P7|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
63800|NCT02326298|156049|P6|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
63801|NCT02326298|156050|P5|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
63802|NCT02326298|156051|P4|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
63803|NCT02326298|156052|P3|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
63804|NCT02326298|156053|P2|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
63805|NCT02326298|156054|P1|NOT COMPLETED|Initial Period (Week 0 to Week 16)||5
63806|NCT02326298|156041|P14|COMPLETED|Initial Period (Week 0 to Week 16)||0
63807|NCT02326298|156042|P13|COMPLETED|Initial Period (Week 0 to Week 16)||0
63808|NCT02326298|156043|P12|COMPLETED|Initial Period (Week 0 to Week 16)||0
63809|NCT02326298|156044|P11|COMPLETED|Initial Period (Week 0 to Week 16)||0
63810|NCT02326298|156045|P10|COMPLETED|Initial Period (Week 0 to Week 16)||0
63811|NCT02326298|156046|P9|COMPLETED|Initial Period (Week 0 to Week 16)||0
63812|NCT02326298|156047|P8|COMPLETED|Initial Period (Week 0 to Week 16)||0
63813|NCT02326298|156048|P7|COMPLETED|Initial Period (Week 0 to Week 16)||0
63814|NCT02326298|156049|P6|COMPLETED|Initial Period (Week 0 to Week 16)||0
63815|NCT02326298|156050|P5|COMPLETED|Initial Period (Week 0 to Week 16)||0
63816|NCT02326298|156051|P4|COMPLETED|Initial Period (Week 0 to Week 16)||0
63817|NCT02326298|156052|P3|COMPLETED|Initial Period (Week 0 to Week 16)||85
63818|NCT02326298|156053|P2|COMPLETED|Initial Period (Week 0 to Week 16)||92
63819|NCT02326298|156054|P1|COMPLETED|Initial Period (Week 0 to Week 16)||46
63820|NCT02326298|156041|P14|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
63821|NCT02326298|156042|P13|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
63822|NCT02326298|156043|P12|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
63823|NCT02326298|156044|P11|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
63824|NCT02326298|156045|P10|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
63825|NCT02326298|156046|P9|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
63826|NCT02326298|156047|P8|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
63827|NCT02326298|156048|P7|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
63828|NCT02326298|156049|P6|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
63829|NCT02326298|156050|P5|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
63830|NCT02326298|156051|P4|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
63831|NCT02326298|156052|P3|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||85
63832|NCT02326298|156053|P2|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||92
63833|NCT02326298|156054|P1|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||46
63834|NCT02326298|156041|P14|Completed Week 16|Initial Period (Week 0 to Week 16)||0
63835|NCT02326298|156042|P13|Completed Week 16|Initial Period (Week 0 to Week 16)||0
63836|NCT02326298|156043|P12|Completed Week 16|Initial Period (Week 0 to Week 16)||0
63837|NCT02326298|156044|P11|Completed Week 16|Initial Period (Week 0 to Week 16)||0
63838|NCT02326298|156045|P10|Completed Week 16|Initial Period (Week 0 to Week 16)||0
63839|NCT02326298|156046|P9|Completed Week 16|Initial Period (Week 0 to Week 16)||0
63840|NCT02326298|156047|P8|Completed Week 16|Initial Period (Week 0 to Week 16)||0
63841|NCT02326298|156048|P7|Completed Week 16|Initial Period (Week 0 to Week 16)||0
63842|NCT02326298|156049|P6|Completed Week 16|Initial Period (Week 0 to Week 16)||0
63843|NCT02326298|156050|P5|Completed Week 16|Initial Period (Week 0 to Week 16)||0
63844|NCT02326298|156051|P4|Completed Week 16|Initial Period (Week 0 to Week 16)||0
63845|NCT02326298|156052|P3|Completed Week 16|Initial Period (Week 0 to Week 16)||87
63846|NCT02326298|156053|P2|Completed Week 16|Initial Period (Week 0 to Week 16)||92
63847|NCT02326298|156054|P1|Completed Week 16|Initial Period (Week 0 to Week 16)||46
63848|NCT02326298|156041|P14|STARTED|Initial Period (Week 0 to Week 16)||0
63849|NCT02326298|156042|P13|STARTED|Initial Period (Week 0 to Week 16)||0
63850|NCT02326298|156043|P12|STARTED|Initial Period (Week 0 to Week 16)||0
63851|NCT02326298|156044|P11|STARTED|Initial Period (Week 0 to Week 16)||0
63852|NCT02326298|156045|P10|STARTED|Initial Period (Week 0 to Week 16)||0
63853|NCT02326298|156046|P9|STARTED|Initial Period (Week 0 to Week 16)||0
63854|NCT02326298|156047|P8|STARTED|Initial Period (Week 0 to Week 16)||0
63855|NCT02326298|156048|P7|STARTED|Initial Period (Week 0 to Week 16)||0
63856|NCT02326298|156049|P6|STARTED|Initial Period (Week 0 to Week 16)||0
63857|NCT02326298|156050|P5|STARTED|Initial Period (Week 0 to Week 16)||0
63858|NCT02326298|156051|P4|STARTED|Initial Period (Week 0 to Week 16)||0
63859|NCT02326298|156052|P3|STARTED|Initial Period (Week 0 to Week 16)||88
63860|NCT02326298|156053|P2|STARTED|Initial Period (Week 0 to Week 16)||95
63861|NCT02326298|156054|P1|STARTED|Initial Period (Week 0 to Week 16)||51
63862|NCT02326272|156077|P15|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||9
63863|NCT02326272|156078|P14|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
63864|NCT02326272|156079|P13|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||11
63865|NCT02326272|156080|P12|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||15
63866|NCT02326272|156081|P11|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||3
63867|NCT02326272|156082|P10|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
63868|NCT02326272|156083|P9|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
63869|NCT02326272|156084|P8|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
63870|NCT02326272|156085|P7|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
63871|NCT02326272|156086|P6|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
63872|NCT02326272|156087|P5|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
63873|NCT02326272|156088|P4|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
63874|NCT02326272|156089|P3|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
63875|NCT02326272|156090|P2|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
63876|NCT02326272|156091|P1|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
63877|NCT02326272|156077|P15|COMPLETED|Open-label Period (Week 48 to Week 144)||31
63878|NCT02326272|156078|P14|COMPLETED|Open-label Period (Week 48 to Week 144)||1
63879|NCT02326272|156079|P13|COMPLETED|Open-label Period (Week 48 to Week 144)||48
63880|NCT02326272|156080|P12|COMPLETED|Open-label Period (Week 48 to Week 144)||51
63881|NCT02326272|156081|P11|COMPLETED|Open-label Period (Week 48 to Week 144)||2
63882|NCT02326272|156082|P10|COMPLETED|Open-label Period (Week 48 to Week 144)||0
63883|NCT02326272|156083|P9|COMPLETED|Open-label Period (Week 48 to Week 144)||0
63884|NCT02326272|156084|P8|COMPLETED|Open-label Period (Week 48 to Week 144)||0
63885|NCT02326272|156085|P7|COMPLETED|Open-label Period (Week 48 to Week 144)||0
63886|NCT02326272|156086|P6|COMPLETED|Open-label Period (Week 48 to Week 144)||0
63887|NCT02326272|156087|P5|COMPLETED|Open-label Period (Week 48 to Week 144)||0
63888|NCT02326272|156088|P4|COMPLETED|Open-label Period (Week 48 to Week 144)||0
63889|NCT02326272|156089|P3|COMPLETED|Open-label Period (Week 48 to Week 144)||0
63890|NCT02326272|156090|P2|COMPLETED|Open-label Period (Week 48 to Week 144)||0
63891|NCT02326272|156091|P1|COMPLETED|Open-label Period (Week 48 to Week 144)||0
63892|NCT02326272|156077|P15|STARTED|Open-label Period (Week 48 to Week 144)||40
63893|NCT02326272|156078|P14|STARTED|Open-label Period (Week 48 to Week 144)||1
63894|NCT02326272|156079|P13|STARTED|Open-label Period (Week 48 to Week 144)||59
63895|NCT02326272|156080|P12|STARTED|Open-label Period (Week 48 to Week 144)||66
63896|NCT02326272|156081|P11|STARTED|Open-label Period (Week 48 to Week 144)||5
63897|NCT02326272|156082|P10|STARTED|Open-label Period (Week 48 to Week 144)||0
63898|NCT02326272|156083|P9|STARTED|Open-label Period (Week 48 to Week 144)||0
63899|NCT02326272|156084|P8|STARTED|Open-label Period (Week 48 to Week 144)||0
63900|NCT02326272|156085|P7|STARTED|Open-label Period (Week 48 to Week 144)||0
63901|NCT02326272|156086|P6|STARTED|Open-label Period (Week 48 to Week 144)||0
63902|NCT02326272|156087|P5|STARTED|Open-label Period (Week 48 to Week 144)||0
63903|NCT02326272|156088|P4|STARTED|Open-label Period (Week 48 to Week 144)||0
63904|NCT02326272|156089|P3|STARTED|Open-label Period (Week 48 to Week 144)||0
63905|NCT02326272|156090|P2|STARTED|Open-label Period (Week 48 to Week 144)||0
63906|NCT02326272|156091|P1|STARTED|Open-label Period (Week 48 to Week 144)||0
63907|NCT02326272|156077|P15|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
63908|NCT02326272|156078|P14|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
63909|NCT02326272|156079|P13|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
63910|NCT02326272|156080|P12|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
63911|NCT02326272|156081|P11|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
63912|NCT02326272|156082|P10|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
63913|NCT02326272|156083|P9|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
63914|NCT02326272|156084|P8|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
63915|NCT02326272|156085|P7|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||9
63916|NCT02326272|156086|P6|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||13
63917|NCT02326272|156087|P5|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
63918|NCT02326272|156088|P4|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
63919|NCT02326272|156089|P3|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
63920|NCT02326272|156090|P2|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
63921|NCT02326272|156091|P1|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
63922|NCT02326272|156077|P15|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
63923|NCT02326272|156078|P14|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
63924|NCT02326272|156079|P13|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
63925|NCT02326272|156080|P12|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
63926|NCT02326272|156081|P11|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
63927|NCT02326272|156082|P10|COMPLETED|Maintenance Period (Week 16 to Week 48)||10
63928|NCT02326272|156083|P9|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
63929|NCT02326272|156084|P8|COMPLETED|Maintenance Period (Week 16 to Week 48)||27
63930|NCT02326272|156085|P7|COMPLETED|Maintenance Period (Week 16 to Week 48)||60
63931|NCT02326272|156086|P6|COMPLETED|Maintenance Period (Week 16 to Week 48)||63
63932|NCT02326272|156087|P5|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
63933|NCT02326272|156088|P4|COMPLETED|Maintenance Period (Week 16 to Week 48)||5
63934|NCT02326272|156089|P3|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
63935|NCT02326272|156090|P2|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
63936|NCT02326272|156091|P1|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
63937|NCT02326272|156077|P15|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
63938|NCT02326272|156078|P14|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
63939|NCT02326272|156079|P13|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
63940|NCT02326272|156080|P12|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
63941|NCT02326272|156081|P11|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
63942|NCT02326272|156082|P10|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||10
63943|NCT02326272|156083|P9|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
63944|NCT02326272|156084|P8|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||27
63945|NCT02326272|156085|P7|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||60
63946|NCT02326272|156086|P6|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||63
63947|NCT02326272|156087|P5|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
63948|NCT02326272|156088|P4|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||5
63949|NCT02326272|156089|P3|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
63950|NCT02326272|156090|P2|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
63951|NCT02326272|156091|P1|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
63952|NCT02326272|156077|P15|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
63953|NCT02326272|156078|P14|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
63954|NCT02326272|156079|P13|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
63955|NCT02326272|156080|P12|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
63956|NCT02326272|156081|P11|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
63957|NCT02326272|156082|P10|Completed Week 48|Maintenance Period (Week 16 to Week 48)||10
63958|NCT02326272|156083|P9|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
63959|NCT02326272|156084|P8|Completed Week 48|Maintenance Period (Week 16 to Week 48)||27
63960|NCT02326272|156085|P7|Completed Week 48|Maintenance Period (Week 16 to Week 48)||61
63961|NCT02326272|156086|P6|Completed Week 48|Maintenance Period (Week 16 to Week 48)||64
63962|NCT02326272|156087|P5|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
63963|NCT02326272|156088|P4|Completed Week 48|Maintenance Period (Week 16 to Week 48)||5
63964|NCT02326272|156089|P3|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
63965|NCT02326272|156090|P2|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
63966|NCT02326272|156091|P1|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
63967|NCT02326272|156077|P15|STARTED|Maintenance Period (Week 16 to Week 48)||0
63968|NCT02326272|156078|P14|STARTED|Maintenance Period (Week 16 to Week 48)||0
63969|NCT02326272|156079|P13|STARTED|Maintenance Period (Week 16 to Week 48)||0
63970|NCT02326272|156080|P12|STARTED|Maintenance Period (Week 16 to Week 48)||0
63971|NCT02326272|156081|P11|STARTED|Maintenance Period (Week 16 to Week 48)||0
63972|NCT02326272|156082|P10|STARTED|Maintenance Period (Week 16 to Week 48)||12
63973|NCT02326272|156083|P9|STARTED|Maintenance Period (Week 16 to Week 48)||8
63974|NCT02326272|156084|P8|STARTED|Maintenance Period (Week 16 to Week 48)||34
63975|NCT02326272|156085|P7|STARTED|Maintenance Period (Week 16 to Week 48)||69
63976|NCT02326272|156086|P6|STARTED|Maintenance Period (Week 16 to Week 48)||76
63977|NCT02326272|156087|P5|STARTED|Maintenance Period (Week 16 to Week 48)||5
63978|NCT02326272|156088|P4|STARTED|Maintenance Period (Week 16 to Week 48)||6
63979|NCT02326272|156089|P3|STARTED|Maintenance Period (Week 16 to Week 48)||0
63980|NCT02326272|156090|P2|STARTED|Maintenance Period (Week 16 to Week 48)||0
63981|NCT02326272|156091|P1|STARTED|Maintenance Period (Week 16 to Week 48)||0
63982|NCT02326272|156077|P15|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
63983|NCT02326272|156078|P14|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
63984|NCT02326272|156079|P13|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
63985|NCT02326272|156080|P12|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
63986|NCT02326272|156081|P11|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
63987|NCT02326272|156082|P10|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
63988|NCT02326272|156083|P9|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
63989|NCT02326272|156084|P8|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
63990|NCT02326272|156085|P7|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
63991|NCT02326272|156086|P6|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
63992|NCT02326272|156087|P5|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
63993|NCT02326272|156088|P4|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
63994|NCT02326272|156089|P3|NOT COMPLETED|Initial Period (Week 0 to Week 16)||6
63995|NCT02326272|156090|P2|NOT COMPLETED|Initial Period (Week 0 to Week 16)||7
63996|NCT02326272|156091|P1|NOT COMPLETED|Initial Period (Week 0 to Week 16)||4
63997|NCT02326272|156077|P15|COMPLETED|Initial Period (Week 0 to Week 16)||0
63998|NCT02326272|156078|P14|COMPLETED|Initial Period (Week 0 to Week 16)||0
63999|NCT02326272|156079|P13|COMPLETED|Initial Period (Week 0 to Week 16)||0
64000|NCT02326272|156080|P12|COMPLETED|Initial Period (Week 0 to Week 16)||0
64001|NCT02326272|156081|P11|COMPLETED|Initial Period (Week 0 to Week 16)||0
64002|NCT02326272|156082|P10|COMPLETED|Initial Period (Week 0 to Week 16)||0
64003|NCT02326272|156083|P9|COMPLETED|Initial Period (Week 0 to Week 16)||0
64004|NCT02326272|156084|P8|COMPLETED|Initial Period (Week 0 to Week 16)||0
64005|NCT02326272|156085|P7|COMPLETED|Initial Period (Week 0 to Week 16)||0
64006|NCT02326272|156086|P6|COMPLETED|Initial Period (Week 0 to Week 16)||0
64007|NCT02326272|156087|P5|COMPLETED|Initial Period (Week 0 to Week 16)||0
64008|NCT02326272|156088|P4|COMPLETED|Initial Period (Week 0 to Week 16)||0
64009|NCT02326272|156089|P3|COMPLETED|Initial Period (Week 0 to Week 16)||81
64010|NCT02326272|156090|P2|COMPLETED|Initial Period (Week 0 to Week 16)||84
64011|NCT02326272|156091|P1|COMPLETED|Initial Period (Week 0 to Week 16)||45
64012|NCT02326272|156077|P15|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
64013|NCT02326272|156078|P14|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
64014|NCT02326272|156079|P13|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
64015|NCT02326272|156080|P12|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
64016|NCT02326272|156081|P11|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
64017|NCT02326272|156082|P10|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
64018|NCT02326272|156083|P9|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
64019|NCT02326272|156084|P8|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
64020|NCT02326272|156085|P7|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
64021|NCT02326272|156086|P6|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
64022|NCT02326272|156087|P5|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
64023|NCT02326272|156088|P4|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
64024|NCT02326272|156089|P3|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||81
64025|NCT02326272|156090|P2|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||84
64026|NCT02326272|156091|P1|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||45
64027|NCT02326272|156077|P15|Completed Week 16|Initial Period (Week 0 to Week 16)||0
64028|NCT02326272|156078|P14|Completed Week 16|Initial Period (Week 0 to Week 16)||0
64029|NCT02326272|156079|P13|Completed Week 16|Initial Period (Week 0 to Week 16)||0
64030|NCT02326272|156080|P12|Completed Week 16|Initial Period (Week 0 to Week 16)||0
64031|NCT02326272|156081|P11|Completed Week 16|Initial Period (Week 0 to Week 16)||0
64032|NCT02326272|156082|P10|Completed Week 16|Initial Period (Week 0 to Week 16)||0
64033|NCT02326272|156083|P9|Completed Week 16|Initial Period (Week 0 to Week 16)||0
64034|NCT02326272|156084|P8|Completed Week 16|Initial Period (Week 0 to Week 16)||0
64035|NCT02326272|156085|P7|Completed Week 16|Initial Period (Week 0 to Week 16)||0
64036|NCT02326272|156086|P6|Completed Week 16|Initial Period (Week 0 to Week 16)||0
64037|NCT02326272|156087|P5|Completed Week 16|Initial Period (Week 0 to Week 16)||0
64038|NCT02326272|156088|P4|Completed Week 16|Initial Period (Week 0 to Week 16)||0
64039|NCT02326272|156089|P3|Completed Week 16|Initial Period (Week 0 to Week 16)||83
64040|NCT02326272|156090|P2|Completed Week 16|Initial Period (Week 0 to Week 16)||84
64041|NCT02326272|156091|P1|Completed Week 16|Initial Period (Week 0 to Week 16)||45
64042|NCT02326272|156077|P15|STARTED|Initial Period (Week 0 to Week 16)||0
64043|NCT02326272|156078|P14|STARTED|Initial Period (Week 0 to Week 16)||0
64044|NCT02326272|156079|P13|STARTED|Initial Period (Week 0 to Week 16)||0
64045|NCT02326272|156080|P12|STARTED|Initial Period (Week 0 to Week 16)||0
64046|NCT02326272|156081|P11|STARTED|Initial Period (Week 0 to Week 16)||0
64047|NCT02326272|156082|P10|STARTED|Initial Period (Week 0 to Week 16)||0
64048|NCT02326272|156083|P9|STARTED|Initial Period (Week 0 to Week 16)||0
64049|NCT02326272|156084|P8|STARTED|Initial Period (Week 0 to Week 16)||0
64050|NCT02326272|156085|P7|STARTED|Initial Period (Week 0 to Week 16)||0
64051|NCT02326272|156086|P6|STARTED|Initial Period (Week 0 to Week 16)||0
64052|NCT02326272|156087|P5|STARTED|Initial Period (Week 0 to Week 16)||0
64053|NCT02326272|156088|P4|STARTED|Initial Period (Week 0 to Week 16)||0
64054|NCT02326272|156089|P3|STARTED|Initial Period (Week 0 to Week 16)||87
64055|NCT02326272|156090|P2|STARTED|Initial Period (Week 0 to Week 16)||91
64056|NCT02326272|156091|P1|STARTED|Initial Period (Week 0 to Week 16)||49
64057|NCT02326233|156113|P2|NOT COMPLETED|Overall Study||1
64058|NCT02326233|156114|P1|NOT COMPLETED|Overall Study||0
64059|NCT02326233|156113|P2|COMPLETED|Overall Study||94
64060|NCT02326233|156114|P1|COMPLETED|Overall Study||95
64061|NCT02326233|156113|P2|STARTED|Overall Study||95
64062|NCT02326233|156114|P1|STARTED|Overall Study||95
64063|NCT02326025|156128|P2|NOT COMPLETED|Overall Study||5
64064|NCT02326025|156129|P1|NOT COMPLETED|Overall Study||5
64065|NCT02326025|156128|P2|COMPLETED|Overall Study||19
64066|NCT02326025|156129|P1|COMPLETED|Overall Study||20
64067|NCT02326025|156128|P2|Received at Least 1 Dose of Study Drug|Overall Study||24
64068|NCT02326025|156129|P1|Received at Least 1 Dose of Study Drug|Overall Study||25
64069|NCT02326025|156128|P2|STARTED|Overall Study||24
64070|NCT02326025|156129|P1|STARTED|Overall Study||25
64071|NCT02325856|156163|P2|NOT COMPLETED|Overall Study||27
64072|NCT02325856|156164|P1|NOT COMPLETED|Overall Study||20
64073|NCT02325856|156163|P2|COMPLETED|Overall Study||123
64074|NCT02325856|156164|P1|COMPLETED|Overall Study||128
64075|NCT02325856|156163|P2|STARTED|Overall Study||150
64076|NCT02325856|156164|P1|STARTED|Overall Study||148
64077|NCT02325791|156176|P4|NOT COMPLETED|Overall Study||26
64078|NCT02325791|156177|P3|NOT COMPLETED|Overall Study||25
64079|NCT02325791|156178|P2|NOT COMPLETED|Overall Study||25
64080|NCT02325791|156179|P1|NOT COMPLETED|Overall Study||0
64081|NCT02325791|156176|P4|COMPLETED|Overall Study||355
64082|NCT02325791|156177|P3|COMPLETED|Overall Study||360
64083|NCT02325791|156178|P2|COMPLETED|Overall Study||358
64084|NCT02325791|156179|P1|COMPLETED|Overall Study||23
64085|NCT02325791|156176|P4|STARTED|Overall Study||381
64086|NCT02325791|156177|P3|STARTED|Overall Study||385
64087|NCT02325791|156178|P2|STARTED|Overall Study||383
64088|NCT02325791|156179|P1|STARTED|Overall Study||23
64089|NCT02325713|156214|P16|NOT COMPLETED|Intervention Period 4 (2 Days)||0
64090|NCT02325713|156215|P15|NOT COMPLETED|Intervention Period 4 (2 Days)||0
64091|NCT02325713|156216|P14|NOT COMPLETED|Intervention Period 4 (2 Days)||0
64092|NCT02325713|156217|P13|NOT COMPLETED|Intervention Period 4 (2 Days)||0
64093|NCT02325713|156218|P12|NOT COMPLETED|Intervention Period 4 (2 Days)||0
64094|NCT02325713|156219|P11|NOT COMPLETED|Intervention Period 4 (2 Days)||0
64095|NCT02325713|156220|P10|NOT COMPLETED|Intervention Period 4 (2 Days)||0
64096|NCT02325713|156221|P9|NOT COMPLETED|Intervention Period 4 (2 Days)||0
64097|NCT02325713|156222|P8|NOT COMPLETED|Intervention Period 4 (2 Days)||0
64098|NCT02325713|156223|P7|NOT COMPLETED|Intervention Period 4 (2 Days)||0
64099|NCT02325713|156224|P6|NOT COMPLETED|Intervention Period 4 (2 Days)||0
64100|NCT02325713|156225|P5|NOT COMPLETED|Intervention Period 4 (2 Days)||0
64101|NCT02325713|156226|P4|NOT COMPLETED|Intervention Period 4 (2 Days)||0
64102|NCT02325713|156227|P3|NOT COMPLETED|Intervention Period 4 (2 Days)||0
64103|NCT02325713|156228|P2|NOT COMPLETED|Intervention Period 4 (2 Days)||0
64104|NCT02325713|156229|P1|NOT COMPLETED|Intervention Period 4 (2 Days)||0
64105|NCT02325713|156214|P16|COMPLETED|Intervention Period 4 (2 Days)||2
64106|NCT02325713|156215|P15|COMPLETED|Intervention Period 4 (2 Days)||2
64107|NCT02325713|156216|P14|COMPLETED|Intervention Period 4 (2 Days)||2
64108|NCT02325713|156217|P13|COMPLETED|Intervention Period 4 (2 Days)||2
64109|NCT02325713|156218|P12|COMPLETED|Intervention Period 4 (2 Days)||2
64110|NCT02325713|156219|P11|COMPLETED|Intervention Period 4 (2 Days)||1
64111|NCT02325713|156220|P10|COMPLETED|Intervention Period 4 (2 Days)||1
64112|NCT02325713|156221|P9|COMPLETED|Intervention Period 4 (2 Days)||2
64113|NCT02325713|156222|P8|COMPLETED|Intervention Period 4 (2 Days)||2
64114|NCT02325713|156223|P7|COMPLETED|Intervention Period 4 (2 Days)||2
64115|NCT02325713|156224|P6|COMPLETED|Intervention Period 4 (2 Days)||2
64116|NCT02325713|156225|P5|COMPLETED|Intervention Period 4 (2 Days)||2
64117|NCT02325713|156226|P4|COMPLETED|Intervention Period 4 (2 Days)||2
64118|NCT02325713|156227|P3|COMPLETED|Intervention Period 4 (2 Days)||2
64119|NCT02325713|156228|P2|COMPLETED|Intervention Period 4 (2 Days)||2
64120|NCT02325713|156229|P1|COMPLETED|Intervention Period 4 (2 Days)||1
64121|NCT02325713|156214|P16|STARTED|Intervention Period 4 (2 Days)||2
64122|NCT02325713|156215|P15|STARTED|Intervention Period 4 (2 Days)||2
64123|NCT02325713|156216|P14|STARTED|Intervention Period 4 (2 Days)||2
64124|NCT02325713|156217|P13|STARTED|Intervention Period 4 (2 Days)||2
64125|NCT02325713|156218|P12|STARTED|Intervention Period 4 (2 Days)||2
64126|NCT02325713|156219|P11|STARTED|Intervention Period 4 (2 Days)||1
64127|NCT02325713|156220|P10|STARTED|Intervention Period 4 (2 Days)||1
64128|NCT02325713|156221|P9|STARTED|Intervention Period 4 (2 Days)||2
64129|NCT02325713|156222|P8|STARTED|Intervention Period 4 (2 Days)||2
64130|NCT02325713|156223|P7|STARTED|Intervention Period 4 (2 Days)||2
64131|NCT02325713|156224|P6|STARTED|Intervention Period 4 (2 Days)||2
64132|NCT02325713|156225|P5|STARTED|Intervention Period 4 (2 Days)||2
64133|NCT02325713|156226|P4|STARTED|Intervention Period 4 (2 Days)||2
64134|NCT02325713|156227|P3|STARTED|Intervention Period 4 (2 Days)||2
64135|NCT02325713|156228|P2|STARTED|Intervention Period 4 (2 Days)||2
64136|NCT02325713|156229|P1|STARTED|Intervention Period 4 (2 Days)||1
64137|NCT02325713|156214|P16|NOT COMPLETED|Intervention Period 3 (2 Days)||0
64138|NCT02325713|156215|P15|NOT COMPLETED|Intervention Period 3 (2 Days)||0
64139|NCT02325713|156216|P14|NOT COMPLETED|Intervention Period 3 (2 Days)||0
64140|NCT02325713|156217|P13|NOT COMPLETED|Intervention Period 3 (2 Days)||0
64141|NCT02325713|156218|P12|NOT COMPLETED|Intervention Period 3 (2 Days)||0
64142|NCT02325713|156219|P11|NOT COMPLETED|Intervention Period 3 (2 Days)||0
64143|NCT02325713|156220|P10|NOT COMPLETED|Intervention Period 3 (2 Days)||1
64144|NCT02325713|156221|P9|NOT COMPLETED|Intervention Period 3 (2 Days)||0
64145|NCT02325713|156222|P8|NOT COMPLETED|Intervention Period 3 (2 Days)||0
64146|NCT02325713|156223|P7|NOT COMPLETED|Intervention Period 3 (2 Days)||0
64147|NCT02325713|156224|P6|NOT COMPLETED|Intervention Period 3 (2 Days)||0
64148|NCT02325713|156225|P5|NOT COMPLETED|Intervention Period 3 (2 Days)||0
64149|NCT02325713|156226|P4|NOT COMPLETED|Intervention Period 3 (2 Days)||0
64150|NCT02325713|156227|P3|NOT COMPLETED|Intervention Period 3 (2 Days)||0
64151|NCT02325713|156228|P2|NOT COMPLETED|Intervention Period 3 (2 Days)||0
64152|NCT02325713|156229|P1|NOT COMPLETED|Intervention Period 3 (2 Days)||0
64153|NCT02325713|156214|P16|COMPLETED|Intervention Period 3 (2 Days)||2
64154|NCT02325713|156215|P15|COMPLETED|Intervention Period 3 (2 Days)||2
64155|NCT02325713|156216|P14|COMPLETED|Intervention Period 3 (2 Days)||2
64156|NCT02325713|156217|P13|COMPLETED|Intervention Period 3 (2 Days)||2
64157|NCT02325713|156218|P12|COMPLETED|Intervention Period 3 (2 Days)||2
64158|NCT02325713|156219|P11|COMPLETED|Intervention Period 3 (2 Days)||1
64159|NCT02325713|156220|P10|COMPLETED|Intervention Period 3 (2 Days)||1
64160|NCT02325713|156221|P9|COMPLETED|Intervention Period 3 (2 Days)||2
64161|NCT02325713|156222|P8|COMPLETED|Intervention Period 3 (2 Days)||2
64162|NCT02325713|156223|P7|COMPLETED|Intervention Period 3 (2 Days)||2
64163|NCT02325713|156224|P6|COMPLETED|Intervention Period 3 (2 Days)||2
64164|NCT02325713|156225|P5|COMPLETED|Intervention Period 3 (2 Days)||2
64165|NCT02325713|156226|P4|COMPLETED|Intervention Period 3 (2 Days)||2
64166|NCT02325713|156227|P3|COMPLETED|Intervention Period 3 (2 Days)||2
64167|NCT02325713|156228|P2|COMPLETED|Intervention Period 3 (2 Days)||2
64168|NCT02325713|156229|P1|COMPLETED|Intervention Period 3 (2 Days)||1
64169|NCT02325713|156214|P16|STARTED|Intervention Period 3 (2 Days)||2
64170|NCT02325713|156215|P15|STARTED|Intervention Period 3 (2 Days)||2
64171|NCT02325713|156216|P14|STARTED|Intervention Period 3 (2 Days)||2
64172|NCT02325713|156217|P13|STARTED|Intervention Period 3 (2 Days)||2
64173|NCT02325713|156218|P12|STARTED|Intervention Period 3 (2 Days)||2
64174|NCT02325713|156219|P11|STARTED|Intervention Period 3 (2 Days)||1
64175|NCT02325713|156220|P10|STARTED|Intervention Period 3 (2 Days)||2
64176|NCT02325713|156221|P9|STARTED|Intervention Period 3 (2 Days)||2
64177|NCT02325713|156222|P8|STARTED|Intervention Period 3 (2 Days)||2
64178|NCT02325713|156223|P7|STARTED|Intervention Period 3 (2 Days)||2
64179|NCT02325713|156224|P6|STARTED|Intervention Period 3 (2 Days)||2
64180|NCT02325713|156225|P5|STARTED|Intervention Period 3 (2 Days)||2
64181|NCT02325713|156226|P4|STARTED|Intervention Period 3 (2 Days)||2
64182|NCT02325713|156227|P3|STARTED|Intervention Period 3 (2 Days)||2
64183|NCT02325713|156228|P2|STARTED|Intervention Period 3 (2 Days)||2
64184|NCT02325713|156229|P1|STARTED|Intervention Period 3 (2 Days)||1
64185|NCT02325713|156214|P16|NOT COMPLETED|Intervention Period 2 (2 Days)||0
64186|NCT02325713|156215|P15|NOT COMPLETED|Intervention Period 2 (2 Days)||0
64187|NCT02325713|156216|P14|NOT COMPLETED|Intervention Period 2 (2 Days)||0
64188|NCT02325713|156217|P13|NOT COMPLETED|Intervention Period 2 (2 Days)||0
64189|NCT02325713|156218|P12|NOT COMPLETED|Intervention Period 2 (2 Days)||0
64190|NCT02325713|156219|P11|NOT COMPLETED|Intervention Period 2 (2 Days)||0
64191|NCT02325713|156220|P10|NOT COMPLETED|Intervention Period 2 (2 Days)||0
64192|NCT02325713|156221|P9|NOT COMPLETED|Intervention Period 2 (2 Days)||0
64193|NCT02325713|156222|P8|NOT COMPLETED|Intervention Period 2 (2 Days)||0
64194|NCT02325713|156223|P7|NOT COMPLETED|Intervention Period 2 (2 Days)||0
64195|NCT02325713|156224|P6|NOT COMPLETED|Intervention Period 2 (2 Days)||0
64196|NCT02325713|156225|P5|NOT COMPLETED|Intervention Period 2 (2 Days)||0
64197|NCT02325713|156226|P4|NOT COMPLETED|Intervention Period 2 (2 Days)||0
64198|NCT02325713|156227|P3|NOT COMPLETED|Intervention Period 2 (2 Days)||0
64199|NCT02325713|156228|P2|NOT COMPLETED|Intervention Period 2 (2 Days)||0
64200|NCT02325713|156229|P1|NOT COMPLETED|Intervention Period 2 (2 Days)||1
64201|NCT02325713|156214|P16|COMPLETED|Intervention Period 2 (2 Days)||2
64202|NCT02325713|156215|P15|COMPLETED|Intervention Period 2 (2 Days)||2
64203|NCT02325713|156216|P14|COMPLETED|Intervention Period 2 (2 Days)||2
64204|NCT02325713|156217|P13|COMPLETED|Intervention Period 2 (2 Days)||2
64205|NCT02325713|156218|P12|COMPLETED|Intervention Period 2 (2 Days)||2
64206|NCT02325713|156219|P11|COMPLETED|Intervention Period 2 (2 Days)||1
64207|NCT02325713|156220|P10|COMPLETED|Intervention Period 2 (2 Days)||2
64208|NCT02325713|156221|P9|COMPLETED|Intervention Period 2 (2 Days)||2
64209|NCT02325713|156222|P8|COMPLETED|Intervention Period 2 (2 Days)||2
64210|NCT02325713|156223|P7|COMPLETED|Intervention Period 2 (2 Days)||2
64211|NCT02325713|156224|P6|COMPLETED|Intervention Period 2 (2 Days)||2
64212|NCT02325713|156225|P5|COMPLETED|Intervention Period 2 (2 Days)||2
64213|NCT02325713|156226|P4|COMPLETED|Intervention Period 2 (2 Days)||2
64214|NCT02325713|156227|P3|COMPLETED|Intervention Period 2 (2 Days)||2
64215|NCT02325713|156228|P2|COMPLETED|Intervention Period 2 (2 Days)||2
64216|NCT02325713|156229|P1|COMPLETED|Intervention Period 2 (2 Days)||1
64217|NCT02325713|156214|P16|STARTED|Intervention Period 2 (2 Days)||2
64218|NCT02325713|156215|P15|STARTED|Intervention Period 2 (2 Days)||2
64219|NCT02325713|156216|P14|STARTED|Intervention Period 2 (2 Days)||2
64220|NCT02325713|156217|P13|STARTED|Intervention Period 2 (2 Days)||2
64221|NCT02325713|156218|P12|STARTED|Intervention Period 2 (2 Days)||2
64222|NCT02325713|156219|P11|STARTED|Intervention Period 2 (2 Days)||1
64223|NCT02325713|156220|P10|STARTED|Intervention Period 2 (2 Days)||2
64224|NCT02325713|156221|P9|STARTED|Intervention Period 2 (2 Days)||2
64225|NCT02325713|156222|P8|STARTED|Intervention Period 2 (2 Days)||2
64226|NCT02325713|156223|P7|STARTED|Intervention Period 2 (2 Days)||2
64227|NCT02325713|156224|P6|STARTED|Intervention Period 2 (2 Days)||2
64228|NCT02325713|156225|P5|STARTED|Intervention Period 2 (2 Days)||2
64229|NCT02325713|156226|P4|STARTED|Intervention Period 2 (2 Days)||2
64230|NCT02325713|156227|P3|STARTED|Intervention Period 2 (2 Days)||2
64231|NCT02325713|156228|P2|STARTED|Intervention Period 2 (2 Days)||2
64232|NCT02325713|156229|P1|STARTED|Intervention Period 2 (2 Days)||2
64233|NCT02325713|156214|P16|NOT COMPLETED|Intervention Period 1 (2 Days)||0
64234|NCT02325713|156215|P15|NOT COMPLETED|Intervention Period 1 (2 Days)||0
64235|NCT02325713|156216|P14|NOT COMPLETED|Intervention Period 1 (2 Days)||0
64236|NCT02325713|156217|P13|NOT COMPLETED|Intervention Period 1 (2 Days)||0
64237|NCT02325713|156218|P12|NOT COMPLETED|Intervention Period 1 (2 Days)||0
64238|NCT02325713|156219|P11|NOT COMPLETED|Intervention Period 1 (2 Days)||1
64239|NCT02325713|156220|P10|NOT COMPLETED|Intervention Period 1 (2 Days)||0
64240|NCT02325713|156221|P9|NOT COMPLETED|Intervention Period 1 (2 Days)||0
64241|NCT02325713|156222|P8|NOT COMPLETED|Intervention Period 1 (2 Days)||0
64242|NCT02325713|156223|P7|NOT COMPLETED|Intervention Period 1 (2 Days)||0
64243|NCT02325713|156224|P6|NOT COMPLETED|Intervention Period 1 (2 Days)||0
64244|NCT02325713|156225|P5|NOT COMPLETED|Intervention Period 1 (2 Days)||0
64245|NCT02325713|156226|P4|NOT COMPLETED|Intervention Period 1 (2 Days)||0
64246|NCT02325713|156227|P3|NOT COMPLETED|Intervention Period 1 (2 Days)||0
64247|NCT02325713|156228|P2|NOT COMPLETED|Intervention Period 1 (2 Days)||0
64248|NCT02325713|156229|P1|NOT COMPLETED|Intervention Period 1 (2 Days)||0
64249|NCT02325713|156214|P16|COMPLETED|Intervention Period 1 (2 Days)||2
64250|NCT02325713|156215|P15|COMPLETED|Intervention Period 1 (2 Days)||2
64251|NCT02325713|156216|P14|COMPLETED|Intervention Period 1 (2 Days)||2
64252|NCT02325713|156217|P13|COMPLETED|Intervention Period 1 (2 Days)||2
64253|NCT02325713|156218|P12|COMPLETED|Intervention Period 1 (2 Days)||2
64254|NCT02325713|156219|P11|COMPLETED|Intervention Period 1 (2 Days)||1
64255|NCT02325713|156220|P10|COMPLETED|Intervention Period 1 (2 Days)||2
64256|NCT02325713|156221|P9|COMPLETED|Intervention Period 1 (2 Days)||2
64257|NCT02325713|156222|P8|COMPLETED|Intervention Period 1 (2 Days)||2
64258|NCT02325713|156223|P7|COMPLETED|Intervention Period 1 (2 Days)||2
64259|NCT02325713|156224|P6|COMPLETED|Intervention Period 1 (2 Days)||2
64260|NCT02325713|156225|P5|COMPLETED|Intervention Period 1 (2 Days)||2
64261|NCT02325713|156226|P4|COMPLETED|Intervention Period 1 (2 Days)||2
64262|NCT02325713|156227|P3|COMPLETED|Intervention Period 1 (2 Days)||2
64263|NCT02325713|156228|P2|COMPLETED|Intervention Period 1 (2 Days)||2
64264|NCT02325713|156229|P1|COMPLETED|Intervention Period 1 (2 Days)||2
64265|NCT02325713|156214|P16|STARTED|Intervention Period 1 (2 Days)||2
64266|NCT02325713|156215|P15|STARTED|Intervention Period 1 (2 Days)||2
64267|NCT02325713|156216|P14|STARTED|Intervention Period 1 (2 Days)||2
64268|NCT02325713|156217|P13|STARTED|Intervention Period 1 (2 Days)||2
64269|NCT02325713|156218|P12|STARTED|Intervention Period 1 (2 Days)||2
64270|NCT02325713|156219|P11|STARTED|Intervention Period 1 (2 Days)||2
64271|NCT02325713|156220|P10|STARTED|Intervention Period 1 (2 Days)||2
64272|NCT02325713|156221|P9|STARTED|Intervention Period 1 (2 Days)||2
64273|NCT02325713|156222|P8|STARTED|Intervention Period 1 (2 Days)||2
64274|NCT02325713|156223|P7|STARTED|Intervention Period 1 (2 Days)||2
64275|NCT02325713|156224|P6|STARTED|Intervention Period 1 (2 Days)||2
64276|NCT02325713|156225|P5|STARTED|Intervention Period 1 (2 Days)||2
64277|NCT02325713|156226|P4|STARTED|Intervention Period 1 (2 Days)||2
64278|NCT02325713|156227|P3|STARTED|Intervention Period 1 (2 Days)||2
64279|NCT02325713|156228|P2|STARTED|Intervention Period 1 (2 Days)||2
64280|NCT02325713|156229|P1|STARTED|Intervention Period 1 (2 Days)||2
64281|NCT02325518|156324|P2|NOT COMPLETED|Overall Study||3
64282|NCT02325518|156325|P1|NOT COMPLETED|Overall Study||4
64283|NCT02325518|156324|P2|COMPLETED|Overall Study||100
64284|NCT02325518|156325|P1|COMPLETED|Overall Study||94
64285|NCT02325518|156324|P2|Per Protocol Set (PPS)|Overall Study||97
64286|NCT02325518|156325|P1|Per Protocol Set (PPS)|Overall Study||92
64287|NCT02325518|156324|P2|Full Analysis Set (FAS)|Overall Study||101
64288|NCT02325518|156325|P1|Full Analysis Set (FAS)|Overall Study||98
64289|NCT02325518|156324|P2|Safety Set|Overall Study||103
64290|NCT02325518|156325|P1|Safety Set|Overall Study||98
64291|NCT02325518|156324|P2|STARTED|Overall Study||103
64292|NCT02325518|156325|P1|STARTED|Overall Study||98
64293|NCT02324972|156336|P2|NOT COMPLETED|Overall Study||5
64294|NCT02324972|156337|P1|NOT COMPLETED|Overall Study||7
64295|NCT02324972|156336|P2|COMPLETED|Overall Study||23
64296|NCT02324972|156337|P1|COMPLETED|Overall Study||19
64297|NCT02324972|156336|P2|STARTED|Overall Study||28
64298|NCT02324972|156337|P1|STARTED|Overall Study||26
64299|NCT02324842|156354|P3|NOT COMPLETED|Overall Study||2
64300|NCT02324842|156355|P2|NOT COMPLETED|Overall Study||1
64301|NCT02324842|156356|P1|NOT COMPLETED|Overall Study||1
64302|NCT02324842|156354|P3|COMPLETED|Overall Study||13
64303|NCT02324842|156355|P2|COMPLETED|Overall Study||14
64304|NCT02324842|156356|P1|COMPLETED|Overall Study||14
64305|NCT02324842|156354|P3|STARTED|Overall Study||15
64306|NCT02324842|156355|P2|STARTED|Overall Study||15
64307|NCT02324842|156356|P1|STARTED|Overall Study||15
64308|NCT02324699|156385|P1|NOT COMPLETED|Overall Study||1
64309|NCT02324699|156385|P1|COMPLETED|Overall Study||0
64310|NCT02324699|156385|P1|STARTED|Overall Study||1
64311|NCT02324673|156395|P3|NOT COMPLETED|Overall Study||0
64312|NCT02324673|156396|P2|NOT COMPLETED|Overall Study||0
64313|NCT02324673|156397|P1|NOT COMPLETED|Overall Study||0
64314|NCT02324673|156395|P3|COMPLETED|Overall Study||21
64315|NCT02324673|156396|P2|COMPLETED|Overall Study||20
64316|NCT02324673|156397|P1|COMPLETED|Overall Study||20
64317|NCT02324673|156395|P3|STARTED|Overall Study||21
64318|NCT02324673|156396|P2|STARTED|Overall Study||20
64319|NCT02324673|156397|P1|STARTED|Overall Study||20
64320|NCT02324660|156498|P1|NOT COMPLETED|Overall Study||32
64321|NCT02324660|156498|P1|COMPLETED|Overall Study||137
64322|NCT02324660|156498|P1|STARTED|Overall Study||169
64323|NCT02324569|156505|P2|NOT COMPLETED|Overall Study||21
64324|NCT02324569|156506|P1|NOT COMPLETED|Overall Study||16
64325|NCT02324569|156505|P2|COMPLETED|Overall Study||103
64326|NCT02324569|156506|P1|COMPLETED|Overall Study||100
64327|NCT02324569|156505|P2|STARTED|Overall Study||124
64328|NCT02324569|156506|P1|STARTED|Overall Study||116
64329|NCT02324504|156530|P1|NOT COMPLETED|Overall Study||0
64330|NCT02324504|156530|P1|COMPLETED|Overall Study||60
64331|NCT02324504|156530|P1|STARTED|Overall Study||60
64332|NCT02324465|156539|P2|NOT COMPLETED|Overall Study||1
64333|NCT02324465|156540|P1|NOT COMPLETED|Overall Study||0
64334|NCT02324465|156539|P2|COMPLETED|Overall Study||21
64335|NCT02324465|156540|P1|COMPLETED|Overall Study||18
64336|NCT02324465|156539|P2|STARTED|Overall Study||22
64337|NCT02324465|156540|P1|STARTED|Overall Study||18
64338|NCT02324335|156554|P2|NOT COMPLETED|Overall Study||9
64339|NCT02324335|156555|P1|NOT COMPLETED|Overall Study||9
64340|NCT02324335|156554|P2|COMPLETED|Overall Study||20
64341|NCT02324335|156555|P1|COMPLETED|Overall Study||21
64342|NCT02324335|156554|P2|STARTED|Overall Study||29
64343|NCT02324335|156555|P1|STARTED|Overall Study||30
64344|NCT02324205|156567|P1|NOT COMPLETED|Overall Study||37
64345|NCT02324205|156567|P1|COMPLETED|Overall Study||159
64346|NCT02324205|156567|P1|STARTED|Overall Study||196
64347|NCT02324049|156577|P1|NOT COMPLETED|Part C||11
64348|NCT02324049|156577|P1|COMPLETED|Part C||0
64349|NCT02324049|156577|P1|Safety Analysis Set|Part C||11
64350|NCT02324049|156577|P1|STARTED|Part C||11
64351|NCT02324049|156577|P1|NOT COMPLETED|Part B||0
64352|NCT02324049|156577|P1|COMPLETED|Part B||11
64353|NCT02324049|156577|P1|Safety Analysis Set|Part B||11
64354|NCT02324049|156577|P1|STARTED|Part B||11
64355|NCT02324049|156577|P1|NOT COMPLETED|Part A||0
64356|NCT02324049|156577|P1|COMPLETED|Part A||11
64357|NCT02324049|156577|P1|Safety Analysis Set|Part A|Participants with informed consent, confirmed MPS IIIB diagnosis, and received any amount of SBC-103|11
64358|NCT02324049|156577|P1|STARTED|Part A||11
64359|NCT02323854|156581|P1|NOT COMPLETED|Overall Study||0
64360|NCT02323854|156581|P1|COMPLETED|Overall Study||15
64361|NCT02323854|156581|P1|STARTED|Overall Study||15
64362|NCT02323646|156590|P3|NOT COMPLETED|Treatment Course 2||3
64363|NCT02323646|156591|P2|NOT COMPLETED|Treatment Course 2||1
64364|NCT02323646|156592|P1|NOT COMPLETED|Treatment Course 2||1
64365|NCT02323646|156590|P3|COMPLETED|Treatment Course 2||9
64366|NCT02323646|156591|P2|COMPLETED|Treatment Course 2||9
64367|NCT02323646|156592|P1|COMPLETED|Treatment Course 2||10
64368|NCT02323646|156590|P3|STARTED|Treatment Course 2||12
64369|NCT02323646|156591|P2|STARTED|Treatment Course 2||10
64370|NCT02323646|156592|P1|STARTED|Treatment Course 2||11
64371|NCT02323646|156590|P3|NOT COMPLETED|Treatment Course 1||3
64372|NCT02323646|156591|P2|NOT COMPLETED|Treatment Course 1||3
64373|NCT02323646|156592|P1|NOT COMPLETED|Treatment Course 1||3
64374|NCT02323646|156590|P3|COMPLETED|Treatment Course 1||12
64375|NCT02323646|156591|P2|COMPLETED|Treatment Course 1||10
64376|NCT02323646|156592|P1|COMPLETED|Treatment Course 1||11
64377|NCT02323646|156590|P3|STARTED|Treatment Course 1||15
64378|NCT02323646|156591|P2|STARTED|Treatment Course 1||13
64379|NCT02323646|156592|P1|STARTED|Treatment Course 1||14
64380|NCT02323204|156640|P4|NOT COMPLETED|6-month Follow-up Survey Completion||44
64381|NCT02323204|156641|P3|NOT COMPLETED|6-month Follow-up Survey Completion||41
64382|NCT02323204|156642|P2|NOT COMPLETED|6-month Follow-up Survey Completion||50
64383|NCT02323204|156643|P1|NOT COMPLETED|6-month Follow-up Survey Completion||49
64384|NCT02323204|156640|P4|COMPLETED|6-month Follow-up Survey Completion||112
64385|NCT02323204|156641|P3|COMPLETED|6-month Follow-up Survey Completion||113
64386|NCT02323204|156642|P2|COMPLETED|6-month Follow-up Survey Completion||96
64387|NCT02323204|156643|P1|COMPLETED|6-month Follow-up Survey Completion||96
64388|NCT02323204|156640|P4|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|156
64389|NCT02323204|156641|P3|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|154
64390|NCT02323204|156642|P2|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|146
64391|NCT02323204|156643|P1|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|145
64392|NCT02323204|156640|P4|NOT COMPLETED|3-month Follow-up Survey Completion||44
64393|NCT02323204|156641|P3|NOT COMPLETED|3-month Follow-up Survey Completion||41
64394|NCT02323204|156642|P2|NOT COMPLETED|3-month Follow-up Survey Completion||47
64395|NCT02323204|156643|P1|NOT COMPLETED|3-month Follow-up Survey Completion||54
64396|NCT02323204|156640|P4|COMPLETED|3-month Follow-up Survey Completion||112
64397|NCT02323204|156641|P3|COMPLETED|3-month Follow-up Survey Completion||113
64398|NCT02323204|156642|P2|COMPLETED|3-month Follow-up Survey Completion||99
64399|NCT02323204|156643|P1|COMPLETED|3-month Follow-up Survey Completion||91
64400|NCT02323204|156640|P4|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|156
64401|NCT02323204|156641|P3|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|154
64483|NCT02322866|156742|P2|STARTED|Overall Study||519
64402|NCT02323204|156642|P2|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|146
64403|NCT02323204|156643|P1|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|145
64404|NCT02323204|156640|P4|NOT COMPLETED|6-week Follow-up Intervention Booster||36
64405|NCT02323204|156641|P3|NOT COMPLETED|6-week Follow-up Intervention Booster||0
64406|NCT02323204|156642|P2|NOT COMPLETED|6-week Follow-up Intervention Booster||43
64407|NCT02323204|156643|P1|NOT COMPLETED|6-week Follow-up Intervention Booster||0
64408|NCT02323204|156640|P4|COMPLETED|6-week Follow-up Intervention Booster||120
64409|NCT02323204|156641|P3|COMPLETED|6-week Follow-up Intervention Booster||0
64410|NCT02323204|156642|P2|COMPLETED|6-week Follow-up Intervention Booster||103
64411|NCT02323204|156643|P1|COMPLETED|6-week Follow-up Intervention Booster||0
64412|NCT02323204|156640|P4|STARTED|6-week Follow-up Intervention Booster|Received intervention-specific booster training via phone between 6-weeks and 1 year post-enrollment|156
64413|NCT02323204|156641|P3|STARTED|6-week Follow-up Intervention Booster|Child participants did not receive intervention booster training.|0
64414|NCT02323204|156642|P2|STARTED|6-week Follow-up Intervention Booster|Received intervention-specific booster training via phone between 6-weeks and 1 year post-enrollment|146
64415|NCT02323204|156643|P1|STARTED|6-week Follow-up Intervention Booster|Child participants did not receive intervention booster training.|0
64416|NCT02323204|156640|P4|NOT COMPLETED|6-week Follow-up Survey Completion||37
64417|NCT02323204|156641|P3|NOT COMPLETED|6-week Follow-up Survey Completion||42
64418|NCT02323204|156642|P2|NOT COMPLETED|6-week Follow-up Survey Completion||36
64419|NCT02323204|156643|P1|NOT COMPLETED|6-week Follow-up Survey Completion||41
64420|NCT02323204|156640|P4|COMPLETED|6-week Follow-up Survey Completion||119
64421|NCT02323204|156641|P3|COMPLETED|6-week Follow-up Survey Completion||112
64422|NCT02323204|156642|P2|COMPLETED|6-week Follow-up Survey Completion||110
64423|NCT02323204|156643|P1|COMPLETED|6-week Follow-up Survey Completion||104
64424|NCT02323204|156640|P4|STARTED|6-week Follow-up Survey Completion||156
64425|NCT02323204|156641|P3|STARTED|6-week Follow-up Survey Completion||154
64426|NCT02323204|156642|P2|STARTED|6-week Follow-up Survey Completion||146
64427|NCT02323204|156643|P1|STARTED|6-week Follow-up Survey Completion||145
64428|NCT02323204|156640|P4|NOT COMPLETED|Baseline Survey Completion||3
64429|NCT02323204|156641|P3|NOT COMPLETED|Baseline Survey Completion||5
64430|NCT02323204|156642|P2|NOT COMPLETED|Baseline Survey Completion||9
64431|NCT02323204|156643|P1|NOT COMPLETED|Baseline Survey Completion||10
64432|NCT02323204|156640|P4|COMPLETED|Baseline Survey Completion||156
64433|NCT02323204|156641|P3|COMPLETED|Baseline Survey Completion||154
64434|NCT02323204|156642|P2|COMPLETED|Baseline Survey Completion||146
64435|NCT02323204|156643|P1|COMPLETED|Baseline Survey Completion||145
64436|NCT02323204|156640|P4|STARTED|Baseline Survey Completion||159
64437|NCT02323204|156641|P3|STARTED|Baseline Survey Completion||159
64438|NCT02323204|156642|P2|STARTED|Baseline Survey Completion||155
64439|NCT02323204|156643|P1|STARTED|Baseline Survey Completion||155
64440|NCT02323048|156698|P5|NOT COMPLETED|Overall Study||0
64441|NCT02323048|156699|P4|NOT COMPLETED|Overall Study||0
64442|NCT02323048|156700|P3|NOT COMPLETED|Overall Study||0
64443|NCT02323048|156701|P2|NOT COMPLETED|Overall Study||2
64444|NCT02323048|156702|P1|NOT COMPLETED|Overall Study||1
64445|NCT02323048|156698|P5|COMPLETED|Overall Study||9
64446|NCT02323048|156699|P4|COMPLETED|Overall Study||7
64447|NCT02323048|156700|P3|COMPLETED|Overall Study||23
64448|NCT02323048|156701|P2|COMPLETED|Overall Study||24
64449|NCT02323048|156702|P1|COMPLETED|Overall Study||24
64450|NCT02323048|156698|P5|STARTED|Overall Study||9
64451|NCT02323048|156699|P4|STARTED|Overall Study||7
64452|NCT02323048|156700|P3|STARTED|Overall Study||23
64453|NCT02323048|156701|P2|STARTED|Overall Study||26
64454|NCT02323048|156702|P1|STARTED|Overall Study||25
64455|NCT02322892|156716|P2|NOT COMPLETED|Overall Study||3
64456|NCT02322892|156717|P1|NOT COMPLETED|Overall Study||2
64457|NCT02322892|156716|P2|COMPLETED|Overall Study|Received thiamine|31
64458|NCT02322892|156717|P1|COMPLETED|Overall Study|Received placebo|33
64459|NCT02322892|156716|P2|STARTED|Overall Study|Number randomized|34
64460|NCT02322892|156717|P1|STARTED|Overall Study|Number randomized|35
64461|NCT02322879|156733|P2|NOT COMPLETED|Second Intervention||0
64462|NCT02322879|156734|P1|NOT COMPLETED|Second Intervention||0
64463|NCT02322879|156733|P2|COMPLETED|Second Intervention||10
64464|NCT02322879|156734|P1|COMPLETED|Second Intervention||10
64465|NCT02322879|156733|P2|STARTED|Second Intervention||10
64466|NCT02322879|156734|P1|STARTED|Second Intervention||10
64467|NCT02322879|156733|P2|NOT COMPLETED|Washout||0
64468|NCT02322879|156734|P1|NOT COMPLETED|Washout||0
64469|NCT02322879|156733|P2|COMPLETED|Washout||10
64470|NCT02322879|156734|P1|COMPLETED|Washout||10
64471|NCT02322879|156733|P2|STARTED|Washout||10
64472|NCT02322879|156734|P1|STARTED|Washout||10
64473|NCT02322879|156733|P2|NOT COMPLETED|First Intervention||0
64474|NCT02322879|156734|P1|NOT COMPLETED|First Intervention||1
64475|NCT02322879|156733|P2|COMPLETED|First Intervention||10
64476|NCT02322879|156734|P1|COMPLETED|First Intervention||10
64477|NCT02322879|156733|P2|STARTED|First Intervention||10
64478|NCT02322879|156734|P1|STARTED|First Intervention||11
64479|NCT02322866|156742|P2|NOT COMPLETED|Overall Study||86
64480|NCT02322866|156743|P1|NOT COMPLETED|Overall Study||71
64481|NCT02322866|156742|P2|COMPLETED|Overall Study||433
64482|NCT02322866|156743|P1|COMPLETED|Overall Study||444
64484|NCT02322866|156743|P1|STARTED|Overall Study||515
64485|NCT02322814|156770|P5|NOT COMPLETED|Overall Study||31
64486|NCT02322814|156771|P4|NOT COMPLETED|Overall Study||32
64487|NCT02322814|156772|P3|NOT COMPLETED|Overall Study||47
64488|NCT02322814|156773|P2|NOT COMPLETED|Overall Study||43
64489|NCT02322814|156774|P1|NOT COMPLETED|Overall Study||16
64490|NCT02322814|156770|P5|COMPLETED|Overall Study||0
64491|NCT02322814|156771|P4|COMPLETED|Overall Study||0
64492|NCT02322814|156772|P3|COMPLETED|Overall Study||0
64493|NCT02322814|156773|P2|COMPLETED|Overall Study||0
64494|NCT02322814|156774|P1|COMPLETED|Overall Study||0
64495|NCT02322814|156770|P5|STARTED|Overall Study||31
64496|NCT02322814|156771|P4|STARTED|Overall Study||32
64497|NCT02322814|156772|P3|STARTED|Overall Study||47
64498|NCT02322814|156773|P2|STARTED|Overall Study||43
64499|NCT02322814|156774|P1|STARTED|Overall Study||16
64500|NCT02322788|156785|P4|NOT COMPLETED|Visit 6||0
64501|NCT02322788|156786|P3|NOT COMPLETED|Visit 6||0
64502|NCT02322788|156787|P2|NOT COMPLETED|Visit 6||0
64503|NCT02322788|156788|P1|NOT COMPLETED|Visit 6||0
64504|NCT02322788|156785|P4|COMPLETED|Visit 6||15
64505|NCT02322788|156786|P3|COMPLETED|Visit 6||15
64506|NCT02322788|156787|P2|COMPLETED|Visit 6||16
64507|NCT02322788|156788|P1|COMPLETED|Visit 6||14
64508|NCT02322788|156785|P4|STARTED|Visit 6||15
64509|NCT02322788|156786|P3|STARTED|Visit 6||15
64510|NCT02322788|156787|P2|STARTED|Visit 6||16
64511|NCT02322788|156788|P1|STARTED|Visit 6||14
64512|NCT02322788|156785|P4|NOT COMPLETED|Visit 5||0
64513|NCT02322788|156786|P3|NOT COMPLETED|Visit 5||0
64514|NCT02322788|156787|P2|NOT COMPLETED|Visit 5||0
64515|NCT02322788|156788|P1|NOT COMPLETED|Visit 5||0
64516|NCT02322788|156785|P4|COMPLETED|Visit 5||14
64517|NCT02322788|156786|P3|COMPLETED|Visit 5||15
64518|NCT02322788|156787|P2|COMPLETED|Visit 5||15
64519|NCT02322788|156788|P1|COMPLETED|Visit 5||16
64520|NCT02322788|156785|P4|STARTED|Visit 5||14
64521|NCT02322788|156786|P3|STARTED|Visit 5||15
64522|NCT02322788|156787|P2|STARTED|Visit 5||15
64523|NCT02322788|156788|P1|STARTED|Visit 5||16
64524|NCT02322788|156785|P4|NOT COMPLETED|Visit 4||0
64525|NCT02322788|156786|P3|NOT COMPLETED|Visit 4||0
64526|NCT02322788|156787|P2|NOT COMPLETED|Visit 4||0
64527|NCT02322788|156788|P1|NOT COMPLETED|Visit 4||0
64528|NCT02322788|156785|P4|COMPLETED|Visit 4||15
64529|NCT02322788|156786|P3|COMPLETED|Visit 4||16
64530|NCT02322788|156787|P2|COMPLETED|Visit 4||14
64531|NCT02322788|156788|P1|COMPLETED|Visit 4||15
64532|NCT02322788|156785|P4|STARTED|Visit 4||15
64533|NCT02322788|156786|P3|STARTED|Visit 4||16
64534|NCT02322788|156787|P2|STARTED|Visit 4||14
64535|NCT02322788|156788|P1|STARTED|Visit 4||15
64536|NCT02322788|156785|P4|NOT COMPLETED|Visit 3||0
64537|NCT02322788|156786|P3|NOT COMPLETED|Visit 3||0
64538|NCT02322788|156787|P2|NOT COMPLETED|Visit 3||0
64539|NCT02322788|156788|P1|NOT COMPLETED|Visit 3||0
64540|NCT02322788|156785|P4|COMPLETED|Visit 3||16
64541|NCT02322788|156786|P3|COMPLETED|Visit 3||14
64542|NCT02322788|156787|P2|COMPLETED|Visit 3||15
64543|NCT02322788|156788|P1|COMPLETED|Visit 3||15
64544|NCT02322788|156785|P4|STARTED|Visit 3||16
64545|NCT02322788|156786|P3|STARTED|Visit 3||14
64546|NCT02322788|156787|P2|STARTED|Visit 3||15
64547|NCT02322788|156788|P1|STARTED|Visit 3||15
64548|NCT02322775|156800|P2|NOT COMPLETED|Overall Study||6
64549|NCT02322775|156801|P1|NOT COMPLETED|Overall Study||5
64550|NCT02322775|156800|P2|COMPLETED|Overall Study||99
64551|NCT02322775|156801|P1|COMPLETED|Overall Study||101
64552|NCT02322775|156800|P2|STARTED|Overall Study||105
64553|NCT02322775|156801|P1|STARTED|Overall Study||106
64554|NCT02322749|156827|P6|NOT COMPLETED|Period 3||0
64555|NCT02322749|156828|P5|NOT COMPLETED|Period 3||0
64556|NCT02322749|156829|P4|NOT COMPLETED|Period 3||0
64557|NCT02322749|156830|P3|NOT COMPLETED|Period 3||1
64558|NCT02322749|156831|P2|NOT COMPLETED|Period 3||0
64559|NCT02322749|156832|P1|NOT COMPLETED|Period 3||0
64560|NCT02322749|156827|P6|COMPLETED|Period 3||8
64561|NCT02322749|156828|P5|COMPLETED|Period 3||8
64562|NCT02322749|156829|P4|COMPLETED|Period 3||6
64563|NCT02322749|156830|P3|COMPLETED|Period 3||7
64564|NCT02322749|156831|P2|COMPLETED|Period 3||8
64565|NCT02322749|156832|P1|COMPLETED|Period 3||8
64566|NCT02322749|156827|P6|STARTED|Period 3||8
64567|NCT02322749|156828|P5|STARTED|Period 3||8
64568|NCT02322749|156829|P4|STARTED|Period 3||6
64569|NCT02322749|156830|P3|STARTED|Period 3||8
64570|NCT02322749|156831|P2|STARTED|Period 3||8
64571|NCT02322749|156832|P1|STARTED|Period 3||8
64572|NCT02322749|156827|P6|NOT COMPLETED|Period 2||0
64573|NCT02322749|156828|P5|NOT COMPLETED|Period 2||0
64574|NCT02322749|156829|P4|NOT COMPLETED|Period 2||2
64575|NCT02322749|156830|P3|NOT COMPLETED|Period 2||0
64576|NCT02322749|156831|P2|NOT COMPLETED|Period 2||0
64577|NCT02322749|156832|P1|NOT COMPLETED|Period 2||0
64578|NCT02322749|156827|P6|COMPLETED|Period 2||8
64579|NCT02322749|156828|P5|COMPLETED|Period 2||8
64580|NCT02322749|156829|P4|COMPLETED|Period 2||6
64581|NCT02322749|156830|P3|COMPLETED|Period 2||8
64582|NCT02322749|156831|P2|COMPLETED|Period 2||8
64583|NCT02322749|156832|P1|COMPLETED|Period 2||8
64584|NCT02322749|156827|P6|STARTED|Period 2||8
64585|NCT02322749|156828|P5|STARTED|Period 2||8
64586|NCT02322749|156829|P4|STARTED|Period 2||8
64587|NCT02322749|156830|P3|STARTED|Period 2||8
64588|NCT02322749|156831|P2|STARTED|Period 2||8
64589|NCT02322749|156832|P1|STARTED|Period 2||8
64590|NCT02322749|156827|P6|NOT COMPLETED|Period 1||0
64591|NCT02322749|156828|P5|NOT COMPLETED|Period 1||0
64592|NCT02322749|156829|P4|NOT COMPLETED|Period 1||0
64593|NCT02322749|156830|P3|NOT COMPLETED|Period 1||0
64594|NCT02322749|156831|P2|NOT COMPLETED|Period 1||0
64595|NCT02322749|156832|P1|NOT COMPLETED|Period 1||0
64596|NCT02322749|156827|P6|COMPLETED|Period 1||8
64597|NCT02322749|156828|P5|COMPLETED|Period 1||8
64598|NCT02322749|156829|P4|COMPLETED|Period 1||8
64599|NCT02322749|156830|P3|COMPLETED|Period 1||8
64600|NCT02322749|156831|P2|COMPLETED|Period 1||8
64601|NCT02322749|156832|P1|COMPLETED|Period 1||8
64602|NCT02322749|156827|P6|STARTED|Period 1||8
64603|NCT02322749|156828|P5|STARTED|Period 1||8
64604|NCT02322749|156829|P4|STARTED|Period 1||8
64605|NCT02322749|156830|P3|STARTED|Period 1||8
64606|NCT02322749|156831|P2|STARTED|Period 1||8
64607|NCT02322749|156832|P1|STARTED|Period 1||8
64608|NCT02322710|156857|P2|NOT COMPLETED|Overall Study||26
64609|NCT02322710|156858|P1|NOT COMPLETED|Overall Study||20
64610|NCT02322710|156857|P2|COMPLETED|Overall Study||73
64611|NCT02322710|156858|P1|COMPLETED|Overall Study||85
64612|NCT02322710|156857|P2|Full Analysis Population|Overall Study||98
64613|NCT02322710|156858|P1|Full Analysis Population|Overall Study||105
64614|NCT02322710|156857|P2|Safety Population|Overall Study||99
64615|NCT02322710|156858|P1|Safety Population|Overall Study||105
64616|NCT02322710|156857|P2|STARTED|Overall Study||99
64617|NCT02322710|156858|P1|STARTED|Overall Study||105
64618|NCT02322528|156864|P1|NOT COMPLETED|Overall Study||0
64619|NCT02322528|156864|P1|COMPLETED|Overall Study||10
64620|NCT02322528|156864|P1|STARTED|Overall Study||10
64621|NCT02322411|156871|P2|NOT COMPLETED|Overall Study||7
64622|NCT02322411|156872|P1|NOT COMPLETED|Overall Study||4
64623|NCT02322411|156871|P2|COMPLETED|Overall Study||9
64624|NCT02322411|156872|P1|COMPLETED|Overall Study||9
64625|NCT02322411|156871|P2|STARTED|Overall Study||16
64626|NCT02322411|156872|P1|STARTED|Overall Study||13
64627|NCT02322281|156891|P3|NOT COMPLETED|Overall Study||74
64628|NCT02322281|156892|P2|NOT COMPLETED|Overall Study||22
64629|NCT02322281|156893|P1|NOT COMPLETED|Overall Study||53
64630|NCT02322281|156891|P3|COMPLETED|Overall Study|Patients who are off study for any reason.|0
64631|NCT02322281|156892|P2|COMPLETED|Overall Study|Patients who are off study for any reason.|0
64632|NCT02322281|156893|P1|COMPLETED|Overall Study|Patients who are off study for any reason.|0
64633|NCT02322281|156891|P3|Crossed Over to Rociletinib 625 mg BID|Overall Study||3
64634|NCT02322281|156892|P2|Crossed Over to Rociletinib 625 mg BID|Overall Study||0
64635|NCT02322281|156893|P1|Crossed Over to Rociletinib 625 mg BID|Overall Study||0
64636|NCT02322281|156891|P3|Crossed Over to Rociletinib 500 mg BID|Overall Study||36
64637|NCT02322281|156892|P2|Crossed Over to Rociletinib 500 mg BID|Overall Study||0
64638|NCT02322281|156893|P1|Crossed Over to Rociletinib 500 mg BID|Overall Study||0
64639|NCT02322281|156891|P3|STARTED|Overall Study||74
64640|NCT02322281|156892|P2|STARTED|Overall Study||22
64641|NCT02322281|156893|P1|STARTED|Overall Study||53
64642|NCT02322229|156914|P1|NOT COMPLETED|Overall Study||2
64643|NCT02322229|156914|P1|COMPLETED|Overall Study||50
64644|NCT02322229|156914|P1|STARTED|Overall Study||52
64645|NCT02322216|156926|P2|NOT COMPLETED|Overall Study||4
64646|NCT02322216|156927|P1|NOT COMPLETED|Overall Study||2
64647|NCT02322216|156926|P2|COMPLETED|Overall Study||123
64648|NCT02322216|156927|P1|COMPLETED|Overall Study||124
64649|NCT02322216|156926|P2|Per Protocol Set (PPS)|Overall Study||122
64650|NCT02322216|156927|P1|Per Protocol Set (PPS)|Overall Study||123
64651|NCT02322216|156926|P2|Treated (Safety Set)|Overall Study||126
64652|NCT02322216|156927|P1|Treated (Safety Set)|Overall Study||126
64653|NCT02322216|156926|P2|STARTED|Overall Study||127
64654|NCT02322216|156927|P1|STARTED|Overall Study||126
64655|NCT02321930|156934|P1|NOT COMPLETED|Overall Study||1
64656|NCT02321930|156934|P1|COMPLETED|Overall Study||24
64657|NCT02321930|156934|P1|STARTED|Overall Study||25
64658|NCT02321748|156944|P2|NOT COMPLETED|Overall Study||0
64659|NCT02321748|156945|P1|NOT COMPLETED|Overall Study||0
64660|NCT02321748|156944|P2|COMPLETED|Overall Study||12
64661|NCT02321748|156945|P1|COMPLETED|Overall Study||12
64662|NCT02321748|156944|P2|Second Intervention (4 Days)|Overall Study||12
64663|NCT02321748|156945|P1|Second Intervention (4 Days)|Overall Study||12
64664|NCT02321748|156944|P2|Wasout (2weeks)|Overall Study||12
64665|NCT02321748|156945|P1|Wasout (2weeks)|Overall Study||12
64666|NCT02321748|156944|P2|First Intervention (4 Days)|Overall Study||12
64667|NCT02321748|156945|P1|First Intervention (4 Days)|Overall Study||12
64668|NCT02321748|156944|P2|STARTED|Overall Study||12
64669|NCT02321748|156945|P1|STARTED|Overall Study||12
64670|NCT02321527|156977|P1|NOT COMPLETED|Overall Study||1
64671|NCT02321527|156977|P1|COMPLETED|Overall Study||20
64672|NCT02321527|156977|P1|STARTED|Overall Study||21
64673|NCT02321462|156983|P2|NOT COMPLETED|Overall Study||3
64674|NCT02321462|156984|P1|NOT COMPLETED|Overall Study||6
64675|NCT02321462|156983|P2|COMPLETED|Overall Study||146
64676|NCT02321462|156984|P1|COMPLETED|Overall Study||141
64677|NCT02321462|156983|P2|Safety Population|Overall Study||147
64678|NCT02321462|156984|P1|Safety Population|Overall Study||147
64679|NCT02321462|156983|P2|Treated Patients|Overall Study||147
64680|NCT02321462|156984|P1|Treated Patients|Overall Study||147
64681|NCT02321462|156983|P2|ITT Population|Overall Study||148
64682|NCT02321462|156984|P1|ITT Population|Overall Study||146
64683|NCT02321462|156983|P2|STARTED|Overall Study||149
64684|NCT02321462|156984|P1|STARTED|Overall Study||147
64685|NCT02321436|157006|P2|NOT COMPLETED|Overall Study||1
64686|NCT02321436|157007|P1|NOT COMPLETED|Overall Study||1
64687|NCT02321436|157006|P2|COMPLETED|Overall Study||13
64688|NCT02321436|157007|P1|COMPLETED|Overall Study||27
64689|NCT02321436|157006|P2|STARTED|Overall Study||14
64690|NCT02321436|157007|P1|STARTED|Overall Study||28
64691|NCT02321111|157023|P6|NOT COMPLETED|Infusion3||0
64692|NCT02321111|157024|P5|NOT COMPLETED|Infusion3||0
64693|NCT02321111|157025|P4|NOT COMPLETED|Infusion3||0
64694|NCT02321111|157026|P3|NOT COMPLETED|Infusion3||0
64695|NCT02321111|157027|P2|NOT COMPLETED|Infusion3||0
64696|NCT02321111|157028|P1|NOT COMPLETED|Infusion3||0
64697|NCT02321111|157023|P6|COMPLETED|Infusion3||0
64698|NCT02321111|157024|P5|COMPLETED|Infusion3||0
64699|NCT02321111|157025|P4|COMPLETED|Infusion3||1
64700|NCT02321111|157026|P3|COMPLETED|Infusion3||4
64701|NCT02321111|157027|P2|COMPLETED|Infusion3||4
64702|NCT02321111|157028|P1|COMPLETED|Infusion3||1
64703|NCT02321111|157023|P6|STARTED|Infusion3||0
64704|NCT02321111|157024|P5|STARTED|Infusion3||0
64705|NCT02321111|157025|P4|STARTED|Infusion3||1
64706|NCT02321111|157026|P3|STARTED|Infusion3||4
64707|NCT02321111|157027|P2|STARTED|Infusion3||4
64708|NCT02321111|157028|P1|STARTED|Infusion3||1
64709|NCT02321111|157023|P6|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
64710|NCT02321111|157024|P5|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
64711|NCT02321111|157025|P4|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
64712|NCT02321111|157026|P3|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
64713|NCT02321111|157027|P2|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
64714|NCT02321111|157028|P1|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
64715|NCT02321111|157023|P6|COMPLETED|Washout2 (3-4weeks Between Infusions)||0
64716|NCT02321111|157024|P5|COMPLETED|Washout2 (3-4weeks Between Infusions)||0
64717|NCT02321111|157025|P4|COMPLETED|Washout2 (3-4weeks Between Infusions)||1
64718|NCT02321111|157026|P3|COMPLETED|Washout2 (3-4weeks Between Infusions)||4
64719|NCT02321111|157027|P2|COMPLETED|Washout2 (3-4weeks Between Infusions)||4
64720|NCT02321111|157028|P1|COMPLETED|Washout2 (3-4weeks Between Infusions)||1
64721|NCT02321111|157023|P6|STARTED|Washout2 (3-4weeks Between Infusions)||0
64722|NCT02321111|157024|P5|STARTED|Washout2 (3-4weeks Between Infusions)||0
64723|NCT02321111|157025|P4|STARTED|Washout2 (3-4weeks Between Infusions)||1
64724|NCT02321111|157026|P3|STARTED|Washout2 (3-4weeks Between Infusions)||4
64725|NCT02321111|157027|P2|STARTED|Washout2 (3-4weeks Between Infusions)||4
64726|NCT02321111|157028|P1|STARTED|Washout2 (3-4weeks Between Infusions)||1
64727|NCT02321111|157023|P6|NOT COMPLETED|Infusion2||0
64728|NCT02321111|157024|P5|NOT COMPLETED|Infusion2||0
64729|NCT02321111|157025|P4|NOT COMPLETED|Infusion2||0
64730|NCT02321111|157026|P3|NOT COMPLETED|Infusion2||0
64731|NCT02321111|157027|P2|NOT COMPLETED|Infusion2||0
64732|NCT02321111|157028|P1|NOT COMPLETED|Infusion2||0
64733|NCT02321111|157023|P6|COMPLETED|Infusion2||0
64734|NCT02321111|157024|P5|COMPLETED|Infusion2||0
64735|NCT02321111|157025|P4|COMPLETED|Infusion2||1
64736|NCT02321111|157026|P3|COMPLETED|Infusion2||4
64737|NCT02321111|157027|P2|COMPLETED|Infusion2||4
64738|NCT02321111|157028|P1|COMPLETED|Infusion2||1
64739|NCT02321111|157023|P6|STARTED|Infusion2||0
64740|NCT02321111|157024|P5|STARTED|Infusion2||0
64741|NCT02321111|157025|P4|STARTED|Infusion2||1
64742|NCT02321111|157026|P3|STARTED|Infusion2||4
64743|NCT02321111|157027|P2|STARTED|Infusion2||4
64744|NCT02321111|157028|P1|STARTED|Infusion2||1
64745|NCT02321111|157023|P6|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
64746|NCT02321111|157024|P5|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
64747|NCT02321111|157025|P4|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
64748|NCT02321111|157026|P3|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
64749|NCT02321111|157027|P2|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
64750|NCT02321111|157028|P1|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
64751|NCT02321111|157023|P6|COMPLETED|Washout1 (3-4weeks Between Infusions)||0
64752|NCT02321111|157024|P5|COMPLETED|Washout1 (3-4weeks Between Infusions)||0
64753|NCT02321111|157025|P4|COMPLETED|Washout1 (3-4weeks Between Infusions)||1
64754|NCT02321111|157026|P3|COMPLETED|Washout1 (3-4weeks Between Infusions)||4
64755|NCT02321111|157027|P2|COMPLETED|Washout1 (3-4weeks Between Infusions)||4
64756|NCT02321111|157028|P1|COMPLETED|Washout1 (3-4weeks Between Infusions)||1
64757|NCT02321111|157023|P6|STARTED|Washout1 (3-4weeks Between Infusions)||0
64758|NCT02321111|157024|P5|STARTED|Washout1 (3-4weeks Between Infusions)||0
64759|NCT02321111|157025|P4|STARTED|Washout1 (3-4weeks Between Infusions)||1
64760|NCT02321111|157026|P3|STARTED|Washout1 (3-4weeks Between Infusions)||4
64761|NCT02321111|157027|P2|STARTED|Washout1 (3-4weeks Between Infusions)||4
64762|NCT02321111|157028|P1|STARTED|Washout1 (3-4weeks Between Infusions)||1
64763|NCT02321111|157023|P6|NOT COMPLETED|Infusion1||0
64764|NCT02321111|157024|P5|NOT COMPLETED|Infusion1||0
64765|NCT02321111|157025|P4|NOT COMPLETED|Infusion1||0
64766|NCT02321111|157026|P3|NOT COMPLETED|Infusion1||0
64767|NCT02321111|157027|P2|NOT COMPLETED|Infusion1||0
64768|NCT02321111|157028|P1|NOT COMPLETED|Infusion1||0
64769|NCT02321111|157023|P6|COMPLETED|Infusion1||0
64770|NCT02321111|157024|P5|COMPLETED|Infusion1||0
64771|NCT02321111|157025|P4|COMPLETED|Infusion1||1
64772|NCT02321111|157026|P3|COMPLETED|Infusion1||4
64773|NCT02321111|157027|P2|COMPLETED|Infusion1||4
64774|NCT02321111|157028|P1|COMPLETED|Infusion1||1
64775|NCT02321111|157023|P6|STARTED|Infusion1||0
64776|NCT02321111|157024|P5|STARTED|Infusion1||0
64777|NCT02321111|157025|P4|STARTED|Infusion1||1
64778|NCT02321111|157026|P3|STARTED|Infusion1||4
64779|NCT02321111|157027|P2|STARTED|Infusion1||4
64780|NCT02321111|157028|P1|STARTED|Infusion1||1
64781|NCT02321098|157051|P3|NOT COMPLETED|Additional 15 Months Treatment||8
64782|NCT02321098|157052|P2|NOT COMPLETED|Additional 15 Months Treatment||0
64783|NCT02321098|157053|P1|NOT COMPLETED|Additional 15 Months Treatment||0
64784|NCT02321098|157051|P3|COMPLETED|Additional 15 Months Treatment||21
64785|NCT02321098|157052|P2|COMPLETED|Additional 15 Months Treatment||0
64786|NCT02321098|157053|P1|COMPLETED|Additional 15 Months Treatment||0
64787|NCT02321098|157051|P3|STARTED|Additional 15 Months Treatment||29
64788|NCT02321098|157052|P2|STARTED|Additional 15 Months Treatment||0
64789|NCT02321098|157053|P1|STARTED|Additional 15 Months Treatment||0
64790|NCT02321098|157051|P3|NOT COMPLETED|12 Weeks Treament||0
64791|NCT02321098|157052|P2|NOT COMPLETED|12 Weeks Treament||1
64792|NCT02321098|157053|P1|NOT COMPLETED|12 Weeks Treament||1
64793|NCT02321098|157051|P3|COMPLETED|12 Weeks Treament||0
64794|NCT02321098|157052|P2|COMPLETED|12 Weeks Treament||23
64795|NCT02321098|157053|P1|COMPLETED|12 Weeks Treament||25
64796|NCT02321098|157051|P3|STARTED|12 Weeks Treament||0
64797|NCT02321098|157052|P2|STARTED|12 Weeks Treament||24
64798|NCT02321098|157053|P1|STARTED|12 Weeks Treament||26
64799|NCT02320903|157065|P3|NOT COMPLETED|Overall Study||16
64800|NCT02320903|157066|P2|NOT COMPLETED|Overall Study||16
64801|NCT02320903|157067|P1|NOT COMPLETED|Overall Study||8
64802|NCT02320903|157065|P3|COMPLETED|Overall Study||16
64803|NCT02320903|157066|P2|COMPLETED|Overall Study||16
64804|NCT02320903|157067|P1|COMPLETED|Overall Study||16
64805|NCT02320903|157065|P3|STARTED|Overall Study||32
64806|NCT02320903|157066|P2|STARTED|Overall Study||32
64807|NCT02320903|157067|P1|STARTED|Overall Study||24
64808|NCT02320838|157100|P5|NOT COMPLETED|Third Intervention (1 Day)||0
64809|NCT02320838|157101|P4|NOT COMPLETED|Third Intervention (1 Day)||0
64810|NCT02320838|157102|P3|NOT COMPLETED|Third Intervention (1 Day)||0
64811|NCT02320838|157103|P2|NOT COMPLETED|Third Intervention (1 Day)||0
64812|NCT02320838|157104|P1|NOT COMPLETED|Third Intervention (1 Day)||0
64813|NCT02320838|157100|P5|COMPLETED|Third Intervention (1 Day)||7
64814|NCT02320838|157101|P4|COMPLETED|Third Intervention (1 Day)||7
64815|NCT02320838|157102|P3|COMPLETED|Third Intervention (1 Day)||8
64816|NCT02320838|157103|P2|COMPLETED|Third Intervention (1 Day)||8
64817|NCT02320838|157104|P1|COMPLETED|Third Intervention (1 Day)||8
64818|NCT02320838|157100|P5|STARTED|Third Intervention (1 Day)||7
64819|NCT02320838|157101|P4|STARTED|Third Intervention (1 Day)||7
64820|NCT02320838|157102|P3|STARTED|Third Intervention (1 Day)||8
64821|NCT02320838|157103|P2|STARTED|Third Intervention (1 Day)||8
64822|NCT02320838|157104|P1|STARTED|Third Intervention (1 Day)||8
64823|NCT02320838|157100|P5|NOT COMPLETED|Washout (1 Day)||0
64824|NCT02320838|157101|P4|NOT COMPLETED|Washout (1 Day)||0
64825|NCT02320838|157102|P3|NOT COMPLETED|Washout (1 Day)||0
64826|NCT02320838|157103|P2|NOT COMPLETED|Washout (1 Day)||0
64827|NCT02320838|157104|P1|NOT COMPLETED|Washout (1 Day)||0
64828|NCT02320838|157100|P5|COMPLETED|Washout (1 Day)||7
64829|NCT02320838|157101|P4|COMPLETED|Washout (1 Day)||7
64830|NCT02320838|157102|P3|COMPLETED|Washout (1 Day)||8
64831|NCT02320838|157103|P2|COMPLETED|Washout (1 Day)||8
64832|NCT02320838|157104|P1|COMPLETED|Washout (1 Day)||8
64833|NCT02320838|157100|P5|STARTED|Washout (1 Day)||7
64834|NCT02320838|157101|P4|STARTED|Washout (1 Day)||7
64835|NCT02320838|157102|P3|STARTED|Washout (1 Day)||8
64836|NCT02320838|157103|P2|STARTED|Washout (1 Day)||8
64837|NCT02320838|157104|P1|STARTED|Washout (1 Day)||8
64838|NCT02320838|157100|P5|NOT COMPLETED|Second Intervention (1 Day)||0
64839|NCT02320838|157101|P4|NOT COMPLETED|Second Intervention (1 Day)||0
64840|NCT02320838|157102|P3|NOT COMPLETED|Second Intervention (1 Day)||0
64841|NCT02320838|157103|P2|NOT COMPLETED|Second Intervention (1 Day)||0
64842|NCT02320838|157104|P1|NOT COMPLETED|Second Intervention (1 Day)||0
64843|NCT02320838|157100|P5|COMPLETED|Second Intervention (1 Day)||7
64844|NCT02320838|157101|P4|COMPLETED|Second Intervention (1 Day)||7
64845|NCT02320838|157102|P3|COMPLETED|Second Intervention (1 Day)||8
64846|NCT02320838|157103|P2|COMPLETED|Second Intervention (1 Day)||8
64847|NCT02320838|157104|P1|COMPLETED|Second Intervention (1 Day)||8
64848|NCT02320838|157100|P5|STARTED|Second Intervention (1 Day)||7
64849|NCT02320838|157101|P4|STARTED|Second Intervention (1 Day)||7
64850|NCT02320838|157102|P3|STARTED|Second Intervention (1 Day)||8
64851|NCT02320838|157103|P2|STARTED|Second Intervention (1 Day)||8
64852|NCT02320838|157104|P1|STARTED|Second Intervention (1 Day)||8
64853|NCT02320838|157100|P5|NOT COMPLETED|Washout (1 Day)||0
64854|NCT02320838|157101|P4|NOT COMPLETED|Washout (1 Day)||0
64855|NCT02320838|157102|P3|NOT COMPLETED|Washout (1 Day)||0
64856|NCT02320838|157103|P2|NOT COMPLETED|Washout (1 Day)||0
64857|NCT02320838|157104|P1|NOT COMPLETED|Washout (1 Day)||0
64858|NCT02320838|157100|P5|COMPLETED|Washout (1 Day)||7
64859|NCT02320838|157101|P4|COMPLETED|Washout (1 Day)||7
64860|NCT02320838|157102|P3|COMPLETED|Washout (1 Day)||8
64861|NCT02320838|157103|P2|COMPLETED|Washout (1 Day)||8
64862|NCT02320838|157104|P1|COMPLETED|Washout (1 Day)||8
64863|NCT02320838|157100|P5|STARTED|Washout (1 Day)||7
64864|NCT02320838|157101|P4|STARTED|Washout (1 Day)||7
64865|NCT02320838|157102|P3|STARTED|Washout (1 Day)||8
64866|NCT02320838|157103|P2|STARTED|Washout (1 Day)||8
64867|NCT02320838|157104|P1|STARTED|Washout (1 Day)||8
64868|NCT02320838|157100|P5|NOT COMPLETED|First Intervention (1 Day)||0
64869|NCT02320838|157101|P4|NOT COMPLETED|First Intervention (1 Day)||0
64870|NCT02320838|157102|P3|NOT COMPLETED|First Intervention (1 Day)||0
64871|NCT02320838|157103|P2|NOT COMPLETED|First Intervention (1 Day)||0
64872|NCT02320838|157104|P1|NOT COMPLETED|First Intervention (1 Day)||0
64873|NCT02320838|157100|P5|COMPLETED|First Intervention (1 Day)||7
64874|NCT02320838|157101|P4|COMPLETED|First Intervention (1 Day)||7
64875|NCT02320838|157102|P3|COMPLETED|First Intervention (1 Day)||8
64876|NCT02320838|157103|P2|COMPLETED|First Intervention (1 Day)||8
64877|NCT02320838|157104|P1|COMPLETED|First Intervention (1 Day)||8
64878|NCT02320838|157100|P5|STARTED|First Intervention (1 Day)||7
64879|NCT02320838|157101|P4|STARTED|First Intervention (1 Day)||7
64880|NCT02320838|157102|P3|STARTED|First Intervention (1 Day)||8
64881|NCT02320838|157103|P2|STARTED|First Intervention (1 Day)||8
64882|NCT02320838|157104|P1|STARTED|First Intervention (1 Day)||8
64883|NCT02320825|157171|P2|NOT COMPLETED|Overall Study||0
64884|NCT02320825|157172|P1|NOT COMPLETED|Overall Study||0
64885|NCT02320825|157171|P2|COMPLETED|Overall Study||8
64886|NCT02320825|157172|P1|COMPLETED|Overall Study||8
64887|NCT02320825|157171|P2|STARTED|Overall Study||8
64888|NCT02320825|157172|P1|STARTED|Overall Study||8
64889|NCT02320812|157182|P1|NOT COMPLETED|Overall Study||0
64890|NCT02320812|157182|P1|COMPLETED|Overall Study||28
64891|NCT02320812|157182|P1|STARTED|Overall Study||28
64892|NCT02320721|157192|P2|NOT COMPLETED|Overall Study||34
64893|NCT02320721|157193|P1|NOT COMPLETED|Overall Study||27
64894|NCT02320721|157192|P2|COMPLETED|Overall Study||472
64895|NCT02320721|157193|P1|COMPLETED|Overall Study||481
64896|NCT02320721|157192|P2|Treated (Safety Population)|Overall Study||505
64897|NCT02320721|157193|P1|Treated (Safety Population)|Overall Study||508
64898|NCT02320721|157192|P2|STARTED|Overall Study||506
64899|NCT02320721|157193|P1|STARTED|Overall Study||508
64900|NCT02320695|157221|P1|NOT COMPLETED|Overall Study||0
64901|NCT02320695|157221|P1|COMPLETED|Overall Study||60
64902|NCT02320695|157221|P1|Pain Relief Ointment|Overall Study||60
64903|NCT02320695|157221|P1|Original Ointment|Overall Study||60
64904|NCT02320695|157221|P1|Antibiotic/Pain Relieving Ointment|Overall Study||60
64905|NCT02320695|157221|P1|Pain Relieving Cream|Overall Study||59
64906|NCT02320695|157221|P1|Alcohol|Overall Study||60
64907|NCT02320695|157221|P1|Saline|Overall Study||60
64908|NCT02320695|157221|P1|STARTED|Overall Study||60
64909|NCT02320487|157248|P1|NOT COMPLETED|Overall Study||21
64910|NCT02320487|157248|P1|COMPLETED|Overall Study|Completed = completed the 6-cycle Treatment Period.|81
64911|NCT02320487|157248|P1|STARTED|Overall Study||102
64912|NCT02320396|157268|P2|NOT COMPLETED|Overall Study||4
64913|NCT02320396|157269|P1|NOT COMPLETED|Overall Study||4
64914|NCT02320396|157268|P2|COMPLETED|Overall Study||221
64915|NCT02320396|157269|P1|COMPLETED|Overall Study||220
64916|NCT02320396|157268|P2|Treated (Full Analysis Set)|Overall Study||225
64917|NCT02320396|157269|P1|Treated (Full Analysis Set)|Overall Study||223
64918|NCT02320396|157268|P2|STARTED|Overall Study||225
64919|NCT02320396|157269|P1|STARTED|Overall Study||224
64920|NCT02320227|157299|P1|NOT COMPLETED|Overall Study||0
64921|NCT02320227|157299|P1|COMPLETED|Overall Study||30
64922|NCT02320227|157299|P1|STARTED|Overall Study||30
64923|NCT02320214|157304|P1|NOT COMPLETED|Overall Study||0
64924|NCT02320214|157304|P1|COMPLETED|Overall Study||30
64925|NCT02320214|157304|P1|STARTED|Overall Study||30
64926|NCT02320149|157311|P2|NOT COMPLETED|Overall Study||80
64927|NCT02320149|157312|P1|NOT COMPLETED|Overall Study||63
64928|NCT02320149|157311|P2|COMPLETED|Overall Study||405
64929|NCT02320149|157312|P1|COMPLETED|Overall Study||420
64930|NCT02320149|157311|P2|STARTED|Overall Study||485
64931|NCT02320149|157312|P1|STARTED|Overall Study||483
64932|NCT02319967|157353|P3|NOT COMPLETED|Overall Study||45
64933|NCT02319967|157354|P2|NOT COMPLETED|Overall Study||44
64934|NCT02319967|157355|P1|NOT COMPLETED|Overall Study||48
64935|NCT02319967|157353|P3|COMPLETED|Overall Study||76
64936|NCT02319967|157354|P2|COMPLETED|Overall Study||82
64937|NCT02319967|157355|P1|COMPLETED|Overall Study||78
64938|NCT02319967|157353|P3|STARTED|Overall Study||121
64939|NCT02319967|157354|P2|STARTED|Overall Study||126
64940|NCT02319967|157355|P1|STARTED|Overall Study||126
64941|NCT02319824|157411|P1|NOT COMPLETED|Overall Study||0
64942|NCT02319824|157411|P1|COMPLETED|Overall Study||2
64943|NCT02319824|157411|P1|STARTED|Overall Study||2
64944|NCT02319668|157419|P2|NOT COMPLETED|Overall Study||2
64945|NCT02319668|157420|P1|NOT COMPLETED|Overall Study||0
64946|NCT02319668|157419|P2|COMPLETED|Overall Study||17
64947|NCT02319668|157420|P1|COMPLETED|Overall Study||19
64948|NCT02319668|157419|P2|STARTED|Overall Study||19
64949|NCT02319668|157420|P1|STARTED|Overall Study||19
64950|NCT02319642|157434|P2|NOT COMPLETED|Overall Study||6
64951|NCT02319642|157435|P1|NOT COMPLETED|Overall Study||4
64952|NCT02319642|157434|P2|COMPLETED|Overall Study||245
64953|NCT02319642|157435|P1|COMPLETED|Overall Study||91
64954|NCT02319642|157434|P2|STARTED|Overall Study||251
64955|NCT02319642|157435|P1|STARTED|Overall Study||95
64956|NCT02319525|157455|P2|NOT COMPLETED|Overall Study||1
64957|NCT02319525|157456|P1|NOT COMPLETED|Overall Study||2
64958|NCT02319525|157455|P2|COMPLETED|Overall Study||147
64959|NCT02319525|157456|P1|COMPLETED|Overall Study||151
64960|NCT02319525|157455|P2|Primary Research Completion|Overall Study||147
64961|NCT02319525|157456|P1|Primary Research Completion|Overall Study||151
64962|NCT02319525|157455|P2|STARTED|Overall Study||148
64963|NCT02319525|157456|P1|STARTED|Overall Study||153
64964|NCT02319486|157474|P1|NOT COMPLETED|Overall Study||0
64965|NCT02319486|157474|P1|COMPLETED|Overall Study||26
64966|NCT02319486|157474|P1|STARTED|Overall Study||26
64967|NCT02319317|157482|P2|NOT COMPLETED|Overall Study||0
64968|NCT02319317|157483|P1|NOT COMPLETED|Overall Study||0
64969|NCT02319317|157482|P2|COMPLETED|Overall Study||29
64970|NCT02319317|157483|P1|COMPLETED|Overall Study||31
64971|NCT02319317|157482|P2|STARTED|Overall Study||29
64972|NCT02319317|157483|P1|STARTED|Overall Study||31
64973|NCT02319174|157489|P1|NOT COMPLETED|Overall Study||1
64974|NCT02319174|157489|P1|COMPLETED|Overall Study||42
64975|NCT02319174|157489|P1|STARTED|Overall Study||43
64976|NCT02319148|157498|P4|NOT COMPLETED|Second Intervention Period||2
64977|NCT02319148|157499|P3|NOT COMPLETED|Second Intervention Period||1
64978|NCT02319148|157500|P2|NOT COMPLETED|Second Intervention Period||1
64979|NCT02319148|157501|P1|NOT COMPLETED|Second Intervention Period||0
64980|NCT02319148|157498|P4|COMPLETED|Second Intervention Period||6
64981|NCT02319148|157499|P3|COMPLETED|Second Intervention Period||6
64982|NCT02319148|157500|P2|COMPLETED|Second Intervention Period||6
64983|NCT02319148|157501|P1|COMPLETED|Second Intervention Period||0
64984|NCT02319148|157498|P4|STARTED|Second Intervention Period||8
64985|NCT02319148|157499|P3|STARTED|Second Intervention Period||7
64986|NCT02319148|157500|P2|STARTED|Second Intervention Period||7
64987|NCT02319148|157501|P1|STARTED|Second Intervention Period||0
64988|NCT02319148|157498|P4|NOT COMPLETED|Washout Period 4 Days||0
64989|NCT02319148|157499|P3|NOT COMPLETED|Washout Period 4 Days||0
64990|NCT02319148|157500|P2|NOT COMPLETED|Washout Period 4 Days||0
64991|NCT02319148|157501|P1|NOT COMPLETED|Washout Period 4 Days||0
64992|NCT02319148|157498|P4|COMPLETED|Washout Period 4 Days||0
64993|NCT02319148|157499|P3|COMPLETED|Washout Period 4 Days||0
64994|NCT02319148|157500|P2|COMPLETED|Washout Period 4 Days||0
64995|NCT02319148|157501|P1|COMPLETED|Washout Period 4 Days||22
64996|NCT02319148|157498|P4|STARTED|Washout Period 4 Days||0
64997|NCT02319148|157499|P3|STARTED|Washout Period 4 Days||0
64998|NCT02319148|157500|P2|STARTED|Washout Period 4 Days||0
64999|NCT02319148|157501|P1|STARTED|Washout Period 4 Days||22
65000|NCT02319148|157498|P4|NOT COMPLETED|First Intervention Period||0
65001|NCT02319148|157499|P3|NOT COMPLETED|First Intervention Period||0
65002|NCT02319148|157500|P2|NOT COMPLETED|First Intervention Period||0
65003|NCT02319148|157501|P1|NOT COMPLETED|First Intervention Period||0
65004|NCT02319148|157498|P4|COMPLETED|First Intervention Period||0
65005|NCT02319148|157499|P3|COMPLETED|First Intervention Period||0
65006|NCT02319148|157500|P2|COMPLETED|First Intervention Period||0
65007|NCT02319148|157501|P1|COMPLETED|First Intervention Period||22
65008|NCT02319148|157498|P4|STARTED|First Intervention Period||0
65009|NCT02319148|157499|P3|STARTED|First Intervention Period||0
65010|NCT02319148|157500|P2|STARTED|First Intervention Period||0
65011|NCT02319148|157501|P1|STARTED|First Intervention Period||22
65012|NCT02319044|157564|P3|NOT COMPLETED|Overall Study||67
65013|NCT02319044|157565|P2|NOT COMPLETED|Overall Study||60
65014|NCT02319044|157566|P1|NOT COMPLETED|Overall Study||122
65015|NCT02319044|157564|P3|COMPLETED|Overall Study||0
65016|NCT02319044|157565|P2|COMPLETED|Overall Study||7
65017|NCT02319044|157566|P1|COMPLETED|Overall Study||11
65018|NCT02319044|157564|P3|STARTED|Overall Study||67
65019|NCT02319044|157565|P2|STARTED|Overall Study||67
65020|NCT02319044|157566|P1|STARTED|Overall Study||133
65021|NCT02319031|157622|P2|NOT COMPLETED|Follow-Up Period||0
65022|NCT02319031|157623|P1|NOT COMPLETED|Follow-Up Period||0
65023|NCT02319031|157622|P2|COMPLETED|Follow-Up Period||26
65024|NCT02319031|157623|P1|COMPLETED|Follow-Up Period||23
65025|NCT02319031|157622|P2|STARTED|Follow-Up Period||26
65026|NCT02319031|157623|P1|STARTED|Follow-Up Period||23
65027|NCT02319031|157622|P2|NOT COMPLETED|Treatment Period||0
65028|NCT02319031|157623|P1|NOT COMPLETED|Treatment Period||1
65029|NCT02319031|157622|P2|COMPLETED|Treatment Period||26
65030|NCT02319031|157623|P1|COMPLETED|Treatment Period||23
65031|NCT02319031|157622|P2|STARTED|Treatment Period||26
65032|NCT02319031|157623|P1|STARTED|Treatment Period||24
65033|NCT02319005|157635|P2|NOT COMPLETED|Overall Study||15
65034|NCT02319005|157636|P1|NOT COMPLETED|Overall Study||48
65035|NCT02319005|157635|P2|COMPLETED|Overall Study||51
65036|NCT02319005|157636|P1|COMPLETED|Overall Study||92
65037|NCT02319005|157635|P2|STARTED|Overall Study||66
65038|NCT02319005|157636|P1|STARTED|Overall Study||140
65039|NCT02318992|157659|P3|NOT COMPLETED|Overall Study||4
65040|NCT02318992|157660|P2|NOT COMPLETED|Overall Study||2
65041|NCT02318992|157661|P1|NOT COMPLETED|Overall Study||2
65042|NCT02318992|157659|P3|COMPLETED|Overall Study||20
65043|NCT02318992|157660|P2|COMPLETED|Overall Study||25
65044|NCT02318992|157661|P1|COMPLETED|Overall Study||25
65045|NCT02318992|157659|P3|STARTED|Overall Study||24
65046|NCT02318992|157660|P2|STARTED|Overall Study||27
65047|NCT02318992|157661|P1|STARTED|Overall Study||27
65048|NCT02318979|157674|P2|NOT COMPLETED|Overall Study||0
65049|NCT02318979|157675|P1|NOT COMPLETED|Overall Study||0
65050|NCT02318979|157674|P2|COMPLETED|Overall Study||15
65051|NCT02318979|157675|P1|COMPLETED|Overall Study||15
65052|NCT02318979|157674|P2|STARTED|Overall Study||15
65053|NCT02318979|157675|P1|STARTED|Overall Study||15
65054|NCT02318940|157687|P2|NOT COMPLETED|Overall Study||0
65055|NCT02318940|157688|P1|NOT COMPLETED|Overall Study||1
65056|NCT02318940|157687|P2|COMPLETED|Overall Study||50
65057|NCT02318940|157688|P1|COMPLETED|Overall Study||49
65058|NCT02318940|157687|P2|STARTED|Overall Study||50
65059|NCT02318940|157688|P1|STARTED|Overall Study|in the last patient we lost the record.|50
65060|NCT02318901|157703|P3|NOT COMPLETED|Overall Study||10
65061|NCT02318901|157704|P2|NOT COMPLETED|Overall Study||1
65062|NCT02318901|157705|P1|NOT COMPLETED|Overall Study||5
65063|NCT02318901|157703|P3|COMPLETED|Overall Study||0
65064|NCT02318901|157704|P2|COMPLETED|Overall Study||0
65065|NCT02318901|157705|P1|COMPLETED|Overall Study||0
65066|NCT02318901|157703|P3|STARTED|Overall Study||10
65067|NCT02318901|157704|P2|STARTED|Overall Study||1
65068|NCT02318901|157705|P1|STARTED|Overall Study||5
65069|NCT02318797|157730|P2|NOT COMPLETED|Overall Study||102
65070|NCT02318797|157731|P1|NOT COMPLETED|Overall Study||88
65071|NCT02318797|157730|P2|COMPLETED|Overall Study||611
65072|NCT02318797|157731|P1|COMPLETED|Overall Study||428
65073|NCT02318797|157730|P2|STARTED|Overall Study||713
65074|NCT02318797|157731|P1|STARTED|Overall Study||516
65075|NCT02318693|157771|P2|NOT COMPLETED|Overall Study||1
65076|NCT02318693|157772|P1|NOT COMPLETED|Overall Study||0
65077|NCT02318693|157771|P2|COMPLETED|Overall Study||26
65078|NCT02318693|157772|P1|COMPLETED|Overall Study||26
65079|NCT02318693|157771|P2|Treated|Overall Study|1 randomized participant did not receive treatment.|26
65080|NCT02318693|157772|P1|Treated|Overall Study||26
65081|NCT02318693|157771|P2|STARTED|Overall Study||27
65082|NCT02318693|157772|P1|STARTED|Overall Study||26
65083|NCT02318667|157786|P1|NOT COMPLETED|Overall Study||9
65084|NCT02318667|157786|P1|COMPLETED|Overall Study||29
65085|NCT02318667|157786|P1|STARTED|Overall Study||38
65086|NCT02318602|157805|P3|NOT COMPLETED|Overall Study||2
65087|NCT02318602|157806|P2|NOT COMPLETED|Overall Study||4
65088|NCT02318602|157807|P1|NOT COMPLETED|Overall Study||1
65089|NCT02318602|157805|P3|COMPLETED|Overall Study||15
65090|NCT02318602|157806|P2|COMPLETED|Overall Study||22
65091|NCT02318602|157807|P1|COMPLETED|Overall Study||8
65092|NCT02318602|157805|P3|STARTED|Overall Study||17
65093|NCT02318602|157806|P2|STARTED|Overall Study||26
65094|NCT02318602|157807|P1|STARTED|Overall Study||9
65095|NCT02318303|157845|P7|NOT COMPLETED|Overall Study||2
65096|NCT02318303|157846|P6|NOT COMPLETED|Overall Study||6
65097|NCT02318303|157847|P5|NOT COMPLETED|Overall Study||5
65098|NCT02318303|157848|P4|NOT COMPLETED|Overall Study||3
65099|NCT02318303|157849|P3|NOT COMPLETED|Overall Study||3
65100|NCT02318303|157850|P2|NOT COMPLETED|Overall Study||3
65101|NCT02318303|157851|P1|NOT COMPLETED|Overall Study||4
65102|NCT02318303|157845|P7|COMPLETED|Overall Study||158
65103|NCT02318303|157846|P6|COMPLETED|Overall Study||153
65104|NCT02318303|157847|P5|COMPLETED|Overall Study||152
65105|NCT02318303|157848|P4|COMPLETED|Overall Study||155
65106|NCT02318303|157849|P3|COMPLETED|Overall Study||157
65107|NCT02318303|157850|P2|COMPLETED|Overall Study||155
65108|NCT02318303|157851|P1|COMPLETED|Overall Study||155
65109|NCT02318303|157845|P7|STARTED|Overall Study||160
65110|NCT02318303|157846|P6|STARTED|Overall Study||159
65111|NCT02318303|157847|P5|STARTED|Overall Study||157
65112|NCT02318303|157848|P4|STARTED|Overall Study||158
65113|NCT02318303|157849|P3|STARTED|Overall Study||160
65114|NCT02318303|157850|P2|STARTED|Overall Study||158
65115|NCT02318303|157851|P1|STARTED|Overall Study||159
65116|NCT02317809|157867|P2|NOT COMPLETED|Second Intervention Period (8 Days)||0
65117|NCT02317809|157868|P1|NOT COMPLETED|Second Intervention Period (8 Days)||0
65118|NCT02317809|157867|P2|COMPLETED|Second Intervention Period (8 Days)||17
65119|NCT02317809|157868|P1|COMPLETED|Second Intervention Period (8 Days)||14
65120|NCT02317809|157867|P2|STARTED|Second Intervention Period (8 Days)||17
65121|NCT02317809|157868|P1|STARTED|Second Intervention Period (8 Days)||14
65122|NCT02317809|157867|P2|NOT COMPLETED|First Intervention Period (8 Days)||0
65123|NCT02317809|157868|P1|NOT COMPLETED|First Intervention Period (8 Days)||3
65124|NCT02317809|157867|P2|COMPLETED|First Intervention Period (8 Days)||17
65125|NCT02317809|157868|P1|COMPLETED|First Intervention Period (8 Days)||14
65126|NCT02317809|157867|P2|STARTED|First Intervention Period (8 Days)||17
65127|NCT02317809|157868|P1|STARTED|First Intervention Period (8 Days)||17
65128|NCT02317744|157920|P2|NOT COMPLETED|Overall Study||2
65129|NCT02317744|157921|P1|NOT COMPLETED|Overall Study||1
65130|NCT02317744|157920|P2|COMPLETED|Overall Study|One Placebo participant stopped the treatment but completed assessments.|8
65131|NCT02317744|157921|P1|COMPLETED|Overall Study|One NB participant stopped the treatment but completed assessments.|11
65132|NCT02317744|157920|P2|Completed Treatment|Overall Study||7
65133|NCT02317744|157921|P1|Completed Treatment|Overall Study||10
65134|NCT02317744|157920|P2|STARTED|Overall Study||10
65135|NCT02317744|157921|P1|STARTED|Overall Study||12
65136|NCT02317692|157935|P2|NOT COMPLETED|Overall Study||0
65137|NCT02317692|157936|P1|NOT COMPLETED|Overall Study||6
65138|NCT02317692|157935|P2|COMPLETED|Overall Study||77
65139|NCT02317692|157936|P1|COMPLETED|Overall Study||63
65140|NCT02317692|157935|P2|STARTED|Overall Study||77
65141|NCT02317692|157936|P1|STARTED|Overall Study||69
65142|NCT02317614|157956|P2|NOT COMPLETED|Overall Study||2
65143|NCT02317614|157957|P1|NOT COMPLETED|Overall Study||3
65144|NCT02317614|157956|P2|COMPLETED|Overall Study||23
65145|NCT02317614|157957|P1|COMPLETED|Overall Study||23
65146|NCT02317614|157956|P2|STARTED|Overall Study||25
65147|NCT02317614|157957|P1|STARTED|Overall Study||26
65148|NCT02317549|157975|P2|NOT COMPLETED|Overall Study||0
65149|NCT02317549|157976|P1|NOT COMPLETED|Overall Study||0
65150|NCT02317549|157975|P2|COMPLETED|Overall Study||3
65151|NCT02317549|157976|P1|COMPLETED|Overall Study||5
65152|NCT02317549|157975|P2|STARTED|Overall Study||3
65153|NCT02317549|157976|P1|STARTED|Overall Study||5
65154|NCT02317510|157984|P2|NOT COMPLETED|Overall Study||1
65155|NCT02317510|157985|P1|NOT COMPLETED|Overall Study||0
65156|NCT02317510|157984|P2|COMPLETED|Overall Study||24
65157|NCT02317510|157985|P1|COMPLETED|Overall Study||25
65158|NCT02317510|157984|P2|STARTED|Overall Study||25
65159|NCT02317510|157985|P1|STARTED|Overall Study||25
65160|NCT02317276|158013|P1|NOT COMPLETED|Overall Study||6
65161|NCT02317276|158013|P1|COMPLETED|Overall Study||5
65162|NCT02317276|158013|P1|STARTED|Overall Study||11
65163|NCT02317016|158017|P1|NOT COMPLETED|Part B: Day 35 to End Part B (AZD9291)||31
65164|NCT02317016|158017|P1|COMPLETED|Part B: Day 35 to End Part B (AZD9291)||11
65165|NCT02317016|158017|P1|STARTED|Part B: Day 35 to End Part B (AZD9291)|41 completed Part A + 1 entered Part B without completing Part A (due to AE) = 42 started Part B|42
65166|NCT02317016|158017|P1|NOT COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||2
65167|NCT02317016|158017|P1|COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||41
65168|NCT02317016|158017|P1|STARTED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||43
65169|NCT02317016|158017|P1|NOT COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||1
65170|NCT02317016|158017|P1|COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||43
65171|NCT02317016|158017|P1|STARTED|Part A: Day 4-31 (AZD9291 Alone)||44
65172|NCT02317016|158017|P1|NOT COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||0
65173|NCT02317016|158017|P1|COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||44
65174|NCT02317016|158017|P1|STARTED|Part A: Day 1-3 (Rosuvastatin Alone)||44
65175|NCT02316847|158045|P2|NOT COMPLETED|Overall Study||86
65176|NCT02316847|158046|P1|NOT COMPLETED|Overall Study||9
65177|NCT02316847|158045|P2|COMPLETED|Overall Study||13
65178|NCT02316847|158046|P1|COMPLETED|Overall Study||0
65179|NCT02316847|158045|P2|STARTED|Overall Study||99
65180|NCT02316847|158046|P1|STARTED|Overall Study||9
65181|NCT02316769|158057|P2|NOT COMPLETED|Overall Study||0
65182|NCT02316769|158058|P1|NOT COMPLETED|Overall Study||2
65183|NCT02316769|158057|P2|COMPLETED|Overall Study||33
65184|NCT02316769|158058|P1|COMPLETED|Overall Study||31
65185|NCT02316769|158057|P2|STARTED|Overall Study||33
65186|NCT02316769|158058|P1|STARTED|Overall Study||33
65187|NCT02316678|158068|P2|NOT COMPLETED|Overall Study||0
65188|NCT02316678|158069|P1|NOT COMPLETED|Overall Study||0
65189|NCT02316678|158068|P2|COMPLETED|Overall Study||7694
65190|NCT02316678|158069|P1|COMPLETED|Overall Study||1879
65191|NCT02316678|158068|P2|STARTED|Overall Study||7694
65192|NCT02316678|158069|P1|STARTED|Overall Study||1879
65193|NCT02316613|158075|P1|NOT COMPLETED|Overall Study||104
65194|NCT02316613|158075|P1|COMPLETED|Overall Study||156
65195|NCT02316613|158075|P1|Overall Population|Overall Study||241
65196|NCT02316613|158075|P1|Safety Population|Overall Study||255
65197|NCT02316613|158075|P1|STARTED|Overall Study||260
65198|NCT02316548|158114|P2|NOT COMPLETED|Overall Study||1
65199|NCT02316548|158115|P1|NOT COMPLETED|Overall Study||0
65200|NCT02316548|158114|P2|COMPLETED|Overall Study|Eligible patients on study until study termination|6
65201|NCT02316548|158115|P1|COMPLETED|Overall Study|Eligible patients on study until study termination|6
65202|NCT02316548|158114|P2|Eligible With Adverse Event Data|Overall Study||2
65203|NCT02316548|158115|P1|Eligible With Adverse Event Data|Overall Study||4
65204|NCT02316548|158114|P2|Eligible With Disease Assessment|Overall Study||1
65205|NCT02316548|158115|P1|Eligible With Disease Assessment|Overall Study||4
65206|NCT02316548|158114|P2|Eligible Population|Overall Study||6
65207|NCT02316548|158115|P1|Eligible Population|Overall Study||6
65208|NCT02316548|158114|P2|STARTED|Overall Study|Randomized|7
65209|NCT02316548|158115|P1|STARTED|Overall Study|Randomized|6
65210|NCT02316470|158129|P4|NOT COMPLETED|Overall Study||2
65211|NCT02316470|158130|P3|NOT COMPLETED|Overall Study||5
65212|NCT02316470|158131|P2|NOT COMPLETED|Overall Study||6
65213|NCT02316470|158132|P1|NOT COMPLETED|Overall Study||5
65214|NCT02316470|158129|P4|COMPLETED|Overall Study||46
65215|NCT02316470|158130|P3|COMPLETED|Overall Study||147
65216|NCT02316470|158131|P2|COMPLETED|Overall Study||146
65217|NCT02316470|158132|P1|COMPLETED|Overall Study||143
65218|NCT02316470|158129|P4|STARTED|Overall Study||48
65219|NCT02316470|158130|P3|STARTED|Overall Study||152
65220|NCT02316470|158131|P2|STARTED|Overall Study||152
65221|NCT02316470|158132|P1|STARTED|Overall Study||148
65222|NCT02316366|158228|P2|NOT COMPLETED|Overall Study||0
65223|NCT02316366|158229|P1|NOT COMPLETED|Overall Study||0
65224|NCT02316366|158228|P2|COMPLETED|Overall Study||40
65225|NCT02316366|158229|P1|COMPLETED|Overall Study||40
65226|NCT02316366|158228|P2|STARTED|Overall Study||40
65227|NCT02316366|158229|P1|STARTED|Overall Study||40
65228|NCT02316353|158245|P2|NOT COMPLETED|Overall Study||8
65229|NCT02316353|158246|P1|NOT COMPLETED|Overall Study||8
65230|NCT02316353|158245|P2|COMPLETED|Overall Study||55
65231|NCT02316353|158246|P1|COMPLETED|Overall Study||55
65232|NCT02316353|158245|P2|STARTED|Overall Study||63
65233|NCT02316353|158246|P1|STARTED|Overall Study|7 subjects assigned to the CSL830 (40) Arm, were titrated up to the 60 IU/kg arm during the study|63
65234|NCT02316171|158266|P4|NOT COMPLETED|Overall Study||0
65235|NCT02316171|158267|P3|NOT COMPLETED|Overall Study||0
65236|NCT02316171|158268|P2|NOT COMPLETED|Overall Study||0
65237|NCT02316171|158269|P1|NOT COMPLETED|Overall Study||1
65238|NCT02316171|158266|P4|COMPLETED|Overall Study||3
65239|NCT02316171|158267|P3|COMPLETED|Overall Study||3
65240|NCT02316171|158268|P2|COMPLETED|Overall Study||6
65241|NCT02316171|158269|P1|COMPLETED|Overall Study||3
65242|NCT02316171|158266|P4|STARTED|Overall Study||3
65243|NCT02316171|158267|P3|STARTED|Overall Study||3
65244|NCT02316171|158268|P2|STARTED|Overall Study||6
65245|NCT02316171|158269|P1|STARTED|Overall Study||4
65246|NCT02316002|158275|P1|NOT COMPLETED|Overall Study||6
65247|NCT02316002|158275|P1|COMPLETED|Overall Study||45
65248|NCT02316002|158275|P1|STARTED|Overall Study||51
65249|NCT02315989|158279|P1|NOT COMPLETED|Overall Study||0
65250|NCT02315989|158279|P1|COMPLETED|Overall Study||6
65251|NCT02315989|158279|P1|STARTED|Overall Study||6
65252|NCT02315872|158289|P2|NOT COMPLETED|Overall Study||1
65253|NCT02315872|158290|P1|NOT COMPLETED|Overall Study||3
65254|NCT02315872|158289|P2|COMPLETED|Overall Study||3
65255|NCT02315872|158290|P1|COMPLETED|Overall Study||1
65256|NCT02315872|158289|P2|STARTED|Overall Study||4
65257|NCT02315872|158290|P1|STARTED|Overall Study||4
65258|NCT02315755|158302|P1|NOT COMPLETED|Overall Study||0
65259|NCT02315755|158302|P1|COMPLETED|Overall Study|Participants who died, were considered as 'completed'.|102
65260|NCT02315755|158302|P1|STARTED|Overall Study||102
65261|NCT02315664|158333|P2|NOT COMPLETED|Overall Study||4
65262|NCT02315664|158334|P1|NOT COMPLETED|Overall Study||1
65263|NCT02315664|158333|P2|COMPLETED|Overall Study||27
65264|NCT02315664|158334|P1|COMPLETED|Overall Study||29
65265|NCT02315664|158333|P2|STARTED|Overall Study||31
65266|NCT02315664|158334|P1|STARTED|Overall Study||30
65267|NCT02315560|158354|P1|NOT COMPLETED|Overall Study||3
65268|NCT02315560|158354|P1|COMPLETED|Overall Study||22
65269|NCT02315560|158354|P1|STARTED|Overall Study||25
65270|NCT02315352|158361|P8|NOT COMPLETED|Fifth Intervention (Day 2)||0
65271|NCT02315352|158362|P7|NOT COMPLETED|Fifth Intervention (Day 2)||0
65272|NCT02315352|158363|P6|NOT COMPLETED|Fifth Intervention (Day 2)||0
65273|NCT02315352|158364|P5|NOT COMPLETED|Fifth Intervention (Day 2)||0
65274|NCT02315352|158365|P4|NOT COMPLETED|Fifth Intervention (Day 2)||0
65275|NCT02315352|158366|P3|NOT COMPLETED|Fifth Intervention (Day 2)||0
65276|NCT02315352|158367|P2|NOT COMPLETED|Fifth Intervention (Day 2)||0
65277|NCT02315352|158368|P1|NOT COMPLETED|Fifth Intervention (Day 2)||0
65278|NCT02315352|158361|P8|COMPLETED|Fifth Intervention (Day 2)||8
65279|NCT02315352|158362|P7|COMPLETED|Fifth Intervention (Day 2)||9
65280|NCT02315352|158363|P6|COMPLETED|Fifth Intervention (Day 2)||7
65281|NCT02315352|158364|P5|COMPLETED|Fifth Intervention (Day 2)||8
65282|NCT02315352|158365|P4|COMPLETED|Fifth Intervention (Day 2)||8
65283|NCT02315352|158366|P3|COMPLETED|Fifth Intervention (Day 2)||7
65284|NCT02315352|158367|P2|COMPLETED|Fifth Intervention (Day 2)||0
65285|NCT02315352|158368|P1|COMPLETED|Fifth Intervention (Day 2)||0
65286|NCT02315352|158361|P8|STARTED|Fifth Intervention (Day 2)||8
65287|NCT02315352|158362|P7|STARTED|Fifth Intervention (Day 2)||9
65288|NCT02315352|158363|P6|STARTED|Fifth Intervention (Day 2)||7
65289|NCT02315352|158364|P5|STARTED|Fifth Intervention (Day 2)||8
65290|NCT02315352|158365|P4|STARTED|Fifth Intervention (Day 2)||8
65291|NCT02315352|158366|P3|STARTED|Fifth Intervention (Day 2)||7
65292|NCT02315352|158367|P2|STARTED|Fifth Intervention (Day 2)||0
65293|NCT02315352|158368|P1|STARTED|Fifth Intervention (Day 2)||0
65294|NCT02315352|158361|P8|NOT COMPLETED|Fourth Intervention (Day 2)||0
65295|NCT02315352|158362|P7|NOT COMPLETED|Fourth Intervention (Day 2)||0
65296|NCT02315352|158363|P6|NOT COMPLETED|Fourth Intervention (Day 2)||0
65297|NCT02315352|158364|P5|NOT COMPLETED|Fourth Intervention (Day 2)||0
65298|NCT02315352|158365|P4|NOT COMPLETED|Fourth Intervention (Day 2)||0
65299|NCT02315352|158366|P3|NOT COMPLETED|Fourth Intervention (Day 2)||0
65300|NCT02315352|158367|P2|NOT COMPLETED|Fourth Intervention (Day 2)||0
65301|NCT02315352|158368|P1|NOT COMPLETED|Fourth Intervention (Day 2)||0
65302|NCT02315352|158361|P8|COMPLETED|Fourth Intervention (Day 2)||8
65303|NCT02315352|158362|P7|COMPLETED|Fourth Intervention (Day 2)||9
65304|NCT02315352|158363|P6|COMPLETED|Fourth Intervention (Day 2)||7
65305|NCT02315352|158364|P5|COMPLETED|Fourth Intervention (Day 2)||8
65306|NCT02315352|158365|P4|COMPLETED|Fourth Intervention (Day 2)||8
65307|NCT02315352|158366|P3|COMPLETED|Fourth Intervention (Day 2)||7
65308|NCT02315352|158367|P2|COMPLETED|Fourth Intervention (Day 2)||0
65309|NCT02315352|158368|P1|COMPLETED|Fourth Intervention (Day 2)||0
65310|NCT02315352|158361|P8|STARTED|Fourth Intervention (Day 2)||8
65311|NCT02315352|158362|P7|STARTED|Fourth Intervention (Day 2)||9
65312|NCT02315352|158363|P6|STARTED|Fourth Intervention (Day 2)||7
65313|NCT02315352|158364|P5|STARTED|Fourth Intervention (Day 2)||8
65314|NCT02315352|158365|P4|STARTED|Fourth Intervention (Day 2)||8
65315|NCT02315352|158366|P3|STARTED|Fourth Intervention (Day 2)||7
65316|NCT02315352|158367|P2|STARTED|Fourth Intervention (Day 2)||0
65317|NCT02315352|158368|P1|STARTED|Fourth Intervention (Day 2)||0
65318|NCT02315352|158361|P8|NOT COMPLETED|Third Intervention (Day 2)||0
65319|NCT02315352|158362|P7|NOT COMPLETED|Third Intervention (Day 2)||0
65320|NCT02315352|158363|P6|NOT COMPLETED|Third Intervention (Day 2)||0
65321|NCT02315352|158364|P5|NOT COMPLETED|Third Intervention (Day 2)||0
65322|NCT02315352|158365|P4|NOT COMPLETED|Third Intervention (Day 2)||0
65323|NCT02315352|158366|P3|NOT COMPLETED|Third Intervention (Day 2)||0
65324|NCT02315352|158367|P2|NOT COMPLETED|Third Intervention (Day 2)||0
65325|NCT02315352|158368|P1|NOT COMPLETED|Third Intervention (Day 2)||0
65326|NCT02315352|158361|P8|COMPLETED|Third Intervention (Day 2)||8
65327|NCT02315352|158362|P7|COMPLETED|Third Intervention (Day 2)||9
65328|NCT02315352|158363|P6|COMPLETED|Third Intervention (Day 2)||7
65329|NCT02315352|158364|P5|COMPLETED|Third Intervention (Day 2)||8
65330|NCT02315352|158365|P4|COMPLETED|Third Intervention (Day 2)||8
65331|NCT02315352|158366|P3|COMPLETED|Third Intervention (Day 2)||7
65332|NCT02315352|158367|P2|COMPLETED|Third Intervention (Day 2)||0
65333|NCT02315352|158368|P1|COMPLETED|Third Intervention (Day 2)||0
65334|NCT02315352|158361|P8|STARTED|Third Intervention (Day 2)||8
65335|NCT02315352|158362|P7|STARTED|Third Intervention (Day 2)||9
65336|NCT02315352|158363|P6|STARTED|Third Intervention (Day 2)||7
65337|NCT02315352|158364|P5|STARTED|Third Intervention (Day 2)||8
65338|NCT02315352|158365|P4|STARTED|Third Intervention (Day 2)||8
65339|NCT02315352|158366|P3|STARTED|Third Intervention (Day 2)||7
65340|NCT02315352|158367|P2|STARTED|Third Intervention (Day 2)||0
65341|NCT02315352|158368|P1|STARTED|Third Intervention (Day 2)||0
65342|NCT02315352|158361|P8|NOT COMPLETED|Second Intervention (Day 1)||0
65343|NCT02315352|158362|P7|NOT COMPLETED|Second Intervention (Day 1)||0
65344|NCT02315352|158363|P6|NOT COMPLETED|Second Intervention (Day 1)||0
65345|NCT02315352|158364|P5|NOT COMPLETED|Second Intervention (Day 1)||0
65346|NCT02315352|158365|P4|NOT COMPLETED|Second Intervention (Day 1)||0
65347|NCT02315352|158366|P3|NOT COMPLETED|Second Intervention (Day 1)||0
65348|NCT02315352|158367|P2|NOT COMPLETED|Second Intervention (Day 1)||0
65349|NCT02315352|158368|P1|NOT COMPLETED|Second Intervention (Day 1)||0
65350|NCT02315352|158361|P8|COMPLETED|Second Intervention (Day 1)||0
65351|NCT02315352|158362|P7|COMPLETED|Second Intervention (Day 1)||0
65352|NCT02315352|158363|P6|COMPLETED|Second Intervention (Day 1)||0
65353|NCT02315352|158364|P5|COMPLETED|Second Intervention (Day 1)||0
65354|NCT02315352|158365|P4|COMPLETED|Second Intervention (Day 1)||0
65355|NCT02315352|158366|P3|COMPLETED|Second Intervention (Day 1)||0
65356|NCT02315352|158367|P2|COMPLETED|Second Intervention (Day 1)||24
65357|NCT02315352|158368|P1|COMPLETED|Second Intervention (Day 1)|Out of 24 subjects completing this period, 1 discontinued before assignment to any sequence on Day 2|24
65358|NCT02315352|158361|P8|STARTED|Second Intervention (Day 1)||0
65359|NCT02315352|158362|P7|STARTED|Second Intervention (Day 1)||0
65360|NCT02315352|158363|P6|STARTED|Second Intervention (Day 1)||0
65361|NCT02315352|158364|P5|STARTED|Second Intervention (Day 1)||0
65362|NCT02315352|158365|P4|STARTED|Second Intervention (Day 1)||0
65363|NCT02315352|158366|P3|STARTED|Second Intervention (Day 1)||0
65364|NCT02315352|158367|P2|STARTED|Second Intervention (Day 1)||24
65365|NCT02315352|158368|P1|STARTED|Second Intervention (Day 1)||24
65366|NCT02315352|158361|P8|NOT COMPLETED|First Intervention (Day 1)||0
65367|NCT02315352|158362|P7|NOT COMPLETED|First Intervention (Day 1)||0
65368|NCT02315352|158363|P6|NOT COMPLETED|First Intervention (Day 1)||0
65369|NCT02315352|158364|P5|NOT COMPLETED|First Intervention (Day 1)||0
65370|NCT02315352|158365|P4|NOT COMPLETED|First Intervention (Day 1)||0
65371|NCT02315352|158366|P3|NOT COMPLETED|First Intervention (Day 1)||0
65372|NCT02315352|158367|P2|NOT COMPLETED|First Intervention (Day 1)||0
65373|NCT02315352|158368|P1|NOT COMPLETED|First Intervention (Day 1)||0
65374|NCT02315352|158361|P8|COMPLETED|First Intervention (Day 1)||0
65375|NCT02315352|158362|P7|COMPLETED|First Intervention (Day 1)||0
65376|NCT02315352|158363|P6|COMPLETED|First Intervention (Day 1)||0
65377|NCT02315352|158364|P5|COMPLETED|First Intervention (Day 1)||0
65378|NCT02315352|158365|P4|COMPLETED|First Intervention (Day 1)||0
65379|NCT02315352|158366|P3|COMPLETED|First Intervention (Day 1)||0
65380|NCT02315352|158367|P2|COMPLETED|First Intervention (Day 1)||24
65381|NCT02315352|158368|P1|COMPLETED|First Intervention (Day 1)||24
65382|NCT02315352|158361|P8|STARTED|First Intervention (Day 1)||0
65383|NCT02315352|158362|P7|STARTED|First Intervention (Day 1)||0
65384|NCT02315352|158363|P6|STARTED|First Intervention (Day 1)||0
65385|NCT02315352|158364|P5|STARTED|First Intervention (Day 1)||0
65386|NCT02315352|158365|P4|STARTED|First Intervention (Day 1)||0
65387|NCT02315352|158366|P3|STARTED|First Intervention (Day 1)||0
65388|NCT02315352|158367|P2|STARTED|First Intervention (Day 1)||24
65389|NCT02315352|158368|P1|STARTED|First Intervention (Day 1)||24
65390|NCT02315261|158395|P1|NOT COMPLETED|Overall Study||0
65391|NCT02315261|158395|P1|COMPLETED|Overall Study||364
65392|NCT02315261|158395|P1|STARTED|Overall Study||364
65393|NCT02314936|158406|P4|NOT COMPLETED|Overall Study||0
65394|NCT02314936|158407|P3|NOT COMPLETED|Overall Study||2
65395|NCT02314936|158408|P2|NOT COMPLETED|Overall Study||0
65396|NCT02314936|158409|P1|NOT COMPLETED|Overall Study||0
65397|NCT02314936|158406|P4|COMPLETED|Overall Study||48
65398|NCT02314936|158407|P3|COMPLETED|Overall Study||46
65399|NCT02314936|158408|P2|COMPLETED|Overall Study||48
65400|NCT02314936|158409|P1|COMPLETED|Overall Study||48
65401|NCT02314936|158406|P4|STARTED|Overall Study||48
65402|NCT02314936|158407|P3|STARTED|Overall Study||48
65403|NCT02314936|158408|P2|STARTED|Overall Study||48
65404|NCT02314936|158409|P1|STARTED|Overall Study||48
65405|NCT02314689|158595|P1|NOT COMPLETED|Overall Study||0
65406|NCT02314689|158595|P1|COMPLETED|Overall Study|Target citrulline level reached with first 4 subjects enrolled at initial IV citrulline of 20 mg/kg|4
65407|NCT02314689|158595|P1|STARTED|Overall Study||4
65408|NCT02314637|158601|P2|NOT COMPLETED|Overall Study||14
65409|NCT02314637|158602|P1|NOT COMPLETED|Overall Study||16
65410|NCT02314637|158601|P2|COMPLETED|Overall Study||75
65411|NCT02314637|158602|P1|COMPLETED|Overall Study||135
65412|NCT02314637|158601|P2|STARTED|Overall Study||89
65413|NCT02314637|158602|P1|STARTED|Overall Study||151
65414|NCT02314598|158612|P1|NOT COMPLETED|Overall Study||0
65415|NCT02314598|158612|P1|COMPLETED|Overall Study||46
65416|NCT02314598|158612|P1|STARTED|Overall Study||46
65417|NCT02314546|158621|P3|NOT COMPLETED|Overall Study||0
65418|NCT02314546|158622|P2|NOT COMPLETED|Overall Study||0
65419|NCT02314546|158623|P1|NOT COMPLETED|Overall Study||0
65420|NCT02314546|158621|P3|COMPLETED|Overall Study||5
65421|NCT02314546|158622|P2|COMPLETED|Overall Study||5
65422|NCT02314546|158623|P1|COMPLETED|Overall Study||5
65423|NCT02314546|158621|P3|STARTED|Overall Study||5
65424|NCT02314546|158622|P2|STARTED|Overall Study||5
65425|NCT02314546|158623|P1|STARTED|Overall Study||5
65426|NCT02314520|158651|P2|NOT COMPLETED|Overall Study||0
65427|NCT02314520|158652|P1|NOT COMPLETED|Overall Study||0
65428|NCT02314520|158651|P2|COMPLETED|Overall Study||80
65429|NCT02314520|158652|P1|COMPLETED|Overall Study||72
65430|NCT02314520|158651|P2|STARTED|Overall Study||80
65431|NCT02314520|158652|P1|STARTED|Overall Study||72
65432|NCT02314260|158664|P1|NOT COMPLETED|Overall Study||0
65433|NCT02314260|158664|P1|COMPLETED|Overall Study||80
65434|NCT02314260|158664|P1|STARTED|Overall Study||80
65435|NCT02314247|158673|P3|NOT COMPLETED|Overall Study||1
65436|NCT02314247|158674|P2|NOT COMPLETED|Overall Study||6
65437|NCT02314247|158675|P1|NOT COMPLETED|Overall Study||9
65438|NCT02314247|158673|P3|COMPLETED|Overall Study||0
65439|NCT02314247|158674|P2|COMPLETED|Overall Study||0
65440|NCT02314247|158675|P1|COMPLETED|Overall Study||0
65441|NCT02314247|158673|P3|STARTED|Overall Study||1
65442|NCT02314247|158674|P2|STARTED|Overall Study||6
65443|NCT02314247|158675|P1|STARTED|Overall Study||9
65444|NCT02314143|158700|P3|NOT COMPLETED|Overall Study||9
65445|NCT02314143|158701|P2|NOT COMPLETED|Overall Study||10
65446|NCT02314143|158702|P1|NOT COMPLETED|Overall Study||8
65447|NCT02314143|158700|P3|COMPLETED|Overall Study||7
65448|NCT02314143|158701|P2|COMPLETED|Overall Study||6
65449|NCT02314143|158702|P1|COMPLETED|Overall Study||8
65450|NCT02314143|158700|P3|STARTED|Overall Study||16
65451|NCT02314143|158701|P2|STARTED|Overall Study||16
65452|NCT02314143|158702|P1|STARTED|Overall Study||16
65453|NCT02314117|158748|P2|NOT COMPLETED|Overall Study||38
65454|NCT02314117|158749|P1|NOT COMPLETED|Overall Study||41
65455|NCT02314117|158748|P2|COMPLETED|Overall Study||281
65456|NCT02314117|158749|P1|COMPLETED|Overall Study||285
65457|NCT02314117|158748|P2|Alive But Off Treatment|Overall Study||50
65458|NCT02314117|158749|P1|Alive But Off Treatment|Overall Study||46
65459|NCT02314117|158748|P2|Death|Overall Study||231
65460|NCT02314117|158749|P1|Death|Overall Study||239
65461|NCT02314117|158748|P2|Received at Least One Dose of Study Drug|Overall Study||315
65462|NCT02314117|158749|P1|Received at Least One Dose of Study Drug|Overall Study||323
65463|NCT02314117|158748|P2|STARTED|Overall Study||319
65464|NCT02314117|158749|P1|STARTED|Overall Study||326
65465|NCT02314104|158780|P3|NOT COMPLETED|Overall Study||18
65466|NCT02314104|158781|P2|NOT COMPLETED|Overall Study||20
65467|NCT02314104|158782|P1|NOT COMPLETED|Overall Study||14
65468|NCT02314104|158780|P3|COMPLETED|Overall Study||53
65469|NCT02314104|158781|P2|COMPLETED|Overall Study||58
65470|NCT02314104|158782|P1|COMPLETED|Overall Study||57
65471|NCT02314104|158780|P3|STARTED|Overall Study||71
65472|NCT02314104|158781|P2|STARTED|Overall Study||78
65473|NCT02314104|158782|P1|STARTED|Overall Study||71
65474|NCT02314052|158802|P6|NOT COMPLETED|Cycles 6 -10.5||0
65475|NCT02314052|158803|P5|NOT COMPLETED|Cycles 6 -10.5||0
65476|NCT02314052|158804|P4|NOT COMPLETED|Cycles 6 -10.5||0
65477|NCT02314052|158805|P3|NOT COMPLETED|Cycles 6 -10.5||0
65478|NCT02314052|158806|P2|NOT COMPLETED|Cycles 6 -10.5||0
65479|NCT02314052|158807|P1|NOT COMPLETED|Cycles 6 -10.5||0
65480|NCT02314052|158802|P6|COMPLETED|Cycles 6 -10.5||0
65481|NCT02314052|158803|P5|COMPLETED|Cycles 6 -10.5|Subject 02-014 only completed 1 of 2 doses in cycle 6|2
65482|NCT02314052|158804|P4|COMPLETED|Cycles 6 -10.5||1
65483|NCT02314052|158805|P3|COMPLETED|Cycles 6 -10.5||0
65484|NCT02314052|158806|P2|COMPLETED|Cycles 6 -10.5||0
65485|NCT02314052|158807|P1|COMPLETED|Cycles 6 -10.5||0
65486|NCT02314052|158802|P6|STARTED|Cycles 6 -10.5||0
65487|NCT02314052|158803|P5|STARTED|Cycles 6 -10.5||2
65488|NCT02314052|158804|P4|STARTED|Cycles 6 -10.5||1
65489|NCT02314052|158805|P3|STARTED|Cycles 6 -10.5||0
65490|NCT02314052|158806|P2|STARTED|Cycles 6 -10.5||0
65491|NCT02314052|158807|P1|STARTED|Cycles 6 -10.5||0
65492|NCT02314052|158802|P6|NOT COMPLETED|Cycle Five||0
65493|NCT02314052|158803|P5|NOT COMPLETED|Cycle Five||0
65494|NCT02314052|158804|P4|NOT COMPLETED|Cycle Five||0
65495|NCT02314052|158805|P3|NOT COMPLETED|Cycle Five||1
65496|NCT02314052|158806|P2|NOT COMPLETED|Cycle Five||2
65497|NCT02314052|158807|P1|NOT COMPLETED|Cycle Five||0
65498|NCT02314052|158802|P6|COMPLETED|Cycle Five||0
65499|NCT02314052|158803|P5|COMPLETED|Cycle Five||2
65500|NCT02314052|158804|P4|COMPLETED|Cycle Five|subject missed cycle four but returned for cycle 5|1
65501|NCT02314052|158805|P3|COMPLETED|Cycle Five||0
65502|NCT02314052|158806|P2|COMPLETED|Cycle Five||0
65503|NCT02314052|158807|P1|COMPLETED|Cycle Five||0
65504|NCT02314052|158802|P6|STARTED|Cycle Five||0
65505|NCT02314052|158803|P5|STARTED|Cycle Five||2
65506|NCT02314052|158804|P4|STARTED|Cycle Five|subject missed cycle four but returned for cycle 5|1
65507|NCT02314052|158805|P3|STARTED|Cycle Five||1
65508|NCT02314052|158806|P2|STARTED|Cycle Five||2
65509|NCT02314052|158807|P1|STARTED|Cycle Five||0
65510|NCT02314052|158802|P6|NOT COMPLETED|Cycle Four||3
65511|NCT02314052|158803|P5|NOT COMPLETED|Cycle Four||0
65512|NCT02314052|158804|P4|NOT COMPLETED|Cycle Four||1
65513|NCT02314052|158805|P3|NOT COMPLETED|Cycle Four||1
65514|NCT02314052|158806|P2|NOT COMPLETED|Cycle Four||0
65515|NCT02314052|158807|P1|NOT COMPLETED|Cycle Four||3
65516|NCT02314052|158802|P6|COMPLETED|Cycle Four||0
65517|NCT02314052|158803|P5|COMPLETED|Cycle Four||2
65518|NCT02314052|158804|P4|COMPLETED|Cycle Four||0
65519|NCT02314052|158805|P3|COMPLETED|Cycle Four||1
65520|NCT02314052|158806|P2|COMPLETED|Cycle Four||2
65521|NCT02314052|158807|P1|COMPLETED|Cycle Four||0
65522|NCT02314052|158802|P6|STARTED|Cycle Four||3
65523|NCT02314052|158803|P5|STARTED|Cycle Four||2
65524|NCT02314052|158804|P4|STARTED|Cycle Four||1
65525|NCT02314052|158805|P3|STARTED|Cycle Four||2
65526|NCT02314052|158806|P2|STARTED|Cycle Four||2
65527|NCT02314052|158807|P1|STARTED|Cycle Four||3
65528|NCT02314052|158802|P6|NOT COMPLETED|Cycle Three||0
65529|NCT02314052|158803|P5|NOT COMPLETED|Cycle Three||0
65530|NCT02314052|158804|P4|NOT COMPLETED|Cycle Three||0
65531|NCT02314052|158805|P3|NOT COMPLETED|Cycle Three||0
65532|NCT02314052|158806|P2|NOT COMPLETED|Cycle Three||0
65533|NCT02314052|158807|P1|NOT COMPLETED|Cycle Three||0
65534|NCT02314052|158802|P6|COMPLETED|Cycle Three||3
65535|NCT02314052|158803|P5|COMPLETED|Cycle Three||2
65536|NCT02314052|158804|P4|COMPLETED|Cycle Three||1
65537|NCT02314052|158805|P3|COMPLETED|Cycle Three||2
65538|NCT02314052|158806|P2|COMPLETED|Cycle Three|1 of 2 completers in cohort 2 (subject 02-005) only completed 1 of 2 infusions during this cycle|2
65539|NCT02314052|158807|P1|COMPLETED|Cycle Three||3
65540|NCT02314052|158802|P6|STARTED|Cycle Three||3
65541|NCT02314052|158803|P5|STARTED|Cycle Three||2
65542|NCT02314052|158804|P4|STARTED|Cycle Three||1
65543|NCT02314052|158805|P3|STARTED|Cycle Three||2
65544|NCT02314052|158806|P2|STARTED|Cycle Three||2
65545|NCT02314052|158807|P1|STARTED|Cycle Three||3
65546|NCT02314052|158802|P6|NOT COMPLETED|Cycle Two||0
65547|NCT02314052|158803|P5|NOT COMPLETED|Cycle Two||4
65548|NCT02314052|158804|P4|NOT COMPLETED|Cycle Two||1
65549|NCT02314052|158805|P3|NOT COMPLETED|Cycle Two||1
65550|NCT02314052|158806|P2|NOT COMPLETED|Cycle Two||1
65551|NCT02314052|158807|P1|NOT COMPLETED|Cycle Two||0
65552|NCT02314052|158802|P6|COMPLETED|Cycle Two||3
65553|NCT02314052|158803|P5|COMPLETED|Cycle Two||2
65554|NCT02314052|158804|P4|COMPLETED|Cycle Two||1
65555|NCT02314052|158805|P3|COMPLETED|Cycle Two||2
65556|NCT02314052|158806|P2|COMPLETED|Cycle Two||2
65557|NCT02314052|158807|P1|COMPLETED|Cycle Two||3
65558|NCT02314052|158802|P6|STARTED|Cycle Two||3
65559|NCT02314052|158803|P5|STARTED|Cycle Two||6
65560|NCT02314052|158804|P4|STARTED|Cycle Two||2
65561|NCT02314052|158805|P3|STARTED|Cycle Two||3
65562|NCT02314052|158806|P2|STARTED|Cycle Two||3
65563|NCT02314052|158807|P1|STARTED|Cycle Two||3
65564|NCT02314052|158802|P6|NOT COMPLETED|Cycle One||0
65565|NCT02314052|158803|P5|NOT COMPLETED|Cycle One||0
65566|NCT02314052|158804|P4|NOT COMPLETED|Cycle One||1
65567|NCT02314052|158805|P3|NOT COMPLETED|Cycle One||0
65568|NCT02314052|158806|P2|NOT COMPLETED|Cycle One||0
65569|NCT02314052|158807|P1|NOT COMPLETED|Cycle One||0
65570|NCT02314052|158802|P6|COMPLETED|Cycle One||3
65571|NCT02314052|158803|P5|COMPLETED|Cycle One||6
65572|NCT02314052|158804|P4|COMPLETED|Cycle One||2
65573|NCT02314052|158805|P3|COMPLETED|Cycle One||3
65574|NCT02314052|158806|P2|COMPLETED|Cycle One||3
65575|NCT02314052|158807|P1|COMPLETED|Cycle One||3
65576|NCT02314052|158802|P6|STARTED|Cycle One||3
65577|NCT02314052|158803|P5|STARTED|Cycle One||6
65578|NCT02314052|158804|P4|STARTED|Cycle One||3
65579|NCT02314052|158805|P3|STARTED|Cycle One||3
65580|NCT02314052|158806|P2|STARTED|Cycle One||3
65581|NCT02314052|158807|P1|STARTED|Cycle One||3
65582|NCT02314026|158875|P1|NOT COMPLETED|Overall Study||28
65583|NCT02314026|158875|P1|COMPLETED|Overall Study||107
65584|NCT02314026|158875|P1|STARTED|Overall Study||135
65585|NCT02314000|158883|P2|NOT COMPLETED|Overall Study||8
65586|NCT02314000|158884|P1|NOT COMPLETED|Overall Study||13
65587|NCT02314000|158883|P2|COMPLETED|Overall Study||57
65588|NCT02314000|158884|P1|COMPLETED|Overall Study||62
65589|NCT02314000|158883|P2|STARTED|Overall Study||65
65590|NCT02314000|158884|P1|STARTED|Overall Study||75
65591|NCT02313909|158893|P2|NOT COMPLETED|Overall Study||50
65592|NCT02313909|158894|P1|NOT COMPLETED|Overall Study||57
65593|NCT02313909|158893|P2|COMPLETED|Overall Study||3554
65594|NCT02313909|158894|P1|COMPLETED|Overall Study||3552
65595|NCT02313909|158893|P2|Treated|Overall Study||3559
65596|NCT02313909|158894|P1|Treated|Overall Study||3562
65597|NCT02313909|158893|P2|STARTED|Overall Study||3604
65598|NCT02313909|158894|P1|STARTED|Overall Study||3609
65599|NCT02313766|158917|P3|NOT COMPLETED|Overall Study||0
65600|NCT02313766|158918|P2|NOT COMPLETED|Overall Study||3
65601|NCT02313766|158919|P1|NOT COMPLETED|Overall Study||1
65602|NCT02313766|158917|P3|COMPLETED|Overall Study||50
65603|NCT02313766|158918|P2|COMPLETED|Overall Study||47
65604|NCT02313766|158919|P1|COMPLETED|Overall Study||49
65605|NCT02313766|158917|P3|STARTED|Overall Study||50
65606|NCT02313766|158918|P2|STARTED|Overall Study||50
65607|NCT02313766|158919|P1|STARTED|Overall Study||50
65608|NCT02313675|158937|P4|NOT COMPLETED|Overall Study||0
65609|NCT02313675|158938|P3|NOT COMPLETED|Overall Study||0
65610|NCT02313675|158939|P2|NOT COMPLETED|Overall Study||0
65611|NCT02313675|158940|P1|NOT COMPLETED|Overall Study||0
65612|NCT02313675|158937|P4|COMPLETED|Overall Study||11
65613|NCT02313675|158938|P3|COMPLETED|Overall Study||11
65614|NCT02313675|158939|P2|COMPLETED|Overall Study||11
65615|NCT02313675|158940|P1|COMPLETED|Overall Study||11
65616|NCT02313675|158937|P4|STARTED|Overall Study||11
65617|NCT02313675|158938|P3|STARTED|Overall Study||11
65618|NCT02313675|158939|P2|STARTED|Overall Study||11
65619|NCT02313675|158940|P1|STARTED|Overall Study||11
65620|NCT02313558|158956|P2|NOT COMPLETED|Overall Study||4
65621|NCT02313558|158957|P1|NOT COMPLETED|Overall Study||6
65622|NCT02313558|158956|P2|COMPLETED|Overall Study||46
65623|NCT02313558|158957|P1|COMPLETED|Overall Study||44
65624|NCT02313558|158956|P2|STARTED|Overall Study||50
65625|NCT02313558|158957|P1|STARTED|Overall Study||50
65626|NCT02313506|158971|P2|NOT COMPLETED|Overall Study||0
65627|NCT02313506|158972|P1|NOT COMPLETED|Overall Study||0
65628|NCT02313506|158971|P2|COMPLETED|Overall Study||17
65629|NCT02313506|158972|P1|COMPLETED|Overall Study||17
65630|NCT02313506|158971|P2|STARTED|Overall Study||17
65631|NCT02313506|158972|P1|STARTED|Overall Study||17
65632|NCT02313233|158994|P2|NOT COMPLETED|Overall Study||3
65633|NCT02313233|158995|P1|NOT COMPLETED|Overall Study||2
65634|NCT02313233|158994|P2|COMPLETED|Overall Study||18
65635|NCT02313233|158995|P1|COMPLETED|Overall Study||18
65636|NCT02313233|158994|P2|STARTED|Overall Study||21
65637|NCT02313233|158995|P1|STARTED|Overall Study||20
65638|NCT02313155|159017|P2|NOT COMPLETED|Overall Study||1
65639|NCT02313155|159018|P1|NOT COMPLETED|Overall Study||0
65640|NCT02313155|159017|P2|COMPLETED|Overall Study||54
65641|NCT02313155|159018|P1|COMPLETED|Overall Study||55
65642|NCT02313155|159017|P2|STARTED|Overall Study||55
65643|NCT02313155|159018|P1|STARTED|Overall Study||55
65644|NCT02312882|159066|P1|NOT COMPLETED|Overall Study||4
65645|NCT02312882|159066|P1|COMPLETED|Overall Study||36
65646|NCT02312882|159066|P1|STARTED|Overall Study||40
65647|NCT02312856|159070|P1|NOT COMPLETED|Overall Study||4
65648|NCT02312856|159070|P1|COMPLETED|Overall Study||30
65649|NCT02312856|159070|P1|STARTED|Overall Study||34
65650|NCT02312739|159076|P2|NOT COMPLETED|Overall Study||2
65651|NCT02312739|159077|P1|NOT COMPLETED|Overall Study||6
65652|NCT02312739|159076|P2|COMPLETED|Overall Study||34
65653|NCT02312739|159077|P1|COMPLETED|Overall Study||30
65654|NCT02312739|159076|P2|Withdrawn Prior to Procedure|Overall Study||2
65655|NCT02312739|159077|P1|Withdrawn Prior to Procedure|Overall Study||6
65656|NCT02312739|159076|P2|STARTED|Overall Study||36
65657|NCT02312739|159077|P1|STARTED|Overall Study||36
65658|NCT02312726|159091|P3|NOT COMPLETED|Overall Study||67
65659|NCT02312726|159092|P2|NOT COMPLETED|Overall Study||0
65660|NCT02312726|159093|P1|NOT COMPLETED|Overall Study||0
65661|NCT02312726|159091|P3|COMPLETED|Overall Study||0
65662|NCT02312726|159092|P2|COMPLETED|Overall Study||30
65663|NCT02312726|159093|P1|COMPLETED|Overall Study||38
65664|NCT02312726|159091|P3|STARTED|Overall Study||67
65665|NCT02312726|159092|P2|STARTED|Overall Study||30
65666|NCT02312726|159093|P1|STARTED|Overall Study||38
65667|NCT02312713|159108|P3|NOT COMPLETED|Overall Study||5
65668|NCT02312713|159109|P2|NOT COMPLETED|Overall Study||30
65669|NCT02312713|159110|P1|NOT COMPLETED|Overall Study||11
65670|NCT02312713|159108|P3|COMPLETED|Overall Study||63
65671|NCT02312713|159109|P2|COMPLETED|Overall Study||112
65672|NCT02312713|159110|P1|COMPLETED|Overall Study||129
65673|NCT02312713|159108|P3|STARTED|Overall Study||68
65674|NCT02312713|159109|P2|STARTED|Overall Study||142
65675|NCT02312713|159110|P1|STARTED|Overall Study||140
65676|NCT02312622|159157|P3|NOT COMPLETED|Overall Study||0
65677|NCT02312622|159158|P2|NOT COMPLETED|Overall Study||0
65678|NCT02312622|159159|P1|NOT COMPLETED|Overall Study||0
65679|NCT02312622|159157|P3|COMPLETED|Overall Study||12
65680|NCT02312622|159158|P2|COMPLETED|Overall Study||3
65681|NCT02312622|159159|P1|COMPLETED|Overall Study||12
65682|NCT02312622|159157|P3|STARTED|Overall Study||12
65683|NCT02312622|159158|P2|STARTED|Overall Study||3
65684|NCT02312622|159159|P1|STARTED|Overall Study||12
65685|NCT02312219|159185|P2|NOT COMPLETED|Overall Study||6
65686|NCT02312219|159186|P1|NOT COMPLETED|Overall Study||1
65687|NCT02312219|159185|P2|COMPLETED|Overall Study||16
65688|NCT02312219|159186|P1|COMPLETED|Overall Study||12
65689|NCT02312219|159185|P2|STARTED|Overall Study||22
65690|NCT02312219|159186|P1|STARTED|Overall Study||13
65691|NCT02312206|159196|P2|NOT COMPLETED|Overall Study||130
65692|NCT02312206|159197|P1|NOT COMPLETED|Overall Study||130
65693|NCT02312206|159196|P2|COMPLETED|Overall Study||0
65694|NCT02312206|159197|P1|COMPLETED|Overall Study||0
65695|NCT02312206|159196|P2|Informed Consent Obtained|Overall Study||130
65696|NCT02312206|159197|P1|Informed Consent Obtained|Overall Study||130
65697|NCT02312206|159196|P2|STARTED|Overall Study||130
65698|NCT02312206|159197|P1|STARTED|Overall Study||130
65699|NCT02312154|159203|P1|NOT COMPLETED|Overall Study||1
65700|NCT02312154|159203|P1|COMPLETED|Overall Study||24
65701|NCT02312154|159203|P1|STARTED|Overall Study||25
65702|NCT02312063|159220|P2|NOT COMPLETED|Overall Study||1
65703|NCT02312063|159221|P1|NOT COMPLETED|Overall Study||0
65704|NCT02312063|159220|P2|COMPLETED|Overall Study||24
65705|NCT02312063|159221|P1|COMPLETED|Overall Study||23
65706|NCT02312063|159220|P2|STARTED|Overall Study||25
65707|NCT02312063|159221|P1|STARTED|Overall Study||23
65708|NCT02311972|159231|P2|NOT COMPLETED|Overall Study||0
65709|NCT02311972|159232|P1|NOT COMPLETED|Overall Study||0
65710|NCT02311972|159231|P2|COMPLETED|Overall Study||8
65711|NCT02311972|159232|P1|COMPLETED|Overall Study||12
65712|NCT02311972|159231|P2|STARTED|Overall Study||8
65713|NCT02311972|159232|P1|STARTED|Overall Study||12
65714|NCT02311907|159251|P2|NOT COMPLETED|Overall Study||0
65715|NCT02311907|159252|P1|NOT COMPLETED|Overall Study||0
65716|NCT02311907|159251|P2|COMPLETED|Overall Study||91
65717|NCT02311907|159252|P1|COMPLETED|Overall Study||94
65718|NCT02311907|159251|P2|STARTED|Overall Study||91
65719|NCT02311907|159252|P1|STARTED|Overall Study||94
65720|NCT02311894|159274|P1|NOT COMPLETED|Overall Study||4
65721|NCT02311894|159274|P1|COMPLETED|Overall Study||78
65722|NCT02311894|159274|P1|Modified ITT Population|Overall Study||81
65723|NCT02311894|159274|P1|STARTED|Overall Study||82
65724|NCT02311881|159286|P3|NOT COMPLETED|Overall Study||41
65725|NCT02311881|159287|P2|NOT COMPLETED|Overall Study||43
65726|NCT02311881|159288|P1|NOT COMPLETED|Overall Study||35
65727|NCT02311881|159286|P3|COMPLETED|Overall Study||196
65728|NCT02311881|159287|P2|COMPLETED|Overall Study||193
65729|NCT02311881|159288|P1|COMPLETED|Overall Study||200
65730|NCT02311881|159286|P3|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|237
65731|NCT02311881|159287|P2|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|236
65732|NCT02311881|159288|P1|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|234
65733|NCT02311881|159286|P3|STARTED|Overall Study|Started refers to all randomized participants.|237
65734|NCT02311881|159287|P2|STARTED|Overall Study|Started refers to all randomized participants.|236
65735|NCT02311881|159288|P1|STARTED|Overall Study|Started refers to all randomized participants.|235
65736|NCT02311478|159323|P1|NOT COMPLETED|Overall Study||7
65737|NCT02311478|159323|P1|COMPLETED|Overall Study||72
65738|NCT02311478|159323|P1|IUD Insertion|Overall Study||78
65739|NCT02311478|159323|P1|STARTED|Overall Study||79
65740|NCT02311309|159331|P3|NOT COMPLETED|Overall Study||0
65741|NCT02311309|159332|P2|NOT COMPLETED|Overall Study||0
65742|NCT02311309|159333|P1|NOT COMPLETED|Overall Study||0
65743|NCT02311309|159331|P3|COMPLETED|Overall Study||863
65744|NCT02311309|159332|P2|COMPLETED|Overall Study||35
65745|NCT02311309|159333|P1|COMPLETED|Overall Study||541
65746|NCT02311309|159331|P3|STARTED|Overall Study||863
65747|NCT02311309|159332|P2|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|35
65748|NCT02311309|159333|P1|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|541
65749|NCT02311153|159346|P2|NOT COMPLETED|Overall Study||7
65750|NCT02311153|159347|P1|NOT COMPLETED|Overall Study||5
65751|NCT02311153|159346|P2|COMPLETED|Overall Study||42
65752|NCT02311153|159347|P1|COMPLETED|Overall Study||48
65753|NCT02311153|159346|P2|STARTED|Overall Study||49
65754|NCT02311153|159347|P1|STARTED|Overall Study||53
65755|NCT02310789|159363|P1|NOT COMPLETED|Overall Study||1
65756|NCT02310789|159363|P1|COMPLETED|Overall Study||7
65757|NCT02310789|159363|P1|STARTED|Overall Study||8
65758|NCT02310776|159368|P1|NOT COMPLETED|Overall Study||0
65759|NCT02310776|159368|P1|COMPLETED|Overall Study||501
65760|NCT02310776|159368|P1|STARTED|Overall Study||501
65761|NCT02310763|159375|P3|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
65762|NCT02310763|159376|P2|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
65763|NCT02310763|159377|P1|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
65764|NCT02310763|159375|P3|COMPLETED|Period 2 (Weeks 49 to 96)||22
65765|NCT02310763|159376|P2|COMPLETED|Period 2 (Weeks 49 to 96)||21
65766|NCT02310763|159377|P1|COMPLETED|Period 2 (Weeks 49 to 96)||22
65767|NCT02310763|159375|P3|STARTED|Period 2 (Weeks 49 to 96)||38
65768|NCT02310763|159376|P2|STARTED|Period 2 (Weeks 49 to 96)||37
65769|NCT02310763|159377|P1|STARTED|Period 2 (Weeks 49 to 96)||38
65770|NCT02310763|159375|P3|NOT COMPLETED|Period 1 (Weeks 1 to 48)||2
65771|NCT02310763|159376|P2|NOT COMPLETED|Period 1 (Weeks 1 to 48)||2
65772|NCT02310763|159377|P1|NOT COMPLETED|Period 1 (Weeks 1 to 48)||3
65773|NCT02310763|159375|P3|COMPLETED|Period 1 (Weeks 1 to 48)||38
65774|NCT02310763|159376|P2|COMPLETED|Period 1 (Weeks 1 to 48)||37
65775|NCT02310763|159377|P1|COMPLETED|Period 1 (Weeks 1 to 48)||38
65776|NCT02310763|159375|P3|STARTED|Period 1 (Weeks 1 to 48)||40
65777|NCT02310763|159376|P2|STARTED|Period 1 (Weeks 1 to 48)||39
65778|NCT02310763|159377|P1|STARTED|Period 1 (Weeks 1 to 48)||41
65779|NCT02310750|159580|P16|NOT COMPLETED|HP MAD and Fasted/Fed||0
65780|NCT02310750|159581|P15|NOT COMPLETED|HP MAD and Fasted/Fed||0
65781|NCT02310750|159582|P14|NOT COMPLETED|HP MAD and Fasted/Fed||0
65782|NCT02310750|159583|P13|NOT COMPLETED|HP MAD and Fasted/Fed||0
65783|NCT02310750|159584|P12|NOT COMPLETED|HP MAD and Fasted/Fed||0
65784|NCT02310750|159585|P11|NOT COMPLETED|HP MAD and Fasted/Fed||0
65785|NCT02310750|159586|P10|NOT COMPLETED|HP MAD and Fasted/Fed||0
65786|NCT02310750|159587|P9|NOT COMPLETED|HP MAD and Fasted/Fed||0
65787|NCT02310750|159588|P8|NOT COMPLETED|HP MAD and Fasted/Fed||0
65788|NCT02310750|159589|P7|NOT COMPLETED|HP MAD and Fasted/Fed||0
65789|NCT02310750|159590|P6|NOT COMPLETED|HP MAD and Fasted/Fed||0
65790|NCT02310750|159591|P5|NOT COMPLETED|HP MAD and Fasted/Fed||1
65791|NCT02310750|159592|P4|NOT COMPLETED|HP MAD and Fasted/Fed||0
65792|NCT02310750|159593|P3|NOT COMPLETED|HP MAD and Fasted/Fed||0
65793|NCT02310750|159594|P2|NOT COMPLETED|HP MAD and Fasted/Fed||0
65794|NCT02310750|159595|P1|NOT COMPLETED|HP MAD and Fasted/Fed||0
65795|NCT02310750|159580|P16|COMPLETED|HP MAD and Fasted/Fed||2
65796|NCT02310750|159581|P15|COMPLETED|HP MAD and Fasted/Fed||2
65797|NCT02310750|159582|P14|COMPLETED|HP MAD and Fasted/Fed||2
65798|NCT02310750|159583|P13|COMPLETED|HP MAD and Fasted/Fed||2
65799|NCT02310750|159584|P12|COMPLETED|HP MAD and Fasted/Fed||2
65800|NCT02310750|159585|P11|COMPLETED|HP MAD and Fasted/Fed||2
65801|NCT02310750|159586|P10|COMPLETED|HP MAD and Fasted/Fed||0
65802|NCT02310750|159587|P9|COMPLETED|HP MAD and Fasted/Fed||0
65803|NCT02310750|159588|P8|COMPLETED|HP MAD and Fasted/Fed||0
65804|NCT02310750|159589|P7|COMPLETED|HP MAD and Fasted/Fed||2
65805|NCT02310750|159590|P6|COMPLETED|HP MAD and Fasted/Fed||0
65806|NCT02310750|159591|P5|COMPLETED|HP MAD and Fasted/Fed||4
65807|NCT02310750|159592|P4|COMPLETED|HP MAD and Fasted/Fed||0
65808|NCT02310750|159593|P3|COMPLETED|HP MAD and Fasted/Fed||0
65809|NCT02310750|159594|P2|COMPLETED|HP MAD and Fasted/Fed||0
65810|NCT02310750|159595|P1|COMPLETED|HP MAD and Fasted/Fed||0
65811|NCT02310750|159580|P16|STARTED|HP MAD and Fasted/Fed||2
65812|NCT02310750|159581|P15|STARTED|HP MAD and Fasted/Fed||2
65813|NCT02310750|159582|P14|STARTED|HP MAD and Fasted/Fed||2
65814|NCT02310750|159583|P13|STARTED|HP MAD and Fasted/Fed||2
65815|NCT02310750|159584|P12|STARTED|HP MAD and Fasted/Fed||2
65816|NCT02310750|159585|P11|STARTED|HP MAD and Fasted/Fed||2
65817|NCT02310750|159586|P10|STARTED|HP MAD and Fasted/Fed||0
65818|NCT02310750|159587|P9|STARTED|HP MAD and Fasted/Fed||0
65819|NCT02310750|159588|P8|STARTED|HP MAD and Fasted/Fed||0
65820|NCT02310750|159589|P7|STARTED|HP MAD and Fasted/Fed||2
65821|NCT02310750|159590|P6|STARTED|HP MAD and Fasted/Fed||0
65822|NCT02310750|159591|P5|STARTED|HP MAD and Fasted/Fed||5
65823|NCT02310750|159592|P4|STARTED|HP MAD and Fasted/Fed||0
65824|NCT02310750|159593|P3|STARTED|HP MAD and Fasted/Fed||0
65825|NCT02310750|159594|P2|STARTED|HP MAD and Fasted/Fed||0
65826|NCT02310750|159595|P1|STARTED|HP MAD and Fasted/Fed||0
65827|NCT02310750|159580|P16|NOT COMPLETED|HP Washout 2||0
65828|NCT02310750|159581|P15|NOT COMPLETED|HP Washout 2||0
65829|NCT02310750|159582|P14|NOT COMPLETED|HP Washout 2||0
65830|NCT02310750|159583|P13|NOT COMPLETED|HP Washout 2||0
65831|NCT02310750|159584|P12|NOT COMPLETED|HP Washout 2||0
65832|NCT02310750|159585|P11|NOT COMPLETED|HP Washout 2||0
65833|NCT02310750|159586|P10|NOT COMPLETED|HP Washout 2||0
65834|NCT02310750|159587|P9|NOT COMPLETED|HP Washout 2||0
65835|NCT02310750|159588|P8|NOT COMPLETED|HP Washout 2||0
65836|NCT02310750|159589|P7|NOT COMPLETED|HP Washout 2||7
65837|NCT02310750|159590|P6|NOT COMPLETED|HP Washout 2||0
65838|NCT02310750|159591|P5|NOT COMPLETED|HP Washout 2||1
65839|NCT02310750|159592|P4|NOT COMPLETED|HP Washout 2||0
65840|NCT02310750|159593|P3|NOT COMPLETED|HP Washout 2||0
65841|NCT02310750|159594|P2|NOT COMPLETED|HP Washout 2||0
65842|NCT02310750|159595|P1|NOT COMPLETED|HP Washout 2||0
65843|NCT02310750|159580|P16|COMPLETED|HP Washout 2||2
65844|NCT02310750|159581|P15|COMPLETED|HP Washout 2||2
65845|NCT02310750|159582|P14|COMPLETED|HP Washout 2||2
65846|NCT02310750|159583|P13|COMPLETED|HP Washout 2||2
65847|NCT02310750|159584|P12|COMPLETED|HP Washout 2||2
65848|NCT02310750|159585|P11|COMPLETED|HP Washout 2||2
65849|NCT02310750|159586|P10|COMPLETED|HP Washout 2||0
65850|NCT02310750|159587|P9|COMPLETED|HP Washout 2||0
65851|NCT02310750|159588|P8|COMPLETED|HP Washout 2||0
65852|NCT02310750|159589|P7|COMPLETED|HP Washout 2||2
65853|NCT02310750|159590|P6|COMPLETED|HP Washout 2||0
65854|NCT02310750|159591|P5|COMPLETED|HP Washout 2||5
65855|NCT02310750|159592|P4|COMPLETED|HP Washout 2||0
65856|NCT02310750|159593|P3|COMPLETED|HP Washout 2||0
65857|NCT02310750|159594|P2|COMPLETED|HP Washout 2||0
65858|NCT02310750|159595|P1|COMPLETED|HP Washout 2||0
65859|NCT02310750|159580|P16|STARTED|HP Washout 2||2
65860|NCT02310750|159581|P15|STARTED|HP Washout 2||2
65861|NCT02310750|159582|P14|STARTED|HP Washout 2||2
65862|NCT02310750|159583|P13|STARTED|HP Washout 2||2
65863|NCT02310750|159584|P12|STARTED|HP Washout 2||2
65864|NCT02310750|159585|P11|STARTED|HP Washout 2||2
65865|NCT02310750|159586|P10|STARTED|HP Washout 2||0
65866|NCT02310750|159587|P9|STARTED|HP Washout 2||0
65867|NCT02310750|159588|P8|STARTED|HP Washout 2||0
65868|NCT02310750|159589|P7|STARTED|HP Washout 2||9
65869|NCT02310750|159590|P6|STARTED|HP Washout 2||0
65870|NCT02310750|159591|P5|STARTED|HP Washout 2||6
65871|NCT02310750|159592|P4|STARTED|HP Washout 2||0
65872|NCT02310750|159593|P3|STARTED|HP Washout 2||0
65873|NCT02310750|159594|P2|STARTED|HP Washout 2||0
65874|NCT02310750|159595|P1|STARTED|HP Washout 2||0
65875|NCT02310750|159580|P16|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
65876|NCT02310750|159581|P15|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
65877|NCT02310750|159582|P14|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
65878|NCT02310750|159583|P13|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
65879|NCT02310750|159584|P12|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
65880|NCT02310750|159585|P11|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
65881|NCT02310750|159586|P10|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
65882|NCT02310750|159587|P9|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||8
65883|NCT02310750|159588|P8|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
65884|NCT02310750|159589|P7|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
65885|NCT02310750|159590|P6|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
65886|NCT02310750|159591|P5|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
65887|NCT02310750|159592|P4|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||1
65888|NCT02310750|159593|P3|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
65889|NCT02310750|159594|P2|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
65890|NCT02310750|159595|P1|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
65891|NCT02310750|159580|P16|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
65892|NCT02310750|159581|P15|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
65893|NCT02310750|159582|P14|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
65894|NCT02310750|159583|P13|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
65895|NCT02310750|159584|P12|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
65896|NCT02310750|159585|P11|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
65897|NCT02310750|159586|P10|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
65898|NCT02310750|159587|P9|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
65899|NCT02310750|159588|P8|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
65900|NCT02310750|159589|P7|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
65901|NCT02310750|159590|P6|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
65902|NCT02310750|159591|P5|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
65903|NCT02310750|159592|P4|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
65904|NCT02310750|159593|P3|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
65905|NCT02310750|159594|P2|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
65906|NCT02310750|159595|P1|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
65907|NCT02310750|159580|P16|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
65908|NCT02310750|159581|P15|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
65909|NCT02310750|159582|P14|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
65910|NCT02310750|159583|P13|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
65911|NCT02310750|159584|P12|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
65912|NCT02310750|159585|P11|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
65913|NCT02310750|159586|P10|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
65914|NCT02310750|159587|P9|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||14
65915|NCT02310750|159588|P8|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
65916|NCT02310750|159589|P7|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
65917|NCT02310750|159590|P6|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
65918|NCT02310750|159591|P5|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
65919|NCT02310750|159592|P4|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
65920|NCT02310750|159593|P3|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
65921|NCT02310750|159594|P2|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
65922|NCT02310750|159595|P1|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
65923|NCT02310750|159580|P16|NOT COMPLETED|HP Washout 1||0
65924|NCT02310750|159581|P15|NOT COMPLETED|HP Washout 1||0
65925|NCT02310750|159582|P14|NOT COMPLETED|HP Washout 1||0
65926|NCT02310750|159583|P13|NOT COMPLETED|HP Washout 1||0
65927|NCT02310750|159584|P12|NOT COMPLETED|HP Washout 1||0
65928|NCT02310750|159585|P11|NOT COMPLETED|HP Washout 1||0
65929|NCT02310750|159586|P10|NOT COMPLETED|HP Washout 1||0
65930|NCT02310750|159587|P9|NOT COMPLETED|HP Washout 1||0
65931|NCT02310750|159588|P8|NOT COMPLETED|HP Washout 1||0
65932|NCT02310750|159589|P7|NOT COMPLETED|HP Washout 1||3
65933|NCT02310750|159590|P6|NOT COMPLETED|HP Washout 1||2
65934|NCT02310750|159591|P5|NOT COMPLETED|HP Washout 1||2
65935|NCT02310750|159592|P4|NOT COMPLETED|HP Washout 1||1
65936|NCT02310750|159593|P3|NOT COMPLETED|HP Washout 1||1
65937|NCT02310750|159594|P2|NOT COMPLETED|HP Washout 1||0
65938|NCT02310750|159595|P1|NOT COMPLETED|HP Washout 1||0
65939|NCT02310750|159580|P16|COMPLETED|HP Washout 1||2
65940|NCT02310750|159581|P15|COMPLETED|HP Washout 1||2
65941|NCT02310750|159582|P14|COMPLETED|HP Washout 1||2
65942|NCT02310750|159583|P13|COMPLETED|HP Washout 1||2
65943|NCT02310750|159584|P12|COMPLETED|HP Washout 1||2
65944|NCT02310750|159585|P11|COMPLETED|HP Washout 1||2
65945|NCT02310750|159586|P10|COMPLETED|HP Washout 1||0
65946|NCT02310750|159587|P9|COMPLETED|HP Washout 1||0
65947|NCT02310750|159588|P8|COMPLETED|HP Washout 1||0
65948|NCT02310750|159589|P7|COMPLETED|HP Washout 1||9
65949|NCT02310750|159590|P6|COMPLETED|HP Washout 1||6
65950|NCT02310750|159591|P5|COMPLETED|HP Washout 1||6
65951|NCT02310750|159592|P4|COMPLETED|HP Washout 1||4
65952|NCT02310750|159593|P3|COMPLETED|HP Washout 1||5
65953|NCT02310750|159594|P2|COMPLETED|HP Washout 1||0
65954|NCT02310750|159595|P1|COMPLETED|HP Washout 1||0
65955|NCT02310750|159580|P16|STARTED|HP Washout 1||2
65956|NCT02310750|159581|P15|STARTED|HP Washout 1||2
65957|NCT02310750|159582|P14|STARTED|HP Washout 1||2
65958|NCT02310750|159583|P13|STARTED|HP Washout 1||2
65959|NCT02310750|159584|P12|STARTED|HP Washout 1||2
65960|NCT02310750|159585|P11|STARTED|HP Washout 1||2
65961|NCT02310750|159586|P10|STARTED|HP Washout 1||0
65962|NCT02310750|159587|P9|STARTED|HP Washout 1||0
65963|NCT02310750|159588|P8|STARTED|HP Washout 1||0
65964|NCT02310750|159589|P7|STARTED|HP Washout 1||12
65965|NCT02310750|159590|P6|STARTED|HP Washout 1||8
65966|NCT02310750|159591|P5|STARTED|HP Washout 1||8
65967|NCT02310750|159592|P4|STARTED|HP Washout 1||5
65968|NCT02310750|159593|P3|STARTED|HP Washout 1||6
65969|NCT02310750|159594|P2|STARTED|HP Washout 1||0
65970|NCT02310750|159595|P1|STARTED|HP Washout 1||0
65971|NCT02310750|159580|P16|NOT COMPLETED|HP Period 1||0
65972|NCT02310750|159581|P15|NOT COMPLETED|HP Period 1||0
65973|NCT02310750|159582|P14|NOT COMPLETED|HP Period 1||0
65974|NCT02310750|159583|P13|NOT COMPLETED|HP Period 1||0
65975|NCT02310750|159584|P12|NOT COMPLETED|HP Period 1||0
65976|NCT02310750|159585|P11|NOT COMPLETED|HP Period 1||0
65977|NCT02310750|159586|P10|NOT COMPLETED|HP Period 1||0
65978|NCT02310750|159587|P9|NOT COMPLETED|HP Period 1||0
65979|NCT02310750|159588|P8|NOT COMPLETED|HP Period 1||0
65980|NCT02310750|159589|P7|NOT COMPLETED|HP Period 1||1
65981|NCT02310750|159590|P6|NOT COMPLETED|HP Period 1||0
65982|NCT02310750|159591|P5|NOT COMPLETED|HP Period 1||0
65983|NCT02310750|159592|P4|NOT COMPLETED|HP Period 1||1
65984|NCT02310750|159593|P3|NOT COMPLETED|HP Period 1||0
65985|NCT02310750|159594|P2|NOT COMPLETED|HP Period 1||0
65986|NCT02310750|159595|P1|NOT COMPLETED|HP Period 1||1
65987|NCT02310750|159580|P16|COMPLETED|HP Period 1||2
65988|NCT02310750|159581|P15|COMPLETED|HP Period 1||2
65989|NCT02310750|159582|P14|COMPLETED|HP Period 1||2
65990|NCT02310750|159583|P13|COMPLETED|HP Period 1||2
65991|NCT02310750|159584|P12|COMPLETED|HP Period 1||2
65992|NCT02310750|159585|P11|COMPLETED|HP Period 1||2
65993|NCT02310750|159586|P10|COMPLETED|HP Period 1||0
65994|NCT02310750|159587|P9|COMPLETED|HP Period 1||0
65995|NCT02310750|159588|P8|COMPLETED|HP Period 1||0
65996|NCT02310750|159589|P7|COMPLETED|HP Period 1||12
65997|NCT02310750|159590|P6|COMPLETED|HP Period 1||8
65998|NCT02310750|159591|P5|COMPLETED|HP Period 1||8
65999|NCT02310750|159592|P4|COMPLETED|HP Period 1||5
66000|NCT02310750|159593|P3|COMPLETED|HP Period 1||6
66001|NCT02310750|159594|P2|COMPLETED|HP Period 1||6
66002|NCT02310750|159595|P1|COMPLETED|HP Period 1||6
66003|NCT02310750|159580|P16|STARTED|HP Period 1||2
66004|NCT02310750|159581|P15|STARTED|HP Period 1||2
66005|NCT02310750|159582|P14|STARTED|HP Period 1||2
66006|NCT02310750|159583|P13|STARTED|HP Period 1||2
66007|NCT02310750|159584|P12|STARTED|HP Period 1||2
66008|NCT02310750|159585|P11|STARTED|HP Period 1||2
66009|NCT02310750|159586|P10|STARTED|HP Period 1||0
66010|NCT02310750|159587|P9|STARTED|HP Period 1||0
66011|NCT02310750|159588|P8|STARTED|HP Period 1||0
66012|NCT02310750|159589|P7|STARTED|HP Period 1||13
66013|NCT02310750|159590|P6|STARTED|HP Period 1||8
66014|NCT02310750|159591|P5|STARTED|HP Period 1||8
66015|NCT02310750|159592|P4|STARTED|HP Period 1||6
66016|NCT02310750|159593|P3|STARTED|HP Period 1||6
66017|NCT02310750|159594|P2|STARTED|HP Period 1||6
66018|NCT02310750|159595|P1|STARTED|HP Period 1||7
66019|NCT02310646|160036|P2|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
66020|NCT02310646|160037|P1|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
66021|NCT02310646|160036|P2|COMPLETED|Second Intervention (Day 8 - Day 14)||104
66022|NCT02310646|160037|P1|COMPLETED|Second Intervention (Day 8 - Day 14)||107
66023|NCT02310646|160036|P2|STARTED|Second Intervention (Day 8 - Day 14)||104
66024|NCT02310646|160037|P1|STARTED|Second Intervention (Day 8 - Day 14)||107
66025|NCT02310646|160036|P2|NOT COMPLETED|First Intervention (Day 1 - Day 7)||0
66026|NCT02310646|160037|P1|NOT COMPLETED|First Intervention (Day 1 - Day 7)||2
66027|NCT02310646|160036|P2|COMPLETED|First Intervention (Day 1 - Day 7)||104
66028|NCT02310646|160037|P1|COMPLETED|First Intervention (Day 1 - Day 7)||107
66029|NCT02310646|160036|P2|STARTED|First Intervention (Day 1 - Day 7)||104
66030|NCT02310646|160037|P1|STARTED|First Intervention (Day 1 - Day 7)||109
66031|NCT02310581|160065|P4|NOT COMPLETED|Overall Study||1
66032|NCT02310581|160066|P3|NOT COMPLETED|Overall Study||1
66033|NCT02310581|160067|P2|NOT COMPLETED|Overall Study||2
66034|NCT02310581|160068|P1|NOT COMPLETED|Overall Study||3
66035|NCT02310581|160065|P4|COMPLETED|Overall Study||9
66036|NCT02310581|160066|P3|COMPLETED|Overall Study||9
66037|NCT02310581|160067|P2|COMPLETED|Overall Study||9
66038|NCT02310581|160068|P1|COMPLETED|Overall Study||6
66039|NCT02310581|160065|P4|STARTED|Overall Study||10
66040|NCT02310581|160066|P3|STARTED|Overall Study||10
66041|NCT02310581|160067|P2|STARTED|Overall Study||11
66042|NCT02310581|160068|P1|STARTED|Overall Study||9
66043|NCT02310568|160107|P5|NOT COMPLETED|Stage 2 (4 Weeks)||1
66044|NCT02310568|160108|P4|NOT COMPLETED|Stage 2 (4 Weeks)||5
66045|NCT02310568|160109|P3|NOT COMPLETED|Stage 2 (4 Weeks)||1
66046|NCT02310568|160110|P2|NOT COMPLETED|Stage 2 (4 Weeks)||1
66047|NCT02310568|160111|P1|NOT COMPLETED|Stage 2 (4 Weeks)||1
66048|NCT02310568|160107|P5|COMPLETED|Stage 2 (4 Weeks)||19
66049|NCT02310568|160108|P4|COMPLETED|Stage 2 (4 Weeks)||17
66050|NCT02310568|160109|P3|COMPLETED|Stage 2 (4 Weeks)||13
66051|NCT02310568|160110|P2|COMPLETED|Stage 2 (4 Weeks)||12
66052|NCT02310568|160111|P1|COMPLETED|Stage 2 (4 Weeks)||11
66053|NCT02310568|160107|P5|STARTED|Stage 2 (4 Weeks)||20
66054|NCT02310568|160108|P4|STARTED|Stage 2 (4 Weeks)||22
66055|NCT02310568|160109|P3|STARTED|Stage 2 (4 Weeks)||14
66056|NCT02310568|160110|P2|STARTED|Stage 2 (4 Weeks)||13
66057|NCT02310568|160111|P1|STARTED|Stage 2 (4 Weeks)||12
66058|NCT02310568|160107|P5|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
66059|NCT02310568|160108|P4|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
66060|NCT02310568|160109|P3|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
66061|NCT02310568|160110|P2|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
66062|NCT02310568|160111|P1|NOT COMPLETED|Stage 1 ( 4 Weeks)||3
66063|NCT02310568|160107|P5|COMPLETED|Stage 1 ( 4 Weeks)||20
66064|NCT02310568|160108|P4|COMPLETED|Stage 1 ( 4 Weeks)||22
66065|NCT02310568|160109|P3|COMPLETED|Stage 1 ( 4 Weeks)||14
66066|NCT02310568|160110|P2|COMPLETED|Stage 1 ( 4 Weeks)||13
66067|NCT02310568|160111|P1|COMPLETED|Stage 1 ( 4 Weeks)||12
66068|NCT02310568|160107|P5|STARTED|Stage 1 ( 4 Weeks)||21
66069|NCT02310568|160108|P4|STARTED|Stage 1 ( 4 Weeks)||24
66070|NCT02310568|160109|P3|STARTED|Stage 1 ( 4 Weeks)||15
66071|NCT02310568|160110|P2|STARTED|Stage 1 ( 4 Weeks)||15
66072|NCT02310568|160111|P1|STARTED|Stage 1 ( 4 Weeks)||15
66073|NCT02310126|160191|P2|NOT COMPLETED|Period 2 (15 Minutes)||0
66074|NCT02310126|160192|P1|NOT COMPLETED|Period 2 (15 Minutes)||0
66075|NCT02310126|160191|P2|COMPLETED|Period 2 (15 Minutes)||95
66076|NCT02310126|160192|P1|COMPLETED|Period 2 (15 Minutes)||94
66077|NCT02310126|160191|P2|Myopes|Period 2 (15 Minutes)||63
66078|NCT02310126|160192|P1|Myopes|Period 2 (15 Minutes)||56
66079|NCT02310126|160191|P2|Hyperopes|Period 2 (15 Minutes)||32
66080|NCT02310126|160192|P1|Hyperopes|Period 2 (15 Minutes)||38
66081|NCT02310126|160191|P2|STARTED|Period 2 (15 Minutes)||95
66082|NCT02310126|160192|P1|STARTED|Period 2 (15 Minutes)||94
66083|NCT02310126|160191|P2|NOT COMPLETED|Period 1 (15 Minutes)||2
66084|NCT02310126|160192|P1|NOT COMPLETED|Period 1 (15 Minutes)||0
66085|NCT02310126|160191|P2|COMPLETED|Period 1 (15 Minutes)||95
66086|NCT02310126|160192|P1|COMPLETED|Period 1 (15 Minutes)||94
66087|NCT02310126|160191|P2|Myopes|Period 1 (15 Minutes)||64
66088|NCT02310126|160192|P1|Myopes|Period 1 (15 Minutes)||56
66089|NCT02310126|160191|P2|Hyperopes|Period 1 (15 Minutes)||33
66090|NCT02310126|160192|P1|Hyperopes|Period 1 (15 Minutes)||38
66091|NCT02310126|160191|P2|STARTED|Period 1 (15 Minutes)||97
66092|NCT02310126|160192|P1|STARTED|Period 1 (15 Minutes)||94
66093|NCT02310100|160198|P1|NOT COMPLETED|Overall Study||18
66094|NCT02310100|160198|P1|COMPLETED|Overall Study||160
66095|NCT02310100|160198|P1|STARTED|Overall Study|First enrollment|178
66096|NCT02309723|160206|P3|NOT COMPLETED|Overall Study||24
66097|NCT02309723|160207|P2|NOT COMPLETED|Overall Study||23
66098|NCT02309723|160208|P1|NOT COMPLETED|Overall Study||24
66099|NCT02309723|160206|P3|COMPLETED|Overall Study||105
66100|NCT02309723|160207|P2|COMPLETED|Overall Study||105
66101|NCT02309723|160208|P1|COMPLETED|Overall Study||105
66102|NCT02309723|160206|P3|STARTED|Overall Study||129
66103|NCT02309723|160207|P2|STARTED|Overall Study||128
66104|NCT02309723|160208|P1|STARTED|Overall Study||129
66105|NCT02309489|160224|P2|NOT COMPLETED|Overall Study||14
66106|NCT02309489|160225|P1|NOT COMPLETED|Overall Study||15
66107|NCT02309489|160224|P2|COMPLETED|Overall Study||547
66108|NCT02309489|160225|P1|COMPLETED|Overall Study||568
66109|NCT02309489|160224|P2|Follow-up at 3 Months Postpartum|Overall Study||541
66110|NCT02309489|160225|P1|Follow-up at 3 Months Postpartum|Overall Study||560
66111|NCT02309489|160224|P2|STARTED|Overall Study||561
66112|NCT02309489|160225|P1|STARTED|Overall Study||583
66113|NCT02309411|160251|P3|NOT COMPLETED|Overall Study||0
66114|NCT02309411|160252|P2|NOT COMPLETED|Overall Study||1
66115|NCT02309411|160253|P1|NOT COMPLETED|Overall Study||2
66116|NCT02309411|160251|P3|COMPLETED|Overall Study||6
66117|NCT02309411|160252|P2|COMPLETED|Overall Study||14
66118|NCT02309411|160253|P1|COMPLETED|Overall Study||23
66119|NCT02309411|160251|P3|STARTED|Overall Study||6
66120|NCT02309411|160252|P2|STARTED|Overall Study||15
66121|NCT02309411|160253|P1|STARTED|Overall Study||25
66122|NCT02309359|160277|P5|NOT COMPLETED|Overall Study||9
66123|NCT02309359|160278|P4|NOT COMPLETED|Overall Study||12
66124|NCT02309359|160279|P3|NOT COMPLETED|Overall Study||11
66125|NCT02309359|160280|P2|NOT COMPLETED|Overall Study||8
66126|NCT02309359|160281|P1|NOT COMPLETED|Overall Study||12
66127|NCT02309359|160277|P5|COMPLETED|Overall Study||60
66128|NCT02309359|160278|P4|COMPLETED|Overall Study||57
66129|NCT02309359|160279|P3|COMPLETED|Overall Study||57
66130|NCT02309359|160280|P2|COMPLETED|Overall Study||62
66131|NCT02309359|160281|P1|COMPLETED|Overall Study||57
66132|NCT02309359|160277|P5|STARTED|Overall Study||69
66133|NCT02309359|160278|P4|STARTED|Overall Study||69
66134|NCT02309359|160279|P3|STARTED|Overall Study||68
66135|NCT02309359|160280|P2|STARTED|Overall Study||70
66136|NCT02309359|160281|P1|STARTED|Overall Study||69
66137|NCT02309294|160408|P1|NOT COMPLETED|Overall Study||2
66138|NCT02309294|160408|P1|COMPLETED|Overall Study||41
66139|NCT02309294|160408|P1|STARTED|Overall Study||43
66140|NCT02309112|160415|P3|NOT COMPLETED|Overall Study||1
66141|NCT02309112|160416|P2|NOT COMPLETED|Overall Study||1
66142|NCT02309112|160417|P1|NOT COMPLETED|Overall Study||1
66143|NCT02309112|160415|P3|COMPLETED|Overall Study||4
66144|NCT02309112|160416|P2|COMPLETED|Overall Study||4
66145|NCT02309112|160417|P1|COMPLETED|Overall Study||4
66146|NCT02309112|160415|P3|Completed Yoga Intervention|Overall Study||4
66147|NCT02309112|160416|P2|Completed Yoga Intervention|Overall Study||5
66148|NCT02309112|160417|P1|Completed Yoga Intervention|Overall Study||4
66149|NCT02309112|160415|P3|STARTED|Overall Study||5
66150|NCT02309112|160416|P2|STARTED|Overall Study||5
66151|NCT02309112|160417|P1|STARTED|Overall Study||5
66152|NCT02309099|160440|P2|NOT COMPLETED|Overall Study||0
66153|NCT02309099|160441|P1|NOT COMPLETED|Overall Study||2
66154|NCT02309099|160440|P2|COMPLETED|Overall Study||3
66155|NCT02309099|160441|P1|COMPLETED|Overall Study|5 participants completed the study (2 did not complete due to adverse event)|5
66156|NCT02309099|160440|P2|Cochlear Implant Use/Follow-Up|Overall Study||3
66157|NCT02309099|160441|P1|Cochlear Implant Use/Follow-Up|Overall Study|5 participants completed cochlear implant use/follow-up (2 did not complete due to adverse event)|5
66158|NCT02309099|160440|P2|Initial Activation|Overall Study||3
66159|NCT02309099|160441|P1|Initial Activation|Overall Study||7
66160|NCT02309099|160440|P2|Cochlear Implantation|Overall Study||3
66161|NCT02309099|160441|P1|Cochlear Implantation|Overall Study||7
66162|NCT02309099|160440|P2|STARTED|Overall Study||3
66163|NCT02309099|160441|P1|STARTED|Overall Study||7
66164|NCT02308787|160487|P1|NOT COMPLETED|Overall Study||0
66165|NCT02308787|160487|P1|COMPLETED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
66166|NCT02308787|160487|P1|STARTED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
66167|NCT02308748|160502|P10|NOT COMPLETED|Period 5||0
66168|NCT02308748|160503|P9|NOT COMPLETED|Period 5||1
66169|NCT02308748|160504|P8|NOT COMPLETED|Period 5||0
66170|NCT02308748|160505|P7|NOT COMPLETED|Period 5||0
66171|NCT02308748|160506|P6|NOT COMPLETED|Period 5||0
66172|NCT02308748|160507|P5|NOT COMPLETED|Period 5||0
66173|NCT02308748|160508|P4|NOT COMPLETED|Period 5||0
66174|NCT02308748|160509|P3|NOT COMPLETED|Period 5||0
66175|NCT02308748|160510|P2|NOT COMPLETED|Period 5||0
66176|NCT02308748|160511|P1|NOT COMPLETED|Period 5||1
66177|NCT02308748|160502|P10|COMPLETED|Period 5||2
66178|NCT02308748|160503|P9|COMPLETED|Period 5||1
66179|NCT02308748|160504|P8|COMPLETED|Period 5||1
66180|NCT02308748|160505|P7|COMPLETED|Period 5||2
66181|NCT02308748|160506|P6|COMPLETED|Period 5||3
66182|NCT02308748|160507|P5|COMPLETED|Period 5||2
66183|NCT02308748|160508|P4|COMPLETED|Period 5||2
66184|NCT02308748|160509|P3|COMPLETED|Period 5||1
66185|NCT02308748|160510|P2|COMPLETED|Period 5||2
66186|NCT02308748|160511|P1|COMPLETED|Period 5||1
66187|NCT02308748|160502|P10|STARTED|Period 5||2
66188|NCT02308748|160503|P9|STARTED|Period 5||2
66189|NCT02308748|160504|P8|STARTED|Period 5||1
66190|NCT02308748|160505|P7|STARTED|Period 5||2
66191|NCT02308748|160506|P6|STARTED|Period 5||3
66192|NCT02308748|160507|P5|STARTED|Period 5||2
66193|NCT02308748|160508|P4|STARTED|Period 5||2
66194|NCT02308748|160509|P3|STARTED|Period 5||1
66195|NCT02308748|160510|P2|STARTED|Period 5||2
66196|NCT02308748|160511|P1|STARTED|Period 5||2
66197|NCT02308748|160502|P10|NOT COMPLETED|Period 4||0
66198|NCT02308748|160503|P9|NOT COMPLETED|Period 4||0
66199|NCT02308748|160504|P8|NOT COMPLETED|Period 4||0
66200|NCT02308748|160505|P7|NOT COMPLETED|Period 4||0
66201|NCT02308748|160506|P6|NOT COMPLETED|Period 4||0
66202|NCT02308748|160507|P5|NOT COMPLETED|Period 4||0
66203|NCT02308748|160508|P4|NOT COMPLETED|Period 4||0
66204|NCT02308748|160509|P3|NOT COMPLETED|Period 4||0
66205|NCT02308748|160510|P2|NOT COMPLETED|Period 4||0
66206|NCT02308748|160511|P1|NOT COMPLETED|Period 4||0
66207|NCT02308748|160502|P10|COMPLETED|Period 4||2
66208|NCT02308748|160503|P9|COMPLETED|Period 4||2
66209|NCT02308748|160504|P8|COMPLETED|Period 4||1
66210|NCT02308748|160505|P7|COMPLETED|Period 4||2
66211|NCT02308748|160506|P6|COMPLETED|Period 4||3
66212|NCT02308748|160507|P5|COMPLETED|Period 4||2
66213|NCT02308748|160508|P4|COMPLETED|Period 4||2
66214|NCT02308748|160509|P3|COMPLETED|Period 4||1
66215|NCT02308748|160510|P2|COMPLETED|Period 4||2
66216|NCT02308748|160511|P1|COMPLETED|Period 4||2
66217|NCT02308748|160502|P10|STARTED|Period 4||2
66218|NCT02308748|160503|P9|STARTED|Period 4||2
66219|NCT02308748|160504|P8|STARTED|Period 4||1
66220|NCT02308748|160505|P7|STARTED|Period 4||2
66221|NCT02308748|160506|P6|STARTED|Period 4||3
66222|NCT02308748|160507|P5|STARTED|Period 4||2
66223|NCT02308748|160508|P4|STARTED|Period 4||2
66224|NCT02308748|160509|P3|STARTED|Period 4||1
66225|NCT02308748|160510|P2|STARTED|Period 4||2
66226|NCT02308748|160511|P1|STARTED|Period 4||2
66227|NCT02308748|160502|P10|NOT COMPLETED|Period 3||1
66228|NCT02308748|160503|P9|NOT COMPLETED|Period 3||0
66229|NCT02308748|160504|P8|NOT COMPLETED|Period 3||0
66230|NCT02308748|160505|P7|NOT COMPLETED|Period 3||0
66231|NCT02308748|160506|P6|NOT COMPLETED|Period 3||0
66232|NCT02308748|160507|P5|NOT COMPLETED|Period 3||0
66233|NCT02308748|160508|P4|NOT COMPLETED|Period 3||0
66234|NCT02308748|160509|P3|NOT COMPLETED|Period 3||0
66235|NCT02308748|160510|P2|NOT COMPLETED|Period 3||0
66236|NCT02308748|160511|P1|NOT COMPLETED|Period 3||0
66237|NCT02308748|160502|P10|COMPLETED|Period 3||2
66238|NCT02308748|160503|P9|COMPLETED|Period 3||2
66239|NCT02308748|160504|P8|COMPLETED|Period 3||1
66240|NCT02308748|160505|P7|COMPLETED|Period 3||2
66241|NCT02308748|160506|P6|COMPLETED|Period 3||3
66242|NCT02308748|160507|P5|COMPLETED|Period 3||2
66243|NCT02308748|160508|P4|COMPLETED|Period 3||2
66244|NCT02308748|160509|P3|COMPLETED|Period 3||1
66245|NCT02308748|160510|P2|COMPLETED|Period 3||2
66246|NCT02308748|160511|P1|COMPLETED|Period 3||2
66247|NCT02308748|160502|P10|STARTED|Period 3||3
66248|NCT02308748|160503|P9|STARTED|Period 3||2
66249|NCT02308748|160504|P8|STARTED|Period 3||1
66250|NCT02308748|160505|P7|STARTED|Period 3||2
66251|NCT02308748|160506|P6|STARTED|Period 3||3
66252|NCT02308748|160507|P5|STARTED|Period 3||2
66253|NCT02308748|160508|P4|STARTED|Period 3||2
66254|NCT02308748|160509|P3|STARTED|Period 3||1
66255|NCT02308748|160510|P2|STARTED|Period 3||2
66256|NCT02308748|160511|P1|STARTED|Period 3||2
66257|NCT02308748|160502|P10|NOT COMPLETED|Period 2||0
66258|NCT02308748|160503|P9|NOT COMPLETED|Period 2||0
66259|NCT02308748|160504|P8|NOT COMPLETED|Period 2||1
66260|NCT02308748|160505|P7|NOT COMPLETED|Period 2||0
66261|NCT02308748|160506|P6|NOT COMPLETED|Period 2||0
66262|NCT02308748|160507|P5|NOT COMPLETED|Period 2||0
66263|NCT02308748|160508|P4|NOT COMPLETED|Period 2||0
66264|NCT02308748|160509|P3|NOT COMPLETED|Period 2||0
66265|NCT02308748|160510|P2|NOT COMPLETED|Period 2||0
66266|NCT02308748|160511|P1|NOT COMPLETED|Period 2||0
66267|NCT02308748|160502|P10|COMPLETED|Period 2||3
66268|NCT02308748|160503|P9|COMPLETED|Period 2||2
66269|NCT02308748|160504|P8|COMPLETED|Period 2||1
66270|NCT02308748|160505|P7|COMPLETED|Period 2||2
66271|NCT02308748|160506|P6|COMPLETED|Period 2||3
66272|NCT02308748|160507|P5|COMPLETED|Period 2||2
66273|NCT02308748|160508|P4|COMPLETED|Period 2||2
66274|NCT02308748|160509|P3|COMPLETED|Period 2||1
66275|NCT02308748|160510|P2|COMPLETED|Period 2||2
66276|NCT02308748|160511|P1|COMPLETED|Period 2||2
66277|NCT02308748|160502|P10|STARTED|Period 2||3
66278|NCT02308748|160503|P9|STARTED|Period 2||2
66279|NCT02308748|160504|P8|STARTED|Period 2||2
66280|NCT02308748|160505|P7|STARTED|Period 2||2
66281|NCT02308748|160506|P6|STARTED|Period 2||3
66282|NCT02308748|160507|P5|STARTED|Period 2||2
66283|NCT02308748|160508|P4|STARTED|Period 2||2
66284|NCT02308748|160509|P3|STARTED|Period 2||1
66285|NCT02308748|160510|P2|STARTED|Period 2||2
66286|NCT02308748|160511|P1|STARTED|Period 2||2
66287|NCT02308748|160502|P10|NOT COMPLETED|Period 1||0
66288|NCT02308748|160503|P9|NOT COMPLETED|Period 1||0
66289|NCT02308748|160504|P8|NOT COMPLETED|Period 1||0
66290|NCT02308748|160505|P7|NOT COMPLETED|Period 1||0
66291|NCT02308748|160506|P6|NOT COMPLETED|Period 1||0
66292|NCT02308748|160507|P5|NOT COMPLETED|Period 1||0
66293|NCT02308748|160508|P4|NOT COMPLETED|Period 1||0
66294|NCT02308748|160509|P3|NOT COMPLETED|Period 1||1
66295|NCT02308748|160510|P2|NOT COMPLETED|Period 1||0
66296|NCT02308748|160511|P1|NOT COMPLETED|Period 1||0
66297|NCT02308748|160502|P10|COMPLETED|Period 1||3
66298|NCT02308748|160503|P9|COMPLETED|Period 1||2
66299|NCT02308748|160504|P8|COMPLETED|Period 1||2
66300|NCT02308748|160505|P7|COMPLETED|Period 1||2
66301|NCT02308748|160506|P6|COMPLETED|Period 1||3
66302|NCT02308748|160507|P5|COMPLETED|Period 1||2
66303|NCT02308748|160508|P4|COMPLETED|Period 1||2
66304|NCT02308748|160509|P3|COMPLETED|Period 1|One subject withdraw consent before starting Period 2|1
66305|NCT02308748|160510|P2|COMPLETED|Period 1||2
66306|NCT02308748|160511|P1|COMPLETED|Period 1||2
66307|NCT02308748|160502|P10|STARTED|Period 1||3
66308|NCT02308748|160503|P9|STARTED|Period 1||2
66309|NCT02308748|160504|P8|STARTED|Period 1||2
66310|NCT02308748|160505|P7|STARTED|Period 1||2
66311|NCT02308748|160506|P6|STARTED|Period 1||3
66312|NCT02308748|160507|P5|STARTED|Period 1||2
66313|NCT02308748|160508|P4|STARTED|Period 1||2
66314|NCT02308748|160509|P3|STARTED|Period 1||2
66315|NCT02308748|160510|P2|STARTED|Period 1||2
66316|NCT02308748|160511|P1|STARTED|Period 1||2
66317|NCT02308696|160525|P2|NOT COMPLETED|Overall Study||31
66318|NCT02308696|160526|P1|NOT COMPLETED|Overall Study||53
66319|NCT02308696|160525|P2|COMPLETED|Overall Study||203
66320|NCT02308696|160526|P1|COMPLETED|Overall Study||169
66321|NCT02308696|160525|P2|STARTED|Overall Study||234
66322|NCT02308696|160526|P1|STARTED|Overall Study||222
66323|NCT02308540|160560|P6|NOT COMPLETED|Overall Study||1
66324|NCT02308540|160561|P5|NOT COMPLETED|Overall Study||0
66325|NCT02308540|160562|P4|NOT COMPLETED|Overall Study||0
66326|NCT02308540|160563|P3|NOT COMPLETED|Overall Study||0
66327|NCT02308540|160564|P2|NOT COMPLETED|Overall Study||0
66328|NCT02308540|160565|P1|NOT COMPLETED|Overall Study||0
66329|NCT02308540|160560|P6|COMPLETED|Overall Study||99
66330|NCT02308540|160561|P5|COMPLETED|Overall Study||100
66331|NCT02308540|160562|P4|COMPLETED|Overall Study||56
66332|NCT02308540|160563|P3|COMPLETED|Overall Study||56
66333|NCT02308540|160564|P2|COMPLETED|Overall Study||17
66334|NCT02308540|160565|P1|COMPLETED|Overall Study||17
66335|NCT02308540|160560|P6|Vaccinated|Overall Study||100
66336|NCT02308540|160561|P5|Vaccinated|Overall Study||100
66337|NCT02308540|160562|P4|Vaccinated|Overall Study||56
66338|NCT02308540|160563|P3|Vaccinated|Overall Study||56
66339|NCT02308540|160564|P2|Vaccinated|Overall Study||17
66340|NCT02308540|160565|P1|Vaccinated|Overall Study||17
66341|NCT02308540|160560|P6|Randomized|Overall Study||100
66342|NCT02308540|160561|P5|Randomized|Overall Study||100
66343|NCT02308540|160562|P4|Randomized|Overall Study||56
66344|NCT02308540|160563|P3|Randomized|Overall Study||56
66345|NCT02308540|160564|P2|Randomized|Overall Study||17
66346|NCT02308540|160565|P1|Randomized|Overall Study||17
66347|NCT02308540|160560|P6|STARTED|Overall Study||100
66348|NCT02308540|160561|P5|STARTED|Overall Study||100
66349|NCT02308540|160562|P4|STARTED|Overall Study||56
66350|NCT02308540|160563|P3|STARTED|Overall Study||56
66351|NCT02308540|160564|P2|STARTED|Overall Study||17
66352|NCT02308540|160565|P1|STARTED|Overall Study||17
66353|NCT02308475|160629|P1|NOT COMPLETED|Overall Study||0
66354|NCT02308475|160629|P1|COMPLETED|Overall Study||2
66355|NCT02308475|160629|P1|STARTED|Overall Study||2
66356|NCT02308371|160637|P2|NOT COMPLETED|Overall Study||0
66357|NCT02308371|160638|P1|NOT COMPLETED|Overall Study||0
66358|NCT02308371|160637|P2|COMPLETED|Overall Study|Consider eligible for retrospective enrollment if admitted up until 10/15/2012|50
66359|NCT02308371|160638|P1|COMPLETED|Overall Study|Ended enrollment and recruitment 3/1/2016|50
66360|NCT02308371|160637|P2|STARTED|Overall Study|Consider eligible for retrospective enrollment if admitted after 4/1/2012|50
66361|NCT02308371|160638|P1|STARTED|Overall Study|Started enrollment and recruitment 11/26/2014|50
66362|NCT02308228|160654|P2|NOT COMPLETED|Overall Study||7
66363|NCT02308228|160655|P1|NOT COMPLETED|Overall Study||8
66364|NCT02308228|160654|P2|COMPLETED|Overall Study||48
66365|NCT02308228|160655|P1|COMPLETED|Overall Study||46
66366|NCT02308228|160654|P2|STARTED|Overall Study||55
66367|NCT02308228|160655|P1|STARTED|Overall Study||54
66368|NCT02308189|160669|P2|NOT COMPLETED|Overall Study||1
66369|NCT02308189|160670|P1|NOT COMPLETED|Overall Study||1
66370|NCT02308189|160669|P2|COMPLETED|Overall Study||14
66371|NCT02308189|160670|P1|COMPLETED|Overall Study||16
66372|NCT02308189|160669|P2|STARTED|Overall Study||15
66373|NCT02308189|160670|P1|STARTED|Overall Study||17
66374|NCT02308124|160683|P3|NOT COMPLETED|Overall Study||8
66375|NCT02308124|160684|P2|NOT COMPLETED|Overall Study||8
66376|NCT02308124|160685|P1|NOT COMPLETED|Overall Study||6
66377|NCT02308124|160683|P3|COMPLETED|Overall Study||21
66378|NCT02308124|160684|P2|COMPLETED|Overall Study||21
66379|NCT02308124|160685|P1|COMPLETED|Overall Study||23
66380|NCT02308124|160683|P3|STARTED|Overall Study||29
66381|NCT02308124|160684|P2|STARTED|Overall Study||29
66382|NCT02308124|160685|P1|STARTED|Overall Study||29
66383|NCT02307838|160708|P3|NOT COMPLETED|Overall Study||0
66384|NCT02307838|160709|P2|NOT COMPLETED|Overall Study||0
66385|NCT02307838|160710|P1|NOT COMPLETED|Overall Study||0
66386|NCT02307838|160708|P3|COMPLETED|Overall Study||55
66387|NCT02307838|160709|P2|COMPLETED|Overall Study||64
66388|NCT02307838|160710|P1|COMPLETED|Overall Study||56
66389|NCT02307838|160708|P3|STARTED|Overall Study||55
66390|NCT02307838|160709|P2|STARTED|Overall Study||64
66391|NCT02307838|160710|P1|STARTED|Overall Study||56
66392|NCT02307682|160756|P3|NOT COMPLETED|Overall Study||64
66393|NCT02307682|160757|P2|NOT COMPLETED|Overall Study||57
66394|NCT02307682|160758|P1|NOT COMPLETED|Overall Study||50
66395|NCT02307682|160756|P3|COMPLETED|Overall Study||297
66396|NCT02307682|160757|P2|COMPLETED|Overall Study||304
66397|NCT02307682|160758|P1|COMPLETED|Overall Study||310
66398|NCT02307682|160756|P3|Randomized and Treated|Overall Study||360
66399|NCT02307682|160757|P2|Randomized and Treated|Overall Study||360
66400|NCT02307682|160758|P1|Randomized and Treated|Overall Study||358
66401|NCT02307682|160756|P3|STARTED|Overall Study||361
66402|NCT02307682|160757|P2|STARTED|Overall Study||361
66403|NCT02307682|160758|P1|STARTED|Overall Study||360
66404|NCT02307552|160858|P1|NOT COMPLETED|Overall Study||0
66405|NCT02307552|160858|P1|COMPLETED|Overall Study||1
66406|NCT02307552|160858|P1|STARTED|Overall Study||1
66407|NCT02307526|160862|P1|NOT COMPLETED|Day 2 - 60 mg of Pyridostigmine||0
66408|NCT02307526|160862|P1|COMPLETED|Day 2 - 60 mg of Pyridostigmine||10
66409|NCT02307526|160862|P1|STARTED|Day 2 - 60 mg of Pyridostigmine||10
66410|NCT02307526|160862|P1|NOT COMPLETED|Day 1 - No Drug||0
66411|NCT02307526|160862|P1|COMPLETED|Day 1 - No Drug||10
66412|NCT02307526|160862|P1|STARTED|Day 1 - No Drug||10
66413|NCT02307513|160874|P2|NOT COMPLETED|Active Treatment Phase (Weeks 13-64)||15
66414|NCT02307513|160875|P1|NOT COMPLETED|Active Treatment Phase (Weeks 13-64)||20
66415|NCT02307513|160874|P2|COMPLETED|Active Treatment Phase (Weeks 13-64)||68
66416|NCT02307513|160875|P1|COMPLETED|Active Treatment Phase (Weeks 13-64)||75
66417|NCT02307513|160874|P2|STARTED|Active Treatment Phase (Weeks 13-64)||83
66418|NCT02307513|160875|P1|STARTED|Active Treatment Phase (Weeks 13-64)|1 participant completed Week 12; did not enter into active treatment|95
66419|NCT02307513|160874|P2|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-12)||20
66420|NCT02307513|160875|P1|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-12)||8
66421|NCT02307513|160874|P2|COMPLETED|Placebo Controlled Phase (Weeks 0-12)||83
66422|NCT02307513|160875|P1|COMPLETED|Placebo Controlled Phase (Weeks 0-12)||96
66423|NCT02307513|160874|P2|STARTED|Placebo Controlled Phase (Weeks 0-12)||103
66424|NCT02307513|160875|P1|STARTED|Placebo Controlled Phase (Weeks 0-12)||104
66425|NCT02307318|160916|P1|NOT COMPLETED|Overall Study||0
66426|NCT02307318|160916|P1|COMPLETED|Overall Study||51
66427|NCT02307318|160916|P1|STARTED|Overall Study||51
66428|NCT02307266|160926|P3|NOT COMPLETED|Overall Study||6
66429|NCT02307266|160927|P2|NOT COMPLETED|Overall Study||1
66430|NCT02307266|160928|P1|NOT COMPLETED|Overall Study||8
66431|NCT02307266|160926|P3|COMPLETED|Overall Study||25
66432|NCT02307266|160927|P2|COMPLETED|Overall Study||32
66433|NCT02307266|160928|P1|COMPLETED|Overall Study||25
66434|NCT02307266|160926|P3|STARTED|Overall Study||31
66435|NCT02307266|160927|P2|STARTED|Overall Study||33
66436|NCT02307266|160928|P1|STARTED|Overall Study||33
66437|NCT02307188|160936|P1|NOT COMPLETED|Overall Study||4
66438|NCT02307188|160936|P1|COMPLETED|Overall Study|Four of 5 patients did not meet required criteria to complete the study after they were enrolled.|1
66439|NCT02307188|160936|P1|STARTED|Overall Study||5
66440|NCT02307123|160940|P1|NOT COMPLETED|Overall Study||0
66441|NCT02307123|160940|P1|COMPLETED|Overall Study||483
66442|NCT02307123|160940|P1|STARTED|Overall Study||483
66443|NCT02306928|160945|P1|NOT COMPLETED|Overall Study||0
66444|NCT02306928|160945|P1|COMPLETED|Overall Study||15
66445|NCT02306928|160945|P1|STARTED|Overall Study||15
66446|NCT02306850|160953|P1|NOT COMPLETED|Overall Study||2
66447|NCT02306850|160953|P1|COMPLETED|Overall Study||8
66448|NCT02306850|160953|P1|STARTED|Overall Study||10
66449|NCT02306759|160960|P2|NOT COMPLETED|Overall Study||0
66450|NCT02306759|160961|P1|NOT COMPLETED|Overall Study||0
66451|NCT02306759|160960|P2|COMPLETED|Overall Study||30
66452|NCT02306759|160961|P1|COMPLETED|Overall Study||30
66453|NCT02306759|160960|P2|STARTED|Overall Study||30
66454|NCT02306759|160961|P1|STARTED|Overall Study||30
66455|NCT02306265|160975|P1|NOT COMPLETED|Overall Study||1
66456|NCT02306265|160975|P1|COMPLETED|Overall Study||249
66457|NCT02306265|160975|P1|STARTED|Overall Study||250
66458|NCT02305888|160984|P3|NOT COMPLETED|Overall Study||1
66459|NCT02305888|160985|P2|NOT COMPLETED|Overall Study||1
66460|NCT02305888|160986|P1|NOT COMPLETED|Overall Study||0
66461|NCT02305888|160984|P3|COMPLETED|Overall Study||62
66462|NCT02305888|160985|P2|COMPLETED|Overall Study||62
66463|NCT02305888|160986|P1|COMPLETED|Overall Study||63
66464|NCT02305888|160984|P3|STARTED|Overall Study||63
66465|NCT02305888|160985|P2|STARTED|Overall Study||63
66466|NCT02305888|160986|P1|STARTED|Overall Study||63
66467|NCT02305797|161005|P2|NOT COMPLETED|Overall Study||38
66468|NCT02305797|161006|P1|NOT COMPLETED|Overall Study||45
66469|NCT02305797|161005|P2|COMPLETED|Overall Study||210
66470|NCT02305797|161006|P1|COMPLETED|Overall Study||202
66471|NCT02305797|161005|P2|STARTED|Overall Study||248
66472|NCT02305797|161006|P1|STARTED|Overall Study||247
66473|NCT02305758|161016|P2|NOT COMPLETED|Overall Study||65
66474|NCT02305758|161017|P1|NOT COMPLETED|Overall Study||65
66475|NCT02305758|161016|P2|COMPLETED|Overall Study||0
66476|NCT02305758|161017|P1|COMPLETED|Overall Study||0
66477|NCT02305758|161016|P2|STARTED|Overall Study||65
66478|NCT02305758|161017|P1|STARTED|Overall Study||65
66479|NCT02305732|161027|P1|NOT COMPLETED|Overall Study||18
66480|NCT02305732|161027|P1|COMPLETED|Overall Study||72
66481|NCT02305732|161027|P1|STARTED|Overall Study||90
66482|NCT02305446|161035|P1|NOT COMPLETED|Overall Study||1
66483|NCT02305446|161035|P1|COMPLETED|Overall Study||54
66484|NCT02305446|161035|P1|STARTED|Overall Study||55
66485|NCT02305381|161043|P3|NOT COMPLETED|Overall Study||7
66486|NCT02305381|161044|P2|NOT COMPLETED|Overall Study||5
66487|NCT02305381|161045|P1|NOT COMPLETED|Overall Study||5
66488|NCT02305381|161043|P3|COMPLETED|Overall Study|Subjects who completed the trial.|126
66489|NCT02305381|161044|P2|COMPLETED|Overall Study|Subjects who completed the trial.|127
66490|NCT02305381|161045|P1|COMPLETED|Overall Study|Subjects who completed the trial.|127
66491|NCT02305381|161043|P3|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|13
66492|NCT02305381|161044|P2|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial|16
66493|NCT02305381|161045|P1|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|14
66494|NCT02305381|161043|P3|Exposed|Overall Study||133
66495|NCT02305381|161044|P2|Exposed|Overall Study||131
66496|NCT02305381|161045|P1|Exposed|Overall Study||132
66497|NCT02305381|161043|P3|STARTED|Overall Study||133
66498|NCT02305381|161044|P2|STARTED|Overall Study||132
66499|NCT02305381|161045|P1|STARTED|Overall Study||132
66500|NCT02305329|161078|P4|NOT COMPLETED|Overall Study||0
66501|NCT02305329|161079|P3|NOT COMPLETED|Overall Study||0
66502|NCT02305329|161080|P2|NOT COMPLETED|Overall Study||1
66503|NCT02305329|161081|P1|NOT COMPLETED|Overall Study||0
66504|NCT02305329|161078|P4|COMPLETED|Overall Study||14
66505|NCT02305329|161079|P3|COMPLETED|Overall Study||14
66506|NCT02305329|161080|P2|COMPLETED|Overall Study||13
66507|NCT02305329|161081|P1|COMPLETED|Overall Study||14
66508|NCT02305329|161078|P4|Period 2|Overall Study||14
66509|NCT02305329|161079|P3|Period 2|Overall Study||14
66510|NCT02305329|161080|P2|Period 2|Overall Study||13
66511|NCT02305329|161081|P1|Period 2|Overall Study||14
66512|NCT02305329|161078|P4|Period 1|Overall Study||14
66513|NCT02305329|161079|P3|Period 1|Overall Study||14
66514|NCT02305329|161080|P2|Period 1|Overall Study||14
66515|NCT02305329|161081|P1|Period 1|Overall Study||14
66516|NCT02305329|161078|P4|STARTED|Overall Study||14
66517|NCT02305329|161079|P3|STARTED|Overall Study||14
66518|NCT02305329|161080|P2|STARTED|Overall Study||14
66519|NCT02305329|161081|P1|STARTED|Overall Study||14
66520|NCT02305316|161105|P2|NOT COMPLETED|Overall Study||0
66521|NCT02305316|161106|P1|NOT COMPLETED|Overall Study||0
66522|NCT02305316|161105|P2|COMPLETED|Overall Study||14
66523|NCT02305316|161106|P1|COMPLETED|Overall Study||14
66524|NCT02305316|161105|P2|STARTED|Overall Study||14
66525|NCT02305316|161106|P1|STARTED|Overall Study||14
66526|NCT02305277|161124|P6|NOT COMPLETED|Overall Study||0
66527|NCT02305277|161125|P5|NOT COMPLETED|Overall Study||1
66528|NCT02305277|161126|P4|NOT COMPLETED|Overall Study||0
66529|NCT02305277|161127|P3|NOT COMPLETED|Overall Study||0
66530|NCT02305277|161128|P2|NOT COMPLETED|Overall Study||0
66531|NCT02305277|161129|P1|NOT COMPLETED|Overall Study||1
66532|NCT02305277|161124|P6|COMPLETED|Overall Study||14
66533|NCT02305277|161125|P5|COMPLETED|Overall Study||13
66534|NCT02305277|161126|P4|COMPLETED|Overall Study||14
66535|NCT02305277|161127|P3|COMPLETED|Overall Study||14
66536|NCT02305277|161128|P2|COMPLETED|Overall Study||14
66537|NCT02305277|161129|P1|COMPLETED|Overall Study||14
66538|NCT02305277|161124|P6|Received TBM|Overall Study||14
66539|NCT02305277|161125|P5|Received TBM|Overall Study||14
66540|NCT02305277|161126|P4|Received TBM|Overall Study||14
66541|NCT02305277|161127|P3|Received TBM|Overall Study||14
66542|NCT02305277|161128|P2|Received TBM|Overall Study||14
66543|NCT02305277|161129|P1|Received TBM|Overall Study||15
66544|NCT02305277|161124|P6|Received CM|Overall Study||14
66545|NCT02305277|161125|P5|Received CM|Overall Study||14
66546|NCT02305277|161126|P4|Received CM|Overall Study||14
66547|NCT02305277|161127|P3|Received CM|Overall Study||14
66548|NCT02305277|161128|P2|Received CM|Overall Study||14
66549|NCT02305277|161129|P1|Received CM|Overall Study||15
66550|NCT02305277|161124|P6|STARTED|Overall Study||14
66551|NCT02305277|161125|P5|STARTED|Overall Study||14
66552|NCT02305277|161126|P4|STARTED|Overall Study||14
66553|NCT02305277|161127|P3|STARTED|Overall Study||14
66554|NCT02305277|161128|P2|STARTED|Overall Study||14
66555|NCT02305277|161129|P1|STARTED|Overall Study||15
66556|NCT02305238|161158|P3|NOT COMPLETED|Overall Study||8
66557|NCT02305238|161159|P2|NOT COMPLETED|Overall Study||19
66558|NCT02305238|161160|P1|NOT COMPLETED|Overall Study||16
66559|NCT02305238|161158|P3|COMPLETED|Overall Study||0
66560|NCT02305238|161159|P2|COMPLETED|Overall Study||104
66561|NCT02305238|161160|P1|COMPLETED|Overall Study||108
66562|NCT02305238|161158|P3|BCVA Post-randomization Assessment|Overall Study||0
66563|NCT02305238|161159|P2|BCVA Post-randomization Assessment|Overall Study||123
66564|NCT02305238|161160|P1|BCVA Post-randomization Assessment|Overall Study||123
66565|NCT02305238|161158|P3|Randomized|Overall Study||0
66566|NCT02305238|161159|P2|Randomized|Overall Study||123
66567|NCT02305238|161160|P1|Randomized|Overall Study||124
66568|NCT02305238|161158|P3|Treated|Overall Study||7
66569|NCT02305238|161159|P2|Treated|Overall Study||123
66570|NCT02305238|161160|P1|Treated|Overall Study||124
66571|NCT02305238|161158|P3|STARTED|Overall Study||8
66572|NCT02305238|161159|P2|STARTED|Overall Study||123
66573|NCT02305238|161160|P1|STARTED|Overall Study||124
66574|NCT02305017|161177|P2|NOT COMPLETED|Overall Study||0
66575|NCT02305017|161178|P1|NOT COMPLETED|Overall Study||0
66576|NCT02305017|161177|P2|COMPLETED|Overall Study||14
66577|NCT02305017|161178|P1|COMPLETED|Overall Study||14
66578|NCT02305017|161177|P2|STARTED|Overall Study||14
66579|NCT02305017|161178|P1|STARTED|Overall Study||14
66580|NCT02304926|161192|P2|NOT COMPLETED|Overall Study||1
66581|NCT02304926|161193|P1|NOT COMPLETED|Overall Study||2
66582|NCT02304926|161192|P2|COMPLETED|Overall Study||19
66583|NCT02304926|161193|P1|COMPLETED|Overall Study||20
66584|NCT02304926|161192|P2|STARTED|Overall Study||20
66585|NCT02304926|161193|P1|STARTED|Overall Study||22
66586|NCT02304705|161239|P2|NOT COMPLETED|Overall Study||7
66587|NCT02304705|161240|P1|NOT COMPLETED|Overall Study||4
66588|NCT02304705|161239|P2|COMPLETED|Overall Study||10
66589|NCT02304705|161240|P1|COMPLETED|Overall Study||12
66590|NCT02304705|161239|P2|STARTED|Overall Study||17
66591|NCT02304705|161240|P1|STARTED|Overall Study||16
66592|NCT02304484|161246|P1|NOT COMPLETED|Overall Study||25
66593|NCT02304484|161246|P1|COMPLETED|Overall Study||745
66594|NCT02304484|161246|P1|STARTED|Overall Study||770
66595|NCT02304432|161251|P4|NOT COMPLETED|Second Open Label DCS||0
66596|NCT02304432|161252|P3|NOT COMPLETED|Second Open Label DCS||0
66597|NCT02304432|161253|P2|NOT COMPLETED|Second Open Label DCS||0
66598|NCT02304432|161254|P1|NOT COMPLETED|Second Open Label DCS||0
66599|NCT02304432|161251|P4|COMPLETED|Second Open Label DCS||2
66600|NCT02304432|161252|P3|COMPLETED|Second Open Label DCS||0
66601|NCT02304432|161253|P2|COMPLETED|Second Open Label DCS||0
66602|NCT02304432|161254|P1|COMPLETED|Second Open Label DCS||0
66603|NCT02304432|161251|P4|STARTED|Second Open Label DCS||2
66604|NCT02304432|161252|P3|STARTED|Second Open Label DCS||0
66605|NCT02304432|161253|P2|STARTED|Second Open Label DCS||0
66606|NCT02304432|161254|P1|STARTED|Second Open Label DCS||0
66607|NCT02304432|161251|P4|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
66608|NCT02304432|161252|P3|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
66609|NCT02304432|161253|P2|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
66610|NCT02304432|161254|P1|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
66611|NCT02304432|161251|P4|COMPLETED|Double-Blind DCS Placebo Crossover||0
66612|NCT02304432|161252|P3|COMPLETED|Double-Blind DCS Placebo Crossover||1
66613|NCT02304432|161253|P2|COMPLETED|Double-Blind DCS Placebo Crossover||1
66614|NCT02304432|161254|P1|COMPLETED|Double-Blind DCS Placebo Crossover||0
66615|NCT02304432|161251|P4|STARTED|Double-Blind DCS Placebo Crossover||0
66616|NCT02304432|161252|P3|STARTED|Double-Blind DCS Placebo Crossover||1
66617|NCT02304432|161253|P2|STARTED|Double-Blind DCS Placebo Crossover||1
66618|NCT02304432|161254|P1|STARTED|Double-Blind DCS Placebo Crossover||0
66619|NCT02304432|161251|P4|NOT COMPLETED|Open Label DCS||0
66620|NCT02304432|161252|P3|NOT COMPLETED|Open Label DCS||0
66621|NCT02304432|161253|P2|NOT COMPLETED|Open Label DCS||0
66622|NCT02304432|161254|P1|NOT COMPLETED|Open Label DCS||0
66623|NCT02304432|161251|P4|COMPLETED|Open Label DCS||0
66624|NCT02304432|161252|P3|COMPLETED|Open Label DCS||0
66625|NCT02304432|161253|P2|COMPLETED|Open Label DCS||0
66626|NCT02304432|161254|P1|COMPLETED|Open Label DCS||2
66627|NCT02304432|161251|P4|STARTED|Open Label DCS||0
66628|NCT02304432|161252|P3|STARTED|Open Label DCS||0
66629|NCT02304432|161253|P2|STARTED|Open Label DCS||0
66630|NCT02304432|161254|P1|STARTED|Open Label DCS||2
66631|NCT02304406|161286|P1|NOT COMPLETED|Overall Study||0
66632|NCT02304406|161286|P1|COMPLETED|Overall Study||449
66633|NCT02304406|161286|P1|STARTED|Overall Study||449
66634|NCT02304159|161305|P2|NOT COMPLETED|Overall Study||2
66635|NCT02304159|161306|P1|NOT COMPLETED|Overall Study||2
66636|NCT02304159|161305|P2|COMPLETED|Overall Study||16
66637|NCT02304159|161306|P1|COMPLETED|Overall Study||19
66638|NCT02304159|161305|P2|STARTED|Overall Study||18
66639|NCT02304159|161306|P1|STARTED|Overall Study||21
66640|NCT02303743|161318|P2|NOT COMPLETED|Overall Study||0
66641|NCT02303743|161319|P1|NOT COMPLETED|Overall Study||0
66642|NCT02303743|161318|P2|COMPLETED|Overall Study||152
66643|NCT02303743|161319|P1|COMPLETED|Overall Study||108
66644|NCT02303743|161318|P2|STARTED|Overall Study||152
66645|NCT02303743|161319|P1|STARTED|Overall Study||108
66646|NCT02303704|161329|P2|NOT COMPLETED|Overall Study||9
66647|NCT02303704|161330|P1|NOT COMPLETED|Overall Study||5
66648|NCT02303704|161329|P2|COMPLETED|Overall Study||219
66649|NCT02303704|161330|P1|COMPLETED|Overall Study||215
66650|NCT02303704|161329|P2|STARTED|Overall Study||228
66651|NCT02303704|161330|P1|STARTED|Overall Study||220
66652|NCT02303574|161358|P10|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
66653|NCT02303574|161359|P9|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
66654|NCT02303574|161360|P8|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||1
66655|NCT02303574|161361|P7|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
66656|NCT02303574|161362|P6|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
66657|NCT02303574|161363|P5|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
66658|NCT02303574|161364|P4|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
66659|NCT02303574|161365|P3|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
66660|NCT02303574|161366|P2|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
66661|NCT02303574|161367|P1|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
66662|NCT02303574|161358|P10|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||12
66663|NCT02303574|161359|P9|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||10
66664|NCT02303574|161360|P8|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||7
66665|NCT02303574|161361|P7|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||6
66666|NCT02303574|161362|P6|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
66667|NCT02303574|161363|P5|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
66668|NCT02303574|161364|P4|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
66669|NCT02303574|161365|P3|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
66670|NCT02303574|161366|P2|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
66671|NCT02303574|161367|P1|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
66672|NCT02303574|161358|P10|STARTED|Part 2 - Multiple Ascending Dose (MAD)|Participants took AZD7986 matching placebo for 28 days (fasted/fed state, based on part 1b results)|12
66673|NCT02303574|161359|P9|STARTED|Part 2 - Multiple Ascending Dose (MAD)||10
66674|NCT02303574|161360|P8|STARTED|Part 2 - Multiple Ascending Dose (MAD)||8
66675|NCT02303574|161361|P7|STARTED|Part 2 - Multiple Ascending Dose (MAD)||6
66676|NCT02303574|161362|P6|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
66677|NCT02303574|161363|P5|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
66678|NCT02303574|161364|P4|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
66679|NCT02303574|161365|P3|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
66680|NCT02303574|161366|P2|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
66681|NCT02303574|161367|P1|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
66682|NCT02303574|161358|P10|NOT COMPLETED|Part 1b (Fed State) - SAD||0
66683|NCT02303574|161359|P9|NOT COMPLETED|Part 1b (Fed State) - SAD||0
66684|NCT02303574|161360|P8|NOT COMPLETED|Part 1b (Fed State) - SAD||0
66685|NCT02303574|161361|P7|NOT COMPLETED|Part 1b (Fed State) - SAD||0
66686|NCT02303574|161362|P6|NOT COMPLETED|Part 1b (Fed State) - SAD||0
66687|NCT02303574|161363|P5|NOT COMPLETED|Part 1b (Fed State) - SAD||0
66688|NCT02303574|161364|P4|NOT COMPLETED|Part 1b (Fed State) - SAD||0
66689|NCT02303574|161365|P3|NOT COMPLETED|Part 1b (Fed State) - SAD||0
66690|NCT02303574|161366|P2|NOT COMPLETED|Part 1b (Fed State) - SAD||0
66691|NCT02303574|161367|P1|NOT COMPLETED|Part 1b (Fed State) - SAD||0
66692|NCT02303574|161358|P10|COMPLETED|Part 1b (Fed State) - SAD||3
66693|NCT02303574|161359|P9|COMPLETED|Part 1b (Fed State) - SAD||0
66694|NCT02303574|161360|P8|COMPLETED|Part 1b (Fed State) - SAD||0
66695|NCT02303574|161361|P7|COMPLETED|Part 1b (Fed State) - SAD||0
66696|NCT02303574|161362|P6|COMPLETED|Part 1b (Fed State) - SAD||5
66697|NCT02303574|161363|P5|COMPLETED|Part 1b (Fed State) - SAD||0
66698|NCT02303574|161364|P4|COMPLETED|Part 1b (Fed State) - SAD||0
66699|NCT02303574|161365|P3|COMPLETED|Part 1b (Fed State) - SAD||0
66700|NCT02303574|161366|P2|COMPLETED|Part 1b (Fed State) - SAD||0
66701|NCT02303574|161367|P1|COMPLETED|Part 1b (Fed State) - SAD||0
66702|NCT02303574|161358|P10|STARTED|Part 1b (Fed State) - SAD|Participants received AZD7986 matching placebo on Day 1 in fed state.|3
66703|NCT02303574|161359|P9|STARTED|Part 1b (Fed State) - SAD||0
66704|NCT02303574|161360|P8|STARTED|Part 1b (Fed State) - SAD||0
66705|NCT02303574|161361|P7|STARTED|Part 1b (Fed State) - SAD||0
66706|NCT02303574|161362|P6|STARTED|Part 1b (Fed State) - SAD||5
66707|NCT02303574|161363|P5|STARTED|Part 1b (Fed State) - SAD||0
66708|NCT02303574|161364|P4|STARTED|Part 1b (Fed State) - SAD||0
66709|NCT02303574|161365|P3|STARTED|Part 1b (Fed State) - SAD||0
66710|NCT02303574|161366|P2|STARTED|Part 1b (Fed State) - SAD||0
66711|NCT02303574|161367|P1|STARTED|Part 1b (Fed State) - SAD||0
66712|NCT02303574|161358|P10|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
66713|NCT02303574|161359|P9|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
66714|NCT02303574|161360|P8|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
66715|NCT02303574|161361|P7|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
66716|NCT02303574|161362|P6|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
66717|NCT02303574|161363|P5|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
66718|NCT02303574|161364|P4|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
66719|NCT02303574|161365|P3|NOT COMPLETED|Part 1a (Fasted State)- SAD||1
66720|NCT02303574|161366|P2|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
66721|NCT02303574|161367|P1|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
66722|NCT02303574|161358|P10|COMPLETED|Part 1a (Fasted State)- SAD||15
66723|NCT02303574|161359|P9|COMPLETED|Part 1a (Fasted State)- SAD||0
66724|NCT02303574|161360|P8|COMPLETED|Part 1a (Fasted State)- SAD||0
66725|NCT02303574|161361|P7|COMPLETED|Part 1a (Fasted State)- SAD||0
66726|NCT02303574|161362|P6|COMPLETED|Part 1a (Fasted State)- SAD||0
66727|NCT02303574|161363|P5|COMPLETED|Part 1a (Fasted State)- SAD||6
66728|NCT02303574|161364|P4|COMPLETED|Part 1a (Fasted State)- SAD||6
66729|NCT02303574|161365|P3|COMPLETED|Part 1a (Fasted State)- SAD||5
66730|NCT02303574|161366|P2|COMPLETED|Part 1a (Fasted State)- SAD||6
66731|NCT02303574|161367|P1|COMPLETED|Part 1a (Fasted State)- SAD||6
66732|NCT02303574|161358|P10|STARTED|Part 1a (Fasted State)- SAD|Participants received AZD7986 matching placebo on Day 1 in fasted state.|15
66733|NCT02303574|161359|P9|STARTED|Part 1a (Fasted State)- SAD||0
66734|NCT02303574|161360|P8|STARTED|Part 1a (Fasted State)- SAD||0
66735|NCT02303574|161361|P7|STARTED|Part 1a (Fasted State)- SAD||0
66736|NCT02303574|161362|P6|STARTED|Part 1a (Fasted State)- SAD||0
66737|NCT02303574|161363|P5|STARTED|Part 1a (Fasted State)- SAD||6
66738|NCT02303574|161364|P4|STARTED|Part 1a (Fasted State)- SAD||6
66739|NCT02303574|161365|P3|STARTED|Part 1a (Fasted State)- SAD||6
66740|NCT02303574|161366|P2|STARTED|Part 1a (Fasted State)- SAD||6
66741|NCT02303574|161367|P1|STARTED|Part 1a (Fasted State)- SAD||6
66742|NCT02303548|161581|P2|NOT COMPLETED|Overall Study||0
66743|NCT02303548|161582|P1|NOT COMPLETED|Overall Study||0
66744|NCT02303548|161581|P2|COMPLETED|Overall Study||25
66745|NCT02303548|161582|P1|COMPLETED|Overall Study||25
66746|NCT02303548|161581|P2|STARTED|Overall Study||25
66747|NCT02303548|161582|P1|STARTED|Overall Study||25
66748|NCT02303262|161588|P1|NOT COMPLETED|Overall Study||2
66749|NCT02303262|161588|P1|COMPLETED|Overall Study||18
66750|NCT02303262|161588|P1|STARTED|Overall Study||20
66751|NCT02303041|161596|P2|NOT COMPLETED|Overall Study||2
66752|NCT02303041|161597|P1|NOT COMPLETED|Overall Study||1
66753|NCT02303041|161596|P2|COMPLETED|Overall Study||4
66754|NCT02303041|161597|P1|COMPLETED|Overall Study||3
66755|NCT02303041|161596|P2|STARTED|Overall Study||6
66756|NCT02303041|161597|P1|STARTED|Overall Study||4
66757|NCT02302846|161611|P1|NOT COMPLETED|Overall Study||1
66758|NCT02302846|161611|P1|COMPLETED|Overall Study||4
66759|NCT02302846|161611|P1|STARTED|Overall Study||5
66760|NCT02302807|161617|P2|NOT COMPLETED|Overall Study||467
66761|NCT02302807|161618|P1|NOT COMPLETED|Overall Study||464
66762|NCT02302807|161617|P2|COMPLETED|Overall Study|Participants still receiving atezolizumab had opportunity to continue treatment in extension study.|0
66763|NCT02302807|161618|P1|COMPLETED|Overall Study|Participants still on chemotherapy were discontinued where that treatment was available locally.|0
66764|NCT02302807|161617|P2|Received Treatment|Overall Study||459
66765|NCT02302807|161618|P1|Received Treatment|Overall Study||443
66766|NCT02302807|161617|P2|STARTED|Overall Study||467
66767|NCT02302807|161618|P1|STARTED|Overall Study||464
66768|NCT02302716|161665|P2|NOT COMPLETED|Overall Study||19
66769|NCT02302716|161666|P1|NOT COMPLETED|Overall Study||19
66770|NCT02302716|161665|P2|COMPLETED|Overall Study||225
66771|NCT02302716|161666|P1|COMPLETED|Overall Study||230
66772|NCT02302716|161665|P2|Received at Least 1 Dose of Study Drug|Overall Study||244
66773|NCT02302716|161666|P1|Received at Least 1 Dose of Study Drug|Overall Study||249
66774|NCT02302716|161665|P2|STARTED|Overall Study||244
66775|NCT02302716|161666|P1|STARTED|Overall Study||249
66776|NCT02302365|161692|P1|NOT COMPLETED|0-24 Hour Period||0
66777|NCT02302365|161692|P1|COMPLETED|0-24 Hour Period||32
66778|NCT02302365|161692|P1|STARTED|0-24 Hour Period|2 of 3 study sites collected additional safety data; 32 pts. 0-24 hour data, 43 pts. 0-2 hour data|32
66779|NCT02302365|161692|P1|NOT COMPLETED|0-2 Hour Period||2
66780|NCT02302365|161692|P1|COMPLETED|0-2 Hour Period|The Per-protocol Analysis Set comprised 54 procedures performed in 41 subjects|41
66781|NCT02302365|161692|P1|STARTED|0-2 Hour Period|Data were collected from 58 WBCD procedures performed in 43 subjects - Full and Safety Analysis Sets|43
66782|NCT02302339|161714|P4|NOT COMPLETED|Overall Study||0
66783|NCT02302339|161715|P3|NOT COMPLETED|Overall Study||1
66784|NCT02302339|161716|P2|NOT COMPLETED|Overall Study||2
66785|NCT02302339|161717|P1|NOT COMPLETED|Overall Study||1
66786|NCT02302339|161714|P4|COMPLETED|Overall Study||7
66787|NCT02302339|161715|P3|COMPLETED|Overall Study||28
66788|NCT02302339|161716|P2|COMPLETED|Overall Study||32
66789|NCT02302339|161717|P1|COMPLETED|Overall Study||61
66790|NCT02302339|161714|P4|STARTED|Overall Study||7
66791|NCT02302339|161715|P3|STARTED|Overall Study||29
66792|NCT02302339|161716|P2|STARTED|Overall Study||34
66793|NCT02302339|161717|P1|STARTED|Overall Study||62
66794|NCT02302222|161750|P2|NOT COMPLETED|Overall Study||6
66795|NCT02302222|161751|P1|NOT COMPLETED|Overall Study||1
66796|NCT02302222|161750|P2|COMPLETED|Overall Study||31
66797|NCT02302222|161751|P1|COMPLETED|Overall Study||33
66798|NCT02302222|161750|P2|STARTED|Overall Study||37
66799|NCT02302222|161751|P1|STARTED|Overall Study||34
66800|NCT02302092|161759|P2|NOT COMPLETED|Overall Study||0
66801|NCT02302092|161760|P1|NOT COMPLETED|Overall Study||0
66802|NCT02302092|161759|P2|COMPLETED|Overall Study||7
66803|NCT02302092|161760|P1|COMPLETED|Overall Study||6
66804|NCT02302092|161759|P2|STARTED|Overall Study||7
66805|NCT02302092|161760|P1|STARTED|Overall Study||6
66806|NCT02301988|161788|P2|NOT COMPLETED|Overall Study||9
66807|NCT02301988|161789|P1|NOT COMPLETED|Overall Study||10
66808|NCT02301988|161788|P2|COMPLETED|Overall Study||66
66809|NCT02301988|161789|P1|COMPLETED|Overall Study||66
66810|NCT02301988|161788|P2|STARTED|Overall Study||75
66811|NCT02301988|161789|P1|STARTED|Overall Study||76
66812|NCT02301975|161822|P3|NOT COMPLETED|Overall Study||22
66813|NCT02301975|161823|P2|NOT COMPLETED|Overall Study||25
66814|NCT02301975|161824|P1|NOT COMPLETED|Overall Study||31
66815|NCT02301975|161822|P3|COMPLETED|Overall Study||477
66816|NCT02301975|161823|P2|COMPLETED|Overall Study||476
66817|NCT02301975|161824|P1|COMPLETED|Overall Study||473
66818|NCT02301975|161822|P3|STARTED|Overall Study||499
66819|NCT02301975|161823|P2|STARTED|Overall Study||501
66820|NCT02301975|161824|P1|STARTED|Overall Study||504
66821|NCT02301936|161852|P2|NOT COMPLETED|Overall Study||0
66822|NCT02301936|161853|P1|NOT COMPLETED|Overall Study||1
66823|NCT02301936|161852|P2|COMPLETED|Overall Study||1
66824|NCT02301936|161853|P1|COMPLETED|Overall Study||8
66825|NCT02301936|161852|P2|STARTED|Overall Study||1
66826|NCT02301936|161853|P1|STARTED|Overall Study||9
66827|NCT02301897|161878|P3|NOT COMPLETED|Treatment Course 2||1
66828|NCT02301897|161879|P2|NOT COMPLETED|Treatment Course 2||5
66829|NCT02301897|161880|P1|NOT COMPLETED|Treatment Course 2||1
66830|NCT02301897|161878|P3|COMPLETED|Treatment Course 2||7
66831|NCT02301897|161879|P2|COMPLETED|Treatment Course 2||9
66832|NCT02301897|161880|P1|COMPLETED|Treatment Course 2||8
66833|NCT02301897|161878|P3|STARTED|Treatment Course 2||8
66834|NCT02301897|161879|P2|STARTED|Treatment Course 2||14
66835|NCT02301897|161880|P1|STARTED|Treatment Course 2||9
66836|NCT02301897|161878|P3|NOT COMPLETED|Treatment Course 1||6
66837|NCT02301897|161879|P2|NOT COMPLETED|Treatment Course 1||3
66838|NCT02301897|161880|P1|NOT COMPLETED|Treatment Course 1||3
66839|NCT02301897|161878|P3|COMPLETED|Treatment Course 1||8
66840|NCT02301897|161879|P2|COMPLETED|Treatment Course 1||14
66841|NCT02301897|161880|P1|COMPLETED|Treatment Course 1||9
66842|NCT02301897|161878|P3|STARTED|Treatment Course 1||14
66843|NCT02301897|161879|P2|STARTED|Treatment Course 1||17
66844|NCT02301897|161880|P1|STARTED|Treatment Course 1||12
66845|NCT02301793|161929|P2|NOT COMPLETED|During and Post Education Study Period||49
66846|NCT02301793|161930|P1|NOT COMPLETED|During and Post Education Study Period||83
66847|NCT02301793|161929|P2|COMPLETED|During and Post Education Study Period||396
66848|NCT02301793|161930|P1|COMPLETED|During and Post Education Study Period||405
66849|NCT02301793|161929|P2|STARTED|During and Post Education Study Period||445
66850|NCT02301793|161930|P1|STARTED|During and Post Education Study Period||488
66851|NCT02301793|161929|P2|NOT COMPLETED|Pre Education Study Period||0
66852|NCT02301793|161930|P1|NOT COMPLETED|Pre Education Study Period||0
66853|NCT02301793|161929|P2|COMPLETED|Pre Education Study Period|Nurses had not been randomized|0
66854|NCT02301793|161930|P1|COMPLETED|Pre Education Study Period|Nurses had not been randomized|0
66855|NCT02301793|161929|P2|STARTED|Pre Education Study Period|Nurses had not been randomized|0
66856|NCT02301793|161930|P1|STARTED|Pre Education Study Period|Nurses had not been randomized|0
66857|NCT02301429|161944|P1|NOT COMPLETED|Overall Study||3
66858|NCT02301429|161944|P1|COMPLETED|Overall Study||13
66859|NCT02301429|161944|P1|STARTED|Overall Study||16
66860|NCT02301416|161950|P2|NOT COMPLETED|Overall Study||0
66861|NCT02301416|161951|P1|NOT COMPLETED|Overall Study||10
66862|NCT02301416|161950|P2|COMPLETED|Overall Study||40
66863|NCT02301416|161951|P1|COMPLETED|Overall Study||15
66864|NCT02301416|161950|P2|STARTED|Overall Study||40
66865|NCT02301416|161951|P1|STARTED|Overall Study||25
66866|NCT02301403|161990|P2|NOT COMPLETED|Overall Study||41
66867|NCT02301403|161991|P1|NOT COMPLETED|Overall Study||28
66868|NCT02301403|161990|P2|COMPLETED|Overall Study||267
66869|NCT02301403|161991|P1|COMPLETED|Overall Study||287
66870|NCT02301403|161990|P2|STARTED|Overall Study||308
66871|NCT02301403|161991|P1|STARTED|Overall Study||315
66872|NCT02301377|161999|P2|NOT COMPLETED|Overall Study||0
66873|NCT02301377|162000|P1|NOT COMPLETED|Overall Study||0
66874|NCT02301377|161999|P2|COMPLETED|Overall Study||2
66875|NCT02301377|162000|P1|COMPLETED|Overall Study||3
66876|NCT02301377|161999|P2|STARTED|Overall Study||2
66877|NCT02301377|162000|P1|STARTED|Overall Study||3
66878|NCT02301364|162010|P1|NOT COMPLETED|Overall Study||0
66879|NCT02301364|162010|P1|COMPLETED|Overall Study||4
66880|NCT02301364|162010|P1|STARTED|Overall Study||4
66881|NCT02301299|162017|P1|NOT COMPLETED|Overall Study||0
66882|NCT02301299|162017|P1|COMPLETED|Overall Study||1322
66883|NCT02301299|162017|P1|STARTED|Overall Study||1322
66884|NCT02301169|162026|P2|NOT COMPLETED|Overall Study||0
66885|NCT02301169|162027|P1|NOT COMPLETED|Overall Study||1
66886|NCT02301169|162026|P2|COMPLETED|Overall Study||21
66887|NCT02301169|162027|P1|COMPLETED|Overall Study||20
66888|NCT02301169|162026|P2|STARTED|Overall Study||21
66889|NCT02301169|162027|P1|STARTED|Overall Study||21
66890|NCT02301143|162041|P2|NOT COMPLETED|Investigator's Choice||10
66891|NCT02301143|162042|P1|NOT COMPLETED|Investigator's Choice||0
66892|NCT02301143|162041|P2|COMPLETED|Investigator's Choice|3 participants completed nab-Paclitaxel+Gemcitabine,18 completed chemoradiation,16 had surgery.|37
66893|NCT02301143|162042|P1|COMPLETED|Investigator's Choice||0
66894|NCT02301143|162041|P2|STARTED|Investigator's Choice|12 participants continued nab-Paclitaxel/Gemcitabine; 18 started chemoradiation;17 underwent surgery|47
66895|NCT02301143|162042|P1|STARTED|Investigator's Choice||0
66896|NCT02301143|162041|P2|NOT COMPLETED|Induction Period||0
66897|NCT02301143|162042|P1|NOT COMPLETED|Induction Period||45
66898|NCT02301143|162041|P2|COMPLETED|Induction Period||0
66899|NCT02301143|162042|P1|COMPLETED|Induction Period||62
66900|NCT02301143|162041|P2|STARTED|Induction Period||0
66901|NCT02301143|162042|P1|STARTED|Induction Period||107
66902|NCT02300727|162064|P6|NOT COMPLETED|Overall Study||0
66903|NCT02300727|162065|P5|NOT COMPLETED|Overall Study||0
66904|NCT02300727|162066|P4|NOT COMPLETED|Overall Study||1
66905|NCT02300727|162067|P3|NOT COMPLETED|Overall Study||0
66906|NCT02300727|162068|P2|NOT COMPLETED|Overall Study||0
66907|NCT02300727|162069|P1|NOT COMPLETED|Overall Study||0
66908|NCT02300727|162064|P6|COMPLETED|Overall Study||0
66909|NCT02300727|162065|P5|COMPLETED|Overall Study||0
66910|NCT02300727|162066|P4|COMPLETED|Overall Study||2
66911|NCT02300727|162067|P3|COMPLETED|Overall Study||3
66912|NCT02300727|162068|P2|COMPLETED|Overall Study||0
66913|NCT02300727|162069|P1|COMPLETED|Overall Study||0
66914|NCT02300727|162064|P6|STARTED|Overall Study||0
66915|NCT02300727|162065|P5|STARTED|Overall Study||0
66916|NCT02300727|162066|P4|STARTED|Overall Study||3
66917|NCT02300727|162067|P3|STARTED|Overall Study||3
66918|NCT02300727|162068|P2|STARTED|Overall Study||0
66919|NCT02300727|162069|P1|STARTED|Overall Study||0
66920|NCT02300610|162086|P3|NOT COMPLETED|Overall Study||1
66921|NCT02300610|162087|P2|NOT COMPLETED|Overall Study||0
66922|NCT02300610|162088|P1|NOT COMPLETED|Overall Study||1
66923|NCT02300610|162086|P3|COMPLETED|Overall Study||3
66924|NCT02300610|162087|P2|COMPLETED|Overall Study||3
66925|NCT02300610|162088|P1|COMPLETED|Overall Study||2
66926|NCT02300610|162086|P3|STARTED|Overall Study||4
66927|NCT02300610|162087|P2|STARTED|Overall Study||3
66928|NCT02300610|162088|P1|STARTED|Overall Study||3
66929|NCT02300558|162103|P1|NOT COMPLETED|Open-Label (OL) Extension Phase||32
66930|NCT02300558|162103|P1|COMPLETED|Open-Label (OL) Extension Phase||0
66931|NCT02300558|162103|P1|STARTED|Open-Label (OL) Extension Phase||32
66932|NCT02300558|162103|P1|NOT COMPLETED|Single Blind Phase (24 Weeks)||6
66933|NCT02300558|162103|P1|COMPLETED|Single Blind Phase (24 Weeks)||35
66934|NCT02300558|162103|P1|STARTED|Single Blind Phase (24 Weeks)||41
66935|NCT02300311|162116|P2|NOT COMPLETED|Overall Study||0
66936|NCT02300311|162117|P1|NOT COMPLETED|Overall Study||19
66937|NCT02300311|162116|P2|COMPLETED|Overall Study||69
66938|NCT02300311|162117|P1|COMPLETED|Overall Study||50
66939|NCT02300311|162116|P2|STARTED|Overall Study||69
66940|NCT02300311|162117|P1|STARTED|Overall Study||69
66941|NCT02300298|162129|P2|NOT COMPLETED|Disposition for Docetaxel||10
66942|NCT02300298|162130|P1|NOT COMPLETED|Disposition for Docetaxel||0
66943|NCT02300298|162129|P2|COMPLETED|Disposition for Docetaxel||0
66944|NCT02300298|162130|P1|COMPLETED|Disposition for Docetaxel||0
66945|NCT02300298|162129|P2|STARTED|Disposition for Docetaxel||10
66946|NCT02300298|162130|P1|STARTED|Disposition for Docetaxel||0
66947|NCT02300298|162129|P2|NOT COMPLETED|Disposition for Nintedanib||0
66948|NCT02300298|162130|P1|NOT COMPLETED|Disposition for Nintedanib||10
66949|NCT02300298|162129|P2|COMPLETED|Disposition for Nintedanib||0
66950|NCT02300298|162130|P1|COMPLETED|Disposition for Nintedanib||0
66951|NCT02300298|162129|P2|STARTED|Disposition for Nintedanib||0
66952|NCT02300298|162130|P1|STARTED|Disposition for Nintedanib||10
66953|NCT02300129|162140|P4|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
66954|NCT02300129|162141|P3|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
66955|NCT02300129|162142|P2|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
66956|NCT02300129|162143|P1|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
66957|NCT02300129|162140|P4|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
66958|NCT02300129|162141|P3|COMPLETED|Period 2 Treatment 2 (2 Weeks)||7
66959|NCT02300129|162142|P2|COMPLETED|Period 2 Treatment 2 (2 Weeks)||4
66960|NCT02300129|162143|P1|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
66961|NCT02300129|162140|P4|STARTED|Period 2 Treatment 2 (2 Weeks)||10
66962|NCT02300129|162141|P3|STARTED|Period 2 Treatment 2 (2 Weeks)||7
66963|NCT02300129|162142|P2|STARTED|Period 2 Treatment 2 (2 Weeks)||4
66964|NCT02300129|162143|P1|STARTED|Period 2 Treatment 2 (2 Weeks)||10
66965|NCT02300129|162140|P4|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
66966|NCT02300129|162141|P3|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
66967|NCT02300129|162142|P2|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
66968|NCT02300129|162143|P1|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
66969|NCT02300129|162140|P4|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
66970|NCT02300129|162141|P3|COMPLETED|Period 2 Treatment 1 (2 Weeks)||7
66971|NCT02300129|162142|P2|COMPLETED|Period 2 Treatment 1 (2 Weeks)||4
66972|NCT02300129|162143|P1|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
66973|NCT02300129|162140|P4|STARTED|Period 2 Treatment 1 (2 Weeks)|Withdrawal consent of 1 subject between the Period 1 and Period 2|11
66974|NCT02300129|162141|P3|STARTED|Period 2 Treatment 1 (2 Weeks)||7
66975|NCT02300129|162142|P2|STARTED|Period 2 Treatment 1 (2 Weeks)||4
66976|NCT02300129|162143|P1|STARTED|Period 2 Treatment 1 (2 Weeks)||11
66977|NCT02300129|162140|P4|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
66978|NCT02300129|162141|P3|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
66979|NCT02300129|162142|P2|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
66980|NCT02300129|162143|P1|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
66981|NCT02300129|162140|P4|COMPLETED|Period 1 Session 3 (Day 5)||11
66982|NCT02300129|162141|P3|COMPLETED|Period 1 Session 3 (Day 5)||7
66983|NCT02300129|162142|P2|COMPLETED|Period 1 Session 3 (Day 5)||4
66984|NCT02300129|162143|P1|COMPLETED|Period 1 Session 3 (Day 5)||11
66985|NCT02300129|162140|P4|STARTED|Period 1 Session 3 (Day 5)||11
66986|NCT02300129|162141|P3|STARTED|Period 1 Session 3 (Day 5)||7
66987|NCT02300129|162142|P2|STARTED|Period 1 Session 3 (Day 5)||4
66988|NCT02300129|162143|P1|STARTED|Period 1 Session 3 (Day 5)||11
66989|NCT02300129|162140|P4|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
66990|NCT02300129|162141|P3|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
66991|NCT02300129|162142|P2|NOT COMPLETED|Period 1 Session 2 (Day 3)||1
66992|NCT02300129|162143|P1|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
66993|NCT02300129|162140|P4|COMPLETED|Period 1 Session 2 (Day 3)||11
66994|NCT02300129|162141|P3|COMPLETED|Period 1 Session 2 (Day 3)||7
66995|NCT02300129|162142|P2|COMPLETED|Period 1 Session 2 (Day 3)||4
66996|NCT02300129|162143|P1|COMPLETED|Period 1 Session 2 (Day 3)||11
66997|NCT02300129|162140|P4|STARTED|Period 1 Session 2 (Day 3)||11
66998|NCT02300129|162141|P3|STARTED|Period 1 Session 2 (Day 3)||7
66999|NCT02300129|162142|P2|STARTED|Period 1 Session 2 (Day 3)|Withdrawal consent of 1 subject between Day 1 and Day 3|5
67000|NCT02300129|162143|P1|STARTED|Period 1 Session 2 (Day 3)||11
67001|NCT02300129|162140|P4|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
67002|NCT02300129|162141|P3|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
67003|NCT02300129|162142|P2|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
67004|NCT02300129|162143|P1|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
67005|NCT02300129|162140|P4|COMPLETED|Period 1 Session 1 (Day 1)||11
67006|NCT02300129|162141|P3|COMPLETED|Period 1 Session 1 (Day 1)||7
67007|NCT02300129|162142|P2|COMPLETED|Period 1 Session 1 (Day 1)||5
67008|NCT02300129|162143|P1|COMPLETED|Period 1 Session 1 (Day 1)||11
67009|NCT02300129|162140|P4|STARTED|Period 1 Session 1 (Day 1)||11
67010|NCT02300129|162141|P3|STARTED|Period 1 Session 1 (Day 1)||7
67011|NCT02300129|162142|P2|STARTED|Period 1 Session 1 (Day 1)||5
67012|NCT02300129|162143|P1|STARTED|Period 1 Session 1 (Day 1)||11
67013|NCT02300103|162153|P1|NOT COMPLETED|Overall Study||6
67014|NCT02300103|162153|P1|COMPLETED|Overall Study||63
67015|NCT02300103|162153|P1|STARTED|Overall Study||69
67016|NCT02300077|162165|P3|NOT COMPLETED|Overall Study||0
67017|NCT02300077|162166|P2|NOT COMPLETED|Overall Study||0
67018|NCT02300077|162167|P1|NOT COMPLETED|Overall Study||0
67019|NCT02300077|162165|P3|COMPLETED|Overall Study||21
67020|NCT02300077|162166|P2|COMPLETED|Overall Study||18
67021|NCT02300077|162167|P1|COMPLETED|Overall Study||21
67022|NCT02300077|162165|P3|STARTED|Overall Study||21
67023|NCT02300077|162166|P2|STARTED|Overall Study||18
67024|NCT02300077|162167|P1|STARTED|Overall Study||21
67025|NCT02300025|162188|P4|NOT COMPLETED|Overall Study||0
67026|NCT02300025|162189|P3|NOT COMPLETED|Overall Study||0
67027|NCT02300025|162190|P2|NOT COMPLETED|Overall Study||0
67028|NCT02300025|162191|P1|NOT COMPLETED|Overall Study||0
67029|NCT02300025|162188|P4|COMPLETED|Overall Study||6
67030|NCT02300025|162189|P3|COMPLETED|Overall Study||6
67031|NCT02300025|162190|P2|COMPLETED|Overall Study||6
67032|NCT02300025|162191|P1|COMPLETED|Overall Study||10
67033|NCT02300025|162188|P4|STARTED|Overall Study||6
67034|NCT02300025|162189|P3|STARTED|Overall Study||6
67035|NCT02300025|162190|P2|STARTED|Overall Study||6
67036|NCT02300025|162191|P1|STARTED|Overall Study||10
67037|NCT02299934|162233|P1|NOT COMPLETED|Overall Study||13
67038|NCT02299934|162233|P1|COMPLETED|Overall Study||0
67039|NCT02299934|162233|P1|STARTED|Overall Study||13
67040|NCT02299869|162248|P4|NOT COMPLETED|Overall Study||0
67041|NCT02299869|162249|P3|NOT COMPLETED|Overall Study||0
67042|NCT02299869|162250|P2|NOT COMPLETED|Overall Study||0
67043|NCT02299869|162251|P1|NOT COMPLETED|Overall Study||0
67044|NCT02299869|162248|P4|COMPLETED|Overall Study||10
67045|NCT02299869|162249|P3|COMPLETED|Overall Study||10
67046|NCT02299869|162250|P2|COMPLETED|Overall Study||10
67047|NCT02299869|162251|P1|COMPLETED|Overall Study||10
67048|NCT02299869|162248|P4|STARTED|Overall Study||10
67049|NCT02299869|162249|P3|STARTED|Overall Study||10
67050|NCT02299869|162250|P2|STARTED|Overall Study||10
67051|NCT02299869|162251|P1|STARTED|Overall Study||10
67052|NCT02299791|162276|P2|NOT COMPLETED|Overall Study||0
67053|NCT02299791|162277|P1|NOT COMPLETED|Overall Study||0
67054|NCT02299791|162276|P2|COMPLETED|Overall Study||2803
67055|NCT02299791|162277|P1|COMPLETED|Overall Study||2053
67056|NCT02299791|162276|P2|STARTED|Overall Study||2803
67057|NCT02299791|162277|P1|STARTED|Overall Study||2053
67058|NCT02299635|162283|P1|NOT COMPLETED|Overall Study||19
67059|NCT02299635|162283|P1|COMPLETED|Overall Study||0
67060|NCT02299635|162283|P1|STARTED|Overall Study||19
67061|NCT02299570|162305|P3|NOT COMPLETED|Overall Study||2
67062|NCT02299570|162306|P2|NOT COMPLETED|Overall Study||0
67063|NCT02299570|162307|P1|NOT COMPLETED|Overall Study||4
67064|NCT02299570|162305|P3|COMPLETED|Overall Study||42
67065|NCT02299570|162306|P2|COMPLETED|Overall Study||44
67066|NCT02299570|162307|P1|COMPLETED|Overall Study||41
67067|NCT02299570|162305|P3|STARTED|Overall Study||44
67068|NCT02299570|162306|P2|STARTED|Overall Study||44
67069|NCT02299570|162307|P1|STARTED|Overall Study||45
67070|NCT02299479|162315|P1|NOT COMPLETED|Overall Study||2
67071|NCT02299479|162315|P1|COMPLETED|Overall Study||18
67072|NCT02299479|162315|P1|STARTED|Overall Study||20
67073|NCT02299427|162323|P2|NOT COMPLETED|Overall Study||3
67074|NCT02299427|162324|P1|NOT COMPLETED|Overall Study||23
67075|NCT02299427|162323|P2|COMPLETED|Overall Study||31
67076|NCT02299427|162324|P1|COMPLETED|Overall Study||12
67077|NCT02299427|162323|P2|STARTED|Overall Study||34
67078|NCT02299427|162324|P1|STARTED|Overall Study||35
67079|NCT02299388|162334|P2|NOT COMPLETED|Overall Study||1
67080|NCT02299388|162335|P1|NOT COMPLETED|Overall Study||0
67081|NCT02299388|162334|P2|COMPLETED|Overall Study||4
67082|NCT02299388|162335|P1|COMPLETED|Overall Study||6
67083|NCT02299388|162334|P2|STARTED|Overall Study||5
67084|NCT02299388|162335|P1|STARTED|Overall Study||6
67085|NCT02299375|162345|P2|NOT COMPLETED|Overall Study||80
67086|NCT02299375|162346|P1|NOT COMPLETED|Overall Study||80
67087|NCT02299375|162345|P2|COMPLETED|Overall Study||10
67088|NCT02299375|162346|P1|COMPLETED|Overall Study||14
67089|NCT02299375|162345|P2|STARTED|Overall Study||90
67090|NCT02299375|162346|P1|STARTED|Overall Study||94
67091|NCT02299349|162396|P2|NOT COMPLETED|Overall Study||0
67092|NCT02299349|162397|P1|NOT COMPLETED|Overall Study||0
67093|NCT02299349|162396|P2|COMPLETED|Overall Study||35
67094|NCT02299349|162397|P1|COMPLETED|Overall Study||35
67095|NCT02299349|162396|P2|STARTED|Overall Study||35
67096|NCT02299349|162397|P1|STARTED|Overall Study||35
67097|NCT02299336|162405|P1|NOT COMPLETED|Overall Study||14
67098|NCT02299336|162405|P1|COMPLETED|Overall Study||46
67099|NCT02299336|162405|P1|STARTED|Overall Study||60
67100|NCT02299297|162421|P1|NOT COMPLETED|Overall Study||1
67101|NCT02299297|162421|P1|COMPLETED|Overall Study||11
67102|NCT02299297|162421|P1|STARTED|Overall Study||12
67103|NCT02299258|162431|P2|NOT COMPLETED|Overall Study||1
67104|NCT02299258|162432|P1|NOT COMPLETED|Overall Study||1
67105|NCT02299258|162431|P2|COMPLETED|Overall Study||30
67106|NCT02299258|162432|P1|COMPLETED|Overall Study||31
67107|NCT02299258|162431|P2|STARTED|Overall Study||31
67108|NCT02299258|162432|P1|STARTED|Overall Study||32
67109|NCT02299206|162440|P1|NOT COMPLETED|Overall Study||2
67110|NCT02299206|162440|P1|COMPLETED|Overall Study||2
67111|NCT02299206|162440|P1|STARTED|Overall Study||4
67112|NCT02299089|162452|P4|NOT COMPLETED|Overall Study||0
67113|NCT02299089|162453|P3|NOT COMPLETED|Overall Study||0
67114|NCT02299089|162454|P2|NOT COMPLETED|Overall Study||0
67115|NCT02299089|162455|P1|NOT COMPLETED|Overall Study||0
67116|NCT02299089|162452|P4|COMPLETED|Overall Study||4
67117|NCT02299089|162453|P3|COMPLETED|Overall Study||1
67118|NCT02299089|162454|P2|COMPLETED|Overall Study||4
67119|NCT02299089|162455|P1|COMPLETED|Overall Study||3
67120|NCT02299089|162452|P4|STARTED|Overall Study||4
67121|NCT02299089|162453|P3|STARTED|Overall Study||1
67122|NCT02299089|162454|P2|STARTED|Overall Study||4
67123|NCT02299089|162455|P1|STARTED|Overall Study||3
67124|NCT02299076|162501|P2|NOT COMPLETED|Overall Study||14
67125|NCT02299076|162502|P1|NOT COMPLETED|Overall Study||20
67126|NCT02299076|162501|P2|COMPLETED|Overall Study||212
67127|NCT02299076|162502|P1|COMPLETED|Overall Study||210
67128|NCT02299076|162501|P2|STARTED|Overall Study||226
67129|NCT02299076|162502|P1|STARTED|Overall Study||230
67130|NCT02299050|162510|P1|NOT COMPLETED|Overall Study||8
67131|NCT02299050|162510|P1|COMPLETED|Overall Study||15
67132|NCT02299050|162510|P1|STARTED|Overall Study||23
67133|NCT02298946|162523|P2|NOT COMPLETED|Overall Study||1
67134|NCT02298946|162524|P1|NOT COMPLETED|Overall Study||4
67135|NCT02298946|162523|P2|COMPLETED|Overall Study||8
67136|NCT02298946|162524|P1|COMPLETED|Overall Study||4
67137|NCT02298946|162523|P2|STARTED|Overall Study||9
67138|NCT02298946|162524|P1|STARTED|Overall Study||8
67139|NCT02298933|162548|P1|NOT COMPLETED|Overall Study||0
67140|NCT02298933|162548|P1|COMPLETED|Overall Study||10
67141|NCT02298933|162548|P1|STARTED|Overall Study||10
67142|NCT02298868|162552|P1|NOT COMPLETED|Overall Study||3
67143|NCT02298868|162552|P1|COMPLETED|Overall Study||7
67144|NCT02298868|162552|P1|STARTED|Overall Study||10
67145|NCT02298842|162566|P2|NOT COMPLETED|Second Platelet Donation (Day 6-8)||6
67146|NCT02298842|162567|P1|NOT COMPLETED|Second Platelet Donation (Day 6-8)||8
67147|NCT02298842|162566|P2|COMPLETED|Second Platelet Donation (Day 6-8)||30
67148|NCT02298842|162567|P1|COMPLETED|Second Platelet Donation (Day 6-8)||30
67149|NCT02298842|162566|P2|STARTED|Second Platelet Donation (Day 6-8)||36
67150|NCT02298842|162567|P1|STARTED|Second Platelet Donation (Day 6-8)||38
67151|NCT02298842|162566|P2|NOT COMPLETED|First Platelet Donation (Day 0)||5
67152|NCT02298842|162567|P1|NOT COMPLETED|First Platelet Donation (Day 0)||6
67153|NCT02298842|162566|P2|COMPLETED|First Platelet Donation (Day 0)||36
67154|NCT02298842|162567|P1|COMPLETED|First Platelet Donation (Day 0)||38
67155|NCT02298842|162566|P2|STARTED|First Platelet Donation (Day 0)||41
67156|NCT02298842|162567|P1|STARTED|First Platelet Donation (Day 0)||44
67157|NCT02298803|162593|P1|NOT COMPLETED|Overall Study||0
67158|NCT02298803|162593|P1|COMPLETED|Overall Study||30
67159|NCT02298803|162593|P1|STARTED|Overall Study||30
67160|NCT02298361|162605|P3|NOT COMPLETED|Overall Study||0
67161|NCT02298361|162606|P2|NOT COMPLETED|Overall Study||0
67162|NCT02298361|162607|P1|NOT COMPLETED|Overall Study||0
67163|NCT02298361|162605|P3|COMPLETED|Overall Study||12227
67164|NCT02298361|162606|P2|COMPLETED|Overall Study||12784
67165|NCT02298361|162607|P1|COMPLETED|Overall Study||2240
67166|NCT02298361|162605|P3|STARTED|Overall Study||12227
67167|NCT02298361|162606|P2|STARTED|Overall Study||12784
67168|NCT02298361|162607|P1|STARTED|Overall Study||2240
67169|NCT02298192|162623|P2|NOT COMPLETED|Overall Study||6
67170|NCT02298192|162624|P1|NOT COMPLETED|Overall Study||19
67171|NCT02298192|162623|P2|COMPLETED|Overall Study||204
67172|NCT02298192|162624|P1|COMPLETED|Overall Study||191
67173|NCT02298192|162623|P2|STARTED|Overall Study||210
67174|NCT02298192|162624|P1|STARTED|Overall Study||210
67175|NCT02298179|162648|P12|NOT COMPLETED|Overall Study||0
67176|NCT02298179|162649|P11|NOT COMPLETED|Overall Study||0
67177|NCT02298179|162650|P10|NOT COMPLETED|Overall Study||0
67178|NCT02298179|162651|P9|NOT COMPLETED|Overall Study||0
67179|NCT02298179|162652|P8|NOT COMPLETED|Overall Study||1
67180|NCT02298179|162653|P7|NOT COMPLETED|Overall Study||0
67181|NCT02298179|162654|P6|NOT COMPLETED|Overall Study||0
67182|NCT02298179|162655|P5|NOT COMPLETED|Overall Study||0
67183|NCT02298179|162656|P4|NOT COMPLETED|Overall Study||0
67184|NCT02298179|162657|P3|NOT COMPLETED|Overall Study||1
67185|NCT02298179|162658|P2|NOT COMPLETED|Overall Study||0
67186|NCT02298179|162659|P1|NOT COMPLETED|Overall Study||0
67187|NCT02298179|162648|P12|COMPLETED|Overall Study||24
67188|NCT02298179|162649|P11|COMPLETED|Overall Study||24
67189|NCT02298179|162650|P10|COMPLETED|Overall Study||24
67190|NCT02298179|162651|P9|COMPLETED|Overall Study||24
67191|NCT02298179|162652|P8|COMPLETED|Overall Study||23
67192|NCT02298179|162653|P7|COMPLETED|Overall Study||24
67193|NCT02298179|162654|P6|COMPLETED|Overall Study||24
67194|NCT02298179|162655|P5|COMPLETED|Overall Study||24
67195|NCT02298179|162656|P4|COMPLETED|Overall Study||24
67196|NCT02298179|162657|P3|COMPLETED|Overall Study||23
67197|NCT02298179|162658|P2|COMPLETED|Overall Study||24
67198|NCT02298179|162659|P1|COMPLETED|Overall Study||24
67199|NCT02298179|162648|P12|STARTED|Overall Study||24
67200|NCT02298179|162649|P11|STARTED|Overall Study||24
67201|NCT02298179|162650|P10|STARTED|Overall Study||24
67202|NCT02298179|162651|P9|STARTED|Overall Study||24
67203|NCT02298179|162652|P8|STARTED|Overall Study||24
67204|NCT02298179|162653|P7|STARTED|Overall Study||24
67205|NCT02298179|162654|P6|STARTED|Overall Study||24
67206|NCT02298179|162655|P5|STARTED|Overall Study||24
67207|NCT02298179|162656|P4|STARTED|Overall Study||24
67208|NCT02298179|162657|P3|STARTED|Overall Study||24
67209|NCT02298179|162658|P2|STARTED|Overall Study||24
67210|NCT02298179|162659|P1|STARTED|Overall Study||24
67211|NCT02297841|162901|P1|NOT COMPLETED|Overall Study||8
67212|NCT02297841|162901|P1|COMPLETED|Overall Study||201
67213|NCT02297841|162901|P1|Challenge Phase|Overall Study||201
67214|NCT02297841|162901|P1|Induction Phase|Overall Study||209
67215|NCT02297841|162901|P1|STARTED|Overall Study||209
67216|NCT02297815|162907|P2|NOT COMPLETED|Overall Study||140
67217|NCT02297815|162908|P1|NOT COMPLETED|Overall Study||236
67218|NCT02297815|162907|P2|COMPLETED|Overall Study||728
67219|NCT02297815|162908|P1|COMPLETED|Overall Study||1368
67220|NCT02297815|162907|P2|14-20 Day Interview|Overall Study||728
67221|NCT02297815|162908|P1|14-20 Day Interview|Overall Study||1368
67222|NCT02297815|162907|P2|5-10 Day Interview|Overall Study||868
67223|NCT02297815|162908|P1|5-10 Day Interview|Overall Study||1604
67224|NCT02297815|162907|P2|STARTED|Overall Study||868
67225|NCT02297815|162908|P1|STARTED|Overall Study||1604
67226|NCT02297516|162926|P2|NOT COMPLETED|Combination Treatment Phase (up to 18 m)||1
67227|NCT02297516|162927|P1|NOT COMPLETED|Combination Treatment Phase (up to 18 m)||0
67228|NCT02297516|162926|P2|COMPLETED|Combination Treatment Phase (up to 18 m)||30
67229|NCT02297516|162927|P1|COMPLETED|Combination Treatment Phase (up to 18 m)||31
67230|NCT02297516|162926|P2|STARTED|Combination Treatment Phase (up to 18 m)||31
67231|NCT02297516|162927|P1|STARTED|Combination Treatment Phase (up to 18 m)||31
67232|NCT02297516|162926|P2|NOT COMPLETED|Single Treatment Phase (6 Months)||2
67233|NCT02297516|162927|P1|NOT COMPLETED|Single Treatment Phase (6 Months)||1
67234|NCT02297516|162926|P2|COMPLETED|Single Treatment Phase (6 Months)||31
67235|NCT02297516|162927|P1|COMPLETED|Single Treatment Phase (6 Months)||31
67236|NCT02297516|162926|P2|STARTED|Single Treatment Phase (6 Months)||33
67237|NCT02297516|162927|P1|STARTED|Single Treatment Phase (6 Months)||32
67238|NCT02297503|162948|P2|NOT COMPLETED|Overall Study||4
67239|NCT02297503|162949|P1|NOT COMPLETED|Overall Study||2
67240|NCT02297503|162948|P2|COMPLETED|Overall Study||27
67241|NCT02297503|162949|P1|COMPLETED|Overall Study||28
67242|NCT02297503|162948|P2|Second Combined Treatment|Overall Study||28
67243|NCT02297503|162949|P1|Second Combined Treatment|Overall Study||28
67244|NCT02297503|162948|P2|First Combined Treatment|Overall Study||28
67245|NCT02297503|162949|P1|First Combined Treatment|Overall Study||28
67246|NCT02297503|162948|P2|Initial Single Treatment|Overall Study||31
67247|NCT02297503|162949|P1|Initial Single Treatment|Overall Study||29
67248|NCT02297503|162948|P2|STARTED|Overall Study||31
67249|NCT02297503|162949|P1|STARTED|Overall Study||30
67250|NCT02297412|162976|P2|NOT COMPLETED|Overall Study||1
67251|NCT02297412|162977|P1|NOT COMPLETED|Overall Study||1
67252|NCT02297412|162976|P2|COMPLETED|Overall Study||23
67253|NCT02297412|162977|P1|COMPLETED|Overall Study||22
67254|NCT02297412|162976|P2|STARTED|Overall Study||24
67255|NCT02297412|162977|P1|STARTED|Overall Study||23
67256|NCT02297308|162987|P1|NOT COMPLETED|Overall Study||0
67257|NCT02297308|162987|P1|COMPLETED|Overall Study||90
67258|NCT02297308|162987|P1|STARTED|Overall Study||90
67259|NCT02297230|162996|P4|NOT COMPLETED|Overall Study||0
67260|NCT02297230|162997|P3|NOT COMPLETED|Overall Study||0
67261|NCT02297230|162998|P2|NOT COMPLETED|Overall Study||0
67262|NCT02297230|162999|P1|NOT COMPLETED|Overall Study||0
67263|NCT02297230|162996|P4|COMPLETED|Overall Study||11
67264|NCT02297230|162997|P3|COMPLETED|Overall Study||11
67265|NCT02297230|162998|P2|COMPLETED|Overall Study||11
67266|NCT02297230|162999|P1|COMPLETED|Overall Study||11
67267|NCT02297230|162996|P4|STARTED|Overall Study||11
67268|NCT02297230|162997|P3|STARTED|Overall Study||11
67269|NCT02297230|162998|P2|STARTED|Overall Study||11
67270|NCT02297230|162999|P1|STARTED|Overall Study||11
67271|NCT02297100|163023|P2|NOT COMPLETED|Overall Study||0
67272|NCT02297100|163024|P1|NOT COMPLETED|Overall Study||0
67273|NCT02297100|163023|P2|COMPLETED|Overall Study||14
67274|NCT02297100|163024|P1|COMPLETED|Overall Study||13
67275|NCT02297100|163023|P2|STARTED|Overall Study||14
67276|NCT02297100|163024|P1|STARTED|Overall Study||13
67277|NCT02296931|163038|P2|NOT COMPLETED|Overall Study||2
67278|NCT02296931|163039|P1|NOT COMPLETED|Overall Study||0
67279|NCT02296931|163038|P2|COMPLETED|Overall Study||22
67280|NCT02296931|163039|P1|COMPLETED|Overall Study||10
67281|NCT02296931|163038|P2|STARTED|Overall Study||24
67282|NCT02296931|163039|P1|STARTED|Overall Study||10
67283|NCT02296892|163048|P3|NOT COMPLETED|Overall Study||5
67284|NCT02296892|163049|P2|NOT COMPLETED|Overall Study||4
67285|NCT02296892|163050|P1|NOT COMPLETED|Overall Study||12
67286|NCT02296892|163048|P3|COMPLETED|Overall Study||68
67287|NCT02296892|163049|P2|COMPLETED|Overall Study||59
67288|NCT02296892|163050|P1|COMPLETED|Overall Study||298
67289|NCT02296892|163048|P3|Complete Trial Treatment Period|Overall Study||69
67290|NCT02296892|163049|P2|Complete Trial Treatment Period|Overall Study||59
67291|NCT02296892|163050|P1|Complete Trial Treatment Period|Overall Study||303
67292|NCT02296892|163048|P3|Safety Population|Overall Study||69
67293|NCT02296892|163049|P2|Safety Population|Overall Study||59
67294|NCT02296892|163050|P1|Safety Population|Overall Study||303
67295|NCT02296892|163048|P3|STARTED|Overall Study||73
67296|NCT02296892|163049|P2|STARTED|Overall Study||63
67297|NCT02296892|163050|P1|STARTED|Overall Study||310
67298|NCT02296840|163069|P2|NOT COMPLETED|Overall Study||19
67299|NCT02296840|163070|P1|NOT COMPLETED|Overall Study||9
67300|NCT02296840|163069|P2|COMPLETED|Overall Study||8
67301|NCT02296840|163070|P1|COMPLETED|Overall Study||9
67302|NCT02296840|163069|P2|STARTED|Overall Study||27
67303|NCT02296840|163070|P1|STARTED|Overall Study||18
67304|NCT02296606|163078|P1|NOT COMPLETED|Overall Study||0
67305|NCT02296606|163078|P1|COMPLETED|Overall Study||127
67306|NCT02296606|163078|P1|STARTED|Overall Study||127
67307|NCT02296502|163086|P4|NOT COMPLETED|Overall Study||0
67308|NCT02296502|163087|P3|NOT COMPLETED|Overall Study||0
67309|NCT02296502|163088|P2|NOT COMPLETED|Overall Study||0
67310|NCT02296502|163089|P1|NOT COMPLETED|Overall Study||0
67311|NCT02296502|163086|P4|COMPLETED|Overall Study||160
67312|NCT02296502|163087|P3|COMPLETED|Overall Study||30
67313|NCT02296502|163088|P2|COMPLETED|Overall Study||1
67314|NCT02296502|163089|P1|COMPLETED|Overall Study||248
67315|NCT02296502|163086|P4|STARTED|Overall Study||160
67316|NCT02296502|163087|P3|STARTED|Overall Study||30
67317|NCT02296502|163088|P2|STARTED|Overall Study||1
67318|NCT02296502|163089|P1|STARTED|Overall Study||248
67319|NCT02296476|163105|P3|NOT COMPLETED|Overall Study||2
67320|NCT02296476|163106|P2|NOT COMPLETED|Overall Study||4
67321|NCT02296476|163107|P1|NOT COMPLETED|Overall Study||6
67322|NCT02296476|163105|P3|COMPLETED|Overall Study||0
67323|NCT02296476|163106|P2|COMPLETED|Overall Study||0
67324|NCT02296476|163107|P1|COMPLETED|Overall Study||0
67325|NCT02296476|163105|P3|STARTED|Overall Study||2
67326|NCT02296476|163106|P2|STARTED|Overall Study||4
67327|NCT02296476|163107|P1|STARTED|Overall Study||6
67328|NCT02296424|163162|P4|NOT COMPLETED|Part 2||0
67329|NCT02296424|163163|P3|NOT COMPLETED|Part 2||3
67330|NCT02296424|163164|P2|NOT COMPLETED|Part 2||0
67331|NCT02296424|163165|P1|NOT COMPLETED|Part 2||0
67332|NCT02296424|163162|P4|COMPLETED|Part 2||37
67333|NCT02296424|163163|P3|COMPLETED|Part 2||35
67334|NCT02296424|163164|P2|COMPLETED|Part 2||0
67335|NCT02296424|163165|P1|COMPLETED|Part 2||0
67336|NCT02296424|163162|P4|STARTED|Part 2||37
67337|NCT02296424|163163|P3|STARTED|Part 2||38
67338|NCT02296424|163164|P2|STARTED|Part 2||0
67339|NCT02296424|163165|P1|STARTED|Part 2||0
67340|NCT02296424|163162|P4|NOT COMPLETED|Part 1||0
67341|NCT02296424|163163|P3|NOT COMPLETED|Part 1||0
67342|NCT02296424|163164|P2|NOT COMPLETED|Part 1||33
67343|NCT02296424|163165|P1|NOT COMPLETED|Part 1||23
67344|NCT02296424|163162|P4|COMPLETED|Part 1||0
67345|NCT02296424|163163|P3|COMPLETED|Part 1||0
67346|NCT02296424|163164|P2|COMPLETED|Part 1||65
67347|NCT02296424|163165|P1|COMPLETED|Part 1||61
67348|NCT02296424|163162|P4|STARTED|Part 1||0
67349|NCT02296424|163163|P3|STARTED|Part 1||0
67350|NCT02296424|163164|P2|STARTED|Part 1||98
67351|NCT02296424|163165|P1|STARTED|Part 1|16 patients immediately went into Part II|84
67352|NCT02296346|163178|P2|NOT COMPLETED|Overall Study||6
67353|NCT02296346|163179|P1|NOT COMPLETED|Overall Study||5
67354|NCT02296346|163178|P2|COMPLETED|Overall Study||0
67355|NCT02296346|163179|P1|COMPLETED|Overall Study||2
67356|NCT02296346|163178|P2|STARTED|Overall Study||6
67357|NCT02296346|163179|P1|STARTED|Overall Study||7
67358|NCT02296320|163190|P3|NOT COMPLETED|Overall Study||37
67359|NCT02296320|163191|P2|NOT COMPLETED|Overall Study||5
67360|NCT02296320|163192|P1|NOT COMPLETED|Overall Study||35
67361|NCT02296320|163190|P3|COMPLETED|Overall Study||59
67362|NCT02296320|163191|P2|COMPLETED|Overall Study||10
67363|NCT02296320|163192|P1|COMPLETED|Overall Study||67
67364|NCT02296320|163190|P3|Treated|Overall Study||96
67365|NCT02296320|163191|P2|Treated|Overall Study||15
67366|NCT02296320|163192|P1|Treated|Overall Study||100
67367|NCT02296320|163190|P3|STARTED|Overall Study||96
67368|NCT02296320|163191|P2|STARTED|Overall Study||15
67369|NCT02296320|163192|P1|STARTED|Overall Study||102
67370|NCT02296242|163231|P5|NOT COMPLETED|Overall Study||21
67371|NCT02296242|163232|P4|NOT COMPLETED|Overall Study||14
67372|NCT02296242|163233|P3|NOT COMPLETED|Overall Study||7
67373|NCT02296242|163234|P2|NOT COMPLETED|Overall Study||6
67374|NCT02296242|163235|P1|NOT COMPLETED|Overall Study||5
67375|NCT02296242|163231|P5|COMPLETED|Overall Study||0
67376|NCT02296242|163232|P4|COMPLETED|Overall Study||0
67377|NCT02296242|163233|P3|COMPLETED|Overall Study||0
67378|NCT02296242|163234|P2|COMPLETED|Overall Study||0
67379|NCT02296242|163235|P1|COMPLETED|Overall Study||0
67380|NCT02296242|163231|P5|STARTED|Overall Study||21
67381|NCT02296242|163232|P4|STARTED|Overall Study||14
67382|NCT02296242|163233|P3|STARTED|Overall Study||7
67383|NCT02296242|163234|P2|STARTED|Overall Study||6
67384|NCT02296242|163235|P1|STARTED|Overall Study||5
67385|NCT02296138|163259|P2|NOT COMPLETED|Overall Study||500
67386|NCT02296138|163260|P1|NOT COMPLETED|Overall Study||661
67387|NCT02296138|163259|P2|COMPLETED|Overall Study||3451
67388|NCT02296138|163260|P1|COMPLETED|Overall Study||3291
67389|NCT02296138|163259|P2|Treated|Overall Study||3939
67390|NCT02296138|163260|P1|Treated|Overall Study||3941
67391|NCT02296138|163259|P2|STARTED|Overall Study||3951
67392|NCT02296138|163260|P1|STARTED|Overall Study||3952
67393|NCT02296125|163276|P4|NOT COMPLETED|Overall Study||44
67394|NCT02296125|163277|P3|NOT COMPLETED|Overall Study||38
67395|NCT02296125|163278|P2|NOT COMPLETED|Overall Study||213
67396|NCT02296125|163279|P1|NOT COMPLETED|Overall Study||138
67397|NCT02296125|163276|P4|COMPLETED|Overall Study||21
67398|NCT02296125|163277|P3|COMPLETED|Overall Study||33
67399|NCT02296125|163278|P2|COMPLETED|Overall Study||64
67400|NCT02296125|163279|P1|COMPLETED|Overall Study||141
67401|NCT02296125|163276|P4|STARTED|Overall Study|There were 7 participants who were in both the Global and China Extension SoC EGFR-TKI Arm.|65
67402|NCT02296125|163277|P3|STARTED|Overall Study||71
67403|NCT02296125|163278|P2|STARTED|Overall Study|183 participant received gefitinib and 93 participants received erlotinib.|277
67404|NCT02296125|163279|P1|STARTED|Overall Study|There were 12 participants who were in both the Global and China Extension Osimertinib Arm.|279
67405|NCT02296112|163331|P1|NOT COMPLETED|Overall Study||9
67406|NCT02296112|163331|P1|COMPLETED|Overall Study||0
67407|NCT02296112|163331|P1|STARTED|Overall Study||9
67408|NCT02296099|163346|P2|NOT COMPLETED|Overall Study||2
67409|NCT02296099|163347|P1|NOT COMPLETED|Overall Study||3
67410|NCT02296099|163346|P2|COMPLETED|Overall Study||55
67411|NCT02296099|163347|P1|COMPLETED|Overall Study||54
67412|NCT02296099|163346|P2|STARTED|Overall Study||57
67413|NCT02296099|163347|P1|STARTED|Overall Study||57
67414|NCT02295774|163371|P1|NOT COMPLETED|Overall Study||3
67415|NCT02295774|163371|P1|COMPLETED|Overall Study||10
67416|NCT02295774|163371|P1|STARTED|Overall Study||13
67417|NCT02295644|163380|P4|NOT COMPLETED|Overall Study||2
67418|NCT02295644|163381|P3|NOT COMPLETED|Overall Study||1
67419|NCT02295644|163382|P2|NOT COMPLETED|Overall Study||0
67420|NCT02295644|163383|P1|NOT COMPLETED|Overall Study||0
67421|NCT02295644|163380|P4|COMPLETED|Overall Study||5
67422|NCT02295644|163381|P3|COMPLETED|Overall Study||6
67423|NCT02295644|163382|P2|COMPLETED|Overall Study||7
67424|NCT02295644|163383|P1|COMPLETED|Overall Study||7
67425|NCT02295644|163380|P4|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
67426|NCT02295644|163381|P3|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
67427|NCT02295644|163382|P2|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
67428|NCT02295644|163383|P1|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
67429|NCT02295553|163405|P4|NOT COMPLETED|Overall Study||1
67430|NCT02295553|163406|P3|NOT COMPLETED|Overall Study||1
67431|NCT02295553|163407|P2|NOT COMPLETED|Overall Study||0
67432|NCT02295553|163408|P1|NOT COMPLETED|Overall Study||0
67433|NCT02295553|163405|P4|COMPLETED|Overall Study||13
67434|NCT02295553|163406|P3|COMPLETED|Overall Study||13
67435|NCT02295553|163407|P2|COMPLETED|Overall Study||14
67436|NCT02295553|163408|P1|COMPLETED|Overall Study||14
67437|NCT02295553|163405|P4|STARTED|Overall Study||14
67438|NCT02295553|163406|P3|STARTED|Overall Study||14
67439|NCT02295553|163407|P2|STARTED|Overall Study||14
67440|NCT02295553|163408|P1|STARTED|Overall Study||14
67441|NCT02295280|163432|P2|NOT COMPLETED|Overall Study||1
67442|NCT02295280|163433|P1|NOT COMPLETED|Overall Study||0
67443|NCT02295280|163432|P2|COMPLETED|Overall Study||34
67444|NCT02295280|163433|P1|COMPLETED|Overall Study||35
67445|NCT02295280|163432|P2|STARTED|Overall Study||35
67446|NCT02295280|163433|P1|STARTED|Overall Study||35
67447|NCT02295020|163441|P2|NOT COMPLETED|Overall Study||3
67448|NCT02295020|163442|P1|NOT COMPLETED|Overall Study||3
67449|NCT02295020|163441|P2|COMPLETED|Overall Study||17
67450|NCT02295020|163442|P1|COMPLETED|Overall Study||17
67451|NCT02295020|163441|P2|STARTED|Overall Study||20
67452|NCT02295020|163442|P1|STARTED|Overall Study||20
67453|NCT02294786|163474|P2|NOT COMPLETED|Overall Study||14
67454|NCT02294786|163475|P1|NOT COMPLETED|Overall Study||11
67455|NCT02294786|163474|P2|COMPLETED|Overall Study||18
67456|NCT02294786|163475|P1|COMPLETED|Overall Study||19
67457|NCT02294786|163474|P2|ITT Population|Overall Study||32
67458|NCT02294786|163475|P1|ITT Population|Overall Study||30
67459|NCT02294786|163474|P2|Safety Population|Overall Study|The subject was included in the No-Octreotide arm.|33
67460|NCT02294786|163475|P1|Safety Population|Overall Study|One subject randomized to Octreotide received only 0.1 mg dose.|29
67461|NCT02294786|163474|P2|STARTED|Overall Study||32
67462|NCT02294786|163475|P1|STARTED|Overall Study||30
67463|NCT02294773|163522|P2|NOT COMPLETED|Overall Study||2
67464|NCT02294773|163523|P1|NOT COMPLETED|Overall Study||0
67465|NCT02294773|163522|P2|COMPLETED|Overall Study||4
67466|NCT02294773|163523|P1|COMPLETED|Overall Study||7
67467|NCT02294773|163522|P2|STARTED|Overall Study||6
67468|NCT02294773|163523|P1|STARTED|Overall Study||7
67469|NCT02294734|163539|P2|NOT COMPLETED|Overall Study||8
67470|NCT02294734|163540|P1|NOT COMPLETED|Overall Study||14
67471|NCT02294734|163539|P2|COMPLETED|Overall Study||55
67472|NCT02294734|163540|P1|COMPLETED|Overall Study||49
67473|NCT02294734|163539|P2|STARTED|Overall Study||63
67474|NCT02294734|163540|P1|STARTED|Overall Study||63
67475|NCT02294682|163592|P2|NOT COMPLETED|Overall Study||0
67476|NCT02294682|163593|P1|NOT COMPLETED|Overall Study||1
67477|NCT02294682|163592|P2|COMPLETED|Overall Study||53
67478|NCT02294682|163593|P1|COMPLETED|Overall Study||52
67479|NCT02294682|163592|P2|STARTED|Overall Study||53
67480|NCT02294682|163593|P1|STARTED|Overall Study||53
67481|NCT02294604|163636|P3|NOT COMPLETED|Overall Study||0
67482|NCT02294604|163637|P2|NOT COMPLETED|Overall Study||3
67483|NCT02294604|163638|P1|NOT COMPLETED|Overall Study||1
67484|NCT02294604|163636|P3|COMPLETED|Overall Study||80
67485|NCT02294604|163637|P2|COMPLETED|Overall Study||77
67486|NCT02294604|163638|P1|COMPLETED|Overall Study||79
67487|NCT02294604|163636|P3|STARTED|Overall Study||80
67488|NCT02294604|163637|P2|STARTED|Overall Study||80
67489|NCT02294604|163638|P1|STARTED|Overall Study||80
67490|NCT02294474|163657|P2|NOT COMPLETED|Overall Study||22
67491|NCT02294474|163658|P1|NOT COMPLETED|Overall Study||25
67492|NCT02294474|163657|P2|COMPLETED|Overall Study||230
67493|NCT02294474|163658|P1|COMPLETED|Overall Study||228
67494|NCT02294474|163657|P2|STARTED|Overall Study||252
67495|NCT02294474|163658|P1|STARTED|Overall Study||253
67496|NCT02294461|163682|P2|NOT COMPLETED|Overall Study||131
67497|NCT02294461|163683|P1|NOT COMPLETED|Overall Study||62
67498|NCT02294461|163682|P2|COMPLETED|Overall Study||59
67499|NCT02294461|163683|P1|COMPLETED|Overall Study|Participants still receiving treatment as of 20 Sept 2016. Data cutoff date: 20 Sep 2015/20 Jan 2016|136
67500|NCT02294461|163682|P2|Treated/Received Study Drug|Overall Study||190
67501|NCT02294461|163683|P1|Treated/Received Study Drug|Overall Study||198
67502|NCT02294461|163682|P2|STARTED|Overall Study||190
67503|NCT02294461|163683|P1|STARTED|Overall Study||198
67504|NCT02294396|163739|P4|NOT COMPLETED|Overall Study||37
67505|NCT02294396|163740|P3|NOT COMPLETED|Overall Study||35
67506|NCT02294396|163741|P2|NOT COMPLETED|Overall Study||33
67507|NCT02294396|163742|P1|NOT COMPLETED|Overall Study||40
67508|NCT02294396|163739|P4|COMPLETED|Overall Study||123
67509|NCT02294396|163740|P3|COMPLETED|Overall Study||126
67510|NCT02294396|163741|P2|COMPLETED|Overall Study||128
67511|NCT02294396|163742|P1|COMPLETED|Overall Study||127
67512|NCT02294396|163739|P4|STARTED|Overall Study||160
67513|NCT02294396|163740|P3|STARTED|Overall Study||161
67514|NCT02294396|163741|P2|STARTED|Overall Study||161
67515|NCT02294396|163742|P1|STARTED|Overall Study||167
67516|NCT02294318|163814|P2|NOT COMPLETED|Overall Study||2
67517|NCT02294318|163815|P1|NOT COMPLETED|Overall Study||3
67518|NCT02294318|163814|P2|COMPLETED|Overall Study||21
67519|NCT02294318|163815|P1|COMPLETED|Overall Study||21
67520|NCT02294318|163814|P2|STARTED|Overall Study||23
67521|NCT02294318|163815|P1|STARTED|Overall Study||24
67522|NCT02294227|163830|P3|NOT COMPLETED|Overall Study||19
67523|NCT02294227|163831|P2|NOT COMPLETED|Overall Study||25
67524|NCT02294227|163832|P1|NOT COMPLETED|Overall Study||25
67525|NCT02294227|163830|P3|COMPLETED|Overall Study||95
67526|NCT02294227|163831|P2|COMPLETED|Overall Study||88
67527|NCT02294227|163832|P1|COMPLETED|Overall Study||89
67528|NCT02294227|163830|P3|STARTED|Overall Study||114
67529|NCT02294227|163831|P2|STARTED|Overall Study||113
67530|NCT02294227|163832|P1|STARTED|Overall Study||114
67531|NCT02294019|163856|P1|NOT COMPLETED|Overall Study||103
67532|NCT02294019|163856|P1|COMPLETED|Overall Study||635
67533|NCT02294019|163856|P1|STARTED|Overall Study||738
67534|NCT02293902|163864|P5|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||6
67535|NCT02293902|163865|P4|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||1
67536|NCT02293902|163866|P3|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||2
67537|NCT02293902|163867|P2|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||8
67538|NCT02293902|163868|P1|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
67539|NCT02293902|163864|P5|COMPLETED|Single-Blind Period (Week 25 to Week 52)|18 rescued and 13 not rescued completed.|31
67540|NCT02293902|163865|P4|COMPLETED|Single-Blind Period (Week 25 to Week 52)|20 rescued and 13 not rescued completed.|33
67541|NCT02293902|163866|P3|COMPLETED|Single-Blind Period (Week 25 to Week 52)|8 rescued and 60 not rescued completed.|68
67542|NCT02293902|163867|P2|COMPLETED|Single-Blind Period (Week 25 to Week 52)|5 rescued and 61 not rescued completed.|66
67543|NCT02293902|163868|P1|COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
67544|NCT02293902|163864|P5|STARTED|Single-Blind Period (Week 25 to Week 52)|15 participants not rescued were switched and 22 rescued continued open label treatment.|37
67545|NCT02293902|163865|P4|STARTED|Single-Blind Period (Week 25 to Week 52)|14 participants not rescued were switched and 20 rescued continued open label treatment.|34
67546|NCT02293902|163866|P3|STARTED|Single-Blind Period (Week 25 to Week 52)|62 participants not rescued continued same treatment and 8 rescued continued open label treatment.|70
67547|NCT02293902|163867|P2|STARTED|Single-Blind Period (Week 25 to Week 52)|68 participants not rescued continued same treatment and 6 rescued continued open label treatment.|74
67548|NCT02293902|163868|P1|STARTED|Single-Blind Period (Week 25 to Week 52)||0
67549|NCT02293902|163864|P5|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
67550|NCT02293902|163865|P4|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
67551|NCT02293902|163866|P3|NOT COMPLETED|Double-Blind Period (Up to Week 24)||10
67552|NCT02293902|163867|P2|NOT COMPLETED|Double-Blind Period (Up to Week 24)||7
67553|NCT02293902|163868|P1|NOT COMPLETED|Double-Blind Period (Up to Week 24)||11
67554|NCT02293902|163864|P5|COMPLETED|Double-Blind Period (Up to Week 24)||0
67555|NCT02293902|163865|P4|COMPLETED|Double-Blind Period (Up to Week 24)||0
67556|NCT02293902|163866|P3|COMPLETED|Double-Blind Period (Up to Week 24)|8 rescued and 62 not rescued completed.|70
67557|NCT02293902|163867|P2|COMPLETED|Double-Blind Period (Up to Week 24)|6 rescued and 68 not rescued completed.|74
67558|NCT02293902|163868|P1|COMPLETED|Double-Blind Period (Up to Week 24)|42 rescued and 29 not rescued completed.|71
67559|NCT02293902|163864|P5|Rescued|Double-Blind Period (Up to Week 24)||0
67560|NCT02293902|163865|P4|Rescued|Double-Blind Period (Up to Week 24)||0
67561|NCT02293902|163866|P3|Rescued|Double-Blind Period (Up to Week 24)||8
67562|NCT02293902|163867|P2|Rescued|Double-Blind Period (Up to Week 24)||6
67563|NCT02293902|163868|P1|Rescued|Double-Blind Period (Up to Week 24)||44
67564|NCT02293902|163864|P5|Treated|Double-Blind Period (Up to Week 24)||0
67565|NCT02293902|163865|P4|Treated|Double-Blind Period (Up to Week 24)||0
67566|NCT02293902|163866|P3|Treated|Double-Blind Period (Up to Week 24)||80
67567|NCT02293902|163867|P2|Treated|Double-Blind Period (Up to Week 24)||81
67568|NCT02293902|163868|P1|Treated|Double-Blind Period (Up to Week 24)||81
67569|NCT02293902|163864|P5|STARTED|Double-Blind Period (Up to Week 24)||0
67570|NCT02293902|163865|P4|STARTED|Double-Blind Period (Up to Week 24)||0
67571|NCT02293902|163866|P3|STARTED|Double-Blind Period (Up to Week 24)||80
67572|NCT02293902|163867|P2|STARTED|Double-Blind Period (Up to Week 24)||81
67573|NCT02293902|163868|P1|STARTED|Double-Blind Period (Up to Week 24)||82
67574|NCT02293863|163930|P3|NOT COMPLETED|Overall Study||9
67575|NCT02293863|163931|P2|NOT COMPLETED|Overall Study||13
67576|NCT02293863|163932|P1|NOT COMPLETED|Overall Study||9
67577|NCT02293863|163930|P3|COMPLETED|Overall Study||38
67578|NCT02293863|163931|P2|COMPLETED|Overall Study||42
67579|NCT02293863|163932|P1|COMPLETED|Overall Study||47
67580|NCT02293863|163930|P3|STARTED|Overall Study||47
67581|NCT02293863|163931|P2|STARTED|Overall Study||55
67582|NCT02293863|163932|P1|STARTED|Overall Study||56
67583|NCT02293798|163995|P1|NOT COMPLETED|Overall Study||0
67584|NCT02293798|163995|P1|COMPLETED|Overall Study|2 units of SERI Mesh placed in each patient|13
67585|NCT02293798|163995|P1|STARTED|Overall Study|2 units of SERI Mesh placed in each patient|13
67586|NCT02293538|164001|P2|NOT COMPLETED|Overall Study||2
67587|NCT02293538|164002|P1|NOT COMPLETED|Overall Study||1
67588|NCT02293538|164001|P2|COMPLETED|Overall Study||69
67589|NCT02293538|164002|P1|COMPLETED|Overall Study||72
67590|NCT02293538|164001|P2|STARTED|Overall Study||71
67591|NCT02293538|164002|P1|STARTED|Overall Study||73
67592|NCT02293512|164019|P4|NOT COMPLETED|Overall Study||2
67593|NCT02293512|164020|P3|NOT COMPLETED|Overall Study||3
67594|NCT02293512|164021|P2|NOT COMPLETED|Overall Study||6
67595|NCT02293512|164022|P1|NOT COMPLETED|Overall Study||4
67596|NCT02293512|164019|P4|COMPLETED|Overall Study||8
67597|NCT02293512|164020|P3|COMPLETED|Overall Study||7
67598|NCT02293512|164021|P2|COMPLETED|Overall Study||4
67599|NCT02293512|164022|P1|COMPLETED|Overall Study||6
67600|NCT02293512|164019|P4|STARTED|Overall Study||10
67601|NCT02293512|164020|P3|STARTED|Overall Study||10
67602|NCT02293512|164021|P2|STARTED|Overall Study||10
67603|NCT02293512|164022|P1|STARTED|Overall Study||10
67604|NCT02293395|164034|P2|NOT COMPLETED|Overall Study||7
67605|NCT02293395|164035|P1|NOT COMPLETED|Overall Study||9
67606|NCT02293395|164034|P2|COMPLETED|Overall Study||1511
67607|NCT02293395|164035|P1|COMPLETED|Overall Study||1510
67608|NCT02293395|164034|P2|Treated|Overall Study||1506
67609|NCT02293395|164035|P1|Treated|Overall Study||1510
67610|NCT02293395|164034|P2|STARTED|Overall Study||1518
67611|NCT02293395|164035|P1|STARTED|Overall Study||1519
67612|NCT02293044|164041|P1|NOT COMPLETED|Overall Study||0
67613|NCT02293044|164041|P1|COMPLETED|Overall Study||15
67614|NCT02293044|164041|P1|STARTED|Overall Study||15
67615|NCT02292927|164048|P2|NOT COMPLETED|Overall Study||7
67616|NCT02292927|164049|P1|NOT COMPLETED|Overall Study||13
67617|NCT02292927|164048|P2|COMPLETED|Overall Study||5
67618|NCT02292927|164049|P1|COMPLETED|Overall Study||0
67619|NCT02292927|164048|P2|STARTED|Overall Study||12
67620|NCT02292927|164049|P1|STARTED|Overall Study||13
67621|NCT02292849|164066|P3|NOT COMPLETED|Overall Study||2
67622|NCT02292849|164067|P2|NOT COMPLETED|Overall Study||2
67623|NCT02292849|164068|P1|NOT COMPLETED|Overall Study||4
67624|NCT02292849|164066|P3|COMPLETED|Overall Study||8
67625|NCT02292849|164067|P2|COMPLETED|Overall Study||6
67626|NCT02292849|164068|P1|COMPLETED|Overall Study||7
67627|NCT02292849|164066|P3|STARTED|Overall Study||10
67628|NCT02292849|164067|P2|STARTED|Overall Study||8
67629|NCT02292849|164068|P1|STARTED|Overall Study||11
67630|NCT02292771|164078|P2|NOT COMPLETED|Overall Study||2
67631|NCT02292771|164079|P1|NOT COMPLETED|Overall Study||4
67632|NCT02292771|164078|P2|COMPLETED|Overall Study||48
67633|NCT02292771|164079|P1|COMPLETED|Overall Study||43
67634|NCT02292771|164078|P2|STARTED|Overall Study||50
67635|NCT02292771|164079|P1|STARTED|Overall Study||47
67636|NCT02292719|164175|P6|NOT COMPLETED|Overall Study||0
67637|NCT02292719|164176|P5|NOT COMPLETED|Overall Study||1
67638|NCT02292719|164177|P4|NOT COMPLETED|Overall Study||1
67639|NCT02292719|164178|P3|NOT COMPLETED|Overall Study||1
67640|NCT02292719|164179|P2|NOT COMPLETED|Overall Study||0
67641|NCT02292719|164180|P1|NOT COMPLETED|Overall Study||0
67642|NCT02292719|164175|P6|COMPLETED|Overall Study||10
67643|NCT02292719|164176|P5|COMPLETED|Overall Study||20
67644|NCT02292719|164177|P4|COMPLETED|Overall Study||8
67645|NCT02292719|164178|P3|COMPLETED|Overall Study||9
67646|NCT02292719|164179|P2|COMPLETED|Overall Study||11
67647|NCT02292719|164180|P1|COMPLETED|Overall Study||9
67648|NCT02292719|164175|P6|STARTED|Overall Study||10
67649|NCT02292719|164176|P5|STARTED|Overall Study||21
67650|NCT02292719|164177|P4|STARTED|Overall Study||9
67651|NCT02292719|164178|P3|STARTED|Overall Study||10
67652|NCT02292719|164179|P2|STARTED|Overall Study||11
67653|NCT02292719|164180|P1|STARTED|Overall Study||9
67654|NCT02292537|164208|P2|NOT COMPLETED|Overall Study||0
67655|NCT02292537|164209|P1|NOT COMPLETED|Overall Study||0
67656|NCT02292537|164208|P2|COMPLETED|Overall Study||84
67657|NCT02292537|164209|P1|COMPLETED|Overall Study||42
67658|NCT02292537|164208|P2|Completed Treatment|Overall Study|1 participant completed the study but did not complete treatments due to early study closure|83
67659|NCT02292537|164209|P1|Completed Treatment|Overall Study||42
67660|NCT02292537|164208|P2|STARTED|Overall Study||84
67661|NCT02292537|164209|P1|STARTED|Overall Study||42
67662|NCT02292446|164243|P1|NOT COMPLETED|Overall Study||20
67663|NCT02292446|164243|P1|COMPLETED|Overall Study||141
67664|NCT02292446|164243|P1|STARTED|Overall Study||161
67665|NCT02292433|164259|P3|NOT COMPLETED|Third Intervention Period (7 Days)||0
67666|NCT02292433|164260|P2|NOT COMPLETED|Third Intervention Period (7 Days)||0
67667|NCT02292433|164261|P1|NOT COMPLETED|Third Intervention Period (7 Days)||0
67668|NCT02292433|164259|P3|COMPLETED|Third Intervention Period (7 Days)||4
67669|NCT02292433|164260|P2|COMPLETED|Third Intervention Period (7 Days)||4
67670|NCT02292433|164261|P1|COMPLETED|Third Intervention Period (7 Days)||4
67671|NCT02292433|164259|P3|STARTED|Third Intervention Period (7 Days)||4
67672|NCT02292433|164260|P2|STARTED|Third Intervention Period (7 Days)||4
67673|NCT02292433|164261|P1|STARTED|Third Intervention Period (7 Days)||4
67674|NCT02292433|164259|P3|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
67675|NCT02292433|164260|P2|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
67676|NCT02292433|164261|P1|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
67677|NCT02292433|164259|P3|COMPLETED|Second Washout Period (7 to 14 Days)||4
67678|NCT02292433|164260|P2|COMPLETED|Second Washout Period (7 to 14 Days)||4
67679|NCT02292433|164261|P1|COMPLETED|Second Washout Period (7 to 14 Days)||4
67680|NCT02292433|164259|P3|STARTED|Second Washout Period (7 to 14 Days)||4
67681|NCT02292433|164260|P2|STARTED|Second Washout Period (7 to 14 Days)||4
67682|NCT02292433|164261|P1|STARTED|Second Washout Period (7 to 14 Days)||4
67683|NCT02292433|164259|P3|NOT COMPLETED|Second Intervention Period (7 Days)||0
67684|NCT02292433|164260|P2|NOT COMPLETED|Second Intervention Period (7 Days)||0
67685|NCT02292433|164261|P1|NOT COMPLETED|Second Intervention Period (7 Days)||0
67686|NCT02292433|164259|P3|COMPLETED|Second Intervention Period (7 Days)||4
67687|NCT02292433|164260|P2|COMPLETED|Second Intervention Period (7 Days)||4
67688|NCT02292433|164261|P1|COMPLETED|Second Intervention Period (7 Days)||4
67689|NCT02292433|164259|P3|STARTED|Second Intervention Period (7 Days)||4
67690|NCT02292433|164260|P2|STARTED|Second Intervention Period (7 Days)||4
67691|NCT02292433|164261|P1|STARTED|Second Intervention Period (7 Days)||4
67692|NCT02292433|164259|P3|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
67693|NCT02292433|164260|P2|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
67694|NCT02292433|164261|P1|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
67695|NCT02292433|164259|P3|COMPLETED|First Washout Period (7 to 14 Days)||4
67696|NCT02292433|164260|P2|COMPLETED|First Washout Period (7 to 14 Days)||4
67697|NCT02292433|164261|P1|COMPLETED|First Washout Period (7 to 14 Days)||4
67698|NCT02292433|164259|P3|STARTED|First Washout Period (7 to 14 Days)||4
67699|NCT02292433|164260|P2|STARTED|First Washout Period (7 to 14 Days)||4
67700|NCT02292433|164261|P1|STARTED|First Washout Period (7 to 14 Days)||4
67701|NCT02292433|164259|P3|NOT COMPLETED|First Intervention Period (7 Days)||0
67702|NCT02292433|164260|P2|NOT COMPLETED|First Intervention Period (7 Days)||0
67703|NCT02292433|164261|P1|NOT COMPLETED|First Intervention Period (7 Days)||0
67704|NCT02292433|164259|P3|COMPLETED|First Intervention Period (7 Days)||4
67705|NCT02292433|164260|P2|COMPLETED|First Intervention Period (7 Days)||4
67706|NCT02292433|164261|P1|COMPLETED|First Intervention Period (7 Days)||4
67707|NCT02292433|164259|P3|STARTED|First Intervention Period (7 Days)||4
67708|NCT02292433|164260|P2|STARTED|First Intervention Period (7 Days)||4
67709|NCT02292433|164261|P1|STARTED|First Intervention Period (7 Days)||4
67710|NCT02292212|164332|P1|NOT COMPLETED|Post-ViE Phase||0
67711|NCT02292212|164332|P1|COMPLETED|Post-ViE Phase||14
67712|NCT02292212|164332|P1|STARTED|Post-ViE Phase||14
67713|NCT02292212|164332|P1|NOT COMPLETED|ViE Phase||3
67714|NCT02292212|164332|P1|COMPLETED|ViE Phase||14
67715|NCT02292212|164332|P1|STARTED|ViE Phase||17
67716|NCT02292212|164332|P1|NOT COMPLETED|Pre-ViE Phase||0
67717|NCT02292212|164332|P1|COMPLETED|Pre-ViE Phase||17
67718|NCT02292212|164332|P1|STARTED|Pre-ViE Phase||17
67719|NCT02292186|164364|P1|NOT COMPLETED|Overall Study||18
67720|NCT02292186|164364|P1|COMPLETED|Overall Study||7
67721|NCT02292186|164364|P1|STARTED|Overall Study||25
67722|NCT02292082|164374|P2|NOT COMPLETED|Overall Study||0
67723|NCT02292082|164375|P1|NOT COMPLETED|Overall Study||0
67724|NCT02292082|164374|P2|COMPLETED|Overall Study||55
67725|NCT02292082|164375|P1|COMPLETED|Overall Study||56
67726|NCT02292082|164374|P2|STARTED|Overall Study||55
67727|NCT02292082|164375|P1|STARTED|Overall Study||56
67728|NCT02291861|164405|P4|NOT COMPLETED|Overall Study||10
67729|NCT02291861|164406|P3|NOT COMPLETED|Overall Study||9
67730|NCT02291861|164407|P2|NOT COMPLETED|Overall Study||8
67731|NCT02291861|164408|P1|NOT COMPLETED|Overall Study||7
67732|NCT02291861|164405|P4|COMPLETED|Overall Study||65
67733|NCT02291861|164406|P3|COMPLETED|Overall Study||65
67734|NCT02291861|164407|P2|COMPLETED|Overall Study||67
67735|NCT02291861|164408|P1|COMPLETED|Overall Study||67
67736|NCT02291861|164405|P4|Modified Intent to Treat Pop (mITT)|Overall Study||55
67737|NCT02291861|164406|P3|Modified Intent to Treat Pop (mITT)|Overall Study||49
67738|NCT02291861|164407|P2|Modified Intent to Treat Pop (mITT)|Overall Study||60
67739|NCT02291861|164408|P1|Modified Intent to Treat Pop (mITT)|Overall Study||58
67740|NCT02291861|164405|P4|Safety Population|Overall Study||74
67741|NCT02291861|164406|P3|Safety Population|Overall Study||73
67742|NCT02291861|164407|P2|Safety Population|Overall Study||74
67743|NCT02291861|164408|P1|Safety Population|Overall Study||72
67744|NCT02291861|164405|P4|STARTED|Overall Study||75
67745|NCT02291861|164406|P3|STARTED|Overall Study||74
67746|NCT02291861|164407|P2|STARTED|Overall Study||75
67747|NCT02291861|164408|P1|STARTED|Overall Study||74
67748|NCT02291718|164449|P3|NOT COMPLETED|Overall Study||0
67749|NCT02291718|164450|P2|NOT COMPLETED|Overall Study||0
67750|NCT02291718|164451|P1|NOT COMPLETED|Overall Study||0
67751|NCT02291718|164449|P3|COMPLETED|Overall Study||50
67752|NCT02291718|164450|P2|COMPLETED|Overall Study||50
67753|NCT02291718|164451|P1|COMPLETED|Overall Study||50
67754|NCT02291718|164449|P3|STARTED|Overall Study||50
67755|NCT02291718|164450|P2|STARTED|Overall Study||50
67756|NCT02291718|164451|P1|STARTED|Overall Study||50
67757|NCT02291679|164471|P3|NOT COMPLETED|Overall Study||59
67758|NCT02291679|164472|P2|NOT COMPLETED|Overall Study||42
67759|NCT02291679|164473|P1|NOT COMPLETED|Overall Study||44
67760|NCT02291679|164471|P3|COMPLETED|Overall Study||352
67761|NCT02291679|164472|P2|COMPLETED|Overall Study||369
67762|NCT02291679|164473|P1|COMPLETED|Overall Study||357
67763|NCT02291679|164471|P3|STARTED|Overall Study||411
67764|NCT02291679|164472|P2|STARTED|Overall Study||411
67765|NCT02291679|164473|P1|STARTED|Overall Study||401
67766|NCT02291549|164504|P2|NOT COMPLETED|Overall Study||1
67767|NCT02291549|164505|P1|NOT COMPLETED|Overall Study||1
67768|NCT02291549|164504|P2|COMPLETED|Overall Study||98
67769|NCT02291549|164505|P1|COMPLETED|Overall Study||200
67770|NCT02291549|164504|P2|STARTED|Overall Study||99
67771|NCT02291549|164505|P1|STARTED|Overall Study||201
67772|NCT02291510|164527|P4|NOT COMPLETED|Overall Study||1
67773|NCT02291510|164528|P3|NOT COMPLETED|Overall Study||0
67774|NCT02291510|164529|P2|NOT COMPLETED|Overall Study||0
67775|NCT02291510|164530|P1|NOT COMPLETED|Overall Study||0
67776|NCT02291510|164527|P4|COMPLETED|Overall Study||4
67777|NCT02291510|164528|P3|COMPLETED|Overall Study||5
67778|NCT02291510|164529|P2|COMPLETED|Overall Study||5
67779|NCT02291510|164530|P1|COMPLETED|Overall Study||5
67780|NCT02291510|164527|P4|Completed Treatment D|Overall Study||5
67781|NCT02291510|164528|P3|Completed Treatment D|Overall Study||5
67782|NCT02291510|164529|P2|Completed Treatment D|Overall Study||5
67783|NCT02291510|164530|P1|Completed Treatment D|Overall Study||5
67784|NCT02291510|164527|P4|Completed Treatment C|Overall Study||4
67785|NCT02291510|164528|P3|Completed Treatment C|Overall Study||5
67786|NCT02291510|164529|P2|Completed Treatment C|Overall Study||5
67787|NCT02291510|164530|P1|Completed Treatment C|Overall Study||5
67788|NCT02291510|164527|P4|Completed Treatment B|Overall Study||4
67789|NCT02291510|164528|P3|Completed Treatment B|Overall Study||5
67790|NCT02291510|164529|P2|Completed Treatment B|Overall Study||5
67791|NCT02291510|164530|P1|Completed Treatment B|Overall Study||5
67792|NCT02291510|164527|P4|Completed Treatment A|Overall Study||5
67793|NCT02291510|164528|P3|Completed Treatment A|Overall Study||5
67794|NCT02291510|164529|P2|Completed Treatment A|Overall Study||5
67795|NCT02291510|164530|P1|Completed Treatment A|Overall Study||5
67796|NCT02291510|164527|P4|STARTED|Overall Study||5
67797|NCT02291510|164528|P3|STARTED|Overall Study||5
67798|NCT02291510|164529|P2|STARTED|Overall Study||5
67799|NCT02291510|164530|P1|STARTED|Overall Study||5
67800|NCT02291419|164546|P2|NOT COMPLETED|Overall Study||5
67801|NCT02291419|164547|P1|NOT COMPLETED|Overall Study||1
67802|NCT02291419|164546|P2|COMPLETED|Overall Study||0
67803|NCT02291419|164547|P1|COMPLETED|Overall Study||0
67804|NCT02291419|164546|P2|STARTED|Overall Study||5
67805|NCT02291419|164547|P1|STARTED|Overall Study||1
67806|NCT02291237|164565|P2|NOT COMPLETED|Overall Study||86
67807|NCT02291237|164566|P1|NOT COMPLETED|Overall Study||86
67808|NCT02291237|164565|P2|COMPLETED|Overall Study||0
67809|NCT02291237|164566|P1|COMPLETED|Overall Study||0
67810|NCT02291237|164565|P2|STARTED|Overall Study||86
67811|NCT02291237|164566|P1|STARTED|Overall Study||86
67812|NCT02291029|164588|P6|NOT COMPLETED|Overall Study||0
67813|NCT02291029|164589|P5|NOT COMPLETED|Overall Study||0
67814|NCT02291029|164590|P4|NOT COMPLETED|Overall Study||0
67815|NCT02291029|164591|P3|NOT COMPLETED|Overall Study||1
67816|NCT02291029|164592|P2|NOT COMPLETED|Overall Study||1
67817|NCT02291029|164593|P1|NOT COMPLETED|Overall Study||0
67818|NCT02291029|164588|P6|COMPLETED|Overall Study||12
67819|NCT02291029|164589|P5|COMPLETED|Overall Study||13
67820|NCT02291029|164590|P4|COMPLETED|Overall Study||11
67821|NCT02291029|164591|P3|COMPLETED|Overall Study||20
67822|NCT02291029|164592|P2|COMPLETED|Overall Study||3
67823|NCT02291029|164593|P1|COMPLETED|Overall Study||8
67824|NCT02291029|164588|P6|STARTED|Overall Study||12
67825|NCT02291029|164589|P5|STARTED|Overall Study||13
67826|NCT02291029|164590|P4|STARTED|Overall Study||11
67827|NCT02291029|164591|P3|STARTED|Overall Study||21
67828|NCT02291029|164592|P2|STARTED|Overall Study||4
67829|NCT02291029|164593|P1|STARTED|Overall Study||8
67830|NCT02291016|164639|P2|NOT COMPLETED|Visit 2||0
67831|NCT02291016|164640|P1|NOT COMPLETED|Visit 2||1
67832|NCT02291016|164639|P2|COMPLETED|Visit 2||5
67833|NCT02291016|164640|P1|COMPLETED|Visit 2|Patients did not meet visit 2 FEV1 criteria ( 15% or closer to value at visit 1)|1
67834|NCT02291016|164639|P2|STARTED|Visit 2||5
67835|NCT02291016|164640|P1|STARTED|Visit 2||2
67836|NCT02291016|164639|P2|NOT COMPLETED|Visit 1||0
67837|NCT02291016|164640|P1|NOT COMPLETED|Visit 1||0
67838|NCT02291016|164639|P2|COMPLETED|Visit 1||5
67839|NCT02291016|164640|P1|COMPLETED|Visit 1||2
67840|NCT02291016|164639|P2|STARTED|Visit 1||5
67841|NCT02291016|164640|P1|STARTED|Visit 1||2
67842|NCT02290925|164664|P2|NOT COMPLETED|Second Period of 3 Months||4
67843|NCT02290925|164665|P1|NOT COMPLETED|Second Period of 3 Months||1
67844|NCT02290925|164664|P2|COMPLETED|Second Period of 3 Months||65
67845|NCT02290925|164665|P1|COMPLETED|Second Period of 3 Months||57
67846|NCT02290925|164664|P2|STARTED|Second Period of 3 Months||69
67847|NCT02290925|164665|P1|STARTED|Second Period of 3 Months||58
67848|NCT02290925|164664|P2|NOT COMPLETED|First Period of Three Months||2
67849|NCT02290925|164665|P1|NOT COMPLETED|First Period of Three Months||4
67850|NCT02290925|164664|P2|COMPLETED|First Period of Three Months||69
67851|NCT02290925|164665|P1|COMPLETED|First Period of Three Months||58
67852|NCT02290925|164664|P2|STARTED|First Period of Three Months||71
67853|NCT02290925|164665|P1|STARTED|First Period of Three Months||62
67854|NCT02290873|164680|P3|NOT COMPLETED|Overall Study||2
67855|NCT02290873|164681|P2|NOT COMPLETED|Overall Study||1
67856|NCT02290873|164682|P1|NOT COMPLETED|Overall Study||2
67857|NCT02290873|164680|P3|COMPLETED|Overall Study||101
67858|NCT02290873|164681|P2|COMPLETED|Overall Study||59
67859|NCT02290873|164682|P1|COMPLETED|Overall Study||296
67860|NCT02290873|164680|P3|Safety Population|Overall Study||102
67861|NCT02290873|164681|P2|Safety Population|Overall Study||60
67862|NCT02290873|164682|P1|Safety Population|Overall Study||296
67863|NCT02290873|164680|P3|Modified Intention to Treat (mITT)|Overall Study||102
67864|NCT02290873|164681|P2|Modified Intention to Treat (mITT)|Overall Study||60
67865|NCT02290873|164682|P1|Modified Intention to Treat (mITT)|Overall Study||296
67866|NCT02290873|164680|P3|STARTED|Overall Study||103
67867|NCT02290873|164681|P2|STARTED|Overall Study||60
67868|NCT02290873|164682|P1|STARTED|Overall Study||298
67869|NCT02290821|164701|P2|NOT COMPLETED|Overall Study||3
67870|NCT02290821|164702|P1|NOT COMPLETED|Overall Study||6
67871|NCT02290821|164701|P2|COMPLETED|Overall Study||103
67872|NCT02290821|164702|P1|COMPLETED|Overall Study||103
67873|NCT02290821|164701|P2|STARTED|Overall Study||106
67874|NCT02290821|164702|P1|STARTED|Overall Study||109
67875|NCT02290691|164710|P2|NOT COMPLETED|Overall Study||9
67876|NCT02290691|164711|P1|NOT COMPLETED|Overall Study||8
67877|NCT02290691|164710|P2|COMPLETED|Overall Study||479
67878|NCT02290691|164711|P1|COMPLETED|Overall Study||488
67879|NCT02290691|164710|P2|STARTED|Overall Study||488
67880|NCT02290691|164711|P1|STARTED|Overall Study||496
67881|NCT02290574|164725|P1|NOT COMPLETED|Overall Study||1
67882|NCT02290574|164725|P1|COMPLETED|Overall Study||13
67883|NCT02290574|164725|P1|STARTED|Overall Study||14
67884|NCT02290509|164735|P2|NOT COMPLETED|Overall Study||14
67885|NCT02290509|164736|P1|NOT COMPLETED|Overall Study||49
67886|NCT02290509|164735|P2|COMPLETED|Overall Study||325
67887|NCT02290509|164736|P1|COMPLETED|Overall Study||962
67888|NCT02290509|164735|P2|STARTED|Overall Study||339
67889|NCT02290509|164736|P1|STARTED|Overall Study||1011
67890|NCT02290431|164748|P1|NOT COMPLETED|Overall Study||27
67891|NCT02290431|164748|P1|COMPLETED|Overall Study||4
67892|NCT02290431|164748|P1|Entered Treatment Phase 2|Overall Study||17
67893|NCT02290431|164748|P1|Subjects Entered Survival f/u Phase|Overall Study||24
67894|NCT02290431|164748|P1|Subjs. Ntered Post-treatment Eval. Phase|Overall Study||31
67895|NCT02290431|164748|P1|Subjects Completed Study Per Protocol|Overall Study||8
67896|NCT02290431|164748|P1|Subjects. Discont. Prematurely|Overall Study||27
67897|NCT02290431|164748|P1|STARTED|Overall Study||31
67898|NCT02290340|164771|P4|NOT COMPLETED|Overall Study||2
67899|NCT02290340|164772|P3|NOT COMPLETED|Overall Study||0
67900|NCT02290340|164773|P2|NOT COMPLETED|Overall Study||0
67901|NCT02290340|164774|P1|NOT COMPLETED|Overall Study||2
67902|NCT02290340|164771|P4|COMPLETED|Overall Study||30
67903|NCT02290340|164772|P3|COMPLETED|Overall Study||31
67904|NCT02290340|164773|P2|COMPLETED|Overall Study||8
67905|NCT02290340|164774|P1|COMPLETED|Overall Study||16
67906|NCT02290340|164771|P4|STARTED|Overall Study||32
67907|NCT02290340|164772|P3|STARTED|Overall Study||31
67908|NCT02290340|164773|P2|STARTED|Overall Study||8
67909|NCT02290340|164774|P1|STARTED|Overall Study||18
67910|NCT02290223|164819|P2|NOT COMPLETED|12 Months||11
67911|NCT02290223|164820|P1|NOT COMPLETED|12 Months||16
67912|NCT02290223|164819|P2|COMPLETED|12 Months||176
67913|NCT02290223|164820|P1|COMPLETED|12 Months||166
67914|NCT02290223|164819|P2|STARTED|12 Months|All participants were contacted at 12 mo, unless deceased or withdrawn (n=0).|187
67915|NCT02290223|164820|P1|STARTED|12 Months|All participants were contacted at 12 mo, unless deceased or withdrawn (n=7).|182
67916|NCT02290223|164819|P2|NOT COMPLETED|6 Months||6
67917|NCT02290223|164820|P1|NOT COMPLETED|6 Months||16
67918|NCT02290223|164819|P2|COMPLETED|6 Months||181
67919|NCT02290223|164820|P1|COMPLETED|6 Months||173
67920|NCT02290223|164819|P2|STARTED|6 Months||187
67921|NCT02290223|164820|P1|STARTED|6 Months||189
67922|NCT02290223|164819|P2|NOT COMPLETED|Baseline||0
67923|NCT02290223|164820|P1|NOT COMPLETED|Baseline||0
67924|NCT02290223|164819|P2|COMPLETED|Baseline||187
67925|NCT02290223|164820|P1|COMPLETED|Baseline||189
67926|NCT02290223|164819|P2|STARTED|Baseline||187
67927|NCT02290223|164820|P1|STARTED|Baseline||189
67928|NCT02290184|164880|P2|NOT COMPLETED|Overall Study||0
67929|NCT02290184|164881|P1|NOT COMPLETED|Overall Study||0
67930|NCT02290184|164880|P2|COMPLETED|Overall Study|6-month follow up visit - completed 3-month intervention and competed study|23
67931|NCT02290184|164881|P1|COMPLETED|Overall Study|6-month follow-up visit - completed the 3-month maintenance phase and completed study|22
67932|NCT02290184|164880|P2|3-month Follow-up|Overall Study|Completed initial 3-month control period and transition to receive the 3-month intervention|23
67933|NCT02290184|164881|P1|3-month Follow-up|Overall Study|Completed initial 3-month intervention and now transition to a 3-month maintenance phase|22
67934|NCT02290184|164880|P2|STARTED|Overall Study||23
67935|NCT02290184|164881|P1|STARTED|Overall Study||22
67936|NCT02290106|164895|P2|NOT COMPLETED|Overall Study||2
67937|NCT02290106|164896|P1|NOT COMPLETED|Overall Study||1
67938|NCT02290106|164895|P2|COMPLETED|Overall Study||23
67939|NCT02290106|164896|P1|COMPLETED|Overall Study||24
67940|NCT02290106|164895|P2|STARTED|Overall Study||25
67941|NCT02290106|164896|P1|STARTED|Overall Study||25
67942|NCT02289989|164916|P2|NOT COMPLETED|Overall Study||0
67943|NCT02289989|164917|P1|NOT COMPLETED|Overall Study||0
67944|NCT02289989|164916|P2|COMPLETED|Overall Study||1
67945|NCT02289989|164917|P1|COMPLETED|Overall Study||0
67946|NCT02289989|164916|P2|STARTED|Overall Study||1
67947|NCT02289989|164917|P1|STARTED|Overall Study||0
67948|NCT02289963|164935|P2|NOT COMPLETED|Overall Study||10
67949|NCT02289963|164936|P1|NOT COMPLETED|Overall Study||5
67950|NCT02289963|164935|P2|COMPLETED|Overall Study||87
67951|NCT02289963|164936|P1|COMPLETED|Overall Study||97
67952|NCT02289963|164935|P2|Treated|Overall Study||97
67953|NCT02289963|164936|P1|Treated|Overall Study||102
67954|NCT02289963|164935|P2|STARTED|Overall Study|Randomized|97
67955|NCT02289963|164936|P1|STARTED|Overall Study|Randomized|102
67956|NCT02289898|164987|P3|NOT COMPLETED|Overall Study||56
67957|NCT02289898|164988|P2|NOT COMPLETED|Overall Study||53
67958|NCT02289898|164989|P1|NOT COMPLETED|Overall Study||52
67959|NCT02289898|164987|P3|COMPLETED|Overall Study||9
67960|NCT02289898|164988|P2|COMPLETED|Overall Study||18
67961|NCT02289898|164989|P1|COMPLETED|Overall Study||16
67962|NCT02289898|164987|P3|STARTED|Overall Study||65
67963|NCT02289898|164988|P2|STARTED|Overall Study||71
67964|NCT02289898|164989|P1|STARTED|Overall Study||68
67965|NCT02289833|164998|P2|NOT COMPLETED|Overall Study||17
67966|NCT02289833|164999|P1|NOT COMPLETED|Overall Study||27
67967|NCT02289833|164998|P2|COMPLETED|Overall Study||3
67968|NCT02289833|164999|P1|COMPLETED|Overall Study||2
67969|NCT02289833|164998|P2|STARTED|Overall Study||20
67970|NCT02289833|164999|P1|STARTED|Overall Study||29
67971|NCT02289820|165035|P7|NOT COMPLETED|Overall Study||2
67972|NCT02289820|165036|P6|NOT COMPLETED|Overall Study||1
67973|NCT02289820|165037|P5|NOT COMPLETED|Overall Study||0
67974|NCT02289820|165038|P4|NOT COMPLETED|Overall Study||2
67975|NCT02289820|165039|P3|NOT COMPLETED|Overall Study||6
67976|NCT02289820|165040|P2|NOT COMPLETED|Overall Study||2
67977|NCT02289820|165041|P1|NOT COMPLETED|Overall Study||2
67978|NCT02289820|165035|P7|COMPLETED|Overall Study||37
67979|NCT02289820|165036|P6|COMPLETED|Overall Study||39
67980|NCT02289820|165037|P5|COMPLETED|Overall Study||40
67981|NCT02289820|165038|P4|COMPLETED|Overall Study||37
67982|NCT02289820|165039|P3|COMPLETED|Overall Study||38
67983|NCT02289820|165040|P2|COMPLETED|Overall Study||18
67984|NCT02289820|165041|P1|COMPLETED|Overall Study||37
67985|NCT02289820|165035|P7|STARTED|Overall Study||39
67986|NCT02289820|165036|P6|STARTED|Overall Study||40
67987|NCT02289820|165037|P5|STARTED|Overall Study||40
67988|NCT02289820|165038|P4|STARTED|Overall Study||39
67989|NCT02289820|165039|P3|STARTED|Overall Study||44
67990|NCT02289820|165040|P2|STARTED|Overall Study||20
67991|NCT02289820|165041|P1|STARTED|Overall Study||39
67992|NCT02289755|165152|P1|NOT COMPLETED|Follow up Period [4 Days]||0
67993|NCT02289755|165152|P1|COMPLETED|Follow up Period [4 Days]||16
67994|NCT02289755|165152|P1|STARTED|Follow up Period [4 Days]||16
67995|NCT02289755|165152|P1|NOT COMPLETED|ALLN-177 Treatment Period [4 Days]||0
67996|NCT02289755|165152|P1|COMPLETED|ALLN-177 Treatment Period [4 Days]||16
67997|NCT02289755|165152|P1|STARTED|ALLN-177 Treatment Period [4 Days]||16
67998|NCT02289755|165152|P1|NOT COMPLETED|Baseline Period [No Treatment, 3 Days]||0
67999|NCT02289755|165152|P1|COMPLETED|Baseline Period [No Treatment, 3 Days]||16
68000|NCT02289755|165152|P1|STARTED|Baseline Period [No Treatment, 3 Days]||16
68001|NCT02289742|165159|P4|NOT COMPLETED|Third Wear Period||1
68002|NCT02289742|165160|P3|NOT COMPLETED|Third Wear Period||0
68003|NCT02289742|165161|P2|NOT COMPLETED|Third Wear Period||1
68004|NCT02289742|165162|P1|NOT COMPLETED|Third Wear Period||0
68005|NCT02289742|165159|P4|COMPLETED|Third Wear Period||8
68006|NCT02289742|165160|P3|COMPLETED|Third Wear Period||11
68007|NCT02289742|165161|P2|COMPLETED|Third Wear Period||10
68008|NCT02289742|165162|P1|COMPLETED|Third Wear Period||11
68009|NCT02289742|165159|P4|STARTED|Third Wear Period||9
68010|NCT02289742|165160|P3|STARTED|Third Wear Period||11
68011|NCT02289742|165161|P2|STARTED|Third Wear Period||11
68012|NCT02289742|165162|P1|STARTED|Third Wear Period||11
68013|NCT02289742|165159|P4|NOT COMPLETED|Second Wear Period||0
68014|NCT02289742|165160|P3|NOT COMPLETED|Second Wear Period||0
68015|NCT02289742|165161|P2|NOT COMPLETED|Second Wear Period||0
68016|NCT02289742|165162|P1|NOT COMPLETED|Second Wear Period||0
68017|NCT02289742|165159|P4|COMPLETED|Second Wear Period||9
68018|NCT02289742|165160|P3|COMPLETED|Second Wear Period||11
68019|NCT02289742|165161|P2|COMPLETED|Second Wear Period||11
68020|NCT02289742|165162|P1|COMPLETED|Second Wear Period||11
68021|NCT02289742|165159|P4|STARTED|Second Wear Period||9
68022|NCT02289742|165160|P3|STARTED|Second Wear Period||11
68023|NCT02289742|165161|P2|STARTED|Second Wear Period||11
68024|NCT02289742|165162|P1|STARTED|Second Wear Period||11
68025|NCT02289742|165159|P4|NOT COMPLETED|First Wear Period||1
68026|NCT02289742|165160|P3|NOT COMPLETED|First Wear Period||1
68027|NCT02289742|165161|P2|NOT COMPLETED|First Wear Period||1
68028|NCT02289742|165162|P1|NOT COMPLETED|First Wear Period||0
68029|NCT02289742|165159|P4|COMPLETED|First Wear Period||9
68030|NCT02289742|165160|P3|COMPLETED|First Wear Period||11
68031|NCT02289742|165161|P2|COMPLETED|First Wear Period||11
68032|NCT02289742|165162|P1|COMPLETED|First Wear Period||11
68033|NCT02289742|165159|P4|Treated|First Wear Period||9
68034|NCT02289742|165160|P3|Treated|First Wear Period||12
68035|NCT02289742|165161|P2|Treated|First Wear Period||11
68036|NCT02289742|165162|P1|Treated|First Wear Period||11
68037|NCT02289742|165159|P4|STARTED|First Wear Period||10
68038|NCT02289742|165160|P3|STARTED|First Wear Period||12
68039|NCT02289742|165161|P2|STARTED|First Wear Period||12
68040|NCT02289742|165162|P1|STARTED|First Wear Period||11
68041|NCT02289729|165179|P1|NOT COMPLETED|Overall Study||6
68042|NCT02289729|165179|P1|COMPLETED|Overall Study||53
68043|NCT02289729|165179|P1|STARTED|Overall Study||59
68044|NCT02289469|165235|P2|NOT COMPLETED|Overall Study||0
68045|NCT02289469|165236|P1|NOT COMPLETED|Overall Study||6
68046|NCT02289469|165235|P2|COMPLETED|Overall Study||244
68047|NCT02289469|165236|P1|COMPLETED|Overall Study||244
68048|NCT02289469|165235|P2|STARTED|Overall Study||244
68049|NCT02289469|165236|P1|STARTED|Overall Study||250
68050|NCT02289456|165244|P1|NOT COMPLETED|Monotherapy Period||16
68051|NCT02289456|165244|P1|COMPLETED|Monotherapy Period||0
68052|NCT02289456|165244|P1|STARTED|Monotherapy Period||16
68053|NCT02289456|165244|P1|NOT COMPLETED|Induction Period||24
68054|NCT02289456|165244|P1|COMPLETED|Induction Period||16
68055|NCT02289456|165244|P1|Treated Population|Induction Period||40
68056|NCT02289456|165244|P1|STARTED|Induction Period||40
68057|NCT02289417|165267|P3|NOT COMPLETED|Overall Study||3
68058|NCT02289417|165268|P2|NOT COMPLETED|Overall Study||4
68059|NCT02289417|165269|P1|NOT COMPLETED|Overall Study||7
68060|NCT02289417|165267|P3|COMPLETED|Overall Study||52
68061|NCT02289417|165268|P2|COMPLETED|Overall Study||53
68062|NCT02289417|165269|P1|COMPLETED|Overall Study||51
68063|NCT02289417|165267|P3|STARTED|Overall Study||55
68064|NCT02289417|165268|P2|STARTED|Overall Study||57
68065|NCT02289417|165269|P1|STARTED|Overall Study||58
68066|NCT02289222|165307|P1|NOT COMPLETED|Overall Study||0
68067|NCT02289222|165307|P1|COMPLETED|Overall Study||48
68068|NCT02289222|165307|P1|STARTED|Overall Study||48
68069|NCT02289157|165315|P2|NOT COMPLETED|Overall Study||0
68070|NCT02289157|165316|P1|NOT COMPLETED|Overall Study||0
68071|NCT02289157|165315|P2|COMPLETED|Overall Study||219
68072|NCT02289157|165316|P1|COMPLETED|Overall Study||222
68073|NCT02289157|165315|P2|No Post op Check or Follow up Phone Call|Overall Study||4
68074|NCT02289157|165316|P1|No Post op Check or Follow up Phone Call|Overall Study||2
68075|NCT02289157|165315|P2|STARTED|Overall Study||219
68076|NCT02289157|165316|P1|STARTED|Overall Study||222
68077|NCT02289105|165350|P2|NOT COMPLETED|Overall Study||0
68078|NCT02289105|165351|P1|NOT COMPLETED|Overall Study||0
68079|NCT02289105|165350|P2|COMPLETED|Overall Study||637
68080|NCT02289105|165351|P1|COMPLETED|Overall Study||642
68081|NCT02289105|165350|P2|STARTED|Overall Study||637
68082|NCT02289105|165351|P1|STARTED|Overall Study||642
68083|NCT02289079|165363|P2|NOT COMPLETED|Overall Study||1
68084|NCT02289079|165364|P1|NOT COMPLETED|Overall Study||2
68085|NCT02289079|165363|P2|COMPLETED|Overall Study||29
68086|NCT02289079|165364|P1|COMPLETED|Overall Study||28
68087|NCT02289079|165363|P2|STARTED|Overall Study||30
68088|NCT02289079|165364|P1|STARTED|Overall Study||30
68089|NCT02288819|165376|P1|NOT COMPLETED|Overall Study||0
68090|NCT02288819|165376|P1|COMPLETED|Overall Study||50
68091|NCT02288819|165376|P1|STARTED|Overall Study||50
68092|NCT02288559|165393|P4|NOT COMPLETED|Overall Study||2
68093|NCT02288559|165394|P3|NOT COMPLETED|Overall Study||11
68094|NCT02288559|165395|P2|NOT COMPLETED|Overall Study||1
68095|NCT02288559|165396|P1|NOT COMPLETED|Overall Study||1
68096|NCT02288559|165393|P4|COMPLETED|Overall Study||20
68097|NCT02288559|165394|P3|COMPLETED|Overall Study||35
68098|NCT02288559|165395|P2|COMPLETED|Overall Study||10
68099|NCT02288559|165396|P1|COMPLETED|Overall Study||9
68100|NCT02288559|165393|P4|STARTED|Overall Study||22
68101|NCT02288559|165394|P3|STARTED|Overall Study||46
68102|NCT02288559|165395|P2|STARTED|Overall Study||11
68103|NCT02288559|165396|P1|STARTED|Overall Study||10
68104|NCT02288364|165422|P2|NOT COMPLETED|Overall Study||0
68105|NCT02288364|165423|P1|NOT COMPLETED|Overall Study||0
68106|NCT02288364|165422|P2|COMPLETED|Overall Study||44
68107|NCT02288364|165423|P1|COMPLETED|Overall Study||42
68108|NCT02288364|165422|P2|STARTED|Overall Study||44
68109|NCT02288364|165423|P1|STARTED|Overall Study||42
68110|NCT02288325|165447|P3|NOT COMPLETED|Double-blind Treatment Period||26
68111|NCT02288325|165448|P2|NOT COMPLETED|Double-blind Treatment Period||24
68112|NCT02288325|165449|P1|NOT COMPLETED|Double-blind Treatment Period||0
68113|NCT02288325|165447|P3|COMPLETED|Double-blind Treatment Period||139
68114|NCT02288325|165448|P2|COMPLETED|Double-blind Treatment Period||135
68115|NCT02288325|165449|P1|COMPLETED|Double-blind Treatment Period||0
68116|NCT02288325|165447|P3|STARTED|Double-blind Treatment Period|7 participants did not enter Double-Blind Period (2 did not meet entry criteria; 5 other reasons)|165
68208|NCT02287779|165658|P8|COMPLETED|Overall Study||9
68117|NCT02288325|165448|P2|STARTED|Double-blind Treatment Period|7 participants did not enter Double-Blind Period (2 did not meet entry criteria; 5 other reasons)|159
68118|NCT02288325|165449|P1|STARTED|Double-blind Treatment Period||0
68119|NCT02288325|165447|P3|NOT COMPLETED|Stabilization Period||0
68120|NCT02288325|165448|P2|NOT COMPLETED|Stabilization Period||0
68121|NCT02288325|165449|P1|NOT COMPLETED|Stabilization Period||98
68122|NCT02288325|165447|P3|COMPLETED|Stabilization Period||0
68123|NCT02288325|165448|P2|COMPLETED|Stabilization Period||0
68124|NCT02288325|165449|P1|COMPLETED|Stabilization Period||331
68125|NCT02288325|165447|P3|STARTED|Stabilization Period||0
68126|NCT02288325|165448|P2|STARTED|Stabilization Period||0
68127|NCT02288325|165449|P1|STARTED|Stabilization Period|70 participants did not enter Stabilization Period (69 did not meet entry criteria; 1 other reason)|429
68128|NCT02288325|165447|P3|NOT COMPLETED|Run-in Period||0
68129|NCT02288325|165448|P2|NOT COMPLETED|Run-in Period||0
68130|NCT02288325|165449|P1|NOT COMPLETED|Run-in Period||145
68131|NCT02288325|165447|P3|COMPLETED|Run-in Period||0
68132|NCT02288325|165448|P2|COMPLETED|Run-in Period||0
68133|NCT02288325|165449|P1|COMPLETED|Run-in Period||499
68134|NCT02288325|165447|P3|STARTED|Run-in Period||0
68135|NCT02288325|165448|P2|STARTED|Run-in Period||0
68136|NCT02288325|165449|P1|STARTED|Run-in Period||644
68137|NCT02288312|165459|P3|NOT COMPLETED|Overall Study||0
68138|NCT02288312|165460|P2|NOT COMPLETED|Overall Study||0
68139|NCT02288312|165461|P1|NOT COMPLETED|Overall Study||1
68140|NCT02288312|165459|P3|COMPLETED|Overall Study||6
68141|NCT02288312|165460|P2|COMPLETED|Overall Study||6
68142|NCT02288312|165461|P1|COMPLETED|Overall Study||5
68143|NCT02288312|165459|P3|STARTED|Overall Study||6
68144|NCT02288312|165460|P2|STARTED|Overall Study||6
68145|NCT02288312|165461|P1|STARTED|Overall Study||6
68146|NCT02288273|165480|P2|NOT COMPLETED|Overall Study||8
68147|NCT02288273|165481|P1|NOT COMPLETED|Overall Study||8
68148|NCT02288273|165480|P2|COMPLETED|Overall Study||48
68149|NCT02288273|165481|P1|COMPLETED|Overall Study||53
68150|NCT02288273|165480|P2|STARTED|Overall Study||56
68151|NCT02288273|165481|P1|STARTED|Overall Study||61
68152|NCT02288182|165501|P2|NOT COMPLETED|Overall Study||2
68153|NCT02288182|165502|P1|NOT COMPLETED|Overall Study||0
68154|NCT02288182|165501|P2|COMPLETED|Overall Study||25
68155|NCT02288182|165502|P1|COMPLETED|Overall Study||25
68156|NCT02288182|165501|P2|STARTED|Overall Study||27
68157|NCT02288182|165502|P1|STARTED|Overall Study||25
68158|NCT02288091|165514|P1|NOT COMPLETED|Overall Study||8
68159|NCT02288091|165514|P1|COMPLETED|Overall Study||24
68160|NCT02288091|165514|P1|Randomized/Treated|Overall Study||25
68161|NCT02288091|165514|P1|STARTED|Overall Study||32
68162|NCT02287922|165526|P4|NOT COMPLETED|Overall Study||7
68163|NCT02287922|165527|P3|NOT COMPLETED|Overall Study||7
68164|NCT02287922|165528|P2|NOT COMPLETED|Overall Study||2
68165|NCT02287922|165529|P1|NOT COMPLETED|Overall Study||3
68166|NCT02287922|165526|P4|COMPLETED|Overall Study||57
68167|NCT02287922|165527|P3|COMPLETED|Overall Study||56
68168|NCT02287922|165528|P2|COMPLETED|Overall Study||60
68169|NCT02287922|165529|P1|COMPLETED|Overall Study||59
68170|NCT02287922|165526|P4|STARTED|Overall Study||64
68171|NCT02287922|165527|P3|STARTED|Overall Study||63
68172|NCT02287922|165528|P2|STARTED|Overall Study||62
68173|NCT02287922|165529|P1|STARTED|Overall Study||62
68174|NCT02287896|165620|P2|NOT COMPLETED|Second Injection Visit||1
68175|NCT02287896|165621|P1|NOT COMPLETED|Second Injection Visit||0
68176|NCT02287896|165620|P2|COMPLETED|Second Injection Visit||25
68177|NCT02287896|165621|P1|COMPLETED|Second Injection Visit||36
68178|NCT02287896|165620|P2|STARTED|Second Injection Visit||26
68179|NCT02287896|165621|P1|STARTED|Second Injection Visit||36
68180|NCT02287896|165620|P2|NOT COMPLETED|First Injection Visit||0
68181|NCT02287896|165621|P1|NOT COMPLETED|First Injection Visit||0
68182|NCT02287896|165620|P2|COMPLETED|First Injection Visit||26
68183|NCT02287896|165621|P1|COMPLETED|First Injection Visit||36
68184|NCT02287896|165620|P2|STARTED|First Injection Visit||26
68185|NCT02287896|165621|P1|STARTED|First Injection Visit||36
68186|NCT02287896|165620|P2|NOT COMPLETED|Screening Visit V1||0
68187|NCT02287896|165621|P1|NOT COMPLETED|Screening Visit V1||0
68188|NCT02287896|165620|P2|COMPLETED|Screening Visit V1||26
68189|NCT02287896|165621|P1|COMPLETED|Screening Visit V1||36
68190|NCT02287896|165620|P2|STARTED|Screening Visit V1||26
68191|NCT02287896|165621|P1|STARTED|Screening Visit V1||36
68192|NCT02287883|165639|P2|NOT COMPLETED|Overall Study||426
68193|NCT02287883|165640|P1|NOT COMPLETED|Overall Study||459
68194|NCT02287883|165639|P2|COMPLETED|Overall Study||669
68195|NCT02287883|165640|P1|COMPLETED|Overall Study||622
68196|NCT02287883|165639|P2|One-year Follow-up Survey|Overall Study||669
68197|NCT02287883|165640|P1|One-year Follow-up Survey|Overall Study||622
68198|NCT02287883|165639|P2|STARTED|Overall Study||1095
68199|NCT02287883|165640|P1|STARTED|Overall Study||1081
68200|NCT02287779|165658|P8|NOT COMPLETED|Overall Study||0
68201|NCT02287779|165659|P7|NOT COMPLETED|Overall Study||0
68202|NCT02287779|165660|P6|NOT COMPLETED|Overall Study||0
68203|NCT02287779|165661|P5|NOT COMPLETED|Overall Study||0
68204|NCT02287779|165662|P4|NOT COMPLETED|Overall Study||0
68205|NCT02287779|165663|P3|NOT COMPLETED|Overall Study||0
68206|NCT02287779|165664|P2|NOT COMPLETED|Overall Study||0
68207|NCT02287779|165665|P1|NOT COMPLETED|Overall Study||0
68209|NCT02287779|165659|P7|COMPLETED|Overall Study||9
68210|NCT02287779|165660|P6|COMPLETED|Overall Study||9
68211|NCT02287779|165661|P5|COMPLETED|Overall Study||9
68212|NCT02287779|165662|P4|COMPLETED|Overall Study||9
68213|NCT02287779|165663|P3|COMPLETED|Overall Study||9
68214|NCT02287779|165664|P2|COMPLETED|Overall Study||9
68215|NCT02287779|165665|P1|COMPLETED|Overall Study||21
68216|NCT02287779|165658|P8|STARTED|Overall Study||9
68217|NCT02287779|165659|P7|STARTED|Overall Study||9
68218|NCT02287779|165660|P6|STARTED|Overall Study||9
68219|NCT02287779|165661|P5|STARTED|Overall Study||9
68220|NCT02287779|165662|P4|STARTED|Overall Study||9
68221|NCT02287779|165663|P3|STARTED|Overall Study||9
68222|NCT02287779|165664|P2|STARTED|Overall Study||9
68223|NCT02287779|165665|P1|STARTED|Overall Study||21
68224|NCT02287688|165803|P1|NOT COMPLETED|Overall Study||0
68225|NCT02287688|165803|P1|COMPLETED|Overall Study||138
68226|NCT02287688|165803|P1|STARTED|Overall Study||138
68227|NCT02287675|165814|P2|NOT COMPLETED|Overall Study||0
68228|NCT02287675|165815|P1|NOT COMPLETED|Overall Study||0
68229|NCT02287675|165814|P2|COMPLETED|Overall Study||18
68230|NCT02287675|165815|P1|COMPLETED|Overall Study||22
68231|NCT02287675|165814|P2|STARTED|Overall Study||18
68232|NCT02287675|165815|P1|STARTED|Overall Study||22
68233|NCT02287623|165833|P2|NOT COMPLETED|Overall Study||1
68234|NCT02287623|165834|P1|NOT COMPLETED|Overall Study||0
68235|NCT02287623|165833|P2|COMPLETED|Overall Study||29
68236|NCT02287623|165834|P1|COMPLETED|Overall Study||30
68237|NCT02287623|165833|P2|STARTED|Overall Study||30
68238|NCT02287623|165834|P1|STARTED|Overall Study||30
68239|NCT02287610|165850|P1|NOT COMPLETED|Overall Study||16
68240|NCT02287610|165850|P1|COMPLETED|Overall Study||48
68241|NCT02287610|165850|P1|Per Protocol Follow-Up|Overall Study||56
68242|NCT02287610|165850|P1|STARTED|Overall Study||64
68243|NCT02287467|165885|P2|NOT COMPLETED|Overall Study||9
68244|NCT02287467|165886|P1|NOT COMPLETED|Overall Study||12
68245|NCT02287467|165885|P2|COMPLETED|Overall Study||152
68246|NCT02287467|165886|P1|COMPLETED|Overall Study||156
68247|NCT02287467|165885|P2|STARTED|Overall Study||161
68248|NCT02287467|165886|P1|STARTED|Overall Study||168
68249|NCT02287415|165928|P1|NOT COMPLETED|Overall Study||0
68250|NCT02287415|165928|P1|COMPLETED|Overall Study||13
68251|NCT02287415|165928|P1|STARTED|Overall Study||13
68252|NCT02287402|165934|P1|NOT COMPLETED|Follow-up||3
68253|NCT02287402|165934|P1|COMPLETED|Follow-up||103
68254|NCT02287402|165934|P1|STARTED|Follow-up|64 participants who completed the Treatment Period did not continue to Follow-up.|106
68255|NCT02287402|165934|P1|NOT COMPLETED|Treatment Period||27
68256|NCT02287402|165934|P1|COMPLETED|Treatment Period||170
68257|NCT02287402|165934|P1|STARTED|Treatment Period||197
68258|NCT02287376|165949|P1|NOT COMPLETED|Overall Study||0
68259|NCT02287376|165949|P1|COMPLETED|Overall Study||25
68260|NCT02287376|165949|P1|STARTED|Overall Study||25
68261|NCT02287350|165992|P1|NOT COMPLETED|Overall Study||3
68262|NCT02287350|165992|P1|COMPLETED|Overall Study||48
68263|NCT02287350|165992|P1|STARTED|Overall Study||51
68264|NCT02287038|166039|P2|NOT COMPLETED|Overall Study||3
68265|NCT02287038|166040|P1|NOT COMPLETED|Overall Study||5
68266|NCT02287038|166039|P2|COMPLETED|Overall Study||18
68267|NCT02287038|166040|P1|COMPLETED|Overall Study||18
68268|NCT02287038|166039|P2|STARTED|Overall Study||21
68269|NCT02287038|166040|P1|STARTED|Overall Study||23
68270|NCT02287025|166050|P2|NOT COMPLETED|Overall Study||9
68271|NCT02287025|166051|P1|NOT COMPLETED|Overall Study||10
68272|NCT02287025|166050|P2|COMPLETED|Overall Study||2
68273|NCT02287025|166051|P1|COMPLETED|Overall Study||2
68274|NCT02287025|166050|P2|STARTED|Overall Study||11
68275|NCT02287025|166051|P1|STARTED|Overall Study||12
68276|NCT02286947|166060|P1|NOT COMPLETED|Overall Study||2
68277|NCT02286947|166060|P1|COMPLETED|Overall Study||22
68278|NCT02286947|166060|P1|STARTED|Overall Study||24
68279|NCT02286921|166071|P2|NOT COMPLETED|Overall Study||0
68280|NCT02286921|166072|P1|NOT COMPLETED|Overall Study||0
68281|NCT02286921|166071|P2|COMPLETED|Overall Study||101
68282|NCT02286921|166072|P1|COMPLETED|Overall Study||94
68283|NCT02286921|166071|P2|STARTED|Overall Study||101
68284|NCT02286921|166072|P1|STARTED|Overall Study||94
68285|NCT02286895|166102|P2|NOT COMPLETED|Assessed for Measles Seroconversion||39
68286|NCT02286895|166103|P1|NOT COMPLETED|Assessed for Measles Seroconversion||48
68287|NCT02286895|166102|P2|COMPLETED|Assessed for Measles Seroconversion||261
68288|NCT02286895|166103|P1|COMPLETED|Assessed for Measles Seroconversion||252
68289|NCT02286895|166102|P2|STARTED|Assessed for Measles Seroconversion||300
68290|NCT02286895|166103|P1|STARTED|Assessed for Measles Seroconversion||300
68291|NCT02286895|166102|P2|NOT COMPLETED|Randomized and Vaccinated||0
68292|NCT02286895|166103|P1|NOT COMPLETED|Randomized and Vaccinated||0
68293|NCT02286895|166102|P2|COMPLETED|Randomized and Vaccinated||300
68294|NCT02286895|166103|P1|COMPLETED|Randomized and Vaccinated||300
68295|NCT02286895|166102|P2|STARTED|Randomized and Vaccinated||300
68296|NCT02286895|166103|P1|STARTED|Randomized and Vaccinated||300
68297|NCT02286713|166147|P2|NOT COMPLETED|Six Month Follow-Up||27
68298|NCT02286713|166148|P1|NOT COMPLETED|Six Month Follow-Up||32
68299|NCT02286713|166147|P2|COMPLETED|Six Month Follow-Up||225
68300|NCT02286713|166148|P1|COMPLETED|Six Month Follow-Up||218
68301|NCT02286713|166147|P2|STARTED|Six Month Follow-Up||252
68302|NCT02286713|166148|P1|STARTED|Six Month Follow-Up||250
68303|NCT02286713|166147|P2|NOT COMPLETED|Three Month Follow-Up||26
68304|NCT02286713|166148|P1|NOT COMPLETED|Three Month Follow-Up||28
68305|NCT02286713|166147|P2|COMPLETED|Three Month Follow-Up||228
68306|NCT02286713|166148|P1|COMPLETED|Three Month Follow-Up||224
68307|NCT02286713|166147|P2|STARTED|Three Month Follow-Up||254
68308|NCT02286713|166148|P1|STARTED|Three Month Follow-Up||252
68309|NCT02286713|166147|P2|NOT COMPLETED|One Week Follow-Up||24
68310|NCT02286713|166148|P1|NOT COMPLETED|One Week Follow-Up||24
68311|NCT02286713|166147|P2|COMPLETED|One Week Follow-Up||233
68312|NCT02286713|166148|P1|COMPLETED|One Week Follow-Up||235
68313|NCT02286713|166147|P2|STARTED|One Week Follow-Up||257
68314|NCT02286713|166148|P1|STARTED|One Week Follow-Up||259
68315|NCT02286518|166174|P14|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
68316|NCT02286518|166175|P13|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
68317|NCT02286518|166176|P12|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
68318|NCT02286518|166177|P11|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
68319|NCT02286518|166178|P10|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
68320|NCT02286518|166179|P9|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
68321|NCT02286518|166180|P8|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
68322|NCT02286518|166181|P7|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
68323|NCT02286518|166182|P6|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
68324|NCT02286518|166183|P5|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
68325|NCT02286518|166184|P4|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
68326|NCT02286518|166185|P3|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
68327|NCT02286518|166186|P2|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
68328|NCT02286518|166187|P1|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
68329|NCT02286518|166174|P14|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
68330|NCT02286518|166175|P13|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
68331|NCT02286518|166176|P12|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
68332|NCT02286518|166177|P11|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
68333|NCT02286518|166178|P10|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
68334|NCT02286518|166179|P9|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
68335|NCT02286518|166180|P8|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
68336|NCT02286518|166181|P7|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
68337|NCT02286518|166182|P6|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
68338|NCT02286518|166183|P5|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
68339|NCT02286518|166184|P4|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
68340|NCT02286518|166185|P3|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
68341|NCT02286518|166186|P2|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
68342|NCT02286518|166187|P1|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
68343|NCT02286518|166174|P14|STARTED|Crossover Treatment (Part 2: 3 Days)||0
68344|NCT02286518|166175|P13|STARTED|Crossover Treatment (Part 2: 3 Days)||0
68345|NCT02286518|166176|P12|STARTED|Crossover Treatment (Part 2: 3 Days)||0
68346|NCT02286518|166177|P11|STARTED|Crossover Treatment (Part 2: 3 Days)||0
68347|NCT02286518|166178|P10|STARTED|Crossover Treatment (Part 2: 3 Days)||0
68348|NCT02286518|166179|P9|STARTED|Crossover Treatment (Part 2: 3 Days)||6
68349|NCT02286518|166180|P8|STARTED|Crossover Treatment (Part 2: 3 Days)||6
68350|NCT02286518|166181|P7|STARTED|Crossover Treatment (Part 2: 3 Days)||0
68351|NCT02286518|166182|P6|STARTED|Crossover Treatment (Part 2: 3 Days)||0
68352|NCT02286518|166183|P5|STARTED|Crossover Treatment (Part 2: 3 Days)||0
68353|NCT02286518|166184|P4|STARTED|Crossover Treatment (Part 2: 3 Days)||0
68354|NCT02286518|166185|P3|STARTED|Crossover Treatment (Part 2: 3 Days)||0
68355|NCT02286518|166186|P2|STARTED|Crossover Treatment (Part 2: 3 Days)||0
68356|NCT02286518|166187|P1|STARTED|Crossover Treatment (Part 2: 3 Days)||0
68357|NCT02286518|166174|P14|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
68358|NCT02286518|166175|P13|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
68359|NCT02286518|166176|P12|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
68360|NCT02286518|166177|P11|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
68361|NCT02286518|166178|P10|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
68362|NCT02286518|166179|P9|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
68363|NCT02286518|166180|P8|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
68364|NCT02286518|166181|P7|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
68365|NCT02286518|166182|P6|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
68366|NCT02286518|166183|P5|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
68367|NCT02286518|166184|P4|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
68368|NCT02286518|166185|P3|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
68369|NCT02286518|166186|P2|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
68370|NCT02286518|166187|P1|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
68371|NCT02286518|166174|P14|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
68372|NCT02286518|166175|P13|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
68373|NCT02286518|166176|P12|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
68374|NCT02286518|166177|P11|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
68375|NCT02286518|166178|P10|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
68376|NCT02286518|166179|P9|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
68377|NCT02286518|166180|P8|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
68378|NCT02286518|166181|P7|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
68379|NCT02286518|166182|P6|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
68380|NCT02286518|166183|P5|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
68381|NCT02286518|166184|P4|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
68382|NCT02286518|166185|P3|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
68383|NCT02286518|166186|P2|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
68384|NCT02286518|166187|P1|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
68385|NCT02286518|166174|P14|STARTED|Washout Crossover Period(Part 2:14 Days)||0
68386|NCT02286518|166175|P13|STARTED|Washout Crossover Period(Part 2:14 Days)||0
68387|NCT02286518|166176|P12|STARTED|Washout Crossover Period(Part 2:14 Days)||0
68388|NCT02286518|166177|P11|STARTED|Washout Crossover Period(Part 2:14 Days)||0
68389|NCT02286518|166178|P10|STARTED|Washout Crossover Period(Part 2:14 Days)||0
68390|NCT02286518|166179|P9|STARTED|Washout Crossover Period(Part 2:14 Days)||6
68391|NCT02286518|166180|P8|STARTED|Washout Crossover Period(Part 2:14 Days)||6
68392|NCT02286518|166181|P7|STARTED|Washout Crossover Period(Part 2:14 Days)||0
68393|NCT02286518|166182|P6|STARTED|Washout Crossover Period(Part 2:14 Days)||0
68394|NCT02286518|166183|P5|STARTED|Washout Crossover Period(Part 2:14 Days)||0
68395|NCT02286518|166184|P4|STARTED|Washout Crossover Period(Part 2:14 Days)||0
68396|NCT02286518|166185|P3|STARTED|Washout Crossover Period(Part 2:14 Days)||0
68397|NCT02286518|166186|P2|STARTED|Washout Crossover Period(Part 2:14 Days)||0
68398|NCT02286518|166187|P1|STARTED|Washout Crossover Period(Part 2:14 Days)||0
68399|NCT02286518|166174|P14|NOT COMPLETED|All Parts (16 Days)||0
68400|NCT02286518|166175|P13|NOT COMPLETED|All Parts (16 Days)||0
68401|NCT02286518|166176|P12|NOT COMPLETED|All Parts (16 Days)||0
68402|NCT02286518|166177|P11|NOT COMPLETED|All Parts (16 Days)||0
68403|NCT02286518|166178|P10|NOT COMPLETED|All Parts (16 Days)||0
68404|NCT02286518|166179|P9|NOT COMPLETED|All Parts (16 Days)||0
68405|NCT02286518|166180|P8|NOT COMPLETED|All Parts (16 Days)||0
68406|NCT02286518|166181|P7|NOT COMPLETED|All Parts (16 Days)||0
68407|NCT02286518|166182|P6|NOT COMPLETED|All Parts (16 Days)||0
68408|NCT02286518|166183|P5|NOT COMPLETED|All Parts (16 Days)||0
68409|NCT02286518|166184|P4|NOT COMPLETED|All Parts (16 Days)||0
68410|NCT02286518|166185|P3|NOT COMPLETED|All Parts (16 Days)||0
68411|NCT02286518|166186|P2|NOT COMPLETED|All Parts (16 Days)||0
68412|NCT02286518|166187|P1|NOT COMPLETED|All Parts (16 Days)||0
68413|NCT02286518|166174|P14|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
68414|NCT02286518|166175|P13|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
68415|NCT02286518|166176|P12|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
68416|NCT02286518|166177|P11|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
68417|NCT02286518|166178|P10|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|4
68418|NCT02286518|166179|P9|COMPLETED|All Parts (16 Days)|Only participants of Part 2 would continue in next period.|6
68419|NCT02286518|166180|P8|COMPLETED|All Parts (16 Days)|Only participants of Part 2 continued in next period.|6
68420|NCT02286518|166181|P7|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
68421|NCT02286518|166182|P6|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
68422|NCT02286518|166183|P5|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
68423|NCT02286518|166184|P4|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
68424|NCT02286518|166185|P3|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
68425|NCT02286518|166186|P2|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
68426|NCT02286518|166187|P1|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
68427|NCT02286518|166174|P14|STARTED|All Parts (16 Days)||6
68428|NCT02286518|166175|P13|STARTED|All Parts (16 Days)||6
68429|NCT02286518|166176|P12|STARTED|All Parts (16 Days)||6
68430|NCT02286518|166177|P11|STARTED|All Parts (16 Days)||6
68431|NCT02286518|166178|P10|STARTED|All Parts (16 Days)||4
68432|NCT02286518|166179|P9|STARTED|All Parts (16 Days)||6
68433|NCT02286518|166180|P8|STARTED|All Parts (16 Days)||6
68434|NCT02286518|166181|P7|STARTED|All Parts (16 Days)||6
68435|NCT02286518|166182|P6|STARTED|All Parts (16 Days)||6
68436|NCT02286518|166183|P5|STARTED|All Parts (16 Days)||6
68437|NCT02286518|166184|P4|STARTED|All Parts (16 Days)||6
68438|NCT02286518|166185|P3|STARTED|All Parts (16 Days)||6
68439|NCT02286518|166186|P2|STARTED|All Parts (16 Days)||6
68440|NCT02286518|166187|P1|STARTED|All Parts (16 Days)||6
68441|NCT02286466|166329|P2|NOT COMPLETED|Overall Study||10
68442|NCT02286466|166330|P1|NOT COMPLETED|Overall Study||7
68443|NCT02286466|166329|P2|COMPLETED|Overall Study||63
68444|NCT02286466|166330|P1|COMPLETED|Overall Study||65
68445|NCT02286466|166329|P2|Post Self-report|Overall Study||68
68446|NCT02286466|166330|P1|Post Self-report|Overall Study||67
68447|NCT02286466|166329|P2|Baseline Clinician Assessment|Overall Study||72
68448|NCT02286466|166330|P1|Baseline Clinician Assessment|Overall Study||72
68449|NCT02286466|166329|P2|STARTED|Overall Study||73
68450|NCT02286466|166330|P1|STARTED|Overall Study||72
68451|NCT02286193|166342|P1|NOT COMPLETED|Overall Study||204
68452|NCT02286193|166342|P1|COMPLETED|Overall Study||418
68453|NCT02286193|166342|P1|STARTED|Overall Study||622
68454|NCT02286102|166349|P2|NOT COMPLETED|Overall Study||1
68455|NCT02286102|166350|P1|NOT COMPLETED|Overall Study||1
68456|NCT02286102|166349|P2|COMPLETED|Overall Study||33
68457|NCT02286102|166350|P1|COMPLETED|Overall Study||35
68458|NCT02286102|166349|P2|STARTED|Overall Study||34
68459|NCT02286102|166350|P1|STARTED|Overall Study||36
68460|NCT02285998|166362|P2|NOT COMPLETED|Overall Study||253
68461|NCT02285998|166363|P1|NOT COMPLETED|Overall Study||246
68462|NCT02285998|166362|P2|COMPLETED|Overall Study||4236
68463|NCT02285998|166363|P1|COMPLETED|Overall Study||4228
68464|NCT02285998|166362|P2|STARTED|Overall Study||4489
68465|NCT02285998|166363|P1|STARTED|Overall Study||4474
68466|NCT02285920|166391|P4|NOT COMPLETED|Overall Study||1
68467|NCT02285920|166392|P3|NOT COMPLETED|Overall Study||5
68468|NCT02285920|166393|P2|NOT COMPLETED|Overall Study||4
68469|NCT02285920|166394|P1|NOT COMPLETED|Overall Study||4
68470|NCT02285920|166391|P4|COMPLETED|Overall Study||24
68471|NCT02285920|166392|P3|COMPLETED|Overall Study||21
68472|NCT02285920|166393|P2|COMPLETED|Overall Study||23
68473|NCT02285920|166394|P1|COMPLETED|Overall Study||47
68474|NCT02285920|166391|P4|STARTED|Overall Study||25
68475|NCT02285920|166392|P3|STARTED|Overall Study||26
68476|NCT02285920|166393|P2|STARTED|Overall Study||27
68477|NCT02285920|166394|P1|STARTED|Overall Study||51
68478|NCT02285907|166456|P1|NOT COMPLETED|Overall Study||0
68479|NCT02285907|166456|P1|COMPLETED|Overall Study||21
68480|NCT02285907|166456|P1|Began 4th Intervention|Overall Study||21
68481|NCT02285907|166456|P1|Began 3rd Intervention|Overall Study||21
68482|NCT02285907|166456|P1|Began 2nd Intervention|Overall Study||21
68483|NCT02285907|166456|P1|Began 1st Intervention|Overall Study||21
68484|NCT02285907|166456|P1|STARTED|Overall Study||21
68485|NCT02285777|166484|P2|NOT COMPLETED|Overall Study||3
68486|NCT02285777|166485|P1|NOT COMPLETED|Overall Study||5
68487|NCT02285777|166484|P2|COMPLETED|Overall Study||91
68488|NCT02285777|166485|P1|COMPLETED|Overall Study||90
68489|NCT02285777|166484|P2|STARTED|Overall Study||94
68490|NCT02285777|166485|P1|STARTED|Overall Study||95
68491|NCT02285634|166541|P4|NOT COMPLETED|Overall Study||1
68492|NCT02285634|166542|P3|NOT COMPLETED|Overall Study||4
68493|NCT02285634|166543|P2|NOT COMPLETED|Overall Study||0
68494|NCT02285634|166544|P1|NOT COMPLETED|Overall Study||0
68495|NCT02285634|166541|P4|COMPLETED|Overall Study||17
68496|NCT02285634|166542|P3|COMPLETED|Overall Study||11
68497|NCT02285634|166543|P2|COMPLETED|Overall Study||20
68498|NCT02285634|166544|P1|COMPLETED|Overall Study||15
68499|NCT02285634|166541|P4|STARTED|Overall Study||18
68500|NCT02285634|166542|P3|STARTED|Overall Study||15
68501|NCT02285634|166543|P2|STARTED|Overall Study||20
68502|NCT02285634|166544|P1|STARTED|Overall Study||15
68503|NCT02285270|166566|P1|NOT COMPLETED|Overall Study||5
68504|NCT02285270|166566|P1|COMPLETED|Overall Study||5
68505|NCT02285270|166566|P1|STARTED|Overall Study||10
68506|NCT02285023|166572|P1|NOT COMPLETED|Overall Study||0
68507|NCT02285023|166572|P1|COMPLETED|Overall Study||166
68508|NCT02285023|166572|P1|STARTED|Overall Study||166
68509|NCT02285010|166584|P2|NOT COMPLETED|Overall Study||1
68510|NCT02285010|166585|P1|NOT COMPLETED|Overall Study||5
68511|NCT02285010|166584|P2|COMPLETED|Overall Study||61
68512|NCT02285010|166585|P1|COMPLETED|Overall Study||58
68513|NCT02285010|166584|P2|STARTED|Overall Study||62
68514|NCT02285010|166585|P1|STARTED|Overall Study||63
68515|NCT02284906|166602|P3|NOT COMPLETED|Overall Study||19
68516|NCT02284906|166603|P2|NOT COMPLETED|Overall Study||18
68517|NCT02284906|166604|P1|NOT COMPLETED|Overall Study||3
68518|NCT02284906|166602|P3|COMPLETED|Overall Study||0
68519|NCT02284906|166603|P2|COMPLETED|Overall Study||0
68520|NCT02284906|166604|P1|COMPLETED|Overall Study||0
68521|NCT02284906|166602|P3|STARTED|Overall Study||19
68522|NCT02284906|166603|P2|STARTED|Overall Study||18
68523|NCT02284906|166604|P1|STARTED|Overall Study||3
68524|NCT02284893|166617|P2|NOT COMPLETED|52 Week (Long Term)||13
68525|NCT02284893|166618|P1|NOT COMPLETED|52 Week (Long Term)||11
68526|NCT02284893|166617|P2|COMPLETED|52 Week (Long Term)||180
68527|NCT02284893|166618|P1|COMPLETED|52 Week (Long Term)||198
68528|NCT02284893|166617|P2|STARTED|52 Week (Long Term)||193
68529|NCT02284893|166618|P1|STARTED|52 Week (Long Term)||209
68530|NCT02284893|166617|P2|NOT COMPLETED|26 Week (Short Term)||31
68531|NCT02284893|166618|P1|NOT COMPLETED|26 Week (Short Term)||19
68532|NCT02284893|166617|P2|COMPLETED|26 Week (Short Term)||198
68533|NCT02284893|166618|P1|COMPLETED|26 Week (Short Term)||213
68534|NCT02284893|166617|P2|STARTED|26 Week (Short Term)||229
68535|NCT02284893|166618|P1|STARTED|26 Week (Short Term)||232
68536|NCT02284880|166632|P4|NOT COMPLETED|Overall Study||0
68537|NCT02284880|166633|P3|NOT COMPLETED|Overall Study||2
68538|NCT02284880|166634|P2|NOT COMPLETED|Overall Study||0
68539|NCT02284880|166635|P1|NOT COMPLETED|Overall Study||0
68540|NCT02284880|166632|P4|COMPLETED|Overall Study||10
68541|NCT02284880|166633|P3|COMPLETED|Overall Study||8
68542|NCT02284880|166634|P2|COMPLETED|Overall Study||9
68543|NCT02284880|166635|P1|COMPLETED|Overall Study||11
68544|NCT02284880|166632|P4|Second Period (4 Days)|Overall Study||10
68545|NCT02284880|166633|P3|Second Period (4 Days)|Overall Study||8
68546|NCT02284880|166634|P2|Second Period (4 Days)|Overall Study||9
68547|NCT02284880|166635|P1|Second Period (4 Days)|Overall Study||11
68548|NCT02284880|166632|P4|Wash-out Period (7 Days)|Overall Study||10
68549|NCT02284880|166633|P3|Wash-out Period (7 Days)|Overall Study||10
68550|NCT02284880|166634|P2|Wash-out Period (7 Days)|Overall Study||9
68551|NCT02284880|166635|P1|Wash-out Period (7 Days)|Overall Study||11
68552|NCT02284880|166632|P4|First Period (4 Days)|Overall Study||10
68553|NCT02284880|166633|P3|First Period (4 Days)|Overall Study||10
68554|NCT02284880|166634|P2|First Period (4 Days)|Overall Study||9
68555|NCT02284880|166635|P1|First Period (4 Days)|Overall Study||11
68556|NCT02284880|166632|P4|STARTED|Overall Study||10
68557|NCT02284880|166633|P3|STARTED|Overall Study||10
68558|NCT02284880|166634|P2|STARTED|Overall Study||9
68559|NCT02284880|166635|P1|STARTED|Overall Study||11
68560|NCT02284867|166651|P2|NOT COMPLETED|Overall Study||0
68561|NCT02284867|166652|P1|NOT COMPLETED|Overall Study||0
68562|NCT02284867|166651|P2|COMPLETED|Overall Study||30
68563|NCT02284867|166652|P1|COMPLETED|Overall Study||30
68564|NCT02284867|166651|P2|STARTED|Overall Study||30
68565|NCT02284867|166652|P1|STARTED|Overall Study||30
68566|NCT02284854|166662|P2|NOT COMPLETED|Overall Study||0
68567|NCT02284854|166663|P1|NOT COMPLETED|Overall Study||5
68568|NCT02284854|166662|P2|COMPLETED|Overall Study||20
68569|NCT02284854|166663|P1|COMPLETED|Overall Study||18
68570|NCT02284854|166662|P2|STARTED|Overall Study||20
68571|NCT02284854|166663|P1|STARTED|Overall Study||23
68572|NCT02284828|166680|P1|NOT COMPLETED|Overall Study||4
68573|NCT02284828|166680|P1|COMPLETED|Overall Study||22
68574|NCT02284828|166680|P1|STARTED|Overall Study||26
68575|NCT02284568|166695|P3|NOT COMPLETED|Overall Study||95
68576|NCT02284568|166696|P2|NOT COMPLETED|Overall Study||46
68577|NCT02284568|166697|P1|NOT COMPLETED|Overall Study||31
68578|NCT02284568|166695|P3|COMPLETED|Overall Study||0
68579|NCT02284568|166696|P2|COMPLETED|Overall Study||93
68580|NCT02284568|166697|P1|COMPLETED|Overall Study||109
68581|NCT02284568|166695|P3|Completed Week 48 MRI - on Treatment|Overall Study||0
68582|NCT02284568|166696|P2|Completed Week 48 MRI - on Treatment|Overall Study||107
68583|NCT02284568|166697|P1|Completed Week 48 MRI - on Treatment|Overall Study||113
68584|NCT02284568|166695|P3|Safety Population|Overall Study||95
68585|NCT02284568|166696|P2|Safety Population|Overall Study||138
68586|NCT02284568|166697|P1|Safety Population|Overall Study||140
68587|NCT02284568|166695|P3|STARTED|Overall Study|Intent to treat (ITT) population|95
68588|NCT02284568|166696|P2|STARTED|Overall Study|Intent to treat (ITT) population|139
68589|NCT02284568|166697|P1|STARTED|Overall Study|Intent to treat (ITT) population|140
68590|NCT02284555|166723|P1|NOT COMPLETED|Overall Study||0
68591|NCT02284555|166723|P1|COMPLETED|Overall Study||12
68592|NCT02284555|166723|P1|STARTED|Overall Study||12
68593|NCT02284516|166730|P2|NOT COMPLETED|Overall Study||36
68594|NCT02284516|166731|P1|NOT COMPLETED|Overall Study||38
68595|NCT02284516|166730|P2|COMPLETED|Overall Study||319
68596|NCT02284516|166731|P1|COMPLETED|Overall Study||318
68597|NCT02284516|166730|P2|Safety Population|Overall Study|Two placebo participants were included in Lifitegrast arm for safety analysis set (N=357).|357
68598|NCT02284516|166731|P1|Safety Population|Overall Study|Two placebo participants were considered for Lifitegrast arm; Placebo safety analysis set (N= 354).|354
68599|NCT02284516|166730|P2|STARTED|Overall Study||355
68600|NCT02284516|166731|P1|STARTED|Overall Study||356
68601|NCT02284399|166741|P2|NOT COMPLETED|Overall Study||0
68602|NCT02284399|166742|P1|NOT COMPLETED|Overall Study||0
68603|NCT02284399|166741|P2|COMPLETED|Overall Study||3074
68604|NCT02284399|166742|P1|COMPLETED|Overall Study||1414
68605|NCT02284399|166741|P2|STARTED|Overall Study||3074
68606|NCT02284399|166742|P1|STARTED|Overall Study||1414
68607|NCT02284386|166750|P1|NOT COMPLETED|Overall Study||0
68608|NCT02284386|166750|P1|COMPLETED|Overall Study||15
68609|NCT02284386|166750|P1|STARTED|Overall Study||15
68610|NCT02284347|166759|P1|NOT COMPLETED|Overall Study||3
68611|NCT02284347|166759|P1|COMPLETED|Overall Study||48
68612|NCT02284347|166759|P1|STARTED|Overall Study||51
68613|NCT02284243|166767|P2|NOT COMPLETED|Overall Study||3
68614|NCT02284243|166768|P1|NOT COMPLETED|Overall Study||4
68615|NCT02284243|166767|P2|COMPLETED|Overall Study||81
68616|NCT02284243|166768|P1|COMPLETED|Overall Study||80
68617|NCT02284243|166767|P2|STARTED|Overall Study||84
68618|NCT02284243|166768|P1|STARTED|Overall Study||84
68619|NCT02284178|166788|P2|NOT COMPLETED|Overall Study||54
68620|NCT02284178|166789|P1|NOT COMPLETED|Overall Study||49
68621|NCT02284178|166788|P2|COMPLETED|Overall Study||204
68622|NCT02284178|166789|P1|COMPLETED|Overall Study||206
68623|NCT02284178|166788|P2|STARTED|Overall Study||258
68624|NCT02284178|166789|P1|STARTED|Overall Study||255
68625|NCT02284165|166812|P3|NOT COMPLETED|Overall Study||0
68626|NCT02284165|166813|P2|NOT COMPLETED|Overall Study||0
68627|NCT02284165|166814|P1|NOT COMPLETED|Overall Study||0
68628|NCT02284165|166812|P3|COMPLETED|Overall Study||70996
68629|NCT02284165|166813|P2|COMPLETED|Overall Study||40272
68630|NCT02284165|166814|P1|COMPLETED|Overall Study||36448
68631|NCT02284165|166812|P3|STARTED|Overall Study||70996
68632|NCT02284165|166813|P2|STARTED|Overall Study||40272
68633|NCT02284165|166814|P1|STARTED|Overall Study||36448
68634|NCT02284009|166832|P2|NOT COMPLETED|Overall Study||10
68635|NCT02284009|166833|P1|NOT COMPLETED|Overall Study||6
68636|NCT02284009|166832|P2|COMPLETED|Overall Study||40
68637|NCT02284009|166833|P1|COMPLETED|Overall Study||11
68638|NCT02284009|166832|P2|STARTED|Overall Study||50
68639|NCT02284009|166833|P1|STARTED|Overall Study||17
68640|NCT02283840|166878|P3|NOT COMPLETED|Overall Study||0
68641|NCT02283840|166879|P2|NOT COMPLETED|Overall Study||1
68642|NCT02283840|166880|P1|NOT COMPLETED|Overall Study||0
68643|NCT02283840|166878|P3|COMPLETED|Overall Study||20
68644|NCT02283840|166879|P2|COMPLETED|Overall Study||19
68645|NCT02283840|166880|P1|COMPLETED|Overall Study||20
68646|NCT02283840|166878|P3|STARTED|Overall Study||20
68647|NCT02283840|166879|P2|STARTED|Overall Study||20
68648|NCT02283840|166880|P1|STARTED|Overall Study||20
68649|NCT02283827|166899|P2|NOT COMPLETED|Overall Study||3
68650|NCT02283827|166900|P1|NOT COMPLETED|Overall Study||1
68651|NCT02283827|166899|P2|COMPLETED|Overall Study||13
68652|NCT02283827|166900|P1|COMPLETED|Overall Study||15
68653|NCT02283827|166899|P2|STARTED|Overall Study||16
68654|NCT02283827|166900|P1|STARTED|Overall Study||16
68655|NCT02283814|166917|P2|NOT COMPLETED|Overall Study||2
68656|NCT02283814|166918|P1|NOT COMPLETED|Overall Study||3
68657|NCT02283814|166917|P2|COMPLETED|Overall Study||14
68658|NCT02283814|166918|P1|COMPLETED|Overall Study||13
68659|NCT02283814|166917|P2|STARTED|Overall Study||16
68660|NCT02283814|166918|P1|STARTED|Overall Study||16
68661|NCT02283788|166932|P4|NOT COMPLETED|Overall Study||2
68662|NCT02283788|166933|P3|NOT COMPLETED|Overall Study||5
68663|NCT02283788|166934|P2|NOT COMPLETED|Overall Study||4
68664|NCT02283788|166935|P1|NOT COMPLETED|Overall Study||1
68665|NCT02283788|166932|P4|COMPLETED|Overall Study||14
68666|NCT02283788|166933|P3|COMPLETED|Overall Study||12
68667|NCT02283788|166934|P2|COMPLETED|Overall Study||13
68668|NCT02283788|166935|P1|COMPLETED|Overall Study||16
68669|NCT02283788|166932|P4|STARTED|Overall Study||16
68670|NCT02283788|166933|P3|STARTED|Overall Study||17
68671|NCT02283788|166934|P2|STARTED|Overall Study||17
68672|NCT02283788|166935|P1|STARTED|Overall Study||17
68673|NCT02283762|166947|P2|NOT COMPLETED|Overall Study||15
68674|NCT02283762|166948|P1|NOT COMPLETED|Overall Study||18
68675|NCT02283762|166947|P2|COMPLETED|Overall Study||46
68676|NCT02283762|166948|P1|COMPLETED|Overall Study||42
68677|NCT02283762|166947|P2|STARTED|Overall Study||61
68678|NCT02283762|166948|P1|STARTED|Overall Study||60
68679|NCT02283749|166964|P1|NOT COMPLETED|Overall Study||0
68680|NCT02283749|166964|P1|COMPLETED|Overall Study||5
68681|NCT02283749|166964|P1|STARTED|Overall Study||5
68682|NCT02283528|166972|P2|NOT COMPLETED|Overall Study||0
68683|NCT02283528|166973|P1|NOT COMPLETED|Overall Study||0
68684|NCT02283528|166972|P2|COMPLETED|Overall Study||24
68685|NCT02283528|166973|P1|COMPLETED|Overall Study||26
68686|NCT02283528|166972|P2|STARTED|Overall Study||24
68687|NCT02283528|166973|P1|STARTED|Overall Study||26
68688|NCT02283411|166983|P1|NOT COMPLETED|Overall Study||31
68689|NCT02283411|166983|P1|COMPLETED|Overall Study||125
68690|NCT02283411|166983|P1|STARTED|Overall Study||156
68691|NCT02283268|166991|P1|NOT COMPLETED|Overall Study||1
68692|NCT02283268|166991|P1|COMPLETED|Overall Study||14
68693|NCT02283268|166991|P1|STARTED|Overall Study||15
68694|NCT02282982|167052|P1|NOT COMPLETED|Overall Study||206
68695|NCT02282982|167052|P1|COMPLETED|Overall Study||153
68696|NCT02282982|167052|P1|Attended Follow-up Visit|Overall Study||349
68697|NCT02282982|167052|P1|Attended Visit 5|Overall Study||83
68698|NCT02282982|167052|P1|Attended Visit 4|Overall Study||194
68699|NCT02282982|167052|P1|Attended Visit 3|Overall Study||298
68700|NCT02282982|167052|P1|Attended Visit 2|Overall Study||341
68701|NCT02282982|167052|P1|Attended Visit 1|Overall Study||359
68702|NCT02282982|167052|P1|STARTED|Overall Study||359
68703|NCT02282930|167067|P1|NOT COMPLETED|Overall Study||1
68704|NCT02282930|167067|P1|COMPLETED|Overall Study||19
68705|NCT02282930|167067|P1|STARTED|Overall Study||20
68706|NCT02282813|167075|P3|NOT COMPLETED|Overall Study||3
68707|NCT02282813|167076|P2|NOT COMPLETED|Overall Study||23
68708|NCT02282813|167077|P1|NOT COMPLETED|Overall Study||12
68709|NCT02282813|167075|P3|COMPLETED|Overall Study||39
68710|NCT02282813|167076|P2|COMPLETED|Overall Study||130
68711|NCT02282813|167077|P1|COMPLETED|Overall Study||91
68712|NCT02282813|167075|P3|STARTED|Overall Study|Randomization to take adjunctive treatment in addition to CTAP101 capsules began after week 12.|42
68713|NCT02282813|167076|P2|STARTED|Overall Study|ITT Population - not randomized or randomized to CTAP101 monotherapy|153
68714|NCT02282813|167077|P1|STARTED|Overall Study|ITT Population|103
68715|NCT02282722|167096|P2|NOT COMPLETED|Overall Study||19
68716|NCT02282722|167097|P1|NOT COMPLETED|Overall Study||23
68717|NCT02282722|167096|P2|COMPLETED|Overall Study||73
68718|NCT02282722|167097|P1|COMPLETED|Overall Study||71
68719|NCT02282722|167096|P2|3-month Assessment|Overall Study||73
68720|NCT02282722|167097|P1|3-month Assessment|Overall Study||71
68721|NCT02282722|167096|P2|2-week Assessment|Overall Study||75
68722|NCT02282722|167097|P1|2-week Assessment|Overall Study||79
68723|NCT02282722|167096|P2|STARTED|Overall Study||92
68724|NCT02282722|167097|P1|STARTED|Overall Study||94
68725|NCT02282631|167123|P2|NOT COMPLETED|Overall Study||0
68726|NCT02282631|167124|P1|NOT COMPLETED|Overall Study||2
68727|NCT02282631|167123|P2|COMPLETED|Overall Study||15
68728|NCT02282631|167124|P1|COMPLETED|Overall Study||12
68729|NCT02282631|167123|P2|STARTED|Overall Study||15
68730|NCT02282631|167124|P1|STARTED|Overall Study|The two dropouts happened on the 2nd and 3rd weeks post-baseline, respectively|14
68731|NCT02282605|167165|P3|NOT COMPLETED|Overall Study||0
68732|NCT02282605|167166|P2|NOT COMPLETED|Overall Study||0
68733|NCT02282605|167167|P1|NOT COMPLETED|Overall Study||3
68734|NCT02282605|167165|P3|COMPLETED|Overall Study||24
68735|NCT02282605|167166|P2|COMPLETED|Overall Study||12
68736|NCT02282605|167167|P1|COMPLETED|Overall Study||24
68737|NCT02282605|167165|P3|STARTED|Overall Study||24
68738|NCT02282605|167166|P2|STARTED|Overall Study||12
68739|NCT02282605|167167|P1|STARTED|Overall Study||27
68740|NCT02282527|167189|P2|NOT COMPLETED|Overall Study||1
68741|NCT02282527|167190|P1|NOT COMPLETED|Overall Study||1
68742|NCT02282527|167189|P2|COMPLETED|Overall Study||15
68743|NCT02282527|167190|P1|COMPLETED|Overall Study||15
68744|NCT02282527|167189|P2|STARTED|Overall Study||16
68745|NCT02282527|167190|P1|STARTED|Overall Study||16
68746|NCT02282293|167202|P2|NOT COMPLETED|Overall Study||3
68747|NCT02282293|167203|P1|NOT COMPLETED|Overall Study||3
68748|NCT02282293|167202|P2|COMPLETED|Overall Study||97
68749|NCT02282293|167203|P1|COMPLETED|Overall Study||97
68750|NCT02282293|167202|P2|STARTED|Overall Study||100
68751|NCT02282293|167203|P1|STARTED|Overall Study||100
68752|NCT02282111|167223|P2|NOT COMPLETED|Overall Study||8
68753|NCT02282111|167224|P1|NOT COMPLETED|Overall Study||7
68754|NCT02282111|167223|P2|COMPLETED|Overall Study||22
68755|NCT02282111|167224|P1|COMPLETED|Overall Study||19
68756|NCT02282111|167223|P2|STARTED|Overall Study||30
68757|NCT02282111|167224|P1|STARTED|Overall Study||26
68758|NCT02281773|167243|P5|NOT COMPLETED|Overall Study||30
68759|NCT02281773|167244|P4|NOT COMPLETED|Overall Study||21
68760|NCT02281773|167245|P3|NOT COMPLETED|Overall Study||18
68761|NCT02281773|167246|P2|NOT COMPLETED|Overall Study||15
68762|NCT02281773|167247|P1|NOT COMPLETED|Overall Study||11
68763|NCT02281773|167243|P5|COMPLETED|Overall Study||143
68764|NCT02281773|167244|P4|COMPLETED|Overall Study||65
68765|NCT02281773|167245|P3|COMPLETED|Overall Study||67
68766|NCT02281773|167246|P2|COMPLETED|Overall Study||70
68767|NCT02281773|167247|P1|COMPLETED|Overall Study||76
68768|NCT02281773|167243|P5|STARTED|Overall Study|Started are the treated patients|173
68769|NCT02281773|167244|P4|STARTED|Overall Study||86
68770|NCT02281773|167245|P3|STARTED|Overall Study||85
68771|NCT02281773|167246|P2|STARTED|Overall Study|Started are the treated patients|85
68772|NCT02281773|167247|P1|STARTED|Overall Study||87
68773|NCT02281591|167308|P4|NOT COMPLETED|Overall Study||0
68774|NCT02281591|167309|P3|NOT COMPLETED|Overall Study||0
68775|NCT02281591|167310|P2|NOT COMPLETED|Overall Study||0
68776|NCT02281591|167311|P1|NOT COMPLETED|Overall Study||0
68777|NCT02281591|167308|P4|COMPLETED|Overall Study||8
68778|NCT02281591|167309|P3|COMPLETED|Overall Study||8
68779|NCT02281591|167310|P2|COMPLETED|Overall Study||8
68780|NCT02281591|167311|P1|COMPLETED|Overall Study||8
68781|NCT02281591|167308|P4|STARTED|Overall Study||8
68782|NCT02281591|167309|P3|STARTED|Overall Study||8
68783|NCT02281591|167310|P2|STARTED|Overall Study||8
68784|NCT02281591|167311|P1|STARTED|Overall Study||8
68785|NCT02281552|167335|P2|NOT COMPLETED|Overall Study||10
68786|NCT02281552|167336|P1|NOT COMPLETED|Overall Study||4
68787|NCT02281552|167335|P2|COMPLETED|Overall Study||95
68788|NCT02281552|167336|P1|COMPLETED|Overall Study||100
68789|NCT02281552|167335|P2|STARTED|Overall Study||105
68790|NCT02281552|167336|P1|STARTED|Overall Study||104
68791|NCT02281526|167376|P2|NOT COMPLETED|Overall Study||0
68792|NCT02281526|167377|P1|NOT COMPLETED|Overall Study||1
68793|NCT02281526|167376|P2|COMPLETED|Overall Study||8
68794|NCT02281526|167377|P1|COMPLETED|Overall Study||8
68795|NCT02281526|167376|P2|STARTED|Overall Study||8
68796|NCT02281526|167377|P1|STARTED|Overall Study||9
68797|NCT02281448|167387|P2|NOT COMPLETED|Overall Study||1
68798|NCT02281448|167388|P1|NOT COMPLETED|Overall Study||2
68799|NCT02281448|167387|P2|COMPLETED|Overall Study||9
68800|NCT02281448|167388|P1|COMPLETED|Overall Study||8
68801|NCT02281448|167387|P2|STARTED|Overall Study||10
68802|NCT02281448|167388|P1|STARTED|Overall Study||10
68803|NCT02281422|167401|P5|NOT COMPLETED|Overall Study||0
68804|NCT02281422|167402|P4|NOT COMPLETED|Overall Study||0
68805|NCT02281422|167403|P3|NOT COMPLETED|Overall Study||0
68806|NCT02281422|167404|P2|NOT COMPLETED|Overall Study||0
68807|NCT02281422|167405|P1|NOT COMPLETED|Overall Study||0
68808|NCT02281422|167401|P5|COMPLETED|Overall Study||8
68809|NCT02281422|167402|P4|COMPLETED|Overall Study||8
68810|NCT02281422|167403|P3|COMPLETED|Overall Study||8
68811|NCT02281422|167404|P2|COMPLETED|Overall Study||8
68812|NCT02281422|167405|P1|COMPLETED|Overall Study||8
68813|NCT02281422|167401|P5|STARTED|Overall Study||8
68814|NCT02281422|167402|P4|STARTED|Overall Study||8
68815|NCT02281422|167403|P3|STARTED|Overall Study||8
68816|NCT02281422|167404|P2|STARTED|Overall Study||8
68817|NCT02281422|167405|P1|STARTED|Overall Study||8
68818|NCT02281357|167429|P2|NOT COMPLETED|Overall Study||4
68819|NCT02281357|167430|P1|NOT COMPLETED|Overall Study||7
68820|NCT02281357|167429|P2|COMPLETED|Overall Study||66
68821|NCT02281357|167430|P1|COMPLETED|Overall Study||63
68822|NCT02281357|167429|P2|STARTED|Overall Study||70
68823|NCT02281357|167430|P1|STARTED|Overall Study||70
68824|NCT02281318|167444|P2|NOT COMPLETED|Overall Study||5
68825|NCT02281318|167445|P1|NOT COMPLETED|Overall Study||14
68826|NCT02281318|167444|P2|COMPLETED|Overall Study||269
68827|NCT02281318|167445|P1|COMPLETED|Overall Study||263
68828|NCT02281318|167444|P2|STARTED|Overall Study||274
68829|NCT02281318|167445|P1|STARTED|Overall Study||277
68830|NCT02281136|167457|P1|NOT COMPLETED|Overall Study||0
68831|NCT02281136|167457|P1|COMPLETED|Overall Study||29
68832|NCT02281136|167457|P1|STARTED|Overall Study||29
68833|NCT02280863|167491|P2|NOT COMPLETED|Integrated Platform||1
68834|NCT02280863|167492|P1|NOT COMPLETED|Integrated Platform||0
68835|NCT02280863|167491|P2|COMPLETED|Integrated Platform||14
68836|NCT02280863|167492|P1|COMPLETED|Integrated Platform||9
68837|NCT02280863|167491|P2|STARTED|Integrated Platform||15
68838|NCT02280863|167492|P1|STARTED|Integrated Platform|One additional participant was enrolled for part 2.|9
68839|NCT02280863|167491|P2|NOT COMPLETED|Android Platform||0
68840|NCT02280863|167492|P1|NOT COMPLETED|Android Platform||0
68841|NCT02280863|167491|P2|COMPLETED|Android Platform||0
68842|NCT02280863|167492|P1|COMPLETED|Android Platform||8
68843|NCT02280863|167491|P2|STARTED|Android Platform||0
68844|NCT02280863|167492|P1|STARTED|Android Platform||8
68845|NCT02280811|167522|P5|NOT COMPLETED|Retreated at the MTD||0
68846|NCT02280811|167523|P4|NOT COMPLETED|Retreated at the MTD||0
68847|NCT02280811|167524|P3|NOT COMPLETED|Retreated at the MTD||0
68848|NCT02280811|167525|P2|NOT COMPLETED|Retreated at the MTD||0
68849|NCT02280811|167526|P1|NOT COMPLETED|Retreated at the MTD||0
68850|NCT02280811|167522|P5|COMPLETED|Retreated at the MTD||1
68851|NCT02280811|167523|P4|COMPLETED|Retreated at the MTD||0
68852|NCT02280811|167524|P3|COMPLETED|Retreated at the MTD||0
68853|NCT02280811|167525|P2|COMPLETED|Retreated at the MTD||0
68854|NCT02280811|167526|P1|COMPLETED|Retreated at the MTD||0
68855|NCT02280811|167522|P5|STARTED|Retreated at the MTD|Patient originally started in Grp1(HPV-16 E6mTCR PBL 1x10^9+HD IL-2) and was retreated at the MTD.|1
68856|NCT02280811|167523|P4|STARTED|Retreated at the MTD||0
68857|NCT02280811|167524|P3|STARTED|Retreated at the MTD||0
68858|NCT02280811|167525|P2|STARTED|Retreated at the MTD||0
68859|NCT02280811|167526|P1|STARTED|Retreated at the MTD||0
68860|NCT02280811|167522|P5|NOT COMPLETED|Drug Administration||0
68861|NCT02280811|167523|P4|NOT COMPLETED|Drug Administration||0
68862|NCT02280811|167524|P3|NOT COMPLETED|Drug Administration||0
68863|NCT02280811|167525|P2|NOT COMPLETED|Drug Administration||0
68864|NCT02280811|167526|P1|NOT COMPLETED|Drug Administration||0
68865|NCT02280811|167522|P5|COMPLETED|Drug Administration||2
68866|NCT02280811|167523|P4|COMPLETED|Drug Administration||6
68867|NCT02280811|167524|P3|COMPLETED|Drug Administration||1
68868|NCT02280811|167525|P2|COMPLETED|Drug Administration||2
68869|NCT02280811|167526|P1|COMPLETED|Drug Administration||1
68870|NCT02280811|167522|P5|STARTED|Drug Administration||2
68871|NCT02280811|167523|P4|STARTED|Drug Administration||6
68872|NCT02280811|167524|P3|STARTED|Drug Administration||1
68873|NCT02280811|167525|P2|STARTED|Drug Administration||2
68874|NCT02280811|167526|P1|STARTED|Drug Administration||1
68875|NCT02280655|167567|P2|NOT COMPLETED|Overall Study||0
68876|NCT02280655|167568|P1|NOT COMPLETED|Overall Study||0
68877|NCT02280655|167567|P2|COMPLETED|Overall Study||18
68878|NCT02280655|167568|P1|COMPLETED|Overall Study||25
68879|NCT02280655|167567|P2|STARTED|Overall Study||18
68880|NCT02280655|167568|P1|STARTED|Overall Study||25
68881|NCT02280499|167576|P1|NOT COMPLETED|Overall Study||61
68882|NCT02280499|167576|P1|COMPLETED|Overall Study||26
68883|NCT02280499|167576|P1|STARTED|Overall Study||87
68884|NCT02280473|167584|P2|NOT COMPLETED|Overall Study||3
68885|NCT02280473|167585|P1|NOT COMPLETED|Overall Study||1
68886|NCT02280473|167584|P2|COMPLETED|Overall Study||91
68887|NCT02280473|167585|P1|COMPLETED|Overall Study||93
68888|NCT02280473|167584|P2|STARTED|Overall Study||94
68889|NCT02280473|167585|P1|STARTED|Overall Study||94
68890|NCT02280421|167601|P2|NOT COMPLETED|Second Intervention(2 Weeks)||0
68891|NCT02280421|167602|P1|NOT COMPLETED|Second Intervention(2 Weeks)||0
68892|NCT02280421|167601|P2|COMPLETED|Second Intervention(2 Weeks)||12
68893|NCT02280421|167602|P1|COMPLETED|Second Intervention(2 Weeks)||12
68894|NCT02280421|167601|P2|Received Intervention|Second Intervention(2 Weeks)||12
68895|NCT02280421|167602|P1|Received Intervention|Second Intervention(2 Weeks)||12
68896|NCT02280421|167601|P2|STARTED|Second Intervention(2 Weeks)||12
68897|NCT02280421|167602|P1|STARTED|Second Intervention(2 Weeks)||12
68898|NCT02280421|167601|P2|NOT COMPLETED|Washout (2 Weeks)||1
68899|NCT02280421|167602|P1|NOT COMPLETED|Washout (2 Weeks)||1
68900|NCT02280421|167601|P2|COMPLETED|Washout (2 Weeks)||11
68901|NCT02280421|167602|P1|COMPLETED|Washout (2 Weeks)||11
68902|NCT02280421|167601|P2|STARTED|Washout (2 Weeks)||12
68903|NCT02280421|167602|P1|STARTED|Washout (2 Weeks)||12
68904|NCT02280421|167601|P2|NOT COMPLETED|First Intervention(2 Weeks)||0
68905|NCT02280421|167602|P1|NOT COMPLETED|First Intervention(2 Weeks)||0
68906|NCT02280421|167601|P2|COMPLETED|First Intervention(2 Weeks)||12
68907|NCT02280421|167602|P1|COMPLETED|First Intervention(2 Weeks)||12
68908|NCT02280421|167601|P2|Received Intervention|First Intervention(2 Weeks)||12
68909|NCT02280421|167602|P1|Received Intervention|First Intervention(2 Weeks)||12
68910|NCT02280421|167601|P2|STARTED|First Intervention(2 Weeks)||12
68911|NCT02280421|167602|P1|STARTED|First Intervention(2 Weeks)||12
68912|NCT02280408|167668|P4|NOT COMPLETED|Overall Study||0
68913|NCT02280408|167669|P3|NOT COMPLETED|Overall Study||0
68914|NCT02280408|167670|P2|NOT COMPLETED|Overall Study||2
68915|NCT02280408|167671|P1|NOT COMPLETED|Overall Study||0
68916|NCT02280408|167668|P4|COMPLETED|Overall Study||9
68917|NCT02280408|167669|P3|COMPLETED|Overall Study||10
68918|NCT02280408|167670|P2|COMPLETED|Overall Study||8
68919|NCT02280408|167671|P1|COMPLETED|Overall Study||10
68920|NCT02280408|167668|P4|Vaccination 2|Overall Study||9
68921|NCT02280408|167669|P3|Vaccination 2|Overall Study||10
68922|NCT02280408|167670|P2|Vaccination 2|Overall Study||10
68923|NCT02280408|167671|P1|Vaccination 2|Overall Study||10
68924|NCT02280408|167668|P4|Vaccination 1|Overall Study||9
68925|NCT02280408|167669|P3|Vaccination 1|Overall Study||10
68926|NCT02280408|167670|P2|Vaccination 1|Overall Study||10
68927|NCT02280408|167671|P1|Vaccination 1|Overall Study||10
68928|NCT02280408|167668|P4|STARTED|Overall Study||9
68929|NCT02280408|167669|P3|STARTED|Overall Study||10
68930|NCT02280408|167670|P2|STARTED|Overall Study||10
68931|NCT02280408|167671|P1|STARTED|Overall Study||10
68932|NCT02280226|167741|P1|NOT COMPLETED|Overall Study||0
68933|NCT02280226|167741|P1|COMPLETED|Overall Study||17
68934|NCT02280226|167741|P1|STARTED|Overall Study||17
68935|NCT02280200|167748|P2|NOT COMPLETED|Overall Study||3
68936|NCT02280200|167749|P1|NOT COMPLETED|Overall Study||3
68937|NCT02280200|167748|P2|COMPLETED|Overall Study||10
68938|NCT02280200|167749|P1|COMPLETED|Overall Study||12
68939|NCT02280200|167748|P2|STARTED|Overall Study||13
68940|NCT02280200|167749|P1|STARTED|Overall Study||15
68941|NCT02280187|167763|P1|NOT COMPLETED|Overall Study||218
68942|NCT02280187|167763|P1|COMPLETED|Overall Study||182
68943|NCT02280187|167763|P1|STARTED|Overall Study||400
68944|NCT02280122|167781|P3|NOT COMPLETED|Overall Study||0
68945|NCT02280122|167782|P2|NOT COMPLETED|Overall Study||0
68946|NCT02280122|167783|P1|NOT COMPLETED|Overall Study||0
68947|NCT02280122|167781|P3|COMPLETED|Overall Study||30
68948|NCT02280122|167782|P2|COMPLETED|Overall Study||15
68949|NCT02280122|167783|P1|COMPLETED|Overall Study||15
68950|NCT02280122|167781|P3|STARTED|Overall Study||30
68951|NCT02280122|167782|P2|STARTED|Overall Study||15
68952|NCT02280122|167783|P1|STARTED|Overall Study||15
68953|NCT02280096|167791|P2|NOT COMPLETED|Overall Study||1
68954|NCT02280096|167792|P1|NOT COMPLETED|Overall Study||2
68955|NCT02280096|167791|P2|COMPLETED|Overall Study||10
68956|NCT02280096|167792|P1|COMPLETED|Overall Study||11
68957|NCT02280096|167791|P2|STARTED|Overall Study||11
68958|NCT02280096|167792|P1|STARTED|Overall Study||13
68959|NCT02280044|167822|P2|NOT COMPLETED|Overall Study||2
68960|NCT02280044|167823|P1|NOT COMPLETED|Overall Study||0
68961|NCT02280044|167822|P2|COMPLETED|Overall Study||13
68962|NCT02280044|167823|P1|COMPLETED|Overall Study||15
68963|NCT02280044|167822|P2|STARTED|Overall Study||15
68964|NCT02280044|167823|P1|STARTED|Overall Study||15
68965|NCT02279862|167833|P2|NOT COMPLETED|Overall Study||25
68966|NCT02279862|167834|P1|NOT COMPLETED|Overall Study||26
68967|NCT02279862|167833|P2|COMPLETED|Overall Study|Completed treatment in induction period|2
68968|NCT02279862|167834|P1|COMPLETED|Overall Study|Completed treatment in induction period|0
68969|NCT02279862|167833|P2|Treated|Overall Study||26
68970|NCT02279862|167834|P1|Treated|Overall Study||25
68971|NCT02279862|167833|P2|STARTED|Overall Study||27
68972|NCT02279862|167834|P1|STARTED|Overall Study||26
68973|NCT02279732|167852|P2|NOT COMPLETED|Overall Study||106
68974|NCT02279732|167853|P1|NOT COMPLETED|Overall Study||98
68975|NCT02279732|167852|P2|COMPLETED|Overall Study||0
68976|NCT02279732|167853|P1|COMPLETED|Overall Study||0
68977|NCT02279732|167852|P2|STARTED|Overall Study||106
68978|NCT02279732|167853|P1|STARTED|Overall Study||98
68979|NCT02279667|167866|P3|NOT COMPLETED|Overall Study||0
68980|NCT02279667|167867|P2|NOT COMPLETED|Overall Study||0
68981|NCT02279667|167868|P1|NOT COMPLETED|Overall Study||0
68982|NCT02279667|167866|P3|COMPLETED|Overall Study||6
68983|NCT02279667|167867|P2|COMPLETED|Overall Study||6
68984|NCT02279667|167868|P1|COMPLETED|Overall Study||6
68985|NCT02279667|167866|P3|STARTED|Overall Study||6
68986|NCT02279667|167867|P2|STARTED|Overall Study||6
68987|NCT02279667|167868|P1|STARTED|Overall Study||6
68988|NCT02279641|167888|P2|NOT COMPLETED|Overall Study||0
68989|NCT02279641|167889|P1|NOT COMPLETED|Overall Study||0
68990|NCT02279641|167888|P2|COMPLETED|Overall Study||6
68991|NCT02279641|167889|P1|COMPLETED|Overall Study||6
68992|NCT02279641|167888|P2|STARTED|Overall Study||6
68993|NCT02279641|167889|P1|STARTED|Overall Study||6
68994|NCT02279498|167945|P2|NOT COMPLETED|Overall Study||4
68995|NCT02279498|167946|P1|NOT COMPLETED|Overall Study||18
68996|NCT02279498|167945|P2|COMPLETED|Overall Study||59
68997|NCT02279498|167946|P1|COMPLETED|Overall Study||47
68998|NCT02279498|167945|P2|STARTED|Overall Study||63
68999|NCT02279498|167946|P1|STARTED|Overall Study||65
69000|NCT02279420|167955|P1|NOT COMPLETED|Overall Study||23
69001|NCT02279420|167955|P1|COMPLETED|Overall Study||50
69002|NCT02279420|167955|P1|STARTED|Overall Study||73
69003|NCT02279407|167963|P4|NOT COMPLETED|Overall Study||1
69004|NCT02279407|167964|P3|NOT COMPLETED|Overall Study||5
69005|NCT02279407|167965|P2|NOT COMPLETED|Overall Study||1
69006|NCT02279407|167966|P1|NOT COMPLETED|Overall Study||2
69007|NCT02279407|167963|P4|COMPLETED|Overall Study||20
69008|NCT02279407|167964|P3|COMPLETED|Overall Study||15
69009|NCT02279407|167965|P2|COMPLETED|Overall Study||20
69010|NCT02279407|167966|P1|COMPLETED|Overall Study||20
69011|NCT02279407|167963|P4|STARTED|Overall Study||21
69012|NCT02279407|167964|P3|STARTED|Overall Study||20
69013|NCT02279407|167965|P2|STARTED|Overall Study||21
69014|NCT02279407|167966|P1|STARTED|Overall Study||22
69015|NCT02279173|167977|P1|NOT COMPLETED|Overall Study||167
69016|NCT02279173|167977|P1|COMPLETED|Overall Study||37
69017|NCT02279173|167977|P1|Enrolled Under Protocol Supplement|Overall Study||79
69018|NCT02279173|167977|P1|Received Treatment|Overall Study||203
69019|NCT02279173|167977|P1|STARTED|Overall Study||204
69020|NCT02279108|167996|P2|NOT COMPLETED|Overall Study||1
69021|NCT02279108|167997|P1|NOT COMPLETED|Overall Study||0
69022|NCT02279108|167996|P2|COMPLETED|Overall Study||49
69023|NCT02279108|167997|P1|COMPLETED|Overall Study||50
69024|NCT02279108|167996|P2|STARTED|Overall Study||50
69025|NCT02279108|167997|P1|STARTED|Overall Study||50
69026|NCT02279082|168019|P1|NOT COMPLETED|Overall Study||33
69027|NCT02279082|168019|P1|COMPLETED|Overall Study||134
69028|NCT02279082|168019|P1|STARTED|Overall Study|Intentions were to have 173 participants, but only 167 participants received study drug.|167
69029|NCT02279043|168026|P3|NOT COMPLETED|Overall Study||0
69030|NCT02279043|168027|P2|NOT COMPLETED|Overall Study||89
69031|NCT02279043|168028|P1|NOT COMPLETED|Overall Study||47
69032|NCT02279043|168026|P3|COMPLETED|Overall Study||140
69033|NCT02279043|168027|P2|COMPLETED|Overall Study||226
69034|NCT02279043|168028|P1|COMPLETED|Overall Study||128
69035|NCT02279043|168026|P3|STARTED|Overall Study||140
69036|NCT02279043|168027|P2|STARTED|Overall Study||315
69037|NCT02279043|168028|P1|STARTED|Overall Study||175
69038|NCT02278939|168060|P2|NOT COMPLETED|Overall Study||1
69039|NCT02278939|168061|P1|NOT COMPLETED|Overall Study||5
69040|NCT02278939|168060|P2|COMPLETED|Overall Study||33
69041|NCT02278939|168061|P1|COMPLETED|Overall Study||28
69042|NCT02278939|168060|P2|STARTED|Overall Study||34
69043|NCT02278939|168061|P1|STARTED|Overall Study||33
69044|NCT02278783|168073|P1|NOT COMPLETED|Overall Study||0
69045|NCT02278783|168073|P1|COMPLETED|Overall Study||1
69046|NCT02278783|168073|P1|STARTED|Overall Study||1
69047|NCT02278640|168080|P1|NOT COMPLETED|Overall Study||0
69048|NCT02278640|168080|P1|COMPLETED|Overall Study||40
69049|NCT02278640|168080|P1|STARTED|Overall Study||40
69050|NCT02278614|168089|P2|NOT COMPLETED|Overall Study||5
69051|NCT02278614|168090|P1|NOT COMPLETED|Overall Study||5
69052|NCT02278614|168089|P2|COMPLETED|Overall Study||110
69053|NCT02278614|168090|P1|COMPLETED|Overall Study||122
69054|NCT02278614|168089|P2|STARTED|Overall Study||115
69055|NCT02278614|168090|P1|STARTED|Overall Study||127
69056|NCT02278562|168099|P3|NOT COMPLETED|Overall Study||0
69057|NCT02278562|168100|P2|NOT COMPLETED|Overall Study||0
69058|NCT02278562|168101|P1|NOT COMPLETED|Overall Study||0
69059|NCT02278562|168099|P3|COMPLETED|Overall Study||8
69060|NCT02278562|168100|P2|COMPLETED|Overall Study||7
69061|NCT02278562|168101|P1|COMPLETED|Overall Study||9
69062|NCT02278562|168099|P3|STARTED|Overall Study||8
69063|NCT02278562|168100|P2|STARTED|Overall Study||7
69064|NCT02278562|168101|P1|STARTED|Overall Study||9
69065|NCT02278484|168115|P1|NOT COMPLETED|Overall Study||0
69066|NCT02278484|168115|P1|COMPLETED|Overall Study||50
69067|NCT02278484|168115|P1|STARTED|Overall Study||50
69068|NCT02278471|168124|P2|NOT COMPLETED|Overall Study||20
69069|NCT02278471|168125|P1|NOT COMPLETED|Overall Study||8
69070|NCT02278471|168124|P2|COMPLETED|Overall Study||128
69071|NCT02278471|168125|P1|COMPLETED|Overall Study||147
69072|NCT02278471|168124|P2|STARTED|Overall Study||148
69073|NCT02278471|168125|P1|STARTED|Overall Study||155
69074|NCT02278328|168141|P3|NOT COMPLETED|Third Washout (1 Week)||0
69075|NCT02278328|168142|P2|NOT COMPLETED|Third Washout (1 Week)||0
69076|NCT02278328|168143|P1|NOT COMPLETED|Third Washout (1 Week)||0
69077|NCT02278328|168141|P3|COMPLETED|Third Washout (1 Week)||6
69078|NCT02278328|168142|P2|COMPLETED|Third Washout (1 Week)||6
69079|NCT02278328|168143|P1|COMPLETED|Third Washout (1 Week)||9
69080|NCT02278328|168141|P3|STARTED|Third Washout (1 Week)||6
69081|NCT02278328|168142|P2|STARTED|Third Washout (1 Week)||6
69082|NCT02278328|168143|P1|STARTED|Third Washout (1 Week)||9
69083|NCT02278328|168141|P3|NOT COMPLETED|Third Intervention (1 Day)||0
69084|NCT02278328|168142|P2|NOT COMPLETED|Third Intervention (1 Day)||0
69085|NCT02278328|168143|P1|NOT COMPLETED|Third Intervention (1 Day)||0
69086|NCT02278328|168141|P3|COMPLETED|Third Intervention (1 Day)||6
69087|NCT02278328|168142|P2|COMPLETED|Third Intervention (1 Day)||6
69088|NCT02278328|168143|P1|COMPLETED|Third Intervention (1 Day)||9
69089|NCT02278328|168141|P3|STARTED|Third Intervention (1 Day)||6
69090|NCT02278328|168142|P2|STARTED|Third Intervention (1 Day)||6
69091|NCT02278328|168143|P1|STARTED|Third Intervention (1 Day)||9
69092|NCT02278328|168141|P3|NOT COMPLETED|Second Washout (1 Week)||0
69093|NCT02278328|168142|P2|NOT COMPLETED|Second Washout (1 Week)||0
69094|NCT02278328|168143|P1|NOT COMPLETED|Second Washout (1 Week)||0
69095|NCT02278328|168141|P3|COMPLETED|Second Washout (1 Week)||6
69096|NCT02278328|168142|P2|COMPLETED|Second Washout (1 Week)||6
69097|NCT02278328|168143|P1|COMPLETED|Second Washout (1 Week)||9
69098|NCT02278328|168141|P3|STARTED|Second Washout (1 Week)||6
69099|NCT02278328|168142|P2|STARTED|Second Washout (1 Week)||6
69100|NCT02278328|168143|P1|STARTED|Second Washout (1 Week)||9
69101|NCT02278328|168141|P3|NOT COMPLETED|Second Intervention (1 Day)||0
69102|NCT02278328|168142|P2|NOT COMPLETED|Second Intervention (1 Day)||0
69103|NCT02278328|168143|P1|NOT COMPLETED|Second Intervention (1 Day)||0
69104|NCT02278328|168141|P3|COMPLETED|Second Intervention (1 Day)||6
69105|NCT02278328|168142|P2|COMPLETED|Second Intervention (1 Day)||6
69106|NCT02278328|168143|P1|COMPLETED|Second Intervention (1 Day)||9
69107|NCT02278328|168141|P3|STARTED|Second Intervention (1 Day)||6
69108|NCT02278328|168142|P2|STARTED|Second Intervention (1 Day)||6
69109|NCT02278328|168143|P1|STARTED|Second Intervention (1 Day)||9
69110|NCT02278328|168141|P3|NOT COMPLETED|Washout (1 Week)||0
69111|NCT02278328|168142|P2|NOT COMPLETED|Washout (1 Week)||0
69112|NCT02278328|168143|P1|NOT COMPLETED|Washout (1 Week)||0
69113|NCT02278328|168141|P3|COMPLETED|Washout (1 Week)||6
69114|NCT02278328|168142|P2|COMPLETED|Washout (1 Week)||6
69115|NCT02278328|168143|P1|COMPLETED|Washout (1 Week)||9
69116|NCT02278328|168141|P3|STARTED|Washout (1 Week)||6
69117|NCT02278328|168142|P2|STARTED|Washout (1 Week)||6
69118|NCT02278328|168143|P1|STARTED|Washout (1 Week)||9
69119|NCT02278328|168141|P3|NOT COMPLETED|First Intervention (1 Day)||0
69120|NCT02278328|168142|P2|NOT COMPLETED|First Intervention (1 Day)||0
69121|NCT02278328|168143|P1|NOT COMPLETED|First Intervention (1 Day)||0
69122|NCT02278328|168141|P3|COMPLETED|First Intervention (1 Day)||6
69123|NCT02278328|168142|P2|COMPLETED|First Intervention (1 Day)||6
69124|NCT02278328|168143|P1|COMPLETED|First Intervention (1 Day)||9
69125|NCT02278328|168141|P3|STARTED|First Intervention (1 Day)||6
69126|NCT02278328|168142|P2|STARTED|First Intervention (1 Day)||6
69127|NCT02278328|168143|P1|STARTED|First Intervention (1 Day)||9
69128|NCT02278328|168141|P3|NOT COMPLETED|Neuropsych Screening||2
69129|NCT02278328|168142|P2|NOT COMPLETED|Neuropsych Screening||1
69130|NCT02278328|168143|P1|NOT COMPLETED|Neuropsych Screening||1
69131|NCT02278328|168141|P3|COMPLETED|Neuropsych Screening||6
69132|NCT02278328|168142|P2|COMPLETED|Neuropsych Screening||6
69133|NCT02278328|168143|P1|COMPLETED|Neuropsych Screening||9
69134|NCT02278328|168141|P3|STARTED|Neuropsych Screening||8
69135|NCT02278328|168142|P2|STARTED|Neuropsych Screening||7
69136|NCT02278328|168143|P1|STARTED|Neuropsych Screening||10
69137|NCT02278237|168153|P1|NOT COMPLETED|Overall Study||7
69138|NCT02278237|168153|P1|COMPLETED|Overall Study||83
69139|NCT02278237|168153|P1|STARTED|Overall Study||90
69140|NCT02278146|168159|P2|NOT COMPLETED|Overall Study||2
69141|NCT02278146|168160|P1|NOT COMPLETED|Overall Study||0
69142|NCT02278146|168159|P2|COMPLETED|Overall Study||8
69143|NCT02278146|168160|P1|COMPLETED|Overall Study||6
69144|NCT02278146|168159|P2|STARTED|Overall Study||10
69145|NCT02278146|168160|P1|STARTED|Overall Study||6
69146|NCT02278120|168172|P2|NOT COMPLETED|Overall Study||216
69147|NCT02278120|168173|P1|NOT COMPLETED|Overall Study||161
69148|NCT02278120|168172|P2|COMPLETED|Overall Study||121
69149|NCT02278120|168173|P1|COMPLETED|Overall Study||174
69150|NCT02278120|168172|P2|STARTED|Overall Study||337
69151|NCT02278120|168173|P1|STARTED|Overall Study||335
69152|NCT02278003|168189|P2|NOT COMPLETED|Overall Study||0
69153|NCT02278003|168190|P1|NOT COMPLETED|Overall Study||19
69154|NCT02278003|168189|P2|COMPLETED|Overall Study||20
69155|NCT02278003|168190|P1|COMPLETED|Overall Study||30
69156|NCT02278003|168189|P2|STARTED|Overall Study||20
69157|NCT02278003|168190|P1|STARTED|Overall Study||49
69158|NCT02277990|168200|P2|NOT COMPLETED|Overall Study||376
69159|NCT02277990|168201|P1|NOT COMPLETED|Overall Study||366
69160|NCT02277990|168200|P2|COMPLETED|Overall Study||3112
69161|NCT02277990|168201|P1|COMPLETED|Overall Study||3129
69162|NCT02277990|168200|P2|STARTED|Overall Study||3488
69163|NCT02277990|168201|P1|STARTED|Overall Study||3495
69164|NCT02277925|168215|P2|NOT COMPLETED|Overall Study||15
69165|NCT02277925|168216|P1|NOT COMPLETED|Overall Study||7
69166|NCT02277925|168215|P2|COMPLETED|Overall Study||87
69167|NCT02277925|168216|P1|COMPLETED|Overall Study||95
69168|NCT02277925|168215|P2|Surgery|Overall Study||101
69169|NCT02277925|168216|P1|Surgery|Overall Study||99
69170|NCT02277925|168215|P2|STARTED|Overall Study||102
69171|NCT02277925|168216|P1|STARTED|Overall Study||102
69172|NCT02277769|168229|P3|NOT COMPLETED|Overall Study||18
69173|NCT02277769|168230|P2|NOT COMPLETED|Overall Study||13
69174|NCT02277769|168231|P1|NOT COMPLETED|Overall Study||46
69175|NCT02277769|168229|P3|COMPLETED|Overall Study||221
69176|NCT02277769|168230|P2|COMPLETED|Overall Study||220
69177|NCT02277769|168231|P1|COMPLETED|Overall Study||190
69178|NCT02277769|168229|P3|Safety Population|Overall Study|2 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|237
69179|NCT02277769|168230|P2|Safety Population|Overall Study|3 participants (1 [placebo] + 2 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|236
69180|NCT02277769|168231|P1|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|234
69181|NCT02277769|168229|P3|Treated|Overall Study||239
69182|NCT02277769|168230|P2|Treated|Overall Study||233
69183|NCT02277769|168231|P1|Treated|Overall Study||235
69184|NCT02277769|168229|P3|STARTED|Overall Study||239
69185|NCT02277769|168230|P2|STARTED|Overall Study||233
69186|NCT02277769|168231|P1|STARTED|Overall Study||236
69187|NCT02277743|168302|P3|NOT COMPLETED|Overall Study||26
69188|NCT02277743|168303|P2|NOT COMPLETED|Overall Study||16
69189|NCT02277743|168304|P1|NOT COMPLETED|Overall Study||40
69190|NCT02277743|168302|P3|COMPLETED|Overall Study||197
69191|NCT02277743|168303|P2|COMPLETED|Overall Study||208
69192|NCT02277743|168304|P1|COMPLETED|Overall Study||184
69193|NCT02277743|168302|P3|Safety Population|Overall Study|5 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|218
69194|NCT02277743|168303|P2|Safety Population|Overall Study|6 participants (1 [placebo] + 5 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|229
69195|NCT02277743|168304|P1|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|222
69196|NCT02277743|168302|P3|Treated|Overall Study||223
69197|NCT02277743|168303|P2|Treated|Overall Study||223
69198|NCT02277743|168304|P1|Treated|Overall Study||223
69199|NCT02277743|168302|P3|STARTED|Overall Study||223
69200|NCT02277743|168303|P2|STARTED|Overall Study||224
69201|NCT02277743|168304|P1|STARTED|Overall Study||224
69202|NCT02277691|168372|P1|NOT COMPLETED|Overall Study||46
69203|NCT02277691|168372|P1|COMPLETED|Overall Study||295
69204|NCT02277691|168372|P1|STARTED|Overall Study||341
69205|NCT02277665|168384|P2|NOT COMPLETED|Overall Study||0
69206|NCT02277665|168385|P1|NOT COMPLETED|Overall Study||0
69207|NCT02277665|168384|P2|COMPLETED|Overall Study||34
69208|NCT02277665|168385|P1|COMPLETED|Overall Study||33
69209|NCT02277665|168384|P2|STARTED|Overall Study||34
69210|NCT02277665|168385|P1|STARTED|Overall Study||33
69211|NCT02277639|168403|P2|NOT COMPLETED|Overall Study||0
69212|NCT02277639|168404|P1|NOT COMPLETED|Overall Study||0
69213|NCT02277639|168403|P2|COMPLETED|Overall Study||2
69214|NCT02277639|168404|P1|COMPLETED|Overall Study||0
69215|NCT02277639|168403|P2|STARTED|Overall Study||2
69216|NCT02277639|168404|P1|STARTED|Overall Study||0
69217|NCT02277626|168410|P2|NOT COMPLETED|Overall Study||0
69218|NCT02277626|168411|P1|NOT COMPLETED|Overall Study||0
69219|NCT02277626|168410|P2|COMPLETED|Overall Study||9
69220|NCT02277626|168411|P1|COMPLETED|Overall Study||6
69221|NCT02277626|168410|P2|STARTED|Overall Study||9
69222|NCT02277626|168411|P1|STARTED|Overall Study||6
69223|NCT02277548|168427|P2|NOT COMPLETED|Overall Study||2
69224|NCT02277548|168428|P1|NOT COMPLETED|Overall Study||0
69225|NCT02277548|168427|P2|COMPLETED|Overall Study||9
69226|NCT02277548|168428|P1|COMPLETED|Overall Study||9
69227|NCT02277548|168427|P2|STARTED|Overall Study||11
69228|NCT02277548|168428|P1|STARTED|Overall Study||9
69229|NCT02277249|168436|P2|NOT COMPLETED|Overall Study||0
69230|NCT02277249|168437|P1|NOT COMPLETED|Overall Study||0
69231|NCT02277249|168436|P2|COMPLETED|Overall Study||30
69232|NCT02277249|168437|P1|COMPLETED|Overall Study||30
69233|NCT02277249|168436|P2|STARTED|Overall Study||30
69234|NCT02277249|168437|P1|STARTED|Overall Study||30
69235|NCT02277119|168446|P3|NOT COMPLETED|Overall Study||8
69236|NCT02277119|168447|P2|NOT COMPLETED|Overall Study||4
69237|NCT02277119|168448|P1|NOT COMPLETED|Overall Study||3
69238|NCT02277119|168446|P3|COMPLETED|Overall Study||19
69239|NCT02277119|168447|P2|COMPLETED|Overall Study||20
69240|NCT02277119|168448|P1|COMPLETED|Overall Study||55
69241|NCT02277119|168446|P3|STARTED|Overall Study||27
69242|NCT02277119|168447|P2|STARTED|Overall Study||24
69243|NCT02277119|168448|P1|STARTED|Overall Study||58
69244|NCT02277093|168465|P1|NOT COMPLETED|Overall Study||0
69245|NCT02277093|168465|P1|COMPLETED|Overall Study||11
69246|NCT02277093|168465|P1|STARTED|Overall Study||11
69247|NCT02277054|168473|P1|NOT COMPLETED|Overall Study||0
69248|NCT02277054|168473|P1|COMPLETED|Overall Study||5
69249|NCT02277054|168473|P1|STARTED|Overall Study||5
69250|NCT02276963|168479|P1|NOT COMPLETED|Overall Study||3
69251|NCT02276963|168479|P1|COMPLETED|Overall Study||3
69252|NCT02276963|168479|P1|STARTED|Overall Study||6
69253|NCT02276872|168486|P3|NOT COMPLETED|Overall Study||0
69254|NCT02276872|168487|P2|NOT COMPLETED|Overall Study||0
69255|NCT02276872|168488|P1|NOT COMPLETED|Overall Study||1
69256|NCT02276872|168486|P3|COMPLETED|Overall Study||12
69257|NCT02276872|168487|P2|COMPLETED|Overall Study||10
69258|NCT02276872|168488|P1|COMPLETED|Overall Study||9
69259|NCT02276872|168486|P3|STARTED|Overall Study||12
69260|NCT02276872|168487|P2|STARTED|Overall Study||10
69261|NCT02276872|168488|P1|STARTED|Overall Study||10
69262|NCT02276807|168564|P2|NOT COMPLETED|Overall Study||17
69263|NCT02276807|168565|P1|NOT COMPLETED|Overall Study||18
69264|NCT02276807|168564|P2|COMPLETED|Overall Study||55
69265|NCT02276807|168565|P1|COMPLETED|Overall Study||50
69266|NCT02276807|168564|P2|12-week Assessment|Overall Study||63
69267|NCT02276807|168565|P1|12-week Assessment|Overall Study||57
69268|NCT02276807|168564|P2|STARTED|Overall Study||72
69269|NCT02276807|168565|P1|STARTED|Overall Study||68
69270|NCT02276638|168582|P3|NOT COMPLETED|Overall Study||0
69271|NCT02276638|168583|P2|NOT COMPLETED|Overall Study||0
69272|NCT02276638|168584|P1|NOT COMPLETED|Overall Study||0
69273|NCT02276638|168582|P3|COMPLETED|Overall Study||23
69274|NCT02276638|168583|P2|COMPLETED|Overall Study||28
69275|NCT02276638|168584|P1|COMPLETED|Overall Study||28
69276|NCT02276638|168582|P3|STARTED|Overall Study||23
69277|NCT02276638|168583|P2|STARTED|Overall Study||28
69278|NCT02276638|168584|P1|STARTED|Overall Study||28
69279|NCT02276612|168600|P2|NOT COMPLETED|Overall Study||0
69280|NCT02276612|168601|P1|NOT COMPLETED|Overall Study||4
69281|NCT02276612|168600|P2|COMPLETED|Overall Study||10
69282|NCT02276612|168601|P1|COMPLETED|Overall Study||46
69283|NCT02276612|168600|P2|STARTED|Overall Study||10
69284|NCT02276612|168601|P1|STARTED|Overall Study||50
69285|NCT02276560|168624|P3|NOT COMPLETED|Overall Study||0
69286|NCT02276560|168625|P2|NOT COMPLETED|Overall Study||0
69287|NCT02276560|168626|P1|NOT COMPLETED|Overall Study||1
69288|NCT02276560|168624|P3|COMPLETED|Overall Study||0
69289|NCT02276560|168625|P2|COMPLETED|Overall Study||0
69290|NCT02276560|168626|P1|COMPLETED|Overall Study||0
69291|NCT02276560|168624|P3|STARTED|Overall Study||0
69292|NCT02276560|168625|P2|STARTED|Overall Study||0
69293|NCT02276560|168626|P1|STARTED|Overall Study||1
69294|NCT02276482|168636|P2|NOT COMPLETED|Overall Study||1
69295|NCT02276482|168637|P1|NOT COMPLETED|Overall Study||3
69296|NCT02276482|168636|P2|COMPLETED|Overall Study||28
69297|NCT02276482|168637|P1|COMPLETED|Overall Study||88
69298|NCT02276482|168636|P2|STARTED|Overall Study||29
69299|NCT02276482|168637|P1|STARTED|Overall Study||91
69300|NCT02276274|168661|P2|NOT COMPLETED|Second Intervention Period||0
69301|NCT02276274|168662|P1|NOT COMPLETED|Second Intervention Period||0
69302|NCT02276274|168661|P2|COMPLETED|Second Intervention Period||6
69303|NCT02276274|168662|P1|COMPLETED|Second Intervention Period||6
69304|NCT02276274|168661|P2|STARTED|Second Intervention Period||6
69305|NCT02276274|168662|P1|STARTED|Second Intervention Period||6
69306|NCT02276274|168661|P2|NOT COMPLETED|Washout Period (at Least 15 Days)||0
69307|NCT02276274|168662|P1|NOT COMPLETED|Washout Period (at Least 15 Days)||0
69308|NCT02276274|168661|P2|COMPLETED|Washout Period (at Least 15 Days)||6
69309|NCT02276274|168662|P1|COMPLETED|Washout Period (at Least 15 Days)||6
69310|NCT02276274|168661|P2|STARTED|Washout Period (at Least 15 Days)||6
69311|NCT02276274|168662|P1|STARTED|Washout Period (at Least 15 Days)||6
69312|NCT02276274|168661|P2|NOT COMPLETED|First Intervention Period||0
69313|NCT02276274|168662|P1|NOT COMPLETED|First Intervention Period||0
69314|NCT02276274|168661|P2|COMPLETED|First Intervention Period||6
69315|NCT02276274|168662|P1|COMPLETED|First Intervention Period||6
69316|NCT02276274|168661|P2|STARTED|First Intervention Period||6
69317|NCT02276274|168662|P1|STARTED|First Intervention Period||6
69318|NCT02276222|168772|P2|NOT COMPLETED|Overall Study||64
69319|NCT02276222|168773|P1|NOT COMPLETED|Overall Study||185
69320|NCT02276222|168772|P2|COMPLETED|Overall Study||402
69321|NCT02276222|168773|P1|COMPLETED|Overall Study|one subject withdrew at randomization due to a pre-treatment event prior to being dosed|436
69322|NCT02276222|168772|P2|STARTED|Overall Study||466
69323|NCT02276222|168773|P1|STARTED|Overall Study||621
69324|NCT02276053|168797|P1|NOT COMPLETED|Overall Study||14
69325|NCT02276053|168797|P1|COMPLETED|Overall Study||79
69326|NCT02276053|168797|P1|STARTED|Overall Study||93
69327|NCT02276040|168813|P1|NOT COMPLETED|Overall Study||15
69328|NCT02276040|168813|P1|COMPLETED|Overall Study||11
69329|NCT02276040|168813|P1|STARTED|Overall Study||26
69330|NCT02275923|168817|P1|NOT COMPLETED|Overall Study||2
69331|NCT02275923|168817|P1|COMPLETED|Overall Study||7
69332|NCT02275923|168817|P1|STARTED|Overall Study||9
69333|NCT02275780|168824|P2|NOT COMPLETED|Extension Study: up to 192 Weeks||233
69334|NCT02275780|168825|P1|NOT COMPLETED|Extension Study: up to 192 Weeks||260
69335|NCT02275780|168824|P2|COMPLETED|Extension Study: up to 192 Weeks|The extension study is ongoing|0
69336|NCT02275780|168825|P1|COMPLETED|Extension Study: up to 192 Weeks|The extension study is ongoing|0
69337|NCT02275780|168824|P2|STARTED|Extension Study: up to 192 Weeks|The extension study is optional; not all eligible participants enrolled|233
69338|NCT02275780|168825|P1|STARTED|Extension Study: up to 192 Weeks|The extension study is optional; not all eligible participants enrolled|260
69339|NCT02275780|168824|P2|NOT COMPLETED|Base Study: 96 Weeks||111
69340|NCT02275780|168825|P1|NOT COMPLETED|Base Study: 96 Weeks||93
69341|NCT02275780|168824|P2|COMPLETED|Base Study: 96 Weeks||273
69342|NCT02275780|168825|P1|COMPLETED|Base Study: 96 Weeks||292
69343|NCT02275780|168824|P2|Treated|Base Study: 96 Weeks||383
69344|NCT02275780|168825|P1|Treated|Base Study: 96 Weeks||383
69345|NCT02275780|168824|P2|STARTED|Base Study: 96 Weeks||384
69346|NCT02275780|168825|P1|STARTED|Base Study: 96 Weeks||385
69347|NCT02275767|168864|P3|NOT COMPLETED|Overall Study||3
69348|NCT02275767|168865|P2|NOT COMPLETED|Overall Study||4
69349|NCT02275767|168866|P1|NOT COMPLETED|Overall Study||2
69350|NCT02275767|168864|P3|COMPLETED|Overall Study||19
69351|NCT02275767|168865|P2|COMPLETED|Overall Study||18
69352|NCT02275767|168866|P1|COMPLETED|Overall Study||20
69353|NCT02275767|168864|P3|STARTED|Overall Study||22
69354|NCT02275767|168865|P2|STARTED|Overall Study||22
69355|NCT02275767|168866|P1|STARTED|Overall Study||22
69356|NCT02275611|168881|P4|NOT COMPLETED|Outpatient Drinking||0
69357|NCT02275611|168882|P3|NOT COMPLETED|Outpatient Drinking||0
69358|NCT02275611|168883|P2|NOT COMPLETED|Outpatient Drinking||0
69359|NCT02275611|168884|P1|NOT COMPLETED|Outpatient Drinking||0
69360|NCT02275611|168881|P4|COMPLETED|Outpatient Drinking||3
69361|NCT02275611|168882|P3|COMPLETED|Outpatient Drinking||6
69362|NCT02275611|168883|P2|COMPLETED|Outpatient Drinking||0
69363|NCT02275611|168884|P1|COMPLETED|Outpatient Drinking||0
69364|NCT02275611|168881|P4|STARTED|Outpatient Drinking||3
69365|NCT02275611|168882|P3|STARTED|Outpatient Drinking||6
69366|NCT02275611|168883|P2|STARTED|Outpatient Drinking||0
69367|NCT02275611|168884|P1|STARTED|Outpatient Drinking||0
69368|NCT02275611|168881|P4|NOT COMPLETED|Inpatient Withdrawal||0
69369|NCT02275611|168882|P3|NOT COMPLETED|Inpatient Withdrawal||0
69370|NCT02275611|168883|P2|NOT COMPLETED|Inpatient Withdrawal||0
69371|NCT02275611|168884|P1|NOT COMPLETED|Inpatient Withdrawal||1
69372|NCT02275611|168881|P4|COMPLETED|Inpatient Withdrawal||0
69373|NCT02275611|168882|P3|COMPLETED|Inpatient Withdrawal||0
69374|NCT02275611|168883|P2|COMPLETED|Inpatient Withdrawal||4
69375|NCT02275611|168884|P1|COMPLETED|Inpatient Withdrawal||4
69376|NCT02275611|168881|P4|STARTED|Inpatient Withdrawal||0
69377|NCT02275611|168882|P3|STARTED|Inpatient Withdrawal||0
69378|NCT02275611|168883|P2|STARTED|Inpatient Withdrawal||4
69379|NCT02275611|168884|P1|STARTED|Inpatient Withdrawal||5
69380|NCT02275546|168896|P2|NOT COMPLETED|Treatment Period 2||2
69381|NCT02275546|168897|P1|NOT COMPLETED|Treatment Period 2||2
69382|NCT02275546|168896|P2|COMPLETED|Treatment Period 2||81
69383|NCT02275546|168897|P1|COMPLETED|Treatment Period 2||79
69384|NCT02275546|168896|P2|STARTED|Treatment Period 2||83
69385|NCT02275546|168897|P1|STARTED|Treatment Period 2||81
69386|NCT02275546|168896|P2|NOT COMPLETED|Treatment Period 1||0
69387|NCT02275546|168897|P1|NOT COMPLETED|Treatment Period 1||0
69388|NCT02275546|168896|P2|COMPLETED|Treatment Period 1||83
69389|NCT02275546|168897|P1|COMPLETED|Treatment Period 1||81
69390|NCT02275546|168896|P2|STARTED|Treatment Period 1||83
69391|NCT02275546|168897|P1|STARTED|Treatment Period 1||81
69392|NCT02275481|168907|P2|NOT COMPLETED|Overall Study||3
69393|NCT02275481|168908|P1|NOT COMPLETED|Overall Study||9
69394|NCT02275481|168907|P2|COMPLETED|Overall Study||31
69395|NCT02275481|168908|P1|COMPLETED|Overall Study||23
69396|NCT02275481|168907|P2|STARTED|Overall Study||34
69397|NCT02275481|168908|P1|STARTED|Overall Study||32
69398|NCT02275364|168914|P2|NOT COMPLETED|Period 4||0
69399|NCT02275364|168915|P1|NOT COMPLETED|Period 4||0
69400|NCT02275364|168914|P2|COMPLETED|Period 4||14
69401|NCT02275364|168915|P1|COMPLETED|Period 4||12
69402|NCT02275364|168914|P2|STARTED|Period 4||14
69403|NCT02275364|168915|P1|STARTED|Period 4||12
69404|NCT02275364|168914|P2|NOT COMPLETED|Period 3||0
69405|NCT02275364|168915|P1|NOT COMPLETED|Period 3||0
69406|NCT02275364|168914|P2|COMPLETED|Period 3||14
69407|NCT02275364|168915|P1|COMPLETED|Period 3||12
69408|NCT02275364|168914|P2|STARTED|Period 3||14
69409|NCT02275364|168915|P1|STARTED|Period 3||12
69410|NCT02275364|168914|P2|NOT COMPLETED|Washout Period 2||0
69411|NCT02275364|168915|P1|NOT COMPLETED|Washout Period 2||0
69412|NCT02275364|168914|P2|COMPLETED|Washout Period 2||14
69413|NCT02275364|168915|P1|COMPLETED|Washout Period 2||12
69414|NCT02275364|168914|P2|STARTED|Washout Period 2||14
69415|NCT02275364|168915|P1|STARTED|Washout Period 2||12
69416|NCT02275364|168914|P2|NOT COMPLETED|Period 2||0
69417|NCT02275364|168915|P1|NOT COMPLETED|Period 2||0
69418|NCT02275364|168914|P2|COMPLETED|Period 2||14
69419|NCT02275364|168915|P1|COMPLETED|Period 2||12
69420|NCT02275364|168914|P2|STARTED|Period 2||14
69421|NCT02275364|168915|P1|STARTED|Period 2||12
69422|NCT02275364|168914|P2|NOT COMPLETED|Washout Period 1||0
69423|NCT02275364|168915|P1|NOT COMPLETED|Washout Period 1||0
69424|NCT02275364|168914|P2|COMPLETED|Washout Period 1||14
69425|NCT02275364|168915|P1|COMPLETED|Washout Period 1||12
69426|NCT02275364|168914|P2|STARTED|Washout Period 1||14
69427|NCT02275364|168915|P1|STARTED|Washout Period 1||12
69428|NCT02275364|168914|P2|NOT COMPLETED|Period 1||0
69429|NCT02275364|168915|P1|NOT COMPLETED|Period 1||2
69430|NCT02275364|168914|P2|COMPLETED|Period 1||14
69431|NCT02275364|168915|P1|COMPLETED|Period 1||12
69432|NCT02275364|168914|P2|STARTED|Period 1||14
69433|NCT02275364|168915|P1|STARTED|Period 1||14
69434|NCT02275338|168944|P1|NOT COMPLETED|Overall Study||33
69435|NCT02275338|168944|P1|COMPLETED|Overall Study||19
69436|NCT02275338|168944|P1|Started Phase 2|Overall Study||21
69437|NCT02275338|168944|P1|Completed Phase 1|Overall Study||25
69438|NCT02275338|168944|P1|STARTED|Overall Study||52
69439|NCT02275156|168959|P3|NOT COMPLETED|Overall Study||0
69440|NCT02275156|168960|P2|NOT COMPLETED|Overall Study||0
69441|NCT02275156|168961|P1|NOT COMPLETED|Overall Study||0
69442|NCT02275156|168959|P3|COMPLETED|Overall Study||6
69443|NCT02275156|168960|P2|COMPLETED|Overall Study||6
69444|NCT02275156|168961|P1|COMPLETED|Overall Study||6
69445|NCT02275156|168959|P3|STARTED|Overall Study||6
69446|NCT02275156|168960|P2|STARTED|Overall Study||6
69447|NCT02275156|168961|P1|STARTED|Overall Study||6
69448|NCT02275052|168988|P4|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||14
69449|NCT02275052|168989|P3|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||5
69450|NCT02275052|168990|P2|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
69451|NCT02275052|168991|P1|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
69452|NCT02275052|168988|P4|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||72
69453|NCT02275052|168989|P3|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||88
69454|NCT02275052|168990|P2|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
69455|NCT02275052|168991|P1|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
69456|NCT02275052|168988|P4|STARTED|Period 2: Treatment Period 2 (12 Weeks)||86
69457|NCT02275052|168989|P3|STARTED|Period 2: Treatment Period 2 (12 Weeks)||93
69458|NCT02275052|168990|P2|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
69459|NCT02275052|168991|P1|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
69460|NCT02275052|168988|P4|NOT COMPLETED|Washout Period (12-17 Days)||0
69461|NCT02275052|168989|P3|NOT COMPLETED|Washout Period (12-17 Days)||0
69462|NCT02275052|168990|P2|NOT COMPLETED|Washout Period (12-17 Days)||0
69463|NCT02275052|168991|P1|NOT COMPLETED|Washout Period (12-17 Days)||4
69464|NCT02275052|168988|P4|COMPLETED|Washout Period (12-17 Days)||0
69465|NCT02275052|168989|P3|COMPLETED|Washout Period (12-17 Days)||0
69466|NCT02275052|168990|P2|COMPLETED|Washout Period (12-17 Days)||93
69467|NCT02275052|168991|P1|COMPLETED|Washout Period (12-17 Days)||86
69468|NCT02275052|168988|P4|STARTED|Washout Period (12-17 Days)||0
69469|NCT02275052|168989|P3|STARTED|Washout Period (12-17 Days)||0
69470|NCT02275052|168990|P2|STARTED|Washout Period (12-17 Days)||93
69471|NCT02275052|168991|P1|STARTED|Washout Period (12-17 Days)||90
69472|NCT02275052|168988|P4|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
69473|NCT02275052|168989|P3|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
69474|NCT02275052|168990|P2|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||6
69475|NCT02275052|168991|P1|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||9
69476|NCT02275052|168988|P4|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
69477|NCT02275052|168989|P3|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
69478|NCT02275052|168990|P2|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||93
69479|NCT02275052|168991|P1|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||90
69480|NCT02275052|168988|P4|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
69481|NCT02275052|168989|P3|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
69482|NCT02275052|168990|P2|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
69483|NCT02275052|168991|P1|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
69484|NCT02274948|169005|P2|NOT COMPLETED|Overall Study||91
69485|NCT02274948|169006|P1|NOT COMPLETED|Overall Study||98
69486|NCT02274948|169005|P2|COMPLETED|Overall Study||82
69487|NCT02274948|169006|P1|COMPLETED|Overall Study||68
69488|NCT02274948|169005|P2|STARTED|Overall Study||173
69489|NCT02274948|169006|P1|STARTED|Overall Study||166
69490|NCT02274870|169022|P2|NOT COMPLETED|Overall Study||0
69491|NCT02274870|169023|P1|NOT COMPLETED|Overall Study||0
69492|NCT02274870|169022|P2|COMPLETED|Overall Study||33
69493|NCT02274870|169023|P1|COMPLETED|Overall Study||32
69494|NCT02274870|169022|P2|STARTED|Overall Study||33
69495|NCT02274870|169023|P1|STARTED|Overall Study||32
69496|NCT02274792|169047|P1|NOT COMPLETED|Overall Study||25
69497|NCT02274792|169047|P1|COMPLETED|Overall Study||107
69498|NCT02274792|169047|P1|Received Treatment|Overall Study||131
69499|NCT02274792|169047|P1|STARTED|Overall Study||132
69500|NCT02274766|169057|P2|NOT COMPLETED|Overall Study||9
69501|NCT02274766|169058|P1|NOT COMPLETED|Overall Study||4
69502|NCT02274766|169057|P2|COMPLETED|Overall Study||29
69503|NCT02274766|169058|P1|COMPLETED|Overall Study||35
69504|NCT02274766|169057|P2|Received Study Drug|Overall Study||37
69505|NCT02274766|169058|P1|Received Study Drug|Overall Study||38
69506|NCT02274766|169057|P2|STARTED|Overall Study||38
69507|NCT02274766|169058|P1|STARTED|Overall Study||39
69508|NCT02274688|169068|P2|NOT COMPLETED|Overall Study||13
69509|NCT02274688|169069|P1|NOT COMPLETED|Overall Study||14
69510|NCT02274688|169068|P2|COMPLETED|Overall Study||72
69511|NCT02274688|169069|P1|COMPLETED|Overall Study||72
69512|NCT02274688|169068|P2|STARTED|Overall Study||85
69513|NCT02274688|169069|P1|STARTED|Overall Study||86
69514|NCT02274675|169091|P1|NOT COMPLETED|Overall Study||0
69515|NCT02274675|169091|P1|COMPLETED|Overall Study||7
69516|NCT02274675|169091|P1|STARTED|Overall Study||7
69517|NCT02274649|169103|P2|NOT COMPLETED|Overall Study||12
69518|NCT02274649|169104|P1|NOT COMPLETED|Overall Study||24
69519|NCT02274649|169103|P2|COMPLETED|Overall Study||81
69520|NCT02274649|169104|P1|COMPLETED|Overall Study||77
69521|NCT02274649|169103|P2|STARTED|Overall Study||93
69522|NCT02274649|169104|P1|STARTED|Overall Study||101
69523|NCT02274558|169125|P3|NOT COMPLETED|Overall Study||9
69524|NCT02274558|169126|P2|NOT COMPLETED|Overall Study||13
69525|NCT02274558|169127|P1|NOT COMPLETED|Overall Study||7
69526|NCT02274558|169125|P3|COMPLETED|Overall Study||71
69527|NCT02274558|169126|P2|COMPLETED|Overall Study||63
69528|NCT02274558|169127|P1|COMPLETED|Overall Study||71
69529|NCT02274558|169125|P3|Included in the Safety Analysis Set|Overall Study||79
69530|NCT02274558|169126|P2|Included in the Safety Analysis Set|Overall Study||72
69531|NCT02274558|169127|P1|Included in the Safety Analysis Set|Overall Study||76
69532|NCT02274558|169125|P3|STARTED|Overall Study||80
69533|NCT02274558|169126|P2|STARTED|Overall Study||76
69534|NCT02274558|169127|P1|STARTED|Overall Study||78
69535|NCT02274493|169141|P1|NOT COMPLETED|Overall Study||1
69536|NCT02274493|169141|P1|COMPLETED|Overall Study||14
69537|NCT02274493|169141|P1|STARTED|Overall Study||15
69538|NCT02274311|169148|P1|NOT COMPLETED|Three Months of Clomiphene Wash-out||1
69539|NCT02274311|169148|P1|COMPLETED|Three Months of Clomiphene Wash-out||15
69540|NCT02274311|169148|P1|STARTED|Three Months of Clomiphene Wash-out||16
69541|NCT02274311|169148|P1|NOT COMPLETED|Three Months of Clomiphene Treatment||0
69542|NCT02274311|169148|P1|COMPLETED|Three Months of Clomiphene Treatment||16
69543|NCT02274311|169148|P1|STARTED|Three Months of Clomiphene Treatment||16
69544|NCT02273973|169156|P2|NOT COMPLETED|Overall Study||8
69545|NCT02273973|169157|P1|NOT COMPLETED|Overall Study||9
69546|NCT02273973|169156|P2|COMPLETED|Overall Study||160
69547|NCT02273973|169157|P1|COMPLETED|Overall Study||157
69548|NCT02273973|169156|P2|STARTED|Overall Study||168
69549|NCT02273973|169157|P1|STARTED|Overall Study||166
69550|NCT02273960|169201|P4|NOT COMPLETED|Long Term Extension||1
69551|NCT02273960|169202|P3|NOT COMPLETED|Long Term Extension||0
69552|NCT02273960|169203|P2|NOT COMPLETED|Long Term Extension||0
69553|NCT02273960|169204|P1|NOT COMPLETED|Long Term Extension||0
69554|NCT02273960|169201|P4|COMPLETED|Long Term Extension||3
69555|NCT02273960|169202|P3|COMPLETED|Long Term Extension||1
69556|NCT02273960|169203|P2|COMPLETED|Long Term Extension||0
69557|NCT02273960|169204|P1|COMPLETED|Long Term Extension||0
69558|NCT02273960|169201|P4|STARTED|Long Term Extension||4
69559|NCT02273960|169202|P3|STARTED|Long Term Extension||1
69560|NCT02273960|169203|P2|STARTED|Long Term Extension||0
69561|NCT02273960|169204|P1|STARTED|Long Term Extension||0
69562|NCT02273960|169201|P4|NOT COMPLETED|Short Term Period||6
69563|NCT02273960|169202|P3|NOT COMPLETED|Short Term Period||4
69564|NCT02273960|169203|P2|NOT COMPLETED|Short Term Period||6
69565|NCT02273960|169204|P1|NOT COMPLETED|Short Term Period||5
69566|NCT02273960|169201|P4|COMPLETED|Short Term Period||4
69567|NCT02273960|169202|P3|COMPLETED|Short Term Period||1
69568|NCT02273960|169203|P2|COMPLETED|Short Term Period||0
69569|NCT02273960|169204|P1|COMPLETED|Short Term Period||0
69570|NCT02273960|169201|P4|STARTED|Short Term Period||10
69571|NCT02273960|169202|P3|STARTED|Short Term Period||5
69572|NCT02273960|169203|P2|STARTED|Short Term Period||6
69573|NCT02273960|169204|P1|STARTED|Short Term Period||5
69574|NCT02273908|169248|P2|NOT COMPLETED|Overall Study||5
69575|NCT02273908|169249|P1|NOT COMPLETED|Overall Study||33
69576|NCT02273908|169248|P2|COMPLETED|Overall Study||169
69577|NCT02273908|169249|P1|COMPLETED|Overall Study||124
69578|NCT02273908|169248|P2|STARTED|Overall Study||174
69579|NCT02273908|169249|P1|STARTED|Overall Study||157
69580|NCT02273752|169271|P1|NOT COMPLETED|Overall Study||2
69581|NCT02273752|169271|P1|COMPLETED|Overall Study||0
69582|NCT02273752|169271|P1|STARTED|Overall Study||2
69583|NCT02273323|169282|P2|NOT COMPLETED|Overall Study||0
69584|NCT02273323|169283|P1|NOT COMPLETED|Overall Study||0
69585|NCT02273323|169282|P2|COMPLETED|Overall Study||15
69586|NCT02273323|169283|P1|COMPLETED|Overall Study||15
69587|NCT02273323|169282|P2|STARTED|Overall Study||15
69588|NCT02273323|169283|P1|STARTED|Overall Study||15
69589|NCT02273310|169301|P2|NOT COMPLETED|Overall Study||3
69590|NCT02273310|169302|P1|NOT COMPLETED|Overall Study||18
69591|NCT02273310|169301|P2|COMPLETED|Overall Study||38
69592|NCT02273310|169302|P1|COMPLETED|Overall Study||24
69593|NCT02273310|169301|P2|STARTED|Overall Study||41
69594|NCT02273310|169302|P1|STARTED|Overall Study||42
69595|NCT02273180|169315|P2|NOT COMPLETED|Overall Study||19
69596|NCT02273180|169316|P1|NOT COMPLETED|Overall Study||27
69597|NCT02273180|169315|P2|COMPLETED|Overall Study||235
69598|NCT02273180|169316|P1|COMPLETED|Overall Study||226
69599|NCT02273180|169315|P2|Treated|Overall Study||254
69600|NCT02273180|169316|P1|Treated|Overall Study||252
69601|NCT02273180|169315|P2|STARTED|Overall Study||254
69602|NCT02273180|169316|P1|STARTED|Overall Study||253
69603|NCT02273167|169341|P3|NOT COMPLETED|Overall Study||21
69604|NCT02273167|169342|P2|NOT COMPLETED|Overall Study||23
69605|NCT02273167|169343|P1|NOT COMPLETED|Overall Study||24
69606|NCT02273167|169341|P3|COMPLETED|Overall Study||262
69607|NCT02273167|169342|P2|COMPLETED|Overall Study||260
69608|NCT02273167|169343|P1|COMPLETED|Overall Study||259
69609|NCT02273167|169341|P3|STARTED|Overall Study||283
69610|NCT02273167|169342|P2|STARTED|Overall Study||283
69611|NCT02273167|169343|P1|STARTED|Overall Study||283
69612|NCT02273141|169368|P2|NOT COMPLETED|Overall Study||25
69613|NCT02273141|169369|P1|NOT COMPLETED|Overall Study||17
69614|NCT02273141|169368|P2|COMPLETED|Overall Study||233
69615|NCT02273141|169369|P1|COMPLETED|Overall Study||240
69616|NCT02273141|169368|P2|STARTED|Overall Study||258
69617|NCT02273141|169369|P1|STARTED|Overall Study||257
69618|NCT02273115|169389|P4|NOT COMPLETED|Overall Study||1
69619|NCT02273115|169390|P3|NOT COMPLETED|Overall Study||0
69620|NCT02273115|169391|P2|NOT COMPLETED|Overall Study||0
69621|NCT02273115|169392|P1|NOT COMPLETED|Overall Study||0
69622|NCT02273115|169389|P4|COMPLETED|Overall Study||71
69623|NCT02273115|169390|P3|COMPLETED|Overall Study||67
69624|NCT02273115|169391|P2|COMPLETED|Overall Study||90
69625|NCT02273115|169392|P1|COMPLETED|Overall Study||94
69626|NCT02273115|169389|P4|STARTED|Overall Study||72
69627|NCT02273115|169390|P3|STARTED|Overall Study||67
69628|NCT02273115|169391|P2|STARTED|Overall Study||90
69629|NCT02273115|169392|P1|STARTED|Overall Study||94
69630|NCT02273063|169434|P1|NOT COMPLETED|Overall Study||5
69631|NCT02273063|169434|P1|COMPLETED|Overall Study||35
69632|NCT02273063|169434|P1|STARTED|Overall Study||40
69633|NCT02273050|169442|P3|NOT COMPLETED|Overall Study||29
69634|NCT02273050|169443|P2|NOT COMPLETED|Overall Study||22
69635|NCT02273050|169444|P1|NOT COMPLETED|Overall Study||24
69636|NCT02273050|169442|P3|COMPLETED|Overall Study||185
69637|NCT02273050|169443|P2|COMPLETED|Overall Study||194
69638|NCT02273050|169444|P1|COMPLETED|Overall Study||186
69639|NCT02273050|169442|P3|STARTED|Overall Study||214
69640|NCT02273050|169443|P2|STARTED|Overall Study||216
69641|NCT02273050|169444|P1|STARTED|Overall Study||210
69642|NCT02273037|169472|P2|NOT COMPLETED|Overall Study||8
69643|NCT02273037|169473|P1|NOT COMPLETED|Overall Study||8
69644|NCT02273037|169472|P2|COMPLETED|Overall Study||992
69645|NCT02273037|169473|P1|COMPLETED|Overall Study||979
69646|NCT02273037|169472|P2|STARTED|Overall Study||1000
69647|NCT02273037|169473|P1|STARTED|Overall Study||987
69648|NCT02272985|169483|P1|NOT COMPLETED|Overall Study||3
69649|NCT02272985|169483|P1|COMPLETED|Overall Study||12
69650|NCT02272985|169483|P1|STARTED|Overall Study||15
69651|NCT02272816|169488|P1|NOT COMPLETED|Overall Study||1
69652|NCT02272816|169488|P1|COMPLETED|Overall Study||47
69653|NCT02272816|169488|P1|STARTED|Overall Study||48
69654|NCT02272803|169496|P2|NOT COMPLETED|Overall Study||17
69655|NCT02272803|169497|P1|NOT COMPLETED|Overall Study||9
69656|NCT02272803|169496|P2|COMPLETED|Overall Study|Completed = Still receiving treatment|25
69657|NCT02272803|169497|P1|COMPLETED|Overall Study|Completed = Still receiving treatment|31
69658|NCT02272803|169496|P2|STARTED|Overall Study||42
69659|NCT02272803|169497|P1|STARTED|Overall Study||40
69660|NCT02272790|169514|P6|NOT COMPLETED|Overall Study||0
69661|NCT02272790|169515|P5|NOT COMPLETED|Overall Study||0
69662|NCT02272790|169516|P4|NOT COMPLETED|Overall Study||0
69663|NCT02272790|169517|P3|NOT COMPLETED|Overall Study||0
69664|NCT02272790|169518|P2|NOT COMPLETED|Overall Study||1
69665|NCT02272790|169519|P1|NOT COMPLETED|Overall Study||0
69666|NCT02272790|169514|P6|COMPLETED|Overall Study||6
69667|NCT02272790|169515|P5|COMPLETED|Overall Study||6
69668|NCT02272790|169516|P4|COMPLETED|Overall Study||12
69669|NCT02272790|169517|P3|COMPLETED|Overall Study||23
69670|NCT02272790|169518|P2|COMPLETED|Overall Study||38
69671|NCT02272790|169519|P1|COMPLETED|Overall Study||9
69672|NCT02272790|169514|P6|STARTED|Overall Study||6
69673|NCT02272790|169515|P5|STARTED|Overall Study||6
69674|NCT02272790|169516|P4|STARTED|Overall Study||12
69675|NCT02272790|169517|P3|STARTED|Overall Study||23
69676|NCT02272790|169518|P2|STARTED|Overall Study||39
69677|NCT02272790|169519|P1|STARTED|Overall Study||9
69678|NCT02272777|169655|P2|NOT COMPLETED|Overall Study||4
69679|NCT02272777|169656|P1|NOT COMPLETED|Overall Study||4
69680|NCT02272777|169655|P2|COMPLETED|Overall Study||109
69681|NCT02272777|169656|P1|COMPLETED|Overall Study||108
69682|NCT02272777|169655|P2|STARTED|Overall Study||113
69683|NCT02272777|169656|P1|STARTED|Overall Study||112
69684|NCT02272725|169664|P2|NOT COMPLETED|Overall Study||0
69685|NCT02272725|169665|P1|NOT COMPLETED|Overall Study||2
69686|NCT02272725|169664|P2|COMPLETED|Overall Study||42
69687|NCT02272725|169665|P1|COMPLETED|Overall Study||47
69688|NCT02272725|169664|P2|STARTED|Overall Study||42
69689|NCT02272725|169665|P1|STARTED|Overall Study||49
69690|NCT02272686|169675|P1|NOT COMPLETED|Overall Study||0
69691|NCT02272686|169675|P1|COMPLETED|Overall Study||1
69692|NCT02272686|169675|P1|STARTED|Overall Study||1
69693|NCT02272244|169682|P2|NOT COMPLETED|Overall Study||0
69694|NCT02272244|169683|P1|NOT COMPLETED|Overall Study||0
69695|NCT02272244|169682|P2|COMPLETED|Overall Study||197
69696|NCT02272244|169683|P1|COMPLETED|Overall Study||203
69697|NCT02272244|169682|P2|STARTED|Overall Study||197
69698|NCT02272244|169683|P1|STARTED|Overall Study||203
69699|NCT02271984|169695|P12|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
69700|NCT02271984|169696|P11|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
69701|NCT02271984|169697|P10|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
69702|NCT02271984|169698|P9|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
69703|NCT02271984|169699|P8|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
69704|NCT02271984|169700|P7|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
69705|NCT02271984|169701|P6|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
69706|NCT02271984|169702|P5|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
69707|NCT02271984|169703|P4|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
69708|NCT02271984|169704|P3|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
69709|NCT02271984|169705|P2|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
69710|NCT02271984|169706|P1|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
69711|NCT02271984|169695|P12|COMPLETED|Fifth Intervention Period (1 Day)||3
69712|NCT02271984|169696|P11|COMPLETED|Fifth Intervention Period (1 Day)||3
69713|NCT02271984|169697|P10|COMPLETED|Fifth Intervention Period (1 Day)||3
69714|NCT02271984|169698|P9|COMPLETED|Fifth Intervention Period (1 Day)||3
69715|NCT02271984|169699|P8|COMPLETED|Fifth Intervention Period (1 Day)||2
69716|NCT02271984|169700|P7|COMPLETED|Fifth Intervention Period (1 Day)||3
69717|NCT02271984|169701|P6|COMPLETED|Fifth Intervention Period (1 Day)||2
69718|NCT02271984|169702|P5|COMPLETED|Fifth Intervention Period (1 Day)||3
69719|NCT02271984|169703|P4|COMPLETED|Fifth Intervention Period (1 Day)||3
69720|NCT02271984|169704|P3|COMPLETED|Fifth Intervention Period (1 Day)||3
69721|NCT02271984|169705|P2|COMPLETED|Fifth Intervention Period (1 Day)||3
69722|NCT02271984|169706|P1|COMPLETED|Fifth Intervention Period (1 Day)||3
69723|NCT02271984|169695|P12|STARTED|Fifth Intervention Period (1 Day)||3
69724|NCT02271984|169696|P11|STARTED|Fifth Intervention Period (1 Day)||3
69725|NCT02271984|169697|P10|STARTED|Fifth Intervention Period (1 Day)||3
69726|NCT02271984|169698|P9|STARTED|Fifth Intervention Period (1 Day)||3
69727|NCT02271984|169699|P8|STARTED|Fifth Intervention Period (1 Day)||2
69728|NCT02271984|169700|P7|STARTED|Fifth Intervention Period (1 Day)||3
69729|NCT02271984|169701|P6|STARTED|Fifth Intervention Period (1 Day)||2
69730|NCT02271984|169702|P5|STARTED|Fifth Intervention Period (1 Day)||3
69731|NCT02271984|169703|P4|STARTED|Fifth Intervention Period (1 Day)||3
69732|NCT02271984|169704|P3|STARTED|Fifth Intervention Period (1 Day)||3
69733|NCT02271984|169705|P2|STARTED|Fifth Intervention Period (1 Day)||3
69734|NCT02271984|169706|P1|STARTED|Fifth Intervention Period (1 Day)||3
69735|NCT02271984|169695|P12|NOT COMPLETED|Washout Period 4 (7 Days)||0
69736|NCT02271984|169696|P11|NOT COMPLETED|Washout Period 4 (7 Days)||0
69737|NCT02271984|169697|P10|NOT COMPLETED|Washout Period 4 (7 Days)||0
69738|NCT02271984|169698|P9|NOT COMPLETED|Washout Period 4 (7 Days)||0
69739|NCT02271984|169699|P8|NOT COMPLETED|Washout Period 4 (7 Days)||1
69740|NCT02271984|169700|P7|NOT COMPLETED|Washout Period 4 (7 Days)||0
69741|NCT02271984|169701|P6|NOT COMPLETED|Washout Period 4 (7 Days)||1
69742|NCT02271984|169702|P5|NOT COMPLETED|Washout Period 4 (7 Days)||0
69743|NCT02271984|169703|P4|NOT COMPLETED|Washout Period 4 (7 Days)||0
69744|NCT02271984|169704|P3|NOT COMPLETED|Washout Period 4 (7 Days)||0
69745|NCT02271984|169705|P2|NOT COMPLETED|Washout Period 4 (7 Days)||0
69746|NCT02271984|169706|P1|NOT COMPLETED|Washout Period 4 (7 Days)||0
69747|NCT02271984|169695|P12|COMPLETED|Washout Period 4 (7 Days)||3
69748|NCT02271984|169696|P11|COMPLETED|Washout Period 4 (7 Days)||3
69749|NCT02271984|169697|P10|COMPLETED|Washout Period 4 (7 Days)||3
69750|NCT02271984|169698|P9|COMPLETED|Washout Period 4 (7 Days)||3
69751|NCT02271984|169699|P8|COMPLETED|Washout Period 4 (7 Days)||2
69752|NCT02271984|169700|P7|COMPLETED|Washout Period 4 (7 Days)||3
69753|NCT02271984|169701|P6|COMPLETED|Washout Period 4 (7 Days)||2
69754|NCT02271984|169702|P5|COMPLETED|Washout Period 4 (7 Days)||3
69755|NCT02271984|169703|P4|COMPLETED|Washout Period 4 (7 Days)||3
69756|NCT02271984|169704|P3|COMPLETED|Washout Period 4 (7 Days)||3
69757|NCT02271984|169705|P2|COMPLETED|Washout Period 4 (7 Days)||3
69758|NCT02271984|169706|P1|COMPLETED|Washout Period 4 (7 Days)||3
69759|NCT02271984|169695|P12|STARTED|Washout Period 4 (7 Days)||3
69760|NCT02271984|169696|P11|STARTED|Washout Period 4 (7 Days)||3
69761|NCT02271984|169697|P10|STARTED|Washout Period 4 (7 Days)||3
69762|NCT02271984|169698|P9|STARTED|Washout Period 4 (7 Days)||3
69763|NCT02271984|169699|P8|STARTED|Washout Period 4 (7 Days)||3
69764|NCT02271984|169700|P7|STARTED|Washout Period 4 (7 Days)||3
69765|NCT02271984|169701|P6|STARTED|Washout Period 4 (7 Days)||3
69766|NCT02271984|169702|P5|STARTED|Washout Period 4 (7 Days)||3
69767|NCT02271984|169703|P4|STARTED|Washout Period 4 (7 Days)||3
69768|NCT02271984|169704|P3|STARTED|Washout Period 4 (7 Days)||3
69769|NCT02271984|169705|P2|STARTED|Washout Period 4 (7 Days)||3
69770|NCT02271984|169706|P1|STARTED|Washout Period 4 (7 Days)||3
69771|NCT02271984|169695|P12|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
69772|NCT02271984|169696|P11|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
69773|NCT02271984|169697|P10|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
69774|NCT02271984|169698|P9|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
69775|NCT02271984|169699|P8|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
69776|NCT02271984|169700|P7|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
69777|NCT02271984|169701|P6|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
69778|NCT02271984|169702|P5|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
69779|NCT02271984|169703|P4|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
69780|NCT02271984|169704|P3|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
69781|NCT02271984|169705|P2|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
69782|NCT02271984|169706|P1|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
69783|NCT02271984|169695|P12|COMPLETED|Fourth Intervention Period (Day 1)||3
69784|NCT02271984|169696|P11|COMPLETED|Fourth Intervention Period (Day 1)||3
69785|NCT02271984|169697|P10|COMPLETED|Fourth Intervention Period (Day 1)||3
69786|NCT02271984|169698|P9|COMPLETED|Fourth Intervention Period (Day 1)||3
69787|NCT02271984|169699|P8|COMPLETED|Fourth Intervention Period (Day 1)||3
69788|NCT02271984|169700|P7|COMPLETED|Fourth Intervention Period (Day 1)||3
69789|NCT02271984|169701|P6|COMPLETED|Fourth Intervention Period (Day 1)||3
69790|NCT02271984|169702|P5|COMPLETED|Fourth Intervention Period (Day 1)||3
69791|NCT02271984|169703|P4|COMPLETED|Fourth Intervention Period (Day 1)||3
69792|NCT02271984|169704|P3|COMPLETED|Fourth Intervention Period (Day 1)||3
69793|NCT02271984|169705|P2|COMPLETED|Fourth Intervention Period (Day 1)||3
69794|NCT02271984|169706|P1|COMPLETED|Fourth Intervention Period (Day 1)||3
69795|NCT02271984|169695|P12|STARTED|Fourth Intervention Period (Day 1)||3
69796|NCT02271984|169696|P11|STARTED|Fourth Intervention Period (Day 1)||3
69797|NCT02271984|169697|P10|STARTED|Fourth Intervention Period (Day 1)||3
69798|NCT02271984|169698|P9|STARTED|Fourth Intervention Period (Day 1)||3
69799|NCT02271984|169699|P8|STARTED|Fourth Intervention Period (Day 1)||3
69800|NCT02271984|169700|P7|STARTED|Fourth Intervention Period (Day 1)||3
69801|NCT02271984|169701|P6|STARTED|Fourth Intervention Period (Day 1)||3
69802|NCT02271984|169702|P5|STARTED|Fourth Intervention Period (Day 1)||3
69803|NCT02271984|169703|P4|STARTED|Fourth Intervention Period (Day 1)||3
69804|NCT02271984|169704|P3|STARTED|Fourth Intervention Period (Day 1)||3
69805|NCT02271984|169705|P2|STARTED|Fourth Intervention Period (Day 1)||3
69806|NCT02271984|169706|P1|STARTED|Fourth Intervention Period (Day 1)||3
69807|NCT02271984|169695|P12|NOT COMPLETED|Washout Period 3 (7 Days)||0
69808|NCT02271984|169696|P11|NOT COMPLETED|Washout Period 3 (7 Days)||0
69809|NCT02271984|169697|P10|NOT COMPLETED|Washout Period 3 (7 Days)||0
69810|NCT02271984|169698|P9|NOT COMPLETED|Washout Period 3 (7 Days)||0
69811|NCT02271984|169699|P8|NOT COMPLETED|Washout Period 3 (7 Days)||0
69812|NCT02271984|169700|P7|NOT COMPLETED|Washout Period 3 (7 Days)||0
69813|NCT02271984|169701|P6|NOT COMPLETED|Washout Period 3 (7 Days)||0
69814|NCT02271984|169702|P5|NOT COMPLETED|Washout Period 3 (7 Days)||0
69815|NCT02271984|169703|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
69816|NCT02271984|169704|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
69817|NCT02271984|169705|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
69818|NCT02271984|169706|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
69819|NCT02271984|169695|P12|COMPLETED|Washout Period 3 (7 Days)||3
69820|NCT02271984|169696|P11|COMPLETED|Washout Period 3 (7 Days)||3
69821|NCT02271984|169697|P10|COMPLETED|Washout Period 3 (7 Days)||3
69822|NCT02271984|169698|P9|COMPLETED|Washout Period 3 (7 Days)||3
69823|NCT02271984|169699|P8|COMPLETED|Washout Period 3 (7 Days)||3
69824|NCT02271984|169700|P7|COMPLETED|Washout Period 3 (7 Days)||3
69825|NCT02271984|169701|P6|COMPLETED|Washout Period 3 (7 Days)||3
69826|NCT02271984|169702|P5|COMPLETED|Washout Period 3 (7 Days)||3
69827|NCT02271984|169703|P4|COMPLETED|Washout Period 3 (7 Days)||3
69828|NCT02271984|169704|P3|COMPLETED|Washout Period 3 (7 Days)||3
69829|NCT02271984|169705|P2|COMPLETED|Washout Period 3 (7 Days)||3
69830|NCT02271984|169706|P1|COMPLETED|Washout Period 3 (7 Days)||3
69831|NCT02271984|169695|P12|STARTED|Washout Period 3 (7 Days)||3
69832|NCT02271984|169696|P11|STARTED|Washout Period 3 (7 Days)||3
69833|NCT02271984|169697|P10|STARTED|Washout Period 3 (7 Days)||3
69834|NCT02271984|169698|P9|STARTED|Washout Period 3 (7 Days)||3
69835|NCT02271984|169699|P8|STARTED|Washout Period 3 (7 Days)||3
69836|NCT02271984|169700|P7|STARTED|Washout Period 3 (7 Days)||3
69837|NCT02271984|169701|P6|STARTED|Washout Period 3 (7 Days)||3
69838|NCT02271984|169702|P5|STARTED|Washout Period 3 (7 Days)||3
69839|NCT02271984|169703|P4|STARTED|Washout Period 3 (7 Days)||3
69840|NCT02271984|169704|P3|STARTED|Washout Period 3 (7 Days)||3
69841|NCT02271984|169705|P2|STARTED|Washout Period 3 (7 Days)||3
69842|NCT02271984|169706|P1|STARTED|Washout Period 3 (7 Days)||3
69843|NCT02271984|169695|P12|NOT COMPLETED|Third Intervention Period (1 Day)||0
69844|NCT02271984|169696|P11|NOT COMPLETED|Third Intervention Period (1 Day)||0
69845|NCT02271984|169697|P10|NOT COMPLETED|Third Intervention Period (1 Day)||0
69846|NCT02271984|169698|P9|NOT COMPLETED|Third Intervention Period (1 Day)||0
69847|NCT02271984|169699|P8|NOT COMPLETED|Third Intervention Period (1 Day)||0
69848|NCT02271984|169700|P7|NOT COMPLETED|Third Intervention Period (1 Day)||0
69849|NCT02271984|169701|P6|NOT COMPLETED|Third Intervention Period (1 Day)||0
69850|NCT02271984|169702|P5|NOT COMPLETED|Third Intervention Period (1 Day)||0
69851|NCT02271984|169703|P4|NOT COMPLETED|Third Intervention Period (1 Day)||0
69852|NCT02271984|169704|P3|NOT COMPLETED|Third Intervention Period (1 Day)||0
69853|NCT02271984|169705|P2|NOT COMPLETED|Third Intervention Period (1 Day)||0
69854|NCT02271984|169706|P1|NOT COMPLETED|Third Intervention Period (1 Day)||0
69855|NCT02271984|169695|P12|COMPLETED|Third Intervention Period (1 Day)||3
69856|NCT02271984|169696|P11|COMPLETED|Third Intervention Period (1 Day)||3
69857|NCT02271984|169697|P10|COMPLETED|Third Intervention Period (1 Day)||3
69858|NCT02271984|169698|P9|COMPLETED|Third Intervention Period (1 Day)||3
69859|NCT02271984|169699|P8|COMPLETED|Third Intervention Period (1 Day)||3
69860|NCT02271984|169700|P7|COMPLETED|Third Intervention Period (1 Day)||3
69861|NCT02271984|169701|P6|COMPLETED|Third Intervention Period (1 Day)||3
69862|NCT02271984|169702|P5|COMPLETED|Third Intervention Period (1 Day)||3
69863|NCT02271984|169703|P4|COMPLETED|Third Intervention Period (1 Day)||3
69864|NCT02271984|169704|P3|COMPLETED|Third Intervention Period (1 Day)||3
69865|NCT02271984|169705|P2|COMPLETED|Third Intervention Period (1 Day)||3
69866|NCT02271984|169706|P1|COMPLETED|Third Intervention Period (1 Day)||3
69867|NCT02271984|169695|P12|STARTED|Third Intervention Period (1 Day)||3
69868|NCT02271984|169696|P11|STARTED|Third Intervention Period (1 Day)||3
69869|NCT02271984|169697|P10|STARTED|Third Intervention Period (1 Day)||3
69870|NCT02271984|169698|P9|STARTED|Third Intervention Period (1 Day)||3
69871|NCT02271984|169699|P8|STARTED|Third Intervention Period (1 Day)||3
69872|NCT02271984|169700|P7|STARTED|Third Intervention Period (1 Day)||3
69873|NCT02271984|169701|P6|STARTED|Third Intervention Period (1 Day)||3
69874|NCT02271984|169702|P5|STARTED|Third Intervention Period (1 Day)||3
69875|NCT02271984|169703|P4|STARTED|Third Intervention Period (1 Day)||3
69876|NCT02271984|169704|P3|STARTED|Third Intervention Period (1 Day)||3
69877|NCT02271984|169705|P2|STARTED|Third Intervention Period (1 Day)||3
69878|NCT02271984|169706|P1|STARTED|Third Intervention Period (1 Day)||3
69879|NCT02271984|169695|P12|NOT COMPLETED|Washout Period 2 (7 Days)||0
69880|NCT02271984|169696|P11|NOT COMPLETED|Washout Period 2 (7 Days)||0
69881|NCT02271984|169697|P10|NOT COMPLETED|Washout Period 2 (7 Days)||0
69882|NCT02271984|169698|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
69883|NCT02271984|169699|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
69884|NCT02271984|169700|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
69885|NCT02271984|169701|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
69886|NCT02271984|169702|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
69887|NCT02271984|169703|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
69888|NCT02271984|169704|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
69889|NCT02271984|169705|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
69890|NCT02271984|169706|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
69891|NCT02271984|169695|P12|COMPLETED|Washout Period 2 (7 Days)||3
69892|NCT02271984|169696|P11|COMPLETED|Washout Period 2 (7 Days)||3
69893|NCT02271984|169697|P10|COMPLETED|Washout Period 2 (7 Days)||3
69894|NCT02271984|169698|P9|COMPLETED|Washout Period 2 (7 Days)||3
69895|NCT02271984|169699|P8|COMPLETED|Washout Period 2 (7 Days)||3
69896|NCT02271984|169700|P7|COMPLETED|Washout Period 2 (7 Days)||3
69897|NCT02271984|169701|P6|COMPLETED|Washout Period 2 (7 Days)||3
69898|NCT02271984|169702|P5|COMPLETED|Washout Period 2 (7 Days)||3
69899|NCT02271984|169703|P4|COMPLETED|Washout Period 2 (7 Days)||3
69900|NCT02271984|169704|P3|COMPLETED|Washout Period 2 (7 Days)||3
69901|NCT02271984|169705|P2|COMPLETED|Washout Period 2 (7 Days)||3
69902|NCT02271984|169706|P1|COMPLETED|Washout Period 2 (7 Days)||3
69903|NCT02271984|169695|P12|STARTED|Washout Period 2 (7 Days)||3
69904|NCT02271984|169696|P11|STARTED|Washout Period 2 (7 Days)||3
69905|NCT02271984|169697|P10|STARTED|Washout Period 2 (7 Days)||3
69906|NCT02271984|169698|P9|STARTED|Washout Period 2 (7 Days)||3
69907|NCT02271984|169699|P8|STARTED|Washout Period 2 (7 Days)||3
69908|NCT02271984|169700|P7|STARTED|Washout Period 2 (7 Days)||3
69909|NCT02271984|169701|P6|STARTED|Washout Period 2 (7 Days)||3
69910|NCT02271984|169702|P5|STARTED|Washout Period 2 (7 Days)||3
69911|NCT02271984|169703|P4|STARTED|Washout Period 2 (7 Days)||3
69912|NCT02271984|169704|P3|STARTED|Washout Period 2 (7 Days)||3
69913|NCT02271984|169705|P2|STARTED|Washout Period 2 (7 Days)||3
69914|NCT02271984|169706|P1|STARTED|Washout Period 2 (7 Days)||3
69915|NCT02271984|169695|P12|NOT COMPLETED|Second Intervention Period (1 Day)||0
69916|NCT02271984|169696|P11|NOT COMPLETED|Second Intervention Period (1 Day)||0
69917|NCT02271984|169697|P10|NOT COMPLETED|Second Intervention Period (1 Day)||0
69918|NCT02271984|169698|P9|NOT COMPLETED|Second Intervention Period (1 Day)||0
69919|NCT02271984|169699|P8|NOT COMPLETED|Second Intervention Period (1 Day)||0
69920|NCT02271984|169700|P7|NOT COMPLETED|Second Intervention Period (1 Day)||0
69921|NCT02271984|169701|P6|NOT COMPLETED|Second Intervention Period (1 Day)||0
69922|NCT02271984|169702|P5|NOT COMPLETED|Second Intervention Period (1 Day)||0
69923|NCT02271984|169703|P4|NOT COMPLETED|Second Intervention Period (1 Day)||0
69924|NCT02271984|169704|P3|NOT COMPLETED|Second Intervention Period (1 Day)||0
69925|NCT02271984|169705|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
69926|NCT02271984|169706|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
69927|NCT02271984|169695|P12|COMPLETED|Second Intervention Period (1 Day)||3
69928|NCT02271984|169696|P11|COMPLETED|Second Intervention Period (1 Day)||3
69929|NCT02271984|169697|P10|COMPLETED|Second Intervention Period (1 Day)||3
69930|NCT02271984|169698|P9|COMPLETED|Second Intervention Period (1 Day)||3
69931|NCT02271984|169699|P8|COMPLETED|Second Intervention Period (1 Day)||3
69932|NCT02271984|169700|P7|COMPLETED|Second Intervention Period (1 Day)||3
69933|NCT02271984|169701|P6|COMPLETED|Second Intervention Period (1 Day)||3
69934|NCT02271984|169702|P5|COMPLETED|Second Intervention Period (1 Day)||3
69935|NCT02271984|169703|P4|COMPLETED|Second Intervention Period (1 Day)||3
69936|NCT02271984|169704|P3|COMPLETED|Second Intervention Period (1 Day)||3
69937|NCT02271984|169705|P2|COMPLETED|Second Intervention Period (1 Day)||3
69938|NCT02271984|169706|P1|COMPLETED|Second Intervention Period (1 Day)||3
69939|NCT02271984|169695|P12|STARTED|Second Intervention Period (1 Day)||3
69940|NCT02271984|169696|P11|STARTED|Second Intervention Period (1 Day)||3
69941|NCT02271984|169697|P10|STARTED|Second Intervention Period (1 Day)||3
69942|NCT02271984|169698|P9|STARTED|Second Intervention Period (1 Day)||3
69943|NCT02271984|169699|P8|STARTED|Second Intervention Period (1 Day)||3
69944|NCT02271984|169700|P7|STARTED|Second Intervention Period (1 Day)||3
69945|NCT02271984|169701|P6|STARTED|Second Intervention Period (1 Day)||3
69946|NCT02271984|169702|P5|STARTED|Second Intervention Period (1 Day)||3
69947|NCT02271984|169703|P4|STARTED|Second Intervention Period (1 Day)||3
69948|NCT02271984|169704|P3|STARTED|Second Intervention Period (1 Day)||3
69949|NCT02271984|169705|P2|STARTED|Second Intervention Period (1 Day)||3
69950|NCT02271984|169706|P1|STARTED|Second Intervention Period (1 Day)||3
69951|NCT02271984|169695|P12|NOT COMPLETED|Washout Period 1 (7 Days)||0
69952|NCT02271984|169696|P11|NOT COMPLETED|Washout Period 1 (7 Days)||0
69953|NCT02271984|169697|P10|NOT COMPLETED|Washout Period 1 (7 Days)||0
69954|NCT02271984|169698|P9|NOT COMPLETED|Washout Period 1 (7 Days)||0
69955|NCT02271984|169699|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
69956|NCT02271984|169700|P7|NOT COMPLETED|Washout Period 1 (7 Days)||0
69957|NCT02271984|169701|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
69958|NCT02271984|169702|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
69959|NCT02271984|169703|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
69960|NCT02271984|169704|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
69961|NCT02271984|169705|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
69962|NCT02271984|169706|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
69963|NCT02271984|169695|P12|COMPLETED|Washout Period 1 (7 Days)||3
69964|NCT02271984|169696|P11|COMPLETED|Washout Period 1 (7 Days)||3
69965|NCT02271984|169697|P10|COMPLETED|Washout Period 1 (7 Days)||3
69966|NCT02271984|169698|P9|COMPLETED|Washout Period 1 (7 Days)||3
69967|NCT02271984|169699|P8|COMPLETED|Washout Period 1 (7 Days)||3
69968|NCT02271984|169700|P7|COMPLETED|Washout Period 1 (7 Days)||3
69969|NCT02271984|169701|P6|COMPLETED|Washout Period 1 (7 Days)||3
69970|NCT02271984|169702|P5|COMPLETED|Washout Period 1 (7 Days)||3
69971|NCT02271984|169703|P4|COMPLETED|Washout Period 1 (7 Days)||3
69972|NCT02271984|169704|P3|COMPLETED|Washout Period 1 (7 Days)||3
69973|NCT02271984|169705|P2|COMPLETED|Washout Period 1 (7 Days)||3
69974|NCT02271984|169706|P1|COMPLETED|Washout Period 1 (7 Days)||3
69975|NCT02271984|169695|P12|STARTED|Washout Period 1 (7 Days)||3
69976|NCT02271984|169696|P11|STARTED|Washout Period 1 (7 Days)||3
69977|NCT02271984|169697|P10|STARTED|Washout Period 1 (7 Days)||3
69978|NCT02271984|169698|P9|STARTED|Washout Period 1 (7 Days)||3
69979|NCT02271984|169699|P8|STARTED|Washout Period 1 (7 Days)||3
69980|NCT02271984|169700|P7|STARTED|Washout Period 1 (7 Days)||3
69981|NCT02271984|169701|P6|STARTED|Washout Period 1 (7 Days)||3
69982|NCT02271984|169702|P5|STARTED|Washout Period 1 (7 Days)||3
69983|NCT02271984|169703|P4|STARTED|Washout Period 1 (7 Days)||3
69984|NCT02271984|169704|P3|STARTED|Washout Period 1 (7 Days)||3
69985|NCT02271984|169705|P2|STARTED|Washout Period 1 (7 Days)||3
69986|NCT02271984|169706|P1|STARTED|Washout Period 1 (7 Days)||3
69987|NCT02271984|169695|P12|NOT COMPLETED|First Intervention Period (1 Day)||0
69988|NCT02271984|169696|P11|NOT COMPLETED|First Intervention Period (1 Day)||0
69989|NCT02271984|169697|P10|NOT COMPLETED|First Intervention Period (1 Day)||0
69990|NCT02271984|169698|P9|NOT COMPLETED|First Intervention Period (1 Day)||0
69991|NCT02271984|169699|P8|NOT COMPLETED|First Intervention Period (1 Day)||0
69992|NCT02271984|169700|P7|NOT COMPLETED|First Intervention Period (1 Day)||0
69993|NCT02271984|169701|P6|NOT COMPLETED|First Intervention Period (1 Day)||0
69994|NCT02271984|169702|P5|NOT COMPLETED|First Intervention Period (1 Day)||0
69995|NCT02271984|169703|P4|NOT COMPLETED|First Intervention Period (1 Day)||0
69996|NCT02271984|169704|P3|NOT COMPLETED|First Intervention Period (1 Day)||0
69997|NCT02271984|169705|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
69998|NCT02271984|169706|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
69999|NCT02271984|169695|P12|COMPLETED|First Intervention Period (1 Day)||3
70000|NCT02271984|169696|P11|COMPLETED|First Intervention Period (1 Day)||3
70001|NCT02271984|169697|P10|COMPLETED|First Intervention Period (1 Day)||3
70002|NCT02271984|169698|P9|COMPLETED|First Intervention Period (1 Day)||3
70003|NCT02271984|169699|P8|COMPLETED|First Intervention Period (1 Day)||3
70004|NCT02271984|169700|P7|COMPLETED|First Intervention Period (1 Day)||3
70005|NCT02271984|169701|P6|COMPLETED|First Intervention Period (1 Day)||3
70006|NCT02271984|169702|P5|COMPLETED|First Intervention Period (1 Day)||3
70007|NCT02271984|169703|P4|COMPLETED|First Intervention Period (1 Day)||3
70008|NCT02271984|169704|P3|COMPLETED|First Intervention Period (1 Day)||3
70009|NCT02271984|169705|P2|COMPLETED|First Intervention Period (1 Day)||3
70010|NCT02271984|169706|P1|COMPLETED|First Intervention Period (1 Day)||3
70011|NCT02271984|169695|P12|STARTED|First Intervention Period (1 Day)||3
70012|NCT02271984|169696|P11|STARTED|First Intervention Period (1 Day)||3
70013|NCT02271984|169697|P10|STARTED|First Intervention Period (1 Day)||3
70014|NCT02271984|169698|P9|STARTED|First Intervention Period (1 Day)||3
70015|NCT02271984|169699|P8|STARTED|First Intervention Period (1 Day)||3
70016|NCT02271984|169700|P7|STARTED|First Intervention Period (1 Day)||3
70017|NCT02271984|169701|P6|STARTED|First Intervention Period (1 Day)||3
70018|NCT02271984|169702|P5|STARTED|First Intervention Period (1 Day)||3
70019|NCT02271984|169703|P4|STARTED|First Intervention Period (1 Day)||3
70020|NCT02271984|169704|P3|STARTED|First Intervention Period (1 Day)||3
70021|NCT02271984|169705|P2|STARTED|First Intervention Period (1 Day)||3
70022|NCT02271984|169706|P1|STARTED|First Intervention Period (1 Day)||3
70023|NCT02271945|169795|P2|NOT COMPLETED|Overall Study||5
70024|NCT02271945|169796|P1|NOT COMPLETED|Overall Study||5
70025|NCT02271945|169795|P2|COMPLETED|Overall Study||0
70026|NCT02271945|169796|P1|COMPLETED|Overall Study||0
70027|NCT02271945|169795|P2|STARTED|Overall Study||5
70028|NCT02271945|169796|P1|STARTED|Overall Study||5
70029|NCT02271906|169832|P1|NOT COMPLETED|Overall Study||0
70030|NCT02271906|169832|P1|COMPLETED|Overall Study||2
70031|NCT02271906|169832|P1|STARTED|Overall Study||2
70032|NCT02271880|169839|P2|NOT COMPLETED|Overall Study||4
70033|NCT02271880|169840|P1|NOT COMPLETED|Overall Study||3
70034|NCT02271880|169839|P2|COMPLETED|Overall Study||0
70035|NCT02271880|169840|P1|COMPLETED|Overall Study||0
70036|NCT02271880|169839|P2|STARTED|Overall Study||4
70037|NCT02271880|169840|P1|STARTED|Overall Study||3
70038|NCT02271854|169870|P1|NOT COMPLETED|Overall Study||4
70039|NCT02271854|169870|P1|COMPLETED|Overall Study||98
70040|NCT02271854|169870|P1|STARTED|Overall Study||102
70041|NCT02271698|169881|P4|NOT COMPLETED|Overall Study||0
70042|NCT02271698|169882|P3|NOT COMPLETED|Overall Study||0
70043|NCT02271698|169883|P2|NOT COMPLETED|Overall Study||0
70044|NCT02271698|169884|P1|NOT COMPLETED|Overall Study||0
70045|NCT02271698|169881|P4|COMPLETED|Overall Study||11
70046|NCT02271698|169882|P3|COMPLETED|Overall Study||10
70047|NCT02271698|169883|P2|COMPLETED|Overall Study||10
70048|NCT02271698|169884|P1|COMPLETED|Overall Study||11
70049|NCT02271698|169881|P4|STARTED|Overall Study||11
70050|NCT02271698|169882|P3|STARTED|Overall Study||10
70051|NCT02271698|169883|P2|STARTED|Overall Study||10
70052|NCT02271698|169884|P1|STARTED|Overall Study||11
70053|NCT02271529|169910|P1|NOT COMPLETED|Overall Study||1
70054|NCT02271529|169910|P1|COMPLETED|Overall Study||39
70055|NCT02271529|169910|P1|STARTED|Overall Study||40
70056|NCT02271477|169916|P2|NOT COMPLETED|Overall Study||0
70057|NCT02271477|169917|P1|NOT COMPLETED|Overall Study||0
70058|NCT02271477|169916|P2|COMPLETED|Overall Study||80
70059|NCT02271477|169917|P1|COMPLETED|Overall Study||80
70060|NCT02271477|169916|P2|STARTED|Overall Study||80
70061|NCT02271477|169917|P1|STARTED|Overall Study||80
70062|NCT02271451|169931|P2|NOT COMPLETED|Overall Study||1
70063|NCT02271451|169932|P1|NOT COMPLETED|Overall Study||0
70064|NCT02271451|169931|P2|COMPLETED|Overall Study|one subject does not have MRI data due to braces|7
70065|NCT02271451|169932|P1|COMPLETED|Overall Study||7
70066|NCT02271451|169931|P2|STARTED|Overall Study||8
70067|NCT02271451|169932|P1|STARTED|Overall Study||7
70068|NCT02271425|169938|P1|NOT COMPLETED|Overall Study||0
70069|NCT02271425|169938|P1|COMPLETED|Overall Study||8
70070|NCT02271425|169938|P1|STARTED|Overall Study||8
70071|NCT02271386|169947|P4|NOT COMPLETED|Intervention Period- 8 Months||0
70072|NCT02271386|169948|P3|NOT COMPLETED|Intervention Period- 8 Months||0
70073|NCT02271386|169949|P2|NOT COMPLETED|Intervention Period- 8 Months||0
70074|NCT02271386|169950|P1|NOT COMPLETED|Intervention Period- 8 Months||0
70075|NCT02271386|169947|P4|COMPLETED|Intervention Period- 8 Months||197
70076|NCT02271386|169948|P3|COMPLETED|Intervention Period- 8 Months||202
70077|NCT02271386|169949|P2|COMPLETED|Intervention Period- 8 Months||52
70078|NCT02271386|169950|P1|COMPLETED|Intervention Period- 8 Months||53
70079|NCT02271386|169947|P4|STARTED|Intervention Period- 8 Months||197
70080|NCT02271386|169948|P3|STARTED|Intervention Period- 8 Months||202
70081|NCT02271386|169949|P2|STARTED|Intervention Period- 8 Months||52
70082|NCT02271386|169950|P1|STARTED|Intervention Period- 8 Months||53
70083|NCT02271386|169947|P4|NOT COMPLETED|Baseline Period- 8 Months||0
70084|NCT02271386|169948|P3|NOT COMPLETED|Baseline Period- 8 Months||0
70085|NCT02271386|169949|P2|NOT COMPLETED|Baseline Period- 8 Months||0
70086|NCT02271386|169950|P1|NOT COMPLETED|Baseline Period- 8 Months||0
70087|NCT02271386|169947|P4|COMPLETED|Baseline Period- 8 Months||191
70088|NCT02271386|169948|P3|COMPLETED|Baseline Period- 8 Months||200
70089|NCT02271386|169949|P2|COMPLETED|Baseline Period- 8 Months||52
70090|NCT02271386|169950|P1|COMPLETED|Baseline Period- 8 Months||53
70091|NCT02271386|169947|P4|STARTED|Baseline Period- 8 Months||191
70092|NCT02271386|169948|P3|STARTED|Baseline Period- 8 Months||200
70093|NCT02271386|169949|P2|STARTED|Baseline Period- 8 Months||52
70094|NCT02271386|169950|P1|STARTED|Baseline Period- 8 Months||53
70095|NCT02271217|170015|P3|NOT COMPLETED|Overall Study||12
70096|NCT02271217|170016|P2|NOT COMPLETED|Overall Study||13
70097|NCT02271217|170017|P1|NOT COMPLETED|Overall Study||11
70098|NCT02271217|170015|P3|COMPLETED|Overall Study||113
70099|NCT02271217|170016|P2|COMPLETED|Overall Study||113
70100|NCT02271217|170017|P1|COMPLETED|Overall Study||115
70101|NCT02271217|170015|P3|STARTED|Overall Study||125
70102|NCT02271217|170016|P2|STARTED|Overall Study||126
70103|NCT02271217|170017|P1|STARTED|Overall Study||126
70104|NCT02270983|170031|P3|NOT COMPLETED|Overall Study||12
70105|NCT02270983|170032|P2|NOT COMPLETED|Overall Study||7
70106|NCT02270983|170033|P1|NOT COMPLETED|Overall Study||9
70107|NCT02270983|170031|P3|COMPLETED|Overall Study||76
70108|NCT02270983|170032|P2|COMPLETED|Overall Study||80
70109|NCT02270983|170033|P1|COMPLETED|Overall Study||70
70110|NCT02270983|170031|P3|STARTED|Overall Study||88
70111|NCT02270983|170032|P2|STARTED|Overall Study||87
70112|NCT02270983|170033|P1|STARTED|Overall Study||79
70113|NCT02270944|170058|P2|NOT COMPLETED|Overall Study||5
70114|NCT02270944|170059|P1|NOT COMPLETED|Overall Study||11
70115|NCT02270944|170058|P2|COMPLETED|Overall Study||516
70116|NCT02270944|170059|P1|COMPLETED|Overall Study||518
70117|NCT02270944|170058|P2|STARTED|Overall Study||521
70118|NCT02270944|170059|P1|STARTED|Overall Study||529
70119|NCT02270684|170075|P2|NOT COMPLETED|Overall Study||3
70120|NCT02270684|170076|P1|NOT COMPLETED|Overall Study||1
70121|NCT02270684|170075|P2|COMPLETED|Overall Study||0
70122|NCT02270684|170076|P1|COMPLETED|Overall Study||0
70123|NCT02270684|170075|P2|STARTED|Overall Study||3
70124|NCT02270684|170076|P1|STARTED|Overall Study||1
70125|NCT02270671|170084|P2|NOT COMPLETED|Overall Study||5
70126|NCT02270671|170085|P1|NOT COMPLETED|Overall Study||5
70127|NCT02270671|170084|P2|COMPLETED|Overall Study||61
70128|NCT02270671|170085|P1|COMPLETED|Overall Study||59
70129|NCT02270671|170084|P2|STARTED|Overall Study||66
70130|NCT02270671|170085|P1|STARTED|Overall Study||64
70131|NCT02270645|170101|P2|NOT COMPLETED|Overall Study||0
70132|NCT02270645|170102|P1|NOT COMPLETED|Overall Study||2
70133|NCT02270645|170101|P2|COMPLETED|Overall Study||4
70134|NCT02270645|170102|P1|COMPLETED|Overall Study||6
70135|NCT02270645|170101|P2|STARTED|Overall Study||4
70136|NCT02270645|170102|P1|STARTED|Overall Study||8
70137|NCT02270515|170110|P1|NOT COMPLETED|Intervention Period 3: 12-18 Months||24
70138|NCT02270515|170110|P1|COMPLETED|Intervention Period 3: 12-18 Months||103
70139|NCT02270515|170110|P1|STARTED|Intervention Period 3: 12-18 Months||127
70140|NCT02270515|170110|P1|NOT COMPLETED|Intervention Period 2: 6-12 Months||32
70141|NCT02270515|170110|P1|COMPLETED|Intervention Period 2: 6-12 Months||127
70142|NCT02270515|170110|P1|STARTED|Intervention Period 2: 6-12 Months||159
70143|NCT02270515|170110|P1|NOT COMPLETED|Intervention Period 1: 0-6 Months||16
70144|NCT02270515|170110|P1|COMPLETED|Intervention Period 1: 0-6 Months||159
70145|NCT02270515|170110|P1|STARTED|Intervention Period 1: 0-6 Months||175
70146|NCT02270255|170127|P2|NOT COMPLETED|Overall Study||0
70147|NCT02270255|170128|P1|NOT COMPLETED|Overall Study||1
70148|NCT02270255|170127|P2|COMPLETED|Overall Study||22
70149|NCT02270255|170128|P1|COMPLETED|Overall Study||21
70150|NCT02270255|170127|P2|Complete Data From Home Survey|Overall Study||22
70151|NCT02270255|170128|P1|Complete Data From Home Survey|Overall Study||21
70152|NCT02270255|170127|P2|Complete Data at Discharge PACU|Overall Study||22
70153|NCT02270255|170128|P1|Complete Data at Discharge PACU|Overall Study||22
70154|NCT02270255|170127|P2|STARTED|Overall Study||22
70155|NCT02270255|170128|P1|STARTED|Overall Study||22
70156|NCT02270060|170139|P3|NOT COMPLETED|Overall Study||0
70157|NCT02270060|170140|P2|NOT COMPLETED|Overall Study||0
70158|NCT02270060|170141|P1|NOT COMPLETED|Overall Study||0
70159|NCT02270060|170139|P3|COMPLETED|Overall Study||20
70160|NCT02270060|170140|P2|COMPLETED|Overall Study||20
70161|NCT02270060|170141|P1|COMPLETED|Overall Study||20
70162|NCT02270060|170139|P3|STARTED|Overall Study||20
70163|NCT02270060|170140|P2|STARTED|Overall Study||20
70164|NCT02270060|170141|P1|STARTED|Overall Study||20
70165|NCT02269943|170169|P2|NOT COMPLETED|Follow-Up Survival Period||26
70166|NCT02269943|170170|P1|NOT COMPLETED|Follow-Up Survival Period||5
70167|NCT02269943|170169|P2|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0
70168|NCT02269943|170170|P1|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0
70169|NCT02269943|170169|P2|STARTED|Follow-Up Survival Period||26
70170|NCT02269943|170170|P1|STARTED|Follow-Up Survival Period||5
70171|NCT02269943|170169|P2|NOT COMPLETED|Treatment Period||30
70172|NCT02269943|170170|P1|NOT COMPLETED|Treatment Period||6
70173|NCT02269943|170169|P2|COMPLETED|Treatment Period|Not applicable according to the study design|0
70174|NCT02269943|170170|P1|COMPLETED|Treatment Period|Not applicable according to the study design|0
70175|NCT02269943|170169|P2|Investigational Product (IP) Stopped|Treatment Period||30
70176|NCT02269943|170170|P1|Investigational Product (IP) Stopped|Treatment Period||6
70177|NCT02269943|170169|P2|STARTED|Treatment Period||30
70178|NCT02269943|170170|P1|STARTED|Treatment Period||6
70179|NCT02269917|170200|P2|NOT COMPLETED|Overall Study||383
70180|NCT02269917|170201|P1|NOT COMPLETED|Overall Study||766
70181|NCT02269917|170200|P2|COMPLETED|Overall Study||0
70182|NCT02269917|170201|P1|COMPLETED|Overall Study||0
70183|NCT02269917|170200|P2|Treated|Overall Study||378
70184|NCT02269917|170201|P1|Treated|Overall Study||763
70185|NCT02269917|170200|P2|STARTED|Overall Study||383
70186|NCT02269917|170201|P1|STARTED|Overall Study||766
70187|NCT02269787|170254|P2|NOT COMPLETED|Overall Study||10
70188|NCT02269787|170255|P1|NOT COMPLETED|Overall Study||22
70189|NCT02269787|170254|P2|COMPLETED|Overall Study||140
70190|NCT02269787|170255|P1|COMPLETED|Overall Study||126
70191|NCT02269787|170254|P2|STARTED|Overall Study||150
70192|NCT02269787|170255|P1|STARTED|Overall Study||148
70193|NCT02269709|170261|P1|NOT COMPLETED|Six Month Follow-up||12
70194|NCT02269709|170261|P1|COMPLETED|Six Month Follow-up||5
70195|NCT02269709|170261|P1|STARTED|Six Month Follow-up||17
70196|NCT02269709|170261|P1|NOT COMPLETED|Prior to Hospital Discharge||0
70197|NCT02269709|170261|P1|COMPLETED|Prior to Hospital Discharge||17
70198|NCT02269709|170261|P1|STARTED|Prior to Hospital Discharge||17
70199|NCT02269709|170261|P1|NOT COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||1
70200|NCT02269709|170261|P1|COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||17
70201|NCT02269709|170261|P1|STARTED|Follow-up #1 (24-72 Hours Post-surgery)||18
70202|NCT02269709|170261|P1|NOT COMPLETED|Time of Enrollment||3
70203|NCT02269709|170261|P1|COMPLETED|Time of Enrollment||18
70204|NCT02269709|170261|P1|STARTED|Time of Enrollment||21
70205|NCT02269657|170266|P1|NOT COMPLETED|Overall Study||3
70206|NCT02269657|170266|P1|COMPLETED|Overall Study||37
70207|NCT02269657|170266|P1|STARTED|Overall Study||40
70208|NCT02269631|170282|P2|NOT COMPLETED|Overall Study||0
70209|NCT02269631|170283|P1|NOT COMPLETED|Overall Study||0
70210|NCT02269631|170282|P2|COMPLETED|Overall Study||5
70211|NCT02269631|170283|P1|COMPLETED|Overall Study||7
70212|NCT02269631|170282|P2|STARTED|Overall Study||5
70213|NCT02269631|170283|P1|STARTED|Overall Study||7
70214|NCT02269488|170297|P1|NOT COMPLETED|Overall Study||0
70215|NCT02269488|170297|P1|COMPLETED|Overall Study||100
70216|NCT02269488|170297|P1|STARTED|Overall Study||100
70217|NCT02269475|170303|P2|NOT COMPLETED|Overall Study||1
70218|NCT02269475|170304|P1|NOT COMPLETED|Overall Study||3
70219|NCT02269475|170303|P2|COMPLETED|Overall Study||432
70220|NCT02269475|170304|P1|COMPLETED|Overall Study||865
70221|NCT02269475|170303|P2|Per Protocol Population|Overall Study||430
70222|NCT02269475|170304|P1|Per Protocol Population|Overall Study||849
70223|NCT02269475|170303|P2|Received IP (Safety Population)|Overall Study||433
70224|NCT02269475|170304|P1|Received IP (Safety Population)|Overall Study||868
70225|NCT02269475|170303|P2|STARTED|Overall Study||433
70226|NCT02269475|170304|P1|STARTED|Overall Study||868
70227|NCT02269423|170319|P4|NOT COMPLETED|Overall Study||1
70228|NCT02269423|170320|P3|NOT COMPLETED|Overall Study||0
70229|NCT02269423|170321|P2|NOT COMPLETED|Overall Study||1
70230|NCT02269423|170322|P1|NOT COMPLETED|Overall Study||0
70231|NCT02269423|170319|P4|COMPLETED|Overall Study||8
70232|NCT02269423|170320|P3|COMPLETED|Overall Study||10
70233|NCT02269423|170321|P2|COMPLETED|Overall Study||9
70234|NCT02269423|170322|P1|COMPLETED|Overall Study||10
70235|NCT02269423|170319|P4|STARTED|Overall Study||9
70236|NCT02269423|170320|P3|STARTED|Overall Study||10
70237|NCT02269423|170321|P2|STARTED|Overall Study||10
70238|NCT02269423|170322|P1|STARTED|Overall Study||10
70239|NCT02269241|170384|P1|NOT COMPLETED|Overall Study||1200
70240|NCT02269241|170384|P1|COMPLETED|Overall Study||352
70241|NCT02269241|170384|P1|STARTED|Overall Study||1552
70242|NCT02269098|170398|P2|NOT COMPLETED|Overall Study||9
70243|NCT02269098|170399|P1|NOT COMPLETED|Overall Study||14
70244|NCT02269098|170398|P2|COMPLETED|Overall Study||41
70245|NCT02269098|170399|P1|COMPLETED|Overall Study||37
70246|NCT02269098|170398|P2|STARTED|Overall Study||50
70247|NCT02269098|170399|P1|STARTED|Overall Study||51
70248|NCT02268994|170415|P2|NOT COMPLETED|Overall Study||35
70249|NCT02268994|170416|P1|NOT COMPLETED|Overall Study||31
70250|NCT02268994|170415|P2|COMPLETED|Overall Study||81
70251|NCT02268994|170416|P1|COMPLETED|Overall Study||86
70252|NCT02268994|170415|P2|STARTED|Overall Study||116
70253|NCT02268994|170416|P1|STARTED|Overall Study||117
70254|NCT02268955|170434|P2|NOT COMPLETED|Overall Study||2
70255|NCT02268955|170435|P1|NOT COMPLETED|Overall Study||2
70256|NCT02268955|170434|P2|COMPLETED|Overall Study||9
70257|NCT02268955|170435|P1|COMPLETED|Overall Study||9
70258|NCT02268955|170434|P2|STARTED|Overall Study||11
70259|NCT02268955|170435|P1|STARTED|Overall Study||11
70260|NCT02268942|170441|P1|NOT COMPLETED|Overall Study||0
70261|NCT02268942|170441|P1|COMPLETED|Overall Study||144
70262|NCT02268942|170441|P1|STARTED|Overall Study||144
70263|NCT02268877|170448|P2|NOT COMPLETED|Overall Study||5
70264|NCT02268877|170449|P1|NOT COMPLETED|Overall Study||4
70265|NCT02268877|170448|P2|COMPLETED|Overall Study|106 patients received the intervention.|106
70266|NCT02268877|170449|P1|COMPLETED|Overall Study||118
70267|NCT02268877|170448|P2|STARTED|Overall Study|111 patients were randomized to this arm.|111
70268|NCT02268877|170449|P1|STARTED|Overall Study||122
70269|NCT02268864|170460|P3|NOT COMPLETED|Overall Study||0
70270|NCT02268864|170461|P2|NOT COMPLETED|Overall Study||1
70271|NCT02268864|170462|P1|NOT COMPLETED|Overall Study||2
70272|NCT02268864|170460|P3|COMPLETED|Overall Study||64
70273|NCT02268864|170461|P2|COMPLETED|Overall Study||24
70274|NCT02268864|170462|P1|COMPLETED|Overall Study||15
70275|NCT02268864|170460|P3|STARTED|Overall Study||64
70276|NCT02268864|170461|P2|STARTED|Overall Study||25
70277|NCT02268864|170462|P1|STARTED|Overall Study||17
70278|NCT02268812|170488|P4|NOT COMPLETED|Overall Study||14
70279|NCT02268812|170489|P3|NOT COMPLETED|Overall Study||9
70280|NCT02268812|170490|P2|NOT COMPLETED|Overall Study||32
70281|NCT02268812|170491|P1|NOT COMPLETED|Overall Study||16
70282|NCT02268812|170488|P4|COMPLETED|Overall Study||26
70283|NCT02268812|170489|P3|COMPLETED|Overall Study||21
70284|NCT02268812|170490|P2|COMPLETED|Overall Study||40
70285|NCT02268812|170491|P1|COMPLETED|Overall Study||61
70286|NCT02268812|170488|P4|STARTED|Overall Study||40
70287|NCT02268812|170489|P3|STARTED|Overall Study||30
70288|NCT02268812|170490|P2|STARTED|Overall Study||72
70289|NCT02268812|170491|P1|STARTED|Overall Study||77
70290|NCT02268526|170524|P3|NOT COMPLETED|Overall Study||5
70291|NCT02268526|170525|P2|NOT COMPLETED|Overall Study||21
70292|NCT02268526|170526|P1|NOT COMPLETED|Overall Study||1
70293|NCT02268526|170524|P3|COMPLETED|Overall Study||16
70294|NCT02268526|170525|P2|COMPLETED|Overall Study||38
70295|NCT02268526|170526|P1|COMPLETED|Overall Study||5
70296|NCT02268526|170524|P3|PD Analysis Set (Cohort 2)|Overall Study||17
70297|NCT02268526|170525|P2|PD Analysis Set (Cohort 2)|Overall Study||42
70298|NCT02268526|170526|P1|PD Analysis Set (Cohort 2)|Overall Study||0
70299|NCT02268526|170524|P3|STARTED|Overall Study||21
70300|NCT02268526|170525|P2|STARTED|Overall Study||59
70301|NCT02268526|170526|P1|STARTED|Overall Study||6
70302|NCT02268396|170547|P1|NOT COMPLETED|Overall Study||12
70303|NCT02268396|170547|P1|COMPLETED|Overall Study||126
70304|NCT02268396|170547|P1|STARTED|Overall Study||138
70305|NCT02268214|170559|P3|NOT COMPLETED|Overall Study||42
70306|NCT02268214|170560|P2|NOT COMPLETED|Overall Study||41
70307|NCT02268214|170561|P1|NOT COMPLETED|Overall Study||42
70308|NCT02268214|170559|P3|COMPLETED|Overall Study||218
70309|NCT02268214|170560|P2|COMPLETED|Overall Study||255
70310|NCT02268214|170561|P1|COMPLETED|Overall Study||235
70311|NCT02268214|170559|P3|COMPLETED 24 WEEK PERIOD|Overall Study||232
70312|NCT02268214|170560|P2|COMPLETED 24 WEEK PERIOD|Overall Study||273
70313|NCT02268214|170561|P1|COMPLETED 24 WEEK PERIOD|Overall Study||252
70314|NCT02268214|170559|P3|STARTED|Overall Study||260
70315|NCT02268214|170560|P2|STARTED|Overall Study||296
70316|NCT02268214|170561|P1|STARTED|Overall Study||277
70317|NCT02268175|170589|P2|NOT COMPLETED|Overall Study||0
70318|NCT02268175|170590|P1|NOT COMPLETED|Overall Study||0
70319|NCT02268175|170589|P2|COMPLETED|Overall Study||25
70320|NCT02268175|170590|P1|COMPLETED|Overall Study||50
70321|NCT02268175|170589|P2|STARTED|Overall Study||25
70322|NCT02268175|170590|P1|STARTED|Overall Study||50
70323|NCT02268058|170608|P4|NOT COMPLETED|Overall Study||0
70324|NCT02268058|170609|P3|NOT COMPLETED|Overall Study||0
70325|NCT02268058|170610|P2|NOT COMPLETED|Overall Study||0
70326|NCT02268058|170611|P1|NOT COMPLETED|Overall Study||1
70327|NCT02268058|170608|P4|COMPLETED|Overall Study||20
70328|NCT02268058|170609|P3|COMPLETED|Overall Study||20
70329|NCT02268058|170610|P2|COMPLETED|Overall Study||20
70330|NCT02268058|170611|P1|COMPLETED|Overall Study||19
70331|NCT02268058|170608|P4|STARTED|Overall Study||20
70332|NCT02268058|170609|P3|STARTED|Overall Study||20
70333|NCT02268058|170610|P2|STARTED|Overall Study||20
70334|NCT02268058|170611|P1|STARTED|Overall Study||20
70335|NCT02268045|170635|P2|NOT COMPLETED|Overall Study||20
70336|NCT02268045|170636|P1|NOT COMPLETED|Overall Study||16
70337|NCT02268045|170635|P2|COMPLETED|Overall Study||116
70338|NCT02268045|170636|P1|COMPLETED|Overall Study||120
70339|NCT02268045|170635|P2|STARTED|Overall Study||136
70340|NCT02268045|170636|P1|STARTED|Overall Study||136
70341|NCT02267850|170660|P2|NOT COMPLETED|Overall Study||2
70342|NCT02267850|170661|P1|NOT COMPLETED|Overall Study||1
70343|NCT02267850|170660|P2|COMPLETED|Overall Study||12
70344|NCT02267850|170661|P1|COMPLETED|Overall Study||14
70345|NCT02267850|170660|P2|STARTED|Overall Study||14
70346|NCT02267850|170661|P1|STARTED|Overall Study||15
70347|NCT02267837|170669|P2|NOT COMPLETED|Overall Study||0
70348|NCT02267837|170670|P1|NOT COMPLETED|Overall Study||0
70349|NCT02267837|170669|P2|COMPLETED|Overall Study||9
70350|NCT02267837|170670|P1|COMPLETED|Overall Study||11
70351|NCT02267837|170669|P2|STARTED|Overall Study||9
70352|NCT02267837|170670|P1|STARTED|Overall Study||11
70353|NCT02267824|170678|P2|NOT COMPLETED|Overall Study||1
70354|NCT02267824|170679|P1|NOT COMPLETED|Overall Study||10
70355|NCT02267824|170678|P2|COMPLETED|Overall Study||17
70356|NCT02267824|170679|P1|COMPLETED|Overall Study||73
70357|NCT02267824|170678|P2|STARTED|Overall Study||18
70358|NCT02267824|170679|P1|STARTED|Overall Study||83
70359|NCT02267811|170687|P2|NOT COMPLETED|Overall Study||2
70360|NCT02267811|170688|P1|NOT COMPLETED|Overall Study||1
70361|NCT02267811|170687|P2|COMPLETED|Overall Study||15
70362|NCT02267811|170688|P1|COMPLETED|Overall Study||15
70363|NCT02267811|170687|P2|STARTED|Overall Study||17
70364|NCT02267811|170688|P1|STARTED|Overall Study||16
70365|NCT02267629|170698|P1|NOT COMPLETED|Overall Study||0
70366|NCT02267629|170698|P1|COMPLETED|Overall Study||7
70367|NCT02267629|170698|P1|STARTED|Overall Study||7
70368|NCT02267603|170703|P1|NOT COMPLETED|Overall Study||44
70369|NCT02267603|170703|P1|COMPLETED|Overall Study||6
70370|NCT02267603|170703|P1|STARTED|Overall Study||50
70371|NCT02267577|170707|P1|NOT COMPLETED|Overall Study||4
70372|NCT02267577|170707|P1|COMPLETED|Overall Study||81
70373|NCT02267577|170707|P1|STARTED|Overall Study||85
70374|NCT02267538|170714|P2|NOT COMPLETED|Overall Study||0
70375|NCT02267538|170715|P1|NOT COMPLETED|Overall Study||0
70376|NCT02267538|170714|P2|COMPLETED|Overall Study||143
70377|NCT02267538|170715|P1|COMPLETED|Overall Study||142
70378|NCT02267538|170714|P2|STARTED|Overall Study||143
70379|NCT02267538|170715|P1|STARTED|Overall Study||142
70380|NCT02267447|170735|P2|NOT COMPLETED|Overall Study||0
70381|NCT02267447|170736|P1|NOT COMPLETED|Overall Study||0
70382|NCT02267447|170735|P2|COMPLETED|Overall Study||26968
70383|NCT02267447|170736|P1|COMPLETED|Overall Study||77251
70384|NCT02267447|170735|P2|STARTED|Overall Study||26968
70385|NCT02267447|170736|P1|STARTED|Overall Study||77251
70386|NCT02267382|170749|P5|NOT COMPLETED|Overall Study||7
70387|NCT02267382|170750|P4|NOT COMPLETED|Overall Study||6
70388|NCT02267382|170751|P3|NOT COMPLETED|Overall Study||9
70389|NCT02267382|170752|P2|NOT COMPLETED|Overall Study||10
70390|NCT02267382|170753|P1|NOT COMPLETED|Overall Study||7
70391|NCT02267382|170749|P5|COMPLETED|Overall Study||39
70392|NCT02267382|170750|P4|COMPLETED|Overall Study||35
70393|NCT02267382|170751|P3|COMPLETED|Overall Study||34
70394|NCT02267382|170752|P2|COMPLETED|Overall Study||33
70395|NCT02267382|170753|P1|COMPLETED|Overall Study||35
70396|NCT02267382|170749|P5|STARTED|Overall Study||46
70397|NCT02267382|170750|P4|STARTED|Overall Study||41
70398|NCT02267382|170751|P3|STARTED|Overall Study||43
70399|NCT02267382|170752|P2|STARTED|Overall Study||43
70400|NCT02267382|170753|P1|STARTED|Overall Study||42
70401|NCT02267278|170765|P1|NOT COMPLETED|Overall Study||5
70402|NCT02267278|170765|P1|COMPLETED|Overall Study||20
70403|NCT02267278|170765|P1|STARTED|Overall Study||25
70404|NCT02267226|170770|P1|NOT COMPLETED|Overall Study||7
70405|NCT02267226|170770|P1|COMPLETED|Overall Study||18
70406|NCT02267226|170770|P1|Surgical Prophylaxis Population|Overall Study||9
70407|NCT02267226|170770|P1|FAS-Bleeding Population|Overall Study||24
70408|NCT02267226|170770|P1|SAFETY Population|Overall Study||25
70409|NCT02267226|170770|P1|STARTED|Overall Study||25
70410|NCT02267187|170789|P1|NOT COMPLETED|Overall Study||5
70411|NCT02267187|170789|P1|COMPLETED|Overall Study||10
70412|NCT02267187|170789|P1|STARTED|Overall Study||15
70413|NCT02267135|170797|P2|NOT COMPLETED|Period 2 (Randomized Set)||1
70414|NCT02267135|170798|P1|NOT COMPLETED|Period 2 (Randomized Set)||4
70415|NCT02267135|170797|P2|COMPLETED|Period 2 (Randomized Set)||46
70416|NCT02267135|170798|P1|COMPLETED|Period 2 (Randomized Set)||46
70417|NCT02267135|170797|P2|STARTED|Period 2 (Randomized Set)||47
70418|NCT02267135|170798|P1|STARTED|Period 2 (Randomized Set)||50
70419|NCT02267135|170797|P2|NOT COMPLETED|Period 1 (Randomized Set)||4
70420|NCT02267135|170798|P1|NOT COMPLETED|Period 1 (Randomized Set)||1
70421|NCT02267135|170797|P2|COMPLETED|Period 1 (Randomized Set)||47
70422|NCT02267135|170798|P1|COMPLETED|Period 1 (Randomized Set)||50
70423|NCT02267135|170797|P2|STARTED|Period 1 (Randomized Set)||51
70424|NCT02267135|170798|P1|STARTED|Period 1 (Randomized Set)||51
70425|NCT02267083|170829|P1|NOT COMPLETED|Overall Study||19
70426|NCT02267083|170829|P1|COMPLETED|Overall Study||3
70427|NCT02267083|170829|P1|STARTED|Overall Study||22
70428|NCT02266914|170836|P1|NOT COMPLETED|Overall Study||9
70429|NCT02266914|170836|P1|COMPLETED|Overall Study||0
70430|NCT02266914|170836|P1|STARTED|Overall Study||9
70431|NCT02266875|170842|P2|NOT COMPLETED|Overall Study||0
70432|NCT02266875|170843|P1|NOT COMPLETED|Overall Study||11
70433|NCT02266875|170842|P2|COMPLETED|Overall Study||30
70434|NCT02266875|170843|P1|COMPLETED|Overall Study||29
70435|NCT02266875|170842|P2|STARTED|Overall Study||30
70436|NCT02266875|170843|P1|STARTED|Overall Study||40
70437|NCT02266810|170855|P2|NOT COMPLETED|Overall Study||1
70438|NCT02266810|170856|P1|NOT COMPLETED|Overall Study||1
70439|NCT02266810|170855|P2|COMPLETED|Overall Study|sinus sides|79
70440|NCT02266810|170856|P1|COMPLETED|Overall Study|sinus sides|79
70441|NCT02266810|170855|P2|STARTED|Overall Study|sinus sides|80
70442|NCT02266810|170856|P1|STARTED|Overall Study|sinus sides|80
70443|NCT02266797|170882|P2|NOT COMPLETED|Overall Study||1
70444|NCT02266797|170883|P1|NOT COMPLETED|Overall Study||0
70445|NCT02266797|170882|P2|COMPLETED|Overall Study||2
70446|NCT02266797|170883|P1|COMPLETED|Overall Study||1
70447|NCT02266797|170882|P2|STARTED|Overall Study||3
70448|NCT02266797|170883|P1|STARTED|Overall Study||1
70449|NCT02266706|170908|P9|NOT COMPLETED|Overall Study||0
70450|NCT02266706|170909|P8|NOT COMPLETED|Overall Study||0
70451|NCT02266706|170910|P7|NOT COMPLETED|Overall Study||1
70452|NCT02266706|170911|P6|NOT COMPLETED|Overall Study||2
70453|NCT02266706|170912|P5|NOT COMPLETED|Overall Study||0
70454|NCT02266706|170913|P4|NOT COMPLETED|Overall Study||1
70455|NCT02266706|170914|P3|NOT COMPLETED|Overall Study||1
70456|NCT02266706|170915|P2|NOT COMPLETED|Overall Study||1
70457|NCT02266706|170916|P1|NOT COMPLETED|Overall Study||0
70458|NCT02266706|170908|P9|COMPLETED|Overall Study||4
70459|NCT02266706|170909|P8|COMPLETED|Overall Study||2
70460|NCT02266706|170910|P7|COMPLETED|Overall Study||7
70461|NCT02266706|170911|P6|COMPLETED|Overall Study||5
70462|NCT02266706|170912|P5|COMPLETED|Overall Study||1
70463|NCT02266706|170913|P4|COMPLETED|Overall Study||3
70464|NCT02266706|170914|P3|COMPLETED|Overall Study||3
70465|NCT02266706|170915|P2|COMPLETED|Overall Study||6
70466|NCT02266706|170916|P1|COMPLETED|Overall Study||6
70467|NCT02266706|170908|P9|Treated|Overall Study||4
70468|NCT02266706|170909|P8|Treated|Overall Study||2
70469|NCT02266706|170910|P7|Treated|Overall Study||7
70470|NCT02266706|170911|P6|Treated|Overall Study||5
70471|NCT02266706|170912|P5|Treated|Overall Study||1
70472|NCT02266706|170913|P4|Treated|Overall Study||3
70473|NCT02266706|170914|P3|Treated|Overall Study||3
70474|NCT02266706|170915|P2|Treated|Overall Study||6
70475|NCT02266706|170916|P1|Treated|Overall Study||6
70476|NCT02266706|170908|P9|STARTED|Overall Study||4
70477|NCT02266706|170909|P8|STARTED|Overall Study||2
70478|NCT02266706|170910|P7|STARTED|Overall Study||8
70479|NCT02266706|170911|P6|STARTED|Overall Study||7
70480|NCT02266706|170912|P5|STARTED|Overall Study||1
70481|NCT02266706|170913|P4|STARTED|Overall Study||4
70482|NCT02266706|170914|P3|STARTED|Overall Study||4
70483|NCT02266706|170915|P2|STARTED|Overall Study||7
70484|NCT02266706|170916|P1|STARTED|Overall Study||6
70485|NCT02266472|171109|P2|NOT COMPLETED|Period 2+ Washout||0
70486|NCT02266472|171110|P1|NOT COMPLETED|Period 2+ Washout||0
70487|NCT02266472|171109|P2|COMPLETED|Period 2+ Washout||15
70488|NCT02266472|171110|P1|COMPLETED|Period 2+ Washout||15
70489|NCT02266472|171109|P2|STARTED|Period 2+ Washout||15
70490|NCT02266472|171110|P1|STARTED|Period 2+ Washout||15
70491|NCT02266472|171109|P2|NOT COMPLETED|Period 1+ Washout||0
70492|NCT02266472|171110|P1|NOT COMPLETED|Period 1+ Washout||0
70493|NCT02266472|171109|P2|COMPLETED|Period 1+ Washout||15
70494|NCT02266472|171110|P1|COMPLETED|Period 1+ Washout||15
70495|NCT02266472|171109|P2|STARTED|Period 1+ Washout||15
70496|NCT02266472|171110|P1|STARTED|Period 1+ Washout||15
70497|NCT02266381|171129|P3|NOT COMPLETED|Overall Study||4
70498|NCT02266381|171130|P2|NOT COMPLETED|Overall Study||5
70499|NCT02266381|171131|P1|NOT COMPLETED|Overall Study||3
70500|NCT02266381|171129|P3|COMPLETED|Overall Study||146
70501|NCT02266381|171130|P2|COMPLETED|Overall Study||145
70502|NCT02266381|171131|P1|COMPLETED|Overall Study||147
70503|NCT02266381|171129|P3|STARTED|Overall Study||150
70504|NCT02266381|171130|P2|STARTED|Overall Study||150
70505|NCT02266381|171131|P1|STARTED|Overall Study||150
70506|NCT02266277|171154|P6|NOT COMPLETED|Overall Study||0
70507|NCT02266277|171155|P5|NOT COMPLETED|Overall Study||0
70508|NCT02266277|171156|P4|NOT COMPLETED|Overall Study||0
70509|NCT02266277|171157|P3|NOT COMPLETED|Overall Study||0
70510|NCT02266277|171158|P2|NOT COMPLETED|Overall Study||0
70511|NCT02266277|171159|P1|NOT COMPLETED|Overall Study||0
70512|NCT02266277|171154|P6|COMPLETED|Overall Study||5000
70513|NCT02266277|171155|P5|COMPLETED|Overall Study||5000
70514|NCT02266277|171156|P4|COMPLETED|Overall Study||5000
70515|NCT02266277|171157|P3|COMPLETED|Overall Study||5000
70516|NCT02266277|171158|P2|COMPLETED|Overall Study||5000
70517|NCT02266277|171159|P1|COMPLETED|Overall Study||5000
70518|NCT02266277|171154|P6|STARTED|Overall Study||5000
70519|NCT02266277|171155|P5|STARTED|Overall Study||5000
70520|NCT02266277|171156|P4|STARTED|Overall Study||5000
70521|NCT02266277|171157|P3|STARTED|Overall Study||5000
70522|NCT02266277|171158|P2|STARTED|Overall Study||5000
70523|NCT02266277|171159|P1|STARTED|Overall Study||5000
70524|NCT02266225|171181|P1|NOT COMPLETED|Overall Study||16
70525|NCT02266225|171181|P1|COMPLETED|Overall Study||32
70526|NCT02266225|171181|P1|Enrolled in Intervention|Overall Study||44
70527|NCT02266225|171181|P1|STARTED|Overall Study||48
70528|NCT02266108|171204|P2|NOT COMPLETED|Overall Study||0
70529|NCT02266108|171205|P1|NOT COMPLETED|Overall Study||0
70530|NCT02266108|171204|P2|COMPLETED|Overall Study||71
70531|NCT02266108|171205|P1|COMPLETED|Overall Study||80
70532|NCT02266108|171204|P2|STARTED|Overall Study||71
70533|NCT02266108|171205|P1|STARTED|Overall Study||80
70534|NCT02265848|171217|P2|NOT COMPLETED|Overall Study||0
70535|NCT02265848|171218|P1|NOT COMPLETED|Overall Study||0
70536|NCT02265848|171217|P2|COMPLETED|Overall Study|Last subject for this study completed the visit on December 24, 2014|11
70537|NCT02265848|171218|P1|COMPLETED|Overall Study||11
70538|NCT02265848|171217|P2|STARTED|Overall Study||11
70539|NCT02265848|171218|P1|STARTED|Overall Study|First subject for this study was randomized on October 1st 2014|11
70540|NCT02265796|171232|P2|NOT COMPLETED|Overall Study||1
70541|NCT02265796|171233|P1|NOT COMPLETED|Overall Study||3
70542|NCT02265796|171232|P2|COMPLETED|Overall Study||24
70543|NCT02265796|171233|P1|COMPLETED|Overall Study||22
70544|NCT02265796|171232|P2|STARTED|Overall Study||25
70545|NCT02265796|171233|P1|STARTED|Overall Study||25
70546|NCT02265783|171243|P1|NOT COMPLETED|Overall Study||0
70547|NCT02265783|171243|P1|COMPLETED|Overall Study|All subjects completed, one excluded from the analysis due to an issue with the data collection|20
70548|NCT02265783|171243|P1|STARTED|Overall Study||20
70549|NCT02265744|171252|P5|NOT COMPLETED|Overall Study||13
70550|NCT02265744|171253|P4|NOT COMPLETED|Overall Study||23
70551|NCT02265744|171254|P3|NOT COMPLETED|Overall Study||17
70552|NCT02265744|171255|P2|NOT COMPLETED|Overall Study||15
70553|NCT02265744|171256|P1|NOT COMPLETED|Overall Study||20
70554|NCT02265744|171252|P5|COMPLETED|Overall Study||58
70555|NCT02265744|171253|P4|COMPLETED|Overall Study||47
70556|NCT02265744|171254|P3|COMPLETED|Overall Study||51
70557|NCT02265744|171255|P2|COMPLETED|Overall Study||53
70558|NCT02265744|171256|P1|COMPLETED|Overall Study||49
70559|NCT02265744|171252|P5|STARTED|Overall Study||71
70560|NCT02265744|171253|P4|STARTED|Overall Study||70
70561|NCT02265744|171254|P3|STARTED|Overall Study||68
70562|NCT02265744|171255|P2|STARTED|Overall Study||68
70563|NCT02265744|171256|P1|STARTED|Overall Study||69
70564|NCT02265705|171435|P7|NOT COMPLETED|Follow-up Period||11
70565|NCT02265705|171436|P6|NOT COMPLETED|Follow-up Period||1
70566|NCT02265705|171437|P5|NOT COMPLETED|Follow-up Period||0
70567|NCT02265705|171438|P4|NOT COMPLETED|Follow-up Period||0
70568|NCT02265705|171439|P3|NOT COMPLETED|Follow-up Period||0
70569|NCT02265705|171440|P2|NOT COMPLETED|Follow-up Period||0
70570|NCT02265705|171441|P1|NOT COMPLETED|Follow-up Period||0
70571|NCT02265705|171435|P7|COMPLETED|Follow-up Period||47
70572|NCT02265705|171436|P6|COMPLETED|Follow-up Period||1
70573|NCT02265705|171437|P5|COMPLETED|Follow-up Period||0
70574|NCT02265705|171438|P4|COMPLETED|Follow-up Period||0
70575|NCT02265705|171439|P3|COMPLETED|Follow-up Period||0
70576|NCT02265705|171440|P2|COMPLETED|Follow-up Period||0
70577|NCT02265705|171441|P1|COMPLETED|Follow-up Period||0
70578|NCT02265705|171435|P7|STARTED|Follow-up Period|Participants who ever took baricitinib and entered the post-treatment follow-up period.|58
70579|NCT02265705|171436|P6|STARTED|Follow-up Period|Participants from placebo who never rescued or switched and entered post-treatment follow-up period.|2
70580|NCT02265705|171437|P5|STARTED|Follow-up Period||0
70581|NCT02265705|171438|P4|STARTED|Follow-up Period||0
70582|NCT02265705|171439|P3|STARTED|Follow-up Period||0
70583|NCT02265705|171440|P2|STARTED|Follow-up Period||0
70584|NCT02265705|171441|P1|STARTED|Follow-up Period||0
70585|NCT02265705|171435|P7|NOT COMPLETED|Open Label Period||0
70586|NCT02265705|171436|P6|NOT COMPLETED|Open Label Period||0
70587|NCT02265705|171437|P5|NOT COMPLETED|Open Label Period||5
70588|NCT02265705|171438|P4|NOT COMPLETED|Open Label Period||2
70589|NCT02265705|171439|P3|NOT COMPLETED|Open Label Period||0
70590|NCT02265705|171440|P2|NOT COMPLETED|Open Label Period||0
70591|NCT02265705|171441|P1|NOT COMPLETED|Open Label Period||0
70592|NCT02265705|171435|P7|COMPLETED|Open Label Period||0
70593|NCT02265705|171436|P6|COMPLETED|Open Label Period||0
70594|NCT02265705|171437|P5|COMPLETED|Open Label Period||115
70595|NCT02265705|171438|P4|COMPLETED|Open Label Period||72
70596|NCT02265705|171439|P3|COMPLETED|Open Label Period||0
70597|NCT02265705|171440|P2|COMPLETED|Open Label Period||0
70598|NCT02265705|171441|P1|COMPLETED|Open Label Period||0
70599|NCT02265705|171435|P7|STARTED|Open Label Period||0
70600|NCT02265705|171436|P6|STARTED|Open Label Period||0
70601|NCT02265705|171437|P5|STARTED|Open Label Period|Completed Wk 24 w/o rescue Tx, switched to or remained on active Tx, and entered Open Label Period.|120
70602|NCT02265705|171438|P4|STARTED|Open Label Period|Completed Wk 24 w/o rescue Tx, switched to or remained on active Tx, and entered Open Label Period.|74
70603|NCT02265705|171439|P3|STARTED|Open Label Period||0
70604|NCT02265705|171440|P2|STARTED|Open Label Period||0
70605|NCT02265705|171441|P1|STARTED|Open Label Period||0
70606|NCT02265705|171435|P7|NOT COMPLETED|Rescue Period||0
70607|NCT02265705|171436|P6|NOT COMPLETED|Rescue Period||0
70608|NCT02265705|171437|P5|NOT COMPLETED|Rescue Period||0
70609|NCT02265705|171438|P4|NOT COMPLETED|Rescue Period||0
70610|NCT02265705|171439|P3|NOT COMPLETED|Rescue Period||3
70611|NCT02265705|171440|P2|NOT COMPLETED|Rescue Period||0
70612|NCT02265705|171441|P1|NOT COMPLETED|Rescue Period||0
70613|NCT02265705|171435|P7|COMPLETED|Rescue Period||0
70614|NCT02265705|171436|P6|COMPLETED|Rescue Period||0
70615|NCT02265705|171437|P5|COMPLETED|Rescue Period||0
70616|NCT02265705|171438|P4|COMPLETED|Rescue Period||0
70617|NCT02265705|171439|P3|COMPLETED|Rescue Period||74
70618|NCT02265705|171440|P2|COMPLETED|Rescue Period||0
70619|NCT02265705|171441|P1|COMPLETED|Rescue Period||0
70620|NCT02265705|171435|P7|STARTED|Rescue Period||0
70621|NCT02265705|171436|P6|STARTED|Rescue Period||0
70622|NCT02265705|171437|P5|STARTED|Rescue Period||0
70623|NCT02265705|171438|P4|STARTED|Rescue Period||0
70624|NCT02265705|171439|P3|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|77
70625|NCT02265705|171440|P2|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
70626|NCT02265705|171441|P1|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
70627|NCT02265705|171435|P7|NOT COMPLETED|Treatment Period Week 0-24||0
70628|NCT02265705|171436|P6|NOT COMPLETED|Treatment Period Week 0-24||0
70629|NCT02265705|171437|P5|NOT COMPLETED|Treatment Period Week 0-24||0
70630|NCT02265705|171438|P4|NOT COMPLETED|Treatment Period Week 0-24||0
70631|NCT02265705|171439|P3|NOT COMPLETED|Treatment Period Week 0-24||0
70632|NCT02265705|171440|P2|NOT COMPLETED|Treatment Period Week 0-24||9
70633|NCT02265705|171441|P1|NOT COMPLETED|Treatment Period Week 0-24||12
70634|NCT02265705|171435|P7|COMPLETED|Treatment Period Week 0-24||0
70635|NCT02265705|171436|P6|COMPLETED|Treatment Period Week 0-24||0
70636|NCT02265705|171437|P5|COMPLETED|Treatment Period Week 0-24||0
70637|NCT02265705|171438|P4|COMPLETED|Treatment Period Week 0-24||0
70638|NCT02265705|171439|P3|COMPLETED|Treatment Period Week 0-24||0
70639|NCT02265705|171440|P2|COMPLETED|Treatment Period Week 0-24|"Completers include rescued participants."|136
70640|NCT02265705|171441|P1|COMPLETED|Treatment Period Week 0-24|"Completers include rescued participants."|133
70641|NCT02265705|171435|P7|Rescued|Treatment Period Week 0-24||0
70642|NCT02265705|171436|P6|Rescued|Treatment Period Week 0-24||0
70643|NCT02265705|171437|P5|Rescued|Treatment Period Week 0-24||0
70644|NCT02265705|171438|P4|Rescued|Treatment Period Week 0-24||0
70645|NCT02265705|171439|P3|Rescued|Treatment Period Week 0-24||0
70646|NCT02265705|171440|P2|Rescued|Treatment Period Week 0-24||17
70647|NCT02265705|171441|P1|Rescued|Treatment Period Week 0-24||59
70648|NCT02265705|171435|P7|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
70649|NCT02265705|171436|P6|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
70650|NCT02265705|171437|P5|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
70651|NCT02265705|171438|P4|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
70652|NCT02265705|171439|P3|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
70653|NCT02265705|171440|P2|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||145
70654|NCT02265705|171441|P1|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||145
70655|NCT02265705|171435|P7|STARTED|Treatment Period Week 0-24||0
70656|NCT02265705|171436|P6|STARTED|Treatment Period Week 0-24||0
70657|NCT02265705|171437|P5|STARTED|Treatment Period Week 0-24||0
70658|NCT02265705|171438|P4|STARTED|Treatment Period Week 0-24||0
70659|NCT02265705|171439|P3|STARTED|Treatment Period Week 0-24||0
70660|NCT02265705|171440|P2|STARTED|Treatment Period Week 0-24||145
70661|NCT02265705|171441|P1|STARTED|Treatment Period Week 0-24||145
70662|NCT02265341|171466|P1|NOT COMPLETED|Overall Study||0
70663|NCT02265341|171466|P1|COMPLETED|Overall Study||12
70664|NCT02265341|171466|P1|STARTED|Overall Study||12
70665|NCT02265237|171478|P4|NOT COMPLETED|As Treated (Overall Study)||1
70666|NCT02265237|171479|P3|NOT COMPLETED|As Treated (Overall Study)||10
70667|NCT02265237|171480|P2|NOT COMPLETED|As Treated (Overall Study)||3
70668|NCT02265237|171481|P1|NOT COMPLETED|As Treated (Overall Study)||5
70669|NCT02265237|171478|P4|COMPLETED|As Treated (Overall Study)||2
70670|NCT02265237|171479|P3|COMPLETED|As Treated (Overall Study)||51
70671|NCT02265237|171480|P2|COMPLETED|As Treated (Overall Study)||57
70672|NCT02265237|171481|P1|COMPLETED|As Treated (Overall Study)||55
70673|NCT02265237|171478|P4|STARTED|As Treated (Overall Study)||3
70674|NCT02265237|171479|P3|STARTED|As Treated (Overall Study)||61
70675|NCT02265237|171480|P2|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
70676|NCT02265237|171481|P1|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
70677|NCT02265237|171478|P4|NOT COMPLETED|As Enrolled (Overall Study)||1
70678|NCT02265237|171479|P3|NOT COMPLETED|As Enrolled (Overall Study)||10
70679|NCT02265237|171480|P2|NOT COMPLETED|As Enrolled (Overall Study)||3
70680|NCT02265237|171481|P1|NOT COMPLETED|As Enrolled (Overall Study)||5
70681|NCT02265237|171478|P4|COMPLETED|As Enrolled (Overall Study)||2
70682|NCT02265237|171479|P3|COMPLETED|As Enrolled (Overall Study)||51
70683|NCT02265237|171480|P2|COMPLETED|As Enrolled (Overall Study)||58
70684|NCT02265237|171481|P1|COMPLETED|As Enrolled (Overall Study)||54
70685|NCT02265237|171478|P4|STARTED|As Enrolled (Overall Study)||3
70686|NCT02265237|171479|P3|STARTED|As Enrolled (Overall Study)||61
70687|NCT02265237|171480|P2|STARTED|As Enrolled (Overall Study)||61
70688|NCT02265237|171481|P1|STARTED|As Enrolled (Overall Study)||59
70689|NCT02264977|171500|P1|NOT COMPLETED|Overall Study||6
70690|NCT02264977|171500|P1|COMPLETED|Overall Study||3
70691|NCT02264977|171500|P1|STARTED|Overall Study||9
70692|NCT02264821|171511|P3|NOT COMPLETED|Overall Study||6
70693|NCT02264821|171512|P2|NOT COMPLETED|Overall Study||3
70694|NCT02264821|171513|P1|NOT COMPLETED|Overall Study||1
70695|NCT02264821|171511|P3|COMPLETED|Overall Study||58
70696|NCT02264821|171512|P2|COMPLETED|Overall Study||61
70697|NCT02264821|171513|P1|COMPLETED|Overall Study||63
70698|NCT02264821|171511|P3|STARTED|Overall Study|Double Blind|64
70699|NCT02264821|171512|P2|STARTED|Overall Study|Double Blind|64
70700|NCT02264821|171513|P1|STARTED|Overall Study|Double Blind|64
70701|NCT02264574|171526|P2|NOT COMPLETED|Overall Study||8
70702|NCT02264574|171527|P1|NOT COMPLETED|Overall Study||6
70703|NCT02264574|171526|P2|COMPLETED|Overall Study||108
70704|NCT02264574|171527|P1|COMPLETED|Overall Study||107
70705|NCT02264574|171526|P2|STARTED|Overall Study||116
70706|NCT02264574|171527|P1|STARTED|Overall Study||113
70707|NCT02264353|171537|P2|NOT COMPLETED|Overall Study||0
70708|NCT02264353|171538|P1|NOT COMPLETED|Overall Study||3
70709|NCT02264353|171537|P2|COMPLETED|Overall Study||24
70710|NCT02264353|171538|P1|COMPLETED|Overall Study||17
70711|NCT02264353|171537|P2|STARTED|Overall Study||24
70712|NCT02264353|171538|P1|STARTED|Overall Study||20
70713|NCT02264249|171551|P3|NOT COMPLETED|Overall Study||0
70714|NCT02264249|171552|P2|NOT COMPLETED|Overall Study||0
70715|NCT02264249|171553|P1|NOT COMPLETED|Overall Study||0
70716|NCT02264249|171551|P3|COMPLETED|Overall Study||241
70717|NCT02264249|171552|P2|COMPLETED|Overall Study||187
70718|NCT02264249|171553|P1|COMPLETED|Overall Study||21
70719|NCT02264249|171551|P3|STARTED|Overall Study||241
70720|NCT02264249|171552|P2|STARTED|Overall Study||187
70721|NCT02264249|171553|P1|STARTED|Overall Study||21
70722|NCT02263911|171567|P4|NOT COMPLETED|Period 5||0
70723|NCT02263911|171568|P3|NOT COMPLETED|Period 5||0
70724|NCT02263911|171569|P2|NOT COMPLETED|Period 5||0
70725|NCT02263911|171570|P1|NOT COMPLETED|Period 5||0
70726|NCT02263911|171567|P4|COMPLETED|Period 5||4
70727|NCT02263911|171568|P3|COMPLETED|Period 5||4
70728|NCT02263911|171569|P2|COMPLETED|Period 5||4
70729|NCT02263911|171570|P1|COMPLETED|Period 5||4
70730|NCT02263911|171567|P4|STARTED|Period 5||4
70731|NCT02263911|171568|P3|STARTED|Period 5||4
70732|NCT02263911|171569|P2|STARTED|Period 5||4
70733|NCT02263911|171570|P1|STARTED|Period 5||4
70734|NCT02263911|171567|P4|NOT COMPLETED|Period 4 Washout||0
70735|NCT02263911|171568|P3|NOT COMPLETED|Period 4 Washout||0
70736|NCT02263911|171569|P2|NOT COMPLETED|Period 4 Washout||0
70737|NCT02263911|171570|P1|NOT COMPLETED|Period 4 Washout||0
70738|NCT02263911|171567|P4|COMPLETED|Period 4 Washout||4
70739|NCT02263911|171568|P3|COMPLETED|Period 4 Washout||4
70740|NCT02263911|171569|P2|COMPLETED|Period 4 Washout||4
70741|NCT02263911|171570|P1|COMPLETED|Period 4 Washout||4
70742|NCT02263911|171567|P4|STARTED|Period 4 Washout||4
70743|NCT02263911|171568|P3|STARTED|Period 4 Washout||4
70744|NCT02263911|171569|P2|STARTED|Period 4 Washout||4
70745|NCT02263911|171570|P1|STARTED|Period 4 Washout||4
70746|NCT02263911|171567|P4|NOT COMPLETED|Period 4||0
70747|NCT02263911|171568|P3|NOT COMPLETED|Period 4||0
70748|NCT02263911|171569|P2|NOT COMPLETED|Period 4||0
70749|NCT02263911|171570|P1|NOT COMPLETED|Period 4||0
70750|NCT02263911|171567|P4|COMPLETED|Period 4||4
70751|NCT02263911|171568|P3|COMPLETED|Period 4||4
70752|NCT02263911|171569|P2|COMPLETED|Period 4||4
70753|NCT02263911|171570|P1|COMPLETED|Period 4||4
70754|NCT02263911|171567|P4|STARTED|Period 4||4
70755|NCT02263911|171568|P3|STARTED|Period 4||4
70756|NCT02263911|171569|P2|STARTED|Period 4||4
70757|NCT02263911|171570|P1|STARTED|Period 4||4
70758|NCT02263911|171567|P4|NOT COMPLETED|Period 3 Washout||0
70759|NCT02263911|171568|P3|NOT COMPLETED|Period 3 Washout||0
70760|NCT02263911|171569|P2|NOT COMPLETED|Period 3 Washout||0
70761|NCT02263911|171570|P1|NOT COMPLETED|Period 3 Washout||0
70762|NCT02263911|171567|P4|COMPLETED|Period 3 Washout||4
70763|NCT02263911|171568|P3|COMPLETED|Period 3 Washout||4
70764|NCT02263911|171569|P2|COMPLETED|Period 3 Washout||4
70765|NCT02263911|171570|P1|COMPLETED|Period 3 Washout||4
70766|NCT02263911|171567|P4|STARTED|Period 3 Washout||4
70767|NCT02263911|171568|P3|STARTED|Period 3 Washout||4
70768|NCT02263911|171569|P2|STARTED|Period 3 Washout||4
70769|NCT02263911|171570|P1|STARTED|Period 3 Washout||4
70770|NCT02263911|171567|P4|NOT COMPLETED|Period 3||0
70771|NCT02263911|171568|P3|NOT COMPLETED|Period 3||0
70772|NCT02263911|171569|P2|NOT COMPLETED|Period 3||0
70773|NCT02263911|171570|P1|NOT COMPLETED|Period 3||0
70774|NCT02263911|171567|P4|COMPLETED|Period 3||4
70775|NCT02263911|171568|P3|COMPLETED|Period 3||4
70776|NCT02263911|171569|P2|COMPLETED|Period 3||4
70777|NCT02263911|171570|P1|COMPLETED|Period 3||4
70778|NCT02263911|171567|P4|STARTED|Period 3||4
70779|NCT02263911|171568|P3|STARTED|Period 3||4
70780|NCT02263911|171569|P2|STARTED|Period 3||4
70781|NCT02263911|171570|P1|STARTED|Period 3||4
70782|NCT02263911|171567|P4|NOT COMPLETED|Period 2 Washout||0
70783|NCT02263911|171568|P3|NOT COMPLETED|Period 2 Washout||0
70784|NCT02263911|171569|P2|NOT COMPLETED|Period 2 Washout||0
70785|NCT02263911|171570|P1|NOT COMPLETED|Period 2 Washout||0
70786|NCT02263911|171567|P4|COMPLETED|Period 2 Washout||4
70787|NCT02263911|171568|P3|COMPLETED|Period 2 Washout||4
70788|NCT02263911|171569|P2|COMPLETED|Period 2 Washout||4
70789|NCT02263911|171570|P1|COMPLETED|Period 2 Washout||4
70790|NCT02263911|171567|P4|STARTED|Period 2 Washout||4
70791|NCT02263911|171568|P3|STARTED|Period 2 Washout||4
70792|NCT02263911|171569|P2|STARTED|Period 2 Washout||4
70793|NCT02263911|171570|P1|STARTED|Period 2 Washout||4
70794|NCT02263911|171567|P4|NOT COMPLETED|Period 2||0
70795|NCT02263911|171568|P3|NOT COMPLETED|Period 2||0
70796|NCT02263911|171569|P2|NOT COMPLETED|Period 2||0
70797|NCT02263911|171570|P1|NOT COMPLETED|Period 2||0
70798|NCT02263911|171567|P4|COMPLETED|Period 2||4
70799|NCT02263911|171568|P3|COMPLETED|Period 2||4
70800|NCT02263911|171569|P2|COMPLETED|Period 2||4
70801|NCT02263911|171570|P1|COMPLETED|Period 2||4
70802|NCT02263911|171567|P4|STARTED|Period 2||4
70803|NCT02263911|171568|P3|STARTED|Period 2||4
70804|NCT02263911|171569|P2|STARTED|Period 2||4
70805|NCT02263911|171570|P1|STARTED|Period 2||4
70806|NCT02263911|171567|P4|NOT COMPLETED|Period 1 Washout||0
70807|NCT02263911|171568|P3|NOT COMPLETED|Period 1 Washout||0
70808|NCT02263911|171569|P2|NOT COMPLETED|Period 1 Washout||0
70809|NCT02263911|171570|P1|NOT COMPLETED|Period 1 Washout||0
70810|NCT02263911|171567|P4|COMPLETED|Period 1 Washout||4
70811|NCT02263911|171568|P3|COMPLETED|Period 1 Washout||4
70812|NCT02263911|171569|P2|COMPLETED|Period 1 Washout||4
70813|NCT02263911|171570|P1|COMPLETED|Period 1 Washout||4
70814|NCT02263911|171567|P4|STARTED|Period 1 Washout||4
70815|NCT02263911|171568|P3|STARTED|Period 1 Washout||4
70816|NCT02263911|171569|P2|STARTED|Period 1 Washout||4
70817|NCT02263911|171570|P1|STARTED|Period 1 Washout||4
70818|NCT02263911|171567|P4|NOT COMPLETED|Period 1||0
70819|NCT02263911|171568|P3|NOT COMPLETED|Period 1||0
70820|NCT02263911|171569|P2|NOT COMPLETED|Period 1||0
70821|NCT02263911|171570|P1|NOT COMPLETED|Period 1||0
70822|NCT02263911|171567|P4|COMPLETED|Period 1||4
70823|NCT02263911|171568|P3|COMPLETED|Period 1||4
70824|NCT02263911|171569|P2|COMPLETED|Period 1||4
70825|NCT02263911|171570|P1|COMPLETED|Period 1||4
70826|NCT02263911|171567|P4|STARTED|Period 1||4
70827|NCT02263911|171568|P3|STARTED|Period 1||4
70828|NCT02263911|171569|P2|STARTED|Period 1||4
70829|NCT02263911|171570|P1|STARTED|Period 1||4
70830|NCT02263833|171592|P1|NOT COMPLETED|Overall Study||0
70831|NCT02263833|171592|P1|COMPLETED|Overall Study||742
70832|NCT02263833|171592|P1|STARTED|Overall Study||742
70833|NCT02263547|171597|P1|NOT COMPLETED|Overall Study||3
70834|NCT02263547|171597|P1|COMPLETED|Overall Study||11
70835|NCT02263547|171597|P1|STARTED|Overall Study||14
70836|NCT02263365|171604|P2|NOT COMPLETED|Overall Study||18
70837|NCT02263365|171605|P1|NOT COMPLETED|Overall Study||22
70838|NCT02263365|171604|P2|COMPLETED|Overall Study||0
70839|NCT02263365|171605|P1|COMPLETED|Overall Study||0
70840|NCT02263365|171604|P2|STARTED|Overall Study||18
70841|NCT02263365|171605|P1|STARTED|Overall Study||22
70842|NCT02263326|171619|P2|NOT COMPLETED|Overall Study||1
70843|NCT02263326|171620|P1|NOT COMPLETED|Overall Study||1
70844|NCT02263326|171619|P2|COMPLETED|Overall Study||44
70845|NCT02263326|171620|P1|COMPLETED|Overall Study||43
70846|NCT02263326|171619|P2|STARTED|Overall Study||45
70847|NCT02263326|171620|P1|STARTED|Overall Study||44
70848|NCT02263131|171642|P2|NOT COMPLETED|Overall Study||1
70849|NCT02263131|171643|P1|NOT COMPLETED|Overall Study||10
70850|NCT02263131|171642|P2|COMPLETED|Overall Study||68
70851|NCT02263131|171643|P1|COMPLETED|Overall Study||337
70852|NCT02263131|171642|P2|STARTED|Overall Study||69
70853|NCT02263131|171643|P1|STARTED|Overall Study||347
70854|NCT02263118|171655|P4|NOT COMPLETED|Overall Study||2
70855|NCT02263118|171656|P3|NOT COMPLETED|Overall Study||8
70856|NCT02263118|171657|P2|NOT COMPLETED|Overall Study||8
70857|NCT02263118|171658|P1|NOT COMPLETED|Overall Study||4
70858|NCT02263118|171655|P4|COMPLETED|Overall Study||12
70859|NCT02263118|171656|P3|COMPLETED|Overall Study||22
70860|NCT02263118|171657|P2|COMPLETED|Overall Study||24
70861|NCT02263118|171658|P1|COMPLETED|Overall Study||20
70862|NCT02263118|171655|P4|STARTED|Overall Study||14
70863|NCT02263118|171656|P3|STARTED|Overall Study||30
70864|NCT02263118|171657|P2|STARTED|Overall Study||32
70865|NCT02263118|171658|P1|STARTED|Overall Study||24
70866|NCT02263040|171682|P2|NOT COMPLETED|Overall Study||0
70867|NCT02263040|171683|P1|NOT COMPLETED|Overall Study||0
70868|NCT02263040|171682|P2|COMPLETED|Overall Study||83
70869|NCT02263040|171683|P1|COMPLETED|Overall Study||87
70870|NCT02263040|171682|P2|STARTED|Overall Study||83
70871|NCT02263040|171683|P1|STARTED|Overall Study||87
70872|NCT02262754|171714|P3|NOT COMPLETED|Overall Study||9
70873|NCT02262754|171715|P2|NOT COMPLETED|Overall Study||9
70874|NCT02262754|171716|P1|NOT COMPLETED|Overall Study||16
70875|NCT02262754|171714|P3|COMPLETED|Overall Study||65
70876|NCT02262754|171715|P2|COMPLETED|Overall Study||65
70877|NCT02262754|171716|P1|COMPLETED|Overall Study||58
70878|NCT02262754|171714|P3|STARTED|Overall Study||74
70879|NCT02262754|171715|P2|STARTED|Overall Study||74
70880|NCT02262754|171716|P1|STARTED|Overall Study||74
70881|NCT02262728|171791|P2|NOT COMPLETED|Follow-up Phase (3 Years)||3
70882|NCT02262728|171792|P1|NOT COMPLETED|Follow-up Phase (3 Years)||4
70883|NCT02262728|171791|P2|COMPLETED|Follow-up Phase (3 Years)||18
70884|NCT02262728|171792|P1|COMPLETED|Follow-up Phase (3 Years)||15
70885|NCT02262728|171791|P2|STARTED|Follow-up Phase (3 Years)||21
70886|NCT02262728|171792|P1|STARTED|Follow-up Phase (3 Years)||19
70887|NCT02262728|171791|P2|NOT COMPLETED|Treatment Period (12 Weeks)||0
70888|NCT02262728|171792|P1|NOT COMPLETED|Treatment Period (12 Weeks)||0
70889|NCT02262728|171791|P2|COMPLETED|Treatment Period (12 Weeks)|Participants who completed continued follow-up phase.|21
70890|NCT02262728|171792|P1|COMPLETED|Treatment Period (12 Weeks)|Participants who completed continued follow-up phase.|19
70891|NCT02262728|171791|P2|STARTED|Treatment Period (12 Weeks)||21
70892|NCT02262728|171792|P1|STARTED|Treatment Period (12 Weeks)||19
70893|NCT02262377|171824|P2|NOT COMPLETED|Overall Study||6
70894|NCT02262377|171825|P1|NOT COMPLETED|Overall Study||12
70895|NCT02262377|171824|P2|COMPLETED|Overall Study||73
70896|NCT02262377|171825|P1|COMPLETED|Overall Study||68
70897|NCT02262377|171824|P2|STARTED|Overall Study||79
70898|NCT02262377|171825|P1|STARTED|Overall Study||80
70899|NCT02262364|171840|P1|NOT COMPLETED|Follow-Up Through 12 Months||0
70900|NCT02262364|171840|P1|COMPLETED|Follow-Up Through 12 Months||10
70901|NCT02262364|171840|P1|STARTED|Follow-Up Through 12 Months||10
70902|NCT02262364|171840|P1|NOT COMPLETED|Injection With APS||0
70903|NCT02262364|171840|P1|COMPLETED|Injection With APS||10
70904|NCT02262364|171840|P1|STARTED|Injection With APS||10
70905|NCT02262364|171840|P1|NOT COMPLETED|Blood Draw for Device Processing||1
70906|NCT02262364|171840|P1|COMPLETED|Blood Draw for Device Processing||10
70907|NCT02262364|171840|P1|STARTED|Blood Draw for Device Processing||11
70908|NCT02262364|171840|P1|NOT COMPLETED|Study Enrollment||0
70909|NCT02262364|171840|P1|COMPLETED|Study Enrollment||11
70910|NCT02262364|171840|P1|STARTED|Study Enrollment||11
70911|NCT02262260|171849|P2|NOT COMPLETED|Overall Study||10
70912|NCT02262260|171850|P1|NOT COMPLETED|Overall Study||11
70913|NCT02262260|171849|P2|COMPLETED|Overall Study||32
70914|NCT02262260|171850|P1|COMPLETED|Overall Study||34
70915|NCT02262260|171849|P2|STARTED|Overall Study||42
70916|NCT02262260|171850|P1|STARTED|Overall Study||45
70917|NCT02262130|171868|P1|NOT COMPLETED|Overall Study||0
70918|NCT02262130|171868|P1|COMPLETED|Overall Study||10
70919|NCT02262130|171868|P1|STARTED|Overall Study||10
70920|NCT02262078|171878|P2|NOT COMPLETED|Overall Study||0
70921|NCT02262078|171879|P1|NOT COMPLETED|Overall Study||0
70922|NCT02262078|171878|P2|COMPLETED|Overall Study||13
70923|NCT02262078|171879|P1|COMPLETED|Overall Study||13
70924|NCT02262078|171878|P2|STARTED|Overall Study||13
70925|NCT02262078|171879|P1|STARTED|Overall Study||13
70926|NCT02262039|171887|P2|NOT COMPLETED|Overall Study||0
70927|NCT02262039|171888|P1|NOT COMPLETED|Overall Study||0
70928|NCT02262039|171887|P2|COMPLETED|Overall Study||27
70929|NCT02262039|171888|P1|COMPLETED|Overall Study||14
70930|NCT02262039|171887|P2|STARTED|Overall Study||27
70931|NCT02262039|171888|P1|STARTED|Overall Study||14
70932|NCT02261974|171908|P2|NOT COMPLETED|Overall Study||7
70933|NCT02261974|171909|P1|NOT COMPLETED|Overall Study||15
70934|NCT02261974|171908|P2|COMPLETED|Overall Study||56
70935|NCT02261974|171909|P1|COMPLETED|Overall Study||108
70936|NCT02261974|171908|P2|Treated|Overall Study||57
70937|NCT02261974|171909|P1|Treated|Overall Study||117
70938|NCT02261974|171908|P2|STARTED|Overall Study||63
70939|NCT02261974|171909|P1|STARTED|Overall Study||123
70940|NCT02261948|171925|P2|NOT COMPLETED|Overall Study||0
70941|NCT02261948|171926|P1|NOT COMPLETED|Overall Study||0
70942|NCT02261948|171925|P2|COMPLETED|Overall Study||19
70943|NCT02261948|171926|P1|COMPLETED|Overall Study||23
70944|NCT02261948|171925|P2|STARTED|Overall Study||19
70945|NCT02261948|171926|P1|STARTED|Overall Study||23
70946|NCT02261818|171936|P1|NOT COMPLETED|Overall Study||3
70947|NCT02261818|171936|P1|COMPLETED|Overall Study||27
70948|NCT02261818|171936|P1|STARTED|Overall Study||30
70949|NCT02261805|171940|P3|NOT COMPLETED|Overall Study||0
70950|NCT02261805|171941|P2|NOT COMPLETED|Overall Study||0
70951|NCT02261805|171942|P1|NOT COMPLETED|Overall Study||0
70952|NCT02261805|171940|P3|COMPLETED|Overall Study||2
70953|NCT02261805|171941|P2|COMPLETED|Overall Study||6
70954|NCT02261805|171942|P1|COMPLETED|Overall Study||3
70955|NCT02261805|171940|P3|STARTED|Overall Study||2
70956|NCT02261805|171941|P2|STARTED|Overall Study||6
70957|NCT02261805|171942|P1|STARTED|Overall Study||3
70958|NCT02261597|171952|P2|NOT COMPLETED|Overall Study||0
70959|NCT02261597|171953|P1|NOT COMPLETED|Overall Study||0
70960|NCT02261597|171952|P2|COMPLETED|Overall Study||22
70961|NCT02261597|171953|P1|COMPLETED|Overall Study||22
70962|NCT02261597|171952|P2|STARTED|Overall Study||22
70963|NCT02261597|171953|P1|STARTED|Overall Study||22
70964|NCT02261493|171966|P3|NOT COMPLETED|Overall Study||26
70965|NCT02261493|171967|P2|NOT COMPLETED|Overall Study||47
70966|NCT02261493|171968|P1|NOT COMPLETED|Overall Study||30
70967|NCT02261493|171966|P3|COMPLETED|Overall Study||287
70968|NCT02261493|171967|P2|COMPLETED|Overall Study||271
70969|NCT02261493|171968|P1|COMPLETED|Overall Study||126
70970|NCT02261493|171966|P3|STARTED|Overall Study||313
70971|NCT02261493|171967|P2|STARTED|Overall Study||318
70972|NCT02261493|171968|P1|STARTED|Overall Study||156
70973|NCT02261467|171996|P2|NOT COMPLETED|Overall Study||37
70974|NCT02261467|171997|P1|NOT COMPLETED|Overall Study||21
70975|NCT02261467|171996|P2|COMPLETED|Overall Study||253
70976|NCT02261467|171997|P1|COMPLETED|Overall Study||80
70977|NCT02261467|171996|P2|STARTED|Overall Study||290
70978|NCT02261467|171997|P1|STARTED|Overall Study||101
70979|NCT02261428|172017|P2|NOT COMPLETED|Overall Study||0
70980|NCT02261428|172018|P1|NOT COMPLETED|Overall Study||0
70981|NCT02261428|172017|P2|COMPLETED|Overall Study||10
70982|NCT02261428|172018|P1|COMPLETED|Overall Study||10
70983|NCT02261428|172017|P2|STARTED|Overall Study|Washout (30 minutes)|10
70984|NCT02261428|172018|P1|STARTED|Overall Study|Washout (30 minutes)|10
70985|NCT02260986|172039|P3|NOT COMPLETED|Overall Study||41
70986|NCT02260986|172040|P2|NOT COMPLETED|Overall Study||13
70987|NCT02260986|172041|P1|NOT COMPLETED|Overall Study||90
70988|NCT02260986|172039|P3|COMPLETED|Overall Study||278
70989|NCT02260986|172040|P2|COMPLETED|Overall Study||93
70990|NCT02260986|172041|P1|COMPLETED|Overall Study||225
70991|NCT02260986|172039|P3|Safety Population|Overall Study|4 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|315
70992|NCT02260986|172040|P2|Safety Population|Overall Study|4 participants from Dupilumab 300 mg qw arm analyzed in Dupilumab 300 mg q2w arm|110
70993|NCT02260986|172041|P1|Safety Population|Overall Study||315
70994|NCT02260986|172039|P3|STARTED|Overall Study||319
70995|NCT02260986|172040|P2|STARTED|Overall Study||106
70996|NCT02260986|172041|P1|STARTED|Overall Study||315
70997|NCT02260934|172159|P2|NOT COMPLETED|Overall Study||14
70998|NCT02260934|172160|P1|NOT COMPLETED|Overall Study||13
70999|NCT02260934|172159|P2|COMPLETED|Overall Study|At primary outcome timepoint: Eleven participants engaged in ongoing scheduled study visits.|7
71000|NCT02260934|172160|P1|COMPLETED|Overall Study|At primary outcome timepoint: Ten participants engaged in ongoing scheduled study visits.|9
71001|NCT02260934|172159|P2|STARTED|Overall Study||21
71002|NCT02260934|172160|P1|STARTED|Overall Study||22
71003|NCT02260882|172170|P2|NOT COMPLETED|Overall Study||1
71004|NCT02260882|172171|P1|NOT COMPLETED|Overall Study||0
71005|NCT02260882|172170|P2|COMPLETED|Overall Study||81
71006|NCT02260882|172171|P1|COMPLETED|Overall Study||161
71007|NCT02260882|172170|P2|STARTED|Overall Study||82
71008|NCT02260882|172171|P1|STARTED|Overall Study||161
71009|NCT02260791|172195|P2|NOT COMPLETED|Overall Study||34
71010|NCT02260791|172196|P1|NOT COMPLETED|Overall Study||33
71011|NCT02260791|172195|P2|COMPLETED|Overall Study||328
71012|NCT02260791|172196|P1|COMPLETED|Overall Study||333
71013|NCT02260791|172195|P2|STARTED|Overall Study||362
71014|NCT02260791|172196|P1|STARTED|Overall Study||366
71015|NCT02260648|172235|P3|NOT COMPLETED|Overall Study||8
71016|NCT02260648|172236|P2|NOT COMPLETED|Overall Study||13
71017|NCT02260648|172237|P1|NOT COMPLETED|Overall Study||18
71018|NCT02260648|172235|P3|COMPLETED|Overall Study||42
71019|NCT02260648|172236|P2|COMPLETED|Overall Study||33
71020|NCT02260648|172237|P1|COMPLETED|Overall Study||35
71021|NCT02260648|172235|P3|Received at Least One Dose of Study Drug|Overall Study||50
71022|NCT02260648|172236|P2|Received at Least One Dose of Study Drug|Overall Study||46
71023|NCT02260648|172237|P1|Received at Least One Dose of Study Drug|Overall Study||53
71024|NCT02260648|172235|P3|STARTED|Overall Study||50
71025|NCT02260648|172236|P2|STARTED|Overall Study||46
71026|NCT02260648|172237|P1|STARTED|Overall Study||53
71027|NCT02260635|172265|P2|NOT COMPLETED|Open-Label Extension||25
71028|NCT02260635|172266|P1|NOT COMPLETED|Open-Label Extension||26
71029|NCT02260635|172265|P2|COMPLETED|Open-Label Extension||0
71030|NCT02260635|172266|P1|COMPLETED|Open-Label Extension||0
71031|NCT02260635|172265|P2|Received at Least One Dose of Study Drug|Open-Label Extension||25
71032|NCT02260635|172266|P1|Received at Least One Dose of Study Drug|Open-Label Extension||26
71033|NCT02260635|172265|P2|STARTED|Open-Label Extension||25
71034|NCT02260635|172266|P1|STARTED|Open-Label Extension||26
71035|NCT02260635|172265|P2|NOT COMPLETED|Double-Blind Treatment Period||2
71036|NCT02260635|172266|P1|NOT COMPLETED|Double-Blind Treatment Period||1
71037|NCT02260635|172265|P2|COMPLETED|Double-Blind Treatment Period||25
71038|NCT02260635|172266|P1|COMPLETED|Double-Blind Treatment Period||26
71039|NCT02260635|172265|P2|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||26
71040|NCT02260635|172266|P1|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||27
71041|NCT02260635|172265|P2|STARTED|Double-Blind Treatment Period||27
71042|NCT02260635|172266|P1|STARTED|Double-Blind Treatment Period||27
71043|NCT02260622|172288|P2|NOT COMPLETED|Overall Study||0
71044|NCT02260622|172289|P1|NOT COMPLETED|Overall Study||0
71045|NCT02260622|172288|P2|COMPLETED|Overall Study||9
71046|NCT02260622|172289|P1|COMPLETED|Overall Study||11
71047|NCT02260622|172288|P2|STARTED|Overall Study||9
71048|NCT02260622|172289|P1|STARTED|Overall Study||11
71049|NCT02260492|172318|P3|NOT COMPLETED|Overall Study||5
71050|NCT02260492|172319|P2|NOT COMPLETED|Overall Study||13
71051|NCT02260492|172320|P1|NOT COMPLETED|Overall Study||23
71052|NCT02260492|172318|P3|COMPLETED|Overall Study||37
71053|NCT02260492|172319|P2|COMPLETED|Overall Study||406
71054|NCT02260492|172320|P1|COMPLETED|Overall Study||395
71055|NCT02260492|172318|P3|Completed Day 1|Overall Study||42
71056|NCT02260492|172319|P2|Completed Day 1|Overall Study||419
71057|NCT02260492|172320|P1|Completed Day 1|Overall Study||418
71058|NCT02260492|172318|P3|STARTED|Overall Study||42
71059|NCT02260492|172319|P2|STARTED|Overall Study||419
71060|NCT02260492|172320|P1|STARTED|Overall Study||418
71061|NCT02260440|172334|P1|NOT COMPLETED|Overall Study||0
71062|NCT02260440|172334|P1|COMPLETED|Overall Study||31
71063|NCT02260440|172334|P1|STARTED|Overall Study||31
71064|NCT02260401|172342|P2|NOT COMPLETED|Overall Study||12
71065|NCT02260401|172343|P1|NOT COMPLETED|Overall Study||5
71066|NCT02260401|172342|P2|COMPLETED|Overall Study||73
71067|NCT02260401|172343|P1|COMPLETED|Overall Study||75
71068|NCT02260401|172342|P2|STARTED|Overall Study||85
71069|NCT02260401|172343|P1|STARTED|Overall Study||80
71070|NCT02260388|172353|P4|NOT COMPLETED|Overall Study||4
71071|NCT02260388|172354|P3|NOT COMPLETED|Overall Study||3
71072|NCT02260388|172355|P2|NOT COMPLETED|Overall Study||8
71073|NCT02260388|172356|P1|NOT COMPLETED|Overall Study||2
71074|NCT02260388|172353|P4|COMPLETED|Overall Study||65
71075|NCT02260388|172354|P3|COMPLETED|Overall Study||70
71076|NCT02260388|172355|P2|COMPLETED|Overall Study||118
71077|NCT02260388|172356|P1|COMPLETED|Overall Study||132
71078|NCT02260388|172353|P4|STARTED|Overall Study||69
71079|NCT02260388|172354|P3|STARTED|Overall Study||73
71080|NCT02260388|172355|P2|STARTED|Overall Study||126
71081|NCT02260388|172356|P1|STARTED|Overall Study||134
71082|NCT02260180|172385|P3|NOT COMPLETED|Overall Study||1
71083|NCT02260180|172386|P2|NOT COMPLETED|Overall Study||0
71084|NCT02260180|172387|P1|NOT COMPLETED|Overall Study||2
71085|NCT02260180|172385|P3|COMPLETED|Overall Study||40
71086|NCT02260180|172386|P2|COMPLETED|Overall Study||39
71087|NCT02260180|172387|P1|COMPLETED|Overall Study||37
71088|NCT02260180|172385|P3|STARTED|Overall Study||41
71089|NCT02260180|172386|P2|STARTED|Overall Study||39
71090|NCT02260180|172387|P1|STARTED|Overall Study||39
71091|NCT02260154|172398|P1|NOT COMPLETED|Overall Study||2
71092|NCT02260154|172398|P1|COMPLETED|Overall Study||218
71093|NCT02260154|172398|P1|STARTED|Overall Study||220
71094|NCT02259699|172414|P2|NOT COMPLETED|Overall Study||20
71095|NCT02259699|172415|P1|NOT COMPLETED|Overall Study||27
71096|NCT02259699|172414|P2|COMPLETED|Overall Study||40
71097|NCT02259699|172415|P1|COMPLETED|Overall Study||37
71098|NCT02259699|172414|P2|STARTED|Overall Study||60
71099|NCT02259699|172415|P1|STARTED|Overall Study||64
71100|NCT02259608|172430|P1|NOT COMPLETED|Overall Study||0
71101|NCT02259608|172430|P1|COMPLETED|Overall Study||15
71102|NCT02259608|172430|P1|STARTED|Overall Study||15
71103|NCT02259582|172438|P3|NOT COMPLETED|Overall Study||21
71104|NCT02259582|172439|P2|NOT COMPLETED|Overall Study||17
71105|NCT02259582|172440|P1|NOT COMPLETED|Overall Study||16
71106|NCT02259582|172438|P3|COMPLETED|Overall Study||8
71107|NCT02259582|172439|P2|COMPLETED|Overall Study||11
71108|NCT02259582|172440|P1|COMPLETED|Overall Study||9
71109|NCT02259582|172438|P3|STARTED|Overall Study||29
71110|NCT02259582|172439|P2|STARTED|Overall Study||28
71111|NCT02259582|172440|P1|STARTED|Overall Study||25
71112|NCT02259400|172450|P2|NOT COMPLETED|Overall Study||2
71113|NCT02259400|172451|P1|NOT COMPLETED|Overall Study||0
71114|NCT02259400|172450|P2|COMPLETED|Overall Study||60
71115|NCT02259400|172451|P1|COMPLETED|Overall Study||62
71116|NCT02259400|172450|P2|STARTED|Overall Study||62
71117|NCT02259400|172451|P1|STARTED|Overall Study||62
71118|NCT02259348|172483|P1|NOT COMPLETED|Overall Study||10
71119|NCT02259348|172483|P1|COMPLETED|Overall Study||2
71120|NCT02259348|172483|P1|One Year Post-transplant|Overall Study||2
71121|NCT02259348|172483|P1|STARTED|Overall Study||12
71122|NCT02259114|172500|P5|NOT COMPLETED|Overall Study||6
71123|NCT02259114|172501|P4|NOT COMPLETED|Overall Study||3
71124|NCT02259114|172502|P3|NOT COMPLETED|Overall Study||13
71125|NCT02259114|172503|P2|NOT COMPLETED|Overall Study||4
71126|NCT02259114|172504|P1|NOT COMPLETED|Overall Study||21
71127|NCT02259114|172500|P5|COMPLETED|Overall Study||0
71128|NCT02259114|172501|P4|COMPLETED|Overall Study||0
71129|NCT02259114|172502|P3|COMPLETED|Overall Study||0
71130|NCT02259114|172503|P2|COMPLETED|Overall Study||0
71131|NCT02259114|172504|P1|COMPLETED|Overall Study||0
71132|NCT02259114|172500|P5|Treated|Overall Study||6
71133|NCT02259114|172501|P4|Treated|Overall Study||3
71134|NCT02259114|172502|P3|Treated|Overall Study||13
71135|NCT02259114|172503|P2|Treated|Overall Study||4
71136|NCT02259114|172504|P1|Treated|Overall Study|One participant was randomized but did not receive treatment due to a protocol violation.|20
71137|NCT02259114|172500|P5|STARTED|Overall Study||6
71138|NCT02259114|172501|P4|STARTED|Overall Study||3
71139|NCT02259114|172502|P3|STARTED|Overall Study||13
71140|NCT02259114|172503|P2|STARTED|Overall Study||4
71141|NCT02259114|172504|P1|STARTED|Overall Study||21
71142|NCT02259088|172563|P2|NOT COMPLETED|Overall Study||14
71143|NCT02259088|172564|P1|NOT COMPLETED|Overall Study||28
71144|NCT02259088|172563|P2|COMPLETED|Overall Study||63
71145|NCT02259088|172564|P1|COMPLETED|Overall Study||279
71146|NCT02259088|172563|P2|Treated (Safety Analysis Set)|Overall Study||75
71147|NCT02259088|172564|P1|Treated (Safety Analysis Set)|Overall Study||307
71148|NCT02259088|172563|P2|Full Analysis Set|Overall Study||77
71149|NCT02259088|172564|P1|Full Analysis Set|Overall Study||307
71150|NCT02259088|172563|P2|STARTED|Overall Study||77
71151|NCT02259088|172564|P1|STARTED|Overall Study||307
71152|NCT02259010|172609|P1|NOT COMPLETED|Overall Study||5
71153|NCT02259010|172609|P1|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK assessment.|19
71154|NCT02259010|172609|P1|STARTED|Overall Study||24
71155|NCT02258542|172638|P4|NOT COMPLETED|Overall Study||5
71156|NCT02258542|172639|P3|NOT COMPLETED|Overall Study||8
71157|NCT02258542|172640|P2|NOT COMPLETED|Overall Study||49
71158|NCT02258542|172641|P1|NOT COMPLETED|Overall Study||42
71159|NCT02258542|172638|P4|COMPLETED|Overall Study|48 enrolled into study MELTEMI|92
71160|NCT02258542|172639|P3|COMPLETED|Overall Study|51 enrolled into study MELTEMI|92
71161|NCT02258542|172640|P2|COMPLETED|Overall Study|178 enrolled into study MELTEMI|924
71162|NCT02258542|172641|P1|COMPLETED|Overall Study|170 enrolled into study MELTEMI|911
71163|NCT02258542|172638|P4|Adolescents Only|Overall Study||0
71164|NCT02258542|172639|P3|Adolescents Only|Overall Study||0
71165|NCT02258542|172640|P2|Adolescents Only|Overall Study||61
71166|NCT02258542|172641|P1|Adolescents Only|Overall Study||25
71167|NCT02258542|172638|P4|Treated|Overall Study||97
71168|NCT02258542|172639|P3|Treated|Overall Study||100
71169|NCT02258542|172640|P2|Treated|Overall Study||971
71170|NCT02258542|172641|P1|Treated|Overall Study||953
71171|NCT02258542|172638|P4|STARTED|Overall Study||97
71172|NCT02258542|172639|P3|STARTED|Overall Study||100
71173|NCT02258542|172640|P2|STARTED|Overall Study||973
71174|NCT02258542|172641|P1|STARTED|Overall Study||953
71175|NCT02258529|172865|P1|NOT COMPLETED|Overall Study||10
71176|NCT02258529|172865|P1|COMPLETED|Overall Study||0
71177|NCT02258529|172865|P1|STARTED|Overall Study||10
71178|NCT02258477|172877|P4|NOT COMPLETED|Fourth Intervention (1 Week)||0
71179|NCT02258477|172878|P3|NOT COMPLETED|Fourth Intervention (1 Week)||0
71180|NCT02258477|172879|P2|NOT COMPLETED|Fourth Intervention (1 Week)||0
71181|NCT02258477|172880|P1|NOT COMPLETED|Fourth Intervention (1 Week)||0
71182|NCT02258477|172877|P4|COMPLETED|Fourth Intervention (1 Week)||8
71183|NCT02258477|172878|P3|COMPLETED|Fourth Intervention (1 Week)||8
71184|NCT02258477|172879|P2|COMPLETED|Fourth Intervention (1 Week)||8
71185|NCT02258477|172880|P1|COMPLETED|Fourth Intervention (1 Week)||9
71186|NCT02258477|172877|P4|STARTED|Fourth Intervention (1 Week)||8
71187|NCT02258477|172878|P3|STARTED|Fourth Intervention (1 Week)||8
71188|NCT02258477|172879|P2|STARTED|Fourth Intervention (1 Week)||8
71189|NCT02258477|172880|P1|STARTED|Fourth Intervention (1 Week)||9
71190|NCT02258477|172877|P4|NOT COMPLETED|Third Intervention (1 Week)||0
71191|NCT02258477|172878|P3|NOT COMPLETED|Third Intervention (1 Week)||0
71192|NCT02258477|172879|P2|NOT COMPLETED|Third Intervention (1 Week)||0
71193|NCT02258477|172880|P1|NOT COMPLETED|Third Intervention (1 Week)||0
71194|NCT02258477|172877|P4|COMPLETED|Third Intervention (1 Week)||8
71195|NCT02258477|172878|P3|COMPLETED|Third Intervention (1 Week)||8
71196|NCT02258477|172879|P2|COMPLETED|Third Intervention (1 Week)||8
71197|NCT02258477|172880|P1|COMPLETED|Third Intervention (1 Week)||9
71198|NCT02258477|172877|P4|STARTED|Third Intervention (1 Week)||8
71199|NCT02258477|172878|P3|STARTED|Third Intervention (1 Week)||8
71200|NCT02258477|172879|P2|STARTED|Third Intervention (1 Week)||8
71201|NCT02258477|172880|P1|STARTED|Third Intervention (1 Week)||9
71202|NCT02258477|172877|P4|NOT COMPLETED|Second Intervention (1 Week)||1
71203|NCT02258477|172878|P3|NOT COMPLETED|Second Intervention (1 Week)||1
71204|NCT02258477|172879|P2|NOT COMPLETED|Second Intervention (1 Week)||0
71205|NCT02258477|172880|P1|NOT COMPLETED|Second Intervention (1 Week)||0
71206|NCT02258477|172877|P4|COMPLETED|Second Intervention (1 Week)||8
71207|NCT02258477|172878|P3|COMPLETED|Second Intervention (1 Week)||8
71208|NCT02258477|172879|P2|COMPLETED|Second Intervention (1 Week)||8
71209|NCT02258477|172880|P1|COMPLETED|Second Intervention (1 Week)||9
71210|NCT02258477|172877|P4|STARTED|Second Intervention (1 Week)||9
71211|NCT02258477|172878|P3|STARTED|Second Intervention (1 Week)||9
71212|NCT02258477|172879|P2|STARTED|Second Intervention (1 Week)||8
71213|NCT02258477|172880|P1|STARTED|Second Intervention (1 Week)||9
71214|NCT02258477|172877|P4|NOT COMPLETED|First Intervention (1 Week)||0
71215|NCT02258477|172878|P3|NOT COMPLETED|First Intervention (1 Week)||0
71216|NCT02258477|172879|P2|NOT COMPLETED|First Intervention (1 Week)||1
71217|NCT02258477|172880|P1|NOT COMPLETED|First Intervention (1 Week)||1
71218|NCT02258477|172877|P4|COMPLETED|First Intervention (1 Week)||9
71219|NCT02258477|172878|P3|COMPLETED|First Intervention (1 Week)||9
71220|NCT02258477|172879|P2|COMPLETED|First Intervention (1 Week)||8
71221|NCT02258477|172880|P1|COMPLETED|First Intervention (1 Week)||9
71222|NCT02258477|172877|P4|STARTED|First Intervention (1 Week)||9
71223|NCT02258477|172878|P3|STARTED|First Intervention (1 Week)||9
71224|NCT02258477|172879|P2|STARTED|First Intervention (1 Week)||9
71225|NCT02258477|172880|P1|STARTED|First Intervention (1 Week)||10
71226|NCT02258412|172898|P3|NOT COMPLETED|Overall Study||0
71227|NCT02258412|172899|P2|NOT COMPLETED|Overall Study||0
71228|NCT02258412|172900|P1|NOT COMPLETED|Overall Study||0
71229|NCT02258412|172898|P3|COMPLETED|Overall Study||61
71230|NCT02258412|172899|P2|COMPLETED|Overall Study||25
71231|NCT02258412|172900|P1|COMPLETED|Overall Study||26
71232|NCT02258412|172898|P3|STARTED|Overall Study||61
71233|NCT02258412|172899|P2|STARTED|Overall Study||25
71234|NCT02258412|172900|P1|STARTED|Overall Study||26
71235|NCT02258373|172909|P2|NOT COMPLETED|Overall Study||2
71236|NCT02258373|172910|P1|NOT COMPLETED|Overall Study||7
71237|NCT02258373|172909|P2|COMPLETED|Overall Study||75
71238|NCT02258373|172910|P1|COMPLETED|Overall Study||142
71239|NCT02258373|172909|P2|STARTED|Overall Study||77
71240|NCT02258373|172910|P1|STARTED|Overall Study||149
71241|NCT02258334|172954|P4|NOT COMPLETED|Overall Study||0
71242|NCT02258334|172955|P3|NOT COMPLETED|Overall Study||0
71243|NCT02258334|172956|P2|NOT COMPLETED|Overall Study||0
71244|NCT02258334|172957|P1|NOT COMPLETED|Overall Study||1
71245|NCT02258334|172954|P4|COMPLETED|Overall Study||52
71246|NCT02258334|172955|P3|COMPLETED|Overall Study||52
71247|NCT02258334|172956|P2|COMPLETED|Overall Study||54
71248|NCT02258334|172957|P1|COMPLETED|Overall Study||49
71249|NCT02258334|172954|P4|STARTED|Overall Study||52
71250|NCT02258334|172955|P3|STARTED|Overall Study||52
71251|NCT02258334|172956|P2|STARTED|Overall Study||54
71252|NCT02258334|172957|P1|STARTED|Overall Study||50
71253|NCT02258256|172983|P1|NOT COMPLETED|Overall Study||0
71254|NCT02258256|172983|P1|COMPLETED|Overall Study||11
71255|NCT02258256|172983|P1|STARTED|Overall Study||11
71256|NCT02258152|172989|P2|NOT COMPLETED|Overall Study||4
71257|NCT02258152|172990|P1|NOT COMPLETED|Overall Study||6
71258|NCT02258152|172989|P2|COMPLETED|Overall Study||34
71259|NCT02258152|172990|P1|COMPLETED|Overall Study||38
71260|NCT02258152|172989|P2|STARTED|Overall Study||38
71261|NCT02258152|172990|P1|STARTED|Overall Study||44
71262|NCT02257970|173002|P4|NOT COMPLETED|Part 3||7
71263|NCT02257970|173003|P3|NOT COMPLETED|Part 3||7
71264|NCT02257970|173004|P2|NOT COMPLETED|Part 3||0
71265|NCT02257970|173005|P1|NOT COMPLETED|Part 3||0
71266|NCT02257970|173002|P4|COMPLETED|Part 3||14
71267|NCT02257970|173003|P3|COMPLETED|Part 3||16
71268|NCT02257970|173004|P2|COMPLETED|Part 3||0
71269|NCT02257970|173005|P1|COMPLETED|Part 3||0
71270|NCT02257970|173002|P4|STARTED|Part 3||21
71271|NCT02257970|173003|P3|STARTED|Part 3||23
71272|NCT02257970|173004|P2|STARTED|Part 3||0
71273|NCT02257970|173005|P1|STARTED|Part 3||0
71274|NCT02257970|173002|P4|NOT COMPLETED|Part 2||0
71275|NCT02257970|173003|P3|NOT COMPLETED|Part 2||0
71276|NCT02257970|173004|P2|NOT COMPLETED|Part 2||7
71277|NCT02257970|173005|P1|NOT COMPLETED|Part 2||0
71278|NCT02257970|173002|P4|COMPLETED|Part 2||0
71279|NCT02257970|173003|P3|COMPLETED|Part 2||0
71280|NCT02257970|173004|P2|COMPLETED|Part 2||16
71281|NCT02257970|173005|P1|COMPLETED|Part 2||0
71282|NCT02257970|173002|P4|STARTED|Part 2||0
71283|NCT02257970|173003|P3|STARTED|Part 2||0
71284|NCT02257970|173004|P2|STARTED|Part 2||23
71285|NCT02257970|173005|P1|STARTED|Part 2||0
71286|NCT02257970|173002|P4|NOT COMPLETED|Part 1||0
71287|NCT02257970|173003|P3|NOT COMPLETED|Part 1||0
71288|NCT02257970|173004|P2|NOT COMPLETED|Part 1||0
71289|NCT02257970|173005|P1|NOT COMPLETED|Part 1||0
71290|NCT02257970|173002|P4|COMPLETED|Part 1||0
71291|NCT02257970|173003|P3|COMPLETED|Part 1||0
71292|NCT02257970|173004|P2|COMPLETED|Part 1||0
71293|NCT02257970|173005|P1|COMPLETED|Part 1||50
71294|NCT02257970|173002|P4|STARTED|Part 1||0
71295|NCT02257970|173003|P3|STARTED|Part 1||0
71296|NCT02257970|173004|P2|STARTED|Part 1||0
71297|NCT02257970|173005|P1|STARTED|Part 1||50
71298|NCT02257918|173031|P3|NOT COMPLETED|Overall Study||2
71299|NCT02257918|173032|P2|NOT COMPLETED|Overall Study||1
71300|NCT02257918|173033|P1|NOT COMPLETED|Overall Study||4
71301|NCT02257918|173031|P3|COMPLETED|Overall Study||39
71302|NCT02257918|173032|P2|COMPLETED|Overall Study||66
71303|NCT02257918|173033|P1|COMPLETED|Overall Study||68
71304|NCT02257918|173031|P3|Test of Cure Visit|Overall Study||40
71305|NCT02257918|173032|P2|Test of Cure Visit|Overall Study||67
71306|NCT02257918|173033|P1|Test of Cure Visit|Overall Study||72
71307|NCT02257918|173031|P3|STARTED|Overall Study||41
71308|NCT02257918|173032|P2|STARTED|Overall Study||67
71309|NCT02257918|173033|P1|STARTED|Overall Study||72
71310|NCT02257684|173083|P1|NOT COMPLETED|Overall Study||4
71311|NCT02257684|173083|P1|COMPLETED|Overall Study||0
71312|NCT02257684|173083|P1|STARTED|Overall Study||4
71313|NCT02257632|173093|P2|NOT COMPLETED|Overall Study||3
71314|NCT02257632|173094|P1|NOT COMPLETED|Overall Study||1
71315|NCT02257632|173093|P2|COMPLETED|Overall Study||19
71316|NCT02257632|173094|P1|COMPLETED|Overall Study||18
71317|NCT02257632|173093|P2|Per-Protocol Set (PPS)|Overall Study||20
71318|NCT02257632|173094|P1|Per-Protocol Set (PPS)|Overall Study||17
71319|NCT02257632|173093|P2|Safety Set (SAF)|Overall Study||21
71320|NCT02257632|173094|P1|Safety Set (SAF)|Overall Study||19
71321|NCT02257632|173093|P2|Full Analysis Set (FAS)|Overall Study||21
71322|NCT02257632|173094|P1|Full Analysis Set (FAS)|Overall Study||19
71323|NCT02257632|173093|P2|STARTED|Overall Study||22
71324|NCT02257632|173094|P1|STARTED|Overall Study||19
71325|NCT02257489|173115|P9|NOT COMPLETED|Overall Study||0
71326|NCT02257489|173116|P8|NOT COMPLETED|Overall Study||0
71327|NCT02257489|173117|P7|NOT COMPLETED|Overall Study||0
71328|NCT02257489|173118|P6|NOT COMPLETED|Overall Study||0
71329|NCT02257489|173119|P5|NOT COMPLETED|Overall Study||0
71330|NCT02257489|173120|P4|NOT COMPLETED|Overall Study||1
71331|NCT02257489|173121|P3|NOT COMPLETED|Overall Study||0
71332|NCT02257489|173122|P2|NOT COMPLETED|Overall Study||0
71333|NCT02257489|173123|P1|NOT COMPLETED|Overall Study||0
71334|NCT02257489|173115|P9|COMPLETED|Overall Study||6
71335|NCT02257489|173116|P8|COMPLETED|Overall Study||10
71336|NCT02257489|173117|P7|COMPLETED|Overall Study||6
71337|NCT02257489|173118|P6|COMPLETED|Overall Study||6
71338|NCT02257489|173119|P5|COMPLETED|Overall Study||6
71339|NCT02257489|173120|P4|COMPLETED|Overall Study||5
71340|NCT02257489|173121|P3|COMPLETED|Overall Study||6
71341|NCT02257489|173122|P2|COMPLETED|Overall Study||6
71342|NCT02257489|173123|P1|COMPLETED|Overall Study||6
71343|NCT02257489|173115|P9|STARTED|Overall Study||6
71344|NCT02257489|173116|P8|STARTED|Overall Study||10
71345|NCT02257489|173117|P7|STARTED|Overall Study||6
71346|NCT02257489|173118|P6|STARTED|Overall Study||6
71347|NCT02257489|173119|P5|STARTED|Overall Study||6
71348|NCT02257489|173120|P4|STARTED|Overall Study||6
71349|NCT02257489|173121|P3|STARTED|Overall Study||6
71350|NCT02257489|173122|P2|STARTED|Overall Study||6
71351|NCT02257489|173123|P1|STARTED|Overall Study||6
71352|NCT02257385|173159|P2|NOT COMPLETED|Overall Study||22
71353|NCT02257385|173160|P1|NOT COMPLETED|Overall Study||22
71354|NCT02257385|173159|P2|COMPLETED|Overall Study||457
71355|NCT02257385|173160|P1|COMPLETED|Overall Study||460
71356|NCT02257385|173159|P2|STARTED|Overall Study||479
71357|NCT02257385|173160|P1|STARTED|Overall Study||482
71358|NCT02257372|173170|P2|NOT COMPLETED|Overall Study||10
71359|NCT02257372|173171|P1|NOT COMPLETED|Overall Study||7
71360|NCT02257372|173170|P2|COMPLETED|Overall Study||109
71361|NCT02257372|173171|P1|COMPLETED|Overall Study||110
71362|NCT02257372|173170|P2|STARTED|Overall Study||119
71363|NCT02257372|173171|P1|STARTED|Overall Study||117
71364|NCT02257099|173179|P1|NOT COMPLETED|Overall Study||0
71365|NCT02257099|173179|P1|COMPLETED|Overall Study||20
71366|NCT02257099|173179|P1|STARTED|Overall Study||20
71367|NCT02256982|173188|P2|NOT COMPLETED|Overall Study||1
71368|NCT02256982|173189|P1|NOT COMPLETED|Overall Study||0
71369|NCT02256982|173188|P2|COMPLETED|Overall Study||1
71370|NCT02256982|173189|P1|COMPLETED|Overall Study||1
71371|NCT02256982|173188|P2|STARTED|Overall Study||2
71372|NCT02256982|173189|P1|STARTED|Overall Study||1
71373|NCT02256969|173198|P3|NOT COMPLETED|Overall Study||1
71374|NCT02256969|173199|P2|NOT COMPLETED|Overall Study||1
71375|NCT02256969|173200|P1|NOT COMPLETED|Overall Study||2
71376|NCT02256969|173198|P3|COMPLETED|Overall Study||14
71377|NCT02256969|173199|P2|COMPLETED|Overall Study||14
71378|NCT02256969|173200|P1|COMPLETED|Overall Study||13
71379|NCT02256969|173198|P3|STARTED|Overall Study||15
71380|NCT02256969|173199|P2|STARTED|Overall Study||15
71381|NCT02256969|173200|P1|STARTED|Overall Study||15
71382|NCT02256891|173219|P2|NOT COMPLETED|Overall Study||13
71383|NCT02256891|173220|P1|NOT COMPLETED|Overall Study||12
71384|NCT02256891|173219|P2|COMPLETED|Overall Study||29
71385|NCT02256891|173220|P1|COMPLETED|Overall Study||43
71386|NCT02256891|173219|P2|STARTED|Overall Study||42
71387|NCT02256891|173220|P1|STARTED|Overall Study||55
71388|NCT02256839|173246|P2|NOT COMPLETED|Overall Study||3
71389|NCT02256839|173247|P1|NOT COMPLETED|Overall Study||2
71390|NCT02256839|173246|P2|COMPLETED|Overall Study||212
71391|NCT02256839|173247|P1|COMPLETED|Overall Study||51
71392|NCT02256839|173246|P2|STARTED|Overall Study||215
71393|NCT02256839|173247|P1|STARTED|Overall Study||53
71394|NCT02256553|173253|P1|NOT COMPLETED|Period III||3
71395|NCT02256553|173253|P1|COMPLETED|Period III||91
71396|NCT02256553|173253|P1|STARTED|Period III||94
71397|NCT02256553|173253|P1|NOT COMPLETED|Period II||2
71398|NCT02256553|173253|P1|COMPLETED|Period II||94
71399|NCT02256553|173253|P1|STARTED|Period II||96
71400|NCT02256553|173253|P1|NOT COMPLETED|Period I||6
71401|NCT02256553|173253|P1|COMPLETED|Period I||96
71402|NCT02256553|173253|P1|STARTED|Period I||102
71403|NCT02256488|173266|P4|NOT COMPLETED|Overall Study||6
71404|NCT02256488|173267|P3|NOT COMPLETED|Overall Study||10
71405|NCT02256488|173268|P2|NOT COMPLETED|Overall Study||6
71406|NCT02256488|173269|P1|NOT COMPLETED|Overall Study||8
71407|NCT02256488|173266|P4|COMPLETED|Overall Study||384
71408|NCT02256488|173267|P3|COMPLETED|Overall Study||382
71409|NCT02256488|173268|P2|COMPLETED|Overall Study||386
71410|NCT02256488|173269|P1|COMPLETED|Overall Study||379
71411|NCT02256488|173266|P4|STARTED|Overall Study||390
71412|NCT02256488|173267|P3|STARTED|Overall Study||392
71413|NCT02256488|173268|P2|STARTED|Overall Study||392
71414|NCT02256488|173269|P1|STARTED|Overall Study||387
71415|NCT02256436|173285|P2|NOT COMPLETED|Overall Study||272
71416|NCT02256436|173286|P1|NOT COMPLETED|Overall Study||270
71417|NCT02256436|173285|P2|COMPLETED|Overall Study||0
71418|NCT02256436|173286|P1|COMPLETED|Overall Study||0
71419|NCT02256436|173285|P2|Treated|Overall Study||255
71420|NCT02256436|173286|P1|Treated|Overall Study||266
71421|NCT02256436|173285|P2|STARTED|Overall Study||272
71422|NCT02256436|173286|P1|STARTED|Overall Study||270
71423|NCT02256358|173324|P2|NOT COMPLETED|Overall Study||1
71424|NCT02256358|173325|P1|NOT COMPLETED|Overall Study||0
71425|NCT02256358|173324|P2|COMPLETED|Overall Study||33
71426|NCT02256358|173325|P1|COMPLETED|Overall Study||34
71427|NCT02256358|173324|P2|STARTED|Overall Study||34
71428|NCT02256358|173325|P1|STARTED|Overall Study||34
71429|NCT02256345|173333|P2|NOT COMPLETED|Overall Study||0
71430|NCT02256345|173334|P1|NOT COMPLETED|Overall Study||0
71431|NCT02256345|173333|P2|COMPLETED|Overall Study||3
71432|NCT02256345|173334|P1|COMPLETED|Overall Study||9
71433|NCT02256345|173333|P2|STARTED|Overall Study||3
71434|NCT02256345|173334|P1|STARTED|Overall Study||9
71435|NCT02256267|173346|P1|NOT COMPLETED|Period 2 (Day 7 to Day 14)||1
71436|NCT02256267|173346|P1|COMPLETED|Period 2 (Day 7 to Day 14)||22
71437|NCT02256267|173346|P1|Received LY2835219 + Rifampin|Period 2 (Day 7 to Day 14)||23
71438|NCT02256267|173346|P1|STARTED|Period 2 (Day 7 to Day 14)||23
71439|NCT02256267|173346|P1|NOT COMPLETED|Period 2 (Day 1 to Day 6)||0
71440|NCT02256267|173346|P1|COMPLETED|Period 2 (Day 1 to Day 6)||23
71441|NCT02256267|173346|P1|Received at Least 1 Dose of Rifampin|Period 2 (Day 1 to Day 6)||23
71442|NCT02256267|173346|P1|STARTED|Period 2 (Day 1 to Day 6)||23
71443|NCT02256267|173346|P1|NOT COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||1
71444|NCT02256267|173346|P1|COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||23
71445|NCT02256267|173346|P1|Received at Least 1 Dose of LY2835219|Period 1 (Day 1; Day 2 to Day 9 Washout)||24
71446|NCT02256267|173346|P1|STARTED|Period 1 (Day 1; Day 2 to Day 9 Washout)||24
71447|NCT02256189|173357|P2|NOT COMPLETED|Overall Study||0
71448|NCT02256189|173358|P1|NOT COMPLETED|Overall Study||0
71449|NCT02256189|173357|P2|COMPLETED|Overall Study||13
71450|NCT02256189|173358|P1|COMPLETED|Overall Study||15
71451|NCT02256189|173357|P2|STARTED|Overall Study||13
71452|NCT02256189|173358|P1|STARTED|Overall Study||15
71453|NCT02256111|173368|P2|NOT COMPLETED|Overall Study||0
71454|NCT02256111|173369|P1|NOT COMPLETED|Overall Study||0
71455|NCT02256111|173368|P2|COMPLETED|Overall Study||13
71456|NCT02256111|173369|P1|COMPLETED|Overall Study||13
71457|NCT02256111|173368|P2|STARTED|Overall Study||13
71458|NCT02256111|173369|P1|STARTED|Overall Study||13
71459|NCT02256072|173404|P2|NOT COMPLETED|Overall Study||29
71460|NCT02256072|173405|P1|NOT COMPLETED|Overall Study||42
71461|NCT02256072|173404|P2|COMPLETED|Overall Study||162
71462|NCT02256072|173405|P1|COMPLETED|Overall Study|Completed the 3-month follow-up|152
71463|NCT02256072|173404|P2|Completed 1 Month Follow-Up|Overall Study||179
71464|NCT02256072|173405|P1|Completed 1 Month Follow-Up|Overall Study|Completed the 1-month follow-up|167
71465|NCT02256072|173404|P2|STARTED|Overall Study||191
71466|NCT02256072|173405|P1|STARTED|Overall Study||194
71467|NCT02255760|173424|P5|NOT COMPLETED|Overall Study||0
71468|NCT02255760|173425|P4|NOT COMPLETED|Overall Study||0
71469|NCT02255760|173426|P3|NOT COMPLETED|Overall Study||0
71470|NCT02255760|173427|P2|NOT COMPLETED|Overall Study||1
71471|NCT02255760|173428|P1|NOT COMPLETED|Overall Study||0
71472|NCT02255760|173424|P5|COMPLETED|Overall Study||9
71473|NCT02255760|173425|P4|COMPLETED|Overall Study||15
71474|NCT02255760|173426|P3|COMPLETED|Overall Study||15
71475|NCT02255760|173427|P2|COMPLETED|Overall Study||2
71476|NCT02255760|173428|P1|COMPLETED|Overall Study||14
71477|NCT02255760|173424|P5|STARTED|Overall Study||9
71478|NCT02255760|173425|P4|STARTED|Overall Study||15
71479|NCT02255760|173426|P3|STARTED|Overall Study||15
71480|NCT02255760|173427|P2|STARTED|Overall Study||3
71481|NCT02255760|173428|P1|STARTED|Overall Study||14
71482|NCT02255565|173483|P3|NOT COMPLETED|Overall Study||0
71483|NCT02255565|173484|P2|NOT COMPLETED|Overall Study||1
71484|NCT02255565|173485|P1|NOT COMPLETED|Overall Study||0
71485|NCT02255565|173483|P3|COMPLETED|Overall Study||9
71486|NCT02255565|173484|P2|COMPLETED|Overall Study||8
71487|NCT02255565|173485|P1|COMPLETED|Overall Study||9
71488|NCT02255565|173483|P3|STARTED|Overall Study||9
71489|NCT02255565|173484|P2|STARTED|Overall Study||9
71490|NCT02255565|173485|P1|STARTED|Overall Study||9
71491|NCT02255357|173546|P2|NOT COMPLETED|Overall Study||10
71492|NCT02255357|173547|P1|NOT COMPLETED|Overall Study||7
71493|NCT02255357|173546|P2|COMPLETED|Overall Study||5
71494|NCT02255357|173547|P1|COMPLETED|Overall Study||4
71495|NCT02255357|173546|P2|STARTED|Overall Study||15
71496|NCT02255357|173547|P1|STARTED|Overall Study||11
71497|NCT02255279|173555|P2|NOT COMPLETED|Overall Study||9
71498|NCT02255279|173556|P1|NOT COMPLETED|Overall Study||5
71499|NCT02255279|173555|P2|COMPLETED|Overall Study||134
71500|NCT02255279|173556|P1|COMPLETED|Overall Study||139
71501|NCT02255279|173555|P2|STARTED|Overall Study||143
71502|NCT02255279|173556|P1|STARTED|Overall Study||144
71503|NCT02255175|173584|P2|NOT COMPLETED|Overall Study||12
71504|NCT02255175|173585|P1|NOT COMPLETED|Overall Study||17
71505|NCT02255175|173584|P2|COMPLETED|Overall Study||19
71506|NCT02255175|173585|P1|COMPLETED|Overall Study||16
71507|NCT02255175|173584|P2|STARTED|Overall Study||31
71508|NCT02255175|173585|P1|STARTED|Overall Study||33
71509|NCT02255149|173609|P1|NOT COMPLETED|Overall Study||5
71510|NCT02255149|173609|P1|COMPLETED|Overall Study||5
71511|NCT02255149|173609|P1|STARTED|Overall Study||10
71512|NCT02255110|173613|P1|NOT COMPLETED|Overall Study||0
71513|NCT02255110|173613|P1|COMPLETED|Overall Study||6
71514|NCT02255110|173613|P1|STARTED|Overall Study||6
71515|NCT02255097|173625|P1|NOT COMPLETED|Overall Study||172
71516|NCT02255097|173625|P1|COMPLETED|Overall Study||0
71517|NCT02255097|173625|P1|Treated|Overall Study||171
71518|NCT02255097|173625|P1|STARTED|Overall Study||172
71519|NCT02254772|173646|P1|NOT COMPLETED|Overall Study||2
71520|NCT02254772|173646|P1|COMPLETED|Overall Study||7
71521|NCT02254772|173646|P1|STARTED|Overall Study||9
71522|NCT02254681|173652|P1|NOT COMPLETED|Overall Study||6
71523|NCT02254681|173652|P1|COMPLETED|Overall Study||0
71524|NCT02254681|173652|P1|STARTED|Overall Study||6
71525|NCT02254551|173662|P1|NOT COMPLETED|Maintenance||0
71526|NCT02254551|173662|P1|COMPLETED|Maintenance||0
71527|NCT02254551|173662|P1|STARTED|Maintenance||0
71528|NCT02254551|173662|P1|NOT COMPLETED|Expansion||0
71529|NCT02254551|173662|P1|COMPLETED|Expansion||0
71530|NCT02254551|173662|P1|STARTED|Expansion||0
71531|NCT02254551|173662|P1|NOT COMPLETED|Dose Escalation||3
71532|NCT02254551|173662|P1|COMPLETED|Dose Escalation|Due to toxicity and lack of efficacy, no other dose levels were examined.|4
71533|NCT02254551|173662|P1|Cohort 3: LDE225 800mg|Dose Escalation||0
71534|NCT02254551|173662|P1|Cohort 2: LDE225 600mg|Dose Escalation||0
71535|NCT02254551|173662|P1|Cohort 1: LDE225 400mg|Dose Escalation|1 patient was found to be refractory to bortezomib and deemed ineligible.|7
71536|NCT02254551|173662|P1|STARTED|Dose Escalation||7
71537|NCT02254486|173672|P2|NOT COMPLETED|Overall Study||55
71538|NCT02254486|173673|P1|NOT COMPLETED|Overall Study||50
71539|NCT02254486|173672|P2|COMPLETED|Overall Study||255
71540|NCT02254486|173673|P1|COMPLETED|Overall Study||261
71541|NCT02254486|173672|P2|STARTED|Overall Study||310
71542|NCT02254486|173673|P1|STARTED|Overall Study||311
71543|NCT02254473|173691|P2|NOT COMPLETED|Overall Study||1
71544|NCT02254473|173692|P1|NOT COMPLETED|Overall Study||2
71545|NCT02254473|173691|P2|COMPLETED|Overall Study||2
71546|NCT02254473|173692|P1|COMPLETED|Overall Study||7
71547|NCT02254473|173691|P2|STARTED|Overall Study||3
71548|NCT02254473|173692|P1|STARTED|Overall Study||9
71549|NCT02254460|173712|P2|NOT COMPLETED|Overall Study||0
71550|NCT02254460|173713|P1|NOT COMPLETED|Overall Study||1
71551|NCT02254460|173712|P2|COMPLETED|Overall Study||12
71552|NCT02254460|173713|P1|COMPLETED|Overall Study||12
71553|NCT02254460|173712|P2|STARTED|Overall Study||12
71554|NCT02254460|173713|P1|STARTED|Overall Study||13
71555|NCT02254421|173721|P2|NOT COMPLETED|Overall Study||3
71556|NCT02254421|173722|P1|NOT COMPLETED|Overall Study||2
71557|NCT02254421|173721|P2|COMPLETED|Overall Study||26
71558|NCT02254421|173722|P1|COMPLETED|Overall Study||29
71559|NCT02254421|173721|P2|STARTED|Overall Study||29
71560|NCT02254421|173722|P1|STARTED|Overall Study||31
71561|NCT02254408|173736|P2|NOT COMPLETED|Overall Study||10
71562|NCT02254408|173737|P1|NOT COMPLETED|Overall Study||8
71563|NCT02254408|173736|P2|COMPLETED|Overall Study||83
71564|NCT02254408|173737|P1|COMPLETED|Overall Study||88
71565|NCT02254408|173736|P2|STARTED|Overall Study||93
71566|NCT02254408|173737|P1|STARTED|Overall Study||96
71567|NCT02254304|173749|P2|NOT COMPLETED|Overall Study||4
71568|NCT02254304|173750|P1|NOT COMPLETED|Overall Study||14
71569|NCT02254304|173749|P2|COMPLETED|Overall Study||13
71570|NCT02254304|173750|P1|COMPLETED|Overall Study||75
71571|NCT02254304|173749|P2|STARTED|Overall Study||17
71572|NCT02254304|173750|P1|STARTED|Overall Study||89
71573|NCT02254291|173810|P3|NOT COMPLETED|Overall Study||2
71574|NCT02254291|173811|P2|NOT COMPLETED|Overall Study||3
71575|NCT02254291|173812|P1|NOT COMPLETED|Overall Study||0
71576|NCT02254291|173810|P3|COMPLETED|Overall Study||101
71577|NCT02254291|173811|P2|COMPLETED|Overall Study||99
71578|NCT02254291|173812|P1|COMPLETED|Overall Study||103
71579|NCT02254291|173810|P3|Exposed|Overall Study||103
71580|NCT02254291|173811|P2|Exposed|Overall Study||102
71581|NCT02254291|173812|P1|Exposed|Overall Study||103
71582|NCT02254291|173810|P3|STARTED|Overall Study||103
71583|NCT02254291|173811|P2|STARTED|Overall Study||102
71584|NCT02254291|173812|P1|STARTED|Overall Study||103
71585|NCT02254265|173829|P3|NOT COMPLETED|Overall Study||8
71586|NCT02254265|173830|P2|NOT COMPLETED|Overall Study||12
71587|NCT02254265|173831|P1|NOT COMPLETED|Overall Study||9
71588|NCT02254265|173829|P3|COMPLETED|Overall Study||144
71589|NCT02254265|173830|P2|COMPLETED|Overall Study||140
71590|NCT02254265|173831|P1|COMPLETED|Overall Study||142
71591|NCT02254265|173829|P3|STARTED|Overall Study||152
71592|NCT02254265|173830|P2|STARTED|Overall Study||152
71593|NCT02254265|173831|P1|STARTED|Overall Study||151
71594|NCT02254252|173856|P2|NOT COMPLETED|Overall Study||2
71595|NCT02254252|173857|P1|NOT COMPLETED|Overall Study||3
71596|NCT02254252|173856|P2|COMPLETED|Overall Study||25
71597|NCT02254252|173857|P1|COMPLETED|Overall Study||24
71598|NCT02254252|173856|P2|STARTED|Overall Study||27
71599|NCT02254252|173857|P1|STARTED|Overall Study||27
71600|NCT02253654|173869|P2|NOT COMPLETED|Overall Study||18
71601|NCT02253654|173870|P1|NOT COMPLETED|Overall Study||23
71602|NCT02253654|173869|P2|COMPLETED|Overall Study||90
71603|NCT02253654|173870|P1|COMPLETED|Overall Study||85
71604|NCT02253654|173869|P2|Received Treatment|Overall Study||107
71605|NCT02253654|173870|P1|Received Treatment|Overall Study||104
71606|NCT02253654|173869|P2|STARTED|Overall Study||108
71607|NCT02253654|173870|P1|STARTED|Overall Study||108
71608|NCT02253537|173890|P1|NOT COMPLETED|Overall Study||0
71609|NCT02253537|173890|P1|COMPLETED|Overall Study||15
71610|NCT02253537|173890|P1|STARTED|Overall Study||15
71611|NCT02253433|173896|P2|NOT COMPLETED|Overall Study||55
71612|NCT02253433|173897|P1|NOT COMPLETED|Overall Study||16
71613|NCT02253433|173896|P2|COMPLETED|Overall Study||79
71614|NCT02253433|173897|P1|COMPLETED|Overall Study||114
71615|NCT02253433|173896|P2|STARTED|Overall Study||134
71616|NCT02253433|173897|P1|STARTED|Overall Study||130
71617|NCT02253394|173907|P2|NOT COMPLETED|Overall Study||0
71618|NCT02253394|173908|P1|NOT COMPLETED|Overall Study||0
71619|NCT02253394|173907|P2|COMPLETED|Overall Study||2
71620|NCT02253394|173908|P1|COMPLETED|Overall Study||0
71621|NCT02253394|173907|P2|STARTED|Overall Study|Ambrisentan 5 or 10 mg QD + placebo (90 d) first, then washout (21 d), then +Spiro 50 mg QD (90 d).|2
71622|NCT02253394|173908|P1|STARTED|Overall Study||0
71623|NCT02253173|173918|P4|NOT COMPLETED|Overall Study||14
71624|NCT02253173|173919|P3|NOT COMPLETED|Overall Study||13
71625|NCT02253173|173920|P2|NOT COMPLETED|Overall Study||17
71626|NCT02253173|173921|P1|NOT COMPLETED|Overall Study||16
71627|NCT02253173|173918|P4|COMPLETED|Overall Study||178
71628|NCT02253173|173919|P3|COMPLETED|Overall Study||177
71629|NCT02253173|173920|P2|COMPLETED|Overall Study||174
71630|NCT02253173|173921|P1|COMPLETED|Overall Study||175
71631|NCT02253173|173918|P4|STARTED|Overall Study||192
71632|NCT02253173|173919|P3|STARTED|Overall Study||190
71633|NCT02253173|173920|P2|STARTED|Overall Study||191
71634|NCT02253173|173921|P1|STARTED|Overall Study||191
71635|NCT02253160|174118|P3|NOT COMPLETED|Overall Study||0
71636|NCT02253160|174119|P2|NOT COMPLETED|Overall Study||0
71637|NCT02253160|174120|P1|NOT COMPLETED|Overall Study||0
71638|NCT02253160|174118|P3|COMPLETED|Overall Study||10
71639|NCT02253160|174119|P2|COMPLETED|Overall Study||12
71640|NCT02253160|174120|P1|COMPLETED|Overall Study||1
71641|NCT02253160|174118|P3|STARTED|Overall Study||10
71642|NCT02253160|174119|P2|STARTED|Overall Study||12
71643|NCT02253160|174120|P1|STARTED|Overall Study||1
71644|NCT02253147|174156|P1|NOT COMPLETED|Overall Study||47
71645|NCT02253147|174156|P1|COMPLETED|Overall Study||71
71646|NCT02253147|174156|P1|N Patients at W52|Overall Study||84
71647|NCT02253147|174156|P1|N Patients at W36|Overall Study||86
71648|NCT02253147|174156|P1|N Patients at W24 (Primary Outcome)|Overall Study||88
71649|NCT02253147|174156|P1|STARTED|Overall Study||118
71650|NCT02252965|174190|P2|NOT COMPLETED|Overall Study||43
71651|NCT02252965|174191|P1|NOT COMPLETED|Overall Study||40
71652|NCT02252965|174190|P2|COMPLETED|Overall Study||222
71653|NCT02252965|174191|P1|COMPLETED|Overall Study||227
71654|NCT02252965|174190|P2|Safety Population|Overall Study||264
71655|NCT02252965|174191|P1|Safety Population|Overall Study|Out of 261, 12 subjects intolerant to the Metformin IR switched to Metformin XR group.|261
71656|NCT02252965|174190|P2|STARTED|Overall Study||265
71657|NCT02252965|174191|P1|STARTED|Overall Study||267
71658|NCT02252939|174218|P1|NOT COMPLETED|Overall Study||3
71659|NCT02252939|174218|P1|COMPLETED|Overall Study||59
71660|NCT02252939|174218|P1|STARTED|Overall Study||62
71661|NCT02252744|174227|P1|NOT COMPLETED|Overall Study||0
71662|NCT02252744|174227|P1|COMPLETED|Overall Study||286
71663|NCT02252744|174227|P1|STARTED|Overall Study||286
71664|NCT02252718|174231|P1|NOT COMPLETED|Overall Study||0
71665|NCT02252718|174231|P1|COMPLETED|Overall Study||100
71666|NCT02252718|174231|P1|STARTED|Overall Study||100
71667|NCT02252666|174235|P1|NOT COMPLETED|Overall Study||0
71668|NCT02252666|174235|P1|COMPLETED|Overall Study||6
71669|NCT02252666|174235|P1|STARTED|Overall Study||6
71670|NCT02252562|174259|P2|NOT COMPLETED|Overall Study||0
71671|NCT02252562|174260|P1|NOT COMPLETED|Overall Study||0
71672|NCT02252562|174259|P2|COMPLETED|Overall Study||1636
71673|NCT02252562|174260|P1|COMPLETED|Overall Study||1620
71674|NCT02252562|174259|P2|STARTED|Overall Study||1636
71675|NCT02252562|174260|P1|STARTED|Overall Study||1620
71676|NCT02252536|174275|P2|NOT COMPLETED|Overall Study||3
71677|NCT02252536|174276|P1|NOT COMPLETED|Overall Study||5
71678|NCT02252536|174275|P2|COMPLETED|Overall Study||170
71679|NCT02252536|174276|P1|COMPLETED|Overall Study||168
71680|NCT02252536|174275|P2|STARTED|Overall Study||173
71681|NCT02252536|174276|P1|STARTED|Overall Study||173
71682|NCT02252445|174310|P2|NOT COMPLETED|Overall Study||0
71683|NCT02252445|174311|P1|NOT COMPLETED|Overall Study||0
71684|NCT02252445|174310|P2|COMPLETED|Overall Study||41
71685|NCT02252445|174311|P1|COMPLETED|Overall Study||41
71686|NCT02252445|174310|P2|STARTED|Overall Study||41
71687|NCT02252445|174311|P1|STARTED|Overall Study||41
71688|NCT02252354|174337|P2|NOT COMPLETED|Overall Study||0
71689|NCT02252354|174338|P1|NOT COMPLETED|Overall Study||0
71690|NCT02252354|174337|P2|COMPLETED|Overall Study||6
71691|NCT02252354|174338|P1|COMPLETED|Overall Study||6
71692|NCT02252354|174337|P2|STARTED|Overall Study||6
71693|NCT02252354|174338|P1|STARTED|Overall Study||6
71694|NCT02252211|174385|P3|NOT COMPLETED|Overall Study||1
71695|NCT02252211|174386|P2|NOT COMPLETED|Overall Study||3
71696|NCT02252211|174387|P1|NOT COMPLETED|Overall Study||5
71697|NCT02252211|174385|P3|COMPLETED|Overall Study||0
71698|NCT02252211|174386|P2|COMPLETED|Overall Study||0
71699|NCT02252211|174387|P1|COMPLETED|Overall Study||0
71700|NCT02252211|174385|P3|Received Further Doses (Through Dose 24)|Overall Study||0
71701|NCT02252211|174386|P2|Received Further Doses (Through Dose 24)|Overall Study||0
71702|NCT02252211|174387|P1|Received Further Doses (Through Dose 24)|Overall Study||1
71703|NCT02252211|174385|P3|Received Dose 4 (Day 36)|Overall Study||0
71704|NCT02252211|174386|P2|Received Dose 4 (Day 36)|Overall Study||1
71705|NCT02252211|174387|P1|Received Dose 4 (Day 36)|Overall Study||1
71706|NCT02252211|174385|P3|Received Dose 3 (Day 22)|Overall Study||0
71707|NCT02252211|174386|P2|Received Dose 3 (Day 22)|Overall Study||3
71708|NCT02252211|174387|P1|Received Dose 3 (Day 22)|Overall Study||3
71709|NCT02252211|174385|P3|Received Dose 2 (Day 8)|Overall Study||0
71710|NCT02252211|174386|P2|Received Dose 2 (Day 8)|Overall Study||3
71711|NCT02252211|174387|P1|Received Dose 2 (Day 8)|Overall Study||4
71712|NCT02252211|174385|P3|Received Dose 1 (Day 1)|Overall Study||0
71713|NCT02252211|174386|P2|Received Dose 1 (Day 1)|Overall Study||3
71714|NCT02252211|174387|P1|Received Dose 1 (Day 1)|Overall Study||4
71715|NCT02252211|174385|P3|STARTED|Overall Study||1
71716|NCT02252211|174386|P2|STARTED|Overall Study||3
71717|NCT02252211|174387|P1|STARTED|Overall Study||5
71718|NCT02252146|174422|P1|NOT COMPLETED|Overall Study||6
71719|NCT02252146|174422|P1|COMPLETED|Overall Study||0
71720|NCT02252146|174422|P1|STARTED|Overall Study||6
71721|NCT02252133|174426|P2|NOT COMPLETED|Period 2||0
71722|NCT02252133|174427|P1|NOT COMPLETED|Period 2||0
71723|NCT02252133|174426|P2|COMPLETED|Period 2||24
71724|NCT02252133|174427|P1|COMPLETED|Period 2||23
71725|NCT02252133|174426|P2|STARTED|Period 2||24
71726|NCT02252133|174427|P1|STARTED|Period 2||23
71727|NCT02252133|174426|P2|NOT COMPLETED|Period 1||0
71728|NCT02252133|174427|P1|NOT COMPLETED|Period 1||0
71729|NCT02252133|174426|P2|COMPLETED|Period 1||24
71730|NCT02252133|174427|P1|COMPLETED|Period 1||23
71731|NCT02252133|174426|P2|STARTED|Period 1||24
71732|NCT02252133|174427|P1|STARTED|Period 1||23
71733|NCT02252042|174435|P2|NOT COMPLETED|Overall Study||248
71734|NCT02252042|174436|P1|NOT COMPLETED|Overall Study||247
71735|NCT02252042|174435|P2|COMPLETED|Overall Study||0
71736|NCT02252042|174436|P1|COMPLETED|Overall Study||0
71737|NCT02252042|174435|P2|Treated|Overall Study|14 participants were randomized but did not receive study treatment.|234
71738|NCT02252042|174436|P1|Treated|Overall Study|1 participant was randomized but did not receive study treatment.|246
71739|NCT02252042|174435|P2|STARTED|Overall Study||248
71740|NCT02252042|174436|P1|STARTED|Overall Study||247
71741|NCT02252016|174476|P2|NOT COMPLETED|Overall Study||3
71742|NCT02252016|174477|P1|NOT COMPLETED|Overall Study||3
71743|NCT02252016|174476|P2|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|49
71744|NCT02252016|174477|P1|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|104
71745|NCT02252016|174476|P2|STARTED|Overall Study||52
71746|NCT02252016|174477|P1|STARTED|Overall Study||107
71747|NCT02251990|174491|P2|NOT COMPLETED|Period 3 (DTG Follow-up)||0
71748|NCT02251990|174492|P1|NOT COMPLETED|Period 3 (DTG Follow-up)||0
71749|NCT02251990|174491|P2|COMPLETED|Period 3 (DTG Follow-up)|Completed 24 weeks of follow-up|121
71750|NCT02251990|174492|P1|COMPLETED|Period 3 (DTG Follow-up)||0
71751|NCT02251990|174491|P2|STARTED|Period 3 (DTG Follow-up)|3 participants that discontinued treatment in Period 2 were included in Follow-up.|121
71752|NCT02251990|174492|P1|STARTED|Period 3 (DTG Follow-up)|The ITG completed the study with Period 2|0
71753|NCT02251990|174491|P2|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||3
71754|NCT02251990|174492|P1|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||0
71755|NCT02251990|174491|P2|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 12 weeks of Grazoprevir/Elbasvir|118
71756|NCT02251990|174492|P1|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 24 weeks of follow-up|360
71757|NCT02251990|174491|P2|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|1 participant completing Period 1 was not eligible for Period 2 and was not treated.|121
71758|NCT02251990|174492|P1|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|2 participants that did not complete Period 1 treatment were included in Follow-up.|360
71759|NCT02251990|174491|P2|NOT COMPLETED|Period 1 (Double-blind [DB])||1
71760|NCT02251990|174492|P1|NOT COMPLETED|Period 1 (Double-blind [DB])||8
71761|NCT02251990|174491|P2|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Placebo|122
71762|NCT02251990|174492|P1|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Grazoprevir/Elbasvir|358
71763|NCT02251990|174491|P2|Treated|Period 1 (Double-blind [DB])|Started Placebo|123
71764|NCT02251990|174492|P1|Treated|Period 1 (Double-blind [DB])|Started Grazoprevir/Elbasvir|365
71765|NCT02251990|174491|P2|STARTED|Period 1 (Double-blind [DB])||123
71766|NCT02251990|174492|P1|STARTED|Period 1 (Double-blind [DB])||366
71767|NCT02251912|174509|P2|NOT COMPLETED|Overall Study||5
71768|NCT02251912|174510|P1|NOT COMPLETED|Overall Study||2
71769|NCT02251912|174509|P2|COMPLETED|Overall Study||5
71770|NCT02251912|174510|P1|COMPLETED|Overall Study||10
71771|NCT02251912|174509|P2|STARTED|Overall Study||10
71772|NCT02251912|174510|P1|STARTED|Overall Study||12
71773|NCT02251886|174524|P4|NOT COMPLETED|Overall Study||0
71774|NCT02251886|174525|P3|NOT COMPLETED|Overall Study||0
71775|NCT02251886|174526|P2|NOT COMPLETED|Overall Study||0
71776|NCT02251886|174527|P1|NOT COMPLETED|Overall Study||0
71777|NCT02251886|174524|P4|COMPLETED|Overall Study||54
71778|NCT02251886|174525|P3|COMPLETED|Overall Study||44
71779|NCT02251886|174526|P2|COMPLETED|Overall Study||54
71780|NCT02251886|174527|P1|COMPLETED|Overall Study||48
71781|NCT02251886|174524|P4|STARTED|Overall Study||54
71782|NCT02251886|174525|P3|STARTED|Overall Study||44
71783|NCT02251886|174526|P2|STARTED|Overall Study||54
71784|NCT02251886|174527|P1|STARTED|Overall Study||48
71785|NCT02251717|174539|P2|NOT COMPLETED|Overall Study||1
71786|NCT02251717|174540|P1|NOT COMPLETED|Overall Study||1
71787|NCT02251717|174539|P2|COMPLETED|Overall Study||56
71788|NCT02251717|174540|P1|COMPLETED|Overall Study||56
71789|NCT02251717|174539|P2|STARTED|Overall Study||57
71790|NCT02251717|174540|P1|STARTED|Overall Study||57
71791|NCT02251652|174552|P1|NOT COMPLETED|Overall Study||1
71792|NCT02251652|174552|P1|COMPLETED|Overall Study||16
71793|NCT02251652|174552|P1|STARTED|Overall Study||17
71794|NCT02251613|174562|P1|NOT COMPLETED|Overall Study||0
71795|NCT02251613|174562|P1|COMPLETED|Overall Study||50
71796|NCT02251613|174562|P1|STARTED|Overall Study||50
71797|NCT02251561|174570|P1|NOT COMPLETED|Overall Study||0
71798|NCT02251561|174570|P1|COMPLETED|Overall Study||28
71799|NCT02251561|174570|P1|STARTED|Overall Study||28
71800|NCT02251379|174580|P2|NOT COMPLETED|Overall Study||20
71801|NCT02251379|174581|P1|NOT COMPLETED|Overall Study||20
71802|NCT02251379|174580|P2|COMPLETED|Overall Study||58
71803|NCT02251379|174581|P1|COMPLETED|Overall Study||57
71804|NCT02251379|174580|P2|STARTED|Overall Study||78
71805|NCT02251379|174581|P1|STARTED|Overall Study||77
71806|NCT02251275|174602|P5|NOT COMPLETED|Overall Study||1
71807|NCT02251275|174603|P4|NOT COMPLETED|Overall Study||1
71808|NCT02251275|174604|P3|NOT COMPLETED|Overall Study||94
71809|NCT02251275|174605|P2|NOT COMPLETED|Overall Study||147
71810|NCT02251275|174606|P1|NOT COMPLETED|Overall Study||72
71811|NCT02251275|174602|P5|COMPLETED|Overall Study||2
71812|NCT02251275|174603|P4|COMPLETED|Overall Study||5
71813|NCT02251275|174604|P3|COMPLETED|Overall Study||624
71814|NCT02251275|174605|P2|COMPLETED|Overall Study||423
71815|NCT02251275|174606|P1|COMPLETED|Overall Study||434
71816|NCT02251275|174602|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
71817|NCT02251275|174603|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
71818|NCT02251275|174604|P3|Received at Least 1 Dose of Study Drug|Overall Study||717
71819|NCT02251275|174605|P2|Received at Least 1 Dose of Study Drug|Overall Study||569
71820|NCT02251275|174606|P1|Received at Least 1 Dose of Study Drug|Overall Study||505
71821|NCT02251275|174602|P5|STARTED|Overall Study|From trials 156-04-251 and 156-09-290|3
71822|NCT02251275|174603|P4|STARTED|Overall Study|From trials 156-04-251 and 156-09-290|6
71823|NCT02251275|174604|P3|STARTED|Overall Study||718
71824|NCT02251275|174605|P2|STARTED|Overall Study||570
71825|NCT02251275|174606|P1|STARTED|Overall Study||506
71826|NCT02251236|174621|P3|NOT COMPLETED|Overall Study||0
71827|NCT02251236|174622|P2|NOT COMPLETED|Overall Study||0
71828|NCT02251236|174623|P1|NOT COMPLETED|Overall Study||0
71829|NCT02251236|174621|P3|COMPLETED|Overall Study||0
71830|NCT02251236|174622|P2|COMPLETED|Overall Study||5
71831|NCT02251236|174623|P1|COMPLETED|Overall Study||9
71832|NCT02251236|174621|P3|STARTED|Overall Study||0
71833|NCT02251236|174622|P2|STARTED|Overall Study||5
71834|NCT02251236|174623|P1|STARTED|Overall Study||9
71835|NCT02250807|174640|P1|NOT COMPLETED|Overall Study||0
71836|NCT02250807|174640|P1|COMPLETED|Overall Study||40
71837|NCT02250807|174640|P1|STARTED|Overall Study||40
71838|NCT02250703|174652|P2|NOT COMPLETED|Overall Study||1
71839|NCT02250703|174653|P1|NOT COMPLETED|Overall Study||1
71840|NCT02250703|174652|P2|COMPLETED|Overall Study||36
71841|NCT02250703|174653|P1|COMPLETED|Overall Study||37
71842|NCT02250703|174652|P2|STARTED|Overall Study||37
71843|NCT02250703|174653|P1|STARTED|Overall Study||38
71844|NCT02250521|174665|P1|NOT COMPLETED|Overall Study||1
71845|NCT02250521|174665|P1|COMPLETED|Overall Study||99
71846|NCT02250521|174665|P1|STARTED|Overall Study||100
71847|NCT02250443|174679|P1|NOT COMPLETED|Overall Study||10
71848|NCT02250443|174679|P1|COMPLETED|Overall Study||0
71849|NCT02250443|174679|P1|STARTED|Overall Study||10
71850|NCT02250417|174692|P2|NOT COMPLETED|Second Intervention (1 Night)||0
71851|NCT02250417|174693|P1|NOT COMPLETED|Second Intervention (1 Night)||0
71852|NCT02250417|174692|P2|COMPLETED|Second Intervention (1 Night)||6
71853|NCT02250417|174693|P1|COMPLETED|Second Intervention (1 Night)||6
71854|NCT02250417|174692|P2|STARTED|Second Intervention (1 Night)||6
71855|NCT02250417|174693|P1|STARTED|Second Intervention (1 Night)||6
71856|NCT02250417|174692|P2|NOT COMPLETED|First Intervention (1 Night)||0
71857|NCT02250417|174693|P1|NOT COMPLETED|First Intervention (1 Night)||0
71858|NCT02250417|174692|P2|COMPLETED|First Intervention (1 Night)||6
71859|NCT02250417|174693|P1|COMPLETED|First Intervention (1 Night)||6
71860|NCT02250417|174692|P2|STARTED|First Intervention (1 Night)||6
71861|NCT02250417|174693|P1|STARTED|First Intervention (1 Night)||6
71862|NCT02250326|174708|P3|NOT COMPLETED|Follow-Up Period||38
71863|NCT02250326|174709|P2|NOT COMPLETED|Follow-Up Period||30
71864|NCT02250326|174710|P1|NOT COMPLETED|Follow-Up Period||49
71865|NCT02250326|174708|P3|COMPLETED|Follow-Up Period||26
71866|NCT02250326|174709|P2|COMPLETED|Follow-Up Period||13
71867|NCT02250326|174710|P1|COMPLETED|Follow-Up Period||18
71868|NCT02250326|174708|P3|STARTED|Follow-Up Period||64
71869|NCT02250326|174709|P2|STARTED|Follow-Up Period||43
71870|NCT02250326|174710|P1|STARTED|Follow-Up Period||67
71871|NCT02250326|174708|P3|NOT COMPLETED|Treatment Period||77
71872|NCT02250326|174709|P2|NOT COMPLETED|Treatment Period||64
71873|NCT02250326|174710|P1|NOT COMPLETED|Treatment Period||81
71874|NCT02250326|174708|P3|COMPLETED|Treatment Period|Data Cut-off Date = 30 August 2017|3
71875|NCT02250326|174709|P2|COMPLETED|Treatment Period|Data Cut-off Date = 23 December 2017|15
71876|NCT02250326|174710|P1|COMPLETED|Treatment Period|Data Cut-off Date = 30 August 2017|0
71877|NCT02250326|174708|P3|Treated Population|Treatment Period||79
71878|NCT02250326|174709|P2|Treated Population|Treatment Period||78
71879|NCT02250326|174710|P1|Treated Population|Treatment Period||79
71880|NCT02250326|174708|P3|STARTED|Treatment Period||80
71881|NCT02250326|174709|P2|STARTED|Treatment Period||79
71882|NCT02250326|174710|P1|STARTED|Treatment Period||81
71883|NCT02250274|174743|P2|NOT COMPLETED|Overall Study||6
71884|NCT02250274|174744|P1|NOT COMPLETED|Overall Study||7
71885|NCT02250274|174743|P2|COMPLETED|Overall Study||40
71886|NCT02250274|174744|P1|COMPLETED|Overall Study||78
71887|NCT02250274|174743|P2|STARTED|Overall Study||46
71888|NCT02250274|174744|P1|STARTED|Overall Study||85
71889|NCT02250183|174760|P1|NOT COMPLETED|Overall Study||8
71890|NCT02250183|174760|P1|COMPLETED|Overall Study||13
71891|NCT02250183|174760|P1|STARTED|Overall Study||21
71892|NCT02249949|174769|P1|NOT COMPLETED|Overall Study||2
71893|NCT02249949|174769|P1|COMPLETED|Overall Study||11
71894|NCT02249949|174769|P1|STARTED|Overall Study||13
71895|NCT02249832|174776|P1|NOT COMPLETED|Overall Study||13
71896|NCT02249832|174776|P1|COMPLETED|Overall Study||42
71897|NCT02249832|174776|P1|STARTED|Overall Study||55
71898|NCT02249819|174788|P2|NOT COMPLETED|Overall Study||0
71899|NCT02249819|174789|P1|NOT COMPLETED|Overall Study||0
71900|NCT02249819|174788|P2|COMPLETED|Overall Study||7
71901|NCT02249819|174789|P1|COMPLETED|Overall Study||8
71902|NCT02249819|174788|P2|STARTED|Overall Study||7
71903|NCT02249819|174789|P1|STARTED|Overall Study||8
71904|NCT02249728|174795|P1|NOT COMPLETED|Part Two (up to 6 Days)||0
71905|NCT02249728|174795|P1|COMPLETED|Part Two (up to 6 Days)||6
71906|NCT02249728|174795|P1|STARTED|Part Two (up to 6 Days)||6
71907|NCT02249728|174795|P1|NOT COMPLETED|Part One (4 Days)||0
71908|NCT02249728|174795|P1|COMPLETED|Part One (4 Days)||6
71909|NCT02249728|174795|P1|STARTED|Part One (4 Days)||6
71910|NCT02249585|174808|P3|NOT COMPLETED|Overall Study||0
71911|NCT02249585|174809|P2|NOT COMPLETED|Overall Study||0
71912|NCT02249585|174810|P1|NOT COMPLETED|Overall Study||0
71913|NCT02249585|174808|P3|COMPLETED|Overall Study||44
71914|NCT02249585|174809|P2|COMPLETED|Overall Study||44
71915|NCT02249585|174810|P1|COMPLETED|Overall Study||43
71916|NCT02249585|174808|P3|STARTED|Overall Study||44
71917|NCT02249585|174809|P2|STARTED|Overall Study||44
71918|NCT02249585|174810|P1|STARTED|Overall Study||43
71919|NCT02249182|174838|P5|NOT COMPLETED|Treatment Phase||0
71920|NCT02249182|174839|P4|NOT COMPLETED|Treatment Phase||0
71921|NCT02249182|174840|P3|NOT COMPLETED|Treatment Phase||0
71922|NCT02249182|174841|P2|NOT COMPLETED|Treatment Phase||0
71923|NCT02249182|174842|P1|NOT COMPLETED|Treatment Phase||4
71924|NCT02249182|174838|P5|COMPLETED|Treatment Phase||34
71925|NCT02249182|174839|P4|COMPLETED|Treatment Phase||2
71926|NCT02249182|174840|P3|COMPLETED|Treatment Phase||1
71927|NCT02249182|174841|P2|COMPLETED|Treatment Phase||89
71928|NCT02249182|174842|P1|COMPLETED|Treatment Phase||96
71929|NCT02249182|174838|P5|STARTED|Treatment Phase|17 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|34
71930|NCT02249182|174839|P4|STARTED|Treatment Phase|2 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|2
71931|NCT02249182|174840|P3|STARTED|Treatment Phase|1 participant enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|1
71932|NCT02249182|174841|P2|STARTED|Treatment Phase|77 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|89
71933|NCT02249182|174842|P1|STARTED|Treatment Phase|90 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|100
71934|NCT02249182|174838|P5|NOT COMPLETED|PK Lead-In Phase||0
71935|NCT02249182|174839|P4|NOT COMPLETED|PK Lead-In Phase||0
71936|NCT02249182|174840|P3|NOT COMPLETED|PK Lead-In Phase||0
71937|NCT02249182|174841|P2|NOT COMPLETED|PK Lead-In Phase||0
71938|NCT02249182|174842|P1|NOT COMPLETED|PK Lead-In Phase||0
71939|NCT02249182|174838|P5|COMPLETED|PK Lead-In Phase||17
71940|NCT02249182|174839|P4|COMPLETED|PK Lead-In Phase||0
71941|NCT02249182|174840|P3|COMPLETED|PK Lead-In Phase||0
71942|NCT02249182|174841|P2|COMPLETED|PK Lead-In Phase||12
71943|NCT02249182|174842|P1|COMPLETED|PK Lead-In Phase||10
71944|NCT02249182|174838|P5|STARTED|PK Lead-In Phase||17
71945|NCT02249182|174839|P4|STARTED|PK Lead-In Phase||0
71946|NCT02249182|174840|P3|STARTED|PK Lead-In Phase||0
71947|NCT02249182|174841|P2|STARTED|PK Lead-In Phase||12
71948|NCT02249182|174842|P1|STARTED|PK Lead-In Phase||10
71949|NCT02249143|174930|P2|NOT COMPLETED|Overall Study||4
71950|NCT02249143|174931|P1|NOT COMPLETED|Overall Study||2
71951|NCT02249143|174930|P2|COMPLETED|Overall Study|with technically acceptable pulmonary function tests in the neonatal intensive care unit|22
71952|NCT02249143|174931|P1|COMPLETED|Overall Study|with technically acceptable pulmonary function tests in the neonatal intensive care unit|22
71953|NCT02249143|174930|P2|STARTED|Overall Study|randomized|26
71954|NCT02249143|174931|P1|STARTED|Overall Study||24
71955|NCT02249104|174957|P1|NOT COMPLETED|Overall Study||3
71956|NCT02249104|174957|P1|COMPLETED|Overall Study||25
71957|NCT02249104|174957|P1|STARTED|Overall Study||28
71958|NCT02249065|174966|P1|NOT COMPLETED|Overall Study||29
71959|NCT02249065|174966|P1|COMPLETED|Overall Study||176
71960|NCT02249065|174966|P1|Treated|Overall Study||181
71961|NCT02249065|174966|P1|STARTED|Overall Study||205
71962|NCT02249052|174974|P1|NOT COMPLETED|Overall Study||0
71963|NCT02249052|174974|P1|COMPLETED|Overall Study||19
71964|NCT02249052|174974|P1|STARTED|Overall Study||19
71965|NCT02248974|174992|P2|NOT COMPLETED|1-Month Follow-Up||3
71966|NCT02248974|174993|P1|NOT COMPLETED|1-Month Follow-Up||2
71967|NCT02248974|174992|P2|COMPLETED|1-Month Follow-Up||31
71968|NCT02248974|174993|P1|COMPLETED|1-Month Follow-Up||27
71969|NCT02248974|174992|P2|STARTED|1-Month Follow-Up||34
71970|NCT02248974|174993|P1|STARTED|1-Month Follow-Up||29
71971|NCT02248974|174992|P2|NOT COMPLETED|1-Week Follow-Up||17
71972|NCT02248974|174993|P1|NOT COMPLETED|1-Week Follow-Up||8
71973|NCT02248974|174992|P2|COMPLETED|1-Week Follow-Up||34
71974|NCT02248974|174993|P1|COMPLETED|1-Week Follow-Up||29
71975|NCT02248974|174992|P2|STARTED|1-Week Follow-Up||51
71976|NCT02248974|174993|P1|STARTED|1-Week Follow-Up||37
71977|NCT02248974|174992|P2|NOT COMPLETED|1-Day Follow-Up||0
71978|NCT02248974|174993|P1|NOT COMPLETED|1-Day Follow-Up||10
71979|NCT02248974|174992|P2|COMPLETED|1-Day Follow-Up|"No DA group did not receive 1-Day Follow-up survey."|0
71980|NCT02248974|174993|P1|COMPLETED|1-Day Follow-Up||37
71981|NCT02248974|174992|P2|STARTED|1-Day Follow-Up|"No DA group did not receive 1-Day Follow-up survey."|0
71982|NCT02248974|174993|P1|STARTED|1-Day Follow-Up||47
71983|NCT02248974|174992|P2|NOT COMPLETED|Baseline||0
71984|NCT02248974|174993|P1|NOT COMPLETED|Baseline||0
71985|NCT02248974|174992|P2|COMPLETED|Baseline||51
71986|NCT02248974|174993|P1|COMPLETED|Baseline||47
71987|NCT02248974|174992|P2|STARTED|Baseline||51
71988|NCT02248974|174993|P1|STARTED|Baseline||47
71989|NCT02248961|175071|P2|NOT COMPLETED|Overall Study||2
71990|NCT02248961|175072|P1|NOT COMPLETED|Overall Study||3
71991|NCT02248961|175071|P2|COMPLETED|Overall Study||88
71992|NCT02248961|175072|P1|COMPLETED|Overall Study||86
71993|NCT02248961|175071|P2|STARTED|Overall Study||90
71994|NCT02248961|175072|P1|STARTED|Overall Study||89
71995|NCT02248922|175092|P2|NOT COMPLETED|Overall Study||0
71996|NCT02248922|175093|P1|NOT COMPLETED|Overall Study||0
71997|NCT02248922|175092|P2|COMPLETED|Overall Study||12
71998|NCT02248922|175093|P1|COMPLETED|Overall Study||5
71999|NCT02248922|175092|P2|STARTED|Overall Study||12
72000|NCT02248922|175093|P1|STARTED|Overall Study||5
72001|NCT02248857|175107|P3|NOT COMPLETED|6 Month||17
72002|NCT02248857|175108|P2|NOT COMPLETED|6 Month||29
72003|NCT02248857|175109|P1|NOT COMPLETED|6 Month||28
72004|NCT02248857|175107|P3|COMPLETED|6 Month||106
72005|NCT02248857|175108|P2|COMPLETED|6 Month||136
72006|NCT02248857|175109|P1|COMPLETED|6 Month||120
72007|NCT02248857|175107|P3|STARTED|6 Month|127 baseline - 4 who withdrew = 123|123
72008|NCT02248857|175108|P2|STARTED|6 Month|168 baseline - 3 who withdrew = 165|165
72009|NCT02248857|175109|P1|STARTED|6 Month|157 baseline - 9 who withdrew = 148|148
72010|NCT02248857|175107|P3|NOT COMPLETED|3 Month||31
72011|NCT02248857|175108|P2|NOT COMPLETED|3 Month||34
72012|NCT02248857|175109|P1|NOT COMPLETED|3 Month||46
72013|NCT02248857|175107|P3|COMPLETED|3 Month||96
72014|NCT02248857|175108|P2|COMPLETED|3 Month||134
72015|NCT02248857|175109|P1|COMPLETED|3 Month||111
72016|NCT02248857|175107|P3|STARTED|3 Month||127
72017|NCT02248857|175108|P2|STARTED|3 Month||168
72018|NCT02248857|175109|P1|STARTED|3 Month||157
72019|NCT02248857|175107|P3|NOT COMPLETED|Baseline||0
72020|NCT02248857|175108|P2|NOT COMPLETED|Baseline||0
72021|NCT02248857|175109|P1|NOT COMPLETED|Baseline||0
72022|NCT02248857|175107|P3|COMPLETED|Baseline||127
72023|NCT02248857|175108|P2|COMPLETED|Baseline||168
72024|NCT02248857|175109|P1|COMPLETED|Baseline||157
72025|NCT02248857|175107|P3|STARTED|Baseline||127
72026|NCT02248857|175108|P2|STARTED|Baseline||168
72027|NCT02248857|175109|P1|STARTED|Baseline||157
72028|NCT02248818|175146|P9|NOT COMPLETED|Randomised Study||0
72029|NCT02248818|175147|P8|NOT COMPLETED|Randomised Study||0
72030|NCT02248818|175148|P7|NOT COMPLETED|Randomised Study||0
72031|NCT02248818|175149|P6|NOT COMPLETED|Randomised Study||8
72032|NCT02248818|175150|P5|NOT COMPLETED|Randomised Study||0
72033|NCT02248818|175151|P4|NOT COMPLETED|Randomised Study||0
72034|NCT02248818|175152|P3|NOT COMPLETED|Randomised Study||0
72035|NCT02248818|175153|P2|NOT COMPLETED|Randomised Study||0
72036|NCT02248818|175154|P1|NOT COMPLETED|Randomised Study||0
72037|NCT02248818|175146|P9|COMPLETED|Randomised Study||0
72038|NCT02248818|175147|P8|COMPLETED|Randomised Study||4
72039|NCT02248818|175148|P7|COMPLETED|Randomised Study||6
72040|NCT02248818|175149|P6|COMPLETED|Randomised Study||0
72041|NCT02248818|175150|P5|COMPLETED|Randomised Study||6
72042|NCT02248818|175151|P4|COMPLETED|Randomised Study||6
72043|NCT02248818|175152|P3|COMPLETED|Randomised Study||6
72044|NCT02248818|175153|P2|COMPLETED|Randomised Study||6
72045|NCT02248818|175154|P1|COMPLETED|Randomised Study||6
72046|NCT02248818|175146|P9|STARTED|Randomised Study||0
72047|NCT02248818|175147|P8|STARTED|Randomised Study||4
72048|NCT02248818|175148|P7|STARTED|Randomised Study||6
72049|NCT02248818|175149|P6|STARTED|Randomised Study||8
72050|NCT02248818|175150|P5|STARTED|Randomised Study||6
72051|NCT02248818|175151|P4|STARTED|Randomised Study||6
72052|NCT02248818|175152|P3|STARTED|Randomised Study||6
72053|NCT02248818|175153|P2|STARTED|Randomised Study||6
72054|NCT02248818|175154|P1|STARTED|Randomised Study||6
72055|NCT02248818|175146|P9|NOT COMPLETED|Screening||107
72056|NCT02248818|175147|P8|NOT COMPLETED|Screening||0
72057|NCT02248818|175148|P7|NOT COMPLETED|Screening||0
72058|NCT02248818|175149|P6|NOT COMPLETED|Screening||0
72059|NCT02248818|175150|P5|NOT COMPLETED|Screening||0
72060|NCT02248818|175151|P4|NOT COMPLETED|Screening||0
72061|NCT02248818|175152|P3|NOT COMPLETED|Screening||0
72062|NCT02248818|175153|P2|NOT COMPLETED|Screening||0
72063|NCT02248818|175154|P1|NOT COMPLETED|Screening||0
72064|NCT02248818|175146|P9|COMPLETED|Screening||48
72065|NCT02248818|175147|P8|COMPLETED|Screening||0
72066|NCT02248818|175148|P7|COMPLETED|Screening||0
72067|NCT02248818|175149|P6|COMPLETED|Screening||0
72068|NCT02248818|175150|P5|COMPLETED|Screening||0
72069|NCT02248818|175151|P4|COMPLETED|Screening||0
72070|NCT02248818|175152|P3|COMPLETED|Screening||0
72071|NCT02248818|175153|P2|COMPLETED|Screening||0
72072|NCT02248818|175154|P1|COMPLETED|Screening||0
72073|NCT02248818|175146|P9|STARTED|Screening||155
72074|NCT02248818|175147|P8|STARTED|Screening||0
72075|NCT02248818|175148|P7|STARTED|Screening||0
72076|NCT02248818|175149|P6|STARTED|Screening||0
72077|NCT02248818|175150|P5|STARTED|Screening||0
72078|NCT02248818|175151|P4|STARTED|Screening||0
72079|NCT02248818|175152|P3|STARTED|Screening||0
72080|NCT02248818|175153|P2|STARTED|Screening||0
72081|NCT02248818|175154|P1|STARTED|Screening||0
72082|NCT02248766|175292|P1|NOT COMPLETED|Overall Study||0
72083|NCT02248766|175292|P1|COMPLETED|Overall Study||30
72084|NCT02248766|175292|P1|STARTED|Overall Study||30
72085|NCT02248740|175306|P2|NOT COMPLETED|Overall Study||18
72086|NCT02248740|175307|P1|NOT COMPLETED|Overall Study||18
72087|NCT02248740|175306|P2|COMPLETED|Overall Study||0
72088|NCT02248740|175307|P1|COMPLETED|Overall Study||0
72089|NCT02248740|175306|P2|STARTED|Overall Study||18
72090|NCT02248740|175307|P1|STARTED|Overall Study||18
72091|NCT02248727|175317|P1|NOT COMPLETED|Overall Study||0
72092|NCT02248727|175317|P1|COMPLETED|Overall Study||30
72093|NCT02248727|175317|P1|STARTED|Overall Study||30
72094|NCT02248714|175330|P2|NOT COMPLETED|Overall Study||4
72095|NCT02248714|175331|P1|NOT COMPLETED|Overall Study||4
72096|NCT02248714|175330|P2|COMPLETED|Overall Study||61
72097|NCT02248714|175331|P1|COMPLETED|Overall Study||62
72098|NCT02248714|175330|P2|STARTED|Overall Study||65
72099|NCT02248714|175331|P1|STARTED|Overall Study||66
72100|NCT02248675|175369|P2|NOT COMPLETED|Overall Study||1
72101|NCT02248675|175370|P1|NOT COMPLETED|Overall Study||3
72102|NCT02248675|175369|P2|COMPLETED|Overall Study||27
72103|NCT02248675|175370|P1|COMPLETED|Overall Study||23
72104|NCT02248675|175369|P2|STARTED|Overall Study||28
72105|NCT02248675|175370|P1|STARTED|Overall Study||26
72106|NCT02248662|175384|P2|NOT COMPLETED|Overall Study||30515
72107|NCT02248662|175385|P1|NOT COMPLETED|Overall Study||4563
72108|NCT02248662|175384|P2|COMPLETED|Overall Study||2679
72109|NCT02248662|175385|P1|COMPLETED|Overall Study||757
72110|NCT02248662|175384|P2|STARTED|Overall Study||33194
72111|NCT02248662|175385|P1|STARTED|Overall Study||5320
72112|NCT02248649|175397|P2|NOT COMPLETED|Overall Study||21
72113|NCT02248649|175398|P1|NOT COMPLETED|Overall Study||21
72114|NCT02248649|175397|P2|COMPLETED|Overall Study||59
72115|NCT02248649|175398|P1|COMPLETED|Overall Study||59
72116|NCT02248649|175397|P2|STARTED|Overall Study||80
72117|NCT02248649|175398|P1|STARTED|Overall Study||80
72118|NCT02248558|175410|P2|NOT COMPLETED|Overall Study||45
72119|NCT02248558|175411|P1|NOT COMPLETED|Overall Study||52
72120|NCT02248558|175410|P2|COMPLETED|Overall Study||307
72121|NCT02248558|175411|P1|COMPLETED|Overall Study||317
72122|NCT02248558|175410|P2|STARTED|Overall Study||352
72123|NCT02248558|175411|P1|STARTED|Overall Study||369
72124|NCT02248480|175423|P2|NOT COMPLETED|Overall Study||14
72125|NCT02248480|175424|P1|NOT COMPLETED|Overall Study||17
72126|NCT02248480|175423|P2|COMPLETED|Overall Study||162
72127|NCT02248480|175424|P1|COMPLETED|Overall Study||161
72128|NCT02248480|175423|P2|Efficacy Population|Overall Study||176
72129|NCT02248480|175424|P1|Efficacy Population|Overall Study||177
72130|NCT02248480|175423|P2|STARTED|Overall Study||176
72131|NCT02248480|175424|P1|STARTED|Overall Study||178
72132|NCT02248285|175464|P2|NOT COMPLETED|Overall Study||287
72133|NCT02248285|175465|P1|NOT COMPLETED|Overall Study||101
72134|NCT02248285|175464|P2|COMPLETED|Overall Study||571
72135|NCT02248285|175465|P1|COMPLETED|Overall Study||586
72136|NCT02248285|175464|P2|STARTED|Overall Study||858
72137|NCT02248285|175465|P1|STARTED|Overall Study||687
72138|NCT02248246|175471|P1|NOT COMPLETED|Overall Study||0
72139|NCT02248246|175471|P1|COMPLETED|Overall Study||40
72140|NCT02248246|175471|P1|STARTED|Overall Study||40
72141|NCT02248103|175478|P2|NOT COMPLETED|Overall Study||0
72142|NCT02248103|175479|P1|NOT COMPLETED|Overall Study||0
72143|NCT02248103|175478|P2|COMPLETED|Overall Study||10
72144|NCT02248103|175479|P1|COMPLETED|Overall Study||10
72145|NCT02248103|175478|P2|STARTED|Overall Study||10
72146|NCT02248103|175479|P1|STARTED|Overall Study||10
72147|NCT02247960|175491|P2|NOT COMPLETED|Catheter Removed||10
72148|NCT02247960|175492|P1|NOT COMPLETED|Catheter Removed||7
72149|NCT02247960|175491|P2|COMPLETED|Catheter Removed||74
72150|NCT02247960|175492|P1|COMPLETED|Catheter Removed||76
72151|NCT02247960|175491|P2|STARTED|Catheter Removed||84
72152|NCT02247960|175492|P1|STARTED|Catheter Removed||83
72153|NCT02247960|175491|P2|NOT COMPLETED|Patient Consent and Randomization||6
72154|NCT02247960|175492|P1|NOT COMPLETED|Patient Consent and Randomization||2
72155|NCT02247960|175491|P2|COMPLETED|Patient Consent and Randomization||84
72156|NCT02247960|175492|P1|COMPLETED|Patient Consent and Randomization||83
72157|NCT02247960|175491|P2|STARTED|Patient Consent and Randomization||90
72158|NCT02247960|175492|P1|STARTED|Patient Consent and Randomization||85
72159|NCT02247765|175502|P1|NOT COMPLETED|Overall Study||0
72160|NCT02247765|175502|P1|COMPLETED|Overall Study||18
72161|NCT02247765|175502|P1|STARTED|Overall Study||18
72162|NCT02247739|175507|P6|NOT COMPLETED|Overall Study||1
72163|NCT02247739|175508|P5|NOT COMPLETED|Overall Study||1
72164|NCT02247739|175509|P4|NOT COMPLETED|Overall Study||0
72165|NCT02247739|175510|P3|NOT COMPLETED|Overall Study||1
72166|NCT02247739|175511|P2|NOT COMPLETED|Overall Study||3
72167|NCT02247739|175512|P1|NOT COMPLETED|Overall Study||0
72168|NCT02247739|175507|P6|COMPLETED|Overall Study||4
72169|NCT02247739|175508|P5|COMPLETED|Overall Study||5
72170|NCT02247739|175509|P4|COMPLETED|Overall Study||5
72171|NCT02247739|175510|P3|COMPLETED|Overall Study||4
72172|NCT02247739|175511|P2|COMPLETED|Overall Study||3
72173|NCT02247739|175512|P1|COMPLETED|Overall Study||5
72174|NCT02247739|175507|P6|STARTED|Overall Study||5
72175|NCT02247739|175508|P5|STARTED|Overall Study||6
72176|NCT02247739|175509|P4|STARTED|Overall Study||5
72177|NCT02247739|175510|P3|STARTED|Overall Study||5
72178|NCT02247739|175511|P2|STARTED|Overall Study||6
72179|NCT02247739|175512|P1|STARTED|Overall Study||5
72180|NCT02247531|175531|P3|NOT COMPLETED|Overall Study||110
72181|NCT02247531|175532|P2|NOT COMPLETED|Overall Study||125
72182|NCT02247531|175533|P1|NOT COMPLETED|Overall Study||106
72183|NCT02247531|175531|P3|COMPLETED|Overall Study||214
72184|NCT02247531|175532|P2|COMPLETED|Overall Study||205
72185|NCT02247531|175533|P1|COMPLETED|Overall Study||215
72186|NCT02247531|175531|P3|STARTED|Overall Study||324
72187|NCT02247531|175532|P2|STARTED|Overall Study||330
72188|NCT02247531|175533|P1|STARTED|Overall Study||321
72189|NCT02247479|175583|P3|NOT COMPLETED|Overall Study||138
72190|NCT02247479|175584|P2|NOT COMPLETED|Overall Study||138
72191|NCT02247479|175585|P1|NOT COMPLETED|Overall Study||142
72192|NCT02247479|175583|P3|COMPLETED|Overall Study||165
72193|NCT02247479|175584|P2|COMPLETED|Overall Study||160
72194|NCT02247479|175585|P1|COMPLETED|Overall Study||163
72195|NCT02247479|175583|P3|STARTED|Overall Study||303
72196|NCT02247479|175584|P2|STARTED|Overall Study||298
72197|NCT02247479|175585|P1|STARTED|Overall Study||305
72198|NCT02247466|175634|P2|NOT COMPLETED|Overall Study||3
72199|NCT02247466|175635|P1|NOT COMPLETED|Overall Study||0
72200|NCT02247466|175634|P2|COMPLETED|Overall Study||15
72201|NCT02247466|175635|P1|COMPLETED|Overall Study||19
72202|NCT02247466|175634|P2|STARTED|Overall Study||18
72203|NCT02247466|175635|P1|STARTED|Overall Study||19
72204|NCT02247440|175653|P1|NOT COMPLETED|Overall Study||4
72205|NCT02247440|175653|P1|COMPLETED|Overall Study||14
72206|NCT02247440|175653|P1|STARTED|Overall Study||18
72207|NCT02247401|175666|P3|NOT COMPLETED|Overall Study||2
72208|NCT02247401|175667|P2|NOT COMPLETED|Overall Study||2
72209|NCT02247401|175668|P1|NOT COMPLETED|Overall Study||6
72210|NCT02247401|175666|P3|COMPLETED|Overall Study||27
72211|NCT02247401|175667|P2|COMPLETED|Overall Study||29
72212|NCT02247401|175668|P1|COMPLETED|Overall Study||94
72213|NCT02247401|175666|P3|STARTED|Overall Study||29
72214|NCT02247401|175667|P2|STARTED|Overall Study||31
72215|NCT02247401|175668|P1|STARTED|Overall Study||100
72216|NCT02247063|175687|P2|NOT COMPLETED|Overall Study||0
72217|NCT02247063|175688|P1|NOT COMPLETED|Overall Study||0
72218|NCT02247063|175687|P2|COMPLETED|Overall Study||12
72219|NCT02247063|175688|P1|COMPLETED|Overall Study||12
72220|NCT02247063|175687|P2|STARTED|Overall Study||12
72221|NCT02247063|175688|P1|STARTED|Overall Study||12
72222|NCT02247011|175698|P1|NOT COMPLETED|Overall Study||125
72223|NCT02247011|175698|P1|COMPLETED|Overall Study||975
72224|NCT02247011|175698|P1|STARTED|Overall Study||1100
72225|NCT02246998|175719|P4|NOT COMPLETED|Overall Study||2
72226|NCT02246998|175720|P3|NOT COMPLETED|Overall Study||3
72227|NCT02246998|175721|P2|NOT COMPLETED|Overall Study||3
72228|NCT02246998|175722|P1|NOT COMPLETED|Overall Study||2
72229|NCT02246998|175719|P4|COMPLETED|Overall Study||16
72230|NCT02246998|175720|P3|COMPLETED|Overall Study||15
72231|NCT02246998|175721|P2|COMPLETED|Overall Study||15
72232|NCT02246998|175722|P1|COMPLETED|Overall Study||16
72233|NCT02246998|175719|P4|STARTED|Overall Study||18
72234|NCT02246998|175720|P3|STARTED|Overall Study||18
72235|NCT02246998|175721|P2|STARTED|Overall Study||18
72236|NCT02246998|175722|P1|STARTED|Overall Study||18
72237|NCT02246777|175832|P1|NOT COMPLETED|Overall Study||3
72238|NCT02246777|175832|P1|COMPLETED|Overall Study||29
72239|NCT02246777|175832|P1|STARTED|Overall Study||32
72240|NCT02246764|175848|P3|NOT COMPLETED|Overall Study||4
72241|NCT02246764|175849|P2|NOT COMPLETED|Overall Study||32
72242|NCT02246764|175850|P1|NOT COMPLETED|Overall Study||18
72243|NCT02246764|175848|P3|COMPLETED|Overall Study||19
72244|NCT02246764|175849|P2|COMPLETED|Overall Study||4
72245|NCT02246764|175850|P1|COMPLETED|Overall Study||16
72246|NCT02246764|175848|P3|STARTED|Overall Study||23
72247|NCT02246764|175849|P2|STARTED|Overall Study||36
72248|NCT02246764|175850|P1|STARTED|Overall Study||34
72249|NCT02246673|175863|P5|NOT COMPLETED|Overall Study||1
72250|NCT02246673|175864|P4|NOT COMPLETED|Overall Study||2
72251|NCT02246673|175865|P3|NOT COMPLETED|Overall Study||0
72252|NCT02246673|175866|P2|NOT COMPLETED|Overall Study||0
72253|NCT02246673|175867|P1|NOT COMPLETED|Overall Study||1
72254|NCT02246673|175863|P5|COMPLETED|Overall Study||11
72255|NCT02246673|175864|P4|COMPLETED|Overall Study||12
72256|NCT02246673|175865|P3|COMPLETED|Overall Study||12
72257|NCT02246673|175866|P2|COMPLETED|Overall Study||12
72258|NCT02246673|175867|P1|COMPLETED|Overall Study||13
72259|NCT02246673|175863|P5|STARTED|Overall Study||12
72260|NCT02246673|175864|P4|STARTED|Overall Study||14
72261|NCT02246673|175865|P3|STARTED|Overall Study||12
72262|NCT02246673|175866|P2|STARTED|Overall Study||12
72263|NCT02246673|175867|P1|STARTED|Overall Study||14
72264|NCT02246660|175975|P3|NOT COMPLETED|Overall Study||1
72265|NCT02246660|175976|P2|NOT COMPLETED|Overall Study||1
72266|NCT02246660|175977|P1|NOT COMPLETED|Overall Study||0
72267|NCT02246660|175975|P3|COMPLETED|Overall Study||21
72268|NCT02246660|175976|P2|COMPLETED|Overall Study||20
72269|NCT02246660|175977|P1|COMPLETED|Overall Study||23
72270|NCT02246660|175975|P3|STARTED|Overall Study||22
72271|NCT02246660|175976|P2|STARTED|Overall Study||21
72272|NCT02246660|175977|P1|STARTED|Overall Study||23
72273|NCT02246647|175987|P2|NOT COMPLETED|Overall Study||1
72274|NCT02246647|175988|P1|NOT COMPLETED|Overall Study||1
72275|NCT02246647|175987|P2|COMPLETED|Overall Study||19
72276|NCT02246647|175988|P1|COMPLETED|Overall Study||18
72277|NCT02246647|175987|P2|STARTED|Overall Study||20
72278|NCT02246647|175988|P1|STARTED|Overall Study||19
72279|NCT02246621|176022|P2|NOT COMPLETED|Overall Study||148
72280|NCT02246621|176023|P1|NOT COMPLETED|Overall Study||296
72281|NCT02246621|176022|P2|COMPLETED|Overall Study||17
72282|NCT02246621|176023|P1|COMPLETED|Overall Study||32
72283|NCT02246621|176022|P2|Received At Least One Dose of Study Drug|Overall Study||162
72284|NCT02246621|176023|P1|Received At Least One Dose of Study Drug|Overall Study||326
72285|NCT02246621|176022|P2|STARTED|Overall Study||165
72286|NCT02246621|176023|P1|STARTED|Overall Study||328
72287|NCT02246608|176051|P2|NOT COMPLETED|Overall Study||10
72288|NCT02246608|176052|P1|NOT COMPLETED|Overall Study||12
72289|NCT02246608|176051|P2|COMPLETED|Overall Study||11
72290|NCT02246608|176052|P1|COMPLETED|Overall Study||10
72291|NCT02246608|176051|P2|STARTED|Overall Study||21
72292|NCT02246608|176052|P1|STARTED|Overall Study||22
72293|NCT02246582|176060|P2|NOT COMPLETED|Overall Study||4
72294|NCT02246582|176061|P1|NOT COMPLETED|Overall Study||3
72295|NCT02246582|176060|P2|COMPLETED|Overall Study||41
72296|NCT02246582|176061|P1|COMPLETED|Overall Study||41
72297|NCT02246582|176060|P2|STARTED|Overall Study||45
72298|NCT02246582|176061|P1|STARTED|Overall Study||44
72299|NCT02246439|176069|P2|NOT COMPLETED|Overall Study||11
72300|NCT02246439|176070|P1|NOT COMPLETED|Overall Study||12
72301|NCT02246439|176069|P2|COMPLETED|Overall Study||118
72302|NCT02246439|176070|P1|COMPLETED|Overall Study||180
72303|NCT02246439|176069|P2|Randomized|Overall Study||132
72304|NCT02246439|176070|P1|Randomized|Overall Study||198
72305|NCT02246439|176069|P2|STARTED|Overall Study|3 participants that enrolled in the study did not receive allocated intervention.|129
72306|NCT02246439|176070|P1|STARTED|Overall Study|6 participants that enrolled in the study did not receive allocated intervention.|192
72307|NCT02246309|176108|P2|NOT COMPLETED|Overall Study||0
72308|NCT02246309|176109|P1|NOT COMPLETED|Overall Study||0
72309|NCT02246309|176108|P2|COMPLETED|Overall Study||15
72310|NCT02246309|176109|P1|COMPLETED|Overall Study||16
72311|NCT02246309|176108|P2|STARTED|Overall Study||15
72312|NCT02246309|176109|P1|STARTED|Overall Study|16 patients going through Time Lapse System and 15 through Standard Embryo Culture.|16
72313|NCT02246218|176121|P2|NOT COMPLETED|Overall Study||6
72314|NCT02246218|176122|P1|NOT COMPLETED|Overall Study||4
72315|NCT02246218|176121|P2|COMPLETED|Overall Study||10
72316|NCT02246218|176122|P1|COMPLETED|Overall Study||6
72317|NCT02246218|176121|P2|STARTED|Overall Study||16
72318|NCT02246218|176122|P1|STARTED|Overall Study||10
72319|NCT02246166|176182|P2|NOT COMPLETED|Overall Study||0
72320|NCT02246166|176183|P1|NOT COMPLETED|Overall Study||1
72321|NCT02246166|176182|P2|COMPLETED|Overall Study||27
72322|NCT02246166|176183|P1|COMPLETED|Overall Study||25
72323|NCT02246166|176182|P2|STARTED|Overall Study||27
72324|NCT02246166|176183|P1|STARTED|Overall Study||26
72325|NCT02246114|176219|P2|NOT COMPLETED|Overall Study||0
72326|NCT02246114|176220|P1|NOT COMPLETED|Overall Study||1
72327|NCT02246114|176219|P2|COMPLETED|Overall Study||0
72328|NCT02246114|176220|P1|COMPLETED|Overall Study||0
72329|NCT02246114|176219|P2|STARTED|Overall Study||0
72330|NCT02246114|176220|P1|STARTED|Overall Study||1
72331|NCT02246062|176230|P4|NOT COMPLETED|Overall Study||0
72332|NCT02246062|176231|P3|NOT COMPLETED|Overall Study||0
72333|NCT02246062|176232|P2|NOT COMPLETED|Overall Study||0
72334|NCT02246062|176233|P1|NOT COMPLETED|Overall Study||0
72335|NCT02246062|176230|P4|COMPLETED|Overall Study||21
72336|NCT02246062|176231|P3|COMPLETED|Overall Study||21
72337|NCT02246062|176232|P2|COMPLETED|Overall Study||21
72338|NCT02246062|176233|P1|COMPLETED|Overall Study||21
72339|NCT02246062|176230|P4|STARTED|Overall Study||21
72340|NCT02246062|176231|P3|STARTED|Overall Study||21
72341|NCT02246062|176232|P2|STARTED|Overall Study||21
72342|NCT02246062|176233|P1|STARTED|Overall Study||21
72343|NCT02246010|176253|P2|NOT COMPLETED|Overall Study||0
72344|NCT02246010|176254|P1|NOT COMPLETED|Overall Study||0
72345|NCT02246010|176253|P2|COMPLETED|Overall Study||2
72346|NCT02246010|176254|P1|COMPLETED|Overall Study||4
72347|NCT02246010|176253|P2|STARTED|Overall Study||2
72348|NCT02246010|176254|P1|STARTED|Overall Study||4
72349|NCT02245737|176271|P3|NOT COMPLETED|Overall Study||571
72350|NCT02245737|176272|P2|NOT COMPLETED|Overall Study||555
72351|NCT02245737|176273|P1|NOT COMPLETED|Overall Study||553
72352|NCT02245737|176271|P3|COMPLETED|Overall Study||168
72353|NCT02245737|176272|P2|COMPLETED|Overall Study||184
72354|NCT02245737|176273|P1|COMPLETED|Overall Study||187
72355|NCT02245737|176271|P3|Received at Least 1 Dose of Study Drug|Overall Study||735
72356|NCT02245737|176272|P2|Received at Least 1 Dose of Study Drug|Overall Study||736
72357|NCT02245737|176273|P1|Received at Least 1 Dose of Study Drug|Overall Study||738
72358|NCT02245737|176271|P3|STARTED|Overall Study||739
72359|NCT02245737|176272|P2|STARTED|Overall Study||739
72360|NCT02245737|176273|P1|STARTED|Overall Study||740
72361|NCT02245412|176331|P3|NOT COMPLETED|Follow-Up Period||2
72362|NCT02245412|176332|P2|NOT COMPLETED|Follow-Up Period||2
72363|NCT02245412|176333|P1|NOT COMPLETED|Follow-Up Period||5
72364|NCT02245412|176331|P3|COMPLETED|Follow-Up Period||0
72365|NCT02245412|176332|P2|COMPLETED|Follow-Up Period||2
72366|NCT02245412|176333|P1|COMPLETED|Follow-Up Period||8
72367|NCT02245412|176331|P3|STARTED|Follow-Up Period||2
72368|NCT02245412|176332|P2|STARTED|Follow-Up Period|One participant who discontinued Study Drug in Treatment Period continued to Follow-Up Period.|4
72369|NCT02245412|176333|P1|STARTED|Follow-Up Period|One participant who discontinued Study Drug in Treatment Period continued to Follow-Up Period.|13
72370|NCT02245412|176331|P3|NOT COMPLETED|Treatment Period||0
72371|NCT02245412|176332|P2|NOT COMPLETED|Treatment Period||3
72372|NCT02245412|176333|P1|NOT COMPLETED|Treatment Period||5
72373|NCT02245412|176331|P3|COMPLETED|Treatment Period||2
72374|NCT02245412|176332|P2|COMPLETED|Treatment Period||3
72375|NCT02245412|176333|P1|COMPLETED|Treatment Period||12
72376|NCT02245412|176331|P3|Modified Full Analysis Set (mFAS)|Treatment Period||2
72377|NCT02245412|176332|P2|Modified Full Analysis Set (mFAS)|Treatment Period||6
72378|NCT02245412|176333|P1|Modified Full Analysis Set (mFAS)|Treatment Period||16
72379|NCT02245412|176331|P3|Received at Least 1 Dose of Study Drug|Treatment Period||2
72380|NCT02245412|176332|P2|Received at Least 1 Dose of Study Drug|Treatment Period||6
72381|NCT02245412|176333|P1|Received at Least 1 Dose of Study Drug|Treatment Period||17
72382|NCT02245412|176331|P3|STARTED|Treatment Period||2
72383|NCT02245412|176332|P2|STARTED|Treatment Period||6
72384|NCT02245412|176333|P1|STARTED|Treatment Period||17
72385|NCT02245360|176352|P2|NOT COMPLETED|Overall Study||2
72386|NCT02245360|176353|P1|NOT COMPLETED|Overall Study||5
72387|NCT02245360|176352|P2|COMPLETED|Overall Study||52
72388|NCT02245360|176353|P1|COMPLETED|Overall Study||48
72389|NCT02245360|176352|P2|STARTED|Overall Study||54
72390|NCT02245360|176353|P1|STARTED|Overall Study||53
72391|NCT02245308|176363|P2|NOT COMPLETED|Overall Study||0
72392|NCT02245308|176364|P1|NOT COMPLETED|Overall Study||0
72393|NCT02245308|176363|P2|COMPLETED|Overall Study|Using intent-to-treat analyses, i.e., missing=smoking|64
72394|NCT02245308|176364|P1|COMPLETED|Overall Study|Using intent-to-treat analyses, i.e., missing=smoking|63
72395|NCT02245308|176363|P2|STARTED|Overall Study||64
72396|NCT02245308|176364|P1|STARTED|Overall Study||63
72397|NCT02245217|176372|P1|NOT COMPLETED|Overall Study||2
72398|NCT02245217|176372|P1|COMPLETED|Overall Study||7
72399|NCT02245217|176372|P1|STARTED|Overall Study||9
72400|NCT02244996|176380|P2|NOT COMPLETED|Overall Study||6
72401|NCT02244996|176381|P1|NOT COMPLETED|Overall Study||2
72402|NCT02244996|176380|P2|COMPLETED|Overall Study||19
72403|NCT02244996|176381|P1|COMPLETED|Overall Study||23
72404|NCT02244996|176380|P2|STARTED|Overall Study||25
72405|NCT02244996|176381|P1|STARTED|Overall Study||25
72406|NCT02244944|176393|P1|NOT COMPLETED|Overall Study||2
72407|NCT02244944|176393|P1|COMPLETED|Overall Study||0
72408|NCT02244944|176393|P1|STARTED|Overall Study||2
72409|NCT02244918|176401|P2|NOT COMPLETED|Overall Study||0
72410|NCT02244918|176402|P1|NOT COMPLETED|Overall Study||0
72411|NCT02244918|176401|P2|COMPLETED|Overall Study||93
72412|NCT02244918|176402|P1|COMPLETED|Overall Study||185
72413|NCT02244918|176401|P2|Week 12|Overall Study||83
72414|NCT02244918|176402|P1|Week 12|Overall Study||160
72415|NCT02244918|176401|P2|STARTED|Overall Study||93
72416|NCT02244918|176402|P1|STARTED|Overall Study||185
72417|NCT02244840|176418|P1|NOT COMPLETED|Overall Study||0
72418|NCT02244840|176418|P1|COMPLETED|Overall Study||40
72419|NCT02244840|176418|P1|STARTED|Overall Study||40
72420|NCT02244619|176424|P2|NOT COMPLETED|Overall Study||21
72421|NCT02244619|176425|P1|NOT COMPLETED|Overall Study||8
72422|NCT02244619|176424|P2|COMPLETED|Overall Study||245
72423|NCT02244619|176425|P1|COMPLETED|Overall Study||241
72424|NCT02244619|176424|P2|STARTED|Overall Study||266
72425|NCT02244619|176425|P1|STARTED|Overall Study||249
72426|NCT02244580|176443|P1|NOT COMPLETED|Overall Study||241
72427|NCT02244580|176443|P1|COMPLETED|Overall Study|An RT-qPCR assay was performed from breast cancer tissues of 769 out of the 1010 patients.|769
72428|NCT02244580|176443|P1|STARTED|Overall Study||1010
72429|NCT02244424|176453|P2|NOT COMPLETED|Overall Study||10
72430|NCT02244424|176454|P1|NOT COMPLETED|Overall Study||20
72431|NCT02244424|176453|P2|COMPLETED|Overall Study|Data were collected on all of the infants of teen moms (n = 26).|52
72432|NCT02244424|176454|P1|COMPLETED|Overall Study|Data were collected on all of the infants of the teen moms (n = 41).|82
72433|NCT02244424|176453|P2|Mothers|Overall Study||31
72434|NCT02244424|176454|P1|Mothers|Overall Study||51
72435|NCT02244424|176453|P2|Infants|Overall Study|Infants of participants included in the study for collection of demographic and weight data.|31
72436|NCT02244424|176454|P1|Infants|Overall Study|Infants of participants included in the study for collection of demographic and weight data.|51
72437|NCT02244424|176453|P2|STARTED|Overall Study|Teen participants received the MIHP standard care. Data were collected on infants.|62
72438|NCT02244424|176454|P1|STARTED|Overall Study|Teens were the participants who received the intervention. Data were collected on the infants.|102
72439|NCT02243943|176462|P2|NOT COMPLETED|Overall Study||0
72440|NCT02243943|176463|P1|NOT COMPLETED|Overall Study||0
72441|NCT02243943|176462|P2|COMPLETED|Overall Study||50
72442|NCT02243943|176463|P1|COMPLETED|Overall Study||50
72443|NCT02243943|176462|P2|STARTED|Overall Study||50
72444|NCT02243943|176463|P1|STARTED|Overall Study||50
72445|NCT02243579|176473|P1|NOT COMPLETED|Overall Study||20
72446|NCT02243579|176473|P1|COMPLETED|Overall Study||4
72447|NCT02243579|176473|P1|STARTED|Overall Study||24
72448|NCT02243527|176484|P2|NOT COMPLETED|Overall Study||0
72449|NCT02243527|176485|P1|NOT COMPLETED|Overall Study||0
72450|NCT02243527|176484|P2|COMPLETED|Overall Study||13
72451|NCT02243527|176485|P1|COMPLETED|Overall Study||12
72452|NCT02243527|176484|P2|STARTED|Overall Study||13
72453|NCT02243527|176485|P1|STARTED|Overall Study||12
72454|NCT02243371|176499|P2|NOT COMPLETED|Overall Study||32
72455|NCT02243371|176500|P1|NOT COMPLETED|Overall Study||37
72456|NCT02243371|176499|P2|COMPLETED|Overall Study||10
72457|NCT02243371|176500|P1|COMPLETED|Overall Study||14
72458|NCT02243371|176499|P2|STARTED|Overall Study||42
72459|NCT02243371|176500|P1|STARTED|Overall Study||51
72460|NCT02243306|176520|P2|NOT COMPLETED|Overall Study||3
72461|NCT02243306|176521|P1|NOT COMPLETED|Overall Study||0
72462|NCT02243306|176520|P2|COMPLETED|Overall Study||4
72463|NCT02243306|176521|P1|COMPLETED|Overall Study||1
72464|NCT02243306|176520|P2|STARTED|Overall Study||7
72465|NCT02243306|176521|P1|STARTED|Overall Study||1
72466|NCT02243293|176596|P22|NOT COMPLETED|Overall Study||3
72467|NCT02243293|176597|P21|NOT COMPLETED|Overall Study||2
72468|NCT02243293|176598|P20|NOT COMPLETED|Overall Study||1
72469|NCT02243293|176599|P19|NOT COMPLETED|Overall Study||0
72470|NCT02243293|176600|P18|NOT COMPLETED|Overall Study||1
72471|NCT02243293|176601|P17|NOT COMPLETED|Overall Study||3
72472|NCT02243293|176602|P16|NOT COMPLETED|Overall Study||1
72473|NCT02243293|176603|P15|NOT COMPLETED|Overall Study||1
72474|NCT02243293|176604|P14|NOT COMPLETED|Overall Study||0
72475|NCT02243293|176605|P13|NOT COMPLETED|Overall Study||0
72476|NCT02243293|176606|P12|NOT COMPLETED|Overall Study||3
72477|NCT02243293|176607|P11|NOT COMPLETED|Overall Study||0
72478|NCT02243293|176608|P10|NOT COMPLETED|Overall Study||2
72479|NCT02243293|176609|P9|NOT COMPLETED|Overall Study||0
72480|NCT02243293|176610|P8|NOT COMPLETED|Overall Study||0
72481|NCT02243293|176611|P7|NOT COMPLETED|Overall Study||3
72482|NCT02243293|176612|P6|NOT COMPLETED|Overall Study||0
72483|NCT02243293|176613|P5|NOT COMPLETED|Overall Study||1
72484|NCT02243293|176614|P4|NOT COMPLETED|Overall Study||1
72485|NCT02243293|176615|P3|NOT COMPLETED|Overall Study||1
72486|NCT02243293|176616|P2|NOT COMPLETED|Overall Study||1
72487|NCT02243293|176617|P1|NOT COMPLETED|Overall Study||2
72488|NCT02243293|176596|P22|COMPLETED|Overall Study||55
72489|NCT02243293|176597|P21|COMPLETED|Overall Study||143
72490|NCT02243293|176598|P20|COMPLETED|Overall Study||47
72491|NCT02243293|176599|P19|COMPLETED|Overall Study||22
72492|NCT02243293|176600|P18|COMPLETED|Overall Study||21
72493|NCT02243293|176601|P17|COMPLETED|Overall Study||37
72494|NCT02243293|176602|P16|COMPLETED|Overall Study||26
72495|NCT02243293|176603|P15|COMPLETED|Overall Study||27
72496|NCT02243293|176604|P14|COMPLETED|Overall Study||0
72497|NCT02243293|176605|P13|COMPLETED|Overall Study||0
72498|NCT02243293|176606|P12|COMPLETED|Overall Study||50
72499|NCT02243293|176607|P11|COMPLETED|Overall Study||0
72500|NCT02243293|176608|P10|COMPLETED|Overall Study||53
72501|NCT02243293|176609|P9|COMPLETED|Overall Study||0
72502|NCT02243293|176610|P8|COMPLETED|Overall Study||0
72503|NCT02243293|176611|P7|COMPLETED|Overall Study||27
72504|NCT02243293|176612|P6|COMPLETED|Overall Study||31
72505|NCT02243293|176613|P5|COMPLETED|Overall Study||30
72506|NCT02243293|176614|P4|COMPLETED|Overall Study||29
72507|NCT02243293|176615|P3|COMPLETED|Overall Study||24
72508|NCT02243293|176616|P2|COMPLETED|Overall Study||23
72509|NCT02243293|176617|P1|COMPLETED|Overall Study||23
72510|NCT02243293|176596|P22|STARTED|Overall Study||58
72511|NCT02243293|176597|P21|STARTED|Overall Study||145
72512|NCT02243293|176598|P20|STARTED|Overall Study||48
72513|NCT02243293|176599|P19|STARTED|Overall Study||22
72514|NCT02243293|176600|P18|STARTED|Overall Study||22
72515|NCT02243293|176601|P17|STARTED|Overall Study||40
72516|NCT02243293|176602|P16|STARTED|Overall Study||27
72517|NCT02243293|176603|P15|STARTED|Overall Study||28
72518|NCT02243293|176604|P14|STARTED|Overall Study||0
72519|NCT02243293|176605|P13|STARTED|Overall Study||0
72520|NCT02243293|176606|P12|STARTED|Overall Study||53
72521|NCT02243293|176607|P11|STARTED|Overall Study||0
72522|NCT02243293|176608|P10|STARTED|Overall Study||55
72523|NCT02243293|176609|P9|STARTED|Overall Study||0
72524|NCT02243293|176610|P8|STARTED|Overall Study||0
72525|NCT02243293|176611|P7|STARTED|Overall Study||30
72526|NCT02243293|176612|P6|STARTED|Overall Study||31
72527|NCT02243293|176613|P5|STARTED|Overall Study||31
72528|NCT02243293|176614|P4|STARTED|Overall Study||30
72529|NCT02243293|176615|P3|STARTED|Overall Study||25
72530|NCT02243293|176616|P2|STARTED|Overall Study||24
72531|NCT02243293|176617|P1|STARTED|Overall Study||25
72532|NCT02243280|176716|P11|NOT COMPLETED|Treated||3
72533|NCT02243280|176717|P10|NOT COMPLETED|Treated||0
72534|NCT02243280|176718|P9|NOT COMPLETED|Treated||1
72535|NCT02243280|176719|P8|NOT COMPLETED|Treated||0
72536|NCT02243280|176720|P7|NOT COMPLETED|Treated||0
72537|NCT02243280|176721|P6|NOT COMPLETED|Treated||0
72538|NCT02243280|176722|P5|NOT COMPLETED|Treated||0
72539|NCT02243280|176723|P4|NOT COMPLETED|Treated||0
72540|NCT02243280|176724|P3|NOT COMPLETED|Treated||0
72541|NCT02243280|176725|P2|NOT COMPLETED|Treated||0
72542|NCT02243280|176726|P1|NOT COMPLETED|Treated||1
72543|NCT02243280|176716|P11|COMPLETED|Treated||31
72544|NCT02243280|176717|P10|COMPLETED|Treated||0
72545|NCT02243280|176718|P9|COMPLETED|Treated||31
72546|NCT02243280|176719|P8|COMPLETED|Treated||0
72547|NCT02243280|176720|P7|COMPLETED|Treated||0
72548|NCT02243280|176721|P6|COMPLETED|Treated||27
72549|NCT02243280|176722|P5|COMPLETED|Treated||0
72550|NCT02243280|176723|P4|COMPLETED|Treated||0
72551|NCT02243280|176724|P3|COMPLETED|Treated||0
72552|NCT02243280|176725|P2|COMPLETED|Treated||39
72553|NCT02243280|176726|P1|COMPLETED|Treated||41
72554|NCT02243280|176716|P11|Completed Treatment|Treated||33
72555|NCT02243280|176717|P10|Completed Treatment|Treated||0
72556|NCT02243280|176718|P9|Completed Treatment|Treated||32
72557|NCT02243280|176719|P8|Completed Treatment|Treated||0
72558|NCT02243280|176720|P7|Completed Treatment|Treated||0
72559|NCT02243280|176721|P6|Completed Treatment|Treated||27
72560|NCT02243280|176722|P5|Completed Treatment|Treated||0
72561|NCT02243280|176723|P4|Completed Treatment|Treated||0
72562|NCT02243280|176724|P3|Completed Treatment|Treated||0
72563|NCT02243280|176725|P2|Completed Treatment|Treated||38
72564|NCT02243280|176726|P1|Completed Treatment|Treated||42
72565|NCT02243280|176716|P11|STARTED|Treated||34
72566|NCT02243280|176717|P10|STARTED|Treated||0
72567|NCT02243280|176718|P9|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|32
72568|NCT02243280|176719|P8|STARTED|Treated||0
72569|NCT02243280|176720|P7|STARTED|Treated||0
72570|NCT02243280|176721|P6|STARTED|Treated||27
72571|NCT02243280|176722|P5|STARTED|Treated||0
72572|NCT02243280|176723|P4|STARTED|Treated||0
72573|NCT02243280|176724|P3|STARTED|Treated||0
72574|NCT02243280|176725|P2|STARTED|Treated||39
72575|NCT02243280|176726|P1|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|42
72576|NCT02243280|176716|P11|NOT COMPLETED|Enrolled||0
72577|NCT02243280|176717|P10|NOT COMPLETED|Enrolled||0
72578|NCT02243280|176718|P9|NOT COMPLETED|Enrolled||0
72579|NCT02243280|176719|P8|NOT COMPLETED|Enrolled||0
72580|NCT02243280|176720|P7|NOT COMPLETED|Enrolled||0
72581|NCT02243280|176721|P6|NOT COMPLETED|Enrolled||0
72582|NCT02243280|176722|P5|NOT COMPLETED|Enrolled||0
72583|NCT02243280|176723|P4|NOT COMPLETED|Enrolled||0
72584|NCT02243280|176724|P3|NOT COMPLETED|Enrolled||0
72585|NCT02243280|176725|P2|NOT COMPLETED|Enrolled||0
72586|NCT02243280|176726|P1|NOT COMPLETED|Enrolled||0
72587|NCT02243280|176716|P11|COMPLETED|Enrolled||34
72588|NCT02243280|176717|P10|COMPLETED|Enrolled||0
72589|NCT02243280|176718|P9|COMPLETED|Enrolled||34
72590|NCT02243280|176719|P8|COMPLETED|Enrolled||0
72591|NCT02243280|176720|P7|COMPLETED|Enrolled||0
72592|NCT02243280|176721|P6|COMPLETED|Enrolled||27
72593|NCT02243280|176722|P5|COMPLETED|Enrolled||0
72594|NCT02243280|176723|P4|COMPLETED|Enrolled||0
72595|NCT02243280|176724|P3|COMPLETED|Enrolled||0
72596|NCT02243280|176725|P2|COMPLETED|Enrolled||39
72597|NCT02243280|176726|P1|COMPLETED|Enrolled||40
72598|NCT02243280|176716|P11|STARTED|Enrolled||34
72599|NCT02243280|176717|P10|STARTED|Enrolled||0
72600|NCT02243280|176718|P9|STARTED|Enrolled||34
72601|NCT02243280|176719|P8|STARTED|Enrolled||0
72602|NCT02243280|176720|P7|STARTED|Enrolled||0
72603|NCT02243280|176721|P6|STARTED|Enrolled||27
72604|NCT02243280|176722|P5|STARTED|Enrolled||0
72605|NCT02243280|176723|P4|STARTED|Enrolled||0
72606|NCT02243280|176724|P3|STARTED|Enrolled||0
72607|NCT02243280|176725|P2|STARTED|Enrolled||39
72608|NCT02243280|176726|P1|STARTED|Enrolled||40
72609|NCT02243202|176781|P4|NOT COMPLETED|Overall Study||23
72610|NCT02243202|176782|P3|NOT COMPLETED|Overall Study||31
72611|NCT02243202|176783|P2|NOT COMPLETED|Overall Study||25
72612|NCT02243202|176784|P1|NOT COMPLETED|Overall Study||25
72613|NCT02243202|176781|P4|COMPLETED|Overall Study||61
72614|NCT02243202|176782|P3|COMPLETED|Overall Study||53
72615|NCT02243202|176783|P2|COMPLETED|Overall Study||60
72616|NCT02243202|176784|P1|COMPLETED|Overall Study||57
72617|NCT02243202|176781|P4|Treated|Overall Study||83
72618|NCT02243202|176782|P3|Treated|Overall Study||84
72619|NCT02243202|176783|P2|Treated|Overall Study||85
72620|NCT02243202|176784|P1|Treated|Overall Study||82
72621|NCT02243202|176781|P4|STARTED|Overall Study||84
72622|NCT02243202|176782|P3|STARTED|Overall Study||84
72623|NCT02243202|176783|P2|STARTED|Overall Study||85
72624|NCT02243202|176784|P1|STARTED|Overall Study||82
72625|NCT02243176|176820|P2|NOT COMPLETED|Overall Study||15
72626|NCT02243176|176821|P1|NOT COMPLETED|Overall Study||14
72627|NCT02243176|176820|P2|COMPLETED|Overall Study||229
72628|NCT02243176|176821|P1|COMPLETED|Overall Study||230
72629|NCT02243176|176820|P2|STARTED|Overall Study||244
72630|NCT02243176|176821|P1|STARTED|Overall Study|3 of the randomized subjects withdrew before taking any medication|244
72631|NCT02243046|176846|P3|NOT COMPLETED|Overall Study||4
72632|NCT02243046|176847|P2|NOT COMPLETED|Overall Study||1
72633|NCT02243046|176848|P1|NOT COMPLETED|Overall Study||1
72634|NCT02243046|176846|P3|COMPLETED|Overall Study||49
72635|NCT02243046|176847|P2|COMPLETED|Overall Study||53
72636|NCT02243046|176848|P1|COMPLETED|Overall Study||54
72637|NCT02243046|176846|P3|6 Month|Overall Study|2 subjects didn't return for 6 month clinic visit|49
72638|NCT02243046|176847|P2|6 Month|Overall Study||53
72639|NCT02243046|176848|P1|6 Month|Overall Study||54
72640|NCT02243046|176846|P3|3 Month|Overall Study|2 subjects didn't return for 3 month clinic visit|51
72641|NCT02243046|176847|P2|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|53
72642|NCT02243046|176848|P1|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|54
72643|NCT02243046|176846|P3|STARTED|Overall Study||53
72644|NCT02243046|176847|P2|STARTED|Overall Study||54
72645|NCT02243046|176848|P1|STARTED|Overall Study||55
72646|NCT02243020|176873|P2|NOT COMPLETED|Overall Study||0
72647|NCT02243020|176874|P1|NOT COMPLETED|Overall Study||0
72648|NCT02243020|176873|P2|COMPLETED|Overall Study||9
72649|NCT02243020|176874|P1|COMPLETED|Overall Study||8
72650|NCT02243020|176873|P2|STARTED|Overall Study||9
72651|NCT02243020|176874|P1|STARTED|Overall Study||8
72652|NCT02243007|176884|P2|NOT COMPLETED|Overall Study||0
72653|NCT02243007|176885|P1|NOT COMPLETED|Overall Study||0
72654|NCT02243007|176884|P2|COMPLETED|Overall Study||3
72655|NCT02243007|176885|P1|COMPLETED|Overall Study||4
72656|NCT02243007|176884|P2|STARTED|Overall Study||3
72657|NCT02243007|176885|P1|STARTED|Overall Study||4
72658|NCT02242994|176907|P1|NOT COMPLETED|Overall Study||0
72659|NCT02242994|176907|P1|COMPLETED|Overall Study||5
72660|NCT02242994|176907|P1|STARTED|Overall Study||5
72661|NCT02242942|176915|P3|NOT COMPLETED|Overall Study||13
72662|NCT02242942|176916|P2|NOT COMPLETED|Overall Study||216
72663|NCT02242942|176917|P1|NOT COMPLETED|Overall Study||216
72664|NCT02242942|176915|P3|COMPLETED|Overall Study||0
72665|NCT02242942|176916|P2|COMPLETED|Overall Study||0
72666|NCT02242942|176917|P1|COMPLETED|Overall Study||0
72667|NCT02242942|176915|P3|Treated|Overall Study||13
72668|NCT02242942|176916|P2|Treated|Overall Study||212
72669|NCT02242942|176917|P1|Treated|Overall Study||214
72670|NCT02242942|176915|P3|STARTED|Overall Study||13
72671|NCT02242942|176916|P2|STARTED|Overall Study||216
72672|NCT02242942|176917|P1|STARTED|Overall Study||216
72673|NCT02242903|176951|P7|NOT COMPLETED|Overall Study||0
72674|NCT02242903|176952|P6|NOT COMPLETED|Overall Study||0
72675|NCT02242903|176953|P5|NOT COMPLETED|Overall Study||0
72676|NCT02242903|176954|P4|NOT COMPLETED|Overall Study||0
72677|NCT02242903|176955|P3|NOT COMPLETED|Overall Study||0
72678|NCT02242903|176956|P2|NOT COMPLETED|Overall Study||0
72679|NCT02242903|176957|P1|NOT COMPLETED|Overall Study||1
72680|NCT02242903|176951|P7|COMPLETED|Overall Study||6
72681|NCT02242903|176952|P6|COMPLETED|Overall Study||6
72682|NCT02242903|176953|P5|COMPLETED|Overall Study||6
72683|NCT02242903|176954|P4|COMPLETED|Overall Study||6
72684|NCT02242903|176955|P3|COMPLETED|Overall Study||6
72685|NCT02242903|176956|P2|COMPLETED|Overall Study||6
72686|NCT02242903|176957|P1|COMPLETED|Overall Study||11
72687|NCT02242903|176951|P7|Received at Least One Dose of Study Drug|Overall Study||6
72688|NCT02242903|176952|P6|Received at Least One Dose of Study Drug|Overall Study||6
72689|NCT02242903|176953|P5|Received at Least One Dose of Study Drug|Overall Study||6
72690|NCT02242903|176954|P4|Received at Least One Dose of Study Drug|Overall Study||6
72691|NCT02242903|176955|P3|Received at Least One Dose of Study Drug|Overall Study||6
72692|NCT02242903|176956|P2|Received at Least One Dose of Study Drug|Overall Study||6
72693|NCT02242903|176957|P1|Received at Least One Dose of Study Drug|Overall Study||12
72694|NCT02242903|176951|P7|STARTED|Overall Study||6
72695|NCT02242903|176952|P6|STARTED|Overall Study||6
72696|NCT02242903|176953|P5|STARTED|Overall Study||6
72697|NCT02242903|176954|P4|STARTED|Overall Study||6
72698|NCT02242903|176955|P3|STARTED|Overall Study||6
72699|NCT02242903|176956|P2|STARTED|Overall Study||6
72700|NCT02242903|176957|P1|STARTED|Overall Study||12
72701|NCT02242643|176987|P2|NOT COMPLETED|Overall Study||78
72702|NCT02242643|176988|P1|NOT COMPLETED|Overall Study||75
72703|NCT02242643|176987|P2|COMPLETED|Overall Study||1139
72704|NCT02242643|176988|P1|COMPLETED|Overall Study||1132
72705|NCT02242643|176987|P2|STARTED|Overall Study||1217
72706|NCT02242643|176988|P1|STARTED|Overall Study||1207
72707|NCT02242630|177024|P4|NOT COMPLETED|Overall Study||0
72708|NCT02242630|177025|P3|NOT COMPLETED|Overall Study||0
72709|NCT02242630|177026|P2|NOT COMPLETED|Overall Study||0
72710|NCT02242630|177027|P1|NOT COMPLETED|Overall Study||0
72711|NCT02242630|177024|P4|COMPLETED|Overall Study||16
72712|NCT02242630|177025|P3|COMPLETED|Overall Study||15
72713|NCT02242630|177026|P2|COMPLETED|Overall Study||15
72714|NCT02242630|177027|P1|COMPLETED|Overall Study||15
72715|NCT02242630|177024|P4|STARTED|Overall Study||16
72716|NCT02242630|177025|P3|STARTED|Overall Study||15
72717|NCT02242630|177026|P2|STARTED|Overall Study||15
72718|NCT02242630|177027|P1|STARTED|Overall Study||15
72719|NCT02242487|177043|P2|NOT COMPLETED|Overall Study||47
72720|NCT02242487|177044|P1|NOT COMPLETED|Overall Study||62
72721|NCT02242487|177043|P2|COMPLETED|Overall Study||117
72722|NCT02242487|177044|P1|COMPLETED|Overall Study||99
72723|NCT02242487|177043|P2|STARTED|Overall Study||164
72724|NCT02242487|177044|P1|STARTED|Overall Study||161
72725|NCT02242305|177060|P2|NOT COMPLETED|Overall Study||10
72726|NCT02242305|177061|P1|NOT COMPLETED|Overall Study||6
72727|NCT02242305|177060|P2|COMPLETED|Overall Study||141
72728|NCT02242305|177061|P1|COMPLETED|Overall Study||145
72729|NCT02242305|177060|P2|STARTED|Overall Study||151
72730|NCT02242305|177061|P1|STARTED|Overall Study||151
72731|NCT02242201|177082|P3|NOT COMPLETED|Overall Study||1
72732|NCT02242201|177083|P2|NOT COMPLETED|Overall Study||1
72733|NCT02242201|177084|P1|NOT COMPLETED|Overall Study||4
72734|NCT02242201|177082|P3|COMPLETED|Overall Study||54
72735|NCT02242201|177083|P2|COMPLETED|Overall Study||54
72736|NCT02242201|177084|P1|COMPLETED|Overall Study||51
72737|NCT02242201|177082|P3|STARTED|Overall Study||55
72738|NCT02242201|177083|P2|STARTED|Overall Study||55
72739|NCT02242201|177084|P1|STARTED|Overall Study||55
72740|NCT02242019|177116|P1|NOT COMPLETED|Overall Study||0
72741|NCT02242019|177116|P1|COMPLETED|Overall Study||109
72742|NCT02242019|177116|P1|STARTED|Overall Study||109
72743|NCT02241889|177122|P6|NOT COMPLETED|Overall Study||1
72744|NCT02241889|177123|P5|NOT COMPLETED|Overall Study||0
72745|NCT02241889|177124|P4|NOT COMPLETED|Overall Study||0
72746|NCT02241889|177125|P3|NOT COMPLETED|Overall Study||1
72747|NCT02241889|177126|P2|NOT COMPLETED|Overall Study||0
72748|NCT02241889|177127|P1|NOT COMPLETED|Overall Study||0
72749|NCT02241889|177122|P6|COMPLETED|Overall Study||3
72750|NCT02241889|177123|P5|COMPLETED|Overall Study||5
72751|NCT02241889|177124|P4|COMPLETED|Overall Study||3
72752|NCT02241889|177125|P3|COMPLETED|Overall Study||2
72753|NCT02241889|177126|P2|COMPLETED|Overall Study||4
72754|NCT02241889|177127|P1|COMPLETED|Overall Study||4
72755|NCT02241889|177122|P6|STARTED|Overall Study||4
72756|NCT02241889|177123|P5|STARTED|Overall Study||5
72757|NCT02241889|177124|P4|STARTED|Overall Study||3
72758|NCT02241889|177125|P3|STARTED|Overall Study||3
72759|NCT02241889|177126|P2|STARTED|Overall Study||4
72760|NCT02241889|177127|P1|STARTED|Overall Study||4
72761|NCT02241785|177162|P1|NOT COMPLETED|Overall Study||47
72762|NCT02241785|177162|P1|COMPLETED|Overall Study||0
72763|NCT02241785|177162|P1|STARTED|Overall Study||47
72764|NCT02241733|177172|P2|NOT COMPLETED|Overall Study||10
72765|NCT02241733|177173|P1|NOT COMPLETED|Overall Study||15
72766|NCT02241733|177172|P2|COMPLETED|Overall Study||30
72767|NCT02241733|177173|P1|COMPLETED|Overall Study||25
72768|NCT02241733|177172|P2|STARTED|Overall Study||40
72769|NCT02241733|177173|P1|STARTED|Overall Study||40
72770|NCT02241720|177185|P1|NOT COMPLETED|Overall Study||4
72771|NCT02241720|177185|P1|COMPLETED|Overall Study||1
72772|NCT02241720|177185|P1|STARTED|Overall Study||5
72773|NCT02241655|177191|P2|NOT COMPLETED|Overall Study||0
72774|NCT02241655|177192|P1|NOT COMPLETED|Overall Study||0
72775|NCT02241655|177191|P2|COMPLETED|Overall Study||618
72776|NCT02241655|177192|P1|COMPLETED|Overall Study||614
72777|NCT02241655|177191|P2|STARTED|Overall Study||618
72778|NCT02241655|177192|P1|STARTED|Overall Study||614
72779|NCT02241551|177212|P2|NOT COMPLETED|Overall Study||0
72780|NCT02241551|177213|P1|NOT COMPLETED|Overall Study||1
72781|NCT02241551|177212|P2|COMPLETED|Overall Study||0
72782|NCT02241551|177213|P1|COMPLETED|Overall Study||0
72783|NCT02241551|177212|P2|STARTED|Overall Study||0
72784|NCT02241551|177213|P1|STARTED|Overall Study||1
72785|NCT02241486|177233|P1|NOT COMPLETED|Overall Study||0
72786|NCT02241486|177233|P1|COMPLETED|Overall Study||2
72787|NCT02241486|177233|P1|STARTED|Overall Study||2
72788|NCT02241187|177237|P1|NOT COMPLETED|Overall Study||2
72789|NCT02241187|177237|P1|COMPLETED|Overall Study||0
72790|NCT02241187|177237|P1|STARTED|Overall Study||2
72791|NCT02240810|177244|P2|NOT COMPLETED|Overall Study||60
72792|NCT02240810|177245|P1|NOT COMPLETED|Overall Study||60
72793|NCT02240810|177244|P2|COMPLETED|Overall Study||2621
72794|NCT02240810|177245|P1|COMPLETED|Overall Study||1441
72795|NCT02240810|177244|P2|STARTED|Overall Study|correct typo|2681
72796|NCT02240810|177245|P1|STARTED|Overall Study||1501
72797|NCT02240693|177269|P5|NOT COMPLETED|Overall Study||1
72798|NCT02240693|177270|P4|NOT COMPLETED|Overall Study||1
72799|NCT02240693|177271|P3|NOT COMPLETED|Overall Study||4
72800|NCT02240693|177272|P2|NOT COMPLETED|Overall Study||0
72801|NCT02240693|177273|P1|NOT COMPLETED|Overall Study||0
72802|NCT02240693|177269|P5|COMPLETED|Overall Study||42
72803|NCT02240693|177270|P4|COMPLETED|Overall Study||20
72804|NCT02240693|177271|P3|COMPLETED|Overall Study||17
72805|NCT02240693|177272|P2|COMPLETED|Overall Study||21
72806|NCT02240693|177273|P1|COMPLETED|Overall Study||22
72807|NCT02240693|177269|P5|STARTED|Overall Study||43
72808|NCT02240693|177270|P4|STARTED|Overall Study||21
72809|NCT02240693|177271|P3|STARTED|Overall Study||21
72810|NCT02240693|177272|P2|STARTED|Overall Study||21
72811|NCT02240693|177273|P1|STARTED|Overall Study||22
72812|NCT02240680|177309|P4|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||7
72813|NCT02240680|177310|P3|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||8
72814|NCT02240680|177311|P2|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0
72815|NCT02240680|177312|P1|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0
72816|NCT02240680|177309|P4|COMPLETED|Japanese Patients (Up to 52 Weeks)||45
72817|NCT02240680|177310|P3|COMPLETED|Japanese Patients (Up to 52 Weeks)||42
72818|NCT02240680|177311|P2|COMPLETED|Japanese Patients (Up to 52 Weeks)||0
72819|NCT02240680|177312|P1|COMPLETED|Japanese Patients (Up to 52 Weeks)||0
72820|NCT02240680|177309|P4|STARTED|Japanese Patients (Up to 52 Weeks)||52
72821|NCT02240680|177310|P3|STARTED|Japanese Patients (Up to 52 Weeks)||50
72822|NCT02240680|177311|P2|STARTED|Japanese Patients (Up to 52 Weeks)||0
72823|NCT02240680|177312|P1|STARTED|Japanese Patients (Up to 52 Weeks)||0
72824|NCT02240680|177309|P4|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0
72825|NCT02240680|177310|P3|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0
72826|NCT02240680|177311|P2|NOT COMPLETED|Overall Study (Up to 24 Weeks)||8
72827|NCT02240680|177312|P1|NOT COMPLETED|Overall Study (Up to 24 Weeks)||15
72828|NCT02240680|177309|P4|COMPLETED|Overall Study (Up to 24 Weeks)||0
72829|NCT02240680|177310|P3|COMPLETED|Overall Study (Up to 24 Weeks)||0
72830|NCT02240680|177311|P2|COMPLETED|Overall Study (Up to 24 Weeks)||143
72831|NCT02240680|177312|P1|COMPLETED|Overall Study (Up to 24 Weeks)||136
72832|NCT02240680|177309|P4|STARTED|Overall Study (Up to 24 Weeks)||0
72833|NCT02240680|177310|P3|STARTED|Overall Study (Up to 24 Weeks)||0
72834|NCT02240680|177311|P2|STARTED|Overall Study (Up to 24 Weeks)||151
72835|NCT02240680|177312|P1|STARTED|Overall Study (Up to 24 Weeks)||151
72836|NCT02240667|177332|P2|NOT COMPLETED|Overall Study||0
72837|NCT02240667|177333|P1|NOT COMPLETED|Overall Study||0
72838|NCT02240667|177332|P2|COMPLETED|Overall Study||650
72839|NCT02240667|177333|P1|COMPLETED|Overall Study||771
72840|NCT02240667|177332|P2|STARTED|Overall Study||650
72841|NCT02240667|177333|P1|STARTED|Overall Study||771
72842|NCT02240654|177348|P5|NOT COMPLETED|Overall Study||0
72843|NCT02240654|177349|P4|NOT COMPLETED|Overall Study||0
72844|NCT02240654|177350|P3|NOT COMPLETED|Overall Study||0
72845|NCT02240654|177351|P2|NOT COMPLETED|Overall Study||0
72846|NCT02240654|177352|P1|NOT COMPLETED|Overall Study||0
72847|NCT02240654|177348|P5|COMPLETED|Overall Study||1285
72848|NCT02240654|177349|P4|COMPLETED|Overall Study||2150
72849|NCT02240654|177350|P3|COMPLETED|Overall Study||28619
72850|NCT02240654|177351|P2|COMPLETED|Overall Study||2813
72851|NCT02240654|177352|P1|COMPLETED|Overall Study||1706
72852|NCT02240654|177348|P5|STARTED|Overall Study||1285
72853|NCT02240654|177349|P4|STARTED|Overall Study||2150
72854|NCT02240654|177350|P3|STARTED|Overall Study||28619
72855|NCT02240654|177351|P2|STARTED|Overall Study||2813
72856|NCT02240654|177352|P1|STARTED|Overall Study||1706
72857|NCT02240628|177366|P2|NOT COMPLETED|Overall Study||5
72858|NCT02240628|177367|P1|NOT COMPLETED|Overall Study||6
72859|NCT02240628|177366|P2|COMPLETED|Overall Study||33
72860|NCT02240628|177367|P1|COMPLETED|Overall Study||32
72861|NCT02240628|177366|P2|STARTED|Overall Study||38
72862|NCT02240628|177367|P1|STARTED|Overall Study||38
72863|NCT02240589|177377|P2|NOT COMPLETED|Overall Study||2
72864|NCT02240589|177378|P1|NOT COMPLETED|Overall Study||2
72865|NCT02240589|177377|P2|COMPLETED|Overall Study||4
72866|NCT02240589|177378|P1|COMPLETED|Overall Study||3
72867|NCT02240589|177377|P2|STARTED|Overall Study||6
72868|NCT02240589|177378|P1|STARTED|Overall Study||5
72869|NCT02240368|177401|P3|NOT COMPLETED|Overall Study||1
72870|NCT02240368|177402|P2|NOT COMPLETED|Overall Study||0
72871|NCT02240368|177403|P1|NOT COMPLETED|Overall Study||1
72872|NCT02240368|177401|P3|COMPLETED|Overall Study||18
72873|NCT02240368|177402|P2|COMPLETED|Overall Study||22
72874|NCT02240368|177403|P1|COMPLETED|Overall Study||8
72875|NCT02240368|177401|P3|STARTED|Overall Study||19
72876|NCT02240368|177402|P2|STARTED|Overall Study||22
72877|NCT02240368|177403|P1|STARTED|Overall Study||9
72878|NCT02240329|177420|P1|NOT COMPLETED|Overall Study||0
72879|NCT02240329|177420|P1|COMPLETED|Overall Study||4
72880|NCT02240329|177420|P1|Determination of Urge to Cough|Overall Study||4
72881|NCT02240329|177420|P1|STARTED|Overall Study||4
72882|NCT02240186|177425|P1|NOT COMPLETED|Overall Study||27
72883|NCT02240186|177425|P1|COMPLETED|Overall Study||23
72884|NCT02240186|177425|P1|STARTED|Overall Study||50
72885|NCT02240121|177435|P2|NOT COMPLETED|Overall Study||20
72886|NCT02240121|177436|P1|NOT COMPLETED|Overall Study||18
72887|NCT02240121|177435|P2|COMPLETED|Overall Study||20
72888|NCT02240121|177436|P1|COMPLETED|Overall Study||22
72889|NCT02240121|177435|P2|STARTED|Overall Study||40
72890|NCT02240121|177436|P1|STARTED|Overall Study||40
72891|NCT02240108|177464|P2|NOT COMPLETED|Overall Study||25
72892|NCT02240108|177465|P1|NOT COMPLETED|Overall Study||14
72893|NCT02240108|177464|P2|COMPLETED|Overall Study||21
72894|NCT02240108|177465|P1|COMPLETED|Overall Study||21
72895|NCT02240108|177464|P2|Intent-to-treat (ITT) Population|Overall Study||45
72896|NCT02240108|177465|P1|Intent-to-treat (ITT) Population|Overall Study||35
72897|NCT02240108|177464|P2|STARTED|Overall Study||46
72898|NCT02240108|177465|P1|STARTED|Overall Study||35
72899|NCT02240030|177494|P3|NOT COMPLETED|Overall Study||15
72900|NCT02240030|177495|P2|NOT COMPLETED|Overall Study||17
72901|NCT02240030|177496|P1|NOT COMPLETED|Overall Study||17
72902|NCT02240030|177494|P3|COMPLETED|Overall Study||97
72903|NCT02240030|177495|P2|COMPLETED|Overall Study||97
72904|NCT02240030|177496|P1|COMPLETED|Overall Study||96
72905|NCT02240030|177494|P3|STARTED|Overall Study||112
72906|NCT02240030|177495|P2|STARTED|Overall Study||114
72907|NCT02240030|177496|P1|STARTED|Overall Study||113
72908|NCT02239978|177520|P2|NOT COMPLETED|Overall Study||0
72909|NCT02239978|177521|P1|NOT COMPLETED|Overall Study||2
72910|NCT02239978|177520|P2|COMPLETED|Overall Study||12
72911|NCT02239978|177521|P1|COMPLETED|Overall Study||28
72912|NCT02239978|177520|P2|STARTED|Overall Study||12
72913|NCT02239978|177521|P1|STARTED|Overall Study||30
72914|NCT02239939|177538|P2|NOT COMPLETED|Overall Study||2
72915|NCT02239939|177539|P1|NOT COMPLETED|Overall Study||2
72916|NCT02239939|177538|P2|COMPLETED|Overall Study||15
72917|NCT02239939|177539|P1|COMPLETED|Overall Study||18
72918|NCT02239939|177538|P2|STARTED|Overall Study||17
72919|NCT02239939|177539|P1|STARTED|Overall Study||20
72920|NCT02239926|177555|P2|NOT COMPLETED|Overall Study||1
72921|NCT02239926|177556|P1|NOT COMPLETED|Overall Study||0
72922|NCT02239926|177555|P2|COMPLETED|Overall Study||1
72923|NCT02239926|177556|P1|COMPLETED|Overall Study||0
72924|NCT02239926|177555|P2|STARTED|Overall Study||2
72925|NCT02239926|177556|P1|STARTED|Overall Study||0
72926|NCT02239770|177570|P6|NOT COMPLETED|Part 2||0
72927|NCT02239770|177571|P5|NOT COMPLETED|Part 2||0
72928|NCT02239770|177572|P4|NOT COMPLETED|Part 2||0
72929|NCT02239770|177573|P3|NOT COMPLETED|Part 2||0
72930|NCT02239770|177574|P2|NOT COMPLETED|Part 2||0
72931|NCT02239770|177575|P1|NOT COMPLETED|Part 2||0
72932|NCT02239770|177570|P6|COMPLETED|Part 2||4
72933|NCT02239770|177571|P5|COMPLETED|Part 2||4
72934|NCT02239770|177572|P4|COMPLETED|Part 2||4
72935|NCT02239770|177573|P3|COMPLETED|Part 2||0
72936|NCT02239770|177574|P2|COMPLETED|Part 2||0
72937|NCT02239770|177575|P1|COMPLETED|Part 2||0
72938|NCT02239770|177570|P6|STARTED|Part 2||4
72939|NCT02239770|177571|P5|STARTED|Part 2||4
72940|NCT02239770|177572|P4|STARTED|Part 2||4
72941|NCT02239770|177573|P3|STARTED|Part 2||0
72942|NCT02239770|177574|P2|STARTED|Part 2||0
72943|NCT02239770|177575|P1|STARTED|Part 2||0
72944|NCT02239770|177570|P6|NOT COMPLETED|Part 1||0
72945|NCT02239770|177571|P5|NOT COMPLETED|Part 1||0
72946|NCT02239770|177572|P4|NOT COMPLETED|Part 1||0
72947|NCT02239770|177573|P3|NOT COMPLETED|Part 1||0
72948|NCT02239770|177574|P2|NOT COMPLETED|Part 1||0
72949|NCT02239770|177575|P1|NOT COMPLETED|Part 1||0
72950|NCT02239770|177570|P6|COMPLETED|Part 1||0
72951|NCT02239770|177571|P5|COMPLETED|Part 1||0
72952|NCT02239770|177572|P4|COMPLETED|Part 1||0
72953|NCT02239770|177573|P3|COMPLETED|Part 1||4
72954|NCT02239770|177574|P2|COMPLETED|Part 1||4
72955|NCT02239770|177575|P1|COMPLETED|Part 1||4
72956|NCT02239770|177570|P6|STARTED|Part 1||0
72957|NCT02239770|177571|P5|STARTED|Part 1||0
72958|NCT02239770|177572|P4|STARTED|Part 1||0
72959|NCT02239770|177573|P3|STARTED|Part 1||4
72960|NCT02239770|177574|P2|STARTED|Part 1||4
72961|NCT02239770|177575|P1|STARTED|Part 1||4
72962|NCT02239744|177603|P2|NOT COMPLETED|Period 2||0
72963|NCT02239744|177604|P1|NOT COMPLETED|Period 2||0
72964|NCT02239744|177603|P2|COMPLETED|Period 2||18
72965|NCT02239744|177604|P1|COMPLETED|Period 2||17
72966|NCT02239744|177603|P2|STARTED|Period 2||18
72967|NCT02239744|177604|P1|STARTED|Period 2||17
72968|NCT02239744|177603|P2|NOT COMPLETED|Period 1||0
72969|NCT02239744|177604|P1|NOT COMPLETED|Period 1||0
72970|NCT02239744|177603|P2|COMPLETED|Period 1||18
72971|NCT02239744|177604|P1|COMPLETED|Period 1||17
72972|NCT02239744|177603|P2|STARTED|Period 1||18
72973|NCT02239744|177604|P1|STARTED|Period 1||17
72974|NCT02239692|177618|P2|NOT COMPLETED|Overall Study||13
72975|NCT02239692|177619|P1|NOT COMPLETED|Overall Study||6
72976|NCT02239692|177618|P2|COMPLETED|Overall Study||118
72977|NCT02239692|177619|P1|COMPLETED|Overall Study||67
72978|NCT02239692|177618|P2|Safety Analysis Set|Overall Study||125
72979|NCT02239692|177619|P1|Safety Analysis Set|Overall Study||70
72980|NCT02239692|177618|P2|Per-protocol Analysis Set|Overall Study||120
72981|NCT02239692|177619|P1|Per-protocol Analysis Set|Overall Study||66
72982|NCT02239692|177618|P2|Intention-to-treat Analysis Set|Overall Study||131
72983|NCT02239692|177619|P1|Intention-to-treat Analysis Set|Overall Study||73
72984|NCT02239692|177618|P2|STARTED|Overall Study||131
72985|NCT02239692|177619|P1|STARTED|Overall Study||73
72986|NCT02239679|177638|P3|NOT COMPLETED|Overall Study||1
72987|NCT02239679|177639|P2|NOT COMPLETED|Overall Study||3
72988|NCT02239679|177640|P1|NOT COMPLETED|Overall Study||3
72989|NCT02239679|177638|P3|COMPLETED|Overall Study||53
72990|NCT02239679|177639|P2|COMPLETED|Overall Study||56
72991|NCT02239679|177640|P1|COMPLETED|Overall Study||50
72992|NCT02239679|177638|P3|STARTED|Overall Study||54
72993|NCT02239679|177639|P2|STARTED|Overall Study||59
72994|NCT02239679|177640|P1|STARTED|Overall Study||53
72995|NCT02239640|177852|P1|NOT COMPLETED|Overall Study||217
72996|NCT02239640|177852|P1|COMPLETED|Overall Study||767
72997|NCT02239640|177852|P1|STARTED|Overall Study||984
72998|NCT02239601|177864|P2|NOT COMPLETED|Overall Study||6
72999|NCT02239601|177865|P1|NOT COMPLETED|Overall Study||7
73000|NCT02239601|177864|P2|COMPLETED|Overall Study||26
73001|NCT02239601|177865|P1|COMPLETED|Overall Study||22
73002|NCT02239601|177864|P2|STARTED|Overall Study||32
73003|NCT02239601|177865|P1|STARTED|Overall Study||29
73004|NCT02239562|177889|P6|NOT COMPLETED|Overall Study||0
73005|NCT02239562|177890|P5|NOT COMPLETED|Overall Study||0
73006|NCT02239562|177891|P4|NOT COMPLETED|Overall Study||0
73007|NCT02239562|177892|P3|NOT COMPLETED|Overall Study||0
73008|NCT02239562|177893|P2|NOT COMPLETED|Overall Study||0
73009|NCT02239562|177894|P1|NOT COMPLETED|Overall Study||0
73010|NCT02239562|177889|P6|COMPLETED|Overall Study||6
73011|NCT02239562|177890|P5|COMPLETED|Overall Study||6
73012|NCT02239562|177891|P4|COMPLETED|Overall Study||6
73013|NCT02239562|177892|P3|COMPLETED|Overall Study||6
73014|NCT02239562|177893|P2|COMPLETED|Overall Study||6
73015|NCT02239562|177894|P1|COMPLETED|Overall Study||6
73016|NCT02239562|177889|P6|STARTED|Overall Study||6
73017|NCT02239562|177890|P5|STARTED|Overall Study||6
73018|NCT02239562|177891|P4|STARTED|Overall Study||6
73019|NCT02239562|177892|P3|STARTED|Overall Study||6
73020|NCT02239562|177893|P2|STARTED|Overall Study||6
73021|NCT02239562|177894|P1|STARTED|Overall Study||6
73022|NCT02239510|177918|P2|NOT COMPLETED|Overall Study||1
73023|NCT02239510|177919|P1|NOT COMPLETED|Overall Study||2
73024|NCT02239510|177918|P2|COMPLETED|Overall Study||3
73025|NCT02239510|177919|P1|COMPLETED|Overall Study||3
73026|NCT02239510|177918|P2|STARTED|Overall Study||4
73027|NCT02239510|177919|P1|STARTED|Overall Study||5
73028|NCT02239380|177931|P1|NOT COMPLETED|Overall Study||0
73029|NCT02239380|177931|P1|COMPLETED|Overall Study||26
73030|NCT02239380|177931|P1|STARTED|Overall Study||26
73031|NCT02239328|177941|P1|NOT COMPLETED|Overall Study||8
73032|NCT02239328|177941|P1|COMPLETED|Overall Study||174
73033|NCT02239328|177941|P1|STARTED|Overall Study||182
73034|NCT02239289|177945|P1|NOT COMPLETED|Overall Study||0
73035|NCT02239289|177945|P1|COMPLETED|Overall Study||21
73036|NCT02239289|177945|P1|STARTED|Overall Study||21
73037|NCT02239120|177966|P2|NOT COMPLETED|Overall Study||72
73038|NCT02239120|177967|P1|NOT COMPLETED|Overall Study||75
73039|NCT02239120|177966|P2|COMPLETED|Overall Study||2623
73040|NCT02239120|177967|P1|COMPLETED|Overall Study||2620
73041|NCT02239120|177966|P2|STARTED|Overall Study||2695
73042|NCT02239120|177967|P1|STARTED|Overall Study||2695
73043|NCT02239094|177991|P1|NOT COMPLETED|Overall Study||2
73044|NCT02239094|177991|P1|COMPLETED|Overall Study||18
73045|NCT02239094|177991|P1|STARTED|Overall Study||20
73046|NCT02238977|177998|P2|NOT COMPLETED|Overall Study||0
73047|NCT02238977|177999|P1|NOT COMPLETED|Overall Study||0
73048|NCT02238977|177998|P2|COMPLETED|Overall Study||1
73049|NCT02238977|177999|P1|COMPLETED|Overall Study||0
73050|NCT02238977|177998|P2|STARTED|Overall Study||1
73051|NCT02238977|177999|P1|STARTED|Overall Study||0
73052|NCT02238925|178005|P1|NOT COMPLETED|Overall Study||25
73053|NCT02238925|178005|P1|COMPLETED|Overall Study||1
73054|NCT02238925|178005|P1|STARTED|Overall Study||26
73055|NCT02238782|178013|P1|NOT COMPLETED|Overall Study||0
73056|NCT02238782|178013|P1|COMPLETED|Overall Study||12
73057|NCT02238782|178013|P1|Subjects Treated|Overall Study||12
73058|NCT02238782|178013|P1|STARTED|Overall Study||12
73059|NCT02238483|178019|P2|NOT COMPLETED|Overall Study||14
73060|NCT02238483|178020|P1|NOT COMPLETED|Overall Study||15
73061|NCT02238483|178019|P2|COMPLETED|Overall Study||91
73062|NCT02238483|178020|P1|COMPLETED|Overall Study||93
73063|NCT02238483|178019|P2|STARTED|Overall Study||105
73064|NCT02238483|178020|P1|STARTED|Overall Study||108
73065|NCT02238379|178058|P2|NOT COMPLETED|Overall Study||0
73066|NCT02238379|178059|P1|NOT COMPLETED|Overall Study||1
73067|NCT02238379|178058|P2|COMPLETED|Overall Study||14
73068|NCT02238379|178059|P1|COMPLETED|Overall Study||11
73069|NCT02238379|178058|P2|STARTED|Overall Study||14
73070|NCT02238379|178059|P1|STARTED|Overall Study||12
73071|NCT02238080|178085|P1|NOT COMPLETED|Overall Study||25
73072|NCT02238080|178085|P1|COMPLETED|Overall Study||172
73073|NCT02238080|178085|P1|STARTED|Overall Study||197
73074|NCT02238067|178099|P1|NOT COMPLETED|Overall Study||45
73075|NCT02238067|178099|P1|COMPLETED|Overall Study||151
73076|NCT02238067|178099|P1|STARTED|Overall Study||196
73077|NCT02238028|178122|P2|NOT COMPLETED|Overall Study||2
73078|NCT02238028|178123|P1|NOT COMPLETED|Overall Study||2
73079|NCT02238028|178122|P2|COMPLETED|Overall Study||12
73080|NCT02238028|178123|P1|COMPLETED|Overall Study||12
73081|NCT02238028|178122|P2|STARTED|Overall Study||14
73082|NCT02238028|178123|P1|STARTED|Overall Study||14
73083|NCT02237950|178144|P2|NOT COMPLETED|Overall Study||48
73084|NCT02237950|178145|P1|NOT COMPLETED|Overall Study||48
73085|NCT02237950|178144|P2|COMPLETED|Overall Study||243
73086|NCT02237950|178145|P1|COMPLETED|Overall Study||247
73087|NCT02237950|178144|P2|STARTED|Overall Study||291
73088|NCT02237950|178145|P1|STARTED|Overall Study||295
73089|NCT02237911|178170|P3|NOT COMPLETED|Overall Study||3
73090|NCT02237911|178171|P2|NOT COMPLETED|Overall Study||8
73091|NCT02237911|178172|P1|NOT COMPLETED|Overall Study||7
73092|NCT02237911|178170|P3|COMPLETED|Overall Study||45
73093|NCT02237911|178171|P2|COMPLETED|Overall Study||88
73094|NCT02237911|178172|P1|COMPLETED|Overall Study||89
73095|NCT02237911|178170|P3|6 Months|Overall Study||45
73096|NCT02237911|178171|P2|6 Months|Overall Study||88
73097|NCT02237911|178172|P1|6 Months|Overall Study||89
73098|NCT02237911|178170|P3|3 Months|Overall Study||44
73099|NCT02237911|178171|P2|3 Months|Overall Study||87
73100|NCT02237911|178172|P1|3 Months|Overall Study||90
73101|NCT02237911|178170|P3|STARTED|Overall Study||48
73102|NCT02237911|178171|P2|STARTED|Overall Study||96
73103|NCT02237911|178172|P1|STARTED|Overall Study||96
73104|NCT02237118|178188|P2|NOT COMPLETED|Overall Study||1
73105|NCT02237118|178189|P1|NOT COMPLETED|Overall Study||1
73106|NCT02237118|178188|P2|COMPLETED|Overall Study||62
73107|NCT02237118|178189|P1|COMPLETED|Overall Study||59
73108|NCT02237118|178188|P2|STARTED|Overall Study||63
73109|NCT02237118|178189|P1|STARTED|Overall Study||60
73110|NCT02237092|178203|P1|NOT COMPLETED|Overall Study||0
73111|NCT02237092|178203|P1|COMPLETED|Overall Study||196
73112|NCT02237092|178203|P1|STARTED|Overall Study||196
73113|NCT02236767|178220|P1|NOT COMPLETED|Overall Study||0
73114|NCT02236767|178220|P1|COMPLETED|Overall Study||1
73115|NCT02236767|178220|P1|STARTED|Overall Study||1
73116|NCT02236611|178226|P2|NOT COMPLETED|Overall Study||34
73117|NCT02236611|178227|P1|NOT COMPLETED|Overall Study||26
73118|NCT02236611|178226|P2|COMPLETED|Overall Study||484
73119|NCT02236611|178227|P1|COMPLETED|Overall Study||490
73120|NCT02236611|178226|P2|STARTED|Overall Study||518
73121|NCT02236611|178227|P1|STARTED|Overall Study||516
73122|NCT02236598|178235|P2|NOT COMPLETED|Overall Study||2
73123|NCT02236598|178236|P1|NOT COMPLETED|Overall Study||0
73124|NCT02236598|178235|P2|COMPLETED|Overall Study||12
73125|NCT02236598|178236|P1|COMPLETED|Overall Study||15
73126|NCT02236598|178235|P2|STARTED|Overall Study||14
73127|NCT02236598|178236|P1|STARTED|Overall Study||15
73128|NCT02236559|178250|P2|NOT COMPLETED|Overall Study||12
73129|NCT02236559|178251|P1|NOT COMPLETED|Overall Study||12
73130|NCT02236559|178250|P2|COMPLETED|Overall Study||104
73131|NCT02236559|178251|P1|COMPLETED|Overall Study||100
73132|NCT02236559|178250|P2|STARTED|Overall Study||116
73133|NCT02236559|178251|P1|STARTED|Overall Study||112
73134|NCT02236546|178277|P1|NOT COMPLETED|Overall Study||0
73135|NCT02236546|178277|P1|COMPLETED|Overall Study||3
73136|NCT02236546|178277|P1|STARTED|Overall Study||3
73137|NCT02236520|178288|P4|NOT COMPLETED|Overall Study||1
73138|NCT02236520|178289|P3|NOT COMPLETED|Overall Study||0
73139|NCT02236520|178290|P2|NOT COMPLETED|Overall Study||5
73140|NCT02236520|178291|P1|NOT COMPLETED|Overall Study||2
73141|NCT02236520|178288|P4|COMPLETED|Overall Study||14
73142|NCT02236520|178289|P3|COMPLETED|Overall Study||15
73143|NCT02236520|178290|P2|COMPLETED|Overall Study||8
73144|NCT02236520|178291|P1|COMPLETED|Overall Study||14
73145|NCT02236520|178288|P4|STARTED|Overall Study||15
73146|NCT02236520|178289|P3|STARTED|Overall Study||15
73147|NCT02236520|178290|P2|STARTED|Overall Study||13
73148|NCT02236520|178291|P1|STARTED|Overall Study||16
73149|NCT02236338|178303|P2|NOT COMPLETED|Overall Study||0
73150|NCT02236338|178304|P1|NOT COMPLETED|Overall Study||0
73151|NCT02236338|178303|P2|COMPLETED|Overall Study||100
73152|NCT02236338|178304|P1|COMPLETED|Overall Study||100
73153|NCT02236338|178303|P2|STARTED|Overall Study||100
73154|NCT02236338|178304|P1|STARTED|Overall Study||100
73155|NCT02236130|178318|P2|NOT COMPLETED|Overall Study||12
73156|NCT02236130|178319|P1|NOT COMPLETED|Overall Study||7
73157|NCT02236130|178318|P2|COMPLETED|Overall Study||15
73158|NCT02236130|178319|P1|COMPLETED|Overall Study||15
73159|NCT02236130|178318|P2|STARTED|Overall Study||27
73160|NCT02236130|178319|P1|STARTED|Overall Study||22
73161|NCT02235987|178327|P1|NOT COMPLETED|Overall Study||1
73162|NCT02235987|178327|P1|COMPLETED|Overall Study||19
73163|NCT02235987|178327|P1|Received 1800 µg DG3173|Overall Study||19
73164|NCT02235987|178327|P1|Received 900 µg DG3173|Overall Study||19
73165|NCT02235987|178327|P1|Received 300 µg DG3173|Overall Study||20
73166|NCT02235987|178327|P1|Received 100 µg DG3173|Overall Study||20
73167|NCT02235987|178327|P1|Received Octreotide|Overall Study||20
73168|NCT02235987|178327|P1|STARTED|Overall Study||20
73169|NCT02235870|178342|P2|NOT COMPLETED|Overall Study||61
73170|NCT02235870|178343|P1|NOT COMPLETED|Overall Study||38
73171|NCT02235870|178342|P2|COMPLETED|Overall Study||128
73172|NCT02235870|178343|P1|COMPLETED|Overall Study||160
73173|NCT02235870|178342|P2|Crossover (Week 24)|Overall Study||138
73174|NCT02235870|178343|P1|Crossover (Week 24)|Overall Study||170
73175|NCT02235870|178342|P2|Completed Phase I (Week 24)|Overall Study||179
73176|NCT02235870|178343|P1|Completed Phase I (Week 24)|Overall Study||182
73177|NCT02235870|178342|P2|STARTED|Overall Study||189
73178|NCT02235870|178343|P1|STARTED|Overall Study||198
73179|NCT02235831|178352|P6|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
73180|NCT02235831|178353|P5|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
73181|NCT02235831|178354|P4|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
73182|NCT02235831|178355|P3|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
73183|NCT02235831|178356|P2|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
73184|NCT02235831|178357|P1|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
73185|NCT02235831|178352|P6|COMPLETED|Period 3, Third 5 Days of Wear||4
73186|NCT02235831|178353|P5|COMPLETED|Period 3, Third 5 Days of Wear||4
73187|NCT02235831|178354|P4|COMPLETED|Period 3, Third 5 Days of Wear||4
73188|NCT02235831|178355|P3|COMPLETED|Period 3, Third 5 Days of Wear||4
73189|NCT02235831|178356|P2|COMPLETED|Period 3, Third 5 Days of Wear||4
73190|NCT02235831|178357|P1|COMPLETED|Period 3, Third 5 Days of Wear||4
73191|NCT02235831|178352|P6|STARTED|Period 3, Third 5 Days of Wear||4
73192|NCT02235831|178353|P5|STARTED|Period 3, Third 5 Days of Wear||4
73193|NCT02235831|178354|P4|STARTED|Period 3, Third 5 Days of Wear||4
73194|NCT02235831|178355|P3|STARTED|Period 3, Third 5 Days of Wear||4
73195|NCT02235831|178356|P2|STARTED|Period 3, Third 5 Days of Wear||4
73196|NCT02235831|178357|P1|STARTED|Period 3, Third 5 Days of Wear||4
73197|NCT02235831|178352|P6|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
73198|NCT02235831|178353|P5|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
73199|NCT02235831|178354|P4|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
73200|NCT02235831|178355|P3|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
73201|NCT02235831|178356|P2|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
73202|NCT02235831|178357|P1|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
73203|NCT02235831|178352|P6|COMPLETED|Period 2, Second 5 Days of Wear||4
73204|NCT02235831|178353|P5|COMPLETED|Period 2, Second 5 Days of Wear||4
73205|NCT02235831|178354|P4|COMPLETED|Period 2, Second 5 Days of Wear||4
73206|NCT02235831|178355|P3|COMPLETED|Period 2, Second 5 Days of Wear||4
73207|NCT02235831|178356|P2|COMPLETED|Period 2, Second 5 Days of Wear||4
73208|NCT02235831|178357|P1|COMPLETED|Period 2, Second 5 Days of Wear||4
73209|NCT02235831|178352|P6|STARTED|Period 2, Second 5 Days of Wear||4
73210|NCT02235831|178353|P5|STARTED|Period 2, Second 5 Days of Wear||4
73211|NCT02235831|178354|P4|STARTED|Period 2, Second 5 Days of Wear||4
73212|NCT02235831|178355|P3|STARTED|Period 2, Second 5 Days of Wear||4
73213|NCT02235831|178356|P2|STARTED|Period 2, Second 5 Days of Wear||4
73214|NCT02235831|178357|P1|STARTED|Period 2, Second 5 Days of Wear||4
73215|NCT02235831|178352|P6|NOT COMPLETED|Period 1, First 5 Days of Wear||0
73216|NCT02235831|178353|P5|NOT COMPLETED|Period 1, First 5 Days of Wear||0
73217|NCT02235831|178354|P4|NOT COMPLETED|Period 1, First 5 Days of Wear||0
73218|NCT02235831|178355|P3|NOT COMPLETED|Period 1, First 5 Days of Wear||0
73219|NCT02235831|178356|P2|NOT COMPLETED|Period 1, First 5 Days of Wear||0
73220|NCT02235831|178357|P1|NOT COMPLETED|Period 1, First 5 Days of Wear||0
73221|NCT02235831|178352|P6|COMPLETED|Period 1, First 5 Days of Wear||4
73222|NCT02235831|178353|P5|COMPLETED|Period 1, First 5 Days of Wear||4
73223|NCT02235831|178354|P4|COMPLETED|Period 1, First 5 Days of Wear||4
73224|NCT02235831|178355|P3|COMPLETED|Period 1, First 5 Days of Wear||4
73225|NCT02235831|178356|P2|COMPLETED|Period 1, First 5 Days of Wear||4
73226|NCT02235831|178357|P1|COMPLETED|Period 1, First 5 Days of Wear||4
73227|NCT02235831|178352|P6|STARTED|Period 1, First 5 Days of Wear||4
73228|NCT02235831|178353|P5|STARTED|Period 1, First 5 Days of Wear||4
73229|NCT02235831|178354|P4|STARTED|Period 1, First 5 Days of Wear||4
73230|NCT02235831|178355|P3|STARTED|Period 1, First 5 Days of Wear||4
73231|NCT02235831|178356|P2|STARTED|Period 1, First 5 Days of Wear||4
73232|NCT02235831|178357|P1|STARTED|Period 1, First 5 Days of Wear||4
73233|NCT02235493|178364|P1|NOT COMPLETED|Overall Study||0
73234|NCT02235493|178364|P1|COMPLETED|Overall Study||6
73235|NCT02235493|178364|P1|STARTED|Overall Study||6
73236|NCT02235454|178369|P1|NOT COMPLETED|Overall Study||2
73237|NCT02235454|178369|P1|COMPLETED|Overall Study||55
73238|NCT02235454|178369|P1|STARTED|Overall Study||57
73239|NCT02235311|178375|P2|NOT COMPLETED|Overall Study||2
73240|NCT02235311|178376|P1|NOT COMPLETED|Overall Study||0
73241|NCT02235311|178375|P2|COMPLETED|Overall Study||0
73242|NCT02235311|178376|P1|COMPLETED|Overall Study||1
73243|NCT02235311|178375|P2|STARTED|Overall Study||2
73244|NCT02235311|178376|P1|STARTED|Overall Study||1
73245|NCT02235285|178388|P1|NOT COMPLETED|Overall Study||13
73246|NCT02235285|178388|P1|COMPLETED|Overall Study||149
73247|NCT02235285|178388|P1|STARTED|Overall Study||162
73248|NCT02235077|178394|P2|NOT COMPLETED|Overall Study||19
73249|NCT02235077|178395|P1|NOT COMPLETED|Overall Study||18
73250|NCT02235077|178394|P2|COMPLETED|Overall Study||159
73251|NCT02235077|178395|P1|COMPLETED|Overall Study||164
73252|NCT02235077|178394|P2|STARTED|Overall Study||178
73253|NCT02235077|178395|P1|STARTED|Overall Study||182
73254|NCT02235064|178423|P2|NOT COMPLETED|Overall Study||0
73255|NCT02235064|178424|P1|NOT COMPLETED|Overall Study||0
73256|NCT02235064|178423|P2|COMPLETED|Overall Study||1
73257|NCT02235064|178424|P1|COMPLETED|Overall Study||1
73258|NCT02235064|178423|P2|STARTED|Overall Study||1
73259|NCT02235064|178424|P1|STARTED|Overall Study||1
73260|NCT02234752|178450|P1|NOT COMPLETED|Overall Study||1
73261|NCT02234752|178450|P1|COMPLETED|Overall Study||2
73262|NCT02234752|178450|P1|STARTED|Overall Study||3
73263|NCT02234687|178464|P3|NOT COMPLETED|Overall Study||4
73264|NCT02234687|178465|P2|NOT COMPLETED|Overall Study||4
73265|NCT02234687|178466|P1|NOT COMPLETED|Overall Study||6
73266|NCT02234687|178464|P3|COMPLETED|Overall Study||0
73267|NCT02234687|178465|P2|COMPLETED|Overall Study||0
73268|NCT02234687|178466|P1|COMPLETED|Overall Study|Study Terminated. No outcome measures were analyzed|0
73269|NCT02234687|178464|P3|STARTED|Overall Study||4
73270|NCT02234687|178465|P2|STARTED|Overall Study||4
73271|NCT02234687|178466|P1|STARTED|Overall Study|Study Terminated. No outcome measures were analyzed|6
73272|NCT02234570|178482|P8|NOT COMPLETED|Overall Study||0
73273|NCT02234570|178483|P7|NOT COMPLETED|Overall Study||0
73274|NCT02234570|178484|P6|NOT COMPLETED|Overall Study||0
73275|NCT02234570|178485|P5|NOT COMPLETED|Overall Study||0
73276|NCT02234570|178486|P4|NOT COMPLETED|Overall Study||0
73277|NCT02234570|178487|P3|NOT COMPLETED|Overall Study||0
73278|NCT02234570|178488|P2|NOT COMPLETED|Overall Study||0
73279|NCT02234570|178489|P1|NOT COMPLETED|Overall Study||0
73280|NCT02234570|178482|P8|COMPLETED|Overall Study||14
73281|NCT02234570|178483|P7|COMPLETED|Overall Study||8
73282|NCT02234570|178484|P6|COMPLETED|Overall Study||8
73283|NCT02234570|178485|P5|COMPLETED|Overall Study||8
73284|NCT02234570|178486|P4|COMPLETED|Overall Study||8
73285|NCT02234570|178487|P3|COMPLETED|Overall Study||8
73286|NCT02234570|178488|P2|COMPLETED|Overall Study||8
73287|NCT02234570|178489|P1|COMPLETED|Overall Study||8
73288|NCT02234570|178482|P8|STARTED|Overall Study||14
73289|NCT02234570|178483|P7|STARTED|Overall Study||8
73290|NCT02234570|178484|P6|STARTED|Overall Study||8
73291|NCT02234570|178485|P5|STARTED|Overall Study||8
73292|NCT02234570|178486|P4|STARTED|Overall Study||8
73293|NCT02234570|178487|P3|STARTED|Overall Study||8
73294|NCT02234570|178488|P2|STARTED|Overall Study||8
73295|NCT02234570|178489|P1|STARTED|Overall Study||8
73296|NCT02234479|178565|P2|NOT COMPLETED|Overall Study||3
73297|NCT02234479|178566|P1|NOT COMPLETED|Overall Study||1
73298|NCT02234479|178565|P2|COMPLETED|Overall Study||15
73299|NCT02234479|178566|P1|COMPLETED|Overall Study||15
73300|NCT02234479|178565|P2|STARTED|Overall Study||18
73301|NCT02234479|178566|P1|STARTED|Overall Study||16
73302|NCT02234427|178572|P1|NOT COMPLETED|Overall Study||1
73303|NCT02234427|178572|P1|COMPLETED|Overall Study|One individual withdrew after first visit|33
73304|NCT02234427|178572|P1|STARTED|Overall Study||34
73305|NCT02234362|178576|P1|NOT COMPLETED|Overall Study||26
73306|NCT02234362|178576|P1|COMPLETED|Overall Study||21
73307|NCT02234362|178576|P1|Received at Least One Dose of Medication|Overall Study||27
73308|NCT02234362|178576|P1|STARTED|Overall Study||47
73309|NCT02234284|178595|P2|NOT COMPLETED|Overall Study||9
73310|NCT02234284|178596|P1|NOT COMPLETED|Overall Study||25
73311|NCT02234284|178595|P2|COMPLETED|Overall Study||83
73312|NCT02234284|178596|P1|COMPLETED|Overall Study||75
73313|NCT02234284|178595|P2|STARTED|Overall Study||92
73314|NCT02234284|178596|P1|STARTED|Overall Study||100
73315|NCT02234180|178644|P2|NOT COMPLETED|Overall Study||0
73316|NCT02234180|178645|P1|NOT COMPLETED|Overall Study||0
73317|NCT02234180|178644|P2|COMPLETED|Overall Study||1
73318|NCT02234180|178645|P1|COMPLETED|Overall Study||2
73319|NCT02234180|178644|P2|STARTED|Overall Study||1
73320|NCT02234180|178645|P1|STARTED|Overall Study||2
73321|NCT02234141|178655|P7|NOT COMPLETED|Long-Term Treatment Period||10
73322|NCT02234141|178656|P6|NOT COMPLETED|Long-Term Treatment Period||12
73323|NCT02234141|178657|P5|NOT COMPLETED|Long-Term Treatment Period||10
73324|NCT02234141|178658|P4|NOT COMPLETED|Long-Term Treatment Period||0
73325|NCT02234141|178659|P3|NOT COMPLETED|Long-Term Treatment Period||33
73326|NCT02234141|178660|P2|NOT COMPLETED|Long-Term Treatment Period||31
73327|NCT02234141|178661|P1|NOT COMPLETED|Long-Term Treatment Period||33
73328|NCT02234141|178655|P7|COMPLETED|Long-Term Treatment Period||0
73329|NCT02234141|178656|P6|COMPLETED|Long-Term Treatment Period||0
73330|NCT02234141|178657|P5|COMPLETED|Long-Term Treatment Period||0
73331|NCT02234141|178658|P4|COMPLETED|Long-Term Treatment Period||0
73332|NCT02234141|178659|P3|COMPLETED|Long-Term Treatment Period||0
73333|NCT02234141|178660|P2|COMPLETED|Long-Term Treatment Period||0
73334|NCT02234141|178661|P1|COMPLETED|Long-Term Treatment Period||0
73335|NCT02234141|178655|P7|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|10
73336|NCT02234141|178656|P6|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|12
73337|NCT02234141|178657|P5|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|10
73338|NCT02234141|178658|P4|STARTED|Long-Term Treatment Period|Participants were rerandomized to receive selonsertib during the Long-Term Treatment Phase.|0
73339|NCT02234141|178659|P3|STARTED|Long-Term Treatment Period|2 participants who completed Period 1 did not continue into the Long-Term Treatment Phase.|33
73340|NCT02234141|178660|P2|STARTED|Long-Term Treatment Period|1 participant who completed the Period 1 did not continue into the Long-Term Treatment Phase.|31
73341|NCT02234141|178661|P1|STARTED|Long-Term Treatment Period|2 participants who completed Period 1 did not continue into the Long-Term Treatment Phase.|33
73342|NCT02234141|178655|P7|NOT COMPLETED|Treatment Period (24 Weeks)||0
73343|NCT02234141|178656|P6|NOT COMPLETED|Treatment Period (24 Weeks)||0
73344|NCT02234141|178657|P5|NOT COMPLETED|Treatment Period (24 Weeks)||0
73345|NCT02234141|178658|P4|NOT COMPLETED|Treatment Period (24 Weeks)||5
73346|NCT02234141|178659|P3|NOT COMPLETED|Treatment Period (24 Weeks)||2
73347|NCT02234141|178660|P2|NOT COMPLETED|Treatment Period (24 Weeks)||6
73348|NCT02234141|178661|P1|NOT COMPLETED|Treatment Period (24 Weeks)||4
73349|NCT02234141|178655|P7|COMPLETED|Treatment Period (24 Weeks)||0
73350|NCT02234141|178656|P6|COMPLETED|Treatment Period (24 Weeks)||0
73351|NCT02234141|178657|P5|COMPLETED|Treatment Period (24 Weeks)||0
73352|NCT02234141|178658|P4|COMPLETED|Treatment Period (24 Weeks)||32
73353|NCT02234141|178659|P3|COMPLETED|Treatment Period (24 Weeks)||35
73354|NCT02234141|178660|P2|COMPLETED|Treatment Period (24 Weeks)||32
73355|NCT02234141|178661|P1|COMPLETED|Treatment Period (24 Weeks)||35
73356|NCT02234141|178655|P7|STARTED|Treatment Period (24 Weeks)||0
73357|NCT02234141|178656|P6|STARTED|Treatment Period (24 Weeks)||0
73358|NCT02234141|178657|P5|STARTED|Treatment Period (24 Weeks)||0
73359|NCT02234141|178658|P4|STARTED|Treatment Period (24 Weeks)||37
73360|NCT02234141|178659|P3|STARTED|Treatment Period (24 Weeks)||37
73361|NCT02234141|178660|P2|STARTED|Treatment Period (24 Weeks)||38
73362|NCT02234141|178661|P1|STARTED|Treatment Period (24 Weeks)||39
73363|NCT02234115|178743|P1|NOT COMPLETED|Overall Study||15
73364|NCT02234115|178743|P1|COMPLETED|Overall Study||122
73365|NCT02234115|178743|P1|PK Subgroup|Overall Study||31
73366|NCT02234115|178743|P1|PP|Overall Study||124
73367|NCT02234115|178743|P1|ITT|Overall Study||137
73368|NCT02234115|178743|P1|STARTED|Overall Study||137
73369|NCT02234011|178748|P1|NOT COMPLETED|Overall Study||0
73370|NCT02234011|178748|P1|COMPLETED|Overall Study||0
73371|NCT02234011|178748|P1|STARTED|Overall Study||0
73372|NCT02233998|178755|P3|NOT COMPLETED|Overall Study||0
73373|NCT02233998|178756|P2|NOT COMPLETED|Overall Study||0
73374|NCT02233998|178757|P1|NOT COMPLETED|Overall Study||0
73375|NCT02233998|178755|P3|COMPLETED|Overall Study||53
73376|NCT02233998|178756|P2|COMPLETED|Overall Study||52
73377|NCT02233998|178757|P1|COMPLETED|Overall Study||53
73378|NCT02233998|178755|P3|STARTED|Overall Study||53
73379|NCT02233998|178756|P2|STARTED|Overall Study||52
73380|NCT02233998|178757|P1|STARTED|Overall Study||53
73381|NCT02233985|178791|P2|NOT COMPLETED|Overall Study||0
73382|NCT02233985|178792|P1|NOT COMPLETED|Overall Study||0
73383|NCT02233985|178791|P2|COMPLETED|Overall Study||31
73384|NCT02233985|178792|P1|COMPLETED|Overall Study||33
73385|NCT02233985|178791|P2|STARTED|Overall Study||31
73386|NCT02233985|178792|P1|STARTED|Overall Study||33
73387|NCT02233842|178800|P1|NOT COMPLETED|Questionnaire 3 Version 2||0
73388|NCT02233842|178800|P1|COMPLETED|Questionnaire 3 Version 2||5
73389|NCT02233842|178800|P1|STARTED|Questionnaire 3 Version 2||5
73390|NCT02233842|178800|P1|NOT COMPLETED|Questionnaire 3 Version 1||0
73391|NCT02233842|178800|P1|COMPLETED|Questionnaire 3 Version 1||5
73392|NCT02233842|178800|P1|STARTED|Questionnaire 3 Version 1||5
73393|NCT02233842|178800|P1|NOT COMPLETED|Questionnaire 2 Version 2||0
73394|NCT02233842|178800|P1|COMPLETED|Questionnaire 2 Version 2||5
73395|NCT02233842|178800|P1|STARTED|Questionnaire 2 Version 2||5
73396|NCT02233842|178800|P1|NOT COMPLETED|Questionnaire 2 Version 1||0
73397|NCT02233842|178800|P1|COMPLETED|Questionnaire 2 Version 1||5
73398|NCT02233842|178800|P1|STARTED|Questionnaire 2 Version 1||5
73399|NCT02233842|178800|P1|NOT COMPLETED|Questionnaire 1 Version 2||0
73400|NCT02233842|178800|P1|COMPLETED|Questionnaire 1 Version 2||5
73401|NCT02233842|178800|P1|STARTED|Questionnaire 1 Version 2||5
73402|NCT02233842|178800|P1|NOT COMPLETED|Questionnaire 1 Version 1||0
73403|NCT02233842|178800|P1|COMPLETED|Questionnaire 1 Version 1||5
73404|NCT02233842|178800|P1|STARTED|Questionnaire 1 Version 1||5
73405|NCT02233803|178807|P2|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
73406|NCT02233803|178808|P1|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
73407|NCT02233803|178807|P2|COMPLETED|Treatment Period 2 (4-Wks)||91
73408|NCT02233803|178808|P1|COMPLETED|Treatment Period 2 (4-Wks)||93
73409|NCT02233803|178807|P2|STARTED|Treatment Period 2 (4-Wks)||93
73410|NCT02233803|178808|P1|STARTED|Treatment Period 2 (4-Wks)||95
73411|NCT02233803|178807|P2|NOT COMPLETED|Washout Period (4-Wks)||2
73412|NCT02233803|178808|P1|NOT COMPLETED|Washout Period (4-Wks)||2
73413|NCT02233803|178807|P2|COMPLETED|Washout Period (4-Wks)||93
73414|NCT02233803|178808|P1|COMPLETED|Washout Period (4-Wks)||95
73415|NCT02233803|178807|P2|STARTED|Washout Period (4-Wks)||95
73416|NCT02233803|178808|P1|STARTED|Washout Period (4-Wks)||97
73417|NCT02233803|178807|P2|NOT COMPLETED|Treatment Period 1 (4-Wks)||4
73418|NCT02233803|178808|P1|NOT COMPLETED|Treatment Period 1 (4-Wks)||3
73419|NCT02233803|178807|P2|COMPLETED|Treatment Period 1 (4-Wks)||95
73420|NCT02233803|178808|P1|COMPLETED|Treatment Period 1 (4-Wks)||97
73421|NCT02233803|178807|P2|STARTED|Treatment Period 1 (4-Wks)||99
73422|NCT02233803|178808|P1|STARTED|Treatment Period 1 (4-Wks)||100
73423|NCT02233751|178820|P2|NOT COMPLETED|Overall Study||0
73424|NCT02233751|178821|P1|NOT COMPLETED|Overall Study||0
73425|NCT02233751|178820|P2|COMPLETED|Overall Study||6
73426|NCT02233751|178821|P1|COMPLETED|Overall Study||6
73427|NCT02233751|178820|P2|STARTED|Overall Study||6
73428|NCT02233751|178821|P1|STARTED|Overall Study||6
73429|NCT02233647|178839|P1|NOT COMPLETED|Overall Study||1
73430|NCT02233647|178839|P1|COMPLETED|Overall Study||10
73431|NCT02233647|178839|P1|80 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
73432|NCT02233647|178839|P1|40 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
73433|NCT02233647|178839|P1|20 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
73434|NCT02233647|178839|P1|10 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
73435|NCT02233647|178839|P1|0 mg Cocaine With 210 mg Phendimetrazine|Overall Study||10
73436|NCT02233647|178839|P1|80 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
73437|NCT02233647|178839|P1|40 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
73438|NCT02233647|178839|P1|20 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
73439|NCT02233647|178839|P1|10 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
73440|NCT02233647|178839|P1|0 mg Cocaine With 140 mg Phendimetrazine|Overall Study||10
73441|NCT02233647|178839|P1|80 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
73442|NCT02233647|178839|P1|40 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
73443|NCT02233647|178839|P1|20 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
73444|NCT02233647|178839|P1|10 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
73445|NCT02233647|178839|P1|0 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
73446|NCT02233647|178839|P1|80 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
73447|NCT02233647|178839|P1|40 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
73448|NCT02233647|178839|P1|20 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
73449|NCT02233647|178839|P1|10 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
73450|NCT02233647|178839|P1|0 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
73451|NCT02233647|178839|P1|STARTED|Overall Study||11
73452|NCT02233543|178868|P2|NOT COMPLETED|Period 2||1
73453|NCT02233543|178869|P1|NOT COMPLETED|Period 2||2
73454|NCT02233543|178868|P2|COMPLETED|Period 2||12
73455|NCT02233543|178869|P1|COMPLETED|Period 2|1 participant erroneously received QVA149 during both periods.|17
73456|NCT02233543|178868|P2|STARTED|Period 2||13
73457|NCT02233543|178869|P1|STARTED|Period 2||19
73458|NCT02233543|178868|P2|NOT COMPLETED|Period 1||3
73459|NCT02233543|178869|P1|NOT COMPLETED|Period 1||3
73460|NCT02233543|178868|P2|COMPLETED|Period 1||13
73461|NCT02233543|178869|P1|COMPLETED|Period 1||19
73462|NCT02233543|178868|P2|STARTED|Period 1||16
73463|NCT02233543|178869|P1|STARTED|Period 1||22
73464|NCT02233517|178879|P2|NOT COMPLETED|Overall Study||4
73465|NCT02233517|178880|P1|NOT COMPLETED|Overall Study||7
73466|NCT02233517|178879|P2|COMPLETED|Overall Study||13
73467|NCT02233517|178880|P1|COMPLETED|Overall Study||12
73468|NCT02233517|178879|P2|STARTED|Overall Study||17
73469|NCT02233517|178880|P1|STARTED|Overall Study||19
73470|NCT02233478|178906|P6|NOT COMPLETED|Third Intervention (1 Day)||0
73471|NCT02233478|178907|P5|NOT COMPLETED|Third Intervention (1 Day)||0
73472|NCT02233478|178908|P4|NOT COMPLETED|Third Intervention (1 Day)||0
73473|NCT02233478|178909|P3|NOT COMPLETED|Third Intervention (1 Day)||0
73474|NCT02233478|178910|P2|NOT COMPLETED|Third Intervention (1 Day)||0
73475|NCT02233478|178911|P1|NOT COMPLETED|Third Intervention (1 Day)||0
73476|NCT02233478|178906|P6|COMPLETED|Third Intervention (1 Day)||3
73477|NCT02233478|178907|P5|COMPLETED|Third Intervention (1 Day)||3
73478|NCT02233478|178908|P4|COMPLETED|Third Intervention (1 Day)||3
73479|NCT02233478|178909|P3|COMPLETED|Third Intervention (1 Day)||3
73480|NCT02233478|178910|P2|COMPLETED|Third Intervention (1 Day)||3
73481|NCT02233478|178911|P1|COMPLETED|Third Intervention (1 Day)||3
73482|NCT02233478|178906|P6|STARTED|Third Intervention (1 Day)||3
73483|NCT02233478|178907|P5|STARTED|Third Intervention (1 Day)||3
73484|NCT02233478|178908|P4|STARTED|Third Intervention (1 Day)||3
73485|NCT02233478|178909|P3|STARTED|Third Intervention (1 Day)||3
73486|NCT02233478|178910|P2|STARTED|Third Intervention (1 Day)||3
73487|NCT02233478|178911|P1|STARTED|Third Intervention (1 Day)||3
73488|NCT02233478|178906|P6|NOT COMPLETED|Washout (7 Days)||0
73489|NCT02233478|178907|P5|NOT COMPLETED|Washout (7 Days)||0
73490|NCT02233478|178908|P4|NOT COMPLETED|Washout (7 Days)||0
73491|NCT02233478|178909|P3|NOT COMPLETED|Washout (7 Days)||0
73492|NCT02233478|178910|P2|NOT COMPLETED|Washout (7 Days)||0
73493|NCT02233478|178911|P1|NOT COMPLETED|Washout (7 Days)||0
73494|NCT02233478|178906|P6|COMPLETED|Washout (7 Days)||3
73495|NCT02233478|178907|P5|COMPLETED|Washout (7 Days)||3
73496|NCT02233478|178908|P4|COMPLETED|Washout (7 Days)||3
73497|NCT02233478|178909|P3|COMPLETED|Washout (7 Days)||3
73498|NCT02233478|178910|P2|COMPLETED|Washout (7 Days)||3
73499|NCT02233478|178911|P1|COMPLETED|Washout (7 Days)||3
73500|NCT02233478|178906|P6|STARTED|Washout (7 Days)||3
73501|NCT02233478|178907|P5|STARTED|Washout (7 Days)||3
73502|NCT02233478|178908|P4|STARTED|Washout (7 Days)||3
73503|NCT02233478|178909|P3|STARTED|Washout (7 Days)||3
73504|NCT02233478|178910|P2|STARTED|Washout (7 Days)||3
73505|NCT02233478|178911|P1|STARTED|Washout (7 Days)||3
73506|NCT02233478|178906|P6|NOT COMPLETED|Second Intervention (1 Day)||0
73507|NCT02233478|178907|P5|NOT COMPLETED|Second Intervention (1 Day)||0
73508|NCT02233478|178908|P4|NOT COMPLETED|Second Intervention (1 Day)||0
73509|NCT02233478|178909|P3|NOT COMPLETED|Second Intervention (1 Day)||0
73510|NCT02233478|178910|P2|NOT COMPLETED|Second Intervention (1 Day)||0
73511|NCT02233478|178911|P1|NOT COMPLETED|Second Intervention (1 Day)||0
73512|NCT02233478|178906|P6|COMPLETED|Second Intervention (1 Day)||3
73513|NCT02233478|178907|P5|COMPLETED|Second Intervention (1 Day)||3
73514|NCT02233478|178908|P4|COMPLETED|Second Intervention (1 Day)||3
73515|NCT02233478|178909|P3|COMPLETED|Second Intervention (1 Day)||3
73516|NCT02233478|178910|P2|COMPLETED|Second Intervention (1 Day)||3
73517|NCT02233478|178911|P1|COMPLETED|Second Intervention (1 Day)||3
73518|NCT02233478|178906|P6|STARTED|Second Intervention (1 Day)||3
73519|NCT02233478|178907|P5|STARTED|Second Intervention (1 Day)||3
73520|NCT02233478|178908|P4|STARTED|Second Intervention (1 Day)||3
73521|NCT02233478|178909|P3|STARTED|Second Intervention (1 Day)||3
73522|NCT02233478|178910|P2|STARTED|Second Intervention (1 Day)||3
73523|NCT02233478|178911|P1|STARTED|Second Intervention (1 Day)||3
73524|NCT02233478|178906|P6|NOT COMPLETED|Washout (7 Days)||0
73525|NCT02233478|178907|P5|NOT COMPLETED|Washout (7 Days)||0
73526|NCT02233478|178908|P4|NOT COMPLETED|Washout (7 Days)||0
73527|NCT02233478|178909|P3|NOT COMPLETED|Washout (7 Days)||0
73528|NCT02233478|178910|P2|NOT COMPLETED|Washout (7 Days)||0
73529|NCT02233478|178911|P1|NOT COMPLETED|Washout (7 Days)||0
73530|NCT02233478|178906|P6|COMPLETED|Washout (7 Days)||3
73531|NCT02233478|178907|P5|COMPLETED|Washout (7 Days)||3
73532|NCT02233478|178908|P4|COMPLETED|Washout (7 Days)||3
73533|NCT02233478|178909|P3|COMPLETED|Washout (7 Days)||3
73534|NCT02233478|178910|P2|COMPLETED|Washout (7 Days)||3
73535|NCT02233478|178911|P1|COMPLETED|Washout (7 Days)||3
73536|NCT02233478|178906|P6|STARTED|Washout (7 Days)||3
73537|NCT02233478|178907|P5|STARTED|Washout (7 Days)||3
73538|NCT02233478|178908|P4|STARTED|Washout (7 Days)||3
73539|NCT02233478|178909|P3|STARTED|Washout (7 Days)||3
73540|NCT02233478|178910|P2|STARTED|Washout (7 Days)||3
73541|NCT02233478|178911|P1|STARTED|Washout (7 Days)||3
73542|NCT02233478|178906|P6|NOT COMPLETED|First Intervention (1 Day)||0
73543|NCT02233478|178907|P5|NOT COMPLETED|First Intervention (1 Day)||0
73544|NCT02233478|178908|P4|NOT COMPLETED|First Intervention (1 Day)||0
73545|NCT02233478|178909|P3|NOT COMPLETED|First Intervention (1 Day)||0
73546|NCT02233478|178910|P2|NOT COMPLETED|First Intervention (1 Day)||0
73547|NCT02233478|178911|P1|NOT COMPLETED|First Intervention (1 Day)||0
73548|NCT02233478|178906|P6|COMPLETED|First Intervention (1 Day)||3
73549|NCT02233478|178907|P5|COMPLETED|First Intervention (1 Day)||3
73550|NCT02233478|178908|P4|COMPLETED|First Intervention (1 Day)||3
73551|NCT02233478|178909|P3|COMPLETED|First Intervention (1 Day)||3
73552|NCT02233478|178910|P2|COMPLETED|First Intervention (1 Day)||3
73553|NCT02233478|178911|P1|COMPLETED|First Intervention (1 Day)||3
73554|NCT02233478|178906|P6|STARTED|First Intervention (1 Day)||3
73555|NCT02233478|178907|P5|STARTED|First Intervention (1 Day)||3
73556|NCT02233478|178908|P4|STARTED|First Intervention (1 Day)||3
73557|NCT02233478|178909|P3|STARTED|First Intervention (1 Day)||3
73558|NCT02233478|178910|P2|STARTED|First Intervention (1 Day)||3
73559|NCT02233478|178911|P1|STARTED|First Intervention (1 Day)||3
73560|NCT02233309|178919|P1|NOT COMPLETED|Overall Study||5
73561|NCT02233309|178919|P1|COMPLETED|Overall Study||31
73562|NCT02233309|178919|P1|STARTED|Overall Study||36
73563|NCT02233296|178925|P2|NOT COMPLETED|Overall Study||0
73564|NCT02233296|178926|P1|NOT COMPLETED|Overall Study||0
73565|NCT02233296|178925|P2|COMPLETED|Overall Study||14
73566|NCT02233296|178926|P1|COMPLETED|Overall Study||16
73567|NCT02233296|178925|P2|STARTED|Overall Study||14
73568|NCT02233296|178926|P1|STARTED|Overall Study||16
73569|NCT02233101|178944|P2|NOT COMPLETED|Overall Study||1
73570|NCT02233101|178945|P1|NOT COMPLETED|Overall Study||12
73571|NCT02233101|178944|P2|COMPLETED|Overall Study||80
73572|NCT02233101|178945|P1|COMPLETED|Overall Study||74
73573|NCT02233101|178944|P2|STARTED|Overall Study||81
73574|NCT02233101|178945|P1|STARTED|Overall Study||86
73575|NCT02232984|178953|P1|NOT COMPLETED|Overall Study||77
73576|NCT02232984|178953|P1|COMPLETED|Overall Study|Total number of subjects who completed study|672
73577|NCT02232984|178953|P1|Successfully Implanted|Overall Study|Successfully implanted subjects|675
73578|NCT02232984|178953|P1|STARTED|Overall Study|Enrolled subjects|749
73579|NCT02232880|178962|P1|NOT COMPLETED|Overall Study||1
73580|NCT02232880|178962|P1|COMPLETED|Overall Study||0
73581|NCT02232880|178962|P1|STARTED|Overall Study||1
73582|NCT02232698|178971|P2|NOT COMPLETED|Overall Study||20
73583|NCT02232698|178972|P1|NOT COMPLETED|Overall Study||10
73584|NCT02232698|178971|P2|COMPLETED|Overall Study||101
73585|NCT02232698|178972|P1|COMPLETED|Overall Study||110
73586|NCT02232698|178971|P2|STARTED|Overall Study||121
73587|NCT02232698|178972|P1|STARTED|Overall Study||120
73588|NCT02232425|178995|P2|NOT COMPLETED|Overall Study||8
73589|NCT02232425|178996|P1|NOT COMPLETED|Overall Study||14
73590|NCT02232425|178995|P2|COMPLETED|Overall Study||22
73591|NCT02232425|178996|P1|COMPLETED|Overall Study||44
73592|NCT02232425|178995|P2|STARTED|Overall Study||30
73593|NCT02232425|178996|P1|STARTED|Overall Study||58
73594|NCT02232243|179029|P3|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
73595|NCT02232243|179030|P2|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
73596|NCT02232243|179031|P1|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
73597|NCT02232243|179029|P3|COMPLETED|Third Dose(200mg HCQ Twice Daily)||3
73598|NCT02232243|179030|P2|COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
73599|NCT02232243|179031|P1|COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
73600|NCT02232243|179029|P3|STARTED|Third Dose(200mg HCQ Twice Daily)||3
73601|NCT02232243|179030|P2|STARTED|Third Dose(200mg HCQ Twice Daily)||0
73602|NCT02232243|179031|P1|STARTED|Third Dose(200mg HCQ Twice Daily)||0
73603|NCT02232243|179029|P3|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
73604|NCT02232243|179030|P2|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||1
73605|NCT02232243|179031|P1|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
73606|NCT02232243|179029|P3|COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
73607|NCT02232243|179030|P2|COMPLETED|Second Dose (400mg HCQ Twice Daily)||3
73608|NCT02232243|179031|P1|COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
73609|NCT02232243|179029|P3|STARTED|Second Dose (400mg HCQ Twice Daily)||0
73610|NCT02232243|179030|P2|STARTED|Second Dose (400mg HCQ Twice Daily)||4
73611|NCT02232243|179031|P1|STARTED|Second Dose (400mg HCQ Twice Daily)||0
73612|NCT02232243|179029|P3|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
73613|NCT02232243|179030|P2|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
73614|NCT02232243|179031|P1|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
73615|NCT02232243|179029|P3|COMPLETED|First Dose (200mg HCQ Twice Daily)||0
73616|NCT02232243|179030|P2|COMPLETED|First Dose (200mg HCQ Twice Daily)||0
73617|NCT02232243|179031|P1|COMPLETED|First Dose (200mg HCQ Twice Daily)||3
73618|NCT02232243|179029|P3|STARTED|First Dose (200mg HCQ Twice Daily)||0
73619|NCT02232243|179030|P2|STARTED|First Dose (200mg HCQ Twice Daily)||0
73620|NCT02232243|179031|P1|STARTED|First Dose (200mg HCQ Twice Daily)||3
73621|NCT02232178|179043|P3|NOT COMPLETED|Overall Study||1
73622|NCT02232178|179044|P2|NOT COMPLETED|Overall Study||1
73623|NCT02232178|179045|P1|NOT COMPLETED|Overall Study||1
73624|NCT02232178|179043|P3|COMPLETED|Overall Study||12
73625|NCT02232178|179044|P2|COMPLETED|Overall Study||24
73626|NCT02232178|179045|P1|COMPLETED|Overall Study||25
73627|NCT02232178|179043|P3|Safety Population|Overall Study||12
73628|NCT02232178|179044|P2|Safety Population|Overall Study||24
73629|NCT02232178|179045|P1|Safety Population|Overall Study||26
73630|NCT02232178|179043|P3|Per Protocol PK Population|Overall Study||11
73631|NCT02232178|179044|P2|Per Protocol PK Population|Overall Study||24
73632|NCT02232178|179045|P1|Per Protocol PK Population|Overall Study||26
73633|NCT02232178|179043|P3|STARTED|Overall Study||13
73634|NCT02232178|179044|P2|STARTED|Overall Study||25
73635|NCT02232178|179045|P1|STARTED|Overall Study||26
73636|NCT02232126|179064|P2|NOT COMPLETED|Overall Study||0
73637|NCT02232126|179065|P1|NOT COMPLETED|Overall Study||0
73638|NCT02232126|179064|P2|COMPLETED|Overall Study||90
73639|NCT02232126|179065|P1|COMPLETED|Overall Study||91
73640|NCT02232126|179064|P2|STARTED|Overall Study||90
73641|NCT02232126|179065|P1|STARTED|Overall Study||91
73642|NCT02232074|179075|P2|NOT COMPLETED|Overall Study||45
73643|NCT02232074|179076|P1|NOT COMPLETED|Overall Study||41
73644|NCT02232074|179075|P2|COMPLETED|Overall Study||107
73645|NCT02232074|179076|P1|COMPLETED|Overall Study||113
73646|NCT02232074|179075|P2|STARTED|Overall Study||152
73647|NCT02232074|179076|P1|STARTED|Overall Study||154
73648|NCT02232022|179122|P1|NOT COMPLETED|Overall Study||2
73649|NCT02232022|179122|P1|COMPLETED|Overall Study||51
73650|NCT02232022|179122|P1|STARTED|Overall Study||53
73651|NCT02232009|179131|P1|NOT COMPLETED|Overall Study||0
73652|NCT02232009|179131|P1|COMPLETED|Overall Study||9
73653|NCT02232009|179131|P1|STARTED|Overall Study||9
73654|NCT02231918|179143|P3|NOT COMPLETED|Overall Study||1
73655|NCT02231918|179144|P2|NOT COMPLETED|Overall Study||1
73656|NCT02231918|179145|P1|NOT COMPLETED|Overall Study||0
73657|NCT02231918|179143|P3|COMPLETED|Overall Study||1
73658|NCT02231918|179144|P2|COMPLETED|Overall Study||14
73659|NCT02231918|179145|P1|COMPLETED|Overall Study||9
73660|NCT02231918|179143|P3|STARTED|Overall Study||2
73661|NCT02231918|179144|P2|STARTED|Overall Study||15
73662|NCT02231918|179145|P1|STARTED|Overall Study||9
73663|NCT02231762|179207|P4|NOT COMPLETED|Maintenance Phase||5
73664|NCT02231762|179208|P3|NOT COMPLETED|Maintenance Phase||5
73665|NCT02231762|179209|P2|NOT COMPLETED|Maintenance Phase||3
73666|NCT02231762|179210|P1|NOT COMPLETED|Maintenance Phase||0
73667|NCT02231762|179207|P4|COMPLETED|Maintenance Phase||7
73668|NCT02231762|179208|P3|COMPLETED|Maintenance Phase||9
73669|NCT02231762|179209|P2|COMPLETED|Maintenance Phase||8
73670|NCT02231762|179210|P1|COMPLETED|Maintenance Phase||0
73671|NCT02231762|179207|P4|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|12
73672|NCT02231762|179208|P3|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|14
73673|NCT02231762|179209|P2|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|11
73674|NCT02231762|179210|P1|STARTED|Maintenance Phase|This arm was not included in period 2 (maintenance phase).|0
73675|NCT02231762|179207|P4|NOT COMPLETED|Combination Phase||0
73676|NCT02231762|179208|P3|NOT COMPLETED|Combination Phase||0
73677|NCT02231762|179209|P2|NOT COMPLETED|Combination Phase||0
73678|NCT02231762|179210|P1|NOT COMPLETED|Combination Phase||20
73679|NCT02231762|179207|P4|COMPLETED|Combination Phase||0
73680|NCT02231762|179208|P3|COMPLETED|Combination Phase||0
73681|NCT02231762|179209|P2|COMPLETED|Combination Phase||0
73682|NCT02231762|179210|P1|COMPLETED|Combination Phase||37
73683|NCT02231762|179207|P4|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
73684|NCT02231762|179208|P3|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
73685|NCT02231762|179209|P2|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
73686|NCT02231762|179210|P1|STARTED|Combination Phase||57
73687|NCT02231749|179243|P2|NOT COMPLETED|Overall Study||449
73688|NCT02231749|179244|P1|NOT COMPLETED|Overall Study||422
73689|NCT02231749|179243|P2|COMPLETED|Overall Study||97
73690|NCT02231749|179244|P1|COMPLETED|Overall Study||128
73691|NCT02231749|179243|P2|Received Treatment|Overall Study||535
73692|NCT02231749|179244|P1|Received Treatment|Overall Study||547
73693|NCT02231749|179243|P2|STARTED|Overall Study||546
73694|NCT02231749|179244|P1|STARTED|Overall Study||550
73695|NCT02231580|179262|P2|NOT COMPLETED|Overall Study||0
73696|NCT02231580|179263|P1|NOT COMPLETED|Overall Study||5
73697|NCT02231580|179262|P2|COMPLETED|Overall Study||3
73698|NCT02231580|179263|P1|COMPLETED|Overall Study||9
73699|NCT02231580|179262|P2|Cohort 2|Overall Study||1
73700|NCT02231580|179263|P1|Cohort 2|Overall Study||6
73701|NCT02231580|179262|P2|Cohort 1|Overall Study||2
73702|NCT02231580|179263|P1|Cohort 1|Overall Study||8
73703|NCT02231580|179262|P2|STARTED|Overall Study||3
73704|NCT02231580|179263|P1|STARTED|Overall Study||14
73705|NCT02231177|179319|P6|NOT COMPLETED|Treatment Period 3 (21 Days)||0
73706|NCT02231177|179320|P5|NOT COMPLETED|Treatment Period 3 (21 Days)||0
73707|NCT02231177|179321|P4|NOT COMPLETED|Treatment Period 3 (21 Days)||0
73708|NCT02231177|179322|P3|NOT COMPLETED|Treatment Period 3 (21 Days)||0
73709|NCT02231177|179323|P2|NOT COMPLETED|Treatment Period 3 (21 Days)||0
73710|NCT02231177|179324|P1|NOT COMPLETED|Treatment Period 3 (21 Days)||0
73711|NCT02231177|179319|P6|COMPLETED|Treatment Period 3 (21 Days)||9
73712|NCT02231177|179320|P5|COMPLETED|Treatment Period 3 (21 Days)||8
73713|NCT02231177|179321|P4|COMPLETED|Treatment Period 3 (21 Days)||7
73714|NCT02231177|179322|P3|COMPLETED|Treatment Period 3 (21 Days)||8
73715|NCT02231177|179323|P2|COMPLETED|Treatment Period 3 (21 Days)||7
73716|NCT02231177|179324|P1|COMPLETED|Treatment Period 3 (21 Days)||8
73717|NCT02231177|179319|P6|STARTED|Treatment Period 3 (21 Days)||9
73718|NCT02231177|179320|P5|STARTED|Treatment Period 3 (21 Days)||8
73719|NCT02231177|179321|P4|STARTED|Treatment Period 3 (21 Days)||7
73720|NCT02231177|179322|P3|STARTED|Treatment Period 3 (21 Days)||8
73721|NCT02231177|179323|P2|STARTED|Treatment Period 3 (21 Days)||7
73722|NCT02231177|179324|P1|STARTED|Treatment Period 3 (21 Days)||8
73723|NCT02231177|179319|P6|NOT COMPLETED|Treatment Period 2 (21 Days)||0
73724|NCT02231177|179320|P5|NOT COMPLETED|Treatment Period 2 (21 Days)||0
73725|NCT02231177|179321|P4|NOT COMPLETED|Treatment Period 2 (21 Days)||0
73726|NCT02231177|179322|P3|NOT COMPLETED|Treatment Period 2 (21 Days)||0
73727|NCT02231177|179323|P2|NOT COMPLETED|Treatment Period 2 (21 Days)||0
73728|NCT02231177|179324|P1|NOT COMPLETED|Treatment Period 2 (21 Days)||0
73729|NCT02231177|179319|P6|COMPLETED|Treatment Period 2 (21 Days)||9
73730|NCT02231177|179320|P5|COMPLETED|Treatment Period 2 (21 Days)||8
73731|NCT02231177|179321|P4|COMPLETED|Treatment Period 2 (21 Days)||7
73732|NCT02231177|179322|P3|COMPLETED|Treatment Period 2 (21 Days)||8
73733|NCT02231177|179323|P2|COMPLETED|Treatment Period 2 (21 Days)||7
73734|NCT02231177|179324|P1|COMPLETED|Treatment Period 2 (21 Days)||8
73735|NCT02231177|179319|P6|STARTED|Treatment Period 2 (21 Days)||9
73736|NCT02231177|179320|P5|STARTED|Treatment Period 2 (21 Days)||8
73737|NCT02231177|179321|P4|STARTED|Treatment Period 2 (21 Days)||7
73738|NCT02231177|179322|P3|STARTED|Treatment Period 2 (21 Days)||8
73739|NCT02231177|179323|P2|STARTED|Treatment Period 2 (21 Days)||7
73740|NCT02231177|179324|P1|STARTED|Treatment Period 2 (21 Days)||8
73741|NCT02231177|179319|P6|NOT COMPLETED|Treatment Period 1 (21 Days)||0
73742|NCT02231177|179320|P5|NOT COMPLETED|Treatment Period 1 (21 Days)||0
73743|NCT02231177|179321|P4|NOT COMPLETED|Treatment Period 1 (21 Days)||0
73744|NCT02231177|179322|P3|NOT COMPLETED|Treatment Period 1 (21 Days)||0
73745|NCT02231177|179323|P2|NOT COMPLETED|Treatment Period 1 (21 Days)||0
73746|NCT02231177|179324|P1|NOT COMPLETED|Treatment Period 1 (21 Days)||0
73747|NCT02231177|179319|P6|COMPLETED|Treatment Period 1 (21 Days)||9
73748|NCT02231177|179320|P5|COMPLETED|Treatment Period 1 (21 Days)||8
73749|NCT02231177|179321|P4|COMPLETED|Treatment Period 1 (21 Days)||7
73750|NCT02231177|179322|P3|COMPLETED|Treatment Period 1 (21 Days)||8
73751|NCT02231177|179323|P2|COMPLETED|Treatment Period 1 (21 Days)||7
73752|NCT02231177|179324|P1|COMPLETED|Treatment Period 1 (21 Days)||8
73753|NCT02231177|179319|P6|STARTED|Treatment Period 1 (21 Days)||9
73754|NCT02231177|179320|P5|STARTED|Treatment Period 1 (21 Days)||8
73755|NCT02231177|179321|P4|STARTED|Treatment Period 1 (21 Days)||7
73756|NCT02231177|179322|P3|STARTED|Treatment Period 1 (21 Days)||8
73757|NCT02231177|179323|P2|STARTED|Treatment Period 1 (21 Days)||7
73758|NCT02231177|179324|P1|STARTED|Treatment Period 1 (21 Days)||8
73759|NCT02231164|179380|P2|NOT COMPLETED|Overall Study||6
73760|NCT02231164|179381|P1|NOT COMPLETED|Overall Study||6
73761|NCT02231164|179380|P2|COMPLETED|Overall Study||0
73762|NCT02231164|179381|P1|COMPLETED|Overall Study||0
73763|NCT02231164|179380|P2|STARTED|Overall Study||6
73764|NCT02231164|179381|P1|STARTED|Overall Study||6
73765|NCT02230995|179389|P2|NOT COMPLETED|Period 2 + Washout||0
73766|NCT02230995|179390|P1|NOT COMPLETED|Period 2 + Washout||0
73767|NCT02230995|179389|P2|COMPLETED|Period 2 + Washout||15
73768|NCT02230995|179390|P1|COMPLETED|Period 2 + Washout||15
73769|NCT02230995|179389|P2|STARTED|Period 2 + Washout||15
73770|NCT02230995|179390|P1|STARTED|Period 2 + Washout||15
73771|NCT02230995|179389|P2|NOT COMPLETED|Period 1 + Washout||0
73772|NCT02230995|179390|P1|NOT COMPLETED|Period 1 + Washout||0
73773|NCT02230995|179389|P2|COMPLETED|Period 1 + Washout||15
73774|NCT02230995|179390|P1|COMPLETED|Period 1 + Washout||15
73775|NCT02230995|179389|P2|STARTED|Period 1 + Washout||15
73776|NCT02230995|179390|P1|STARTED|Period 1 + Washout||15
73777|NCT02230956|179409|P3|NOT COMPLETED|Overall Study||7
73778|NCT02230956|179410|P2|NOT COMPLETED|Overall Study||6
73779|NCT02230956|179411|P1|NOT COMPLETED|Overall Study||5
73780|NCT02230956|179409|P3|COMPLETED|Overall Study||82
73781|NCT02230956|179410|P2|COMPLETED|Overall Study||37
73782|NCT02230956|179411|P1|COMPLETED|Overall Study||39
73783|NCT02230956|179409|P3|STARTED|Overall Study||89
73784|NCT02230956|179410|P2|STARTED|Overall Study||43
73785|NCT02230956|179411|P1|STARTED|Overall Study||44
73786|NCT02230904|179433|P2|NOT COMPLETED|Overall Study||1
73787|NCT02230904|179434|P1|NOT COMPLETED|Overall Study||0
73788|NCT02230904|179433|P2|COMPLETED|Overall Study||27
73789|NCT02230904|179434|P1|COMPLETED|Overall Study||29
73790|NCT02230904|179433|P2|STARTED|Overall Study||28
73791|NCT02230904|179434|P1|STARTED|Overall Study||29
73792|NCT02230761|179456|P2|NOT COMPLETED|Overall Study||1
73793|NCT02230761|179457|P1|NOT COMPLETED|Overall Study||0
73794|NCT02230761|179456|P2|COMPLETED|Overall Study||29
73795|NCT02230761|179457|P1|COMPLETED|Overall Study||60
73796|NCT02230761|179456|P2|STARTED|Overall Study||30
73797|NCT02230761|179457|P1|STARTED|Overall Study||60
73798|NCT02230683|179467|P1|NOT COMPLETED|Overall Study||1
73799|NCT02230683|179467|P1|COMPLETED|Overall Study||22
73800|NCT02230683|179467|P1|STARTED|Overall Study||23
73801|NCT02230670|179484|P2|NOT COMPLETED|Overall Study||8
73802|NCT02230670|179485|P1|NOT COMPLETED|Overall Study||4
73803|NCT02230670|179484|P2|COMPLETED|Overall Study||34
73804|NCT02230670|179485|P1|COMPLETED|Overall Study||40
73805|NCT02230670|179484|P2|STARTED|Overall Study|One subject randomized to placebo withdrew from the study before receiving any study treatment.|42
73806|NCT02230670|179485|P1|STARTED|Overall Study||44
73807|NCT02230579|179502|P7|NOT COMPLETED|Overall Study||0
73808|NCT02230579|179503|P6|NOT COMPLETED|Overall Study||0
73809|NCT02230579|179504|P5|NOT COMPLETED|Overall Study||0
73810|NCT02230579|179505|P4|NOT COMPLETED|Overall Study||0
73811|NCT02230579|179506|P3|NOT COMPLETED|Overall Study||0
73812|NCT02230579|179507|P2|NOT COMPLETED|Overall Study||0
73813|NCT02230579|179508|P1|NOT COMPLETED|Overall Study||0
73814|NCT02230579|179502|P7|COMPLETED|Overall Study||12
73815|NCT02230579|179503|P6|COMPLETED|Overall Study||6
73816|NCT02230579|179504|P5|COMPLETED|Overall Study||6
73817|NCT02230579|179505|P4|COMPLETED|Overall Study||6
73818|NCT02230579|179506|P3|COMPLETED|Overall Study||6
73819|NCT02230579|179507|P2|COMPLETED|Overall Study||6
73820|NCT02230579|179508|P1|COMPLETED|Overall Study||6
73821|NCT02230579|179502|P7|STARTED|Overall Study||12
73822|NCT02230579|179503|P6|STARTED|Overall Study||6
73823|NCT02230579|179504|P5|STARTED|Overall Study||6
73824|NCT02230579|179505|P4|STARTED|Overall Study||6
73825|NCT02230579|179506|P3|STARTED|Overall Study||6
73826|NCT02230579|179507|P2|STARTED|Overall Study||6
73827|NCT02230579|179508|P1|STARTED|Overall Study||6
73828|NCT02230566|179546|P4|NOT COMPLETED|Overall Study||0
73829|NCT02230566|179547|P3|NOT COMPLETED|Overall Study||0
73830|NCT02230566|179548|P2|NOT COMPLETED|Overall Study||0
73831|NCT02230566|179549|P1|NOT COMPLETED|Overall Study||0
73832|NCT02230566|179546|P4|COMPLETED|Overall Study||3
73833|NCT02230566|179547|P3|COMPLETED|Overall Study||3
73834|NCT02230566|179548|P2|COMPLETED|Overall Study||3
73835|NCT02230566|179549|P1|COMPLETED|Overall Study||3
73836|NCT02230566|179546|P4|STARTED|Overall Study||3
73837|NCT02230566|179547|P3|STARTED|Overall Study||3
73838|NCT02230566|179548|P2|STARTED|Overall Study||3
73839|NCT02230566|179549|P1|STARTED|Overall Study||3
73840|NCT02230540|179564|P2|NOT COMPLETED|Overall Study||0
73841|NCT02230540|179565|P1|NOT COMPLETED|Overall Study||0
73842|NCT02230540|179564|P2|COMPLETED|Overall Study||0
73843|NCT02230540|179565|P1|COMPLETED|Overall Study||8
73844|NCT02230540|179564|P2|STARTED|Overall Study|The study was terminated before initiation of sequence B. Sequence B was therefore not initiated.|0
73845|NCT02230540|179565|P1|STARTED|Overall Study||8
73846|NCT02230384|179571|P2|NOT COMPLETED|Phase 2 Wash Out||0
73847|NCT02230384|179572|P1|NOT COMPLETED|Phase 2 Wash Out||0
73848|NCT02230384|179571|P2|COMPLETED|Phase 2 Wash Out||30
73849|NCT02230384|179572|P1|COMPLETED|Phase 2 Wash Out||26
73850|NCT02230384|179571|P2|STARTED|Phase 2 Wash Out||30
73851|NCT02230384|179572|P1|STARTED|Phase 2 Wash Out||26
73852|NCT02230384|179571|P2|NOT COMPLETED|Phase 2 - Switch||1
73853|NCT02230384|179572|P1|NOT COMPLETED|Phase 2 - Switch||3
73854|NCT02230384|179571|P2|COMPLETED|Phase 2 - Switch||30
73855|NCT02230384|179572|P1|COMPLETED|Phase 2 - Switch||26
73856|NCT02230384|179571|P2|STARTED|Phase 2 - Switch||31
73857|NCT02230384|179572|P1|STARTED|Phase 2 - Switch||29
73858|NCT02230384|179571|P2|NOT COMPLETED|Phase 1 Wash Out||0
73859|NCT02230384|179572|P1|NOT COMPLETED|Phase 1 Wash Out||0
73860|NCT02230384|179571|P2|COMPLETED|Phase 1 Wash Out||31
73861|NCT02230384|179572|P1|COMPLETED|Phase 1 Wash Out||29
73862|NCT02230384|179571|P2|STARTED|Phase 1 Wash Out||31
73863|NCT02230384|179572|P1|STARTED|Phase 1 Wash Out||29
73864|NCT02230384|179571|P2|NOT COMPLETED|Phase 1||1
73865|NCT02230384|179572|P1|NOT COMPLETED|Phase 1||1
73866|NCT02230384|179571|P2|COMPLETED|Phase 1||31
73867|NCT02230384|179572|P1|COMPLETED|Phase 1||29
73868|NCT02230384|179571|P2|STARTED|Phase 1||32
73869|NCT02230384|179572|P1|STARTED|Phase 1||30
73870|NCT02230332|179592|P2|NOT COMPLETED|Overall Study||1
73871|NCT02230332|179593|P1|NOT COMPLETED|Overall Study||4
73872|NCT02230332|179592|P2|COMPLETED|Overall Study||39
73873|NCT02230332|179593|P1|COMPLETED|Overall Study||34
73874|NCT02230332|179592|P2|STARTED|Overall Study||40
73875|NCT02230332|179593|P1|STARTED|Overall Study||38
73876|NCT02230306|179609|P1|NOT COMPLETED|Overall Study||1
73877|NCT02230306|179609|P1|COMPLETED|Overall Study||4
73878|NCT02230306|179609|P1|STARTED|Overall Study||5
73879|NCT02230085|179620|P1|NOT COMPLETED|Overall Study||4
73880|NCT02230085|179620|P1|COMPLETED|Overall Study||106
73881|NCT02230085|179620|P1|STARTED|Overall Study||110
73882|NCT02229864|179624|P1|NOT COMPLETED|3 - Year Visit||2
73883|NCT02229864|179624|P1|COMPLETED|3 - Year Visit||10
73884|NCT02229864|179624|P1|STARTED|3 - Year Visit|The missed visit participant in the 2nd year has joined the study for 3rd year follow-up.|12
73885|NCT02229864|179624|P1|NOT COMPLETED|2 - Year Visit||1
73886|NCT02229864|179624|P1|COMPLETED|2 - Year Visit||11
73887|NCT02229864|179624|P1|STARTED|2 - Year Visit||12
73888|NCT02229864|179624|P1|NOT COMPLETED|1 - Year Visit||0
73889|NCT02229864|179624|P1|COMPLETED|1 - Year Visit||12
73890|NCT02229864|179624|P1|STARTED|1 - Year Visit||12
73891|NCT02229864|179624|P1|NOT COMPLETED|6 - Month Visit||0
73892|NCT02229864|179624|P1|COMPLETED|6 - Month Visit||12
73893|NCT02229864|179624|P1|STARTED|6 - Month Visit||12
73894|NCT02229864|179624|P1|NOT COMPLETED|1 - Month Visit||0
73895|NCT02229864|179624|P1|COMPLETED|1 - Month Visit||12
73896|NCT02229864|179624|P1|STARTED|1 - Month Visit||12
73897|NCT02229539|179679|P3|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||10
73898|NCT02229539|179680|P2|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||7
73899|NCT02229539|179681|P1|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||9
73900|NCT02229539|179679|P3|COMPLETED|Cycle 2 (Optional Continuation Phase)||22
73901|NCT02229539|179680|P2|COMPLETED|Cycle 2 (Optional Continuation Phase)||29
73902|NCT02229539|179681|P1|COMPLETED|Cycle 2 (Optional Continuation Phase)||26
73903|NCT02229539|179679|P3|STARTED|Cycle 2 (Optional Continuation Phase)||32
73904|NCT02229539|179680|P2|STARTED|Cycle 2 (Optional Continuation Phase)||36
73905|NCT02229539|179681|P1|STARTED|Cycle 2 (Optional Continuation Phase)||35
73906|NCT02229539|179679|P3|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
73907|NCT02229539|179680|P2|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||5
73908|NCT02229539|179681|P1|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
73909|NCT02229539|179679|P3|COMPLETED|Cycle 1 (Treatment Per Protocol)||72
73910|NCT02229539|179680|P2|COMPLETED|Cycle 1 (Treatment Per Protocol)||71
73911|NCT02229539|179681|P1|COMPLETED|Cycle 1 (Treatment Per Protocol)||74
73912|NCT02229539|179679|P3|STARTED|Cycle 1 (Treatment Per Protocol)||75
73913|NCT02229539|179680|P2|STARTED|Cycle 1 (Treatment Per Protocol)||76
73914|NCT02229539|179681|P1|STARTED|Cycle 1 (Treatment Per Protocol)||77
73915|NCT02229513|179691|P2|NOT COMPLETED|Overall Study||0
73916|NCT02229513|179692|P1|NOT COMPLETED|Overall Study||0
73917|NCT02229513|179691|P2|COMPLETED|Overall Study||100
73918|NCT02229513|179692|P1|COMPLETED|Overall Study||100
73919|NCT02229513|179691|P2|STARTED|Overall Study||100
73920|NCT02229513|179692|P1|STARTED|Overall Study||100
73921|NCT02229487|179728|P2|NOT COMPLETED|Overall Study||0
73922|NCT02229487|179729|P1|NOT COMPLETED|Overall Study||0
73923|NCT02229487|179728|P2|COMPLETED|Overall Study||27
73924|NCT02229487|179729|P1|COMPLETED|Overall Study||24
73925|NCT02229487|179728|P2|STARTED|Overall Study||27
73926|NCT02229487|179729|P1|STARTED|Overall Study||24
73927|NCT02229474|179737|P2|NOT COMPLETED|Overall Study||3
73928|NCT02229474|179738|P1|NOT COMPLETED|Overall Study||0
73929|NCT02229474|179737|P2|COMPLETED|Overall Study||15
73930|NCT02229474|179738|P1|COMPLETED|Overall Study||16
73931|NCT02229474|179737|P2|STARTED|Overall Study||18
73932|NCT02229474|179738|P1|STARTED|Overall Study||16
73933|NCT02229461|179771|P6|NOT COMPLETED|Overall Study||0
73934|NCT02229461|179772|P5|NOT COMPLETED|Overall Study||0
73935|NCT02229461|179773|P4|NOT COMPLETED|Overall Study||0
73936|NCT02229461|179774|P3|NOT COMPLETED|Overall Study||0
73937|NCT02229461|179775|P2|NOT COMPLETED|Overall Study||0
73938|NCT02229461|179776|P1|NOT COMPLETED|Overall Study||0
73939|NCT02229461|179771|P6|COMPLETED|Overall Study||17
73940|NCT02229461|179772|P5|COMPLETED|Overall Study||17
73941|NCT02229461|179773|P4|COMPLETED|Overall Study||17
73942|NCT02229461|179774|P3|COMPLETED|Overall Study||17
73943|NCT02229461|179775|P2|COMPLETED|Overall Study||17
73944|NCT02229461|179776|P1|COMPLETED|Overall Study||17
73945|NCT02229461|179771|P6|STARTED|Overall Study|Randomized and received treatment|17
73946|NCT02229461|179772|P5|STARTED|Overall Study|Randomized and received treatment|17
73947|NCT02229461|179773|P4|STARTED|Overall Study|Randomized and received treatment|17
73948|NCT02229461|179774|P3|STARTED|Overall Study|Randomized and received treatment|17
73949|NCT02229461|179775|P2|STARTED|Overall Study|Randomized and received treatment|17
73950|NCT02229461|179776|P1|STARTED|Overall Study|Randomized and received treatment|17
73951|NCT02229396|179812|P3|NOT COMPLETED|Overall Study||95
73952|NCT02229396|179813|P2|NOT COMPLETED|Overall Study||77
73953|NCT02229396|179814|P1|NOT COMPLETED|Overall Study||78
73954|NCT02229396|179812|P3|COMPLETED|Overall Study||136
73955|NCT02229396|179813|P2|COMPLETED|Overall Study||154
73956|NCT02229396|179814|P1|COMPLETED|Overall Study||155
73957|NCT02229396|179812|P3|Completed 52-Week Study Period|Overall Study||177
73958|NCT02229396|179813|P2|Completed 52-Week Study Period|Overall Study||193
73959|NCT02229396|179814|P1|Completed 52-Week Study Period|Overall Study||194
73960|NCT02229396|179812|P3|Completed 28-Week Study Period|Overall Study||193
73961|NCT02229396|179813|P2|Completed 28-Week Study Period|Overall Study||202
73962|NCT02229396|179814|P1|Completed 28-Week Study Period|Overall Study||208
73963|NCT02229396|179812|P3|Intent-to-Treat (ITT) Analysis Set|Overall Study||227
73964|NCT02229396|179813|P2|Intent-to-Treat (ITT) Analysis Set|Overall Study||228
73965|NCT02229396|179814|P1|Intent-to-Treat (ITT) Analysis Set|Overall Study||230
73966|NCT02229396|179812|P3|Safety Analysis Set|Overall Study||230
73967|NCT02229396|179813|P2|Safety Analysis Set|Overall Study||231
73968|NCT02229396|179814|P1|Safety Analysis Set|Overall Study||233
73969|NCT02229396|179812|P3|Randomization Code Allocated|Overall Study||231
73970|NCT02229396|179813|P2|Randomization Code Allocated|Overall Study||231
73971|NCT02229396|179814|P1|Randomization Code Allocated|Overall Study||233
73972|NCT02229396|179812|P3|STARTED|Overall Study||231
73973|NCT02229396|179813|P2|STARTED|Overall Study||231
73974|NCT02229396|179814|P1|STARTED|Overall Study||233
73975|NCT02229383|179845|P2|NOT COMPLETED|Overall Study||22
73976|NCT02229383|179846|P1|NOT COMPLETED|Overall Study||20
73977|NCT02229383|179845|P2|COMPLETED|Overall Study||207
73978|NCT02229383|179846|P1|COMPLETED|Overall Study||212
73979|NCT02229383|179845|P2|Intent-to-treat (ITT) Analysis Set|Overall Study||228
73980|NCT02229383|179846|P1|Intent-to-treat (ITT) Analysis Set|Overall Study||230
73981|NCT02229383|179845|P2|Safety Analysis Set|Overall Study||229
73982|NCT02229383|179846|P1|Safety Analysis Set|Overall Study||231
73983|NCT02229383|179845|P2|Received Treatment|Overall Study||229
73984|NCT02229383|179846|P1|Received Treatment|Overall Study||231
73985|NCT02229383|179845|P2|STARTED|Overall Study||229
73986|NCT02229383|179846|P1|STARTED|Overall Study||232
73987|NCT02229318|179864|P1|NOT COMPLETED|Overall Study||0
73988|NCT02229318|179864|P1|COMPLETED|Overall Study|September 15th 2014 11 completed|11
73989|NCT02229318|179864|P1|STARTED|Overall Study|September 6th 2014 11 enrolled|11
73990|NCT02229227|179871|P2|NOT COMPLETED|Overall Study||62
73991|NCT02229227|179872|P1|NOT COMPLETED|Overall Study||51
73992|NCT02229227|179871|P2|COMPLETED|Overall Study||350
73993|NCT02229227|179872|P1|COMPLETED|Overall Study||351
73994|NCT02229227|179871|P2|STARTED|Overall Study||412
73995|NCT02229227|179872|P1|STARTED|Overall Study||402
73996|NCT02229214|179957|P2|NOT COMPLETED|Overall Study||0
73997|NCT02229214|179958|P1|NOT COMPLETED|Overall Study||6
73998|NCT02229214|179957|P2|COMPLETED|Overall Study||10
73999|NCT02229214|179958|P1|COMPLETED|Overall Study||35
74000|NCT02229214|179957|P2|STARTED|Overall Study||10
74001|NCT02229214|179958|P1|STARTED|Overall Study||41
74002|NCT02228980|179982|P4|NOT COMPLETED|Overall Study||3
74003|NCT02228980|179983|P3|NOT COMPLETED|Overall Study||2
74004|NCT02228980|179984|P2|NOT COMPLETED|Overall Study||3
74005|NCT02228980|179985|P1|NOT COMPLETED|Overall Study||24
74006|NCT02228980|179982|P4|COMPLETED|Overall Study||148
74007|NCT02228980|179983|P3|COMPLETED|Overall Study||149
74008|NCT02228980|179984|P2|COMPLETED|Overall Study||147
74009|NCT02228980|179985|P1|COMPLETED|Overall Study||126
74010|NCT02228980|179982|P4|STARTED|Overall Study||151
74011|NCT02228980|179983|P3|STARTED|Overall Study||151
74012|NCT02228980|179984|P2|STARTED|Overall Study||150
74013|NCT02228980|179985|P1|STARTED|Overall Study||150
74014|NCT02228967|180009|P2|NOT COMPLETED|Overall Study||160
74015|NCT02228967|180010|P1|NOT COMPLETED|Overall Study||159
74016|NCT02228967|180009|P2|COMPLETED|Overall Study||228
74017|NCT02228967|180010|P1|COMPLETED|Overall Study||244
74018|NCT02228967|180009|P2|STARTED|Overall Study||388
74019|NCT02228967|180010|P1|STARTED|Overall Study||403
74020|NCT02228824|180032|P2|NOT COMPLETED|Overall Study||22
74021|NCT02228824|180033|P1|NOT COMPLETED|Overall Study||29
74022|NCT02228824|180032|P2|COMPLETED|Overall Study||98
74023|NCT02228824|180033|P1|COMPLETED|Overall Study||89
74024|NCT02228824|180032|P2|STARTED|Overall Study||120
74025|NCT02228824|180033|P1|STARTED|Overall Study||118
74026|NCT02228720|180047|P1|NOT COMPLETED|Open Label - Day 90||0
74027|NCT02228720|180047|P1|COMPLETED|Open Label - Day 90||14
74028|NCT02228720|180047|P1|STARTED|Open Label - Day 90||14
74029|NCT02228720|180047|P1|NOT COMPLETED|Open Label - Day 30||1
74030|NCT02228720|180047|P1|COMPLETED|Open Label - Day 30||14
74031|NCT02228720|180047|P1|STARTED|Open Label - Day 30||15
74032|NCT02228720|180047|P1|NOT COMPLETED|Open Label - Baseline||0
74033|NCT02228720|180047|P1|COMPLETED|Open Label - Baseline||15
74034|NCT02228720|180047|P1|STARTED|Open Label - Baseline||15
74035|NCT02228681|180057|P2|NOT COMPLETED|Overall Study||0
74036|NCT02228681|180058|P1|NOT COMPLETED|Overall Study||0
74037|NCT02228681|180057|P2|COMPLETED|Overall Study||37
74038|NCT02228681|180058|P1|COMPLETED|Overall Study||37
74039|NCT02228681|180057|P2|STARTED|Overall Study||37
74040|NCT02228681|180058|P1|STARTED|Overall Study||37
74041|NCT02228499|180072|P2|NOT COMPLETED|Overall Study||26
74042|NCT02228499|180073|P1|NOT COMPLETED|Overall Study||23
74043|NCT02228499|180072|P2|COMPLETED|Overall Study||10
74044|NCT02228499|180073|P1|COMPLETED|Overall Study||7
74045|NCT02228499|180072|P2|STARTED|Overall Study||36
74046|NCT02228499|180073|P1|STARTED|Overall Study||30
74047|NCT02228395|180079|P3|NOT COMPLETED|Third Intervention Period||0
74048|NCT02228395|180080|P2|NOT COMPLETED|Third Intervention Period||0
74049|NCT02228395|180081|P1|NOT COMPLETED|Third Intervention Period||0
74050|NCT02228395|180079|P3|COMPLETED|Third Intervention Period||3
74051|NCT02228395|180080|P2|COMPLETED|Third Intervention Period||3
74052|NCT02228395|180081|P1|COMPLETED|Third Intervention Period||3
74053|NCT02228395|180079|P3|STARTED|Third Intervention Period||3
74054|NCT02228395|180080|P2|STARTED|Third Intervention Period||3
74055|NCT02228395|180081|P1|STARTED|Third Intervention Period||3
74056|NCT02228395|180079|P3|NOT COMPLETED|Washout Period (at Least 10 Days)||0
74057|NCT02228395|180080|P2|NOT COMPLETED|Washout Period (at Least 10 Days)||0
74058|NCT02228395|180081|P1|NOT COMPLETED|Washout Period (at Least 10 Days)||0
74059|NCT02228395|180079|P3|COMPLETED|Washout Period (at Least 10 Days)||3
74060|NCT02228395|180080|P2|COMPLETED|Washout Period (at Least 10 Days)||3
74061|NCT02228395|180081|P1|COMPLETED|Washout Period (at Least 10 Days)||3
74062|NCT02228395|180079|P3|STARTED|Washout Period (at Least 10 Days)||3
74063|NCT02228395|180080|P2|STARTED|Washout Period (at Least 10 Days)||3
74064|NCT02228395|180081|P1|STARTED|Washout Period (at Least 10 Days)||3
74065|NCT02228395|180079|P3|NOT COMPLETED|Second Intervention Period||0
74066|NCT02228395|180080|P2|NOT COMPLETED|Second Intervention Period||0
74067|NCT02228395|180081|P1|NOT COMPLETED|Second Intervention Period||0
74068|NCT02228395|180079|P3|COMPLETED|Second Intervention Period||3
74069|NCT02228395|180080|P2|COMPLETED|Second Intervention Period||3
74070|NCT02228395|180081|P1|COMPLETED|Second Intervention Period||3
74071|NCT02228395|180079|P3|STARTED|Second Intervention Period||3
74072|NCT02228395|180080|P2|STARTED|Second Intervention Period||3
74073|NCT02228395|180081|P1|STARTED|Second Intervention Period||3
74074|NCT02228395|180079|P3|NOT COMPLETED|Washout Period (at Least 10 Days)||0
74075|NCT02228395|180080|P2|NOT COMPLETED|Washout Period (at Least 10 Days)||0
74076|NCT02228395|180081|P1|NOT COMPLETED|Washout Period (at Least 10 Days)||0
74077|NCT02228395|180079|P3|COMPLETED|Washout Period (at Least 10 Days)||3
74078|NCT02228395|180080|P2|COMPLETED|Washout Period (at Least 10 Days)||3
74079|NCT02228395|180081|P1|COMPLETED|Washout Period (at Least 10 Days)||3
74080|NCT02228395|180079|P3|STARTED|Washout Period (at Least 10 Days)||3
74081|NCT02228395|180080|P2|STARTED|Washout Period (at Least 10 Days)||3
74082|NCT02228395|180081|P1|STARTED|Washout Period (at Least 10 Days)||3
74083|NCT02228395|180079|P3|NOT COMPLETED|First Intervention Period||1
74084|NCT02228395|180080|P2|NOT COMPLETED|First Intervention Period||1
74085|NCT02228395|180081|P1|NOT COMPLETED|First Intervention Period||1
74086|NCT02228395|180079|P3|COMPLETED|First Intervention Period||2
74087|NCT02228395|180080|P2|COMPLETED|First Intervention Period||2
74088|NCT02228395|180081|P1|COMPLETED|First Intervention Period||2
74089|NCT02228395|180079|P3|STARTED|First Intervention Period||3
74090|NCT02228395|180080|P2|STARTED|First Intervention Period||3
74091|NCT02228395|180081|P1|STARTED|First Intervention Period||3
74092|NCT02228174|180145|P1|NOT COMPLETED|Overall Study||5
74093|NCT02228174|180145|P1|COMPLETED|Overall Study||142
74094|NCT02228174|180145|P1|Full Analysis Population|Overall Study|Subjects who didn't become pregnant or diagnosed with an interfering medical condition at 12-months|143
74095|NCT02228174|180145|P1|STARTED|Overall Study||147
74096|NCT02227849|180165|P1|NOT COMPLETED|Overall Study||8
74097|NCT02227849|180165|P1|COMPLETED|Overall Study||63
74098|NCT02227849|180165|P1|STARTED|Overall Study||71
74099|NCT02227836|180173|P1|NOT COMPLETED|Overall Study||0
74100|NCT02227836|180173|P1|COMPLETED|Overall Study||8
74101|NCT02227836|180173|P1|STARTED|Overall Study||8
74102|NCT02227810|180179|P2|NOT COMPLETED|Overall Study||5
74103|NCT02227810|180180|P1|NOT COMPLETED|Overall Study||2
74104|NCT02227810|180179|P2|COMPLETED|Overall Study||29
74105|NCT02227810|180180|P1|COMPLETED|Overall Study||17
74106|NCT02227810|180179|P2|STARTED|Overall Study||34
74107|NCT02227810|180180|P1|STARTED|Overall Study||19
74108|NCT02227784|180196|P5|NOT COMPLETED|Open-Label Extension Phase (OLE)||248
74109|NCT02227784|180197|P4|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
74110|NCT02227784|180198|P3|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
74111|NCT02227784|180199|P2|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
74112|NCT02227784|180200|P1|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
74113|NCT02227784|180196|P5|COMPLETED|Open-Label Extension Phase (OLE)||0
74114|NCT02227784|180197|P4|COMPLETED|Open-Label Extension Phase (OLE)||0
74115|NCT02227784|180198|P3|COMPLETED|Open-Label Extension Phase (OLE)||0
74116|NCT02227784|180199|P2|COMPLETED|Open-Label Extension Phase (OLE)||0
74117|NCT02227784|180200|P1|COMPLETED|Open-Label Extension Phase (OLE)||0
74118|NCT02227784|180196|P5|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||247
74119|NCT02227784|180197|P4|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
74120|NCT02227784|180198|P3|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
74121|NCT02227784|180199|P2|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
74122|NCT02227784|180200|P1|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
74123|NCT02227784|180196|P5|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|248
74124|NCT02227784|180197|P4|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
74125|NCT02227784|180198|P3|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
74126|NCT02227784|180199|P2|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
74127|NCT02227784|180200|P1|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
74128|NCT02227784|180196|P5|NOT COMPLETED|Double-Blind Phase||0
74129|NCT02227784|180197|P4|NOT COMPLETED|Double-Blind Phase||39
74130|NCT02227784|180198|P3|NOT COMPLETED|Double-Blind Phase||21
74131|NCT02227784|180199|P2|NOT COMPLETED|Double-Blind Phase||18
74132|NCT02227784|180200|P1|NOT COMPLETED|Double-Blind Phase||40
74133|NCT02227784|180196|P5|COMPLETED|Double-Blind Phase||0
74134|NCT02227784|180197|P4|COMPLETED|Double-Blind Phase||88
74135|NCT02227784|180198|P3|COMPLETED|Double-Blind Phase||41
74136|NCT02227784|180199|P2|COMPLETED|Double-Blind Phase||36
74137|NCT02227784|180200|P1|COMPLETED|Double-Blind Phase||83
74138|NCT02227784|180196|P5|STARTED|Double-Blind Phase||0
74139|NCT02227784|180197|P4|STARTED|Double-Blind Phase||127
74140|NCT02227784|180198|P3|STARTED|Double-Blind Phase||62
74141|NCT02227784|180199|P2|STARTED|Double-Blind Phase||54
74142|NCT02227784|180200|P1|STARTED|Double-Blind Phase||123
74143|NCT02227758|180235|P1|NOT COMPLETED|Overall Study||67
74144|NCT02227758|180235|P1|COMPLETED|Overall Study||45
74145|NCT02227758|180235|P1|STARTED|Overall Study||112
74146|NCT02227693|180251|P4|NOT COMPLETED|Overall Study||0
74147|NCT02227693|180252|P3|NOT COMPLETED|Overall Study||0
74148|NCT02227693|180253|P2|NOT COMPLETED|Overall Study||0
74149|NCT02227693|180254|P1|NOT COMPLETED|Overall Study||0
74150|NCT02227693|180251|P4|COMPLETED|Overall Study||10
74151|NCT02227693|180252|P3|COMPLETED|Overall Study||11
74152|NCT02227693|180253|P2|COMPLETED|Overall Study||7
74153|NCT02227693|180254|P1|COMPLETED|Overall Study||11
74154|NCT02227693|180251|P4|STARTED|Overall Study||10
74155|NCT02227693|180252|P3|STARTED|Overall Study||11
74156|NCT02227693|180253|P2|STARTED|Overall Study||7
74157|NCT02227693|180254|P1|STARTED|Overall Study||11
74158|NCT02227485|180310|P2|NOT COMPLETED|Second Follow-up||2
74159|NCT02227485|180311|P1|NOT COMPLETED|Second Follow-up||2
74160|NCT02227485|180310|P2|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|36
74161|NCT02227485|180311|P1|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|34
74162|NCT02227485|180310|P2|STARTED|Second Follow-up||38
74163|NCT02227485|180311|P1|STARTED|Second Follow-up||36
74164|NCT02227485|180310|P2|NOT COMPLETED|First Follow-up||2
74165|NCT02227485|180311|P1|NOT COMPLETED|First Follow-up||4
74250|NCT02226653|180511|P1|STARTED|Treatment Period 4 Fasted State||23
74166|NCT02227485|180310|P2|COMPLETED|First Follow-up|After 2 weeks, 2 patients had withdrew the study.|38
74167|NCT02227485|180311|P1|COMPLETED|First Follow-up|At the first follow-up we lost 4 patients.|36
74168|NCT02227485|180310|P2|STARTED|First Follow-up||40
74169|NCT02227485|180311|P1|STARTED|First Follow-up||40
74170|NCT02227368|180329|P2|NOT COMPLETED|Overall Study||4
74171|NCT02227368|180330|P1|NOT COMPLETED|Overall Study||2
74172|NCT02227368|180329|P2|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|20
74173|NCT02227368|180330|P1|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|14
74174|NCT02227368|180329|P2|Sujects Who Completed Treatment|Overall Study||17
74175|NCT02227368|180330|P1|Sujects Who Completed Treatment|Overall Study||10
74176|NCT02227368|180329|P2|Sujects Who Received Treatment|Overall Study||24
74177|NCT02227368|180330|P1|Sujects Who Received Treatment|Overall Study||16
74178|NCT02227368|180329|P2|STARTED|Overall Study||24
74179|NCT02227368|180330|P1|STARTED|Overall Study||16
74180|NCT02227329|180340|P2|NOT COMPLETED|Overall Study||0
74181|NCT02227329|180341|P1|NOT COMPLETED|Overall Study||0
74182|NCT02227329|180340|P2|COMPLETED|Overall Study||20
74183|NCT02227329|180341|P1|COMPLETED|Overall Study||18
74184|NCT02227329|180340|P2|STARTED|Overall Study||20
74185|NCT02227329|180341|P1|STARTED|Overall Study||18
74186|NCT02227316|180351|P4|NOT COMPLETED|Overall Study||0
74187|NCT02227316|180352|P3|NOT COMPLETED|Overall Study||0
74188|NCT02227316|180353|P2|NOT COMPLETED|Overall Study||0
74189|NCT02227316|180354|P1|NOT COMPLETED|Overall Study||0
74190|NCT02227316|180351|P4|COMPLETED|Overall Study||16
74191|NCT02227316|180352|P3|COMPLETED|Overall Study||16
74192|NCT02227316|180353|P2|COMPLETED|Overall Study||4
74193|NCT02227316|180354|P1|COMPLETED|Overall Study||4
74194|NCT02227316|180351|P4|STARTED|Overall Study||16
74195|NCT02227316|180352|P3|STARTED|Overall Study||16
74196|NCT02227316|180353|P2|STARTED|Overall Study||4
74197|NCT02227316|180354|P1|STARTED|Overall Study||4
74198|NCT02227238|180386|P2|NOT COMPLETED|Overall Study||67
74199|NCT02227238|180387|P1|NOT COMPLETED|Overall Study||37
74200|NCT02227238|180386|P2|COMPLETED|Overall Study||245
74201|NCT02227238|180387|P1|COMPLETED|Overall Study||275
74202|NCT02227238|180386|P2|STARTED|Overall Study||312
74203|NCT02227238|180387|P1|STARTED|Overall Study||312
74204|NCT02227147|180453|P2|NOT COMPLETED|Follow-up Period||5
74205|NCT02227147|180454|P1|NOT COMPLETED|Follow-up Period||3
74206|NCT02227147|180453|P2|COMPLETED|Follow-up Period||16
74207|NCT02227147|180454|P1|COMPLETED|Follow-up Period||15
74208|NCT02227147|180453|P2|STARTED|Follow-up Period||21
74209|NCT02227147|180454|P1|STARTED|Follow-up Period||18
74210|NCT02227147|180453|P2|NOT COMPLETED|Controlled Treatment Period||3
74211|NCT02227147|180454|P1|NOT COMPLETED|Controlled Treatment Period||6
74212|NCT02227147|180453|P2|COMPLETED|Controlled Treatment Period||21
74213|NCT02227147|180454|P1|COMPLETED|Controlled Treatment Period||18
74214|NCT02227147|180453|P2|STARTED|Controlled Treatment Period||24
74215|NCT02227147|180454|P1|STARTED|Controlled Treatment Period||24
74216|NCT02227121|180477|P1|NOT COMPLETED|Overall Study||0
74217|NCT02227121|180477|P1|COMPLETED|Overall Study||16
74218|NCT02227121|180477|P1|STARTED|Overall Study||16
74219|NCT02227108|180481|P1|NOT COMPLETED|Overall Study||31
74220|NCT02227108|180481|P1|COMPLETED|Overall Study||1
74221|NCT02227108|180481|P1|Treated|Overall Study||30
74222|NCT02227108|180481|P1|STARTED|Overall Study||32
74223|NCT02226653|180510|P2|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0
74224|NCT02226653|180511|P1|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0
74225|NCT02226653|180510|P2|COMPLETED|Washout Period 5 (at Least 21 Days)||23
74226|NCT02226653|180511|P1|COMPLETED|Washout Period 5 (at Least 21 Days)||23
74227|NCT02226653|180510|P2|STARTED|Washout Period 5 (at Least 21 Days)||23
74228|NCT02226653|180511|P1|STARTED|Washout Period 5 (at Least 21 Days)||23
74229|NCT02226653|180510|P2|NOT COMPLETED|Treatment Period 5 Fed State||1
74230|NCT02226653|180511|P1|NOT COMPLETED|Treatment Period 5 Fed State||0
74231|NCT02226653|180510|P2|COMPLETED|Treatment Period 5 Fed State||23
74232|NCT02226653|180511|P1|COMPLETED|Treatment Period 5 Fed State||23
74233|NCT02226653|180510|P2|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||24
74234|NCT02226653|180511|P1|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||23
74235|NCT02226653|180510|P2|STARTED|Treatment Period 5 Fed State||24
74236|NCT02226653|180511|P1|STARTED|Treatment Period 5 Fed State||23
74237|NCT02226653|180510|P2|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0
74238|NCT02226653|180511|P1|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0
74239|NCT02226653|180510|P2|COMPLETED|Washout Period 4 (at Least 21 Days)||24
74240|NCT02226653|180511|P1|COMPLETED|Washout Period 4 (at Least 21 Days)||23
74241|NCT02226653|180510|P2|STARTED|Washout Period 4 (at Least 21 Days)||24
74242|NCT02226653|180511|P1|STARTED|Washout Period 4 (at Least 21 Days)||23
74243|NCT02226653|180510|P2|NOT COMPLETED|Treatment Period 4 Fasted State||0
74244|NCT02226653|180511|P1|NOT COMPLETED|Treatment Period 4 Fasted State||0
74245|NCT02226653|180510|P2|COMPLETED|Treatment Period 4 Fasted State||24
74246|NCT02226653|180511|P1|COMPLETED|Treatment Period 4 Fasted State||23
74247|NCT02226653|180510|P2|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||24
74248|NCT02226653|180511|P1|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||23
74249|NCT02226653|180510|P2|STARTED|Treatment Period 4 Fasted State||24
74251|NCT02226653|180510|P2|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0
74252|NCT02226653|180511|P1|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0
74253|NCT02226653|180510|P2|COMPLETED|Washout Period 3 (at Least 21 Days)||24
74254|NCT02226653|180511|P1|COMPLETED|Washout Period 3 (at Least 21 Days)||23
74255|NCT02226653|180510|P2|STARTED|Washout Period 3 (at Least 21 Days)||24
74256|NCT02226653|180511|P1|STARTED|Washout Period 3 (at Least 21 Days)||23
74257|NCT02226653|180510|P2|NOT COMPLETED|Treatment Period 3 Fasted State||0
74258|NCT02226653|180511|P1|NOT COMPLETED|Treatment Period 3 Fasted State||0
74259|NCT02226653|180510|P2|COMPLETED|Treatment Period 3 Fasted State||24
74260|NCT02226653|180511|P1|COMPLETED|Treatment Period 3 Fasted State||23
74261|NCT02226653|180510|P2|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||24
74262|NCT02226653|180511|P1|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||23
74263|NCT02226653|180510|P2|STARTED|Treatment Period 3 Fasted State||24
74264|NCT02226653|180511|P1|STARTED|Treatment Period 3 Fasted State||23
74265|NCT02226653|180510|P2|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0
74266|NCT02226653|180511|P1|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0
74267|NCT02226653|180510|P2|COMPLETED|Washout Period 2 (at Least 21 Days)||24
74268|NCT02226653|180511|P1|COMPLETED|Washout Period 2 (at Least 21 Days)||23
74269|NCT02226653|180510|P2|STARTED|Washout Period 2 (at Least 21 Days)||24
74270|NCT02226653|180511|P1|STARTED|Washout Period 2 (at Least 21 Days)||23
74271|NCT02226653|180510|P2|NOT COMPLETED|Treatment Period 2 Fasted State||0
74272|NCT02226653|180511|P1|NOT COMPLETED|Treatment Period 2 Fasted State||1
74273|NCT02226653|180510|P2|COMPLETED|Treatment Period 2 Fasted State||24
74274|NCT02226653|180511|P1|COMPLETED|Treatment Period 2 Fasted State||23
74275|NCT02226653|180510|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24
74276|NCT02226653|180511|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24
74277|NCT02226653|180510|P2|STARTED|Treatment Period 2 Fasted State||24
74278|NCT02226653|180511|P1|STARTED|Treatment Period 2 Fasted State||24
74279|NCT02226653|180510|P2|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0
74280|NCT02226653|180511|P1|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0
74281|NCT02226653|180510|P2|COMPLETED|Washout Period 1 (at Least 21 Days)||24
74282|NCT02226653|180511|P1|COMPLETED|Washout Period 1 (at Least 21 Days)||24
74283|NCT02226653|180510|P2|STARTED|Washout Period 1 (at Least 21 Days)||24
74284|NCT02226653|180511|P1|STARTED|Washout Period 1 (at Least 21 Days)||24
74285|NCT02226653|180510|P2|NOT COMPLETED|Treatment Period 1 Fasted State||0
74286|NCT02226653|180511|P1|NOT COMPLETED|Treatment Period 1 Fasted State||0
74287|NCT02226653|180510|P2|COMPLETED|Treatment Period 1 Fasted State||24
74288|NCT02226653|180511|P1|COMPLETED|Treatment Period 1 Fasted State||24
74289|NCT02226653|180510|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24
74290|NCT02226653|180511|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24
74291|NCT02226653|180510|P2|STARTED|Treatment Period 1 Fasted State||24
74292|NCT02226653|180511|P1|STARTED|Treatment Period 1 Fasted State||24
74293|NCT02226562|180535|P2|NOT COMPLETED|Overall Study||1
74294|NCT02226562|180536|P1|NOT COMPLETED|Overall Study||0
74295|NCT02226562|180535|P2|COMPLETED|Overall Study|Lost to follow up|95
74296|NCT02226562|180536|P1|COMPLETED|Overall Study||95
74297|NCT02226562|180535|P2|STARTED|Overall Study||96
74298|NCT02226562|180536|P1|STARTED|Overall Study||95
74299|NCT02226549|180554|P2|NOT COMPLETED|Overall Study||1
74300|NCT02226549|180555|P1|NOT COMPLETED|Overall Study||1
74301|NCT02226549|180554|P2|COMPLETED|Overall Study||23
74302|NCT02226549|180555|P1|COMPLETED|Overall Study||22
74303|NCT02226549|180554|P2|STARTED|Overall Study||24
74304|NCT02226549|180555|P1|STARTED|Overall Study||23
74305|NCT02226198|180565|P3|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
74306|NCT02226198|180566|P2|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
74307|NCT02226198|180567|P1|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
74308|NCT02226198|180565|P3|COMPLETED|Maintenance Phase (12 Weeks)||0
74309|NCT02226198|180566|P2|COMPLETED|Maintenance Phase (12 Weeks)||0
74310|NCT02226198|180567|P1|COMPLETED|Maintenance Phase (12 Weeks)||13
74311|NCT02226198|180565|P3|STARTED|Maintenance Phase (12 Weeks)||0
74312|NCT02226198|180566|P2|STARTED|Maintenance Phase (12 Weeks)||0
74313|NCT02226198|180567|P1|STARTED|Maintenance Phase (12 Weeks)||13
74314|NCT02226198|180565|P3|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
74315|NCT02226198|180566|P2|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
74316|NCT02226198|180567|P1|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
74317|NCT02226198|180565|P3|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||7
74318|NCT02226198|180566|P2|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||6
74319|NCT02226198|180567|P1|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
74320|NCT02226198|180565|P3|STARTED|Cross-Over: Second Interv. (6 Weeks)||7
74321|NCT02226198|180566|P2|STARTED|Cross-Over: Second Interv. (6 Weeks)||6
74322|NCT02226198|180567|P1|STARTED|Cross-Over: Second Interv. (6 Weeks)||0
74323|NCT02226198|180565|P3|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
74324|NCT02226198|180566|P2|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||1
74325|NCT02226198|180567|P1|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
74326|NCT02226198|180565|P3|COMPLETED|Cross-Over: First Intervention (6 Weeks)||7
74327|NCT02226198|180566|P2|COMPLETED|Cross-Over: First Intervention (6 Weeks)||6
74328|NCT02226198|180567|P1|COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
74329|NCT02226198|180565|P3|STARTED|Cross-Over: First Intervention (6 Weeks)||7
74330|NCT02226198|180566|P2|STARTED|Cross-Over: First Intervention (6 Weeks)||7
74331|NCT02226198|180567|P1|STARTED|Cross-Over: First Intervention (6 Weeks)||0
74332|NCT02226198|180565|P3|NOT COMPLETED|Lead-in Phase||0
74333|NCT02226198|180566|P2|NOT COMPLETED|Lead-in Phase||0
74334|NCT02226198|180567|P1|NOT COMPLETED|Lead-in Phase||1
74335|NCT02226198|180565|P3|COMPLETED|Lead-in Phase||0
74336|NCT02226198|180566|P2|COMPLETED|Lead-in Phase||0
74337|NCT02226198|180567|P1|COMPLETED|Lead-in Phase||10
74338|NCT02226198|180565|P3|STARTED|Lead-in Phase||0
74339|NCT02226198|180566|P2|STARTED|Lead-in Phase||0
74340|NCT02226198|180567|P1|STARTED|Lead-in Phase||11
74341|NCT02226172|180640|P1|NOT COMPLETED|Overall Study||17
74342|NCT02226172|180640|P1|COMPLETED|Overall Study||4
74343|NCT02226172|180640|P1|STARTED|Overall Study||21
74344|NCT02226120|180671|P1|NOT COMPLETED|Overall Study||320
74345|NCT02226120|180671|P1|COMPLETED|Overall Study||1660
74346|NCT02226120|180671|P1|STARTED|Overall Study||1980
74347|NCT02226003|180678|P3|NOT COMPLETED|Overall Study||6
74348|NCT02226003|180679|P2|NOT COMPLETED|Overall Study||1
74349|NCT02226003|180680|P1|NOT COMPLETED|Overall Study||2
74350|NCT02226003|180678|P3|COMPLETED|Overall Study||91
74351|NCT02226003|180679|P2|COMPLETED|Overall Study||95
74352|NCT02226003|180680|P1|COMPLETED|Overall Study||96
74353|NCT02226003|180678|P3|STARTED|Overall Study||97
74354|NCT02226003|180679|P2|STARTED|Overall Study||96
74355|NCT02226003|180680|P1|STARTED|Overall Study||98
74356|NCT02225860|180714|P2|NOT COMPLETED|Overall Study||0
74357|NCT02225860|180715|P1|NOT COMPLETED|Overall Study||1
74358|NCT02225860|180714|P2|COMPLETED|Overall Study||17
74359|NCT02225860|180715|P1|COMPLETED|Overall Study||16
74360|NCT02225860|180714|P2|STARTED|Overall Study||17
74361|NCT02225860|180715|P1|STARTED|Overall Study||17
74362|NCT02225743|180725|P1|NOT COMPLETED|Overall Study||18
74363|NCT02225743|180725|P1|COMPLETED|Overall Study|18 patients chose not to participate on the day of surgery.|102
74364|NCT02225743|180725|P1|STARTED|Overall Study||120
74365|NCT02225353|180732|P3|NOT COMPLETED|Overall Study||15
74366|NCT02225353|180733|P2|NOT COMPLETED|Overall Study||6
74367|NCT02225353|180734|P1|NOT COMPLETED|Overall Study||4
74368|NCT02225353|180732|P3|COMPLETED|Overall Study||75
74369|NCT02225353|180733|P2|COMPLETED|Overall Study||84
74370|NCT02225353|180734|P1|COMPLETED|Overall Study||87
74371|NCT02225353|180732|P3|STARTED|Overall Study||90
74372|NCT02225353|180733|P2|STARTED|Overall Study||90
74373|NCT02225353|180734|P1|STARTED|Overall Study||91
74374|NCT02225132|180757|P1|NOT COMPLETED|Overall Study||0
74375|NCT02225132|180757|P1|COMPLETED|Overall Study||10
74376|NCT02225132|180757|P1|STARTED|Overall Study||10
74377|NCT02225106|180762|P1|NOT COMPLETED|Overall Study||0
74378|NCT02225106|180762|P1|COMPLETED|Overall Study||11
74379|NCT02225106|180762|P1|STARTED|Overall Study||11
74380|NCT02225080|180766|P1|NOT COMPLETED|Overall Study||0
74381|NCT02225080|180766|P1|COMPLETED|Overall Study||100
74382|NCT02225080|180766|P1|STARTED|Overall Study||100
74383|NCT02224846|180775|P2|NOT COMPLETED|Period 2 (Month 12 to Month 24)||74
74384|NCT02224846|180776|P1|NOT COMPLETED|Period 2 (Month 12 to Month 24)||42
74385|NCT02224846|180775|P2|COMPLETED|Period 2 (Month 12 to Month 24)||283
74386|NCT02224846|180776|P1|COMPLETED|Period 2 (Month 12 to Month 24)||131
74387|NCT02224846|180775|P2|STARTED|Period 2 (Month 12 to Month 24)||357
74388|NCT02224846|180776|P1|STARTED|Period 2 (Month 12 to Month 24)||173
74389|NCT02224846|180775|P2|NOT COMPLETED|Period 2 (Month 3 to Month 12)||31
74390|NCT02224846|180776|P1|NOT COMPLETED|Period 2 (Month 3 to Month 12)||19
74391|NCT02224846|180775|P2|COMPLETED|Period 2 (Month 3 to Month 12)||357
74392|NCT02224846|180776|P1|COMPLETED|Period 2 (Month 3 to Month 12)||173
74393|NCT02224846|180775|P2|STARTED|Period 2 (Month 3 to Month 12)||388
74394|NCT02224846|180776|P1|STARTED|Period 2 (Month 3 to Month 12)||192
74395|NCT02224846|180775|P2|NOT COMPLETED|Period 1 (Month 3)||36
74396|NCT02224846|180776|P1|NOT COMPLETED|Period 1 (Month 3)||19
74397|NCT02224846|180775|P2|COMPLETED|Period 1 (Month 3)||388
74398|NCT02224846|180776|P1|COMPLETED|Period 1 (Month 3)||192
74399|NCT02224846|180775|P2|Received at Least One Dose of Study Drug|Period 1 (Month 3)||421
74400|NCT02224846|180776|P1|Received at Least One Dose of Study Drug|Period 1 (Month 3)||210
74401|NCT02224846|180775|P2|STARTED|Period 1 (Month 3)||424
74402|NCT02224846|180776|P1|STARTED|Period 1 (Month 3)||211
74403|NCT02224820|180796|P1|NOT COMPLETED|Overall Study||0
74404|NCT02224820|180796|P1|COMPLETED|Overall Study|One patient did not receive full dose|8
74405|NCT02224820|180796|P1|STARTED|Overall Study||8
74406|NCT02224755|180806|P2|NOT COMPLETED|Two Year Follow up Post-implant||226
74407|NCT02224755|180807|P1|NOT COMPLETED|Two Year Follow up Post-implant||258
74408|NCT02224755|180806|P2|COMPLETED|Two Year Follow up Post-implant||289
74409|NCT02224755|180807|P1|COMPLETED|Two Year Follow up Post-implant||247
74410|NCT02224755|180806|P2|STARTED|Two Year Follow up Post-implant||515
74411|NCT02224755|180807|P1|STARTED|Two Year Follow up Post-implant||505
74412|NCT02224755|180806|P2|NOT COMPLETED|Randomization to Device Implant||1
74413|NCT02224755|180807|P1|NOT COMPLETED|Randomization to Device Implant||7
74414|NCT02224755|180806|P2|COMPLETED|Randomization to Device Implant|Patients who underwent HeartMate 3 LVAS implant|515
74415|NCT02224755|180807|P1|COMPLETED|Randomization to Device Implant|Patients who underwent HeartMate II LVAS implant|505
74416|NCT02224755|180806|P2|STARTED|Randomization to Device Implant|Patients in the Full Study Cohort (n=1028) who were randomized to HeartMate 3|516
74417|NCT02224755|180807|P1|STARTED|Randomization to Device Implant|Patients in the Full Study Cohort (n=1028) who were randomized to HeartMate II|512
74418|NCT02224729|180831|P1|NOT COMPLETED|Overall Study||0
74419|NCT02224729|180831|P1|COMPLETED|Overall Study||24
74420|NCT02224729|180831|P1|STARTED|Overall Study||24
74421|NCT02224703|180842|P3|NOT COMPLETED|Overall Study||0
74422|NCT02224703|180843|P2|NOT COMPLETED|Overall Study||6
74423|NCT02224703|180844|P1|NOT COMPLETED|Overall Study||3
74424|NCT02224703|180842|P3|COMPLETED|Overall Study||65
74425|NCT02224703|180843|P2|COMPLETED|Overall Study||61
74426|NCT02224703|180844|P1|COMPLETED|Overall Study||64
74427|NCT02224703|180842|P3|Intent to Treat (ITT) Analysis Set|Overall Study||65
74428|NCT02224703|180843|P2|Intent to Treat (ITT) Analysis Set|Overall Study||67
74429|NCT02224703|180844|P1|Intent to Treat (ITT) Analysis Set|Overall Study||66
74430|NCT02224703|180842|P3|Safety Analysis Set|Overall Study||65
74431|NCT02224703|180843|P2|Safety Analysis Set|Overall Study|Two participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group|69
74432|NCT02224703|180844|P1|Safety Analysis Set|Overall Study|Two participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group|64
74433|NCT02224703|180842|P3|Received at Least 1 Dose of Study Drug|Overall Study||65
74434|NCT02224703|180843|P2|Received at Least 1 Dose of Study Drug|Overall Study||67
74435|NCT02224703|180844|P1|Received at Least 1 Dose of Study Drug|Overall Study||66
74436|NCT02224703|180842|P3|STARTED|Overall Study||65
74437|NCT02224703|180843|P2|STARTED|Overall Study||67
74438|NCT02224703|180844|P1|STARTED|Overall Study||67
74439|NCT02224690|180863|P2|NOT COMPLETED|Overall Study||1
74440|NCT02224690|180864|P1|NOT COMPLETED|Overall Study||14
74441|NCT02224690|180863|P2|COMPLETED|Overall Study||84
74442|NCT02224690|180864|P1|COMPLETED|Overall Study||72
74443|NCT02224690|180863|P2|Intent to Treat (ITT) Analysis Set|Overall Study||85
74444|NCT02224690|180864|P1|Intent to Treat (ITT) Analysis Set|Overall Study||86
74445|NCT02224690|180863|P2|Safety Analysis Set|Overall Study||85
74446|NCT02224690|180864|P1|Safety Analysis Set|Overall Study||86
74447|NCT02224690|180863|P2|STARTED|Overall Study||85
74448|NCT02224690|180864|P1|STARTED|Overall Study||86
74449|NCT02224664|180876|P5|NOT COMPLETED|Dose Escalation Period (21 Days)||11
74450|NCT02224664|180877|P4|NOT COMPLETED|Dose Escalation Period (21 Days)||3
74451|NCT02224664|180878|P3|NOT COMPLETED|Dose Escalation Period (21 Days)||2
74452|NCT02224664|180879|P2|NOT COMPLETED|Dose Escalation Period (21 Days)||0
74453|NCT02224664|180880|P1|NOT COMPLETED|Dose Escalation Period (21 Days)||0
74454|NCT02224664|180876|P5|COMPLETED|Dose Escalation Period (21 Days)||8
74455|NCT02224664|180877|P4|COMPLETED|Dose Escalation Period (21 Days)||3
74456|NCT02224664|180878|P3|COMPLETED|Dose Escalation Period (21 Days)||9
74457|NCT02224664|180879|P2|COMPLETED|Dose Escalation Period (21 Days)||9
74458|NCT02224664|180880|P1|COMPLETED|Dose Escalation Period (21 Days)||0
74459|NCT02224664|180876|P5|STARTED|Dose Escalation Period (21 Days)||19
74460|NCT02224664|180877|P4|STARTED|Dose Escalation Period (21 Days)||6
74461|NCT02224664|180878|P3|STARTED|Dose Escalation Period (21 Days)||11
74462|NCT02224664|180879|P2|STARTED|Dose Escalation Period (21 Days)||9
74463|NCT02224664|180880|P1|STARTED|Dose Escalation Period (21 Days)||0
74464|NCT02224664|180876|P5|NOT COMPLETED|Lead-in Period (3 Days)||0
74465|NCT02224664|180877|P4|NOT COMPLETED|Lead-in Period (3 Days)||0
74466|NCT02224664|180878|P3|NOT COMPLETED|Lead-in Period (3 Days)||0
74467|NCT02224664|180879|P2|NOT COMPLETED|Lead-in Period (3 Days)||0
74468|NCT02224664|180880|P1|NOT COMPLETED|Lead-in Period (3 Days)||5
74469|NCT02224664|180876|P5|COMPLETED|Lead-in Period (3 Days)||0
74470|NCT02224664|180877|P4|COMPLETED|Lead-in Period (3 Days)||0
74471|NCT02224664|180878|P3|COMPLETED|Lead-in Period (3 Days)||0
74472|NCT02224664|180879|P2|COMPLETED|Lead-in Period (3 Days)||0
74473|NCT02224664|180880|P1|COMPLETED|Lead-in Period (3 Days)||45
74474|NCT02224664|180876|P5|STARTED|Lead-in Period (3 Days)||0
74475|NCT02224664|180877|P4|STARTED|Lead-in Period (3 Days)||0
74476|NCT02224664|180878|P3|STARTED|Lead-in Period (3 Days)||0
74477|NCT02224664|180879|P2|STARTED|Lead-in Period (3 Days)||0
74478|NCT02224664|180880|P1|STARTED|Lead-in Period (3 Days)||50
74479|NCT02224638|180962|P2|NOT COMPLETED|Overall Study||1
74480|NCT02224638|180963|P1|NOT COMPLETED|Overall Study||1
74481|NCT02224638|180962|P2|COMPLETED|Overall Study||9
74482|NCT02224638|180963|P1|COMPLETED|Overall Study||10
74483|NCT02224638|180962|P2|STARTED|Overall Study||10
74484|NCT02224638|180963|P1|STARTED|Overall Study||11
74485|NCT02224625|180971|P1|NOT COMPLETED|Sensitization||55
74486|NCT02224625|180971|P1|COMPLETED|Sensitization||194
74487|NCT02224625|180971|P1|STARTED|Sensitization|Subjects from Irritation study also participated in Sensitization Study|249
74488|NCT02224625|180971|P1|NOT COMPLETED|Irritation||6
74489|NCT02224625|180971|P1|COMPLETED|Irritation||33
74490|NCT02224625|180971|P1|STARTED|Irritation||39
74491|NCT02224612|180983|P2|NOT COMPLETED|Overall Study||0
74492|NCT02224612|180984|P1|NOT COMPLETED|Overall Study||0
74493|NCT02224612|180983|P2|COMPLETED|Overall Study||48
74494|NCT02224612|180984|P1|COMPLETED|Overall Study||48
74495|NCT02224612|180983|P2|STARTED|Overall Study||48
74496|NCT02224612|180984|P1|STARTED|Overall Study||48
74497|NCT02224560|180995|P3|NOT COMPLETED|Overall Study||2
74498|NCT02224560|180996|P2|NOT COMPLETED|Overall Study||2
74499|NCT02224560|180997|P1|NOT COMPLETED|Overall Study||9
74500|NCT02224560|180995|P3|COMPLETED|Overall Study||74
74501|NCT02224560|180996|P2|COMPLETED|Overall Study||71
74502|NCT02224560|180997|P1|COMPLETED|Overall Study||67
74503|NCT02224560|180995|P3|Intent to Treat (ITT) Analysis Set|Overall Study||76
74504|NCT02224560|180996|P2|Intent to Treat (ITT) Analysis Set|Overall Study||73
74505|NCT02224560|180997|P1|Intent to Treat (ITT) Analysis Set|Overall Study||76
74506|NCT02224560|180995|P3|Safety Analysis Set|Overall Study||76
74507|NCT02224560|180996|P2|Safety Analysis Set|Overall Study|Six participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group.|67
74508|NCT02224560|180997|P1|Safety Analysis Set|Overall Study|Six participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group.|82
74509|NCT02224560|180995|P3|STARTED|Overall Study||76
74510|NCT02224560|180996|P2|STARTED|Overall Study||73
74511|NCT02224560|180997|P1|STARTED|Overall Study||76
74512|NCT02224508|181016|P2|NOT COMPLETED|Overall Study||0
74513|NCT02224508|181017|P1|NOT COMPLETED|Overall Study||0
74514|NCT02224508|181016|P2|COMPLETED|Overall Study||653
74515|NCT02224508|181017|P1|COMPLETED|Overall Study||935
74516|NCT02224508|181016|P2|STARTED|Overall Study|Number of patients surveyed in the control segment of the health plan (contracted care).|653
74517|NCT02224508|181017|P1|STARTED|Overall Study|Number of patients surveyed in intervention segment of the health plan (group practice).|935
74518|NCT02224404|181027|P1|NOT COMPLETED|Overall Study||0
74519|NCT02224404|181027|P1|COMPLETED|Overall Study||21
74520|NCT02224404|181027|P1|STARTED|Overall Study||21
74521|NCT02224274|181034|P2|NOT COMPLETED|Overall Study||0
74522|NCT02224274|181035|P1|NOT COMPLETED|Overall Study||1
74523|NCT02224274|181034|P2|COMPLETED|Overall Study||20
74524|NCT02224274|181035|P1|COMPLETED|Overall Study||16
74525|NCT02224274|181034|P2|STARTED|Overall Study||20
74526|NCT02224274|181035|P1|STARTED|Overall Study||17
74527|NCT02224157|181047|P2|NOT COMPLETED|Overall Study||111
74528|NCT02224157|181048|P1|NOT COMPLETED|Overall Study||110
74529|NCT02224157|181047|P2|COMPLETED|Overall Study||1983
74530|NCT02224157|181048|P1|COMPLETED|Overall Study||1985
74531|NCT02224157|181047|P2|Patients Who Completed Treatment|Overall Study||1903
74532|NCT02224157|181048|P1|Patients Who Completed Treatment|Overall Study||1924
74533|NCT02224157|181047|P2|STARTED|Overall Study||2094
74534|NCT02224157|181048|P1|STARTED|Overall Study||2095
74535|NCT02224053|181072|P1|NOT COMPLETED|AZD9291 Alone||0
74536|NCT02224053|181072|P1|COMPLETED|AZD9291 Alone||47
74537|NCT02224053|181072|P1|STARTED|AZD9291 Alone||47
74538|NCT02224053|181072|P1|NOT COMPLETED|AZD9291 and Omeprazole Co-administration||21
74539|NCT02224053|181072|P1|COMPLETED|AZD9291 and Omeprazole Co-administration||47
74540|NCT02224053|181072|P1|STARTED|AZD9291 and Omeprazole Co-administration||68
74541|NCT02223871|181104|P1|NOT COMPLETED|Overall Study||0
74542|NCT02223871|181104|P1|COMPLETED|Overall Study||8
74543|NCT02223871|181104|P1|STARTED|Overall Study||8
74544|NCT02223858|181118|P2|NOT COMPLETED|Overall Study||26
74545|NCT02223858|181119|P1|NOT COMPLETED|Overall Study||24
74546|NCT02223858|181118|P2|COMPLETED|Overall Study||154
74547|NCT02223858|181119|P1|COMPLETED|Overall Study||156
74548|NCT02223858|181118|P2|6-month Follow-up|Overall Study||154
74549|NCT02223858|181119|P1|6-month Follow-up|Overall Study||156
74550|NCT02223858|181118|P2|3-month Follow-up|Overall Study||154
74551|NCT02223858|181119|P1|3-month Follow-up|Overall Study||155
74552|NCT02223858|181118|P2|1-month Follow-up|Overall Study||150
74553|NCT02223858|181119|P1|1-month Follow-up|Overall Study||156
74554|NCT02223858|181118|P2|STARTED|Overall Study||180
74555|NCT02223858|181119|P1|STARTED|Overall Study||180
74556|NCT02223793|181132|P3|NOT COMPLETED|Overall Study||13
74557|NCT02223793|181133|P2|NOT COMPLETED|Overall Study||9
74558|NCT02223793|181134|P1|NOT COMPLETED|Overall Study||17
74559|NCT02223793|181132|P3|COMPLETED|Overall Study||185
74560|NCT02223793|181133|P2|COMPLETED|Overall Study||190
74561|NCT02223793|181134|P1|COMPLETED|Overall Study||168
74562|NCT02223793|181132|P3|STARTED|Overall Study||198
74563|NCT02223793|181133|P2|STARTED|Overall Study||199
74564|NCT02223793|181134|P1|STARTED|Overall Study||185
74565|NCT02223754|181147|P2|NOT COMPLETED|Period 2||3
74566|NCT02223754|181148|P1|NOT COMPLETED|Period 2||3
74567|NCT02223754|181147|P2|COMPLETED|Period 2||141
74568|NCT02223754|181148|P1|COMPLETED|Period 2||156
74569|NCT02223754|181147|P2|STARTED|Period 2||144
74570|NCT02223754|181148|P1|STARTED|Period 2||159
74571|NCT02223754|181147|P2|NOT COMPLETED|Period 1||15
74572|NCT02223754|181148|P1|NOT COMPLETED|Period 1||4
74573|NCT02223754|181147|P2|COMPLETED|Period 1||144
74574|NCT02223754|181148|P1|COMPLETED|Period 1||159
74575|NCT02223754|181147|P2|STARTED|Period 1||159
74576|NCT02223754|181148|P1|STARTED|Period 1||163
74577|NCT02223715|181168|P1|NOT COMPLETED|Overall Study||104
74578|NCT02223715|181168|P1|COMPLETED|Overall Study||496
74579|NCT02223715|181168|P1|STARTED|Overall Study||600
74580|NCT02223702|181177|P2|NOT COMPLETED|Overall Study||4
74581|NCT02223702|181178|P1|NOT COMPLETED|Overall Study||1
74582|NCT02223702|181177|P2|COMPLETED|Overall Study||15
74583|NCT02223702|181178|P1|COMPLETED|Overall Study||19
74584|NCT02223702|181177|P2|STARTED|Overall Study||19
74585|NCT02223702|181178|P1|STARTED|Overall Study||20
74586|NCT02223689|181186|P1|NOT COMPLETED|Overall Study||0
74587|NCT02223689|181186|P1|COMPLETED|Overall Study||35
74588|NCT02223689|181186|P1|STARTED|Overall Study||35
74589|NCT02223650|181193|P2|NOT COMPLETED|Overall Study||0
74590|NCT02223650|181194|P1|NOT COMPLETED|Overall Study||0
74591|NCT02223650|181193|P2|COMPLETED|Overall Study||31
74592|NCT02223650|181194|P1|COMPLETED|Overall Study||27
74593|NCT02223650|181193|P2|STARTED|Overall Study||31
74594|NCT02223650|181194|P1|STARTED|Overall Study||27
74595|NCT02223637|181224|P1|NOT COMPLETED|Overall Study||0
74596|NCT02223637|181224|P1|COMPLETED|Overall Study||82
74597|NCT02223637|181224|P1|STARTED|Overall Study||82
74598|NCT02223455|181250|P3|NOT COMPLETED|Overall Study||0
74599|NCT02223455|181251|P2|NOT COMPLETED|Overall Study||0
74600|NCT02223455|181252|P1|NOT COMPLETED|Overall Study||0
74601|NCT02223455|181250|P3|COMPLETED|Overall Study|Participant level data not collected.|0
74602|NCT02223455|181251|P2|COMPLETED|Overall Study|Participant level data not collected.|0
74603|NCT02223455|181252|P1|COMPLETED|Overall Study|Participant level data not collected.|0
74604|NCT02223455|181250|P3|STARTED|Overall Study|Participant level data not collected.|0
74605|NCT02223455|181251|P2|STARTED|Overall Study|Participant level data not collected.|0
74606|NCT02223455|181252|P1|STARTED|Overall Study|Participant level data not collected.|0
74607|NCT02223429|181264|P4|NOT COMPLETED|Overall Study||0
74608|NCT02223429|181265|P3|NOT COMPLETED|Overall Study||0
74609|NCT02223429|181266|P2|NOT COMPLETED|Overall Study||0
74610|NCT02223429|181267|P1|NOT COMPLETED|Overall Study||1
74611|NCT02223429|181264|P4|COMPLETED|Overall Study||8
74612|NCT02223429|181265|P3|COMPLETED|Overall Study||8
74613|NCT02223429|181266|P2|COMPLETED|Overall Study||8
74614|NCT02223429|181267|P1|COMPLETED|Overall Study||7
74615|NCT02223429|181264|P4|STARTED|Overall Study||8
74616|NCT02223429|181265|P3|STARTED|Overall Study||8
74617|NCT02223429|181266|P2|STARTED|Overall Study||8
74618|NCT02223429|181267|P1|STARTED|Overall Study||8
74619|NCT02223390|181297|P2|NOT COMPLETED|Overall Study||4
74620|NCT02223390|181298|P1|NOT COMPLETED|Overall Study||9
74621|NCT02223390|181297|P2|COMPLETED|Overall Study||28
74622|NCT02223390|181298|P1|COMPLETED|Overall Study||23
74623|NCT02223390|181297|P2|STARTED|Overall Study||32
74624|NCT02223390|181298|P1|STARTED|Overall Study||32
74625|NCT02223364|181309|P3|NOT COMPLETED|Overall Study||3
74626|NCT02223364|181310|P2|NOT COMPLETED|Overall Study||0
74627|NCT02223364|181311|P1|NOT COMPLETED|Overall Study||5
74628|NCT02223364|181309|P3|COMPLETED|Overall Study||52
74629|NCT02223364|181310|P2|COMPLETED|Overall Study||55
74630|NCT02223364|181311|P1|COMPLETED|Overall Study||50
74631|NCT02223364|181309|P3|STARTED|Overall Study||55
74632|NCT02223364|181310|P2|STARTED|Overall Study||55
74633|NCT02223364|181311|P1|STARTED|Overall Study||55
74634|NCT02223351|181363|P2|NOT COMPLETED|Overall Study||0
74635|NCT02223351|181364|P1|NOT COMPLETED|Overall Study||0
74636|NCT02223351|181363|P2|COMPLETED|Overall Study||24
74637|NCT02223351|181364|P1|COMPLETED|Overall Study||24
74638|NCT02223351|181363|P2|Second Intervention (8 Days)|Overall Study||24
74639|NCT02223351|181364|P1|Second Intervention (8 Days)|Overall Study||24
74640|NCT02223351|181363|P2|Wasout (2weeks)|Overall Study||24
74641|NCT02223351|181364|P1|Wasout (2weeks)|Overall Study||24
74642|NCT02223351|181363|P2|First Intervention (8 Days)|Overall Study||24
74643|NCT02223351|181364|P1|First Intervention (8 Days)|Overall Study||24
74644|NCT02223351|181363|P2|STARTED|Overall Study||24
74645|NCT02223351|181364|P1|STARTED|Overall Study||24
74646|NCT02223338|181424|P2|NOT COMPLETED|Overall Study||0
74647|NCT02223338|181425|P1|NOT COMPLETED|Overall Study||0
74648|NCT02223338|181424|P2|COMPLETED|Overall Study||60
74649|NCT02223338|181425|P1|COMPLETED|Overall Study||60
74650|NCT02223338|181424|P2|STARTED|Overall Study||60
74651|NCT02223338|181425|P1|STARTED|Overall Study||60
74652|NCT02223260|181433|P1|NOT COMPLETED|Overall Study||0
74653|NCT02223260|181433|P1|COMPLETED|Overall Study||8
74654|NCT02223260|181433|P1|STARTED|Overall Study||8
74655|NCT02223065|181451|P2|NOT COMPLETED|Overall Study||0
74656|NCT02223065|181452|P1|NOT COMPLETED|Overall Study||0
74657|NCT02223065|181451|P2|COMPLETED|Overall Study||18
74658|NCT02223065|181452|P1|COMPLETED|Overall Study||18
74659|NCT02223065|181451|P2|STARTED|Overall Study||18
74660|NCT02223065|181452|P1|STARTED|Overall Study||18
74661|NCT02222870|181470|P2|NOT COMPLETED|Overall Study||0
74662|NCT02222870|181471|P1|NOT COMPLETED|Overall Study||0
74663|NCT02222870|181470|P2|COMPLETED|Overall Study||30
74664|NCT02222870|181471|P1|COMPLETED|Overall Study||30
74665|NCT02222870|181470|P2|STARTED|Overall Study||30
74666|NCT02222870|181471|P1|STARTED|Overall Study||30
74667|NCT02222818|181487|P2|NOT COMPLETED|Period 2||0
74668|NCT02222818|181488|P1|NOT COMPLETED|Period 2||0
74669|NCT02222818|181487|P2|COMPLETED|Period 2|End of CAFR evaluation period|30
74670|NCT02222818|181488|P1|COMPLETED|Period 2|End of CAFRPlus evaluation period|33
74671|NCT02222818|181487|P2|STARTED|Period 2|Start of CAFR evaluation period|30
74672|NCT02222818|181488|P1|STARTED|Period 2|Start of CAFRPlus evaluation period|33
74673|NCT02222818|181487|P2|NOT COMPLETED|Period 1||3
74674|NCT02222818|181488|P1|NOT COMPLETED|Period 1||0
74675|NCT02222818|181487|P2|COMPLETED|Period 1|End of CAFRPlus evaluation period|30
74676|NCT02222818|181488|P1|COMPLETED|Period 1|End of CAFR evaluation period|33
74677|NCT02222818|181487|P2|STARTED|Period 1|Start of CAFRPlus evaluation period|33
74678|NCT02222818|181488|P1|STARTED|Period 1|Start of CAFR evaluation period|33
74679|NCT02222714|181500|P5|NOT COMPLETED|Overall Study||7
74680|NCT02222714|181501|P4|NOT COMPLETED|Overall Study||4
74681|NCT02222714|181502|P3|NOT COMPLETED|Overall Study||4
74682|NCT02222714|181503|P2|NOT COMPLETED|Overall Study||2
74683|NCT02222714|181504|P1|NOT COMPLETED|Overall Study||0
74684|NCT02222714|181500|P5|COMPLETED|Overall Study||37
74685|NCT02222714|181501|P4|COMPLETED|Overall Study||11
74686|NCT02222714|181502|P3|COMPLETED|Overall Study||8
74687|NCT02222714|181503|P2|COMPLETED|Overall Study||22
74688|NCT02222714|181504|P1|COMPLETED|Overall Study||15
74689|NCT02222714|181500|P5|STARTED|Overall Study||44
74690|NCT02222714|181501|P4|STARTED|Overall Study||15
74691|NCT02222714|181502|P3|STARTED|Overall Study||12
74692|NCT02222714|181503|P2|STARTED|Overall Study||24
74693|NCT02222714|181504|P1|STARTED|Overall Study||15
74694|NCT02222558|181543|P6|NOT COMPLETED|Period 3||1
74695|NCT02222558|181544|P5|NOT COMPLETED|Period 3||0
74696|NCT02222558|181545|P4|NOT COMPLETED|Period 3||0
74697|NCT02222558|181546|P3|NOT COMPLETED|Period 3||0
74698|NCT02222558|181547|P2|NOT COMPLETED|Period 3||0
74699|NCT02222558|181548|P1|NOT COMPLETED|Period 3||0
74700|NCT02222558|181543|P6|COMPLETED|Period 3||7
74701|NCT02222558|181544|P5|COMPLETED|Period 3||8
74702|NCT02222558|181545|P4|COMPLETED|Period 3||1
74703|NCT02222558|181546|P3|COMPLETED|Period 3||4
74704|NCT02222558|181547|P2|COMPLETED|Period 3||0
74705|NCT02222558|181548|P1|COMPLETED|Period 3||0
74706|NCT02222558|181543|P6|STARTED|Period 3||8
74707|NCT02222558|181544|P5|STARTED|Period 3||8
74708|NCT02222558|181545|P4|STARTED|Period 3||1
74709|NCT02222558|181546|P3|STARTED|Period 3||4
74710|NCT02222558|181547|P2|STARTED|Period 3||0
74711|NCT02222558|181548|P1|STARTED|Period 3||0
74712|NCT02222558|181543|P6|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
74713|NCT02222558|181544|P5|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
74714|NCT02222558|181545|P4|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
74715|NCT02222558|181546|P3|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
74716|NCT02222558|181547|P2|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
74717|NCT02222558|181548|P1|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
74718|NCT02222558|181543|P6|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
74719|NCT02222558|181544|P5|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
74720|NCT02222558|181545|P4|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
74721|NCT02222558|181546|P3|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
74722|NCT02222558|181547|P2|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||21
74723|NCT02222558|181548|P1|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
74724|NCT02222558|181543|P6|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
74725|NCT02222558|181544|P5|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
74726|NCT02222558|181545|P4|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
74727|NCT02222558|181546|P3|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
74728|NCT02222558|181547|P2|STARTED|Period 2: Two Times Daily Dosing 90 mg||21
74729|NCT02222558|181548|P1|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
74730|NCT02222558|181543|P6|NOT COMPLETED|Period 1: Single Dose||0
74731|NCT02222558|181544|P5|NOT COMPLETED|Period 1: Single Dose||0
74732|NCT02222558|181545|P4|NOT COMPLETED|Period 1: Single Dose||0
74733|NCT02222558|181546|P3|NOT COMPLETED|Period 1: Single Dose||0
74734|NCT02222558|181547|P2|NOT COMPLETED|Period 1: Single Dose||0
74735|NCT02222558|181548|P1|NOT COMPLETED|Period 1: Single Dose||4
74736|NCT02222558|181543|P6|COMPLETED|Period 1: Single Dose||0
74737|NCT02222558|181544|P5|COMPLETED|Period 1: Single Dose||0
74738|NCT02222558|181545|P4|COMPLETED|Period 1: Single Dose||0
74739|NCT02222558|181546|P3|COMPLETED|Period 1: Single Dose||0
74740|NCT02222558|181547|P2|COMPLETED|Period 1: Single Dose||0
74741|NCT02222558|181548|P1|COMPLETED|Period 1: Single Dose||21
74742|NCT02222558|181543|P6|STARTED|Period 1: Single Dose||0
74743|NCT02222558|181544|P5|STARTED|Period 1: Single Dose||0
74744|NCT02222558|181545|P4|STARTED|Period 1: Single Dose||0
74745|NCT02222558|181546|P3|STARTED|Period 1: Single Dose||0
74746|NCT02222558|181547|P2|STARTED|Period 1: Single Dose||0
74747|NCT02222558|181548|P1|STARTED|Period 1: Single Dose||25
74748|NCT02222493|181564|P2|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
74749|NCT02222493|181565|P1|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||31
74750|NCT02222493|181564|P2|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
74751|NCT02222493|181565|P1|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||474
74752|NCT02222493|181564|P2|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||0
74753|NCT02222493|181565|P1|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||505
74754|NCT02222493|181564|P2|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||17
74755|NCT02222493|181565|P1|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||43
74756|NCT02222493|181564|P2|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||126
74757|NCT02222493|181565|P1|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||380
74758|NCT02222493|181564|P2|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||143
74759|NCT02222493|181565|P1|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||423
74760|NCT02222493|181564|P2|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||40
74761|NCT02222493|181565|P1|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||44
74762|NCT02222493|181564|P2|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||286
74763|NCT02222493|181565|P1|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||280
74764|NCT02222493|181564|P2|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||326
74765|NCT02222493|181565|P1|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||323
74766|NCT02222493|181564|P2|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||326
74767|NCT02222493|181565|P1|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||324
74768|NCT02222337|181683|P2|NOT COMPLETED|Overall Study||24
74769|NCT02222337|181684|P1|NOT COMPLETED|Overall Study||26
74770|NCT02222337|181683|P2|COMPLETED|Overall Study||108
74771|NCT02222337|181684|P1|COMPLETED|Overall Study||114
74772|NCT02222337|181683|P2|STARTED|Overall Study|132 participants were enrolled but 2 withdrew and never provided any data.|132
74773|NCT02222337|181684|P1|STARTED|Overall Study||140
74774|NCT02222246|181716|P2|NOT COMPLETED|Overall Study||27
74775|NCT02222246|181717|P1|NOT COMPLETED|Overall Study||27
74776|NCT02222246|181716|P2|COMPLETED|Overall Study||26
74777|NCT02222246|181717|P1|COMPLETED|Overall Study||26
74778|NCT02222246|181716|P2|STARTED|Overall Study||53
74779|NCT02222246|181717|P1|STARTED|Overall Study||53
74780|NCT02222207|181745|P1|NOT COMPLETED|Overall Study||4
74781|NCT02222207|181745|P1|COMPLETED|Overall Study||48
74782|NCT02222207|181745|P1|Treated and Valid for Full Analysis Set|Overall Study||51
74783|NCT02222207|181745|P1|STARTED|Overall Study||52
74784|NCT02222181|181752|P1|NOT COMPLETED|Overall Study||108
74785|NCT02222181|181752|P1|COMPLETED|Overall Study||55
74786|NCT02222181|181752|P1|STARTED|Overall Study||163
74787|NCT02222129|181764|P2|NOT COMPLETED|Overall Study||0
74788|NCT02222129|181765|P1|NOT COMPLETED|Overall Study||0
74789|NCT02222129|181764|P2|COMPLETED|Overall Study||106
74790|NCT02222129|181765|P1|COMPLETED|Overall Study||100
74791|NCT02222129|181764|P2|STARTED|Overall Study||106
74792|NCT02222129|181765|P1|STARTED|Overall Study||100
74793|NCT02221947|181773|P2|NOT COMPLETED|Overall Study||0
74794|NCT02221947|181774|P1|NOT COMPLETED|Overall Study||0
74795|NCT02221947|181773|P2|COMPLETED|Overall Study||3
74796|NCT02221947|181774|P1|COMPLETED|Overall Study||6
74797|NCT02221947|181773|P2|STARTED|Overall Study||3
74798|NCT02221947|181774|P1|STARTED|Overall Study||6
74799|NCT02221882|181792|P6|NOT COMPLETED|Overall Study||2
74800|NCT02221882|181793|P5|NOT COMPLETED|Overall Study||2
74801|NCT02221882|181794|P4|NOT COMPLETED|Overall Study||2
74802|NCT02221882|181795|P3|NOT COMPLETED|Overall Study||4
74803|NCT02221882|181796|P2|NOT COMPLETED|Overall Study||1
74804|NCT02221882|181797|P1|NOT COMPLETED|Overall Study||0
74805|NCT02221882|181792|P6|COMPLETED|Overall Study||2
74806|NCT02221882|181793|P5|COMPLETED|Overall Study||3
74807|NCT02221882|181794|P4|COMPLETED|Overall Study||1
74808|NCT02221882|181795|P3|COMPLETED|Overall Study||7
74809|NCT02221882|181796|P2|COMPLETED|Overall Study||2
74810|NCT02221882|181797|P1|COMPLETED|Overall Study||3
74811|NCT02221882|181792|P6|Received at Least One Dose of Study Drug|Overall Study||4
74812|NCT02221882|181793|P5|Received at Least One Dose of Study Drug|Overall Study||5
74813|NCT02221882|181794|P4|Received at Least One Dose of Study Drug|Overall Study||3
74814|NCT02221882|181795|P3|Received at Least One Dose of Study Drug|Overall Study||11
74815|NCT02221882|181796|P2|Received at Least One Dose of Study Drug|Overall Study||3
74816|NCT02221882|181797|P1|Received at Least One Dose of Study Drug|Overall Study||3
74817|NCT02221882|181792|P6|STARTED|Overall Study||4
74818|NCT02221882|181793|P5|STARTED|Overall Study||5
74819|NCT02221882|181794|P4|STARTED|Overall Study||3
74820|NCT02221882|181795|P3|STARTED|Overall Study||11
74821|NCT02221882|181796|P2|STARTED|Overall Study||3
74822|NCT02221882|181797|P1|STARTED|Overall Study||3
74823|NCT02221869|181840|P3|NOT COMPLETED|Overall Study||10
74824|NCT02221869|181841|P2|NOT COMPLETED|Overall Study||0
74825|NCT02221869|181842|P1|NOT COMPLETED|Overall Study||1
74826|NCT02221869|181840|P3|COMPLETED|Overall Study||33
74827|NCT02221869|181841|P2|COMPLETED|Overall Study||32
74828|NCT02221869|181842|P1|COMPLETED|Overall Study||30
74829|NCT02221869|181840|P3|STARTED|Overall Study||43
74830|NCT02221869|181841|P2|STARTED|Overall Study||32
74831|NCT02221869|181842|P1|STARTED|Overall Study||31
74832|NCT02221739|181856|P1|NOT COMPLETED|Overall Study||18
74833|NCT02221739|181856|P1|COMPLETED|Overall Study||21
74834|NCT02221739|181856|P1|STARTED|Overall Study||39
74835|NCT02221674|181864|P3|NOT COMPLETED|Overall Study||0
74836|NCT02221674|181865|P2|NOT COMPLETED|Overall Study||0
74837|NCT02221674|181866|P1|NOT COMPLETED|Overall Study||1
74838|NCT02221674|181864|P3|COMPLETED|Overall Study||5
74839|NCT02221674|181865|P2|COMPLETED|Overall Study||6
74840|NCT02221674|181866|P1|COMPLETED|Overall Study||7
74841|NCT02221674|181864|P3|STARTED|Overall Study||5
74842|NCT02221674|181865|P2|STARTED|Overall Study||6
74843|NCT02221674|181866|P1|STARTED|Overall Study||8
74844|NCT02221648|181882|P2|NOT COMPLETED|Overall Study||3
74845|NCT02221648|181883|P1|NOT COMPLETED|Overall Study||3
74846|NCT02221648|181882|P2|COMPLETED|Overall Study||18
74847|NCT02221648|181883|P1|COMPLETED|Overall Study||19
74848|NCT02221648|181882|P2|STARTED|Overall Study||21
74849|NCT02221648|181883|P1|STARTED|Overall Study||22
74850|NCT02221557|181893|P1|NOT COMPLETED|Overall Study||3
74851|NCT02221557|181893|P1|COMPLETED|Overall Study||5
74852|NCT02221557|181893|P1|STARTED|Overall Study||8
74853|NCT02221284|181901|P1|NOT COMPLETED|Overall Study||61
74854|NCT02221284|181901|P1|COMPLETED|Overall Study||903
74855|NCT02221284|181901|P1|STARTED|Overall Study||964
74856|NCT02221037|181933|P4|NOT COMPLETED|Overall Study||0
74857|NCT02221037|181934|P3|NOT COMPLETED|Overall Study||1
74858|NCT02221037|181935|P2|NOT COMPLETED|Overall Study||0
74859|NCT02221037|181936|P1|NOT COMPLETED|Overall Study||0
74860|NCT02221037|181933|P4|COMPLETED|Overall Study||9
74861|NCT02221037|181934|P3|COMPLETED|Overall Study||7
74862|NCT02221037|181935|P2|COMPLETED|Overall Study||11
74863|NCT02221037|181936|P1|COMPLETED|Overall Study||5
74864|NCT02221037|181933|P4|STARTED|Overall Study||9
74865|NCT02221037|181934|P3|STARTED|Overall Study||8
74866|NCT02221037|181935|P2|STARTED|Overall Study||11
74867|NCT02221037|181936|P1|STARTED|Overall Study||5
74868|NCT02220998|182022|P2|NOT COMPLETED|Overall Study||11
74869|NCT02220998|182023|P1|NOT COMPLETED|Overall Study||7
74870|NCT02220998|182022|P2|COMPLETED|Overall Study||123
74871|NCT02220998|182023|P1|COMPLETED|Overall Study||128
74872|NCT02220998|182022|P2|STARTED|Overall Study||134
74873|NCT02220998|182023|P1|STARTED|Overall Study||135
74874|NCT02220920|182041|P2|NOT COMPLETED|Overall Study||3
74875|NCT02220920|182042|P1|NOT COMPLETED|Overall Study||3
74876|NCT02220920|182041|P2|COMPLETED|Overall Study||67
74877|NCT02220920|182042|P1|COMPLETED|Overall Study||73
74878|NCT02220920|182041|P2|STARTED|Overall Study||70
74879|NCT02220920|182042|P1|STARTED|Overall Study||76
74880|NCT02220907|182056|P1|NOT COMPLETED|Overall Study||11
74881|NCT02220907|182056|P1|COMPLETED|Overall Study||142
74882|NCT02220907|182056|P1|STARTED|Overall Study||153
74883|NCT02220894|182065|P2|NOT COMPLETED|Overall Study||637
74884|NCT02220894|182066|P1|NOT COMPLETED|Overall Study||637
74885|NCT02220894|182065|P2|COMPLETED|Overall Study||0
74886|NCT02220894|182066|P1|COMPLETED|Overall Study||0
74887|NCT02220894|182065|P2|Treated|Overall Study||615
74888|NCT02220894|182066|P1|Treated|Overall Study||636
74889|NCT02220894|182065|P2|STARTED|Overall Study||637
74890|NCT02220894|182066|P1|STARTED|Overall Study|1 additional participant was randomized in error|637
74891|NCT02220855|182092|P1|NOT COMPLETED|Overall Study||14
74892|NCT02220855|182092|P1|COMPLETED|Overall Study||0
74893|NCT02220855|182092|P1|STARTED|Overall Study||14
74894|NCT02220764|182102|P2|NOT COMPLETED|Overall Study||1
74895|NCT02220764|182103|P1|NOT COMPLETED|Overall Study||4
74896|NCT02220764|182102|P2|COMPLETED|Overall Study||7
74897|NCT02220764|182103|P1|COMPLETED|Overall Study||20
74898|NCT02220764|182102|P2|STARTED|Overall Study||8
74899|NCT02220764|182103|P1|STARTED|Overall Study||24
74900|NCT02220725|182117|P4|NOT COMPLETED|Overall Study||2
74901|NCT02220725|182118|P3|NOT COMPLETED|Overall Study||0
74902|NCT02220725|182119|P2|NOT COMPLETED|Overall Study||0
74903|NCT02220725|182120|P1|NOT COMPLETED|Overall Study||0
74904|NCT02220725|182117|P4|COMPLETED|Overall Study||24
74905|NCT02220725|182118|P3|COMPLETED|Overall Study||13
74906|NCT02220725|182119|P2|COMPLETED|Overall Study||27
74907|NCT02220725|182120|P1|COMPLETED|Overall Study||14
74908|NCT02220725|182117|P4|STARTED|Overall Study||26
74909|NCT02220725|182118|P3|STARTED|Overall Study||13
74910|NCT02220725|182119|P2|STARTED|Overall Study||27
74911|NCT02220725|182120|P1|STARTED|Overall Study||14
74912|NCT02220205|182150|P2|NOT COMPLETED|Overall Study||0
74913|NCT02220205|182151|P1|NOT COMPLETED|Overall Study||1
74914|NCT02220205|182150|P2|COMPLETED|Overall Study||30
74915|NCT02220205|182151|P1|COMPLETED|Overall Study||29
74916|NCT02220205|182150|P2|STARTED|Overall Study||30
74917|NCT02220205|182151|P1|STARTED|Overall Study||30
74918|NCT02219997|182161|P3|NOT COMPLETED|Second Filter||0
74919|NCT02219997|182162|P2|NOT COMPLETED|Second Filter||0
74920|NCT02219997|182163|P1|NOT COMPLETED|Second Filter||0
74921|NCT02219997|182161|P3|COMPLETED|Second Filter||18
74922|NCT02219997|182162|P2|COMPLETED|Second Filter||17
74923|NCT02219997|182163|P1|COMPLETED|Second Filter||0
74924|NCT02219997|182161|P3|STARTED|Second Filter||18
74925|NCT02219997|182162|P2|STARTED|Second Filter||17
74926|NCT02219997|182163|P1|STARTED|Second Filter||0
74927|NCT02219997|182161|P3|NOT COMPLETED|First Filter||0
74928|NCT02219997|182162|P2|NOT COMPLETED|First Filter||0
74929|NCT02219997|182163|P1|NOT COMPLETED|First Filter||0
74930|NCT02219997|182161|P3|COMPLETED|First Filter||18
74931|NCT02219997|182162|P2|COMPLETED|First Filter||17
74932|NCT02219997|182163|P1|COMPLETED|First Filter||33
74933|NCT02219997|182161|P3|STARTED|First Filter||18
74934|NCT02219997|182162|P2|STARTED|First Filter||17
74935|NCT02219997|182163|P1|STARTED|First Filter||33
74936|NCT02219932|182176|P2|NOT COMPLETED|Overall Study||51
74937|NCT02219932|182177|P1|NOT COMPLETED|Overall Study||65
74938|NCT02219932|182176|P2|COMPLETED|Overall Study||266
74939|NCT02219932|182177|P1|COMPLETED|Overall Study||254
74940|NCT02219932|182176|P2|Randomized, Not Treated|Overall Study||1
74941|NCT02219932|182177|P1|Randomized, Not Treated|Overall Study||0
74942|NCT02219932|182176|P2|STARTED|Overall Study||317
74943|NCT02219932|182177|P1|STARTED|Overall Study||319
74944|NCT02219685|182193|P2|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
74945|NCT02219685|182194|P1|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
74946|NCT02219685|182193|P2|COMPLETED|Open-Label (After Posttreatment Week 4)||14
74947|NCT02219685|182194|P1|COMPLETED|Open-Label (After Posttreatment Week 4)||0
74948|NCT02219685|182193|P2|STARTED|Open-Label (After Posttreatment Week 4)||14
74949|NCT02219685|182194|P1|STARTED|Open-Label (After Posttreatment Week 4)|Only participants from the Placebo arm were eligible to enroll in the Open-Label Phase.|0
74950|NCT02219685|182193|P2|NOT COMPLETED|Blinded Treatment Phase||0
74951|NCT02219685|182194|P1|NOT COMPLETED|Blinded Treatment Phase||2
74952|NCT02219685|182193|P2|COMPLETED|Blinded Treatment Phase||14
74953|NCT02219685|182194|P1|COMPLETED|Blinded Treatment Phase||24
74954|NCT02219685|182193|P2|STARTED|Blinded Treatment Phase||14
74955|NCT02219685|182194|P1|STARTED|Blinded Treatment Phase||26
74956|NCT02219516|182242|P4|NOT COMPLETED|Overall Study||0
74957|NCT02219516|182243|P3|NOT COMPLETED|Overall Study||0
74958|NCT02219516|182244|P2|NOT COMPLETED|Overall Study||0
74959|NCT02219516|182245|P1|NOT COMPLETED|Overall Study||0
74960|NCT02219516|182242|P4|COMPLETED|Overall Study||8
74961|NCT02219516|182243|P3|COMPLETED|Overall Study||7
74962|NCT02219516|182244|P2|COMPLETED|Overall Study||8
74963|NCT02219516|182245|P1|COMPLETED|Overall Study||8
74964|NCT02219516|182242|P4|STARTED|Overall Study||8
74965|NCT02219516|182243|P3|STARTED|Overall Study||7
74966|NCT02219516|182244|P2|STARTED|Overall Study||8
74967|NCT02219516|182245|P1|STARTED|Overall Study||8
74968|NCT02219503|182291|P1|NOT COMPLETED|Overall Study||0
74969|NCT02219503|182291|P1|COMPLETED|Overall Study||60
74970|NCT02219503|182291|P1|STARTED|Overall Study||60
74971|NCT02219477|182300|P3|NOT COMPLETED|Overall Study||1
74972|NCT02219477|182301|P2|NOT COMPLETED|Overall Study||2
74973|NCT02219477|182302|P1|NOT COMPLETED|Overall Study||0
74974|NCT02219477|182300|P3|COMPLETED|Overall Study||2
74975|NCT02219477|182301|P2|COMPLETED|Overall Study||22
74976|NCT02219477|182302|P1|COMPLETED|Overall Study||9
74977|NCT02219477|182300|P3|STARTED|Overall Study||3
74978|NCT02219477|182301|P2|STARTED|Overall Study||24
74979|NCT02219477|182302|P1|STARTED|Overall Study||9
74980|NCT02219464|182330|P2|NOT COMPLETED|Overall Study||0
74981|NCT02219464|182331|P1|NOT COMPLETED|Overall Study||3
74982|NCT02219464|182330|P2|COMPLETED|Overall Study||30
74983|NCT02219464|182331|P1|COMPLETED|Overall Study||27
74984|NCT02219464|182330|P2|STARTED|Overall Study||30
74985|NCT02219464|182331|P1|STARTED|Overall Study||30
74986|NCT02219308|182341|P2|NOT COMPLETED|Overall Study||2
74987|NCT02219308|182342|P1|NOT COMPLETED|Overall Study||1
74988|NCT02219308|182341|P2|COMPLETED|Overall Study||33
74989|NCT02219308|182342|P1|COMPLETED|Overall Study||31
74990|NCT02219308|182341|P2|STARTED|Overall Study||35
74991|NCT02219308|182342|P1|STARTED|Overall Study||32
74992|NCT02219282|182352|P2|NOT COMPLETED|Overall Study||1
74993|NCT02219282|182353|P1|NOT COMPLETED|Overall Study||1
74994|NCT02219282|182352|P2|COMPLETED|Overall Study||32
74995|NCT02219282|182353|P1|COMPLETED|Overall Study||32
74996|NCT02219282|182352|P2|STARTED|Overall Study||33
74997|NCT02219282|182353|P1|STARTED|Overall Study||33
74998|NCT02219256|182379|P12|NOT COMPLETED|Overall Study||0
74999|NCT02219256|182380|P11|NOT COMPLETED|Overall Study||0
75000|NCT02219256|182381|P10|NOT COMPLETED|Overall Study||0
75001|NCT02219256|182382|P9|NOT COMPLETED|Overall Study||0
75002|NCT02219256|182383|P8|NOT COMPLETED|Overall Study||0
75003|NCT02219256|182384|P7|NOT COMPLETED|Overall Study||0
75004|NCT02219256|182385|P6|NOT COMPLETED|Overall Study||0
75005|NCT02219256|182386|P5|NOT COMPLETED|Overall Study||0
75006|NCT02219256|182387|P4|NOT COMPLETED|Overall Study||0
75007|NCT02219256|182388|P3|NOT COMPLETED|Overall Study||0
75008|NCT02219256|182389|P2|NOT COMPLETED|Overall Study||0
75009|NCT02219256|182390|P1|NOT COMPLETED|Overall Study||0
75010|NCT02219256|182379|P12|COMPLETED|Overall Study||6
75011|NCT02219256|182380|P11|COMPLETED|Overall Study||6
75012|NCT02219256|182381|P10|COMPLETED|Overall Study||6
75013|NCT02219256|182382|P9|COMPLETED|Overall Study||6
75014|NCT02219256|182383|P8|COMPLETED|Overall Study||8
75015|NCT02219256|182384|P7|COMPLETED|Overall Study||6
75016|NCT02219256|182385|P6|COMPLETED|Overall Study||6
75017|NCT02219256|182386|P5|COMPLETED|Overall Study||6
75018|NCT02219256|182387|P4|COMPLETED|Overall Study||4
75019|NCT02219256|182388|P3|COMPLETED|Overall Study||4
75020|NCT02219256|182389|P2|COMPLETED|Overall Study||4
75021|NCT02219256|182390|P1|COMPLETED|Overall Study||12
75022|NCT02219256|182379|P12|STARTED|Overall Study||6
75023|NCT02219256|182380|P11|STARTED|Overall Study||6
75024|NCT02219256|182381|P10|STARTED|Overall Study||6
75025|NCT02219256|182382|P9|STARTED|Overall Study||6
75026|NCT02219256|182383|P8|STARTED|Overall Study||8
75027|NCT02219256|182384|P7|STARTED|Overall Study||6
75028|NCT02219256|182385|P6|STARTED|Overall Study||6
75029|NCT02219256|182386|P5|STARTED|Overall Study||6
75030|NCT02219256|182387|P4|STARTED|Overall Study||4
75031|NCT02219256|182388|P3|STARTED|Overall Study||4
75032|NCT02219256|182389|P2|STARTED|Overall Study||4
75033|NCT02219256|182390|P1|STARTED|Overall Study||12
75034|NCT02219087|182502|P2|NOT COMPLETED|Overall Study||1
75035|NCT02219087|182503|P1|NOT COMPLETED|Overall Study||0
75036|NCT02219087|182502|P2|COMPLETED|Overall Study|Randomization envelope pulled out of sequence for consented patient. Excluded by request of IRB|29
75037|NCT02219087|182503|P1|COMPLETED|Overall Study||30
75038|NCT02219087|182502|P2|STARTED|Overall Study||30
75039|NCT02219087|182503|P1|STARTED|Overall Study||30
75040|NCT02219048|182523|P2|NOT COMPLETED|Overall Study||21
75041|NCT02219048|182524|P1|NOT COMPLETED|Overall Study||21
75042|NCT02219048|182523|P2|COMPLETED|Overall Study||4
75043|NCT02219048|182524|P1|COMPLETED|Overall Study||5
75044|NCT02219048|182523|P2|STARTED|Overall Study||25
75045|NCT02219048|182524|P1|STARTED|Overall Study||26
75046|NCT02219009|182550|P2|NOT COMPLETED|Overall Study||8
75047|NCT02219009|182551|P1|NOT COMPLETED|Overall Study||10
75048|NCT02219009|182550|P2|COMPLETED|Overall Study||22
75049|NCT02219009|182551|P1|COMPLETED|Overall Study||27
75050|NCT02219009|182550|P2|STARTED|Overall Study||30
75051|NCT02219009|182551|P1|STARTED|Overall Study||37
75052|NCT02218736|182563|P2|NOT COMPLETED|Overall Study||9
75053|NCT02218736|182564|P1|NOT COMPLETED|Overall Study||12
75054|NCT02218736|182563|P2|COMPLETED|Overall Study||35
75055|NCT02218736|182564|P1|COMPLETED|Overall Study||33
75056|NCT02218736|182563|P2|STARTED|Overall Study||44
75057|NCT02218736|182564|P1|STARTED|Overall Study||45
75058|NCT02218697|182576|P2|NOT COMPLETED|Overall Study||6
75059|NCT02218697|182577|P1|NOT COMPLETED|Overall Study||2
75060|NCT02218697|182576|P2|COMPLETED|Overall Study||171
75061|NCT02218697|182577|P1|COMPLETED|Overall Study||177
75062|NCT02218697|182576|P2|STARTED|Overall Study||177
75063|NCT02218697|182577|P1|STARTED|Overall Study||179
75064|NCT02218541|182617|P2|NOT COMPLETED|Overall Study||2
75065|NCT02218541|182618|P1|NOT COMPLETED|Overall Study||6
75066|NCT02218541|182617|P2|COMPLETED|Overall Study||9
75067|NCT02218541|182618|P1|COMPLETED|Overall Study||5
75068|NCT02218541|182617|P2|STARTED|Overall Study||11
75069|NCT02218541|182618|P1|STARTED|Overall Study||11
75070|NCT02218463|182630|P2|NOT COMPLETED|Overall Study||3
75071|NCT02218463|182631|P1|NOT COMPLETED|Overall Study||3
75072|NCT02218463|182630|P2|COMPLETED|Overall Study||19
75073|NCT02218463|182631|P1|COMPLETED|Overall Study||18
75074|NCT02218463|182630|P2|STARTED|Overall Study||22
75075|NCT02218463|182631|P1|STARTED|Overall Study||21
75076|NCT02218424|182641|P2|NOT COMPLETED|Overall Study||0
75077|NCT02218424|182642|P1|NOT COMPLETED|Overall Study||0
75078|NCT02218424|182641|P2|COMPLETED|Overall Study||30
75079|NCT02218424|182642|P1|COMPLETED|Overall Study||30
75080|NCT02218424|182641|P2|STARTED|Overall Study||30
75081|NCT02218424|182642|P1|STARTED|Overall Study||30
75082|NCT02218372|182664|P2|NOT COMPLETED|Overall Study||6
75083|NCT02218372|182665|P1|NOT COMPLETED|Overall Study||5
75084|NCT02218372|182664|P2|COMPLETED|Overall Study||42
75085|NCT02218372|182665|P1|COMPLETED|Overall Study||95
75086|NCT02218372|182664|P2|Treated|Overall Study||44
75087|NCT02218372|182665|P1|Treated|Overall Study||98
75088|NCT02218372|182664|P2|STARTED|Overall Study||48
75089|NCT02218372|182665|P1|STARTED|Overall Study||100
75090|NCT02218320|182723|P2|NOT COMPLETED|Overall Study||0
75091|NCT02218320|182724|P1|NOT COMPLETED|Overall Study||0
75092|NCT02218320|182723|P2|COMPLETED|Overall Study|Last participant contact on this arm was October 2015|10
75093|NCT02218320|182724|P1|COMPLETED|Overall Study|Last participant contact on this arm was June 2015|10
75094|NCT02218320|182723|P2|STARTED|Overall Study|First participant contact on this arm was December 2014|10
75095|NCT02218320|182724|P1|STARTED|Overall Study|First participant visit on this arm Dec 2014|10
75096|NCT02218307|182736|P2|NOT COMPLETED|Overall Study||1
75097|NCT02218307|182737|P1|NOT COMPLETED|Overall Study||9
75098|NCT02218307|182736|P2|COMPLETED|Overall Study||33
75099|NCT02218307|182737|P1|COMPLETED|Overall Study||25
75100|NCT02218307|182736|P2|STARTED|Overall Study||34
75101|NCT02218307|182737|P1|STARTED|Overall Study||34
75102|NCT02218268|182745|P2|NOT COMPLETED|Final Phase (2 Hours)||0
75103|NCT02218268|182746|P1|NOT COMPLETED|Final Phase (2 Hours)||0
75104|NCT02218268|182745|P2|COMPLETED|Final Phase (2 Hours)||21
75105|NCT02218268|182746|P1|COMPLETED|Final Phase (2 Hours)||19
75106|NCT02218268|182745|P2|STARTED|Final Phase (2 Hours)||21
75107|NCT02218268|182746|P1|STARTED|Final Phase (2 Hours)||19
75108|NCT02218268|182745|P2|NOT COMPLETED|24 Hour Washout||9
75109|NCT02218268|182746|P1|NOT COMPLETED|24 Hour Washout||11
75110|NCT02218268|182745|P2|COMPLETED|24 Hour Washout||21
75111|NCT02218268|182746|P1|COMPLETED|24 Hour Washout||19
75112|NCT02218268|182745|P2|STARTED|24 Hour Washout||30
75113|NCT02218268|182746|P1|STARTED|24 Hour Washout||30
75114|NCT02218268|182745|P2|NOT COMPLETED|First Phase (2 Hours)||0
75115|NCT02218268|182746|P1|NOT COMPLETED|First Phase (2 Hours)||0
75116|NCT02218268|182745|P2|COMPLETED|First Phase (2 Hours)||30
75117|NCT02218268|182746|P1|COMPLETED|First Phase (2 Hours)||30
75118|NCT02218268|182745|P2|STARTED|First Phase (2 Hours)||30
75119|NCT02218268|182746|P1|STARTED|First Phase (2 Hours)||30
75120|NCT02218242|182752|P1|NOT COMPLETED|Overall Study||0
75121|NCT02218242|182752|P1|COMPLETED|Overall Study||9
75122|NCT02218242|182752|P1|STARTED|Overall Study||9
75123|NCT02218216|182758|P3|NOT COMPLETED|Overall Study||0
75124|NCT02218216|182759|P2|NOT COMPLETED|Overall Study||0
75125|NCT02218216|182760|P1|NOT COMPLETED|Overall Study||6
75126|NCT02218216|182758|P3|COMPLETED|Overall Study||3
75127|NCT02218216|182759|P2|COMPLETED|Overall Study||2
75128|NCT02218216|182760|P1|COMPLETED|Overall Study||8
75129|NCT02218216|182758|P3|STARTED|Overall Study||3
75130|NCT02218216|182759|P2|STARTED|Overall Study||2
75131|NCT02218216|182760|P1|STARTED|Overall Study||14
75132|NCT02218203|182768|P1|NOT COMPLETED|Overall Study||0
75133|NCT02218203|182768|P1|COMPLETED|Overall Study|2 subjects did not complete the placebo, medium dose, and high dose dex/lido combination arms.|26
75134|NCT02218203|182768|P1|High Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
75135|NCT02218203|182768|P1|High Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
75136|NCT02218203|182768|P1|High Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
75137|NCT02218203|182768|P1|High Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
75138|NCT02218203|182768|P1|Medium Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
75139|NCT02218203|182768|P1|Medium Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
75140|NCT02218203|182768|P1|Medium Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
75141|NCT02218203|182768|P1|Medium Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
75142|NCT02218203|182768|P1|Low Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||26
75143|NCT02218203|182768|P1|Low Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||26
75144|NCT02218203|182768|P1|Low Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||26
75145|NCT02218203|182768|P1|Low Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||26
75146|NCT02218203|182768|P1|Placebo Dex v. 4mg/km LBM Lidocaine|Overall Study||24
75147|NCT02218203|182768|P1|Placebo Dex v. 2mg/km LBM Lidocaine|Overall Study||24
75148|NCT02218203|182768|P1|Placebo Dex v. 1mg/km LBM Lidocaine|Overall Study||24
75149|NCT02218203|182768|P1|Placebo Dex v. 0mg/km LBM Lidocaine|Overall Study||24
75150|NCT02218203|182768|P1|STARTED|Overall Study||26
75151|NCT02218190|182792|P2|NOT COMPLETED|Overall Study||0
75152|NCT02218190|182793|P1|NOT COMPLETED|Overall Study||0
75153|NCT02218190|182792|P2|COMPLETED|Overall Study||13
75154|NCT02218190|182793|P1|COMPLETED|Overall Study||13
75155|NCT02218190|182792|P2|STARTED|Overall Study||13
75156|NCT02218190|182793|P1|STARTED|Overall Study||13
75157|NCT02218164|182803|P1|NOT COMPLETED|Overall Study||0
75158|NCT02218164|182803|P1|COMPLETED|Overall Study||8
75159|NCT02218164|182803|P1|STARTED|Overall Study||8
75160|NCT02218008|182813|P6|NOT COMPLETED|Stage 2 (S2)||6
75161|NCT02218008|182814|P5|NOT COMPLETED|Stage 2 (S2)||4
75162|NCT02218008|182815|P4|NOT COMPLETED|Stage 2 (S2)||4
75163|NCT02218008|182816|P3|NOT COMPLETED|Stage 2 (S2)||0
75164|NCT02218008|182817|P2|NOT COMPLETED|Stage 2 (S2)||0
75165|NCT02218008|182818|P1|NOT COMPLETED|Stage 2 (S2)||0
75166|NCT02218008|182813|P6|COMPLETED|Stage 2 (S2)||57
75167|NCT02218008|182814|P5|COMPLETED|Stage 2 (S2)||58
75168|NCT02218008|182815|P4|COMPLETED|Stage 2 (S2)||58
75169|NCT02218008|182816|P3|COMPLETED|Stage 2 (S2)||0
75170|NCT02218008|182817|P2|COMPLETED|Stage 2 (S2)||0
75171|NCT02218008|182818|P1|COMPLETED|Stage 2 (S2)||0
75172|NCT02218008|182813|P6|STARTED|Stage 2 (S2)||63
75173|NCT02218008|182814|P5|STARTED|Stage 2 (S2)||62
75174|NCT02218008|182815|P4|STARTED|Stage 2 (S2)||62
75175|NCT02218008|182816|P3|STARTED|Stage 2 (S2)||0
75176|NCT02218008|182817|P2|STARTED|Stage 2 (S2)||0
75177|NCT02218008|182818|P1|STARTED|Stage 2 (S2)||0
75178|NCT02218008|182813|P6|NOT COMPLETED|Stage 1 (S1)||0
75179|NCT02218008|182814|P5|NOT COMPLETED|Stage 1 (S1)||0
75180|NCT02218008|182815|P4|NOT COMPLETED|Stage 1 (S1)||0
75181|NCT02218008|182816|P3|NOT COMPLETED|Stage 1 (S1)||15
75182|NCT02218008|182817|P2|NOT COMPLETED|Stage 1 (S1)||7
75183|NCT02218008|182818|P1|NOT COMPLETED|Stage 1 (S1)||22
75184|NCT02218008|182813|P6|COMPLETED|Stage 1 (S1)||0
75185|NCT02218008|182814|P5|COMPLETED|Stage 1 (S1)||0
75186|NCT02218008|182815|P4|COMPLETED|Stage 1 (S1)||0
75187|NCT02218008|182816|P3|COMPLETED|Stage 1 (S1)||48
75188|NCT02218008|182817|P2|COMPLETED|Stage 1 (S1)||56
75189|NCT02218008|182818|P1|COMPLETED|Stage 1 (S1)||258
75190|NCT02218008|182813|P6|STARTED|Stage 1 (S1)||0
75191|NCT02218008|182814|P5|STARTED|Stage 1 (S1)||0
75192|NCT02218008|182815|P4|STARTED|Stage 1 (S1)||0
75193|NCT02218008|182816|P3|STARTED|Stage 1 (S1)||63
75194|NCT02218008|182817|P2|STARTED|Stage 1 (S1)||63
75195|NCT02218008|182818|P1|STARTED|Stage 1 (S1)||280
75196|NCT02217982|182864|P2|NOT COMPLETED|Overall Study||1
75197|NCT02217982|182865|P1|NOT COMPLETED|Overall Study||1
75198|NCT02217982|182864|P2|COMPLETED|Overall Study||3
75199|NCT02217982|182865|P1|COMPLETED|Overall Study|Trial closed before patient finished|0
75200|NCT02217982|182864|P2|STARTED|Overall Study||4
75201|NCT02217982|182865|P1|STARTED|Overall Study||1
75202|NCT02217904|182878|P7|NOT COMPLETED|Overall Study||0
75203|NCT02217904|182879|P6|NOT COMPLETED|Overall Study||0
75204|NCT02217904|182880|P5|NOT COMPLETED|Overall Study||0
75205|NCT02217904|182881|P4|NOT COMPLETED|Overall Study||0
75206|NCT02217904|182882|P3|NOT COMPLETED|Overall Study||0
75207|NCT02217904|182883|P2|NOT COMPLETED|Overall Study||0
75208|NCT02217904|182884|P1|NOT COMPLETED|Overall Study||0
75209|NCT02217904|182878|P7|COMPLETED|Overall Study||0
75210|NCT02217904|182879|P6|COMPLETED|Overall Study||0
75211|NCT02217904|182880|P5|COMPLETED|Overall Study||6
75212|NCT02217904|182881|P4|COMPLETED|Overall Study||6
75213|NCT02217904|182882|P3|COMPLETED|Overall Study||6
75214|NCT02217904|182883|P2|COMPLETED|Overall Study||6
75215|NCT02217904|182884|P1|COMPLETED|Overall Study||6
75216|NCT02217904|182878|P7|STARTED|Overall Study||0
75217|NCT02217904|182879|P6|STARTED|Overall Study||0
75218|NCT02217904|182880|P5|STARTED|Overall Study||6
75219|NCT02217904|182881|P4|STARTED|Overall Study||6
75220|NCT02217904|182882|P3|STARTED|Overall Study||6
75221|NCT02217904|182883|P2|STARTED|Overall Study||6
75222|NCT02217904|182884|P1|STARTED|Overall Study||6
75223|NCT02217878|182948|P2|NOT COMPLETED|Overall Study||2
75224|NCT02217878|182949|P1|NOT COMPLETED|Overall Study||2
75225|NCT02217878|182948|P2|COMPLETED|Overall Study||35
75226|NCT02217878|182949|P1|COMPLETED|Overall Study||35
75227|NCT02217878|182948|P2|STARTED|Overall Study||37
75228|NCT02217878|182949|P1|STARTED|Overall Study||37
75229|NCT02217800|183029|P1|NOT COMPLETED|Overall Study||0
75230|NCT02217800|183029|P1|COMPLETED|Overall Study||8
75231|NCT02217800|183029|P1|STARTED|Overall Study||8
75232|NCT02217618|183041|P1|NOT COMPLETED|Overall Study||0
75233|NCT02217618|183041|P1|COMPLETED|Overall Study||16
75234|NCT02217618|183041|P1|Received Study Drug|Overall Study||16
75235|NCT02217618|183041|P1|STARTED|Overall Study||16
75236|NCT02217527|183049|P2|NOT COMPLETED|Drug Condition 2: Second Study Phase||1
75237|NCT02217527|183050|P1|NOT COMPLETED|Drug Condition 2: Second Study Phase||0
75238|NCT02217527|183049|P2|COMPLETED|Drug Condition 2: Second Study Phase||14
75239|NCT02217527|183050|P1|COMPLETED|Drug Condition 2: Second Study Phase||17
75240|NCT02217527|183049|P2|STARTED|Drug Condition 2: Second Study Phase||15
75241|NCT02217527|183050|P1|STARTED|Drug Condition 2: Second Study Phase||17
75242|NCT02217527|183049|P2|NOT COMPLETED|Drug Condition 1: First Study Phase||3
75243|NCT02217527|183050|P1|NOT COMPLETED|Drug Condition 1: First Study Phase||1
75244|NCT02217527|183049|P2|COMPLETED|Drug Condition 1: First Study Phase||15
75245|NCT02217527|183050|P1|COMPLETED|Drug Condition 1: First Study Phase||17
75246|NCT02217527|183049|P2|STARTED|Drug Condition 1: First Study Phase||18
75247|NCT02217527|183050|P1|STARTED|Drug Condition 1: First Study Phase||18
75248|NCT02217475|183063|P3|NOT COMPLETED|Treatment Period 2 (Year 2)||12
75249|NCT02217475|183064|P2|NOT COMPLETED|Treatment Period 2 (Year 2)||2
75250|NCT02217475|183065|P1|NOT COMPLETED|Treatment Period 2 (Year 2)||2
75251|NCT02217475|183063|P3|COMPLETED|Treatment Period 2 (Year 2)||109
75252|NCT02217475|183064|P2|COMPLETED|Treatment Period 2 (Year 2)||59
75253|NCT02217475|183065|P1|COMPLETED|Treatment Period 2 (Year 2)||58
75254|NCT02217475|183063|P3|STARTED|Treatment Period 2 (Year 2)||121
75255|NCT02217475|183064|P2|STARTED|Treatment Period 2 (Year 2)||61
75256|NCT02217475|183065|P1|STARTED|Treatment Period 2 (Year 2)||60
75257|NCT02217475|183063|P3|NOT COMPLETED|Discontinued After Period 1||3
75258|NCT02217475|183064|P2|NOT COMPLETED|Discontinued After Period 1||3
75259|NCT02217475|183065|P1|NOT COMPLETED|Discontinued After Period 1||2
75260|NCT02217475|183063|P3|COMPLETED|Discontinued After Period 1||121
75261|NCT02217475|183064|P2|COMPLETED|Discontinued After Period 1||61
75262|NCT02217475|183065|P1|COMPLETED|Discontinued After Period 1||60
75263|NCT02217475|183063|P3|STARTED|Discontinued After Period 1||124
75264|NCT02217475|183064|P2|STARTED|Discontinued After Period 1||64
75265|NCT02217475|183065|P1|STARTED|Discontinued After Period 1||62
75266|NCT02217475|183063|P3|NOT COMPLETED|Treatment Period 1 (Year 1)||21
75267|NCT02217475|183064|P2|NOT COMPLETED|Treatment Period 1 (Year 1)||8
75268|NCT02217475|183065|P1|NOT COMPLETED|Treatment Period 1 (Year 1)||10
75269|NCT02217475|183063|P3|COMPLETED|Treatment Period 1 (Year 1)||124
75270|NCT02217475|183064|P2|COMPLETED|Treatment Period 1 (Year 1)||64
75271|NCT02217475|183065|P1|COMPLETED|Treatment Period 1 (Year 1)||62
75272|NCT02217475|183063|P3|Safety Analysis Set|Treatment Period 1 (Year 1)||144
75273|NCT02217475|183064|P2|Safety Analysis Set|Treatment Period 1 (Year 1)||72
75274|NCT02217475|183065|P1|Safety Analysis Set|Treatment Period 1 (Year 1)||72
75275|NCT02217475|183063|P3|STARTED|Treatment Period 1 (Year 1)||145
75276|NCT02217475|183064|P2|STARTED|Treatment Period 1 (Year 1)||72
75277|NCT02217475|183065|P1|STARTED|Treatment Period 1 (Year 1)||72
75278|NCT02217436|183182|P2|NOT COMPLETED|Overall Study||2
75279|NCT02217436|183183|P1|NOT COMPLETED|Overall Study||1
75280|NCT02217436|183182|P2|COMPLETED|Overall Study||38
75281|NCT02217436|183183|P1|COMPLETED|Overall Study||39
75282|NCT02217436|183182|P2|STARTED|Overall Study||40
75283|NCT02217436|183183|P1|STARTED|Overall Study||40
75284|NCT02217410|183194|P3|NOT COMPLETED|Overall Study||5
75285|NCT02217410|183195|P2|NOT COMPLETED|Overall Study||4
75286|NCT02217410|183196|P1|NOT COMPLETED|Overall Study||1
75287|NCT02217410|183194|P3|COMPLETED|Overall Study||13
75288|NCT02217410|183195|P2|COMPLETED|Overall Study||30
75289|NCT02217410|183196|P1|COMPLETED|Overall Study||6
75290|NCT02217410|183194|P3|STARTED|Overall Study||18
75291|NCT02217410|183195|P2|STARTED|Overall Study||34
75292|NCT02217410|183196|P1|STARTED|Overall Study||7
75293|NCT02217280|183219|P1|NOT COMPLETED|Overall Study||4
75294|NCT02217280|183219|P1|COMPLETED|Overall Study||16
75295|NCT02217280|183219|P1|STARTED|Overall Study||20
75296|NCT02216812|183226|P2|NOT COMPLETED|Overall Study||5
75297|NCT02216812|183227|P1|NOT COMPLETED|Overall Study||10
75298|NCT02216812|183226|P2|COMPLETED|Overall Study||62
75299|NCT02216812|183227|P1|COMPLETED|Overall Study||57
75300|NCT02216812|183226|P2|STARTED|Overall Study||67
75301|NCT02216812|183227|P1|STARTED|Overall Study||67
75302|NCT02216773|183243|P2|NOT COMPLETED|Overall Study||5
75303|NCT02216773|183244|P1|NOT COMPLETED|Overall Study||12
75304|NCT02216773|183243|P2|COMPLETED|Overall Study||24
75305|NCT02216773|183244|P1|COMPLETED|Overall Study||16
75306|NCT02216773|183243|P2|Underwent Procedure (PVE/RALPPS)|Overall Study||26
75307|NCT02216773|183244|P1|Underwent Procedure (PVE/RALPPS)|Overall Study||24
75308|NCT02216773|183243|P2|STARTED|Overall Study||29
75309|NCT02216773|183244|P1|STARTED|Overall Study||28
75310|NCT02216695|183254|P1|NOT COMPLETED|Overall Study||0
75311|NCT02216695|183254|P1|COMPLETED|Overall Study|This is a database study and hence, 64882 patients were finally included|64882
75312|NCT02216695|183254|P1|STARTED|Overall Study||64882
75313|NCT02216591|183265|P2|NOT COMPLETED|Overall Study||1
75314|NCT02216591|183266|P1|NOT COMPLETED|Overall Study||0
75315|NCT02216591|183265|P2|COMPLETED|Overall Study||9
75316|NCT02216591|183266|P1|COMPLETED|Overall Study||11
75317|NCT02216591|183265|P2|STARTED|Overall Study||10
75318|NCT02216591|183266|P1|STARTED|Overall Study||11
75319|NCT02216526|183279|P3|NOT COMPLETED|Overall Study||8
75320|NCT02216526|183280|P2|NOT COMPLETED|Overall Study||3
75321|NCT02216526|183281|P1|NOT COMPLETED|Overall Study||5
75322|NCT02216526|183279|P3|COMPLETED|Overall Study||36
75323|NCT02216526|183280|P2|COMPLETED|Overall Study||41
75324|NCT02216526|183281|P1|COMPLETED|Overall Study||40
75325|NCT02216526|183279|P3|STARTED|Overall Study||44
75326|NCT02216526|183280|P2|STARTED|Overall Study||44
75327|NCT02216526|183281|P1|STARTED|Overall Study||45
75328|NCT02216422|183391|P1|NOT COMPLETED|Overall Study||0
75329|NCT02216422|183391|P1|COMPLETED|Overall Study||36
75330|NCT02216422|183391|P1|STARTED|Overall Study||36
75331|NCT02216357|183399|P2|NOT COMPLETED|Overall Study||1
75332|NCT02216357|183400|P1|NOT COMPLETED|Overall Study||2
75333|NCT02216357|183399|P2|COMPLETED|Overall Study||4
75334|NCT02216357|183400|P1|COMPLETED|Overall Study||12
75335|NCT02216357|183399|P2|STARTED|Overall Study||5
75336|NCT02216357|183400|P1|STARTED|Overall Study||14
75337|NCT02216214|183426|P2|NOT COMPLETED|Overall Study||36
75338|NCT02216214|183427|P1|NOT COMPLETED|Overall Study||43
75339|NCT02216214|183426|P2|COMPLETED|Overall Study||409
75340|NCT02216214|183427|P1|COMPLETED|Overall Study||400
75341|NCT02216214|183426|P2|Treated|Overall Study||445
75342|NCT02216214|183427|P1|Treated|Overall Study||442
75343|NCT02216214|183426|P2|STARTED|Overall Study||445
75344|NCT02216214|183427|P1|STARTED|Overall Study||443
75345|NCT02216136|183486|P3|NOT COMPLETED|Overall Study||0
75346|NCT02216136|183487|P2|NOT COMPLETED|Overall Study||0
75347|NCT02216136|183488|P1|NOT COMPLETED|Overall Study||0
75348|NCT02216136|183486|P3|COMPLETED|Overall Study||0
75349|NCT02216136|183487|P2|COMPLETED|Overall Study||90
75350|NCT02216136|183488|P1|COMPLETED|Overall Study||72
75351|NCT02216136|183486|P3|STARTED|Overall Study||0
75352|NCT02216136|183487|P2|STARTED|Overall Study||90
75353|NCT02216136|183488|P1|STARTED|Overall Study||72
75354|NCT02216123|183498|P2|NOT COMPLETED|Overall Study||2
75355|NCT02216123|183499|P1|NOT COMPLETED|Overall Study||6
75356|NCT02216123|183498|P2|COMPLETED|Overall Study||83
75357|NCT02216123|183499|P1|COMPLETED|Overall Study||160
75358|NCT02216123|183498|P2|STARTED|Overall Study||85
75359|NCT02216123|183499|P1|STARTED|Overall Study||166
75360|NCT02216097|183565|P2|NOT COMPLETED|Overall Study||0
75361|NCT02216097|183566|P1|NOT COMPLETED|Overall Study||0
75362|NCT02216097|183565|P2|COMPLETED|Overall Study||6
75363|NCT02216097|183566|P1|COMPLETED|Overall Study||8
75364|NCT02216097|183565|P2|STARTED|Overall Study||6
75365|NCT02216097|183566|P1|STARTED|Overall Study||8
75366|NCT02215967|183592|P4|NOT COMPLETED|Overall Study||3
75367|NCT02215967|183593|P3|NOT COMPLETED|Overall Study||1
75368|NCT02215967|183594|P2|NOT COMPLETED|Overall Study||0
75369|NCT02215967|183595|P1|NOT COMPLETED|Overall Study||0
75370|NCT02215967|183592|P4|COMPLETED|Overall Study||16
75371|NCT02215967|183593|P3|COMPLETED|Overall Study||4
75372|NCT02215967|183594|P2|COMPLETED|Overall Study||3
75373|NCT02215967|183595|P1|COMPLETED|Overall Study||3
75374|NCT02215967|183592|P4|STARTED|Overall Study||19
75375|NCT02215967|183593|P3|STARTED|Overall Study||5
75376|NCT02215967|183594|P2|STARTED|Overall Study||3
75377|NCT02215967|183595|P1|STARTED|Overall Study||3
75378|NCT02215954|183616|P3|NOT COMPLETED|Overall Study||6
75379|NCT02215954|183617|P2|NOT COMPLETED|Overall Study||1
75380|NCT02215954|183618|P1|NOT COMPLETED|Overall Study||1
75381|NCT02215954|183616|P3|COMPLETED|Overall Study||205
75382|NCT02215954|183617|P2|COMPLETED|Overall Study||211
75383|NCT02215954|183618|P1|COMPLETED|Overall Study||213
75384|NCT02215954|183616|P3|Safety Analysis Set|Overall Study||208
75385|NCT02215954|183617|P2|Safety Analysis Set|Overall Study||211
75386|NCT02215954|183618|P1|Safety Analysis Set|Overall Study||213
75387|NCT02215954|183616|P3|Per Protocol (PP) Analysis Set|Overall Study||205
75388|NCT02215954|183617|P2|Per Protocol (PP) Analysis Set|Overall Study||208
75389|NCT02215954|183618|P1|Per Protocol (PP) Analysis Set|Overall Study||212
75390|NCT02215954|183616|P3|Intention-To-Treat (ITT) Analysis Set|Overall Study||211
75391|NCT02215954|183617|P2|Intention-To-Treat (ITT) Analysis Set|Overall Study||212
75392|NCT02215954|183618|P1|Intention-To-Treat (ITT) Analysis Set|Overall Study||214
75393|NCT02215954|183616|P3|STARTED|Overall Study||211
75394|NCT02215954|183617|P2|STARTED|Overall Study||212
75395|NCT02215954|183618|P1|STARTED|Overall Study||214
75396|NCT02215616|183642|P4|NOT COMPLETED|Overall Study||13
75397|NCT02215616|183643|P3|NOT COMPLETED|Overall Study||14
75398|NCT02215616|183644|P2|NOT COMPLETED|Overall Study||17
75399|NCT02215616|183645|P1|NOT COMPLETED|Overall Study||11
75400|NCT02215616|183642|P4|COMPLETED|Overall Study||17
75401|NCT02215616|183643|P3|COMPLETED|Overall Study||93
75402|NCT02215616|183644|P2|COMPLETED|Overall Study||90
75403|NCT02215616|183645|P1|COMPLETED|Overall Study||97
75404|NCT02215616|183642|P4|Received at Least 1 Dose of Study Drug|Overall Study||29
75405|NCT02215616|183643|P3|Received at Least 1 Dose of Study Drug|Overall Study||106
75406|NCT02215616|183644|P2|Received at Least 1 Dose of Study Drug|Overall Study||107
75407|NCT02215616|183645|P1|Received at Least 1 Dose of Study Drug|Overall Study||108
75408|NCT02215616|183642|P4|STARTED|Overall Study||30
75409|NCT02215616|183643|P3|STARTED|Overall Study||107
75410|NCT02215616|183644|P2|STARTED|Overall Study||107
75411|NCT02215616|183645|P1|STARTED|Overall Study||108
75412|NCT02215252|183662|P3|NOT COMPLETED|Overall Study||4
75413|NCT02215252|183663|P2|NOT COMPLETED|Overall Study||8
75414|NCT02215252|183664|P1|NOT COMPLETED|Overall Study||2
75415|NCT02215252|183662|P3|COMPLETED|Overall Study||41
75416|NCT02215252|183663|P2|COMPLETED|Overall Study||38
75417|NCT02215252|183664|P1|COMPLETED|Overall Study||42
75418|NCT02215252|183662|P3|STARTED|Overall Study||45
75419|NCT02215252|183663|P2|STARTED|Overall Study||46
75420|NCT02215252|183664|P1|STARTED|Overall Study||44
75421|NCT02215161|183721|P1|NOT COMPLETED|Overall Study||0
75422|NCT02215161|183721|P1|COMPLETED|Overall Study||14
75423|NCT02215161|183721|P1|STARTED|Overall Study||14
75424|NCT02214628|183741|P2|NOT COMPLETED|Overall Study||29
75425|NCT02214628|183742|P1|NOT COMPLETED|Overall Study||27
75426|NCT02214628|183741|P2|COMPLETED|Overall Study||9
75427|NCT02214628|183742|P1|COMPLETED|Overall Study||36
75428|NCT02214628|183741|P2|STARTED|Overall Study||38
75429|NCT02214628|183742|P1|STARTED|Overall Study||63
75430|NCT02214615|183752|P2|NOT COMPLETED|Second Intervention||0
75431|NCT02214615|183753|P1|NOT COMPLETED|Second Intervention||0
75432|NCT02214615|183752|P2|COMPLETED|Second Intervention||1
75433|NCT02214615|183753|P1|COMPLETED|Second Intervention||1
75434|NCT02214615|183752|P2|STARTED|Second Intervention||1
75435|NCT02214615|183753|P1|STARTED|Second Intervention||1
75436|NCT02214615|183752|P2|NOT COMPLETED|Washout||0
75437|NCT02214615|183753|P1|NOT COMPLETED|Washout||0
75438|NCT02214615|183752|P2|COMPLETED|Washout||1
75439|NCT02214615|183753|P1|COMPLETED|Washout||1
75440|NCT02214615|183752|P2|STARTED|Washout||1
75441|NCT02214615|183753|P1|STARTED|Washout||1
75442|NCT02214615|183752|P2|NOT COMPLETED|First Intervention||0
75443|NCT02214615|183753|P1|NOT COMPLETED|First Intervention||0
75444|NCT02214615|183752|P2|COMPLETED|First Intervention||1
75445|NCT02214615|183753|P1|COMPLETED|First Intervention||1
75446|NCT02214615|183752|P2|STARTED|First Intervention||1
75447|NCT02214615|183753|P1|STARTED|First Intervention||1
75448|NCT02214420|183763|P2|NOT COMPLETED|Overall Study||0
75449|NCT02214420|183764|P1|NOT COMPLETED|Overall Study||1
75450|NCT02214420|183763|P2|COMPLETED|Overall Study||10
75451|NCT02214420|183764|P1|COMPLETED|Overall Study||13
75452|NCT02214420|183763|P2|STARTED|Overall Study||10
75453|NCT02214420|183764|P1|STARTED|Overall Study||14
75454|NCT02214277|183773|P3|NOT COMPLETED|Overall Study||34
75455|NCT02214277|183774|P2|NOT COMPLETED|Overall Study||25
75456|NCT02214277|183775|P1|NOT COMPLETED|Overall Study||19
75457|NCT02214277|183773|P3|COMPLETED|Overall Study||85
75458|NCT02214277|183774|P2|COMPLETED|Overall Study||96
75459|NCT02214277|183775|P1|COMPLETED|Overall Study||104
75460|NCT02214277|183773|P3|STARTED|Overall Study||119
75461|NCT02214277|183774|P2|STARTED|Overall Study||121
75462|NCT02214277|183775|P1|STARTED|Overall Study||123
75463|NCT02214238|183785|P2|NOT COMPLETED|Overall Study||6
75464|NCT02214238|183786|P1|NOT COMPLETED|Overall Study||6
75465|NCT02214238|183785|P2|COMPLETED|Overall Study||17
75466|NCT02214238|183786|P1|COMPLETED|Overall Study||20
75467|NCT02214238|183785|P2|STARTED|Overall Study||23
75468|NCT02214238|183786|P1|STARTED|Overall Study||26
75469|NCT02214225|183799|P3|NOT COMPLETED|Overall Study||22
75470|NCT02214225|183800|P2|NOT COMPLETED|Overall Study||19
75471|NCT02214225|183801|P1|NOT COMPLETED|Overall Study||55
75472|NCT02214225|183799|P3|COMPLETED|Overall Study||850
75473|NCT02214225|183800|P2|COMPLETED|Overall Study||852
75474|NCT02214225|183801|P1|COMPLETED|Overall Study||1686
75475|NCT02214225|183799|P3|STARTED|Overall Study||872
75476|NCT02214225|183800|P2|STARTED|Overall Study||871
75477|NCT02214225|183801|P1|STARTED|Overall Study||1741
75478|NCT02214186|183860|P2|NOT COMPLETED|Overall Study||2
75479|NCT02214186|183861|P1|NOT COMPLETED|Overall Study||2
75480|NCT02214186|183860|P2|COMPLETED|Overall Study||21
75481|NCT02214186|183861|P1|COMPLETED|Overall Study||21
75482|NCT02214186|183860|P2|STARTED|Overall Study||23
75483|NCT02214186|183861|P1|STARTED|Overall Study||23
75484|NCT02214147|183886|P3|NOT COMPLETED|Overall Study||0
75485|NCT02214147|183887|P2|NOT COMPLETED|Overall Study||0
75486|NCT02214147|183888|P1|NOT COMPLETED|Overall Study||0
75487|NCT02214147|183886|P3|COMPLETED|Overall Study||8
75488|NCT02214147|183887|P2|COMPLETED|Overall Study||12
75489|NCT02214147|183888|P1|COMPLETED|Overall Study||16
75490|NCT02214147|183886|P3|STARTED|Overall Study||8
75491|NCT02214147|183887|P2|STARTED|Overall Study||12
75492|NCT02214147|183888|P1|STARTED|Overall Study||16
75493|NCT02214121|183929|P3|NOT COMPLETED|Part B||1
75494|NCT02214121|183930|P2|NOT COMPLETED|Part B||3
75495|NCT02214121|183931|P1|NOT COMPLETED|Part B||0
75496|NCT02214121|183929|P3|COMPLETED|Part B||7
75497|NCT02214121|183930|P2|COMPLETED|Part B||14
75498|NCT02214121|183931|P1|COMPLETED|Part B||0
75499|NCT02214121|183929|P3|STARTED|Part B||8
75500|NCT02214121|183930|P2|STARTED|Part B||17
75501|NCT02214121|183931|P1|STARTED|Part B||0
75502|NCT02214121|183929|P3|NOT COMPLETED|Part A||0
75503|NCT02214121|183930|P2|NOT COMPLETED|Part A||0
75504|NCT02214121|183931|P1|NOT COMPLETED|Part A||7
75505|NCT02214121|183929|P3|COMPLETED|Part A||0
75506|NCT02214121|183930|P2|COMPLETED|Part A||0
75507|NCT02214121|183931|P1|COMPLETED|Part A||39
75508|NCT02214121|183929|P3|STARTED|Part A||0
75509|NCT02214121|183930|P2|STARTED|Part A||0
75510|NCT02214121|183931|P1|STARTED|Part A||46
75511|NCT02214017|184010|P2|NOT COMPLETED|Overall Study||0
75512|NCT02214017|184011|P1|NOT COMPLETED|Overall Study||0
75513|NCT02214017|184010|P2|COMPLETED|Overall Study||18
75514|NCT02214017|184011|P1|COMPLETED|Overall Study||22
75515|NCT02214017|184010|P2|STARTED|Overall Study||18
75516|NCT02214017|184011|P1|STARTED|Overall Study||22
75517|NCT02213926|184021|P1|NOT COMPLETED|Overall Study||70
75518|NCT02213926|184021|P1|COMPLETED|Overall Study||54
75519|NCT02213926|184021|P1|STARTED|Overall Study||124
75520|NCT02213900|184027|P2|NOT COMPLETED|Overall Study||0
75521|NCT02213900|184028|P1|NOT COMPLETED|Overall Study||0
75522|NCT02213900|184027|P2|COMPLETED|Overall Study||67
75523|NCT02213900|184028|P1|COMPLETED|Overall Study||68
75524|NCT02213900|184027|P2|STARTED|Overall Study||67
75525|NCT02213900|184028|P1|STARTED|Overall Study||68
75526|NCT02213666|184040|P1|NOT COMPLETED|Overall Study||1
75527|NCT02213666|184040|P1|COMPLETED|Overall Study||71
75528|NCT02213666|184040|P1|STARTED|Overall Study||72
75529|NCT02213510|184046|P2|NOT COMPLETED|Overall Study||1
75530|NCT02213510|184047|P1|NOT COMPLETED|Overall Study||1
75531|NCT02213510|184046|P2|COMPLETED|Overall Study||18
75532|NCT02213510|184047|P1|COMPLETED|Overall Study||20
75533|NCT02213510|184046|P2|STARTED|Overall Study||19
75534|NCT02213510|184047|P1|STARTED|Overall Study||21
75535|NCT02213263|184075|P2|NOT COMPLETED|Overall Study||26
75536|NCT02213263|184076|P1|NOT COMPLETED|Overall Study||28
75537|NCT02213263|184075|P2|COMPLETED|Overall Study||170
75538|NCT02213263|184076|P1|COMPLETED|Overall Study||170
75539|NCT02213263|184075|P2|Treated|Overall Study||196
75540|NCT02213263|184076|P1|Treated|Overall Study||197
75541|NCT02213263|184075|P2|STARTED|Overall Study||196
75542|NCT02213263|184076|P1|STARTED|Overall Study||198
75543|NCT02213250|184112|P2|NOT COMPLETED|Overall Study||0
75544|NCT02213250|184113|P1|NOT COMPLETED|Overall Study||0
75545|NCT02213250|184112|P2|COMPLETED|Overall Study||8
75546|NCT02213250|184113|P1|COMPLETED|Overall Study||4
75547|NCT02213250|184112|P2|STARTED|Overall Study||8
75548|NCT02213250|184113|P1|STARTED|Overall Study||4
75549|NCT02213198|184144|P2|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||7
75550|NCT02213198|184145|P1|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||23
75551|NCT02213198|184144|P2|COMPLETED|Follow up 2 6 Months Post TCC Treatment||60
75552|NCT02213198|184145|P1|COMPLETED|Follow up 2 6 Months Post TCC Treatment||102
75553|NCT02213198|184144|P2|STARTED|Follow up 2 6 Months Post TCC Treatment||67
75554|NCT02213198|184145|P1|STARTED|Follow up 2 6 Months Post TCC Treatment||125
75555|NCT02213198|184144|P2|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||41
75556|NCT02213198|184145|P1|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||93
75557|NCT02213198|184144|P2|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||67
75558|NCT02213198|184145|P1|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||125
75559|NCT02213198|184144|P2|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||108
75560|NCT02213198|184145|P1|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||218
75561|NCT02213198|184144|P2|NOT COMPLETED|Baseline||51
75562|NCT02213198|184145|P1|NOT COMPLETED|Baseline||88
75563|NCT02213198|184144|P2|COMPLETED|Baseline||108
75564|NCT02213198|184145|P1|COMPLETED|Baseline||218
75565|NCT02213198|184144|P2|STARTED|Baseline||159
75566|NCT02213198|184145|P1|STARTED|Baseline||306
75567|NCT02213094|184155|P2|NOT COMPLETED|Overall Study||0
75568|NCT02213094|184156|P1|NOT COMPLETED|Overall Study||1
75569|NCT02213094|184155|P2|COMPLETED|Overall Study||5
75570|NCT02213094|184156|P1|COMPLETED|Overall Study|One subject stopped study agent early because of elevation in LFTs > 3x ULN|4
75571|NCT02213094|184155|P2|STARTED|Overall Study||5
75572|NCT02213094|184156|P1|STARTED|Overall Study||5
75573|NCT02213055|184164|P2|NOT COMPLETED|Overall Study||0
75574|NCT02213055|184165|P1|NOT COMPLETED|Overall Study||39
75575|NCT02213055|184164|P2|COMPLETED|Overall Study||0
75576|NCT02213055|184165|P1|COMPLETED|Overall Study||58
75577|NCT02213055|184164|P2|STARTED|Overall Study||0
75578|NCT02213055|184165|P1|STARTED|Overall Study||97
75579|NCT02212977|184173|P2|NOT COMPLETED|Overall Study||6
75580|NCT02212977|184174|P1|NOT COMPLETED|Overall Study||5
75581|NCT02212977|184173|P2|COMPLETED|Overall Study||48
75582|NCT02212977|184174|P1|COMPLETED|Overall Study||50
75583|NCT02212977|184173|P2|STARTED|Overall Study||54
75584|NCT02212977|184174|P1|STARTED|Overall Study||55
75585|NCT02212834|184190|P2|NOT COMPLETED|Overall Study||0
75586|NCT02212834|184191|P1|NOT COMPLETED|Overall Study||0
75587|NCT02212834|184190|P2|COMPLETED|Overall Study||2506
75588|NCT02212834|184191|P1|COMPLETED|Overall Study||33938
75589|NCT02212834|184190|P2|STARTED|Overall Study||2506
75590|NCT02212834|184191|P1|STARTED|Overall Study||33938
75591|NCT02212678|184197|P1|NOT COMPLETED|Overall Study||1
75592|NCT02212678|184197|P1|COMPLETED|Overall Study||7
75593|NCT02212678|184197|P1|STARTED|Overall Study||8
75594|NCT02212457|184207|P6|NOT COMPLETED|Overall Study||13
75595|NCT02212457|184208|P5|NOT COMPLETED|Overall Study||15
75596|NCT02212457|184209|P4|NOT COMPLETED|Overall Study||11
75597|NCT02212457|184210|P3|NOT COMPLETED|Overall Study||16
75598|NCT02212457|184211|P2|NOT COMPLETED|Overall Study||21
75599|NCT02212457|184212|P1|NOT COMPLETED|Overall Study||19
75600|NCT02212457|184207|P6|COMPLETED|Overall Study||147
75601|NCT02212457|184208|P5|COMPLETED|Overall Study||137
75602|NCT02212457|184209|P4|COMPLETED|Overall Study||123
75603|NCT02212457|184210|P3|COMPLETED|Overall Study||141
75604|NCT02212457|184211|P2|COMPLETED|Overall Study||211
75605|NCT02212457|184212|P1|COMPLETED|Overall Study||209
75606|NCT02212457|184207|P6|STARTED|Overall Study||160
75607|NCT02212457|184208|P5|STARTED|Overall Study||152
75608|NCT02212457|184209|P4|STARTED|Overall Study||134
75609|NCT02212457|184210|P3|STARTED|Overall Study||157
75610|NCT02212457|184211|P2|STARTED|Overall Study||232
75611|NCT02212457|184212|P1|STARTED|Overall Study||228
75612|NCT02212301|184336|P2|NOT COMPLETED|Period 2||0
75613|NCT02212301|184337|P1|NOT COMPLETED|Period 2||0
75614|NCT02212301|184336|P2|COMPLETED|Period 2||21
75615|NCT02212301|184337|P1|COMPLETED|Period 2||21
75616|NCT02212301|184336|P2|STARTED|Period 2||21
75617|NCT02212301|184337|P1|STARTED|Period 2||21
75618|NCT02212301|184336|P2|NOT COMPLETED|Period 1||1
75619|NCT02212301|184337|P1|NOT COMPLETED|Period 1||0
75620|NCT02212301|184336|P2|COMPLETED|Period 1||21
75621|NCT02212301|184337|P1|COMPLETED|Period 1||21
75622|NCT02212301|184336|P2|STARTED|Period 1||22
75623|NCT02212301|184337|P1|STARTED|Period 1||21
75624|NCT02212197|184348|P3|NOT COMPLETED|Overall Study||0
75625|NCT02212197|184349|P2|NOT COMPLETED|Overall Study||0
75626|NCT02212197|184350|P1|NOT COMPLETED|Overall Study||1
75627|NCT02212197|184348|P3|COMPLETED|Overall Study||17
75628|NCT02212197|184349|P2|COMPLETED|Overall Study||15
75629|NCT02212197|184350|P1|COMPLETED|Overall Study||18
75630|NCT02212197|184348|P3|STARTED|Overall Study||17
75631|NCT02212197|184349|P2|STARTED|Overall Study||15
75632|NCT02212197|184350|P1|STARTED|Overall Study||19
75633|NCT02212106|184375|P2|NOT COMPLETED|Overall Study||4
75634|NCT02212106|184376|P1|NOT COMPLETED|Overall Study||10
75635|NCT02212106|184375|P2|COMPLETED|Overall Study||96
75636|NCT02212106|184376|P1|COMPLETED|Overall Study||292
75637|NCT02212106|184375|P2|STARTED|Overall Study||100
75638|NCT02212106|184376|P1|STARTED|Overall Study||302
75639|NCT02212028|184394|P2|NOT COMPLETED|Overall Study||0
75640|NCT02212028|184395|P1|NOT COMPLETED|Overall Study||0
75641|NCT02212028|184394|P2|COMPLETED|Overall Study||26
75642|NCT02212028|184395|P1|COMPLETED|Overall Study||26
75643|NCT02212028|184394|P2|STARTED|Overall Study||26
75644|NCT02212028|184395|P1|STARTED|Overall Study||26
75645|NCT02211638|184403|P1|NOT COMPLETED|Overall Study||983
75646|NCT02211638|184403|P1|COMPLETED|Overall Study||17130
75647|NCT02211638|184403|P1|STARTED|Overall Study||18113
75648|NCT02211534|184414|P2|NOT COMPLETED|Overall Study||5
75649|NCT02211534|184415|P1|NOT COMPLETED|Overall Study||13
75650|NCT02211534|184414|P2|COMPLETED|Overall Study||6
75651|NCT02211534|184415|P1|COMPLETED|Overall Study||11
75652|NCT02211534|184414|P2|STARTED|Overall Study||11
75653|NCT02211534|184415|P1|STARTED|Overall Study||24
75654|NCT02211313|184437|P2|NOT COMPLETED|Overall Study||3
75655|NCT02211313|184438|P1|NOT COMPLETED|Overall Study||6
75656|NCT02211313|184437|P2|COMPLETED|Overall Study||20
75657|NCT02211313|184438|P1|COMPLETED|Overall Study||12
75658|NCT02211313|184437|P2|STARTED|Overall Study||23
75659|NCT02211313|184438|P1|STARTED|Overall Study||18
75660|NCT02211261|184455|P11|NOT COMPLETED|Overall Study||0
75661|NCT02211261|184456|P10|NOT COMPLETED|Overall Study||2
75662|NCT02211261|184457|P9|NOT COMPLETED|Overall Study||0
75663|NCT02211261|184458|P8|NOT COMPLETED|Overall Study||1
75664|NCT02211261|184459|P7|NOT COMPLETED|Overall Study||0
75665|NCT02211261|184460|P6|NOT COMPLETED|Overall Study||1
75666|NCT02211261|184461|P5|NOT COMPLETED|Overall Study||2
75667|NCT02211261|184462|P4|NOT COMPLETED|Overall Study||0
75668|NCT02211261|184463|P3|NOT COMPLETED|Overall Study||1
75669|NCT02211261|184464|P2|NOT COMPLETED|Overall Study||0
75670|NCT02211261|184465|P1|NOT COMPLETED|Overall Study||0
75671|NCT02211261|184455|P11|COMPLETED|Overall Study||8
75672|NCT02211261|184456|P10|COMPLETED|Overall Study||14
75673|NCT02211261|184457|P9|COMPLETED|Overall Study||8
75674|NCT02211261|184458|P8|COMPLETED|Overall Study||7
75675|NCT02211261|184459|P7|COMPLETED|Overall Study||6
75676|NCT02211261|184460|P6|COMPLETED|Overall Study||1
75677|NCT02211261|184461|P5|COMPLETED|Overall Study||7
75678|NCT02211261|184462|P4|COMPLETED|Overall Study||6
75679|NCT02211261|184463|P3|COMPLETED|Overall Study||5
75680|NCT02211261|184464|P2|COMPLETED|Overall Study||6
75681|NCT02211261|184465|P1|COMPLETED|Overall Study||9
75682|NCT02211261|184455|P11|STARTED|Overall Study||8
75683|NCT02211261|184456|P10|STARTED|Overall Study||16
75684|NCT02211261|184457|P9|STARTED|Overall Study||8
75685|NCT02211261|184458|P8|STARTED|Overall Study||8
75686|NCT02211261|184459|P7|STARTED|Overall Study||6
75687|NCT02211261|184460|P6|STARTED|Overall Study||2
75688|NCT02211261|184461|P5|STARTED|Overall Study||9
75689|NCT02211261|184462|P4|STARTED|Overall Study||6
75690|NCT02211261|184463|P3|STARTED|Overall Study||6
75691|NCT02211261|184464|P2|STARTED|Overall Study||6
75692|NCT02211261|184465|P1|STARTED|Overall Study||9
75693|NCT02210208|184586|P1|NOT COMPLETED|Period B (Donor Site)||7
75694|NCT02210208|184586|P1|COMPLETED|Period B (Donor Site)||12
75695|NCT02210208|184586|P1|STARTED|Period B (Donor Site)|6 subjects was decided by the Physician not to be included in the Part B.|19
75696|NCT02210208|184586|P1|NOT COMPLETED|Period A (Graft Site)||2
75697|NCT02210208|184586|P1|COMPLETED|Period A (Graft Site)||23
75698|NCT02210208|184586|P1|STARTED|Period A (Graft Site)||25
75699|NCT02210195|184595|P2|NOT COMPLETED|Overall Study||0
75700|NCT02210195|184596|P1|NOT COMPLETED|Overall Study||4
75701|NCT02210195|184595|P2|COMPLETED|Overall Study||10
75702|NCT02210195|184596|P1|COMPLETED|Overall Study||6
75703|NCT02210195|184595|P2|STARTED|Overall Study||10
75704|NCT02210195|184596|P1|STARTED|Overall Study||10
75705|NCT02210091|184606|P2|NOT COMPLETED|Overall Study||2
75706|NCT02210091|184607|P1|NOT COMPLETED|Overall Study||0
75707|NCT02210091|184606|P2|COMPLETED|Overall Study||32
75708|NCT02210091|184607|P1|COMPLETED|Overall Study||32
75709|NCT02210091|184606|P2|STARTED|Overall Study||34
75710|NCT02210091|184607|P1|STARTED|Overall Study||32
75711|NCT02210052|184679|P1|NOT COMPLETED|Overall Study||0
75712|NCT02210052|184679|P1|COMPLETED|Overall Study||6
75713|NCT02210052|184679|P1|STARTED|Overall Study||6
75714|NCT02210039|184683|P1|NOT COMPLETED|Overall Study||0
75715|NCT02210039|184683|P1|COMPLETED|Overall Study||6
75716|NCT02210039|184683|P1|STARTED|Overall Study||6
75717|NCT02210000|184689|P2|NOT COMPLETED|Overall Study||21
75718|NCT02210000|184690|P1|NOT COMPLETED|Overall Study||19
75719|NCT02210000|184689|P2|COMPLETED|Overall Study||36
75720|NCT02210000|184690|P1|COMPLETED|Overall Study||38
75721|NCT02210000|184689|P2|STARTED|Overall Study||57
75722|NCT02210000|184690|P1|STARTED|Overall Study||57
75723|NCT02209766|184716|P5|NOT COMPLETED|Overall Study||0
75724|NCT02209766|184717|P4|NOT COMPLETED|Overall Study||1
75725|NCT02209766|184718|P3|NOT COMPLETED|Overall Study||0
75726|NCT02209766|184719|P2|NOT COMPLETED|Overall Study||0
75727|NCT02209766|184720|P1|NOT COMPLETED|Overall Study||0
75728|NCT02209766|184716|P5|COMPLETED|Overall Study||6
75729|NCT02209766|184717|P4|COMPLETED|Overall Study||2
75730|NCT02209766|184718|P3|COMPLETED|Overall Study||6
75731|NCT02209766|184719|P2|COMPLETED|Overall Study||3
75732|NCT02209766|184720|P1|COMPLETED|Overall Study||6
75733|NCT02209766|184716|P5|STARTED|Overall Study||6
75734|NCT02209766|184717|P4|STARTED|Overall Study||3
75735|NCT02209766|184718|P3|STARTED|Overall Study||6
75736|NCT02209766|184719|P2|STARTED|Overall Study||3
75737|NCT02209766|184720|P1|STARTED|Overall Study||6
75738|NCT02209610|184768|P2|NOT COMPLETED|Overall Study||0
75739|NCT02209610|184769|P1|NOT COMPLETED|Overall Study||0
75740|NCT02209610|184768|P2|COMPLETED|Overall Study||16
75741|NCT02209610|184769|P1|COMPLETED|Overall Study||16
75742|NCT02209610|184768|P2|STARTED|Overall Study||16
75743|NCT02209610|184769|P1|STARTED|Overall Study||16
75744|NCT02209532|184781|P2|NOT COMPLETED|Overall Study||1
75745|NCT02209532|184782|P1|NOT COMPLETED|Overall Study||3
75746|NCT02209532|184781|P2|COMPLETED|Overall Study||89
75747|NCT02209532|184782|P1|COMPLETED|Overall Study||87
75748|NCT02209532|184781|P2|STARTED|Overall Study||90
75749|NCT02209532|184782|P1|STARTED|Overall Study||90
75750|NCT02209506|184803|P5|NOT COMPLETED|Overall Study||1
75751|NCT02209506|184804|P4|NOT COMPLETED|Overall Study||0
75752|NCT02209506|184805|P3|NOT COMPLETED|Overall Study||0
75753|NCT02209506|184806|P2|NOT COMPLETED|Overall Study||0
75754|NCT02209506|184807|P1|NOT COMPLETED|Overall Study||0
75755|NCT02209506|184803|P5|COMPLETED|Overall Study||5
75756|NCT02209506|184804|P4|COMPLETED|Overall Study||2
75757|NCT02209506|184805|P3|COMPLETED|Overall Study||6
75758|NCT02209506|184806|P2|COMPLETED|Overall Study||6
75759|NCT02209506|184807|P1|COMPLETED|Overall Study||3
75760|NCT02209506|184803|P5|STARTED|Overall Study||6
75761|NCT02209506|184804|P4|STARTED|Overall Study||2
75762|NCT02209506|184805|P3|STARTED|Overall Study||6
75763|NCT02209506|184806|P2|STARTED|Overall Study||6
75764|NCT02209506|184807|P1|STARTED|Overall Study||3
75765|NCT02209454|184882|P2|NOT COMPLETED|Second Period||0
75766|NCT02209454|184883|P1|NOT COMPLETED|Second Period||1
75767|NCT02209454|184882|P2|COMPLETED|Second Period||13
75768|NCT02209454|184883|P1|COMPLETED|Second Period||12
75769|NCT02209454|184882|P2|STARTED|Second Period||13
75770|NCT02209454|184883|P1|STARTED|Second Period||13
75771|NCT02209454|184882|P2|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
75772|NCT02209454|184883|P1|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
75773|NCT02209454|184882|P2|COMPLETED|Washout Period a Minimum of a 7 Day||13
75774|NCT02209454|184883|P1|COMPLETED|Washout Period a Minimum of a 7 Day||13
75775|NCT02209454|184882|P2|STARTED|Washout Period a Minimum of a 7 Day||13
75776|NCT02209454|184883|P1|STARTED|Washout Period a Minimum of a 7 Day||13
75777|NCT02209454|184882|P2|NOT COMPLETED|First Period||0
75778|NCT02209454|184883|P1|NOT COMPLETED|First Period||0
75779|NCT02209454|184882|P2|COMPLETED|First Period||13
75780|NCT02209454|184883|P1|COMPLETED|First Period||13
75781|NCT02209454|184882|P2|STARTED|First Period||13
75782|NCT02209454|184883|P1|STARTED|First Period||13
75783|NCT02209272|184899|P2|NOT COMPLETED|Overall Study||0
75784|NCT02209272|184900|P1|NOT COMPLETED|Overall Study||0
75785|NCT02209272|184899|P2|COMPLETED|Overall Study||36
75786|NCT02209272|184900|P1|COMPLETED|Overall Study||32
75787|NCT02209272|184899|P2|STARTED|Overall Study||36
75788|NCT02209272|184900|P1|STARTED|Overall Study||32
75789|NCT02209259|184913|P3|NOT COMPLETED|Overall Study||0
75790|NCT02209259|184914|P2|NOT COMPLETED|Overall Study||0
75791|NCT02209259|184915|P1|NOT COMPLETED|Overall Study||0
75792|NCT02209259|184913|P3|COMPLETED|Overall Study||56
75793|NCT02209259|184914|P2|COMPLETED|Overall Study||56
75794|NCT02209259|184915|P1|COMPLETED|Overall Study||56
75795|NCT02209259|184913|P3|STARTED|Overall Study||56
75796|NCT02209259|184914|P2|STARTED|Overall Study||56
75797|NCT02209259|184915|P1|STARTED|Overall Study||56
75798|NCT02209181|184933|P4|NOT COMPLETED|Overall Study||0
75799|NCT02209181|184934|P3|NOT COMPLETED|Overall Study||1
75800|NCT02209181|184935|P2|NOT COMPLETED|Overall Study||1
75801|NCT02209181|184936|P1|NOT COMPLETED|Overall Study||1
75802|NCT02209181|184933|P4|COMPLETED|Overall Study||66
75803|NCT02209181|184934|P3|COMPLETED|Overall Study||68
75804|NCT02209181|184935|P2|COMPLETED|Overall Study||66
75805|NCT02209181|184936|P1|COMPLETED|Overall Study||66
75806|NCT02209181|184933|P4|STARTED|Overall Study||66
75807|NCT02209181|184934|P3|STARTED|Overall Study||69
75808|NCT02209181|184935|P2|STARTED|Overall Study||67
75809|NCT02209181|184936|P1|STARTED|Overall Study||67
75810|NCT02209064|185098|P1|NOT COMPLETED|Overall Study||0
75811|NCT02209064|185098|P1|COMPLETED|Overall Study||25
75812|NCT02209064|185098|P1|STARTED|Overall Study||25
75813|NCT02208999|185107|P1|NOT COMPLETED|Overall Study||1
75814|NCT02208999|185107|P1|COMPLETED|Overall Study||105
75815|NCT02208999|185107|P1|STARTED|Overall Study||106
75816|NCT02208843|185129|P1|NOT COMPLETED|Overall Study||60
75817|NCT02208843|185129|P1|COMPLETED|Overall Study||0
75818|NCT02208843|185129|P1|STARTED|Overall Study||60
75819|NCT02208349|185137|P2|NOT COMPLETED|Sixth 6 Month||0
75820|NCT02208349|185138|P1|NOT COMPLETED|Sixth 6 Month||0
75821|NCT02208349|185137|P2|COMPLETED|Sixth 6 Month||2
75822|NCT02208349|185138|P1|COMPLETED|Sixth 6 Month||3
75823|NCT02208349|185137|P2|STARTED|Sixth 6 Month||2
75824|NCT02208349|185138|P1|STARTED|Sixth 6 Month||3
75825|NCT02208349|185137|P2|NOT COMPLETED|Fifth 6 Month||0
75826|NCT02208349|185138|P1|NOT COMPLETED|Fifth 6 Month||0
75827|NCT02208349|185137|P2|COMPLETED|Fifth 6 Month||2
75828|NCT02208349|185138|P1|COMPLETED|Fifth 6 Month||7
75829|NCT02208349|185137|P2|STARTED|Fifth 6 Month||2
75830|NCT02208349|185138|P1|STARTED|Fifth 6 Month||7
75831|NCT02208349|185137|P2|NOT COMPLETED|Fourth 6 Month||0
75832|NCT02208349|185138|P1|NOT COMPLETED|Fourth 6 Month||0
75833|NCT02208349|185137|P2|COMPLETED|Fourth 6 Month||2
75834|NCT02208349|185138|P1|COMPLETED|Fourth 6 Month||14
75835|NCT02208349|185137|P2|STARTED|Fourth 6 Month||2
75836|NCT02208349|185138|P1|STARTED|Fourth 6 Month||14
75837|NCT02208349|185137|P2|NOT COMPLETED|Third 6 Month||0
75838|NCT02208349|185138|P1|NOT COMPLETED|Third 6 Month||0
75839|NCT02208349|185137|P2|COMPLETED|Third 6 Month||3
75840|NCT02208349|185138|P1|COMPLETED|Third 6 Month||6
75841|NCT02208349|185137|P2|STARTED|Third 6 Month||3
75842|NCT02208349|185138|P1|STARTED|Third 6 Month||6
75843|NCT02208349|185137|P2|NOT COMPLETED|Second 6 Months||0
75844|NCT02208349|185138|P1|NOT COMPLETED|Second 6 Months||0
75845|NCT02208349|185137|P2|COMPLETED|Second 6 Months||7
75846|NCT02208349|185138|P1|COMPLETED|Second 6 Months||11
75847|NCT02208349|185137|P2|STARTED|Second 6 Months||7
75848|NCT02208349|185138|P1|STARTED|Second 6 Months||11
75849|NCT02208349|185137|P2|NOT COMPLETED|Initial 6 Months||0
75850|NCT02208349|185138|P1|NOT COMPLETED|Initial 6 Months||0
75851|NCT02208349|185137|P2|COMPLETED|Initial 6 Months||9
75852|NCT02208349|185138|P1|COMPLETED|Initial 6 Months||16
75853|NCT02208349|185137|P2|STARTED|Initial 6 Months||9
75854|NCT02208349|185138|P1|STARTED|Initial 6 Months||16
75855|NCT02208310|185148|P2|NOT COMPLETED|Overall Study||5
75856|NCT02208310|185149|P1|NOT COMPLETED|Overall Study||6
75857|NCT02208310|185148|P2|COMPLETED|Overall Study||0
75858|NCT02208310|185149|P1|COMPLETED|Overall Study||0
75859|NCT02208310|185148|P2|Day 180|Overall Study||1
75860|NCT02208310|185149|P1|Day 180|Overall Study||0
75861|NCT02208310|185148|P2|STARTED|Overall Study||5
75862|NCT02208310|185149|P1|STARTED|Overall Study||6
75863|NCT02208089|185181|P2|NOT COMPLETED|Overall Study||0
75864|NCT02208089|185182|P1|NOT COMPLETED|Overall Study||7
75865|NCT02208089|185181|P2|COMPLETED|Overall Study||47
75866|NCT02208089|185182|P1|COMPLETED|Overall Study||40
75867|NCT02208089|185181|P2|STARTED|Overall Study||47
75868|NCT02208089|185182|P1|STARTED|Overall Study||47
75869|NCT02208037|185199|P3|NOT COMPLETED|Overall Study||1
75870|NCT02208037|185200|P2|NOT COMPLETED|Overall Study||1
75871|NCT02208037|185201|P1|NOT COMPLETED|Overall Study||4
75872|NCT02208037|185199|P3|COMPLETED|Overall Study||92
75873|NCT02208037|185200|P2|COMPLETED|Overall Study||92
75874|NCT02208037|185201|P1|COMPLETED|Overall Study||89
75875|NCT02208037|185199|P3|STARTED|Overall Study||93
75876|NCT02208037|185200|P2|STARTED|Overall Study||93
75877|NCT02208037|185201|P1|STARTED|Overall Study||93
75878|NCT02207972|185250|P2|NOT COMPLETED|Overall Study||0
75879|NCT02207972|185251|P1|NOT COMPLETED|Overall Study||0
75880|NCT02207972|185250|P2|COMPLETED|Overall Study||24
75881|NCT02207972|185251|P1|COMPLETED|Overall Study||22
75882|NCT02207972|185250|P2|STARTED|Overall Study||24
75883|NCT02207972|185251|P1|STARTED|Overall Study||22
75884|NCT02207907|185263|P2|NOT COMPLETED|Overall Study||8
75885|NCT02207907|185264|P1|NOT COMPLETED|Overall Study||11
75886|NCT02207907|185263|P2|COMPLETED|Overall Study||115
75887|NCT02207907|185264|P1|COMPLETED|Overall Study||113
75888|NCT02207907|185263|P2|STARTED|Overall Study||123
75889|NCT02207907|185264|P1|STARTED|Overall Study||124
75890|NCT02207829|185282|P2|NOT COMPLETED|Overall Study||34
75891|NCT02207829|185283|P1|NOT COMPLETED|Overall Study||42
75892|NCT02207829|185282|P2|COMPLETED|Overall Study||474
75893|NCT02207829|185283|P1|COMPLETED|Overall Study||467
75894|NCT02207829|185282|P2|STARTED|Overall Study||508
75895|NCT02207829|185283|P1|STARTED|Overall Study||509
75896|NCT02207816|185292|P3|NOT COMPLETED|Overall Study||67
75897|NCT02207816|185293|P2|NOT COMPLETED|Overall Study||86
75898|NCT02207816|185294|P1|NOT COMPLETED|Overall Study||51
75899|NCT02207816|185292|P3|COMPLETED|Overall Study||961
75900|NCT02207816|185293|P2|COMPLETED|Overall Study||924
75901|NCT02207816|185294|P1|COMPLETED|Overall Study||995
75902|NCT02207816|185292|P3|STARTED|Overall Study||1028
75903|NCT02207816|185293|P2|STARTED|Overall Study||1010
75904|NCT02207816|185294|P1|STARTED|Overall Study||1046
75905|NCT02207803|185439|P2|NOT COMPLETED|Overall Study||17
75906|NCT02207803|185440|P1|NOT COMPLETED|Overall Study||15
75907|NCT02207803|185439|P2|COMPLETED|Overall Study||108
75908|NCT02207803|185440|P1|COMPLETED|Overall Study||110
75909|NCT02207803|185439|P2|STARTED|Overall Study||125
75910|NCT02207803|185440|P1|STARTED|Overall Study||125
75911|NCT02207725|185452|P4|NOT COMPLETED|Overall Study||1
75912|NCT02207725|185453|P3|NOT COMPLETED|Overall Study||1
75913|NCT02207725|185454|P2|NOT COMPLETED|Overall Study||1
75914|NCT02207725|185455|P1|NOT COMPLETED|Overall Study||0
75915|NCT02207725|185452|P4|COMPLETED|Overall Study||24
75916|NCT02207725|185453|P3|COMPLETED|Overall Study||8
75917|NCT02207725|185454|P2|COMPLETED|Overall Study||24
75918|NCT02207725|185455|P1|COMPLETED|Overall Study||9
75919|NCT02207725|185452|P4|STARTED|Overall Study||25
75920|NCT02207725|185453|P3|STARTED|Overall Study||9
75921|NCT02207725|185454|P2|STARTED|Overall Study||25
75922|NCT02207725|185455|P1|STARTED|Overall Study||9
75923|NCT02207634|185485|P2|NOT COMPLETED|Overall Study||31
75924|NCT02207634|185486|P1|NOT COMPLETED|Overall Study||22
75925|NCT02207634|185485|P2|COMPLETED|Overall Study||953
75926|NCT02207634|185486|P1|COMPLETED|Overall Study||968
75927|NCT02207634|185485|P2|Received Treatment|Overall Study||983
75928|NCT02207634|185486|P1|Received Treatment|Overall Study||990
75929|NCT02207634|185485|P2|STARTED|Overall Study||984
75930|NCT02207634|185486|P1|STARTED|Overall Study||990
75931|NCT02207621|185501|P3|NOT COMPLETED|Overall Study||168
75932|NCT02207621|185502|P2|NOT COMPLETED|Overall Study||47
75933|NCT02207621|185503|P1|NOT COMPLETED|Overall Study||105
75934|NCT02207621|185501|P3|COMPLETED|Overall Study||86
75935|NCT02207621|185502|P2|COMPLETED|Overall Study||204
75936|NCT02207621|185503|P1|COMPLETED|Overall Study||146
75937|NCT02207621|185501|P3|STARTED|Overall Study||254
75938|NCT02207621|185502|P2|STARTED|Overall Study||251
75939|NCT02207621|185503|P1|STARTED|Overall Study||251
75940|NCT02207608|185516|P2|NOT COMPLETED|Overall Study||0
75941|NCT02207608|185517|P1|NOT COMPLETED|Overall Study||1
75942|NCT02207608|185516|P2|COMPLETED|Overall Study||15
75943|NCT02207608|185517|P1|COMPLETED|Overall Study||14
75944|NCT02207608|185516|P2|STARTED|Overall Study||15
75945|NCT02207608|185517|P1|STARTED|Overall Study||15
75946|NCT02207569|185523|P1|NOT COMPLETED|6 Months - 1 Year||9
75947|NCT02207569|185523|P1|COMPLETED|6 Months - 1 Year||213
75948|NCT02207569|185523|P1|STARTED|6 Months - 1 Year||222
75949|NCT02207569|185523|P1|NOT COMPLETED|30 Days to 6 Months||11
75950|NCT02207569|185523|P1|COMPLETED|30 Days to 6 Months||222
75951|NCT02207569|185523|P1|STARTED|30 Days to 6 Months||233
75952|NCT02207569|185523|P1|NOT COMPLETED|Implant to 30 Days||4
75953|NCT02207569|185523|P1|COMPLETED|Implant to 30 Days||233
75954|NCT02207569|185523|P1|STARTED|Implant to 30 Days||237
75955|NCT02207569|185523|P1|NOT COMPLETED|Enrolled to Implant||4
75956|NCT02207569|185523|P1|COMPLETED|Enrolled to Implant|237 actual implants|237
75957|NCT02207569|185523|P1|STARTED|Enrolled to Implant|241 entered procedure room for implant|241
75958|NCT02207530|185541|P1|NOT COMPLETED|Overall Study||91
75959|NCT02207530|185541|P1|COMPLETED|Overall Study||21
75960|NCT02207530|185541|P1|STARTED|Overall Study||112
75961|NCT02207491|185555|P2|NOT COMPLETED|Overall Study||13
75962|NCT02207491|185556|P1|NOT COMPLETED|Overall Study||31
75963|NCT02207491|185555|P2|COMPLETED|Overall Study||196
75964|NCT02207491|185556|P1|COMPLETED|Overall Study||171
75965|NCT02207491|185555|P2|STARTED|Overall Study||209
75966|NCT02207491|185556|P1|STARTED|Overall Study||202
75967|NCT02207478|185566|P2|NOT COMPLETED|Overall Study||0
75968|NCT02207478|185567|P1|NOT COMPLETED|Overall Study||0
75969|NCT02207478|185566|P2|COMPLETED|Overall Study||46
75970|NCT02207478|185567|P1|COMPLETED|Overall Study||40
75971|NCT02207478|185566|P2|STARTED|Overall Study||46
75972|NCT02207478|185567|P1|STARTED|Overall Study||40
75973|NCT02207413|185581|P6|NOT COMPLETED|Overall Study||13
75974|NCT02207413|185582|P5|NOT COMPLETED|Overall Study||7
75975|NCT02207413|185583|P4|NOT COMPLETED|Overall Study||1
75976|NCT02207413|185584|P3|NOT COMPLETED|Overall Study||0
75977|NCT02207413|185585|P2|NOT COMPLETED|Overall Study||0
75978|NCT02207413|185586|P1|NOT COMPLETED|Overall Study||1
75979|NCT02207413|185581|P6|COMPLETED|Overall Study|Primed subjects: 41; Unprimed subjects: 420|461
75980|NCT02207413|185582|P5|COMPLETED|Overall Study|Primed subjects: 40; Unprimed subjects: 419|459
75981|NCT02207413|185583|P4|COMPLETED|Overall Study|Primed subjects: 312; Unprimed subjects: 98|410
75982|NCT02207413|185584|P3|COMPLETED|Overall Study|Primed subjects: 309; Unprimed subjects: 101|410
75983|NCT02207413|185585|P2|COMPLETED|Overall Study||60
75984|NCT02207413|185586|P1|COMPLETED|Overall Study||59
75985|NCT02207413|185581|P6|STARTED|Overall Study||474
75986|NCT02207413|185582|P5|STARTED|Overall Study||466
75987|NCT02207413|185583|P4|STARTED|Overall Study||411
75988|NCT02207413|185584|P3|STARTED|Overall Study||410
75989|NCT02207413|185585|P2|STARTED|Overall Study||60
75990|NCT02207413|185586|P1|STARTED|Overall Study||60
75991|NCT02207400|185682|P2|NOT COMPLETED|Overall Study||14
75992|NCT02207400|185683|P1|NOT COMPLETED|Overall Study||16
75993|NCT02207400|185682|P2|COMPLETED|Overall Study||109
75994|NCT02207400|185683|P1|COMPLETED|Overall Study||107
75995|NCT02207400|185682|P2|STARTED|Overall Study||123
75996|NCT02207400|185683|P1|STARTED|Overall Study||123
75997|NCT02207374|185704|P3|NOT COMPLETED|Overall Study||6
75998|NCT02207374|185705|P2|NOT COMPLETED|Overall Study||10
75999|NCT02207374|185706|P1|NOT COMPLETED|Overall Study||6
76000|NCT02207374|185704|P3|COMPLETED|Overall Study||115
76001|NCT02207374|185705|P2|COMPLETED|Overall Study||231
76002|NCT02207374|185706|P1|COMPLETED|Overall Study||233
76003|NCT02207374|185704|P3|Exposed|Overall Study||120
76004|NCT02207374|185705|P2|Exposed|Overall Study||241
76005|NCT02207374|185706|P1|Exposed|Overall Study||239
76006|NCT02207374|185704|P3|STARTED|Overall Study||121
76007|NCT02207374|185705|P2|STARTED|Overall Study||241
76008|NCT02207374|185706|P1|STARTED|Overall Study||239
76009|NCT02207322|185722|P2|NOT COMPLETED|Overall Study||10
76010|NCT02207322|185723|P1|NOT COMPLETED|Overall Study||9
76011|NCT02207322|185722|P2|COMPLETED|Overall Study|6-month|71
76012|NCT02207322|185723|P1|COMPLETED|Overall Study|6-month|70
76013|NCT02207322|185722|P2|3-month|Overall Study||75
76014|NCT02207322|185723|P1|3-month|Overall Study||74
76015|NCT02207322|185722|P2|Week-2|Overall Study||80
76016|NCT02207322|185723|P1|Week-2|Overall Study||77
76017|NCT02207322|185722|P2|STARTED|Overall Study||81
76018|NCT02207322|185723|P1|STARTED|Overall Study||79
76019|NCT02207244|185770|P9|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||8
76020|NCT02207244|185771|P8|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||13
76021|NCT02207244|185772|P7|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||8
76022|NCT02207244|185773|P6|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
76023|NCT02207244|185774|P5|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
76024|NCT02207244|185775|P4|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
76025|NCT02207244|185776|P3|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
76026|NCT02207244|185777|P2|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
76027|NCT02207244|185778|P1|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
76028|NCT02207244|185770|P9|COMPLETED|Withdrawal, Retreatment Period:Week28-48||220
76029|NCT02207244|185771|P8|COMPLETED|Withdrawal, Retreatment Period:Week28-48||457
76030|NCT02207244|185772|P7|COMPLETED|Withdrawal, Retreatment Period:Week28-48||219
76031|NCT02207244|185773|P6|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
76032|NCT02207244|185774|P5|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
76033|NCT02207244|185775|P4|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
76034|NCT02207244|185776|P3|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
76035|NCT02207244|185777|P2|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
76036|NCT02207244|185778|P1|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
76037|NCT02207244|185770|P9|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||34
76038|NCT02207244|185771|P8|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||16
76039|NCT02207244|185772|P7|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||4
76040|NCT02207244|185773|P6|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
76041|NCT02207244|185774|P5|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
76042|NCT02207244|185775|P4|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
76043|NCT02207244|185776|P3|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
76044|NCT02207244|185777|P2|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
76045|NCT02207244|185778|P1|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
76046|NCT02207244|185770|P9|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
76047|NCT02207244|185771|P8|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||193
76048|NCT02207244|185772|P7|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
76049|NCT02207244|185773|P6|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
76050|NCT02207244|185774|P5|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
76051|NCT02207244|185775|P4|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
76052|NCT02207244|185776|P3|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
76053|NCT02207244|185777|P2|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
76054|NCT02207244|185778|P1|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
76055|NCT02207244|185770|P9|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||82
76056|NCT02207244|185771|P8|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||166
76057|NCT02207244|185772|P7|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||143
76058|NCT02207244|185773|P6|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
76059|NCT02207244|185774|P5|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
76060|NCT02207244|185775|P4|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
76061|NCT02207244|185776|P3|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
76062|NCT02207244|185777|P2|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
76063|NCT02207244|185778|P1|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
76064|NCT02207244|185770|P9|Non-Responders|Withdrawal, Retreatment Period:Week28-48||112
76065|NCT02207244|185771|P8|Non-Responders|Withdrawal, Retreatment Period:Week28-48||95
76066|NCT02207244|185772|P7|Non-Responders|Withdrawal, Retreatment Period:Week28-48||80
76067|NCT02207244|185773|P6|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
76068|NCT02207244|185774|P5|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
76069|NCT02207244|185775|P4|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
76070|NCT02207244|185776|P3|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
76071|NCT02207244|185777|P2|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
76072|NCT02207244|185778|P1|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
76073|NCT02207244|185770|P9|STARTED|Withdrawal, Retreatment Period:Week28-48||228
76074|NCT02207244|185771|P8|STARTED|Withdrawal, Retreatment Period:Week28-48||470
76075|NCT02207244|185772|P7|STARTED|Withdrawal, Retreatment Period:Week28-48||227
76076|NCT02207244|185773|P6|STARTED|Withdrawal, Retreatment Period:Week28-48||0
76077|NCT02207244|185774|P5|STARTED|Withdrawal, Retreatment Period:Week28-48||0
76078|NCT02207244|185775|P4|STARTED|Withdrawal, Retreatment Period:Week28-48||0
76079|NCT02207244|185776|P3|STARTED|Withdrawal, Retreatment Period:Week28-48||0
76080|NCT02207244|185777|P2|STARTED|Withdrawal, Retreatment Period:Week28-48||0
76081|NCT02207244|185778|P1|STARTED|Withdrawal, Retreatment Period:Week28-48||0
76082|NCT02207244|185770|P9|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
76083|NCT02207244|185771|P8|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
76084|NCT02207244|185772|P7|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
76085|NCT02207244|185773|P6|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||9
76086|NCT02207244|185774|P5|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||8
76087|NCT02207244|185775|P4|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||6
76088|NCT02207244|185776|P3|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
76089|NCT02207244|185777|P2|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
76090|NCT02207244|185778|P1|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
76091|NCT02207244|185770|P9|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
76092|NCT02207244|185771|P8|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
76093|NCT02207244|185772|P7|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
76094|NCT02207244|185773|P6|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||228
76095|NCT02207244|185774|P5|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||470
76096|NCT02207244|185775|P4|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||227
76097|NCT02207244|185776|P3|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
76098|NCT02207244|185777|P2|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
76099|NCT02207244|185778|P1|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
76100|NCT02207244|185770|P9|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
76101|NCT02207244|185771|P8|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
76102|NCT02207244|185772|P7|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
76103|NCT02207244|185773|P6|STARTED|Placebo Crossover and ACP: Week 16 - 28||237
76104|NCT02207244|185774|P5|STARTED|Placebo Crossover and ACP: Week 16 - 28||478
76105|NCT02207244|185775|P4|STARTED|Placebo Crossover and ACP: Week 16 - 28||233
76106|NCT02207244|185776|P3|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
76107|NCT02207244|185777|P2|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
76108|NCT02207244|185778|P1|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
76109|NCT02207244|185770|P9|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
76110|NCT02207244|185771|P8|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
76111|NCT02207244|185772|P7|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
76112|NCT02207244|185773|P6|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
76113|NCT02207244|185774|P5|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
76114|NCT02207244|185775|P4|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
76115|NCT02207244|185776|P3|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||11
76116|NCT02207244|185777|P2|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||18
76117|NCT02207244|185778|P1|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||15
76118|NCT02207244|185770|P9|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
76119|NCT02207244|185771|P8|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
76120|NCT02207244|185772|P7|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
76121|NCT02207244|185773|P6|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
76122|NCT02207244|185774|P5|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
76123|NCT02207244|185775|P4|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
76124|NCT02207244|185776|P3|COMPLETED|Placebo Controlled Period: Week 0 - 16||237
76125|NCT02207244|185777|P2|COMPLETED|Placebo Controlled Period: Week 0 - 16||478
76126|NCT02207244|185778|P1|COMPLETED|Placebo Controlled Period: Week 0 - 16||233
76127|NCT02207244|185770|P9|Treated|Placebo Controlled Period: Week 0 - 16||0
76128|NCT02207244|185771|P8|Treated|Placebo Controlled Period: Week 0 - 16||0
76129|NCT02207244|185772|P7|Treated|Placebo Controlled Period: Week 0 - 16||0
76130|NCT02207244|185773|P6|Treated|Placebo Controlled Period: Week 0 - 16||0
76131|NCT02207244|185774|P5|Treated|Placebo Controlled Period: Week 0 - 16||0
76132|NCT02207244|185775|P4|Treated|Placebo Controlled Period: Week 0 - 16||0
76133|NCT02207244|185776|P3|Treated|Placebo Controlled Period: Week 0 - 16||248
76134|NCT02207244|185777|P2|Treated|Placebo Controlled Period: Week 0 - 16||494
76135|NCT02207244|185778|P1|Treated|Placebo Controlled Period: Week 0 - 16||248
76136|NCT02207244|185770|P9|STARTED|Placebo Controlled Period: Week 0 - 16||0
76137|NCT02207244|185771|P8|STARTED|Placebo Controlled Period: Week 0 - 16||0
76138|NCT02207244|185772|P7|STARTED|Placebo Controlled Period: Week 0 - 16||0
76139|NCT02207244|185773|P6|STARTED|Placebo Controlled Period: Week 0 - 16||0
76140|NCT02207244|185774|P5|STARTED|Placebo Controlled Period: Week 0 - 16||0
76141|NCT02207244|185775|P4|STARTED|Placebo Controlled Period: Week 0 - 16||0
76142|NCT02207244|185776|P3|STARTED|Placebo Controlled Period: Week 0 - 16||248
76143|NCT02207244|185777|P2|STARTED|Placebo Controlled Period: Week 0 - 16||496
76144|NCT02207244|185778|P1|STARTED|Placebo Controlled Period: Week 0 - 16||248
76145|NCT02207231|185819|P3|NOT COMPLETED|Active Controlled Period: Week 16 - 48||42
76146|NCT02207231|185820|P2|NOT COMPLETED|Active Controlled Period: Week 16 - 48||21
76147|NCT02207231|185821|P1|NOT COMPLETED|Active Controlled Period: Week 16 - 48||3
76148|NCT02207231|185819|P3|COMPLETED|Active Controlled Period: Week 16 - 48||282
76149|NCT02207231|185820|P2|COMPLETED|Active Controlled Period: Week 16 - 48||301
76150|NCT02207231|185821|P1|COMPLETED|Active Controlled Period: Week 16 - 48||162
76151|NCT02207231|185819|P3|STARTED|Active Controlled Period: Week 16 - 48||324
76152|NCT02207231|185820|P2|STARTED|Active Controlled Period: Week 16 - 48||322
76153|NCT02207231|185821|P1|STARTED|Active Controlled Period: Week 16 - 48|2 participants did not cross-over.|165
76154|NCT02207231|185819|P3|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||10
76155|NCT02207231|185820|P2|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
76156|NCT02207231|185821|P1|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
76157|NCT02207231|185819|P3|COMPLETED|Placebo Controlled Period: Week 0 - 16||324
76158|NCT02207231|185820|P2|COMPLETED|Placebo Controlled Period: Week 0 - 16||322
76159|NCT02207231|185821|P1|COMPLETED|Placebo Controlled Period: Week 0 - 16||167
76160|NCT02207231|185819|P3|Treated|Placebo Controlled Period: Week 0 - 16||333
76161|NCT02207231|185820|P2|Treated|Placebo Controlled Period: Week 0 - 16||329
76162|NCT02207231|185821|P1|Treated|Placebo Controlled Period: Week 0 - 16||174
76163|NCT02207231|185819|P3|STARTED|Placebo Controlled Period: Week 0 - 16||334
76164|NCT02207231|185820|P2|STARTED|Placebo Controlled Period: Week 0 - 16||329
76165|NCT02207231|185821|P1|STARTED|Placebo Controlled Period: Week 0 - 16||174
76166|NCT02207088|185853|P1|NOT COMPLETED|Overall Study||2
76167|NCT02207088|185853|P1|COMPLETED|Overall Study||66
76168|NCT02207088|185853|P1|STARTED|Overall Study||68
76169|NCT02206828|185859|P1|NOT COMPLETED|Overall Study||7
76170|NCT02206828|185859|P1|COMPLETED|Overall Study||93
76171|NCT02206828|185859|P1|STARTED|Overall Study||100
76172|NCT02206776|185888|P2|NOT COMPLETED|Overall Study||0
76173|NCT02206776|185889|P1|NOT COMPLETED|Overall Study||0
76174|NCT02206776|185888|P2|COMPLETED|Overall Study||1
76175|NCT02206776|185889|P1|COMPLETED|Overall Study||1
76176|NCT02206776|185888|P2|STARTED|Overall Study||1
76177|NCT02206776|185889|P1|STARTED|Overall Study||1
76178|NCT02206620|185895|P2|NOT COMPLETED|Phase II - Second Intervention (6 Weeks)||2
76179|NCT02206620|185896|P1|NOT COMPLETED|Phase II - Second Intervention (6 Weeks)||0
76180|NCT02206620|185895|P2|COMPLETED|Phase II - Second Intervention (6 Weeks)||24
76181|NCT02206620|185896|P1|COMPLETED|Phase II - Second Intervention (6 Weeks)||21
76182|NCT02206620|185895|P2|STARTED|Phase II - Second Intervention (6 Weeks)||26
76183|NCT02206620|185896|P1|STARTED|Phase II - Second Intervention (6 Weeks)||21
76184|NCT02206620|185895|P2|NOT COMPLETED|Washout (6 Weeks)||0
76185|NCT02206620|185896|P1|NOT COMPLETED|Washout (6 Weeks)||0
76186|NCT02206620|185895|P2|COMPLETED|Washout (6 Weeks)||26
76187|NCT02206620|185896|P1|COMPLETED|Washout (6 Weeks)||21
76188|NCT02206620|185895|P2|STARTED|Washout (6 Weeks)||26
76189|NCT02206620|185896|P1|STARTED|Washout (6 Weeks)||21
76190|NCT02206620|185895|P2|NOT COMPLETED|Phase I - First Intervention (6 Weeks)||1
76191|NCT02206620|185896|P1|NOT COMPLETED|Phase I - First Intervention (6 Weeks)||1
76192|NCT02206620|185895|P2|COMPLETED|Phase I - First Intervention (6 Weeks)||26
76193|NCT02206620|185896|P1|COMPLETED|Phase I - First Intervention (6 Weeks)||21
76194|NCT02206620|185895|P2|STARTED|Phase I - First Intervention (6 Weeks)||27
76195|NCT02206620|185896|P1|STARTED|Phase I - First Intervention (6 Weeks)||22
76196|NCT02206607|185912|P5|NOT COMPLETED|Fourth Intervention Period||0
76197|NCT02206607|185913|P4|NOT COMPLETED|Fourth Intervention Period||0
76198|NCT02206607|185914|P3|NOT COMPLETED|Fourth Intervention Period||0
76199|NCT02206607|185915|P2|NOT COMPLETED|Fourth Intervention Period||0
76200|NCT02206607|185916|P1|NOT COMPLETED|Fourth Intervention Period||0
76201|NCT02206607|185912|P5|COMPLETED|Fourth Intervention Period||10
76202|NCT02206607|185913|P4|COMPLETED|Fourth Intervention Period||10
76203|NCT02206607|185914|P3|COMPLETED|Fourth Intervention Period||9
76204|NCT02206607|185915|P2|COMPLETED|Fourth Intervention Period||9
76205|NCT02206607|185916|P1|COMPLETED|Fourth Intervention Period||0
76206|NCT02206607|185912|P5|STARTED|Fourth Intervention Period||10
76207|NCT02206607|185913|P4|STARTED|Fourth Intervention Period||10
76208|NCT02206607|185914|P3|STARTED|Fourth Intervention Period||9
76209|NCT02206607|185915|P2|STARTED|Fourth Intervention Period||9
76210|NCT02206607|185916|P1|STARTED|Fourth Intervention Period||0
76211|NCT02206607|185912|P5|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
76212|NCT02206607|185913|P4|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
76213|NCT02206607|185914|P3|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
76214|NCT02206607|185915|P2|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
76215|NCT02206607|185916|P1|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
76216|NCT02206607|185912|P5|COMPLETED|Third Washout Period 5 to 10 Days||10
76217|NCT02206607|185913|P4|COMPLETED|Third Washout Period 5 to 10 Days||10
76218|NCT02206607|185914|P3|COMPLETED|Third Washout Period 5 to 10 Days||9
76219|NCT02206607|185915|P2|COMPLETED|Third Washout Period 5 to 10 Days||9
76220|NCT02206607|185916|P1|COMPLETED|Third Washout Period 5 to 10 Days||0
76221|NCT02206607|185912|P5|STARTED|Third Washout Period 5 to 10 Days||10
76222|NCT02206607|185913|P4|STARTED|Third Washout Period 5 to 10 Days||10
76223|NCT02206607|185914|P3|STARTED|Third Washout Period 5 to 10 Days||9
76224|NCT02206607|185915|P2|STARTED|Third Washout Period 5 to 10 Days||9
76225|NCT02206607|185916|P1|STARTED|Third Washout Period 5 to 10 Days||0
76226|NCT02206607|185912|P5|NOT COMPLETED|Third Intervention Period||0
76227|NCT02206607|185913|P4|NOT COMPLETED|Third Intervention Period||0
76228|NCT02206607|185914|P3|NOT COMPLETED|Third Intervention Period||0
76229|NCT02206607|185915|P2|NOT COMPLETED|Third Intervention Period||0
76230|NCT02206607|185916|P1|NOT COMPLETED|Third Intervention Period||0
76231|NCT02206607|185912|P5|COMPLETED|Third Intervention Period||10
76232|NCT02206607|185913|P4|COMPLETED|Third Intervention Period||10
76233|NCT02206607|185914|P3|COMPLETED|Third Intervention Period||9
76234|NCT02206607|185915|P2|COMPLETED|Third Intervention Period||9
76235|NCT02206607|185916|P1|COMPLETED|Third Intervention Period||0
76236|NCT02206607|185912|P5|STARTED|Third Intervention Period||10
76237|NCT02206607|185913|P4|STARTED|Third Intervention Period||10
76238|NCT02206607|185914|P3|STARTED|Third Intervention Period||9
76239|NCT02206607|185915|P2|STARTED|Third Intervention Period||9
76240|NCT02206607|185916|P1|STARTED|Third Intervention Period||0
76241|NCT02206607|185912|P5|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
76242|NCT02206607|185913|P4|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
76243|NCT02206607|185914|P3|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
76244|NCT02206607|185915|P2|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
76245|NCT02206607|185916|P1|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
76246|NCT02206607|185912|P5|COMPLETED|Second Washout Period 5 to 10 Days||10
76247|NCT02206607|185913|P4|COMPLETED|Second Washout Period 5 to 10 Days||10
76248|NCT02206607|185914|P3|COMPLETED|Second Washout Period 5 to 10 Days||9
76249|NCT02206607|185915|P2|COMPLETED|Second Washout Period 5 to 10 Days||9
76250|NCT02206607|185916|P1|COMPLETED|Second Washout Period 5 to 10 Days||0
76251|NCT02206607|185912|P5|STARTED|Second Washout Period 5 to 10 Days||10
76252|NCT02206607|185913|P4|STARTED|Second Washout Period 5 to 10 Days||10
76253|NCT02206607|185914|P3|STARTED|Second Washout Period 5 to 10 Days||9
76254|NCT02206607|185915|P2|STARTED|Second Washout Period 5 to 10 Days||9
76255|NCT02206607|185916|P1|STARTED|Second Washout Period 5 to 10 Days||0
76256|NCT02206607|185912|P5|NOT COMPLETED|Second Intervention Period||0
76257|NCT02206607|185913|P4|NOT COMPLETED|Second Intervention Period||1
76258|NCT02206607|185914|P3|NOT COMPLETED|Second Intervention Period||0
76259|NCT02206607|185915|P2|NOT COMPLETED|Second Intervention Period||0
76260|NCT02206607|185916|P1|NOT COMPLETED|Second Intervention Period||0
76261|NCT02206607|185912|P5|COMPLETED|Second Intervention Period||10
76262|NCT02206607|185913|P4|COMPLETED|Second Intervention Period||10
76263|NCT02206607|185914|P3|COMPLETED|Second Intervention Period||9
76264|NCT02206607|185915|P2|COMPLETED|Second Intervention Period||9
76265|NCT02206607|185916|P1|COMPLETED|Second Intervention Period||0
76266|NCT02206607|185912|P5|STARTED|Second Intervention Period||10
76267|NCT02206607|185913|P4|STARTED|Second Intervention Period||11
76268|NCT02206607|185914|P3|STARTED|Second Intervention Period||9
76269|NCT02206607|185915|P2|STARTED|Second Intervention Period||9
76270|NCT02206607|185916|P1|STARTED|Second Intervention Period||0
76271|NCT02206607|185912|P5|NOT COMPLETED|First Washout Period 5 to 10 Days||0
76272|NCT02206607|185913|P4|NOT COMPLETED|First Washout Period 5 to 10 Days||0
76273|NCT02206607|185914|P3|NOT COMPLETED|First Washout Period 5 to 10 Days||0
76274|NCT02206607|185915|P2|NOT COMPLETED|First Washout Period 5 to 10 Days||0
76275|NCT02206607|185916|P1|NOT COMPLETED|First Washout Period 5 to 10 Days||0
76276|NCT02206607|185912|P5|COMPLETED|First Washout Period 5 to 10 Days||10
76277|NCT02206607|185913|P4|COMPLETED|First Washout Period 5 to 10 Days||11
76278|NCT02206607|185914|P3|COMPLETED|First Washout Period 5 to 10 Days||9
76279|NCT02206607|185915|P2|COMPLETED|First Washout Period 5 to 10 Days||9
76280|NCT02206607|185916|P1|COMPLETED|First Washout Period 5 to 10 Days||0
76281|NCT02206607|185912|P5|STARTED|First Washout Period 5 to 10 Days||10
76282|NCT02206607|185913|P4|STARTED|First Washout Period 5 to 10 Days||11
76283|NCT02206607|185914|P3|STARTED|First Washout Period 5 to 10 Days||9
76284|NCT02206607|185915|P2|STARTED|First Washout Period 5 to 10 Days||9
76285|NCT02206607|185916|P1|STARTED|First Washout Period 5 to 10 Days||0
76286|NCT02206607|185912|P5|NOT COMPLETED|First Intervention Period||0
76287|NCT02206607|185913|P4|NOT COMPLETED|First Intervention Period||0
76288|NCT02206607|185914|P3|NOT COMPLETED|First Intervention Period||0
76289|NCT02206607|185915|P2|NOT COMPLETED|First Intervention Period||0
76290|NCT02206607|185916|P1|NOT COMPLETED|First Intervention Period||0
76291|NCT02206607|185912|P5|COMPLETED|First Intervention Period||10
76292|NCT02206607|185913|P4|COMPLETED|First Intervention Period||11
76293|NCT02206607|185914|P3|COMPLETED|First Intervention Period||9
76294|NCT02206607|185915|P2|COMPLETED|First Intervention Period||9
76295|NCT02206607|185916|P1|COMPLETED|First Intervention Period||0
76296|NCT02206607|185912|P5|STARTED|First Intervention Period||10
76297|NCT02206607|185913|P4|STARTED|First Intervention Period||11
76298|NCT02206607|185914|P3|STARTED|First Intervention Period||9
76299|NCT02206607|185915|P2|STARTED|First Intervention Period||9
76300|NCT02206607|185916|P1|STARTED|First Intervention Period||0
76301|NCT02206607|185912|P5|NOT COMPLETED|Open-Label Run-In||0
76302|NCT02206607|185913|P4|NOT COMPLETED|Open-Label Run-In||0
76303|NCT02206607|185914|P3|NOT COMPLETED|Open-Label Run-In||0
76304|NCT02206607|185915|P2|NOT COMPLETED|Open-Label Run-In||0
76305|NCT02206607|185916|P1|NOT COMPLETED|Open-Label Run-In||3
76306|NCT02206607|185912|P5|COMPLETED|Open-Label Run-In||0
76307|NCT02206607|185913|P4|COMPLETED|Open-Label Run-In||0
76308|NCT02206607|185914|P3|COMPLETED|Open-Label Run-In||0
76309|NCT02206607|185915|P2|COMPLETED|Open-Label Run-In||0
76310|NCT02206607|185916|P1|COMPLETED|Open-Label Run-In||39
76311|NCT02206607|185912|P5|STARTED|Open-Label Run-In||0
76312|NCT02206607|185913|P4|STARTED|Open-Label Run-In||0
76313|NCT02206607|185914|P3|STARTED|Open-Label Run-In||0
76314|NCT02206607|185915|P2|STARTED|Open-Label Run-In||0
76315|NCT02206607|185916|P1|STARTED|Open-Label Run-In||42
76316|NCT02206217|185970|P2|NOT COMPLETED|Overall Study||14
76317|NCT02206217|185971|P1|NOT COMPLETED|Overall Study||9
76318|NCT02206217|185970|P2|COMPLETED|Overall Study||79
76319|NCT02206217|185971|P1|COMPLETED|Overall Study||81
76320|NCT02206217|185970|P2|STARTED|Overall Study||93
76321|NCT02206217|185971|P1|STARTED|Overall Study||90
76322|NCT02205983|185983|P4|NOT COMPLETED|Overall Study||0
76323|NCT02205983|185984|P3|NOT COMPLETED|Overall Study||0
76324|NCT02205983|185985|P2|NOT COMPLETED|Overall Study||0
76325|NCT02205983|185986|P1|NOT COMPLETED|Overall Study||0
76326|NCT02205983|185983|P4|COMPLETED|Overall Study||13
76327|NCT02205983|185984|P3|COMPLETED|Overall Study||13
76328|NCT02205983|185985|P2|COMPLETED|Overall Study||12
76329|NCT02205983|185986|P1|COMPLETED|Overall Study||12
76330|NCT02205983|185983|P4|STARTED|Overall Study||13
76331|NCT02205983|185984|P3|STARTED|Overall Study||13
76332|NCT02205983|185985|P2|STARTED|Overall Study||12
76333|NCT02205983|185986|P1|STARTED|Overall Study||12
76334|NCT02205814|186000|P4|NOT COMPLETED|Overall Study||4
76335|NCT02205814|186001|P3|NOT COMPLETED|Overall Study||5
76336|NCT02205814|186002|P2|NOT COMPLETED|Overall Study||1
76337|NCT02205814|186003|P1|NOT COMPLETED|Overall Study||2
76338|NCT02205814|186000|P4|COMPLETED|Overall Study||104
76339|NCT02205814|186001|P3|COMPLETED|Overall Study||103
76340|NCT02205814|186002|P2|COMPLETED|Overall Study||109
76341|NCT02205814|186003|P1|COMPLETED|Overall Study||108
76342|NCT02205814|186000|P4|STARTED|Overall Study||108
76343|NCT02205814|186001|P3|STARTED|Overall Study||108
76344|NCT02205814|186002|P2|STARTED|Overall Study||110
76345|NCT02205814|186003|P1|STARTED|Overall Study||110
76346|NCT02205801|186029|P4|NOT COMPLETED|Overall Study||0
76347|NCT02205801|186030|P3|NOT COMPLETED|Overall Study||0
76348|NCT02205801|186031|P2|NOT COMPLETED|Overall Study||0
76349|NCT02205801|186032|P1|NOT COMPLETED|Overall Study||0
76350|NCT02205801|186029|P4|COMPLETED|Overall Study||8
76351|NCT02205801|186030|P3|COMPLETED|Overall Study||9
76352|NCT02205801|186031|P2|COMPLETED|Overall Study||8
76353|NCT02205801|186032|P1|COMPLETED|Overall Study||11
76354|NCT02205801|186029|P4|STARTED|Overall Study||8
76355|NCT02205801|186030|P3|STARTED|Overall Study||9
76356|NCT02205801|186031|P2|STARTED|Overall Study||8
76357|NCT02205801|186032|P1|STARTED|Overall Study||11
76358|NCT02205476|186056|P2|NOT COMPLETED|Overall Study||3
76359|NCT02205476|186057|P1|NOT COMPLETED|Overall Study||7
76360|NCT02205476|186056|P2|COMPLETED|Overall Study||0
76361|NCT02205476|186057|P1|COMPLETED|Overall Study||0
76362|NCT02205476|186056|P2|STARTED|Overall Study||3
76363|NCT02205476|186057|P1|STARTED|Overall Study||7
76364|NCT02205333|186096|P9|NOT COMPLETED|Overall Study||0
76365|NCT02205333|186097|P8|NOT COMPLETED|Overall Study||2
76366|NCT02205333|186098|P7|NOT COMPLETED|Overall Study||5
76367|NCT02205333|186099|P6|NOT COMPLETED|Overall Study||3
76368|NCT02205333|186100|P5|NOT COMPLETED|Overall Study||5
76369|NCT02205333|186101|P4|NOT COMPLETED|Overall Study||7
76370|NCT02205333|186102|P3|NOT COMPLETED|Overall Study||2
76371|NCT02205333|186103|P2|NOT COMPLETED|Overall Study||6
76372|NCT02205333|186104|P1|NOT COMPLETED|Overall Study||6
76373|NCT02205333|186096|P9|COMPLETED|Overall Study||1
76374|NCT02205333|186097|P8|COMPLETED|Overall Study||1
76375|NCT02205333|186098|P7|COMPLETED|Overall Study||2
76376|NCT02205333|186099|P6|COMPLETED|Overall Study||4
76377|NCT02205333|186100|P5|COMPLETED|Overall Study||1
76378|NCT02205333|186101|P4|COMPLETED|Overall Study||0
76379|NCT02205333|186102|P3|COMPLETED|Overall Study||1
76380|NCT02205333|186103|P2|COMPLETED|Overall Study||0
76381|NCT02205333|186104|P1|COMPLETED|Overall Study||2
76382|NCT02205333|186096|P9|STARTED|Overall Study||1
76383|NCT02205333|186097|P8|STARTED|Overall Study||3
76384|NCT02205333|186098|P7|STARTED|Overall Study||7
76385|NCT02205333|186099|P6|STARTED|Overall Study||7
76386|NCT02205333|186100|P5|STARTED|Overall Study||6
76387|NCT02205333|186101|P4|STARTED|Overall Study||7
76388|NCT02205333|186102|P3|STARTED|Overall Study||3
76389|NCT02205333|186103|P2|STARTED|Overall Study||6
76390|NCT02205333|186104|P1|STARTED|Overall Study||8
76391|NCT02205177|186279|P2|NOT COMPLETED|Overall Study||0
76392|NCT02205177|186280|P1|NOT COMPLETED|Overall Study||2
76393|NCT02205177|186279|P2|COMPLETED|Overall Study||2
76394|NCT02205177|186280|P1|COMPLETED|Overall Study||6
76395|NCT02205177|186279|P2|STARTED|Overall Study||2
76396|NCT02205177|186280|P1|STARTED|Overall Study||8
76397|NCT02204982|186290|P2|NOT COMPLETED|Overall Study||7
76398|NCT02204982|186291|P1|NOT COMPLETED|Overall Study||4
76399|NCT02204982|186290|P2|COMPLETED|Overall Study||0
76400|NCT02204982|186291|P1|COMPLETED|Overall Study||2
76401|NCT02204982|186290|P2|STARTED|Overall Study||7
76402|NCT02204982|186291|P1|STARTED|Overall Study||6
76403|NCT02204917|186299|P1|NOT COMPLETED|Overall Study||1
76404|NCT02204917|186299|P1|COMPLETED|Overall Study||30
76405|NCT02204917|186299|P1|STARTED|Overall Study||31
76406|NCT02204761|186306|P1|NOT COMPLETED|Overall Study||0
76407|NCT02204761|186306|P1|COMPLETED|Overall Study||6
76408|NCT02204761|186306|P1|STARTED|Overall Study||6
76409|NCT02204748|186313|P1|NOT COMPLETED|Overall Study||0
76410|NCT02204748|186313|P1|COMPLETED|Overall Study||5
76411|NCT02204748|186313|P1|STARTED|Overall Study||5
76412|NCT02204657|186327|P2|NOT COMPLETED|Overall Study||0
76413|NCT02204657|186328|P1|NOT COMPLETED|Overall Study||7
76414|NCT02204657|186327|P2|COMPLETED|Overall Study||25
76415|NCT02204657|186328|P1|COMPLETED|Overall Study||25
76416|NCT02204657|186327|P2|STARTED|Overall Study||25
76417|NCT02204657|186328|P1|STARTED|Overall Study||32
76418|NCT02204579|186336|P1|NOT COMPLETED|Overall Study||2
76419|NCT02204579|186336|P1|COMPLETED|Overall Study||5
76420|NCT02204579|186336|P1|Treated|Overall Study||5
76421|NCT02204579|186336|P1|Participants Started in Post-Amendment|Overall Study|Two participants from pre-amendment were re-enrolled with different identification numbers.|5
76422|NCT02204579|186336|P1|Participants Started in Pre-Amendment|Overall Study|Two participants completed treatment in pre-amendment and were re-enrolled in post-amendment.|2
76423|NCT02204579|186336|P1|STARTED|Overall Study||7
76424|NCT02204566|186388|P1|NOT COMPLETED|Overall Study||4
76425|NCT02204566|186388|P1|COMPLETED|Overall Study||1
76426|NCT02204566|186388|P1|STARTED|Overall Study||5
76427|NCT02204449|186394|P2|NOT COMPLETED|Overall Study||11
76428|NCT02204449|186395|P1|NOT COMPLETED|Overall Study||7
76429|NCT02204449|186394|P2|COMPLETED|Overall Study||37
76430|NCT02204449|186395|P1|COMPLETED|Overall Study||39
76431|NCT02204449|186394|P2|STARTED|Overall Study||48
76432|NCT02204449|186395|P1|STARTED|Overall Study||46
76433|NCT02204410|186405|P1|NOT COMPLETED|Overall Study||11
76434|NCT02204410|186405|P1|COMPLETED|Overall Study||10
76435|NCT02204410|186405|P1|STARTED|Overall Study||21
76436|NCT02204371|186410|P1|NOT COMPLETED|Overall Study||1
76437|NCT02204371|186410|P1|COMPLETED|Overall Study||6
76438|NCT02204371|186410|P1|STARTED|Overall Study||7
76439|NCT02204319|186433|P1|NOT COMPLETED|Overall Study||3
76440|NCT02204319|186433|P1|COMPLETED|Overall Study|3 did not complete study.|7
76441|NCT02204319|186433|P1|STARTED|Overall Study||10
76442|NCT02204176|186442|P3|NOT COMPLETED|Overall Study||16
76443|NCT02204176|186443|P2|NOT COMPLETED|Overall Study||12
76444|NCT02204176|186444|P1|NOT COMPLETED|Overall Study||10
76445|NCT02204176|186442|P3|COMPLETED|Overall Study||58
76446|NCT02204176|186443|P2|COMPLETED|Overall Study||61
76447|NCT02204176|186444|P1|COMPLETED|Overall Study||64
76448|NCT02204176|186442|P3|STARTED|Overall Study||74
76449|NCT02204176|186443|P2|STARTED|Overall Study||73
76450|NCT02204176|186444|P1|STARTED|Overall Study||74
76451|NCT02204150|186467|P1|NOT COMPLETED|Overall Study||0
76452|NCT02204150|186467|P1|COMPLETED|Overall Study||56
76453|NCT02204150|186467|P1|STARTED|Overall Study||56
76454|NCT02204124|186473|P2|NOT COMPLETED|Overall Study||0
76455|NCT02204124|186474|P1|NOT COMPLETED|Overall Study||0
76456|NCT02204124|186473|P2|COMPLETED|Overall Study||19
76457|NCT02204124|186474|P1|COMPLETED|Overall Study||13
76458|NCT02204124|186473|P2|STARTED|Overall Study||19
76459|NCT02204124|186474|P1|STARTED|Overall Study||13
76460|NCT02204007|186494|P2|NOT COMPLETED|Overall Study||1
76461|NCT02204007|186495|P1|NOT COMPLETED|Overall Study||1
76462|NCT02204007|186494|P2|COMPLETED|Overall Study||17
76463|NCT02204007|186495|P1|COMPLETED|Overall Study||17
76464|NCT02204007|186494|P2|STARTED|Overall Study||18
76465|NCT02204007|186495|P1|STARTED|Overall Study||18
76466|NCT02203916|186506|P3|NOT COMPLETED|Overall Study||11
76467|NCT02203916|186507|P2|NOT COMPLETED|Overall Study||10
76468|NCT02203916|186508|P1|NOT COMPLETED|Overall Study||8
76469|NCT02203916|186506|P3|COMPLETED|Overall Study||120
76470|NCT02203916|186507|P2|COMPLETED|Overall Study||122
76471|NCT02203916|186508|P1|COMPLETED|Overall Study||57
76472|NCT02203916|186506|P3|Safety Analysis Set (SAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the SAS.|130
76473|NCT02203916|186507|P2|Safety Analysis Set (SAS)|Overall Study||132
76474|NCT02203916|186508|P1|Safety Analysis Set (SAS)|Overall Study||65
76475|NCT02203916|186506|P3|Full Analysis Set (FAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the FAS.|130
76476|NCT02203916|186507|P2|Full Analysis Set (FAS)|Overall Study||132
76477|NCT02203916|186508|P1|Full Analysis Set (FAS)|Overall Study||65
76478|NCT02203916|186506|P3|STARTED|Overall Study|1 participant was randomized twice and counted only once.|131
76479|NCT02203916|186507|P2|STARTED|Overall Study||132
76480|NCT02203916|186508|P1|STARTED|Overall Study||65
76481|NCT02203851|186528|P1|NOT COMPLETED|Overall Study||11
76482|NCT02203851|186528|P1|COMPLETED|Overall Study||99
76483|NCT02203851|186528|P1|STARTED|Overall Study||110
76484|NCT02203838|186566|P4|NOT COMPLETED|Overall Study||18
76485|NCT02203838|186567|P3|NOT COMPLETED|Overall Study||16
76486|NCT02203838|186568|P2|NOT COMPLETED|Overall Study||22
76487|NCT02203838|186569|P1|NOT COMPLETED|Overall Study||210
76488|NCT02203838|186566|P4|COMPLETED|Overall Study||15
76489|NCT02203838|186567|P3|COMPLETED|Overall Study||15
76490|NCT02203838|186568|P2|COMPLETED|Overall Study||6
76491|NCT02203838|186569|P1|COMPLETED|Overall Study||198
76492|NCT02203838|186566|P4|STARTED|Overall Study||33
76493|NCT02203838|186567|P3|STARTED|Overall Study||31
76494|NCT02203838|186568|P2|STARTED|Overall Study||28
76495|NCT02203838|186569|P1|STARTED|Overall Study||408
76496|NCT02203786|186603|P4|NOT COMPLETED|Overall Study||0
76497|NCT02203786|186604|P3|NOT COMPLETED|Overall Study||2
76498|NCT02203786|186605|P2|NOT COMPLETED|Overall Study||0
76499|NCT02203786|186606|P1|NOT COMPLETED|Overall Study||0
76500|NCT02203786|186603|P4|COMPLETED|Overall Study||15
76501|NCT02203786|186604|P3|COMPLETED|Overall Study||15
76502|NCT02203786|186605|P2|COMPLETED|Overall Study||15
76503|NCT02203786|186606|P1|COMPLETED|Overall Study||15
76504|NCT02203786|186603|P4|STARTED|Overall Study||15
76505|NCT02203786|186604|P3|STARTED|Overall Study||17
76506|NCT02203786|186605|P2|STARTED|Overall Study||15
76507|NCT02203786|186606|P1|STARTED|Overall Study||15
76508|NCT02203747|186638|P2|NOT COMPLETED|Overall Study||0
76509|NCT02203747|186639|P1|NOT COMPLETED|Overall Study||0
76510|NCT02203747|186638|P2|COMPLETED|Overall Study||34
76511|NCT02203747|186639|P1|COMPLETED|Overall Study||45
76512|NCT02203747|186638|P2|STARTED|Overall Study||34
76513|NCT02203747|186639|P1|STARTED|Overall Study||45
76514|NCT02203721|186649|P2|NOT COMPLETED|Overall Study||3
76515|NCT02203721|186650|P1|NOT COMPLETED|Overall Study||1
76516|NCT02203721|186649|P2|COMPLETED|Overall Study||148
76517|NCT02203721|186650|P1|COMPLETED|Overall Study||147
76518|NCT02203721|186649|P2|STARTED|Overall Study||151
76519|NCT02203721|186650|P1|STARTED|Overall Study||148
76520|NCT02203630|186660|P2|NOT COMPLETED|Overall Study||0
76521|NCT02203630|186661|P1|NOT COMPLETED|Overall Study||0
76522|NCT02203630|186660|P2|COMPLETED|Overall Study||9
76523|NCT02203630|186661|P1|COMPLETED|Overall Study||8
76524|NCT02203630|186660|P2|STARTED|Overall Study||9
76525|NCT02203630|186661|P1|STARTED|Overall Study||8
76526|NCT02203578|186731|P1|NOT COMPLETED|Overall Study||0
76527|NCT02203578|186731|P1|COMPLETED|Overall Study||1
76528|NCT02203578|186731|P1|STARTED|Overall Study||1
76529|NCT02203565|186743|P1|NOT COMPLETED|Overall Study||1
76530|NCT02203565|186743|P1|COMPLETED|Overall Study||19
76531|NCT02203565|186743|P1|STARTED|Overall Study||20
76532|NCT02203357|186750|P3|NOT COMPLETED|Overall Study||70
76533|NCT02203357|186751|P2|NOT COMPLETED|Overall Study||66
76534|NCT02203357|186752|P1|NOT COMPLETED|Overall Study||58
76535|NCT02203357|186750|P3|COMPLETED|Overall Study||55
76536|NCT02203357|186751|P2|COMPLETED|Overall Study||45
76537|NCT02203357|186752|P1|COMPLETED|Overall Study||59
76538|NCT02203357|186750|P3|mon24|Overall Study||55
76539|NCT02203357|186751|P2|mon24|Overall Study||45
76540|NCT02203357|186752|P1|mon24|Overall Study||59
76541|NCT02203357|186750|P3|mon12|Overall Study||122
76542|NCT02203357|186751|P2|mon12|Overall Study||101
76543|NCT02203357|186752|P1|mon12|Overall Study||113
76544|NCT02203357|186750|P3|mon7/2/3|Overall Study||124
76545|NCT02203357|186751|P2|mon7/2/3|Overall Study||110
76546|NCT02203357|186752|P1|mon7/2/3|Overall Study||114
76547|NCT02203357|186750|P3|STARTED|Overall Study||125
76548|NCT02203357|186751|P2|STARTED|Overall Study||111
76549|NCT02203357|186752|P1|STARTED|Overall Study||117
76550|NCT02203331|186775|P6|NOT COMPLETED|Overall Study||7
76551|NCT02203331|186776|P5|NOT COMPLETED|Overall Study||7
76552|NCT02203331|186777|P4|NOT COMPLETED|Overall Study||7
76553|NCT02203331|186778|P3|NOT COMPLETED|Overall Study||5
76554|NCT02203331|186779|P2|NOT COMPLETED|Overall Study||14
76555|NCT02203331|186780|P1|NOT COMPLETED|Overall Study||7
76556|NCT02203331|186775|P6|COMPLETED|Overall Study||46
76557|NCT02203331|186776|P5|COMPLETED|Overall Study||46
76558|NCT02203331|186777|P4|COMPLETED|Overall Study||46
76559|NCT02203331|186778|P3|COMPLETED|Overall Study||50
76560|NCT02203331|186779|P2|COMPLETED|Overall Study||39
76561|NCT02203331|186780|P1|COMPLETED|Overall Study||45
76562|NCT02203331|186775|P6|Treated|Overall Study||53
76563|NCT02203331|186776|P5|Treated|Overall Study||50
76564|NCT02203331|186777|P4|Treated|Overall Study||49
76565|NCT02203331|186778|P3|Treated|Overall Study||54
76566|NCT02203331|186779|P2|Treated|Overall Study||50
76567|NCT02203331|186780|P1|Treated|Overall Study||49
76568|NCT02203331|186775|P6|STARTED|Overall Study||53
76569|NCT02203331|186776|P5|STARTED|Overall Study||53
76570|NCT02203331|186777|P4|STARTED|Overall Study||53
76571|NCT02203331|186778|P3|STARTED|Overall Study||55
76572|NCT02203331|186779|P2|STARTED|Overall Study||53
76573|NCT02203331|186780|P1|STARTED|Overall Study||52
76574|NCT02203162|186830|P1|NOT COMPLETED|Overall Study||0
76575|NCT02203162|186830|P1|COMPLETED|Overall Study||30
76576|NCT02203162|186830|P1|STARTED|Overall Study||30
76577|NCT02203149|186839|P5|NOT COMPLETED|Part 2||1
76578|NCT02203149|186840|P4|NOT COMPLETED|Part 2||3
76579|NCT02203149|186841|P3|NOT COMPLETED|Part 2||1
76580|NCT02203149|186842|P2|NOT COMPLETED|Part 2||0
76581|NCT02203149|186843|P1|NOT COMPLETED|Part 2||0
76582|NCT02203149|186839|P5|COMPLETED|Part 2||34
76583|NCT02203149|186840|P4|COMPLETED|Part 2||71
76584|NCT02203149|186841|P3|COMPLETED|Part 2||226
76585|NCT02203149|186842|P2|COMPLETED|Part 2||0
76586|NCT02203149|186843|P1|COMPLETED|Part 2||0
76587|NCT02203149|186839|P5|Started Deferred Active Treatment|Part 2||0
76588|NCT02203149|186840|P4|Started Deferred Active Treatment|Part 2|1 participant in Deferred Treatment Arm receiving Placebo did not receive Deferred Active Treatment.|73
76589|NCT02203149|186841|P3|Started Deferred Active Treatment|Part 2||0
76590|NCT02203149|186842|P2|Started Deferred Active Treatment|Part 2||0
76591|NCT02203149|186843|P1|Started Deferred Active Treatment|Part 2||0
76592|NCT02203149|186839|P5|STARTED|Part 2||35
76593|NCT02203149|186840|P4|STARTED|Part 2||74
76594|NCT02203149|186841|P3|STARTED|Part 2||227
76595|NCT02203149|186842|P2|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
76596|NCT02203149|186843|P1|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
76597|NCT02203149|186839|P5|NOT COMPLETED|Part 1||0
76598|NCT02203149|186840|P4|NOT COMPLETED|Part 1||0
76599|NCT02203149|186841|P3|NOT COMPLETED|Part 1||0
76600|NCT02203149|186842|P2|NOT COMPLETED|Part 1||1
76601|NCT02203149|186843|P1|NOT COMPLETED|Part 1||0
76602|NCT02203149|186839|P5|COMPLETED|Part 1||0
76603|NCT02203149|186840|P4|COMPLETED|Part 1||0
76604|NCT02203149|186841|P3|COMPLETED|Part 1||0
76605|NCT02203149|186842|P2|COMPLETED|Part 1||31
76606|NCT02203149|186843|P1|COMPLETED|Part 1||31
76607|NCT02203149|186839|P5|STARTED|Part 1||0
76608|NCT02203149|186840|P4|STARTED|Part 1||0
76609|NCT02203149|186841|P3|STARTED|Part 1||0
76610|NCT02203149|186842|P2|STARTED|Part 1||32
76611|NCT02203149|186843|P1|STARTED|Part 1||31
76612|NCT02203032|186876|P4|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||46
76613|NCT02203032|186877|P3|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||26
76614|NCT02203032|186878|P2|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||15
76615|NCT02203032|186879|P1|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||0
76616|NCT02203032|186876|P4|COMPLETED|Blinded Phase (Week 16 to Week 44)||539
76617|NCT02203032|186877|P3|COMPLETED|Blinded Phase (Week 16 to Week 44)||107
76618|NCT02203032|186878|P2|COMPLETED|Blinded Phase (Week 16 to Week 44)||120
76619|NCT02203032|186879|P1|COMPLETED|Blinded Phase (Week 16 to Week 44)||0
76620|NCT02203032|186876|P4|STARTED|Blinded Phase (Week 16 to Week 44)||585
76621|NCT02203032|186877|P3|STARTED|Blinded Phase (Week 16 to Week 44)||133
76622|NCT02203032|186878|P2|STARTED|Blinded Phase (Week 16 to Week 44)||135
76623|NCT02203032|186879|P1|STARTED|Blinded Phase (Week 16 to Week 44)||0
76624|NCT02203032|186876|P4|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
76625|NCT02203032|186877|P3|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
76626|NCT02203032|186878|P2|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
76627|NCT02203032|186879|P1|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||19
76628|NCT02203032|186876|P4|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
76629|NCT02203032|186877|P3|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
76630|NCT02203032|186878|P2|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
76631|NCT02203032|186879|P1|COMPLETED|Open Label Run-in (Week 0 to Week 16)||853
76632|NCT02203032|186876|P4|Treated|Open Label Run-in (Week 0 to Week 16)||0
76633|NCT02203032|186877|P3|Treated|Open Label Run-in (Week 0 to Week 16)||0
76634|NCT02203032|186878|P2|Treated|Open Label Run-in (Week 0 to Week 16)||0
76635|NCT02203032|186879|P1|Treated|Open Label Run-in (Week 0 to Week 16)||871
76636|NCT02203032|186876|P4|STARTED|Open Label Run-in (Week 0 to Week 16)||0
76637|NCT02203032|186877|P3|STARTED|Open Label Run-in (Week 0 to Week 16)||0
76638|NCT02203032|186878|P2|STARTED|Open Label Run-in (Week 0 to Week 16)||0
76639|NCT02203032|186879|P1|STARTED|Open Label Run-in (Week 0 to Week 16)||872
76640|NCT02202980|186907|P14|NOT COMPLETED|Overall Study||0
76641|NCT02202980|186908|P13|NOT COMPLETED|Overall Study||11
76642|NCT02202980|186909|P12|NOT COMPLETED|Overall Study||3
76643|NCT02202980|186910|P11|NOT COMPLETED|Overall Study||0
76644|NCT02202980|186911|P10|NOT COMPLETED|Overall Study||0
76645|NCT02202980|186912|P9|NOT COMPLETED|Overall Study||4
76646|NCT02202980|186913|P8|NOT COMPLETED|Overall Study||3
76647|NCT02202980|186914|P7|NOT COMPLETED|Overall Study||11
76648|NCT02202980|186915|P6|NOT COMPLETED|Overall Study||1
76649|NCT02202980|186916|P5|NOT COMPLETED|Overall Study||6
76650|NCT02202980|186917|P4|NOT COMPLETED|Overall Study||4
76651|NCT02202980|186918|P3|NOT COMPLETED|Overall Study||10
76652|NCT02202980|186919|P2|NOT COMPLETED|Overall Study||2
76653|NCT02202980|186920|P1|NOT COMPLETED|Overall Study||1
76654|NCT02202980|186907|P14|COMPLETED|Overall Study||4
76655|NCT02202980|186908|P13|COMPLETED|Overall Study||19
76656|NCT02202980|186909|P12|COMPLETED|Overall Study||25
76657|NCT02202980|186910|P11|COMPLETED|Overall Study||19
76658|NCT02202980|186911|P10|COMPLETED|Overall Study||17
76659|NCT02202980|186912|P9|COMPLETED|Overall Study||14
76660|NCT02202980|186913|P8|COMPLETED|Overall Study||12
76661|NCT02202980|186914|P7|COMPLETED|Overall Study||4
76662|NCT02202980|186915|P6|COMPLETED|Overall Study||14
76663|NCT02202980|186916|P5|COMPLETED|Overall Study||7
76664|NCT02202980|186917|P4|COMPLETED|Overall Study||28
76665|NCT02202980|186918|P3|COMPLETED|Overall Study||17
76666|NCT02202980|186919|P2|COMPLETED|Overall Study||24
76667|NCT02202980|186920|P1|COMPLETED|Overall Study||13
76668|NCT02202980|186907|P14|STARTED|Overall Study||4
76669|NCT02202980|186908|P13|STARTED|Overall Study||30
76670|NCT02202980|186909|P12|STARTED|Overall Study||28
76671|NCT02202980|186910|P11|STARTED|Overall Study||19
76672|NCT02202980|186911|P10|STARTED|Overall Study||17
76673|NCT02202980|186912|P9|STARTED|Overall Study||18
76674|NCT02202980|186913|P8|STARTED|Overall Study||15
76675|NCT02202980|186914|P7|STARTED|Overall Study||15
76676|NCT02202980|186915|P6|STARTED|Overall Study||15
76677|NCT02202980|186916|P5|STARTED|Overall Study||13
76678|NCT02202980|186917|P4|STARTED|Overall Study||32
76679|NCT02202980|186918|P3|STARTED|Overall Study||27
76680|NCT02202980|186919|P2|STARTED|Overall Study||26
76681|NCT02202980|186920|P1|STARTED|Overall Study||14
76682|NCT02202850|187008|P2|NOT COMPLETED|Overall Study||6
76683|NCT02202850|187009|P1|NOT COMPLETED|Overall Study||24
76684|NCT02202850|187008|P2|COMPLETED|Overall Study||8
76685|NCT02202850|187009|P1|COMPLETED|Overall Study||46
76686|NCT02202850|187008|P2|STARTED|Overall Study||14
76687|NCT02202850|187009|P1|STARTED|Overall Study||70
76688|NCT02202837|187061|P2|NOT COMPLETED|Overall Study||5
76689|NCT02202837|187062|P1|NOT COMPLETED|Overall Study||53
76690|NCT02202837|187061|P2|COMPLETED|Overall Study||12
76691|NCT02202837|187062|P1|COMPLETED|Overall Study||87
76692|NCT02202837|187061|P2|STARTED|Overall Study||17
76693|NCT02202837|187062|P1|STARTED|Overall Study||140
76694|NCT02202785|187113|P3|NOT COMPLETED|Overall Study||17
76695|NCT02202785|187114|P2|NOT COMPLETED|Overall Study||15
76696|NCT02202785|187115|P1|NOT COMPLETED|Overall Study||11
76697|NCT02202785|187113|P3|COMPLETED|Overall Study||0
76698|NCT02202785|187114|P2|COMPLETED|Overall Study||0
76699|NCT02202785|187115|P1|COMPLETED|Overall Study||0
76700|NCT02202785|187113|P3|STARTED|Overall Study||17
76701|NCT02202785|187114|P2|STARTED|Overall Study||15
76702|NCT02202785|187115|P1|STARTED|Overall Study||11
76703|NCT02202759|187152|P3|NOT COMPLETED|Overall Study||14
76704|NCT02202759|187153|P2|NOT COMPLETED|Overall Study||15
76705|NCT02202759|187154|P1|NOT COMPLETED|Overall Study||9
76706|NCT02202759|187152|P3|COMPLETED|Overall Study||0
76707|NCT02202759|187153|P2|COMPLETED|Overall Study||0
76708|NCT02202759|187154|P1|COMPLETED|Overall Study||0
76709|NCT02202759|187152|P3|STARTED|Overall Study||14
76710|NCT02202759|187153|P2|STARTED|Overall Study||15
76711|NCT02202759|187154|P1|STARTED|Overall Study||9
76712|NCT02202616|187188|P1|NOT COMPLETED|Overall Study||100
76713|NCT02202616|187188|P1|COMPLETED|Overall Study||301
76714|NCT02202616|187188|P1|Intent to Treat Set (ITT)|Overall Study||338
76715|NCT02202616|187188|P1|STARTED|Overall Study||401
76716|NCT02202538|187199|P1|NOT COMPLETED|Overall Study||8
76717|NCT02202538|187199|P1|COMPLETED|Overall Study||45
76718|NCT02202538|187199|P1|Screen Failure|Overall Study||2
76719|NCT02202538|187199|P1|STARTED|Overall Study||53
76720|NCT02202499|187213|P3|NOT COMPLETED|Overall Study||2
76721|NCT02202499|187214|P2|NOT COMPLETED|Overall Study||0
76722|NCT02202499|187215|P1|NOT COMPLETED|Overall Study||2
76723|NCT02202499|187213|P3|COMPLETED|Overall Study||19
76724|NCT02202499|187214|P2|COMPLETED|Overall Study||20
76725|NCT02202499|187215|P1|COMPLETED|Overall Study||19
76726|NCT02202499|187213|P3|STARTED|Overall Study||21
76727|NCT02202499|187214|P2|STARTED|Overall Study||20
76728|NCT02202499|187215|P1|STARTED|Overall Study||21
76729|NCT02202434|187242|P4|NOT COMPLETED|Overall Study||37
76730|NCT02202434|187243|P3|NOT COMPLETED|Overall Study||15
76731|NCT02202434|187244|P2|NOT COMPLETED|Overall Study||69
76732|NCT02202434|187245|P1|NOT COMPLETED|Overall Study||109
76733|NCT02202434|187242|P4|COMPLETED|Overall Study||258
76734|NCT02202434|187243|P3|COMPLETED|Overall Study||87
76735|NCT02202434|187244|P2|COMPLETED|Overall Study||236
76736|NCT02202434|187245|P1|COMPLETED|Overall Study||498
76737|NCT02202434|187242|P4|STARTED|Overall Study||295
76738|NCT02202434|187243|P3|STARTED|Overall Study||102
76739|NCT02202434|187244|P2|STARTED|Overall Study||305
76740|NCT02202434|187245|P1|STARTED|Overall Study||607
76741|NCT02202317|187369|P1|NOT COMPLETED|Overall Study||1
76742|NCT02202317|187369|P1|COMPLETED|Overall Study||8
76743|NCT02202317|187369|P1|STARTED|Overall Study||9
76744|NCT02202252|187377|P2|NOT COMPLETED|Overall Study||0
76745|NCT02202252|187378|P1|NOT COMPLETED|Overall Study||0
76746|NCT02202252|187377|P2|COMPLETED|Overall Study||30
76747|NCT02202252|187378|P1|COMPLETED|Overall Study||30
76748|NCT02202252|187377|P2|STARTED|Overall Study||30
76749|NCT02202252|187378|P1|STARTED|Overall Study||30
76750|NCT02202161|187396|P8|NOT COMPLETED|Overall Study||6
76751|NCT02202161|187397|P7|NOT COMPLETED|Overall Study||0
76752|NCT02202161|187398|P6|NOT COMPLETED|Overall Study||1
76753|NCT02202161|187399|P5|NOT COMPLETED|Overall Study||1
76754|NCT02202161|187400|P4|NOT COMPLETED|Overall Study||0
76755|NCT02202161|187401|P3|NOT COMPLETED|Overall Study||0
76756|NCT02202161|187402|P2|NOT COMPLETED|Overall Study||1
76757|NCT02202161|187403|P1|NOT COMPLETED|Overall Study||1
76758|NCT02202161|187396|P8|COMPLETED|Overall Study||0
76759|NCT02202161|187397|P7|COMPLETED|Overall Study||13
76760|NCT02202161|187398|P6|COMPLETED|Overall Study||9
76761|NCT02202161|187399|P5|COMPLETED|Overall Study||8
76762|NCT02202161|187400|P4|COMPLETED|Overall Study||9
76763|NCT02202161|187401|P3|COMPLETED|Overall Study||5
76764|NCT02202161|187402|P2|COMPLETED|Overall Study||4
76765|NCT02202161|187403|P1|COMPLETED|Overall Study||12
76766|NCT02202161|187396|P8|STARTED|Overall Study||6
76767|NCT02202161|187397|P7|STARTED|Overall Study||13
76768|NCT02202161|187398|P6|STARTED|Overall Study||10
76769|NCT02202161|187399|P5|STARTED|Overall Study||9
76770|NCT02202161|187400|P4|STARTED|Overall Study||9
76771|NCT02202161|187401|P3|STARTED|Overall Study||5
76772|NCT02202161|187402|P2|STARTED|Overall Study||5
76773|NCT02202161|187403|P1|STARTED|Overall Study||13
76774|NCT02202135|187557|P1|NOT COMPLETED|Overall Study||0
76775|NCT02202135|187557|P1|COMPLETED|Overall Study||4
76776|NCT02202135|187557|P1|STARTED|Overall Study||4
76777|NCT02202109|187563|P2|NOT COMPLETED|Overall Study||87
76778|NCT02202109|187564|P1|NOT COMPLETED|Overall Study||90
76779|NCT02202109|187563|P2|COMPLETED|Overall Study||213
76780|NCT02202109|187564|P1|COMPLETED|Overall Study||212
76781|NCT02202109|187563|P2|STARTED|Overall Study||300
76782|NCT02202109|187564|P1|STARTED|Overall Study||302
76783|NCT02202044|187574|P1|NOT COMPLETED|Overall Study||0
76784|NCT02202044|187574|P1|COMPLETED|Overall Study||0
76785|NCT02202044|187574|P1|STARTED|Overall Study||0
76786|NCT02202031|187581|P2|NOT COMPLETED|Overall Study||5
76787|NCT02202031|187582|P1|NOT COMPLETED|Overall Study||5
76788|NCT02202031|187581|P2|COMPLETED|Overall Study||74
76789|NCT02202031|187582|P1|COMPLETED|Overall Study||77
76790|NCT02202031|187581|P2|STARTED|Overall Study||79
76791|NCT02202031|187582|P1|STARTED|Overall Study||82
76792|NCT02201953|187630|P2|NOT COMPLETED|Overall Study||56
76793|NCT02201953|187631|P1|NOT COMPLETED|Overall Study||20
76794|NCT02201953|187630|P2|COMPLETED|Overall Study||224
76795|NCT02201953|187631|P1|COMPLETED|Overall Study||258
76796|NCT02201953|187630|P2|STARTED|Overall Study||280
76797|NCT02201953|187631|P1|STARTED|Overall Study||278
76798|NCT02201940|187649|P2|NOT COMPLETED|Overall Study||116
76799|NCT02201940|187650|P1|NOT COMPLETED|Overall Study||12
76800|NCT02201940|187649|P2|COMPLETED|Overall Study||0
76801|NCT02201940|187650|P1|COMPLETED|Overall Study||613
76802|NCT02201940|187649|P2|STARTED|Overall Study||116
76803|NCT02201940|187650|P1|STARTED|Overall Study||625
76804|NCT02201901|187669|P3|NOT COMPLETED|Overall Study||13
76805|NCT02201901|187670|P2|NOT COMPLETED|Overall Study||9
76806|NCT02201901|187671|P1|NOT COMPLETED|Overall Study||15
76807|NCT02201901|187669|P3|COMPLETED|Overall Study||77
76808|NCT02201901|187670|P2|COMPLETED|Overall Study||79
76809|NCT02201901|187671|P1|COMPLETED|Overall Study||75
76810|NCT02201901|187669|P3|STARTED|Overall Study||90
76811|NCT02201901|187670|P2|STARTED|Overall Study||88
76812|NCT02201901|187671|P1|STARTED|Overall Study||90
76813|NCT02201784|187702|P2|NOT COMPLETED|Overall Study||0
76814|NCT02201784|187703|P1|NOT COMPLETED|Overall Study||2
76815|NCT02201784|187702|P2|COMPLETED|Overall Study||30
76816|NCT02201784|187703|P1|COMPLETED|Overall Study||28
76817|NCT02201784|187702|P2|STARTED|Overall Study||30
76818|NCT02201784|187703|P1|STARTED|Overall Study||30
76819|NCT02201771|187720|P3|NOT COMPLETED|Overall Study||10
76820|NCT02201771|187721|P2|NOT COMPLETED|Overall Study||10
76821|NCT02201771|187722|P1|NOT COMPLETED|Overall Study||13
76822|NCT02201771|187720|P3|COMPLETED|Overall Study||156
76823|NCT02201771|187721|P2|COMPLETED|Overall Study||158
76824|NCT02201771|187722|P1|COMPLETED|Overall Study||153
76825|NCT02201771|187720|P3|STARTED|Overall Study||166
76826|NCT02201771|187721|P2|STARTED|Overall Study||168
76827|NCT02201771|187722|P1|STARTED|Overall Study||166
76828|NCT02201524|187749|P4|NOT COMPLETED|Overall Study||4
76829|NCT02201524|187750|P3|NOT COMPLETED|Overall Study||4
76830|NCT02201524|187751|P2|NOT COMPLETED|Overall Study||3
76831|NCT02201524|187752|P1|NOT COMPLETED|Overall Study||2
76832|NCT02201524|187749|P4|COMPLETED|Overall Study||10
76833|NCT02201524|187750|P3|COMPLETED|Overall Study||12
76834|NCT02201524|187751|P2|COMPLETED|Overall Study||12
76835|NCT02201524|187752|P1|COMPLETED|Overall Study||12
76836|NCT02201524|187749|P4|STARTED|Overall Study||14
76837|NCT02201524|187750|P3|STARTED|Overall Study||16
76838|NCT02201524|187751|P2|STARTED|Overall Study||15
76839|NCT02201524|187752|P1|STARTED|Overall Study||14
76840|NCT02201446|187836|P2|NOT COMPLETED|Overall Study||0
76841|NCT02201446|187837|P1|NOT COMPLETED|Overall Study||0
76842|NCT02201446|187836|P2|COMPLETED|Overall Study||58
76843|NCT02201446|187837|P1|COMPLETED|Overall Study||81
76844|NCT02201446|187836|P2|STARTED|Overall Study||58
76845|NCT02201446|187837|P1|STARTED|Overall Study||81
76846|NCT02201420|187865|P1|NOT COMPLETED|Overall Study||0
76847|NCT02201420|187865|P1|COMPLETED|Overall Study||5
76848|NCT02201420|187865|P1|STARTED|Overall Study||5
76849|NCT02201394|187870|P1|NOT COMPLETED|Maintenance Dose||0
76850|NCT02201394|187870|P1|COMPLETED|Maintenance Dose||20
76851|NCT02201394|187870|P1|STARTED|Maintenance Dose||20
76852|NCT02201394|187870|P1|NOT COMPLETED|Loading Dose||0
76853|NCT02201394|187870|P1|COMPLETED|Loading Dose||20
76854|NCT02201394|187870|P1|STARTED|Loading Dose||20
76855|NCT02201329|187877|P1|NOT COMPLETED|Overall Study||5
76856|NCT02201329|187877|P1|COMPLETED|Overall Study||0
76857|NCT02201329|187877|P1|STARTED|Overall Study||5
76858|NCT02201290|187885|P1|NOT COMPLETED|Overall Study||5
76859|NCT02201290|187885|P1|COMPLETED|Overall Study||4
76860|NCT02201290|187885|P1|STARTED|Overall Study||9
76861|NCT02201277|187891|P2|NOT COMPLETED|Overall Study||5
76862|NCT02201277|187892|P1|NOT COMPLETED|Overall Study||7
76863|NCT02201277|187891|P2|COMPLETED|Overall Study||16
76864|NCT02201277|187892|P1|COMPLETED|Overall Study||17
76865|NCT02201277|187891|P2|Failed Retrieval (Referred Elsewhere)|Overall Study||0
76866|NCT02201277|187892|P1|Failed Retrieval (Referred Elsewhere)|Overall Study||1
76867|NCT02201277|187891|P2|Complicated Retrieval|Overall Study||0
76868|NCT02201277|187892|P1|Complicated Retrieval|Overall Study||2
76869|NCT02201277|187891|P2|Death (Before Removal)|Overall Study||4
76870|NCT02201277|187892|P1|Death (Before Removal)|Overall Study||3
76871|NCT02201277|187891|P2|Lost to Follow up|Overall Study||1
76872|NCT02201277|187892|P1|Lost to Follow up|Overall Study||2
76873|NCT02201277|187891|P2|Filter Ruled to be Permanent|Overall Study||2
76874|NCT02201277|187892|P1|Filter Ruled to be Permanent|Overall Study||2
76875|NCT02201277|187891|P2|Signed ICF But Did Not Enroll|Overall Study||1
76876|NCT02201277|187892|P1|Signed ICF But Did Not Enroll|Overall Study|Physician had preference for a specific filter so patient not randomized.|0
76877|NCT02201277|187891|P2|Filter Retrieval|Overall Study||16
76878|NCT02201277|187892|P1|Filter Retrieval|Overall Study||17
76879|NCT02201277|187891|P2|STARTED|Overall Study|1 patient was withdrawn after signing consent due to physician preference for the option filter.|21
76880|NCT02201277|187892|P1|STARTED|Overall Study|24 patients were consented but 1 patient had denali filter placed twice.|24
76881|NCT02201056|187919|P7|NOT COMPLETED|Overall Study||0
76882|NCT02201056|187920|P6|NOT COMPLETED|Overall Study||0
76883|NCT02201056|187921|P5|NOT COMPLETED|Overall Study||0
76884|NCT02201056|187922|P4|NOT COMPLETED|Overall Study||0
76885|NCT02201056|187923|P3|NOT COMPLETED|Overall Study||0
76886|NCT02201056|187924|P2|NOT COMPLETED|Overall Study||0
76887|NCT02201056|187925|P1|NOT COMPLETED|Overall Study||0
76888|NCT02201056|187919|P7|COMPLETED|Overall Study||6
76889|NCT02201056|187920|P6|COMPLETED|Overall Study||6
76890|NCT02201056|187921|P5|COMPLETED|Overall Study||6
76891|NCT02201056|187922|P4|COMPLETED|Overall Study||6
76892|NCT02201056|187923|P3|COMPLETED|Overall Study||6
76893|NCT02201056|187924|P2|COMPLETED|Overall Study||6
76894|NCT02201056|187925|P1|COMPLETED|Overall Study||12
76895|NCT02201056|187919|P7|STARTED|Overall Study||6
76896|NCT02201056|187920|P6|STARTED|Overall Study||6
76897|NCT02201056|187921|P5|STARTED|Overall Study||6
76898|NCT02201056|187922|P4|STARTED|Overall Study||6
76899|NCT02201056|187923|P3|STARTED|Overall Study||6
76900|NCT02201056|187924|P2|STARTED|Overall Study||6
76901|NCT02201056|187925|P1|STARTED|Overall Study||12
76902|NCT02200614|187982|P2|NOT COMPLETED|Follow-up Period||163
76903|NCT02200614|187983|P1|NOT COMPLETED|Follow-up Period||174
76904|NCT02200614|187982|P2|COMPLETED|Follow-up Period||169
76905|NCT02200614|187983|P1|COMPLETED|Follow-up Period||117
76906|NCT02200614|187982|P2|STARTED|Follow-up Period|Not all participants from treatment period entered follow-up|332
76907|NCT02200614|187983|P1|STARTED|Follow-up Period|Not all participants from treatment period entered follow-up|291
76908|NCT02200614|187982|P2|NOT COMPLETED|Treatment Period to Primary Completion||354
76909|NCT02200614|187983|P1|NOT COMPLETED|Treatment Period to Primary Completion||340
76910|NCT02200614|187982|P2|COMPLETED|Treatment Period to Primary Completion||200
76911|NCT02200614|187983|P1|COMPLETED|Treatment Period to Primary Completion||615
76912|NCT02200614|187982|P2|Treated|Treatment Period to Primary Completion|Safety population|554
76913|NCT02200614|187983|P1|Treated|Treatment Period to Primary Completion|Safety population|954
76914|NCT02200614|187982|P2|Ongoing|Treatment Period to Primary Completion||200
76915|NCT02200614|187983|P1|Ongoing|Treatment Period to Primary Completion||615
76916|NCT02200614|187982|P2|STARTED|Treatment Period to Primary Completion||554
76917|NCT02200614|187983|P1|STARTED|Treatment Period to Primary Completion||955
76918|NCT02200536|188000|P3|NOT COMPLETED|Overall Study||0
76919|NCT02200536|188001|P2|NOT COMPLETED|Overall Study||0
76920|NCT02200536|188002|P1|NOT COMPLETED|Overall Study||0
76921|NCT02200536|188000|P3|COMPLETED|Overall Study||30
76922|NCT02200536|188001|P2|COMPLETED|Overall Study||30
76923|NCT02200536|188002|P1|COMPLETED|Overall Study||32
76924|NCT02200536|188000|P3|STARTED|Overall Study||30
76925|NCT02200536|188001|P2|STARTED|Overall Study||30
76926|NCT02200536|188002|P1|STARTED|Overall Study||32
76927|NCT02200510|188015|P2|NOT COMPLETED|Overall Study||3
76928|NCT02200510|188016|P1|NOT COMPLETED|Overall Study||9
76929|NCT02200510|188015|P2|COMPLETED|Overall Study|This number is the number of participants with both baseline and post data.|44
76930|NCT02200510|188016|P1|COMPLETED|Overall Study|This is the number of participants with baseline and post data.|22
76931|NCT02200510|188015|P2|STARTED|Overall Study|Number who only completed portal or completed it before self-management (could do 6 months later).|47
76932|NCT02200510|188016|P1|STARTED|Overall Study|Number who only completed self-management or completed it before portal (could do 6 months later).|31
76933|NCT02200458|188022|P1|NOT COMPLETED|Overall Study||0
76934|NCT02200458|188022|P1|COMPLETED|Overall Study||62
76935|NCT02200458|188022|P1|STARTED|Overall Study||62
76936|NCT02200328|188028|P2|NOT COMPLETED|Overall Study||33
76937|NCT02200328|188029|P1|NOT COMPLETED|Overall Study||43
76938|NCT02200328|188028|P2|COMPLETED|Overall Study||0
76939|NCT02200328|188029|P1|COMPLETED|Overall Study||0
76940|NCT02200328|188028|P2|STARTED|Overall Study||33
76941|NCT02200328|188029|P1|STARTED|Overall Study||43
76942|NCT02200211|188041|P4|NOT COMPLETED|Overall Study||2
76943|NCT02200211|188042|P3|NOT COMPLETED|Overall Study||1
76944|NCT02200211|188043|P2|NOT COMPLETED|Overall Study||7
76945|NCT02200211|188044|P1|NOT COMPLETED|Overall Study||8
76946|NCT02200211|188041|P4|COMPLETED|Overall Study||58
76947|NCT02200211|188042|P3|COMPLETED|Overall Study||39
76948|NCT02200211|188043|P2|COMPLETED|Overall Study||188
76949|NCT02200211|188044|P1|COMPLETED|Overall Study||182
76950|NCT02200211|188041|P4|Included in 16-week Primary Analysis|Overall Study||56
76951|NCT02200211|188042|P3|Included in 16-week Primary Analysis|Overall Study||39
76952|NCT02200211|188043|P2|Included in 16-week Primary Analysis|Overall Study||186
76953|NCT02200211|188044|P1|Included in 16-week Primary Analysis|Overall Study||177
76954|NCT02200211|188041|P4|STARTED|Overall Study||60
76955|NCT02200211|188042|P3|STARTED|Overall Study||40
76956|NCT02200211|188043|P2|STARTED|Overall Study||195
76957|NCT02200211|188044|P1|STARTED|Overall Study||190
76958|NCT02200055|188140|P1|NOT COMPLETED|Overall Study||0
76959|NCT02200055|188140|P1|COMPLETED|Overall Study||86
76960|NCT02200055|188140|P1|STARTED|Overall Study||86
76961|NCT02200042|188157|P2|NOT COMPLETED|Overall Study||1
76962|NCT02200042|188158|P1|NOT COMPLETED|Overall Study||0
76963|NCT02200042|188157|P2|COMPLETED|Overall Study||0
76964|NCT02200042|188158|P1|COMPLETED|Overall Study||0
76965|NCT02200042|188157|P2|STARTED|Overall Study||1
76966|NCT02200042|188158|P1|STARTED|Overall Study||0
76967|NCT02199795|188176|P2|NOT COMPLETED|Overall Study||0
76968|NCT02199795|188177|P1|NOT COMPLETED|Overall Study||2
76969|NCT02199795|188176|P2|COMPLETED|Overall Study||3
76970|NCT02199795|188177|P1|COMPLETED|Overall Study||2
76971|NCT02199795|188176|P2|STARTED|Overall Study||3
76972|NCT02199795|188177|P1|STARTED|Overall Study||4
76973|NCT02199717|188189|P1|NOT COMPLETED|Overall Study||0
76974|NCT02199717|188189|P1|COMPLETED|Overall Study||66
76975|NCT02199717|188189|P1|STARTED|Overall Study||66
76976|NCT02199652|188198|P2|NOT COMPLETED|Overall Study||7
76977|NCT02199652|188199|P1|NOT COMPLETED|Overall Study||7
76978|NCT02199652|188198|P2|COMPLETED|Overall Study||3
76979|NCT02199652|188199|P1|COMPLETED|Overall Study||3
76980|NCT02199652|188198|P2|STARTED|Overall Study||10
76981|NCT02199652|188199|P1|STARTED|Overall Study||10
76982|NCT02199574|188209|P1|NOT COMPLETED|Overall Study||0
76983|NCT02199574|188209|P1|COMPLETED|Overall Study||12
76984|NCT02199574|188209|P1|STARTED|Overall Study||12
76985|NCT02199509|188218|P2|NOT COMPLETED|Overall Study||1
76986|NCT02199509|188219|P1|NOT COMPLETED|Overall Study||1
76987|NCT02199509|188218|P2|COMPLETED|Overall Study||3
76988|NCT02199509|188219|P1|COMPLETED|Overall Study||2
76989|NCT02199509|188218|P2|STARTED|Overall Study||4
76990|NCT02199509|188219|P1|STARTED|Overall Study||3
76991|NCT02199197|188233|P2|NOT COMPLETED|Overall Study||2
76992|NCT02199197|188234|P1|NOT COMPLETED|Overall Study||0
76993|NCT02199197|188233|P2|COMPLETED|Overall Study||12
76994|NCT02199197|188234|P1|COMPLETED|Overall Study||35
76995|NCT02199197|188233|P2|STARTED|Overall Study||14
76996|NCT02199197|188234|P1|STARTED|Overall Study||35
76997|NCT02199080|188242|P1|NOT COMPLETED|Overall Study||12
76998|NCT02199080|188242|P1|COMPLETED|Overall Study||2494
76999|NCT02199080|188242|P1|STARTED|Overall Study||2506
77000|NCT02199041|188252|P1|NOT COMPLETED|Overall Study||0
77001|NCT02199041|188252|P1|COMPLETED|Overall Study||12
77002|NCT02199041|188252|P1|STARTED|Overall Study||12
77003|NCT02199028|188267|P2|NOT COMPLETED|Week 4||0
77004|NCT02199028|188268|P1|NOT COMPLETED|Week 4||0
77005|NCT02199028|188267|P2|COMPLETED|Week 4||15
77006|NCT02199028|188268|P1|COMPLETED|Week 4||13
77007|NCT02199028|188267|P2|STARTED|Week 4||15
77008|NCT02199028|188268|P1|STARTED|Week 4||13
77009|NCT02199028|188267|P2|NOT COMPLETED|Week 3||0
77010|NCT02199028|188268|P1|NOT COMPLETED|Week 3||1
77011|NCT02199028|188267|P2|COMPLETED|Week 3||15
77012|NCT02199028|188268|P1|COMPLETED|Week 3||13
77013|NCT02199028|188267|P2|STARTED|Week 3||15
77014|NCT02199028|188268|P1|STARTED|Week 3||14
77015|NCT02199028|188267|P2|NOT COMPLETED|Week 2||0
77016|NCT02199028|188268|P1|NOT COMPLETED|Week 2||0
77017|NCT02199028|188267|P2|COMPLETED|Week 2||15
77018|NCT02199028|188268|P1|COMPLETED|Week 2||14
77019|NCT02199028|188267|P2|STARTED|Week 2||15
77020|NCT02199028|188268|P1|STARTED|Week 2||14
77021|NCT02199028|188267|P2|NOT COMPLETED|Week 1||0
77022|NCT02199028|188268|P1|NOT COMPLETED|Week 1||1
77023|NCT02199028|188267|P2|COMPLETED|Week 1||15
77024|NCT02199028|188268|P1|COMPLETED|Week 1||14
77025|NCT02199028|188267|P2|STARTED|Week 1||15
77026|NCT02199028|188268|P1|STARTED|Week 1||15
77027|NCT02198963|188277|P1|NOT COMPLETED|Overall Study||7
77028|NCT02198963|188277|P1|COMPLETED|Overall Study||36
77029|NCT02198963|188277|P1|STARTED|Overall Study||43
77030|NCT02198833|188288|P2|NOT COMPLETED|Overall Study||0
77031|NCT02198833|188289|P1|NOT COMPLETED|Overall Study||0
77032|NCT02198833|188288|P2|COMPLETED|Overall Study||1
77033|NCT02198833|188289|P1|COMPLETED|Overall Study||1
77034|NCT02198833|188288|P2|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed.|1
77035|NCT02198833|188289|P1|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed|1
77036|NCT02198651|188301|P5|NOT COMPLETED|Open-label Rescue Period||0
77037|NCT02198651|188302|P4|NOT COMPLETED|Open-label Rescue Period||3
77038|NCT02198651|188303|P3|NOT COMPLETED|Open-label Rescue Period||0
77039|NCT02198651|188304|P2|NOT COMPLETED|Open-label Rescue Period||0
77040|NCT02198651|188305|P1|NOT COMPLETED|Open-label Rescue Period||0
77041|NCT02198651|188301|P5|COMPLETED|Open-label Rescue Period||8
77042|NCT02198651|188302|P4|COMPLETED|Open-label Rescue Period||28
77043|NCT02198651|188303|P3|COMPLETED|Open-label Rescue Period||0
77044|NCT02198651|188304|P2|COMPLETED|Open-label Rescue Period||0
77045|NCT02198651|188305|P1|COMPLETED|Open-label Rescue Period||0
77046|NCT02198651|188301|P5|Correctly Entered Open-label Rescue|Open-label Rescue Period||8
77047|NCT02198651|188302|P4|Correctly Entered Open-label Rescue|Open-label Rescue Period||30
77048|NCT02198651|188303|P3|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
77049|NCT02198651|188304|P2|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
77050|NCT02198651|188305|P1|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
77051|NCT02198651|188301|P5|STARTED|Open-label Rescue Period||8
77052|NCT02198651|188302|P4|STARTED|Open-label Rescue Period||31
77053|NCT02198651|188303|P3|STARTED|Open-label Rescue Period||0
77054|NCT02198651|188304|P2|STARTED|Open-label Rescue Period||0
77055|NCT02198651|188305|P1|STARTED|Open-label Rescue Period||0
77056|NCT02198651|188301|P5|NOT COMPLETED|Double-blind Period||0
77057|NCT02198651|188302|P4|NOT COMPLETED|Double-blind Period||0
77058|NCT02198651|188303|P3|NOT COMPLETED|Double-blind Period||1
77059|NCT02198651|188304|P2|NOT COMPLETED|Double-blind Period||9
77060|NCT02198651|188305|P1|NOT COMPLETED|Double-blind Period||0
77061|NCT02198651|188301|P5|COMPLETED|Double-blind Period||0
77062|NCT02198651|188302|P4|COMPLETED|Double-blind Period||0
77063|NCT02198651|188303|P3|COMPLETED|Double-blind Period||19
77064|NCT02198651|188304|P2|COMPLETED|Double-blind Period||93
77065|NCT02198651|188305|P1|COMPLETED|Double-blind Period||0
77066|NCT02198651|188301|P5|STARTED|Double-blind Period||0
77067|NCT02198651|188302|P4|STARTED|Double-blind Period||0
77068|NCT02198651|188303|P3|STARTED|Double-blind Period||20
77069|NCT02198651|188304|P2|STARTED|Double-blind Period||102
77070|NCT02198651|188305|P1|STARTED|Double-blind Period||0
77071|NCT02198651|188301|P5|NOT COMPLETED|Lead-in Period||0
77072|NCT02198651|188302|P4|NOT COMPLETED|Lead-in Period||0
77073|NCT02198651|188303|P3|NOT COMPLETED|Lead-in Period||0
77074|NCT02198651|188304|P2|NOT COMPLETED|Lead-in Period||0
77075|NCT02198651|188305|P1|NOT COMPLETED|Lead-in Period||37
77076|NCT02198651|188301|P5|COMPLETED|Lead-in Period||0
77077|NCT02198651|188302|P4|COMPLETED|Lead-in Period||0
77078|NCT02198651|188303|P3|COMPLETED|Lead-in Period||0
77079|NCT02198651|188304|P2|COMPLETED|Lead-in Period||0
77080|NCT02198651|188305|P1|COMPLETED|Lead-in Period||112
77081|NCT02198651|188301|P5|Participants Treated in Lead-In Period|Lead-in Period||0
77082|NCT02198651|188302|P4|Participants Treated in Lead-In Period|Lead-in Period||0
77083|NCT02198651|188303|P3|Participants Treated in Lead-In Period|Lead-in Period||0
77084|NCT02198651|188304|P2|Participants Treated in Lead-In Period|Lead-in Period||0
77085|NCT02198651|188305|P1|Participants Treated in Lead-In Period|Lead-in Period||146
77086|NCT02198651|188301|P5|STARTED|Lead-in Period||0
77087|NCT02198651|188302|P4|STARTED|Lead-in Period||0
77088|NCT02198651|188303|P3|STARTED|Lead-in Period||0
77089|NCT02198651|188304|P2|STARTED|Lead-in Period||0
77090|NCT02198651|188305|P1|STARTED|Lead-in Period||149
77091|NCT02198430|188390|P2|NOT COMPLETED|Overall Study||0
77092|NCT02198430|188391|P1|NOT COMPLETED|Overall Study||0
77093|NCT02198430|188390|P2|COMPLETED|Overall Study||51
77094|NCT02198430|188391|P1|COMPLETED|Overall Study||53
77095|NCT02198430|188390|P2|STARTED|Overall Study||51
77096|NCT02198430|188391|P1|STARTED|Overall Study||53
77097|NCT02198235|188406|P3|NOT COMPLETED|Overall Study||2
77098|NCT02198235|188407|P2|NOT COMPLETED|Overall Study||2
77099|NCT02198235|188408|P1|NOT COMPLETED|Overall Study||3
77100|NCT02198235|188406|P3|COMPLETED|Overall Study||28
77101|NCT02198235|188407|P2|COMPLETED|Overall Study||28
77102|NCT02198235|188408|P1|COMPLETED|Overall Study||27
77103|NCT02198235|188406|P3|STARTED|Overall Study||30
77104|NCT02198235|188407|P2|STARTED|Overall Study||30
77105|NCT02198235|188408|P1|STARTED|Overall Study||30
77106|NCT02198040|188428|P3|NOT COMPLETED|Overall Study||1
77107|NCT02198040|188429|P2|NOT COMPLETED|Overall Study||1
77108|NCT02198040|188430|P1|NOT COMPLETED|Overall Study||0
77109|NCT02198040|188428|P3|COMPLETED|Overall Study||8
77110|NCT02198040|188429|P2|COMPLETED|Overall Study||8
77111|NCT02198040|188430|P1|COMPLETED|Overall Study||9
77112|NCT02198040|188428|P3|STARTED|Overall Study||9
77113|NCT02198040|188429|P2|STARTED|Overall Study||9
77114|NCT02198040|188430|P1|STARTED|Overall Study||9
77115|NCT02197806|188460|P4|NOT COMPLETED|Overall Study||1
77116|NCT02197806|188461|P3|NOT COMPLETED|Overall Study||0
77117|NCT02197806|188462|P2|NOT COMPLETED|Overall Study||1
77118|NCT02197806|188463|P1|NOT COMPLETED|Overall Study||0
77119|NCT02197806|188460|P4|COMPLETED|Overall Study||16
77120|NCT02197806|188461|P3|COMPLETED|Overall Study||16
77121|NCT02197806|188462|P2|COMPLETED|Overall Study||16
77122|NCT02197806|188463|P1|COMPLETED|Overall Study||15
77123|NCT02197806|188460|P4|STARTED|Overall Study||17
77124|NCT02197806|188461|P3|STARTED|Overall Study||16
77125|NCT02197806|188462|P2|STARTED|Overall Study||17
77126|NCT02197806|188463|P1|STARTED|Overall Study||15
77127|NCT02197767|188473|P1|NOT COMPLETED|Overall Study||0
77128|NCT02197767|188473|P1|COMPLETED|Overall Study||11
77129|NCT02197767|188473|P1|STARTED|Overall Study||11
77130|NCT02197520|188478|P2|NOT COMPLETED|Period 2||2
77131|NCT02197520|188479|P1|NOT COMPLETED|Period 2||1
77132|NCT02197520|188478|P2|COMPLETED|Period 2||10
77133|NCT02197520|188479|P1|COMPLETED|Period 2||10
77134|NCT02197520|188478|P2|STARTED|Period 2||12
77135|NCT02197520|188479|P1|STARTED|Period 2||11
77136|NCT02197520|188478|P2|NOT COMPLETED|Period 1||0
77137|NCT02197520|188479|P1|NOT COMPLETED|Period 1||1
77138|NCT02197520|188478|P2|COMPLETED|Period 1||12
77139|NCT02197520|188479|P1|COMPLETED|Period 1||11
77140|NCT02197520|188478|P2|STARTED|Period 1||12
77141|NCT02197520|188479|P1|STARTED|Period 1||12
77142|NCT02197481|188497|P2|NOT COMPLETED|Overall Study||0
77143|NCT02197481|188498|P1|NOT COMPLETED|Overall Study||0
77144|NCT02197481|188497|P2|COMPLETED|Overall Study||43
77145|NCT02197481|188498|P1|COMPLETED|Overall Study|February 2016|43
77146|NCT02197481|188497|P2|STARTED|Overall Study||43
77147|NCT02197481|188498|P1|STARTED|Overall Study|October 2014|43
77148|NCT02197455|188518|P1|NOT COMPLETED|Overall Study||0
77149|NCT02197455|188518|P1|COMPLETED|Overall Study||30
77150|NCT02197455|188518|P1|STARTED|Overall Study||30
77151|NCT02197377|188525|P2|NOT COMPLETED|Overall Study||3
77152|NCT02197377|188526|P1|NOT COMPLETED|Overall Study||0
77153|NCT02197377|188525|P2|COMPLETED|Overall Study||27
77154|NCT02197377|188526|P1|COMPLETED|Overall Study||30
77155|NCT02197377|188525|P2|STARTED|Overall Study||30
77156|NCT02197377|188526|P1|STARTED|Overall Study||30
77157|NCT02197273|188536|P2|NOT COMPLETED|Overall Study||0
77158|NCT02197273|188537|P1|NOT COMPLETED|Overall Study||0
77159|NCT02197273|188536|P2|COMPLETED|Overall Study||104
77160|NCT02197273|188537|P1|COMPLETED|Overall Study||107
77161|NCT02197273|188536|P2|STARTED|Overall Study||104
77162|NCT02197273|188537|P1|STARTED|Overall Study||107
77163|NCT02197247|188547|P1|NOT COMPLETED|Part B: Day 78 to End Part B (AZD9291)||15
77164|NCT02197247|188547|P1|COMPLETED|Part B: Day 78 to End Part B (AZD9291)||19
77165|NCT02197247|188547|P1|STARTED|Part B: Day 78 to End Part B (AZD9291)|32 completed Part A + 2 entered Part B without completing Part A (both due to AE) =34 started Part B|34
77166|NCT02197247|188547|P1|NOT COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||5
77167|NCT02197247|188547|P1|COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||32
77168|NCT02197247|188547|P1|STARTED|Part A: Day 50-77 (AZD9291 Alone)||37
77169|NCT02197247|188547|P1|NOT COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||4
77170|NCT02197247|188547|P1|COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||37
77171|NCT02197247|188547|P1|STARTED|Part A: Day 29-49 (AZD9291+Rifampicin)||41
77172|NCT02197247|188547|P1|NOT COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||0
77173|NCT02197247|188547|P1|COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||41
77174|NCT02197247|188547|P1|STARTED|Part A: Day 1-28 (AZD9291 Alone)||41
77175|NCT02197234|188592|P1|NOT COMPLETED|Part B: Day 33 to End Part B (AZD9291)||30
77176|NCT02197234|188592|P1|COMPLETED|Part B: Day 33 to End Part B (AZD9291)||20
77177|NCT02197234|188592|P1|STARTED|Part B: Day 33 to End Part B (AZD9291)|49 completed Part A + 1 entered Part B without completing Part A (due to AE) = 50 started Part B|50
77178|NCT02197234|188592|P1|NOT COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||0
77179|NCT02197234|188592|P1|COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
77180|NCT02197234|188592|P1|STARTED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
77181|NCT02197234|188592|P1|NOT COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||3
77182|NCT02197234|188592|P1|COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||49
77183|NCT02197234|188592|P1|STARTED|Part A: Day 3-30 (AZD9291 Alone)||52
77184|NCT02197234|188592|P1|NOT COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||0
77185|NCT02197234|188592|P1|COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||52
77186|NCT02197234|188592|P1|STARTED|Part A: Day 1-2 (Simvastatin Alone)||52
77187|NCT02197130|188614|P3|NOT COMPLETED|Overall Study||32
77188|NCT02197130|188615|P2|NOT COMPLETED|Overall Study||8
77189|NCT02197130|188616|P1|NOT COMPLETED|Overall Study||16
77190|NCT02197130|188614|P3|COMPLETED|Overall Study||56
77191|NCT02197130|188615|P2|COMPLETED|Overall Study||81
77192|NCT02197130|188616|P1|COMPLETED|Overall Study||79
77193|NCT02197130|188614|P3|Received Treatment|Overall Study||87
77194|NCT02197130|188615|P2|Received Treatment|Overall Study||88
77195|NCT02197130|188616|P1|Received Treatment|Overall Study||95
77196|NCT02197130|188614|P3|STARTED|Overall Study||88
77197|NCT02197130|188615|P2|STARTED|Overall Study||89
77198|NCT02197130|188616|P1|STARTED|Overall Study||95
77199|NCT02197065|188668|P2|NOT COMPLETED|Overall Study||0
77200|NCT02197065|188669|P1|NOT COMPLETED|Overall Study||0
77201|NCT02197065|188668|P2|COMPLETED|Overall Study||10
77202|NCT02197065|188669|P1|COMPLETED|Overall Study||10
77203|NCT02197065|188668|P2|STARTED|Overall Study||10
77204|NCT02197065|188669|P1|STARTED|Overall Study||10
77205|NCT02196922|188680|P2|NOT COMPLETED|Overall Study||0
77206|NCT02196922|188681|P1|NOT COMPLETED|Overall Study||0
77207|NCT02196922|188680|P2|COMPLETED|Overall Study||46
77208|NCT02196922|188681|P1|COMPLETED|Overall Study||58
77209|NCT02196922|188680|P2|STARTED|Overall Study||46
77210|NCT02196922|188681|P1|STARTED|Overall Study||58
77211|NCT02196766|188691|P2|NOT COMPLETED|Second Intervention (7 Days)||0
77212|NCT02196766|188692|P1|NOT COMPLETED|Second Intervention (7 Days)||0
77213|NCT02196766|188691|P2|COMPLETED|Second Intervention (7 Days)||15
77214|NCT02196766|188692|P1|COMPLETED|Second Intervention (7 Days)||15
77215|NCT02196766|188691|P2|STARTED|Second Intervention (7 Days)||15
77216|NCT02196766|188692|P1|STARTED|Second Intervention (7 Days)||15
77217|NCT02196766|188691|P2|NOT COMPLETED|First Intervention (7 Days)||0
77218|NCT02196766|188692|P1|NOT COMPLETED|First Intervention (7 Days)||0
77219|NCT02196766|188691|P2|COMPLETED|First Intervention (7 Days)||15
77220|NCT02196766|188692|P1|COMPLETED|First Intervention (7 Days)||15
77221|NCT02196766|188691|P2|STARTED|First Intervention (7 Days)||15
77222|NCT02196766|188692|P1|STARTED|First Intervention (7 Days)||15
77223|NCT02196714|188708|P4|NOT COMPLETED|Overall Study||0
77224|NCT02196714|188709|P3|NOT COMPLETED|Overall Study||1
77225|NCT02196714|188710|P2|NOT COMPLETED|Overall Study||0
77226|NCT02196714|188711|P1|NOT COMPLETED|Overall Study||0
77227|NCT02196714|188708|P4|COMPLETED|Overall Study||24
77228|NCT02196714|188709|P3|COMPLETED|Overall Study||23
77229|NCT02196714|188710|P2|COMPLETED|Overall Study||23
77230|NCT02196714|188711|P1|COMPLETED|Overall Study||24
77231|NCT02196714|188708|P4|STARTED|Overall Study||24
77232|NCT02196714|188709|P3|STARTED|Overall Study||24
77233|NCT02196714|188710|P2|STARTED|Overall Study||23
77234|NCT02196714|188711|P1|STARTED|Overall Study||24
77235|NCT02196701|188833|P1|NOT COMPLETED|Overall Study||3
77236|NCT02196701|188833|P1|COMPLETED|Overall Study||43
77237|NCT02196701|188833|P1|STARTED|Overall Study||46
77238|NCT02196688|188891|P2|NOT COMPLETED|Overall Study||1
77239|NCT02196688|188892|P1|NOT COMPLETED|Overall Study||7
77240|NCT02196688|188891|P2|COMPLETED|Overall Study||23
77241|NCT02196688|188892|P1|COMPLETED|Overall Study||40
77242|NCT02196688|188891|P2|STARTED|Overall Study||24
77243|NCT02196688|188892|P1|STARTED|Overall Study||47
77244|NCT02196675|188907|P3|NOT COMPLETED|Overall Study||1
77245|NCT02196675|188908|P2|NOT COMPLETED|Overall Study||2
77246|NCT02196675|188909|P1|NOT COMPLETED|Overall Study||2
77247|NCT02196675|188907|P3|COMPLETED|Overall Study||7
77248|NCT02196675|188908|P2|COMPLETED|Overall Study||68
77249|NCT02196675|188909|P1|COMPLETED|Overall Study||25
77250|NCT02196675|188907|P3|STARTED|Overall Study||8
77251|NCT02196675|188908|P2|STARTED|Overall Study||70
77252|NCT02196675|188909|P1|STARTED|Overall Study||27
77253|NCT02196506|188931|P4|NOT COMPLETED|Phase A+||14
77254|NCT02196506|188932|P3|NOT COMPLETED|Phase A+||0
77255|NCT02196506|188933|P2|NOT COMPLETED|Phase A+||0
77256|NCT02196506|188934|P1|NOT COMPLETED|Phase A+||0
77257|NCT02196506|188931|P4|COMPLETED|Phase A+||308
77258|NCT02196506|188932|P3|COMPLETED|Phase A+||0
77259|NCT02196506|188933|P2|COMPLETED|Phase A+||0
77260|NCT02196506|188934|P1|COMPLETED|Phase A+||0
77261|NCT02196506|188931|P4|STARTED|Phase A+||322
77262|NCT02196506|188932|P3|STARTED|Phase A+||0
77263|NCT02196506|188933|P2|STARTED|Phase A+||0
77264|NCT02196506|188934|P1|STARTED|Phase A+||0
77265|NCT02196506|188931|P4|NOT COMPLETED|Phase B||0
77266|NCT02196506|188932|P3|NOT COMPLETED|Phase B||6
77267|NCT02196506|188933|P2|NOT COMPLETED|Phase B||15
77268|NCT02196506|188934|P1|NOT COMPLETED|Phase B||0
77269|NCT02196506|188931|P4|COMPLETED|Phase B||0
77270|NCT02196506|188932|P3|COMPLETED|Phase B||196
77271|NCT02196506|188933|P2|COMPLETED|Phase B||177
77272|NCT02196506|188934|P1|COMPLETED|Phase B||0
77273|NCT02196506|188931|P4|STARTED|Phase B||0
77274|NCT02196506|188932|P3|STARTED|Phase B||202
77275|NCT02196506|188933|P2|STARTED|Phase B||192
77276|NCT02196506|188934|P1|STARTED|Phase B||0
77277|NCT02196506|188931|P4|NOT COMPLETED|Phase A||0
77278|NCT02196506|188932|P3|NOT COMPLETED|Phase A||0
77279|NCT02196506|188933|P2|NOT COMPLETED|Phase A||0
77280|NCT02196506|188934|P1|NOT COMPLETED|Phase A||121
77281|NCT02196506|188931|P4|COMPLETED|Phase A||0
77282|NCT02196506|188932|P3|COMPLETED|Phase A||0
77283|NCT02196506|188933|P2|COMPLETED|Phase A||0
77284|NCT02196506|188934|P1|COMPLETED|Phase A||716
77285|NCT02196506|188931|P4|STARTED|Phase A||0
77286|NCT02196506|188932|P3|STARTED|Phase A||0
77287|NCT02196506|188933|P2|STARTED|Phase A||0
77288|NCT02196506|188934|P1|STARTED|Phase A||837
77289|NCT02196259|188949|P3|NOT COMPLETED|Overall Study||1
77290|NCT02196259|188950|P2|NOT COMPLETED|Overall Study||3
77291|NCT02196259|188951|P1|NOT COMPLETED|Overall Study||0
77292|NCT02196259|188949|P3|COMPLETED|Overall Study||2
77293|NCT02196259|188950|P2|COMPLETED|Overall Study||4
77294|NCT02196259|188951|P1|COMPLETED|Overall Study||3
77295|NCT02196259|188949|P3|STARTED|Overall Study||3
77296|NCT02196259|188950|P2|STARTED|Overall Study||7
77297|NCT02196259|188951|P1|STARTED|Overall Study||3
77298|NCT02196168|188960|P2|NOT COMPLETED|Overall Study||0
77299|NCT02196168|188961|P1|NOT COMPLETED|Overall Study||0
77300|NCT02196168|188960|P2|COMPLETED|Overall Study||0
77301|NCT02196168|188961|P1|COMPLETED|Overall Study||6
77302|NCT02196168|188960|P2|STARTED|Overall Study||0
77303|NCT02196168|188961|P1|STARTED|Overall Study||6
77304|NCT02196077|188979|P1|NOT COMPLETED|Overall Study||47
77305|NCT02196077|188979|P1|COMPLETED|Overall Study||133
77306|NCT02196077|188979|P1|FF MDI 9.6 μg|Overall Study||157
77307|NCT02196077|188979|P1|BD MDI 320 μg|Overall Study||108
77308|NCT02196077|188979|P1|BFF MDI 80/9.6 μg|Overall Study||103
77309|NCT02196077|188979|P1|BFF MDI 160/9.6 μg|Overall Study||106
77310|NCT02196077|188979|P1|BFF MDI 320/9.6 μg|Overall Study||155
77311|NCT02196077|188979|P1|STARTED|Overall Study||180
77312|NCT02195986|189029|P3|NOT COMPLETED|Overall Study||2
77313|NCT02195986|189030|P2|NOT COMPLETED|Overall Study||5
77314|NCT02195986|189031|P1|NOT COMPLETED|Overall Study||3
77315|NCT02195986|189029|P3|COMPLETED|Overall Study||71
77316|NCT02195986|189030|P2|COMPLETED|Overall Study||142
77317|NCT02195986|189031|P1|COMPLETED|Overall Study||143
77318|NCT02195986|189029|P3|STARTED|Overall Study||73
77319|NCT02195986|189030|P2|STARTED|Overall Study||147
77320|NCT02195986|189031|P1|STARTED|Overall Study||146
77321|NCT02195895|189046|P1|NOT COMPLETED|Overall Study||0
77322|NCT02195895|189046|P1|COMPLETED|Overall Study||17
77323|NCT02195895|189046|P1|STARTED|Overall Study||17
77324|NCT02195869|189054|P1|NOT COMPLETED|Overall Study||42
77325|NCT02195869|189054|P1|COMPLETED|Overall Study||0
77326|NCT02195869|189054|P1|All-Treated Population|Overall Study||42
77327|NCT02195869|189054|P1|STARTED|Overall Study|Phase 1b: 6 patients, 420 mg, no DLT observed. Phase 2: 42 patients, 420 mg|42
77328|NCT02195713|189067|P2|NOT COMPLETED|Overall Study||0
77329|NCT02195713|189068|P1|NOT COMPLETED|Overall Study||0
77330|NCT02195713|189067|P2|COMPLETED|Overall Study||10
77331|NCT02195713|189068|P1|COMPLETED|Overall Study||10
77332|NCT02195713|189067|P2|STARTED|Overall Study||10
77333|NCT02195713|189068|P1|STARTED|Overall Study||10
77334|NCT02195700|189076|P2|NOT COMPLETED|Overall Study||7
77335|NCT02195700|189077|P1|NOT COMPLETED|Overall Study||6
77336|NCT02195700|189076|P2|COMPLETED|Overall Study||52
77337|NCT02195700|189077|P1|COMPLETED|Overall Study||52
77338|NCT02195700|189076|P2|Maintenance Period|Overall Study||54
77339|NCT02195700|189077|P1|Maintenance Period|Overall Study||53
77340|NCT02195700|189076|P2|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|57
77341|NCT02195700|189077|P1|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|56
77342|NCT02195700|189076|P2|Safety and ITT Populations|Overall Study||59
77343|NCT02195700|189077|P1|Safety and ITT Populations|Overall Study||58
77344|NCT02195700|189076|P2|STARTED|Overall Study||59
77345|NCT02195700|189077|P1|STARTED|Overall Study||58
77346|NCT02195687|189099|P2|NOT COMPLETED|Overall Study||2
77347|NCT02195687|189100|P1|NOT COMPLETED|Overall Study||5
77348|NCT02195687|189099|P2|COMPLETED|Overall Study||99
77349|NCT02195687|189100|P1|COMPLETED|Overall Study||311
77350|NCT02195687|189099|P2|STARTED|Overall Study||101
77351|NCT02195687|189100|P1|STARTED|Overall Study||316
77352|NCT02195622|189118|P2|NOT COMPLETED|Overall Study||0
77353|NCT02195622|189119|P1|NOT COMPLETED|Overall Study||0
77354|NCT02195622|189118|P2|COMPLETED|Overall Study||37
77355|NCT02195622|189119|P1|COMPLETED|Overall Study||37
77356|NCT02195622|189118|P2|STARTED|Overall Study||37
77357|NCT02195622|189119|P1|STARTED|Overall Study||37
77358|NCT02195583|189125|P1|NOT COMPLETED|Overall Study||9
77359|NCT02195583|189125|P1|COMPLETED|Overall Study||53
77360|NCT02195583|189125|P1|Sodium Fluoride (1426 Ppm) + Zinc Base B|Overall Study|Discontinuations: 1 withdrawal of consent in Period 2;1 adverse event each in Period 3 and Period 4|60
77361|NCT02195583|189125|P1|Sodium Fluoride (1426 Ppm)|Overall Study|Discontinuation:1 lost to follow up, 1 withdrawal of consent in Period 2, 1 other reason in Period 5|59
77362|NCT02195583|189125|P1|Sodium Fluoride (250 Ppm)|Overall Study||55
77363|NCT02195583|189125|P1|Sodium Fluoride (1426 Ppm) + Zinc Base A|Overall Study|Discontinuations: 1 withdrawal of consent in Period 3 and 1 withdrawal of consent in Period 4|58
77364|NCT02195583|189125|P1|Sodium Fluoride (0 Ppm)|Overall Study||59
77365|NCT02195583|189125|P1|Sodium Fluoride (1150 Ppm)|Overall Study|Discontinuations: 1 due to other reason in Period 5|57
77366|NCT02195583|189125|P1|STARTED|Overall Study||62
77367|NCT02195531|189160|P3|NOT COMPLETED|Overall Study||1
77368|NCT02195531|189161|P2|NOT COMPLETED|Overall Study||1
77369|NCT02195531|189162|P1|NOT COMPLETED|Overall Study||1
77370|NCT02195531|189160|P3|COMPLETED|Overall Study||55
77371|NCT02195531|189161|P2|COMPLETED|Overall Study||48
77372|NCT02195531|189162|P1|COMPLETED|Overall Study||63
77373|NCT02195531|189160|P3|STARTED|Overall Study||56
77374|NCT02195531|189161|P2|STARTED|Overall Study||49
77375|NCT02195531|189162|P1|STARTED|Overall Study||64
77376|NCT02195518|189187|P1|NOT COMPLETED|Overall Study||9
77377|NCT02195518|189187|P1|COMPLETED|Overall Study||204
77378|NCT02195518|189187|P1|STARTED|Overall Study||213
77379|NCT02195479|189210|P2|NOT COMPLETED|Overall Study||350
77380|NCT02195479|189211|P1|NOT COMPLETED|Overall Study||356
77381|NCT02195479|189210|P2|COMPLETED|Overall Study|None of the participants completed the study as the study is still on-going.|0
77382|NCT02195479|189211|P1|COMPLETED|Overall Study|None of the participants completed the study as the study is still on-going.|0
77383|NCT02195479|189210|P2|Treated|Overall Study||346
77384|NCT02195479|189211|P1|Treated|Overall Study||354
77385|NCT02195479|189210|P2|STARTED|Overall Study||350
77386|NCT02195479|189211|P1|STARTED|Overall Study||356
77387|NCT02195427|189249|P2|NOT COMPLETED|Overall Study||27
77388|NCT02195427|189250|P1|NOT COMPLETED|Overall Study||26
77389|NCT02195427|189249|P2|COMPLETED|Overall Study||47
77390|NCT02195427|189250|P1|COMPLETED|Overall Study||47
77391|NCT02195427|189249|P2|N Patients at W52|Overall Study||56
77392|NCT02195427|189250|P1|N Patients at W52|Overall Study||63
77393|NCT02195427|189249|P2|N Patients at W36|Overall Study||59
77394|NCT02195427|189250|P1|N Patients at W36|Overall Study||65
77395|NCT02195427|189249|P2|N Patients at W24 (Primary Outcome)|Overall Study||62
77396|NCT02195427|189250|P1|N Patients at W24 (Primary Outcome)|Overall Study||67
77397|NCT02195427|189249|P2|STARTED|Overall Study||74
77398|NCT02195427|189250|P1|STARTED|Overall Study||73
77399|NCT02195414|189312|P1|NOT COMPLETED|Overall Study||0
77400|NCT02195414|189312|P1|COMPLETED|Overall Study||31
77401|NCT02195414|189312|P1|Primary Endpoint|Overall Study||31
77402|NCT02195414|189312|P1|STARTED|Overall Study||31
77403|NCT02195349|189330|P11|NOT COMPLETED|Overall Study||0
77404|NCT02195349|189331|P10|NOT COMPLETED|Overall Study||0
77405|NCT02195349|189332|P9|NOT COMPLETED|Overall Study||0
77406|NCT02195349|189333|P8|NOT COMPLETED|Overall Study||0
77407|NCT02195349|189334|P7|NOT COMPLETED|Overall Study||0
77408|NCT02195349|189335|P6|NOT COMPLETED|Overall Study||0
77409|NCT02195349|189336|P5|NOT COMPLETED|Overall Study||0
77410|NCT02195349|189337|P4|NOT COMPLETED|Overall Study||0
77411|NCT02195349|189338|P3|NOT COMPLETED|Overall Study||0
77412|NCT02195349|189339|P2|NOT COMPLETED|Overall Study||0
77413|NCT02195349|189340|P1|NOT COMPLETED|Overall Study||0
77414|NCT02195349|189330|P11|COMPLETED|Overall Study||6
77415|NCT02195349|189331|P10|COMPLETED|Overall Study||6
77416|NCT02195349|189332|P9|COMPLETED|Overall Study||6
77417|NCT02195349|189333|P8|COMPLETED|Overall Study||9
77418|NCT02195349|189334|P7|COMPLETED|Overall Study||6
77419|NCT02195349|189335|P6|COMPLETED|Overall Study||6
77420|NCT02195349|189336|P5|COMPLETED|Overall Study||6
77421|NCT02195349|189337|P4|COMPLETED|Overall Study||6
77422|NCT02195349|189338|P3|COMPLETED|Overall Study||1
77423|NCT02195349|189339|P2|COMPLETED|Overall Study||1
77424|NCT02195349|189340|P1|COMPLETED|Overall Study||14
77425|NCT02195349|189330|P11|STARTED|Overall Study||6
77426|NCT02195349|189331|P10|STARTED|Overall Study||6
77427|NCT02195349|189332|P9|STARTED|Overall Study||6
77428|NCT02195349|189333|P8|STARTED|Overall Study||9
77429|NCT02195349|189334|P7|STARTED|Overall Study||6
77430|NCT02195349|189335|P6|STARTED|Overall Study||6
77431|NCT02195349|189336|P5|STARTED|Overall Study||6
77432|NCT02195349|189337|P4|STARTED|Overall Study||6
77433|NCT02195349|189338|P3|STARTED|Overall Study||1
77434|NCT02195349|189339|P2|STARTED|Overall Study||1
77435|NCT02195349|189340|P1|STARTED|Overall Study||14
77436|NCT02195310|189593|P2|NOT COMPLETED|Overall Study||16
77437|NCT02195310|189594|P1|NOT COMPLETED|Overall Study||20
77438|NCT02195310|189593|P2|COMPLETED|Overall Study||153
77439|NCT02195310|189594|P1|COMPLETED|Overall Study||153
77440|NCT02195310|189593|P2|STARTED|Overall Study||169
77441|NCT02195310|189594|P1|STARTED|Overall Study||173
77442|NCT02195232|189602|P2|NOT COMPLETED|Overall Study||3
77443|NCT02195232|189603|P1|NOT COMPLETED|Overall Study||4
77444|NCT02195232|189602|P2|COMPLETED|Overall Study|Evaluated for VTE and safety|29
77445|NCT02195232|189603|P1|COMPLETED|Overall Study|Evaluated for VTE and safety|28
77446|NCT02195232|189602|P2|STARTED|Overall Study|patients consented|32
77447|NCT02195232|189603|P1|STARTED|Overall Study|patients consented|32
77448|NCT02195011|189615|P2|NOT COMPLETED|Overall Study||1
77449|NCT02195011|189616|P1|NOT COMPLETED|Overall Study||25
77450|NCT02195011|189615|P2|COMPLETED|Overall Study||0
77451|NCT02195011|189616|P1|COMPLETED|Overall Study||0
77452|NCT02195011|189615|P2|STARTED|Overall Study||1
77453|NCT02195011|189616|P1|STARTED|Overall Study||25
77454|NCT02194998|189632|P4|NOT COMPLETED|Post-HCV Treatment Follow-Up||0
77455|NCT02194998|189633|P3|NOT COMPLETED|Post-HCV Treatment Follow-Up||1
77456|NCT02194998|189634|P2|NOT COMPLETED|Post-HCV Treatment Follow-Up||0
77457|NCT02194998|189635|P1|NOT COMPLETED|Post-HCV Treatment Follow-Up||1
77458|NCT02194998|189632|P4|COMPLETED|Post-HCV Treatment Follow-Up||4
77459|NCT02194998|189633|P3|COMPLETED|Post-HCV Treatment Follow-Up||14
77460|NCT02194998|189634|P2|COMPLETED|Post-HCV Treatment Follow-Up||5
77461|NCT02194998|189635|P1|COMPLETED|Post-HCV Treatment Follow-Up||20
77462|NCT02194998|189632|P4|STARTED|Post-HCV Treatment Follow-Up||4
77463|NCT02194998|189633|P3|STARTED|Post-HCV Treatment Follow-Up||15
77464|NCT02194998|189634|P2|STARTED|Post-HCV Treatment Follow-Up||5
77465|NCT02194998|189635|P1|STARTED|Post-HCV Treatment Follow-Up||21
77466|NCT02194998|189632|P4|NOT COMPLETED|On-HCV Treatment||0
77467|NCT02194998|189633|P3|NOT COMPLETED|On-HCV Treatment||0
77468|NCT02194998|189634|P2|NOT COMPLETED|On-HCV Treatment||1
77469|NCT02194998|189635|P1|NOT COMPLETED|On-HCV Treatment||0
77470|NCT02194998|189632|P4|COMPLETED|On-HCV Treatment||4
77471|NCT02194998|189633|P3|COMPLETED|On-HCV Treatment||15
77472|NCT02194998|189634|P2|COMPLETED|On-HCV Treatment||5
77473|NCT02194998|189635|P1|COMPLETED|On-HCV Treatment||21
77474|NCT02194998|189632|P4|STARTED|On-HCV Treatment||4
77475|NCT02194998|189633|P3|STARTED|On-HCV Treatment||15
77476|NCT02194998|189634|P2|STARTED|On-HCV Treatment||6
77477|NCT02194998|189635|P1|STARTED|On-HCV Treatment||21
77478|NCT02194933|189699|P2|NOT COMPLETED|Overall Study||9
77479|NCT02194933|189700|P1|NOT COMPLETED|Overall Study||3
77480|NCT02194933|189699|P2|COMPLETED|Overall Study||10
77481|NCT02194933|189700|P1|COMPLETED|Overall Study||16
77482|NCT02194933|189699|P2|STARTED|Overall Study||19
77483|NCT02194933|189700|P1|STARTED|Overall Study||19
77484|NCT02194699|189754|P2|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||52
77485|NCT02194699|189755|P1|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||50
77486|NCT02194699|189754|P2|COMPLETED|With Potential to Receive 52 Weeks of IP||365
77487|NCT02194699|189755|P1|COMPLETED|With Potential to Receive 52 Weeks of IP||370
77488|NCT02194699|189754|P2|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|417
77489|NCT02194699|189755|P1|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|420
77490|NCT02194699|189754|P2|NOT COMPLETED|Randomised||11
77491|NCT02194699|189755|P1|NOT COMPLETED|Randomised||8
77492|NCT02194699|189754|P2|COMPLETED|Randomised||417
77493|NCT02194699|189755|P1|COMPLETED|Randomised||420
77494|NCT02194699|189754|P2|STARTED|Randomised||428
77495|NCT02194699|189755|P1|STARTED|Randomised||428
77496|NCT02194621|189863|P3|NOT COMPLETED|Overall Study||9
77497|NCT02194621|189864|P2|NOT COMPLETED|Overall Study||6
77498|NCT02194621|189865|P1|NOT COMPLETED|Overall Study||6
77499|NCT02194621|189863|P3|COMPLETED|Overall Study||34
77500|NCT02194621|189864|P2|COMPLETED|Overall Study||36
77501|NCT02194621|189865|P1|COMPLETED|Overall Study||37
77502|NCT02194621|189863|P3|STARTED|Overall Study||43
77503|NCT02194621|189864|P2|STARTED|Overall Study||42
77504|NCT02194621|189865|P1|STARTED|Overall Study||43
77505|NCT02194088|189884|P2|NOT COMPLETED|Overall Study||0
77506|NCT02194088|189885|P1|NOT COMPLETED|Overall Study||0
77507|NCT02194088|189884|P2|COMPLETED|Overall Study||25
77508|NCT02194088|189885|P1|COMPLETED|Overall Study||75
77509|NCT02194088|189884|P2|STARTED|Overall Study||25
77510|NCT02194088|189885|P1|STARTED|Overall Study||75
77511|NCT02194062|189898|P3|NOT COMPLETED|Overall Study||5
77512|NCT02194062|189899|P2|NOT COMPLETED|Overall Study||2
77513|NCT02194062|189900|P1|NOT COMPLETED|Overall Study||2
77514|NCT02194062|189898|P3|COMPLETED|Overall Study||7
77515|NCT02194062|189899|P2|COMPLETED|Overall Study||8
77516|NCT02194062|189900|P1|COMPLETED|Overall Study||8
77517|NCT02194062|189898|P3|STARTED|Overall Study||12
77518|NCT02194062|189899|P2|STARTED|Overall Study||10
77519|NCT02194062|189900|P1|STARTED|Overall Study||10
77520|NCT02193880|189911|P1|NOT COMPLETED|Overall Study||3
77521|NCT02193880|189911|P1|COMPLETED|Overall Study||4
77522|NCT02193880|189911|P1|STARTED|Overall Study||7
77523|NCT02193867|189916|P1|NOT COMPLETED|Overall Study||4
77524|NCT02193867|189916|P1|COMPLETED|Overall Study||6
77525|NCT02193867|189916|P1|Completed 18 Months Of Treatment|Overall Study||8
77526|NCT02193867|189916|P1|Received At Least 1 Dose Of Study Drug|Overall Study||10
77527|NCT02193867|189916|P1|STARTED|Overall Study||10
77528|NCT02193828|189934|P4|NOT COMPLETED|Overall Study||1
77529|NCT02193828|189935|P3|NOT COMPLETED|Overall Study||1
77530|NCT02193828|189936|P2|NOT COMPLETED|Overall Study||0
77531|NCT02193828|189937|P1|NOT COMPLETED|Overall Study||0
77532|NCT02193828|189934|P4|COMPLETED|Overall Study||16
77533|NCT02193828|189935|P3|COMPLETED|Overall Study||22
77534|NCT02193828|189936|P2|COMPLETED|Overall Study||18
77535|NCT02193828|189937|P1|COMPLETED|Overall Study||18
77536|NCT02193828|189934|P4|STARTED|Overall Study||17
77537|NCT02193828|189935|P3|STARTED|Overall Study||23
77538|NCT02193828|189936|P2|STARTED|Overall Study||18
77539|NCT02193828|189937|P1|STARTED|Overall Study||18
77540|NCT02193815|189975|P1|NOT COMPLETED|Overall Study||0
77541|NCT02193815|189975|P1|COMPLETED|Overall Study||15
77542|NCT02193815|189975|P1|STARTED|Overall Study||15
77543|NCT02193776|190014|P4|NOT COMPLETED|Overall Study||2
77544|NCT02193776|190015|P3|NOT COMPLETED|Overall Study||2
77545|NCT02193776|190016|P2|NOT COMPLETED|Overall Study||7
77546|NCT02193776|190017|P1|NOT COMPLETED|Overall Study||8
77547|NCT02193776|190014|P4|COMPLETED|Overall Study||58
77548|NCT02193776|190015|P3|COMPLETED|Overall Study||59
77549|NCT02193776|190016|P2|COMPLETED|Overall Study||53
77550|NCT02193776|190017|P1|COMPLETED|Overall Study||51
77551|NCT02193776|190014|P4|Completed Day 140 Follow-up|Overall Study||58
77552|NCT02193776|190015|P3|Completed Day 140 Follow-up|Overall Study||58
77553|NCT02193776|190016|P2|Completed Day 140 Follow-up|Overall Study||52
77554|NCT02193776|190017|P1|Completed Day 140 Follow-up|Overall Study||52
77555|NCT02193776|190014|P4|Completed Day 70 Follow-up|Overall Study||60
77556|NCT02193776|190015|P3|Completed Day 70 Follow-up|Overall Study||60
77557|NCT02193776|190016|P2|Completed Day 70 Follow-up|Overall Study||56
77558|NCT02193776|190017|P1|Completed Day 70 Follow-up|Overall Study||54
77559|NCT02193776|190014|P4|STARTED|Overall Study||60
77560|NCT02193776|190015|P3|STARTED|Overall Study||61
77561|NCT02193776|190016|P2|STARTED|Overall Study||60
77562|NCT02193776|190017|P1|STARTED|Overall Study||59
77563|NCT02193490|190033|P2|NOT COMPLETED|Overall Study||2
77564|NCT02193490|190034|P1|NOT COMPLETED|Overall Study||4
77565|NCT02193490|190033|P2|COMPLETED|Overall Study||20
77566|NCT02193490|190034|P1|COMPLETED|Overall Study||21
77567|NCT02193490|190033|P2|STARTED|Overall Study||22
77568|NCT02193490|190034|P1|STARTED|Overall Study||25
77569|NCT02193178|190044|P1|NOT COMPLETED|Overall Study||2
77570|NCT02193178|190044|P1|COMPLETED|Overall Study||13
77571|NCT02193178|190044|P1|STARTED|Overall Study||15
77572|NCT02193165|190094|P3|NOT COMPLETED|6 Week Product Use||0
77573|NCT02193165|190095|P2|NOT COMPLETED|6 Week Product Use||1
77574|NCT02193165|190096|P1|NOT COMPLETED|6 Week Product Use||0
77575|NCT02193165|190094|P3|COMPLETED|6 Week Product Use||39
77576|NCT02193165|190095|P2|COMPLETED|6 Week Product Use|1 subject failed to keep appointment time and didn't return to clinical site.|38
77577|NCT02193165|190096|P1|COMPLETED|6 Week Product Use||39
77578|NCT02193165|190094|P3|STARTED|6 Week Product Use||39
77579|NCT02193165|190095|P2|STARTED|6 Week Product Use||39
77580|NCT02193165|190096|P1|STARTED|6 Week Product Use||39
77581|NCT02193165|190094|P3|NOT COMPLETED|4 Week Product Use||1
77582|NCT02193165|190095|P2|NOT COMPLETED|4 Week Product Use||1
77583|NCT02193165|190096|P1|NOT COMPLETED|4 Week Product Use||1
77584|NCT02193165|190094|P3|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
77585|NCT02193165|190095|P2|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
77586|NCT02193165|190096|P1|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
77587|NCT02193165|190094|P3|STARTED|4 Week Product Use||40
77588|NCT02193165|190095|P2|STARTED|4 Week Product Use||40
77589|NCT02193165|190096|P1|STARTED|4 Week Product Use||40
77590|NCT02193087|190123|P4|NOT COMPLETED|Overall Study||79
77591|NCT02193087|190124|P3|NOT COMPLETED|Overall Study||7
77592|NCT02193087|190125|P2|NOT COMPLETED|Overall Study||14
77593|NCT02193087|190126|P1|NOT COMPLETED|Overall Study||37
77594|NCT02193087|190123|P4|COMPLETED|Overall Study||524
77595|NCT02193087|190124|P3|COMPLETED|Overall Study||93
77596|NCT02193087|190125|P2|COMPLETED|Overall Study||86
77597|NCT02193087|190126|P1|COMPLETED|Overall Study||162
77598|NCT02193087|190123|P4|Received Vaccination|Overall Study||602
77599|NCT02193087|190124|P3|Received Vaccination|Overall Study||100
77600|NCT02193087|190125|P2|Received Vaccination|Overall Study||97
77601|NCT02193087|190126|P1|Received Vaccination|Overall Study||197
77602|NCT02193087|190123|P4|STARTED|Overall Study||603
77603|NCT02193087|190124|P3|STARTED|Overall Study||100
77604|NCT02193087|190125|P2|STARTED|Overall Study||100
77605|NCT02193087|190126|P1|STARTED|Overall Study||199
77606|NCT02193074|190171|P2|NOT COMPLETED|Overall Study||15
77607|NCT02193074|190172|P1|NOT COMPLETED|Overall Study||17
77608|NCT02193074|190171|P2|COMPLETED|Overall Study||65
77609|NCT02193074|190172|P1|COMPLETED|Overall Study||24
77610|NCT02193074|190171|P2|Completed Due to Early Study Termination|Overall Study||39
77611|NCT02193074|190172|P1|Completed Due to Early Study Termination|Overall Study||13
77612|NCT02193074|190171|P2|Completed During Follow-Up Period|Overall Study||26
77613|NCT02193074|190172|P1|Completed During Follow-Up Period|Overall Study||11
77614|NCT02193074|190171|P2|STARTED|Overall Study|Randomized and received double-blind treatment.|80
77615|NCT02193074|190172|P1|STARTED|Overall Study|Randomized and received double-blind treatment.|41
77616|NCT02192905|190204|P1|NOT COMPLETED|Overall Study||1
77617|NCT02192905|190204|P1|COMPLETED|Overall Study|Reporting a minimum of current weight at 16-week follow-up|42
77618|NCT02192905|190204|P1|STARTED|Overall Study||43
77619|NCT02192879|190218|P3|NOT COMPLETED|Overall Study||0
77620|NCT02192879|190219|P2|NOT COMPLETED|Overall Study||0
77621|NCT02192879|190220|P1|NOT COMPLETED|Overall Study||0
77622|NCT02192879|190218|P3|COMPLETED|Overall Study||3
77623|NCT02192879|190219|P2|COMPLETED|Overall Study||4
77624|NCT02192879|190220|P1|COMPLETED|Overall Study||3
77625|NCT02192879|190218|P3|STARTED|Overall Study||3
77626|NCT02192879|190219|P2|STARTED|Overall Study||4
77627|NCT02192879|190220|P1|STARTED|Overall Study||3
77628|NCT02192814|190246|P1|NOT COMPLETED|Overall Study||0
77629|NCT02192814|190246|P1|COMPLETED|Overall Study||9
77630|NCT02192814|190246|P1|STARTED|Overall Study||9
77631|NCT02192684|190259|P2|NOT COMPLETED|Overall Study||0
77632|NCT02192684|190260|P1|NOT COMPLETED|Overall Study||0
77633|NCT02192684|190259|P2|COMPLETED|Overall Study||15
77634|NCT02192684|190260|P1|COMPLETED|Overall Study||30
77635|NCT02192684|190259|P2|STARTED|Overall Study||15
77636|NCT02192684|190260|P1|STARTED|Overall Study||30
77637|NCT02192606|190268|P2|NOT COMPLETED|Overall Study||4
77638|NCT02192606|190269|P1|NOT COMPLETED|Overall Study||2
77639|NCT02192606|190268|P2|COMPLETED|Overall Study||24
77640|NCT02192606|190269|P1|COMPLETED|Overall Study||27
77641|NCT02192606|190268|P2|STARTED|Overall Study||28
77642|NCT02192606|190269|P1|STARTED|Overall Study||29
77643|NCT02192541|190279|P2|NOT COMPLETED|Overall Study||0
77644|NCT02192541|190280|P1|NOT COMPLETED|Overall Study||0
77645|NCT02192541|190279|P2|COMPLETED|Overall Study||3
77646|NCT02192541|190280|P1|COMPLETED|Overall Study||2
77647|NCT02192541|190279|P2|Evaluable for Response|Overall Study||3
77648|NCT02192541|190280|P1|Evaluable for Response|Overall Study||1
77649|NCT02192541|190279|P2|Treated|Overall Study||3
77650|NCT02192541|190280|P1|Treated|Overall Study||2
77651|NCT02192541|190279|P2|STARTED|Overall Study||3
77652|NCT02192541|190280|P1|STARTED|Overall Study||2
77653|NCT02192307|190302|P2|NOT COMPLETED|Overall Study||0
77654|NCT02192307|190303|P1|NOT COMPLETED|Overall Study||0
77655|NCT02192307|190302|P2|COMPLETED|Overall Study||30
77656|NCT02192307|190303|P1|COMPLETED|Overall Study||30
77657|NCT02192307|190302|P2|STARTED|Overall Study||30
77658|NCT02192307|190303|P1|STARTED|Overall Study||30
77659|NCT02192190|190317|P6|NOT COMPLETED|Overall Study||29
77660|NCT02192190|190318|P5|NOT COMPLETED|Overall Study||30
77661|NCT02192190|190319|P4|NOT COMPLETED|Overall Study||26
77662|NCT02192190|190320|P3|NOT COMPLETED|Overall Study||25
77663|NCT02192190|190321|P2|NOT COMPLETED|Overall Study||29
77664|NCT02192190|190322|P1|NOT COMPLETED|Overall Study||54
77665|NCT02192190|190317|P6|COMPLETED|Overall Study||9
77666|NCT02192190|190318|P5|COMPLETED|Overall Study||9
77667|NCT02192190|190319|P4|COMPLETED|Overall Study||12
77668|NCT02192190|190320|P3|COMPLETED|Overall Study||13
77669|NCT02192190|190321|P2|COMPLETED|Overall Study||10
77670|NCT02192190|190322|P1|COMPLETED|Overall Study||22
77671|NCT02192190|190317|P6|Received at Least 1 Dose of Study Drug|Overall Study||37
77672|NCT02192190|190318|P5|Received at Least 1 Dose of Study Drug|Overall Study||38
77673|NCT02192190|190319|P4|Received at Least 1 Dose of Study Drug|Overall Study||38
77674|NCT02192190|190320|P3|Received at Least 1 Dose of Study Drug|Overall Study||38
77675|NCT02192190|190321|P2|Received at Least 1 Dose of Study Drug|Overall Study||39
77676|NCT02192190|190322|P1|Received at Least 1 Dose of Study Drug|Overall Study||76
77677|NCT02192190|190317|P6|STARTED|Overall Study||38
77678|NCT02192190|190318|P5|STARTED|Overall Study||39
77679|NCT02192190|190319|P4|STARTED|Overall Study||38
77680|NCT02192190|190320|P3|STARTED|Overall Study||38
77681|NCT02192190|190321|P2|STARTED|Overall Study||39
77682|NCT02192190|190322|P1|STARTED|Overall Study||76
77683|NCT02192164|190366|P1|NOT COMPLETED|Overall Study||14
77684|NCT02192164|190366|P1|COMPLETED|Overall Study||112
77685|NCT02192164|190366|P1|Etanercept Treated Population|Overall Study||112
77686|NCT02192164|190366|P1|STARTED|Overall Study||126
77687|NCT02192099|190382|P1|NOT COMPLETED|Overall Study||61
77688|NCT02192099|190382|P1|COMPLETED|Overall Study||0
77689|NCT02192099|190382|P1|STARTED|Overall Study||61
77690|NCT02191865|190389|P3|NOT COMPLETED|Overall Study||0
77691|NCT02191865|190390|P2|NOT COMPLETED|Overall Study||0
77692|NCT02191865|190391|P1|NOT COMPLETED|Overall Study||0
77693|NCT02191865|190389|P3|COMPLETED|Overall Study||17
77694|NCT02191865|190390|P2|COMPLETED|Overall Study||8
77695|NCT02191865|190391|P1|COMPLETED|Overall Study||8
77696|NCT02191865|190389|P3|STARTED|Overall Study||17
77697|NCT02191865|190390|P2|STARTED|Overall Study||8
77698|NCT02191865|190391|P1|STARTED|Overall Study||8
77699|NCT02191605|190416|P5|NOT COMPLETED|Overall Study||4
77700|NCT02191605|190417|P4|NOT COMPLETED|Overall Study||3
77701|NCT02191605|190418|P3|NOT COMPLETED|Overall Study||7
77702|NCT02191605|190419|P2|NOT COMPLETED|Overall Study||4
77703|NCT02191605|190420|P1|NOT COMPLETED|Overall Study||9
77704|NCT02191605|190416|P5|COMPLETED|Overall Study||3
77705|NCT02191605|190417|P4|COMPLETED|Overall Study||5
77706|NCT02191605|190418|P3|COMPLETED|Overall Study||8
77707|NCT02191605|190419|P2|COMPLETED|Overall Study||11
77708|NCT02191605|190420|P1|COMPLETED|Overall Study||6
77709|NCT02191605|190416|P5|Completed Intervention Portion|Overall Study||7
77710|NCT02191605|190417|P4|Completed Intervention Portion|Overall Study||8
77711|NCT02191605|190418|P3|Completed Intervention Portion|Overall Study||15
77712|NCT02191605|190419|P2|Completed Intervention Portion|Overall Study||15
77713|NCT02191605|190420|P1|Completed Intervention Portion|Overall Study||15
77714|NCT02191605|190416|P5|STARTED|Overall Study||7
77715|NCT02191605|190417|P4|STARTED|Overall Study||8
77716|NCT02191605|190418|P3|STARTED|Overall Study||15
77717|NCT02191605|190419|P2|STARTED|Overall Study||15
77718|NCT02191605|190420|P1|STARTED|Overall Study||15
77719|NCT02191579|190439|P2|NOT COMPLETED|Treatment 2||25
77720|NCT02191579|190440|P1|NOT COMPLETED|Treatment 2||0
77721|NCT02191579|190439|P2|COMPLETED|Treatment 2||55
77722|NCT02191579|190440|P1|COMPLETED|Treatment 2||0
77723|NCT02191579|190439|P2|STARTED|Treatment 2||80
77724|NCT02191579|190440|P1|STARTED|Treatment 2||0
77725|NCT02191579|190439|P2|NOT COMPLETED|Treatment 1||58
77726|NCT02191579|190440|P1|NOT COMPLETED|Treatment 1||27
77727|NCT02191579|190439|P2|COMPLETED|Treatment 1||84
77728|NCT02191579|190440|P1|COMPLETED|Treatment 1||113
77729|NCT02191579|190439|P2|STARTED|Treatment 1||142
77730|NCT02191579|190440|P1|STARTED|Treatment 1||140
77731|NCT02191397|190454|P2|NOT COMPLETED|Overall Study||70
77732|NCT02191397|190455|P1|NOT COMPLETED|Overall Study||83
77733|NCT02191397|190454|P2|COMPLETED|Overall Study||198
77734|NCT02191397|190455|P1|COMPLETED|Overall Study||183
77735|NCT02191397|190454|P2|STARTED|Overall Study||268
77736|NCT02191397|190455|P1|STARTED|Overall Study||266
77737|NCT02191267|190516|P3|NOT COMPLETED|Overall Study||0
77738|NCT02191267|190517|P2|NOT COMPLETED|Overall Study||0
77739|NCT02191267|190518|P1|NOT COMPLETED|Overall Study||1
77740|NCT02191267|190516|P3|COMPLETED|Overall Study||4
77741|NCT02191267|190517|P2|COMPLETED|Overall Study||6
77742|NCT02191267|190518|P1|COMPLETED|Overall Study||19
77743|NCT02191267|190516|P3|STARTED|Overall Study||4
77744|NCT02191267|190517|P2|STARTED|Overall Study||6
77745|NCT02191267|190518|P1|STARTED|Overall Study||20
77746|NCT02191137|190529|P1|NOT COMPLETED|Follow-up||5
77747|NCT02191137|190529|P1|COMPLETED|Follow-up||60
77748|NCT02191137|190529|P1|STARTED|Follow-up||65
77749|NCT02191137|190529|P1|NOT COMPLETED|Treatment||10
77750|NCT02191137|190529|P1|COMPLETED|Treatment||65
77751|NCT02191137|190529|P1|STARTED|Treatment||75
77752|NCT02191046|190559|P2|NOT COMPLETED|Overall Study||1
77753|NCT02191046|190560|P1|NOT COMPLETED|Overall Study||5
77754|NCT02191046|190559|P2|COMPLETED|Overall Study|exclude 1 patient because low compliance|38
77755|NCT02191046|190560|P1|COMPLETED|Overall Study|exclude 5 patients because low compliance|36
77756|NCT02191046|190559|P2|STARTED|Overall Study||39
77757|NCT02191046|190560|P1|STARTED|Overall Study||41
77758|NCT02191033|190568|P2|NOT COMPLETED|Overall Study||1
77759|NCT02191033|190569|P1|NOT COMPLETED|Overall Study||2
77760|NCT02191033|190568|P2|COMPLETED|Overall Study||19
77761|NCT02191033|190569|P1|COMPLETED|Overall Study||18
77762|NCT02191033|190568|P2|STARTED|Overall Study||20
77763|NCT02191033|190569|P1|STARTED|Overall Study||20
77764|NCT02190903|190581|P2|NOT COMPLETED|Overall Study||0
77765|NCT02190903|190582|P1|NOT COMPLETED|Overall Study||0
77766|NCT02190903|190581|P2|COMPLETED|Overall Study||6
77767|NCT02190903|190582|P1|COMPLETED|Overall Study||6
77768|NCT02190903|190581|P2|STARTED|Overall Study||6
77769|NCT02190903|190582|P1|STARTED|Overall Study||6
77770|NCT02190721|190591|P3|NOT COMPLETED|Overall Study||0
77771|NCT02190721|190592|P2|NOT COMPLETED|Overall Study||1
77772|NCT02190721|190593|P1|NOT COMPLETED|Overall Study||0
77773|NCT02190721|190591|P3|COMPLETED|Overall Study||18
77774|NCT02190721|190592|P2|COMPLETED|Overall Study||29
77775|NCT02190721|190593|P1|COMPLETED|Overall Study||2
77776|NCT02190721|190591|P3|Completed 90 Day Follow-up|Overall Study||18
77777|NCT02190721|190592|P2|Completed 90 Day Follow-up|Overall Study||29
77778|NCT02190721|190593|P1|Completed 90 Day Follow-up|Overall Study||2
77779|NCT02190721|190591|P3|Completed 30 Day Follow-up|Overall Study||18
77780|NCT02190721|190592|P2|Completed 30 Day Follow-up|Overall Study||29
77781|NCT02190721|190593|P1|Completed 30 Day Follow-up|Overall Study||2
77782|NCT02190721|190591|P3|Completed Treatment|Overall Study||18
77783|NCT02190721|190592|P2|Completed Treatment|Overall Study||30
77784|NCT02190721|190593|P1|Completed Treatment|Overall Study||2
77785|NCT02190721|190591|P3|STARTED|Overall Study||18
77786|NCT02190721|190592|P2|STARTED|Overall Study||30
77787|NCT02190721|190593|P1|STARTED|Overall Study||2
77788|NCT02190604|190716|P19|NOT COMPLETED|Part 3 (Patients)||0
77789|NCT02190604|190717|P18|NOT COMPLETED|Part 3 (Patients)||0
77790|NCT02190604|190718|P17|NOT COMPLETED|Part 3 (Patients)||0
77791|NCT02190604|190719|P16|NOT COMPLETED|Part 3 (Patients)||0
77792|NCT02190604|190720|P15|NOT COMPLETED|Part 3 (Patients)||0
77793|NCT02190604|190721|P14|NOT COMPLETED|Part 3 (Patients)||0
77794|NCT02190604|190722|P13|NOT COMPLETED|Part 3 (Patients)||0
77795|NCT02190604|190723|P12|NOT COMPLETED|Part 3 (Patients)||0
77796|NCT02190604|190724|P11|NOT COMPLETED|Part 3 (Patients)||0
77797|NCT02190604|190725|P10|NOT COMPLETED|Part 3 (Patients)||0
77798|NCT02190604|190726|P9|NOT COMPLETED|Part 3 (Patients)||0
77799|NCT02190604|190727|P8|NOT COMPLETED|Part 3 (Patients)||0
77800|NCT02190604|190728|P7|NOT COMPLETED|Part 3 (Patients)||0
77801|NCT02190604|190729|P6|NOT COMPLETED|Part 3 (Patients)||0
77802|NCT02190604|190730|P5|NOT COMPLETED|Part 3 (Patients)||0
77803|NCT02190604|190731|P4|NOT COMPLETED|Part 3 (Patients)||0
77804|NCT02190604|190732|P3|NOT COMPLETED|Part 3 (Patients)||0
77805|NCT02190604|190733|P2|NOT COMPLETED|Part 3 (Patients)||0
77806|NCT02190604|190734|P1|NOT COMPLETED|Part 3 (Patients)||0
77807|NCT02190604|190716|P19|COMPLETED|Part 3 (Patients)||12
77808|NCT02190604|190717|P18|COMPLETED|Part 3 (Patients)||19
77809|NCT02190604|190718|P17|COMPLETED|Part 3 (Patients)||12
77810|NCT02190604|190719|P16|COMPLETED|Part 3 (Patients)||6
77811|NCT02190604|190720|P15|COMPLETED|Part 3 (Patients)||0
77812|NCT02190604|190721|P14|COMPLETED|Part 3 (Patients)||0
77813|NCT02190604|190722|P13|COMPLETED|Part 3 (Patients)||0
77814|NCT02190604|190723|P12|COMPLETED|Part 3 (Patients)||0
77815|NCT02190604|190724|P11|COMPLETED|Part 3 (Patients)||0
77816|NCT02190604|190725|P10|COMPLETED|Part 3 (Patients)||0
77817|NCT02190604|190726|P9|COMPLETED|Part 3 (Patients)||0
77818|NCT02190604|190727|P8|COMPLETED|Part 3 (Patients)||0
77819|NCT02190604|190728|P7|COMPLETED|Part 3 (Patients)||0
77820|NCT02190604|190729|P6|COMPLETED|Part 3 (Patients)||0
77821|NCT02190604|190730|P5|COMPLETED|Part 3 (Patients)||0
77822|NCT02190604|190731|P4|COMPLETED|Part 3 (Patients)||0
77823|NCT02190604|190732|P3|COMPLETED|Part 3 (Patients)||0
77824|NCT02190604|190733|P2|COMPLETED|Part 3 (Patients)||0
77825|NCT02190604|190734|P1|COMPLETED|Part 3 (Patients)||0
77826|NCT02190604|190716|P19|STARTED|Part 3 (Patients)||12
77827|NCT02190604|190717|P18|STARTED|Part 3 (Patients)||19
77828|NCT02190604|190718|P17|STARTED|Part 3 (Patients)||12
77829|NCT02190604|190719|P16|STARTED|Part 3 (Patients)||6
77830|NCT02190604|190720|P15|STARTED|Part 3 (Patients)||0
77831|NCT02190604|190721|P14|STARTED|Part 3 (Patients)||0
77832|NCT02190604|190722|P13|STARTED|Part 3 (Patients)||0
77833|NCT02190604|190723|P12|STARTED|Part 3 (Patients)||0
77834|NCT02190604|190724|P11|STARTED|Part 3 (Patients)||0
77835|NCT02190604|190725|P10|STARTED|Part 3 (Patients)||0
77836|NCT02190604|190726|P9|STARTED|Part 3 (Patients)||0
77837|NCT02190604|190727|P8|STARTED|Part 3 (Patients)||0
77838|NCT02190604|190728|P7|STARTED|Part 3 (Patients)||0
77839|NCT02190604|190729|P6|STARTED|Part 3 (Patients)||0
77840|NCT02190604|190730|P5|STARTED|Part 3 (Patients)||0
77841|NCT02190604|190731|P4|STARTED|Part 3 (Patients)||0
77842|NCT02190604|190732|P3|STARTED|Part 3 (Patients)||0
77843|NCT02190604|190733|P2|STARTED|Part 3 (Patients)||0
77844|NCT02190604|190734|P1|STARTED|Part 3 (Patients)||0
77845|NCT02190604|190716|P19|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
77846|NCT02190604|190717|P18|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
77847|NCT02190604|190718|P17|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
77848|NCT02190604|190719|P16|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
77849|NCT02190604|190720|P15|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||2
77850|NCT02190604|190721|P14|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||1
77851|NCT02190604|190722|P13|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
77852|NCT02190604|190723|P12|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
77853|NCT02190604|190724|P11|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
77854|NCT02190604|190725|P10|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
77855|NCT02190604|190726|P9|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
77856|NCT02190604|190727|P8|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
77857|NCT02190604|190728|P7|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
77858|NCT02190604|190729|P6|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
77859|NCT02190604|190730|P5|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
77860|NCT02190604|190731|P4|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
77861|NCT02190604|190732|P3|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
77862|NCT02190604|190733|P2|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
77863|NCT02190604|190734|P1|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
77864|NCT02190604|190716|P19|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
77865|NCT02190604|190717|P18|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
77866|NCT02190604|190718|P17|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
77867|NCT02190604|190719|P16|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
77868|NCT02190604|190720|P15|COMPLETED|Part 1 and 2 (Healthy Volunteers)||8
77869|NCT02190604|190721|P14|COMPLETED|Part 1 and 2 (Healthy Volunteers)||5
77870|NCT02190604|190722|P13|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
77871|NCT02190604|190723|P12|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
77872|NCT02190604|190724|P11|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
77873|NCT02190604|190725|P10|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
77874|NCT02190604|190726|P9|COMPLETED|Part 1 and 2 (Healthy Volunteers)||16
77875|NCT02190604|190727|P8|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
77876|NCT02190604|190728|P7|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
77877|NCT02190604|190729|P6|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
77878|NCT02190604|190730|P5|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
77879|NCT02190604|190731|P4|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
77880|NCT02190604|190732|P3|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
77881|NCT02190604|190733|P2|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
77882|NCT02190604|190734|P1|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
77883|NCT02190604|190716|P19|STARTED|Part 1 and 2 (Healthy Volunteers)||0
77884|NCT02190604|190717|P18|STARTED|Part 1 and 2 (Healthy Volunteers)||0
77885|NCT02190604|190718|P17|STARTED|Part 1 and 2 (Healthy Volunteers)||0
77886|NCT02190604|190719|P16|STARTED|Part 1 and 2 (Healthy Volunteers)||0
77887|NCT02190604|190720|P15|STARTED|Part 1 and 2 (Healthy Volunteers)||10
77888|NCT02190604|190721|P14|STARTED|Part 1 and 2 (Healthy Volunteers)||6
77889|NCT02190604|190722|P13|STARTED|Part 1 and 2 (Healthy Volunteers)||6
77890|NCT02190604|190723|P12|STARTED|Part 1 and 2 (Healthy Volunteers)||6
77891|NCT02190604|190724|P11|STARTED|Part 1 and 2 (Healthy Volunteers)||6
77892|NCT02190604|190725|P10|STARTED|Part 1 and 2 (Healthy Volunteers)||6
77893|NCT02190604|190726|P9|STARTED|Part 1 and 2 (Healthy Volunteers)||16
77894|NCT02190604|190727|P8|STARTED|Part 1 and 2 (Healthy Volunteers)||6
77895|NCT02190604|190728|P7|STARTED|Part 1 and 2 (Healthy Volunteers)||6
77896|NCT02190604|190729|P6|STARTED|Part 1 and 2 (Healthy Volunteers)||6
77897|NCT02190604|190730|P5|STARTED|Part 1 and 2 (Healthy Volunteers)||6
77898|NCT02190604|190731|P4|STARTED|Part 1 and 2 (Healthy Volunteers)||6
77899|NCT02190604|190732|P3|STARTED|Part 1 and 2 (Healthy Volunteers)||6
77900|NCT02190604|190733|P2|STARTED|Part 1 and 2 (Healthy Volunteers)||6
77901|NCT02190604|190734|P1|STARTED|Part 1 and 2 (Healthy Volunteers)||6
77902|NCT02190591|190925|P2|NOT COMPLETED|Overall Study||11
77903|NCT02190591|190926|P1|NOT COMPLETED|Overall Study||2
77904|NCT02190591|190925|P2|COMPLETED|Overall Study||91
77905|NCT02190591|190926|P1|COMPLETED|Overall Study||100
77906|NCT02190591|190925|P2|STARTED|Overall Study||102
77907|NCT02190591|190926|P1|STARTED|Overall Study||102
77908|NCT02190552|190936|P1|NOT COMPLETED|Overall Study||4
77909|NCT02190552|190936|P1|COMPLETED|Overall Study||36
77910|NCT02190552|190936|P1|STARTED|Overall Study||40
77911|NCT02190435|190949|P2|NOT COMPLETED|Overall Study||0
77912|NCT02190435|190950|P1|NOT COMPLETED|Overall Study||15
77913|NCT02190435|190949|P2|COMPLETED|Overall Study||24
77914|NCT02190435|190950|P1|COMPLETED|Overall Study||26
77915|NCT02190435|190949|P2|STARTED|Overall Study||24
77916|NCT02190435|190950|P1|STARTED|Overall Study||41
77917|NCT02190279|190961|P3|NOT COMPLETED|Overall Study||3
77918|NCT02190279|190962|P2|NOT COMPLETED|Overall Study||0
77919|NCT02190279|190963|P1|NOT COMPLETED|Overall Study||3
77920|NCT02190279|190961|P3|COMPLETED|Overall Study||28
77921|NCT02190279|190962|P2|COMPLETED|Overall Study||69
77922|NCT02190279|190963|P1|COMPLETED|Overall Study||13
77923|NCT02190279|190961|P3|STARTED|Overall Study||31
77924|NCT02190279|190962|P2|STARTED|Overall Study||69
77925|NCT02190279|190963|P1|STARTED|Overall Study||16
77926|NCT02190045|190984|P2|NOT COMPLETED|Overall Study||0
77927|NCT02190045|190985|P1|NOT COMPLETED|Overall Study||3
77928|NCT02190045|190984|P2|COMPLETED|Overall Study||15
77929|NCT02190045|190985|P1|COMPLETED|Overall Study||12
77930|NCT02190045|190984|P2|STARTED|Overall Study||15
77931|NCT02190045|190985|P1|STARTED|Overall Study||15
77932|NCT02189954|190993|P2|NOT COMPLETED|Overall Study||0
77933|NCT02189954|190994|P1|NOT COMPLETED|Overall Study||0
77934|NCT02189954|190993|P2|COMPLETED|Overall Study||45
77935|NCT02189954|190994|P1|COMPLETED|Overall Study||45
77936|NCT02189954|190993|P2|STARTED|Overall Study||45
77937|NCT02189954|190994|P1|STARTED|Overall Study||45
77938|NCT02189941|191002|P3|NOT COMPLETED|Overall Study||1
77939|NCT02189941|191003|P2|NOT COMPLETED|Overall Study||0
77940|NCT02189941|191004|P1|NOT COMPLETED|Overall Study||0
77941|NCT02189941|191002|P3|COMPLETED|Overall Study||2
77942|NCT02189941|191003|P2|COMPLETED|Overall Study||4
77943|NCT02189941|191004|P1|COMPLETED|Overall Study||4
77944|NCT02189941|191002|P3|STARTED|Overall Study||3
77945|NCT02189941|191003|P2|STARTED|Overall Study||4
77946|NCT02189941|191004|P1|STARTED|Overall Study||4
77947|NCT02189915|191027|P1|NOT COMPLETED|Overall Study||3
77948|NCT02189915|191027|P1|COMPLETED|Overall Study||11
77949|NCT02189915|191027|P1|STARTED|Overall Study||14
77950|NCT02189863|191032|P2|NOT COMPLETED|Second 2 Weeks||0
77951|NCT02189863|191033|P1|NOT COMPLETED|Second 2 Weeks||0
77952|NCT02189863|191032|P2|COMPLETED|Second 2 Weeks||13
77953|NCT02189863|191033|P1|COMPLETED|Second 2 Weeks||8
77954|NCT02189863|191032|P2|STARTED|Second 2 Weeks||13
77955|NCT02189863|191033|P1|STARTED|Second 2 Weeks||8
77956|NCT02189863|191032|P2|NOT COMPLETED|First 2 Weeks||2
77957|NCT02189863|191033|P1|NOT COMPLETED|First 2 Weeks||4
77958|NCT02189863|191032|P2|COMPLETED|First 2 Weeks||13
77959|NCT02189863|191033|P1|COMPLETED|First 2 Weeks||8
77960|NCT02189863|191032|P2|STARTED|First 2 Weeks||15
77961|NCT02189863|191033|P1|STARTED|First 2 Weeks||12
77962|NCT02189837|191048|P4|NOT COMPLETED|Overall Study||2
77963|NCT02189837|191049|P3|NOT COMPLETED|Overall Study||3
77964|NCT02189837|191050|P2|NOT COMPLETED|Overall Study||1
77965|NCT02189837|191051|P1|NOT COMPLETED|Overall Study||2
77966|NCT02189837|191048|P4|COMPLETED|Overall Study||19
77967|NCT02189837|191049|P3|COMPLETED|Overall Study||20
77968|NCT02189837|191050|P2|COMPLETED|Overall Study||22
77969|NCT02189837|191051|P1|COMPLETED|Overall Study||20
77970|NCT02189837|191048|P4|Received Treatment|Overall Study||20
77971|NCT02189837|191049|P3|Received Treatment|Overall Study||22
77972|NCT02189837|191050|P2|Received Treatment|Overall Study||22
77973|NCT02189837|191051|P1|Received Treatment|Overall Study||21
77974|NCT02189837|191048|P4|STARTED|Overall Study||21
77975|NCT02189837|191049|P3|STARTED|Overall Study||23
77976|NCT02189837|191050|P2|STARTED|Overall Study||23
77977|NCT02189837|191051|P1|STARTED|Overall Study||22
77978|NCT02189759|191081|P4|NOT COMPLETED|Overall Study||5
77979|NCT02189759|191082|P3|NOT COMPLETED|Overall Study||2
77980|NCT02189759|191083|P2|NOT COMPLETED|Overall Study||0
77981|NCT02189759|191084|P1|NOT COMPLETED|Overall Study||0
77982|NCT02189759|191081|P4|COMPLETED|Overall Study||84
77983|NCT02189759|191082|P3|COMPLETED|Overall Study||81
77984|NCT02189759|191083|P2|COMPLETED|Overall Study||101
77985|NCT02189759|191084|P1|COMPLETED|Overall Study||102
77986|NCT02189759|191081|P4|STARTED|Overall Study||89
77987|NCT02189759|191082|P3|STARTED|Overall Study||83
77988|NCT02189759|191083|P2|STARTED|Overall Study||101
77989|NCT02189759|191084|P1|STARTED|Overall Study||102
77990|NCT02189668|191104|P2|NOT COMPLETED|Overall Study||0
77991|NCT02189668|191105|P1|NOT COMPLETED|Overall Study||0
77992|NCT02189668|191104|P2|COMPLETED|Overall Study||9
77993|NCT02189668|191105|P1|COMPLETED|Overall Study||5
77994|NCT02189668|191104|P2|STARTED|Overall Study||9
77995|NCT02189668|191105|P1|STARTED|Overall Study||5
77996|NCT02189629|191113|P1|NOT COMPLETED|Overall Study||105
77997|NCT02189629|191113|P1|COMPLETED|Overall Study||348
77998|NCT02189629|191113|P1|STARTED|Overall Study||453
77999|NCT02189382|191120|P2|NOT COMPLETED|Overall Study||0
78000|NCT02189382|191121|P1|NOT COMPLETED|Overall Study||0
78001|NCT02189382|191120|P2|COMPLETED|Overall Study||35
78002|NCT02189382|191121|P1|COMPLETED|Overall Study||35
78003|NCT02189382|191120|P2|STARTED|Overall Study||35
78004|NCT02189382|191121|P1|STARTED|Overall Study||35
78005|NCT02189317|191131|P2|NOT COMPLETED|Overall Study||0
78006|NCT02189317|191132|P1|NOT COMPLETED|Overall Study||0
78007|NCT02189317|191131|P2|COMPLETED|Overall Study||16
78008|NCT02189317|191132|P1|COMPLETED|Overall Study||16
78009|NCT02189317|191131|P2|STARTED|Overall Study||16
78010|NCT02189317|191132|P1|STARTED|Overall Study||16
78011|NCT02189252|191146|P4|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
78012|NCT02189252|191147|P3|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
78013|NCT02189252|191148|P2|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
78014|NCT02189252|191149|P1|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
78015|NCT02189252|191146|P4|COMPLETED|Period 2 (Visit6b, Week 12)||4
78016|NCT02189252|191147|P3|COMPLETED|Period 2 (Visit6b, Week 12)||3
78017|NCT02189252|191148|P2|COMPLETED|Period 2 (Visit6b, Week 12)||2
78018|NCT02189252|191149|P1|COMPLETED|Period 2 (Visit6b, Week 12)||4
78019|NCT02189252|191146|P4|STARTED|Period 2 (Visit6b, Week 12)||4
78020|NCT02189252|191147|P3|STARTED|Period 2 (Visit6b, Week 12)||3
78021|NCT02189252|191148|P2|STARTED|Period 2 (Visit6b, Week 12)||2
78022|NCT02189252|191149|P1|STARTED|Period 2 (Visit6b, Week 12)||4
78023|NCT02189252|191146|P4|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
78024|NCT02189252|191147|P3|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
78025|NCT02189252|191148|P2|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||2
78026|NCT02189252|191149|P1|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
78027|NCT02189252|191146|P4|COMPLETED|Period 1 (Visit 4b, Week 4)||4
78028|NCT02189252|191147|P3|COMPLETED|Period 1 (Visit 4b, Week 4)||3
78029|NCT02189252|191148|P2|COMPLETED|Period 1 (Visit 4b, Week 4)||2
78030|NCT02189252|191149|P1|COMPLETED|Period 1 (Visit 4b, Week 4)||4
78031|NCT02189252|191146|P4|STARTED|Period 1 (Visit 4b, Week 4)||4
78032|NCT02189252|191147|P3|STARTED|Period 1 (Visit 4b, Week 4)||3
78033|NCT02189252|191148|P2|STARTED|Period 1 (Visit 4b, Week 4)||4
78034|NCT02189252|191149|P1|STARTED|Period 1 (Visit 4b, Week 4)||4
78035|NCT02189161|191181|P1|NOT COMPLETED|Overall Study||0
78036|NCT02189161|191181|P1|COMPLETED|Overall Study||10
78037|NCT02189161|191181|P1|STARTED|Overall Study||10
78038|NCT02189122|191189|P2|NOT COMPLETED|Overall Study||0
78039|NCT02189122|191190|P1|NOT COMPLETED|Overall Study||0
78040|NCT02189122|191189|P2|COMPLETED|Overall Study||18
78041|NCT02189122|191190|P1|COMPLETED|Overall Study||18
78042|NCT02189122|191189|P2|STARTED|Overall Study||18
78043|NCT02189122|191190|P1|STARTED|Overall Study||18
78044|NCT02188849|191208|P2|NOT COMPLETED|Overall Study||8
78045|NCT02188849|191209|P1|NOT COMPLETED|Overall Study||3
78046|NCT02188849|191208|P2|COMPLETED|Overall Study||17
78047|NCT02188849|191209|P1|COMPLETED|Overall Study||22
78048|NCT02188849|191208|P2|STARTED|Overall Study||25
78049|NCT02188849|191209|P1|STARTED|Overall Study||25
78050|NCT02188784|191223|P2|NOT COMPLETED|Overall Study||13
78051|NCT02188784|191224|P1|NOT COMPLETED|Overall Study||9
78052|NCT02188784|191223|P2|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|101
78053|NCT02188784|191224|P1|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|102
78054|NCT02188784|191223|P2|STARTED|Overall Study||114
78055|NCT02188784|191224|P1|STARTED|Overall Study||111
78056|NCT02188589|191240|P1|NOT COMPLETED|Overall Study||5
78057|NCT02188589|191240|P1|COMPLETED|Overall Study||25
78058|NCT02188589|191240|P1|24 Months|Overall Study||25
78059|NCT02188589|191240|P1|12 Months|Overall Study||30
78060|NCT02188589|191240|P1|6 Months|Overall Study||30
78061|NCT02188589|191240|P1|STARTED|Overall Study||30
78062|NCT02187887|191248|P2|NOT COMPLETED|Overall Study||4
78063|NCT02187887|191249|P1|NOT COMPLETED|Overall Study||5
78064|NCT02187887|191248|P2|COMPLETED|Overall Study||396
78065|NCT02187887|191249|P1|COMPLETED|Overall Study||388
78066|NCT02187887|191248|P2|STARTED|Overall Study||400
78067|NCT02187887|191249|P1|STARTED|Overall Study||393
78068|NCT02187861|191261|P4|NOT COMPLETED|Overall Study||32
78069|NCT02187861|191262|P3|NOT COMPLETED|Overall Study||32
78070|NCT02187861|191263|P2|NOT COMPLETED|Overall Study||48
78071|NCT02187861|191264|P1|NOT COMPLETED|Overall Study||6
78072|NCT02187861|191261|P4|COMPLETED|Overall Study||19
78073|NCT02187861|191262|P3|COMPLETED|Overall Study||19
78074|NCT02187861|191263|P2|COMPLETED|Overall Study||4
78075|NCT02187861|191264|P1|COMPLETED|Overall Study||3
78076|NCT02187861|191261|P4|Treated|Overall Study||50
78077|NCT02187861|191262|P3|Treated|Overall Study||49
78078|NCT02187861|191263|P2|Treated|Overall Study||52
78079|NCT02187861|191264|P1|Treated|Overall Study||9
78080|NCT02187861|191261|P4|STARTED|Overall Study||51
78081|NCT02187861|191262|P3|STARTED|Overall Study||51
78082|NCT02187861|191263|P2|STARTED|Overall Study||52
78083|NCT02187861|191264|P1|STARTED|Overall Study||9
78084|NCT02187809|191360|P1|NOT COMPLETED|Overall Study||3
78085|NCT02187809|191360|P1|COMPLETED|Overall Study||0
78086|NCT02187809|191360|P1|Treated|Overall Study||1
78087|NCT02187809|191360|P1|STARTED|Overall Study||3
78088|NCT02187783|191370|P1|NOT COMPLETED|Overall Study||106
78089|NCT02187783|191370|P1|COMPLETED|Overall Study||0
78090|NCT02187783|191370|P1|Patients With Solid Tumors|Overall Study||105
78091|NCT02187783|191370|P1|STARTED|Overall Study||106
78092|NCT02187744|191381|P2|NOT COMPLETED|Treatment||5
78093|NCT02187744|191382|P1|NOT COMPLETED|Treatment||4
78094|NCT02187744|191381|P2|COMPLETED|Treatment||107
78095|NCT02187744|191382|P1|COMPLETED|Treatment||109
78096|NCT02187744|191381|P2|STARTED|Treatment||112
78097|NCT02187744|191382|P1|STARTED|Treatment||113
78098|NCT02187744|191381|P2|NOT COMPLETED|Study||6
78099|NCT02187744|191382|P1|NOT COMPLETED|Study||4
78100|NCT02187744|191381|P2|COMPLETED|Study||106
78101|NCT02187744|191382|P1|COMPLETED|Study||109
78102|NCT02187744|191381|P2|STARTED|Study|Received treatment|112
78103|NCT02187744|191382|P1|STARTED|Study|Received treatment|113
78104|NCT02187172|191400|P2|NOT COMPLETED|Overall Study||6
78105|NCT02187172|191401|P1|NOT COMPLETED|Overall Study||3
78106|NCT02187172|191400|P2|COMPLETED|Overall Study||15
78107|NCT02187172|191401|P1|COMPLETED|Overall Study||19
78108|NCT02187172|191400|P2|RCT Phase Completed|Overall Study||19
78109|NCT02187172|191401|P1|RCT Phase Completed|Overall Study||22
78110|NCT02187172|191400|P2|STARTED|Overall Study||21
78111|NCT02187172|191401|P1|STARTED|Overall Study||22
78112|NCT02187055|191568|P3|NOT COMPLETED|Overall Study||74
78113|NCT02187055|191569|P2|NOT COMPLETED|Overall Study||73
78114|NCT02187055|191570|P1|NOT COMPLETED|Overall Study||69
78115|NCT02187055|191568|P3|COMPLETED|Overall Study||312
78116|NCT02187055|191569|P2|COMPLETED|Overall Study||303
78117|NCT02187055|191570|P1|COMPLETED|Overall Study||315
78118|NCT02187055|191568|P3|STARTED|Overall Study|Treated|386
78119|NCT02187055|191569|P2|STARTED|Overall Study|Treated|376
78120|NCT02187055|191570|P1|STARTED|Overall Study|Treated|384
78121|NCT02187042|191670|P2|NOT COMPLETED|Overall Study||14
78122|NCT02187042|191671|P1|NOT COMPLETED|Overall Study||13
78123|NCT02187042|191670|P2|COMPLETED|Overall Study||13
78124|NCT02187042|191671|P1|COMPLETED|Overall Study||29
78125|NCT02187042|191670|P2|STARTED|Overall Study||27
78126|NCT02187042|191671|P1|STARTED|Overall Study||42
78127|NCT02187029|191717|P4|NOT COMPLETED|Overall Study||3
78128|NCT02187029|191718|P3|NOT COMPLETED|Overall Study||11
78129|NCT02187029|191719|P2|NOT COMPLETED|Overall Study||1
78130|NCT02187029|191720|P1|NOT COMPLETED|Overall Study||1
78131|NCT02187029|191717|P4|COMPLETED|Overall Study||6
78132|NCT02187029|191718|P3|COMPLETED|Overall Study||0
78133|NCT02187029|191719|P2|COMPLETED|Overall Study||2
78134|NCT02187029|191720|P1|COMPLETED|Overall Study||6
78135|NCT02187029|191717|P4|STARTED|Overall Study||9
78136|NCT02187029|191718|P3|STARTED|Overall Study||11
78137|NCT02187029|191719|P2|STARTED|Overall Study||3
78138|NCT02187029|191720|P1|STARTED|Overall Study||7
78139|NCT02187016|191796|P4|NOT COMPLETED|Overall Study||0
78140|NCT02187016|191797|P3|NOT COMPLETED|Overall Study||1
78141|NCT02187016|191798|P2|NOT COMPLETED|Overall Study||2
78142|NCT02187016|191799|P1|NOT COMPLETED|Overall Study||1
78143|NCT02187016|191796|P4|COMPLETED|Overall Study||51
78144|NCT02187016|191797|P3|COMPLETED|Overall Study||78
78145|NCT02187016|191798|P2|COMPLETED|Overall Study||78
78146|NCT02187016|191799|P1|COMPLETED|Overall Study||79
78147|NCT02187016|191796|P4|STARTED|Overall Study||51
78148|NCT02187016|191797|P3|STARTED|Overall Study||79
78149|NCT02187016|191798|P2|STARTED|Overall Study||80
78150|NCT02187016|191799|P1|STARTED|Overall Study||80
78151|NCT02186938|191831|P2|NOT COMPLETED|Overall Study||3
78152|NCT02186938|191832|P1|NOT COMPLETED|Overall Study||9
78153|NCT02186938|191831|P2|COMPLETED|Overall Study||44
78154|NCT02186938|191832|P1|COMPLETED|Overall Study||38
78155|NCT02186938|191831|P2|STARTED|Overall Study||47
78156|NCT02186938|191832|P1|STARTED|Overall Study|2012|47
78157|NCT02186873|191842|P2|NOT COMPLETED|Overall Study||8
78158|NCT02186873|191843|P1|NOT COMPLETED|Overall Study||9
78159|NCT02186873|191842|P2|COMPLETED|Overall Study||97
78160|NCT02186873|191843|P1|COMPLETED|Overall Study||94
78161|NCT02186873|191842|P2|End of Control Period|Overall Study|Participants continued to receive golimumab|105
78162|NCT02186873|191843|P1|End of Control Period|Overall Study|Participants taking placebo crossed over to golimumab|99
78163|NCT02186873|191842|P2|STARTED|Overall Study||105
78164|NCT02186873|191843|P1|STARTED|Overall Study||103
78165|NCT02186834|191866|P6|NOT COMPLETED|Treatment at RP2D||1
78166|NCT02186834|191867|P5|NOT COMPLETED|Treatment at RP2D||0
78167|NCT02186834|191868|P4|NOT COMPLETED|Treatment at RP2D||0
78168|NCT02186834|191869|P3|NOT COMPLETED|Treatment at RP2D||0
78169|NCT02186834|191870|P2|NOT COMPLETED|Treatment at RP2D||0
78170|NCT02186834|191871|P1|NOT COMPLETED|Treatment at RP2D||0
78171|NCT02186834|191866|P6|COMPLETED|Treatment at RP2D||13
78172|NCT02186834|191867|P5|COMPLETED|Treatment at RP2D||0
78173|NCT02186834|191868|P4|COMPLETED|Treatment at RP2D||0
78174|NCT02186834|191869|P3|COMPLETED|Treatment at RP2D||0
78175|NCT02186834|191870|P2|COMPLETED|Treatment at RP2D||0
78176|NCT02186834|191871|P1|COMPLETED|Treatment at RP2D||0
78177|NCT02186834|191866|P6|STARTED|Treatment at RP2D||14
78178|NCT02186834|191867|P5|STARTED|Treatment at RP2D||0
78179|NCT02186834|191868|P4|STARTED|Treatment at RP2D||0
78180|NCT02186834|191869|P3|STARTED|Treatment at RP2D||0
78181|NCT02186834|191870|P2|STARTED|Treatment at RP2D||0
78182|NCT02186834|191871|P1|STARTED|Treatment at RP2D||0
78183|NCT02186834|191866|P6|NOT COMPLETED|Dose Escalation||0
78184|NCT02186834|191867|P5|NOT COMPLETED|Dose Escalation||0
78185|NCT02186834|191868|P4|NOT COMPLETED|Dose Escalation||1
78186|NCT02186834|191869|P3|NOT COMPLETED|Dose Escalation||0
78187|NCT02186834|191870|P2|NOT COMPLETED|Dose Escalation||0
78188|NCT02186834|191871|P1|NOT COMPLETED|Dose Escalation||0
78189|NCT02186834|191866|P6|COMPLETED|Dose Escalation||0
78190|NCT02186834|191867|P5|COMPLETED|Dose Escalation||4
78191|NCT02186834|191868|P4|COMPLETED|Dose Escalation||6
78192|NCT02186834|191869|P3|COMPLETED|Dose Escalation||0
78193|NCT02186834|191870|P2|COMPLETED|Dose Escalation||3
78194|NCT02186834|191871|P1|COMPLETED|Dose Escalation||6
78195|NCT02186834|191866|P6|STARTED|Dose Escalation||0
78196|NCT02186834|191867|P5|STARTED|Dose Escalation||4
78197|NCT02186834|191868|P4|STARTED|Dose Escalation||7
78198|NCT02186834|191869|P3|STARTED|Dose Escalation||0
78199|NCT02186834|191870|P2|STARTED|Dose Escalation||3
78200|NCT02186834|191871|P1|STARTED|Dose Escalation||6
78201|NCT02186808|191882|P1|NOT COMPLETED|Overall Study||13
78202|NCT02186808|191882|P1|COMPLETED|Overall Study||67
78203|NCT02186808|191882|P1|STARTED|Overall Study||80
78204|NCT02186795|191889|P2|NOT COMPLETED|Overall Study||0
78205|NCT02186795|191890|P1|NOT COMPLETED|Overall Study||0
78206|NCT02186795|191889|P2|COMPLETED|Overall Study||24
78207|NCT02186795|191890|P1|COMPLETED|Overall Study||24
78208|NCT02186795|191889|P2|STARTED|Overall Study||24
78209|NCT02186795|191890|P1|STARTED|Overall Study||24
78210|NCT02186665|191898|P2|NOT COMPLETED|Overall Study||1
78211|NCT02186665|191899|P1|NOT COMPLETED|Overall Study||0
78212|NCT02186665|191898|P2|COMPLETED|Overall Study||10
78213|NCT02186665|191899|P1|COMPLETED|Overall Study||8
78214|NCT02186665|191898|P2|STARTED|Overall Study||11
78215|NCT02186665|191899|P1|STARTED|Overall Study||8
78216|NCT02186652|191907|P2|NOT COMPLETED|Overall Study||0
78217|NCT02186652|191908|P1|NOT COMPLETED|Overall Study||2
78218|NCT02186652|191907|P2|COMPLETED|Overall Study||22
78219|NCT02186652|191908|P1|COMPLETED|Overall Study||17
78220|NCT02186652|191907|P2|STARTED|Overall Study||22
78221|NCT02186652|191908|P1|STARTED|Overall Study||19
78222|NCT02186587|191935|P2|NOT COMPLETED|Overall Study||0
78223|NCT02186587|191936|P1|NOT COMPLETED|Overall Study||5
78224|NCT02186587|191935|P2|COMPLETED|Overall Study||0
78225|NCT02186587|191936|P1|COMPLETED|Overall Study||23
78226|NCT02186587|191935|P2|STARTED|Overall Study||0
78227|NCT02186587|191936|P1|STARTED|Overall Study||28
78228|NCT02186561|191941|P1|NOT COMPLETED|3 - Year Post Index Procedure Visit||13
78229|NCT02186561|191941|P1|COMPLETED|3 - Year Post Index Procedure Visit||128
78230|NCT02186561|191941|P1|STARTED|3 - Year Post Index Procedure Visit||141
78231|NCT02186561|191941|P1|NOT COMPLETED|2 - Year Post Index Procedure Visit||7
78232|NCT02186561|191941|P1|COMPLETED|2 - Year Post Index Procedure Visit||134
78233|NCT02186561|191941|P1|STARTED|2 - Year Post Index Procedure Visit||141
78234|NCT02186561|191941|P1|NOT COMPLETED|1- Year Post Index Procedure Visit||2
78235|NCT02186561|191941|P1|COMPLETED|1- Year Post Index Procedure Visit||139
78236|NCT02186561|191941|P1|STARTED|1- Year Post Index Procedure Visit||141
78237|NCT02186561|191941|P1|NOT COMPLETED|180- Day Post Index Procedure Visit||7
78238|NCT02186561|191941|P1|COMPLETED|180- Day Post Index Procedure Visit||134
78239|NCT02186561|191941|P1|STARTED|180- Day Post Index Procedure Visit||141
78240|NCT02186561|191941|P1|NOT COMPLETED|30-Day Post Index Procedure Visit||1
78241|NCT02186561|191941|P1|COMPLETED|30-Day Post Index Procedure Visit||140
78242|NCT02186561|191941|P1|STARTED|30-Day Post Index Procedure Visit||141
78243|NCT02186561|191941|P1|NOT COMPLETED|Subjects Implanted With Device||0
78244|NCT02186561|191941|P1|COMPLETED|Subjects Implanted With Device||141
78245|NCT02186561|191941|P1|STARTED|Subjects Implanted With Device||141
78246|NCT02186561|191941|P1|NOT COMPLETED|Enrollment||56
78247|NCT02186561|191941|P1|COMPLETED|Enrollment||141
78248|NCT02186561|191941|P1|STARTED|Enrollment||197
78249|NCT02186509|191951|P1|NOT COMPLETED|Overall Study||0
78250|NCT02186509|191951|P1|COMPLETED|Overall Study||17
78251|NCT02186509|191951|P1|STARTED|Overall Study||17
78252|NCT02186301|191961|P3|NOT COMPLETED|Overall Study||50
78253|NCT02186301|191962|P2|NOT COMPLETED|Overall Study||30
78254|NCT02186301|191963|P1|NOT COMPLETED|Overall Study||20
78255|NCT02186301|191961|P3|COMPLETED|Overall Study|Patients who are off study for any reason.|0
78256|NCT02186301|191962|P2|COMPLETED|Overall Study|Patients who are off study for any reason.|0
78257|NCT02186301|191963|P1|COMPLETED|Overall Study|Patients who are off study for any reason.|0
78258|NCT02186301|191961|P3|STARTED|Overall Study||50
78259|NCT02186301|191962|P2|STARTED|Overall Study||30
78260|NCT02186301|191963|P1|STARTED|Overall Study||20
78261|NCT02186223|191979|P1|NOT COMPLETED|Overall Study||21
78262|NCT02186223|191979|P1|COMPLETED|Overall Study||151
78263|NCT02186223|191979|P1|Device Placed|Overall Study||163
78264|NCT02186223|191979|P1|STARTED|Overall Study||172
78265|NCT02186210|191990|P2|NOT COMPLETED|Overall Study||0
78266|NCT02186210|191991|P1|NOT COMPLETED|Overall Study||0
78267|NCT02186210|191990|P2|COMPLETED|Overall Study||20
78268|NCT02186210|191991|P1|COMPLETED|Overall Study||20
78269|NCT02186210|191990|P2|STARTED|Overall Study||20
78270|NCT02186210|191991|P1|STARTED|Overall Study||20
78271|NCT02186171|192001|P2|NOT COMPLETED|Overall Study||15
78272|NCT02186171|192002|P1|NOT COMPLETED|Overall Study||4
78273|NCT02186171|192001|P2|COMPLETED|Overall Study||148
78274|NCT02186171|192002|P1|COMPLETED|Overall Study||78
78275|NCT02186171|192001|P2|Received Treatment|Overall Study||163
78276|NCT02186171|192002|P1|Received Treatment|Overall Study||81
78277|NCT02186171|192001|P2|STARTED|Overall Study||163
78278|NCT02186171|192002|P1|STARTED|Overall Study||82
78279|NCT02185729|192018|P1|NOT COMPLETED|24 Hours Into Dextrose Infusion||0
78280|NCT02185729|192018|P1|COMPLETED|24 Hours Into Dextrose Infusion||12
78281|NCT02185729|192018|P1|STARTED|24 Hours Into Dextrose Infusion||12
78282|NCT02185729|192018|P1|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
78283|NCT02185729|192018|P1|COMPLETED|4 Hours Into Dextrose Infusion||12
78284|NCT02185729|192018|P1|STARTED|4 Hours Into Dextrose Infusion||12
78285|NCT02185729|192018|P1|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
78286|NCT02185729|192018|P1|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
78287|NCT02185729|192018|P1|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
78288|NCT02185729|192018|P1|NOT COMPLETED|24 Hours Into ClinOleic Infusion||0
78289|NCT02185729|192018|P1|COMPLETED|24 Hours Into ClinOleic Infusion||12
78290|NCT02185729|192018|P1|STARTED|24 Hours Into ClinOleic Infusion||12
78291|NCT02185729|192018|P1|NOT COMPLETED|4 Hours Into ClinOleic Infusion||0
78292|NCT02185729|192018|P1|COMPLETED|4 Hours Into ClinOleic Infusion||12
78293|NCT02185729|192018|P1|STARTED|4 Hours Into ClinOleic Infusion||12
78294|NCT02185729|192018|P1|NOT COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||0
78295|NCT02185729|192018|P1|COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||12
78296|NCT02185729|192018|P1|STARTED|0 Hour (Baseline) of ClinOleic Infusion||12
78297|NCT02185729|192018|P1|NOT COMPLETED|24 Hours Into Intralipid Infusion||0
78298|NCT02185729|192018|P1|COMPLETED|24 Hours Into Intralipid Infusion||12
78299|NCT02185729|192018|P1|STARTED|24 Hours Into Intralipid Infusion||12
78300|NCT02185729|192018|P1|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
78301|NCT02185729|192018|P1|COMPLETED|4 Hours Into Intralipid Infusion||12
78302|NCT02185729|192018|P1|STARTED|4 Hours Into Intralipid Infusion||12
78303|NCT02185729|192018|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
78304|NCT02185729|192018|P1|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
78305|NCT02185729|192018|P1|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
78306|NCT02185729|192018|P1|NOT COMPLETED|24 Hours Into Saline Infusion||0
78307|NCT02185729|192018|P1|COMPLETED|24 Hours Into Saline Infusion||12
78308|NCT02185729|192018|P1|STARTED|24 Hours Into Saline Infusion||12
78309|NCT02185729|192018|P1|NOT COMPLETED|4 Hours Into Saline Infusion||0
78310|NCT02185729|192018|P1|COMPLETED|4 Hours Into Saline Infusion||12
78311|NCT02185729|192018|P1|STARTED|4 Hours Into Saline Infusion||12
78312|NCT02185729|192018|P1|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
78313|NCT02185729|192018|P1|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
78314|NCT02185729|192018|P1|STARTED|0 Hour (Baseline) of Saline Infusion||12
78315|NCT02185534|192039|P6|NOT COMPLETED|Third Period||0
78316|NCT02185534|192040|P5|NOT COMPLETED|Third Period||0
78317|NCT02185534|192041|P4|NOT COMPLETED|Third Period||0
78318|NCT02185534|192042|P3|NOT COMPLETED|Third Period||0
78319|NCT02185534|192043|P2|NOT COMPLETED|Third Period||0
78320|NCT02185534|192044|P1|NOT COMPLETED|Third Period||0
78321|NCT02185534|192039|P6|COMPLETED|Third Period||13
78322|NCT02185534|192040|P5|COMPLETED|Third Period||13
78323|NCT02185534|192041|P4|COMPLETED|Third Period||13
78324|NCT02185534|192042|P3|COMPLETED|Third Period||14
78325|NCT02185534|192043|P2|COMPLETED|Third Period||14
78326|NCT02185534|192044|P1|COMPLETED|Third Period||13
78327|NCT02185534|192039|P6|STARTED|Third Period||13
78328|NCT02185534|192040|P5|STARTED|Third Period||13
78329|NCT02185534|192041|P4|STARTED|Third Period||13
78330|NCT02185534|192042|P3|STARTED|Third Period||14
78331|NCT02185534|192043|P2|STARTED|Third Period||14
78332|NCT02185534|192044|P1|STARTED|Third Period||13
78333|NCT02185534|192039|P6|NOT COMPLETED|Second Washout Period||0
78334|NCT02185534|192040|P5|NOT COMPLETED|Second Washout Period||0
78335|NCT02185534|192041|P4|NOT COMPLETED|Second Washout Period||0
78336|NCT02185534|192042|P3|NOT COMPLETED|Second Washout Period||0
78337|NCT02185534|192043|P2|NOT COMPLETED|Second Washout Period||0
78338|NCT02185534|192044|P1|NOT COMPLETED|Second Washout Period||0
78339|NCT02185534|192039|P6|COMPLETED|Second Washout Period||13
78340|NCT02185534|192040|P5|COMPLETED|Second Washout Period||13
78341|NCT02185534|192041|P4|COMPLETED|Second Washout Period||13
78342|NCT02185534|192042|P3|COMPLETED|Second Washout Period||14
78343|NCT02185534|192043|P2|COMPLETED|Second Washout Period||14
78344|NCT02185534|192044|P1|COMPLETED|Second Washout Period||13
78345|NCT02185534|192039|P6|STARTED|Second Washout Period||13
78346|NCT02185534|192040|P5|STARTED|Second Washout Period||13
78347|NCT02185534|192041|P4|STARTED|Second Washout Period||13
78348|NCT02185534|192042|P3|STARTED|Second Washout Period||14
78349|NCT02185534|192043|P2|STARTED|Second Washout Period||14
78350|NCT02185534|192044|P1|STARTED|Second Washout Period||13
78351|NCT02185534|192039|P6|NOT COMPLETED|Second Period||0
78352|NCT02185534|192040|P5|NOT COMPLETED|Second Period||0
78353|NCT02185534|192041|P4|NOT COMPLETED|Second Period||0
78354|NCT02185534|192042|P3|NOT COMPLETED|Second Period||0
78355|NCT02185534|192043|P2|NOT COMPLETED|Second Period||0
78356|NCT02185534|192044|P1|NOT COMPLETED|Second Period||0
78357|NCT02185534|192039|P6|COMPLETED|Second Period||13
78358|NCT02185534|192040|P5|COMPLETED|Second Period||13
78359|NCT02185534|192041|P4|COMPLETED|Second Period||13
78360|NCT02185534|192042|P3|COMPLETED|Second Period||14
78361|NCT02185534|192043|P2|COMPLETED|Second Period||14
78362|NCT02185534|192044|P1|COMPLETED|Second Period||13
78363|NCT02185534|192039|P6|STARTED|Second Period||13
78364|NCT02185534|192040|P5|STARTED|Second Period||13
78365|NCT02185534|192041|P4|STARTED|Second Period||13
78366|NCT02185534|192042|P3|STARTED|Second Period||14
78367|NCT02185534|192043|P2|STARTED|Second Period||14
78368|NCT02185534|192044|P1|STARTED|Second Period||13
78369|NCT02185534|192039|P6|NOT COMPLETED|First Washout Period||1
78370|NCT02185534|192040|P5|NOT COMPLETED|First Washout Period||1
78371|NCT02185534|192041|P4|NOT COMPLETED|First Washout Period||0
78372|NCT02185534|192042|P3|NOT COMPLETED|First Washout Period||0
78373|NCT02185534|192043|P2|NOT COMPLETED|First Washout Period||0
78374|NCT02185534|192044|P1|NOT COMPLETED|First Washout Period||1
78375|NCT02185534|192039|P6|COMPLETED|First Washout Period||13
78376|NCT02185534|192040|P5|COMPLETED|First Washout Period||13
78377|NCT02185534|192041|P4|COMPLETED|First Washout Period||13
78378|NCT02185534|192042|P3|COMPLETED|First Washout Period||14
78379|NCT02185534|192043|P2|COMPLETED|First Washout Period||14
78380|NCT02185534|192044|P1|COMPLETED|First Washout Period||13
78381|NCT02185534|192039|P6|STARTED|First Washout Period||14
78382|NCT02185534|192040|P5|STARTED|First Washout Period||14
78383|NCT02185534|192041|P4|STARTED|First Washout Period||13
78384|NCT02185534|192042|P3|STARTED|First Washout Period||14
78385|NCT02185534|192043|P2|STARTED|First Washout Period||14
78386|NCT02185534|192044|P1|STARTED|First Washout Period||14
78387|NCT02185534|192039|P6|NOT COMPLETED|First Period||0
78388|NCT02185534|192040|P5|NOT COMPLETED|First Period||0
78389|NCT02185534|192041|P4|NOT COMPLETED|First Period||1
78390|NCT02185534|192042|P3|NOT COMPLETED|First Period||0
78391|NCT02185534|192043|P2|NOT COMPLETED|First Period||0
78392|NCT02185534|192044|P1|NOT COMPLETED|First Period||0
78393|NCT02185534|192039|P6|COMPLETED|First Period||14
78394|NCT02185534|192040|P5|COMPLETED|First Period||14
78395|NCT02185534|192041|P4|COMPLETED|First Period||13
78396|NCT02185534|192042|P3|COMPLETED|First Period||14
78397|NCT02185534|192043|P2|COMPLETED|First Period||14
78398|NCT02185534|192044|P1|COMPLETED|First Period||14
78399|NCT02185534|192039|P6|STARTED|First Period||14
78400|NCT02185534|192040|P5|STARTED|First Period||14
78401|NCT02185534|192041|P4|STARTED|First Period||14
78402|NCT02185534|192042|P3|STARTED|First Period||14
78403|NCT02185534|192043|P2|STARTED|First Period||14
78404|NCT02185534|192044|P1|STARTED|First Period||14
78405|NCT02185521|192059|P1|NOT COMPLETED|Overall Study||2
78406|NCT02185521|192059|P1|COMPLETED|Overall Study||125
78407|NCT02185521|192059|P1|STARTED|Overall Study||127
78408|NCT02185339|192066|P2|NOT COMPLETED|Overall Study||1
78409|NCT02185339|192067|P1|NOT COMPLETED|Overall Study||0
78410|NCT02185339|192066|P2|COMPLETED|Overall Study||30
78411|NCT02185339|192067|P1|COMPLETED|Overall Study||30
78412|NCT02185339|192066|P2|STARTED|Overall Study||31
78413|NCT02185339|192067|P1|STARTED|Overall Study||30
78414|NCT02185183|192089|P1|NOT COMPLETED|Overall Study||0
78415|NCT02185183|192089|P1|COMPLETED|Overall Study||14
78416|NCT02185183|192089|P1|STARTED|Overall Study||14
78417|NCT02185131|192095|P2|NOT COMPLETED|Overall Study||1
78418|NCT02185131|192096|P1|NOT COMPLETED|Overall Study||1
78419|NCT02185131|192095|P2|COMPLETED|Overall Study||8
78420|NCT02185131|192096|P1|COMPLETED|Overall Study||6
78421|NCT02185131|192095|P2|STARTED|Overall Study||9
78422|NCT02185131|192096|P1|STARTED|Overall Study||7
78423|NCT02185105|192104|P1|NOT COMPLETED|Overall Study||0
78424|NCT02185105|192104|P1|COMPLETED|Overall Study||30
78425|NCT02185105|192104|P1|STARTED|Overall Study||30
78426|NCT02185014|192147|P1|NOT COMPLETED|Overall Study||54
78427|NCT02185014|192147|P1|COMPLETED|Overall Study||198
78428|NCT02185014|192147|P1|STARTED|Overall Study||252
78429|NCT02184988|192151|P1|NOT COMPLETED|Overall Study||55
78430|NCT02184988|192151|P1|COMPLETED|Overall Study||297
78431|NCT02184988|192151|P1|STARTED|Overall Study||352
78432|NCT02184624|192161|P5|NOT COMPLETED|Overall Study||0
78433|NCT02184624|192162|P4|NOT COMPLETED|Overall Study||0
78434|NCT02184624|192163|P3|NOT COMPLETED|Overall Study||0
78435|NCT02184624|192164|P2|NOT COMPLETED|Overall Study||0
78436|NCT02184624|192165|P1|NOT COMPLETED|Overall Study||0
78437|NCT02184624|192161|P5|COMPLETED|Overall Study||98
78438|NCT02184624|192162|P4|COMPLETED|Overall Study||118
78439|NCT02184624|192163|P3|COMPLETED|Overall Study||100
78440|NCT02184624|192164|P2|COMPLETED|Overall Study||80
78441|NCT02184624|192165|P1|COMPLETED|Overall Study||171
78442|NCT02184624|192161|P5|STARTED|Overall Study||98
78443|NCT02184624|192162|P4|STARTED|Overall Study||118
78444|NCT02184624|192163|P3|STARTED|Overall Study||100
78445|NCT02184624|192164|P2|STARTED|Overall Study||80
78446|NCT02184624|192165|P1|STARTED|Overall Study||171
78447|NCT02184611|192209|P2|NOT COMPLETED|Overall Study||28
78448|NCT02184611|192210|P1|NOT COMPLETED|Overall Study||21
78449|NCT02184611|192209|P2|COMPLETED|Overall Study||177
78450|NCT02184611|192210|P1|COMPLETED|Overall Study||80
78451|NCT02184611|192209|P2|STARTED|Overall Study||205
78452|NCT02184611|192210|P1|STARTED|Overall Study||101
78453|NCT02184572|192246|P2|NOT COMPLETED|Overall Study||30
78454|NCT02184572|192247|P1|NOT COMPLETED|Overall Study||47
78455|NCT02184572|192246|P2|COMPLETED|Overall Study||542
78456|NCT02184572|192247|P1|COMPLETED|Overall Study||1117
78457|NCT02184572|192246|P2|STARTED|Overall Study||572
78458|NCT02184572|192247|P1|STARTED|Overall Study||1164
78459|NCT02184494|192286|P3|NOT COMPLETED|Overall Study||0
78460|NCT02184494|192287|P2|NOT COMPLETED|Overall Study||2
78461|NCT02184494|192288|P1|NOT COMPLETED|Overall Study||1
78462|NCT02184494|192286|P3|COMPLETED|Overall Study||8
78463|NCT02184494|192287|P2|COMPLETED|Overall Study||11
78464|NCT02184494|192288|P1|COMPLETED|Overall Study||12
78465|NCT02184494|192286|P3|STARTED|Overall Study||8
78466|NCT02184494|192287|P2|STARTED|Overall Study||13
78467|NCT02184494|192288|P1|STARTED|Overall Study||13
78468|NCT02184455|192308|P1|NOT COMPLETED|Overall Study||1
78469|NCT02184455|192308|P1|COMPLETED|Overall Study||10
78470|NCT02184455|192308|P1|STARTED|Overall Study||11
78471|NCT02184442|192319|P2|NOT COMPLETED|Overall Study||76
78472|NCT02184442|192320|P1|NOT COMPLETED|Overall Study||64
78473|NCT02184442|192319|P2|COMPLETED|Overall Study||200
78474|NCT02184442|192320|P1|COMPLETED|Overall Study||220
78475|NCT02184442|192319|P2|Valve-Implant|Overall Study||263
78476|NCT02184442|192320|P1|Valve-Implant|Overall Study||280
78477|NCT02184442|192319|P2|As-Treated|Overall Study||271
78478|NCT02184442|192320|P1|As-Treated|Overall Study||282
78479|NCT02184442|192319|P2|STARTED|Overall Study||276
78480|NCT02184442|192320|P1|STARTED|Overall Study||284
78481|NCT02184208|192332|P1|NOT COMPLETED|Overall Study||56
78482|NCT02184208|192332|P1|COMPLETED|Overall Study||222
78483|NCT02184208|192332|P1|STARTED|Overall Study||278
78484|NCT02184143|192340|P2|NOT COMPLETED|Overall Study||7
78485|NCT02184143|192341|P1|NOT COMPLETED|Overall Study||10
78486|NCT02184143|192340|P2|COMPLETED|Overall Study|117 patients completed PROs. 100 actigraph valid wear time.|117
78487|NCT02184143|192341|P1|COMPLETED|Overall Study|114 patients completed PROs. 98 actigraph valid wear time.|114
78488|NCT02184143|192340|P2|STARTED|Overall Study|124 participants randomized; 121 received intervention|124
78489|NCT02184143|192341|P1|STARTED|Overall Study|124 participants randomized; 118 participant received intervention|124
78490|NCT02183792|192355|P2|NOT COMPLETED|Overall Study||0
78491|NCT02183792|192356|P1|NOT COMPLETED|Overall Study||0
78492|NCT02183792|192355|P2|COMPLETED|Overall Study||15
78493|NCT02183792|192356|P1|COMPLETED|Overall Study||18
78494|NCT02183792|192355|P2|STARTED|Overall Study||15
78495|NCT02183792|192356|P1|STARTED|Overall Study||18
78496|NCT02183675|192370|P6|NOT COMPLETED|Treatment Period 3 (10 Days)||0
78497|NCT02183675|192371|P5|NOT COMPLETED|Treatment Period 3 (10 Days)||0
78498|NCT02183675|192372|P4|NOT COMPLETED|Treatment Period 3 (10 Days)||0
78499|NCT02183675|192373|P3|NOT COMPLETED|Treatment Period 3 (10 Days)||0
78500|NCT02183675|192374|P2|NOT COMPLETED|Treatment Period 3 (10 Days)||0
78501|NCT02183675|192375|P1|NOT COMPLETED|Treatment Period 3 (10 Days)||0
78502|NCT02183675|192370|P6|COMPLETED|Treatment Period 3 (10 Days)||4
78503|NCT02183675|192371|P5|COMPLETED|Treatment Period 3 (10 Days)||6
78504|NCT02183675|192372|P4|COMPLETED|Treatment Period 3 (10 Days)||6
78505|NCT02183675|192373|P3|COMPLETED|Treatment Period 3 (10 Days)||6
78506|NCT02183675|192374|P2|COMPLETED|Treatment Period 3 (10 Days)||6
78507|NCT02183675|192375|P1|COMPLETED|Treatment Period 3 (10 Days)||6
78508|NCT02183675|192370|P6|STARTED|Treatment Period 3 (10 Days)||4
78509|NCT02183675|192371|P5|STARTED|Treatment Period 3 (10 Days)||6
78510|NCT02183675|192372|P4|STARTED|Treatment Period 3 (10 Days)||6
78511|NCT02183675|192373|P3|STARTED|Treatment Period 3 (10 Days)||6
78512|NCT02183675|192374|P2|STARTED|Treatment Period 3 (10 Days)||6
78513|NCT02183675|192375|P1|STARTED|Treatment Period 3 (10 Days)||6
78514|NCT02183675|192370|P6|NOT COMPLETED|Treatment Period 2 (10 Days)||2
78515|NCT02183675|192371|P5|NOT COMPLETED|Treatment Period 2 (10 Days)||0
78516|NCT02183675|192372|P4|NOT COMPLETED|Treatment Period 2 (10 Days)||0
78517|NCT02183675|192373|P3|NOT COMPLETED|Treatment Period 2 (10 Days)||0
78518|NCT02183675|192374|P2|NOT COMPLETED|Treatment Period 2 (10 Days)||0
78519|NCT02183675|192375|P1|NOT COMPLETED|Treatment Period 2 (10 Days)||0
78520|NCT02183675|192370|P6|COMPLETED|Treatment Period 2 (10 Days)|Patients withdrew after completion of treatment period 2 but before beginning of treatment period 3|4
78521|NCT02183675|192371|P5|COMPLETED|Treatment Period 2 (10 Days)||6
78522|NCT02183675|192372|P4|COMPLETED|Treatment Period 2 (10 Days)||6
78523|NCT02183675|192373|P3|COMPLETED|Treatment Period 2 (10 Days)||6
78524|NCT02183675|192374|P2|COMPLETED|Treatment Period 2 (10 Days)||6
78525|NCT02183675|192375|P1|COMPLETED|Treatment Period 2 (10 Days)||6
78526|NCT02183675|192370|P6|STARTED|Treatment Period 2 (10 Days)||6
78527|NCT02183675|192371|P5|STARTED|Treatment Period 2 (10 Days)||6
78528|NCT02183675|192372|P4|STARTED|Treatment Period 2 (10 Days)||6
78529|NCT02183675|192373|P3|STARTED|Treatment Period 2 (10 Days)||6
78530|NCT02183675|192374|P2|STARTED|Treatment Period 2 (10 Days)||6
78531|NCT02183675|192375|P1|STARTED|Treatment Period 2 (10 Days)||6
78532|NCT02183675|192370|P6|NOT COMPLETED|Treatment Period 1 (10 Days)||0
78533|NCT02183675|192371|P5|NOT COMPLETED|Treatment Period 1 (10 Days)||0
78534|NCT02183675|192372|P4|NOT COMPLETED|Treatment Period 1 (10 Days)||0
78535|NCT02183675|192373|P3|NOT COMPLETED|Treatment Period 1 (10 Days)||0
78536|NCT02183675|192374|P2|NOT COMPLETED|Treatment Period 1 (10 Days)||0
78537|NCT02183675|192375|P1|NOT COMPLETED|Treatment Period 1 (10 Days)||0
78538|NCT02183675|192370|P6|COMPLETED|Treatment Period 1 (10 Days)||6
78539|NCT02183675|192371|P5|COMPLETED|Treatment Period 1 (10 Days)||6
78540|NCT02183675|192372|P4|COMPLETED|Treatment Period 1 (10 Days)||6
78541|NCT02183675|192373|P3|COMPLETED|Treatment Period 1 (10 Days)||6
78542|NCT02183675|192374|P2|COMPLETED|Treatment Period 1 (10 Days)||6
78543|NCT02183675|192375|P1|COMPLETED|Treatment Period 1 (10 Days)||6
78544|NCT02183675|192370|P6|STARTED|Treatment Period 1 (10 Days)||6
78545|NCT02183675|192371|P5|STARTED|Treatment Period 1 (10 Days)||6
78546|NCT02183675|192372|P4|STARTED|Treatment Period 1 (10 Days)||6
78547|NCT02183675|192373|P3|STARTED|Treatment Period 1 (10 Days)||6
78548|NCT02183675|192374|P2|STARTED|Treatment Period 1 (10 Days)||6
78549|NCT02183675|192375|P1|STARTED|Treatment Period 1 (10 Days)||6
78550|NCT02183519|192399|P2|NOT COMPLETED|Overall Study||3
78551|NCT02183519|192400|P1|NOT COMPLETED|Overall Study||3
78552|NCT02183519|192399|P2|COMPLETED|Overall Study||13
78553|NCT02183519|192400|P1|COMPLETED|Overall Study||25
78554|NCT02183519|192399|P2|STARTED|Overall Study||16
78555|NCT02183519|192400|P1|STARTED|Overall Study||28
78556|NCT02182999|192408|P2|NOT COMPLETED|Overall Study||3
78557|NCT02182999|192409|P1|NOT COMPLETED|Overall Study||5
78558|NCT02182999|192408|P2|COMPLETED|Overall Study||22
78559|NCT02182999|192409|P1|COMPLETED|Overall Study||20
78560|NCT02182999|192408|P2|STARTED|Overall Study||25
78561|NCT02182999|192409|P1|STARTED|Overall Study||25
78562|NCT02182973|192425|P2|NOT COMPLETED|Overall Study||0
78563|NCT02182973|192426|P1|NOT COMPLETED|Overall Study||3
78564|NCT02182973|192425|P2|COMPLETED|Overall Study||9
78565|NCT02182973|192426|P1|COMPLETED|Overall Study||9
78566|NCT02182973|192425|P2|STARTED|Overall Study||9
78567|NCT02182973|192426|P1|STARTED|Overall Study||12
78568|NCT02182895|192438|P2|NOT COMPLETED|Overall Study||4
78569|NCT02182895|192439|P1|NOT COMPLETED|Overall Study||2
78570|NCT02182895|192438|P2|COMPLETED|Overall Study||33
78571|NCT02182895|192439|P1|COMPLETED|Overall Study||33
78572|NCT02182895|192438|P2|STARTED|Overall Study||37
78573|NCT02182895|192439|P1|STARTED|Overall Study||35
78574|NCT02182843|192459|P1|NOT COMPLETED|Overall Study||10
78575|NCT02182843|192459|P1|COMPLETED|Overall Study||71
78576|NCT02182843|192459|P1|STARTED|Overall Study||81
78577|NCT02182830|192466|P2|NOT COMPLETED|Overall Study||15
78578|NCT02182830|192467|P1|NOT COMPLETED|Overall Study||15
78579|NCT02182830|192466|P2|COMPLETED|Overall Study||68
78580|NCT02182830|192467|P1|COMPLETED|Overall Study||68
78581|NCT02182830|192466|P2|Treated Set (TS)|Overall Study|From RS, 1 duplicate patient and 1 non treated patient was removed|80
78582|NCT02182830|192467|P1|Treated Set (TS)|Overall Study|From RS, 1 duplicate patient and 1 non treated patient was removed|77
78583|NCT02182830|192466|P2|Randomised Set (RS)|Overall Study|From started, 1 patient from one site was removed|82
78584|NCT02182830|192467|P1|Randomised Set (RS)|Overall Study|From started, 2 duplicate patients and 2 patients from one site were removed|79
78585|NCT02182830|192466|P2|STARTED|Overall Study||83
78586|NCT02182830|192467|P1|STARTED|Overall Study||83
78587|NCT02182492|192495|P2|NOT COMPLETED|Overall Study||8
78588|NCT02182492|192496|P1|NOT COMPLETED|Overall Study||7
78589|NCT02182492|192495|P2|COMPLETED|Overall Study|CRSsNP: 29; Non-Eos CRSwNP: 28; Eos CRSwNP: 29|86
78590|NCT02182492|192496|P1|COMPLETED|Overall Study|CRSsNP: 27; Non-Eos CRSwNP: 31; Eos CRSwNP: 28|86
78591|NCT02182492|192495|P2|STARTED|Overall Study|CRSsNP: 30; Non-Eos CRSwNP: 32; Eos CRSwNP: 32|94
78592|NCT02182492|192496|P1|STARTED|Overall Study|CRSsNP: 28; Non-Eos CRSwNP: 34; Eos CRSwNP: 31|93
78593|NCT02182115|192506|P2|NOT COMPLETED|Overall Study||0
78594|NCT02182115|192507|P1|NOT COMPLETED|Overall Study||0
78595|NCT02182115|192506|P2|COMPLETED|Overall Study||57
78596|NCT02182115|192507|P1|COMPLETED|Overall Study||53
78597|NCT02182115|192506|P2|STARTED|Overall Study||57
78598|NCT02182115|192507|P1|STARTED|Overall Study||53
78599|NCT02181842|192513|P1|NOT COMPLETED|Overall Study||2
78600|NCT02181842|192513|P1|COMPLETED|Overall Study||244
78601|NCT02181842|192513|P1|STARTED|Overall Study||246
78602|NCT02181816|192530|P1|NOT COMPLETED|Overall Study||59
78603|NCT02181816|192530|P1|COMPLETED|Overall Study||1031
78604|NCT02181816|192530|P1|STARTED|Overall Study||1090
78605|NCT02181790|192538|P2|NOT COMPLETED|Overall Study||0
78606|NCT02181790|192539|P1|NOT COMPLETED|Overall Study||2
78607|NCT02181790|192538|P2|COMPLETED|Overall Study||0
78608|NCT02181790|192539|P1|COMPLETED|Overall Study||0
78609|NCT02181790|192538|P2|STARTED|Overall Study||0
78610|NCT02181790|192539|P1|STARTED|Overall Study||2
78611|NCT02181738|192551|P4|NOT COMPLETED|Overall Study||2
78612|NCT02181738|192552|P3|NOT COMPLETED|Overall Study||10
78613|NCT02181738|192553|P2|NOT COMPLETED|Overall Study||9
78614|NCT02181738|192554|P1|NOT COMPLETED|Overall Study||2
78615|NCT02181738|192551|P4|COMPLETED|Overall Study||49
78616|NCT02181738|192552|P3|COMPLETED|Overall Study||90
78617|NCT02181738|192553|P2|COMPLETED|Overall Study||71
78618|NCT02181738|192554|P1|COMPLETED|Overall Study||61
78619|NCT02181738|192551|P4|STARTED|Overall Study||51
78620|NCT02181738|192552|P3|STARTED|Overall Study||100
78621|NCT02181738|192553|P2|STARTED|Overall Study||80
78622|NCT02181738|192554|P1|STARTED|Overall Study||63
78623|NCT02181673|192595|P3|NOT COMPLETED|Week 24-Week 60||17
78624|NCT02181673|192596|P2|NOT COMPLETED|Week 24-Week 60||8
78625|NCT02181673|192597|P1|NOT COMPLETED|Week 24-Week 60||0
78626|NCT02181673|192595|P3|COMPLETED|Week 24-Week 60||213
78627|NCT02181673|192596|P2|COMPLETED|Week 24-Week 60||214
78628|NCT02181673|192597|P1|COMPLETED|Week 24-Week 60||0
78629|NCT02181673|192595|P3|Treated|Week 24-Week 60||230
78630|NCT02181673|192596|P2|Treated|Week 24-Week 60||220
78631|NCT02181673|192597|P1|Treated|Week 24-Week 60||0
78632|NCT02181673|192595|P3|STARTED|Week 24-Week 60||230
78633|NCT02181673|192596|P2|STARTED|Week 24-Week 60||222
78634|NCT02181673|192597|P1|STARTED|Week 24-Week 60||0
78635|NCT02181673|192595|P3|NOT COMPLETED|Up to Week 24||11
78636|NCT02181673|192596|P2|NOT COMPLETED|Up to Week 24||0
78637|NCT02181673|192597|P1|NOT COMPLETED|Up to Week 24||17
78638|NCT02181673|192595|P3|COMPLETED|Up to Week 24||230
78639|NCT02181673|192596|P2|COMPLETED|Up to Week 24||0
78640|NCT02181673|192597|P1|COMPLETED|Up to Week 24||222
78641|NCT02181673|192595|P3|Treated|Up to Week 24||240
78642|NCT02181673|192596|P2|Treated|Up to Week 24||0
78643|NCT02181673|192597|P1|Treated|Up to Week 24||239
78644|NCT02181673|192595|P3|STARTED|Up to Week 24||241
78645|NCT02181673|192596|P2|STARTED|Up to Week 24||0
78646|NCT02181673|192597|P1|STARTED|Up to Week 24||239
78647|NCT02181634|192624|P1|NOT COMPLETED|Overall Study||72
78648|NCT02181634|192624|P1|COMPLETED|Overall Study||2
78649|NCT02181634|192624|P1|Eligible and Treated|Overall Study||73
78650|NCT02181634|192624|P1|STARTED|Overall Study||74
78651|NCT02181530|192635|P1|NOT COMPLETED|Overall Study||0
78652|NCT02181530|192635|P1|COMPLETED|Overall Study||43
78653|NCT02181530|192635|P1|STARTED|Overall Study||43
78654|NCT02181517|192648|P3|NOT COMPLETED|Overall Study||0
78655|NCT02181517|192649|P2|NOT COMPLETED|Overall Study||0
78656|NCT02181517|192650|P1|NOT COMPLETED|Overall Study||0
78657|NCT02181517|192648|P3|COMPLETED|Overall Study||5
78658|NCT02181517|192649|P2|COMPLETED|Overall Study||10
78659|NCT02181517|192650|P1|COMPLETED|Overall Study||10
78660|NCT02181517|192648|P3|STARTED|Overall Study||5
78661|NCT02181517|192649|P2|STARTED|Overall Study||10
78662|NCT02181517|192650|P1|STARTED|Overall Study||10
78663|NCT02181504|192673|P3|NOT COMPLETED|Overall Study||1
78664|NCT02181504|192674|P2|NOT COMPLETED|Overall Study||1
78665|NCT02181504|192675|P1|NOT COMPLETED|Overall Study||1
78666|NCT02181504|192673|P3|COMPLETED|Overall Study||4
78667|NCT02181504|192674|P2|COMPLETED|Overall Study||9
78668|NCT02181504|192675|P1|COMPLETED|Overall Study||9
78669|NCT02181504|192673|P3|STARTED|Overall Study||5
78670|NCT02181504|192674|P2|STARTED|Overall Study||10
78671|NCT02181504|192675|P1|STARTED|Overall Study||10
78672|NCT02181426|192699|P4|NOT COMPLETED|Overall Study||0
78673|NCT02181426|192700|P3|NOT COMPLETED|Overall Study||0
78674|NCT02181426|192701|P2|NOT COMPLETED|Overall Study||0
78675|NCT02181426|192702|P1|NOT COMPLETED|Overall Study||0
78676|NCT02181426|192699|P4|COMPLETED|Overall Study||28
78677|NCT02181426|192700|P3|COMPLETED|Overall Study||28
78678|NCT02181426|192701|P2|COMPLETED|Overall Study||28
78679|NCT02181426|192702|P1|COMPLETED|Overall Study||28
78680|NCT02181426|192699|P4|STARTED|Overall Study||28
78681|NCT02181426|192700|P3|STARTED|Overall Study||28
78682|NCT02181426|192701|P2|STARTED|Overall Study||28
78683|NCT02181426|192702|P1|STARTED|Overall Study||28
78684|NCT02181413|192714|P2|NOT COMPLETED|Overall Study||197
78685|NCT02181413|192715|P1|NOT COMPLETED|Overall Study||152
78686|NCT02181413|192714|P2|COMPLETED|Overall Study||198
78687|NCT02181413|192715|P1|COMPLETED|Overall Study||109
78688|NCT02181413|192714|P2|Per Protocol (PP) Population|Overall Study||387
78689|NCT02181413|192715|P1|Per Protocol (PP) Population|Overall Study||256
78690|NCT02181413|192714|P2|Safety Population|Overall Study||394
78691|NCT02181413|192715|P1|Safety Population|Overall Study||259
78692|NCT02181413|192714|P2|Intent-to-Treat (ITT) Population|Overall Study||395
78693|NCT02181413|192715|P1|Intent-to-Treat (ITT) Population|Overall Study||261
78694|NCT02181413|192714|P2|STARTED|Overall Study||395
78695|NCT02181413|192715|P1|STARTED|Overall Study||261
78696|NCT02181387|192723|P2|NOT COMPLETED|Overall Study||4
78697|NCT02181387|192724|P1|NOT COMPLETED|Overall Study||2
78698|NCT02181387|192723|P2|COMPLETED|Overall Study||15
78699|NCT02181387|192724|P1|COMPLETED|Overall Study||12
78700|NCT02181387|192723|P2|STARTED|Overall Study||19
78701|NCT02181387|192724|P1|STARTED|Overall Study||14
78702|NCT02181296|192732|P2|NOT COMPLETED|Overall Study||6
78703|NCT02181296|192733|P1|NOT COMPLETED|Overall Study||7
78704|NCT02181296|192732|P2|COMPLETED|Overall Study||19
78705|NCT02181296|192733|P1|COMPLETED|Overall Study||18
78706|NCT02181296|192732|P2|STARTED|Overall Study||25
78707|NCT02181296|192733|P1|STARTED|Overall Study||25
78708|NCT02181231|192747|P2|NOT COMPLETED|Overall Study||0
78709|NCT02181231|192748|P1|NOT COMPLETED|Overall Study||2
78710|NCT02181231|192747|P2|COMPLETED|Overall Study||6
78711|NCT02181231|192748|P1|COMPLETED|Overall Study||10
78712|NCT02181231|192747|P2|STARTED|Overall Study||6
78713|NCT02181231|192748|P1|STARTED|Overall Study||12
78714|NCT02181140|192764|P1|NOT COMPLETED|Overall Study||0
78715|NCT02181140|192764|P1|COMPLETED|Overall Study||56
78716|NCT02181140|192764|P1|STARTED|Overall Study||56
78717|NCT02181127|192770|P1|NOT COMPLETED|Overall Study||0
78718|NCT02181127|192770|P1|COMPLETED|Overall Study||22
78719|NCT02181127|192770|P1|STARTED|Overall Study||22
78720|NCT02181075|192816|P2|NOT COMPLETED|Overall Study||0
78721|NCT02181075|192817|P1|NOT COMPLETED|Overall Study||0
78722|NCT02181075|192816|P2|COMPLETED|Overall Study||4
78723|NCT02181075|192817|P1|COMPLETED|Overall Study||6
78724|NCT02181075|192816|P2|STARTED|Overall Study||4
78725|NCT02181075|192817|P1|STARTED|Overall Study||6
78726|NCT02180893|192835|P2|NOT COMPLETED|Overall Study||7
78727|NCT02180893|192836|P1|NOT COMPLETED|Overall Study||3
78728|NCT02180893|192835|P2|COMPLETED|Overall Study||23
78729|NCT02180893|192836|P1|COMPLETED|Overall Study||27
78730|NCT02180893|192835|P2|STARTED|Overall Study||30
78731|NCT02180893|192836|P1|STARTED|Overall Study||30
78732|NCT02180828|192850|P2|NOT COMPLETED|Overall Study||7
78733|NCT02180828|192851|P1|NOT COMPLETED|Overall Study||5
78734|NCT02180828|192850|P2|COMPLETED|Overall Study||113
78735|NCT02180828|192851|P1|COMPLETED|Overall Study||115
78736|NCT02180828|192850|P2|STARTED|Overall Study||120
78737|NCT02180828|192851|P1|STARTED|Overall Study||120
78738|NCT02180659|192875|P2|NOT COMPLETED|Overall Study||5
78739|NCT02180659|192876|P1|NOT COMPLETED|Overall Study||6
78740|NCT02180659|192875|P2|COMPLETED|Overall Study||84
78741|NCT02180659|192876|P1|COMPLETED|Overall Study||81
78742|NCT02180659|192875|P2|STARTED|Overall Study|N=90 randomized, however N=89 received study medication|89
78743|NCT02180659|192876|P1|STARTED|Overall Study||87
78744|NCT02180646|192898|P2|NOT COMPLETED|Second Intervention (7 Days)||0
78745|NCT02180646|192899|P1|NOT COMPLETED|Second Intervention (7 Days)||0
78746|NCT02180646|192898|P2|COMPLETED|Second Intervention (7 Days)||6
78747|NCT02180646|192899|P1|COMPLETED|Second Intervention (7 Days)||6
78748|NCT02180646|192898|P2|STARTED|Second Intervention (7 Days)||6
78749|NCT02180646|192899|P1|STARTED|Second Intervention (7 Days)||6
78750|NCT02180646|192898|P2|NOT COMPLETED|Washout (7 Days)||0
78751|NCT02180646|192899|P1|NOT COMPLETED|Washout (7 Days)||0
78752|NCT02180646|192898|P2|COMPLETED|Washout (7 Days)||6
78753|NCT02180646|192899|P1|COMPLETED|Washout (7 Days)||6
78754|NCT02180646|192898|P2|STARTED|Washout (7 Days)||6
78755|NCT02180646|192899|P1|STARTED|Washout (7 Days)||6
78756|NCT02180646|192898|P2|NOT COMPLETED|First Intervention (7 Days)||0
78757|NCT02180646|192899|P1|NOT COMPLETED|First Intervention (7 Days)||0
78758|NCT02180646|192898|P2|COMPLETED|First Intervention (7 Days)||6
78759|NCT02180646|192899|P1|COMPLETED|First Intervention (7 Days)||6
78760|NCT02180646|192898|P2|STARTED|First Intervention (7 Days)||6
78761|NCT02180646|192899|P1|STARTED|First Intervention (7 Days)||6
78762|NCT02180438|192911|P1|NOT COMPLETED|Overall Study||1
78763|NCT02180438|192911|P1|COMPLETED|Overall Study||29
78764|NCT02180438|192911|P1|STARTED|Overall Study||30
78765|NCT02180230|192926|P1|NOT COMPLETED|Overall Study||7
78766|NCT02180230|192926|P1|COMPLETED|Overall Study||31
78767|NCT02180230|192926|P1|STARTED|Overall Study||38
78768|NCT02180165|192935|P4|NOT COMPLETED|Overall Study||6
78769|NCT02180165|192936|P3|NOT COMPLETED|Overall Study||29
78770|NCT02180165|192937|P2|NOT COMPLETED|Overall Study||1
78771|NCT02180165|192938|P1|NOT COMPLETED|Overall Study||11
78772|NCT02180165|192935|P4|COMPLETED|Overall Study||25
78773|NCT02180165|192936|P3|COMPLETED|Overall Study||34
78774|NCT02180165|192937|P2|COMPLETED|Overall Study||6
78775|NCT02180165|192938|P1|COMPLETED|Overall Study||4
78776|NCT02180165|192935|P4|Type of Aspergillosis|Overall Study|Invasive Aspergillosis and Chronic Pulmonary Aspergillosis|27
78777|NCT02180165|192936|P3|Type of Aspergillosis|Overall Study|Invasive Aspergillosis and Chronic Pulmonary Aspergillosis|57
78778|NCT02180165|192937|P2|Type of Aspergillosis|Overall Study|Chronic Pulmonary Aspergillosis|7
78779|NCT02180165|192938|P1|Type of Aspergillosis|Overall Study|Chronic Pulmonary Aspergillosis|15
78780|NCT02180165|192935|P4|Treated Participants|Overall Study||31
78781|NCT02180165|192936|P3|Treated Participants|Overall Study||62
78782|NCT02180165|192937|P2|Treated Participants|Overall Study||7
78783|NCT02180165|192938|P1|Treated Participants|Overall Study||15
78784|NCT02180165|192935|P4|STARTED|Overall Study||31
78785|NCT02180165|192936|P3|STARTED|Overall Study||63
78786|NCT02180165|192937|P2|STARTED|Overall Study||7
78787|NCT02180165|192938|P1|STARTED|Overall Study||15
78788|NCT02180061|193026|P2|NOT COMPLETED|Overall Study||8
78789|NCT02180061|193027|P1|NOT COMPLETED|Overall Study||25
78790|NCT02180061|193026|P2|COMPLETED|Overall Study||0
78791|NCT02180061|193027|P1|COMPLETED|Overall Study||9
78792|NCT02180061|193026|P2|STARTED|Overall Study||8
78793|NCT02180061|193027|P1|STARTED|Overall Study||34
78794|NCT02179918|193046|P5|NOT COMPLETED|Overall Study||8
78795|NCT02179918|193047|P4|NOT COMPLETED|Overall Study||3
78796|NCT02179918|193048|P3|NOT COMPLETED|Overall Study||2
78797|NCT02179918|193049|P2|NOT COMPLETED|Overall Study||3
78798|NCT02179918|193050|P1|NOT COMPLETED|Overall Study||4
78799|NCT02179918|193046|P5|COMPLETED|Overall Study||1
78800|NCT02179918|193047|P4|COMPLETED|Overall Study||0
78801|NCT02179918|193048|P3|COMPLETED|Overall Study||1
78802|NCT02179918|193049|P2|COMPLETED|Overall Study||0
78803|NCT02179918|193050|P1|COMPLETED|Overall Study||1
78804|NCT02179918|193046|P5|STARTED|Overall Study||9
78805|NCT02179918|193047|P4|STARTED|Overall Study||3
78806|NCT02179918|193048|P3|STARTED|Overall Study||3
78807|NCT02179918|193049|P2|STARTED|Overall Study||3
78808|NCT02179918|193050|P1|STARTED|Overall Study||5
78809|NCT02179892|193176|P2|NOT COMPLETED|Overall Study||0
78810|NCT02179892|193177|P1|NOT COMPLETED|Overall Study||0
78811|NCT02179892|193176|P2|COMPLETED|Overall Study||4
78812|NCT02179892|193177|P1|COMPLETED|Overall Study||5
78813|NCT02179892|193176|P2|STARTED|Overall Study||4
78814|NCT02179892|193177|P1|STARTED|Overall Study||5
78815|NCT02179671|193194|P5|NOT COMPLETED|Overall Study||13
78816|NCT02179671|193195|P4|NOT COMPLETED|Overall Study||13
78817|NCT02179671|193196|P3|NOT COMPLETED|Overall Study||1
78818|NCT02179671|193197|P2|NOT COMPLETED|Overall Study||1
78819|NCT02179671|193198|P1|NOT COMPLETED|Overall Study||1
78820|NCT02179671|193194|P5|COMPLETED|Overall Study||1
78821|NCT02179671|193195|P4|COMPLETED|Overall Study||1
78822|NCT02179671|193196|P3|COMPLETED|Overall Study||1
78823|NCT02179671|193197|P2|COMPLETED|Overall Study||0
78824|NCT02179671|193198|P1|COMPLETED|Overall Study||0
78825|NCT02179671|193194|P5|STARTED|Overall Study||14
78826|NCT02179671|193195|P4|STARTED|Overall Study||14
78827|NCT02179671|193196|P3|STARTED|Overall Study||2
78828|NCT02179671|193197|P2|STARTED|Overall Study||1
78829|NCT02179671|193198|P1|STARTED|Overall Study||1
78830|NCT02179424|193234|P4|NOT COMPLETED|Overall Study||0
78831|NCT02179424|193235|P3|NOT COMPLETED|Overall Study||0
78832|NCT02179424|193236|P2|NOT COMPLETED|Overall Study||0
78833|NCT02179424|193237|P1|NOT COMPLETED|Overall Study||0
78834|NCT02179424|193234|P4|COMPLETED|Overall Study||39
78835|NCT02179424|193235|P3|COMPLETED|Overall Study||516
78836|NCT02179424|193236|P2|COMPLETED|Overall Study||11
78837|NCT02179424|193237|P1|COMPLETED|Overall Study||76
78838|NCT02179424|193234|P4|STARTED|Overall Study||39
78839|NCT02179424|193235|P3|STARTED|Overall Study||516
78840|NCT02179424|193236|P2|STARTED|Overall Study||11
78841|NCT02179424|193237|P1|STARTED|Overall Study||76
78842|NCT02179398|193254|P2|NOT COMPLETED|Overall Study||4
78843|NCT02179398|193255|P1|NOT COMPLETED|Overall Study||3
78844|NCT02179398|193254|P2|COMPLETED|Overall Study||140
78845|NCT02179398|193255|P1|COMPLETED|Overall Study||131
78846|NCT02179398|193254|P2|STARTED|Overall Study||144
78847|NCT02179398|193255|P1|STARTED|Overall Study||134
78848|NCT02179190|193273|P1|NOT COMPLETED|Follow-Up Post Barrel VRD Implanted||9
78849|NCT02179190|193273|P1|COMPLETED|Follow-Up Post Barrel VRD Implanted||111
78850|NCT02179190|193273|P1|STARTED|Follow-Up Post Barrel VRD Implanted||120
78851|NCT02179190|193273|P1|NOT COMPLETED|Index Procedure With Barrel VRD Attempt||7
78852|NCT02179190|193273|P1|COMPLETED|Index Procedure With Barrel VRD Attempt||120
78853|NCT02179190|193273|P1|STARTED|Index Procedure With Barrel VRD Attempt||127
78854|NCT02179190|193273|P1|NOT COMPLETED|Enrollment||11
78855|NCT02179190|193273|P1|COMPLETED|Enrollment||127
78856|NCT02179190|193273|P1|STARTED|Enrollment||138
78857|NCT02178995|193286|P9|NOT COMPLETED|Open Label||0
78858|NCT02178995|193287|P8|NOT COMPLETED|Open Label||0
78859|NCT02178995|193288|P7|NOT COMPLETED|Open Label||0
78860|NCT02178995|193289|P6|NOT COMPLETED|Open Label||0
78861|NCT02178995|193290|P5|NOT COMPLETED|Open Label||0
78862|NCT02178995|193291|P4|NOT COMPLETED|Open Label||0
78863|NCT02178995|193292|P3|NOT COMPLETED|Open Label||0
78864|NCT02178995|193293|P2|NOT COMPLETED|Open Label||0
78865|NCT02178995|193294|P1|NOT COMPLETED|Open Label||2
78866|NCT02178995|193286|P9|COMPLETED|Open Label||0
78867|NCT02178995|193287|P8|COMPLETED|Open Label||0
78868|NCT02178995|193288|P7|COMPLETED|Open Label||0
78869|NCT02178995|193289|P6|COMPLETED|Open Label||0
78870|NCT02178995|193290|P5|COMPLETED|Open Label||0
78871|NCT02178995|193291|P4|COMPLETED|Open Label||0
78872|NCT02178995|193292|P3|COMPLETED|Open Label||0
78873|NCT02178995|193293|P2|COMPLETED|Open Label||14
78874|NCT02178995|193294|P1|COMPLETED|Open Label||28
78875|NCT02178995|193286|P9|STARTED|Open Label||0
78876|NCT02178995|193287|P8|STARTED|Open Label||0
78877|NCT02178995|193288|P7|STARTED|Open Label||0
78878|NCT02178995|193289|P6|STARTED|Open Label||0
78879|NCT02178995|193290|P5|STARTED|Open Label||0
78880|NCT02178995|193291|P4|STARTED|Open Label||0
78881|NCT02178995|193292|P3|STARTED|Open Label||0
78882|NCT02178995|193293|P2|STARTED|Open Label|One was lost to follow-up after completion of visit 4.|14
78883|NCT02178995|193294|P1|STARTED|Open Label|2 declined to join open-label. 1 withdrew from double-blind but rejoined open-label due to benefit.|30
78884|NCT02178995|193286|P9|NOT COMPLETED|Double Blind||1
78885|NCT02178995|193287|P8|NOT COMPLETED|Double Blind||2
78886|NCT02178995|193288|P7|NOT COMPLETED|Double Blind||0
78887|NCT02178995|193289|P6|NOT COMPLETED|Double Blind||1
78888|NCT02178995|193290|P5|NOT COMPLETED|Double Blind||0
78889|NCT02178995|193291|P4|NOT COMPLETED|Double Blind||0
78890|NCT02178995|193292|P3|NOT COMPLETED|Double Blind||0
78891|NCT02178995|193293|P2|NOT COMPLETED|Double Blind||1
78892|NCT02178995|193294|P1|NOT COMPLETED|Double Blind||0
78893|NCT02178995|193286|P9|COMPLETED|Double Blind||0
78894|NCT02178995|193287|P8|COMPLETED|Double Blind||4
78895|NCT02178995|193288|P7|COMPLETED|Double Blind||5
78896|NCT02178995|193289|P6|COMPLETED|Double Blind||5
78897|NCT02178995|193290|P5|COMPLETED|Double Blind||6
78898|NCT02178995|193291|P4|COMPLETED|Double Blind||6
78899|NCT02178995|193292|P3|COMPLETED|Double Blind||5
78900|NCT02178995|193293|P2|COMPLETED|Double Blind||15
78901|NCT02178995|193294|P1|COMPLETED|Double Blind||0
78902|NCT02178995|193286|P9|STARTED|Double Blind||1
78903|NCT02178995|193287|P8|STARTED|Double Blind||6
78904|NCT02178995|193288|P7|STARTED|Double Blind||5
78905|NCT02178995|193289|P6|STARTED|Double Blind||6
78906|NCT02178995|193290|P5|STARTED|Double Blind||6
78907|NCT02178995|193291|P4|STARTED|Double Blind||6
78908|NCT02178995|193292|P3|STARTED|Double Blind||5
78909|NCT02178995|193293|P2|STARTED|Double Blind||16
78910|NCT02178995|193294|P1|STARTED|Double Blind||0
78911|NCT02178800|193367|P2|NOT COMPLETED|Overall Study||6
78912|NCT02178800|193368|P1|NOT COMPLETED|Overall Study||20
78913|NCT02178800|193367|P2|COMPLETED|Overall Study|Number of participants who weren't terminated at week 41|42
78914|NCT02178800|193368|P1|COMPLETED|Overall Study|Number of participants who weren't terminated at week 41|131
78915|NCT02178800|193367|P2|STARTED|Overall Study||48
78916|NCT02178800|193368|P1|STARTED|Overall Study||151
78917|NCT02178787|193376|P2|NOT COMPLETED|Overall Study||9
78918|NCT02178787|193377|P1|NOT COMPLETED|Overall Study||5
78919|NCT02178787|193376|P2|COMPLETED|Overall Study||30
78920|NCT02178787|193377|P1|COMPLETED|Overall Study||30
78921|NCT02178787|193376|P2|STARTED|Overall Study||39
78922|NCT02178787|193377|P1|STARTED|Overall Study||35
78923|NCT02178696|193385|P2|NOT COMPLETED|Open-label Antidepressant||7
78924|NCT02178696|193386|P1|NOT COMPLETED|Open-label Antidepressant||6
78925|NCT02178696|193385|P2|COMPLETED|Open-label Antidepressant||13
78926|NCT02178696|193386|P1|COMPLETED|Open-label Antidepressant||14
78927|NCT02178696|193385|P2|STARTED|Open-label Antidepressant||20
78928|NCT02178696|193386|P1|STARTED|Open-label Antidepressant||20
78929|NCT02178696|193385|P2|NOT COMPLETED|Second Assignment After Crossover||0
78930|NCT02178696|193386|P1|NOT COMPLETED|Second Assignment After Crossover||0
78931|NCT02178696|193385|P2|COMPLETED|Second Assignment After Crossover||20
78932|NCT02178696|193386|P1|COMPLETED|Second Assignment After Crossover||20
78933|NCT02178696|193385|P2|STARTED|Second Assignment After Crossover||20
78934|NCT02178696|193386|P1|STARTED|Second Assignment After Crossover||20
78935|NCT02178696|193385|P2|NOT COMPLETED|First Assignment and Washout||0
78936|NCT02178696|193386|P1|NOT COMPLETED|First Assignment and Washout||0
78937|NCT02178696|193385|P2|COMPLETED|First Assignment and Washout||20
78938|NCT02178696|193386|P1|COMPLETED|First Assignment and Washout||20
78939|NCT02178696|193385|P2|STARTED|First Assignment and Washout||20
78940|NCT02178696|193386|P1|STARTED|First Assignment and Washout||20
78941|NCT02178592|193401|P2|NOT COMPLETED|Overall Study||9
78942|NCT02178592|193402|P1|NOT COMPLETED|Overall Study||19
78943|NCT02178592|193401|P2|COMPLETED|Overall Study||35
78944|NCT02178592|193402|P1|COMPLETED|Overall Study||50
78945|NCT02178592|193401|P2|STARTED|Overall Study||44
78946|NCT02178592|193402|P1|STARTED|Overall Study||69
78947|NCT02178540|193428|P1|NOT COMPLETED|Overall Study||0
78948|NCT02178540|193428|P1|COMPLETED|Overall Study||45
78949|NCT02178540|193428|P1|STARTED|Overall Study||45
78950|NCT02178475|193435|P1|NOT COMPLETED|Overall Study||129
78951|NCT02178475|193435|P1|COMPLETED|Overall Study||814
78952|NCT02178475|193435|P1|Primary Analysis Set|Overall Study|All enrolled participants who met eligibility criteria|844
78953|NCT02178475|193435|P1|STARTED|Overall Study||943
78954|NCT02178059|193455|P2|NOT COMPLETED|Second Intervention||0
78955|NCT02178059|193456|P1|NOT COMPLETED|Second Intervention||0
78956|NCT02178059|193455|P2|COMPLETED|Second Intervention||17
78957|NCT02178059|193456|P1|COMPLETED|Second Intervention||16
78958|NCT02178059|193455|P2|STARTED|Second Intervention||17
78959|NCT02178059|193456|P1|STARTED|Second Intervention||16
78960|NCT02178059|193455|P2|NOT COMPLETED|Washout||0
78961|NCT02178059|193456|P1|NOT COMPLETED|Washout||1
78962|NCT02178059|193455|P2|COMPLETED|Washout||17
78963|NCT02178059|193456|P1|COMPLETED|Washout||16
78964|NCT02178059|193455|P2|STARTED|Washout||17
78965|NCT02178059|193456|P1|STARTED|Washout||17
78966|NCT02178059|193455|P2|NOT COMPLETED|First Intervention||0
78967|NCT02178059|193456|P1|NOT COMPLETED|First Intervention||0
78968|NCT02178059|193455|P2|COMPLETED|First Intervention||17
78969|NCT02178059|193456|P1|COMPLETED|First Intervention||17
78970|NCT02178059|193455|P2|STARTED|First Intervention||17
78971|NCT02178059|193456|P1|STARTED|First Intervention||17
78972|NCT02177942|193474|P2|NOT COMPLETED|Overall Study||88
78973|NCT02177942|193475|P1|NOT COMPLETED|Overall Study||77
78974|NCT02177942|193474|P2|COMPLETED|Overall Study||178
78975|NCT02177942|193475|P1|COMPLETED|Overall Study||185
78976|NCT02177942|193474|P2|STARTED|Overall Study||266
78977|NCT02177942|193475|P1|STARTED|Overall Study||262
78978|NCT02177812|193506|P9|NOT COMPLETED|Part 2 (Up to 14 Months)||0
78979|NCT02177812|193507|P8|NOT COMPLETED|Part 2 (Up to 14 Months)||0
78980|NCT02177812|193508|P7|NOT COMPLETED|Part 2 (Up to 14 Months)||0
78981|NCT02177812|193509|P6|NOT COMPLETED|Part 2 (Up to 14 Months)||0
78982|NCT02177812|193510|P5|NOT COMPLETED|Part 2 (Up to 14 Months)||0
78983|NCT02177812|193511|P4|NOT COMPLETED|Part 2 (Up to 14 Months)||0
78984|NCT02177812|193512|P3|NOT COMPLETED|Part 2 (Up to 14 Months)||0
78985|NCT02177812|193513|P2|NOT COMPLETED|Part 2 (Up to 14 Months)||0
78986|NCT02177812|193514|P1|NOT COMPLETED|Part 2 (Up to 14 Months)||0
78987|NCT02177812|193506|P9|COMPLETED|Part 2 (Up to 14 Months)||0
78988|NCT02177812|193507|P8|COMPLETED|Part 2 (Up to 14 Months)||0
78989|NCT02177812|193508|P7|COMPLETED|Part 2 (Up to 14 Months)||0
78990|NCT02177812|193509|P6|COMPLETED|Part 2 (Up to 14 Months)||0
78991|NCT02177812|193510|P5|COMPLETED|Part 2 (Up to 14 Months)||0
78992|NCT02177812|193511|P4|COMPLETED|Part 2 (Up to 14 Months)||0
78993|NCT02177812|193512|P3|COMPLETED|Part 2 (Up to 14 Months)||0
78994|NCT02177812|193513|P2|COMPLETED|Part 2 (Up to 14 Months)||0
78995|NCT02177812|193514|P1|COMPLETED|Part 2 (Up to 14 Months)||0
78996|NCT02177812|193506|P9|STARTED|Part 2 (Up to 14 Months)||0
78997|NCT02177812|193507|P8|STARTED|Part 2 (Up to 14 Months)||0
78998|NCT02177812|193508|P7|STARTED|Part 2 (Up to 14 Months)||0
78999|NCT02177812|193509|P6|STARTED|Part 2 (Up to 14 Months)||0
79000|NCT02177812|193510|P5|STARTED|Part 2 (Up to 14 Months)||0
79001|NCT02177812|193511|P4|STARTED|Part 2 (Up to 14 Months)||0
79002|NCT02177812|193512|P3|STARTED|Part 2 (Up to 14 Months)||0
79003|NCT02177812|193513|P2|STARTED|Part 2 (Up to 14 Months)||0
79004|NCT02177812|193514|P1|STARTED|Part 2 (Up to 14 Months)||0
79005|NCT02177812|193506|P9|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
79006|NCT02177812|193507|P8|NOT COMPLETED|Part 1 (Median of 4 Weeks)||2
79007|NCT02177812|193508|P7|NOT COMPLETED|Part 1 (Median of 4 Weeks)||9
79008|NCT02177812|193509|P6|NOT COMPLETED|Part 1 (Median of 4 Weeks)||3
79009|NCT02177812|193510|P5|NOT COMPLETED|Part 1 (Median of 4 Weeks)||1
79010|NCT02177812|193511|P4|NOT COMPLETED|Part 1 (Median of 4 Weeks)||1
79011|NCT02177812|193512|P3|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
79012|NCT02177812|193513|P2|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
79013|NCT02177812|193514|P1|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
79014|NCT02177812|193506|P9|COMPLETED|Part 1 (Median of 4 Weeks)||0
79015|NCT02177812|193507|P8|COMPLETED|Part 1 (Median of 4 Weeks)||4
79016|NCT02177812|193508|P7|COMPLETED|Part 1 (Median of 4 Weeks)||1
79017|NCT02177812|193509|P6|COMPLETED|Part 1 (Median of 4 Weeks)||1
79018|NCT02177812|193510|P5|COMPLETED|Part 1 (Median of 4 Weeks)||5
79019|NCT02177812|193511|P4|COMPLETED|Part 1 (Median of 4 Weeks)||4
79020|NCT02177812|193512|P3|COMPLETED|Part 1 (Median of 4 Weeks)||7
79021|NCT02177812|193513|P2|COMPLETED|Part 1 (Median of 4 Weeks)||2
79022|NCT02177812|193514|P1|COMPLETED|Part 1 (Median of 4 Weeks)||1
79023|NCT02177812|193506|P9|STARTED|Part 1 (Median of 4 Weeks)||0
79024|NCT02177812|193507|P8|STARTED|Part 1 (Median of 4 Weeks)||6
79025|NCT02177812|193508|P7|STARTED|Part 1 (Median of 4 Weeks)||10
79026|NCT02177812|193509|P6|STARTED|Part 1 (Median of 4 Weeks)||4
79027|NCT02177812|193510|P5|STARTED|Part 1 (Median of 4 Weeks)||6
79028|NCT02177812|193511|P4|STARTED|Part 1 (Median of 4 Weeks)||5
79029|NCT02177812|193512|P3|STARTED|Part 1 (Median of 4 Weeks)||7
79030|NCT02177812|193513|P2|STARTED|Part 1 (Median of 4 Weeks)||2
79031|NCT02177812|193514|P1|STARTED|Part 1 (Median of 4 Weeks)||1
79032|NCT02177786|193731|P4|NOT COMPLETED|Overall Study||13
79033|NCT02177786|193732|P3|NOT COMPLETED|Overall Study||18
79034|NCT02177786|193733|P2|NOT COMPLETED|Overall Study||14
79035|NCT02177786|193734|P1|NOT COMPLETED|Overall Study||6
79036|NCT02177786|193731|P4|COMPLETED|Overall Study||72
79037|NCT02177786|193732|P3|COMPLETED|Overall Study||66
79038|NCT02177786|193733|P2|COMPLETED|Overall Study||70
79039|NCT02177786|193734|P1|COMPLETED|Overall Study||75
79040|NCT02177786|193731|P4|Randomized and Treated|Overall Study||85
79041|NCT02177786|193732|P3|Randomized and Treated|Overall Study||83
79042|NCT02177786|193733|P2|Randomized and Treated|Overall Study||84
79043|NCT02177786|193734|P1|Randomized and Treated|Overall Study||81
79044|NCT02177786|193731|P4|STARTED|Overall Study||85
79045|NCT02177786|193732|P3|STARTED|Overall Study||84
79046|NCT02177786|193733|P2|STARTED|Overall Study||84
79047|NCT02177786|193734|P1|STARTED|Overall Study||81
79048|NCT02177773|193748|P1|NOT COMPLETED|Overall Study||0
79049|NCT02177773|193748|P1|COMPLETED|Overall Study||300
79050|NCT02177773|193748|P1|STARTED|Overall Study||300
79051|NCT02177266|193757|P2|NOT COMPLETED|Overall Study||1
79052|NCT02177266|193758|P1|NOT COMPLETED|Overall Study||1
79053|NCT02177266|193757|P2|COMPLETED|Overall Study||0
79054|NCT02177266|193758|P1|COMPLETED|Overall Study||0
79055|NCT02177266|193757|P2|STARTED|Overall Study||1
79056|NCT02177266|193758|P1|STARTED|Overall Study||1
79057|NCT02177201|193770|P2|NOT COMPLETED|Overall Study||3
79058|NCT02177201|193771|P1|NOT COMPLETED|Overall Study||3
79059|NCT02177201|193770|P2|COMPLETED|Overall Study||77
79060|NCT02177201|193771|P1|COMPLETED|Overall Study||77
79061|NCT02177201|193770|P2|STARTED|Overall Study||80
79062|NCT02177201|193771|P1|STARTED|Overall Study||80
79063|NCT02177136|193780|P3|NOT COMPLETED|Overall Study||4
79064|NCT02177136|193781|P2|NOT COMPLETED|Overall Study||5
79065|NCT02177136|193782|P1|NOT COMPLETED|Overall Study||6
79066|NCT02177136|193780|P3|COMPLETED|Overall Study||21
79067|NCT02177136|193781|P2|COMPLETED|Overall Study||21
79068|NCT02177136|193782|P1|COMPLETED|Overall Study||19
79069|NCT02177136|193780|P3|STARTED|Overall Study||25
79070|NCT02177136|193781|P2|STARTED|Overall Study||26
79071|NCT02177136|193782|P1|STARTED|Overall Study||25
79072|NCT02177032|193815|P4|NOT COMPLETED|Overall Study||0
79073|NCT02177032|193816|P3|NOT COMPLETED|Overall Study||3
79074|NCT02177032|193817|P2|NOT COMPLETED|Overall Study||2
79075|NCT02177032|193818|P1|NOT COMPLETED|Overall Study||5
79076|NCT02177032|193815|P4|COMPLETED|Overall Study||88
79077|NCT02177032|193816|P3|COMPLETED|Overall Study||351
79078|NCT02177032|193817|P2|COMPLETED|Overall Study||86
79079|NCT02177032|193818|P1|COMPLETED|Overall Study||350
79080|NCT02177032|193815|P4|STARTED|Overall Study||88
79081|NCT02177032|193816|P3|STARTED|Overall Study||354
79082|NCT02177032|193817|P2|STARTED|Overall Study||88
79083|NCT02177032|193818|P1|STARTED|Overall Study||355
79084|NCT02176837|193852|P1|NOT COMPLETED|Overall Study||6
79085|NCT02176837|193852|P1|COMPLETED|Overall Study||0
79086|NCT02176837|193852|P1|STARTED|Overall Study||6
79087|NCT02176655|193856|P1|NOT COMPLETED|Overall Study||6
79088|NCT02176655|193856|P1|COMPLETED|Overall Study||25
79089|NCT02176655|193856|P1|STARTED|Overall Study||31
79090|NCT02176642|193879|P2|NOT COMPLETED|Overall Study||1
79091|NCT02176642|193880|P1|NOT COMPLETED|Overall Study||0
79092|NCT02176642|193879|P2|COMPLETED|Overall Study||16
79093|NCT02176642|193880|P1|COMPLETED|Overall Study||18
79094|NCT02176642|193879|P2|STARTED|Overall Study||17
79095|NCT02176642|193880|P1|STARTED|Overall Study||18
79096|NCT02176525|193910|P8|NOT COMPLETED|Overall Study||0
79097|NCT02176525|193911|P7|NOT COMPLETED|Overall Study||1
79098|NCT02176525|193912|P6|NOT COMPLETED|Overall Study||1
79099|NCT02176525|193913|P5|NOT COMPLETED|Overall Study||1
79100|NCT02176525|193914|P4|NOT COMPLETED|Overall Study||1
79101|NCT02176525|193915|P3|NOT COMPLETED|Overall Study||0
79102|NCT02176525|193916|P2|NOT COMPLETED|Overall Study||0
79103|NCT02176525|193917|P1|NOT COMPLETED|Overall Study||1
79104|NCT02176525|193910|P8|COMPLETED|Overall Study||10
79105|NCT02176525|193911|P7|COMPLETED|Overall Study||8
79106|NCT02176525|193912|P6|COMPLETED|Overall Study||5
79107|NCT02176525|193913|P5|COMPLETED|Overall Study||7
79108|NCT02176525|193914|P4|COMPLETED|Overall Study||8
79109|NCT02176525|193915|P3|COMPLETED|Overall Study||9
79110|NCT02176525|193916|P2|COMPLETED|Overall Study||9
79111|NCT02176525|193917|P1|COMPLETED|Overall Study||14
79112|NCT02176525|193910|P8|STARTED|Overall Study||10
79113|NCT02176525|193911|P7|STARTED|Overall Study||9
79114|NCT02176525|193912|P6|STARTED|Overall Study|6 subjects randomized, 5 subjects treated with at least one dose, 1 subject was not treated|6
79115|NCT02176525|193913|P5|STARTED|Overall Study||8
79116|NCT02176525|193914|P4|STARTED|Overall Study||9
79117|NCT02176525|193915|P3|STARTED|Overall Study||9
79118|NCT02176525|193916|P2|STARTED|Overall Study||9
79119|NCT02176525|193917|P1|STARTED|Overall Study|15 subjects randomized, 14 subjects treated with at least one dose, 1 subject was not treated|15
79120|NCT02176486|194097|P3|NOT COMPLETED|Overall Study||0
79121|NCT02176486|194098|P2|NOT COMPLETED|Overall Study||0
79122|NCT02176486|194099|P1|NOT COMPLETED|Overall Study||0
79123|NCT02176486|194097|P3|COMPLETED|Overall Study||4
79124|NCT02176486|194098|P2|COMPLETED|Overall Study||5
79125|NCT02176486|194099|P1|COMPLETED|Overall Study||3
79126|NCT02176486|194097|P3|STARTED|Overall Study||4
79127|NCT02176486|194098|P2|STARTED|Overall Study||5
79128|NCT02176486|194099|P1|STARTED|Overall Study||3
79129|NCT02176421|194133|P1|NOT COMPLETED|Overall Study||5
79130|NCT02176421|194133|P1|COMPLETED|Overall Study||75
79131|NCT02176421|194133|P1|STARTED|Overall Study||80
79132|NCT02176408|194144|P2|NOT COMPLETED|Overall Study||4
79133|NCT02176408|194145|P1|NOT COMPLETED|Overall Study||6
79134|NCT02176408|194144|P2|COMPLETED|Overall Study||12
79135|NCT02176408|194145|P1|COMPLETED|Overall Study||9
79136|NCT02176408|194144|P2|STARTED|Overall Study||16
79137|NCT02176408|194145|P1|STARTED|Overall Study||15
79138|NCT02176356|194165|P1|NOT COMPLETED|Overall Study||23
79139|NCT02176356|194165|P1|COMPLETED|Overall Study||93
79140|NCT02176356|194165|P1|Eligible and Received Treatment|Overall Study||100
79141|NCT02176356|194165|P1|STARTED|Overall Study||116
79142|NCT02176343|194182|P1|NOT COMPLETED|Overall Study||0
79143|NCT02176343|194182|P1|COMPLETED|Overall Study||31
79144|NCT02176343|194182|P1|STARTED|Overall Study||31
79145|NCT02176291|194195|P2|NOT COMPLETED|Overall Study||0
79146|NCT02176291|194196|P1|NOT COMPLETED|Overall Study||5
79147|NCT02176291|194195|P2|COMPLETED|Overall Study||11
79148|NCT02176291|194196|P1|COMPLETED|Overall Study||15
79149|NCT02176291|194195|P2|STARTED|Overall Study||11
79150|NCT02176291|194196|P1|STARTED|Overall Study||20
79151|NCT02176226|194204|P1|NOT COMPLETED|Overall Study||9
79152|NCT02176226|194204|P1|COMPLETED|Overall Study||96
79153|NCT02176226|194204|P1|STARTED|Overall Study||105
79154|NCT02176018|194212|P2|NOT COMPLETED|Overall Study||6
79155|NCT02176018|194213|P1|NOT COMPLETED|Overall Study||5
79156|NCT02176018|194212|P2|COMPLETED|Overall Study||17
79157|NCT02176018|194213|P1|COMPLETED|Overall Study||17
79158|NCT02176018|194212|P2|STARTED|Overall Study||23
79159|NCT02176018|194213|P1|STARTED|Overall Study||22
79160|NCT02175979|194239|P2|NOT COMPLETED|Overall Study||8
79161|NCT02175979|194240|P1|NOT COMPLETED|Overall Study||7
79162|NCT02175979|194239|P2|COMPLETED|Overall Study||132
79163|NCT02175979|194240|P1|COMPLETED|Overall Study||133
79164|NCT02175979|194239|P2|STARTED|Overall Study||140
79165|NCT02175979|194240|P1|STARTED|Overall Study||140
79166|NCT02175966|194264|P2|NOT COMPLETED|Follow-up Period||6
79167|NCT02175966|194265|P1|NOT COMPLETED|Follow-up Period||10
79168|NCT02175966|194264|P2|COMPLETED|Follow-up Period||8
79169|NCT02175966|194265|P1|COMPLETED|Follow-up Period||4
79170|NCT02175966|194264|P2|STARTED|Follow-up Period||14
79171|NCT02175966|194265|P1|STARTED|Follow-up Period||14
79172|NCT02175966|194264|P2|NOT COMPLETED|Treatment Period||0
79173|NCT02175966|194265|P1|NOT COMPLETED|Treatment Period||0
79174|NCT02175966|194264|P2|COMPLETED|Treatment Period||14
79175|NCT02175966|194265|P1|COMPLETED|Treatment Period||14
79176|NCT02175966|194264|P2|STARTED|Treatment Period||14
79177|NCT02175966|194265|P1|STARTED|Treatment Period||14
79178|NCT02175771|194293|P9|NOT COMPLETED|Treatment Period||6
79179|NCT02175771|194294|P8|NOT COMPLETED|Treatment Period||17
79180|NCT02175771|194295|P7|NOT COMPLETED|Treatment Period||5
79181|NCT02175771|194296|P6|NOT COMPLETED|Treatment Period||10
79182|NCT02175771|194297|P5|NOT COMPLETED|Treatment Period||5
79183|NCT02175771|194298|P4|NOT COMPLETED|Treatment Period||13
79184|NCT02175771|194299|P3|NOT COMPLETED|Treatment Period||7
79185|NCT02175771|194300|P2|NOT COMPLETED|Treatment Period||16
79186|NCT02175771|194301|P1|NOT COMPLETED|Treatment Period||0
79187|NCT02175771|194293|P9|COMPLETED|Treatment Period||38
79188|NCT02175771|194294|P8|COMPLETED|Treatment Period||116
79189|NCT02175771|194295|P7|COMPLETED|Treatment Period||36
79190|NCT02175771|194296|P6|COMPLETED|Treatment Period||110
79191|NCT02175771|194297|P5|COMPLETED|Treatment Period||36
79192|NCT02175771|194298|P4|COMPLETED|Treatment Period||113
79193|NCT02175771|194299|P3|COMPLETED|Treatment Period||35
79194|NCT02175771|194300|P2|COMPLETED|Treatment Period||111
79195|NCT02175771|194301|P1|COMPLETED|Treatment Period||0
79196|NCT02175771|194293|P9|STARTED|Treatment Period||44
79197|NCT02175771|194294|P8|STARTED|Treatment Period||133
79198|NCT02175771|194295|P7|STARTED|Treatment Period||41
79199|NCT02175771|194296|P6|STARTED|Treatment Period||120
79200|NCT02175771|194297|P5|STARTED|Treatment Period||41
79201|NCT02175771|194298|P4|STARTED|Treatment Period||126
79202|NCT02175771|194299|P3|STARTED|Treatment Period||42
79203|NCT02175771|194300|P2|STARTED|Treatment Period||127
79204|NCT02175771|194301|P1|STARTED|Treatment Period||0
79205|NCT02175771|194293|P9|NOT COMPLETED|Run-In Period (Pre-assignment)||0
79206|NCT02175771|194294|P8|NOT COMPLETED|Run-In Period (Pre-assignment)||0
79207|NCT02175771|194295|P7|NOT COMPLETED|Run-In Period (Pre-assignment)||0
79208|NCT02175771|194296|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
79209|NCT02175771|194297|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
79210|NCT02175771|194298|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
79211|NCT02175771|194299|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
79212|NCT02175771|194300|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
79213|NCT02175771|194301|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||84
79214|NCT02175771|194293|P9|COMPLETED|Run-In Period (Pre-assignment)||0
79215|NCT02175771|194294|P8|COMPLETED|Run-In Period (Pre-assignment)||0
79216|NCT02175771|194295|P7|COMPLETED|Run-In Period (Pre-assignment)||0
79217|NCT02175771|194296|P6|COMPLETED|Run-In Period (Pre-assignment)||0
79218|NCT02175771|194297|P5|COMPLETED|Run-In Period (Pre-assignment)||0
79219|NCT02175771|194298|P4|COMPLETED|Run-In Period (Pre-assignment)||0
79220|NCT02175771|194299|P3|COMPLETED|Run-In Period (Pre-assignment)||0
79221|NCT02175771|194300|P2|COMPLETED|Run-In Period (Pre-assignment)||0
79222|NCT02175771|194301|P1|COMPLETED|Run-In Period (Pre-assignment)||674
79223|NCT02175771|194293|P9|STARTED|Run-In Period (Pre-assignment)||0
79224|NCT02175771|194294|P8|STARTED|Run-In Period (Pre-assignment)||0
79225|NCT02175771|194295|P7|STARTED|Run-In Period (Pre-assignment)||0
79226|NCT02175771|194296|P6|STARTED|Run-In Period (Pre-assignment)||0
79227|NCT02175771|194297|P5|STARTED|Run-In Period (Pre-assignment)||0
79228|NCT02175771|194298|P4|STARTED|Run-In Period (Pre-assignment)||0
79229|NCT02175771|194299|P3|STARTED|Run-In Period (Pre-assignment)||0
79230|NCT02175771|194300|P2|STARTED|Run-In Period (Pre-assignment)||0
79231|NCT02175771|194301|P1|STARTED|Run-In Period (Pre-assignment)|Enrolled; two participants were enrolled but had no enrollment date in their records.|758
79232|NCT02175758|194365|P6|NOT COMPLETED|Treatment Phase||0
79233|NCT02175758|194366|P5|NOT COMPLETED|Treatment Phase||1
79234|NCT02175758|194367|P4|NOT COMPLETED|Treatment Phase||0
79235|NCT02175758|194368|P3|NOT COMPLETED|Treatment Phase||0
79236|NCT02175758|194369|P2|NOT COMPLETED|Treatment Phase||1
79237|NCT02175758|194370|P1|NOT COMPLETED|Treatment Phase||0
79238|NCT02175758|194365|P6|COMPLETED|Treatment Phase||8
79239|NCT02175758|194366|P5|COMPLETED|Treatment Phase||4
79240|NCT02175758|194367|P4|COMPLETED|Treatment Phase||28
79241|NCT02175758|194368|P3|COMPLETED|Treatment Phase||13
79242|NCT02175758|194369|P2|COMPLETED|Treatment Phase||38
79243|NCT02175758|194370|P1|COMPLETED|Treatment Phase||13
79244|NCT02175758|194365|P6|STARTED|Treatment Phase||8
79245|NCT02175758|194366|P5|STARTED|Treatment Phase|1 participant enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|5
79246|NCT02175758|194367|P4|STARTED|Treatment Phase|18 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|28
79247|NCT02175758|194368|P3|STARTED|Treatment Phase|11 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|13
79248|NCT02175758|194369|P2|STARTED|Treatment Phase|33 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|39
79249|NCT02175758|194370|P1|STARTED|Treatment Phase|9 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|13
79250|NCT02175758|194365|P6|NOT COMPLETED|PK Lead-in Phase||0
79251|NCT02175758|194366|P5|NOT COMPLETED|PK Lead-in Phase||0
79252|NCT02175758|194367|P4|NOT COMPLETED|PK Lead-in Phase||0
79253|NCT02175758|194368|P3|NOT COMPLETED|PK Lead-in Phase||0
79254|NCT02175758|194369|P2|NOT COMPLETED|PK Lead-in Phase||0
79255|NCT02175758|194370|P1|NOT COMPLETED|PK Lead-in Phase||0
79256|NCT02175758|194365|P6|COMPLETED|PK Lead-in Phase||8
79257|NCT02175758|194366|P5|COMPLETED|PK Lead-in Phase||4
79258|NCT02175758|194367|P4|COMPLETED|PK Lead-in Phase||10
79259|NCT02175758|194368|P3|COMPLETED|PK Lead-in Phase||2
79260|NCT02175758|194369|P2|COMPLETED|PK Lead-in Phase||6
79261|NCT02175758|194370|P1|COMPLETED|PK Lead-in Phase||4
79262|NCT02175758|194365|P6|STARTED|PK Lead-in Phase||8
79263|NCT02175758|194366|P5|STARTED|PK Lead-in Phase||4
79264|NCT02175758|194367|P4|STARTED|PK Lead-in Phase||10
79265|NCT02175758|194368|P3|STARTED|PK Lead-in Phase||2
79266|NCT02175758|194369|P2|STARTED|PK Lead-in Phase||6
79267|NCT02175758|194370|P1|STARTED|PK Lead-in Phase||4
79268|NCT02175745|194473|P1|NOT COMPLETED|Overall Study||1
79269|NCT02175745|194473|P1|COMPLETED|Overall Study||1
79270|NCT02175745|194473|P1|STARTED|Overall Study||2
79271|NCT02175628|194480|P2|NOT COMPLETED|Overall Study||0
79272|NCT02175628|194481|P1|NOT COMPLETED|Overall Study||0
79273|NCT02175628|194480|P2|COMPLETED|Overall Study||17
79274|NCT02175628|194481|P1|COMPLETED|Overall Study||6
79275|NCT02175628|194480|P2|STARTED|Overall Study||17
79276|NCT02175628|194481|P1|STARTED|Overall Study||6
79277|NCT02175472|194497|P2|NOT COMPLETED|Overall Study||2
79278|NCT02175472|194498|P1|NOT COMPLETED|Overall Study||7
79279|NCT02175472|194497|P2|COMPLETED|Overall Study||45
79280|NCT02175472|194498|P1|COMPLETED|Overall Study||38
79281|NCT02175472|194497|P2|STARTED|Overall Study||47
79282|NCT02175472|194498|P1|STARTED|Overall Study||45
79283|NCT02175368|194512|P1|NOT COMPLETED|Overall Study||1
79284|NCT02175368|194512|P1|COMPLETED|Overall Study||27
79285|NCT02175368|194512|P1|STARTED|Overall Study||28
79286|NCT02175277|194517|P1|NOT COMPLETED|Overall Study||1
79287|NCT02175277|194517|P1|COMPLETED|Overall Study||8
79288|NCT02175277|194517|P1|STARTED|Overall Study||9
79289|NCT02175225|194523|P2|NOT COMPLETED|Overall Study||11
79290|NCT02175225|194524|P1|NOT COMPLETED|Overall Study||8
79291|NCT02175225|194523|P2|COMPLETED|Overall Study||138
79292|NCT02175225|194524|P1|COMPLETED|Overall Study||137
79293|NCT02175225|194523|P2|180 Day Outcome Obtained|Overall Study||135
79294|NCT02175225|194524|P1|180 Day Outcome Obtained|Overall Study||135
79295|NCT02175225|194523|P2|90 Day Outcome Obtained|Overall Study||143
79296|NCT02175225|194524|P1|90 Day Outcome Obtained|Overall Study||140
79297|NCT02175225|194523|P2|Initiated Study Drug|Overall Study|Subjects in whom study drug was not initiated are not subsequently followed per the protocol.|147
79298|NCT02175225|194524|P1|Initiated Study Drug|Overall Study|Subjects in whom study drug was not initiated are not subsequently followed per the protocol.|144
79299|NCT02175225|194523|P2|STARTED|Overall Study||149
79300|NCT02175225|194524|P1|STARTED|Overall Study||145
79301|NCT02175212|194558|P2|NOT COMPLETED|Overall Study||147
79302|NCT02175212|194559|P1|NOT COMPLETED|Overall Study||163
79303|NCT02175212|194558|P2|COMPLETED|Overall Study||31
79304|NCT02175212|194559|P1|COMPLETED|Overall Study||14
79305|NCT02175212|194558|P2|STARTED|Overall Study||178
79306|NCT02175212|194559|P1|STARTED|Overall Study||177
79307|NCT02175199|194575|P2|NOT COMPLETED|Overall Study||5
79308|NCT02175199|194576|P1|NOT COMPLETED|Overall Study||3
79309|NCT02175199|194575|P2|COMPLETED|Overall Study||71
79310|NCT02175199|194576|P1|COMPLETED|Overall Study||71
79311|NCT02175199|194575|P2|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|74
79312|NCT02175199|194576|P1|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|72
79313|NCT02175199|194575|P2|STARTED|Overall Study||76
79314|NCT02175199|194576|P1|STARTED|Overall Study||74
79315|NCT02175121|194590|P5|NOT COMPLETED|Overall Study||1
79316|NCT02175121|194591|P4|NOT COMPLETED|Overall Study||1
79317|NCT02175121|194592|P3|NOT COMPLETED|Overall Study||2
79318|NCT02175121|194593|P2|NOT COMPLETED|Overall Study||1
79319|NCT02175121|194594|P1|NOT COMPLETED|Overall Study||1
79320|NCT02175121|194590|P5|COMPLETED|Overall Study||33
79321|NCT02175121|194591|P4|COMPLETED|Overall Study||34
79322|NCT02175121|194592|P3|COMPLETED|Overall Study||32
79323|NCT02175121|194593|P2|COMPLETED|Overall Study||34
79324|NCT02175121|194594|P1|COMPLETED|Overall Study||33
79325|NCT02175121|194590|P5|STARTED|Overall Study||34
79326|NCT02175121|194591|P4|STARTED|Overall Study||35
79327|NCT02175121|194592|P3|STARTED|Overall Study||34
79328|NCT02175121|194593|P2|STARTED|Overall Study||35
79329|NCT02175121|194594|P1|STARTED|Overall Study||34
79330|NCT02174861|194721|P1|NOT COMPLETED|Overall Study||158
79331|NCT02174861|194721|P1|COMPLETED|Overall Study||451
79332|NCT02174861|194721|P1|Enrolled in CHU Substudy|Overall Study||53
79333|NCT02174861|194721|P1|STARTED|Overall Study||609
79334|NCT02174848|194735|P2|NOT COMPLETED|Overall Study||6
79335|NCT02174848|194736|P1|NOT COMPLETED|Overall Study||7
79336|NCT02174848|194735|P2|COMPLETED|Overall Study||38
79337|NCT02174848|194736|P1|COMPLETED|Overall Study||17
79338|NCT02174848|194735|P2|Provided Post-baseline Efficacy Data|Overall Study||43
79339|NCT02174848|194736|P1|Provided Post-baseline Efficacy Data|Overall Study||19
79340|NCT02174848|194735|P2|STARTED|Overall Study||44
79341|NCT02174848|194736|P1|STARTED|Overall Study||24
79342|NCT02174523|194757|P2|NOT COMPLETED|Overall Study||0
79343|NCT02174523|194758|P1|NOT COMPLETED|Overall Study||1
79344|NCT02174523|194757|P2|COMPLETED|Overall Study||4
79345|NCT02174523|194758|P1|COMPLETED|Overall Study||9
79346|NCT02174523|194757|P2|STARTED|Overall Study||4
79347|NCT02174523|194758|P1|STARTED|Overall Study||10
79348|NCT02174510|194789|P4|NOT COMPLETED|Overall Study||0
79349|NCT02174510|194790|P3|NOT COMPLETED|Overall Study||0
79350|NCT02174510|194791|P2|NOT COMPLETED|Overall Study||0
79351|NCT02174510|194792|P1|NOT COMPLETED|Overall Study||0
79352|NCT02174510|194789|P4|COMPLETED|Overall Study||9
79353|NCT02174510|194790|P3|COMPLETED|Overall Study||12
79354|NCT02174510|194791|P2|COMPLETED|Overall Study||8
79355|NCT02174510|194792|P1|COMPLETED|Overall Study||8
79356|NCT02174510|194789|P4|STARTED|Overall Study||9
79357|NCT02174510|194790|P3|STARTED|Overall Study||12
79358|NCT02174510|194791|P2|STARTED|Overall Study||8
79359|NCT02174510|194792|P1|STARTED|Overall Study||8
79360|NCT02174276|194826|P4|NOT COMPLETED|OTEP (Weeks 48 to 144)||2
79361|NCT02174276|194827|P3|NOT COMPLETED|OTEP (Weeks 48 to 144)||3
79362|NCT02174276|194828|P2|NOT COMPLETED|OTEP (Weeks 48 to 144)||0
79363|NCT02174276|194829|P1|NOT COMPLETED|OTEP (Weeks 48 to 144)||1
79364|NCT02174276|194826|P4|COMPLETED|OTEP (Weeks 48 to 144)||50
79365|NCT02174276|194827|P3|COMPLETED|OTEP (Weeks 48 to 144)||48
79366|NCT02174276|194828|P2|COMPLETED|OTEP (Weeks 48 to 144)||54
79367|NCT02174276|194829|P1|COMPLETED|OTEP (Weeks 48 to 144)||25
79368|NCT02174276|194826|P4|STARTED|OTEP (Weeks 48 to 144)|3 Participants completed the study treatment phase but did not continue in OTEP.|52
79369|NCT02174276|194827|P3|STARTED|OTEP (Weeks 48 to 144)|2 Participants completed the study treatment phase but did not continue in OTEP.|51
79370|NCT02174276|194828|P2|STARTED|OTEP (Weeks 48 to 144)|2 Participants completed the study treatment phase but did not continue in OTEP.|54
79371|NCT02174276|194829|P1|STARTED|OTEP (Weeks 48 to 144)||26
79372|NCT02174276|194826|P4|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||0
79373|NCT02174276|194827|P3|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||3
79374|NCT02174276|194828|P2|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||1
79375|NCT02174276|194829|P1|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||1
79376|NCT02174276|194826|P4|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||55
79377|NCT02174276|194827|P3|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||53
79378|NCT02174276|194828|P2|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||56
79379|NCT02174276|194829|P1|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||26
79380|NCT02174276|194826|P4|STARTED|Study Treatment Phase (Weeks 1 to 48)||55
79381|NCT02174276|194827|P3|STARTED|Study Treatment Phase (Weeks 1 to 48)||56
79382|NCT02174276|194828|P2|STARTED|Study Treatment Phase (Weeks 1 to 48)||57
79383|NCT02174276|194829|P1|STARTED|Study Treatment Phase (Weeks 1 to 48)||27
79384|NCT02174198|194913|P2|NOT COMPLETED|Overall Study||0
79385|NCT02174198|194914|P1|NOT COMPLETED|Overall Study||0
79386|NCT02174198|194913|P2|COMPLETED|Overall Study||16
79387|NCT02174198|194914|P1|COMPLETED|Overall Study||16
79388|NCT02174198|194913|P2|STARTED|Overall Study||16
79389|NCT02174198|194914|P1|STARTED|Overall Study||16
79390|NCT02173769|194936|P1|NOT COMPLETED|Overall Study||4
79391|NCT02173769|194936|P1|COMPLETED|Overall Study||1854
79392|NCT02173769|194936|P1|STARTED|Overall Study||1858
79393|NCT02173704|194949|P2|NOT COMPLETED|Overall Study||4
79394|NCT02173704|194950|P1|NOT COMPLETED|Overall Study||13
79395|NCT02173704|194949|P2|COMPLETED|Overall Study||71
79396|NCT02173704|194950|P1|COMPLETED|Overall Study||137
79397|NCT02173704|194949|P2|STARTED|Overall Study||75
79398|NCT02173704|194950|P1|STARTED|Overall Study||150
79399|NCT02173548|194976|P2|NOT COMPLETED|Overall Study||2
79400|NCT02173548|194977|P1|NOT COMPLETED|Overall Study||1
79401|NCT02173548|194976|P2|COMPLETED|Overall Study||8
79402|NCT02173548|194977|P1|COMPLETED|Overall Study||20
79403|NCT02173548|194976|P2|STARTED|Overall Study||10
79404|NCT02173548|194977|P1|STARTED|Overall Study||21
79405|NCT02173535|195017|P20|NOT COMPLETED|Period 5||0
79406|NCT02173535|195018|P19|NOT COMPLETED|Period 5||0
79407|NCT02173535|195019|P18|NOT COMPLETED|Period 5||0
79408|NCT02173535|195020|P17|NOT COMPLETED|Period 5||0
79409|NCT02173535|195021|P16|NOT COMPLETED|Period 5||0
79410|NCT02173535|195022|P15|NOT COMPLETED|Period 5||0
79411|NCT02173535|195023|P14|NOT COMPLETED|Period 5||0
79412|NCT02173535|195024|P13|NOT COMPLETED|Period 5||0
79413|NCT02173535|195025|P12|NOT COMPLETED|Period 5||0
79414|NCT02173535|195026|P11|NOT COMPLETED|Period 5||0
79415|NCT02173535|195027|P10|NOT COMPLETED|Period 5||0
79416|NCT02173535|195028|P9|NOT COMPLETED|Period 5||0
79417|NCT02173535|195029|P8|NOT COMPLETED|Period 5||0
79418|NCT02173535|195030|P7|NOT COMPLETED|Period 5||0
79419|NCT02173535|195031|P6|NOT COMPLETED|Period 5||0
79420|NCT02173535|195032|P5|NOT COMPLETED|Period 5||0
79421|NCT02173535|195033|P4|NOT COMPLETED|Period 5||0
79422|NCT02173535|195034|P3|NOT COMPLETED|Period 5||0
79423|NCT02173535|195035|P2|NOT COMPLETED|Period 5||0
79424|NCT02173535|195036|P1|NOT COMPLETED|Period 5||0
79425|NCT02173535|195017|P20|COMPLETED|Period 5||12
79426|NCT02173535|195018|P19|COMPLETED|Period 5||12
79427|NCT02173535|195019|P18|COMPLETED|Period 5||12
79428|NCT02173535|195020|P17|COMPLETED|Period 5||12
79429|NCT02173535|195021|P16|COMPLETED|Period 5||12
79430|NCT02173535|195022|P15|COMPLETED|Period 5||12
79431|NCT02173535|195023|P14|COMPLETED|Period 5||12
79432|NCT02173535|195024|P13|COMPLETED|Period 5||12
79433|NCT02173535|195025|P12|COMPLETED|Period 5||12
79434|NCT02173535|195026|P11|COMPLETED|Period 5||12
79435|NCT02173535|195027|P10|COMPLETED|Period 5||12
79436|NCT02173535|195028|P9|COMPLETED|Period 5||12
79437|NCT02173535|195029|P8|COMPLETED|Period 5||12
79438|NCT02173535|195030|P7|COMPLETED|Period 5||12
79439|NCT02173535|195031|P6|COMPLETED|Period 5||12
79440|NCT02173535|195032|P5|COMPLETED|Period 5||12
79441|NCT02173535|195033|P4|COMPLETED|Period 5||12
79442|NCT02173535|195034|P3|COMPLETED|Period 5||12
79443|NCT02173535|195035|P2|COMPLETED|Period 5||12
79444|NCT02173535|195036|P1|COMPLETED|Period 5||12
79445|NCT02173535|195017|P20|STARTED|Period 5||12
79446|NCT02173535|195018|P19|STARTED|Period 5||12
79447|NCT02173535|195019|P18|STARTED|Period 5||12
79448|NCT02173535|195020|P17|STARTED|Period 5||12
79449|NCT02173535|195021|P16|STARTED|Period 5||12
79450|NCT02173535|195022|P15|STARTED|Period 5||12
79451|NCT02173535|195023|P14|STARTED|Period 5||12
79452|NCT02173535|195024|P13|STARTED|Period 5||12
79453|NCT02173535|195025|P12|STARTED|Period 5||12
79454|NCT02173535|195026|P11|STARTED|Period 5||12
79455|NCT02173535|195027|P10|STARTED|Period 5||12
79456|NCT02173535|195028|P9|STARTED|Period 5||12
79457|NCT02173535|195029|P8|STARTED|Period 5||12
79458|NCT02173535|195030|P7|STARTED|Period 5||12
79459|NCT02173535|195031|P6|STARTED|Period 5||12
79460|NCT02173535|195032|P5|STARTED|Period 5||12
79461|NCT02173535|195033|P4|STARTED|Period 5||12
79462|NCT02173535|195034|P3|STARTED|Period 5||12
79463|NCT02173535|195035|P2|STARTED|Period 5||12
79464|NCT02173535|195036|P1|STARTED|Period 5||12
79465|NCT02173535|195017|P20|NOT COMPLETED|Period 4||0
79466|NCT02173535|195018|P19|NOT COMPLETED|Period 4||0
79467|NCT02173535|195019|P18|NOT COMPLETED|Period 4||0
79468|NCT02173535|195020|P17|NOT COMPLETED|Period 4||0
79469|NCT02173535|195021|P16|NOT COMPLETED|Period 4||0
79470|NCT02173535|195022|P15|NOT COMPLETED|Period 4||0
79471|NCT02173535|195023|P14|NOT COMPLETED|Period 4||0
79472|NCT02173535|195024|P13|NOT COMPLETED|Period 4||0
79473|NCT02173535|195025|P12|NOT COMPLETED|Period 4||0
79474|NCT02173535|195026|P11|NOT COMPLETED|Period 4||0
79475|NCT02173535|195027|P10|NOT COMPLETED|Period 4||0
79476|NCT02173535|195028|P9|NOT COMPLETED|Period 4||0
79477|NCT02173535|195029|P8|NOT COMPLETED|Period 4||0
79478|NCT02173535|195030|P7|NOT COMPLETED|Period 4||0
79479|NCT02173535|195031|P6|NOT COMPLETED|Period 4||0
79480|NCT02173535|195032|P5|NOT COMPLETED|Period 4||0
79481|NCT02173535|195033|P4|NOT COMPLETED|Period 4||0
79482|NCT02173535|195034|P3|NOT COMPLETED|Period 4||0
79483|NCT02173535|195035|P2|NOT COMPLETED|Period 4||0
79484|NCT02173535|195036|P1|NOT COMPLETED|Period 4||0
79485|NCT02173535|195017|P20|COMPLETED|Period 4||12
79486|NCT02173535|195018|P19|COMPLETED|Period 4||12
79487|NCT02173535|195019|P18|COMPLETED|Period 4||12
79488|NCT02173535|195020|P17|COMPLETED|Period 4||12
79489|NCT02173535|195021|P16|COMPLETED|Period 4||12
79490|NCT02173535|195022|P15|COMPLETED|Period 4||12
79491|NCT02173535|195023|P14|COMPLETED|Period 4||12
79492|NCT02173535|195024|P13|COMPLETED|Period 4||12
79493|NCT02173535|195025|P12|COMPLETED|Period 4||12
79494|NCT02173535|195026|P11|COMPLETED|Period 4||12
79495|NCT02173535|195027|P10|COMPLETED|Period 4||12
79496|NCT02173535|195028|P9|COMPLETED|Period 4||12
79497|NCT02173535|195029|P8|COMPLETED|Period 4||12
79498|NCT02173535|195030|P7|COMPLETED|Period 4||12
79499|NCT02173535|195031|P6|COMPLETED|Period 4||12
79500|NCT02173535|195032|P5|COMPLETED|Period 4||12
79501|NCT02173535|195033|P4|COMPLETED|Period 4||12
79502|NCT02173535|195034|P3|COMPLETED|Period 4||12
79503|NCT02173535|195035|P2|COMPLETED|Period 4||12
79504|NCT02173535|195036|P1|COMPLETED|Period 4||12
79505|NCT02173535|195017|P20|STARTED|Period 4||12
79506|NCT02173535|195018|P19|STARTED|Period 4||12
79507|NCT02173535|195019|P18|STARTED|Period 4||12
79508|NCT02173535|195020|P17|STARTED|Period 4||12
79509|NCT02173535|195021|P16|STARTED|Period 4||12
79510|NCT02173535|195022|P15|STARTED|Period 4||12
79511|NCT02173535|195023|P14|STARTED|Period 4||12
79512|NCT02173535|195024|P13|STARTED|Period 4||12
79513|NCT02173535|195025|P12|STARTED|Period 4||12
79514|NCT02173535|195026|P11|STARTED|Period 4||12
79515|NCT02173535|195027|P10|STARTED|Period 4||12
79516|NCT02173535|195028|P9|STARTED|Period 4||12
79517|NCT02173535|195029|P8|STARTED|Period 4||12
79518|NCT02173535|195030|P7|STARTED|Period 4||12
79519|NCT02173535|195031|P6|STARTED|Period 4||12
79520|NCT02173535|195032|P5|STARTED|Period 4||12
79521|NCT02173535|195033|P4|STARTED|Period 4||12
79522|NCT02173535|195034|P3|STARTED|Period 4||12
79523|NCT02173535|195035|P2|STARTED|Period 4||12
79524|NCT02173535|195036|P1|STARTED|Period 4||12
79525|NCT02173535|195017|P20|NOT COMPLETED|Period 3||0
79526|NCT02173535|195018|P19|NOT COMPLETED|Period 3||0
79527|NCT02173535|195019|P18|NOT COMPLETED|Period 3||0
79528|NCT02173535|195020|P17|NOT COMPLETED|Period 3||0
79529|NCT02173535|195021|P16|NOT COMPLETED|Period 3||0
79530|NCT02173535|195022|P15|NOT COMPLETED|Period 3||0
79531|NCT02173535|195023|P14|NOT COMPLETED|Period 3||0
79532|NCT02173535|195024|P13|NOT COMPLETED|Period 3||0
79533|NCT02173535|195025|P12|NOT COMPLETED|Period 3||0
79534|NCT02173535|195026|P11|NOT COMPLETED|Period 3||0
79535|NCT02173535|195027|P10|NOT COMPLETED|Period 3||0
79536|NCT02173535|195028|P9|NOT COMPLETED|Period 3||0
79537|NCT02173535|195029|P8|NOT COMPLETED|Period 3||0
79538|NCT02173535|195030|P7|NOT COMPLETED|Period 3||0
79539|NCT02173535|195031|P6|NOT COMPLETED|Period 3||0
79540|NCT02173535|195032|P5|NOT COMPLETED|Period 3||0
79541|NCT02173535|195033|P4|NOT COMPLETED|Period 3||0
79542|NCT02173535|195034|P3|NOT COMPLETED|Period 3||0
79543|NCT02173535|195035|P2|NOT COMPLETED|Period 3||0
79544|NCT02173535|195036|P1|NOT COMPLETED|Period 3||0
79545|NCT02173535|195017|P20|COMPLETED|Period 3||12
79546|NCT02173535|195018|P19|COMPLETED|Period 3||12
79547|NCT02173535|195019|P18|COMPLETED|Period 3||12
79548|NCT02173535|195020|P17|COMPLETED|Period 3||12
79549|NCT02173535|195021|P16|COMPLETED|Period 3||12
79550|NCT02173535|195022|P15|COMPLETED|Period 3||12
79551|NCT02173535|195023|P14|COMPLETED|Period 3||12
79552|NCT02173535|195024|P13|COMPLETED|Period 3||12
79553|NCT02173535|195025|P12|COMPLETED|Period 3||12
79554|NCT02173535|195026|P11|COMPLETED|Period 3||12
79555|NCT02173535|195027|P10|COMPLETED|Period 3||12
79556|NCT02173535|195028|P9|COMPLETED|Period 3||12
79557|NCT02173535|195029|P8|COMPLETED|Period 3||12
79558|NCT02173535|195030|P7|COMPLETED|Period 3||12
79559|NCT02173535|195031|P6|COMPLETED|Period 3||12
79560|NCT02173535|195032|P5|COMPLETED|Period 3||12
79561|NCT02173535|195033|P4|COMPLETED|Period 3||12
79562|NCT02173535|195034|P3|COMPLETED|Period 3||12
79563|NCT02173535|195035|P2|COMPLETED|Period 3||12
79564|NCT02173535|195036|P1|COMPLETED|Period 3||12
79565|NCT02173535|195017|P20|STARTED|Period 3||12
79566|NCT02173535|195018|P19|STARTED|Period 3||12
79567|NCT02173535|195019|P18|STARTED|Period 3||12
79568|NCT02173535|195020|P17|STARTED|Period 3||12
79569|NCT02173535|195021|P16|STARTED|Period 3||12
79570|NCT02173535|195022|P15|STARTED|Period 3||12
79571|NCT02173535|195023|P14|STARTED|Period 3||12
79572|NCT02173535|195024|P13|STARTED|Period 3||12
79573|NCT02173535|195025|P12|STARTED|Period 3||12
79574|NCT02173535|195026|P11|STARTED|Period 3||12
79575|NCT02173535|195027|P10|STARTED|Period 3||12
79576|NCT02173535|195028|P9|STARTED|Period 3||12
79577|NCT02173535|195029|P8|STARTED|Period 3||12
79578|NCT02173535|195030|P7|STARTED|Period 3||12
79579|NCT02173535|195031|P6|STARTED|Period 3||12
79580|NCT02173535|195032|P5|STARTED|Period 3||12
79581|NCT02173535|195033|P4|STARTED|Period 3||12
79582|NCT02173535|195034|P3|STARTED|Period 3||12
79583|NCT02173535|195035|P2|STARTED|Period 3||12
79584|NCT02173535|195036|P1|STARTED|Period 3||12
79585|NCT02173535|195017|P20|NOT COMPLETED|Period 2||0
79586|NCT02173535|195018|P19|NOT COMPLETED|Period 2||0
79587|NCT02173535|195019|P18|NOT COMPLETED|Period 2||0
79588|NCT02173535|195020|P17|NOT COMPLETED|Period 2||0
79589|NCT02173535|195021|P16|NOT COMPLETED|Period 2||0
79590|NCT02173535|195022|P15|NOT COMPLETED|Period 2||0
79591|NCT02173535|195023|P14|NOT COMPLETED|Period 2||0
79592|NCT02173535|195024|P13|NOT COMPLETED|Period 2||0
79593|NCT02173535|195025|P12|NOT COMPLETED|Period 2||0
79594|NCT02173535|195026|P11|NOT COMPLETED|Period 2||0
79595|NCT02173535|195027|P10|NOT COMPLETED|Period 2||0
79596|NCT02173535|195028|P9|NOT COMPLETED|Period 2||0
79597|NCT02173535|195029|P8|NOT COMPLETED|Period 2||0
79598|NCT02173535|195030|P7|NOT COMPLETED|Period 2||0
79599|NCT02173535|195031|P6|NOT COMPLETED|Period 2||0
79600|NCT02173535|195032|P5|NOT COMPLETED|Period 2||0
79601|NCT02173535|195033|P4|NOT COMPLETED|Period 2||0
79602|NCT02173535|195034|P3|NOT COMPLETED|Period 2||0
79603|NCT02173535|195035|P2|NOT COMPLETED|Period 2||0
79604|NCT02173535|195036|P1|NOT COMPLETED|Period 2||0
79605|NCT02173535|195017|P20|COMPLETED|Period 2||12
79606|NCT02173535|195018|P19|COMPLETED|Period 2||12
79607|NCT02173535|195019|P18|COMPLETED|Period 2||12
79608|NCT02173535|195020|P17|COMPLETED|Period 2||12
79609|NCT02173535|195021|P16|COMPLETED|Period 2||12
79610|NCT02173535|195022|P15|COMPLETED|Period 2||12
79611|NCT02173535|195023|P14|COMPLETED|Period 2||12
79612|NCT02173535|195024|P13|COMPLETED|Period 2||12
79613|NCT02173535|195025|P12|COMPLETED|Period 2||12
79614|NCT02173535|195026|P11|COMPLETED|Period 2||12
79615|NCT02173535|195027|P10|COMPLETED|Period 2||12
79616|NCT02173535|195028|P9|COMPLETED|Period 2||12
79617|NCT02173535|195029|P8|COMPLETED|Period 2||12
79618|NCT02173535|195030|P7|COMPLETED|Period 2||12
79619|NCT02173535|195031|P6|COMPLETED|Period 2||12
79620|NCT02173535|195032|P5|COMPLETED|Period 2||12
79621|NCT02173535|195033|P4|COMPLETED|Period 2||12
79622|NCT02173535|195034|P3|COMPLETED|Period 2||12
79623|NCT02173535|195035|P2|COMPLETED|Period 2||12
79624|NCT02173535|195036|P1|COMPLETED|Period 2||12
79625|NCT02173535|195017|P20|STARTED|Period 2||12
79626|NCT02173535|195018|P19|STARTED|Period 2||12
79627|NCT02173535|195019|P18|STARTED|Period 2||12
79628|NCT02173535|195020|P17|STARTED|Period 2||12
79629|NCT02173535|195021|P16|STARTED|Period 2||12
79630|NCT02173535|195022|P15|STARTED|Period 2||12
79631|NCT02173535|195023|P14|STARTED|Period 2||12
79632|NCT02173535|195024|P13|STARTED|Period 2||12
79633|NCT02173535|195025|P12|STARTED|Period 2||12
79634|NCT02173535|195026|P11|STARTED|Period 2||12
79635|NCT02173535|195027|P10|STARTED|Period 2||12
79636|NCT02173535|195028|P9|STARTED|Period 2||12
79637|NCT02173535|195029|P8|STARTED|Period 2||12
79638|NCT02173535|195030|P7|STARTED|Period 2||12
79639|NCT02173535|195031|P6|STARTED|Period 2||12
79640|NCT02173535|195032|P5|STARTED|Period 2||12
79641|NCT02173535|195033|P4|STARTED|Period 2||12
79642|NCT02173535|195034|P3|STARTED|Period 2||12
79643|NCT02173535|195035|P2|STARTED|Period 2||12
79644|NCT02173535|195036|P1|STARTED|Period 2||12
79645|NCT02173535|195017|P20|NOT COMPLETED|Period 1||0
79646|NCT02173535|195018|P19|NOT COMPLETED|Period 1||0
79647|NCT02173535|195019|P18|NOT COMPLETED|Period 1||0
79648|NCT02173535|195020|P17|NOT COMPLETED|Period 1||0
79649|NCT02173535|195021|P16|NOT COMPLETED|Period 1||0
79650|NCT02173535|195022|P15|NOT COMPLETED|Period 1||0
79651|NCT02173535|195023|P14|NOT COMPLETED|Period 1||0
79652|NCT02173535|195024|P13|NOT COMPLETED|Period 1||0
79653|NCT02173535|195025|P12|NOT COMPLETED|Period 1||0
79654|NCT02173535|195026|P11|NOT COMPLETED|Period 1||0
79655|NCT02173535|195027|P10|NOT COMPLETED|Period 1||0
79656|NCT02173535|195028|P9|NOT COMPLETED|Period 1||0
79657|NCT02173535|195029|P8|NOT COMPLETED|Period 1||0
79658|NCT02173535|195030|P7|NOT COMPLETED|Period 1||0
79659|NCT02173535|195031|P6|NOT COMPLETED|Period 1||0
79660|NCT02173535|195032|P5|NOT COMPLETED|Period 1||0
79661|NCT02173535|195033|P4|NOT COMPLETED|Period 1||0
79662|NCT02173535|195034|P3|NOT COMPLETED|Period 1||0
79663|NCT02173535|195035|P2|NOT COMPLETED|Period 1||0
79664|NCT02173535|195036|P1|NOT COMPLETED|Period 1||0
79665|NCT02173535|195017|P20|COMPLETED|Period 1||12
79666|NCT02173535|195018|P19|COMPLETED|Period 1||12
79667|NCT02173535|195019|P18|COMPLETED|Period 1||12
79668|NCT02173535|195020|P17|COMPLETED|Period 1||12
79669|NCT02173535|195021|P16|COMPLETED|Period 1||12
79670|NCT02173535|195022|P15|COMPLETED|Period 1||12
79671|NCT02173535|195023|P14|COMPLETED|Period 1||12
79672|NCT02173535|195024|P13|COMPLETED|Period 1||12
79673|NCT02173535|195025|P12|COMPLETED|Period 1||12
79674|NCT02173535|195026|P11|COMPLETED|Period 1||12
79675|NCT02173535|195027|P10|COMPLETED|Period 1||12
79676|NCT02173535|195028|P9|COMPLETED|Period 1||12
79677|NCT02173535|195029|P8|COMPLETED|Period 1||12
79678|NCT02173535|195030|P7|COMPLETED|Period 1||12
79679|NCT02173535|195031|P6|COMPLETED|Period 1||12
79680|NCT02173535|195032|P5|COMPLETED|Period 1||12
79681|NCT02173535|195033|P4|COMPLETED|Period 1||12
79682|NCT02173535|195034|P3|COMPLETED|Period 1||12
79683|NCT02173535|195035|P2|COMPLETED|Period 1||12
79684|NCT02173535|195036|P1|COMPLETED|Period 1||12
79685|NCT02173535|195017|P20|STARTED|Period 1||12
79686|NCT02173535|195018|P19|STARTED|Period 1||12
79687|NCT02173535|195019|P18|STARTED|Period 1||12
79688|NCT02173535|195020|P17|STARTED|Period 1||12
79689|NCT02173535|195021|P16|STARTED|Period 1||12
79690|NCT02173535|195022|P15|STARTED|Period 1||12
79691|NCT02173535|195023|P14|STARTED|Period 1||12
79692|NCT02173535|195024|P13|STARTED|Period 1||12
79693|NCT02173535|195025|P12|STARTED|Period 1||12
79694|NCT02173535|195026|P11|STARTED|Period 1||12
79695|NCT02173535|195027|P10|STARTED|Period 1||12
79696|NCT02173535|195028|P9|STARTED|Period 1||12
79697|NCT02173535|195029|P8|STARTED|Period 1||12
79698|NCT02173535|195030|P7|STARTED|Period 1||12
79699|NCT02173535|195031|P6|STARTED|Period 1||12
79700|NCT02173535|195032|P5|STARTED|Period 1||12
79701|NCT02173535|195033|P4|STARTED|Period 1||12
79702|NCT02173535|195034|P3|STARTED|Period 1||12
79703|NCT02173535|195035|P2|STARTED|Period 1||12
79704|NCT02173535|195036|P1|STARTED|Period 1||12
79705|NCT02173522|195075|P2|NOT COMPLETED|Overall Study||0
79706|NCT02173522|195076|P1|NOT COMPLETED|Overall Study||0
79707|NCT02173522|195075|P2|COMPLETED|Overall Study||0
79708|NCT02173522|195076|P1|COMPLETED|Overall Study||4
79709|NCT02173522|195075|P2|STARTED|Overall Study||0
79710|NCT02173522|195076|P1|STARTED|Overall Study||4
79711|NCT02173392|195096|P2|NOT COMPLETED|Overall Study||4
79712|NCT02173392|195097|P1|NOT COMPLETED|Overall Study||14
79713|NCT02173392|195096|P2|COMPLETED|Overall Study||68
79714|NCT02173392|195097|P1|COMPLETED|Overall Study||59
79715|NCT02173392|195096|P2|STARTED|Overall Study||72
79716|NCT02173392|195097|P1|STARTED|Overall Study||73
79717|NCT02173379|195109|P2|NOT COMPLETED|Overall Study||7
79718|NCT02173379|195110|P1|NOT COMPLETED|Overall Study||9
79719|NCT02173379|195109|P2|COMPLETED|Overall Study||1301
79720|NCT02173379|195110|P1|COMPLETED|Overall Study||1287
79721|NCT02173379|195109|P2|STARTED|Overall Study||1308
79722|NCT02173379|195110|P1|STARTED|Overall Study||1296
79723|NCT02173158|195176|P1|NOT COMPLETED|Safety Phase||0
79724|NCT02173158|195176|P1|COMPLETED|Safety Phase||8
79725|NCT02173158|195176|P1|STARTED|Safety Phase||8
79726|NCT02173158|195176|P1|NOT COMPLETED|Efficacy Phase||1
79727|NCT02173158|195176|P1|COMPLETED|Efficacy Phase||8
79728|NCT02173158|195176|P1|STARTED|Efficacy Phase||9
79729|NCT02173054|195193|P3|NOT COMPLETED|Overall Study||1
79730|NCT02173054|195194|P2|NOT COMPLETED|Overall Study||0
79731|NCT02173054|195195|P1|NOT COMPLETED|Overall Study||1
79732|NCT02173054|195193|P3|COMPLETED|Overall Study||39
79733|NCT02173054|195194|P2|COMPLETED|Overall Study||40
79734|NCT02173054|195195|P1|COMPLETED|Overall Study||39
79735|NCT02173054|195193|P3|STARTED|Overall Study||40
79736|NCT02173054|195194|P2|STARTED|Overall Study||40
79737|NCT02173054|195195|P1|STARTED|Overall Study||40
79738|NCT02172820|195217|P2|NOT COMPLETED|Overall Study||0
79739|NCT02172820|195218|P1|NOT COMPLETED|Overall Study||0
79740|NCT02172820|195217|P2|COMPLETED|Overall Study||65
79741|NCT02172820|195218|P1|COMPLETED|Overall Study||65
79742|NCT02172820|195217|P2|STARTED|Overall Study||65
79743|NCT02172820|195218|P1|STARTED|Overall Study||65
79744|NCT02172755|195230|P2|NOT COMPLETED|Overall Study||4
79745|NCT02172755|195231|P1|NOT COMPLETED|Overall Study||2
79746|NCT02172755|195230|P2|COMPLETED|Overall Study||12
79747|NCT02172755|195231|P1|COMPLETED|Overall Study||12
79748|NCT02172755|195230|P2|STARTED|Overall Study||16
79749|NCT02172755|195231|P1|STARTED|Overall Study||14
79750|NCT02172742|195243|P2|NOT COMPLETED|Overall Study||0
79751|NCT02172742|195244|P1|NOT COMPLETED|Overall Study||1
79752|NCT02172742|195243|P2|COMPLETED|Overall Study||6
79753|NCT02172742|195244|P1|COMPLETED|Overall Study||6
79754|NCT02172742|195243|P2|STARTED|Overall Study||6
79755|NCT02172742|195244|P1|STARTED|Overall Study||7
79756|NCT02172664|195251|P2|NOT COMPLETED|Overall Study||6
79757|NCT02172664|195252|P1|NOT COMPLETED|Overall Study||6
79758|NCT02172664|195251|P2|COMPLETED|Overall Study||27
79759|NCT02172664|195252|P1|COMPLETED|Overall Study||27
79760|NCT02172664|195251|P2|STARTED|Overall Study||33
79761|NCT02172664|195252|P1|STARTED|Overall Study||33
79762|NCT02172625|195261|P2|NOT COMPLETED|Overall Study||3
79763|NCT02172625|195262|P1|NOT COMPLETED|Overall Study||0
79764|NCT02172625|195261|P2|COMPLETED|Overall Study||16
79765|NCT02172625|195262|P1|COMPLETED|Overall Study||19
79766|NCT02172625|195261|P2|STARTED|Overall Study||19
79767|NCT02172625|195262|P1|STARTED|Overall Study||19
79768|NCT02172040|195284|P4|NOT COMPLETED|Overall Study||1
79769|NCT02172040|195285|P3|NOT COMPLETED|Overall Study||2
79770|NCT02172040|195286|P2|NOT COMPLETED|Overall Study||3
79771|NCT02172040|195287|P1|NOT COMPLETED|Overall Study||0
79772|NCT02172040|195284|P4|COMPLETED|Overall Study||26
79773|NCT02172040|195285|P3|COMPLETED|Overall Study||29
79774|NCT02172040|195286|P2|COMPLETED|Overall Study||42
79775|NCT02172040|195287|P1|COMPLETED|Overall Study||49
79776|NCT02172040|195284|P4|STARTED|Overall Study||27
79777|NCT02172040|195285|P3|STARTED|Overall Study||31
79778|NCT02172040|195286|P2|STARTED|Overall Study||45
79779|NCT02172040|195287|P1|STARTED|Overall Study||49
79780|NCT02171819|195336|P3|NOT COMPLETED|Overall Study||0
79781|NCT02171819|195337|P2|NOT COMPLETED|Overall Study||0
79782|NCT02171819|195338|P1|NOT COMPLETED|Overall Study||0
79783|NCT02171819|195336|P3|COMPLETED|Overall Study||12
79784|NCT02171819|195337|P2|COMPLETED|Overall Study||32
79785|NCT02171819|195338|P1|COMPLETED|Overall Study||31
79786|NCT02171819|195336|P3|STARTED|Overall Study||12
79787|NCT02171819|195337|P2|STARTED|Overall Study||32
79788|NCT02171819|195338|P1|STARTED|Overall Study||31
79789|NCT02171611|195373|P6|NOT COMPLETED|Overall Study||0
79790|NCT02171611|195374|P5|NOT COMPLETED|Overall Study||0
79791|NCT02171611|195375|P4|NOT COMPLETED|Overall Study||0
79792|NCT02171611|195376|P3|NOT COMPLETED|Overall Study||0
79793|NCT02171611|195377|P2|NOT COMPLETED|Overall Study||0
79794|NCT02171611|195378|P1|NOT COMPLETED|Overall Study||0
79795|NCT02171611|195373|P6|COMPLETED|Overall Study||5
79796|NCT02171611|195374|P5|COMPLETED|Overall Study||5
79797|NCT02171611|195375|P4|COMPLETED|Overall Study||5
79798|NCT02171611|195376|P3|COMPLETED|Overall Study||5
79799|NCT02171611|195377|P2|COMPLETED|Overall Study||5
79800|NCT02171611|195378|P1|COMPLETED|Overall Study||5
79801|NCT02171611|195373|P6|STARTED|Overall Study||5
79802|NCT02171611|195374|P5|STARTED|Overall Study||5
79803|NCT02171611|195375|P4|STARTED|Overall Study||5
79804|NCT02171611|195376|P3|STARTED|Overall Study||5
79805|NCT02171611|195377|P2|STARTED|Overall Study||5
79806|NCT02171611|195378|P1|STARTED|Overall Study||5
79807|NCT02171260|195450|P4|NOT COMPLETED|Overall Study||5
79808|NCT02171260|195451|P3|NOT COMPLETED|Overall Study||5
79809|NCT02171260|195452|P2|NOT COMPLETED|Overall Study||6
79810|NCT02171260|195453|P1|NOT COMPLETED|Overall Study||6
79811|NCT02171260|195450|P4|COMPLETED|Overall Study||0
79812|NCT02171260|195451|P3|COMPLETED|Overall Study||0
79813|NCT02171260|195452|P2|COMPLETED|Overall Study||0
79814|NCT02171260|195453|P1|COMPLETED|Overall Study||0
79815|NCT02171260|195450|P4|STARTED|Overall Study||5
79816|NCT02171260|195451|P3|STARTED|Overall Study||5
79817|NCT02171260|195452|P2|STARTED|Overall Study||6
79818|NCT02171260|195453|P1|STARTED|Overall Study||6
79819|NCT02171247|195510|P2|NOT COMPLETED|Overall Study||0
79820|NCT02171247|195511|P1|NOT COMPLETED|Overall Study||0
79821|NCT02171247|195510|P2|COMPLETED|Overall Study||17
79822|NCT02171247|195511|P1|COMPLETED|Overall Study||16
79823|NCT02171247|195510|P2|STARTED|Overall Study||17
79824|NCT02171247|195511|P1|STARTED|Overall Study||16
79825|NCT02171234|195528|P5|NOT COMPLETED|Overall Study||0
79826|NCT02171234|195529|P4|NOT COMPLETED|Overall Study||0
79827|NCT02171234|195530|P3|NOT COMPLETED|Overall Study||0
79828|NCT02171234|195531|P2|NOT COMPLETED|Overall Study||0
79829|NCT02171234|195532|P1|NOT COMPLETED|Overall Study||0
79830|NCT02171234|195528|P5|COMPLETED|Overall Study||6
79831|NCT02171234|195529|P4|COMPLETED|Overall Study||6
79832|NCT02171234|195530|P3|COMPLETED|Overall Study||6
79833|NCT02171234|195531|P2|COMPLETED|Overall Study||6
79834|NCT02171234|195532|P1|COMPLETED|Overall Study||8
79835|NCT02171234|195528|P5|STARTED|Overall Study||6
79836|NCT02171234|195529|P4|STARTED|Overall Study||6
79837|NCT02171234|195530|P3|STARTED|Overall Study||6
79838|NCT02171234|195531|P2|STARTED|Overall Study||6
79839|NCT02171234|195532|P1|STARTED|Overall Study||8
79840|NCT02171195|195561|P9|NOT COMPLETED|Overall Study||0
79841|NCT02171195|195562|P8|NOT COMPLETED|Overall Study||0
79842|NCT02171195|195563|P7|NOT COMPLETED|Overall Study||0
79843|NCT02171195|195564|P6|NOT COMPLETED|Overall Study||0
79844|NCT02171195|195565|P5|NOT COMPLETED|Overall Study||0
79845|NCT02171195|195566|P4|NOT COMPLETED|Overall Study||0
79846|NCT02171195|195567|P3|NOT COMPLETED|Overall Study||0
79847|NCT02171195|195568|P2|NOT COMPLETED|Overall Study||0
79848|NCT02171195|195569|P1|NOT COMPLETED|Overall Study||0
79849|NCT02171195|195561|P9|COMPLETED|Overall Study||6
79850|NCT02171195|195562|P8|COMPLETED|Overall Study||6
79851|NCT02171195|195563|P7|COMPLETED|Overall Study||6
79852|NCT02171195|195564|P6|COMPLETED|Overall Study||6
79853|NCT02171195|195565|P5|COMPLETED|Overall Study||6
79854|NCT02171195|195566|P4|COMPLETED|Overall Study||6
79855|NCT02171195|195567|P3|COMPLETED|Overall Study||6
79856|NCT02171195|195568|P2|COMPLETED|Overall Study||6
79857|NCT02171195|195569|P1|COMPLETED|Overall Study||16
79858|NCT02171195|195561|P9|STARTED|Overall Study||6
79859|NCT02171195|195562|P8|STARTED|Overall Study||6
79860|NCT02171195|195563|P7|STARTED|Overall Study||6
79861|NCT02171195|195564|P6|STARTED|Overall Study||6
79862|NCT02171195|195565|P5|STARTED|Overall Study||6
79863|NCT02171195|195566|P4|STARTED|Overall Study||6
79864|NCT02171195|195567|P3|STARTED|Overall Study||6
79865|NCT02171195|195568|P2|STARTED|Overall Study||6
79866|NCT02171195|195569|P1|STARTED|Overall Study||16
79867|NCT02171130|195589|P1|NOT COMPLETED|Overall Study||28
79868|NCT02171130|195589|P1|COMPLETED|Overall Study|Including participants who completed the 6-month study but did not experience any hypoglycemia event|101
79869|NCT02171130|195589|P1|Experienced Hypoglycemic Event|Overall Study|Experienced at least one hypoglycemic event and received at least one dose of study drug.|87
79870|NCT02171130|195589|P1|Received at Least One Dose of Study Drug|Overall Study||87
79871|NCT02171130|195589|P1|STARTED|Overall Study||129
79872|NCT02170870|195603|P6|NOT COMPLETED|Overall Study||0
79873|NCT02170870|195604|P5|NOT COMPLETED|Overall Study||0
79874|NCT02170870|195605|P4|NOT COMPLETED|Overall Study||0
79875|NCT02170870|195606|P3|NOT COMPLETED|Overall Study||0
79876|NCT02170870|195607|P2|NOT COMPLETED|Overall Study||0
79877|NCT02170870|195608|P1|NOT COMPLETED|Overall Study||0
79878|NCT02170870|195603|P6|COMPLETED|Overall Study||20
79879|NCT02170870|195604|P5|COMPLETED|Overall Study||20
79880|NCT02170870|195605|P4|COMPLETED|Overall Study||20
79881|NCT02170870|195606|P3|COMPLETED|Overall Study||20
79882|NCT02170870|195607|P2|COMPLETED|Overall Study||11
79883|NCT02170870|195608|P1|COMPLETED|Overall Study||13
79884|NCT02170870|195603|P6|STARTED|Overall Study||20
79885|NCT02170870|195604|P5|STARTED|Overall Study||20
79886|NCT02170870|195605|P4|STARTED|Overall Study||20
79887|NCT02170870|195606|P3|STARTED|Overall Study||20
79888|NCT02170870|195607|P2|STARTED|Overall Study||11
79889|NCT02170870|195608|P1|STARTED|Overall Study||13
79890|NCT02170779|195630|P2|NOT COMPLETED|Overall Study||1
79891|NCT02170779|195631|P1|NOT COMPLETED|Overall Study||1
79892|NCT02170779|195630|P2|COMPLETED|Overall Study||19
79893|NCT02170779|195631|P1|COMPLETED|Overall Study||19
79894|NCT02170779|195630|P2|STARTED|Overall Study||20
79895|NCT02170779|195631|P1|STARTED|Overall Study||20
79896|NCT02170727|195655|P2|NOT COMPLETED|Overall Study||0
79897|NCT02170727|195656|P1|NOT COMPLETED|Overall Study||3
79898|NCT02170727|195655|P2|COMPLETED|Overall Study||31
79899|NCT02170727|195656|P1|COMPLETED|Overall Study||135
79900|NCT02170727|195655|P2|STARTED|Overall Study||31
79901|NCT02170727|195656|P1|STARTED|Overall Study||138
79902|NCT02170688|195687|P5|NOT COMPLETED|Overall Study||0
79903|NCT02170688|195688|P4|NOT COMPLETED|Overall Study||2
79904|NCT02170688|195689|P3|NOT COMPLETED|Overall Study||4
79905|NCT02170688|195690|P2|NOT COMPLETED|Overall Study||3
79906|NCT02170688|195691|P1|NOT COMPLETED|Overall Study||4
79907|NCT02170688|195687|P5|COMPLETED|Overall Study||25
79908|NCT02170688|195688|P4|COMPLETED|Overall Study||25
79909|NCT02170688|195689|P3|COMPLETED|Overall Study||25
79910|NCT02170688|195690|P2|COMPLETED|Overall Study||26
79911|NCT02170688|195691|P1|COMPLETED|Overall Study||25
79912|NCT02170688|195687|P5|STARTED|Overall Study||25
79913|NCT02170688|195688|P4|STARTED|Overall Study||27
79914|NCT02170688|195689|P3|STARTED|Overall Study||29
79915|NCT02170688|195690|P2|STARTED|Overall Study||29
79916|NCT02170688|195691|P1|STARTED|Overall Study||29
79917|NCT02170662|195710|P2|NOT COMPLETED|Overall Study||0
79918|NCT02170662|195711|P1|NOT COMPLETED|Overall Study||0
79919|NCT02170662|195710|P2|COMPLETED|Overall Study||6
79920|NCT02170662|195711|P1|COMPLETED|Overall Study||3
79921|NCT02170662|195710|P2|STARTED|Overall Study||6
79922|NCT02170662|195711|P1|STARTED|Overall Study||3
79923|NCT02170649|195723|P1|NOT COMPLETED|Fed Period||0
79924|NCT02170649|195723|P1|COMPLETED|Fed Period||12
79925|NCT02170649|195723|P1|STARTED|Fed Period||12
79926|NCT02170649|195723|P1|NOT COMPLETED|Fasting Period||0
79927|NCT02170649|195723|P1|COMPLETED|Fasting Period||12
79928|NCT02170649|195723|P1|STARTED|Fasting Period||12
79929|NCT02170532|195730|P1|NOT COMPLETED|Overall Study||0
79930|NCT02170532|195730|P1|COMPLETED|Overall Study||10
79931|NCT02170532|195730|P1|STARTED|Overall Study||10
79932|NCT02170519|195760|P2|NOT COMPLETED|Overall Study||0
79933|NCT02170519|195761|P1|NOT COMPLETED|Overall Study||0
79934|NCT02170519|195760|P2|COMPLETED|Overall Study||5
79935|NCT02170519|195761|P1|COMPLETED|Overall Study||22
79936|NCT02170519|195760|P2|STARTED|Overall Study||5
79937|NCT02170519|195761|P1|STARTED|Overall Study||22
79938|NCT02170376|195782|P5|NOT COMPLETED|Overall Study||0
79939|NCT02170376|195783|P4|NOT COMPLETED|Overall Study||0
79940|NCT02170376|195784|P3|NOT COMPLETED|Overall Study||0
79941|NCT02170376|195785|P2|NOT COMPLETED|Overall Study||1
79942|NCT02170376|195786|P1|NOT COMPLETED|Overall Study||0
79943|NCT02170376|195782|P5|COMPLETED|Overall Study||16
79944|NCT02170376|195783|P4|COMPLETED|Overall Study||16
79945|NCT02170376|195784|P3|COMPLETED|Overall Study||16
79946|NCT02170376|195785|P2|COMPLETED|Overall Study||15
79947|NCT02170376|195786|P1|COMPLETED|Overall Study||16
79948|NCT02170376|195782|P5|Pharmacokinetic Population|Overall Study||16
79949|NCT02170376|195783|P4|Pharmacokinetic Population|Overall Study||16
79950|NCT02170376|195784|P3|Pharmacokinetic Population|Overall Study||16
79951|NCT02170376|195785|P2|Pharmacokinetic Population|Overall Study||15
79952|NCT02170376|195786|P1|Pharmacokinetic Population|Overall Study||16
79953|NCT02170376|195782|P5|STARTED|Overall Study||16
79954|NCT02170376|195783|P4|STARTED|Overall Study||16
79955|NCT02170376|195784|P3|STARTED|Overall Study||16
79956|NCT02170376|195785|P2|STARTED|Overall Study||16
79957|NCT02170376|195786|P1|STARTED|Overall Study||16
79958|NCT02170363|195823|P1|NOT COMPLETED|Overall Study||0
79959|NCT02170363|195823|P1|COMPLETED|Overall Study|Followed to the 6-Month Primary Endpoint|50
79960|NCT02170363|195823|P1|STARTED|Overall Study||50
79961|NCT02170220|195837|P2|NOT COMPLETED|Overall Study||0
79962|NCT02170220|195838|P1|NOT COMPLETED|Overall Study||0
79963|NCT02170220|195837|P2|COMPLETED|Overall Study||6
79964|NCT02170220|195838|P1|COMPLETED|Overall Study||6
79965|NCT02170220|195837|P2|STARTED|Overall Study||6
79966|NCT02170220|195838|P1|STARTED|Overall Study||6
79967|NCT02170207|195864|P1|NOT COMPLETED|Overall Study||5
79968|NCT02170207|195864|P1|COMPLETED|Overall Study||58
79969|NCT02170207|195864|P1|STARTED|Overall Study||63
79970|NCT02170077|195875|P3|NOT COMPLETED|Overall Study||12
79971|NCT02170077|195876|P2|NOT COMPLETED|Overall Study||13
79972|NCT02170077|195877|P1|NOT COMPLETED|Overall Study||9
79973|NCT02170077|195875|P3|COMPLETED|Overall Study||35
79974|NCT02170077|195876|P2|COMPLETED|Overall Study||34
79975|NCT02170077|195877|P1|COMPLETED|Overall Study||41
79976|NCT02170077|195875|P3|Intent to Treat (ITT) Population|Overall Study||47
79977|NCT02170077|195876|P2|Intent to Treat (ITT) Population|Overall Study||46
79978|NCT02170077|195877|P1|Intent to Treat (ITT) Population|Overall Study||50
79979|NCT02170077|195875|P3|STARTED|Overall Study||47
79980|NCT02170077|195876|P2|STARTED|Overall Study||47
79981|NCT02170077|195877|P1|STARTED|Overall Study||50
79982|NCT02170064|195888|P3|NOT COMPLETED|Overall Study||1
79983|NCT02170064|195889|P2|NOT COMPLETED|Overall Study||2
79984|NCT02170064|195890|P1|NOT COMPLETED|Overall Study||6
79985|NCT02170064|195888|P3|COMPLETED|Overall Study||10
79986|NCT02170064|195889|P2|COMPLETED|Overall Study||7
79987|NCT02170064|195890|P1|COMPLETED|Overall Study||9
79988|NCT02170064|195888|P3|Efficacy Population (EP)|Overall Study||10
79989|NCT02170064|195889|P2|Efficacy Population (EP)|Overall Study||8
79990|NCT02170064|195890|P1|Efficacy Population (EP)|Overall Study||11
79991|NCT02170064|195888|P3|Pharmacokinetic Population (PKP)|Overall Study||10
79992|NCT02170064|195889|P2|Pharmacokinetic Population (PKP)|Overall Study||8
79993|NCT02170064|195890|P1|Pharmacokinetic Population (PKP)|Overall Study||11
79994|NCT02170064|195888|P3|Safety Population (SP)|Overall Study||11
79995|NCT02170064|195889|P2|Safety Population (SP)|Overall Study||8
79996|NCT02170064|195890|P1|Safety Population (SP)|Overall Study||12
79997|NCT02170064|195888|P3|STARTED|Overall Study||11
79998|NCT02170064|195889|P2|STARTED|Overall Study||9
79999|NCT02170064|195890|P1|STARTED|Overall Study||15
80000|NCT02170025|195906|P2|NOT COMPLETED|Overall Study||0
80001|NCT02170025|195907|P1|NOT COMPLETED|Overall Study||2
80002|NCT02170025|195906|P2|COMPLETED|Overall Study||7
80003|NCT02170025|195907|P1|COMPLETED|Overall Study||12
80004|NCT02170025|195906|P2|STARTED|Overall Study||7
80005|NCT02170025|195907|P1|STARTED|Overall Study||14
80006|NCT02169895|195919|P4|NOT COMPLETED|Overall Study||2
80007|NCT02169895|195920|P3|NOT COMPLETED|Overall Study||0
80008|NCT02169895|195921|P2|NOT COMPLETED|Overall Study||0
80009|NCT02169895|195922|P1|NOT COMPLETED|Overall Study||0
80010|NCT02169895|195919|P4|COMPLETED|Overall Study||2
80011|NCT02169895|195920|P3|COMPLETED|Overall Study||4
80012|NCT02169895|195921|P2|COMPLETED|Overall Study||4
80013|NCT02169895|195922|P1|COMPLETED|Overall Study||4
80014|NCT02169895|195919|P4|Placebo|Overall Study||4
80015|NCT02169895|195920|P3|Placebo|Overall Study||4
80016|NCT02169895|195921|P2|Placebo|Overall Study||4
80017|NCT02169895|195922|P1|Placebo|Overall Study||4
80018|NCT02169895|195919|P4|100 mg BIA 9-1067|Overall Study||2
80019|NCT02169895|195920|P3|100 mg BIA 9-1067|Overall Study||4
80020|NCT02169895|195921|P2|100 mg BIA 9-1067|Overall Study||4
80021|NCT02169895|195922|P1|100 mg BIA 9-1067|Overall Study||4
80022|NCT02169895|195919|P4|50 mg BIA 9-1067|Overall Study||4
80023|NCT02169895|195920|P3|50 mg BIA 9-1067|Overall Study||4
80024|NCT02169895|195921|P2|50 mg BIA 9-1067|Overall Study||4
80025|NCT02169895|195922|P1|50 mg BIA 9-1067|Overall Study||4
80026|NCT02169895|195919|P4|25 mg BIA 9-1067|Overall Study||4
80027|NCT02169895|195920|P3|25 mg BIA 9-1067|Overall Study||4
80028|NCT02169895|195921|P2|25 mg BIA 9-1067|Overall Study||4
80029|NCT02169895|195922|P1|25 mg BIA 9-1067|Overall Study||4
80030|NCT02169895|195919|P4|STARTED|Overall Study||4
80031|NCT02169895|195920|P3|STARTED|Overall Study||4
80032|NCT02169895|195921|P2|STARTED|Overall Study||4
80033|NCT02169895|195922|P1|STARTED|Overall Study||4
80034|NCT02169869|195942|P2|NOT COMPLETED|Overall Study||0
80035|NCT02169869|195943|P1|NOT COMPLETED|Overall Study||0
80036|NCT02169869|195942|P2|COMPLETED|Overall Study||16
80037|NCT02169869|195943|P1|COMPLETED|Overall Study||17
80038|NCT02169869|195942|P2|STARTED|Overall Study||16
80039|NCT02169869|195943|P1|STARTED|Overall Study||17
80040|NCT02169674|195951|P2|NOT COMPLETED|Overall Study||78
80041|NCT02169674|195952|P1|NOT COMPLETED|Overall Study||32
80042|NCT02169674|195951|P2|COMPLETED|Overall Study||135
80043|NCT02169674|195952|P1|COMPLETED|Overall Study||105
80044|NCT02169674|195951|P2|STARTED|Overall Study||213
80045|NCT02169674|195952|P1|STARTED|Overall Study||137
80046|NCT02169505|195966|P1|NOT COMPLETED|Overall Study||1
80047|NCT02169505|195966|P1|COMPLETED|Overall Study||1
80048|NCT02169505|195966|P1|STARTED|Overall Study||2
80049|NCT02169479|195981|P4|NOT COMPLETED|Overall Study||0
80050|NCT02169479|195982|P3|NOT COMPLETED|Overall Study||0
80051|NCT02169479|195983|P2|NOT COMPLETED|Overall Study||1
80052|NCT02169479|195984|P1|NOT COMPLETED|Overall Study||1
80053|NCT02169479|195981|P4|COMPLETED|Overall Study||4
80054|NCT02169479|195982|P3|COMPLETED|Overall Study||4
80055|NCT02169479|195983|P2|COMPLETED|Overall Study||3
80056|NCT02169479|195984|P1|COMPLETED|Overall Study||3
80057|NCT02169479|195981|P4|Placebo|Overall Study||4
80058|NCT02169479|195982|P3|Placebo|Overall Study||4
80059|NCT02169479|195983|P2|Placebo|Overall Study||3
80060|NCT02169479|195984|P1|Placebo|Overall Study||3
80061|NCT02169479|195981|P4|100 mg BIA 9-1067|Overall Study||4
80062|NCT02169479|195982|P3|100 mg BIA 9-1067|Overall Study||4
80063|NCT02169479|195983|P2|100 mg BIA 9-1067|Overall Study||4
80064|NCT02169479|195984|P1|100 mg BIA 9-1067|Overall Study||3
80065|NCT02169479|195981|P4|50 mg BIA 9-1067|Overall Study||4
80066|NCT02169479|195982|P3|50 mg BIA 9-1067|Overall Study||4
80067|NCT02169479|195983|P2|50 mg BIA 9-1067|Overall Study||4
80068|NCT02169479|195984|P1|50 mg BIA 9-1067|Overall Study||4
80069|NCT02169479|195981|P4|25 mg BIA 9-1067|Overall Study||4
80070|NCT02169479|195982|P3|25 mg BIA 9-1067|Overall Study||4
80071|NCT02169479|195983|P2|25 mg BIA 9-1067|Overall Study||3
80072|NCT02169479|195984|P1|25 mg BIA 9-1067|Overall Study||4
80073|NCT02169479|195981|P4|STARTED|Overall Study||4
80074|NCT02169479|195982|P3|STARTED|Overall Study||4
80075|NCT02169479|195983|P2|STARTED|Overall Study||4
80076|NCT02169479|195984|P1|STARTED|Overall Study||4
80077|NCT02169466|196006|P4|NOT COMPLETED|Overall Study||0
80078|NCT02169466|196007|P3|NOT COMPLETED|Overall Study||0
80079|NCT02169466|196008|P2|NOT COMPLETED|Overall Study||1
80080|NCT02169466|196009|P1|NOT COMPLETED|Overall Study||1
80081|NCT02169466|196006|P4|COMPLETED|Overall Study||5
80082|NCT02169466|196007|P3|COMPLETED|Overall Study||5
80083|NCT02169466|196008|P2|COMPLETED|Overall Study||5
80084|NCT02169466|196009|P1|COMPLETED|Overall Study||5
80085|NCT02169466|196006|P4|Placebo|Overall Study||5
80086|NCT02169466|196007|P3|Placebo|Overall Study||5
80087|NCT02169466|196008|P2|Placebo|Overall Study||6
80088|NCT02169466|196009|P1|Placebo|Overall Study||5
80089|NCT02169466|196006|P4|100 mg BIA 9-1067|Overall Study||5
80090|NCT02169466|196007|P3|100 mg BIA 9-1067|Overall Study||5
80091|NCT02169466|196008|P2|100 mg BIA 9-1067|Overall Study||6
80092|NCT02169466|196009|P1|100 mg BIA 9-1067|Overall Study||6
80093|NCT02169466|196006|P4|50 mg BIA 9-1067|Overall Study||5
80094|NCT02169466|196007|P3|50 mg BIA 9-1067|Overall Study||5
80095|NCT02169466|196008|P2|50 mg BIA 9-1067|Overall Study||6
80096|NCT02169466|196009|P1|50 mg BIA 9-1067|Overall Study||6
80097|NCT02169466|196006|P4|25 mg BIA 9-1067|Overall Study||5
80098|NCT02169466|196007|P3|25 mg BIA 9-1067|Overall Study||5
80099|NCT02169466|196008|P2|25 mg BIA 9-1067|Overall Study||5
80100|NCT02169466|196009|P1|25 mg BIA 9-1067|Overall Study||6
80101|NCT02169466|196006|P4|STARTED|Overall Study||5
80102|NCT02169466|196007|P3|STARTED|Overall Study||5
80103|NCT02169466|196008|P2|STARTED|Overall Study||6
80104|NCT02169466|196009|P1|STARTED|Overall Study||6
80105|NCT02169453|196035|P4|NOT COMPLETED|Overall Study||0
80106|NCT02169453|196036|P3|NOT COMPLETED|Overall Study||1
80107|NCT02169453|196037|P2|NOT COMPLETED|Overall Study||0
80108|NCT02169453|196038|P1|NOT COMPLETED|Overall Study||0
80109|NCT02169453|196035|P4|COMPLETED|Overall Study||3
80110|NCT02169453|196036|P3|COMPLETED|Overall Study||2
80111|NCT02169453|196037|P2|COMPLETED|Overall Study||3
80112|NCT02169453|196038|P1|COMPLETED|Overall Study||3
80113|NCT02169453|196035|P4|Placebo|Overall Study||3
80114|NCT02169453|196036|P3|Placebo|Overall Study||3
80115|NCT02169453|196037|P2|Placebo|Overall Study||3
80116|NCT02169453|196038|P1|Placebo|Overall Study||3
80117|NCT02169453|196035|P4|100 mg BIA 9-1067|Overall Study||3
80118|NCT02169453|196036|P3|100 mg BIA 9-1067|Overall Study||3
80119|NCT02169453|196037|P2|100 mg BIA 9-1067|Overall Study||3
80120|NCT02169453|196038|P1|100 mg BIA 9-1067|Overall Study||3
80121|NCT02169453|196035|P4|50 mg BIA 9-1067|Overall Study||3
80122|NCT02169453|196036|P3|50 mg BIA 9-1067|Overall Study||2
80123|NCT02169453|196037|P2|50 mg BIA 9-1067|Overall Study||3
80124|NCT02169453|196038|P1|50 mg BIA 9-1067|Overall Study||3
80125|NCT02169453|196035|P4|25 mg BIA 9-1067|Overall Study||3
80126|NCT02169453|196036|P3|25 mg BIA 9-1067|Overall Study||3
80127|NCT02169453|196037|P2|25 mg BIA 9-1067|Overall Study||3
80128|NCT02169453|196038|P1|25 mg BIA 9-1067|Overall Study||3
80129|NCT02169453|196035|P4|STARTED|Overall Study||3
80130|NCT02169453|196036|P3|STARTED|Overall Study||3
80131|NCT02169453|196037|P2|STARTED|Overall Study||3
80132|NCT02169453|196038|P1|STARTED|Overall Study||3
80133|NCT02169440|196070|P2|NOT COMPLETED|Overall Study||0
80134|NCT02169440|196071|P1|NOT COMPLETED|Overall Study||0
80135|NCT02169440|196070|P2|COMPLETED|Overall Study||10
80136|NCT02169440|196071|P1|COMPLETED|Overall Study||10
80137|NCT02169440|196070|P2|STARTED|Overall Study||10
80138|NCT02169440|196071|P1|STARTED|Overall Study||10
80139|NCT02169427|196084|P1|NOT COMPLETED|Overall Study||0
80140|NCT02169427|196084|P1|COMPLETED|Overall Study||6
80141|NCT02169427|196084|P1|STARTED|Overall Study||6
80142|NCT02169414|196094|P4|NOT COMPLETED|Overall Study||0
80143|NCT02169414|196095|P3|NOT COMPLETED|Overall Study||0
80144|NCT02169414|196096|P2|NOT COMPLETED|Overall Study||1
80145|NCT02169414|196097|P1|NOT COMPLETED|Overall Study||1
80146|NCT02169414|196094|P4|COMPLETED|Overall Study||18
80147|NCT02169414|196095|P3|COMPLETED|Overall Study||18
80148|NCT02169414|196096|P2|COMPLETED|Overall Study||18
80149|NCT02169414|196097|P1|COMPLETED|Overall Study||18
80150|NCT02169414|196094|P4|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
80151|NCT02169414|196095|P3|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
80245|NCT02168309|196399|P2|COMPLETED|Overall Study||25
80152|NCT02169414|196096|P2|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
80153|NCT02169414|196097|P1|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
80154|NCT02169414|196094|P4|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
80155|NCT02169414|196095|P3|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
80156|NCT02169414|196096|P2|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||19
80157|NCT02169414|196097|P1|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
80158|NCT02169414|196094|P4|STARTED|Overall Study||18
80159|NCT02169414|196095|P3|STARTED|Overall Study||18
80160|NCT02169414|196096|P2|STARTED|Overall Study||19
80161|NCT02169414|196097|P1|STARTED|Overall Study||19
80162|NCT02169336|196138|P3|NOT COMPLETED|Overall Study||3
80163|NCT02169336|196139|P2|NOT COMPLETED|Overall Study||4
80164|NCT02169336|196140|P1|NOT COMPLETED|Overall Study||4
80165|NCT02169336|196138|P3|COMPLETED|Overall Study||29
80166|NCT02169336|196139|P2|COMPLETED|Overall Study||28
80167|NCT02169336|196140|P1|COMPLETED|Overall Study||27
80168|NCT02169336|196138|P3|STARTED|Overall Study||32
80169|NCT02169336|196139|P2|STARTED|Overall Study||32
80170|NCT02169336|196140|P1|STARTED|Overall Study||31
80171|NCT02169219|196148|P1|NOT COMPLETED|Overall Study||6
80172|NCT02169219|196148|P1|COMPLETED|Overall Study||14
80173|NCT02169219|196148|P1|STARTED|Overall Study||20
80174|NCT02169115|196162|P3|NOT COMPLETED|Overall Study||0
80175|NCT02169115|196163|P2|NOT COMPLETED|Overall Study||0
80176|NCT02169115|196164|P1|NOT COMPLETED|Overall Study||0
80177|NCT02169115|196162|P3|COMPLETED|Overall Study||21
80178|NCT02169115|196163|P2|COMPLETED|Overall Study||21
80179|NCT02169115|196164|P1|COMPLETED|Overall Study||19
80180|NCT02169115|196162|P3|STARTED|Overall Study||21
80181|NCT02169115|196163|P2|STARTED|Overall Study||21
80182|NCT02169115|196164|P1|STARTED|Overall Study||19
80183|NCT02168946|196174|P2|NOT COMPLETED|Overall Study||5
80184|NCT02168946|196175|P1|NOT COMPLETED|Overall Study||12
80185|NCT02168946|196174|P2|COMPLETED|Overall Study||20
80186|NCT02168946|196175|P1|COMPLETED|Overall Study||38
80187|NCT02168946|196174|P2|STARTED|Overall Study||25
80188|NCT02168946|196175|P1|STARTED|Overall Study|2 additional subjects were randomized to Vabomere but did not receive study drug|50
80189|NCT02168933|196211|P1|NOT COMPLETED|Overall Study||1
80190|NCT02168933|196211|P1|COMPLETED|Overall Study||7
80191|NCT02168933|196211|P1|STARTED|Overall Study||8
80192|NCT02168816|196221|P2|NOT COMPLETED|Overall Study||2
80193|NCT02168816|196222|P1|NOT COMPLETED|Overall Study||2
80194|NCT02168816|196221|P2|COMPLETED|Overall Study||5
80195|NCT02168816|196222|P1|COMPLETED|Overall Study||3
80196|NCT02168816|196221|P2|STARTED|Overall Study||7
80197|NCT02168816|196222|P1|STARTED|Overall Study||5
80198|NCT02168803|196233|P3|NOT COMPLETED|Overall Study||6
80199|NCT02168803|196234|P2|NOT COMPLETED|Overall Study||3
80200|NCT02168803|196235|P1|NOT COMPLETED|Overall Study||2
80201|NCT02168803|196233|P3|COMPLETED|Overall Study||33
80202|NCT02168803|196234|P2|COMPLETED|Overall Study||29
80203|NCT02168803|196235|P1|COMPLETED|Overall Study||28
80204|NCT02168803|196233|P3|Received at Least 1 Dose of Study Drug|Overall Study||39
80205|NCT02168803|196234|P2|Received at Least 1 Dose of Study Drug|Overall Study||32
80206|NCT02168803|196235|P1|Received at Least 1 Dose of Study Drug|Overall Study||30
80207|NCT02168803|196233|P3|STARTED|Overall Study||39
80208|NCT02168803|196234|P2|STARTED|Overall Study||32
80209|NCT02168803|196235|P1|STARTED|Overall Study||30
80210|NCT02168777|196265|P3|NOT COMPLETED|Overall Study||11
80211|NCT02168777|196266|P2|NOT COMPLETED|Overall Study||7
80212|NCT02168777|196267|P1|NOT COMPLETED|Overall Study||2
80213|NCT02168777|196265|P3|COMPLETED|Overall Study||0
80214|NCT02168777|196266|P2|COMPLETED|Overall Study||0
80215|NCT02168777|196267|P1|COMPLETED|Overall Study||0
80216|NCT02168777|196265|P3|STARTED|Overall Study||11
80217|NCT02168777|196266|P2|STARTED|Overall Study||7
80218|NCT02168777|196267|P1|STARTED|Overall Study||2
80219|NCT02168491|196344|P1|NOT COMPLETED|Overall Study||1
80220|NCT02168491|196344|P1|COMPLETED|Overall Study||8
80221|NCT02168491|196344|P1|STARTED|Overall Study||9
80222|NCT02168478|196350|P1|NOT COMPLETED|Overall Study||4
80223|NCT02168478|196350|P1|COMPLETED|Overall Study||202
80224|NCT02168478|196350|P1|STARTED|Overall Study||206
80225|NCT02168439|196356|P2|NOT COMPLETED|Overall Study||2
80226|NCT02168439|196357|P1|NOT COMPLETED|Overall Study||0
80227|NCT02168439|196356|P2|COMPLETED|Overall Study||18
80228|NCT02168439|196357|P1|COMPLETED|Overall Study||20
80229|NCT02168439|196356|P2|STARTED|Overall Study||20
80230|NCT02168439|196357|P1|STARTED|Overall Study||20
80231|NCT02168387|196375|P2|NOT COMPLETED|Overall Study||3
80232|NCT02168387|196376|P1|NOT COMPLETED|Overall Study||7
80233|NCT02168387|196375|P2|COMPLETED|Overall Study||16
80234|NCT02168387|196376|P1|COMPLETED|Overall Study||13
80235|NCT02168387|196375|P2|STARTED|Overall Study||19
80236|NCT02168387|196376|P1|STARTED|Overall Study||20
80237|NCT02168361|196388|P2|NOT COMPLETED|Overall Study||10
80238|NCT02168361|196389|P1|NOT COMPLETED|Overall Study||5
80239|NCT02168361|196388|P2|COMPLETED|Overall Study||21
80240|NCT02168361|196389|P1|COMPLETED|Overall Study||57
80241|NCT02168361|196388|P2|STARTED|Overall Study||31
80242|NCT02168361|196389|P1|STARTED|Overall Study||62
80243|NCT02168309|196399|P2|NOT COMPLETED|Overall Study||0
80244|NCT02168309|196400|P1|NOT COMPLETED|Overall Study||0
80246|NCT02168309|196400|P1|COMPLETED|Overall Study||25
80247|NCT02168309|196399|P2|STARTED|Overall Study||25
80248|NCT02168309|196400|P1|STARTED|Overall Study||25
80249|NCT02168270|196408|P1|NOT COMPLETED|Overall Study||4
80250|NCT02168270|196408|P1|COMPLETED|Overall Study||0
80251|NCT02168270|196408|P1|STARTED|Overall Study||4
80252|NCT02168153|196417|P2|NOT COMPLETED|Overall Study||0
80253|NCT02168153|196418|P1|NOT COMPLETED|Overall Study||3
80254|NCT02168153|196417|P2|COMPLETED|Overall Study||60
80255|NCT02168153|196418|P1|COMPLETED|Overall Study||57
80256|NCT02168153|196417|P2|STARTED|Overall Study||60
80257|NCT02168153|196418|P1|STARTED|Overall Study||60
80258|NCT02167893|196432|P1|NOT COMPLETED|Overall Study||163
80259|NCT02167893|196432|P1|COMPLETED|Overall Study||11125
80260|NCT02167893|196432|P1|STARTED|Overall Study||11288
80261|NCT02167867|196443|P2|NOT COMPLETED|Overall Study||0
80262|NCT02167867|196444|P1|NOT COMPLETED|Overall Study||0
80263|NCT02167867|196443|P2|COMPLETED|Overall Study||22
80264|NCT02167867|196444|P1|COMPLETED|Overall Study||22
80265|NCT02167867|196443|P2|STARTED|Overall Study||22
80266|NCT02167867|196444|P1|STARTED|Overall Study||22
80267|NCT02167815|196452|P2|NOT COMPLETED|Overall Study||0
80268|NCT02167815|196453|P1|NOT COMPLETED|Overall Study||0
80269|NCT02167815|196452|P2|COMPLETED|Overall Study||21
80270|NCT02167815|196453|P1|COMPLETED|Overall Study||9
80271|NCT02167815|196452|P2|STARTED|Overall Study||21
80272|NCT02167815|196453|P1|STARTED|Overall Study||9
80273|NCT02167256|196466|P2|NOT COMPLETED|Overall Study||10
80274|NCT02167256|196467|P1|NOT COMPLETED|Overall Study||21
80275|NCT02167256|196466|P2|COMPLETED|Overall Study||70
80276|NCT02167256|196467|P1|COMPLETED|Overall Study||58
80277|NCT02167256|196466|P2|STARTED|Overall Study||80
80278|NCT02167256|196467|P1|STARTED|Overall Study||79
80279|NCT02167217|196483|P1|NOT COMPLETED|Overall Study||2
80280|NCT02167217|196483|P1|COMPLETED|Overall Study||23
80281|NCT02167217|196483|P1|STARTED|Overall Study||25
80282|NCT02167139|196489|P4|NOT COMPLETED|Transition-extension||5
80283|NCT02167139|196490|P3|NOT COMPLETED|Transition-extension||8
80284|NCT02167139|196491|P2|NOT COMPLETED|Transition-extension||0
80285|NCT02167139|196492|P1|NOT COMPLETED|Transition-extension||6
80286|NCT02167139|196489|P4|COMPLETED|Transition-extension||124
80287|NCT02167139|196490|P3|COMPLETED|Transition-extension||117
80288|NCT02167139|196491|P2|COMPLETED|Transition-extension||0
80289|NCT02167139|196492|P1|COMPLETED|Transition-extension||248
80290|NCT02167139|196489|P4|STARTED|Transition-extension||129
80291|NCT02167139|196490|P3|STARTED|Transition-extension||125
80292|NCT02167139|196491|P2|STARTED|Transition-extension||0
80293|NCT02167139|196492|P1|STARTED|Transition-extension||254
80294|NCT02167139|196489|P4|NOT COMPLETED|Randomised, Double-blind||0
80295|NCT02167139|196490|P3|NOT COMPLETED|Randomised, Double-blind||0
80296|NCT02167139|196491|P2|NOT COMPLETED|Randomised, Double-blind||19
80297|NCT02167139|196492|P1|NOT COMPLETED|Randomised, Double-blind||17
80298|NCT02167139|196489|P4|COMPLETED|Randomised, Double-blind||0
80299|NCT02167139|196490|P3|COMPLETED|Randomised, Double-blind||0
80300|NCT02167139|196491|P2|COMPLETED|Randomised, Double-blind||254
80301|NCT02167139|196492|P1|COMPLETED|Randomised, Double-blind||254
80302|NCT02167139|196489|P4|STARTED|Randomised, Double-blind||0
80303|NCT02167139|196490|P3|STARTED|Randomised, Double-blind||0
80304|NCT02167139|196491|P2|STARTED|Randomised, Double-blind||273
80305|NCT02167139|196492|P1|STARTED|Randomised, Double-blind||271
80306|NCT02167035|196508|P2|NOT COMPLETED|Overall Study||6
80307|NCT02167035|196509|P1|NOT COMPLETED|Overall Study||5
80308|NCT02167035|196508|P2|COMPLETED|Overall Study||16
80309|NCT02167035|196509|P1|COMPLETED|Overall Study||16
80310|NCT02167035|196508|P2|STARTED|Overall Study||22
80311|NCT02167035|196509|P1|STARTED|Overall Study||21
80312|NCT02166697|196517|P1|NOT COMPLETED|Overall Study||347
80313|NCT02166697|196517|P1|COMPLETED|Overall Study||13804
80314|NCT02166697|196517|P1|STARTED|Overall Study||14151
80315|NCT02166606|196526|P1|NOT COMPLETED|Overall Study||78
80316|NCT02166606|196526|P1|COMPLETED|Overall Study||1106
80317|NCT02166606|196526|P1|Consent Eligible|Overall Study||1174
80318|NCT02166606|196526|P1|Actively Enrolled|Overall Study||1180
80319|NCT02166606|196526|P1|STARTED|Overall Study||1184
80320|NCT02166476|196533|P2|NOT COMPLETED|Overall Study||23
80321|NCT02166476|196534|P1|NOT COMPLETED|Overall Study||14
80322|NCT02166476|196533|P2|COMPLETED|Overall Study||250
80323|NCT02166476|196534|P1|COMPLETED|Overall Study||258
80324|NCT02166476|196533|P2|Received at Least 1 Dose of Study Drug|Overall Study||273
80325|NCT02166476|196534|P1|Received at Least 1 Dose of Study Drug|Overall Study||272
80326|NCT02166476|196533|P2|STARTED|Overall Study||273
80327|NCT02166476|196534|P1|STARTED|Overall Study||272
80328|NCT02166346|196567|P2|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||0
80329|NCT02166346|196568|P1|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||1
80330|NCT02166346|196567|P2|COMPLETED|Intervention - Phase 2 (After Crossover)||6
80331|NCT02166346|196568|P1|COMPLETED|Intervention - Phase 2 (After Crossover)||7
80332|NCT02166346|196567|P2|STARTED|Intervention - Phase 2 (After Crossover)||6
80333|NCT02166346|196568|P1|STARTED|Intervention - Phase 2 (After Crossover)||8
80334|NCT02166346|196567|P2|NOT COMPLETED|Intervention - Phase 1||2
80335|NCT02166346|196568|P1|NOT COMPLETED|Intervention - Phase 1||0
80336|NCT02166346|196567|P2|COMPLETED|Intervention - Phase 1||6
80337|NCT02166346|196568|P1|COMPLETED|Intervention - Phase 1||8
80338|NCT02166346|196567|P2|STARTED|Intervention - Phase 1||8
80339|NCT02166346|196568|P1|STARTED|Intervention - Phase 1||8
80340|NCT02166346|196567|P2|NOT COMPLETED|Screening and Randomization||4
80341|NCT02166346|196568|P1|NOT COMPLETED|Screening and Randomization||4
80342|NCT02166346|196567|P2|COMPLETED|Screening and Randomization||8
80343|NCT02166346|196568|P1|COMPLETED|Screening and Randomization||8
80344|NCT02166346|196567|P2|STARTED|Screening and Randomization||12
80345|NCT02166346|196568|P1|STARTED|Screening and Randomization||12
80346|NCT02165904|196576|P1|NOT COMPLETED|Overall Study||0
80347|NCT02165904|196576|P1|COMPLETED|Overall Study||10
80348|NCT02165904|196576|P1|STARTED|Overall Study||10
80349|NCT02165826|196598|P3|NOT COMPLETED|Down-Titration Period||7
80350|NCT02165826|196599|P2|NOT COMPLETED|Down-Titration Period||11
80351|NCT02165826|196600|P1|NOT COMPLETED|Down-Titration Period||7
80352|NCT02165826|196598|P3|COMPLETED|Down-Titration Period||31
80353|NCT02165826|196599|P2|COMPLETED|Down-Titration Period||28
80354|NCT02165826|196600|P1|COMPLETED|Down-Titration Period||20
80355|NCT02165826|196598|P3|Safety Analysis Set: Received Study Drug|Down-Titration Period||38
80356|NCT02165826|196599|P2|Safety Analysis Set: Received Study Drug|Down-Titration Period||39
80357|NCT02165826|196600|P1|Safety Analysis Set: Received Study Drug|Down-Titration Period||27
80358|NCT02165826|196598|P3|STARTED|Down-Titration Period||38
80359|NCT02165826|196599|P2|STARTED|Down-Titration Period||39
80360|NCT02165826|196600|P1|STARTED|Down-Titration Period||27
80361|NCT02165826|196598|P3|NOT COMPLETED|Main Treatment Period||109
80362|NCT02165826|196599|P2|NOT COMPLETED|Main Treatment Period||90
80363|NCT02165826|196600|P1|NOT COMPLETED|Main Treatment Period||81
80364|NCT02165826|196598|P3|COMPLETED|Main Treatment Period||334
80365|NCT02165826|196599|P2|COMPLETED|Main Treatment Period||349
80366|NCT02165826|196600|P1|COMPLETED|Main Treatment Period||360
80367|NCT02165826|196598|P3|Safety Analysis Set: Received Study Drug|Main Treatment Period||443
80368|NCT02165826|196599|P2|Safety Analysis Set: Received Study Drug|Main Treatment Period||437
80369|NCT02165826|196600|P1|Safety Analysis Set: Received Study Drug|Main Treatment Period||441
80370|NCT02165826|196598|P3|STARTED|Main Treatment Period||443
80371|NCT02165826|196599|P2|STARTED|Main Treatment Period||439
80372|NCT02165826|196600|P1|STARTED|Main Treatment Period||441
80373|NCT02165761|196659|P2|NOT COMPLETED|Overall Study||14
80374|NCT02165761|196660|P1|NOT COMPLETED|Overall Study||19
80375|NCT02165761|196659|P2|COMPLETED|Overall Study||5
80376|NCT02165761|196660|P1|COMPLETED|Overall Study||4
80377|NCT02165761|196659|P2|STARTED|Overall Study||19
80378|NCT02165761|196660|P1|STARTED|Overall Study||23
80379|NCT02165735|196668|P2|NOT COMPLETED|Overall Study||14
80380|NCT02165735|196669|P1|NOT COMPLETED|Overall Study||16
80381|NCT02165735|196668|P2|COMPLETED|Overall Study||166
80382|NCT02165735|196669|P1|COMPLETED|Overall Study||164
80383|NCT02165735|196668|P2|STARTED|Overall Study||180
80384|NCT02165735|196669|P1|STARTED|Overall Study||180
80385|NCT02165722|196697|P2|NOT COMPLETED|Overall Study||0
80386|NCT02165722|196698|P1|NOT COMPLETED|Overall Study||0
80387|NCT02165722|196697|P2|COMPLETED|Overall Study|Started and completed participants reflect the longitudinal analytic data set of patients used|2202
80388|NCT02165722|196698|P1|COMPLETED|Overall Study|Started and completed participants reflect the longitudinal analytic data set of patients used|1971
80389|NCT02165722|196697|P2|STARTED|Overall Study||2202
80390|NCT02165722|196698|P1|STARTED|Overall Study||1971
80391|NCT02165462|196710|P1|NOT COMPLETED|Overall Study||0
80392|NCT02165462|196710|P1|COMPLETED|Overall Study||17
80393|NCT02165462|196710|P1|STARTED|Overall Study||17
80394|NCT02165384|196727|P1|NOT COMPLETED|Overall Study||0
80395|NCT02165384|196727|P1|COMPLETED|Overall Study||199
80396|NCT02165384|196727|P1|STARTED|Overall Study||199
80397|NCT02165202|196734|P2|NOT COMPLETED|Injection Phase||6
80398|NCT02165202|196735|P1|NOT COMPLETED|Injection Phase||10
80399|NCT02165202|196734|P2|COMPLETED|Injection Phase||36
80400|NCT02165202|196735|P1|COMPLETED|Injection Phase||70
80401|NCT02165202|196734|P2|STARTED|Injection Phase|Participants who received at least one injection.|42
80402|NCT02165202|196735|P1|STARTED|Injection Phase|Participants who received at least one injection.|80
80403|NCT02165202|196734|P2|NOT COMPLETED|Oral Phase||3
80404|NCT02165202|196735|P1|NOT COMPLETED|Oral Phase||11
80405|NCT02165202|196734|P2|COMPLETED|Oral Phase||42
80406|NCT02165202|196735|P1|COMPLETED|Oral Phase||80
80407|NCT02165202|196734|P2|STARTED|Oral Phase|Participants Enrolled in the study|45
80408|NCT02165202|196735|P1|STARTED|Oral Phase|Participants Enrolled in the study|91
80409|NCT02165124|196741|P1|NOT COMPLETED|Overall Study||5
80410|NCT02165124|196741|P1|COMPLETED|Overall Study||15
80411|NCT02165124|196741|P1|STARTED|Overall Study||20
80412|NCT02165111|196747|P2|NOT COMPLETED|Overall Study||0
80413|NCT02165111|196748|P1|NOT COMPLETED|Overall Study||0
80414|NCT02165111|196747|P2|COMPLETED|Overall Study||40
80415|NCT02165111|196748|P1|COMPLETED|Overall Study||40
80416|NCT02165111|196747|P2|STARTED|Overall Study||40
80417|NCT02165111|196748|P1|STARTED|Overall Study||40
80418|NCT02165072|196764|P1|NOT COMPLETED|Overall Study||0
80419|NCT02165072|196764|P1|COMPLETED|Overall Study||30
80420|NCT02165072|196764|P1|STARTED|Overall Study||30
80421|NCT02164981|196772|P3|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||0
80422|NCT02164981|196773|P2|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2
80423|NCT02164981|196774|P1|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2
80424|NCT02164981|196772|P3|COMPLETED|Phase 2 (Day 14 - Day 28)||18
80425|NCT02164981|196773|P2|COMPLETED|Phase 2 (Day 14 - Day 28)||12
80426|NCT02164981|196774|P1|COMPLETED|Phase 2 (Day 14 - Day 28)||16
80427|NCT02164981|196772|P3|STARTED|Phase 2 (Day 14 - Day 28)||18
80428|NCT02164981|196773|P2|STARTED|Phase 2 (Day 14 - Day 28)||14
80429|NCT02164981|196774|P1|STARTED|Phase 2 (Day 14 - Day 28)||18
80430|NCT02164981|196772|P3|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0
80431|NCT02164981|196773|P2|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||2
80432|NCT02164981|196774|P1|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0
80433|NCT02164981|196772|P3|COMPLETED|Phase 1 (Day 0 - Day 14)||18
80434|NCT02164981|196773|P2|COMPLETED|Phase 1 (Day 0 - Day 14)||14
80435|NCT02164981|196774|P1|COMPLETED|Phase 1 (Day 0 - Day 14)||18
80436|NCT02164981|196772|P3|STARTED|Phase 1 (Day 0 - Day 14)||18
80437|NCT02164981|196773|P2|STARTED|Phase 1 (Day 0 - Day 14)||16
80438|NCT02164981|196774|P1|STARTED|Phase 1 (Day 0 - Day 14)||18
80439|NCT02164981|196772|P3|NOT COMPLETED|Started||0
80440|NCT02164981|196773|P2|NOT COMPLETED|Started||3
80441|NCT02164981|196774|P1|NOT COMPLETED|Started||5
80442|NCT02164981|196772|P3|COMPLETED|Started||18
80443|NCT02164981|196773|P2|COMPLETED|Started||16
80444|NCT02164981|196774|P1|COMPLETED|Started||18
80445|NCT02164981|196772|P3|STARTED|Started||18
80446|NCT02164981|196773|P2|STARTED|Started||19
80447|NCT02164981|196774|P1|STARTED|Started||23
80448|NCT02164929|196847|P4|NOT COMPLETED|Overall Study||2
80449|NCT02164929|196848|P3|NOT COMPLETED|Overall Study||1
80450|NCT02164929|196849|P2|NOT COMPLETED|Overall Study||0
80451|NCT02164929|196850|P1|NOT COMPLETED|Overall Study||1
80452|NCT02164929|196847|P4|COMPLETED|Overall Study||2
80453|NCT02164929|196848|P3|COMPLETED|Overall Study||4
80454|NCT02164929|196849|P2|COMPLETED|Overall Study||3
80455|NCT02164929|196850|P1|COMPLETED|Overall Study||3
80456|NCT02164929|196847|P4|STARTED|Overall Study||4
80457|NCT02164929|196848|P3|STARTED|Overall Study||5
80458|NCT02164929|196849|P2|STARTED|Overall Study||3
80459|NCT02164929|196850|P1|STARTED|Overall Study||4
80460|NCT02164916|196894|P2|NOT COMPLETED|Overall Study||54
80461|NCT02164916|196895|P1|NOT COMPLETED|Overall Study||52
80462|NCT02164916|196894|P2|COMPLETED|Overall Study||0
80463|NCT02164916|196895|P1|COMPLETED|Overall Study||0
80464|NCT02164916|196894|P2|Cross-over to Arm II|Overall Study||0
80465|NCT02164916|196895|P1|Cross-over to Arm II|Overall Study|Following disease progression on Arm 1. Note: these patients are also counted in 'Not Completed'.|24
80466|NCT02164916|196894|P2|Eligible|Overall Study||49
80467|NCT02164916|196895|P1|Eligible|Overall Study||50
80468|NCT02164916|196894|P2|STARTED|Overall Study||54
80469|NCT02164916|196895|P1|STARTED|Overall Study||52
80470|NCT02164864|196915|P3|NOT COMPLETED|Overall Study||132
80471|NCT02164864|196916|P2|NOT COMPLETED|Overall Study||60
80472|NCT02164864|196917|P1|NOT COMPLETED|Overall Study||95
80473|NCT02164864|196915|P3|COMPLETED|Overall Study||849
80474|NCT02164864|196916|P2|COMPLETED|Overall Study||703
80475|NCT02164864|196917|P1|COMPLETED|Overall Study||886
80476|NCT02164864|196915|P3|STARTED|Overall Study|Started are the Randomised/entered patients.|981
80477|NCT02164864|196916|P2|STARTED|Overall Study|Started are the Randomised/entered patients.|763
80478|NCT02164864|196917|P1|STARTED|Overall Study|Started are the Randomised/entered patients.|981
80479|NCT02164539|196982|P7|NOT COMPLETED|Treatment Phase C (1 Week)||2
80480|NCT02164539|196983|P6|NOT COMPLETED|Treatment Phase C (1 Week)||0
80481|NCT02164539|196984|P5|NOT COMPLETED|Treatment Phase C (1 Week)||0
80482|NCT02164539|196985|P4|NOT COMPLETED|Treatment Phase C (1 Week)||0
80483|NCT02164539|196986|P3|NOT COMPLETED|Treatment Phase C (1 Week)||0
80484|NCT02164539|196987|P2|NOT COMPLETED|Treatment Phase C (1 Week)||0
80485|NCT02164539|196988|P1|NOT COMPLETED|Treatment Phase C (1 Week)||1
80486|NCT02164539|196982|P7|COMPLETED|Treatment Phase C (1 Week)||78
80487|NCT02164539|196983|P6|COMPLETED|Treatment Phase C (1 Week)||82
80488|NCT02164539|196984|P5|COMPLETED|Treatment Phase C (1 Week)||84
80489|NCT02164539|196985|P4|COMPLETED|Treatment Phase C (1 Week)||0
80490|NCT02164539|196986|P3|COMPLETED|Treatment Phase C (1 Week)||0
80491|NCT02164539|196987|P2|COMPLETED|Treatment Phase C (1 Week)||0
80492|NCT02164539|196988|P1|COMPLETED|Treatment Phase C (1 Week)||78
80493|NCT02164539|196982|P7|STARTED|Treatment Phase C (1 Week)||80
80494|NCT02164539|196983|P6|STARTED|Treatment Phase C (1 Week)||82
80495|NCT02164539|196984|P5|STARTED|Treatment Phase C (1 Week)||84
80496|NCT02164539|196985|P4|STARTED|Treatment Phase C (1 Week)||0
80497|NCT02164539|196986|P3|STARTED|Treatment Phase C (1 Week)||0
80498|NCT02164539|196987|P2|STARTED|Treatment Phase C (1 Week)||0
80499|NCT02164539|196988|P1|STARTED|Treatment Phase C (1 Week)||79
80500|NCT02164539|196982|P7|NOT COMPLETED|Treatment Phase B (1 Week)||1
80501|NCT02164539|196983|P6|NOT COMPLETED|Treatment Phase B (1 Week)||0
80502|NCT02164539|196984|P5|NOT COMPLETED|Treatment Phase B (1 Week)||3
80503|NCT02164539|196985|P4|NOT COMPLETED|Treatment Phase B (1 Week)||0
80504|NCT02164539|196986|P3|NOT COMPLETED|Treatment Phase B (1 Week)||0
80505|NCT02164539|196987|P2|NOT COMPLETED|Treatment Phase B (1 Week)||0
80506|NCT02164539|196988|P1|NOT COMPLETED|Treatment Phase B (1 Week)||0
80507|NCT02164539|196982|P7|COMPLETED|Treatment Phase B (1 Week)||162
80508|NCT02164539|196983|P6|COMPLETED|Treatment Phase B (1 Week)||0
80509|NCT02164539|196984|P5|COMPLETED|Treatment Phase B (1 Week)||163
80510|NCT02164539|196985|P4|COMPLETED|Treatment Phase B (1 Week)||0
80511|NCT02164539|196986|P3|COMPLETED|Treatment Phase B (1 Week)||0
80512|NCT02164539|196987|P2|COMPLETED|Treatment Phase B (1 Week)||0
80513|NCT02164539|196988|P1|COMPLETED|Treatment Phase B (1 Week)||0
80514|NCT02164539|196982|P7|STARTED|Treatment Phase B (1 Week)||163
80515|NCT02164539|196983|P6|STARTED|Treatment Phase B (1 Week)||0
80516|NCT02164539|196984|P5|STARTED|Treatment Phase B (1 Week)||166
80517|NCT02164539|196985|P4|STARTED|Treatment Phase B (1 Week)||0
80518|NCT02164539|196986|P3|STARTED|Treatment Phase B (1 Week)||0
80519|NCT02164539|196987|P2|STARTED|Treatment Phase B (1 Week)||0
80520|NCT02164539|196988|P1|STARTED|Treatment Phase B (1 Week)||0
80521|NCT02164539|196982|P7|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
80522|NCT02164539|196983|P6|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
80523|NCT02164539|196984|P5|NOT COMPLETED|Treatment Phase A (4 Weeks)||3
80524|NCT02164539|196985|P4|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
80525|NCT02164539|196986|P3|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
80526|NCT02164539|196987|P2|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
80527|NCT02164539|196988|P1|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
80528|NCT02164539|196982|P7|COMPLETED|Treatment Phase A (4 Weeks)||0
80529|NCT02164539|196983|P6|COMPLETED|Treatment Phase A (4 Weeks)||83
80530|NCT02164539|196984|P5|COMPLETED|Treatment Phase A (4 Weeks)||82
80531|NCT02164539|196985|P4|COMPLETED|Treatment Phase A (4 Weeks)||44
80532|NCT02164539|196986|P3|COMPLETED|Treatment Phase A (4 Weeks)||39
80533|NCT02164539|196987|P2|COMPLETED|Treatment Phase A (4 Weeks)||42
80534|NCT02164539|196988|P1|COMPLETED|Treatment Phase A (4 Weeks)||39
80535|NCT02164539|196982|P7|STARTED|Treatment Phase A (4 Weeks)||0
80536|NCT02164539|196983|P6|STARTED|Treatment Phase A (4 Weeks)||84
80537|NCT02164539|196984|P5|STARTED|Treatment Phase A (4 Weeks)||85
80538|NCT02164539|196985|P4|STARTED|Treatment Phase A (4 Weeks)||46
80539|NCT02164539|196986|P3|STARTED|Treatment Phase A (4 Weeks)||40
80540|NCT02164539|196987|P2|STARTED|Treatment Phase A (4 Weeks)||42
80541|NCT02164539|196988|P1|STARTED|Treatment Phase A (4 Weeks)||41
80542|NCT02164513|197036|P3|NOT COMPLETED|Overall Study||295
80543|NCT02164513|197037|P2|NOT COMPLETED|Overall Study||536
80544|NCT02164513|197038|P1|NOT COMPLETED|Overall Study||437
80545|NCT02164513|197036|P3|COMPLETED|Overall Study||1775
80546|NCT02164513|197037|P2|COMPLETED|Overall Study||3598
80547|NCT02164513|197038|P1|COMPLETED|Overall Study||3714
80548|NCT02164513|197036|P3|WIP :Did Not Complete Study Treatment|Overall Study||0
80549|NCT02164513|197037|P2|WIP :Did Not Complete Study Treatment|Overall Study||1
80550|NCT02164513|197038|P1|WIP :Did Not Complete Study Treatment|Overall Study||1
80551|NCT02164513|197036|P3|WIP: Withdrawal by Participant|Overall Study||153
80552|NCT02164513|197037|P2|WIP: Withdrawal by Participant|Overall Study||296
80553|NCT02164513|197038|P1|WIP: Withdrawal by Participant|Overall Study||250
80554|NCT02164513|197036|P3|WIP: Investigator Discretion|Overall Study||15
80555|NCT02164513|197037|P2|WIP: Investigator Discretion|Overall Study||36
80556|NCT02164513|197038|P1|WIP: Investigator Discretion|Overall Study||33
80557|NCT02164513|197036|P3|WIP: Lost to Follow-up|Overall Study||14
80558|NCT02164513|197037|P2|WIP: Lost to Follow-up|Overall Study||25
80559|NCT02164513|197038|P1|WIP: Lost to Follow-up|Overall Study||21
80560|NCT02164513|197036|P3|WIP: Study Closed/Terminated|Overall Study||5
80561|NCT02164513|197037|P2|WIP: Study Closed/Terminated|Overall Study||2
80562|NCT02164513|197038|P1|WIP: Study Closed/Terminated|Overall Study||5
80563|NCT02164513|197036|P3|WIP (Other): Stopping Criteria Reached|Overall Study||2
80564|NCT02164513|197037|P2|WIP (Other): Stopping Criteria Reached|Overall Study||1
80565|NCT02164513|197038|P1|WIP (Other): Stopping Criteria Reached|Overall Study||4
80566|NCT02164513|197036|P3|Withdrew IP: Protocol Deviation|Overall Study||19
80567|NCT02164513|197037|P2|Withdrew IP: Protocol Deviation|Overall Study||41
80568|NCT02164513|197038|P1|Withdrew IP: Protocol Deviation|Overall Study||32
80569|NCT02164513|197036|P3|WIP: Lack of Efficacy|Overall Study||172
80570|NCT02164513|197037|P2|WIP: Lack of Efficacy|Overall Study||313
80571|NCT02164513|197038|P1|WIP: Lack of Efficacy|Overall Study||163
80572|NCT02164513|197036|P3|Withdrew IP (WIP): Adverse Event|Overall Study||186
80573|NCT02164513|197037|P2|Withdrew IP (WIP): Adverse Event|Overall Study||325
80574|NCT02164513|197038|P1|Withdrew IP (WIP): Adverse Event|Overall Study||249
80575|NCT02164513|197036|P3|Not Completed IP|Overall Study||566
80576|NCT02164513|197037|P2|Not Completed IP|Overall Study||1040
80577|NCT02164513|197038|P1|Not Completed IP|Overall Study||758
80578|NCT02164513|197036|P3|Completed Investigational Product (IP)|Overall Study||1504
80579|NCT02164513|197037|P2|Completed Investigational Product (IP)|Overall Study||3094
80580|NCT02164513|197038|P1|Completed Investigational Product (IP)|Overall Study||3393
80581|NCT02164513|197036|P3|STARTED|Overall Study||2070
80582|NCT02164513|197037|P2|STARTED|Overall Study||4134
80583|NCT02164513|197038|P1|STARTED|Overall Study||4151
80584|NCT02164396|197063|P3|NOT COMPLETED|Overall Study||0
80585|NCT02164396|197064|P2|NOT COMPLETED|Overall Study||0
80586|NCT02164396|197065|P1|NOT COMPLETED|Overall Study||0
80587|NCT02164396|197063|P3|COMPLETED|Overall Study||10
80588|NCT02164396|197064|P2|COMPLETED|Overall Study||10
80589|NCT02164396|197065|P1|COMPLETED|Overall Study||10
80590|NCT02164396|197063|P3|STARTED|Overall Study||10
80591|NCT02164396|197064|P2|STARTED|Overall Study||10
80592|NCT02164396|197065|P1|STARTED|Overall Study||10
80593|NCT02164383|197075|P2|NOT COMPLETED|Overall Study||0
80594|NCT02164383|197076|P1|NOT COMPLETED|Overall Study||1
80595|NCT02164383|197075|P2|COMPLETED|Overall Study||14
80596|NCT02164383|197076|P1|COMPLETED|Overall Study||15
80597|NCT02164383|197075|P2|STARTED|Overall Study||14
80598|NCT02164383|197076|P1|STARTED|Overall Study||16
80599|NCT02164318|197086|P4|NOT COMPLETED|Overall Study||1
80600|NCT02164318|197087|P3|NOT COMPLETED|Overall Study||0
80601|NCT02164318|197088|P2|NOT COMPLETED|Overall Study||1
80602|NCT02164318|197089|P1|NOT COMPLETED|Overall Study||0
80603|NCT02164318|197086|P4|COMPLETED|Overall Study||2
80604|NCT02164318|197087|P3|COMPLETED|Overall Study||1
80605|NCT02164318|197088|P2|COMPLETED|Overall Study||2
80606|NCT02164318|197089|P1|COMPLETED|Overall Study||4
80607|NCT02164318|197086|P4|STARTED|Overall Study||3
80608|NCT02164318|197087|P3|STARTED|Overall Study||1
80609|NCT02164318|197088|P2|STARTED|Overall Study||3
80610|NCT02164318|197089|P1|STARTED|Overall Study||4
80611|NCT02164240|197107|P3|NOT COMPLETED|Overall Study||0
80612|NCT02164240|197108|P2|NOT COMPLETED|Overall Study||0
80613|NCT02164240|197109|P1|NOT COMPLETED|Overall Study||0
80614|NCT02164240|197107|P3|COMPLETED|Overall Study||4
80615|NCT02164240|197108|P2|COMPLETED|Overall Study||5
80616|NCT02164240|197109|P1|COMPLETED|Overall Study||5
80617|NCT02164240|197107|P3|STARTED|Overall Study||4
80618|NCT02164240|197108|P2|STARTED|Overall Study||5
80619|NCT02164240|197109|P1|STARTED|Overall Study||5
80620|NCT02163993|197124|P5|NOT COMPLETED|Post-treatment Period||3
80621|NCT02163993|197125|P4|NOT COMPLETED|Post-treatment Period||2
80622|NCT02163993|197126|P3|NOT COMPLETED|Post-treatment Period||4
80623|NCT02163993|197127|P2|NOT COMPLETED|Post-treatment Period||6
80624|NCT02163993|197128|P1|NOT COMPLETED|Post-treatment Period||4
80625|NCT02163993|197124|P5|COMPLETED|Post-treatment Period||62
80626|NCT02163993|197125|P4|COMPLETED|Post-treatment Period||61
80627|NCT02163993|197126|P3|COMPLETED|Post-treatment Period||62
80628|NCT02163993|197127|P2|COMPLETED|Post-treatment Period||55
80629|NCT02163993|197128|P1|COMPLETED|Post-treatment Period||121
80630|NCT02163993|197124|P5|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|65
80631|NCT02163993|197125|P4|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|63
80632|NCT02163993|197126|P3|STARTED|Post-treatment Period||66
80633|NCT02163993|197127|P2|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|61
80634|NCT02163993|197128|P1|STARTED|Post-treatment Period|One participant discontinued after Treatment Period. Did not enter into Post-treatment Period.|125
80635|NCT02163993|197124|P5|NOT COMPLETED|Treatment Period||7
80636|NCT02163993|197125|P4|NOT COMPLETED|Treatment Period||9
80637|NCT02163993|197126|P3|NOT COMPLETED|Treatment Period||2
80638|NCT02163993|197127|P2|NOT COMPLETED|Treatment Period||9
80639|NCT02163993|197128|P1|NOT COMPLETED|Treatment Period||12
80640|NCT02163993|197124|P5|COMPLETED|Treatment Period||62
80641|NCT02163993|197125|P4|COMPLETED|Treatment Period||62
80642|NCT02163993|197126|P3|COMPLETED|Treatment Period||66
80643|NCT02163993|197127|P2|COMPLETED|Treatment Period||59
80644|NCT02163993|197128|P1|COMPLETED|Treatment Period||126
80645|NCT02163993|197124|P5|Received at Least 1 Dose of Study Drug|Treatment Period||67
80646|NCT02163993|197125|P4|Received at Least 1 Dose of Study Drug|Treatment Period||70
80647|NCT02163993|197126|P3|Received at Least 1 Dose of Study Drug|Treatment Period||68
80648|NCT02163993|197127|P2|Received at Least 1 Dose of Study Drug|Treatment Period||68
80649|NCT02163993|197128|P1|Received at Least 1 Dose of Study Drug|Treatment Period||137
80650|NCT02163993|197124|P5|STARTED|Treatment Period||69
80651|NCT02163993|197125|P4|STARTED|Treatment Period||71
80652|NCT02163993|197126|P3|STARTED|Treatment Period||68
80653|NCT02163993|197127|P2|STARTED|Treatment Period||68
80654|NCT02163993|197128|P1|STARTED|Treatment Period||138
80655|NCT02163967|197204|P6|NOT COMPLETED|Third Intervention/Day 3||0
80656|NCT02163967|197205|P5|NOT COMPLETED|Third Intervention/Day 3||0
80657|NCT02163967|197206|P4|NOT COMPLETED|Third Intervention/Day 3||0
80658|NCT02163967|197207|P3|NOT COMPLETED|Third Intervention/Day 3||0
80659|NCT02163967|197208|P2|NOT COMPLETED|Third Intervention/Day 3||0
80660|NCT02163967|197209|P1|NOT COMPLETED|Third Intervention/Day 3||0
80661|NCT02163967|197204|P6|COMPLETED|Third Intervention/Day 3||3
80662|NCT02163967|197205|P5|COMPLETED|Third Intervention/Day 3||3
80663|NCT02163967|197206|P4|COMPLETED|Third Intervention/Day 3||4
80664|NCT02163967|197207|P3|COMPLETED|Third Intervention/Day 3||2
80665|NCT02163967|197208|P2|COMPLETED|Third Intervention/Day 3||3
80666|NCT02163967|197209|P1|COMPLETED|Third Intervention/Day 3||3
80667|NCT02163967|197204|P6|STARTED|Third Intervention/Day 3||3
80668|NCT02163967|197205|P5|STARTED|Third Intervention/Day 3||3
80669|NCT02163967|197206|P4|STARTED|Third Intervention/Day 3||4
80670|NCT02163967|197207|P3|STARTED|Third Intervention/Day 3||2
80671|NCT02163967|197208|P2|STARTED|Third Intervention/Day 3||3
80672|NCT02163967|197209|P1|STARTED|Third Intervention/Day 3||3
80673|NCT02163967|197204|P6|NOT COMPLETED|Second Intevention/Day 2||0
80674|NCT02163967|197205|P5|NOT COMPLETED|Second Intevention/Day 2||0
80675|NCT02163967|197206|P4|NOT COMPLETED|Second Intevention/Day 2||0
80676|NCT02163967|197207|P3|NOT COMPLETED|Second Intevention/Day 2||0
80677|NCT02163967|197208|P2|NOT COMPLETED|Second Intevention/Day 2||0
80678|NCT02163967|197209|P1|NOT COMPLETED|Second Intevention/Day 2||0
80679|NCT02163967|197204|P6|COMPLETED|Second Intevention/Day 2||3
80680|NCT02163967|197205|P5|COMPLETED|Second Intevention/Day 2||3
80681|NCT02163967|197206|P4|COMPLETED|Second Intevention/Day 2||4
80682|NCT02163967|197207|P3|COMPLETED|Second Intevention/Day 2||2
80683|NCT02163967|197208|P2|COMPLETED|Second Intevention/Day 2||4
80684|NCT02163967|197209|P1|COMPLETED|Second Intevention/Day 2||3
80685|NCT02163967|197204|P6|STARTED|Second Intevention/Day 2||3
80686|NCT02163967|197205|P5|STARTED|Second Intevention/Day 2||3
80687|NCT02163967|197206|P4|STARTED|Second Intevention/Day 2||4
80688|NCT02163967|197207|P3|STARTED|Second Intevention/Day 2||2
80689|NCT02163967|197208|P2|STARTED|Second Intevention/Day 2||4
80690|NCT02163967|197209|P1|STARTED|Second Intevention/Day 2||3
80691|NCT02163967|197204|P6|NOT COMPLETED|First Intervention/ Day 1||0
80692|NCT02163967|197205|P5|NOT COMPLETED|First Intervention/ Day 1||0
80693|NCT02163967|197206|P4|NOT COMPLETED|First Intervention/ Day 1||0
80694|NCT02163967|197207|P3|NOT COMPLETED|First Intervention/ Day 1||0
80695|NCT02163967|197208|P2|NOT COMPLETED|First Intervention/ Day 1||0
80696|NCT02163967|197209|P1|NOT COMPLETED|First Intervention/ Day 1||0
80697|NCT02163967|197204|P6|COMPLETED|First Intervention/ Day 1||3
80698|NCT02163967|197205|P5|COMPLETED|First Intervention/ Day 1||3
80699|NCT02163967|197206|P4|COMPLETED|First Intervention/ Day 1||4
80700|NCT02163967|197207|P3|COMPLETED|First Intervention/ Day 1||3
80701|NCT02163967|197208|P2|COMPLETED|First Intervention/ Day 1||4
80702|NCT02163967|197209|P1|COMPLETED|First Intervention/ Day 1||4
80703|NCT02163967|197204|P6|STARTED|First Intervention/ Day 1||3
80704|NCT02163967|197205|P5|STARTED|First Intervention/ Day 1||3
80705|NCT02163967|197206|P4|STARTED|First Intervention/ Day 1||4
80706|NCT02163967|197207|P3|STARTED|First Intervention/ Day 1||3
80707|NCT02163967|197208|P2|STARTED|First Intervention/ Day 1||4
80708|NCT02163967|197209|P1|STARTED|First Intervention/ Day 1||4
80709|NCT02163915|197231|P5|NOT COMPLETED|Overall Study||4
80710|NCT02163915|197232|P4|NOT COMPLETED|Overall Study||3
80711|NCT02163915|197233|P3|NOT COMPLETED|Overall Study||2
80712|NCT02163915|197234|P2|NOT COMPLETED|Overall Study||0
80713|NCT02163915|197235|P1|NOT COMPLETED|Overall Study||3
80714|NCT02163915|197231|P5|COMPLETED|Overall Study||6
80715|NCT02163915|197232|P4|COMPLETED|Overall Study||6
80716|NCT02163915|197233|P3|COMPLETED|Overall Study||8
80717|NCT02163915|197234|P2|COMPLETED|Overall Study||8
80718|NCT02163915|197235|P1|COMPLETED|Overall Study||7
80719|NCT02163915|197231|P5|STARTED|Overall Study||10
80720|NCT02163915|197232|P4|STARTED|Overall Study||9
80721|NCT02163915|197233|P3|STARTED|Overall Study||10
80722|NCT02163915|197234|P2|STARTED|Overall Study||8
80723|NCT02163915|197235|P1|STARTED|Overall Study||10
80724|NCT02163837|197288|P1|NOT COMPLETED|Day 28 of Rifaximin Treatment||0
80725|NCT02163837|197288|P1|COMPLETED|Day 28 of Rifaximin Treatment||15
80726|NCT02163837|197288|P1|STARTED|Day 28 of Rifaximin Treatment||15
80727|NCT02163837|197288|P1|NOT COMPLETED|Before Rifaximin||0
80728|NCT02163837|197288|P1|COMPLETED|Before Rifaximin||15
80729|NCT02163837|197288|P1|STARTED|Before Rifaximin||15
80730|NCT02163733|197298|P3|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||24
80731|NCT02163733|197299|P2|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
80732|NCT02163733|197300|P1|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
80733|NCT02163733|197298|P3|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||14
80734|NCT02163733|197299|P2|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
80735|NCT02163733|197300|P1|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
80736|NCT02163733|197298|P3|STARTED|Part B: Day 15 to End Part B (AZD9291)|No patients completed previous period as relates to Part A and arm is applicable only for Part B.|38
80737|NCT02163733|197299|P2|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
80738|NCT02163733|197300|P1|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
80739|NCT02163733|197298|P3|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
80740|NCT02163733|197299|P2|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
80741|NCT02163733|197300|P1|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
80742|NCT02163733|197298|P3|COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
80743|NCT02163733|197299|P2|COMPLETED|Part A: Day 10-15 (2nd Intervention)||20
80744|NCT02163733|197300|P1|COMPLETED|Part A: Day 10-15 (2nd Intervention)||18
80745|NCT02163733|197298|P3|STARTED|Part A: Day 10-15 (2nd Intervention)||0
80746|NCT02163733|197299|P2|STARTED|Part A: Day 10-15 (2nd Intervention)||20
80747|NCT02163733|197300|P1|STARTED|Part A: Day 10-15 (2nd Intervention)||18
80748|NCT02163733|197298|P3|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
80749|NCT02163733|197299|P2|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
80750|NCT02163733|197300|P1|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
80751|NCT02163733|197298|P3|COMPLETED|Part A: Day 1-9 (1st Intervention)||0
80752|NCT02163733|197299|P2|COMPLETED|Part A: Day 1-9 (1st Intervention)||20
80753|NCT02163733|197300|P1|COMPLETED|Part A: Day 1-9 (1st Intervention)||18
80754|NCT02163733|197298|P3|STARTED|Part A: Day 1-9 (1st Intervention)||0
80755|NCT02163733|197299|P2|STARTED|Part A: Day 1-9 (1st Intervention)||20
80756|NCT02163733|197300|P1|STARTED|Part A: Day 1-9 (1st Intervention)||18
80757|NCT02163577|197337|P2|NOT COMPLETED|Overall Study||0
80758|NCT02163577|197338|P1|NOT COMPLETED|Overall Study||0
80759|NCT02163577|197337|P2|COMPLETED|Overall Study||26
80760|NCT02163577|197338|P1|COMPLETED|Overall Study||26
80761|NCT02163577|197337|P2|STARTED|Overall Study||26
80762|NCT02163577|197338|P1|STARTED|Overall Study||26
80763|NCT02163538|197402|P2|NOT COMPLETED|Overall Study||1
80764|NCT02163538|197403|P1|NOT COMPLETED|Overall Study||1
80765|NCT02163538|197402|P2|COMPLETED|Overall Study||70
80766|NCT02163538|197403|P1|COMPLETED|Overall Study||70
80767|NCT02163538|197402|P2|STARTED|Overall Study||71
80768|NCT02163538|197403|P1|STARTED|Overall Study||71
80769|NCT02163499|197419|P1|NOT COMPLETED|Extended Dosing Phase: ZS||280
80770|NCT02163499|197419|P1|COMPLETED|Extended Dosing Phase: ZS||466
80771|NCT02163499|197419|P1|STARTED|Extended Dosing Phase: ZS||746
80772|NCT02163499|197419|P1|NOT COMPLETED|Acute Phase: ZS 10 g TID||5
80773|NCT02163499|197419|P1|COMPLETED|Acute Phase: ZS 10 g TID||746
80774|NCT02163499|197419|P1|STARTED|Acute Phase: ZS 10 g TID||751
80775|NCT02163486|197429|P2|NOT COMPLETED|Overall Study||2
80776|NCT02163486|197430|P1|NOT COMPLETED|Overall Study||1
80777|NCT02163486|197429|P2|COMPLETED|Overall Study||50
80778|NCT02163486|197430|P1|COMPLETED|Overall Study||50
80779|NCT02163486|197429|P2|STARTED|Overall Study||52
80780|NCT02163486|197430|P1|STARTED|Overall Study||51
80781|NCT02163447|197447|P3|NOT COMPLETED|Overall Study||3
80782|NCT02163447|197448|P2|NOT COMPLETED|Overall Study||6
80783|NCT02163447|197449|P1|NOT COMPLETED|Overall Study||6
80784|NCT02163447|197447|P3|COMPLETED|Overall Study||97
80785|NCT02163447|197448|P2|COMPLETED|Overall Study||88
80786|NCT02163447|197449|P1|COMPLETED|Overall Study||100
80787|NCT02163447|197447|P3|STARTED|Overall Study||100
80788|NCT02163447|197448|P2|STARTED|Overall Study||94
80789|NCT02163447|197449|P1|STARTED|Overall Study||106
80790|NCT02163421|197479|P4|NOT COMPLETED|Overall Study||0
80791|NCT02163421|197480|P3|NOT COMPLETED|Overall Study||0
80792|NCT02163421|197481|P2|NOT COMPLETED|Overall Study||0
80793|NCT02163421|197482|P1|NOT COMPLETED|Overall Study||0
80794|NCT02163421|197479|P4|COMPLETED|Overall Study||12
80795|NCT02163421|197480|P3|COMPLETED|Overall Study||12
80796|NCT02163421|197481|P2|COMPLETED|Overall Study||12
80797|NCT02163421|197482|P1|COMPLETED|Overall Study||12
80798|NCT02163421|197479|P4|STARTED|Overall Study||12
80799|NCT02163421|197480|P3|STARTED|Overall Study||12
80800|NCT02163421|197481|P2|STARTED|Overall Study||12
80801|NCT02163421|197482|P1|STARTED|Overall Study||12
80802|NCT02163395|197489|P1|NOT COMPLETED|Overall Study||5
80803|NCT02163395|197489|P1|COMPLETED|Overall Study||39
80804|NCT02163395|197489|P1|STARTED|Overall Study||44
80805|NCT02163187|197498|P2|NOT COMPLETED|Overall Study||0
80806|NCT02163187|197499|P1|NOT COMPLETED|Overall Study||2
80807|NCT02163187|197498|P2|COMPLETED|Overall Study||0
80808|NCT02163187|197499|P1|COMPLETED|Overall Study||2
80809|NCT02163187|197498|P2|Treatment|Overall Study||0
80810|NCT02163187|197499|P1|Treatment|Overall Study||2
80811|NCT02163187|197498|P2|STARTED|Overall Study||0
80812|NCT02163187|197499|P1|STARTED|Overall Study||4
80813|NCT02162992|197509|P2|NOT COMPLETED|Overall Study||1
80814|NCT02162992|197510|P1|NOT COMPLETED|Overall Study||5
80815|NCT02162992|197509|P2|COMPLETED|Overall Study||99
80816|NCT02162992|197510|P1|COMPLETED|Overall Study||46
80817|NCT02162992|197509|P2|STARTED|Overall Study||100
80818|NCT02162992|197510|P1|STARTED|Overall Study||51
80819|NCT02162979|197520|P2|NOT COMPLETED|Overall Study||0
80820|NCT02162979|197521|P1|NOT COMPLETED|Overall Study||0
80821|NCT02162979|197520|P2|COMPLETED|Overall Study||0
80822|NCT02162979|197521|P1|COMPLETED|Overall Study||0
80823|NCT02162979|197520|P2|STARTED|Overall Study||0
80824|NCT02162979|197521|P1|STARTED|Overall Study||0
80825|NCT02162862|197534|P3|NOT COMPLETED|Overall Study||4
80826|NCT02162862|197535|P2|NOT COMPLETED|Overall Study||11
80827|NCT02162862|197536|P1|NOT COMPLETED|Overall Study||0
80828|NCT02162862|197534|P3|COMPLETED|Overall Study||29
80829|NCT02162862|197535|P2|COMPLETED|Overall Study||24
80830|NCT02162862|197536|P1|COMPLETED|Overall Study||31
80831|NCT02162862|197534|P3|STARTED|Overall Study||33
80832|NCT02162862|197535|P2|STARTED|Overall Study||35
80833|NCT02162862|197536|P1|STARTED|Overall Study||31
80834|NCT02162758|197549|P2|NOT COMPLETED|Overall Study||1
80835|NCT02162758|197550|P1|NOT COMPLETED|Overall Study||0
80836|NCT02162758|197549|P2|COMPLETED|Overall Study||2
80837|NCT02162758|197550|P1|COMPLETED|Overall Study||3
80838|NCT02162758|197549|P2|STARTED|Overall Study||3
80839|NCT02162758|197550|P1|STARTED|Overall Study||3
80840|NCT02162680|197565|P3|NOT COMPLETED|Overall Study||0
80841|NCT02162680|197566|P2|NOT COMPLETED|Overall Study||0
80842|NCT02162680|197567|P1|NOT COMPLETED|Overall Study||0
80843|NCT02162680|197565|P3|COMPLETED|Overall Study||32
80844|NCT02162680|197566|P2|COMPLETED|Overall Study||33
80845|NCT02162680|197567|P1|COMPLETED|Overall Study||33
80846|NCT02162680|197565|P3|STARTED|Overall Study||32
80847|NCT02162680|197566|P2|STARTED|Overall Study||33
80848|NCT02162680|197567|P1|STARTED|Overall Study||33
80849|NCT02162667|197577|P2|NOT COMPLETED|Adjuvant Period||13
80850|NCT02162667|197578|P1|NOT COMPLETED|Adjuvant Period||12
80851|NCT02162667|197577|P2|COMPLETED|Adjuvant Period||255
80852|NCT02162667|197578|P1|COMPLETED|Adjuvant Period||248
80853|NCT02162667|197577|P2|STARTED|Adjuvant Period||268
80854|NCT02162667|197578|P1|STARTED|Adjuvant Period||260
80855|NCT02162667|197577|P2|NOT COMPLETED|Neoadjuvant Period||17
80856|NCT02162667|197578|P1|NOT COMPLETED|Neoadjuvant Period||14
80857|NCT02162667|197577|P2|COMPLETED|Neoadjuvant Period||267
80858|NCT02162667|197578|P1|COMPLETED|Neoadjuvant Period||264
80859|NCT02162667|197577|P2|STARTED|Neoadjuvant Period||284
80860|NCT02162667|197578|P1|STARTED|Neoadjuvant Period||278
80861|NCT02162576|197604|P1|NOT COMPLETED|Overall Study||0
80862|NCT02162576|197604|P1|COMPLETED|Overall Study||95
80863|NCT02162576|197604|P1|STARTED|Overall Study||95
80864|NCT02162446|197610|P1|NOT COMPLETED|Overall Study||0
80865|NCT02162446|197610|P1|COMPLETED|Overall Study||12
80866|NCT02162446|197610|P1|STARTED|Overall Study||12
80867|NCT02161757|197644|P3|NOT COMPLETED|Treatment Through Study Completion||39
80868|NCT02161757|197645|P2|NOT COMPLETED|Treatment Through Study Completion||43
80869|NCT02161757|197646|P1|NOT COMPLETED|Treatment Through Study Completion||57
80870|NCT02161757|197644|P3|COMPLETED|Treatment Through Study Completion||361
80871|NCT02161757|197645|P2|COMPLETED|Treatment Through Study Completion||361
80872|NCT02161757|197646|P1|COMPLETED|Treatment Through Study Completion||341
80873|NCT02161757|197644|P3|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||360
80874|NCT02161757|197645|P2|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||355
80875|NCT02161757|197646|P1|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||332
80876|NCT02161757|197644|P3|STARTED|Treatment Through Study Completion||400
80877|NCT02161757|197645|P2|STARTED|Treatment Through Study Completion||404
80878|NCT02161757|197646|P1|STARTED|Treatment Through Study Completion||398
80879|NCT02161757|197644|P3|NOT COMPLETED|Randomised Through Start Treatment||0
80880|NCT02161757|197645|P2|NOT COMPLETED|Randomised Through Start Treatment||2
80881|NCT02161757|197646|P1|NOT COMPLETED|Randomised Through Start Treatment||3
80882|NCT02161757|197644|P3|COMPLETED|Randomised Through Start Treatment||400
80883|NCT02161757|197645|P2|COMPLETED|Randomised Through Start Treatment||404
80884|NCT02161757|197646|P1|COMPLETED|Randomised Through Start Treatment||398
80885|NCT02161757|197644|P3|STARTED|Randomised Through Start Treatment||400
80886|NCT02161757|197645|P2|STARTED|Randomised Through Start Treatment||406
80887|NCT02161757|197646|P1|STARTED|Randomised Through Start Treatment||401
80888|NCT02161731|197704|P2|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||2
80889|NCT02161731|197705|P1|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0
80890|NCT02161731|197704|P2|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||22
80891|NCT02161731|197705|P1|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0
80892|NCT02161731|197704|P2|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||24
80893|NCT02161731|197705|P1|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||0
80894|NCT02161731|197704|P2|STARTED|Period 2 (Day 7 Dosing to Day 23)||24
80895|NCT02161731|197705|P1|STARTED|Period 2 (Day 7 Dosing to Day 23)||0
80896|NCT02161731|197704|P2|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
80897|NCT02161731|197705|P1|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
80898|NCT02161731|197704|P2|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
80899|NCT02161731|197705|P1|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||24
80900|NCT02161731|197704|P2|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||0
80901|NCT02161731|197705|P1|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||24
80902|NCT02161731|197704|P2|STARTED|Period 1 (Day -1 to Day 7 Predose)||0
80903|NCT02161731|197705|P1|STARTED|Period 1 (Day -1 to Day 7 Predose)||24
80904|NCT02161575|197722|P1|NOT COMPLETED|Overall Study||11
80905|NCT02161575|197722|P1|COMPLETED|Overall Study||92
80906|NCT02161575|197722|P1|Safety (SAF) Population|Overall Study||100
80907|NCT02161575|197722|P1|Full Analysis Set (FAS) Population|Overall Study||100
80908|NCT02161575|197722|P1|STARTED|Overall Study||103
80909|NCT02161562|197742|P2|NOT COMPLETED|Overall Study||17
80910|NCT02161562|197743|P1|NOT COMPLETED|Overall Study||26
80911|NCT02161562|197742|P2|COMPLETED|Overall Study||119
80912|NCT02161562|197743|P1|COMPLETED|Overall Study||152
80913|NCT02161562|197742|P2|STARTED|Overall Study||136
80914|NCT02161562|197743|P1|STARTED|Overall Study||178
80915|NCT02161549|197771|P2|NOT COMPLETED|Overall Study||2
80916|NCT02161549|197772|P1|NOT COMPLETED|Overall Study||6
80917|NCT02161549|197771|P2|COMPLETED|Overall Study||29
80918|NCT02161549|197772|P1|COMPLETED|Overall Study||34
80919|NCT02161549|197771|P2|STARTED|Overall Study||31
80920|NCT02161549|197772|P1|STARTED|Overall Study||40
80921|NCT02161536|197781|P3|NOT COMPLETED|Overall Study||0
80922|NCT02161536|197782|P2|NOT COMPLETED|Overall Study||0
80923|NCT02161536|197783|P1|NOT COMPLETED|Overall Study||0
80924|NCT02161536|197781|P3|COMPLETED|Overall Study||20
80925|NCT02161536|197782|P2|COMPLETED|Overall Study||21
80926|NCT02161536|197783|P1|COMPLETED|Overall Study||6
80927|NCT02161536|197781|P3|STARTED|Overall Study||20
80928|NCT02161536|197782|P2|STARTED|Overall Study||21
80929|NCT02161536|197783|P1|STARTED|Overall Study||6
80930|NCT02161484|197793|P2|NOT COMPLETED|Overall Study||3
80931|NCT02161484|197794|P1|NOT COMPLETED|Overall Study||4
80932|NCT02161484|197793|P2|COMPLETED|Overall Study||2
80933|NCT02161484|197794|P1|COMPLETED|Overall Study||1
80934|NCT02161484|197793|P2|STARTED|Overall Study||5
80935|NCT02161484|197794|P1|STARTED|Overall Study||5
80936|NCT02161458|197820|P4|NOT COMPLETED|Overall Study||0
80937|NCT02161458|197821|P3|NOT COMPLETED|Overall Study||5
80938|NCT02161458|197822|P2|NOT COMPLETED|Overall Study||6
80939|NCT02161458|197823|P1|NOT COMPLETED|Overall Study||0
80940|NCT02161458|197820|P4|COMPLETED|Overall Study||8
80941|NCT02161458|197821|P3|COMPLETED|Overall Study||28
80942|NCT02161458|197822|P2|COMPLETED|Overall Study||29
80943|NCT02161458|197823|P1|COMPLETED|Overall Study||22
80944|NCT02161458|197820|P4|STARTED|Overall Study||8
80945|NCT02161458|197821|P3|STARTED|Overall Study||33
80946|NCT02161458|197822|P2|STARTED|Overall Study||35
80947|NCT02161458|197823|P1|STARTED|Overall Study||22
80948|NCT02161406|197835|P2|NOT COMPLETED|Overall Study||9
80949|NCT02161406|197836|P1|NOT COMPLETED|Overall Study||10
80950|NCT02161406|197835|P2|COMPLETED|Overall Study||35
80951|NCT02161406|197836|P1|COMPLETED|Overall Study||34
80952|NCT02161406|197835|P2|STARTED|Overall Study||44
80953|NCT02161406|197836|P1|STARTED|Overall Study||44
80954|NCT02161185|197910|P1|NOT COMPLETED|Treatment Phase||7
80955|NCT02161185|197910|P1|COMPLETED|Treatment Phase||0
80956|NCT02161185|197910|P1|STARTED|Treatment Phase||7
80957|NCT02161185|197910|P1|NOT COMPLETED|Test Dose Phase||0
80958|NCT02161185|197910|P1|COMPLETED|Test Dose Phase||7
80959|NCT02161185|197910|P1|STARTED|Test Dose Phase||7
80960|NCT02161146|197920|P5|NOT COMPLETED|Overall Study||1
80961|NCT02161146|197921|P4|NOT COMPLETED|Overall Study||3
80962|NCT02161146|197922|P3|NOT COMPLETED|Overall Study||0
80963|NCT02161146|197923|P2|NOT COMPLETED|Overall Study||4
80964|NCT02161146|197924|P1|NOT COMPLETED|Overall Study||1
80965|NCT02161146|197920|P5|COMPLETED|Overall Study||48
80966|NCT02161146|197921|P4|COMPLETED|Overall Study||45
80967|NCT02161146|197922|P3|COMPLETED|Overall Study||49
80968|NCT02161146|197923|P2|COMPLETED|Overall Study||43
80969|NCT02161146|197924|P1|COMPLETED|Overall Study||46
80970|NCT02161146|197920|P5|STARTED|Overall Study||49
80971|NCT02161146|197921|P4|STARTED|Overall Study||48
80972|NCT02161146|197922|P3|STARTED|Overall Study||49
80973|NCT02161146|197923|P2|STARTED|Overall Study||47
80974|NCT02161146|197924|P1|STARTED|Overall Study||47
80975|NCT02161016|197937|P1|NOT COMPLETED|Overall Study||1
80976|NCT02161016|197937|P1|COMPLETED|Overall Study||0
80977|NCT02161016|197937|P1|STARTED|Overall Study||1
80978|NCT02160990|197947|P2|NOT COMPLETED|Overall Study||0
80979|NCT02160990|197948|P1|NOT COMPLETED|Overall Study||0
80980|NCT02160990|197947|P2|COMPLETED|Overall Study||10
80981|NCT02160990|197948|P1|COMPLETED|Overall Study||10
80982|NCT02160990|197947|P2|STARTED|Overall Study||10
80983|NCT02160990|197948|P1|STARTED|Overall Study||10
80984|NCT02160977|197968|P2|NOT COMPLETED|Six Months After Surgery||1
80985|NCT02160977|197969|P1|NOT COMPLETED|Six Months After Surgery||2
80986|NCT02160977|197968|P2|COMPLETED|Six Months After Surgery||42
80987|NCT02160977|197969|P1|COMPLETED|Six Months After Surgery||42
80988|NCT02160977|197968|P2|STARTED|Six Months After Surgery||43
80989|NCT02160977|197969|P1|STARTED|Six Months After Surgery||44
80990|NCT02160977|197968|P2|NOT COMPLETED|Three Months After Surgery||2
80991|NCT02160977|197969|P1|NOT COMPLETED|Three Months After Surgery||0
80992|NCT02160977|197968|P2|COMPLETED|Three Months After Surgery||43
80993|NCT02160977|197969|P1|COMPLETED|Three Months After Surgery||44
80994|NCT02160977|197968|P2|STARTED|Three Months After Surgery||45
80995|NCT02160977|197969|P1|STARTED|Three Months After Surgery||44
80996|NCT02160977|197968|P2|NOT COMPLETED|Six Weeks After Surgery||0
80997|NCT02160977|197969|P1|NOT COMPLETED|Six Weeks After Surgery||1
80998|NCT02160977|197968|P2|COMPLETED|Six Weeks After Surgery||45
80999|NCT02160977|197969|P1|COMPLETED|Six Weeks After Surgery||44
81000|NCT02160977|197968|P2|STARTED|Six Weeks After Surgery||45
81001|NCT02160977|197969|P1|STARTED|Six Weeks After Surgery||45
81002|NCT02160977|197968|P2|NOT COMPLETED|One Week After Surgery||0
81003|NCT02160977|197969|P1|NOT COMPLETED|One Week After Surgery||0
81004|NCT02160977|197968|P2|COMPLETED|One Week After Surgery||45
81005|NCT02160977|197969|P1|COMPLETED|One Week After Surgery||45
81006|NCT02160977|197968|P2|STARTED|One Week After Surgery||45
81007|NCT02160977|197969|P1|STARTED|One Week After Surgery||45
81008|NCT02160873|197981|P2|NOT COMPLETED|Overall Study||0
81009|NCT02160873|197982|P1|NOT COMPLETED|Overall Study||0
81010|NCT02160873|197981|P2|COMPLETED|Overall Study||6
81011|NCT02160873|197982|P1|COMPLETED|Overall Study||6
81012|NCT02160873|197981|P2|STARTED|Overall Study||6
81013|NCT02160873|197982|P1|STARTED|Overall Study||6
81014|NCT02160847|197996|P2|NOT COMPLETED|Overall Study||0
81015|NCT02160847|197997|P1|NOT COMPLETED|Overall Study||0
81016|NCT02160847|197996|P2|COMPLETED|Overall Study||16
81017|NCT02160847|197997|P1|COMPLETED|Overall Study||16
81018|NCT02160847|197996|P2|STARTED|Overall Study||16
81019|NCT02160847|197997|P1|STARTED|Overall Study||16
81020|NCT02160626|198008|P3|NOT COMPLETED|Overall Study||1
81021|NCT02160626|198009|P2|NOT COMPLETED|Overall Study||1
81022|NCT02160626|198010|P1|NOT COMPLETED|Overall Study||1
81023|NCT02160626|198008|P3|COMPLETED|Overall Study||56
81024|NCT02160626|198009|P2|COMPLETED|Overall Study||56
81025|NCT02160626|198010|P1|COMPLETED|Overall Study||57
81026|NCT02160626|198008|P3|STARTED|Overall Study||57
81027|NCT02160626|198009|P2|STARTED|Overall Study||57
81028|NCT02160626|198010|P1|STARTED|Overall Study||58
81029|NCT02160535|198024|P1|NOT COMPLETED|Overall Study||3
81030|NCT02160535|198024|P1|COMPLETED|Overall Study||10
81031|NCT02160535|198024|P1|STARTED|Overall Study||13
81032|NCT02160314|198033|P2|NOT COMPLETED|Overall Study||13
81033|NCT02160314|198034|P1|NOT COMPLETED|Overall Study||1
81034|NCT02160314|198033|P2|COMPLETED|Overall Study||59
81035|NCT02160314|198034|P1|COMPLETED|Overall Study||72
81036|NCT02160314|198033|P2|STARTED|Overall Study||72
81037|NCT02160314|198034|P1|STARTED|Overall Study||73
81038|NCT02160145|198042|P3|NOT COMPLETED|Randomized Double-blind Period||28
81039|NCT02160145|198043|P2|NOT COMPLETED|Randomized Double-blind Period||29
81040|NCT02160145|198044|P1|NOT COMPLETED|Randomized Double-blind Period||0
81041|NCT02160145|198042|P3|COMPLETED|Randomized Double-blind Period||659
81042|NCT02160145|198043|P2|COMPLETED|Randomized Double-blind Period||654
81043|NCT02160145|198044|P1|COMPLETED|Randomized Double-blind Period||0
81044|NCT02160145|198042|P3|Off-treatment Completers|Randomized Double-blind Period||22
81045|NCT02160145|198043|P2|Off-treatment Completers|Randomized Double-blind Period||76
81046|NCT02160145|198044|P1|Off-treatment Completers|Randomized Double-blind Period||0
81047|NCT02160145|198042|P3|On-treatment Completers|Randomized Double-blind Period||637
81048|NCT02160145|198043|P2|On-treatment Completers|Randomized Double-blind Period||578
81049|NCT02160145|198044|P1|On-treatment Completers|Randomized Double-blind Period||0
81050|NCT02160145|198042|P3|STARTED|Randomized Double-blind Period|Subjects completed the single-blind period and were randomized to receive placebo.|687
81051|NCT02160145|198043|P2|STARTED|Randomized Double-blind Period|Subjects completed the single-blind period and were randomized to receive tolvaptan.|683
81052|NCT02160145|198044|P1|STARTED|Randomized Double-blind Period|1370 subjects were randomized to receive tolvaptan or placebo in the double-blind period.|0
81053|NCT02160145|198042|P3|NOT COMPLETED|Prerandomization Single-blind Period||0
81054|NCT02160145|198043|P2|NOT COMPLETED|Prerandomization Single-blind Period||0
81055|NCT02160145|198044|P1|NOT COMPLETED|Prerandomization Single-blind Period||149
81056|NCT02160145|198042|P3|COMPLETED|Prerandomization Single-blind Period||0
81057|NCT02160145|198043|P2|COMPLETED|Prerandomization Single-blind Period||0
81058|NCT02160145|198044|P1|COMPLETED|Prerandomization Single-blind Period||1370
81059|NCT02160145|198042|P3|Randomized|Prerandomization Single-blind Period||0
81060|NCT02160145|198043|P2|Randomized|Prerandomization Single-blind Period||0
81061|NCT02160145|198044|P1|Randomized|Prerandomization Single-blind Period||1370
81062|NCT02160145|198042|P3|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0
81063|NCT02160145|198043|P2|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0
81064|NCT02160145|198044|P1|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||1491
81065|NCT02160145|198042|P3|Treated in Placebo Run-in|Prerandomization Single-blind Period||0
81066|NCT02160145|198043|P2|Treated in Placebo Run-in|Prerandomization Single-blind Period||0
81067|NCT02160145|198044|P1|Treated in Placebo Run-in|Prerandomization Single-blind Period||1514
81068|NCT02160145|198042|P3|STARTED|Prerandomization Single-blind Period||0
81069|NCT02160145|198043|P2|STARTED|Prerandomization Single-blind Period||0
81070|NCT02160145|198044|P1|STARTED|Prerandomization Single-blind Period||1519
81071|NCT02160041|198057|P1|NOT COMPLETED|Overall Study||84
81072|NCT02160041|198057|P1|COMPLETED|Overall Study||0
81073|NCT02160041|198057|P1|STARTED|Overall Study||84
81074|NCT02160002|198069|P2|NOT COMPLETED|Overall Study||1
81075|NCT02160002|198070|P1|NOT COMPLETED|Overall Study||2
81076|NCT02160002|198069|P2|COMPLETED|Overall Study||178
81077|NCT02160002|198070|P1|COMPLETED|Overall Study||185
81078|NCT02160002|198069|P2|Primary Outcome|Overall Study||178
81079|NCT02160002|198070|P1|Primary Outcome|Overall Study||185
81080|NCT02160002|198069|P2|STARTED|Overall Study||179
81081|NCT02160002|198070|P1|STARTED|Overall Study||187
81082|NCT02159976|198102|P2|NOT COMPLETED|Overall Study||25
81083|NCT02159976|198103|P1|NOT COMPLETED|Overall Study||30
81084|NCT02159976|198102|P2|COMPLETED|Overall Study||170
81085|NCT02159976|198103|P1|COMPLETED|Overall Study||165
81086|NCT02159976|198102|P2|STARTED|Overall Study||195
81087|NCT02159976|198103|P1|STARTED|Overall Study||195
81088|NCT02159950|198117|P2|NOT COMPLETED|Overall Study||2
81089|NCT02159950|198118|P1|NOT COMPLETED|Overall Study||0
81090|NCT02159950|198117|P2|COMPLETED|Overall Study||0
81091|NCT02159950|198118|P1|COMPLETED|Overall Study||0
81092|NCT02159950|198117|P2|STARTED|Overall Study||2
81093|NCT02159950|198118|P1|STARTED|Overall Study||0
81094|NCT02159898|198152|P2|NOT COMPLETED|Overall Study||0
81095|NCT02159898|198153|P1|NOT COMPLETED|Overall Study||1
81096|NCT02159898|198152|P2|COMPLETED|Overall Study||30
81097|NCT02159898|198153|P1|COMPLETED|Overall Study||29
81098|NCT02159898|198152|P2|STARTED|Overall Study||30
81099|NCT02159898|198153|P1|STARTED|Overall Study||30
81100|NCT02159859|198161|P1|NOT COMPLETED|Overall Study||0
81101|NCT02159859|198161|P1|COMPLETED|Overall Study||7
81102|NCT02159859|198161|P1|STARTED|Overall Study||7
81103|NCT02159807|198177|P3|NOT COMPLETED|Overall Study||3
81104|NCT02159807|198178|P2|NOT COMPLETED|Overall Study||1
81105|NCT02159807|198179|P1|NOT COMPLETED|Overall Study||1
81106|NCT02159807|198177|P3|COMPLETED|Overall Study||48
81107|NCT02159807|198178|P2|COMPLETED|Overall Study||51
81108|NCT02159807|198179|P1|COMPLETED|Overall Study||66
81109|NCT02159807|198177|P3|STARTED|Overall Study||51
81110|NCT02159807|198178|P2|STARTED|Overall Study||52
81111|NCT02159807|198179|P1|STARTED|Overall Study||67
81112|NCT02159768|198193|P1|NOT COMPLETED|Overall Study||0
81113|NCT02159768|198193|P1|COMPLETED|Overall Study|Completed 27 July 2015|30
81114|NCT02159768|198193|P1|STARTED|Overall Study|Started 16 July 2014|30
81115|NCT02159703|198198|P1|NOT COMPLETED|Overall Study||0
81116|NCT02159703|198198|P1|COMPLETED|Overall Study||60
81117|NCT02159703|198198|P1|STARTED|Overall Study||60
81118|NCT02159547|198204|P2|NOT COMPLETED|Overall Study||0
81119|NCT02159547|198205|P1|NOT COMPLETED|Overall Study||0
81120|NCT02159547|198204|P2|COMPLETED|Overall Study||112
81121|NCT02159547|198205|P1|COMPLETED|Overall Study||112
81122|NCT02159547|198204|P2|STARTED|Overall Study||112
81123|NCT02159547|198205|P1|STARTED|Overall Study||112
81124|NCT02159482|198213|P1|NOT COMPLETED|Overall Study||5
81125|NCT02159482|198213|P1|COMPLETED|Overall Study||6
81126|NCT02159482|198213|P1|STARTED|Overall Study||11
81127|NCT02159469|198218|P1|NOT COMPLETED|Overall Study||53
81128|NCT02159469|198218|P1|COMPLETED|Overall Study||97
81129|NCT02159469|198218|P1|Completed 12 Week|Overall Study||137
81130|NCT02159469|198218|P1|STARTED|Overall Study||150
81131|NCT02159365|198223|P1|NOT COMPLETED|Overall Study||70
81132|NCT02159365|198223|P1|COMPLETED|Overall Study|Completed = Still on treatment|0
81133|NCT02159365|198223|P1|STARTED|Overall Study||70
81134|NCT02159352|198230|P2|NOT COMPLETED|Overall Study||2
81135|NCT02159352|198231|P1|NOT COMPLETED|Overall Study||3
81136|NCT02159352|198230|P2|COMPLETED|Overall Study||12
81137|NCT02159352|198231|P1|COMPLETED|Overall Study||11
81138|NCT02159352|198230|P2|Phase 2 (Day 5-14)|Overall Study||12
81139|NCT02159352|198231|P1|Phase 2 (Day 5-14)|Overall Study||11
81140|NCT02159352|198230|P2|Phase 1 (Day 1- 4)|Overall Study||14
81141|NCT02159352|198231|P1|Phase 1 (Day 1- 4)|Overall Study||14
81142|NCT02159352|198230|P2|STARTED|Overall Study||14
81143|NCT02159352|198231|P1|STARTED|Overall Study||14
81144|NCT02159183|198283|P2|NOT COMPLETED|Analysis of Primary Endpoint (12 Mts)||1
81145|NCT02159183|198284|P1|NOT COMPLETED|Analysis of Primary Endpoint (12 Mts)||3
81146|NCT02159183|198283|P2|COMPLETED|Analysis of Primary Endpoint (12 Mts)||20
81147|NCT02159183|198284|P1|COMPLETED|Analysis of Primary Endpoint (12 Mts)||19
81148|NCT02159183|198283|P2|STARTED|Analysis of Primary Endpoint (12 Mts)||21
81149|NCT02159183|198284|P1|STARTED|Analysis of Primary Endpoint (12 Mts)||22
81150|NCT02159183|198283|P2|NOT COMPLETED|Analysis After the 36 Months Follow-up||2
81151|NCT02159183|198284|P1|NOT COMPLETED|Analysis After the 36 Months Follow-up||3
81152|NCT02159183|198283|P2|COMPLETED|Analysis After the 36 Months Follow-up||19
81153|NCT02159183|198284|P1|COMPLETED|Analysis After the 36 Months Follow-up||19
81154|NCT02159183|198283|P2|STARTED|Analysis After the 36 Months Follow-up||21
81155|NCT02159183|198284|P1|STARTED|Analysis After the 36 Months Follow-up||22
81156|NCT02159118|198310|P2|NOT COMPLETED|Overall Study||0
81157|NCT02159118|198311|P1|NOT COMPLETED|Overall Study||0
81158|NCT02159118|198310|P2|COMPLETED|Overall Study||22
81159|NCT02159118|198311|P1|COMPLETED|Overall Study||22
81160|NCT02159118|198310|P2|STARTED|Overall Study||22
81161|NCT02159118|198311|P1|STARTED|Overall Study||22
81162|NCT02159079|198335|P2|NOT COMPLETED|Overall Study||0
81163|NCT02159079|198336|P1|NOT COMPLETED|Overall Study||0
81164|NCT02159079|198335|P2|COMPLETED|Overall Study||15
81165|NCT02159079|198336|P1|COMPLETED|Overall Study||15
81166|NCT02159079|198335|P2|STARTED|Overall Study||15
81167|NCT02159079|198336|P1|STARTED|Overall Study||15
81168|NCT02159053|198357|P3|NOT COMPLETED|Overall Study||20
81169|NCT02159053|198358|P2|NOT COMPLETED|Overall Study||21
81170|NCT02159053|198359|P1|NOT COMPLETED|Overall Study||20
81171|NCT02159053|198357|P3|COMPLETED|Overall Study||97
81172|NCT02159053|198358|P2|COMPLETED|Overall Study||96
81173|NCT02159053|198359|P1|COMPLETED|Overall Study||96
81174|NCT02159053|198357|P3|Paticipants Week 16 Onwards|Overall Study||113
81175|NCT02159053|198358|P2|Paticipants Week 16 Onwards|Overall Study||117
81176|NCT02159053|198359|P1|Paticipants Week 16 Onwards|Overall Study||116
81177|NCT02159053|198357|P3|STARTED|Overall Study||117
81178|NCT02159053|198358|P2|STARTED|Overall Study||117
81179|NCT02159053|198359|P1|STARTED|Overall Study||116
81180|NCT02159040|198396|P1|NOT COMPLETED|Overall Study||1
81181|NCT02159040|198396|P1|COMPLETED|Overall Study||0
81182|NCT02159040|198396|P1|STARTED|Overall Study||1
81183|NCT02158975|198409|P1|NOT COMPLETED|Overall Study||1
81184|NCT02158975|198409|P1|COMPLETED|Overall Study||12
81185|NCT02158975|198409|P1|STARTED|Overall Study||13
81186|NCT02158936|198419|P2|NOT COMPLETED|Overall Study||177
81187|NCT02158936|198420|P1|NOT COMPLETED|Overall Study||179
81188|NCT02158936|198419|P2|COMPLETED|Overall Study||0
81189|NCT02158936|198420|P1|COMPLETED|Overall Study||0
81190|NCT02158936|198419|P2|Untreated|Overall Study||0
81191|NCT02158936|198420|P1|Untreated|Overall Study||2
81192|NCT02158936|198419|P2|Treated|Overall Study||177
81193|NCT02158936|198420|P1|Treated|Overall Study||177
81194|NCT02158936|198419|P2|STARTED|Overall Study||177
81195|NCT02158936|198420|P1|STARTED|Overall Study||179
81196|NCT02158884|198462|P1|NOT COMPLETED|12 Month Assessment||17
81197|NCT02158884|198462|P1|COMPLETED|12 Month Assessment||64
81198|NCT02158884|198462|P1|STARTED|12 Month Assessment||81
81199|NCT02158884|198462|P1|NOT COMPLETED|6 Month Assessment||20
81200|NCT02158884|198462|P1|COMPLETED|6 Month Assessment||61
81201|NCT02158884|198462|P1|STARTED|6 Month Assessment||81
81202|NCT02158884|198462|P1|NOT COMPLETED|Post Intervention (~4 Weeks)||10
81203|NCT02158884|198462|P1|COMPLETED|Post Intervention (~4 Weeks)||71
81204|NCT02158884|198462|P1|STARTED|Post Intervention (~4 Weeks)||81
81205|NCT02158884|198462|P1|NOT COMPLETED|Intervention: IDEO and PT Program||6
81206|NCT02158884|198462|P1|COMPLETED|Intervention: IDEO and PT Program||81
81207|NCT02158884|198462|P1|STARTED|Intervention: IDEO and PT Program||87
81208|NCT02158884|198462|P1|NOT COMPLETED|Baseline Assessment||4
81209|NCT02158884|198462|P1|COMPLETED|Baseline Assessment||87
81210|NCT02158884|198462|P1|STARTED|Baseline Assessment||91
81211|NCT02158806|198497|P2|NOT COMPLETED|Overall Study||5
81212|NCT02158806|198498|P1|NOT COMPLETED|Overall Study||4
81213|NCT02158806|198497|P2|COMPLETED|Overall Study|We had information on all participants for the primary outcome (time to complete healing).|121
81214|NCT02158806|198498|P1|COMPLETED|Overall Study|We had information on all participants for the primary outcome (time to complete healing).|121
81215|NCT02158806|198497|P2|STARTED|Overall Study||126
81216|NCT02158806|198498|P1|STARTED|Overall Study||125
81217|NCT02158728|198518|P1|NOT COMPLETED|Overall Study||27
81218|NCT02158728|198518|P1|COMPLETED|Overall Study||53
81219|NCT02158728|198518|P1|STARTED|Overall Study||80
81220|NCT02158572|198522|P1|NOT COMPLETED|Overall Study||1043
81221|NCT02158572|198522|P1|COMPLETED|Overall Study||989
81222|NCT02158572|198522|P1|STARTED|Overall Study||2032
81223|NCT02158546|198537|P4|NOT COMPLETED|Overall Study||6
81224|NCT02158546|198538|P3|NOT COMPLETED|Overall Study||4
81225|NCT02158546|198539|P2|NOT COMPLETED|Overall Study||17
81226|NCT02158546|198540|P1|NOT COMPLETED|Overall Study||19
81227|NCT02158546|198537|P4|COMPLETED|Overall Study||13
81228|NCT02158546|198538|P3|COMPLETED|Overall Study||14
81229|NCT02158546|198539|P2|COMPLETED|Overall Study||136
81230|NCT02158546|198540|P1|COMPLETED|Overall Study||133
81231|NCT02158546|198537|P4|STARTED|Overall Study||19
81232|NCT02158546|198538|P3|STARTED|Overall Study||18
81233|NCT02158546|198539|P2|STARTED|Overall Study||153
81234|NCT02158546|198540|P1|STARTED|Overall Study||152
81235|NCT02158533|198559|P6|NOT COMPLETED|Stage 2||6
81236|NCT02158533|198560|P5|NOT COMPLETED|Stage 2||4
81237|NCT02158533|198561|P4|NOT COMPLETED|Stage 2||3
81238|NCT02158533|198562|P3|NOT COMPLETED|Stage 2||0
81239|NCT02158533|198563|P2|NOT COMPLETED|Stage 2||0
81240|NCT02158533|198564|P1|NOT COMPLETED|Stage 2||0
81241|NCT02158533|198559|P6|COMPLETED|Stage 2||50
81242|NCT02158533|198560|P5|COMPLETED|Stage 2||52
81243|NCT02158533|198561|P4|COMPLETED|Stage 2||53
81244|NCT02158533|198562|P3|COMPLETED|Stage 2||0
81245|NCT02158533|198563|P2|COMPLETED|Stage 2||0
81246|NCT02158533|198564|P1|COMPLETED|Stage 2||0
81247|NCT02158533|198559|P6|STARTED|Stage 2||56
81248|NCT02158533|198560|P5|STARTED|Stage 2||56
81249|NCT02158533|198561|P4|STARTED|Stage 2||56
81250|NCT02158533|198562|P3|STARTED|Stage 2||0
81251|NCT02158533|198563|P2|STARTED|Stage 2||0
81252|NCT02158533|198564|P1|STARTED|Stage 2||0
81253|NCT02158533|198559|P6|NOT COMPLETED|Stage 1||0
81254|NCT02158533|198560|P5|NOT COMPLETED|Stage 1||0
81255|NCT02158533|198561|P4|NOT COMPLETED|Stage 1||0
81256|NCT02158533|198562|P3|NOT COMPLETED|Stage 1||8
81257|NCT02158533|198563|P2|NOT COMPLETED|Stage 1||8
81258|NCT02158533|198564|P1|NOT COMPLETED|Stage 1||14
81259|NCT02158533|198559|P6|COMPLETED|Stage 1||0
81260|NCT02158533|198560|P5|COMPLETED|Stage 1||0
81261|NCT02158533|198561|P4|COMPLETED|Stage 1||0
81262|NCT02158533|198562|P3|COMPLETED|Stage 1||52
81263|NCT02158533|198563|P2|COMPLETED|Stage 1||51
81264|NCT02158533|198564|P1|COMPLETED|Stage 1||251
81265|NCT02158533|198559|P6|STARTED|Stage 1||0
81266|NCT02158533|198560|P5|STARTED|Stage 1||0
81267|NCT02158533|198561|P4|STARTED|Stage 1||0
81268|NCT02158533|198562|P3|STARTED|Stage 1||60
81269|NCT02158533|198563|P2|STARTED|Stage 1||59
81270|NCT02158533|198564|P1|STARTED|Stage 1||265
81271|NCT02158494|198598|P2|NOT COMPLETED|Overall Study||1
81272|NCT02158494|198599|P1|NOT COMPLETED|Overall Study||0
81273|NCT02158494|198598|P2|COMPLETED|Overall Study||21
81274|NCT02158494|198599|P1|COMPLETED|Overall Study||22
81275|NCT02158494|198598|P2|STARTED|Overall Study||22
81276|NCT02158494|198599|P1|STARTED|Overall Study||22
81277|NCT02158442|198623|P2|NOT COMPLETED|Overall Study||0
81278|NCT02158442|198624|P1|NOT COMPLETED|Overall Study||2
81279|NCT02158442|198623|P2|COMPLETED|Overall Study||7
81280|NCT02158442|198624|P1|COMPLETED|Overall Study||6
81281|NCT02158442|198623|P2|STARTED|Overall Study||7
81282|NCT02158442|198624|P1|STARTED|Overall Study||8
81283|NCT02158364|198630|P1|NOT COMPLETED|Overall Study||60
81284|NCT02158364|198630|P1|COMPLETED|Overall Study||3271
81285|NCT02158364|198630|P1|STARTED|Overall Study||3331
81286|NCT02158273|198637|P2|NOT COMPLETED|Overall Study||3
81287|NCT02158273|198638|P1|NOT COMPLETED|Overall Study||3
81288|NCT02158273|198637|P2|COMPLETED|Overall Study||22
81289|NCT02158273|198638|P1|COMPLETED|Overall Study||22
81290|NCT02158273|198637|P2|STARTED|Overall Study||25
81291|NCT02158273|198638|P1|STARTED|Overall Study||25
81292|NCT02158247|198648|P1|NOT COMPLETED|Overall Study||5
81293|NCT02158247|198648|P1|COMPLETED|Overall Study||176
81294|NCT02158247|198648|P1|STARTED|Overall Study||181
81295|NCT02158091|198667|P3|NOT COMPLETED|Overall Study||0
81296|NCT02158091|198668|P2|NOT COMPLETED|Overall Study||1
81297|NCT02158091|198669|P1|NOT COMPLETED|Overall Study||2
81298|NCT02158091|198667|P3|COMPLETED|Overall Study||20
81299|NCT02158091|198668|P2|COMPLETED|Overall Study||5
81300|NCT02158091|198669|P1|COMPLETED|Overall Study||4
81301|NCT02158091|198667|P3|STARTED|Overall Study||20
81302|NCT02158091|198668|P2|STARTED|Overall Study||6
81303|NCT02158091|198669|P1|STARTED|Overall Study||6
81304|NCT02158039|198677|P1|NOT COMPLETED|Overall Study||10
81305|NCT02158039|198677|P1|COMPLETED|Overall Study||23
81306|NCT02158039|198677|P1|STARTED|Overall Study||33
81307|NCT02157948|198684|P2|NOT COMPLETED|Overall Study||9
81308|NCT02157948|198685|P1|NOT COMPLETED|Overall Study||9
81309|NCT02157948|198684|P2|COMPLETED|Overall Study||188
81310|NCT02157948|198685|P1|COMPLETED|Overall Study||188
81311|NCT02157948|198684|P2|Received Treatment|Overall Study||196
81312|NCT02157948|198685|P1|Received Treatment|Overall Study||196
81313|NCT02157948|198684|P2|STARTED|Overall Study||197
81314|NCT02157948|198685|P1|STARTED|Overall Study||197
81315|NCT02157935|198697|P2|NOT COMPLETED|Overall Study||65
81316|NCT02157935|198698|P1|NOT COMPLETED|Overall Study||39
81317|NCT02157935|198697|P2|COMPLETED|Overall Study||548
81318|NCT02157935|198698|P1|COMPLETED|Overall Study||567
81319|NCT02157935|198697|P2|STARTED|Overall Study||613
81320|NCT02157935|198698|P1|STARTED|Overall Study||606
81321|NCT02157909|198716|P2|NOT COMPLETED|Overall Study||0
81322|NCT02157909|198717|P1|NOT COMPLETED|Overall Study||0
81323|NCT02157909|198716|P2|COMPLETED|Overall Study||66
81324|NCT02157909|198717|P1|COMPLETED|Overall Study||66
81325|NCT02157909|198716|P2|STARTED|Overall Study||66
81326|NCT02157909|198717|P1|STARTED|Overall Study||66
81327|NCT02157883|198724|P1|NOT COMPLETED|Part B: Day 19 to End Part B (AZD9291)||22
81328|NCT02157883|198724|P1|COMPLETED|Part B: Day 19 to End Part B (AZD9291)||16
81329|NCT02157883|198724|P1|STARTED|Part B: Day 19 to End Part B (AZD9291)||38
81330|NCT02157883|198724|P1|NOT COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||1
81331|NCT02157883|198724|P1|COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||38
81332|NCT02157883|198724|P1|STARTED|Part A: Day 6-18 (AZD9291+Itraconozole)||39
81333|NCT02157883|198724|P1|NOT COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||0
81334|NCT02157883|198724|P1|COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||39
81335|NCT02157883|198724|P1|STARTED|Part A: Day 1-5 (AZD9291 Alone)||39
81336|NCT02157623|198755|P2|NOT COMPLETED|Overall Study||3
81337|NCT02157623|198756|P1|NOT COMPLETED|Overall Study||4
81338|NCT02157623|198755|P2|COMPLETED|Overall Study||0
81339|NCT02157623|198756|P1|COMPLETED|Overall Study||0
81340|NCT02157623|198755|P2|STARTED|Overall Study||3
81341|NCT02157623|198756|P1|STARTED|Overall Study||4
81342|NCT02157519|198764|P2|NOT COMPLETED|Overall Study||1
81343|NCT02157519|198765|P1|NOT COMPLETED|Overall Study||11
81344|NCT02157519|198764|P2|COMPLETED|Overall Study||89
81345|NCT02157519|198765|P1|COMPLETED|Overall Study||80
81346|NCT02157519|198764|P2|MEMScap Collected|Overall Study||86
81347|NCT02157519|198765|P1|MEMScap Collected|Overall Study||84
81348|NCT02157519|198764|P2|STARTED|Overall Study||90
81349|NCT02157519|198765|P1|STARTED|Overall Study||91
81350|NCT02157506|198788|P5|NOT COMPLETED|Overall Study||0
81351|NCT02157506|198789|P4|NOT COMPLETED|Overall Study||0
81352|NCT02157506|198790|P3|NOT COMPLETED|Overall Study||1
81353|NCT02157506|198791|P2|NOT COMPLETED|Overall Study||1
81354|NCT02157506|198792|P1|NOT COMPLETED|Overall Study||0
81355|NCT02157506|198788|P5|COMPLETED|Overall Study||7
81356|NCT02157506|198789|P4|COMPLETED|Overall Study||12
81357|NCT02157506|198790|P3|COMPLETED|Overall Study||8
81358|NCT02157506|198791|P2|COMPLETED|Overall Study||5
81359|NCT02157506|198792|P1|COMPLETED|Overall Study||12
81360|NCT02157506|198788|P5|STARTED|Overall Study||7
81361|NCT02157506|198789|P4|STARTED|Overall Study||12
81362|NCT02157506|198790|P3|STARTED|Overall Study||9
81363|NCT02157506|198791|P2|STARTED|Overall Study||6
81364|NCT02157506|198792|P1|STARTED|Overall Study||12
81365|NCT02157376|198851|P2|NOT COMPLETED|Overall Study||18
81366|NCT02157376|198852|P1|NOT COMPLETED|Overall Study||22
81367|NCT02157376|198851|P2|COMPLETED|Overall Study||138
81368|NCT02157376|198852|P1|COMPLETED|Overall Study||133
81369|NCT02157376|198851|P2|STARTED|Overall Study||156
81370|NCT02157376|198852|P1|STARTED|Overall Study||155
81371|NCT02157298|198862|P2|NOT COMPLETED|Overall Study||2
81372|NCT02157298|198863|P1|NOT COMPLETED|Overall Study||4
81373|NCT02157298|198862|P2|COMPLETED|Overall Study||58
81374|NCT02157298|198863|P1|COMPLETED|Overall Study||119
81375|NCT02157298|198862|P2|STARTED|Overall Study||60
81376|NCT02157298|198863|P1|STARTED|Overall Study||123
81377|NCT02157168|198880|P3|NOT COMPLETED|Overall Study||0
81378|NCT02157168|198881|P2|NOT COMPLETED|Overall Study||0
81379|NCT02157168|198882|P1|NOT COMPLETED|Overall Study||0
81380|NCT02157168|198880|P3|COMPLETED|Overall Study||1362
81381|NCT02157168|198881|P2|COMPLETED|Overall Study||159
81382|NCT02157168|198882|P1|COMPLETED|Overall Study||746
81383|NCT02157168|198880|P3|STARTED|Overall Study||1362
81384|NCT02157168|198881|P2|STARTED|Overall Study||159
81385|NCT02157168|198882|P1|STARTED|Overall Study||746
81386|NCT02157116|198902|P1|NOT COMPLETED|Overall Study||9
81387|NCT02157116|198902|P1|COMPLETED|Overall Study||4
81388|NCT02157116|198902|P1|STARTED|Overall Study|signed consent form|13
81389|NCT02157103|198911|P1|NOT COMPLETED|Overall Study||0
81390|NCT02157103|198911|P1|COMPLETED|Overall Study||3
81391|NCT02157103|198911|P1|STARTED|Overall Study||3
81392|NCT02156492|198920|P3|NOT COMPLETED|Period 3||0
81393|NCT02156492|198921|P2|NOT COMPLETED|Period 3||1
81394|NCT02156492|198922|P1|NOT COMPLETED|Period 3||0
81395|NCT02156492|198920|P3|COMPLETED|Period 3||22
81396|NCT02156492|198921|P2|COMPLETED|Period 3||22
81397|NCT02156492|198922|P1|COMPLETED|Period 3||0
81398|NCT02156492|198920|P3|STARTED|Period 3||22
81399|NCT02156492|198921|P2|STARTED|Period 3||23
81400|NCT02156492|198922|P1|STARTED|Period 3|Cohort A participated in Period 1 and Period 2 only.|0
81401|NCT02156492|198920|P3|NOT COMPLETED|Period 2||0
81402|NCT02156492|198921|P2|NOT COMPLETED|Period 2||0
81403|NCT02156492|198922|P1|NOT COMPLETED|Period 2||0
81404|NCT02156492|198920|P3|COMPLETED|Period 2||22
81405|NCT02156492|198921|P2|COMPLETED|Period 2||23
81406|NCT02156492|198922|P1|COMPLETED|Period 2||16
81407|NCT02156492|198920|P3|STARTED|Period 2||22
81408|NCT02156492|198921|P2|STARTED|Period 2||23
81409|NCT02156492|198922|P1|STARTED|Period 2||16
81410|NCT02156492|198920|P3|NOT COMPLETED|Period 1||0
81411|NCT02156492|198921|P2|NOT COMPLETED|Period 1||1
81412|NCT02156492|198922|P1|NOT COMPLETED|Period 1||0
81413|NCT02156492|198920|P3|COMPLETED|Period 1||22
81414|NCT02156492|198921|P2|COMPLETED|Period 1||23
81415|NCT02156492|198922|P1|COMPLETED|Period 1||16
81416|NCT02156492|198920|P3|Received at Least One Dose of Study Drug|Period 1||22
81417|NCT02156492|198921|P2|Received at Least One Dose of Study Drug|Period 1||24
81418|NCT02156492|198922|P1|Received at Least One Dose of Study Drug|Period 1||16
81419|NCT02156492|198920|P3|STARTED|Period 1||22
81420|NCT02156492|198921|P2|STARTED|Period 1||24
81421|NCT02156492|198922|P1|STARTED|Period 1||16
81422|NCT02156466|198948|P5|NOT COMPLETED|Overall Study||0
81423|NCT02156466|198949|P4|NOT COMPLETED|Overall Study||2
81424|NCT02156466|198950|P3|NOT COMPLETED|Overall Study||1
81425|NCT02156466|198951|P2|NOT COMPLETED|Overall Study||0
81426|NCT02156466|198952|P1|NOT COMPLETED|Overall Study||0
81427|NCT02156466|198948|P5|COMPLETED|Overall Study||8
81428|NCT02156466|198949|P4|COMPLETED|Overall Study||7
81429|NCT02156466|198950|P3|COMPLETED|Overall Study||7
81430|NCT02156466|198951|P2|COMPLETED|Overall Study||8
81431|NCT02156466|198952|P1|COMPLETED|Overall Study||8
81432|NCT02156466|198948|P5|STARTED|Overall Study||8
81433|NCT02156466|198949|P4|STARTED|Overall Study||9
81434|NCT02156466|198950|P3|STARTED|Overall Study||8
81435|NCT02156466|198951|P2|STARTED|Overall Study||8
81436|NCT02156466|198952|P1|STARTED|Overall Study||8
81437|NCT02156271|199133|P2|NOT COMPLETED|Overall Study||3
81438|NCT02156271|199134|P1|NOT COMPLETED|Overall Study||4
81439|NCT02156271|199133|P2|COMPLETED|Overall Study||10
81440|NCT02156271|199134|P1|COMPLETED|Overall Study||22
81441|NCT02156271|199133|P2|STARTED|Overall Study||13
81442|NCT02156271|199134|P1|STARTED|Overall Study||26
81443|NCT02156167|199166|P1|NOT COMPLETED|Overall Study||0
81444|NCT02156167|199166|P1|COMPLETED|Overall Study||15
81445|NCT02156167|199166|P1|STARTED|Overall Study||15
81446|NCT02156076|199174|P4|NOT COMPLETED|Follow-up Period||0
81447|NCT02156076|199175|P3|NOT COMPLETED|Follow-up Period||0
81448|NCT02156076|199176|P2|NOT COMPLETED|Follow-up Period||0
81449|NCT02156076|199177|P1|NOT COMPLETED|Follow-up Period||1
81450|NCT02156076|199174|P4|COMPLETED|Follow-up Period||4
81451|NCT02156076|199175|P3|COMPLETED|Follow-up Period||4
81452|NCT02156076|199176|P2|COMPLETED|Follow-up Period||5
81453|NCT02156076|199177|P1|COMPLETED|Follow-up Period||6
81454|NCT02156076|199174|P4|STARTED|Follow-up Period||4
81455|NCT02156076|199175|P3|STARTED|Follow-up Period||4
81456|NCT02156076|199176|P2|STARTED|Follow-up Period||5
81457|NCT02156076|199177|P1|STARTED|Follow-up Period||7
81458|NCT02156076|199174|P4|NOT COMPLETED|Treatment Period||2
81459|NCT02156076|199175|P3|NOT COMPLETED|Treatment Period||2
81460|NCT02156076|199176|P2|NOT COMPLETED|Treatment Period||2
81461|NCT02156076|199177|P1|NOT COMPLETED|Treatment Period||0
81462|NCT02156076|199174|P4|COMPLETED|Treatment Period||4
81463|NCT02156076|199175|P3|COMPLETED|Treatment Period||4
81464|NCT02156076|199176|P2|COMPLETED|Treatment Period||5
81465|NCT02156076|199177|P1|COMPLETED|Treatment Period||7
81466|NCT02156076|199174|P4|STARTED|Treatment Period||6
81467|NCT02156076|199175|P3|STARTED|Treatment Period||6
81468|NCT02156076|199176|P2|STARTED|Treatment Period||7
81469|NCT02156076|199177|P1|STARTED|Treatment Period||7
81470|NCT02155985|199234|P3|NOT COMPLETED|Overall Study||1
81471|NCT02155985|199235|P2|NOT COMPLETED|Overall Study||0
81472|NCT02155985|199236|P1|NOT COMPLETED|Overall Study||1
81473|NCT02155985|199234|P3|COMPLETED|Overall Study||39
81474|NCT02155985|199235|P2|COMPLETED|Overall Study||41
81475|NCT02155985|199236|P1|COMPLETED|Overall Study||39
81476|NCT02155985|199234|P3|STARTED|Overall Study||40
81477|NCT02155985|199235|P2|STARTED|Overall Study||41
81478|NCT02155985|199236|P1|STARTED|Overall Study||40
81479|NCT02155881|199303|P2|NOT COMPLETED|Overall Study||4
81480|NCT02155881|199304|P1|NOT COMPLETED|Overall Study||2
81481|NCT02155881|199303|P2|COMPLETED|Overall Study||36
81482|NCT02155881|199304|P1|COMPLETED|Overall Study||38
81483|NCT02155881|199303|P2|STARTED|Overall Study||40
81484|NCT02155881|199304|P1|STARTED|Overall Study||40
81485|NCT02155738|199328|P4|NOT COMPLETED|Overall Study||1
81486|NCT02155738|199329|P3|NOT COMPLETED|Overall Study||0
81487|NCT02155738|199330|P2|NOT COMPLETED|Overall Study||0
81488|NCT02155738|199331|P1|NOT COMPLETED|Overall Study||1
81489|NCT02155738|199328|P4|COMPLETED|Overall Study||50
81490|NCT02155738|199329|P3|COMPLETED|Overall Study||51
81491|NCT02155738|199330|P2|COMPLETED|Overall Study||52
81492|NCT02155738|199331|P1|COMPLETED|Overall Study||49
81493|NCT02155738|199328|P4|STARTED|Overall Study||51
81494|NCT02155738|199329|P3|STARTED|Overall Study||51
81495|NCT02155738|199330|P2|STARTED|Overall Study||52
81496|NCT02155738|199331|P1|STARTED|Overall Study||50
81497|NCT02155712|199351|P2|NOT COMPLETED|Secondary Objectives||134
81498|NCT02155712|199352|P1|NOT COMPLETED|Secondary Objectives||319
81499|NCT02155712|199351|P2|COMPLETED|Secondary Objectives||0
81500|NCT02155712|199352|P1|COMPLETED|Secondary Objectives||0
81501|NCT02155712|199351|P2|STARTED|Secondary Objectives|This period will be updated when posting secondary objective results.|134
81502|NCT02155712|199352|P1|STARTED|Secondary Objectives||319
81503|NCT02155712|199351|P2|NOT COMPLETED|Primary Objective||0
81504|NCT02155712|199352|P1|NOT COMPLETED|Primary Objective||60
81505|NCT02155712|199351|P2|COMPLETED|Primary Objective||0
81506|NCT02155712|199352|P1|COMPLETED|Primary Objective||259
81507|NCT02155712|199351|P2|STARTED|Primary Objective|Cohort 2 isn't included in primary obj analysis|0
81508|NCT02155712|199352|P1|STARTED|Primary Objective||319
81509|NCT02155660|199362|P4|NOT COMPLETED|Overall Study||61
81510|NCT02155660|199363|P3|NOT COMPLETED|Overall Study||60
81511|NCT02155660|199364|P2|NOT COMPLETED|Overall Study||73
81512|NCT02155660|199365|P1|NOT COMPLETED|Overall Study||58
81513|NCT02155660|199362|P4|COMPLETED|Overall Study||507
81514|NCT02155660|199363|P3|COMPLETED|Overall Study||502
81515|NCT02155660|199364|P2|COMPLETED|Overall Study||489
81516|NCT02155660|199365|P1|COMPLETED|Overall Study||504
81517|NCT02155660|199362|P4|STARTED|Overall Study||568
81518|NCT02155660|199363|P3|STARTED|Overall Study||562
81519|NCT02155660|199364|P2|STARTED|Overall Study||562
81520|NCT02155660|199365|P1|STARTED|Overall Study||562
81521|NCT02155608|199448|P2|NOT COMPLETED|1b: 1 Week Blinded Post Treatment||1
81522|NCT02155608|199449|P1|NOT COMPLETED|1b: 1 Week Blinded Post Treatment||1
81523|NCT02155608|199448|P2|COMPLETED|1b: 1 Week Blinded Post Treatment||28
81524|NCT02155608|199449|P1|COMPLETED|1b: 1 Week Blinded Post Treatment||31
81525|NCT02155608|199448|P2|STARTED|1b: 1 Week Blinded Post Treatment||29
81526|NCT02155608|199449|P1|STARTED|1b: 1 Week Blinded Post Treatment||32
81527|NCT02155608|199448|P2|NOT COMPLETED|1a: 4 Week Double Blind Sham Controlled||1
81528|NCT02155608|199449|P1|NOT COMPLETED|1a: 4 Week Double Blind Sham Controlled||0
81529|NCT02155608|199448|P2|COMPLETED|1a: 4 Week Double Blind Sham Controlled||29
81530|NCT02155608|199449|P1|COMPLETED|1a: 4 Week Double Blind Sham Controlled||32
81531|NCT02155608|199448|P2|STARTED|1a: 4 Week Double Blind Sham Controlled||30
81532|NCT02155608|199449|P1|STARTED|1a: 4 Week Double Blind Sham Controlled||32
81533|NCT02155543|199488|P7|NOT COMPLETED|Overall Study||0
81534|NCT02155543|199489|P6|NOT COMPLETED|Overall Study||0
81535|NCT02155543|199490|P5|NOT COMPLETED|Overall Study||0
81536|NCT02155543|199491|P4|NOT COMPLETED|Overall Study||0
81537|NCT02155543|199492|P3|NOT COMPLETED|Overall Study||0
81538|NCT02155543|199493|P2|NOT COMPLETED|Overall Study||0
81539|NCT02155543|199494|P1|NOT COMPLETED|Overall Study||0
81540|NCT02155543|199488|P7|COMPLETED|Overall Study||9
81541|NCT02155543|199489|P6|COMPLETED|Overall Study||3
81542|NCT02155543|199490|P5|COMPLETED|Overall Study||3
81543|NCT02155543|199491|P4|COMPLETED|Overall Study||9
81544|NCT02155543|199492|P3|COMPLETED|Overall Study||9
81545|NCT02155543|199493|P2|COMPLETED|Overall Study||9
81546|NCT02155543|199494|P1|COMPLETED|Overall Study||9
81547|NCT02155543|199488|P7|STARTED|Overall Study||9
81548|NCT02155543|199489|P6|STARTED|Overall Study||3
81549|NCT02155543|199490|P5|STARTED|Overall Study||3
81550|NCT02155543|199491|P4|STARTED|Overall Study||9
81551|NCT02155543|199492|P3|STARTED|Overall Study||9
81552|NCT02155543|199493|P2|STARTED|Overall Study||9
81553|NCT02155543|199494|P1|STARTED|Overall Study||9
81554|NCT02155465|199514|P7|NOT COMPLETED|Overall Study||0
81555|NCT02155465|199515|P6|NOT COMPLETED|Overall Study||0
81556|NCT02155465|199516|P5|NOT COMPLETED|Overall Study||0
81557|NCT02155465|199517|P4|NOT COMPLETED|Overall Study||0
81558|NCT02155465|199518|P3|NOT COMPLETED|Overall Study||0
81559|NCT02155465|199519|P2|NOT COMPLETED|Overall Study||0
81560|NCT02155465|199520|P1|NOT COMPLETED|Overall Study||0
81561|NCT02155465|199514|P7|COMPLETED|Overall Study||5
81562|NCT02155465|199515|P6|COMPLETED|Overall Study||2
81563|NCT02155465|199516|P5|COMPLETED|Overall Study||1
81564|NCT02155465|199517|P4|COMPLETED|Overall Study||2
81565|NCT02155465|199518|P3|COMPLETED|Overall Study||6
81566|NCT02155465|199519|P2|COMPLETED|Overall Study||3
81567|NCT02155465|199520|P1|COMPLETED|Overall Study||3
81568|NCT02155465|199514|P7|STARTED|Overall Study||5
81569|NCT02155465|199515|P6|STARTED|Overall Study||2
81570|NCT02155465|199516|P5|STARTED|Overall Study||1
81571|NCT02155465|199517|P4|STARTED|Overall Study||2
81572|NCT02155465|199518|P3|STARTED|Overall Study||6
81573|NCT02155465|199519|P2|STARTED|Overall Study||3
81574|NCT02155465|199520|P1|STARTED|Overall Study||3
81575|NCT02155335|199540|P2|NOT COMPLETED|Period 2||0
81576|NCT02155335|199541|P1|NOT COMPLETED|Period 2||0
81577|NCT02155335|199540|P2|COMPLETED|Period 2||49
81578|NCT02155335|199541|P1|COMPLETED|Period 2||50
81579|NCT02155335|199540|P2|STARTED|Period 2||49
81580|NCT02155335|199541|P1|STARTED|Period 2||50
81581|NCT02155335|199540|P2|NOT COMPLETED|Period 1||1
81582|NCT02155335|199541|P1|NOT COMPLETED|Period 1||0
81583|NCT02155335|199540|P2|COMPLETED|Period 1||49
81584|NCT02155335|199541|P1|COMPLETED|Period 1||50
81585|NCT02155335|199540|P2|Treated|Period 1||49
81586|NCT02155335|199541|P1|Treated|Period 1||50
81587|NCT02155335|199540|P2|STARTED|Period 1||50
81588|NCT02155335|199541|P1|STARTED|Period 1||50
81589|NCT02155322|199546|P1|NOT COMPLETED|Overall Study||14
81590|NCT02155322|199546|P1|COMPLETED|Overall Study||19
81591|NCT02155322|199546|P1|Treated|Overall Study|32 of 33 participants treated. 1 participant not treated at the discretion of the investigator.|32
81592|NCT02155322|199546|P1|STARTED|Overall Study||33
81593|NCT02155309|199553|P3|NOT COMPLETED|Overall Study||1
81594|NCT02155309|199554|P2|NOT COMPLETED|Overall Study||0
81595|NCT02155309|199555|P1|NOT COMPLETED|Overall Study||0
81596|NCT02155309|199553|P3|COMPLETED|Overall Study||12
81597|NCT02155309|199554|P2|COMPLETED|Overall Study||10
81598|NCT02155309|199555|P1|COMPLETED|Overall Study||13
81599|NCT02155309|199553|P3|STARTED|Overall Study||13
81600|NCT02155309|199554|P2|STARTED|Overall Study||10
81601|NCT02155309|199555|P1|STARTED|Overall Study||13
81602|NCT02155283|199562|P1|NOT COMPLETED|Overall Study||7
81603|NCT02155283|199562|P1|COMPLETED|Overall Study||9
81604|NCT02155283|199562|P1|STARTED|Overall Study||16
81605|NCT02155257|199570|P3|NOT COMPLETED|Overall Study||0
81606|NCT02155257|199571|P2|NOT COMPLETED|Overall Study||0
81607|NCT02155257|199572|P1|NOT COMPLETED|Overall Study||0
81608|NCT02155257|199570|P3|COMPLETED|Overall Study||10
81609|NCT02155257|199571|P2|COMPLETED|Overall Study||10
81610|NCT02155257|199572|P1|COMPLETED|Overall Study||10
81611|NCT02155257|199570|P3|STARTED|Overall Study||10
81612|NCT02155257|199571|P2|STARTED|Overall Study||10
81613|NCT02155257|199572|P1|STARTED|Overall Study||10
81614|NCT02155101|199588|P2|NOT COMPLETED|Overall Study||1
81615|NCT02155101|199589|P1|NOT COMPLETED|Overall Study||0
81616|NCT02155101|199588|P2|COMPLETED|Overall Study||80
81617|NCT02155101|199589|P1|COMPLETED|Overall Study||39
81618|NCT02155101|199588|P2|STARTED|Overall Study||81
81619|NCT02155101|199589|P1|STARTED|Overall Study||39
81620|NCT02155010|199601|P2|NOT COMPLETED|Overall Study||6
81621|NCT02155010|199602|P1|NOT COMPLETED|Overall Study||6
81622|NCT02155010|199601|P2|COMPLETED|Overall Study||31
81623|NCT02155010|199602|P1|COMPLETED|Overall Study||31
81624|NCT02155010|199601|P2|STARTED|Overall Study||37
81625|NCT02155010|199602|P1|STARTED|Overall Study||37
81626|NCT02154906|199612|P2|NOT COMPLETED|Overall Study||3
81627|NCT02154906|199613|P1|NOT COMPLETED|Overall Study||2
81628|NCT02154906|199612|P2|COMPLETED|Overall Study||17
81629|NCT02154906|199613|P1|COMPLETED|Overall Study||19
81630|NCT02154906|199612|P2|STARTED|Overall Study||20
81631|NCT02154906|199613|P1|STARTED|Overall Study||21
81632|NCT02154763|199623|P2|NOT COMPLETED|Overall Study||14
81633|NCT02154763|199624|P1|NOT COMPLETED|Overall Study||14
81634|NCT02154763|199623|P2|COMPLETED|Overall Study||46
81635|NCT02154763|199624|P1|COMPLETED|Overall Study||46
81636|NCT02154763|199623|P2|STARTED|Overall Study||60
81637|NCT02154763|199624|P1|STARTED|Overall Study||60
81638|NCT02154581|199738|P2|NOT COMPLETED|Overall Study||8
81639|NCT02154581|199739|P1|NOT COMPLETED|Overall Study||7
81640|NCT02154581|199738|P2|COMPLETED|Overall Study||12
81641|NCT02154581|199739|P1|COMPLETED|Overall Study||14
81642|NCT02154581|199738|P2|STARTED|Overall Study||20
81643|NCT02154581|199739|P1|STARTED|Overall Study||21
81644|NCT02154477|199757|P2|NOT COMPLETED|Overall Study||0
81645|NCT02154477|199758|P1|NOT COMPLETED|Overall Study||0
81646|NCT02154477|199757|P2|COMPLETED|Overall Study||8
81647|NCT02154477|199758|P1|COMPLETED|Overall Study||6
81648|NCT02154477|199757|P2|STARTED|Overall Study||8
81649|NCT02154477|199758|P1|STARTED|Overall Study||6
81650|NCT02154425|199764|P1|NOT COMPLETED|Sampling Period||0
81651|NCT02154425|199764|P1|COMPLETED|Sampling Period||17
81652|NCT02154425|199764|P1|STARTED|Sampling Period||17
81653|NCT02154425|199764|P1|NOT COMPLETED|Screening Period||1
81654|NCT02154425|199764|P1|COMPLETED|Screening Period||17
81655|NCT02154425|199764|P1|STARTED|Screening Period||18
81656|NCT02154386|199796|P2|NOT COMPLETED|Overall Study||2
81657|NCT02154386|199797|P1|NOT COMPLETED|Overall Study||1
81658|NCT02154386|199796|P2|COMPLETED|Overall Study||21
81659|NCT02154386|199797|P1|COMPLETED|Overall Study||22
81660|NCT02154386|199796|P2|STARTED|Overall Study||23
81661|NCT02154386|199797|P1|STARTED|Overall Study||23
81662|NCT02154347|199809|P2|NOT COMPLETED|Open-label Period||25
81663|NCT02154347|199810|P1|NOT COMPLETED|Open-label Period||7
81664|NCT02154347|199809|P2|COMPLETED|Open-label Period||88
81665|NCT02154347|199810|P1|COMPLETED|Open-label Period||50
81666|NCT02154347|199809|P2|STARTED|Open-label Period||113
81667|NCT02154347|199810|P1|STARTED|Open-label Period||57
81668|NCT02154347|199809|P2|NOT COMPLETED|Double-blind Period||4
81669|NCT02154347|199810|P1|NOT COMPLETED|Double-blind Period||3
81670|NCT02154347|199809|P2|COMPLETED|Double-blind Period||114
81671|NCT02154347|199810|P1|COMPLETED|Double-blind Period||57
81672|NCT02154347|199809|P2|STARTED|Double-blind Period||118
81673|NCT02154347|199810|P1|STARTED|Double-blind Period||60
81674|NCT02154243|199820|P3|NOT COMPLETED|Overall Study||0
81675|NCT02154243|199821|P2|NOT COMPLETED|Overall Study||0
81676|NCT02154243|199822|P1|NOT COMPLETED|Overall Study||0
81677|NCT02154243|199820|P3|COMPLETED|Overall Study||4
81678|NCT02154243|199821|P2|COMPLETED|Overall Study||4
81679|NCT02154243|199822|P1|COMPLETED|Overall Study||5
81680|NCT02154243|199820|P3|STARTED|Overall Study||4
81681|NCT02154243|199821|P2|STARTED|Overall Study||4
81682|NCT02154243|199822|P1|STARTED|Overall Study||5
81683|NCT02154139|199833|P1|NOT COMPLETED|Overall Study||7
81684|NCT02154139|199833|P1|COMPLETED|Overall Study||644
81685|NCT02154139|199833|P1|STARTED|Overall Study||651
81686|NCT02154087|199841|P1|NOT COMPLETED|Overall Study||1
81687|NCT02154087|199841|P1|COMPLETED|Overall Study||0
81688|NCT02154087|199841|P1|STARTED|Overall Study||1
81689|NCT02154061|199847|P2|NOT COMPLETED|Overall Study||0
81690|NCT02154061|199848|P1|NOT COMPLETED|Overall Study||2
81691|NCT02154061|199847|P2|COMPLETED|Overall Study||17
81692|NCT02154061|199848|P1|COMPLETED|Overall Study||14
81693|NCT02154061|199847|P2|STARTED|Overall Study||17
81694|NCT02154061|199848|P1|STARTED|Overall Study||16
81695|NCT02154048|199857|P3|NOT COMPLETED|Overall Study||0
81696|NCT02154048|199858|P2|NOT COMPLETED|Overall Study||0
81697|NCT02154048|199859|P1|NOT COMPLETED|Overall Study||0
81698|NCT02154048|199857|P3|COMPLETED|Overall Study||1
81699|NCT02154048|199858|P2|COMPLETED|Overall Study||2
81700|NCT02154048|199859|P1|COMPLETED|Overall Study||2
81701|NCT02154048|199857|P3|STARTED|Overall Study||1
81702|NCT02154048|199858|P2|STARTED|Overall Study||2
81703|NCT02154048|199859|P1|STARTED|Overall Study||2
81704|NCT02153983|199873|P6|NOT COMPLETED|Overall Study||0
81705|NCT02153983|199874|P5|NOT COMPLETED|Overall Study||0
81706|NCT02153983|199875|P4|NOT COMPLETED|Overall Study||0
81707|NCT02153983|199876|P3|NOT COMPLETED|Overall Study||2
81708|NCT02153983|199877|P2|NOT COMPLETED|Overall Study||3
81709|NCT02153983|199878|P1|NOT COMPLETED|Overall Study||0
81710|NCT02153983|199873|P6|COMPLETED|Overall Study||1
81711|NCT02153983|199874|P5|COMPLETED|Overall Study||19
81712|NCT02153983|199875|P4|COMPLETED|Overall Study||13
81713|NCT02153983|199876|P3|COMPLETED|Overall Study||2
81714|NCT02153983|199877|P2|COMPLETED|Overall Study||18
81715|NCT02153983|199878|P1|COMPLETED|Overall Study||19
81716|NCT02153983|199873|P6|STARTED|Overall Study||1
81717|NCT02153983|199874|P5|STARTED|Overall Study||19
81718|NCT02153983|199875|P4|STARTED|Overall Study||13
81719|NCT02153983|199876|P3|STARTED|Overall Study||4
81720|NCT02153983|199877|P2|STARTED|Overall Study||21
81721|NCT02153983|199878|P1|STARTED|Overall Study||19
81722|NCT02153918|199895|P1|NOT COMPLETED|Overall Study||1
81723|NCT02153918|199895|P1|COMPLETED|Overall Study||26
81724|NCT02153918|199895|P1|STARTED|Overall Study||27
81725|NCT02153905|199906|P2|NOT COMPLETED|Overall Study||0
81726|NCT02153905|199907|P1|NOT COMPLETED|Overall Study||1
81727|NCT02153905|199906|P2|COMPLETED|Overall Study||2
81728|NCT02153905|199907|P1|COMPLETED|Overall Study||0
81729|NCT02153905|199906|P2|STARTED|Overall Study||2
81730|NCT02153905|199907|P1|STARTED|Overall Study||1
81731|NCT02153827|199925|P2|NOT COMPLETED|Overall Study||9
81732|NCT02153827|199926|P1|NOT COMPLETED|Overall Study||3
81733|NCT02153827|199925|P2|COMPLETED|Overall Study||14
81734|NCT02153827|199926|P1|COMPLETED|Overall Study||22
81735|NCT02153827|199925|P2|STARTED|Overall Study||23
81736|NCT02153827|199926|P1|STARTED|Overall Study||25
81737|NCT02153788|199942|P2|NOT COMPLETED|Overall Study||1
81738|NCT02153788|199943|P1|NOT COMPLETED|Overall Study||2
81739|NCT02153788|199942|P2|COMPLETED|Overall Study||18
81740|NCT02153788|199943|P1|COMPLETED|Overall Study||23
81741|NCT02153788|199942|P2|STARTED|Overall Study||19
81742|NCT02153788|199943|P1|STARTED|Overall Study||25
81743|NCT02153736|199963|P2|NOT COMPLETED|Overall Study||2
81744|NCT02153736|199964|P1|NOT COMPLETED|Overall Study||2
81745|NCT02153736|199963|P2|COMPLETED|Overall Study||5
81746|NCT02153736|199964|P1|COMPLETED|Overall Study||5
81747|NCT02153736|199963|P2|STARTED|Overall Study||7
81748|NCT02153736|199964|P1|STARTED|Overall Study||7
81749|NCT02153723|199980|P1|NOT COMPLETED|Overall Study||0
81750|NCT02153723|199980|P1|COMPLETED|Overall Study||10
81751|NCT02153723|199980|P1|STARTED|Overall Study||10
81752|NCT02153710|199991|P2|NOT COMPLETED|Overall Study||0
81753|NCT02153710|199992|P1|NOT COMPLETED|Overall Study||0
81754|NCT02153710|199991|P2|COMPLETED|Overall Study||30
81755|NCT02153710|199992|P1|COMPLETED|Overall Study||28
81756|NCT02153710|199991|P2|STARTED|Overall Study||30
81757|NCT02153710|199992|P1|STARTED|Overall Study||28
81758|NCT02153671|200004|P2|NOT COMPLETED|Overall Study||0
81759|NCT02153671|200005|P1|NOT COMPLETED|Overall Study||0
81760|NCT02153671|200004|P2|COMPLETED|Overall Study||24
81761|NCT02153671|200005|P1|COMPLETED|Overall Study||19
81762|NCT02153671|200004|P2|STARTED|Overall Study||24
81763|NCT02153671|200005|P1|STARTED|Overall Study||19
81764|NCT02153645|200084|P3|NOT COMPLETED|Overall Study||10
81765|NCT02153645|200085|P2|NOT COMPLETED|Overall Study||10
81766|NCT02153645|200086|P1|NOT COMPLETED|Overall Study||13
81767|NCT02153645|200084|P3|COMPLETED|Overall Study||18
81768|NCT02153645|200085|P2|COMPLETED|Overall Study||19
81769|NCT02153645|200086|P1|COMPLETED|Overall Study||17
81770|NCT02153645|200084|P3|STARTED|Overall Study||28
81771|NCT02153645|200085|P2|STARTED|Overall Study||29
81772|NCT02153645|200086|P1|STARTED|Overall Study||30
81773|NCT02153632|200100|P3|NOT COMPLETED|Overall Study||19
81774|NCT02153632|200101|P2|NOT COMPLETED|Overall Study||19
81775|NCT02153632|200102|P1|NOT COMPLETED|Overall Study||18
81776|NCT02153632|200100|P3|COMPLETED|Overall Study||25
81777|NCT02153632|200101|P2|COMPLETED|Overall Study||27
81778|NCT02153632|200102|P1|COMPLETED|Overall Study||27
81779|NCT02153632|200100|P3|STARTED|Overall Study||44
81780|NCT02153632|200101|P2|STARTED|Overall Study||46
81781|NCT02153632|200102|P1|STARTED|Overall Study||45
81782|NCT02153489|200113|P2|NOT COMPLETED|Period 2||0
81783|NCT02153489|200114|P1|NOT COMPLETED|Period 2||0
81784|NCT02153489|200113|P2|COMPLETED|Period 2||15
81785|NCT02153489|200114|P1|COMPLETED|Period 2||15
81786|NCT02153489|200113|P2|STARTED|Period 2||15
81787|NCT02153489|200114|P1|STARTED|Period 2||15
81788|NCT02153489|200113|P2|NOT COMPLETED|Period 1||0
81789|NCT02153489|200114|P1|NOT COMPLETED|Period 1||0
81790|NCT02153489|200113|P2|COMPLETED|Period 1||15
81791|NCT02153489|200114|P1|COMPLETED|Period 1||15
81792|NCT02153489|200113|P2|STARTED|Period 1||15
81793|NCT02153489|200114|P1|STARTED|Period 1||15
81794|NCT02153476|200154|P2|NOT COMPLETED|Overall Study||0
81795|NCT02153476|200155|P1|NOT COMPLETED|Overall Study||1
81796|NCT02153476|200154|P2|COMPLETED|Overall Study||22
81797|NCT02153476|200155|P1|COMPLETED|Overall Study||22
81798|NCT02153476|200154|P2|STARTED|Overall Study||22
81799|NCT02153476|200155|P1|STARTED|Overall Study||23
81800|NCT02153398|200166|P5|NOT COMPLETED|Overall Study||0
81801|NCT02153398|200167|P4|NOT COMPLETED|Overall Study||1
81802|NCT02153398|200168|P3|NOT COMPLETED|Overall Study||1
81803|NCT02153398|200169|P2|NOT COMPLETED|Overall Study||0
81804|NCT02153398|200170|P1|NOT COMPLETED|Overall Study||1
81805|NCT02153398|200166|P5|COMPLETED|Overall Study||10
81806|NCT02153398|200167|P4|COMPLETED|Overall Study||9
81807|NCT02153398|200168|P3|COMPLETED|Overall Study||9
81808|NCT02153398|200169|P2|COMPLETED|Overall Study||10
81809|NCT02153398|200170|P1|COMPLETED|Overall Study||9
81810|NCT02153398|200166|P5|STARTED|Overall Study||10
81811|NCT02153398|200167|P4|STARTED|Overall Study||10
81812|NCT02153398|200168|P3|STARTED|Overall Study||10
81813|NCT02153398|200169|P2|STARTED|Overall Study||10
81814|NCT02153398|200170|P1|STARTED|Overall Study||10
81815|NCT02153359|200292|P2|NOT COMPLETED|Intervention 2 (1 Month)||2
81816|NCT02153359|200293|P1|NOT COMPLETED|Intervention 2 (1 Month)||0
81817|NCT02153359|200292|P2|COMPLETED|Intervention 2 (1 Month)||10
81818|NCT02153359|200293|P1|COMPLETED|Intervention 2 (1 Month)||11
81819|NCT02153359|200292|P2|STARTED|Intervention 2 (1 Month)||12
81820|NCT02153359|200293|P1|STARTED|Intervention 2 (1 Month)||11
81821|NCT02153359|200292|P2|NOT COMPLETED|Washout (at Least 1 Month)||0
81822|NCT02153359|200293|P1|NOT COMPLETED|Washout (at Least 1 Month)||0
81823|NCT02153359|200292|P2|COMPLETED|Washout (at Least 1 Month)||12
81824|NCT02153359|200293|P1|COMPLETED|Washout (at Least 1 Month)||11
81825|NCT02153359|200292|P2|STARTED|Washout (at Least 1 Month)||12
81826|NCT02153359|200293|P1|STARTED|Washout (at Least 1 Month)||11
81827|NCT02153359|200292|P2|NOT COMPLETED|Intervention 1 (1 Month)||0
81828|NCT02153359|200293|P1|NOT COMPLETED|Intervention 1 (1 Month)||0
81829|NCT02153359|200292|P2|COMPLETED|Intervention 1 (1 Month)||12
81830|NCT02153359|200293|P1|COMPLETED|Intervention 1 (1 Month)||11
81831|NCT02153359|200292|P2|STARTED|Intervention 1 (1 Month)||12
81832|NCT02153359|200293|P1|STARTED|Intervention 1 (1 Month)||11
81833|NCT02153346|200327|P1|NOT COMPLETED|Overall Study||11
81834|NCT02153346|200327|P1|COMPLETED|Overall Study||90
81835|NCT02153346|200327|P1|STARTED|Overall Study||101
81836|NCT02153112|200344|P10|NOT COMPLETED|Overall Study||14
81837|NCT02153112|200345|P9|NOT COMPLETED|Overall Study||15
81838|NCT02153112|200346|P8|NOT COMPLETED|Overall Study||2
81839|NCT02153112|200347|P7|NOT COMPLETED|Overall Study||8
81840|NCT02153112|200348|P6|NOT COMPLETED|Overall Study||2
81841|NCT02153112|200349|P5|NOT COMPLETED|Overall Study||3
81842|NCT02153112|200350|P4|NOT COMPLETED|Overall Study||2
81843|NCT02153112|200351|P3|NOT COMPLETED|Overall Study||3
81844|NCT02153112|200352|P2|NOT COMPLETED|Overall Study||2
81845|NCT02153112|200353|P1|NOT COMPLETED|Overall Study||4
81846|NCT02153112|200344|P10|COMPLETED|Overall Study||166
81847|NCT02153112|200345|P9|COMPLETED|Overall Study||165
81848|NCT02153112|200346|P8|COMPLETED|Overall Study||58
81849|NCT02153112|200347|P7|COMPLETED|Overall Study||52
81850|NCT02153112|200348|P6|COMPLETED|Overall Study||58
81851|NCT02153112|200349|P5|COMPLETED|Overall Study||57
81852|NCT02153112|200350|P4|COMPLETED|Overall Study||57
81853|NCT02153112|200351|P3|COMPLETED|Overall Study||58
81854|NCT02153112|200352|P2|COMPLETED|Overall Study||57
81855|NCT02153112|200353|P1|COMPLETED|Overall Study||57
81856|NCT02153112|200344|P10|STARTED|Overall Study||180
81857|NCT02153112|200345|P9|STARTED|Overall Study||180
81858|NCT02153112|200346|P8|STARTED|Overall Study||60
81859|NCT02153112|200347|P7|STARTED|Overall Study||60
81860|NCT02153112|200348|P6|STARTED|Overall Study||60
81861|NCT02153112|200349|P5|STARTED|Overall Study||60
81862|NCT02153112|200350|P4|STARTED|Overall Study||59
81863|NCT02153112|200351|P3|STARTED|Overall Study||61
81864|NCT02153112|200352|P2|STARTED|Overall Study||59
81865|NCT02153112|200353|P1|STARTED|Overall Study||61
81866|NCT02153099|200632|P7|NOT COMPLETED|Overall Study||0
81867|NCT02153099|200633|P6|NOT COMPLETED|Overall Study||0
81868|NCT02153099|200634|P5|NOT COMPLETED|Overall Study||0
81869|NCT02153099|200635|P4|NOT COMPLETED|Overall Study||0
81870|NCT02153099|200636|P3|NOT COMPLETED|Overall Study||0
81871|NCT02153099|200637|P2|NOT COMPLETED|Overall Study||0
81872|NCT02153099|200638|P1|NOT COMPLETED|Overall Study||0
81873|NCT02153099|200632|P7|COMPLETED|Overall Study||12
81874|NCT02153099|200633|P6|COMPLETED|Overall Study||6
81875|NCT02153099|200634|P5|COMPLETED|Overall Study||6
81876|NCT02153099|200635|P4|COMPLETED|Overall Study||6
81877|NCT02153099|200636|P3|COMPLETED|Overall Study||6
81878|NCT02153099|200637|P2|COMPLETED|Overall Study||6
81879|NCT02153099|200638|P1|COMPLETED|Overall Study||6
81880|NCT02153099|200632|P7|STARTED|Overall Study||12
81881|NCT02153099|200633|P6|STARTED|Overall Study||6
81882|NCT02153099|200634|P5|STARTED|Overall Study||6
81883|NCT02153099|200635|P4|STARTED|Overall Study||6
81884|NCT02153099|200636|P3|STARTED|Overall Study||6
81885|NCT02153099|200637|P2|STARTED|Overall Study||6
81886|NCT02153099|200638|P1|STARTED|Overall Study||6
81887|NCT02153086|200692|P1|NOT COMPLETED|Overall Study||4
81888|NCT02153086|200692|P1|COMPLETED|Overall Study||232
81889|NCT02153086|200692|P1|STARTED|Overall Study||236
81890|NCT02153073|200706|P1|NOT COMPLETED|Overall Study||298
81891|NCT02153073|200706|P1|COMPLETED|Overall Study||2786
81892|NCT02153073|200706|P1|STARTED|Overall Study||3084
81893|NCT02152631|200721|P2|NOT COMPLETED|Overall Study||26
81894|NCT02152631|200722|P1|NOT COMPLETED|Overall Study||66
81895|NCT02152631|200721|P2|COMPLETED|Overall Study||157
81896|NCT02152631|200722|P1|COMPLETED|Overall Study||204
81897|NCT02152631|200721|P2|Progressive Disease|Overall Study||137
81898|NCT02152631|200722|P1|Progressive Disease|Overall Study||174
81899|NCT02152631|200721|P2|Death Due to Any Cause|Overall Study||20
81900|NCT02152631|200722|P1|Death Due to Any Cause|Overall Study||30
81901|NCT02152631|200721|P2|Off Treatment|Overall Study||172
81902|NCT02152631|200722|P1|Off Treatment|Overall Study||246
81903|NCT02152631|200721|P2|Received at Least One Dose of Study Drug|Overall Study||175
81904|NCT02152631|200722|P1|Received at Least One Dose of Study Drug|Overall Study||265
81905|NCT02152631|200721|P2|STARTED|Overall Study||183
81906|NCT02152631|200722|P1|STARTED|Overall Study||270
81907|NCT02152605|200741|P2|NOT COMPLETED|Overall Study||18
81908|NCT02152605|200742|P1|NOT COMPLETED|Overall Study||19
81909|NCT02152605|200741|P2|COMPLETED|Overall Study||230
81910|NCT02152605|200742|P1|COMPLETED|Overall Study||229
81911|NCT02152605|200741|P2|STARTED|Overall Study||248
81912|NCT02152605|200742|P1|STARTED|Overall Study||248
81913|NCT02152566|200752|P1|NOT COMPLETED|Overall Study||3
81914|NCT02152566|200752|P1|COMPLETED|Overall Study||3
81915|NCT02152566|200752|P1|STARTED|Overall Study||6
81916|NCT02152540|200758|P2|NOT COMPLETED|Overall Study||0
81917|NCT02152540|200759|P1|NOT COMPLETED|Overall Study||0
81918|NCT02152540|200758|P2|COMPLETED|Overall Study||16
81919|NCT02152540|200759|P1|COMPLETED|Overall Study||17
81920|NCT02152540|200758|P2|STARTED|Overall Study||16
81921|NCT02152540|200759|P1|STARTED|Overall Study||17
81922|NCT02152384|200765|P2|NOT COMPLETED|Period 2||0
81923|NCT02152384|200766|P1|NOT COMPLETED|Period 2||0
81924|NCT02152384|200765|P2|COMPLETED|Period 2||12
81925|NCT02152384|200766|P1|COMPLETED|Period 2||13
81926|NCT02152384|200765|P2|STARTED|Period 2||12
81927|NCT02152384|200766|P1|STARTED|Period 2||13
81928|NCT02152384|200765|P2|NOT COMPLETED|Period 1||2
81929|NCT02152384|200766|P1|NOT COMPLETED|Period 1||1
81930|NCT02152384|200765|P2|COMPLETED|Period 1||12
81931|NCT02152384|200766|P1|COMPLETED|Period 1||13
81932|NCT02152384|200765|P2|Received at Least 1 Dose of Study Drug|Period 1||14
81933|NCT02152384|200766|P1|Received at Least 1 Dose of Study Drug|Period 1||14
81934|NCT02152384|200765|P2|STARTED|Period 1||14
81935|NCT02152384|200766|P1|STARTED|Period 1||14
81936|NCT02152384|200765|P2|NOT COMPLETED|Run In (1-5 Week Transition)||0
81937|NCT02152384|200766|P1|NOT COMPLETED|Run In (1-5 Week Transition)||0
81938|NCT02152384|200765|P2|COMPLETED|Run In (1-5 Week Transition)||14
81939|NCT02152384|200766|P1|COMPLETED|Run In (1-5 Week Transition)||14
81940|NCT02152384|200765|P2|STARTED|Run In (1-5 Week Transition)||14
81941|NCT02152384|200766|P1|STARTED|Run In (1-5 Week Transition)||14
81942|NCT02152371|200786|P2|NOT COMPLETED|Overall Study||16
81943|NCT02152371|200787|P1|NOT COMPLETED|Overall Study||12
81944|NCT02152371|200786|P2|COMPLETED|Overall Study||134
81945|NCT02152371|200787|P1|COMPLETED|Overall Study||138
81946|NCT02152371|200786|P2|Received at Least 1 Dose of Study Drug.|Overall Study||150
81947|NCT02152371|200787|P1|Received at Least 1 Dose of Study Drug.|Overall Study||150
81948|NCT02152371|200786|P2|STARTED|Overall Study||150
81949|NCT02152371|200787|P1|STARTED|Overall Study||150
81950|NCT02152345|200825|P2|NOT COMPLETED|Overall Study||5
81951|NCT02152345|200826|P1|NOT COMPLETED|Overall Study||4
81952|NCT02152345|200825|P2|COMPLETED|Overall Study|The last subject randomized to Standard Immunosuppression was on 25-Dec-2016.|24
81953|NCT02152345|200826|P1|COMPLETED|Overall Study|The last subject randomized to Belatacept was on 29-Dec-2016.|24
81954|NCT02152345|200825|P2|STARTED|Overall Study|The first subject randomized to Standard Immunosuppression was on 14-Jun-2014.|29
81955|NCT02152345|200826|P1|STARTED|Overall Study|The first subject randomized to Belatacept was on 15-Sep-2014.|28
81956|NCT02152007|200838|P1|NOT COMPLETED|Overall Study||1
81957|NCT02152007|200838|P1|COMPLETED|Overall Study||14
81958|NCT02152007|200838|P1|STARTED|Overall Study||15
81959|NCT02151994|200847|P13|NOT COMPLETED|Food Effect (FE): Fed||0
81960|NCT02151994|200848|P12|NOT COMPLETED|Food Effect (FE): Fed||0
81961|NCT02151994|200849|P11|NOT COMPLETED|Food Effect (FE): Fed||0
81962|NCT02151994|200850|P10|NOT COMPLETED|Food Effect (FE): Fed||0
81963|NCT02151994|200851|P9|NOT COMPLETED|Food Effect (FE): Fed||0
81964|NCT02151994|200852|P8|NOT COMPLETED|Food Effect (FE): Fed||0
81965|NCT02151994|200853|P7|NOT COMPLETED|Food Effect (FE): Fed||0
81966|NCT02151994|200854|P6|NOT COMPLETED|Food Effect (FE): Fed||0
81967|NCT02151994|200855|P5|NOT COMPLETED|Food Effect (FE): Fed||0
81968|NCT02151994|200856|P4|NOT COMPLETED|Food Effect (FE): Fed||0
81969|NCT02151994|200857|P3|NOT COMPLETED|Food Effect (FE): Fed||0
81970|NCT02151994|200858|P2|NOT COMPLETED|Food Effect (FE): Fed||0
81971|NCT02151994|200859|P1|NOT COMPLETED|Food Effect (FE): Fed||0
81972|NCT02151994|200847|P13|COMPLETED|Food Effect (FE): Fed||12
81973|NCT02151994|200848|P12|COMPLETED|Food Effect (FE): Fed||0
81974|NCT02151994|200849|P11|COMPLETED|Food Effect (FE): Fed||0
81975|NCT02151994|200850|P10|COMPLETED|Food Effect (FE): Fed||0
81976|NCT02151994|200851|P9|COMPLETED|Food Effect (FE): Fed||0
81977|NCT02151994|200852|P8|COMPLETED|Food Effect (FE): Fed||0
81978|NCT02151994|200853|P7|COMPLETED|Food Effect (FE): Fed||0
81979|NCT02151994|200854|P6|COMPLETED|Food Effect (FE): Fed||0
81980|NCT02151994|200855|P5|COMPLETED|Food Effect (FE): Fed||0
81981|NCT02151994|200856|P4|COMPLETED|Food Effect (FE): Fed||0
81982|NCT02151994|200857|P3|COMPLETED|Food Effect (FE): Fed||0
81983|NCT02151994|200858|P2|COMPLETED|Food Effect (FE): Fed||0
81984|NCT02151994|200859|P1|COMPLETED|Food Effect (FE): Fed||0
81985|NCT02151994|200847|P13|STARTED|Food Effect (FE): Fed||12
81986|NCT02151994|200848|P12|STARTED|Food Effect (FE): Fed||0
81987|NCT02151994|200849|P11|STARTED|Food Effect (FE): Fed||0
81988|NCT02151994|200850|P10|STARTED|Food Effect (FE): Fed||0
81989|NCT02151994|200851|P9|STARTED|Food Effect (FE): Fed||0
81990|NCT02151994|200852|P8|STARTED|Food Effect (FE): Fed||0
81991|NCT02151994|200853|P7|STARTED|Food Effect (FE): Fed||0
81992|NCT02151994|200854|P6|STARTED|Food Effect (FE): Fed||0
81993|NCT02151994|200855|P5|STARTED|Food Effect (FE): Fed||0
81994|NCT02151994|200856|P4|STARTED|Food Effect (FE): Fed||0
81995|NCT02151994|200857|P3|STARTED|Food Effect (FE): Fed||0
81996|NCT02151994|200858|P2|STARTED|Food Effect (FE): Fed||0
81997|NCT02151994|200859|P1|STARTED|Food Effect (FE): Fed||0
81998|NCT02151994|200847|P13|NOT COMPLETED|Food Effect (FE): Fasted||0
81999|NCT02151994|200848|P12|NOT COMPLETED|Food Effect (FE): Fasted||0
82000|NCT02151994|200849|P11|NOT COMPLETED|Food Effect (FE): Fasted||0
82001|NCT02151994|200850|P10|NOT COMPLETED|Food Effect (FE): Fasted||0
82002|NCT02151994|200851|P9|NOT COMPLETED|Food Effect (FE): Fasted||0
82003|NCT02151994|200852|P8|NOT COMPLETED|Food Effect (FE): Fasted||0
82004|NCT02151994|200853|P7|NOT COMPLETED|Food Effect (FE): Fasted||0
82005|NCT02151994|200854|P6|NOT COMPLETED|Food Effect (FE): Fasted||0
82006|NCT02151994|200855|P5|NOT COMPLETED|Food Effect (FE): Fasted||0
82007|NCT02151994|200856|P4|NOT COMPLETED|Food Effect (FE): Fasted||0
82008|NCT02151994|200857|P3|NOT COMPLETED|Food Effect (FE): Fasted||0
82009|NCT02151994|200858|P2|NOT COMPLETED|Food Effect (FE): Fasted||0
82010|NCT02151994|200859|P1|NOT COMPLETED|Food Effect (FE): Fasted||0
82011|NCT02151994|200847|P13|COMPLETED|Food Effect (FE): Fasted||0
82012|NCT02151994|200848|P12|COMPLETED|Food Effect (FE): Fasted||12
82013|NCT02151994|200849|P11|COMPLETED|Food Effect (FE): Fasted||0
82014|NCT02151994|200850|P10|COMPLETED|Food Effect (FE): Fasted||0
82015|NCT02151994|200851|P9|COMPLETED|Food Effect (FE): Fasted||0
82016|NCT02151994|200852|P8|COMPLETED|Food Effect (FE): Fasted||0
82017|NCT02151994|200853|P7|COMPLETED|Food Effect (FE): Fasted||0
82018|NCT02151994|200854|P6|COMPLETED|Food Effect (FE): Fasted||0
82019|NCT02151994|200855|P5|COMPLETED|Food Effect (FE): Fasted||0
82020|NCT02151994|200856|P4|COMPLETED|Food Effect (FE): Fasted||0
82021|NCT02151994|200857|P3|COMPLETED|Food Effect (FE): Fasted||0
82022|NCT02151994|200858|P2|COMPLETED|Food Effect (FE): Fasted||0
82023|NCT02151994|200859|P1|COMPLETED|Food Effect (FE): Fasted||0
82024|NCT02151994|200847|P13|STARTED|Food Effect (FE): Fasted||0
82025|NCT02151994|200848|P12|STARTED|Food Effect (FE): Fasted||12
82026|NCT02151994|200849|P11|STARTED|Food Effect (FE): Fasted||0
82027|NCT02151994|200850|P10|STARTED|Food Effect (FE): Fasted||0
82028|NCT02151994|200851|P9|STARTED|Food Effect (FE): Fasted||0
82029|NCT02151994|200852|P8|STARTED|Food Effect (FE): Fasted||0
82030|NCT02151994|200853|P7|STARTED|Food Effect (FE): Fasted||0
82031|NCT02151994|200854|P6|STARTED|Food Effect (FE): Fasted||0
82032|NCT02151994|200855|P5|STARTED|Food Effect (FE): Fasted||0
82033|NCT02151994|200856|P4|STARTED|Food Effect (FE): Fasted||0
82034|NCT02151994|200857|P3|STARTED|Food Effect (FE): Fasted||0
82035|NCT02151994|200858|P2|STARTED|Food Effect (FE): Fasted||0
82036|NCT02151994|200859|P1|STARTED|Food Effect (FE): Fasted||0
82037|NCT02151994|200847|P13|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
82038|NCT02151994|200848|P12|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
82039|NCT02151994|200849|P11|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
82040|NCT02151994|200850|P10|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
82041|NCT02151994|200851|P9|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
82042|NCT02151994|200852|P8|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
82043|NCT02151994|200853|P7|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
82044|NCT02151994|200854|P6|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
82045|NCT02151994|200855|P5|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
82046|NCT02151994|200856|P4|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
82047|NCT02151994|200857|P3|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
82048|NCT02151994|200858|P2|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
82049|NCT02151994|200859|P1|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
82050|NCT02151994|200847|P13|COMPLETED|Multiple Ascending Dose (MAD)||0
82051|NCT02151994|200848|P12|COMPLETED|Multiple Ascending Dose (MAD)||0
82052|NCT02151994|200849|P11|COMPLETED|Multiple Ascending Dose (MAD)||0
82053|NCT02151994|200850|P10|COMPLETED|Multiple Ascending Dose (MAD)||0
82054|NCT02151994|200851|P9|COMPLETED|Multiple Ascending Dose (MAD)||6
82055|NCT02151994|200852|P8|COMPLETED|Multiple Ascending Dose (MAD)||0
82056|NCT02151994|200853|P7|COMPLETED|Multiple Ascending Dose (MAD)||6
82057|NCT02151994|200854|P6|COMPLETED|Multiple Ascending Dose (MAD)||6
82058|NCT02151994|200855|P5|COMPLETED|Multiple Ascending Dose (MAD)||6
82059|NCT02151994|200856|P4|COMPLETED|Multiple Ascending Dose (MAD)||6
82060|NCT02151994|200857|P3|COMPLETED|Multiple Ascending Dose (MAD)||0
82061|NCT02151994|200858|P2|COMPLETED|Multiple Ascending Dose (MAD)||0
82062|NCT02151994|200859|P1|COMPLETED|Multiple Ascending Dose (MAD)||10
82063|NCT02151994|200847|P13|STARTED|Multiple Ascending Dose (MAD)||0
82064|NCT02151994|200848|P12|STARTED|Multiple Ascending Dose (MAD)||0
82065|NCT02151994|200849|P11|STARTED|Multiple Ascending Dose (MAD)||0
82066|NCT02151994|200850|P10|STARTED|Multiple Ascending Dose (MAD)||0
82067|NCT02151994|200851|P9|STARTED|Multiple Ascending Dose (MAD)||6
82068|NCT02151994|200852|P8|STARTED|Multiple Ascending Dose (MAD)||0
82069|NCT02151994|200853|P7|STARTED|Multiple Ascending Dose (MAD)||6
82070|NCT02151994|200854|P6|STARTED|Multiple Ascending Dose (MAD)||6
82071|NCT02151994|200855|P5|STARTED|Multiple Ascending Dose (MAD)||6
82072|NCT02151994|200856|P4|STARTED|Multiple Ascending Dose (MAD)||6
82073|NCT02151994|200857|P3|STARTED|Multiple Ascending Dose (MAD)||0
82074|NCT02151994|200858|P2|STARTED|Multiple Ascending Dose (MAD)||0
82075|NCT02151994|200859|P1|STARTED|Multiple Ascending Dose (MAD)||10
82076|NCT02151994|200847|P13|NOT COMPLETED|Single Ascending Dose (SAD)||0
82077|NCT02151994|200848|P12|NOT COMPLETED|Single Ascending Dose (SAD)||0
82078|NCT02151994|200849|P11|NOT COMPLETED|Single Ascending Dose (SAD)||0
82079|NCT02151994|200850|P10|NOT COMPLETED|Single Ascending Dose (SAD)||0
82080|NCT02151994|200851|P9|NOT COMPLETED|Single Ascending Dose (SAD)||0
82081|NCT02151994|200852|P8|NOT COMPLETED|Single Ascending Dose (SAD)||0
82082|NCT02151994|200853|P7|NOT COMPLETED|Single Ascending Dose (SAD)||0
82083|NCT02151994|200854|P6|NOT COMPLETED|Single Ascending Dose (SAD)||0
82084|NCT02151994|200855|P5|NOT COMPLETED|Single Ascending Dose (SAD)||0
82085|NCT02151994|200856|P4|NOT COMPLETED|Single Ascending Dose (SAD)||0
82086|NCT02151994|200857|P3|NOT COMPLETED|Single Ascending Dose (SAD)||0
82087|NCT02151994|200858|P2|NOT COMPLETED|Single Ascending Dose (SAD)||0
82088|NCT02151994|200859|P1|NOT COMPLETED|Single Ascending Dose (SAD)||0
82089|NCT02151994|200847|P13|COMPLETED|Single Ascending Dose (SAD)||0
82090|NCT02151994|200848|P12|COMPLETED|Single Ascending Dose (SAD)||0
82091|NCT02151994|200849|P11|COMPLETED|Single Ascending Dose (SAD)||6
82092|NCT02151994|200850|P10|COMPLETED|Single Ascending Dose (SAD)||6
82093|NCT02151994|200851|P9|COMPLETED|Single Ascending Dose (SAD)||0
82094|NCT02151994|200852|P8|COMPLETED|Single Ascending Dose (SAD)||6
82095|NCT02151994|200853|P7|COMPLETED|Single Ascending Dose (SAD)||6
82096|NCT02151994|200854|P6|COMPLETED|Single Ascending Dose (SAD)||6
82097|NCT02151994|200855|P5|COMPLETED|Single Ascending Dose (SAD)||6
82098|NCT02151994|200856|P4|COMPLETED|Single Ascending Dose (SAD)||6
82099|NCT02151994|200857|P3|COMPLETED|Single Ascending Dose (SAD)||6
82100|NCT02151994|200858|P2|COMPLETED|Single Ascending Dose (SAD)||6
82101|NCT02151994|200859|P1|COMPLETED|Single Ascending Dose (SAD)||18
82102|NCT02151994|200847|P13|STARTED|Single Ascending Dose (SAD)||0
82103|NCT02151994|200848|P12|STARTED|Single Ascending Dose (SAD)||0
82104|NCT02151994|200849|P11|STARTED|Single Ascending Dose (SAD)||6
82105|NCT02151994|200850|P10|STARTED|Single Ascending Dose (SAD)||6
82106|NCT02151994|200851|P9|STARTED|Single Ascending Dose (SAD)||0
82107|NCT02151994|200852|P8|STARTED|Single Ascending Dose (SAD)||6
82108|NCT02151994|200853|P7|STARTED|Single Ascending Dose (SAD)||6
82109|NCT02151994|200854|P6|STARTED|Single Ascending Dose (SAD)||6
82110|NCT02151994|200855|P5|STARTED|Single Ascending Dose (SAD)||6
82111|NCT02151994|200856|P4|STARTED|Single Ascending Dose (SAD)||6
82112|NCT02151994|200857|P3|STARTED|Single Ascending Dose (SAD)||6
82113|NCT02151994|200858|P2|STARTED|Single Ascending Dose (SAD)||6
82114|NCT02151994|200859|P1|STARTED|Single Ascending Dose (SAD)||18
82115|NCT02151981|200899|P2|NOT COMPLETED|Overall Study||140
82116|NCT02151981|200900|P1|NOT COMPLETED|Overall Study||279
82117|NCT02151981|200899|P2|COMPLETED|Overall Study||0
82118|NCT02151981|200900|P1|COMPLETED|Overall Study||0
82119|NCT02151981|200899|P2|Crossed Over AZD9291|Overall Study|Patients randomised to chemotherapy were allowed to crossover to AZD9291 after progression|82
82120|NCT02151981|200900|P1|Crossed Over AZD9291|Overall Study||0
82121|NCT02151981|200899|P2|Did Not Receive Treatment|Overall Study||4
82122|NCT02151981|200900|P1|Did Not Receive Treatment|Overall Study||0
82123|NCT02151981|200899|P2|Received Randomised Treatment Only|Overall Study||54
82124|NCT02151981|200900|P1|Received Randomised Treatment Only|Overall Study||279
82125|NCT02151981|200899|P2|STARTED|Overall Study||140
82126|NCT02151981|200900|P1|STARTED|Overall Study||279
82127|NCT02151851|200918|P2|NOT COMPLETED|Overall Study||130
82128|NCT02151851|200919|P1|NOT COMPLETED|Overall Study||76
82129|NCT02151851|200918|P2|COMPLETED|Overall Study||186
82130|NCT02151851|200919|P1|COMPLETED|Overall Study||38
82131|NCT02151851|200918|P2|Included in the Safety Set|Overall Study||316
82132|NCT02151851|200919|P1|Included in the Safety Set|Overall Study||113
82133|NCT02151851|200918|P2|STARTED|Overall Study||316
82134|NCT02151851|200919|P1|STARTED|Overall Study||114
82135|NCT02151786|200931|P1|NOT COMPLETED|Overall Study||36
82136|NCT02151786|200931|P1|COMPLETED|Overall Study||1084
82137|NCT02151786|200931|P1|STARTED|Overall Study||1120
82138|NCT02151773|200942|P1|NOT COMPLETED|Overall Study||64
82139|NCT02151773|200942|P1|COMPLETED|Overall Study||3429
82140|NCT02151773|200942|P1|STARTED|Overall Study||3493
82141|NCT02151682|200949|P6|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||7
82142|NCT02151682|200950|P5|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
82143|NCT02151682|200951|P4|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
82144|NCT02151682|200952|P3|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
82145|NCT02151682|200953|P2|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
82146|NCT02151682|200954|P1|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
82147|NCT02151682|200949|P6|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||19
82148|NCT02151682|200950|P5|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
82149|NCT02151682|200951|P4|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
82150|NCT02151682|200952|P3|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
82151|NCT02151682|200953|P2|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
82152|NCT02151682|200954|P1|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
82153|NCT02151682|200949|P6|STARTED|Part 2: Observ. Aft. Tapent. Extension|19 tapentadol and 7 morphine completers (Part 1) who discontinued from tapentadol treatm. in Part 2.|26
82154|NCT02151682|200950|P5|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
82155|NCT02151682|200951|P4|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
82156|NCT02151682|200952|P3|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
82157|NCT02151682|200953|P2|STARTED|Part 2: Observ. Aft. Tapent. Extension|Group not defined for Part 2.|0
82158|NCT02151682|200954|P1|STARTED|Part 2: Observ. Aft. Tapent. Extension|Group not defined for Part 2.|0
82159|NCT02151682|200949|P6|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
82160|NCT02151682|200950|P5|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
82161|NCT02151682|200951|P4|NOT COMPLETED|Part 2: Tapent. Extension or Observation||4
82162|NCT02151682|200952|P3|NOT COMPLETED|Part 2: Tapent. Extension or Observation||28
82163|NCT02151682|200953|P2|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
82164|NCT02151682|200954|P1|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
82165|NCT02151682|200949|P6|COMPLETED|Part 2: Tapent. Extension or Observation||0
82166|NCT02151682|200950|P5|COMPLETED|Part 2: Tapent. Extension or Observation||14
82167|NCT02151682|200951|P4|COMPLETED|Part 2: Tapent. Extension or Observation||14
82168|NCT02151682|200952|P3|COMPLETED|Part 2: Tapent. Extension or Observation|12 Month of tapentadol treatment completed and final visit of Part 2 performed.|8
82169|NCT02151682|200953|P2|COMPLETED|Part 2: Tapent. Extension or Observation||0
82170|NCT02151682|200954|P1|COMPLETED|Part 2: Tapent. Extension or Observation||0
82171|NCT02151682|200949|P6|STARTED|Part 2: Tapent. Extension or Observation||0
82172|NCT02151682|200950|P5|STARTED|Part 2: Tapent. Extension or Observation|12 Completers and 2 non-completers from morphine treatment in Part 1.|14
82173|NCT02151682|200951|P4|STARTED|Part 2: Tapent. Extension or Observation|14 Completers and 4 of 5 non-completers on tapentadol in Part 1.|18
82174|NCT02151682|200952|P3|STARTED|Part 2: Tapent. Extension or Observation|26 Completers on tapentadol PR and 10 completers on morphine PR from Part 1.|36
82175|NCT02151682|200953|P2|STARTED|Part 2: Tapent. Extension or Observation|Group not defined for Part 2.|0
82176|NCT02151682|200954|P1|STARTED|Part 2: Tapent. Extension or Observation|Group not defined for Part 2.|0
82177|NCT02151682|200949|P6|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
82178|NCT02151682|200950|P5|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
82179|NCT02151682|200951|P4|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
82180|NCT02151682|200952|P3|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
82181|NCT02151682|200953|P2|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||5
82182|NCT02151682|200954|P1|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||2
82183|NCT02151682|200949|P6|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
82184|NCT02151682|200950|P5|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
82185|NCT02151682|200951|P4|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
82186|NCT02151682|200952|P3|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
82187|NCT02151682|200953|P2|COMPLETED|Part 1: 14 Days Morphine or Tapentadol|14-Day treatment and final post-treatment visit completed or tapentadol treatment in Part 2 entered.|40
82188|NCT02151682|200954|P1|COMPLETED|Part 1: 14 Days Morphine or Tapentadol|14-Day treatment and final post-treatment visit completed or tapentadol treatment in Part 2 entered.|22
82189|NCT02151682|200949|P6|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
82190|NCT02151682|200950|P5|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
82191|NCT02151682|200951|P4|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
82192|NCT02151682|200952|P3|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
82193|NCT02151682|200953|P2|STARTED|Part 1: 14 Days Morphine or Tapentadol||45
82194|NCT02151682|200954|P1|STARTED|Part 1: 14 Days Morphine or Tapentadol||24
82195|NCT02151643|201004|P5|NOT COMPLETED|Overall Study||3
82196|NCT02151643|201005|P4|NOT COMPLETED|Overall Study||7
82197|NCT02151643|201006|P3|NOT COMPLETED|Overall Study||4
82198|NCT02151643|201007|P2|NOT COMPLETED|Overall Study||4
82199|NCT02151643|201008|P1|NOT COMPLETED|Overall Study||6
82200|NCT02151643|201004|P5|COMPLETED|Overall Study||35
82201|NCT02151643|201005|P4|COMPLETED|Overall Study||32
82202|NCT02151643|201006|P3|COMPLETED|Overall Study||21
82203|NCT02151643|201007|P2|COMPLETED|Overall Study||21
82204|NCT02151643|201008|P1|COMPLETED|Overall Study||20
82205|NCT02151643|201004|P5|STARTED|Overall Study||38
82206|NCT02151643|201005|P4|STARTED|Overall Study||39
82207|NCT02151643|201006|P3|STARTED|Overall Study||25
82208|NCT02151643|201007|P2|STARTED|Overall Study||25
82209|NCT02151643|201008|P1|STARTED|Overall Study||26
82210|NCT02151487|201049|P4|NOT COMPLETED|Overall Study||3
82211|NCT02151487|201050|P3|NOT COMPLETED|Overall Study||4
82212|NCT02151487|201051|P2|NOT COMPLETED|Overall Study||5
82213|NCT02151487|201052|P1|NOT COMPLETED|Overall Study||2
82214|NCT02151487|201049|P4|COMPLETED|Overall Study||20
82215|NCT02151487|201050|P3|COMPLETED|Overall Study||16
82216|NCT02151487|201051|P2|COMPLETED|Overall Study||22
82217|NCT02151487|201052|P1|COMPLETED|Overall Study||25
82218|NCT02151487|201049|P4|STARTED|Overall Study||23
82219|NCT02151487|201050|P3|STARTED|Overall Study||20
82220|NCT02151487|201051|P2|STARTED|Overall Study||27
82221|NCT02151487|201052|P1|STARTED|Overall Study||27
82222|NCT02151461|201070|P4|NOT COMPLETED|Overall Study||4
82223|NCT02151461|201071|P3|NOT COMPLETED|Overall Study||3
82224|NCT02151461|201072|P2|NOT COMPLETED|Overall Study||1
82225|NCT02151461|201073|P1|NOT COMPLETED|Overall Study||6
82226|NCT02151461|201070|P4|COMPLETED|Overall Study||19
82227|NCT02151461|201071|P3|COMPLETED|Overall Study||21
82228|NCT02151461|201072|P2|COMPLETED|Overall Study||24
82229|NCT02151461|201073|P1|COMPLETED|Overall Study||18
82230|NCT02151461|201070|P4|STARTED|Overall Study||23
82231|NCT02151461|201071|P3|STARTED|Overall Study||24
82232|NCT02151461|201072|P2|STARTED|Overall Study||25
82233|NCT02151461|201073|P1|STARTED|Overall Study||24
82234|NCT02151383|201114|P3|NOT COMPLETED|Overall Study||0
82235|NCT02151383|201115|P2|NOT COMPLETED|Overall Study||0
82236|NCT02151383|201116|P1|NOT COMPLETED|Overall Study||0
82237|NCT02151383|201114|P3|COMPLETED|Overall Study||1
82238|NCT02151383|201115|P2|COMPLETED|Overall Study||3
82239|NCT02151383|201116|P1|COMPLETED|Overall Study||8
82240|NCT02151383|201114|P3|High-dose|Overall Study||0
82241|NCT02151383|201115|P2|High-dose|Overall Study||0
82242|NCT02151383|201116|P1|High-dose|Overall Study||6
82243|NCT02151383|201114|P3|Low-dose|Overall Study||1
82244|NCT02151383|201115|P2|Low-dose|Overall Study||3
82245|NCT02151383|201116|P1|Low-dose|Overall Study||2
82246|NCT02151383|201114|P3|STARTED|Overall Study||1
82247|NCT02151383|201115|P2|STARTED|Overall Study||3
82248|NCT02151383|201116|P1|STARTED|Overall Study||8
82249|NCT02151331|201174|P2|NOT COMPLETED|Overall Study||40
82250|NCT02151331|201175|P1|NOT COMPLETED|Overall Study||32
82251|NCT02151331|201174|P2|COMPLETED|Overall Study||52
82252|NCT02151331|201175|P1|COMPLETED|Overall Study||45
82253|NCT02151331|201174|P2|STARTED|Overall Study||92
82254|NCT02151331|201175|P1|STARTED|Overall Study||77
82255|NCT02151266|201190|P3|NOT COMPLETED|Overall Study||7
82256|NCT02151266|201191|P2|NOT COMPLETED|Overall Study||15
82257|NCT02151266|201192|P1|NOT COMPLETED|Overall Study||8
82258|NCT02151266|201190|P3|COMPLETED|Overall Study||14
82259|NCT02151266|201191|P2|COMPLETED|Overall Study||14
82260|NCT02151266|201192|P1|COMPLETED|Overall Study||11
82261|NCT02151266|201190|P3|STARTED|Overall Study||21
82262|NCT02151266|201191|P2|STARTED|Overall Study||29
82263|NCT02151266|201192|P1|STARTED|Overall Study||19
82264|NCT02151253|201218|P2|NOT COMPLETED|Overall Study||0
82265|NCT02151253|201219|P1|NOT COMPLETED|Overall Study||0
82266|NCT02151253|201218|P2|COMPLETED|Overall Study||15
82267|NCT02151253|201219|P1|COMPLETED|Overall Study||13
82268|NCT02151253|201218|P2|STARTED|Overall Study||15
82269|NCT02151253|201219|P1|STARTED|Overall Study||13
82270|NCT02151149|201235|P2|NOT COMPLETED|Follow-Up Period||37
82271|NCT02151149|201236|P1|NOT COMPLETED|Follow-Up Period||39
82272|NCT02151149|201235|P2|COMPLETED|Follow-Up Period|Completed = participants alive at final data cut-off date|18
82273|NCT02151149|201236|P1|COMPLETED|Follow-Up Period|Completed = participants alive at final data cut-off date|19
82274|NCT02151149|201235|P2|STARTED|Follow-Up Period||55
82275|NCT02151149|201236|P1|STARTED|Follow-Up Period||58
82276|NCT02151149|201235|P2|NOT COMPLETED|Treatment Period||71
82277|NCT02151149|201236|P1|NOT COMPLETED|Treatment Period||70
82278|NCT02151149|201235|P2|COMPLETED|Treatment Period||1
82279|NCT02151149|201236|P1|COMPLETED|Treatment Period||1
82280|NCT02151149|201235|P2|Treated Population|Treatment Period||70
82281|NCT02151149|201236|P1|Treated Population|Treatment Period||68
82282|NCT02151149|201235|P2|STARTED|Treatment Period|2 participants did not receive treatment|72
82283|NCT02151149|201236|P1|STARTED|Treatment Period|3 participants did not receive treatment|71
82284|NCT02151110|201268|P8|NOT COMPLETED|Overall Study||3
82285|NCT02151110|201269|P7|NOT COMPLETED|Overall Study||0
82286|NCT02151110|201270|P6|NOT COMPLETED|Overall Study||0
82287|NCT02151110|201271|P5|NOT COMPLETED|Overall Study||0
82288|NCT02151110|201272|P4|NOT COMPLETED|Overall Study||0
82289|NCT02151110|201273|P3|NOT COMPLETED|Overall Study||0
82290|NCT02151110|201274|P2|NOT COMPLETED|Overall Study||0
82291|NCT02151110|201275|P1|NOT COMPLETED|Overall Study||0
82292|NCT02151110|201268|P8|COMPLETED|Overall Study||5
82293|NCT02151110|201269|P7|COMPLETED|Overall Study||8
82294|NCT02151110|201270|P6|COMPLETED|Overall Study||8
82295|NCT02151110|201271|P5|COMPLETED|Overall Study||8
82296|NCT02151110|201272|P4|COMPLETED|Overall Study||8
82297|NCT02151110|201273|P3|COMPLETED|Overall Study||2
82298|NCT02151110|201274|P2|COMPLETED|Overall Study||2
82299|NCT02151110|201275|P1|COMPLETED|Overall Study||12
82300|NCT02151110|201268|P8|STARTED|Overall Study||8
82301|NCT02151110|201269|P7|STARTED|Overall Study||8
82302|NCT02151110|201270|P6|STARTED|Overall Study||8
82303|NCT02151110|201271|P5|STARTED|Overall Study||8
82304|NCT02151110|201272|P4|STARTED|Overall Study||8
82305|NCT02151110|201273|P3|STARTED|Overall Study||2
82306|NCT02151110|201274|P2|STARTED|Overall Study||2
82307|NCT02151110|201275|P1|STARTED|Overall Study||12
82308|NCT02151058|201368|P3|NOT COMPLETED|Overall Study||5
82309|NCT02151058|201369|P2|NOT COMPLETED|Overall Study||1
82310|NCT02151058|201370|P1|NOT COMPLETED|Overall Study||2
82311|NCT02151058|201368|P3|COMPLETED|Overall Study||86
82312|NCT02151058|201369|P2|COMPLETED|Overall Study||90
82313|NCT02151058|201370|P1|COMPLETED|Overall Study||43
82314|NCT02151058|201368|P3|STARTED|Overall Study||91
82315|NCT02151058|201369|P2|STARTED|Overall Study||91
82316|NCT02151058|201370|P1|STARTED|Overall Study||45
82317|NCT02150954|201404|P2|NOT COMPLETED|Overall Study||0
82318|NCT02150954|201405|P1|NOT COMPLETED|Overall Study||1
82319|NCT02150954|201404|P2|COMPLETED|Overall Study||59
82320|NCT02150954|201405|P1|COMPLETED|Overall Study||57
82321|NCT02150954|201404|P2|STARTED|Overall Study||59
82322|NCT02150954|201405|P1|STARTED|Overall Study||58
82323|NCT02150863|201430|P3|NOT COMPLETED|Overall Study||0
82324|NCT02150863|201431|P2|NOT COMPLETED|Overall Study||1
82325|NCT02150863|201432|P1|NOT COMPLETED|Overall Study||0
82326|NCT02150863|201430|P3|COMPLETED|Overall Study||0
82327|NCT02150863|201431|P2|COMPLETED|Overall Study||0
82328|NCT02150863|201432|P1|COMPLETED|Overall Study||0
82329|NCT02150863|201430|P3|STARTED|Overall Study||0
82330|NCT02150863|201431|P2|STARTED|Overall Study||1
82331|NCT02150863|201432|P1|STARTED|Overall Study||0
82332|NCT02150837|201442|P2|NOT COMPLETED|Overall Study||125
82333|NCT02150837|201443|P1|NOT COMPLETED|Overall Study||25
82334|NCT02150837|201442|P2|COMPLETED|Overall Study|There was no predefined study period to complete. 185 remained through the 12 wk primary endpoint.|185
82335|NCT02150837|201443|P1|COMPLETED|Overall Study|There was no predefined study period to complete. 37 remained through the 12 wk primary endpoint.|37
82336|NCT02150837|201442|P2|STARTED|Overall Study|478 charts were screened with 168 screen failures due to exclusion criteria.|310
82337|NCT02150837|201443|P1|STARTED|Overall Study|87 Charts were screened with 25 screen failures due to exclusion criteria.|62
82338|NCT02150759|201615|P2|NOT COMPLETED|Overall Study||2
82339|NCT02150759|201616|P1|NOT COMPLETED|Overall Study||1
82340|NCT02150759|201615|P2|COMPLETED|Overall Study||21
82341|NCT02150759|201616|P1|COMPLETED|Overall Study||22
82342|NCT02150759|201615|P2|STARTED|Overall Study||23
82343|NCT02150759|201616|P1|STARTED|Overall Study||23
82344|NCT02150499|201626|P2|NOT COMPLETED|Overall Study||0
82345|NCT02150499|201627|P1|NOT COMPLETED|Overall Study||0
82346|NCT02150499|201626|P2|COMPLETED|Overall Study||9
82347|NCT02150499|201627|P1|COMPLETED|Overall Study||9
82348|NCT02150499|201626|P2|STARTED|Overall Study||9
82349|NCT02150499|201627|P1|STARTED|Overall Study||9
82350|NCT02150460|201649|P2|NOT COMPLETED|Overall Study||0
82351|NCT02150460|201650|P1|NOT COMPLETED|Overall Study||0
82352|NCT02150460|201649|P2|COMPLETED|Overall Study||50
82353|NCT02150460|201650|P1|COMPLETED|Overall Study||50
82354|NCT02150460|201649|P2|STARTED|Overall Study||50
82355|NCT02150460|201650|P1|STARTED|Overall Study||50
82356|NCT02150343|201678|P4|NOT COMPLETED|Overall Study||10
82357|NCT02150343|201679|P3|NOT COMPLETED|Overall Study||12
82358|NCT02150343|201680|P2|NOT COMPLETED|Overall Study||20
82359|NCT02150343|201681|P1|NOT COMPLETED|Overall Study||21
82360|NCT02150343|201678|P4|COMPLETED|Overall Study||168
82361|NCT02150343|201679|P3|COMPLETED|Overall Study||166
82362|NCT02150343|201680|P2|COMPLETED|Overall Study||158
82363|NCT02150343|201681|P1|COMPLETED|Overall Study||159
82364|NCT02150343|201678|P4|STARTED|Overall Study||178
82365|NCT02150343|201679|P3|STARTED|Overall Study||178
82366|NCT02150343|201680|P2|STARTED|Overall Study||178
82367|NCT02150343|201681|P1|STARTED|Overall Study||180
82368|NCT02150213|201719|P1|NOT COMPLETED|Overall Study||2
82369|NCT02150213|201719|P1|COMPLETED|Overall Study||57
82370|NCT02150213|201719|P1|STARTED|Overall Study||59
82371|NCT02150109|201724|P1|NOT COMPLETED|Overall Study||0
82372|NCT02150109|201724|P1|COMPLETED|Overall Study||372
82373|NCT02150109|201724|P1|STARTED|Overall Study||372
82374|NCT02150057|201738|P2|NOT COMPLETED|Overall Study||4
82375|NCT02150057|201739|P1|NOT COMPLETED|Overall Study||6
82376|NCT02150057|201738|P2|COMPLETED|Overall Study||22
82377|NCT02150057|201739|P1|COMPLETED|Overall Study||19
82378|NCT02150057|201738|P2|STARTED|Overall Study||26
82379|NCT02150057|201739|P1|STARTED|Overall Study||25
82380|NCT02150044|201745|P1|NOT COMPLETED|Overall Study||0
82381|NCT02150044|201745|P1|COMPLETED|Overall Study||29
82382|NCT02150044|201745|P1|Study Cohort|Overall Study||13
82383|NCT02150044|201745|P1|Lead-In Subjects|Overall Study||16
82384|NCT02150044|201745|P1|STARTED|Overall Study||29
82385|NCT02149875|201754|P3|NOT COMPLETED|Overall Study||9
82386|NCT02149875|201755|P2|NOT COMPLETED|Overall Study||8
82387|NCT02149875|201756|P1|NOT COMPLETED|Overall Study||7
82388|NCT02149875|201754|P3|COMPLETED|Overall Study||20
82389|NCT02149875|201755|P2|COMPLETED|Overall Study||20
82390|NCT02149875|201756|P1|COMPLETED|Overall Study||20
82391|NCT02149875|201754|P3|STARTED|Overall Study||29
82392|NCT02149875|201755|P2|STARTED|Overall Study||28
82393|NCT02149875|201756|P1|STARTED|Overall Study||27
82394|NCT02149836|201767|P1|NOT COMPLETED|Overall Study||1
82395|NCT02149836|201767|P1|COMPLETED|Overall Study||17
82396|NCT02149836|201767|P1|STARTED|Overall Study||18
82397|NCT02149524|201776|P2|NOT COMPLETED|Overall Study||57
82398|NCT02149524|201777|P1|NOT COMPLETED|Overall Study||54
82399|NCT02149524|201776|P2|COMPLETED|Overall Study||380
82400|NCT02149524|201777|P1|COMPLETED|Overall Study||384
82401|NCT02149524|201776|P2|STARTED|Overall Study||437
82402|NCT02149524|201777|P1|STARTED|Overall Study||438
82403|NCT02149420|201794|P3|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||0
82404|NCT02149420|201795|P2|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||0
82405|NCT02149420|201796|P1|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||1
82406|NCT02149420|201794|P3|COMPLETED|Open Label VAY736 10 mg/kg Extension||0
82407|NCT02149420|201795|P2|COMPLETED|Open Label VAY736 10 mg/kg Extension||0
82408|NCT02149420|201796|P1|COMPLETED|Open Label VAY736 10 mg/kg Extension||4
82409|NCT02149420|201794|P3|STARTED|Open Label VAY736 10 mg/kg Extension|Only patients origianally randomized to Placebo were allowed to enter this Period.|0
82410|NCT02149420|201795|P2|STARTED|Open Label VAY736 10 mg/kg Extension|Only patients origianally randomized to Placebo were allowed to enter this Period.|0
82411|NCT02149420|201796|P1|STARTED|Open Label VAY736 10 mg/kg Extension|Patients received single dose of VAY736 10mg/kg at Week 24.|5
82412|NCT02149420|201794|P3|NOT COMPLETED|Core Study||2
82413|NCT02149420|201795|P2|NOT COMPLETED|Core Study||1
82414|NCT02149420|201796|P1|NOT COMPLETED|Core Study||0
82415|NCT02149420|201794|P3|COMPLETED|Core Study||10
82416|NCT02149420|201795|P2|COMPLETED|Core Study||5
82417|NCT02149420|201796|P1|COMPLETED|Core Study||9
82418|NCT02149420|201794|P3|PD (Pharmacodynamics) Analysis Set|Core Study||12
82419|NCT02149420|201795|P2|PD (Pharmacodynamics) Analysis Set|Core Study||6
82420|NCT02149420|201796|P1|PD (Pharmacodynamics) Analysis Set|Core Study||9
82421|NCT02149420|201794|P3|PK Analysis Set|Core Study||12
82422|NCT02149420|201795|P2|PK Analysis Set|Core Study||6
82423|NCT02149420|201796|P1|PK Analysis Set|Core Study|for patients entering open label VAY736 10 mg/kg at Week 24|5
82424|NCT02149420|201794|P3|Safety Analysis Set|Core Study||12
82425|NCT02149420|201795|P2|Safety Analysis Set|Core Study||6
82426|NCT02149420|201796|P1|Safety Analysis Set|Core Study||9
82427|NCT02149420|201794|P3|STARTED|Core Study||12
82428|NCT02149420|201795|P2|STARTED|Core Study||6
82429|NCT02149420|201796|P1|STARTED|Core Study||9
82430|NCT02149342|201846|P1|NOT COMPLETED|Overall Study||0
82431|NCT02149342|201846|P1|COMPLETED|Overall Study|14 patients|14
82432|NCT02149342|201846|P1|STARTED|Overall Study|14 patients|14
82433|NCT02149303|201858|P1|NOT COMPLETED|Overall Study||0
82434|NCT02149303|201858|P1|COMPLETED|Overall Study||191
82435|NCT02149303|201858|P1|STARTED|Overall Study||191
82436|NCT02149264|201864|P1|NOT COMPLETED|Overall Study||20
82437|NCT02149264|201864|P1|COMPLETED|Overall Study||139
82438|NCT02149264|201864|P1|STARTED|Overall Study|Of the 160 enrolled subjects, one discontinued before receiving treatment.|159
82439|NCT02149199|201880|P3|NOT COMPLETED|Overall Study||147
82440|NCT02149199|201881|P2|NOT COMPLETED|Overall Study||193
82441|NCT02149199|201882|P1|NOT COMPLETED|Overall Study||133
82442|NCT02149199|201880|P3|COMPLETED|Overall Study||1135
82443|NCT02149199|201881|P2|COMPLETED|Overall Study||1084
82444|NCT02149199|201882|P1|COMPLETED|Overall Study||1144
82445|NCT02149199|201880|P3|STARTED|Overall Study||1282
82446|NCT02149199|201881|P2|STARTED|Overall Study||1277
82447|NCT02149199|201882|P1|STARTED|Overall Study||1277
82448|NCT02149108|201949|P2|NOT COMPLETED|Overall Study||383
82449|NCT02149108|201950|P1|NOT COMPLETED|Overall Study||380
82450|NCT02149108|201949|P2|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|3
82451|NCT02149108|201950|P1|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|2
82452|NCT02149108|201949|P2|STARTED|Overall Study|Randomised patients.|386
82453|NCT02149108|201950|P1|STARTED|Overall Study|Randomised patients.|382
82454|NCT02148952|201964|P2|NOT COMPLETED|Follow-Up||279
82455|NCT02148952|201965|P1|NOT COMPLETED|Follow-Up||265
82456|NCT02148952|201964|P2|COMPLETED|Follow-Up||77347
82457|NCT02148952|201965|P1|COMPLETED|Follow-Up||79798
82458|NCT02148952|201964|P2|STARTED|Follow-Up||77626
82459|NCT02148952|201965|P1|STARTED|Follow-Up||80063
82460|NCT02148952|201964|P2|NOT COMPLETED|Assessing Eligibility and Consent||3147
82461|NCT02148952|201965|P1|NOT COMPLETED|Assessing Eligibility and Consent||3103
82462|NCT02148952|201964|P2|COMPLETED|Assessing Eligibility and Consent||77626
82463|NCT02148952|201965|P1|COMPLETED|Assessing Eligibility and Consent||80063
82464|NCT02148952|201964|P2|STARTED|Assessing Eligibility and Consent||80773
82465|NCT02148952|201965|P1|STARTED|Assessing Eligibility and Consent||83166
82466|NCT02148874|202023|P2|NOT COMPLETED|Overall Study||2
82467|NCT02148874|202024|P1|NOT COMPLETED|Overall Study||7
82468|NCT02148874|202023|P2|COMPLETED|Overall Study||84
82469|NCT02148874|202024|P1|COMPLETED|Overall Study||194
82470|NCT02148874|202023|P2|STARTED|Overall Study||86
82471|NCT02148874|202024|P1|STARTED|Overall Study||201
82472|NCT02148835|202036|P2|NOT COMPLETED|Overall Study||0
82473|NCT02148835|202037|P1|NOT COMPLETED|Overall Study||0
82474|NCT02148835|202036|P2|COMPLETED|Overall Study||22
82475|NCT02148835|202037|P1|COMPLETED|Overall Study||22
82476|NCT02148835|202036|P2|STARTED|Overall Study||22
82477|NCT02148835|202037|P1|STARTED|Overall Study||22
82478|NCT02148809|202043|P1|NOT COMPLETED|Overall Study||0
82479|NCT02148809|202043|P1|COMPLETED|Overall Study||14
82480|NCT02148809|202043|P1|STARTED|Overall Study||14
82481|NCT02148718|202048|P1|NOT COMPLETED|Overall Study||31
82482|NCT02148718|202048|P1|COMPLETED|Overall Study||55
82483|NCT02148718|202048|P1|STARTED|Overall Study||86
82484|NCT02148588|202069|P1|NOT COMPLETED|Overall Study||0
82485|NCT02148588|202069|P1|COMPLETED|Overall Study||8
82486|NCT02148588|202069|P1|STARTED|Overall Study||8
82487|NCT02148523|202081|P3|NOT COMPLETED|Overall Study||0
82488|NCT02148523|202082|P2|NOT COMPLETED|Overall Study||0
82489|NCT02148523|202083|P1|NOT COMPLETED|Overall Study||0
82490|NCT02148523|202081|P3|COMPLETED|Overall Study||67
82491|NCT02148523|202082|P2|COMPLETED|Overall Study||67
82492|NCT02148523|202083|P1|COMPLETED|Overall Study||67
82493|NCT02148523|202081|P3|STARTED|Overall Study||67
82494|NCT02148523|202082|P2|STARTED|Overall Study||67
82495|NCT02148523|202083|P1|STARTED|Overall Study||67
82496|NCT02148445|202096|P2|NOT COMPLETED|Overall Study||3
82497|NCT02148445|202097|P1|NOT COMPLETED|Overall Study||1
82498|NCT02148445|202096|P2|COMPLETED|Overall Study||197
82499|NCT02148445|202097|P1|COMPLETED|Overall Study||197
82500|NCT02148445|202096|P2|STARTED|Overall Study||200
82501|NCT02148445|202097|P1|STARTED|Overall Study||198
82502|NCT02148133|202133|P1|NOT COMPLETED|Overall Study||5
82503|NCT02148133|202133|P1|COMPLETED|Overall Study||16
82504|NCT02148133|202133|P1|Pharmacokinetic Analysis Set (PAS)|Overall Study||21
82505|NCT02148133|202133|P1|Safety Set (SS)|Overall Study||21
82506|NCT02148133|202133|P1|STARTED|Overall Study||21
82507|NCT02148107|202155|P3|NOT COMPLETED|Overall Study||0
82508|NCT02148107|202156|P2|NOT COMPLETED|Overall Study||0
82509|NCT02148107|202157|P1|NOT COMPLETED|Overall Study||0
82510|NCT02148107|202155|P3|COMPLETED|Overall Study||3
82511|NCT02148107|202156|P2|COMPLETED|Overall Study||7
82512|NCT02148107|202157|P1|COMPLETED|Overall Study||8
82513|NCT02148107|202155|P3|STARTED|Overall Study||3
82514|NCT02148107|202156|P2|STARTED|Overall Study||7
82515|NCT02148107|202157|P1|STARTED|Overall Study||8
82516|NCT02147899|202176|P3|NOT COMPLETED|Overall Study||0
82517|NCT02147899|202177|P2|NOT COMPLETED|Overall Study||0
82518|NCT02147899|202178|P1|NOT COMPLETED|Overall Study||0
82519|NCT02147899|202176|P3|COMPLETED|Overall Study||72
82520|NCT02147899|202177|P2|COMPLETED|Overall Study||72
82521|NCT02147899|202178|P1|COMPLETED|Overall Study||71
82522|NCT02147899|202176|P3|STARTED|Overall Study||72
82523|NCT02147899|202177|P2|STARTED|Overall Study||72
82524|NCT02147899|202178|P1|STARTED|Overall Study||71
82525|NCT02147834|202191|P2|NOT COMPLETED|Overall Study||0
82526|NCT02147834|202192|P1|NOT COMPLETED|Overall Study||0
82527|NCT02147834|202191|P2|COMPLETED|Overall Study||2
82528|NCT02147834|202192|P1|COMPLETED|Overall Study||3
82529|NCT02147834|202191|P2|STARTED|Overall Study||2
82530|NCT02147834|202192|P1|STARTED|Overall Study||3
82531|NCT02147691|202204|P2|NOT COMPLETED|Overall Study||1
82532|NCT02147691|202205|P1|NOT COMPLETED|Overall Study||4
82533|NCT02147691|202204|P2|COMPLETED|Overall Study||11
82534|NCT02147691|202205|P1|COMPLETED|Overall Study||6
82535|NCT02147691|202204|P2|STARTED|Overall Study||12
82536|NCT02147691|202205|P1|STARTED|Overall Study||10
82537|NCT02147613|202251|P2|NOT COMPLETED|Overall Study||3
82538|NCT02147613|202252|P1|NOT COMPLETED|Overall Study||1
82539|NCT02147613|202251|P2|COMPLETED|Overall Study||6
82540|NCT02147613|202252|P1|COMPLETED|Overall Study||9
82541|NCT02147613|202251|P2|STARTED|Overall Study||9
82542|NCT02147613|202252|P1|STARTED|Overall Study||10
82543|NCT02147587|202264|P2|NOT COMPLETED|Overall Study||5
82544|NCT02147587|202265|P1|NOT COMPLETED|Overall Study||11
82545|NCT02147587|202264|P2|COMPLETED|Overall Study||50
82546|NCT02147587|202265|P1|COMPLETED|Overall Study||46
82547|NCT02147587|202264|P2|STARTED|Overall Study||55
82548|NCT02147587|202265|P1|STARTED|Overall Study||57
82549|NCT02147561|202285|P1|NOT COMPLETED|Overall Study||4
82550|NCT02147561|202285|P1|COMPLETED|Overall Study||276
82551|NCT02147561|202285|P1|STARTED|Overall Study||280
82552|NCT02147522|202293|P2|NOT COMPLETED|Overall Study||48
82553|NCT02147522|202294|P1|NOT COMPLETED|Overall Study||56
82554|NCT02147522|202293|P2|COMPLETED|Overall Study||122
82555|NCT02147522|202294|P1|COMPLETED|Overall Study||122
82556|NCT02147522|202293|P2|STARTED|Overall Study||170
82557|NCT02147522|202294|P1|STARTED|Overall Study||178
82558|NCT02147353|202306|P2|NOT COMPLETED|Overall Study||0
82559|NCT02147353|202307|P1|NOT COMPLETED|Overall Study||9
82560|NCT02147353|202306|P2|COMPLETED|Overall Study||21
82561|NCT02147353|202307|P1|COMPLETED|Overall Study||12
82562|NCT02147353|202306|P2|STARTED|Overall Study||21
82563|NCT02147353|202307|P1|STARTED|Overall Study||21
82564|NCT02147301|202325|P1|NOT COMPLETED|Overall Study||0
82565|NCT02147301|202325|P1|COMPLETED|Overall Study||17
82566|NCT02147301|202325|P1|STARTED|Overall Study||17
82567|NCT02147288|202340|P10|NOT COMPLETED|Overall Study||0
82568|NCT02147288|202341|P9|NOT COMPLETED|Overall Study||0
82569|NCT02147288|202342|P8|NOT COMPLETED|Overall Study||0
82570|NCT02147288|202343|P7|NOT COMPLETED|Overall Study||0
82571|NCT02147288|202344|P6|NOT COMPLETED|Overall Study||0
82572|NCT02147288|202345|P5|NOT COMPLETED|Overall Study||0
82573|NCT02147288|202346|P4|NOT COMPLETED|Overall Study||0
82574|NCT02147288|202347|P3|NOT COMPLETED|Overall Study||0
82575|NCT02147288|202348|P2|NOT COMPLETED|Overall Study||2
82576|NCT02147288|202349|P1|NOT COMPLETED|Overall Study||1
82577|NCT02147288|202340|P10|COMPLETED|Overall Study||0
82578|NCT02147288|202341|P9|COMPLETED|Overall Study||0
82579|NCT02147288|202342|P8|COMPLETED|Overall Study||0
82580|NCT02147288|202343|P7|COMPLETED|Overall Study||0
82581|NCT02147288|202344|P6|COMPLETED|Overall Study||0
82582|NCT02147288|202345|P5|COMPLETED|Overall Study||0
82583|NCT02147288|202346|P4|COMPLETED|Overall Study||0
82584|NCT02147288|202347|P3|COMPLETED|Overall Study||0
82585|NCT02147288|202348|P2|COMPLETED|Overall Study||22
82586|NCT02147288|202349|P1|COMPLETED|Overall Study||21
82587|NCT02147288|202340|P10|STARTED|Overall Study||0
82588|NCT02147288|202341|P9|STARTED|Overall Study||0
82589|NCT02147288|202342|P8|STARTED|Overall Study||0
82590|NCT02147288|202343|P7|STARTED|Overall Study||0
82591|NCT02147288|202344|P6|STARTED|Overall Study||0
82592|NCT02147288|202345|P5|STARTED|Overall Study||0
82593|NCT02147288|202346|P4|STARTED|Overall Study||0
82594|NCT02147288|202347|P3|STARTED|Overall Study||0
82595|NCT02147288|202348|P2|STARTED|Overall Study||24
82596|NCT02147288|202349|P1|STARTED|Overall Study||22
82597|NCT02147197|202358|P3|NOT COMPLETED|Overall Study||9
82598|NCT02147197|202359|P2|NOT COMPLETED|Overall Study||6
82599|NCT02147197|202360|P1|NOT COMPLETED|Overall Study||9
82600|NCT02147197|202358|P3|COMPLETED|Overall Study||39
82601|NCT02147197|202359|P2|COMPLETED|Overall Study||47
82602|NCT02147197|202360|P1|COMPLETED|Overall Study||47
82603|NCT02147197|202358|P3|STARTED|Overall Study||48
82604|NCT02147197|202359|P2|STARTED|Overall Study||53
82605|NCT02147197|202360|P1|STARTED|Overall Study||56
82606|NCT02147184|202379|P2|NOT COMPLETED|Overall Study||27
82607|NCT02147184|202380|P1|NOT COMPLETED|Overall Study||49
82608|NCT02147184|202379|P2|COMPLETED|Overall Study||110
82609|NCT02147184|202380|P1|COMPLETED|Overall Study||78
82610|NCT02147184|202379|P2|STARTED|Overall Study||137
82611|NCT02147184|202380|P1|STARTED|Overall Study||127
82612|NCT02147158|202404|P6|NOT COMPLETED|Off-Treatment Interval 2||4
82613|NCT02147158|202405|P5|NOT COMPLETED|Off-Treatment Interval 2||2
82614|NCT02147158|202406|P4|NOT COMPLETED|Off-Treatment Interval 2||11
82615|NCT02147158|202407|P3|NOT COMPLETED|Off-Treatment Interval 2||10
82616|NCT02147158|202408|P2|NOT COMPLETED|Off-Treatment Interval 2||4
82617|NCT02147158|202409|P1|NOT COMPLETED|Off-Treatment Interval 2||4
82618|NCT02147158|202404|P6|COMPLETED|Off-Treatment Interval 2||39
82619|NCT02147158|202405|P5|COMPLETED|Off-Treatment Interval 2||39
82620|NCT02147158|202406|P4|COMPLETED|Off-Treatment Interval 2||66
82621|NCT02147158|202407|P3|COMPLETED|Off-Treatment Interval 2||69
82622|NCT02147158|202408|P2|COMPLETED|Off-Treatment Interval 2||25
82623|NCT02147158|202409|P1|COMPLETED|Off-Treatment Interval 2||36
82624|NCT02147158|202404|P6|STARTED|Off-Treatment Interval 2||43
82625|NCT02147158|202405|P5|STARTED|Off-Treatment Interval 2||41
82626|NCT02147158|202406|P4|STARTED|Off-Treatment Interval 2||77
82627|NCT02147158|202407|P3|STARTED|Off-Treatment Interval 2||79
82628|NCT02147158|202408|P2|STARTED|Off-Treatment Interval 2||29
82629|NCT02147158|202409|P1|STARTED|Off-Treatment Interval 2||40
82630|NCT02147158|202404|P6|NOT COMPLETED|Treatment Course 2||2
82631|NCT02147158|202405|P5|NOT COMPLETED|Treatment Course 2||0
82632|NCT02147158|202406|P4|NOT COMPLETED|Treatment Course 2||5
82633|NCT02147158|202407|P3|NOT COMPLETED|Treatment Course 2||5
82634|NCT02147158|202408|P2|NOT COMPLETED|Treatment Course 2||5
82635|NCT02147158|202409|P1|NOT COMPLETED|Treatment Course 2||1
82636|NCT02147158|202404|P6|COMPLETED|Treatment Course 2||43
82637|NCT02147158|202405|P5|COMPLETED|Treatment Course 2||41
82638|NCT02147158|202406|P4|COMPLETED|Treatment Course 2||77
82639|NCT02147158|202407|P3|COMPLETED|Treatment Course 2||79
82640|NCT02147158|202408|P2|COMPLETED|Treatment Course 2||29
82641|NCT02147158|202409|P1|COMPLETED|Treatment Course 2||40
82642|NCT02147158|202404|P6|STARTED|Treatment Course 2||45
82643|NCT02147158|202405|P5|STARTED|Treatment Course 2||41
82644|NCT02147158|202406|P4|STARTED|Treatment Course 2||82
82645|NCT02147158|202407|P3|STARTED|Treatment Course 2||84
82646|NCT02147158|202408|P2|STARTED|Treatment Course 2||34
82647|NCT02147158|202409|P1|STARTED|Treatment Course 2||41
82648|NCT02147158|202404|P6|NOT COMPLETED|Off-Treatment Interval 1||5
82649|NCT02147158|202405|P5|NOT COMPLETED|Off-Treatment Interval 1||8
82650|NCT02147158|202406|P4|NOT COMPLETED|Off-Treatment Interval 1||15
82651|NCT02147158|202407|P3|NOT COMPLETED|Off-Treatment Interval 1||15
82652|NCT02147158|202408|P2|NOT COMPLETED|Off-Treatment Interval 1||4
82653|NCT02147158|202409|P1|NOT COMPLETED|Off-Treatment Interval 1||10
82654|NCT02147158|202404|P6|COMPLETED|Off-Treatment Interval 1||45
82655|NCT02147158|202405|P5|COMPLETED|Off-Treatment Interval 1||41
82656|NCT02147158|202406|P4|COMPLETED|Off-Treatment Interval 1||82
82657|NCT02147158|202407|P3|COMPLETED|Off-Treatment Interval 1||84
82658|NCT02147158|202408|P2|COMPLETED|Off-Treatment Interval 1||34
82659|NCT02147158|202409|P1|COMPLETED|Off-Treatment Interval 1||41
82660|NCT02147158|202404|P6|STARTED|Off-Treatment Interval 1||50
82661|NCT02147158|202405|P5|STARTED|Off-Treatment Interval 1||49
82662|NCT02147158|202406|P4|STARTED|Off-Treatment Interval 1||97
82663|NCT02147158|202407|P3|STARTED|Off-Treatment Interval 1||99
82664|NCT02147158|202408|P2|STARTED|Off-Treatment Interval 1||38
82665|NCT02147158|202409|P1|STARTED|Off-Treatment Interval 1||51
82666|NCT02147158|202404|P6|NOT COMPLETED|Treatment Course 1||8
82667|NCT02147158|202405|P5|NOT COMPLETED|Treatment Course 1||6
82668|NCT02147158|202406|P4|NOT COMPLETED|Treatment Course 1||13
82669|NCT02147158|202407|P3|NOT COMPLETED|Treatment Course 1||8
82670|NCT02147158|202408|P2|NOT COMPLETED|Treatment Course 1||9
82671|NCT02147158|202409|P1|NOT COMPLETED|Treatment Course 1||4
82672|NCT02147158|202404|P6|COMPLETED|Treatment Course 1||50
82673|NCT02147158|202405|P5|COMPLETED|Treatment Course 1||49
82674|NCT02147158|202406|P4|COMPLETED|Treatment Course 1||97
82675|NCT02147158|202407|P3|COMPLETED|Treatment Course 1||99
82676|NCT02147158|202408|P2|COMPLETED|Treatment Course 1||38
82677|NCT02147158|202409|P1|COMPLETED|Treatment Course 1||51
82678|NCT02147158|202404|P6|STARTED|Treatment Course 1||58
82679|NCT02147158|202405|P5|STARTED|Treatment Course 1||55
82680|NCT02147158|202406|P4|STARTED|Treatment Course 1||110
82681|NCT02147158|202407|P3|STARTED|Treatment Course 1||107
82682|NCT02147158|202408|P2|STARTED|Treatment Course 1||47
82683|NCT02147158|202409|P1|STARTED|Treatment Course 1||55
82684|NCT02147132|202438|P4|NOT COMPLETED|Overall Study||0
82685|NCT02147132|202439|P3|NOT COMPLETED|Overall Study||0
82686|NCT02147132|202440|P2|NOT COMPLETED|Overall Study||0
82687|NCT02147132|202441|P1|NOT COMPLETED|Overall Study||1
82688|NCT02147132|202438|P4|COMPLETED|Overall Study||2
82689|NCT02147132|202439|P3|COMPLETED|Overall Study||1
82690|NCT02147132|202440|P2|COMPLETED|Overall Study||2
82691|NCT02147132|202441|P1|COMPLETED|Overall Study||1
82692|NCT02147132|202438|P4|STARTED|Overall Study||2
82693|NCT02147132|202439|P3|STARTED|Overall Study||1
82694|NCT02147132|202440|P2|STARTED|Overall Study||2
82695|NCT02147132|202441|P1|STARTED|Overall Study||2
82696|NCT02147093|202461|P2|NOT COMPLETED|Period 2||0
82697|NCT02147093|202462|P1|NOT COMPLETED|Period 2||2
82698|NCT02147093|202461|P2|COMPLETED|Period 2||19
82699|NCT02147093|202462|P1|COMPLETED|Period 2||18
82700|NCT02147093|202461|P2|STARTED|Period 2||19
82701|NCT02147093|202462|P1|STARTED|Period 2||20
82702|NCT02147093|202461|P2|NOT COMPLETED|Period 1||1
82703|NCT02147093|202462|P1|NOT COMPLETED|Period 1||0
82704|NCT02147093|202461|P2|COMPLETED|Period 1||19
82705|NCT02147093|202462|P1|COMPLETED|Period 1||20
82706|NCT02147093|202461|P2|STARTED|Period 1||20
82707|NCT02147093|202462|P1|STARTED|Period 1||20
82708|NCT02147067|202472|P2|NOT COMPLETED|Overall Study||2
82709|NCT02147067|202473|P1|NOT COMPLETED|Overall Study||2
82710|NCT02147067|202472|P2|COMPLETED|Overall Study||11
82711|NCT02147067|202473|P1|COMPLETED|Overall Study||11
82712|NCT02147067|202472|P2|STARTED|Overall Study||13
82713|NCT02147067|202473|P1|STARTED|Overall Study||13
82714|NCT02146599|202499|P1|NOT COMPLETED|Overall Study||5
82715|NCT02146599|202499|P1|COMPLETED|Overall Study||296
82716|NCT02146599|202499|P1|STARTED|Overall Study||301
82717|NCT02146482|202505|P2|NOT COMPLETED|Overall Study||0
82718|NCT02146482|202506|P1|NOT COMPLETED|Overall Study||0
82719|NCT02146482|202505|P2|COMPLETED|Overall Study||25
82720|NCT02146482|202506|P1|COMPLETED|Overall Study||21
82721|NCT02146482|202505|P2|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|25
82722|NCT02146482|202506|P1|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|21
82723|NCT02146352|202512|P1|NOT COMPLETED|Overall Study||2
82724|NCT02146352|202512|P1|COMPLETED|Overall Study||28
82725|NCT02146352|202512|P1|7 Days Post-stent Removal|Overall Study||28
82726|NCT02146352|202512|P1|30 or 60 Days Post-procedure|Overall Study||30
82727|NCT02146352|202512|P1|STARTED|Overall Study||30
82728|NCT02146326|202530|P4|NOT COMPLETED|Overall Study||48
82729|NCT02146326|202531|P3|NOT COMPLETED|Overall Study||43
82730|NCT02146326|202532|P2|NOT COMPLETED|Overall Study||37
82731|NCT02146326|202533|P1|NOT COMPLETED|Overall Study||28
82732|NCT02146326|202530|P4|COMPLETED|Overall Study||210
82733|NCT02146326|202531|P3|COMPLETED|Overall Study||168
82734|NCT02146326|202532|P2|COMPLETED|Overall Study||66
82735|NCT02146326|202533|P1|COMPLETED|Overall Study||61
82736|NCT02146326|202530|P4|12 Months|Overall Study||210
82737|NCT02146326|202531|P3|12 Months|Overall Study||168
82738|NCT02146326|202532|P2|12 Months|Overall Study||66
82739|NCT02146326|202533|P1|12 Months|Overall Study||61
82740|NCT02146326|202530|P4|6 Months|Overall Study||235
82741|NCT02146326|202531|P3|6 Months|Overall Study||186
82742|NCT02146326|202532|P2|6 Months|Overall Study||71
82743|NCT02146326|202533|P1|6 Months|Overall Study||71
82744|NCT02146326|202530|P4|3 Months|Overall Study||0
82745|NCT02146326|202531|P3|3 Months|Overall Study||0
82746|NCT02146326|202532|P2|3 Months|Overall Study||83
82747|NCT02146326|202533|P1|3 Months|Overall Study||71
82748|NCT02146326|202530|P4|Baseline|Overall Study||258
82749|NCT02146326|202531|P3|Baseline|Overall Study||211
82750|NCT02146326|202532|P2|Baseline|Overall Study||103
82751|NCT02146326|202533|P1|Baseline|Overall Study||89
82752|NCT02146326|202530|P4|STARTED|Overall Study||258
82753|NCT02146326|202531|P3|STARTED|Overall Study||211
82754|NCT02146326|202532|P2|STARTED|Overall Study||103
82755|NCT02146326|202533|P1|STARTED|Overall Study||89
82756|NCT02146274|202695|P1|NOT COMPLETED|Overall Study||73
82757|NCT02146274|202695|P1|COMPLETED|Overall Study||1804
82758|NCT02146274|202695|P1|STARTED|Overall Study||1877
82759|NCT02146248|202702|P1|NOT COMPLETED|Overall Study||2
82760|NCT02146248|202702|P1|COMPLETED|Overall Study||9
82761|NCT02146248|202702|P1|HSG 5|Overall Study||1
82762|NCT02146248|202702|P1|HSG 4|Overall Study||7
82763|NCT02146248|202702|P1|HSG 3|Overall Study||9
82764|NCT02146248|202702|P1|HSG 2|Overall Study||10
82765|NCT02146248|202702|P1|HSG 1|Overall Study||10
82766|NCT02146248|202702|P1|Uterine Sounding|Overall Study|one subject dropped out after uterine sound before HSG #1|11
82767|NCT02146248|202702|P1|Enrolled|Overall Study||11
82768|NCT02146248|202702|P1|STARTED|Overall Study||11
82769|NCT02146131|202712|P2|NOT COMPLETED|Overall Study||56
82770|NCT02146131|202713|P1|NOT COMPLETED|Overall Study||61
82771|NCT02146131|202712|P2|COMPLETED|Overall Study||113
82772|NCT02146131|202713|P1|COMPLETED|Overall Study||109
82773|NCT02146131|202712|P2|STARTED|Overall Study||169
82774|NCT02146131|202713|P1|STARTED|Overall Study||170
82775|NCT02146105|202719|P1|NOT COMPLETED|Overall Study||6
82776|NCT02146105|202719|P1|COMPLETED|Overall Study||39
82777|NCT02146105|202719|P1|STARTED|Overall Study||45
82778|NCT02146001|202725|P2|NOT COMPLETED|Overall Study||0
82779|NCT02146001|202726|P1|NOT COMPLETED|Overall Study||0
82780|NCT02146001|202725|P2|COMPLETED|Overall Study||19
82781|NCT02146001|202726|P1|COMPLETED|Overall Study||19
82782|NCT02146001|202725|P2|STARTED|Overall Study||19
82783|NCT02146001|202726|P1|STARTED|Overall Study||19
82784|NCT02145754|202736|P1|NOT COMPLETED|Overall Study||0
82785|NCT02145754|202736|P1|COMPLETED|Overall Study||235
82786|NCT02145754|202736|P1|STARTED|Overall Study||235
82787|NCT02145676|202743|P3|NOT COMPLETED|Overall Study||0
82788|NCT02145676|202744|P2|NOT COMPLETED|Overall Study||0
82789|NCT02145676|202745|P1|NOT COMPLETED|Overall Study||0
82790|NCT02145676|202743|P3|COMPLETED|Overall Study||18
82791|NCT02145676|202744|P2|COMPLETED|Overall Study||18
82792|NCT02145676|202745|P1|COMPLETED|Overall Study||17
82793|NCT02145676|202743|P3|STARTED|Overall Study||18
82794|NCT02145676|202744|P2|STARTED|Overall Study||18
82795|NCT02145676|202745|P1|STARTED|Overall Study||17
82796|NCT02145468|202770|P2|NOT COMPLETED|Overall Study||8
82797|NCT02145468|202771|P1|NOT COMPLETED|Overall Study||5
82798|NCT02145468|202770|P2|COMPLETED|Overall Study||1723
82799|NCT02145468|202771|P1|COMPLETED|Overall Study||1753
82800|NCT02145468|202770|P2|STARTED|Overall Study||1731
82801|NCT02145468|202771|P1|STARTED|Overall Study||1758
82802|NCT02145429|202829|P2|NOT COMPLETED|Overall Study||11
82803|NCT02145429|202830|P1|NOT COMPLETED|Overall Study||16
82804|NCT02145429|202829|P2|COMPLETED|Overall Study||79
82805|NCT02145429|202830|P1|COMPLETED|Overall Study||75
82806|NCT02145429|202829|P2|STARTED|Overall Study||90
82807|NCT02145429|202830|P1|STARTED|Overall Study||91
82808|NCT02145390|202840|P1|NOT COMPLETED|Overall Study||1
82809|NCT02145390|202840|P1|COMPLETED|Overall Study||0
82810|NCT02145390|202840|P1|STARTED|Overall Study||1
82811|NCT02145299|202851|P2|NOT COMPLETED|Overall Study||0
82812|NCT02145299|202852|P1|NOT COMPLETED|Overall Study||0
82813|NCT02145299|202851|P2|COMPLETED|Overall Study||2
82814|NCT02145299|202852|P1|COMPLETED|Overall Study||6
82815|NCT02145299|202851|P2|STARTED|Overall Study||2
82816|NCT02145299|202852|P1|STARTED|Overall Study||6
82817|NCT02145247|202880|P2|NOT COMPLETED|Overall Study||0
82818|NCT02145247|202881|P1|NOT COMPLETED|Overall Study||0
82819|NCT02145247|202880|P2|COMPLETED|Overall Study||19
82820|NCT02145247|202881|P1|COMPLETED|Overall Study||20
82821|NCT02145247|202880|P2|STARTED|Overall Study||19
82822|NCT02145247|202881|P1|STARTED|Overall Study||20
82823|NCT02145182|202889|P2|NOT COMPLETED|Overall Study||16
82824|NCT02145182|202890|P1|NOT COMPLETED|Overall Study||18
82825|NCT02145182|202889|P2|COMPLETED|Overall Study||130
82826|NCT02145182|202890|P1|COMPLETED|Overall Study||124
82827|NCT02145182|202889|P2|Received at Least 1 Dose of Study Drug|Overall Study||146
82828|NCT02145182|202890|P1|Received at Least 1 Dose of Study Drug|Overall Study||142
82829|NCT02145182|202889|P2|STARTED|Overall Study||146
82830|NCT02145182|202890|P1|STARTED|Overall Study||142
82831|NCT02145156|202907|P3|NOT COMPLETED|Overall Study||41
82832|NCT02145156|202908|P2|NOT COMPLETED|Overall Study||52
82833|NCT02145156|202909|P1|NOT COMPLETED|Overall Study||60
82834|NCT02145156|202907|P3|COMPLETED|Overall Study||398
82835|NCT02145156|202908|P2|COMPLETED|Overall Study||373
82836|NCT02145156|202909|P1|COMPLETED|Overall Study||370
82837|NCT02145156|202907|P3|STARTED|Overall Study||439
82838|NCT02145156|202908|P2|STARTED|Overall Study||425
82839|NCT02145156|202909|P1|STARTED|Overall Study||430
82840|NCT02144714|202953|P3|NOT COMPLETED|Overall Study||0
82841|NCT02144714|202954|P2|NOT COMPLETED|Overall Study||0
82842|NCT02144714|202955|P1|NOT COMPLETED|Overall Study||0
82843|NCT02144714|202953|P3|COMPLETED|Overall Study||63
82844|NCT02144714|202954|P2|COMPLETED|Overall Study||63
82845|NCT02144714|202955|P1|COMPLETED|Overall Study||63
82846|NCT02144714|202953|P3|STARTED|Overall Study||63
82847|NCT02144714|202954|P2|STARTED|Overall Study||63
82848|NCT02144714|202955|P1|STARTED|Overall Study||63
82849|NCT02144701|202974|P2|NOT COMPLETED|Overall Study||3
82850|NCT02144701|202975|P1|NOT COMPLETED|Overall Study||9
82851|NCT02144701|202974|P2|COMPLETED|Overall Study||8
82852|NCT02144701|202975|P1|COMPLETED|Overall Study||13
82853|NCT02144701|202974|P2|STARTED|Overall Study||11
82854|NCT02144701|202975|P1|STARTED|Overall Study||22
82855|NCT02144675|202993|P2|NOT COMPLETED|Overall Study||0
82856|NCT02144675|202994|P1|NOT COMPLETED|Overall Study||0
82857|NCT02144675|202993|P2|COMPLETED|Overall Study||14
82858|NCT02144675|202994|P1|COMPLETED|Overall Study||13
82859|NCT02144675|202993|P2|STARTED|Overall Study||14
82860|NCT02144675|202994|P1|STARTED|Overall Study||13
82861|NCT02144610|203002|P2|NOT COMPLETED|Overall Study||22
82862|NCT02144610|203003|P1|NOT COMPLETED|Overall Study||23
82863|NCT02144610|203002|P2|COMPLETED|Overall Study||1
82864|NCT02144610|203003|P1|COMPLETED|Overall Study||0
82865|NCT02144610|203002|P2|STARTED|Overall Study||23
82866|NCT02144610|203003|P1|STARTED|Overall Study||23
82867|NCT02144519|203033|P2|NOT COMPLETED|Year 3||0
82868|NCT02144519|203034|P1|NOT COMPLETED|Year 3||0
82869|NCT02144519|203033|P2|COMPLETED|Year 3||760
82870|NCT02144519|203034|P1|COMPLETED|Year 3||894
82871|NCT02144519|203033|P2|STARTED|Year 3||760
82872|NCT02144519|203034|P1|STARTED|Year 3||894
82873|NCT02144519|203033|P2|NOT COMPLETED|Year 2||0
82874|NCT02144519|203034|P1|NOT COMPLETED|Year 2||0
82875|NCT02144519|203033|P2|COMPLETED|Year 2||864
82876|NCT02144519|203034|P1|COMPLETED|Year 2||763
82877|NCT02144519|203033|P2|STARTED|Year 2||864
82878|NCT02144519|203034|P1|STARTED|Year 2||763
82879|NCT02144519|203033|P2|NOT COMPLETED|Year 1||0
82880|NCT02144519|203034|P1|NOT COMPLETED|Year 1||0
82881|NCT02144519|203033|P2|COMPLETED|Year 1||870
82882|NCT02144519|203034|P1|COMPLETED|Year 1||895
82883|NCT02144519|203033|P2|STARTED|Year 1||870
82884|NCT02144519|203034|P1|STARTED|Year 1||895
82885|NCT02144337|203044|P2|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||0
82886|NCT02144337|203045|P1|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||3
82887|NCT02144337|203044|P2|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
82888|NCT02144337|203045|P1|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
82889|NCT02144337|203044|P2|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|5
82890|NCT02144337|203045|P1|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|8
82891|NCT02144337|203044|P2|NOT COMPLETED|T2 Follow-up (Post-intervention)||1
82892|NCT02144337|203045|P1|NOT COMPLETED|T2 Follow-up (Post-intervention)||4
82893|NCT02144337|203044|P2|COMPLETED|T2 Follow-up (Post-intervention)||4
82894|NCT02144337|203045|P1|COMPLETED|T2 Follow-up (Post-intervention)||4
82895|NCT02144337|203044|P2|STARTED|T2 Follow-up (Post-intervention)||5
82896|NCT02144337|203045|P1|STARTED|T2 Follow-up (Post-intervention)||8
82897|NCT02144337|203044|P2|NOT COMPLETED|Baseline 0 Months||0
82898|NCT02144337|203045|P1|NOT COMPLETED|Baseline 0 Months||0
82899|NCT02144337|203044|P2|COMPLETED|Baseline 0 Months||5
82900|NCT02144337|203045|P1|COMPLETED|Baseline 0 Months||8
82901|NCT02144337|203044|P2|STARTED|Baseline 0 Months||5
82902|NCT02144337|203045|P1|STARTED|Baseline 0 Months||8
82903|NCT02144285|203065|P10|NOT COMPLETED|Overall Study||0
82904|NCT02144285|203066|P9|NOT COMPLETED|Overall Study||0
82905|NCT02144285|203067|P8|NOT COMPLETED|Overall Study||0
82906|NCT02144285|203068|P7|NOT COMPLETED|Overall Study||0
82907|NCT02144285|203069|P6|NOT COMPLETED|Overall Study||0
82908|NCT02144285|203070|P5|NOT COMPLETED|Overall Study||1
82909|NCT02144285|203071|P4|NOT COMPLETED|Overall Study||0
82910|NCT02144285|203072|P3|NOT COMPLETED|Overall Study||0
82911|NCT02144285|203073|P2|NOT COMPLETED|Overall Study||0
82912|NCT02144285|203074|P1|NOT COMPLETED|Overall Study||0
82913|NCT02144285|203065|P10|COMPLETED|Overall Study||6
82914|NCT02144285|203066|P9|COMPLETED|Overall Study||2
82915|NCT02144285|203067|P8|COMPLETED|Overall Study||6
82916|NCT02144285|203068|P7|COMPLETED|Overall Study||6
82917|NCT02144285|203069|P6|COMPLETED|Overall Study||6
82918|NCT02144285|203070|P5|COMPLETED|Overall Study||5
82919|NCT02144285|203071|P4|COMPLETED|Overall Study||6
82920|NCT02144285|203072|P3|COMPLETED|Overall Study||6
82921|NCT02144285|203073|P2|COMPLETED|Overall Study||6
82922|NCT02144285|203074|P1|COMPLETED|Overall Study||14
82923|NCT02144285|203065|P10|Received At Least One Dose of Study Drug|Overall Study||6
82924|NCT02144285|203066|P9|Received At Least One Dose of Study Drug|Overall Study||2
82925|NCT02144285|203067|P8|Received At Least One Dose of Study Drug|Overall Study||6
82926|NCT02144285|203068|P7|Received At Least One Dose of Study Drug|Overall Study||6
82927|NCT02144285|203069|P6|Received At Least One Dose of Study Drug|Overall Study||6
82928|NCT02144285|203070|P5|Received At Least One Dose of Study Drug|Overall Study||6
82929|NCT02144285|203071|P4|Received At Least One Dose of Study Drug|Overall Study||6
82930|NCT02144285|203072|P3|Received At Least One Dose of Study Drug|Overall Study||6
82931|NCT02144285|203073|P2|Received At Least One Dose of Study Drug|Overall Study||6
82932|NCT02144285|203074|P1|Received At Least One Dose of Study Drug|Overall Study||14
82933|NCT02144285|203065|P10|STARTED|Overall Study||6
82934|NCT02144285|203066|P9|STARTED|Overall Study||2
82935|NCT02144285|203067|P8|STARTED|Overall Study||6
82936|NCT02144285|203068|P7|STARTED|Overall Study||6
82937|NCT02144285|203069|P6|STARTED|Overall Study||6
82938|NCT02144285|203070|P5|STARTED|Overall Study||6
82939|NCT02144285|203071|P4|STARTED|Overall Study||6
82940|NCT02144285|203072|P3|STARTED|Overall Study||6
82941|NCT02144285|203073|P2|STARTED|Overall Study||6
82942|NCT02144285|203074|P1|STARTED|Overall Study||14
82943|NCT02144259|203147|P3|NOT COMPLETED|Overall Study||18
82944|NCT02144259|203148|P2|NOT COMPLETED|Overall Study||5
82945|NCT02144259|203149|P1|NOT COMPLETED|Overall Study||10
82946|NCT02144259|203147|P3|COMPLETED|Overall Study||16
82947|NCT02144259|203148|P2|COMPLETED|Overall Study||28
82948|NCT02144259|203149|P1|COMPLETED|Overall Study||23
82949|NCT02144259|203147|P3|STARTED|Overall Study||34
82950|NCT02144259|203148|P2|STARTED|Overall Study||33
82951|NCT02144259|203149|P1|STARTED|Overall Study||33
82952|NCT02144220|203163|P1|NOT COMPLETED|Overall Study||19
82953|NCT02144220|203163|P1|COMPLETED|Overall Study||258
82954|NCT02144220|203163|P1|STARTED|Overall Study||277
82955|NCT02144077|203173|P2|NOT COMPLETED|Overall Study||11
82956|NCT02144077|203174|P1|NOT COMPLETED|Overall Study||10
82957|NCT02144077|203173|P2|COMPLETED|Overall Study||132
82958|NCT02144077|203174|P1|COMPLETED|Overall Study||128
82959|NCT02144077|203173|P2|STARTED|Overall Study||143
82960|NCT02144077|203174|P1|STARTED|Overall Study||138
82961|NCT02144012|203192|P2|NOT COMPLETED|Overall Study||15
82962|NCT02144012|203193|P1|NOT COMPLETED|Overall Study||34
82963|NCT02144012|203192|P2|COMPLETED|Overall Study||0
82964|NCT02144012|203193|P1|COMPLETED|Overall Study||0
82965|NCT02144012|203192|P2|STARTED|Overall Study||15
82966|NCT02144012|203193|P1|STARTED|Overall Study||34
82967|NCT02143947|203230|P2|NOT COMPLETED|Overall Study||2
82968|NCT02143947|203231|P1|NOT COMPLETED|Overall Study||4
82969|NCT02143947|203230|P2|COMPLETED|Overall Study||42
82970|NCT02143947|203231|P1|COMPLETED|Overall Study||32
82971|NCT02143947|203230|P2|STARTED|Overall Study||44
82972|NCT02143947|203231|P1|STARTED|Overall Study||36
82973|NCT02143843|203243|P1|NOT COMPLETED|Overall Study||12
82974|NCT02143843|203243|P1|COMPLETED|Overall Study||63
82975|NCT02143843|203243|P1|STARTED|Overall Study||75
82976|NCT02143778|203248|P1|NOT COMPLETED|Overall Study||3
82977|NCT02143778|203248|P1|COMPLETED|Overall Study||243
82978|NCT02143778|203248|P1|STARTED|Overall Study||246
82979|NCT02143713|203257|P4|NOT COMPLETED|Post-treatment Follow-up (12 Months)||27
82980|NCT02143713|203258|P3|NOT COMPLETED|Post-treatment Follow-up (12 Months)||29
82981|NCT02143713|203259|P2|NOT COMPLETED|Post-treatment Follow-up (12 Months)||24
82982|NCT02143713|203260|P1|NOT COMPLETED|Post-treatment Follow-up (12 Months)||12
82983|NCT02143713|203257|P4|COMPLETED|Post-treatment Follow-up (12 Months)||95
82984|NCT02143713|203258|P3|COMPLETED|Post-treatment Follow-up (12 Months)||96
82985|NCT02143713|203259|P2|COMPLETED|Post-treatment Follow-up (12 Months)||81
82986|NCT02143713|203260|P1|COMPLETED|Post-treatment Follow-up (12 Months)||73
82987|NCT02143713|203257|P4|STARTED|Post-treatment Follow-up (12 Months)||122
82988|NCT02143713|203258|P3|STARTED|Post-treatment Follow-up (12 Months)||125
82989|NCT02143713|203259|P2|STARTED|Post-treatment Follow-up (12 Months)||105
82990|NCT02143713|203260|P1|STARTED|Post-treatment Follow-up (12 Months)||85
82991|NCT02143713|203257|P4|NOT COMPLETED|Treatment Period (6 Months)||28
82992|NCT02143713|203258|P3|NOT COMPLETED|Treatment Period (6 Months)||22
82993|NCT02143713|203259|P2|NOT COMPLETED|Treatment Period (6 Months)||12
82994|NCT02143713|203260|P1|NOT COMPLETED|Treatment Period (6 Months)||20
82995|NCT02143713|203257|P4|COMPLETED|Treatment Period (6 Months)||112
82996|NCT02143713|203258|P3|COMPLETED|Treatment Period (6 Months)||120
82997|NCT02143713|203259|P2|COMPLETED|Treatment Period (6 Months)||99
82998|NCT02143713|203260|P1|COMPLETED|Treatment Period (6 Months)||82
82999|NCT02143713|203257|P4|Received Elagolix|Treatment Period (6 Months)||140
83000|NCT02143713|203258|P3|Received Elagolix|Treatment Period (6 Months)||142
83001|NCT02143713|203259|P2|Received Elagolix|Treatment Period (6 Months)||111
83002|NCT02143713|203260|P1|Received Elagolix|Treatment Period (6 Months)||102
83003|NCT02143713|203257|P4|STARTED|Treatment Period (6 Months)||140
83004|NCT02143713|203258|P3|STARTED|Treatment Period (6 Months)||142
83005|NCT02143713|203259|P2|STARTED|Treatment Period (6 Months)||111
83006|NCT02143713|203260|P1|STARTED|Treatment Period (6 Months)||102
83007|NCT02143583|203341|P3|NOT COMPLETED|Overall Study||2
83008|NCT02143583|203342|P2|NOT COMPLETED|Overall Study||0
83009|NCT02143583|203343|P1|NOT COMPLETED|Overall Study||1
83010|NCT02143583|203341|P3|COMPLETED|Overall Study||66
83011|NCT02143583|203342|P2|COMPLETED|Overall Study||66
83012|NCT02143583|203343|P1|COMPLETED|Overall Study||61
83013|NCT02143583|203341|P3|STARTED|Overall Study||68
83014|NCT02143583|203342|P2|STARTED|Overall Study||66
83015|NCT02143583|203343|P1|STARTED|Overall Study||62
83016|NCT02143310|203354|P1|NOT COMPLETED|Overall Study||107
83017|NCT02143310|203354|P1|COMPLETED|Overall Study||102
83018|NCT02143310|203354|P1|STARTED|Overall Study||209
83019|NCT02143141|203366|P2|NOT COMPLETED|Overall Study||0
83020|NCT02143141|203367|P1|NOT COMPLETED|Overall Study||1
83021|NCT02143141|203366|P2|COMPLETED|Overall Study||6
83022|NCT02143141|203367|P1|COMPLETED|Overall Study||6
83023|NCT02143141|203366|P2|STARTED|Overall Study||6
83024|NCT02143141|203367|P1|STARTED|Overall Study||7
83025|NCT02143102|203379|P2|NOT COMPLETED|Overall Study||0
83026|NCT02143102|203380|P1|NOT COMPLETED|Overall Study||11
83027|NCT02143102|203379|P2|COMPLETED|Overall Study||28
83028|NCT02143102|203380|P1|COMPLETED|Overall Study||86
83029|NCT02143102|203379|P2|STARTED|Overall Study||28
83030|NCT02143102|203380|P1|STARTED|Overall Study||97
83031|NCT02142894|203388|P1|NOT COMPLETED|Overall Study||8
83032|NCT02142894|203388|P1|COMPLETED|Overall Study||25
83033|NCT02142894|203388|P1|STARTED|Overall Study||33
83034|NCT02142738|203394|P2|NOT COMPLETED|Overall Study||151
83035|NCT02142738|203395|P1|NOT COMPLETED|Overall Study||154
83036|NCT02142738|203394|P2|COMPLETED|Overall Study||0
83037|NCT02142738|203395|P1|COMPLETED|Overall Study||0
83038|NCT02142738|203394|P2|Treated|Overall Study||150
83039|NCT02142738|203395|P1|Treated|Overall Study||154
83040|NCT02142738|203394|P2|STARTED|Overall Study||151
83041|NCT02142738|203395|P1|STARTED|Overall Study||154
83042|NCT02142712|203408|P4|NOT COMPLETED|Overall Study||0
83043|NCT02142712|203409|P3|NOT COMPLETED|Overall Study||1
83044|NCT02142712|203410|P2|NOT COMPLETED|Overall Study||1
83045|NCT02142712|203411|P1|NOT COMPLETED|Overall Study||1
83046|NCT02142712|203408|P4|COMPLETED|Overall Study||0
83047|NCT02142712|203409|P3|COMPLETED|Overall Study||0
83048|NCT02142712|203410|P2|COMPLETED|Overall Study||0
83049|NCT02142712|203411|P1|COMPLETED|Overall Study||0
83050|NCT02142712|203408|P4|STARTED|Overall Study||0
83051|NCT02142712|203409|P3|STARTED|Overall Study||1
83052|NCT02142712|203410|P2|STARTED|Overall Study||1
83053|NCT02142712|203411|P1|STARTED|Overall Study||1
83054|NCT02142504|203434|P3|NOT COMPLETED|Overall Study||43
83055|NCT02142504|203435|P2|NOT COMPLETED|Overall Study||42
83056|NCT02142504|203436|P1|NOT COMPLETED|Overall Study||31
83057|NCT02142504|203434|P3|COMPLETED|Overall Study||111
83058|NCT02142504|203435|P2|COMPLETED|Overall Study||105
83059|NCT02142504|203436|P1|COMPLETED|Overall Study||122
83060|NCT02142504|203434|P3|Received Booster (Second Vaccination)|Overall Study||116
83061|NCT02142504|203435|P2|Received Booster (Second Vaccination)|Overall Study||109
83062|NCT02142504|203436|P1|Received Booster (Second Vaccination)|Overall Study||126
83063|NCT02142504|203434|P3|Randomized and Received Treatment|Overall Study||154
83064|NCT02142504|203435|P2|Randomized and Received Treatment|Overall Study||145
83065|NCT02142504|203436|P1|Randomized and Received Treatment|Overall Study||153
83066|NCT02142504|203434|P3|STARTED|Overall Study||154
83067|NCT02142504|203435|P2|STARTED|Overall Study||147
83068|NCT02142504|203436|P1|STARTED|Overall Study||153
83069|NCT02142361|203522|P3|NOT COMPLETED|Overall Study||0
83070|NCT02142361|203523|P2|NOT COMPLETED|Overall Study||0
83071|NCT02142361|203524|P1|NOT COMPLETED|Overall Study||0
83072|NCT02142361|203522|P3|COMPLETED|Overall Study||20
83073|NCT02142361|203523|P2|COMPLETED|Overall Study||20
83074|NCT02142361|203524|P1|COMPLETED|Overall Study||20
83075|NCT02142361|203522|P3|STARTED|Overall Study||20
83076|NCT02142361|203523|P2|STARTED|Overall Study||20
83077|NCT02142361|203524|P1|STARTED|Overall Study||20
83078|NCT02142283|203625|P2|NOT COMPLETED|Overall Study||21
83079|NCT02142283|203626|P1|NOT COMPLETED|Overall Study||21
83080|NCT02142283|203625|P2|COMPLETED|Overall Study||78
83081|NCT02142283|203626|P1|COMPLETED|Overall Study||86
83082|NCT02142283|203625|P2|STARTED|Overall Study||99
83083|NCT02142283|203626|P1|STARTED|Overall Study||107
83084|NCT02142153|203656|P10|NOT COMPLETED|Overall Study||0
83085|NCT02142153|203657|P9|NOT COMPLETED|Overall Study||0
83086|NCT02142153|203658|P8|NOT COMPLETED|Overall Study||0
83087|NCT02142153|203659|P7|NOT COMPLETED|Overall Study||0
83088|NCT02142153|203660|P6|NOT COMPLETED|Overall Study||0
83089|NCT02142153|203661|P5|NOT COMPLETED|Overall Study||0
83090|NCT02142153|203662|P4|NOT COMPLETED|Overall Study||0
83091|NCT02142153|203663|P3|NOT COMPLETED|Overall Study||0
83092|NCT02142153|203664|P2|NOT COMPLETED|Overall Study||0
83093|NCT02142153|203665|P1|NOT COMPLETED|Overall Study||0
83094|NCT02142153|203656|P10|COMPLETED|Overall Study||2
83095|NCT02142153|203657|P9|COMPLETED|Overall Study||6
83096|NCT02142153|203658|P8|COMPLETED|Overall Study||2
83097|NCT02142153|203659|P7|COMPLETED|Overall Study||6
83098|NCT02142153|203660|P6|COMPLETED|Overall Study||2
83099|NCT02142153|203661|P5|COMPLETED|Overall Study||6
83100|NCT02142153|203662|P4|COMPLETED|Overall Study||2
83101|NCT02142153|203663|P3|COMPLETED|Overall Study||6
83102|NCT02142153|203664|P2|COMPLETED|Overall Study||2
83103|NCT02142153|203665|P1|COMPLETED|Overall Study||6
83104|NCT02142153|203656|P10|STARTED|Overall Study||2
83105|NCT02142153|203657|P9|STARTED|Overall Study||6
83106|NCT02142153|203658|P8|STARTED|Overall Study||2
83107|NCT02142153|203659|P7|STARTED|Overall Study||6
83108|NCT02142153|203660|P6|STARTED|Overall Study||2
83109|NCT02142153|203661|P5|STARTED|Overall Study||6
83110|NCT02142153|203662|P4|STARTED|Overall Study||2
83111|NCT02142153|203663|P3|STARTED|Overall Study||6
83112|NCT02142153|203664|P2|STARTED|Overall Study||2
83113|NCT02142153|203665|P1|STARTED|Overall Study||6
83114|NCT02142049|203702|P5|NOT COMPLETED|Overall Study||0
83115|NCT02142049|203703|P4|NOT COMPLETED|Overall Study||0
83116|NCT02142049|203704|P3|NOT COMPLETED|Overall Study||0
83117|NCT02142049|203705|P2|NOT COMPLETED|Overall Study||0
83118|NCT02142049|203706|P1|NOT COMPLETED|Overall Study||0
83119|NCT02142049|203702|P5|COMPLETED|Overall Study||20
83120|NCT02142049|203703|P4|COMPLETED|Overall Study||6
83121|NCT02142049|203704|P3|COMPLETED|Overall Study||3
83122|NCT02142049|203705|P2|COMPLETED|Overall Study||3
83123|NCT02142049|203706|P1|COMPLETED|Overall Study||3
83124|NCT02142049|203702|P5|STARTED|Overall Study||20
83125|NCT02142049|203703|P4|STARTED|Overall Study||6
83126|NCT02142049|203704|P3|STARTED|Overall Study||3
83127|NCT02142049|203705|P2|STARTED|Overall Study||3
83128|NCT02142049|203706|P1|STARTED|Overall Study||3
83129|NCT02141997|203735|P4|NOT COMPLETED|Overall Study||1
83130|NCT02141997|203736|P3|NOT COMPLETED|Overall Study||3
83131|NCT02141997|203737|P2|NOT COMPLETED|Overall Study||6
83132|NCT02141997|203738|P1|NOT COMPLETED|Overall Study||3
83133|NCT02141997|203735|P4|COMPLETED|Overall Study||54
83134|NCT02141997|203736|P3|COMPLETED|Overall Study||53
83135|NCT02141997|203737|P2|COMPLETED|Overall Study||49
83136|NCT02141997|203738|P1|COMPLETED|Overall Study||53
83137|NCT02141997|203735|P4|STARTED|Overall Study||55
83138|NCT02141997|203736|P3|STARTED|Overall Study||56
83139|NCT02141997|203737|P2|STARTED|Overall Study||55
83140|NCT02141997|203738|P1|STARTED|Overall Study||56
83141|NCT02141984|203776|P1|NOT COMPLETED|Overall Study||2
83142|NCT02141984|203776|P1|COMPLETED|Overall Study||26
83143|NCT02141984|203776|P1|STARTED|Overall Study||28
83144|NCT02141867|203783|P1|NOT COMPLETED|Overall Study||94
83145|NCT02141867|203783|P1|COMPLETED|Overall Study||3927
83146|NCT02141867|203783|P1|STARTED|Overall Study||4021
83147|NCT02141854|203795|P6|NOT COMPLETED|Treatment Period||38
83148|NCT02141854|203796|P5|NOT COMPLETED|Treatment Period||10
83149|NCT02141854|203797|P4|NOT COMPLETED|Treatment Period||11
83150|NCT02141854|203798|P3|NOT COMPLETED|Treatment Period||9
83151|NCT02141854|203799|P2|NOT COMPLETED|Treatment Period||10
83152|NCT02141854|203800|P1|NOT COMPLETED|Treatment Period||0
83153|NCT02141854|203795|P6|COMPLETED|Treatment Period||107
83154|NCT02141854|203796|P5|COMPLETED|Treatment Period||136
83155|NCT02141854|203797|P4|COMPLETED|Treatment Period||135
83156|NCT02141854|203798|P3|COMPLETED|Treatment Period||136
83157|NCT02141854|203799|P2|COMPLETED|Treatment Period||136
83158|NCT02141854|203800|P1|COMPLETED|Treatment Period||0
83159|NCT02141854|203795|P6|Full Analysis Set|Treatment Period||143
83160|NCT02141854|203796|P5|Full Analysis Set|Treatment Period||145
83161|NCT02141854|203797|P4|Full Analysis Set|Treatment Period||146
83162|NCT02141854|203798|P3|Full Analysis Set|Treatment Period||141
83163|NCT02141854|203799|P2|Full Analysis Set|Treatment Period||145
83164|NCT02141854|203800|P1|Full Analysis Set|Treatment Period||0
83165|NCT02141854|203795|P6|Safety Population|Treatment Period||144
83166|NCT02141854|203796|P5|Safety Population|Treatment Period||145
83167|NCT02141854|203797|P4|Safety Population|Treatment Period||146
83168|NCT02141854|203798|P3|Safety Population|Treatment Period||143
83169|NCT02141854|203799|P2|Safety Population|Treatment Period||145
83170|NCT02141854|203800|P1|Safety Population|Treatment Period||0
83171|NCT02141854|203795|P6|Intent to Treat Population|Treatment Period||145
83172|NCT02141854|203796|P5|Intent to Treat Population|Treatment Period||146
83173|NCT02141854|203797|P4|Intent to Treat Population|Treatment Period||146
83174|NCT02141854|203798|P3|Intent to Treat Population|Treatment Period||145
83175|NCT02141854|203799|P2|Intent to Treat Population|Treatment Period||146
83176|NCT02141854|203800|P1|Intent to Treat Population|Treatment Period||0
83177|NCT02141854|203795|P6|STARTED|Treatment Period||145
83178|NCT02141854|203796|P5|STARTED|Treatment Period||146
83179|NCT02141854|203797|P4|STARTED|Treatment Period||146
83180|NCT02141854|203798|P3|STARTED|Treatment Period||145
83181|NCT02141854|203799|P2|STARTED|Treatment Period||146
83182|NCT02141854|203800|P1|STARTED|Treatment Period||0
83183|NCT02141854|203795|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
83184|NCT02141854|203796|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
83185|NCT02141854|203797|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
83186|NCT02141854|203798|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
83187|NCT02141854|203799|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
83188|NCT02141854|203800|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||154
83189|NCT02141854|203795|P6|COMPLETED|Run-In Period (Pre-assignment)||0
83190|NCT02141854|203796|P5|COMPLETED|Run-In Period (Pre-assignment)||0
83191|NCT02141854|203797|P4|COMPLETED|Run-In Period (Pre-assignment)||0
83192|NCT02141854|203798|P3|COMPLETED|Run-In Period (Pre-assignment)||0
83193|NCT02141854|203799|P2|COMPLETED|Run-In Period (Pre-assignment)||0
83194|NCT02141854|203800|P1|COMPLETED|Run-In Period (Pre-assignment)||728
83195|NCT02141854|203795|P6|STARTED|Run-In Period (Pre-assignment)||0
83196|NCT02141854|203796|P5|STARTED|Run-In Period (Pre-assignment)||0
83197|NCT02141854|203797|P4|STARTED|Run-In Period (Pre-assignment)||0
83198|NCT02141854|203798|P3|STARTED|Run-In Period (Pre-assignment)||0
83199|NCT02141854|203799|P2|STARTED|Run-In Period (Pre-assignment)||0
83200|NCT02141854|203800|P1|STARTED|Run-In Period (Pre-assignment)||882
83201|NCT02141659|203858|P6|NOT COMPLETED|Overall Study||2
83202|NCT02141659|203859|P5|NOT COMPLETED|Overall Study||2
83203|NCT02141659|203860|P4|NOT COMPLETED|Overall Study||0
83204|NCT02141659|203861|P3|NOT COMPLETED|Overall Study||0
83205|NCT02141659|203862|P2|NOT COMPLETED|Overall Study||1
83206|NCT02141659|203863|P1|NOT COMPLETED|Overall Study||0
83207|NCT02141659|203858|P6|COMPLETED|Overall Study||13
83208|NCT02141659|203859|P5|COMPLETED|Overall Study||13
83209|NCT02141659|203860|P4|COMPLETED|Overall Study||3
83210|NCT02141659|203861|P3|COMPLETED|Overall Study||3
83211|NCT02141659|203862|P2|COMPLETED|Overall Study||3
83212|NCT02141659|203863|P1|COMPLETED|Overall Study||3
83213|NCT02141659|203858|P6|STARTED|Overall Study||15
83214|NCT02141659|203859|P5|STARTED|Overall Study||15
83215|NCT02141659|203860|P4|STARTED|Overall Study||3
83216|NCT02141659|203861|P3|STARTED|Overall Study||3
83217|NCT02141659|203862|P2|STARTED|Overall Study||4
83218|NCT02141659|203863|P1|STARTED|Overall Study||3
83219|NCT02141633|203919|P2|NOT COMPLETED|Overall Study||0
83220|NCT02141633|203920|P1|NOT COMPLETED|Overall Study||1
83221|NCT02141633|203919|P2|COMPLETED|Overall Study||15
83222|NCT02141633|203920|P1|COMPLETED|Overall Study||15
83223|NCT02141633|203919|P2|STARTED|Overall Study||15
83224|NCT02141633|203920|P1|STARTED|Overall Study||16
83225|NCT02141620|203928|P2|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
83226|NCT02141620|203929|P1|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
83227|NCT02141620|203928|P2|COMPLETED|Treatment Condition 2 (7 Days)||7
83228|NCT02141620|203929|P1|COMPLETED|Treatment Condition 2 (7 Days)||7
83229|NCT02141620|203928|P2|STARTED|Treatment Condition 2 (7 Days)||7
83230|NCT02141620|203929|P1|STARTED|Treatment Condition 2 (7 Days)||7
83231|NCT02141620|203928|P2|NOT COMPLETED|Treatment Condition 1 (7 Days)||0
83232|NCT02141620|203929|P1|NOT COMPLETED|Treatment Condition 1 (7 Days)||1
83233|NCT02141620|203928|P2|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to placebo for Condition 2.|7
83234|NCT02141620|203929|P1|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to n-acetylcysteine for Condition 2.|7
83235|NCT02141620|203928|P2|STARTED|Treatment Condition 1 (7 Days)||7
83236|NCT02141620|203929|P1|STARTED|Treatment Condition 1 (7 Days)||8
83237|NCT02141581|203990|P3|NOT COMPLETED|Overall Study||0
83238|NCT02141581|203991|P2|NOT COMPLETED|Overall Study||0
83239|NCT02141581|203992|P1|NOT COMPLETED|Overall Study||0
83240|NCT02141581|203990|P3|COMPLETED|Overall Study||25
83241|NCT02141581|203991|P2|COMPLETED|Overall Study||19
83242|NCT02141581|203992|P1|COMPLETED|Overall Study||42
83243|NCT02141581|203990|P3|STARTED|Overall Study||25
83244|NCT02141581|203991|P2|STARTED|Overall Study||19
83245|NCT02141581|203992|P1|STARTED|Overall Study||42
83246|NCT02141555|204005|P2|NOT COMPLETED|Overall Study||0
83247|NCT02141555|204006|P1|NOT COMPLETED|Overall Study||0
83248|NCT02141555|204005|P2|COMPLETED|Overall Study||2
83249|NCT02141555|204006|P1|COMPLETED|Overall Study||2
83250|NCT02141555|204005|P2|STARTED|Overall Study||2
83251|NCT02141555|204006|P1|STARTED|Overall Study||2
83252|NCT02141516|204021|P3|NOT COMPLETED|Overall Study||0
83253|NCT02141516|204022|P2|NOT COMPLETED|Overall Study||5
83254|NCT02141516|204023|P1|NOT COMPLETED|Overall Study||0
83255|NCT02141516|204021|P3|COMPLETED|Overall Study||87
83256|NCT02141516|204022|P2|COMPLETED|Overall Study||107
83257|NCT02141516|204023|P1|COMPLETED|Overall Study||40
83258|NCT02141516|204021|P3|STARTED|Overall Study||87
83259|NCT02141516|204022|P2|STARTED|Overall Study||112
83260|NCT02141516|204023|P1|STARTED|Overall Study||40
83261|NCT02141490|204074|P3|NOT COMPLETED|Overall Study||0
83262|NCT02141490|204075|P2|NOT COMPLETED|Overall Study||0
83263|NCT02141490|204076|P1|NOT COMPLETED|Overall Study||4
83264|NCT02141490|204074|P3|COMPLETED|Overall Study||3
83265|NCT02141490|204075|P2|COMPLETED|Overall Study||6
83266|NCT02141490|204076|P1|COMPLETED|Overall Study||30
83267|NCT02141490|204074|P3|STARTED|Overall Study||3
83268|NCT02141490|204075|P2|STARTED|Overall Study||6
83269|NCT02141490|204076|P1|STARTED|Overall Study||34
83270|NCT02141399|204089|P1|NOT COMPLETED|Overall Study||744
83271|NCT02141399|204089|P1|COMPLETED|Overall Study||741
83272|NCT02141399|204089|P1|STARTED|Overall Study||1485
83273|NCT02141360|204095|P3|NOT COMPLETED|Overall Study||0
83274|NCT02141360|204096|P2|NOT COMPLETED|Overall Study||0
83275|NCT02141360|204097|P1|NOT COMPLETED|Overall Study||7
83276|NCT02141360|204095|P3|COMPLETED|Overall Study||6
83277|NCT02141360|204096|P2|COMPLETED|Overall Study||6
83278|NCT02141360|204097|P1|COMPLETED|Overall Study||4
83279|NCT02141360|204095|P3|STARTED|Overall Study||6
83280|NCT02141360|204096|P2|STARTED|Overall Study||6
83281|NCT02141360|204097|P1|STARTED|Overall Study||11
83282|NCT02141217|204107|P2|NOT COMPLETED|Overall Study||8
83283|NCT02141217|204108|P1|NOT COMPLETED|Overall Study||11
83284|NCT02141217|204107|P2|COMPLETED|Overall Study||229
83285|NCT02141217|204108|P1|COMPLETED|Overall Study||223
83286|NCT02141217|204107|P2|ITT Population-Actual Treatment Received|Overall Study||235
83287|NCT02141217|204108|P1|ITT Population-Actual Treatment Received|Overall Study||236
83288|NCT02141217|204107|P2|ITT Population-Randomized Treatment Arm|Overall Study||237
83289|NCT02141217|204108|P1|ITT Population-Randomized Treatment Arm|Overall Study||234
83290|NCT02141217|204107|P2|STARTED|Overall Study||237
83291|NCT02141217|204108|P1|STARTED|Overall Study||234
83292|NCT02140957|204128|P2|NOT COMPLETED|Overall Study||23
83293|NCT02140957|204129|P1|NOT COMPLETED|Overall Study||27
83294|NCT02140957|204128|P2|COMPLETED|Overall Study||99
83295|NCT02140957|204129|P1|COMPLETED|Overall Study||102
83296|NCT02140957|204128|P2|STARTED|Overall Study||122
83297|NCT02140957|204129|P1|STARTED|Overall Study||129
83298|NCT02140788|204139|P4|NOT COMPLETED|Overall Study||0
83299|NCT02140788|204140|P3|NOT COMPLETED|Overall Study||0
83300|NCT02140788|204141|P2|NOT COMPLETED|Overall Study||0
83301|NCT02140788|204142|P1|NOT COMPLETED|Overall Study||0
83302|NCT02140788|204139|P4|COMPLETED|Overall Study||0
83303|NCT02140788|204140|P3|COMPLETED|Overall Study||0
83304|NCT02140788|204141|P2|COMPLETED|Overall Study||0
83305|NCT02140788|204142|P1|COMPLETED|Overall Study||0
83306|NCT02140788|204139|P4|STARTED|Overall Study||0
83307|NCT02140788|204140|P3|STARTED|Overall Study||0
83308|NCT02140788|204141|P2|STARTED|Overall Study||0
83309|NCT02140788|204142|P1|STARTED|Overall Study||0
83310|NCT02140762|204170|P2|NOT COMPLETED|Overall Study||12
83311|NCT02140762|204171|P1|NOT COMPLETED|Overall Study||17
83312|NCT02140762|204170|P2|COMPLETED|Overall Study||139
83313|NCT02140762|204171|P1|COMPLETED|Overall Study||137
83314|NCT02140762|204170|P2|STARTED|Overall Study||151
83315|NCT02140762|204171|P1|STARTED|Overall Study||154
83316|NCT02140645|204237|P6|NOT COMPLETED|Overall Study||70896
83317|NCT02140645|204238|P5|NOT COMPLETED|Overall Study||3286
83318|NCT02140645|204239|P4|NOT COMPLETED|Overall Study||13833
83319|NCT02140645|204240|P3|NOT COMPLETED|Overall Study||4236
83320|NCT02140645|204241|P2|NOT COMPLETED|Overall Study||61654
83321|NCT02140645|204242|P1|NOT COMPLETED|Overall Study||5489
83322|NCT02140645|204237|P6|COMPLETED|Overall Study||3050
83323|NCT02140645|204238|P5|COMPLETED|Overall Study||150
83324|NCT02140645|204239|P4|COMPLETED|Overall Study||530
83325|NCT02140645|204240|P3|COMPLETED|Overall Study||205
83326|NCT02140645|204241|P2|COMPLETED|Overall Study||3041
83327|NCT02140645|204242|P1|COMPLETED|Overall Study||243
83328|NCT02140645|204237|P6|STARTED|Overall Study||73946
83329|NCT02140645|204238|P5|STARTED|Overall Study||3436
83330|NCT02140645|204239|P4|STARTED|Overall Study||14363
83331|NCT02140645|204240|P3|STARTED|Overall Study||4441
83332|NCT02140645|204241|P2|STARTED|Overall Study||64695
83333|NCT02140645|204242|P1|STARTED|Overall Study||5732
83334|NCT02140593|204331|P2|NOT COMPLETED|Overall Study||0
83335|NCT02140593|204332|P1|NOT COMPLETED|Overall Study||0
83336|NCT02140593|204331|P2|COMPLETED|Overall Study||65
83337|NCT02140593|204332|P1|COMPLETED|Overall Study||63
83338|NCT02140593|204331|P2|STARTED|Overall Study||65
83339|NCT02140593|204332|P1|STARTED|Overall Study||63
83340|NCT02140567|204340|P1|NOT COMPLETED|Overall Study||6
83341|NCT02140567|204340|P1|COMPLETED|Overall Study||134
83342|NCT02140567|204340|P1|STARTED|Overall Study||140
83343|NCT02140411|204345|P1|NOT COMPLETED|Overall Study||1
83344|NCT02140411|204345|P1|COMPLETED|Overall Study||20
83345|NCT02140411|204345|P1|STARTED|Overall Study||21
83346|NCT02140372|204354|P1|NOT COMPLETED|Overall Study||0
83347|NCT02140372|204354|P1|COMPLETED|Overall Study||10
83348|NCT02140372|204354|P1|STARTED|Overall Study||10
83349|NCT02140164|204365|P1|NOT COMPLETED|Overall Study||2
83350|NCT02140164|204365|P1|COMPLETED|Overall Study||5
83351|NCT02140164|204365|P1|STARTED|Overall Study||7
83352|NCT02140060|204386|P6|NOT COMPLETED|Overall Study||1
83353|NCT02140060|204387|P5|NOT COMPLETED|Overall Study||1
83354|NCT02140060|204388|P4|NOT COMPLETED|Overall Study||2
83355|NCT02140060|204389|P3|NOT COMPLETED|Overall Study||0
83356|NCT02140060|204390|P2|NOT COMPLETED|Overall Study||0
83357|NCT02140060|204391|P1|NOT COMPLETED|Overall Study||0
83358|NCT02140060|204386|P6|COMPLETED|Overall Study||43
83359|NCT02140060|204387|P5|COMPLETED|Overall Study||44
83360|NCT02140060|204388|P4|COMPLETED|Overall Study||43
83361|NCT02140060|204389|P3|COMPLETED|Overall Study||44
83362|NCT02140060|204390|P2|COMPLETED|Overall Study||44
83363|NCT02140060|204391|P1|COMPLETED|Overall Study||44
83364|NCT02140060|204386|P6|STARTED|Overall Study||44
83365|NCT02140060|204387|P5|STARTED|Overall Study||45
83366|NCT02140060|204388|P4|STARTED|Overall Study||45
83367|NCT02140060|204389|P3|STARTED|Overall Study||44
83368|NCT02140060|204390|P2|STARTED|Overall Study||44
83369|NCT02140060|204391|P1|STARTED|Overall Study||44
83370|NCT02139982|204416|P10|NOT COMPLETED|Overall Study||0
83371|NCT02139982|204417|P9|NOT COMPLETED|Overall Study||0
83372|NCT02139982|204418|P8|NOT COMPLETED|Overall Study||0
83373|NCT02139982|204419|P7|NOT COMPLETED|Overall Study||0
83374|NCT02139982|204420|P6|NOT COMPLETED|Overall Study||0
83375|NCT02139982|204421|P5|NOT COMPLETED|Overall Study||0
83376|NCT02139982|204422|P4|NOT COMPLETED|Overall Study||1
83377|NCT02139982|204423|P3|NOT COMPLETED|Overall Study||0
83378|NCT02139982|204424|P2|NOT COMPLETED|Overall Study||1
83379|NCT02139982|204425|P1|NOT COMPLETED|Overall Study||0
83380|NCT02139982|204416|P10|COMPLETED|Overall Study||13
83381|NCT02139982|204417|P9|COMPLETED|Overall Study||13
83382|NCT02139982|204418|P8|COMPLETED|Overall Study||13
83383|NCT02139982|204419|P7|COMPLETED|Overall Study||13
83384|NCT02139982|204420|P6|COMPLETED|Overall Study||13
83385|NCT02139982|204421|P5|COMPLETED|Overall Study||13
83386|NCT02139982|204422|P4|COMPLETED|Overall Study||7
83387|NCT02139982|204423|P3|COMPLETED|Overall Study||8
83388|NCT02139982|204424|P2|COMPLETED|Overall Study||7
83389|NCT02139982|204425|P1|COMPLETED|Overall Study||8
83390|NCT02139982|204416|P10|STARTED|Overall Study||13
83391|NCT02139982|204417|P9|STARTED|Overall Study||13
83392|NCT02139982|204418|P8|STARTED|Overall Study||13
83393|NCT02139982|204419|P7|STARTED|Overall Study||13
83394|NCT02139982|204420|P6|STARTED|Overall Study||13
83395|NCT02139982|204421|P5|STARTED|Overall Study||13
83396|NCT02139982|204422|P4|STARTED|Overall Study||8
83397|NCT02139982|204423|P3|STARTED|Overall Study||8
83398|NCT02139982|204424|P2|STARTED|Overall Study||8
83399|NCT02139982|204425|P1|STARTED|Overall Study||8
83400|NCT02139943|204470|P3|NOT COMPLETED|Overall Study||7
83401|NCT02139943|204471|P2|NOT COMPLETED|Overall Study||6
83402|NCT02139943|204472|P1|NOT COMPLETED|Overall Study||10
83403|NCT02139943|204470|P3|COMPLETED|Overall Study||110
83404|NCT02139943|204471|P2|COMPLETED|Overall Study||111
83405|NCT02139943|204472|P1|COMPLETED|Overall Study||107
83406|NCT02139943|204470|P3|STARTED|Overall Study||117
83407|NCT02139943|204471|P2|STARTED|Overall Study||117
83408|NCT02139943|204472|P1|STARTED|Overall Study||117
83409|NCT02139878|204483|P2|NOT COMPLETED|Second Intervention (7 Days)||0
83410|NCT02139878|204484|P1|NOT COMPLETED|Second Intervention (7 Days)||0
83411|NCT02139878|204483|P2|COMPLETED|Second Intervention (7 Days)||10
83412|NCT02139878|204484|P1|COMPLETED|Second Intervention (7 Days)||9
83413|NCT02139878|204483|P2|STARTED|Second Intervention (7 Days)||10
83414|NCT02139878|204484|P1|STARTED|Second Intervention (7 Days)||9
83415|NCT02139878|204483|P2|NOT COMPLETED|Washout Period (8 Days)||0
83416|NCT02139878|204484|P1|NOT COMPLETED|Washout Period (8 Days)||0
83417|NCT02139878|204483|P2|COMPLETED|Washout Period (8 Days)||10
83418|NCT02139878|204484|P1|COMPLETED|Washout Period (8 Days)||9
83419|NCT02139878|204483|P2|STARTED|Washout Period (8 Days)||10
83420|NCT02139878|204484|P1|STARTED|Washout Period (8 Days)||9
83421|NCT02139878|204483|P2|NOT COMPLETED|First Intervention (7 Days)||0
83422|NCT02139878|204484|P1|NOT COMPLETED|First Intervention (7 Days)||1
83423|NCT02139878|204483|P2|COMPLETED|First Intervention (7 Days)||10
83424|NCT02139878|204484|P1|COMPLETED|First Intervention (7 Days)||9
83425|NCT02139878|204483|P2|STARTED|First Intervention (7 Days)||10
83426|NCT02139878|204484|P1|STARTED|First Intervention (7 Days)||10
83427|NCT02139644|204497|P6|NOT COMPLETED|Treatment Period||17
83428|NCT02139644|204498|P5|NOT COMPLETED|Treatment Period||8
83429|NCT02139644|204499|P4|NOT COMPLETED|Treatment Period||9
83430|NCT02139644|204500|P3|NOT COMPLETED|Treatment Period||8
83431|NCT02139644|204501|P2|NOT COMPLETED|Treatment Period||3
83432|NCT02139644|204502|P1|NOT COMPLETED|Treatment Period||0
83433|NCT02139644|204497|P6|COMPLETED|Treatment Period||113
83434|NCT02139644|204498|P5|COMPLETED|Treatment Period||121
83435|NCT02139644|204499|P4|COMPLETED|Treatment Period||121
83436|NCT02139644|204500|P3|COMPLETED|Treatment Period||121
83437|NCT02139644|204501|P2|COMPLETED|Treatment Period||126
83438|NCT02139644|204502|P1|COMPLETED|Treatment Period||0
83439|NCT02139644|204497|P6|STARTED|Treatment Period|Randomized|130
83440|NCT02139644|204498|P5|STARTED|Treatment Period|Randomized|129
83441|NCT02139644|204499|P4|STARTED|Treatment Period|Randomized|130
83442|NCT02139644|204500|P3|STARTED|Treatment Period|Randomized|129
83443|NCT02139644|204501|P2|STARTED|Treatment Period|Randomized|129
83444|NCT02139644|204502|P1|STARTED|Treatment Period||0
83445|NCT02139644|204497|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
83446|NCT02139644|204498|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
83447|NCT02139644|204499|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
83448|NCT02139644|204500|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
83449|NCT02139644|204501|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
83450|NCT02139644|204502|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||140
83451|NCT02139644|204497|P6|COMPLETED|Run-In Period (Pre-assignment)||0
83452|NCT02139644|204498|P5|COMPLETED|Run-In Period (Pre-assignment)||0
83453|NCT02139644|204499|P4|COMPLETED|Run-In Period (Pre-assignment)||0
83454|NCT02139644|204500|P3|COMPLETED|Run-In Period (Pre-assignment)||0
83455|NCT02139644|204501|P2|COMPLETED|Run-In Period (Pre-assignment)||0
83456|NCT02139644|204502|P1|COMPLETED|Run-In Period (Pre-assignment)||647
83457|NCT02139644|204497|P6|STARTED|Run-In Period (Pre-assignment)||0
83458|NCT02139644|204498|P5|STARTED|Run-In Period (Pre-assignment)||0
83459|NCT02139644|204499|P4|STARTED|Run-In Period (Pre-assignment)||0
83460|NCT02139644|204500|P3|STARTED|Run-In Period (Pre-assignment)||0
83461|NCT02139644|204501|P2|STARTED|Run-In Period (Pre-assignment)||0
83462|NCT02139644|204502|P1|STARTED|Run-In Period (Pre-assignment)|Enrolled|787
83463|NCT02139592|204554|P1|NOT COMPLETED|Overall Study||8
83464|NCT02139592|204554|P1|COMPLETED|Overall Study||284
83465|NCT02139592|204554|P1|STARTED|Overall Study||292
83466|NCT02139358|204560|P1|NOT COMPLETED|Overall Study||0
83467|NCT02139358|204560|P1|COMPLETED|Overall Study||15
83468|NCT02139358|204560|P1|STARTED|Overall Study||15
83469|NCT02139228|204569|P2|NOT COMPLETED|Overall Study||0
83470|NCT02139228|204570|P1|NOT COMPLETED|Overall Study||0
83471|NCT02139228|204569|P2|COMPLETED|Overall Study||211
83472|NCT02139228|204570|P1|COMPLETED|Overall Study||215
83473|NCT02139228|204569|P2|STARTED|Overall Study||211
83474|NCT02139228|204570|P1|STARTED|Overall Study||215
83475|NCT02139176|204580|P2|NOT COMPLETED|Overall Study||0
83476|NCT02139176|204581|P1|NOT COMPLETED|Overall Study||0
83477|NCT02139176|204580|P2|COMPLETED|Overall Study||100
83478|NCT02139176|204581|P1|COMPLETED|Overall Study||100
83479|NCT02139176|204580|P2|STARTED|Overall Study||100
83480|NCT02139176|204581|P1|STARTED|Overall Study||100
83481|NCT02139137|204593|P2|NOT COMPLETED|Overall Study||10
83482|NCT02139137|204594|P1|NOT COMPLETED|Overall Study||7
83483|NCT02139137|204593|P2|COMPLETED|Overall Study||10
83484|NCT02139137|204594|P1|COMPLETED|Overall Study||15
83485|NCT02139137|204593|P2|STARTED|Overall Study||20
83486|NCT02139137|204594|P1|STARTED|Overall Study||22
83487|NCT02139124|204613|P5|NOT COMPLETED|Overall Study||13
83488|NCT02139124|204614|P4|NOT COMPLETED|Overall Study||12
83489|NCT02139124|204615|P3|NOT COMPLETED|Overall Study||4
83490|NCT02139124|204616|P2|NOT COMPLETED|Overall Study||4
83491|NCT02139124|204617|P1|NOT COMPLETED|Overall Study||9
83492|NCT02139124|204613|P5|COMPLETED|Overall Study||61
83493|NCT02139124|204614|P4|COMPLETED|Overall Study||61
83494|NCT02139124|204615|P3|COMPLETED|Overall Study||69
83495|NCT02139124|204616|P2|COMPLETED|Overall Study||73
83496|NCT02139124|204617|P1|COMPLETED|Overall Study||69
83497|NCT02139124|204613|P5|STARTED|Overall Study||74
83498|NCT02139124|204614|P4|STARTED|Overall Study||73
83499|NCT02139124|204615|P3|STARTED|Overall Study||73
83500|NCT02139124|204616|P2|STARTED|Overall Study||77
83501|NCT02139124|204617|P1|STARTED|Overall Study||78
83502|NCT02139046|204634|P5|NOT COMPLETED|Overall Study||57
83503|NCT02139046|204635|P4|NOT COMPLETED|Overall Study||68
83504|NCT02139046|204636|P3|NOT COMPLETED|Overall Study||59
83505|NCT02139046|204637|P2|NOT COMPLETED|Overall Study||54
83506|NCT02139046|204638|P1|NOT COMPLETED|Overall Study||62
83507|NCT02139046|204634|P5|COMPLETED|Overall Study||301
83508|NCT02139046|204635|P4|COMPLETED|Overall Study||290
83509|NCT02139046|204636|P3|COMPLETED|Overall Study||298
83510|NCT02139046|204637|P2|COMPLETED|Overall Study||305
83511|NCT02139046|204638|P1|COMPLETED|Overall Study|Completed=Completed Study Drug|296
83512|NCT02139046|204634|P5|Full Analysis Set|Overall Study||357
83513|NCT02139046|204635|P4|Full Analysis Set|Overall Study||357
83514|NCT02139046|204636|P3|Full Analysis Set|Overall Study||355
83515|NCT02139046|204637|P2|Full Analysis Set|Overall Study||357
83516|NCT02139046|204638|P1|Full Analysis Set|Overall Study||357
83517|NCT02139046|204634|P5|Safety Analysis Set|Overall Study||357
83518|NCT02139046|204635|P4|Safety Analysis Set|Overall Study||357
83519|NCT02139046|204636|P3|Safety Analysis Set|Overall Study||355
83520|NCT02139046|204637|P2|Safety Analysis Set|Overall Study||358
83521|NCT02139046|204638|P1|Safety Analysis Set|Overall Study||356
83522|NCT02139046|204634|P5|STARTED|Overall Study||358
83523|NCT02139046|204635|P4|STARTED|Overall Study||358
83524|NCT02139046|204636|P3|STARTED|Overall Study||357
83525|NCT02139046|204637|P2|STARTED|Overall Study||359
83526|NCT02139046|204638|P1|STARTED|Overall Study||358
83527|NCT02139007|204662|P2|NOT COMPLETED|Patient Participant Recruitment||1
83528|NCT02139007|204663|P1|NOT COMPLETED|Patient Participant Recruitment||2
83529|NCT02139007|204662|P2|COMPLETED|Patient Participant Recruitment||13
83530|NCT02139007|204663|P1|COMPLETED|Patient Participant Recruitment||11
83531|NCT02139007|204662|P2|STARTED|Patient Participant Recruitment||14
83532|NCT02139007|204663|P1|STARTED|Patient Participant Recruitment||13
83533|NCT02139007|204662|P2|NOT COMPLETED|Study Site Recruitment||4
83534|NCT02139007|204663|P1|NOT COMPLETED|Study Site Recruitment||3
83535|NCT02139007|204662|P2|COMPLETED|Study Site Recruitment||1
83536|NCT02139007|204663|P1|COMPLETED|Study Site Recruitment||1
83537|NCT02139007|204662|P2|STARTED|Study Site Recruitment||5
83538|NCT02139007|204663|P1|STARTED|Study Site Recruitment||4
83539|NCT02138916|204679|P3|NOT COMPLETED|Overall Study||59
83540|NCT02138916|204680|P2|NOT COMPLETED|Overall Study||60
83541|NCT02138916|204681|P1|NOT COMPLETED|Overall Study||57
83542|NCT02138916|204679|P3|COMPLETED|Overall Study||491
83543|NCT02138916|204680|P2|COMPLETED|Overall Study||492
83544|NCT02138916|204681|P1|COMPLETED|Overall Study||497
83545|NCT02138916|204679|P3|STARTED|Overall Study||550
83546|NCT02138916|204680|P2|STARTED|Overall Study||552
83547|NCT02138916|204681|P1|STARTED|Overall Study||554
83548|NCT02138890|204744|P2|NOT COMPLETED|Overall Study||0
83549|NCT02138890|204745|P1|NOT COMPLETED|Overall Study||1
83550|NCT02138890|204744|P2|COMPLETED|Overall Study||15
83551|NCT02138890|204745|P1|COMPLETED|Overall Study||30
83552|NCT02138890|204744|P2|STARTED|Overall Study||15
83553|NCT02138890|204745|P1|STARTED|Overall Study||31
83554|NCT02138838|204787|P2|NOT COMPLETED|Overall Study||11
83555|NCT02138838|204788|P1|NOT COMPLETED|Overall Study||8
83556|NCT02138838|204787|P2|COMPLETED|Overall Study||16
83557|NCT02138838|204788|P1|COMPLETED|Overall Study||20
83558|NCT02138838|204787|P2|Received Study Drug|Overall Study||25
83559|NCT02138838|204788|P1|Received Study Drug|Overall Study||28
83560|NCT02138838|204787|P2|STARTED|Overall Study||27
83561|NCT02138838|204788|P1|STARTED|Overall Study||28
83562|NCT02138825|204806|P2|NOT COMPLETED|Safety Follow-up||17
83563|NCT02138825|204807|P1|NOT COMPLETED|Safety Follow-up||22
83564|NCT02138825|204806|P2|COMPLETED|Safety Follow-up||47
83565|NCT02138825|204807|P1|COMPLETED|Safety Follow-up||50
83566|NCT02138825|204806|P2|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|64
83567|NCT02138825|204807|P1|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|72
83568|NCT02138825|204806|P2|NOT COMPLETED|Long-term Extension||38
83569|NCT02138825|204807|P1|NOT COMPLETED|Long-term Extension||32
83570|NCT02138825|204806|P2|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
83571|NCT02138825|204807|P1|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
83572|NCT02138825|204806|P2|STARTED|Long-term Extension||38
83573|NCT02138825|204807|P1|STARTED|Long-term Extension||32
83574|NCT02138825|204806|P2|NOT COMPLETED|Main Study Treatment||35
83575|NCT02138825|204807|P1|NOT COMPLETED|Main Study Treatment||40
83576|NCT02138825|204806|P2|COMPLETED|Main Study Treatment||39
83577|NCT02138825|204807|P1|COMPLETED|Main Study Treatment||33
83578|NCT02138825|204806|P2|STARTED|Main Study Treatment|safety population|74
83579|NCT02138825|204807|P1|STARTED|Main Study Treatment|safety population|73
83580|NCT02138747|204825|P4|NOT COMPLETED|Treatment Period 2||3
83581|NCT02138747|204826|P3|NOT COMPLETED|Treatment Period 2||2
83582|NCT02138747|204827|P2|NOT COMPLETED|Treatment Period 2||7
83583|NCT02138747|204828|P1|NOT COMPLETED|Treatment Period 2||17
83584|NCT02138747|204825|P4|COMPLETED|Treatment Period 2||24
83585|NCT02138747|204826|P3|COMPLETED|Treatment Period 2||24
83586|NCT02138747|204827|P2|COMPLETED|Treatment Period 2||125
83587|NCT02138747|204828|P1|COMPLETED|Treatment Period 2||121
83588|NCT02138747|204825|P4|STARTED|Treatment Period 2|One participant completed treatment in period 1.|27
83589|NCT02138747|204826|P3|STARTED|Treatment Period 2|One participant completed treatment in period 1.|26
83590|NCT02138747|204827|P2|STARTED|Treatment Period 2||132
83591|NCT02138747|204828|P1|STARTED|Treatment Period 2|Two participants who discontinued treatment in period 1 entered period 2.|138
83592|NCT02138747|204825|P4|NOT COMPLETED|Treatment Period 1||4
83593|NCT02138747|204826|P3|NOT COMPLETED|Treatment Period 1||4
83594|NCT02138747|204827|P2|NOT COMPLETED|Treatment Period 1||25
83595|NCT02138747|204828|P1|NOT COMPLETED|Treatment Period 1||20
83596|NCT02138747|204825|P4|COMPLETED|Treatment Period 1||28
83597|NCT02138747|204826|P3|COMPLETED|Treatment Period 1||27
83598|NCT02138747|204827|P2|COMPLETED|Treatment Period 1||132
83599|NCT02138747|204828|P1|COMPLETED|Treatment Period 1||136
83600|NCT02138747|204825|P4|STARTED|Treatment Period 1||32
83601|NCT02138747|204826|P3|STARTED|Treatment Period 1||31
83602|NCT02138747|204827|P2|STARTED|Treatment Period 1||157
83603|NCT02138747|204828|P1|STARTED|Treatment Period 1||156
83604|NCT02138578|204863|P3|NOT COMPLETED|Overall Study||0
83605|NCT02138578|204864|P2|NOT COMPLETED|Overall Study||0
83606|NCT02138578|204865|P1|NOT COMPLETED|Overall Study||0
83607|NCT02138578|204863|P3|COMPLETED|Overall Study||3
83608|NCT02138578|204864|P2|COMPLETED|Overall Study||0
83609|NCT02138578|204865|P1|COMPLETED|Overall Study||1
83610|NCT02138578|204863|P3|STARTED|Overall Study||3
83611|NCT02138578|204864|P2|STARTED|Overall Study||0
83612|NCT02138578|204865|P1|STARTED|Overall Study||1
83613|NCT02138461|204893|P2|NOT COMPLETED|Overall Study||0
83614|NCT02138461|204894|P1|NOT COMPLETED|Overall Study||0
83615|NCT02138461|204893|P2|COMPLETED|Overall Study||110
83616|NCT02138461|204894|P1|COMPLETED|Overall Study||101
83617|NCT02138461|204893|P2|STARTED|Overall Study||110
83618|NCT02138461|204894|P1|STARTED|Overall Study||101
83619|NCT02138240|204900|P1|NOT COMPLETED|Overall Study||0
83620|NCT02138240|204900|P1|COMPLETED|Overall Study||34
83621|NCT02138240|204900|P1|STARTED|Overall Study||34
83622|NCT02138227|204912|P2|NOT COMPLETED|Overall Study||0
83623|NCT02138227|204913|P1|NOT COMPLETED|Overall Study||0
83624|NCT02138227|204912|P2|COMPLETED|Overall Study||218
83625|NCT02138227|204913|P1|COMPLETED|Overall Study||55
83626|NCT02138227|204912|P2|STARTED|Overall Study||218
83627|NCT02138227|204913|P1|STARTED|Overall Study||55
83628|NCT02138110|204944|P1|NOT COMPLETED|6-month Post-implantation Follow-up||3
83629|NCT02138110|204944|P1|COMPLETED|6-month Post-implantation Follow-up||16
83630|NCT02138110|204944|P1|STARTED|6-month Post-implantation Follow-up||19
83631|NCT02138110|204944|P1|NOT COMPLETED|Enrolled for Scaffold Implantation||1
83632|NCT02138110|204944|P1|COMPLETED|Enrolled for Scaffold Implantation||19
83633|NCT02138110|204944|P1|STARTED|Enrolled for Scaffold Implantation||20
83634|NCT02138110|204944|P1|NOT COMPLETED|Enrolled in Study||5
83635|NCT02138110|204944|P1|COMPLETED|Enrolled in Study||20
83636|NCT02138110|204944|P1|STARTED|Enrolled in Study||25
83637|NCT02138097|204972|P2|NOT COMPLETED|Overall Study||0
83638|NCT02138097|204973|P1|NOT COMPLETED|Overall Study||0
83639|NCT02138097|204972|P2|COMPLETED|Overall Study||459722
83640|NCT02138097|204973|P1|COMPLETED|Overall Study||155345
83641|NCT02138097|204972|P2|STARTED|Overall Study||459722
83642|NCT02138097|204973|P1|STARTED|Overall Study||155345
83643|NCT02138006|205165|P2|NOT COMPLETED|Overall Study||0
83644|NCT02138006|205166|P1|NOT COMPLETED|Overall Study||0
83645|NCT02138006|205165|P2|COMPLETED|Overall Study||54
83646|NCT02138006|205166|P1|COMPLETED|Overall Study||48
83647|NCT02138006|205165|P2|STARTED|Overall Study||54
83648|NCT02138006|205166|P1|STARTED|Overall Study||48
83649|NCT02137785|205176|P2|NOT COMPLETED|Overall Study||4
83650|NCT02137785|205177|P1|NOT COMPLETED|Overall Study||3
83651|NCT02137785|205176|P2|COMPLETED|Overall Study||130
83652|NCT02137785|205177|P1|COMPLETED|Overall Study||132
83653|NCT02137785|205176|P2|STARTED|Overall Study||134
83654|NCT02137785|205177|P1|STARTED|Overall Study||135
83655|NCT02137772|205285|P2|NOT COMPLETED|Overall Study||75
83656|NCT02137772|205286|P1|NOT COMPLETED|Overall Study||132
83657|NCT02137772|205285|P2|COMPLETED|Overall Study||119
83658|NCT02137772|205286|P1|COMPLETED|Overall Study||244
83659|NCT02137772|205285|P2|Treated Participants|Overall Study||192
83660|NCT02137772|205286|P1|Treated Participants|Overall Study||373
83661|NCT02137772|205285|P2|STARTED|Overall Study|Randomized participants|194
83662|NCT02137772|205286|P1|STARTED|Overall Study|Randomized participants|376
83663|NCT02137603|205312|P2|NOT COMPLETED|Overall Study||0
83664|NCT02137603|205313|P1|NOT COMPLETED|Overall Study||2
83665|NCT02137603|205312|P2|COMPLETED|Overall Study||18
83666|NCT02137603|205313|P1|COMPLETED|Overall Study||16
83667|NCT02137603|205312|P2|STARTED|Overall Study||18
83668|NCT02137603|205313|P1|STARTED|Overall Study||18
83669|NCT02137512|205321|P1|NOT COMPLETED|5-Month 24/7 Closed-Loop||0
83670|NCT02137512|205321|P1|COMPLETED|5-Month 24/7 Closed-Loop||14
83671|NCT02137512|205321|P1|STARTED|5-Month 24/7 Closed-Loop||14
83672|NCT02137512|205321|P1|NOT COMPLETED|2-Week 24/7 Closed-Loop||0
83673|NCT02137512|205321|P1|COMPLETED|2-Week 24/7 Closed-Loop||30
83674|NCT02137512|205321|P1|STARTED|2-Week 24/7 Closed-Loop||30
83675|NCT02137512|205321|P1|NOT COMPLETED|2-Week Overnight-Only Closed-Loop||0
83676|NCT02137512|205321|P1|COMPLETED|2-Week Overnight-Only Closed-Loop||30
83677|NCT02137512|205321|P1|STARTED|2-Week Overnight-Only Closed-Loop||30
83678|NCT02137512|205321|P1|NOT COMPLETED|2-Week Baseline Sensor-Augmented Pump||0
83679|NCT02137512|205321|P1|COMPLETED|2-Week Baseline Sensor-Augmented Pump||30
83680|NCT02137512|205321|P1|STARTED|2-Week Baseline Sensor-Augmented Pump||30
83681|NCT02137499|205478|P4|NOT COMPLETED|Overall Study||0
83682|NCT02137499|205479|P3|NOT COMPLETED|Overall Study||0
83683|NCT02137499|205480|P2|NOT COMPLETED|Overall Study||0
83684|NCT02137499|205481|P1|NOT COMPLETED|Overall Study||0
83685|NCT02137499|205478|P4|COMPLETED|Overall Study||10
83686|NCT02137499|205479|P3|COMPLETED|Overall Study||10
83687|NCT02137499|205480|P2|COMPLETED|Overall Study||10
83688|NCT02137499|205481|P1|COMPLETED|Overall Study||10
83689|NCT02137499|205478|P4|STARTED|Overall Study||10
83690|NCT02137499|205479|P3|STARTED|Overall Study||10
83691|NCT02137499|205480|P2|STARTED|Overall Study||10
83692|NCT02137499|205481|P1|STARTED|Overall Study||10
83693|NCT02137486|205501|P2|NOT COMPLETED|Overall Study||0
83694|NCT02137486|205502|P1|NOT COMPLETED|Overall Study||0
83695|NCT02137486|205501|P2|COMPLETED|Overall Study||102
83696|NCT02137486|205502|P1|COMPLETED|Overall Study||112
83697|NCT02137486|205501|P2|STARTED|Overall Study||102
83698|NCT02137486|205502|P1|STARTED|Overall Study||112
83699|NCT02137447|205518|P1|NOT COMPLETED|Overall Study||0
83700|NCT02137447|205518|P1|COMPLETED|Overall Study||10
83701|NCT02137447|205518|P1|STARTED|Overall Study||10
83702|NCT02137382|205523|P2|NOT COMPLETED|Cross-over Period 2||0
83703|NCT02137382|205524|P1|NOT COMPLETED|Cross-over Period 2||0
83704|NCT02137382|205523|P2|COMPLETED|Cross-over Period 2||21
83705|NCT02137382|205524|P1|COMPLETED|Cross-over Period 2||18
83706|NCT02137382|205523|P2|STARTED|Cross-over Period 2||21
83707|NCT02137382|205524|P1|STARTED|Cross-over Period 2||18
83708|NCT02137382|205523|P2|NOT COMPLETED|Wash Out||0
83709|NCT02137382|205524|P1|NOT COMPLETED|Wash Out||0
83710|NCT02137382|205523|P2|COMPLETED|Wash Out||21
83711|NCT02137382|205524|P1|COMPLETED|Wash Out||18
83712|NCT02137382|205523|P2|STARTED|Wash Out||21
83713|NCT02137382|205524|P1|STARTED|Wash Out||18
83714|NCT02137382|205523|P2|NOT COMPLETED|Cross-over Period 1||0
83715|NCT02137382|205524|P1|NOT COMPLETED|Cross-over Period 1||2
83716|NCT02137382|205523|P2|COMPLETED|Cross-over Period 1||21
83717|NCT02137382|205524|P1|COMPLETED|Cross-over Period 1||18
83718|NCT02137382|205523|P2|STARTED|Cross-over Period 1||21
83719|NCT02137382|205524|P1|STARTED|Cross-over Period 1||20
83720|NCT02137226|205544|P5|NOT COMPLETED|Period 2 (Re - Randomization)||9
83721|NCT02137226|205545|P4|NOT COMPLETED|Period 2 (Re - Randomization)||8
83722|NCT02137226|205546|P3|NOT COMPLETED|Period 2 (Re - Randomization)||17
83723|NCT02137226|205547|P2|NOT COMPLETED|Period 2 (Re - Randomization)||0
83724|NCT02137226|205548|P1|NOT COMPLETED|Period 2 (Re - Randomization)||0
83725|NCT02137226|205544|P5|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|138
83726|NCT02137226|205545|P4|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|140
83727|NCT02137226|205546|P3|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|281
83728|NCT02137226|205547|P2|COMPLETED|Period 2 (Re - Randomization)||0
83729|NCT02137226|205548|P1|COMPLETED|Period 2 (Re - Randomization)||0
83730|NCT02137226|205544|P5|STARTED|Period 2 (Re - Randomization)||147
83731|NCT02137226|205545|P4|STARTED|Period 2 (Re - Randomization)||148
83732|NCT02137226|205546|P3|STARTED|Period 2 (Re - Randomization)||298
83733|NCT02137226|205547|P2|STARTED|Period 2 (Re - Randomization)||0
83734|NCT02137226|205548|P1|STARTED|Period 2 (Re - Randomization)||0
83735|NCT02137226|205544|P5|NOT COMPLETED|Period 1 (Initial Randomization)||0
83736|NCT02137226|205545|P4|NOT COMPLETED|Period 1 (Initial Randomization)||0
83737|NCT02137226|205546|P3|NOT COMPLETED|Period 1 (Initial Randomization)||0
83738|NCT02137226|205547|P2|NOT COMPLETED|Period 1 (Initial Randomization)||16
83739|NCT02137226|205548|P1|NOT COMPLETED|Period 1 (Initial Randomization)||20
83740|NCT02137226|205544|P5|COMPLETED|Period 1 (Initial Randomization)||0
83741|NCT02137226|205545|P4|COMPLETED|Period 1 (Initial Randomization)||0
83742|NCT02137226|205546|P3|COMPLETED|Period 1 (Initial Randomization)||0
83743|NCT02137226|205547|P2|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|305
83744|NCT02137226|205548|P1|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|304
83745|NCT02137226|205544|P5|STARTED|Period 1 (Initial Randomization)||0
83746|NCT02137226|205545|P4|STARTED|Period 1 (Initial Randomization)||0
83747|NCT02137226|205546|P3|STARTED|Period 1 (Initial Randomization)||0
83748|NCT02137226|205547|P2|STARTED|Period 1 (Initial Randomization)||321
83749|NCT02137226|205548|P1|STARTED|Period 1 (Initial Randomization)||324
83750|NCT02137096|205560|P1|NOT COMPLETED|Overall Study||0
83751|NCT02137096|205560|P1|COMPLETED|Overall Study||1
83752|NCT02137096|205560|P1|STARTED|Overall Study||1
83753|NCT02136914|205566|P2|NOT COMPLETED|Overall Study||21
83754|NCT02136914|205567|P1|NOT COMPLETED|Overall Study||21
83755|NCT02136914|205566|P2|COMPLETED|Overall Study||42
83756|NCT02136914|205567|P1|COMPLETED|Overall Study||42
83757|NCT02136914|205566|P2|Received Study Drug|Overall Study||63
83758|NCT02136914|205567|P1|Received Study Drug|Overall Study||60
83759|NCT02136914|205566|P2|STARTED|Overall Study||63
83760|NCT02136914|205567|P1|STARTED|Overall Study||63
83761|NCT02136810|205581|P1|NOT COMPLETED|Overall Study||0
83762|NCT02136810|205581|P1|COMPLETED|Overall Study||200
83763|NCT02136810|205581|P1|STARTED|Overall Study||200
83764|NCT02136680|205587|P2|NOT COMPLETED|Overall Study||29
83765|NCT02136680|205588|P1|NOT COMPLETED|Overall Study||32
83766|NCT02136680|205587|P2|COMPLETED|Overall Study||56
83767|NCT02136680|205588|P1|COMPLETED|Overall Study||80
83768|NCT02136680|205587|P2|Interview 3|Overall Study||56
83769|NCT02136680|205588|P1|Interview 3|Overall Study||80
83770|NCT02136680|205587|P2|Interview 2|Overall Study||70
83771|NCT02136680|205588|P1|Interview 2|Overall Study||97
83772|NCT02136680|205587|P2|Interview 1|Overall Study||85
83773|NCT02136680|205588|P1|Interview 1|Overall Study||112
83774|NCT02136680|205587|P2|STARTED|Overall Study||85
83775|NCT02136680|205588|P1|STARTED|Overall Study||112
83776|NCT02136498|205604|P2|NOT COMPLETED|Overall Study||0
83777|NCT02136498|205605|P1|NOT COMPLETED|Overall Study||0
83778|NCT02136498|205604|P2|COMPLETED|Overall Study||33
83779|NCT02136498|205605|P1|COMPLETED|Overall Study||33
83780|NCT02136498|205604|P2|STARTED|Overall Study||33
83781|NCT02136498|205605|P1|STARTED|Overall Study||33
83782|NCT02136420|205617|P10|NOT COMPLETED|Overall Study||0
83783|NCT02136420|205618|P9|NOT COMPLETED|Overall Study||0
83784|NCT02136420|205619|P8|NOT COMPLETED|Overall Study||0
83785|NCT02136420|205620|P7|NOT COMPLETED|Overall Study||0
83786|NCT02136420|205621|P6|NOT COMPLETED|Overall Study||0
83787|NCT02136420|205622|P5|NOT COMPLETED|Overall Study||0
83788|NCT02136420|205623|P4|NOT COMPLETED|Overall Study||0
83789|NCT02136420|205624|P3|NOT COMPLETED|Overall Study||0
83790|NCT02136420|205625|P2|NOT COMPLETED|Overall Study||0
83791|NCT02136420|205626|P1|NOT COMPLETED|Overall Study||1
83792|NCT02136420|205617|P10|COMPLETED|Overall Study||5
83793|NCT02136420|205618|P9|COMPLETED|Overall Study||5
83794|NCT02136420|205619|P8|COMPLETED|Overall Study||0
83795|NCT02136420|205620|P7|COMPLETED|Overall Study||0
83796|NCT02136420|205621|P6|COMPLETED|Overall Study||0
83797|NCT02136420|205622|P5|COMPLETED|Overall Study||10
83798|NCT02136420|205623|P4|COMPLETED|Overall Study||0
83799|NCT02136420|205624|P3|COMPLETED|Overall Study||0
83800|NCT02136420|205625|P2|COMPLETED|Overall Study||0
83801|NCT02136420|205626|P1|COMPLETED|Overall Study||9
83802|NCT02136420|205617|P10|STARTED|Overall Study||5
83803|NCT02136420|205618|P9|STARTED|Overall Study||5
83804|NCT02136420|205619|P8|STARTED|Overall Study||0
83805|NCT02136420|205620|P7|STARTED|Overall Study||0
83806|NCT02136420|205621|P6|STARTED|Overall Study||0
83807|NCT02136420|205622|P5|STARTED|Overall Study||10
83808|NCT02136420|205623|P4|STARTED|Overall Study||0
83809|NCT02136420|205624|P3|STARTED|Overall Study||0
83810|NCT02136420|205625|P2|STARTED|Overall Study||0
83811|NCT02136420|205626|P1|STARTED|Overall Study||10
83812|NCT02136238|205648|P3|NOT COMPLETED|Overall Study||0
83813|NCT02136238|205649|P2|NOT COMPLETED|Overall Study||0
83814|NCT02136238|205650|P1|NOT COMPLETED|Overall Study||0
83815|NCT02136238|205648|P3|COMPLETED|Overall Study||10
83816|NCT02136238|205649|P2|COMPLETED|Overall Study||4
83817|NCT02136238|205650|P1|COMPLETED|Overall Study||4
83818|NCT02136238|205648|P3|STARTED|Overall Study||10
83819|NCT02136238|205649|P2|STARTED|Overall Study||4
83820|NCT02136238|205650|P1|STARTED|Overall Study||4
83821|NCT02136134|205663|P2|NOT COMPLETED|Overall Study||251
83822|NCT02136134|205664|P1|NOT COMPLETED|Overall Study||247
83823|NCT02136134|205663|P2|COMPLETED|Overall Study||0
83824|NCT02136134|205664|P1|COMPLETED|Overall Study||0
83825|NCT02136134|205663|P2|Treated|Overall Study||243
83826|NCT02136134|205664|P1|Treated|Overall Study||237
83827|NCT02136134|205663|P2|STARTED|Overall Study||251
83828|NCT02136134|205664|P1|STARTED|Overall Study||247
83829|NCT02136004|205682|P1|NOT COMPLETED|Overall Study||1
83830|NCT02136004|205682|P1|COMPLETED|Overall Study||219
83831|NCT02136004|205682|P1|STARTED|Overall Study|Enrollment commenced on May 20, 2014 and the last subject completed follow-up on February 28, 2015|220
83832|NCT02135900|205693|P1|NOT COMPLETED|Overall Study||0
83833|NCT02135900|205693|P1|COMPLETED|Overall Study||32
83834|NCT02135900|205693|P1|STARTED|Overall Study|32 subjects started the study. 50 subjects were screened.|32
83835|NCT02135861|205703|P3|NOT COMPLETED|Overall Study||0
83836|NCT02135861|205704|P2|NOT COMPLETED|Overall Study||0
83837|NCT02135861|205705|P1|NOT COMPLETED|Overall Study||0
83838|NCT02135861|205703|P3|COMPLETED|Overall Study||3
83839|NCT02135861|205704|P2|COMPLETED|Overall Study||12
83840|NCT02135861|205705|P1|COMPLETED|Overall Study||21
83841|NCT02135861|205703|P3|STARTED|Overall Study||3
83842|NCT02135861|205704|P2|STARTED|Overall Study||12
83843|NCT02135861|205705|P1|STARTED|Overall Study||21
83844|NCT02135848|205726|P2|NOT COMPLETED|Overall Study||1
83845|NCT02135848|205727|P1|NOT COMPLETED|Overall Study||3
83846|NCT02135848|205726|P2|COMPLETED|Overall Study||19
83847|NCT02135848|205727|P1|COMPLETED|Overall Study||23
83848|NCT02135848|205726|P2|STARTED|Overall Study||20
83849|NCT02135848|205727|P1|STARTED|Overall Study||26
83850|NCT02135692|205785|P1|NOT COMPLETED|Overall Study||339
83851|NCT02135692|205785|P1|COMPLETED|Overall Study||0
83852|NCT02135692|205785|P1|STARTED|Overall Study||339
83853|NCT02135614|205804|P2|NOT COMPLETED|Overall Study||5
83854|NCT02135614|205805|P1|NOT COMPLETED|Overall Study||8
83855|NCT02135614|205804|P2|COMPLETED|Overall Study||90
83856|NCT02135614|205805|P1|COMPLETED|Overall Study||86
83857|NCT02135614|205804|P2|STARTED|Overall Study||95
83858|NCT02135614|205805|P1|STARTED|Overall Study||94
83859|NCT02135445|205819|P2|NOT COMPLETED|Overall Study||0
83860|NCT02135445|205820|P1|NOT COMPLETED|Overall Study||2
83861|NCT02135445|205819|P2|COMPLETED|Overall Study||38
83862|NCT02135445|205820|P1|COMPLETED|Overall Study||63
83863|NCT02135445|205819|P2|STARTED|Overall Study||38
83864|NCT02135445|205820|P1|STARTED|Overall Study||65
83865|NCT02135432|205871|P2|NOT COMPLETED|Overall Study||0
83866|NCT02135432|205872|P1|NOT COMPLETED|Overall Study||0
83867|NCT02135432|205871|P2|COMPLETED|Overall Study||4
83868|NCT02135432|205872|P1|COMPLETED|Overall Study||8
83869|NCT02135432|205871|P2|STARTED|Overall Study||4
83870|NCT02135432|205872|P1|STARTED|Overall Study||8
83871|NCT02135107|205886|P4|NOT COMPLETED|Maintenance Therapy Period||20
83872|NCT02135107|205887|P3|NOT COMPLETED|Maintenance Therapy Period||15
83873|NCT02135107|205888|P2|NOT COMPLETED|Maintenance Therapy Period||0
83874|NCT02135107|205889|P1|NOT COMPLETED|Maintenance Therapy Period||0
83875|NCT02135107|205886|P4|COMPLETED|Maintenance Therapy Period||161
83876|NCT02135107|205887|P3|COMPLETED|Maintenance Therapy Period||163
83877|NCT02135107|205888|P2|COMPLETED|Maintenance Therapy Period||0
83878|NCT02135107|205889|P1|COMPLETED|Maintenance Therapy Period||0
83879|NCT02135107|205886|P4|STARTED|Maintenance Therapy Period|Only eligible participants entered into the Maintenance Therapy Period|181
83880|NCT02135107|205887|P3|STARTED|Maintenance Therapy Period|Only eligible participants entered into the Maintenance Therapy Period|178
83881|NCT02135107|205888|P2|STARTED|Maintenance Therapy Period|Treatment Phase only|0
83882|NCT02135107|205889|P1|STARTED|Maintenance Therapy Period|Treatment Phase only|0
83883|NCT02135107|205886|P4|NOT COMPLETED|Treatment Period||0
83884|NCT02135107|205887|P3|NOT COMPLETED|Treatment Period||0
83885|NCT02135107|205888|P2|NOT COMPLETED|Treatment Period||26
83886|NCT02135107|205889|P1|NOT COMPLETED|Treatment Period||132
83887|NCT02135107|205886|P4|COMPLETED|Treatment Period||0
83888|NCT02135107|205887|P3|COMPLETED|Treatment Period||0
83889|NCT02135107|205888|P2|COMPLETED|Treatment Period||54
83890|NCT02135107|205889|P1|COMPLETED|Treatment Period||305
83891|NCT02135107|205886|P4|STARTED|Treatment Period||0
83892|NCT02135107|205887|P3|STARTED|Treatment Period||0
83893|NCT02135107|205888|P2|STARTED|Treatment Period||80
83894|NCT02135107|205889|P1|STARTED|Treatment Period||437
83895|NCT02135094|205917|P2|NOT COMPLETED|Overall Study||0
83896|NCT02135094|205918|P1|NOT COMPLETED|Overall Study||0
83897|NCT02135094|205917|P2|COMPLETED|Overall Study||8
83898|NCT02135094|205918|P1|COMPLETED|Overall Study||25
83899|NCT02135094|205917|P2|Week 4|Overall Study||8
83900|NCT02135094|205918|P1|Week 4|Overall Study||25
83901|NCT02135094|205917|P2|Week 3|Overall Study||8
83902|NCT02135094|205918|P1|Week 3|Overall Study||25
83903|NCT02135094|205917|P2|Week 2|Overall Study||8
83904|NCT02135094|205918|P1|Week 2|Overall Study||25
83905|NCT02135094|205917|P2|STARTED|Overall Study||8
83906|NCT02135094|205918|P1|STARTED|Overall Study||25
83907|NCT02135029|205935|P3|NOT COMPLETED|Overall Study||3
83908|NCT02135029|205936|P2|NOT COMPLETED|Overall Study||5
83909|NCT02135029|205937|P1|NOT COMPLETED|Overall Study||4
83910|NCT02135029|205935|P3|COMPLETED|Overall Study||34
83911|NCT02135029|205936|P2|COMPLETED|Overall Study||69
83912|NCT02135029|205937|P1|COMPLETED|Overall Study||69
83913|NCT02135029|205935|P3|Treated|Overall Study||36
83914|NCT02135029|205936|P2|Treated|Overall Study||74
83915|NCT02135029|205937|P1|Treated|Overall Study||73
83916|NCT02135029|205935|P3|STARTED|Overall Study||37
83917|NCT02135029|205936|P2|STARTED|Overall Study||74
83918|NCT02135029|205937|P1|STARTED|Overall Study||73
83919|NCT02135016|206020|P3|NOT COMPLETED|Overall Study||0
83920|NCT02135016|206021|P2|NOT COMPLETED|Overall Study||0
83921|NCT02135016|206022|P1|NOT COMPLETED|Overall Study||0
83922|NCT02135016|206020|P3|COMPLETED|Overall Study||15
83923|NCT02135016|206021|P2|COMPLETED|Overall Study||15
83924|NCT02135016|206022|P1|COMPLETED|Overall Study||15
83925|NCT02135016|206020|P3|STARTED|Overall Study||15
83926|NCT02135016|206021|P2|STARTED|Overall Study||15
83927|NCT02135016|206022|P1|STARTED|Overall Study||15
83928|NCT02134977|206042|P1|NOT COMPLETED|Overall Study||102
83929|NCT02134977|206042|P1|COMPLETED|Overall Study||2714
83930|NCT02134977|206042|P1|STARTED|Overall Study||2816
83931|NCT02134951|206065|P2|NOT COMPLETED|Overall Study||0
83932|NCT02134951|206066|P1|NOT COMPLETED|Overall Study||0
83933|NCT02134951|206065|P2|COMPLETED|Overall Study|number of subjects with at least one valid scan|20
83934|NCT02134951|206066|P1|COMPLETED|Overall Study|number of subjects with at least one valid scan|39
83935|NCT02134951|206065|P2|STARTED|Overall Study||20
83936|NCT02134951|206066|P1|STARTED|Overall Study||39
83937|NCT02134925|206076|P2|NOT COMPLETED|Overall Study||6
83938|NCT02134925|206077|P1|NOT COMPLETED|Overall Study||2
83939|NCT02134925|206076|P2|COMPLETED|Overall Study||50
83940|NCT02134925|206077|P1|COMPLETED|Overall Study||52
83941|NCT02134925|206076|P2|STARTED|Overall Study||56
83942|NCT02134925|206077|P1|STARTED|Overall Study||54
83943|NCT02134912|206087|P2|NOT COMPLETED|Overall Study||0
83944|NCT02134912|206088|P1|NOT COMPLETED|Overall Study||0
83945|NCT02134912|206087|P2|COMPLETED|Overall Study||0
83946|NCT02134912|206088|P1|COMPLETED|Overall Study||0
83947|NCT02134912|206087|P2|STARTED|Overall Study||0
83948|NCT02134912|206088|P1|STARTED|Overall Study||0
83949|NCT02134717|206104|P1|NOT COMPLETED|Overall Study||0
83950|NCT02134717|206104|P1|COMPLETED|Overall Study||3
83951|NCT02134717|206104|P1|STARTED|Overall Study||3
83952|NCT02134587|206110|P1|NOT COMPLETED|Overall Study||30
83953|NCT02134587|206110|P1|COMPLETED|Overall Study||173
83954|NCT02134587|206110|P1|STARTED|Overall Study||203
83955|NCT02134522|206119|P1|NOT COMPLETED|Overall Study||0
83956|NCT02134522|206119|P1|COMPLETED|Overall Study||1
83957|NCT02134522|206119|P1|STARTED|Overall Study||1
83958|NCT02134314|206126|P2|NOT COMPLETED|Overall Study||1
83959|NCT02134314|206127|P1|NOT COMPLETED|Overall Study||1
83960|NCT02134314|206126|P2|COMPLETED|Overall Study||34
83961|NCT02134314|206127|P1|COMPLETED|Overall Study||34
83962|NCT02134314|206126|P2|STARTED|Overall Study||35
83963|NCT02134314|206127|P1|STARTED|Overall Study||35
83964|NCT02134210|206159|P2|NOT COMPLETED|Part Two: Weeks 13-48||28
83965|NCT02134210|206160|P1|NOT COMPLETED|Part Two: Weeks 13-48||30
83966|NCT02134210|206159|P2|COMPLETED|Part Two: Weeks 13-48||227
83967|NCT02134210|206160|P1|COMPLETED|Part Two: Weeks 13-48||211
83968|NCT02134210|206159|P2|STARTED|Part Two: Weeks 13-48||255
83969|NCT02134210|206160|P1|STARTED|Part Two: Weeks 13-48||241
83970|NCT02134210|206159|P2|NOT COMPLETED|Part One: Weeks 0-12||6
83971|NCT02134210|206160|P1|NOT COMPLETED|Part One: Weeks 0-12||19
83972|NCT02134210|206159|P2|COMPLETED|Part One: Weeks 0-12||255
83973|NCT02134210|206160|P1|COMPLETED|Part One: Weeks 0-12||241
83974|NCT02134210|206159|P2|STARTED|Part One: Weeks 0-12||261
83975|NCT02134210|206160|P1|STARTED|Part One: Weeks 0-12||260
83976|NCT02134184|206193|P3|NOT COMPLETED|Overall Study||0
83977|NCT02134184|206194|P2|NOT COMPLETED|Overall Study||0
83978|NCT02134184|206195|P1|NOT COMPLETED|Overall Study||0
83979|NCT02134184|206193|P3|COMPLETED|Overall Study||8
83980|NCT02134184|206194|P2|COMPLETED|Overall Study||37
83981|NCT02134184|206195|P1|COMPLETED|Overall Study||33
83982|NCT02134184|206193|P3|STARTED|Overall Study||8
83983|NCT02134184|206194|P2|STARTED|Overall Study||37
83984|NCT02134184|206195|P1|STARTED|Overall Study||33
83985|NCT02134119|206208|P2|NOT COMPLETED|Overall Study||0
83986|NCT02134119|206209|P1|NOT COMPLETED|Overall Study||0
83987|NCT02134119|206208|P2|COMPLETED|Overall Study||15
83988|NCT02134119|206209|P1|COMPLETED|Overall Study||30
83989|NCT02134119|206208|P2|STARTED|Overall Study||15
83990|NCT02134119|206209|P1|STARTED|Overall Study||30
83991|NCT02134015|206249|P2|NOT COMPLETED|Overall Study||74
83992|NCT02134015|206250|P1|NOT COMPLETED|Overall Study||71
83993|NCT02134015|206249|P2|COMPLETED|Overall Study||0
83994|NCT02134015|206250|P1|COMPLETED|Overall Study||0
83995|NCT02134015|206249|P2|STARTED|Overall Study||74
83996|NCT02134015|206250|P1|STARTED|Overall Study||71
83997|NCT02133781|206273|P3|NOT COMPLETED|Overall Study||0
83998|NCT02133781|206274|P2|NOT COMPLETED|Overall Study||0
83999|NCT02133781|206275|P1|NOT COMPLETED|Overall Study||0
84000|NCT02133781|206273|P3|COMPLETED|Overall Study||21
84001|NCT02133781|206274|P2|COMPLETED|Overall Study||24
84002|NCT02133781|206275|P1|COMPLETED|Overall Study||6
84003|NCT02133781|206273|P3|STARTED|Overall Study||21
84004|NCT02133781|206274|P2|STARTED|Overall Study||24
84005|NCT02133781|206275|P1|STARTED|Overall Study||6
84006|NCT02133742|206286|P1|NOT COMPLETED|Period 2:Dose Expansion Phase (903 Days)||52
84007|NCT02133742|206286|P1|COMPLETED|Period 2:Dose Expansion Phase (903 Days)||0
84008|NCT02133742|206286|P1|STARTED|Period 2:Dose Expansion Phase (903 Days)|Participants participated in dose finding phase continued treatment in dose expansion phase.|52
84009|NCT02133742|206286|P1|NOT COMPLETED|Period 1: Dose Finding Phase (6 Months)||0
84010|NCT02133742|206286|P1|COMPLETED|Period 1: Dose Finding Phase (6 Months)||11
84011|NCT02133742|206286|P1|STARTED|Period 1: Dose Finding Phase (6 Months)||11
84012|NCT02133664|206305|P2|NOT COMPLETED|Overall Study||7
84013|NCT02133664|206306|P1|NOT COMPLETED|Overall Study||5
84014|NCT02133664|206305|P2|COMPLETED|Overall Study||21
84015|NCT02133664|206306|P1|COMPLETED|Overall Study||21
84016|NCT02133664|206305|P2|STARTED|Overall Study||28
84017|NCT02133664|206306|P1|STARTED|Overall Study||26
84018|NCT02133534|206318|P1|NOT COMPLETED|Overall Study||0
84019|NCT02133534|206318|P1|COMPLETED|Overall Study||1
84020|NCT02133534|206318|P1|STARTED|Overall Study||1
84021|NCT02133508|206322|P1|NOT COMPLETED|Overall Study||15
84022|NCT02133508|206322|P1|COMPLETED|Overall Study||141
84023|NCT02133508|206322|P1|STARTED|Overall Study||156
84024|NCT02133352|206330|P1|NOT COMPLETED|Longer Term Extension||6
84025|NCT02133352|206330|P1|COMPLETED|Longer Term Extension||4
84026|NCT02133352|206330|P1|STARTED|Longer Term Extension||10
84027|NCT02133352|206330|P1|NOT COMPLETED|Main Study (180 Day)||0
84028|NCT02133352|206330|P1|COMPLETED|Main Study (180 Day)||10
84029|NCT02133352|206330|P1|STARTED|Main Study (180 Day)||10
84030|NCT02133235|206341|P2|NOT COMPLETED|Overall Study||0
84031|NCT02133235|206342|P1|NOT COMPLETED|Overall Study||0
84032|NCT02133235|206341|P2|COMPLETED|Overall Study||57
84033|NCT02133235|206342|P1|COMPLETED|Overall Study||55
84034|NCT02133235|206341|P2|STARTED|Overall Study||57
84035|NCT02133235|206342|P1|STARTED|Overall Study||55
84036|NCT02133131|206361|P7|NOT COMPLETED|Overall Study||12
84037|NCT02133131|206362|P6|NOT COMPLETED|Overall Study||14
84038|NCT02133131|206363|P5|NOT COMPLETED|Overall Study||15
84039|NCT02133131|206364|P4|NOT COMPLETED|Overall Study||6
84040|NCT02133131|206365|P3|NOT COMPLETED|Overall Study||1
84041|NCT02133131|206366|P2|NOT COMPLETED|Overall Study||5
84042|NCT02133131|206367|P1|NOT COMPLETED|Overall Study||5
84043|NCT02133131|206361|P7|COMPLETED|Overall Study||0
84044|NCT02133131|206362|P6|COMPLETED|Overall Study||0
84045|NCT02133131|206363|P5|COMPLETED|Overall Study||0
84046|NCT02133131|206364|P4|COMPLETED|Overall Study||15
84047|NCT02133131|206365|P3|COMPLETED|Overall Study||19
84048|NCT02133131|206366|P2|COMPLETED|Overall Study||25
84049|NCT02133131|206367|P1|COMPLETED|Overall Study||26
84050|NCT02133131|206361|P7|STARTED|Overall Study||12
84051|NCT02133131|206362|P6|STARTED|Overall Study||14
84052|NCT02133131|206363|P5|STARTED|Overall Study||15
84053|NCT02133131|206364|P4|STARTED|Overall Study||21
84054|NCT02133131|206365|P3|STARTED|Overall Study||20
84055|NCT02133131|206366|P2|STARTED|Overall Study||30
84056|NCT02133131|206367|P1|STARTED|Overall Study||31
84057|NCT02133066|206406|P2|NOT COMPLETED|Overall Study||0
84058|NCT02133066|206407|P1|NOT COMPLETED|Overall Study||0
84059|NCT02133066|206406|P2|COMPLETED|Overall Study||64
84060|NCT02133066|206407|P1|COMPLETED|Overall Study||64
84061|NCT02133066|206406|P2|STARTED|Overall Study||64
84062|NCT02133066|206407|P1|STARTED|Overall Study||64
84063|NCT02133001|206421|P2|NOT COMPLETED|Follow-Up Phase (Day 26-81)||3
84064|NCT02133001|206422|P1|NOT COMPLETED|Follow-Up Phase (Day 26-81)||2
84065|NCT02133001|206421|P2|COMPLETED|Follow-Up Phase (Day 26-81)||24
84066|NCT02133001|206422|P1|COMPLETED|Follow-Up Phase (Day 26-81)||20
84067|NCT02133001|206421|P2|STARTED|Follow-Up Phase (Day 26-81)||27
84068|NCT02133001|206422|P1|STARTED|Follow-Up Phase (Day 26-81)||22
84069|NCT02133001|206421|P2|NOT COMPLETED|Double Blind (Day 1-25)||9
84070|NCT02133001|206422|P1|NOT COMPLETED|Double Blind (Day 1-25)||10
84071|NCT02133001|206421|P2|COMPLETED|Double Blind (Day 1-25)|Participants who completed continued to follow-up phase.|27
84072|NCT02133001|206422|P1|COMPLETED|Double Blind (Day 1-25)|Participants who completed continued to follow-up phase.|22
84073|NCT02133001|206421|P2|Safety|Double Blind (Day 1-25)||35
84074|NCT02133001|206422|P1|Safety|Double Blind (Day 1-25)||31
84075|NCT02133001|206421|P2|STARTED|Double Blind (Day 1-25)||36
84076|NCT02133001|206422|P1|STARTED|Double Blind (Day 1-25)||32
84077|NCT02132949|206470|P2|NOT COMPLETED|Adjuvant Treatment Period||167
84078|NCT02132949|206471|P1|NOT COMPLETED|Adjuvant Treatment Period||149
84079|NCT02132949|206470|P2|COMPLETED|Adjuvant Treatment Period||23
84080|NCT02132949|206471|P1|COMPLETED|Adjuvant Treatment Period||29
84081|NCT02132949|206470|P2|STARTED|Adjuvant Treatment Period|Includes a participant who did not complete neoadjuvant treatment but started adjuvant treatment.|190
84082|NCT02132949|206471|P1|STARTED|Adjuvant Treatment Period|At clinical cutoff (03 March 2016), some participants had not yet received adjuvant treatment.|178
84083|NCT02132949|206470|P2|NOT COMPLETED|Neoadjuvant Treatment Period||12
84084|NCT02132949|206471|P1|NOT COMPLETED|Neoadjuvant Treatment Period||17
84085|NCT02132949|206470|P2|COMPLETED|Neoadjuvant Treatment Period||189
84086|NCT02132949|206471|P1|COMPLETED|Neoadjuvant Treatment Period||182
84087|NCT02132949|206470|P2|No Treatment|Neoadjuvant Treatment Period||3
84088|NCT02132949|206471|P1|No Treatment|Neoadjuvant Treatment Period||1
84089|NCT02132949|206470|P2|STARTED|Neoadjuvant Treatment Period||201
84090|NCT02132949|206471|P1|STARTED|Neoadjuvant Treatment Period|A participant enrolled in Cohort B received Cohort A treatment, hence counted under Cohort A.|199
84091|NCT02132936|206503|P4|NOT COMPLETED|Overall Study||14
84092|NCT02132936|206504|P3|NOT COMPLETED|Overall Study||14
84093|NCT02132936|206505|P2|NOT COMPLETED|Overall Study||9
84094|NCT02132936|206506|P1|NOT COMPLETED|Overall Study||10
84095|NCT02132936|206503|P4|COMPLETED|Overall Study||29
84096|NCT02132936|206504|P3|COMPLETED|Overall Study||174
84097|NCT02132936|206505|P2|COMPLETED|Overall Study||38
84098|NCT02132936|206506|P1|COMPLETED|Overall Study||175
84099|NCT02132936|206503|P4|STARTED|Overall Study||43
84100|NCT02132936|206504|P3|STARTED|Overall Study||188
84101|NCT02132936|206505|P2|STARTED|Overall Study||47
84102|NCT02132936|206506|P1|STARTED|Overall Study||185
84103|NCT02132910|206524|P2|NOT COMPLETED|Overall Study||0
84104|NCT02132910|206525|P1|NOT COMPLETED|Overall Study||0
84105|NCT02132910|206524|P2|COMPLETED|Overall Study||34
84106|NCT02132910|206525|P1|COMPLETED|Overall Study||34
84107|NCT02132910|206524|P2|STARTED|Overall Study||34
84108|NCT02132910|206525|P1|STARTED|Overall Study||34
84109|NCT02132884|206539|P2|NOT COMPLETED|Overall Study||0
84110|NCT02132884|206540|P1|NOT COMPLETED|Overall Study||0
84111|NCT02132884|206539|P2|COMPLETED|Overall Study||0
84112|NCT02132884|206540|P1|COMPLETED|Overall Study||0
84113|NCT02132884|206539|P2|STARTED|Overall Study||0
84114|NCT02132884|206540|P1|STARTED|Overall Study||0
84115|NCT02132832|206552|P2|NOT COMPLETED|Overall Study||7
84116|NCT02132832|206553|P1|NOT COMPLETED|Overall Study||3
84117|NCT02132832|206552|P2|COMPLETED|Overall Study||16
84118|NCT02132832|206553|P1|COMPLETED|Overall Study||16
84119|NCT02132832|206552|P2|STARTED|Overall Study||23
84120|NCT02132832|206553|P1|STARTED|Overall Study||19
84121|NCT02132767|206583|P2|NOT COMPLETED|Overall Study||15
84122|NCT02132767|206584|P1|NOT COMPLETED|Overall Study||17
84123|NCT02132767|206583|P2|COMPLETED|Overall Study||246
84124|NCT02132767|206584|P1|COMPLETED|Overall Study||245
84125|NCT02132767|206583|P2|STARTED|Overall Study||261
84126|NCT02132767|206584|P1|STARTED|Overall Study||262
84127|NCT02132637|206606|P2|NOT COMPLETED|Study Period 2 (Crossover)||1
84128|NCT02132637|206607|P1|NOT COMPLETED|Study Period 2 (Crossover)||2
84129|NCT02132637|206606|P2|COMPLETED|Study Period 2 (Crossover)||29
84130|NCT02132637|206607|P1|COMPLETED|Study Period 2 (Crossover)||31
84131|NCT02132637|206606|P2|STARTED|Study Period 2 (Crossover)||30
84132|NCT02132637|206607|P1|STARTED|Study Period 2 (Crossover)||33
84133|NCT02132637|206606|P2|NOT COMPLETED|Study Period 1||4
84134|NCT02132637|206607|P1|NOT COMPLETED|Study Period 1||1
84135|NCT02132637|206606|P2|COMPLETED|Study Period 1||30
84136|NCT02132637|206607|P1|COMPLETED|Study Period 1||33
84137|NCT02132637|206606|P2|Received at Least One Dose of Study Drug|Study Period 1||34
84138|NCT02132637|206607|P1|Received at Least One Dose of Study Drug|Study Period 1||34
84139|NCT02132637|206606|P2|STARTED|Study Period 1||34
84140|NCT02132637|206607|P1|STARTED|Study Period 1||34
84141|NCT02132611|206631|P1|NOT COMPLETED|Overall Study||2
84142|NCT02132611|206631|P1|COMPLETED|Overall Study||98
84143|NCT02132611|206631|P1|STARTED|Overall Study||100
84144|NCT02132572|206636|P1|NOT COMPLETED|Overall Study||0
84145|NCT02132572|206636|P1|COMPLETED|Overall Study||201
84146|NCT02132572|206636|P1|STARTED|Overall Study||201
84147|NCT02132520|206643|P3|NOT COMPLETED|Overall Study||0
84148|NCT02132520|206644|P2|NOT COMPLETED|Overall Study||0
84149|NCT02132520|206645|P1|NOT COMPLETED|Overall Study||0
84150|NCT02132520|206643|P3|COMPLETED|Overall Study||2
84151|NCT02132520|206644|P2|COMPLETED|Overall Study||1
84152|NCT02132520|206645|P1|COMPLETED|Overall Study||0
84153|NCT02132520|206643|P3|STARTED|Overall Study||2
84154|NCT02132520|206644|P2|STARTED|Overall Study||1
84155|NCT02132520|206645|P1|STARTED|Overall Study||0
84156|NCT02132468|206658|P1|NOT COMPLETED|Overall Study||7
84157|NCT02132468|206658|P1|COMPLETED|Overall Study||11
84158|NCT02132468|206658|P1|STARTED|Overall Study||18
84159|NCT02132247|206667|P2|NOT COMPLETED|Overall Study||0
84160|NCT02132247|206668|P1|NOT COMPLETED|Overall Study||1
84161|NCT02132247|206667|P2|COMPLETED|Overall Study||52
84162|NCT02132247|206668|P1|COMPLETED|Overall Study||51
84163|NCT02132247|206667|P2|STARTED|Overall Study||52
84164|NCT02132247|206668|P1|STARTED|Overall Study||52
84165|NCT02132195|206683|P3|NOT COMPLETED|Rescue Therapy||11
84166|NCT02132195|206684|P2|NOT COMPLETED|Rescue Therapy||0
84167|NCT02132195|206685|P1|NOT COMPLETED|Rescue Therapy||0
84168|NCT02132195|206683|P3|COMPLETED|Rescue Therapy||2
84169|NCT02132195|206684|P2|COMPLETED|Rescue Therapy||0
84170|NCT02132195|206685|P1|COMPLETED|Rescue Therapy||0
84171|NCT02132195|206683|P3|STARTED|Rescue Therapy||13
84172|NCT02132195|206684|P2|STARTED|Rescue Therapy||0
84173|NCT02132195|206685|P1|STARTED|Rescue Therapy||0
84174|NCT02132195|206683|P3|NOT COMPLETED|Initial Assignment||0
84175|NCT02132195|206684|P2|NOT COMPLETED|Initial Assignment||0
84176|NCT02132195|206685|P1|NOT COMPLETED|Initial Assignment||14
84177|NCT02132195|206683|P3|COMPLETED|Initial Assignment||0
84178|NCT02132195|206684|P2|COMPLETED|Initial Assignment||16
84179|NCT02132195|206685|P1|COMPLETED|Initial Assignment||1
84180|NCT02132195|206683|P3|STARTED|Initial Assignment||0
84181|NCT02132195|206684|P2|STARTED|Initial Assignment||16
84182|NCT02132195|206685|P1|STARTED|Initial Assignment||15
84183|NCT02132169|206701|P2|NOT COMPLETED|Overall Study||9
84184|NCT02132169|206702|P1|NOT COMPLETED|Overall Study||15
84185|NCT02132169|206701|P2|COMPLETED|Overall Study||162
84186|NCT02132169|206702|P1|COMPLETED|Overall Study||326
84187|NCT02132169|206701|P2|STARTED|Overall Study||171
84188|NCT02132169|206702|P1|STARTED|Overall Study||341
84189|NCT02132117|206716|P2|NOT COMPLETED|Overall Study||5
84190|NCT02132117|206717|P1|NOT COMPLETED|Overall Study||11
84191|NCT02132117|206716|P2|COMPLETED|Overall Study||216
84192|NCT02132117|206717|P1|COMPLETED|Overall Study||213
84193|NCT02132117|206716|P2|STARTED|Overall Study||221
84194|NCT02132117|206717|P1|STARTED|Overall Study||224
84195|NCT02131662|206738|P5|NOT COMPLETED|Overall Study||18
84196|NCT02131662|206739|P4|NOT COMPLETED|Overall Study||21
84197|NCT02131662|206740|P3|NOT COMPLETED|Overall Study||7
84198|NCT02131662|206741|P2|NOT COMPLETED|Overall Study||14
84199|NCT02131662|206742|P1|NOT COMPLETED|Overall Study||8
84200|NCT02131662|206738|P5|COMPLETED|Overall Study||43
84201|NCT02131662|206739|P4|COMPLETED|Overall Study||41
84202|NCT02131662|206740|P3|COMPLETED|Overall Study||56
84203|NCT02131662|206741|P2|COMPLETED|Overall Study||47
84204|NCT02131662|206742|P1|COMPLETED|Overall Study||54
84205|NCT02131662|206738|P5|Completed Follow-up|Overall Study||44
84206|NCT02131662|206739|P4|Completed Follow-up|Overall Study||42
84207|NCT02131662|206740|P3|Completed Follow-up|Overall Study||56
84208|NCT02131662|206741|P2|Completed Follow-up|Overall Study||47
84209|NCT02131662|206742|P1|Completed Follow-up|Overall Study||54
84210|NCT02131662|206738|P5|Completed Treatment|Overall Study||52
84211|NCT02131662|206739|P4|Completed Treatment|Overall Study||56
84212|NCT02131662|206740|P3|Completed Treatment|Overall Study||61
84213|NCT02131662|206741|P2|Completed Treatment|Overall Study||60
84214|NCT02131662|206742|P1|Completed Treatment|Overall Study||57
84215|NCT02131662|206738|P5|Treated|Overall Study||58
84216|NCT02131662|206739|P4|Treated|Overall Study||60
84217|NCT02131662|206740|P3|Treated|Overall Study||61
84218|NCT02131662|206741|P2|Treated|Overall Study||61
84219|NCT02131662|206742|P1|Treated|Overall Study||60
84220|NCT02131662|206738|P5|STARTED|Overall Study||61
84221|NCT02131662|206739|P4|STARTED|Overall Study||62
84222|NCT02131662|206740|P3|STARTED|Overall Study||63
84223|NCT02131662|206741|P2|STARTED|Overall Study||61
84224|NCT02131662|206742|P1|STARTED|Overall Study||62
84225|NCT02131636|206788|P2|NOT COMPLETED|Overall Study||5
84226|NCT02131636|206789|P1|NOT COMPLETED|Overall Study||12
84227|NCT02131636|206788|P2|COMPLETED|Overall Study||213
84228|NCT02131636|206789|P1|COMPLETED|Overall Study||210
84229|NCT02131636|206788|P2|STARTED|Overall Study||218
84230|NCT02131636|206789|P1|STARTED|Overall Study||222
84231|NCT02131532|206805|P1|NOT COMPLETED|Overall Study||4
84232|NCT02131532|206805|P1|COMPLETED|Overall Study||8
84233|NCT02131532|206805|P1|STARTED|Overall Study||12
84234|NCT02131402|206824|P1|NOT COMPLETED|Overall Study||0
84235|NCT02131402|206824|P1|COMPLETED|Overall Study||60
84236|NCT02131402|206824|P1|STARTED|Overall Study||60
84237|NCT02131324|206897|P2|NOT COMPLETED|Overall Study||3
84238|NCT02131324|206898|P1|NOT COMPLETED|Overall Study||2
84239|NCT02131324|206897|P2|COMPLETED|Overall Study||23
84240|NCT02131324|206898|P1|COMPLETED|Overall Study||22
84241|NCT02131324|206897|P2|Analyzed|Overall Study||24
84242|NCT02131324|206898|P1|Analyzed|Overall Study||22
84243|NCT02131324|206897|P2|STARTED|Overall Study|2 subjects randomized into DFD-06 not included in analysis as there was no post-baseline information|26
84244|NCT02131324|206898|P1|STARTED|Overall Study|2 subjects randomized into Comp01 not included in analysis as there was no post-baseline information|24
84245|NCT02131311|206904|P1|NOT COMPLETED|Overall Study||4
84246|NCT02131311|206904|P1|COMPLETED|Overall Study||86
84247|NCT02131311|206904|P1|STARTED|Overall Study||90
84248|NCT02131272|206916|P2|NOT COMPLETED|Overall Study||2
84249|NCT02131272|206917|P1|NOT COMPLETED|Overall Study||1
84250|NCT02131272|206916|P2|COMPLETED|Overall Study||20
84251|NCT02131272|206917|P1|COMPLETED|Overall Study||19
84252|NCT02131272|206916|P2|STARTED|Overall Study||22
84253|NCT02131272|206917|P1|STARTED|Overall Study||20
84254|NCT02131259|206935|P1|NOT COMPLETED|Overall Study||1225
84255|NCT02131259|206935|P1|COMPLETED|Overall Study|Completed is defined as 52 weeks follow-up after starting administration of GIOTRIF® tablets.|377
84256|NCT02131259|206935|P1|STARTED|Overall Study|Patients received treatment of GIOTRIF® Tablets|1602
84257|NCT02131233|206942|P2|NOT COMPLETED|Overall Study||42
84258|NCT02131233|206943|P1|NOT COMPLETED|Overall Study||66
84259|NCT02131233|206942|P2|COMPLETED|Overall Study|Completed to Week 96|227
84260|NCT02131233|206943|P1|COMPLETED|Overall Study|Completed to Week 96|467
84261|NCT02131233|206942|P2|Treated|Overall Study||266
84262|NCT02131233|206943|P1|Treated|Overall Study||531
84263|NCT02131233|206942|P2|STARTED|Overall Study|Enrolled participants|269
84264|NCT02131233|206943|P1|STARTED|Overall Study|Enrolled participants|533
84265|NCT02131155|206977|P2|NOT COMPLETED|Overall Study||11
84266|NCT02131155|206978|P1|NOT COMPLETED|Overall Study||25
84267|NCT02131155|206977|P2|COMPLETED|Overall Study|Completed are patients who completed study procedures as protocol requires.|0
84268|NCT02131155|206978|P1|COMPLETED|Overall Study|Completed are patients who completed study procedures as protocol requires.|0
84269|NCT02131155|206977|P2|STARTED|Overall Study|Started are treated patients.|11
84270|NCT02131155|206978|P1|STARTED|Overall Study|Started are treated patients.|25
84271|NCT02131129|206992|P2|NOT COMPLETED|Overall Study||0
84272|NCT02131129|206993|P1|NOT COMPLETED|Overall Study||1
84273|NCT02131129|206992|P2|COMPLETED|Overall Study||10
84274|NCT02131129|206993|P1|COMPLETED|Overall Study||9
84275|NCT02131129|206992|P2|STARTED|Overall Study||10
84276|NCT02131129|206993|P1|STARTED|Overall Study||10
84277|NCT02131064|207011|P2|NOT COMPLETED|Overall Study||34
84278|NCT02131064|207012|P1|NOT COMPLETED|Overall Study||25
84279|NCT02131064|207011|P2|COMPLETED|Overall Study||189
84280|NCT02131064|207012|P1|COMPLETED|Overall Study||196
84281|NCT02131064|207011|P2|STARTED|Overall Study||223
84282|NCT02131064|207012|P1|STARTED|Overall Study||221
84283|NCT02130999|207052|P2|NOT COMPLETED|Overall Study||0
84284|NCT02130999|207053|P1|NOT COMPLETED|Overall Study||0
84285|NCT02130999|207052|P2|COMPLETED|Overall Study||8
84286|NCT02130999|207053|P1|COMPLETED|Overall Study||6
84287|NCT02130999|207052|P2|STARTED|Overall Study||8
84288|NCT02130999|207053|P1|STARTED|Overall Study||6
84289|NCT02130986|207081|P2|NOT COMPLETED|Overall Study||164
84290|NCT02130986|207082|P1|NOT COMPLETED|Overall Study||155
84291|NCT02130986|207081|P2|COMPLETED|Overall Study||670
84292|NCT02130986|207082|P1|COMPLETED|Overall Study||675
84293|NCT02130986|207081|P2|STARTED|Overall Study||834
84294|NCT02130986|207082|P1|STARTED|Overall Study||830
84295|NCT02130765|207096|P4|NOT COMPLETED|Overall Study||0
84296|NCT02130765|207097|P3|NOT COMPLETED|Overall Study||0
84297|NCT02130765|207098|P2|NOT COMPLETED|Overall Study||0
84298|NCT02130765|207099|P1|NOT COMPLETED|Overall Study||4
84299|NCT02130765|207096|P4|COMPLETED|Overall Study||19
84300|NCT02130765|207097|P3|COMPLETED|Overall Study||26
84301|NCT02130765|207098|P2|COMPLETED|Overall Study||8
84302|NCT02130765|207099|P1|COMPLETED|Overall Study||7
84303|NCT02130765|207096|P4|STARTED|Overall Study||19
84304|NCT02130765|207097|P3|STARTED|Overall Study||26
84305|NCT02130765|207098|P2|STARTED|Overall Study||8
84306|NCT02130765|207099|P1|STARTED|Overall Study||11
84307|NCT02130635|207127|P9|NOT COMPLETED|Part B-Dose-Response Relationship||0
84308|NCT02130635|207128|P8|NOT COMPLETED|Part B-Dose-Response Relationship||0
84309|NCT02130635|207129|P7|NOT COMPLETED|Part B-Dose-Response Relationship||0
84310|NCT02130635|207130|P6|NOT COMPLETED|Part B-Dose-Response Relationship||0
84311|NCT02130635|207131|P5|NOT COMPLETED|Part B-Dose-Response Relationship||0
84312|NCT02130635|207132|P4|NOT COMPLETED|Part B-Dose-Response Relationship||0
84313|NCT02130635|207133|P3|NOT COMPLETED|Part B-Dose-Response Relationship||0
84314|NCT02130635|207134|P2|NOT COMPLETED|Part B-Dose-Response Relationship||0
84315|NCT02130635|207135|P1|NOT COMPLETED|Part B-Dose-Response Relationship||0
84316|NCT02130635|207127|P9|COMPLETED|Part B-Dose-Response Relationship||5
84317|NCT02130635|207128|P8|COMPLETED|Part B-Dose-Response Relationship||5
84318|NCT02130635|207129|P7|COMPLETED|Part B-Dose-Response Relationship||6
84319|NCT02130635|207130|P6|COMPLETED|Part B-Dose-Response Relationship||5
84320|NCT02130635|207131|P5|COMPLETED|Part B-Dose-Response Relationship||5
84321|NCT02130635|207132|P4|COMPLETED|Part B-Dose-Response Relationship||5
84322|NCT02130635|207133|P3|COMPLETED|Part B-Dose-Response Relationship||5
84323|NCT02130635|207134|P2|COMPLETED|Part B-Dose-Response Relationship||0
84324|NCT02130635|207135|P1|COMPLETED|Part B-Dose-Response Relationship||0
84325|NCT02130635|207127|P9|STARTED|Part B-Dose-Response Relationship||5
84326|NCT02130635|207128|P8|STARTED|Part B-Dose-Response Relationship||5
84327|NCT02130635|207129|P7|STARTED|Part B-Dose-Response Relationship||6
84328|NCT02130635|207130|P6|STARTED|Part B-Dose-Response Relationship||5
84329|NCT02130635|207131|P5|STARTED|Part B-Dose-Response Relationship||5
84330|NCT02130635|207132|P4|STARTED|Part B-Dose-Response Relationship||5
84331|NCT02130635|207133|P3|STARTED|Part B-Dose-Response Relationship||5
84332|NCT02130635|207134|P2|STARTED|Part B-Dose-Response Relationship||0
84333|NCT02130635|207135|P1|STARTED|Part B-Dose-Response Relationship||0
84334|NCT02130635|207127|P9|NOT COMPLETED|Part A-Safety and Tolerability||0
84335|NCT02130635|207128|P8|NOT COMPLETED|Part A-Safety and Tolerability||0
84336|NCT02130635|207129|P7|NOT COMPLETED|Part A-Safety and Tolerability||0
84337|NCT02130635|207130|P6|NOT COMPLETED|Part A-Safety and Tolerability||0
84338|NCT02130635|207131|P5|NOT COMPLETED|Part A-Safety and Tolerability||0
84339|NCT02130635|207132|P4|NOT COMPLETED|Part A-Safety and Tolerability||0
84340|NCT02130635|207133|P3|NOT COMPLETED|Part A-Safety and Tolerability||0
84341|NCT02130635|207134|P2|NOT COMPLETED|Part A-Safety and Tolerability||0
84342|NCT02130635|207135|P1|NOT COMPLETED|Part A-Safety and Tolerability||0
84343|NCT02130635|207127|P9|COMPLETED|Part A-Safety and Tolerability||0
84344|NCT02130635|207128|P8|COMPLETED|Part A-Safety and Tolerability||0
84345|NCT02130635|207129|P7|COMPLETED|Part A-Safety and Tolerability||0
84346|NCT02130635|207130|P6|COMPLETED|Part A-Safety and Tolerability||0
84347|NCT02130635|207131|P5|COMPLETED|Part A-Safety and Tolerability||0
84348|NCT02130635|207132|P4|COMPLETED|Part A-Safety and Tolerability||0
84349|NCT02130635|207133|P3|COMPLETED|Part A-Safety and Tolerability||0
84350|NCT02130635|207134|P2|COMPLETED|Part A-Safety and Tolerability||21
84351|NCT02130635|207135|P1|COMPLETED|Part A-Safety and Tolerability||7
84352|NCT02130635|207127|P9|STARTED|Part A-Safety and Tolerability||0
84353|NCT02130635|207128|P8|STARTED|Part A-Safety and Tolerability||0
84354|NCT02130635|207129|P7|STARTED|Part A-Safety and Tolerability||0
84355|NCT02130635|207130|P6|STARTED|Part A-Safety and Tolerability||0
84356|NCT02130635|207131|P5|STARTED|Part A-Safety and Tolerability||0
84357|NCT02130635|207132|P4|STARTED|Part A-Safety and Tolerability||0
84358|NCT02130635|207133|P3|STARTED|Part A-Safety and Tolerability||0
84359|NCT02130635|207134|P2|STARTED|Part A-Safety and Tolerability||21
84360|NCT02130635|207135|P1|STARTED|Part A-Safety and Tolerability||7
84361|NCT02130622|207309|P2|NOT COMPLETED|Overall Study||0
84362|NCT02130622|207310|P1|NOT COMPLETED|Overall Study||0
84363|NCT02130622|207309|P2|COMPLETED|Overall Study||1
84364|NCT02130622|207310|P1|COMPLETED|Overall Study||2
84365|NCT02130622|207309|P2|STARTED|Overall Study||1
84366|NCT02130622|207310|P1|STARTED|Overall Study||2
84367|NCT02130583|207324|P2|NOT COMPLETED|Overall Study||7
84368|NCT02130583|207325|P1|NOT COMPLETED|Overall Study||9
84369|NCT02130583|207324|P2|COMPLETED|Overall Study||19
84370|NCT02130583|207325|P1|COMPLETED|Overall Study||17
84371|NCT02130583|207324|P2|STARTED|Overall Study||26
84372|NCT02130583|207325|P1|STARTED|Overall Study||26
84373|NCT02130570|207345|P2|NOT COMPLETED|Overall Study||13
84374|NCT02130570|207346|P1|NOT COMPLETED|Overall Study||9
84375|NCT02130570|207345|P2|COMPLETED|Overall Study|Participants enrolled, did not die during index admission, did not withdraw consent|679
84376|NCT02130570|207346|P1|COMPLETED|Overall Study|Participants enrolled, did not die during index admission, did not withdraw consent|978
84377|NCT02130570|207345|P2|STARTED|Overall Study||692
84378|NCT02130570|207346|P1|STARTED|Overall Study||987
84379|NCT02130557|207364|P2|NOT COMPLETED|Overall Study||268
84380|NCT02130557|207365|P1|NOT COMPLETED|Overall Study||268
84381|NCT02130557|207364|P2|COMPLETED|Overall Study||0
84382|NCT02130557|207365|P1|COMPLETED|Overall Study||0
84383|NCT02130557|207364|P2|mITT Population|Overall Study||241
84384|NCT02130557|207365|P1|mITT Population|Overall Study||246
84385|NCT02130557|207364|P2|Treated|Overall Study||265
84386|NCT02130557|207365|P1|Treated|Overall Study||268
84387|NCT02130557|207364|P2|STARTED|Overall Study||268
84388|NCT02130557|207365|P1|STARTED|Overall Study||268
84389|NCT02130284|207397|P1|NOT COMPLETED|Overall Study||9
84390|NCT02130284|207397|P1|COMPLETED|Overall Study||71
84391|NCT02130284|207397|P1|STARTED|Overall Study||80
84392|NCT02130258|207410|P2|NOT COMPLETED|Overall Study||0
84393|NCT02130258|207411|P1|NOT COMPLETED|Overall Study||0
84394|NCT02130258|207410|P2|COMPLETED|Overall Study||11
84395|NCT02130258|207411|P1|COMPLETED|Overall Study||9
84396|NCT02130258|207410|P2|STARTED|Overall Study||11
84397|NCT02130258|207411|P1|STARTED|Overall Study||9
84398|NCT02130193|207423|P3|NOT COMPLETED|Part B: 52-week Double-blind Period||8
84399|NCT02130193|207424|P2|NOT COMPLETED|Part B: 52-week Double-blind Period||10
84400|NCT02130193|207425|P1|NOT COMPLETED|Part B: 52-week Double-blind Period||0
84401|NCT02130193|207423|P3|COMPLETED|Part B: 52-week Double-blind Period||37
84402|NCT02130193|207424|P2|COMPLETED|Part B: 52-week Double-blind Period||38
84403|NCT02130193|207425|P1|COMPLETED|Part B: 52-week Double-blind Period||0
84404|NCT02130193|207423|P3|STARTED|Part B: 52-week Double-blind Period||45
84405|NCT02130193|207424|P2|STARTED|Part B: 52-week Double-blind Period||48
84406|NCT02130193|207425|P1|STARTED|Part B: 52-week Double-blind Period||0
84407|NCT02130193|207423|P3|NOT COMPLETED|Part A: 4-week Open-label Period||0
84408|NCT02130193|207424|P2|NOT COMPLETED|Part A: 4-week Open-label Period||0
84409|NCT02130193|207425|P1|NOT COMPLETED|Part A: 4-week Open-label Period||0
84410|NCT02130193|207423|P3|COMPLETED|Part A: 4-week Open-label Period||0
84411|NCT02130193|207424|P2|COMPLETED|Part A: 4-week Open-label Period||0
84412|NCT02130193|207425|P1|COMPLETED|Part A: 4-week Open-label Period||9
84413|NCT02130193|207423|P3|STARTED|Part A: 4-week Open-label Period||0
84414|NCT02130193|207424|P2|STARTED|Part A: 4-week Open-label Period||0
84415|NCT02130193|207425|P1|STARTED|Part A: 4-week Open-label Period||9
84416|NCT02130063|207491|P2|NOT COMPLETED|Overall Study||17
84417|NCT02130063|207492|P1|NOT COMPLETED|Overall Study||25
84418|NCT02130063|207491|P2|COMPLETED|Overall Study||152
84419|NCT02130063|207492|P1|COMPLETED|Overall Study||317
84420|NCT02130063|207491|P2|STARTED|Overall Study||169
84421|NCT02130063|207492|P1|STARTED|Overall Study||342
84422|NCT02130024|207506|P2|NOT COMPLETED|Overall Study||31
84423|NCT02130024|207507|P1|NOT COMPLETED|Overall Study||25
84424|NCT02130024|207506|P2|COMPLETED|Overall Study||108
84425|NCT02130024|207507|P1|COMPLETED|Overall Study||117
84426|NCT02130024|207506|P2|Full Analysis Set (FAS)|Overall Study|2 patients had no post Baseline geographic atrophy (GA) data|137
84427|NCT02130024|207507|P1|Full Analysis Set (FAS)|Overall Study||141
84428|NCT02130024|207506|P2|Safety Set|Overall Study||139
84429|NCT02130024|207507|P1|Safety Set|Overall Study|One randomized patient did not receive treatment|141
84430|NCT02130024|207506|P2|STARTED|Overall Study||139
84431|NCT02130024|207507|P1|STARTED|Overall Study||142
84432|NCT02129777|207544|P7|NOT COMPLETED|Open-Label Period||48
84433|NCT02129777|207545|P6|NOT COMPLETED|Open-Label Period||12
84434|NCT02129777|207546|P5|NOT COMPLETED|Open-Label Period||0
84435|NCT02129777|207547|P4|NOT COMPLETED|Open-Label Period||0
84436|NCT02129777|207548|P3|NOT COMPLETED|Open-Label Period||0
84437|NCT02129777|207549|P2|NOT COMPLETED|Open-Label Period||0
84438|NCT02129777|207550|P1|NOT COMPLETED|Open-Label Period||0
84439|NCT02129777|207544|P7|COMPLETED|Open-Label Period||0
84440|NCT02129777|207545|P6|COMPLETED|Open-Label Period||0
84441|NCT02129777|207546|P5|COMPLETED|Open-Label Period||0
84442|NCT02129777|207547|P4|COMPLETED|Open-Label Period||0
84443|NCT02129777|207548|P3|COMPLETED|Open-Label Period||0
84444|NCT02129777|207549|P2|COMPLETED|Open-Label Period||0
84445|NCT02129777|207550|P1|COMPLETED|Open-Label Period||0
84446|NCT02129777|207544|P7|STARTED|Open-Label Period||48
84447|NCT02129777|207545|P6|STARTED|Open-Label Period||12
84448|NCT02129777|207546|P5|STARTED|Open-Label Period||0
84449|NCT02129777|207547|P4|STARTED|Open-Label Period||0
84450|NCT02129777|207548|P3|STARTED|Open-Label Period||0
84451|NCT02129777|207549|P2|STARTED|Open-Label Period||0
84452|NCT02129777|207550|P1|STARTED|Open-Label Period||0
84453|NCT02129777|207544|P7|NOT COMPLETED|Double-Blind Period||0
84454|NCT02129777|207545|P6|NOT COMPLETED|Double-Blind Period||0
84455|NCT02129777|207546|P5|NOT COMPLETED|Double-Blind Period||7
84456|NCT02129777|207547|P4|NOT COMPLETED|Double-Blind Period||7
84457|NCT02129777|207548|P3|NOT COMPLETED|Double-Blind Period||4
84458|NCT02129777|207549|P2|NOT COMPLETED|Double-Blind Period||8
84459|NCT02129777|207550|P1|NOT COMPLETED|Double-Blind Period||7
84460|NCT02129777|207544|P7|COMPLETED|Double-Blind Period||0
84461|NCT02129777|207545|P6|COMPLETED|Double-Blind Period||0
84462|NCT02129777|207546|P5|COMPLETED|Double-Blind Period||18
84463|NCT02129777|207547|P4|COMPLETED|Double-Blind Period||18
84464|NCT02129777|207548|P3|COMPLETED|Double-Blind Period||20
84465|NCT02129777|207549|P2|COMPLETED|Double-Blind Period||16
84466|NCT02129777|207550|P1|COMPLETED|Double-Blind Period||17
84467|NCT02129777|207544|P7|STARTED|Double-Blind Period||0
84468|NCT02129777|207545|P6|STARTED|Double-Blind Period||0
84469|NCT02129777|207546|P5|STARTED|Double-Blind Period||25
84470|NCT02129777|207547|P4|STARTED|Double-Blind Period||25
84471|NCT02129777|207548|P3|STARTED|Double-Blind Period||24
84472|NCT02129777|207549|P2|STARTED|Double-Blind Period||24
84473|NCT02129777|207550|P1|STARTED|Double-Blind Period||24
84474|NCT02129725|207656|P2|NOT COMPLETED|Overall Study||3
84475|NCT02129725|207657|P1|NOT COMPLETED|Overall Study||2
84476|NCT02129725|207656|P2|COMPLETED|Overall Study||4
84477|NCT02129725|207657|P1|COMPLETED|Overall Study||6
84478|NCT02129725|207656|P2|STARTED|Overall Study||7
84479|NCT02129725|207657|P1|STARTED|Overall Study||8
84480|NCT02129660|207668|P5|NOT COMPLETED|Overall Study||2
84481|NCT02129660|207669|P4|NOT COMPLETED|Overall Study||0
84482|NCT02129660|207670|P3|NOT COMPLETED|Overall Study||1
84483|NCT02129660|207671|P2|NOT COMPLETED|Overall Study||0
84484|NCT02129660|207672|P1|NOT COMPLETED|Overall Study||2
84485|NCT02129660|207668|P5|COMPLETED|Overall Study||20
84486|NCT02129660|207669|P4|COMPLETED|Overall Study||20
84487|NCT02129660|207670|P3|COMPLETED|Overall Study||21
84488|NCT02129660|207671|P2|COMPLETED|Overall Study||20
84489|NCT02129660|207672|P1|COMPLETED|Overall Study||19
84490|NCT02129660|207668|P5|STARTED|Overall Study||22
84491|NCT02129660|207669|P4|STARTED|Overall Study||20
84492|NCT02129660|207670|P3|STARTED|Overall Study||22
84493|NCT02129660|207671|P2|STARTED|Overall Study||20
84494|NCT02129660|207672|P1|STARTED|Overall Study||21
84495|NCT02129608|207717|P3|NOT COMPLETED|Overall Study||3
84496|NCT02129608|207718|P2|NOT COMPLETED|Overall Study||1
84497|NCT02129608|207719|P1|NOT COMPLETED|Overall Study||0
84498|NCT02129608|207717|P3|COMPLETED|Overall Study||12
84499|NCT02129608|207718|P2|COMPLETED|Overall Study||13
84500|NCT02129608|207719|P1|COMPLETED|Overall Study||15
84501|NCT02129608|207717|P3|End of Treatment|Overall Study||12
84502|NCT02129608|207718|P2|End of Treatment|Overall Study||13
84503|NCT02129608|207719|P1|End of Treatment|Overall Study||15
84504|NCT02129608|207717|P3|STARTED|Overall Study||15
84505|NCT02129608|207718|P2|STARTED|Overall Study||14
84506|NCT02129608|207719|P1|STARTED|Overall Study||15
84507|NCT02129556|207733|P4|NOT COMPLETED|Overall Study||0
84508|NCT02129556|207734|P3|NOT COMPLETED|Overall Study||3
84509|NCT02129556|207735|P2|NOT COMPLETED|Overall Study||0
84510|NCT02129556|207736|P1|NOT COMPLETED|Overall Study||0
84511|NCT02129556|207733|P4|COMPLETED|Overall Study||12
84512|NCT02129556|207734|P3|COMPLETED|Overall Study||37
84513|NCT02129556|207735|P2|COMPLETED|Overall Study||3
84514|NCT02129556|207736|P1|COMPLETED|Overall Study||3
84515|NCT02129556|207733|P4|STARTED|Overall Study||12
84516|NCT02129556|207734|P3|STARTED|Overall Study||40
84517|NCT02129556|207735|P2|STARTED|Overall Study||3
84518|NCT02129556|207736|P1|STARTED|Overall Study||3
84519|NCT02129205|207770|P10|NOT COMPLETED|Overall Study||0
84520|NCT02129205|207771|P9|NOT COMPLETED|Overall Study||2
84521|NCT02129205|207772|P8|NOT COMPLETED|Overall Study||2
84522|NCT02129205|207773|P7|NOT COMPLETED|Overall Study||4
84523|NCT02129205|207774|P6|NOT COMPLETED|Overall Study||4
84524|NCT02129205|207775|P5|NOT COMPLETED|Overall Study||3
84525|NCT02129205|207776|P4|NOT COMPLETED|Overall Study||0
84526|NCT02129205|207777|P3|NOT COMPLETED|Overall Study||0
84527|NCT02129205|207778|P2|NOT COMPLETED|Overall Study||0
84528|NCT02129205|207779|P1|NOT COMPLETED|Overall Study||1
84529|NCT02129205|207770|P10|COMPLETED|Overall Study||0
84530|NCT02129205|207771|P9|COMPLETED|Overall Study||0
84531|NCT02129205|207772|P8|COMPLETED|Overall Study||4
84532|NCT02129205|207773|P7|COMPLETED|Overall Study||2
84533|NCT02129205|207774|P6|COMPLETED|Overall Study||7
84534|NCT02129205|207775|P5|COMPLETED|Overall Study||4
84535|NCT02129205|207776|P4|COMPLETED|Overall Study||2
84536|NCT02129205|207777|P3|COMPLETED|Overall Study||2
84537|NCT02129205|207778|P2|COMPLETED|Overall Study||2
84538|NCT02129205|207779|P1|COMPLETED|Overall Study||1
84539|NCT02129205|207770|P10|STARTED|Overall Study||0
84540|NCT02129205|207771|P9|STARTED|Overall Study||2
84541|NCT02129205|207772|P8|STARTED|Overall Study||6
84542|NCT02129205|207773|P7|STARTED|Overall Study||6
84543|NCT02129205|207774|P6|STARTED|Overall Study||11
84544|NCT02129205|207775|P5|STARTED|Overall Study||7
84545|NCT02129205|207776|P4|STARTED|Overall Study||2
84546|NCT02129205|207777|P3|STARTED|Overall Study||2
84547|NCT02129205|207778|P2|STARTED|Overall Study||2
84548|NCT02129205|207779|P1|STARTED|Overall Study||2
84549|NCT02129192|207932|P2|NOT COMPLETED|Period 5||0
84550|NCT02129192|207933|P1|NOT COMPLETED|Period 5||0
84551|NCT02129192|207932|P2|COMPLETED|Period 5||0
84552|NCT02129192|207933|P1|COMPLETED|Period 5||36
84553|NCT02129192|207932|P2|STARTED|Period 5|This sequence consists of only 4 periods.|0
84554|NCT02129192|207933|P1|STARTED|Period 5||36
84555|NCT02129192|207932|P2|NOT COMPLETED|Period 4 Including Washout Period||0
84556|NCT02129192|207933|P1|NOT COMPLETED|Period 4 Including Washout Period||0
84557|NCT02129192|207932|P2|COMPLETED|Period 4 Including Washout Period||35
84558|NCT02129192|207933|P1|COMPLETED|Period 4 Including Washout Period||36
84559|NCT02129192|207932|P2|STARTED|Period 4 Including Washout Period||35
84560|NCT02129192|207933|P1|STARTED|Period 4 Including Washout Period||36
84561|NCT02129192|207932|P2|NOT COMPLETED|Period 3 Including Washout Period||0
84562|NCT02129192|207933|P1|NOT COMPLETED|Period 3 Including Washout Period||0
84563|NCT02129192|207932|P2|COMPLETED|Period 3 Including Washout Period||35
84564|NCT02129192|207933|P1|COMPLETED|Period 3 Including Washout Period||36
84565|NCT02129192|207932|P2|STARTED|Period 3 Including Washout Period||35
84566|NCT02129192|207933|P1|STARTED|Period 3 Including Washout Period||36
84567|NCT02129192|207932|P2|NOT COMPLETED|Period 2 Including Washout Period||0
84568|NCT02129192|207933|P1|NOT COMPLETED|Period 2 Including Washout Period||0
84569|NCT02129192|207932|P2|COMPLETED|Period 2 Including Washout Period||35
84570|NCT02129192|207933|P1|COMPLETED|Period 2 Including Washout Period||36
84571|NCT02129192|207932|P2|STARTED|Period 2 Including Washout Period||35
84572|NCT02129192|207933|P1|STARTED|Period 2 Including Washout Period||36
84573|NCT02129192|207932|P2|NOT COMPLETED|Period 1 Including Washout Period||1
84574|NCT02129192|207933|P1|NOT COMPLETED|Period 1 Including Washout Period||0
84575|NCT02129192|207932|P2|COMPLETED|Period 1 Including Washout Period|Withdrawal by one subject in washout period|35
84576|NCT02129192|207933|P1|COMPLETED|Period 1 Including Washout Period||36
84577|NCT02129192|207932|P2|STARTED|Period 1 Including Washout Period||36
84578|NCT02129192|207933|P1|STARTED|Period 1 Including Washout Period||36
84579|NCT02129062|207950|P1|NOT COMPLETED|Overall Study||3
84580|NCT02129062|207950|P1|COMPLETED|Overall Study||0
84581|NCT02129062|207950|P1|STARTED|Overall Study||3
84582|NCT02128997|207957|P2|NOT COMPLETED|Overall Study||11
84583|NCT02128997|207958|P1|NOT COMPLETED|Overall Study||6
84584|NCT02128997|207957|P2|COMPLETED|Overall Study||58
84585|NCT02128997|207958|P1|COMPLETED|Overall Study||61
84586|NCT02128997|207957|P2|STARTED|Overall Study||69
84587|NCT02128997|207958|P1|STARTED|Overall Study||67
84588|NCT02128932|207973|P3|NOT COMPLETED|Overall Study||18
84589|NCT02128932|207974|P2|NOT COMPLETED|Overall Study||19
84590|NCT02128932|207975|P1|NOT COMPLETED|Overall Study||27
84591|NCT02128932|207973|P3|COMPLETED|Overall Study||342
84592|NCT02128932|207974|P2|COMPLETED|Overall Study||341
84593|NCT02128932|207975|P1|COMPLETED|Overall Study||335
84594|NCT02128932|207973|P3|STARTED|Overall Study||360
84595|NCT02128932|207974|P2|STARTED|Overall Study||360
84596|NCT02128932|207975|P1|STARTED|Overall Study||362
84597|NCT02128919|208006|P2|NOT COMPLETED|Overall Study||1
84598|NCT02128919|208007|P1|NOT COMPLETED|Overall Study||3
84599|NCT02128919|208006|P2|COMPLETED|Overall Study||15
84600|NCT02128919|208007|P1|COMPLETED|Overall Study||14
84601|NCT02128919|208006|P2|STARTED|Overall Study||16
84602|NCT02128919|208007|P1|STARTED|Overall Study||17
84603|NCT02128867|208020|P3|NOT COMPLETED|Overall Study||4
84604|NCT02128867|208021|P2|NOT COMPLETED|Overall Study||2
84605|NCT02128867|208022|P1|NOT COMPLETED|Overall Study||3
84606|NCT02128867|208020|P3|COMPLETED|Overall Study||50
84607|NCT02128867|208021|P2|COMPLETED|Overall Study||50
84608|NCT02128867|208022|P1|COMPLETED|Overall Study||50
84609|NCT02128867|208020|P3|STARTED|Overall Study||54
84610|NCT02128867|208021|P2|STARTED|Overall Study||52
84611|NCT02128867|208022|P1|STARTED|Overall Study||53
84612|NCT02128763|208032|P2|NOT COMPLETED|Overall Study||16
84613|NCT02128763|208033|P1|NOT COMPLETED|Overall Study||20
84614|NCT02128763|208032|P2|COMPLETED|Overall Study||170
84615|NCT02128763|208033|P1|COMPLETED|Overall Study||329
84616|NCT02128763|208032|P2|STARTED|Overall Study||186
84617|NCT02128763|208033|P1|STARTED|Overall Study||349
84618|NCT02128724|208071|P4|NOT COMPLETED|Overall Study||3
84619|NCT02128724|208072|P3|NOT COMPLETED|Overall Study||0
84620|NCT02128724|208073|P2|NOT COMPLETED|Overall Study||1
84621|NCT02128724|208074|P1|NOT COMPLETED|Overall Study||1
84622|NCT02128724|208071|P4|COMPLETED|Overall Study||7
84623|NCT02128724|208072|P3|COMPLETED|Overall Study||3
84624|NCT02128724|208073|P2|COMPLETED|Overall Study||3
84625|NCT02128724|208074|P1|COMPLETED|Overall Study||3
84626|NCT02128724|208071|P4|STARTED|Overall Study||10
84627|NCT02128724|208072|P3|STARTED|Overall Study||3
84628|NCT02128724|208073|P2|STARTED|Overall Study||4
84629|NCT02128724|208074|P1|STARTED|Overall Study||4
84630|NCT02128542|208129|P2|NOT COMPLETED|Overall Study||0
84631|NCT02128542|208130|P1|NOT COMPLETED|Overall Study||4
84632|NCT02128542|208129|P2|COMPLETED|Overall Study||19
84633|NCT02128542|208130|P1|COMPLETED|Overall Study||43
84634|NCT02128542|208129|P2|STARTED|Overall Study||19
84635|NCT02128542|208130|P1|STARTED|Overall Study||47
84636|NCT02128490|208148|P5|NOT COMPLETED|Overall Study||7
84637|NCT02128490|208149|P4|NOT COMPLETED|Overall Study||6
84638|NCT02128490|208150|P3|NOT COMPLETED|Overall Study||5
84639|NCT02128490|208151|P2|NOT COMPLETED|Overall Study||6
84640|NCT02128490|208152|P1|NOT COMPLETED|Overall Study||5
84641|NCT02128490|208148|P5|COMPLETED|Overall Study||31
84642|NCT02128490|208149|P4|COMPLETED|Overall Study||31
84643|NCT02128490|208150|P3|COMPLETED|Overall Study||34
84644|NCT02128490|208151|P2|COMPLETED|Overall Study||31
84645|NCT02128490|208152|P1|COMPLETED|Overall Study||33
84646|NCT02128490|208148|P5|STARTED|Overall Study||38
84647|NCT02128490|208149|P4|STARTED|Overall Study||37
84648|NCT02128490|208150|P3|STARTED|Overall Study||39
84649|NCT02128490|208151|P2|STARTED|Overall Study||37
84650|NCT02128490|208152|P1|STARTED|Overall Study||38
84651|NCT02128269|208174|P1|NOT COMPLETED|Follow-up||0
84652|NCT02128269|208174|P1|COMPLETED|Follow-up||9
84653|NCT02128269|208174|P1|STARTED|Follow-up|All enrolled patients were followed for 12 weeks after their last infusion of ALXN1007.|9
84654|NCT02128269|208174|P1|NOT COMPLETED|Treatment Period||2
84655|NCT02128269|208174|P1|COMPLETED|Treatment Period||7
84656|NCT02128269|208174|P1|STARTED|Treatment Period||9
84657|NCT02128217|208180|P2|NOT COMPLETED|Overall Study||1
84658|NCT02128217|208181|P1|NOT COMPLETED|Overall Study||0
84659|NCT02128217|208180|P2|COMPLETED|Overall Study||26
84660|NCT02128217|208181|P1|COMPLETED|Overall Study||17
84661|NCT02128217|208180|P2|STARTED|Overall Study||27
84662|NCT02128217|208181|P1|STARTED|Overall Study||17
84663|NCT02128074|208223|P1|NOT COMPLETED|Overall Study||6
84664|NCT02128074|208223|P1|COMPLETED|Overall Study||26
84665|NCT02128074|208223|P1|STARTED|Overall Study||32
84666|NCT02127970|208229|P2|NOT COMPLETED|Overall Study||27
84667|NCT02127970|208230|P1|NOT COMPLETED|Overall Study||26
84668|NCT02127970|208229|P2|COMPLETED|Overall Study||322
84669|NCT02127970|208230|P1|COMPLETED|Overall Study||323
84670|NCT02127970|208229|P2|STARTED|Overall Study||349
84671|NCT02127970|208230|P1|STARTED|Overall Study||349
84672|NCT02127892|208256|P4|NOT COMPLETED|Overall Study||0
84673|NCT02127892|208257|P3|NOT COMPLETED|Overall Study||0
84674|NCT02127892|208258|P2|NOT COMPLETED|Overall Study||1
84675|NCT02127892|208259|P1|NOT COMPLETED|Overall Study||1
84676|NCT02127892|208256|P4|COMPLETED|Overall Study||0
84677|NCT02127892|208257|P3|COMPLETED|Overall Study||0
84678|NCT02127892|208258|P2|COMPLETED|Overall Study||1
84679|NCT02127892|208259|P1|COMPLETED|Overall Study||6
84680|NCT02127892|208256|P4|STARTED|Overall Study||0
84681|NCT02127892|208257|P3|STARTED|Overall Study||0
84682|NCT02127892|208258|P2|STARTED|Overall Study||2
84683|NCT02127892|208259|P1|STARTED|Overall Study||7
84684|NCT02127710|208288|P3|NOT COMPLETED|Overall Study||0
84685|NCT02127710|208289|P2|NOT COMPLETED|Overall Study||0
84686|NCT02127710|208290|P1|NOT COMPLETED|Overall Study||0
84687|NCT02127710|208288|P3|COMPLETED|Overall Study||19
84688|NCT02127710|208289|P2|COMPLETED|Overall Study||46
84689|NCT02127710|208290|P1|COMPLETED|Overall Study||44
84690|NCT02127710|208288|P3|STARTED|Overall Study||19
84691|NCT02127710|208289|P2|STARTED|Overall Study||46
84692|NCT02127710|208290|P1|STARTED|Overall Study||44
84693|NCT02127632|208332|P2|NOT COMPLETED|Overall Study||0
84694|NCT02127632|208333|P1|NOT COMPLETED|Overall Study||0
84695|NCT02127632|208332|P2|COMPLETED|Overall Study||50
84696|NCT02127632|208333|P1|COMPLETED|Overall Study||50
84697|NCT02127632|208332|P2|STARTED|Overall Study||50
84698|NCT02127632|208333|P1|STARTED|Overall Study||50
84699|NCT02127567|208343|P1|NOT COMPLETED|Overall Study||0
84700|NCT02127567|208343|P1|COMPLETED|Overall Study||41
84701|NCT02127567|208343|P1|STARTED|Overall Study|41 participants completed 123 domains, 3 domains were completed with the tool per participant|41
84702|NCT02127372|208365|P2|NOT COMPLETED|Overall Study||0
84703|NCT02127372|208366|P1|NOT COMPLETED|Overall Study||1
84704|NCT02127372|208365|P2|COMPLETED|Overall Study||28
84705|NCT02127372|208366|P1|COMPLETED|Overall Study|Completed at least one cycle and were available for dose limiting toxicity (DLT) evaluation.|14
84706|NCT02127372|208365|P2|Started Study Treatment|Overall Study||28
84707|NCT02127372|208366|P1|Started Study Treatment|Overall Study||15
84708|NCT02127372|208365|P2|STARTED|Overall Study|Signed Consent|28
84709|NCT02127372|208366|P1|STARTED|Overall Study|Signed Consent|15
84710|NCT02127307|208376|P1|NOT COMPLETED|Overall Study||308
84711|NCT02127307|208376|P1|COMPLETED|Overall Study||656
84712|NCT02127307|208376|P1|STARTED|Overall Study||964
84713|NCT02127281|208382|P2|NOT COMPLETED|Overall Study||0
84714|NCT02127281|208383|P1|NOT COMPLETED|Overall Study||1
84715|NCT02127281|208382|P2|COMPLETED|Overall Study||80
84716|NCT02127281|208383|P1|COMPLETED|Overall Study||79
84717|NCT02127281|208382|P2|STARTED|Overall Study||80
84718|NCT02127281|208383|P1|STARTED|Overall Study||80
84719|NCT02126969|208411|P2|NOT COMPLETED|Overall Study||2
84720|NCT02126969|208412|P1|NOT COMPLETED|Overall Study||1
84721|NCT02126969|208411|P2|COMPLETED|Overall Study||20
84722|NCT02126969|208412|P1|COMPLETED|Overall Study||22
84723|NCT02126969|208411|P2|STARTED|Overall Study||22
84724|NCT02126969|208412|P1|STARTED|Overall Study||23
84725|NCT02126839|208422|P2|NOT COMPLETED|Overall Study||14
84726|NCT02126839|208423|P1|NOT COMPLETED|Overall Study||10
84727|NCT02126839|208422|P2|COMPLETED|Overall Study||80
84728|NCT02126839|208423|P1|COMPLETED|Overall Study||82
84729|NCT02126839|208422|P2|Full Analysis Set|Overall Study||92
84730|NCT02126839|208423|P1|Full Analysis Set|Overall Study||92
84731|NCT02126839|208422|P2|Safety Population|Overall Study||93
84732|NCT02126839|208423|P1|Safety Population|Overall Study||92
84733|NCT02126839|208422|P2|STARTED|Overall Study||94
84734|NCT02126839|208423|P1|STARTED|Overall Study||92
84735|NCT02126826|208440|P7|NOT COMPLETED|Overall Study||0
84736|NCT02126826|208441|P6|NOT COMPLETED|Overall Study||0
84737|NCT02126826|208442|P5|NOT COMPLETED|Overall Study||0
84738|NCT02126826|208443|P4|NOT COMPLETED|Overall Study||1
84739|NCT02126826|208444|P3|NOT COMPLETED|Overall Study||0
84740|NCT02126826|208445|P2|NOT COMPLETED|Overall Study||0
84741|NCT02126826|208446|P1|NOT COMPLETED|Overall Study||0
84742|NCT02126826|208440|P7|COMPLETED|Overall Study||8
84743|NCT02126826|208441|P6|COMPLETED|Overall Study||9
84744|NCT02126826|208442|P5|COMPLETED|Overall Study||5
84745|NCT02126826|208443|P4|COMPLETED|Overall Study||8
84746|NCT02126826|208444|P3|COMPLETED|Overall Study||9
84747|NCT02126826|208445|P2|COMPLETED|Overall Study||9
84748|NCT02126826|208446|P1|COMPLETED|Overall Study||9
84749|NCT02126826|208440|P7|STARTED|Overall Study||8
84750|NCT02126826|208441|P6|STARTED|Overall Study||9
84751|NCT02126826|208442|P5|STARTED|Overall Study||5
84752|NCT02126826|208443|P4|STARTED|Overall Study||9
84753|NCT02126826|208444|P3|STARTED|Overall Study||9
84754|NCT02126826|208445|P2|STARTED|Overall Study||9
84755|NCT02126826|208446|P1|STARTED|Overall Study||9
84756|NCT02126748|208500|P3|NOT COMPLETED|Overall Study||5
84757|NCT02126748|208501|P2|NOT COMPLETED|Overall Study||3
84758|NCT02126748|208502|P1|NOT COMPLETED|Overall Study||2
84759|NCT02126748|208500|P3|COMPLETED|Overall Study||31
84760|NCT02126748|208501|P2|COMPLETED|Overall Study||31
84761|NCT02126748|208502|P1|COMPLETED|Overall Study||31
84762|NCT02126748|208500|P3|STARTED|Overall Study||36
84763|NCT02126748|208501|P2|STARTED|Overall Study||34
84764|NCT02126748|208502|P1|STARTED|Overall Study||33
84765|NCT02126670|208514|P4|NOT COMPLETED|Overall Study||1
84766|NCT02126670|208515|P3|NOT COMPLETED|Overall Study||0
84767|NCT02126670|208516|P2|NOT COMPLETED|Overall Study||0
84768|NCT02126670|208517|P1|NOT COMPLETED|Overall Study||1
84769|NCT02126670|208514|P4|COMPLETED|Overall Study||24
84770|NCT02126670|208515|P3|COMPLETED|Overall Study||25
84771|NCT02126670|208516|P2|COMPLETED|Overall Study||24
84772|NCT02126670|208517|P1|COMPLETED|Overall Study||25
84773|NCT02126670|208514|P4|STARTED|Overall Study||25
84774|NCT02126670|208515|P3|STARTED|Overall Study||25
84775|NCT02126670|208516|P2|STARTED|Overall Study||24
84776|NCT02126670|208517|P1|STARTED|Overall Study||26
84777|NCT02126319|208533|P2|NOT COMPLETED|Overall Study||24
84778|NCT02126319|208534|P1|NOT COMPLETED|Overall Study||21
84779|NCT02126319|208533|P2|COMPLETED|Overall Study||43
84780|NCT02126319|208534|P1|COMPLETED|Overall Study||40
84781|NCT02126319|208533|P2|STARTED|Overall Study||67
84782|NCT02126319|208534|P1|STARTED|Overall Study||61
84783|NCT02126306|208560|P2|NOT COMPLETED|Overall Study||0
84784|NCT02126306|208561|P1|NOT COMPLETED|Overall Study||0
84785|NCT02126306|208560|P2|COMPLETED|Overall Study||13
84786|NCT02126306|208561|P1|COMPLETED|Overall Study||10
84787|NCT02126306|208560|P2|STARTED|Overall Study||13
84788|NCT02126306|208561|P1|STARTED|Overall Study||10
84789|NCT02125877|208569|P2|NOT COMPLETED|Overall Study||10
84790|NCT02125877|208570|P1|NOT COMPLETED|Overall Study||13
84791|NCT02125877|208569|P2|COMPLETED|Overall Study||77
84792|NCT02125877|208570|P1|COMPLETED|Overall Study||73
84793|NCT02125877|208569|P2|Safety Set|Overall Study||87
84794|NCT02125877|208570|P1|Safety Set|Overall Study||86
84795|NCT02125877|208569|P2|Pharmacokinetic Subset A|Overall Study||15
84796|NCT02125877|208570|P1|Pharmacokinetic Subset A|Overall Study||16
84797|NCT02125877|208569|P2|Pharmacokinetic Analysis Set|Overall Study||83
84798|NCT02125877|208570|P1|Pharmacokinetic Analysis Set|Overall Study||83
84799|NCT02125877|208569|P2|STARTED|Overall Study||87
84800|NCT02125877|208570|P1|STARTED|Overall Study||86
84801|NCT02125838|208600|P2|NOT COMPLETED|Overall Study||4
84802|NCT02125838|208601|P1|NOT COMPLETED|Overall Study||4
84803|NCT02125838|208600|P2|COMPLETED|Overall Study|Analysed (n=50 )|50
84804|NCT02125838|208601|P1|COMPLETED|Overall Study|Analysed (n=50 )|50
84805|NCT02125838|208600|P2|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions) (n= 2) NBA used (n= 2)|54
84806|NCT02125838|208601|P1|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions)(n= 2) NBA used (n= 2)|54
84807|NCT02125734|208619|P2|NOT COMPLETED|Period 2||1
84808|NCT02125734|208620|P1|NOT COMPLETED|Period 2||0
84809|NCT02125734|208619|P2|COMPLETED|Period 2||47
84810|NCT02125734|208620|P1|COMPLETED|Period 2||40
84811|NCT02125734|208619|P2|STARTED|Period 2||48
84812|NCT02125734|208620|P1|STARTED|Period 2||40
84813|NCT02125734|208619|P2|NOT COMPLETED|Period 1||0
84814|NCT02125734|208620|P1|NOT COMPLETED|Period 1||0
84815|NCT02125734|208619|P2|COMPLETED|Period 1||48
84816|NCT02125734|208620|P1|COMPLETED|Period 1||40
84817|NCT02125734|208619|P2|STARTED|Period 1||48
84818|NCT02125734|208620|P1|STARTED|Period 1||40
84819|NCT02125604|208630|P1|NOT COMPLETED|Overall Study||31
84820|NCT02125604|208630|P1|COMPLETED|Overall Study||180
84821|NCT02125604|208630|P1|STARTED|Overall Study|enrolled and received at least 1 dose of study drug|211
84822|NCT02125461|208646|P2|NOT COMPLETED|Overall Study||129
84823|NCT02125461|208647|P1|NOT COMPLETED|Overall Study||203
84824|NCT02125461|208646|P2|COMPLETED|Overall Study||108
84825|NCT02125461|208647|P1|COMPLETED|Overall Study||273
84826|NCT02125461|208646|P2|Completed 12 Months of Treatment|Overall Study||82
84827|NCT02125461|208647|P1|Completed 12 Months of Treatment|Overall Study||232
84828|NCT02125461|208646|P2|Safety Analysis Set|Overall Study||234
84829|NCT02125461|208647|P1|Safety Analysis Set|Overall Study||475
84830|NCT02125461|208646|P2|Receieved Treatment|Overall Study||236
84831|NCT02125461|208647|P1|Receieved Treatment|Overall Study||473
84832|NCT02125461|208646|P2|Full Analysis Set (FAS)|Overall Study||237
84833|NCT02125461|208647|P1|Full Analysis Set (FAS)|Overall Study||476
84834|NCT02125461|208646|P2|STARTED|Overall Study||237
84835|NCT02125461|208647|P1|STARTED|Overall Study||476
84836|NCT02125292|208676|P6|NOT COMPLETED|Third Intervention (1 Hour)||0
84837|NCT02125292|208677|P5|NOT COMPLETED|Third Intervention (1 Hour)||0
84838|NCT02125292|208678|P4|NOT COMPLETED|Third Intervention (1 Hour)||0
84839|NCT02125292|208679|P3|NOT COMPLETED|Third Intervention (1 Hour)||0
84840|NCT02125292|208680|P2|NOT COMPLETED|Third Intervention (1 Hour)||0
84841|NCT02125292|208681|P1|NOT COMPLETED|Third Intervention (1 Hour)||0
84842|NCT02125292|208676|P6|COMPLETED|Third Intervention (1 Hour)||3
84843|NCT02125292|208677|P5|COMPLETED|Third Intervention (1 Hour)||3
84844|NCT02125292|208678|P4|COMPLETED|Third Intervention (1 Hour)||3
84845|NCT02125292|208679|P3|COMPLETED|Third Intervention (1 Hour)||3
84846|NCT02125292|208680|P2|COMPLETED|Third Intervention (1 Hour)||3
84847|NCT02125292|208681|P1|COMPLETED|Third Intervention (1 Hour)||3
84848|NCT02125292|208676|P6|STARTED|Third Intervention (1 Hour)||3
84849|NCT02125292|208677|P5|STARTED|Third Intervention (1 Hour)||3
84850|NCT02125292|208678|P4|STARTED|Third Intervention (1 Hour)||3
84851|NCT02125292|208679|P3|STARTED|Third Intervention (1 Hour)||3
84852|NCT02125292|208680|P2|STARTED|Third Intervention (1 Hour)||3
84853|NCT02125292|208681|P1|STARTED|Third Intervention (1 Hour)||3
84854|NCT02125292|208676|P6|NOT COMPLETED|Washout (2 Hours)||0
84855|NCT02125292|208677|P5|NOT COMPLETED|Washout (2 Hours)||0
84856|NCT02125292|208678|P4|NOT COMPLETED|Washout (2 Hours)||0
84857|NCT02125292|208679|P3|NOT COMPLETED|Washout (2 Hours)||0
84858|NCT02125292|208680|P2|NOT COMPLETED|Washout (2 Hours)||0
84859|NCT02125292|208681|P1|NOT COMPLETED|Washout (2 Hours)||0
84860|NCT02125292|208676|P6|COMPLETED|Washout (2 Hours)||3
84861|NCT02125292|208677|P5|COMPLETED|Washout (2 Hours)||3
84862|NCT02125292|208678|P4|COMPLETED|Washout (2 Hours)||3
84863|NCT02125292|208679|P3|COMPLETED|Washout (2 Hours)||3
84864|NCT02125292|208680|P2|COMPLETED|Washout (2 Hours)||3
84865|NCT02125292|208681|P1|COMPLETED|Washout (2 Hours)||3
84866|NCT02125292|208676|P6|STARTED|Washout (2 Hours)||3
84867|NCT02125292|208677|P5|STARTED|Washout (2 Hours)||3
84868|NCT02125292|208678|P4|STARTED|Washout (2 Hours)||3
84869|NCT02125292|208679|P3|STARTED|Washout (2 Hours)||3
84870|NCT02125292|208680|P2|STARTED|Washout (2 Hours)||3
84871|NCT02125292|208681|P1|STARTED|Washout (2 Hours)||3
84872|NCT02125292|208676|P6|NOT COMPLETED|Second Intervention (1 Hour)||0
84873|NCT02125292|208677|P5|NOT COMPLETED|Second Intervention (1 Hour)||0
84874|NCT02125292|208678|P4|NOT COMPLETED|Second Intervention (1 Hour)||0
84875|NCT02125292|208679|P3|NOT COMPLETED|Second Intervention (1 Hour)||0
84876|NCT02125292|208680|P2|NOT COMPLETED|Second Intervention (1 Hour)||0
84877|NCT02125292|208681|P1|NOT COMPLETED|Second Intervention (1 Hour)||0
84878|NCT02125292|208676|P6|COMPLETED|Second Intervention (1 Hour)||3
84879|NCT02125292|208677|P5|COMPLETED|Second Intervention (1 Hour)||3
84880|NCT02125292|208678|P4|COMPLETED|Second Intervention (1 Hour)||3
84881|NCT02125292|208679|P3|COMPLETED|Second Intervention (1 Hour)||3
84882|NCT02125292|208680|P2|COMPLETED|Second Intervention (1 Hour)||3
84883|NCT02125292|208681|P1|COMPLETED|Second Intervention (1 Hour)||3
84884|NCT02125292|208676|P6|STARTED|Second Intervention (1 Hour)||3
84885|NCT02125292|208677|P5|STARTED|Second Intervention (1 Hour)||3
84886|NCT02125292|208678|P4|STARTED|Second Intervention (1 Hour)||3
84887|NCT02125292|208679|P3|STARTED|Second Intervention (1 Hour)||3
84888|NCT02125292|208680|P2|STARTED|Second Intervention (1 Hour)||3
84889|NCT02125292|208681|P1|STARTED|Second Intervention (1 Hour)||3
84890|NCT02125292|208676|P6|NOT COMPLETED|Washout (2 Hours)||0
84891|NCT02125292|208677|P5|NOT COMPLETED|Washout (2 Hours)||0
84892|NCT02125292|208678|P4|NOT COMPLETED|Washout (2 Hours)||0
84893|NCT02125292|208679|P3|NOT COMPLETED|Washout (2 Hours)||0
84894|NCT02125292|208680|P2|NOT COMPLETED|Washout (2 Hours)||0
84895|NCT02125292|208681|P1|NOT COMPLETED|Washout (2 Hours)||0
84896|NCT02125292|208676|P6|COMPLETED|Washout (2 Hours)||3
84897|NCT02125292|208677|P5|COMPLETED|Washout (2 Hours)||3
84898|NCT02125292|208678|P4|COMPLETED|Washout (2 Hours)||3
84899|NCT02125292|208679|P3|COMPLETED|Washout (2 Hours)||3
84900|NCT02125292|208680|P2|COMPLETED|Washout (2 Hours)||3
84901|NCT02125292|208681|P1|COMPLETED|Washout (2 Hours)||3
84902|NCT02125292|208676|P6|STARTED|Washout (2 Hours)||3
84903|NCT02125292|208677|P5|STARTED|Washout (2 Hours)||3
84904|NCT02125292|208678|P4|STARTED|Washout (2 Hours)||3
84905|NCT02125292|208679|P3|STARTED|Washout (2 Hours)||3
84906|NCT02125292|208680|P2|STARTED|Washout (2 Hours)||3
84907|NCT02125292|208681|P1|STARTED|Washout (2 Hours)||3
84908|NCT02125292|208676|P6|NOT COMPLETED|First Intervention (1 Hour)||0
84909|NCT02125292|208677|P5|NOT COMPLETED|First Intervention (1 Hour)||0
84910|NCT02125292|208678|P4|NOT COMPLETED|First Intervention (1 Hour)||0
84911|NCT02125292|208679|P3|NOT COMPLETED|First Intervention (1 Hour)||0
84912|NCT02125292|208680|P2|NOT COMPLETED|First Intervention (1 Hour)||0
84913|NCT02125292|208681|P1|NOT COMPLETED|First Intervention (1 Hour)||0
84914|NCT02125292|208676|P6|COMPLETED|First Intervention (1 Hour)||3
84915|NCT02125292|208677|P5|COMPLETED|First Intervention (1 Hour)||3
84916|NCT02125292|208678|P4|COMPLETED|First Intervention (1 Hour)||3
84917|NCT02125292|208679|P3|COMPLETED|First Intervention (1 Hour)||3
84918|NCT02125292|208680|P2|COMPLETED|First Intervention (1 Hour)||3
84919|NCT02125292|208681|P1|COMPLETED|First Intervention (1 Hour)||3
84920|NCT02125292|208676|P6|STARTED|First Intervention (1 Hour)||3
84921|NCT02125292|208677|P5|STARTED|First Intervention (1 Hour)||3
84922|NCT02125292|208678|P4|STARTED|First Intervention (1 Hour)||3
84923|NCT02125292|208679|P3|STARTED|First Intervention (1 Hour)||3
84924|NCT02125292|208680|P2|STARTED|First Intervention (1 Hour)||3
84925|NCT02125292|208681|P1|STARTED|First Intervention (1 Hour)||3
84926|NCT02125279|208702|P1|NOT COMPLETED|Overall Study||13
84927|NCT02125279|208702|P1|COMPLETED|Overall Study||41
84928|NCT02125279|208702|P1|STARTED|Overall Study||54
84929|NCT02124889|208731|P2|NOT COMPLETED|Overall Study||0
84930|NCT02124889|208732|P1|NOT COMPLETED|Overall Study||0
84931|NCT02124889|208731|P2|COMPLETED|Overall Study||12
84932|NCT02124889|208732|P1|COMPLETED|Overall Study||12
84933|NCT02124889|208731|P2|STARTED|Overall Study||12
84934|NCT02124889|208732|P1|STARTED|Overall Study||12
84935|NCT02124863|208738|P1|NOT COMPLETED|Overall Study||17
84936|NCT02124863|208738|P1|COMPLETED|Overall Study||50
84937|NCT02124863|208738|P1|STARTED|Overall Study||67
84938|NCT02124811|208746|P2|NOT COMPLETED|Overall Study||2
84939|NCT02124811|208747|P1|NOT COMPLETED|Overall Study||3
84940|NCT02124811|208746|P2|COMPLETED|Overall Study||3
84941|NCT02124811|208747|P1|COMPLETED|Overall Study||2
84942|NCT02124811|208746|P2|STARTED|Overall Study||5
84943|NCT02124811|208747|P1|STARTED|Overall Study||5
84944|NCT02124798|208763|P1|NOT COMPLETED|Overall Study||4
84945|NCT02124798|208763|P1|COMPLETED|Overall Study||91
84946|NCT02124798|208763|P1|STARTED|Overall Study||95
84947|NCT02124603|208769|P1|NOT COMPLETED|Overall Study||0
84948|NCT02124603|208769|P1|COMPLETED|Overall Study||120
84949|NCT02124603|208769|P1|STARTED|Overall Study||120
84950|NCT02124564|208775|P1|NOT COMPLETED|Taper Period||0
84951|NCT02124564|208775|P1|COMPLETED|Taper Period||2
84952|NCT02124564|208775|P1|STARTED|Taper Period||2
84953|NCT02124564|208775|P1|NOT COMPLETED|Treatment Period||7
84954|NCT02124564|208775|P1|COMPLETED|Treatment Period||12
84955|NCT02124564|208775|P1|Started Follow-Up Period|Treatment Period||13
84956|NCT02124564|208775|P1|Started Evaluation Period|Treatment Period||17
84957|NCT02124564|208775|P1|Started Monotherapy Period|Treatment Period||17
84958|NCT02124564|208775|P1|Started AED Withdrawal Period|Treatment Period||19
84959|NCT02124564|208775|P1|Started Titration Period|Treatment Period||19
84960|NCT02124564|208775|P1|Started Treatment Period|Treatment Period||19
84961|NCT02124564|208775|P1|STARTED|Treatment Period||19
84962|NCT02124512|208787|P2|NOT COMPLETED|Overall Study||0
84963|NCT02124512|208788|P1|NOT COMPLETED|Overall Study||0
84964|NCT02124512|208787|P2|COMPLETED|Overall Study||6
84965|NCT02124512|208788|P1|COMPLETED|Overall Study||6
84966|NCT02124512|208787|P2|STARTED|Overall Study||6
84967|NCT02124512|208788|P1|STARTED|Overall Study||6
84968|NCT02124460|208798|P2|NOT COMPLETED|Overall Study||24
84969|NCT02124460|208799|P1|NOT COMPLETED|Overall Study||33
84970|NCT02124460|208798|P2|COMPLETED|Overall Study||336
84971|NCT02124460|208799|P1|COMPLETED|Overall Study||328
84972|NCT02124460|208798|P2|STARTED|Overall Study||360
84973|NCT02124460|208799|P1|STARTED|Overall Study||361
84974|NCT02124304|208831|P2|NOT COMPLETED|Overall Study||0
84975|NCT02124304|208832|P1|NOT COMPLETED|Overall Study||0
84976|NCT02124304|208831|P2|COMPLETED|Overall Study||15
84977|NCT02124304|208832|P1|COMPLETED|Overall Study||15
84978|NCT02124304|208831|P2|STARTED|Overall Study||15
84979|NCT02124304|208832|P1|STARTED|Overall Study||15
84980|NCT02124265|208840|P1|NOT COMPLETED|Overall Study||1
84981|NCT02124265|208840|P1|COMPLETED|Overall Study||2
84982|NCT02124265|208840|P1|STARTED|Overall Study||3
84983|NCT02124161|208846|P2|NOT COMPLETED|Overall Study||15
84984|NCT02124161|208847|P1|NOT COMPLETED|Overall Study||16
84985|NCT02124161|208846|P2|COMPLETED|Overall Study||426
84986|NCT02124161|208847|P1|COMPLETED|Overall Study||425
84987|NCT02124161|208846|P2|Vaccination 2|Overall Study||432
84988|NCT02124161|208847|P1|Vaccination 2|Overall Study||431
84989|NCT02124161|208846|P2|Vaccination 1|Overall Study||437
84990|NCT02124161|208847|P1|Vaccination 1|Overall Study||439
84991|NCT02124161|208846|P2|STARTED|Overall Study||441
84992|NCT02124161|208847|P1|STARTED|Overall Study||441
84993|NCT02124122|208879|P2|NOT COMPLETED|Overall Study||0
84994|NCT02124122|208880|P1|NOT COMPLETED|Overall Study||0
84995|NCT02124122|208879|P2|COMPLETED|Overall Study||19
84996|NCT02124122|208880|P1|COMPLETED|Overall Study||41
84997|NCT02124122|208879|P2|STARTED|Overall Study||19
84998|NCT02124122|208880|P1|STARTED|Overall Study||41
84999|NCT02124083|208888|P1|NOT COMPLETED|Overall Study||1
85000|NCT02124083|208888|P1|COMPLETED|Overall Study||11
85001|NCT02124083|208888|P1|STARTED|Overall Study||12
85002|NCT02124044|208899|P2|NOT COMPLETED|Overall Study||1
85003|NCT02124044|208900|P1|NOT COMPLETED|Overall Study||0
85004|NCT02124044|208899|P2|COMPLETED|Overall Study||9
85005|NCT02124044|208900|P1|COMPLETED|Overall Study||20
85006|NCT02124044|208899|P2|STARTED|Overall Study||10
85007|NCT02124044|208900|P1|STARTED|Overall Study||20
85008|NCT02124018|208909|P3|NOT COMPLETED|Overall Study||0
85009|NCT02124018|208910|P2|NOT COMPLETED|Overall Study||0
85010|NCT02124018|208911|P1|NOT COMPLETED|Overall Study||0
85011|NCT02124018|208909|P3|COMPLETED|Overall Study|Numbers do not add up to 575 (enrolled) due to refusals of programmed ventricular stimulation|41
85012|NCT02124018|208910|P2|COMPLETED|Overall Study||111
85013|NCT02124018|208911|P1|COMPLETED|Overall Study||371
85014|NCT02124018|208909|P3|STARTED|Overall Study||41
85015|NCT02124018|208910|P2|STARTED|Overall Study||111
85016|NCT02124018|208911|P1|STARTED|Overall Study||371
85017|NCT02123966|208922|P1|NOT COMPLETED|Overall Study||1
85018|NCT02123966|208922|P1|COMPLETED|Overall Study||9
85019|NCT02123966|208922|P1|STARTED|Overall Study||10
85020|NCT02123849|208929|P2|NOT COMPLETED|Overall Study||9
85021|NCT02123849|208930|P1|NOT COMPLETED|Overall Study||4
85022|NCT02123849|208929|P2|COMPLETED|Overall Study||18
85023|NCT02123849|208930|P1|COMPLETED|Overall Study||23
85024|NCT02123849|208929|P2|STARTED|Overall Study||27
85025|NCT02123849|208930|P1|STARTED|Overall Study||27
85026|NCT02123745|208954|P1|NOT COMPLETED|Overall Study||0
85027|NCT02123745|208954|P1|COMPLETED|Overall Study||71
85028|NCT02123745|208954|P1|STARTED|Overall Study||71
85029|NCT02123576|208964|P2|NOT COMPLETED|Overall Study||0
85030|NCT02123576|208965|P1|NOT COMPLETED|Overall Study||1
85031|NCT02123576|208964|P2|COMPLETED|Overall Study||6
85032|NCT02123576|208965|P1|COMPLETED|Overall Study||5
85033|NCT02123576|208964|P2|STARTED|Overall Study||6
85034|NCT02123576|208965|P1|STARTED|Overall Study||6
85035|NCT02123511|208983|P2|NOT COMPLETED|Overall Study||4
85036|NCT02123511|208984|P1|NOT COMPLETED|Overall Study||2
85037|NCT02123511|208983|P2|COMPLETED|Overall Study||12
85038|NCT02123511|208984|P1|COMPLETED|Overall Study||16
85039|NCT02123511|208983|P2|Eligible Patients|Overall Study||15
85040|NCT02123511|208984|P1|Eligible Patients|Overall Study||17
85041|NCT02123511|208983|P2|STARTED|Overall Study||16
85042|NCT02123511|208984|P1|STARTED|Overall Study||18
85043|NCT02123472|209008|P2|NOT COMPLETED|Period 2 (7 Days)||1
85044|NCT02123472|209009|P1|NOT COMPLETED|Period 2 (7 Days)||0
85045|NCT02123472|209008|P2|COMPLETED|Period 2 (7 Days)||13
85046|NCT02123472|209009|P1|COMPLETED|Period 2 (7 Days)||14
85047|NCT02123472|209008|P2|STARTED|Period 2 (7 Days)||14
85048|NCT02123472|209009|P1|STARTED|Period 2 (7 Days)||14
85049|NCT02123472|209008|P2|NOT COMPLETED|Washout Period (1 Day)||0
85050|NCT02123472|209009|P1|NOT COMPLETED|Washout Period (1 Day)||0
85051|NCT02123472|209008|P2|COMPLETED|Washout Period (1 Day)||14
85052|NCT02123472|209009|P1|COMPLETED|Washout Period (1 Day)||14
85053|NCT02123472|209008|P2|STARTED|Washout Period (1 Day)||14
85054|NCT02123472|209009|P1|STARTED|Washout Period (1 Day)||14
85055|NCT02123472|209008|P2|NOT COMPLETED|Period 1 (7 Days)||0
85056|NCT02123472|209009|P1|NOT COMPLETED|Period 1 (7 Days)||0
85057|NCT02123472|209008|P2|COMPLETED|Period 1 (7 Days)||14
85058|NCT02123472|209009|P1|COMPLETED|Period 1 (7 Days)||14
85059|NCT02123472|209008|P2|STARTED|Period 1 (7 Days)||14
85060|NCT02123472|209009|P1|STARTED|Period 1 (7 Days)||14
85061|NCT02123459|209019|P2|NOT COMPLETED|Period 2 (7 Days)||0
85062|NCT02123459|209020|P1|NOT COMPLETED|Period 2 (7 Days)||0
85063|NCT02123459|209019|P2|COMPLETED|Period 2 (7 Days)||14
85064|NCT02123459|209020|P1|COMPLETED|Period 2 (7 Days)||13
85065|NCT02123459|209019|P2|STARTED|Period 2 (7 Days)||14
85066|NCT02123459|209020|P1|STARTED|Period 2 (7 Days)||13
85067|NCT02123459|209019|P2|NOT COMPLETED|Washout Period (1 Day)||0
85068|NCT02123459|209020|P1|NOT COMPLETED|Washout Period (1 Day)||1
85069|NCT02123459|209019|P2|COMPLETED|Washout Period (1 Day)||14
85070|NCT02123459|209020|P1|COMPLETED|Washout Period (1 Day)||13
85071|NCT02123459|209019|P2|STARTED|Washout Period (1 Day)||14
85072|NCT02123459|209020|P1|STARTED|Washout Period (1 Day)||14
85073|NCT02123459|209019|P2|NOT COMPLETED|Period 1 (7 Days)||0
85074|NCT02123459|209020|P1|NOT COMPLETED|Period 1 (7 Days)||0
85075|NCT02123459|209019|P2|COMPLETED|Period 1 (7 Days)||14
85076|NCT02123459|209020|P1|COMPLETED|Period 1 (7 Days)||14
85077|NCT02123459|209019|P2|STARTED|Period 1 (7 Days)||14
85078|NCT02123459|209020|P1|STARTED|Period 1 (7 Days)||14
85079|NCT02123446|209030|P2|NOT COMPLETED|Period 2 (7 Days)||0
85080|NCT02123446|209031|P1|NOT COMPLETED|Period 2 (7 Days)||0
85081|NCT02123446|209030|P2|COMPLETED|Period 2 (7 Days)||14
85082|NCT02123446|209031|P1|COMPLETED|Period 2 (7 Days)||13
85083|NCT02123446|209030|P2|STARTED|Period 2 (7 Days)||14
85084|NCT02123446|209031|P1|STARTED|Period 2 (7 Days)||13
85085|NCT02123446|209030|P2|NOT COMPLETED|Washout Period (1 Day)||0
85086|NCT02123446|209031|P1|NOT COMPLETED|Washout Period (1 Day)||1
85087|NCT02123446|209030|P2|COMPLETED|Washout Period (1 Day)||14
85088|NCT02123446|209031|P1|COMPLETED|Washout Period (1 Day)||13
85089|NCT02123446|209030|P2|STARTED|Washout Period (1 Day)||14
85090|NCT02123446|209031|P1|STARTED|Washout Period (1 Day)||14
85091|NCT02123446|209030|P2|NOT COMPLETED|Period 1 (7 Days)||0
85092|NCT02123446|209031|P1|NOT COMPLETED|Period 1 (7 Days)||0
85093|NCT02123446|209030|P2|COMPLETED|Period 1 (7 Days)||14
85094|NCT02123446|209031|P1|COMPLETED|Period 1 (7 Days)||14
85095|NCT02123446|209030|P2|STARTED|Period 1 (7 Days)||14
85096|NCT02123446|209031|P1|STARTED|Period 1 (7 Days)||14
85097|NCT02123329|209043|P2|NOT COMPLETED|12 Month Outcome Measure||79
85098|NCT02123329|209044|P1|NOT COMPLETED|12 Month Outcome Measure||64
85099|NCT02123329|209043|P2|COMPLETED|12 Month Outcome Measure||88
85100|NCT02123329|209044|P1|COMPLETED|12 Month Outcome Measure||83
85101|NCT02123329|209043|P2|STARTED|12 Month Outcome Measure||167
85102|NCT02123329|209044|P1|STARTED|12 Month Outcome Measure||147
85103|NCT02123329|209043|P2|NOT COMPLETED|6 Month Outcome Measure||67
85104|NCT02123329|209044|P1|NOT COMPLETED|6 Month Outcome Measure||48
85105|NCT02123329|209043|P2|COMPLETED|6 Month Outcome Measure||100
85106|NCT02123329|209044|P1|COMPLETED|6 Month Outcome Measure||99
85107|NCT02123329|209043|P2|STARTED|6 Month Outcome Measure||167
85108|NCT02123329|209044|P1|STARTED|6 Month Outcome Measure||147
85109|NCT02123329|209043|P2|NOT COMPLETED|3 Month Outcome Measure||66
85110|NCT02123329|209044|P1|NOT COMPLETED|3 Month Outcome Measure||49
85111|NCT02123329|209043|P2|COMPLETED|3 Month Outcome Measure||101
85112|NCT02123329|209044|P1|COMPLETED|3 Month Outcome Measure||98
85113|NCT02123329|209043|P2|STARTED|3 Month Outcome Measure||167
85114|NCT02123329|209044|P1|STARTED|3 Month Outcome Measure||147
85115|NCT02123251|209072|P2|NOT COMPLETED|Overall Study||30
85116|NCT02123251|209073|P1|NOT COMPLETED|Overall Study||34
85117|NCT02123251|209072|P2|COMPLETED|Overall Study||131
85118|NCT02123251|209073|P1|COMPLETED|Overall Study||125
85119|NCT02123251|209072|P2|STARTED|Overall Study||161
85120|NCT02123251|209073|P1|STARTED|Overall Study||159
85121|NCT02123017|209100|P3|NOT COMPLETED|Overall Study||0
85122|NCT02123017|209101|P2|NOT COMPLETED|Overall Study||0
85123|NCT02123017|209102|P1|NOT COMPLETED|Overall Study||0
85124|NCT02123017|209100|P3|COMPLETED|Overall Study||12
85125|NCT02123017|209101|P2|COMPLETED|Overall Study||12
85126|NCT02123017|209102|P1|COMPLETED|Overall Study||8
85127|NCT02123017|209100|P3|STARTED|Overall Study||12
85128|NCT02123017|209101|P2|STARTED|Overall Study||12
85129|NCT02123017|209102|P1|STARTED|Overall Study||8
85130|NCT02122952|209121|P2|NOT COMPLETED|Overall Study||0
85131|NCT02122952|209122|P1|NOT COMPLETED|Overall Study||0
85132|NCT02122952|209121|P2|COMPLETED|Overall Study||12
85133|NCT02122952|209122|P1|COMPLETED|Overall Study||3
85134|NCT02122952|209121|P2|STARTED|Overall Study||12
85135|NCT02122952|209122|P1|STARTED|Overall Study||3
85136|NCT02122887|209136|P2|NOT COMPLETED|Overall Study||2
85137|NCT02122887|209137|P1|NOT COMPLETED|Overall Study||20
85138|NCT02122887|209136|P2|COMPLETED|Overall Study||39
85139|NCT02122887|209137|P1|COMPLETED|Overall Study||40
85140|NCT02122887|209136|P2|STARTED|Overall Study||41
85141|NCT02122887|209137|P1|STARTED|Overall Study||60
85142|NCT02122796|209155|P2|NOT COMPLETED|Visit 2||1
85143|NCT02122796|209156|P1|NOT COMPLETED|Visit 2||3
85144|NCT02122796|209155|P2|COMPLETED|Visit 2||14
85145|NCT02122796|209156|P1|COMPLETED|Visit 2||12
85146|NCT02122796|209155|P2|STARTED|Visit 2||15
85147|NCT02122796|209156|P1|STARTED|Visit 2||15
85148|NCT02122796|209155|P2|NOT COMPLETED|Visit 1||0
85149|NCT02122796|209156|P1|NOT COMPLETED|Visit 1||0
85150|NCT02122796|209155|P2|COMPLETED|Visit 1||15
85151|NCT02122796|209156|P1|COMPLETED|Visit 1||15
85152|NCT02122796|209155|P2|STARTED|Visit 1||15
85153|NCT02122796|209156|P1|STARTED|Visit 1||15
85154|NCT02122770|209173|P6|NOT COMPLETED|Part B: Standard of Care||13
85155|NCT02122770|209174|P5|NOT COMPLETED|Part B: Standard of Care||23
85156|NCT02122770|209175|P4|NOT COMPLETED|Part B: Standard of Care||0
85157|NCT02122770|209176|P3|NOT COMPLETED|Part B: Standard of Care||0
85158|NCT02122770|209177|P2|NOT COMPLETED|Part B: Standard of Care||0
85159|NCT02122770|209178|P1|NOT COMPLETED|Part B: Standard of Care||0
85160|NCT02122770|209173|P6|COMPLETED|Part B: Standard of Care||0
85161|NCT02122770|209174|P5|COMPLETED|Part B: Standard of Care||0
85162|NCT02122770|209175|P4|COMPLETED|Part B: Standard of Care||0
85163|NCT02122770|209176|P3|COMPLETED|Part B: Standard of Care||0
85164|NCT02122770|209177|P2|COMPLETED|Part B: Standard of Care||0
85165|NCT02122770|209178|P1|COMPLETED|Part B: Standard of Care||0
85166|NCT02122770|209173|P6|STARTED|Part B: Standard of Care||13
85167|NCT02122770|209174|P5|STARTED|Part B: Standard of Care||23
85168|NCT02122770|209175|P4|STARTED|Part B: Standard of Care||0
85169|NCT02122770|209176|P3|STARTED|Part B: Standard of Care||0
85170|NCT02122770|209177|P2|STARTED|Part B: Standard of Care||0
85171|NCT02122770|209178|P1|STARTED|Part B: Standard of Care||0
85172|NCT02122770|209173|P6|NOT COMPLETED|Part A: Drug-drug Interaction 2||0
85173|NCT02122770|209174|P5|NOT COMPLETED|Part A: Drug-drug Interaction 2||0
85174|NCT02122770|209175|P4|NOT COMPLETED|Part A: Drug-drug Interaction 2||3
85175|NCT02122770|209176|P3|NOT COMPLETED|Part A: Drug-drug Interaction 2||2
85176|NCT02122770|209177|P2|NOT COMPLETED|Part A: Drug-drug Interaction 2||6
85177|NCT02122770|209178|P1|NOT COMPLETED|Part A: Drug-drug Interaction 2||4
85178|NCT02122770|209173|P6|COMPLETED|Part A: Drug-drug Interaction 2||0
85179|NCT02122770|209174|P5|COMPLETED|Part A: Drug-drug Interaction 2||0
85180|NCT02122770|209175|P4|COMPLETED|Part A: Drug-drug Interaction 2||16
85181|NCT02122770|209176|P3|COMPLETED|Part A: Drug-drug Interaction 2||4
85182|NCT02122770|209177|P2|COMPLETED|Part A: Drug-drug Interaction 2||7
85183|NCT02122770|209178|P1|COMPLETED|Part A: Drug-drug Interaction 2||9
85184|NCT02122770|209173|P6|STARTED|Part A: Drug-drug Interaction 2||0
85185|NCT02122770|209174|P5|STARTED|Part A: Drug-drug Interaction 2||0
85186|NCT02122770|209175|P4|STARTED|Part A: Drug-drug Interaction 2||19
85187|NCT02122770|209176|P3|STARTED|Part A: Drug-drug Interaction 2||6
85188|NCT02122770|209177|P2|STARTED|Part A: Drug-drug Interaction 2||13
85189|NCT02122770|209178|P1|STARTED|Part A: Drug-drug Interaction 2||13
85190|NCT02122549|209258|P1|NOT COMPLETED|Overall Study||0
85191|NCT02122549|209258|P1|COMPLETED|Overall Study||59
85192|NCT02122549|209258|P1|STARTED|Overall Study||59
85193|NCT02122471|209265|P3|NOT COMPLETED|Overall Study||44
85194|NCT02122471|209266|P2|NOT COMPLETED|Overall Study||51
85195|NCT02122471|209267|P1|NOT COMPLETED|Overall Study||39
85196|NCT02122471|209265|P3|COMPLETED|Overall Study||405
85197|NCT02122471|209266|P2|COMPLETED|Overall Study||392
85198|NCT02122471|209267|P1|COMPLETED|Overall Study||406
85199|NCT02122471|209265|P3|STARTED|Overall Study||449
85200|NCT02122471|209266|P2|STARTED|Overall Study||443
85201|NCT02122471|209267|P1|STARTED|Overall Study||445
85202|NCT02122445|209287|P1|NOT COMPLETED|Overall Study||0
85203|NCT02122445|209287|P1|COMPLETED|Overall Study||20
85204|NCT02122445|209287|P1|STARTED|Overall Study||20
85205|NCT02122406|209292|P1|NOT COMPLETED|Overall Study||0
85206|NCT02122406|209292|P1|COMPLETED|Overall Study||200
85207|NCT02122406|209292|P1|STARTED|Overall Study||200
85208|NCT02122341|209298|P2|NOT COMPLETED|Overall Study||0
85209|NCT02122341|209299|P1|NOT COMPLETED|Overall Study||0
85210|NCT02122341|209298|P2|COMPLETED|Overall Study||18
85211|NCT02122341|209299|P1|COMPLETED|Overall Study||17
85212|NCT02122341|209298|P2|STARTED|Overall Study||18
85213|NCT02122341|209299|P1|STARTED|Overall Study||17
85214|NCT02122146|209321|P8|NOT COMPLETED|Part 3: Expansion||0
85215|NCT02122146|209322|P7|NOT COMPLETED|Part 3: Expansion||0
85216|NCT02122146|209323|P6|NOT COMPLETED|Part 3: Expansion||0
85217|NCT02122146|209324|P5|NOT COMPLETED|Part 3: Expansion||0
85218|NCT02122146|209325|P4|NOT COMPLETED|Part 3: Expansion||0
85219|NCT02122146|209326|P3|NOT COMPLETED|Part 3: Expansion||0
85220|NCT02122146|209327|P2|NOT COMPLETED|Part 3: Expansion||0
85221|NCT02122146|209328|P1|NOT COMPLETED|Part 3: Expansion||0
85222|NCT02122146|209321|P8|COMPLETED|Part 3: Expansion||0
85223|NCT02122146|209322|P7|COMPLETED|Part 3: Expansion||0
85224|NCT02122146|209323|P6|COMPLETED|Part 3: Expansion||0
85225|NCT02122146|209324|P5|COMPLETED|Part 3: Expansion||0
85226|NCT02122146|209325|P4|COMPLETED|Part 3: Expansion||0
85227|NCT02122146|209326|P3|COMPLETED|Part 3: Expansion||0
85228|NCT02122146|209327|P2|COMPLETED|Part 3: Expansion||0
85229|NCT02122146|209328|P1|COMPLETED|Part 3: Expansion||0
85230|NCT02122146|209321|P8|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
85231|NCT02122146|209322|P7|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
85232|NCT02122146|209323|P6|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
85233|NCT02122146|209324|P5|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
85234|NCT02122146|209325|P4|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
85235|NCT02122146|209326|P3|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
85236|NCT02122146|209327|P2|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
85237|NCT02122146|209328|P1|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
85238|NCT02122146|209321|P8|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
85239|NCT02122146|209322|P7|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
85240|NCT02122146|209323|P6|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
85241|NCT02122146|209324|P5|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
85242|NCT02122146|209325|P4|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
85243|NCT02122146|209326|P3|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
85244|NCT02122146|209327|P2|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
85245|NCT02122146|209328|P1|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
85246|NCT02122146|209321|P8|COMPLETED|Part 2: Maximum Tolerated Dose||0
85247|NCT02122146|209322|P7|COMPLETED|Part 2: Maximum Tolerated Dose||0
85248|NCT02122146|209323|P6|COMPLETED|Part 2: Maximum Tolerated Dose||0
85249|NCT02122146|209324|P5|COMPLETED|Part 2: Maximum Tolerated Dose||0
85250|NCT02122146|209325|P4|COMPLETED|Part 2: Maximum Tolerated Dose||0
85251|NCT02122146|209326|P3|COMPLETED|Part 2: Maximum Tolerated Dose||0
85252|NCT02122146|209327|P2|COMPLETED|Part 2: Maximum Tolerated Dose||0
85253|NCT02122146|209328|P1|COMPLETED|Part 2: Maximum Tolerated Dose||0
85254|NCT02122146|209321|P8|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
85255|NCT02122146|209322|P7|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
85256|NCT02122146|209323|P6|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
85257|NCT02122146|209324|P5|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
85258|NCT02122146|209325|P4|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
85259|NCT02122146|209326|P3|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
85260|NCT02122146|209327|P2|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
85261|NCT02122146|209328|P1|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
85262|NCT02122146|209321|P8|NOT COMPLETED|Part 1: Dose Escalation||2
85263|NCT02122146|209322|P7|NOT COMPLETED|Part 1: Dose Escalation||1
85264|NCT02122146|209323|P6|NOT COMPLETED|Part 1: Dose Escalation||1
85265|NCT02122146|209324|P5|NOT COMPLETED|Part 1: Dose Escalation||1
85266|NCT02122146|209325|P4|NOT COMPLETED|Part 1: Dose Escalation||1
85267|NCT02122146|209326|P3|NOT COMPLETED|Part 1: Dose Escalation||2
85268|NCT02122146|209327|P2|NOT COMPLETED|Part 1: Dose Escalation||1
85269|NCT02122146|209328|P1|NOT COMPLETED|Part 1: Dose Escalation||1
85270|NCT02122146|209321|P8|COMPLETED|Part 1: Dose Escalation||6
85271|NCT02122146|209322|P7|COMPLETED|Part 1: Dose Escalation||0
85272|NCT02122146|209323|P6|COMPLETED|Part 1: Dose Escalation||5
85273|NCT02122146|209324|P5|COMPLETED|Part 1: Dose Escalation||3
85274|NCT02122146|209325|P4|COMPLETED|Part 1: Dose Escalation||3
85275|NCT02122146|209326|P3|COMPLETED|Part 1: Dose Escalation||2
85276|NCT02122146|209327|P2|COMPLETED|Part 1: Dose Escalation||1
85277|NCT02122146|209328|P1|COMPLETED|Part 1: Dose Escalation||1
85278|NCT02122146|209321|P8|STARTED|Part 1: Dose Escalation||8
85279|NCT02122146|209322|P7|STARTED|Part 1: Dose Escalation||1
85280|NCT02122146|209323|P6|STARTED|Part 1: Dose Escalation||6
85281|NCT02122146|209324|P5|STARTED|Part 1: Dose Escalation||4
85282|NCT02122146|209325|P4|STARTED|Part 1: Dose Escalation||4
85283|NCT02122146|209326|P3|STARTED|Part 1: Dose Escalation||4
85284|NCT02122146|209327|P2|STARTED|Part 1: Dose Escalation||2
85285|NCT02122146|209328|P1|STARTED|Part 1: Dose Escalation||2
85286|NCT02121912|209565|P2|NOT COMPLETED|Overall Study||0
85287|NCT02121912|209566|P1|NOT COMPLETED|Overall Study||4
85288|NCT02121912|209565|P2|COMPLETED|Overall Study||25
85289|NCT02121912|209566|P1|COMPLETED|Overall Study||21
85290|NCT02121912|209565|P2|STARTED|Overall Study||25
85291|NCT02121912|209566|P1|STARTED|Overall Study||25
85292|NCT02121860|209580|P4|NOT COMPLETED|Overall Study||0
85293|NCT02121860|209581|P3|NOT COMPLETED|Overall Study||0
85294|NCT02121860|209582|P2|NOT COMPLETED|Overall Study||0
85295|NCT02121860|209583|P1|NOT COMPLETED|Overall Study||0
85296|NCT02121860|209580|P4|COMPLETED|Overall Study||8
85297|NCT02121860|209581|P3|COMPLETED|Overall Study||8
85298|NCT02121860|209582|P2|COMPLETED|Overall Study||12
85299|NCT02121860|209583|P1|COMPLETED|Overall Study||8
85300|NCT02121860|209580|P4|STARTED|Overall Study||8
85301|NCT02121860|209581|P3|STARTED|Overall Study||8
85302|NCT02121860|209582|P2|STARTED|Overall Study||12
85303|NCT02121860|209583|P1|STARTED|Overall Study||8
85304|NCT02121847|209602|P1|NOT COMPLETED|Overall Study||3
85305|NCT02121847|209602|P1|COMPLETED|Overall Study||37
85306|NCT02121847|209602|P1|STARTED|Overall Study||40
85307|NCT02121834|209628|P7|NOT COMPLETED|Overall Study||0
85308|NCT02121834|209629|P6|NOT COMPLETED|Overall Study||0
85309|NCT02121834|209630|P5|NOT COMPLETED|Overall Study||0
85310|NCT02121834|209631|P4|NOT COMPLETED|Overall Study||0
85311|NCT02121834|209632|P3|NOT COMPLETED|Overall Study||2
85312|NCT02121834|209633|P2|NOT COMPLETED|Overall Study||2
85313|NCT02121834|209634|P1|NOT COMPLETED|Overall Study||0
85314|NCT02121834|209628|P7|COMPLETED|Overall Study||3
85315|NCT02121834|209629|P6|COMPLETED|Overall Study||9
85316|NCT02121834|209630|P5|COMPLETED|Overall Study||9
85317|NCT02121834|209631|P4|COMPLETED|Overall Study||10
85318|NCT02121834|209632|P3|COMPLETED|Overall Study||7
85319|NCT02121834|209633|P2|COMPLETED|Overall Study||9
85320|NCT02121834|209634|P1|COMPLETED|Overall Study||12
85321|NCT02121834|209628|P7|Received at Least One Dose of Study Drug|Overall Study||3
85322|NCT02121834|209629|P6|Received at Least One Dose of Study Drug|Overall Study||9
85323|NCT02121834|209630|P5|Received at Least One Dose of Study Drug|Overall Study||9
85324|NCT02121834|209631|P4|Received at Least One Dose of Study Drug|Overall Study||10
85325|NCT02121834|209632|P3|Received at Least One Dose of Study Drug|Overall Study||9
85326|NCT02121834|209633|P2|Received at Least One Dose of Study Drug|Overall Study||11
85327|NCT02121834|209634|P1|Received at Least One Dose of Study Drug|Overall Study||12
85328|NCT02121834|209628|P7|STARTED|Overall Study||3
85329|NCT02121834|209629|P6|STARTED|Overall Study||9
85330|NCT02121834|209630|P5|STARTED|Overall Study||9
85331|NCT02121834|209631|P4|STARTED|Overall Study||10
85332|NCT02121834|209632|P3|STARTED|Overall Study||9
85333|NCT02121834|209633|P2|STARTED|Overall Study||11
85334|NCT02121834|209634|P1|STARTED|Overall Study||12
85335|NCT02121808|209660|P1|NOT COMPLETED|Overall Study||3
85336|NCT02121808|209660|P1|COMPLETED|Overall Study||17
85337|NCT02121808|209660|P1|STARTED|Overall Study||20
85338|NCT02121795|209671|P2|NOT COMPLETED|Overall Study||334
85339|NCT02121795|209672|P1|NOT COMPLETED|Overall Study||334
85340|NCT02121795|209671|P2|COMPLETED|Overall Study||0
85341|NCT02121795|209672|P1|COMPLETED|Overall Study||0
85342|NCT02121795|209671|P2|STARTED|Overall Study||334
85343|NCT02121795|209672|P1|STARTED|Overall Study||334
85344|NCT02121756|209688|P2|NOT COMPLETED|Overall Study||2
85345|NCT02121756|209689|P1|NOT COMPLETED|Overall Study||6
85346|NCT02121756|209688|P2|COMPLETED|Overall Study||17
85347|NCT02121756|209689|P1|COMPLETED|Overall Study||15
85348|NCT02121756|209688|P2|STARTED|Overall Study||19
85349|NCT02121756|209689|P1|STARTED|Overall Study||21
85350|NCT02121535|209726|P2|NOT COMPLETED|Period 4 (8 Trial Days)||0
85351|NCT02121535|209727|P1|NOT COMPLETED|Period 4 (8 Trial Days)||0
85352|NCT02121535|209726|P2|COMPLETED|Period 4 (8 Trial Days)||35
85353|NCT02121535|209727|P1|COMPLETED|Period 4 (8 Trial Days)||35
85354|NCT02121535|209726|P2|STARTED|Period 4 (8 Trial Days)||35
85355|NCT02121535|209727|P1|STARTED|Period 4 (8 Trial Days)||35
85356|NCT02121535|209726|P2|NOT COMPLETED|Period 3 (8 Trial Days)||0
85357|NCT02121535|209727|P1|NOT COMPLETED|Period 3 (8 Trial Days)||1
85358|NCT02121535|209726|P2|COMPLETED|Period 3 (8 Trial Days)||35
85359|NCT02121535|209727|P1|COMPLETED|Period 3 (8 Trial Days)|1 subject withdrew consent during the washout period between Period 3 and 4.|35
85360|NCT02121535|209726|P2|STARTED|Period 3 (8 Trial Days)||35
85361|NCT02121535|209727|P1|STARTED|Period 3 (8 Trial Days)||36
85362|NCT02121535|209726|P2|NOT COMPLETED|Period 2 (8 Trial Days)||0
85363|NCT02121535|209727|P1|NOT COMPLETED|Period 2 (8 Trial Days)||0
85364|NCT02121535|209726|P2|COMPLETED|Period 2 (8 Trial Days)||35
85365|NCT02121535|209727|P1|COMPLETED|Period 2 (8 Trial Days)||36
85366|NCT02121535|209726|P2|STARTED|Period 2 (8 Trial Days)||35
85367|NCT02121535|209727|P1|STARTED|Period 2 (8 Trial Days)||36
85368|NCT02121535|209726|P2|NOT COMPLETED|Period 1 (8 Trial Days)||1
85369|NCT02121535|209727|P1|NOT COMPLETED|Period 1 (8 Trial Days)||0
85370|NCT02121535|209726|P2|COMPLETED|Period 1 (8 Trial Days)|1 subject withdrew his consent during the washout period between Period 1 and 2.|35
85371|NCT02121535|209727|P1|COMPLETED|Period 1 (8 Trial Days)||36
85372|NCT02121535|209726|P2|STARTED|Period 1 (8 Trial Days)||36
85373|NCT02121535|209727|P1|STARTED|Period 1 (8 Trial Days)||36
85374|NCT02121522|209750|P1|NOT COMPLETED|Overall Study||1
85375|NCT02121522|209750|P1|COMPLETED|Overall Study||13
85376|NCT02121522|209750|P1|STARTED|Overall Study||14
85377|NCT02121509|209757|P4|NOT COMPLETED|Treatment Period-2 (4 Days)||0
85378|NCT02121509|209758|P3|NOT COMPLETED|Treatment Period-2 (4 Days)||0
85379|NCT02121509|209759|P2|NOT COMPLETED|Treatment Period-2 (4 Days)||0
85380|NCT02121509|209760|P1|NOT COMPLETED|Treatment Period-2 (4 Days)||0
85381|NCT02121509|209757|P4|COMPLETED|Treatment Period-2 (4 Days)||8
85382|NCT02121509|209758|P3|COMPLETED|Treatment Period-2 (4 Days)||8
85383|NCT02121509|209759|P2|COMPLETED|Treatment Period-2 (4 Days)||24
85384|NCT02121509|209760|P1|COMPLETED|Treatment Period-2 (4 Days)||28
85385|NCT02121509|209757|P4|STARTED|Treatment Period-2 (4 Days)||8
85386|NCT02121509|209758|P3|STARTED|Treatment Period-2 (4 Days)||8
85387|NCT02121509|209759|P2|STARTED|Treatment Period-2 (4 Days)||24
85388|NCT02121509|209760|P1|STARTED|Treatment Period-2 (4 Days)||28
85389|NCT02121509|209757|P4|NOT COMPLETED|Washout Period (35 Days)||0
85390|NCT02121509|209758|P3|NOT COMPLETED|Washout Period (35 Days)||0
85391|NCT02121509|209759|P2|NOT COMPLETED|Washout Period (35 Days)||4
85392|NCT02121509|209760|P1|NOT COMPLETED|Washout Period (35 Days)||2
85393|NCT02121509|209757|P4|COMPLETED|Washout Period (35 Days)||8
85394|NCT02121509|209758|P3|COMPLETED|Washout Period (35 Days)||8
85395|NCT02121509|209759|P2|COMPLETED|Washout Period (35 Days)||24
85396|NCT02121509|209760|P1|COMPLETED|Washout Period (35 Days)||28
85397|NCT02121509|209757|P4|STARTED|Washout Period (35 Days)||8
85398|NCT02121509|209758|P3|STARTED|Washout Period (35 Days)||8
85399|NCT02121509|209759|P2|STARTED|Washout Period (35 Days)||28
85400|NCT02121509|209760|P1|STARTED|Washout Period (35 Days)||30
85401|NCT02121509|209757|P4|NOT COMPLETED|Treatment Period-1 (4 Days)||0
85402|NCT02121509|209758|P3|NOT COMPLETED|Treatment Period-1 (4 Days)||0
85403|NCT02121509|209759|P2|NOT COMPLETED|Treatment Period-1 (4 Days)||0
85404|NCT02121509|209760|P1|NOT COMPLETED|Treatment Period-1 (4 Days)||0
85405|NCT02121509|209757|P4|COMPLETED|Treatment Period-1 (4 Days)||8
85406|NCT02121509|209758|P3|COMPLETED|Treatment Period-1 (4 Days)||8
85407|NCT02121509|209759|P2|COMPLETED|Treatment Period-1 (4 Days)||28
85408|NCT02121509|209760|P1|COMPLETED|Treatment Period-1 (4 Days)||30
85409|NCT02121509|209757|P4|STARTED|Treatment Period-1 (4 Days)||8
85410|NCT02121509|209758|P3|STARTED|Treatment Period-1 (4 Days)||8
85411|NCT02121509|209759|P2|STARTED|Treatment Period-1 (4 Days)||28
85412|NCT02121509|209760|P1|STARTED|Treatment Period-1 (4 Days)||30
85413|NCT02121483|209793|P3|NOT COMPLETED|Overall Study||0
85414|NCT02121483|209794|P2|NOT COMPLETED|Overall Study||0
85415|NCT02121483|209795|P1|NOT COMPLETED|Overall Study||0
85416|NCT02121483|209793|P3|COMPLETED|Overall Study||10
85417|NCT02121483|209794|P2|COMPLETED|Overall Study||8
85418|NCT02121483|209795|P1|COMPLETED|Overall Study||9
85419|NCT02121483|209793|P3|STARTED|Overall Study||10
85420|NCT02121483|209794|P2|STARTED|Overall Study||8
85421|NCT02121483|209795|P1|STARTED|Overall Study||9
85422|NCT02121418|209824|P1|NOT COMPLETED|Overall Study||0
85423|NCT02121418|209824|P1|COMPLETED|Overall Study||12
85424|NCT02121418|209824|P1|STARTED|Overall Study||12
85425|NCT02121210|209831|P2|NOT COMPLETED|Overall Study||9
85426|NCT02121210|209832|P1|NOT COMPLETED|Overall Study||7
85427|NCT02121210|209831|P2|COMPLETED|Overall Study||58
85428|NCT02121210|209832|P1|COMPLETED|Overall Study||58
85429|NCT02121210|209831|P2|STARTED|Overall Study||67
85430|NCT02121210|209832|P1|STARTED|Overall Study||65
85431|NCT02121067|209840|P1|NOT COMPLETED|Overall Study||0
85432|NCT02121067|209840|P1|COMPLETED|Overall Study||50
85433|NCT02121067|209840|P1|STARTED|Overall Study||50
85434|NCT02121041|209848|P2|NOT COMPLETED|Overall Study||6
85435|NCT02121041|209849|P1|NOT COMPLETED|Overall Study||1
85436|NCT02121041|209848|P2|COMPLETED|Overall Study||8
85437|NCT02121041|209849|P1|COMPLETED|Overall Study||13
85438|NCT02121041|209848|P2|STARTED|Overall Study||14
85439|NCT02121041|209849|P1|STARTED|Overall Study||14
85440|NCT02120950|209857|P3|NOT COMPLETED|Overall Study||15
85441|NCT02120950|209858|P2|NOT COMPLETED|Overall Study||14
85442|NCT02120950|209859|P1|NOT COMPLETED|Overall Study||20
85443|NCT02120950|209857|P3|COMPLETED|Overall Study||0
85444|NCT02120950|209858|P2|COMPLETED|Overall Study|Completed Treatment (Week 96)|147
85445|NCT02120950|209859|P1|COMPLETED|Overall Study|Completed Treatment (Week 96)|137
85446|NCT02120950|209857|P3|STARTED|Overall Study||15
85447|NCT02120950|209858|P2|STARTED|Overall Study||161
85448|NCT02120950|209859|P1|STARTED|Overall Study||157
85449|NCT02120833|209894|P2|NOT COMPLETED|Overall Study||1
85450|NCT02120833|209895|P1|NOT COMPLETED|Overall Study||4
85451|NCT02120833|209894|P2|COMPLETED|Overall Study||11
85452|NCT02120833|209895|P1|COMPLETED|Overall Study||35
85453|NCT02120833|209894|P2|STARTED|Overall Study||12
85454|NCT02120833|209895|P1|STARTED|Overall Study||39
85455|NCT02120794|210049|P1|NOT COMPLETED|Overall Study||58
85456|NCT02120794|210049|P1|COMPLETED|Overall Study||136
85457|NCT02120794|210049|P1|STARTED|Overall Study||194
85458|NCT02120716|210058|P2|NOT COMPLETED|Overall Study||0
85459|NCT02120716|210059|P1|NOT COMPLETED|Overall Study||1
85460|NCT02120716|210058|P2|COMPLETED|Overall Study||19
85461|NCT02120716|210059|P1|COMPLETED|Overall Study||30
85462|NCT02120716|210058|P2|STARTED|Overall Study||19
85463|NCT02120716|210059|P1|STARTED|Overall Study||31
85464|NCT02120664|210073|P5|NOT COMPLETED|Overall Study||0
85465|NCT02120664|210074|P4|NOT COMPLETED|Overall Study||1
85466|NCT02120664|210075|P3|NOT COMPLETED|Overall Study||0
85467|NCT02120664|210076|P2|NOT COMPLETED|Overall Study||0
85468|NCT02120664|210077|P1|NOT COMPLETED|Overall Study||0
85469|NCT02120664|210073|P5|COMPLETED|Overall Study||10
85470|NCT02120664|210074|P4|COMPLETED|Overall Study||3
85471|NCT02120664|210075|P3|COMPLETED|Overall Study||7
85472|NCT02120664|210076|P2|COMPLETED|Overall Study||4
85473|NCT02120664|210077|P1|COMPLETED|Overall Study||10
85474|NCT02120664|210073|P5|STARTED|Overall Study||10
85475|NCT02120664|210074|P4|STARTED|Overall Study||4
85476|NCT02120664|210075|P3|STARTED|Overall Study||7
85477|NCT02120664|210076|P2|STARTED|Overall Study||4
85478|NCT02120664|210077|P1|STARTED|Overall Study||10
85479|NCT02120625|210095|P1|NOT COMPLETED|Overall Study||2
85480|NCT02120625|210095|P1|COMPLETED|Overall Study||6
85481|NCT02120625|210095|P1|STARTED|Overall Study||8
85482|NCT02120456|210111|P9|NOT COMPLETED|Part 2 Double-blind Phase||1
85483|NCT02120456|210112|P8|NOT COMPLETED|Part 2 Double-blind Phase||0
85484|NCT02120456|210113|P7|NOT COMPLETED|Part 2 Double-blind Phase||2
85485|NCT02120456|210114|P6|NOT COMPLETED|Part 2 Double-blind Phase||0
85486|NCT02120456|210115|P5|NOT COMPLETED|Part 2 Double-blind Phase||0
85487|NCT02120456|210116|P4|NOT COMPLETED|Part 2 Double-blind Phase||0
85488|NCT02120456|210117|P3|NOT COMPLETED|Part 2 Double-blind Phase||0
85489|NCT02120456|210118|P2|NOT COMPLETED|Part 2 Double-blind Phase||0
85490|NCT02120456|210119|P1|NOT COMPLETED|Part 2 Double-blind Phase||0
85491|NCT02120456|210111|P9|COMPLETED|Part 2 Double-blind Phase||62
85492|NCT02120456|210112|P8|COMPLETED|Part 2 Double-blind Phase||60
85493|NCT02120456|210113|P7|COMPLETED|Part 2 Double-blind Phase||30
85494|NCT02120456|210114|P6|COMPLETED|Part 2 Double-blind Phase||0
85495|NCT02120456|210115|P5|COMPLETED|Part 2 Double-blind Phase||0
85496|NCT02120456|210116|P4|COMPLETED|Part 2 Double-blind Phase||0
85497|NCT02120456|210117|P3|COMPLETED|Part 2 Double-blind Phase||0
85498|NCT02120456|210118|P2|COMPLETED|Part 2 Double-blind Phase||0
85499|NCT02120456|210119|P1|COMPLETED|Part 2 Double-blind Phase||0
85500|NCT02120456|210111|P9|STARTED|Part 2 Double-blind Phase||63
85501|NCT02120456|210112|P8|STARTED|Part 2 Double-blind Phase||60
85502|NCT02120456|210113|P7|STARTED|Part 2 Double-blind Phase||32
85503|NCT02120456|210114|P6|STARTED|Part 2 Double-blind Phase||0
85504|NCT02120456|210115|P5|STARTED|Part 2 Double-blind Phase||0
85505|NCT02120456|210116|P4|STARTED|Part 2 Double-blind Phase||0
85506|NCT02120456|210117|P3|STARTED|Part 2 Double-blind Phase||0
85507|NCT02120456|210118|P2|STARTED|Part 2 Double-blind Phase||0
85508|NCT02120456|210119|P1|STARTED|Part 2 Double-blind Phase||0
85509|NCT02120456|210111|P9|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
85510|NCT02120456|210112|P8|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
85511|NCT02120456|210113|P7|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
85512|NCT02120456|210114|P6|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
85513|NCT02120456|210115|P5|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
85514|NCT02120456|210116|P4|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
85515|NCT02120456|210117|P3|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
85516|NCT02120456|210118|P2|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
85517|NCT02120456|210119|P1|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
85518|NCT02120456|210111|P9|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
85519|NCT02120456|210112|P8|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
85520|NCT02120456|210113|P7|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
85521|NCT02120456|210114|P6|COMPLETED|Part 1 Open-label, Dose-escalation Phase||9
85522|NCT02120456|210115|P5|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
85523|NCT02120456|210116|P4|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
85524|NCT02120456|210117|P3|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
85525|NCT02120456|210118|P2|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
85526|NCT02120456|210119|P1|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
85527|NCT02120456|210111|P9|STARTED|Part 1 Open-label, Dose-escalation Phase||0
85528|NCT02120456|210112|P8|STARTED|Part 1 Open-label, Dose-escalation Phase||0
85529|NCT02120456|210113|P7|STARTED|Part 1 Open-label, Dose-escalation Phase||0
85530|NCT02120456|210114|P6|STARTED|Part 1 Open-label, Dose-escalation Phase||9
85531|NCT02120456|210115|P5|STARTED|Part 1 Open-label, Dose-escalation Phase||12
85532|NCT02120456|210116|P4|STARTED|Part 1 Open-label, Dose-escalation Phase||12
85533|NCT02120456|210117|P3|STARTED|Part 1 Open-label, Dose-escalation Phase||12
85534|NCT02120456|210118|P2|STARTED|Part 1 Open-label, Dose-escalation Phase||12
85535|NCT02120456|210119|P1|STARTED|Part 1 Open-label, Dose-escalation Phase||12
85536|NCT02120443|210145|P1|NOT COMPLETED|Overall Study||0
85537|NCT02120443|210145|P1|COMPLETED|Overall Study||43
85538|NCT02120443|210145|P1|STARTED|Overall Study||43
85539|NCT02120417|210153|P2|NOT COMPLETED|Overall Study||68
85540|NCT02120417|210154|P1|NOT COMPLETED|Overall Study||60
85541|NCT02120417|210153|P2|COMPLETED|Overall Study||5
85542|NCT02120417|210154|P1|COMPLETED|Overall Study||16
85543|NCT02120417|210153|P2|STARTED|Overall Study||73
85544|NCT02120417|210154|P1|STARTED|Overall Study||76
85545|NCT02120300|210176|P4|NOT COMPLETED|Overall Study||1
85546|NCT02120300|210177|P3|NOT COMPLETED|Overall Study||0
85547|NCT02120300|210178|P2|NOT COMPLETED|Overall Study||0
85548|NCT02120300|210179|P1|NOT COMPLETED|Overall Study||3
85549|NCT02120300|210176|P4|COMPLETED|Overall Study||5
85550|NCT02120300|210177|P3|COMPLETED|Overall Study||10
85551|NCT02120300|210178|P2|COMPLETED|Overall Study||5
85552|NCT02120300|210179|P1|COMPLETED|Overall Study||98
85553|NCT02120300|210176|P4|STARTED|Overall Study||6
85554|NCT02120300|210177|P3|STARTED|Overall Study||10
85555|NCT02120300|210178|P2|STARTED|Overall Study||5
85556|NCT02120300|210179|P1|STARTED|Overall Study||101
85557|NCT02120287|210215|P1|NOT COMPLETED|Overall Study||0
85558|NCT02120287|210215|P1|COMPLETED|Overall Study||16
85559|NCT02120287|210215|P1|STARTED|Overall Study||16
85560|NCT02120261|210235|P2|NOT COMPLETED|Overall Study||0
85561|NCT02120261|210236|P1|NOT COMPLETED|Overall Study||0
85562|NCT02120261|210235|P2|COMPLETED|Overall Study||25
85563|NCT02120261|210236|P1|COMPLETED|Overall Study||23
85564|NCT02120261|210235|P2|STARTED|Overall Study||25
85565|NCT02120261|210236|P1|STARTED|Overall Study||23
85566|NCT02120157|210250|P2|NOT COMPLETED|Overall Study||2
85567|NCT02120157|210251|P1|NOT COMPLETED|Overall Study||6
85568|NCT02120157|210250|P2|COMPLETED|Overall Study||11
85569|NCT02120157|210251|P1|COMPLETED|Overall Study||13
85570|NCT02120157|210250|P2|Undergoing Follow-up|Overall Study||8
85571|NCT02120157|210251|P1|Undergoing Follow-up|Overall Study||7
85572|NCT02120157|210250|P2|Completed 180 Days|Overall Study||3
85573|NCT02120157|210251|P1|Completed 180 Days|Overall Study||5
85574|NCT02120157|210250|P2|STARTED|Overall Study||13
85575|NCT02120157|210251|P1|STARTED|Overall Study||19
85576|NCT02120027|210261|P2|NOT COMPLETED|Overall Study||119
85577|NCT02120027|210262|P1|NOT COMPLETED|Overall Study||116
85578|NCT02120027|210261|P2|COMPLETED|Overall Study||160
85579|NCT02120027|210262|P1|COMPLETED|Overall Study||161
85580|NCT02120027|210261|P2|STARTED|Overall Study||279
85581|NCT02120027|210262|P1|STARTED|Overall Study||277
85582|NCT02120001|210278|P2|NOT COMPLETED|Overall Study||0
85583|NCT02120001|210279|P1|NOT COMPLETED|Overall Study||0
85584|NCT02120001|210278|P2|COMPLETED|Overall Study||19
85585|NCT02120001|210279|P1|COMPLETED|Overall Study||17
85586|NCT02120001|210278|P2|STARTED|Overall Study||19
85587|NCT02120001|210279|P1|STARTED|Overall Study||17
85588|NCT02119936|210287|P1|NOT COMPLETED|Overall Study||10
85589|NCT02119936|210287|P1|COMPLETED|Overall Study||0
85590|NCT02119936|210287|P1|STARTED|Overall Study||10
85591|NCT02119871|210298|P2|NOT COMPLETED|Overall Study||0
85592|NCT02119871|210299|P1|NOT COMPLETED|Overall Study||0
85593|NCT02119871|210298|P2|COMPLETED|Overall Study||10
85594|NCT02119871|210299|P1|COMPLETED|Overall Study||10
85595|NCT02119871|210298|P2|STARTED|Overall Study||10
85596|NCT02119871|210299|P1|STARTED|Overall Study||10
85597|NCT02119676|210321|P4|NOT COMPLETED|Overall Study||101
85598|NCT02119676|210322|P3|NOT COMPLETED|Overall Study||97
85599|NCT02119676|210323|P2|NOT COMPLETED|Overall Study||86
85600|NCT02119676|210324|P1|NOT COMPLETED|Overall Study||83
85601|NCT02119676|210321|P4|COMPLETED|Overall Study||10
85602|NCT02119676|210322|P3|COMPLETED|Overall Study||13
85603|NCT02119676|210323|P2|COMPLETED|Overall Study||2
85604|NCT02119676|210324|P1|COMPLETED|Overall Study||4
85605|NCT02119676|210321|P4|Treated Patients|Overall Study||106
85606|NCT02119676|210322|P3|Treated Patients|Overall Study||106
85607|NCT02119676|210323|P2|Treated Patients|Overall Study||86
85608|NCT02119676|210324|P1|Treated Patients|Overall Study||85
85609|NCT02119676|210321|P4|STARTED|Overall Study||111
85610|NCT02119676|210322|P3|STARTED|Overall Study||110
85611|NCT02119676|210323|P2|STARTED|Overall Study||88
85612|NCT02119676|210324|P1|STARTED|Overall Study||87
85613|NCT02119663|210356|P2|NOT COMPLETED|Overall Study||41
85614|NCT02119663|210357|P1|NOT COMPLETED|Overall Study||40
85615|NCT02119663|210356|P2|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|2
85616|NCT02119663|210357|P1|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|3
85617|NCT02119663|210356|P2|STARTED|Overall Study||43
85618|NCT02119663|210357|P1|STARTED|Overall Study||43
85619|NCT02119650|210375|P2|NOT COMPLETED|Overall Study||26
85620|NCT02119650|210376|P1|NOT COMPLETED|Overall Study||25
85621|NCT02119650|210375|P2|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|11
85622|NCT02119650|210376|P1|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|14
85623|NCT02119650|210375|P2|STARTED|Overall Study||37
85624|NCT02119650|210376|P1|STARTED|Overall Study||39
85625|NCT02119442|210390|P1|NOT COMPLETED|Overall Study||0
85626|NCT02119442|210390|P1|COMPLETED|Overall Study||90
85627|NCT02119442|210390|P1|STARTED|Overall Study||90
85628|NCT02119325|210394|P2|NOT COMPLETED|Period 2||0
85629|NCT02119325|210395|P1|NOT COMPLETED|Period 2||0
85630|NCT02119325|210394|P2|COMPLETED|Period 2||47
85631|NCT02119325|210395|P1|COMPLETED|Period 2||48
85632|NCT02119325|210394|P2|STARTED|Period 2||47
85633|NCT02119325|210395|P1|STARTED|Period 2||48
85634|NCT02119325|210394|P2|NOT COMPLETED|Washout Period 1||1
85635|NCT02119325|210395|P1|NOT COMPLETED|Washout Period 1||0
85636|NCT02119325|210394|P2|COMPLETED|Washout Period 1||47
85637|NCT02119325|210395|P1|COMPLETED|Washout Period 1||48
85638|NCT02119325|210394|P2|STARTED|Washout Period 1||48
85639|NCT02119325|210395|P1|STARTED|Washout Period 1||48
85640|NCT02119325|210394|P2|NOT COMPLETED|Period 1||0
85641|NCT02119325|210395|P1|NOT COMPLETED|Period 1||0
85642|NCT02119325|210394|P2|COMPLETED|Period 1||48
85643|NCT02119325|210395|P1|COMPLETED|Period 1||48
85644|NCT02119325|210394|P2|STARTED|Period 1||48
85645|NCT02119325|210395|P1|STARTED|Period 1||48
85646|NCT02119299|210439|P1|NOT COMPLETED|Overall Study||9
85647|NCT02119299|210439|P1|COMPLETED|Overall Study||67
85648|NCT02119299|210439|P1|STARTED|Overall Study||76
85649|NCT02119286|210453|P3|NOT COMPLETED|Overall Study||7
85650|NCT02119286|210454|P2|NOT COMPLETED|Overall Study||11
85651|NCT02119286|210455|P1|NOT COMPLETED|Overall Study||26
85652|NCT02119286|210453|P3|COMPLETED|Overall Study||200
85653|NCT02119286|210454|P2|COMPLETED|Overall Study||195
85654|NCT02119286|210455|P1|COMPLETED|Overall Study||180
85655|NCT02119286|210453|P3|STARTED|Overall Study||207
85656|NCT02119286|210454|P2|STARTED|Overall Study||206
85657|NCT02119286|210455|P1|STARTED|Overall Study||206
85658|NCT02119260|210473|P7|NOT COMPLETED|Overall Study||0
85659|NCT02119260|210474|P6|NOT COMPLETED|Overall Study||0
85660|NCT02119260|210475|P5|NOT COMPLETED|Overall Study||0
85661|NCT02119260|210476|P4|NOT COMPLETED|Overall Study||0
85662|NCT02119260|210477|P3|NOT COMPLETED|Overall Study||1
85663|NCT02119260|210478|P2|NOT COMPLETED|Overall Study||1
85664|NCT02119260|210479|P1|NOT COMPLETED|Overall Study||1
85665|NCT02119260|210473|P7|COMPLETED|Overall Study||2
85666|NCT02119260|210474|P6|COMPLETED|Overall Study||6
85667|NCT02119260|210475|P5|COMPLETED|Overall Study||13
85668|NCT02119260|210476|P4|COMPLETED|Overall Study||10
85669|NCT02119260|210477|P3|COMPLETED|Overall Study||7
85670|NCT02119260|210478|P2|COMPLETED|Overall Study||11
85671|NCT02119260|210479|P1|COMPLETED|Overall Study||8
85672|NCT02119260|210473|P7|STARTED|Overall Study||2
85673|NCT02119260|210474|P6|STARTED|Overall Study||6
85674|NCT02119260|210475|P5|STARTED|Overall Study||13
85675|NCT02119260|210476|P4|STARTED|Overall Study||10
85676|NCT02119260|210477|P3|STARTED|Overall Study||8
85677|NCT02119260|210478|P2|STARTED|Overall Study||12
85678|NCT02119260|210479|P1|STARTED|Overall Study||9
85679|NCT02119104|210549|P1|NOT COMPLETED|Overall Study||16
85680|NCT02119104|210549|P1|COMPLETED|Overall Study||1071
85681|NCT02119104|210549|P1|STARTED|Overall Study||1087
85682|NCT02119026|210555|P2|NOT COMPLETED|2nd-line Treatment||2
85683|NCT02119026|210556|P1|NOT COMPLETED|2nd-line Treatment||9
85684|NCT02119026|210555|P2|COMPLETED|2nd-line Treatment||22
85685|NCT02119026|210556|P1|COMPLETED|2nd-line Treatment||23
85686|NCT02119026|210555|P2|STARTED|2nd-line Treatment||24
85687|NCT02119026|210556|P1|STARTED|2nd-line Treatment||32
85688|NCT02119026|210555|P2|NOT COMPLETED|1st-line Treatment||38
85689|NCT02119026|210556|P1|NOT COMPLETED|1st-line Treatment||26
85690|NCT02119026|210555|P2|COMPLETED|1st-line Treatment||24
85691|NCT02119026|210556|P1|COMPLETED|1st-line Treatment||32
85692|NCT02119026|210555|P2|STARTED|1st-line Treatment||62
85693|NCT02119026|210556|P1|STARTED|1st-line Treatment||58
85694|NCT02118961|210580|P2|NOT COMPLETED|Overall Study||0
85695|NCT02118961|210581|P1|NOT COMPLETED|Overall Study||1
85696|NCT02118961|210580|P2|COMPLETED|Overall Study||222
85697|NCT02118961|210581|P1|COMPLETED|Overall Study||223
85698|NCT02118961|210580|P2|STARTED|Overall Study||222
85699|NCT02118961|210581|P1|STARTED|Overall Study||224
85700|NCT02118896|210609|P10|NOT COMPLETED|Overall Study||2
85701|NCT02118896|210610|P9|NOT COMPLETED|Overall Study||4
85702|NCT02118896|210611|P8|NOT COMPLETED|Overall Study||2
85703|NCT02118896|210612|P7|NOT COMPLETED|Overall Study||2
85704|NCT02118896|210613|P6|NOT COMPLETED|Overall Study||28
85705|NCT02118896|210614|P5|NOT COMPLETED|Overall Study||17
85706|NCT02118896|210615|P4|NOT COMPLETED|Overall Study||24
85707|NCT02118896|210616|P3|NOT COMPLETED|Overall Study||14
85708|NCT02118896|210617|P2|NOT COMPLETED|Overall Study||15
85709|NCT02118896|210618|P1|NOT COMPLETED|Overall Study||17
85710|NCT02118896|210609|P10|COMPLETED|Overall Study||7
85711|NCT02118896|210610|P9|COMPLETED|Overall Study||84
85712|NCT02118896|210611|P8|COMPLETED|Overall Study||105
85713|NCT02118896|210612|P7|COMPLETED|Overall Study||83
85714|NCT02118896|210613|P6|COMPLETED|Overall Study||163
85715|NCT02118896|210614|P5|COMPLETED|Overall Study||113
85716|NCT02118896|210615|P4|COMPLETED|Overall Study||55
85717|NCT02118896|210616|P3|COMPLETED|Overall Study||53
85718|NCT02118896|210617|P2|COMPLETED|Overall Study||32
85719|NCT02118896|210618|P1|COMPLETED|Overall Study||30
85720|NCT02118896|210609|P10|STARTED|Overall Study||9
85721|NCT02118896|210610|P9|STARTED|Overall Study||88
85722|NCT02118896|210611|P8|STARTED|Overall Study||107
85723|NCT02118896|210612|P7|STARTED|Overall Study||85
85724|NCT02118896|210613|P6|STARTED|Overall Study||191
85725|NCT02118896|210614|P5|STARTED|Overall Study||130
85726|NCT02118896|210615|P4|STARTED|Overall Study||79
85727|NCT02118896|210616|P3|STARTED|Overall Study||67
85728|NCT02118896|210617|P2|STARTED|Overall Study||47
85729|NCT02118896|210618|P1|STARTED|Overall Study||47
85730|NCT02118831|210693|P3|NOT COMPLETED|Overall Study||0
85731|NCT02118831|210694|P2|NOT COMPLETED|Overall Study||0
85732|NCT02118831|210695|P1|NOT COMPLETED|Overall Study||0
85733|NCT02118831|210693|P3|COMPLETED|Overall Study||20
85734|NCT02118831|210694|P2|COMPLETED|Overall Study||15
85735|NCT02118831|210695|P1|COMPLETED|Overall Study||21
85736|NCT02118831|210693|P3|STARTED|Overall Study||20
85737|NCT02118831|210694|P2|STARTED|Overall Study||15
85738|NCT02118831|210695|P1|STARTED|Overall Study||21
85739|NCT02118792|210708|P2|NOT COMPLETED|Overall Study||37
85740|NCT02118792|210709|P1|NOT COMPLETED|Overall Study||31
85741|NCT02118792|210708|P2|COMPLETED|Overall Study||213
85742|NCT02118792|210709|P1|COMPLETED|Overall Study||483
85743|NCT02118792|210708|P2|Treated|Overall Study||250
85744|NCT02118792|210709|P1|Treated|Overall Study||513
85745|NCT02118792|210708|P2|STARTED|Overall Study||250
85746|NCT02118792|210709|P1|STARTED|Overall Study||514
85747|NCT02118766|210751|P2|NOT COMPLETED|Overall Study||31
85748|NCT02118766|210752|P1|NOT COMPLETED|Overall Study||30
85749|NCT02118766|210751|P2|COMPLETED|Overall Study||225
85750|NCT02118766|210752|P1|COMPLETED|Overall Study||477
85751|NCT02118766|210751|P2|Treated|Overall Study||256
85752|NCT02118766|210752|P1|Treated|Overall Study||503
85753|NCT02118766|210751|P2|STARTED|Overall Study||256
85754|NCT02118766|210752|P1|STARTED|Overall Study||507
85755|NCT02118714|210774|P1|NOT COMPLETED|Overall Study||3
85756|NCT02118714|210774|P1|COMPLETED|Overall Study||17
85757|NCT02118714|210774|P1|STARTED|Overall Study||20
85758|NCT02118597|210788|P1|NOT COMPLETED|Overall Study||16
85759|NCT02118597|210788|P1|COMPLETED|Overall Study||3
85760|NCT02118597|210788|P1|STARTED|Overall Study||19
85761|NCT02118441|210804|P2|NOT COMPLETED|Overall Study||1
85762|NCT02118441|210805|P1|NOT COMPLETED|Overall Study||3
85763|NCT02118441|210804|P2|COMPLETED|Overall Study||63
85764|NCT02118441|210805|P1|COMPLETED|Overall Study||62
85765|NCT02118441|210804|P2|STARTED|Overall Study||64
85766|NCT02118441|210805|P1|STARTED|Overall Study||65
85767|NCT02118428|210819|P3|NOT COMPLETED|Overall Study||1
85768|NCT02118428|210820|P2|NOT COMPLETED|Overall Study||9
85769|NCT02118428|210821|P1|NOT COMPLETED|Overall Study||13
85770|NCT02118428|210819|P3|COMPLETED|Overall Study||0
85771|NCT02118428|210820|P2|COMPLETED|Overall Study||104
85772|NCT02118428|210821|P1|COMPLETED|Overall Study||100
85773|NCT02118428|210819|P3|Received Study Transfusion|Overall Study||0
85774|NCT02118428|210820|P2|Received Study Transfusion|Overall Study||112
85775|NCT02118428|210821|P1|Received Study Transfusion|Overall Study||111
85776|NCT02118428|210819|P3|STARTED|Overall Study||1
85777|NCT02118428|210820|P2|STARTED|Overall Study||113
85778|NCT02118428|210821|P1|STARTED|Overall Study||113
85779|NCT02117999|210861|P2|NOT COMPLETED|Overall Study||0
85780|NCT02117999|210862|P1|NOT COMPLETED|Overall Study||0
85781|NCT02117999|210861|P2|COMPLETED|Overall Study||10
85782|NCT02117999|210862|P1|COMPLETED|Overall Study||20
85783|NCT02117999|210861|P2|Mean Kmax Change in Corneal Topography|Overall Study||10
85784|NCT02117999|210862|P1|Mean Kmax Change in Corneal Topography|Overall Study||20
85785|NCT02117999|210861|P2|STARTED|Overall Study||10
85786|NCT02117999|210862|P1|STARTED|Overall Study||20
85787|NCT02117934|210880|P2|NOT COMPLETED|Overall Study||215
85788|NCT02117934|210881|P1|NOT COMPLETED|Overall Study||500
85789|NCT02117934|210880|P2|COMPLETED|Overall Study||2567
85790|NCT02117934|210881|P1|COMPLETED|Overall Study||5092
85791|NCT02117934|210880|P2|STARTED|Overall Study||2782
85792|NCT02117934|210881|P1|STARTED|Overall Study||5592
85793|NCT02117687|210891|P2|NOT COMPLETED|Overall Study||4
85794|NCT02117687|210892|P1|NOT COMPLETED|Overall Study||1
85795|NCT02117687|210891|P2|COMPLETED|Overall Study||36
85796|NCT02117687|210892|P1|COMPLETED|Overall Study||39
85797|NCT02117687|210891|P2|STARTED|Overall Study||40
85798|NCT02117687|210892|P1|STARTED|Overall Study||40
85799|NCT02117648|210924|P1|NOT COMPLETED|Abemaciclib Safety-Extension Phase||20
85800|NCT02117648|210924|P1|COMPLETED|Abemaciclib Safety-Extension Phase||0
85801|NCT02117648|210924|P1|STARTED|Abemaciclib Safety-Extension Phase||20
85802|NCT02117648|210924|P1|NOT COMPLETED|Abemaciclib + Clarithromycin Period 2||4
85803|NCT02117648|210924|P1|COMPLETED|Abemaciclib + Clarithromycin Period 2||20
85804|NCT02117648|210924|P1|Received at Least 1 Dose of Study Drug|Abemaciclib + Clarithromycin Period 2||21
85805|NCT02117648|210924|P1|STARTED|Abemaciclib + Clarithromycin Period 2||24
85806|NCT02117648|210924|P1|NOT COMPLETED|Abemaciclib Alone Period 1||2
85807|NCT02117648|210924|P1|COMPLETED|Abemaciclib Alone Period 1||24
85808|NCT02117648|210924|P1|Received at Least 1 Dose of Study Drug|Abemaciclib Alone Period 1||26
85809|NCT02117648|210924|P1|STARTED|Abemaciclib Alone Period 1||26
85810|NCT02117570|210937|P3|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||6
85811|NCT02117570|210938|P2|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||3
85812|NCT02117570|210939|P1|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||1
85813|NCT02117570|210937|P3|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||54
85814|NCT02117570|210938|P2|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||59
85815|NCT02117570|210939|P1|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||20
85816|NCT02117570|210937|P3|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
85817|NCT02117570|210938|P2|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
85818|NCT02117570|210939|P1|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||4
85819|NCT02117570|210937|P3|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||50
85820|NCT02117570|210938|P2|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||53
85821|NCT02117570|210939|P1|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||17
85822|NCT02117570|210937|P3|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||60
85823|NCT02117570|210938|P2|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||61
85824|NCT02117570|210939|P1|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||21
85825|NCT02117570|210937|P3|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|60
85826|NCT02117570|210938|P2|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|62
85827|NCT02117570|210939|P1|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|21
85828|NCT02117570|210937|P3|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
85829|NCT02117570|210938|P2|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||3
85830|NCT02117570|210939|P1|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
85831|NCT02117570|210937|P3|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||17
85832|NCT02117570|210938|P2|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||15
85833|NCT02117570|210939|P1|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||5
85834|NCT02117570|210937|P3|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||18
85835|NCT02117570|210938|P2|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||17
85836|NCT02117570|210939|P1|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||6
85837|NCT02117570|210937|P3|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
85838|NCT02117570|210938|P2|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
85839|NCT02117570|210939|P1|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||6
85840|NCT02117570|210937|P3|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
85841|NCT02117570|210938|P2|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
85842|NCT02117570|210939|P1|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||6
85843|NCT02117570|210937|P3|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
85844|NCT02117570|210938|P2|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
85845|NCT02117570|210939|P1|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|6
85846|NCT02117544|210989|P2|NOT COMPLETED|Period 2||0
85847|NCT02117544|210990|P1|NOT COMPLETED|Period 2||0
85848|NCT02117544|210989|P2|COMPLETED|Period 2||55
85849|NCT02117544|210990|P1|COMPLETED|Period 2||52
85850|NCT02117544|210989|P2|STARTED|Period 2||55
85851|NCT02117544|210990|P1|STARTED|Period 2||52
85852|NCT02117544|210989|P2|NOT COMPLETED|Period 1||0
85853|NCT02117544|210990|P1|NOT COMPLETED|Period 1||2
85854|NCT02117544|210989|P2|COMPLETED|Period 1||55
85855|NCT02117544|210990|P1|COMPLETED|Period 1||52
85856|NCT02117544|210989|P2|Treated|Period 1||55
85857|NCT02117544|210990|P1|Treated|Period 1||52
85858|NCT02117544|210989|P2|STARTED|Period 1||55
85859|NCT02117544|210990|P1|STARTED|Period 1||54
85860|NCT02117479|211005|P2|NOT COMPLETED|Overall Study||156
85861|NCT02117479|211006|P1|NOT COMPLETED|Overall Study||156
85862|NCT02117479|211005|P2|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|4
85863|NCT02117479|211006|P1|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|5
85864|NCT02117479|211005|P2|STARTED|Overall Study||160
85865|NCT02117479|211006|P1|STARTED|Overall Study||161
85866|NCT02117427|211025|P3|NOT COMPLETED|Overall Study||0
85867|NCT02117427|211026|P2|NOT COMPLETED|Overall Study||5
85868|NCT02117427|211027|P1|NOT COMPLETED|Overall Study||5
85869|NCT02117427|211025|P3|COMPLETED|Overall Study||0
85870|NCT02117427|211026|P2|COMPLETED|Overall Study||0
85871|NCT02117427|211027|P1|COMPLETED|Overall Study||1
85872|NCT02117427|211025|P3|Long Term Safety Follow-up|Overall Study||0
85873|NCT02117427|211026|P2|Long Term Safety Follow-up|Overall Study||0
85874|NCT02117427|211027|P1|Long Term Safety Follow-up|Overall Study||1
85875|NCT02117427|211025|P3|Safety Follow-up|Overall Study||0
85876|NCT02117427|211026|P2|Safety Follow-up|Overall Study||0
85877|NCT02117427|211027|P1|Safety Follow-up|Overall Study||1
85878|NCT02117427|211025|P3|Implantation & Efficacy|Overall Study||0
85879|NCT02117427|211026|P2|Implantation & Efficacy|Overall Study||4
85880|NCT02117427|211027|P1|Implantation & Efficacy|Overall Study||6
85881|NCT02117427|211025|P3|Run in Phase & Harvest|Overall Study||0
85882|NCT02117427|211026|P2|Run in Phase & Harvest|Overall Study||4
85883|NCT02117427|211027|P1|Run in Phase & Harvest|Overall Study||6
85884|NCT02117427|211025|P3|STARTED|Overall Study||0
85885|NCT02117427|211026|P2|STARTED|Overall Study||5
85886|NCT02117427|211027|P1|STARTED|Overall Study||6
85887|NCT02117414|211037|P2|NOT COMPLETED|Overall Study||6
85888|NCT02117414|211038|P1|NOT COMPLETED|Overall Study||15
85889|NCT02117414|211037|P2|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the Control group.|82
85890|NCT02117414|211038|P1|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the MRI group.|160
85891|NCT02117414|211037|P2|STARTED|Overall Study|Subjects randomized to the Control group.|88
85892|NCT02117414|211038|P1|STARTED|Overall Study|Subjects randomized to the MRI group.|175
85893|NCT02117310|211056|P1|NOT COMPLETED|Overall Study||0
85894|NCT02117310|211056|P1|COMPLETED|Overall Study||5
85895|NCT02117310|211056|P1|STARTED|Overall Study||5
85896|NCT02117193|211060|P1|NOT COMPLETED|Overall Study||0
85897|NCT02117193|211060|P1|COMPLETED|Overall Study||10
85898|NCT02117193|211060|P1|Placebo Intake + Sleep Deprivation|Overall Study||10
85899|NCT02117193|211060|P1|Alcohol Intake + Sleep Deprivation|Overall Study||10
85900|NCT02117193|211060|P1|Placebo Intake + Normal Sleep|Overall Study||10
85901|NCT02117193|211060|P1|Alcohol Intake + Normal Sleep|Overall Study||10
85902|NCT02117193|211060|P1|STARTED|Overall Study||10
85903|NCT02117050|211082|P1|NOT COMPLETED|Overall Study||1
85904|NCT02117050|211082|P1|COMPLETED|Overall Study||0
85905|NCT02117050|211082|P1|STARTED|Overall Study||1
85906|NCT02116972|211097|P3|NOT COMPLETED|Overall Study||19
85907|NCT02116972|211098|P2|NOT COMPLETED|Overall Study||17
85908|NCT02116972|211099|P1|NOT COMPLETED|Overall Study||19
85909|NCT02116972|211097|P3|COMPLETED|Overall Study||85
85910|NCT02116972|211098|P2|COMPLETED|Overall Study||87
85911|NCT02116972|211099|P1|COMPLETED|Overall Study||83
85912|NCT02116972|211097|P3|STARTED|Overall Study||104
85913|NCT02116972|211098|P2|STARTED|Overall Study||104
85914|NCT02116972|211099|P1|STARTED|Overall Study||102
85915|NCT02116803|211131|P2|NOT COMPLETED|Overall Study||2
85916|NCT02116803|211132|P1|NOT COMPLETED|Overall Study||10
85917|NCT02116803|211131|P2|COMPLETED|Overall Study||0
85918|NCT02116803|211132|P1|COMPLETED|Overall Study||0
85919|NCT02116803|211131|P2|STARTED|Overall Study||2
85920|NCT02116803|211132|P1|STARTED|Overall Study||10
85921|NCT02116660|211140|P2|NOT COMPLETED|Overall Study||4
85922|NCT02116660|211141|P1|NOT COMPLETED|Overall Study||2
85923|NCT02116660|211140|P2|COMPLETED|Overall Study||1
85924|NCT02116660|211141|P1|COMPLETED|Overall Study||4
85925|NCT02116660|211140|P2|STARTED|Overall Study||5
85926|NCT02116660|211141|P1|STARTED|Overall Study||6
85927|NCT02116621|211185|P2|NOT COMPLETED|Twelve Month Follow-up||12
85928|NCT02116621|211186|P1|NOT COMPLETED|Twelve Month Follow-up||16
85929|NCT02116621|211185|P2|COMPLETED|Twelve Month Follow-up||86
85930|NCT02116621|211186|P1|COMPLETED|Twelve Month Follow-up||84
85931|NCT02116621|211185|P2|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|98
85932|NCT02116621|211186|P1|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|100
85933|NCT02116621|211185|P2|NOT COMPLETED|Six Month Follow-up||3
85934|NCT02116621|211186|P1|NOT COMPLETED|Six Month Follow-up||4
85935|NCT02116621|211185|P2|COMPLETED|Six Month Follow-up||97
85936|NCT02116621|211186|P1|COMPLETED|Six Month Follow-up||99
85937|NCT02116621|211185|P2|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up|100
85938|NCT02116621|211186|P1|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up.|103
85939|NCT02116621|211185|P2|NOT COMPLETED|Three Month Follow-up||7
85940|NCT02116621|211186|P1|NOT COMPLETED|Three Month Follow-up||19
85941|NCT02116621|211185|P2|COMPLETED|Three Month Follow-up||96
85942|NCT02116621|211186|P1|COMPLETED|Three Month Follow-up||89
85943|NCT02116621|211185|P2|STARTED|Three Month Follow-up||103
85944|NCT02116621|211186|P1|STARTED|Three Month Follow-up||108
85945|NCT02116621|211185|P2|NOT COMPLETED|Baseline||4
85946|NCT02116621|211186|P1|NOT COMPLETED|Baseline||0
85947|NCT02116621|211185|P2|COMPLETED|Baseline||103
85948|NCT02116621|211186|P1|COMPLETED|Baseline||108
85949|NCT02116621|211185|P2|Completed Intervention Period|Baseline||103
85950|NCT02116621|211186|P1|Completed Intervention Period|Baseline||95
85951|NCT02116621|211185|P2|Completed Baseline Visit|Baseline||103
85952|NCT02116621|211186|P1|Completed Baseline Visit|Baseline||108
85953|NCT02116621|211185|P2|STARTED|Baseline||107
85954|NCT02116621|211186|P1|STARTED|Baseline||108
85955|NCT02116582|211274|P1|NOT COMPLETED|Overall Study||215
85956|NCT02116582|211274|P1|COMPLETED|Overall Study||0
85957|NCT02116582|211274|P1|Treated|Overall Study||214
85958|NCT02116582|211274|P1|STARTED|Overall Study||215
85959|NCT02116530|211284|P2|NOT COMPLETED|Overall Study||4
85960|NCT02116530|211285|P1|NOT COMPLETED|Overall Study||9
85961|NCT02116530|211284|P2|COMPLETED|Overall Study||184
85962|NCT02116530|211285|P1|COMPLETED|Overall Study||183
85963|NCT02116530|211284|P2|STARTED|Overall Study||188
85964|NCT02116530|211285|P1|STARTED|Overall Study||192
85965|NCT02116361|211303|P4|NOT COMPLETED|Overall Study||31
85966|NCT02116361|211304|P3|NOT COMPLETED|Overall Study||26
85967|NCT02116361|211305|P2|NOT COMPLETED|Overall Study||31
85968|NCT02116361|211306|P1|NOT COMPLETED|Overall Study||31
85969|NCT02116361|211303|P4|COMPLETED|Overall Study||34
85970|NCT02116361|211304|P3|COMPLETED|Overall Study||33
85971|NCT02116361|211305|P2|COMPLETED|Overall Study||34
85972|NCT02116361|211306|P1|COMPLETED|Overall Study||38
85973|NCT02116361|211303|P4|STARTED|Overall Study||65
85974|NCT02116361|211304|P3|STARTED|Overall Study||59
85975|NCT02116361|211305|P2|STARTED|Overall Study||65
85976|NCT02116361|211306|P1|STARTED|Overall Study||69
85977|NCT02116322|211336|P1|NOT COMPLETED|Overall Study||0
85978|NCT02116322|211336|P1|COMPLETED|Overall Study||1
85979|NCT02116322|211336|P1|STARTED|Overall Study||1
85980|NCT02116309|211343|P2|NOT COMPLETED|Overall Study||1
85981|NCT02116309|211344|P1|NOT COMPLETED|Overall Study||0
85982|NCT02116309|211343|P2|COMPLETED|Overall Study||477
85983|NCT02116309|211344|P1|COMPLETED|Overall Study||482
85984|NCT02116309|211343|P2|STARTED|Overall Study||478
85985|NCT02116309|211344|P1|STARTED|Overall Study||482
85986|NCT02115984|211354|P2|NOT COMPLETED|Overall Study||7
85987|NCT02115984|211355|P1|NOT COMPLETED|Overall Study||6
85988|NCT02115984|211354|P2|COMPLETED|Overall Study||16
85989|NCT02115984|211355|P1|COMPLETED|Overall Study||51
85990|NCT02115984|211354|P2|STARTED|Overall Study||23
85991|NCT02115984|211355|P1|STARTED|Overall Study||57
85992|NCT02115828|211361|P1|NOT COMPLETED|Overall Study||0
85993|NCT02115828|211361|P1|COMPLETED|Overall Study||9
85994|NCT02115828|211361|P1|STARTED|Overall Study||9
85995|NCT02115815|211376|P7|NOT COMPLETED|Overall Study||0
85996|NCT02115815|211377|P6|NOT COMPLETED|Overall Study||2
85997|NCT02115815|211378|P5|NOT COMPLETED|Overall Study||0
85998|NCT02115815|211379|P4|NOT COMPLETED|Overall Study||0
85999|NCT02115815|211380|P3|NOT COMPLETED|Overall Study||0
86000|NCT02115815|211381|P2|NOT COMPLETED|Overall Study||0
86001|NCT02115815|211382|P1|NOT COMPLETED|Overall Study||2
86002|NCT02115815|211376|P7|COMPLETED|Overall Study||20
86003|NCT02115815|211377|P6|COMPLETED|Overall Study||20
86004|NCT02115815|211378|P5|COMPLETED|Overall Study||20
86005|NCT02115815|211379|P4|COMPLETED|Overall Study||20
86006|NCT02115815|211380|P3|COMPLETED|Overall Study||20
86007|NCT02115815|211381|P2|COMPLETED|Overall Study||20
86008|NCT02115815|211382|P1|COMPLETED|Overall Study||22
86009|NCT02115815|211376|P7|STARTED|Overall Study||20
86010|NCT02115815|211377|P6|STARTED|Overall Study||22
86011|NCT02115815|211378|P5|STARTED|Overall Study||20
86012|NCT02115815|211379|P4|STARTED|Overall Study||20
86013|NCT02115815|211380|P3|STARTED|Overall Study||20
86014|NCT02115815|211381|P2|STARTED|Overall Study||20
86015|NCT02115815|211382|P1|STARTED|Overall Study||24
86016|NCT02115750|211477|P2|NOT COMPLETED|Part 2: All Subjects Receive CHS-0214||12
86017|NCT02115750|211478|P1|NOT COMPLETED|Part 2: All Subjects Receive CHS-0214||11
86018|NCT02115750|211477|P2|COMPLETED|Part 2: All Subjects Receive CHS-0214||272
86019|NCT02115750|211478|P1|COMPLETED|Part 2: All Subjects Receive CHS-0214||269
86020|NCT02115750|211477|P2|STARTED|Part 2: All Subjects Receive CHS-0214||284
86021|NCT02115750|211478|P1|STARTED|Part 2: All Subjects Receive CHS-0214||280
86022|NCT02115750|211477|P2|NOT COMPLETED|Part 1||12
86023|NCT02115750|211478|P1|NOT COMPLETED|Part 1||22
86024|NCT02115750|211477|P2|COMPLETED|Part 1||312
86025|NCT02115750|211478|P1|COMPLETED|Part 1||301
86026|NCT02115750|211477|P2|STARTED|Part 1||324
86027|NCT02115750|211478|P1|STARTED|Part 1||323
86028|NCT02115646|211496|P1|NOT COMPLETED|Overall Study||7
86029|NCT02115646|211496|P1|COMPLETED|Overall Study||22
86030|NCT02115646|211496|P1|STARTED|Overall Study||29
86031|NCT02115633|211511|P2|NOT COMPLETED|Overall Study||0
86032|NCT02115633|211512|P1|NOT COMPLETED|Overall Study||0
86033|NCT02115633|211511|P2|COMPLETED|Overall Study||16
86034|NCT02115633|211512|P1|COMPLETED|Overall Study||15
86035|NCT02115633|211511|P2|STARTED|Overall Study||16
86036|NCT02115633|211512|P1|STARTED|Overall Study||15
86037|NCT02115607|211524|P1|NOT COMPLETED|Overall Study||1
86038|NCT02115607|211524|P1|COMPLETED|Overall Study||16
86039|NCT02115607|211524|P1|STARTED|Overall Study||17
86040|NCT02115581|211533|P2|NOT COMPLETED|Overall Study||0
86041|NCT02115581|211534|P1|NOT COMPLETED|Overall Study||0
86042|NCT02115581|211533|P2|COMPLETED|Overall Study||21
86043|NCT02115581|211534|P1|COMPLETED|Overall Study||17
86044|NCT02115581|211533|P2|STARTED|Overall Study||21
86045|NCT02115581|211534|P1|STARTED|Overall Study||17
86046|NCT02115373|211547|P3|NOT COMPLETED|Overall Study||0
86047|NCT02115373|211548|P2|NOT COMPLETED|Overall Study||0
86048|NCT02115373|211549|P1|NOT COMPLETED|Overall Study||0
86049|NCT02115373|211547|P3|COMPLETED|Overall Study||49
86050|NCT02115373|211548|P2|COMPLETED|Overall Study||13
86051|NCT02115373|211549|P1|COMPLETED|Overall Study||4
86052|NCT02115373|211547|P3|STARTED|Overall Study||49
86053|NCT02115373|211548|P2|STARTED|Overall Study||13
86054|NCT02115373|211549|P1|STARTED|Overall Study||4
86055|NCT02115347|211615|P3|NOT COMPLETED|Overall Study||0
86056|NCT02115347|211616|P2|NOT COMPLETED|Overall Study||0
86057|NCT02115347|211617|P1|NOT COMPLETED|Overall Study||0
86058|NCT02115347|211615|P3|COMPLETED|Overall Study||0
86059|NCT02115347|211616|P2|COMPLETED|Overall Study||8
86060|NCT02115347|211617|P1|COMPLETED|Overall Study||8
86061|NCT02115347|211615|P3|STARTED|Overall Study||0
86062|NCT02115347|211616|P2|STARTED|Overall Study||8
86063|NCT02115347|211617|P1|STARTED|Overall Study||8
86064|NCT02115321|211637|P2|NOT COMPLETED|Overall Study||0
86065|NCT02115321|211638|P1|NOT COMPLETED|Overall Study||1
86066|NCT02115321|211637|P2|COMPLETED|Overall Study||10
86067|NCT02115321|211638|P1|COMPLETED|Overall Study||29
86068|NCT02115321|211637|P2|STARTED|Overall Study||10
86069|NCT02115321|211638|P1|STARTED|Overall Study||30
86070|NCT02115308|211660|P2|NOT COMPLETED|Overall Study||2
86071|NCT02115308|211661|P1|NOT COMPLETED|Overall Study||2
86072|NCT02115308|211660|P2|COMPLETED|Overall Study|Number of subjects recruited to the CAD group meeting all inclusion criteria.|23
86073|NCT02115308|211661|P1|COMPLETED|Overall Study|Number of subjects recruited to the Control group meeting all inclusion criteria.|13
86074|NCT02115308|211660|P2|STARTED|Overall Study|Number of subjects recruited for the CAD group.|25
86075|NCT02115308|211661|P1|STARTED|Overall Study|Number of subjects recruited for the CONTROL group.|15
86076|NCT02115269|211677|P1|NOT COMPLETED|Overall Study||57
86077|NCT02115269|211677|P1|COMPLETED|Overall Study||702
86078|NCT02115269|211677|P1|STARTED|Overall Study||759
86079|NCT02115256|211697|P2|NOT COMPLETED|Overall Study||1
86080|NCT02115256|211698|P1|NOT COMPLETED|Overall Study||0
86081|NCT02115256|211697|P2|COMPLETED|Overall Study||2
86082|NCT02115256|211698|P1|COMPLETED|Overall Study||3
86083|NCT02115256|211697|P2|STARTED|Overall Study||3
86084|NCT02115256|211698|P1|STARTED|Overall Study||3
86085|NCT02115113|211710|P3|NOT COMPLETED|Participants Randomized||0
86086|NCT02115113|211711|P2|NOT COMPLETED|Participants Randomized||0
86087|NCT02115113|211712|P1|NOT COMPLETED|Participants Randomized||2
86088|NCT02115113|211710|P3|COMPLETED|Participants Randomized||0
86089|NCT02115113|211711|P2|COMPLETED|Participants Randomized||26
86090|NCT02115113|211712|P1|COMPLETED|Participants Randomized||22
86091|NCT02115113|211710|P3|STARTED|Participants Randomized||0
86092|NCT02115113|211711|P2|STARTED|Participants Randomized||26
86093|NCT02115113|211712|P1|STARTED|Participants Randomized||24
86094|NCT02115113|211710|P3|NOT COMPLETED|Participants in Run-in Period||10
86095|NCT02115113|211711|P2|NOT COMPLETED|Participants in Run-in Period||0
86096|NCT02115113|211712|P1|NOT COMPLETED|Participants in Run-in Period||0
86097|NCT02115113|211710|P3|COMPLETED|Participants in Run-in Period||68
86098|NCT02115113|211711|P2|COMPLETED|Participants in Run-in Period||0
86099|NCT02115113|211712|P1|COMPLETED|Participants in Run-in Period||0
86100|NCT02115113|211710|P3|STARTED|Participants in Run-in Period||78
86101|NCT02115113|211711|P2|STARTED|Participants in Run-in Period||0
86102|NCT02115113|211712|P1|STARTED|Participants in Run-in Period||0
86103|NCT02114931|211727|P2|NOT COMPLETED|Overall Study||30
86104|NCT02114931|211728|P1|NOT COMPLETED|Overall Study||25
86105|NCT02114931|211727|P2|COMPLETED|Overall Study||207
86106|NCT02114931|211728|P1|COMPLETED|Overall Study||205
86107|NCT02114931|211727|P2|Received Treatment|Overall Study||237
86108|NCT02114931|211728|P1|Received Treatment|Overall Study|One participant was enrolled in error and did not receive treatment in the extension study|229
86109|NCT02114931|211727|P2|STARTED|Overall Study||237
86110|NCT02114931|211728|P1|STARTED|Overall Study||230
86111|NCT02114892|211744|P2|NOT COMPLETED|Overall Study||2
86112|NCT02114892|211745|P1|NOT COMPLETED|Overall Study||1
86113|NCT02114892|211744|P2|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawl|10
86114|NCT02114892|211745|P1|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
86115|NCT02114892|211744|P2|STARTED|Overall Study||12
86116|NCT02114892|211745|P1|STARTED|Overall Study||12
86117|NCT02114697|211781|P2|NOT COMPLETED|Overall Study||4
86118|NCT02114697|211782|P1|NOT COMPLETED|Overall Study||5
86119|NCT02114697|211781|P2|COMPLETED|Overall Study||0
86120|NCT02114697|211782|P1|COMPLETED|Overall Study||0
86121|NCT02114697|211781|P2|Completed Month 18 Visit|Overall Study||1
86122|NCT02114697|211782|P1|Completed Month 18 Visit|Overall Study||0
86123|NCT02114697|211781|P2|STARTED|Overall Study||4
86124|NCT02114697|211782|P1|STARTED|Overall Study||5
86125|NCT02114684|211790|P2|NOT COMPLETED|Overall Study||10
86126|NCT02114684|211791|P1|NOT COMPLETED|Overall Study||12
86127|NCT02114684|211790|P2|COMPLETED|Overall Study||88
86128|NCT02114684|211791|P1|COMPLETED|Overall Study||86
86129|NCT02114684|211790|P2|STARTED|Overall Study||98
86130|NCT02114684|211791|P1|STARTED|Overall Study||98
86131|NCT02114515|211809|P2|NOT COMPLETED|Overall Study||150
86132|NCT02114515|211810|P1|NOT COMPLETED|Overall Study||133
86133|NCT02114515|211809|P2|COMPLETED|Overall Study||368
86134|NCT02114515|211810|P1|COMPLETED|Overall Study||378
86135|NCT02114515|211809|P2|STARTED|Overall Study||518
86136|NCT02114515|211810|P1|STARTED|Overall Study||511
86137|NCT02114385|211856|P2|NOT COMPLETED|Overall Study||8
86138|NCT02114385|211857|P1|NOT COMPLETED|Overall Study||3
86139|NCT02114385|211856|P2|COMPLETED|Overall Study||243
86140|NCT02114385|211857|P1|COMPLETED|Overall Study||246
86141|NCT02114385|211856|P2|Vaccinated|Overall Study||251
86142|NCT02114385|211857|P1|Vaccinated|Overall Study||249
86143|NCT02114385|211856|P2|STARTED|Overall Study||251
86144|NCT02114385|211857|P1|STARTED|Overall Study||249
86145|NCT02114307|211881|P2|NOT COMPLETED|Overall Study||0
86146|NCT02114307|211882|P1|NOT COMPLETED|Overall Study||1
86147|NCT02114307|211881|P2|COMPLETED|Overall Study||11
86148|NCT02114307|211882|P1|COMPLETED|Overall Study||10
86149|NCT02114307|211881|P2|STARTED|Overall Study||11
86150|NCT02114307|211882|P1|STARTED|Overall Study||11
86151|NCT02114268|211898|P6|NOT COMPLETED|Overall Study||3
86152|NCT02114268|211899|P5|NOT COMPLETED|Overall Study||0
86153|NCT02114268|211900|P4|NOT COMPLETED|Overall Study||0
86154|NCT02114268|211901|P3|NOT COMPLETED|Overall Study||1
86155|NCT02114268|211902|P2|NOT COMPLETED|Overall Study||1
86156|NCT02114268|211903|P1|NOT COMPLETED|Overall Study||6
86157|NCT02114268|211898|P6|COMPLETED|Overall Study||75
86158|NCT02114268|211899|P5|COMPLETED|Overall Study||6
86159|NCT02114268|211900|P4|COMPLETED|Overall Study||6
86160|NCT02114268|211901|P3|COMPLETED|Overall Study||5
86161|NCT02114268|211902|P2|COMPLETED|Overall Study||5
86162|NCT02114268|211903|P1|COMPLETED|Overall Study||28
86163|NCT02114268|211898|P6|STARTED|Overall Study||78
86164|NCT02114268|211899|P5|STARTED|Overall Study||6
86165|NCT02114268|211900|P4|STARTED|Overall Study||6
86166|NCT02114268|211901|P3|STARTED|Overall Study||6
86167|NCT02114268|211902|P2|STARTED|Overall Study||6
86168|NCT02114268|211903|P1|STARTED|Overall Study||34
86169|NCT02114216|211956|P3|NOT COMPLETED|Overall Study||0
86170|NCT02114216|211957|P2|NOT COMPLETED|Overall Study||0
86171|NCT02114216|211958|P1|NOT COMPLETED|Overall Study||0
86172|NCT02114216|211956|P3|COMPLETED|Overall Study||14
86173|NCT02114216|211957|P2|COMPLETED|Overall Study||45
86174|NCT02114216|211958|P1|COMPLETED|Overall Study||16
86175|NCT02114216|211956|P3|STARTED|Overall Study||14
86176|NCT02114216|211957|P2|STARTED|Overall Study||45
86177|NCT02114216|211958|P1|STARTED|Overall Study||16
86178|NCT02114203|211972|P3|NOT COMPLETED|Overall Study||0
86179|NCT02114203|211973|P2|NOT COMPLETED|Overall Study||2
86180|NCT02114203|211974|P1|NOT COMPLETED|Overall Study||0
86181|NCT02114203|211972|P3|COMPLETED|Overall Study||7
86182|NCT02114203|211973|P2|COMPLETED|Overall Study||14
86183|NCT02114203|211974|P1|COMPLETED|Overall Study||7
86184|NCT02114203|211972|P3|STARTED|Overall Study||7
86185|NCT02114203|211973|P2|STARTED|Overall Study||16
86186|NCT02114203|211974|P1|STARTED|Overall Study||7
86187|NCT02114177|212008|P2|NOT COMPLETED|Overall Study||4
86188|NCT02114177|212009|P1|NOT COMPLETED|Overall Study||9
86189|NCT02114177|212008|P2|COMPLETED|Overall Study||151
86190|NCT02114177|212009|P1|COMPLETED|Overall Study||146
86191|NCT02114177|212008|P2|STARTED|Overall Study||155
86192|NCT02114177|212009|P1|STARTED|Overall Study||155
86193|NCT02114151|212033|P1|NOT COMPLETED|Overall Study||7
86194|NCT02114151|212033|P1|COMPLETED|Overall Study||96
86195|NCT02114151|212033|P1|STARTED|Overall Study||103
86196|NCT02113956|212050|P2|NOT COMPLETED|3 Month Post-intervention||2
86197|NCT02113956|212051|P1|NOT COMPLETED|3 Month Post-intervention||4
86198|NCT02113956|212050|P2|COMPLETED|3 Month Post-intervention||146
86199|NCT02113956|212051|P1|COMPLETED|3 Month Post-intervention||137
86200|NCT02113956|212050|P2|STARTED|3 Month Post-intervention||148
86201|NCT02113956|212051|P1|STARTED|3 Month Post-intervention||141
86202|NCT02113956|212050|P2|NOT COMPLETED|Intervention End (5 Weeks Post Baseline)||4
86203|NCT02113956|212051|P1|NOT COMPLETED|Intervention End (5 Weeks Post Baseline)||9
86204|NCT02113956|212050|P2|COMPLETED|Intervention End (5 Weeks Post Baseline)||148
86205|NCT02113956|212051|P1|COMPLETED|Intervention End (5 Weeks Post Baseline)||141
86206|NCT02113956|212050|P2|STARTED|Intervention End (5 Weeks Post Baseline)||152
86207|NCT02113956|212051|P1|STARTED|Intervention End (5 Weeks Post Baseline)||150
86208|NCT02113579|212085|P2|NOT COMPLETED|Overall Study||4
86209|NCT02113579|212086|P1|NOT COMPLETED|Overall Study||10
86210|NCT02113579|212085|P2|COMPLETED|Overall Study||185
86211|NCT02113579|212086|P1|COMPLETED|Overall Study||176
86212|NCT02113579|212085|P2|STARTED|Overall Study||189
86213|NCT02113579|212086|P1|STARTED|Overall Study||186
86214|NCT02113449|212110|P1|NOT COMPLETED|Overall Study||4
86215|NCT02113449|212110|P1|COMPLETED|Overall Study||143
86216|NCT02113449|212110|P1|STARTED|Overall Study||147
86217|NCT02113436|212126|P4|NOT COMPLETED|Period 2: 16 Weeks||11
86218|NCT02113436|212127|P3|NOT COMPLETED|Period 2: 16 Weeks||9
86219|NCT02113436|212128|P2|NOT COMPLETED|Period 2: 16 Weeks||0
86220|NCT02113436|212129|P1|NOT COMPLETED|Period 2: 16 Weeks||0
86221|NCT02113436|212126|P4|COMPLETED|Period 2: 16 Weeks||136
86222|NCT02113436|212127|P3|COMPLETED|Period 2: 16 Weeks||132
86223|NCT02113436|212128|P2|COMPLETED|Period 2: 16 Weeks||0
86224|NCT02113436|212129|P1|COMPLETED|Period 2: 16 Weeks||0
86225|NCT02113436|212126|P4|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn’t transfer to TP2.|147
86226|NCT02113436|212127|P3|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn’t transfer to TP2.|141
86227|NCT02113436|212128|P2|STARTED|Period 2: 16 Weeks||0
86228|NCT02113436|212129|P1|STARTED|Period 2: 16 Weeks||0
86229|NCT02113436|212126|P4|NOT COMPLETED|Period 1: 8 Weeks||0
86230|NCT02113436|212127|P3|NOT COMPLETED|Period 1: 8 Weeks||0
86231|NCT02113436|212128|P2|NOT COMPLETED|Period 1: 8 Weeks||2
86232|NCT02113436|212129|P1|NOT COMPLETED|Period 1: 8 Weeks||8
86233|NCT02113436|212126|P4|COMPLETED|Period 1: 8 Weeks||0
86234|NCT02113436|212127|P3|COMPLETED|Period 1: 8 Weeks||0
86235|NCT02113436|212128|P2|COMPLETED|Period 1: 8 Weeks||148
86236|NCT02113436|212129|P1|COMPLETED|Period 1: 8 Weeks||142
86237|NCT02113436|212126|P4|STARTED|Period 1: 8 Weeks||0
86238|NCT02113436|212127|P3|STARTED|Period 1: 8 Weeks||0
86239|NCT02113436|212128|P2|STARTED|Period 1: 8 Weeks||150
86240|NCT02113436|212129|P1|STARTED|Period 1: 8 Weeks||150
86241|NCT02113410|212152|P2|NOT COMPLETED|Overall Study||3
86242|NCT02113410|212153|P1|NOT COMPLETED|Overall Study||16
86243|NCT02113410|212152|P2|COMPLETED|Overall Study||63
86244|NCT02113410|212153|P1|COMPLETED|Overall Study||49
86245|NCT02113410|212152|P2|STARTED|Overall Study||66
86246|NCT02113410|212153|P1|STARTED|Overall Study||65
86247|NCT02113189|212180|P3|NOT COMPLETED|Overall Study||3
86248|NCT02113189|212181|P2|NOT COMPLETED|Overall Study||1
86249|NCT02113189|212182|P1|NOT COMPLETED|Overall Study||2
86250|NCT02113189|212180|P3|COMPLETED|Overall Study||2
86251|NCT02113189|212181|P2|COMPLETED|Overall Study||3
86252|NCT02113189|212182|P1|COMPLETED|Overall Study||2
86253|NCT02113189|212180|P3|STARTED|Overall Study||5
86254|NCT02113189|212181|P2|STARTED|Overall Study||4
86255|NCT02113189|212182|P1|STARTED|Overall Study||4
86256|NCT02113124|212198|P2|NOT COMPLETED|Overall Study||1
86257|NCT02113124|212199|P1|NOT COMPLETED|Overall Study||1
86258|NCT02113124|212198|P2|COMPLETED|Overall Study||24
86259|NCT02113124|212199|P1|COMPLETED|Overall Study||17
86260|NCT02113124|212198|P2|STARTED|Overall Study||25
86261|NCT02113124|212199|P1|STARTED|Overall Study||18
86262|NCT02113007|212205|P1|NOT COMPLETED|Overall Study||2
86263|NCT02113007|212205|P1|COMPLETED|Overall Study||0
86264|NCT02113007|212205|P1|STARTED|Overall Study||2
86265|NCT02112994|212211|P3|NOT COMPLETED|Overall Study||3
86266|NCT02112994|212212|P2|NOT COMPLETED|Overall Study||3
86267|NCT02112994|212213|P1|NOT COMPLETED|Overall Study||0
86268|NCT02112994|212211|P3|COMPLETED|Overall Study||6
86269|NCT02112994|212212|P2|COMPLETED|Overall Study||13
86270|NCT02112994|212213|P1|COMPLETED|Overall Study||6
86271|NCT02112994|212211|P3|Completed 96-week Treatment Period|Overall Study||8
86272|NCT02112994|212212|P2|Completed 96-week Treatment Period|Overall Study||14
86273|NCT02112994|212213|P1|Completed 96-week Treatment Period|Overall Study||6
86274|NCT02112994|212211|P3|Received 3 mg/kg QW|Overall Study||1
86275|NCT02112994|212212|P2|Received 3 mg/kg QW|Overall Study||1
86276|NCT02112994|212213|P1|Received 3 mg/kg QW|Overall Study||2
86277|NCT02112994|212211|P3|Received 3 mg/kg QOW|Overall Study||3
86278|NCT02112994|212212|P2|Received 3 mg/kg QOW|Overall Study||5
86279|NCT02112994|212213|P1|Received 3 mg/kg QOW|Overall Study||3
86280|NCT02112994|212211|P3|Received 1 mg/kg QW|Overall Study||0
86281|NCT02112994|212212|P2|Received 1 mg/kg QW|Overall Study||1
86282|NCT02112994|212213|P1|Received 1 mg/kg QW|Overall Study||1
86283|NCT02112994|212211|P3|Received 1 mg/kg QOW|Overall Study||9
86284|NCT02112994|212212|P2|Received 1 mg/kg QOW|Overall Study||16
86285|NCT02112994|212213|P1|Received 1 mg/kg QOW|Overall Study||6
86286|NCT02112994|212211|P3|Received 0.35 mg/kg QOW|Overall Study||1
86287|NCT02112994|212212|P2|Received 0.35 mg/kg QOW|Overall Study||0
86288|NCT02112994|212213|P1|Received 0.35 mg/kg QOW|Overall Study||0
86289|NCT02112994|212211|P3|Received at Least 1 Dose of Study Drug|Overall Study||9
86290|NCT02112994|212212|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
86291|NCT02112994|212213|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
86292|NCT02112994|212211|P3|STARTED|Overall Study||9
86293|NCT02112994|212212|P2|STARTED|Overall Study||16
86294|NCT02112994|212213|P1|STARTED|Overall Study||6
86295|NCT02112877|212231|P2|NOT COMPLETED|Overall Study||13
86296|NCT02112877|212232|P1|NOT COMPLETED|Overall Study||2
86297|NCT02112877|212231|P2|COMPLETED|Overall Study||157
86298|NCT02112877|212232|P1|COMPLETED|Overall Study||28
86299|NCT02112877|212231|P2|STARTED|Overall Study||170
86300|NCT02112877|212232|P1|STARTED|Overall Study||30
86301|NCT02112838|212257|P3|NOT COMPLETED|Overall Study||1
86302|NCT02112838|212258|P2|NOT COMPLETED|Overall Study||2
86303|NCT02112838|212259|P1|NOT COMPLETED|Overall Study||5
86304|NCT02112838|212257|P3|COMPLETED|Overall Study||24
86305|NCT02112838|212258|P2|COMPLETED|Overall Study||24
86306|NCT02112838|212259|P1|COMPLETED|Overall Study||20
86307|NCT02112838|212257|P3|STARTED|Overall Study||25
86308|NCT02112838|212258|P2|STARTED|Overall Study||26
86309|NCT02112838|212259|P1|STARTED|Overall Study||25
86310|NCT02112448|212311|P2|NOT COMPLETED|Overall Study||10
86311|NCT02112448|212312|P1|NOT COMPLETED|Overall Study||8
86312|NCT02112448|212311|P2|COMPLETED|Overall Study||30
86313|NCT02112448|212312|P1|COMPLETED|Overall Study||30
86314|NCT02112448|212311|P2|STARTED|Overall Study||40
86315|NCT02112448|212312|P1|STARTED|Overall Study||38
86316|NCT02112370|212322|P2|NOT COMPLETED|Overall Study||0
86317|NCT02112370|212323|P1|NOT COMPLETED|Overall Study||0
86318|NCT02112370|212322|P2|COMPLETED|Overall Study||74
86319|NCT02112370|212323|P1|COMPLETED|Overall Study||74
86320|NCT02112370|212322|P2|STARTED|Overall Study||74
86321|NCT02112370|212323|P1|STARTED|Overall Study||74
86322|NCT02112045|212345|P2|NOT COMPLETED|Overall Study||0
86323|NCT02112045|212346|P1|NOT COMPLETED|Overall Study||1
86324|NCT02112045|212345|P2|COMPLETED|Overall Study||45
86325|NCT02112045|212346|P1|COMPLETED|Overall Study||44
86326|NCT02112045|212345|P2|STARTED|Overall Study||45
86327|NCT02112045|212346|P1|STARTED|Overall Study||45
86328|NCT02111993|212366|P2|NOT COMPLETED|Overall Study||4
86329|NCT02111993|212367|P1|NOT COMPLETED|Overall Study||5
86330|NCT02111993|212366|P2|COMPLETED|Overall Study||26
86331|NCT02111993|212367|P1|COMPLETED|Overall Study||25
86332|NCT02111993|212366|P2|STARTED|Overall Study||30
86333|NCT02111993|212367|P1|STARTED|Overall Study||30
86334|NCT02111863|212377|P1|NOT COMPLETED|Overall Study||0
86335|NCT02111863|212377|P1|COMPLETED|Overall Study||6
86336|NCT02111863|212377|P1|STARTED|Overall Study||6
86337|NCT02111785|212387|P4|NOT COMPLETED|Overall Study||0
86338|NCT02111785|212388|P3|NOT COMPLETED|Overall Study||0
86339|NCT02111785|212389|P2|NOT COMPLETED|Overall Study||1
86340|NCT02111785|212390|P1|NOT COMPLETED|Overall Study||0
86341|NCT02111785|212387|P4|COMPLETED|Overall Study||1
86342|NCT02111785|212388|P3|COMPLETED|Overall Study||1
86343|NCT02111785|212389|P2|COMPLETED|Overall Study||4
86344|NCT02111785|212390|P1|COMPLETED|Overall Study||3
86345|NCT02111785|212387|P4|STARTED|Overall Study||1
86346|NCT02111785|212388|P3|STARTED|Overall Study||1
86347|NCT02111785|212389|P2|STARTED|Overall Study||5
86348|NCT02111785|212390|P1|STARTED|Overall Study||3
86349|NCT02111772|212418|P2|NOT COMPLETED|Overall Study||0
86350|NCT02111772|212419|P1|NOT COMPLETED|Overall Study||0
86351|NCT02111772|212418|P2|COMPLETED|Overall Study||14
86352|NCT02111772|212419|P1|COMPLETED|Overall Study||12
86353|NCT02111772|212418|P2|STARTED|Overall Study||14
86354|NCT02111772|212419|P1|STARTED|Overall Study||12
86355|NCT02111746|212429|P2|NOT COMPLETED|Overall Study||2
86356|NCT02111746|212430|P1|NOT COMPLETED|Overall Study||3
86357|NCT02111746|212429|P2|COMPLETED|Overall Study||169
86358|NCT02111746|212430|P1|COMPLETED|Overall Study||169
86359|NCT02111746|212429|P2|STARTED|Overall Study||171
86360|NCT02111746|212430|P1|STARTED|Overall Study||172
86361|NCT02111603|212452|P1|NOT COMPLETED|Overall Study||1
86362|NCT02111603|212452|P1|COMPLETED|Overall Study||12
86363|NCT02111603|212452|P1|STARTED|Overall Study||13
86364|NCT02111564|212463|P2|NOT COMPLETED|Overall Study||143
86365|NCT02111564|212464|P1|NOT COMPLETED|Overall Study||131
86366|NCT02111564|212463|P2|COMPLETED|Overall Study||5869
86367|NCT02111564|212464|P1|COMPLETED|Overall Study||5876
86368|NCT02111564|212463|P2|Treated|Overall Study||5980
86369|NCT02111564|212464|P1|Treated|Overall Study||5982
86370|NCT02111564|212463|P2|STARTED|Overall Study||6012
86371|NCT02111564|212464|P1|STARTED|Overall Study||6007
86372|NCT02111447|212486|P4|NOT COMPLETED|Overall Study||0
86373|NCT02111447|212487|P3|NOT COMPLETED|Overall Study||0
86374|NCT02111447|212488|P2|NOT COMPLETED|Overall Study||0
86375|NCT02111447|212489|P1|NOT COMPLETED|Overall Study||0
86376|NCT02111447|212486|P4|COMPLETED|Overall Study||0
86377|NCT02111447|212487|P3|COMPLETED|Overall Study||1
86378|NCT02111447|212488|P2|COMPLETED|Overall Study||5
86379|NCT02111447|212489|P1|COMPLETED|Overall Study||0
86380|NCT02111447|212486|P4|STARTED|Overall Study||0
86381|NCT02111447|212487|P3|STARTED|Overall Study||1
86382|NCT02111447|212488|P2|STARTED|Overall Study||5
86383|NCT02111447|212489|P1|STARTED|Overall Study||0
86384|NCT02111369|212503|P1|NOT COMPLETED|Overall Study||3
86385|NCT02111369|212503|P1|COMPLETED|Overall Study||15
86386|NCT02111369|212503|P1|STARTED|Overall Study||18
86387|NCT02111252|212511|P1|NOT COMPLETED|Overall Study||0
86388|NCT02111252|212511|P1|COMPLETED|Overall Study||55
86389|NCT02111252|212511|P1|STARTED|Overall Study||55
86390|NCT02111213|212527|P2|NOT COMPLETED|Overall Study||6
86391|NCT02111213|212528|P1|NOT COMPLETED|Overall Study||6
86392|NCT02111213|212527|P2|COMPLETED|Overall Study||117
86393|NCT02111213|212528|P1|COMPLETED|Overall Study||116
86394|NCT02111213|212527|P2|STARTED|Overall Study||123
86395|NCT02111213|212528|P1|STARTED|Overall Study||122
86396|NCT02111200|212538|P4|NOT COMPLETED|Overall Study||0
86397|NCT02111200|212539|P3|NOT COMPLETED|Overall Study||0
86398|NCT02111200|212540|P2|NOT COMPLETED|Overall Study||0
86399|NCT02111200|212541|P1|NOT COMPLETED|Overall Study||0
86400|NCT02111200|212538|P4|COMPLETED|Overall Study||1
86401|NCT02111200|212539|P3|COMPLETED|Overall Study||1
86402|NCT02111200|212540|P2|COMPLETED|Overall Study||2
86403|NCT02111200|212541|P1|COMPLETED|Overall Study||3
86404|NCT02111200|212538|P4|STARTED|Overall Study||1
86405|NCT02111200|212539|P3|STARTED|Overall Study||1
86406|NCT02111200|212540|P2|STARTED|Overall Study||2
86407|NCT02111200|212541|P1|STARTED|Overall Study||3
86408|NCT02111187|212557|P2|NOT COMPLETED|Overall Study||0
86409|NCT02111187|212558|P1|NOT COMPLETED|Overall Study||0
86410|NCT02111187|212557|P2|COMPLETED|Overall Study||7
86411|NCT02111187|212558|P1|COMPLETED|Overall Study||7
86412|NCT02111187|212557|P2|STARTED|Overall Study||7
86413|NCT02111187|212558|P1|STARTED|Overall Study||7
86414|NCT02111174|212572|P2|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7
86415|NCT02111174|212573|P1|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||8
86416|NCT02111174|212572|P2|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||9
86417|NCT02111174|212573|P1|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7
86418|NCT02111174|212572|P2|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||11
86419|NCT02111174|212573|P1|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||8
86420|NCT02111174|212572|P2|STARTED|Secondary Outcomes (2 and 3 Month f/u)||16
86421|NCT02111174|212573|P1|STARTED|Secondary Outcomes (2 and 3 Month f/u)||15
86422|NCT02111174|212572|P2|NOT COMPLETED|Treatment and Primary Outcome||2
86423|NCT02111174|212573|P1|NOT COMPLETED|Treatment and Primary Outcome||3
86424|NCT02111174|212572|P2|COMPLETED|Treatment and Primary Outcome||16
86425|NCT02111174|212573|P1|COMPLETED|Treatment and Primary Outcome||15
86426|NCT02111174|212572|P2|STARTED|Treatment and Primary Outcome||18
86427|NCT02111174|212573|P1|STARTED|Treatment and Primary Outcome||18
86428|NCT02111096|212602|P3|NOT COMPLETED|Overall Study||66
86429|NCT02111096|212603|P2|NOT COMPLETED|Overall Study||41
86430|NCT02111096|212604|P1|NOT COMPLETED|Overall Study||64
86431|NCT02111096|212602|P3|COMPLETED|Overall Study||2
86432|NCT02111096|212603|P2|COMPLETED|Overall Study||0
86433|NCT02111096|212604|P1|COMPLETED|Overall Study||1
86434|NCT02111096|212602|P3|Received at Least 1 Dose of Study Drug|Overall Study||68
86435|NCT02111096|212603|P2|Received at Least 1 Dose of Study Drug|Overall Study||41
86436|NCT02111096|212604|P1|Received at Least 1 Dose of Study Drug|Overall Study||65
86437|NCT02111096|212602|P3|STARTED|Overall Study||68
86438|NCT02111096|212603|P2|STARTED|Overall Study||41
86439|NCT02111096|212604|P1|STARTED|Overall Study||65
86440|NCT02111083|212652|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
86441|NCT02111083|212653|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
86442|NCT02111083|212652|P2|COMPLETED|Fourth Intervention (1 Day)||18
86443|NCT02111083|212653|P1|COMPLETED|Fourth Intervention (1 Day)||18
86444|NCT02111083|212652|P2|STARTED|Fourth Intervention (1 Day)||18
86445|NCT02111083|212653|P1|STARTED|Fourth Intervention (1 Day)||18
86446|NCT02111083|212652|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
86447|NCT02111083|212653|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
86448|NCT02111083|212652|P2|COMPLETED|Interval Between Dosing (7-8 Days)||18
86449|NCT02111083|212653|P1|COMPLETED|Interval Between Dosing (7-8 Days)||18
86450|NCT02111083|212652|P2|STARTED|Interval Between Dosing (7-8 Days)||19
86451|NCT02111083|212653|P1|STARTED|Interval Between Dosing (7-8 Days)||19
86452|NCT02111083|212652|P2|NOT COMPLETED|Third Intervention (1 Day)||0
86453|NCT02111083|212653|P1|NOT COMPLETED|Third Intervention (1 Day)||0
86454|NCT02111083|212652|P2|COMPLETED|Third Intervention (1 Day)||19
86455|NCT02111083|212653|P1|COMPLETED|Third Intervention (1 Day)||19
86456|NCT02111083|212652|P2|STARTED|Third Intervention (1 Day)||19
86457|NCT02111083|212653|P1|STARTED|Third Intervention (1 Day)||19
86458|NCT02111083|212652|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
86459|NCT02111083|212653|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
86460|NCT02111083|212652|P2|COMPLETED|Interval Between Dosing (7-8 Days)||19
86461|NCT02111083|212653|P1|COMPLETED|Interval Between Dosing (7-8 Days)||19
86462|NCT02111083|212652|P2|STARTED|Interval Between Dosing (7-8 Days)||19
86463|NCT02111083|212653|P1|STARTED|Interval Between Dosing (7-8 Days)||19
86464|NCT02111083|212652|P2|NOT COMPLETED|Second Intervention (1 Day)||0
86465|NCT02111083|212653|P1|NOT COMPLETED|Second Intervention (1 Day)||0
86466|NCT02111083|212652|P2|COMPLETED|Second Intervention (1 Day)||19
86467|NCT02111083|212653|P1|COMPLETED|Second Intervention (1 Day)||19
86468|NCT02111083|212652|P2|STARTED|Second Intervention (1 Day)||19
86469|NCT02111083|212653|P1|STARTED|Second Intervention (1 Day)||19
86470|NCT02111083|212652|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
86471|NCT02111083|212653|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
86472|NCT02111083|212652|P2|COMPLETED|Interval Between Dosing (7-8 Days)||19
86473|NCT02111083|212653|P1|COMPLETED|Interval Between Dosing (7-8 Days)||19
86474|NCT02111083|212652|P2|STARTED|Interval Between Dosing (7-8 Days)||19
86475|NCT02111083|212653|P1|STARTED|Interval Between Dosing (7-8 Days)||19
86476|NCT02111083|212652|P2|NOT COMPLETED|First Intervention (1 Day)||0
86477|NCT02111083|212653|P1|NOT COMPLETED|First Intervention (1 Day)||0
86478|NCT02111083|212652|P2|COMPLETED|First Intervention (1 Day)||19
86479|NCT02111083|212653|P1|COMPLETED|First Intervention (1 Day)||19
86480|NCT02111083|212652|P2|STARTED|First Intervention (1 Day)||19
86481|NCT02111083|212653|P1|STARTED|First Intervention (1 Day)||19
86482|NCT02110901|212673|P2|NOT COMPLETED|Overall Study||14
86483|NCT02110901|212674|P1|NOT COMPLETED|Overall Study||30
86484|NCT02110901|212673|P2|COMPLETED|Overall Study||88
86485|NCT02110901|212674|P1|COMPLETED|Overall Study||179
86486|NCT02110901|212673|P2|STARTED|Overall Study||102
86487|NCT02110901|212674|P1|STARTED|Overall Study||209
86488|NCT02110706|212688|P2|NOT COMPLETED|Overall Study||4
86489|NCT02110706|212689|P1|NOT COMPLETED|Overall Study||5
86490|NCT02110706|212688|P2|COMPLETED|Overall Study||23
86491|NCT02110706|212689|P1|COMPLETED|Overall Study||20
86492|NCT02110706|212688|P2|No. Completing Study Through Week 52|Overall Study||24
86493|NCT02110706|212689|P1|No. Completing Study Through Week 52|Overall Study||23
86494|NCT02110706|212688|P2|STARTED|Overall Study||27
86495|NCT02110706|212689|P1|STARTED|Overall Study||25
86496|NCT02110693|212701|P2|NOT COMPLETED|Overall Study||29
86497|NCT02110693|212702|P1|NOT COMPLETED|Overall Study||28
86498|NCT02110693|212701|P2|COMPLETED|Overall Study||1002
86499|NCT02110693|212702|P1|COMPLETED|Overall Study||998
86500|NCT02110693|212701|P2|STARTED|Overall Study||1031
86501|NCT02110693|212702|P1|STARTED|Overall Study||1026
86502|NCT02110485|212729|P2|NOT COMPLETED|Overall Study||19
86503|NCT02110485|212730|P1|NOT COMPLETED|Overall Study||7
86504|NCT02110485|212729|P2|COMPLETED|Overall Study||83
86505|NCT02110485|212730|P1|COMPLETED|Overall Study||91
86506|NCT02110485|212729|P2|STARTED|Overall Study||102
86507|NCT02110485|212730|P1|STARTED|Overall Study||98
86508|NCT02110381|212748|P2|NOT COMPLETED|Dual Modality||1
86509|NCT02110381|212749|P1|NOT COMPLETED|Dual Modality||2
86510|NCT02110381|212748|P2|COMPLETED|Dual Modality||7
86511|NCT02110381|212749|P1|COMPLETED|Dual Modality||5
86512|NCT02110381|212748|P2|Began Active Treatment|Dual Modality||7
86513|NCT02110381|212749|P1|Began Active Treatment|Dual Modality||7
86514|NCT02110381|212748|P2|STARTED|Dual Modality||8
86515|NCT02110381|212749|P1|STARTED|Dual Modality||7
86516|NCT02110381|212748|P2|NOT COMPLETED|Single Modality||1
86517|NCT02110381|212749|P1|NOT COMPLETED|Single Modality||2
86518|NCT02110381|212748|P2|COMPLETED|Single Modality||8
86519|NCT02110381|212749|P1|COMPLETED|Single Modality||7
86520|NCT02110381|212748|P2|STARTED|Single Modality||9
86521|NCT02110381|212749|P1|STARTED|Single Modality||9
86522|NCT02110277|212760|P1|NOT COMPLETED|Overall Study||2
86523|NCT02110277|212760|P1|COMPLETED|Overall Study||0
86524|NCT02110277|212760|P1|STARTED|Overall Study||2
86525|NCT02110238|212767|P2|NOT COMPLETED|14 Week Blinded Extension Phase||12
86526|NCT02110238|212768|P1|NOT COMPLETED|14 Week Blinded Extension Phase||12
86527|NCT02110238|212767|P2|COMPLETED|14 Week Blinded Extension Phase||188
86528|NCT02110238|212768|P1|COMPLETED|14 Week Blinded Extension Phase||190
86529|NCT02110238|212767|P2|STARTED|14 Week Blinded Extension Phase||200
86530|NCT02110238|212768|P1|STARTED|14 Week Blinded Extension Phase||202
86531|NCT02110238|212767|P2|NOT COMPLETED|12 Week Pivotal Phase||9
86532|NCT02110238|212768|P1|NOT COMPLETED|12 Week Pivotal Phase||10
86533|NCT02110238|212767|P2|COMPLETED|12 Week Pivotal Phase||200
86534|NCT02110238|212768|P1|COMPLETED|12 Week Pivotal Phase||202
86535|NCT02110238|212767|P2|STARTED|12 Week Pivotal Phase||209
86536|NCT02110238|212768|P1|STARTED|12 Week Pivotal Phase|One subject was randomized but not treated. As a result there were 211 safety subjects|212
86537|NCT02110225|212777|P3|NOT COMPLETED|Overall Study||0
86538|NCT02110225|212778|P2|NOT COMPLETED|Overall Study||1
86539|NCT02110225|212779|P1|NOT COMPLETED|Overall Study||0
86540|NCT02110225|212777|P3|COMPLETED|Overall Study||10
86541|NCT02110225|212778|P2|COMPLETED|Overall Study||19
86542|NCT02110225|212779|P1|COMPLETED|Overall Study||20
86543|NCT02110225|212777|P3|STARTED|Overall Study||10
86544|NCT02110225|212778|P2|STARTED|Overall Study||20
86545|NCT02110225|212779|P1|STARTED|Overall Study||20
86546|NCT02110147|212831|P1|NOT COMPLETED|Overall Study||0
86547|NCT02110147|212831|P1|COMPLETED|Overall Study||4
86548|NCT02110147|212831|P1|STARTED|Overall Study||4
86549|NCT02109809|212837|P1|NOT COMPLETED|Overall Study||3
86550|NCT02109809|212837|P1|COMPLETED|Overall Study||1
86551|NCT02109809|212837|P1|STARTED|Overall Study||4
86552|NCT02109731|212843|P1|NOT COMPLETED|Overall Study||0
86553|NCT02109731|212843|P1|COMPLETED|Overall Study||15
86554|NCT02109731|212843|P1|STARTED|Overall Study||15
86555|NCT02109640|212849|P2|NOT COMPLETED|Overall Study||0
86556|NCT02109640|212850|P1|NOT COMPLETED|Overall Study||0
86557|NCT02109640|212849|P2|COMPLETED|Overall Study||23
86558|NCT02109640|212850|P1|COMPLETED|Overall Study||27
86559|NCT02109640|212849|P2|STARTED|Overall Study||23
86560|NCT02109640|212850|P1|STARTED|Overall Study||27
86561|NCT02109562|212863|P3|NOT COMPLETED|Overall Study||35
86562|NCT02109562|212864|P2|NOT COMPLETED|Overall Study||34
86563|NCT02109562|212865|P1|NOT COMPLETED|Overall Study||26
86564|NCT02109562|212863|P3|COMPLETED|Overall Study||84
86565|NCT02109562|212864|P2|COMPLETED|Overall Study||85
86566|NCT02109562|212865|P1|COMPLETED|Overall Study||90
86567|NCT02109562|212863|P3|Intent to Treat (ITT)|Overall Study||112
86568|NCT02109562|212864|P2|Intent to Treat (ITT)|Overall Study||114
86569|NCT02109562|212865|P1|Intent to Treat (ITT)|Overall Study||111
86570|NCT02109562|212863|P3|Safety|Overall Study||118
86571|NCT02109562|212864|P2|Safety|Overall Study||117
86572|NCT02109562|212865|P1|Safety|Overall Study||115
86573|NCT02109562|212863|P3|STARTED|Overall Study||119
86574|NCT02109562|212864|P2|STARTED|Overall Study||119
86575|NCT02109562|212865|P1|STARTED|Overall Study||116
86576|NCT02109497|212879|P1|NOT COMPLETED|Overall Study||1
86577|NCT02109497|212879|P1|COMPLETED|Overall Study|One participant completed the safety assessments but did not complete all doses of the study drugs.|17
86578|NCT02109497|212879|P1|STARTED|Overall Study||18
86579|NCT02109484|212892|P8|NOT COMPLETED|Overall Study||3
86580|NCT02109484|212893|P7|NOT COMPLETED|Overall Study||3
86581|NCT02109484|212894|P6|NOT COMPLETED|Overall Study||1
86582|NCT02109484|212895|P5|NOT COMPLETED|Overall Study||4
86583|NCT02109484|212896|P4|NOT COMPLETED|Overall Study||1
86584|NCT02109484|212897|P3|NOT COMPLETED|Overall Study||0
86585|NCT02109484|212898|P2|NOT COMPLETED|Overall Study||0
86586|NCT02109484|212899|P1|NOT COMPLETED|Overall Study||0
86587|NCT02109484|212892|P8|COMPLETED|Overall Study||47
86588|NCT02109484|212893|P7|COMPLETED|Overall Study||47
86589|NCT02109484|212894|P6|COMPLETED|Overall Study||11
86590|NCT02109484|212895|P5|COMPLETED|Overall Study||46
86591|NCT02109484|212896|P4|COMPLETED|Overall Study||11
86592|NCT02109484|212897|P3|COMPLETED|Overall Study||12
86593|NCT02109484|212898|P2|COMPLETED|Overall Study||13
86594|NCT02109484|212899|P1|COMPLETED|Overall Study||5
86595|NCT02109484|212892|P8|STARTED|Overall Study||50
86596|NCT02109484|212893|P7|STARTED|Overall Study||50
86597|NCT02109484|212894|P6|STARTED|Overall Study||12
86598|NCT02109484|212895|P5|STARTED|Overall Study||50
86599|NCT02109484|212896|P4|STARTED|Overall Study||12
86600|NCT02109484|212897|P3|STARTED|Overall Study||12
86601|NCT02109484|212898|P2|STARTED|Overall Study||13
86602|NCT02109484|212899|P1|STARTED|Overall Study||5
86603|NCT02109458|212948|P1|NOT COMPLETED|Overall Study||0
86604|NCT02109458|212948|P1|COMPLETED|Overall Study||24
86605|NCT02109458|212948|P1|STARTED|Overall Study||24
86606|NCT02109445|212955|P1|NOT COMPLETED|Overall Study||3
86607|NCT02109445|212955|P1|COMPLETED|Overall Study||0
86608|NCT02109445|212955|P1|STARTED|Overall Study||3
86609|NCT02109432|212988|P1|NOT COMPLETED|Overall Study||1
86610|NCT02109432|212988|P1|COMPLETED|Overall Study||6
86611|NCT02109432|212988|P1|STARTED|Overall Study||7
86612|NCT02109419|212992|P1|NOT COMPLETED|Overall Study||0
86613|NCT02109419|212992|P1|COMPLETED|Overall Study||57
86614|NCT02109419|212992|P1|STARTED|Overall Study||57
86615|NCT02109172|212998|P6|NOT COMPLETED|Overall Study||1
86616|NCT02109172|212999|P5|NOT COMPLETED|Overall Study||1
86617|NCT02109172|213000|P4|NOT COMPLETED|Overall Study||1
86618|NCT02109172|213001|P3|NOT COMPLETED|Overall Study||1
86619|NCT02109172|213002|P2|NOT COMPLETED|Overall Study||0
86620|NCT02109172|213003|P1|NOT COMPLETED|Overall Study||1
86621|NCT02109172|212998|P6|COMPLETED|Overall Study||10
86622|NCT02109172|212999|P5|COMPLETED|Overall Study||9
86623|NCT02109172|213000|P4|COMPLETED|Overall Study||10
86624|NCT02109172|213001|P3|COMPLETED|Overall Study||9
86625|NCT02109172|213002|P2|COMPLETED|Overall Study||11
86626|NCT02109172|213003|P1|COMPLETED|Overall Study||10
86627|NCT02109172|212998|P6|STARTED|Overall Study||11
86628|NCT02109172|212999|P5|STARTED|Overall Study||10
86629|NCT02109172|213000|P4|STARTED|Overall Study||11
86630|NCT02109172|213001|P3|STARTED|Overall Study||10
86631|NCT02109172|213002|P2|STARTED|Overall Study||11
86632|NCT02109172|213003|P1|STARTED|Overall Study||11
86633|NCT02109159|213013|P2|NOT COMPLETED|Overall Study||0
86634|NCT02109159|213014|P1|NOT COMPLETED|Overall Study||0
86635|NCT02109159|213013|P2|COMPLETED|Overall Study||4175
86636|NCT02109159|213014|P1|COMPLETED|Overall Study||4178
86637|NCT02109159|213013|P2|STARTED|Overall Study||4175
86638|NCT02109159|213014|P1|STARTED|Overall Study||4178
86639|NCT02109133|213024|P2|NOT COMPLETED|Overall Study||0
86640|NCT02109133|213025|P1|NOT COMPLETED|Overall Study||1
86641|NCT02109133|213024|P2|COMPLETED|Overall Study||34
86642|NCT02109133|213025|P1|COMPLETED|Overall Study||32
86643|NCT02109133|213024|P2|STARTED|Overall Study||34
86644|NCT02109133|213025|P1|STARTED|Overall Study||33
86645|NCT02109107|213037|P1|NOT COMPLETED|Overall Study||2
86646|NCT02109107|213037|P1|COMPLETED|Overall Study||52
86647|NCT02109107|213037|P1|STARTED|Overall Study||54
86648|NCT02109042|213044|P1|NOT COMPLETED|Overall Study||15
86649|NCT02109042|213044|P1|COMPLETED|Overall Study||0
86650|NCT02109042|213044|P1|Receive at Least 1 Subsequent 90 mg Dose|Overall Study||15
86651|NCT02109042|213044|P1|Received 180 mg Loading Dose|Overall Study||15
86652|NCT02109042|213044|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
86653|NCT02109042|213044|P1|STARTED|Overall Study||15
86654|NCT02109029|213053|P6|NOT COMPLETED|Part B||1
86655|NCT02109029|213054|P5|NOT COMPLETED|Part B||1
86656|NCT02109029|213055|P4|NOT COMPLETED|Part B||0
86657|NCT02109029|213056|P3|NOT COMPLETED|Part B||0
86658|NCT02109029|213057|P2|NOT COMPLETED|Part B||0
86659|NCT02109029|213058|P1|NOT COMPLETED|Part B||0
86660|NCT02109029|213053|P6|COMPLETED|Part B||5
86661|NCT02109029|213054|P5|COMPLETED|Part B||5
86662|NCT02109029|213055|P4|COMPLETED|Part B||0
86663|NCT02109029|213056|P3|COMPLETED|Part B||0
86664|NCT02109029|213057|P2|COMPLETED|Part B||0
86665|NCT02109029|213058|P1|COMPLETED|Part B||0
86666|NCT02109029|213053|P6|Received at Least One Dose of Study Drug|Part B||6
86667|NCT02109029|213054|P5|Received at Least One Dose of Study Drug|Part B||6
86668|NCT02109029|213055|P4|Received at Least One Dose of Study Drug|Part B||0
86669|NCT02109029|213056|P3|Received at Least One Dose of Study Drug|Part B||0
86670|NCT02109029|213057|P2|Received at Least One Dose of Study Drug|Part B||0
86671|NCT02109029|213058|P1|Received at Least One Dose of Study Drug|Part B||0
86672|NCT02109029|213053|P6|STARTED|Part B|New participants entered Part B.|6
86673|NCT02109029|213054|P5|STARTED|Part B|New participants entered Part B.|6
86674|NCT02109029|213055|P4|STARTED|Part B||0
86675|NCT02109029|213056|P3|STARTED|Part B||0
86676|NCT02109029|213057|P2|STARTED|Part B||0
86677|NCT02109029|213058|P1|STARTED|Part B||0
86678|NCT02109029|213053|P6|NOT COMPLETED|Part A||0
86679|NCT02109029|213054|P5|NOT COMPLETED|Part A||0
86680|NCT02109029|213055|P4|NOT COMPLETED|Part A||0
86681|NCT02109029|213056|P3|NOT COMPLETED|Part A||0
86682|NCT02109029|213057|P2|NOT COMPLETED|Part A||0
86683|NCT02109029|213058|P1|NOT COMPLETED|Part A||0
86684|NCT02109029|213053|P6|COMPLETED|Part A||0
86685|NCT02109029|213054|P5|COMPLETED|Part A||0
86686|NCT02109029|213055|P4|COMPLETED|Part A|Participants from Part A did not move on to Part B.|4
86687|NCT02109029|213056|P3|COMPLETED|Part A|Participants from Part A did not move on to Part B.|4
86688|NCT02109029|213057|P2|COMPLETED|Part A|Participants from Part A did not move on to Part B.|2
86689|NCT02109029|213058|P1|COMPLETED|Part A|Participants from Part A did not move on to Part B.|2
86690|NCT02109029|213053|P6|Received One Dose of Study Drug|Part A||0
86691|NCT02109029|213054|P5|Received One Dose of Study Drug|Part A||0
86692|NCT02109029|213055|P4|Received One Dose of Study Drug|Part A||4
86693|NCT02109029|213056|P3|Received One Dose of Study Drug|Part A||4
86694|NCT02109029|213057|P2|Received One Dose of Study Drug|Part A||2
86695|NCT02109029|213058|P1|Received One Dose of Study Drug|Part A||2
86696|NCT02109029|213053|P6|STARTED|Part A||0
86697|NCT02109029|213054|P5|STARTED|Part A||0
86698|NCT02109029|213055|P4|STARTED|Part A||4
86699|NCT02109029|213056|P3|STARTED|Part A||4
86700|NCT02109029|213057|P2|STARTED|Part A||2
86701|NCT02109029|213058|P1|STARTED|Part A||2
86702|NCT02108977|213072|P2|NOT COMPLETED|Overall Study||1
86703|NCT02108977|213073|P1|NOT COMPLETED|Overall Study||10
86704|NCT02108977|213072|P2|COMPLETED|Overall Study||19
86705|NCT02108977|213073|P1|COMPLETED|Overall Study||8
86706|NCT02108977|213072|P2|STARTED|Overall Study||20
86707|NCT02108977|213073|P1|STARTED|Overall Study||18
86708|NCT02108951|213087|P1|NOT COMPLETED|Overall Study||16
86709|NCT02108951|213087|P1|COMPLETED|Overall Study||4
86710|NCT02108951|213087|P1|STARTED|Overall Study|Indicates patients in enrolled, full analysis and safety set|20
86711|NCT02108912|213106|P2|NOT COMPLETED|Overall Study||1
86712|NCT02108912|213107|P1|NOT COMPLETED|Overall Study||3
86713|NCT02108912|213106|P2|COMPLETED|Overall Study||6
86714|NCT02108912|213107|P1|COMPLETED|Overall Study||6
86715|NCT02108912|213106|P2|STARTED|Overall Study||7
86716|NCT02108912|213107|P1|STARTED|Overall Study||9
86717|NCT02108691|213117|P2|NOT COMPLETED|Overall Study||9
86718|NCT02108691|213118|P1|NOT COMPLETED|Overall Study||8
86719|NCT02108691|213117|P2|COMPLETED|Overall Study||31
86720|NCT02108691|213118|P1|COMPLETED|Overall Study||32
86721|NCT02108691|213117|P2|STARTED|Overall Study||40
86722|NCT02108691|213118|P1|STARTED|Overall Study||40
86723|NCT02108652|213136|P1|NOT COMPLETED|Overall Study||310
86724|NCT02108652|213136|P1|COMPLETED|Overall Study||0
86725|NCT02108652|213136|P1|STARTED|Overall Study||310
86726|NCT02108457|213159|P2|NOT COMPLETED|Overall Study||2
86727|NCT02108457|213160|P1|NOT COMPLETED|Overall Study||0
86728|NCT02108457|213159|P2|COMPLETED|Overall Study||10
86729|NCT02108457|213160|P1|COMPLETED|Overall Study||3
86730|NCT02108457|213159|P2|STARTED|Overall Study||12
86731|NCT02108457|213160|P1|STARTED|Overall Study||3
86732|NCT02108288|213169|P3|NOT COMPLETED|Overall Study||0
86733|NCT02108288|213170|P2|NOT COMPLETED|Overall Study||0
86734|NCT02108288|213171|P1|NOT COMPLETED|Overall Study||0
86735|NCT02108288|213169|P3|COMPLETED|Overall Study||10
86736|NCT02108288|213170|P2|COMPLETED|Overall Study||10
86737|NCT02108288|213171|P1|COMPLETED|Overall Study||10
86738|NCT02108288|213169|P3|STARTED|Overall Study||10
86739|NCT02108288|213170|P2|STARTED|Overall Study||10
86740|NCT02108288|213171|P1|STARTED|Overall Study||10
86741|NCT02108223|213187|P3|NOT COMPLETED|Overall Study||0
86742|NCT02108223|213188|P2|NOT COMPLETED|Overall Study||0
86743|NCT02108223|213189|P1|NOT COMPLETED|Overall Study||0
86744|NCT02108223|213187|P3|COMPLETED|Overall Study||35
86745|NCT02108223|213188|P2|COMPLETED|Overall Study||50
86746|NCT02108223|213189|P1|COMPLETED|Overall Study||52
86747|NCT02108223|213187|P3|STARTED|Overall Study||35
86748|NCT02108223|213188|P2|STARTED|Overall Study||50
86749|NCT02108223|213189|P1|STARTED|Overall Study||52
86750|NCT02108171|213211|P2|NOT COMPLETED|Overall Study||0
86751|NCT02108171|213212|P1|NOT COMPLETED|Overall Study||0
86752|NCT02108171|213211|P2|COMPLETED|Overall Study||41
86753|NCT02108171|213212|P1|COMPLETED|Overall Study||40
86754|NCT02108171|213211|P2|STARTED|Overall Study||41
86755|NCT02108171|213212|P1|STARTED|Overall Study||40
86756|NCT02107898|213314|P2|NOT COMPLETED|Overall Study||12
86757|NCT02107898|213315|P1|NOT COMPLETED|Overall Study||6
86758|NCT02107898|213314|P2|COMPLETED|Overall Study||132
86759|NCT02107898|213315|P1|COMPLETED|Overall Study||66
86760|NCT02107898|213314|P2|Treated|Overall Study||143
86761|NCT02107898|213315|P1|Treated|Overall Study||72
86762|NCT02107898|213314|P2|STARTED|Overall Study|Randomized|144
86763|NCT02107898|213315|P1|STARTED|Overall Study|Randomized|72
86764|NCT02107703|213369|P2|NOT COMPLETED|Overall Study||175
86765|NCT02107703|213370|P1|NOT COMPLETED|Overall Study||361
86766|NCT02107703|213369|P2|COMPLETED|Overall Study||48
86767|NCT02107703|213370|P1|COMPLETED|Overall Study||85
86768|NCT02107703|213369|P2|Received at Least 1 Dose of Study Drug|Overall Study||223
86769|NCT02107703|213370|P1|Received at Least 1 Dose of Study Drug|Overall Study||441
86770|NCT02107703|213369|P2|STARTED|Overall Study||223
86771|NCT02107703|213370|P1|STARTED|Overall Study||446
86772|NCT02107599|213395|P1|NOT COMPLETED|Overall Study||0
86773|NCT02107599|213395|P1|COMPLETED|Overall Study||96
86774|NCT02107599|213395|P1|STARTED|Overall Study||96
86775|NCT02107482|213402|P1|NOT COMPLETED|Overall Study||4
86776|NCT02107482|213402|P1|COMPLETED|Overall Study||17
86777|NCT02107482|213402|P1|STARTED|Overall Study|21 participants enrolled. Total of 21 participants recvd both active and sham|21
86778|NCT02107443|213410|P2|NOT COMPLETED|Overall Study||83
86779|NCT02107443|213411|P1|NOT COMPLETED|Overall Study||98
86780|NCT02107443|213410|P2|COMPLETED|Overall Study||167
86781|NCT02107443|213411|P1|COMPLETED|Overall Study||198
86782|NCT02107443|213410|P2|STARTED|Overall Study||250
86783|NCT02107443|213411|P1|STARTED|Overall Study||296
86784|NCT02107339|213421|P2|NOT COMPLETED|Overall Study||4
86785|NCT02107339|213422|P1|NOT COMPLETED|Overall Study||1
86786|NCT02107339|213421|P2|COMPLETED|Overall Study||53
86787|NCT02107339|213422|P1|COMPLETED|Overall Study||62
86788|NCT02107339|213421|P2|STARTED|Overall Study||57
86789|NCT02107339|213422|P1|STARTED|Overall Study||63
86790|NCT02107313|213458|P2|NOT COMPLETED|Overall Study||1
86791|NCT02107313|213459|P1|NOT COMPLETED|Overall Study||0
86792|NCT02107313|213458|P2|COMPLETED|Overall Study||8
86793|NCT02107313|213459|P1|COMPLETED|Overall Study||9
86794|NCT02107313|213458|P2|STARTED|Overall Study|One participant from the study did not cross over and participate in the FED cohort|9
86795|NCT02107313|213459|P1|STARTED|Overall Study||9
86796|NCT02107300|213469|P2|NOT COMPLETED|Overall Study||0
86797|NCT02107300|213470|P1|NOT COMPLETED|Overall Study||0
86798|NCT02107300|213469|P2|COMPLETED|Overall Study||15
86799|NCT02107300|213470|P1|COMPLETED|Overall Study||16
86800|NCT02107300|213469|P2|STARTED|Overall Study||15
86801|NCT02107300|213470|P1|STARTED|Overall Study||16
86802|NCT02107274|213480|P2|NOT COMPLETED|Control Phase||2
86803|NCT02107274|213481|P1|NOT COMPLETED|Control Phase||3
86804|NCT02107274|213480|P2|COMPLETED|Control Phase||35
86805|NCT02107274|213481|P1|COMPLETED|Control Phase||33
86806|NCT02107274|213480|P2|STARTED|Control Phase||37
86807|NCT02107274|213481|P1|STARTED|Control Phase||36
86808|NCT02107274|213480|P2|NOT COMPLETED|Treatment vs. Placebo||2
86809|NCT02107274|213481|P1|NOT COMPLETED|Treatment vs. Placebo||3
86810|NCT02107274|213480|P2|COMPLETED|Treatment vs. Placebo||37
86811|NCT02107274|213481|P1|COMPLETED|Treatment vs. Placebo||36
86812|NCT02107274|213480|P2|STARTED|Treatment vs. Placebo||39
86813|NCT02107274|213481|P1|STARTED|Treatment vs. Placebo||39
86814|NCT02107196|213495|P2|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||5
86815|NCT02107196|213496|P1|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||23
86816|NCT02107196|213495|P2|COMPLETED|4-week Randomized Withdrawal (RW) Period||109
86817|NCT02107196|213496|P1|COMPLETED|4-week Randomized Withdrawal (RW) Period||315
86818|NCT02107196|213495|P2|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|90
86819|NCT02107196|213496|P1|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|272
86820|NCT02107196|213495|P2|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of placebo during RW period|114
86821|NCT02107196|213496|P1|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of ibodutant during RW period|338
86822|NCT02107196|213495|P2|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|114
86823|NCT02107196|213496|P1|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|338
86824|NCT02107196|213495|P2|NOT COMPLETED|12-week Treatment Period||39
86825|NCT02107196|213496|P1|NOT COMPLETED|12-week Treatment Period||44
86826|NCT02107196|213495|P2|COMPLETED|12-week Treatment Period||225
86827|NCT02107196|213496|P1|COMPLETED|12-week Treatment Period||227
86828|NCT02107196|213495|P2|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|216
86829|NCT02107196|213496|P1|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|221
86830|NCT02107196|213495|P2|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|264
86831|NCT02107196|213496|P1|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|271
86832|NCT02107196|213495|P2|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|264
86833|NCT02107196|213496|P1|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|271
86834|NCT02107131|213511|P2|NOT COMPLETED|Overall Study||9
86835|NCT02107131|213512|P1|NOT COMPLETED|Overall Study||8
86836|NCT02107131|213511|P2|COMPLETED|Overall Study||11
86837|NCT02107131|213512|P1|COMPLETED|Overall Study||12
86838|NCT02107131|213511|P2|STARTED|Overall Study||20
86839|NCT02107131|213512|P1|STARTED|Overall Study||20
86840|NCT02107092|213524|P1|NOT COMPLETED|Overall Study||44
86841|NCT02107092|213524|P1|COMPLETED|Overall Study||79
86842|NCT02107092|213524|P1|STARTED|Overall Study||123
86843|NCT02107014|213529|P1|NOT COMPLETED|Overall Study||1
86844|NCT02107014|213529|P1|COMPLETED|Overall Study||8
86845|NCT02107014|213529|P1|STARTED|Overall Study||9
86846|NCT02106975|213599|P2|NOT COMPLETED|Overall Study||39
86847|NCT02106975|213600|P1|NOT COMPLETED|Overall Study||25
86848|NCT02106975|213599|P2|COMPLETED|Overall Study||44
86849|NCT02106975|213600|P1|COMPLETED|Overall Study||59
86850|NCT02106975|213599|P2|STARTED|Overall Study||83
86851|NCT02106975|213600|P1|STARTED|Overall Study||84
86852|NCT02106962|213648|P2|NOT COMPLETED|Overall Study||0
86853|NCT02106962|213649|P1|NOT COMPLETED|Overall Study||0
86854|NCT02106962|213648|P2|COMPLETED|Overall Study||9
86855|NCT02106962|213649|P1|COMPLETED|Overall Study||8
86856|NCT02106962|213648|P2|STARTED|Overall Study||9
86857|NCT02106962|213649|P1|STARTED|Overall Study||8
86858|NCT02106923|213660|P6|NOT COMPLETED|Overall Study||1
86859|NCT02106923|213661|P5|NOT COMPLETED|Overall Study||0
86860|NCT02106923|213662|P4|NOT COMPLETED|Overall Study||0
86861|NCT02106923|213663|P3|NOT COMPLETED|Overall Study||0
86862|NCT02106923|213664|P2|NOT COMPLETED|Overall Study||0
86863|NCT02106923|213665|P1|NOT COMPLETED|Overall Study||0
86864|NCT02106923|213660|P6|COMPLETED|Overall Study||11
86865|NCT02106923|213661|P5|COMPLETED|Overall Study||12
86866|NCT02106923|213662|P4|COMPLETED|Overall Study||12
86867|NCT02106923|213663|P3|COMPLETED|Overall Study||12
86868|NCT02106923|213664|P2|COMPLETED|Overall Study||12
86869|NCT02106923|213665|P1|COMPLETED|Overall Study||12
86870|NCT02106923|213660|P6|STARTED|Overall Study||12
86871|NCT02106923|213661|P5|STARTED|Overall Study||12
86872|NCT02106923|213662|P4|STARTED|Overall Study||12
86873|NCT02106923|213663|P3|STARTED|Overall Study||12
86874|NCT02106923|213664|P2|STARTED|Overall Study||12
86875|NCT02106923|213665|P1|STARTED|Overall Study||12
86876|NCT02106884|213711|P2|NOT COMPLETED|Overall Study||1
86877|NCT02106884|213712|P1|NOT COMPLETED|Overall Study||0
86878|NCT02106884|213711|P2|COMPLETED|Overall Study|ITT analysis based on treatment assigned at baseline.|73
86879|NCT02106884|213712|P1|COMPLETED|Overall Study||72
86880|NCT02106884|213711|P2|STARTED|Overall Study||74
86881|NCT02106884|213712|P1|STARTED|Overall Study||72
86882|NCT02106832|213736|P4|NOT COMPLETED|Overall Study||15
86883|NCT02106832|213737|P3|NOT COMPLETED|Overall Study||16
86884|NCT02106832|213738|P2|NOT COMPLETED|Overall Study||25
86885|NCT02106832|213739|P1|NOT COMPLETED|Overall Study||23
86886|NCT02106832|213736|P4|COMPLETED|Overall Study||73
86887|NCT02106832|213737|P3|COMPLETED|Overall Study||70
86888|NCT02106832|213738|P2|COMPLETED|Overall Study||151
86889|NCT02106832|213739|P1|COMPLETED|Overall Study||148
86890|NCT02106832|213736|P4|Participants Received Treatment|Overall Study||88
86891|NCT02106832|213737|P3|Participants Received Treatment|Overall Study||86
86892|NCT02106832|213738|P2|Participants Received Treatment|Overall Study||174
86893|NCT02106832|213739|P1|Participants Received Treatment|Overall Study||171
86894|NCT02106832|213736|P4|STARTED|Overall Study||88
86895|NCT02106832|213737|P3|STARTED|Overall Study||86
86896|NCT02106832|213738|P2|STARTED|Overall Study||176
86897|NCT02106832|213739|P1|STARTED|Overall Study||171
86898|NCT02106728|213774|P2|NOT COMPLETED|Overall Study||0
86899|NCT02106728|213775|P1|NOT COMPLETED|Overall Study||0
86900|NCT02106728|213774|P2|COMPLETED|Overall Study||47
86901|NCT02106728|213775|P1|COMPLETED|Overall Study||70
86902|NCT02106728|213774|P2|STARTED|Overall Study||47
86903|NCT02106728|213775|P1|STARTED|Overall Study||70
86904|NCT02106494|213791|P2|NOT COMPLETED|Overall Study||25
86905|NCT02106494|213792|P1|NOT COMPLETED|Overall Study||26
86906|NCT02106494|213791|P2|COMPLETED|Overall Study||446
86907|NCT02106494|213792|P1|COMPLETED|Overall Study||445
86908|NCT02106494|213791|P2|Efficacy Population|Overall Study||452
86909|NCT02106494|213792|P1|Efficacy Population|Overall Study||450
86910|NCT02106494|213791|P2|Safety Population|Overall Study||459
86911|NCT02106494|213792|P1|Safety Population|Overall Study||456
86912|NCT02106494|213791|P2|STARTED|Overall Study||471
86913|NCT02106494|213792|P1|STARTED|Overall Study||471
86914|NCT02106455|213806|P1|NOT COMPLETED|Overall Study||8
86915|NCT02106455|213806|P1|COMPLETED|Overall Study||307
86916|NCT02106455|213806|P1|STARTED|Overall Study||315
86917|NCT02106442|213820|P1|NOT COMPLETED|Overall Study||37
86918|NCT02106442|213820|P1|COMPLETED|Overall Study||542
86919|NCT02106442|213820|P1|STARTED|Overall Study||579
86920|NCT02106403|213838|P6|NOT COMPLETED|Follow-Up Visit 3||1
86921|NCT02106403|213839|P5|NOT COMPLETED|Follow-Up Visit 3||0
86922|NCT02106403|213840|P4|NOT COMPLETED|Follow-Up Visit 3||0
86923|NCT02106403|213841|P3|NOT COMPLETED|Follow-Up Visit 3||0
86924|NCT02106403|213842|P2|NOT COMPLETED|Follow-Up Visit 3||0
86925|NCT02106403|213843|P1|NOT COMPLETED|Follow-Up Visit 3||0
86926|NCT02106403|213838|P6|COMPLETED|Follow-Up Visit 3||8
86927|NCT02106403|213839|P5|COMPLETED|Follow-Up Visit 3||8
86928|NCT02106403|213840|P4|COMPLETED|Follow-Up Visit 3||8
86929|NCT02106403|213841|P3|COMPLETED|Follow-Up Visit 3||9
86930|NCT02106403|213842|P2|COMPLETED|Follow-Up Visit 3||8
86931|NCT02106403|213843|P1|COMPLETED|Follow-Up Visit 3||8
86932|NCT02106403|213838|P6|STARTED|Follow-Up Visit 3||9
86933|NCT02106403|213839|P5|STARTED|Follow-Up Visit 3||8
86934|NCT02106403|213840|P4|STARTED|Follow-Up Visit 3||8
86935|NCT02106403|213841|P3|STARTED|Follow-Up Visit 3||9
86936|NCT02106403|213842|P2|STARTED|Follow-Up Visit 3||8
86937|NCT02106403|213843|P1|STARTED|Follow-Up Visit 3||8
86938|NCT02106403|213838|P6|NOT COMPLETED|Follow-Up Visit 2||0
86939|NCT02106403|213839|P5|NOT COMPLETED|Follow-Up Visit 2||0
86940|NCT02106403|213840|P4|NOT COMPLETED|Follow-Up Visit 2||0
86941|NCT02106403|213841|P3|NOT COMPLETED|Follow-Up Visit 2||0
86942|NCT02106403|213842|P2|NOT COMPLETED|Follow-Up Visit 2||0
86943|NCT02106403|213843|P1|NOT COMPLETED|Follow-Up Visit 2||0
86944|NCT02106403|213838|P6|COMPLETED|Follow-Up Visit 2||9
86945|NCT02106403|213839|P5|COMPLETED|Follow-Up Visit 2||8
86946|NCT02106403|213840|P4|COMPLETED|Follow-Up Visit 2||8
86947|NCT02106403|213841|P3|COMPLETED|Follow-Up Visit 2||9
86948|NCT02106403|213842|P2|COMPLETED|Follow-Up Visit 2||8
86949|NCT02106403|213843|P1|COMPLETED|Follow-Up Visit 2||8
86950|NCT02106403|213838|P6|STARTED|Follow-Up Visit 2||9
86951|NCT02106403|213839|P5|STARTED|Follow-Up Visit 2||8
86952|NCT02106403|213840|P4|STARTED|Follow-Up Visit 2||8
86953|NCT02106403|213841|P3|STARTED|Follow-Up Visit 2||9
86954|NCT02106403|213842|P2|STARTED|Follow-Up Visit 2||8
86955|NCT02106403|213843|P1|STARTED|Follow-Up Visit 2||8
86956|NCT02106403|213838|P6|NOT COMPLETED|Visit 1, Treatment Period 3||0
86957|NCT02106403|213839|P5|NOT COMPLETED|Visit 1, Treatment Period 3||0
86958|NCT02106403|213840|P4|NOT COMPLETED|Visit 1, Treatment Period 3||0
86959|NCT02106403|213841|P3|NOT COMPLETED|Visit 1, Treatment Period 3||0
86960|NCT02106403|213842|P2|NOT COMPLETED|Visit 1, Treatment Period 3||0
86961|NCT02106403|213843|P1|NOT COMPLETED|Visit 1, Treatment Period 3||0
86962|NCT02106403|213838|P6|COMPLETED|Visit 1, Treatment Period 3||9
86963|NCT02106403|213839|P5|COMPLETED|Visit 1, Treatment Period 3||8
86964|NCT02106403|213840|P4|COMPLETED|Visit 1, Treatment Period 3||8
86965|NCT02106403|213841|P3|COMPLETED|Visit 1, Treatment Period 3||9
86966|NCT02106403|213842|P2|COMPLETED|Visit 1, Treatment Period 3||8
86967|NCT02106403|213843|P1|COMPLETED|Visit 1, Treatment Period 3||8
86968|NCT02106403|213838|P6|STARTED|Visit 1, Treatment Period 3||9
86969|NCT02106403|213839|P5|STARTED|Visit 1, Treatment Period 3||8
86970|NCT02106403|213840|P4|STARTED|Visit 1, Treatment Period 3||8
86971|NCT02106403|213841|P3|STARTED|Visit 1, Treatment Period 3||9
86972|NCT02106403|213842|P2|STARTED|Visit 1, Treatment Period 3||8
86973|NCT02106403|213843|P1|STARTED|Visit 1, Treatment Period 3||8
86974|NCT02106403|213838|P6|NOT COMPLETED|Visit 1, Treatment Period 2||0
86975|NCT02106403|213839|P5|NOT COMPLETED|Visit 1, Treatment Period 2||0
86976|NCT02106403|213840|P4|NOT COMPLETED|Visit 1, Treatment Period 2||0
86977|NCT02106403|213841|P3|NOT COMPLETED|Visit 1, Treatment Period 2||0
86978|NCT02106403|213842|P2|NOT COMPLETED|Visit 1, Treatment Period 2||0
86979|NCT02106403|213843|P1|NOT COMPLETED|Visit 1, Treatment Period 2||0
86980|NCT02106403|213838|P6|COMPLETED|Visit 1, Treatment Period 2||9
86981|NCT02106403|213839|P5|COMPLETED|Visit 1, Treatment Period 2||8
86982|NCT02106403|213840|P4|COMPLETED|Visit 1, Treatment Period 2||8
86983|NCT02106403|213841|P3|COMPLETED|Visit 1, Treatment Period 2||9
86984|NCT02106403|213842|P2|COMPLETED|Visit 1, Treatment Period 2||8
86985|NCT02106403|213843|P1|COMPLETED|Visit 1, Treatment Period 2||8
86986|NCT02106403|213838|P6|STARTED|Visit 1, Treatment Period 2||9
86987|NCT02106403|213839|P5|STARTED|Visit 1, Treatment Period 2||8
86988|NCT02106403|213840|P4|STARTED|Visit 1, Treatment Period 2||8
86989|NCT02106403|213841|P3|STARTED|Visit 1, Treatment Period 2||9
86990|NCT02106403|213842|P2|STARTED|Visit 1, Treatment Period 2||8
86991|NCT02106403|213843|P1|STARTED|Visit 1, Treatment Period 2||8
86992|NCT02106403|213838|P6|NOT COMPLETED|Visit 1, Treatment Period 1||0
86993|NCT02106403|213839|P5|NOT COMPLETED|Visit 1, Treatment Period 1||0
86994|NCT02106403|213840|P4|NOT COMPLETED|Visit 1, Treatment Period 1||0
86995|NCT02106403|213841|P3|NOT COMPLETED|Visit 1, Treatment Period 1||0
86996|NCT02106403|213842|P2|NOT COMPLETED|Visit 1, Treatment Period 1||0
86997|NCT02106403|213843|P1|NOT COMPLETED|Visit 1, Treatment Period 1||0
86998|NCT02106403|213838|P6|COMPLETED|Visit 1, Treatment Period 1||9
86999|NCT02106403|213839|P5|COMPLETED|Visit 1, Treatment Period 1||8
87000|NCT02106403|213840|P4|COMPLETED|Visit 1, Treatment Period 1||8
87001|NCT02106403|213841|P3|COMPLETED|Visit 1, Treatment Period 1||9
87002|NCT02106403|213842|P2|COMPLETED|Visit 1, Treatment Period 1||8
87003|NCT02106403|213843|P1|COMPLETED|Visit 1, Treatment Period 1||8
87004|NCT02106403|213838|P6|STARTED|Visit 1, Treatment Period 1||9
87005|NCT02106403|213839|P5|STARTED|Visit 1, Treatment Period 1||8
87006|NCT02106403|213840|P4|STARTED|Visit 1, Treatment Period 1||8
87007|NCT02106403|213841|P3|STARTED|Visit 1, Treatment Period 1||9
87008|NCT02106403|213842|P2|STARTED|Visit 1, Treatment Period 1||8
87009|NCT02106403|213843|P1|STARTED|Visit 1, Treatment Period 1||8
87010|NCT02106390|213866|P3|NOT COMPLETED|Overall Study||43
87011|NCT02106390|213867|P2|NOT COMPLETED|Overall Study||48
87012|NCT02106390|213868|P1|NOT COMPLETED|Overall Study||49
87013|NCT02106390|213866|P3|COMPLETED|Overall Study||205
87014|NCT02106390|213867|P2|COMPLETED|Overall Study||202
87015|NCT02106390|213868|P1|COMPLETED|Overall Study||203
87016|NCT02106390|213866|P3|STARTED|Overall Study||248
87017|NCT02106390|213867|P2|STARTED|Overall Study||250
87018|NCT02106390|213868|P1|STARTED|Overall Study||252
87019|NCT02106325|213944|P2|NOT COMPLETED|Phase 3||1
87020|NCT02106325|213945|P1|NOT COMPLETED|Phase 3||2
87021|NCT02106325|213944|P2|COMPLETED|Phase 3||2
87022|NCT02106325|213945|P1|COMPLETED|Phase 3||0
87023|NCT02106325|213944|P2|STARTED|Phase 3||3
87024|NCT02106325|213945|P1|STARTED|Phase 3||2
87025|NCT02106325|213944|P2|NOT COMPLETED|Phase 2||3
87026|NCT02106325|213945|P1|NOT COMPLETED|Phase 2||2
87027|NCT02106325|213944|P2|COMPLETED|Phase 2||1
87028|NCT02106325|213945|P1|COMPLETED|Phase 2||2
87029|NCT02106325|213944|P2|STARTED|Phase 2||4
87030|NCT02106325|213945|P1|STARTED|Phase 2||4
87031|NCT02106325|213944|P2|NOT COMPLETED|Phase 1||2
87032|NCT02106325|213945|P1|NOT COMPLETED|Phase 1||2
87033|NCT02106325|213944|P2|COMPLETED|Phase 1||1
87034|NCT02106325|213945|P1|COMPLETED|Phase 1||3
87035|NCT02106325|213944|P2|STARTED|Phase 1||3
87036|NCT02106325|213945|P1|STARTED|Phase 1||5
87037|NCT02106156|213970|P3|NOT COMPLETED|Overall Study||0
87038|NCT02106156|213971|P2|NOT COMPLETED|Overall Study||40
87039|NCT02106156|213972|P1|NOT COMPLETED|Overall Study||2549
87040|NCT02106156|213970|P3|COMPLETED|Overall Study||518
87041|NCT02106156|213971|P2|COMPLETED|Overall Study||50
87042|NCT02106156|213972|P1|COMPLETED|Overall Study||7071
87043|NCT02106156|213970|P3|STARTED|Overall Study||518
87044|NCT02106156|213971|P2|STARTED|Overall Study||90
87045|NCT02106156|213972|P1|STARTED|Overall Study||9620
87046|NCT02105987|213996|P6|NOT COMPLETED|Continuation Phase||0
87047|NCT02105987|213997|P5|NOT COMPLETED|Continuation Phase||1
87048|NCT02105987|213998|P4|NOT COMPLETED|Continuation Phase||0
87049|NCT02105987|213999|P3|NOT COMPLETED|Continuation Phase||0
87050|NCT02105987|214000|P2|NOT COMPLETED|Continuation Phase||0
87051|NCT02105987|214001|P1|NOT COMPLETED|Continuation Phase||0
87052|NCT02105987|213996|P6|COMPLETED|Continuation Phase||23
87053|NCT02105987|213997|P5|COMPLETED|Continuation Phase||13
87054|NCT02105987|213998|P4|COMPLETED|Continuation Phase||0
87055|NCT02105987|213999|P3|COMPLETED|Continuation Phase||0
87056|NCT02105987|214000|P2|COMPLETED|Continuation Phase||0
87057|NCT02105987|214001|P1|COMPLETED|Continuation Phase||0
87058|NCT02105987|213996|P6|STARTED|Continuation Phase||23
87059|NCT02105987|213997|P5|STARTED|Continuation Phase||14
87060|NCT02105987|213998|P4|STARTED|Continuation Phase||0
87061|NCT02105987|213999|P3|STARTED|Continuation Phase||0
87062|NCT02105987|214000|P2|STARTED|Continuation Phase||0
87063|NCT02105987|214001|P1|STARTED|Continuation Phase||0
87064|NCT02105987|213996|P6|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
87065|NCT02105987|213997|P5|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
87066|NCT02105987|213998|P4|NOT COMPLETED|Late Switch Phase (24 Weeks)||14
87067|NCT02105987|213999|P3|NOT COMPLETED|Late Switch Phase (24 Weeks)||45
87068|NCT02105987|214000|P2|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
87069|NCT02105987|214001|P1|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
87070|NCT02105987|213996|P6|COMPLETED|Late Switch Phase (24 Weeks)||0
87071|NCT02105987|213997|P5|COMPLETED|Late Switch Phase (24 Weeks)||0
87072|NCT02105987|213998|P4|COMPLETED|Late Switch Phase (24 Weeks)||230
87073|NCT02105987|213999|P3|COMPLETED|Late Switch Phase (24 Weeks)||230
87074|NCT02105987|214000|P2|COMPLETED|Late Switch Phase (24 Weeks)||0
87075|NCT02105987|214001|P1|COMPLETED|Late Switch Phase (24 Weeks)||0
87076|NCT02105987|213996|P6|STARTED|Late Switch Phase (24 Weeks)||0
87077|NCT02105987|213997|P5|STARTED|Late Switch Phase (24 Weeks)||0
87078|NCT02105987|213998|P4|STARTED|Late Switch Phase (24 Weeks)||244
87079|NCT02105987|213999|P3|STARTED|Late Switch Phase (24 Weeks)||275
87080|NCT02105987|214000|P2|STARTED|Late Switch Phase (24 Weeks)||0
87081|NCT02105987|214001|P1|STARTED|Late Switch Phase (24 Weeks)||0
87082|NCT02105987|213996|P6|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
87083|NCT02105987|213997|P5|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
87084|NCT02105987|213998|P4|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
87085|NCT02105987|213999|P3|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
87086|NCT02105987|214000|P2|NOT COMPLETED|Early Switch Phase (24 Weeks)||34
87087|NCT02105987|214001|P1|NOT COMPLETED|Early Switch Phase (24 Weeks)||36
87088|NCT02105987|213996|P6|COMPLETED|Early Switch Phase (24 Weeks)||0
87089|NCT02105987|213997|P5|COMPLETED|Early Switch Phase (24 Weeks)||0
87090|NCT02105987|213998|P4|COMPLETED|Early Switch Phase (24 Weeks)||0
87091|NCT02105987|213999|P3|COMPLETED|Early Switch Phase (24 Weeks)||0
87092|NCT02105987|214000|P2|COMPLETED|Early Switch Phase (24 Weeks)||244
87093|NCT02105987|214001|P1|COMPLETED|Early Switch Phase (24 Weeks)||239
87094|NCT02105987|213996|P6|STARTED|Early Switch Phase (24 Weeks)||0
87095|NCT02105987|213997|P5|STARTED|Early Switch Phase (24 Weeks)||0
87096|NCT02105987|213998|P4|STARTED|Early Switch Phase (24 Weeks)||0
87097|NCT02105987|213999|P3|STARTED|Early Switch Phase (24 Weeks)||0
87098|NCT02105987|214000|P2|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|278
87099|NCT02105987|214001|P1|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|275
87100|NCT02105974|214055|P3|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||58
87101|NCT02105974|214056|P2|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||42
87102|NCT02105974|214057|P1|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||0
87103|NCT02105974|214055|P3|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|756
87104|NCT02105974|214056|P2|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|764
87105|NCT02105974|214057|P1|COMPLETED|12 Week (Wk) Treatment Period (TP)||0
87106|NCT02105974|214055|P3|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|754
87107|NCT02105974|214056|P2|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|764
87108|NCT02105974|214057|P1|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)||0
87109|NCT02105974|214055|P3|STARTED|12 Week (Wk) Treatment Period (TP)||814
87110|NCT02105974|214056|P2|STARTED|12 Week (Wk) Treatment Period (TP)||806
87111|NCT02105974|214057|P1|STARTED|12 Week (Wk) Treatment Period (TP)||0
87112|NCT02105974|214055|P3|NOT COMPLETED|2 Week Run-in Period||0
87113|NCT02105974|214056|P2|NOT COMPLETED|2 Week Run-in Period||0
87114|NCT02105974|214057|P1|NOT COMPLETED|2 Week Run-in Period||801
87115|NCT02105974|214055|P3|COMPLETED|2 Week Run-in Period||0
87116|NCT02105974|214056|P2|COMPLETED|2 Week Run-in Period||0
87117|NCT02105974|214057|P1|COMPLETED|2 Week Run-in Period||1622
87118|NCT02105974|214055|P3|STARTED|2 Week Run-in Period||0
87119|NCT02105974|214056|P2|STARTED|2 Week Run-in Period||0
87120|NCT02105974|214057|P1|STARTED|2 Week Run-in Period||2423
87121|NCT02105961|214070|P3|NOT COMPLETED|Overall Study||30
87122|NCT02105961|214071|P2|NOT COMPLETED|Overall Study||17
87123|NCT02105961|214072|P1|NOT COMPLETED|Overall Study||41
87124|NCT02105961|214070|P3|COMPLETED|Overall Study||195
87125|NCT02105961|214071|P2|COMPLETED|Overall Study||206
87126|NCT02105961|214072|P1|COMPLETED|Overall Study||185
87127|NCT02105961|214070|P3|Withdrew IP Due to: Site Closed|Overall Study||1
87128|NCT02105961|214071|P2|Withdrew IP Due to: Site Closed|Overall Study||0
87129|NCT02105961|214072|P1|Withdrew IP Due to: Site Closed|Overall Study||1
87130|NCT02105961|214070|P3|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
87131|NCT02105961|214071|P2|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
87132|NCT02105961|214072|P1|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
87133|NCT02105961|214070|P3|Withdrew IP Due to: Physician Decision|Overall Study||1
87134|NCT02105961|214071|P2|Withdrew IP Due to: Physician Decision|Overall Study||3
87135|NCT02105961|214072|P1|Withdrew IP Due to: Physician Decision|Overall Study||2
87136|NCT02105961|214070|P3|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
87137|NCT02105961|214071|P2|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
87138|NCT02105961|214072|P1|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
87139|NCT02105961|214070|P3|Withdrew IP Due to: Protocol Deviation|Overall Study||1
87140|NCT02105961|214071|P2|Withdrew IP Due to: Protocol Deviation|Overall Study||0
87141|NCT02105961|214072|P1|Withdrew IP Due to: Protocol Deviation|Overall Study||2
87142|NCT02105961|214070|P3|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
87143|NCT02105961|214071|P2|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
87144|NCT02105961|214072|P1|Withdrew IP Due to: Lack of Efficacy|Overall Study||6
87145|NCT02105961|214070|P3|Withdrew IP Due to: Stopping Criteria|Overall Study||0
87146|NCT02105961|214071|P2|Withdrew IP Due to: Stopping Criteria|Overall Study||1
87147|NCT02105961|214072|P1|Withdrew IP Due to: Stopping Criteria|Overall Study||1
87148|NCT02105961|214070|P3|Withdrew IP Due to: Adverse Event|Overall Study||25
87149|NCT02105961|214071|P2|Withdrew IP Due to: Adverse Event|Overall Study||9
87150|NCT02105961|214072|P1|Withdrew IP Due to: Adverse Event|Overall Study||27
87151|NCT02105961|214070|P3|Not Completed IP|Overall Study||42
87152|NCT02105961|214071|P2|Not Completed IP|Overall Study||27
87153|NCT02105961|214072|P1|Not Completed IP|Overall Study||56
87154|NCT02105961|214070|P3|Completed Investigational Product (IP)|Overall Study||183
87155|NCT02105961|214071|P2|Completed Investigational Product (IP)|Overall Study||196
87156|NCT02105961|214072|P1|Completed Investigational Product (IP)|Overall Study||170
87157|NCT02105961|214070|P3|STARTED|Overall Study||225
87158|NCT02105961|214071|P2|STARTED|Overall Study||223
87159|NCT02105961|214072|P1|STARTED|Overall Study||226
87160|NCT02105948|214096|P4|NOT COMPLETED|Overall Study||27
87161|NCT02105948|214097|P3|NOT COMPLETED|Overall Study||28
87162|NCT02105948|214098|P2|NOT COMPLETED|Overall Study||20
87163|NCT02105948|214099|P1|NOT COMPLETED|Overall Study||27
87164|NCT02105948|214096|P4|COMPLETED|Overall Study||157
87165|NCT02105948|214097|P3|COMPLETED|Overall Study||162
87166|NCT02105948|214098|P2|COMPLETED|Overall Study||213
87167|NCT02105948|214099|P1|COMPLETED|Overall Study||202
87168|NCT02105948|214096|P4|Withdrew IP Due to: Stopping Criteria|Overall Study||1
87169|NCT02105948|214097|P3|Withdrew IP Due to: Stopping Criteria|Overall Study||0
87170|NCT02105948|214098|P2|Withdrew IP Due to: Stopping Criteria|Overall Study||0
87171|NCT02105948|214099|P1|Withdrew IP Due to: Stopping Criteria|Overall Study||0
87172|NCT02105948|214096|P4|Withdrew IP Due to: Physician Decision|Overall Study||2
87173|NCT02105948|214097|P3|Withdrew IP Due to: Physician Decision|Overall Study||4
87174|NCT02105948|214098|P2|Withdrew IP Due to: Physician Decision|Overall Study||1
87175|NCT02105948|214099|P1|Withdrew IP Due to: Physician Decision|Overall Study||2
87176|NCT02105948|214096|P4|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||15
87177|NCT02105948|214097|P3|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
87178|NCT02105948|214098|P2|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||8
87179|NCT02105948|214099|P1|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
87180|NCT02105948|214096|P4|Withdrew IP Due to: Lost to Follow-up|Overall Study||2
87181|NCT02105948|214097|P3|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
87182|NCT02105948|214098|P2|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
87183|NCT02105948|214099|P1|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
87184|NCT02105948|214096|P4|Withdrew IP Due to: Protocol Deviation|Overall Study||0
87185|NCT02105948|214097|P3|Withdrew IP Due to: Protocol Deviation|Overall Study||3
87186|NCT02105948|214098|P2|Withdrew IP Due to: Protocol Deviation|Overall Study||3
87187|NCT02105948|214099|P1|Withdrew IP Due to: Protocol Deviation|Overall Study||1
87188|NCT02105948|214096|P4|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
87189|NCT02105948|214097|P3|Withdrew IP Due to: Lack of Efficacy|Overall Study||8
87190|NCT02105948|214098|P2|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
87191|NCT02105948|214099|P1|Withdrew IP Due to: Lack of Efficacy|Overall Study||5
87192|NCT02105948|214096|P4|Withdrew IP Due to: Adverse Event|Overall Study||13
87193|NCT02105948|214097|P3|Withdrew IP Due to: Adverse Event|Overall Study||15
87194|NCT02105948|214098|P2|Withdrew IP Due to: Adverse Event|Overall Study||16
87195|NCT02105948|214099|P1|Withdrew IP Due to: Adverse Event|Overall Study||20
87196|NCT02105948|214096|P4|Not Completed IP|Overall Study||35
87197|NCT02105948|214097|P3|Not Completed IP|Overall Study||42
87198|NCT02105948|214098|P2|Not Completed IP|Overall Study||30
87199|NCT02105948|214099|P1|Not Completed IP|Overall Study||44
87200|NCT02105948|214096|P4|Completed Investigational Product (IP)|Overall Study||149
87201|NCT02105948|214097|P3|Completed Investigational Product (IP)|Overall Study||148
87202|NCT02105948|214098|P2|Completed Investigational Product (IP)|Overall Study||203
87203|NCT02105948|214099|P1|Completed Investigational Product (IP)|Overall Study||185
87204|NCT02105948|214096|P4|STARTED|Overall Study||184
87205|NCT02105948|214097|P3|STARTED|Overall Study||190
87206|NCT02105948|214098|P2|STARTED|Overall Study||233
87207|NCT02105948|214099|P1|STARTED|Overall Study||229
87208|NCT02105740|214127|P2|NOT COMPLETED|Overall Study||1
87209|NCT02105740|214128|P1|NOT COMPLETED|Overall Study||0
87210|NCT02105740|214127|P2|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|11
87211|NCT02105740|214128|P1|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|12
87212|NCT02105740|214127|P2|Second|Overall Study|Application of EVA and HADS scales. One accompanying lost|11
87213|NCT02105740|214128|P1|Second|Overall Study|Intervention with hypnosis and application of EVA scales and HADS (n = 12)|12
87214|NCT02105740|214127|P2|STARTED|Overall Study|Application of EVA and HADS scales|12
87215|NCT02105740|214128|P1|STARTED|Overall Study|Application of EVA and HADS scales and after that application of hypnosis intervention|12
87216|NCT02105701|214140|P4|NOT COMPLETED|Overall Study||2
87217|NCT02105701|214141|P3|NOT COMPLETED|Overall Study||3
87218|NCT02105701|214142|P2|NOT COMPLETED|Overall Study||1
87219|NCT02105701|214143|P1|NOT COMPLETED|Overall Study||4
87220|NCT02105701|214140|P4|COMPLETED|Overall Study||104
87221|NCT02105701|214141|P3|COMPLETED|Overall Study||102
87222|NCT02105701|214142|P2|COMPLETED|Overall Study||103
87223|NCT02105701|214143|P1|COMPLETED|Overall Study||101
87224|NCT02105701|214140|P4|STARTED|Overall Study||106
87225|NCT02105701|214141|P3|STARTED|Overall Study||105
87226|NCT02105701|214142|P2|STARTED|Overall Study||104
87227|NCT02105701|214143|P1|STARTED|Overall Study||105
87228|NCT02105688|214167|P2|NOT COMPLETED|Overall Study||99
87229|NCT02105688|214168|P1|NOT COMPLETED|Overall Study||26
87230|NCT02105688|214167|P2|COMPLETED|Overall Study|Completed means participant completed Follow-Up Week 24 visit|1
87231|NCT02105688|214168|P1|COMPLETED|Overall Study|Completed means participant completed Follow-Up Week 24 visit|175
87232|NCT02105688|214167|P2|Not Reached FU Week 12 Visit|Overall Study||15
87233|NCT02105688|214168|P1|Not Reached FU Week 12 Visit|Overall Study||2
87234|NCT02105688|214167|P2|Completed FU Week 12 Visit, Still in FU|Overall Study||75
87235|NCT02105688|214168|P1|Completed FU Week 12 Visit, Still in FU|Overall Study||10
87236|NCT02105688|214167|P2|STARTED|Overall Study||100
87237|NCT02105688|214168|P1|STARTED|Overall Study||201
87238|NCT02105662|214178|P1|NOT COMPLETED|Overall Study||6
87239|NCT02105662|214178|P1|COMPLETED|Overall Study||212
87240|NCT02105662|214178|P1|STARTED|Overall Study||218
87241|NCT02105636|214187|P2|NOT COMPLETED|Overall Study||108
87242|NCT02105636|214188|P1|NOT COMPLETED|Overall Study||195
87243|NCT02105636|214187|P2|COMPLETED|Overall Study|Completed=Still on Treatment|3
87244|NCT02105636|214188|P1|COMPLETED|Overall Study|Completed=Still on Treatment|41
87245|NCT02105636|214187|P2|STARTED|Overall Study||111
87246|NCT02105636|214188|P1|STARTED|Overall Study||236
87247|NCT02105558|214200|P2|NOT COMPLETED|Overall Study||0
87248|NCT02105558|214201|P1|NOT COMPLETED|Overall Study||0
87249|NCT02105558|214200|P2|COMPLETED|Overall Study||28
87250|NCT02105558|214201|P1|COMPLETED|Overall Study||15
87251|NCT02105558|214200|P2|STARTED|Overall Study||28
87252|NCT02105558|214201|P1|STARTED|Overall Study||15
87253|NCT02105467|214231|P2|NOT COMPLETED|Period 3||1
87254|NCT02105467|214232|P1|NOT COMPLETED|Period 3||0
87255|NCT02105467|214231|P2|COMPLETED|Period 3||102
87256|NCT02105467|214232|P1|COMPLETED|Period 3||0
87257|NCT02105467|214231|P2|STARTED|Period 3|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|103
87258|NCT02105467|214232|P1|STARTED|Period 3|The Immediate Treatment Group completed the study with Period 2|0
87259|NCT02105467|214231|P2|NOT COMPLETED|Period 2||2
87260|NCT02105467|214232|P1|NOT COMPLETED|Period 2||2
87261|NCT02105467|214231|P2|COMPLETED|Period 2||102
87262|NCT02105467|214232|P1|COMPLETED|Period 2||312
87263|NCT02105467|214231|P2|STARTED|Period 2|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|104
87264|NCT02105467|214232|P1|STARTED|Period 2||314
87265|NCT02105467|214231|P2|NOT COMPLETED|Period 1||0
87266|NCT02105467|214232|P1|NOT COMPLETED|Period 1||2
87267|NCT02105467|214231|P2|COMPLETED|Period 1||105
87268|NCT02105467|214232|P1|COMPLETED|Period 1||314
87269|NCT02105467|214231|P2|STARTED|Period 1||105
87270|NCT02105467|214232|P1|STARTED|Period 1||316
87271|NCT02105454|214244|P1|NOT COMPLETED|Overall Study||1
87272|NCT02105454|214244|P1|COMPLETED|Overall Study||78
87273|NCT02105454|214244|P1|STARTED|Overall Study||79
87274|NCT02105415|214253|P2|NOT COMPLETED|Overall Study||5
87275|NCT02105415|214254|P1|NOT COMPLETED|Overall Study||3
87276|NCT02105415|214253|P2|COMPLETED|Overall Study||79
87277|NCT02105415|214254|P1|COMPLETED|Overall Study||73
87278|NCT02105415|214253|P2|STARTED|Overall Study||84
87279|NCT02105415|214254|P1|STARTED|Overall Study||76
87280|NCT02105324|214276|P2|NOT COMPLETED|Period 2||0
87281|NCT02105324|214277|P1|NOT COMPLETED|Period 2||0
87282|NCT02105324|214276|P2|COMPLETED|Period 2||10
87283|NCT02105324|214277|P1|COMPLETED|Period 2||9
87284|NCT02105324|214276|P2|STARTED|Period 2||10
87285|NCT02105324|214277|P1|STARTED|Period 2||9
87286|NCT02105324|214276|P2|NOT COMPLETED|Period 1||0
87287|NCT02105324|214277|P1|NOT COMPLETED|Period 1||0
87288|NCT02105324|214276|P2|COMPLETED|Period 1||10
87289|NCT02105324|214277|P1|COMPLETED|Period 1||9
87290|NCT02105324|214276|P2|STARTED|Period 1||10
87291|NCT02105324|214277|P1|STARTED|Period 1||9
87292|NCT02105285|214356|P3|NOT COMPLETED|Overall Study||0
87293|NCT02105285|214357|P2|NOT COMPLETED|Overall Study||2
87294|NCT02105285|214358|P1|NOT COMPLETED|Overall Study||2
87295|NCT02105285|214356|P3|COMPLETED|Overall Study||37
87296|NCT02105285|214357|P2|COMPLETED|Overall Study||76
87297|NCT02105285|214358|P1|COMPLETED|Overall Study||76
87298|NCT02105285|214356|P3|STARTED|Overall Study||37
87299|NCT02105285|214357|P2|STARTED|Overall Study||78
87300|NCT02105285|214358|P1|STARTED|Overall Study||78
87301|NCT02105272|214377|P2|NOT COMPLETED|Overall Study||3
87302|NCT02105272|214378|P1|NOT COMPLETED|Overall Study||5
87303|NCT02105272|214377|P2|COMPLETED|Overall Study||116
87304|NCT02105272|214378|P1|COMPLETED|Overall Study||113
87305|NCT02105272|214377|P2|STARTED|Overall Study||119
87306|NCT02105272|214378|P1|STARTED|Overall Study||118
87307|NCT02105246|214396|P2|NOT COMPLETED|Overall Study||0
87308|NCT02105246|214397|P1|NOT COMPLETED|Overall Study||0
87309|NCT02105246|214396|P2|COMPLETED|Overall Study||597
87310|NCT02105246|214397|P1|COMPLETED|Overall Study||557
87311|NCT02105246|214396|P2|STARTED|Overall Study||597
87312|NCT02105246|214397|P1|STARTED|Overall Study||557
87313|NCT02105116|214407|P1|NOT COMPLETED|Overall Study||6
87314|NCT02105116|214407|P1|COMPLETED|Overall Study||0
87315|NCT02105116|214407|P1|STARTED|Overall Study||6
87316|NCT02105012|214414|P1|NOT COMPLETED|Overall Study||33
87317|NCT02105012|214414|P1|COMPLETED|Overall Study||114
87318|NCT02105012|214414|P1|Placebo MDI|Overall Study||127
87319|NCT02105012|214414|P1|BD MDI 40 µg|Overall Study||63
87320|NCT02105012|214414|P1|BD MDI 80 µg|Overall Study||64
87321|NCT02105012|214414|P1|BD MDI 160 µg|Overall Study||132
87322|NCT02105012|214414|P1|BD MDI 320 µg|Overall Study||124
87323|NCT02105012|214414|P1|STARTED|Overall Study||147
87324|NCT02104947|214448|P2|NOT COMPLETED|Overall Study||56
87325|NCT02104947|214449|P1|NOT COMPLETED|Overall Study||79
87326|NCT02104947|214448|P2|COMPLETED|Overall Study||146
87327|NCT02104947|214449|P1|COMPLETED|Overall Study||222
87328|NCT02104947|214448|P2|STARTED|Overall Study||202
87329|NCT02104947|214449|P1|STARTED|Overall Study||301
87330|NCT02104895|214467|P2|NOT COMPLETED|Overall Study||14
87331|NCT02104895|214468|P1|NOT COMPLETED|Overall Study||0
87332|NCT02104895|214467|P2|COMPLETED|Overall Study||246
87333|NCT02104895|214468|P1|COMPLETED|Overall Study||260
87334|NCT02104895|214467|P2|STARTED|Overall Study||260
87335|NCT02104895|214468|P1|STARTED|Overall Study||260
87336|NCT02104830|214481|P3|NOT COMPLETED|Overall Study||7
87337|NCT02104830|214482|P2|NOT COMPLETED|Overall Study||7
87338|NCT02104830|214483|P1|NOT COMPLETED|Overall Study||4
87339|NCT02104830|214481|P3|COMPLETED|Overall Study||36
87340|NCT02104830|214482|P2|COMPLETED|Overall Study||36
87341|NCT02104830|214483|P1|COMPLETED|Overall Study||38
87342|NCT02104830|214481|P3|STARTED|Overall Study||43
87343|NCT02104830|214482|P2|STARTED|Overall Study||43
87344|NCT02104830|214483|P1|STARTED|Overall Study||42
87345|NCT02104804|214508|P2|NOT COMPLETED|Overall Study||19
87346|NCT02104804|214509|P1|NOT COMPLETED|Overall Study||16
87347|NCT02104804|214508|P2|COMPLETED|Overall Study|Of the 19 who did not complete, 1 did not take study medication after randomization.|213
87348|NCT02104804|214509|P1|COMPLETED|Overall Study|Number of patients who completed 24 weeks of treatment|218
87349|NCT02104804|214508|P2|STARTED|Overall Study|Number of patients who were randomized|232
87350|NCT02104804|214509|P1|STARTED|Overall Study|Number of patients who were randomized|234
87351|NCT02104765|214532|P7|NOT COMPLETED|Overall Study||1
87352|NCT02104765|214533|P6|NOT COMPLETED|Overall Study||0
87353|NCT02104765|214534|P5|NOT COMPLETED|Overall Study||1
87354|NCT02104765|214535|P4|NOT COMPLETED|Overall Study||1
87355|NCT02104765|214536|P3|NOT COMPLETED|Overall Study||1
87356|NCT02104765|214537|P2|NOT COMPLETED|Overall Study||0
87357|NCT02104765|214538|P1|NOT COMPLETED|Overall Study||0
87358|NCT02104765|214532|P7|COMPLETED|Overall Study||7
87359|NCT02104765|214533|P6|COMPLETED|Overall Study||2
87360|NCT02104765|214534|P5|COMPLETED|Overall Study||7
87361|NCT02104765|214535|P4|COMPLETED|Overall Study||6
87362|NCT02104765|214536|P3|COMPLETED|Overall Study||5
87363|NCT02104765|214537|P2|COMPLETED|Overall Study||6
87364|NCT02104765|214538|P1|COMPLETED|Overall Study||8
87365|NCT02104765|214532|P7|Received at Least 1 Dose of Study Drug|Overall Study||8
87366|NCT02104765|214533|P6|Received at Least 1 Dose of Study Drug|Overall Study||2
87367|NCT02104765|214534|P5|Received at Least 1 Dose of Study Drug|Overall Study||8
87368|NCT02104765|214535|P4|Received at Least 1 Dose of Study Drug|Overall Study||7
87369|NCT02104765|214536|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
87370|NCT02104765|214537|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
87371|NCT02104765|214538|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
87372|NCT02104765|214532|P7|STARTED|Overall Study||8
87373|NCT02104765|214533|P6|STARTED|Overall Study||2
87374|NCT02104765|214534|P5|STARTED|Overall Study||8
87375|NCT02104765|214535|P4|STARTED|Overall Study||7
87376|NCT02104765|214536|P3|STARTED|Overall Study||6
87377|NCT02104765|214537|P2|STARTED|Overall Study||6
87378|NCT02104765|214538|P1|STARTED|Overall Study||8
87379|NCT02104752|214566|P2|NOT COMPLETED|Overall Study||2
87380|NCT02104752|214567|P1|NOT COMPLETED|Overall Study||1
87381|NCT02104752|214566|P2|COMPLETED|Overall Study||19
87382|NCT02104752|214567|P1|COMPLETED|Overall Study||17
87383|NCT02104752|214566|P2|STARTED|Overall Study||21
87384|NCT02104752|214567|P1|STARTED|Overall Study||18
87385|NCT02104739|214581|P7|NOT COMPLETED|Extension Phase (6 Weeks)||1
87386|NCT02104739|214582|P6|NOT COMPLETED|Extension Phase (6 Weeks)||0
87387|NCT02104739|214583|P5|NOT COMPLETED|Extension Phase (6 Weeks)||0
87388|NCT02104739|214584|P4|NOT COMPLETED|Extension Phase (6 Weeks)||0
87389|NCT02104739|214585|P3|NOT COMPLETED|Extension Phase (6 Weeks)||0
87390|NCT02104739|214586|P2|NOT COMPLETED|Extension Phase (6 Weeks)||0
87391|NCT02104739|214587|P1|NOT COMPLETED|Extension Phase (6 Weeks)||0
87392|NCT02104739|214581|P7|COMPLETED|Extension Phase (6 Weeks)||7
87393|NCT02104739|214582|P6|COMPLETED|Extension Phase (6 Weeks)||0
87394|NCT02104739|214583|P5|COMPLETED|Extension Phase (6 Weeks)||0
87395|NCT02104739|214584|P4|COMPLETED|Extension Phase (6 Weeks)||0
87396|NCT02104739|214585|P3|COMPLETED|Extension Phase (6 Weeks)||0
87397|NCT02104739|214586|P2|COMPLETED|Extension Phase (6 Weeks)||0
87398|NCT02104739|214587|P1|COMPLETED|Extension Phase (6 Weeks)||0
87399|NCT02104739|214581|P7|STARTED|Extension Phase (6 Weeks)||8
87400|NCT02104739|214582|P6|STARTED|Extension Phase (6 Weeks)||0
87401|NCT02104739|214583|P5|STARTED|Extension Phase (6 Weeks)||0
87402|NCT02104739|214584|P4|STARTED|Extension Phase (6 Weeks)||0
87403|NCT02104739|214585|P3|STARTED|Extension Phase (6 Weeks)||0
87404|NCT02104739|214586|P2|STARTED|Extension Phase (6 Weeks)||0
87405|NCT02104739|214587|P1|STARTED|Extension Phase (6 Weeks)||0
87406|NCT02104739|214581|P7|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||1
87407|NCT02104739|214582|P6|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
87408|NCT02104739|214583|P5|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
87409|NCT02104739|214584|P4|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
87410|NCT02104739|214585|P3|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
87411|NCT02104739|214586|P2|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
87412|NCT02104739|214587|P1|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
87413|NCT02104739|214581|P7|COMPLETED|Washout (Min of 10 and Max of 323 Days)||7
87414|NCT02104739|214582|P6|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
87415|NCT02104739|214583|P5|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
87416|NCT02104739|214584|P4|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
87417|NCT02104739|214585|P3|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
87418|NCT02104739|214586|P2|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
87419|NCT02104739|214587|P1|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
87420|NCT02104739|214581|P7|STARTED|Washout (Min of 10 and Max of 323 Days)||8
87421|NCT02104739|214582|P6|STARTED|Washout (Min of 10 and Max of 323 Days)||0
87422|NCT02104739|214583|P5|STARTED|Washout (Min of 10 and Max of 323 Days)||0
87423|NCT02104739|214584|P4|STARTED|Washout (Min of 10 and Max of 323 Days)||0
87424|NCT02104739|214585|P3|STARTED|Washout (Min of 10 and Max of 323 Days)||0
87425|NCT02104739|214586|P2|STARTED|Washout (Min of 10 and Max of 323 Days)||0
87426|NCT02104739|214587|P1|STARTED|Washout (Min of 10 and Max of 323 Days)||0
87427|NCT02104739|214581|P7|NOT COMPLETED|Third Intervention (1 Day)||0
87428|NCT02104739|214582|P6|NOT COMPLETED|Third Intervention (1 Day)||0
87429|NCT02104739|214583|P5|NOT COMPLETED|Third Intervention (1 Day)||0
87430|NCT02104739|214584|P4|NOT COMPLETED|Third Intervention (1 Day)||0
87431|NCT02104739|214585|P3|NOT COMPLETED|Third Intervention (1 Day)||0
87432|NCT02104739|214586|P2|NOT COMPLETED|Third Intervention (1 Day)||0
87433|NCT02104739|214587|P1|NOT COMPLETED|Third Intervention (1 Day)||0
87434|NCT02104739|214581|P7|COMPLETED|Third Intervention (1 Day)||0
87435|NCT02104739|214582|P6|COMPLETED|Third Intervention (1 Day)||2
87436|NCT02104739|214583|P5|COMPLETED|Third Intervention (1 Day)||0
87437|NCT02104739|214584|P4|COMPLETED|Third Intervention (1 Day)||7
87438|NCT02104739|214585|P3|COMPLETED|Third Intervention (1 Day)||2
87439|NCT02104739|214586|P2|COMPLETED|Third Intervention (1 Day)||4
87440|NCT02104739|214587|P1|COMPLETED|Third Intervention (1 Day)||1
87441|NCT02104739|214581|P7|STARTED|Third Intervention (1 Day)||0
87442|NCT02104739|214582|P6|STARTED|Third Intervention (1 Day)||2
87443|NCT02104739|214583|P5|STARTED|Third Intervention (1 Day)||0
87444|NCT02104739|214584|P4|STARTED|Third Intervention (1 Day)||7
87445|NCT02104739|214585|P3|STARTED|Third Intervention (1 Day)||2
87446|NCT02104739|214586|P2|STARTED|Third Intervention (1 Day)||4
87447|NCT02104739|214587|P1|STARTED|Third Intervention (1 Day)||1
87448|NCT02104739|214581|P7|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
87449|NCT02104739|214582|P6|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
87450|NCT02104739|214583|P5|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
87451|NCT02104739|214584|P4|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
87452|NCT02104739|214585|P3|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
87453|NCT02104739|214586|P2|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
87454|NCT02104739|214587|P1|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
87455|NCT02104739|214581|P7|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
87456|NCT02104739|214582|P6|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
87457|NCT02104739|214583|P5|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
87458|NCT02104739|214584|P4|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7
87459|NCT02104739|214585|P3|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
87460|NCT02104739|214586|P2|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4
87461|NCT02104739|214587|P1|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1
87462|NCT02104739|214581|P7|STARTED|Washout (Min of 10 and Max of 107 Days)||0
87463|NCT02104739|214582|P6|STARTED|Washout (Min of 10 and Max of 107 Days)||2
87464|NCT02104739|214583|P5|STARTED|Washout (Min of 10 and Max of 107 Days)||0
87465|NCT02104739|214584|P4|STARTED|Washout (Min of 10 and Max of 107 Days)||7
87466|NCT02104739|214585|P3|STARTED|Washout (Min of 10 and Max of 107 Days)||2
87467|NCT02104739|214586|P2|STARTED|Washout (Min of 10 and Max of 107 Days)||4
87468|NCT02104739|214587|P1|STARTED|Washout (Min of 10 and Max of 107 Days)||1
87469|NCT02104739|214581|P7|NOT COMPLETED|Second Intervention (1 Day)||0
87470|NCT02104739|214582|P6|NOT COMPLETED|Second Intervention (1 Day)||0
87471|NCT02104739|214583|P5|NOT COMPLETED|Second Intervention (1 Day)||0
87472|NCT02104739|214584|P4|NOT COMPLETED|Second Intervention (1 Day)||0
87473|NCT02104739|214585|P3|NOT COMPLETED|Second Intervention (1 Day)||0
87474|NCT02104739|214586|P2|NOT COMPLETED|Second Intervention (1 Day)||0
87475|NCT02104739|214587|P1|NOT COMPLETED|Second Intervention (1 Day)||0
87476|NCT02104739|214581|P7|COMPLETED|Second Intervention (1 Day)||0
87477|NCT02104739|214582|P6|COMPLETED|Second Intervention (1 Day)||2
87478|NCT02104739|214583|P5|COMPLETED|Second Intervention (1 Day)||0
87479|NCT02104739|214584|P4|COMPLETED|Second Intervention (1 Day)||7
87480|NCT02104739|214585|P3|COMPLETED|Second Intervention (1 Day)||2
87481|NCT02104739|214586|P2|COMPLETED|Second Intervention (1 Day)||4
87482|NCT02104739|214587|P1|COMPLETED|Second Intervention (1 Day)||1
87483|NCT02104739|214581|P7|STARTED|Second Intervention (1 Day)||0
87484|NCT02104739|214582|P6|STARTED|Second Intervention (1 Day)||2
87485|NCT02104739|214583|P5|STARTED|Second Intervention (1 Day)||0
87486|NCT02104739|214584|P4|STARTED|Second Intervention (1 Day)||7
87487|NCT02104739|214585|P3|STARTED|Second Intervention (1 Day)||2
87488|NCT02104739|214586|P2|STARTED|Second Intervention (1 Day)||4
87489|NCT02104739|214587|P1|STARTED|Second Intervention (1 Day)||1
87490|NCT02104739|214581|P7|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
87491|NCT02104739|214582|P6|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
87492|NCT02104739|214583|P5|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
87493|NCT02104739|214584|P4|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
87494|NCT02104739|214585|P3|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
87495|NCT02104739|214586|P2|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
87496|NCT02104739|214587|P1|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
87497|NCT02104739|214581|P7|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
87498|NCT02104739|214582|P6|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
87499|NCT02104739|214583|P5|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
87500|NCT02104739|214584|P4|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7
87501|NCT02104739|214585|P3|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
87502|NCT02104739|214586|P2|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4
87503|NCT02104739|214587|P1|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1
87504|NCT02104739|214581|P7|STARTED|Washout (Min of 10 and Max of 107 Days)||0
87505|NCT02104739|214582|P6|STARTED|Washout (Min of 10 and Max of 107 Days)||2
87506|NCT02104739|214583|P5|STARTED|Washout (Min of 10 and Max of 107 Days)||0
87507|NCT02104739|214584|P4|STARTED|Washout (Min of 10 and Max of 107 Days)||7
87508|NCT02104739|214585|P3|STARTED|Washout (Min of 10 and Max of 107 Days)||2
87509|NCT02104739|214586|P2|STARTED|Washout (Min of 10 and Max of 107 Days)||4
87510|NCT02104739|214587|P1|STARTED|Washout (Min of 10 and Max of 107 Days)||1
87511|NCT02104739|214581|P7|NOT COMPLETED|First Intervention (1 Day)||0
87512|NCT02104739|214582|P6|NOT COMPLETED|First Intervention (1 Day)||0
87513|NCT02104739|214583|P5|NOT COMPLETED|First Intervention (1 Day)||0
87514|NCT02104739|214584|P4|NOT COMPLETED|First Intervention (1 Day)||1
87515|NCT02104739|214585|P3|NOT COMPLETED|First Intervention (1 Day)||0
87516|NCT02104739|214586|P2|NOT COMPLETED|First Intervention (1 Day)||1
87517|NCT02104739|214587|P1|NOT COMPLETED|First Intervention (1 Day)||0
87518|NCT02104739|214581|P7|COMPLETED|First Intervention (1 Day)||0
87519|NCT02104739|214582|P6|COMPLETED|First Intervention (1 Day)||3
87520|NCT02104739|214583|P5|COMPLETED|First Intervention (1 Day)||0
87521|NCT02104739|214584|P4|COMPLETED|First Intervention (1 Day)||7
87522|NCT02104739|214585|P3|COMPLETED|First Intervention (1 Day)||2
87523|NCT02104739|214586|P2|COMPLETED|First Intervention (1 Day)||4
87524|NCT02104739|214587|P1|COMPLETED|First Intervention (1 Day)||2
87525|NCT02104739|214581|P7|STARTED|First Intervention (1 Day)||0
87526|NCT02104739|214582|P6|STARTED|First Intervention (1 Day)||3
87527|NCT02104739|214583|P5|STARTED|First Intervention (1 Day)||0
87528|NCT02104739|214584|P4|STARTED|First Intervention (1 Day)||8
87529|NCT02104739|214585|P3|STARTED|First Intervention (1 Day)||2
87530|NCT02104739|214586|P2|STARTED|First Intervention (1 Day)||5
87531|NCT02104739|214587|P1|STARTED|First Intervention (1 Day)||2
87532|NCT02104583|214650|P5|NOT COMPLETED|Overall Study||12
87533|NCT02104583|214651|P4|NOT COMPLETED|Overall Study||17
87534|NCT02104583|214652|P3|NOT COMPLETED|Overall Study||16
87535|NCT02104583|214653|P2|NOT COMPLETED|Overall Study||11
87536|NCT02104583|214654|P1|NOT COMPLETED|Overall Study||18
87537|NCT02104583|214650|P5|COMPLETED|Overall Study||63
87538|NCT02104583|214651|P4|COMPLETED|Overall Study||57
87539|NCT02104583|214652|P3|COMPLETED|Overall Study||54
87540|NCT02104583|214653|P2|COMPLETED|Overall Study||35
87541|NCT02104583|214654|P1|COMPLETED|Overall Study||30
87542|NCT02104583|214650|P5|STARTED|Overall Study||75
87543|NCT02104583|214651|P4|STARTED|Overall Study||74
87544|NCT02104583|214652|P3|STARTED|Overall Study||70
87545|NCT02104583|214653|P2|STARTED|Overall Study||46
87546|NCT02104583|214654|P1|STARTED|Overall Study||48
87547|NCT02104505|214717|P2|NOT COMPLETED|Second Intervention (14 Days)||1
87548|NCT02104505|214718|P1|NOT COMPLETED|Second Intervention (14 Days)||2
87549|NCT02104505|214717|P2|COMPLETED|Second Intervention (14 Days)||7
87550|NCT02104505|214718|P1|COMPLETED|Second Intervention (14 Days)||8
87551|NCT02104505|214717|P2|STARTED|Second Intervention (14 Days)||8
87552|NCT02104505|214718|P1|STARTED|Second Intervention (14 Days)||10
87553|NCT02104505|214717|P2|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
87554|NCT02104505|214718|P1|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
87555|NCT02104505|214717|P2|COMPLETED|Washout (Minimum 3 Weeks)||8
87556|NCT02104505|214718|P1|COMPLETED|Washout (Minimum 3 Weeks)||10
87557|NCT02104505|214717|P2|STARTED|Washout (Minimum 3 Weeks)||8
87558|NCT02104505|214718|P1|STARTED|Washout (Minimum 3 Weeks)||10
87559|NCT02104505|214717|P2|NOT COMPLETED|First Intervention (14 Days)||3
87560|NCT02104505|214718|P1|NOT COMPLETED|First Intervention (14 Days)||2
87561|NCT02104505|214717|P2|COMPLETED|First Intervention (14 Days)||8
87562|NCT02104505|214718|P1|COMPLETED|First Intervention (14 Days)||10
87563|NCT02104505|214717|P2|STARTED|First Intervention (14 Days)|one participant withdrew prior to receiving study drug|11
87564|NCT02104505|214718|P1|STARTED|First Intervention (14 Days)||12
87565|NCT02104427|214730|P1|NOT COMPLETED|Overall Study||0
87566|NCT02104427|214730|P1|COMPLETED|Overall Study||12
87567|NCT02104427|214730|P1|STARTED|Overall Study||12
87568|NCT02104414|214756|P3|NOT COMPLETED|Overall Study||0
87569|NCT02104414|214757|P2|NOT COMPLETED|Overall Study||0
87570|NCT02104414|214758|P1|NOT COMPLETED|Overall Study||0
87571|NCT02104414|214756|P3|COMPLETED|Overall Study||2
87572|NCT02104414|214757|P2|COMPLETED|Overall Study||4
87573|NCT02104414|214758|P1|COMPLETED|Overall Study||5
87574|NCT02104414|214756|P3|STARTED|Overall Study||2
87575|NCT02104414|214757|P2|STARTED|Overall Study||4
87576|NCT02104414|214758|P1|STARTED|Overall Study||5
87577|NCT02104219|214781|P1|NOT COMPLETED|Overall Study||0
87578|NCT02104219|214781|P1|COMPLETED|Overall Study||32
87579|NCT02104219|214781|P1|STARTED|Overall Study||32
87580|NCT02104180|214790|P2|NOT COMPLETED|Overall Study||0
87581|NCT02104180|214791|P1|NOT COMPLETED|Overall Study||1
87582|NCT02104180|214790|P2|COMPLETED|Overall Study||31
87583|NCT02104180|214791|P1|COMPLETED|Overall Study||30
87584|NCT02104180|214790|P2|STARTED|Overall Study||31
87585|NCT02104180|214791|P1|STARTED|Overall Study||31
87586|NCT02104167|214797|P1|NOT COMPLETED|Overall Study||0
87587|NCT02104167|214797|P1|COMPLETED|Overall Study||110
87588|NCT02104167|214797|P1|STARTED|Overall Study||110
87589|NCT02104141|214802|P1|NOT COMPLETED|Overall Study||0
87590|NCT02104141|214802|P1|COMPLETED|Overall Study||51
87591|NCT02104141|214802|P1|STARTED|Overall Study||51
87592|NCT02103855|214807|P1|NOT COMPLETED|Overall Study||2
87593|NCT02103855|214807|P1|COMPLETED|Overall Study||4
87594|NCT02103855|214807|P1|STARTED|Overall Study||6
87595|NCT02103608|214815|P1|NOT COMPLETED|Overall Study||2
87596|NCT02103608|214815|P1|COMPLETED|Overall Study||15
87597|NCT02103608|214815|P1|STARTED|Overall Study||17
87598|NCT02103439|214821|P2|NOT COMPLETED|Overall Study||3
87599|NCT02103439|214822|P1|NOT COMPLETED|Overall Study||3
87600|NCT02103439|214821|P2|COMPLETED|Overall Study||67
87601|NCT02103439|214822|P1|COMPLETED|Overall Study||67
87602|NCT02103439|214821|P2|STARTED|Overall Study||70
87603|NCT02103439|214822|P1|STARTED|Overall Study||70
87604|NCT02103309|214842|P2|NOT COMPLETED|Overall Study||0
87605|NCT02103309|214843|P1|NOT COMPLETED|Overall Study||0
87606|NCT02103309|214842|P2|COMPLETED|Overall Study||22
87607|NCT02103309|214843|P1|COMPLETED|Overall Study||20
87608|NCT02103309|214842|P2|STARTED|Overall Study||22
87609|NCT02103309|214843|P1|STARTED|Overall Study||20
87610|NCT02103270|214858|P3|NOT COMPLETED|Overall Study||24
87611|NCT02103270|214859|P2|NOT COMPLETED|Overall Study||6
87612|NCT02103270|214860|P1|NOT COMPLETED|Overall Study||9
87613|NCT02103270|214858|P3|COMPLETED|Overall Study||1
87614|NCT02103270|214859|P2|COMPLETED|Overall Study||29
87615|NCT02103270|214860|P1|COMPLETED|Overall Study||51
87616|NCT02103270|214858|P3|STARTED|Overall Study||25
87617|NCT02103270|214859|P2|STARTED|Overall Study||35
87618|NCT02103270|214860|P1|STARTED|Overall Study||60
87619|NCT02103218|214875|P4|NOT COMPLETED|Overall Study||7
87620|NCT02103218|214876|P3|NOT COMPLETED|Overall Study||4
87621|NCT02103218|214877|P2|NOT COMPLETED|Overall Study||8
87622|NCT02103218|214878|P1|NOT COMPLETED|Overall Study||5
87623|NCT02103218|214875|P4|COMPLETED|Overall Study||47
87624|NCT02103218|214876|P3|COMPLETED|Overall Study||44
87625|NCT02103218|214877|P2|COMPLETED|Overall Study||51
87626|NCT02103218|214878|P1|COMPLETED|Overall Study||46
87627|NCT02103218|214875|P4|STARTED|Overall Study||54
87628|NCT02103218|214876|P3|STARTED|Overall Study||48
87629|NCT02103218|214877|P2|STARTED|Overall Study||59
87630|NCT02103218|214878|P1|STARTED|Overall Study||51
87631|NCT02103114|214924|P2|NOT COMPLETED|Overall Study||1
87632|NCT02103114|214925|P1|NOT COMPLETED|Overall Study||0
87633|NCT02103114|214924|P2|COMPLETED|Overall Study||19
87634|NCT02103114|214925|P1|COMPLETED|Overall Study||20
87635|NCT02103114|214924|P2|STARTED|Overall Study||20
87636|NCT02103114|214925|P1|STARTED|Overall Study||20
87637|NCT02103062|214981|P2|NOT COMPLETED|Overall Study||23
87638|NCT02103062|214982|P1|NOT COMPLETED|Overall Study||18
87639|NCT02103062|214981|P2|COMPLETED|Overall Study||0
87640|NCT02103062|214982|P1|COMPLETED|Overall Study||0
87641|NCT02103062|214981|P2|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|20
87642|NCT02103062|214982|P1|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|17
87643|NCT02103062|214981|P2|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|23
87644|NCT02103062|214982|P1|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|18
87645|NCT02103062|214981|P2|STARTED|Overall Study||23
87646|NCT02103062|214982|P1|STARTED|Overall Study||18
87647|NCT02102932|215008|P8|NOT COMPLETED|Overall Study||0
87648|NCT02102932|215009|P7|NOT COMPLETED|Overall Study||0
87649|NCT02102932|215010|P6|NOT COMPLETED|Overall Study||0
87650|NCT02102932|215011|P5|NOT COMPLETED|Overall Study||0
87651|NCT02102932|215012|P4|NOT COMPLETED|Overall Study||0
87652|NCT02102932|215013|P3|NOT COMPLETED|Overall Study||0
87653|NCT02102932|215014|P2|NOT COMPLETED|Overall Study||0
87654|NCT02102932|215015|P1|NOT COMPLETED|Overall Study||0
87655|NCT02102932|215008|P8|COMPLETED|Overall Study||12
87656|NCT02102932|215009|P7|COMPLETED|Overall Study||12
87657|NCT02102932|215010|P6|COMPLETED|Overall Study||12
87658|NCT02102932|215011|P5|COMPLETED|Overall Study||12
87659|NCT02102932|215012|P4|COMPLETED|Overall Study||12
87660|NCT02102932|215013|P3|COMPLETED|Overall Study||12
87661|NCT02102932|215014|P2|COMPLETED|Overall Study||12
87662|NCT02102932|215015|P1|COMPLETED|Overall Study||12
87663|NCT02102932|215008|P8|STARTED|Overall Study||12
87664|NCT02102932|215009|P7|STARTED|Overall Study||12
87665|NCT02102932|215010|P6|STARTED|Overall Study||12
87666|NCT02102932|215011|P5|STARTED|Overall Study||12
87667|NCT02102932|215012|P4|STARTED|Overall Study||12
87668|NCT02102932|215013|P3|STARTED|Overall Study||12
87669|NCT02102932|215014|P2|STARTED|Overall Study||12
87670|NCT02102932|215015|P1|STARTED|Overall Study||12
87671|NCT02102724|215075|P2|NOT COMPLETED|Overall Study||1
87672|NCT02102724|215076|P1|NOT COMPLETED|Overall Study||2
87673|NCT02102724|215075|P2|COMPLETED|Overall Study||18
87674|NCT02102724|215076|P1|COMPLETED|Overall Study||16
87675|NCT02102724|215075|P2|STARTED|Overall Study||19
87676|NCT02102724|215076|P1|STARTED|Overall Study||18
87677|NCT02102490|215082|P1|NOT COMPLETED|Overall Study||7
87678|NCT02102490|215082|P1|COMPLETED|Overall Study||125
87679|NCT02102490|215082|P1|Received at Least 1 Dose of Study Drug|Overall Study||132
87680|NCT02102490|215082|P1|STARTED|Overall Study||132
87681|NCT02102464|215096|P3|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
87682|NCT02102464|215097|P2|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
87683|NCT02102464|215098|P1|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
87684|NCT02102464|215096|P3|COMPLETED|Crossover LipiFlow Treatment of Control||25
87685|NCT02102464|215097|P2|COMPLETED|Crossover LipiFlow Treatment of Control||0
87686|NCT02102464|215098|P1|COMPLETED|Crossover LipiFlow Treatment of Control||0
87687|NCT02102464|215096|P3|STARTED|Crossover LipiFlow Treatment of Control||25
87688|NCT02102464|215097|P2|STARTED|Crossover LipiFlow Treatment of Control||0
87689|NCT02102464|215098|P1|STARTED|Crossover LipiFlow Treatment of Control||0
87690|NCT02102464|215096|P3|NOT COMPLETED|Randomized Study||0
87691|NCT02102464|215097|P2|NOT COMPLETED|Randomized Study||1
87692|NCT02102464|215098|P1|NOT COMPLETED|Randomized Study||0
87693|NCT02102464|215096|P3|COMPLETED|Randomized Study||0
87694|NCT02102464|215097|P2|COMPLETED|Randomized Study||25
87695|NCT02102464|215098|P1|COMPLETED|Randomized Study||29
87696|NCT02102464|215096|P3|STARTED|Randomized Study||0
87697|NCT02102464|215097|P2|STARTED|Randomized Study||26
87698|NCT02102464|215098|P1|STARTED|Randomized Study||29
87699|NCT02102399|215117|P2|NOT COMPLETED|Overall Study||4
87700|NCT02102399|215118|P1|NOT COMPLETED|Overall Study||6
87701|NCT02102399|215117|P2|COMPLETED|Overall Study||17
87702|NCT02102399|215118|P1|COMPLETED|Overall Study||14
87703|NCT02102399|215117|P2|STARTED|Overall Study||21
87704|NCT02102399|215118|P1|STARTED|Overall Study||20
87705|NCT02102230|215169|P3|NOT COMPLETED|Overall Study||17
87706|NCT02102230|215170|P2|NOT COMPLETED|Overall Study||17
87707|NCT02102230|215171|P1|NOT COMPLETED|Overall Study||17
87708|NCT02102230|215169|P3|COMPLETED|Overall Study||24
87709|NCT02102230|215170|P2|COMPLETED|Overall Study||11
87710|NCT02102230|215171|P1|COMPLETED|Overall Study||25
87711|NCT02102230|215169|P3|STARTED|Overall Study||41
87712|NCT02102230|215170|P2|STARTED|Overall Study||28
87713|NCT02102230|215171|P1|STARTED|Overall Study||42
87714|NCT02102204|215188|P1|NOT COMPLETED|Overall Study||304
87715|NCT02102204|215188|P1|COMPLETED|Overall Study||598
87716|NCT02102204|215188|P1|Received Etelcalcetide|Overall Study||884
87717|NCT02102204|215188|P1|STARTED|Overall Study||902
87718|NCT02102100|215199|P2|NOT COMPLETED|Overall Study||7
87719|NCT02102100|215200|P1|NOT COMPLETED|Overall Study||9
87720|NCT02102100|215199|P2|COMPLETED|Overall Study||18
87721|NCT02102100|215200|P1|COMPLETED|Overall Study||23
87722|NCT02102100|215199|P2|STARTED|Overall Study||25
87723|NCT02102100|215200|P1|STARTED|Overall Study||32
87724|NCT02101983|215208|P2|NOT COMPLETED|Overall Study||0
87725|NCT02101983|215209|P1|NOT COMPLETED|Overall Study||1
87726|NCT02101983|215208|P2|COMPLETED|Overall Study||6
87727|NCT02101983|215209|P1|COMPLETED|Overall Study||4
87728|NCT02101983|215208|P2|STARTED|Overall Study||6
87729|NCT02101983|215209|P1|STARTED|Overall Study||5
87730|NCT02101515|215221|P2|NOT COMPLETED|Overall Study||0
87731|NCT02101515|215222|P1|NOT COMPLETED|Overall Study||0
87732|NCT02101515|215221|P2|COMPLETED|Overall Study||41
87733|NCT02101515|215222|P1|COMPLETED|Overall Study||37
87734|NCT02101515|215221|P2|STARTED|Overall Study||41
87735|NCT02101515|215222|P1|STARTED|Overall Study||37
87736|NCT02101437|215264|P4|NOT COMPLETED|Overall Study||0
87737|NCT02101437|215265|P3|NOT COMPLETED|Overall Study||0
87738|NCT02101437|215266|P2|NOT COMPLETED|Overall Study||0
87739|NCT02101437|215267|P1|NOT COMPLETED|Overall Study||0
87740|NCT02101437|215264|P4|COMPLETED|Overall Study||49
87741|NCT02101437|215265|P3|COMPLETED|Overall Study||52
87742|NCT02101437|215266|P2|COMPLETED|Overall Study||54
87743|NCT02101437|215267|P1|COMPLETED|Overall Study||20
87744|NCT02101437|215264|P4|STARTED|Overall Study||49
87745|NCT02101437|215265|P3|STARTED|Overall Study||52
87746|NCT02101437|215266|P2|STARTED|Overall Study||54
87747|NCT02101437|215267|P1|STARTED|Overall Study||20
87748|NCT02101411|215280|P3|NOT COMPLETED|Overall Study||10
87749|NCT02101411|215281|P2|NOT COMPLETED|Overall Study||7
87750|NCT02101411|215282|P1|NOT COMPLETED|Overall Study||4
87751|NCT02101411|215280|P3|COMPLETED|Overall Study||104
87752|NCT02101411|215281|P2|COMPLETED|Overall Study||102
87753|NCT02101411|215282|P1|COMPLETED|Overall Study||107
87754|NCT02101411|215280|P3|STARTED|Overall Study||114
87755|NCT02101411|215281|P2|STARTED|Overall Study||109
87756|NCT02101411|215282|P1|STARTED|Overall Study||111
87757|NCT02101359|215292|P2|NOT COMPLETED|Overall Study||19
87758|NCT02101359|215293|P1|NOT COMPLETED|Overall Study||29
87759|NCT02101359|215292|P2|COMPLETED|Overall Study||277
87760|NCT02101359|215293|P1|COMPLETED|Overall Study||266
87761|NCT02101359|215292|P2|STARTED|Overall Study||296
87762|NCT02101359|215293|P1|STARTED|Overall Study||295
87763|NCT02101294|215299|P1|NOT COMPLETED|Overall Study||11
87764|NCT02101294|215299|P1|COMPLETED|Overall Study||20
87765|NCT02101294|215299|P1|STARTED|Overall Study||31
87766|NCT02101281|215308|P2|NOT COMPLETED|Overall Study||1
87767|NCT02101281|215309|P1|NOT COMPLETED|Overall Study||0
87768|NCT02101281|215308|P2|COMPLETED|Overall Study||19
87769|NCT02101281|215309|P1|COMPLETED|Overall Study||20
87770|NCT02101281|215308|P2|STARTED|Overall Study||20
87771|NCT02101281|215309|P1|STARTED|Overall Study||20
87772|NCT02101190|215351|P2|NOT COMPLETED|Overall Study||0
87773|NCT02101190|215352|P1|NOT COMPLETED|Overall Study||0
87774|NCT02101190|215351|P2|COMPLETED|Overall Study||8
87775|NCT02101190|215352|P1|COMPLETED|Overall Study||8
87776|NCT02101190|215351|P2|STARTED|Overall Study||8
87777|NCT02101190|215352|P1|STARTED|Overall Study||8
87778|NCT02101112|215362|P6|NOT COMPLETED|Overall Study||0
87779|NCT02101112|215363|P5|NOT COMPLETED|Overall Study||1
87780|NCT02101112|215364|P4|NOT COMPLETED|Overall Study||0
87781|NCT02101112|215365|P3|NOT COMPLETED|Overall Study||1
87782|NCT02101112|215366|P2|NOT COMPLETED|Overall Study||0
87783|NCT02101112|215367|P1|NOT COMPLETED|Overall Study||0
87784|NCT02101112|215362|P6|COMPLETED|Overall Study||5
87785|NCT02101112|215363|P5|COMPLETED|Overall Study||5
87786|NCT02101112|215364|P4|COMPLETED|Overall Study||5
87787|NCT02101112|215365|P3|COMPLETED|Overall Study||5
87788|NCT02101112|215366|P2|COMPLETED|Overall Study||5
87789|NCT02101112|215367|P1|COMPLETED|Overall Study||6
87790|NCT02101112|215362|P6|STARTED|Overall Study||5
87791|NCT02101112|215363|P5|STARTED|Overall Study||6
87792|NCT02101112|215364|P4|STARTED|Overall Study||5
87793|NCT02101112|215365|P3|STARTED|Overall Study||6
87794|NCT02101112|215366|P2|STARTED|Overall Study||5
87795|NCT02101112|215367|P1|STARTED|Overall Study||6
87796|NCT02101021|215397|P5|NOT COMPLETED|Overall Study||4
87797|NCT02101021|215398|P4|NOT COMPLETED|Overall Study||3
87798|NCT02101021|215399|P3|NOT COMPLETED|Overall Study||7
87799|NCT02101021|215400|P2|NOT COMPLETED|Overall Study||4
87800|NCT02101021|215401|P1|NOT COMPLETED|Overall Study||7
87801|NCT02101021|215397|P5|COMPLETED|Overall Study||0
87802|NCT02101021|215398|P4|COMPLETED|Overall Study||0
87803|NCT02101021|215399|P3|COMPLETED|Overall Study||0
87804|NCT02101021|215400|P2|COMPLETED|Overall Study||0
87805|NCT02101021|215401|P1|COMPLETED|Overall Study||0
87806|NCT02101021|215397|P5|STARTED|Overall Study||4
87807|NCT02101021|215398|P4|STARTED|Overall Study||3
87808|NCT02101021|215399|P3|STARTED|Overall Study||7
87809|NCT02101021|215400|P2|STARTED|Overall Study||4
87810|NCT02101021|215401|P1|STARTED|Overall Study||7
87811|NCT02101008|215443|P1|NOT COMPLETED|Overall Study||0
87812|NCT02101008|215443|P1|COMPLETED|Overall Study||12
87813|NCT02101008|215443|P1|STARTED|Overall Study||12
87814|NCT02100839|215450|P2|NOT COMPLETED|Multiple Ascending Dose||0
87815|NCT02100839|215451|P1|NOT COMPLETED|Multiple Ascending Dose||4
87816|NCT02100839|215450|P2|COMPLETED|Multiple Ascending Dose||3
87817|NCT02100839|215451|P1|COMPLETED|Multiple Ascending Dose||9
87818|NCT02100839|215450|P2|STARTED|Multiple Ascending Dose||3
87819|NCT02100839|215451|P1|STARTED|Multiple Ascending Dose||13
87820|NCT02100839|215450|P2|NOT COMPLETED|Single Ascending Dose||0
87821|NCT02100839|215451|P1|NOT COMPLETED|Single Ascending Dose||0
87822|NCT02100839|215450|P2|COMPLETED|Single Ascending Dose||12
87823|NCT02100839|215451|P1|COMPLETED|Single Ascending Dose||24
87824|NCT02100839|215450|P2|STARTED|Single Ascending Dose||12
87825|NCT02100839|215451|P1|STARTED|Single Ascending Dose||24
87826|NCT02100826|215463|P2|NOT COMPLETED|Period 2 (7 Days)||0
87827|NCT02100826|215464|P1|NOT COMPLETED|Period 2 (7 Days)||0
87828|NCT02100826|215463|P2|COMPLETED|Period 2 (7 Days)||14
87829|NCT02100826|215464|P1|COMPLETED|Period 2 (7 Days)||14
87830|NCT02100826|215463|P2|STARTED|Period 2 (7 Days)||14
87831|NCT02100826|215464|P1|STARTED|Period 2 (7 Days)||14
87832|NCT02100826|215463|P2|NOT COMPLETED|Washout Period (1 Day)||0
87833|NCT02100826|215464|P1|NOT COMPLETED|Washout Period (1 Day)||0
87834|NCT02100826|215463|P2|COMPLETED|Washout Period (1 Day)||14
87835|NCT02100826|215464|P1|COMPLETED|Washout Period (1 Day)||14
87836|NCT02100826|215463|P2|STARTED|Washout Period (1 Day)||14
87837|NCT02100826|215464|P1|STARTED|Washout Period (1 Day)||14
87838|NCT02100826|215463|P2|NOT COMPLETED|Period 1 (7 Days)||0
87839|NCT02100826|215464|P1|NOT COMPLETED|Period 1 (7 Days)||0
87840|NCT02100826|215463|P2|COMPLETED|Period 1 (7 Days)||14
87841|NCT02100826|215464|P1|COMPLETED|Period 1 (7 Days)||14
87842|NCT02100826|215463|P2|STARTED|Period 1 (7 Days)||14
87843|NCT02100826|215464|P1|STARTED|Period 1 (7 Days)||14
87844|NCT02100813|215482|P8|NOT COMPLETED|Overall Study||1
87845|NCT02100813|215483|P7|NOT COMPLETED|Overall Study||0
87846|NCT02100813|215484|P6|NOT COMPLETED|Overall Study||0
87847|NCT02100813|215485|P5|NOT COMPLETED|Overall Study||0
87848|NCT02100813|215486|P4|NOT COMPLETED|Overall Study||0
87849|NCT02100813|215487|P3|NOT COMPLETED|Overall Study||0
87850|NCT02100813|215488|P2|NOT COMPLETED|Overall Study||0
87851|NCT02100813|215489|P1|NOT COMPLETED|Overall Study||0
87852|NCT02100813|215482|P8|COMPLETED|Overall Study||66
87853|NCT02100813|215483|P7|COMPLETED|Overall Study||64
87854|NCT02100813|215484|P6|COMPLETED|Overall Study||32
87855|NCT02100813|215485|P5|COMPLETED|Overall Study||12
87856|NCT02100813|215486|P4|COMPLETED|Overall Study||12
87857|NCT02100813|215487|P3|COMPLETED|Overall Study||12
87858|NCT02100813|215488|P2|COMPLETED|Overall Study||11
87859|NCT02100813|215489|P1|COMPLETED|Overall Study||10
87860|NCT02100813|215482|P8|STARTED|Overall Study||67
87861|NCT02100813|215483|P7|STARTED|Overall Study||64
87862|NCT02100813|215484|P6|STARTED|Overall Study||32
87863|NCT02100813|215485|P5|STARTED|Overall Study||12
87864|NCT02100813|215486|P4|STARTED|Overall Study||12
87865|NCT02100813|215487|P3|STARTED|Overall Study||12
87866|NCT02100813|215488|P2|STARTED|Overall Study||11
87867|NCT02100813|215489|P1|STARTED|Overall Study||10
87868|NCT02100670|215517|P4|NOT COMPLETED|Overall Study||1
87869|NCT02100670|215518|P3|NOT COMPLETED|Overall Study||4
87870|NCT02100670|215519|P2|NOT COMPLETED|Overall Study||7
87871|NCT02100670|215520|P1|NOT COMPLETED|Overall Study||13
87872|NCT02100670|215517|P4|COMPLETED|Overall Study||75
87873|NCT02100670|215518|P3|COMPLETED|Overall Study||74
87874|NCT02100670|215519|P2|COMPLETED|Overall Study||106
87875|NCT02100670|215520|P1|COMPLETED|Overall Study||105
87876|NCT02100670|215517|P4|STARTED|Overall Study||76
87877|NCT02100670|215518|P3|STARTED|Overall Study||78
87878|NCT02100670|215519|P2|STARTED|Overall Study||113
87879|NCT02100670|215520|P1|STARTED|Overall Study||118
87880|NCT02100644|215580|P3|NOT COMPLETED|LTG and VPA Maintenance Phase||0
87881|NCT02100644|215581|P2|NOT COMPLETED|LTG and VPA Maintenance Phase||0
87882|NCT02100644|215582|P1|NOT COMPLETED|LTG and VPA Maintenance Phase||0
87883|NCT02100644|215580|P3|COMPLETED|LTG and VPA Maintenance Phase||20
87884|NCT02100644|215581|P2|COMPLETED|LTG and VPA Maintenance Phase||0
87885|NCT02100644|215582|P1|COMPLETED|LTG and VPA Maintenance Phase||0
87886|NCT02100644|215580|P3|STARTED|LTG and VPA Maintenance Phase||20
87887|NCT02100644|215581|P2|STARTED|LTG and VPA Maintenance Phase||0
87888|NCT02100644|215582|P1|STARTED|LTG and VPA Maintenance Phase||0
87889|NCT02100644|215580|P3|NOT COMPLETED|VPA Reduction Phase||0
87890|NCT02100644|215581|P2|NOT COMPLETED|VPA Reduction Phase||0
87891|NCT02100644|215582|P1|NOT COMPLETED|VPA Reduction Phase||0
87892|NCT02100644|215580|P3|COMPLETED|VPA Reduction Phase||0
87893|NCT02100644|215581|P2|COMPLETED|VPA Reduction Phase||20
87894|NCT02100644|215582|P1|COMPLETED|VPA Reduction Phase||0
87895|NCT02100644|215580|P3|STARTED|VPA Reduction Phase||0
87896|NCT02100644|215581|P2|STARTED|VPA Reduction Phase||20
87897|NCT02100644|215582|P1|STARTED|VPA Reduction Phase||0
87898|NCT02100644|215580|P3|NOT COMPLETED|LTG Escalation Phase||0
87899|NCT02100644|215581|P2|NOT COMPLETED|LTG Escalation Phase||0
87900|NCT02100644|215582|P1|NOT COMPLETED|LTG Escalation Phase||13
87901|NCT02100644|215580|P3|COMPLETED|LTG Escalation Phase||0
87902|NCT02100644|215581|P2|COMPLETED|LTG Escalation Phase||0
87903|NCT02100644|215582|P1|COMPLETED|LTG Escalation Phase||20
87904|NCT02100644|215580|P3|STARTED|LTG Escalation Phase||0
87905|NCT02100644|215581|P2|STARTED|LTG Escalation Phase||0
87906|NCT02100644|215582|P1|STARTED|LTG Escalation Phase||33
87907|NCT02100579|215594|P2|NOT COMPLETED|Overall Study||0
87908|NCT02100579|215595|P1|NOT COMPLETED|Overall Study||0
87909|NCT02100579|215594|P2|COMPLETED|Overall Study||20
87910|NCT02100579|215595|P1|COMPLETED|Overall Study||20
87911|NCT02100579|215594|P2|STARTED|Overall Study||20
87912|NCT02100579|215595|P1|STARTED|Overall Study||20
87913|NCT02100514|215607|P5|NOT COMPLETED|Extension Period||0
87914|NCT02100514|215608|P4|NOT COMPLETED|Extension Period||0
87915|NCT02100514|215609|P3|NOT COMPLETED|Extension Period||2
87916|NCT02100514|215610|P2|NOT COMPLETED|Extension Period||0
87917|NCT02100514|215611|P1|NOT COMPLETED|Extension Period||0
87918|NCT02100514|215607|P5|COMPLETED|Extension Period||56
87919|NCT02100514|215608|P4|COMPLETED|Extension Period||33
87920|NCT02100514|215609|P3|COMPLETED|Extension Period||42
87921|NCT02100514|215610|P2|COMPLETED|Extension Period||0
87922|NCT02100514|215611|P1|COMPLETED|Extension Period||0
87923|NCT02100514|215607|P5|STARTED|Extension Period||56
87924|NCT02100514|215608|P4|STARTED|Extension Period||33
87925|NCT02100514|215609|P3|STARTED|Extension Period||44
87926|NCT02100514|215610|P2|STARTED|Extension Period||0
87927|NCT02100514|215611|P1|STARTED|Extension Period||0
87928|NCT02100514|215607|P5|NOT COMPLETED|Treatment Period||0
87929|NCT02100514|215608|P4|NOT COMPLETED|Treatment Period||0
87930|NCT02100514|215609|P3|NOT COMPLETED|Treatment Period||0
87931|NCT02100514|215610|P2|NOT COMPLETED|Treatment Period||74
87932|NCT02100514|215611|P1|NOT COMPLETED|Treatment Period||29
87933|NCT02100514|215607|P5|COMPLETED|Treatment Period||0
87934|NCT02100514|215608|P4|COMPLETED|Treatment Period||0
87935|NCT02100514|215609|P3|COMPLETED|Treatment Period||0
87936|NCT02100514|215610|P2|COMPLETED|Treatment Period||425
87937|NCT02100514|215611|P1|COMPLETED|Treatment Period||218
87938|NCT02100514|215607|P5|STARTED|Treatment Period||0
87939|NCT02100514|215608|P4|STARTED|Treatment Period||0
87940|NCT02100514|215609|P3|STARTED|Treatment Period||0
87941|NCT02100514|215610|P2|STARTED|Treatment Period||499
87942|NCT02100514|215611|P1|STARTED|Treatment Period||247
87943|NCT02100475|215679|P2|NOT COMPLETED|Overall Study||2
87944|NCT02100475|215680|P1|NOT COMPLETED|Overall Study||2
87945|NCT02100475|215679|P2|COMPLETED|Overall Study||13
87946|NCT02100475|215680|P1|COMPLETED|Overall Study||14
87947|NCT02100475|215679|P2|STARTED|Overall Study||15
87948|NCT02100475|215680|P1|STARTED|Overall Study||16
87949|NCT02100410|215690|P6|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
87950|NCT02100410|215691|P5|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
87951|NCT02100410|215692|P4|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
87952|NCT02100410|215693|P3|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
87953|NCT02100410|215694|P2|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
87954|NCT02100410|215695|P1|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
87955|NCT02100410|215690|P6|COMPLETED|Exposure Pair 3, 30 Minutes||9
87956|NCT02100410|215691|P5|COMPLETED|Exposure Pair 3, 30 Minutes||8
87957|NCT02100410|215692|P4|COMPLETED|Exposure Pair 3, 30 Minutes||8
87958|NCT02100410|215693|P3|COMPLETED|Exposure Pair 3, 30 Minutes||8
87959|NCT02100410|215694|P2|COMPLETED|Exposure Pair 3, 30 Minutes||8
87960|NCT02100410|215695|P1|COMPLETED|Exposure Pair 3, 30 Minutes||8
87961|NCT02100410|215690|P6|STARTED|Exposure Pair 3, 30 Minutes||9
87962|NCT02100410|215691|P5|STARTED|Exposure Pair 3, 30 Minutes||8
87963|NCT02100410|215692|P4|STARTED|Exposure Pair 3, 30 Minutes||8
87964|NCT02100410|215693|P3|STARTED|Exposure Pair 3, 30 Minutes||8
87965|NCT02100410|215694|P2|STARTED|Exposure Pair 3, 30 Minutes||8
87966|NCT02100410|215695|P1|STARTED|Exposure Pair 3, 30 Minutes||8
87967|NCT02100410|215690|P6|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
87968|NCT02100410|215691|P5|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
87969|NCT02100410|215692|P4|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
87970|NCT02100410|215693|P3|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
87971|NCT02100410|215694|P2|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
87972|NCT02100410|215695|P1|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
87973|NCT02100410|215690|P6|COMPLETED|Exposure Pair 2, 30 Minutes||9
87974|NCT02100410|215691|P5|COMPLETED|Exposure Pair 2, 30 Minutes||8
87975|NCT02100410|215692|P4|COMPLETED|Exposure Pair 2, 30 Minutes||8
87976|NCT02100410|215693|P3|COMPLETED|Exposure Pair 2, 30 Minutes||8
87977|NCT02100410|215694|P2|COMPLETED|Exposure Pair 2, 30 Minutes||8
87978|NCT02100410|215695|P1|COMPLETED|Exposure Pair 2, 30 Minutes||8
87979|NCT02100410|215690|P6|STARTED|Exposure Pair 2, 30 Minutes||9
87980|NCT02100410|215691|P5|STARTED|Exposure Pair 2, 30 Minutes||8
87981|NCT02100410|215692|P4|STARTED|Exposure Pair 2, 30 Minutes||8
87982|NCT02100410|215693|P3|STARTED|Exposure Pair 2, 30 Minutes||8
87983|NCT02100410|215694|P2|STARTED|Exposure Pair 2, 30 Minutes||8
87984|NCT02100410|215695|P1|STARTED|Exposure Pair 2, 30 Minutes||8
87985|NCT02100410|215690|P6|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
87986|NCT02100410|215691|P5|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
87987|NCT02100410|215692|P4|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
87988|NCT02100410|215693|P3|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
87989|NCT02100410|215694|P2|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
87990|NCT02100410|215695|P1|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
87991|NCT02100410|215690|P6|COMPLETED|Exposure Pair 1, 30 Minutes||9
87992|NCT02100410|215691|P5|COMPLETED|Exposure Pair 1, 30 Minutes||8
87993|NCT02100410|215692|P4|COMPLETED|Exposure Pair 1, 30 Minutes||8
87994|NCT02100410|215693|P3|COMPLETED|Exposure Pair 1, 30 Minutes||8
87995|NCT02100410|215694|P2|COMPLETED|Exposure Pair 1, 30 Minutes||8
87996|NCT02100410|215695|P1|COMPLETED|Exposure Pair 1, 30 Minutes||8
87997|NCT02100410|215690|P6|STARTED|Exposure Pair 1, 30 Minutes||9
87998|NCT02100410|215691|P5|STARTED|Exposure Pair 1, 30 Minutes||8
87999|NCT02100410|215692|P4|STARTED|Exposure Pair 1, 30 Minutes||8
88000|NCT02100410|215693|P3|STARTED|Exposure Pair 1, 30 Minutes||8
88001|NCT02100410|215694|P2|STARTED|Exposure Pair 1, 30 Minutes||8
88002|NCT02100410|215695|P1|STARTED|Exposure Pair 1, 30 Minutes||8
88003|NCT02100319|215711|P1|NOT COMPLETED|Overall Study||16
88004|NCT02100319|215711|P1|COMPLETED|Overall Study||371
88005|NCT02100319|215711|P1|STARTED|Overall Study||387
88006|NCT02100280|215722|P2|NOT COMPLETED|Overall Study||4
88007|NCT02100280|215723|P1|NOT COMPLETED|Overall Study||4
88008|NCT02100280|215722|P2|COMPLETED|Overall Study||44
88009|NCT02100280|215723|P1|COMPLETED|Overall Study||44
88010|NCT02100280|215722|P2|STARTED|Overall Study||48
88011|NCT02100280|215723|P1|STARTED|Overall Study||48
88012|NCT02100228|215739|P2|NOT COMPLETED|Overall Study||90
88013|NCT02100228|215740|P1|NOT COMPLETED|Overall Study||75
88014|NCT02100228|215739|P2|COMPLETED|Overall Study||657
88015|NCT02100228|215740|P1|COMPLETED|Overall Study||678
88016|NCT02100228|215739|P2|STARTED|Overall Study|721 treated with Usual Care|747
88017|NCT02100228|215740|P1|STARTED|Overall Study|735 treated with Apixaban|753
88018|NCT02100189|215766|P1|NOT COMPLETED|Overall Study||0
88019|NCT02100189|215766|P1|COMPLETED|Overall Study||50
88020|NCT02100189|215766|P1|STARTED|Overall Study||50
88021|NCT02100124|215776|P3|NOT COMPLETED|Overall Study||3
88022|NCT02100124|215777|P2|NOT COMPLETED|Overall Study||11
88023|NCT02100124|215778|P1|NOT COMPLETED|Overall Study||6
88024|NCT02100124|215776|P3|COMPLETED|Overall Study||323
88025|NCT02100124|215777|P2|COMPLETED|Overall Study||318
88026|NCT02100124|215778|P1|COMPLETED|Overall Study||323
88027|NCT02100124|215776|P3|STARTED|Overall Study||326
88028|NCT02100124|215777|P2|STARTED|Overall Study||329
88029|NCT02100124|215778|P1|STARTED|Overall Study||329
88030|NCT02100007|215795|P1|NOT COMPLETED|Overall Study||0
88031|NCT02100007|215795|P1|COMPLETED|Overall Study||46
88032|NCT02100007|215795|P1|STARTED|Overall Study||46
88033|NCT02099838|215808|P2|NOT COMPLETED|Overall Study||2
88034|NCT02099838|215809|P1|NOT COMPLETED|Overall Study||4
88035|NCT02099838|215808|P2|COMPLETED|Overall Study||49
88036|NCT02099838|215809|P1|COMPLETED|Overall Study||43
88037|NCT02099838|215808|P2|STARTED|Overall Study||51
88038|NCT02099838|215809|P1|STARTED|Overall Study||47
88039|NCT02099786|215841|P2|NOT COMPLETED|Overall Study||8
88040|NCT02099786|215842|P1|NOT COMPLETED|Overall Study||3
88041|NCT02099786|215841|P2|COMPLETED|Overall Study||15
88042|NCT02099786|215842|P1|COMPLETED|Overall Study||21
88043|NCT02099786|215841|P2|Program Eval 3|Overall Study|One year post randomization|15
88044|NCT02099786|215842|P1|Program Eval 3|Overall Study|One year post randomization|21
88045|NCT02099786|215841|P2|Program Eval 2|Overall Study|One month post randomization|19
88046|NCT02099786|215842|P1|Program Eval 2|Overall Study|One month post randomization|23
88047|NCT02099786|215841|P2|Program Eval 1|Overall Study|Baseline (prior to randomization and first cisplatin dose)|23
88048|NCT02099786|215842|P1|Program Eval 1|Overall Study|Baseline (prior to randomization and first cisplatin dose)|24
88049|NCT02099786|215841|P2|STARTED|Overall Study||23
88050|NCT02099786|215842|P1|STARTED|Overall Study||24
88051|NCT02099708|215854|P1|NOT COMPLETED|Overall Study||200
88052|NCT02099708|215854|P1|COMPLETED|Overall Study||3302
88053|NCT02099708|215854|P1|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3302
88054|NCT02099708|215854|P1|STARTED|Overall Study|Number of cases.|3502
88055|NCT02099682|215865|P1|NOT COMPLETED|Overall Study||111
88056|NCT02099682|215865|P1|COMPLETED|Overall Study||3255
88057|NCT02099682|215865|P1|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3255
88058|NCT02099682|215865|P1|STARTED|Overall Study|Number of cases.|3366
88059|NCT02099461|215879|P3|NOT COMPLETED|Overall Study||0
88060|NCT02099461|215880|P2|NOT COMPLETED|Overall Study||0
88061|NCT02099461|215881|P1|NOT COMPLETED|Overall Study||0
88062|NCT02099461|215879|P3|COMPLETED|Overall Study||28
88063|NCT02099461|215880|P2|COMPLETED|Overall Study||27
88064|NCT02099461|215881|P1|COMPLETED|Overall Study||27
88065|NCT02099461|215879|P3|STARTED|Overall Study||28
88066|NCT02099461|215880|P2|STARTED|Overall Study||27
88067|NCT02099461|215881|P1|STARTED|Overall Study||27
88068|NCT02099344|215891|P2|NOT COMPLETED|Overall Study||0
88069|NCT02099344|215892|P1|NOT COMPLETED|Overall Study||1
88070|NCT02099344|215891|P2|COMPLETED|Overall Study||0
88071|NCT02099344|215892|P1|COMPLETED|Overall Study||0
88072|NCT02099344|215891|P2|STARTED|Overall Study||0
88073|NCT02099344|215892|P1|STARTED|Overall Study||1
88074|NCT02099318|215902|P2|NOT COMPLETED|Overall Study||0
88075|NCT02099318|215903|P1|NOT COMPLETED|Overall Study||0
88076|NCT02099318|215902|P2|COMPLETED|Overall Study||20
88077|NCT02099318|215903|P1|COMPLETED|Overall Study||20
88078|NCT02099318|215902|P2|STARTED|Overall Study||20
88079|NCT02099318|215903|P1|STARTED|Overall Study||20
88080|NCT02099266|215917|P1|NOT COMPLETED|Overall Study||0
88081|NCT02099266|215917|P1|COMPLETED|Overall Study||15
88082|NCT02099266|215917|P1|STARTED|Overall Study||15
88083|NCT02099110|215929|P5|NOT COMPLETED|Overall Study||27
88084|NCT02099110|215930|P4|NOT COMPLETED|Overall Study||22
88085|NCT02099110|215931|P3|NOT COMPLETED|Overall Study||28
88086|NCT02099110|215932|P2|NOT COMPLETED|Overall Study||31
88087|NCT02099110|215933|P1|NOT COMPLETED|Overall Study||24
88088|NCT02099110|215929|P5|COMPLETED|Overall Study||218
88089|NCT02099110|215930|P4|COMPLETED|Overall Study||221
88090|NCT02099110|215931|P3|COMPLETED|Overall Study||219
88091|NCT02099110|215932|P2|COMPLETED|Overall Study||217
88092|NCT02099110|215933|P1|COMPLETED|Overall Study||226
88093|NCT02099110|215929|P5|Treated|Overall Study||244
88094|NCT02099110|215930|P4|Treated|Overall Study||243
88095|NCT02099110|215931|P3|Treated|Overall Study||247
88096|NCT02099110|215932|P2|Treated|Overall Study||248
88097|NCT02099110|215933|P1|Treated|Overall Study||250
88098|NCT02099110|215929|P5|STARTED|Overall Study||245
88099|NCT02099110|215930|P4|STARTED|Overall Study||243
88100|NCT02099110|215931|P3|STARTED|Overall Study||247
88101|NCT02099110|215932|P2|STARTED|Overall Study||248
88102|NCT02099110|215933|P1|STARTED|Overall Study||250
88103|NCT02099084|215980|P2|NOT COMPLETED|Second Intervention||0
88104|NCT02099084|215981|P1|NOT COMPLETED|Second Intervention||0
88105|NCT02099084|215980|P2|COMPLETED|Second Intervention||4
88106|NCT02099084|215981|P1|COMPLETED|Second Intervention||4
88107|NCT02099084|215980|P2|STARTED|Second Intervention||4
88108|NCT02099084|215981|P1|STARTED|Second Intervention||4
88109|NCT02099084|215980|P2|NOT COMPLETED|Washout Period of 14 Days||0
88110|NCT02099084|215981|P1|NOT COMPLETED|Washout Period of 14 Days||0
88111|NCT02099084|215980|P2|COMPLETED|Washout Period of 14 Days||4
88112|NCT02099084|215981|P1|COMPLETED|Washout Period of 14 Days||4
88113|NCT02099084|215980|P2|STARTED|Washout Period of 14 Days||4
88114|NCT02099084|215981|P1|STARTED|Washout Period of 14 Days||4
88115|NCT02099084|215980|P2|NOT COMPLETED|First Intervention||0
88116|NCT02099084|215981|P1|NOT COMPLETED|First Intervention||0
88117|NCT02099084|215980|P2|COMPLETED|First Intervention||4
88118|NCT02099084|215981|P1|COMPLETED|First Intervention||4
88119|NCT02099084|215980|P2|STARTED|First Intervention||4
88120|NCT02099084|215981|P1|STARTED|First Intervention||4
88121|NCT02099006|215999|P1|NOT COMPLETED|Overall Study||1
88122|NCT02099006|215999|P1|COMPLETED|Overall Study||8
88123|NCT02099006|215999|P1|Received Gabapentin|Overall Study||8
88124|NCT02099006|215999|P1|Received Ketamine|Overall Study||6
88125|NCT02099006|215999|P1|Received Loperamide|Overall Study||7
88126|NCT02099006|215999|P1|Received Ketoprofen|Overall Study||3
88127|NCT02099006|215999|P1|Received Amitriptyline/ Baclofen|Overall Study||7
88128|NCT02099006|215999|P1|Received Placebo|Overall Study||9
88129|NCT02099006|215999|P1|STARTED|Overall Study||9
88130|NCT02098993|216009|P2|NOT COMPLETED|Overall Study||0
88131|NCT02098993|216010|P1|NOT COMPLETED|Overall Study||0
88132|NCT02098993|216009|P2|COMPLETED|Overall Study||3
88133|NCT02098993|216010|P1|COMPLETED|Overall Study||4
88134|NCT02098993|216009|P2|STARTED|Overall Study||3
88135|NCT02098993|216010|P1|STARTED|Overall Study||4
88136|NCT02098746|216034|P1|NOT COMPLETED|Overall Study||5
88137|NCT02098746|216034|P1|COMPLETED|Overall Study||289
88138|NCT02098746|216034|P1|STARTED|Overall Study||294
88139|NCT02098733|216042|P1|NOT COMPLETED|Overall Study||10
88140|NCT02098733|216042|P1|COMPLETED|Overall Study||1158
88141|NCT02098733|216042|P1|STARTED|Overall Study||1168
88142|NCT02098395|216056|P4|NOT COMPLETED|Overall Study||27
88143|NCT02098395|216057|P3|NOT COMPLETED|Overall Study||42
88144|NCT02098395|216058|P2|NOT COMPLETED|Overall Study||32
88145|NCT02098395|216059|P1|NOT COMPLETED|Overall Study||26
88146|NCT02098395|216056|P4|COMPLETED|Overall Study||180
88147|NCT02098395|216057|P3|COMPLETED|Overall Study||165
88148|NCT02098395|216058|P2|COMPLETED|Overall Study||177
88149|NCT02098395|216059|P1|COMPLETED|Overall Study||186
88150|NCT02098395|216056|P4|Exposed|Overall Study||206
88151|NCT02098395|216057|P3|Exposed|Overall Study||206
88152|NCT02098395|216058|P2|Exposed|Overall Study||209
88153|NCT02098395|216059|P1|Exposed|Overall Study||211
88154|NCT02098395|216056|P4|STARTED|Overall Study||207
88155|NCT02098395|216057|P3|STARTED|Overall Study||207
88156|NCT02098395|216058|P2|STARTED|Overall Study||209
88157|NCT02098395|216059|P1|STARTED|Overall Study||212
88158|NCT02098369|216080|P3|NOT COMPLETED|Overall Study||5
88159|NCT02098369|216081|P2|NOT COMPLETED|Overall Study||9
88160|NCT02098369|216082|P1|NOT COMPLETED|Overall Study||7
88161|NCT02098369|216080|P3|COMPLETED|Overall Study||143
88162|NCT02098369|216081|P2|COMPLETED|Overall Study||145
88163|NCT02098369|216082|P1|COMPLETED|Overall Study||135
88164|NCT02098369|216080|P3|STARTED|Overall Study||148
88165|NCT02098369|216081|P2|STARTED|Overall Study||154
88166|NCT02098369|216082|P1|STARTED|Overall Study||142
88167|NCT02098304|216111|P1|NOT COMPLETED|Overall Study||0
88168|NCT02098304|216111|P1|COMPLETED|Overall Study||42
88169|NCT02098304|216111|P1|STARTED|Overall Study||42
88170|NCT02098109|216120|P2|NOT COMPLETED|Overall Study||0
88171|NCT02098109|216121|P1|NOT COMPLETED|Overall Study||3
88172|NCT02098109|216120|P2|COMPLETED|Overall Study||51
88173|NCT02098109|216121|P1|COMPLETED|Overall Study||46
88174|NCT02098109|216120|P2|STARTED|Overall Study||51
88175|NCT02098109|216121|P1|STARTED|Overall Study||49
88176|NCT02097992|216147|P4|NOT COMPLETED|Treatment 3 (4 Weeks)||0
88177|NCT02097992|216148|P3|NOT COMPLETED|Treatment 3 (4 Weeks)||0
88178|NCT02097992|216149|P2|NOT COMPLETED|Treatment 3 (4 Weeks)||0
88179|NCT02097992|216150|P1|NOT COMPLETED|Treatment 3 (4 Weeks)||0
88180|NCT02097992|216147|P4|COMPLETED|Treatment 3 (4 Weeks)||2
88181|NCT02097992|216148|P3|COMPLETED|Treatment 3 (4 Weeks)||4
88182|NCT02097992|216149|P2|COMPLETED|Treatment 3 (4 Weeks)||3
88183|NCT02097992|216150|P1|COMPLETED|Treatment 3 (4 Weeks)||2
88184|NCT02097992|216147|P4|STARTED|Treatment 3 (4 Weeks)||2
88185|NCT02097992|216148|P3|STARTED|Treatment 3 (4 Weeks)||4
88186|NCT02097992|216149|P2|STARTED|Treatment 3 (4 Weeks)||3
88187|NCT02097992|216150|P1|STARTED|Treatment 3 (4 Weeks)||2
88188|NCT02097992|216147|P4|NOT COMPLETED|Washout (4 Weeks)||0
88189|NCT02097992|216148|P3|NOT COMPLETED|Washout (4 Weeks)||0
88190|NCT02097992|216149|P2|NOT COMPLETED|Washout (4 Weeks)||0
88191|NCT02097992|216150|P1|NOT COMPLETED|Washout (4 Weeks)||0
88192|NCT02097992|216147|P4|COMPLETED|Washout (4 Weeks)||2
88193|NCT02097992|216148|P3|COMPLETED|Washout (4 Weeks)||4
88194|NCT02097992|216149|P2|COMPLETED|Washout (4 Weeks)||3
88195|NCT02097992|216150|P1|COMPLETED|Washout (4 Weeks)||2
88196|NCT02097992|216147|P4|STARTED|Washout (4 Weeks)||2
88197|NCT02097992|216148|P3|STARTED|Washout (4 Weeks)||4
88198|NCT02097992|216149|P2|STARTED|Washout (4 Weeks)||3
88199|NCT02097992|216150|P1|STARTED|Washout (4 Weeks)||2
88200|NCT02097992|216147|P4|NOT COMPLETED|Treatment 2 (4 Weeks)||0
88201|NCT02097992|216148|P3|NOT COMPLETED|Treatment 2 (4 Weeks)||0
88202|NCT02097992|216149|P2|NOT COMPLETED|Treatment 2 (4 Weeks)||0
88203|NCT02097992|216150|P1|NOT COMPLETED|Treatment 2 (4 Weeks)||0
88204|NCT02097992|216147|P4|COMPLETED|Treatment 2 (4 Weeks)||2
88205|NCT02097992|216148|P3|COMPLETED|Treatment 2 (4 Weeks)||4
88206|NCT02097992|216149|P2|COMPLETED|Treatment 2 (4 Weeks)||3
88207|NCT02097992|216150|P1|COMPLETED|Treatment 2 (4 Weeks)||2
88208|NCT02097992|216147|P4|STARTED|Treatment 2 (4 Weeks)||2
88209|NCT02097992|216148|P3|STARTED|Treatment 2 (4 Weeks)||4
88210|NCT02097992|216149|P2|STARTED|Treatment 2 (4 Weeks)||3
88211|NCT02097992|216150|P1|STARTED|Treatment 2 (4 Weeks)||2
88212|NCT02097992|216147|P4|NOT COMPLETED|Treatment 1 (1 Day)||0
88213|NCT02097992|216148|P3|NOT COMPLETED|Treatment 1 (1 Day)||0
88214|NCT02097992|216149|P2|NOT COMPLETED|Treatment 1 (1 Day)||0
88215|NCT02097992|216150|P1|NOT COMPLETED|Treatment 1 (1 Day)||0
88216|NCT02097992|216147|P4|COMPLETED|Treatment 1 (1 Day)||2
88217|NCT02097992|216148|P3|COMPLETED|Treatment 1 (1 Day)||4
88218|NCT02097992|216149|P2|COMPLETED|Treatment 1 (1 Day)||3
88219|NCT02097992|216150|P1|COMPLETED|Treatment 1 (1 Day)||2
88220|NCT02097992|216147|P4|STARTED|Treatment 1 (1 Day)||2
88221|NCT02097992|216148|P3|STARTED|Treatment 1 (1 Day)||4
88222|NCT02097992|216149|P2|STARTED|Treatment 1 (1 Day)||3
88223|NCT02097992|216150|P1|STARTED|Treatment 1 (1 Day)||2
88224|NCT02097849|216160|P2|NOT COMPLETED|Overall Study||0
88225|NCT02097849|216161|P1|NOT COMPLETED|Overall Study||0
88226|NCT02097849|216160|P2|COMPLETED|Overall Study||38
88227|NCT02097849|216161|P1|COMPLETED|Overall Study||33
88228|NCT02097849|216160|P2|STARTED|Overall Study||38
88229|NCT02097849|216161|P1|STARTED|Overall Study||33
88230|NCT02097823|216199|P2|NOT COMPLETED|Overall Study||1
88231|NCT02097823|216200|P1|NOT COMPLETED|Overall Study||1
88232|NCT02097823|216199|P2|COMPLETED|Overall Study||3
88233|NCT02097823|216200|P1|COMPLETED|Overall Study||10
88234|NCT02097823|216199|P2|STARTED|Overall Study||4
88235|NCT02097823|216200|P1|STARTED|Overall Study||11
88236|NCT02097745|216215|P1|NOT COMPLETED|Overall Study||178
88237|NCT02097745|216215|P1|COMPLETED|Overall Study||157
88238|NCT02097745|216215|P1|STARTED|Overall Study|Six participants did not receive any treatment and were not included in any analyses.|335
88239|NCT02097732|216239|P2|NOT COMPLETED|Overall Study||0
88240|NCT02097732|216240|P1|NOT COMPLETED|Overall Study||0
88241|NCT02097732|216239|P2|COMPLETED|Overall Study||3
88242|NCT02097732|216240|P1|COMPLETED|Overall Study||1
88243|NCT02097732|216239|P2|STARTED|Overall Study||3
88244|NCT02097732|216240|P1|STARTED|Overall Study||1
88245|NCT02097719|216251|P2|NOT COMPLETED|Overall Study||1
88246|NCT02097719|216252|P1|NOT COMPLETED|Overall Study||3
88247|NCT02097719|216251|P2|COMPLETED|Overall Study||50
88248|NCT02097719|216252|P1|COMPLETED|Overall Study||46
88249|NCT02097719|216251|P2|STARTED|Overall Study||51
88250|NCT02097719|216252|P1|STARTED|Overall Study||49
88251|NCT02097641|216260|P2|NOT COMPLETED|Overall Study||0
88252|NCT02097641|216261|P1|NOT COMPLETED|Overall Study||0
88253|NCT02097641|216260|P2|COMPLETED|Overall Study||20
88254|NCT02097641|216261|P1|COMPLETED|Overall Study||40
88255|NCT02097641|216260|P2|STARTED|Overall Study||20
88256|NCT02097641|216261|P1|STARTED|Overall Study||40
88257|NCT02097537|216303|P1|NOT COMPLETED|Overall Study||0
88258|NCT02097537|216303|P1|COMPLETED|Overall Study||10
88259|NCT02097537|216303|P1|Follow-Up|Overall Study||10
88260|NCT02097537|216303|P1|Enrollment|Overall Study|Inhalation of Methacholine Chloride|10
88261|NCT02097537|216303|P1|STARTED|Overall Study||10
88262|NCT02097472|216317|P8|NOT COMPLETED|Assessed for Immunogenicity||1
88263|NCT02097472|216318|P7|NOT COMPLETED|Assessed for Immunogenicity||2
88264|NCT02097472|216319|P6|NOT COMPLETED|Assessed for Immunogenicity||2
88265|NCT02097472|216320|P5|NOT COMPLETED|Assessed for Immunogenicity||0
88266|NCT02097472|216321|P4|NOT COMPLETED|Assessed for Immunogenicity||2
88267|NCT02097472|216322|P3|NOT COMPLETED|Assessed for Immunogenicity||1
88268|NCT02097472|216323|P2|NOT COMPLETED|Assessed for Immunogenicity||0
88269|NCT02097472|216324|P1|NOT COMPLETED|Assessed for Immunogenicity||0
88270|NCT02097472|216317|P8|COMPLETED|Assessed for Immunogenicity||49
88271|NCT02097472|216318|P7|COMPLETED|Assessed for Immunogenicity||47
88272|NCT02097472|216319|P6|COMPLETED|Assessed for Immunogenicity||48
88273|NCT02097472|216320|P5|COMPLETED|Assessed for Immunogenicity||50
88274|NCT02097472|216321|P4|COMPLETED|Assessed for Immunogenicity||48
88275|NCT02097472|216322|P3|COMPLETED|Assessed for Immunogenicity||17
88276|NCT02097472|216323|P2|COMPLETED|Assessed for Immunogenicity||18
88277|NCT02097472|216324|P1|COMPLETED|Assessed for Immunogenicity||18
88278|NCT02097472|216317|P8|STARTED|Assessed for Immunogenicity||50
88279|NCT02097472|216318|P7|STARTED|Assessed for Immunogenicity||49
88280|NCT02097472|216319|P6|STARTED|Assessed for Immunogenicity||50
88281|NCT02097472|216320|P5|STARTED|Assessed for Immunogenicity||50
88282|NCT02097472|216321|P4|STARTED|Assessed for Immunogenicity||50
88283|NCT02097472|216322|P3|STARTED|Assessed for Immunogenicity||18
88284|NCT02097472|216323|P2|STARTED|Assessed for Immunogenicity||18
88285|NCT02097472|216324|P1|STARTED|Assessed for Immunogenicity||18
88286|NCT02097472|216317|P8|NOT COMPLETED|Received Vaccination 2||0
88287|NCT02097472|216318|P7|NOT COMPLETED|Received Vaccination 2||1
88288|NCT02097472|216319|P6|NOT COMPLETED|Received Vaccination 2||0
88289|NCT02097472|216320|P5|NOT COMPLETED|Received Vaccination 2||0
88290|NCT02097472|216321|P4|NOT COMPLETED|Received Vaccination 2||0
88291|NCT02097472|216322|P3|NOT COMPLETED|Received Vaccination 2||0
88292|NCT02097472|216323|P2|NOT COMPLETED|Received Vaccination 2||0
88293|NCT02097472|216324|P1|NOT COMPLETED|Received Vaccination 2||0
88294|NCT02097472|216317|P8|COMPLETED|Received Vaccination 2||50
88295|NCT02097472|216318|P7|COMPLETED|Received Vaccination 2||49
88296|NCT02097472|216319|P6|COMPLETED|Received Vaccination 2||50
88297|NCT02097472|216320|P5|COMPLETED|Received Vaccination 2||50
88298|NCT02097472|216321|P4|COMPLETED|Received Vaccination 2||50
88299|NCT02097472|216322|P3|COMPLETED|Received Vaccination 2||18
88300|NCT02097472|216323|P2|COMPLETED|Received Vaccination 2||18
88301|NCT02097472|216324|P1|COMPLETED|Received Vaccination 2||18
88302|NCT02097472|216317|P8|STARTED|Received Vaccination 2||50
88303|NCT02097472|216318|P7|STARTED|Received Vaccination 2||50
88304|NCT02097472|216319|P6|STARTED|Received Vaccination 2||50
88305|NCT02097472|216320|P5|STARTED|Received Vaccination 2||50
88306|NCT02097472|216321|P4|STARTED|Received Vaccination 2||50
88307|NCT02097472|216322|P3|STARTED|Received Vaccination 2||18
88308|NCT02097472|216323|P2|STARTED|Received Vaccination 2||18
88309|NCT02097472|216324|P1|STARTED|Received Vaccination 2||18
88310|NCT02097472|216317|P8|NOT COMPLETED|Received Vaccination 1||0
88311|NCT02097472|216318|P7|NOT COMPLETED|Received Vaccination 1||0
88312|NCT02097472|216319|P6|NOT COMPLETED|Received Vaccination 1||0
88313|NCT02097472|216320|P5|NOT COMPLETED|Received Vaccination 1||0
88314|NCT02097472|216321|P4|NOT COMPLETED|Received Vaccination 1||0
88315|NCT02097472|216322|P3|NOT COMPLETED|Received Vaccination 1||0
88316|NCT02097472|216323|P2|NOT COMPLETED|Received Vaccination 1||0
88317|NCT02097472|216324|P1|NOT COMPLETED|Received Vaccination 1||0
88318|NCT02097472|216317|P8|COMPLETED|Received Vaccination 1||50
88319|NCT02097472|216318|P7|COMPLETED|Received Vaccination 1||50
88320|NCT02097472|216319|P6|COMPLETED|Received Vaccination 1||50
88321|NCT02097472|216320|P5|COMPLETED|Received Vaccination 1||50
88322|NCT02097472|216321|P4|COMPLETED|Received Vaccination 1||50
88323|NCT02097472|216322|P3|COMPLETED|Received Vaccination 1||18
88324|NCT02097472|216323|P2|COMPLETED|Received Vaccination 1||18
88325|NCT02097472|216324|P1|COMPLETED|Received Vaccination 1||18
88326|NCT02097472|216317|P8|STARTED|Received Vaccination 1||50
88327|NCT02097472|216318|P7|STARTED|Received Vaccination 1||50
88328|NCT02097472|216319|P6|STARTED|Received Vaccination 1||50
88329|NCT02097472|216320|P5|STARTED|Received Vaccination 1||50
88330|NCT02097472|216321|P4|STARTED|Received Vaccination 1||50
88331|NCT02097472|216322|P3|STARTED|Received Vaccination 1||18
88332|NCT02097472|216323|P2|STARTED|Received Vaccination 1||18
88333|NCT02097472|216324|P1|STARTED|Received Vaccination 1||18
88334|NCT02097303|216745|P1|NOT COMPLETED|Overall Study||5
88335|NCT02097303|216745|P1|COMPLETED|Overall Study||31
88336|NCT02097303|216745|P1|STARTED|Overall Study||36
88337|NCT02097290|216755|P1|NOT COMPLETED|Overall Study||17
88338|NCT02097290|216755|P1|COMPLETED|Overall Study|Active subjects at the end of 3 month follow up visit for primary end point data collection|193
88339|NCT02097290|216755|P1|STARTED|Overall Study||210
88340|NCT02097277|216770|P5|NOT COMPLETED|Overall Study||1
88341|NCT02097277|216771|P4|NOT COMPLETED|Overall Study||4
88342|NCT02097277|216772|P3|NOT COMPLETED|Overall Study||2
88343|NCT02097277|216773|P2|NOT COMPLETED|Overall Study||3
88344|NCT02097277|216774|P1|NOT COMPLETED|Overall Study||2
88345|NCT02097277|216770|P5|COMPLETED|Overall Study||23
88346|NCT02097277|216771|P4|COMPLETED|Overall Study||20
88347|NCT02097277|216772|P3|COMPLETED|Overall Study||22
88348|NCT02097277|216773|P2|COMPLETED|Overall Study||21
88349|NCT02097277|216774|P1|COMPLETED|Overall Study||22
88350|NCT02097277|216770|P5|STARTED|Overall Study||24
88351|NCT02097277|216771|P4|STARTED|Overall Study||24
88352|NCT02097277|216772|P3|STARTED|Overall Study||24
88353|NCT02097277|216773|P2|STARTED|Overall Study||24
88354|NCT02097277|216774|P1|STARTED|Overall Study||24
88355|NCT02097238|216857|P1|NOT COMPLETED|Overall Study||19
88356|NCT02097238|216857|P1|COMPLETED|Overall Study||0
88357|NCT02097238|216857|P1|STARTED|Overall Study||19
88358|NCT02097134|216863|P1|NOT COMPLETED|Overall Study||9
88359|NCT02097134|216863|P1|COMPLETED|Overall Study||5
88360|NCT02097134|216863|P1|STARTED|Overall Study||14
88361|NCT02097108|216871|P1|NOT COMPLETED|Overall Study||2
88362|NCT02097108|216871|P1|COMPLETED|Overall Study||9
88363|NCT02097108|216871|P1|STARTED|Overall Study||11
88364|NCT02097056|216878|P1|NOT COMPLETED|Overall Study||58
88365|NCT02097056|216878|P1|COMPLETED|Overall Study||113
88366|NCT02097056|216878|P1|ParticipantsTreated|Overall Study||170
88367|NCT02097056|216878|P1|STARTED|Overall Study||171
88368|NCT02097030|216886|P2|NOT COMPLETED|Second Intervention (3 Days)||0
88369|NCT02097030|216887|P1|NOT COMPLETED|Second Intervention (3 Days)||0
88370|NCT02097030|216886|P2|COMPLETED|Second Intervention (3 Days)||16
88371|NCT02097030|216887|P1|COMPLETED|Second Intervention (3 Days)||14
88372|NCT02097030|216886|P2|STARTED|Second Intervention (3 Days)||16
88373|NCT02097030|216887|P1|STARTED|Second Intervention (3 Days)||14
88374|NCT02097030|216886|P2|NOT COMPLETED|First Intervention (3 Days)||1
88375|NCT02097030|216887|P1|NOT COMPLETED|First Intervention (3 Days)||1
88376|NCT02097030|216886|P2|COMPLETED|First Intervention (3 Days)||16
88377|NCT02097030|216887|P1|COMPLETED|First Intervention (3 Days)||14
88378|NCT02097030|216886|P2|STARTED|First Intervention (3 Days)||17
88379|NCT02097030|216887|P1|STARTED|First Intervention (3 Days)||15
88380|NCT02096952|216948|P1|NOT COMPLETED|Overall Study||1
88381|NCT02096952|216948|P1|COMPLETED|Overall Study||14
88382|NCT02096952|216948|P1|STARTED|Overall Study||15
88383|NCT02096900|216954|P2|NOT COMPLETED|Overall Study||2
88384|NCT02096900|216955|P1|NOT COMPLETED|Overall Study||4
88385|NCT02096900|216954|P2|COMPLETED|Overall Study||42
88386|NCT02096900|216955|P1|COMPLETED|Overall Study||38
88387|NCT02096900|216954|P2|STARTED|Overall Study|Allocated to Zolpidem|44
88388|NCT02096900|216955|P1|STARTED|Overall Study|Allocated to Midazolam|42
88389|NCT02096861|216973|P4|NOT COMPLETED|Overall Study||10
88390|NCT02096861|216974|P3|NOT COMPLETED|Overall Study||17
88391|NCT02096861|216975|P2|NOT COMPLETED|Overall Study||15
88392|NCT02096861|216976|P1|NOT COMPLETED|Overall Study||12
88393|NCT02096861|216973|P4|COMPLETED|Overall Study||45
88394|NCT02096861|216974|P3|COMPLETED|Overall Study||37
88395|NCT02096861|216975|P2|COMPLETED|Overall Study||40
88396|NCT02096861|216976|P1|COMPLETED|Overall Study||44
88397|NCT02096861|216973|P4|Drug Switching at Week 30|Overall Study||47
88398|NCT02096861|216974|P3|Drug Switching at Week 30|Overall Study||41
88399|NCT02096861|216975|P2|Drug Switching at Week 30|Overall Study||44
88400|NCT02096861|216976|P1|Drug Switching at Week 30|Overall Study||48
88401|NCT02096861|216973|P4|STARTED|Overall Study|Remicade followed by CT-P13 from Week 30|55
88402|NCT02096861|216974|P3|STARTED|Overall Study|Remicade followed by Remicade from Week 30|54
88403|NCT02096861|216975|P2|STARTED|Overall Study|CT-P13 followed by Remicade from Week 30|55
88404|NCT02096861|216976|P1|STARTED|Overall Study|CT-P13 followed by CT-P13 from Week 30|56
88405|NCT02096835|217007|P3|NOT COMPLETED|Overall Study||1
88406|NCT02096835|217008|P2|NOT COMPLETED|Overall Study||0
88407|NCT02096835|217009|P1|NOT COMPLETED|Overall Study||3
88408|NCT02096835|217007|P3|COMPLETED|Overall Study||50
88409|NCT02096835|217008|P2|COMPLETED|Overall Study||53
88410|NCT02096835|217009|P1|COMPLETED|Overall Study||50
88411|NCT02096835|217007|P3|STARTED|Overall Study||51
88412|NCT02096835|217008|P2|STARTED|Overall Study||53
88413|NCT02096835|217009|P1|STARTED|Overall Study||53
88414|NCT02096744|217026|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||1
88415|NCT02096744|217027|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
88416|NCT02096744|217026|P2|COMPLETED|Treatment Period 3 (7 Days)||27
88417|NCT02096744|217027|P1|COMPLETED|Treatment Period 3 (7 Days)||28
88418|NCT02096744|217026|P2|STARTED|Treatment Period 3 (7 Days)||28
88419|NCT02096744|217027|P1|STARTED|Treatment Period 3 (7 Days)||28
88420|NCT02096744|217026|P2|NOT COMPLETED|Washout Period 2 (3 Days)||0
88421|NCT02096744|217027|P1|NOT COMPLETED|Washout Period 2 (3 Days)||0
88422|NCT02096744|217026|P2|COMPLETED|Washout Period 2 (3 Days)||28
88423|NCT02096744|217027|P1|COMPLETED|Washout Period 2 (3 Days)||28
88424|NCT02096744|217026|P2|STARTED|Washout Period 2 (3 Days)||28
88425|NCT02096744|217027|P1|STARTED|Washout Period 2 (3 Days)||28
88426|NCT02096744|217026|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||0
88427|NCT02096744|217027|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
88428|NCT02096744|217026|P2|COMPLETED|Treatment Period 2 (7 Days)||28
88429|NCT02096744|217027|P1|COMPLETED|Treatment Period 2 (7 Days)||28
88430|NCT02096744|217026|P2|STARTED|Treatment Period 2 (7 Days)||28
88431|NCT02096744|217027|P1|STARTED|Treatment Period 2 (7 Days)||28
88432|NCT02096744|217026|P2|NOT COMPLETED|Washout Period 1(7 Days)||0
88433|NCT02096744|217027|P1|NOT COMPLETED|Washout Period 1(7 Days)||0
88434|NCT02096744|217026|P2|COMPLETED|Washout Period 1(7 Days)||28
88435|NCT02096744|217027|P1|COMPLETED|Washout Period 1(7 Days)||28
88436|NCT02096744|217026|P2|STARTED|Washout Period 1(7 Days)||28
88437|NCT02096744|217027|P1|STARTED|Washout Period 1(7 Days)||28
88438|NCT02096744|217026|P2|NOT COMPLETED|Treatment Period 1(7 Days)||1
88439|NCT02096744|217027|P1|NOT COMPLETED|Treatment Period 1(7 Days)||1
88440|NCT02096744|217026|P2|COMPLETED|Treatment Period 1(7 Days)||28
88441|NCT02096744|217027|P1|COMPLETED|Treatment Period 1(7 Days)||28
88442|NCT02096744|217026|P2|STARTED|Treatment Period 1(7 Days)||29
88443|NCT02096744|217027|P1|STARTED|Treatment Period 1(7 Days)||29
88444|NCT02096731|217042|P2|NOT COMPLETED|Overall Study||0
88445|NCT02096731|217043|P1|NOT COMPLETED|Overall Study||0
88446|NCT02096731|217042|P2|COMPLETED|Overall Study||88955
88447|NCT02096731|217043|P1|COMPLETED|Overall Study||26442
88448|NCT02096731|217042|P2|STARTED|Overall Study||88955
88449|NCT02096731|217043|P1|STARTED|Overall Study||26442
88450|NCT02096718|217060|P3|NOT COMPLETED|Overall Study||0
88451|NCT02096718|217061|P2|NOT COMPLETED|Overall Study||0
88452|NCT02096718|217062|P1|NOT COMPLETED|Overall Study||0
88453|NCT02096718|217060|P3|COMPLETED|Overall Study||14
88454|NCT02096718|217061|P2|COMPLETED|Overall Study||8
88455|NCT02096718|217062|P1|COMPLETED|Overall Study||8
88456|NCT02096718|217060|P3|STARTED|Overall Study||14
88457|NCT02096718|217061|P2|STARTED|Overall Study||8
88458|NCT02096718|217062|P1|STARTED|Overall Study||8
88459|NCT02096705|217081|P2|NOT COMPLETED|Follow-up||4
88460|NCT02096705|217082|P1|NOT COMPLETED|Follow-up||4
88461|NCT02096705|217081|P2|COMPLETED|Follow-up||135
88462|NCT02096705|217082|P1|COMPLETED|Follow-up||125
88463|NCT02096705|217081|P2|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|139
88464|NCT02096705|217082|P1|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|129
88465|NCT02096705|217081|P2|NOT COMPLETED|Treatment||5
88466|NCT02096705|217082|P1|NOT COMPLETED|Treatment||9
88467|NCT02096705|217081|P2|COMPLETED|Treatment||134
88468|NCT02096705|217082|P1|COMPLETED|Treatment||124
88469|NCT02096705|217081|P2|STARTED|Treatment||139
88470|NCT02096705|217082|P1|STARTED|Treatment||133
88471|NCT02096692|217094|P1|NOT COMPLETED|Overall Study||4
88472|NCT02096692|217094|P1|COMPLETED|Overall Study||150
88473|NCT02096692|217094|P1|STARTED|Overall Study||154
88474|NCT02096679|217100|P1|NOT COMPLETED|Overall Study||0
88475|NCT02096679|217100|P1|COMPLETED|Overall Study||8
88476|NCT02096679|217100|P1|STARTED|Overall Study||8
88477|NCT02096588|217125|P2|NOT COMPLETED|Overall Study||1
88478|NCT02096588|217126|P1|NOT COMPLETED|Overall Study||2
88479|NCT02096588|217125|P2|COMPLETED|Overall Study||15
88480|NCT02096588|217126|P1|COMPLETED|Overall Study||13
88481|NCT02096588|217125|P2|STARTED|Overall Study||16
88482|NCT02096588|217126|P1|STARTED|Overall Study||15
88483|NCT02096575|217136|P3|NOT COMPLETED|Overall Study||5
88484|NCT02096575|217137|P2|NOT COMPLETED|Overall Study||0
88485|NCT02096575|217138|P1|NOT COMPLETED|Overall Study||0
88486|NCT02096575|217136|P3|COMPLETED|Overall Study||0
88487|NCT02096575|217137|P2|COMPLETED|Overall Study||67
88488|NCT02096575|217138|P1|COMPLETED|Overall Study||68
88489|NCT02096575|217136|P3|STARTED|Overall Study||5
88490|NCT02096575|217137|P2|STARTED|Overall Study||67
88491|NCT02096575|217138|P1|STARTED|Overall Study||68
88492|NCT02096471|217152|P1|NOT COMPLETED|Overall Study||13
88493|NCT02096471|217152|P1|COMPLETED|Overall Study|Participants terminated the study if a partial response was not achieved and/or maintained.|6
88494|NCT02096471|217152|P1|STARTED|Overall Study||19
88495|NCT02096458|217163|P1|NOT COMPLETED|Overall Study||0
88496|NCT02096458|217163|P1|COMPLETED|Overall Study||8
88497|NCT02096458|217163|P1|STARTED|Overall Study||8
88498|NCT02096263|217170|P3|NOT COMPLETED|Overall Study||39
88499|NCT02096263|217171|P2|NOT COMPLETED|Overall Study||36
88500|NCT02096263|217172|P1|NOT COMPLETED|Overall Study||34
88501|NCT02096263|217170|P3|COMPLETED|Overall Study||157
88502|NCT02096263|217171|P2|COMPLETED|Overall Study||158
88503|NCT02096263|217172|P1|COMPLETED|Overall Study||161
88504|NCT02096263|217170|P3|STARTED|Overall Study||196
88505|NCT02096263|217171|P2|STARTED|Overall Study||194
88506|NCT02096263|217172|P1|STARTED|Overall Study||195
88507|NCT02096107|217308|P2|NOT COMPLETED|Overall Study||0
88508|NCT02096107|217309|P1|NOT COMPLETED|Overall Study||0
88509|NCT02096107|217308|P2|COMPLETED|Overall Study||30
88510|NCT02096107|217309|P1|COMPLETED|Overall Study||30
88511|NCT02096107|217308|P2|STARTED|Overall Study||30
88512|NCT02096107|217309|P1|STARTED|Overall Study||30
88513|NCT02096081|217327|P2|NOT COMPLETED|Overall Study||4
88514|NCT02096081|217328|P1|NOT COMPLETED|Overall Study||3
88515|NCT02096081|217327|P2|COMPLETED|Overall Study||124
88516|NCT02096081|217328|P1|COMPLETED|Overall Study||119
88517|NCT02096081|217327|P2|STARTED|Overall Study||128
88518|NCT02096081|217328|P1|STARTED|Overall Study||122
88519|NCT02096042|217360|P3|NOT COMPLETED|Overall Study||0
88520|NCT02096042|217361|P2|NOT COMPLETED|Overall Study||0
88521|NCT02096042|217362|P1|NOT COMPLETED|Overall Study||1
88522|NCT02096042|217360|P3|COMPLETED|Overall Study||0
88523|NCT02096042|217361|P2|COMPLETED|Overall Study||0
88524|NCT02096042|217362|P1|COMPLETED|Overall Study||0
88525|NCT02096042|217360|P3|STARTED|Overall Study||0
88526|NCT02096042|217361|P2|STARTED|Overall Study||0
88527|NCT02096042|217362|P1|STARTED|Overall Study||1
88528|NCT02096029|217371|P2|NOT COMPLETED|Overall Study||0
88529|NCT02096029|217372|P1|NOT COMPLETED|Overall Study||0
88530|NCT02096029|217371|P2|COMPLETED|Overall Study||593
88531|NCT02096029|217372|P1|COMPLETED|Overall Study||652
88532|NCT02096029|217371|P2|STARTED|Overall Study||593
88533|NCT02096029|217372|P1|STARTED|Overall Study||652
88534|NCT02096003|217384|P2|NOT COMPLETED|Overall Study||3
88535|NCT02096003|217385|P1|NOT COMPLETED|Overall Study||2
88536|NCT02096003|217384|P2|COMPLETED|Overall Study||37
88537|NCT02096003|217385|P1|COMPLETED|Overall Study||38
88538|NCT02096003|217384|P2|STARTED|Overall Study||40
88539|NCT02096003|217385|P1|STARTED|Overall Study||40
88540|NCT02095951|217401|P2|NOT COMPLETED|Overall Study||6
88541|NCT02095951|217402|P1|NOT COMPLETED|Overall Study||9
88542|NCT02095951|217401|P2|COMPLETED|Overall Study||8
88543|NCT02095951|217402|P1|COMPLETED|Overall Study||4
88544|NCT02095951|217401|P2|STARTED|Overall Study|1 participant with 2 episodes of catheter infection was enrolled twice in this group.|14
88545|NCT02095951|217402|P1|STARTED|Overall Study|2 participants with 4 episodes of catheter infection was enrolled twice in this group.|13
88546|NCT02095873|217422|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
88547|NCT02095873|217423|P1|NOT COMPLETED|Second Intervention (8 Weeks)||2
88548|NCT02095873|217422|P2|COMPLETED|Second Intervention (8 Weeks)||16
88549|NCT02095873|217423|P1|COMPLETED|Second Intervention (8 Weeks)||13
88550|NCT02095873|217422|P2|STARTED|Second Intervention (8 Weeks)||16
88551|NCT02095873|217423|P1|STARTED|Second Intervention (8 Weeks)||15
88552|NCT02095873|217422|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
88553|NCT02095873|217423|P1|NOT COMPLETED|First Intervention (8 Weeks)||1
88554|NCT02095873|217422|P2|COMPLETED|First Intervention (8 Weeks)||16
88555|NCT02095873|217423|P1|COMPLETED|First Intervention (8 Weeks)||15
88556|NCT02095873|217422|P2|STARTED|First Intervention (8 Weeks)||16
88557|NCT02095873|217423|P1|STARTED|First Intervention (8 Weeks)||16
88558|NCT02095691|217435|P1|NOT COMPLETED|Overall Study||1
88559|NCT02095691|217435|P1|COMPLETED|Overall Study|Subjects with follow up available at 12 months.|18
88560|NCT02095691|217435|P1|STARTED|Overall Study|Subjects who were consented and treated with study ablation catheter.|19
88561|NCT02095561|217454|P2|NOT COMPLETED|Overall Study||0
88562|NCT02095561|217455|P1|NOT COMPLETED|Overall Study||0
88563|NCT02095561|217454|P2|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|2964
88564|NCT02095561|217455|P1|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|3049
88565|NCT02095561|217454|P2|HPV Tested at Health Centers|Overall Study||599
88566|NCT02095561|217455|P1|HPV Tested at Health Centers|Overall Study||99
88567|NCT02095561|217454|P2|HPV Self-tested Women|Overall Study|HPV self-testing only applies to the HPV self-testing arm|0
88568|NCT02095561|217455|P1|HPV Self-tested Women|Overall Study||2519
88569|NCT02095561|217454|P2|Self-testing Acceptability|Overall Study|Acceptablity only applies to the group of women being offered self-testing.|0
88570|NCT02095561|217455|P1|Self-testing Acceptability|Overall Study||2616
88571|NCT02095561|217454|P2|STARTED|Overall Study||2964
88572|NCT02095561|217455|P1|STARTED|Overall Study||3049
88573|NCT02095535|217467|P1|NOT COMPLETED|Analysis||0
88574|NCT02095535|217467|P1|COMPLETED|Analysis||18
88575|NCT02095535|217467|P1|STARTED|Analysis||18
88576|NCT02095535|217467|P1|NOT COMPLETED|Recruitment||2
88577|NCT02095535|217467|P1|COMPLETED|Recruitment||18
88578|NCT02095535|217467|P1|STARTED|Recruitment||20
88579|NCT02095223|217473|P2|NOT COMPLETED|Overall Study||0
88580|NCT02095223|217474|P1|NOT COMPLETED|Overall Study||1
88581|NCT02095223|217473|P2|COMPLETED|Overall Study||2
88582|NCT02095223|217474|P1|COMPLETED|Overall Study|1 participant dropped out of this study due to the time commitment associated with participation.|1
88583|NCT02095223|217473|P2|STARTED|Overall Study||2
88584|NCT02095223|217474|P1|STARTED|Overall Study||2
88585|NCT02095197|217484|P2|NOT COMPLETED|Overall Study||3
88586|NCT02095197|217485|P1|NOT COMPLETED|Overall Study||0
88587|NCT02095197|217484|P2|COMPLETED|Overall Study||36
88588|NCT02095197|217485|P1|COMPLETED|Overall Study||40
88589|NCT02095197|217484|P2|STARTED|Overall Study||39
88590|NCT02095197|217485|P1|STARTED|Overall Study||40
88591|NCT02095158|217497|P1|NOT COMPLETED|Overall Study||75
88592|NCT02095158|217497|P1|COMPLETED|Overall Study||365
88593|NCT02095158|217497|P1|STARTED|Overall Study||440
88594|NCT02095106|217504|P2|NOT COMPLETED|Second Intervention (14 Days)||1
88595|NCT02095106|217505|P1|NOT COMPLETED|Second Intervention (14 Days)||0
88596|NCT02095106|217504|P2|COMPLETED|Second Intervention (14 Days)||12
88597|NCT02095106|217505|P1|COMPLETED|Second Intervention (14 Days)||14
88598|NCT02095106|217504|P2|STARTED|Second Intervention (14 Days)||13
88599|NCT02095106|217505|P1|STARTED|Second Intervention (14 Days)||14
88600|NCT02095106|217504|P2|NOT COMPLETED|First Intervention (14 Days)||0
88601|NCT02095106|217505|P1|NOT COMPLETED|First Intervention (14 Days)||0
88602|NCT02095106|217504|P2|COMPLETED|First Intervention (14 Days)||13
88603|NCT02095106|217505|P1|COMPLETED|First Intervention (14 Days)||14
88604|NCT02095106|217504|P2|STARTED|First Intervention (14 Days)||13
88605|NCT02095106|217505|P1|STARTED|First Intervention (14 Days)||14
88606|NCT02094937|217521|P4|NOT COMPLETED|12 Weeks in Period 2||12
88607|NCT02094937|217522|P3|NOT COMPLETED|12 Weeks in Period 2||12
88608|NCT02094937|217523|P2|NOT COMPLETED|12 Weeks in Period 2||11
88609|NCT02094937|217524|P1|NOT COMPLETED|12 Weeks in Period 2||0
88610|NCT02094937|217521|P4|COMPLETED|12 Weeks in Period 2||112
88611|NCT02094937|217522|P3|COMPLETED|12 Weeks in Period 2||112
88612|NCT02094937|217523|P2|COMPLETED|12 Weeks in Period 2||112
88613|NCT02094937|217524|P1|COMPLETED|12 Weeks in Period 2||0
88614|NCT02094937|217521|P4|STARTED|12 Weeks in Period 2||124
88615|NCT02094937|217522|P3|STARTED|12 Weeks in Period 2||124
88616|NCT02094937|217523|P2|STARTED|12 Weeks in Period 2||123
88617|NCT02094937|217524|P1|STARTED|12 Weeks in Period 2||0
88618|NCT02094937|217521|P4|NOT COMPLETED|8 Weeks in Period 1||0
88619|NCT02094937|217522|P3|NOT COMPLETED|8 Weeks in Period 1||0
88620|NCT02094937|217523|P2|NOT COMPLETED|8 Weeks in Period 1||0
88621|NCT02094937|217524|P1|NOT COMPLETED|8 Weeks in Period 1||60
88622|NCT02094937|217521|P4|COMPLETED|8 Weeks in Period 1||0
88623|NCT02094937|217522|P3|COMPLETED|8 Weeks in Period 1||0
88624|NCT02094937|217523|P2|COMPLETED|8 Weeks in Period 1||0
88625|NCT02094937|217524|P1|COMPLETED|8 Weeks in Period 1||370
88626|NCT02094937|217521|P4|STARTED|8 Weeks in Period 1||0
88627|NCT02094937|217522|P3|STARTED|8 Weeks in Period 1||0
88628|NCT02094937|217523|P2|STARTED|8 Weeks in Period 1||0
88629|NCT02094937|217524|P1|STARTED|8 Weeks in Period 1||430
88630|NCT02094898|217554|P1|NOT COMPLETED|Overall Study||5
88631|NCT02094898|217554|P1|COMPLETED|Overall Study||7
88632|NCT02094898|217554|P1|STARTED|Overall Study||12
88633|NCT02094885|217601|P2|NOT COMPLETED|Overall Study||5
88634|NCT02094885|217602|P1|NOT COMPLETED|Overall Study||2
88635|NCT02094885|217601|P2|COMPLETED|Overall Study||122
88636|NCT02094885|217602|P1|COMPLETED|Overall Study||123
88637|NCT02094885|217601|P2|STARTED|Overall Study||127
88638|NCT02094885|217602|P1|STARTED|Overall Study||125
88639|NCT02094755|217614|P1|NOT COMPLETED|Overall Study||0
88640|NCT02094755|217614|P1|COMPLETED|Overall Study||100
88641|NCT02094755|217614|P1|STARTED|Overall Study||100
88642|NCT02094677|217620|P2|NOT COMPLETED|Overall Study||1
88643|NCT02094677|217621|P1|NOT COMPLETED|Overall Study||3
88644|NCT02094677|217620|P2|COMPLETED|Overall Study||30
88645|NCT02094677|217621|P1|COMPLETED|Overall Study||40
88646|NCT02094677|217620|P2|STARTED|Overall Study||31
88647|NCT02094677|217621|P1|STARTED|Overall Study||43
88648|NCT02094664|217685|P2|NOT COMPLETED|Overall Study||0
88649|NCT02094664|217686|P1|NOT COMPLETED|Overall Study||0
88650|NCT02094664|217685|P2|COMPLETED|Overall Study||16
88651|NCT02094664|217686|P1|COMPLETED|Overall Study||16
88652|NCT02094664|217685|P2|STARTED|Overall Study||16
88653|NCT02094664|217686|P1|STARTED|Overall Study||16
88654|NCT02094612|217700|P2|NOT COMPLETED|Overall Study||70
88655|NCT02094612|217701|P1|NOT COMPLETED|Overall Study||79
88656|NCT02094612|217700|P2|COMPLETED|Overall Study||25
88657|NCT02094612|217701|P1|COMPLETED|Overall Study||33
88658|NCT02094612|217700|P2|6 Month Follow up|Overall Study||25
88659|NCT02094612|217701|P1|6 Month Follow up|Overall Study||33
88660|NCT02094612|217700|P2|3 Month Follow up|Overall Study||43
88661|NCT02094612|217701|P1|3 Month Follow up|Overall Study||50
88662|NCT02094612|217700|P2|1 Month Follow up|Overall Study||50
88663|NCT02094612|217701|P1|1 Month Follow up|Overall Study||67
88664|NCT02094612|217700|P2|STARTED|Overall Study||95
88665|NCT02094612|217701|P1|STARTED|Overall Study||112
88666|NCT02094573|217721|P2|NOT COMPLETED|Overall Study||110
88667|NCT02094573|217722|P1|NOT COMPLETED|Overall Study||112
88668|NCT02094573|217721|P2|COMPLETED|Overall Study||0
88669|NCT02094573|217722|P1|COMPLETED|Overall Study||0
88670|NCT02094573|217721|P2|Treated|Overall Study||110
88671|NCT02094573|217722|P1|Treated|Overall Study||109
88672|NCT02094573|217721|P2|STARTED|Overall Study||110
88673|NCT02094573|217722|P1|STARTED|Overall Study||112
88674|NCT02094534|217756|P2|NOT COMPLETED|Overall Study||0
88675|NCT02094534|217757|P1|NOT COMPLETED|Overall Study||0
88676|NCT02094534|217756|P2|COMPLETED|Overall Study||10
88677|NCT02094534|217757|P1|COMPLETED|Overall Study||15
88678|NCT02094534|217756|P2|STARTED|Overall Study||10
88679|NCT02094534|217757|P1|STARTED|Overall Study||15
88680|NCT02094443|217767|P2|NOT COMPLETED|Overall Study||17
88681|NCT02094443|217768|P1|NOT COMPLETED|Overall Study||15
88682|NCT02094443|217767|P2|COMPLETED|Overall Study||9
88683|NCT02094443|217768|P1|COMPLETED|Overall Study||11
88684|NCT02094443|217767|P2|Completed at Week 24|Overall Study||8
88685|NCT02094443|217768|P1|Completed at Week 24|Overall Study||11
88686|NCT02094443|217767|P2|Completed at Week 12|Overall Study||1
88687|NCT02094443|217768|P1|Completed at Week 12|Overall Study||0
88688|NCT02094443|217767|P2|STARTED|Overall Study||26
88689|NCT02094443|217768|P1|STARTED|Overall Study||26
88690|NCT02094352|217788|P2|NOT COMPLETED|Overall Study||0
88691|NCT02094352|217789|P1|NOT COMPLETED|Overall Study||0
88692|NCT02094352|217788|P2|COMPLETED|Overall Study||1
88693|NCT02094352|217789|P1|COMPLETED|Overall Study||2
88694|NCT02094352|217788|P2|STARTED|Overall Study||1
88695|NCT02094352|217789|P1|STARTED|Overall Study||2
88696|NCT02094326|217795|P1|NOT COMPLETED|Overall Study||0
88697|NCT02094326|217795|P1|COMPLETED|Overall Study||301
88698|NCT02094326|217795|P1|STARTED|Overall Study||301
88699|NCT02094300|217804|P1|NOT COMPLETED|Overall Study||20
88700|NCT02094300|217804|P1|COMPLETED|Overall Study||6
88701|NCT02094300|217804|P1|30 Days|Overall Study||24
88702|NCT02094300|217804|P1|STARTED|Overall Study||26
88703|NCT02094261|217808|P1|NOT COMPLETED|Overall Study||210
88704|NCT02094261|217808|P1|COMPLETED|Overall Study||0
88705|NCT02094261|217808|P1|STARTED|Overall Study||210
88706|NCT02093962|217817|P2|NOT COMPLETED|Overall Study||131
88707|NCT02093962|217818|P1|NOT COMPLETED|Overall Study||134
88708|NCT02093962|217817|P2|COMPLETED|Overall Study||0
88709|NCT02093962|217818|P1|COMPLETED|Overall Study||0
88710|NCT02093962|217817|P2|Received Treatment|Overall Study||130
88711|NCT02093962|217818|P1|Received Treatment|Overall Study||130
88712|NCT02093962|217817|P2|STARTED|Overall Study||131
88713|NCT02093962|217818|P1|STARTED|Overall Study||134
88714|NCT02093949|217826|P2|NOT COMPLETED|Overall Study||0
88715|NCT02093949|217827|P1|NOT COMPLETED|Overall Study||0
88716|NCT02093949|217826|P2|COMPLETED|Overall Study||47
88717|NCT02093949|217827|P1|COMPLETED|Overall Study||105
88718|NCT02093949|217826|P2|STARTED|Overall Study||47
88719|NCT02093949|217827|P1|STARTED|Overall Study||105
88720|NCT02093923|217850|P5|NOT COMPLETED|Overall Study||0
88721|NCT02093923|217851|P4|NOT COMPLETED|Overall Study||2
88722|NCT02093923|217852|P3|NOT COMPLETED|Overall Study||0
88723|NCT02093923|217853|P2|NOT COMPLETED|Overall Study||0
88724|NCT02093923|217854|P1|NOT COMPLETED|Overall Study||0
88725|NCT02093923|217850|P5|COMPLETED|Overall Study||13
88726|NCT02093923|217851|P4|COMPLETED|Overall Study||10
88727|NCT02093923|217852|P3|COMPLETED|Overall Study||5
88728|NCT02093923|217853|P2|COMPLETED|Overall Study||4
88729|NCT02093923|217854|P1|COMPLETED|Overall Study||4
88730|NCT02093923|217850|P5|Treated - 2 Doses:|Overall Study||13
88731|NCT02093923|217851|P4|Treated - 2 Doses:|Overall Study||10
88732|NCT02093923|217852|P3|Treated - 2 Doses:|Overall Study||5
88733|NCT02093923|217853|P2|Treated - 2 Doses:|Overall Study||4
88734|NCT02093923|217854|P1|Treated - 2 Doses:|Overall Study||4
88735|NCT02093923|217850|P5|Treated - 1 Dose Only:|Overall Study||0
88736|NCT02093923|217851|P4|Treated - 1 Dose Only:|Overall Study||1
88737|NCT02093923|217852|P3|Treated - 1 Dose Only:|Overall Study||0
88738|NCT02093923|217853|P2|Treated - 1 Dose Only:|Overall Study||0
88739|NCT02093923|217854|P1|Treated - 1 Dose Only:|Overall Study||0
88740|NCT02093923|217850|P5|Total Treated|Overall Study||13
88741|NCT02093923|217851|P4|Total Treated|Overall Study||11
88742|NCT02093923|217852|P3|Total Treated|Overall Study||5
88743|NCT02093923|217853|P2|Total Treated|Overall Study||4
88744|NCT02093923|217854|P1|Total Treated|Overall Study||4
88745|NCT02093923|217850|P5|STARTED|Overall Study||13
88746|NCT02093923|217851|P4|STARTED|Overall Study||12
88747|NCT02093923|217852|P3|STARTED|Overall Study||5
88748|NCT02093923|217853|P2|STARTED|Overall Study||4
88749|NCT02093923|217854|P1|STARTED|Overall Study||4
88750|NCT02093897|217909|P1|NOT COMPLETED|Overall Study||19
88751|NCT02093897|217909|P1|COMPLETED|Overall Study||65
88752|NCT02093897|217909|P1|STARTED|Overall Study||84
88753|NCT02093819|217937|P8|NOT COMPLETED|Overall Study||0
88754|NCT02093819|217938|P7|NOT COMPLETED|Overall Study||0
88755|NCT02093819|217939|P6|NOT COMPLETED|Overall Study||0
88756|NCT02093819|217940|P5|NOT COMPLETED|Overall Study||0
88757|NCT02093819|217941|P4|NOT COMPLETED|Overall Study||0
88758|NCT02093819|217942|P3|NOT COMPLETED|Overall Study||0
88759|NCT02093819|217943|P2|NOT COMPLETED|Overall Study||0
88760|NCT02093819|217944|P1|NOT COMPLETED|Overall Study||0
88761|NCT02093819|217937|P8|COMPLETED|Overall Study||6
88762|NCT02093819|217938|P7|COMPLETED|Overall Study||5
88763|NCT02093819|217939|P6|COMPLETED|Overall Study||6
88764|NCT02093819|217940|P5|COMPLETED|Overall Study||6
88765|NCT02093819|217941|P4|COMPLETED|Overall Study||6
88766|NCT02093819|217942|P3|COMPLETED|Overall Study||10
88767|NCT02093819|217943|P2|COMPLETED|Overall Study||6
88768|NCT02093819|217944|P1|COMPLETED|Overall Study||15
88769|NCT02093819|217937|P8|STARTED|Overall Study||6
88770|NCT02093819|217938|P7|STARTED|Overall Study||5
88771|NCT02093819|217939|P6|STARTED|Overall Study||6
88772|NCT02093819|217940|P5|STARTED|Overall Study||6
88773|NCT02093819|217941|P4|STARTED|Overall Study||6
88774|NCT02093819|217942|P3|STARTED|Overall Study||10
88775|NCT02093819|217943|P2|STARTED|Overall Study||6
88776|NCT02093819|217944|P1|STARTED|Overall Study||15
88777|NCT02093702|217980|P2|NOT COMPLETED|Overall Study||0
88778|NCT02093702|217981|P1|NOT COMPLETED|Overall Study||0
88779|NCT02093702|217980|P2|COMPLETED|Overall Study||3
88780|NCT02093702|217981|P1|COMPLETED|Overall Study||2
88781|NCT02093702|217980|P2|STARTED|Overall Study||3
88782|NCT02093702|217981|P1|STARTED|Overall Study||2
88783|NCT02093689|218012|P3|NOT COMPLETED|Overall Study||0
88784|NCT02093689|218013|P2|NOT COMPLETED|Overall Study||0
88785|NCT02093689|218014|P1|NOT COMPLETED|Overall Study||4
88786|NCT02093689|218012|P3|COMPLETED|Overall Study||0
88787|NCT02093689|218013|P2|COMPLETED|Overall Study||0
88788|NCT02093689|218014|P1|COMPLETED|Overall Study||14
88789|NCT02093689|218012|P3|STARTED|Overall Study||0
88790|NCT02093689|218013|P2|STARTED|Overall Study||0
88791|NCT02093689|218014|P1|STARTED|Overall Study||18
88792|NCT02093520|218022|P2|NOT COMPLETED|Overall Study||22
88793|NCT02093520|218023|P1|NOT COMPLETED|Overall Study||6
88794|NCT02093520|218022|P2|COMPLETED|Overall Study||131
88795|NCT02093520|218023|P1|COMPLETED|Overall Study||143
88796|NCT02093520|218022|P2|STARTED|Overall Study||153
88797|NCT02093520|218023|P1|STARTED|Overall Study||149
88798|NCT02093390|218035|P2|NOT COMPLETED|Overall Study||1
88799|NCT02093390|218036|P1|NOT COMPLETED|Overall Study||0
88800|NCT02093390|218035|P2|COMPLETED|Overall Study||19
88801|NCT02093390|218036|P1|COMPLETED|Overall Study||20
88802|NCT02093390|218035|P2|STARTED|Overall Study||20
88803|NCT02093390|218036|P1|STARTED|Overall Study||20
88804|NCT02093351|218075|P4|NOT COMPLETED|Part B||63
88805|NCT02093351|218076|P3|NOT COMPLETED|Part B||0
88806|NCT02093351|218077|P2|NOT COMPLETED|Part B||0
88807|NCT02093351|218078|P1|NOT COMPLETED|Part B||0
88808|NCT02093351|218075|P4|COMPLETED|Part B||6
88809|NCT02093351|218076|P3|COMPLETED|Part B||0
88810|NCT02093351|218077|P2|COMPLETED|Part B||0
88811|NCT02093351|218078|P1|COMPLETED|Part B||0
88812|NCT02093351|218075|P4|STARTED|Part B|Eligible patients completing Part A entered Part B for continued access to olaparib.|69
88813|NCT02093351|218076|P3|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
88814|NCT02093351|218077|P2|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
88815|NCT02093351|218078|P1|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
88816|NCT02093351|218075|P4|NOT COMPLETED|Part A||0
88817|NCT02093351|218076|P3|NOT COMPLETED|Part A||3
88818|NCT02093351|218077|P2|NOT COMPLETED|Part A||2
88819|NCT02093351|218078|P1|NOT COMPLETED|Part A||2
88820|NCT02093351|218075|P4|COMPLETED|Part A||0
88821|NCT02093351|218076|P3|COMPLETED|Part A||23
88822|NCT02093351|218077|P2|COMPLETED|Part A||21
88823|NCT02093351|218078|P1|COMPLETED|Part A||28
88824|NCT02093351|218075|P4|Completing Treatment Period 3|Part A||0
88825|NCT02093351|218076|P3|Completing Treatment Period 3|Part A||23
88826|NCT02093351|218077|P2|Completing Treatment Period 3|Part A||21
88827|NCT02093351|218078|P1|Completing Treatment Period 3|Part A||28
88828|NCT02093351|218075|P4|Completing Treatment Period 2|Part A||0
88829|NCT02093351|218076|P3|Completing Treatment Period 2|Part A||23
88830|NCT02093351|218077|P2|Completing Treatment Period 2|Part A||21
88831|NCT02093351|218078|P1|Completing Treatment Period 2|Part A||29
88832|NCT02093351|218075|P4|Completing Treatment Period 1|Part A||0
88833|NCT02093351|218076|P3|Completing Treatment Period 1|Part A||23
88834|NCT02093351|218077|P2|Completing Treatment Period 1|Part A||22
88835|NCT02093351|218078|P1|Completing Treatment Period 1|Part A||29
88836|NCT02093351|218075|P4|STARTED|Part A||0
88837|NCT02093351|218076|P3|STARTED|Part A||26
88838|NCT02093351|218077|P2|STARTED|Part A||23
88839|NCT02093351|218078|P1|STARTED|Part A||30
88840|NCT02093234|218111|P3|NOT COMPLETED|Overall Study||4
88841|NCT02093234|218112|P2|NOT COMPLETED|Overall Study||4
88842|NCT02093234|218113|P1|NOT COMPLETED|Overall Study||3
88843|NCT02093234|218111|P3|COMPLETED|Overall Study||50
88844|NCT02093234|218112|P2|COMPLETED|Overall Study||52
88845|NCT02093234|218113|P1|COMPLETED|Overall Study||53
88846|NCT02093234|218111|P3|STARTED|Overall Study||54
88847|NCT02093234|218112|P2|STARTED|Overall Study||56
88848|NCT02093234|218113|P1|STARTED|Overall Study||56
88849|NCT02093221|218135|P5|NOT COMPLETED|Overall Study||8
88850|NCT02093221|218136|P4|NOT COMPLETED|Overall Study||8
88851|NCT02093221|218137|P3|NOT COMPLETED|Overall Study||9
88852|NCT02093221|218138|P2|NOT COMPLETED|Overall Study||8
88853|NCT02093221|218139|P1|NOT COMPLETED|Overall Study||10
88854|NCT02093221|218135|P5|COMPLETED|Overall Study||7
88855|NCT02093221|218136|P4|COMPLETED|Overall Study||7
88856|NCT02093221|218137|P3|COMPLETED|Overall Study||6
88857|NCT02093221|218138|P2|COMPLETED|Overall Study||8
88858|NCT02093221|218139|P1|COMPLETED|Overall Study||5
88859|NCT02093221|218135|P5|STARTED|Overall Study||15
88860|NCT02093221|218136|P4|STARTED|Overall Study||15
88861|NCT02093221|218137|P3|STARTED|Overall Study||15
88862|NCT02093221|218138|P2|STARTED|Overall Study||16
88863|NCT02093221|218139|P1|STARTED|Overall Study||15
88864|NCT02093026|218176|P1|NOT COMPLETED|Overall Study||193
88865|NCT02093026|218176|P1|COMPLETED|Overall Study|At predefined end-of-treatment date, 272 ongoing participants were designated as completed study.|272
88866|NCT02093026|218176|P1|STARTED|Overall Study||465
88867|NCT02092961|218198|P3|NOT COMPLETED|Overall Study||16
88868|NCT02092961|218199|P2|NOT COMPLETED|Overall Study||14
88869|NCT02092961|218200|P1|NOT COMPLETED|Overall Study||21
88870|NCT02092961|218198|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|13
88871|NCT02092961|218199|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|14
88872|NCT02092961|218200|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|12
88873|NCT02092961|218198|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
88874|NCT02092961|218199|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/study stopped|5
88875|NCT02092961|218200|P1|Randomised But Did Not Receive Treatment|Overall Study|Study stopped|1
88876|NCT02092961|218198|P3|STARTED|Overall Study|Patients who received treatment|29
88877|NCT02092961|218199|P2|STARTED|Overall Study|Patients who received treatment|28
88878|NCT02092961|218200|P1|STARTED|Overall Study|Patients who received treatment|33
88879|NCT02092909|218225|P4|NOT COMPLETED|Overall Study||6
88880|NCT02092909|218226|P3|NOT COMPLETED|Overall Study||9
88881|NCT02092909|218227|P2|NOT COMPLETED|Overall Study||3
88882|NCT02092909|218228|P1|NOT COMPLETED|Overall Study||1
88883|NCT02092909|218225|P4|COMPLETED|Overall Study||0
88884|NCT02092909|218226|P3|COMPLETED|Overall Study||5
88885|NCT02092909|218227|P2|COMPLETED|Overall Study||2
88886|NCT02092909|218228|P1|COMPLETED|Overall Study||5
88887|NCT02092909|218225|P4|STARTED|Overall Study||6
88888|NCT02092909|218226|P3|STARTED|Overall Study||14
88889|NCT02092909|218227|P2|STARTED|Overall Study||5
88890|NCT02092909|218228|P1|STARTED|Overall Study||6
88891|NCT02092857|218257|P3|NOT COMPLETED|Overall Study||13
88892|NCT02092857|218258|P2|NOT COMPLETED|Overall Study||12
88893|NCT02092857|218259|P1|NOT COMPLETED|Overall Study||10
88894|NCT02092857|218257|P3|COMPLETED|Overall Study||16
88895|NCT02092857|218258|P2|COMPLETED|Overall Study||18
88896|NCT02092857|218259|P1|COMPLETED|Overall Study||20
88897|NCT02092857|218257|P3|STARTED|Overall Study||29
88898|NCT02092857|218258|P2|STARTED|Overall Study||30
88899|NCT02092857|218259|P1|STARTED|Overall Study||30
88900|NCT02092662|218269|P2|NOT COMPLETED|Overall Study||0
88901|NCT02092662|218270|P1|NOT COMPLETED|Overall Study||13
88902|NCT02092662|218269|P2|COMPLETED|Overall Study||19
88903|NCT02092662|218270|P1|COMPLETED|Overall Study||25
88904|NCT02092662|218269|P2|Recruited|Overall Study||19
88905|NCT02092662|218270|P1|Recruited|Overall Study||38
88906|NCT02092662|218269|P2|STARTED|Overall Study||19
88907|NCT02092662|218270|P1|STARTED|Overall Study||38
88908|NCT02092649|218279|P2|NOT COMPLETED|Overall Study||0
88909|NCT02092649|218280|P1|NOT COMPLETED|Overall Study||0
88910|NCT02092649|218279|P2|COMPLETED|Overall Study|13 participants finished study|13
88911|NCT02092649|218280|P1|COMPLETED|Overall Study|13 participants finished study|13
88912|NCT02092649|218279|P2|STARTED|Overall Study|13 participants recruited|13
88913|NCT02092649|218280|P1|STARTED|Overall Study|13 participants recruited|13
88914|NCT02092610|218298|P2|NOT COMPLETED|Overall Study||12
88915|NCT02092610|218299|P1|NOT COMPLETED|Overall Study||8
88916|NCT02092610|218298|P2|COMPLETED|Overall Study||40
88917|NCT02092610|218299|P1|COMPLETED|Overall Study||17
88918|NCT02092610|218298|P2|STARTED|Overall Study||52
88919|NCT02092610|218299|P1|STARTED|Overall Study||25
88920|NCT02092441|218313|P2|NOT COMPLETED|Overall Study||0
88921|NCT02092441|218314|P1|NOT COMPLETED|Overall Study||0
88922|NCT02092441|218313|P2|COMPLETED|Overall Study||43
88923|NCT02092441|218314|P1|COMPLETED|Overall Study||37
88924|NCT02092441|218313|P2|STARTED|Overall Study||43
88925|NCT02092441|218314|P1|STARTED|Overall Study||37
88926|NCT02092415|218324|P1|NOT COMPLETED|Overall Study||0
88927|NCT02092415|218324|P1|COMPLETED|Overall Study||10
88928|NCT02092415|218324|P1|STARTED|Overall Study||10
88929|NCT02092389|218329|P1|NOT COMPLETED|Overall Study||6
88930|NCT02092389|218329|P1|COMPLETED|Overall Study||4
88931|NCT02092389|218329|P1|STARTED|Overall Study||10
88932|NCT02092350|218341|P2|NOT COMPLETED|Overall Study||12
88933|NCT02092350|218342|P1|NOT COMPLETED|Overall Study||10
88934|NCT02092350|218341|P2|COMPLETED|Overall Study||102
88935|NCT02092350|218342|P1|COMPLETED|Overall Study||113
88936|NCT02092350|218341|P2|STARTED|Overall Study||114
88937|NCT02092350|218342|P1|STARTED|Overall Study||123
88938|NCT02092311|218359|P2|NOT COMPLETED|Overall Study||0
88939|NCT02092311|218360|P1|NOT COMPLETED|Overall Study||0
88940|NCT02092311|218359|P2|COMPLETED|Overall Study||285
88941|NCT02092311|218360|P1|COMPLETED|Overall Study||285
88942|NCT02092311|218359|P2|STARTED|Overall Study||285
88943|NCT02092311|218360|P1|STARTED|Overall Study||285
88944|NCT02092285|218370|P1|NOT COMPLETED|Maintenance Phase & Follow-up||110
88945|NCT02092285|218370|P1|COMPLETED|Maintenance Phase & Follow-up||60
88946|NCT02092285|218370|P1|STARTED|Maintenance Phase & Follow-up||170
88947|NCT02092285|218370|P1|NOT COMPLETED|Induction Phase||35
88948|NCT02092285|218370|P1|COMPLETED|Induction Phase||170
88949|NCT02092285|218370|P1|STARTED|Induction Phase||205
88950|NCT02092220|218374|P2|NOT COMPLETED|Period 2||1
88951|NCT02092220|218375|P1|NOT COMPLETED|Period 2||1
88952|NCT02092220|218374|P2|COMPLETED|Period 2||19
88953|NCT02092220|218375|P1|COMPLETED|Period 2||20
88954|NCT02092220|218374|P2|STARTED|Period 2||20
88955|NCT02092220|218375|P1|STARTED|Period 2||21
88956|NCT02092220|218374|P2|NOT COMPLETED|Period 1||2
88957|NCT02092220|218375|P1|NOT COMPLETED|Period 1||0
88958|NCT02092220|218374|P2|COMPLETED|Period 1||20
88959|NCT02092220|218375|P1|COMPLETED|Period 1||21
88960|NCT02092220|218374|P2|STARTED|Period 1||22
88961|NCT02092220|218375|P1|STARTED|Period 1||21
88962|NCT02092168|218435|P2|NOT COMPLETED|Overall Study||0
88963|NCT02092168|218436|P1|NOT COMPLETED|Overall Study||0
88964|NCT02092168|218435|P2|COMPLETED|Overall Study||12
88965|NCT02092168|218436|P1|COMPLETED|Overall Study||12
88966|NCT02092168|218435|P2|STARTED|Overall Study||12
88967|NCT02092168|218436|P1|STARTED|Overall Study||12
88968|NCT02092116|218448|P2|NOT COMPLETED|Overall Study||4
88969|NCT02092116|218449|P1|NOT COMPLETED|Overall Study||0
88970|NCT02092116|218448|P2|COMPLETED|Overall Study||16
88971|NCT02092116|218449|P1|COMPLETED|Overall Study||6
88972|NCT02092116|218448|P2|STARTED|Overall Study||20
88973|NCT02092116|218449|P1|STARTED|Overall Study||6
88974|NCT02092025|218458|P1|NOT COMPLETED|Overall Study||68
88975|NCT02092025|218458|P1|COMPLETED|Overall Study||3369
88976|NCT02092025|218458|P1|STARTED|Overall Study||3437
88977|NCT02091986|218467|P3|NOT COMPLETED|Overall Study||8
88978|NCT02091986|218468|P2|NOT COMPLETED|Overall Study||11
88979|NCT02091986|218469|P1|NOT COMPLETED|Overall Study||7
88980|NCT02091986|218467|P3|COMPLETED|Overall Study||84
88981|NCT02091986|218468|P2|COMPLETED|Overall Study||84
88982|NCT02091986|218469|P1|COMPLETED|Overall Study||85
88983|NCT02091986|218467|P3|STARTED|Overall Study||92
88984|NCT02091986|218468|P2|STARTED|Overall Study||95
88985|NCT02091986|218469|P1|STARTED|Overall Study||92
88986|NCT02091960|218516|P1|NOT COMPLETED|Overall Study||51
88987|NCT02091960|218516|P1|COMPLETED|Overall Study|Completed indicates participants with disease progression|52
88988|NCT02091960|218516|P1|Received Treatment|Overall Study||103
88989|NCT02091960|218516|P1|STARTED|Overall Study||103
88990|NCT02091921|218527|P1|NOT COMPLETED|Overall Study||3
88991|NCT02091921|218527|P1|COMPLETED|Overall Study||50
88992|NCT02091921|218527|P1|STARTED|Overall Study||53
88993|NCT02091869|218536|P2|NOT COMPLETED|Overall Study||3
88994|NCT02091869|218537|P1|NOT COMPLETED|Overall Study||0
88995|NCT02091869|218536|P2|COMPLETED|Overall Study||14
88996|NCT02091869|218537|P1|COMPLETED|Overall Study||17
88997|NCT02091869|218536|P2|STARTED|Overall Study||17
88998|NCT02091869|218537|P1|STARTED|Overall Study||17
88999|NCT02091856|218552|P3|NOT COMPLETED|Follow-up Assessment||0
89000|NCT02091856|218553|P2|NOT COMPLETED|Follow-up Assessment||3
89001|NCT02091856|218554|P1|NOT COMPLETED|Follow-up Assessment||5
89002|NCT02091856|218552|P3|COMPLETED|Follow-up Assessment||0
89003|NCT02091856|218553|P2|COMPLETED|Follow-up Assessment||9
89004|NCT02091856|218554|P1|COMPLETED|Follow-up Assessment||10
89005|NCT02091856|218552|P3|STARTED|Follow-up Assessment|WLCG participants were lost at follow-up.|0
89006|NCT02091856|218553|P2|STARTED|Follow-up Assessment|Only a subset of R-CBT participants responded to our request to complete the follow-up assessment.|12
89007|NCT02091856|218554|P1|STARTED|Follow-up Assessment|Only a subset of C-CBT participants responded to our request to complete the follow-up assessment.|15
89008|NCT02091856|218552|P3|NOT COMPLETED|Active Intervention Interval||7
89009|NCT02091856|218553|P2|NOT COMPLETED|Active Intervention Interval||7
89010|NCT02091856|218554|P1|NOT COMPLETED|Active Intervention Interval||19
89011|NCT02091856|218552|P3|COMPLETED|Active Intervention Interval||19
89012|NCT02091856|218553|P2|COMPLETED|Active Intervention Interval||12
89013|NCT02091856|218554|P1|COMPLETED|Active Intervention Interval||15
89014|NCT02091856|218552|P3|STARTED|Active Intervention Interval||26
89015|NCT02091856|218553|P2|STARTED|Active Intervention Interval||19
89016|NCT02091856|218554|P1|STARTED|Active Intervention Interval||34
89017|NCT02091778|218574|P1|NOT COMPLETED|Overall Study||1
89018|NCT02091778|218574|P1|COMPLETED|Overall Study||20
89019|NCT02091778|218574|P1|STARTED|Overall Study||21
89020|NCT02091752|218578|P1|NOT COMPLETED|Overall Study||3
89021|NCT02091752|218578|P1|COMPLETED|Overall Study||0
89022|NCT02091752|218578|P1|STARTED|Overall Study||3
89023|NCT02091739|218592|P5|NOT COMPLETED|EP: 48 Weeks||14
89024|NCT02091739|218593|P4|NOT COMPLETED|EP: 48 Weeks||8
89025|NCT02091739|218594|P3|NOT COMPLETED|EP: 48 Weeks||0
89026|NCT02091739|218595|P2|NOT COMPLETED|EP: 48 Weeks||0
89027|NCT02091739|218596|P1|NOT COMPLETED|EP: 48 Weeks||0
89028|NCT02091739|218592|P5|COMPLETED|EP: 48 Weeks||75
89029|NCT02091739|218593|P4|COMPLETED|EP: 48 Weeks||76
89030|NCT02091739|218594|P3|COMPLETED|EP: 48 Weeks||0
89031|NCT02091739|218595|P2|COMPLETED|EP: 48 Weeks||0
89032|NCT02091739|218596|P1|COMPLETED|EP: 48 Weeks||0
89033|NCT02091739|218592|P5|STARTED|EP: 48 Weeks||89
89034|NCT02091739|218593|P4|STARTED|EP: 48 Weeks||84
89035|NCT02091739|218594|P3|STARTED|EP: 48 Weeks||0
89036|NCT02091739|218595|P2|STARTED|EP: 48 Weeks||0
89037|NCT02091739|218596|P1|STARTED|EP: 48 Weeks||0
89038|NCT02091739|218592|P5|NOT COMPLETED|MP: 16 Weeks||0
89039|NCT02091739|218593|P4|NOT COMPLETED|MP: 16 Weeks||0
89040|NCT02091739|218594|P3|NOT COMPLETED|MP: 16 Weeks||2
89041|NCT02091739|218595|P2|NOT COMPLETED|MP: 16 Weeks||5
89042|NCT02091739|218596|P1|NOT COMPLETED|MP: 16 Weeks||4
89043|NCT02091739|218592|P5|COMPLETED|MP: 16 Weeks||0
89044|NCT02091739|218593|P4|COMPLETED|MP: 16 Weeks||0
89045|NCT02091739|218594|P3|COMPLETED|MP: 16 Weeks||72
89046|NCT02091739|218595|P2|COMPLETED|MP: 16 Weeks||69
89047|NCT02091739|218596|P1|COMPLETED|MP: 16 Weeks||32
89048|NCT02091739|218592|P5|STARTED|MP: 16 Weeks||0
89049|NCT02091739|218593|P4|STARTED|MP: 16 Weeks||0
89050|NCT02091739|218594|P3|STARTED|MP: 16 Weeks||74
89051|NCT02091739|218595|P2|STARTED|MP: 16 Weeks||74
89052|NCT02091739|218596|P1|STARTED|MP: 16 Weeks||36
89053|NCT02091726|218615|P1|NOT COMPLETED|Overall Study||6
89054|NCT02091726|218615|P1|COMPLETED|Overall Study||104
89055|NCT02091726|218615|P1|4 Week Followup|Overall Study||104
89056|NCT02091726|218615|P1|1 Week Followup|Overall Study||110
89057|NCT02091726|218615|P1|STARTED|Overall Study||110
89058|NCT02091531|218623|P1|NOT COMPLETED|Overall Study||0
89059|NCT02091531|218623|P1|COMPLETED|Overall Study||9
89060|NCT02091531|218623|P1|STARTED|Overall Study||9
89061|NCT02091466|218631|P2|NOT COMPLETED|Overall Study||0
89062|NCT02091466|218632|P1|NOT COMPLETED|Overall Study||0
89063|NCT02091466|218631|P2|COMPLETED|Overall Study||20
89064|NCT02091466|218632|P1|COMPLETED|Overall Study||20
89065|NCT02091466|218631|P2|STARTED|Overall Study||20
89066|NCT02091466|218632|P1|STARTED|Overall Study||20
89067|NCT02091440|218638|P1|NOT COMPLETED|Overall Study||2
89068|NCT02091440|218638|P1|COMPLETED|Overall Study||4
89069|NCT02091440|218638|P1|Overall Survival at 180 Days|Overall Study||6
89070|NCT02091440|218638|P1|Primary Endpoint (Success at 180 Days)|Overall Study||6
89071|NCT02091440|218638|P1|STARTED|Overall Study||6
89072|NCT02091414|218648|P1|NOT COMPLETED|Overall Study||4
89073|NCT02091414|218648|P1|COMPLETED|Overall Study||32
89074|NCT02091414|218648|P1|STARTED|Overall Study||36
89075|NCT02091375|218662|P2|NOT COMPLETED|Overall Study||3
89076|NCT02091375|218663|P1|NOT COMPLETED|Overall Study||9
89077|NCT02091375|218662|P2|COMPLETED|Overall Study||56
89078|NCT02091375|218663|P1|COMPLETED|Overall Study||52
89079|NCT02091375|218662|P2|Intention to Treat (ITT) Analysis Set|Overall Study||59
89080|NCT02091375|218663|P1|Intention to Treat (ITT) Analysis Set|Overall Study||61
89081|NCT02091375|218662|P2|Safety Analysis Set|Overall Study||59
89082|NCT02091375|218663|P1|Safety Analysis Set|Overall Study||61
89083|NCT02091375|218662|P2|STARTED|Overall Study||59
89084|NCT02091375|218663|P1|STARTED|Overall Study||61
89085|NCT02091362|218693|P2|NOT COMPLETED|Period 2||2
89086|NCT02091362|218694|P1|NOT COMPLETED|Period 2||2
89087|NCT02091362|218693|P2|COMPLETED|Period 2||128
89088|NCT02091362|218694|P1|COMPLETED|Period 2||125
89089|NCT02091362|218693|P2|STARTED|Period 2||130
89090|NCT02091362|218694|P1|STARTED|Period 2||127
89091|NCT02091362|218693|P2|NOT COMPLETED|Wash-out||3
89092|NCT02091362|218694|P1|NOT COMPLETED|Wash-out||1
89093|NCT02091362|218693|P2|COMPLETED|Wash-out||130
89094|NCT02091362|218694|P1|COMPLETED|Wash-out||127
89095|NCT02091362|218693|P2|STARTED|Wash-out||133
89096|NCT02091362|218694|P1|STARTED|Wash-out||128
89097|NCT02091362|218693|P2|NOT COMPLETED|Period 1||4
89098|NCT02091362|218694|P1|NOT COMPLETED|Period 1||5
89099|NCT02091362|218693|P2|COMPLETED|Period 1||133
89100|NCT02091362|218694|P1|COMPLETED|Period 1||128
89101|NCT02091362|218693|P2|STARTED|Period 1||137
89102|NCT02091362|218694|P1|STARTED|Period 1||133
89103|NCT02091284|218716|P2|NOT COMPLETED|Overall Study||1
89104|NCT02091284|218717|P1|NOT COMPLETED|Overall Study||3
89105|NCT02091284|218716|P2|COMPLETED|Overall Study||22
89106|NCT02091284|218717|P1|COMPLETED|Overall Study||23
89107|NCT02091284|218716|P2|STARTED|Overall Study|One subject from this group discontinued the protocol|23
89108|NCT02091284|218717|P1|STARTED|Overall Study|Two subjects from this group discontinued the protocol, data from one subject could not be included.|26
89109|NCT02091206|218739|P4|NOT COMPLETED|Taper Period||2
89110|NCT02091206|218740|P3|NOT COMPLETED|Taper Period||0
89111|NCT02091206|218741|P2|NOT COMPLETED|Taper Period||0
89112|NCT02091206|218742|P1|NOT COMPLETED|Taper Period||1
89113|NCT02091206|218739|P4|COMPLETED|Taper Period||5
89114|NCT02091206|218740|P3|COMPLETED|Taper Period||8
89115|NCT02091206|218741|P2|COMPLETED|Taper Period||7
89116|NCT02091206|218742|P1|COMPLETED|Taper Period||9
89117|NCT02091206|218739|P4|STARTED|Taper Period||7
89118|NCT02091206|218740|P3|STARTED|Taper Period||8
89119|NCT02091206|218741|P2|STARTED|Taper Period||7
89120|NCT02091206|218742|P1|STARTED|Taper Period||10
89121|NCT02091206|218739|P4|NOT COMPLETED|Treatment Period||0
89122|NCT02091206|218740|P3|NOT COMPLETED|Treatment Period||1
89123|NCT02091206|218741|P2|NOT COMPLETED|Treatment Period||1
89124|NCT02091206|218742|P1|NOT COMPLETED|Treatment Period||0
89125|NCT02091206|218739|P4|COMPLETED|Treatment Period||7
89126|NCT02091206|218740|P3|COMPLETED|Treatment Period||8
89127|NCT02091206|218741|P2|COMPLETED|Treatment Period||7
89128|NCT02091206|218742|P1|COMPLETED|Treatment Period||10
89129|NCT02091206|218739|P4|Safety Analysis Set|Treatment Period||7
89130|NCT02091206|218740|P3|Safety Analysis Set|Treatment Period||9
89131|NCT02091206|218741|P2|Safety Analysis Set|Treatment Period||8
89132|NCT02091206|218742|P1|Safety Analysis Set|Treatment Period||10
89133|NCT02091206|218739|P4|STARTED|Treatment Period||7
89134|NCT02091206|218740|P3|STARTED|Treatment Period||9
89135|NCT02091206|218741|P2|STARTED|Treatment Period||8
89136|NCT02091206|218742|P1|STARTED|Treatment Period||10
89137|NCT02091167|218761|P2|NOT COMPLETED|Overall Study||2
89138|NCT02091167|218762|P1|NOT COMPLETED|Overall Study||0
89139|NCT02091167|218761|P2|COMPLETED|Overall Study||14
89140|NCT02091167|218762|P1|COMPLETED|Overall Study||19
89141|NCT02091167|218761|P2|STARTED|Overall Study||16
89142|NCT02091167|218762|P1|STARTED|Overall Study||19
89143|NCT02090894|218770|P1|NOT COMPLETED|Overall Study||0
89144|NCT02090894|218770|P1|COMPLETED|Overall Study||11
89145|NCT02090894|218770|P1|STARTED|Overall Study||11
89146|NCT02090855|218775|P1|NOT COMPLETED|Overall Study||2
89147|NCT02090855|218775|P1|COMPLETED|Overall Study||106
89148|NCT02090855|218775|P1|STARTED|Overall Study||108
89149|NCT02090777|218782|P1|NOT COMPLETED|Overall Study||0
89150|NCT02090777|218782|P1|COMPLETED|Overall Study||4
89151|NCT02090777|218782|P1|STARTED|Overall Study||4
89152|NCT02090764|218788|P2|NOT COMPLETED|Overall Study||20
89153|NCT02090764|218789|P1|NOT COMPLETED|Overall Study||6
89154|NCT02090764|218788|P2|COMPLETED|Overall Study||186
89155|NCT02090764|218789|P1|COMPLETED|Overall Study||200
89156|NCT02090764|218788|P2|STARTED|Overall Study||206
89157|NCT02090764|218789|P1|STARTED|Overall Study||206
89158|NCT02090725|218795|P1|NOT COMPLETED|Overall Study||4
89159|NCT02090725|218795|P1|COMPLETED|Overall Study||0
89160|NCT02090725|218795|P1|STARTED|Overall Study||4
89161|NCT02090413|218802|P3|NOT COMPLETED|Overall Study||23
89162|NCT02090413|218803|P2|NOT COMPLETED|Overall Study||20
89163|NCT02090413|218804|P1|NOT COMPLETED|Overall Study||19
89164|NCT02090413|218802|P3|COMPLETED|Overall Study||57
89165|NCT02090413|218803|P2|COMPLETED|Overall Study||60
89166|NCT02090413|218804|P1|COMPLETED|Overall Study||62
89167|NCT02090413|218802|P3|STARTED|Overall Study||80
89168|NCT02090413|218803|P2|STARTED|Overall Study||80
89169|NCT02090413|218804|P1|STARTED|Overall Study||81
89170|NCT02090283|218881|P3|NOT COMPLETED|Overall Study||10
89171|NCT02090283|218882|P2|NOT COMPLETED|Overall Study||15
89172|NCT02090283|218883|P1|NOT COMPLETED|Overall Study||17
89173|NCT02090283|218881|P3|COMPLETED|Overall Study||0
89174|NCT02090283|218882|P2|COMPLETED|Overall Study||0
89175|NCT02090283|218883|P1|COMPLETED|Overall Study||0
89176|NCT02090283|218881|P3|Received At Least 1 Dose Of Study Drug|Overall Study||10
89177|NCT02090283|218882|P2|Received At Least 1 Dose Of Study Drug|Overall Study||15
89178|NCT02090283|218883|P1|Received At Least 1 Dose Of Study Drug|Overall Study||17
89179|NCT02090283|218881|P3|STARTED|Overall Study||10
89180|NCT02090283|218882|P2|STARTED|Overall Study||15
89181|NCT02090283|218883|P1|STARTED|Overall Study||17
89182|NCT02090088|218894|P1|NOT COMPLETED|Overall Study||0
89183|NCT02090088|218894|P1|COMPLETED|Overall Study||4
89184|NCT02090088|218894|P1|Gave Birth|Overall Study||4
89185|NCT02090088|218894|P1|STARTED|Overall Study||4
89186|NCT02090075|218908|P2|NOT COMPLETED|Overall Study||3
89187|NCT02090075|218909|P1|NOT COMPLETED|Overall Study||7
89188|NCT02090075|218908|P2|COMPLETED|Overall Study||30
89189|NCT02090075|218909|P1|COMPLETED|Overall Study||26
89190|NCT02090075|218908|P2|STARTED|Overall Study||33
89191|NCT02090075|218909|P1|STARTED|Overall Study||33
89192|NCT02089997|218917|P1|NOT COMPLETED|Overall Study||246
89193|NCT02089997|218917|P1|COMPLETED|Overall Study||3058
89194|NCT02089997|218917|P1|STARTED|Overall Study||3304
89195|NCT02089737|218932|P1|NOT COMPLETED|Overall Study||6
89196|NCT02089737|218932|P1|COMPLETED|Overall Study||3085
89197|NCT02089737|218932|P1|STARTED|Overall Study||3091
89198|NCT02089659|218941|P3|NOT COMPLETED|Overall Study||0
89199|NCT02089659|218942|P2|NOT COMPLETED|Overall Study||0
89200|NCT02089659|218943|P1|NOT COMPLETED|Overall Study||0
89201|NCT02089659|218941|P3|COMPLETED|Overall Study||0
89202|NCT02089659|218942|P2|COMPLETED|Overall Study||8
89203|NCT02089659|218943|P1|COMPLETED|Overall Study||8
89204|NCT02089659|218941|P3|STARTED|Overall Study||0
89205|NCT02089659|218942|P2|STARTED|Overall Study||8
89206|NCT02089659|218943|P1|STARTED|Overall Study||8
89207|NCT02089347|218957|P2|NOT COMPLETED|Overall Study||0
89208|NCT02089347|218958|P1|NOT COMPLETED|Overall Study||1
89209|NCT02089347|218957|P2|COMPLETED|Overall Study||178
89210|NCT02089347|218958|P1|COMPLETED|Overall Study||355
89211|NCT02089347|218957|P2|STARTED|Overall Study||178
89212|NCT02089347|218958|P1|STARTED|Overall Study||356
89213|NCT02089191|218980|P2|NOT COMPLETED|Period 2, Second 12 Hours||0
89214|NCT02089191|218981|P1|NOT COMPLETED|Period 2, Second 12 Hours||0
89215|NCT02089191|218980|P2|COMPLETED|Period 2, Second 12 Hours||15
89216|NCT02089191|218981|P1|COMPLETED|Period 2, Second 12 Hours||15
89217|NCT02089191|218980|P2|STARTED|Period 2, Second 12 Hours||15
89218|NCT02089191|218981|P1|STARTED|Period 2, Second 12 Hours|One participant discontinued between Period 1 and Period 2 due to availability|15
89219|NCT02089191|218980|P2|NOT COMPLETED|Period 1, First 12 Hours||0
89220|NCT02089191|218981|P1|NOT COMPLETED|Period 1, First 12 Hours||0
89221|NCT02089191|218980|P2|COMPLETED|Period 1, First 12 Hours||15
89222|NCT02089191|218981|P1|COMPLETED|Period 1, First 12 Hours||16
89223|NCT02089191|218980|P2|STARTED|Period 1, First 12 Hours||15
89224|NCT02089191|218981|P1|STARTED|Period 1, First 12 Hours||16
89225|NCT02089113|218991|P2|NOT COMPLETED|Overall Study||0
89226|NCT02089113|218992|P1|NOT COMPLETED|Overall Study||1
89227|NCT02089113|218991|P2|COMPLETED|Overall Study||80
89228|NCT02089113|218992|P1|COMPLETED|Overall Study||160
89229|NCT02089113|218991|P2|STARTED|Overall Study||80
89230|NCT02089113|218992|P1|STARTED|Overall Study||161
89231|NCT02088957|219000|P2|NOT COMPLETED|Overall Study||0
89232|NCT02088957|219001|P1|NOT COMPLETED|Overall Study||1
89233|NCT02088957|219000|P2|COMPLETED|Overall Study||0
89234|NCT02088957|219001|P1|COMPLETED|Overall Study||0
89235|NCT02088957|219000|P2|STARTED|Overall Study||0
89236|NCT02088957|219001|P1|STARTED|Overall Study||1
89237|NCT02088905|219019|P2|NOT COMPLETED|Overall Study||1
89238|NCT02088905|219020|P1|NOT COMPLETED|Overall Study||5
89239|NCT02088905|219019|P2|COMPLETED|Overall Study||9
89240|NCT02088905|219020|P1|COMPLETED|Overall Study||8
89241|NCT02088905|219019|P2|Week 9|Overall Study||9
89242|NCT02088905|219020|P1|Week 9|Overall Study||10
89243|NCT02088905|219019|P2|STARTED|Overall Study||10
89244|NCT02088905|219020|P1|STARTED|Overall Study||13
89245|NCT02088788|219042|P2|NOT COMPLETED|Overall Study||41
89246|NCT02088788|219043|P1|NOT COMPLETED|Overall Study||30
89247|NCT02088788|219042|P2|COMPLETED|Overall Study||89
89248|NCT02088788|219043|P1|COMPLETED|Overall Study||105
89249|NCT02088788|219042|P2|STARTED|Overall Study||130
89250|NCT02088788|219043|P1|STARTED|Overall Study||135
89251|NCT02088385|219053|P2|NOT COMPLETED|Overall Study||0
89252|NCT02088385|219054|P1|NOT COMPLETED|Overall Study||0
89253|NCT02088385|219053|P2|COMPLETED|Overall Study||10
89254|NCT02088385|219054|P1|COMPLETED|Overall Study||10
89255|NCT02088385|219053|P2|STARTED|Overall Study||10
89256|NCT02088385|219054|P1|STARTED|Overall Study||10
89257|NCT02088216|219064|P2|NOT COMPLETED|Overall Study||10
89258|NCT02088216|219065|P1|NOT COMPLETED|Overall Study||12
89259|NCT02088216|219064|P2|COMPLETED|Overall Study||70
89260|NCT02088216|219065|P1|COMPLETED|Overall Study||69
89261|NCT02088216|219064|P2|STARTED|Overall Study||80
89262|NCT02088216|219065|P1|STARTED|Overall Study||81
89263|NCT02088177|219091|P1|NOT COMPLETED|Overall Study||3
89264|NCT02088177|219091|P1|COMPLETED|Overall Study||9
89265|NCT02088177|219091|P1|STARTED|Overall Study||12
89266|NCT02088073|219101|P5|NOT COMPLETED|Maintanance Phase||7
89267|NCT02088073|219102|P4|NOT COMPLETED|Maintanance Phase||7
89268|NCT02088073|219103|P3|NOT COMPLETED|Maintanance Phase||5
89269|NCT02088073|219104|P2|NOT COMPLETED|Maintanance Phase||10
89270|NCT02088073|219105|P1|NOT COMPLETED|Maintanance Phase||0
89271|NCT02088073|219101|P5|COMPLETED|Maintanance Phase||49
89272|NCT02088073|219102|P4|COMPLETED|Maintanance Phase||44
89273|NCT02088073|219103|P3|COMPLETED|Maintanance Phase||40
89274|NCT02088073|219104|P2|COMPLETED|Maintanance Phase||75
89275|NCT02088073|219105|P1|COMPLETED|Maintanance Phase|251 subjects completed the AP; 240 were eligible to enter the MP. 237 entered the MP.|0
89276|NCT02088073|219101|P5|STARTED|Maintanance Phase||56
89277|NCT02088073|219102|P4|STARTED|Maintanance Phase||51
89278|NCT02088073|219103|P3|STARTED|Maintanance Phase||45
89279|NCT02088073|219104|P2|STARTED|Maintanance Phase||85
89280|NCT02088073|219105|P1|STARTED|Maintanance Phase||0
89281|NCT02088073|219101|P5|NOT COMPLETED|Acute Phase||0
89282|NCT02088073|219102|P4|NOT COMPLETED|Acute Phase||0
89283|NCT02088073|219103|P3|NOT COMPLETED|Acute Phase||0
89284|NCT02088073|219104|P2|NOT COMPLETED|Acute Phase||0
89285|NCT02088073|219105|P1|NOT COMPLETED|Acute Phase||7
89286|NCT02088073|219101|P5|COMPLETED|Acute Phase||0
89287|NCT02088073|219102|P4|COMPLETED|Acute Phase||0
89288|NCT02088073|219103|P3|COMPLETED|Acute Phase||0
89289|NCT02088073|219104|P2|COMPLETED|Acute Phase||0
89290|NCT02088073|219105|P1|COMPLETED|Acute Phase||251
89291|NCT02088073|219101|P5|STARTED|Acute Phase||0
89292|NCT02088073|219102|P4|STARTED|Acute Phase||0
89293|NCT02088073|219103|P3|STARTED|Acute Phase||0
89294|NCT02088073|219104|P2|STARTED|Acute Phase||0
89295|NCT02088073|219105|P1|STARTED|Acute Phase||258
89296|NCT02087995|219157|P1|NOT COMPLETED|Overall Study||0
89297|NCT02087995|219157|P1|COMPLETED|Overall Study||51
89298|NCT02087995|219157|P1|STARTED|Overall Study||51
89299|NCT02087956|219163|P2|NOT COMPLETED|Overall Study||5
89300|NCT02087956|219164|P1|NOT COMPLETED|Overall Study||6
89301|NCT02087956|219163|P2|COMPLETED|Overall Study||107
89302|NCT02087956|219164|P1|COMPLETED|Overall Study||105
89303|NCT02087956|219163|P2|STARTED|Overall Study||112
89304|NCT02087956|219164|P1|STARTED|Overall Study||111
89305|NCT02087943|219179|P5|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
89306|NCT02087943|219180|P4|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
89307|NCT02087943|219181|P3|NOT COMPLETED|Observational Follow-up Phase Week 24-30||3
89308|NCT02087943|219182|P2|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
89309|NCT02087943|219183|P1|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
89310|NCT02087943|219179|P5|COMPLETED|Observational Follow-up Phase Week 24-30||22
89392|NCT02087514|219370|P2|COMPLETED|Overall Study||10
89311|NCT02087943|219180|P4|COMPLETED|Observational Follow-up Phase Week 24-30||23
89312|NCT02087943|219181|P3|COMPLETED|Observational Follow-up Phase Week 24-30||45
89313|NCT02087943|219182|P2|COMPLETED|Observational Follow-up Phase Week 24-30||46
89314|NCT02087943|219183|P1|COMPLETED|Observational Follow-up Phase Week 24-30||0
89315|NCT02087943|219179|P5|STARTED|Observational Follow-up Phase Week 24-30||23
89316|NCT02087943|219180|P4|STARTED|Observational Follow-up Phase Week 24-30||24
89317|NCT02087943|219181|P3|STARTED|Observational Follow-up Phase Week 24-30||48
89318|NCT02087943|219182|P2|STARTED|Observational Follow-up Phase Week 24-30||46
89319|NCT02087943|219183|P1|STARTED|Observational Follow-up Phase Week 24-30||0
89320|NCT02087943|219179|P5|NOT COMPLETED|Active Treatment Phase Week 12-24||2
89321|NCT02087943|219180|P4|NOT COMPLETED|Active Treatment Phase Week 12-24||2
89322|NCT02087943|219181|P3|NOT COMPLETED|Active Treatment Phase Week 12-24||5
89323|NCT02087943|219182|P2|NOT COMPLETED|Active Treatment Phase Week 12-24||4
89324|NCT02087943|219183|P1|NOT COMPLETED|Active Treatment Phase Week 12-24||0
89325|NCT02087943|219179|P5|COMPLETED|Active Treatment Phase Week 12-24||21
89326|NCT02087943|219180|P4|COMPLETED|Active Treatment Phase Week 12-24||22
89327|NCT02087943|219181|P3|COMPLETED|Active Treatment Phase Week 12-24||44
89328|NCT02087943|219182|P2|COMPLETED|Active Treatment Phase Week 12-24||42
89329|NCT02087943|219183|P1|COMPLETED|Active Treatment Phase Week 12-24||0
89330|NCT02087943|219179|P5|STARTED|Active Treatment Phase Week 12-24||23
89331|NCT02087943|219180|P4|STARTED|Active Treatment Phase Week 12-24||24
89332|NCT02087943|219181|P3|STARTED|Active Treatment Phase Week 12-24||49
89333|NCT02087943|219182|P2|STARTED|Active Treatment Phase Week 12-24||46
89334|NCT02087943|219183|P1|STARTED|Active Treatment Phase Week 12-24||0
89335|NCT02087943|219179|P5|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
89336|NCT02087943|219180|P4|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
89337|NCT02087943|219181|P3|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||13
89338|NCT02087943|219182|P2|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||12
89339|NCT02087943|219183|P1|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||14
89340|NCT02087943|219179|P5|COMPLETED|Placebo-Controlled Phase Week 0-12||0
89341|NCT02087943|219180|P4|COMPLETED|Placebo-Controlled Phase Week 0-12||0
89342|NCT02087943|219181|P3|COMPLETED|Placebo-Controlled Phase Week 0-12|1 participant who completed week 12 did not enter the active treatment phase.|50
89343|NCT02087943|219182|P2|COMPLETED|Placebo-Controlled Phase Week 0-12||46
89344|NCT02087943|219183|P1|COMPLETED|Placebo-Controlled Phase Week 0-12|3 participants who completed week 12 did not enter the active treatment phase.|50
89345|NCT02087943|219179|P5|Safety Population|Placebo-Controlled Phase Week 0-12||0
89346|NCT02087943|219180|P4|Safety Population|Placebo-Controlled Phase Week 0-12||0
89347|NCT02087943|219181|P3|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|63
89348|NCT02087943|219182|P2|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|58
89349|NCT02087943|219183|P1|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|64
89350|NCT02087943|219179|P5|STARTED|Placebo-Controlled Phase Week 0-12||0
89351|NCT02087943|219180|P4|STARTED|Placebo-Controlled Phase Week 0-12||0
89352|NCT02087943|219181|P3|STARTED|Placebo-Controlled Phase Week 0-12||63
89353|NCT02087943|219182|P2|STARTED|Placebo-Controlled Phase Week 0-12||58
89354|NCT02087943|219183|P1|STARTED|Placebo-Controlled Phase Week 0-12||64
89355|NCT02087904|219211|P4|NOT COMPLETED|Overall Study||25
89356|NCT02087904|219212|P3|NOT COMPLETED|Overall Study||22
89357|NCT02087904|219213|P2|NOT COMPLETED|Overall Study||19
89358|NCT02087904|219214|P1|NOT COMPLETED|Overall Study||25
89359|NCT02087904|219211|P4|COMPLETED|Overall Study||64
89360|NCT02087904|219212|P3|COMPLETED|Overall Study||65
89361|NCT02087904|219213|P2|COMPLETED|Overall Study||70
89362|NCT02087904|219214|P1|COMPLETED|Overall Study||60
89363|NCT02087904|219211|P4|STARTED|Overall Study||89
89364|NCT02087904|219212|P3|STARTED|Overall Study||87
89365|NCT02087904|219213|P2|STARTED|Overall Study||89
89366|NCT02087904|219214|P1|STARTED|Overall Study||85
89367|NCT02087774|219330|P2|NOT COMPLETED|Overall Study||20
89368|NCT02087774|219331|P1|NOT COMPLETED|Overall Study||8
89369|NCT02087774|219330|P2|COMPLETED|Overall Study||130
89370|NCT02087774|219331|P1|COMPLETED|Overall Study||142
89371|NCT02087774|219330|P2|STARTED|Overall Study||150
89372|NCT02087774|219331|P1|STARTED|Overall Study||150
89373|NCT02087748|219339|P1|NOT COMPLETED|Overall Study||0
89374|NCT02087748|219339|P1|COMPLETED|Overall Study||24
89375|NCT02087748|219339|P1|STARTED|Overall Study||24
89376|NCT02087670|219351|P2|NOT COMPLETED|Overall Study||2
89377|NCT02087670|219352|P1|NOT COMPLETED|Overall Study||3
89378|NCT02087670|219351|P2|COMPLETED|Overall Study||20
89379|NCT02087670|219352|P1|COMPLETED|Overall Study||17
89380|NCT02087670|219351|P2|STARTED|Overall Study||22
89381|NCT02087670|219352|P1|STARTED|Overall Study||20
89382|NCT02087514|219366|P6|NOT COMPLETED|Overall Study||1
89383|NCT02087514|219367|P5|NOT COMPLETED|Overall Study||0
89384|NCT02087514|219368|P4|NOT COMPLETED|Overall Study||2
89385|NCT02087514|219369|P3|NOT COMPLETED|Overall Study||3
89386|NCT02087514|219370|P2|NOT COMPLETED|Overall Study||0
89387|NCT02087514|219371|P1|NOT COMPLETED|Overall Study||2
89388|NCT02087514|219366|P6|COMPLETED|Overall Study||9
89389|NCT02087514|219367|P5|COMPLETED|Overall Study||10
89390|NCT02087514|219368|P4|COMPLETED|Overall Study||8
89391|NCT02087514|219369|P3|COMPLETED|Overall Study||7
89393|NCT02087514|219371|P1|COMPLETED|Overall Study||8
89394|NCT02087514|219366|P6|STARTED|Overall Study||10
89395|NCT02087514|219367|P5|STARTED|Overall Study||10
89396|NCT02087514|219368|P4|STARTED|Overall Study||10
89397|NCT02087514|219369|P3|STARTED|Overall Study||10
89398|NCT02087514|219370|P2|STARTED|Overall Study||10
89399|NCT02087514|219371|P1|STARTED|Overall Study||10
89400|NCT02087423|219388|P3|NOT COMPLETED|Overall Study||68
89401|NCT02087423|219389|P2|NOT COMPLETED|Overall Study||265
89402|NCT02087423|219390|P1|NOT COMPLETED|Overall Study||111
89403|NCT02087423|219388|P3|COMPLETED|Overall Study||0
89404|NCT02087423|219389|P2|COMPLETED|Overall Study||0
89405|NCT02087423|219390|P1|COMPLETED|Overall Study||0
89406|NCT02087423|219388|P3|Completed 12 Months of Treatment|Overall Study||26
89407|NCT02087423|219389|P2|Completed 12 Months of Treatment|Overall Study||60
89408|NCT02087423|219390|P1|Completed 12 Months of Treatment|Overall Study||18
89409|NCT02087423|219388|P3|STARTED|Overall Study|Treated|68
89410|NCT02087423|219389|P2|STARTED|Overall Study|Treated|265
89411|NCT02087423|219390|P1|STARTED|Overall Study|Treated|111
89412|NCT02087241|219419|P4|NOT COMPLETED|Overall Study||7
89413|NCT02087241|219420|P3|NOT COMPLETED|Overall Study||1
89414|NCT02087241|219421|P2|NOT COMPLETED|Overall Study||3
89415|NCT02087241|219422|P1|NOT COMPLETED|Overall Study||3
89416|NCT02087241|219419|P4|COMPLETED|Overall Study||0
89417|NCT02087241|219420|P3|COMPLETED|Overall Study||0
89418|NCT02087241|219421|P2|COMPLETED|Overall Study||0
89419|NCT02087241|219422|P1|COMPLETED|Overall Study||0
89420|NCT02087241|219419|P4|STARTED|Overall Study||7
89421|NCT02087241|219420|P3|STARTED|Overall Study||1
89422|NCT02087241|219421|P2|STARTED|Overall Study||3
89423|NCT02087241|219422|P1|STARTED|Overall Study||3
89424|NCT02087176|219448|P1|NOT COMPLETED|Overall Study||32
89425|NCT02087176|219448|P1|COMPLETED|Overall Study|The sponsor terminated the study early.|0
89426|NCT02087176|219448|P1|STARTED|Overall Study||32
89427|NCT02087163|219453|P1|NOT COMPLETED|Overall Study||17
89428|NCT02087163|219453|P1|COMPLETED|Overall Study||73
89429|NCT02087163|219453|P1|STARTED|Overall Study||90
89430|NCT02087150|219461|P3|NOT COMPLETED|Overall Study||11
89431|NCT02087150|219462|P2|NOT COMPLETED|Overall Study||34
89432|NCT02087150|219463|P1|NOT COMPLETED|Overall Study||10
89433|NCT02087150|219461|P3|COMPLETED|Overall Study||69
89434|NCT02087150|219462|P2|COMPLETED|Overall Study||128
89435|NCT02087150|219463|P1|COMPLETED|Overall Study||71
89436|NCT02087150|219461|P3|Received a Crossover MM ETBC Procedure|Overall Study||70
89437|NCT02087150|219462|P2|Received a Crossover MM ETBC Procedure|Overall Study||0
89438|NCT02087150|219463|P1|Received a Crossover MM ETBC Procedure|Overall Study||0
89439|NCT02087150|219461|P3|Had a Lead-in or Randomized ETBC Proc|Overall Study||0
89440|NCT02087150|219462|P2|Had a Lead-in or Randomized ETBC Proc|Overall Study||149
89441|NCT02087150|219463|P1|Had a Lead-in or Randomized ETBC Proc|Overall Study||80
89442|NCT02087150|219461|P3|STARTED|Overall Study||80
89443|NCT02087150|219462|P2|STARTED|Overall Study||162
89444|NCT02087150|219463|P1|STARTED|Overall Study||81
89445|NCT02087085|219482|P2|NOT COMPLETED|Overall Study||116
89446|NCT02087085|219483|P1|NOT COMPLETED|Overall Study||120
89447|NCT02087085|219482|P2|COMPLETED|Overall Study||40
89448|NCT02087085|219483|P1|COMPLETED|Overall Study||34
89449|NCT02087085|219482|P2|STARTED|Overall Study||156
89450|NCT02087085|219483|P1|STARTED|Overall Study||154
89451|NCT02087059|219493|P1|NOT COMPLETED|Overall Study||7
89452|NCT02087059|219493|P1|COMPLETED|Overall Study||44
89453|NCT02087059|219493|P1|STARTED|Overall Study||51
89454|NCT02086786|219503|P2|NOT COMPLETED|Overall Study||16
89455|NCT02086786|219504|P1|NOT COMPLETED|Overall Study||18
89456|NCT02086786|219503|P2|COMPLETED|Overall Study||19
89457|NCT02086786|219504|P1|COMPLETED|Overall Study||17
89458|NCT02086786|219503|P2|STARTED|Overall Study||35
89459|NCT02086786|219504|P1|STARTED|Overall Study||35
89460|NCT02086708|219528|P1|NOT COMPLETED|Overall Study||0
89461|NCT02086708|219528|P1|COMPLETED|Overall Study||24
89462|NCT02086708|219528|P1|STARTED|Overall Study||24
89463|NCT02086682|219542|P2|NOT COMPLETED|Overall Study||0
89464|NCT02086682|219543|P1|NOT COMPLETED|Overall Study||0
89465|NCT02086682|219542|P2|COMPLETED|Overall Study||182
89466|NCT02086682|219543|P1|COMPLETED|Overall Study||156
89467|NCT02086682|219542|P2|STARTED|Overall Study||182
89468|NCT02086682|219543|P1|STARTED|Overall Study||156
89469|NCT02086591|219549|P1|NOT COMPLETED|Overall Study||5
89470|NCT02086591|219549|P1|COMPLETED|Overall Study||2
89471|NCT02086591|219549|P1|STARTED|Overall Study||7
89472|NCT02086565|219557|P2|NOT COMPLETED|Overall Study||12
89473|NCT02086565|219558|P1|NOT COMPLETED|Overall Study||16
89474|NCT02086565|219557|P2|COMPLETED|Overall Study||138
89475|NCT02086565|219558|P1|COMPLETED|Overall Study||135
89476|NCT02086565|219557|P2|STARTED|Overall Study||150
89477|NCT02086565|219558|P1|STARTED|Overall Study||151
89478|NCT02086552|219572|P1|NOT COMPLETED|Overall Study||1
89479|NCT02086552|219572|P1|COMPLETED|Overall Study||27
89480|NCT02086552|219572|P1|STARTED|Overall Study||28
89481|NCT02086162|219581|P2|NOT COMPLETED|Overall Study||7
89482|NCT02086162|219582|P1|NOT COMPLETED|Overall Study||10
89483|NCT02086162|219581|P2|COMPLETED|Overall Study||77
89484|NCT02086162|219582|P1|COMPLETED|Overall Study||68
89485|NCT02086162|219581|P2|STARTED|Overall Study||84
89486|NCT02086162|219582|P1|STARTED|Overall Study||78
89487|NCT02086110|219594|P2|NOT COMPLETED|Overall Study||1
89488|NCT02086110|219595|P1|NOT COMPLETED|Overall Study||1
89489|NCT02086110|219594|P2|COMPLETED|Overall Study||5
89490|NCT02086110|219595|P1|COMPLETED|Overall Study||4
89491|NCT02086110|219594|P2|STARTED|Overall Study||6
89492|NCT02086110|219595|P1|STARTED|Overall Study||5
89493|NCT02085785|219606|P2|NOT COMPLETED|Overall Study||2
89494|NCT02085785|219607|P1|NOT COMPLETED|Overall Study||2
89495|NCT02085785|219606|P2|COMPLETED|Overall Study||6
89496|NCT02085785|219607|P1|COMPLETED|Overall Study||5
89497|NCT02085785|219606|P2|STARTED|Overall Study||8
89498|NCT02085785|219607|P1|STARTED|Overall Study||7
89499|NCT02085720|219619|P1|NOT COMPLETED|Overall Study||0
89500|NCT02085720|219619|P1|COMPLETED|Overall Study||819
89501|NCT02085720|219619|P1|STARTED|Overall Study||819
89502|NCT02085473|219631|P4|NOT COMPLETED|Overall Study||0
89503|NCT02085473|219632|P3|NOT COMPLETED|Overall Study||0
89504|NCT02085473|219633|P2|NOT COMPLETED|Overall Study||0
89505|NCT02085473|219634|P1|NOT COMPLETED|Overall Study||0
89506|NCT02085473|219631|P4|COMPLETED|Overall Study||15
89507|NCT02085473|219632|P3|COMPLETED|Overall Study||15
89508|NCT02085473|219633|P2|COMPLETED|Overall Study||15
89509|NCT02085473|219634|P1|COMPLETED|Overall Study||15
89510|NCT02085473|219631|P4|STARTED|Overall Study||15
89511|NCT02085473|219632|P3|STARTED|Overall Study||15
89512|NCT02085473|219633|P2|STARTED|Overall Study||15
89513|NCT02085473|219634|P1|STARTED|Overall Study||15
89514|NCT02085356|219700|P4|NOT COMPLETED|Overall Study||0
89515|NCT02085356|219701|P3|NOT COMPLETED|Overall Study||0
89516|NCT02085356|219702|P2|NOT COMPLETED|Overall Study||0
89517|NCT02085356|219703|P1|NOT COMPLETED|Overall Study||0
89518|NCT02085356|219700|P4|COMPLETED|Overall Study||361
89519|NCT02085356|219701|P3|COMPLETED|Overall Study||681
89520|NCT02085356|219702|P2|COMPLETED|Overall Study||348
89521|NCT02085356|219703|P1|COMPLETED|Overall Study||577
89522|NCT02085356|219700|P4|STARTED|Overall Study||361
89523|NCT02085356|219701|P3|STARTED|Overall Study||681
89524|NCT02085356|219702|P2|STARTED|Overall Study||348
89525|NCT02085356|219703|P1|STARTED|Overall Study||577
89526|NCT02085252|219731|P2|NOT COMPLETED|Overall Study||4
89527|NCT02085252|219732|P1|NOT COMPLETED|Overall Study||1
89528|NCT02085252|219731|P2|COMPLETED|Overall Study||53
89529|NCT02085252|219732|P1|COMPLETED|Overall Study||57
89530|NCT02085252|219731|P2|STARTED|Overall Study||57
89531|NCT02085252|219732|P1|STARTED|Overall Study||58
89532|NCT02085161|219756|P4|NOT COMPLETED|Overall Study||10
89533|NCT02085161|219757|P3|NOT COMPLETED|Overall Study||5
89534|NCT02085161|219758|P2|NOT COMPLETED|Overall Study||10
89535|NCT02085161|219759|P1|NOT COMPLETED|Overall Study||12
89536|NCT02085161|219756|P4|COMPLETED|Overall Study||66
89537|NCT02085161|219757|P3|COMPLETED|Overall Study||71
89538|NCT02085161|219758|P2|COMPLETED|Overall Study||66
89539|NCT02085161|219759|P1|COMPLETED|Overall Study||64
89540|NCT02085161|219756|P4|STARTED|Overall Study||76
89541|NCT02085161|219757|P3|STARTED|Overall Study||76
89542|NCT02085161|219758|P2|STARTED|Overall Study||76
89543|NCT02085161|219759|P1|STARTED|Overall Study||76
89544|NCT02085135|219800|P2|NOT COMPLETED|Overall Study||9
89545|NCT02085135|219801|P1|NOT COMPLETED|Overall Study||11
89546|NCT02085135|219800|P2|COMPLETED|Overall Study||23
89547|NCT02085135|219801|P1|COMPLETED|Overall Study||23
89548|NCT02085135|219800|P2|STARTED|Overall Study||32
89549|NCT02085135|219801|P1|STARTED|Overall Study||34
89550|NCT02084797|219807|P1|NOT COMPLETED|Overall Study||0
89551|NCT02084797|219807|P1|COMPLETED|Overall Study||10
89552|NCT02084797|219807|P1|STARTED|Overall Study||10
89553|NCT02084706|219816|P2|NOT COMPLETED|Overall Study||0
89554|NCT02084706|219817|P1|NOT COMPLETED|Overall Study||0
89555|NCT02084706|219816|P2|COMPLETED|Overall Study||31
89556|NCT02084706|219817|P1|COMPLETED|Overall Study||29
89557|NCT02084706|219816|P2|STARTED|Overall Study||31
89558|NCT02084706|219817|P1|STARTED|Overall Study||29
89559|NCT02084628|219823|P1|NOT COMPLETED|Overall Study||0
89560|NCT02084628|219823|P1|COMPLETED|Overall Study||1
89561|NCT02084628|219823|P1|STARTED|Overall Study||1
89562|NCT02084511|219840|P4|NOT COMPLETED|Overall Study||0
89563|NCT02084511|219841|P3|NOT COMPLETED|Overall Study||0
89564|NCT02084511|219842|P2|NOT COMPLETED|Overall Study||0
89565|NCT02084511|219843|P1|NOT COMPLETED|Overall Study||0
89566|NCT02084511|219840|P4|COMPLETED|Overall Study||20
89567|NCT02084511|219841|P3|COMPLETED|Overall Study||20
89568|NCT02084511|219842|P2|COMPLETED|Overall Study||20
89569|NCT02084511|219843|P1|COMPLETED|Overall Study||20
89570|NCT02084511|219840|P4|STARTED|Overall Study||20
89571|NCT02084511|219841|P3|STARTED|Overall Study||20
89572|NCT02084511|219842|P2|STARTED|Overall Study||20
89573|NCT02084511|219843|P1|STARTED|Overall Study||20
89574|NCT02084238|219873|P1|NOT COMPLETED|Overall Study||2
89575|NCT02084238|219873|P1|COMPLETED|Overall Study||38
89576|NCT02084238|219873|P1|STARTED|Overall Study||40
89577|NCT02084160|219884|P1|NOT COMPLETED|Overall Study||0
89578|NCT02084160|219884|P1|COMPLETED|Overall Study||579
89579|NCT02084160|219884|P1|STARTED|Overall Study||579
89580|NCT02084147|219888|P1|NOT COMPLETED|Overall Study||0
89581|NCT02084147|219888|P1|COMPLETED|Overall Study||72
89582|NCT02084147|219888|P1|STARTED|Overall Study||72
89583|NCT02084134|219898|P2|NOT COMPLETED|Overall Study||3
89584|NCT02084134|219899|P1|NOT COMPLETED|Overall Study||4
89585|NCT02084134|219898|P2|COMPLETED|Overall Study||17
89586|NCT02084134|219899|P1|COMPLETED|Overall Study||19
89587|NCT02084134|219898|P2|STARTED|Overall Study||20
89588|NCT02084134|219899|P1|STARTED|Overall Study||23
89589|NCT02084082|219909|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
89590|NCT02084082|219910|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
89591|NCT02084082|219911|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
89592|NCT02084082|219912|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
89593|NCT02084082|219909|P4|COMPLETED|Treatment Period 2 (4 Days)||6
89594|NCT02084082|219910|P3|COMPLETED|Treatment Period 2 (4 Days)||7
89595|NCT02084082|219911|P2|COMPLETED|Treatment Period 2 (4 Days)||26
89596|NCT02084082|219912|P1|COMPLETED|Treatment Period 2 (4 Days)||26
89597|NCT02084082|219909|P4|STARTED|Treatment Period 2 (4 Days)||6
89598|NCT02084082|219910|P3|STARTED|Treatment Period 2 (4 Days)||7
89599|NCT02084082|219911|P2|STARTED|Treatment Period 2 (4 Days)||26
89600|NCT02084082|219912|P1|STARTED|Treatment Period 2 (4 Days)||26
89601|NCT02084082|219909|P4|NOT COMPLETED|Washout Period 1 (35 Days)||2
89602|NCT02084082|219910|P3|NOT COMPLETED|Washout Period 1 (35 Days)||1
89603|NCT02084082|219911|P2|NOT COMPLETED|Washout Period 1 (35 Days)||0
89604|NCT02084082|219912|P1|NOT COMPLETED|Washout Period 1 (35 Days)||0
89605|NCT02084082|219909|P4|COMPLETED|Washout Period 1 (35 Days)||6
89606|NCT02084082|219910|P3|COMPLETED|Washout Period 1 (35 Days)||7
89607|NCT02084082|219911|P2|COMPLETED|Washout Period 1 (35 Days)||26
89608|NCT02084082|219912|P1|COMPLETED|Washout Period 1 (35 Days)||26
89609|NCT02084082|219909|P4|STARTED|Washout Period 1 (35 Days)||8
89610|NCT02084082|219910|P3|STARTED|Washout Period 1 (35 Days)||8
89611|NCT02084082|219911|P2|STARTED|Washout Period 1 (35 Days)||26
89612|NCT02084082|219912|P1|STARTED|Washout Period 1 (35 Days)||26
89613|NCT02084082|219909|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
89614|NCT02084082|219910|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
89615|NCT02084082|219911|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
89616|NCT02084082|219912|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
89617|NCT02084082|219909|P4|COMPLETED|Treatment Period 1 (4 Days)||8
89618|NCT02084082|219910|P3|COMPLETED|Treatment Period 1 (4 Days)||8
89619|NCT02084082|219911|P2|COMPLETED|Treatment Period 1 (4 Days)||26
89620|NCT02084082|219912|P1|COMPLETED|Treatment Period 1 (4 Days)||26
89621|NCT02084082|219909|P4|STARTED|Treatment Period 1 (4 Days)||8
89622|NCT02084082|219910|P3|STARTED|Treatment Period 1 (4 Days)||8
89623|NCT02084082|219911|P2|STARTED|Treatment Period 1 (4 Days)||26
89624|NCT02084082|219912|P1|STARTED|Treatment Period 1 (4 Days)||26
89625|NCT02084069|219944|P2|NOT COMPLETED|Overall Study||0
89626|NCT02084069|219945|P1|NOT COMPLETED|Overall Study||0
89627|NCT02084069|219944|P2|COMPLETED|Overall Study||29
89628|NCT02084069|219945|P1|COMPLETED|Overall Study||29
89629|NCT02084069|219944|P2|STARTED|Overall Study||29
89630|NCT02084069|219945|P1|STARTED|Overall Study||29
89631|NCT02084056|219953|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
89632|NCT02084056|219954|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
89633|NCT02084056|219955|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
89634|NCT02084056|219956|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
89635|NCT02084056|219953|P4|COMPLETED|Treatment Period 2 (4 Days)||8
89636|NCT02084056|219954|P3|COMPLETED|Treatment Period 2 (4 Days)||8
89637|NCT02084056|219955|P2|COMPLETED|Treatment Period 2 (4 Days)||30
89638|NCT02084056|219956|P1|COMPLETED|Treatment Period 2 (4 Days)||26
89639|NCT02084056|219953|P4|STARTED|Treatment Period 2 (4 Days)||8
89640|NCT02084056|219954|P3|STARTED|Treatment Period 2 (4 Days)||8
89641|NCT02084056|219955|P2|STARTED|Treatment Period 2 (4 Days)||30
89642|NCT02084056|219956|P1|STARTED|Treatment Period 2 (4 Days)||26
89643|NCT02084056|219953|P4|NOT COMPLETED|Washout Period 1 (35 Days)||0
89644|NCT02084056|219954|P3|NOT COMPLETED|Washout Period 1 (35 Days)||0
89645|NCT02084056|219955|P2|NOT COMPLETED|Washout Period 1 (35 Days)||0
89646|NCT02084056|219956|P1|NOT COMPLETED|Washout Period 1 (35 Days)||1
89647|NCT02084056|219953|P4|COMPLETED|Washout Period 1 (35 Days)||8
89648|NCT02084056|219954|P3|COMPLETED|Washout Period 1 (35 Days)||8
89649|NCT02084056|219955|P2|COMPLETED|Washout Period 1 (35 Days)||30
89650|NCT02084056|219956|P1|COMPLETED|Washout Period 1 (35 Days)||26
89651|NCT02084056|219953|P4|STARTED|Washout Period 1 (35 Days)||8
89652|NCT02084056|219954|P3|STARTED|Washout Period 1 (35 Days)||8
89653|NCT02084056|219955|P2|STARTED|Washout Period 1 (35 Days)||30
89654|NCT02084056|219956|P1|STARTED|Washout Period 1 (35 Days)||27
89655|NCT02084056|219953|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
89656|NCT02084056|219954|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
89657|NCT02084056|219955|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
89658|NCT02084056|219956|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||1
89659|NCT02084056|219953|P4|COMPLETED|Treatment Period 1 (4 Days)||8
89660|NCT02084056|219954|P3|COMPLETED|Treatment Period 1 (4 Days)||8
89661|NCT02084056|219955|P2|COMPLETED|Treatment Period 1 (4 Days)||30
89662|NCT02084056|219956|P1|COMPLETED|Treatment Period 1 (4 Days)||27
89663|NCT02084056|219953|P4|STARTED|Treatment Period 1 (4 Days)||8
89664|NCT02084056|219954|P3|STARTED|Treatment Period 1 (4 Days)||8
89665|NCT02084056|219955|P2|STARTED|Treatment Period 1 (4 Days)||30
89666|NCT02084056|219956|P1|STARTED|Treatment Period 1 (4 Days)||28
89667|NCT02083965|219988|P2|NOT COMPLETED|Treatment Period||0
89668|NCT02083965|219989|P1|NOT COMPLETED|Treatment Period||1
89669|NCT02083965|219988|P2|COMPLETED|Treatment Period||8
89670|NCT02083965|219989|P1|COMPLETED|Treatment Period||9
89671|NCT02083965|219988|P2|STARTED|Treatment Period|1 participant completed PK period 1 and 2, then chose to withdraw and did not enter treatment period|8
89672|NCT02083965|219989|P1|STARTED|Treatment Period||10
89673|NCT02083965|219988|P2|NOT COMPLETED|PK Period 2||0
89674|NCT02083965|219989|P1|NOT COMPLETED|PK Period 2||0
89675|NCT02083965|219988|P2|COMPLETED|PK Period 2||9
89676|NCT02083965|219989|P1|COMPLETED|PK Period 2||10
89677|NCT02083965|219988|P2|STARTED|PK Period 2||9
89678|NCT02083965|219989|P1|STARTED|PK Period 2||10
89679|NCT02083965|219988|P2|NOT COMPLETED|Washout Period||0
89680|NCT02083965|219989|P1|NOT COMPLETED|Washout Period||0
89681|NCT02083965|219988|P2|COMPLETED|Washout Period||9
89682|NCT02083965|219989|P1|COMPLETED|Washout Period||10
89683|NCT02083965|219988|P2|STARTED|Washout Period||9
89684|NCT02083965|219989|P1|STARTED|Washout Period||10
89685|NCT02083965|219988|P2|NOT COMPLETED|PK Period 1||0
89686|NCT02083965|219989|P1|NOT COMPLETED|PK Period 1||0
89687|NCT02083965|219988|P2|COMPLETED|PK Period 1||9
89688|NCT02083965|219989|P1|COMPLETED|PK Period 1||10
89689|NCT02083965|219988|P2|STARTED|PK Period 1||9
89690|NCT02083965|219989|P1|STARTED|PK Period 1||10
89691|NCT02083861|220047|P2|NOT COMPLETED|Overall Study||3
89692|NCT02083861|220048|P1|NOT COMPLETED|Overall Study||6
89693|NCT02083861|220047|P2|COMPLETED|Overall Study||33
89694|NCT02083861|220048|P1|COMPLETED|Overall Study||51
89695|NCT02083861|220047|P2|Treated|Overall Study||35
89696|NCT02083861|220048|P1|Treated|Overall Study||55
89697|NCT02083861|220047|P2|STARTED|Overall Study||36
89698|NCT02083861|220048|P1|STARTED|Overall Study||57
89699|NCT02083679|220064|P4|NOT COMPLETED|Overall Study||0
89700|NCT02083679|220065|P3|NOT COMPLETED|Overall Study||0
89701|NCT02083679|220066|P2|NOT COMPLETED|Overall Study||0
89702|NCT02083679|220067|P1|NOT COMPLETED|Overall Study||0
89703|NCT02083679|220064|P4|COMPLETED|Overall Study||3
89704|NCT02083679|220065|P3|COMPLETED|Overall Study||3
89705|NCT02083679|220066|P2|COMPLETED|Overall Study||6
89706|NCT02083679|220067|P1|COMPLETED|Overall Study||3
89707|NCT02083679|220064|P4|STARTED|Overall Study||3
89708|NCT02083679|220065|P3|STARTED|Overall Study||3
89709|NCT02083679|220066|P2|STARTED|Overall Study||6
89710|NCT02083679|220067|P1|STARTED|Overall Study||3
89711|NCT02083653|220084|P3|NOT COMPLETED|Overall Study||84
89712|NCT02083653|220085|P2|NOT COMPLETED|Overall Study||85
89713|NCT02083653|220086|P1|NOT COMPLETED|Overall Study||82
89714|NCT02083653|220084|P3|COMPLETED|Overall Study||1
89715|NCT02083653|220085|P2|COMPLETED|Overall Study||1
89716|NCT02083653|220086|P1|COMPLETED|Overall Study||1
89717|NCT02083653|220084|P3|STARTED|Overall Study||85
89718|NCT02083653|220085|P2|STARTED|Overall Study||86
89719|NCT02083653|220086|P1|STARTED|Overall Study||83
89720|NCT02083406|220132|P3|NOT COMPLETED|Overall Study||0
89721|NCT02083406|220133|P2|NOT COMPLETED|Overall Study||0
89722|NCT02083406|220134|P1|NOT COMPLETED|Overall Study||0
89723|NCT02083406|220132|P3|COMPLETED|Overall Study||7
89724|NCT02083406|220133|P2|COMPLETED|Overall Study||8
89725|NCT02083406|220134|P1|COMPLETED|Overall Study||7
89726|NCT02083406|220132|P3|STARTED|Overall Study||7
89727|NCT02083406|220133|P2|STARTED|Overall Study||8
89728|NCT02083406|220134|P1|STARTED|Overall Study||7
89729|NCT02083380|220154|P3|NOT COMPLETED|Overall Study||84
89730|NCT02083380|220155|P2|NOT COMPLETED|Overall Study||95
89731|NCT02083380|220156|P1|NOT COMPLETED|Overall Study||91
89732|NCT02083380|220154|P3|COMPLETED|Overall Study||65
89733|NCT02083380|220155|P2|COMPLETED|Overall Study||56
89734|NCT02083380|220156|P1|COMPLETED|Overall Study||57
89735|NCT02083380|220154|P3|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|149
89736|NCT02083380|220155|P2|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|151
89737|NCT02083380|220156|P1|STARTED|Overall Study|5 subjects excluded from safety / ITT population - no drug administered|148
89738|NCT02083263|220251|P2|NOT COMPLETED|Overall Study||0
89739|NCT02083263|220252|P1|NOT COMPLETED|Overall Study||0
89740|NCT02083263|220251|P2|COMPLETED|Overall Study||16
89741|NCT02083263|220252|P1|COMPLETED|Overall Study||16
89742|NCT02083263|220251|P2|STARTED|Overall Study||16
89743|NCT02083263|220252|P1|STARTED|Overall Study||16
89744|NCT02083185|220261|P3|NOT COMPLETED|Overall Study||7
89745|NCT02083185|220262|P2|NOT COMPLETED|Overall Study||29
89746|NCT02083185|220263|P1|NOT COMPLETED|Overall Study||20
89747|NCT02083185|220261|P3|COMPLETED|Overall Study||17
89748|NCT02083185|220262|P2|COMPLETED|Overall Study||27
89749|NCT02083185|220263|P1|COMPLETED|Overall Study||36
89750|NCT02083185|220261|P3|Safety Population|Overall Study||24
89751|NCT02083185|220262|P2|Safety Population|Overall Study||54
89752|NCT02083185|220263|P1|Safety Population|Overall Study||56
89753|NCT02083185|220261|P3|STARTED|Overall Study||24
89754|NCT02083185|220262|P2|STARTED|Overall Study||56
89755|NCT02083185|220263|P1|STARTED|Overall Study||56
89756|NCT02083107|220321|P3|NOT COMPLETED|Overall Study||0
89757|NCT02083107|220322|P2|NOT COMPLETED|Overall Study||0
89758|NCT02083107|220323|P1|NOT COMPLETED|Overall Study||0
89759|NCT02083107|220321|P3|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
89760|NCT02083107|220322|P2|COMPLETED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
89761|NCT02083107|220323|P1|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
89762|NCT02083107|220321|P3|STARTED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
89763|NCT02083107|220322|P2|STARTED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
89764|NCT02083107|220323|P1|STARTED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
89765|NCT02082977|220368|P10|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
89766|NCT02082977|220369|P9|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
89767|NCT02082977|220370|P8|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
89768|NCT02082977|220371|P7|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
89769|NCT02082977|220372|P6|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
89770|NCT02082977|220373|P5|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
89771|NCT02082977|220374|P4|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
89772|NCT02082977|220375|P3|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
89773|NCT02082977|220376|P2|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
89774|NCT02082977|220377|P1|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
89775|NCT02082977|220368|P10|COMPLETED|Part 2 (Up to 3.2 Years)||0
89776|NCT02082977|220369|P9|COMPLETED|Part 2 (Up to 3.2 Years)||0
89777|NCT02082977|220370|P8|COMPLETED|Part 2 (Up to 3.2 Years)||0
89778|NCT02082977|220371|P7|COMPLETED|Part 2 (Up to 3.2 Years)||0
89779|NCT02082977|220372|P6|COMPLETED|Part 2 (Up to 3.2 Years)||0
89780|NCT02082977|220373|P5|COMPLETED|Part 2 (Up to 3.2 Years)||0
89781|NCT02082977|220374|P4|COMPLETED|Part 2 (Up to 3.2 Years)||0
89782|NCT02082977|220375|P3|COMPLETED|Part 2 (Up to 3.2 Years)||0
89783|NCT02082977|220376|P2|COMPLETED|Part 2 (Up to 3.2 Years)||0
89784|NCT02082977|220377|P1|COMPLETED|Part 2 (Up to 3.2 Years)||0
89785|NCT02082977|220368|P10|STARTED|Part 2 (Up to 3.2 Years)||0
89786|NCT02082977|220369|P9|STARTED|Part 2 (Up to 3.2 Years)||0
89787|NCT02082977|220370|P8|STARTED|Part 2 (Up to 3.2 Years)||0
89788|NCT02082977|220371|P7|STARTED|Part 2 (Up to 3.2 Years)||0
89789|NCT02082977|220372|P6|STARTED|Part 2 (Up to 3.2 Years)||0
89790|NCT02082977|220373|P5|STARTED|Part 2 (Up to 3.2 Years)||0
89791|NCT02082977|220374|P4|STARTED|Part 2 (Up to 3.2 Years)||0
89792|NCT02082977|220375|P3|STARTED|Part 2 (Up to 3.2 Years)||0
89793|NCT02082977|220376|P2|STARTED|Part 2 (Up to 3.2 Years)||0
89794|NCT02082977|220377|P1|STARTED|Part 2 (Up to 3.2 Years)||0
89795|NCT02082977|220368|P10|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
89796|NCT02082977|220369|P9|NOT COMPLETED|Part 1 (Up to 3.2 Years)||3
89797|NCT02082977|220370|P8|NOT COMPLETED|Part 1 (Up to 3.2 Years)||5
89798|NCT02082977|220371|P7|NOT COMPLETED|Part 1 (Up to 3.2 Years)||6
89799|NCT02082977|220372|P6|NOT COMPLETED|Part 1 (Up to 3.2 Years)||3
89800|NCT02082977|220373|P5|NOT COMPLETED|Part 1 (Up to 3.2 Years)||1
89801|NCT02082977|220374|P4|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
89802|NCT02082977|220375|P3|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
89803|NCT02082977|220376|P2|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
89804|NCT02082977|220377|P1|NOT COMPLETED|Part 1 (Up to 3.2 Years)||1
89805|NCT02082977|220368|P10|COMPLETED|Part 1 (Up to 3.2 Years)||0
89806|NCT02082977|220369|P9|COMPLETED|Part 1 (Up to 3.2 Years)||4
89807|NCT02082977|220370|P8|COMPLETED|Part 1 (Up to 3.2 Years)||7
89808|NCT02082977|220371|P7|COMPLETED|Part 1 (Up to 3.2 Years)||4
89809|NCT02082977|220372|P6|COMPLETED|Part 1 (Up to 3.2 Years)||1
89810|NCT02082977|220373|P5|COMPLETED|Part 1 (Up to 3.2 Years)||2
89811|NCT02082977|220374|P4|COMPLETED|Part 1 (Up to 3.2 Years)||1
89812|NCT02082977|220375|P3|COMPLETED|Part 1 (Up to 3.2 Years)||1
89813|NCT02082977|220376|P2|COMPLETED|Part 1 (Up to 3.2 Years)||1
89814|NCT02082977|220377|P1|COMPLETED|Part 1 (Up to 3.2 Years)||1
89815|NCT02082977|220368|P10|STARTED|Part 1 (Up to 3.2 Years)||0
89816|NCT02082977|220369|P9|STARTED|Part 1 (Up to 3.2 Years)||7
89817|NCT02082977|220370|P8|STARTED|Part 1 (Up to 3.2 Years)||12
89818|NCT02082977|220371|P7|STARTED|Part 1 (Up to 3.2 Years)||10
89819|NCT02082977|220372|P6|STARTED|Part 1 (Up to 3.2 Years)||4
89820|NCT02082977|220373|P5|STARTED|Part 1 (Up to 3.2 Years)||3
89821|NCT02082977|220374|P4|STARTED|Part 1 (Up to 3.2 Years)||1
89822|NCT02082977|220375|P3|STARTED|Part 1 (Up to 3.2 Years)||1
89823|NCT02082977|220376|P2|STARTED|Part 1 (Up to 3.2 Years)||1
89824|NCT02082977|220377|P1|STARTED|Part 1 (Up to 3.2 Years)||2
89825|NCT02082912|220631|P2|NOT COMPLETED|Overall Study||1
89826|NCT02082912|220632|P1|NOT COMPLETED|Overall Study||0
89827|NCT02082912|220631|P2|COMPLETED|Overall Study||6
89828|NCT02082912|220632|P1|COMPLETED|Overall Study||7
89829|NCT02082912|220631|P2|STARTED|Overall Study||7
89830|NCT02082912|220632|P1|STARTED|Overall Study||7
89831|NCT02082769|220649|P3|NOT COMPLETED|Overall Study||36
89832|NCT02082769|220650|P2|NOT COMPLETED|Overall Study||27
89833|NCT02082769|220651|P1|NOT COMPLETED|Overall Study||24
89834|NCT02082769|220649|P3|COMPLETED|Overall Study||132
89835|NCT02082769|220650|P2|COMPLETED|Overall Study||141
89836|NCT02082769|220651|P1|COMPLETED|Overall Study||144
89837|NCT02082769|220649|P3|STARTED|Overall Study||168
89838|NCT02082769|220650|P2|STARTED|Overall Study||168
89839|NCT02082769|220651|P1|STARTED|Overall Study||168
89840|NCT02082522|220667|P2|NOT COMPLETED|Overall Study||13
89841|NCT02082522|220668|P1|NOT COMPLETED|Overall Study||15
89842|NCT02082522|220667|P2|COMPLETED|Overall Study||0
89843|NCT02082522|220668|P1|COMPLETED|Overall Study||0
89844|NCT02082522|220667|P2|STARTED|Overall Study||13
89845|NCT02082522|220668|P1|STARTED|Overall Study||15
89846|NCT02082392|220718|P2|NOT COMPLETED|Overall Study||0
89847|NCT02082392|220719|P1|NOT COMPLETED|Overall Study||0
89848|NCT02082392|220718|P2|COMPLETED|Overall Study||1
89849|NCT02082392|220719|P1|COMPLETED|Overall Study||2
89850|NCT02082392|220718|P2|STARTED|Overall Study||1
89851|NCT02082392|220719|P1|STARTED|Overall Study||2
89852|NCT02082288|220751|P1|NOT COMPLETED|Overall Study||0
89853|NCT02082288|220751|P1|COMPLETED|Overall Study||243
89854|NCT02082288|220751|P1|STARTED|Overall Study||243
89855|NCT02082262|220755|P1|NOT COMPLETED|Overall Study||51
89856|NCT02082262|220755|P1|COMPLETED|Overall Study||89
89857|NCT02082262|220755|P1|STARTED|Overall Study||140
89858|NCT02082184|220761|P2|NOT COMPLETED|Overall Study||13
89859|NCT02082184|220762|P1|NOT COMPLETED|Overall Study||10
89860|NCT02082184|220761|P2|COMPLETED|Overall Study||62
89861|NCT02082184|220762|P1|COMPLETED|Overall Study||139
89862|NCT02082184|220761|P2|STARTED|Overall Study||75
89863|NCT02082184|220762|P1|STARTED|Overall Study||149
89864|NCT02082158|220787|P6|NOT COMPLETED|Overall Study||7
89865|NCT02082158|220788|P5|NOT COMPLETED|Overall Study||4
89866|NCT02082158|220789|P4|NOT COMPLETED|Overall Study||4
89867|NCT02082158|220790|P3|NOT COMPLETED|Overall Study||14
89868|NCT02082158|220791|P2|NOT COMPLETED|Overall Study||8
89869|NCT02082158|220792|P1|NOT COMPLETED|Overall Study||8
89870|NCT02082158|220787|P6|COMPLETED|Overall Study||56
89871|NCT02082158|220788|P5|COMPLETED|Overall Study||64
89872|NCT02082158|220789|P4|COMPLETED|Overall Study|Includes completion with respirator from secondary randomization after fit-test failure of 1st model|68
89873|NCT02082158|220790|P3|COMPLETED|Overall Study||38
89874|NCT02082158|220791|P2|COMPLETED|Overall Study||53
89875|NCT02082158|220792|P1|COMPLETED|Overall Study||58
89876|NCT02082158|220787|P6|STARTED|Overall Study||63
89877|NCT02082158|220788|P5|STARTED|Overall Study||68
89878|NCT02082158|220789|P4|STARTED|Overall Study||72
89879|NCT02082158|220790|P3|STARTED|Overall Study||52
89880|NCT02082158|220791|P2|STARTED|Overall Study||61
89881|NCT02082158|220792|P1|STARTED|Overall Study||66
89882|NCT02082145|220814|P2|NOT COMPLETED|Overall Study||0
89883|NCT02082145|220815|P1|NOT COMPLETED|Overall Study||0
89884|NCT02082145|220814|P2|COMPLETED|Overall Study||9
89885|NCT02082145|220815|P1|COMPLETED|Overall Study||5
89886|NCT02082145|220814|P2|STARTED|Overall Study||9
89887|NCT02082145|220815|P1|STARTED|Overall Study||5
89888|NCT02081963|220829|P2|NOT COMPLETED|Overall Study||4
89889|NCT02081963|220830|P1|NOT COMPLETED|Overall Study||5
89890|NCT02081963|220829|P2|COMPLETED|Overall Study||69
89891|NCT02081963|220830|P1|COMPLETED|Overall Study||74
89892|NCT02081963|220829|P2|STARTED|Overall Study||73
89893|NCT02081963|220830|P1|STARTED|Overall Study||79
89894|NCT02081859|220846|P2|NOT COMPLETED|Overall Study||31
89895|NCT02081859|220847|P1|NOT COMPLETED|Overall Study||34
89896|NCT02081859|220846|P2|COMPLETED|Overall Study||119
89897|NCT02081859|220847|P1|COMPLETED|Overall Study||116
89898|NCT02081859|220846|P2|STARTED|Overall Study||150
89899|NCT02081859|220847|P1|STARTED|Overall Study||150
89900|NCT02081846|220857|P2|NOT COMPLETED|Overall Study||0
89901|NCT02081846|220858|P1|NOT COMPLETED|Overall Study||2
89902|NCT02081846|220857|P2|COMPLETED|Overall Study||749
89903|NCT02081846|220858|P1|COMPLETED|Overall Study||749
89904|NCT02081846|220857|P2|STARTED|Overall Study||749
89905|NCT02081846|220858|P1|STARTED|Overall Study||751
89906|NCT02081807|220884|P8|NOT COMPLETED|Overall Study||0
89907|NCT02081807|220885|P7|NOT COMPLETED|Overall Study||0
89908|NCT02081807|220886|P6|NOT COMPLETED|Overall Study||0
89909|NCT02081807|220887|P5|NOT COMPLETED|Overall Study||0
89910|NCT02081807|220888|P4|NOT COMPLETED|Overall Study||0
89911|NCT02081807|220889|P3|NOT COMPLETED|Overall Study||0
89912|NCT02081807|220890|P2|NOT COMPLETED|Overall Study||0
89913|NCT02081807|220891|P1|NOT COMPLETED|Overall Study||0
89914|NCT02081807|220884|P8|COMPLETED|Overall Study||19729
89915|NCT02081807|220885|P7|COMPLETED|Overall Study||40207
89916|NCT02081807|220886|P6|COMPLETED|Overall Study||76055
89917|NCT02081807|220887|P5|COMPLETED|Overall Study||27456
89918|NCT02081807|220888|P4|COMPLETED|Overall Study||9112
89919|NCT02081807|220889|P3|COMPLETED|Overall Study||14852
89920|NCT02081807|220890|P2|COMPLETED|Overall Study||26149
89921|NCT02081807|220891|P1|COMPLETED|Overall Study||7668
89922|NCT02081807|220884|P8|STARTED|Overall Study||19729
89923|NCT02081807|220885|P7|STARTED|Overall Study||40207
89924|NCT02081807|220886|P6|STARTED|Overall Study||76055
89925|NCT02081807|220887|P5|STARTED|Overall Study||27456
89926|NCT02081807|220888|P4|STARTED|Overall Study||9112
89927|NCT02081807|220889|P3|STARTED|Overall Study||14852
89928|NCT02081807|220890|P2|STARTED|Overall Study||26149
89929|NCT02081807|220891|P1|STARTED|Overall Study||7668
89930|NCT02081690|221027|P1|NOT COMPLETED|Overall Study||7
89931|NCT02081690|221027|P1|COMPLETED|Overall Study||81
89932|NCT02081690|221027|P1|STARTED|Overall Study||88
89933|NCT02081677|221038|P4|NOT COMPLETED|Overall Study||0
89934|NCT02081677|221039|P3|NOT COMPLETED|Overall Study||2
89935|NCT02081677|221040|P2|NOT COMPLETED|Overall Study||1
89936|NCT02081677|221041|P1|NOT COMPLETED|Overall Study||1
89937|NCT02081677|221038|P4|COMPLETED|Overall Study||19
89938|NCT02081677|221039|P3|COMPLETED|Overall Study||17
89939|NCT02081677|221040|P2|COMPLETED|Overall Study||18
89940|NCT02081677|221041|P1|COMPLETED|Overall Study||18
89941|NCT02081677|221038|P4|STARTED|Overall Study||19
89942|NCT02081677|221039|P3|STARTED|Overall Study||19
89943|NCT02081677|221040|P2|STARTED|Overall Study||19
89944|NCT02081677|221041|P1|STARTED|Overall Study||19
89945|NCT02081599|221133|P2|NOT COMPLETED|Period 2：Open-label Period||4
89946|NCT02081599|221134|P1|NOT COMPLETED|Period 2：Open-label Period||6
89947|NCT02081599|221133|P2|COMPLETED|Period 2：Open-label Period||71
89948|NCT02081599|221134|P1|COMPLETED|Period 2：Open-label Period||57
89949|NCT02081599|221133|P2|STARTED|Period 2：Open-label Period||75
89950|NCT02081599|221134|P1|STARTED|Period 2：Open-label Period||63
89951|NCT02081599|221133|P2|NOT COMPLETED|Period 1：Double-blind Period||2
89952|NCT02081599|221134|P1|NOT COMPLETED|Period 1：Double-blind Period||8
89953|NCT02081599|221133|P2|COMPLETED|Period 1：Double-blind Period||75
89954|NCT02081599|221134|P1|COMPLETED|Period 1：Double-blind Period||63
89955|NCT02081599|221133|P2|STARTED|Period 1：Double-blind Period||77
89956|NCT02081599|221134|P1|STARTED|Period 1：Double-blind Period||71
89957|NCT02081586|221152|P4|NOT COMPLETED|Overall Study||1
89958|NCT02081586|221153|P3|NOT COMPLETED|Overall Study||1
89959|NCT02081586|221154|P2|NOT COMPLETED|Overall Study||1
89960|NCT02081586|221155|P1|NOT COMPLETED|Overall Study||0
89961|NCT02081586|221152|P4|COMPLETED|Overall Study||2
89962|NCT02081586|221153|P3|COMPLETED|Overall Study||3
89963|NCT02081586|221154|P2|COMPLETED|Overall Study||2
89964|NCT02081586|221155|P1|COMPLETED|Overall Study||3
89965|NCT02081586|221152|P4|STARTED|Overall Study||3
89966|NCT02081586|221153|P3|STARTED|Overall Study||4
89967|NCT02081586|221154|P2|STARTED|Overall Study||3
89968|NCT02081586|221155|P1|STARTED|Overall Study||3
89969|NCT02081573|221182|P1|NOT COMPLETED|Overall Study||0
89970|NCT02081573|221182|P1|COMPLETED|Overall Study||10
89971|NCT02081573|221182|P1|STARTED|Overall Study||10
89972|NCT02081456|221193|P2|NOT COMPLETED|Overall Study||0
89973|NCT02081456|221194|P1|NOT COMPLETED|Overall Study||0
89974|NCT02081456|221193|P2|COMPLETED|Overall Study||12
89975|NCT02081456|221194|P1|COMPLETED|Overall Study||11
89976|NCT02081456|221193|P2|STARTED|Overall Study||12
89977|NCT02081456|221194|P1|STARTED|Overall Study||11
89978|NCT02081443|221208|P2|NOT COMPLETED|Overall Study||0
89979|NCT02081443|221209|P1|NOT COMPLETED|Overall Study||0
89980|NCT02081443|221208|P2|COMPLETED|Overall Study||30
89981|NCT02081443|221209|P1|COMPLETED|Overall Study||30
89982|NCT02081443|221208|P2|STARTED|Overall Study||30
89983|NCT02081443|221209|P1|STARTED|Overall Study||30
89984|NCT02081417|221221|P2|NOT COMPLETED|Overall Study||51
89985|NCT02081417|221222|P1|NOT COMPLETED|Overall Study||56
89986|NCT02081417|221221|P2|COMPLETED|Overall Study||115
89987|NCT02081417|221222|P1|COMPLETED|Overall Study||107
89988|NCT02081417|221221|P2|6-Month Follow-Up|Overall Study||92
89989|NCT02081417|221222|P1|6-Month Follow-Up|Overall Study||82
89990|NCT02081417|221221|P2|3-Month Follow-Up|Overall Study||95
89991|NCT02081417|221222|P1|3-Month Follow-Up|Overall Study||94
89992|NCT02081417|221221|P2|1st Interview Completed|Overall Study||145
89993|NCT02081417|221222|P1|1st Interview Completed|Overall Study||146
89994|NCT02081417|221221|P2|STARTED|Overall Study||166
89995|NCT02081417|221222|P1|STARTED|Overall Study|Randomized to intervention|163
89996|NCT02081365|221240|P2|NOT COMPLETED|Overall Study||23
89997|NCT02081365|221241|P1|NOT COMPLETED|Overall Study||30
89998|NCT02081365|221240|P2|COMPLETED|Overall Study||54
89999|NCT02081365|221241|P1|COMPLETED|Overall Study||44
90000|NCT02081365|221240|P2|Received Allocated Intervention|Overall Study||59
90001|NCT02081365|221241|P1|Received Allocated Intervention|Overall Study||46
90002|NCT02081365|221240|P2|STARTED|Overall Study||77
90003|NCT02081365|221241|P1|STARTED|Overall Study||74
90004|NCT02081248|221255|P2|NOT COMPLETED|Overall Study||13
90005|NCT02081248|221256|P1|NOT COMPLETED|Overall Study||22
90006|NCT02081248|221255|P2|COMPLETED|Overall Study||87
90007|NCT02081248|221256|P1|COMPLETED|Overall Study||76
90008|NCT02081248|221255|P2|STARTED|Overall Study||100
90009|NCT02081248|221256|P1|STARTED|Overall Study||98
90010|NCT02081183|221280|P2|NOT COMPLETED|Overall Study||4
90011|NCT02081183|221281|P1|NOT COMPLETED|Overall Study||4
90012|NCT02081183|221280|P2|COMPLETED|Overall Study||2
90013|NCT02081183|221281|P1|COMPLETED|Overall Study||1
90014|NCT02081183|221280|P2|STARTED|Overall Study||6
90015|NCT02081183|221281|P1|STARTED|Overall Study||5
90016|NCT02081079|221297|P2|NOT COMPLETED|Overall Study||2
90017|NCT02081079|221298|P1|NOT COMPLETED|Overall Study||4
90018|NCT02081079|221297|P2|COMPLETED|Overall Study||39
90019|NCT02081079|221298|P1|COMPLETED|Overall Study||40
90020|NCT02081079|221297|P2|STARTED|Overall Study||41
90021|NCT02081079|221298|P1|STARTED|Overall Study||44
90022|NCT02081014|221320|P6|NOT COMPLETED|Overall Study||0
90023|NCT02081014|221321|P5|NOT COMPLETED|Overall Study||0
90024|NCT02081014|221322|P4|NOT COMPLETED|Overall Study||0
90025|NCT02081014|221323|P3|NOT COMPLETED|Overall Study||0
90026|NCT02081014|221324|P2|NOT COMPLETED|Overall Study||0
90027|NCT02081014|221325|P1|NOT COMPLETED|Overall Study||0
90028|NCT02081014|221320|P6|COMPLETED|Overall Study||2
90029|NCT02081014|221321|P5|COMPLETED|Overall Study||2
90030|NCT02081014|221322|P4|COMPLETED|Overall Study||2
90031|NCT02081014|221323|P3|COMPLETED|Overall Study||2
90032|NCT02081014|221324|P2|COMPLETED|Overall Study||2
90033|NCT02081014|221325|P1|COMPLETED|Overall Study||2
90034|NCT02081014|221320|P6|STARTED|Overall Study||2
90035|NCT02081014|221321|P5|STARTED|Overall Study||2
90036|NCT02081014|221322|P4|STARTED|Overall Study||2
90037|NCT02081014|221323|P3|STARTED|Overall Study||2
90038|NCT02081014|221324|P2|STARTED|Overall Study||2
90039|NCT02081014|221325|P1|STARTED|Overall Study||2
90040|NCT02081001|221371|P12|NOT COMPLETED|Overall Study||0
90041|NCT02081001|221372|P11|NOT COMPLETED|Overall Study||0
90042|NCT02081001|221373|P10|NOT COMPLETED|Overall Study||0
90043|NCT02081001|221374|P9|NOT COMPLETED|Overall Study||0
90044|NCT02081001|221375|P8|NOT COMPLETED|Overall Study||0
90045|NCT02081001|221376|P7|NOT COMPLETED|Overall Study||0
90046|NCT02081001|221377|P6|NOT COMPLETED|Overall Study||0
90047|NCT02081001|221378|P5|NOT COMPLETED|Overall Study||1
90048|NCT02081001|221379|P4|NOT COMPLETED|Overall Study||0
90049|NCT02081001|221380|P3|NOT COMPLETED|Overall Study||0
90050|NCT02081001|221381|P2|NOT COMPLETED|Overall Study||0
90051|NCT02081001|221382|P1|NOT COMPLETED|Overall Study||0
90052|NCT02081001|221371|P12|COMPLETED|Overall Study||1
90053|NCT02081001|221372|P11|COMPLETED|Overall Study||2
90054|NCT02081001|221373|P10|COMPLETED|Overall Study||1
90055|NCT02081001|221374|P9|COMPLETED|Overall Study||2
90056|NCT02081001|221375|P8|COMPLETED|Overall Study||1
90057|NCT02081001|221376|P7|COMPLETED|Overall Study||2
90058|NCT02081001|221377|P6|COMPLETED|Overall Study||1
90059|NCT02081001|221378|P5|COMPLETED|Overall Study||2
90060|NCT02081001|221379|P4|COMPLETED|Overall Study||1
90061|NCT02081001|221380|P3|COMPLETED|Overall Study||2
90062|NCT02081001|221381|P2|COMPLETED|Overall Study||1
90063|NCT02081001|221382|P1|COMPLETED|Overall Study||2
90064|NCT02081001|221371|P12|STARTED|Overall Study||1
90065|NCT02081001|221372|P11|STARTED|Overall Study||2
90066|NCT02081001|221373|P10|STARTED|Overall Study||1
90067|NCT02081001|221374|P9|STARTED|Overall Study||2
90068|NCT02081001|221375|P8|STARTED|Overall Study||1
90069|NCT02081001|221376|P7|STARTED|Overall Study||2
90070|NCT02081001|221377|P6|STARTED|Overall Study||1
90071|NCT02081001|221378|P5|STARTED|Overall Study||3
90072|NCT02081001|221379|P4|STARTED|Overall Study||1
90073|NCT02081001|221380|P3|STARTED|Overall Study||2
90074|NCT02081001|221381|P2|STARTED|Overall Study||1
90075|NCT02081001|221382|P1|STARTED|Overall Study||2
90076|NCT02080871|221446|P1|NOT COMPLETED|Overall Study||2
90077|NCT02080871|221446|P1|COMPLETED|Overall Study||132
90078|NCT02080871|221446|P1|STARTED|Overall Study||134
90079|NCT02080832|221530|P3|NOT COMPLETED|Overall Study||16
90080|NCT02080832|221531|P2|NOT COMPLETED|Overall Study||12
90081|NCT02080832|221532|P1|NOT COMPLETED|Overall Study||9
90082|NCT02080832|221530|P3|COMPLETED|Overall Study||6
90083|NCT02080832|221531|P2|COMPLETED|Overall Study||5
90084|NCT02080832|221532|P1|COMPLETED|Overall Study||6
90085|NCT02080832|221530|P3|STARTED|Overall Study||22
90086|NCT02080832|221531|P2|STARTED|Overall Study||17
90087|NCT02080832|221532|P1|STARTED|Overall Study||15
90088|NCT02080819|221549|P3|NOT COMPLETED|Overall Study||22
90089|NCT02080819|221550|P2|NOT COMPLETED|Overall Study||26
90090|NCT02080819|221551|P1|NOT COMPLETED|Overall Study||25
90091|NCT02080819|221549|P3|COMPLETED|Overall Study||11
90092|NCT02080819|221550|P2|COMPLETED|Overall Study||9
90093|NCT02080819|221551|P1|COMPLETED|Overall Study||38
90094|NCT02080819|221549|P3|STARTED|Overall Study||33
90095|NCT02080819|221550|P2|STARTED|Overall Study||35
90096|NCT02080819|221551|P1|STARTED|Overall Study||63
90097|NCT02080780|221559|P1|NOT COMPLETED|Overall Study||0
90098|NCT02080780|221559|P1|COMPLETED|Overall Study||24
90099|NCT02080780|221559|P1|STARTED|Overall Study||24
90100|NCT02080637|221568|P2|NOT COMPLETED|Overall Study||0
90101|NCT02080637|221569|P1|NOT COMPLETED|Overall Study||0
90102|NCT02080637|221568|P2|COMPLETED|Overall Study||3
90103|NCT02080637|221569|P1|COMPLETED|Overall Study||13
90104|NCT02080637|221568|P2|STARTED|Overall Study||3
90105|NCT02080637|221569|P1|STARTED|Overall Study||13
90106|NCT02080546|221582|P2|NOT COMPLETED|Overall Study||11
90107|NCT02080546|221583|P1|NOT COMPLETED|Overall Study||8
90108|NCT02080546|221582|P2|COMPLETED|Overall Study||52
90109|NCT02080546|221583|P1|COMPLETED|Overall Study||49
90110|NCT02080546|221582|P2|STARTED|Overall Study||63
90111|NCT02080546|221583|P1|STARTED|Overall Study||57
90112|NCT02080507|221593|P2|NOT COMPLETED|Overall Study||0
90113|NCT02080507|221594|P1|NOT COMPLETED|Overall Study||0
90114|NCT02080507|221593|P2|COMPLETED|Overall Study||7
90115|NCT02080507|221594|P1|COMPLETED|Overall Study||5
90116|NCT02080507|221593|P2|STARTED|Overall Study||7
90117|NCT02080507|221594|P1|STARTED|Overall Study||5
90118|NCT02080481|221604|P2|NOT COMPLETED|Overall Study||0
90119|NCT02080481|221605|P1|NOT COMPLETED|Overall Study||1
90120|NCT02080481|221604|P2|COMPLETED|Overall Study||67
90121|NCT02080481|221605|P1|COMPLETED|Overall Study||67
90122|NCT02080481|221604|P2|STARTED|Overall Study||67
90123|NCT02080481|221605|P1|STARTED|Overall Study||68
90124|NCT02080468|221619|P2|NOT COMPLETED|Overall Study||2
90125|NCT02080468|221620|P1|NOT COMPLETED|Overall Study||2
90126|NCT02080468|221619|P2|COMPLETED|Overall Study||14
90127|NCT02080468|221620|P1|COMPLETED|Overall Study||14
90128|NCT02080468|221619|P2|STARTED|Overall Study||16
90129|NCT02080468|221620|P1|STARTED|Overall Study||16
90130|NCT02080312|221684|P1|NOT COMPLETED|Overall Study||0
90131|NCT02080312|221684|P1|COMPLETED|Overall Study||6
90132|NCT02080312|221684|P1|STARTED|Overall Study||6
90133|NCT02080273|221693|P3|NOT COMPLETED|Overall Study||0
90134|NCT02080273|221694|P2|NOT COMPLETED|Overall Study||0
90135|NCT02080273|221695|P1|NOT COMPLETED|Overall Study||0
90136|NCT02080273|221693|P3|COMPLETED|Overall Study||45
90137|NCT02080273|221694|P2|COMPLETED|Overall Study||45
90138|NCT02080273|221695|P1|COMPLETED|Overall Study||45
90139|NCT02080273|221693|P3|STARTED|Overall Study||45
90140|NCT02080273|221694|P2|STARTED|Overall Study||45
90141|NCT02080273|221695|P1|STARTED|Overall Study||45
90142|NCT02080260|221724|P1|NOT COMPLETED|Overall Study||19
90143|NCT02080260|221724|P1|COMPLETED|Overall Study|Defined as still alive in follow-up when the study was terminated and the database was locked.|1
90144|NCT02080260|221724|P1|STARTED|Overall Study||20
90145|NCT02080195|221732|P1|NOT COMPLETED|Overall Study||0
90146|NCT02080195|221732|P1|COMPLETED|Overall Study||1
90147|NCT02080195|221732|P1|STARTED|Overall Study||1
90148|NCT02080091|221741|P1|NOT COMPLETED|Overall Study||25
90149|NCT02080091|221741|P1|COMPLETED|Overall Study||0
90150|NCT02080091|221741|P1|STARTED|Overall Study||25
90151|NCT02079987|221749|P2|NOT COMPLETED|Overall Study||0
90152|NCT02079987|221750|P1|NOT COMPLETED|Overall Study||0
90153|NCT02079987|221749|P2|COMPLETED|Overall Study||544
90154|NCT02079987|221750|P1|COMPLETED|Overall Study||557
90155|NCT02079987|221749|P2|STARTED|Overall Study||544
90156|NCT02079987|221750|P1|STARTED|Overall Study||557
90157|NCT02079909|221769|P3|NOT COMPLETED|Overall Study||18
90158|NCT02079909|221770|P2|NOT COMPLETED|Overall Study||49
90159|NCT02079909|221771|P1|NOT COMPLETED|Overall Study||38
90160|NCT02079909|221769|P3|COMPLETED|Overall Study||140
90161|NCT02079909|221770|P2|COMPLETED|Overall Study||117
90162|NCT02079909|221771|P1|COMPLETED|Overall Study||120
90163|NCT02079909|221769|P3|STARTED|Overall Study||158
90164|NCT02079909|221770|P2|STARTED|Overall Study||166
90165|NCT02079909|221771|P1|STARTED|Overall Study||158
90166|NCT02079844|221788|P3|NOT COMPLETED|Treatment Period 3||0
90167|NCT02079844|221789|P2|NOT COMPLETED|Treatment Period 3||0
90168|NCT02079844|221790|P1|NOT COMPLETED|Treatment Period 3||0
90169|NCT02079844|221788|P3|COMPLETED|Treatment Period 3||5
90170|NCT02079844|221789|P2|COMPLETED|Treatment Period 3||5
90171|NCT02079844|221790|P1|COMPLETED|Treatment Period 3||5
90172|NCT02079844|221788|P3|STARTED|Treatment Period 3||5
90173|NCT02079844|221789|P2|STARTED|Treatment Period 3|1 Participant Voluntarily Withdrew after completing Period 2.|5
90174|NCT02079844|221790|P1|STARTED|Treatment Period 3||5
90175|NCT02079844|221788|P3|NOT COMPLETED|Treatment Period 2||0
90176|NCT02079844|221789|P2|NOT COMPLETED|Treatment Period 2||1
90177|NCT02079844|221790|P1|NOT COMPLETED|Treatment Period 2||0
90178|NCT02079844|221788|P3|COMPLETED|Treatment Period 2||5
90179|NCT02079844|221789|P2|COMPLETED|Treatment Period 2||6
90180|NCT02079844|221790|P1|COMPLETED|Treatment Period 2||5
90181|NCT02079844|221788|P3|STARTED|Treatment Period 2||5
90182|NCT02079844|221789|P2|STARTED|Treatment Period 2||7
90183|NCT02079844|221790|P1|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|5
90184|NCT02079844|221788|P3|NOT COMPLETED|Treatment Period 1||2
90185|NCT02079844|221789|P2|NOT COMPLETED|Treatment Period 1||0
90186|NCT02079844|221790|P1|NOT COMPLETED|Treatment Period 1||0
90187|NCT02079844|221788|P3|COMPLETED|Treatment Period 1||5
90188|NCT02079844|221789|P2|COMPLETED|Treatment Period 1||7
90189|NCT02079844|221790|P1|COMPLETED|Treatment Period 1||6
90190|NCT02079844|221788|P3|STARTED|Treatment Period 1||7
90191|NCT02079844|221789|P2|STARTED|Treatment Period 1||7
90192|NCT02079844|221790|P1|STARTED|Treatment Period 1||6
90193|NCT02079805|221848|P2|NOT COMPLETED|Overall Study||2
90194|NCT02079805|221849|P1|NOT COMPLETED|Overall Study||0
90195|NCT02079805|221848|P2|COMPLETED|Overall Study||15
90196|NCT02079805|221849|P1|COMPLETED|Overall Study||16
90197|NCT02079805|221848|P2|STARTED|Overall Study||17
90198|NCT02079805|221849|P1|STARTED|Overall Study||16
90199|NCT02079649|221871|P4|NOT COMPLETED|Overall Study||2
90200|NCT02079649|221872|P3|NOT COMPLETED|Overall Study||1
90201|NCT02079649|221873|P2|NOT COMPLETED|Overall Study||0
90202|NCT02079649|221874|P1|NOT COMPLETED|Overall Study||1
90203|NCT02079649|221871|P4|COMPLETED|Overall Study||38
90204|NCT02079649|221872|P3|COMPLETED|Overall Study||40
90205|NCT02079649|221873|P2|COMPLETED|Overall Study||41
90206|NCT02079649|221874|P1|COMPLETED|Overall Study||41
90207|NCT02079649|221871|P4|Treated|Overall Study||40
90208|NCT02079649|221872|P3|Treated|Overall Study||40
90209|NCT02079649|221873|P2|Treated|Overall Study||41
90210|NCT02079649|221874|P1|Treated|Overall Study||41
90211|NCT02079649|221871|P4|STARTED|Overall Study||40
90212|NCT02079649|221872|P3|STARTED|Overall Study||41
90213|NCT02079649|221873|P2|STARTED|Overall Study||41
90214|NCT02079649|221874|P1|STARTED|Overall Study||42
90215|NCT02079610|221891|P2|NOT COMPLETED|Overall Study||1
90216|NCT02079610|221892|P1|NOT COMPLETED|Overall Study||1
90217|NCT02079610|221891|P2|COMPLETED|Overall Study||16
90218|NCT02079610|221892|P1|COMPLETED|Overall Study||18
90219|NCT02079610|221891|P2|STARTED|Overall Study||17
90220|NCT02079610|221892|P1|STARTED|Overall Study||19
90221|NCT02079532|221902|P1|NOT COMPLETED|Overall Study||29
90222|NCT02079532|221902|P1|COMPLETED|Overall Study||273
90223|NCT02079532|221902|P1|STARTED|Overall Study||302
90224|NCT02079519|221924|P1|NOT COMPLETED|Overall Study||10
90225|NCT02079519|221924|P1|COMPLETED|Overall Study||0
90226|NCT02079519|221924|P1|STARTED|Overall Study||10
90227|NCT02079311|221930|P2|NOT COMPLETED|Overall Study||1
90228|NCT02079311|221931|P1|NOT COMPLETED|Overall Study||0
90229|NCT02079311|221930|P2|COMPLETED|Overall Study||26
90230|NCT02079311|221931|P1|COMPLETED|Overall Study||28
90231|NCT02079311|221930|P2|STARTED|Overall Study||27
90232|NCT02079311|221931|P1|STARTED|Overall Study||28
90233|NCT02079246|221937|P2|NOT COMPLETED|OLEX-MEM||19
90234|NCT02079246|221938|P1|NOT COMPLETED|OLEX-MEM||0
90235|NCT02079246|221937|P2|COMPLETED|OLEX-MEM||82
90236|NCT02079246|221938|P1|COMPLETED|OLEX-MEM||0
90237|NCT02079246|221937|P2|STARTED|OLEX-MEM||101
90238|NCT02079246|221938|P1|STARTED|OLEX-MEM||0
90239|NCT02079246|221937|P2|NOT COMPLETED|OLEX||0
90240|NCT02079246|221938|P1|NOT COMPLETED|OLEX||228
90241|NCT02079246|221937|P2|COMPLETED|OLEX||0
90242|NCT02079246|221938|P1|COMPLETED|OLEX||1235
90243|NCT02079246|221937|P2|STARTED|OLEX||0
90244|NCT02079246|221938|P1|STARTED|OLEX||1463
90245|NCT02079077|221957|P2|NOT COMPLETED|Overall Study||9
90246|NCT02079077|221958|P1|NOT COMPLETED|Overall Study||6
90247|NCT02079077|221957|P2|COMPLETED|Overall Study||39
90248|NCT02079077|221958|P1|COMPLETED|Overall Study||37
90249|NCT02079077|221957|P2|STARTED|Overall Study||48
90250|NCT02079077|221958|P1|STARTED|Overall Study||43
90251|NCT02079025|221968|P2|NOT COMPLETED|Overall Study||0
90252|NCT02079025|221969|P1|NOT COMPLETED|Overall Study||0
90253|NCT02079025|221968|P2|COMPLETED|Overall Study||837
90254|NCT02079025|221969|P1|COMPLETED|Overall Study||839
90255|NCT02079025|221968|P2|STARTED|Overall Study||837
90256|NCT02079025|221969|P1|STARTED|Overall Study||839
90257|NCT02078960|221981|P3|NOT COMPLETED|Follow-up Period||0
90258|NCT02078960|221982|P2|NOT COMPLETED|Follow-up Period||1
90259|NCT02078960|221983|P1|NOT COMPLETED|Follow-up Period||2
90260|NCT02078960|221981|P3|COMPLETED|Follow-up Period||1
90261|NCT02078960|221982|P2|COMPLETED|Follow-up Period||1
90262|NCT02078960|221983|P1|COMPLETED|Follow-up Period||0
90263|NCT02078960|221981|P3|STARTED|Follow-up Period||1
90264|NCT02078960|221982|P2|STARTED|Follow-up Period||2
90265|NCT02078960|221983|P1|STARTED|Follow-up Period||2
90266|NCT02078960|221981|P3|NOT COMPLETED|Treatment Period||3
90267|NCT02078960|221982|P2|NOT COMPLETED|Treatment Period||3
90268|NCT02078960|221983|P1|NOT COMPLETED|Treatment Period||2
90269|NCT02078960|221981|P3|COMPLETED|Treatment Period||1
90270|NCT02078960|221982|P2|COMPLETED|Treatment Period||1
90271|NCT02078960|221983|P1|COMPLETED|Treatment Period||0
90272|NCT02078960|221981|P3|STARTED|Treatment Period||4
90273|NCT02078960|221982|P2|STARTED|Treatment Period||4
90274|NCT02078960|221983|P1|STARTED|Treatment Period||2
90275|NCT02078752|222015|P10|NOT COMPLETED|Overall Study||10
90276|NCT02078752|222016|P9|NOT COMPLETED|Overall Study||0
90277|NCT02078752|222017|P8|NOT COMPLETED|Overall Study||3
90278|NCT02078752|222018|P7|NOT COMPLETED|Overall Study||2
90279|NCT02078752|222019|P6|NOT COMPLETED|Overall Study||4
90280|NCT02078752|222020|P5|NOT COMPLETED|Overall Study||1
90281|NCT02078752|222021|P4|NOT COMPLETED|Overall Study||2
90282|NCT02078752|222022|P3|NOT COMPLETED|Overall Study||1
90283|NCT02078752|222023|P2|NOT COMPLETED|Overall Study||7
90284|NCT02078752|222024|P1|NOT COMPLETED|Overall Study||2
90285|NCT02078752|222015|P10|COMPLETED|Overall Study||2
90286|NCT02078752|222016|P9|COMPLETED|Overall Study||2
90287|NCT02078752|222017|P8|COMPLETED|Overall Study||3
90288|NCT02078752|222018|P7|COMPLETED|Overall Study||1
90289|NCT02078752|222019|P6|COMPLETED|Overall Study||5
90290|NCT02078752|222020|P5|COMPLETED|Overall Study||2
90291|NCT02078752|222021|P4|COMPLETED|Overall Study||5
90292|NCT02078752|222022|P3|COMPLETED|Overall Study||1
90293|NCT02078752|222023|P2|COMPLETED|Overall Study||6
90294|NCT02078752|222024|P1|COMPLETED|Overall Study||1
90295|NCT02078752|222015|P10|STARTED|Overall Study||12
90296|NCT02078752|222016|P9|STARTED|Overall Study||2
90297|NCT02078752|222017|P8|STARTED|Overall Study||6
90298|NCT02078752|222018|P7|STARTED|Overall Study||3
90299|NCT02078752|222019|P6|STARTED|Overall Study||9
90300|NCT02078752|222020|P5|STARTED|Overall Study||3
90301|NCT02078752|222021|P4|STARTED|Overall Study||7
90302|NCT02078752|222022|P3|STARTED|Overall Study||2
90303|NCT02078752|222023|P2|STARTED|Overall Study||13
90304|NCT02078752|222024|P1|STARTED|Overall Study||3
90305|NCT02078713|222300|P4|NOT COMPLETED|Overall Study||0
90306|NCT02078713|222301|P3|NOT COMPLETED|Overall Study||0
90307|NCT02078713|222302|P2|NOT COMPLETED|Overall Study||61
90308|NCT02078713|222303|P1|NOT COMPLETED|Overall Study||52
90309|NCT02078713|222300|P4|COMPLETED|Overall Study||13
90310|NCT02078713|222301|P3|COMPLETED|Overall Study||15
90311|NCT02078713|222302|P2|COMPLETED|Overall Study||290
90312|NCT02078713|222303|P1|COMPLETED|Overall Study||355
90313|NCT02078713|222300|P4|STARTED|Overall Study||13
90314|NCT02078713|222301|P3|STARTED|Overall Study||15
90315|NCT02078713|222302|P2|STARTED|Overall Study||351
90316|NCT02078713|222303|P1|STARTED|Overall Study||407
90317|NCT02078557|222355|P1|NOT COMPLETED|Overall Study||0
90318|NCT02078557|222355|P1|COMPLETED|Overall Study||4
90319|NCT02078557|222355|P1|STARTED|Overall Study||4
90320|NCT02078492|222364|P3|NOT COMPLETED|Overall Study||0
90321|NCT02078492|222365|P2|NOT COMPLETED|Overall Study||0
90322|NCT02078492|222366|P1|NOT COMPLETED|Overall Study||0
90323|NCT02078492|222364|P3|COMPLETED|Overall Study||80
90324|NCT02078492|222365|P2|COMPLETED|Overall Study||80
90325|NCT02078492|222366|P1|COMPLETED|Overall Study||80
90326|NCT02078492|222364|P3|STARTED|Overall Study||80
90327|NCT02078492|222365|P2|STARTED|Overall Study||80
90328|NCT02078492|222366|P1|STARTED|Overall Study||80
90329|NCT02078219|222388|P5|NOT COMPLETED|Overall Study||2
90330|NCT02078219|222389|P4|NOT COMPLETED|Overall Study||4
90331|NCT02078219|222390|P3|NOT COMPLETED|Overall Study||6
90332|NCT02078219|222391|P2|NOT COMPLETED|Overall Study||4
90333|NCT02078219|222392|P1|NOT COMPLETED|Overall Study||3
90334|NCT02078219|222388|P5|COMPLETED|Overall Study||39
90335|NCT02078219|222389|P4|COMPLETED|Overall Study||37
90336|NCT02078219|222390|P3|COMPLETED|Overall Study||35
90337|NCT02078219|222391|P2|COMPLETED|Overall Study||36
90338|NCT02078219|222392|P1|COMPLETED|Overall Study||38
90339|NCT02078219|222388|P5|STARTED|Overall Study||41
90340|NCT02078219|222389|P4|STARTED|Overall Study||41
90341|NCT02078219|222390|P3|STARTED|Overall Study||41
90342|NCT02078219|222391|P2|STARTED|Overall Study||40
90343|NCT02078219|222392|P1|STARTED|Overall Study||41
90344|NCT02078193|222419|P1|NOT COMPLETED|Overall Study||0
90345|NCT02078193|222419|P1|COMPLETED|Overall Study||3
90346|NCT02078193|222419|P1|STARTED|Overall Study||3
90347|NCT02078180|222425|P1|NOT COMPLETED|Overall Study||5
90348|NCT02078180|222425|P1|COMPLETED|Overall Study||29
90349|NCT02078180|222425|P1|XL 300|Overall Study||32
90350|NCT02078180|222425|P1|XL 150|Overall Study||31
90351|NCT02078180|222425|P1|SR150|Overall Study||32
90352|NCT02078180|222425|P1|SR100|Overall Study||31
90353|NCT02078180|222425|P1|IR100|Overall Study||31
90354|NCT02078180|222425|P1|IR75|Overall Study||30
90355|NCT02078180|222425|P1|STARTED|Overall Study||34
90356|NCT02077374|222442|P2|NOT COMPLETED|Overall Study||2
90357|NCT02077374|222443|P1|NOT COMPLETED|Overall Study||0
90358|NCT02077374|222442|P2|COMPLETED|Overall Study||17
90359|NCT02077374|222443|P1|COMPLETED|Overall Study||19
90360|NCT02077374|222442|P2|STARTED|Overall Study||19
90361|NCT02077374|222443|P1|STARTED|Overall Study||19
90362|NCT02077140|222464|P5|NOT COMPLETED|Overall Study||5
90363|NCT02077140|222465|P4|NOT COMPLETED|Overall Study||4
90364|NCT02077140|222466|P3|NOT COMPLETED|Overall Study||2
90365|NCT02077140|222467|P2|NOT COMPLETED|Overall Study||2
90366|NCT02077140|222468|P1|NOT COMPLETED|Overall Study||4
90367|NCT02077140|222464|P5|COMPLETED|Overall Study||43
90368|NCT02077140|222465|P4|COMPLETED|Overall Study||32
90369|NCT02077140|222466|P3|COMPLETED|Overall Study||34
90370|NCT02077140|222467|P2|COMPLETED|Overall Study||34
90371|NCT02077140|222468|P1|COMPLETED|Overall Study||32
90372|NCT02077140|222464|P5|STARTED|Overall Study||48
90373|NCT02077140|222465|P4|STARTED|Overall Study||36
90374|NCT02077140|222466|P3|STARTED|Overall Study||36
90375|NCT02077140|222467|P2|STARTED|Overall Study||36
90376|NCT02077140|222468|P1|STARTED|Overall Study||36
90377|NCT02076919|222567|P4|NOT COMPLETED|Overall Study||0
90378|NCT02076919|222568|P3|NOT COMPLETED|Overall Study||0
90379|NCT02076919|222569|P2|NOT COMPLETED|Overall Study||0
90380|NCT02076919|222570|P1|NOT COMPLETED|Overall Study||0
90381|NCT02076919|222567|P4|COMPLETED|Overall Study||12
90382|NCT02076919|222568|P3|COMPLETED|Overall Study||36
90383|NCT02076919|222569|P2|COMPLETED|Overall Study||8
90384|NCT02076919|222570|P1|COMPLETED|Overall Study||24
90385|NCT02076919|222567|P4|STARTED|Overall Study||12
90386|NCT02076919|222568|P3|STARTED|Overall Study||36
90387|NCT02076919|222569|P2|STARTED|Overall Study||8
90388|NCT02076919|222570|P1|STARTED|Overall Study||24
90389|NCT02076776|222671|P3|NOT COMPLETED|Overall Study||0
90390|NCT02076776|222672|P2|NOT COMPLETED|Overall Study||2
90391|NCT02076776|222673|P1|NOT COMPLETED|Overall Study||1
90392|NCT02076776|222671|P3|COMPLETED|Overall Study||6
90393|NCT02076776|222672|P2|COMPLETED|Overall Study||6
90394|NCT02076776|222673|P1|COMPLETED|Overall Study||5
90395|NCT02076776|222671|P3|STARTED|Overall Study||6
90396|NCT02076776|222672|P2|STARTED|Overall Study||8
90397|NCT02076776|222673|P1|STARTED|Overall Study||6
90398|NCT02076412|222689|P2|NOT COMPLETED|Overall Study||22
90399|NCT02076412|222690|P1|NOT COMPLETED|Overall Study||37
90400|NCT02076412|222689|P2|COMPLETED|Overall Study||2
90401|NCT02076412|222690|P1|COMPLETED|Overall Study||13
90402|NCT02076412|222689|P2|STARTED|Overall Study||24
90403|NCT02076412|222690|P1|STARTED|Overall Study||50
90404|NCT02076399|222710|P2|NOT COMPLETED|Overall Study||24
90405|NCT02076399|222711|P1|NOT COMPLETED|Overall Study||39
90406|NCT02076399|222710|P2|COMPLETED|Overall Study||1
90407|NCT02076399|222711|P1|COMPLETED|Overall Study||12
90408|NCT02076399|222710|P2|STARTED|Overall Study||25
90409|NCT02076399|222711|P1|STARTED|Overall Study||51
90410|NCT02076334|222733|P4|NOT COMPLETED|Overall Study||1
90411|NCT02076334|222734|P3|NOT COMPLETED|Overall Study||1
90412|NCT02076334|222735|P2|NOT COMPLETED|Overall Study||1
90413|NCT02076334|222736|P1|NOT COMPLETED|Overall Study||1
90414|NCT02076334|222733|P4|COMPLETED|Overall Study||20
90415|NCT02076334|222734|P3|COMPLETED|Overall Study||20
90416|NCT02076334|222735|P2|COMPLETED|Overall Study||20
90417|NCT02076334|222736|P1|COMPLETED|Overall Study||20
90418|NCT02076334|222733|P4|STARTED|Overall Study||21
90419|NCT02076334|222734|P3|STARTED|Overall Study||21
90420|NCT02076334|222735|P2|STARTED|Overall Study||21
90421|NCT02076334|222736|P1|STARTED|Overall Study||21
90422|NCT02076321|222752|P2|NOT COMPLETED|Overall Study||2
90423|NCT02076321|222753|P1|NOT COMPLETED|Overall Study||5
90424|NCT02076321|222752|P2|COMPLETED|Overall Study||49
90425|NCT02076321|222753|P1|COMPLETED|Overall Study||46
90426|NCT02076321|222752|P2|STARTED|Overall Study||51
90427|NCT02076321|222753|P1|STARTED|Overall Study||51
90428|NCT02076243|222759|P1|NOT COMPLETED|Overall Study||2
90429|NCT02076243|222759|P1|COMPLETED|Overall Study||0
90430|NCT02076243|222759|P1|STARTED|Overall Study||2
90431|NCT02076178|222769|P2|NOT COMPLETED|Injection Phase||7
90432|NCT02076178|222770|P1|NOT COMPLETED|Injection Phase||1
90433|NCT02076178|222769|P2|COMPLETED|Injection Phase||87
90434|NCT02076178|222770|P1|COMPLETED|Injection Phase||20
90435|NCT02076178|222769|P2|STARTED|Injection Phase||94
90436|NCT02076178|222770|P1|STARTED|Injection Phase||21
90437|NCT02076178|222769|P2|NOT COMPLETED|Oral Phase||12
90438|NCT02076178|222770|P1|NOT COMPLETED|Oral Phase||0
90439|NCT02076178|222769|P2|COMPLETED|Oral Phase||94
90440|NCT02076178|222770|P1|COMPLETED|Oral Phase||21
90441|NCT02076178|222769|P2|STARTED|Oral Phase||106
90442|NCT02076178|222770|P1|STARTED|Oral Phase||21
90443|NCT02076165|222804|P2|NOT COMPLETED|Overall Study||6
90444|NCT02076165|222805|P1|NOT COMPLETED|Overall Study||8
90445|NCT02076165|222804|P2|COMPLETED|Overall Study||69
90446|NCT02076165|222805|P1|COMPLETED|Overall Study||66
90447|NCT02076165|222804|P2|STARTED|Overall Study||75
90448|NCT02076165|222805|P1|STARTED|Overall Study||74
90449|NCT02076100|222836|P7|NOT COMPLETED|Overall Study||0
90450|NCT02076100|222837|P6|NOT COMPLETED|Overall Study||0
90451|NCT02076100|222838|P5|NOT COMPLETED|Overall Study||0
90452|NCT02076100|222839|P4|NOT COMPLETED|Overall Study||0
90453|NCT02076100|222840|P3|NOT COMPLETED|Overall Study||0
90454|NCT02076100|222841|P2|NOT COMPLETED|Overall Study||0
90455|NCT02076100|222842|P1|NOT COMPLETED|Overall Study||0
90456|NCT02076100|222836|P7|COMPLETED|Overall Study||4
90457|NCT02076100|222837|P6|COMPLETED|Overall Study||3
90458|NCT02076100|222838|P5|COMPLETED|Overall Study||3
90459|NCT02076100|222839|P4|COMPLETED|Overall Study||3
90460|NCT02076100|222840|P3|COMPLETED|Overall Study||3
90461|NCT02076100|222841|P2|COMPLETED|Overall Study||3
90462|NCT02076100|222842|P1|COMPLETED|Overall Study||3
90463|NCT02076100|222836|P7|STARTED|Overall Study||4
90464|NCT02076100|222837|P6|STARTED|Overall Study||3
90465|NCT02076100|222838|P5|STARTED|Overall Study||3
90466|NCT02076100|222839|P4|STARTED|Overall Study||3
90467|NCT02076100|222840|P3|STARTED|Overall Study||3
90468|NCT02076100|222841|P2|STARTED|Overall Study||3
90469|NCT02076100|222842|P1|STARTED|Overall Study||3
90470|NCT02076022|222875|P2|NOT COMPLETED|Overall Study||0
90471|NCT02076022|222876|P1|NOT COMPLETED|Overall Study||2
90472|NCT02076022|222875|P2|COMPLETED|Overall Study||3
90473|NCT02076022|222876|P1|COMPLETED|Overall Study||5
90474|NCT02076022|222875|P2|STARTED|Overall Study||3
90475|NCT02076022|222876|P1|STARTED|Overall Study||7
90476|NCT02076009|222888|P2|NOT COMPLETED|Overall Study||286
90477|NCT02076009|222889|P1|NOT COMPLETED|Overall Study||283
90478|NCT02076009|222888|P2|COMPLETED|Overall Study||0
90479|NCT02076009|222889|P1|COMPLETED|Overall Study||0
90480|NCT02076009|222888|P2|Treated|Overall Study||283
90481|NCT02076009|222889|P1|Treated|Overall Study||281
90482|NCT02076009|222888|P2|STARTED|Overall Study||286
90483|NCT02076009|222889|P1|STARTED|Overall Study||283
90484|NCT02075840|222911|P2|NOT COMPLETED|Overall Study||151
90485|NCT02075840|222912|P1|NOT COMPLETED|Overall Study||152
90486|NCT02075840|222911|P2|COMPLETED|Overall Study||0
90487|NCT02075840|222912|P1|COMPLETED|Overall Study||0
90488|NCT02075840|222911|P2|STARTED|Overall Study||151
90489|NCT02075840|222912|P1|STARTED|Overall Study||152
90490|NCT02075658|222968|P2|NOT COMPLETED|Overall Study||2
90491|NCT02075658|222969|P1|NOT COMPLETED|Overall Study||2
90492|NCT02075658|222968|P2|COMPLETED|Overall Study||28
90493|NCT02075658|222969|P1|COMPLETED|Overall Study||28
90494|NCT02075658|222968|P2|STARTED|Overall Study||30
90495|NCT02075658|222969|P1|STARTED|Overall Study||30
90496|NCT02075632|222979|P2|NOT COMPLETED|Overall Study||5
90497|NCT02075632|222980|P1|NOT COMPLETED|Overall Study||1
90498|NCT02075632|222979|P2|COMPLETED|Overall Study||143
90499|NCT02075632|222980|P1|COMPLETED|Overall Study||161
90500|NCT02075632|222979|P2|STARTED|Overall Study||148
90501|NCT02075632|222980|P1|STARTED|Overall Study||162
90502|NCT02075606|222990|P1|NOT COMPLETED|Overall Study||10
90503|NCT02075606|222990|P1|COMPLETED|Overall Study||40
90504|NCT02075606|222990|P1|STARTED|Overall Study||50
90505|NCT02075541|223014|P2|NOT COMPLETED|Overall Study||8
90506|NCT02075541|223015|P1|NOT COMPLETED|Overall Study||4
90507|NCT02075541|223014|P2|COMPLETED|Overall Study||64
90508|NCT02075541|223015|P1|COMPLETED|Overall Study||69
90509|NCT02075541|223014|P2|STARTED|Overall Study||72
90510|NCT02075541|223015|P1|STARTED|Overall Study||73
90511|NCT02075515|223064|P3|NOT COMPLETED|Overall Study||8
90512|NCT02075515|223065|P2|NOT COMPLETED|Overall Study||5
90513|NCT02075515|223066|P1|NOT COMPLETED|Overall Study||4
90514|NCT02075515|223064|P3|COMPLETED|Overall Study||208
90515|NCT02075515|223065|P2|COMPLETED|Overall Study||212
90516|NCT02075515|223066|P1|COMPLETED|Overall Study||214
90517|NCT02075515|223064|P3|STARTED|Overall Study||216
90518|NCT02075515|223065|P2|STARTED|Overall Study||217
90519|NCT02075515|223066|P1|STARTED|Overall Study||218
90520|NCT02075463|223101|P1|NOT COMPLETED|Overall Study||8
90521|NCT02075463|223101|P1|COMPLETED|Overall Study||7
90522|NCT02075463|223101|P1|STARTED|Overall Study||15
90523|NCT02075411|223130|P4|NOT COMPLETED|Overall Study||0
90524|NCT02075411|223131|P3|NOT COMPLETED|Overall Study||0
90525|NCT02075411|223132|P2|NOT COMPLETED|Overall Study||0
90526|NCT02075411|223133|P1|NOT COMPLETED|Overall Study||0
90527|NCT02075411|223130|P4|COMPLETED|Overall Study||1
90528|NCT02075411|223131|P3|COMPLETED|Overall Study||0
90529|NCT02075411|223132|P2|COMPLETED|Overall Study||0
90530|NCT02075411|223133|P1|COMPLETED|Overall Study||0
90531|NCT02075411|223130|P4|STARTED|Overall Study||1
90532|NCT02075411|223131|P3|STARTED|Overall Study||0
90533|NCT02075411|223132|P2|STARTED|Overall Study||0
90534|NCT02075411|223133|P1|STARTED|Overall Study||0
90535|NCT02075320|223151|P1|NOT COMPLETED|Overall Study||2
90536|NCT02075320|223151|P1|COMPLETED|Overall Study||48
90537|NCT02075320|223151|P1|STARTED|Overall Study||50
90538|NCT02075255|223161|P3|NOT COMPLETED|Overall Study||3
90539|NCT02075255|223162|P2|NOT COMPLETED|Overall Study||4
90540|NCT02075255|223163|P1|NOT COMPLETED|Overall Study||4
90541|NCT02075255|223161|P3|COMPLETED|Overall Study||72
90542|NCT02075255|223162|P2|COMPLETED|Overall Study||69
90543|NCT02075255|223163|P1|COMPLETED|Overall Study||68
90544|NCT02075255|223161|P3|STARTED|Overall Study||75
90545|NCT02075255|223162|P2|STARTED|Overall Study||73
90546|NCT02075255|223163|P1|STARTED|Overall Study||72
90547|NCT02075203|223273|P3|NOT COMPLETED|Overall Study||1
90548|NCT02075203|223274|P2|NOT COMPLETED|Overall Study||0
90549|NCT02075203|223275|P1|NOT COMPLETED|Overall Study||3
90550|NCT02075203|223273|P3|COMPLETED|Overall Study||328
90551|NCT02075203|223274|P2|COMPLETED|Overall Study||330
90552|NCT02075203|223275|P1|COMPLETED|Overall Study||327
90553|NCT02075203|223273|P3|STARTED|Overall Study||329
90554|NCT02075203|223274|P2|STARTED|Overall Study||330
90555|NCT02075203|223275|P1|STARTED|Overall Study||330
90556|NCT02075125|223294|P2|NOT COMPLETED|Overall Study||1
90557|NCT02075125|223295|P1|NOT COMPLETED|Overall Study||0
90558|NCT02075125|223294|P2|COMPLETED|Overall Study|One patient switched to clopidogrel treatment after 18 days of ticagrelor treatment.|19
90559|NCT02075125|223295|P1|COMPLETED|Overall Study||19
90560|NCT02075125|223294|P2|STARTED|Overall Study||20
90561|NCT02075125|223295|P1|STARTED|Overall Study||19
90562|NCT02075073|223316|P3|NOT COMPLETED|Overall Study||0
90563|NCT02075073|223317|P2|NOT COMPLETED|Overall Study||1
90564|NCT02075073|223318|P1|NOT COMPLETED|Overall Study||0
90565|NCT02075073|223316|P3|COMPLETED|Overall Study||36
90566|NCT02075073|223317|P2|COMPLETED|Overall Study||36
90567|NCT02075073|223318|P1|COMPLETED|Overall Study||36
90568|NCT02075073|223316|P3|STARTED|Overall Study||36
90569|NCT02075073|223317|P2|STARTED|Overall Study||37
90570|NCT02075073|223318|P1|STARTED|Overall Study||36
90571|NCT02075021|223335|P1|NOT COMPLETED|Overall Study||0
90572|NCT02075021|223335|P1|COMPLETED|Overall Study||3
90573|NCT02075021|223335|P1|STARTED|Overall Study||3
90574|NCT02075008|223340|P1|NOT COMPLETED|Overall Study||176
90575|NCT02075008|223340|P1|COMPLETED|Overall Study||94
90576|NCT02075008|223340|P1|STARTED|Overall Study||270
90577|NCT02074995|223344|P3|NOT COMPLETED|Overall Study||0
90578|NCT02074995|223345|P2|NOT COMPLETED|Overall Study||0
90579|NCT02074995|223346|P1|NOT COMPLETED|Overall Study||0
90580|NCT02074995|223344|P3|COMPLETED|Overall Study||0
90581|NCT02074995|223345|P2|COMPLETED|Overall Study||0
90582|NCT02074995|223346|P1|COMPLETED|Overall Study||1
90583|NCT02074995|223344|P3|STARTED|Overall Study||0
90584|NCT02074995|223345|P2|STARTED|Overall Study||0
90585|NCT02074995|223346|P1|STARTED|Overall Study||1
90586|NCT02074982|223363|P2|NOT COMPLETED|Overall Study||54
90587|NCT02074982|223364|P1|NOT COMPLETED|Overall Study||51
90588|NCT02074982|223363|P2|COMPLETED|Overall Study||285
90589|NCT02074982|223364|P1|COMPLETED|Overall Study||286
90590|NCT02074982|223363|P2|Safety Set (SF)|Overall Study||336
90591|NCT02074982|223364|P1|Safety Set (SF)|Overall Study||335
90592|NCT02074982|223363|P2|Full Analysis Set (FAS)|Overall Study||339
90593|NCT02074982|223364|P1|Full Analysis Set (FAS)|Overall Study||336
90594|NCT02074982|223363|P2|STARTED|Overall Study||339
90595|NCT02074982|223364|P1|STARTED|Overall Study||337
90596|NCT02074904|223376|P2|NOT COMPLETED|Overall Study||0
90597|NCT02074904|223377|P1|NOT COMPLETED|Overall Study||0
90598|NCT02074904|223376|P2|COMPLETED|Overall Study||0
90599|NCT02074904|223377|P1|COMPLETED|Overall Study||1
90600|NCT02074904|223376|P2|STARTED|Overall Study||0
90601|NCT02074904|223377|P1|STARTED|Overall Study||1
90602|NCT02074735|223393|P2|NOT COMPLETED|Overall Study||4
90603|NCT02074735|223394|P1|NOT COMPLETED|Overall Study||3
90604|NCT02074735|223393|P2|COMPLETED|Overall Study||29
90605|NCT02074735|223394|P1|COMPLETED|Overall Study||26
90606|NCT02074735|223393|P2|STARTED|Overall Study||33
90607|NCT02074735|223394|P1|STARTED|Overall Study||29
90608|NCT02074709|223402|P2|NOT COMPLETED|Overall Study||1
90609|NCT02074709|223403|P1|NOT COMPLETED|Overall Study||1
90610|NCT02074709|223402|P2|COMPLETED|Overall Study||29
90611|NCT02074709|223403|P1|COMPLETED|Overall Study||29
90612|NCT02074709|223402|P2|STARTED|Overall Study||30
90613|NCT02074709|223403|P1|STARTED|Overall Study||30
90614|NCT02074553|223411|P8|NOT COMPLETED|Intervention Period 4||0
90615|NCT02074553|223412|P7|NOT COMPLETED|Intervention Period 4||0
90616|NCT02074553|223413|P6|NOT COMPLETED|Intervention Period 4||0
90617|NCT02074553|223414|P5|NOT COMPLETED|Intervention Period 4||0
90618|NCT02074553|223415|P4|NOT COMPLETED|Intervention Period 4||0
90619|NCT02074553|223416|P3|NOT COMPLETED|Intervention Period 4||0
90620|NCT02074553|223417|P2|NOT COMPLETED|Intervention Period 4||0
90621|NCT02074553|223418|P1|NOT COMPLETED|Intervention Period 4||0
90622|NCT02074553|223411|P8|COMPLETED|Intervention Period 4||11
90623|NCT02074553|223412|P7|COMPLETED|Intervention Period 4||11
90624|NCT02074553|223413|P6|COMPLETED|Intervention Period 4||10
90625|NCT02074553|223414|P5|COMPLETED|Intervention Period 4||12
90626|NCT02074553|223415|P4|COMPLETED|Intervention Period 4||11
90627|NCT02074553|223416|P3|COMPLETED|Intervention Period 4||11
90628|NCT02074553|223417|P2|COMPLETED|Intervention Period 4||12
90629|NCT02074553|223418|P1|COMPLETED|Intervention Period 4||11
90630|NCT02074553|223411|P8|STARTED|Intervention Period 4||11
90631|NCT02074553|223412|P7|STARTED|Intervention Period 4||11
90632|NCT02074553|223413|P6|STARTED|Intervention Period 4||10
90633|NCT02074553|223414|P5|STARTED|Intervention Period 4||12
90634|NCT02074553|223415|P4|STARTED|Intervention Period 4||11
90635|NCT02074553|223416|P3|STARTED|Intervention Period 4||11
90636|NCT02074553|223417|P2|STARTED|Intervention Period 4||12
90637|NCT02074553|223418|P1|STARTED|Intervention Period 4||11
90638|NCT02074553|223411|P8|NOT COMPLETED|Washout Period 3||1
90639|NCT02074553|223412|P7|NOT COMPLETED|Washout Period 3||0
90640|NCT02074553|223413|P6|NOT COMPLETED|Washout Period 3||0
90641|NCT02074553|223414|P5|NOT COMPLETED|Washout Period 3||0
90642|NCT02074553|223415|P4|NOT COMPLETED|Washout Period 3||0
90643|NCT02074553|223416|P3|NOT COMPLETED|Washout Period 3||0
90644|NCT02074553|223417|P2|NOT COMPLETED|Washout Period 3||0
90645|NCT02074553|223418|P1|NOT COMPLETED|Washout Period 3||0
90646|NCT02074553|223411|P8|COMPLETED|Washout Period 3||11
90647|NCT02074553|223412|P7|COMPLETED|Washout Period 3||11
90648|NCT02074553|223413|P6|COMPLETED|Washout Period 3||10
90649|NCT02074553|223414|P5|COMPLETED|Washout Period 3||12
90650|NCT02074553|223415|P4|COMPLETED|Washout Period 3||11
90651|NCT02074553|223416|P3|COMPLETED|Washout Period 3||11
90652|NCT02074553|223417|P2|COMPLETED|Washout Period 3||12
90653|NCT02074553|223418|P1|COMPLETED|Washout Period 3||11
90654|NCT02074553|223411|P8|STARTED|Washout Period 3||12
90655|NCT02074553|223412|P7|STARTED|Washout Period 3||11
90656|NCT02074553|223413|P6|STARTED|Washout Period 3||10
90657|NCT02074553|223414|P5|STARTED|Washout Period 3||12
90658|NCT02074553|223415|P4|STARTED|Washout Period 3||11
90659|NCT02074553|223416|P3|STARTED|Washout Period 3||11
90660|NCT02074553|223417|P2|STARTED|Washout Period 3||12
90661|NCT02074553|223418|P1|STARTED|Washout Period 3||11
90662|NCT02074553|223411|P8|NOT COMPLETED|Intervention Period 3||0
90663|NCT02074553|223412|P7|NOT COMPLETED|Intervention Period 3||0
90664|NCT02074553|223413|P6|NOT COMPLETED|Intervention Period 3||0
90665|NCT02074553|223414|P5|NOT COMPLETED|Intervention Period 3||0
90666|NCT02074553|223415|P4|NOT COMPLETED|Intervention Period 3||0
90667|NCT02074553|223416|P3|NOT COMPLETED|Intervention Period 3||0
90668|NCT02074553|223417|P2|NOT COMPLETED|Intervention Period 3||0
90669|NCT02074553|223418|P1|NOT COMPLETED|Intervention Period 3||0
90670|NCT02074553|223411|P8|COMPLETED|Intervention Period 3||12
90671|NCT02074553|223412|P7|COMPLETED|Intervention Period 3||11
90672|NCT02074553|223413|P6|COMPLETED|Intervention Period 3||10
90673|NCT02074553|223414|P5|COMPLETED|Intervention Period 3||12
90674|NCT02074553|223415|P4|COMPLETED|Intervention Period 3||11
90675|NCT02074553|223416|P3|COMPLETED|Intervention Period 3||11
90676|NCT02074553|223417|P2|COMPLETED|Intervention Period 3||12
90677|NCT02074553|223418|P1|COMPLETED|Intervention Period 3||11
90678|NCT02074553|223411|P8|STARTED|Intervention Period 3||12
90679|NCT02074553|223412|P7|STARTED|Intervention Period 3||11
90680|NCT02074553|223413|P6|STARTED|Intervention Period 3||10
90681|NCT02074553|223414|P5|STARTED|Intervention Period 3||12
90682|NCT02074553|223415|P4|STARTED|Intervention Period 3||11
90683|NCT02074553|223416|P3|STARTED|Intervention Period 3||11
90684|NCT02074553|223417|P2|STARTED|Intervention Period 3||12
90685|NCT02074553|223418|P1|STARTED|Intervention Period 3||11
90686|NCT02074553|223411|P8|NOT COMPLETED|Washout Period 2||0
90687|NCT02074553|223412|P7|NOT COMPLETED|Washout Period 2||1
90688|NCT02074553|223413|P6|NOT COMPLETED|Washout Period 2||1
90689|NCT02074553|223414|P5|NOT COMPLETED|Washout Period 2||0
90690|NCT02074553|223415|P4|NOT COMPLETED|Washout Period 2||0
90691|NCT02074553|223416|P3|NOT COMPLETED|Washout Period 2||1
90692|NCT02074553|223417|P2|NOT COMPLETED|Washout Period 2||0
90693|NCT02074553|223418|P1|NOT COMPLETED|Washout Period 2||0
90694|NCT02074553|223411|P8|COMPLETED|Washout Period 2||12
90695|NCT02074553|223412|P7|COMPLETED|Washout Period 2||11
90696|NCT02074553|223413|P6|COMPLETED|Washout Period 2||10
90697|NCT02074553|223414|P5|COMPLETED|Washout Period 2||12
90698|NCT02074553|223415|P4|COMPLETED|Washout Period 2||11
90699|NCT02074553|223416|P3|COMPLETED|Washout Period 2||11
90700|NCT02074553|223417|P2|COMPLETED|Washout Period 2||12
90701|NCT02074553|223418|P1|COMPLETED|Washout Period 2||11
90702|NCT02074553|223411|P8|STARTED|Washout Period 2||12
90703|NCT02074553|223412|P7|STARTED|Washout Period 2||12
90704|NCT02074553|223413|P6|STARTED|Washout Period 2||11
90705|NCT02074553|223414|P5|STARTED|Washout Period 2||12
90706|NCT02074553|223415|P4|STARTED|Washout Period 2||11
90707|NCT02074553|223416|P3|STARTED|Washout Period 2||12
90708|NCT02074553|223417|P2|STARTED|Washout Period 2||12
90709|NCT02074553|223418|P1|STARTED|Washout Period 2||11
90710|NCT02074553|223411|P8|NOT COMPLETED|Intervention Period 2||0
90711|NCT02074553|223412|P7|NOT COMPLETED|Intervention Period 2||0
90712|NCT02074553|223413|P6|NOT COMPLETED|Intervention Period 2||0
90713|NCT02074553|223414|P5|NOT COMPLETED|Intervention Period 2||0
90714|NCT02074553|223415|P4|NOT COMPLETED|Intervention Period 2||0
90715|NCT02074553|223416|P3|NOT COMPLETED|Intervention Period 2||0
90716|NCT02074553|223417|P2|NOT COMPLETED|Intervention Period 2||0
90717|NCT02074553|223418|P1|NOT COMPLETED|Intervention Period 2||0
90718|NCT02074553|223411|P8|COMPLETED|Intervention Period 2||12
90719|NCT02074553|223412|P7|COMPLETED|Intervention Period 2||12
90720|NCT02074553|223413|P6|COMPLETED|Intervention Period 2||11
90721|NCT02074553|223414|P5|COMPLETED|Intervention Period 2||12
90722|NCT02074553|223415|P4|COMPLETED|Intervention Period 2||11
90723|NCT02074553|223416|P3|COMPLETED|Intervention Period 2||12
90724|NCT02074553|223417|P2|COMPLETED|Intervention Period 2||12
90725|NCT02074553|223418|P1|COMPLETED|Intervention Period 2||11
90726|NCT02074553|223411|P8|STARTED|Intervention Period 2||12
90727|NCT02074553|223412|P7|STARTED|Intervention Period 2||12
90728|NCT02074553|223413|P6|STARTED|Intervention Period 2||11
90729|NCT02074553|223414|P5|STARTED|Intervention Period 2||12
90730|NCT02074553|223415|P4|STARTED|Intervention Period 2||11
90731|NCT02074553|223416|P3|STARTED|Intervention Period 2||12
90732|NCT02074553|223417|P2|STARTED|Intervention Period 2||12
90733|NCT02074553|223418|P1|STARTED|Intervention Period 2||11
90734|NCT02074553|223411|P8|NOT COMPLETED|Washout Period 1||0
90735|NCT02074553|223412|P7|NOT COMPLETED|Washout Period 1||0
90736|NCT02074553|223413|P6|NOT COMPLETED|Washout Period 1||1
90737|NCT02074553|223414|P5|NOT COMPLETED|Washout Period 1||0
90738|NCT02074553|223415|P4|NOT COMPLETED|Washout Period 1||1
90739|NCT02074553|223416|P3|NOT COMPLETED|Washout Period 1||0
90740|NCT02074553|223417|P2|NOT COMPLETED|Washout Period 1||0
90741|NCT02074553|223418|P1|NOT COMPLETED|Washout Period 1||1
90742|NCT02074553|223411|P8|COMPLETED|Washout Period 1||12
90743|NCT02074553|223412|P7|COMPLETED|Washout Period 1||12
90744|NCT02074553|223413|P6|COMPLETED|Washout Period 1||11
90745|NCT02074553|223414|P5|COMPLETED|Washout Period 1||12
90746|NCT02074553|223415|P4|COMPLETED|Washout Period 1||11
90747|NCT02074553|223416|P3|COMPLETED|Washout Period 1||12
90748|NCT02074553|223417|P2|COMPLETED|Washout Period 1||12
90749|NCT02074553|223418|P1|COMPLETED|Washout Period 1||11
90750|NCT02074553|223411|P8|STARTED|Washout Period 1||12
90751|NCT02074553|223412|P7|STARTED|Washout Period 1||12
90752|NCT02074553|223413|P6|STARTED|Washout Period 1||12
90753|NCT02074553|223414|P5|STARTED|Washout Period 1||12
90754|NCT02074553|223415|P4|STARTED|Washout Period 1||12
90755|NCT02074553|223416|P3|STARTED|Washout Period 1||12
90756|NCT02074553|223417|P2|STARTED|Washout Period 1||12
90757|NCT02074553|223418|P1|STARTED|Washout Period 1||12
90758|NCT02074553|223411|P8|NOT COMPLETED|Intervention Period 1||0
90759|NCT02074553|223412|P7|NOT COMPLETED|Intervention Period 1||0
90760|NCT02074553|223413|P6|NOT COMPLETED|Intervention Period 1||0
90761|NCT02074553|223414|P5|NOT COMPLETED|Intervention Period 1||0
90762|NCT02074553|223415|P4|NOT COMPLETED|Intervention Period 1||1
90763|NCT02074553|223416|P3|NOT COMPLETED|Intervention Period 1||0
90764|NCT02074553|223417|P2|NOT COMPLETED|Intervention Period 1||0
90765|NCT02074553|223418|P1|NOT COMPLETED|Intervention Period 1||0
90766|NCT02074553|223411|P8|COMPLETED|Intervention Period 1||12
90767|NCT02074553|223412|P7|COMPLETED|Intervention Period 1||12
90768|NCT02074553|223413|P6|COMPLETED|Intervention Period 1||12
90769|NCT02074553|223414|P5|COMPLETED|Intervention Period 1||12
90770|NCT02074553|223415|P4|COMPLETED|Intervention Period 1||12
90771|NCT02074553|223416|P3|COMPLETED|Intervention Period 1||12
90772|NCT02074553|223417|P2|COMPLETED|Intervention Period 1||12
90773|NCT02074553|223418|P1|COMPLETED|Intervention Period 1||12
90774|NCT02074553|223411|P8|STARTED|Intervention Period 1||12
90775|NCT02074553|223412|P7|STARTED|Intervention Period 1||12
90776|NCT02074553|223413|P6|STARTED|Intervention Period 1||12
90777|NCT02074553|223414|P5|STARTED|Intervention Period 1||12
90778|NCT02074553|223415|P4|STARTED|Intervention Period 1||13
90779|NCT02074553|223416|P3|STARTED|Intervention Period 1||12
90780|NCT02074553|223417|P2|STARTED|Intervention Period 1||12
90781|NCT02074553|223418|P1|STARTED|Intervention Period 1||12
90782|NCT02074514|223600|P2|NOT COMPLETED|Overall Study||4
90783|NCT02074514|223601|P1|NOT COMPLETED|Overall Study||3
90784|NCT02074514|223600|P2|COMPLETED|Overall Study||54
90785|NCT02074514|223601|P1|COMPLETED|Overall Study||56
90786|NCT02074514|223600|P2|STARTED|Overall Study||58
90787|NCT02074514|223601|P1|STARTED|Overall Study||59
90788|NCT02074384|223622|P3|NOT COMPLETED|Overall Study||0
90789|NCT02074384|223623|P2|NOT COMPLETED|Overall Study||0
90790|NCT02074384|223624|P1|NOT COMPLETED|Overall Study||0
90791|NCT02074384|223622|P3|COMPLETED|Overall Study||17
90792|NCT02074384|223623|P2|COMPLETED|Overall Study||70
90793|NCT02074384|223624|P1|COMPLETED|Overall Study||74
90794|NCT02074384|223622|P3|STARTED|Overall Study||17
90795|NCT02074384|223623|P2|STARTED|Overall Study||70
90796|NCT02074384|223624|P1|STARTED|Overall Study||74
90797|NCT02074358|223632|P6|NOT COMPLETED|Overall Study||0
90798|NCT02074358|223633|P5|NOT COMPLETED|Overall Study||0
90799|NCT02074358|223634|P4|NOT COMPLETED|Overall Study||0
90800|NCT02074358|223635|P3|NOT COMPLETED|Overall Study||0
90801|NCT02074358|223636|P2|NOT COMPLETED|Overall Study||0
90802|NCT02074358|223637|P1|NOT COMPLETED|Overall Study||0
90803|NCT02074358|223632|P6|COMPLETED|Overall Study||2
90804|NCT02074358|223633|P5|COMPLETED|Overall Study||3
90805|NCT02074358|223634|P4|COMPLETED|Overall Study||2
90806|NCT02074358|223635|P3|COMPLETED|Overall Study||2
90807|NCT02074358|223636|P2|COMPLETED|Overall Study||3
90808|NCT02074358|223637|P1|COMPLETED|Overall Study||3
90809|NCT02074358|223632|P6|STARTED|Overall Study||2
90810|NCT02074358|223633|P5|STARTED|Overall Study||3
90811|NCT02074358|223634|P4|STARTED|Overall Study||2
90812|NCT02074358|223635|P3|STARTED|Overall Study||2
90813|NCT02074358|223636|P2|STARTED|Overall Study||3
90814|NCT02074358|223637|P1|STARTED|Overall Study||3
90815|NCT02074345|223726|P1|NOT COMPLETED|Overall Study||0
90816|NCT02074345|223726|P1|COMPLETED|Overall Study||31
90817|NCT02074345|223726|P1|STARTED|Overall Study||31
90818|NCT02074059|223742|P6|NOT COMPLETED|Overall Study||1
90819|NCT02074059|223743|P5|NOT COMPLETED|Overall Study||1
90820|NCT02074059|223744|P4|NOT COMPLETED|Overall Study||0
90821|NCT02074059|223745|P3|NOT COMPLETED|Overall Study||0
90822|NCT02074059|223746|P2|NOT COMPLETED|Overall Study||0
90823|NCT02074059|223747|P1|NOT COMPLETED|Overall Study||0
90824|NCT02074059|223742|P6|COMPLETED|Overall Study||39
90825|NCT02074059|223743|P5|COMPLETED|Overall Study||7
90826|NCT02074059|223744|P4|COMPLETED|Overall Study||8
90827|NCT02074059|223745|P3|COMPLETED|Overall Study||8
90828|NCT02074059|223746|P2|COMPLETED|Overall Study||8
90829|NCT02074059|223747|P1|COMPLETED|Overall Study||8
90830|NCT02074059|223742|P6|STARTED|Overall Study||40
90831|NCT02074059|223743|P5|STARTED|Overall Study||8
90832|NCT02074059|223744|P4|STARTED|Overall Study||8
90833|NCT02074059|223745|P3|STARTED|Overall Study||8
90834|NCT02074059|223746|P2|STARTED|Overall Study||8
90835|NCT02074059|223747|P1|STARTED|Overall Study||8
90836|NCT02073929|223787|P2|NOT COMPLETED|Overall Study||3
90837|NCT02073929|223788|P1|NOT COMPLETED|Overall Study||4
90838|NCT02073929|223787|P2|COMPLETED|Overall Study||21
90839|NCT02073929|223788|P1|COMPLETED|Overall Study||44
90840|NCT02073929|223787|P2|STARTED|Overall Study||24
90841|NCT02073929|223788|P1|STARTED|Overall Study||48
90842|NCT02073747|223816|P2|NOT COMPLETED|Overall Study||1
90843|NCT02073747|223817|P1|NOT COMPLETED|Overall Study||1
90844|NCT02073747|223816|P2|COMPLETED|Overall Study||14
90845|NCT02073747|223817|P1|COMPLETED|Overall Study||14
90846|NCT02073747|223816|P2|STARTED|Overall Study||15
90847|NCT02073747|223817|P1|STARTED|Overall Study||15
90848|NCT02073682|223825|P2|NOT COMPLETED|Overall Study||370
90849|NCT02073682|223826|P1|NOT COMPLETED|Overall Study||322
90850|NCT02073682|223825|P2|COMPLETED|Overall Study||154
90851|NCT02073682|223826|P1|COMPLETED|Overall Study||200
90852|NCT02073682|223825|P2|STARTED|Overall Study||524
90853|NCT02073682|223826|P1|STARTED|Overall Study||522
90854|NCT02073656|223844|P1|NOT COMPLETED|Retreatment Substudy||0
90855|NCT02073656|223844|P1|COMPLETED|Retreatment Substudy||9
90856|NCT02073656|223844|P1|STARTED|Retreatment Substudy|Only participants experiencing virologic relapse in the Primary Study were eligible for retreatment.|9
90857|NCT02073656|223844|P1|NOT COMPLETED|Primary Study||8
90858|NCT02073656|223844|P1|COMPLETED|Primary Study||327
90859|NCT02073656|223844|P1|STARTED|Primary Study||335
90860|NCT02073643|223860|P1|NOT COMPLETED|Overall Study||24
90861|NCT02073643|223860|P1|COMPLETED|Overall Study||180
90862|NCT02073643|223860|P1|STARTED|Overall Study||204
90863|NCT02073565|223871|P2|NOT COMPLETED|Cohort C||4
90864|NCT02073565|223872|P1|NOT COMPLETED|Cohort C||0
90865|NCT02073565|223871|P2|COMPLETED|Cohort C||211
90866|NCT02073565|223872|P1|COMPLETED|Cohort C||217
90867|NCT02073565|223871|P2|STARTED|Cohort C||215
90868|NCT02073565|223872|P1|STARTED|Cohort C||217
90869|NCT02073565|223871|P2|NOT COMPLETED|Cohort B||2
90870|NCT02073565|223872|P1|NOT COMPLETED|Cohort B||1
90871|NCT02073565|223871|P2|COMPLETED|Cohort B||54
90872|NCT02073565|223872|P1|COMPLETED|Cohort B||53
90873|NCT02073565|223871|P2|STARTED|Cohort B||56
90874|NCT02073565|223872|P1|STARTED|Cohort B||54
90875|NCT02073565|223871|P2|NOT COMPLETED|Cohort A||0
90876|NCT02073565|223872|P1|NOT COMPLETED|Cohort A||1
90877|NCT02073565|223871|P2|COMPLETED|Cohort A||14
90878|NCT02073565|223872|P1|COMPLETED|Cohort A||15
90879|NCT02073565|223871|P2|STARTED|Cohort A||14
90880|NCT02073565|223872|P1|STARTED|Cohort A||16
90881|NCT02073565|223871|P2|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||6
90882|NCT02073565|223872|P1|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||2
90883|NCT02073565|223871|P2|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||279
90884|NCT02073565|223872|P1|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||285
90885|NCT02073565|223871|P2|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||285
90886|NCT02073565|223872|P1|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||287
90887|NCT02073461|223887|P3|NOT COMPLETED|Overall Study||1
90888|NCT02073461|223888|P2|NOT COMPLETED|Overall Study||1
90889|NCT02073461|223889|P1|NOT COMPLETED|Overall Study||4
90890|NCT02073461|223887|P3|COMPLETED|Overall Study||78
90891|NCT02073461|223888|P2|COMPLETED|Overall Study||77
90892|NCT02073461|223889|P1|COMPLETED|Overall Study||75
90893|NCT02073461|223887|P3|STARTED|Overall Study||79
90894|NCT02073461|223888|P2|STARTED|Overall Study||78
90895|NCT02073461|223889|P1|STARTED|Overall Study||79
90896|NCT02073448|223918|P3|NOT COMPLETED|Overall Study||5
90897|NCT02073448|223919|P2|NOT COMPLETED|Overall Study||12
90898|NCT02073448|223920|P1|NOT COMPLETED|Overall Study||2
90899|NCT02073448|223918|P3|COMPLETED|Overall Study||99
90900|NCT02073448|223919|P2|COMPLETED|Overall Study||200
90901|NCT02073448|223920|P1|COMPLETED|Overall Study||99
90902|NCT02073448|223918|P3|STARTED|Overall Study||104
90903|NCT02073448|223919|P2|STARTED|Overall Study||212
90904|NCT02073448|223920|P1|STARTED|Overall Study||101
90905|NCT02073435|223948|P2|NOT COMPLETED|Overall Study||0
90906|NCT02073435|223949|P1|NOT COMPLETED|Overall Study||0
90907|NCT02073435|223948|P2|COMPLETED|Overall Study||96
90908|NCT02073435|223949|P1|COMPLETED|Overall Study||81
90909|NCT02073435|223948|P2|STARTED|Overall Study||96
90910|NCT02073435|223949|P1|STARTED|Overall Study||81
90911|NCT02073331|223957|P1|NOT COMPLETED|Overall Study||0
90912|NCT02073331|223957|P1|COMPLETED|Overall Study||1420
90913|NCT02073331|223957|P1|STARTED|Overall Study||1420
90914|NCT02073162|223963|P2|NOT COMPLETED|Overall Study||11
90915|NCT02073162|223964|P1|NOT COMPLETED|Overall Study||6
90916|NCT02073162|223963|P2|COMPLETED|Overall Study||1490
90917|NCT02073162|223964|P1|COMPLETED|Overall Study||1493
90918|NCT02073162|223963|P2|STARTED|Overall Study||1501
90919|NCT02073162|223964|P1|STARTED|Overall Study||1499
90920|NCT02072980|223992|P2|NOT COMPLETED|Period 2, Second Wear||1
90921|NCT02072980|223993|P1|NOT COMPLETED|Period 2, Second Wear||0
90922|NCT02072980|223992|P2|COMPLETED|Period 2, Second Wear||7
90923|NCT02072980|223993|P1|COMPLETED|Period 2, Second Wear||7
90924|NCT02072980|223992|P2|STARTED|Period 2, Second Wear||8
90925|NCT02072980|223993|P1|STARTED|Period 2, Second Wear||7
90926|NCT02072980|223992|P2|NOT COMPLETED|Period 1, First Wear||0
90927|NCT02072980|223993|P1|NOT COMPLETED|Period 1, First Wear||0
90928|NCT02072980|223992|P2|COMPLETED|Period 1, First Wear||8
90929|NCT02072980|223993|P1|COMPLETED|Period 1, First Wear||7
90930|NCT02072980|223992|P2|STARTED|Period 1, First Wear||8
90931|NCT02072980|223993|P1|STARTED|Period 1, First Wear||7
90932|NCT02072941|224001|P2|NOT COMPLETED|Overall Study||29
90933|NCT02072941|224002|P1|NOT COMPLETED|Overall Study||38
90934|NCT02072941|224001|P2|COMPLETED|Overall Study||197
90935|NCT02072941|224002|P1|COMPLETED|Overall Study||181
90936|NCT02072941|224001|P2|STARTED|Overall Study||226
90937|NCT02072941|224002|P1|STARTED|Overall Study||219
90938|NCT02072928|224010|P1|NOT COMPLETED|Overall Study||0
90939|NCT02072928|224010|P1|COMPLETED|Overall Study||55
90940|NCT02072928|224010|P1|STARTED|Overall Study||55
90941|NCT02072824|224017|P3|NOT COMPLETED|Overall Study||3
90942|NCT02072824|224018|P2|NOT COMPLETED|Overall Study||1
90943|NCT02072824|224019|P1|NOT COMPLETED|Overall Study||2
90944|NCT02072824|224017|P3|COMPLETED|Overall Study||67
90945|NCT02072824|224018|P2|COMPLETED|Overall Study||33
90946|NCT02072824|224019|P1|COMPLETED|Overall Study||69
90947|NCT02072824|224017|P3|STARTED|Overall Study||70
90948|NCT02072824|224018|P2|STARTED|Overall Study||34
90949|NCT02072824|224019|P1|STARTED|Overall Study||71
90950|NCT02072434|224056|P2|NOT COMPLETED|Overall Study||90
90951|NCT02072434|224057|P1|NOT COMPLETED|Overall Study||54
90952|NCT02072434|224056|P2|COMPLETED|Overall Study||1014
90953|NCT02072434|224057|P1|COMPLETED|Overall Study||1041
90954|NCT02072434|224056|P2|Safety Analysis Set|Overall Study||1082
90955|NCT02072434|224057|P1|Safety Analysis Set|Overall Study||1067
90956|NCT02072434|224056|P2|Received Study Drug|Overall Study||1082
90957|NCT02072434|224057|P1|Received Study Drug|Overall Study||1067
90958|NCT02072434|224056|P2|Intent to Treat Analysis Set|Overall Study||1104
90959|NCT02072434|224057|P1|Intent to Treat Analysis Set|Overall Study||1095
90960|NCT02072434|224056|P2|STARTED|Overall Study||1104
90961|NCT02072434|224057|P1|STARTED|Overall Study||1095
90962|NCT02072421|224067|P1|NOT COMPLETED|Overall Study||390
90963|NCT02072421|224067|P1|COMPLETED|Overall Study||2489
90964|NCT02072421|224067|P1|STARTED|Overall Study||2879
90965|NCT02072226|224077|P2|NOT COMPLETED|Overall Study||10
90966|NCT02072226|224078|P1|NOT COMPLETED|Overall Study||15
90967|NCT02072226|224077|P2|COMPLETED|Overall Study||147
90968|NCT02072226|224078|P1|COMPLETED|Overall Study||141
90969|NCT02072226|224077|P2|STARTED|Overall Study||157
90970|NCT02072226|224078|P1|STARTED|Overall Study||156
90971|NCT02072200|224100|P1|NOT COMPLETED|Overall Study||2
90972|NCT02072200|224100|P1|COMPLETED|Overall Study||145
90973|NCT02072200|224100|P1|STARTED|Overall Study||147
90974|NCT02072174|224108|P2|NOT COMPLETED|Overall Study||39
90975|NCT02072174|224109|P1|NOT COMPLETED|Overall Study||32
90976|NCT02072174|224108|P2|COMPLETED|Overall Study||240
90977|NCT02072174|224109|P1|COMPLETED|Overall Study||258
90978|NCT02072174|224108|P2|STARTED|Overall Study||279
90979|NCT02072174|224109|P1|STARTED|Overall Study||290
90980|NCT02072096|224133|P2|NOT COMPLETED|Overall Study||78
90981|NCT02072096|224134|P1|NOT COMPLETED|Overall Study||85
90982|NCT02072096|224133|P2|COMPLETED|Overall Study||15
90983|NCT02072096|224134|P1|COMPLETED|Overall Study||14
90984|NCT02072096|224133|P2|Received at Least One Dose of Study Drug|Overall Study||93
90985|NCT02072096|224134|P1|Received at Least One Dose of Study Drug|Overall Study||98
90986|NCT02072096|224133|P2|STARTED|Overall Study||93
90987|NCT02072096|224134|P1|STARTED|Overall Study||99
90988|NCT02071849|224156|P1|NOT COMPLETED|2-year Extended Follow-up||1
90989|NCT02071849|224156|P1|COMPLETED|2-year Extended Follow-up||14
90990|NCT02071849|224156|P1|STARTED|2-year Extended Follow-up||15
90991|NCT02071849|224156|P1|NOT COMPLETED|6-month Primary Endpoint||5
90992|NCT02071849|224156|P1|COMPLETED|6-month Primary Endpoint||15
90993|NCT02071849|224156|P1|STARTED|6-month Primary Endpoint||20
90994|NCT02071823|224190|P2|NOT COMPLETED|Overall Study||0
90995|NCT02071823|224191|P1|NOT COMPLETED|Overall Study||1
90996|NCT02071823|224190|P2|COMPLETED|Overall Study||6
90997|NCT02071823|224191|P1|COMPLETED|Overall Study||5
90998|NCT02071823|224190|P2|STARTED|Overall Study||6
90999|NCT02071823|224191|P1|STARTED|Overall Study||6
91000|NCT02071810|224206|P5|NOT COMPLETED|Overall Study||1
91001|NCT02071810|224207|P4|NOT COMPLETED|Overall Study||1
91002|NCT02071810|224208|P3|NOT COMPLETED|Overall Study||0
91003|NCT02071810|224209|P2|NOT COMPLETED|Overall Study||0
91004|NCT02071810|224210|P1|NOT COMPLETED|Overall Study||0
91005|NCT02071810|224206|P5|COMPLETED|Overall Study||8
91006|NCT02071810|224207|P4|COMPLETED|Overall Study||6
91007|NCT02071810|224208|P3|COMPLETED|Overall Study||6
91008|NCT02071810|224209|P2|COMPLETED|Overall Study||6
91009|NCT02071810|224210|P1|COMPLETED|Overall Study||6
91010|NCT02071810|224206|P5|STARTED|Overall Study||9
91011|NCT02071810|224207|P4|STARTED|Overall Study||7
91012|NCT02071810|224208|P3|STARTED|Overall Study||6
91013|NCT02071810|224209|P2|STARTED|Overall Study||6
91014|NCT02071810|224210|P1|STARTED|Overall Study||6
91015|NCT02071771|224222|P2|NOT COMPLETED|Period 2: Second 10 Days||0
91016|NCT02071771|224223|P1|NOT COMPLETED|Period 2: Second 10 Days||0
91017|NCT02071771|224222|P2|COMPLETED|Period 2: Second 10 Days||38
91018|NCT02071771|224223|P1|COMPLETED|Period 2: Second 10 Days||39
91019|NCT02071771|224222|P2|STARTED|Period 2: Second 10 Days|One participant completed Period 1 but did not start Period 2 due to unacceptable fit with DACP T.|38
91020|NCT02071771|224223|P1|STARTED|Period 2: Second 10 Days||39
91021|NCT02071771|224222|P2|NOT COMPLETED|Period 1: First 10 Days||0
91022|NCT02071771|224223|P1|NOT COMPLETED|Period 1: First 10 Days||2
91023|NCT02071771|224222|P2|COMPLETED|Period 1: First 10 Days||39
91024|NCT02071771|224223|P1|COMPLETED|Period 1: First 10 Days||39
91025|NCT02071771|224222|P2|Dispensed|Period 1: First 10 Days||39
91026|NCT02071771|224223|P1|Dispensed|Period 1: First 10 Days||39
91027|NCT02071771|224222|P2|STARTED|Period 1: First 10 Days||39
91028|NCT02071771|224223|P1|STARTED|Period 1: First 10 Days||41
91029|NCT02071706|224231|P1|NOT COMPLETED|Overall Study||3
91030|NCT02071706|224231|P1|COMPLETED|Overall Study||59
91031|NCT02071706|224231|P1|STARTED|Overall Study||62
91032|NCT02071420|224238|P2|NOT COMPLETED|Overall Study||3
91033|NCT02071420|224239|P1|NOT COMPLETED|Overall Study||3
91034|NCT02071420|224238|P2|COMPLETED|Overall Study||27
91035|NCT02071420|224239|P1|COMPLETED|Overall Study||27
91036|NCT02071420|224238|P2|STARTED|Overall Study||30
91037|NCT02071420|224239|P1|STARTED|Overall Study||30
91038|NCT02071290|224247|P2|NOT COMPLETED|Overall Study||7
91039|NCT02071290|224248|P1|NOT COMPLETED|Overall Study||4
91040|NCT02071290|224247|P2|COMPLETED|Overall Study||18
91041|NCT02071290|224248|P1|COMPLETED|Overall Study||21
91042|NCT02071290|224247|P2|STARTED|Overall Study||25
91043|NCT02071290|224248|P1|STARTED|Overall Study||25
91044|NCT02071225|224302|P1|NOT COMPLETED|Overall Study||30
91045|NCT02071225|224302|P1|COMPLETED|Overall Study||42
91046|NCT02071225|224302|P1|STARTED|Overall Study||72
91047|NCT02071108|224320|P1|NOT COMPLETED|Overall Study||0
91048|NCT02071108|224320|P1|COMPLETED|Overall Study||35
91049|NCT02071108|224320|P1|STARTED|Overall Study||35
91050|NCT02071095|224341|P2|NOT COMPLETED|Overall Study||0
91051|NCT02071095|224342|P1|NOT COMPLETED|Overall Study||0
91052|NCT02071095|224341|P2|COMPLETED|Overall Study||3
91053|NCT02071095|224342|P1|COMPLETED|Overall Study||12
91054|NCT02071095|224341|P2|STARTED|Overall Study||3
91055|NCT02071095|224342|P1|STARTED|Overall Study||12
91056|NCT02071082|224358|P2|NOT COMPLETED|Overall Study||7
91057|NCT02071082|224359|P1|NOT COMPLETED|Overall Study||2
91058|NCT02071082|224358|P2|COMPLETED|Overall Study||68
91059|NCT02071082|224359|P1|COMPLETED|Overall Study||2
91060|NCT02071082|224358|P2|STARTED|Overall Study||75
91061|NCT02071082|224359|P1|STARTED|Overall Study||4
91062|NCT02070991|224389|P2|NOT COMPLETED|Overall Study||0
91063|NCT02070991|224390|P1|NOT COMPLETED|Overall Study||3
91064|NCT02070991|224389|P2|COMPLETED|Overall Study||32
91065|NCT02070991|224390|P1|COMPLETED|Overall Study||28
91066|NCT02070991|224389|P2|STARTED|Overall Study||32
91067|NCT02070991|224390|P1|STARTED|Overall Study||31
91068|NCT02070978|224413|P3|NOT COMPLETED|Overall Study||53
91069|NCT02070978|224414|P2|NOT COMPLETED|Overall Study||53
91070|NCT02070978|224415|P1|NOT COMPLETED|Overall Study||47
91071|NCT02070978|224413|P3|COMPLETED|Overall Study||35
91072|NCT02070978|224414|P2|COMPLETED|Overall Study||29
91073|NCT02070978|224415|P1|COMPLETED|Overall Study||36
91074|NCT02070978|224413|P3|STARTED|Overall Study||88
91075|NCT02070978|224414|P2|STARTED|Overall Study||82
91076|NCT02070978|224415|P1|STARTED|Overall Study||83
91077|NCT02070965|224477|P3|NOT COMPLETED|Overall Study||1
91078|NCT02070965|224478|P2|NOT COMPLETED|Overall Study||2
91079|NCT02070965|224479|P1|NOT COMPLETED|Overall Study||2
91080|NCT02070965|224477|P3|COMPLETED|Overall Study||24
91081|NCT02070965|224478|P2|COMPLETED|Overall Study||21
91082|NCT02070965|224479|P1|COMPLETED|Overall Study||25
91083|NCT02070965|224477|P3|STARTED|Overall Study||25
91084|NCT02070965|224478|P2|STARTED|Overall Study||23
91085|NCT02070965|224479|P1|STARTED|Overall Study||27
91086|NCT02070757|224489|P2|NOT COMPLETED|Overall Study||114
91087|NCT02070757|224490|P1|NOT COMPLETED|Overall Study||117
91088|NCT02070757|224489|P2|COMPLETED|Overall Study||250
91089|NCT02070757|224490|P1|COMPLETED|Overall Study||245
91090|NCT02070757|224489|P2|Treated Participants|Overall Study||359
91091|NCT02070757|224490|P1|Treated Participants|Overall Study||361
91092|NCT02070757|224489|P2|STARTED|Overall Study||364
91093|NCT02070757|224490|P1|STARTED|Overall Study||362
91094|NCT02070744|224524|P5|NOT COMPLETED|OLE Phase (48 Weeks)||3
91095|NCT02070744|224525|P4|NOT COMPLETED|OLE Phase (48 Weeks)||0
91096|NCT02070744|224526|P3|NOT COMPLETED|OLE Phase (48 Weeks)||0
91097|NCT02070744|224527|P2|NOT COMPLETED|OLE Phase (48 Weeks)||0
91098|NCT02070744|224528|P1|NOT COMPLETED|OLE Phase (48 Weeks)||0
91099|NCT02070744|224524|P5|COMPLETED|OLE Phase (48 Weeks)||24
91100|NCT02070744|224525|P4|COMPLETED|OLE Phase (48 Weeks)||0
91101|NCT02070744|224526|P3|COMPLETED|OLE Phase (48 Weeks)||0
91102|NCT02070744|224527|P2|COMPLETED|OLE Phase (48 Weeks)||0
91103|NCT02070744|224528|P1|COMPLETED|OLE Phase (48 Weeks)||0
91104|NCT02070744|224524|P5|STARTED|OLE Phase (48 Weeks)|12 participants completed PC phase, but did not enter OLE phase.|27
91105|NCT02070744|224525|P4|STARTED|OLE Phase (48 Weeks)||0
91106|NCT02070744|224526|P3|STARTED|OLE Phase (48 Weeks)||0
91107|NCT02070744|224527|P2|STARTED|OLE Phase (48 Weeks)||0
91108|NCT02070744|224528|P1|STARTED|OLE Phase (48 Weeks)||0
91109|NCT02070744|224524|P5|NOT COMPLETED|PC Phase (12 Weeks)||0
91110|NCT02070744|224525|P4|NOT COMPLETED|PC Phase (12 Weeks)||1
91111|NCT02070744|224526|P3|NOT COMPLETED|PC Phase (12 Weeks)||0
91112|NCT02070744|224527|P2|NOT COMPLETED|PC Phase (12 Weeks)||0
91113|NCT02070744|224528|P1|NOT COMPLETED|PC Phase (12 Weeks)||0
91114|NCT02070744|224524|P5|COMPLETED|PC Phase (12 Weeks)||0
91115|NCT02070744|224525|P4|COMPLETED|PC Phase (12 Weeks)||13
91116|NCT02070744|224526|P3|COMPLETED|PC Phase (12 Weeks)||15
91117|NCT02070744|224527|P2|COMPLETED|PC Phase (12 Weeks)||5
91118|NCT02070744|224528|P1|COMPLETED|PC Phase (12 Weeks)||6
91119|NCT02070744|224524|P5|Treated|PC Phase (12 Weeks)||0
91120|NCT02070744|224525|P4|Treated|PC Phase (12 Weeks)||13
91121|NCT02070744|224526|P3|Treated|PC Phase (12 Weeks)||15
91122|NCT02070744|224527|P2|Treated|PC Phase (12 Weeks)||5
91123|NCT02070744|224528|P1|Treated|PC Phase (12 Weeks)||6
91124|NCT02070744|224524|P5|STARTED|PC Phase (12 Weeks)||0
91125|NCT02070744|224525|P4|STARTED|PC Phase (12 Weeks)||14
91126|NCT02070744|224526|P3|STARTED|PC Phase (12 Weeks)||15
91127|NCT02070744|224527|P2|STARTED|PC Phase (12 Weeks)||5
91128|NCT02070744|224528|P1|STARTED|PC Phase (12 Weeks)||6
91129|NCT02070692|224580|P2|NOT COMPLETED|Overall Study||12
91130|NCT02070692|224581|P1|NOT COMPLETED|Overall Study||10
91131|NCT02070692|224580|P2|COMPLETED|Overall Study||16
91132|NCT02070692|224581|P1|COMPLETED|Overall Study||18
91133|NCT02070692|224580|P2|STARTED|Overall Study||28
91134|NCT02070692|224581|P1|STARTED|Overall Study||28
91135|NCT02070640|224597|P2|NOT COMPLETED|Overall Study||0
91136|NCT02070640|224598|P1|NOT COMPLETED|Overall Study||11
91137|NCT02070640|224597|P2|COMPLETED|Overall Study||6
91138|NCT02070640|224598|P1|COMPLETED|Overall Study||82
91139|NCT02070640|224597|P2|STARTED|Overall Study||6
91140|NCT02070640|224598|P1|STARTED|Overall Study||93
91141|NCT02070588|224611|P3|NOT COMPLETED|Overall Study||0
91142|NCT02070588|224612|P2|NOT COMPLETED|Overall Study||1
91143|NCT02070588|224613|P1|NOT COMPLETED|Overall Study||39
91144|NCT02070588|224611|P3|COMPLETED|Overall Study||0
91145|NCT02070588|224612|P2|COMPLETED|Overall Study||25
91146|NCT02070588|224613|P1|COMPLETED|Overall Study||47
91147|NCT02070588|224611|P3|STARTED|Overall Study||0
91148|NCT02070588|224612|P2|STARTED|Overall Study||26
91149|NCT02070588|224613|P1|STARTED|Overall Study||86
91150|NCT02070484|224629|P2|NOT COMPLETED|Overall Study||0
91151|NCT02070484|224630|P1|NOT COMPLETED|Overall Study||1
91152|NCT02070484|224629|P2|COMPLETED|Overall Study||3
91153|NCT02070484|224630|P1|COMPLETED|Overall Study||2
91154|NCT02070484|224629|P2|STARTED|Overall Study||3
91155|NCT02070484|224630|P1|STARTED|Overall Study||3
91156|NCT02070380|224652|P4|NOT COMPLETED|Second Injection||5
91157|NCT02070380|224653|P3|NOT COMPLETED|Second Injection||1
91158|NCT02070380|224654|P2|NOT COMPLETED|Second Injection||2
91159|NCT02070380|224655|P1|NOT COMPLETED|Second Injection||0
91160|NCT02070380|224652|P4|COMPLETED|Second Injection||46
91161|NCT02070380|224653|P3|COMPLETED|Second Injection||50
91162|NCT02070380|224654|P2|COMPLETED|Second Injection||32
91163|NCT02070380|224655|P1|COMPLETED|Second Injection||31
91164|NCT02070380|224652|P4|STARTED|Second Injection||51
91165|NCT02070380|224653|P3|STARTED|Second Injection||51
91166|NCT02070380|224654|P2|STARTED|Second Injection||34
91167|NCT02070380|224655|P1|STARTED|Second Injection||31
91168|NCT02070380|224652|P4|NOT COMPLETED|Washout (no Second Injection/MRI)||3
91169|NCT02070380|224653|P3|NOT COMPLETED|Washout (no Second Injection/MRI)||2
91170|NCT02070380|224654|P2|NOT COMPLETED|Washout (no Second Injection/MRI)||5
91171|NCT02070380|224655|P1|NOT COMPLETED|Washout (no Second Injection/MRI)||0
91172|NCT02070380|224652|P4|COMPLETED|Washout (no Second Injection/MRI)||51
91173|NCT02070380|224653|P3|COMPLETED|Washout (no Second Injection/MRI)||51
91174|NCT02070380|224654|P2|COMPLETED|Washout (no Second Injection/MRI)||34
91175|NCT02070380|224655|P1|COMPLETED|Washout (no Second Injection/MRI)||31
91176|NCT02070380|224652|P4|STARTED|Washout (no Second Injection/MRI)||54
91177|NCT02070380|224653|P3|STARTED|Washout (no Second Injection/MRI)||53
91178|NCT02070380|224654|P2|STARTED|Washout (no Second Injection/MRI)||39
91179|NCT02070380|224655|P1|STARTED|Washout (no Second Injection/MRI)||31
91180|NCT02070380|224652|P4|NOT COMPLETED|First Injection||0
91181|NCT02070380|224653|P3|NOT COMPLETED|First Injection||0
91182|NCT02070380|224654|P2|NOT COMPLETED|First Injection||0
91183|NCT02070380|224655|P1|NOT COMPLETED|First Injection||0
91184|NCT02070380|224652|P4|COMPLETED|First Injection||54
91185|NCT02070380|224653|P3|COMPLETED|First Injection||53
91186|NCT02070380|224654|P2|COMPLETED|First Injection||39
91187|NCT02070380|224655|P1|COMPLETED|First Injection||31
91188|NCT02070380|224652|P4|STARTED|First Injection||54
91189|NCT02070380|224653|P3|STARTED|First Injection||53
91190|NCT02070380|224654|P2|STARTED|First Injection||39
91191|NCT02070380|224655|P1|STARTED|First Injection||31
91192|NCT02070302|224705|P2|NOT COMPLETED|Overall Study||0
91193|NCT02070302|224706|P1|NOT COMPLETED|Overall Study||0
91194|NCT02070302|224705|P2|COMPLETED|Overall Study||5
91195|NCT02070302|224706|P1|COMPLETED|Overall Study||5
91196|NCT02070302|224705|P2|STARTED|Overall Study||5
91197|NCT02070302|224706|P1|STARTED|Overall Study||5
91198|NCT02070237|224724|P2|NOT COMPLETED|Overall Study||3
91199|NCT02070237|224725|P1|NOT COMPLETED|Overall Study||3
91200|NCT02070237|224724|P2|COMPLETED|Overall Study||42
91201|NCT02070237|224725|P1|COMPLETED|Overall Study||42
91202|NCT02070237|224724|P2|STARTED|Overall Study||45
91203|NCT02070237|224725|P1|STARTED|Overall Study||45
91204|NCT02069704|224735|P2|NOT COMPLETED|Overall Study||0
91205|NCT02069704|224736|P1|NOT COMPLETED|Overall Study||0
91206|NCT02069704|224735|P2|COMPLETED|Overall Study||71
91207|NCT02069704|224736|P1|COMPLETED|Overall Study||69
91208|NCT02069704|224735|P2|STARTED|Overall Study||71
91209|NCT02069704|224736|P1|STARTED|Overall Study|Two patients were randomized but they did not received study treatment|69
91210|NCT02069392|224768|P2|NOT COMPLETED|Overall Study||2
91211|NCT02069392|224769|P1|NOT COMPLETED|Overall Study||4
91212|NCT02069392|224768|P2|COMPLETED|Overall Study||15
91213|NCT02069392|224769|P1|COMPLETED|Overall Study||10
91214|NCT02069392|224768|P2|STARTED|Overall Study||17
91215|NCT02069392|224769|P1|STARTED|Overall Study||14
91216|NCT02069379|224793|P4|NOT COMPLETED|Second Treatment Arm||0
91217|NCT02069379|224794|P3|NOT COMPLETED|Second Treatment Arm||1
91218|NCT02069379|224795|P2|NOT COMPLETED|Second Treatment Arm||0
91219|NCT02069379|224796|P1|NOT COMPLETED|Second Treatment Arm||0
91220|NCT02069379|224793|P4|COMPLETED|Second Treatment Arm||0
91221|NCT02069379|224794|P3|COMPLETED|Second Treatment Arm||0
91222|NCT02069379|224795|P2|COMPLETED|Second Treatment Arm||1
91223|NCT02069379|224796|P1|COMPLETED|Second Treatment Arm||0
91224|NCT02069379|224793|P4|STARTED|Second Treatment Arm|Insulin resistant women who are not randomized are not involved after initial baseline collection|0
91225|NCT02069379|224794|P3|STARTED|Second Treatment Arm||1
91226|NCT02069379|224795|P2|STARTED|Second Treatment Arm||1
91227|NCT02069379|224796|P1|STARTED|Second Treatment Arm|Controls are not involved after initial baseline collection|0
91228|NCT02069379|224793|P4|NOT COMPLETED|Washout Period (4 Weeks)||0
91229|NCT02069379|224794|P3|NOT COMPLETED|Washout Period (4 Weeks)||0
91230|NCT02069379|224795|P2|NOT COMPLETED|Washout Period (4 Weeks)||2
91231|NCT02069379|224796|P1|NOT COMPLETED|Washout Period (4 Weeks)||0
91232|NCT02069379|224793|P4|COMPLETED|Washout Period (4 Weeks)||0
91233|NCT02069379|224794|P3|COMPLETED|Washout Period (4 Weeks)||1
91234|NCT02069379|224795|P2|COMPLETED|Washout Period (4 Weeks)||1
91235|NCT02069379|224796|P1|COMPLETED|Washout Period (4 Weeks)||0
91236|NCT02069379|224793|P4|STARTED|Washout Period (4 Weeks)|Insulin resistant woman who were not randomized are not involved after initial baseline collection|0
91237|NCT02069379|224794|P3|STARTED|Washout Period (4 Weeks)||1
91238|NCT02069379|224795|P2|STARTED|Washout Period (4 Weeks)||3
91239|NCT02069379|224796|P1|STARTED|Washout Period (4 Weeks)|Controls are not involved after initial baseline collection|0
91240|NCT02069379|224793|P4|NOT COMPLETED|First Treatment Arm||0
91241|NCT02069379|224794|P3|NOT COMPLETED|First Treatment Arm||1
91242|NCT02069379|224795|P2|NOT COMPLETED|First Treatment Arm||1
91243|NCT02069379|224796|P1|NOT COMPLETED|First Treatment Arm||0
91244|NCT02069379|224793|P4|COMPLETED|First Treatment Arm||0
91245|NCT02069379|224794|P3|COMPLETED|First Treatment Arm||1
91246|NCT02069379|224795|P2|COMPLETED|First Treatment Arm||3
91247|NCT02069379|224796|P1|COMPLETED|First Treatment Arm||0
91338|NCT02068495|225005|P1|STARTED|Overall Study||3409
91248|NCT02069379|224793|P4|STARTED|First Treatment Arm|Insulin resistant woman not randomized are not involved after initial baseline collection|0
91249|NCT02069379|224794|P3|STARTED|First Treatment Arm||2
91250|NCT02069379|224795|P2|STARTED|First Treatment Arm||4
91251|NCT02069379|224796|P1|STARTED|First Treatment Arm|Controls are not involved after initial baseline collection|0
91252|NCT02069379|224793|P4|NOT COMPLETED|Baseline Measurements||2
91253|NCT02069379|224794|P3|NOT COMPLETED|Baseline Measurements||0
91254|NCT02069379|224795|P2|NOT COMPLETED|Baseline Measurements||0
91255|NCT02069379|224796|P1|NOT COMPLETED|Baseline Measurements||3
91256|NCT02069379|224793|P4|COMPLETED|Baseline Measurements||4
91257|NCT02069379|224794|P3|COMPLETED|Baseline Measurements||2
91258|NCT02069379|224795|P2|COMPLETED|Baseline Measurements||4
91259|NCT02069379|224796|P1|COMPLETED|Baseline Measurements||27
91260|NCT02069379|224793|P4|Baseline Measurements Taken|Baseline Measurements||6
91261|NCT02069379|224794|P3|Baseline Measurements Taken|Baseline Measurements||2
91262|NCT02069379|224795|P2|Baseline Measurements Taken|Baseline Measurements||4
91263|NCT02069379|224796|P1|Baseline Measurements Taken|Baseline Measurements||30
91264|NCT02069379|224793|P4|STARTED|Baseline Measurements||6
91265|NCT02069379|224794|P3|STARTED|Baseline Measurements||2
91266|NCT02069379|224795|P2|STARTED|Baseline Measurements||4
91267|NCT02069379|224796|P1|STARTED|Baseline Measurements||30
91268|NCT02069353|224822|P1|NOT COMPLETED|Overall Study||0
91269|NCT02069353|224822|P1|COMPLETED|Overall Study||4
91270|NCT02069353|224822|P1|STARTED|Overall Study||4
91271|NCT02069184|224833|P2|NOT COMPLETED|Overall Study||2
91272|NCT02069184|224834|P1|NOT COMPLETED|Overall Study||6
91273|NCT02069184|224833|P2|COMPLETED|Overall Study||31
91274|NCT02069184|224834|P1|COMPLETED|Overall Study||27
91275|NCT02069184|224833|P2|STARTED|Overall Study||33
91276|NCT02069184|224834|P1|STARTED|Overall Study||33
91277|NCT02069119|224856|P4|NOT COMPLETED|Overall Study||0
91278|NCT02069119|224857|P3|NOT COMPLETED|Overall Study||0
91279|NCT02069119|224858|P2|NOT COMPLETED|Overall Study||0
91280|NCT02069119|224859|P1|NOT COMPLETED|Overall Study||0
91281|NCT02069119|224856|P4|COMPLETED|Overall Study||4
91282|NCT02069119|224857|P3|COMPLETED|Overall Study||20
91283|NCT02069119|224858|P2|COMPLETED|Overall Study||4
91284|NCT02069119|224859|P1|COMPLETED|Overall Study||20
91285|NCT02069119|224856|P4|STARTED|Overall Study||4
91286|NCT02069119|224857|P3|STARTED|Overall Study||20
91287|NCT02069119|224858|P2|STARTED|Overall Study||4
91288|NCT02069119|224859|P1|STARTED|Overall Study||20
91289|NCT02069093|224883|P1|NOT COMPLETED|Overall Study||30
91290|NCT02069093|224883|P1|COMPLETED|Overall Study||56
91291|NCT02069093|224883|P1|Pharmacokinetic Analysis Set|Overall Study||50
91292|NCT02069093|224883|P1|STARTED|Overall Study||86
91293|NCT02069041|224892|P1|NOT COMPLETED|Overall Study||0
91294|NCT02069041|224892|P1|COMPLETED|Overall Study||8
91295|NCT02069041|224892|P1|Received at Least One Dose of Study Drug|Overall Study||8
91296|NCT02069041|224892|P1|STARTED|Overall Study||8
91297|NCT02068846|224902|P2|NOT COMPLETED|Overall Study||1
91298|NCT02068846|224903|P1|NOT COMPLETED|Overall Study||1
91299|NCT02068846|224902|P2|COMPLETED|Overall Study||7
91300|NCT02068846|224903|P1|COMPLETED|Overall Study||8
91301|NCT02068846|224902|P2|STARTED|Overall Study||8
91302|NCT02068846|224903|P1|STARTED|Overall Study||9
91303|NCT02068820|224921|P2|NOT COMPLETED|Overall Study||0
91304|NCT02068820|224922|P1|NOT COMPLETED|Overall Study||0
91305|NCT02068820|224921|P2|COMPLETED|Overall Study||180
91306|NCT02068820|224922|P1|COMPLETED|Overall Study||20
91307|NCT02068820|224921|P2|STARTED|Overall Study||180
91308|NCT02068820|224922|P1|STARTED|Overall Study||20
91309|NCT02068768|224933|P1|NOT COMPLETED|Overall Study||7
91310|NCT02068768|224933|P1|COMPLETED|Overall Study||6
91311|NCT02068768|224933|P1|STARTED|Overall Study||13
91312|NCT02068599|224942|P3|NOT COMPLETED|Overall Study||13
91313|NCT02068599|224943|P2|NOT COMPLETED|Overall Study||10
91314|NCT02068599|224944|P1|NOT COMPLETED|Overall Study||11
91315|NCT02068599|224942|P3|COMPLETED|Overall Study||117
91316|NCT02068599|224943|P2|COMPLETED|Overall Study||119
91317|NCT02068599|224944|P1|COMPLETED|Overall Study||119
91318|NCT02068599|224942|P3|Full Analysis Set|Overall Study||130
91319|NCT02068599|224943|P2|Full Analysis Set|Overall Study||128
91320|NCT02068599|224944|P1|Full Analysis Set|Overall Study||129
91321|NCT02068599|224942|P3|Safety Analysis Set|Overall Study||130
91322|NCT02068599|224943|P2|Safety Analysis Set|Overall Study|One participant withdrew before taking any study drug.|128
91323|NCT02068599|224944|P1|Safety Analysis Set|Overall Study|One participant withdrew before taking any study drug.|129
91324|NCT02068599|224942|P3|STARTED|Overall Study||130
91325|NCT02068599|224943|P2|STARTED|Overall Study||129
91326|NCT02068599|224944|P1|STARTED|Overall Study||130
91327|NCT02068547|224984|P2|NOT COMPLETED|Overall Study||3
91328|NCT02068547|224985|P1|NOT COMPLETED|Overall Study||4
91329|NCT02068547|224984|P2|COMPLETED|Overall Study||1
91330|NCT02068547|224985|P1|COMPLETED|Overall Study||0
91331|NCT02068547|224984|P2|STARTED|Overall Study||4
91332|NCT02068547|224985|P1|STARTED|Overall Study||4
91333|NCT02068508|224995|P1|NOT COMPLETED|Overall Study||32
91334|NCT02068508|224995|P1|COMPLETED|Overall Study||1035
91335|NCT02068508|224995|P1|STARTED|Overall Study||1067
91336|NCT02068495|225005|P1|NOT COMPLETED|Overall Study||109
91337|NCT02068495|225005|P1|COMPLETED|Overall Study||3300
91339|NCT02068443|225017|P3|NOT COMPLETED|Overall Study||3
91340|NCT02068443|225018|P2|NOT COMPLETED|Overall Study||6
91341|NCT02068443|225019|P1|NOT COMPLETED|Overall Study||7
91342|NCT02068443|225017|P3|COMPLETED|Overall Study||148
91343|NCT02068443|225018|P2|COMPLETED|Overall Study||146
91344|NCT02068443|225019|P1|COMPLETED|Overall Study||64
91345|NCT02068443|225017|P3|STARTED|Overall Study||151
91346|NCT02068443|225018|P2|STARTED|Overall Study||152
91347|NCT02068443|225019|P1|STARTED|Overall Study||71
91348|NCT02068222|225054|P1|NOT COMPLETED|Overall Study||1
91349|NCT02068222|225054|P1|COMPLETED|Overall Study||9
91350|NCT02068222|225054|P1|STARTED|Overall Study||10
91351|NCT02068157|225061|P1|NOT COMPLETED|Overall Study||0
91352|NCT02068157|225061|P1|COMPLETED|Overall Study||3
91353|NCT02068157|225061|P1|STARTED|Overall Study||3
91354|NCT02068027|225068|P2|NOT COMPLETED|Overall Study||16
91355|NCT02068027|225069|P1|NOT COMPLETED|Overall Study||13
91356|NCT02068027|225068|P2|COMPLETED|Overall Study||114
91357|NCT02068027|225069|P1|COMPLETED|Overall Study||117
91358|NCT02068027|225068|P2|STARTED|Overall Study||130
91359|NCT02068027|225069|P1|STARTED|Overall Study||130
91360|NCT02067858|225077|P1|NOT COMPLETED|Overall Study||0
91361|NCT02067858|225077|P1|COMPLETED|Overall Study||6
91362|NCT02067858|225077|P1|STARTED|Overall Study||6
91363|NCT02067728|225085|P2|NOT COMPLETED|6 Month Measurements||97
91364|NCT02067728|225086|P1|NOT COMPLETED|6 Month Measurements||114
91365|NCT02067728|225085|P2|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|113
91366|NCT02067728|225086|P1|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|106
91367|NCT02067728|225085|P2|STARTED|6 Month Measurements||210
91368|NCT02067728|225086|P1|STARTED|6 Month Measurements||220
91369|NCT02067728|225085|P2|NOT COMPLETED|6 Month Follow up Survey||60
91370|NCT02067728|225086|P1|NOT COMPLETED|6 Month Follow up Survey||48
91371|NCT02067728|225085|P2|COMPLETED|6 Month Follow up Survey|150 parent/guardians completed surveys at this time point, along with 69 teens.|150
91372|NCT02067728|225086|P1|COMPLETED|6 Month Follow up Survey|172 parent/guardians completed surveys at this time point, along with 71 teens.|172
91373|NCT02067728|225085|P2|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|210
91374|NCT02067728|225086|P1|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|220
91375|NCT02067728|225085|P2|NOT COMPLETED|Baseline - 1 Month Follow up Survey||28
91376|NCT02067728|225086|P1|NOT COMPLETED|Baseline - 1 Month Follow up Survey||7
91377|NCT02067728|225085|P2|COMPLETED|Baseline - 1 Month Follow up Survey|182 parent/guardians completed the surveys, along with 75 teens.|182
91378|NCT02067728|225086|P1|COMPLETED|Baseline - 1 Month Follow up Survey|213 parents/guardians completed the surveys, along with 82 teens.|213
91379|NCT02067728|225085|P2|STARTED|Baseline - 1 Month Follow up Survey||210
91380|NCT02067728|225086|P1|STARTED|Baseline - 1 Month Follow up Survey||220
91381|NCT02067676|225120|P6|NOT COMPLETED|Overall Study||0
91382|NCT02067676|225121|P5|NOT COMPLETED|Overall Study||0
91383|NCT02067676|225122|P4|NOT COMPLETED|Overall Study||0
91384|NCT02067676|225123|P3|NOT COMPLETED|Overall Study||0
91385|NCT02067676|225124|P2|NOT COMPLETED|Overall Study||0
91386|NCT02067676|225125|P1|NOT COMPLETED|Overall Study||1
91387|NCT02067676|225120|P6|COMPLETED|Overall Study||8
91388|NCT02067676|225121|P5|COMPLETED|Overall Study||8
91389|NCT02067676|225122|P4|COMPLETED|Overall Study||8
91390|NCT02067676|225123|P3|COMPLETED|Overall Study||8
91391|NCT02067676|225124|P2|COMPLETED|Overall Study||8
91392|NCT02067676|225125|P1|COMPLETED|Overall Study||7
91393|NCT02067676|225120|P6|STARTED|Overall Study||8
91394|NCT02067676|225121|P5|STARTED|Overall Study||8
91395|NCT02067676|225122|P4|STARTED|Overall Study||8
91396|NCT02067676|225123|P3|STARTED|Overall Study||8
91397|NCT02067676|225124|P2|STARTED|Overall Study||8
91398|NCT02067676|225125|P1|STARTED|Overall Study||8
91399|NCT02067663|225165|P2|NOT COMPLETED|Overall Study||14
91400|NCT02067663|225166|P1|NOT COMPLETED|Overall Study||13
91401|NCT02067663|225165|P2|COMPLETED|Overall Study||41
91402|NCT02067663|225166|P1|COMPLETED|Overall Study||55
91403|NCT02067663|225165|P2|STARTED|Overall Study||55
91404|NCT02067663|225166|P1|STARTED|Overall Study||68
91405|NCT02067611|225186|P3|NOT COMPLETED|Overall Study||4
91406|NCT02067611|225187|P2|NOT COMPLETED|Overall Study||6
91407|NCT02067611|225188|P1|NOT COMPLETED|Overall Study||6
91408|NCT02067611|225186|P3|COMPLETED|Overall Study||68
91409|NCT02067611|225187|P2|COMPLETED|Overall Study||66
91410|NCT02067611|225188|P1|COMPLETED|Overall Study||66
91411|NCT02067611|225186|P3|STARTED|Overall Study||72
91412|NCT02067611|225187|P2|STARTED|Overall Study||72
91413|NCT02067611|225188|P1|STARTED|Overall Study||72
91414|NCT02067585|225226|P3|NOT COMPLETED|Overall Study||0
91415|NCT02067585|225227|P2|NOT COMPLETED|Overall Study||0
91416|NCT02067585|225228|P1|NOT COMPLETED|Overall Study||0
91417|NCT02067585|225226|P3|COMPLETED|Overall Study||16
91418|NCT02067585|225227|P2|COMPLETED|Overall Study||16
91419|NCT02067585|225228|P1|COMPLETED|Overall Study||16
91420|NCT02067585|225226|P3|STARTED|Overall Study||16
91421|NCT02067585|225227|P2|STARTED|Overall Study||16
91422|NCT02067585|225228|P1|STARTED|Overall Study||16
91423|NCT02067533|225265|P2|NOT COMPLETED|Overall Study||2
91424|NCT02067533|225266|P1|NOT COMPLETED|Overall Study||4
91425|NCT02067533|225265|P2|COMPLETED|Overall Study||44
91426|NCT02067533|225266|P1|COMPLETED|Overall Study||41
91427|NCT02067533|225265|P2|STARTED|Overall Study||46
91428|NCT02067533|225266|P1|STARTED|Overall Study||45
91429|NCT02067468|225275|P3|NOT COMPLETED|Overall Study||0
91430|NCT02067468|225276|P2|NOT COMPLETED|Overall Study||0
91431|NCT02067468|225277|P1|NOT COMPLETED|Overall Study||0
91432|NCT02067468|225275|P3|COMPLETED|Overall Study||889
91433|NCT02067468|225276|P2|COMPLETED|Overall Study||890
91434|NCT02067468|225277|P1|COMPLETED|Overall Study||882
91435|NCT02067468|225275|P3|Had at Least One Routine Colposcopy|Overall Study||462
91436|NCT02067468|225276|P2|Had at Least One Routine Colposcopy|Overall Study||372
91437|NCT02067468|225277|P1|Had at Least One Routine Colposcopy|Overall Study||772
91438|NCT02067468|225275|P3|Followed-up Through Medical Records|Overall Study||889
91439|NCT02067468|225276|P2|Followed-up Through Medical Records|Overall Study||890
91440|NCT02067468|225277|P1|Followed-up Through Medical Records|Overall Study||882
91441|NCT02067468|225275|P3|STARTED|Overall Study||889
91442|NCT02067468|225276|P2|STARTED|Overall Study||890
91443|NCT02067468|225277|P1|STARTED|Overall Study||882
91444|NCT02067273|225308|P2|NOT COMPLETED|Overall Study||3
91445|NCT02067273|225309|P1|NOT COMPLETED|Overall Study||0
91446|NCT02067273|225308|P2|COMPLETED|Overall Study||12
91447|NCT02067273|225309|P1|COMPLETED|Overall Study||5
91448|NCT02067273|225308|P2|STARTED|Overall Study||15
91449|NCT02067273|225309|P1|STARTED|Overall Study||5
91450|NCT02067104|225317|P2|NOT COMPLETED|Overall Study||5
91451|NCT02067104|225318|P1|NOT COMPLETED|Overall Study||4
91452|NCT02067104|225317|P2|COMPLETED|Overall Study||0
91453|NCT02067104|225318|P1|COMPLETED|Overall Study||0
91454|NCT02067104|225317|P2|STARTED|Overall Study||5
91455|NCT02067104|225318|P1|STARTED|Overall Study||4
91456|NCT02066922|225326|P1|NOT COMPLETED|Overall Study||1
91457|NCT02066922|225326|P1|COMPLETED|Overall Study||14
91458|NCT02066922|225326|P1|STARTED|Overall Study||15
91459|NCT02066896|225336|P2|NOT COMPLETED|Overall Study||0
91460|NCT02066896|225337|P1|NOT COMPLETED|Overall Study||0
91461|NCT02066896|225336|P2|COMPLETED|Overall Study||33
91462|NCT02066896|225337|P1|COMPLETED|Overall Study||33
91463|NCT02066896|225336|P2|STARTED|Overall Study||33
91464|NCT02066896|225337|P1|STARTED|Overall Study||33
91465|NCT02066857|225349|P2|NOT COMPLETED|Overall Study||1
91466|NCT02066857|225350|P1|NOT COMPLETED|Overall Study||1
91467|NCT02066857|225349|P2|COMPLETED|Overall Study||3
91468|NCT02066857|225350|P1|COMPLETED|Overall Study||0
91469|NCT02066857|225349|P2|STARTED|Overall Study||4
91470|NCT02066857|225350|P1|STARTED|Overall Study||1
91471|NCT02066740|225364|P1|NOT COMPLETED|Overall Study||2
91472|NCT02066740|225364|P1|COMPLETED|Overall Study||32
91473|NCT02066740|225364|P1|STARTED|Overall Study||34
91474|NCT02066727|225371|P2|NOT COMPLETED|Overall Study||0
91475|NCT02066727|225372|P1|NOT COMPLETED|Overall Study||0
91476|NCT02066727|225371|P2|COMPLETED|Overall Study||30
91477|NCT02066727|225372|P1|COMPLETED|Overall Study||30
91478|NCT02066727|225371|P2|STARTED|Overall Study||30
91479|NCT02066727|225372|P1|STARTED|Overall Study||30
91480|NCT02066467|225378|P1|NOT COMPLETED|Overall Study||215
91481|NCT02066467|225378|P1|COMPLETED|Overall Study||648
91482|NCT02066467|225378|P1|STARTED|Overall Study||863
91483|NCT02066415|225387|P3|NOT COMPLETED|Overall Study||8
91484|NCT02066415|225388|P2|NOT COMPLETED|Overall Study||7
91485|NCT02066415|225389|P1|NOT COMPLETED|Overall Study||21
91486|NCT02066415|225387|P3|COMPLETED|Overall Study||182
91487|NCT02066415|225388|P2|COMPLETED|Overall Study||184
91488|NCT02066415|225389|P1|COMPLETED|Overall Study||265
91489|NCT02066415|225387|P3|Received Study Drug|Overall Study||188
91490|NCT02066415|225388|P2|Received Study Drug|Overall Study||190
91491|NCT02066415|225389|P1|Received Study Drug|Overall Study||282
91492|NCT02066415|225387|P3|STARTED|Overall Study||190
91493|NCT02066415|225388|P2|STARTED|Overall Study||191
91494|NCT02066415|225389|P1|STARTED|Overall Study||286
91495|NCT02066402|225414|P2|NOT COMPLETED|Overall Study||23
91496|NCT02066402|225415|P1|NOT COMPLETED|Overall Study||26
91497|NCT02066402|225414|P2|COMPLETED|Overall Study||275
91498|NCT02066402|225415|P1|COMPLETED|Overall Study||274
91499|NCT02066402|225414|P2|Completed Study Treatment Period|Overall Study||256
91500|NCT02066402|225415|P1|Completed Study Treatment Period|Overall Study||261
91501|NCT02066402|225414|P2|Participants Received Treatment|Overall Study||297
91502|NCT02066402|225415|P1|Participants Received Treatment|Overall Study||292
91503|NCT02066402|225414|P2|STARTED|Overall Study||298
91504|NCT02066402|225415|P1|STARTED|Overall Study||300
91505|NCT02066389|225447|P6|NOT COMPLETED|Overall Study||5
91506|NCT02066389|225448|P5|NOT COMPLETED|Overall Study||7
91507|NCT02066389|225449|P4|NOT COMPLETED|Overall Study||3
91508|NCT02066389|225450|P3|NOT COMPLETED|Overall Study||6
91509|NCT02066389|225451|P2|NOT COMPLETED|Overall Study||1
91510|NCT02066389|225452|P1|NOT COMPLETED|Overall Study||5
91511|NCT02066389|225447|P6|COMPLETED|Overall Study||45
91512|NCT02066389|225448|P5|COMPLETED|Overall Study||43
91513|NCT02066389|225449|P4|COMPLETED|Overall Study||47
91514|NCT02066389|225450|P3|COMPLETED|Overall Study||44
91515|NCT02066389|225451|P2|COMPLETED|Overall Study||49
91516|NCT02066389|225452|P1|COMPLETED|Overall Study||45
91517|NCT02066389|225447|P6|Received Study Drug|Overall Study||49
91518|NCT02066389|225448|P5|Received Study Drug|Overall Study||50
91519|NCT02066389|225449|P4|Received Study Drug|Overall Study||50
91520|NCT02066389|225450|P3|Received Study Drug|Overall Study||50
91521|NCT02066389|225451|P2|Received Study Drug|Overall Study||50
91522|NCT02066389|225452|P1|Received Study Drug|Overall Study||50
91523|NCT02066389|225447|P6|STARTED|Overall Study||50
91524|NCT02066389|225448|P5|STARTED|Overall Study||50
91525|NCT02066389|225449|P4|STARTED|Overall Study||50
91526|NCT02066389|225450|P3|STARTED|Overall Study||50
91527|NCT02066389|225451|P2|STARTED|Overall Study||50
91528|NCT02066389|225452|P1|STARTED|Overall Study||50
91529|NCT02066298|225508|P6|NOT COMPLETED|Overall Study||12
91530|NCT02066298|225509|P5|NOT COMPLETED|Overall Study||9
91531|NCT02066298|225510|P4|NOT COMPLETED|Overall Study||6
91532|NCT02066298|225511|P3|NOT COMPLETED|Overall Study||10
91533|NCT02066298|225512|P2|NOT COMPLETED|Overall Study||8
91534|NCT02066298|225513|P1|NOT COMPLETED|Overall Study||9
91535|NCT02066298|225508|P6|COMPLETED|Overall Study||38
91536|NCT02066298|225509|P5|COMPLETED|Overall Study||38
91537|NCT02066298|225510|P4|COMPLETED|Overall Study||45
91538|NCT02066298|225511|P3|COMPLETED|Overall Study||40
91539|NCT02066298|225512|P2|COMPLETED|Overall Study||40
91540|NCT02066298|225513|P1|COMPLETED|Overall Study||40
91541|NCT02066298|225508|P6|Completed 3rd Period|Overall Study||38
91542|NCT02066298|225509|P5|Completed 3rd Period|Overall Study||38
91543|NCT02066298|225510|P4|Completed 3rd Period|Overall Study||45
91544|NCT02066298|225511|P3|Completed 3rd Period|Overall Study||40
91545|NCT02066298|225512|P2|Completed 3rd Period|Overall Study||40
91546|NCT02066298|225513|P1|Completed 3rd Period|Overall Study||40
91547|NCT02066298|225508|P6|Completed 2nd Period|Overall Study||41
91548|NCT02066298|225509|P5|Completed 2nd Period|Overall Study||42
91549|NCT02066298|225510|P4|Completed 2nd Period|Overall Study||46
91550|NCT02066298|225511|P3|Completed 2nd Period|Overall Study||41
91551|NCT02066298|225512|P2|Completed 2nd Period|Overall Study||41
91552|NCT02066298|225513|P1|Completed 2nd Period|Overall Study||41
91553|NCT02066298|225508|P6|Completed 1st Period|Overall Study||45
91554|NCT02066298|225509|P5|Completed 1st Period|Overall Study||46
91555|NCT02066298|225510|P4|Completed 1st Period|Overall Study||48
91556|NCT02066298|225511|P3|Completed 1st Period|Overall Study||45
91557|NCT02066298|225512|P2|Completed 1st Period|Overall Study||47
91558|NCT02066298|225513|P1|Completed 1st Period|Overall Study||44
91559|NCT02066298|225508|P6|STARTED|Overall Study||50
91560|NCT02066298|225509|P5|STARTED|Overall Study||47
91561|NCT02066298|225510|P4|STARTED|Overall Study||51
91562|NCT02066298|225511|P3|STARTED|Overall Study||50
91563|NCT02066298|225512|P2|STARTED|Overall Study||48
91564|NCT02066298|225513|P1|STARTED|Overall Study||49
91565|NCT02066233|225537|P2|NOT COMPLETED|Standard Endoscopy (Day 2)||0
91566|NCT02066233|225538|P1|NOT COMPLETED|Standard Endoscopy (Day 2)||0
91567|NCT02066233|225537|P2|COMPLETED|Standard Endoscopy (Day 2)||44
91568|NCT02066233|225538|P1|COMPLETED|Standard Endoscopy (Day 2)||44
91569|NCT02066233|225537|P2|STARTED|Standard Endoscopy (Day 2)||44
91570|NCT02066233|225538|P1|STARTED|Standard Endoscopy (Day 2)||44
91571|NCT02066233|225537|P2|NOT COMPLETED|EG Scan II (Day 1)||6
91572|NCT02066233|225538|P1|NOT COMPLETED|EG Scan II (Day 1)||6
91573|NCT02066233|225537|P2|COMPLETED|EG Scan II (Day 1)||44
91574|NCT02066233|225538|P1|COMPLETED|EG Scan II (Day 1)||44
91575|NCT02066233|225537|P2|STARTED|EG Scan II (Day 1)||50
91576|NCT02066233|225538|P1|STARTED|EG Scan II (Day 1)||50
91577|NCT02066181|225548|P2|NOT COMPLETED|Overall Study||1
91578|NCT02066181|225549|P1|NOT COMPLETED|Overall Study||1
91579|NCT02066181|225548|P2|COMPLETED|Overall Study||36
91580|NCT02066181|225549|P1|COMPLETED|Overall Study||49
91581|NCT02066181|225548|P2|Crossed Over|Overall Study||28
91582|NCT02066181|225549|P1|Crossed Over|Overall Study||0
91583|NCT02066181|225548|P2|STARTED|Overall Study||37
91584|NCT02066181|225549|P1|STARTED|Overall Study||50
91585|NCT02066129|225571|P2|NOT COMPLETED|Overall Study||33
91586|NCT02066129|225572|P1|NOT COMPLETED|Overall Study||29
91587|NCT02066129|225571|P2|COMPLETED|Overall Study||94
91588|NCT02066129|225572|P1|COMPLETED|Overall Study||98
91589|NCT02066129|225571|P2|STARTED|Overall Study||127
91590|NCT02066129|225572|P1|STARTED|Overall Study||127
91591|NCT02066051|225586|P1|NOT COMPLETED|Overall Study||1
91592|NCT02066051|225586|P1|COMPLETED|Overall Study||7
91593|NCT02066051|225586|P1|STARTED|Overall Study||8
91594|NCT02065895|225591|P6|NOT COMPLETED|Overall Study||0
91595|NCT02065895|225592|P5|NOT COMPLETED|Overall Study||0
91596|NCT02065895|225593|P4|NOT COMPLETED|Overall Study||1
91597|NCT02065895|225594|P3|NOT COMPLETED|Overall Study||0
91598|NCT02065895|225595|P2|NOT COMPLETED|Overall Study||1
91599|NCT02065895|225596|P1|NOT COMPLETED|Overall Study||1
91600|NCT02065895|225591|P6|COMPLETED|Overall Study||1
91601|NCT02065895|225592|P5|COMPLETED|Overall Study||1
91602|NCT02065895|225593|P4|COMPLETED|Overall Study||0
91603|NCT02065895|225594|P3|COMPLETED|Overall Study||1
91604|NCT02065895|225595|P2|COMPLETED|Overall Study||2
91605|NCT02065895|225596|P1|COMPLETED|Overall Study||0
91606|NCT02065895|225591|P6|STARTED|Overall Study||1
91607|NCT02065895|225592|P5|STARTED|Overall Study||1
91608|NCT02065895|225593|P4|STARTED|Overall Study||1
91609|NCT02065895|225594|P3|STARTED|Overall Study||1
91610|NCT02065895|225595|P2|STARTED|Overall Study||3
91611|NCT02065895|225596|P1|STARTED|Overall Study||1
91612|NCT02065791|225615|P2|NOT COMPLETED|Overall Study||15
91613|NCT02065791|225616|P1|NOT COMPLETED|Overall Study||25
91614|NCT02065791|225615|P2|COMPLETED|Overall Study||2187
91615|NCT02065791|225616|P1|COMPLETED|Overall Study||2174
91616|NCT02065791|225615|P2|Treated|Overall Study||2200
91617|NCT02065791|225616|P1|Treated|Overall Study||2197
91618|NCT02065791|225615|P2|STARTED|Overall Study||2202
91619|NCT02065791|225616|P1|STARTED|Overall Study||2199
91620|NCT02065518|225640|P4|NOT COMPLETED|Overall Study||5
91621|NCT02065518|225641|P3|NOT COMPLETED|Overall Study||9
91622|NCT02065518|225642|P2|NOT COMPLETED|Overall Study||8
91623|NCT02065518|225643|P1|NOT COMPLETED|Overall Study||6
91624|NCT02065518|225640|P4|COMPLETED|Overall Study||15
91625|NCT02065518|225641|P3|COMPLETED|Overall Study||11
91626|NCT02065518|225642|P2|COMPLETED|Overall Study||11
91627|NCT02065518|225643|P1|COMPLETED|Overall Study||13
91628|NCT02065518|225640|P4|STARTED|Overall Study||20
91629|NCT02065518|225641|P3|STARTED|Overall Study||20
91630|NCT02065518|225642|P2|STARTED|Overall Study||19
91631|NCT02065518|225643|P1|STARTED|Overall Study||19
91632|NCT02065453|225695|P2|NOT COMPLETED|Overall Study||4
91633|NCT02065453|225696|P1|NOT COMPLETED|Overall Study||3
91634|NCT02065453|225695|P2|COMPLETED|Overall Study||21
91635|NCT02065453|225696|P1|COMPLETED|Overall Study||24
91636|NCT02065453|225695|P2|STARTED|Overall Study||25
91637|NCT02065453|225696|P1|STARTED|Overall Study||27
91638|NCT02065336|225709|P10|NOT COMPLETED|Extension Phase||8
91639|NCT02065336|225710|P9|NOT COMPLETED|Extension Phase||2
91640|NCT02065336|225711|P8|NOT COMPLETED|Extension Phase||0
91641|NCT02065336|225712|P7|NOT COMPLETED|Extension Phase||0
91642|NCT02065336|225713|P6|NOT COMPLETED|Extension Phase||0
91643|NCT02065336|225714|P5|NOT COMPLETED|Extension Phase||0
91644|NCT02065336|225715|P4|NOT COMPLETED|Extension Phase||0
91645|NCT02065336|225716|P3|NOT COMPLETED|Extension Phase||0
91646|NCT02065336|225717|P2|NOT COMPLETED|Extension Phase||0
91647|NCT02065336|225718|P1|NOT COMPLETED|Extension Phase||0
91648|NCT02065336|225709|P10|COMPLETED|Extension Phase||0
91649|NCT02065336|225710|P9|COMPLETED|Extension Phase||0
91650|NCT02065336|225711|P8|COMPLETED|Extension Phase||0
91651|NCT02065336|225712|P7|COMPLETED|Extension Phase||0
91652|NCT02065336|225713|P6|COMPLETED|Extension Phase||0
91653|NCT02065336|225714|P5|COMPLETED|Extension Phase||0
91654|NCT02065336|225715|P4|COMPLETED|Extension Phase||0
91655|NCT02065336|225716|P3|COMPLETED|Extension Phase||0
91656|NCT02065336|225717|P2|COMPLETED|Extension Phase||0
91657|NCT02065336|225718|P1|COMPLETED|Extension Phase||0
91658|NCT02065336|225709|P10|STARTED|Extension Phase||8
91659|NCT02065336|225710|P9|STARTED|Extension Phase||2
91660|NCT02065336|225711|P8|STARTED|Extension Phase||0
91661|NCT02065336|225712|P7|STARTED|Extension Phase||0
91662|NCT02065336|225713|P6|STARTED|Extension Phase||0
91663|NCT02065336|225714|P5|STARTED|Extension Phase||0
91664|NCT02065336|225715|P4|STARTED|Extension Phase||0
91665|NCT02065336|225716|P3|STARTED|Extension Phase||0
91666|NCT02065336|225717|P2|STARTED|Extension Phase||0
91667|NCT02065336|225718|P1|STARTED|Extension Phase||0
91668|NCT02065336|225709|P10|NOT COMPLETED|Main Study||0
91669|NCT02065336|225710|P9|NOT COMPLETED|Main Study||0
91670|NCT02065336|225711|P8|NOT COMPLETED|Main Study||0
91671|NCT02065336|225712|P7|NOT COMPLETED|Main Study||0
91672|NCT02065336|225713|P6|NOT COMPLETED|Main Study||0
91673|NCT02065336|225714|P5|NOT COMPLETED|Main Study||0
91674|NCT02065336|225715|P4|NOT COMPLETED|Main Study||0
91675|NCT02065336|225716|P3|NOT COMPLETED|Main Study||0
91676|NCT02065336|225717|P2|NOT COMPLETED|Main Study||0
91677|NCT02065336|225718|P1|NOT COMPLETED|Main Study||0
91678|NCT02065336|225709|P10|COMPLETED|Main Study||0
91679|NCT02065336|225710|P9|COMPLETED|Main Study||0
91680|NCT02065336|225711|P8|COMPLETED|Main Study||10
91681|NCT02065336|225712|P7|COMPLETED|Main Study||12
91682|NCT02065336|225713|P6|COMPLETED|Main Study||6
91683|NCT02065336|225714|P5|COMPLETED|Main Study||6
91684|NCT02065336|225715|P4|COMPLETED|Main Study||6
91685|NCT02065336|225716|P3|COMPLETED|Main Study||6
91686|NCT02065336|225717|P2|COMPLETED|Main Study||6
91687|NCT02065336|225718|P1|COMPLETED|Main Study||6
91688|NCT02065336|225709|P10|STARTED|Main Study||0
91689|NCT02065336|225710|P9|STARTED|Main Study||0
91690|NCT02065336|225711|P8|STARTED|Main Study||10
91691|NCT02065336|225712|P7|STARTED|Main Study||12
91692|NCT02065336|225713|P6|STARTED|Main Study||6
91693|NCT02065336|225714|P5|STARTED|Main Study||6
91694|NCT02065336|225715|P4|STARTED|Main Study||6
91695|NCT02065336|225716|P3|STARTED|Main Study||6
91696|NCT02065336|225717|P2|STARTED|Main Study||6
91697|NCT02065336|225718|P1|STARTED|Main Study||6
91698|NCT02064985|225813|P3|NOT COMPLETED|Overall Study||0
91699|NCT02064985|225814|P2|NOT COMPLETED|Overall Study||0
91700|NCT02064985|225815|P1|NOT COMPLETED|Overall Study||0
91701|NCT02064985|225813|P3|COMPLETED|Overall Study||12
91702|NCT02064985|225814|P2|COMPLETED|Overall Study||12
91703|NCT02064985|225815|P1|COMPLETED|Overall Study||12
91704|NCT02064985|225813|P3|STARTED|Overall Study||12
91705|NCT02064985|225814|P2|STARTED|Overall Study||12
91706|NCT02064985|225815|P1|STARTED|Overall Study||12
91707|NCT02064920|225978|P2|NOT COMPLETED|Overall Study||9
91708|NCT02064920|225979|P1|NOT COMPLETED|Overall Study||1
91709|NCT02064920|225978|P2|COMPLETED|Overall Study||21
91710|NCT02064920|225979|P1|COMPLETED|Overall Study||5
91711|NCT02064920|225978|P2|Treated|Overall Study|Two participants discontinued from study prior to treatment|28
91712|NCT02064920|225979|P1|Treated|Overall Study||6
91713|NCT02064920|225978|P2|STARTED|Overall Study||30
91714|NCT02064920|225979|P1|STARTED|Overall Study||6
91715|NCT02064907|225989|P2|NOT COMPLETED|Period 2||0
91716|NCT02064907|225990|P1|NOT COMPLETED|Period 2||0
91717|NCT02064907|225989|P2|COMPLETED|Period 2||26
91718|NCT02064907|225990|P1|COMPLETED|Period 2||26
91719|NCT02064907|225989|P2|STARTED|Period 2||26
91720|NCT02064907|225990|P1|STARTED|Period 2||26
91721|NCT02064907|225989|P2|NOT COMPLETED|Period 1||0
91722|NCT02064907|225990|P1|NOT COMPLETED|Period 1||0
91723|NCT02064907|225989|P2|COMPLETED|Period 1||26
91724|NCT02064907|225990|P1|COMPLETED|Period 1||26
91725|NCT02064907|225989|P2|STARTED|Period 1||26
91726|NCT02064907|225990|P1|STARTED|Period 1||26
91727|NCT02064894|226009|P3|NOT COMPLETED|Overall Study||115
91728|NCT02064894|226010|P2|NOT COMPLETED|Overall Study||102
91729|NCT02064894|226011|P1|NOT COMPLETED|Overall Study||43
91730|NCT02064894|226009|P3|COMPLETED|Overall Study||86
91731|NCT02064894|226010|P2|COMPLETED|Overall Study||99
91732|NCT02064894|226011|P1|COMPLETED|Overall Study||56
91733|NCT02064894|226009|P3|Avalaible at T-90|Overall Study||129
91734|NCT02064894|226010|P2|Avalaible at T-90|Overall Study||134
91735|NCT02064894|226011|P1|Avalaible at T-90|Overall Study||74
91736|NCT02064894|226009|P3|Available at T-60|Overall Study||177
91737|NCT02064894|226010|P2|Available at T-60|Overall Study||188
91738|NCT02064894|226011|P1|Available at T-60|Overall Study||91
91739|NCT02064894|226009|P3|STARTED|Overall Study|"Received allocated intervention (n=199)~Did not receive allocated intervention (n=2)"|201
91740|NCT02064894|226010|P2|STARTED|Overall Study|"Received allocated intervention (n=198)~Did not receive allocated intervention (n=3)"|201
91741|NCT02064894|226011|P1|STARTED|Overall Study|"Received allocated intervention (n=98)~Did not receive intervention (n=1)"|99
91742|NCT02064868|226024|P2|NOT COMPLETED|Overall Study||13
91743|NCT02064868|226025|P1|NOT COMPLETED|Overall Study||34
91744|NCT02064868|226024|P2|COMPLETED|Overall Study||881
91745|NCT02064868|226025|P1|COMPLETED|Overall Study||1722
91746|NCT02064868|226024|P2|Per Protocol Set|Overall Study||627
91747|NCT02064868|226025|P1|Per Protocol Set|Overall Study||1155
91748|NCT02064868|226024|P2|Safety Set|Overall Study||894
91749|NCT02064868|226025|P1|Safety Set|Overall Study|The Safety Set includes one patient not randomized but treated with serelaxin|1729
91750|NCT02064868|226024|P2|Full Analysis Set|Overall Study||894
91751|NCT02064868|226025|P1|Full Analysis Set|Overall Study||1756
91752|NCT02064868|226024|P2|STARTED|Overall Study||894
91753|NCT02064868|226025|P1|STARTED|Overall Study||1756
91754|NCT02064816|226045|P2|NOT COMPLETED|Overall Study||8
91755|NCT02064816|226046|P1|NOT COMPLETED|Overall Study||8
91756|NCT02064816|226045|P2|COMPLETED|Overall Study||88
91757|NCT02064816|226046|P1|COMPLETED|Overall Study||96
91758|NCT02064816|226045|P2|STARTED|Overall Study||96
91759|NCT02064816|226046|P1|STARTED|Overall Study||104
91760|NCT02064439|226087|P3|NOT COMPLETED|Overall Study||182
91761|NCT02064439|226088|P2|NOT COMPLETED|Overall Study||138
91762|NCT02064439|226089|P1|NOT COMPLETED|Overall Study||143
91763|NCT02064439|226087|P3|COMPLETED|Overall Study||949
91764|NCT02064439|226088|P2|COMPLETED|Overall Study||969
91765|NCT02064439|226089|P1|COMPLETED|Overall Study||984
91766|NCT02064439|226087|P3|STARTED|Overall Study|FAS, randomized and received study medication|1131
91767|NCT02064439|226088|P2|STARTED|Overall Study|FAS, randomized and received study medication|1107
91768|NCT02064439|226089|P1|STARTED|Overall Study|Full Analysis Set (FAS), randomized and received study medication|1127
91769|NCT02064387|226117|P11|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||13
91770|NCT02064387|226118|P10|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
91771|NCT02064387|226119|P9|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
91772|NCT02064387|226120|P8|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
91773|NCT02064387|226121|P7|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
91774|NCT02064387|226122|P6|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
91775|NCT02064387|226123|P5|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
91776|NCT02064387|226124|P4|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
91777|NCT02064387|226125|P3|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
91778|NCT02064387|226126|P2|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
91779|NCT02064387|226127|P1|NOT COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
91780|NCT02064387|226117|P11|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||22
91781|NCT02064387|226118|P10|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
91782|NCT02064387|226119|P9|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
91783|NCT02064387|226120|P8|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
91784|NCT02064387|226121|P7|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
91785|NCT02064387|226122|P6|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
91786|NCT02064387|226123|P5|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
91787|NCT02064387|226124|P4|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
91788|NCT02064387|226125|P3|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
91789|NCT02064387|226126|P2|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
91790|NCT02064387|226127|P1|COMPLETED|Part 2 Max 24.2 Mnths Follow-up Duration||0
91791|NCT02064387|226117|P11|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||35
91792|NCT02064387|226118|P10|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||0
91793|NCT02064387|226119|P9|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||0
91794|NCT02064387|226120|P8|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||0
91795|NCT02064387|226121|P7|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||0
91796|NCT02064387|226122|P6|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||0
91797|NCT02064387|226123|P5|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||0
91798|NCT02064387|226124|P4|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||0
91799|NCT02064387|226125|P3|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||0
91800|NCT02064387|226126|P2|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||0
91801|NCT02064387|226127|P1|STARTED|Part 2 Max 24.2 Mnths Follow-up Duration||0
91802|NCT02064387|226117|P11|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||0
91803|NCT02064387|226118|P10|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||1
91804|NCT02064387|226119|P9|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||1
91805|NCT02064387|226120|P8|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||3
91806|NCT02064387|226121|P7|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||0
91807|NCT02064387|226122|P6|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||0
91808|NCT02064387|226123|P5|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||0
91809|NCT02064387|226124|P4|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||0
91810|NCT02064387|226125|P3|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||0
91811|NCT02064387|226126|P2|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||0
91812|NCT02064387|226127|P1|NOT COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||0
91813|NCT02064387|226117|P11|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||0
91814|NCT02064387|226118|P10|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||5
91815|NCT02064387|226119|P9|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||2
91816|NCT02064387|226120|P8|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||5
91817|NCT02064387|226121|P7|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||4
91818|NCT02064387|226122|P6|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||3
91819|NCT02064387|226123|P5|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||4
91820|NCT02064387|226124|P4|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||4
91821|NCT02064387|226125|P3|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||4
91822|NCT02064387|226126|P2|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||1
91823|NCT02064387|226127|P1|COMPLETED|Part 1 Max 21.6 Mnths Follow-up Duration||1
91824|NCT02064387|226117|P11|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||0
91825|NCT02064387|226118|P10|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||6
91826|NCT02064387|226119|P9|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||3
91827|NCT02064387|226120|P8|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||8
91828|NCT02064387|226121|P7|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||4
91829|NCT02064387|226122|P6|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||3
91830|NCT02064387|226123|P5|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||4
91831|NCT02064387|226124|P4|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||4
91832|NCT02064387|226125|P3|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||4
91833|NCT02064387|226126|P2|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||1
91834|NCT02064387|226127|P1|STARTED|Part 1 Max 21.6 Mnths Follow-up Duration||1
91835|NCT02064270|226426|P2|NOT COMPLETED|Overall Study||32
91836|NCT02064270|226427|P1|NOT COMPLETED|Overall Study||62
91837|NCT02064270|226426|P2|COMPLETED|Overall Study||231
91838|NCT02064270|226427|P1|COMPLETED|Overall Study||201
91839|NCT02064270|226426|P2|STARTED|Overall Study||263
91840|NCT02064270|226427|P1|STARTED|Overall Study||263
91841|NCT02064231|226442|P4|NOT COMPLETED|Third Test Period (Own Product)||0
91842|NCT02064231|226443|P3|NOT COMPLETED|Third Test Period (Own Product)||0
91843|NCT02064231|226444|P2|NOT COMPLETED|Third Test Period (Own Product)||0
91844|NCT02064231|226445|P1|NOT COMPLETED|Third Test Period (Own Product)||0
91845|NCT02064231|226442|P4|COMPLETED|Third Test Period (Own Product)||1
91846|NCT02064231|226443|P3|COMPLETED|Third Test Period (Own Product)||0
91847|NCT02064231|226444|P2|COMPLETED|Third Test Period (Own Product)||8
91848|NCT02064231|226445|P1|COMPLETED|Third Test Period (Own Product)||8
91849|NCT02064231|226442|P4|STARTED|Third Test Period (Own Product)||1
91850|NCT02064231|226443|P3|STARTED|Third Test Period (Own Product)||0
91851|NCT02064231|226444|P2|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test C proceeded to test Own product afterwards|8
91852|NCT02064231|226445|P1|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test A proceeded to test Own product afterwards.|8
91853|NCT02064231|226442|P4|NOT COMPLETED|Second Test Period (Test B or Test D)||0
91854|NCT02064231|226443|P3|NOT COMPLETED|Second Test Period (Test B or Test D)||0
91855|NCT02064231|226444|P2|NOT COMPLETED|Second Test Period (Test B or Test D)||1
91856|NCT02064231|226445|P1|NOT COMPLETED|Second Test Period (Test B or Test D)||1
91857|NCT02064231|226442|P4|COMPLETED|Second Test Period (Test B or Test D)||1
91858|NCT02064231|226443|P3|COMPLETED|Second Test Period (Test B or Test D)||0
91859|NCT02064231|226444|P2|COMPLETED|Second Test Period (Test B or Test D)||7
91860|NCT02064231|226445|P1|COMPLETED|Second Test Period (Test B or Test D)||6
91861|NCT02064231|226442|P4|STARTED|Second Test Period (Test B or Test D)||1
91862|NCT02064231|226443|P3|STARTED|Second Test Period (Test B or Test D)||0
91863|NCT02064231|226444|P2|STARTED|Second Test Period (Test B or Test D)||8
91864|NCT02064231|226445|P1|STARTED|Second Test Period (Test B or Test D)||7
91865|NCT02064231|226442|P4|NOT COMPLETED|First Test Period (Test A or Test C)||0
91866|NCT02064231|226443|P3|NOT COMPLETED|First Test Period (Test A or Test C)||1
91867|NCT02064231|226444|P2|NOT COMPLETED|First Test Period (Test A or Test C)||4
91868|NCT02064231|226445|P1|NOT COMPLETED|First Test Period (Test A or Test C)||7
91869|NCT02064231|226442|P4|COMPLETED|First Test Period (Test A or Test C)||1
91870|NCT02064231|226443|P3|COMPLETED|First Test Period (Test A or Test C)||0
91871|NCT02064231|226444|P2|COMPLETED|First Test Period (Test A or Test C)||8
91872|NCT02064231|226445|P1|COMPLETED|First Test Period (Test A or Test C)||7
91873|NCT02064231|226442|P4|STARTED|First Test Period (Test A or Test C)||1
91874|NCT02064231|226443|P3|STARTED|First Test Period (Test A or Test C)||1
91875|NCT02064231|226444|P2|STARTED|First Test Period (Test A or Test C)||12
91876|NCT02064231|226445|P1|STARTED|First Test Period (Test A or Test C)||14
91877|NCT02064205|226457|P1|NOT COMPLETED|Overall Study||1
91878|NCT02064205|226457|P1|COMPLETED|Overall Study||31
91879|NCT02064205|226457|P1|Condition D|Overall Study||32
91880|NCT02064205|226457|P1|Condition C|Overall Study||31
91881|NCT02064205|226457|P1|Condition B|Overall Study||32
91882|NCT02064205|226457|P1|Condition A|Overall Study||32
91883|NCT02064205|226457|P1|STARTED|Overall Study||32
91884|NCT02064166|226475|P2|NOT COMPLETED|Overall Study||0
91885|NCT02064166|226476|P1|NOT COMPLETED|Overall Study||1
91886|NCT02064166|226475|P2|COMPLETED|Overall Study||6
91887|NCT02064166|226476|P1|COMPLETED|Overall Study||8
91888|NCT02064166|226475|P2|STARTED|Overall Study||6
91889|NCT02064166|226476|P1|STARTED|Overall Study||9
91890|NCT02063880|226506|P2|NOT COMPLETED|Overall Study||27
91891|NCT02063880|226507|P1|NOT COMPLETED|Overall Study||28
91892|NCT02063880|226506|P2|COMPLETED|Overall Study||66
91893|NCT02063880|226507|P1|COMPLETED|Overall Study||62
91894|NCT02063880|226506|P2|STARTED|Overall Study||93
91895|NCT02063880|226507|P1|STARTED|Overall Study||90
91896|NCT02063867|226519|P2|NOT COMPLETED|Overall Study||2965
91897|NCT02063867|226520|P1|NOT COMPLETED|Overall Study||4291
91898|NCT02063867|226519|P2|COMPLETED|Overall Study||180048
91899|NCT02063867|226520|P1|COMPLETED|Overall Study||152598
91900|NCT02063867|226519|P2|STARTED|Overall Study||183013
91901|NCT02063867|226520|P1|STARTED|Overall Study||156889
91902|NCT02063854|226545|P7|NOT COMPLETED|Overall Study||6
91903|NCT02063854|226546|P6|NOT COMPLETED|Overall Study||31
91904|NCT02063854|226547|P5|NOT COMPLETED|Overall Study||11
91905|NCT02063854|226548|P4|NOT COMPLETED|Overall Study||10
91906|NCT02063854|226549|P3|NOT COMPLETED|Overall Study||30
91907|NCT02063854|226550|P2|NOT COMPLETED|Overall Study||12
91908|NCT02063854|226551|P1|NOT COMPLETED|Overall Study||21
91909|NCT02063854|226545|P7|COMPLETED|Overall Study||60
91910|NCT02063854|226546|P6|COMPLETED|Overall Study||170
91911|NCT02063854|226547|P5|COMPLETED|Overall Study||54
91912|NCT02063854|226548|P4|COMPLETED|Overall Study||58
91913|NCT02063854|226549|P3|COMPLETED|Overall Study||176
91914|NCT02063854|226550|P2|COMPLETED|Overall Study||54
91915|NCT02063854|226551|P1|COMPLETED|Overall Study||178
91916|NCT02063854|226545|P7|Full Analysis Set: Received Study Drug|Overall Study||66
91917|NCT02063854|226546|P6|Full Analysis Set: Received Study Drug|Overall Study||200
91918|NCT02063854|226547|P5|Full Analysis Set: Received Study Drug|Overall Study||65
91919|NCT02063854|226548|P4|Full Analysis Set: Received Study Drug|Overall Study||68
91920|NCT02063854|226549|P3|Full Analysis Set: Received Study Drug|Overall Study||206
91921|NCT02063854|226550|P2|Full Analysis Set: Received Study Drug|Overall Study||66
91922|NCT02063854|226551|P1|Full Analysis Set: Received Study Drug|Overall Study||199
91923|NCT02063854|226545|P7|STARTED|Overall Study||66
91924|NCT02063854|226546|P6|STARTED|Overall Study||201
91925|NCT02063854|226547|P5|STARTED|Overall Study||65
91926|NCT02063854|226548|P4|STARTED|Overall Study||68
91927|NCT02063854|226549|P3|STARTED|Overall Study||206
91928|NCT02063854|226550|P2|STARTED|Overall Study||66
91929|NCT02063854|226551|P1|STARTED|Overall Study||199
91930|NCT02063737|226635|P2|NOT COMPLETED|Overall Study||4
91931|NCT02063737|226636|P1|NOT COMPLETED|Overall Study||11
91932|NCT02063737|226635|P2|COMPLETED|Overall Study||44
91933|NCT02063737|226636|P1|COMPLETED|Overall Study||41
91934|NCT02063737|226635|P2|STARTED|Overall Study||48
91935|NCT02063737|226636|P1|STARTED|Overall Study||52
91936|NCT02063724|226668|P1|NOT COMPLETED|Overall Study||1
91937|NCT02063724|226668|P1|COMPLETED|Overall Study||14
91938|NCT02063724|226668|P1|STARTED|Overall Study||15
91939|NCT02063698|226676|P2|NOT COMPLETED|Overall Study||2
91940|NCT02063698|226677|P1|NOT COMPLETED|Overall Study||1
91941|NCT02063698|226676|P2|COMPLETED|Overall Study||13
91942|NCT02063698|226677|P1|COMPLETED|Overall Study||14
91943|NCT02063698|226676|P2|STARTED|Overall Study||15
91944|NCT02063698|226677|P1|STARTED|Overall Study||15
91945|NCT02063672|226701|P2|NOT COMPLETED|Overall Study||22
91946|NCT02063672|226702|P1|NOT COMPLETED|Overall Study||35
91947|NCT02063672|226701|P2|COMPLETED|Overall Study||7
91948|NCT02063672|226702|P1|COMPLETED|Overall Study||18
91949|NCT02063672|226701|P2|STARTED|Overall Study||29
91950|NCT02063672|226702|P1|STARTED|Overall Study||53
91951|NCT02063659|226749|P4|NOT COMPLETED|Open-Label Extension Period (OLE)||20
91952|NCT02063659|226750|P3|NOT COMPLETED|Open-Label Extension Period (OLE)||0
91953|NCT02063659|226751|P2|NOT COMPLETED|Open-Label Extension Period (OLE)||0
91954|NCT02063659|226752|P1|NOT COMPLETED|Open-Label Extension Period (OLE)||0
91955|NCT02063659|226749|P4|COMPLETED|Open-Label Extension Period (OLE)||47
91956|NCT02063659|226750|P3|COMPLETED|Open-Label Extension Period (OLE)||0
91957|NCT02063659|226751|P2|COMPLETED|Open-Label Extension Period (OLE)||0
91958|NCT02063659|226752|P1|COMPLETED|Open-Label Extension Period (OLE)||0
91959|NCT02063659|226749|P4|STARTED|Open-Label Extension Period (OLE)||67
91960|NCT02063659|226750|P3|STARTED|Open-Label Extension Period (OLE)||0
91961|NCT02063659|226751|P2|STARTED|Open-Label Extension Period (OLE)||0
91962|NCT02063659|226752|P1|STARTED|Open-Label Extension Period (OLE)||0
91963|NCT02063659|226749|P4|NOT COMPLETED|Double-Blind Treatment Period||0
91964|NCT02063659|226750|P3|NOT COMPLETED|Double-Blind Treatment Period||3
91965|NCT02063659|226751|P2|NOT COMPLETED|Double-Blind Treatment Period||3
91966|NCT02063659|226752|P1|NOT COMPLETED|Double-Blind Treatment Period||2
91967|NCT02063659|226749|P4|COMPLETED|Double-Blind Treatment Period||0
91968|NCT02063659|226750|P3|COMPLETED|Double-Blind Treatment Period||22
91969|NCT02063659|226751|P2|COMPLETED|Double-Blind Treatment Period||22
91970|NCT02063659|226752|P1|COMPLETED|Double-Blind Treatment Period||24
91971|NCT02063659|226749|P4|STARTED|Double-Blind Treatment Period||0
91972|NCT02063659|226750|P3|STARTED|Double-Blind Treatment Period||25
91973|NCT02063659|226751|P2|STARTED|Double-Blind Treatment Period||25
91974|NCT02063659|226752|P1|STARTED|Double-Blind Treatment Period||26
91975|NCT02063516|226784|P2|NOT COMPLETED|Overall Study||0
91976|NCT02063516|226785|P1|NOT COMPLETED|Overall Study||0
91977|NCT02063516|226784|P2|COMPLETED|Overall Study||40
91978|NCT02063516|226785|P1|COMPLETED|Overall Study||40
91979|NCT02063516|226784|P2|STARTED|Overall Study||40
91980|NCT02063516|226785|P1|STARTED|Overall Study||40
91981|NCT02063230|226799|P4|NOT COMPLETED|Overall Study||0
91982|NCT02063230|226800|P3|NOT COMPLETED|Overall Study||0
91983|NCT02063230|226801|P2|NOT COMPLETED|Overall Study||0
91984|NCT02063230|226802|P1|NOT COMPLETED|Overall Study||0
91985|NCT02063230|226799|P4|COMPLETED|Overall Study||8
91986|NCT02063230|226800|P3|COMPLETED|Overall Study||8
91987|NCT02063230|226801|P2|COMPLETED|Overall Study||8
91988|NCT02063230|226802|P1|COMPLETED|Overall Study||8
91989|NCT02063230|226799|P4|Received Treatment|Overall Study||8
91990|NCT02063230|226800|P3|Received Treatment|Overall Study||8
91991|NCT02063230|226801|P2|Received Treatment|Overall Study||8
91992|NCT02063230|226802|P1|Received Treatment|Overall Study||8
91993|NCT02063230|226799|P4|STARTED|Overall Study||8
91994|NCT02063230|226800|P3|STARTED|Overall Study||8
91995|NCT02063230|226801|P2|STARTED|Overall Study||8
91996|NCT02063230|226802|P1|STARTED|Overall Study||8
91997|NCT02063217|226835|P3|NOT COMPLETED|Overall Study||0
91998|NCT02063217|226836|P2|NOT COMPLETED|Overall Study||0
91999|NCT02063217|226837|P1|NOT COMPLETED|Overall Study||1
92000|NCT02063217|226835|P3|COMPLETED|Overall Study||12
92001|NCT02063217|226836|P2|COMPLETED|Overall Study||12
92002|NCT02063217|226837|P1|COMPLETED|Overall Study||11
92003|NCT02063217|226835|P3|STARTED|Overall Study||12
92004|NCT02063217|226836|P2|STARTED|Overall Study||12
92005|NCT02063217|226837|P1|STARTED|Overall Study||12
92006|NCT02063178|226847|P2|NOT COMPLETED|Overall Study||47
92007|NCT02063178|226848|P1|NOT COMPLETED|Overall Study||29
92008|NCT02063178|226847|P2|COMPLETED|Overall Study||77
92009|NCT02063178|226848|P1|COMPLETED|Overall Study||95
92010|NCT02063178|226847|P2|STARTED|Overall Study||124
92011|NCT02063178|226848|P1|STARTED|Overall Study||124
92012|NCT02063087|226862|P2|NOT COMPLETED|7 Day Follow-up||0
92013|NCT02063087|226863|P1|NOT COMPLETED|7 Day Follow-up||0
92014|NCT02063087|226862|P2|COMPLETED|7 Day Follow-up||478
92015|NCT02063087|226863|P1|COMPLETED|7 Day Follow-up||493
92016|NCT02063087|226862|P2|STARTED|7 Day Follow-up||478
92017|NCT02063087|226863|P1|STARTED|7 Day Follow-up||493
92018|NCT02063087|226862|P2|NOT COMPLETED|Emergency Department Intervention||0
92019|NCT02063087|226863|P1|NOT COMPLETED|Emergency Department Intervention||0
92020|NCT02063087|226862|P2|COMPLETED|Emergency Department Intervention||478
92021|NCT02063087|226863|P1|COMPLETED|Emergency Department Intervention||493
92022|NCT02063087|226862|P2|STARTED|Emergency Department Intervention||478
92023|NCT02063087|226863|P1|STARTED|Emergency Department Intervention||493
92024|NCT02063035|226887|P2|NOT COMPLETED|Overall Study||0
92025|NCT02063035|226888|P1|NOT COMPLETED|Overall Study||0
92026|NCT02063035|226887|P2|COMPLETED|Overall Study||17
92027|NCT02063035|226888|P1|COMPLETED|Overall Study||12
92028|NCT02063035|226887|P2|STARTED|Overall Study||17
92029|NCT02063035|226888|P1|STARTED|Overall Study||12
92030|NCT02062905|226902|P2|NOT COMPLETED|Overall Study||2
92031|NCT02062905|226903|P1|NOT COMPLETED|Overall Study||7
92032|NCT02062905|226902|P2|COMPLETED|Overall Study||31
92033|NCT02062905|226903|P1|COMPLETED|Overall Study||28
92034|NCT02062905|226902|P2|STARTED|Overall Study||33
92035|NCT02062905|226903|P1|STARTED|Overall Study||35
92036|NCT02062879|226913|P2|NOT COMPLETED|Overall Study||1
92037|NCT02062879|226914|P1|NOT COMPLETED|Overall Study||4
92038|NCT02062879|226913|P2|COMPLETED|Overall Study||9
92039|NCT02062879|226914|P1|COMPLETED|Overall Study||6
92040|NCT02062879|226913|P2|STARTED|Overall Study||10
92041|NCT02062879|226914|P1|STARTED|Overall Study||10
92042|NCT02062801|226926|P2|NOT COMPLETED|Overall Study||4
92043|NCT02062801|226927|P1|NOT COMPLETED|Overall Study||2
92044|NCT02062801|226926|P2|COMPLETED|Overall Study||297
92045|NCT02062801|226927|P1|COMPLETED|Overall Study||299
92046|NCT02062801|226926|P2|STARTED|Overall Study||301
92047|NCT02062801|226927|P1|STARTED|Overall Study||301
92048|NCT02062710|226937|P6|NOT COMPLETED|Overall Study||0
92049|NCT02062710|226938|P5|NOT COMPLETED|Overall Study||0
92050|NCT02062710|226939|P4|NOT COMPLETED|Overall Study||0
92051|NCT02062710|226940|P3|NOT COMPLETED|Overall Study||0
92052|NCT02062710|226941|P2|NOT COMPLETED|Overall Study||0
92053|NCT02062710|226942|P1|NOT COMPLETED|Overall Study||0
92054|NCT02062710|226937|P6|COMPLETED|Overall Study||4
92055|NCT02062710|226938|P5|COMPLETED|Overall Study||3
92056|NCT02062710|226939|P4|COMPLETED|Overall Study||3
92057|NCT02062710|226940|P3|COMPLETED|Overall Study||5
92058|NCT02062710|226941|P2|COMPLETED|Overall Study||4
92059|NCT02062710|226942|P1|COMPLETED|Overall Study||3
92060|NCT02062710|226937|P6|STARTED|Overall Study|4 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
92061|NCT02062710|226938|P5|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this aprticular sequence|3
92062|NCT02062710|226939|P4|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
92063|NCT02062710|226940|P3|STARTED|Overall Study|5 of total of 22 subjects randomized to receive the 3 study drugs in this particular sequence|5
92064|NCT02062710|226941|P2|STARTED|Overall Study|4 of the total 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
92065|NCT02062710|226942|P1|STARTED|Overall Study|3 of total 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
92066|NCT02062658|226950|P1|NOT COMPLETED|Overall Study||2
92067|NCT02062658|226950|P1|COMPLETED|Overall Study||8
92068|NCT02062658|226950|P1|STARTED|Overall Study||10
92069|NCT02062645|226954|P1|NOT COMPLETED|Overall Study||15
92070|NCT02062645|226954|P1|COMPLETED|Overall Study||100
92071|NCT02062645|226954|P1|STARTED|Overall Study||115
92072|NCT02062632|226962|P1|NOT COMPLETED|Overall Study||1
92073|NCT02062632|226962|P1|COMPLETED|Overall Study||2
92074|NCT02062632|226962|P1|STARTED|Overall Study||3
92075|NCT02062580|226971|P2|NOT COMPLETED|Overall Study||13
92076|NCT02062580|226972|P1|NOT COMPLETED|Overall Study||12
92077|NCT02062580|226971|P2|COMPLETED|Overall Study||65
92078|NCT02062580|226972|P1|COMPLETED|Overall Study||59
92079|NCT02062580|226971|P2|STARTED|Overall Study||78
92080|NCT02062580|226972|P1|STARTED|Overall Study||71
92081|NCT02062502|226982|P2|NOT COMPLETED|Overall Study||35
92082|NCT02062502|226983|P1|NOT COMPLETED|Overall Study||43
92083|NCT02062502|226982|P2|COMPLETED|Overall Study||270
92084|NCT02062502|226983|P1|COMPLETED|Overall Study||263
92085|NCT02062502|226982|P2|Vaccinated Dose 1|Overall Study||305
92086|NCT02062502|226983|P1|Vaccinated Dose 1|Overall Study||306
92087|NCT02062502|226982|P2|STARTED|Overall Study||305
92088|NCT02062502|226983|P1|STARTED|Overall Study||306
92089|NCT02062450|227003|P1|NOT COMPLETED|Overall Study||124
92090|NCT02062450|227003|P1|COMPLETED|Overall Study||255
92091|NCT02062450|227003|P1|Per Protocol Cohort|Overall Study|255 patients attended their 2-year follow-up visit.|255
92092|NCT02062450|227003|P1|STARTED|Overall Study|379 patients were successfully reached by phone and convoked for the 2-year follow-up visit.|379
92093|NCT02062437|227017|P1|NOT COMPLETED|Overall Study||52
92094|NCT02062437|227017|P1|COMPLETED|Overall Study|80 patients were effectively enrolled, when coming back for their 2-year follow-up visit.|80
92095|NCT02062437|227017|P1|STARTED|Overall Study|132 patients who undergone THR (July-Oct 2010), complying with in/exclusion criteria were identified|132
92096|NCT02062385|227030|P4|NOT COMPLETED|Overall Study||9
92097|NCT02062385|227031|P3|NOT COMPLETED|Overall Study||12
92098|NCT02062385|227032|P2|NOT COMPLETED|Overall Study||65
92099|NCT02062385|227033|P1|NOT COMPLETED|Overall Study||78
92100|NCT02062385|227030|P4|COMPLETED|Overall Study||391
92101|NCT02062385|227031|P3|COMPLETED|Overall Study||388
92102|NCT02062385|227032|P2|COMPLETED|Overall Study||1555
92103|NCT02062385|227033|P1|COMPLETED|Overall Study||1542
92104|NCT02062385|227030|P4|Received Vaccination 3|Overall Study||392
92105|NCT02062385|227031|P3|Received Vaccination 3|Overall Study||389
92106|NCT02062385|227032|P2|Received Vaccination 3|Overall Study||1554
92107|NCT02062385|227033|P1|Received Vaccination 3|Overall Study||1543
92108|NCT02062385|227030|P4|Received Vaccination 2|Overall Study||393
92109|NCT02062385|227031|P3|Received Vaccination 2|Overall Study||392
92110|NCT02062385|227032|P2|Received Vaccination 2|Overall Study||1566
92111|NCT02062385|227033|P1|Received Vaccination 2|Overall Study||1554
92112|NCT02062385|227030|P4|Received Vaccination 1|Overall Study||400
92113|NCT02062385|227031|P3|Received Vaccination 1|Overall Study||400
92114|NCT02062385|227032|P2|Received Vaccination 1|Overall Study||1619
92115|NCT02062385|227033|P1|Received Vaccination 1|Overall Study||1618
92116|NCT02062385|227030|P4|STARTED|Overall Study||400
92117|NCT02062385|227031|P3|STARTED|Overall Study||400
92118|NCT02062385|227032|P2|STARTED|Overall Study||1620
92119|NCT02062385|227033|P1|STARTED|Overall Study||1620
92120|NCT02062359|227053|P1|NOT COMPLETED|Overall Study||0
92121|NCT02062359|227053|P1|COMPLETED|Overall Study||2
92122|NCT02062359|227053|P1|STARTED|Overall Study||2
92123|NCT02062294|227059|P1|NOT COMPLETED|Overall Study||0
92124|NCT02062294|227059|P1|COMPLETED|Overall Study||14
92125|NCT02062294|227059|P1|STARTED|Overall Study||14
92126|NCT02062177|227066|P2|NOT COMPLETED|Overall Study||0
92127|NCT02062177|227067|P1|NOT COMPLETED|Overall Study||0
92128|NCT02062177|227066|P2|COMPLETED|Overall Study||70
92129|NCT02062177|227067|P1|COMPLETED|Overall Study||70
92130|NCT02062177|227066|P2|STARTED|Overall Study||70
92131|NCT02062177|227067|P1|STARTED|Overall Study||70
92132|NCT02062151|227077|P1|NOT COMPLETED|Overall Study||1
92133|NCT02062151|227077|P1|COMPLETED|Overall Study||20
92134|NCT02062151|227077|P1|STARTED|Overall Study||21
92135|NCT02061969|227084|P2|NOT COMPLETED|Overall Study||0
92136|NCT02061969|227085|P1|NOT COMPLETED|Overall Study||0
92137|NCT02061969|227084|P2|COMPLETED|Overall Study||67
92138|NCT02061969|227085|P1|COMPLETED|Overall Study||73
92139|NCT02061969|227084|P2|STARTED|Overall Study||67
92140|NCT02061969|227085|P1|STARTED|Overall Study||73
92141|NCT02061748|227115|P2|NOT COMPLETED|Overall Study||0
92142|NCT02061748|227116|P1|NOT COMPLETED|Overall Study||0
92143|NCT02061748|227115|P2|COMPLETED|Overall Study||30853
92144|NCT02061748|227116|P1|COMPLETED|Overall Study||7646
92145|NCT02061748|227115|P2|STARTED|Overall Study||30853
92146|NCT02061748|227116|P1|STARTED|Overall Study||7646
92147|NCT02061696|227190|P2|NOT COMPLETED|Overall Study||0
92148|NCT02061696|227191|P1|NOT COMPLETED|Overall Study||0
92149|NCT02061696|227190|P2|COMPLETED|Overall Study||22
92150|NCT02061696|227191|P1|COMPLETED|Overall Study||17
92151|NCT02061696|227190|P2|STARTED|Overall Study||22
92152|NCT02061696|227191|P1|STARTED|Overall Study||17
92153|NCT02061683|227215|P1|NOT COMPLETED|Overall Study||60
92154|NCT02061683|227215|P1|COMPLETED|Overall Study||203
92155|NCT02061683|227215|P1|STARTED|Overall Study||263
92156|NCT02061592|227222|P2|NOT COMPLETED|Period 2||1
92157|NCT02061592|227223|P1|NOT COMPLETED|Period 2||0
92158|NCT02061592|227222|P2|COMPLETED|Period 2||61
92159|NCT02061592|227223|P1|COMPLETED|Period 2||64
92160|NCT02061592|227222|P2|STARTED|Period 2||62
92161|NCT02061592|227223|P1|STARTED|Period 2||64
92162|NCT02061592|227222|P2|NOT COMPLETED|Period 1||0
92163|NCT02061592|227223|P1|NOT COMPLETED|Period 1||2
92164|NCT02061592|227222|P2|COMPLETED|Period 1||62
92165|NCT02061592|227223|P1|COMPLETED|Period 1||64
92166|NCT02061592|227222|P2|STARTED|Period 1||62
92167|NCT02061592|227223|P1|STARTED|Period 1||66
92168|NCT02061540|227235|P1|NOT COMPLETED|Overall Study||4
92169|NCT02061540|227235|P1|COMPLETED|Overall Study||23
92170|NCT02061540|227235|P1|Down-Titrated on LUM001 During the Study|Overall Study||5
92171|NCT02061540|227235|P1|STARTED|Overall Study||27
92172|NCT02061358|227257|P9|NOT COMPLETED|Overall Study||0
92173|NCT02061358|227258|P8|NOT COMPLETED|Overall Study||0
92174|NCT02061358|227259|P7|NOT COMPLETED|Overall Study||0
92175|NCT02061358|227260|P6|NOT COMPLETED|Overall Study||0
92176|NCT02061358|227261|P5|NOT COMPLETED|Overall Study||0
92177|NCT02061358|227262|P4|NOT COMPLETED|Overall Study||0
92178|NCT02061358|227263|P3|NOT COMPLETED|Overall Study||0
92179|NCT02061358|227264|P2|NOT COMPLETED|Overall Study||0
92180|NCT02061358|227265|P1|NOT COMPLETED|Overall Study||0
92181|NCT02061358|227257|P9|COMPLETED|Overall Study||16
92182|NCT02061358|227258|P8|COMPLETED|Overall Study||6
92183|NCT02061358|227259|P7|COMPLETED|Overall Study||6
92184|NCT02061358|227260|P6|COMPLETED|Overall Study||6
92185|NCT02061358|227261|P5|COMPLETED|Overall Study||6
92186|NCT02061358|227262|P4|COMPLETED|Overall Study||6
92187|NCT02061358|227263|P3|COMPLETED|Overall Study||6
92188|NCT02061358|227264|P2|COMPLETED|Overall Study||6
92189|NCT02061358|227265|P1|COMPLETED|Overall Study||6
92190|NCT02061358|227257|P9|STARTED|Overall Study||16
92191|NCT02061358|227258|P8|STARTED|Overall Study||6
92192|NCT02061358|227259|P7|STARTED|Overall Study||6
92193|NCT02061358|227260|P6|STARTED|Overall Study||6
92194|NCT02061358|227261|P5|STARTED|Overall Study||6
92195|NCT02061358|227262|P4|STARTED|Overall Study||6
92196|NCT02061358|227263|P3|STARTED|Overall Study||6
92197|NCT02061358|227264|P2|STARTED|Overall Study||6
92198|NCT02061358|227265|P1|STARTED|Overall Study||6
92199|NCT02061280|227403|P2|NOT COMPLETED|Overall Study||12
92200|NCT02061280|227404|P1|NOT COMPLETED|Overall Study||18
92201|NCT02061280|227403|P2|COMPLETED|Overall Study||25
92202|NCT02061280|227404|P1|COMPLETED|Overall Study||53
92203|NCT02061280|227403|P2|Randomized to Treatment|Overall Study||25
92204|NCT02061280|227404|P1|Randomized to Treatment|Overall Study||54
92205|NCT02061280|227403|P2|STARTED|Overall Study||37
92206|NCT02061280|227404|P1|STARTED|Overall Study||71
92207|NCT02061202|227436|P2|NOT COMPLETED|Overall Study||1
92208|NCT02061202|227437|P1|NOT COMPLETED|Overall Study||1
92209|NCT02061202|227436|P2|COMPLETED|Overall Study||17
92210|NCT02061202|227437|P1|COMPLETED|Overall Study||35
92211|NCT02061202|227436|P2|STARTED|Overall Study||18
92212|NCT02061202|227437|P1|STARTED|Overall Study||36
92213|NCT02060890|227461|P1|NOT COMPLETED|Overall Study||4
92214|NCT02060890|227461|P1|COMPLETED|Overall Study||16
92215|NCT02060890|227461|P1|STARTED|Overall Study||20
92216|NCT02060838|227470|P2|NOT COMPLETED|Overall Study||0
92217|NCT02060838|227471|P1|NOT COMPLETED|Overall Study||0
92218|NCT02060838|227470|P2|COMPLETED|Overall Study||22
92219|NCT02060838|227471|P1|COMPLETED|Overall Study||28
92220|NCT02060838|227470|P2|STARTED|Overall Study||22
92221|NCT02060838|227471|P1|STARTED|Overall Study||28
92222|NCT02060539|227479|P1|NOT COMPLETED|Overall Study||0
92223|NCT02060539|227479|P1|COMPLETED|Overall Study||19
92224|NCT02060539|227479|P1|STARTED|Overall Study||19
92225|NCT02060526|227527|P3|NOT COMPLETED|Overall Study||0
92226|NCT02060526|227528|P2|NOT COMPLETED|Overall Study||0
92227|NCT02060526|227529|P1|NOT COMPLETED|Overall Study||0
92228|NCT02060526|227527|P3|COMPLETED|Overall Study||7
92229|NCT02060526|227528|P2|COMPLETED|Overall Study||7
92230|NCT02060526|227529|P1|COMPLETED|Overall Study||7
92231|NCT02060526|227527|P3|STARTED|Overall Study||7
92232|NCT02060526|227528|P2|STARTED|Overall Study||7
92233|NCT02060526|227529|P1|STARTED|Overall Study||7
92234|NCT02060461|227565|P1|NOT COMPLETED|Overall Study||0
92235|NCT02060461|227565|P1|COMPLETED|Overall Study||33
92236|NCT02060461|227565|P1|STARTED|Overall Study||33
92237|NCT02060383|227576|P5|NOT COMPLETED|Extension Phase||7
92238|NCT02060383|227577|P4|NOT COMPLETED|Extension Phase||2
92239|NCT02060383|227578|P3|NOT COMPLETED|Extension Phase||3
92240|NCT02060383|227579|P2|NOT COMPLETED|Extension Phase||3
92241|NCT02060383|227580|P1|NOT COMPLETED|Extension Phase||3
92242|NCT02060383|227576|P5|COMPLETED|Extension Phase||46
92243|NCT02060383|227577|P4|COMPLETED|Extension Phase||19
92244|NCT02060383|227578|P3|COMPLETED|Extension Phase||7
92245|NCT02060383|227579|P2|COMPLETED|Extension Phase||14
92246|NCT02060383|227580|P1|COMPLETED|Extension Phase||14
92247|NCT02060383|227576|P5|STARTED|Extension Phase||53
92248|NCT02060383|227577|P4|STARTED|Extension Phase||21
92249|NCT02060383|227578|P3|STARTED|Extension Phase||10
92250|NCT02060383|227579|P2|STARTED|Extension Phase||17
92251|NCT02060383|227580|P1|STARTED|Extension Phase||17
92252|NCT02060383|227576|P5|NOT COMPLETED|Core Phase||8
92253|NCT02060383|227577|P4|NOT COMPLETED|Core Phase||7
92254|NCT02060383|227578|P3|NOT COMPLETED|Core Phase||0
92255|NCT02060383|227579|P2|NOT COMPLETED|Core Phase||6
92256|NCT02060383|227580|P1|NOT COMPLETED|Core Phase||3
92257|NCT02060383|227576|P5|COMPLETED|Core Phase||95
92258|NCT02060383|227577|P4|COMPLETED|Core Phase||39
92259|NCT02060383|227578|P3|COMPLETED|Core Phase||19
92260|NCT02060383|227579|P2|COMPLETED|Core Phase||37
92261|NCT02060383|227580|P1|COMPLETED|Core Phase||35
92262|NCT02060383|227576|P5|Completed Core/Did Not Enter Extension|Core Phase||42
92263|NCT02060383|227577|P4|Completed Core/Did Not Enter Extension|Core Phase||18
92264|NCT02060383|227578|P3|Completed Core/Did Not Enter Extension|Core Phase||9
92265|NCT02060383|227579|P2|Completed Core/Did Not Enter Extension|Core Phase||20
92266|NCT02060383|227580|P1|Completed Core/Did Not Enter Extension|Core Phase||18
92267|NCT02060383|227576|P5|Completed Core/Entered Extension|Core Phase||53
92268|NCT02060383|227577|P4|Completed Core/Entered Extension|Core Phase||21
92269|NCT02060383|227578|P3|Completed Core/Entered Extension|Core Phase||10
92270|NCT02060383|227579|P2|Completed Core/Entered Extension|Core Phase||17
92271|NCT02060383|227580|P1|Completed Core/Entered Extension|Core Phase||17
92272|NCT02060383|227576|P5|STARTED|Core Phase||103
92273|NCT02060383|227577|P4|STARTED|Core Phase||46
92274|NCT02060383|227578|P3|STARTED|Core Phase||19
92275|NCT02060383|227579|P2|STARTED|Core Phase||43
92276|NCT02060383|227580|P1|STARTED|Core Phase||38
92277|NCT02060058|227609|P3|NOT COMPLETED|Overall Study||0
92278|NCT02060058|227610|P2|NOT COMPLETED|Overall Study||0
92279|NCT02060058|227611|P1|NOT COMPLETED|Overall Study||0
92280|NCT02060058|227609|P3|COMPLETED|Overall Study||8
92281|NCT02060058|227610|P2|COMPLETED|Overall Study||0
92282|NCT02060058|227611|P1|COMPLETED|Overall Study||4
92283|NCT02060058|227609|P3|STARTED|Overall Study||8
92284|NCT02060058|227610|P2|STARTED|Overall Study||0
92285|NCT02060058|227611|P1|STARTED|Overall Study||4
92286|NCT02059993|227627|P2|NOT COMPLETED|Overall Study||4
92287|NCT02059993|227628|P1|NOT COMPLETED|Overall Study||2
92288|NCT02059993|227627|P2|COMPLETED|Overall Study||37
92289|NCT02059993|227628|P1|COMPLETED|Overall Study||40
92290|NCT02059993|227627|P2|STARTED|Overall Study||41
92291|NCT02059993|227628|P1|STARTED|Overall Study||42
92292|NCT02059980|227636|P2|NOT COMPLETED|Overall Study||1
92293|NCT02059980|227637|P1|NOT COMPLETED|Overall Study||2
92294|NCT02059980|227636|P2|COMPLETED|Overall Study||14
92295|NCT02059980|227637|P1|COMPLETED|Overall Study||16
92296|NCT02059980|227636|P2|STARTED|Overall Study||15
92297|NCT02059980|227637|P1|STARTED|Overall Study||18
92298|NCT02059928|227649|P1|NOT COMPLETED|Overall Study||0
92299|NCT02059928|227649|P1|COMPLETED|Overall Study||20
92300|NCT02059928|227649|P1|STARTED|Overall Study||20
92301|NCT02059902|227655|P2|NOT COMPLETED|Overall Study||4
92302|NCT02059902|227656|P1|NOT COMPLETED|Overall Study||4
92303|NCT02059902|227655|P2|COMPLETED|Overall Study||14
92304|NCT02059902|227656|P1|COMPLETED|Overall Study||14
92305|NCT02059902|227655|P2|STARTED|Overall Study||18
92306|NCT02059902|227656|P1|STARTED|Overall Study||18
92307|NCT02059642|227664|P2|NOT COMPLETED|Overall Study||24
92308|NCT02059642|227665|P1|NOT COMPLETED|Overall Study||27
92309|NCT02059642|227664|P2|COMPLETED|Overall Study||128
92310|NCT02059642|227665|P1|COMPLETED|Overall Study||121
92311|NCT02059642|227664|P2|STARTED|Overall Study||152
92312|NCT02059642|227665|P1|STARTED|Overall Study||148
92313|NCT02059434|227682|P9|NOT COMPLETED|Period 8||0
92314|NCT02059434|227683|P8|NOT COMPLETED|Period 8||0
92315|NCT02059434|227684|P7|NOT COMPLETED|Period 8||0
92316|NCT02059434|227685|P6|NOT COMPLETED|Period 8||0
92317|NCT02059434|227686|P5|NOT COMPLETED|Period 8||0
92318|NCT02059434|227687|P4|NOT COMPLETED|Period 8||0
92319|NCT02059434|227688|P3|NOT COMPLETED|Period 8||0
92320|NCT02059434|227689|P2|NOT COMPLETED|Period 8||0
92321|NCT02059434|227690|P1|NOT COMPLETED|Period 8||0
92322|NCT02059434|227682|P9|COMPLETED|Period 8||34
92323|NCT02059434|227683|P8|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
92324|NCT02059434|227684|P7|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
92325|NCT02059434|227685|P6|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
92326|NCT02059434|227686|P5|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
92327|NCT02059434|227687|P4|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
92328|NCT02059434|227688|P3|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
92329|NCT02059434|227689|P2|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
92330|NCT02059434|227690|P1|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
92331|NCT02059434|227682|P9|STARTED|Period 8||34
92332|NCT02059434|227683|P8|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
92333|NCT02059434|227684|P7|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
92334|NCT02059434|227685|P6|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
92335|NCT02059434|227686|P5|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
92336|NCT02059434|227687|P4|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
92337|NCT02059434|227688|P3|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
92338|NCT02059434|227689|P2|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
92339|NCT02059434|227690|P1|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
92340|NCT02059434|227682|P9|NOT COMPLETED|Washout Between Periods 7 and 8||2
92341|NCT02059434|227683|P8|NOT COMPLETED|Washout Between Periods 7 and 8||0
92342|NCT02059434|227684|P7|NOT COMPLETED|Washout Between Periods 7 and 8||0
92343|NCT02059434|227685|P6|NOT COMPLETED|Washout Between Periods 7 and 8||0
92344|NCT02059434|227686|P5|NOT COMPLETED|Washout Between Periods 7 and 8||0
92345|NCT02059434|227687|P4|NOT COMPLETED|Washout Between Periods 7 and 8||0
92346|NCT02059434|227688|P3|NOT COMPLETED|Washout Between Periods 7 and 8||0
92347|NCT02059434|227689|P2|NOT COMPLETED|Washout Between Periods 7 and 8||0
92348|NCT02059434|227690|P1|NOT COMPLETED|Washout Between Periods 7 and 8||0
92349|NCT02059434|227682|P9|COMPLETED|Washout Between Periods 7 and 8||34
92350|NCT02059434|227683|P8|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
92351|NCT02059434|227684|P7|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
92352|NCT02059434|227685|P6|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
92353|NCT02059434|227686|P5|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
92354|NCT02059434|227687|P4|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
92355|NCT02059434|227688|P3|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
92356|NCT02059434|227689|P2|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
92357|NCT02059434|227690|P1|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
92358|NCT02059434|227682|P9|STARTED|Washout Between Periods 7 and 8||36
92359|NCT02059434|227683|P8|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
92360|NCT02059434|227684|P7|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
92361|NCT02059434|227685|P6|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
92362|NCT02059434|227686|P5|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
92363|NCT02059434|227687|P4|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
92364|NCT02059434|227688|P3|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
92365|NCT02059434|227689|P2|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
92366|NCT02059434|227690|P1|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
92367|NCT02059434|227682|P9|NOT COMPLETED|Period 7||0
92368|NCT02059434|227683|P8|NOT COMPLETED|Period 7||0
92369|NCT02059434|227684|P7|NOT COMPLETED|Period 7||0
92370|NCT02059434|227685|P6|NOT COMPLETED|Period 7||0
92371|NCT02059434|227686|P5|NOT COMPLETED|Period 7||0
92372|NCT02059434|227687|P4|NOT COMPLETED|Period 7||0
92373|NCT02059434|227688|P3|NOT COMPLETED|Period 7||0
92374|NCT02059434|227689|P2|NOT COMPLETED|Period 7||0
92375|NCT02059434|227690|P1|NOT COMPLETED|Period 7||0
92376|NCT02059434|227682|P9|COMPLETED|Period 7||36
92377|NCT02059434|227683|P8|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
92378|NCT02059434|227684|P7|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
92379|NCT02059434|227685|P6|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
92380|NCT02059434|227686|P5|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
92381|NCT02059434|227687|P4|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
92382|NCT02059434|227688|P3|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
92383|NCT02059434|227689|P2|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
92384|NCT02059434|227690|P1|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
92385|NCT02059434|227682|P9|STARTED|Period 7||36
92386|NCT02059434|227683|P8|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
92387|NCT02059434|227684|P7|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
92388|NCT02059434|227685|P6|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
92389|NCT02059434|227686|P5|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
92390|NCT02059434|227687|P4|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
92391|NCT02059434|227688|P3|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
92392|NCT02059434|227689|P2|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
92607|NCT02059434|227688|P3|STARTED|Washout Between Periods 2 and 3||2
92393|NCT02059434|227690|P1|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
92394|NCT02059434|227682|P9|NOT COMPLETED|Washout Between Periods 6 and 7||1
92395|NCT02059434|227683|P8|NOT COMPLETED|Washout Between Periods 6 and 7||0
92396|NCT02059434|227684|P7|NOT COMPLETED|Washout Between Periods 6 and 7||0
92397|NCT02059434|227685|P6|NOT COMPLETED|Washout Between Periods 6 and 7||0
92398|NCT02059434|227686|P5|NOT COMPLETED|Washout Between Periods 6 and 7||0
92399|NCT02059434|227687|P4|NOT COMPLETED|Washout Between Periods 6 and 7||0
92400|NCT02059434|227688|P3|NOT COMPLETED|Washout Between Periods 6 and 7||0
92401|NCT02059434|227689|P2|NOT COMPLETED|Washout Between Periods 6 and 7||0
92402|NCT02059434|227690|P1|NOT COMPLETED|Washout Between Periods 6 and 7||0
92403|NCT02059434|227682|P9|COMPLETED|Washout Between Periods 6 and 7||36
92404|NCT02059434|227683|P8|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
92405|NCT02059434|227684|P7|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
92406|NCT02059434|227685|P6|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
92407|NCT02059434|227686|P5|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
92408|NCT02059434|227687|P4|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
92409|NCT02059434|227688|P3|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
92410|NCT02059434|227689|P2|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
92411|NCT02059434|227690|P1|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
92412|NCT02059434|227682|P9|STARTED|Washout Between Periods 6 and 7||37
92413|NCT02059434|227683|P8|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
92414|NCT02059434|227684|P7|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
92415|NCT02059434|227685|P6|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
92416|NCT02059434|227686|P5|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
92417|NCT02059434|227687|P4|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
92418|NCT02059434|227688|P3|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
92419|NCT02059434|227689|P2|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
92420|NCT02059434|227690|P1|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
92421|NCT02059434|227682|P9|NOT COMPLETED|Period 6||0
92422|NCT02059434|227683|P8|NOT COMPLETED|Period 6||0
92423|NCT02059434|227684|P7|NOT COMPLETED|Period 6||0
92424|NCT02059434|227685|P6|NOT COMPLETED|Period 6||0
92425|NCT02059434|227686|P5|NOT COMPLETED|Period 6||0
92426|NCT02059434|227687|P4|NOT COMPLETED|Period 6||0
92427|NCT02059434|227688|P3|NOT COMPLETED|Period 6||0
92428|NCT02059434|227689|P2|NOT COMPLETED|Period 6||0
92429|NCT02059434|227690|P1|NOT COMPLETED|Period 6||0
92430|NCT02059434|227682|P9|COMPLETED|Period 6||37
92431|NCT02059434|227683|P8|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
92432|NCT02059434|227684|P7|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
92433|NCT02059434|227685|P6|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
92434|NCT02059434|227686|P5|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
92435|NCT02059434|227687|P4|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
92436|NCT02059434|227688|P3|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
92437|NCT02059434|227689|P2|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
92438|NCT02059434|227690|P1|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
92439|NCT02059434|227682|P9|STARTED|Period 6||37
92440|NCT02059434|227683|P8|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
92441|NCT02059434|227684|P7|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
92442|NCT02059434|227685|P6|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
92443|NCT02059434|227686|P5|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
92444|NCT02059434|227687|P4|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
92445|NCT02059434|227688|P3|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
92446|NCT02059434|227689|P2|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
92447|NCT02059434|227690|P1|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
92448|NCT02059434|227682|P9|NOT COMPLETED|Washout Between Periods 5 and 6||0
92449|NCT02059434|227683|P8|NOT COMPLETED|Washout Between Periods 5 and 6||0
92450|NCT02059434|227684|P7|NOT COMPLETED|Washout Between Periods 5 and 6||0
92451|NCT02059434|227685|P6|NOT COMPLETED|Washout Between Periods 5 and 6||0
92452|NCT02059434|227686|P5|NOT COMPLETED|Washout Between Periods 5 and 6||0
92453|NCT02059434|227687|P4|NOT COMPLETED|Washout Between Periods 5 and 6||0
92454|NCT02059434|227688|P3|NOT COMPLETED|Washout Between Periods 5 and 6||0
92455|NCT02059434|227689|P2|NOT COMPLETED|Washout Between Periods 5 and 6||0
92456|NCT02059434|227690|P1|NOT COMPLETED|Washout Between Periods 5 and 6||0
92457|NCT02059434|227682|P9|COMPLETED|Washout Between Periods 5 and 6||37
92458|NCT02059434|227683|P8|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
92459|NCT02059434|227684|P7|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
92460|NCT02059434|227685|P6|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
92461|NCT02059434|227686|P5|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
92462|NCT02059434|227687|P4|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
92608|NCT02059434|227689|P2|STARTED|Washout Between Periods 2 and 3||2
92463|NCT02059434|227688|P3|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
92464|NCT02059434|227689|P2|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
92465|NCT02059434|227690|P1|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
92466|NCT02059434|227682|P9|STARTED|Washout Between Periods 5 and 6||37
92467|NCT02059434|227683|P8|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
92468|NCT02059434|227684|P7|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
92469|NCT02059434|227685|P6|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
92470|NCT02059434|227686|P5|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
92471|NCT02059434|227687|P4|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
92472|NCT02059434|227688|P3|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
92473|NCT02059434|227689|P2|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
92474|NCT02059434|227690|P1|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
92475|NCT02059434|227682|P9|NOT COMPLETED|Period 5||0
92476|NCT02059434|227683|P8|NOT COMPLETED|Period 5||0
92477|NCT02059434|227684|P7|NOT COMPLETED|Period 5||0
92478|NCT02059434|227685|P6|NOT COMPLETED|Period 5||0
92479|NCT02059434|227686|P5|NOT COMPLETED|Period 5||0
92480|NCT02059434|227687|P4|NOT COMPLETED|Period 5||0
92481|NCT02059434|227688|P3|NOT COMPLETED|Period 5||0
92482|NCT02059434|227689|P2|NOT COMPLETED|Period 5||0
92483|NCT02059434|227690|P1|NOT COMPLETED|Period 5||0
92484|NCT02059434|227682|P9|COMPLETED|Period 5||37
92485|NCT02059434|227683|P8|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
92486|NCT02059434|227684|P7|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
92487|NCT02059434|227685|P6|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
92488|NCT02059434|227686|P5|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
92489|NCT02059434|227687|P4|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
92490|NCT02059434|227688|P3|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
92491|NCT02059434|227689|P2|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
92492|NCT02059434|227690|P1|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
92493|NCT02059434|227682|P9|STARTED|Period 5||37
92494|NCT02059434|227683|P8|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
92495|NCT02059434|227684|P7|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
92496|NCT02059434|227685|P6|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
92497|NCT02059434|227686|P5|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
92498|NCT02059434|227687|P4|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
92499|NCT02059434|227688|P3|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
92500|NCT02059434|227689|P2|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
92501|NCT02059434|227690|P1|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
92502|NCT02059434|227682|P9|NOT COMPLETED|Washout Between Periods 4 and 5||1
92503|NCT02059434|227683|P8|NOT COMPLETED|Washout Between Periods 4 and 5||0
92504|NCT02059434|227684|P7|NOT COMPLETED|Washout Between Periods 4 and 5||0
92505|NCT02059434|227685|P6|NOT COMPLETED|Washout Between Periods 4 and 5||0
92506|NCT02059434|227686|P5|NOT COMPLETED|Washout Between Periods 4 and 5||0
92507|NCT02059434|227687|P4|NOT COMPLETED|Washout Between Periods 4 and 5||0
92508|NCT02059434|227688|P3|NOT COMPLETED|Washout Between Periods 4 and 5||0
92509|NCT02059434|227689|P2|NOT COMPLETED|Washout Between Periods 4 and 5||0
92510|NCT02059434|227690|P1|NOT COMPLETED|Washout Between Periods 4 and 5||0
92511|NCT02059434|227682|P9|COMPLETED|Washout Between Periods 4 and 5||37
92512|NCT02059434|227683|P8|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
92513|NCT02059434|227684|P7|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
92514|NCT02059434|227685|P6|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
92515|NCT02059434|227686|P5|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
92516|NCT02059434|227687|P4|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
92517|NCT02059434|227688|P3|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
92518|NCT02059434|227689|P2|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
92519|NCT02059434|227690|P1|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
92520|NCT02059434|227682|P9|STARTED|Washout Between Periods 4 and 5||38
92521|NCT02059434|227683|P8|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
92522|NCT02059434|227684|P7|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
92523|NCT02059434|227685|P6|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
92524|NCT02059434|227686|P5|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
92525|NCT02059434|227687|P4|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
92526|NCT02059434|227688|P3|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
92527|NCT02059434|227689|P2|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
92528|NCT02059434|227690|P1|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
92529|NCT02059434|227682|P9|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
92530|NCT02059434|227683|P8|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
92531|NCT02059434|227684|P7|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
92532|NCT02059434|227685|P6|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
92533|NCT02059434|227686|P5|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
92534|NCT02059434|227687|P4|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
92535|NCT02059434|227688|P3|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
92536|NCT02059434|227689|P2|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
92537|NCT02059434|227690|P1|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
92538|NCT02059434|227682|P9|COMPLETED|Period 4 (After Screening/run-in Period)||38
92539|NCT02059434|227683|P8|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
92540|NCT02059434|227684|P7|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
92541|NCT02059434|227685|P6|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
92542|NCT02059434|227686|P5|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
92543|NCT02059434|227687|P4|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
92544|NCT02059434|227688|P3|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
92545|NCT02059434|227689|P2|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
92546|NCT02059434|227690|P1|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
92547|NCT02059434|227682|P9|STARTED|Period 4 (After Screening/run-in Period)||38
92548|NCT02059434|227683|P8|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
92549|NCT02059434|227684|P7|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
92550|NCT02059434|227685|P6|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
92551|NCT02059434|227686|P5|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
92552|NCT02059434|227687|P4|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
92553|NCT02059434|227688|P3|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
92554|NCT02059434|227689|P2|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
92555|NCT02059434|227690|P1|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
92556|NCT02059434|227682|P9|NOT COMPLETED|Period 3||0
92557|NCT02059434|227683|P8|NOT COMPLETED|Period 3||0
92558|NCT02059434|227684|P7|NOT COMPLETED|Period 3||0
92559|NCT02059434|227685|P6|NOT COMPLETED|Period 3||0
92560|NCT02059434|227686|P5|NOT COMPLETED|Period 3||0
92561|NCT02059434|227687|P4|NOT COMPLETED|Period 3||0
92562|NCT02059434|227688|P3|NOT COMPLETED|Period 3||0
92563|NCT02059434|227689|P2|NOT COMPLETED|Period 3||0
92564|NCT02059434|227690|P1|NOT COMPLETED|Period 3||0
92565|NCT02059434|227682|P9|COMPLETED|Period 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
92566|NCT02059434|227683|P8|COMPLETED|Period 3||2
92567|NCT02059434|227684|P7|COMPLETED|Period 3||2
92568|NCT02059434|227685|P6|COMPLETED|Period 3||2
92569|NCT02059434|227686|P5|COMPLETED|Period 3||2
92570|NCT02059434|227687|P4|COMPLETED|Period 3||2
92571|NCT02059434|227688|P3|COMPLETED|Period 3||2
92572|NCT02059434|227689|P2|COMPLETED|Period 3||2
92573|NCT02059434|227690|P1|COMPLETED|Period 3||2
92574|NCT02059434|227682|P9|STARTED|Period 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
92575|NCT02059434|227683|P8|STARTED|Period 3||2
92576|NCT02059434|227684|P7|STARTED|Period 3||2
92577|NCT02059434|227685|P6|STARTED|Period 3||2
92578|NCT02059434|227686|P5|STARTED|Period 3||2
92579|NCT02059434|227687|P4|STARTED|Period 3||2
92580|NCT02059434|227688|P3|STARTED|Period 3||2
92581|NCT02059434|227689|P2|STARTED|Period 3||2
92582|NCT02059434|227690|P1|STARTED|Period 3||2
92583|NCT02059434|227682|P9|NOT COMPLETED|Washout Between Periods 2 and 3||0
92584|NCT02059434|227683|P8|NOT COMPLETED|Washout Between Periods 2 and 3||0
92585|NCT02059434|227684|P7|NOT COMPLETED|Washout Between Periods 2 and 3||0
92586|NCT02059434|227685|P6|NOT COMPLETED|Washout Between Periods 2 and 3||0
92587|NCT02059434|227686|P5|NOT COMPLETED|Washout Between Periods 2 and 3||0
92588|NCT02059434|227687|P4|NOT COMPLETED|Washout Between Periods 2 and 3||0
92589|NCT02059434|227688|P3|NOT COMPLETED|Washout Between Periods 2 and 3||0
92590|NCT02059434|227689|P2|NOT COMPLETED|Washout Between Periods 2 and 3||0
92591|NCT02059434|227690|P1|NOT COMPLETED|Washout Between Periods 2 and 3||0
92592|NCT02059434|227682|P9|COMPLETED|Washout Between Periods 2 and 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
92593|NCT02059434|227683|P8|COMPLETED|Washout Between Periods 2 and 3||2
92594|NCT02059434|227684|P7|COMPLETED|Washout Between Periods 2 and 3||2
92595|NCT02059434|227685|P6|COMPLETED|Washout Between Periods 2 and 3||2
92596|NCT02059434|227686|P5|COMPLETED|Washout Between Periods 2 and 3||2
92597|NCT02059434|227687|P4|COMPLETED|Washout Between Periods 2 and 3||2
92598|NCT02059434|227688|P3|COMPLETED|Washout Between Periods 2 and 3||2
92599|NCT02059434|227689|P2|COMPLETED|Washout Between Periods 2 and 3||2
92600|NCT02059434|227690|P1|COMPLETED|Washout Between Periods 2 and 3||2
92601|NCT02059434|227682|P9|STARTED|Washout Between Periods 2 and 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
92602|NCT02059434|227683|P8|STARTED|Washout Between Periods 2 and 3||2
92603|NCT02059434|227684|P7|STARTED|Washout Between Periods 2 and 3||2
92604|NCT02059434|227685|P6|STARTED|Washout Between Periods 2 and 3||2
92605|NCT02059434|227686|P5|STARTED|Washout Between Periods 2 and 3||2
92606|NCT02059434|227687|P4|STARTED|Washout Between Periods 2 and 3||2
92609|NCT02059434|227690|P1|STARTED|Washout Between Periods 2 and 3||2
92610|NCT02059434|227682|P9|NOT COMPLETED|Period 2||0
92611|NCT02059434|227683|P8|NOT COMPLETED|Period 2||0
92612|NCT02059434|227684|P7|NOT COMPLETED|Period 2||0
92613|NCT02059434|227685|P6|NOT COMPLETED|Period 2||0
92614|NCT02059434|227686|P5|NOT COMPLETED|Period 2||0
92615|NCT02059434|227687|P4|NOT COMPLETED|Period 2||0
92616|NCT02059434|227688|P3|NOT COMPLETED|Period 2||0
92617|NCT02059434|227689|P2|NOT COMPLETED|Period 2||0
92618|NCT02059434|227690|P1|NOT COMPLETED|Period 2||0
92619|NCT02059434|227682|P9|COMPLETED|Period 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
92620|NCT02059434|227683|P8|COMPLETED|Period 2||2
92621|NCT02059434|227684|P7|COMPLETED|Period 2||2
92622|NCT02059434|227685|P6|COMPLETED|Period 2||2
92623|NCT02059434|227686|P5|COMPLETED|Period 2||2
92624|NCT02059434|227687|P4|COMPLETED|Period 2||2
92625|NCT02059434|227688|P3|COMPLETED|Period 2||2
92626|NCT02059434|227689|P2|COMPLETED|Period 2||2
92627|NCT02059434|227690|P1|COMPLETED|Period 2||2
92628|NCT02059434|227682|P9|STARTED|Period 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
92629|NCT02059434|227683|P8|STARTED|Period 2||2
92630|NCT02059434|227684|P7|STARTED|Period 2||2
92631|NCT02059434|227685|P6|STARTED|Period 2||2
92632|NCT02059434|227686|P5|STARTED|Period 2||2
92633|NCT02059434|227687|P4|STARTED|Period 2||2
92634|NCT02059434|227688|P3|STARTED|Period 2||2
92635|NCT02059434|227689|P2|STARTED|Period 2||2
92636|NCT02059434|227690|P1|STARTED|Period 2||2
92637|NCT02059434|227682|P9|NOT COMPLETED|Washout Between Periods 1 and 2||0
92638|NCT02059434|227683|P8|NOT COMPLETED|Washout Between Periods 1 and 2||1
92639|NCT02059434|227684|P7|NOT COMPLETED|Washout Between Periods 1 and 2||0
92640|NCT02059434|227685|P6|NOT COMPLETED|Washout Between Periods 1 and 2||0
92641|NCT02059434|227686|P5|NOT COMPLETED|Washout Between Periods 1 and 2||0
92642|NCT02059434|227687|P4|NOT COMPLETED|Washout Between Periods 1 and 2||0
92643|NCT02059434|227688|P3|NOT COMPLETED|Washout Between Periods 1 and 2||0
92644|NCT02059434|227689|P2|NOT COMPLETED|Washout Between Periods 1 and 2||0
92645|NCT02059434|227690|P1|NOT COMPLETED|Washout Between Periods 1 and 2||0
92646|NCT02059434|227682|P9|COMPLETED|Washout Between Periods 1 and 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
92647|NCT02059434|227683|P8|COMPLETED|Washout Between Periods 1 and 2||2
92648|NCT02059434|227684|P7|COMPLETED|Washout Between Periods 1 and 2||2
92649|NCT02059434|227685|P6|COMPLETED|Washout Between Periods 1 and 2||2
92650|NCT02059434|227686|P5|COMPLETED|Washout Between Periods 1 and 2||2
92651|NCT02059434|227687|P4|COMPLETED|Washout Between Periods 1 and 2||2
92652|NCT02059434|227688|P3|COMPLETED|Washout Between Periods 1 and 2||2
92653|NCT02059434|227689|P2|COMPLETED|Washout Between Periods 1 and 2||2
92654|NCT02059434|227690|P1|COMPLETED|Washout Between Periods 1 and 2||2
92655|NCT02059434|227682|P9|STARTED|Washout Between Periods 1 and 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
92656|NCT02059434|227683|P8|STARTED|Washout Between Periods 1 and 2||3
92657|NCT02059434|227684|P7|STARTED|Washout Between Periods 1 and 2||2
92658|NCT02059434|227685|P6|STARTED|Washout Between Periods 1 and 2||2
92659|NCT02059434|227686|P5|STARTED|Washout Between Periods 1 and 2||2
92660|NCT02059434|227687|P4|STARTED|Washout Between Periods 1 and 2||2
92661|NCT02059434|227688|P3|STARTED|Washout Between Periods 1 and 2||2
92662|NCT02059434|227689|P2|STARTED|Washout Between Periods 1 and 2||2
92663|NCT02059434|227690|P1|STARTED|Washout Between Periods 1 and 2||2
92664|NCT02059434|227682|P9|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
92665|NCT02059434|227683|P8|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
92666|NCT02059434|227684|P7|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
92667|NCT02059434|227685|P6|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
92668|NCT02059434|227686|P5|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
92669|NCT02059434|227687|P4|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
92670|NCT02059434|227688|P3|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
92671|NCT02059434|227689|P2|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
92672|NCT02059434|227690|P1|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
92673|NCT02059434|227682|P9|COMPLETED|Period 1 (After Screening/run-in Period)|Part 2 followed Part 1, and comprised 5 treatment periods|0
92674|NCT02059434|227683|P8|COMPLETED|Period 1 (After Screening/run-in Period)||3
92675|NCT02059434|227684|P7|COMPLETED|Period 1 (After Screening/run-in Period)||2
92676|NCT02059434|227685|P6|COMPLETED|Period 1 (After Screening/run-in Period)||2
92677|NCT02059434|227686|P5|COMPLETED|Period 1 (After Screening/run-in Period)||2
92678|NCT02059434|227687|P4|COMPLETED|Period 1 (After Screening/run-in Period)||2
92679|NCT02059434|227688|P3|COMPLETED|Period 1 (After Screening/run-in Period)||2
92680|NCT02059434|227689|P2|COMPLETED|Period 1 (After Screening/run-in Period)||2
92681|NCT02059434|227690|P1|COMPLETED|Period 1 (After Screening/run-in Period)||2
92682|NCT02059434|227682|P9|STARTED|Period 1 (After Screening/run-in Period)|Part 2 followed Part 1, and comprised 5 treatment periods|0
92683|NCT02059434|227683|P8|STARTED|Period 1 (After Screening/run-in Period)||3
92684|NCT02059434|227684|P7|STARTED|Period 1 (After Screening/run-in Period)||2
92685|NCT02059434|227685|P6|STARTED|Period 1 (After Screening/run-in Period)||2
92686|NCT02059434|227686|P5|STARTED|Period 1 (After Screening/run-in Period)||2
92687|NCT02059434|227687|P4|STARTED|Period 1 (After Screening/run-in Period)||2
92688|NCT02059434|227688|P3|STARTED|Period 1 (After Screening/run-in Period)||2
92689|NCT02059434|227689|P2|STARTED|Period 1 (After Screening/run-in Period)||2
92690|NCT02059434|227690|P1|STARTED|Period 1 (After Screening/run-in Period)||2
92691|NCT02059395|227754|P2|NOT COMPLETED|Overall Study||4
92692|NCT02059395|227755|P1|NOT COMPLETED|Overall Study||2
92693|NCT02059395|227754|P2|COMPLETED|Overall Study||23
92694|NCT02059395|227755|P1|COMPLETED|Overall Study||20
92695|NCT02059395|227754|P2|STARTED|Overall Study||27
92696|NCT02059395|227755|P1|STARTED|Overall Study||22
92697|NCT02059291|227770|P25|NOT COMPLETED|Epoch 4||0
92698|NCT02059291|227771|P24|NOT COMPLETED|Epoch 4||1
92699|NCT02059291|227772|P23|NOT COMPLETED|Epoch 4||1
92700|NCT02059291|227773|P22|NOT COMPLETED|Epoch 4||0
92701|NCT02059291|227774|P21|NOT COMPLETED|Epoch 4||1
92702|NCT02059291|227775|P20|NOT COMPLETED|Epoch 4||0
92703|NCT02059291|227776|P19|NOT COMPLETED|Epoch 4||0
92704|NCT02059291|227777|P18|NOT COMPLETED|Epoch 4||0
92705|NCT02059291|227778|P17|NOT COMPLETED|Epoch 4||2
92706|NCT02059291|227779|P16|NOT COMPLETED|Epoch 4||0
92707|NCT02059291|227780|P15|NOT COMPLETED|Epoch 4||0
92708|NCT02059291|227781|P14|NOT COMPLETED|Epoch 4||0
92709|NCT02059291|227782|P13|NOT COMPLETED|Epoch 4||0
92710|NCT02059291|227783|P12|NOT COMPLETED|Epoch 4||0
92711|NCT02059291|227784|P11|NOT COMPLETED|Epoch 4||0
92712|NCT02059291|227785|P10|NOT COMPLETED|Epoch 4||0
92713|NCT02059291|227786|P9|NOT COMPLETED|Epoch 4||0
92714|NCT02059291|227787|P8|NOT COMPLETED|Epoch 4||0
92715|NCT02059291|227788|P7|NOT COMPLETED|Epoch 4||0
92716|NCT02059291|227789|P6|NOT COMPLETED|Epoch 4||0
92717|NCT02059291|227790|P5|NOT COMPLETED|Epoch 4||0
92718|NCT02059291|227791|P4|NOT COMPLETED|Epoch 4||0
92719|NCT02059291|227792|P3|NOT COMPLETED|Epoch 4||0
92720|NCT02059291|227793|P2|NOT COMPLETED|Epoch 4||0
92721|NCT02059291|227794|P1|NOT COMPLETED|Epoch 4||0
92722|NCT02059291|227770|P25|COMPLETED|Epoch 4||0
92723|NCT02059291|227771|P24|COMPLETED|Epoch 4||21
92724|NCT02059291|227772|P23|COMPLETED|Epoch 4||30
92725|NCT02059291|227773|P22|COMPLETED|Epoch 4||14
92726|NCT02059291|227774|P21|COMPLETED|Epoch 4||33
92727|NCT02059291|227775|P20|COMPLETED|Epoch 4||18
92728|NCT02059291|227776|P19|COMPLETED|Epoch 4||2
92729|NCT02059291|227777|P18|COMPLETED|Epoch 4||14
92730|NCT02059291|227778|P17|COMPLETED|Epoch 4||41
92731|NCT02059291|227779|P16|COMPLETED|Epoch 4||0
92732|NCT02059291|227780|P15|COMPLETED|Epoch 4||0
92733|NCT02059291|227781|P14|COMPLETED|Epoch 4||0
92734|NCT02059291|227782|P13|COMPLETED|Epoch 4||0
92735|NCT02059291|227783|P12|COMPLETED|Epoch 4||0
92736|NCT02059291|227784|P11|COMPLETED|Epoch 4||0
92737|NCT02059291|227785|P10|COMPLETED|Epoch 4||0
92738|NCT02059291|227786|P9|COMPLETED|Epoch 4||0
92739|NCT02059291|227787|P8|COMPLETED|Epoch 4||0
92740|NCT02059291|227788|P7|COMPLETED|Epoch 4||0
92741|NCT02059291|227789|P6|COMPLETED|Epoch 4||0
92742|NCT02059291|227790|P5|COMPLETED|Epoch 4||0
92743|NCT02059291|227791|P4|COMPLETED|Epoch 4||0
92744|NCT02059291|227792|P3|COMPLETED|Epoch 4||0
92745|NCT02059291|227793|P2|COMPLETED|Epoch 4||0
92746|NCT02059291|227794|P1|COMPLETED|Epoch 4||0
92747|NCT02059291|227770|P25|STARTED|Epoch 4||0
92748|NCT02059291|227771|P24|STARTED|Epoch 4||22
92749|NCT02059291|227772|P23|STARTED|Epoch 4||31
92750|NCT02059291|227773|P22|STARTED|Epoch 4||14
92751|NCT02059291|227774|P21|STARTED|Epoch 4||34
92752|NCT02059291|227775|P20|STARTED|Epoch 4||18
92753|NCT02059291|227776|P19|STARTED|Epoch 4||2
92754|NCT02059291|227777|P18|STARTED|Epoch 4||14
92755|NCT02059291|227778|P17|STARTED|Epoch 4||43
92756|NCT02059291|227779|P16|STARTED|Epoch 4||0
92757|NCT02059291|227780|P15|STARTED|Epoch 4||0
92758|NCT02059291|227781|P14|STARTED|Epoch 4||0
92759|NCT02059291|227782|P13|STARTED|Epoch 4||0
92760|NCT02059291|227783|P12|STARTED|Epoch 4||0
92761|NCT02059291|227784|P11|STARTED|Epoch 4||0
92762|NCT02059291|227785|P10|STARTED|Epoch 4||0
92763|NCT02059291|227786|P9|STARTED|Epoch 4||0
92764|NCT02059291|227787|P8|STARTED|Epoch 4||0
92765|NCT02059291|227788|P7|STARTED|Epoch 4||0
92766|NCT02059291|227789|P6|STARTED|Epoch 4||0
92767|NCT02059291|227790|P5|STARTED|Epoch 4||0
92768|NCT02059291|227791|P4|STARTED|Epoch 4||0
92769|NCT02059291|227792|P3|STARTED|Epoch 4||0
92770|NCT02059291|227793|P2|STARTED|Epoch 4||0
92771|NCT02059291|227794|P1|STARTED|Epoch 4||0
92772|NCT02059291|227770|P25|NOT COMPLETED|Epoch 3||0
92773|NCT02059291|227771|P24|NOT COMPLETED|Epoch 3||0
92774|NCT02059291|227772|P23|NOT COMPLETED|Epoch 3||0
92775|NCT02059291|227773|P22|NOT COMPLETED|Epoch 3||0
92776|NCT02059291|227774|P21|NOT COMPLETED|Epoch 3||0
92777|NCT02059291|227775|P20|NOT COMPLETED|Epoch 3||0
92778|NCT02059291|227776|P19|NOT COMPLETED|Epoch 3||0
92779|NCT02059291|227777|P18|NOT COMPLETED|Epoch 3||0
92780|NCT02059291|227778|P17|NOT COMPLETED|Epoch 3||0
92781|NCT02059291|227779|P16|NOT COMPLETED|Epoch 3||6
92782|NCT02059291|227780|P15|NOT COMPLETED|Epoch 3||0
92783|NCT02059291|227781|P14|NOT COMPLETED|Epoch 3||1
92784|NCT02059291|227782|P13|NOT COMPLETED|Epoch 3||0
92785|NCT02059291|227783|P12|NOT COMPLETED|Epoch 3||0
92786|NCT02059291|227784|P11|NOT COMPLETED|Epoch 3||0
92787|NCT02059291|227785|P10|NOT COMPLETED|Epoch 3||0
92788|NCT02059291|227786|P9|NOT COMPLETED|Epoch 3||0
92789|NCT02059291|227787|P8|NOT COMPLETED|Epoch 3||0
92790|NCT02059291|227788|P7|NOT COMPLETED|Epoch 3||0
92791|NCT02059291|227789|P6|NOT COMPLETED|Epoch 3||0
92792|NCT02059291|227790|P5|NOT COMPLETED|Epoch 3||0
92793|NCT02059291|227791|P4|NOT COMPLETED|Epoch 3||0
92794|NCT02059291|227792|P3|NOT COMPLETED|Epoch 3||0
92795|NCT02059291|227793|P2|NOT COMPLETED|Epoch 3||0
92796|NCT02059291|227794|P1|NOT COMPLETED|Epoch 3||0
92797|NCT02059291|227770|P25|COMPLETED|Epoch 3||0
92798|NCT02059291|227771|P24|COMPLETED|Epoch 3||0
92799|NCT02059291|227772|P23|COMPLETED|Epoch 3||0
92800|NCT02059291|227773|P22|COMPLETED|Epoch 3||0
92801|NCT02059291|227774|P21|COMPLETED|Epoch 3||0
92802|NCT02059291|227775|P20|COMPLETED|Epoch 3||0
92803|NCT02059291|227776|P19|COMPLETED|Epoch 3||0
92804|NCT02059291|227777|P18|COMPLETED|Epoch 3||0
92805|NCT02059291|227778|P17|COMPLETED|Epoch 3||0
92806|NCT02059291|227779|P16|COMPLETED|Epoch 3||120
92807|NCT02059291|227780|P15|COMPLETED|Epoch 3||5
92808|NCT02059291|227781|P14|COMPLETED|Epoch 3||3
92809|NCT02059291|227782|P13|COMPLETED|Epoch 3||7
92810|NCT02059291|227783|P12|COMPLETED|Epoch 3||6
92811|NCT02059291|227784|P11|COMPLETED|Epoch 3||10
92812|NCT02059291|227785|P10|COMPLETED|Epoch 3||9
92813|NCT02059291|227786|P9|COMPLETED|Epoch 3||0
92814|NCT02059291|227787|P8|COMPLETED|Epoch 3||1
92815|NCT02059291|227788|P7|COMPLETED|Epoch 3||2
92816|NCT02059291|227789|P6|COMPLETED|Epoch 3||0
92817|NCT02059291|227790|P5|COMPLETED|Epoch 3||0
92818|NCT02059291|227791|P4|COMPLETED|Epoch 3||0
92819|NCT02059291|227792|P3|COMPLETED|Epoch 3||0
92820|NCT02059291|227793|P2|COMPLETED|Epoch 3||0
92821|NCT02059291|227794|P1|COMPLETED|Epoch 3||0
92822|NCT02059291|227770|P25|STARTED|Epoch 3||0
92823|NCT02059291|227771|P24|STARTED|Epoch 3||0
92824|NCT02059291|227772|P23|STARTED|Epoch 3||0
92825|NCT02059291|227773|P22|STARTED|Epoch 3||0
92826|NCT02059291|227774|P21|STARTED|Epoch 3||0
92827|NCT02059291|227775|P20|STARTED|Epoch 3||0
92828|NCT02059291|227776|P19|STARTED|Epoch 3||0
92829|NCT02059291|227777|P18|STARTED|Epoch 3||0
92830|NCT02059291|227778|P17|STARTED|Epoch 3||0
92831|NCT02059291|227779|P16|STARTED|Epoch 3||126
92832|NCT02059291|227780|P15|STARTED|Epoch 3||5
92833|NCT02059291|227781|P14|STARTED|Epoch 3||4
92834|NCT02059291|227782|P13|STARTED|Epoch 3||7
92835|NCT02059291|227783|P12|STARTED|Epoch 3||6
92836|NCT02059291|227784|P11|STARTED|Epoch 3||10
92837|NCT02059291|227785|P10|STARTED|Epoch 3||9
92838|NCT02059291|227786|P9|STARTED|Epoch 3|Presented in Epoch 2.|0
92839|NCT02059291|227787|P8|STARTED|Epoch 3||1
92840|NCT02059291|227788|P7|STARTED|Epoch 3||2
92841|NCT02059291|227789|P6|STARTED|Epoch 3||0
92842|NCT02059291|227790|P5|STARTED|Epoch 3||0
92843|NCT02059291|227791|P4|STARTED|Epoch 3||0
92844|NCT02059291|227792|P3|STARTED|Epoch 3||0
92845|NCT02059291|227793|P2|STARTED|Epoch 3||0
92846|NCT02059291|227794|P1|STARTED|Epoch 3||0
92847|NCT02059291|227770|P25|NOT COMPLETED|Epoch 2||0
92848|NCT02059291|227771|P24|NOT COMPLETED|Epoch 2||0
92849|NCT02059291|227772|P23|NOT COMPLETED|Epoch 2||0
92850|NCT02059291|227773|P22|NOT COMPLETED|Epoch 2||0
92851|NCT02059291|227774|P21|NOT COMPLETED|Epoch 2||0
92852|NCT02059291|227775|P20|NOT COMPLETED|Epoch 2||0
92853|NCT02059291|227776|P19|NOT COMPLETED|Epoch 2||0
92854|NCT02059291|227777|P18|NOT COMPLETED|Epoch 2||0
92855|NCT02059291|227778|P17|NOT COMPLETED|Epoch 2||0
92856|NCT02059291|227779|P16|NOT COMPLETED|Epoch 2||0
92857|NCT02059291|227780|P15|NOT COMPLETED|Epoch 2||0
92858|NCT02059291|227781|P14|NOT COMPLETED|Epoch 2||0
92859|NCT02059291|227782|P13|NOT COMPLETED|Epoch 2||0
92860|NCT02059291|227783|P12|NOT COMPLETED|Epoch 2||0
92861|NCT02059291|227784|P11|NOT COMPLETED|Epoch 2||0
92862|NCT02059291|227785|P10|NOT COMPLETED|Epoch 2||0
92863|NCT02059291|227786|P9|NOT COMPLETED|Epoch 2||2
92864|NCT02059291|227787|P8|NOT COMPLETED|Epoch 2||1
92865|NCT02059291|227788|P7|NOT COMPLETED|Epoch 2||0
92866|NCT02059291|227789|P6|NOT COMPLETED|Epoch 2||2
92867|NCT02059291|227790|P5|NOT COMPLETED|Epoch 2||0
92868|NCT02059291|227791|P4|NOT COMPLETED|Epoch 2||2
92869|NCT02059291|227792|P3|NOT COMPLETED|Epoch 2||1
92870|NCT02059291|227793|P2|NOT COMPLETED|Epoch 2||1
92871|NCT02059291|227794|P1|NOT COMPLETED|Epoch 2||0
92872|NCT02059291|227770|P25|COMPLETED|Epoch 2||0
92873|NCT02059291|227771|P24|COMPLETED|Epoch 2||0
92874|NCT02059291|227772|P23|COMPLETED|Epoch 2||0
92875|NCT02059291|227773|P22|COMPLETED|Epoch 2||0
92876|NCT02059291|227774|P21|COMPLETED|Epoch 2||0
92877|NCT02059291|227775|P20|COMPLETED|Epoch 2||0
92878|NCT02059291|227776|P19|COMPLETED|Epoch 2||0
92879|NCT02059291|227777|P18|COMPLETED|Epoch 2||0
92880|NCT02059291|227778|P17|COMPLETED|Epoch 2||0
92881|NCT02059291|227779|P16|COMPLETED|Epoch 2||0
92882|NCT02059291|227780|P15|COMPLETED|Epoch 2||0
92883|NCT02059291|227781|P14|COMPLETED|Epoch 2||0
92884|NCT02059291|227782|P13|COMPLETED|Epoch 2||0
92885|NCT02059291|227783|P12|COMPLETED|Epoch 2||0
92886|NCT02059291|227784|P11|COMPLETED|Epoch 2||0
92887|NCT02059291|227785|P10|COMPLETED|Epoch 2||0
92888|NCT02059291|227786|P9|COMPLETED|Epoch 2||16
92889|NCT02059291|227787|P8|COMPLETED|Epoch 2||1
92890|NCT02059291|227788|P7|COMPLETED|Epoch 2||2
92891|NCT02059291|227789|P6|COMPLETED|Epoch 2||22
92892|NCT02059291|227790|P5|COMPLETED|Epoch 2||22
92893|NCT02059291|227791|P4|COMPLETED|Epoch 2||33
92894|NCT02059291|227792|P3|COMPLETED|Epoch 2||36
92895|NCT02059291|227793|P2|COMPLETED|Epoch 2||31
92896|NCT02059291|227794|P1|COMPLETED|Epoch 2||31
92897|NCT02059291|227770|P25|STARTED|Epoch 2||0
92898|NCT02059291|227771|P24|STARTED|Epoch 2||0
92899|NCT02059291|227772|P23|STARTED|Epoch 2||0
92900|NCT02059291|227773|P22|STARTED|Epoch 2||0
92901|NCT02059291|227774|P21|STARTED|Epoch 2||0
92902|NCT02059291|227775|P20|STARTED|Epoch 2||0
92903|NCT02059291|227776|P19|STARTED|Epoch 2||0
92904|NCT02059291|227777|P18|STARTED|Epoch 2||0
92905|NCT02059291|227778|P17|STARTED|Epoch 2||0
92906|NCT02059291|227779|P16|STARTED|Epoch 2||0
92907|NCT02059291|227780|P15|STARTED|Epoch 2||0
92908|NCT02059291|227781|P14|STARTED|Epoch 2||0
92909|NCT02059291|227782|P13|STARTED|Epoch 2||0
92910|NCT02059291|227783|P12|STARTED|Epoch 2||0
92911|NCT02059291|227784|P11|STARTED|Epoch 2||0
92912|NCT02059291|227785|P10|STARTED|Epoch 2||0
92913|NCT02059291|227786|P9|STARTED|Epoch 2|This Epoch 3 group is shown in Epoch 2 to account for the 203 patients enrolled in the study.|18
92914|NCT02059291|227787|P8|STARTED|Epoch 2||2
92915|NCT02059291|227788|P7|STARTED|Epoch 2||2
92916|NCT02059291|227789|P6|STARTED|Epoch 2||24
92917|NCT02059291|227790|P5|STARTED|Epoch 2||22
92918|NCT02059291|227791|P4|STARTED|Epoch 2||35
92919|NCT02059291|227792|P3|STARTED|Epoch 2||37
92920|NCT02059291|227793|P2|STARTED|Epoch 2||32
92921|NCT02059291|227794|P1|STARTED|Epoch 2||31
92922|NCT02059278|227848|P2|NOT COMPLETED|Overall Study||4
92923|NCT02059278|227849|P1|NOT COMPLETED|Overall Study||3
92924|NCT02059278|227848|P2|COMPLETED|Overall Study||166
92925|NCT02059278|227849|P1|COMPLETED|Overall Study||162
92926|NCT02059278|227848|P2|STARTED|Overall Study||170
92927|NCT02059278|227849|P1|STARTED|Overall Study||165
92928|NCT02059265|227863|P1|NOT COMPLETED|Overall Study||4
92929|NCT02059265|227863|P1|COMPLETED|Overall Study||28
92930|NCT02059265|227863|P1|STARTED|Overall Study||32
92931|NCT02059213|227873|P2|NOT COMPLETED|Overall Study||2
92932|NCT02059213|227874|P1|NOT COMPLETED|Overall Study||0
92933|NCT02059213|227873|P2|COMPLETED|Overall Study||40
92934|NCT02059213|227874|P1|COMPLETED|Overall Study||20
92935|NCT02059213|227873|P2|Initiated Treatment|Overall Study||40
92936|NCT02059213|227874|P1|Initiated Treatment|Overall Study||20
92937|NCT02059213|227873|P2|STARTED|Overall Study||42
92938|NCT02059213|227874|P1|STARTED|Overall Study||20
92939|NCT02059187|227882|P2|NOT COMPLETED|Overall Study||22
92940|NCT02059187|227883|P1|NOT COMPLETED|Overall Study||25
92941|NCT02059187|227882|P2|COMPLETED|Overall Study||244
92942|NCT02059187|227883|P1|COMPLETED|Overall Study||240
92943|NCT02059187|227882|P2|STARTED|Overall Study||266
92944|NCT02059187|227883|P1|STARTED|Overall Study||265
92945|NCT02059174|227909|P2|NOT COMPLETED|Period 4||0
92946|NCT02059174|227910|P1|NOT COMPLETED|Period 4||0
92947|NCT02059174|227909|P2|COMPLETED|Period 4||35
92948|NCT02059174|227910|P1|COMPLETED|Period 4||35
92949|NCT02059174|227909|P2|STARTED|Period 4||35
92950|NCT02059174|227910|P1|STARTED|Period 4||35
92951|NCT02059174|227909|P2|NOT COMPLETED|Period 3||0
92952|NCT02059174|227910|P1|NOT COMPLETED|Period 3||1
92953|NCT02059174|227909|P2|COMPLETED|Period 3||35
92954|NCT02059174|227910|P1|COMPLETED|Period 3||35
92955|NCT02059174|227909|P2|STARTED|Period 3||35
92956|NCT02059174|227910|P1|STARTED|Period 3||36
92957|NCT02059174|227909|P2|NOT COMPLETED|Period 2||2
92958|NCT02059174|227910|P1|NOT COMPLETED|Period 2||1
92959|NCT02059174|227909|P2|COMPLETED|Period 2||35
92960|NCT02059174|227910|P1|COMPLETED|Period 2||36
92961|NCT02059174|227909|P2|STARTED|Period 2||37
92962|NCT02059174|227910|P1|STARTED|Period 2||37
92963|NCT02059174|227909|P2|NOT COMPLETED|Period 1||2
92964|NCT02059174|227910|P1|NOT COMPLETED|Period 1||0
92965|NCT02059174|227909|P2|COMPLETED|Period 1||37
92966|NCT02059174|227910|P1|COMPLETED|Period 1||37
92967|NCT02059174|227909|P2|STARTED|Period 1||39
92968|NCT02059174|227910|P1|STARTED|Period 1||37
92969|NCT02059161|227934|P2|NOT COMPLETED|Overall Study||41
92970|NCT02059161|227935|P1|NOT COMPLETED|Overall Study||49
92971|NCT02059161|227934|P2|COMPLETED|Overall Study||222
92972|NCT02059161|227935|P1|COMPLETED|Overall Study||196
92973|NCT02059161|227934|P2|Treated|Overall Study||258
92974|NCT02059161|227935|P1|Treated|Overall Study||241
92975|NCT02059161|227934|P2|STARTED|Overall Study||263
92976|NCT02059161|227935|P1|STARTED|Overall Study||245
92977|NCT02059148|227995|P6|NOT COMPLETED|Treatment 3||0
92978|NCT02059148|227996|P5|NOT COMPLETED|Treatment 3||0
92979|NCT02059148|227997|P4|NOT COMPLETED|Treatment 3||0
92980|NCT02059148|227998|P3|NOT COMPLETED|Treatment 3||0
92981|NCT02059148|227999|P2|NOT COMPLETED|Treatment 3||0
92982|NCT02059148|228000|P1|NOT COMPLETED|Treatment 3||0
92983|NCT02059148|227995|P6|COMPLETED|Treatment 3||3
92984|NCT02059148|227996|P5|COMPLETED|Treatment 3||4
92985|NCT02059148|227997|P4|COMPLETED|Treatment 3||4
92986|NCT02059148|227998|P3|COMPLETED|Treatment 3||4
92987|NCT02059148|227999|P2|COMPLETED|Treatment 3||4
92988|NCT02059148|228000|P1|COMPLETED|Treatment 3||4
92989|NCT02059148|227995|P6|STARTED|Treatment 3||3
92990|NCT02059148|227996|P5|STARTED|Treatment 3||4
92991|NCT02059148|227997|P4|STARTED|Treatment 3||4
92992|NCT02059148|227998|P3|STARTED|Treatment 3||4
92993|NCT02059148|227999|P2|STARTED|Treatment 3||4
92994|NCT02059148|228000|P1|STARTED|Treatment 3||4
92995|NCT02059148|227995|P6|NOT COMPLETED|Treatment 2||0
92996|NCT02059148|227996|P5|NOT COMPLETED|Treatment 2||0
92997|NCT02059148|227997|P4|NOT COMPLETED|Treatment 2||0
92998|NCT02059148|227998|P3|NOT COMPLETED|Treatment 2||0
92999|NCT02059148|227999|P2|NOT COMPLETED|Treatment 2||0
93000|NCT02059148|228000|P1|NOT COMPLETED|Treatment 2||0
93001|NCT02059148|227995|P6|COMPLETED|Treatment 2||3
93002|NCT02059148|227996|P5|COMPLETED|Treatment 2||4
93003|NCT02059148|227997|P4|COMPLETED|Treatment 2||4
93004|NCT02059148|227998|P3|COMPLETED|Treatment 2||4
93005|NCT02059148|227999|P2|COMPLETED|Treatment 2||4
93006|NCT02059148|228000|P1|COMPLETED|Treatment 2||4
93007|NCT02059148|227995|P6|STARTED|Treatment 2||3
93008|NCT02059148|227996|P5|STARTED|Treatment 2||4
93009|NCT02059148|227997|P4|STARTED|Treatment 2||4
93010|NCT02059148|227998|P3|STARTED|Treatment 2||4
93011|NCT02059148|227999|P2|STARTED|Treatment 2||4
93012|NCT02059148|228000|P1|STARTED|Treatment 2||4
93013|NCT02059148|227995|P6|NOT COMPLETED|Treatment 1||1
93014|NCT02059148|227996|P5|NOT COMPLETED|Treatment 1||0
93015|NCT02059148|227997|P4|NOT COMPLETED|Treatment 1||0
93016|NCT02059148|227998|P3|NOT COMPLETED|Treatment 1||0
93017|NCT02059148|227999|P2|NOT COMPLETED|Treatment 1||0
93018|NCT02059148|228000|P1|NOT COMPLETED|Treatment 1||0
93019|NCT02059148|227995|P6|COMPLETED|Treatment 1||3
93020|NCT02059148|227996|P5|COMPLETED|Treatment 1||4
93021|NCT02059148|227997|P4|COMPLETED|Treatment 1||4
93022|NCT02059148|227998|P3|COMPLETED|Treatment 1||4
93023|NCT02059148|227999|P2|COMPLETED|Treatment 1||4
93024|NCT02059148|228000|P1|COMPLETED|Treatment 1||4
93025|NCT02059148|227995|P6|STARTED|Treatment 1||4
93026|NCT02059148|227996|P5|STARTED|Treatment 1||4
93027|NCT02059148|227997|P4|STARTED|Treatment 1||4
93028|NCT02059148|227998|P3|STARTED|Treatment 1||4
93029|NCT02059148|227999|P2|STARTED|Treatment 1||4
93030|NCT02059148|228000|P1|STARTED|Treatment 1||4
93031|NCT02059135|228019|P2|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
93032|NCT02059135|228020|P1|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
93033|NCT02059135|228019|P2|COMPLETED|Neonatal Follow-up (Safety Population)||50
93034|NCT02059135|228020|P1|COMPLETED|Neonatal Follow-up (Safety Population)||56
93035|NCT02059135|228019|P2|STARTED|Neonatal Follow-up (Safety Population)||54
93036|NCT02059135|228020|P1|STARTED|Neonatal Follow-up (Safety Population)||60
93037|NCT02059135|228019|P2|NOT COMPLETED|Maternal Follow-up (ITT Population)||7
93038|NCT02059135|228020|P1|NOT COMPLETED|Maternal Follow-up (ITT Population)||3
93039|NCT02059135|228019|P2|COMPLETED|Maternal Follow-up (ITT Population)||51
93040|NCT02059135|228020|P1|COMPLETED|Maternal Follow-up (ITT Population)||59
93041|NCT02059135|228019|P2|STARTED|Maternal Follow-up (ITT Population)||58
93042|NCT02059135|228020|P1|STARTED|Maternal Follow-up (ITT Population)||62
93043|NCT02059070|228034|P2|NOT COMPLETED|Overall Study||4
93044|NCT02059070|228035|P1|NOT COMPLETED|Overall Study||5
93045|NCT02059070|228034|P2|COMPLETED|Overall Study||16
93046|NCT02059070|228035|P1|COMPLETED|Overall Study||14
93047|NCT02059070|228034|P2|STARTED|Overall Study||20
93048|NCT02059070|228035|P1|STARTED|Overall Study||19
93049|NCT02059057|228047|P1|NOT COMPLETED|Overall Study||15
93050|NCT02059057|228047|P1|COMPLETED|Overall Study||87
93051|NCT02059057|228047|P1|STARTED|Overall Study||102
93052|NCT02059005|228056|P2|NOT COMPLETED|Overall Study||24
93053|NCT02059005|228057|P1|NOT COMPLETED|Overall Study||20
93054|NCT02059005|228056|P2|COMPLETED|Overall Study||24
93055|NCT02059005|228057|P1|COMPLETED|Overall Study||29
93056|NCT02059005|228056|P2|6 Month Assessment|Overall Study||24
93057|NCT02059005|228057|P1|6 Month Assessment|Overall Study||29
93058|NCT02059005|228056|P2|3 Month Assessment|Overall Study||33
93059|NCT02059005|228057|P1|3 Month Assessment|Overall Study||37
93060|NCT02059005|228056|P2|STARTED|Overall Study||48
93061|NCT02059005|228057|P1|STARTED|Overall Study||49
93062|NCT02058992|228067|P1|NOT COMPLETED|Overall Study||116
93063|NCT02058992|228067|P1|COMPLETED|Overall Study||3223
93064|NCT02058992|228067|P1|STARTED|Overall Study||3339
93065|NCT02058966|228076|P1|NOT COMPLETED|Fourth Intervention||0
93066|NCT02058966|228076|P1|COMPLETED|Fourth Intervention||12
93067|NCT02058966|228076|P1|Received Entacapone-Meth|Fourth Intervention||2
93068|NCT02058966|228076|P1|Received Entacapone-Placebo|Fourth Intervention||3
93069|NCT02058966|228076|P1|Received Placebo-Meth|Fourth Intervention||3
93070|NCT02058966|228076|P1|Received Placebo-Placebo|Fourth Intervention||4
93071|NCT02058966|228076|P1|STARTED|Fourth Intervention||12
93072|NCT02058966|228076|P1|NOT COMPLETED|Third Intervention||0
93073|NCT02058966|228076|P1|COMPLETED|Third Intervention||12
93074|NCT02058966|228076|P1|Received Entacapone-Meth|Third Intervention||3
93075|NCT02058966|228076|P1|Received Entacapone-Placebo|Third Intervention||1
93076|NCT02058966|228076|P1|Received Placebo-Meth|Third Intervention||4
93077|NCT02058966|228076|P1|Received Placebo-Placebo|Third Intervention||4
93078|NCT02058966|228076|P1|STARTED|Third Intervention||12
93079|NCT02058966|228076|P1|NOT COMPLETED|Second Intervention||0
93080|NCT02058966|228076|P1|COMPLETED|Second Intervention||13
93081|NCT02058966|228076|P1|Received Entacapone-Meth|Second Intervention||3
93082|NCT02058966|228076|P1|Received Entacapone-Placebo|Second Intervention||6
93083|NCT02058966|228076|P1|Received Placebo-Meth|Second Intervention||2
93084|NCT02058966|228076|P1|Received Placebo-Placebo|Second Intervention||2
93085|NCT02058966|228076|P1|STARTED|Second Intervention||13
93086|NCT02058966|228076|P1|NOT COMPLETED|First Intervention||1
93087|NCT02058966|228076|P1|COMPLETED|First Intervention||14
93088|NCT02058966|228076|P1|Received Entacapone-Meth|First Intervention||5
93089|NCT02058966|228076|P1|Received Entacapone-Placebo|First Intervention||2
93090|NCT02058966|228076|P1|Received Placebo-Meth|First Intervention||4
93091|NCT02058966|228076|P1|Received Placebo-Placebo|First Intervention||3
93092|NCT02058966|228076|P1|STARTED|First Intervention||15
93093|NCT02058966|228076|P1|NOT COMPLETED|Open-Label Methamphetamine||1
93094|NCT02058966|228076|P1|COMPLETED|Open-Label Methamphetamine||18
93095|NCT02058966|228076|P1|Received Methamphetamine|Open-Label Methamphetamine||18
93096|NCT02058966|228076|P1|STARTED|Open-Label Methamphetamine||19
93097|NCT02058940|228103|P1|NOT COMPLETED|Overall Study||1
93098|NCT02058940|228103|P1|COMPLETED|Overall Study||7
93099|NCT02058940|228103|P1|STARTED|Overall Study||8
93100|NCT02058849|228127|P2|NOT COMPLETED|Overall Study||1
93101|NCT02058849|228128|P1|NOT COMPLETED|Overall Study||7
93102|NCT02058849|228127|P2|COMPLETED|Overall Study||1
93103|NCT02058849|228128|P1|COMPLETED|Overall Study||4
93104|NCT02058849|228127|P2|STARTED|Overall Study||2
93105|NCT02058849|228128|P1|STARTED|Overall Study||11
93106|NCT02058836|228156|P2|NOT COMPLETED|Overall Study||1
93107|NCT02058836|228157|P1|NOT COMPLETED|Overall Study||1
93108|NCT02058836|228156|P2|COMPLETED|Overall Study||3
93109|NCT02058836|228157|P1|COMPLETED|Overall Study||3
93110|NCT02058836|228156|P2|STARTED|Overall Study||4
93111|NCT02058836|228157|P1|STARTED|Overall Study||4
93112|NCT02058628|228187|P2|NOT COMPLETED|Overall Study||8
93113|NCT02058628|228188|P1|NOT COMPLETED|Overall Study||7
93114|NCT02058628|228187|P2|COMPLETED|Overall Study||102
93115|NCT02058628|228188|P1|COMPLETED|Overall Study||104
93116|NCT02058628|228187|P2|STARTED|Overall Study||110
93117|NCT02058628|228188|P1|STARTED|Overall Study||111
93118|NCT02058589|228220|P2|NOT COMPLETED|Overall Study||2
93119|NCT02058589|228221|P1|NOT COMPLETED|Overall Study||2
93120|NCT02058589|228220|P2|COMPLETED|Overall Study||130
93121|NCT02058589|228221|P1|COMPLETED|Overall Study||130
93122|NCT02058589|228220|P2|STARTED|Overall Study||132
93123|NCT02058589|228221|P1|STARTED|Overall Study||132
93124|NCT02058563|228263|P2|NOT COMPLETED|Overall Study||24
93125|NCT02058563|228264|P1|NOT COMPLETED|Overall Study||28
93126|NCT02058563|228263|P2|COMPLETED|Overall Study||433
93127|NCT02058563|228264|P1|COMPLETED|Overall Study||426
93128|NCT02058563|228263|P2|STARTED|Overall Study||457
93129|NCT02058563|228264|P1|STARTED|Overall Study||454
93130|NCT02058537|228300|P1|NOT COMPLETED|Overall Study||1
93131|NCT02058537|228300|P1|COMPLETED|Overall Study||2
93132|NCT02058537|228300|P1|STARTED|Overall Study||3
93133|NCT02058511|228306|P1|NOT COMPLETED|Overall Study||0
93134|NCT02058511|228306|P1|COMPLETED|Overall Study||24
93135|NCT02058511|228306|P1|STARTED|Overall Study||24
93136|NCT02058498|228311|P1|NOT COMPLETED|Overall Study||4
93137|NCT02058498|228311|P1|COMPLETED|Overall Study||8
93138|NCT02058498|228311|P1|6 Weeks|Overall Study||8
93139|NCT02058498|228311|P1|STARTED|Overall Study||12
93140|NCT02058368|228319|P2|NOT COMPLETED|Overall Study||54
93141|NCT02058368|228320|P1|NOT COMPLETED|Overall Study||41
93142|NCT02058368|228319|P2|COMPLETED|Overall Study||251
93143|NCT02058368|228320|P1|COMPLETED|Overall Study||261
93144|NCT02058368|228319|P2|STARTED|Overall Study||305
93145|NCT02058368|228320|P1|STARTED|Overall Study||302
93146|NCT02058290|228372|P2|NOT COMPLETED|Overall Study||9
93147|NCT02058290|228373|P1|NOT COMPLETED|Overall Study||11
93148|NCT02058290|228372|P2|COMPLETED|Overall Study||36
93149|NCT02058290|228373|P1|COMPLETED|Overall Study||66
93150|NCT02058290|228372|P2|STARTED|Overall Study||45
93151|NCT02058290|228373|P1|STARTED|Overall Study||77
93152|NCT02058251|228389|P2|NOT COMPLETED|Overall Study||0
93153|NCT02058251|228390|P1|NOT COMPLETED|Overall Study||0
93154|NCT02058251|228389|P2|COMPLETED|Overall Study||38
93155|NCT02058251|228390|P1|COMPLETED|Overall Study||35
93156|NCT02058251|228389|P2|STARTED|Overall Study||38
93157|NCT02058251|228390|P1|STARTED|Overall Study||35
93158|NCT02058160|228400|P2|NOT COMPLETED|Overall Study||14
93159|NCT02058160|228401|P1|NOT COMPLETED|Overall Study||31
93160|NCT02058160|228400|P2|COMPLETED|Overall Study||355
93161|NCT02058160|228401|P1|COMPLETED|Overall Study||336
93162|NCT02058160|228400|P2|Treated|Overall Study||365
93163|NCT02058160|228401|P1|Treated|Overall Study||365
93164|NCT02058160|228400|P2|STARTED|Overall Study||369
93165|NCT02058160|228401|P1|STARTED|Overall Study||367
93166|NCT02058147|228438|P3|NOT COMPLETED|Overall Study||29
93167|NCT02058147|228439|P2|NOT COMPLETED|Overall Study||27
93168|NCT02058147|228440|P1|NOT COMPLETED|Overall Study||29
93169|NCT02058147|228438|P3|COMPLETED|Overall Study||205
93170|NCT02058147|228439|P2|COMPLETED|Overall Study||440
93171|NCT02058147|228440|P1|COMPLETED|Overall Study||440
93172|NCT02058147|228438|P3|Treated|Overall Study||233
93173|NCT02058147|228439|P2|Treated|Overall Study||467
93174|NCT02058147|228440|P1|Treated|Overall Study||469
93175|NCT02058147|228438|P3|STARTED|Overall Study||234
93176|NCT02058147|228439|P2|STARTED|Overall Study||467
93177|NCT02058147|228440|P1|STARTED|Overall Study||469
93178|NCT02058108|228491|P2|NOT COMPLETED|Overall Study||10
93179|NCT02058108|228492|P1|NOT COMPLETED|Overall Study||41
93180|NCT02058108|228491|P2|COMPLETED|Overall Study||0
93181|NCT02058108|228492|P1|COMPLETED|Overall Study||2
93182|NCT02058108|228491|P2|Switched to Telbivudine After Week 24|Overall Study||5
93183|NCT02058108|228492|P1|Switched to Telbivudine After Week 24|Overall Study||0
93184|NCT02058108|228491|P2|STARTED|Overall Study||10
93185|NCT02058108|228492|P1|STARTED|Overall Study||43
93186|NCT02058069|228516|P1|NOT COMPLETED|Overall Study||11
93187|NCT02058069|228516|P1|COMPLETED|Overall Study||89
93188|NCT02058069|228516|P1|STARTED|Overall Study||100
93189|NCT02057952|228528|P3|NOT COMPLETED|Overall Study||22
93190|NCT02057952|228529|P2|NOT COMPLETED|Overall Study||10
93191|NCT02057952|228530|P1|NOT COMPLETED|Overall Study||8
93192|NCT02057952|228528|P3|COMPLETED|Overall Study||28
93193|NCT02057952|228529|P2|COMPLETED|Overall Study||39
93194|NCT02057952|228530|P1|COMPLETED|Overall Study||43
93195|NCT02057952|228528|P3|STARTED|Overall Study||50
93196|NCT02057952|228529|P2|STARTED|Overall Study||49
93197|NCT02057952|228530|P1|STARTED|Overall Study||51
93198|NCT02057939|228565|P1|NOT COMPLETED|Overall Study||1
93199|NCT02057939|228565|P1|COMPLETED|Overall Study||37
93200|NCT02057939|228565|P1|STARTED|Overall Study||38
93201|NCT02057874|228575|P1|NOT COMPLETED|Overall Study||1
93202|NCT02057874|228575|P1|COMPLETED|Overall Study||1
93203|NCT02057874|228575|P1|STARTED|Overall Study||2
93204|NCT02057835|228593|P10|NOT COMPLETED|Overall Study||0
93205|NCT02057835|228594|P9|NOT COMPLETED|Overall Study||0
93206|NCT02057835|228595|P8|NOT COMPLETED|Overall Study||0
93207|NCT02057835|228596|P7|NOT COMPLETED|Overall Study||0
93208|NCT02057835|228597|P6|NOT COMPLETED|Overall Study||0
93209|NCT02057835|228598|P5|NOT COMPLETED|Overall Study||0
93210|NCT02057835|228599|P4|NOT COMPLETED|Overall Study||0
93211|NCT02057835|228600|P3|NOT COMPLETED|Overall Study||0
93212|NCT02057835|228601|P2|NOT COMPLETED|Overall Study||2
93213|NCT02057835|228602|P1|NOT COMPLETED|Overall Study||0
93214|NCT02057835|228593|P10|COMPLETED|Overall Study||6
93215|NCT02057835|228594|P9|COMPLETED|Overall Study||6
93216|NCT02057835|228595|P8|COMPLETED|Overall Study||6
93217|NCT02057835|228596|P7|COMPLETED|Overall Study||6
93218|NCT02057835|228597|P6|COMPLETED|Overall Study||8
93219|NCT02057835|228598|P5|COMPLETED|Overall Study||6
93220|NCT02057835|228599|P4|COMPLETED|Overall Study||6
93221|NCT02057835|228600|P3|COMPLETED|Overall Study||6
93222|NCT02057835|228601|P2|COMPLETED|Overall Study||4
93223|NCT02057835|228602|P1|COMPLETED|Overall Study||8
93224|NCT02057835|228593|P10|STARTED|Overall Study||6
93225|NCT02057835|228594|P9|STARTED|Overall Study||6
93226|NCT02057835|228595|P8|STARTED|Overall Study||6
93227|NCT02057835|228596|P7|STARTED|Overall Study||6
93228|NCT02057835|228597|P6|STARTED|Overall Study||8
93229|NCT02057835|228598|P5|STARTED|Overall Study||6
93230|NCT02057835|228599|P4|STARTED|Overall Study||6
93231|NCT02057835|228600|P3|STARTED|Overall Study||6
93232|NCT02057835|228601|P2|STARTED|Overall Study||6
93233|NCT02057835|228602|P1|STARTED|Overall Study||8
93234|NCT02057757|228681|P2|NOT COMPLETED|Overall Study||8
93235|NCT02057757|228682|P1|NOT COMPLETED|Overall Study||14
93236|NCT02057757|228681|P2|COMPLETED|Overall Study||121
93237|NCT02057757|228682|P1|COMPLETED|Overall Study||117
93238|NCT02057757|228681|P2|Intent to Treat|Overall Study||127
93239|NCT02057757|228682|P1|Intent to Treat|Overall Study||130
93240|NCT02057757|228681|P2|STARTED|Overall Study||129
93241|NCT02057757|228682|P1|STARTED|Overall Study||131
93242|NCT02057692|228736|P4|NOT COMPLETED|Overall Study||1
93243|NCT02057692|228737|P3|NOT COMPLETED|Overall Study||0
93244|NCT02057692|228738|P2|NOT COMPLETED|Overall Study||0
93245|NCT02057692|228739|P1|NOT COMPLETED|Overall Study||1
93246|NCT02057692|228736|P4|COMPLETED|Overall Study||11
93247|NCT02057692|228737|P3|COMPLETED|Overall Study||6
93248|NCT02057692|228738|P2|COMPLETED|Overall Study||11
93249|NCT02057692|228739|P1|COMPLETED|Overall Study||7
93250|NCT02057692|228736|P4|STARTED|Overall Study||12
93251|NCT02057692|228737|P3|STARTED|Overall Study||6
93252|NCT02057692|228738|P2|STARTED|Overall Study||11
93253|NCT02057692|228739|P1|STARTED|Overall Study||8
93254|NCT02057575|228771|P4|NOT COMPLETED|Overall Study||1
93255|NCT02057575|228772|P3|NOT COMPLETED|Overall Study||0
93256|NCT02057575|228773|P2|NOT COMPLETED|Overall Study||4
93257|NCT02057575|228774|P1|NOT COMPLETED|Overall Study||1
93258|NCT02057575|228771|P4|COMPLETED|Overall Study||72
93259|NCT02057575|228772|P3|COMPLETED|Overall Study||78
93260|NCT02057575|228773|P2|COMPLETED|Overall Study||69
93261|NCT02057575|228774|P1|COMPLETED|Overall Study||73
93262|NCT02057575|228771|P4|STARTED|Overall Study||73
93263|NCT02057575|228772|P3|STARTED|Overall Study||78
93264|NCT02057575|228773|P2|STARTED|Overall Study||73
93265|NCT02057575|228774|P1|STARTED|Overall Study||74
93266|NCT02057549|228786|P2|NOT COMPLETED|Overall Study||0
93267|NCT02057549|228787|P1|NOT COMPLETED|Overall Study||3
93268|NCT02057549|228786|P2|COMPLETED|Overall Study||18
93269|NCT02057549|228787|P1|COMPLETED|Overall Study||15
93270|NCT02057549|228786|P2|STARTED|Overall Study||18
93271|NCT02057549|228787|P1|STARTED|Overall Study||18
93272|NCT02057406|228810|P3|NOT COMPLETED|Overall Study||4
93273|NCT02057406|228811|P2|NOT COMPLETED|Overall Study||3
93274|NCT02057406|228812|P1|NOT COMPLETED|Overall Study||1
93275|NCT02057406|228810|P3|COMPLETED|Overall Study||32
93276|NCT02057406|228811|P2|COMPLETED|Overall Study||33
93277|NCT02057406|228812|P1|COMPLETED|Overall Study||35
93278|NCT02057406|228810|P3|STARTED|Overall Study||36
93279|NCT02057406|228811|P2|STARTED|Overall Study||36
93280|NCT02057406|228812|P1|STARTED|Overall Study||36
93281|NCT02057393|228823|P1|NOT COMPLETED|Overall Study||2
93282|NCT02057393|228823|P1|COMPLETED|Overall Study||87
93283|NCT02057393|228823|P1|STARTED|Overall Study||89
93284|NCT02057276|228829|P2|NOT COMPLETED|Overall Study||0
93285|NCT02057276|228830|P1|NOT COMPLETED|Overall Study||0
93286|NCT02057276|228829|P2|COMPLETED|Overall Study||0
93287|NCT02057276|228830|P1|COMPLETED|Overall Study||0
93288|NCT02057276|228829|P2|STARTED|Overall Study||0
93289|NCT02057276|228830|P1|STARTED|Overall Study||0
93290|NCT02057250|228844|P5|NOT COMPLETED|Extension Phase||36
93291|NCT02057250|228845|P4|NOT COMPLETED|Extension Phase||0
93292|NCT02057250|228846|P3|NOT COMPLETED|Extension Phase||0
93293|NCT02057250|228847|P2|NOT COMPLETED|Extension Phase||0
93294|NCT02057250|228848|P1|NOT COMPLETED|Extension Phase||0
93295|NCT02057250|228844|P5|COMPLETED|Extension Phase||156
93296|NCT02057250|228845|P4|COMPLETED|Extension Phase||0
93297|NCT02057250|228846|P3|COMPLETED|Extension Phase||0
93298|NCT02057250|228847|P2|COMPLETED|Extension Phase||0
93299|NCT02057250|228848|P1|COMPLETED|Extension Phase||0
93300|NCT02057250|228844|P5|Treated|Extension Phase||188
93301|NCT02057250|228845|P4|Treated|Extension Phase||0
93302|NCT02057250|228846|P3|Treated|Extension Phase||0
93303|NCT02057250|228847|P2|Treated|Extension Phase||0
93304|NCT02057250|228848|P1|Treated|Extension Phase||0
93305|NCT02057250|228844|P5|STARTED|Extension Phase|9 participants who completed AID Assessment phase did not enter extension phase.|192
93306|NCT02057250|228845|P4|STARTED|Extension Phase||0
93307|NCT02057250|228846|P3|STARTED|Extension Phase||0
93308|NCT02057250|228847|P2|STARTED|Extension Phase||0
93309|NCT02057250|228848|P1|STARTED|Extension Phase||0
93310|NCT02057250|228844|P5|NOT COMPLETED|AID Assessment Phase||0
93311|NCT02057250|228845|P4|NOT COMPLETED|AID Assessment Phase||2
93312|NCT02057250|228846|P3|NOT COMPLETED|AID Assessment Phase||7
93313|NCT02057250|228847|P2|NOT COMPLETED|AID Assessment Phase||3
93314|NCT02057250|228848|P1|NOT COMPLETED|AID Assessment Phase||4
93315|NCT02057250|228844|P5|COMPLETED|AID Assessment Phase||0
93316|NCT02057250|228845|P4|COMPLETED|AID Assessment Phase||54
93317|NCT02057250|228846|P3|COMPLETED|AID Assessment Phase||45
93318|NCT02057250|228847|P2|COMPLETED|AID Assessment Phase||50
93319|NCT02057250|228848|P1|COMPLETED|AID Assessment Phase||52
93320|NCT02057250|228844|P5|STARTED|AID Assessment Phase||0
93321|NCT02057250|228845|P4|STARTED|AID Assessment Phase||56
93322|NCT02057250|228846|P3|STARTED|AID Assessment Phase||52
93323|NCT02057250|228847|P2|STARTED|AID Assessment Phase||53
93324|NCT02057250|228848|P1|STARTED|AID Assessment Phase||56
93325|NCT02057237|228861|P1|NOT COMPLETED|Overall Study||0
93326|NCT02057237|228861|P1|COMPLETED|Overall Study||1
93327|NCT02057237|228861|P1|STARTED|Overall Study||1
93328|NCT02057198|228869|P3|NOT COMPLETED|Overall Study||1
93329|NCT02057198|228870|P2|NOT COMPLETED|Overall Study||1
93330|NCT02057198|228871|P1|NOT COMPLETED|Overall Study||0
93331|NCT02057198|228869|P3|COMPLETED|Overall Study||10
93332|NCT02057198|228870|P2|COMPLETED|Overall Study||10
93333|NCT02057198|228871|P1|COMPLETED|Overall Study||11
93334|NCT02057198|228869|P3|STARTED|Overall Study||11
93335|NCT02057198|228870|P2|STARTED|Overall Study||11
93336|NCT02057198|228871|P1|STARTED|Overall Study||11
93337|NCT02057068|228896|P2|NOT COMPLETED|Overall Study||8
93338|NCT02057068|228897|P1|NOT COMPLETED|Overall Study||8
93339|NCT02057068|228896|P2|COMPLETED|Overall Study||28
93340|NCT02057068|228897|P1|COMPLETED|Overall Study||52
93341|NCT02057068|228896|P2|STARTED|Overall Study||36
93342|NCT02057068|228897|P1|STARTED|Overall Study||60
93343|NCT02057042|228909|P2|NOT COMPLETED|Overall Study||66
93344|NCT02057042|228910|P1|NOT COMPLETED|Overall Study||45
93345|NCT02057042|228909|P2|COMPLETED|Overall Study||101
93346|NCT02057042|228910|P1|COMPLETED|Overall Study||118
93347|NCT02057042|228909|P2|STARTED|Overall Study||167
93348|NCT02057042|228910|P1|STARTED|Overall Study||163
93349|NCT02056834|228926|P1|NOT COMPLETED|Overall Study||7
93350|NCT02056834|228926|P1|COMPLETED|Overall Study||29
93351|NCT02056834|228926|P1|6 Months|Overall Study||31
93352|NCT02056834|228926|P1|6 Weeks|Overall Study||34
93353|NCT02056834|228926|P1|STARTED|Overall Study||36
93354|NCT02056652|228947|P2|NOT COMPLETED|Overall Study||3
93355|NCT02056652|228948|P1|NOT COMPLETED|Overall Study||1
93356|NCT02056652|228947|P2|COMPLETED|Overall Study||58
93357|NCT02056652|228948|P1|COMPLETED|Overall Study||60
93358|NCT02056652|228947|P2|STARTED|Overall Study||61
93359|NCT02056652|228948|P1|STARTED|Overall Study||61
93360|NCT02056639|228966|P2|NOT COMPLETED|Overall Study||0
93361|NCT02056639|228967|P1|NOT COMPLETED|Overall Study||0
93362|NCT02056639|228966|P2|COMPLETED|Overall Study||23
93363|NCT02056639|228967|P1|COMPLETED|Overall Study||23
93364|NCT02056639|228966|P2|STARTED|Overall Study||23
93365|NCT02056639|228967|P1|STARTED|Overall Study||23
93366|NCT02056626|228985|P4|NOT COMPLETED|Overall Study||0
93367|NCT02056626|228986|P3|NOT COMPLETED|Overall Study||0
93368|NCT02056626|228987|P2|NOT COMPLETED|Overall Study||1
93369|NCT02056626|228988|P1|NOT COMPLETED|Overall Study||3
93370|NCT02056626|228985|P4|COMPLETED|Overall Study||14
93371|NCT02056626|228986|P3|COMPLETED|Overall Study||4
93372|NCT02056626|228987|P2|COMPLETED|Overall Study||12
93373|NCT02056626|228988|P1|COMPLETED|Overall Study||10
93374|NCT02056626|228985|P4|STARTED|Overall Study||14
93375|NCT02056626|228986|P3|STARTED|Overall Study||4
93376|NCT02056626|228987|P2|STARTED|Overall Study||13
93377|NCT02056626|228988|P1|STARTED|Overall Study||13
93378|NCT02056431|229008|P2|NOT COMPLETED|Overall Study||47
93379|NCT02056431|229009|P1|NOT COMPLETED|Overall Study||44
93380|NCT02056431|229008|P2|COMPLETED|Overall Study||619
93381|NCT02056431|229009|P1|COMPLETED|Overall Study||560
93382|NCT02056431|229008|P2|STARTED|Overall Study||666
93383|NCT02056431|229009|P1|STARTED|Overall Study||604
93384|NCT02056392|229023|P6|NOT COMPLETED|Overall Study||0
93385|NCT02056392|229024|P5|NOT COMPLETED|Overall Study||1
93386|NCT02056392|229025|P4|NOT COMPLETED|Overall Study||0
93387|NCT02056392|229026|P3|NOT COMPLETED|Overall Study||3
93388|NCT02056392|229027|P2|NOT COMPLETED|Overall Study||1
93389|NCT02056392|229028|P1|NOT COMPLETED|Overall Study||2
93390|NCT02056392|229023|P6|COMPLETED|Overall Study||9
93391|NCT02056392|229024|P5|COMPLETED|Overall Study||7
93392|NCT02056392|229025|P4|COMPLETED|Overall Study||9
93393|NCT02056392|229026|P3|COMPLETED|Overall Study||6
93394|NCT02056392|229027|P2|COMPLETED|Overall Study||8
93395|NCT02056392|229028|P1|COMPLETED|Overall Study||8
93396|NCT02056392|229023|P6|STARTED|Overall Study||9
93397|NCT02056392|229024|P5|STARTED|Overall Study||8
93398|NCT02056392|229025|P4|STARTED|Overall Study||9
93399|NCT02056392|229026|P3|STARTED|Overall Study||9
93400|NCT02056392|229027|P2|STARTED|Overall Study||9
93401|NCT02056392|229028|P1|STARTED|Overall Study||10
93402|NCT02056340|229065|P2|NOT COMPLETED|Overall Study||11
93403|NCT02056340|229066|P1|NOT COMPLETED|Overall Study||7
93404|NCT02056340|229065|P2|COMPLETED|Overall Study||46
93405|NCT02056340|229066|P1|COMPLETED|Overall Study||52
93406|NCT02056340|229065|P2|STARTED|Overall Study||57
93407|NCT02056340|229066|P1|STARTED|Overall Study||59
93408|NCT02056171|229076|P2|NOT COMPLETED|Overall Study||0
93409|NCT02056171|229077|P1|NOT COMPLETED|Overall Study||0
93410|NCT02056171|229076|P2|COMPLETED|Overall Study||3
93411|NCT02056171|229077|P1|COMPLETED|Overall Study||3
93412|NCT02056171|229076|P2|STARTED|Overall Study||3
93413|NCT02056171|229077|P1|STARTED|Overall Study||3
93414|NCT02055976|229096|P9|NOT COMPLETED|Overall Study||0
93415|NCT02055976|229097|P8|NOT COMPLETED|Overall Study||0
93416|NCT02055976|229098|P7|NOT COMPLETED|Overall Study||2
93417|NCT02055976|229099|P6|NOT COMPLETED|Overall Study||1
93418|NCT02055976|229100|P5|NOT COMPLETED|Overall Study||0
93419|NCT02055976|229101|P4|NOT COMPLETED|Overall Study||1
93420|NCT02055976|229102|P3|NOT COMPLETED|Overall Study||1
93421|NCT02055976|229103|P2|NOT COMPLETED|Overall Study||0
93422|NCT02055976|229104|P1|NOT COMPLETED|Overall Study||0
93423|NCT02055976|229096|P9|COMPLETED|Overall Study||23
93424|NCT02055976|229097|P8|COMPLETED|Overall Study||24
93425|NCT02055976|229098|P7|COMPLETED|Overall Study||23
93426|NCT02055976|229099|P6|COMPLETED|Overall Study||24
93427|NCT02055976|229100|P5|COMPLETED|Overall Study||22
93428|NCT02055976|229101|P4|COMPLETED|Overall Study||25
93429|NCT02055976|229102|P3|COMPLETED|Overall Study||23
93430|NCT02055976|229103|P2|COMPLETED|Overall Study||24
93431|NCT02055976|229104|P1|COMPLETED|Overall Study||25
93432|NCT02055976|229096|P9|STARTED|Overall Study||23
93433|NCT02055976|229097|P8|STARTED|Overall Study||24
93434|NCT02055976|229098|P7|STARTED|Overall Study||25
93435|NCT02055976|229099|P6|STARTED|Overall Study||25
93436|NCT02055976|229100|P5|STARTED|Overall Study||22
93437|NCT02055976|229101|P4|STARTED|Overall Study||26
93438|NCT02055976|229102|P3|STARTED|Overall Study||24
93439|NCT02055976|229103|P2|STARTED|Overall Study||24
93440|NCT02055976|229104|P1|STARTED|Overall Study||25
93441|NCT02055820|229533|P10|NOT COMPLETED|Phase II: Expansion||0
93442|NCT02055820|229534|P9|NOT COMPLETED|Phase II: Expansion||0
93443|NCT02055820|229535|P8|NOT COMPLETED|Phase II: Expansion||0
93444|NCT02055820|229536|P7|NOT COMPLETED|Phase II: Expansion||0
93445|NCT02055820|229537|P6|NOT COMPLETED|Phase II: Expansion||0
93446|NCT02055820|229538|P5|NOT COMPLETED|Phase II: Expansion||208
93447|NCT02055820|229539|P4|NOT COMPLETED|Phase II: Expansion||0
93448|NCT02055820|229540|P3|NOT COMPLETED|Phase II: Expansion||0
93449|NCT02055820|229541|P2|NOT COMPLETED|Phase II: Expansion||0
93450|NCT02055820|229542|P1|NOT COMPLETED|Phase II: Expansion||0
93451|NCT02055820|229533|P10|COMPLETED|Phase II: Expansion||0
93452|NCT02055820|229534|P9|COMPLETED|Phase II: Expansion||0
93453|NCT02055820|229535|P8|COMPLETED|Phase II: Expansion||0
93454|NCT02055820|229536|P7|COMPLETED|Phase II: Expansion||0
93455|NCT02055820|229537|P6|COMPLETED|Phase II: Expansion||0
93456|NCT02055820|229538|P5|COMPLETED|Phase II: Expansion|Study is still on-going|0
93457|NCT02055820|229539|P4|COMPLETED|Phase II: Expansion||0
93458|NCT02055820|229540|P3|COMPLETED|Phase II: Expansion||0
93459|NCT02055820|229541|P2|COMPLETED|Phase II: Expansion||0
93460|NCT02055820|229542|P1|COMPLETED|Phase II: Expansion||0
93461|NCT02055820|229533|P10|STARTED|Phase II: Expansion||0
93462|NCT02055820|229534|P9|STARTED|Phase II: Expansion||0
93463|NCT02055820|229535|P8|STARTED|Phase II: Expansion||0
93464|NCT02055820|229536|P7|STARTED|Phase II: Expansion||0
93465|NCT02055820|229537|P6|STARTED|Phase II: Expansion||0
93466|NCT02055820|229538|P5|STARTED|Phase II: Expansion||208
93467|NCT02055820|229539|P4|STARTED|Phase II: Expansion||0
93468|NCT02055820|229540|P3|STARTED|Phase II: Expansion||0
93469|NCT02055820|229541|P2|STARTED|Phase II: Expansion||0
93470|NCT02055820|229542|P1|STARTED|Phase II: Expansion||0
93471|NCT02055820|229533|P10|NOT COMPLETED|Phase I: Dose-Finding||6
93472|NCT02055820|229534|P9|NOT COMPLETED|Phase I: Dose-Finding||6
93473|NCT02055820|229535|P8|NOT COMPLETED|Phase I: Dose-Finding||6
93474|NCT02055820|229536|P7|NOT COMPLETED|Phase I: Dose-Finding||7
93475|NCT02055820|229537|P6|NOT COMPLETED|Phase I: Dose-Finding||7
93476|NCT02055820|229538|P5|NOT COMPLETED|Phase I: Dose-Finding||0
93477|NCT02055820|229539|P4|NOT COMPLETED|Phase I: Dose-Finding||6
93478|NCT02055820|229540|P3|NOT COMPLETED|Phase I: Dose-Finding||8
93479|NCT02055820|229541|P2|NOT COMPLETED|Phase I: Dose-Finding||3
93480|NCT02055820|229542|P1|NOT COMPLETED|Phase I: Dose-Finding||7
93481|NCT02055820|229533|P10|COMPLETED|Phase I: Dose-Finding|Study is still ongoing|0
93482|NCT02055820|229534|P9|COMPLETED|Phase I: Dose-Finding|Study is still ongoing|0
93483|NCT02055820|229535|P8|COMPLETED|Phase I: Dose-Finding|Study is still ongoing|0
93484|NCT02055820|229536|P7|COMPLETED|Phase I: Dose-Finding|Study is still ongoing|0
93485|NCT02055820|229537|P6|COMPLETED|Phase I: Dose-Finding|Study is still ongoing|0
93486|NCT02055820|229538|P5|COMPLETED|Phase I: Dose-Finding||0
93487|NCT02055820|229539|P4|COMPLETED|Phase I: Dose-Finding|Study is still ongoing|0
93488|NCT02055820|229540|P3|COMPLETED|Phase I: Dose-Finding|Study is still ongoing|0
93489|NCT02055820|229541|P2|COMPLETED|Phase I: Dose-Finding|Study is still ongoing|0
93490|NCT02055820|229542|P1|COMPLETED|Phase I: Dose-Finding|Study is still ongoing|0
93491|NCT02055820|229533|P10|STARTED|Phase I: Dose-Finding||6
93492|NCT02055820|229534|P9|STARTED|Phase I: Dose-Finding||6
93493|NCT02055820|229535|P8|STARTED|Phase I: Dose-Finding||6
93494|NCT02055820|229536|P7|STARTED|Phase I: Dose-Finding||7
93495|NCT02055820|229537|P6|STARTED|Phase I: Dose-Finding||7
93496|NCT02055820|229538|P5|STARTED|Phase I: Dose-Finding||0
93497|NCT02055820|229539|P4|STARTED|Phase I: Dose-Finding||6
93498|NCT02055820|229540|P3|STARTED|Phase I: Dose-Finding||8
93499|NCT02055820|229541|P2|STARTED|Phase I: Dose-Finding||3
93500|NCT02055820|229542|P1|STARTED|Phase I: Dose-Finding||7
93501|NCT02055638|229646|P2|NOT COMPLETED|Overall Study||8
93502|NCT02055638|229647|P1|NOT COMPLETED|Overall Study||10
93503|NCT02055638|229646|P2|COMPLETED|Overall Study||40
93504|NCT02055638|229647|P1|COMPLETED|Overall Study||39
93505|NCT02055638|229646|P2|STARTED|Overall Study||48
93506|NCT02055638|229647|P1|STARTED|Overall Study||49
93507|NCT02055430|229655|P2|NOT COMPLETED|Overall Study||0
93508|NCT02055430|229656|P1|NOT COMPLETED|Overall Study||0
93509|NCT02055430|229655|P2|COMPLETED|Overall Study||45
93510|NCT02055430|229656|P1|COMPLETED|Overall Study||45
93511|NCT02055430|229655|P2|STARTED|Overall Study||45
93512|NCT02055430|229656|P1|STARTED|Overall Study||45
93513|NCT02055404|229662|P1|NOT COMPLETED|Overall Study||0
93514|NCT02055404|229662|P1|COMPLETED|Overall Study||3
93515|NCT02055404|229662|P1|STARTED|Overall Study||3
93516|NCT02055365|229675|P1|NOT COMPLETED|Overall Study||1
93517|NCT02055365|229675|P1|COMPLETED|Overall Study||9
93518|NCT02055365|229675|P1|STARTED|Overall Study||10
93519|NCT02055352|229688|P2|NOT COMPLETED|Overall Study||17
93520|NCT02055352|229689|P1|NOT COMPLETED|Overall Study||6
93521|NCT02055352|229688|P2|COMPLETED|Overall Study||96
93522|NCT02055352|229689|P1|COMPLETED|Overall Study||103
93523|NCT02055352|229688|P2|Per-Protocol Set (PPS)|Overall Study||111
93524|NCT02055352|229689|P1|Per-Protocol Set (PPS)|Overall Study||108
93525|NCT02055352|229688|P2|STARTED|Overall Study||113
93526|NCT02055352|229689|P1|STARTED|Overall Study||109
93527|NCT02055118|229706|P3|NOT COMPLETED|Overall Study||0
93528|NCT02055118|229707|P2|NOT COMPLETED|Overall Study||2
93529|NCT02055118|229708|P1|NOT COMPLETED|Overall Study||0
93530|NCT02055118|229706|P3|COMPLETED|Overall Study||9
93531|NCT02055118|229707|P2|COMPLETED|Overall Study||32
93532|NCT02055118|229708|P1|COMPLETED|Overall Study||15
93533|NCT02055118|229706|P3|STARTED|Overall Study||9
93534|NCT02055118|229707|P2|STARTED|Overall Study||34
93535|NCT02055118|229708|P1|STARTED|Overall Study||15
93536|NCT02054910|229767|P2|NOT COMPLETED|Overall Study||1
93537|NCT02054910|229768|P1|NOT COMPLETED|Overall Study||4
93538|NCT02054910|229767|P2|COMPLETED|Overall Study||0
93539|NCT02054910|229768|P1|COMPLETED|Overall Study||0
93540|NCT02054910|229767|P2|STARTED|Overall Study||1
93541|NCT02054910|229768|P1|STARTED|Overall Study||4
93542|NCT02054897|229787|P3|NOT COMPLETED|Overall Study||12
93543|NCT02054897|229788|P2|NOT COMPLETED|Overall Study||7
93544|NCT02054897|229789|P1|NOT COMPLETED|Overall Study||10
93545|NCT02054897|229787|P3|COMPLETED|Overall Study||117
93546|NCT02054897|229788|P2|COMPLETED|Overall Study||123
93547|NCT02054897|229789|P1|COMPLETED|Overall Study||119
93548|NCT02054897|229787|P3|Exposed|Overall Study||129
93549|NCT02054897|229788|P2|Exposed|Overall Study||130
93550|NCT02054897|229789|P1|Exposed|Overall Study||128
93551|NCT02054897|229787|P3|STARTED|Overall Study||129
93552|NCT02054897|229788|P2|STARTED|Overall Study||130
93553|NCT02054897|229789|P1|STARTED|Overall Study||129
93554|NCT02054754|229814|P6|NOT COMPLETED|Overall Study||0
93555|NCT02054754|229815|P5|NOT COMPLETED|Overall Study||0
93556|NCT02054754|229816|P4|NOT COMPLETED|Overall Study||0
93557|NCT02054754|229817|P3|NOT COMPLETED|Overall Study||0
93558|NCT02054754|229818|P2|NOT COMPLETED|Overall Study||0
93559|NCT02054754|229819|P1|NOT COMPLETED|Overall Study||0
93560|NCT02054754|229814|P6|COMPLETED|Overall Study||10
93561|NCT02054754|229815|P5|COMPLETED|Overall Study||6
93562|NCT02054754|229816|P4|COMPLETED|Overall Study||6
93563|NCT02054754|229817|P3|COMPLETED|Overall Study||6
93564|NCT02054754|229818|P2|COMPLETED|Overall Study||6
93565|NCT02054754|229819|P1|COMPLETED|Overall Study||6
93566|NCT02054754|229814|P6|STARTED|Overall Study||10
93567|NCT02054754|229815|P5|STARTED|Overall Study||6
93568|NCT02054754|229816|P4|STARTED|Overall Study||6
93569|NCT02054754|229817|P3|STARTED|Overall Study||6
93570|NCT02054754|229818|P2|STARTED|Overall Study||6
93571|NCT02054754|229819|P1|STARTED|Overall Study||6
93572|NCT02054715|229836|P2|NOT COMPLETED|Follow-up 2||19
93573|NCT02054715|229837|P1|NOT COMPLETED|Follow-up 2||19
93574|NCT02054715|229836|P2|COMPLETED|Follow-up 2||173
93575|NCT02054715|229837|P1|COMPLETED|Follow-up 2||192
93576|NCT02054715|229836|P2|STARTED|Follow-up 2||192
93577|NCT02054715|229837|P1|STARTED|Follow-up 2||211
93578|NCT02054715|229836|P2|NOT COMPLETED|Baseline/Follow-up 1||7
93579|NCT02054715|229837|P1|NOT COMPLETED|Baseline/Follow-up 1||8
93580|NCT02054715|229836|P2|COMPLETED|Baseline/Follow-up 1||192
93581|NCT02054715|229837|P1|COMPLETED|Baseline/Follow-up 1||211
93582|NCT02054715|229836|P2|STARTED|Baseline/Follow-up 1||199
93583|NCT02054715|229837|P1|STARTED|Baseline/Follow-up 1||219
93584|NCT02054702|229851|P2|NOT COMPLETED|Overall Study||12
93585|NCT02054702|229852|P1|NOT COMPLETED|Overall Study||24
93586|NCT02054702|229851|P2|COMPLETED|Overall Study||21
93587|NCT02054702|229852|P1|COMPLETED|Overall Study||40
93588|NCT02054702|229851|P2|STARTED|Overall Study||33
93589|NCT02054702|229852|P1|STARTED|Overall Study||64
93590|NCT02054572|229880|P1|NOT COMPLETED|Overall Study||0
93591|NCT02054572|229880|P1|COMPLETED|Overall Study||6
93592|NCT02054572|229880|P1|STARTED|Overall Study||6
93593|NCT02054481|229907|P4|NOT COMPLETED|Overall Study||1
93594|NCT02054481|229908|P3|NOT COMPLETED|Overall Study||2
93595|NCT02054481|229909|P2|NOT COMPLETED|Overall Study||2
93596|NCT02054481|229910|P1|NOT COMPLETED|Overall Study||4
93597|NCT02054481|229907|P4|COMPLETED|Overall Study||39
93598|NCT02054481|229908|P3|COMPLETED|Overall Study||40
93599|NCT02054481|229909|P2|COMPLETED|Overall Study||39
93600|NCT02054481|229910|P1|COMPLETED|Overall Study||39
93601|NCT02054481|229907|P4|STARTED|Overall Study||40
93602|NCT02054481|229908|P3|STARTED|Overall Study||42
93603|NCT02054481|229909|P2|STARTED|Overall Study||41
93604|NCT02054481|229910|P1|STARTED|Overall Study||43
93605|NCT02054338|229958|P2|NOT COMPLETED|Overall Study||501
93606|NCT02054338|229959|P1|NOT COMPLETED|Overall Study||503
93607|NCT02054338|229958|P2|COMPLETED|Overall Study||0
93608|NCT02054338|229959|P1|COMPLETED|Overall Study||0
93609|NCT02054338|229958|P2|STARTED|Overall Study||501
93610|NCT02054338|229959|P1|STARTED|Overall Study||503
93611|NCT02054325|229971|P2|NOT COMPLETED|Overall Study||5
93612|NCT02054325|229972|P1|NOT COMPLETED|Overall Study||8
93613|NCT02054325|229971|P2|COMPLETED|Overall Study||50
93614|NCT02054325|229972|P1|COMPLETED|Overall Study||43
93615|NCT02054325|229971|P2|STARTED|Overall Study||55
93616|NCT02054325|229972|P1|STARTED|Overall Study||51
93617|NCT02054156|229982|P2|NOT COMPLETED|Overall Study||81
93618|NCT02054156|229983|P1|NOT COMPLETED|Overall Study||75
93619|NCT02054156|229982|P2|COMPLETED|Overall Study||30
93620|NCT02054156|229983|P1|COMPLETED|Overall Study||35
93621|NCT02054156|229982|P2|STARTED|Overall Study||111
93622|NCT02054156|229983|P1|STARTED|Overall Study||110
93623|NCT02054130|229999|P4|NOT COMPLETED|Overall Study||22
93624|NCT02054130|230000|P3|NOT COMPLETED|Overall Study||15
93625|NCT02054130|230001|P2|NOT COMPLETED|Overall Study||11
93626|NCT02054130|230002|P1|NOT COMPLETED|Overall Study||8
93627|NCT02054130|229999|P4|COMPLETED|Overall Study||115
93628|NCT02054130|230000|P3|COMPLETED|Overall Study||122
93629|NCT02054130|230001|P2|COMPLETED|Overall Study||127
93630|NCT02054130|230002|P1|COMPLETED|Overall Study||130
93631|NCT02054130|229999|P4|STARTED|Overall Study||137
93632|NCT02054130|230000|P3|STARTED|Overall Study||137
93633|NCT02054130|230001|P2|STARTED|Overall Study||138
93634|NCT02054130|230002|P1|STARTED|Overall Study||138
93635|NCT02053753|230096|P2|NOT COMPLETED|Overall Study||8
93636|NCT02053753|230097|P1|NOT COMPLETED|Overall Study||7
93637|NCT02053753|230096|P2|COMPLETED|Overall Study||66
93638|NCT02053753|230097|P1|COMPLETED|Overall Study||65
93639|NCT02053753|230096|P2|Received Treatment|Overall Study||71
93640|NCT02053753|230097|P1|Received Treatment|Overall Study||71
93641|NCT02053753|230096|P2|STARTED|Overall Study||74
93642|NCT02053753|230097|P1|STARTED|Overall Study||72
93643|NCT02053610|230121|P2|NOT COMPLETED|Overall Study||67
93644|NCT02053610|230122|P1|NOT COMPLETED|Overall Study||42
93645|NCT02053610|230121|P2|COMPLETED|Overall Study|Completed=Completed Treatment|266
93646|NCT02053610|230122|P1|COMPLETED|Overall Study|Completed=Completed Treatment|288
93647|NCT02053610|230121|P2|Received Study Drug|Overall Study||331
93648|NCT02053610|230122|P1|Received Study Drug|Overall Study||326
93649|NCT02053610|230121|P2|STARTED|Overall Study||333
93650|NCT02053610|230122|P1|STARTED|Overall Study||330
93651|NCT02053493|230154|P2|NOT COMPLETED|Overall Study||1
93652|NCT02053493|230155|P1|NOT COMPLETED|Overall Study||1
93653|NCT02053493|230154|P2|COMPLETED|Overall Study||58
93654|NCT02053493|230155|P1|COMPLETED|Overall Study||50
93655|NCT02053493|230154|P2|STARTED|Overall Study||59
93656|NCT02053493|230155|P1|STARTED|Overall Study||51
93657|NCT02053376|230193|P1|NOT COMPLETED|Overall Study||0
93658|NCT02053376|230193|P1|COMPLETED|Overall Study||43
93659|NCT02053376|230193|P1|STARTED|Overall Study||43
93660|NCT02053168|230204|P1|NOT COMPLETED|Overall Study||3
93661|NCT02053168|230204|P1|COMPLETED|Overall Study||22
93662|NCT02053168|230204|P1|STARTED|Overall Study||25
93663|NCT02052895|230221|P3|NOT COMPLETED|Overall Study||0
93664|NCT02052895|230222|P2|NOT COMPLETED|Overall Study||0
93665|NCT02052895|230223|P1|NOT COMPLETED|Overall Study||0
93666|NCT02052895|230221|P3|COMPLETED|Overall Study||15
93667|NCT02052895|230222|P2|COMPLETED|Overall Study||15
93668|NCT02052895|230223|P1|COMPLETED|Overall Study||196
93669|NCT02052895|230221|P3|STARTED|Overall Study||15
93670|NCT02052895|230222|P2|STARTED|Overall Study||15
93671|NCT02052895|230223|P1|STARTED|Overall Study||196
93672|NCT02052752|230233|P3|NOT COMPLETED|Overall Study||0
93673|NCT02052752|230234|P2|NOT COMPLETED|Overall Study||0
93674|NCT02052752|230235|P1|NOT COMPLETED|Overall Study||0
93675|NCT02052752|230233|P3|COMPLETED|Overall Study||30
93676|NCT02052752|230234|P2|COMPLETED|Overall Study||30
93677|NCT02052752|230235|P1|COMPLETED|Overall Study||30
93678|NCT02052752|230233|P3|STARTED|Overall Study||30
93679|NCT02052752|230234|P2|STARTED|Overall Study||30
93680|NCT02052752|230235|P1|STARTED|Overall Study||30
93681|NCT02052661|230258|P1|NOT COMPLETED|Overall Study||0
93682|NCT02052661|230258|P1|COMPLETED|Overall Study||300
93683|NCT02052661|230258|P1|STARTED|Overall Study||300
93684|NCT02052635|230272|P2|NOT COMPLETED|Overall Study||0
93685|NCT02052635|230273|P1|NOT COMPLETED|Overall Study||0
93686|NCT02052635|230272|P2|COMPLETED|Overall Study||6
93687|NCT02052635|230273|P1|COMPLETED|Overall Study||7
93688|NCT02052635|230272|P2|STARTED|Overall Study||6
93689|NCT02052635|230273|P1|STARTED|Overall Study||7
93690|NCT02052596|230283|P2|NOT COMPLETED|Safety Phase||35
93691|NCT02052596|230284|P1|NOT COMPLETED|Safety Phase||27
93692|NCT02052596|230283|P2|COMPLETED|Safety Phase||383
93693|NCT02052596|230284|P1|COMPLETED|Safety Phase||385
93694|NCT02052596|230283|P2|STARTED|Safety Phase||418
93695|NCT02052596|230284|P1|STARTED|Safety Phase||412
93696|NCT02052596|230283|P2|NOT COMPLETED|Active Phase||20
93697|NCT02052596|230284|P1|NOT COMPLETED|Active Phase||16
93698|NCT02052596|230283|P2|COMPLETED|Active Phase||398
93699|NCT02052596|230284|P1|COMPLETED|Active Phase||396
93700|NCT02052596|230283|P2|STARTED|Active Phase||418
93701|NCT02052596|230284|P1|STARTED|Active Phase||412
93702|NCT02052544|230309|P1|NOT COMPLETED|Overall Study||0
93703|NCT02052544|230309|P1|COMPLETED|Overall Study|Last Subject Out|123
93704|NCT02052544|230309|P1|STARTED|Overall Study|First Subject In|123
93705|NCT02052466|230314|P1|NOT COMPLETED|Overall Study||2
93706|NCT02052466|230314|P1|COMPLETED|Overall Study||30
93707|NCT02052466|230314|P1|STARTED|Overall Study||32
93708|NCT02052440|230331|P2|NOT COMPLETED|Overall Study||1
93709|NCT02052440|230332|P1|NOT COMPLETED|Overall Study||0
93710|NCT02052440|230331|P2|COMPLETED|Overall Study||51
93711|NCT02052440|230332|P1|COMPLETED|Overall Study||50
93712|NCT02052440|230331|P2|STARTED|Overall Study||52
93713|NCT02052440|230332|P1|STARTED|Overall Study||50
93714|NCT02052414|230344|P1|NOT COMPLETED|Overall Study||17
93715|NCT02052414|230344|P1|COMPLETED|Overall Study||17
93716|NCT02052414|230344|P1|STARTED|Overall Study||34
93717|NCT02052141|230354|P2|NOT COMPLETED|Intervention Period 2||0
93718|NCT02052141|230355|P1|NOT COMPLETED|Intervention Period 2||0
93719|NCT02052141|230354|P2|COMPLETED|Intervention Period 2||7
93720|NCT02052141|230355|P1|COMPLETED|Intervention Period 2||5
93721|NCT02052141|230354|P2|STARTED|Intervention Period 2||7
93722|NCT02052141|230355|P1|STARTED|Intervention Period 2||5
93723|NCT02052141|230354|P2|NOT COMPLETED|Intervention Period 1||0
93724|NCT02052141|230355|P1|NOT COMPLETED|Intervention Period 1||0
93725|NCT02052141|230354|P2|COMPLETED|Intervention Period 1||7
93726|NCT02052141|230355|P1|COMPLETED|Intervention Period 1||5
93727|NCT02052141|230354|P2|STARTED|Intervention Period 1||7
93728|NCT02052141|230355|P1|STARTED|Intervention Period 1||5
93729|NCT02052011|230379|P2|NOT COMPLETED|Overall Study||2
93730|NCT02052011|230380|P1|NOT COMPLETED|Overall Study||4
93731|NCT02052011|230379|P2|COMPLETED|Overall Study||8
93732|NCT02052011|230380|P1|COMPLETED|Overall Study||17
93733|NCT02052011|230379|P2|STARTED|Overall Study||10
93734|NCT02052011|230380|P1|STARTED|Overall Study||21
93735|NCT02051816|230390|P4|NOT COMPLETED|Overall Study||0
93736|NCT02051816|230391|P3|NOT COMPLETED|Overall Study||0
93737|NCT02051816|230392|P2|NOT COMPLETED|Overall Study||0
93738|NCT02051816|230393|P1|NOT COMPLETED|Overall Study||0
93739|NCT02051816|230390|P4|COMPLETED|Overall Study||36
93740|NCT02051816|230391|P3|COMPLETED|Overall Study||37
93741|NCT02051816|230392|P2|COMPLETED|Overall Study||40
93742|NCT02051816|230393|P1|COMPLETED|Overall Study||37
93743|NCT02051816|230390|P4|STARTED|Overall Study||36
93744|NCT02051816|230391|P3|STARTED|Overall Study||37
93745|NCT02051816|230392|P2|STARTED|Overall Study||40
93746|NCT02051816|230393|P1|STARTED|Overall Study||37
93747|NCT02051790|230431|P1|NOT COMPLETED|Overall Study||0
93748|NCT02051790|230431|P1|COMPLETED|Overall Study||241
93749|NCT02051790|230431|P1|STARTED|Overall Study||241
93750|NCT02051686|230437|P2|NOT COMPLETED|Overall Study||0
93751|NCT02051686|230438|P1|NOT COMPLETED|Overall Study||0
93752|NCT02051686|230437|P2|COMPLETED|Overall Study||46
93753|NCT02051686|230438|P1|COMPLETED|Overall Study||42
93754|NCT02051686|230437|P2|STARTED|Overall Study||46
93755|NCT02051686|230438|P1|STARTED|Overall Study||42
93756|NCT02051595|230446|P1|NOT COMPLETED|Overall Study||0
93757|NCT02051595|230446|P1|COMPLETED|Overall Study||25
93758|NCT02051595|230446|P1|STARTED|Overall Study||25
93759|NCT02051452|230452|P2|NOT COMPLETED|Overall Study||0
93760|NCT02051452|230453|P1|NOT COMPLETED|Overall Study||0
93761|NCT02051452|230452|P2|COMPLETED|Overall Study||16
93762|NCT02051452|230453|P1|COMPLETED|Overall Study||16
93763|NCT02051452|230452|P2|STARTED|Overall Study||16
93764|NCT02051452|230453|P1|STARTED|Overall Study||16
93765|NCT02051426|230465|P2|NOT COMPLETED|Second Intervention||0
93766|NCT02051426|230466|P1|NOT COMPLETED|Second Intervention||0
93767|NCT02051426|230465|P2|COMPLETED|Second Intervention||19
93768|NCT02051426|230466|P1|COMPLETED|Second Intervention||16
93769|NCT02051426|230465|P2|STARTED|Second Intervention||19
93770|NCT02051426|230466|P1|STARTED|Second Intervention||16
93771|NCT02051426|230465|P2|NOT COMPLETED|Washout Period of 1 Month||0
93772|NCT02051426|230466|P1|NOT COMPLETED|Washout Period of 1 Month||0
93773|NCT02051426|230465|P2|COMPLETED|Washout Period of 1 Month||19
93774|NCT02051426|230466|P1|COMPLETED|Washout Period of 1 Month||16
93775|NCT02051426|230465|P2|STARTED|Washout Period of 1 Month||19
93776|NCT02051426|230466|P1|STARTED|Washout Period of 1 Month||16
93777|NCT02051426|230465|P2|NOT COMPLETED|First Intervention||0
93778|NCT02051426|230466|P1|NOT COMPLETED|First Intervention||0
93779|NCT02051426|230465|P2|COMPLETED|First Intervention||19
93780|NCT02051426|230466|P1|COMPLETED|First Intervention||16
93781|NCT02051426|230465|P2|STARTED|First Intervention||19
93782|NCT02051426|230466|P1|STARTED|First Intervention||16
93783|NCT02051335|230480|P4|NOT COMPLETED|Period 4||0
93784|NCT02051335|230481|P3|NOT COMPLETED|Period 4||0
93785|NCT02051335|230482|P2|NOT COMPLETED|Period 4||0
93786|NCT02051335|230483|P1|NOT COMPLETED|Period 4||0
93787|NCT02051335|230480|P4|COMPLETED|Period 4||4
93788|NCT02051335|230481|P3|COMPLETED|Period 4||5
93789|NCT02051335|230482|P2|COMPLETED|Period 4||7
93790|NCT02051335|230483|P1|COMPLETED|Period 4||7
93791|NCT02051335|230480|P4|STARTED|Period 4||4
93792|NCT02051335|230481|P3|STARTED|Period 4||5
93793|NCT02051335|230482|P2|STARTED|Period 4||7
93794|NCT02051335|230483|P1|STARTED|Period 4||7
93795|NCT02051335|230480|P4|NOT COMPLETED|Period 3||0
93796|NCT02051335|230481|P3|NOT COMPLETED|Period 3||0
93797|NCT02051335|230482|P2|NOT COMPLETED|Period 3||0
93798|NCT02051335|230483|P1|NOT COMPLETED|Period 3||0
93799|NCT02051335|230480|P4|COMPLETED|Period 3||4
93800|NCT02051335|230481|P3|COMPLETED|Period 3||5
93801|NCT02051335|230482|P2|COMPLETED|Period 3||7
93802|NCT02051335|230483|P1|COMPLETED|Period 3||7
93803|NCT02051335|230480|P4|STARTED|Period 3||4
93804|NCT02051335|230481|P3|STARTED|Period 3|2 Participants received treatment in Period 2 but discontinued prior to Period 3.|5
93805|NCT02051335|230482|P2|STARTED|Period 3||7
93806|NCT02051335|230483|P1|STARTED|Period 3||7
93807|NCT02051335|230480|P4|NOT COMPLETED|Period 2||0
93808|NCT02051335|230481|P3|NOT COMPLETED|Period 2||0
93809|NCT02051335|230482|P2|NOT COMPLETED|Period 2||0
93810|NCT02051335|230483|P1|NOT COMPLETED|Period 2||0
93811|NCT02051335|230480|P4|COMPLETED|Period 2||4
93812|NCT02051335|230481|P3|COMPLETED|Period 2||7
93813|NCT02051335|230482|P2|COMPLETED|Period 2||7
93814|NCT02051335|230483|P1|COMPLETED|Period 2||7
93815|NCT02051335|230480|P4|STARTED|Period 2|2 Participants received treatment in Period 1 but discontinued prior to Period 2.|4
93816|NCT02051335|230481|P3|STARTED|Period 2||7
93817|NCT02051335|230482|P2|STARTED|Period 2||7
93818|NCT02051335|230483|P1|STARTED|Period 2||7
93819|NCT02051335|230480|P4|NOT COMPLETED|Period 1||0
93820|NCT02051335|230481|P3|NOT COMPLETED|Period 1||0
93821|NCT02051335|230482|P2|NOT COMPLETED|Period 1||0
93822|NCT02051335|230483|P1|NOT COMPLETED|Period 1||0
93823|NCT02051335|230480|P4|COMPLETED|Period 1||6
93824|NCT02051335|230481|P3|COMPLETED|Period 1||7
93825|NCT02051335|230482|P2|COMPLETED|Period 1||7
93826|NCT02051335|230483|P1|COMPLETED|Period 1||7
93827|NCT02051335|230480|P4|STARTED|Period 1||6
93828|NCT02051335|230481|P3|STARTED|Period 1||7
93829|NCT02051335|230482|P2|STARTED|Period 1||7
93830|NCT02051335|230483|P1|STARTED|Period 1||7
93831|NCT02051296|230535|P2|NOT COMPLETED|Overall Study||9
93832|NCT02051296|230536|P1|NOT COMPLETED|Overall Study||8
93833|NCT02051296|230535|P2|COMPLETED|Overall Study||56
93834|NCT02051296|230536|P1|COMPLETED|Overall Study||58
93835|NCT02051296|230535|P2|Received Allocated Intervention|Overall Study||58
93836|NCT02051296|230536|P1|Received Allocated Intervention|Overall Study||59
93837|NCT02051296|230535|P2|STARTED|Overall Study||65
93838|NCT02051296|230536|P1|STARTED|Overall Study||66
93839|NCT02050841|230542|P1|NOT COMPLETED|Overall Study||0
93840|NCT02050841|230542|P1|COMPLETED|Overall Study||50
93841|NCT02050841|230542|P1|STARTED|Overall Study||50
93842|NCT02050334|230583|P2|NOT COMPLETED|Overall Study||0
93843|NCT02050334|230584|P1|NOT COMPLETED|Overall Study||0
93844|NCT02050334|230583|P2|COMPLETED|Overall Study||9
93845|NCT02050334|230584|P1|COMPLETED|Overall Study||9
93846|NCT02050334|230583|P2|STARTED|Overall Study||9
93847|NCT02050334|230584|P1|STARTED|Overall Study||9
93848|NCT02050321|230592|P1|NOT COMPLETED|Overall Study||2
93849|NCT02050321|230592|P1|COMPLETED|Overall Study||0
93850|NCT02050321|230592|P1|STARTED|Overall Study||2
93851|NCT02050308|230599|P2|NOT COMPLETED|Overall Study||102
93852|NCT02050308|230600|P1|NOT COMPLETED|Overall Study||99
93853|NCT02050308|230599|P2|COMPLETED|Overall Study||22
93854|NCT02050308|230600|P1|COMPLETED|Overall Study||28
93855|NCT02050308|230599|P2|STARTED|Overall Study||124
93856|NCT02050308|230600|P1|STARTED|Overall Study||127
93857|NCT02050048|230608|P2|NOT COMPLETED|Overall Study||2
93858|NCT02050048|230609|P1|NOT COMPLETED|Overall Study||5
93859|NCT02050048|230608|P2|COMPLETED|Overall Study||10
93860|NCT02050048|230609|P1|COMPLETED|Overall Study||9
93861|NCT02050048|230608|P2|STARTED|Overall Study||12
93862|NCT02050048|230609|P1|STARTED|Overall Study||14
93863|NCT02049931|230618|P3|NOT COMPLETED|Overall Study||3
93864|NCT02049931|230619|P2|NOT COMPLETED|Overall Study||5
93865|NCT02049931|230620|P1|NOT COMPLETED|Overall Study||3
93866|NCT02049931|230618|P3|COMPLETED|Overall Study||17
93867|NCT02049931|230619|P2|COMPLETED|Overall Study||15
93868|NCT02049931|230620|P1|COMPLETED|Overall Study||17
93869|NCT02049931|230618|P3|STARTED|Overall Study||20
93870|NCT02049931|230619|P2|STARTED|Overall Study||20
93871|NCT02049931|230620|P1|STARTED|Overall Study||20
93872|NCT02049814|230642|P2|NOT COMPLETED|Overall Study||27
93873|NCT02049814|230643|P1|NOT COMPLETED|Overall Study||29
93874|NCT02049814|230642|P2|COMPLETED|Overall Study||219
93875|NCT02049814|230643|P1|COMPLETED|Overall Study||219
93876|NCT02049814|230642|P2|Safety Set|Overall Study||245
93877|NCT02049814|230643|P1|Safety Set|Overall Study||248
93878|NCT02049814|230642|P2|STARTED|Overall Study||246
93879|NCT02049814|230643|P1|STARTED|Overall Study||248
93880|NCT02049749|230671|P2|NOT COMPLETED|Overall Study||0
93881|NCT02049749|230672|P1|NOT COMPLETED|Overall Study||0
93882|NCT02049749|230671|P2|COMPLETED|Overall Study|80 children plus 80 caregivers|160
93883|NCT02049749|230672|P1|COMPLETED|Overall Study||80
93884|NCT02049749|230671|P2|STARTED|Overall Study|80 children plus 80 caregivers|160
93885|NCT02049749|230672|P1|STARTED|Overall Study|40 children plus 40 caregivers|80
93886|NCT02049502|230680|P1|NOT COMPLETED|Overall Study||0
93887|NCT02049502|230680|P1|COMPLETED|Overall Study||8
93888|NCT02049502|230680|P1|STARTED|Overall Study||8
93889|NCT02049476|230685|P1|NOT COMPLETED|Overall Study||0
93890|NCT02049476|230685|P1|COMPLETED|Overall Study|20th patient completed the study|20
93891|NCT02049476|230685|P1|STARTED|Overall Study|First patient enrolled on 1/31/2014|20
93892|NCT02049450|230692|P1|NOT COMPLETED|Overall Study||4
93893|NCT02049450|230692|P1|COMPLETED|Overall Study|Completed = Completed Core phase of study|26
93894|NCT02049450|230692|P1|Entered Extension Phase|Overall Study|Of 26 who completed Core phase 18 moved into Ext. phase; All 18 eventually discontinued Ext. phase|18
93895|NCT02049450|230692|P1|Discontinued Treatment Prior to Week 30|Overall Study||4
93896|NCT02049450|230692|P1|STARTED|Overall Study||30
93897|NCT02049385|230706|P2|NOT COMPLETED|Second Intervention||2
93898|NCT02049385|230707|P1|NOT COMPLETED|Second Intervention||0
93899|NCT02049385|230706|P2|COMPLETED|Second Intervention||0
93900|NCT02049385|230707|P1|COMPLETED|Second Intervention||1
93901|NCT02049385|230706|P2|STARTED|Second Intervention||2
93902|NCT02049385|230707|P1|STARTED|Second Intervention||1
93903|NCT02049385|230706|P2|NOT COMPLETED|First Intervention||0
93904|NCT02049385|230707|P1|NOT COMPLETED|First Intervention||3
93905|NCT02049385|230706|P2|COMPLETED|First Intervention||2
93906|NCT02049385|230707|P1|COMPLETED|First Intervention||1
93907|NCT02049385|230706|P2|STARTED|First Intervention||2
93908|NCT02049385|230707|P1|STARTED|First Intervention||4
93909|NCT02049151|230715|P2|NOT COMPLETED|Overall Study||0
93910|NCT02049151|230716|P1|NOT COMPLETED|Overall Study||0
93911|NCT02049151|230715|P2|COMPLETED|Overall Study||17
93912|NCT02049151|230716|P1|COMPLETED|Overall Study||15
93913|NCT02049151|230715|P2|STARTED|Overall Study|1 subject did not receive treatment|17
93914|NCT02049151|230716|P1|STARTED|Overall Study|2 subjects did not receive treatment|15
93915|NCT02048904|230730|P1|NOT COMPLETED|Overall Study||77
93916|NCT02048904|230730|P1|COMPLETED|Overall Study||65
93917|NCT02048904|230730|P1|STARTED|Overall Study||142
93918|NCT02048891|230736|P2|NOT COMPLETED|Overall Study||0
93919|NCT02048891|230737|P1|NOT COMPLETED|Overall Study||0
93920|NCT02048891|230736|P2|COMPLETED|Overall Study||1
93921|NCT02048891|230737|P1|COMPLETED|Overall Study||2
93922|NCT02048891|230736|P2|STARTED|Overall Study||1
93923|NCT02048891|230737|P1|STARTED|Overall Study||2
93924|NCT02048670|230745|P2|NOT COMPLETED|Overall Study||0
93925|NCT02048670|230746|P1|NOT COMPLETED|Overall Study||0
93926|NCT02048670|230745|P2|COMPLETED|Overall Study||6
93927|NCT02048670|230746|P1|COMPLETED|Overall Study||6
93928|NCT02048670|230745|P2|STARTED|Overall Study||6
93929|NCT02048670|230746|P1|STARTED|Overall Study||6
93930|NCT02048241|230756|P2|NOT COMPLETED|Overall Study||1
93931|NCT02048241|230757|P1|NOT COMPLETED|Overall Study||0
93932|NCT02048241|230756|P2|COMPLETED|Overall Study||5
93933|NCT02048241|230757|P1|COMPLETED|Overall Study||5
93934|NCT02048241|230756|P2|STARTED|Overall Study||6
93935|NCT02048241|230757|P1|STARTED|Overall Study||5
93936|NCT02048072|230763|P1|NOT COMPLETED|Overall Study||4
93937|NCT02048072|230763|P1|COMPLETED|Overall Study||29
93938|NCT02048072|230763|P1|STARTED|Overall Study||33
93939|NCT02047929|230770|P3|NOT COMPLETED|Overall Study||0
93940|NCT02047929|230771|P2|NOT COMPLETED|Overall Study||0
93941|NCT02047929|230772|P1|NOT COMPLETED|Overall Study||0
93942|NCT02047929|230770|P3|COMPLETED|Overall Study||2248
93943|NCT02047929|230771|P2|COMPLETED|Overall Study||2523
93944|NCT02047929|230772|P1|COMPLETED|Overall Study||1503
93945|NCT02047929|230770|P3|Surveys Collected|Overall Study|Per protocol, practice did not receive any interaction from practice facilitator|0
93946|NCT02047929|230771|P2|Surveys Collected|Overall Study||2523
93947|NCT02047929|230772|P1|Surveys Collected|Overall Study||1503
93948|NCT02047929|230770|P3|Practice Refresher|Overall Study|Per protocol, practices did not receive any interaction from practice facilitator|0
93949|NCT02047929|230771|P2|Practice Refresher|Overall Study||2523
93950|NCT02047929|230772|P1|Practice Refresher|Overall Study||1503
93951|NCT02047929|230770|P3|Practice Rollout|Overall Study|Per protocol, practice did not receive any intervention from practice facilitator|0
93952|NCT02047929|230771|P2|Practice Rollout|Overall Study||2523
93953|NCT02047929|230772|P1|Practice Rollout|Overall Study||1503
93954|NCT02047929|230770|P3|STARTED|Overall Study||2248
93955|NCT02047929|230771|P2|STARTED|Overall Study||2523
93956|NCT02047929|230772|P1|STARTED|Overall Study||1503
93957|NCT02047747|230785|P1|NOT COMPLETED|Overall Study||3
93958|NCT02047747|230785|P1|COMPLETED|Overall Study||1
93959|NCT02047747|230785|P1|STARTED|Overall Study||4
93960|NCT02047643|230790|P2|NOT COMPLETED|Overall Study||0
93961|NCT02047643|230791|P1|NOT COMPLETED|Overall Study||0
93962|NCT02047643|230790|P2|COMPLETED|Overall Study||9
93963|NCT02047643|230791|P1|COMPLETED|Overall Study||9
93964|NCT02047643|230790|P2|STARTED|Overall Study||9
93965|NCT02047643|230791|P1|STARTED|Overall Study||9
93966|NCT02047500|230799|P1|NOT COMPLETED|Overall Study||19
93967|NCT02047500|230799|P1|COMPLETED|Overall Study||0
93968|NCT02047500|230799|P1|STARTED|Overall Study||19
93969|NCT02047253|230803|P1|NOT COMPLETED|Overall Study||8
93970|NCT02047253|230803|P1|COMPLETED|Overall Study||20
93971|NCT02047253|230803|P1|STARTED|Overall Study||28
93972|NCT02047227|230813|P2|NOT COMPLETED|Overall Study||130
93973|NCT02047227|230814|P1|NOT COMPLETED|Overall Study||144
93974|NCT02047227|230813|P2|COMPLETED|Overall Study||347
93975|NCT02047227|230814|P1|COMPLETED|Overall Study||318
93976|NCT02047227|230813|P2|Completed Ovarian Stimulation Phase|Overall Study||440
93977|NCT02047227|230814|P1|Completed Ovarian Stimulation Phase|Overall Study||424
93978|NCT02047227|230813|P2|STARTED|Overall Study||477
93979|NCT02047227|230814|P1|STARTED|Overall Study||462
93980|NCT02047110|230834|P4|NOT COMPLETED|OLE Treatment Period||0
93981|NCT02047110|230835|P3|NOT COMPLETED|OLE Treatment Period||1
93982|NCT02047110|230836|P2|NOT COMPLETED|OLE Treatment Period||0
93983|NCT02047110|230837|P1|NOT COMPLETED|OLE Treatment Period||0
93984|NCT02047110|230834|P4|COMPLETED|OLE Treatment Period||9
93985|NCT02047110|230835|P3|COMPLETED|OLE Treatment Period||4
93986|NCT02047110|230836|P2|COMPLETED|OLE Treatment Period||8
93987|NCT02047110|230837|P1|COMPLETED|OLE Treatment Period||4
93988|NCT02047110|230834|P4|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|9
93989|NCT02047110|230835|P3|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|5
93990|NCT02047110|230836|P2|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|8
93991|NCT02047110|230837|P1|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|4
93992|NCT02047110|230834|P4|NOT COMPLETED|Escape Treatment Period||2
93993|NCT02047110|230835|P3|NOT COMPLETED|Escape Treatment Period||3
93994|NCT02047110|230836|P2|NOT COMPLETED|Escape Treatment Period||6
93995|NCT02047110|230837|P1|NOT COMPLETED|Escape Treatment Period||3
93996|NCT02047110|230834|P4|COMPLETED|Escape Treatment Period||24
93997|NCT02047110|230835|P3|COMPLETED|Escape Treatment Period||20
93998|NCT02047110|230836|P2|COMPLETED|Escape Treatment Period||15
93999|NCT02047110|230837|P1|COMPLETED|Escape Treatment Period||23
94000|NCT02047110|230834|P4|STARTED|Escape Treatment Period|ASAS 20 nonresponders|26
94001|NCT02047110|230835|P3|STARTED|Escape Treatment Period|ASAS 20 nonresponders|23
94002|NCT02047110|230836|P2|STARTED|Escape Treatment Period|ASAS 20 nonresponders|21
94003|NCT02047110|230837|P1|STARTED|Escape Treatment Period|Assessment in SpondyloArthritis international Society (ASAS) 20 nonresponders|26
94004|NCT02047110|230834|P4|NOT COMPLETED|DB (Week 12 up to Week 24)||0
94005|NCT02047110|230835|P3|NOT COMPLETED|DB (Week 12 up to Week 24)||1
94006|NCT02047110|230836|P2|NOT COMPLETED|DB (Week 12 up to Week 24)||2
94007|NCT02047110|230837|P1|NOT COMPLETED|DB (Week 12 up to Week 24)||0
94008|NCT02047110|230834|P4|COMPLETED|DB (Week 12 up to Week 24)||12
94009|NCT02047110|230835|P3|COMPLETED|DB (Week 12 up to Week 24)||12
94010|NCT02047110|230836|P2|COMPLETED|DB (Week 12 up to Week 24)||15
94011|NCT02047110|230837|P1|COMPLETED|DB (Week 12 up to Week 24)||9
94012|NCT02047110|230834|P4|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|12
94101|NCT02046382|231120|P1|NOT COMPLETED|Overall Study||8
94013|NCT02047110|230835|P3|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|13
94014|NCT02047110|230836|P2|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|17
94015|NCT02047110|230837|P1|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|9
94016|NCT02047110|230834|P4|NOT COMPLETED|DB Treatment Period up to Week 24||2
94017|NCT02047110|230835|P3|NOT COMPLETED|DB Treatment Period up to Week 24||3
94018|NCT02047110|230836|P2|NOT COMPLETED|DB Treatment Period up to Week 24||2
94019|NCT02047110|230837|P1|NOT COMPLETED|DB Treatment Period up to Week 24||5
94020|NCT02047110|230834|P4|COMPLETED|DB Treatment Period up to Week 24||38
94021|NCT02047110|230835|P3|COMPLETED|DB Treatment Period up to Week 24||36
94022|NCT02047110|230836|P2|COMPLETED|DB Treatment Period up to Week 24||38
94023|NCT02047110|230837|P1|COMPLETED|DB Treatment Period up to Week 24||35
94024|NCT02047110|230834|P4|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
94025|NCT02047110|230835|P3|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|39
94026|NCT02047110|230836|P2|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
94027|NCT02047110|230837|P1|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
94028|NCT02047032|230880|P2|NOT COMPLETED|Overall Study||15
94029|NCT02047032|230881|P1|NOT COMPLETED|Overall Study||5
94030|NCT02047032|230880|P2|COMPLETED|Overall Study||235
94031|NCT02047032|230881|P1|COMPLETED|Overall Study||245
94032|NCT02047032|230880|P2|STARTED|Overall Study||250
94033|NCT02047032|230881|P1|STARTED|Overall Study||250
94034|NCT02046993|230910|P2|NOT COMPLETED|Overall Study||11
94035|NCT02046993|230911|P1|NOT COMPLETED|Overall Study||3
94036|NCT02046993|230910|P2|COMPLETED|Overall Study||94
94037|NCT02046993|230911|P1|COMPLETED|Overall Study||102
94038|NCT02046993|230910|P2|6th Month|Overall Study||94
94039|NCT02046993|230911|P1|6th Month|Overall Study||102
94040|NCT02046993|230910|P2|3rd Month|Overall Study||97
94041|NCT02046993|230911|P1|3rd Month|Overall Study||104
94042|NCT02046993|230910|P2|STARTED|Overall Study||105
94043|NCT02046993|230911|P1|STARTED|Overall Study||105
94044|NCT02046980|230930|P3|NOT COMPLETED|Overall Study||1
94045|NCT02046980|230931|P2|NOT COMPLETED|Overall Study||5
94046|NCT02046980|230932|P1|NOT COMPLETED|Overall Study||2
94047|NCT02046980|230930|P3|COMPLETED|Overall Study||72
94048|NCT02046980|230931|P2|COMPLETED|Overall Study||67
94049|NCT02046980|230932|P1|COMPLETED|Overall Study||70
94050|NCT02046980|230930|P3|STARTED|Overall Study||73
94051|NCT02046980|230931|P2|STARTED|Overall Study||72
94052|NCT02046980|230932|P1|STARTED|Overall Study||72
94053|NCT02046941|230940|P1|NOT COMPLETED|Overall Study||7
94054|NCT02046941|230940|P1|COMPLETED|Overall Study||10
94055|NCT02046941|230940|P1|STARTED|Overall Study||17
94056|NCT02046902|230949|P3|NOT COMPLETED|Overall Study||0
94057|NCT02046902|230950|P2|NOT COMPLETED|Overall Study||0
94058|NCT02046902|230951|P1|NOT COMPLETED|Overall Study||0
94059|NCT02046902|230949|P3|COMPLETED|Overall Study||137
94060|NCT02046902|230950|P2|COMPLETED|Overall Study||113
94061|NCT02046902|230951|P1|COMPLETED|Overall Study||336
94062|NCT02046902|230949|P3|STARTED|Overall Study||137
94063|NCT02046902|230950|P2|STARTED|Overall Study||113
94064|NCT02046902|230951|P1|STARTED|Overall Study||336
94065|NCT02046863|230962|P1|NOT COMPLETED|Overall Study||0
94066|NCT02046863|230962|P1|COMPLETED|Overall Study||7
94067|NCT02046863|230962|P1|STARTED|Overall Study||7
94068|NCT02046772|230968|P2|NOT COMPLETED|Overall Study||0
94069|NCT02046772|230969|P1|NOT COMPLETED|Overall Study||0
94070|NCT02046772|230968|P2|COMPLETED|Overall Study||33
94071|NCT02046772|230969|P1|COMPLETED|Overall Study||30
94072|NCT02046772|230968|P2|STARTED|Overall Study||33
94073|NCT02046772|230969|P1|STARTED|Overall Study||30
94074|NCT02046616|230983|P1|NOT COMPLETED|8-Week FU Period||1
94075|NCT02046616|230983|P1|COMPLETED|8-Week FU Period||113
94076|NCT02046616|230983|P1|STARTED|8-Week FU Period||114
94077|NCT02046616|230983|P1|NOT COMPLETED|24-Week Treatment Period||19
94078|NCT02046616|230983|P1|COMPLETED|24-Week Treatment Period||114
94079|NCT02046616|230983|P1|STARTED|24-Week Treatment Period||133
94080|NCT02046603|231005|P2|NOT COMPLETED|Overall Study||75
94081|NCT02046603|231006|P1|NOT COMPLETED|Overall Study||15
94082|NCT02046603|231005|P2|COMPLETED|Overall Study||65
94083|NCT02046603|231006|P1|COMPLETED|Overall Study||7
94084|NCT02046603|231005|P2|Received at Least 1 Dose of Tocilizumab|Overall Study||140
94085|NCT02046603|231006|P1|Received at Least 1 Dose of Tocilizumab|Overall Study||21
94086|NCT02046603|231005|P2|STARTED|Overall Study||140
94087|NCT02046603|231006|P1|STARTED|Overall Study||22
94088|NCT02046564|231085|P2|NOT COMPLETED|Overall Study||20
94089|NCT02046564|231086|P1|NOT COMPLETED|Overall Study||15
94090|NCT02046564|231085|P2|COMPLETED|Overall Study||183
94091|NCT02046564|231086|P1|COMPLETED|Overall Study||194
94092|NCT02046564|231085|P2|STARTED|Overall Study||203
94093|NCT02046564|231086|P1|STARTED|Overall Study||209
94094|NCT02046525|231110|P2|NOT COMPLETED|Overall Study||0
94095|NCT02046525|231111|P1|NOT COMPLETED|Overall Study||0
94096|NCT02046525|231110|P2|COMPLETED|Overall Study||5
94097|NCT02046525|231111|P1|COMPLETED|Overall Study||5
94098|NCT02046525|231110|P2|STARTED|Overall Study||5
94099|NCT02046525|231111|P1|STARTED|Overall Study||5
94100|NCT02046382|231119|P2|NOT COMPLETED|Overall Study||20
94102|NCT02046382|231119|P2|COMPLETED|Overall Study||47
94103|NCT02046382|231120|P1|COMPLETED|Overall Study||57
94104|NCT02046382|231119|P2|STARTED|Overall Study||67
94105|NCT02046382|231120|P1|STARTED|Overall Study||65
94106|NCT02046369|231134|P2|NOT COMPLETED|Overall Study||18
94107|NCT02046369|231135|P1|NOT COMPLETED|Overall Study||14
94108|NCT02046369|231134|P2|COMPLETED|Overall Study||156
94109|NCT02046369|231135|P1|COMPLETED|Overall Study||162
94110|NCT02046369|231134|P2|STARTED|Overall Study||174
94111|NCT02046369|231135|P1|STARTED|Overall Study||176
94112|NCT02046317|231153|P2|NOT COMPLETED|Overall Study||0
94113|NCT02046317|231154|P1|NOT COMPLETED|Overall Study||0
94114|NCT02046317|231153|P2|COMPLETED|Overall Study||8
94115|NCT02046317|231154|P1|COMPLETED|Overall Study||4
94116|NCT02046317|231153|P2|STARTED|Overall Study||8
94117|NCT02046317|231154|P1|STARTED|Overall Study||4
94118|NCT02046265|231166|P4|NOT COMPLETED|Overall Study||2
94119|NCT02046265|231167|P3|NOT COMPLETED|Overall Study||2
94120|NCT02046265|231168|P2|NOT COMPLETED|Overall Study||2
94121|NCT02046265|231169|P1|NOT COMPLETED|Overall Study||1
94122|NCT02046265|231166|P4|COMPLETED|Overall Study||12
94123|NCT02046265|231167|P3|COMPLETED|Overall Study||10
94124|NCT02046265|231168|P2|COMPLETED|Overall Study||15
94125|NCT02046265|231169|P1|COMPLETED|Overall Study||16
94126|NCT02046265|231166|P4|STARTED|Overall Study||14
94127|NCT02046265|231167|P3|STARTED|Overall Study||12
94128|NCT02046265|231168|P2|STARTED|Overall Study||17
94129|NCT02046265|231169|P1|STARTED|Overall Study||17
94130|NCT02046226|231179|P1|NOT COMPLETED|Overall Study||7
94131|NCT02046226|231179|P1|COMPLETED|Overall Study||0
94132|NCT02046226|231179|P1|STARTED|Overall Study||7
94133|NCT02046200|231186|P2|NOT COMPLETED|Second Intervention (1 Day)||0
94134|NCT02046200|231187|P1|NOT COMPLETED|Second Intervention (1 Day)||0
94135|NCT02046200|231186|P2|COMPLETED|Second Intervention (1 Day)||6
94136|NCT02046200|231187|P1|COMPLETED|Second Intervention (1 Day)||5
94137|NCT02046200|231186|P2|STARTED|Second Intervention (1 Day)||6
94138|NCT02046200|231187|P1|STARTED|Second Intervention (1 Day)||5
94139|NCT02046200|231186|P2|NOT COMPLETED|First Intervention (1 Day)||0
94140|NCT02046200|231187|P1|NOT COMPLETED|First Intervention (1 Day)||0
94141|NCT02046200|231186|P2|COMPLETED|First Intervention (1 Day)||6
94142|NCT02046200|231187|P1|COMPLETED|First Intervention (1 Day)||5
94143|NCT02046200|231186|P2|STARTED|First Intervention (1 Day)||6
94144|NCT02046200|231187|P1|STARTED|First Intervention (1 Day)||5
94145|NCT02046148|231227|P2|NOT COMPLETED|Overall Study||3
94146|NCT02046148|231228|P1|NOT COMPLETED|Overall Study||1
94147|NCT02046148|231227|P2|COMPLETED|Overall Study||23
94148|NCT02046148|231228|P1|COMPLETED|Overall Study||48
94149|NCT02046148|231227|P2|STARTED|Overall Study||26
94150|NCT02046148|231228|P1|STARTED|Overall Study||49
94151|NCT02046122|231288|P1|NOT COMPLETED|Overall Study||9
94152|NCT02046122|231288|P1|COMPLETED|Overall Study||8
94153|NCT02046122|231288|P1|STARTED|Overall Study||17
94154|NCT02046070|231298|P3|NOT COMPLETED|Overall Study||70
94155|NCT02046070|231299|P2|NOT COMPLETED|Overall Study||28
94156|NCT02046070|231300|P1|NOT COMPLETED|Overall Study||32
94157|NCT02046070|231298|P3|COMPLETED|Overall Study||8
94158|NCT02046070|231299|P2|COMPLETED|Overall Study||6
94159|NCT02046070|231300|P1|COMPLETED|Overall Study||4
94160|NCT02046070|231298|P3|STARTED|Overall Study||78
94161|NCT02046070|231299|P2|STARTED|Overall Study||34
94162|NCT02046070|231300|P1|STARTED|Overall Study||36
94163|NCT02046005|231347|P3|NOT COMPLETED|Overall Study||10
94164|NCT02046005|231348|P2|NOT COMPLETED|Overall Study||7
94165|NCT02046005|231349|P1|NOT COMPLETED|Overall Study||8
94166|NCT02046005|231347|P3|COMPLETED|Overall Study||70
94167|NCT02046005|231348|P2|COMPLETED|Overall Study||71
94168|NCT02046005|231349|P1|COMPLETED|Overall Study||72
94169|NCT02046005|231347|P3|STARTED|Overall Study||80
94170|NCT02046005|231348|P2|STARTED|Overall Study||78
94171|NCT02046005|231349|P1|STARTED|Overall Study||80
94172|NCT02045979|231360|P3|NOT COMPLETED|Overall Study||1
94173|NCT02045979|231361|P2|NOT COMPLETED|Overall Study||1
94174|NCT02045979|231362|P1|NOT COMPLETED|Overall Study||2
94175|NCT02045979|231360|P3|COMPLETED|Overall Study||107
94176|NCT02045979|231361|P2|COMPLETED|Overall Study||107
94177|NCT02045979|231362|P1|COMPLETED|Overall Study||106
94178|NCT02045979|231360|P3|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108
94179|NCT02045979|231361|P2|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication..|108
94180|NCT02045979|231362|P1|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108
94181|NCT02045875|231399|P2|NOT COMPLETED|Overall Study||3
94182|NCT02045875|231400|P1|NOT COMPLETED|Overall Study||7
94183|NCT02045875|231399|P2|COMPLETED|Overall Study||20
94184|NCT02045875|231400|P1|COMPLETED|Overall Study||20
94185|NCT02045875|231399|P2|STARTED|Overall Study||23
94186|NCT02045875|231400|P1|STARTED|Overall Study||27
94187|NCT02045862|231411|P3|NOT COMPLETED|Overall Study||126
94188|NCT02045862|231412|P2|NOT COMPLETED|Overall Study||40
94189|NCT02045862|231413|P1|NOT COMPLETED|Overall Study||39
94190|NCT02045862|231411|P3|COMPLETED|Overall Study||1092
94191|NCT02045862|231412|P2|COMPLETED|Overall Study||265
94192|NCT02045862|231413|P1|COMPLETED|Overall Study||267
94193|NCT02045862|231411|P3|Treated|Overall Study||1210
94194|NCT02045862|231412|P2|Treated|Overall Study||303
94195|NCT02045862|231413|P1|Treated|Overall Study||306
94196|NCT02045862|231411|P3|STARTED|Overall Study||1218
94197|NCT02045862|231412|P2|STARTED|Overall Study||305
94198|NCT02045862|231413|P1|STARTED|Overall Study||306
94199|NCT02045836|231594|P2|NOT COMPLETED|Overall Study||14
94200|NCT02045836|231595|P1|NOT COMPLETED|Overall Study||9
94201|NCT02045836|231594|P2|COMPLETED|Overall Study||419
94202|NCT02045836|231595|P1|COMPLETED|Overall Study||423
94203|NCT02045836|231594|P2|STARTED|Overall Study||433
94204|NCT02045836|231595|P1|STARTED|Overall Study||432
94205|NCT02045797|231627|P3|NOT COMPLETED|Overall Study||1
94206|NCT02045797|231628|P2|NOT COMPLETED|Overall Study||7
94207|NCT02045797|231629|P1|NOT COMPLETED|Overall Study||7
94208|NCT02045797|231627|P3|COMPLETED|Overall Study||24
94209|NCT02045797|231628|P2|COMPLETED|Overall Study||32
94210|NCT02045797|231629|P1|COMPLETED|Overall Study||51
94211|NCT02045797|231627|P3|STARTED|Overall Study||25
94212|NCT02045797|231628|P2|STARTED|Overall Study||39
94213|NCT02045797|231629|P1|STARTED|Overall Study||58
94214|NCT02045732|231774|P2|NOT COMPLETED|Overall Study||1
94215|NCT02045732|231775|P1|NOT COMPLETED|Overall Study||1
94216|NCT02045732|231774|P2|COMPLETED|Overall Study||2
94217|NCT02045732|231775|P1|COMPLETED|Overall Study||0
94218|NCT02045732|231774|P2|STARTED|Overall Study||3
94219|NCT02045732|231775|P1|STARTED|Overall Study||1
94220|NCT02045511|231795|P2|NOT COMPLETED|Overall Study||0
94221|NCT02045511|231796|P1|NOT COMPLETED|Overall Study||0
94222|NCT02045511|231795|P2|COMPLETED|Overall Study||7
94223|NCT02045511|231796|P1|COMPLETED|Overall Study||8
94224|NCT02045511|231795|P2|STARTED|Overall Study||7
94225|NCT02045511|231796|P1|STARTED|Overall Study||8
94226|NCT02045433|231812|P1|NOT COMPLETED|Overall Study||1
94227|NCT02045433|231812|P1|COMPLETED|Overall Study|Study was Prematurely ended due to toxicity|15
94228|NCT02045433|231812|P1|STARTED|Overall Study||16
94229|NCT02045264|231816|P1|NOT COMPLETED|Overall Study||0
94230|NCT02045264|231816|P1|COMPLETED|Overall Study||12
94231|NCT02045264|231816|P1|STARTED|Overall Study||12
94232|NCT02045238|231833|P2|NOT COMPLETED|Overall Study||1
94233|NCT02045238|231834|P1|NOT COMPLETED|Overall Study||7
94234|NCT02045238|231833|P2|COMPLETED|Overall Study||14
94235|NCT02045238|231834|P1|COMPLETED|Overall Study||9
94236|NCT02045238|231833|P2|STARTED|Overall Study||15
94237|NCT02045238|231834|P1|STARTED|Overall Study||16
94238|NCT02045212|231844|P2|NOT COMPLETED|Overall Study||1
94239|NCT02045212|231845|P1|NOT COMPLETED|Overall Study||2
94240|NCT02045212|231844|P2|COMPLETED|Overall Study||8
94241|NCT02045212|231845|P1|COMPLETED|Overall Study||11
94242|NCT02045212|231844|P2|STARTED|Overall Study||9
94243|NCT02045212|231845|P1|STARTED|Overall Study||13
94244|NCT02045108|231861|P4|NOT COMPLETED|Overall Study||1
94245|NCT02045108|231862|P3|NOT COMPLETED|Overall Study||2
94246|NCT02045108|231863|P2|NOT COMPLETED|Overall Study||3
94247|NCT02045108|231864|P1|NOT COMPLETED|Overall Study||1
94248|NCT02045108|231861|P4|COMPLETED|Overall Study||19
94249|NCT02045108|231862|P3|COMPLETED|Overall Study||18
94250|NCT02045108|231863|P2|COMPLETED|Overall Study||12
94251|NCT02045108|231864|P1|COMPLETED|Overall Study||21
94252|NCT02045108|231861|P4|STARTED|Overall Study||20
94253|NCT02045108|231862|P3|STARTED|Overall Study||20
94254|NCT02045108|231863|P2|STARTED|Overall Study||15
94255|NCT02045108|231864|P1|STARTED|Overall Study||22
94256|NCT02045095|231910|P7|NOT COMPLETED|Overall Study||1
94257|NCT02045095|231911|P6|NOT COMPLETED|Overall Study||8
94258|NCT02045095|231912|P5|NOT COMPLETED|Overall Study||5
94259|NCT02045095|231913|P4|NOT COMPLETED|Overall Study||4
94260|NCT02045095|231914|P3|NOT COMPLETED|Overall Study||4
94261|NCT02045095|231915|P2|NOT COMPLETED|Overall Study||4
94262|NCT02045095|231916|P1|NOT COMPLETED|Overall Study||3
94263|NCT02045095|231910|P7|COMPLETED|Overall Study||0
94264|NCT02045095|231911|P6|COMPLETED|Overall Study||0
94265|NCT02045095|231912|P5|COMPLETED|Overall Study||0
94266|NCT02045095|231913|P4|COMPLETED|Overall Study||0
94267|NCT02045095|231914|P3|COMPLETED|Overall Study||0
94268|NCT02045095|231915|P2|COMPLETED|Overall Study||0
94269|NCT02045095|231916|P1|COMPLETED|Overall Study||0
94270|NCT02045095|231910|P7|STARTED|Overall Study||1
94271|NCT02045095|231911|P6|STARTED|Overall Study||8
94272|NCT02045095|231912|P5|STARTED|Overall Study||5
94273|NCT02045095|231913|P4|STARTED|Overall Study||4
94274|NCT02045095|231914|P3|STARTED|Overall Study||4
94275|NCT02045095|231915|P2|STARTED|Overall Study||4
94276|NCT02045095|231916|P1|STARTED|Overall Study||3
94277|NCT02044991|232060|P2|NOT COMPLETED|Overall Study||0
94278|NCT02044991|232061|P1|NOT COMPLETED|Overall Study||0
94279|NCT02044991|232060|P2|COMPLETED|Overall Study||0
94280|NCT02044991|232061|P1|COMPLETED|Overall Study||2
94281|NCT02044991|232060|P2|STARTED|Overall Study||0
94282|NCT02044991|232061|P1|STARTED|Overall Study||2
94283|NCT02044874|232074|P3|NOT COMPLETED|Overall Study||60
94284|NCT02044874|232075|P2|NOT COMPLETED|Overall Study||55
94285|NCT02044874|232076|P1|NOT COMPLETED|Overall Study||30
94286|NCT02044874|232074|P3|COMPLETED|Overall Study||140
94287|NCT02044874|232075|P2|COMPLETED|Overall Study||147
94288|NCT02044874|232076|P1|COMPLETED|Overall Study||171
94289|NCT02044874|232074|P3|STARTED|Overall Study||200
94290|NCT02044874|232075|P2|STARTED|Overall Study||202
94291|NCT02044874|232076|P1|STARTED|Overall Study||201
94292|NCT02044848|232098|P2|NOT COMPLETED|Overall Study||3
94293|NCT02044848|232099|P1|NOT COMPLETED|Overall Study||2
94294|NCT02044848|232098|P2|COMPLETED|Overall Study||0
94295|NCT02044848|232099|P1|COMPLETED|Overall Study||0
94296|NCT02044848|232098|P2|STARTED|Overall Study||3
94297|NCT02044848|232099|P1|STARTED|Overall Study||2
94298|NCT02044822|232105|P1|NOT COMPLETED|Overall Study||93
94299|NCT02044822|232105|P1|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|9
94300|NCT02044822|232105|P1|STARTED|Overall Study||102
94301|NCT02044796|232117|P10|NOT COMPLETED|Overall Study||0
94302|NCT02044796|232118|P9|NOT COMPLETED|Overall Study||0
94303|NCT02044796|232119|P8|NOT COMPLETED|Overall Study||0
94304|NCT02044796|232120|P7|NOT COMPLETED|Overall Study||0
94305|NCT02044796|232121|P6|NOT COMPLETED|Overall Study||0
94306|NCT02044796|232122|P5|NOT COMPLETED|Overall Study||0
94307|NCT02044796|232123|P4|NOT COMPLETED|Overall Study||0
94308|NCT02044796|232124|P3|NOT COMPLETED|Overall Study||0
94309|NCT02044796|232125|P2|NOT COMPLETED|Overall Study||0
94310|NCT02044796|232126|P1|NOT COMPLETED|Overall Study||0
94311|NCT02044796|232117|P10|COMPLETED|Overall Study||34
94312|NCT02044796|232118|P9|COMPLETED|Overall Study||106
94313|NCT02044796|232119|P8|COMPLETED|Overall Study||4
94314|NCT02044796|232120|P7|COMPLETED|Overall Study||6
94315|NCT02044796|232121|P6|COMPLETED|Overall Study||6
94316|NCT02044796|232122|P5|COMPLETED|Overall Study||10
94317|NCT02044796|232123|P4|COMPLETED|Overall Study||6
94318|NCT02044796|232124|P3|COMPLETED|Overall Study||9
94319|NCT02044796|232125|P2|COMPLETED|Overall Study||9
94320|NCT02044796|232126|P1|COMPLETED|Overall Study||9
94321|NCT02044796|232117|P10|STARTED|Overall Study||34
94322|NCT02044796|232118|P9|STARTED|Overall Study||106
94323|NCT02044796|232119|P8|STARTED|Overall Study||4
94324|NCT02044796|232120|P7|STARTED|Overall Study||6
94325|NCT02044796|232121|P6|STARTED|Overall Study||6
94326|NCT02044796|232122|P5|STARTED|Overall Study||10
94327|NCT02044796|232123|P4|STARTED|Overall Study||6
94328|NCT02044796|232124|P3|STARTED|Overall Study||9
94329|NCT02044796|232125|P2|STARTED|Overall Study||9
94330|NCT02044796|232126|P1|STARTED|Overall Study||9
94331|NCT02044510|232146|P2|NOT COMPLETED|Overall Study||2
94332|NCT02044510|232147|P1|NOT COMPLETED|Overall Study||1
94333|NCT02044510|232146|P2|COMPLETED|Overall Study||14
94334|NCT02044510|232147|P1|COMPLETED|Overall Study||15
94335|NCT02044510|232146|P2|STARTED|Overall Study||16
94336|NCT02044510|232147|P1|STARTED|Overall Study||16
94337|NCT02044458|232155|P2|NOT COMPLETED|Overall Study||8
94338|NCT02044458|232156|P1|NOT COMPLETED|Overall Study||3
94339|NCT02044458|232155|P2|COMPLETED|Overall Study||61
94340|NCT02044458|232156|P1|COMPLETED|Overall Study||62
94341|NCT02044458|232155|P2|STARTED|Overall Study||69
94342|NCT02044458|232156|P1|STARTED|Overall Study||65
94343|NCT02044419|232169|P3|NOT COMPLETED|Third Intervention||0
94344|NCT02044419|232170|P2|NOT COMPLETED|Third Intervention||0
94345|NCT02044419|232171|P1|NOT COMPLETED|Third Intervention||0
94346|NCT02044419|232169|P3|COMPLETED|Third Intervention||10
94347|NCT02044419|232170|P2|COMPLETED|Third Intervention||9
94348|NCT02044419|232171|P1|COMPLETED|Third Intervention||11
94349|NCT02044419|232169|P3|STARTED|Third Intervention||10
94350|NCT02044419|232170|P2|STARTED|Third Intervention||9
94351|NCT02044419|232171|P1|STARTED|Third Intervention||11
94352|NCT02044419|232169|P3|NOT COMPLETED|Second Intervention||0
94353|NCT02044419|232170|P2|NOT COMPLETED|Second Intervention||0
94354|NCT02044419|232171|P1|NOT COMPLETED|Second Intervention||0
94355|NCT02044419|232169|P3|COMPLETED|Second Intervention||10
94356|NCT02044419|232170|P2|COMPLETED|Second Intervention||9
94357|NCT02044419|232171|P1|COMPLETED|Second Intervention||11
94358|NCT02044419|232169|P3|STARTED|Second Intervention||10
94359|NCT02044419|232170|P2|STARTED|Second Intervention||9
94360|NCT02044419|232171|P1|STARTED|Second Intervention||11
94361|NCT02044419|232169|P3|NOT COMPLETED|First Intervention||1
94362|NCT02044419|232170|P2|NOT COMPLETED|First Intervention||1
94363|NCT02044419|232171|P1|NOT COMPLETED|First Intervention||0
94364|NCT02044419|232169|P3|COMPLETED|First Intervention||10
94365|NCT02044419|232170|P2|COMPLETED|First Intervention||9
94366|NCT02044419|232171|P1|COMPLETED|First Intervention||11
94367|NCT02044419|232169|P3|STARTED|First Intervention||11
94368|NCT02044419|232170|P2|STARTED|First Intervention||10
94369|NCT02044419|232171|P1|STARTED|First Intervention||11
94370|NCT02044393|232196|P2|NOT COMPLETED|Period 2||0
94371|NCT02044393|232197|P1|NOT COMPLETED|Period 2||0
94372|NCT02044393|232196|P2|COMPLETED|Period 2||10
94373|NCT02044393|232197|P1|COMPLETED|Period 2||10
94374|NCT02044393|232196|P2|STARTED|Period 2||10
94375|NCT02044393|232197|P1|STARTED|Period 2||10
94376|NCT02044393|232196|P2|NOT COMPLETED|Period 1||0
94377|NCT02044393|232197|P1|NOT COMPLETED|Period 1||0
94378|NCT02044393|232196|P2|COMPLETED|Period 1||10
94379|NCT02044393|232197|P1|COMPLETED|Period 1||10
94380|NCT02044393|232196|P2|STARTED|Period 1||10
94381|NCT02044393|232197|P1|STARTED|Period 1||10
94382|NCT02044380|232210|P1|NOT COMPLETED|Overall Study||0
94383|NCT02044380|232210|P1|COMPLETED|Overall Study||14
94478|NCT02043782|232378|P5|COMPLETED|Period 1||6
94384|NCT02044380|232210|P1|STARTED|Overall Study|Started are the treated patients|14
94385|NCT02044367|232214|P6|NOT COMPLETED|Overall Study||0
94386|NCT02044367|232215|P5|NOT COMPLETED|Overall Study||0
94387|NCT02044367|232216|P4|NOT COMPLETED|Overall Study||0
94388|NCT02044367|232217|P3|NOT COMPLETED|Overall Study||0
94389|NCT02044367|232218|P2|NOT COMPLETED|Overall Study||0
94390|NCT02044367|232219|P1|NOT COMPLETED|Overall Study||0
94391|NCT02044367|232214|P6|COMPLETED|Overall Study||9
94392|NCT02044367|232215|P5|COMPLETED|Overall Study||9
94393|NCT02044367|232216|P4|COMPLETED|Overall Study||9
94394|NCT02044367|232217|P3|COMPLETED|Overall Study||9
94395|NCT02044367|232218|P2|COMPLETED|Overall Study||9
94396|NCT02044367|232219|P1|COMPLETED|Overall Study||9
94397|NCT02044367|232214|P6|STARTED|Overall Study||9
94398|NCT02044367|232215|P5|STARTED|Overall Study||9
94399|NCT02044367|232216|P4|STARTED|Overall Study||9
94400|NCT02044367|232217|P3|STARTED|Overall Study||9
94401|NCT02044367|232218|P2|STARTED|Overall Study||9
94402|NCT02044367|232219|P1|STARTED|Overall Study||9
94403|NCT02044302|232242|P2|NOT COMPLETED|Overall Study||0
94404|NCT02044302|232243|P1|NOT COMPLETED|Overall Study||2
94405|NCT02044302|232242|P2|COMPLETED|Overall Study||0
94406|NCT02044302|232243|P1|COMPLETED|Overall Study||0
94407|NCT02044302|232242|P2|STARTED|Overall Study||0
94408|NCT02044302|232243|P1|STARTED|Overall Study||2
94409|NCT02044159|232251|P2|NOT COMPLETED|Overall Study||4
94410|NCT02044159|232252|P1|NOT COMPLETED|Overall Study||4
94411|NCT02044159|232251|P2|COMPLETED|Overall Study||26
94412|NCT02044159|232252|P1|COMPLETED|Overall Study||23
94413|NCT02044159|232251|P2|STARTED|Overall Study||30
94414|NCT02044159|232252|P1|STARTED|Overall Study||27
94415|NCT02044094|232265|P1|NOT COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||13
94416|NCT02044094|232265|P1|COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||17
94417|NCT02044094|232265|P1|STARTED|RBP-6000 Injection 2 (Day 29 to Week 12)||30
94418|NCT02044094|232265|P1|NOT COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||9
94419|NCT02044094|232265|P1|COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||30
94420|NCT02044094|232265|P1|Completers Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects that reached Day 28 + completed all challenges at Week 4 were considered study completers.|30
94421|NCT02044094|232265|P1|Intent to Treat Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects who receive >=1 dose of RBP-6000 and have >=1 complete sequence of hydromorphone challenges|38
94422|NCT02044094|232265|P1|STARTED|RBP-6000 Injection 1 (Day 1 to Day 28)||39
94423|NCT02043938|232322|P1|NOT COMPLETED|Overall Study||10
94424|NCT02043938|232322|P1|COMPLETED|Overall Study||36
94425|NCT02043938|232322|P1|STARTED|Overall Study||46
94426|NCT02043860|232332|P1|NOT COMPLETED|Overall Study||0
94427|NCT02043860|232332|P1|COMPLETED|Overall Study||2
94428|NCT02043860|232332|P1|STARTED|Overall Study||2
94429|NCT02043808|232338|P2|NOT COMPLETED|Overall Study||0
94430|NCT02043808|232339|P1|NOT COMPLETED|Overall Study||0
94431|NCT02043808|232338|P2|COMPLETED|Overall Study||12793
94432|NCT02043808|232339|P1|COMPLETED|Overall Study||12793
94433|NCT02043808|232338|P2|STARTED|Overall Study||12793
94434|NCT02043808|232339|P1|STARTED|Overall Study||12793
94435|NCT02043782|232377|P6|NOT COMPLETED|Period 3||0
94436|NCT02043782|232378|P5|NOT COMPLETED|Period 3||0
94437|NCT02043782|232379|P4|NOT COMPLETED|Period 3||0
94438|NCT02043782|232380|P3|NOT COMPLETED|Period 3||0
94439|NCT02043782|232381|P2|NOT COMPLETED|Period 3||0
94440|NCT02043782|232382|P1|NOT COMPLETED|Period 3||0
94441|NCT02043782|232377|P6|COMPLETED|Period 3||6
94442|NCT02043782|232378|P5|COMPLETED|Period 3||6
94443|NCT02043782|232379|P4|COMPLETED|Period 3||6
94444|NCT02043782|232380|P3|COMPLETED|Period 3||6
94445|NCT02043782|232381|P2|COMPLETED|Period 3||6
94446|NCT02043782|232382|P1|COMPLETED|Period 3||7
94447|NCT02043782|232377|P6|STARTED|Period 3||6
94448|NCT02043782|232378|P5|STARTED|Period 3||6
94449|NCT02043782|232379|P4|STARTED|Period 3||6
94450|NCT02043782|232380|P3|STARTED|Period 3||6
94451|NCT02043782|232381|P2|STARTED|Period 3||6
94452|NCT02043782|232382|P1|STARTED|Period 3||7
94453|NCT02043782|232377|P6|NOT COMPLETED|Period 2||0
94454|NCT02043782|232378|P5|NOT COMPLETED|Period 2||0
94455|NCT02043782|232379|P4|NOT COMPLETED|Period 2||0
94456|NCT02043782|232380|P3|NOT COMPLETED|Period 2||0
94457|NCT02043782|232381|P2|NOT COMPLETED|Period 2||0
94458|NCT02043782|232382|P1|NOT COMPLETED|Period 2||0
94459|NCT02043782|232377|P6|COMPLETED|Period 2||6
94460|NCT02043782|232378|P5|COMPLETED|Period 2||6
94461|NCT02043782|232379|P4|COMPLETED|Period 2||6
94462|NCT02043782|232380|P3|COMPLETED|Period 2||6
94463|NCT02043782|232381|P2|COMPLETED|Period 2||6
94464|NCT02043782|232382|P1|COMPLETED|Period 2||7
94465|NCT02043782|232377|P6|STARTED|Period 2||6
94466|NCT02043782|232378|P5|STARTED|Period 2||6
94467|NCT02043782|232379|P4|STARTED|Period 2||6
94468|NCT02043782|232380|P3|STARTED|Period 2||6
94469|NCT02043782|232381|P2|STARTED|Period 2||6
94470|NCT02043782|232382|P1|STARTED|Period 2||7
94471|NCT02043782|232377|P6|NOT COMPLETED|Period 1||0
94472|NCT02043782|232378|P5|NOT COMPLETED|Period 1||0
94473|NCT02043782|232379|P4|NOT COMPLETED|Period 1||0
94474|NCT02043782|232380|P3|NOT COMPLETED|Period 1||1
94475|NCT02043782|232381|P2|NOT COMPLETED|Period 1||0
94476|NCT02043782|232382|P1|NOT COMPLETED|Period 1||0
94477|NCT02043782|232377|P6|COMPLETED|Period 1||6
94479|NCT02043782|232379|P4|COMPLETED|Period 1||6
94480|NCT02043782|232380|P3|COMPLETED|Period 1|One subject discontinued due to an adverse event while testing own product|6
94481|NCT02043782|232381|P2|COMPLETED|Period 1||6
94482|NCT02043782|232382|P1|COMPLETED|Period 1||7
94483|NCT02043782|232377|P6|STARTED|Period 1||6
94484|NCT02043782|232378|P5|STARTED|Period 1||6
94485|NCT02043782|232379|P4|STARTED|Period 1||6
94486|NCT02043782|232380|P3|STARTED|Period 1||7
94487|NCT02043782|232381|P2|STARTED|Period 1||6
94488|NCT02043782|232382|P1|STARTED|Period 1||7
94489|NCT02043704|232392|P2|NOT COMPLETED|Overall Study||7
94490|NCT02043704|232393|P1|NOT COMPLETED|Overall Study||3
94491|NCT02043704|232392|P2|COMPLETED|Overall Study||43
94492|NCT02043704|232393|P1|COMPLETED|Overall Study||47
94493|NCT02043704|232392|P2|STARTED|Overall Study||50
94494|NCT02043704|232393|P1|STARTED|Overall Study||50
94495|NCT02043678|232425|P2|NOT COMPLETED|Overall Study||405
94496|NCT02043678|232426|P1|NOT COMPLETED|Overall Study||401
94497|NCT02043678|232425|P2|COMPLETED|Overall Study||0
94498|NCT02043678|232426|P1|COMPLETED|Overall Study||0
94499|NCT02043678|232425|P2|Treated|Overall Study||396
94500|NCT02043678|232426|P1|Treated|Overall Study||390
94501|NCT02043678|232425|P2|STARTED|Overall Study||405
94502|NCT02043678|232426|P1|STARTED|Overall Study||401
94503|NCT02043652|232442|P1|NOT COMPLETED|Overall Study||26
94504|NCT02043652|232442|P1|COMPLETED|Overall Study||93
94505|NCT02043652|232442|P1|STARTED|Overall Study||119
94506|NCT02043509|232449|P2|NOT COMPLETED|Baseline to 2nd Follow-up||72
94507|NCT02043509|232450|P1|NOT COMPLETED|Baseline to 2nd Follow-up||74
94508|NCT02043509|232449|P2|COMPLETED|Baseline to 2nd Follow-up||132
94509|NCT02043509|232450|P1|COMPLETED|Baseline to 2nd Follow-up||129
94510|NCT02043509|232449|P2|STARTED|Baseline to 2nd Follow-up||204
94511|NCT02043509|232450|P1|STARTED|Baseline to 2nd Follow-up||203
94512|NCT02043509|232449|P2|NOT COMPLETED|Baseline to 1st Follow-up||47
94513|NCT02043509|232450|P1|NOT COMPLETED|Baseline to 1st Follow-up||65
94514|NCT02043509|232449|P2|COMPLETED|Baseline to 1st Follow-up||157
94515|NCT02043509|232450|P1|COMPLETED|Baseline to 1st Follow-up||138
94516|NCT02043509|232449|P2|STARTED|Baseline to 1st Follow-up||204
94517|NCT02043509|232450|P1|STARTED|Baseline to 1st Follow-up||203
94518|NCT02043379|232475|P2|NOT COMPLETED|Overall Study||0
94519|NCT02043379|232476|P1|NOT COMPLETED|Overall Study||0
94520|NCT02043379|232475|P2|COMPLETED|Overall Study||20
94521|NCT02043379|232476|P1|COMPLETED|Overall Study||30
94522|NCT02043379|232475|P2|STARTED|Overall Study||20
94523|NCT02043379|232476|P1|STARTED|Overall Study||30
94524|NCT02043366|232538|P6|NOT COMPLETED|Overall Study||2
94525|NCT02043366|232539|P5|NOT COMPLETED|Overall Study||2
94526|NCT02043366|232540|P4|NOT COMPLETED|Overall Study||2
94527|NCT02043366|232541|P3|NOT COMPLETED|Overall Study||2
94528|NCT02043366|232542|P2|NOT COMPLETED|Overall Study||2
94529|NCT02043366|232543|P1|NOT COMPLETED|Overall Study||2
94530|NCT02043366|232538|P6|COMPLETED|Overall Study||28
94531|NCT02043366|232539|P5|COMPLETED|Overall Study||28
94532|NCT02043366|232540|P4|COMPLETED|Overall Study||28
94533|NCT02043366|232541|P3|COMPLETED|Overall Study||28
94534|NCT02043366|232542|P2|COMPLETED|Overall Study||28
94535|NCT02043366|232543|P1|COMPLETED|Overall Study||28
94536|NCT02043366|232538|P6|STARTED|Overall Study||30
94537|NCT02043366|232539|P5|STARTED|Overall Study||30
94538|NCT02043366|232540|P4|STARTED|Overall Study||30
94539|NCT02043366|232541|P3|STARTED|Overall Study||30
94540|NCT02043366|232542|P2|STARTED|Overall Study||30
94541|NCT02043366|232543|P1|STARTED|Overall Study||30
94542|NCT02043301|232566|P3|NOT COMPLETED|Overall Study||0
94543|NCT02043301|232567|P2|NOT COMPLETED|Overall Study||1
94544|NCT02043301|232568|P1|NOT COMPLETED|Overall Study||0
94545|NCT02043301|232566|P3|COMPLETED|Overall Study||25
94546|NCT02043301|232567|P2|COMPLETED|Overall Study||24
94547|NCT02043301|232568|P1|COMPLETED|Overall Study||25
94548|NCT02043301|232566|P3|STARTED|Overall Study||25
94549|NCT02043301|232567|P2|STARTED|Overall Study||25
94550|NCT02043301|232568|P1|STARTED|Overall Study||25
94551|NCT02043197|232626|P1|NOT COMPLETED|Overall Study||8
94552|NCT02043197|232626|P1|COMPLETED|Overall Study||292
94553|NCT02043197|232626|P1|STARTED|Overall Study||300
94554|NCT02043145|232650|P3|NOT COMPLETED|Overall Study||0
94555|NCT02043145|232651|P2|NOT COMPLETED|Overall Study||0
94556|NCT02043145|232652|P1|NOT COMPLETED|Overall Study||0
94557|NCT02043145|232650|P3|COMPLETED|Overall Study||425
94558|NCT02043145|232651|P2|COMPLETED|Overall Study||247
94559|NCT02043145|232652|P1|COMPLETED|Overall Study||55
94560|NCT02043145|232650|P3|STARTED|Overall Study||425
94561|NCT02043145|232651|P2|STARTED|Overall Study||247
94562|NCT02043145|232652|P1|STARTED|Overall Study||55
94563|NCT02043132|232665|P2|NOT COMPLETED|Overall Study||9
94564|NCT02043132|232666|P1|NOT COMPLETED|Overall Study||5
94565|NCT02043132|232665|P2|COMPLETED|Overall Study||49
94566|NCT02043132|232666|P1|COMPLETED|Overall Study||53
94567|NCT02043132|232665|P2|STARTED|Overall Study||58
94568|NCT02043132|232666|P1|STARTED|Overall Study||58
94569|NCT02043015|232686|P1|NOT COMPLETED|Overall Study||28
94570|NCT02043015|232686|P1|COMPLETED|Overall Study||87
94571|NCT02043015|232686|P1|STARTED|Overall Study||115
94572|NCT02042950|232699|P1|NOT COMPLETED|Overall Study||4
94573|NCT02042950|232699|P1|COMPLETED|Overall Study||0
94574|NCT02042950|232699|P1|STARTED|Overall Study||4
94575|NCT02042924|232705|P1|NOT COMPLETED|Overall Study||1
94576|NCT02042924|232705|P1|COMPLETED|Overall Study||1
94577|NCT02042924|232705|P1|STARTED|Overall Study||2
94578|NCT02042911|232711|P1|NOT COMPLETED|Overall Study||1
94579|NCT02042911|232711|P1|COMPLETED|Overall Study||9
94580|NCT02042911|232711|P1|STARTED|Overall Study||10
94581|NCT02042872|232725|P2|NOT COMPLETED|Overall Study||5
94582|NCT02042872|232726|P1|NOT COMPLETED|Overall Study||0
94583|NCT02042872|232725|P2|COMPLETED|Overall Study||8
94584|NCT02042872|232726|P1|COMPLETED|Overall Study||8
94585|NCT02042872|232725|P2|STARTED|Overall Study||13
94586|NCT02042872|232726|P1|STARTED|Overall Study||8
94587|NCT02042534|232736|P2|NOT COMPLETED|Overall Study||0
94588|NCT02042534|232737|P1|NOT COMPLETED|Overall Study||0
94589|NCT02042534|232736|P2|COMPLETED|Overall Study||94
94590|NCT02042534|232737|P1|COMPLETED|Overall Study||101
94591|NCT02042534|232736|P2|STARTED|Overall Study||94
94592|NCT02042534|232737|P1|STARTED|Overall Study||101
94593|NCT02042443|232753|P2|NOT COMPLETED|Overall Study||26
94594|NCT02042443|232754|P1|NOT COMPLETED|Overall Study||27
94595|NCT02042443|232753|P2|COMPLETED|Overall Study||0
94596|NCT02042443|232754|P1|COMPLETED|Overall Study||0
94597|NCT02042443|232753|P2|Eligible and Analyzable|Overall Study||20
94598|NCT02042443|232754|P1|Eligible and Analyzable|Overall Study||24
94599|NCT02042443|232753|P2|STARTED|Overall Study||26
94600|NCT02042443|232754|P1|STARTED|Overall Study||27
94601|NCT02042404|232766|P2|NOT COMPLETED|Overall Study||0
94602|NCT02042404|232767|P1|NOT COMPLETED|Overall Study||5
94603|NCT02042404|232766|P2|COMPLETED|Overall Study||5
94604|NCT02042404|232767|P1|COMPLETED|Overall Study|39 subjects completed 30 days evaluation. 38 subjects completed 120 days evaluation.|38
94605|NCT02042404|232766|P2|STARTED|Overall Study||5
94606|NCT02042404|232767|P1|STARTED|Overall Study|Enrollment was stopped after 43 were enrolled, had approval to enroll 45 primary cohort subjects|43
94607|NCT02042274|232778|P1|NOT COMPLETED|Overall Study||0
94608|NCT02042274|232778|P1|COMPLETED|Overall Study||12
94609|NCT02042274|232778|P1|STARTED|Overall Study||12
94610|NCT02042131|232786|P3|NOT COMPLETED|Overall Study||0
94611|NCT02042131|232787|P2|NOT COMPLETED|Overall Study||0
94612|NCT02042131|232788|P1|NOT COMPLETED|Overall Study||0
94613|NCT02042131|232786|P3|COMPLETED|Overall Study||33
94614|NCT02042131|232787|P2|COMPLETED|Overall Study||32
94615|NCT02042131|232788|P1|COMPLETED|Overall Study||32
94616|NCT02042131|232786|P3|STARTED|Overall Study||33
94617|NCT02042131|232787|P2|STARTED|Overall Study||32
94618|NCT02042131|232788|P1|STARTED|Overall Study||32
94619|NCT02042014|232805|P1|NOT COMPLETED|Overall Study||8
94620|NCT02042014|232805|P1|COMPLETED|Overall Study||0
94621|NCT02042014|232805|P1|STARTED|Overall Study||8
94622|NCT02041962|232811|P2|NOT COMPLETED|Overall Study||84
94623|NCT02041962|232812|P1|NOT COMPLETED|Overall Study||81
94624|NCT02041962|232811|P2|COMPLETED|Overall Study||31
94625|NCT02041962|232812|P1|COMPLETED|Overall Study||42
94626|NCT02041962|232811|P2|Participants Completing 12 mo. f/up|Overall Study||31
94627|NCT02041962|232812|P1|Participants Completing 12 mo. f/up|Overall Study||42
94628|NCT02041962|232811|P2|Participants Completing 6 mo. f/up|Overall Study||44
94629|NCT02041962|232812|P1|Participants Completing 6 mo. f/up|Overall Study||69
94630|NCT02041962|232811|P2|STARTED|Overall Study||115
94631|NCT02041962|232812|P1|STARTED|Overall Study||123
94632|NCT02041702|232822|P2|NOT COMPLETED|Overall Study||9
94633|NCT02041702|232823|P1|NOT COMPLETED|Overall Study||11
94634|NCT02041702|232822|P2|COMPLETED|Overall Study||134
94635|NCT02041702|232823|P1|COMPLETED|Overall Study||129
94636|NCT02041702|232822|P2|Post MRI Scan/ Post Waiting|Overall Study||140
94637|NCT02041702|232823|P1|Post MRI Scan/ Post Waiting|Overall Study||129
94638|NCT02041702|232822|P2|Pre MRI Scan/ Pre Waitng|Overall Study||140
94639|NCT02041702|232823|P1|Pre MRI Scan/ Pre Waitng|Overall Study||129
94640|NCT02041702|232822|P2|STARTED|Overall Study||143
94641|NCT02041702|232823|P1|STARTED|Overall Study||140
94642|NCT02041533|232838|P2|NOT COMPLETED|Overall Study||258
94643|NCT02041533|232839|P1|NOT COMPLETED|Overall Study||228
94644|NCT02041533|232838|P2|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|12
94645|NCT02041533|232839|P1|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|43
94646|NCT02041533|232838|P2|Began Treatment|Overall Study||263
94647|NCT02041533|232839|P1|Began Treatment|Overall Study||267
94648|NCT02041533|232838|P2|STARTED|Overall Study||270
94649|NCT02041533|232839|P1|STARTED|Overall Study||271
94650|NCT02041520|232861|P2|NOT COMPLETED|Overall Study||7
94651|NCT02041520|232862|P1|NOT COMPLETED|Overall Study||6
94652|NCT02041520|232861|P2|COMPLETED|Overall Study||28
94653|NCT02041520|232862|P1|COMPLETED|Overall Study||29
94654|NCT02041520|232861|P2|STARTED|Overall Study|35 patients randomly assigned to placebo|35
94655|NCT02041520|232862|P1|STARTED|Overall Study|35 patients randomly assigned to omega 3 fatty acids|35
94656|NCT02041377|232882|P1|NOT COMPLETED|Overall Study||0
94657|NCT02041377|232882|P1|COMPLETED|Overall Study||134
94658|NCT02041377|232882|P1|STARTED|Overall Study||134
94659|NCT02041325|232892|P2|NOT COMPLETED|Overall Study||3
94660|NCT02041325|232893|P1|NOT COMPLETED|Overall Study||3
94661|NCT02041325|232892|P2|COMPLETED|Overall Study||13
94662|NCT02041325|232893|P1|COMPLETED|Overall Study||19
94663|NCT02041325|232892|P2|STARTED|Overall Study||16
94664|NCT02041325|232893|P1|STARTED|Overall Study||22
94665|NCT02041286|232905|P1|NOT COMPLETED|Overall Study||1
94666|NCT02041286|232905|P1|COMPLETED|Overall Study|One subject discontinued from testing after low BG fingerstick result (hypoglycemia AE).|135
94667|NCT02041286|232905|P1|STARTED|Overall Study||136
94668|NCT02041221|232919|P6|NOT COMPLETED|Part 2||0
94669|NCT02041221|232920|P5|NOT COMPLETED|Part 2||0
94670|NCT02041221|232921|P4|NOT COMPLETED|Part 2||0
94671|NCT02041221|232922|P3|NOT COMPLETED|Part 2||1
94672|NCT02041221|232923|P2|NOT COMPLETED|Part 2||0
94673|NCT02041221|232924|P1|NOT COMPLETED|Part 2||0
94674|NCT02041221|232919|P6|COMPLETED|Part 2||6
94675|NCT02041221|232920|P5|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
94676|NCT02041221|232921|P4|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
94677|NCT02041221|232922|P3|COMPLETED|Part 2||5
94678|NCT02041221|232923|P2|COMPLETED|Part 2||6
94679|NCT02041221|232924|P1|COMPLETED|Part 2||6
94680|NCT02041221|232919|P6|STARTED|Part 2||6
94681|NCT02041221|232920|P5|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
94682|NCT02041221|232921|P4|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually.|0
94683|NCT02041221|232922|P3|STARTED|Part 2||6
94684|NCT02041221|232923|P2|STARTED|Part 2||6
94685|NCT02041221|232924|P1|STARTED|Part 2||6
94686|NCT02041221|232919|P6|NOT COMPLETED|Part 1||0
94687|NCT02041221|232920|P5|NOT COMPLETED|Part 1||0
94688|NCT02041221|232921|P4|NOT COMPLETED|Part 1||0
94689|NCT02041221|232922|P3|NOT COMPLETED|Part 1||0
94690|NCT02041221|232923|P2|NOT COMPLETED|Part 1||0
94691|NCT02041221|232924|P1|NOT COMPLETED|Part 1||0
94692|NCT02041221|232919|P6|COMPLETED|Part 1||10
94693|NCT02041221|232920|P5|COMPLETED|Part 1||6
94694|NCT02041221|232921|P4|COMPLETED|Part 1||6
94695|NCT02041221|232922|P3|COMPLETED|Part 1||6
94696|NCT02041221|232923|P2|COMPLETED|Part 1||6
94697|NCT02041221|232924|P1|COMPLETED|Part 1||6
94698|NCT02041221|232919|P6|STARTED|Part 1||10
94699|NCT02041221|232920|P5|STARTED|Part 1||6
94700|NCT02041221|232921|P4|STARTED|Part 1||6
94701|NCT02041221|232922|P3|STARTED|Part 1||6
94702|NCT02041221|232923|P2|STARTED|Part 1||6
94703|NCT02041221|232924|P1|STARTED|Part 1||6
94704|NCT02041104|232940|P2|NOT COMPLETED|Overall Study||7
94705|NCT02041104|232941|P1|NOT COMPLETED|Overall Study||1
94706|NCT02041104|232940|P2|COMPLETED|Overall Study||16
94707|NCT02041104|232941|P1|COMPLETED|Overall Study||27
94708|NCT02041104|232940|P2|STARTED|Overall Study||23
94709|NCT02041104|232941|P1|STARTED|Overall Study||28
94710|NCT02041091|232981|P2|NOT COMPLETED|Optional Safety Extension Period||82
94711|NCT02041091|232982|P1|NOT COMPLETED|Optional Safety Extension Period||85
94712|NCT02041091|232981|P2|COMPLETED|Optional Safety Extension Period||0
94713|NCT02041091|232982|P1|COMPLETED|Optional Safety Extension Period||0
94714|NCT02041091|232981|P2|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|82
94715|NCT02041091|232982|P1|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|85
94716|NCT02041091|232981|P2|NOT COMPLETED|Treatment||23
94717|NCT02041091|232982|P1|NOT COMPLETED|Treatment||22
94718|NCT02041091|232981|P2|COMPLETED|Treatment||91
94719|NCT02041091|232982|P1|COMPLETED|Treatment||90
94720|NCT02041091|232981|P2|Participated in Follow Up|Treatment||96
94721|NCT02041091|232982|P1|Participated in Follow Up|Treatment||106
94722|NCT02041091|232981|P2|Received At Least One Dose of Study Drug|Treatment||114
94723|NCT02041091|232982|P1|Received At Least One Dose of Study Drug|Treatment||112
94724|NCT02041091|232981|P2|STARTED|Treatment||114
94725|NCT02041091|232982|P1|STARTED|Treatment||112
94726|NCT02040870|233004|P1|NOT COMPLETED|Overall Study||103
94727|NCT02040870|233004|P1|COMPLETED|Overall Study||0
94728|NCT02040870|233004|P1|Discontinue From Study|Overall Study||26
94729|NCT02040870|233004|P1|Entered Survival Follow-up|Overall Study||75
94730|NCT02040870|233004|P1|Entered Post-treatment Follow-up|Overall Study||2
94731|NCT02040870|233004|P1|STARTED|Overall Study||103
94732|NCT02040844|233028|P3|NOT COMPLETED|Overall Study||47
94733|NCT02040844|233029|P2|NOT COMPLETED|Overall Study||39
94734|NCT02040844|233030|P1|NOT COMPLETED|Overall Study||50
94735|NCT02040844|233028|P3|COMPLETED|Overall Study||97
94736|NCT02040844|233029|P2|COMPLETED|Overall Study||109
94737|NCT02040844|233030|P1|COMPLETED|Overall Study||88
94738|NCT02040844|233028|P3|STARTED|Overall Study||144
94739|NCT02040844|233029|P2|STARTED|Overall Study||148
94740|NCT02040844|233030|P1|STARTED|Overall Study||138
94741|NCT02040792|233058|P5|NOT COMPLETED|Overall Study||7
94742|NCT02040792|233059|P4|NOT COMPLETED|Overall Study||7
94743|NCT02040792|233060|P3|NOT COMPLETED|Overall Study||3
94744|NCT02040792|233061|P2|NOT COMPLETED|Overall Study||3
94745|NCT02040792|233062|P1|NOT COMPLETED|Overall Study||6
94746|NCT02040792|233058|P5|COMPLETED|Overall Study||67
94747|NCT02040792|233059|P4|COMPLETED|Overall Study||64
94748|NCT02040792|233060|P3|COMPLETED|Overall Study||68
94749|NCT02040792|233061|P2|COMPLETED|Overall Study||65
94750|NCT02040792|233062|P1|COMPLETED|Overall Study||64
94751|NCT02040792|233058|P5|STARTED|Overall Study||74
94752|NCT02040792|233059|P4|STARTED|Overall Study||71
94753|NCT02040792|233060|P3|STARTED|Overall Study||71
94754|NCT02040792|233061|P2|STARTED|Overall Study||68
94755|NCT02040792|233062|P1|STARTED|Overall Study||70
94756|NCT02040779|233077|P3|NOT COMPLETED|Overall Study||4
94757|NCT02040779|233078|P2|NOT COMPLETED|Overall Study||7
94758|NCT02040779|233079|P1|NOT COMPLETED|Overall Study||12
94759|NCT02040779|233077|P3|COMPLETED|Overall Study||88
94760|NCT02040779|233078|P2|COMPLETED|Overall Study||83
94761|NCT02040779|233079|P1|COMPLETED|Overall Study||79
94762|NCT02040779|233077|P3|Full Analysis Set (FAS)|Overall Study||92
94763|NCT02040779|233078|P2|Full Analysis Set (FAS)|Overall Study||88
94764|NCT02040779|233079|P1|Full Analysis Set (FAS)|Overall Study||90
94765|NCT02040779|233077|P3|STARTED|Overall Study||92
94766|NCT02040779|233078|P2|STARTED|Overall Study||90
94767|NCT02040779|233079|P1|STARTED|Overall Study||91
94768|NCT02040766|233119|P5|NOT COMPLETED|Overall Study||13
94769|NCT02040766|233120|P4|NOT COMPLETED|Overall Study||13
94770|NCT02040766|233121|P3|NOT COMPLETED|Overall Study||12
94771|NCT02040766|233122|P2|NOT COMPLETED|Overall Study||10
94772|NCT02040766|233123|P1|NOT COMPLETED|Overall Study||18
94773|NCT02040766|233119|P5|COMPLETED|Overall Study||112
94774|NCT02040766|233120|P4|COMPLETED|Overall Study||112
94775|NCT02040766|233121|P3|COMPLETED|Overall Study||113
94776|NCT02040766|233122|P2|COMPLETED|Overall Study||116
94777|NCT02040766|233123|P1|COMPLETED|Overall Study||109
94778|NCT02040766|233119|P5|STARTED|Overall Study||125
94779|NCT02040766|233120|P4|STARTED|Overall Study||125
94780|NCT02040766|233121|P3|STARTED|Overall Study||125
94781|NCT02040766|233122|P2|STARTED|Overall Study||126
94782|NCT02040766|233123|P1|STARTED|Overall Study||127
94783|NCT02040623|233164|P3|NOT COMPLETED|Overall Study||2
94784|NCT02040623|233165|P2|NOT COMPLETED|Overall Study||6
94785|NCT02040623|233166|P1|NOT COMPLETED|Overall Study||4
94786|NCT02040623|233164|P3|COMPLETED|Overall Study||10
94787|NCT02040623|233165|P2|COMPLETED|Overall Study||6
94788|NCT02040623|233166|P1|COMPLETED|Overall Study||7
94789|NCT02040623|233164|P3|STARTED|Overall Study||12
94790|NCT02040623|233165|P2|STARTED|Overall Study||12
94791|NCT02040623|233166|P1|STARTED|Overall Study||11
94792|NCT02040584|233176|P2|NOT COMPLETED|Overall Study||32
94793|NCT02040584|233177|P1|NOT COMPLETED|Overall Study||35
94794|NCT02040584|233176|P2|COMPLETED|Overall Study||74
94795|NCT02040584|233177|P1|COMPLETED|Overall Study||70
94796|NCT02040584|233176|P2|STARTED|Overall Study||106
94797|NCT02040584|233177|P1|STARTED|Overall Study||105
94798|NCT02040532|233210|P1|NOT COMPLETED|Overall Study||12
94799|NCT02040532|233210|P1|COMPLETED|Overall Study||20
94800|NCT02040532|233210|P1|Received at Least One Dose of Medication|Overall Study||26
94801|NCT02040532|233210|P1|STARTED|Overall Study||32
94802|NCT02040428|233223|P2|NOT COMPLETED|Overall Study||4
94803|NCT02040428|233224|P1|NOT COMPLETED|Overall Study||5
94804|NCT02040428|233223|P2|COMPLETED|Overall Study||77
94805|NCT02040428|233224|P1|COMPLETED|Overall Study||70
94806|NCT02040428|233223|P2|Intent to Treat (Randomized Subjects)|Overall Study||80
94807|NCT02040428|233224|P1|Intent to Treat (Randomized Subjects)|Overall Study||76
94808|NCT02040428|233223|P2|STARTED|Overall Study||81
94809|NCT02040428|233224|P1|STARTED|Overall Study||75
94810|NCT02040116|233236|P1|NOT COMPLETED|Overall Study||0
94811|NCT02040116|233236|P1|COMPLETED|Overall Study||19
94812|NCT02040116|233236|P1|STARTED|Overall Study||19
94813|NCT02040077|233247|P3|NOT COMPLETED|Overall Study||0
94814|NCT02040077|233248|P2|NOT COMPLETED|Overall Study||0
94815|NCT02040077|233249|P1|NOT COMPLETED|Overall Study||0
94816|NCT02040077|233247|P3|COMPLETED|Overall Study||25
94817|NCT02040077|233248|P2|COMPLETED|Overall Study||24
94818|NCT02040077|233249|P1|COMPLETED|Overall Study||27
94819|NCT02040077|233247|P3|STARTED|Overall Study||25
94820|NCT02040077|233248|P2|STARTED|Overall Study||24
94821|NCT02040077|233249|P1|STARTED|Overall Study||27
94822|NCT02039947|233264|P4|NOT COMPLETED|Overall Study||0
94823|NCT02039947|233265|P3|NOT COMPLETED|Overall Study||0
94824|NCT02039947|233266|P2|NOT COMPLETED|Overall Study||0
94825|NCT02039947|233267|P1|NOT COMPLETED|Overall Study||0
94826|NCT02039947|233264|P4|COMPLETED|Overall Study||17
94827|NCT02039947|233265|P3|COMPLETED|Overall Study||16
94828|NCT02039947|233266|P2|COMPLETED|Overall Study||16
94829|NCT02039947|233267|P1|COMPLETED|Overall Study||76
94830|NCT02039947|233264|P4|STARTED|Overall Study||17
94831|NCT02039947|233265|P3|STARTED|Overall Study||16
94832|NCT02039947|233266|P2|STARTED|Overall Study||16
94833|NCT02039947|233267|P1|STARTED|Overall Study||76
94834|NCT02039908|233302|P4|NOT COMPLETED|Phase 2-School Year||8
94835|NCT02039908|233303|P3|NOT COMPLETED|Phase 2-School Year||12
94836|NCT02039908|233304|P2|NOT COMPLETED|Phase 2-School Year||0
94837|NCT02039908|233305|P1|NOT COMPLETED|Phase 2-School Year||0
94838|NCT02039908|233302|P4|COMPLETED|Phase 2-School Year||116
94839|NCT02039908|233303|P3|COMPLETED|Phase 2-School Year||109
94840|NCT02039908|233304|P2|COMPLETED|Phase 2-School Year||0
94841|NCT02039908|233305|P1|COMPLETED|Phase 2-School Year||0
94842|NCT02039908|233302|P4|STARTED|Phase 2-School Year||124
94843|NCT02039908|233303|P3|STARTED|Phase 2-School Year||121
94844|NCT02039908|233304|P2|STARTED|Phase 2-School Year||0
94845|NCT02039908|233305|P1|STARTED|Phase 2-School Year||0
94846|NCT02039908|233302|P4|NOT COMPLETED|Phase 1-Summer||0
94847|NCT02039908|233303|P3|NOT COMPLETED|Phase 1-Summer||0
94848|NCT02039908|233304|P2|NOT COMPLETED|Phase 1-Summer||6
94849|NCT02039908|233305|P1|NOT COMPLETED|Phase 1-Summer||13
94850|NCT02039908|233302|P4|COMPLETED|Phase 1-Summer||0
94851|NCT02039908|233303|P3|COMPLETED|Phase 1-Summer||0
94852|NCT02039908|233304|P2|COMPLETED|Phase 1-Summer||132
94853|NCT02039908|233305|P1|COMPLETED|Phase 1-Summer||116
94854|NCT02039908|233302|P4|STARTED|Phase 1-Summer||0
94855|NCT02039908|233303|P3|STARTED|Phase 1-Summer||0
94856|NCT02039908|233304|P2|STARTED|Phase 1-Summer||138
94857|NCT02039908|233305|P1|STARTED|Phase 1-Summer||129
94858|NCT02039856|233319|P2|NOT COMPLETED|Overall Study||853
94859|NCT02039856|233320|P1|NOT COMPLETED|Overall Study||2027
94860|NCT02039856|233319|P2|COMPLETED|Overall Study||327
94861|NCT02039856|233320|P1|COMPLETED|Overall Study||693
94862|NCT02039856|233319|P2|Total 24-month Completed|Overall Study||327
94863|NCT02039856|233320|P1|Total 24-month Completed|Overall Study||693
94864|NCT02039856|233319|P2|24-month Completed Providers/Staff|Overall Study||105
94865|NCT02039856|233320|P1|24-month Completed Providers/Staff|Overall Study||174
94866|NCT02039856|233319|P2|24-month Started Providers/Staff|Overall Study||304
94867|NCT02039856|233320|P1|24-month Started Providers/Staff|Overall Study||565
94868|NCT02039856|233319|P2|24-month Completed - Patients|Overall Study||222
94869|NCT02039856|233320|P1|24-month Completed - Patients|Overall Study||519
94870|NCT02039856|233319|P2|24-month Started - Patients|Overall Study||442
94871|NCT02039856|233320|P1|24-month Started - Patients|Overall Study||953
94872|NCT02039856|233319|P2|24-month Started|Overall Study||746
94873|NCT02039856|233320|P1|24-month Started|Overall Study||1518
94874|NCT02039856|233319|P2|12-month Providers/Staff|Overall Study||0
94875|NCT02039856|233320|P1|12-month Providers/Staff|Overall Study||0
94876|NCT02039856|233319|P2|12-month Completed- Patients|Overall Study||241
94877|NCT02039856|233320|P1|12-month Completed- Patients|Overall Study||580
94878|NCT02039856|233319|P2|12-month Started-patients|Overall Study||442
94879|NCT02039856|233320|P1|12-month Started-patients|Overall Study||953
94880|NCT02039856|233319|P2|Total Baseline Completed|Overall Study||536
94881|NCT02039856|233320|P1|Total Baseline Completed|Overall Study||1147
94882|NCT02039856|233319|P2|Baseline Completed -Providers/Staff|Overall Study||94
94883|NCT02039856|233320|P1|Baseline Completed -Providers/Staff|Overall Study||194
94884|NCT02039856|233319|P2|Baseline Started - Providers/Staff|Overall Study||261
94885|NCT02039856|233320|P1|Baseline Started - Providers/Staff|Overall Study||537
94886|NCT02039856|233319|P2|Baseline Completed - Patients|Overall Study||442
94887|NCT02039856|233320|P1|Baseline Completed - Patients|Overall Study||953
94888|NCT02039856|233319|P2|Baseline Started - Patients|Overall Study||919
94889|NCT02039856|233320|P1|Baseline Started - Patients|Overall Study||2183
94890|NCT02039856|233319|P2|STARTED|Overall Study||1180
94891|NCT02039856|233320|P1|STARTED|Overall Study||2720
94892|NCT02039817|233342|P2|NOT COMPLETED|Overall Study||0
94893|NCT02039817|233343|P1|NOT COMPLETED|Overall Study||0
94894|NCT02039817|233342|P2|COMPLETED|Overall Study||8
94895|NCT02039817|233343|P1|COMPLETED|Overall Study||8
94896|NCT02039817|233342|P2|STARTED|Overall Study||8
94897|NCT02039817|233343|P1|STARTED|Overall Study||8
94898|NCT02039778|233352|P1|NOT COMPLETED|Overall Study||4
94899|NCT02039778|233352|P1|COMPLETED|Overall Study||0
94900|NCT02039778|233352|P1|STARTED|Overall Study||4
94901|NCT02039687|233364|P4|NOT COMPLETED|Overall Study||0
94902|NCT02039687|233365|P3|NOT COMPLETED|Overall Study||3
94903|NCT02039687|233366|P2|NOT COMPLETED|Overall Study||1
94904|NCT02039687|233367|P1|NOT COMPLETED|Overall Study||0
94905|NCT02039687|233364|P4|COMPLETED|Overall Study||16
94906|NCT02039687|233365|P3|COMPLETED|Overall Study||13
94907|NCT02039687|233366|P2|COMPLETED|Overall Study||15
94908|NCT02039687|233367|P1|COMPLETED|Overall Study||16
94909|NCT02039687|233364|P4|STARTED|Overall Study||16
94910|NCT02039687|233365|P3|STARTED|Overall Study||16
94911|NCT02039687|233366|P2|STARTED|Overall Study||16
94912|NCT02039687|233367|P1|STARTED|Overall Study||16
94913|NCT02039674|233402|P9|NOT COMPLETED|Overall Study||45
94914|NCT02039674|233403|P8|NOT COMPLETED|Overall Study||63
94915|NCT02039674|233404|P7|NOT COMPLETED|Overall Study||60
94916|NCT02039674|233405|P6|NOT COMPLETED|Overall Study||7
94917|NCT02039674|233406|P5|NOT COMPLETED|Overall Study||12
94918|NCT02039674|233407|P4|NOT COMPLETED|Overall Study||6
94919|NCT02039674|233408|P3|NOT COMPLETED|Overall Study||24
94920|NCT02039674|233409|P2|NOT COMPLETED|Overall Study||25
94921|NCT02039674|233410|P1|NOT COMPLETED|Overall Study||24
94922|NCT02039674|233402|P9|COMPLETED|Overall Study||0
94923|NCT02039674|233403|P8|COMPLETED|Overall Study||0
94924|NCT02039674|233404|P7|COMPLETED|Overall Study||0
94925|NCT02039674|233405|P6|COMPLETED|Overall Study||0
94926|NCT02039674|233406|P5|COMPLETED|Overall Study||0
94927|NCT02039674|233407|P4|COMPLETED|Overall Study||0
94928|NCT02039674|233408|P3|COMPLETED|Overall Study||0
94929|NCT02039674|233409|P2|COMPLETED|Overall Study||0
94930|NCT02039674|233410|P1|COMPLETED|Overall Study||1
94931|NCT02039674|233402|P9|Treated|Overall Study||45
94932|NCT02039674|233403|P8|Treated|Overall Study|One participant was randomized but did not receive study treatment|62
94933|NCT02039674|233404|P7|Treated|Overall Study|One participant was randomized but did not receive study treatment.|59
94934|NCT02039674|233405|P6|Treated|Overall Study||7
94935|NCT02039674|233406|P5|Treated|Overall Study||12
94936|NCT02039674|233407|P4|Treated|Overall Study||6
94937|NCT02039674|233408|P3|Treated|Overall Study||24
94938|NCT02039674|233409|P2|Treated|Overall Study|One participant was randomized but did not receive study treatment.|24
94939|NCT02039674|233410|P1|Treated|Overall Study||25
94940|NCT02039674|233402|P9|STARTED|Overall Study||45
94941|NCT02039674|233403|P8|STARTED|Overall Study||63
94942|NCT02039674|233404|P7|STARTED|Overall Study||60
94943|NCT02039674|233405|P6|STARTED|Overall Study||7
94944|NCT02039674|233406|P5|STARTED|Overall Study||12
94945|NCT02039674|233407|P4|STARTED|Overall Study||6
94946|NCT02039674|233408|P3|STARTED|Overall Study||24
94947|NCT02039674|233409|P2|STARTED|Overall Study||25
94948|NCT02039674|233410|P1|STARTED|Overall Study||25
94949|NCT02039505|233445|P7|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||71
94950|NCT02039505|233446|P6|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
94951|NCT02039505|233447|P5|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
94952|NCT02039505|233448|P4|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
94953|NCT02039505|233449|P3|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
94954|NCT02039505|233450|P2|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
94955|NCT02039505|233451|P1|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
94956|NCT02039505|233445|P7|COMPLETED|Open-Label (Week 10 up to Week 154)||188
94957|NCT02039505|233446|P6|COMPLETED|Open-Label (Week 10 up to Week 154)||0
94958|NCT02039505|233447|P5|COMPLETED|Open-Label (Week 10 up to Week 154)||0
94959|NCT02039505|233448|P4|COMPLETED|Open-Label (Week 10 up to Week 154)||0
94960|NCT02039505|233449|P3|COMPLETED|Open-Label (Week 10 up to Week 154)||0
94961|NCT02039505|233450|P2|COMPLETED|Open-Label (Week 10 up to Week 154)||0
94962|NCT02039505|233451|P1|COMPLETED|Open-Label (Week 10 up to Week 154)||0
94963|NCT02039505|233445|P7|STARTED|Open-Label (Week 10 up to Week 154)||259
94964|NCT02039505|233446|P6|STARTED|Open-Label (Week 10 up to Week 154)||0
94965|NCT02039505|233447|P5|STARTED|Open-Label (Week 10 up to Week 154)||0
94966|NCT02039505|233448|P4|STARTED|Open-Label (Week 10 up to Week 154)||0
94967|NCT02039505|233449|P3|STARTED|Open-Label (Week 10 up to Week 154)||0
94968|NCT02039505|233450|P2|STARTED|Open-Label (Week 10 up to Week 154)||0
94969|NCT02039505|233451|P1|STARTED|Open-Label (Week 10 up to Week 154)||0
94970|NCT02039505|233445|P7|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
94971|NCT02039505|233446|P6|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||14
94972|NCT02039505|233447|P5|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||11
94973|NCT02039505|233448|P4|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||24
94974|NCT02039505|233449|P3|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
94975|NCT02039505|233450|P2|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
94976|NCT02039505|233451|P1|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
94977|NCT02039505|233445|P7|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
94978|NCT02039505|233446|P6|COMPLETED|Maintenance Phase (Week 14 to Week 60)||12
94979|NCT02039505|233447|P5|COMPLETED|Maintenance Phase (Week 14 to Week 60)||30
94980|NCT02039505|233448|P4|COMPLETED|Maintenance Phase (Week 14 to Week 60)||18
94981|NCT02039505|233449|P3|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
94982|NCT02039505|233450|P2|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
94983|NCT02039505|233451|P1|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
94984|NCT02039505|233445|P7|STARTED|Maintenance Phase (Week 14 to Week 60)||0
94985|NCT02039505|233446|P6|STARTED|Maintenance Phase (Week 14 to Week 60)||26
94986|NCT02039505|233447|P5|STARTED|Maintenance Phase (Week 14 to Week 60)||41
94987|NCT02039505|233448|P4|STARTED|Maintenance Phase (Week 14 to Week 60)||42
94988|NCT02039505|233449|P3|STARTED|Maintenance Phase (Week 14 to Week 60)||0
94989|NCT02039505|233450|P2|STARTED|Maintenance Phase (Week 14 to Week 60)||0
94990|NCT02039505|233451|P1|STARTED|Maintenance Phase (Week 14 to Week 60)||0
94991|NCT02039505|233445|P7|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
94992|NCT02039505|233446|P6|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
94993|NCT02039505|233447|P5|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
94994|NCT02039505|233448|P4|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
94995|NCT02039505|233449|P3|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||10
94996|NCT02039505|233450|P2|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||9
94997|NCT02039505|233451|P1|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||4
94998|NCT02039505|233445|P7|COMPLETED|Induction Phase (Week 0 to Week 14)||0
94999|NCT02039505|233446|P6|COMPLETED|Induction Phase (Week 0 to Week 14)||0
95000|NCT02039505|233447|P5|COMPLETED|Induction Phase (Week 0 to Week 14)||0
95001|NCT02039505|233448|P4|COMPLETED|Induction Phase (Week 0 to Week 14)||0
95002|NCT02039505|233449|P3|COMPLETED|Induction Phase (Week 0 to Week 14)||36
95003|NCT02039505|233450|P2|COMPLETED|Induction Phase (Week 0 to Week 14)||155
95004|NCT02039505|233451|P1|COMPLETED|Induction Phase (Week 0 to Week 14)||78
95005|NCT02039505|233445|P7|STARTED|Induction Phase (Week 0 to Week 14)||0
95006|NCT02039505|233446|P6|STARTED|Induction Phase (Week 0 to Week 14)||0
95007|NCT02039505|233447|P5|STARTED|Induction Phase (Week 0 to Week 14)||0
95008|NCT02039505|233448|P4|STARTED|Induction Phase (Week 0 to Week 14)||0
95009|NCT02039505|233449|P3|STARTED|Induction Phase (Week 0 to Week 14)||46
95010|NCT02039505|233450|P2|STARTED|Induction Phase (Week 0 to Week 14)||164
95011|NCT02039505|233451|P1|STARTED|Induction Phase (Week 0 to Week 14)||82
95012|NCT02039427|233527|P4|NOT COMPLETED|Overall Study||5
95013|NCT02039427|233528|P3|NOT COMPLETED|Overall Study||3
95014|NCT02039427|233529|P2|NOT COMPLETED|Overall Study||1
95015|NCT02039427|233530|P1|NOT COMPLETED|Overall Study||3
95016|NCT02039427|233527|P4|COMPLETED|Overall Study||43
95017|NCT02039427|233528|P3|COMPLETED|Overall Study||45
95018|NCT02039427|233529|P2|COMPLETED|Overall Study||47
95019|NCT02039427|233530|P1|COMPLETED|Overall Study||45
95020|NCT02039427|233527|P4|STARTED|Overall Study||48
95021|NCT02039427|233528|P3|STARTED|Overall Study||48
95022|NCT02039427|233529|P2|STARTED|Overall Study||48
95023|NCT02039427|233530|P1|STARTED|Overall Study||48
95024|NCT02039414|233550|P2|NOT COMPLETED|Overall Study||2
95025|NCT02039414|233551|P1|NOT COMPLETED|Overall Study||6
95026|NCT02039414|233550|P2|COMPLETED|Overall Study||16
95027|NCT02039414|233551|P1|COMPLETED|Overall Study||16
95028|NCT02039414|233550|P2|STARTED|Overall Study||18
95029|NCT02039414|233551|P1|STARTED|Overall Study||22
95030|NCT02039115|233565|P2|NOT COMPLETED|Overall Study||0
95031|NCT02039115|233566|P1|NOT COMPLETED|Overall Study||0
95032|NCT02039115|233565|P2|COMPLETED|Overall Study||0
95033|NCT02039115|233566|P1|COMPLETED|Overall Study||1
95034|NCT02039115|233565|P2|STARTED|Overall Study||0
95035|NCT02039115|233566|P1|STARTED|Overall Study||1
95036|NCT02038959|233574|P2|NOT COMPLETED|Overall Study||8
95037|NCT02038959|233575|P1|NOT COMPLETED|Overall Study||6
95038|NCT02038959|233574|P2|COMPLETED|Overall Study||89
95039|NCT02038959|233575|P1|COMPLETED|Overall Study||92
95040|NCT02038959|233574|P2|STARTED|Overall Study||97
95041|NCT02038959|233575|P1|STARTED|Overall Study||98
95042|NCT02038946|233601|P1|NOT COMPLETED|Overall Study||11
95043|NCT02038946|233601|P1|COMPLETED|Overall Study||81
95044|NCT02038946|233601|P1|STARTED|Overall Study||92
95045|NCT02038933|233612|P1|NOT COMPLETED|Follow-up||19
95046|NCT02038933|233612|P1|COMPLETED|Follow-up|Includes subjects still on-treatment and subjects off-treatment continuing in the Follow-up period.|102
95047|NCT02038933|233612|P1|STARTED|Follow-up||121
95048|NCT02038933|233612|P1|NOT COMPLETED|Treatment||114
95049|NCT02038933|233612|P1|COMPLETED|Treatment|Subjects continuing in the treatment period|7
95050|NCT02038933|233612|P1|STARTED|Treatment||121
95051|NCT02038907|233645|P14|NOT COMPLETED|Overall Study||0
95052|NCT02038907|233646|P13|NOT COMPLETED|Overall Study||0
95053|NCT02038907|233647|P12|NOT COMPLETED|Overall Study||0
95054|NCT02038907|233648|P11|NOT COMPLETED|Overall Study||2
95055|NCT02038907|233649|P10|NOT COMPLETED|Overall Study||0
95056|NCT02038907|233650|P9|NOT COMPLETED|Overall Study||0
95057|NCT02038907|233651|P8|NOT COMPLETED|Overall Study||0
95058|NCT02038907|233652|P7|NOT COMPLETED|Overall Study||0
95059|NCT02038907|233653|P6|NOT COMPLETED|Overall Study||0
95060|NCT02038907|233654|P5|NOT COMPLETED|Overall Study||0
95061|NCT02038907|233655|P4|NOT COMPLETED|Overall Study||0
95062|NCT02038907|233656|P3|NOT COMPLETED|Overall Study||0
95063|NCT02038907|233657|P2|NOT COMPLETED|Overall Study||0
95064|NCT02038907|233658|P1|NOT COMPLETED|Overall Study||0
95065|NCT02038907|233645|P14|COMPLETED|Overall Study||31
95066|NCT02038907|233646|P13|COMPLETED|Overall Study||29
95067|NCT02038907|233647|P12|COMPLETED|Overall Study||28
95068|NCT02038907|233648|P11|COMPLETED|Overall Study||27
95069|NCT02038907|233649|P10|COMPLETED|Overall Study||30
95070|NCT02038907|233650|P9|COMPLETED|Overall Study||29
95071|NCT02038907|233651|P8|COMPLETED|Overall Study||32
95072|NCT02038907|233652|P7|COMPLETED|Overall Study||30
95073|NCT02038907|233653|P6|COMPLETED|Overall Study||31
95074|NCT02038907|233654|P5|COMPLETED|Overall Study||30
95075|NCT02038907|233655|P4|COMPLETED|Overall Study||31
95076|NCT02038907|233656|P3|COMPLETED|Overall Study||30
95077|NCT02038907|233657|P2|COMPLETED|Overall Study||30
95078|NCT02038907|233658|P1|COMPLETED|Overall Study||30
95079|NCT02038907|233645|P14|STARTED|Overall Study||31
95080|NCT02038907|233646|P13|STARTED|Overall Study||29
95081|NCT02038907|233647|P12|STARTED|Overall Study||28
95082|NCT02038907|233648|P11|STARTED|Overall Study||29
95083|NCT02038907|233649|P10|STARTED|Overall Study||30
95084|NCT02038907|233650|P9|STARTED|Overall Study||29
95085|NCT02038907|233651|P8|STARTED|Overall Study||32
95086|NCT02038907|233652|P7|STARTED|Overall Study||30
95087|NCT02038907|233653|P6|STARTED|Overall Study||31
95088|NCT02038907|233654|P5|STARTED|Overall Study||30
95089|NCT02038907|233655|P4|STARTED|Overall Study||31
95090|NCT02038907|233656|P3|STARTED|Overall Study||30
95091|NCT02038907|233657|P2|STARTED|Overall Study||30
95092|NCT02038907|233658|P1|STARTED|Overall Study||30
95093|NCT02038829|234186|P12|NOT COMPLETED|Treatment Period 6||0
95094|NCT02038829|234187|P11|NOT COMPLETED|Treatment Period 6||0
95095|NCT02038829|234188|P10|NOT COMPLETED|Treatment Period 6||0
95096|NCT02038829|234189|P9|NOT COMPLETED|Treatment Period 6||0
95097|NCT02038829|234190|P8|NOT COMPLETED|Treatment Period 6||0
95098|NCT02038829|234191|P7|NOT COMPLETED|Treatment Period 6||0
95099|NCT02038829|234192|P6|NOT COMPLETED|Treatment Period 6||0
95100|NCT02038829|234193|P5|NOT COMPLETED|Treatment Period 6||0
95101|NCT02038829|234194|P4|NOT COMPLETED|Treatment Period 6||0
95102|NCT02038829|234195|P3|NOT COMPLETED|Treatment Period 6||1
95103|NCT02038829|234196|P2|NOT COMPLETED|Treatment Period 6||0
95104|NCT02038829|234197|P1|NOT COMPLETED|Treatment Period 6||0
95105|NCT02038829|234186|P12|COMPLETED|Treatment Period 6||8
95106|NCT02038829|234187|P11|COMPLETED|Treatment Period 6||7
95107|NCT02038829|234188|P10|COMPLETED|Treatment Period 6||8
95108|NCT02038829|234189|P9|COMPLETED|Treatment Period 6||7
95109|NCT02038829|234190|P8|COMPLETED|Treatment Period 6||8
95110|NCT02038829|234191|P7|COMPLETED|Treatment Period 6||7
95111|NCT02038829|234192|P6|COMPLETED|Treatment Period 6||7
95112|NCT02038829|234193|P5|COMPLETED|Treatment Period 6||7
95113|NCT02038829|234194|P4|COMPLETED|Treatment Period 6||8
95114|NCT02038829|234195|P3|COMPLETED|Treatment Period 6||7
95115|NCT02038829|234196|P2|COMPLETED|Treatment Period 6||7
95116|NCT02038829|234197|P1|COMPLETED|Treatment Period 6||7
95117|NCT02038829|234186|P12|STARTED|Treatment Period 6||8
95118|NCT02038829|234187|P11|STARTED|Treatment Period 6||7
95119|NCT02038829|234188|P10|STARTED|Treatment Period 6||8
95120|NCT02038829|234189|P9|STARTED|Treatment Period 6||7
95121|NCT02038829|234190|P8|STARTED|Treatment Period 6||8
95122|NCT02038829|234191|P7|STARTED|Treatment Period 6||7
95123|NCT02038829|234192|P6|STARTED|Treatment Period 6||7
95124|NCT02038829|234193|P5|STARTED|Treatment Period 6||7
95125|NCT02038829|234194|P4|STARTED|Treatment Period 6||8
95126|NCT02038829|234195|P3|STARTED|Treatment Period 6||8
95127|NCT02038829|234196|P2|STARTED|Treatment Period 6||7
95128|NCT02038829|234197|P1|STARTED|Treatment Period 6||7
95129|NCT02038829|234186|P12|NOT COMPLETED|Washout Period 5||0
95130|NCT02038829|234187|P11|NOT COMPLETED|Washout Period 5||0
95131|NCT02038829|234188|P10|NOT COMPLETED|Washout Period 5||0
95132|NCT02038829|234189|P9|NOT COMPLETED|Washout Period 5||0
95133|NCT02038829|234190|P8|NOT COMPLETED|Washout Period 5||0
95134|NCT02038829|234191|P7|NOT COMPLETED|Washout Period 5||0
95135|NCT02038829|234192|P6|NOT COMPLETED|Washout Period 5||0
95136|NCT02038829|234193|P5|NOT COMPLETED|Washout Period 5||0
95137|NCT02038829|234194|P4|NOT COMPLETED|Washout Period 5||0
95138|NCT02038829|234195|P3|NOT COMPLETED|Washout Period 5||0
95139|NCT02038829|234196|P2|NOT COMPLETED|Washout Period 5||0
95140|NCT02038829|234197|P1|NOT COMPLETED|Washout Period 5||0
95141|NCT02038829|234186|P12|COMPLETED|Washout Period 5||8
95142|NCT02038829|234187|P11|COMPLETED|Washout Period 5||7
95143|NCT02038829|234188|P10|COMPLETED|Washout Period 5||8
95144|NCT02038829|234189|P9|COMPLETED|Washout Period 5||7
95145|NCT02038829|234190|P8|COMPLETED|Washout Period 5||8
95146|NCT02038829|234191|P7|COMPLETED|Washout Period 5||7
95147|NCT02038829|234192|P6|COMPLETED|Washout Period 5||7
95148|NCT02038829|234193|P5|COMPLETED|Washout Period 5||7
95149|NCT02038829|234194|P4|COMPLETED|Washout Period 5||8
95150|NCT02038829|234195|P3|COMPLETED|Washout Period 5||8
95151|NCT02038829|234196|P2|COMPLETED|Washout Period 5||7
95152|NCT02038829|234197|P1|COMPLETED|Washout Period 5||7
95153|NCT02038829|234186|P12|STARTED|Washout Period 5||8
95154|NCT02038829|234187|P11|STARTED|Washout Period 5||7
95155|NCT02038829|234188|P10|STARTED|Washout Period 5||8
95156|NCT02038829|234189|P9|STARTED|Washout Period 5||7
95157|NCT02038829|234190|P8|STARTED|Washout Period 5||8
95158|NCT02038829|234191|P7|STARTED|Washout Period 5||7
95159|NCT02038829|234192|P6|STARTED|Washout Period 5||7
95160|NCT02038829|234193|P5|STARTED|Washout Period 5||7
95161|NCT02038829|234194|P4|STARTED|Washout Period 5||8
95162|NCT02038829|234195|P3|STARTED|Washout Period 5||8
95163|NCT02038829|234196|P2|STARTED|Washout Period 5||7
95164|NCT02038829|234197|P1|STARTED|Washout Period 5||7
95165|NCT02038829|234186|P12|NOT COMPLETED|Treatment Period 5||0
95166|NCT02038829|234187|P11|NOT COMPLETED|Treatment Period 5||0
95167|NCT02038829|234188|P10|NOT COMPLETED|Treatment Period 5||0
95168|NCT02038829|234189|P9|NOT COMPLETED|Treatment Period 5||0
95169|NCT02038829|234190|P8|NOT COMPLETED|Treatment Period 5||0
95170|NCT02038829|234191|P7|NOT COMPLETED|Treatment Period 5||0
95171|NCT02038829|234192|P6|NOT COMPLETED|Treatment Period 5||0
95172|NCT02038829|234193|P5|NOT COMPLETED|Treatment Period 5||0
95173|NCT02038829|234194|P4|NOT COMPLETED|Treatment Period 5||0
95174|NCT02038829|234195|P3|NOT COMPLETED|Treatment Period 5||0
95175|NCT02038829|234196|P2|NOT COMPLETED|Treatment Period 5||0
95176|NCT02038829|234197|P1|NOT COMPLETED|Treatment Period 5||0
95177|NCT02038829|234186|P12|COMPLETED|Treatment Period 5||8
95178|NCT02038829|234187|P11|COMPLETED|Treatment Period 5||7
95179|NCT02038829|234188|P10|COMPLETED|Treatment Period 5||8
95180|NCT02038829|234189|P9|COMPLETED|Treatment Period 5||7
95181|NCT02038829|234190|P8|COMPLETED|Treatment Period 5||8
95182|NCT02038829|234191|P7|COMPLETED|Treatment Period 5||7
95183|NCT02038829|234192|P6|COMPLETED|Treatment Period 5||7
95184|NCT02038829|234193|P5|COMPLETED|Treatment Period 5||7
95185|NCT02038829|234194|P4|COMPLETED|Treatment Period 5||8
95186|NCT02038829|234195|P3|COMPLETED|Treatment Period 5||8
95187|NCT02038829|234196|P2|COMPLETED|Treatment Period 5||7
95188|NCT02038829|234197|P1|COMPLETED|Treatment Period 5||7
95189|NCT02038829|234186|P12|STARTED|Treatment Period 5||8
95190|NCT02038829|234187|P11|STARTED|Treatment Period 5||7
95191|NCT02038829|234188|P10|STARTED|Treatment Period 5||8
95192|NCT02038829|234189|P9|STARTED|Treatment Period 5||7
95193|NCT02038829|234190|P8|STARTED|Treatment Period 5||8
95194|NCT02038829|234191|P7|STARTED|Treatment Period 5||7
95195|NCT02038829|234192|P6|STARTED|Treatment Period 5||7
95196|NCT02038829|234193|P5|STARTED|Treatment Period 5||7
95197|NCT02038829|234194|P4|STARTED|Treatment Period 5||8
95198|NCT02038829|234195|P3|STARTED|Treatment Period 5||8
95199|NCT02038829|234196|P2|STARTED|Treatment Period 5||7
95200|NCT02038829|234197|P1|STARTED|Treatment Period 5||7
95201|NCT02038829|234186|P12|NOT COMPLETED|Washout Period 4||0
95202|NCT02038829|234187|P11|NOT COMPLETED|Washout Period 4||0
95203|NCT02038829|234188|P10|NOT COMPLETED|Washout Period 4||0
95204|NCT02038829|234189|P9|NOT COMPLETED|Washout Period 4||0
95205|NCT02038829|234190|P8|NOT COMPLETED|Washout Period 4||0
95206|NCT02038829|234191|P7|NOT COMPLETED|Washout Period 4||1
95207|NCT02038829|234192|P6|NOT COMPLETED|Washout Period 4||0
95208|NCT02038829|234193|P5|NOT COMPLETED|Washout Period 4||0
95209|NCT02038829|234194|P4|NOT COMPLETED|Washout Period 4||0
95210|NCT02038829|234195|P3|NOT COMPLETED|Washout Period 4||0
95211|NCT02038829|234196|P2|NOT COMPLETED|Washout Period 4||0
95212|NCT02038829|234197|P1|NOT COMPLETED|Washout Period 4||0
95213|NCT02038829|234186|P12|COMPLETED|Washout Period 4||8
95214|NCT02038829|234187|P11|COMPLETED|Washout Period 4||7
95215|NCT02038829|234188|P10|COMPLETED|Washout Period 4||8
95216|NCT02038829|234189|P9|COMPLETED|Washout Period 4||7
95217|NCT02038829|234190|P8|COMPLETED|Washout Period 4||8
95218|NCT02038829|234191|P7|COMPLETED|Washout Period 4||7
95219|NCT02038829|234192|P6|COMPLETED|Washout Period 4||7
95220|NCT02038829|234193|P5|COMPLETED|Washout Period 4||7
95221|NCT02038829|234194|P4|COMPLETED|Washout Period 4||8
95222|NCT02038829|234195|P3|COMPLETED|Washout Period 4||8
95223|NCT02038829|234196|P2|COMPLETED|Washout Period 4||7
95224|NCT02038829|234197|P1|COMPLETED|Washout Period 4||7
95225|NCT02038829|234186|P12|STARTED|Washout Period 4||8
95226|NCT02038829|234187|P11|STARTED|Washout Period 4||7
95227|NCT02038829|234188|P10|STARTED|Washout Period 4||8
95228|NCT02038829|234189|P9|STARTED|Washout Period 4||7
95229|NCT02038829|234190|P8|STARTED|Washout Period 4||8
95230|NCT02038829|234191|P7|STARTED|Washout Period 4||8
95231|NCT02038829|234192|P6|STARTED|Washout Period 4||7
95232|NCT02038829|234193|P5|STARTED|Washout Period 4||7
95233|NCT02038829|234194|P4|STARTED|Washout Period 4||8
95234|NCT02038829|234195|P3|STARTED|Washout Period 4||8
95235|NCT02038829|234196|P2|STARTED|Washout Period 4||7
95236|NCT02038829|234197|P1|STARTED|Washout Period 4||7
95237|NCT02038829|234186|P12|NOT COMPLETED|Treatment Period 4||0
95238|NCT02038829|234187|P11|NOT COMPLETED|Treatment Period 4||0
95239|NCT02038829|234188|P10|NOT COMPLETED|Treatment Period 4||0
95240|NCT02038829|234189|P9|NOT COMPLETED|Treatment Period 4||0
95241|NCT02038829|234190|P8|NOT COMPLETED|Treatment Period 4||0
95242|NCT02038829|234191|P7|NOT COMPLETED|Treatment Period 4||0
95243|NCT02038829|234192|P6|NOT COMPLETED|Treatment Period 4||0
95244|NCT02038829|234193|P5|NOT COMPLETED|Treatment Period 4||0
95245|NCT02038829|234194|P4|NOT COMPLETED|Treatment Period 4||0
95246|NCT02038829|234195|P3|NOT COMPLETED|Treatment Period 4||0
95247|NCT02038829|234196|P2|NOT COMPLETED|Treatment Period 4||1
95248|NCT02038829|234197|P1|NOT COMPLETED|Treatment Period 4||0
95249|NCT02038829|234186|P12|COMPLETED|Treatment Period 4||8
95250|NCT02038829|234187|P11|COMPLETED|Treatment Period 4||7
95251|NCT02038829|234188|P10|COMPLETED|Treatment Period 4||8
95252|NCT02038829|234189|P9|COMPLETED|Treatment Period 4||7
95253|NCT02038829|234190|P8|COMPLETED|Treatment Period 4||8
95254|NCT02038829|234191|P7|COMPLETED|Treatment Period 4||8
95255|NCT02038829|234192|P6|COMPLETED|Treatment Period 4||7
95256|NCT02038829|234193|P5|COMPLETED|Treatment Period 4||7
95257|NCT02038829|234194|P4|COMPLETED|Treatment Period 4||8
95258|NCT02038829|234195|P3|COMPLETED|Treatment Period 4||8
95259|NCT02038829|234196|P2|COMPLETED|Treatment Period 4||7
95260|NCT02038829|234197|P1|COMPLETED|Treatment Period 4||7
95261|NCT02038829|234186|P12|STARTED|Treatment Period 4||8
95262|NCT02038829|234187|P11|STARTED|Treatment Period 4||7
95263|NCT02038829|234188|P10|STARTED|Treatment Period 4||8
95264|NCT02038829|234189|P9|STARTED|Treatment Period 4||7
95265|NCT02038829|234190|P8|STARTED|Treatment Period 4||8
95266|NCT02038829|234191|P7|STARTED|Treatment Period 4||8
95267|NCT02038829|234192|P6|STARTED|Treatment Period 4||7
95268|NCT02038829|234193|P5|STARTED|Treatment Period 4||7
95269|NCT02038829|234194|P4|STARTED|Treatment Period 4||8
95270|NCT02038829|234195|P3|STARTED|Treatment Period 4||8
95271|NCT02038829|234196|P2|STARTED|Treatment Period 4||8
95272|NCT02038829|234197|P1|STARTED|Treatment Period 4||7
95273|NCT02038829|234186|P12|NOT COMPLETED|Washout Period 3||0
95274|NCT02038829|234187|P11|NOT COMPLETED|Washout Period 3||0
95275|NCT02038829|234188|P10|NOT COMPLETED|Washout Period 3||0
95276|NCT02038829|234189|P9|NOT COMPLETED|Washout Period 3||0
95277|NCT02038829|234190|P8|NOT COMPLETED|Washout Period 3||0
95278|NCT02038829|234191|P7|NOT COMPLETED|Washout Period 3||0
95279|NCT02038829|234192|P6|NOT COMPLETED|Washout Period 3||0
95280|NCT02038829|234193|P5|NOT COMPLETED|Washout Period 3||0
95281|NCT02038829|234194|P4|NOT COMPLETED|Washout Period 3||0
95282|NCT02038829|234195|P3|NOT COMPLETED|Washout Period 3||0
95283|NCT02038829|234196|P2|NOT COMPLETED|Washout Period 3||0
95284|NCT02038829|234197|P1|NOT COMPLETED|Washout Period 3||0
95285|NCT02038829|234186|P12|COMPLETED|Washout Period 3||8
95286|NCT02038829|234187|P11|COMPLETED|Washout Period 3||7
95287|NCT02038829|234188|P10|COMPLETED|Washout Period 3||8
95288|NCT02038829|234189|P9|COMPLETED|Washout Period 3||7
95289|NCT02038829|234190|P8|COMPLETED|Washout Period 3||8
95290|NCT02038829|234191|P7|COMPLETED|Washout Period 3||8
95291|NCT02038829|234192|P6|COMPLETED|Washout Period 3||7
95292|NCT02038829|234193|P5|COMPLETED|Washout Period 3||7
95293|NCT02038829|234194|P4|COMPLETED|Washout Period 3||8
95294|NCT02038829|234195|P3|COMPLETED|Washout Period 3||8
95295|NCT02038829|234196|P2|COMPLETED|Washout Period 3||8
95296|NCT02038829|234197|P1|COMPLETED|Washout Period 3||7
95297|NCT02038829|234186|P12|STARTED|Washout Period 3||8
95298|NCT02038829|234187|P11|STARTED|Washout Period 3||7
95299|NCT02038829|234188|P10|STARTED|Washout Period 3||8
95300|NCT02038829|234189|P9|STARTED|Washout Period 3||7
95301|NCT02038829|234190|P8|STARTED|Washout Period 3||8
95302|NCT02038829|234191|P7|STARTED|Washout Period 3||8
95303|NCT02038829|234192|P6|STARTED|Washout Period 3||7
95304|NCT02038829|234193|P5|STARTED|Washout Period 3||7
95305|NCT02038829|234194|P4|STARTED|Washout Period 3||8
95306|NCT02038829|234195|P3|STARTED|Washout Period 3||8
95307|NCT02038829|234196|P2|STARTED|Washout Period 3||8
95308|NCT02038829|234197|P1|STARTED|Washout Period 3||7
95309|NCT02038829|234186|P12|NOT COMPLETED|Treatment Period 3||0
95310|NCT02038829|234187|P11|NOT COMPLETED|Treatment Period 3||0
95311|NCT02038829|234188|P10|NOT COMPLETED|Treatment Period 3||0
95312|NCT02038829|234189|P9|NOT COMPLETED|Treatment Period 3||0
95313|NCT02038829|234190|P8|NOT COMPLETED|Treatment Period 3||0
95314|NCT02038829|234191|P7|NOT COMPLETED|Treatment Period 3||0
95315|NCT02038829|234192|P6|NOT COMPLETED|Treatment Period 3||0
95316|NCT02038829|234193|P5|NOT COMPLETED|Treatment Period 3||0
95317|NCT02038829|234194|P4|NOT COMPLETED|Treatment Period 3||0
95318|NCT02038829|234195|P3|NOT COMPLETED|Treatment Period 3||0
95319|NCT02038829|234196|P2|NOT COMPLETED|Treatment Period 3||0
95320|NCT02038829|234197|P1|NOT COMPLETED|Treatment Period 3||0
95321|NCT02038829|234186|P12|COMPLETED|Treatment Period 3||8
95322|NCT02038829|234187|P11|COMPLETED|Treatment Period 3||7
95323|NCT02038829|234188|P10|COMPLETED|Treatment Period 3||8
95324|NCT02038829|234189|P9|COMPLETED|Treatment Period 3||7
95325|NCT02038829|234190|P8|COMPLETED|Treatment Period 3||8
95326|NCT02038829|234191|P7|COMPLETED|Treatment Period 3||8
95327|NCT02038829|234192|P6|COMPLETED|Treatment Period 3||7
95328|NCT02038829|234193|P5|COMPLETED|Treatment Period 3||7
95329|NCT02038829|234194|P4|COMPLETED|Treatment Period 3||8
95330|NCT02038829|234195|P3|COMPLETED|Treatment Period 3||8
95331|NCT02038829|234196|P2|COMPLETED|Treatment Period 3||8
95332|NCT02038829|234197|P1|COMPLETED|Treatment Period 3||7
95333|NCT02038829|234186|P12|STARTED|Treatment Period 3||8
95334|NCT02038829|234187|P11|STARTED|Treatment Period 3||7
95335|NCT02038829|234188|P10|STARTED|Treatment Period 3||8
95336|NCT02038829|234189|P9|STARTED|Treatment Period 3||7
95337|NCT02038829|234190|P8|STARTED|Treatment Period 3||8
95338|NCT02038829|234191|P7|STARTED|Treatment Period 3||8
95339|NCT02038829|234192|P6|STARTED|Treatment Period 3||7
95340|NCT02038829|234193|P5|STARTED|Treatment Period 3||7
95341|NCT02038829|234194|P4|STARTED|Treatment Period 3||8
95342|NCT02038829|234195|P3|STARTED|Treatment Period 3||8
95343|NCT02038829|234196|P2|STARTED|Treatment Period 3||8
95344|NCT02038829|234197|P1|STARTED|Treatment Period 3||7
95345|NCT02038829|234186|P12|NOT COMPLETED|Washout Period 2||0
95346|NCT02038829|234187|P11|NOT COMPLETED|Washout Period 2||0
95347|NCT02038829|234188|P10|NOT COMPLETED|Washout Period 2||0
95348|NCT02038829|234189|P9|NOT COMPLETED|Washout Period 2||1
95349|NCT02038829|234190|P8|NOT COMPLETED|Washout Period 2||0
95350|NCT02038829|234191|P7|NOT COMPLETED|Washout Period 2||0
95351|NCT02038829|234192|P6|NOT COMPLETED|Washout Period 2||1
95352|NCT02038829|234193|P5|NOT COMPLETED|Washout Period 2||0
95353|NCT02038829|234194|P4|NOT COMPLETED|Washout Period 2||0
95354|NCT02038829|234195|P3|NOT COMPLETED|Washout Period 2||0
95355|NCT02038829|234196|P2|NOT COMPLETED|Washout Period 2||0
95356|NCT02038829|234197|P1|NOT COMPLETED|Washout Period 2||0
95357|NCT02038829|234186|P12|COMPLETED|Washout Period 2||8
95358|NCT02038829|234187|P11|COMPLETED|Washout Period 2||7
95359|NCT02038829|234188|P10|COMPLETED|Washout Period 2||8
95360|NCT02038829|234189|P9|COMPLETED|Washout Period 2||7
95361|NCT02038829|234190|P8|COMPLETED|Washout Period 2||8
95362|NCT02038829|234191|P7|COMPLETED|Washout Period 2||8
95363|NCT02038829|234192|P6|COMPLETED|Washout Period 2||7
95364|NCT02038829|234193|P5|COMPLETED|Washout Period 2||7
95365|NCT02038829|234194|P4|COMPLETED|Washout Period 2||8
95366|NCT02038829|234195|P3|COMPLETED|Washout Period 2||8
95367|NCT02038829|234196|P2|COMPLETED|Washout Period 2||8
95368|NCT02038829|234197|P1|COMPLETED|Washout Period 2||7
95369|NCT02038829|234186|P12|STARTED|Washout Period 2||8
95370|NCT02038829|234187|P11|STARTED|Washout Period 2||7
95371|NCT02038829|234188|P10|STARTED|Washout Period 2||8
95372|NCT02038829|234189|P9|STARTED|Washout Period 2||8
95373|NCT02038829|234190|P8|STARTED|Washout Period 2||8
95374|NCT02038829|234191|P7|STARTED|Washout Period 2||8
95375|NCT02038829|234192|P6|STARTED|Washout Period 2||8
95376|NCT02038829|234193|P5|STARTED|Washout Period 2||7
95377|NCT02038829|234194|P4|STARTED|Washout Period 2||8
95378|NCT02038829|234195|P3|STARTED|Washout Period 2||8
95379|NCT02038829|234196|P2|STARTED|Washout Period 2||8
95380|NCT02038829|234197|P1|STARTED|Washout Period 2||7
95381|NCT02038829|234186|P12|NOT COMPLETED|Treatment Period 2||0
95382|NCT02038829|234187|P11|NOT COMPLETED|Treatment Period 2||1
95383|NCT02038829|234188|P10|NOT COMPLETED|Treatment Period 2||0
95384|NCT02038829|234189|P9|NOT COMPLETED|Treatment Period 2||0
95385|NCT02038829|234190|P8|NOT COMPLETED|Treatment Period 2||0
95386|NCT02038829|234191|P7|NOT COMPLETED|Treatment Period 2||0
95387|NCT02038829|234192|P6|NOT COMPLETED|Treatment Period 2||0
95388|NCT02038829|234193|P5|NOT COMPLETED|Treatment Period 2||0
95389|NCT02038829|234194|P4|NOT COMPLETED|Treatment Period 2||0
95390|NCT02038829|234195|P3|NOT COMPLETED|Treatment Period 2||0
95391|NCT02038829|234196|P2|NOT COMPLETED|Treatment Period 2||0
95392|NCT02038829|234197|P1|NOT COMPLETED|Treatment Period 2||1
95393|NCT02038829|234186|P12|COMPLETED|Treatment Period 2||8
95394|NCT02038829|234187|P11|COMPLETED|Treatment Period 2||7
95395|NCT02038829|234188|P10|COMPLETED|Treatment Period 2||8
95396|NCT02038829|234189|P9|COMPLETED|Treatment Period 2||8
95397|NCT02038829|234190|P8|COMPLETED|Treatment Period 2||8
95398|NCT02038829|234191|P7|COMPLETED|Treatment Period 2||8
95399|NCT02038829|234192|P6|COMPLETED|Treatment Period 2||8
95400|NCT02038829|234193|P5|COMPLETED|Treatment Period 2||7
95401|NCT02038829|234194|P4|COMPLETED|Treatment Period 2||8
95402|NCT02038829|234195|P3|COMPLETED|Treatment Period 2||8
95403|NCT02038829|234196|P2|COMPLETED|Treatment Period 2||8
95404|NCT02038829|234197|P1|COMPLETED|Treatment Period 2||7
95405|NCT02038829|234186|P12|STARTED|Treatment Period 2||8
95406|NCT02038829|234187|P11|STARTED|Treatment Period 2||8
95407|NCT02038829|234188|P10|STARTED|Treatment Period 2||8
95408|NCT02038829|234189|P9|STARTED|Treatment Period 2||8
95409|NCT02038829|234190|P8|STARTED|Treatment Period 2||8
95410|NCT02038829|234191|P7|STARTED|Treatment Period 2||8
95411|NCT02038829|234192|P6|STARTED|Treatment Period 2||8
95412|NCT02038829|234193|P5|STARTED|Treatment Period 2||7
95413|NCT02038829|234194|P4|STARTED|Treatment Period 2||8
95414|NCT02038829|234195|P3|STARTED|Treatment Period 2||8
95415|NCT02038829|234196|P2|STARTED|Treatment Period 2||8
95416|NCT02038829|234197|P1|STARTED|Treatment Period 2||8
95417|NCT02038829|234186|P12|NOT COMPLETED|Washout Period 1||0
95418|NCT02038829|234187|P11|NOT COMPLETED|Washout Period 1||0
95419|NCT02038829|234188|P10|NOT COMPLETED|Washout Period 1||0
95420|NCT02038829|234189|P9|NOT COMPLETED|Washout Period 1||0
95421|NCT02038829|234190|P8|NOT COMPLETED|Washout Period 1||0
95422|NCT02038829|234191|P7|NOT COMPLETED|Washout Period 1||0
95423|NCT02038829|234192|P6|NOT COMPLETED|Washout Period 1||0
95424|NCT02038829|234193|P5|NOT COMPLETED|Washout Period 1||1
95425|NCT02038829|234194|P4|NOT COMPLETED|Washout Period 1||0
95426|NCT02038829|234195|P3|NOT COMPLETED|Washout Period 1||0
95427|NCT02038829|234196|P2|NOT COMPLETED|Washout Period 1||0
95428|NCT02038829|234197|P1|NOT COMPLETED|Washout Period 1||0
95429|NCT02038829|234186|P12|COMPLETED|Washout Period 1||8
95430|NCT02038829|234187|P11|COMPLETED|Washout Period 1||8
95431|NCT02038829|234188|P10|COMPLETED|Washout Period 1||8
95432|NCT02038829|234189|P9|COMPLETED|Washout Period 1||8
95433|NCT02038829|234190|P8|COMPLETED|Washout Period 1||8
95434|NCT02038829|234191|P7|COMPLETED|Washout Period 1||8
95435|NCT02038829|234192|P6|COMPLETED|Washout Period 1||8
95436|NCT02038829|234193|P5|COMPLETED|Washout Period 1||7
95437|NCT02038829|234194|P4|COMPLETED|Washout Period 1||8
95438|NCT02038829|234195|P3|COMPLETED|Washout Period 1||8
95439|NCT02038829|234196|P2|COMPLETED|Washout Period 1||8
95440|NCT02038829|234197|P1|COMPLETED|Washout Period 1||8
95441|NCT02038829|234186|P12|STARTED|Washout Period 1||8
95442|NCT02038829|234187|P11|STARTED|Washout Period 1||8
95443|NCT02038829|234188|P10|STARTED|Washout Period 1||8
95444|NCT02038829|234189|P9|STARTED|Washout Period 1||8
95445|NCT02038829|234190|P8|STARTED|Washout Period 1||8
95446|NCT02038829|234191|P7|STARTED|Washout Period 1||8
95447|NCT02038829|234192|P6|STARTED|Washout Period 1||8
95448|NCT02038829|234193|P5|STARTED|Washout Period 1||8
95449|NCT02038829|234194|P4|STARTED|Washout Period 1||8
95450|NCT02038829|234195|P3|STARTED|Washout Period 1||8
95451|NCT02038829|234196|P2|STARTED|Washout Period 1||8
95452|NCT02038829|234197|P1|STARTED|Washout Period 1||8
95453|NCT02038829|234186|P12|NOT COMPLETED|Treatment Period 1||0
95454|NCT02038829|234187|P11|NOT COMPLETED|Treatment Period 1||0
95455|NCT02038829|234188|P10|NOT COMPLETED|Treatment Period 1||0
95456|NCT02038829|234189|P9|NOT COMPLETED|Treatment Period 1||0
95457|NCT02038829|234190|P8|NOT COMPLETED|Treatment Period 1||0
95458|NCT02038829|234191|P7|NOT COMPLETED|Treatment Period 1||0
95459|NCT02038829|234192|P6|NOT COMPLETED|Treatment Period 1||0
95460|NCT02038829|234193|P5|NOT COMPLETED|Treatment Period 1||0
95461|NCT02038829|234194|P4|NOT COMPLETED|Treatment Period 1||0
95462|NCT02038829|234195|P3|NOT COMPLETED|Treatment Period 1||0
95463|NCT02038829|234196|P2|NOT COMPLETED|Treatment Period 1||0
95464|NCT02038829|234197|P1|NOT COMPLETED|Treatment Period 1||0
95465|NCT02038829|234186|P12|COMPLETED|Treatment Period 1||8
95466|NCT02038829|234187|P11|COMPLETED|Treatment Period 1||8
95467|NCT02038829|234188|P10|COMPLETED|Treatment Period 1||8
95468|NCT02038829|234189|P9|COMPLETED|Treatment Period 1||8
95469|NCT02038829|234190|P8|COMPLETED|Treatment Period 1||8
95470|NCT02038829|234191|P7|COMPLETED|Treatment Period 1||8
95471|NCT02038829|234192|P6|COMPLETED|Treatment Period 1||8
95472|NCT02038829|234193|P5|COMPLETED|Treatment Period 1||8
95473|NCT02038829|234194|P4|COMPLETED|Treatment Period 1||8
95474|NCT02038829|234195|P3|COMPLETED|Treatment Period 1||8
95475|NCT02038829|234196|P2|COMPLETED|Treatment Period 1||8
95476|NCT02038829|234197|P1|COMPLETED|Treatment Period 1||8
95477|NCT02038829|234186|P12|STARTED|Treatment Period 1||8
95478|NCT02038829|234187|P11|STARTED|Treatment Period 1||8
95479|NCT02038829|234188|P10|STARTED|Treatment Period 1||8
95480|NCT02038829|234189|P9|STARTED|Treatment Period 1||8
95481|NCT02038829|234190|P8|STARTED|Treatment Period 1||8
95482|NCT02038829|234191|P7|STARTED|Treatment Period 1||8
95483|NCT02038829|234192|P6|STARTED|Treatment Period 1||8
95484|NCT02038829|234193|P5|STARTED|Treatment Period 1||8
95485|NCT02038829|234194|P4|STARTED|Treatment Period 1||8
95486|NCT02038829|234195|P3|STARTED|Treatment Period 1||8
95487|NCT02038829|234196|P2|STARTED|Treatment Period 1||8
95488|NCT02038829|234197|P1|STARTED|Treatment Period 1||8
95489|NCT02038790|234231|P2|NOT COMPLETED|Day 1 - Second Treatment||0
95490|NCT02038790|234232|P1|NOT COMPLETED|Day 1 - Second Treatment||0
95491|NCT02038790|234231|P2|COMPLETED|Day 1 - Second Treatment||16
95492|NCT02038790|234232|P1|COMPLETED|Day 1 - Second Treatment||15
95493|NCT02038790|234231|P2|STARTED|Day 1 - Second Treatment||16
95494|NCT02038790|234232|P1|STARTED|Day 1 - Second Treatment||15
95495|NCT02038790|234231|P2|NOT COMPLETED|Day 0 - First Treatment||1
95496|NCT02038790|234232|P1|NOT COMPLETED|Day 0 - First Treatment||1
95497|NCT02038790|234231|P2|COMPLETED|Day 0 - First Treatment||16
95498|NCT02038790|234232|P1|COMPLETED|Day 0 - First Treatment||15
95499|NCT02038790|234231|P2|STARTED|Day 0 - First Treatment||17
95500|NCT02038790|234232|P1|STARTED|Day 0 - First Treatment||16
95501|NCT02038764|234268|P5|NOT COMPLETED|Overall Study||1
95502|NCT02038764|234269|P4|NOT COMPLETED|Overall Study||0
95503|NCT02038764|234270|P3|NOT COMPLETED|Overall Study||2
95504|NCT02038764|234271|P2|NOT COMPLETED|Overall Study||1
95505|NCT02038764|234272|P1|NOT COMPLETED|Overall Study||1
95506|NCT02038764|234268|P5|COMPLETED|Overall Study||7
95507|NCT02038764|234269|P4|COMPLETED|Overall Study||5
95508|NCT02038764|234270|P3|COMPLETED|Overall Study||7
95509|NCT02038764|234271|P2|COMPLETED|Overall Study||7
95510|NCT02038764|234272|P1|COMPLETED|Overall Study||6
95511|NCT02038764|234268|P5|STARTED|Overall Study||8
95512|NCT02038764|234269|P4|STARTED|Overall Study||5
95513|NCT02038764|234270|P3|STARTED|Overall Study||9
95514|NCT02038764|234271|P2|STARTED|Overall Study||8
95515|NCT02038764|234272|P1|STARTED|Overall Study||7
95516|NCT02038647|234374|P2|NOT COMPLETED|Overall Study||89
95517|NCT02038647|234375|P1|NOT COMPLETED|Overall Study||89
95518|NCT02038647|234374|P2|COMPLETED|Overall Study||0
95519|NCT02038647|234375|P1|COMPLETED|Overall Study||0
95520|NCT02038647|234374|P2|STARTED|Overall Study||89
95521|NCT02038647|234375|P1|STARTED|Overall Study||89
95522|NCT02038569|234407|P1|NOT COMPLETED|Overall Study||5
95523|NCT02038569|234407|P1|COMPLETED|Overall Study||102
95524|NCT02038569|234407|P1|STARTED|Overall Study||107
95525|NCT02038543|234438|P4|NOT COMPLETED|Overall Study||2
95526|NCT02038543|234439|P3|NOT COMPLETED|Overall Study||0
95527|NCT02038543|234440|P2|NOT COMPLETED|Overall Study||0
95528|NCT02038543|234441|P1|NOT COMPLETED|Overall Study||0
95529|NCT02038543|234438|P4|COMPLETED|Overall Study||1
95530|NCT02038543|234439|P3|COMPLETED|Overall Study||8
95531|NCT02038543|234440|P2|COMPLETED|Overall Study||4
95532|NCT02038543|234441|P1|COMPLETED|Overall Study||7
95533|NCT02038543|234438|P4|STARTED|Overall Study||3
95534|NCT02038543|234439|P3|STARTED|Overall Study||8
95535|NCT02038543|234440|P2|STARTED|Overall Study||4
95536|NCT02038543|234441|P1|STARTED|Overall Study||7
95537|NCT02038075|234457|P2|NOT COMPLETED|Overall Study||0
95538|NCT02038075|234458|P1|NOT COMPLETED|Overall Study||3
95539|NCT02038075|234457|P2|COMPLETED|Overall Study||76
95540|NCT02038075|234458|P1|COMPLETED|Overall Study||73
95541|NCT02038075|234457|P2|STARTED|Overall Study||76
95542|NCT02038075|234458|P1|STARTED|Overall Study||76
95543|NCT02038049|234466|P2|NOT COMPLETED|Overall Study||0
95544|NCT02038049|234467|P1|NOT COMPLETED|Overall Study||1
95545|NCT02038049|234466|P2|COMPLETED|Overall Study||4
95546|NCT02038049|234467|P1|COMPLETED|Overall Study||3
95547|NCT02038049|234466|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||4
95548|NCT02038049|234467|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||4
95549|NCT02038049|234466|P2|STARTED|Overall Study||4
95550|NCT02038049|234467|P1|STARTED|Overall Study||4
95551|NCT02038023|234489|P1|NOT COMPLETED|Overall Study||1
95552|NCT02038023|234489|P1|COMPLETED|Overall Study||73
95553|NCT02038023|234489|P1|STARTED|Overall Study||74
95554|NCT02037984|234504|P8|NOT COMPLETED|Overall Study||12
95555|NCT02037984|234505|P7|NOT COMPLETED|Overall Study||17
95556|NCT02037984|234506|P6|NOT COMPLETED|Overall Study||12
95557|NCT02037984|234507|P5|NOT COMPLETED|Overall Study||12
95558|NCT02037984|234508|P4|NOT COMPLETED|Overall Study||21
95559|NCT02037984|234509|P3|NOT COMPLETED|Overall Study||12
95560|NCT02037984|234510|P2|NOT COMPLETED|Overall Study||0
95561|NCT02037984|234511|P1|NOT COMPLETED|Overall Study||1
95562|NCT02037984|234504|P8|COMPLETED|Overall Study||39
95563|NCT02037984|234505|P7|COMPLETED|Overall Study||33
95564|NCT02037984|234506|P6|COMPLETED|Overall Study||37
95565|NCT02037984|234507|P5|COMPLETED|Overall Study||38
95566|NCT02037984|234508|P4|COMPLETED|Overall Study||30
95567|NCT02037984|234509|P3|COMPLETED|Overall Study||38
95568|NCT02037984|234510|P2|COMPLETED|Overall Study||20
95569|NCT02037984|234511|P1|COMPLETED|Overall Study||19
95570|NCT02037984|234504|P8|STARTED|Overall Study||51
95571|NCT02037984|234505|P7|STARTED|Overall Study||50
95572|NCT02037984|234506|P6|STARTED|Overall Study||49
95573|NCT02037984|234507|P5|STARTED|Overall Study||50
95574|NCT02037984|234508|P4|STARTED|Overall Study||51
95575|NCT02037984|234509|P3|STARTED|Overall Study||50
95576|NCT02037984|234510|P2|STARTED|Overall Study||20
95577|NCT02037984|234511|P1|STARTED|Overall Study||20
95578|NCT02037893|234578|P4|NOT COMPLETED|Overall Study||0
95579|NCT02037893|234579|P3|NOT COMPLETED|Overall Study||1
95580|NCT02037893|234580|P2|NOT COMPLETED|Overall Study||0
95581|NCT02037893|234581|P1|NOT COMPLETED|Overall Study||0
95582|NCT02037893|234578|P4|COMPLETED|Overall Study||28
95583|NCT02037893|234579|P3|COMPLETED|Overall Study||26
95584|NCT02037893|234580|P2|COMPLETED|Overall Study||25
95585|NCT02037893|234581|P1|COMPLETED|Overall Study||32
95586|NCT02037893|234578|P4|STARTED|Overall Study||28
95587|NCT02037893|234579|P3|STARTED|Overall Study||27
95588|NCT02037893|234580|P2|STARTED|Overall Study||25
95589|NCT02037893|234581|P1|STARTED|Overall Study||32
95590|NCT02037776|234633|P2|NOT COMPLETED|Overall Study||4
95591|NCT02037776|234634|P1|NOT COMPLETED|Overall Study||5
95592|NCT02037776|234633|P2|COMPLETED|Overall Study||60
95593|NCT02037776|234634|P1|COMPLETED|Overall Study||56
95594|NCT02037776|234633|P2|STARTED|Overall Study||64
95595|NCT02037776|234634|P1|STARTED|Overall Study||61
95596|NCT02037607|234650|P1|NOT COMPLETED|Overall Study||9
95597|NCT02037607|234650|P1|COMPLETED|Overall Study||91
95598|NCT02037607|234650|P1|STARTED|Overall Study||100
95599|NCT02037568|234656|P2|NOT COMPLETED|Overall Study||39
95600|NCT02037568|234657|P1|NOT COMPLETED|Overall Study||36
95601|NCT02037568|234656|P2|COMPLETED|Overall Study||37
95602|NCT02037568|234657|P1|COMPLETED|Overall Study||47
95603|NCT02037568|234656|P2|Month 6 (Post Transplantation)|Overall Study||52
95604|NCT02037568|234657|P1|Month 6 (Post Transplantation)|Overall Study||63
95605|NCT02037568|234656|P2|Month 3 (Post Transplantation)|Overall Study||62
95606|NCT02037568|234657|P1|Month 3 (Post Transplantation)|Overall Study||66
95607|NCT02037568|234656|P2|Month 1.5 (Post Transplantation)|Overall Study||76
95608|NCT02037568|234657|P1|Month 1.5 (Post Transplantation)|Overall Study||79
95609|NCT02037568|234656|P2|STARTED|Overall Study||76
95610|NCT02037568|234657|P1|STARTED|Overall Study||83
95611|NCT02037555|234681|P2|NOT COMPLETED|Overall Study||21
95612|NCT02037555|234682|P1|NOT COMPLETED|Overall Study||23
95613|NCT02037555|234681|P2|COMPLETED|Overall Study||191
95614|NCT02037555|234682|P1|COMPLETED|Overall Study||190
95615|NCT02037555|234681|P2|Dosed and Operated On|Overall Study||196
95616|NCT02037555|234682|P1|Dosed and Operated On|Overall Study||200
95617|NCT02037555|234681|P2|Dosed|Overall Study||198
95618|NCT02037555|234682|P1|Dosed|Overall Study||201
95619|NCT02037555|234681|P2|STARTED|Overall Study||212
95620|NCT02037555|234682|P1|STARTED|Overall Study||213
95621|NCT02037477|234692|P4|NOT COMPLETED|Treatment Period 2||0
95622|NCT02037477|234693|P3|NOT COMPLETED|Treatment Period 2||0
95623|NCT02037477|234694|P2|NOT COMPLETED|Treatment Period 2||0
95624|NCT02037477|234695|P1|NOT COMPLETED|Treatment Period 2||0
95625|NCT02037477|234692|P4|COMPLETED|Treatment Period 2||5
95626|NCT02037477|234693|P3|COMPLETED|Treatment Period 2||4
95627|NCT02037477|234694|P2|COMPLETED|Treatment Period 2||5
95628|NCT02037477|234695|P1|COMPLETED|Treatment Period 2||5
95629|NCT02037477|234692|P4|STARTED|Treatment Period 2||5
95630|NCT02037477|234693|P3|STARTED|Treatment Period 2||4
95631|NCT02037477|234694|P2|STARTED|Treatment Period 2||5
95632|NCT02037477|234695|P1|STARTED|Treatment Period 2||5
95633|NCT02037477|234692|P4|NOT COMPLETED|Treatment Period 1||0
95634|NCT02037477|234693|P3|NOT COMPLETED|Treatment Period 1||1
95635|NCT02037477|234694|P2|NOT COMPLETED|Treatment Period 1||0
95636|NCT02037477|234695|P1|NOT COMPLETED|Treatment Period 1||0
95637|NCT02037477|234692|P4|COMPLETED|Treatment Period 1||5
95638|NCT02037477|234693|P3|COMPLETED|Treatment Period 1||4
95639|NCT02037477|234694|P2|COMPLETED|Treatment Period 1||5
95640|NCT02037477|234695|P1|COMPLETED|Treatment Period 1||5
95641|NCT02037477|234692|P4|STARTED|Treatment Period 1||5
95642|NCT02037477|234693|P3|STARTED|Treatment Period 1||5
95643|NCT02037477|234694|P2|STARTED|Treatment Period 1||5
95644|NCT02037477|234695|P1|STARTED|Treatment Period 1||5
95645|NCT02037438|234723|P2|NOT COMPLETED|Overall Study||355
95646|NCT02037438|234724|P1|NOT COMPLETED|Overall Study||346
95647|NCT02037438|234723|P2|COMPLETED|Overall Study||561
95648|NCT02037438|234724|P1|COMPLETED|Overall Study||574
95649|NCT02037438|234723|P2|STARTED|Overall Study||916
95650|NCT02037438|234724|P1|STARTED|Overall Study||920
95651|NCT02037425|234738|P1|NOT COMPLETED|Overall Study||26
95652|NCT02037425|234738|P1|COMPLETED|Overall Study||18
95653|NCT02037425|234738|P1|Randomized to Treatment|Overall Study||32
95654|NCT02037425|234738|P1|STARTED|Overall Study||44
95655|NCT02037347|234780|P1|NOT COMPLETED|Overall Study||0
95656|NCT02037347|234780|P1|COMPLETED|Overall Study||1
95657|NCT02037347|234780|P1|STARTED|Overall Study||1
95658|NCT02037204|234786|P1|NOT COMPLETED|Overall Study||0
95659|NCT02037204|234786|P1|COMPLETED|Overall Study||35
95660|NCT02037204|234786|P1|STARTED|Overall Study||35
95661|NCT02037165|234796|P5|NOT COMPLETED|Period 5 (2 Days)||0
95662|NCT02037165|234797|P4|NOT COMPLETED|Period 5 (2 Days)||0
95663|NCT02037165|234798|P3|NOT COMPLETED|Period 5 (2 Days)||0
95664|NCT02037165|234799|P2|NOT COMPLETED|Period 5 (2 Days)||0
95665|NCT02037165|234800|P1|NOT COMPLETED|Period 5 (2 Days)||0
95666|NCT02037165|234796|P5|COMPLETED|Period 5 (2 Days)||4
95667|NCT02037165|234797|P4|COMPLETED|Period 5 (2 Days)||5
95668|NCT02037165|234798|P3|COMPLETED|Period 5 (2 Days)||5
95669|NCT02037165|234799|P2|COMPLETED|Period 5 (2 Days)||5
95670|NCT02037165|234800|P1|COMPLETED|Period 5 (2 Days)||5
95671|NCT02037165|234796|P5|STARTED|Period 5 (2 Days)||4
95672|NCT02037165|234797|P4|STARTED|Period 5 (2 Days)||5
95673|NCT02037165|234798|P3|STARTED|Period 5 (2 Days)||5
95674|NCT02037165|234799|P2|STARTED|Period 5 (2 Days)||5
95675|NCT02037165|234800|P1|STARTED|Period 5 (2 Days)||5
95676|NCT02037165|234796|P5|NOT COMPLETED|Washout Period 4 (6 Days)||1
95677|NCT02037165|234797|P4|NOT COMPLETED|Washout Period 4 (6 Days)||0
95678|NCT02037165|234798|P3|NOT COMPLETED|Washout Period 4 (6 Days)||0
95679|NCT02037165|234799|P2|NOT COMPLETED|Washout Period 4 (6 Days)||0
95680|NCT02037165|234800|P1|NOT COMPLETED|Washout Period 4 (6 Days)||0
95681|NCT02037165|234796|P5|COMPLETED|Washout Period 4 (6 Days)||4
95682|NCT02037165|234797|P4|COMPLETED|Washout Period 4 (6 Days)||5
95683|NCT02037165|234798|P3|COMPLETED|Washout Period 4 (6 Days)||5
95684|NCT02037165|234799|P2|COMPLETED|Washout Period 4 (6 Days)||5
95685|NCT02037165|234800|P1|COMPLETED|Washout Period 4 (6 Days)||5
95686|NCT02037165|234796|P5|STARTED|Washout Period 4 (6 Days)||5
95687|NCT02037165|234797|P4|STARTED|Washout Period 4 (6 Days)||5
95688|NCT02037165|234798|P3|STARTED|Washout Period 4 (6 Days)||5
95689|NCT02037165|234799|P2|STARTED|Washout Period 4 (6 Days)||5
95690|NCT02037165|234800|P1|STARTED|Washout Period 4 (6 Days)||5
95691|NCT02037165|234796|P5|NOT COMPLETED|Period 4 (2 Days)||0
95692|NCT02037165|234797|P4|NOT COMPLETED|Period 4 (2 Days)||0
95693|NCT02037165|234798|P3|NOT COMPLETED|Period 4 (2 Days)||0
95694|NCT02037165|234799|P2|NOT COMPLETED|Period 4 (2 Days)||0
95695|NCT02037165|234800|P1|NOT COMPLETED|Period 4 (2 Days)||0
95696|NCT02037165|234796|P5|COMPLETED|Period 4 (2 Days)||5
95697|NCT02037165|234797|P4|COMPLETED|Period 4 (2 Days)||5
95698|NCT02037165|234798|P3|COMPLETED|Period 4 (2 Days)||5
95699|NCT02037165|234799|P2|COMPLETED|Period 4 (2 Days)||5
95700|NCT02037165|234800|P1|COMPLETED|Period 4 (2 Days)||5
95701|NCT02037165|234796|P5|STARTED|Period 4 (2 Days)||5
95702|NCT02037165|234797|P4|STARTED|Period 4 (2 Days)||5
95703|NCT02037165|234798|P3|STARTED|Period 4 (2 Days)||5
95704|NCT02037165|234799|P2|STARTED|Period 4 (2 Days)||5
95705|NCT02037165|234800|P1|STARTED|Period 4 (2 Days)||5
95706|NCT02037165|234796|P5|NOT COMPLETED|Washout Period 3 (6 Days)||0
95707|NCT02037165|234797|P4|NOT COMPLETED|Washout Period 3 (6 Days)||0
95708|NCT02037165|234798|P3|NOT COMPLETED|Washout Period 3 (6 Days)||0
95709|NCT02037165|234799|P2|NOT COMPLETED|Washout Period 3 (6 Days)||0
95710|NCT02037165|234800|P1|NOT COMPLETED|Washout Period 3 (6 Days)||0
95711|NCT02037165|234796|P5|COMPLETED|Washout Period 3 (6 Days)||5
95712|NCT02037165|234797|P4|COMPLETED|Washout Period 3 (6 Days)||5
95713|NCT02037165|234798|P3|COMPLETED|Washout Period 3 (6 Days)||5
95714|NCT02037165|234799|P2|COMPLETED|Washout Period 3 (6 Days)||5
95715|NCT02037165|234800|P1|COMPLETED|Washout Period 3 (6 Days)||5
95716|NCT02037165|234796|P5|STARTED|Washout Period 3 (6 Days)||5
95717|NCT02037165|234797|P4|STARTED|Washout Period 3 (6 Days)||5
95718|NCT02037165|234798|P3|STARTED|Washout Period 3 (6 Days)||5
95719|NCT02037165|234799|P2|STARTED|Washout Period 3 (6 Days)||5
95720|NCT02037165|234800|P1|STARTED|Washout Period 3 (6 Days)||5
95721|NCT02037165|234796|P5|NOT COMPLETED|Period 3 (2 Days)||0
95722|NCT02037165|234797|P4|NOT COMPLETED|Period 3 (2 Days)||0
95723|NCT02037165|234798|P3|NOT COMPLETED|Period 3 (2 Days)||0
95724|NCT02037165|234799|P2|NOT COMPLETED|Period 3 (2 Days)||0
95725|NCT02037165|234800|P1|NOT COMPLETED|Period 3 (2 Days)||0
95726|NCT02037165|234796|P5|COMPLETED|Period 3 (2 Days)||5
95727|NCT02037165|234797|P4|COMPLETED|Period 3 (2 Days)||5
95728|NCT02037165|234798|P3|COMPLETED|Period 3 (2 Days)||5
95729|NCT02037165|234799|P2|COMPLETED|Period 3 (2 Days)||5
95730|NCT02037165|234800|P1|COMPLETED|Period 3 (2 Days)||5
95731|NCT02037165|234796|P5|STARTED|Period 3 (2 Days)||5
95732|NCT02037165|234797|P4|STARTED|Period 3 (2 Days)||5
95733|NCT02037165|234798|P3|STARTED|Period 3 (2 Days)||5
95734|NCT02037165|234799|P2|STARTED|Period 3 (2 Days)||5
95735|NCT02037165|234800|P1|STARTED|Period 3 (2 Days)||5
95736|NCT02037165|234796|P5|NOT COMPLETED|Washout Period 2 (6 Days)||0
95737|NCT02037165|234797|P4|NOT COMPLETED|Washout Period 2 (6 Days)||0
95738|NCT02037165|234798|P3|NOT COMPLETED|Washout Period 2 (6 Days)||0
95739|NCT02037165|234799|P2|NOT COMPLETED|Washout Period 2 (6 Days)||0
95740|NCT02037165|234800|P1|NOT COMPLETED|Washout Period 2 (6 Days)||0
95741|NCT02037165|234796|P5|COMPLETED|Washout Period 2 (6 Days)||5
95742|NCT02037165|234797|P4|COMPLETED|Washout Period 2 (6 Days)||5
95743|NCT02037165|234798|P3|COMPLETED|Washout Period 2 (6 Days)||5
95744|NCT02037165|234799|P2|COMPLETED|Washout Period 2 (6 Days)||5
95745|NCT02037165|234800|P1|COMPLETED|Washout Period 2 (6 Days)||5
95746|NCT02037165|234796|P5|STARTED|Washout Period 2 (6 Days)||5
95747|NCT02037165|234797|P4|STARTED|Washout Period 2 (6 Days)||5
95748|NCT02037165|234798|P3|STARTED|Washout Period 2 (6 Days)||5
95749|NCT02037165|234799|P2|STARTED|Washout Period 2 (6 Days)||5
95750|NCT02037165|234800|P1|STARTED|Washout Period 2 (6 Days)||5
95751|NCT02037165|234796|P5|NOT COMPLETED|Period 2 (2 Days)||0
95752|NCT02037165|234797|P4|NOT COMPLETED|Period 2 (2 Days)||0
95753|NCT02037165|234798|P3|NOT COMPLETED|Period 2 (2 Days)||0
95754|NCT02037165|234799|P2|NOT COMPLETED|Period 2 (2 Days)||0
95755|NCT02037165|234800|P1|NOT COMPLETED|Period 2 (2 Days)||0
95756|NCT02037165|234796|P5|COMPLETED|Period 2 (2 Days)||5
95757|NCT02037165|234797|P4|COMPLETED|Period 2 (2 Days)||5
95758|NCT02037165|234798|P3|COMPLETED|Period 2 (2 Days)||5
95759|NCT02037165|234799|P2|COMPLETED|Period 2 (2 Days)||5
95760|NCT02037165|234800|P1|COMPLETED|Period 2 (2 Days)||5
95761|NCT02037165|234796|P5|STARTED|Period 2 (2 Days)||5
95762|NCT02037165|234797|P4|STARTED|Period 2 (2 Days)||5
95763|NCT02037165|234798|P3|STARTED|Period 2 (2 Days)||5
95764|NCT02037165|234799|P2|STARTED|Period 2 (2 Days)||5
95765|NCT02037165|234800|P1|STARTED|Period 2 (2 Days)||5
95766|NCT02037165|234796|P5|NOT COMPLETED|Washout Period 1 (6 Days)||0
95767|NCT02037165|234797|P4|NOT COMPLETED|Washout Period 1 (6 Days)||0
95768|NCT02037165|234798|P3|NOT COMPLETED|Washout Period 1 (6 Days)||0
95769|NCT02037165|234799|P2|NOT COMPLETED|Washout Period 1 (6 Days)||0
95770|NCT02037165|234800|P1|NOT COMPLETED|Washout Period 1 (6 Days)||0
95771|NCT02037165|234796|P5|COMPLETED|Washout Period 1 (6 Days)||5
95772|NCT02037165|234797|P4|COMPLETED|Washout Period 1 (6 Days)||5
95773|NCT02037165|234798|P3|COMPLETED|Washout Period 1 (6 Days)||5
95774|NCT02037165|234799|P2|COMPLETED|Washout Period 1 (6 Days)||5
95775|NCT02037165|234800|P1|COMPLETED|Washout Period 1 (6 Days)||5
95776|NCT02037165|234796|P5|STARTED|Washout Period 1 (6 Days)||5
95777|NCT02037165|234797|P4|STARTED|Washout Period 1 (6 Days)||5
95778|NCT02037165|234798|P3|STARTED|Washout Period 1 (6 Days)||5
95779|NCT02037165|234799|P2|STARTED|Washout Period 1 (6 Days)||5
95780|NCT02037165|234800|P1|STARTED|Washout Period 1 (6 Days)||5
95781|NCT02037165|234796|P5|NOT COMPLETED|Period 1 (2 Days)||0
95782|NCT02037165|234797|P4|NOT COMPLETED|Period 1 (2 Days)||0
95783|NCT02037165|234798|P3|NOT COMPLETED|Period 1 (2 Days)||0
95784|NCT02037165|234799|P2|NOT COMPLETED|Period 1 (2 Days)||0
95785|NCT02037165|234800|P1|NOT COMPLETED|Period 1 (2 Days)||0
95786|NCT02037165|234796|P5|COMPLETED|Period 1 (2 Days)||5
95787|NCT02037165|234797|P4|COMPLETED|Period 1 (2 Days)||5
95788|NCT02037165|234798|P3|COMPLETED|Period 1 (2 Days)||5
95789|NCT02037165|234799|P2|COMPLETED|Period 1 (2 Days)||5
95790|NCT02037165|234800|P1|COMPLETED|Period 1 (2 Days)||5
95791|NCT02037165|234796|P5|STARTED|Period 1 (2 Days)|randomized subjects|5
95792|NCT02037165|234797|P4|STARTED|Period 1 (2 Days)|randomized subjects|5
95793|NCT02037165|234798|P3|STARTED|Period 1 (2 Days)|randomized subjects|5
95794|NCT02037165|234799|P2|STARTED|Period 1 (2 Days)|randomized subjects|5
95795|NCT02037165|234800|P1|STARTED|Period 1 (2 Days)|randomized subjects|5
95796|NCT02037061|234845|P2|NOT COMPLETED|Overall Study||0
95797|NCT02037061|234846|P1|NOT COMPLETED|Overall Study||0
95798|NCT02037061|234845|P2|COMPLETED|Overall Study||24
95799|NCT02037061|234846|P1|COMPLETED|Overall Study||22
95800|NCT02037061|234845|P2|STARTED|Overall Study||24
95801|NCT02037061|234846|P1|STARTED|Overall Study||22
95802|NCT02036840|234856|P1|NOT COMPLETED|Overall Study||0
95803|NCT02036840|234856|P1|COMPLETED|Overall Study||513
95804|NCT02036840|234856|P1|STARTED|Overall Study||513
95805|NCT02036775|234860|P6|NOT COMPLETED|Treatment Period 3 (6 Days)||0
95806|NCT02036775|234861|P5|NOT COMPLETED|Treatment Period 3 (6 Days)||0
95807|NCT02036775|234862|P4|NOT COMPLETED|Treatment Period 3 (6 Days)||0
95808|NCT02036775|234863|P3|NOT COMPLETED|Treatment Period 3 (6 Days)||0
95809|NCT02036775|234864|P2|NOT COMPLETED|Treatment Period 3 (6 Days)||0
95810|NCT02036775|234865|P1|NOT COMPLETED|Treatment Period 3 (6 Days)||0
95811|NCT02036775|234860|P6|COMPLETED|Treatment Period 3 (6 Days)||3
95812|NCT02036775|234861|P5|COMPLETED|Treatment Period 3 (6 Days)||4
95813|NCT02036775|234862|P4|COMPLETED|Treatment Period 3 (6 Days)||4
95814|NCT02036775|234863|P3|COMPLETED|Treatment Period 3 (6 Days)||4
95815|NCT02036775|234864|P2|COMPLETED|Treatment Period 3 (6 Days)||4
95816|NCT02036775|234865|P1|COMPLETED|Treatment Period 3 (6 Days)||4
95817|NCT02036775|234860|P6|STARTED|Treatment Period 3 (6 Days)||3
95818|NCT02036775|234861|P5|STARTED|Treatment Period 3 (6 Days)||4
95819|NCT02036775|234862|P4|STARTED|Treatment Period 3 (6 Days)||4
95820|NCT02036775|234863|P3|STARTED|Treatment Period 3 (6 Days)||4
95821|NCT02036775|234864|P2|STARTED|Treatment Period 3 (6 Days)||4
95822|NCT02036775|234865|P1|STARTED|Treatment Period 3 (6 Days)||4
95823|NCT02036775|234860|P6|NOT COMPLETED|Treatment Period 2 (6 Days)||1
95824|NCT02036775|234861|P5|NOT COMPLETED|Treatment Period 2 (6 Days)||0
95825|NCT02036775|234862|P4|NOT COMPLETED|Treatment Period 2 (6 Days)||0
95826|NCT02036775|234863|P3|NOT COMPLETED|Treatment Period 2 (6 Days)||0
95827|NCT02036775|234864|P2|NOT COMPLETED|Treatment Period 2 (6 Days)||0
95828|NCT02036775|234865|P1|NOT COMPLETED|Treatment Period 2 (6 Days)||0
95829|NCT02036775|234860|P6|COMPLETED|Treatment Period 2 (6 Days)||3
95830|NCT02036775|234861|P5|COMPLETED|Treatment Period 2 (6 Days)||4
95831|NCT02036775|234862|P4|COMPLETED|Treatment Period 2 (6 Days)||4
95832|NCT02036775|234863|P3|COMPLETED|Treatment Period 2 (6 Days)||4
95833|NCT02036775|234864|P2|COMPLETED|Treatment Period 2 (6 Days)||4
95834|NCT02036775|234865|P1|COMPLETED|Treatment Period 2 (6 Days)||4
95835|NCT02036775|234860|P6|STARTED|Treatment Period 2 (6 Days)||4
95836|NCT02036775|234861|P5|STARTED|Treatment Period 2 (6 Days)||4
95837|NCT02036775|234862|P4|STARTED|Treatment Period 2 (6 Days)||4
95838|NCT02036775|234863|P3|STARTED|Treatment Period 2 (6 Days)||4
95839|NCT02036775|234864|P2|STARTED|Treatment Period 2 (6 Days)||4
95840|NCT02036775|234865|P1|STARTED|Treatment Period 2 (6 Days)||4
95841|NCT02036775|234860|P6|NOT COMPLETED|Treatment Period 1 (6 Days)||0
95842|NCT02036775|234861|P5|NOT COMPLETED|Treatment Period 1 (6 Days)||0
95843|NCT02036775|234862|P4|NOT COMPLETED|Treatment Period 1 (6 Days)||0
95844|NCT02036775|234863|P3|NOT COMPLETED|Treatment Period 1 (6 Days)||0
95845|NCT02036775|234864|P2|NOT COMPLETED|Treatment Period 1 (6 Days)||0
95846|NCT02036775|234865|P1|NOT COMPLETED|Treatment Period 1 (6 Days)||0
95847|NCT02036775|234860|P6|COMPLETED|Treatment Period 1 (6 Days)||4
95848|NCT02036775|234861|P5|COMPLETED|Treatment Period 1 (6 Days)||4
95849|NCT02036775|234862|P4|COMPLETED|Treatment Period 1 (6 Days)||4
95850|NCT02036775|234863|P3|COMPLETED|Treatment Period 1 (6 Days)||4
95851|NCT02036775|234864|P2|COMPLETED|Treatment Period 1 (6 Days)||4
95852|NCT02036775|234865|P1|COMPLETED|Treatment Period 1 (6 Days)||4
95853|NCT02036775|234860|P6|STARTED|Treatment Period 1 (6 Days)||4
95854|NCT02036775|234861|P5|STARTED|Treatment Period 1 (6 Days)||4
95855|NCT02036775|234862|P4|STARTED|Treatment Period 1 (6 Days)||4
95856|NCT02036775|234863|P3|STARTED|Treatment Period 1 (6 Days)||4
95857|NCT02036775|234864|P2|STARTED|Treatment Period 1 (6 Days)||4
95858|NCT02036775|234865|P1|STARTED|Treatment Period 1 (6 Days)||4
95859|NCT02036645|234915|P12|NOT COMPLETED|MAD Cohorts: Study Part 2||0
95860|NCT02036645|234916|P11|NOT COMPLETED|MAD Cohorts: Study Part 2||0
95861|NCT02036645|234917|P10|NOT COMPLETED|MAD Cohorts: Study Part 2||0
95862|NCT02036645|234918|P9|NOT COMPLETED|MAD Cohorts: Study Part 2||0
95863|NCT02036645|234919|P8|NOT COMPLETED|MAD Cohorts: Study Part 2||0
95864|NCT02036645|234920|P7|NOT COMPLETED|MAD Cohorts: Study Part 2||0
95865|NCT02036645|234921|P6|NOT COMPLETED|MAD Cohorts: Study Part 2||0
95866|NCT02036645|234922|P5|NOT COMPLETED|MAD Cohorts: Study Part 2||0
95867|NCT02036645|234923|P4|NOT COMPLETED|MAD Cohorts: Study Part 2||0
95868|NCT02036645|234924|P3|NOT COMPLETED|MAD Cohorts: Study Part 2||0
95869|NCT02036645|234925|P2|NOT COMPLETED|MAD Cohorts: Study Part 2||0
95870|NCT02036645|234926|P1|NOT COMPLETED|MAD Cohorts: Study Part 2||0
95871|NCT02036645|234915|P12|COMPLETED|MAD Cohorts: Study Part 2||6
95872|NCT02036645|234916|P11|COMPLETED|MAD Cohorts: Study Part 2||6
95873|NCT02036645|234917|P10|COMPLETED|MAD Cohorts: Study Part 2||6
95874|NCT02036645|234918|P9|COMPLETED|MAD Cohorts: Study Part 2||6
95875|NCT02036645|234919|P8|COMPLETED|MAD Cohorts: Study Part 2||8
95876|NCT02036645|234920|P7|COMPLETED|MAD Cohorts: Study Part 2||0
95877|NCT02036645|234921|P6|COMPLETED|MAD Cohorts: Study Part 2||0
95878|NCT02036645|234922|P5|COMPLETED|MAD Cohorts: Study Part 2||0
95879|NCT02036645|234923|P4|COMPLETED|MAD Cohorts: Study Part 2||0
95880|NCT02036645|234924|P3|COMPLETED|MAD Cohorts: Study Part 2||0
95881|NCT02036645|234925|P2|COMPLETED|MAD Cohorts: Study Part 2||0
95882|NCT02036645|234926|P1|COMPLETED|MAD Cohorts: Study Part 2||0
95883|NCT02036645|234915|P12|STARTED|MAD Cohorts: Study Part 2||6
95884|NCT02036645|234916|P11|STARTED|MAD Cohorts: Study Part 2||6
95885|NCT02036645|234917|P10|STARTED|MAD Cohorts: Study Part 2||6
95886|NCT02036645|234918|P9|STARTED|MAD Cohorts: Study Part 2||6
95887|NCT02036645|234919|P8|STARTED|MAD Cohorts: Study Part 2||8
95888|NCT02036645|234920|P7|STARTED|MAD Cohorts: Study Part 2||0
95889|NCT02036645|234921|P6|STARTED|MAD Cohorts: Study Part 2||0
95890|NCT02036645|234922|P5|STARTED|MAD Cohorts: Study Part 2||0
95891|NCT02036645|234923|P4|STARTED|MAD Cohorts: Study Part 2||0
95892|NCT02036645|234924|P3|STARTED|MAD Cohorts: Study Part 2||0
95893|NCT02036645|234925|P2|STARTED|MAD Cohorts: Study Part 2||0
95894|NCT02036645|234926|P1|STARTED|MAD Cohorts: Study Part 2|Pooled across Cohorts 7 to 9 (2 per cohort)|0
95895|NCT02036645|234915|P12|NOT COMPLETED|SAD Cohorts : Study Part 1||0
95896|NCT02036645|234916|P11|NOT COMPLETED|SAD Cohorts : Study Part 1||0
95897|NCT02036645|234917|P10|NOT COMPLETED|SAD Cohorts : Study Part 1||0
95898|NCT02036645|234918|P9|NOT COMPLETED|SAD Cohorts : Study Part 1||0
95899|NCT02036645|234919|P8|NOT COMPLETED|SAD Cohorts : Study Part 1||0
95900|NCT02036645|234920|P7|NOT COMPLETED|SAD Cohorts : Study Part 1||1
95901|NCT02036645|234921|P6|NOT COMPLETED|SAD Cohorts : Study Part 1||0
95902|NCT02036645|234922|P5|NOT COMPLETED|SAD Cohorts : Study Part 1||0
95903|NCT02036645|234923|P4|NOT COMPLETED|SAD Cohorts : Study Part 1||1
95904|NCT02036645|234924|P3|NOT COMPLETED|SAD Cohorts : Study Part 1||0
95905|NCT02036645|234925|P2|NOT COMPLETED|SAD Cohorts : Study Part 1||0
95906|NCT02036645|234926|P1|NOT COMPLETED|SAD Cohorts : Study Part 1||0
95907|NCT02036645|234915|P12|COMPLETED|SAD Cohorts : Study Part 1||0
95908|NCT02036645|234916|P11|COMPLETED|SAD Cohorts : Study Part 1||0
95909|NCT02036645|234917|P10|COMPLETED|SAD Cohorts : Study Part 1||0
95910|NCT02036645|234918|P9|COMPLETED|SAD Cohorts : Study Part 1||0
95911|NCT02036645|234919|P8|COMPLETED|SAD Cohorts : Study Part 1||0
95912|NCT02036645|234920|P7|COMPLETED|SAD Cohorts : Study Part 1||5
95913|NCT02036645|234921|P6|COMPLETED|SAD Cohorts : Study Part 1||6
95914|NCT02036645|234922|P5|COMPLETED|SAD Cohorts : Study Part 1||6
95915|NCT02036645|234923|P4|COMPLETED|SAD Cohorts : Study Part 1||5
95916|NCT02036645|234924|P3|COMPLETED|SAD Cohorts : Study Part 1||6
95917|NCT02036645|234925|P2|COMPLETED|SAD Cohorts : Study Part 1||3
95918|NCT02036645|234926|P1|COMPLETED|SAD Cohorts : Study Part 1||12
95919|NCT02036645|234915|P12|STARTED|SAD Cohorts : Study Part 1||0
95920|NCT02036645|234916|P11|STARTED|SAD Cohorts : Study Part 1||0
95921|NCT02036645|234917|P10|STARTED|SAD Cohorts : Study Part 1||0
95922|NCT02036645|234918|P9|STARTED|SAD Cohorts : Study Part 1||0
95923|NCT02036645|234919|P8|STARTED|SAD Cohorts : Study Part 1||0
95924|NCT02036645|234920|P7|STARTED|SAD Cohorts : Study Part 1||6
95925|NCT02036645|234921|P6|STARTED|SAD Cohorts : Study Part 1||6
95926|NCT02036645|234922|P5|STARTED|SAD Cohorts : Study Part 1||6
95927|NCT02036645|234923|P4|STARTED|SAD Cohorts : Study Part 1||6
95928|NCT02036645|234924|P3|STARTED|SAD Cohorts : Study Part 1||6
95929|NCT02036645|234925|P2|STARTED|SAD Cohorts : Study Part 1||3
95930|NCT02036645|234926|P1|STARTED|SAD Cohorts : Study Part 1|Pooled across cohorts 1-5 (2 per cohort)|12
95931|NCT02036580|235031|P3|NOT COMPLETED|Overall Study||0
95932|NCT02036580|235032|P2|NOT COMPLETED|Overall Study||1
95933|NCT02036580|235033|P1|NOT COMPLETED|Overall Study||1
95934|NCT02036580|235031|P3|COMPLETED|Overall Study||4
95935|NCT02036580|235032|P2|COMPLETED|Overall Study||7
95936|NCT02036580|235033|P1|COMPLETED|Overall Study||7
95937|NCT02036580|235031|P3|STARTED|Overall Study||4
95938|NCT02036580|235032|P2|STARTED|Overall Study||8
95939|NCT02036580|235033|P1|STARTED|Overall Study||8
95940|NCT02036541|235046|P1|NOT COMPLETED|Overall Study||16
95941|NCT02036541|235046|P1|COMPLETED|Overall Study||49
95942|NCT02036541|235046|P1|Completed Endpoint Visit|Overall Study||54
95943|NCT02036541|235046|P1|STARTED|Overall Study||65
95944|NCT02036515|235054|P3|NOT COMPLETED|Overall Study||14
95945|NCT02036515|235055|P2|NOT COMPLETED|Overall Study||12
95946|NCT02036515|235056|P1|NOT COMPLETED|Overall Study||5
95947|NCT02036515|235054|P3|COMPLETED|Overall Study||139
95948|NCT02036515|235055|P2|COMPLETED|Overall Study||143
95949|NCT02036515|235056|P1|COMPLETED|Overall Study||151
95950|NCT02036515|235054|P3|Treated|Overall Study||153
95951|NCT02036515|235055|P2|Treated|Overall Study||153
95952|NCT02036515|235056|P1|Treated|Overall Study||156
95953|NCT02036515|235054|P3|STARTED|Overall Study||153
95954|NCT02036515|235055|P2|STARTED|Overall Study||155
95955|NCT02036515|235056|P1|STARTED|Overall Study||156
95956|NCT02036424|235135|P2|NOT COMPLETED|Overall Study||0
95957|NCT02036424|235136|P1|NOT COMPLETED|Overall Study||0
95958|NCT02036424|235135|P2|COMPLETED|Overall Study|27 study eyes, not number of subjects|27
95959|NCT02036424|235136|P1|COMPLETED|Overall Study|23 study eyes, not number of subjects|23
95960|NCT02036424|235135|P2|STARTED|Overall Study|27 study eyes, not number of subjects|27
95961|NCT02036424|235136|P1|STARTED|Overall Study|23 study eyes, not number of subjects|23
95962|NCT02036320|235144|P2|NOT COMPLETED|Period 2||0
95963|NCT02036320|235145|P1|NOT COMPLETED|Period 2||0
95964|NCT02036320|235144|P2|COMPLETED|Period 2||95
95965|NCT02036320|235145|P1|COMPLETED|Period 2||95
95966|NCT02036320|235144|P2|STARTED|Period 2||95
95967|NCT02036320|235145|P1|STARTED|Period 2||95
95968|NCT02036320|235144|P2|NOT COMPLETED|Period 1||0
95969|NCT02036320|235145|P1|NOT COMPLETED|Period 1||0
95970|NCT02036320|235144|P2|COMPLETED|Period 1||95
95971|NCT02036320|235145|P1|COMPLETED|Period 1||95
95972|NCT02036320|235144|P2|STARTED|Period 1||95
95973|NCT02036320|235145|P1|STARTED|Period 1||95
95974|NCT02036294|235157|P2|NOT COMPLETED|Overall Study||11
95975|NCT02036294|235158|P1|NOT COMPLETED|Overall Study||9
95976|NCT02036294|235157|P2|COMPLETED|Overall Study||109
95977|NCT02036294|235158|P1|COMPLETED|Overall Study||111
95978|NCT02036294|235157|P2|STARTED|Overall Study||120
95979|NCT02036294|235158|P1|STARTED|Overall Study||120
95980|NCT02035748|235174|P1|NOT COMPLETED|Overall Study||20
95981|NCT02035748|235174|P1|COMPLETED|Overall Study||448
95982|NCT02035748|235174|P1|STARTED|Overall Study||468
95983|NCT02035696|235188|P4|NOT COMPLETED|Overall Study||3
95984|NCT02035696|235189|P3|NOT COMPLETED|Overall Study||3
95985|NCT02035696|235190|P2|NOT COMPLETED|Overall Study||3
95986|NCT02035696|235191|P1|NOT COMPLETED|Overall Study||3
95987|NCT02035696|235188|P4|COMPLETED|Overall Study||161
95988|NCT02035696|235189|P3|COMPLETED|Overall Study||164
95989|NCT02035696|235190|P2|COMPLETED|Overall Study||163
95990|NCT02035696|235191|P1|COMPLETED|Overall Study||171
95991|NCT02035696|235188|P4|STARTED|Overall Study||164
95992|NCT02035696|235189|P3|STARTED|Overall Study||167
95993|NCT02035696|235190|P2|STARTED|Overall Study||166
95994|NCT02035696|235191|P1|STARTED|Overall Study||174
95995|NCT02035553|235247|P2|NOT COMPLETED|Overall Study||23
95996|NCT02035553|235248|P1|NOT COMPLETED|Overall Study||18
95997|NCT02035553|235247|P2|COMPLETED|Overall Study||67
95998|NCT02035553|235248|P1|COMPLETED|Overall Study||73
95999|NCT02035553|235247|P2|STARTED|Overall Study||90
96000|NCT02035553|235248|P1|STARTED|Overall Study||91
96001|NCT02035475|235254|P1|NOT COMPLETED|Overall Study||6
96002|NCT02035475|235254|P1|COMPLETED|Overall Study|Six subjects did not complete the study due to withdrawal of consent.|114
96003|NCT02035475|235254|P1|STARTED|Overall Study|120 subjects were consented for participation in the study.|120
96004|NCT02035345|235260|P1|NOT COMPLETED|Overall Study||0
96005|NCT02035345|235260|P1|COMPLETED|Overall Study||15
96006|NCT02035345|235260|P1|STARTED|Overall Study||15
96007|NCT02035332|235265|P1|NOT COMPLETED|Overall Study||1
96008|NCT02035332|235265|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|20
96009|NCT02035332|235265|P1|Treated|Overall Study|Treatment Completed|20
96010|NCT02035332|235265|P1|STARTED|Overall Study|Treatment Attempted|21
96011|NCT02035202|235274|P3|NOT COMPLETED|Overall Study||2
96012|NCT02035202|235275|P2|NOT COMPLETED|Overall Study||16
96013|NCT02035202|235276|P1|NOT COMPLETED|Overall Study||8
96014|NCT02035202|235274|P3|COMPLETED|Overall Study||83
96015|NCT02035202|235275|P2|COMPLETED|Overall Study||69
96016|NCT02035202|235276|P1|COMPLETED|Overall Study||77
96017|NCT02035202|235274|P3|STARTED|Overall Study||85
96018|NCT02035202|235275|P2|STARTED|Overall Study||85
96019|NCT02035202|235276|P1|STARTED|Overall Study||85
96020|NCT02034916|235292|P2|NOT COMPLETED|Overall Study||35
96021|NCT02034916|235293|P1|NOT COMPLETED|Overall Study||49
96022|NCT02034916|235292|P2|COMPLETED|Overall Study||0
96023|NCT02034916|235293|P1|COMPLETED|Overall Study||0
96024|NCT02034916|235292|P2|Treated|Overall Study||35
96025|NCT02034916|235293|P1|Treated|Overall Study||48
96026|NCT02034916|235292|P2|STARTED|Overall Study||35
96027|NCT02034916|235293|P1|STARTED|Overall Study||49
96028|NCT02034877|235330|P2|NOT COMPLETED|Overall Study||6
96029|NCT02034877|235331|P1|NOT COMPLETED|Overall Study||0
96030|NCT02034877|235330|P2|COMPLETED|Overall Study||993
96031|NCT02034877|235331|P1|COMPLETED|Overall Study||200
96032|NCT02034877|235330|P2|STARTED|Overall Study||999
96033|NCT02034877|235331|P1|STARTED|Overall Study||200
96034|NCT02034799|235349|P2|NOT COMPLETED|Overall Study||4
96035|NCT02034799|235350|P1|NOT COMPLETED|Overall Study||2
96036|NCT02034799|235349|P2|COMPLETED|Overall Study||123
96037|NCT02034799|235350|P1|COMPLETED|Overall Study||127
96038|NCT02034799|235349|P2|STARTED|Overall Study||127
96039|NCT02034799|235350|P1|STARTED|Overall Study||129
96040|NCT02034708|235364|P2|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
96041|NCT02034708|235365|P1|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
96042|NCT02034708|235364|P2|COMPLETED|Second Contrast Agent Injection (1 Day)||120
96043|NCT02034708|235365|P1|COMPLETED|Second Contrast Agent Injection (1 Day)||129
96044|NCT02034708|235364|P2|STARTED|Second Contrast Agent Injection (1 Day)||120
96045|NCT02034708|235365|P1|STARTED|Second Contrast Agent Injection (1 Day)||129
96046|NCT02034708|235364|P2|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||10
96047|NCT02034708|235365|P1|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||9
96048|NCT02034708|235364|P2|COMPLETED|Wash-out (From 2 Days up to 14 Days)||120
96049|NCT02034708|235365|P1|COMPLETED|Wash-out (From 2 Days up to 14 Days)||129
96050|NCT02034708|235364|P2|STARTED|Wash-out (From 2 Days up to 14 Days)||130
96051|NCT02034708|235365|P1|STARTED|Wash-out (From 2 Days up to 14 Days)||138
96052|NCT02034708|235364|P2|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
96053|NCT02034708|235365|P1|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
96054|NCT02034708|235364|P2|COMPLETED|First Contrast Agent Injection (1 Day)||130
96055|NCT02034708|235365|P1|COMPLETED|First Contrast Agent Injection (1 Day)||138
96056|NCT02034708|235364|P2|STARTED|First Contrast Agent Injection (1 Day)||130
96057|NCT02034708|235365|P1|STARTED|First Contrast Agent Injection (1 Day)||138
96058|NCT02034591|235376|P6|NOT COMPLETED|Overall Study||0
96059|NCT02034591|235377|P5|NOT COMPLETED|Overall Study||1
96060|NCT02034591|235378|P4|NOT COMPLETED|Overall Study||0
96061|NCT02034591|235379|P3|NOT COMPLETED|Overall Study||0
96062|NCT02034591|235380|P2|NOT COMPLETED|Overall Study||0
96063|NCT02034591|235381|P1|NOT COMPLETED|Overall Study||0
96064|NCT02034591|235376|P6|COMPLETED|Overall Study||3
96065|NCT02034591|235377|P5|COMPLETED|Overall Study||3
96066|NCT02034591|235378|P4|COMPLETED|Overall Study||3
96067|NCT02034591|235379|P3|COMPLETED|Overall Study||4
96068|NCT02034591|235380|P2|COMPLETED|Overall Study||3
96069|NCT02034591|235381|P1|COMPLETED|Overall Study||4
96070|NCT02034591|235376|P6|STARTED|Overall Study||3
96071|NCT02034591|235377|P5|STARTED|Overall Study||4
96072|NCT02034591|235378|P4|STARTED|Overall Study||3
96073|NCT02034591|235379|P3|STARTED|Overall Study||4
96074|NCT02034591|235380|P2|STARTED|Overall Study||3
96075|NCT02034591|235381|P1|STARTED|Overall Study||4
96076|NCT02034578|235404|P6|NOT COMPLETED|Overall Study||0
96077|NCT02034578|235405|P5|NOT COMPLETED|Overall Study||0
96078|NCT02034578|235406|P4|NOT COMPLETED|Overall Study||0
96079|NCT02034578|235407|P3|NOT COMPLETED|Overall Study||0
96080|NCT02034578|235408|P2|NOT COMPLETED|Overall Study||0
96081|NCT02034578|235409|P1|NOT COMPLETED|Overall Study||0
96082|NCT02034578|235404|P6|COMPLETED|Overall Study||3
96083|NCT02034578|235405|P5|COMPLETED|Overall Study||4
96084|NCT02034578|235406|P4|COMPLETED|Overall Study||3
96085|NCT02034578|235407|P3|COMPLETED|Overall Study||4
96086|NCT02034578|235408|P2|COMPLETED|Overall Study||3
96087|NCT02034578|235409|P1|COMPLETED|Overall Study||4
96088|NCT02034578|235404|P6|STARTED|Overall Study||3
96089|NCT02034578|235405|P5|STARTED|Overall Study||4
96090|NCT02034578|235406|P4|STARTED|Overall Study||3
96091|NCT02034578|235407|P3|STARTED|Overall Study||4
96092|NCT02034578|235408|P2|STARTED|Overall Study||3
96093|NCT02034578|235409|P1|STARTED|Overall Study||4
96094|NCT02034565|235436|P2|NOT COMPLETED|Overall Study||0
96095|NCT02034565|235437|P1|NOT COMPLETED|Overall Study||1
96096|NCT02034565|235436|P2|COMPLETED|Overall Study||7
96097|NCT02034565|235437|P1|COMPLETED|Overall Study||6
96098|NCT02034565|235436|P2|STARTED|Overall Study||7
96099|NCT02034565|235437|P1|STARTED|Overall Study||7
96100|NCT02034552|235454|P3|NOT COMPLETED|Overall Study||17
96101|NCT02034552|235455|P2|NOT COMPLETED|Overall Study||20
96102|NCT02034552|235456|P1|NOT COMPLETED|Overall Study||14
96103|NCT02034552|235454|P3|COMPLETED|Overall Study||5
96104|NCT02034552|235455|P2|COMPLETED|Overall Study||4
96105|NCT02034552|235456|P1|COMPLETED|Overall Study||8
96106|NCT02034552|235454|P3|Received Treatment|Overall Study||22
96107|NCT02034552|235455|P2|Received Treatment|Overall Study||22
96108|NCT02034552|235456|P1|Received Treatment|Overall Study||19
96109|NCT02034552|235454|P3|STARTED|Overall Study||22
96110|NCT02034552|235455|P2|STARTED|Overall Study||24
96111|NCT02034552|235456|P1|STARTED|Overall Study||22
96112|NCT02034513|235487|P2|NOT COMPLETED|Overall Study||57
96113|NCT02034513|235488|P1|NOT COMPLETED|Overall Study||49
96114|NCT02034513|235487|P2|COMPLETED|Overall Study||195
96115|NCT02034513|235488|P1|COMPLETED|Overall Study||200
96116|NCT02034513|235487|P2|Exposed|Overall Study||251
96117|NCT02034513|235488|P1|Exposed|Overall Study||249
96118|NCT02034513|235487|P2|STARTED|Overall Study||252
96119|NCT02034513|235488|P1|STARTED|Overall Study||249
96120|NCT02034474|235506|P2|NOT COMPLETED|Overall Study||4
96121|NCT02034474|235507|P1|NOT COMPLETED|Overall Study||4
96122|NCT02034474|235506|P2|COMPLETED|Overall Study||13
96123|NCT02034474|235507|P1|COMPLETED|Overall Study||15
96124|NCT02034474|235506|P2|3 Doses|Overall Study||13
96125|NCT02034474|235507|P1|3 Doses|Overall Study||15
96126|NCT02034474|235506|P2|2 Doses|Overall Study||0
96127|NCT02034474|235507|P1|2 Doses|Overall Study||2
96128|NCT02034474|235506|P2|1 Dose|Overall Study||4
96129|NCT02034474|235507|P1|1 Dose|Overall Study||2
96130|NCT02034474|235506|P2|STARTED|Overall Study||17
96131|NCT02034474|235507|P1|STARTED|Overall Study||19
96132|NCT02034175|235517|P1|NOT COMPLETED|Overall Study||0
96133|NCT02034175|235517|P1|COMPLETED|Overall Study||190
96134|NCT02034175|235517|P1|STARTED|Overall Study||190
96135|NCT02034162|235523|P3|NOT COMPLETED|Open-label||0
96136|NCT02034162|235524|P2|NOT COMPLETED|Open-label||0
96137|NCT02034162|235525|P1|NOT COMPLETED|Open-label||0
96138|NCT02034162|235523|P3|COMPLETED|Open-label||278
96139|NCT02034162|235524|P2|COMPLETED|Open-label||0
96140|NCT02034162|235525|P1|COMPLETED|Open-label||0
96141|NCT02034162|235523|P3|STARTED|Open-label||278
96142|NCT02034162|235524|P2|STARTED|Open-label||0
96143|NCT02034162|235525|P1|STARTED|Open-label||0
96144|NCT02034162|235523|P3|NOT COMPLETED|Double-blind||0
96145|NCT02034162|235524|P2|NOT COMPLETED|Double-blind||8
96146|NCT02034162|235525|P1|NOT COMPLETED|Double-blind||9
96147|NCT02034162|235523|P3|COMPLETED|Double-blind||0
96148|NCT02034162|235524|P2|COMPLETED|Double-blind||141
96149|NCT02034162|235525|P1|COMPLETED|Double-blind||137
96150|NCT02034162|235523|P3|STARTED|Double-blind||0
96151|NCT02034162|235524|P2|STARTED|Double-blind||149
96152|NCT02034162|235525|P1|STARTED|Double-blind||146
96153|NCT02034123|235571|P18|NOT COMPLETED|Part2(Up to 2 Years)||0
96154|NCT02034123|235572|P17|NOT COMPLETED|Part2(Up to 2 Years)||0
96155|NCT02034123|235573|P16|NOT COMPLETED|Part2(Up to 2 Years)||0
96156|NCT02034123|235574|P15|NOT COMPLETED|Part2(Up to 2 Years)||0
96157|NCT02034123|235575|P14|NOT COMPLETED|Part2(Up to 2 Years)||0
96158|NCT02034123|235576|P13|NOT COMPLETED|Part2(Up to 2 Years)||0
96159|NCT02034123|235577|P12|NOT COMPLETED|Part2(Up to 2 Years)||0
96160|NCT02034123|235578|P11|NOT COMPLETED|Part2(Up to 2 Years)||0
96161|NCT02034123|235579|P10|NOT COMPLETED|Part2(Up to 2 Years)||0
96162|NCT02034123|235580|P9|NOT COMPLETED|Part2(Up to 2 Years)||0
96163|NCT02034123|235581|P8|NOT COMPLETED|Part2(Up to 2 Years)||0
96164|NCT02034123|235582|P7|NOT COMPLETED|Part2(Up to 2 Years)||0
96165|NCT02034123|235583|P6|NOT COMPLETED|Part2(Up to 2 Years)||0
96166|NCT02034123|235584|P5|NOT COMPLETED|Part2(Up to 2 Years)||0
96167|NCT02034123|235585|P4|NOT COMPLETED|Part2(Up to 2 Years)||0
96168|NCT02034123|235586|P3|NOT COMPLETED|Part2(Up to 2 Years)||0
96169|NCT02034123|235587|P2|NOT COMPLETED|Part2(Up to 2 Years)||0
96170|NCT02034123|235588|P1|NOT COMPLETED|Part2(Up to 2 Years)||0
96171|NCT02034123|235571|P18|COMPLETED|Part2(Up to 2 Years)||0
96172|NCT02034123|235572|P17|COMPLETED|Part2(Up to 2 Years)||0
96173|NCT02034123|235573|P16|COMPLETED|Part2(Up to 2 Years)||0
96174|NCT02034123|235574|P15|COMPLETED|Part2(Up to 2 Years)||0
96175|NCT02034123|235575|P14|COMPLETED|Part2(Up to 2 Years)||0
96176|NCT02034123|235576|P13|COMPLETED|Part2(Up to 2 Years)||0
96177|NCT02034123|235577|P12|COMPLETED|Part2(Up to 2 Years)||0
96178|NCT02034123|235578|P11|COMPLETED|Part2(Up to 2 Years)||0
96179|NCT02034123|235579|P10|COMPLETED|Part2(Up to 2 Years)||0
96180|NCT02034123|235580|P9|COMPLETED|Part2(Up to 2 Years)||0
96181|NCT02034123|235581|P8|COMPLETED|Part2(Up to 2 Years)||0
96182|NCT02034123|235582|P7|COMPLETED|Part2(Up to 2 Years)||0
96183|NCT02034123|235583|P6|COMPLETED|Part2(Up to 2 Years)||0
96184|NCT02034123|235584|P5|COMPLETED|Part2(Up to 2 Years)||0
96185|NCT02034123|235585|P4|COMPLETED|Part2(Up to 2 Years)||0
96186|NCT02034123|235586|P3|COMPLETED|Part2(Up to 2 Years)||0
96187|NCT02034123|235587|P2|COMPLETED|Part2(Up to 2 Years)||0
96188|NCT02034123|235588|P1|COMPLETED|Part2(Up to 2 Years)||0
96189|NCT02034123|235571|P18|STARTED|Part2(Up to 2 Years)||0
96190|NCT02034123|235572|P17|STARTED|Part2(Up to 2 Years)||0
96191|NCT02034123|235573|P16|STARTED|Part2(Up to 2 Years)||0
96192|NCT02034123|235574|P15|STARTED|Part2(Up to 2 Years)||0
96193|NCT02034123|235575|P14|STARTED|Part2(Up to 2 Years)||0
96194|NCT02034123|235576|P13|STARTED|Part2(Up to 2 Years)||0
96195|NCT02034123|235577|P12|STARTED|Part2(Up to 2 Years)||0
96196|NCT02034123|235578|P11|STARTED|Part2(Up to 2 Years)||0
96197|NCT02034123|235579|P10|STARTED|Part2(Up to 2 Years)||0
96198|NCT02034123|235580|P9|STARTED|Part2(Up to 2 Years)||0
96199|NCT02034123|235581|P8|STARTED|Part2(Up to 2 Years)||0
96200|NCT02034123|235582|P7|STARTED|Part2(Up to 2 Years)||0
96201|NCT02034123|235583|P6|STARTED|Part2(Up to 2 Years)||0
96202|NCT02034123|235584|P5|STARTED|Part2(Up to 2 Years)||0
96203|NCT02034123|235585|P4|STARTED|Part2(Up to 2 Years)||0
96204|NCT02034123|235586|P3|STARTED|Part2(Up to 2 Years)||0
96205|NCT02034123|235587|P2|STARTED|Part2(Up to 2 Years)||0
96206|NCT02034123|235588|P1|STARTED|Part2(Up to 2 Years)||0
96207|NCT02034123|235571|P18|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
96208|NCT02034123|235572|P17|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
96209|NCT02034123|235573|P16|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
96210|NCT02034123|235574|P15|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
96211|NCT02034123|235575|P14|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
96212|NCT02034123|235576|P13|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
96213|NCT02034123|235577|P12|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
96214|NCT02034123|235578|P11|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
96215|NCT02034123|235579|P10|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
96216|NCT02034123|235580|P9|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
96217|NCT02034123|235581|P8|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
96218|NCT02034123|235582|P7|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
96219|NCT02034123|235583|P6|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
96220|NCT02034123|235584|P5|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
96221|NCT02034123|235585|P4|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
96222|NCT02034123|235586|P3|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
96223|NCT02034123|235587|P2|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
96224|NCT02034123|235588|P1|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
96225|NCT02034123|235571|P18|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
96226|NCT02034123|235572|P17|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
96227|NCT02034123|235573|P16|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
96228|NCT02034123|235574|P15|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
96229|NCT02034123|235575|P14|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
96230|NCT02034123|235576|P13|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
96231|NCT02034123|235577|P12|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
96232|NCT02034123|235578|P11|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
96233|NCT02034123|235579|P10|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
96234|NCT02034123|235580|P9|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
96235|NCT02034123|235581|P8|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||4
96236|NCT02034123|235582|P7|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
96237|NCT02034123|235583|P6|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||3
96238|NCT02034123|235584|P5|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||5
96239|NCT02034123|235585|P4|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
96240|NCT02034123|235586|P3|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||5
96241|NCT02034123|235587|P2|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
96242|NCT02034123|235588|P1|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
96243|NCT02034123|235571|P18|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
96244|NCT02034123|235572|P17|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
96245|NCT02034123|235573|P16|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
96246|NCT02034123|235574|P15|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
96247|NCT02034123|235575|P14|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
96248|NCT02034123|235576|P13|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
96249|NCT02034123|235577|P12|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
96250|NCT02034123|235578|P11|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
96251|NCT02034123|235579|P10|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
96252|NCT02034123|235580|P9|STARTED|Part1(Median of 7.286 Weeks of Exposure)||2
96253|NCT02034123|235581|P8|STARTED|Part1(Median of 7.286 Weeks of Exposure)||5
96254|NCT02034123|235582|P7|STARTED|Part1(Median of 7.286 Weeks of Exposure)||2
96255|NCT02034123|235583|P6|STARTED|Part1(Median of 7.286 Weeks of Exposure)||3
96256|NCT02034123|235584|P5|STARTED|Part1(Median of 7.286 Weeks of Exposure)||7
96257|NCT02034123|235585|P4|STARTED|Part1(Median of 7.286 Weeks of Exposure)||3
96258|NCT02034123|235586|P3|STARTED|Part1(Median of 7.286 Weeks of Exposure)||5
96259|NCT02034123|235587|P2|STARTED|Part1(Median of 7.286 Weeks of Exposure)||1
96260|NCT02034123|235588|P1|STARTED|Part1(Median of 7.286 Weeks of Exposure)||1
96261|NCT02034006|235909|P1|NOT COMPLETED|Overall Study||14
96262|NCT02034006|235909|P1|COMPLETED|Overall Study||186
96263|NCT02034006|235909|P1|Re-treated Patients|Overall Study||130
96264|NCT02034006|235909|P1|Once Treated Patients|Overall Study||70
96265|NCT02034006|235909|P1|STARTED|Overall Study||200
96266|NCT02033889|235943|P3|NOT COMPLETED|Overall Study||25
96267|NCT02033889|235944|P2|NOT COMPLETED|Overall Study||20
96268|NCT02033889|235945|P1|NOT COMPLETED|Overall Study||34
96269|NCT02033889|235943|P3|COMPLETED|Overall Study||180
96270|NCT02033889|235944|P2|COMPLETED|Overall Study||187
96271|NCT02033889|235945|P1|COMPLETED|Overall Study||175
96272|NCT02033889|235943|P3|STARTED|Overall Study||205
96273|NCT02033889|235944|P2|STARTED|Overall Study||207
96274|NCT02033889|235945|P1|STARTED|Overall Study||209
96275|NCT02033876|236099|P2|NOT COMPLETED|Overall Study||0
96276|NCT02033876|236100|P1|NOT COMPLETED|Overall Study||0
96277|NCT02033876|236099|P2|COMPLETED|Overall Study||12
96278|NCT02033876|236100|P1|COMPLETED|Overall Study||12
96279|NCT02033876|236099|P2|STARTED|Overall Study||12
96280|NCT02033876|236100|P1|STARTED|Overall Study||12
96281|NCT02033850|236122|P2|NOT COMPLETED|Overall Study||1
96282|NCT02033850|236123|P1|NOT COMPLETED|Overall Study||2
96283|NCT02033850|236122|P2|COMPLETED|Overall Study||22
96284|NCT02033850|236123|P1|COMPLETED|Overall Study||21
96285|NCT02033850|236122|P2|STARTED|Overall Study||23
96286|NCT02033850|236123|P1|STARTED|Overall Study||23
96287|NCT02033499|236148|P3|NOT COMPLETED|Overall Study||9
96288|NCT02033499|236149|P2|NOT COMPLETED|Overall Study||8
96289|NCT02033499|236150|P1|NOT COMPLETED|Overall Study||5
96290|NCT02033499|236148|P3|COMPLETED|Overall Study||139
96291|NCT02033499|236149|P2|COMPLETED|Overall Study||142
96292|NCT02033499|236150|P1|COMPLETED|Overall Study||147
96293|NCT02033499|236148|P3|STARTED|Overall Study||148
96294|NCT02033499|236149|P2|STARTED|Overall Study||150
96295|NCT02033499|236150|P1|STARTED|Overall Study||152
96296|NCT02033369|236190|P2|NOT COMPLETED|Overall Study||5
96297|NCT02033369|236191|P1|NOT COMPLETED|Overall Study||5
96298|NCT02033369|236190|P2|COMPLETED|Overall Study||21
96299|NCT02033369|236191|P1|COMPLETED|Overall Study||21
96300|NCT02033369|236190|P2|STARTED|Overall Study||26
96301|NCT02033369|236191|P1|STARTED|Overall Study||26
96302|NCT02033317|236201|P1|NOT COMPLETED|Overall Study||0
96303|NCT02033317|236201|P1|COMPLETED|Overall Study||6
96304|NCT02033317|236201|P1|STARTED|Overall Study||6
96305|NCT02033213|236208|P2|NOT COMPLETED|Overall Study||0
96306|NCT02033213|236209|P1|NOT COMPLETED|Overall Study||0
96307|NCT02033213|236208|P2|COMPLETED|Overall Study||8
96308|NCT02033213|236209|P1|COMPLETED|Overall Study||8
96309|NCT02033213|236208|P2|STARTED|Overall Study||8
96310|NCT02033213|236209|P1|STARTED|Overall Study||8
96311|NCT02033200|236227|P2|NOT COMPLETED|Overall Study||0
96312|NCT02033200|236228|P1|NOT COMPLETED|Overall Study||0
96313|NCT02033200|236227|P2|COMPLETED|Overall Study||40
96314|NCT02033200|236228|P1|COMPLETED|Overall Study||40
96315|NCT02033200|236227|P2|STARTED|Overall Study||40
96316|NCT02033200|236228|P1|STARTED|Overall Study||40
96317|NCT02033174|236248|P2|NOT COMPLETED|Second Intervention||0
96318|NCT02033174|236249|P1|NOT COMPLETED|Second Intervention||0
96319|NCT02033174|236248|P2|COMPLETED|Second Intervention||8
96320|NCT02033174|236249|P1|COMPLETED|Second Intervention||8
96321|NCT02033174|236248|P2|STARTED|Second Intervention||8
96322|NCT02033174|236249|P1|STARTED|Second Intervention||8
96323|NCT02033174|236248|P2|NOT COMPLETED|Washout (1 Week)||0
96324|NCT02033174|236249|P1|NOT COMPLETED|Washout (1 Week)||0
96325|NCT02033174|236248|P2|COMPLETED|Washout (1 Week)||8
96326|NCT02033174|236249|P1|COMPLETED|Washout (1 Week)||8
96327|NCT02033174|236248|P2|STARTED|Washout (1 Week)||8
96328|NCT02033174|236249|P1|STARTED|Washout (1 Week)||8
96329|NCT02033174|236248|P2|NOT COMPLETED|First Intervention||0
96330|NCT02033174|236249|P1|NOT COMPLETED|First Intervention||0
96331|NCT02033174|236248|P2|COMPLETED|First Intervention||8
96332|NCT02033174|236249|P1|COMPLETED|First Intervention||8
96333|NCT02033174|236248|P2|STARTED|First Intervention||8
96334|NCT02033174|236249|P1|STARTED|First Intervention||8
96335|NCT02033083|236257|P2|NOT COMPLETED|Overall Study||1
96336|NCT02033083|236258|P1|NOT COMPLETED|Overall Study||1
96337|NCT02033083|236257|P2|COMPLETED|Overall Study||88
96338|NCT02033083|236258|P1|COMPLETED|Overall Study||88
96339|NCT02033083|236257|P2|STARTED|Overall Study||89
96340|NCT02033083|236258|P1|STARTED|Overall Study||89
96341|NCT02033005|236267|P3|NOT COMPLETED|Overall Study||10
96342|NCT02033005|236268|P2|NOT COMPLETED|Overall Study||0
96343|NCT02033005|236269|P1|NOT COMPLETED|Overall Study||44
96344|NCT02033005|236267|P3|COMPLETED|Overall Study||25
96345|NCT02033005|236268|P2|COMPLETED|Overall Study||9
96346|NCT02033005|236269|P1|COMPLETED|Overall Study||36
96347|NCT02033005|236267|P3|STARTED|Overall Study||35
96348|NCT02033005|236268|P2|STARTED|Overall Study||9
96349|NCT02033005|236269|P1|STARTED|Overall Study||80
96350|NCT02032901|236285|P2|NOT COMPLETED|Follow-Up Period (24 Weeks)||1
96351|NCT02032901|236286|P1|NOT COMPLETED|Follow-Up Period (24 Weeks)||0
96352|NCT02032901|236285|P2|COMPLETED|Follow-Up Period (24 Weeks)||50
96353|NCT02032901|236286|P1|COMPLETED|Follow-Up Period (24 Weeks)||101
96354|NCT02032901|236285|P2|STARTED|Follow-Up Period (24 Weeks)||51
96355|NCT02032901|236286|P1|STARTED|Follow-Up Period (24 Weeks)|Participant could enter follow up period even if the treatment period was not completed.|101
96356|NCT02032901|236285|P2|NOT COMPLETED|Treatment Period (12 Weeks)||0
96357|NCT02032901|236286|P1|NOT COMPLETED|Treatment Period (12 Weeks)||1
96358|NCT02032901|236285|P2|COMPLETED|Treatment Period (12 Weeks)||51
96359|NCT02032901|236286|P1|COMPLETED|Treatment Period (12 Weeks)||100
96360|NCT02032901|236285|P2|STARTED|Treatment Period (12 Weeks)||51
96361|NCT02032901|236286|P1|STARTED|Treatment Period (12 Weeks)||101
96362|NCT02032888|236310|P3|NOT COMPLETED|Follow-up Period||0
96363|NCT02032888|236311|P2|NOT COMPLETED|Follow-up Period||2
96364|NCT02032888|236312|P1|NOT COMPLETED|Follow-up Period||3
96365|NCT02032888|236310|P3|COMPLETED|Follow-up Period||52
96366|NCT02032888|236311|P2|COMPLETED|Follow-up Period||47
96367|NCT02032888|236312|P1|COMPLETED|Follow-up Period||97
96368|NCT02032888|236310|P3|STARTED|Follow-up Period||52
96369|NCT02032888|236311|P2|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|49
96370|NCT02032888|236312|P1|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|100
96371|NCT02032888|236310|P3|NOT COMPLETED|Treatment Period||0
96372|NCT02032888|236311|P2|NOT COMPLETED|Treatment Period||2
96373|NCT02032888|236312|P1|NOT COMPLETED|Treatment Period||2
96374|NCT02032888|236310|P3|COMPLETED|Treatment Period||52
96375|NCT02032888|236311|P2|COMPLETED|Treatment Period||48
96376|NCT02032888|236312|P1|COMPLETED|Treatment Period||99
96377|NCT02032888|236310|P3|STARTED|Treatment Period||52
96378|NCT02032888|236311|P2|STARTED|Treatment Period||50
96379|NCT02032888|236312|P1|STARTED|Treatment Period||101
96380|NCT02032875|236343|P2|NOT COMPLETED|Follow-up Period||11
96381|NCT02032875|236344|P1|NOT COMPLETED|Follow-up Period||3
96382|NCT02032875|236343|P2|COMPLETED|Follow-up Period||46
96383|NCT02032875|236344|P1|COMPLETED|Follow-up Period||50
96384|NCT02032875|236343|P2|STARTED|Follow-up Period|Of 60 participants in treatment period, 57 continued in follow-up, 3 entered treatment extension.|57
96385|NCT02032875|236344|P1|STARTED|Follow-up Period|Out of 53 participants who entered the treatment period, all 53 continued in the follow-up period.|53
96386|NCT02032875|236343|P2|NOT COMPLETED|Treatment Period||4
96387|NCT02032875|236344|P1|NOT COMPLETED|Treatment Period||1
96388|NCT02032875|236343|P2|COMPLETED|Treatment Period||56
96389|NCT02032875|236344|P1|COMPLETED|Treatment Period||52
96390|NCT02032875|236343|P2|STARTED|Treatment Period||60
96391|NCT02032875|236344|P1|STARTED|Treatment Period||53
96392|NCT02032810|236364|P2|NOT COMPLETED|Overall Study||0
96393|NCT02032810|236365|P1|NOT COMPLETED|Overall Study||0
96394|NCT02032810|236364|P2|COMPLETED|Overall Study||11
96395|NCT02032810|236365|P1|COMPLETED|Overall Study||6
96396|NCT02032810|236364|P2|STARTED|Overall Study||11
96397|NCT02032810|236365|P1|STARTED|Overall Study||6
96398|NCT02032758|236378|P2|NOT COMPLETED|Overall Study||0
96399|NCT02032758|236379|P1|NOT COMPLETED|Overall Study||0
96400|NCT02032758|236378|P2|COMPLETED|Overall Study||11
96401|NCT02032758|236379|P1|COMPLETED|Overall Study||27
96402|NCT02032758|236378|P2|STARTED|Overall Study||11
96403|NCT02032758|236379|P1|STARTED|Overall Study||27
96404|NCT02032706|236387|P1|NOT COMPLETED|Overall Study||6
96405|NCT02032706|236387|P1|COMPLETED|Overall Study||30
96406|NCT02032706|236387|P1|STARTED|Overall Study||36
96407|NCT02032641|236400|P1|NOT COMPLETED|Overall Study||1
96408|NCT02032641|236400|P1|COMPLETED|Overall Study|16 brows completed study (half underwent treatment, half were control)|8
96409|NCT02032641|236400|P1|STARTED|Overall Study|18 Brows enrolled for evaluation|9
96410|NCT02032433|236412|P2|NOT COMPLETED|Overall Study||62
96411|NCT02032433|236413|P1|NOT COMPLETED|Overall Study||78
96412|NCT02032433|236412|P2|COMPLETED|Overall Study||225
96413|NCT02032433|236413|P1|COMPLETED|Overall Study||205
96414|NCT02032433|236412|P2|STARTED|Overall Study||287
96415|NCT02032433|236413|P1|STARTED|Overall Study||283
96416|NCT02032420|236431|P2|NOT COMPLETED|Overall Study||0
96417|NCT02032420|236432|P1|NOT COMPLETED|Overall Study||0
96418|NCT02032420|236431|P2|COMPLETED|Overall Study||17
96419|NCT02032420|236432|P1|COMPLETED|Overall Study||18
96420|NCT02032420|236431|P2|STARTED|Overall Study||17
96421|NCT02032420|236432|P1|STARTED|Overall Study||18
96422|NCT02032407|236444|P1|NOT COMPLETED|Overall Study||5
96423|NCT02032407|236444|P1|COMPLETED|Overall Study||63
96424|NCT02032407|236444|P1|STARTED|Overall Study||68
96425|NCT02032238|236457|P2|NOT COMPLETED|Overall Study||0
96426|NCT02032238|236458|P1|NOT COMPLETED|Overall Study||2
96427|NCT02032238|236457|P2|COMPLETED|Overall Study||0
96428|NCT02032238|236458|P1|COMPLETED|Overall Study||10
96429|NCT02032238|236457|P2|STARTED|Overall Study|Study Terminated due to slow enrollment, no subjects enrolled in this study arm|0
96430|NCT02032238|236458|P1|STARTED|Overall Study||12
96431|NCT02032212|236468|P4|NOT COMPLETED|Overall Study||0
96432|NCT02032212|236469|P3|NOT COMPLETED|Overall Study||0
96433|NCT02032212|236470|P2|NOT COMPLETED|Overall Study||0
96434|NCT02032212|236471|P1|NOT COMPLETED|Overall Study||0
96435|NCT02032212|236468|P4|COMPLETED|Overall Study||3
96436|NCT02032212|236469|P3|COMPLETED|Overall Study||3
96437|NCT02032212|236470|P2|COMPLETED|Overall Study||3
96438|NCT02032212|236471|P1|COMPLETED|Overall Study||3
96439|NCT02032212|236468|P4|STARTED|Overall Study||3
96440|NCT02032212|236469|P3|STARTED|Overall Study||3
96441|NCT02032212|236470|P2|STARTED|Overall Study||3
96442|NCT02032212|236471|P1|STARTED|Overall Study||3
96443|NCT02031679|236499|P2|NOT COMPLETED|Overall Study||2
96444|NCT02031679|236500|P1|NOT COMPLETED|Overall Study||0
96445|NCT02031679|236499|P2|COMPLETED|Overall Study||12
96446|NCT02031679|236500|P1|COMPLETED|Overall Study||14
96447|NCT02031679|236499|P2|STARTED|Overall Study||14
96448|NCT02031679|236500|P1|STARTED|Overall Study||14
96449|NCT02031640|236515|P6|NOT COMPLETED|Double-blind Treatment Period||3
96450|NCT02031640|236516|P5|NOT COMPLETED|Double-blind Treatment Period||11
96451|NCT02031640|236517|P4|NOT COMPLETED|Double-blind Treatment Period||7
96452|NCT02031640|236518|P3|NOT COMPLETED|Double-blind Treatment Period||6
96453|NCT02031640|236519|P2|NOT COMPLETED|Double-blind Treatment Period||22
96454|NCT02031640|236520|P1|NOT COMPLETED|Double-blind Treatment Period||0
96455|NCT02031640|236515|P6|COMPLETED|Double-blind Treatment Period||104
96456|NCT02031640|236516|P5|COMPLETED|Double-blind Treatment Period||96
96457|NCT02031640|236517|P4|COMPLETED|Double-blind Treatment Period||99
96458|NCT02031640|236518|P3|COMPLETED|Double-blind Treatment Period||100
96459|NCT02031640|236519|P2|COMPLETED|Double-blind Treatment Period||84
96460|NCT02031640|236520|P1|COMPLETED|Double-blind Treatment Period||0
96461|NCT02031640|236515|P6|Full Analysis Set|Double-blind Treatment Period||107
96462|NCT02031640|236516|P5|Full Analysis Set|Double-blind Treatment Period||106
96463|NCT02031640|236517|P4|Full Analysis Set|Double-blind Treatment Period||106
96464|NCT02031640|236518|P3|Full Analysis Set|Double-blind Treatment Period||104
96465|NCT02031640|236519|P2|Full Analysis Set|Double-blind Treatment Period||106
96466|NCT02031640|236520|P1|Full Analysis Set|Double-blind Treatment Period||0
96467|NCT02031640|236515|P6|STARTED|Double-blind Treatment Period||107
96468|NCT02031640|236516|P5|STARTED|Double-blind Treatment Period||107
96469|NCT02031640|236517|P4|STARTED|Double-blind Treatment Period||106
96470|NCT02031640|236518|P3|STARTED|Double-blind Treatment Period||106
96471|NCT02031640|236519|P2|STARTED|Double-blind Treatment Period||106
96472|NCT02031640|236520|P1|STARTED|Double-blind Treatment Period||0
96473|NCT02031640|236515|P6|NOT COMPLETED|Run-In Period||0
96474|NCT02031640|236516|P5|NOT COMPLETED|Run-In Period||0
96475|NCT02031640|236517|P4|NOT COMPLETED|Run-In Period||0
96476|NCT02031640|236518|P3|NOT COMPLETED|Run-In Period||0
96477|NCT02031640|236519|P2|NOT COMPLETED|Run-In Period||0
96478|NCT02031640|236520|P1|NOT COMPLETED|Run-In Period||169
96479|NCT02031640|236515|P6|COMPLETED|Run-In Period||0
96480|NCT02031640|236516|P5|COMPLETED|Run-In Period||0
96481|NCT02031640|236517|P4|COMPLETED|Run-In Period||0
96482|NCT02031640|236518|P3|COMPLETED|Run-In Period||0
96483|NCT02031640|236519|P2|COMPLETED|Run-In Period||0
96484|NCT02031640|236520|P1|COMPLETED|Run-In Period||532
96485|NCT02031640|236515|P6|STARTED|Run-In Period||0
96486|NCT02031640|236516|P5|STARTED|Run-In Period||0
96487|NCT02031640|236517|P4|STARTED|Run-In Period||0
96488|NCT02031640|236518|P3|STARTED|Run-In Period||0
96489|NCT02031640|236519|P2|STARTED|Run-In Period||0
96490|NCT02031640|236520|P1|STARTED|Run-In Period||701
96491|NCT02031640|236515|P6|NOT COMPLETED|Screening Period||0
96492|NCT02031640|236516|P5|NOT COMPLETED|Screening Period||0
96493|NCT02031640|236517|P4|NOT COMPLETED|Screening Period||0
96494|NCT02031640|236518|P3|NOT COMPLETED|Screening Period||0
96495|NCT02031640|236519|P2|NOT COMPLETED|Screening Period||0
96496|NCT02031640|236520|P1|NOT COMPLETED|Screening Period||412
96497|NCT02031640|236515|P6|COMPLETED|Screening Period||0
96498|NCT02031640|236516|P5|COMPLETED|Screening Period||0
96499|NCT02031640|236517|P4|COMPLETED|Screening Period||0
96500|NCT02031640|236518|P3|COMPLETED|Screening Period||0
96501|NCT02031640|236519|P2|COMPLETED|Screening Period||0
96502|NCT02031640|236520|P1|COMPLETED|Screening Period||701
96503|NCT02031640|236515|P6|STARTED|Screening Period||0
96504|NCT02031640|236516|P5|STARTED|Screening Period||0
96505|NCT02031640|236517|P4|STARTED|Screening Period||0
96506|NCT02031640|236518|P3|STARTED|Screening Period||0
96507|NCT02031640|236519|P2|STARTED|Screening Period||0
96508|NCT02031640|236520|P1|STARTED|Screening Period|Consented|1113
96509|NCT02031471|236563|P1|NOT COMPLETED|Long Term Extension (LTE) Period||2
96510|NCT02031471|236563|P1|COMPLETED|Long Term Extension (LTE) Period||37
96511|NCT02031471|236563|P1|STARTED|Long Term Extension (LTE) Period|Only participants who achieved at least a moderate EULAR response at Week 24 entered the LTE Period.|39
96512|NCT02031471|236563|P1|NOT COMPLETED|24 Week Treatment Period||11
96513|NCT02031471|236563|P1|COMPLETED|24 Week Treatment Period||46
96514|NCT02031471|236563|P1|STARTED|24 Week Treatment Period||57
96515|NCT02031458|236596|P3|NOT COMPLETED|Overall Study||253
96516|NCT02031458|236597|P2|NOT COMPLETED|Overall Study||267
96517|NCT02031458|236598|P1|NOT COMPLETED|Overall Study||139
96518|NCT02031458|236596|P3|COMPLETED|Overall Study||0
96519|NCT02031458|236597|P2|COMPLETED|Overall Study||0
96520|NCT02031458|236598|P1|COMPLETED|Overall Study||0
96521|NCT02031458|236596|P3|STARTED|Overall Study||253
96522|NCT02031458|236597|P2|STARTED|Overall Study||267
96523|NCT02031458|236598|P1|STARTED|Overall Study||139
96524|NCT02031302|236694|P2|NOT COMPLETED|Overall Study||0
96525|NCT02031302|236695|P1|NOT COMPLETED|Overall Study||164
96526|NCT02031302|236694|P2|COMPLETED|Overall Study||50
96527|NCT02031302|236695|P1|COMPLETED|Overall Study||850
96528|NCT02031302|236694|P2|STARTED|Overall Study||50
96529|NCT02031302|236695|P1|STARTED|Overall Study||1014
96530|NCT02031276|236716|P3|NOT COMPLETED|Period 3 Open-label Risankizumab SC||2
96531|NCT02031276|236717|P2|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3
96532|NCT02031276|236718|P1|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3
96533|NCT02031276|236716|P3|COMPLETED|Period 3 Open-label Risankizumab SC||19
96534|NCT02031276|236717|P2|COMPLETED|Period 3 Open-label Risankizumab SC||19
96535|NCT02031276|236718|P1|COMPLETED|Period 3 Open-label Risankizumab SC||16
96536|NCT02031276|236716|P3|STARTED|Period 3 Open-label Risankizumab SC|17 participants did not enter period 3 (not in clinical remission)|21
96537|NCT02031276|236717|P2|STARTED|Period 3 Open-label Risankizumab SC|11 participants did not enter period 3 (not in clinical remission)|22
96538|NCT02031276|236718|P1|STARTED|Period 3 Open-label Risankizumab SC|10 participants did not enter period 3 (not in clinical remission)|19
96539|NCT02031276|236716|P3|NOT COMPLETED|Period 2 Open-label Risankizumab IV||1
96540|NCT02031276|236717|P2|NOT COMPLETED|Period 2 Open-label Risankizumab IV||2
96541|NCT02031276|236718|P1|NOT COMPLETED|Period 2 Open-label Risankizumab IV||4
96542|NCT02031276|236716|P3|COMPLETED|Period 2 Open-label Risankizumab IV||38
96543|NCT02031276|236717|P2|COMPLETED|Period 2 Open-label Risankizumab IV||33
96544|NCT02031276|236718|P1|COMPLETED|Period 2 Open-label Risankizumab IV||29
96545|NCT02031276|236716|P3|STARTED|Period 2 Open-label Risankizumab IV|1 participant did not enter Period 2 (declined open-label treatment in Period 2)|39
96546|NCT02031276|236717|P2|STARTED|Period 2 Open-label Risankizumab IV||35
96547|NCT02031276|236718|P1|STARTED|Period 2 Open-label Risankizumab IV||33
96548|NCT02031276|236716|P3|NOT COMPLETED|Period 1 Double-blind IV||1
96549|NCT02031276|236717|P2|NOT COMPLETED|Period 1 Double-blind IV||6
96550|NCT02031276|236718|P1|NOT COMPLETED|Period 1 Double-blind IV||6
96551|NCT02031276|236716|P3|COMPLETED|Period 1 Double-blind IV||40
96552|NCT02031276|236717|P2|COMPLETED|Period 1 Double-blind IV||35
96553|NCT02031276|236718|P1|COMPLETED|Period 1 Double-blind IV||33
96554|NCT02031276|236716|P3|STARTED|Period 1 Double-blind IV||41
96555|NCT02031276|236717|P2|STARTED|Period 1 Double-blind IV||41
96556|NCT02031276|236718|P1|STARTED|Period 1 Double-blind IV||39
96557|NCT02031237|236752|P3|NOT COMPLETED|Overall Study||3
96558|NCT02031237|236753|P2|NOT COMPLETED|Overall Study||14
96559|NCT02031237|236754|P1|NOT COMPLETED|Overall Study||5
96560|NCT02031237|236752|P3|COMPLETED|Overall Study||0
96561|NCT02031237|236753|P2|COMPLETED|Overall Study||21
96562|NCT02031237|236754|P1|COMPLETED|Overall Study||9
96563|NCT02031237|236752|P3|STARTED|Overall Study||3
96564|NCT02031237|236753|P2|STARTED|Overall Study||35
96565|NCT02031237|236754|P1|STARTED|Overall Study||14
96566|NCT02030847|236761|P1|NOT COMPLETED|Overall Study||37
96567|NCT02030847|236761|P1|COMPLETED|Overall Study||5
96568|NCT02030847|236761|P1|STARTED|Overall Study||42
96569|NCT02030821|236770|P4|NOT COMPLETED|Overall Study||2
96570|NCT02030821|236771|P3|NOT COMPLETED|Overall Study||5
96571|NCT02030821|236772|P2|NOT COMPLETED|Overall Study||2
96572|NCT02030821|236773|P1|NOT COMPLETED|Overall Study||2
96573|NCT02030821|236770|P4|COMPLETED|Overall Study||72
96574|NCT02030821|236771|P3|COMPLETED|Overall Study||73
96575|NCT02030821|236772|P2|COMPLETED|Overall Study||44
96576|NCT02030821|236773|P1|COMPLETED|Overall Study||46
96577|NCT02030821|236770|P4|STARTED|Overall Study||74
96578|NCT02030821|236771|P3|STARTED|Overall Study||78
96579|NCT02030821|236772|P2|STARTED|Overall Study||46
96580|NCT02030821|236773|P1|STARTED|Overall Study||48
96581|NCT02030600|236801|P2|NOT COMPLETED|Treatment Period 2||18
96582|NCT02030600|236802|P1|NOT COMPLETED|Treatment Period 2||25
96583|NCT02030600|236801|P2|COMPLETED|Treatment Period 2||297
96584|NCT02030600|236802|P1|COMPLETED|Treatment Period 2||283
96585|NCT02030600|236801|P2|STARTED|Treatment Period 2||315
96586|NCT02030600|236802|P1|STARTED|Treatment Period 2||308
96587|NCT02030600|236801|P2|NOT COMPLETED|Treatment Period 1||45
96588|NCT02030600|236802|P1|NOT COMPLETED|Treatment Period 1||53
96589|NCT02030600|236801|P2|COMPLETED|Treatment Period 1||315
96590|NCT02030600|236802|P1|COMPLETED|Treatment Period 1||308
96591|NCT02030600|236801|P2|Exposed|Treatment Period 1||357
96592|NCT02030600|236802|P1|Exposed|Treatment Period 1||356
96593|NCT02030600|236801|P2|STARTED|Treatment Period 1||360
96594|NCT02030600|236802|P1|STARTED|Treatment Period 1||361
96595|NCT02030574|236818|P1|NOT COMPLETED|Overall Study||0
96596|NCT02030574|236818|P1|COMPLETED|Overall Study||2
96597|NCT02030574|236818|P1|STARTED|Overall Study||2
96598|NCT02030535|236823|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
96599|NCT02030535|236823|P1|COMPLETED|Treatment Period 3 (1 Day)||52
96600|NCT02030535|236823|P1|STARTED|Treatment Period 3 (1 Day)||52
96601|NCT02030535|236823|P1|NOT COMPLETED|Washout Period 2 (21 Days)||0
96602|NCT02030535|236823|P1|COMPLETED|Washout Period 2 (21 Days)||52
96603|NCT02030535|236823|P1|STARTED|Washout Period 2 (21 Days)||52
96604|NCT02030535|236823|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
96605|NCT02030535|236823|P1|COMPLETED|Treatment Period 2 (1 Day)||52
96606|NCT02030535|236823|P1|STARTED|Treatment Period 2 (1 Day)||52
96607|NCT02030535|236823|P1|NOT COMPLETED|Washout Period 1 (21 Days)||1
96608|NCT02030535|236823|P1|COMPLETED|Washout Period 1 (21 Days)||52
96609|NCT02030535|236823|P1|STARTED|Washout Period 1 (21 Days)||53
96610|NCT02030535|236823|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
96611|NCT02030535|236823|P1|COMPLETED|Treatment Period 1 (1 Day)||53
96612|NCT02030535|236823|P1|STARTED|Treatment Period 1 (1 Day)||53
96613|NCT02030405|236891|P1|NOT COMPLETED|Overall Study||2
96614|NCT02030405|236891|P1|COMPLETED|Overall Study||2
96615|NCT02030405|236891|P1|STARTED|Overall Study||4
96616|NCT02030119|236902|P4|NOT COMPLETED|Overall Study||3
96617|NCT02030119|236903|P3|NOT COMPLETED|Overall Study||6
96618|NCT02030119|236904|P2|NOT COMPLETED|Overall Study||2
96619|NCT02030119|236905|P1|NOT COMPLETED|Overall Study||3
96620|NCT02030119|236902|P4|COMPLETED|Overall Study||67
96621|NCT02030119|236903|P3|COMPLETED|Overall Study||65
96622|NCT02030119|236904|P2|COMPLETED|Overall Study||68
96623|NCT02030119|236905|P1|COMPLETED|Overall Study||67
96624|NCT02030119|236902|P4|STARTED|Overall Study||70
96625|NCT02030119|236903|P3|STARTED|Overall Study||71
96626|NCT02030119|236904|P2|STARTED|Overall Study||70
96627|NCT02030119|236905|P1|STARTED|Overall Study||70
96628|NCT02030080|236923|P4|NOT COMPLETED|Overall Study||2
96629|NCT02030080|236924|P3|NOT COMPLETED|Overall Study||0
96630|NCT02030080|236925|P2|NOT COMPLETED|Overall Study||0
96631|NCT02030080|236926|P1|NOT COMPLETED|Overall Study||0
96632|NCT02030080|236923|P4|COMPLETED|Overall Study||42
96633|NCT02030080|236924|P3|COMPLETED|Overall Study||80
96634|NCT02030080|236925|P2|COMPLETED|Overall Study||64
96635|NCT02030080|236926|P1|COMPLETED|Overall Study||100
96636|NCT02030080|236923|P4|STARTED|Overall Study|11 teams|44
96637|NCT02030080|236924|P3|STARTED|Overall Study|20 teams|80
96638|NCT02030080|236925|P2|STARTED|Overall Study|16 teams|64
96639|NCT02030080|236926|P1|STARTED|Overall Study|25 teams|100
96640|NCT02030041|236943|P3|NOT COMPLETED|Overall Study||1
96641|NCT02030041|236944|P2|NOT COMPLETED|Overall Study||2
96642|NCT02030041|236945|P1|NOT COMPLETED|Overall Study||2
96643|NCT02030041|236943|P3|COMPLETED|Overall Study||10
96644|NCT02030041|236944|P2|COMPLETED|Overall Study||9
96645|NCT02030041|236945|P1|COMPLETED|Overall Study||9
96646|NCT02030041|236943|P3|STARTED|Overall Study||11
96647|NCT02030041|236944|P2|STARTED|Overall Study||11
96648|NCT02030041|236945|P1|STARTED|Overall Study||11
96649|NCT02029989|236958|P2|NOT COMPLETED|Overall Study||11
96650|NCT02029989|236959|P1|NOT COMPLETED|Overall Study||16
96651|NCT02029989|236958|P2|COMPLETED|Overall Study||49
96652|NCT02029989|236959|P1|COMPLETED|Overall Study||45
96653|NCT02029989|236958|P2|STARTED|Overall Study||60
96654|NCT02029989|236959|P1|STARTED|Overall Study|A subject was given the same ID# as withdrawn subject (ID # counted twice) causing N=61 discrepancy.|61
96655|NCT02029911|236965|P1|NOT COMPLETED|Overall Study||0
96656|NCT02029911|236965|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|60
96657|NCT02029911|236965|P1|Treated|Overall Study|Treatment Completed|60
96658|NCT02029911|236965|P1|STARTED|Overall Study|Treatment Attempted|60
96659|NCT02029872|236973|P2|NOT COMPLETED|Overall Study||3
96660|NCT02029872|236974|P1|NOT COMPLETED|Overall Study||2
96661|NCT02029872|236973|P2|COMPLETED|Overall Study||6
96662|NCT02029872|236974|P1|COMPLETED|Overall Study||7
96663|NCT02029872|236973|P2|STARTED|Overall Study||9
96664|NCT02029872|236974|P1|STARTED|Overall Study||9
96665|NCT02029846|236982|P2|NOT COMPLETED|Overall Study||1
96666|NCT02029846|236983|P1|NOT COMPLETED|Overall Study||1
96667|NCT02029846|236982|P2|COMPLETED|Overall Study||0
96668|NCT02029846|236983|P1|COMPLETED|Overall Study||0
96669|NCT02029846|236982|P2|STARTED|Overall Study||1
96670|NCT02029846|236983|P1|STARTED|Overall Study||1
96671|NCT02029755|236996|P3|NOT COMPLETED|Overall Study||0
96672|NCT02029755|236997|P2|NOT COMPLETED|Overall Study||0
96673|NCT02029755|236998|P1|NOT COMPLETED|Overall Study||0
96674|NCT02029755|236996|P3|COMPLETED|Overall Study||36
96675|NCT02029755|236997|P2|COMPLETED|Overall Study||36
96676|NCT02029755|236998|P1|COMPLETED|Overall Study||36
96677|NCT02029755|236996|P3|STARTED|Overall Study||36
96678|NCT02029755|236997|P2|STARTED|Overall Study||36
96679|NCT02029755|236998|P1|STARTED|Overall Study||36
96680|NCT02029703|237011|P2|NOT COMPLETED|Overall Study||0
96681|NCT02029703|237012|P1|NOT COMPLETED|Overall Study||0
96682|NCT02029703|237011|P2|COMPLETED|Overall Study||22
96683|NCT02029703|237012|P1|COMPLETED|Overall Study||20
96684|NCT02029703|237011|P2|STARTED|Overall Study||22
96685|NCT02029703|237012|P1|STARTED|Overall Study||20
96686|NCT02029638|237021|P3|NOT COMPLETED|Overall Study||1
96687|NCT02029638|237022|P2|NOT COMPLETED|Overall Study||0
96688|NCT02029638|237023|P1|NOT COMPLETED|Overall Study||2
96689|NCT02029638|237021|P3|COMPLETED|Overall Study||0
96690|NCT02029638|237022|P2|COMPLETED|Overall Study||1
96691|NCT02029638|237023|P1|COMPLETED|Overall Study||0
96692|NCT02029638|237021|P3|STARTED|Overall Study||1
96693|NCT02029638|237022|P2|STARTED|Overall Study||1
96694|NCT02029638|237023|P1|STARTED|Overall Study||2
96695|NCT02029521|237052|P2|NOT COMPLETED|Overall Study||1
96696|NCT02029521|237053|P1|NOT COMPLETED|Overall Study||2
96697|NCT02029521|237052|P2|COMPLETED|Overall Study||22
96698|NCT02029521|237053|P1|COMPLETED|Overall Study||22
96699|NCT02029521|237052|P2|STARTED|Overall Study||23
96700|NCT02029521|237053|P1|STARTED|Overall Study||24
96701|NCT02029495|237138|P3|NOT COMPLETED|Overall Study||2
96702|NCT02029495|237139|P2|NOT COMPLETED|Overall Study||0
96703|NCT02029495|237140|P1|NOT COMPLETED|Overall Study||1
96704|NCT02029495|237138|P3|COMPLETED|Overall Study||159
96705|NCT02029495|237139|P2|COMPLETED|Overall Study||158
96706|NCT02029495|237140|P1|COMPLETED|Overall Study||158
96707|NCT02029495|237138|P3|STARTED|Overall Study||161
96708|NCT02029495|237139|P2|STARTED|Overall Study||158
96709|NCT02029495|237140|P1|STARTED|Overall Study||159
96710|NCT02029417|237151|P1|NOT COMPLETED|Overall Study||2
96711|NCT02029417|237151|P1|COMPLETED|Overall Study||0
96712|NCT02029417|237151|P1|STARTED|Overall Study||2
96713|NCT02029274|237160|P4|NOT COMPLETED|Overall Study||2
96714|NCT02029274|237161|P3|NOT COMPLETED|Overall Study||2
96715|NCT02029274|237162|P2|NOT COMPLETED|Overall Study||0
96716|NCT02029274|237163|P1|NOT COMPLETED|Overall Study||1
96717|NCT02029274|237160|P4|COMPLETED|Overall Study||2
96718|NCT02029274|237161|P3|COMPLETED|Overall Study||2
96719|NCT02029274|237162|P2|COMPLETED|Overall Study||4
96720|NCT02029274|237163|P1|COMPLETED|Overall Study||4
96721|NCT02029274|237160|P4|Fixed Dose Period 2|Overall Study||4
96722|NCT02029274|237161|P3|Fixed Dose Period 2|Overall Study||4
96723|NCT02029274|237162|P2|Fixed Dose Period 2|Overall Study||4
96724|NCT02029274|237163|P1|Fixed Dose Period 2|Overall Study||5
96725|NCT02029274|237160|P4|STARTED|Overall Study||4
96726|NCT02029274|237161|P3|STARTED|Overall Study||4
96727|NCT02029274|237162|P2|STARTED|Overall Study||4
96728|NCT02029274|237163|P1|STARTED|Overall Study||5
96729|NCT02029235|237195|P2|NOT COMPLETED|Overall Study||1
96730|NCT02029235|237196|P1|NOT COMPLETED|Overall Study||4
96731|NCT02029235|237195|P2|COMPLETED|Overall Study||30
96732|NCT02029235|237196|P1|COMPLETED|Overall Study||30
96733|NCT02029235|237195|P2|STARTED|Overall Study||31
96734|NCT02029235|237196|P1|STARTED|Overall Study||34
96735|NCT02029196|237206|P2|NOT COMPLETED|Overall Study||1
96736|NCT02029196|237207|P1|NOT COMPLETED|Overall Study||20
96737|NCT02029196|237206|P2|COMPLETED|Overall Study||101
96738|NCT02029196|237207|P1|COMPLETED|Overall Study||286
96739|NCT02029196|237206|P2|STARTED|Overall Study||102
96740|NCT02029196|237207|P1|STARTED|Overall Study||306
96741|NCT02029040|237217|P2|NOT COMPLETED|Overall Study||0
96742|NCT02029040|237218|P1|NOT COMPLETED|Overall Study||0
96743|NCT02029040|237217|P2|COMPLETED|Overall Study||25
96744|NCT02029040|237218|P1|COMPLETED|Overall Study||27
96745|NCT02029040|237217|P2|STARTED|Overall Study||25
96746|NCT02029040|237218|P1|STARTED|Overall Study||27
96747|NCT02028871|237228|P2|NOT COMPLETED|Overall Study||3
96748|NCT02028871|237229|P1|NOT COMPLETED|Overall Study||4
96749|NCT02028871|237228|P2|COMPLETED|Overall Study||9
96750|NCT02028871|237229|P1|COMPLETED|Overall Study||10
96751|NCT02028871|237228|P2|STARTED|Overall Study||12
96752|NCT02028871|237229|P1|STARTED|Overall Study||14
96753|NCT02028780|237250|P12|NOT COMPLETED|Follow up Phase||0
96754|NCT02028780|237251|P11|NOT COMPLETED|Follow up Phase||0
96755|NCT02028780|237252|P10|NOT COMPLETED|Follow up Phase||0
96756|NCT02028780|237253|P9|NOT COMPLETED|Follow up Phase||0
96757|NCT02028780|237254|P8|NOT COMPLETED|Follow up Phase||0
96758|NCT02028780|237255|P7|NOT COMPLETED|Follow up Phase||0
96759|NCT02028780|237256|P6|NOT COMPLETED|Follow up Phase||0
96760|NCT02028780|237257|P5|NOT COMPLETED|Follow up Phase||0
96761|NCT02028780|237258|P4|NOT COMPLETED|Follow up Phase||0
96762|NCT02028780|237259|P3|NOT COMPLETED|Follow up Phase||0
96763|NCT02028780|237260|P2|NOT COMPLETED|Follow up Phase||0
96764|NCT02028780|237261|P1|NOT COMPLETED|Follow up Phase||0
96765|NCT02028780|237250|P12|COMPLETED|Follow up Phase||9
96766|NCT02028780|237251|P11|COMPLETED|Follow up Phase||9
96767|NCT02028780|237252|P10|COMPLETED|Follow up Phase||9
96768|NCT02028780|237253|P9|COMPLETED|Follow up Phase||9
96769|NCT02028780|237254|P8|COMPLETED|Follow up Phase||3
96770|NCT02028780|237255|P7|COMPLETED|Follow up Phase||9
96771|NCT02028780|237256|P6|COMPLETED|Follow up Phase||6
96772|NCT02028780|237257|P5|COMPLETED|Follow up Phase||6
96773|NCT02028780|237258|P4|COMPLETED|Follow up Phase||6
96774|NCT02028780|237259|P3|COMPLETED|Follow up Phase||6
96775|NCT02028780|237260|P2|COMPLETED|Follow up Phase||2
96776|NCT02028780|237261|P1|COMPLETED|Follow up Phase||6
96777|NCT02028780|237250|P12|STARTED|Follow up Phase||9
96778|NCT02028780|237251|P11|STARTED|Follow up Phase||9
96779|NCT02028780|237252|P10|STARTED|Follow up Phase||9
96780|NCT02028780|237253|P9|STARTED|Follow up Phase||9
96781|NCT02028780|237254|P8|STARTED|Follow up Phase||3
96782|NCT02028780|237255|P7|STARTED|Follow up Phase||9
96783|NCT02028780|237256|P6|STARTED|Follow up Phase||6
96784|NCT02028780|237257|P5|STARTED|Follow up Phase||6
96785|NCT02028780|237258|P4|STARTED|Follow up Phase||6
96786|NCT02028780|237259|P3|STARTED|Follow up Phase||6
96787|NCT02028780|237260|P2|STARTED|Follow up Phase||2
96788|NCT02028780|237261|P1|STARTED|Follow up Phase||6
96789|NCT02028780|237250|P12|NOT COMPLETED|Observation Phase||0
96790|NCT02028780|237251|P11|NOT COMPLETED|Observation Phase||0
96791|NCT02028780|237252|P10|NOT COMPLETED|Observation Phase||0
96792|NCT02028780|237253|P9|NOT COMPLETED|Observation Phase||0
96793|NCT02028780|237254|P8|NOT COMPLETED|Observation Phase||0
96794|NCT02028780|237255|P7|NOT COMPLETED|Observation Phase||0
96795|NCT02028780|237256|P6|NOT COMPLETED|Observation Phase||0
96796|NCT02028780|237257|P5|NOT COMPLETED|Observation Phase||0
96797|NCT02028780|237258|P4|NOT COMPLETED|Observation Phase||0
96798|NCT02028780|237259|P3|NOT COMPLETED|Observation Phase||0
96799|NCT02028780|237260|P2|NOT COMPLETED|Observation Phase||0
96800|NCT02028780|237261|P1|NOT COMPLETED|Observation Phase||0
96801|NCT02028780|237250|P12|COMPLETED|Observation Phase||9
96802|NCT02028780|237251|P11|COMPLETED|Observation Phase||9
96803|NCT02028780|237252|P10|COMPLETED|Observation Phase||9
96804|NCT02028780|237253|P9|COMPLETED|Observation Phase||9
96805|NCT02028780|237254|P8|COMPLETED|Observation Phase||3
96806|NCT02028780|237255|P7|COMPLETED|Observation Phase||9
96807|NCT02028780|237256|P6|COMPLETED|Observation Phase||6
96808|NCT02028780|237257|P5|COMPLETED|Observation Phase||6
96809|NCT02028780|237258|P4|COMPLETED|Observation Phase||6
96810|NCT02028780|237259|P3|COMPLETED|Observation Phase||6
96811|NCT02028780|237260|P2|COMPLETED|Observation Phase||2
96812|NCT02028780|237261|P1|COMPLETED|Observation Phase||6
96813|NCT02028780|237250|P12|STARTED|Observation Phase||9
96814|NCT02028780|237251|P11|STARTED|Observation Phase||9
96815|NCT02028780|237252|P10|STARTED|Observation Phase||9
96816|NCT02028780|237253|P9|STARTED|Observation Phase||9
96817|NCT02028780|237254|P8|STARTED|Observation Phase||3
96818|NCT02028780|237255|P7|STARTED|Observation Phase||9
96819|NCT02028780|237256|P6|STARTED|Observation Phase||6
96820|NCT02028780|237257|P5|STARTED|Observation Phase||6
96821|NCT02028780|237258|P4|STARTED|Observation Phase||6
96822|NCT02028780|237259|P3|STARTED|Observation Phase||6
96823|NCT02028780|237260|P2|STARTED|Observation Phase||2
96824|NCT02028780|237261|P1|STARTED|Observation Phase||6
96825|NCT02028767|237326|P2|NOT COMPLETED|Treatment Period 2||0
96826|NCT02028767|237327|P1|NOT COMPLETED|Treatment Period 2||2
96827|NCT02028767|237326|P2|COMPLETED|Treatment Period 2||16
96828|NCT02028767|237327|P1|COMPLETED|Treatment Period 2||14
96829|NCT02028767|237326|P2|STARTED|Treatment Period 2||16
96830|NCT02028767|237327|P1|STARTED|Treatment Period 2||16
96831|NCT02028767|237326|P2|NOT COMPLETED|Treatment Period 1||0
96832|NCT02028767|237327|P1|NOT COMPLETED|Treatment Period 1||0
96833|NCT02028767|237326|P2|COMPLETED|Treatment Period 1||16
96834|NCT02028767|237327|P1|COMPLETED|Treatment Period 1||16
96835|NCT02028767|237326|P2|STARTED|Treatment Period 1||16
96836|NCT02028767|237327|P1|STARTED|Treatment Period 1||16
96837|NCT02028754|237339|P2|NOT COMPLETED|Overall Study||8
96838|NCT02028754|237340|P1|NOT COMPLETED|Overall Study||7
96839|NCT02028754|237339|P2|COMPLETED|Overall Study||82
96840|NCT02028754|237340|P1|COMPLETED|Overall Study||83
96841|NCT02028754|237339|P2|STARTED|Overall Study||90
96842|NCT02028754|237340|P1|STARTED|Overall Study||90
96843|NCT02028715|237360|P2|NOT COMPLETED|Overall Study||4
96844|NCT02028715|237361|P1|NOT COMPLETED|Overall Study||5
96845|NCT02028715|237360|P2|COMPLETED|Overall Study||30
96846|NCT02028715|237361|P1|COMPLETED|Overall Study||29
96847|NCT02028715|237360|P2|STARTED|Overall Study||34
96848|NCT02028715|237361|P1|STARTED|Overall Study||34
96849|NCT02028676|237388|P9|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
96850|NCT02028676|237389|P8|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
96851|NCT02028676|237390|P7|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
96852|NCT02028676|237391|P6|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
96853|NCT02028676|237392|P5|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
96854|NCT02028676|237393|P4|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
96855|NCT02028676|237394|P3|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
96856|NCT02028676|237395|P2|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
96857|NCT02028676|237396|P1|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
96858|NCT02028676|237388|P9|COMPLETED|Subsequent Cotrimoxazole Randomization||382
96859|NCT02028676|237389|P8|COMPLETED|Subsequent Cotrimoxazole Randomization||376
96860|NCT02028676|237390|P7|COMPLETED|Subsequent Cotrimoxazole Randomization||0
96861|NCT02028676|237391|P6|COMPLETED|Subsequent Cotrimoxazole Randomization||0
96862|NCT02028676|237392|P5|COMPLETED|Subsequent Cotrimoxazole Randomization||0
96863|NCT02028676|237393|P4|COMPLETED|Subsequent Cotrimoxazole Randomization||0
96864|NCT02028676|237394|P3|COMPLETED|Subsequent Cotrimoxazole Randomization||0
96865|NCT02028676|237395|P2|COMPLETED|Subsequent Cotrimoxazole Randomization||0
96866|NCT02028676|237396|P1|COMPLETED|Subsequent Cotrimoxazole Randomization||0
96867|NCT02028676|237388|P9|STARTED|Subsequent Cotrimoxazole Randomization||382
96868|NCT02028676|237389|P8|STARTED|Subsequent Cotrimoxazole Randomization||376
96869|NCT02028676|237390|P7|STARTED|Subsequent Cotrimoxazole Randomization||0
96870|NCT02028676|237391|P6|STARTED|Subsequent Cotrimoxazole Randomization||0
96871|NCT02028676|237392|P5|STARTED|Subsequent Cotrimoxazole Randomization||0
96872|NCT02028676|237393|P4|STARTED|Subsequent Cotrimoxazole Randomization||0
96873|NCT02028676|237394|P3|STARTED|Subsequent Cotrimoxazole Randomization||0
96874|NCT02028676|237395|P2|STARTED|Subsequent Cotrimoxazole Randomization||0
96875|NCT02028676|237396|P1|STARTED|Subsequent Cotrimoxazole Randomization||0
96876|NCT02028676|237388|P9|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
96877|NCT02028676|237389|P8|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
96878|NCT02028676|237390|P7|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
96879|NCT02028676|237391|P6|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
96880|NCT02028676|237392|P5|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
96881|NCT02028676|237393|P4|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
96882|NCT02028676|237394|P3|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
96883|NCT02028676|237395|P2|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
96884|NCT02028676|237396|P1|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
96885|NCT02028676|237388|P9|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
96886|NCT02028676|237389|P8|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
96887|NCT02028676|237390|P7|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||333
96888|NCT02028676|237391|P6|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||336
96889|NCT02028676|237392|P5|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
96890|NCT02028676|237393|P4|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
96891|NCT02028676|237394|P3|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
96892|NCT02028676|237395|P2|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
96893|NCT02028676|237396|P1|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
96894|NCT02028676|237388|P9|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
96895|NCT02028676|237389|P8|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
96896|NCT02028676|237390|P7|STARTED|Subsequent Once vs Twice Daily ABC+3TC||333
96897|NCT02028676|237391|P6|STARTED|Subsequent Once vs Twice Daily ABC+3TC||336
96898|NCT02028676|237392|P5|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
96899|NCT02028676|237393|P4|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
96900|NCT02028676|237394|P3|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
96901|NCT02028676|237395|P2|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
96902|NCT02028676|237396|P1|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
96903|NCT02028676|237388|P9|NOT COMPLETED|Initial Enrolment: Induction ART||0
96904|NCT02028676|237389|P8|NOT COMPLETED|Initial Enrolment: Induction ART||0
96905|NCT02028676|237390|P7|NOT COMPLETED|Initial Enrolment: Induction ART||0
96906|NCT02028676|237391|P6|NOT COMPLETED|Initial Enrolment: Induction ART||0
96907|NCT02028676|237392|P5|NOT COMPLETED|Initial Enrolment: Induction ART||0
96908|NCT02028676|237393|P4|NOT COMPLETED|Initial Enrolment: Induction ART||0
96909|NCT02028676|237394|P3|NOT COMPLETED|Initial Enrolment: Induction ART||0
96910|NCT02028676|237395|P2|NOT COMPLETED|Initial Enrolment: Induction ART||0
96911|NCT02028676|237396|P1|NOT COMPLETED|Initial Enrolment: Induction ART||0
96912|NCT02028676|237388|P9|COMPLETED|Initial Enrolment: Induction ART||0
96913|NCT02028676|237389|P8|COMPLETED|Initial Enrolment: Induction ART||0
96914|NCT02028676|237390|P7|COMPLETED|Initial Enrolment: Induction ART||0
96915|NCT02028676|237391|P6|COMPLETED|Initial Enrolment: Induction ART||0
96916|NCT02028676|237392|P5|COMPLETED|Initial Enrolment: Induction ART||405
96917|NCT02028676|237393|P4|COMPLETED|Initial Enrolment: Induction ART||404
96918|NCT02028676|237394|P3|COMPLETED|Initial Enrolment: Induction ART||397
96919|NCT02028676|237395|P2|COMPLETED|Initial Enrolment: Induction ART||0
96920|NCT02028676|237396|P1|COMPLETED|Initial Enrolment: Induction ART||0
96921|NCT02028676|237388|P9|STARTED|Initial Enrolment: Induction ART||0
96922|NCT02028676|237389|P8|STARTED|Initial Enrolment: Induction ART||0
96923|NCT02028676|237390|P7|STARTED|Initial Enrolment: Induction ART||0
96924|NCT02028676|237391|P6|STARTED|Initial Enrolment: Induction ART||0
96925|NCT02028676|237392|P5|STARTED|Initial Enrolment: Induction ART||405
96926|NCT02028676|237393|P4|STARTED|Initial Enrolment: Induction ART||404
96927|NCT02028676|237394|P3|STARTED|Initial Enrolment: Induction ART||397
96928|NCT02028676|237395|P2|STARTED|Initial Enrolment: Induction ART||0
96929|NCT02028676|237396|P1|STARTED|Initial Enrolment: Induction ART||0
96930|NCT02028676|237388|P9|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
96931|NCT02028676|237389|P8|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
96932|NCT02028676|237390|P7|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
96933|NCT02028676|237391|P6|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
96934|NCT02028676|237392|P5|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
96935|NCT02028676|237393|P4|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
96936|NCT02028676|237394|P3|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
96937|NCT02028676|237395|P2|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
96938|NCT02028676|237396|P1|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
96939|NCT02028676|237388|P9|COMPLETED|Initial Enrolment: CDM vs LCM||0
96940|NCT02028676|237389|P8|COMPLETED|Initial Enrolment: CDM vs LCM||0
96941|NCT02028676|237390|P7|COMPLETED|Initial Enrolment: CDM vs LCM||0
96942|NCT02028676|237391|P6|COMPLETED|Initial Enrolment: CDM vs LCM||0
96943|NCT02028676|237392|P5|COMPLETED|Initial Enrolment: CDM vs LCM||0
96944|NCT02028676|237393|P4|COMPLETED|Initial Enrolment: CDM vs LCM||0
96945|NCT02028676|237394|P3|COMPLETED|Initial Enrolment: CDM vs LCM||0
96946|NCT02028676|237395|P2|COMPLETED|Initial Enrolment: CDM vs LCM||600
96947|NCT02028676|237396|P1|COMPLETED|Initial Enrolment: CDM vs LCM||606
96948|NCT02028676|237388|P9|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
96949|NCT02028676|237389|P8|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
96950|NCT02028676|237390|P7|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
96951|NCT02028676|237391|P6|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
96952|NCT02028676|237392|P5|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
96953|NCT02028676|237393|P4|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
96954|NCT02028676|237394|P3|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
96955|NCT02028676|237395|P2|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|600
96956|NCT02028676|237396|P1|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|606
96957|NCT02028325|237569|P1|NOT COMPLETED|Overall Study||10
96958|NCT02028325|237569|P1|COMPLETED|Overall Study||126
96959|NCT02028325|237569|P1|STARTED|Overall Study||136
96960|NCT02028169|237573|P1|NOT COMPLETED|Overall Study||28
96961|NCT02028169|237573|P1|COMPLETED|Overall Study||92
96962|NCT02028169|237573|P1|STARTED|Overall Study||120
96963|NCT02028065|237599|P3|NOT COMPLETED|Treatment Through Study Completion||14
96964|NCT02028065|237600|P2|NOT COMPLETED|Treatment Through Study Completion||15
96965|NCT02028065|237601|P1|NOT COMPLETED|Treatment Through Study Completion||12
96966|NCT02028065|237599|P3|COMPLETED|Treatment Through Study Completion||134
96967|NCT02028065|237600|P2|COMPLETED|Treatment Through Study Completion||136
96968|NCT02028065|237601|P1|COMPLETED|Treatment Through Study Completion||64
96969|NCT02028065|237599|P3|Received Third Dose|Treatment Through Study Completion||134
96970|NCT02028065|237600|P2|Received Third Dose|Treatment Through Study Completion||136
96971|NCT02028065|237601|P1|Received Third Dose|Treatment Through Study Completion||64
96972|NCT02028065|237599|P3|Received Second Dose|Treatment Through Study Completion||138
96973|NCT02028065|237600|P2|Received Second Dose|Treatment Through Study Completion||140
96974|NCT02028065|237601|P1|Received Second Dose|Treatment Through Study Completion||69
96975|NCT02028065|237599|P3|Received First Dose|Treatment Through Study Completion||148
96976|NCT02028065|237600|P2|Received First Dose|Treatment Through Study Completion||151
96977|NCT02028065|237601|P1|Received First Dose|Treatment Through Study Completion||76
96978|NCT02028065|237599|P3|STARTED|Treatment Through Study Completion|Does not include the 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|148
96979|NCT02028065|237600|P2|STARTED|Treatment Through Study Completion||151
96980|NCT02028065|237601|P1|STARTED|Treatment Through Study Completion|Includes 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|76
96981|NCT02028065|237599|P3|NOT COMPLETED|Randomization Through Start Treatment||3
96982|NCT02028065|237600|P2|NOT COMPLETED|Randomization Through Start Treatment||3
96983|NCT02028065|237601|P1|NOT COMPLETED|Randomization Through Start Treatment||1
96984|NCT02028065|237599|P3|COMPLETED|Randomization Through Start Treatment||149
96985|NCT02028065|237600|P2|COMPLETED|Randomization Through Start Treatment||151
96986|NCT02028065|237601|P1|COMPLETED|Randomization Through Start Treatment||75
96987|NCT02028065|237599|P3|STARTED|Randomization Through Start Treatment|Randomized|152
96988|NCT02028065|237600|P2|STARTED|Randomization Through Start Treatment|Randomized|154
96989|NCT02028065|237601|P1|STARTED|Randomization Through Start Treatment|Randomized|76
96990|NCT02027883|237614|P2|NOT COMPLETED|Overall Study||0
96991|NCT02027883|237615|P1|NOT COMPLETED|Overall Study||0
96992|NCT02027883|237614|P2|COMPLETED|Overall Study||50
96993|NCT02027883|237615|P1|COMPLETED|Overall Study||50
96994|NCT02027883|237614|P2|STARTED|Overall Study||50
96995|NCT02027883|237615|P1|STARTED|Overall Study||50
96996|NCT02027844|237628|P3|NOT COMPLETED|Overall Study||2
96997|NCT02027844|237629|P2|NOT COMPLETED|Overall Study||6
96998|NCT02027844|237630|P1|NOT COMPLETED|Overall Study||5
96999|NCT02027844|237628|P3|COMPLETED|Overall Study||37
97000|NCT02027844|237629|P2|COMPLETED|Overall Study||33
97001|NCT02027844|237630|P1|COMPLETED|Overall Study||34
97002|NCT02027844|237628|P3|STARTED|Overall Study||39
97003|NCT02027844|237629|P2|STARTED|Overall Study||39
97004|NCT02027844|237630|P1|STARTED|Overall Study||39
97005|NCT02027701|237647|P1|NOT COMPLETED|Overall Study||16
97006|NCT02027701|237647|P1|COMPLETED|Overall Study||66
97007|NCT02027701|237647|P1|STARTED|Overall Study||82
97008|NCT02027623|237665|P2|NOT COMPLETED|Overall Study||11
97009|NCT02027623|237666|P1|NOT COMPLETED|Overall Study||9
97010|NCT02027623|237665|P2|COMPLETED|Overall Study||66
97011|NCT02027623|237666|P1|COMPLETED|Overall Study||68
97012|NCT02027623|237665|P2|STARTED|Overall Study||77
97013|NCT02027623|237666|P1|STARTED|Overall Study||77
97014|NCT02027558|237678|P2|NOT COMPLETED|Overall Study||2
97015|NCT02027558|237679|P1|NOT COMPLETED|Overall Study||9
97016|NCT02027558|237678|P2|COMPLETED|Overall Study||61
97017|NCT02027558|237679|P1|COMPLETED|Overall Study||53
97018|NCT02027558|237678|P2|6-month Follow-up|Overall Study||61
97019|NCT02027558|237679|P1|6-month Follow-up|Overall Study||53
97020|NCT02027558|237678|P2|3-month Follow-up|Overall Study||58
97021|NCT02027558|237679|P1|3-month Follow-up|Overall Study||53
97022|NCT02027558|237678|P2|Post-treatment|Overall Study||60
97023|NCT02027558|237679|P1|Post-treatment|Overall Study||49
97024|NCT02027558|237678|P2|STARTED|Overall Study||63
97025|NCT02027558|237679|P1|STARTED|Overall Study||62
97026|NCT02027428|237697|P3|NOT COMPLETED|Survival Follow-up||30
97027|NCT02027428|237698|P2|NOT COMPLETED|Survival Follow-up||48
97028|NCT02027428|237699|P1|NOT COMPLETED|Survival Follow-up||0
97029|NCT02027428|237697|P3|COMPLETED|Survival Follow-up||19
97030|NCT02027428|237698|P2|COMPLETED|Survival Follow-up||43
97031|NCT02027428|237699|P1|COMPLETED|Survival Follow-up||0
97032|NCT02027428|237697|P3|STARTED|Survival Follow-up|Participants are not taking study intervention but are on appropriate standard of care.|49
97033|NCT02027428|237698|P2|STARTED|Survival Follow-up|Participants are not taking study intervention but are on appropriate standard of care.|91
97034|NCT02027428|237699|P1|STARTED|Survival Follow-up||0
97035|NCT02027428|237697|P3|NOT COMPLETED|Maintenance||60
97036|NCT02027428|237698|P2|NOT COMPLETED|Maintenance||124
97037|NCT02027428|237699|P1|NOT COMPLETED|Maintenance||0
97038|NCT02027428|237697|P3|COMPLETED|Maintenance||6
97039|NCT02027428|237698|P2|COMPLETED|Maintenance||12
97040|NCT02027428|237699|P1|COMPLETED|Maintenance||0
97041|NCT02027428|237697|P3|STARTED|Maintenance||66
97042|NCT02027428|237698|P2|STARTED|Maintenance||136
97043|NCT02027428|237699|P1|STARTED|Maintenance||0
97044|NCT02027428|237697|P3|NOT COMPLETED|Induction||0
97045|NCT02027428|237698|P2|NOT COMPLETED|Induction||0
97046|NCT02027428|237699|P1|NOT COMPLETED|Induction||225
97047|NCT02027428|237697|P3|COMPLETED|Induction||0
97048|NCT02027428|237698|P2|COMPLETED|Induction||0
97049|NCT02027428|237699|P1|COMPLETED|Induction|If radiologically CR, PR or SD after 4 cycles of treatment, participants continue on to Maintenance.|202
97050|NCT02027428|237697|P3|STARTED|Induction||0
97051|NCT02027428|237698|P2|STARTED|Induction||0
97052|NCT02027428|237699|P1|STARTED|Induction||427
97053|NCT02027402|237737|P2|NOT COMPLETED|Overall Study||1
97054|NCT02027402|237738|P1|NOT COMPLETED|Overall Study||4
97055|NCT02027402|237737|P2|COMPLETED|Overall Study||99
97056|NCT02027402|237738|P1|COMPLETED|Overall Study||94
97057|NCT02027402|237737|P2|STARTED|Overall Study||100
97058|NCT02027402|237738|P1|STARTED|Overall Study||98
97059|NCT02027376|237750|P3|NOT COMPLETED|Overall Study||0
97060|NCT02027376|237751|P2|NOT COMPLETED|Overall Study||0
97061|NCT02027376|237752|P1|NOT COMPLETED|Overall Study||1
97062|NCT02027376|237750|P3|COMPLETED|Overall Study||3
97063|NCT02027376|237751|P2|COMPLETED|Overall Study||4
97064|NCT02027376|237752|P1|COMPLETED|Overall Study||4
97065|NCT02027376|237750|P3|STARTED|Overall Study||3
97066|NCT02027376|237751|P2|STARTED|Overall Study||4
97067|NCT02027376|237752|P1|STARTED|Overall Study||5
97068|NCT02027311|237778|P2|NOT COMPLETED|Overall Study||2
97069|NCT02027311|237779|P1|NOT COMPLETED|Overall Study||3
97070|NCT02027311|237778|P2|COMPLETED|Overall Study|1 cases was dropped due to tachycardia and 1 were desaturation.|33
97071|NCT02027311|237779|P1|COMPLETED|Overall Study|1 case was dropped due to hypotension and 2 were desaturation.|30
97072|NCT02027311|237778|P2|STARTED|Overall Study||35
97073|NCT02027311|237779|P1|STARTED|Overall Study||33
97074|NCT02027272|237789|P2|NOT COMPLETED|Overall Study||1
97075|NCT02027272|237790|P1|NOT COMPLETED|Overall Study||0
97076|NCT02027272|237789|P2|COMPLETED|Overall Study||0
97077|NCT02027272|237790|P1|COMPLETED|Overall Study||0
97078|NCT02027272|237789|P2|STARTED|Overall Study||1
97079|NCT02027272|237790|P1|STARTED|Overall Study||0
97080|NCT02027025|237799|P3|NOT COMPLETED|Overall Study||1
97081|NCT02027025|237800|P2|NOT COMPLETED|Overall Study||5
97082|NCT02027025|237801|P1|NOT COMPLETED|Overall Study||1
97083|NCT02027025|237799|P3|COMPLETED|Overall Study||46
97084|NCT02027025|237800|P2|COMPLETED|Overall Study||42
97085|NCT02027025|237801|P1|COMPLETED|Overall Study||47
97086|NCT02027025|237799|P3|STARTED|Overall Study||47
97087|NCT02027025|237800|P2|STARTED|Overall Study||47
97088|NCT02027025|237801|P1|STARTED|Overall Study||48
97089|NCT02026687|237822|P2|NOT COMPLETED|Overall Study||2
97090|NCT02026687|237823|P1|NOT COMPLETED|Overall Study||1
97091|NCT02026687|237822|P2|COMPLETED|Overall Study||38
97092|NCT02026687|237823|P1|COMPLETED|Overall Study||39
97093|NCT02026687|237822|P2|STARTED|Overall Study||40
97094|NCT02026687|237823|P1|STARTED|Overall Study||40
97095|NCT02026453|237836|P3|NOT COMPLETED|Overall Study||13
97096|NCT02026453|237837|P2|NOT COMPLETED|Overall Study||9
97097|NCT02026453|237838|P1|NOT COMPLETED|Overall Study||6
97098|NCT02026453|237836|P3|COMPLETED|Overall Study||89
97099|NCT02026453|237837|P2|COMPLETED|Overall Study||94
97100|NCT02026453|237838|P1|COMPLETED|Overall Study||95
97101|NCT02026453|237836|P3|STARTED|Overall Study||102
97102|NCT02026453|237837|P2|STARTED|Overall Study||103
97103|NCT02026453|237838|P1|STARTED|Overall Study||101
97104|NCT02026258|237851|P2|NOT COMPLETED|Recieved Allocated Intervention||2
97105|NCT02026258|237852|P1|NOT COMPLETED|Recieved Allocated Intervention||1
97106|NCT02026258|237851|P2|COMPLETED|Recieved Allocated Intervention||17
97107|NCT02026258|237852|P1|COMPLETED|Recieved Allocated Intervention||15
97108|NCT02026258|237851|P2|STARTED|Recieved Allocated Intervention||19
97109|NCT02026258|237852|P1|STARTED|Recieved Allocated Intervention||16
97110|NCT02026258|237851|P2|NOT COMPLETED|Randomized||2
97111|NCT02026258|237852|P1|NOT COMPLETED|Randomized||4
97112|NCT02026258|237851|P2|COMPLETED|Randomized||19
97113|NCT02026258|237852|P1|COMPLETED|Randomized||16
97114|NCT02026258|237851|P2|STARTED|Randomized||21
97115|NCT02026258|237852|P1|STARTED|Randomized||20
97116|NCT02026206|237866|P2|NOT COMPLETED|Overall Study||8
97117|NCT02026206|237867|P1|NOT COMPLETED|Overall Study||4
97118|NCT02026206|237866|P2|COMPLETED|Overall Study||36
97119|NCT02026206|237867|P1|COMPLETED|Overall Study||40
97120|NCT02026206|237866|P2|STARTED|Overall Study||44
97121|NCT02026206|237867|P1|STARTED|Overall Study||44
97122|NCT02026193|237877|P2|NOT COMPLETED|Overall Study||0
97123|NCT02026193|237878|P1|NOT COMPLETED|Overall Study||0
97124|NCT02026193|237877|P2|COMPLETED|Overall Study||8
97125|NCT02026193|237878|P1|COMPLETED|Overall Study||3
97126|NCT02026193|237877|P2|STARTED|Overall Study||8
97127|NCT02026193|237878|P1|STARTED|Overall Study||3
97128|NCT02026141|237886|P2|NOT COMPLETED|Overall Study||1
97129|NCT02026141|237887|P1|NOT COMPLETED|Overall Study||0
97130|NCT02026141|237886|P2|COMPLETED|Overall Study||19
97131|NCT02026141|237887|P1|COMPLETED|Overall Study||20
97132|NCT02026141|237886|P2|STARTED|Overall Study||20
97133|NCT02026141|237887|P1|STARTED|Overall Study||20
97134|NCT02026063|237895|P2|NOT COMPLETED|Overall Study||49
97135|NCT02026063|237896|P1|NOT COMPLETED|Overall Study||9
97136|NCT02026063|237895|P2|COMPLETED|Overall Study||53
97137|NCT02026063|237896|P1|COMPLETED|Overall Study||13
97138|NCT02026063|237895|P2|STARTED|Overall Study||102
97139|NCT02026063|237896|P1|STARTED|Overall Study||22
97140|NCT02026011|237908|P2|NOT COMPLETED|Allocation 2 (Second Set of Medication)||2
97141|NCT02026011|237909|P1|NOT COMPLETED|Allocation 2 (Second Set of Medication)||1
97142|NCT02026011|237908|P2|COMPLETED|Allocation 2 (Second Set of Medication)||35
97143|NCT02026011|237909|P1|COMPLETED|Allocation 2 (Second Set of Medication)||37
97144|NCT02026011|237908|P2|STARTED|Allocation 2 (Second Set of Medication)||37
97145|NCT02026011|237909|P1|STARTED|Allocation 2 (Second Set of Medication)||38
97146|NCT02026011|237908|P2|NOT COMPLETED|Allocation 1 (First Set of Medication)||2
97147|NCT02026011|237909|P1|NOT COMPLETED|Allocation 1 (First Set of Medication)||8
97148|NCT02026011|237908|P2|COMPLETED|Allocation 1 (First Set of Medication)||39
97149|NCT02026011|237909|P1|COMPLETED|Allocation 1 (First Set of Medication)||38
97150|NCT02026011|237908|P2|STARTED|Allocation 1 (First Set of Medication)||41
97151|NCT02026011|237909|P1|STARTED|Allocation 1 (First Set of Medication)||46
97152|NCT02025907|237935|P2|NOT COMPLETED|Overall Study||12
97153|NCT02025907|237936|P1|NOT COMPLETED|Overall Study||27
97154|NCT02025907|237935|P2|COMPLETED|Overall Study||96
97155|NCT02025907|237936|P1|COMPLETED|Overall Study||81
97156|NCT02025907|237935|P2|STARTED|Overall Study|Participant flow is presented for safety population.|108
97157|NCT02025907|237936|P1|STARTED|Overall Study|Participant flow is presented for safety population.|108
97158|NCT02025829|237952|P2|NOT COMPLETED|Overall Study||0
97159|NCT02025829|237953|P1|NOT COMPLETED|Overall Study||0
97160|NCT02025829|237952|P2|COMPLETED|Overall Study||11
97161|NCT02025829|237953|P1|COMPLETED|Overall Study||3
97162|NCT02025829|237952|P2|STARTED|Overall Study||11
97163|NCT02025829|237953|P1|STARTED|Overall Study||3
97164|NCT02025647|237962|P1|NOT COMPLETED|Overall Study||0
97165|NCT02025647|237962|P1|COMPLETED|Overall Study||139
97166|NCT02025647|237962|P1|Session 3 (Rating Module: 30-45 Days)|Overall Study|"27 did not generate IRS~36 lost to follow up"|76
97167|NCT02025647|237962|P1|Session 2 (Narrative Module: 24-48 Hrs)|Overall Study|"19 lost to follow up or technology issues~3 administered wrong session"|117
97168|NCT02025647|237962|P1|Immediate Retest (Rating Module: 5 Min)|Overall Study|"27 did not generate IRS~15 technology issues or administered wrong session"|97
97169|NCT02025647|237962|P1|Session 1 (Narrative Module)|Overall Study||139
97170|NCT02025647|237962|P1|STARTED|Overall Study||139
97171|NCT02025621|237993|P2|NOT COMPLETED|Overall Study||19
97172|NCT02025621|237994|P1|NOT COMPLETED|Overall Study||14
97173|NCT02025621|237993|P2|COMPLETED|Overall Study||421
97174|NCT02025621|237994|P1|COMPLETED|Overall Study||428
97175|NCT02025621|237993|P2|STARTED|Overall Study||440
97176|NCT02025621|237994|P1|STARTED|Overall Study||442
97177|NCT02025530|238014|P2|NOT COMPLETED|Overall Study||1
97178|NCT02025530|238015|P1|NOT COMPLETED|Overall Study||5
97179|NCT02025530|238014|P2|COMPLETED|Overall Study||733
97180|NCT02025530|238015|P1|COMPLETED|Overall Study||291
97181|NCT02025530|238014|P2|STARTED|Overall Study||734
97182|NCT02025530|238015|P1|STARTED|Overall Study||296
97183|NCT02025205|238027|P2|NOT COMPLETED|Overall Study||3
97184|NCT02025205|238028|P1|NOT COMPLETED|Overall Study||3
97185|NCT02025205|238027|P2|COMPLETED|Overall Study||47
97186|NCT02025205|238028|P1|COMPLETED|Overall Study||40
97187|NCT02025205|238027|P2|STARTED|Overall Study||50
97188|NCT02025205|238028|P1|STARTED|Overall Study||43
97189|NCT02025179|238072|P3|NOT COMPLETED|Overall Study||1
97190|NCT02025179|238073|P2|NOT COMPLETED|Overall Study||0
97191|NCT02025179|238074|P1|NOT COMPLETED|Overall Study||0
97192|NCT02025179|238072|P3|COMPLETED|Overall Study||7
97193|NCT02025179|238073|P2|COMPLETED|Overall Study||9
97194|NCT02025179|238074|P1|COMPLETED|Overall Study||8
97195|NCT02025179|238072|P3|STARTED|Overall Study||8
97196|NCT02025179|238073|P2|STARTED|Overall Study||9
97197|NCT02025179|238074|P1|STARTED|Overall Study||8
97198|NCT02025075|238099|P2|NOT COMPLETED|Overall Study||2
97199|NCT02025075|238100|P1|NOT COMPLETED|Overall Study||0
97200|NCT02025075|238099|P2|COMPLETED|Overall Study||19
97201|NCT02025075|238100|P1|COMPLETED|Overall Study||16
97202|NCT02025075|238099|P2|STARTED|Overall Study||21
97203|NCT02025075|238100|P1|STARTED|Overall Study||16
97204|NCT02024971|238124|P1|NOT COMPLETED|Overall Study||36
97205|NCT02024971|238124|P1|COMPLETED|Overall Study|Including 162 patients with missing efficacy data at two or more time points.|1067
97206|NCT02024971|238124|P1|Safety Analysis Set|Overall Study|All participants with available data who were enrolled prior to Day 15 of the start of treatment.|1067
97207|NCT02024971|238124|P1|STARTED|Overall Study||1103
97208|NCT02024932|238137|P6|NOT COMPLETED|Overall Study||0
97209|NCT02024932|238138|P5|NOT COMPLETED|Overall Study||2
97210|NCT02024932|238139|P4|NOT COMPLETED|Overall Study||2
97211|NCT02024932|238140|P3|NOT COMPLETED|Overall Study||0
97212|NCT02024932|238141|P2|NOT COMPLETED|Overall Study||3
97213|NCT02024932|238142|P1|NOT COMPLETED|Overall Study||2
97214|NCT02024932|238137|P6|COMPLETED|Overall Study||9
97215|NCT02024932|238138|P5|COMPLETED|Overall Study||16
97216|NCT02024932|238139|P4|COMPLETED|Overall Study||0
97217|NCT02024932|238140|P3|COMPLETED|Overall Study||2
97218|NCT02024932|238141|P2|COMPLETED|Overall Study||1
97219|NCT02024932|238142|P1|COMPLETED|Overall Study||0
97220|NCT02024932|238137|P6|Pharmacodynamic (PD) Analysis Set|Overall Study||9
97221|NCT02024932|238138|P5|Pharmacodynamic (PD) Analysis Set|Overall Study||18
97222|NCT02024932|238139|P4|Pharmacodynamic (PD) Analysis Set|Overall Study||2
97223|NCT02024932|238140|P3|Pharmacodynamic (PD) Analysis Set|Overall Study||2
97224|NCT02024932|238141|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||4
97225|NCT02024932|238142|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||2
97226|NCT02024932|238137|P6|Pharmacokinetic (PK) Analysis Set|Overall Study||0
97227|NCT02024932|238138|P5|Pharmacokinetic (PK) Analysis Set|Overall Study||18
97228|NCT02024932|238139|P4|Pharmacokinetic (PK) Analysis Set|Overall Study||2
97229|NCT02024932|238140|P3|Pharmacokinetic (PK) Analysis Set|Overall Study||0
97230|NCT02024932|238141|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||4
97231|NCT02024932|238142|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||2
97232|NCT02024932|238137|P6|Safety Analysis Set|Overall Study||9
97233|NCT02024932|238138|P5|Safety Analysis Set|Overall Study||18
97234|NCT02024932|238139|P4|Safety Analysis Set|Overall Study||2
97235|NCT02024932|238140|P3|Safety Analysis Set|Overall Study||2
97236|NCT02024932|238141|P2|Safety Analysis Set|Overall Study||4
97237|NCT02024932|238142|P1|Safety Analysis Set|Overall Study||2
97238|NCT02024932|238137|P6|STARTED|Overall Study||9
97239|NCT02024932|238138|P5|STARTED|Overall Study||18
97240|NCT02024932|238139|P4|STARTED|Overall Study||2
97241|NCT02024932|238140|P3|STARTED|Overall Study||2
97242|NCT02024932|238141|P2|STARTED|Overall Study||4
97243|NCT02024932|238142|P1|STARTED|Overall Study||2
97244|NCT02024867|238201|P2|NOT COMPLETED|Overall Study||7
97245|NCT02024867|238202|P1|NOT COMPLETED|Overall Study||9
97246|NCT02024867|238201|P2|COMPLETED|Overall Study||124
97247|NCT02024867|238202|P1|COMPLETED|Overall Study||125
97248|NCT02024867|238201|P2|STARTED|Overall Study||131
97249|NCT02024867|238202|P1|STARTED|Overall Study||134
97250|NCT02024750|238220|P2|NOT COMPLETED|Overall Study||1
97251|NCT02024750|238221|P1|NOT COMPLETED|Overall Study||2
97252|NCT02024750|238220|P2|COMPLETED|Overall Study||107
97253|NCT02024750|238221|P1|COMPLETED|Overall Study||104
97254|NCT02024750|238220|P2|STARTED|Overall Study||108
97255|NCT02024750|238221|P1|STARTED|Overall Study||106
97256|NCT02024724|238235|P2|NOT COMPLETED|Overall Study||0
97257|NCT02024724|238236|P1|NOT COMPLETED|Overall Study||1
97258|NCT02024724|238235|P2|COMPLETED|Overall Study||30
97259|NCT02024724|238236|P1|COMPLETED|Overall Study||29
97260|NCT02024724|238235|P2|STARTED|Overall Study||30
97261|NCT02024724|238236|P1|STARTED|Overall Study||30
97262|NCT02024698|238242|P2|NOT COMPLETED|Second Intervention (7 Days)||0
97263|NCT02024698|238243|P1|NOT COMPLETED|Second Intervention (7 Days)||0
97264|NCT02024698|238242|P2|COMPLETED|Second Intervention (7 Days)||26
97265|NCT02024698|238243|P1|COMPLETED|Second Intervention (7 Days)||16
97266|NCT02024698|238242|P2|Received Etafilcon A Twice|Second Intervention (7 Days)||0
97267|NCT02024698|238243|P1|Received Etafilcon A Twice|Second Intervention (7 Days)||1
97268|NCT02024698|238242|P2|STARTED|Second Intervention (7 Days)||26
97269|NCT02024698|238243|P1|STARTED|Second Intervention (7 Days)||16
97270|NCT02024698|238242|P2|NOT COMPLETED|First Intervention (7 Days)||1
97271|NCT02024698|238243|P1|NOT COMPLETED|First Intervention (7 Days)||0
97272|NCT02024698|238242|P2|COMPLETED|First Intervention (7 Days)||26
97273|NCT02024698|238243|P1|COMPLETED|First Intervention (7 Days)||16
97274|NCT02024698|238242|P2|STARTED|First Intervention (7 Days)||27
97275|NCT02024698|238243|P1|STARTED|First Intervention (7 Days)||16
97276|NCT02024477|238271|P2|NOT COMPLETED|Overall Study||0
97277|NCT02024477|238272|P1|NOT COMPLETED|Overall Study||0
97278|NCT02024477|238271|P2|COMPLETED|Overall Study||21
97279|NCT02024477|238272|P1|COMPLETED|Overall Study||21
97280|NCT02024477|238271|P2|STARTED|Overall Study||21
97281|NCT02024477|238272|P1|STARTED|Overall Study||21
97282|NCT02024386|238293|P3|NOT COMPLETED|Overall Study||0
97283|NCT02024386|238294|P2|NOT COMPLETED|Overall Study||0
97284|NCT02024386|238295|P1|NOT COMPLETED|Overall Study||0
97285|NCT02024386|238293|P3|COMPLETED|Overall Study||5
97286|NCT02024386|238294|P2|COMPLETED|Overall Study||11
97287|NCT02024386|238295|P1|COMPLETED|Overall Study||6
97288|NCT02024386|238293|P3|STARTED|Overall Study||5
97289|NCT02024386|238294|P2|STARTED|Overall Study||11
97290|NCT02024386|238295|P1|STARTED|Overall Study||6
97291|NCT02024165|238318|P1|NOT COMPLETED|Overall Study||0
97292|NCT02024165|238318|P1|COMPLETED|Overall Study||71
97293|NCT02024165|238318|P1|STARTED|Overall Study||71
97294|NCT02023983|238325|P2|NOT COMPLETED|Overall Study||0
97295|NCT02023983|238326|P1|NOT COMPLETED|Overall Study||0
97296|NCT02023983|238325|P2|COMPLETED|Overall Study||75
97297|NCT02023983|238326|P1|COMPLETED|Overall Study||76
97298|NCT02023983|238325|P2|STARTED|Overall Study||75
97299|NCT02023983|238326|P1|STARTED|Overall Study||76
97300|NCT02023944|238336|P2|NOT COMPLETED|Overall Study||1
97301|NCT02023944|238337|P1|NOT COMPLETED|Overall Study||0
97302|NCT02023944|238336|P2|COMPLETED|Overall Study||24
97303|NCT02023944|238337|P1|COMPLETED|Overall Study||25
97304|NCT02023944|238336|P2|STARTED|Overall Study||25
97305|NCT02023944|238337|P1|STARTED|Overall Study||25
97306|NCT02023918|238345|P1|NOT COMPLETED|Overall Study||0
97307|NCT02023918|238345|P1|COMPLETED|Overall Study||6
97308|NCT02023918|238345|P1|STARTED|Overall Study||6
97309|NCT02023879|238353|P3|NOT COMPLETED|Extension Open Label Treatment||5
97310|NCT02023879|238354|P2|NOT COMPLETED|Extension Open Label Treatment||17
97311|NCT02023879|238355|P1|NOT COMPLETED|Extension Open Label Treatment||5
97312|NCT02023879|238353|P3|COMPLETED|Extension Open Label Treatment||43
97313|NCT02023879|238354|P2|COMPLETED|Extension Open Label Treatment||89
97314|NCT02023879|238355|P1|COMPLETED|Extension Open Label Treatment||46
97315|NCT02023879|238353|P3|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|48
97316|NCT02023879|238354|P2|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|106
97317|NCT02023879|238355|P1|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|51
97318|NCT02023879|238353|P3|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9
97319|NCT02023879|238354|P2|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9
97320|NCT02023879|238355|P1|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||4
97321|NCT02023879|238353|P3|COMPLETED|Period 1: 24-Week Double-blind Treatment||50
97322|NCT02023879|238354|P2|COMPLETED|Period 1: 24-Week Double-blind Treatment||107
97323|NCT02023879|238355|P1|COMPLETED|Period 1: 24-Week Double-blind Treatment||54
97324|NCT02023879|238353|P3|Treated|Period 1: 24-Week Double-blind Treatment||58
97325|NCT02023879|238354|P2|Treated|Period 1: 24-Week Double-blind Treatment||115
97326|NCT02023879|238355|P1|Treated|Period 1: 24-Week Double-blind Treatment||58
97327|NCT02023879|238353|P3|STARTED|Period 1: 24-Week Double-blind Treatment||59
97328|NCT02023879|238354|P2|STARTED|Period 1: 24-Week Double-blind Treatment||116
97329|NCT02023879|238355|P1|STARTED|Period 1: 24-Week Double-blind Treatment||58
97330|NCT02023866|238444|P1|NOT COMPLETED|Overall Study||6
97331|NCT02023866|238444|P1|COMPLETED|Overall Study||30
97332|NCT02023866|238444|P1|STARTED|Overall Study||36
97333|NCT02023801|238457|P1|NOT COMPLETED|Overall Study||0
97334|NCT02023801|238457|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|24
97335|NCT02023801|238457|P1|Treated|Overall Study|Treatment Completed|24
97336|NCT02023801|238457|P1|STARTED|Overall Study|Treatment Attempted|24
97337|NCT02023697|238466|P3|NOT COMPLETED|Long-term Follow-up Period||17
97338|NCT02023697|238467|P2|NOT COMPLETED|Long-term Follow-up Period||21
97339|NCT02023697|238468|P1|NOT COMPLETED|Long-term Follow-up Period||28
97340|NCT02023697|238466|P3|COMPLETED|Long-term Follow-up Period||0
97341|NCT02023697|238467|P2|COMPLETED|Long-term Follow-up Period||0
97342|NCT02023697|238468|P1|COMPLETED|Long-term Follow-up Period||0
97343|NCT02023697|238466|P3|STARTED|Long-term Follow-up Period||17
97344|NCT02023697|238467|P2|STARTED|Long-term Follow-up Period||21
97345|NCT02023697|238468|P1|STARTED|Long-term Follow-up Period||28
97346|NCT02023697|238466|P3|NOT COMPLETED|Active Follow-up Period||99
97347|NCT02023697|238467|P2|NOT COMPLETED|Active Follow-up Period||99
97348|NCT02023697|238468|P1|NOT COMPLETED|Active Follow-up Period||92
97349|NCT02023697|238466|P3|COMPLETED|Active Follow-up Period||17
97350|NCT02023697|238467|P2|COMPLETED|Active Follow-up Period||21
97351|NCT02023697|238468|P1|COMPLETED|Active Follow-up Period||28
97352|NCT02023697|238466|P3|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|116
97353|NCT02023697|238467|P2|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|120
97354|NCT02023697|238468|P1|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|120
97355|NCT02023697|238466|P3|NOT COMPLETED|Treatment Period||102
97356|NCT02023697|238467|P2|NOT COMPLETED|Treatment Period||63
97357|NCT02023697|238468|P1|NOT COMPLETED|Treatment Period||46
97358|NCT02023697|238466|P3|COMPLETED|Treatment Period||29
97359|NCT02023697|238467|P2|COMPLETED|Treatment Period||67
97360|NCT02023697|238468|P1|COMPLETED|Treatment Period||84
97361|NCT02023697|238466|P3|Received Treatment|Treatment Period||121
97362|NCT02023697|238467|P2|Received Treatment|Treatment Period||124
97363|NCT02023697|238468|P1|Received Treatment|Treatment Period||125
97364|NCT02023697|238466|P3|STARTED|Treatment Period||131
97365|NCT02023697|238467|P2|STARTED|Treatment Period||130
97366|NCT02023697|238468|P1|STARTED|Treatment Period||130
97367|NCT02023515|238570|P2|NOT COMPLETED|Overall Study||3
97368|NCT02023515|238571|P1|NOT COMPLETED|Overall Study||1
97369|NCT02023515|238570|P2|COMPLETED|Overall Study||22
97370|NCT02023515|238571|P1|COMPLETED|Overall Study||23
97371|NCT02023515|238570|P2|STARTED|Overall Study||25
97372|NCT02023515|238571|P1|STARTED|Overall Study||24
97373|NCT02023268|238581|P2|NOT COMPLETED|Overall Study||4
97374|NCT02023268|238582|P1|NOT COMPLETED|Overall Study||0
97375|NCT02023268|238581|P2|COMPLETED|Overall Study||49
97376|NCT02023268|238582|P1|COMPLETED|Overall Study||52
97377|NCT02023268|238581|P2|STARTED|Overall Study||53
97378|NCT02023268|238582|P1|STARTED|Overall Study||52
97379|NCT02023151|238588|P1|NOT COMPLETED|Overall Study||4
97380|NCT02023151|238588|P1|COMPLETED|Overall Study||13
97381|NCT02023151|238588|P1|STARTED|Overall Study||17
97382|NCT02023125|238595|P3|NOT COMPLETED|Period 2||0
97383|NCT02023125|238596|P2|NOT COMPLETED|Period 2||0
97384|NCT02023125|238597|P1|NOT COMPLETED|Period 2||0
97385|NCT02023125|238595|P3|COMPLETED|Period 2||24
97386|NCT02023125|238596|P2|COMPLETED|Period 2||9
97387|NCT02023125|238597|P1|COMPLETED|Period 2||9
97388|NCT02023125|238595|P3|STARTED|Period 2||24
97389|NCT02023125|238596|P2|STARTED|Period 2||9
97390|NCT02023125|238597|P1|STARTED|Period 2||9
97391|NCT02023125|238595|P3|NOT COMPLETED|Washout Period||0
97392|NCT02023125|238596|P2|NOT COMPLETED|Washout Period||0
97393|NCT02023125|238597|P1|NOT COMPLETED|Washout Period||0
97394|NCT02023125|238595|P3|COMPLETED|Washout Period||24
97395|NCT02023125|238596|P2|COMPLETED|Washout Period||9
97396|NCT02023125|238597|P1|COMPLETED|Washout Period||9
97397|NCT02023125|238595|P3|STARTED|Washout Period||24
97398|NCT02023125|238596|P2|STARTED|Washout Period||9
97399|NCT02023125|238597|P1|STARTED|Washout Period||9
97400|NCT02023125|238595|P3|NOT COMPLETED|Period 1||0
97401|NCT02023125|238596|P2|NOT COMPLETED|Period 1||0
97402|NCT02023125|238597|P1|NOT COMPLETED|Period 1||0
97403|NCT02023125|238595|P3|COMPLETED|Period 1||24
97404|NCT02023125|238596|P2|COMPLETED|Period 1||9
97405|NCT02023125|238597|P1|COMPLETED|Period 1||9
97406|NCT02023125|238595|P3|STARTED|Period 1||24
97407|NCT02023125|238596|P2|STARTED|Period 1||9
97408|NCT02023125|238597|P1|STARTED|Period 1||9
97409|NCT02023112|238658|P2|NOT COMPLETED|Overall Study||1
97410|NCT02023112|238659|P1|NOT COMPLETED|Overall Study||2
97411|NCT02023112|238658|P2|COMPLETED|Overall Study||85
97412|NCT02023112|238659|P1|COMPLETED|Overall Study||83
97413|NCT02023112|238658|P2|STARTED|Overall Study||86
97414|NCT02023112|238659|P1|STARTED|Overall Study||85
97415|NCT02023099|238680|P3|NOT COMPLETED|Overall Study||3
97416|NCT02023099|238681|P2|NOT COMPLETED|Overall Study||0
97417|NCT02023099|238682|P1|NOT COMPLETED|Overall Study||3
97418|NCT02023099|238680|P3|COMPLETED|Overall Study||39
97419|NCT02023099|238681|P2|COMPLETED|Overall Study||106
97420|NCT02023099|238682|P1|COMPLETED|Overall Study||212
97421|NCT02023099|238680|P3|STARTED|Overall Study||42
97422|NCT02023099|238681|P2|STARTED|Overall Study||106
97423|NCT02023099|238682|P1|STARTED|Overall Study||215
97424|NCT02022826|238698|P1|NOT COMPLETED|Overall Study||28
97425|NCT02022826|238698|P1|COMPLETED|Overall Study||139
97426|NCT02022826|238698|P1|STARTED|Overall Study||167
97427|NCT02022748|238705|P3|NOT COMPLETED|Overall Study||0
97428|NCT02022748|238706|P2|NOT COMPLETED|Overall Study||2
97429|NCT02022748|238707|P1|NOT COMPLETED|Overall Study||1
97430|NCT02022748|238705|P3|COMPLETED|Overall Study||13
97431|NCT02022748|238706|P2|COMPLETED|Overall Study||4
97432|NCT02022748|238707|P1|COMPLETED|Overall Study||7
97433|NCT02022748|238705|P3|Subjects Who Completed Treatment|Overall Study||13
97434|NCT02022748|238706|P2|Subjects Who Completed Treatment|Overall Study||4
97435|NCT02022748|238707|P1|Subjects Who Completed Treatment|Overall Study||7
97436|NCT02022748|238705|P3|Subject Who Started Treatment|Overall Study||13
97437|NCT02022748|238706|P2|Subject Who Started Treatment|Overall Study||6
97438|NCT02022748|238707|P1|Subject Who Started Treatment|Overall Study||8
97439|NCT02022748|238705|P3|STARTED|Overall Study||13
97440|NCT02022748|238706|P2|STARTED|Overall Study||6
97441|NCT02022748|238707|P1|STARTED|Overall Study||8
97442|NCT02022670|238733|P3|NOT COMPLETED|Overall Study||1
97443|NCT02022670|238734|P2|NOT COMPLETED|Overall Study||0
97444|NCT02022670|238735|P1|NOT COMPLETED|Overall Study||1
97445|NCT02022670|238733|P3|COMPLETED|Overall Study||11
97446|NCT02022670|238734|P2|COMPLETED|Overall Study||10
97447|NCT02022670|238735|P1|COMPLETED|Overall Study||10
97448|NCT02022670|238733|P3|STARTED|Overall Study||12
97449|NCT02022670|238734|P2|STARTED|Overall Study||10
97450|NCT02022670|238735|P1|STARTED|Overall Study||11
97451|NCT02022657|238749|P6|NOT COMPLETED|Overall Study||1
97452|NCT02022657|238750|P5|NOT COMPLETED|Overall Study||0
97453|NCT02022657|238751|P4|NOT COMPLETED|Overall Study||0
97454|NCT02022657|238752|P3|NOT COMPLETED|Overall Study||1
97455|NCT02022657|238753|P2|NOT COMPLETED|Overall Study||0
97456|NCT02022657|238754|P1|NOT COMPLETED|Overall Study||2
97457|NCT02022657|238749|P6|COMPLETED|Overall Study||8
97458|NCT02022657|238750|P5|COMPLETED|Overall Study||8
97459|NCT02022657|238751|P4|COMPLETED|Overall Study||8
97460|NCT02022657|238752|P3|COMPLETED|Overall Study||8
97461|NCT02022657|238753|P2|COMPLETED|Overall Study||8
97462|NCT02022657|238754|P1|COMPLETED|Overall Study||8
97463|NCT02022657|238749|P6|STARTED|Overall Study||9
97464|NCT02022657|238750|P5|STARTED|Overall Study||8
97465|NCT02022657|238751|P4|STARTED|Overall Study||8
97466|NCT02022657|238752|P3|STARTED|Overall Study||9
97467|NCT02022657|238753|P2|STARTED|Overall Study||8
97468|NCT02022657|238754|P1|STARTED|Overall Study||10
97469|NCT02022085|238760|P1|NOT COMPLETED|Overall Study||1
97470|NCT02022085|238760|P1|COMPLETED|Overall Study||53
97471|NCT02022085|238760|P1|STARTED|Overall Study||54
97472|NCT02022020|238786|P1|NOT COMPLETED|Overall Study||0
97473|NCT02022020|238786|P1|COMPLETED|Overall Study||220
97474|NCT02022020|238786|P1|STARTED|Overall Study||220
97475|NCT02022007|238795|P3|NOT COMPLETED|Overall Study||2
97476|NCT02022007|238796|P2|NOT COMPLETED|Overall Study||1
97477|NCT02022007|238797|P1|NOT COMPLETED|Overall Study||1
97478|NCT02022007|238795|P3|COMPLETED|Overall Study||11
97479|NCT02022007|238796|P2|COMPLETED|Overall Study||11
97480|NCT02022007|238797|P1|COMPLETED|Overall Study||12
97481|NCT02022007|238795|P3|STARTED|Overall Study||13
97482|NCT02022007|238796|P2|STARTED|Overall Study||12
97483|NCT02022007|238797|P1|STARTED|Overall Study||13
97484|NCT02021942|238838|P1|NOT COMPLETED|Overall Study||0
97485|NCT02021942|238838|P1|COMPLETED|Overall Study||16
97486|NCT02021942|238838|P1|STARTED|Overall Study||16
97487|NCT02021929|238850|P2|NOT COMPLETED|Overall Study||1
97488|NCT02021929|238851|P1|NOT COMPLETED|Overall Study||2
97489|NCT02021929|238850|P2|COMPLETED|Overall Study||11
97490|NCT02021929|238851|P1|COMPLETED|Overall Study||14
97491|NCT02021929|238850|P2|STARTED|Overall Study||12
97492|NCT02021929|238851|P1|STARTED|Overall Study||16
97493|NCT02021812|238861|P1|NOT COMPLETED|Overall Study||24
97494|NCT02021812|238861|P1|COMPLETED|Overall Study||7
97495|NCT02021812|238861|P1|STARTED|Overall Study||31
97496|NCT02021669|238871|P2|NOT COMPLETED|Overall Study||3
97497|NCT02021669|238872|P1|NOT COMPLETED|Overall Study||7
97498|NCT02021669|238871|P2|COMPLETED|Overall Study||70
97499|NCT02021669|238872|P1|COMPLETED|Overall Study||64
97500|NCT02021669|238871|P2|STARTED|Overall Study||73
97501|NCT02021669|238872|P1|STARTED|Overall Study||71
97502|NCT02021656|238880|P1|NOT COMPLETED|Overall Study||6
97503|NCT02021656|238880|P1|COMPLETED|Overall Study||378
97504|NCT02021656|238880|P1|STARTED|Overall Study||384
97505|NCT02021643|238900|P4|NOT COMPLETED|Overall Study||12
97506|NCT02021643|238901|P3|NOT COMPLETED|Overall Study||0
97507|NCT02021643|238902|P2|NOT COMPLETED|Overall Study||10
97508|NCT02021643|238903|P1|NOT COMPLETED|Overall Study||9
97509|NCT02021643|238900|P4|COMPLETED|Overall Study||218
97510|NCT02021643|238901|P3|COMPLETED|Overall Study||11
97511|NCT02021643|238902|P2|COMPLETED|Overall Study||280
97512|NCT02021643|238903|P1|COMPLETED|Overall Study||147
97513|NCT02021643|238900|P4|STARTED|Overall Study||230
97514|NCT02021643|238901|P3|STARTED|Overall Study||11
97515|NCT02021643|238902|P2|STARTED|Overall Study||290
97516|NCT02021643|238903|P1|STARTED|Overall Study||156
97517|NCT02021565|238945|P2|NOT COMPLETED|3-month Follow-up||2
97518|NCT02021565|238946|P1|NOT COMPLETED|3-month Follow-up||10
97519|NCT02021565|238945|P2|COMPLETED|3-month Follow-up||34
97520|NCT02021565|238946|P1|COMPLETED|3-month Follow-up||50
97521|NCT02021565|238945|P2|Care Recipients|3-month Follow-up||18
97522|NCT02021565|238946|P1|Care Recipients|3-month Follow-up||30
97523|NCT02021565|238945|P2|Caregivers|3-month Follow-up||18
97524|NCT02021565|238946|P1|Caregivers|3-month Follow-up||30
97525|NCT02021565|238945|P2|STARTED|3-month Follow-up||36
97526|NCT02021565|238946|P1|STARTED|3-month Follow-up||60
97527|NCT02021565|238945|P2|NOT COMPLETED|Baseline Through Intervention||18
97528|NCT02021565|238946|P1|NOT COMPLETED|Baseline Through Intervention||12
97529|NCT02021565|238945|P2|COMPLETED|Baseline Through Intervention||36
97530|NCT02021565|238946|P1|COMPLETED|Baseline Through Intervention||60
97531|NCT02021565|238945|P2|Care Recipients|Baseline Through Intervention||27
97532|NCT02021565|238946|P1|Care Recipients|Baseline Through Intervention||36
97533|NCT02021565|238945|P2|Caregivers|Baseline Through Intervention||27
97534|NCT02021565|238946|P1|Caregivers|Baseline Through Intervention||36
97535|NCT02021565|238945|P2|STARTED|Baseline Through Intervention||54
97536|NCT02021565|238946|P1|STARTED|Baseline Through Intervention||72
97537|NCT02021461|238958|P1|NOT COMPLETED|Overall Study||0
97538|NCT02021461|238958|P1|COMPLETED|Overall Study||38
97539|NCT02021461|238958|P1|STARTED|Overall Study||38
97540|NCT02021331|238966|P2|NOT COMPLETED|Overall Study||2
97541|NCT02021331|238967|P1|NOT COMPLETED|Overall Study||0
97542|NCT02021331|238966|P2|COMPLETED|Overall Study||1
97543|NCT02021331|238967|P1|COMPLETED|Overall Study||2
97544|NCT02021331|238966|P2|STARTED|Overall Study||3
97545|NCT02021331|238967|P1|STARTED|Overall Study||2
97546|NCT02021292|238979|P2|NOT COMPLETED|Overall Study||3
97547|NCT02021292|238980|P1|NOT COMPLETED|Overall Study||0
97548|NCT02021292|238979|P2|COMPLETED|Overall Study||37
97549|NCT02021292|238980|P1|COMPLETED|Overall Study||40
97550|NCT02021292|238979|P2|STARTED|Overall Study||40
97551|NCT02021292|238980|P1|STARTED|Overall Study||40
97552|NCT02021071|238998|P2|NOT COMPLETED|Overall Study||0
97553|NCT02021071|238999|P1|NOT COMPLETED|Overall Study||0
97554|NCT02021071|238998|P2|COMPLETED|Overall Study||12
97555|NCT02021071|238999|P1|COMPLETED|Overall Study||12
97556|NCT02021071|238998|P2|STARTED|Overall Study||12
97557|NCT02021071|238999|P1|STARTED|Overall Study||12
97558|NCT02020941|239006|P1|NOT COMPLETED|Overall Study||8
97559|NCT02020941|239006|P1|COMPLETED|Overall Study||2
97560|NCT02020941|239006|P1|STARTED|Overall Study||10
97561|NCT02020889|239017|P2|NOT COMPLETED|Overall Study||3
97562|NCT02020889|239018|P1|NOT COMPLETED|Overall Study||7
97563|NCT02020889|239017|P2|COMPLETED|Overall Study||65
97564|NCT02020889|239018|P1|COMPLETED|Overall Study||61
97565|NCT02020889|239017|P2|STARTED|Overall Study||68
97566|NCT02020889|239018|P1|STARTED|Overall Study||68
97567|NCT02020863|239072|P1|NOT COMPLETED|Overall Study||5
97568|NCT02020863|239072|P1|COMPLETED|Overall Study||35
97569|NCT02020863|239072|P1|STARTED|Overall Study||40
97570|NCT02020837|239076|P1|NOT COMPLETED|Overall Study||0
97571|NCT02020837|239076|P1|COMPLETED|Overall Study||2
97572|NCT02020837|239076|P1|STARTED|Overall Study||2
97573|NCT02020785|239082|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
97574|NCT02020785|239083|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
97575|NCT02020785|239082|P2|COMPLETED|Second Intervention (3 Weeks)||16
97576|NCT02020785|239083|P1|COMPLETED|Second Intervention (3 Weeks)||15
97577|NCT02020785|239082|P2|STARTED|Second Intervention (3 Weeks)||16
97578|NCT02020785|239083|P1|STARTED|Second Intervention (3 Weeks)||15
97579|NCT02020785|239082|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
97580|NCT02020785|239083|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
97581|NCT02020785|239082|P2|COMPLETED|First Intervention (3 Weeks)||16
97582|NCT02020785|239083|P1|COMPLETED|First Intervention (3 Weeks)||15
97583|NCT02020785|239082|P2|STARTED|First Intervention (3 Weeks)||16
97584|NCT02020785|239083|P1|STARTED|First Intervention (3 Weeks)||15
97585|NCT02020616|239102|P7|NOT COMPLETED|Overall Study||4
97586|NCT02020616|239103|P6|NOT COMPLETED|Overall Study||5
97587|NCT02020616|239104|P5|NOT COMPLETED|Overall Study||2
97588|NCT02020616|239105|P4|NOT COMPLETED|Overall Study||2
97589|NCT02020616|239106|P3|NOT COMPLETED|Overall Study||2
97590|NCT02020616|239107|P2|NOT COMPLETED|Overall Study||1
97591|NCT02020616|239108|P1|NOT COMPLETED|Overall Study||0
97592|NCT02020616|239102|P7|COMPLETED|Overall Study||6
97593|NCT02020616|239103|P6|COMPLETED|Overall Study||3
97594|NCT02020616|239104|P5|COMPLETED|Overall Study||6
97595|NCT02020616|239105|P4|COMPLETED|Overall Study||6
97596|NCT02020616|239106|P3|COMPLETED|Overall Study||6
97597|NCT02020616|239107|P2|COMPLETED|Overall Study||7
97598|NCT02020616|239108|P1|COMPLETED|Overall Study||10
97687|NCT02019602|239436|P2|COMPLETED|Screening Period||16
97599|NCT02020616|239102|P7|Received at Least One Dose of Study Drug|Overall Study||10
97600|NCT02020616|239103|P6|Received at Least One Dose of Study Drug|Overall Study||8
97601|NCT02020616|239104|P5|Received at Least One Dose of Study Drug|Overall Study||8
97602|NCT02020616|239105|P4|Received at Least One Dose of Study Drug|Overall Study||7
97603|NCT02020616|239106|P3|Received at Least One Dose of Study Drug|Overall Study||8
97604|NCT02020616|239107|P2|Received at Least One Dose of Study Drug|Overall Study||8
97605|NCT02020616|239108|P1|Received at Least One Dose of Study Drug|Overall Study||10
97606|NCT02020616|239102|P7|STARTED|Overall Study||10
97607|NCT02020616|239103|P6|STARTED|Overall Study||8
97608|NCT02020616|239104|P5|STARTED|Overall Study||8
97609|NCT02020616|239105|P4|STARTED|Overall Study||8
97610|NCT02020616|239106|P3|STARTED|Overall Study||8
97611|NCT02020616|239107|P2|STARTED|Overall Study||8
97612|NCT02020616|239108|P1|STARTED|Overall Study||10
97613|NCT02020577|239201|P2|NOT COMPLETED|Overall Study||55
97614|NCT02020577|239202|P1|NOT COMPLETED|Overall Study||3
97615|NCT02020577|239201|P2|COMPLETED|Overall Study||0
97616|NCT02020577|239202|P1|COMPLETED|Overall Study||0
97617|NCT02020577|239201|P2|STARTED|Overall Study||55
97618|NCT02020577|239202|P1|STARTED|Overall Study||3
97619|NCT02020512|239229|P1|NOT COMPLETED|Overall Study||8
97620|NCT02020512|239229|P1|COMPLETED|Overall Study||79
97621|NCT02020512|239229|P1|STARTED|Overall Study||87
97622|NCT02020369|239235|P2|NOT COMPLETED|Overall Study||2
97623|NCT02020369|239236|P1|NOT COMPLETED|Overall Study||3
97624|NCT02020369|239235|P2|COMPLETED|Overall Study||11
97625|NCT02020369|239236|P1|COMPLETED|Overall Study||11
97626|NCT02020369|239235|P2|STARTED|Overall Study||13
97627|NCT02020369|239236|P1|STARTED|Overall Study||14
97628|NCT02020304|239252|P2|NOT COMPLETED|Overall Study||2
97629|NCT02020304|239253|P1|NOT COMPLETED|Overall Study||3
97630|NCT02020304|239252|P2|COMPLETED|Overall Study||26
97631|NCT02020304|239253|P1|COMPLETED|Overall Study||27
97632|NCT02020304|239252|P2|STARTED|Overall Study||28
97633|NCT02020304|239253|P1|STARTED|Overall Study||30
97634|NCT02020135|239269|P1|NOT COMPLETED|Overall Study||9
97635|NCT02020135|239269|P1|COMPLETED|Overall Study||0
97636|NCT02020135|239269|P1|STARTED|Overall Study||9
97637|NCT02020031|239281|P2|NOT COMPLETED|Overall Study||1
97638|NCT02020031|239282|P1|NOT COMPLETED|Overall Study||1
97639|NCT02020031|239281|P2|COMPLETED|Overall Study||10
97640|NCT02020031|239282|P1|COMPLETED|Overall Study||10
97641|NCT02020031|239281|P2|STARTED|Overall Study||11
97642|NCT02020031|239282|P1|STARTED|Overall Study||11
97643|NCT02020018|239292|P2|NOT COMPLETED|Overall Study||0
97644|NCT02020018|239293|P1|NOT COMPLETED|Overall Study||0
97645|NCT02020018|239292|P2|COMPLETED|Overall Study||1597
97646|NCT02020018|239293|P1|COMPLETED|Overall Study||272
97647|NCT02020018|239292|P2|STARTED|Overall Study||1597
97648|NCT02020018|239293|P1|STARTED|Overall Study||272
97649|NCT02019979|239303|P1|NOT COMPLETED|Overall Study||14
97650|NCT02019979|239303|P1|COMPLETED|Overall Study||0
97651|NCT02019979|239303|P1|STARTED|Overall Study||14
97652|NCT02019758|239311|P2|NOT COMPLETED|Overall Study||9
97653|NCT02019758|239312|P1|NOT COMPLETED|Overall Study||9
97654|NCT02019758|239311|P2|COMPLETED|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|55
97655|NCT02019758|239312|P1|COMPLETED|Overall Study||56
97656|NCT02019758|239311|P2|Lost to Follow-up|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|8
97657|NCT02019758|239312|P1|Lost to Follow-up|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|8
97658|NCT02019758|239311|P2|Did Not Receive Intervention|Overall Study||1
97659|NCT02019758|239312|P1|Did Not Receive Intervention|Overall Study||1
97660|NCT02019758|239311|P2|Received Intervention|Overall Study||63
97661|NCT02019758|239312|P1|Received Intervention|Overall Study||64
97662|NCT02019758|239311|P2|STARTED|Overall Study|63 received intervention; 1 did not receive intervention|64
97663|NCT02019758|239312|P1|STARTED|Overall Study|64 received intervention; 1 did not receive intervention|65
97664|NCT02019719|239333|P5|NOT COMPLETED|Overall Study||2
97665|NCT02019719|239334|P4|NOT COMPLETED|Overall Study||2
97666|NCT02019719|239335|P3|NOT COMPLETED|Overall Study||0
97667|NCT02019719|239336|P2|NOT COMPLETED|Overall Study||1
97668|NCT02019719|239337|P1|NOT COMPLETED|Overall Study||6
97669|NCT02019719|239333|P5|COMPLETED|Overall Study||18
97670|NCT02019719|239334|P4|COMPLETED|Overall Study||17
97671|NCT02019719|239335|P3|COMPLETED|Overall Study||20
97672|NCT02019719|239336|P2|COMPLETED|Overall Study||18
97673|NCT02019719|239337|P1|COMPLETED|Overall Study||13
97674|NCT02019719|239333|P5|STARTED|Overall Study||20
97675|NCT02019719|239334|P4|STARTED|Overall Study||19
97676|NCT02019719|239335|P3|STARTED|Overall Study||20
97677|NCT02019719|239336|P2|STARTED|Overall Study||19
97678|NCT02019719|239337|P1|STARTED|Overall Study||19
97679|NCT02019602|239436|P2|NOT COMPLETED|Sampling Period||0
97680|NCT02019602|239437|P1|NOT COMPLETED|Sampling Period||0
97681|NCT02019602|239436|P2|COMPLETED|Sampling Period||16
97682|NCT02019602|239437|P1|COMPLETED|Sampling Period||16
97683|NCT02019602|239436|P2|STARTED|Sampling Period||16
97684|NCT02019602|239437|P1|STARTED|Sampling Period||16
97685|NCT02019602|239436|P2|NOT COMPLETED|Screening Period||0
97686|NCT02019602|239437|P1|NOT COMPLETED|Screening Period||5
97688|NCT02019602|239437|P1|COMPLETED|Screening Period||16
97689|NCT02019602|239436|P2|STARTED|Screening Period||16
97690|NCT02019602|239437|P1|STARTED|Screening Period||21
97691|NCT02019563|239449|P2|NOT COMPLETED|Overall Study||0
97692|NCT02019563|239450|P1|NOT COMPLETED|Overall Study||0
97693|NCT02019563|239449|P2|COMPLETED|Overall Study|72 incisors were treated in the RCT group|30
97694|NCT02019563|239450|P1|COMPLETED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
97695|NCT02019563|239449|P2|STARTED|Overall Study|72 incisors were treated in the RCT group|30
97696|NCT02019563|239450|P1|STARTED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
97697|NCT02019550|239466|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
97698|NCT02019550|239467|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
97699|NCT02019550|239466|P2|COMPLETED|Treatment Period 2 (4 Weeks)||50
97700|NCT02019550|239467|P1|COMPLETED|Treatment Period 2 (4 Weeks)||46
97701|NCT02019550|239466|P2|STARTED|Treatment Period 2 (4 Weeks)||50
97702|NCT02019550|239467|P1|STARTED|Treatment Period 2 (4 Weeks)||46
97703|NCT02019550|239466|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
97704|NCT02019550|239467|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
97705|NCT02019550|239466|P2|COMPLETED|Treatment Period 1 (4 Weeks)||50
97706|NCT02019550|239467|P1|COMPLETED|Treatment Period 1 (4 Weeks)||46
97707|NCT02019550|239466|P2|STARTED|Treatment Period 1 (4 Weeks)||51
97708|NCT02019550|239467|P1|STARTED|Treatment Period 1 (4 Weeks)||46
97709|NCT02019472|239508|P3|NOT COMPLETED|Overall Study||42
97710|NCT02019472|239509|P2|NOT COMPLETED|Overall Study||52
97711|NCT02019472|239510|P1|NOT COMPLETED|Overall Study||37
97712|NCT02019472|239508|P3|COMPLETED|Overall Study||145
97713|NCT02019472|239509|P2|COMPLETED|Overall Study||134
97714|NCT02019472|239510|P1|COMPLETED|Overall Study||149
97715|NCT02019472|239508|P3|STARTED|Overall Study||187
97716|NCT02019472|239509|P2|STARTED|Overall Study||186
97717|NCT02019472|239510|P1|STARTED|Overall Study||186
97718|NCT02019420|239533|P2|NOT COMPLETED|Overall Study||106
97719|NCT02019420|239534|P1|NOT COMPLETED|Overall Study||108
97720|NCT02019420|239533|P2|COMPLETED|Overall Study||254
97721|NCT02019420|239534|P1|COMPLETED|Overall Study||258
97722|NCT02019420|239533|P2|Treated|Overall Study||357
97723|NCT02019420|239534|P1|Treated|Overall Study||361
97724|NCT02019420|239533|P2|STARTED|Overall Study||360
97725|NCT02019420|239534|P1|STARTED|Overall Study||366
97726|NCT02019277|239562|P1|NOT COMPLETED|Overall Study||12
97727|NCT02019277|239562|P1|COMPLETED|Overall Study||38
97728|NCT02019277|239562|P1|STARTED|Overall Study||50
97729|NCT02019264|239581|P2|NOT COMPLETED|Overall Study||207
97730|NCT02019264|239582|P1|NOT COMPLETED|Overall Study||248
97731|NCT02019264|239581|P2|COMPLETED|Overall Study||5793
97732|NCT02019264|239582|P1|COMPLETED|Overall Study||5752
97733|NCT02019264|239581|P2|Safety Analysis Set|Overall Study||5995
97734|NCT02019264|239582|P1|Safety Analysis Set|Overall Study||5992
97735|NCT02019264|239581|P2|STARTED|Overall Study||6000
97736|NCT02019264|239582|P1|STARTED|Overall Study||6000
97737|NCT02019108|239618|P2|NOT COMPLETED|Overall Study||7
97738|NCT02019108|239619|P1|NOT COMPLETED|Overall Study||5
97739|NCT02019108|239618|P2|COMPLETED|Overall Study||32
97740|NCT02019108|239619|P1|COMPLETED|Overall Study||35
97741|NCT02019108|239618|P2|Retention (Week 21)|Overall Study||32
97742|NCT02019108|239619|P1|Retention (Week 21)|Overall Study||35
97743|NCT02019108|239618|P2|Follow-up (Week 17)|Overall Study||36
97744|NCT02019108|239619|P1|Follow-up (Week 17)|Overall Study||38
97745|NCT02019108|239618|P2|Baseline (Week 0)|Overall Study||39
97746|NCT02019108|239619|P1|Baseline (Week 0)|Overall Study||40
97747|NCT02019108|239618|P2|STARTED|Overall Study||39
97748|NCT02019108|239619|P1|STARTED|Overall Study||40
97749|NCT02019069|239641|P1|NOT COMPLETED|Overall Study||0
97750|NCT02019069|239641|P1|COMPLETED|Overall Study||11
97751|NCT02019069|239641|P1|STARTED|Overall Study||11
97752|NCT02018887|239661|P11|NOT COMPLETED|Part C: Cohort 8 Overall||1
97753|NCT02018887|239662|P10|NOT COMPLETED|Part C: Cohort 8 Overall||3
97754|NCT02018887|239663|P9|NOT COMPLETED|Part C: Cohort 8 Overall||3
97755|NCT02018887|239664|P8|NOT COMPLETED|Part C: Cohort 8 Overall||0
97756|NCT02018887|239665|P7|NOT COMPLETED|Part C: Cohort 8 Overall||0
97757|NCT02018887|239666|P6|NOT COMPLETED|Part C: Cohort 8 Overall||0
97758|NCT02018887|239667|P5|NOT COMPLETED|Part C: Cohort 8 Overall||0
97759|NCT02018887|239668|P4|NOT COMPLETED|Part C: Cohort 8 Overall||0
97760|NCT02018887|239669|P3|NOT COMPLETED|Part C: Cohort 8 Overall||0
97761|NCT02018887|239670|P2|NOT COMPLETED|Part C: Cohort 8 Overall||0
97762|NCT02018887|239671|P1|NOT COMPLETED|Part C: Cohort 8 Overall||0
97763|NCT02018887|239661|P11|COMPLETED|Part C: Cohort 8 Overall||6
97764|NCT02018887|239662|P10|COMPLETED|Part C: Cohort 8 Overall||1
97765|NCT02018887|239663|P9|COMPLETED|Part C: Cohort 8 Overall||7
97766|NCT02018887|239664|P8|COMPLETED|Part C: Cohort 8 Overall||0
97767|NCT02018887|239665|P7|COMPLETED|Part C: Cohort 8 Overall||0
97768|NCT02018887|239666|P6|COMPLETED|Part C: Cohort 8 Overall||0
97769|NCT02018887|239667|P5|COMPLETED|Part C: Cohort 8 Overall||0
97770|NCT02018887|239668|P4|COMPLETED|Part C: Cohort 8 Overall||0
97771|NCT02018887|239669|P3|COMPLETED|Part C: Cohort 8 Overall||0
97772|NCT02018887|239670|P2|COMPLETED|Part C: Cohort 8 Overall||0
97773|NCT02018887|239671|P1|COMPLETED|Part C: Cohort 8 Overall||0
97774|NCT02018887|239661|P11|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||7
97847|NCT02018887|239668|P4|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
97775|NCT02018887|239662|P10|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||4
97776|NCT02018887|239663|P9|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||10
97777|NCT02018887|239664|P8|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
97778|NCT02018887|239665|P7|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
97779|NCT02018887|239666|P6|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
97780|NCT02018887|239667|P5|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
97781|NCT02018887|239668|P4|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
97782|NCT02018887|239669|P3|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
97783|NCT02018887|239670|P2|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
97784|NCT02018887|239671|P1|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
97785|NCT02018887|239661|P11|STARTED|Part C: Cohort 8 Overall||7
97786|NCT02018887|239662|P10|STARTED|Part C: Cohort 8 Overall||4
97787|NCT02018887|239663|P9|STARTED|Part C: Cohort 8 Overall||10
97788|NCT02018887|239664|P8|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
97789|NCT02018887|239665|P7|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
97790|NCT02018887|239666|P6|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
97791|NCT02018887|239667|P5|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
97792|NCT02018887|239668|P4|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
97793|NCT02018887|239669|P3|STARTED|Part C: Cohort 8 Overall|Placebo was not administered in this period.|0
97794|NCT02018887|239670|P2|STARTED|Part C: Cohort 8 Overall||0
97795|NCT02018887|239671|P1|STARTED|Part C: Cohort 8 Overall||0
97796|NCT02018887|239661|P11|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
97797|NCT02018887|239662|P10|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
97798|NCT02018887|239663|P9|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
97799|NCT02018887|239664|P8|NOT COMPLETED|Part B: Cohorts 3-7 Overall||4
97800|NCT02018887|239665|P7|NOT COMPLETED|Part B: Cohorts 3-7 Overall||1
97801|NCT02018887|239666|P6|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
97802|NCT02018887|239667|P5|NOT COMPLETED|Part B: Cohorts 3-7 Overall||1
97803|NCT02018887|239668|P4|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
97804|NCT02018887|239669|P3|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
97805|NCT02018887|239670|P2|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
97806|NCT02018887|239671|P1|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
97807|NCT02018887|239661|P11|COMPLETED|Part B: Cohorts 3-7 Overall||0
97808|NCT02018887|239662|P10|COMPLETED|Part B: Cohorts 3-7 Overall||0
97809|NCT02018887|239663|P9|COMPLETED|Part B: Cohorts 3-7 Overall||0
97810|NCT02018887|239664|P8|COMPLETED|Part B: Cohorts 3-7 Overall||5
97811|NCT02018887|239665|P7|COMPLETED|Part B: Cohorts 3-7 Overall||8
97812|NCT02018887|239666|P6|COMPLETED|Part B: Cohorts 3-7 Overall||9
97813|NCT02018887|239667|P5|COMPLETED|Part B: Cohorts 3-7 Overall||8
97814|NCT02018887|239668|P4|COMPLETED|Part B: Cohorts 3-7 Overall||9
97815|NCT02018887|239669|P3|COMPLETED|Part B: Cohorts 3-7 Overall||15
97816|NCT02018887|239670|P2|COMPLETED|Part B: Cohorts 3-7 Overall||0
97817|NCT02018887|239671|P1|COMPLETED|Part B: Cohorts 3-7 Overall||0
97818|NCT02018887|239661|P11|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
97819|NCT02018887|239662|P10|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
97820|NCT02018887|239663|P9|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
97821|NCT02018887|239664|P8|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
97822|NCT02018887|239665|P7|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
97823|NCT02018887|239666|P6|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
97824|NCT02018887|239667|P5|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
97825|NCT02018887|239668|P4|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
97826|NCT02018887|239669|P3|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||15
97827|NCT02018887|239670|P2|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
97828|NCT02018887|239671|P1|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
97829|NCT02018887|239661|P11|STARTED|Part B: Cohorts 3-7 Overall|This dose was not administered in this period.|0
97830|NCT02018887|239662|P10|STARTED|Part B: Cohorts 3-7 Overall|This dose was not administered in this period.|0
97831|NCT02018887|239663|P9|STARTED|Part B: Cohorts 3-7 Overall|Placebo was not administered in this period.|0
97832|NCT02018887|239664|P8|STARTED|Part B: Cohorts 3-7 Overall||9
97833|NCT02018887|239665|P7|STARTED|Part B: Cohorts 3-7 Overall||9
97834|NCT02018887|239666|P6|STARTED|Part B: Cohorts 3-7 Overall||9
97835|NCT02018887|239667|P5|STARTED|Part B: Cohorts 3-7 Overall||9
97836|NCT02018887|239668|P4|STARTED|Part B: Cohorts 3-7 Overall||9
97837|NCT02018887|239669|P3|STARTED|Part B: Cohorts 3-7 Overall||15
97838|NCT02018887|239670|P2|STARTED|Part B: Cohorts 3-7 Overall|Column for Part A data only.|0
97839|NCT02018887|239671|P1|STARTED|Part B: Cohorts 3-7 Overall|Column for Part A data only.|0
97840|NCT02018887|239661|P11|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
97841|NCT02018887|239662|P10|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
97842|NCT02018887|239663|P9|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
97843|NCT02018887|239664|P8|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
97844|NCT02018887|239665|P7|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
97845|NCT02018887|239666|P6|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
97846|NCT02018887|239667|P5|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
97848|NCT02018887|239669|P3|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
97849|NCT02018887|239670|P2|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
97850|NCT02018887|239671|P1|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||1
97851|NCT02018887|239661|P11|COMPLETED|Part A: Cohorts 1-2: Period 3||0
97852|NCT02018887|239662|P10|COMPLETED|Part A: Cohorts 1-2: Period 3||0
97853|NCT02018887|239663|P9|COMPLETED|Part A: Cohorts 1-2: Period 3||0
97854|NCT02018887|239664|P8|COMPLETED|Part A: Cohorts 1-2: Period 3||0
97855|NCT02018887|239665|P7|COMPLETED|Part A: Cohorts 1-2: Period 3||0
97856|NCT02018887|239666|P6|COMPLETED|Part A: Cohorts 1-2: Period 3||0
97857|NCT02018887|239667|P5|COMPLETED|Part A: Cohorts 1-2: Period 3||0
97858|NCT02018887|239668|P4|COMPLETED|Part A: Cohorts 1-2: Period 3||0
97859|NCT02018887|239669|P3|COMPLETED|Part A: Cohorts 1-2: Period 3||0
97860|NCT02018887|239670|P2|COMPLETED|Part A: Cohorts 1-2: Period 3||9
97861|NCT02018887|239671|P1|COMPLETED|Part A: Cohorts 1-2: Period 3||8
97862|NCT02018887|239661|P11|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
97863|NCT02018887|239662|P10|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
97864|NCT02018887|239663|P9|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
97865|NCT02018887|239664|P8|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
97866|NCT02018887|239665|P7|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
97867|NCT02018887|239666|P6|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
97868|NCT02018887|239667|P5|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
97869|NCT02018887|239668|P4|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
97870|NCT02018887|239669|P3|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
97871|NCT02018887|239670|P2|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||9
97872|NCT02018887|239671|P1|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||8
97873|NCT02018887|239661|P11|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
97874|NCT02018887|239662|P10|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
97875|NCT02018887|239663|P9|STARTED|Part A: Cohorts 1-2: Period 3|Placebo was not administered in this period.|0
97876|NCT02018887|239664|P8|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
97877|NCT02018887|239665|P7|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
97878|NCT02018887|239666|P6|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
97879|NCT02018887|239667|P5|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
97880|NCT02018887|239668|P4|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
97881|NCT02018887|239669|P3|STARTED|Part A: Cohorts 1-2: Period 3|Placebo was not administered in this period.|0
97882|NCT02018887|239670|P2|STARTED|Part A: Cohorts 1-2: Period 3||9
97883|NCT02018887|239671|P1|STARTED|Part A: Cohorts 1-2: Period 3||9
97884|NCT02018887|239661|P11|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
97885|NCT02018887|239662|P10|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
97886|NCT02018887|239663|P9|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
97887|NCT02018887|239664|P8|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
97888|NCT02018887|239665|P7|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
97889|NCT02018887|239666|P6|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
97890|NCT02018887|239667|P5|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
97891|NCT02018887|239668|P4|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
97892|NCT02018887|239669|P3|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
97893|NCT02018887|239670|P2|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
97894|NCT02018887|239671|P1|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
97895|NCT02018887|239661|P11|COMPLETED|Part A: Cohorts 1-2: Period 2||0
97896|NCT02018887|239662|P10|COMPLETED|Part A: Cohorts 1-2: Period 2||0
97897|NCT02018887|239663|P9|COMPLETED|Part A: Cohorts 1-2: Period 2||0
97898|NCT02018887|239664|P8|COMPLETED|Part A: Cohorts 1-2: Period 2||0
97899|NCT02018887|239665|P7|COMPLETED|Part A: Cohorts 1-2: Period 2||0
97900|NCT02018887|239666|P6|COMPLETED|Part A: Cohorts 1-2: Period 2||0
97901|NCT02018887|239667|P5|COMPLETED|Part A: Cohorts 1-2: Period 2||0
97902|NCT02018887|239668|P4|COMPLETED|Part A: Cohorts 1-2: Period 2||0
97903|NCT02018887|239669|P3|COMPLETED|Part A: Cohorts 1-2: Period 2||0
97904|NCT02018887|239670|P2|COMPLETED|Part A: Cohorts 1-2: Period 2||9
97905|NCT02018887|239671|P1|COMPLETED|Part A: Cohorts 1-2: Period 2||9
97906|NCT02018887|239661|P11|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
97907|NCT02018887|239662|P10|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
97908|NCT02018887|239663|P9|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
97909|NCT02018887|239664|P8|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
97910|NCT02018887|239665|P7|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
97911|NCT02018887|239666|P6|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
97912|NCT02018887|239667|P5|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
97913|NCT02018887|239668|P4|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
97914|NCT02018887|239669|P3|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
97915|NCT02018887|239670|P2|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||9
97916|NCT02018887|239671|P1|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||9
97917|NCT02018887|239661|P11|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
97918|NCT02018887|239662|P10|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
97919|NCT02018887|239663|P9|STARTED|Part A: Cohorts 1-2: Period 2|Placebo was not administered in this period.|0
97920|NCT02018887|239664|P8|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
97921|NCT02018887|239665|P7|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
97922|NCT02018887|239666|P6|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
97923|NCT02018887|239667|P5|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
97924|NCT02018887|239668|P4|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
97925|NCT02018887|239669|P3|STARTED|Part A: Cohorts 1-2: Period 2|Placebo was not administered in this period.|0
97926|NCT02018887|239670|P2|STARTED|Part A: Cohorts 1-2: Period 2||9
97927|NCT02018887|239671|P1|STARTED|Part A: Cohorts 1-2: Period 2||9
97928|NCT02018887|239661|P11|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
97929|NCT02018887|239662|P10|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
97930|NCT02018887|239663|P9|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
97931|NCT02018887|239664|P8|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
97932|NCT02018887|239665|P7|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
97933|NCT02018887|239666|P6|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
97934|NCT02018887|239667|P5|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
97935|NCT02018887|239668|P4|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
97936|NCT02018887|239669|P3|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
97937|NCT02018887|239670|P2|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
97938|NCT02018887|239671|P1|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
97939|NCT02018887|239661|P11|COMPLETED|Part A: Cohorts 1-2: Period 1||0
97940|NCT02018887|239662|P10|COMPLETED|Part A: Cohorts 1-2: Period 1||0
97941|NCT02018887|239663|P9|COMPLETED|Part A: Cohorts 1-2: Period 1||0
97942|NCT02018887|239664|P8|COMPLETED|Part A: Cohorts 1-2: Period 1||0
97943|NCT02018887|239665|P7|COMPLETED|Part A: Cohorts 1-2: Period 1||0
97944|NCT02018887|239666|P6|COMPLETED|Part A: Cohorts 1-2: Period 1||0
97945|NCT02018887|239667|P5|COMPLETED|Part A: Cohorts 1-2: Period 1||0
97946|NCT02018887|239668|P4|COMPLETED|Part A: Cohorts 1-2: Period 1||0
97947|NCT02018887|239669|P3|COMPLETED|Part A: Cohorts 1-2: Period 1||0
97948|NCT02018887|239670|P2|COMPLETED|Part A: Cohorts 1-2: Period 1||9
97949|NCT02018887|239671|P1|COMPLETED|Part A: Cohorts 1-2: Period 1||9
97950|NCT02018887|239661|P11|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
97951|NCT02018887|239662|P10|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
97952|NCT02018887|239663|P9|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
97953|NCT02018887|239664|P8|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
97954|NCT02018887|239665|P7|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
97955|NCT02018887|239666|P6|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
97956|NCT02018887|239667|P5|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
97957|NCT02018887|239668|P4|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
97958|NCT02018887|239669|P3|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
97959|NCT02018887|239670|P2|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||9
97960|NCT02018887|239671|P1|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||9
97961|NCT02018887|239661|P11|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
97962|NCT02018887|239662|P10|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
97963|NCT02018887|239663|P9|STARTED|Part A: Cohorts 1-2: Period 1|Placebo was not administered in this period.|0
97964|NCT02018887|239664|P8|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
97965|NCT02018887|239665|P7|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
97966|NCT02018887|239666|P6|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
97967|NCT02018887|239667|P5|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
97968|NCT02018887|239668|P4|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
97969|NCT02018887|239669|P3|STARTED|Part A: Cohorts 1-2: Period 1|Placebo was not administered in this period.|0
97970|NCT02018887|239670|P2|STARTED|Part A: Cohorts 1-2: Period 1||9
97971|NCT02018887|239671|P1|STARTED|Part A: Cohorts 1-2: Period 1||9
97972|NCT02018822|239760|P3|NOT COMPLETED|Overall Study||6
97973|NCT02018822|239761|P2|NOT COMPLETED|Overall Study||8
97974|NCT02018822|239762|P1|NOT COMPLETED|Overall Study||6
97975|NCT02018822|239760|P3|COMPLETED|Overall Study||29
97976|NCT02018822|239761|P2|COMPLETED|Overall Study||42
97977|NCT02018822|239762|P1|COMPLETED|Overall Study||44
97978|NCT02018822|239760|P3|STARTED|Overall Study||35
97979|NCT02018822|239761|P2|STARTED|Overall Study||50
97980|NCT02018822|239762|P1|STARTED|Overall Study||50
97981|NCT02018809|239789|P4|NOT COMPLETED|Overall Study||0
97982|NCT02018809|239790|P3|NOT COMPLETED|Overall Study||0
97983|NCT02018809|239791|P2|NOT COMPLETED|Overall Study||0
97984|NCT02018809|239792|P1|NOT COMPLETED|Overall Study||0
97985|NCT02018809|239789|P4|COMPLETED|Overall Study||50
97986|NCT02018809|239790|P3|COMPLETED|Overall Study||50
97987|NCT02018809|239791|P2|COMPLETED|Overall Study||50
97988|NCT02018809|239792|P1|COMPLETED|Overall Study||50
97989|NCT02018809|239789|P4|STARTED|Overall Study||50
97990|NCT02018809|239790|P3|STARTED|Overall Study||50
97991|NCT02018809|239791|P2|STARTED|Overall Study||50
97992|NCT02018809|239792|P1|STARTED|Overall Study||50
97993|NCT02018653|239808|P2|NOT COMPLETED|Overall Study||1
97994|NCT02018653|239809|P1|NOT COMPLETED|Overall Study||0
97995|NCT02018653|239808|P2|COMPLETED|Overall Study||0
97996|NCT02018653|239809|P1|COMPLETED|Overall Study||1
97997|NCT02018653|239808|P2|STARTED|Overall Study||1
97998|NCT02018653|239809|P1|STARTED|Overall Study||1
97999|NCT02018627|239817|P2|NOT COMPLETED|Overall Study||0
98000|NCT02018627|239818|P1|NOT COMPLETED|Overall Study||0
98001|NCT02018627|239817|P2|COMPLETED|Overall Study||6
98002|NCT02018627|239818|P1|COMPLETED|Overall Study||7
98003|NCT02018627|239817|P2|STARTED|Overall Study||6
98004|NCT02018627|239818|P1|STARTED|Overall Study||7
98005|NCT02018562|239842|P2|NOT COMPLETED|Overall Study||0
98006|NCT02018562|239843|P1|NOT COMPLETED|Overall Study||3
98007|NCT02018562|239842|P2|COMPLETED|Overall Study||25
98008|NCT02018562|239843|P1|COMPLETED|Overall Study||22
98009|NCT02018562|239842|P2|STARTED|Overall Study||25
98010|NCT02018562|239843|P1|STARTED|Overall Study||25
98011|NCT02018315|239861|P1|NOT COMPLETED|Overall Study||0
98012|NCT02018315|239861|P1|COMPLETED|Overall Study||14
98013|NCT02018315|239861|P1|STARTED|Overall Study||14
98014|NCT02018042|239866|P1|NOT COMPLETED|Overall Study||1
98015|NCT02018042|239866|P1|COMPLETED|Overall Study||14
98016|NCT02018042|239866|P1|STARTED|Overall Study||15
98017|NCT02017964|239872|P1|NOT COMPLETED|Overall Study||1
98018|NCT02017964|239872|P1|COMPLETED|Overall Study||25
98019|NCT02017964|239872|P1|STARTED|Overall Study||26
98020|NCT02017899|239886|P6|NOT COMPLETED|Overall Study||0
98021|NCT02017899|239887|P5|NOT COMPLETED|Overall Study||1
98022|NCT02017899|239888|P4|NOT COMPLETED|Overall Study||1
98023|NCT02017899|239889|P3|NOT COMPLETED|Overall Study||0
98024|NCT02017899|239890|P2|NOT COMPLETED|Overall Study||0
98025|NCT02017899|239891|P1|NOT COMPLETED|Overall Study||0
98026|NCT02017899|239886|P6|COMPLETED|Overall Study||8
98027|NCT02017899|239887|P5|COMPLETED|Overall Study||8
98028|NCT02017899|239888|P4|COMPLETED|Overall Study||7
98029|NCT02017899|239889|P3|COMPLETED|Overall Study||8
98030|NCT02017899|239890|P2|COMPLETED|Overall Study||9
98031|NCT02017899|239891|P1|COMPLETED|Overall Study||8
98032|NCT02017899|239886|P6|STARTED|Overall Study||8
98033|NCT02017899|239887|P5|STARTED|Overall Study||9
98034|NCT02017899|239888|P4|STARTED|Overall Study||8
98035|NCT02017899|239889|P3|STARTED|Overall Study||8
98036|NCT02017899|239890|P2|STARTED|Overall Study||9
98037|NCT02017899|239891|P1|STARTED|Overall Study||8
98038|NCT02017574|239967|P2|NOT COMPLETED|Overall Study||0
98039|NCT02017574|239968|P1|NOT COMPLETED|Overall Study||0
98040|NCT02017574|239967|P2|COMPLETED|Overall Study||12
98041|NCT02017574|239968|P1|COMPLETED|Overall Study||12
98042|NCT02017574|239967|P2|STARTED|Overall Study||12
98043|NCT02017574|239968|P1|STARTED|Overall Study||12
98044|NCT02017522|239976|P1|NOT COMPLETED|Overall Study||1
98045|NCT02017522|239976|P1|COMPLETED|Overall Study||2
98046|NCT02017522|239976|P1|Scan|Overall Study||2
98047|NCT02017522|239976|P1|STARTED|Overall Study||3
98048|NCT02017223|239981|P1|NOT COMPLETED|Overall Study||2
98049|NCT02017223|239981|P1|COMPLETED|Overall Study||10
98050|NCT02017223|239981|P1|STARTED|Overall Study||12
98051|NCT02017093|239987|P2|NOT COMPLETED|Overall Study||0
98052|NCT02017093|239988|P1|NOT COMPLETED|Overall Study||0
98053|NCT02017093|239987|P2|COMPLETED|Overall Study||3
98054|NCT02017093|239988|P1|COMPLETED|Overall Study||4
98055|NCT02017093|239987|P2|STARTED|Overall Study||3
98056|NCT02017093|239988|P1|STARTED|Overall Study||4
98057|NCT02017015|239996|P1|NOT COMPLETED|Overall Study||69
98058|NCT02017015|239996|P1|COMPLETED|Overall Study|Completed = Participants remaining on treatment at the time of the data cut-off of 01 Jun 2015|14
98059|NCT02017015|239996|P1|Safety Population|Overall Study||83
98060|NCT02017015|239996|P1|STARTED|Overall Study||83
98061|NCT02016963|240003|P1|NOT COMPLETED|Overall Study||0
98062|NCT02016963|240003|P1|COMPLETED|Overall Study||20
98063|NCT02016963|240003|P1|STARTED|Overall Study||20
98064|NCT02016898|240021|P2|NOT COMPLETED|Overall Study||5
98065|NCT02016898|240022|P1|NOT COMPLETED|Overall Study||5
98066|NCT02016898|240021|P2|COMPLETED|Overall Study||40
98067|NCT02016898|240022|P1|COMPLETED|Overall Study||45
98068|NCT02016898|240021|P2|STARTED|Overall Study||45
98069|NCT02016898|240022|P1|STARTED|Overall Study||50
98070|NCT02016885|240035|P5|NOT COMPLETED|Overall Study||1
98071|NCT02016885|240036|P4|NOT COMPLETED|Overall Study||10
98072|NCT02016885|240037|P3|NOT COMPLETED|Overall Study||1
98073|NCT02016885|240038|P2|NOT COMPLETED|Overall Study||4
98074|NCT02016885|240039|P1|NOT COMPLETED|Overall Study||4
98075|NCT02016885|240035|P5|COMPLETED|Overall Study||39
98076|NCT02016885|240036|P4|COMPLETED|Overall Study||30
98077|NCT02016885|240037|P3|COMPLETED|Overall Study||39
98078|NCT02016885|240038|P2|COMPLETED|Overall Study||36
98079|NCT02016885|240039|P1|COMPLETED|Overall Study||34
98080|NCT02016885|240035|P5|STARTED|Overall Study||40
98081|NCT02016885|240036|P4|STARTED|Overall Study||40
98082|NCT02016885|240037|P3|STARTED|Overall Study||40
98083|NCT02016885|240038|P2|STARTED|Overall Study||40
98084|NCT02016885|240039|P1|STARTED|Overall Study||38
98085|NCT02016716|240079|P3|NOT COMPLETED|Overall Study||6
98086|NCT02016716|240080|P2|NOT COMPLETED|Overall Study||8
98087|NCT02016716|240081|P1|NOT COMPLETED|Overall Study||6
98088|NCT02016716|240079|P3|COMPLETED|Overall Study||117
98089|NCT02016716|240080|P2|COMPLETED|Overall Study||110
98090|NCT02016716|240081|P1|COMPLETED|Overall Study||47
98091|NCT02016716|240079|P3|Received Study Treatment|Overall Study||123
98092|NCT02016716|240080|P2|Received Study Treatment|Overall Study||118
98093|NCT02016716|240081|P1|Received Study Treatment|Overall Study||53
98094|NCT02016716|240079|P3|STARTED|Overall Study||123
98095|NCT02016716|240080|P2|STARTED|Overall Study||118
98096|NCT02016716|240081|P1|STARTED|Overall Study||53
98097|NCT02016690|240102|P1|NOT COMPLETED|Overall Study||24
98098|NCT02016690|240102|P1|COMPLETED|Overall Study|(Effectiveness analysis set)|288
98099|NCT02016690|240102|P1|Safety Analysis Set (SAS)|Overall Study||304
98100|NCT02016690|240102|P1|Treated|Overall Study||312
98101|NCT02016690|240102|P1|STARTED|Overall Study||312
98102|NCT02016625|240115|P2|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||0
98103|NCT02016625|240116|P1|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||3
98104|NCT02016625|240115|P2|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
98105|NCT02016625|240116|P1|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||13
98106|NCT02016625|240115|P2|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
98107|NCT02016625|240116|P1|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||16
98108|NCT02016625|240115|P2|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||1
98109|NCT02016625|240116|P1|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||0
98110|NCT02016625|240115|P2|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||15
98111|NCT02016625|240116|P1|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||16
98112|NCT02016625|240115|P2|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
98113|NCT02016625|240116|P1|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
98114|NCT02016612|240152|P4|NOT COMPLETED|Overall Study||0
98115|NCT02016612|240153|P3|NOT COMPLETED|Overall Study||0
98116|NCT02016612|240154|P2|NOT COMPLETED|Overall Study||0
98117|NCT02016612|240155|P1|NOT COMPLETED|Overall Study||0
98118|NCT02016612|240152|P4|COMPLETED|Overall Study||61
98119|NCT02016612|240153|P3|COMPLETED|Overall Study||26
98120|NCT02016612|240154|P2|COMPLETED|Overall Study||25
98121|NCT02016612|240155|P1|COMPLETED|Overall Study||25
98122|NCT02016612|240152|P4|STARTED|Overall Study||61
98123|NCT02016612|240153|P3|STARTED|Overall Study||26
98124|NCT02016612|240154|P2|STARTED|Overall Study||25
98125|NCT02016612|240155|P1|STARTED|Overall Study||25
98126|NCT02016482|240171|P2|NOT COMPLETED|Period B||7
98127|NCT02016482|240172|P1|NOT COMPLETED|Period B||13
98128|NCT02016482|240171|P2|COMPLETED|Period B||87
98129|NCT02016482|240172|P1|COMPLETED|Period B||81
98130|NCT02016482|240171|P2|STARTED|Period B||94
98131|NCT02016482|240172|P1|STARTED|Period B||94
98132|NCT02016482|240171|P2|NOT COMPLETED|Period A||15
98133|NCT02016482|240172|P1|NOT COMPLETED|Period A||14
98134|NCT02016482|240171|P2|COMPLETED|Period A|8 participants early escaped to the end of Period A and 86 continued to the end of Period A.|94
98135|NCT02016482|240172|P1|COMPLETED|Period A|56 participants early escaped to the end of Period A and 38 continued to the end of Period A.|94
98136|NCT02016482|240171|P2|STARTED|Period A||109
98137|NCT02016482|240172|P1|STARTED|Period A||108
98138|NCT02016300|240262|P2|NOT COMPLETED|Overall Study||3
98139|NCT02016300|240263|P1|NOT COMPLETED|Overall Study||0
98140|NCT02016300|240262|P2|COMPLETED|Overall Study||9
98141|NCT02016300|240263|P1|COMPLETED|Overall Study||12
98142|NCT02016300|240262|P2|STARTED|Overall Study||12
98143|NCT02016300|240263|P1|STARTED|Overall Study||12
98144|NCT02016183|240281|P1|NOT COMPLETED|Overall Study||65
98145|NCT02016183|240281|P1|COMPLETED|Overall Study||3157
98146|NCT02016183|240281|P1|STARTED|Overall Study||3222
98147|NCT02016170|240291|P3|NOT COMPLETED|Overall Study||0
98148|NCT02016170|240292|P2|NOT COMPLETED|Overall Study||1
98149|NCT02016170|240293|P1|NOT COMPLETED|Overall Study||2
98150|NCT02016170|240291|P3|COMPLETED|Overall Study||27
98151|NCT02016170|240292|P2|COMPLETED|Overall Study||27
98152|NCT02016170|240293|P1|COMPLETED|Overall Study||25
98153|NCT02016170|240291|P3|STARTED|Overall Study||27
98154|NCT02016170|240292|P2|STARTED|Overall Study||28
98155|NCT02016170|240293|P1|STARTED|Overall Study||27
98156|NCT02016105|240304|P6|NOT COMPLETED|EXTENSION PERIOD||6
98157|NCT02016105|240305|P5|NOT COMPLETED|EXTENSION PERIOD||6
98158|NCT02016105|240306|P4|NOT COMPLETED|EXTENSION PERIOD||5
98159|NCT02016105|240307|P3|NOT COMPLETED|EXTENSION PERIOD||5
98160|NCT02016105|240308|P2|NOT COMPLETED|EXTENSION PERIOD||0
98161|NCT02016105|240309|P1|NOT COMPLETED|EXTENSION PERIOD||0
98162|NCT02016105|240304|P6|COMPLETED|EXTENSION PERIOD||100
98163|NCT02016105|240305|P5|COMPLETED|EXTENSION PERIOD||50
98164|NCT02016105|240306|P4|COMPLETED|EXTENSION PERIOD||104
98165|NCT02016105|240307|P3|COMPLETED|EXTENSION PERIOD||47
98166|NCT02016105|240308|P2|COMPLETED|EXTENSION PERIOD||0
98167|NCT02016105|240309|P1|COMPLETED|EXTENSION PERIOD||0
98168|NCT02016105|240304|P6|STARTED|EXTENSION PERIOD|6 patients did not proceed from Treatment Period 2 into Extension Period|106
98169|NCT02016105|240305|P5|STARTED|EXTENSION PERIOD|3 patients did not proceed from Treatment Period 2 into Extension Period|56
98170|NCT02016105|240306|P4|STARTED|EXTENSION PERIOD|7 patients did not proceed from Treatment Period 2 into Extension Period|109
98171|NCT02016105|240307|P3|STARTED|EXTENSION PERIOD|5 patients did not proceed from Treatment Period 2 into Extension Period|52
98172|NCT02016105|240308|P2|STARTED|EXTENSION PERIOD||0
98173|NCT02016105|240309|P1|STARTED|EXTENSION PERIOD||0
98174|NCT02016105|240304|P6|NOT COMPLETED|TREATMENT PERIOD 2||14
98175|NCT02016105|240305|P5|NOT COMPLETED|TREATMENT PERIOD 2||4
98176|NCT02016105|240306|P4|NOT COMPLETED|TREATMENT PERIOD 2||11
98177|NCT02016105|240307|P3|NOT COMPLETED|TREATMENT PERIOD 2||6
98178|NCT02016105|240308|P2|NOT COMPLETED|TREATMENT PERIOD 2||0
98179|NCT02016105|240309|P1|NOT COMPLETED|TREATMENT PERIOD 2||0
98180|NCT02016105|240304|P6|COMPLETED|TREATMENT PERIOD 2||112
98181|NCT02016105|240305|P5|COMPLETED|TREATMENT PERIOD 2||59
98182|NCT02016105|240306|P4|COMPLETED|TREATMENT PERIOD 2||116
98183|NCT02016105|240307|P3|COMPLETED|TREATMENT PERIOD 2||57
98184|NCT02016105|240308|P2|COMPLETED|TREATMENT PERIOD 2||0
98185|NCT02016105|240309|P1|COMPLETED|TREATMENT PERIOD 2||0
98186|NCT02016105|240304|P6|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|126
98187|NCT02016105|240305|P5|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|63
98188|NCT02016105|240306|P4|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|127
98189|NCT02016105|240307|P3|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|63
98190|NCT02016105|240308|P2|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
98191|NCT02016105|240309|P1|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
98192|NCT02016105|240304|P6|NOT COMPLETED|TREATMENT PERIOD 1||0
98193|NCT02016105|240305|P5|NOT COMPLETED|TREATMENT PERIOD 1||0
98194|NCT02016105|240306|P4|NOT COMPLETED|TREATMENT PERIOD 1||0
98195|NCT02016105|240307|P3|NOT COMPLETED|TREATMENT PERIOD 1||0
98196|NCT02016105|240308|P2|NOT COMPLETED|TREATMENT PERIOD 1||33
98197|NCT02016105|240309|P1|NOT COMPLETED|TREATMENT PERIOD 1||30
98198|NCT02016105|240304|P6|COMPLETED|TREATMENT PERIOD 1||0
98199|NCT02016105|240305|P5|COMPLETED|TREATMENT PERIOD 1||0
98200|NCT02016105|240306|P4|COMPLETED|TREATMENT PERIOD 1||0
98201|NCT02016105|240307|P3|COMPLETED|TREATMENT PERIOD 1||0
98202|NCT02016105|240308|P2|COMPLETED|TREATMENT PERIOD 1|11 patients did not proceed into Treatment Period 2|201
98203|NCT02016105|240309|P1|COMPLETED|TREATMENT PERIOD 1|12 patients did not proceed into Treatment Period 2|201
98204|NCT02016105|240304|P6|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
98205|NCT02016105|240305|P5|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
98206|NCT02016105|240306|P4|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
98207|NCT02016105|240307|P3|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
98208|NCT02016105|240308|P2|STARTED|TREATMENT PERIOD 1||234
98209|NCT02016105|240309|P1|STARTED|TREATMENT PERIOD 1||231
98210|NCT02015910|240359|P2|NOT COMPLETED|Overall Study||0
98211|NCT02015910|240360|P1|NOT COMPLETED|Overall Study||0
98212|NCT02015910|240359|P2|COMPLETED|Overall Study||1
98213|NCT02015910|240360|P1|COMPLETED|Overall Study||0
98214|NCT02015910|240359|P2|STARTED|Overall Study||1
98215|NCT02015910|240360|P1|STARTED|Overall Study||0
98216|NCT02015793|240368|P2|NOT COMPLETED|Overall Study||4
98217|NCT02015793|240369|P1|NOT COMPLETED|Overall Study||4
98218|NCT02015793|240368|P2|COMPLETED|Overall Study||11
98219|NCT02015793|240369|P1|COMPLETED|Overall Study||11
98220|NCT02015793|240368|P2|Entered Open-label Extension Period|Overall Study||14
98221|NCT02015793|240369|P1|Entered Open-label Extension Period|Overall Study||13
98222|NCT02015793|240368|P2|Completed Double-Blind Period|Overall Study||14
98223|NCT02015793|240369|P1|Completed Double-Blind Period|Overall Study||14
98224|NCT02015793|240368|P2|STARTED|Overall Study||15
98225|NCT02015793|240369|P1|STARTED|Overall Study||15
98226|NCT02015754|240399|P1|NOT COMPLETED|Overall Study||11
98227|NCT02015754|240399|P1|COMPLETED|Overall Study||3
98228|NCT02015754|240399|P1|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to follow-up|13
98229|NCT02015754|240399|P1|Completed First TACE|Overall Study||14
98230|NCT02015754|240399|P1|STARTED|Overall Study|17 participants were consented, but 3 participants were screened out prior to treatment|14
98231|NCT02015676|240419|P3|NOT COMPLETED|Overall Study||3
98232|NCT02015676|240420|P2|NOT COMPLETED|Overall Study||34
98233|NCT02015676|240421|P1|NOT COMPLETED|Overall Study||9
98234|NCT02015676|240419|P3|COMPLETED|Overall Study||3
98235|NCT02015676|240420|P2|COMPLETED|Overall Study||14
98236|NCT02015676|240421|P1|COMPLETED|Overall Study||6
98237|NCT02015676|240419|P3|STARTED|Overall Study||6
98238|NCT02015676|240420|P2|STARTED|Overall Study||48
98239|NCT02015676|240421|P1|STARTED|Overall Study||15
98240|NCT02015663|240437|P2|NOT COMPLETED|Overall Study||12
98241|NCT02015663|240438|P1|NOT COMPLETED|Overall Study||15
98242|NCT02015663|240437|P2|COMPLETED|Overall Study||4
98243|NCT02015663|240438|P1|COMPLETED|Overall Study||1
98244|NCT02015663|240437|P2|STARTED|Overall Study||16
98245|NCT02015663|240438|P1|STARTED|Overall Study||16
98246|NCT02015637|240469|P2|NOT COMPLETED|Overall Study||5
98247|NCT02015637|240470|P1|NOT COMPLETED|Overall Study||8
98248|NCT02015637|240469|P2|COMPLETED|Overall Study||149
98249|NCT02015637|240470|P1|COMPLETED|Overall Study||298
98250|NCT02015637|240469|P2|STARTED|Overall Study||154
98251|NCT02015637|240470|P1|STARTED|Overall Study||306
98252|NCT02015546|240481|P3|NOT COMPLETED|Overall Study||4
98253|NCT02015546|240482|P2|NOT COMPLETED|Overall Study||2
98254|NCT02015546|240483|P1|NOT COMPLETED|Overall Study||3
98255|NCT02015546|240481|P3|COMPLETED|Overall Study||22
98256|NCT02015546|240482|P2|COMPLETED|Overall Study||19
98257|NCT02015546|240483|P1|COMPLETED|Overall Study||20
98258|NCT02015546|240481|P3|STARTED|Overall Study||26
98259|NCT02015546|240482|P2|STARTED|Overall Study||21
98260|NCT02015546|240483|P1|STARTED|Overall Study||23
98261|NCT02015481|240515|P1|NOT COMPLETED|Overall Study||1
98262|NCT02015481|240515|P1|COMPLETED|Overall Study||24
98263|NCT02015481|240515|P1|STARTED|Overall Study||25
98264|NCT02015442|240522|P2|NOT COMPLETED|Second Intervention (7 Days)||0
98265|NCT02015442|240523|P1|NOT COMPLETED|Second Intervention (7 Days)||0
98266|NCT02015442|240522|P2|COMPLETED|Second Intervention (7 Days)||4
98267|NCT02015442|240523|P1|COMPLETED|Second Intervention (7 Days)||5
98268|NCT02015442|240522|P2|STARTED|Second Intervention (7 Days)||4
98269|NCT02015442|240523|P1|STARTED|Second Intervention (7 Days)||5
98270|NCT02015442|240522|P2|NOT COMPLETED|Wash-out (4 Weeks)||0
98271|NCT02015442|240523|P1|NOT COMPLETED|Wash-out (4 Weeks)||0
98272|NCT02015442|240522|P2|COMPLETED|Wash-out (4 Weeks)||4
98273|NCT02015442|240523|P1|COMPLETED|Wash-out (4 Weeks)||5
98274|NCT02015442|240522|P2|STARTED|Wash-out (4 Weeks)||4
98275|NCT02015442|240523|P1|STARTED|Wash-out (4 Weeks)||5
98276|NCT02015442|240522|P2|NOT COMPLETED|First Intervention (7 Days)||0
98277|NCT02015442|240523|P1|NOT COMPLETED|First Intervention (7 Days)||0
98278|NCT02015442|240522|P2|COMPLETED|First Intervention (7 Days)||4
98279|NCT02015442|240523|P1|COMPLETED|First Intervention (7 Days)||5
98280|NCT02015442|240522|P2|STARTED|First Intervention (7 Days)||4
98281|NCT02015442|240523|P1|STARTED|First Intervention (7 Days)||5
98282|NCT02015234|240533|P2|NOT COMPLETED|Overall Study||25
98283|NCT02015234|240534|P1|NOT COMPLETED|Overall Study||36
98284|NCT02015234|240533|P2|COMPLETED|Overall Study||54
98285|NCT02015234|240534|P1|COMPLETED|Overall Study||43
98286|NCT02015234|240533|P2|STARTED|Overall Study||79
98287|NCT02015234|240534|P1|STARTED|Overall Study||79
98288|NCT02015221|240548|P2|NOT COMPLETED|Overall Study||6
98289|NCT02015221|240549|P1|NOT COMPLETED|Overall Study||9
98290|NCT02015221|240548|P2|COMPLETED|Overall Study||34
98291|NCT02015221|240549|P1|COMPLETED|Overall Study||32
98292|NCT02015221|240548|P2|STARTED|Overall Study||40
98293|NCT02015221|240549|P1|STARTED|Overall Study||41
98294|NCT02015195|240562|P7|NOT COMPLETED|Overall Study||0
98295|NCT02015195|240563|P6|NOT COMPLETED|Overall Study||0
98296|NCT02015195|240564|P5|NOT COMPLETED|Overall Study||0
98297|NCT02015195|240565|P4|NOT COMPLETED|Overall Study||1
98298|NCT02015195|240566|P3|NOT COMPLETED|Overall Study||0
98299|NCT02015195|240567|P2|NOT COMPLETED|Overall Study||0
98300|NCT02015195|240568|P1|NOT COMPLETED|Overall Study||0
98301|NCT02015195|240562|P7|COMPLETED|Overall Study||16
98302|NCT02015195|240563|P6|COMPLETED|Overall Study||16
98303|NCT02015195|240564|P5|COMPLETED|Overall Study||16
98304|NCT02015195|240565|P4|COMPLETED|Overall Study||0
98305|NCT02015195|240566|P3|COMPLETED|Overall Study||16
98306|NCT02015195|240567|P2|COMPLETED|Overall Study||16
98307|NCT02015195|240568|P1|COMPLETED|Overall Study||16
98308|NCT02015195|240562|P7|STARTED|Overall Study||16
98309|NCT02015195|240563|P6|STARTED|Overall Study||16
98310|NCT02015195|240564|P5|STARTED|Overall Study||16
98311|NCT02015195|240565|P4|STARTED|Overall Study||1
98312|NCT02015195|240566|P3|STARTED|Overall Study||16
98313|NCT02015195|240567|P2|STARTED|Overall Study||16
98314|NCT02015195|240568|P1|STARTED|Overall Study||16
98315|NCT02015065|240592|P3|NOT COMPLETED|Overall Study||1
98316|NCT02015065|240593|P2|NOT COMPLETED|Overall Study||2
98317|NCT02015065|240594|P1|NOT COMPLETED|Overall Study||1
98318|NCT02015065|240592|P3|COMPLETED|Overall Study||1
98319|NCT02015065|240593|P2|COMPLETED|Overall Study||3
98320|NCT02015065|240594|P1|COMPLETED|Overall Study||1
98321|NCT02015065|240592|P3|STARTED|Overall Study||2
98322|NCT02015065|240593|P2|STARTED|Overall Study||5
98323|NCT02015065|240594|P1|STARTED|Overall Study||2
98324|NCT02015039|240613|P2|NOT COMPLETED|Overall Study||1
98325|NCT02015039|240614|P1|NOT COMPLETED|Overall Study||0
98326|NCT02015039|240613|P2|COMPLETED|Overall Study||6
98327|NCT02015039|240614|P1|COMPLETED|Overall Study||6
98328|NCT02015039|240613|P2|STARTED|Overall Study||7
98329|NCT02015039|240614|P1|STARTED|Overall Study||6
98330|NCT02014740|240634|P2|NOT COMPLETED|Overall Study||5
98331|NCT02014740|240635|P1|NOT COMPLETED|Overall Study||6
98332|NCT02014740|240634|P2|COMPLETED|Overall Study||40
98333|NCT02014740|240635|P1|COMPLETED|Overall Study||49
98334|NCT02014740|240634|P2|STARTED|Overall Study||45
98335|NCT02014740|240635|P1|STARTED|Overall Study||55
98336|NCT02014584|240643|P6|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
98337|NCT02014584|240644|P5|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||1
98338|NCT02014584|240645|P4|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
98339|NCT02014584|240646|P3|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
98340|NCT02014584|240647|P2|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
98341|NCT02014584|240648|P1|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
98342|NCT02014584|240643|P6|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
98343|NCT02014584|240644|P5|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
98344|NCT02014584|240645|P4|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
98345|NCT02014584|240646|P3|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
98346|NCT02014584|240647|P2|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
98347|NCT02014584|240648|P1|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
98348|NCT02014584|240643|P6|STARTED|Target Follow-up (F/U) Period (24 Weeks)||2
98349|NCT02014584|240644|P5|STARTED|Target Follow-up (F/U) Period (24 Weeks)||3
98350|NCT02014584|240645|P4|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
98351|NCT02014584|240646|P3|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
98352|NCT02014584|240647|P2|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
98353|NCT02014584|240648|P1|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
98354|NCT02014584|240643|P6|NOT COMPLETED|Open-Label Period (24 Weeks)||0
98355|NCT02014584|240644|P5|NOT COMPLETED|Open-Label Period (24 Weeks)||0
98356|NCT02014584|240645|P4|NOT COMPLETED|Open-Label Period (24 Weeks)||1
98357|NCT02014584|240646|P3|NOT COMPLETED|Open-Label Period (24 Weeks)||5
98358|NCT02014584|240647|P2|NOT COMPLETED|Open-Label Period (24 Weeks)||0
98359|NCT02014584|240648|P1|NOT COMPLETED|Open-Label Period (24 Weeks)||0
98360|NCT02014584|240643|P6|COMPLETED|Open-Label Period (24 Weeks)||0
98361|NCT02014584|240644|P5|COMPLETED|Open-Label Period (24 Weeks)||0
98362|NCT02014584|240645|P4|COMPLETED|Open-Label Period (24 Weeks)||47
98363|NCT02014584|240646|P3|COMPLETED|Open-Label Period (24 Weeks)||44
98364|NCT02014584|240647|P2|COMPLETED|Open-Label Period (24 Weeks)||0
98365|NCT02014584|240648|P1|COMPLETED|Open-Label Period (24 Weeks)||0
98366|NCT02014584|240643|P6|STARTED|Open-Label Period (24 Weeks)||0
98367|NCT02014584|240644|P5|STARTED|Open-Label Period (24 Weeks)||0
98368|NCT02014584|240645|P4|STARTED|Open-Label Period (24 Weeks)||48
98369|NCT02014584|240646|P3|STARTED|Open-Label Period (24 Weeks)||49
98370|NCT02014584|240647|P2|STARTED|Open-Label Period (24 Weeks)||0
98371|NCT02014584|240648|P1|STARTED|Open-Label Period (24 Weeks)||0
98372|NCT02014584|240643|P6|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
98373|NCT02014584|240644|P5|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
98374|NCT02014584|240645|P4|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
98375|NCT02014584|240646|P3|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
98376|NCT02014584|240647|P2|NOT COMPLETED|Double-Blind Period (24 Weeks)||6
98377|NCT02014584|240648|P1|NOT COMPLETED|Double-Blind Period (24 Weeks)||2
98378|NCT02014584|240643|P6|COMPLETED|Double-Blind Period (24 Weeks)||0
98379|NCT02014584|240644|P5|COMPLETED|Double-Blind Period (24 Weeks)||0
98380|NCT02014584|240645|P4|COMPLETED|Double-Blind Period (24 Weeks)||0
98381|NCT02014584|240646|P3|COMPLETED|Double-Blind Period (24 Weeks)||0
98382|NCT02014584|240647|P2|COMPLETED|Double-Blind Period (24 Weeks)||52
98383|NCT02014584|240648|P1|COMPLETED|Double-Blind Period (24 Weeks)||57
98384|NCT02014584|240643|P6|STARTED|Double-Blind Period (24 Weeks)||0
98385|NCT02014584|240644|P5|STARTED|Double-Blind Period (24 Weeks)||0
98386|NCT02014584|240645|P4|STARTED|Double-Blind Period (24 Weeks)||0
98387|NCT02014584|240646|P3|STARTED|Double-Blind Period (24 Weeks)||0
98388|NCT02014584|240647|P2|STARTED|Double-Blind Period (24 Weeks)||58
98389|NCT02014584|240648|P1|STARTED|Double-Blind Period (24 Weeks)||59
98390|NCT02014558|240778|P13|NOT COMPLETED|Overall Study||17
98391|NCT02014558|240779|P12|NOT COMPLETED|Overall Study||102
98392|NCT02014558|240780|P11|NOT COMPLETED|Overall Study||69
98393|NCT02014558|240781|P10|NOT COMPLETED|Overall Study||21
98394|NCT02014558|240782|P9|NOT COMPLETED|Overall Study||15
98395|NCT02014558|240783|P8|NOT COMPLETED|Overall Study||11
98396|NCT02014558|240784|P7|NOT COMPLETED|Overall Study||4
98397|NCT02014558|240785|P6|NOT COMPLETED|Overall Study||3
98398|NCT02014558|240786|P5|NOT COMPLETED|Overall Study||4
98399|NCT02014558|240787|P4|NOT COMPLETED|Overall Study||3
98400|NCT02014558|240788|P3|NOT COMPLETED|Overall Study||3
98401|NCT02014558|240789|P2|NOT COMPLETED|Overall Study||3
98402|NCT02014558|240790|P1|NOT COMPLETED|Overall Study||5
98403|NCT02014558|240778|P13|COMPLETED|Overall Study||0
98404|NCT02014558|240779|P12|COMPLETED|Overall Study||0
98405|NCT02014558|240780|P11|COMPLETED|Overall Study||0
98406|NCT02014558|240781|P10|COMPLETED|Overall Study||0
98407|NCT02014558|240782|P9|COMPLETED|Overall Study||0
98408|NCT02014558|240783|P8|COMPLETED|Overall Study||0
98409|NCT02014558|240784|P7|COMPLETED|Overall Study||0
98410|NCT02014558|240785|P6|COMPLETED|Overall Study||0
98411|NCT02014558|240786|P5|COMPLETED|Overall Study||0
98412|NCT02014558|240787|P4|COMPLETED|Overall Study||0
98413|NCT02014558|240788|P3|COMPLETED|Overall Study||0
98414|NCT02014558|240789|P2|COMPLETED|Overall Study||0
98415|NCT02014558|240790|P1|COMPLETED|Overall Study||0
98416|NCT02014558|240778|P13|Treated|Overall Study||17
98417|NCT02014558|240779|P12|Treated|Overall Study||100
98418|NCT02014558|240780|P11|Treated|Overall Study|A participant randomized to the 120 mg was treated with an initial dose of 20 mg by mistake.|66
98419|NCT02014558|240781|P10|Treated|Overall Study||21
98420|NCT02014558|240782|P9|Treated|Overall Study||13
98421|NCT02014558|240783|P8|Treated|Overall Study|A participant randomized to the 120 mg was treated with an initial dose of 20 mg by mistake.|12
98422|NCT02014558|240784|P7|Treated|Overall Study||3
98423|NCT02014558|240785|P6|Treated|Overall Study||3
98424|NCT02014558|240786|P5|Treated|Overall Study||3
98425|NCT02014558|240787|P4|Treated|Overall Study||3
98426|NCT02014558|240788|P3|Treated|Overall Study||3
98427|NCT02014558|240789|P2|Treated|Overall Study||3
98428|NCT02014558|240790|P1|Treated|Overall Study||5
98429|NCT02014558|240778|P13|STARTED|Overall Study||17
98430|NCT02014558|240779|P12|STARTED|Overall Study||102
98431|NCT02014558|240780|P11|STARTED|Overall Study||69
98432|NCT02014558|240781|P10|STARTED|Overall Study||21
98433|NCT02014558|240782|P9|STARTED|Overall Study||15
98434|NCT02014558|240783|P8|STARTED|Overall Study||11
98435|NCT02014558|240784|P7|STARTED|Overall Study||4
98436|NCT02014558|240785|P6|STARTED|Overall Study||3
98437|NCT02014558|240786|P5|STARTED|Overall Study||4
98438|NCT02014558|240787|P4|STARTED|Overall Study||3
98439|NCT02014558|240788|P3|STARTED|Overall Study||3
98440|NCT02014558|240789|P2|STARTED|Overall Study||3
98441|NCT02014558|240790|P1|STARTED|Overall Study||5
98442|NCT02014519|241098|P1|NOT COMPLETED|Overall Study||0
98443|NCT02014519|241098|P1|COMPLETED|Overall Study||2000
98444|NCT02014519|241098|P1|STARTED|Overall Study||2000
98445|NCT02014480|241155|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||2
98446|NCT02014480|241156|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
98447|NCT02014480|241157|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
98448|NCT02014480|241158|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
98449|NCT02014480|241159|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||1
98450|NCT02014480|241160|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
98451|NCT02014480|241155|P6|COMPLETED|Treatment Period 3 (14 Days)||32
98452|NCT02014480|241156|P5|COMPLETED|Treatment Period 3 (14 Days)||34
98453|NCT02014480|241157|P4|COMPLETED|Treatment Period 3 (14 Days)||31
98454|NCT02014480|241158|P3|COMPLETED|Treatment Period 3 (14 Days)||29
98455|NCT02014480|241159|P2|COMPLETED|Treatment Period 3 (14 Days)||32
98456|NCT02014480|241160|P1|COMPLETED|Treatment Period 3 (14 Days)||34
98457|NCT02014480|241155|P6|STARTED|Treatment Period 3 (14 Days)||34
98458|NCT02014480|241156|P5|STARTED|Treatment Period 3 (14 Days)||34
98459|NCT02014480|241157|P4|STARTED|Treatment Period 3 (14 Days)||31
98460|NCT02014480|241158|P3|STARTED|Treatment Period 3 (14 Days)||30
98461|NCT02014480|241159|P2|STARTED|Treatment Period 3 (14 Days)||33
98462|NCT02014480|241160|P1|STARTED|Treatment Period 3 (14 Days)||34
98463|NCT02014480|241155|P6|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
98464|NCT02014480|241156|P5|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
98465|NCT02014480|241157|P4|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
98466|NCT02014480|241158|P3|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
98467|NCT02014480|241159|P2|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
98468|NCT02014480|241160|P1|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
98469|NCT02014480|241155|P6|COMPLETED|Washout Period 2 (10 to 14 Days)||34
98470|NCT02014480|241156|P5|COMPLETED|Washout Period 2 (10 to 14 Days)||34
98471|NCT02014480|241157|P4|COMPLETED|Washout Period 2 (10 to 14 Days)||31
98472|NCT02014480|241158|P3|COMPLETED|Washout Period 2 (10 to 14 Days)||30
98473|NCT02014480|241159|P2|COMPLETED|Washout Period 2 (10 to 14 Days)||33
98474|NCT02014480|241160|P1|COMPLETED|Washout Period 2 (10 to 14 Days)||34
98475|NCT02014480|241155|P6|STARTED|Washout Period 2 (10 to 14 Days)||34
98476|NCT02014480|241156|P5|STARTED|Washout Period 2 (10 to 14 Days)||34
98477|NCT02014480|241157|P4|STARTED|Washout Period 2 (10 to 14 Days)||31
98478|NCT02014480|241158|P3|STARTED|Washout Period 2 (10 to 14 Days)||30
98479|NCT02014480|241159|P2|STARTED|Washout Period 2 (10 to 14 Days)||33
98480|NCT02014480|241160|P1|STARTED|Washout Period 2 (10 to 14 Days)||34
98481|NCT02014480|241155|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
98482|NCT02014480|241156|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
98483|NCT02014480|241157|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
98484|NCT02014480|241158|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||2
98485|NCT02014480|241159|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
98486|NCT02014480|241160|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||1
98487|NCT02014480|241155|P6|COMPLETED|Treatment Period 2 (14 Days)||34
98488|NCT02014480|241156|P5|COMPLETED|Treatment Period 2 (14 Days)||34
98489|NCT02014480|241157|P4|COMPLETED|Treatment Period 2 (14 Days)||31
98490|NCT02014480|241158|P3|COMPLETED|Treatment Period 2 (14 Days)||30
98491|NCT02014480|241159|P2|COMPLETED|Treatment Period 2 (14 Days)||33
98492|NCT02014480|241160|P1|COMPLETED|Treatment Period 2 (14 Days)||34
98493|NCT02014480|241155|P6|STARTED|Treatment Period 2 (14 Days)||34
98494|NCT02014480|241156|P5|STARTED|Treatment Period 2 (14 Days)||34
98495|NCT02014480|241157|P4|STARTED|Treatment Period 2 (14 Days)||32
98496|NCT02014480|241158|P3|STARTED|Treatment Period 2 (14 Days)||32
98497|NCT02014480|241159|P2|STARTED|Treatment Period 2 (14 Days)||34
98498|NCT02014480|241160|P1|STARTED|Treatment Period 2 (14 Days)||35
98499|NCT02014480|241155|P6|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
98500|NCT02014480|241156|P5|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
98501|NCT02014480|241157|P4|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
98502|NCT02014480|241158|P3|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
98503|NCT02014480|241159|P2|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
98504|NCT02014480|241160|P1|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
98505|NCT02014480|241155|P6|COMPLETED|Washout Period 1 (10 to 14 Days)||34
98506|NCT02014480|241156|P5|COMPLETED|Washout Period 1 (10 to 14 Days)||34
98507|NCT02014480|241157|P4|COMPLETED|Washout Period 1 (10 to 14 Days)||32
98508|NCT02014480|241158|P3|COMPLETED|Washout Period 1 (10 to 14 Days)||32
98509|NCT02014480|241159|P2|COMPLETED|Washout Period 1 (10 to 14 Days)||34
98510|NCT02014480|241160|P1|COMPLETED|Washout Period 1 (10 to 14 Days)||35
98511|NCT02014480|241155|P6|STARTED|Washout Period 1 (10 to 14 Days)||34
98512|NCT02014480|241156|P5|STARTED|Washout Period 1 (10 to 14 Days)||34
98513|NCT02014480|241157|P4|STARTED|Washout Period 1 (10 to 14 Days)||32
98514|NCT02014480|241158|P3|STARTED|Washout Period 1 (10 to 14 Days)||33
98515|NCT02014480|241159|P2|STARTED|Washout Period 1 (10 to 14 Days)||34
98516|NCT02014480|241160|P1|STARTED|Washout Period 1 (10 to 14 Days)||35
98517|NCT02014480|241155|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||0
98518|NCT02014480|241156|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||1
98519|NCT02014480|241157|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||2
98520|NCT02014480|241158|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||1
98521|NCT02014480|241159|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
98522|NCT02014480|241160|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||0
98523|NCT02014480|241155|P6|COMPLETED|Treatment Period 1 (14 Days)||34
98524|NCT02014480|241156|P5|COMPLETED|Treatment Period 1 (14 Days)||34
98525|NCT02014480|241157|P4|COMPLETED|Treatment Period 1 (14 Days)||32
98526|NCT02014480|241158|P3|COMPLETED|Treatment Period 1 (14 Days)||33
98527|NCT02014480|241159|P2|COMPLETED|Treatment Period 1 (14 Days)||34
98528|NCT02014480|241160|P1|COMPLETED|Treatment Period 1 (14 Days)||35
98529|NCT02014480|241155|P6|STARTED|Treatment Period 1 (14 Days)|One participant randomized to Sequence 6 actually received UMEC in Treatment Periods 2 and 3.|34
98530|NCT02014480|241156|P5|STARTED|Treatment Period 1 (14 Days)||35
98531|NCT02014480|241157|P4|STARTED|Treatment Period 1 (14 Days)||34
98532|NCT02014480|241158|P3|STARTED|Treatment Period 1 (14 Days)||34
98533|NCT02014480|241159|P2|STARTED|Treatment Period 1 (14 Days)||35
98534|NCT02014480|241160|P1|STARTED|Treatment Period 1 (14 Days)||35
98535|NCT02014467|241179|P2|NOT COMPLETED|Overall Study||7
98536|NCT02014467|241180|P1|NOT COMPLETED|Overall Study||25
98537|NCT02014467|241179|P2|COMPLETED|Overall Study||112
98538|NCT02014467|241180|P1|COMPLETED|Overall Study||340
98539|NCT02014467|241179|P2|STARTED|Overall Study||119
98540|NCT02014467|241180|P1|STARTED|Overall Study||365
98541|NCT02014441|241240|P1|NOT COMPLETED|Overall Study||12
98542|NCT02014441|241240|P1|COMPLETED|Overall Study||49
98543|NCT02014441|241240|P1|Received Treatment|Overall Study||60
98544|NCT02014441|241240|P1|STARTED|Overall Study||61
98545|NCT02014402|241336|P4|NOT COMPLETED|Overall Study||3
98546|NCT02014402|241337|P3|NOT COMPLETED|Overall Study||3
98547|NCT02014402|241338|P2|NOT COMPLETED|Overall Study||3
98548|NCT02014402|241339|P1|NOT COMPLETED|Overall Study||2
98549|NCT02014402|241336|P4|COMPLETED|Overall Study||82
98550|NCT02014402|241337|P3|COMPLETED|Overall Study||32
98551|NCT02014402|241338|P2|COMPLETED|Overall Study||27
98552|NCT02014402|241339|P1|COMPLETED|Overall Study||29
98553|NCT02014402|241336|P4|Bovine Thrombin|Overall Study||28
98554|NCT02014402|241337|P3|Bovine Thrombin|Overall Study||12
98555|NCT02014402|241338|P2|Bovine Thrombin|Overall Study||10
98556|NCT02014402|241339|P1|Bovine Thrombin|Overall Study||11
98557|NCT02014402|241336|P4|Human Thrombin|Overall Study||57
98558|NCT02014402|241337|P3|Human Thrombin|Overall Study||23
98559|NCT02014402|241338|P2|Human Thrombin|Overall Study||20
98560|NCT02014402|241339|P1|Human Thrombin|Overall Study||20
98561|NCT02014402|241336|P4|STARTED|Overall Study||85
98562|NCT02014402|241337|P3|STARTED|Overall Study||35
98563|NCT02014402|241338|P2|STARTED|Overall Study||30
98564|NCT02014402|241339|P1|STARTED|Overall Study||31
98565|NCT02014363|241369|P3|NOT COMPLETED|Overall Study||24
98566|NCT02014363|241370|P2|NOT COMPLETED|Overall Study||19
98567|NCT02014363|241371|P1|NOT COMPLETED|Overall Study||17
98568|NCT02014363|241369|P3|COMPLETED|Overall Study||31
98569|NCT02014363|241370|P2|COMPLETED|Overall Study||35
98570|NCT02014363|241371|P1|COMPLETED|Overall Study||38
98571|NCT02014363|241369|P3|STARTED|Overall Study||55
98572|NCT02014363|241370|P2|STARTED|Overall Study||54
98573|NCT02014363|241371|P1|STARTED|Overall Study||55
98574|NCT02014272|241379|P2|NOT COMPLETED|Intervention Period 2||0
98575|NCT02014272|241380|P1|NOT COMPLETED|Intervention Period 2||0
98576|NCT02014272|241379|P2|COMPLETED|Intervention Period 2||13
98577|NCT02014272|241380|P1|COMPLETED|Intervention Period 2||13
98578|NCT02014272|241379|P2|STARTED|Intervention Period 2||13
98579|NCT02014272|241380|P1|STARTED|Intervention Period 2||13
98580|NCT02014272|241379|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
98581|NCT02014272|241380|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
98582|NCT02014272|241379|P2|COMPLETED|Washout Period 1 (7 Days)||13
98583|NCT02014272|241380|P1|COMPLETED|Washout Period 1 (7 Days)||13
98584|NCT02014272|241379|P2|STARTED|Washout Period 1 (7 Days)||13
98585|NCT02014272|241380|P1|STARTED|Washout Period 1 (7 Days)||13
98586|NCT02014272|241379|P2|NOT COMPLETED|Intervention Period 1||1
98587|NCT02014272|241380|P1|NOT COMPLETED|Intervention Period 1||1
98588|NCT02014272|241379|P2|COMPLETED|Intervention Period 1||13
98589|NCT02014272|241380|P1|COMPLETED|Intervention Period 1||13
98590|NCT02014272|241379|P2|STARTED|Intervention Period 1||14
98591|NCT02014272|241380|P1|STARTED|Intervention Period 1||14
98592|NCT02014051|241398|P2|NOT COMPLETED|Overall Study||1
98593|NCT02014051|241399|P1|NOT COMPLETED|Overall Study||1
98594|NCT02014051|241398|P2|COMPLETED|Overall Study||5
98595|NCT02014051|241399|P1|COMPLETED|Overall Study||2
98596|NCT02014051|241398|P2|STARTED|Overall Study||6
98597|NCT02014051|241399|P1|STARTED|Overall Study||3
98598|NCT02013830|241412|P1|NOT COMPLETED|Overall Study||30
98599|NCT02013830|241412|P1|COMPLETED|Overall Study||15
98600|NCT02013830|241412|P1|STARTED|Overall Study||45
98601|NCT02013817|241423|P1|NOT COMPLETED|Overall Study||27
98602|NCT02013817|241423|P1|COMPLETED|Overall Study||16
98603|NCT02013817|241423|P1|STARTED|Overall Study||43
98604|NCT02013791|241441|P9|NOT COMPLETED|Period 2||0
98605|NCT02013791|241442|P8|NOT COMPLETED|Period 2||0
98606|NCT02013791|241443|P7|NOT COMPLETED|Period 2||0
98607|NCT02013791|241444|P6|NOT COMPLETED|Period 2||0
98608|NCT02013791|241445|P5|NOT COMPLETED|Period 2||0
98609|NCT02013791|241446|P4|NOT COMPLETED|Period 2||0
98610|NCT02013791|241447|P3|NOT COMPLETED|Period 2||0
98611|NCT02013791|241448|P2|NOT COMPLETED|Period 2||0
98612|NCT02013791|241449|P1|NOT COMPLETED|Period 2||0
98613|NCT02013791|241441|P9|COMPLETED|Period 2||0
98614|NCT02013791|241442|P8|COMPLETED|Period 2||0
98615|NCT02013791|241443|P7|COMPLETED|Period 2||3
98616|NCT02013791|241444|P6|COMPLETED|Period 2||0
98617|NCT02013791|241445|P5|COMPLETED|Period 2||0
98618|NCT02013791|241446|P4|COMPLETED|Period 2||0
98619|NCT02013791|241447|P3|COMPLETED|Period 2||2
98620|NCT02013791|241448|P2|COMPLETED|Period 2||0
98621|NCT02013791|241449|P1|COMPLETED|Period 2||0
98622|NCT02013791|241441|P9|STARTED|Period 2||0
98623|NCT02013791|241442|P8|STARTED|Period 2||0
98624|NCT02013791|241443|P7|STARTED|Period 2||3
98625|NCT02013791|241444|P6|STARTED|Period 2||0
98626|NCT02013791|241445|P5|STARTED|Period 2||0
98627|NCT02013791|241446|P4|STARTED|Period 2||0
98628|NCT02013791|241447|P3|STARTED|Period 2||2
98629|NCT02013791|241448|P2|STARTED|Period 2||0
98630|NCT02013791|241449|P1|STARTED|Period 2||0
98631|NCT02013791|241441|P9|NOT COMPLETED|Period 1||0
98632|NCT02013791|241442|P8|NOT COMPLETED|Period 1||1
98633|NCT02013791|241443|P7|NOT COMPLETED|Period 1||1
98634|NCT02013791|241444|P6|NOT COMPLETED|Period 1||0
98635|NCT02013791|241445|P5|NOT COMPLETED|Period 1||0
98636|NCT02013791|241446|P4|NOT COMPLETED|Period 1||1
98637|NCT02013791|241447|P3|NOT COMPLETED|Period 1||0
98638|NCT02013791|241448|P2|NOT COMPLETED|Period 1||2
98639|NCT02013791|241449|P1|NOT COMPLETED|Period 1||0
98640|NCT02013791|241441|P9|COMPLETED|Period 1||3
98641|NCT02013791|241442|P8|COMPLETED|Period 1||7
98642|NCT02013791|241443|P7|COMPLETED|Period 1||3
98643|NCT02013791|241444|P6|COMPLETED|Period 1||8
98644|NCT02013791|241445|P5|COMPLETED|Period 1||4
98645|NCT02013791|241446|P4|COMPLETED|Period 1||7
98646|NCT02013791|241447|P3|COMPLETED|Period 1||4
98647|NCT02013791|241448|P2|COMPLETED|Period 1||6
98648|NCT02013791|241449|P1|COMPLETED|Period 1||8
98649|NCT02013791|241441|P9|STARTED|Period 1||3
98650|NCT02013791|241442|P8|STARTED|Period 1||8
98651|NCT02013791|241443|P7|STARTED|Period 1||4
98652|NCT02013791|241444|P6|STARTED|Period 1||8
98653|NCT02013791|241445|P5|STARTED|Period 1||4
98654|NCT02013791|241446|P4|STARTED|Period 1||8
98655|NCT02013791|241447|P3|STARTED|Period 1||4
98656|NCT02013791|241448|P2|STARTED|Period 1||8
98657|NCT02013791|241449|P1|STARTED|Period 1||8
98658|NCT02013765|241470|P1|NOT COMPLETED|Overall Study||1
98659|NCT02013765|241470|P1|COMPLETED|Overall Study||4
98660|NCT02013765|241470|P1|STARTED|Overall Study||5
98661|NCT02013687|241484|P4|NOT COMPLETED|Overall Study||2
98662|NCT02013687|241485|P3|NOT COMPLETED|Overall Study||2
98663|NCT02013687|241486|P2|NOT COMPLETED|Overall Study||0
98664|NCT02013687|241487|P1|NOT COMPLETED|Overall Study||0
98665|NCT02013687|241484|P4|COMPLETED|Overall Study||14
98666|NCT02013687|241485|P3|COMPLETED|Overall Study||14
98667|NCT02013687|241486|P2|COMPLETED|Overall Study||6
98668|NCT02013687|241487|P1|COMPLETED|Overall Study||6
98669|NCT02013687|241484|P4|STARTED|Overall Study||16
98670|NCT02013687|241485|P3|STARTED|Overall Study||16
98671|NCT02013687|241486|P2|STARTED|Overall Study||6
98672|NCT02013687|241487|P1|STARTED|Overall Study||6
98673|NCT02013622|241517|P1|NOT COMPLETED|Overall Study||24
98674|NCT02013622|241517|P1|COMPLETED|Overall Study||25
98675|NCT02013622|241517|P1|STARTED|Overall Study||49
98676|NCT02013609|241537|P1|NOT COMPLETED|Overall Study||18
98677|NCT02013609|241537|P1|COMPLETED|Overall Study||29
98678|NCT02013609|241537|P1|STARTED|Overall Study|One participant out of 48 participants enrolled had discontinued before receiving study medication.|47
98679|NCT02013544|241562|P2|NOT COMPLETED|Overall Study||20
98680|NCT02013544|241563|P1|NOT COMPLETED|Overall Study||11
98681|NCT02013544|241562|P2|COMPLETED|Overall Study||356
98682|NCT02013544|241563|P1|COMPLETED|Overall Study||171
98683|NCT02013544|241562|P2|ITT Population|Overall Study||325
98684|NCT02013544|241563|P1|ITT Population|Overall Study||157
98685|NCT02013544|241562|P2|Safety Population|Overall Study||374
98686|NCT02013544|241563|P1|Safety Population|Overall Study||180
98687|NCT02013544|241562|P2|STARTED|Overall Study||376
98688|NCT02013544|241563|P1|STARTED|Overall Study||182
98689|NCT02013531|241585|P1|NOT COMPLETED|Overall Study||5
98690|NCT02013531|241585|P1|COMPLETED|Overall Study||32
98691|NCT02013531|241585|P1|STARTED|Overall Study||37
98692|NCT02013414|241607|P1|NOT COMPLETED|Overall Study||0
98693|NCT02013414|241607|P1|COMPLETED|Overall Study||9
98694|NCT02013414|241607|P1|STARTED|Overall Study||9
98695|NCT02013388|241621|P8|NOT COMPLETED|Overall Study||0
98696|NCT02013388|241622|P7|NOT COMPLETED|Overall Study||0
98697|NCT02013388|241623|P6|NOT COMPLETED|Overall Study||0
98698|NCT02013388|241624|P5|NOT COMPLETED|Overall Study||1
98699|NCT02013388|241625|P4|NOT COMPLETED|Overall Study||0
98700|NCT02013388|241626|P3|NOT COMPLETED|Overall Study||0
98701|NCT02013388|241627|P2|NOT COMPLETED|Overall Study||0
98702|NCT02013388|241628|P1|NOT COMPLETED|Overall Study||1
98703|NCT02013388|241621|P8|COMPLETED|Overall Study||4
98704|NCT02013388|241622|P7|COMPLETED|Overall Study||6
98705|NCT02013388|241623|P6|COMPLETED|Overall Study||6
98706|NCT02013388|241624|P5|COMPLETED|Overall Study||5
98707|NCT02013388|241625|P4|COMPLETED|Overall Study||6
98708|NCT02013388|241626|P3|COMPLETED|Overall Study||6
98709|NCT02013388|241627|P2|COMPLETED|Overall Study||6
98710|NCT02013388|241628|P1|COMPLETED|Overall Study||8
98711|NCT02013388|241621|P8|STARTED|Overall Study||4
98712|NCT02013388|241622|P7|STARTED|Overall Study||6
98713|NCT02013388|241623|P6|STARTED|Overall Study||6
98714|NCT02013388|241624|P5|STARTED|Overall Study||6
98715|NCT02013388|241625|P4|STARTED|Overall Study||6
98716|NCT02013388|241626|P3|STARTED|Overall Study||6
98717|NCT02013388|241627|P2|STARTED|Overall Study||6
98718|NCT02013388|241628|P1|STARTED|Overall Study||9
98719|NCT02013375|241662|P1|NOT COMPLETED|Overall Study||2
98720|NCT02013375|241662|P1|COMPLETED|Overall Study||0
98721|NCT02013375|241662|P1|STARTED|Overall Study||2
98722|NCT02013245|241673|P4|NOT COMPLETED|Overall Study||0
98723|NCT02013245|241674|P3|NOT COMPLETED|Overall Study||0
98724|NCT02013245|241675|P2|NOT COMPLETED|Overall Study||1
98725|NCT02013245|241676|P1|NOT COMPLETED|Overall Study||0
98726|NCT02013245|241673|P4|COMPLETED|Overall Study||9
98727|NCT02013245|241674|P3|COMPLETED|Overall Study||9
98728|NCT02013245|241675|P2|COMPLETED|Overall Study||8
98729|NCT02013245|241676|P1|COMPLETED|Overall Study||9
98730|NCT02013245|241673|P4|STARTED|Overall Study||9
98731|NCT02013245|241674|P3|STARTED|Overall Study||9
98732|NCT02013245|241675|P2|STARTED|Overall Study||9
98733|NCT02013245|241676|P1|STARTED|Overall Study||9
98734|NCT02013206|241692|P2|NOT COMPLETED|Overall Study||22
98735|NCT02013206|241693|P1|NOT COMPLETED|Overall Study||27
98736|NCT02013206|241692|P2|COMPLETED|Overall Study||1
98737|NCT02013206|241693|P1|COMPLETED|Overall Study|3 Patients were on-going at clinical cut-off. Not Completed=patients who discontinued treatment.|2
98738|NCT02013206|241692|P2|Received Study Drug|Overall Study||23
98739|NCT02013206|241693|P1|Received Study Drug|Overall Study||26
98740|NCT02013206|241692|P2|STARTED|Overall Study||23
98741|NCT02013206|241693|P1|STARTED|Overall Study||29
98742|NCT02013180|241715|P2|NOT COMPLETED|Overall Study||0
98743|NCT02013180|241716|P1|NOT COMPLETED|Overall Study||0
98744|NCT02013180|241715|P2|COMPLETED|Overall Study||361
98745|NCT02013180|241716|P1|COMPLETED|Overall Study||119
98746|NCT02013180|241715|P2|STARTED|Overall Study||361
98747|NCT02013180|241716|P1|STARTED|Overall Study||119
98748|NCT02013167|241724|P2|NOT COMPLETED|Overall Study||178
98749|NCT02013167|241725|P1|NOT COMPLETED|Overall Study||101
98750|NCT02013167|241724|P2|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off; 22 were receiving treatment|93
98751|NCT02013167|241725|P1|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off|33
98752|NCT02013167|241724|P2|Received Treatment|Overall Study||267
98753|NCT02013167|241725|P1|Received Treatment|Overall Study||109
98754|NCT02013167|241724|P2|STARTED|Overall Study||271
98755|NCT02013167|241725|P1|STARTED|Overall Study||134
98756|NCT02013050|241756|P4|NOT COMPLETED|Overall Study||4
98757|NCT02013050|241757|P3|NOT COMPLETED|Overall Study||0
98758|NCT02013050|241758|P2|NOT COMPLETED|Overall Study||5
98759|NCT02013050|241759|P1|NOT COMPLETED|Overall Study||4
98760|NCT02013050|241756|P4|COMPLETED|Overall Study||19
98761|NCT02013050|241757|P3|COMPLETED|Overall Study||3
98762|NCT02013050|241758|P2|COMPLETED|Overall Study||36
98763|NCT02013050|241759|P1|COMPLETED|Overall Study||38
98764|NCT02013050|241756|P4|STARTED|Overall Study||23
98765|NCT02013050|241757|P3|STARTED|Overall Study||3
98766|NCT02013050|241758|P2|STARTED|Overall Study||41
98767|NCT02013050|241759|P1|STARTED|Overall Study||42
98768|NCT02012959|241801|P5|NOT COMPLETED|Treatment Phase B||0
98769|NCT02012959|241802|P4|NOT COMPLETED|Treatment Phase B||0
98770|NCT02012959|241803|P3|NOT COMPLETED|Treatment Phase B||0
98771|NCT02012959|241804|P2|NOT COMPLETED|Treatment Phase B||0
98772|NCT02012959|241805|P1|NOT COMPLETED|Treatment Phase B||0
98773|NCT02012959|241801|P5|COMPLETED|Treatment Phase B||1
98774|NCT02012959|241802|P4|COMPLETED|Treatment Phase B||1
98775|NCT02012959|241803|P3|COMPLETED|Treatment Phase B||3
98776|NCT02012959|241804|P2|COMPLETED|Treatment Phase B||2
98777|NCT02012959|241805|P1|COMPLETED|Treatment Phase B||0
98778|NCT02012959|241801|P5|Received At Least 1 Dose of Study Drug|Treatment Phase B||1
98779|NCT02012959|241802|P4|Received At Least 1 Dose of Study Drug|Treatment Phase B||1
98780|NCT02012959|241803|P3|Received At Least 1 Dose of Study Drug|Treatment Phase B||3
98781|NCT02012959|241804|P2|Received At Least 1 Dose of Study Drug|Treatment Phase B||2
98782|NCT02012959|241805|P1|Received At Least 1 Dose of Study Drug|Treatment Phase B||0
98783|NCT02012959|241801|P5|STARTED|Treatment Phase B|Participants in this group could receive the investigator's preferred standard of care|1
98784|NCT02012959|241802|P4|STARTED|Treatment Phase B|Participants in this group could continue study drug treatment, per the investigator’s discretion|1
98785|NCT02012959|241803|P3|STARTED|Treatment Phase B|Participants in this group did not receive additional study drug after Phase A|3
98786|NCT02012959|241804|P2|STARTED|Treatment Phase B|Participants in this group continued treatment with the study drug|2
98787|NCT02012959|241805|P1|STARTED|Treatment Phase B|Zero participants noted because participants had completed Phase A|0
98788|NCT02012959|241801|P5|NOT COMPLETED|Treatment Phase A||0
98789|NCT02012959|241802|P4|NOT COMPLETED|Treatment Phase A||0
98790|NCT02012959|241803|P3|NOT COMPLETED|Treatment Phase A||0
98791|NCT02012959|241804|P2|NOT COMPLETED|Treatment Phase A||0
98792|NCT02012959|241805|P1|NOT COMPLETED|Treatment Phase A||2
98793|NCT02012959|241801|P5|COMPLETED|Treatment Phase A||0
98794|NCT02012959|241802|P4|COMPLETED|Treatment Phase A||0
98795|NCT02012959|241803|P3|COMPLETED|Treatment Phase A||0
98796|NCT02012959|241804|P2|COMPLETED|Treatment Phase A||0
98797|NCT02012959|241805|P1|COMPLETED|Treatment Phase A||7
98798|NCT02012959|241801|P5|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
98799|NCT02012959|241802|P4|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
98800|NCT02012959|241803|P3|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
98801|NCT02012959|241804|P2|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
98802|NCT02012959|241805|P1|Received At Least 1 Dose of Study Drug|Treatment Phase A||9
98803|NCT02012959|241801|P5|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
98804|NCT02012959|241802|P4|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
98805|NCT02012959|241803|P3|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
98806|NCT02012959|241804|P2|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
98807|NCT02012959|241805|P1|STARTED|Treatment Phase A||9
98808|NCT02012686|241818|P2|NOT COMPLETED|Overall Study||2
98809|NCT02012686|241819|P1|NOT COMPLETED|Overall Study||0
98810|NCT02012686|241818|P2|COMPLETED|Overall Study||48
98811|NCT02012686|241819|P1|COMPLETED|Overall Study||50
98812|NCT02012686|241818|P2|STARTED|Overall Study||50
98813|NCT02012686|241819|P1|STARTED|Overall Study||50
98814|NCT02012621|241831|P1|NOT COMPLETED|Overall Study||0
98815|NCT02012621|241831|P1|COMPLETED|Overall Study||807
98816|NCT02012621|241831|P1|Visit 3 Completed|Overall Study||444
98817|NCT02012621|241831|P1|Visit 2 Completed|Overall Study||688
98818|NCT02012621|241831|P1|Visit 1 Completed|Overall Study||807
98819|NCT02012621|241831|P1|STARTED|Overall Study||807
98820|NCT02012608|241839|P2|NOT COMPLETED|Overall Study||0
98821|NCT02012608|241840|P1|NOT COMPLETED|Overall Study||3
98822|NCT02012608|241839|P2|COMPLETED|Overall Study||7
98823|NCT02012608|241840|P1|COMPLETED|Overall Study||4
98824|NCT02012608|241839|P2|STARTED|Overall Study||7
98825|NCT02012608|241840|P1|STARTED|Overall Study||7
98826|NCT02012582|241850|P4|NOT COMPLETED|Overall Study||1
98827|NCT02012582|241851|P3|NOT COMPLETED|Overall Study||0
98828|NCT02012582|241852|P2|NOT COMPLETED|Overall Study||0
98829|NCT02012582|241853|P1|NOT COMPLETED|Overall Study||0
98830|NCT02012582|241850|P4|COMPLETED|Overall Study||7
98831|NCT02012582|241851|P3|COMPLETED|Overall Study||8
98832|NCT02012582|241852|P2|COMPLETED|Overall Study||8
98833|NCT02012582|241853|P1|COMPLETED|Overall Study||8
98834|NCT02012582|241850|P4|STARTED|Overall Study||8
98835|NCT02012582|241851|P3|STARTED|Overall Study||8
98836|NCT02012582|241852|P2|STARTED|Overall Study||8
98837|NCT02012582|241853|P1|STARTED|Overall Study||8
98838|NCT02012491|241881|P2|NOT COMPLETED|Overall Study||1
98839|NCT02012491|241882|P1|NOT COMPLETED|Overall Study||2
98840|NCT02012491|241881|P2|COMPLETED|Overall Study||148
98841|NCT02012491|241882|P1|COMPLETED|Overall Study||149
98842|NCT02012491|241881|P2|STARTED|Overall Study||149
98843|NCT02012491|241882|P1|STARTED|Overall Study||151
98844|NCT02012452|241900|P2|NOT COMPLETED|Overall Study||1
98845|NCT02012452|241901|P1|NOT COMPLETED|Overall Study||6
98846|NCT02012452|241900|P2|COMPLETED|Overall Study||1
98847|NCT02012452|241901|P1|COMPLETED|Overall Study||1
98848|NCT02012452|241900|P2|STARTED|Overall Study||2
98849|NCT02012452|241901|P1|STARTED|Overall Study||7
98850|NCT02012348|241912|P3|NOT COMPLETED|Overall Study||0
98851|NCT02012348|241913|P2|NOT COMPLETED|Overall Study||0
98852|NCT02012348|241914|P1|NOT COMPLETED|Overall Study||0
98853|NCT02012348|241912|P3|COMPLETED|Overall Study||10
98854|NCT02012348|241913|P2|COMPLETED|Overall Study||10
98855|NCT02012348|241914|P1|COMPLETED|Overall Study||10
98856|NCT02012348|241912|P3|STARTED|Overall Study||10
98857|NCT02012348|241913|P2|STARTED|Overall Study||10
98858|NCT02012348|241914|P1|STARTED|Overall Study||10
98859|NCT02012283|241927|P2|NOT COMPLETED|Third Intervention||0
98860|NCT02012283|241928|P1|NOT COMPLETED|Third Intervention||0
98861|NCT02012283|241927|P2|COMPLETED|Third Intervention||10
98862|NCT02012283|241928|P1|COMPLETED|Third Intervention||10
98863|NCT02012283|241927|P2|STARTED|Third Intervention||10
98864|NCT02012283|241928|P1|STARTED|Third Intervention||10
98865|NCT02012283|241927|P2|NOT COMPLETED|Second Intervention||0
98866|NCT02012283|241928|P1|NOT COMPLETED|Second Intervention||0
98867|NCT02012283|241927|P2|COMPLETED|Second Intervention||10
98868|NCT02012283|241928|P1|COMPLETED|Second Intervention||10
98869|NCT02012283|241927|P2|STARTED|Second Intervention||10
98870|NCT02012283|241928|P1|STARTED|Second Intervention||10
98871|NCT02012283|241927|P2|NOT COMPLETED|First Intervention||0
98872|NCT02012283|241928|P1|NOT COMPLETED|First Intervention||0
98873|NCT02012283|241927|P2|COMPLETED|First Intervention||10
98874|NCT02012283|241928|P1|COMPLETED|First Intervention||10
98875|NCT02012283|241927|P2|STARTED|First Intervention||10
98876|NCT02012283|241928|P1|STARTED|First Intervention||10
98877|NCT02012218|241944|P5|NOT COMPLETED|Overall Study||1
98878|NCT02012218|241945|P4|NOT COMPLETED|Overall Study||2
98879|NCT02012218|241946|P3|NOT COMPLETED|Overall Study||2
98880|NCT02012218|241947|P2|NOT COMPLETED|Overall Study||1
98881|NCT02012218|241948|P1|NOT COMPLETED|Overall Study||4
98882|NCT02012218|241944|P5|COMPLETED|Overall Study||5
98883|NCT02012218|241945|P4|COMPLETED|Overall Study||17
98884|NCT02012218|241946|P3|COMPLETED|Overall Study||11
98885|NCT02012218|241947|P2|COMPLETED|Overall Study||10
98886|NCT02012218|241948|P1|COMPLETED|Overall Study||8
98887|NCT02012218|241944|P5|STARTED|Overall Study||6
98888|NCT02012218|241945|P4|STARTED|Overall Study||19
98889|NCT02012218|241946|P3|STARTED|Overall Study||13
98890|NCT02012218|241947|P2|STARTED|Overall Study||11
98891|NCT02012218|241948|P1|STARTED|Overall Study||12
98892|NCT02012192|241962|P2|NOT COMPLETED|Overall Study||0
98893|NCT02012192|241963|P1|NOT COMPLETED|Overall Study||27
98894|NCT02012192|241962|P2|COMPLETED|Overall Study||43
98895|NCT02012192|241963|P1|COMPLETED|Overall Study||63
98896|NCT02012192|241962|P2|STARTED|Overall Study||43
98897|NCT02012192|241963|P1|STARTED|Overall Study||90
98898|NCT02011893|241969|P3|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||1
98899|NCT02011893|241970|P2|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
98900|NCT02011893|241971|P1|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
98901|NCT02011893|241969|P3|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||51
98902|NCT02011893|241970|P2|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||45
98903|NCT02011893|241971|P1|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
98904|NCT02011893|241969|P3|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
98905|NCT02011893|241970|P2|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||45
98906|NCT02011893|241971|P1|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
98907|NCT02011893|241969|P3|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
98908|NCT02011893|241970|P2|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||44
98909|NCT02011893|241971|P1|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
98910|NCT02011893|241969|P3|STARTED|Period 2 (12 Weeks to 24 Weeks)||52
98911|NCT02011893|241970|P2|STARTED|Period 2 (12 Weeks to 24 Weeks)||45
98912|NCT02011893|241971|P1|STARTED|Period 2 (12 Weeks to 24 Weeks)||0
98913|NCT02011893|241969|P3|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||3
98914|NCT02011893|241970|P2|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
98915|NCT02011893|241971|P1|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
98916|NCT02011893|241969|P3|COMPLETED|Period 1 (Randomization to 12 Weeks)||52
98917|NCT02011893|241970|P2|COMPLETED|Period 1 (Randomization to 12 Weeks)||45
98918|NCT02011893|241971|P1|COMPLETED|Period 1 (Randomization to 12 Weeks)||0
98919|NCT02011893|241969|P3|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
98920|NCT02011893|241970|P2|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
98921|NCT02011893|241971|P1|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
98922|NCT02011893|241969|P3|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
98923|NCT02011893|241970|P2|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
98924|NCT02011893|241971|P1|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
98925|NCT02011893|241969|P3|STARTED|Period 1 (Randomization to 12 Weeks)||55
98926|NCT02011893|241970|P2|STARTED|Period 1 (Randomization to 12 Weeks)||45
98927|NCT02011893|241971|P1|STARTED|Period 1 (Randomization to 12 Weeks)||0
98928|NCT02011893|241969|P3|NOT COMPLETED|Enrollment to Randomization||0
98929|NCT02011893|241970|P2|NOT COMPLETED|Enrollment to Randomization||0
98930|NCT02011893|241971|P1|NOT COMPLETED|Enrollment to Randomization||73
98931|NCT02011893|241969|P3|COMPLETED|Enrollment to Randomization||0
98932|NCT02011893|241970|P2|COMPLETED|Enrollment to Randomization||0
98933|NCT02011893|241971|P1|COMPLETED|Enrollment to Randomization||100
98934|NCT02011893|241969|P3|Randomization|Enrollment to Randomization||0
98935|NCT02011893|241970|P2|Randomization|Enrollment to Randomization||0
98936|NCT02011893|241971|P1|Randomization|Enrollment to Randomization||100
98937|NCT02011893|241969|P3|Permanent Stimulation Implant|Enrollment to Randomization||0
98938|NCT02011893|241970|P2|Permanent Stimulation Implant|Enrollment to Randomization||0
98939|NCT02011893|241971|P1|Permanent Stimulation Implant|Enrollment to Randomization||101
98940|NCT02011893|241969|P3|Trial Stimulation Implant|Enrollment to Randomization||0
98941|NCT02011893|241970|P2|Trial Stimulation Implant|Enrollment to Randomization||0
98942|NCT02011893|241971|P1|Trial Stimulation Implant|Enrollment to Randomization||121
98943|NCT02011893|241969|P3|Baseline|Enrollment to Randomization||0
98944|NCT02011893|241970|P2|Baseline|Enrollment to Randomization||0
98945|NCT02011893|241971|P1|Baseline|Enrollment to Randomization||141
98946|NCT02011893|241969|P3|STARTED|Enrollment to Randomization||0
98947|NCT02011893|241970|P2|STARTED|Enrollment to Randomization||0
98948|NCT02011893|241971|P1|STARTED|Enrollment to Randomization||173
98949|NCT02011542|241982|P1|NOT COMPLETED|Overall Study||1
98950|NCT02011542|241982|P1|COMPLETED|Overall Study||29
98951|NCT02011542|241982|P1|STARTED|Overall Study||30
98952|NCT02011516|241989|P2|NOT COMPLETED|Overall Study||2
98953|NCT02011516|241990|P1|NOT COMPLETED|Overall Study||4
98954|NCT02011516|241989|P2|COMPLETED|Overall Study||6
98955|NCT02011516|241990|P1|COMPLETED|Overall Study||4
98956|NCT02011516|241989|P2|STARTED|Overall Study||8
98957|NCT02011516|241990|P1|STARTED|Overall Study||8
98958|NCT02011490|241999|P6|NOT COMPLETED|Part 2||0
98959|NCT02011490|242000|P5|NOT COMPLETED|Part 2||0
98960|NCT02011490|242001|P4|NOT COMPLETED|Part 2||0
98961|NCT02011490|242002|P3|NOT COMPLETED|Part 2||0
98962|NCT02011490|242003|P2|NOT COMPLETED|Part 2||0
98963|NCT02011490|242004|P1|NOT COMPLETED|Part 2||0
98964|NCT02011490|241999|P6|COMPLETED|Part 2||6
98965|NCT02011490|242000|P5|COMPLETED|Part 2||6
98966|NCT02011490|242001|P4|COMPLETED|Part 2||6
98967|NCT02011490|242002|P3|COMPLETED|Part 2||0
98968|NCT02011490|242003|P2|COMPLETED|Part 2||0
98969|NCT02011490|242004|P1|COMPLETED|Part 2||0
98970|NCT02011490|241999|P6|STARTED|Part 2|2 had also participated in Part 1 (both in healthy group)|6
98971|NCT02011490|242000|P5|STARTED|Part 2|3 had also participated in Part 1 (2 in moderate, 1 in severe groups)|6
98972|NCT02011490|242001|P4|STARTED|Part 2|4 had also participated in Part 1 (all in severe group)|6
98973|NCT02011490|242002|P3|STARTED|Part 2||0
98974|NCT02011490|242003|P2|STARTED|Part 2||0
98975|NCT02011490|242004|P1|STARTED|Part 2||0
98976|NCT02011490|241999|P6|NOT COMPLETED|Part 1||0
98977|NCT02011490|242000|P5|NOT COMPLETED|Part 1||0
98978|NCT02011490|242001|P4|NOT COMPLETED|Part 1||0
98979|NCT02011490|242002|P3|NOT COMPLETED|Part 1||0
98980|NCT02011490|242003|P2|NOT COMPLETED|Part 1||0
98981|NCT02011490|242004|P1|NOT COMPLETED|Part 1||0
98982|NCT02011490|241999|P6|COMPLETED|Part 1||0
98983|NCT02011490|242000|P5|COMPLETED|Part 1||0
98984|NCT02011490|242001|P4|COMPLETED|Part 1||0
98985|NCT02011490|242002|P3|COMPLETED|Part 1||8
98986|NCT02011490|242003|P2|COMPLETED|Part 1||8
98987|NCT02011490|242004|P1|COMPLETED|Part 1||8
98988|NCT02011490|241999|P6|STARTED|Part 1||0
98989|NCT02011490|242000|P5|STARTED|Part 1||0
98990|NCT02011490|242001|P4|STARTED|Part 1||0
98991|NCT02011490|242002|P3|STARTED|Part 1||8
98992|NCT02011490|242003|P2|STARTED|Part 1||8
98993|NCT02011490|242004|P1|STARTED|Part 1||8
98994|NCT02011464|242092|P2|NOT COMPLETED|Overall Study||0
98995|NCT02011464|242093|P1|NOT COMPLETED|Overall Study||0
98996|NCT02011464|242092|P2|COMPLETED|Overall Study||10
98997|NCT02011464|242093|P1|COMPLETED|Overall Study||10
98998|NCT02011464|242092|P2|STARTED|Overall Study||10
98999|NCT02011464|242093|P1|STARTED|Overall Study||10
99000|NCT02011113|242113|P1|NOT COMPLETED|Overall Study||36
99001|NCT02011113|242113|P1|COMPLETED|Overall Study|Completed = participants with progressive disease were considered as completed.|0
99002|NCT02011113|242113|P1|STARTED|Overall Study||36
99003|NCT02010996|242129|P2|NOT COMPLETED|Overall Study||0
99004|NCT02010996|242130|P1|NOT COMPLETED|Overall Study||0
99005|NCT02010996|242129|P2|COMPLETED|Overall Study||36
99006|NCT02010996|242130|P1|COMPLETED|Overall Study||36
99007|NCT02010996|242129|P2|STARTED|Overall Study||36
99008|NCT02010996|242130|P1|STARTED|Overall Study||36
99009|NCT02010775|242145|P5|NOT COMPLETED|Overall Study||6
99010|NCT02010775|242146|P4|NOT COMPLETED|Overall Study||3
99011|NCT02010775|242147|P3|NOT COMPLETED|Overall Study||3
99012|NCT02010775|242148|P2|NOT COMPLETED|Overall Study||3
99013|NCT02010775|242149|P1|NOT COMPLETED|Overall Study||5
99014|NCT02010775|242145|P5|COMPLETED|Overall Study||31
99015|NCT02010775|242146|P4|COMPLETED|Overall Study||34
99016|NCT02010775|242147|P3|COMPLETED|Overall Study||34
99017|NCT02010775|242148|P2|COMPLETED|Overall Study||35
99018|NCT02010775|242149|P1|COMPLETED|Overall Study||33
99019|NCT02010775|242145|P5|STARTED|Overall Study||37
99020|NCT02010775|242146|P4|STARTED|Overall Study||37
99021|NCT02010775|242147|P3|STARTED|Overall Study||37
99022|NCT02010775|242148|P2|STARTED|Overall Study||38
99023|NCT02010775|242149|P1|STARTED|Overall Study||38
99024|NCT02010697|242169|P3|NOT COMPLETED|Overall Study||0
99025|NCT02010697|242170|P2|NOT COMPLETED|Overall Study||0
99026|NCT02010697|242171|P1|NOT COMPLETED|Overall Study||0
99027|NCT02010697|242169|P3|COMPLETED|Overall Study||1043
99028|NCT02010697|242170|P2|COMPLETED|Overall Study||1038
99029|NCT02010697|242171|P1|COMPLETED|Overall Study||1044
99030|NCT02010697|242169|P3|STARTED|Overall Study||1043
99031|NCT02010697|242170|P2|STARTED|Overall Study||1038
99032|NCT02010697|242171|P1|STARTED|Overall Study||1044
99033|NCT02010684|242190|P2|NOT COMPLETED|Overall Study||23
99034|NCT02010684|242191|P1|NOT COMPLETED|Overall Study||12
99035|NCT02010684|242190|P2|COMPLETED|Overall Study||59
99036|NCT02010684|242191|P1|COMPLETED|Overall Study||27
99037|NCT02010684|242190|P2|STARTED|Overall Study||82
99038|NCT02010684|242191|P1|STARTED|Overall Study||39
99039|NCT02010632|242209|P2|NOT COMPLETED|Second Intervention (7 Days)||0
99040|NCT02010632|242210|P1|NOT COMPLETED|Second Intervention (7 Days)||1
99041|NCT02010632|242209|P2|COMPLETED|Second Intervention (7 Days)||16
99042|NCT02010632|242210|P1|COMPLETED|Second Intervention (7 Days)||15
99043|NCT02010632|242209|P2|STARTED|Second Intervention (7 Days)||16
99044|NCT02010632|242210|P1|STARTED|Second Intervention (7 Days)||16
99045|NCT02010632|242209|P2|NOT COMPLETED|Wash Out Period (14 Days)||0
99046|NCT02010632|242210|P1|NOT COMPLETED|Wash Out Period (14 Days)||0
99047|NCT02010632|242209|P2|COMPLETED|Wash Out Period (14 Days)||16
99048|NCT02010632|242210|P1|COMPLETED|Wash Out Period (14 Days)||16
99049|NCT02010632|242209|P2|STARTED|Wash Out Period (14 Days)||16
99050|NCT02010632|242210|P1|STARTED|Wash Out Period (14 Days)||16
99051|NCT02010632|242209|P2|NOT COMPLETED|First Intervention (7 Days)||0
99052|NCT02010632|242210|P1|NOT COMPLETED|First Intervention (7 Days)||0
99053|NCT02010632|242209|P2|COMPLETED|First Intervention (7 Days)||16
99054|NCT02010632|242210|P1|COMPLETED|First Intervention (7 Days)||16
99055|NCT02010632|242209|P2|STARTED|First Intervention (7 Days)||16
99056|NCT02010632|242210|P1|STARTED|First Intervention (7 Days)||16
99057|NCT02010567|242221|P5|NOT COMPLETED|Overall Study||1
99058|NCT02010567|242222|P4|NOT COMPLETED|Overall Study||0
99059|NCT02010567|242223|P3|NOT COMPLETED|Overall Study||1
99060|NCT02010567|242224|P2|NOT COMPLETED|Overall Study||0
99061|NCT02010567|242225|P1|NOT COMPLETED|Overall Study||0
99062|NCT02010567|242221|P5|COMPLETED|Overall Study||5
99063|NCT02010567|242222|P4|COMPLETED|Overall Study||3
99064|NCT02010567|242223|P3|COMPLETED|Overall Study||13
99065|NCT02010567|242224|P2|COMPLETED|Overall Study||6
99066|NCT02010567|242225|P1|COMPLETED|Overall Study||3
99067|NCT02010567|242221|P5|STARTED|Overall Study||6
99068|NCT02010567|242222|P4|STARTED|Overall Study||3
99069|NCT02010567|242223|P3|STARTED|Overall Study||14
99070|NCT02010567|242224|P2|STARTED|Overall Study||6
99071|NCT02010567|242225|P1|STARTED|Overall Study||3
99072|NCT02010359|242238|P2|NOT COMPLETED|Overall Study||2
99073|NCT02010359|242239|P1|NOT COMPLETED|Overall Study||2
99074|NCT02010359|242238|P2|COMPLETED|Overall Study||12
99075|NCT02010359|242239|P1|COMPLETED|Overall Study||13
99076|NCT02010359|242238|P2|STARTED|Overall Study||14
99077|NCT02010359|242239|P1|STARTED|Overall Study||15
99078|NCT02010255|242277|P14|NOT COMPLETED|Overall Study||1
99079|NCT02010255|242278|P13|NOT COMPLETED|Overall Study||0
99080|NCT02010255|242279|P12|NOT COMPLETED|Overall Study||1
99081|NCT02010255|242280|P11|NOT COMPLETED|Overall Study||2
99082|NCT02010255|242281|P10|NOT COMPLETED|Overall Study||0
99083|NCT02010255|242282|P9|NOT COMPLETED|Overall Study||1
99084|NCT02010255|242283|P8|NOT COMPLETED|Overall Study||1
99085|NCT02010255|242284|P7|NOT COMPLETED|Overall Study||1
99086|NCT02010255|242285|P6|NOT COMPLETED|Overall Study||0
99087|NCT02010255|242286|P5|NOT COMPLETED|Overall Study||4
99088|NCT02010255|242287|P4|NOT COMPLETED|Overall Study||6
99089|NCT02010255|242288|P3|NOT COMPLETED|Overall Study||7
99090|NCT02010255|242289|P2|NOT COMPLETED|Overall Study||2
99091|NCT02010255|242290|P1|NOT COMPLETED|Overall Study||6
99092|NCT02010255|242277|P14|COMPLETED|Overall Study||2
99093|NCT02010255|242278|P13|COMPLETED|Overall Study||3
99094|NCT02010255|242279|P12|COMPLETED|Overall Study||4
99095|NCT02010255|242280|P11|COMPLETED|Overall Study||1
99096|NCT02010255|242281|P10|COMPLETED|Overall Study||23
99097|NCT02010255|242282|P9|COMPLETED|Overall Study||21
99098|NCT02010255|242283|P8|COMPLETED|Overall Study||32
99099|NCT02010255|242284|P7|COMPLETED|Overall Study||33
99100|NCT02010255|242285|P6|COMPLETED|Overall Study||49
99101|NCT02010255|242286|P5|COMPLETED|Overall Study||48
99102|NCT02010255|242287|P4|COMPLETED|Overall Study||20
99103|NCT02010255|242288|P3|COMPLETED|Overall Study||18
99104|NCT02010255|242289|P2|COMPLETED|Overall Study||26
99105|NCT02010255|242290|P1|COMPLETED|Overall Study||22
99106|NCT02010255|242277|P14|STARTED|Overall Study||3
99107|NCT02010255|242278|P13|STARTED|Overall Study||3
99108|NCT02010255|242279|P12|STARTED|Overall Study||5
99109|NCT02010255|242280|P11|STARTED|Overall Study||3
99110|NCT02010255|242281|P10|STARTED|Overall Study||23
99111|NCT02010255|242282|P9|STARTED|Overall Study||22
99112|NCT02010255|242283|P8|STARTED|Overall Study||33
99113|NCT02010255|242284|P7|STARTED|Overall Study||34
99114|NCT02010255|242285|P6|STARTED|Overall Study||49
99115|NCT02010255|242286|P5|STARTED|Overall Study||52
99116|NCT02010255|242287|P4|STARTED|Overall Study||26
99117|NCT02010255|242288|P3|STARTED|Overall Study||25
99118|NCT02010255|242289|P2|STARTED|Overall Study||28
99119|NCT02010255|242290|P1|STARTED|Overall Study||28
99120|NCT02010216|242614|P1|NOT COMPLETED|Overall Study||0
99121|NCT02010216|242614|P1|COMPLETED|Overall Study||23
99122|NCT02010216|242614|P1|STARTED|Overall Study||23
99123|NCT02010021|242622|P2|NOT COMPLETED|Overall Study||0
99124|NCT02010021|242623|P1|NOT COMPLETED|Overall Study||0
99125|NCT02010021|242622|P2|COMPLETED|Overall Study||7
99126|NCT02010021|242623|P1|COMPLETED|Overall Study||10
99127|NCT02010021|242622|P2|STARTED|Overall Study||7
99128|NCT02010021|242623|P1|STARTED|Overall Study||10
99129|NCT02009982|242633|P2|NOT COMPLETED|Overall Study||0
99130|NCT02009982|242634|P1|NOT COMPLETED|Overall Study||0
99131|NCT02009982|242633|P2|COMPLETED|Overall Study||2
99132|NCT02009982|242634|P1|COMPLETED|Overall Study||1
99133|NCT02009982|242633|P2|STARTED|Overall Study||2
99134|NCT02009982|242634|P1|STARTED|Overall Study||1
99135|NCT02009878|242645|P3|NOT COMPLETED|Overall Study||0
99136|NCT02009878|242646|P2|NOT COMPLETED|Overall Study||1
99137|NCT02009878|242647|P1|NOT COMPLETED|Overall Study||0
99138|NCT02009878|242645|P3|COMPLETED|Overall Study||9
99139|NCT02009878|242646|P2|COMPLETED|Overall Study||10
99140|NCT02009878|242647|P1|COMPLETED|Overall Study||10
99141|NCT02009878|242645|P3|STARTED|Overall Study||9
99142|NCT02009878|242646|P2|STARTED|Overall Study||11
99143|NCT02009878|242647|P1|STARTED|Overall Study||10
99144|NCT02009865|242681|P2|NOT COMPLETED|Overall Study||5
99145|NCT02009865|242682|P1|NOT COMPLETED|Overall Study||1
99146|NCT02009865|242681|P2|COMPLETED|Overall Study||76
99147|NCT02009865|242682|P1|COMPLETED|Overall Study||80
99148|NCT02009865|242681|P2|STARTED|Overall Study||81
99149|NCT02009865|242682|P1|STARTED|Overall Study||81
99150|NCT02009722|242698|P2|NOT COMPLETED|Overall Study||3
99151|NCT02009722|242699|P1|NOT COMPLETED|Overall Study||1
99152|NCT02009722|242698|P2|COMPLETED|Overall Study||40
99153|NCT02009722|242699|P1|COMPLETED|Overall Study||40
99154|NCT02009722|242698|P2|Received Intervention|Overall Study||42
99155|NCT02009722|242699|P1|Received Intervention|Overall Study||41
99156|NCT02009722|242698|P2|STARTED|Overall Study||43
99157|NCT02009722|242699|P1|STARTED|Overall Study||41
99158|NCT02009696|242723|P1|NOT COMPLETED|Overall Study||2
99159|NCT02009696|242723|P1|COMPLETED|Overall Study||219
99160|NCT02009696|242723|P1|STARTED|Overall Study||221
99161|NCT02009501|242733|P2|NOT COMPLETED|Overall Study||0
99162|NCT02009501|242734|P1|NOT COMPLETED|Overall Study||0
99163|NCT02009501|242733|P2|COMPLETED|Overall Study||11
99164|NCT02009501|242734|P1|COMPLETED|Overall Study||9
99165|NCT02009501|242733|P2|STARTED|Overall Study||11
99166|NCT02009501|242734|P1|STARTED|Overall Study||9
99167|NCT02009163|242740|P3|NOT COMPLETED|Randomized-withdrawal Period||35
99168|NCT02009163|242741|P2|NOT COMPLETED|Randomized-withdrawal Period||88
99169|NCT02009163|242742|P1|NOT COMPLETED|Randomized-withdrawal Period||0
99170|NCT02009163|242740|P3|COMPLETED|Randomized-withdrawal Period||102
99171|NCT02009163|242741|P2|COMPLETED|Randomized-withdrawal Period||50
99172|NCT02009163|242742|P1|COMPLETED|Randomized-withdrawal Period||0
99173|NCT02009163|242740|P3|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|137
99174|NCT02009163|242741|P2|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|138
99175|NCT02009163|242742|P1|STARTED|Randomized-withdrawal Period|The open-label treatment group is not an arm of the randomized-withdrawal period.|0
99176|NCT02009163|242740|P3|NOT COMPLETED|Open-label Period (Non-randomized)||0
99177|NCT02009163|242741|P2|NOT COMPLETED|Open-label Period (Non-randomized)||0
99178|NCT02009163|242742|P1|NOT COMPLETED|Open-label Period (Non-randomized)||143
99179|NCT02009163|242740|P3|COMPLETED|Open-label Period (Non-randomized)||0
99180|NCT02009163|242741|P2|COMPLETED|Open-label Period (Non-randomized)||0
99181|NCT02009163|242742|P1|COMPLETED|Open-label Period (Non-randomized)||275
99182|NCT02009163|242740|P3|STARTED|Open-label Period (Non-randomized)||0
99183|NCT02009163|242741|P2|STARTED|Open-label Period (Non-randomized)||0
99184|NCT02009163|242742|P1|STARTED|Open-label Period (Non-randomized)||418
99185|NCT02009046|242777|P2|NOT COMPLETED|Overall Study||206
99186|NCT02009046|242778|P1|NOT COMPLETED|Overall Study||256
99187|NCT02009046|242777|P2|COMPLETED|Overall Study||678
99188|NCT02009046|242778|P1|COMPLETED|Overall Study||769
99189|NCT02009046|242777|P2|Ctrl Curriculm +1 SchoolWide Component|Overall Study||428
99190|NCT02009046|242778|P1|Ctrl Curriculm +1 SchoolWide Component|Overall Study||0
99191|NCT02009046|242777|P2|Ctrl Curriculum Only|Overall Study||456
99192|NCT02009046|242778|P1|Ctrl Curriculum Only|Overall Study||0
99193|NCT02009046|242777|P2|SEI Curriculum + 3 SchoolWide Components|Overall Study||0
99194|NCT02009046|242778|P1|SEI Curriculum + 3 SchoolWide Components|Overall Study||544
99195|NCT02009046|242777|P2|SEI Curriculum Only|Overall Study||0
99196|NCT02009046|242778|P1|SEI Curriculum Only|Overall Study||461
99197|NCT02009046|242777|P2|STARTED|Overall Study||884
99198|NCT02009046|242778|P1|STARTED|Overall Study||1025
99199|NCT02008942|242828|P2|NOT COMPLETED|Second Intervention||0
99200|NCT02008942|242829|P1|NOT COMPLETED|Second Intervention||1
99201|NCT02008942|242828|P2|COMPLETED|Second Intervention||30
99202|NCT02008942|242829|P1|COMPLETED|Second Intervention||25
99203|NCT02008942|242828|P2|STARTED|Second Intervention||30
99204|NCT02008942|242829|P1|STARTED|Second Intervention||26
99205|NCT02008942|242828|P2|NOT COMPLETED|First Intervention||0
99206|NCT02008942|242829|P1|NOT COMPLETED|First Intervention||0
99207|NCT02008942|242828|P2|COMPLETED|First Intervention||30
99208|NCT02008942|242829|P1|COMPLETED|First Intervention||27
99209|NCT02008942|242828|P2|STARTED|First Intervention||30
99210|NCT02008942|242829|P1|STARTED|First Intervention||27
99211|NCT02008916|242838|P3|NOT COMPLETED|Week 16 - 156||10
99212|NCT02008916|242839|P2|NOT COMPLETED|Week 16 - 156||13
99213|NCT02008916|242840|P1|NOT COMPLETED|Week 16 - 156||19
99214|NCT02008916|242838|P3|COMPLETED|Week 16 - 156||63
99215|NCT02008916|242839|P2|COMPLETED|Week 16 - 156||62
99216|NCT02008916|242840|P1|COMPLETED|Week 16 - 156||55
99217|NCT02008916|242838|P3|STARTED|Week 16 - 156||73
99218|NCT02008916|242839|P2|STARTED|Week 16 - 156||75
99219|NCT02008916|242840|P1|STARTED|Week 16 - 156||74
99220|NCT02008916|242838|P3|NOT COMPLETED|Primary Assessment (up to Week 16)||3
99221|NCT02008916|242839|P2|NOT COMPLETED|Primary Assessment (up to Week 16)||1
99222|NCT02008916|242840|P1|NOT COMPLETED|Primary Assessment (up to Week 16)||0
99223|NCT02008916|242838|P3|COMPLETED|Primary Assessment (up to Week 16)||73
99224|NCT02008916|242839|P2|COMPLETED|Primary Assessment (up to Week 16)||75
99225|NCT02008916|242840|P1|COMPLETED|Primary Assessment (up to Week 16)||74
99226|NCT02008916|242838|P3|Safety Set|Primary Assessment (up to Week 16)||75
99227|NCT02008916|242839|P2|Safety Set|Primary Assessment (up to Week 16)||76
99228|NCT02008916|242840|P1|Safety Set|Primary Assessment (up to Week 16)||74
99229|NCT02008916|242838|P3|FAS|Primary Assessment (up to Week 16)||76
99230|NCT02008916|242839|P2|FAS|Primary Assessment (up to Week 16)||76
99231|NCT02008916|242840|P1|FAS|Primary Assessment (up to Week 16)||74
99232|NCT02008916|242838|P3|STARTED|Primary Assessment (up to Week 16)||76
99233|NCT02008916|242839|P2|STARTED|Primary Assessment (up to Week 16)||76
99234|NCT02008916|242840|P1|STARTED|Primary Assessment (up to Week 16)||74
99235|NCT02008890|242876|P5|NOT COMPLETED|Extension Period||4
99236|NCT02008890|242877|P4|NOT COMPLETED|Extension Period||4
99237|NCT02008890|242878|P3|NOT COMPLETED|Extension Period||0
99238|NCT02008890|242879|P2|NOT COMPLETED|Extension Period||5
99239|NCT02008890|242880|P1|NOT COMPLETED|Extension Period||5
99240|NCT02008890|242876|P5|COMPLETED|Extension Period||13
99241|NCT02008890|242877|P4|COMPLETED|Extension Period||6
99242|NCT02008890|242878|P3|COMPLETED|Extension Period||0
99243|NCT02008890|242879|P2|COMPLETED|Extension Period||31
99244|NCT02008890|242880|P1|COMPLETED|Extension Period||26
99245|NCT02008890|242876|P5|STARTED|Extension Period||17
99246|NCT02008890|242877|P4|STARTED|Extension Period||10
99247|NCT02008890|242878|P3|STARTED|Extension Period||0
99248|NCT02008890|242879|P2|STARTED|Extension Period||36
99249|NCT02008890|242880|P1|STARTED|Extension Period||31
99250|NCT02008890|242876|P5|NOT COMPLETED|Period 2||8
99251|NCT02008890|242877|P4|NOT COMPLETED|Period 2||14
99252|NCT02008890|242878|P3|NOT COMPLETED|Period 2||1
99253|NCT02008890|242879|P2|NOT COMPLETED|Period 2||15
99254|NCT02008890|242880|P1|NOT COMPLETED|Period 2||27
99255|NCT02008890|242876|P5|COMPLETED|Period 2||20
99256|NCT02008890|242877|P4|COMPLETED|Period 2||13
99257|NCT02008890|242878|P3|COMPLETED|Period 2||9
99258|NCT02008890|242879|P2|COMPLETED|Period 2||49
99259|NCT02008890|242880|P1|COMPLETED|Period 2||38
99260|NCT02008890|242876|P5|STARTED|Period 2||28
99261|NCT02008890|242877|P4|STARTED|Period 2||27
99262|NCT02008890|242878|P3|STARTED|Period 2||10
99263|NCT02008890|242879|P2|STARTED|Period 2||64
99264|NCT02008890|242880|P1|STARTED|Period 2||65
99265|NCT02008890|242876|P5|NOT COMPLETED|Period 1||0
99266|NCT02008890|242877|P4|NOT COMPLETED|Period 1||0
99267|NCT02008890|242878|P3|NOT COMPLETED|Period 1||12
99268|NCT02008890|242879|P2|NOT COMPLETED|Period 1||15
99269|NCT02008890|242880|P1|NOT COMPLETED|Period 1||15
99270|NCT02008890|242876|P5|COMPLETED|Period 1||0
99271|NCT02008890|242877|P4|COMPLETED|Period 1||0
99272|NCT02008890|242878|P3|COMPLETED|Period 1||66
99273|NCT02008890|242879|P2|COMPLETED|Period 1||64
99274|NCT02008890|242880|P1|COMPLETED|Period 1||65
99275|NCT02008890|242876|P5|STARTED|Period 1||0
99276|NCT02008890|242877|P4|STARTED|Period 1||0
99277|NCT02008890|242878|P3|STARTED|Period 1||78
99278|NCT02008890|242879|P2|STARTED|Period 1||79
99279|NCT02008890|242880|P1|STARTED|Period 1||80
99280|NCT02008877|242916|P3|NOT COMPLETED|Overall Study||0
99281|NCT02008877|242917|P2|NOT COMPLETED|Overall Study||1
99282|NCT02008877|242918|P1|NOT COMPLETED|Overall Study||0
99283|NCT02008877|242916|P3|COMPLETED|Overall Study||10
99284|NCT02008877|242917|P2|COMPLETED|Overall Study||6
99285|NCT02008877|242918|P1|COMPLETED|Overall Study||3
99286|NCT02008877|242916|P3|STARTED|Overall Study||10
99287|NCT02008877|242917|P2|STARTED|Overall Study||7
99288|NCT02008877|242918|P1|STARTED|Overall Study||3
99289|NCT02008773|242937|P4|NOT COMPLETED|Overall Study||12
99290|NCT02008773|242938|P3|NOT COMPLETED|Overall Study||14
99291|NCT02008773|242939|P2|NOT COMPLETED|Overall Study||9
99292|NCT02008773|242940|P1|NOT COMPLETED|Overall Study||13
99293|NCT02008773|242937|P4|COMPLETED|Overall Study||38
99294|NCT02008773|242938|P3|COMPLETED|Overall Study||32
99295|NCT02008773|242939|P2|COMPLETED|Overall Study||25
99296|NCT02008773|242940|P1|COMPLETED|Overall Study||27
99297|NCT02008773|242937|P4|STARTED|Overall Study||50
99298|NCT02008773|242938|P3|STARTED|Overall Study||46
99299|NCT02008773|242939|P2|STARTED|Overall Study||34
99300|NCT02008773|242940|P1|STARTED|Overall Study||40
99301|NCT02008682|242970|P2|NOT COMPLETED|Overall Study||14
99302|NCT02008682|242971|P1|NOT COMPLETED|Overall Study||27
99303|NCT02008682|242970|P2|COMPLETED|Overall Study|Completed without discontinuation of trial product|170
99304|NCT02008682|242971|P1|COMPLETED|Overall Study|Completed without discontinuation of trial product|157
99305|NCT02008682|242970|P2|Exposed|Overall Study||184
99306|NCT02008682|242971|P1|Exposed|Overall Study|1 subject withdrawn before exposure to trial product|183
99307|NCT02008682|242970|P2|STARTED|Overall Study||184
99308|NCT02008682|242971|P1|STARTED|Overall Study||184
99309|NCT02008617|242989|P2|NOT COMPLETED|Overall Study||0
99310|NCT02008617|242990|P1|NOT COMPLETED|Overall Study||0
99311|NCT02008617|242989|P2|COMPLETED|Overall Study||10
99312|NCT02008617|242990|P1|COMPLETED|Overall Study||8
99313|NCT02008617|242989|P2|STARTED|Overall Study||10
99314|NCT02008617|242990|P1|STARTED|Overall Study||8
99315|NCT02008565|243006|P4|NOT COMPLETED|Overall Study||0
99316|NCT02008565|243007|P3|NOT COMPLETED|Overall Study||2
99317|NCT02008565|243008|P2|NOT COMPLETED|Overall Study||1
99318|NCT02008565|243009|P1|NOT COMPLETED|Overall Study||1
99319|NCT02008565|243006|P4|COMPLETED|Overall Study||42
99320|NCT02008565|243007|P3|COMPLETED|Overall Study||86
99321|NCT02008565|243008|P2|COMPLETED|Overall Study||83
99322|NCT02008565|243009|P1|COMPLETED|Overall Study||85
99323|NCT02008565|243006|P4|STARTED|Overall Study||42
99324|NCT02008565|243007|P3|STARTED|Overall Study||88
99325|NCT02008565|243008|P2|STARTED|Overall Study||84
99326|NCT02008565|243009|P1|STARTED|Overall Study||86
99327|NCT02008526|243070|P3|NOT COMPLETED|Overall Study||9
99328|NCT02008526|243071|P2|NOT COMPLETED|Overall Study||14
99329|NCT02008526|243072|P1|NOT COMPLETED|Overall Study||8
99330|NCT02008526|243070|P3|COMPLETED|Overall Study||84
99331|NCT02008526|243071|P2|COMPLETED|Overall Study||85
99332|NCT02008526|243072|P1|COMPLETED|Overall Study||86
99333|NCT02008526|243070|P3|STARTED|Overall Study||93
99334|NCT02008526|243071|P2|STARTED|Overall Study||99
99335|NCT02008526|243072|P1|STARTED|Overall Study||94
99336|NCT02008370|243083|P1|NOT COMPLETED|Overall Study||7
99337|NCT02008370|243083|P1|COMPLETED|Overall Study||0
99338|NCT02008370|243083|P1|STARTED|Overall Study||7
99339|NCT02008318|243091|P2|NOT COMPLETED|Overall Study||1
99340|NCT02008318|243092|P1|NOT COMPLETED|Overall Study||12
99341|NCT02008318|243091|P2|COMPLETED|Overall Study||1
99342|NCT02008318|243092|P1|COMPLETED|Overall Study||29
99343|NCT02008318|243091|P2|Received At Least 1 Dose of Study Drug|Overall Study||2
99344|NCT02008318|243092|P1|Received At Least 1 Dose of Study Drug|Overall Study||41
99345|NCT02008318|243091|P2|STARTED|Overall Study||2
99346|NCT02008318|243092|P1|STARTED|Overall Study||41
99347|NCT02008227|243113|P2|NOT COMPLETED|Overall Study||613
99348|NCT02008227|243114|P1|NOT COMPLETED|Overall Study||612
99349|NCT02008227|243113|P2|COMPLETED|Overall Study||0
99350|NCT02008227|243114|P1|COMPLETED|Overall Study||0
99351|NCT02008227|243113|P2|Treated|Overall Study||608
99352|NCT02008227|243114|P1|Treated|Overall Study||579
99353|NCT02008227|243113|P2|STARTED|Overall Study||613
99354|NCT02008227|243114|P1|STARTED|Overall Study||612
99355|NCT02008149|243178|P3|NOT COMPLETED|Overall Study||0
99356|NCT02008149|243179|P2|NOT COMPLETED|Overall Study||1
99357|NCT02008149|243180|P1|NOT COMPLETED|Overall Study||3
99358|NCT02008149|243178|P3|COMPLETED|Overall Study||1
99359|NCT02008149|243179|P2|COMPLETED|Overall Study||0
99360|NCT02008149|243180|P1|COMPLETED|Overall Study||4
99361|NCT02008149|243178|P3|STARTED|Overall Study||1
99362|NCT02008149|243179|P2|STARTED|Overall Study||1
99363|NCT02008149|243180|P1|STARTED|Overall Study||7
99364|NCT02007954|243188|P1|NOT COMPLETED|Overall Study||7
99365|NCT02007954|243188|P1|COMPLETED|Overall Study||17
99366|NCT02007954|243188|P1|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to first imaging follow-up due to unrelated serious adverse event and death|23
99367|NCT02007954|243188|P1|Completed First TACE|Overall Study||24
99368|NCT02007954|243188|P1|STARTED|Overall Study|A total of 32 participants were consented, with 8 patients screened out prior to treatment.|24
99369|NCT02007863|243201|P1|NOT COMPLETED|Overall Study||0
99370|NCT02007863|243201|P1|COMPLETED|Overall Study||2
99371|NCT02007863|243201|P1|STARTED|Overall Study||2
99372|NCT02007720|243207|P2|NOT COMPLETED|Overall Study||72
99373|NCT02007720|243208|P1|NOT COMPLETED|Overall Study||82
99374|NCT02007720|243207|P2|COMPLETED|Overall Study||368
99375|NCT02007720|243208|P1|COMPLETED|Overall Study||354
99376|NCT02007720|243207|P2|Safety Set|Overall Study||432
99377|NCT02007720|243208|P1|Safety Set|Overall Study||426
99378|NCT02007720|243207|P2|Full Analysis Set|Overall Study||437
99379|NCT02007720|243208|P1|Full Analysis Set|Overall Study||433
99380|NCT02007720|243207|P2|STARTED|Overall Study||440
99381|NCT02007720|243208|P1|STARTED|Overall Study||436
99382|NCT02007577|243243|P2|NOT COMPLETED|Overall Study||1
99383|NCT02007577|243244|P1|NOT COMPLETED|Overall Study||1
99384|NCT02007577|243243|P2|COMPLETED|Overall Study||13
99385|NCT02007577|243244|P1|COMPLETED|Overall Study||26
99386|NCT02007577|243243|P2|STARTED|Overall Study||14
99387|NCT02007577|243244|P1|STARTED|Overall Study||27
99388|NCT02007512|243256|P4|NOT COMPLETED|Open Label Treatment Period||12
99389|NCT02007512|243257|P3|NOT COMPLETED|Open Label Treatment Period||0
99390|NCT02007512|243258|P2|NOT COMPLETED|Open Label Treatment Period||21
99391|NCT02007512|243259|P1|NOT COMPLETED|Open Label Treatment Period||0
99392|NCT02007512|243256|P4|COMPLETED|Open Label Treatment Period||0
99393|NCT02007512|243257|P3|COMPLETED|Open Label Treatment Period||0
99394|NCT02007512|243258|P2|COMPLETED|Open Label Treatment Period||0
99395|NCT02007512|243259|P1|COMPLETED|Open Label Treatment Period||0
99396|NCT02007512|243256|P4|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 12 entered open label period.|12
99397|NCT02007512|243257|P3|STARTED|Open Label Treatment Period||0
99398|NCT02007512|243258|P2|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 21 entered open label period.|21
99399|NCT02007512|243259|P1|STARTED|Open Label Treatment Period||0
99400|NCT02007512|243256|P4|NOT COMPLETED|Double Blind Treatment Period||60
99401|NCT02007512|243257|P3|NOT COMPLETED|Double Blind Treatment Period||60
99402|NCT02007512|243258|P2|NOT COMPLETED|Double Blind Treatment Period||64
99403|NCT02007512|243259|P1|NOT COMPLETED|Double Blind Treatment Period||63
99404|NCT02007512|243256|P4|COMPLETED|Double Blind Treatment Period||0
99405|NCT02007512|243257|P3|COMPLETED|Double Blind Treatment Period||0
99406|NCT02007512|243258|P2|COMPLETED|Double Blind Treatment Period||0
99407|NCT02007512|243259|P1|COMPLETED|Double Blind Treatment Period||0
99408|NCT02007512|243256|P4|Treated|Double Blind Treatment Period||60
99409|NCT02007512|243257|P3|Treated|Double Blind Treatment Period||60
99410|NCT02007512|243258|P2|Treated|Double Blind Treatment Period||63
99411|NCT02007512|243259|P1|Treated|Double Blind Treatment Period||62
99412|NCT02007512|243256|P4|STARTED|Double Blind Treatment Period||60
99413|NCT02007512|243257|P3|STARTED|Double Blind Treatment Period||60
99414|NCT02007512|243258|P2|STARTED|Double Blind Treatment Period||64
99415|NCT02007512|243259|P1|STARTED|Double Blind Treatment Period||63
99416|NCT02007434|243337|P8|NOT COMPLETED|Overall Study||0
99417|NCT02007434|243338|P7|NOT COMPLETED|Overall Study||0
99418|NCT02007434|243339|P6|NOT COMPLETED|Overall Study||0
99419|NCT02007434|243340|P5|NOT COMPLETED|Overall Study||0
99420|NCT02007434|243341|P4|NOT COMPLETED|Overall Study||0
99421|NCT02007434|243342|P3|NOT COMPLETED|Overall Study||1
99422|NCT02007434|243343|P2|NOT COMPLETED|Overall Study||1
99423|NCT02007434|243344|P1|NOT COMPLETED|Overall Study||1
99424|NCT02007434|243337|P8|COMPLETED|Overall Study||4
99425|NCT02007434|243338|P7|COMPLETED|Overall Study||18
99426|NCT02007434|243339|P6|COMPLETED|Overall Study||4
99427|NCT02007434|243340|P5|COMPLETED|Overall Study||16
99428|NCT02007434|243341|P4|COMPLETED|Overall Study||4
99429|NCT02007434|243342|P3|COMPLETED|Overall Study||16
99430|NCT02007434|243343|P2|COMPLETED|Overall Study||3
99431|NCT02007434|243344|P1|COMPLETED|Overall Study||16
99432|NCT02007434|243337|P8|Received Treatment|Overall Study||4
99433|NCT02007434|243338|P7|Received Treatment|Overall Study||18
99434|NCT02007434|243339|P6|Received Treatment|Overall Study||4
99435|NCT02007434|243340|P5|Received Treatment|Overall Study||16
99436|NCT02007434|243341|P4|Received Treatment|Overall Study||4
99437|NCT02007434|243342|P3|Received Treatment|Overall Study||17
99438|NCT02007434|243343|P2|Received Treatment|Overall Study||3
99439|NCT02007434|243344|P1|Received Treatment|Overall Study||17
99440|NCT02007434|243337|P8|STARTED|Overall Study||4
99441|NCT02007434|243338|P7|STARTED|Overall Study||18
99442|NCT02007434|243339|P6|STARTED|Overall Study||4
99443|NCT02007434|243340|P5|STARTED|Overall Study||16
99444|NCT02007434|243341|P4|STARTED|Overall Study||4
99445|NCT02007434|243342|P3|STARTED|Overall Study||17
99446|NCT02007434|243343|P2|STARTED|Overall Study||4
99447|NCT02007434|243344|P1|STARTED|Overall Study||17
99448|NCT02007369|243445|P3|NOT COMPLETED|Overall Study||0
99449|NCT02007369|243446|P2|NOT COMPLETED|Overall Study||0
99450|NCT02007369|243447|P1|NOT COMPLETED|Overall Study||0
99451|NCT02007369|243445|P3|COMPLETED|Overall Study||54
99452|NCT02007369|243446|P2|COMPLETED|Overall Study||40
99453|NCT02007369|243447|P1|COMPLETED|Overall Study||42
99454|NCT02007369|243445|P3|STARTED|Overall Study||54
99455|NCT02007369|243446|P2|STARTED|Overall Study||40
99456|NCT02007369|243447|P1|STARTED|Overall Study||42
99457|NCT02007291|243464|P2|NOT COMPLETED|Overall Study||0
99458|NCT02007291|243465|P1|NOT COMPLETED|Overall Study||0
99459|NCT02007291|243464|P2|COMPLETED|Overall Study||23
99460|NCT02007291|243465|P1|COMPLETED|Overall Study||48
99461|NCT02007291|243464|P2|STARTED|Overall Study||23
99462|NCT02007291|243465|P1|STARTED|Overall Study||48
99463|NCT02007278|243475|P2|NOT COMPLETED|Overall Study||3
99464|NCT02007278|243476|P1|NOT COMPLETED|Overall Study||2
99465|NCT02007278|243475|P2|COMPLETED|Overall Study||17
99466|NCT02007278|243476|P1|COMPLETED|Overall Study||18
99467|NCT02007278|243475|P2|STARTED|Overall Study||20
99468|NCT02007278|243476|P1|STARTED|Overall Study||20
99469|NCT02007252|243498|P2|NOT COMPLETED|Overall Study||11
99470|NCT02007252|243499|P1|NOT COMPLETED|Overall Study||11
99471|NCT02007252|243498|P2|COMPLETED|Overall Study||22
99472|NCT02007252|243499|P1|COMPLETED|Overall Study||20
99473|NCT02007252|243498|P2|Pharmacodynamic Analysis Set|Overall Study||33
99474|NCT02007252|243499|P1|Pharmacodynamic Analysis Set|Overall Study||31
99475|NCT02007252|243498|P2|Safety Analysis Set|Overall Study||33
99476|NCT02007252|243499|P1|Safety Analysis Set|Overall Study||31
99477|NCT02007252|243498|P2|STARTED|Overall Study||33
99478|NCT02007252|243499|P1|STARTED|Overall Study||31
99479|NCT02007200|243505|P1|NOT COMPLETED|Overall Study||0
99480|NCT02007200|243505|P1|COMPLETED|Overall Study||55
99481|NCT02007200|243505|P1|STARTED|Overall Study||55
99482|NCT02007096|243514|P2|NOT COMPLETED|Overall Study||16
99483|NCT02007096|243515|P1|NOT COMPLETED|Overall Study||11
99484|NCT02007096|243514|P2|COMPLETED|Overall Study||48
99485|NCT02007096|243515|P1|COMPLETED|Overall Study||52
99486|NCT02007096|243514|P2|STARTED|Overall Study||64
99487|NCT02007096|243515|P1|STARTED|Overall Study||63
99488|NCT02007070|243527|P1|NOT COMPLETED|Overall Study||33
99489|NCT02007070|243527|P1|COMPLETED|Overall Study|Completed 2 years of treatment.|5
99490|NCT02007070|243527|P1|STARTED|Overall Study||38
99491|NCT02006979|243548|P2|NOT COMPLETED|Overall Study||2
99492|NCT02006979|243549|P1|NOT COMPLETED|Overall Study||1
99493|NCT02006979|243548|P2|COMPLETED|Overall Study||11
99494|NCT02006979|243549|P1|COMPLETED|Overall Study||13
99495|NCT02006979|243548|P2|STARTED|Overall Study||13
99496|NCT02006979|243549|P1|STARTED|Overall Study||14
99497|NCT02006888|243564|P3|NOT COMPLETED|Overall Study||22
99498|NCT02006888|243565|P2|NOT COMPLETED|Overall Study||34
99499|NCT02006888|243566|P1|NOT COMPLETED|Overall Study||36
99500|NCT02006888|243564|P3|COMPLETED|Overall Study||58
99501|NCT02006888|243565|P2|COMPLETED|Overall Study||122
99502|NCT02006888|243566|P1|COMPLETED|Overall Study||122
99503|NCT02006888|243564|P3|STARTED|Overall Study||80
99504|NCT02006888|243565|P2|STARTED|Overall Study||156
99505|NCT02006888|243566|P1|STARTED|Overall Study||158
99506|NCT02006836|243577|P3|NOT COMPLETED|Self-control Period: Month 7-month 12||0
99507|NCT02006836|243578|P2|NOT COMPLETED|Self-control Period: Month 7-month 12||0
99508|NCT02006836|243579|P1|NOT COMPLETED|Self-control Period: Month 7-month 12||0
99509|NCT02006836|243577|P3|COMPLETED|Self-control Period: Month 7-month 12||19
99510|NCT02006836|243578|P2|COMPLETED|Self-control Period: Month 7-month 12||0
99511|NCT02006836|243579|P1|COMPLETED|Self-control Period: Month 7-month 12||0
99512|NCT02006836|243577|P3|STARTED|Self-control Period: Month 7-month 12||19
99513|NCT02006836|243578|P2|STARTED|Self-control Period: Month 7-month 12||0
99514|NCT02006836|243579|P1|STARTED|Self-control Period: Month 7-month 12||0
99515|NCT02006836|243577|P3|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
99516|NCT02006836|243578|P2|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
99517|NCT02006836|243579|P1|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
99518|NCT02006836|243577|P3|COMPLETED|Case-control Period: Month 1- Month 6||0
99519|NCT02006836|243578|P2|COMPLETED|Case-control Period: Month 1- Month 6||20
99520|NCT02006836|243579|P1|COMPLETED|Case-control Period: Month 1- Month 6||20
99521|NCT02006836|243577|P3|STARTED|Case-control Period: Month 1- Month 6||0
99522|NCT02006836|243578|P2|STARTED|Case-control Period: Month 1- Month 6||20
99523|NCT02006836|243579|P1|STARTED|Case-control Period: Month 1- Month 6||20
99524|NCT02006758|243595|P1|NOT COMPLETED|Overall Study||13
99525|NCT02006758|243595|P1|COMPLETED|Overall Study||55
99526|NCT02006758|243595|P1|12-month Follow up|Overall Study|12-month follow up completed|55
99527|NCT02006758|243595|P1|6-month Follow up|Overall Study|6-month follow up completed|60
99528|NCT02006758|243595|P1|1-month Follow up|Overall Study|1-month follow up completed|66
99529|NCT02006758|243595|P1|Underwent Renal Denervation|Overall Study|Underwent renal denervation|67
99530|NCT02006758|243595|P1|STARTED|Overall Study|Total number of enrolled participants|68
99531|NCT02006732|243626|P4|NOT COMPLETED|Overall Study||4
99532|NCT02006732|243627|P3|NOT COMPLETED|Overall Study||9
99533|NCT02006732|243628|P2|NOT COMPLETED|Overall Study||12
99534|NCT02006732|243629|P1|NOT COMPLETED|Overall Study||20
99535|NCT02006732|243626|P4|COMPLETED|Overall Study||198
99536|NCT02006732|243627|P3|COMPLETED|Overall Study||193
99537|NCT02006732|243628|P2|COMPLETED|Overall Study||191
99538|NCT02006732|243629|P1|COMPLETED|Overall Study||182
99539|NCT02006732|243626|P4|STARTED|Overall Study||202
99540|NCT02006732|243627|P3|STARTED|Overall Study||202
99541|NCT02006732|243628|P2|STARTED|Overall Study||203
99542|NCT02006732|243629|P1|STARTED|Overall Study||202
99543|NCT02006719|243669|P2|NOT COMPLETED|Overall Study||5
99544|NCT02006719|243670|P1|NOT COMPLETED|Overall Study||18
99545|NCT02006719|243669|P2|COMPLETED|Overall Study||80
99546|NCT02006719|243670|P1|COMPLETED|Overall Study||219
99547|NCT02006719|243669|P2|STARTED|Overall Study||85
99548|NCT02006719|243670|P1|STARTED|Overall Study||237
99549|NCT02006706|243700|P1|NOT COMPLETED|Overall Study||1
99550|NCT02006706|243700|P1|COMPLETED|Overall Study||14
99551|NCT02006706|243700|P1|STARTED|Overall Study||15
99552|NCT02006693|243707|P2|NOT COMPLETED|Overall Study||13
99553|NCT02006693|243708|P1|NOT COMPLETED|Overall Study||28
99554|NCT02006693|243707|P2|COMPLETED|Overall Study||74
99555|NCT02006693|243708|P1|COMPLETED|Overall Study||84
99556|NCT02006693|243707|P2|STARTED|Overall Study||87
99557|NCT02006693|243708|P1|STARTED|Overall Study||112
99558|NCT02006667|243720|P1|NOT COMPLETED|Overall Study||6
99559|NCT02006667|243720|P1|COMPLETED|Overall Study||7
99560|NCT02006667|243720|P1|STARTED|Overall Study||13
99561|NCT02006654|243732|P2|NOT COMPLETED|Overall Study||44
99562|NCT02006654|243733|P1|NOT COMPLETED|Overall Study||45
99563|NCT02006654|243732|P2|COMPLETED|Overall Study||321
99564|NCT02006654|243733|P1|COMPLETED|Overall Study||324
99565|NCT02006654|243732|P2|Treated|Overall Study||363
99566|NCT02006654|243733|P1|Treated|Overall Study||365
99567|NCT02006654|243732|P2|STARTED|Overall Study||365
99568|NCT02006654|243733|P1|STARTED|Overall Study||369
99569|NCT02006641|243762|P3|NOT COMPLETED|Overall Study||36
99570|NCT02006641|243763|P2|NOT COMPLETED|Overall Study||33
99571|NCT02006641|243764|P1|NOT COMPLETED|Overall Study||26
99572|NCT02006641|243762|P3|COMPLETED|Overall Study||248
99573|NCT02006641|243763|P2|COMPLETED|Overall Study||257
99574|NCT02006641|243764|P1|COMPLETED|Overall Study||258
99575|NCT02006641|243762|P3|Treated|Overall Study||281
99576|NCT02006641|243763|P2|Treated|Overall Study||285
99577|NCT02006641|243764|P1|Treated|Overall Study||282
99578|NCT02006641|243762|P3|STARTED|Overall Study||284
99579|NCT02006641|243763|P2|STARTED|Overall Study||290
99580|NCT02006641|243764|P1|STARTED|Overall Study||284
99581|NCT02006628|243804|P2|NOT COMPLETED|Overall Study||2
99582|NCT02006628|243805|P1|NOT COMPLETED|Overall Study||3
99583|NCT02006628|243804|P2|COMPLETED|Overall Study||43
99584|NCT02006628|243805|P1|COMPLETED|Overall Study||40
99585|NCT02006628|243804|P2|Intention to Treat (ITT) Analysis Set|Overall Study||44
99586|NCT02006628|243805|P1|Intention to Treat (ITT) Analysis Set|Overall Study||42
99587|NCT02006628|243804|P2|Received at Least 1 Dose of Study Drug|Overall Study||45
99588|NCT02006628|243805|P1|Received at Least 1 Dose of Study Drug|Overall Study||43
99589|NCT02006628|243804|P2|STARTED|Overall Study||45
99590|NCT02006628|243805|P1|STARTED|Overall Study||43
99591|NCT02006420|243829|P2|NOT COMPLETED|Overall Study||0
99592|NCT02006420|243830|P1|NOT COMPLETED|Overall Study||0
99593|NCT02006420|243829|P2|COMPLETED|Overall Study||21
99594|NCT02006420|243830|P1|COMPLETED|Overall Study||24
99595|NCT02006420|243829|P2|STARTED|Overall Study||21
99596|NCT02006420|243830|P1|STARTED|Overall Study||24
99597|NCT02006407|243844|P1|NOT COMPLETED|Overall Study||0
99598|NCT02006407|243844|P1|COMPLETED|Overall Study||5
99599|NCT02006407|243844|P1|STARTED|Overall Study||5
99600|NCT02006342|243852|P2|NOT COMPLETED|Overall Study||0
99601|NCT02006342|243853|P1|NOT COMPLETED|Overall Study||1
99602|NCT02006342|243852|P2|COMPLETED|Overall Study||20
99603|NCT02006342|243853|P1|COMPLETED|Overall Study||19
99604|NCT02006342|243852|P2|STARTED|Overall Study||20
99605|NCT02006342|243853|P1|STARTED|Overall Study||20
99606|NCT02006264|243869|P2|NOT COMPLETED|Overall Study||0
99607|NCT02006264|243870|P1|NOT COMPLETED|Overall Study||1
99608|NCT02006264|243869|P2|COMPLETED|Overall Study||15
99609|NCT02006264|243870|P1|COMPLETED|Overall Study||14
99610|NCT02006264|243869|P2|STARTED|Overall Study||15
99611|NCT02006264|243870|P1|STARTED|Overall Study||15
99612|NCT02006160|243890|P2|NOT COMPLETED|Overall Study||0
99613|NCT02006160|243891|P1|NOT COMPLETED|Overall Study||4
99614|NCT02006160|243890|P2|COMPLETED|Overall Study||16
99615|NCT02006160|243891|P1|COMPLETED|Overall Study||41
99616|NCT02006160|243890|P2|STARTED|Overall Study||16
99617|NCT02006160|243891|P1|STARTED|Overall Study||45
99618|NCT02006121|243899|P2|NOT COMPLETED|Open Label Phase||0
99619|NCT02006121|243900|P1|NOT COMPLETED|Open Label Phase||25
99620|NCT02006121|243899|P2|COMPLETED|Open Label Phase||0
99621|NCT02006121|243900|P1|COMPLETED|Open Label Phase|30 who continued on apomorphine from blinded phase, 29 who switched to apomorphine from placebo|59
99622|NCT02006121|243899|P2|STARTED|Open Label Phase|No patients received placebo in the open label phase|0
99623|NCT02006121|243900|P1|STARTED|Open Label Phase|From Apo: 38 completers and 2 early switched; From Placebo: 28 completers and 16 early switched|84
99624|NCT02006121|243899|P2|NOT COMPLETED|Double Blind Phase||24
99625|NCT02006121|243900|P1|NOT COMPLETED|Double Blind Phase||12
99626|NCT02006121|243899|P2|COMPLETED|Double Blind Phase|16 placebo-treated patients early switched to open label phase due to lack of efficacy|29
99627|NCT02006121|243900|P1|COMPLETED|Double Blind Phase|Early switching to open label: 1 for lack of efficacy, 1 could not tolerate 3 mg/hour minimum rate|42
99628|NCT02006121|243899|P2|STARTED|Double Blind Phase||53
99629|NCT02006121|243900|P1|STARTED|Double Blind Phase||54
99630|NCT02006108|243914|P1|NOT COMPLETED|Overall Study||2
99631|NCT02006108|243914|P1|COMPLETED|Overall Study||19
99632|NCT02006108|243914|P1|MR Imaging|Overall Study||19
99633|NCT02006108|243914|P1|STARTED|Overall Study||21
99634|NCT02006056|243921|P2|NOT COMPLETED|Overall Study||0
99635|NCT02006056|243922|P1|NOT COMPLETED|Overall Study||0
99636|NCT02006056|243921|P2|COMPLETED|Overall Study||4
99637|NCT02006056|243922|P1|COMPLETED|Overall Study||26
99638|NCT02006056|243921|P2|STARTED|Overall Study||4
99639|NCT02006056|243922|P1|STARTED|Overall Study||26
99640|NCT02005887|243933|P2|NOT COMPLETED|Overall Study||2
99641|NCT02005887|243934|P1|NOT COMPLETED|Overall Study||0
99642|NCT02005887|243933|P2|COMPLETED|Overall Study||23
99643|NCT02005887|243934|P1|COMPLETED|Overall Study||26
99644|NCT02005887|243933|P2|STARTED|Overall Study||25
99645|NCT02005887|243934|P1|STARTED|Overall Study||26
99646|NCT02005692|243952|P1|NOT COMPLETED|Overall Study||7
99647|NCT02005692|243952|P1|COMPLETED|Overall Study||63
99648|NCT02005692|243952|P1|STARTED|Overall Study||70
99649|NCT02005601|243959|P2|NOT COMPLETED|Overall Study||0
99650|NCT02005601|243960|P1|NOT COMPLETED|Overall Study||0
99651|NCT02005601|243959|P2|COMPLETED|Overall Study||53
99652|NCT02005601|243960|P1|COMPLETED|Overall Study||53
99653|NCT02005601|243959|P2|STARTED|Overall Study||53
99654|NCT02005601|243960|P1|STARTED|Overall Study||53
99655|NCT02005562|243972|P2|NOT COMPLETED|Overall Study||15
99656|NCT02005562|243973|P1|NOT COMPLETED|Overall Study||12
99657|NCT02005562|243972|P2|COMPLETED|Overall Study||110
99658|NCT02005562|243973|P1|COMPLETED|Overall Study||115
99659|NCT02005562|243972|P2|Transplanted|Overall Study||121
99660|NCT02005562|243973|P1|Transplanted|Overall Study||126
99661|NCT02005562|243972|P2|STARTED|Overall Study||125
99662|NCT02005562|243973|P1|STARTED|Overall Study||127
99663|NCT02005549|244001|P1|NOT COMPLETED|Overall Study||0
99664|NCT02005549|244001|P1|COMPLETED|Overall Study||18
99665|NCT02005549|244001|P1|STARTED|Overall Study||18
99666|NCT02005536|244007|P1|NOT COMPLETED|Overall Study||0
99667|NCT02005536|244007|P1|COMPLETED|Overall Study||60
99668|NCT02005536|244007|P1|STARTED|Overall Study||60
99669|NCT02005484|244015|P1|NOT COMPLETED|Overall Study||4
99670|NCT02005484|244015|P1|COMPLETED|Overall Study||2
99671|NCT02005484|244015|P1|STARTED|Overall Study||6
99672|NCT02005471|244027|P2|NOT COMPLETED|Overall Study||194
99673|NCT02005471|244028|P1|NOT COMPLETED|Overall Study||195
99674|NCT02005471|244027|P2|COMPLETED|Overall Study||0
99675|NCT02005471|244028|P1|COMPLETED|Overall Study||0
99676|NCT02005471|244027|P2|Treated|Overall Study||194
99677|NCT02005471|244028|P1|Treated|Overall Study||188
99678|NCT02005471|244027|P2|STARTED|Overall Study||194
99679|NCT02005471|244028|P1|STARTED|Overall Study||195
99680|NCT02005445|244083|P2|NOT COMPLETED|Overall Study||1
99681|NCT02005445|244084|P1|NOT COMPLETED|Overall Study||0
99682|NCT02005445|244083|P2|COMPLETED|Overall Study||1
99683|NCT02005445|244084|P1|COMPLETED|Overall Study||2
99684|NCT02005445|244083|P2|STARTED|Overall Study||2
99685|NCT02005445|244084|P1|STARTED|Overall Study||2
99686|NCT02005393|244090|P1|NOT COMPLETED|Overall Study||0
99687|NCT02005393|244090|P1|COMPLETED|Overall Study||20
99688|NCT02005393|244090|P1|STARTED|Overall Study||20
99689|NCT02005354|244096|P2|NOT COMPLETED|Overall Study||0
99690|NCT02005354|244097|P1|NOT COMPLETED|Overall Study||0
99691|NCT02005354|244096|P2|COMPLETED|Overall Study||35
99692|NCT02005354|244097|P1|COMPLETED|Overall Study||35
99693|NCT02005354|244096|P2|STARTED|Overall Study||35
99694|NCT02005354|244097|P1|STARTED|Overall Study||35
99695|NCT02005276|244107|P4|NOT COMPLETED|Overall Study||3
99696|NCT02005276|244108|P3|NOT COMPLETED|Overall Study||3
99697|NCT02005276|244109|P2|NOT COMPLETED|Overall Study||2
99698|NCT02005276|244110|P1|NOT COMPLETED|Overall Study||5
99699|NCT02005276|244107|P4|COMPLETED|Overall Study||41
99700|NCT02005276|244108|P3|COMPLETED|Overall Study||56
99701|NCT02005276|244109|P2|COMPLETED|Overall Study||39
99702|NCT02005276|244110|P1|COMPLETED|Overall Study||60
99703|NCT02005276|244107|P4|Completed Intervention|Overall Study||42
99704|NCT02005276|244108|P3|Completed Intervention|Overall Study||56
99705|NCT02005276|244109|P2|Completed Intervention|Overall Study||39
99706|NCT02005276|244110|P1|Completed Intervention|Overall Study||61
99707|NCT02005276|244107|P4|STARTED|Overall Study||44
99708|NCT02005276|244108|P3|STARTED|Overall Study||59
99709|NCT02005276|244109|P2|STARTED|Overall Study||41
99710|NCT02005276|244110|P1|STARTED|Overall Study||65
99711|NCT02005211|244131|P7|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
99712|NCT02005211|244132|P6|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
99713|NCT02005211|244133|P5|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||1
99714|NCT02005211|244134|P4|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
99715|NCT02005211|244135|P3|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
99716|NCT02005211|244136|P2|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
99717|NCT02005211|244137|P1|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
99718|NCT02005211|244131|P7|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
99719|NCT02005211|244132|P6|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
99720|NCT02005211|244133|P5|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||5
99721|NCT02005211|244134|P4|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
99722|NCT02005211|244135|P3|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
99723|NCT02005211|244136|P2|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
99724|NCT02005211|244137|P1|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
99725|NCT02005211|244131|P7|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
99726|NCT02005211|244132|P6|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
99727|NCT02005211|244133|P5|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
99728|NCT02005211|244134|P4|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
99729|NCT02005211|244135|P3|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
99730|NCT02005211|244136|P2|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
99731|NCT02005211|244137|P1|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
99732|NCT02005211|244131|P7|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
99733|NCT02005211|244132|P6|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
99734|NCT02005211|244133|P5|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
99735|NCT02005211|244134|P4|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
99736|NCT02005211|244135|P3|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
99737|NCT02005211|244136|P2|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
99738|NCT02005211|244137|P1|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
99739|NCT02005211|244131|P7|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
99740|NCT02005211|244132|P6|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
99741|NCT02005211|244133|P5|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
99742|NCT02005211|244134|P4|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
99743|NCT02005211|244135|P3|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
99744|NCT02005211|244136|P2|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
99745|NCT02005211|244137|P1|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
99746|NCT02005211|244131|P7|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
99747|NCT02005211|244132|P6|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
99748|NCT02005211|244133|P5|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
99749|NCT02005211|244134|P4|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
99750|NCT02005211|244135|P3|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
99751|NCT02005211|244136|P2|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
99752|NCT02005211|244137|P1|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
99753|NCT02005029|244172|P2|NOT COMPLETED|Second Intervention (1 Day)||0
99754|NCT02005029|244173|P1|NOT COMPLETED|Second Intervention (1 Day)||0
99755|NCT02005029|244172|P2|COMPLETED|Second Intervention (1 Day)||5
99756|NCT02005029|244173|P1|COMPLETED|Second Intervention (1 Day)||4
99757|NCT02005029|244172|P2|STARTED|Second Intervention (1 Day)||5
99758|NCT02005029|244173|P1|STARTED|Second Intervention (1 Day)||4
99759|NCT02005029|244172|P2|NOT COMPLETED|Washout (2 Weeks)||0
99760|NCT02005029|244173|P1|NOT COMPLETED|Washout (2 Weeks)||0
99761|NCT02005029|244172|P2|COMPLETED|Washout (2 Weeks)||5
99762|NCT02005029|244173|P1|COMPLETED|Washout (2 Weeks)||4
99763|NCT02005029|244172|P2|STARTED|Washout (2 Weeks)||5
99764|NCT02005029|244173|P1|STARTED|Washout (2 Weeks)||4
99765|NCT02005029|244172|P2|NOT COMPLETED|First Intervention (1 Day)||0
99766|NCT02005029|244173|P1|NOT COMPLETED|First Intervention (1 Day)||1
99767|NCT02005029|244172|P2|COMPLETED|First Intervention (1 Day)||5
99768|NCT02005029|244173|P1|COMPLETED|First Intervention (1 Day)||4
99769|NCT02005029|244172|P2|STARTED|First Intervention (1 Day)||5
99770|NCT02005029|244173|P1|STARTED|First Intervention (1 Day)||5
99771|NCT02005016|244199|P1|NOT COMPLETED|Overall Study||2
99772|NCT02005016|244199|P1|COMPLETED|Overall Study||44
99773|NCT02005016|244199|P1|STARTED|Overall Study||46
99774|NCT02004990|244204|P1|NOT COMPLETED|Overall Study||0
99775|NCT02004990|244204|P1|COMPLETED|Overall Study||12
99776|NCT02004990|244204|P1|STARTED|Overall Study||12
99777|NCT02004977|244211|P2|NOT COMPLETED|Overall Study||5
99778|NCT02004977|244212|P1|NOT COMPLETED|Overall Study||54
99779|NCT02004977|244211|P2|COMPLETED|Overall Study||436
99780|NCT02004977|244212|P1|COMPLETED|Overall Study||409
99781|NCT02004977|244211|P2|STARTED|Overall Study||441
99782|NCT02004977|244212|P1|STARTED|Overall Study||463
99783|NCT02004886|244230|P4|NOT COMPLETED|Overall Study||0
99784|NCT02004886|244231|P3|NOT COMPLETED|Overall Study||0
99785|NCT02004886|244232|P2|NOT COMPLETED|Overall Study||1
99786|NCT02004886|244233|P1|NOT COMPLETED|Overall Study||1
99787|NCT02004886|244230|P4|COMPLETED|Overall Study||19
99788|NCT02004886|244231|P3|COMPLETED|Overall Study||18
99789|NCT02004886|244232|P2|COMPLETED|Overall Study||17
99790|NCT02004886|244233|P1|COMPLETED|Overall Study||18
99791|NCT02004886|244230|P4|STARTED|Overall Study||19
99792|NCT02004886|244231|P3|STARTED|Overall Study||18
99793|NCT02004886|244232|P2|STARTED|Overall Study||18
99794|NCT02004886|244233|P1|STARTED|Overall Study||19
99795|NCT02004873|244283|P1|NOT COMPLETED|Overall Study||424
99796|NCT02004873|244283|P1|COMPLETED|Overall Study|6-Month Follow-up|301
99797|NCT02004873|244283|P1|Micra Implant Success|Overall Study||719
99798|NCT02004873|244283|P1|STARTED|Overall Study|Micra Implant Attempt|725
99799|NCT02004847|244292|P2|NOT COMPLETED|Overall Study||1
99800|NCT02004847|244293|P1|NOT COMPLETED|Overall Study||1
99801|NCT02004847|244292|P2|COMPLETED|Overall Study||22
99802|NCT02004847|244293|P1|COMPLETED|Overall Study||23
99803|NCT02004847|244292|P2|STARTED|Overall Study||23
99804|NCT02004847|244293|P1|STARTED|Overall Study||24
99805|NCT02004522|244339|P2|NOT COMPLETED|Overall Study||159
99806|NCT02004522|244340|P1|NOT COMPLETED|Overall Study||126
99807|NCT02004522|244339|P2|COMPLETED|Overall Study|Completed defined here as still on treatment.|0
99808|NCT02004522|244340|P1|COMPLETED|Overall Study|Completed defined here as still on treatment.|34
99809|NCT02004522|244339|P2|Number of Subjects Treated|Overall Study||155
99810|NCT02004522|244340|P1|Number of Subjects Treated|Overall Study||158
99811|NCT02004522|244339|P2|STARTED|Overall Study||159
99812|NCT02004522|244340|P1|STARTED|Overall Study||160
99813|NCT02004366|244364|P5|NOT COMPLETED|On Discharge||0
99814|NCT02004366|244365|P4|NOT COMPLETED|On Discharge||0
99815|NCT02004366|244366|P3|NOT COMPLETED|On Discharge||0
99816|NCT02004366|244367|P2|NOT COMPLETED|On Discharge||0
99817|NCT02004366|244368|P1|NOT COMPLETED|On Discharge||0
99818|NCT02004366|244364|P5|COMPLETED|On Discharge||39
99819|NCT02004366|244365|P4|COMPLETED|On Discharge||93
99820|NCT02004366|244366|P3|COMPLETED|On Discharge||92
99821|NCT02004366|244367|P2|COMPLETED|On Discharge||0
99822|NCT02004366|244368|P1|COMPLETED|On Discharge||0
99823|NCT02004366|244364|P5|STARTED|On Discharge||39
99824|NCT02004366|244365|P4|STARTED|On Discharge||93
99825|NCT02004366|244366|P3|STARTED|On Discharge||92
99826|NCT02004366|244367|P2|STARTED|On Discharge||0
99827|NCT02004366|244368|P1|STARTED|On Discharge||0
99828|NCT02004366|244364|P5|NOT COMPLETED|In-hospital||0
99829|NCT02004366|244365|P4|NOT COMPLETED|In-hospital||0
99830|NCT02004366|244366|P3|NOT COMPLETED|In-hospital||0
99831|NCT02004366|244367|P2|NOT COMPLETED|In-hospital||0
99832|NCT02004366|244368|P1|NOT COMPLETED|In-hospital||0
99833|NCT02004366|244364|P5|COMPLETED|In-hospital||0
99834|NCT02004366|244365|P4|COMPLETED|In-hospital||0
99835|NCT02004366|244366|P3|COMPLETED|In-hospital||0
99836|NCT02004366|244367|P2|COMPLETED|In-hospital||122
99837|NCT02004366|244368|P1|COMPLETED|In-hospital||128
99838|NCT02004366|244364|P5|STARTED|In-hospital||0
99839|NCT02004366|244365|P4|STARTED|In-hospital||0
99840|NCT02004366|244366|P3|STARTED|In-hospital||0
99841|NCT02004366|244367|P2|STARTED|In-hospital||122
99842|NCT02004366|244368|P1|STARTED|In-hospital||128
99843|NCT02004262|244461|P6|NOT COMPLETED|Overall Study||30
99844|NCT02004262|244462|P5|NOT COMPLETED|Overall Study||31
99845|NCT02004262|244463|P4|NOT COMPLETED|Overall Study||29
99846|NCT02004262|244464|P3|NOT COMPLETED|Overall Study||72
99847|NCT02004262|244465|P2|NOT COMPLETED|Overall Study||68
99848|NCT02004262|244466|P1|NOT COMPLETED|Overall Study||73
99849|NCT02004262|244461|P6|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
99850|NCT02004262|244462|P5|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
99851|NCT02004262|244463|P4|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
99852|NCT02004262|244464|P3|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
99853|NCT02004262|244465|P2|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
99854|NCT02004262|244466|P1|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
99855|NCT02004262|244461|P6|Treated|Overall Study||11
99856|NCT02004262|244462|P5|Treated|Overall Study||29
99857|NCT02004262|244463|P4|Treated|Overall Study||26
99858|NCT02004262|244464|P3|Treated|Overall Study||43
99859|NCT02004262|244465|P2|Treated|Overall Study||58
99860|NCT02004262|244466|P1|Treated|Overall Study||68
99861|NCT02004262|244461|P6|STARTED|Overall Study||30
99862|NCT02004262|244462|P5|STARTED|Overall Study||31
99863|NCT02004262|244463|P4|STARTED|Overall Study||29
99864|NCT02004262|244464|P3|STARTED|Overall Study||72
99865|NCT02004262|244465|P2|STARTED|Overall Study||68
99866|NCT02004262|244466|P1|STARTED|Overall Study||73
99867|NCT02004236|244486|P3|NOT COMPLETED|Overall Study||16
99868|NCT02004236|244487|P2|NOT COMPLETED|Overall Study||0
99869|NCT02004236|244488|P1|NOT COMPLETED|Overall Study||0
99870|NCT02004236|244486|P3|COMPLETED|Overall Study|Leave the group because the parents does't find any clinical improvement.|59
99871|NCT02004236|244487|P2|COMPLETED|Overall Study||75
99872|NCT02004236|244488|P1|COMPLETED|Overall Study||75
99873|NCT02004236|244486|P3|STARTED|Overall Study||75
99874|NCT02004236|244487|P2|STARTED|Overall Study||75
99875|NCT02004236|244488|P1|STARTED|Overall Study||75
99876|NCT02004158|244532|P1|NOT COMPLETED|Overall Study||3
99877|NCT02004158|244532|P1|COMPLETED|Overall Study||20
99878|NCT02004158|244532|P1|STARTED|Overall Study||23
99879|NCT02004132|244540|P1|NOT COMPLETED|Overall Study||0
99880|NCT02004132|244540|P1|COMPLETED|Overall Study||12
99881|NCT02004132|244540|P1|Received Study Drug|Overall Study||12
99882|NCT02004132|244540|P1|STARTED|Overall Study||12
99883|NCT02004093|244548|P2|NOT COMPLETED|Overall Study||73
99884|NCT02004093|244549|P1|NOT COMPLETED|Overall Study||74
99885|NCT02004093|244548|P2|COMPLETED|Overall Study||1
99886|NCT02004093|244549|P1|COMPLETED|Overall Study||1
99887|NCT02004093|244548|P2|STARTED|Overall Study||74
99888|NCT02004093|244549|P1|STARTED|Overall Study|Includes 1 participant who was randomized to chemotherapy group but received pertuzumab+chemotherapy|75
99889|NCT02003963|244581|P2|NOT COMPLETED|Overall Study||1
99890|NCT02003963|244582|P1|NOT COMPLETED|Overall Study||2
99891|NCT02003963|244581|P2|COMPLETED|Overall Study|1 participant was removed from analysis for completing final visit outside of visit window.|18
99892|NCT02003963|244582|P1|COMPLETED|Overall Study|2 participants dropped out: 1 due to lack of interest and 1 due to a mental health hospitalization.|20
99893|NCT02003963|244581|P2|STARTED|Overall Study||19
99894|NCT02003963|244582|P1|STARTED|Overall Study||22
99895|NCT02003924|244604|P2|NOT COMPLETED|Overall Study||468
99896|NCT02003924|244605|P1|NOT COMPLETED|Overall Study||933
99897|NCT02003924|244604|P2|COMPLETED|Overall Study||0
99898|NCT02003924|244605|P1|COMPLETED|Overall Study||0
99899|NCT02003924|244604|P2|Treated|Overall Study||465
99900|NCT02003924|244605|P1|Treated|Overall Study||930
99901|NCT02003924|244604|P2|STARTED|Overall Study||468
99902|NCT02003924|244605|P1|STARTED|Overall Study||933
99903|NCT02003898|244703|P1|NOT COMPLETED|Overall Study||67
99904|NCT02003898|244703|P1|COMPLETED|Overall Study||305
99905|NCT02003898|244703|P1|STARTED|Overall Study||372
99906|NCT02003638|244712|P2|NOT COMPLETED|Overall Study||0
99907|NCT02003638|244713|P1|NOT COMPLETED|Overall Study||1
99908|NCT02003638|244712|P2|COMPLETED|Overall Study||3
99909|NCT02003638|244713|P1|COMPLETED|Overall Study|1 withdrew after developing bacterial pharyngitis. Not considered treatment-emergent.|5
99910|NCT02003638|244712|P2|STARTED|Overall Study||3
99911|NCT02003638|244713|P1|STARTED|Overall Study||6
99912|NCT02003573|244722|P3|NOT COMPLETED|Overall Study||6
99913|NCT02003573|244723|P2|NOT COMPLETED|Overall Study||4
99914|NCT02003573|244724|P1|NOT COMPLETED|Overall Study||3
99915|NCT02003573|244722|P3|COMPLETED|Overall Study||0
99916|NCT02003573|244723|P2|COMPLETED|Overall Study||0
99917|NCT02003573|244724|P1|COMPLETED|Overall Study||0
99918|NCT02003573|244722|P3|STARTED|Overall Study|Started are treated patients|6
99919|NCT02003573|244723|P2|STARTED|Overall Study|Started are treated patients|4
99920|NCT02003573|244724|P1|STARTED|Overall Study|Started are treated patients|3
99921|NCT02003534|244734|P1|NOT COMPLETED|Overall Study||47
99922|NCT02003534|244734|P1|COMPLETED|Overall Study||329
99923|NCT02003534|244734|P1|STARTED|Overall Study||376
99924|NCT02003404|244738|P1|NOT COMPLETED|Overall Study||0
99925|NCT02003404|244738|P1|COMPLETED|Overall Study||17
99926|NCT02003404|244738|P1|STARTED|Overall Study||17
99927|NCT02003391|244746|P2|NOT COMPLETED|Overall Study||2
99928|NCT02003391|244747|P1|NOT COMPLETED|Overall Study||3
99929|NCT02003391|244746|P2|COMPLETED|Overall Study||73
99930|NCT02003391|244747|P1|COMPLETED|Overall Study||78
99931|NCT02003391|244746|P2|Intent to Treat Population|Overall Study||73
99932|NCT02003391|244747|P1|Intent to Treat Population|Overall Study||78
99933|NCT02003391|244746|P2|Safety Population|Overall Study||75
99934|NCT02003391|244747|P1|Safety Population|Overall Study||81
99935|NCT02003391|244746|P2|STARTED|Overall Study||75
99936|NCT02003391|244747|P1|STARTED|Overall Study||81
99937|NCT02003365|244760|P3|NOT COMPLETED|Overall Study||1
99938|NCT02003365|244761|P2|NOT COMPLETED|Overall Study||0
99939|NCT02003365|244762|P1|NOT COMPLETED|Overall Study||0
99940|NCT02003365|244760|P3|COMPLETED|Overall Study||9
99941|NCT02003365|244761|P2|COMPLETED|Overall Study||30
99942|NCT02003365|244762|P1|COMPLETED|Overall Study||10
99943|NCT02003365|244760|P3|STARTED|Overall Study||10
99944|NCT02003365|244761|P2|STARTED|Overall Study||30
99945|NCT02003365|244762|P1|STARTED|Overall Study||10
99946|NCT02003352|244773|P1|NOT COMPLETED|Overall Study||0
99947|NCT02003352|244773|P1|COMPLETED|Overall Study||98
99948|NCT02003352|244773|P1|STARTED|Overall Study||98
99949|NCT02003183|244779|P2|NOT COMPLETED|Overall Study||2
99950|NCT02003183|244780|P1|NOT COMPLETED|Overall Study||0
99951|NCT02003183|244779|P2|COMPLETED|Overall Study||15
99952|NCT02003183|244780|P1|COMPLETED|Overall Study||7
99953|NCT02003183|244779|P2|STARTED|Overall Study||17
99954|NCT02003183|244780|P1|STARTED|Overall Study||7
99955|NCT02003053|244788|P2|NOT COMPLETED|Overall Study||0
99956|NCT02003053|244789|P1|NOT COMPLETED|Overall Study||0
99957|NCT02003053|244788|P2|COMPLETED|Overall Study||3
99958|NCT02003053|244789|P1|COMPLETED|Overall Study||4
99959|NCT02003053|244788|P2|STARTED|Overall Study||3
99960|NCT02003053|244789|P1|STARTED|Overall Study||4
99961|NCT02003014|244795|P1|NOT COMPLETED|Overall Study||19
99962|NCT02003014|244795|P1|COMPLETED|Overall Study||880
99963|NCT02003014|244795|P1|STARTED|Overall Study||899
99964|NCT02002975|244805|P1|NOT COMPLETED|Overall Study||572
99965|NCT02002975|244805|P1|COMPLETED|Overall Study||17651
99966|NCT02002975|244805|P1|STARTED|Overall Study||18223
99967|NCT02002936|244821|P1|NOT COMPLETED|Overall Study||0
99968|NCT02002936|244821|P1|COMPLETED|Overall Study||1
99969|NCT02002936|244821|P1|STARTED|Overall Study||1
99970|NCT02002871|244830|P1|NOT COMPLETED|Overall Study||1
99971|NCT02002871|244830|P1|COMPLETED|Overall Study||20
99972|NCT02002871|244830|P1|STARTED|Overall Study||21
99973|NCT02002832|244858|P2|NOT COMPLETED|Overall Study||26
99974|NCT02002832|244859|P1|NOT COMPLETED|Overall Study||28
99975|NCT02002832|244858|P2|COMPLETED|Overall Study||168
99976|NCT02002832|244859|P1|COMPLETED|Overall Study||166
99977|NCT02002832|244858|P2|STARTED|Overall Study||194
99978|NCT02002832|244859|P1|STARTED|Overall Study||194
99979|NCT02002702|244870|P3|NOT COMPLETED|Overall Study||0
99980|NCT02002702|244871|P2|NOT COMPLETED|Overall Study||0
99981|NCT02002702|244872|P1|NOT COMPLETED|Overall Study||0
99982|NCT02002702|244870|P3|COMPLETED|Overall Study||15
99983|NCT02002702|244871|P2|COMPLETED|Overall Study||15
99984|NCT02002702|244872|P1|COMPLETED|Overall Study||16
99985|NCT02002702|244870|P3|STARTED|Overall Study||15
99986|NCT02002702|244871|P2|STARTED|Overall Study||15
99987|NCT02002702|244872|P1|STARTED|Overall Study||16
99988|NCT02002689|244904|P1|NOT COMPLETED|Overall Study||10
99989|NCT02002689|244904|P1|COMPLETED|Overall Study||0
99990|NCT02002689|244904|P1|STARTED|Overall Study||10
99991|NCT02002650|244912|P2|NOT COMPLETED|Overall Study||0
99992|NCT02002650|244913|P1|NOT COMPLETED|Overall Study||0
99993|NCT02002650|244912|P2|COMPLETED|Overall Study||1303
99994|NCT02002650|244913|P1|COMPLETED|Overall Study||1297
99995|NCT02002650|244912|P2|STARTED|Overall Study||1303
99996|NCT02002650|244913|P1|STARTED|Overall Study||1297
99997|NCT02002533|244923|P2|NOT COMPLETED|Overall Study||18
99998|NCT02002533|244924|P1|NOT COMPLETED|Overall Study||6
99999|NCT02002533|244923|P2|COMPLETED|Overall Study||19
100000|NCT02002533|244924|P1|COMPLETED|Overall Study||28
100001|NCT02002533|244923|P2|STARTED|Overall Study||37
100002|NCT02002533|244924|P1|STARTED|Overall Study||34
100003|NCT02002221|244949|P2|NOT COMPLETED|Overall Study||3
100004|NCT02002221|244950|P1|NOT COMPLETED|Overall Study||2
100005|NCT02002221|244949|P2|COMPLETED|Overall Study||75
100006|NCT02002221|244950|P1|COMPLETED|Overall Study||76
100007|NCT02002221|244949|P2|STARTED|Overall Study||78
100008|NCT02002221|244950|P1|STARTED|Overall Study||78
100009|NCT02002208|244966|P2|NOT COMPLETED|Overall Study||40
100010|NCT02002208|244967|P1|NOT COMPLETED|Overall Study||37
100011|NCT02002208|244966|P2|COMPLETED|Overall Study||30
100012|NCT02002208|244967|P1|COMPLETED|Overall Study||32
100013|NCT02002208|244966|P2|STARTED|Overall Study||70
100014|NCT02002208|244967|P1|STARTED|Overall Study||69
100015|NCT02002091|244977|P2|NOT COMPLETED|One Year Follow up||0
100016|NCT02002091|244978|P1|NOT COMPLETED|One Year Follow up||0
100017|NCT02002091|244977|P2|COMPLETED|One Year Follow up||191
100018|NCT02002091|244978|P1|COMPLETED|One Year Follow up||109
100019|NCT02002091|244977|P2|STARTED|One Year Follow up||191
100020|NCT02002091|244978|P1|STARTED|One Year Follow up||109
100021|NCT02002091|244977|P2|NOT COMPLETED|Screening||14
100022|NCT02002091|244978|P1|NOT COMPLETED|Screening||13
100023|NCT02002091|244977|P2|COMPLETED|Screening||191
100024|NCT02002091|244978|P1|COMPLETED|Screening||109
100025|NCT02002091|244977|P2|STARTED|Screening||205
100026|NCT02002091|244978|P1|STARTED|Screening||122
100027|NCT02001987|245013|P1|NOT COMPLETED|LTE Period (52 Weeks)||9
100028|NCT02001987|245013|P1|COMPLETED|LTE Period (52 Weeks)||107
100029|NCT02001987|245013|P1|STARTED|LTE Period (52 Weeks)||116
100030|NCT02001987|245013|P1|NOT COMPLETED|Core Study Period (24 Weeks)||23
100031|NCT02001987|245013|P1|COMPLETED|Core Study Period (24 Weeks)||116
100032|NCT02001987|245013|P1|STARTED|Core Study Period (24 Weeks)||139
100033|NCT02001714|245089|P2|NOT COMPLETED|Overall Study||12
100034|NCT02001714|245090|P1|NOT COMPLETED|Overall Study||22
100035|NCT02001714|245089|P2|COMPLETED|Overall Study||219
100036|NCT02001714|245090|P1|COMPLETED|Overall Study||210
100037|NCT02001714|245089|P2|STARTED|Overall Study||231
100038|NCT02001714|245090|P1|STARTED|Overall Study||232
100039|NCT02001558|245098|P2|NOT COMPLETED|Overall Study||14
100040|NCT02001558|245099|P1|NOT COMPLETED|Overall Study||8
100041|NCT02001558|245098|P2|COMPLETED|Overall Study||19
100042|NCT02001558|245099|P1|COMPLETED|Overall Study||24
100043|NCT02001558|245098|P2|STARTED|Overall Study||33
100044|NCT02001558|245099|P1|STARTED|Overall Study||32
100045|NCT02001194|245135|P4|NOT COMPLETED|Follow-Up Period (13 Weeks)||0
100046|NCT02001194|245136|P3|NOT COMPLETED|Follow-Up Period (13 Weeks)||1
100047|NCT02001194|245137|P2|NOT COMPLETED|Follow-Up Period (13 Weeks)||2
100048|NCT02001194|245138|P1|NOT COMPLETED|Follow-Up Period (13 Weeks)||3
100049|NCT02001194|245135|P4|COMPLETED|Follow-Up Period (13 Weeks)||78
100050|NCT02001194|245136|P3|COMPLETED|Follow-Up Period (13 Weeks)||73
100051|NCT02001194|245137|P2|COMPLETED|Follow-Up Period (13 Weeks)||78
100052|NCT02001194|245138|P1|COMPLETED|Follow-Up Period (13 Weeks)||64
100053|NCT02001194|245135|P4|STARTED|Follow-Up Period (13 Weeks)||78
100054|NCT02001194|245136|P3|STARTED|Follow-Up Period (13 Weeks)||74
100055|NCT02001194|245137|P2|STARTED|Follow-Up Period (13 Weeks)||80
100056|NCT02001194|245138|P1|STARTED|Follow-Up Period (13 Weeks)||67
100057|NCT02001194|245135|P4|NOT COMPLETED|Intervention Period (13 Weeks)||2
100058|NCT02001194|245136|P3|NOT COMPLETED|Intervention Period (13 Weeks)||2
100059|NCT02001194|245137|P2|NOT COMPLETED|Intervention Period (13 Weeks)||0
100060|NCT02001194|245138|P1|NOT COMPLETED|Intervention Period (13 Weeks)||1
100061|NCT02001194|245135|P4|COMPLETED|Intervention Period (13 Weeks)|20 teams|78
100062|NCT02001194|245136|P3|COMPLETED|Intervention Period (13 Weeks)|19 teams|74
100063|NCT02001194|245137|P2|COMPLETED|Intervention Period (13 Weeks)|20 teams|80
100064|NCT02001194|245138|P1|COMPLETED|Intervention Period (13 Weeks)|16 teams|67
100065|NCT02001194|245135|P4|STARTED|Intervention Period (13 Weeks)|20 teams|80
100066|NCT02001194|245136|P3|STARTED|Intervention Period (13 Weeks)|19 teams|76
100067|NCT02001194|245137|P2|STARTED|Intervention Period (13 Weeks)|20 teams|80
100068|NCT02001194|245138|P1|STARTED|Intervention Period (13 Weeks)|17 teams|68
100069|NCT02001181|245154|P2|NOT COMPLETED|Overall Study||3
100070|NCT02001181|245155|P1|NOT COMPLETED|Overall Study||1
100071|NCT02001181|245154|P2|COMPLETED|Overall Study||31
100072|NCT02001181|245155|P1|COMPLETED|Overall Study||34
100073|NCT02001181|245154|P2|STARTED|Overall Study||34
100074|NCT02001181|245155|P1|STARTED|Overall Study||35
100075|NCT02001051|245171|P2|NOT COMPLETED|Overall Study||1
100076|NCT02001051|245172|P1|NOT COMPLETED|Overall Study||0
100077|NCT02001051|245171|P2|COMPLETED|Overall Study||1
100078|NCT02001051|245172|P1|COMPLETED|Overall Study||2
100079|NCT02001051|245171|P2|STARTED|Overall Study||2
100080|NCT02001051|245172|P1|STARTED|Overall Study||2
100081|NCT02000973|245196|P4|NOT COMPLETED|Overall Study||0
100082|NCT02000973|245197|P3|NOT COMPLETED|Overall Study||0
100083|NCT02000973|245198|P2|NOT COMPLETED|Overall Study||0
100084|NCT02000973|245199|P1|NOT COMPLETED|Overall Study||0
100085|NCT02000973|245196|P4|COMPLETED|Overall Study||20
100086|NCT02000973|245197|P3|COMPLETED|Overall Study||20
100087|NCT02000973|245198|P2|COMPLETED|Overall Study||20
100088|NCT02000973|245199|P1|COMPLETED|Overall Study||20
100089|NCT02000973|245196|P4|STARTED|Overall Study||20
100090|NCT02000973|245197|P3|STARTED|Overall Study||20
100091|NCT02000973|245198|P2|STARTED|Overall Study||20
100092|NCT02000973|245199|P1|STARTED|Overall Study||20
100093|NCT02000921|245224|P3|NOT COMPLETED|Overall Study||10
100094|NCT02000921|245225|P2|NOT COMPLETED|Overall Study||16
100095|NCT02000921|245226|P1|NOT COMPLETED|Overall Study||5
100096|NCT02000921|245224|P3|COMPLETED|Overall Study||46
100097|NCT02000921|245225|P2|COMPLETED|Overall Study||37
100098|NCT02000921|245226|P1|COMPLETED|Overall Study||22
100099|NCT02000921|245224|P3|STARTED|Overall Study||56
100100|NCT02000921|245225|P2|STARTED|Overall Study||53
100101|NCT02000921|245226|P1|STARTED|Overall Study||27
100102|NCT02000908|245245|P2|NOT COMPLETED|Overall Study||4
100103|NCT02000908|245246|P1|NOT COMPLETED|Overall Study||2
100104|NCT02000908|245245|P2|COMPLETED|Overall Study||36
100105|NCT02000908|245246|P1|COMPLETED|Overall Study||28
100106|NCT02000908|245245|P2|STARTED|Overall Study||40
100107|NCT02000908|245246|P1|STARTED|Overall Study||30
100108|NCT02000817|245256|P4|NOT COMPLETED|Overall Study||0
100109|NCT02000817|245257|P3|NOT COMPLETED|Overall Study||1
100110|NCT02000817|245258|P2|NOT COMPLETED|Overall Study||1
100111|NCT02000817|245259|P1|NOT COMPLETED|Overall Study||2
100112|NCT02000817|245256|P4|COMPLETED|Overall Study||7
100113|NCT02000817|245257|P3|COMPLETED|Overall Study||7
100114|NCT02000817|245258|P2|COMPLETED|Overall Study||8
100115|NCT02000817|245259|P1|COMPLETED|Overall Study||4
100116|NCT02000817|245256|P4|STARTED|Overall Study||7
100117|NCT02000817|245257|P3|STARTED|Overall Study||8
100118|NCT02000817|245258|P2|STARTED|Overall Study||9
100119|NCT02000817|245259|P1|STARTED|Overall Study||6
100120|NCT02000752|245354|P2|NOT COMPLETED|Overall Study||13
100121|NCT02000752|245355|P1|NOT COMPLETED|Overall Study||31
100122|NCT02000752|245354|P2|COMPLETED|Overall Study||47
100123|NCT02000752|245355|P1|COMPLETED|Overall Study||29
100124|NCT02000752|245354|P2|STARTED|Overall Study||60
100125|NCT02000752|245355|P1|STARTED|Overall Study||60
100126|NCT02000622|245369|P2|NOT COMPLETED|Overall Study||53
100127|NCT02000622|245370|P1|NOT COMPLETED|Overall Study||101
100128|NCT02000622|245369|P2|COMPLETED|Overall Study|Patients were ongoing on the study at the data cut-off.|44
100129|NCT02000622|245370|P1|COMPLETED|Overall Study|Patients were ongoing on the study at the data cut-off.|104
100130|NCT02000622|245369|P2|STARTED|Overall Study||97
100131|NCT02000622|245370|P1|STARTED|Overall Study||205
100132|NCT02000531|245392|P2|NOT COMPLETED|Overall Study||8
100133|NCT02000531|245393|P1|NOT COMPLETED|Overall Study||4
100134|NCT02000531|245392|P2|COMPLETED|Overall Study||16
100135|NCT02000531|245393|P1|COMPLETED|Overall Study||17
100136|NCT02000531|245392|P2|Safety Population|Overall Study||24
100137|NCT02000531|245393|P1|Safety Population|Overall Study||21
100138|NCT02000531|245392|P2|STARTED|Overall Study||24
100139|NCT02000531|245393|P1|STARTED|Overall Study||21
100140|NCT02000440|245401|P1|NOT COMPLETED|Overall Study||4
100141|NCT02000440|245401|P1|COMPLETED|Overall Study||13
100142|NCT02000440|245401|P1|STARTED|Overall Study||17
100143|NCT02000427|245421|P1|NOT COMPLETED|Overall Study||22
100144|NCT02000427|245421|P1|COMPLETED|Overall Study|Indicates participants ongoing in study as of the data cut-off date of 20 May 2015.|23
100145|NCT02000427|245421|P1|STARTED|Overall Study||45
100146|NCT02000180|245438|P2|NOT COMPLETED|Overall Study||0
100147|NCT02000180|245439|P1|NOT COMPLETED|Overall Study||0
100148|NCT02000180|245438|P2|COMPLETED|Overall Study||19
100149|NCT02000180|245439|P1|COMPLETED|Overall Study||18
100150|NCT02000180|245438|P2|STARTED|Overall Study||19
100151|NCT02000180|245439|P1|STARTED|Overall Study||18
100152|NCT02000154|245451|P1|NOT COMPLETED|Overall Study||0
100153|NCT02000154|245451|P1|COMPLETED|Overall Study||1
100154|NCT02000154|245451|P1|STARTED|Overall Study||1
100155|NCT01999985|245459|P3|NOT COMPLETED|Overall Study||0
100156|NCT01999985|245460|P2|NOT COMPLETED|Overall Study||0
100157|NCT01999985|245461|P1|NOT COMPLETED|Overall Study||0
100158|NCT01999985|245459|P3|COMPLETED|Overall Study||14
100159|NCT01999985|245460|P2|COMPLETED|Overall Study||3
100160|NCT01999985|245461|P1|COMPLETED|Overall Study||8
100161|NCT01999985|245459|P3|STARTED|Overall Study||14
100162|NCT01999985|245460|P2|STARTED|Overall Study||3
100163|NCT01999985|245461|P1|STARTED|Overall Study||8
100164|NCT01999972|245475|P6|NOT COMPLETED|Dose Expansion Part||7
100165|NCT01999972|245476|P5|NOT COMPLETED|Dose Expansion Part||21
100166|NCT01999972|245477|P4|NOT COMPLETED|Dose Expansion Part||0
100167|NCT01999972|245478|P3|NOT COMPLETED|Dose Expansion Part||0
100168|NCT01999972|245479|P2|NOT COMPLETED|Dose Expansion Part||0
100169|NCT01999972|245480|P1|NOT COMPLETED|Dose Expansion Part||0
100170|NCT01999972|245475|P6|COMPLETED|Dose Expansion Part||0
100171|NCT01999972|245476|P5|COMPLETED|Dose Expansion Part||0
100172|NCT01999972|245477|P4|COMPLETED|Dose Expansion Part||0
100173|NCT01999972|245478|P3|COMPLETED|Dose Expansion Part||0
100174|NCT01999972|245479|P2|COMPLETED|Dose Expansion Part||0
100175|NCT01999972|245480|P1|COMPLETED|Dose Expansion Part||0
100176|NCT01999972|245475|P6|Treated|Dose Expansion Part||7
100177|NCT01999972|245476|P5|Treated|Dose Expansion Part||21
100178|NCT01999972|245477|P4|Treated|Dose Expansion Part||0
100179|NCT01999972|245478|P3|Treated|Dose Expansion Part||0
100180|NCT01999972|245479|P2|Treated|Dose Expansion Part||0
100181|NCT01999972|245480|P1|Treated|Dose Expansion Part||0
100182|NCT01999972|245475|P6|STARTED|Dose Expansion Part||7
100183|NCT01999972|245476|P5|STARTED|Dose Expansion Part||21
100184|NCT01999972|245477|P4|STARTED|Dose Expansion Part||0
100185|NCT01999972|245478|P3|STARTED|Dose Expansion Part||0
100186|NCT01999972|245479|P2|STARTED|Dose Expansion Part||0
100187|NCT01999972|245480|P1|STARTED|Dose Expansion Part||0
100188|NCT01999972|245475|P6|NOT COMPLETED|Dose Escalation Part||0
100189|NCT01999972|245476|P5|NOT COMPLETED|Dose Escalation Part||0
100190|NCT01999972|245477|P4|NOT COMPLETED|Dose Escalation Part||11
100191|NCT01999972|245478|P3|NOT COMPLETED|Dose Escalation Part||5
100192|NCT01999972|245479|P2|NOT COMPLETED|Dose Escalation Part||3
100193|NCT01999972|245480|P1|NOT COMPLETED|Dose Escalation Part||5
100194|NCT01999972|245475|P6|COMPLETED|Dose Escalation Part||0
100195|NCT01999972|245476|P5|COMPLETED|Dose Escalation Part||0
100196|NCT01999972|245477|P4|COMPLETED|Dose Escalation Part||0
100197|NCT01999972|245478|P3|COMPLETED|Dose Escalation Part||0
100198|NCT01999972|245479|P2|COMPLETED|Dose Escalation Part||0
100199|NCT01999972|245480|P1|COMPLETED|Dose Escalation Part||0
100200|NCT01999972|245475|P6|Treated|Dose Escalation Part||0
100201|NCT01999972|245476|P5|Treated|Dose Escalation Part||0
100202|NCT01999972|245477|P4|Treated|Dose Escalation Part||10
100203|NCT01999972|245478|P3|Treated|Dose Escalation Part||4
100204|NCT01999972|245479|P2|Treated|Dose Escalation Part||3
100205|NCT01999972|245480|P1|Treated|Dose Escalation Part||5
100206|NCT01999972|245475|P6|STARTED|Dose Escalation Part||0
100207|NCT01999972|245476|P5|STARTED|Dose Escalation Part||0
100208|NCT01999972|245477|P4|STARTED|Dose Escalation Part||11
100209|NCT01999972|245478|P3|STARTED|Dose Escalation Part||5
100210|NCT01999972|245479|P2|STARTED|Dose Escalation Part||3
100211|NCT01999972|245480|P1|STARTED|Dose Escalation Part||5
100212|NCT01999920|245594|P2|NOT COMPLETED|Overall Study||2
100213|NCT01999920|245595|P1|NOT COMPLETED|Overall Study||6
100214|NCT01999920|245594|P2|COMPLETED|Overall Study||9
100215|NCT01999920|245595|P1|COMPLETED|Overall Study||7
100216|NCT01999920|245594|P2|STARTED|Overall Study||11
100217|NCT01999920|245595|P1|STARTED|Overall Study||13
100218|NCT01999894|245611|P1|NOT COMPLETED|Overall Study||36
100219|NCT01999894|245611|P1|COMPLETED|Overall Study||66
100220|NCT01999894|245611|P1|STARTED|Overall Study||102
100221|NCT01999868|245619|P3|NOT COMPLETED|Blinded Observation Phase (Week 40 – 88)||0
100222|NCT01999868|245620|P2|NOT COMPLETED|Blinded Observation Phase (Week 40 – 88)||29
100223|NCT01999868|245621|P1|NOT COMPLETED|Blinded Observation Phase (Week 40 – 88)||23
100224|NCT01999868|245619|P3|COMPLETED|Blinded Observation Phase (Week 40 – 88)||0
100225|NCT01999868|245620|P2|COMPLETED|Blinded Observation Phase (Week 40 – 88)||6
100226|NCT01999868|245621|P1|COMPLETED|Blinded Observation Phase (Week 40 – 88)||4
100227|NCT01999868|245619|P3|STARTED|Blinded Observation Phase (Week 40 – 88)||0
100228|NCT01999868|245620|P2|STARTED|Blinded Observation Phase (Week 40 – 88)||35
100229|NCT01999868|245621|P1|STARTED|Blinded Observation Phase (Week 40 – 88)||27
100230|NCT01999868|245619|P3|NOT COMPLETED|Blinded Treatment Phase (Week 12 – 40)||0
100231|NCT01999868|245620|P2|NOT COMPLETED|Blinded Treatment Phase (Week 12 – 40)||11
100232|NCT01999868|245621|P1|NOT COMPLETED|Blinded Treatment Phase (Week 12 – 40)||18
100233|NCT01999868|245619|P3|COMPLETED|Blinded Treatment Phase (Week 12 – 40)||0
100234|NCT01999868|245620|P2|COMPLETED|Blinded Treatment Phase (Week 12 – 40)||35
100235|NCT01999868|245621|P1|COMPLETED|Blinded Treatment Phase (Week 12 – 40)||27
100236|NCT01999868|245619|P3|STARTED|Blinded Treatment Phase (Week 12 – 40)|Participants didn't meet eligibility requirements for randomization or withdrew prior to Week 12.|0
100237|NCT01999868|245620|P2|STARTED|Blinded Treatment Phase (Week 12 – 40)||46
100238|NCT01999868|245621|P1|STARTED|Blinded Treatment Phase (Week 12 – 40)||45
100239|NCT01999868|245619|P3|NOT COMPLETED|Lead-in Phase (Week 0 – 12)||5
100240|NCT01999868|245620|P2|NOT COMPLETED|Lead-in Phase (Week 0 – 12)||0
100241|NCT01999868|245621|P1|NOT COMPLETED|Lead-in Phase (Week 0 – 12)||0
100242|NCT01999868|245619|P3|COMPLETED|Lead-in Phase (Week 0 – 12)||12
100243|NCT01999868|245620|P2|COMPLETED|Lead-in Phase (Week 0 – 12)||46
100244|NCT01999868|245621|P1|COMPLETED|Lead-in Phase (Week 0 – 12)||45
100245|NCT01999868|245619|P3|STARTED|Lead-in Phase (Week 0 – 12)||17
100246|NCT01999868|245620|P2|STARTED|Lead-in Phase (Week 0 – 12)||46
100247|NCT01999868|245621|P1|STARTED|Lead-in Phase (Week 0 – 12)||45
100248|NCT01999777|245648|P2|NOT COMPLETED|Overall Study||0
100249|NCT01999777|245649|P1|NOT COMPLETED|Overall Study||0
100250|NCT01999777|245648|P2|COMPLETED|Overall Study||31
100251|NCT01999777|245649|P1|COMPLETED|Overall Study||31
100252|NCT01999777|245648|P2|STARTED|Overall Study||31
100253|NCT01999777|245649|P1|STARTED|Overall Study||31
100254|NCT01999530|245657|P1|NOT COMPLETED|Overall Study||13
100255|NCT01999530|245657|P1|COMPLETED|Overall Study||7
100256|NCT01999530|245657|P1|STARTED|Overall Study||20
100257|NCT01999517|245663|P2|NOT COMPLETED|Overall Study||0
100258|NCT01999517|245664|P1|NOT COMPLETED|Overall Study||0
100259|NCT01999517|245663|P2|COMPLETED|Overall Study||54
100260|NCT01999517|245664|P1|COMPLETED|Overall Study||68
100261|NCT01999517|245663|P2|STARTED|Overall Study||54
100262|NCT01999517|245664|P1|STARTED|Overall Study||68
100263|NCT01999465|245672|P2|NOT COMPLETED|Overall Study||3
100264|NCT01999465|245673|P1|NOT COMPLETED|Overall Study||0
100265|NCT01999465|245672|P2|COMPLETED|Overall Study||7
100266|NCT01999465|245673|P1|COMPLETED|Overall Study||10
100267|NCT01999465|245672|P2|STARTED|Overall Study||10
100268|NCT01999465|245673|P1|STARTED|Overall Study||10
100269|NCT01999400|245681|P6|NOT COMPLETED|Fourth Intervention (1 Day)||0
100270|NCT01999400|245682|P5|NOT COMPLETED|Fourth Intervention (1 Day)||0
100271|NCT01999400|245683|P4|NOT COMPLETED|Fourth Intervention (1 Day)||0
100272|NCT01999400|245684|P3|NOT COMPLETED|Fourth Intervention (1 Day)||0
100273|NCT01999400|245685|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
100274|NCT01999400|245686|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
100275|NCT01999400|245681|P6|COMPLETED|Fourth Intervention (1 Day)||0
100276|NCT01999400|245682|P5|COMPLETED|Fourth Intervention (1 Day)||0
100277|NCT01999400|245683|P4|COMPLETED|Fourth Intervention (1 Day)||0
100278|NCT01999400|245684|P3|COMPLETED|Fourth Intervention (1 Day)||1
100279|NCT01999400|245685|P2|COMPLETED|Fourth Intervention (1 Day)||0
100280|NCT01999400|245686|P1|COMPLETED|Fourth Intervention (1 Day)||1
100281|NCT01999400|245681|P6|STARTED|Fourth Intervention (1 Day)||0
100282|NCT01999400|245682|P5|STARTED|Fourth Intervention (1 Day)||0
100283|NCT01999400|245683|P4|STARTED|Fourth Intervention (1 Day)||0
100284|NCT01999400|245684|P3|STARTED|Fourth Intervention (1 Day)||1
100285|NCT01999400|245685|P2|STARTED|Fourth Intervention (1 Day)||0
100286|NCT01999400|245686|P1|STARTED|Fourth Intervention (1 Day)||1
100287|NCT01999400|245681|P6|NOT COMPLETED|Washout (10 Days)||0
100288|NCT01999400|245682|P5|NOT COMPLETED|Washout (10 Days)||0
100289|NCT01999400|245683|P4|NOT COMPLETED|Washout (10 Days)||0
100290|NCT01999400|245684|P3|NOT COMPLETED|Washout (10 Days)||0
100291|NCT01999400|245685|P2|NOT COMPLETED|Washout (10 Days)||0
100292|NCT01999400|245686|P1|NOT COMPLETED|Washout (10 Days)||0
100293|NCT01999400|245681|P6|COMPLETED|Washout (10 Days)||0
100294|NCT01999400|245682|P5|COMPLETED|Washout (10 Days)||0
100295|NCT01999400|245683|P4|COMPLETED|Washout (10 Days)||0
100296|NCT01999400|245684|P3|COMPLETED|Washout (10 Days)||1
100297|NCT01999400|245685|P2|COMPLETED|Washout (10 Days)||0
100298|NCT01999400|245686|P1|COMPLETED|Washout (10 Days)||1
100299|NCT01999400|245681|P6|STARTED|Washout (10 Days)||0
100300|NCT01999400|245682|P5|STARTED|Washout (10 Days)||0
100301|NCT01999400|245683|P4|STARTED|Washout (10 Days)||0
100302|NCT01999400|245684|P3|STARTED|Washout (10 Days)||1
100303|NCT01999400|245685|P2|STARTED|Washout (10 Days)||0
100304|NCT01999400|245686|P1|STARTED|Washout (10 Days)||1
100305|NCT01999400|245681|P6|NOT COMPLETED|Third Intervention (1 Day)||1
100306|NCT01999400|245682|P5|NOT COMPLETED|Third Intervention (1 Day)||0
100307|NCT01999400|245683|P4|NOT COMPLETED|Third Intervention (1 Day)||0
100308|NCT01999400|245684|P3|NOT COMPLETED|Third Intervention (1 Day)||0
100309|NCT01999400|245685|P2|NOT COMPLETED|Third Intervention (1 Day)||0
100310|NCT01999400|245686|P1|NOT COMPLETED|Third Intervention (1 Day)||0
100311|NCT01999400|245681|P6|COMPLETED|Third Intervention (1 Day)||0
100312|NCT01999400|245682|P5|COMPLETED|Third Intervention (1 Day)||1
100313|NCT01999400|245683|P4|COMPLETED|Third Intervention (1 Day)||1
100314|NCT01999400|245684|P3|COMPLETED|Third Intervention (1 Day)||1
100315|NCT01999400|245685|P2|COMPLETED|Third Intervention (1 Day)||0
100316|NCT01999400|245686|P1|COMPLETED|Third Intervention (1 Day)||2
100317|NCT01999400|245681|P6|STARTED|Third Intervention (1 Day)||1
100318|NCT01999400|245682|P5|STARTED|Third Intervention (1 Day)||1
100319|NCT01999400|245683|P4|STARTED|Third Intervention (1 Day)||1
100320|NCT01999400|245684|P3|STARTED|Third Intervention (1 Day)||1
100321|NCT01999400|245685|P2|STARTED|Third Intervention (1 Day)||0
100322|NCT01999400|245686|P1|STARTED|Third Intervention (1 Day)||2
100323|NCT01999400|245681|P6|NOT COMPLETED|Washout (10 Days)||0
100324|NCT01999400|245682|P5|NOT COMPLETED|Washout (10 Days)||0
100325|NCT01999400|245683|P4|NOT COMPLETED|Washout (10 Days)||0
100326|NCT01999400|245684|P3|NOT COMPLETED|Washout (10 Days)||0
100327|NCT01999400|245685|P2|NOT COMPLETED|Washout (10 Days)||0
100328|NCT01999400|245686|P1|NOT COMPLETED|Washout (10 Days)||0
100329|NCT01999400|245681|P6|COMPLETED|Washout (10 Days)||1
100330|NCT01999400|245682|P5|COMPLETED|Washout (10 Days)||1
100331|NCT01999400|245683|P4|COMPLETED|Washout (10 Days)||1
100332|NCT01999400|245684|P3|COMPLETED|Washout (10 Days)||1
100333|NCT01999400|245685|P2|COMPLETED|Washout (10 Days)||0
100334|NCT01999400|245686|P1|COMPLETED|Washout (10 Days)||2
100335|NCT01999400|245681|P6|STARTED|Washout (10 Days)||1
100336|NCT01999400|245682|P5|STARTED|Washout (10 Days)||1
100337|NCT01999400|245683|P4|STARTED|Washout (10 Days)||1
100338|NCT01999400|245684|P3|STARTED|Washout (10 Days)||1
100339|NCT01999400|245685|P2|STARTED|Washout (10 Days)||0
100340|NCT01999400|245686|P1|STARTED|Washout (10 Days)||2
100341|NCT01999400|245681|P6|NOT COMPLETED|Second Intervention (1 Day)||0
100342|NCT01999400|245682|P5|NOT COMPLETED|Second Intervention (1 Day)||0
100343|NCT01999400|245683|P4|NOT COMPLETED|Second Intervention (1 Day)||0
100344|NCT01999400|245684|P3|NOT COMPLETED|Second Intervention (1 Day)||0
100345|NCT01999400|245685|P2|NOT COMPLETED|Second Intervention (1 Day)||0
100346|NCT01999400|245686|P1|NOT COMPLETED|Second Intervention (1 Day)||0
100347|NCT01999400|245681|P6|COMPLETED|Second Intervention (1 Day)||3
100348|NCT01999400|245682|P5|COMPLETED|Second Intervention (1 Day)||3
100349|NCT01999400|245683|P4|COMPLETED|Second Intervention (1 Day)||2
100350|NCT01999400|245684|P3|COMPLETED|Second Intervention (1 Day)||3
100351|NCT01999400|245685|P2|COMPLETED|Second Intervention (1 Day)||4
100352|NCT01999400|245686|P1|COMPLETED|Second Intervention (1 Day)||5
100353|NCT01999400|245681|P6|STARTED|Second Intervention (1 Day)||3
100354|NCT01999400|245682|P5|STARTED|Second Intervention (1 Day)||3
100355|NCT01999400|245683|P4|STARTED|Second Intervention (1 Day)||2
100356|NCT01999400|245684|P3|STARTED|Second Intervention (1 Day)||3
100357|NCT01999400|245685|P2|STARTED|Second Intervention (1 Day)||4
100358|NCT01999400|245686|P1|STARTED|Second Intervention (1 Day)||5
100359|NCT01999400|245681|P6|NOT COMPLETED|Washout (10 Days)||0
100360|NCT01999400|245682|P5|NOT COMPLETED|Washout (10 Days)||0
100361|NCT01999400|245683|P4|NOT COMPLETED|Washout (10 Days)||0
100362|NCT01999400|245684|P3|NOT COMPLETED|Washout (10 Days)||0
100363|NCT01999400|245685|P2|NOT COMPLETED|Washout (10 Days)||0
100364|NCT01999400|245686|P1|NOT COMPLETED|Washout (10 Days)||0
100365|NCT01999400|245681|P6|COMPLETED|Washout (10 Days)||3
100366|NCT01999400|245682|P5|COMPLETED|Washout (10 Days)||3
100367|NCT01999400|245683|P4|COMPLETED|Washout (10 Days)||2
100368|NCT01999400|245684|P3|COMPLETED|Washout (10 Days)||3
100369|NCT01999400|245685|P2|COMPLETED|Washout (10 Days)||4
100370|NCT01999400|245686|P1|COMPLETED|Washout (10 Days)||5
100371|NCT01999400|245681|P6|STARTED|Washout (10 Days)||3
100372|NCT01999400|245682|P5|STARTED|Washout (10 Days)||3
100373|NCT01999400|245683|P4|STARTED|Washout (10 Days)||2
100374|NCT01999400|245684|P3|STARTED|Washout (10 Days)||3
100375|NCT01999400|245685|P2|STARTED|Washout (10 Days)||4
100376|NCT01999400|245686|P1|STARTED|Washout (10 Days)||5
100377|NCT01999400|245681|P6|NOT COMPLETED|First Intervention (1 Day)||1
100378|NCT01999400|245682|P5|NOT COMPLETED|First Intervention (1 Day)||0
100379|NCT01999400|245683|P4|NOT COMPLETED|First Intervention (1 Day)||3
100380|NCT01999400|245684|P3|NOT COMPLETED|First Intervention (1 Day)||2
100381|NCT01999400|245685|P2|NOT COMPLETED|First Intervention (1 Day)||2
100382|NCT01999400|245686|P1|NOT COMPLETED|First Intervention (1 Day)||2
100383|NCT01999400|245681|P6|COMPLETED|First Intervention (1 Day)||3
100384|NCT01999400|245682|P5|COMPLETED|First Intervention (1 Day)||4
100385|NCT01999400|245683|P4|COMPLETED|First Intervention (1 Day)||2
100386|NCT01999400|245684|P3|COMPLETED|First Intervention (1 Day)||3
100387|NCT01999400|245685|P2|COMPLETED|First Intervention (1 Day)||4
100388|NCT01999400|245686|P1|COMPLETED|First Intervention (1 Day)||4
100389|NCT01999400|245681|P6|STARTED|First Intervention (1 Day)||4
100390|NCT01999400|245682|P5|STARTED|First Intervention (1 Day)||4
100391|NCT01999400|245683|P4|STARTED|First Intervention (1 Day)||5
100392|NCT01999400|245684|P3|STARTED|First Intervention (1 Day)||5
100393|NCT01999400|245685|P2|STARTED|First Intervention (1 Day)||6
100394|NCT01999400|245686|P1|STARTED|First Intervention (1 Day)||6
100395|NCT01999348|245706|P1|NOT COMPLETED|Overall Study||120
100396|NCT01999348|245706|P1|COMPLETED|Overall Study||1433
100397|NCT01999348|245706|P1|STARTED|Overall Study||1553
100398|NCT01999322|245718|P2|NOT COMPLETED|Overall Study||0
100399|NCT01999322|245719|P1|NOT COMPLETED|Overall Study||1
100400|NCT01999322|245718|P2|COMPLETED|Overall Study||12
100401|NCT01999322|245719|P1|COMPLETED|Overall Study||24
100402|NCT01999322|245718|P2|STARTED|Overall Study||12
100403|NCT01999322|245719|P1|STARTED|Overall Study||25
100404|NCT01999231|245735|P4|NOT COMPLETED|Overall Study||0
100405|NCT01999231|245736|P3|NOT COMPLETED|Overall Study||0
100406|NCT01999231|245737|P2|NOT COMPLETED|Overall Study||0
100407|NCT01999231|245738|P1|NOT COMPLETED|Overall Study||0
100408|NCT01999231|245735|P4|COMPLETED|Overall Study||6
100409|NCT01999231|245736|P3|COMPLETED|Overall Study||6
100410|NCT01999231|245737|P2|COMPLETED|Overall Study||6
100411|NCT01999231|245738|P1|COMPLETED|Overall Study||6
100412|NCT01999231|245735|P4|STARTED|Overall Study||6
100413|NCT01999231|245736|P3|STARTED|Overall Study||6
100414|NCT01999231|245737|P2|STARTED|Overall Study||6
100415|NCT01999231|245738|P1|STARTED|Overall Study||6
100416|NCT01999218|245771|P3|NOT COMPLETED|Overall Study||110
100417|NCT01999218|245772|P2|NOT COMPLETED|Overall Study||101
100418|NCT01999218|245773|P1|NOT COMPLETED|Overall Study||109
100419|NCT01999218|245771|P3|COMPLETED|Overall Study||327
100420|NCT01999218|245772|P2|COMPLETED|Overall Study||340
100421|NCT01999218|245773|P1|COMPLETED|Overall Study||339
100422|NCT01999218|245771|P3|Site Issue|Overall Study||435
100423|NCT01999218|245772|P2|Site Issue|Overall Study||435
100424|NCT01999218|245773|P1|Site Issue|Overall Study||445
100425|NCT01999218|245771|P3|Treated|Overall Study||437
100426|NCT01999218|245772|P2|Treated|Overall Study||440
100427|NCT01999218|245773|P1|Treated|Overall Study||448
100428|NCT01999218|245771|P3|STARTED|Overall Study||437
100429|NCT01999218|245772|P2|STARTED|Overall Study||441
100430|NCT01999218|245773|P1|STARTED|Overall Study||448
100431|NCT01999192|245800|P4|NOT COMPLETED|Extension Phase||0
100432|NCT01999192|245801|P3|NOT COMPLETED|Extension Phase||24
100433|NCT01999192|245802|P2|NOT COMPLETED|Extension Phase||18
100434|NCT01999192|245803|P1|NOT COMPLETED|Extension Phase||13
100435|NCT01999192|245800|P4|COMPLETED|Extension Phase||0
100436|NCT01999192|245801|P3|COMPLETED|Extension Phase||44
100437|NCT01999192|245802|P2|COMPLETED|Extension Phase||38
100438|NCT01999192|245803|P1|COMPLETED|Extension Phase||41
100439|NCT01999192|245800|P4|STARTED|Extension Phase|No Placebo arm for Extension Phase, all patients terminated or were switched to tregalizumab Groups.|0
100440|NCT01999192|245801|P3|STARTED|Extension Phase|Some patients terminated after Main Phase 2.|68
100441|NCT01999192|245802|P2|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|56
100442|NCT01999192|245803|P1|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|54
100443|NCT01999192|245800|P4|NOT COMPLETED|Main Phase II||1
100444|NCT01999192|245801|P3|NOT COMPLETED|Main Phase II||22
100445|NCT01999192|245802|P2|NOT COMPLETED|Main Phase II||9
100446|NCT01999192|245803|P1|NOT COMPLETED|Main Phase II||9
100447|NCT01999192|245800|P4|COMPLETED|Main Phase II||43
100448|NCT01999192|245801|P3|COMPLETED|Main Phase II||76
100449|NCT01999192|245802|P2|COMPLETED|Main Phase II||66
100450|NCT01999192|245803|P1|COMPLETED|Main Phase II||55
100451|NCT01999192|245800|P4|STARTED|Main Phase II|non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched|44
100452|NCT01999192|245801|P3|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|98
100453|NCT01999192|245802|P2|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|75
100454|NCT01999192|245803|P1|STARTED|Main Phase II|Non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched.|64
100455|NCT01999192|245800|P4|NOT COMPLETED|Main Phase I||8
100456|NCT01999192|245801|P3|NOT COMPLETED|Main Phase I||8
100457|NCT01999192|245802|P2|NOT COMPLETED|Main Phase I||10
100458|NCT01999192|245803|P1|NOT COMPLETED|Main Phase I||11
100459|NCT01999192|245800|P4|COMPLETED|Main Phase I||72
100460|NCT01999192|245801|P3|COMPLETED|Main Phase I||70
100461|NCT01999192|245802|P2|COMPLETED|Main Phase I||70
100462|NCT01999192|245803|P1|COMPLETED|Main Phase I||72
100463|NCT01999192|245800|P4|STARTED|Main Phase I||80
100464|NCT01999192|245801|P3|STARTED|Main Phase I||78
100465|NCT01999192|245802|P2|STARTED|Main Phase I||80
100466|NCT01999192|245803|P1|STARTED|Main Phase I||83
100467|NCT01999114|245818|P5|NOT COMPLETED|Overall Study||4
100468|NCT01999114|245819|P4|NOT COMPLETED|Overall Study||3
100469|NCT01999114|245820|P3|NOT COMPLETED|Overall Study||5
100470|NCT01999114|245821|P2|NOT COMPLETED|Overall Study||7
100471|NCT01999114|245822|P1|NOT COMPLETED|Overall Study||8
100472|NCT01999114|245818|P5|COMPLETED|Overall Study||61
100473|NCT01999114|245819|P4|COMPLETED|Overall Study||62
100474|NCT01999114|245820|P3|COMPLETED|Overall Study||61
100475|NCT01999114|245821|P2|COMPLETED|Overall Study||59
100476|NCT01999114|245822|P1|COMPLETED|Overall Study||58
100477|NCT01999114|245818|P5|STARTED|Overall Study||65
100478|NCT01999114|245819|P4|STARTED|Overall Study||65
100479|NCT01999114|245820|P3|STARTED|Overall Study||66
100480|NCT01999114|245821|P2|STARTED|Overall Study||66
100481|NCT01999114|245822|P1|STARTED|Overall Study||66
100482|NCT01998984|245890|P4|NOT COMPLETED|Overall Study||3
100483|NCT01998984|245891|P3|NOT COMPLETED|Overall Study||1
100484|NCT01998984|245892|P2|NOT COMPLETED|Overall Study||1
100485|NCT01998984|245893|P1|NOT COMPLETED|Overall Study||0
100486|NCT01998984|245890|P4|COMPLETED|Overall Study||58
100487|NCT01998984|245891|P3|COMPLETED|Overall Study||48
100488|NCT01998984|245892|P2|COMPLETED|Overall Study||58
100489|NCT01998984|245893|P1|COMPLETED|Overall Study||55
100490|NCT01998984|245890|P4|STARTED|Overall Study||61
100491|NCT01998984|245891|P3|STARTED|Overall Study||49
100492|NCT01998984|245892|P2|STARTED|Overall Study||59
100493|NCT01998984|245893|P1|STARTED|Overall Study||55
100494|NCT01998958|245918|P32|NOT COMPLETED|Follow-up Phase||0
100495|NCT01998958|245919|P31|NOT COMPLETED|Follow-up Phase||0
100496|NCT01998958|245920|P30|NOT COMPLETED|Follow-up Phase||0
100497|NCT01998958|245921|P29|NOT COMPLETED|Follow-up Phase||0
100498|NCT01998958|245922|P28|NOT COMPLETED|Follow-up Phase||0
100499|NCT01998958|245923|P27|NOT COMPLETED|Follow-up Phase||0
100500|NCT01998958|245924|P26|NOT COMPLETED|Follow-up Phase||0
100501|NCT01998958|245925|P25|NOT COMPLETED|Follow-up Phase||0
100502|NCT01998958|245926|P24|NOT COMPLETED|Follow-up Phase||0
100503|NCT01998958|245927|P23|NOT COMPLETED|Follow-up Phase||0
100504|NCT01998958|245928|P22|NOT COMPLETED|Follow-up Phase||0
100505|NCT01998958|245929|P21|NOT COMPLETED|Follow-up Phase||0
100506|NCT01998958|245930|P20|NOT COMPLETED|Follow-up Phase||0
100507|NCT01998958|245931|P19|NOT COMPLETED|Follow-up Phase||0
100508|NCT01998958|245932|P18|NOT COMPLETED|Follow-up Phase||0
100509|NCT01998958|245933|P17|NOT COMPLETED|Follow-up Phase||0
100510|NCT01998958|245934|P16|NOT COMPLETED|Follow-up Phase||0
100511|NCT01998958|245935|P15|NOT COMPLETED|Follow-up Phase||0
100512|NCT01998958|245936|P14|NOT COMPLETED|Follow-up Phase||0
100513|NCT01998958|245937|P13|NOT COMPLETED|Follow-up Phase||0
100514|NCT01998958|245938|P12|NOT COMPLETED|Follow-up Phase||0
100515|NCT01998958|245939|P11|NOT COMPLETED|Follow-up Phase||0
100516|NCT01998958|245940|P10|NOT COMPLETED|Follow-up Phase||0
100517|NCT01998958|245941|P9|NOT COMPLETED|Follow-up Phase||0
100518|NCT01998958|245942|P8|NOT COMPLETED|Follow-up Phase||0
100519|NCT01998958|245943|P7|NOT COMPLETED|Follow-up Phase||0
100520|NCT01998958|245944|P6|NOT COMPLETED|Follow-up Phase||0
100521|NCT01998958|245945|P5|NOT COMPLETED|Follow-up Phase||0
100522|NCT01998958|245946|P4|NOT COMPLETED|Follow-up Phase||0
100523|NCT01998958|245947|P3|NOT COMPLETED|Follow-up Phase||0
100524|NCT01998958|245948|P2|NOT COMPLETED|Follow-up Phase||0
100525|NCT01998958|245949|P1|NOT COMPLETED|Follow-up Phase||0
100526|NCT01998958|245918|P32|COMPLETED|Follow-up Phase||42
100527|NCT01998958|245919|P31|COMPLETED|Follow-up Phase||39
100528|NCT01998958|245920|P30|COMPLETED|Follow-up Phase||12
100529|NCT01998958|245921|P29|COMPLETED|Follow-up Phase||4
100530|NCT01998958|245922|P28|COMPLETED|Follow-up Phase||1
100531|NCT01998958|245923|P27|COMPLETED|Follow-up Phase||0
100532|NCT01998958|245924|P26|COMPLETED|Follow-up Phase||0
100533|NCT01998958|245925|P25|COMPLETED|Follow-up Phase||0
100534|NCT01998958|245926|P24|COMPLETED|Follow-up Phase||0
100535|NCT01998958|245927|P23|COMPLETED|Follow-up Phase||0
100536|NCT01998958|245928|P22|COMPLETED|Follow-up Phase||0
100537|NCT01998958|245929|P21|COMPLETED|Follow-up Phase||0
100538|NCT01998958|245930|P20|COMPLETED|Follow-up Phase||0
100539|NCT01998958|245931|P19|COMPLETED|Follow-up Phase||0
100540|NCT01998958|245932|P18|COMPLETED|Follow-up Phase||0
100541|NCT01998958|245933|P17|COMPLETED|Follow-up Phase||0
100542|NCT01998958|245934|P16|COMPLETED|Follow-up Phase||0
100543|NCT01998958|245935|P15|COMPLETED|Follow-up Phase||0
100544|NCT01998958|245936|P14|COMPLETED|Follow-up Phase||0
100545|NCT01998958|245937|P13|COMPLETED|Follow-up Phase||0
100546|NCT01998958|245938|P12|COMPLETED|Follow-up Phase||0
100547|NCT01998958|245939|P11|COMPLETED|Follow-up Phase||0
100548|NCT01998958|245940|P10|COMPLETED|Follow-up Phase||0
100549|NCT01998958|245941|P9|COMPLETED|Follow-up Phase||0
100550|NCT01998958|245942|P8|COMPLETED|Follow-up Phase||0
100551|NCT01998958|245943|P7|COMPLETED|Follow-up Phase||0
100552|NCT01998958|245944|P6|COMPLETED|Follow-up Phase||0
100553|NCT01998958|245945|P5|COMPLETED|Follow-up Phase||0
100554|NCT01998958|245946|P4|COMPLETED|Follow-up Phase||0
100555|NCT01998958|245947|P3|COMPLETED|Follow-up Phase||0
100556|NCT01998958|245948|P2|COMPLETED|Follow-up Phase||0
100557|NCT01998958|245949|P1|COMPLETED|Follow-up Phase||0
100558|NCT01998958|245918|P32|STARTED|Follow-up Phase||42
100559|NCT01998958|245919|P31|STARTED|Follow-up Phase||39
100560|NCT01998958|245920|P30|STARTED|Follow-up Phase||12
100561|NCT01998958|245921|P29|STARTED|Follow-up Phase||4
100562|NCT01998958|245922|P28|STARTED|Follow-up Phase||1
100563|NCT01998958|245923|P27|STARTED|Follow-up Phase||0
100564|NCT01998958|245924|P26|STARTED|Follow-up Phase||0
100565|NCT01998958|245925|P25|STARTED|Follow-up Phase||0
100566|NCT01998958|245926|P24|STARTED|Follow-up Phase||0
100567|NCT01998958|245927|P23|STARTED|Follow-up Phase||0
100568|NCT01998958|245928|P22|STARTED|Follow-up Phase||0
100569|NCT01998958|245929|P21|STARTED|Follow-up Phase||0
100570|NCT01998958|245930|P20|STARTED|Follow-up Phase||0
100571|NCT01998958|245931|P19|STARTED|Follow-up Phase||0
100572|NCT01998958|245932|P18|STARTED|Follow-up Phase||0
100573|NCT01998958|245933|P17|STARTED|Follow-up Phase||0
100574|NCT01998958|245934|P16|STARTED|Follow-up Phase||0
100575|NCT01998958|245935|P15|STARTED|Follow-up Phase||0
100576|NCT01998958|245936|P14|STARTED|Follow-up Phase||0
100577|NCT01998958|245937|P13|STARTED|Follow-up Phase||0
100578|NCT01998958|245938|P12|STARTED|Follow-up Phase||0
100579|NCT01998958|245939|P11|STARTED|Follow-up Phase||0
100580|NCT01998958|245940|P10|STARTED|Follow-up Phase||0
100581|NCT01998958|245941|P9|STARTED|Follow-up Phase||0
100582|NCT01998958|245942|P8|STARTED|Follow-up Phase||0
100583|NCT01998958|245943|P7|STARTED|Follow-up Phase||0
100584|NCT01998958|245944|P6|STARTED|Follow-up Phase||0
100585|NCT01998958|245945|P5|STARTED|Follow-up Phase||0
100586|NCT01998958|245946|P4|STARTED|Follow-up Phase||0
100587|NCT01998958|245947|P3|STARTED|Follow-up Phase||0
100588|NCT01998958|245948|P2|STARTED|Follow-up Phase||0
100589|NCT01998958|245949|P1|STARTED|Follow-up Phase||0
100590|NCT01998958|245918|P32|NOT COMPLETED|Open Label Phase (Optional)||0
100591|NCT01998958|245919|P31|NOT COMPLETED|Open Label Phase (Optional)||0
100592|NCT01998958|245920|P30|NOT COMPLETED|Open Label Phase (Optional)||0
100593|NCT01998958|245921|P29|NOT COMPLETED|Open Label Phase (Optional)||0
100594|NCT01998958|245922|P28|NOT COMPLETED|Open Label Phase (Optional)||0
100595|NCT01998958|245923|P27|NOT COMPLETED|Open Label Phase (Optional)||0
100596|NCT01998958|245924|P26|NOT COMPLETED|Open Label Phase (Optional)||0
100597|NCT01998958|245925|P25|NOT COMPLETED|Open Label Phase (Optional)||0
100598|NCT01998958|245926|P24|NOT COMPLETED|Open Label Phase (Optional)||4
100599|NCT01998958|245927|P23|NOT COMPLETED|Open Label Phase (Optional)||9
100600|NCT01998958|245928|P22|NOT COMPLETED|Open Label Phase (Optional)||3
100601|NCT01998958|245929|P21|NOT COMPLETED|Open Label Phase (Optional)||0
100602|NCT01998958|245930|P20|NOT COMPLETED|Open Label Phase (Optional)||0
100603|NCT01998958|245931|P19|NOT COMPLETED|Open Label Phase (Optional)||0
100604|NCT01998958|245932|P18|NOT COMPLETED|Open Label Phase (Optional)||0
100605|NCT01998958|245933|P17|NOT COMPLETED|Open Label Phase (Optional)||0
100606|NCT01998958|245934|P16|NOT COMPLETED|Open Label Phase (Optional)||0
100607|NCT01998958|245935|P15|NOT COMPLETED|Open Label Phase (Optional)||0
100608|NCT01998958|245936|P14|NOT COMPLETED|Open Label Phase (Optional)||0
100609|NCT01998958|245937|P13|NOT COMPLETED|Open Label Phase (Optional)||0
100610|NCT01998958|245938|P12|NOT COMPLETED|Open Label Phase (Optional)||0
100611|NCT01998958|245939|P11|NOT COMPLETED|Open Label Phase (Optional)||0
100612|NCT01998958|245940|P10|NOT COMPLETED|Open Label Phase (Optional)||0
100613|NCT01998958|245941|P9|NOT COMPLETED|Open Label Phase (Optional)||0
100614|NCT01998958|245942|P8|NOT COMPLETED|Open Label Phase (Optional)||0
100615|NCT01998958|245943|P7|NOT COMPLETED|Open Label Phase (Optional)||0
100616|NCT01998958|245944|P6|NOT COMPLETED|Open Label Phase (Optional)||0
100617|NCT01998958|245945|P5|NOT COMPLETED|Open Label Phase (Optional)||0
100618|NCT01998958|245946|P4|NOT COMPLETED|Open Label Phase (Optional)||0
100619|NCT01998958|245947|P3|NOT COMPLETED|Open Label Phase (Optional)||0
100620|NCT01998958|245948|P2|NOT COMPLETED|Open Label Phase (Optional)||0
100621|NCT01998958|245949|P1|NOT COMPLETED|Open Label Phase (Optional)||0
100622|NCT01998958|245918|P32|COMPLETED|Open Label Phase (Optional)||0
100623|NCT01998958|245919|P31|COMPLETED|Open Label Phase (Optional)||0
100624|NCT01998958|245920|P30|COMPLETED|Open Label Phase (Optional)||0
100625|NCT01998958|245921|P29|COMPLETED|Open Label Phase (Optional)||0
100626|NCT01998958|245922|P28|COMPLETED|Open Label Phase (Optional)||0
100627|NCT01998958|245923|P27|COMPLETED|Open Label Phase (Optional)||19
100628|NCT01998958|245924|P26|COMPLETED|Open Label Phase (Optional)||7
100629|NCT01998958|245925|P25|COMPLETED|Open Label Phase (Optional)||13
100630|NCT01998958|245926|P24|COMPLETED|Open Label Phase (Optional)||23
100631|NCT01998958|245927|P23|COMPLETED|Open Label Phase (Optional)||11
100632|NCT01998958|245928|P22|COMPLETED|Open Label Phase (Optional)||7
100633|NCT01998958|245929|P21|COMPLETED|Open Label Phase (Optional)||0
100634|NCT01998958|245930|P20|COMPLETED|Open Label Phase (Optional)||0
100635|NCT01998958|245931|P19|COMPLETED|Open Label Phase (Optional)||0
100636|NCT01998958|245932|P18|COMPLETED|Open Label Phase (Optional)||0
100637|NCT01998958|245933|P17|COMPLETED|Open Label Phase (Optional)||0
100638|NCT01998958|245934|P16|COMPLETED|Open Label Phase (Optional)||0
100639|NCT01998958|245935|P15|COMPLETED|Open Label Phase (Optional)||0
100640|NCT01998958|245936|P14|COMPLETED|Open Label Phase (Optional)||0
100641|NCT01998958|245937|P13|COMPLETED|Open Label Phase (Optional)||0
100642|NCT01998958|245938|P12|COMPLETED|Open Label Phase (Optional)||0
100643|NCT01998958|245939|P11|COMPLETED|Open Label Phase (Optional)||0
100644|NCT01998958|245940|P10|COMPLETED|Open Label Phase (Optional)||0
100645|NCT01998958|245941|P9|COMPLETED|Open Label Phase (Optional)||0
100646|NCT01998958|245942|P8|COMPLETED|Open Label Phase (Optional)||0
100647|NCT01998958|245943|P7|COMPLETED|Open Label Phase (Optional)||0
100648|NCT01998958|245944|P6|COMPLETED|Open Label Phase (Optional)||0
100649|NCT01998958|245945|P5|COMPLETED|Open Label Phase (Optional)||0
100650|NCT01998958|245946|P4|COMPLETED|Open Label Phase (Optional)||0
100651|NCT01998958|245947|P3|COMPLETED|Open Label Phase (Optional)||0
100652|NCT01998958|245948|P2|COMPLETED|Open Label Phase (Optional)||0
100653|NCT01998958|245949|P1|COMPLETED|Open Label Phase (Optional)||0
100654|NCT01998958|245918|P32|STARTED|Open Label Phase (Optional)||0
100655|NCT01998958|245919|P31|STARTED|Open Label Phase (Optional)||0
100656|NCT01998958|245920|P30|STARTED|Open Label Phase (Optional)||0
100657|NCT01998958|245921|P29|STARTED|Open Label Phase (Optional)||0
100658|NCT01998958|245922|P28|STARTED|Open Label Phase (Optional)||0
100659|NCT01998958|245923|P27|STARTED|Open Label Phase (Optional)||19
100660|NCT01998958|245924|P26|STARTED|Open Label Phase (Optional)||7
100661|NCT01998958|245925|P25|STARTED|Open Label Phase (Optional)||13
100662|NCT01998958|245926|P24|STARTED|Open Label Phase (Optional)||27
100663|NCT01998958|245927|P23|STARTED|Open Label Phase (Optional)||20
100664|NCT01998958|245928|P22|STARTED|Open Label Phase (Optional)||10
100665|NCT01998958|245929|P21|STARTED|Open Label Phase (Optional)||0
100666|NCT01998958|245930|P20|STARTED|Open Label Phase (Optional)||0
100667|NCT01998958|245931|P19|STARTED|Open Label Phase (Optional)||0
100668|NCT01998958|245932|P18|STARTED|Open Label Phase (Optional)||0
100669|NCT01998958|245933|P17|STARTED|Open Label Phase (Optional)||0
100670|NCT01998958|245934|P16|STARTED|Open Label Phase (Optional)||0
100671|NCT01998958|245935|P15|STARTED|Open Label Phase (Optional)||0
100672|NCT01998958|245936|P14|STARTED|Open Label Phase (Optional)||0
100673|NCT01998958|245937|P13|STARTED|Open Label Phase (Optional)||0
100674|NCT01998958|245938|P12|STARTED|Open Label Phase (Optional)||0
100675|NCT01998958|245939|P11|STARTED|Open Label Phase (Optional)||0
100676|NCT01998958|245940|P10|STARTED|Open Label Phase (Optional)||0
100677|NCT01998958|245941|P9|STARTED|Open Label Phase (Optional)||0
100678|NCT01998958|245942|P8|STARTED|Open Label Phase (Optional)||0
100679|NCT01998958|245943|P7|STARTED|Open Label Phase (Optional)||0
100680|NCT01998958|245944|P6|STARTED|Open Label Phase (Optional)||0
100681|NCT01998958|245945|P5|STARTED|Open Label Phase (Optional)||0
100682|NCT01998958|245946|P4|STARTED|Open Label Phase (Optional)||0
100683|NCT01998958|245947|P3|STARTED|Open Label Phase (Optional)||0
100684|NCT01998958|245948|P2|STARTED|Open Label Phase (Optional)||0
100685|NCT01998958|245949|P1|STARTED|Open Label Phase (Optional)||0
100686|NCT01998958|245918|P32|NOT COMPLETED|Period 2 (Panel A and B)||0
100687|NCT01998958|245919|P31|NOT COMPLETED|Period 2 (Panel A and B)||0
100688|NCT01998958|245920|P30|NOT COMPLETED|Period 2 (Panel A and B)||0
100689|NCT01998958|245921|P29|NOT COMPLETED|Period 2 (Panel A and B)||0
100690|NCT01998958|245922|P28|NOT COMPLETED|Period 2 (Panel A and B)||0
100691|NCT01998958|245923|P27|NOT COMPLETED|Period 2 (Panel A and B)||0
100692|NCT01998958|245924|P26|NOT COMPLETED|Period 2 (Panel A and B)||0
100693|NCT01998958|245925|P25|NOT COMPLETED|Period 2 (Panel A and B)||0
100694|NCT01998958|245926|P24|NOT COMPLETED|Period 2 (Panel A and B)||0
100695|NCT01998958|245927|P23|NOT COMPLETED|Period 2 (Panel A and B)||0
100696|NCT01998958|245928|P22|NOT COMPLETED|Period 2 (Panel A and B)||0
100697|NCT01998958|245929|P21|NOT COMPLETED|Period 2 (Panel A and B)||0
100698|NCT01998958|245930|P20|NOT COMPLETED|Period 2 (Panel A and B)||0
100699|NCT01998958|245931|P19|NOT COMPLETED|Period 2 (Panel A and B)||1
100700|NCT01998958|245932|P18|NOT COMPLETED|Period 2 (Panel A and B)||0
100701|NCT01998958|245933|P17|NOT COMPLETED|Period 2 (Panel A and B)||0
100702|NCT01998958|245934|P16|NOT COMPLETED|Period 2 (Panel A and B)||0
100703|NCT01998958|245935|P15|NOT COMPLETED|Period 2 (Panel A and B)||2
100704|NCT01998958|245936|P14|NOT COMPLETED|Period 2 (Panel A and B)||0
100705|NCT01998958|245937|P13|NOT COMPLETED|Period 2 (Panel A and B)||0
100706|NCT01998958|245938|P12|NOT COMPLETED|Period 2 (Panel A and B)||0
100707|NCT01998958|245939|P11|NOT COMPLETED|Period 2 (Panel A and B)||1
100708|NCT01998958|245940|P10|NOT COMPLETED|Period 2 (Panel A and B)||0
100709|NCT01998958|245941|P9|NOT COMPLETED|Period 2 (Panel A and B)||0
100710|NCT01998958|245942|P8|NOT COMPLETED|Period 2 (Panel A and B)||0
100711|NCT01998958|245943|P7|NOT COMPLETED|Period 2 (Panel A and B)||0
100712|NCT01998958|245944|P6|NOT COMPLETED|Period 2 (Panel A and B)||0
100713|NCT01998958|245945|P5|NOT COMPLETED|Period 2 (Panel A and B)||0
100714|NCT01998958|245946|P4|NOT COMPLETED|Period 2 (Panel A and B)||0
100715|NCT01998958|245947|P3|NOT COMPLETED|Period 2 (Panel A and B)||0
100716|NCT01998958|245948|P2|NOT COMPLETED|Period 2 (Panel A and B)||0
100717|NCT01998958|245949|P1|NOT COMPLETED|Period 2 (Panel A and B)||0
100718|NCT01998958|245918|P32|COMPLETED|Period 2 (Panel A and B)||0
100719|NCT01998958|245919|P31|COMPLETED|Period 2 (Panel A and B)||0
100720|NCT01998958|245920|P30|COMPLETED|Period 2 (Panel A and B)||0
100721|NCT01998958|245921|P29|COMPLETED|Period 2 (Panel A and B)||0
100722|NCT01998958|245922|P28|COMPLETED|Period 2 (Panel A and B)||0
100723|NCT01998958|245923|P27|COMPLETED|Period 2 (Panel A and B)||0
100724|NCT01998958|245924|P26|COMPLETED|Period 2 (Panel A and B)||0
100725|NCT01998958|245925|P25|COMPLETED|Period 2 (Panel A and B)||0
100726|NCT01998958|245926|P24|COMPLETED|Period 2 (Panel A and B)||0
100727|NCT01998958|245927|P23|COMPLETED|Period 2 (Panel A and B)||0
100728|NCT01998958|245928|P22|COMPLETED|Period 2 (Panel A and B)||0
100729|NCT01998958|245929|P21|COMPLETED|Period 2 (Panel A and B)||9
100730|NCT01998958|245930|P20|COMPLETED|Period 2 (Panel A and B)||11
100731|NCT01998958|245931|P19|COMPLETED|Period 2 (Panel A and B)||2
100732|NCT01998958|245932|P18|COMPLETED|Period 2 (Panel A and B)||5
100733|NCT01998958|245933|P17|COMPLETED|Period 2 (Panel A and B)||8
100734|NCT01998958|245934|P16|COMPLETED|Period 2 (Panel A and B)||5
100735|NCT01998958|245935|P15|COMPLETED|Period 2 (Panel A and B)||10
100736|NCT01998958|245936|P14|COMPLETED|Period 2 (Panel A and B)||11
100737|NCT01998958|245937|P13|COMPLETED|Period 2 (Panel A and B)||8
100738|NCT01998958|245938|P12|COMPLETED|Period 2 (Panel A and B)||5
100739|NCT01998958|245939|P11|COMPLETED|Period 2 (Panel A and B)||8
100740|NCT01998958|245940|P10|COMPLETED|Period 2 (Panel A and B)||8
100741|NCT01998958|245941|P9|COMPLETED|Period 2 (Panel A and B)||4
100742|NCT01998958|245942|P8|COMPLETED|Period 2 (Panel A and B)||6
100743|NCT01998958|245943|P7|COMPLETED|Period 2 (Panel A and B)||0
100744|NCT01998958|245944|P6|COMPLETED|Period 2 (Panel A and B)||0
100745|NCT01998958|245945|P5|COMPLETED|Period 2 (Panel A and B)||0
100746|NCT01998958|245946|P4|COMPLETED|Period 2 (Panel A and B)||0
100747|NCT01998958|245947|P3|COMPLETED|Period 2 (Panel A and B)||0
100748|NCT01998958|245948|P2|COMPLETED|Period 2 (Panel A and B)||0
100749|NCT01998958|245949|P1|COMPLETED|Period 2 (Panel A and B)||0
100750|NCT01998958|245918|P32|STARTED|Period 2 (Panel A and B)||0
100751|NCT01998958|245919|P31|STARTED|Period 2 (Panel A and B)||0
100752|NCT01998958|245920|P30|STARTED|Period 2 (Panel A and B)||0
100753|NCT01998958|245921|P29|STARTED|Period 2 (Panel A and B)||0
100754|NCT01998958|245922|P28|STARTED|Period 2 (Panel A and B)||0
100755|NCT01998958|245923|P27|STARTED|Period 2 (Panel A and B)||0
100756|NCT01998958|245924|P26|STARTED|Period 2 (Panel A and B)||0
100757|NCT01998958|245925|P25|STARTED|Period 2 (Panel A and B)||0
100758|NCT01998958|245926|P24|STARTED|Period 2 (Panel A and B)||0
100759|NCT01998958|245927|P23|STARTED|Period 2 (Panel A and B)||0
100760|NCT01998958|245928|P22|STARTED|Period 2 (Panel A and B)||0
100761|NCT01998958|245929|P21|STARTED|Period 2 (Panel A and B)||9
100762|NCT01998958|245930|P20|STARTED|Period 2 (Panel A and B)||11
100763|NCT01998958|245931|P19|STARTED|Period 2 (Panel A and B)||3
100764|NCT01998958|245932|P18|STARTED|Period 2 (Panel A and B)||5
100765|NCT01998958|245933|P17|STARTED|Period 2 (Panel A and B)||8
100766|NCT01998958|245934|P16|STARTED|Period 2 (Panel A and B)||5
100767|NCT01998958|245935|P15|STARTED|Period 2 (Panel A and B)||12
100768|NCT01998958|245936|P14|STARTED|Period 2 (Panel A and B)||11
100769|NCT01998958|245937|P13|STARTED|Period 2 (Panel A and B)||8
100770|NCT01998958|245938|P12|STARTED|Period 2 (Panel A and B)||5
100771|NCT01998958|245939|P11|STARTED|Period 2 (Panel A and B)||9
100772|NCT01998958|245940|P10|STARTED|Period 2 (Panel A and B)||8
100773|NCT01998958|245941|P9|STARTED|Period 2 (Panel A and B)||4
100774|NCT01998958|245942|P8|STARTED|Period 2 (Panel A and B)||6
100775|NCT01998958|245943|P7|STARTED|Period 2 (Panel A and B)||0
100776|NCT01998958|245944|P6|STARTED|Period 2 (Panel A and B)||0
100777|NCT01998958|245945|P5|STARTED|Period 2 (Panel A and B)||0
100778|NCT01998958|245946|P4|STARTED|Period 2 (Panel A and B)||0
100779|NCT01998958|245947|P3|STARTED|Period 2 (Panel A and B)||0
100780|NCT01998958|245948|P2|STARTED|Period 2 (Panel A and B)||0
100781|NCT01998958|245949|P1|STARTED|Period 2 (Panel A and B)||0
100782|NCT01998958|245918|P32|NOT COMPLETED|Period 1 (Panel A and B)||0
100783|NCT01998958|245919|P31|NOT COMPLETED|Period 1 (Panel A and B)||0
100784|NCT01998958|245920|P30|NOT COMPLETED|Period 1 (Panel A and B)||0
100785|NCT01998958|245921|P29|NOT COMPLETED|Period 1 (Panel A and B)||0
100786|NCT01998958|245922|P28|NOT COMPLETED|Period 1 (Panel A and B)||0
100787|NCT01998958|245923|P27|NOT COMPLETED|Period 1 (Panel A and B)||0
100788|NCT01998958|245924|P26|NOT COMPLETED|Period 1 (Panel A and B)||0
100789|NCT01998958|245925|P25|NOT COMPLETED|Period 1 (Panel A and B)||0
100790|NCT01998958|245926|P24|NOT COMPLETED|Period 1 (Panel A and B)||0
100791|NCT01998958|245927|P23|NOT COMPLETED|Period 1 (Panel A and B)||0
100792|NCT01998958|245928|P22|NOT COMPLETED|Period 1 (Panel A and B)||0
100793|NCT01998958|245929|P21|NOT COMPLETED|Period 1 (Panel A and B)||0
100794|NCT01998958|245930|P20|NOT COMPLETED|Period 1 (Panel A and B)||0
100795|NCT01998958|245931|P19|NOT COMPLETED|Period 1 (Panel A and B)||0
100796|NCT01998958|245932|P18|NOT COMPLETED|Period 1 (Panel A and B)||0
100797|NCT01998958|245933|P17|NOT COMPLETED|Period 1 (Panel A and B)||0
100798|NCT01998958|245934|P16|NOT COMPLETED|Period 1 (Panel A and B)||0
100799|NCT01998958|245935|P15|NOT COMPLETED|Period 1 (Panel A and B)||0
100800|NCT01998958|245936|P14|NOT COMPLETED|Period 1 (Panel A and B)||0
100801|NCT01998958|245937|P13|NOT COMPLETED|Period 1 (Panel A and B)||0
100802|NCT01998958|245938|P12|NOT COMPLETED|Period 1 (Panel A and B)||0
100803|NCT01998958|245939|P11|NOT COMPLETED|Period 1 (Panel A and B)||0
100804|NCT01998958|245940|P10|NOT COMPLETED|Period 1 (Panel A and B)||0
100805|NCT01998958|245941|P9|NOT COMPLETED|Period 1 (Panel A and B)||0
100806|NCT01998958|245942|P8|NOT COMPLETED|Period 1 (Panel A and B)||0
100807|NCT01998958|245943|P7|NOT COMPLETED|Period 1 (Panel A and B)||0
100808|NCT01998958|245944|P6|NOT COMPLETED|Period 1 (Panel A and B)||0
100809|NCT01998958|245945|P5|NOT COMPLETED|Period 1 (Panel A and B)||0
100810|NCT01998958|245946|P4|NOT COMPLETED|Period 1 (Panel A and B)||0
100811|NCT01998958|245947|P3|NOT COMPLETED|Period 1 (Panel A and B)||0
100812|NCT01998958|245948|P2|NOT COMPLETED|Period 1 (Panel A and B)||3
100813|NCT01998958|245949|P1|NOT COMPLETED|Period 1 (Panel A and B)||1
100814|NCT01998958|245918|P32|COMPLETED|Period 1 (Panel A and B)||0
100815|NCT01998958|245919|P31|COMPLETED|Period 1 (Panel A and B)||0
100816|NCT01998958|245920|P30|COMPLETED|Period 1 (Panel A and B)||0
100817|NCT01998958|245921|P29|COMPLETED|Period 1 (Panel A and B)||0
100818|NCT01998958|245922|P28|COMPLETED|Period 1 (Panel A and B)||0
100819|NCT01998958|245923|P27|COMPLETED|Period 1 (Panel A and B)||0
100820|NCT01998958|245924|P26|COMPLETED|Period 1 (Panel A and B)||0
100821|NCT01998958|245925|P25|COMPLETED|Period 1 (Panel A and B)||0
100822|NCT01998958|245926|P24|COMPLETED|Period 1 (Panel A and B)||0
100823|NCT01998958|245927|P23|COMPLETED|Period 1 (Panel A and B)||0
100824|NCT01998958|245928|P22|COMPLETED|Period 1 (Panel A and B)||0
100825|NCT01998958|245929|P21|COMPLETED|Period 1 (Panel A and B)||0
100826|NCT01998958|245930|P20|COMPLETED|Period 1 (Panel A and B)||0
100827|NCT01998958|245931|P19|COMPLETED|Period 1 (Panel A and B)||0
100828|NCT01998958|245932|P18|COMPLETED|Period 1 (Panel A and B)||0
100829|NCT01998958|245933|P17|COMPLETED|Period 1 (Panel A and B)||0
100830|NCT01998958|245934|P16|COMPLETED|Period 1 (Panel A and B)||0
100831|NCT01998958|245935|P15|COMPLETED|Period 1 (Panel A and B)||0
100832|NCT01998958|245936|P14|COMPLETED|Period 1 (Panel A and B)||0
100833|NCT01998958|245937|P13|COMPLETED|Period 1 (Panel A and B)||0
100834|NCT01998958|245938|P12|COMPLETED|Period 1 (Panel A and B)||0
100835|NCT01998958|245939|P11|COMPLETED|Period 1 (Panel A and B)||0
100836|NCT01998958|245940|P10|COMPLETED|Period 1 (Panel A and B)||0
100837|NCT01998958|245941|P9|COMPLETED|Period 1 (Panel A and B)||0
100838|NCT01998958|245942|P8|COMPLETED|Period 1 (Panel A and B)||0
100839|NCT01998958|245943|P7|COMPLETED|Period 1 (Panel A and B)||9
100840|NCT01998958|245944|P6|COMPLETED|Period 1 (Panel A and B)||11
100841|NCT01998958|245945|P5|COMPLETED|Period 1 (Panel A and B)||21
100842|NCT01998958|245946|P4|COMPLETED|Period 1 (Panel A and B)||12
100843|NCT01998958|245947|P3|COMPLETED|Period 1 (Panel A and B)||11
100844|NCT01998958|245948|P2|COMPLETED|Period 1 (Panel A and B)||8
100845|NCT01998958|245949|P1|COMPLETED|Period 1 (Panel A and B)||32
100846|NCT01998958|245918|P32|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
100847|NCT01998958|245919|P31|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
100848|NCT01998958|245920|P30|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
100849|NCT01998958|245921|P29|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
100850|NCT01998958|245922|P28|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
100851|NCT01998958|245923|P27|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
100852|NCT01998958|245924|P26|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
100853|NCT01998958|245925|P25|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
100854|NCT01998958|245926|P24|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
100855|NCT01998958|245927|P23|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
100856|NCT01998958|245928|P22|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
100857|NCT01998958|245929|P21|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
100858|NCT01998958|245930|P20|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
100859|NCT01998958|245931|P19|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
100860|NCT01998958|245932|P18|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
100861|NCT01998958|245933|P17|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
100862|NCT01998958|245934|P16|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
100863|NCT01998958|245935|P15|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
100864|NCT01998958|245936|P14|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
100865|NCT01998958|245937|P13|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
100866|NCT01998958|245938|P12|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
100867|NCT01998958|245939|P11|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
100868|NCT01998958|245940|P10|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
100869|NCT01998958|245941|P9|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
100870|NCT01998958|245942|P8|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
100871|NCT01998958|245943|P7|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
100872|NCT01998958|245944|P6|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
100873|NCT01998958|245945|P5|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
100874|NCT01998958|245946|P4|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
100875|NCT01998958|245947|P3|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
100876|NCT01998958|245948|P2|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
100877|NCT01998958|245949|P1|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||5
100878|NCT01998958|245918|P32|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
100879|NCT01998958|245919|P31|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
100880|NCT01998958|245920|P30|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
100881|NCT01998958|245921|P29|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
100882|NCT01998958|245922|P28|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
100883|NCT01998958|245923|P27|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
100884|NCT01998958|245924|P26|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
100885|NCT01998958|245925|P25|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
100886|NCT01998958|245926|P24|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
100887|NCT01998958|245927|P23|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
100888|NCT01998958|245928|P22|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
100889|NCT01998958|245929|P21|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
100890|NCT01998958|245930|P20|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
100891|NCT01998958|245931|P19|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
100892|NCT01998958|245932|P18|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
100893|NCT01998958|245933|P17|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
100894|NCT01998958|245934|P16|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
100895|NCT01998958|245935|P15|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
100896|NCT01998958|245936|P14|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
100897|NCT01998958|245937|P13|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
100898|NCT01998958|245938|P12|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
100899|NCT01998958|245939|P11|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
100900|NCT01998958|245940|P10|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
100901|NCT01998958|245941|P9|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
100902|NCT01998958|245942|P8|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
100903|NCT01998958|245943|P7|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
100904|NCT01998958|245944|P6|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
100905|NCT01998958|245945|P5|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
100984|NCT01998906|246112|P1|NOT COMPLETED|Overall Study||114
100906|NCT01998958|245946|P4|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
100907|NCT01998958|245947|P3|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
100908|NCT01998958|245948|P2|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
100909|NCT01998958|245949|P1|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||8
100910|NCT01998958|245918|P32|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
100911|NCT01998958|245919|P31|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
100912|NCT01998958|245920|P30|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
100913|NCT01998958|245921|P29|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
100914|NCT01998958|245922|P28|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
100915|NCT01998958|245923|P27|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
100916|NCT01998958|245924|P26|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
100917|NCT01998958|245925|P25|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
100918|NCT01998958|245926|P24|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
100919|NCT01998958|245927|P23|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
100920|NCT01998958|245928|P22|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
100921|NCT01998958|245929|P21|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
100922|NCT01998958|245930|P20|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
100923|NCT01998958|245931|P19|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
100924|NCT01998958|245932|P18|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
100925|NCT01998958|245933|P17|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
100926|NCT01998958|245934|P16|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
100927|NCT01998958|245935|P15|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
100928|NCT01998958|245936|P14|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
100929|NCT01998958|245937|P13|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
100930|NCT01998958|245938|P12|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
100931|NCT01998958|245939|P11|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
100932|NCT01998958|245940|P10|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
100933|NCT01998958|245941|P9|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
100934|NCT01998958|245942|P8|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
100935|NCT01998958|245943|P7|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
100936|NCT01998958|245944|P6|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
100937|NCT01998958|245945|P5|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
100938|NCT01998958|245946|P4|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
100939|NCT01998958|245947|P3|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
100940|NCT01998958|245948|P2|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
100941|NCT01998958|245949|P1|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||9
100942|NCT01998958|245918|P32|STARTED|Period 1 (Panel A and B)||0
100943|NCT01998958|245919|P31|STARTED|Period 1 (Panel A and B)||0
100944|NCT01998958|245920|P30|STARTED|Period 1 (Panel A and B)||0
100945|NCT01998958|245921|P29|STARTED|Period 1 (Panel A and B)||0
100946|NCT01998958|245922|P28|STARTED|Period 1 (Panel A and B)||0
100947|NCT01998958|245923|P27|STARTED|Period 1 (Panel A and B)||0
100948|NCT01998958|245924|P26|STARTED|Period 1 (Panel A and B)||0
100949|NCT01998958|245925|P25|STARTED|Period 1 (Panel A and B)||0
100950|NCT01998958|245926|P24|STARTED|Period 1 (Panel A and B)||0
100951|NCT01998958|245927|P23|STARTED|Period 1 (Panel A and B)||0
100952|NCT01998958|245928|P22|STARTED|Period 1 (Panel A and B)||0
100953|NCT01998958|245929|P21|STARTED|Period 1 (Panel A and B)||0
100954|NCT01998958|245930|P20|STARTED|Period 1 (Panel A and B)||0
100955|NCT01998958|245931|P19|STARTED|Period 1 (Panel A and B)||0
100956|NCT01998958|245932|P18|STARTED|Period 1 (Panel A and B)||0
100957|NCT01998958|245933|P17|STARTED|Period 1 (Panel A and B)||0
100958|NCT01998958|245934|P16|STARTED|Period 1 (Panel A and B)||0
100959|NCT01998958|245935|P15|STARTED|Period 1 (Panel A and B)||0
100960|NCT01998958|245936|P14|STARTED|Period 1 (Panel A and B)||0
100961|NCT01998958|245937|P13|STARTED|Period 1 (Panel A and B)||0
100962|NCT01998958|245938|P12|STARTED|Period 1 (Panel A and B)||0
100963|NCT01998958|245939|P11|STARTED|Period 1 (Panel A and B)||0
100964|NCT01998958|245940|P10|STARTED|Period 1 (Panel A and B)||0
100965|NCT01998958|245941|P9|STARTED|Period 1 (Panel A and B)||0
100966|NCT01998958|245942|P8|STARTED|Period 1 (Panel A and B)||0
100967|NCT01998958|245943|P7|STARTED|Period 1 (Panel A and B)||9
100968|NCT01998958|245944|P6|STARTED|Period 1 (Panel A and B)||11
100969|NCT01998958|245945|P5|STARTED|Period 1 (Panel A and B)||21
100970|NCT01998958|245946|P4|STARTED|Period 1 (Panel A and B)||12
100971|NCT01998958|245947|P3|STARTED|Period 1 (Panel A and B)||11
100972|NCT01998958|245948|P2|STARTED|Period 1 (Panel A and B)||11
100973|NCT01998958|245949|P1|STARTED|Period 1 (Panel A and B)||33
100974|NCT01998919|246088|P2|NOT COMPLETED|Overall Study||35
100975|NCT01998919|246089|P1|NOT COMPLETED|Overall Study||42
100976|NCT01998919|246088|P2|COMPLETED|Overall Study||39
100977|NCT01998919|246089|P1|COMPLETED|Overall Study||37
100978|NCT01998919|246088|P2|Randomized|Overall Study|One participant withdrew consent prior to 1st dose and was excluded from safety analysis population.|76
100979|NCT01998919|246089|P1|Randomized|Overall Study|1 participant randomized to erlotinib didn't receive study drug; analyzed in placebo for safety|78
100980|NCT01998919|246088|P2|STARTED|Overall Study||74
100981|NCT01998919|246089|P1|STARTED|Overall Study||79
100982|NCT01998906|246110|P3|NOT COMPLETED|Overall Study||98
100983|NCT01998906|246111|P2|NOT COMPLETED|Overall Study||114
100985|NCT01998906|246110|P3|COMPLETED|Overall Study||1
100986|NCT01998906|246111|P2|COMPLETED|Overall Study||2
100987|NCT01998906|246112|P1|COMPLETED|Overall Study||1
100988|NCT01998906|246110|P3|STARTED|Overall Study||99
100989|NCT01998906|246111|P2|STARTED|Overall Study||116
100990|NCT01998906|246112|P1|STARTED|Overall Study||115
100991|NCT01998893|246156|P1|NOT COMPLETED|Overall Study||17
100992|NCT01998893|246156|P1|COMPLETED|Overall Study||21
100993|NCT01998893|246156|P1|2nd Treatment Cycle Completed Until PD|Overall Study||3
100994|NCT01998893|246156|P1|2nd Treatment Cycle Started|Overall Study||5
100995|NCT01998893|246156|P1|1st Treatment Cycle Completed Until PD|Overall Study|Progressive disease (PD)|30
100996|NCT01998893|246156|P1|STARTED|Overall Study||38
100997|NCT01998880|246168|P2|NOT COMPLETED|Overall Study||40
100998|NCT01998880|246169|P1|NOT COMPLETED|Overall Study||28
100999|NCT01998880|246168|P2|COMPLETED|Overall Study||78
101000|NCT01998880|246169|P1|COMPLETED|Overall Study|Completed=Completed treatment.|205
101001|NCT01998880|246168|P2|Received Study Drug|Overall Study||116
101002|NCT01998880|246169|P1|Received Study Drug|Overall Study||230
101003|NCT01998880|246168|P2|STARTED|Overall Study||118
101004|NCT01998880|246169|P1|STARTED|Overall Study||233
101005|NCT01998737|246201|P2|NOT COMPLETED|Overall Study||0
101006|NCT01998737|246202|P1|NOT COMPLETED|Overall Study||23
101007|NCT01998737|246201|P2|COMPLETED|Overall Study||100
101008|NCT01998737|246202|P1|COMPLETED|Overall Study||888
101009|NCT01998737|246201|P2|STARTED|Overall Study||100
101010|NCT01998737|246202|P1|STARTED|Overall Study||911
101011|NCT01998633|246214|P1|NOT COMPLETED|Overall Study||1
101012|NCT01998633|246214|P1|COMPLETED|Overall Study||46
101013|NCT01998633|246214|P1|STARTED|Overall Study||47
101014|NCT01998581|246232|P2|NOT COMPLETED|Overall Study||12
101015|NCT01998581|246233|P1|NOT COMPLETED|Overall Study||46
101016|NCT01998581|246232|P2|COMPLETED|Overall Study||44
101017|NCT01998581|246233|P1|COMPLETED|Overall Study||123
101018|NCT01998581|246232|P2|STARTED|Overall Study||56
101019|NCT01998581|246233|P1|STARTED|Overall Study||169
101020|NCT01998477|246246|P2|NOT COMPLETED|Overall Study||5
101021|NCT01998477|246247|P1|NOT COMPLETED|Overall Study||10
101022|NCT01998477|246246|P2|COMPLETED|Overall Study||143
101023|NCT01998477|246247|P1|COMPLETED|Overall Study||272
101024|NCT01998477|246246|P2|STARTED|Overall Study||148
101025|NCT01998477|246247|P1|STARTED|Overall Study||282
101026|NCT01998438|246281|P3|NOT COMPLETED|Overall Study||0
101027|NCT01998438|246282|P2|NOT COMPLETED|Overall Study||0
101028|NCT01998438|246283|P1|NOT COMPLETED|Overall Study||0
101029|NCT01998438|246281|P3|COMPLETED|Overall Study||318
101030|NCT01998438|246282|P2|COMPLETED|Overall Study||318
101031|NCT01998438|246283|P1|COMPLETED|Overall Study||319
101032|NCT01998438|246281|P3|STARTED|Overall Study||318
101033|NCT01998438|246282|P2|STARTED|Overall Study||318
101034|NCT01998438|246283|P1|STARTED|Overall Study||319
101035|NCT01998399|246293|P2|NOT COMPLETED|Overall Study||9
101036|NCT01998399|246294|P1|NOT COMPLETED|Overall Study||8
101037|NCT01998399|246293|P2|COMPLETED|Overall Study||4
101038|NCT01998399|246294|P1|COMPLETED|Overall Study||4
101039|NCT01998399|246293|P2|STARTED|Overall Study||13
101040|NCT01998399|246294|P1|STARTED|Overall Study||12
101041|NCT01998360|246328|P2|NOT COMPLETED|Overall Study||0
101042|NCT01998360|246329|P1|NOT COMPLETED|Overall Study||0
101043|NCT01998360|246328|P2|COMPLETED|Overall Study||50
101044|NCT01998360|246329|P1|COMPLETED|Overall Study||50
101045|NCT01998360|246328|P2|STARTED|Overall Study||50
101046|NCT01998360|246329|P1|STARTED|Overall Study||50
101047|NCT01998269|246343|P1|NOT COMPLETED|Overall Study||0
101048|NCT01998269|246343|P1|COMPLETED|Overall Study||193
101049|NCT01998269|246343|P1|STARTED|Overall Study||193
101050|NCT01998243|246349|P2|NOT COMPLETED|Overall Study||7
101051|NCT01998243|246350|P1|NOT COMPLETED|Overall Study||8
101052|NCT01998243|246349|P2|COMPLETED|Overall Study||32
101053|NCT01998243|246350|P1|COMPLETED|Overall Study||34
101054|NCT01998243|246349|P2|STARTED|Overall Study||39
101055|NCT01998243|246350|P1|STARTED|Overall Study||42
101056|NCT01997905|246364|P1|NOT COMPLETED|Overall Study||3
101057|NCT01997905|246364|P1|COMPLETED|Overall Study||10
101058|NCT01997905|246364|P1|Baseline Completed|Overall Study||11
101059|NCT01997905|246364|P1|STARTED|Overall Study||13
101060|NCT01997892|246373|P1|NOT COMPLETED|Overall Study||68
101061|NCT01997892|246373|P1|COMPLETED|Overall Study||959
101062|NCT01997892|246373|P1|Received Darbepoetin Alfa|Overall Study||987
101063|NCT01997892|246373|P1|STARTED|Overall Study||1027
101064|NCT01997723|246385|P1|NOT COMPLETED|Overall Study||0
101065|NCT01997723|246385|P1|COMPLETED|Overall Study||75
101066|NCT01997723|246385|P1|STARTED|Overall Study||75
101067|NCT01997567|246393|P2|NOT COMPLETED|Overall Study||0
101068|NCT01997567|246394|P1|NOT COMPLETED|Overall Study||0
101069|NCT01997567|246393|P2|COMPLETED|Overall Study||0
101070|NCT01997567|246394|P1|COMPLETED|Overall Study||0
101071|NCT01997567|246393|P2|STARTED|Overall Study||0
101072|NCT01997567|246394|P1|STARTED|Overall Study||0
101073|NCT01997515|246414|P2|NOT COMPLETED|Overall Study||5
101074|NCT01997515|246415|P1|NOT COMPLETED|Overall Study||4
101075|NCT01997515|246414|P2|COMPLETED|Overall Study||35
101076|NCT01997515|246415|P1|COMPLETED|Overall Study||36
101077|NCT01997515|246414|P2|STARTED|Overall Study||40
101078|NCT01997515|246415|P1|STARTED|Overall Study||40
101079|NCT01997437|246427|P1|NOT COMPLETED|Overall Study||0
101080|NCT01997437|246427|P1|COMPLETED|Overall Study||6
101081|NCT01997437|246427|P1|STARTED|Overall Study||6
101082|NCT01997411|246439|P8|NOT COMPLETED|Overall Study||0
101083|NCT01997411|246440|P7|NOT COMPLETED|Overall Study||0
101084|NCT01997411|246441|P6|NOT COMPLETED|Overall Study||1
101085|NCT01997411|246442|P5|NOT COMPLETED|Overall Study||0
101086|NCT01997411|246443|P4|NOT COMPLETED|Overall Study||0
101087|NCT01997411|246444|P3|NOT COMPLETED|Overall Study||0
101088|NCT01997411|246445|P2|NOT COMPLETED|Overall Study||0
101089|NCT01997411|246446|P1|NOT COMPLETED|Overall Study||0
101090|NCT01997411|246439|P8|COMPLETED|Overall Study||6
101091|NCT01997411|246440|P7|COMPLETED|Overall Study||6
101092|NCT01997411|246441|P6|COMPLETED|Overall Study||5
101093|NCT01997411|246442|P5|COMPLETED|Overall Study||6
101094|NCT01997411|246443|P4|COMPLETED|Overall Study||6
101095|NCT01997411|246444|P3|COMPLETED|Overall Study||6
101096|NCT01997411|246445|P2|COMPLETED|Overall Study||6
101097|NCT01997411|246446|P1|COMPLETED|Overall Study||6
101098|NCT01997411|246439|P8|STARTED|Overall Study||6
101099|NCT01997411|246440|P7|STARTED|Overall Study||6
101100|NCT01997411|246441|P6|STARTED|Overall Study||6
101101|NCT01997411|246442|P5|STARTED|Overall Study||6
101102|NCT01997411|246443|P4|STARTED|Overall Study||6
101103|NCT01997411|246444|P3|STARTED|Overall Study||6
101104|NCT01997411|246445|P2|STARTED|Overall Study||6
101105|NCT01997411|246446|P1|STARTED|Overall Study||6
101106|NCT01997398|246536|P1|NOT COMPLETED|Overall Study||1
101107|NCT01997398|246536|P1|COMPLETED|Overall Study|One patient took PD meds 3 hours prior to 6 mo. UPDRS testing and was excluded from the analysis.|34
101108|NCT01997398|246536|P1|STARTED|Overall Study||35
101109|NCT01997333|246547|P2|NOT COMPLETED|Survival Follow up||14
101110|NCT01997333|246548|P1|NOT COMPLETED|Survival Follow up||16
101111|NCT01997333|246547|P2|COMPLETED|Survival Follow up||199
101112|NCT01997333|246548|P1|COMPLETED|Survival Follow up||76
101113|NCT01997333|246547|P2|STARTED|Survival Follow up||213
101114|NCT01997333|246548|P1|STARTED|Survival Follow up||92
101115|NCT01997333|246547|P2|NOT COMPLETED|Randomization and Treatment||203
101116|NCT01997333|246548|P1|NOT COMPLETED|Randomization and Treatment||103
101117|NCT01997333|246547|P2|COMPLETED|Randomization and Treatment||15
101118|NCT01997333|246548|P1|COMPLETED|Randomization and Treatment||6
101119|NCT01997333|246547|P2|STARTED|Randomization and Treatment||218
101120|NCT01997333|246548|P1|STARTED|Randomization and Treatment||109
101121|NCT01997229|246565|P2|NOT COMPLETED|Overall Study||2
101122|NCT01997229|246566|P1|NOT COMPLETED|Overall Study||5
101123|NCT01997229|246565|P2|COMPLETED|Overall Study||61
101124|NCT01997229|246566|P1|COMPLETED|Overall Study||57
101125|NCT01997229|246565|P2|STARTED|Overall Study||63
101126|NCT01997229|246566|P1|STARTED|Overall Study||62
101127|NCT01997216|246572|P2|NOT COMPLETED|Second 9 Hours||0
101128|NCT01997216|246573|P1|NOT COMPLETED|Second 9 Hours||0
101129|NCT01997216|246572|P2|COMPLETED|Second 9 Hours||21
101130|NCT01997216|246573|P1|COMPLETED|Second 9 Hours||19
101131|NCT01997216|246572|P2|STARTED|Second 9 Hours||21
101132|NCT01997216|246573|P1|STARTED|Second 9 Hours|One participant was not exposed to Pair 1 due to product unavailability, but was exposed to Pair 2.|19
101133|NCT01997216|246572|P2|NOT COMPLETED|First 9 Hours||0
101134|NCT01997216|246573|P1|NOT COMPLETED|First 9 Hours||0
101135|NCT01997216|246572|P2|COMPLETED|First 9 Hours||21
101136|NCT01997216|246573|P1|COMPLETED|First 9 Hours||18
101137|NCT01997216|246572|P2|STARTED|First 9 Hours||21
101138|NCT01997216|246573|P1|STARTED|First 9 Hours||18
101139|NCT01996982|246583|P1|NOT COMPLETED|Overall Study||7
101140|NCT01996982|246583|P1|COMPLETED|Overall Study||0
101141|NCT01996982|246583|P1|STARTED|Overall Study||7
101142|NCT01996917|246588|P1|NOT COMPLETED|Overall Study||0
101143|NCT01996917|246588|P1|COMPLETED|Overall Study||21
101144|NCT01996917|246588|P1|STARTED|Overall Study||21
101145|NCT01996904|246599|P2|NOT COMPLETED|Overall Study||27
101146|NCT01996904|246600|P1|NOT COMPLETED|Overall Study||38
101147|NCT01996904|246599|P2|COMPLETED|Overall Study||90
101148|NCT01996904|246600|P1|COMPLETED|Overall Study||101
101149|NCT01996904|246599|P2|STARTED|Overall Study||117
101150|NCT01996904|246600|P1|STARTED|Overall Study||139
101151|NCT01996852|246609|P3|NOT COMPLETED|Overall Study||0
101152|NCT01996852|246610|P2|NOT COMPLETED|Overall Study||0
101153|NCT01996852|246611|P1|NOT COMPLETED|Overall Study||0
101154|NCT01996852|246609|P3|COMPLETED|Overall Study||0
101155|NCT01996852|246610|P2|COMPLETED|Overall Study||0
101156|NCT01996852|246611|P1|COMPLETED|Overall Study||0
101157|NCT01996852|246609|P3|STARTED|Overall Study||0
101158|NCT01996852|246610|P2|STARTED|Overall Study||0
101159|NCT01996852|246611|P1|STARTED|Overall Study||0
101160|NCT01996813|246657|P2|NOT COMPLETED|Overall Study||0
101161|NCT01996813|246658|P1|NOT COMPLETED|Overall Study||0
101162|NCT01996813|246657|P2|COMPLETED|Overall Study||24
101163|NCT01996813|246658|P1|COMPLETED|Overall Study||23
101164|NCT01996813|246657|P2|STARTED|Overall Study||24
101165|NCT01996813|246658|P1|STARTED|Overall Study||23
101166|NCT01996748|246668|P2|NOT COMPLETED|Overall Study||6
101167|NCT01996748|246669|P1|NOT COMPLETED|Overall Study||8
101168|NCT01996748|246668|P2|COMPLETED|Overall Study||63
101169|NCT01996748|246669|P1|COMPLETED|Overall Study||58
101170|NCT01996748|246668|P2|STARTED|Overall Study||69
101171|NCT01996748|246669|P1|STARTED|Overall Study||66
101172|NCT01996709|246683|P2|NOT COMPLETED|Overall Study||1
101173|NCT01996709|246684|P1|NOT COMPLETED|Overall Study||5
101174|NCT01996709|246683|P2|COMPLETED|Overall Study||67
101175|NCT01996709|246684|P1|COMPLETED|Overall Study||61
101176|NCT01996709|246683|P2|STARTED|Overall Study||68
101177|NCT01996709|246684|P1|STARTED|Overall Study||66
101178|NCT01996657|246701|P3|NOT COMPLETED|Overall Study||14
101179|NCT01996657|246702|P2|NOT COMPLETED|Overall Study||11
101180|NCT01996657|246703|P1|NOT COMPLETED|Overall Study||13
101181|NCT01996657|246701|P3|COMPLETED|Overall Study||234
101182|NCT01996657|246702|P2|COMPLETED|Overall Study||239
101183|NCT01996657|246703|P1|COMPLETED|Overall Study||237
101184|NCT01996657|246701|P3|STARTED|Overall Study||248
101185|NCT01996657|246702|P2|STARTED|Overall Study||250
101186|NCT01996657|246703|P1|STARTED|Overall Study||250
101187|NCT01996644|246719|P2|NOT COMPLETED|Overall Study||0
101188|NCT01996644|246720|P1|NOT COMPLETED|Overall Study||0
101189|NCT01996644|246719|P2|COMPLETED|Overall Study||16
101190|NCT01996644|246720|P1|COMPLETED|Overall Study||20
101191|NCT01996644|246719|P2|STARTED|Overall Study||16
101192|NCT01996644|246720|P1|STARTED|Overall Study||20
101193|NCT01996592|246731|P1|NOT COMPLETED|Overall Study||45
101194|NCT01996592|246731|P1|COMPLETED|Overall Study||530
101195|NCT01996592|246731|P1|STARTED|Overall Study||575
101196|NCT01996410|246748|P8|NOT COMPLETED|Overall Study||0
101197|NCT01996410|246749|P7|NOT COMPLETED|Overall Study||0
101198|NCT01996410|246750|P6|NOT COMPLETED|Overall Study||0
101199|NCT01996410|246751|P5|NOT COMPLETED|Overall Study||0
101200|NCT01996410|246752|P4|NOT COMPLETED|Overall Study||0
101201|NCT01996410|246753|P3|NOT COMPLETED|Overall Study||0
101202|NCT01996410|246754|P2|NOT COMPLETED|Overall Study||0
101203|NCT01996410|246755|P1|NOT COMPLETED|Overall Study||0
101204|NCT01996410|246748|P8|COMPLETED|Overall Study||0
101205|NCT01996410|246749|P7|COMPLETED|Overall Study||0
101206|NCT01996410|246750|P6|COMPLETED|Overall Study||2
101207|NCT01996410|246751|P5|COMPLETED|Overall Study||2
101208|NCT01996410|246752|P4|COMPLETED|Overall Study||0
101209|NCT01996410|246753|P3|COMPLETED|Overall Study||0
101210|NCT01996410|246754|P2|COMPLETED|Overall Study||3
101211|NCT01996410|246755|P1|COMPLETED|Overall Study||3
101212|NCT01996410|246748|P8|STARTED|Overall Study||0
101213|NCT01996410|246749|P7|STARTED|Overall Study||0
101214|NCT01996410|246750|P6|STARTED|Overall Study||2
101215|NCT01996410|246751|P5|STARTED|Overall Study||2
101216|NCT01996410|246752|P4|STARTED|Overall Study||0
101217|NCT01996410|246753|P3|STARTED|Overall Study||0
101218|NCT01996410|246754|P2|STARTED|Overall Study||3
101219|NCT01996410|246755|P1|STARTED|Overall Study||3
101220|NCT01996332|246767|P1|NOT COMPLETED|Overall Study||1805
101221|NCT01996332|246767|P1|COMPLETED|Overall Study||0
101222|NCT01996332|246767|P1|STARTED|Overall Study||1805
101223|NCT01996319|246775|P2|NOT COMPLETED|Overall Study||3
101224|NCT01996319|246776|P1|NOT COMPLETED|Overall Study||8
101225|NCT01996319|246775|P2|COMPLETED|Overall Study||95
101226|NCT01996319|246776|P1|COMPLETED|Overall Study||88
101227|NCT01996319|246775|P2|STARTED|Overall Study||98
101228|NCT01996319|246776|P1|STARTED|Overall Study||96
101229|NCT01996241|246798|P2|NOT COMPLETED|Overall Study||235
101230|NCT01996241|246799|P1|NOT COMPLETED|Overall Study||252
101231|NCT01996241|246798|P2|COMPLETED|Overall Study||876
101232|NCT01996241|246799|P1|COMPLETED|Overall Study||912
101233|NCT01996241|246798|P2|STARTED|Overall Study||1111
101234|NCT01996241|246799|P1|STARTED|Overall Study||1164
101235|NCT01996033|246815|P1|NOT COMPLETED|Overall Study||9
101236|NCT01996033|246815|P1|COMPLETED|Overall Study||16
101237|NCT01996033|246815|P1|STARTED|Overall Study||25
101238|NCT01995552|246828|P1|NOT COMPLETED|Overall Study||17
101239|NCT01995552|246828|P1|COMPLETED|Overall Study|There were 233 patients who were eligible for primary objective analysis|233
101240|NCT01995552|246828|P1|STARTED|Overall Study|There were 249 patients were included for Baseline cohort and 233 in analysis cohort|250
101241|NCT01995539|246834|P1|NOT COMPLETED|Overall Study||33
101242|NCT01995539|246834|P1|COMPLETED|Overall Study||148
101243|NCT01995539|246834|P1|STARTED|Overall Study||181
101244|NCT01995526|246839|P1|NOT COMPLETED|Overall Study||1
101245|NCT01995526|246839|P1|COMPLETED|Overall Study||10
101246|NCT01995526|246839|P1|Received One Dose of Study Drug|Overall Study||11
101247|NCT01995526|246839|P1|STARTED|Overall Study||11
101248|NCT01995513|246847|P3|NOT COMPLETED|Double Blind Treatment Period||125
101249|NCT01995513|246848|P2|NOT COMPLETED|Double Blind Treatment Period||126
101250|NCT01995513|246849|P1|NOT COMPLETED|Double Blind Treatment Period||0
101251|NCT01995513|246847|P3|COMPLETED|Double Blind Treatment Period||0
101252|NCT01995513|246848|P2|COMPLETED|Double Blind Treatment Period||0
101253|NCT01995513|246849|P1|COMPLETED|Double Blind Treatment Period||0
101254|NCT01995513|246847|P3|Treated|Double Blind Treatment Period||124
101255|NCT01995513|246848|P2|Treated|Double Blind Treatment Period||125
101256|NCT01995513|246849|P1|Treated|Double Blind Treatment Period||0
101257|NCT01995513|246847|P3|STARTED|Double Blind Treatment Period||125
101258|NCT01995513|246848|P2|STARTED|Double Blind Treatment Period||126
101259|NCT01995513|246849|P1|STARTED|Double Blind Treatment Period||0
101260|NCT01995513|246847|P3|NOT COMPLETED|Open Label Treatment Period||0
101261|NCT01995513|246848|P2|NOT COMPLETED|Open Label Treatment Period||0
101262|NCT01995513|246849|P1|NOT COMPLETED|Open Label Treatment Period||258
101263|NCT01995513|246847|P3|COMPLETED|Open Label Treatment Period||0
101264|NCT01995513|246848|P2|COMPLETED|Open Label Treatment Period||0
101265|NCT01995513|246849|P1|COMPLETED|Open Label Treatment Period||251
101266|NCT01995513|246847|P3|STARTED|Open Label Treatment Period||0
101267|NCT01995513|246848|P2|STARTED|Open Label Treatment Period||0
101268|NCT01995513|246849|P1|STARTED|Open Label Treatment Period||509
101269|NCT01995461|246892|P1|NOT COMPLETED|Overall Study||5
101270|NCT01995461|246892|P1|COMPLETED|Overall Study||21
101271|NCT01995461|246892|P1|STARTED|Overall Study||26
101272|NCT01995357|246898|P6|NOT COMPLETED|Period 5||0
101273|NCT01995357|246899|P5|NOT COMPLETED|Period 5||0
101274|NCT01995357|246900|P4|NOT COMPLETED|Period 5||0
101275|NCT01995357|246901|P3|NOT COMPLETED|Period 5||1
101276|NCT01995357|246902|P2|NOT COMPLETED|Period 5||0
101277|NCT01995357|246903|P1|NOT COMPLETED|Period 5||2
101278|NCT01995357|246898|P6|COMPLETED|Period 5||4
101279|NCT01995357|246899|P5|COMPLETED|Period 5||4
101280|NCT01995357|246900|P4|COMPLETED|Period 5||3
101281|NCT01995357|246901|P3|COMPLETED|Period 5||3
101282|NCT01995357|246902|P2|COMPLETED|Period 5||3
101283|NCT01995357|246903|P1|COMPLETED|Period 5||2
101284|NCT01995357|246898|P6|STARTED|Period 5||4
101285|NCT01995357|246899|P5|STARTED|Period 5|1 subject terminated due to an adverse event. Subject counted as completed as some B products tested|4
101286|NCT01995357|246900|P4|STARTED|Period 5||3
101287|NCT01995357|246901|P3|STARTED|Period 5||4
101288|NCT01995357|246902|P2|STARTED|Period 5||3
101289|NCT01995357|246903|P1|STARTED|Period 5|The two discontinued subjects tested zero planned B products in period 5.|4
101290|NCT01995357|246898|P6|NOT COMPLETED|Period 4||0
101291|NCT01995357|246899|P5|NOT COMPLETED|Period 4||0
101292|NCT01995357|246900|P4|NOT COMPLETED|Period 4||0
101293|NCT01995357|246901|P3|NOT COMPLETED|Period 4||0
101294|NCT01995357|246902|P2|NOT COMPLETED|Period 4||0
101295|NCT01995357|246903|P1|NOT COMPLETED|Period 4||0
101296|NCT01995357|246898|P6|COMPLETED|Period 4||4
101297|NCT01995357|246899|P5|COMPLETED|Period 4||4
101298|NCT01995357|246900|P4|COMPLETED|Period 4||3
101299|NCT01995357|246901|P3|COMPLETED|Period 4||4
101300|NCT01995357|246902|P2|COMPLETED|Period 4||3
101301|NCT01995357|246903|P1|COMPLETED|Period 4||4
101302|NCT01995357|246898|P6|STARTED|Period 4||4
101303|NCT01995357|246899|P5|STARTED|Period 4||4
101304|NCT01995357|246900|P4|STARTED|Period 4||3
101305|NCT01995357|246901|P3|STARTED|Period 4|The subject who did not complete period 5, erroneously used product A when B should have been used.|4
101306|NCT01995357|246902|P2|STARTED|Period 4||3
101307|NCT01995357|246903|P1|STARTED|Period 4||4
101308|NCT01995357|246898|P6|NOT COMPLETED|Period 3||0
101309|NCT01995357|246899|P5|NOT COMPLETED|Period 3||0
101310|NCT01995357|246900|P4|NOT COMPLETED|Period 3||0
101311|NCT01995357|246901|P3|NOT COMPLETED|Period 3||0
101312|NCT01995357|246902|P2|NOT COMPLETED|Period 3||0
101313|NCT01995357|246903|P1|NOT COMPLETED|Period 3||0
101314|NCT01995357|246898|P6|COMPLETED|Period 3||4
101315|NCT01995357|246899|P5|COMPLETED|Period 3||4
101316|NCT01995357|246900|P4|COMPLETED|Period 3||3
101317|NCT01995357|246901|P3|COMPLETED|Period 3||4
101318|NCT01995357|246902|P2|COMPLETED|Period 3||3
101319|NCT01995357|246903|P1|COMPLETED|Period 3||4
101320|NCT01995357|246898|P6|STARTED|Period 3||4
101321|NCT01995357|246899|P5|STARTED|Period 3||4
101322|NCT01995357|246900|P4|STARTED|Period 3||3
101323|NCT01995357|246901|P3|STARTED|Period 3||4
101324|NCT01995357|246902|P2|STARTED|Period 3||3
101325|NCT01995357|246903|P1|STARTED|Period 3||4
101326|NCT01995357|246898|P6|NOT COMPLETED|Period 2||0
101327|NCT01995357|246899|P5|NOT COMPLETED|Period 2||0
101328|NCT01995357|246900|P4|NOT COMPLETED|Period 2||0
101329|NCT01995357|246901|P3|NOT COMPLETED|Period 2||0
101330|NCT01995357|246902|P2|NOT COMPLETED|Period 2||0
101331|NCT01995357|246903|P1|NOT COMPLETED|Period 2||0
101332|NCT01995357|246898|P6|COMPLETED|Period 2||4
101333|NCT01995357|246899|P5|COMPLETED|Period 2||4
101334|NCT01995357|246900|P4|COMPLETED|Period 2||3
101335|NCT01995357|246901|P3|COMPLETED|Period 2||4
101336|NCT01995357|246902|P2|COMPLETED|Period 2||3
101337|NCT01995357|246903|P1|COMPLETED|Period 2||4
101338|NCT01995357|246898|P6|STARTED|Period 2||4
101339|NCT01995357|246899|P5|STARTED|Period 2||4
101340|NCT01995357|246900|P4|STARTED|Period 2||3
101341|NCT01995357|246901|P3|STARTED|Period 2||4
101342|NCT01995357|246902|P2|STARTED|Period 2||3
101343|NCT01995357|246903|P1|STARTED|Period 2||4
101344|NCT01995357|246898|P6|NOT COMPLETED|Period 1||0
101345|NCT01995357|246899|P5|NOT COMPLETED|Period 1||0
101346|NCT01995357|246900|P4|NOT COMPLETED|Period 1||0
101347|NCT01995357|246901|P3|NOT COMPLETED|Period 1||0
101348|NCT01995357|246902|P2|NOT COMPLETED|Period 1||0
101349|NCT01995357|246903|P1|NOT COMPLETED|Period 1||0
101350|NCT01995357|246898|P6|COMPLETED|Period 1||4
101351|NCT01995357|246899|P5|COMPLETED|Period 1||4
101352|NCT01995357|246900|P4|COMPLETED|Period 1||3
101353|NCT01995357|246901|P3|COMPLETED|Period 1||4
101354|NCT01995357|246902|P2|COMPLETED|Period 1||3
101355|NCT01995357|246903|P1|COMPLETED|Period 1||4
101356|NCT01995357|246898|P6|STARTED|Period 1||4
101357|NCT01995357|246899|P5|STARTED|Period 1||4
101358|NCT01995357|246900|P4|STARTED|Period 1||3
101359|NCT01995357|246901|P3|STARTED|Period 1||4
101360|NCT01995357|246902|P2|STARTED|Period 1||3
101361|NCT01995357|246903|P1|STARTED|Period 1||4
101362|NCT01995266|246919|P1|NOT COMPLETED|Overall Study||9
101363|NCT01995266|246919|P1|COMPLETED|Overall Study||150
101364|NCT01995266|246919|P1|STARTED|Overall Study||159
101365|NCT01995201|246934|P7|NOT COMPLETED|From Week 24 Until Week 48||2
101366|NCT01995201|246935|P6|NOT COMPLETED|From Week 24 Until Week 48||8
101367|NCT01995201|246936|P5|NOT COMPLETED|From Week 24 Until Week 48||6
101368|NCT01995201|246937|P4|NOT COMPLETED|From Week 24 Until Week 48||1
101369|NCT01995201|246938|P3|NOT COMPLETED|From Week 24 Until Week 48||5
101370|NCT01995201|246939|P2|NOT COMPLETED|From Week 24 Until Week 48||0
101371|NCT01995201|246940|P1|NOT COMPLETED|From Week 24 Until Week 48||0
101372|NCT01995201|246934|P7|COMPLETED|From Week 24 Until Week 48||0
101373|NCT01995201|246935|P6|COMPLETED|From Week 24 Until Week 48||59
101374|NCT01995201|246936|P5|COMPLETED|From Week 24 Until Week 48||89
101375|NCT01995201|246937|P4|COMPLETED|From Week 24 Until Week 48||89
101376|NCT01995201|246938|P3|COMPLETED|From Week 24 Until Week 48||84
101377|NCT01995201|246939|P2|COMPLETED|From Week 24 Until Week 48||0
101378|NCT01995201|246940|P1|COMPLETED|From Week 24 Until Week 48||0
101379|NCT01995201|246934|P7|STARTED|From Week 24 Until Week 48||2
101380|NCT01995201|246935|P6|STARTED|From Week 24 Until Week 48||67
101381|NCT01995201|246936|P5|STARTED|From Week 24 Until Week 48||95
101382|NCT01995201|246937|P4|STARTED|From Week 24 Until Week 48||90
101383|NCT01995201|246938|P3|STARTED|From Week 24 Until Week 48||89
101384|NCT01995201|246939|P2|STARTED|From Week 24 Until Week 48||0
101385|NCT01995201|246940|P1|STARTED|From Week 24 Until Week 48||0
101386|NCT01995201|246934|P7|NOT COMPLETED|From Baseline Until Week 24||0
101387|NCT01995201|246935|P6|NOT COMPLETED|From Baseline Until Week 24||0
101388|NCT01995201|246936|P5|NOT COMPLETED|From Baseline Until Week 24||0
101389|NCT01995201|246937|P4|NOT COMPLETED|From Baseline Until Week 24||0
101390|NCT01995201|246938|P3|NOT COMPLETED|From Baseline Until Week 24||0
101391|NCT01995201|246939|P2|NOT COMPLETED|From Baseline Until Week 24||46
101392|NCT01995201|246940|P1|NOT COMPLETED|From Baseline Until Week 24||10
101393|NCT01995201|246934|P7|COMPLETED|From Baseline Until Week 24||0
101394|NCT01995201|246935|P6|COMPLETED|From Baseline Until Week 24||0
101395|NCT01995201|246936|P5|COMPLETED|From Baseline Until Week 24||0
101396|NCT01995201|246937|P4|COMPLETED|From Baseline Until Week 24||0
101397|NCT01995201|246938|P3|COMPLETED|From Baseline Until Week 24||0
101398|NCT01995201|246939|P2|COMPLETED|From Baseline Until Week 24||281
101399|NCT01995201|246940|P1|COMPLETED|From Baseline Until Week 24||64
101400|NCT01995201|246934|P7|STARTED|From Baseline Until Week 24||0
101401|NCT01995201|246935|P6|STARTED|From Baseline Until Week 24||0
101402|NCT01995201|246936|P5|STARTED|From Baseline Until Week 24||0
101403|NCT01995201|246937|P4|STARTED|From Baseline Until Week 24||0
101404|NCT01995201|246938|P3|STARTED|From Baseline Until Week 24||0
101405|NCT01995201|246939|P2|STARTED|From Baseline Until Week 24||327
101406|NCT01995201|246940|P1|STARTED|From Baseline Until Week 24||74
101407|NCT01995175|247049|P1|NOT COMPLETED|Overall Study||253
101408|NCT01995175|247049|P1|COMPLETED|Overall Study||2148
101409|NCT01995175|247049|P1|STARTED|Overall Study||2401
101410|NCT01995136|247059|P1|NOT COMPLETED|Overall Study||1
101411|NCT01995136|247059|P1|COMPLETED|Overall Study||31
101412|NCT01995136|247059|P1|STARTED|Overall Study||32
101413|NCT01995071|247075|P12|NOT COMPLETED|Overall Study||0
101414|NCT01995071|247076|P11|NOT COMPLETED|Overall Study||1
101415|NCT01995071|247077|P10|NOT COMPLETED|Overall Study||0
101416|NCT01995071|247078|P9|NOT COMPLETED|Overall Study||1
101417|NCT01995071|247079|P8|NOT COMPLETED|Overall Study||2
101418|NCT01995071|247080|P7|NOT COMPLETED|Overall Study||1
101419|NCT01995071|247081|P6|NOT COMPLETED|Overall Study||0
101420|NCT01995071|247082|P5|NOT COMPLETED|Overall Study||1
101421|NCT01995071|247083|P4|NOT COMPLETED|Overall Study||0
101422|NCT01995071|247084|P3|NOT COMPLETED|Overall Study||1
101423|NCT01995071|247085|P2|NOT COMPLETED|Overall Study||0
101424|NCT01995071|247086|P1|NOT COMPLETED|Overall Study||1
101425|NCT01995071|247075|P12|COMPLETED|Overall Study||0
101426|NCT01995071|247076|P11|COMPLETED|Overall Study||7
101427|NCT01995071|247077|P10|COMPLETED|Overall Study||8
101428|NCT01995071|247078|P9|COMPLETED|Overall Study||7
101429|NCT01995071|247079|P8|COMPLETED|Overall Study||6
101430|NCT01995071|247080|P7|COMPLETED|Overall Study||7
101431|NCT01995071|247081|P6|COMPLETED|Overall Study||8
101432|NCT01995071|247082|P5|COMPLETED|Overall Study||7
101433|NCT01995071|247083|P4|COMPLETED|Overall Study||8
101434|NCT01995071|247084|P3|COMPLETED|Overall Study||8
101435|NCT01995071|247085|P2|COMPLETED|Overall Study||8
101436|NCT01995071|247086|P1|COMPLETED|Overall Study||7
101437|NCT01995071|247075|P12|STARTED|Overall Study||0
101438|NCT01995071|247076|P11|STARTED|Overall Study||8
101439|NCT01995071|247077|P10|STARTED|Overall Study||8
101440|NCT01995071|247078|P9|STARTED|Overall Study||8
101441|NCT01995071|247079|P8|STARTED|Overall Study||8
101442|NCT01995071|247080|P7|STARTED|Overall Study||8
101443|NCT01995071|247081|P6|STARTED|Overall Study||8
101444|NCT01995071|247082|P5|STARTED|Overall Study||8
101445|NCT01995071|247083|P4|STARTED|Overall Study||8
101446|NCT01995071|247084|P3|STARTED|Overall Study||9
101447|NCT01995071|247085|P2|STARTED|Overall Study||8
101448|NCT01995071|247086|P1|STARTED|Overall Study||8
101449|NCT01995045|247147|P2|NOT COMPLETED|Overall Study||0
101450|NCT01995045|247148|P1|NOT COMPLETED|Overall Study||0
101451|NCT01995045|247147|P2|COMPLETED|Overall Study||28
101452|NCT01995045|247148|P1|COMPLETED|Overall Study||29
101453|NCT01995045|247147|P2|STARTED|Overall Study||28
101454|NCT01995045|247148|P1|STARTED|Overall Study||29
101455|NCT01994993|247165|P5|NOT COMPLETED|Overall Study||2
101456|NCT01994993|247166|P4|NOT COMPLETED|Overall Study||46
101457|NCT01994993|247167|P3|NOT COMPLETED|Overall Study||47
101458|NCT01994993|247168|P2|NOT COMPLETED|Overall Study||35
101459|NCT01994993|247169|P1|NOT COMPLETED|Overall Study||35
101460|NCT01994993|247165|P5|COMPLETED|Overall Study||22
101461|NCT01994993|247166|P4|COMPLETED|Overall Study||9
101462|NCT01994993|247167|P3|COMPLETED|Overall Study||23
101463|NCT01994993|247168|P2|COMPLETED|Overall Study||12
101464|NCT01994993|247169|P1|COMPLETED|Overall Study||28
101465|NCT01994993|247165|P5|STARTED|Overall Study||24
101466|NCT01994993|247166|P4|STARTED|Overall Study||55
101467|NCT01994993|247167|P3|STARTED|Overall Study||70
101468|NCT01994993|247168|P2|STARTED|Overall Study||47
101469|NCT01994993|247169|P1|STARTED|Overall Study||63
101470|NCT01994954|247223|P2|NOT COMPLETED|Overall Study||30
101471|NCT01994954|247224|P1|NOT COMPLETED|Overall Study||25
101472|NCT01994954|247223|P2|COMPLETED|Overall Study||67
101473|NCT01994954|247224|P1|COMPLETED|Overall Study||74
101474|NCT01994954|247223|P2|STARTED|Overall Study||97
101475|NCT01994954|247224|P1|STARTED|Overall Study||99
101476|NCT01994902|247242|P2|NOT COMPLETED|Test Period 2||6
101477|NCT01994902|247243|P1|NOT COMPLETED|Test Period 2||0
101478|NCT01994902|247242|P2|COMPLETED|Test Period 2||55
101479|NCT01994902|247243|P1|COMPLETED|Test Period 2||57
101480|NCT01994902|247242|P2|STARTED|Test Period 2||61
101481|NCT01994902|247243|P1|STARTED|Test Period 2||57
101482|NCT01994902|247242|P2|NOT COMPLETED|Test Period 1||3
101483|NCT01994902|247243|P1|NOT COMPLETED|Test Period 1||6
101484|NCT01994902|247242|P2|COMPLETED|Test Period 1|The subject testing Coloplast test product discontinued due to device deficiency with adverse event|61
101485|NCT01994902|247243|P1|COMPLETED|Test Period 1||57
101486|NCT01994902|247242|P2|STARTED|Test Period 1|Randomisation mistake:a subject randomised to SenSura Convex Light but tested Coloplast test product|64
101487|NCT01994902|247243|P1|STARTED|Test Period 1||63
101488|NCT01994889|247252|P3|NOT COMPLETED|Overall Study||92
101489|NCT01994889|247253|P2|NOT COMPLETED|Overall Study||63
101490|NCT01994889|247254|P1|NOT COMPLETED|Overall Study||28
101491|NCT01994889|247252|P3|COMPLETED|Overall Study||85
101492|NCT01994889|247253|P2|COMPLETED|Overall Study||113
101493|NCT01994889|247254|P1|COMPLETED|Overall Study||60
101494|NCT01994889|247252|P3|STARTED|Overall Study||177
101495|NCT01994889|247253|P2|STARTED|Overall Study||176
101496|NCT01994889|247254|P1|STARTED|Overall Study||88
101497|NCT01994876|247273|P2|NOT COMPLETED|Test Period 2||1
101498|NCT01994876|247274|P1|NOT COMPLETED|Test Period 2||1
101499|NCT01994876|247273|P2|COMPLETED|Test Period 2||6
101500|NCT01994876|247274|P1|COMPLETED|Test Period 2||8
101501|NCT01994876|247273|P2|STARTED|Test Period 2||7
101502|NCT01994876|247274|P1|STARTED|Test Period 2||9
101503|NCT01994876|247273|P2|NOT COMPLETED|Test Period 1||2
101504|NCT01994876|247274|P1|NOT COMPLETED|Test Period 1||0
101505|NCT01994876|247273|P2|COMPLETED|Test Period 1||7
101506|NCT01994876|247274|P1|COMPLETED|Test Period 1||9
101507|NCT01994876|247273|P2|STARTED|Test Period 1||9
101508|NCT01994876|247274|P1|STARTED|Test Period 1||9
101509|NCT01994876|247273|P2|NOT COMPLETED|Baseline - Own Product||0
101510|NCT01994876|247274|P1|NOT COMPLETED|Baseline - Own Product||0
101511|NCT01994876|247273|P2|COMPLETED|Baseline - Own Product||9
101512|NCT01994876|247274|P1|COMPLETED|Baseline - Own Product||9
101513|NCT01994876|247273|P2|STARTED|Baseline - Own Product||9
101514|NCT01994876|247274|P1|STARTED|Baseline - Own Product||9
101515|NCT01994863|247282|P2|NOT COMPLETED|Period 2||4
101516|NCT01994863|247283|P1|NOT COMPLETED|Period 2||1
101517|NCT01994863|247282|P2|COMPLETED|Period 2||5
101518|NCT01994863|247283|P1|COMPLETED|Period 2||7
101519|NCT01994863|247282|P2|STARTED|Period 2||9
101520|NCT01994863|247283|P1|STARTED|Period 2||8
101521|NCT01994863|247282|P2|NOT COMPLETED|Period 1||3
101522|NCT01994863|247283|P1|NOT COMPLETED|Period 1||7
101523|NCT01994863|247282|P2|COMPLETED|Period 1||9
101524|NCT01994863|247283|P1|COMPLETED|Period 1||4
101525|NCT01994863|247282|P2|STARTED|Period 1||12
101526|NCT01994863|247283|P1|STARTED|Period 1||11
101527|NCT01994850|247289|P1|NOT COMPLETED|Overall Study||2
101528|NCT01994850|247289|P1|COMPLETED|Overall Study||30
101529|NCT01994850|247289|P1|STARTED|Overall Study||32
101530|NCT01994837|247294|P1|NOT COMPLETED|Overall Study||32
101531|NCT01994837|247294|P1|COMPLETED|Overall Study||0
101532|NCT01994837|247294|P1|Treated|Overall Study||32
101533|NCT01994837|247294|P1|STARTED|Overall Study||32
101534|NCT01994785|247311|P4|NOT COMPLETED|Overall Study||3
101535|NCT01994785|247312|P3|NOT COMPLETED|Overall Study||0
101536|NCT01994785|247313|P2|NOT COMPLETED|Overall Study||1
101537|NCT01994785|247314|P1|NOT COMPLETED|Overall Study||8
101538|NCT01994785|247311|P4|COMPLETED|Overall Study||114
101539|NCT01994785|247312|P3|COMPLETED|Overall Study||117
101540|NCT01994785|247313|P2|COMPLETED|Overall Study||108
101541|NCT01994785|247314|P1|COMPLETED|Overall Study||101
101542|NCT01994785|247311|P4|STARTED|Overall Study||117
101543|NCT01994785|247312|P3|STARTED|Overall Study||117
101544|NCT01994785|247313|P2|STARTED|Overall Study||109
101545|NCT01994785|247314|P1|STARTED|Overall Study||109
101546|NCT01994746|247324|P2|NOT COMPLETED|Second Visit||0
101547|NCT01994746|247325|P1|NOT COMPLETED|Second Visit||0
101548|NCT01994746|247324|P2|COMPLETED|Second Visit||38
101549|NCT01994746|247325|P1|COMPLETED|Second Visit||38
101550|NCT01994746|247324|P2|Completed Both Dosing Visits|Second Visit||38
101551|NCT01994746|247325|P1|Completed Both Dosing Visits|Second Visit||38
101552|NCT01994746|247324|P2|STARTED|Second Visit||38
101553|NCT01994746|247325|P1|STARTED|Second Visit|One participant requested to withdraw after completing the first dosing visit.|38
101554|NCT01994746|247324|P2|NOT COMPLETED|First Visit||0
101555|NCT01994746|247325|P1|NOT COMPLETED|First Visit||0
101556|NCT01994746|247324|P2|COMPLETED|First Visit||38
101557|NCT01994746|247325|P1|COMPLETED|First Visit||39
101558|NCT01994746|247324|P2|Received At Least 1 Dose|First Visit||38
101559|NCT01994746|247325|P1|Received At Least 1 Dose|First Visit||39
101560|NCT01994746|247324|P2|STARTED|First Visit||38
101561|NCT01994746|247325|P1|STARTED|First Visit||39
101562|NCT01994720|247351|P2|NOT COMPLETED|Overall Study||56
101563|NCT01994720|247352|P1|NOT COMPLETED|Overall Study||46
101564|NCT01994720|247351|P2|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6554
101565|NCT01994720|247352|P1|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6543
101566|NCT01994720|247351|P2|STARTED|Overall Study||6610
101567|NCT01994720|247352|P1|STARTED|Overall Study||6589
101568|NCT01994629|247394|P2|NOT COMPLETED|Overall Study||3
101569|NCT01994629|247395|P1|NOT COMPLETED|Overall Study||1
101570|NCT01994629|247394|P2|COMPLETED|Overall Study||99
101571|NCT01994629|247395|P1|COMPLETED|Overall Study||99
101572|NCT01994629|247394|P2|STARTED|Overall Study||102
101573|NCT01994629|247395|P1|STARTED|Overall Study||100
101574|NCT01994590|247419|P1|NOT COMPLETED|Overall Study||2
101575|NCT01994590|247419|P1|COMPLETED|Overall Study||2
101576|NCT01994590|247419|P1|STARTED|Overall Study||4
101577|NCT01994486|247423|P1|NOT COMPLETED|Overall Study||0
101578|NCT01994486|247423|P1|COMPLETED|Overall Study||20
101579|NCT01994486|247423|P1|STARTED|Overall Study||20
101580|NCT01994395|247434|P2|NOT COMPLETED|Overall Study||2
101581|NCT01994395|247435|P1|NOT COMPLETED|Overall Study||1
101582|NCT01994395|247434|P2|COMPLETED|Overall Study||25
101583|NCT01994395|247435|P1|COMPLETED|Overall Study||25
101584|NCT01994395|247434|P2|STARTED|Overall Study||27
101585|NCT01994395|247435|P1|STARTED|Overall Study||26
101586|NCT01994291|247460|P3|NOT COMPLETED|Overall Study||9
101587|NCT01994291|247461|P2|NOT COMPLETED|Overall Study||7
101588|NCT01994291|247462|P1|NOT COMPLETED|Overall Study||15
101589|NCT01994291|247460|P3|COMPLETED|Overall Study||47
101590|NCT01994291|247461|P2|COMPLETED|Overall Study||36
101591|NCT01994291|247462|P1|COMPLETED|Overall Study||84
101592|NCT01994291|247460|P3|Received Treatment|Overall Study||56
101593|NCT01994291|247461|P2|Received Treatment|Overall Study||43
101594|NCT01994291|247462|P1|Received Treatment|Overall Study||99
101595|NCT01994291|247460|P3|STARTED|Overall Study||56
101596|NCT01994291|247461|P2|STARTED|Overall Study||43
101597|NCT01994291|247462|P1|STARTED|Overall Study||99
101598|NCT01994226|247518|P2|NOT COMPLETED|Overall Study||21
101599|NCT01994226|247519|P1|NOT COMPLETED|Overall Study||19
101600|NCT01994226|247518|P2|COMPLETED|Overall Study||179
101601|NCT01994226|247519|P1|COMPLETED|Overall Study||180
101602|NCT01994226|247518|P2|STARTED|Overall Study||200
101603|NCT01994226|247519|P1|STARTED|Overall Study||199
101604|NCT01994109|247528|P4|NOT COMPLETED|Open-label Phase (Part B)||42
101605|NCT01994109|247529|P3|NOT COMPLETED|Open-label Phase (Part B)||0
101606|NCT01994109|247530|P2|NOT COMPLETED|Open-label Phase (Part B)||0
101607|NCT01994109|247531|P1|NOT COMPLETED|Open-label Phase (Part B)||0
101608|NCT01994109|247528|P4|COMPLETED|Open-label Phase (Part B)||128
101609|NCT01994109|247529|P3|COMPLETED|Open-label Phase (Part B)|No placebo group in Part B.|0
101610|NCT01994109|247530|P2|COMPLETED|Open-label Phase (Part B)||0
101611|NCT01994109|247531|P1|COMPLETED|Open-label Phase (Part B)||0
101612|NCT01994109|247528|P4|STARTED|Open-label Phase (Part B)|61 from 2500 U group, 57 from 3500 U group, 52 from Placebo group continued to Part B|170
101613|NCT01994109|247529|P3|STARTED|Open-label Phase (Part B)|No placebo group in Part B.|0
101614|NCT01994109|247530|P2|STARTED|Open-label Phase (Part B)||0
101615|NCT01994109|247531|P1|STARTED|Open-label Phase (Part B)||0
101616|NCT01994109|247528|P4|NOT COMPLETED|Double-blind Phase (Part A)||0
101617|NCT01994109|247529|P3|NOT COMPLETED|Double-blind Phase (Part A)||7
101618|NCT01994109|247530|P2|NOT COMPLETED|Double-blind Phase (Part A)||3
101619|NCT01994109|247531|P1|NOT COMPLETED|Double-blind Phase (Part A)||1
101620|NCT01994109|247528|P4|COMPLETED|Double-blind Phase (Part A)||0
101621|NCT01994109|247529|P3|COMPLETED|Double-blind Phase (Part A)||53
101622|NCT01994109|247530|P2|COMPLETED|Double-blind Phase (Part A)||61
101623|NCT01994109|247531|P1|COMPLETED|Double-blind Phase (Part A)||62
101624|NCT01994109|247528|P4|STARTED|Double-blind Phase (Part A)||0
101625|NCT01994109|247529|P3|STARTED|Double-blind Phase (Part A)||60
101626|NCT01994109|247530|P2|STARTED|Double-blind Phase (Part A)||64
101627|NCT01994109|247531|P1|STARTED|Double-blind Phase (Part A)||63
101628|NCT01993940|247545|P2|NOT COMPLETED|Overall Study||44
101629|NCT01993940|247546|P1|NOT COMPLETED|Overall Study||40
101630|NCT01993940|247545|P2|COMPLETED|Overall Study||232
101631|NCT01993940|247546|P1|COMPLETED|Overall Study||237
101632|NCT01993940|247545|P2|Received Treatment|Overall Study||276
101633|NCT01993940|247546|P1|Received Treatment|Overall Study||272
101634|NCT01993940|247545|P2|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|276
101635|NCT01993940|247546|P1|STARTED|Overall Study|Includes one participant who enrolled at two different sites|277
101636|NCT01993927|247560|P1|NOT COMPLETED|Overall Study||29
101637|NCT01993927|247560|P1|COMPLETED|Overall Study||713
101638|NCT01993927|247560|P1|STARTED|Overall Study||742
101639|NCT01993888|247568|P2|NOT COMPLETED|Overall Study||3
101640|NCT01993888|247569|P1|NOT COMPLETED|Overall Study||2
101641|NCT01993888|247568|P2|COMPLETED|Overall Study||49
101642|NCT01993888|247569|P1|COMPLETED|Overall Study||48
101643|NCT01993888|247568|P2|STARTED|Overall Study||52
101644|NCT01993888|247569|P1|STARTED|Overall Study||50
101645|NCT01993849|247587|P2|NOT COMPLETED|Overall Study||2
101646|NCT01993849|247588|P1|NOT COMPLETED|Overall Study||3
101647|NCT01993849|247587|P2|COMPLETED|Overall Study||9
101648|NCT01993849|247588|P1|COMPLETED|Overall Study||9
101649|NCT01993849|247587|P2|STARTED|Overall Study||11
101650|NCT01993849|247588|P1|STARTED|Overall Study||12
101651|NCT01993823|247598|P2|NOT COMPLETED|Overall Study||16
101652|NCT01993823|247599|P1|NOT COMPLETED|Overall Study||7
101653|NCT01993823|247598|P2|COMPLETED|Overall Study||79
101654|NCT01993823|247599|P1|COMPLETED|Overall Study||88
101655|NCT01993823|247598|P2|STARTED|Overall Study||95
101656|NCT01993823|247599|P1|STARTED|Overall Study||95
101657|NCT01993667|247609|P2|NOT COMPLETED|Overall Study||19
101658|NCT01993667|247610|P1|NOT COMPLETED|Overall Study||21
101659|NCT01993667|247609|P2|COMPLETED|Overall Study||47
101660|NCT01993667|247610|P1|COMPLETED|Overall Study||43
101661|NCT01993667|247609|P2|STARTED|Overall Study||66
101662|NCT01993667|247610|P1|STARTED|Overall Study||64
101663|NCT01993238|247618|P1|NOT COMPLETED|Overall Study||0
101664|NCT01993238|247618|P1|COMPLETED|Overall Study||11
101665|NCT01993238|247618|P1|STARTED|Overall Study||11
101666|NCT01993108|247625|P2|NOT COMPLETED|Overall Study||0
101667|NCT01993108|247626|P1|NOT COMPLETED|Overall Study||0
101668|NCT01993108|247625|P2|COMPLETED|Overall Study||12
101669|NCT01993108|247626|P1|COMPLETED|Overall Study||11
101670|NCT01993108|247625|P2|STARTED|Overall Study||12
101671|NCT01993108|247626|P1|STARTED|Overall Study||11
101672|NCT01993030|247657|P2|NOT COMPLETED|Overall Study||4
101673|NCT01993030|247658|P1|NOT COMPLETED|Overall Study||0
101674|NCT01993030|247657|P2|COMPLETED|Overall Study||31
101675|NCT01993030|247658|P1|COMPLETED|Overall Study||36
101676|NCT01993030|247657|P2|STARTED|Overall Study||35
101677|NCT01993030|247658|P1|STARTED|Overall Study||36
101678|NCT01992874|247672|P3|NOT COMPLETED|Part B||0
101679|NCT01992874|247673|P2|NOT COMPLETED|Part B||0
101680|NCT01992874|247674|P1|NOT COMPLETED|Part B||0
101681|NCT01992874|247672|P3|COMPLETED|Part B||38
101682|NCT01992874|247673|P2|COMPLETED|Part B||0
101683|NCT01992874|247674|P1|COMPLETED|Part B||0
101684|NCT01992874|247672|P3|STARTED|Part B||38
101685|NCT01992874|247673|P2|STARTED|Part B||0
101686|NCT01992874|247674|P1|STARTED|Part B||0
101687|NCT01992874|247672|P3|NOT COMPLETED|Part A||0
101688|NCT01992874|247673|P2|NOT COMPLETED|Part A||0
101689|NCT01992874|247674|P1|NOT COMPLETED|Part A||0
101690|NCT01992874|247672|P3|COMPLETED|Part A||0
101691|NCT01992874|247673|P2|COMPLETED|Part A||17
101692|NCT01992874|247674|P1|COMPLETED|Part A||21
101693|NCT01992874|247672|P3|STARTED|Part A||0
101694|NCT01992874|247673|P2|STARTED|Part A||17
101695|NCT01992874|247674|P1|STARTED|Part A||21
101696|NCT01992757|247702|P1|NOT COMPLETED|Overall Study||2
101697|NCT01992757|247702|P1|COMPLETED|Overall Study||49
101698|NCT01992757|247702|P1|STARTED|Overall Study||51
101699|NCT01992536|247717|P10|NOT COMPLETED|Overall Study||1
101700|NCT01992536|247718|P9|NOT COMPLETED|Overall Study||1
101701|NCT01992536|247719|P8|NOT COMPLETED|Overall Study||0
101702|NCT01992536|247720|P7|NOT COMPLETED|Overall Study||7
101703|NCT01992536|247721|P6|NOT COMPLETED|Overall Study||1
101704|NCT01992536|247722|P5|NOT COMPLETED|Overall Study||0
101705|NCT01992536|247723|P4|NOT COMPLETED|Overall Study||2
101706|NCT01992536|247724|P3|NOT COMPLETED|Overall Study||1
101707|NCT01992536|247725|P2|NOT COMPLETED|Overall Study||3
101708|NCT01992536|247726|P1|NOT COMPLETED|Overall Study||4
101709|NCT01992536|247717|P10|COMPLETED|Overall Study||18
101710|NCT01992536|247718|P9|COMPLETED|Overall Study||18
101711|NCT01992536|247719|P8|COMPLETED|Overall Study||21
101712|NCT01992536|247720|P7|COMPLETED|Overall Study||0
101713|NCT01992536|247721|P6|COMPLETED|Overall Study||20
101714|NCT01992536|247722|P5|COMPLETED|Overall Study||11
101715|NCT01992536|247723|P4|COMPLETED|Overall Study||22
101716|NCT01992536|247724|P3|COMPLETED|Overall Study||16
101717|NCT01992536|247725|P2|COMPLETED|Overall Study||22
101718|NCT01992536|247726|P1|COMPLETED|Overall Study||22
101719|NCT01992536|247717|P10|STARTED|Overall Study||19
101720|NCT01992536|247718|P9|STARTED|Overall Study||19
101721|NCT01992536|247719|P8|STARTED|Overall Study||21
101722|NCT01992536|247720|P7|STARTED|Overall Study||7
101723|NCT01992536|247721|P6|STARTED|Overall Study||21
101724|NCT01992536|247722|P5|STARTED|Overall Study||11
101725|NCT01992536|247723|P4|STARTED|Overall Study||24
101726|NCT01992536|247724|P3|STARTED|Overall Study||17
101727|NCT01992536|247725|P2|STARTED|Overall Study||25
101728|NCT01992536|247726|P1|STARTED|Overall Study||26
101729|NCT01992523|247943|P2|NOT COMPLETED|Overall Study||0
101730|NCT01992523|247944|P1|NOT COMPLETED|Overall Study||0
101731|NCT01992523|247943|P2|COMPLETED|Overall Study||41
101732|NCT01992523|247944|P1|COMPLETED|Overall Study||41
101733|NCT01992523|247943|P2|STARTED|Overall Study||41
101734|NCT01992523|247944|P1|STARTED|Overall Study||41
101735|NCT01992354|247956|P1|NOT COMPLETED|Overall Study||0
101736|NCT01992354|247956|P1|COMPLETED|Overall Study||4
101737|NCT01992354|247956|P1|STARTED|Overall Study||4
101738|NCT01992185|247963|P2|NOT COMPLETED|Overall Study||0
101739|NCT01992185|247964|P1|NOT COMPLETED|Overall Study||0
101740|NCT01992185|247963|P2|COMPLETED|Overall Study||8
101741|NCT01992185|247964|P1|COMPLETED|Overall Study||7
101742|NCT01992185|247963|P2|STARTED|Overall Study||8
101743|NCT01992185|247964|P1|STARTED|Overall Study||7
101744|NCT01992172|247972|P2|NOT COMPLETED|Overall Study||0
101745|NCT01992172|247973|P1|NOT COMPLETED|Overall Study||0
101746|NCT01992172|247972|P2|COMPLETED|Overall Study||0
101747|NCT01992172|247973|P1|COMPLETED|Overall Study||7
101748|NCT01992172|247972|P2|STARTED|Overall Study||0
101749|NCT01992172|247973|P1|STARTED|Overall Study||7
101750|NCT01992159|247983|P4|NOT COMPLETED|Overall Study||4
101751|NCT01992159|247984|P3|NOT COMPLETED|Overall Study||1
101752|NCT01992159|247985|P2|NOT COMPLETED|Overall Study||8
101753|NCT01992159|247986|P1|NOT COMPLETED|Overall Study||4
101754|NCT01992159|247983|P4|COMPLETED|Overall Study||59
101755|NCT01992159|247984|P3|COMPLETED|Overall Study||62
101756|NCT01992159|247985|P2|COMPLETED|Overall Study||55
101757|NCT01992159|247986|P1|COMPLETED|Overall Study||59
101758|NCT01992159|247983|P4|Completed First 12 Months of Study|Overall Study||59
101759|NCT01992159|247984|P3|Completed First 12 Months of Study|Overall Study||63
101760|NCT01992159|247985|P2|Completed First 12 Months of Study|Overall Study||56
101761|NCT01992159|247986|P1|Completed First 12 Months of Study|Overall Study||59
101762|NCT01992159|247983|P4|Received Treatment|Overall Study||63
101763|NCT01992159|247984|P3|Received Treatment|Overall Study||63
101764|NCT01992159|247985|P2|Received Treatment|Overall Study||63
101765|NCT01992159|247986|P1|Received Treatment|Overall Study||63
101766|NCT01992159|247983|P4|STARTED|Overall Study||63
101767|NCT01992159|247984|P3|STARTED|Overall Study||63
101768|NCT01992159|247985|P2|STARTED|Overall Study||63
101769|NCT01992159|247986|P1|STARTED|Overall Study||63
101770|NCT01992107|248039|P3|NOT COMPLETED|Overall Study||36
101771|NCT01992107|248040|P2|NOT COMPLETED|Overall Study||33
101772|NCT01992107|248041|P1|NOT COMPLETED|Overall Study||68
101773|NCT01992107|248039|P3|COMPLETED|Overall Study||545
101774|NCT01992107|248040|P2|COMPLETED|Overall Study||560
101775|NCT01992107|248041|P1|COMPLETED|Overall Study||1091
101776|NCT01992107|248039|P3|STARTED|Overall Study||581
101777|NCT01992107|248040|P2|STARTED|Overall Study||593
101778|NCT01992107|248041|P1|STARTED|Overall Study||1159
101779|NCT01992094|248097|P3|NOT COMPLETED|Overall Study||21
101780|NCT01992094|248098|P2|NOT COMPLETED|Overall Study||24
101781|NCT01992094|248099|P1|NOT COMPLETED|Overall Study||50
101782|NCT01992094|248097|P3|COMPLETED|Overall Study||648
101783|NCT01992094|248098|P2|COMPLETED|Overall Study||652
101784|NCT01992094|248099|P1|COMPLETED|Overall Study||1285
101785|NCT01992094|248097|P3|STARTED|Overall Study||669
101786|NCT01992094|248098|P2|STARTED|Overall Study||676
101787|NCT01992094|248099|P1|STARTED|Overall Study||1335
101788|NCT01992016|248157|P2|NOT COMPLETED|Overall Study||0
101789|NCT01992016|248158|P1|NOT COMPLETED|Overall Study||0
101790|NCT01992016|248157|P2|COMPLETED|Overall Study||7
101791|NCT01992016|248158|P1|COMPLETED|Overall Study||4
101792|NCT01992016|248157|P2|STARTED|Overall Study||7
101793|NCT01992016|248158|P1|STARTED|Overall Study||4
101794|NCT01991990|248166|P2|NOT COMPLETED|Overall Study||0
101795|NCT01991990|248167|P1|NOT COMPLETED|Overall Study||0
101796|NCT01991990|248166|P2|COMPLETED|Overall Study||12
101797|NCT01991990|248167|P1|COMPLETED|Overall Study||6
101798|NCT01991990|248166|P2|STARTED|Overall Study||12
101799|NCT01991990|248167|P1|STARTED|Overall Study||6
101800|NCT01991860|248209|P2|NOT COMPLETED|Overall Study||2
101801|NCT01991860|248210|P1|NOT COMPLETED|Overall Study||4
101802|NCT01991860|248209|P2|COMPLETED|Overall Study||164
101803|NCT01991860|248210|P1|COMPLETED|Overall Study||172
101804|NCT01991860|248209|P2|STARTED|Overall Study||166
101805|NCT01991860|248210|P1|STARTED|Overall Study||176
101806|NCT01991821|248230|P2|NOT COMPLETED|Overall Study||167
101807|NCT01991821|248231|P1|NOT COMPLETED|Overall Study||163
101808|NCT01991821|248230|P2|COMPLETED|Overall Study||11
101809|NCT01991821|248231|P1|COMPLETED|Overall Study||6
101810|NCT01991821|248230|P2|STARTED|Overall Study||178
101811|NCT01991821|248231|P1|STARTED|Overall Study||169
101812|NCT01991808|248249|P1|NOT COMPLETED|Overall Study||0
101813|NCT01991808|248249|P1|COMPLETED|Overall Study||16
101814|NCT01991808|248249|P1|STARTED|Overall Study||16
101815|NCT01991548|248253|P1|NOT COMPLETED|Overall Study||1
101816|NCT01991548|248253|P1|COMPLETED|Overall Study||39
101817|NCT01991548|248253|P1|STARTED|Overall Study||40
101818|NCT01991522|248259|P2|NOT COMPLETED|Overall Study||0
101819|NCT01991522|248260|P1|NOT COMPLETED|Overall Study||0
101820|NCT01991522|248259|P2|COMPLETED|Overall Study||17
101821|NCT01991522|248260|P1|COMPLETED|Overall Study||16
101822|NCT01991522|248259|P2|STARTED|Overall Study||17
101823|NCT01991522|248260|P1|STARTED|Overall Study||16
101824|NCT01991483|248272|P4|NOT COMPLETED|Dose Level 1000 mg||1
101825|NCT01991483|248273|P3|NOT COMPLETED|Dose Level 1000 mg||0
101826|NCT01991483|248274|P2|NOT COMPLETED|Dose Level 1000 mg||0
101827|NCT01991483|248275|P1|NOT COMPLETED|Dose Level 1000 mg||0
101828|NCT01991483|248272|P4|COMPLETED|Dose Level 1000 mg||3
101829|NCT01991483|248273|P3|COMPLETED|Dose Level 1000 mg||0
101830|NCT01991483|248274|P2|COMPLETED|Dose Level 1000 mg||0
101831|NCT01991483|248275|P1|COMPLETED|Dose Level 1000 mg||0
101832|NCT01991483|248272|P4|Received at Least One Dose of Study Drug|Dose Level 1000 mg||4
101833|NCT01991483|248273|P3|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
101834|NCT01991483|248274|P2|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
101835|NCT01991483|248275|P1|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
101836|NCT01991483|248272|P4|STARTED|Dose Level 1000 mg|Multiple periods were added for each dose level to represent dose escalation.|4
101837|NCT01991483|248273|P3|STARTED|Dose Level 1000 mg|Multiple periods were added for each dose level to represent dose escalation.|0
101838|NCT01991483|248274|P2|STARTED|Dose Level 1000 mg||0
101839|NCT01991483|248275|P1|STARTED|Dose Level 1000 mg||0
101840|NCT01991483|248272|P4|NOT COMPLETED|Dose Level 600 mg||0
101841|NCT01991483|248273|P3|NOT COMPLETED|Dose Level 600 mg||2
101842|NCT01991483|248274|P2|NOT COMPLETED|Dose Level 600 mg||0
101843|NCT01991483|248275|P1|NOT COMPLETED|Dose Level 600 mg||0
101844|NCT01991483|248272|P4|COMPLETED|Dose Level 600 mg||0
101845|NCT01991483|248273|P3|COMPLETED|Dose Level 600 mg||9
101846|NCT01991483|248274|P2|COMPLETED|Dose Level 600 mg||0
101847|NCT01991483|248275|P1|COMPLETED|Dose Level 600 mg||0
101848|NCT01991483|248272|P4|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
101849|NCT01991483|248273|P3|Receive at Least One Dose of Study Drug|Dose Level 600 mg||11
101850|NCT01991483|248274|P2|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
101851|NCT01991483|248275|P1|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
101852|NCT01991483|248272|P4|STARTED|Dose Level 600 mg||0
101853|NCT01991483|248273|P3|STARTED|Dose Level 600 mg|Multiple periods were added for each dose level to represent dose escalation.|11
101854|NCT01991483|248274|P2|STARTED|Dose Level 600 mg|Multiple periods were added for each dose level to represent dose escalation.|0
101855|NCT01991483|248275|P1|STARTED|Dose Level 600 mg||0
101856|NCT01991483|248272|P4|NOT COMPLETED|Dose Level 300 mg||0
101857|NCT01991483|248273|P3|NOT COMPLETED|Dose Level 300 mg||0
101858|NCT01991483|248274|P2|NOT COMPLETED|Dose Level 300 mg||0
101859|NCT01991483|248275|P1|NOT COMPLETED|Dose Level 300 mg||0
101860|NCT01991483|248272|P4|COMPLETED|Dose Level 300 mg||0
101861|NCT01991483|248273|P3|COMPLETED|Dose Level 300 mg||0
101862|NCT01991483|248274|P2|COMPLETED|Dose Level 300 mg||6
101863|NCT01991483|248275|P1|COMPLETED|Dose Level 300 mg||0
101864|NCT01991483|248272|P4|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
101865|NCT01991483|248273|P3|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
101866|NCT01991483|248274|P2|Received at Least One Dose of Study Drug|Dose Level 300 mg||6
101867|NCT01991483|248275|P1|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
101868|NCT01991483|248272|P4|STARTED|Dose Level 300 mg||0
101869|NCT01991483|248273|P3|STARTED|Dose Level 300 mg||0
101870|NCT01991483|248274|P2|STARTED|Dose Level 300 mg|Multiple periods were added for each dose level to represent dose escalation.|6
101871|NCT01991483|248275|P1|STARTED|Dose Level 300 mg|Multiple periods were added for each dose level to represent dose escalation.|0
101872|NCT01991483|248272|P4|NOT COMPLETED|Dose Level: Placebo||0
101873|NCT01991483|248273|P3|NOT COMPLETED|Dose Level: Placebo||0
101874|NCT01991483|248274|P2|NOT COMPLETED|Dose Level: Placebo||0
101875|NCT01991483|248275|P1|NOT COMPLETED|Dose Level: Placebo||0
101876|NCT01991483|248272|P4|COMPLETED|Dose Level: Placebo||0
101877|NCT01991483|248273|P3|COMPLETED|Dose Level: Placebo||0
101878|NCT01991483|248274|P2|COMPLETED|Dose Level: Placebo||0
101879|NCT01991483|248275|P1|COMPLETED|Dose Level: Placebo||7
101880|NCT01991483|248272|P4|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
101881|NCT01991483|248273|P3|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
101882|NCT01991483|248274|P2|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
101883|NCT01991483|248275|P1|Received at Least One Dose of Study Drug|Dose Level: Placebo||7
101884|NCT01991483|248272|P4|STARTED|Dose Level: Placebo||0
101885|NCT01991483|248273|P3|STARTED|Dose Level: Placebo||0
101886|NCT01991483|248274|P2|STARTED|Dose Level: Placebo||0
101887|NCT01991483|248275|P1|STARTED|Dose Level: Placebo||7
101888|NCT01991470|248341|P1|NOT COMPLETED|Enlite 3 Period||12
101889|NCT01991470|248341|P1|COMPLETED|Enlite 3 Period||146
101890|NCT01991470|248341|P1|STARTED|Enlite 3 Period|Additional 25 subjects who participated only Enlite 3 phase|158
101891|NCT01991470|248341|P1|NOT COMPLETED|Enlite 1 Period||20
101892|NCT01991470|248341|P1|COMPLETED|Enlite 1 Period||141
101893|NCT01991470|248341|P1|STARTED|Enlite 1 Period||161
101894|NCT01991314|248355|P2|NOT COMPLETED|Overall Study||11
101895|NCT01991314|248356|P1|NOT COMPLETED|Overall Study||11
101896|NCT01991314|248355|P2|COMPLETED|Overall Study||32
101897|NCT01991314|248356|P1|COMPLETED|Overall Study||34
101898|NCT01991314|248355|P2|STARTED|Overall Study||43
101899|NCT01991314|248356|P1|STARTED|Overall Study||45
101900|NCT01990898|248374|P1|NOT COMPLETED|Overall Study||4
101901|NCT01990898|248374|P1|COMPLETED|Overall Study||22
101902|NCT01990898|248374|P1|3 Months|Overall Study||22
101903|NCT01990898|248374|P1|STARTED|Overall Study||26
101904|NCT01990859|248378|P1|NOT COMPLETED|90 Day Follow Up for All Participants||0
101905|NCT01990859|248378|P1|COMPLETED|90 Day Follow Up for All Participants||20
101906|NCT01990859|248378|P1|STARTED|90 Day Follow Up for All Participants|All entered into 90 day follow-up whether treatment and/or post dose follow up was completed or not.|20
101907|NCT01990859|248378|P1|NOT COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||17
101908|NCT01990859|248378|P1|COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||3
101909|NCT01990859|248378|P1|STARTED|Week 12 to Week 24 Post Dosing Follow Up|All were entered into follow-up whether dosing was completed or not.|20
101910|NCT01990859|248378|P1|NOT COMPLETED|Treatment (4 Doses Over 12 Weeks)||5
101911|NCT01990859|248378|P1|COMPLETED|Treatment (4 Doses Over 12 Weeks)||15
101912|NCT01990859|248378|P1|STARTED|Treatment (4 Doses Over 12 Weeks)||20
101913|NCT01990820|248391|P2|NOT COMPLETED|Overall Study||0
101914|NCT01990820|248392|P1|NOT COMPLETED|Overall Study||0
101915|NCT01990820|248391|P2|COMPLETED|Overall Study||12
101916|NCT01990820|248392|P1|COMPLETED|Overall Study||13
101917|NCT01990820|248391|P2|STARTED|Overall Study||12
101918|NCT01990820|248392|P1|STARTED|Overall Study||13
101919|NCT01990794|248398|P1|NOT COMPLETED|Overall Study||3
101920|NCT01990794|248398|P1|COMPLETED|Overall Study||10
101921|NCT01990794|248398|P1|One Month Into Study|Overall Study||10
101922|NCT01990794|248398|P1|STARTED|Overall Study||13
101923|NCT01990768|248513|P3|NOT COMPLETED|6-Month Follow-up||58
101924|NCT01990768|248514|P2|NOT COMPLETED|6-Month Follow-up||51
101925|NCT01990768|248515|P1|NOT COMPLETED|6-Month Follow-up||39
101926|NCT01990768|248513|P3|COMPLETED|6-Month Follow-up||288
101927|NCT01990768|248514|P2|COMPLETED|6-Month Follow-up||261
101928|NCT01990768|248515|P1|COMPLETED|6-Month Follow-up||270
101929|NCT01990768|248513|P3|STARTED|6-Month Follow-up||346
101930|NCT01990768|248514|P2|STARTED|6-Month Follow-up||312
101931|NCT01990768|248515|P1|STARTED|6-Month Follow-up||309
101932|NCT01990768|248513|P3|NOT COMPLETED|In-Hospital Study Drug Infusion||80
101933|NCT01990768|248514|P2|NOT COMPLETED|In-Hospital Study Drug Infusion||83
101934|NCT01990768|248515|P1|NOT COMPLETED|In-Hospital Study Drug Infusion||95
101935|NCT01990768|248513|P3|COMPLETED|In-Hospital Study Drug Infusion||266
101936|NCT01990768|248514|P2|COMPLETED|In-Hospital Study Drug Infusion||229
101937|NCT01990768|248515|P1|COMPLETED|In-Hospital Study Drug Infusion||214
101938|NCT01990768|248513|P3|STARTED|In-Hospital Study Drug Infusion||346
101939|NCT01990768|248514|P2|STARTED|In-Hospital Study Drug Infusion||312
101940|NCT01990768|248515|P1|STARTED|In-Hospital Study Drug Infusion||309
101941|NCT01990768|248513|P3|NOT COMPLETED|Prehospital Study Drug Infusion||19
101942|NCT01990768|248514|P2|NOT COMPLETED|Prehospital Study Drug Infusion||27
101943|NCT01990768|248515|P1|NOT COMPLETED|Prehospital Study Drug Infusion||19
101944|NCT01990768|248513|P3|COMPLETED|Prehospital Study Drug Infusion||327
101945|NCT01990768|248514|P2|COMPLETED|Prehospital Study Drug Infusion||285
101946|NCT01990768|248515|P1|COMPLETED|Prehospital Study Drug Infusion||290
101947|NCT01990768|248513|P3|STARTED|Prehospital Study Drug Infusion||346
101948|NCT01990768|248514|P2|STARTED|Prehospital Study Drug Infusion||312
101949|NCT01990768|248515|P1|STARTED|Prehospital Study Drug Infusion||309
101950|NCT01990768|248513|P3|NOT COMPLETED|Intervention Started||27
101951|NCT01990768|248514|P2|NOT COMPLETED|Intervention Started||33
101952|NCT01990768|248515|P1|NOT COMPLETED|Intervention Started||36
101953|NCT01990768|248513|P3|COMPLETED|Intervention Started||346
101954|NCT01990768|248514|P2|COMPLETED|Intervention Started||312
101955|NCT01990768|248515|P1|COMPLETED|Intervention Started||309
101956|NCT01990768|248513|P3|STARTED|Intervention Started||373
101957|NCT01990768|248514|P2|STARTED|Intervention Started||345
101958|NCT01990768|248515|P1|STARTED|Intervention Started||345
101959|NCT01990742|248580|P2|NOT COMPLETED|Overall Study||1353
101960|NCT01990742|248581|P1|NOT COMPLETED|Overall Study||407
101961|NCT01990742|248580|P2|COMPLETED|Overall Study|Eleven nursing homes completed the control group /usual care allocation.|2978
101962|NCT01990742|248581|P1|COMPLETED|Overall Study|Fourteen facilities completed the intervention.|2852
101963|NCT01990742|248580|P2|STARTED|Overall Study|This is a facility-level control , access to individual participants occurred only via MDS records.|4331
101964|NCT01990742|248581|P1|STARTED|Overall Study|This is a facility-level intervention, access to individual level records occurred via MDS data only|3259
101965|NCT01990703|248593|P2|NOT COMPLETED|Overall Study||45
101966|NCT01990703|248594|P1|NOT COMPLETED|Overall Study||39
101967|NCT01990703|248593|P2|COMPLETED|Overall Study||93
101968|NCT01990703|248594|P1|COMPLETED|Overall Study||108
101969|NCT01990703|248593|P2|STARTED|Overall Study||138
101970|NCT01990703|248594|P1|STARTED|Overall Study||147
101971|NCT01990677|248604|P2|NOT COMPLETED|Overall Study||1
101972|NCT01990677|248605|P1|NOT COMPLETED|Overall Study||2
101973|NCT01990677|248604|P2|COMPLETED|Overall Study||5
101974|NCT01990677|248605|P1|COMPLETED|Overall Study||10
101975|NCT01990677|248604|P2|STARTED|Overall Study||6
101976|NCT01990677|248605|P1|STARTED|Overall Study||12
101977|NCT01990664|248617|P2|NOT COMPLETED|Overall Study||11
101978|NCT01990664|248618|P1|NOT COMPLETED|Overall Study||7
101979|NCT01990664|248617|P2|COMPLETED|Overall Study||79
101980|NCT01990664|248618|P1|COMPLETED|Overall Study||95
101981|NCT01990664|248617|P2|STARTED|Overall Study||90
101982|NCT01990664|248618|P1|STARTED|Overall Study||102
101983|NCT01990612|248626|P2|NOT COMPLETED|Overall Study||3
101984|NCT01990612|248627|P1|NOT COMPLETED|Overall Study||7
101985|NCT01990612|248626|P2|COMPLETED|Overall Study||3059
101986|NCT01990612|248627|P1|COMPLETED|Overall Study||3037
101987|NCT01990612|248626|P2|STARTED|Overall Study||3062
101988|NCT01990612|248627|P1|STARTED|Overall Study||3044
101989|NCT01990560|248705|P1|NOT COMPLETED|Overall Study||1
101990|NCT01990560|248705|P1|COMPLETED|Overall Study||7
101991|NCT01990560|248705|P1|STARTED|Overall Study||8
101992|NCT01990534|248719|P1|NOT COMPLETED|Overall Study||60
101993|NCT01990534|248719|P1|COMPLETED|Overall Study||0
101994|NCT01990534|248719|P1|Ongoing|Overall Study||36
101995|NCT01990534|248719|P1|STARTED|Overall Study||60
101996|NCT01990339|248735|P1|NOT COMPLETED|Overall Study||2312
101997|NCT01990339|248735|P1|COMPLETED|Overall Study||12653
101998|NCT01990339|248735|P1|STARTED|Overall Study||14965
101999|NCT01990313|248740|P1|NOT COMPLETED|Overall Study||1
102000|NCT01990313|248740|P1|COMPLETED|Overall Study||14
102001|NCT01990313|248740|P1|STARTED|Overall Study||15
102002|NCT01990300|248745|P1|NOT COMPLETED|Overall Study||142
102003|NCT01990300|248745|P1|COMPLETED|Overall Study||3139
102004|NCT01990300|248745|P1|STARTED|Overall Study||3281
102005|NCT01990261|248751|P1|NOT COMPLETED|Overall Study||25
102006|NCT01990261|248751|P1|COMPLETED|Overall Study||8
102007|NCT01990261|248751|P1|Treated|Overall Study||29
102008|NCT01990261|248751|P1|STARTED|Overall Study||33
102009|NCT01989975|248761|P1|NOT COMPLETED|Overall Study||0
102010|NCT01989975|248761|P1|COMPLETED|Overall Study||40
102011|NCT01989975|248761|P1|STARTED|Overall Study||40
102012|NCT01989910|248770|P2|NOT COMPLETED|Overall Study||0
102013|NCT01989910|248771|P1|NOT COMPLETED|Overall Study||2
102014|NCT01989910|248770|P2|COMPLETED|Overall Study||54
102015|NCT01989910|248771|P1|COMPLETED|Overall Study||51
102016|NCT01989910|248770|P2|STARTED|Overall Study||54
102017|NCT01989910|248771|P1|STARTED|Overall Study||53
102018|NCT01989793|248783|P2|NOT COMPLETED|Overall Study||4
102019|NCT01989793|248784|P1|NOT COMPLETED|Overall Study||8
102020|NCT01989793|248783|P2|COMPLETED|Overall Study||15
102021|NCT01989793|248784|P1|COMPLETED|Overall Study||10
102022|NCT01989793|248783|P2|STARTED|Overall Study||19
102023|NCT01989793|248784|P1|STARTED|Overall Study||18
102024|NCT01989754|248808|P2|NOT COMPLETED|Overall Study||35
102025|NCT01989754|248809|P1|NOT COMPLETED|Overall Study||39
102026|NCT01989754|248808|P2|COMPLETED|Overall Study|Participants who died are included in this category.|2872
102027|NCT01989754|248809|P1|COMPLETED|Overall Study|Participants who died are included in this category.|2866
102028|NCT01989754|248808|P2|Treated|Overall Study||2904
102029|NCT01989754|248809|P1|Treated|Overall Study||2903
102030|NCT01989754|248808|P2|STARTED|Overall Study||2907
102031|NCT01989754|248809|P1|STARTED|Overall Study||2905
102032|NCT01989689|248821|P2|NOT COMPLETED|Treatment Period ( 3 Months)||0
102033|NCT01989689|248822|P1|NOT COMPLETED|Treatment Period ( 3 Months)||0
102034|NCT01989689|248821|P2|COMPLETED|Treatment Period ( 3 Months)||10
102035|NCT01989689|248822|P1|COMPLETED|Treatment Period ( 3 Months)||11
102036|NCT01989689|248821|P2|STARTED|Treatment Period ( 3 Months)||10
102037|NCT01989689|248822|P1|STARTED|Treatment Period ( 3 Months)||11
102038|NCT01989689|248821|P2|NOT COMPLETED|Treatment Period 1 ( 3 Months)||3
102039|NCT01989689|248822|P1|NOT COMPLETED|Treatment Period 1 ( 3 Months)||0
102040|NCT01989689|248821|P2|COMPLETED|Treatment Period 1 ( 3 Months)||10
102041|NCT01989689|248822|P1|COMPLETED|Treatment Period 1 ( 3 Months)||11
102042|NCT01989689|248821|P2|STARTED|Treatment Period 1 ( 3 Months)||13
102043|NCT01989689|248822|P1|STARTED|Treatment Period 1 ( 3 Months)||11
102044|NCT01989689|248821|P2|NOT COMPLETED|Baseline||0
102045|NCT01989689|248822|P1|NOT COMPLETED|Baseline||0
102046|NCT01989689|248821|P2|COMPLETED|Baseline||13
102047|NCT01989689|248822|P1|COMPLETED|Baseline||11
102048|NCT01989689|248821|P2|STARTED|Baseline||13
102049|NCT01989689|248822|P1|STARTED|Baseline||11
102050|NCT01989676|248834|P2|NOT COMPLETED|Overall Study||347
102051|NCT01989676|248835|P1|NOT COMPLETED|Overall Study||338
102052|NCT01989676|248834|P2|COMPLETED|Overall Study||6
102053|NCT01989676|248835|P1|COMPLETED|Overall Study||11
102054|NCT01989676|248834|P2|STARTED|Overall Study|Treated (355 randomized)|353
102055|NCT01989676|248835|P1|STARTED|Overall Study|Treated (352 randomized)|349
102056|NCT01989572|248861|P6|NOT COMPLETED|Overall Study||110
102057|NCT01989572|248862|P5|NOT COMPLETED|Overall Study||98
102058|NCT01989572|248863|P4|NOT COMPLETED|Overall Study||51
102059|NCT01989572|248864|P3|NOT COMPLETED|Overall Study||62
102060|NCT01989572|248865|P2|NOT COMPLETED|Overall Study||58
102061|NCT01989572|248866|P1|NOT COMPLETED|Overall Study||55
102062|NCT01989572|248861|P6|COMPLETED|Overall Study||79
102063|NCT01989572|248862|P5|COMPLETED|Overall Study||92
102064|NCT01989572|248863|P4|COMPLETED|Overall Study||56
102065|NCT01989572|248864|P3|COMPLETED|Overall Study||47
102066|NCT01989572|248865|P2|COMPLETED|Overall Study||53
102067|NCT01989572|248866|P1|COMPLETED|Overall Study||54
102068|NCT01989572|248861|P6|Treated|Overall Study||171
102069|NCT01989572|248862|P5|Treated|Overall Study||186
102070|NCT01989572|248863|P4|Treated|Overall Study||104
102071|NCT01989572|248864|P3|Treated|Overall Study||107
102072|NCT01989572|248865|P2|Treated|Overall Study||110
102073|NCT01989572|248866|P1|Treated|Overall Study||104
102074|NCT01989572|248861|P6|STARTED|Overall Study||189
102075|NCT01989572|248862|P5|STARTED|Overall Study||190
102076|NCT01989572|248863|P4|STARTED|Overall Study||107
102077|NCT01989572|248864|P3|STARTED|Overall Study||109
102078|NCT01989572|248865|P2|STARTED|Overall Study||111
102079|NCT01989572|248866|P1|STARTED|Overall Study||109
102080|NCT01989468|248897|P5|NOT COMPLETED|Overall Study||8
102081|NCT01989468|248898|P4|NOT COMPLETED|Overall Study||16
102082|NCT01989468|248899|P3|NOT COMPLETED|Overall Study||19
102083|NCT01989468|248900|P2|NOT COMPLETED|Overall Study||37
102084|NCT01989468|248901|P1|NOT COMPLETED|Overall Study||47
102085|NCT01989468|248897|P5|COMPLETED|Overall Study||0
102086|NCT01989468|248898|P4|COMPLETED|Overall Study||49
102087|NCT01989468|248899|P3|COMPLETED|Overall Study||45
102088|NCT01989468|248900|P2|COMPLETED|Overall Study||102
102089|NCT01989468|248901|P1|COMPLETED|Overall Study||91
102090|NCT01989468|248897|P5|STARTED|Overall Study||8
102091|NCT01989468|248898|P4|STARTED|Overall Study||65
102092|NCT01989468|248899|P3|STARTED|Overall Study||64
102093|NCT01989468|248900|P2|STARTED|Overall Study||139
102094|NCT01989468|248901|P1|STARTED|Overall Study||138
102095|NCT01989455|248943|P5|NOT COMPLETED|Overall Study||1
102096|NCT01989455|248944|P4|NOT COMPLETED|Overall Study||0
102097|NCT01989455|248945|P3|NOT COMPLETED|Overall Study||1
102098|NCT01989455|248946|P2|NOT COMPLETED|Overall Study||2
102099|NCT01989455|248947|P1|NOT COMPLETED|Overall Study||0
102100|NCT01989455|248943|P5|COMPLETED|Overall Study||7
102101|NCT01989455|248944|P4|COMPLETED|Overall Study||14
102102|NCT01989455|248945|P3|COMPLETED|Overall Study||13
102103|NCT01989455|248946|P2|COMPLETED|Overall Study||12
102104|NCT01989455|248947|P1|COMPLETED|Overall Study||14
102105|NCT01989455|248943|P5|STARTED|Overall Study||8
102106|NCT01989455|248944|P4|STARTED|Overall Study||14
102107|NCT01989455|248945|P3|STARTED|Overall Study||14
102108|NCT01989455|248946|P2|STARTED|Overall Study||14
102109|NCT01989455|248947|P1|STARTED|Overall Study||14
102110|NCT01989195|248981|P1|NOT COMPLETED|Overall Study||0
102111|NCT01989195|248981|P1|COMPLETED|Overall Study||6
102112|NCT01989195|248981|P1|STARTED|Overall Study||6
102113|NCT01989169|248991|P2|NOT COMPLETED|Period 2||1
102114|NCT01989169|248992|P1|NOT COMPLETED|Period 2||0
102115|NCT01989169|248991|P2|COMPLETED|Period 2||14
102116|NCT01989169|248992|P1|COMPLETED|Period 2||15
102117|NCT01989169|248991|P2|STARTED|Period 2||15
102118|NCT01989169|248992|P1|STARTED|Period 2||15
102119|NCT01989169|248991|P2|NOT COMPLETED|Period 1||0
102120|NCT01989169|248992|P1|NOT COMPLETED|Period 1||0
102121|NCT01989169|248991|P2|COMPLETED|Period 1||15
102122|NCT01989169|248992|P1|COMPLETED|Period 1||15
102123|NCT01989169|248991|P2|STARTED|Period 1||15
102124|NCT01989169|248992|P1|STARTED|Period 1||15
102125|NCT01989156|249005|P3|NOT COMPLETED|End of Study (Population at Day 90)||3
102126|NCT01989156|249006|P2|NOT COMPLETED|End of Study (Population at Day 90)||5
102127|NCT01989156|249007|P1|NOT COMPLETED|End of Study (Population at Day 90)||7
102128|NCT01989156|249005|P3|COMPLETED|End of Study (Population at Day 90)||31
102129|NCT01989156|249006|P2|COMPLETED|End of Study (Population at Day 90)||35
102130|NCT01989156|249007|P1|COMPLETED|End of Study (Population at Day 90)||73
102131|NCT01989156|249005|P3|STARTED|End of Study (Population at Day 90)||34
102132|NCT01989156|249006|P2|STARTED|End of Study (Population at Day 90)||40
102133|NCT01989156|249007|P1|STARTED|End of Study (Population at Day 90)||80
102134|NCT01989156|249005|P3|NOT COMPLETED|Confinement Period (Population at Day 5)||5
102135|NCT01989156|249006|P2|NOT COMPLETED|Confinement Period (Population at Day 5)||1
102136|NCT01989156|249007|P1|NOT COMPLETED|Confinement Period (Population at Day 5)||0
102137|NCT01989156|249005|P3|COMPLETED|Confinement Period (Population at Day 5)||34
102138|NCT01989156|249006|P2|COMPLETED|Confinement Period (Population at Day 5)||40
102139|NCT01989156|249007|P1|COMPLETED|Confinement Period (Population at Day 5)||80
102140|NCT01989156|249005|P3|STARTED|Confinement Period (Population at Day 5)||39
102141|NCT01989156|249006|P2|STARTED|Confinement Period (Population at Day 5)||41
102142|NCT01989156|249007|P1|STARTED|Confinement Period (Population at Day 5)||80
102143|NCT01989130|249029|P2|NOT COMPLETED|Overall Study||0
102144|NCT01989130|249030|P1|NOT COMPLETED|Overall Study||0
102145|NCT01989130|249029|P2|COMPLETED|Overall Study||27
102146|NCT01989130|249030|P1|COMPLETED|Overall Study||43
102147|NCT01989130|249029|P2|STARTED|Overall Study||27
102148|NCT01989130|249030|P1|STARTED|Overall Study||43
102149|NCT01988922|249045|P3|NOT COMPLETED|Overall Study||0
102150|NCT01988922|249046|P2|NOT COMPLETED|Overall Study||0
102151|NCT01988922|249047|P1|NOT COMPLETED|Overall Study||0
102152|NCT01988922|249045|P3|COMPLETED|Overall Study||10
102153|NCT01988922|249046|P2|COMPLETED|Overall Study||10
102154|NCT01988922|249047|P1|COMPLETED|Overall Study||10
102155|NCT01988922|249045|P3|STARTED|Overall Study||10
102156|NCT01988922|249046|P2|STARTED|Overall Study||10
102157|NCT01988922|249047|P1|STARTED|Overall Study||10
102158|NCT01988857|249058|P1|NOT COMPLETED|Overall Study||0
102159|NCT01988857|249058|P1|COMPLETED|Overall Study||300
102160|NCT01988857|249058|P1|STARTED|Overall Study||300
102161|NCT01988662|249067|P2|NOT COMPLETED|Overall Study||2
102162|NCT01988662|249068|P1|NOT COMPLETED|Overall Study||4
102163|NCT01988662|249067|P2|COMPLETED|Overall Study||99
102164|NCT01988662|249068|P1|COMPLETED|Overall Study||100
102165|NCT01988662|249067|P2|STARTED|Overall Study||101
102166|NCT01988662|249068|P1|STARTED|Overall Study||104
102167|NCT01988493|249090|P5|NOT COMPLETED|Overall Study||1
102168|NCT01988493|249091|P4|NOT COMPLETED|Overall Study||2
102169|NCT01988493|249092|P3|NOT COMPLETED|Overall Study||0
102170|NCT01988493|249093|P2|NOT COMPLETED|Overall Study||0
102171|NCT01988493|249094|P1|NOT COMPLETED|Overall Study||0
102172|NCT01988493|249090|P5|COMPLETED|Overall Study||44
102173|NCT01988493|249091|P4|COMPLETED|Overall Study||43
102174|NCT01988493|249092|P3|COMPLETED|Overall Study||6
102175|NCT01988493|249093|P2|COMPLETED|Overall Study||14
102176|NCT01988493|249094|P1|COMPLETED|Overall Study||7
102177|NCT01988493|249090|P5|Safety Population|Overall Study||44
102178|NCT01988493|249091|P4|Safety Population|Overall Study||45
102179|NCT01988493|249092|P3|Safety Population|Overall Study||6
102180|NCT01988493|249093|P2|Safety Population|Overall Study||14
102181|NCT01988493|249094|P1|Safety Population|Overall Study||7
102182|NCT01988493|249090|P5|Treated|Overall Study||44
102183|NCT01988493|249091|P4|Treated|Overall Study||45
102184|NCT01988493|249092|P3|Treated|Overall Study||6
102185|NCT01988493|249093|P2|Treated|Overall Study||14
102186|NCT01988493|249094|P1|Treated|Overall Study||7
102187|NCT01988493|249090|P5|STARTED|Overall Study||45
102188|NCT01988493|249091|P4|STARTED|Overall Study||45
102189|NCT01988493|249092|P3|STARTED|Overall Study||6
102190|NCT01988493|249093|P2|STARTED|Overall Study||14
102191|NCT01988493|249094|P1|STARTED|Overall Study||7
102192|NCT01988415|249163|P1|NOT COMPLETED|Overall Study||0
102193|NCT01988415|249163|P1|COMPLETED|Overall Study||26
102194|NCT01988415|249163|P1|STARTED|Overall Study|52 eyes of 26 subjects (paired-eyes: commercial and investigational software)|26
102195|NCT01988402|249173|P2|NOT COMPLETED|Overall Study||2
102196|NCT01988402|249174|P1|NOT COMPLETED|Overall Study||2
102197|NCT01988402|249173|P2|COMPLETED|Overall Study||17
102198|NCT01988402|249174|P1|COMPLETED|Overall Study||14
102199|NCT01988402|249173|P2|STARTED|Overall Study||19
102200|NCT01988402|249174|P1|STARTED|Overall Study||16
102201|NCT01988376|249188|P2|NOT COMPLETED|Overall Study||0
102202|NCT01988376|249189|P1|NOT COMPLETED|Overall Study||0
102203|NCT01988376|249188|P2|COMPLETED|Overall Study||129
102204|NCT01988376|249189|P1|COMPLETED|Overall Study||129
102205|NCT01988376|249188|P2|STARTED|Overall Study||129
102206|NCT01988376|249189|P1|STARTED|Overall Study||129
102207|NCT01988129|249197|P2|NOT COMPLETED|Overall Study||0
102208|NCT01988129|249198|P1|NOT COMPLETED|Overall Study||0
102209|NCT01988129|249197|P2|COMPLETED|Overall Study||588
102210|NCT01988129|249198|P1|COMPLETED|Overall Study||601
102211|NCT01988129|249197|P2|Completed 1-year Follow-up Survey|Overall Study||4
102212|NCT01988129|249198|P1|Completed 1-year Follow-up Survey|Overall Study||100
102213|NCT01988129|249197|P2|Screened for Sleep Disorders|Overall Study||15
102214|NCT01988129|249198|P1|Screened for Sleep Disorders|Overall Study||416
102215|NCT01988129|249197|P2|Attended Education Session|Overall Study||18
102216|NCT01988129|249198|P1|Attended Education Session|Overall Study||542
102217|NCT01988129|249197|P2|STARTED|Overall Study|Control participant data obtained from department. Individuals were not enrolled.|588
102218|NCT01988129|249198|P1|STARTED|Overall Study|Intervention participant data obtained from department. Individuals not enrolled for primary aim.|601
102219|NCT01988090|249227|P2|NOT COMPLETED|Complete Study After Start||1
102220|NCT01988090|249228|P1|NOT COMPLETED|Complete Study After Start||3
102221|NCT01988090|249227|P2|COMPLETED|Complete Study After Start||42
102222|NCT01988090|249228|P1|COMPLETED|Complete Study After Start||41
102223|NCT01988090|249227|P2|STARTED|Complete Study After Start||43
102224|NCT01988090|249228|P1|STARTED|Complete Study After Start||44
102225|NCT01988090|249227|P2|NOT COMPLETED|Start Treament After Randomization||4
102226|NCT01988090|249228|P1|NOT COMPLETED|Start Treament After Randomization||2
102227|NCT01988090|249227|P2|COMPLETED|Start Treament After Randomization||43
102228|NCT01988090|249228|P1|COMPLETED|Start Treament After Randomization||44
102229|NCT01988090|249227|P2|STARTED|Start Treament After Randomization||47
102230|NCT01988090|249228|P1|STARTED|Start Treament After Randomization||46
102231|NCT01988012|249238|P1|NOT COMPLETED|Overall Study||15
102232|NCT01988012|249238|P1|COMPLETED|Overall Study||85
102233|NCT01988012|249238|P1|STARTED|Overall Study||100
102234|NCT01987986|249264|P4|NOT COMPLETED|Overall Study||0
102235|NCT01987986|249265|P3|NOT COMPLETED|Overall Study||2
102236|NCT01987986|249266|P2|NOT COMPLETED|Overall Study||0
102237|NCT01987986|249267|P1|NOT COMPLETED|Overall Study||2
102238|NCT01987986|249264|P4|COMPLETED|Overall Study||24
102239|NCT01987986|249265|P3|COMPLETED|Overall Study||38
102240|NCT01987986|249266|P2|COMPLETED|Overall Study||43
102241|NCT01987986|249267|P1|COMPLETED|Overall Study||41
102242|NCT01987986|249264|P4|STARTED|Overall Study||24
102243|NCT01987986|249265|P3|STARTED|Overall Study||40
102244|NCT01987986|249266|P2|STARTED|Overall Study||43
102245|NCT01987986|249267|P1|STARTED|Overall Study||43
102246|NCT01987960|249307|P4|NOT COMPLETED|Period 3||71
102247|NCT01987960|249308|P3|NOT COMPLETED|Period 3||0
102248|NCT01987960|249309|P2|NOT COMPLETED|Period 3||0
102249|NCT01987960|249310|P1|NOT COMPLETED|Period 3||0
102250|NCT01987960|249307|P4|COMPLETED|Period 3||119
102251|NCT01987960|249308|P3|COMPLETED|Period 3||0
102252|NCT01987960|249309|P2|COMPLETED|Period 3||0
102253|NCT01987960|249310|P1|COMPLETED|Period 3||0
102254|NCT01987960|249307|P4|STARTED|Period 3||190
102255|NCT01987960|249308|P3|STARTED|Period 3||0
102256|NCT01987960|249309|P2|STARTED|Period 3||0
102257|NCT01987960|249310|P1|STARTED|Period 3||0
102258|NCT01987960|249307|P4|NOT COMPLETED|Period 2||0
102259|NCT01987960|249308|P3|NOT COMPLETED|Period 2||9
102260|NCT01987960|249309|P2|NOT COMPLETED|Period 2||5
102261|NCT01987960|249310|P1|NOT COMPLETED|Period 2||0
102262|NCT01987960|249307|P4|COMPLETED|Period 2||0
102263|NCT01987960|249308|P3|COMPLETED|Period 2||14
102264|NCT01987960|249309|P2|COMPLETED|Period 2||12
102265|NCT01987960|249310|P1|COMPLETED|Period 2||0
102266|NCT01987960|249307|P4|STARTED|Period 2||0
102267|NCT01987960|249308|P3|STARTED|Period 2||23
102268|NCT01987960|249309|P2|STARTED|Period 2||17
102269|NCT01987960|249310|P1|STARTED|Period 2||0
102270|NCT01987960|249307|P4|NOT COMPLETED|Period 1||0
102271|NCT01987960|249308|P3|NOT COMPLETED|Period 1||0
102272|NCT01987960|249309|P2|NOT COMPLETED|Period 1||0
102273|NCT01987960|249310|P1|NOT COMPLETED|Period 1||186
102274|NCT01987960|249307|P4|COMPLETED|Period 1||0
102275|NCT01987960|249308|P3|COMPLETED|Period 1||0
102276|NCT01987960|249309|P2|COMPLETED|Period 1||0
102277|NCT01987960|249310|P1|COMPLETED|Period 1||231
102278|NCT01987960|249307|P4|STARTED|Period 1||0
102279|NCT01987960|249308|P3|STARTED|Period 1||0
102280|NCT01987960|249309|P2|STARTED|Period 1||0
102281|NCT01987960|249310|P1|STARTED|Period 1||417
102282|NCT01987908|249322|P3|NOT COMPLETED|Post-Treatment Observation Period||0
102283|NCT01987908|249323|P2|NOT COMPLETED|Post-Treatment Observation Period||3
102284|NCT01987908|249324|P1|NOT COMPLETED|Post-Treatment Observation Period||0
102285|NCT01987908|249322|P3|COMPLETED|Post-Treatment Observation Period||2
102286|NCT01987908|249323|P2|COMPLETED|Post-Treatment Observation Period||7
102287|NCT01987908|249324|P1|COMPLETED|Post-Treatment Observation Period||0
102288|NCT01987908|249322|P3|STARTED|Post-Treatment Observation Period||2
102289|NCT01987908|249323|P2|STARTED|Post-Treatment Observation Period||10
102290|NCT01987908|249324|P1|STARTED|Post-Treatment Observation Period||0
102291|NCT01987908|249322|P3|NOT COMPLETED|Treatment Period||1
102292|NCT01987908|249323|P2|NOT COMPLETED|Treatment Period||1
102293|NCT01987908|249324|P1|NOT COMPLETED|Treatment Period||0
102294|NCT01987908|249322|P3|COMPLETED|Treatment Period||2
102295|NCT01987908|249323|P2|COMPLETED|Treatment Period||10
102296|NCT01987908|249324|P1|COMPLETED|Treatment Period||0
102297|NCT01987908|249322|P3|STARTED|Treatment Period||3
102298|NCT01987908|249323|P2|STARTED|Treatment Period||11
102299|NCT01987908|249324|P1|STARTED|Treatment Period||0
102300|NCT01987908|249322|P3|NOT COMPLETED|Placebo Lead-in Period||0
102301|NCT01987908|249323|P2|NOT COMPLETED|Placebo Lead-in Period||0
102302|NCT01987908|249324|P1|NOT COMPLETED|Placebo Lead-in Period||9
102303|NCT01987908|249322|P3|COMPLETED|Placebo Lead-in Period||0
102304|NCT01987908|249323|P2|COMPLETED|Placebo Lead-in Period||0
102305|NCT01987908|249324|P1|COMPLETED|Placebo Lead-in Period||14
102306|NCT01987908|249322|P3|STARTED|Placebo Lead-in Period||0
102307|NCT01987908|249323|P2|STARTED|Placebo Lead-in Period||0
102308|NCT01987908|249324|P1|STARTED|Placebo Lead-in Period||23
102309|NCT01987895|249407|P2|NOT COMPLETED|Overall Study||30
102310|NCT01987895|249408|P1|NOT COMPLETED|Overall Study||30
102311|NCT01987895|249407|P2|COMPLETED|Overall Study||296
102312|NCT01987895|249408|P1|COMPLETED|Overall Study||276
102313|NCT01987895|249407|P2|STARTED|Overall Study||326
102314|NCT01987895|249408|P1|STARTED|Overall Study||306
102315|NCT01987765|249432|P1|NOT COMPLETED|Overall Study||102
102316|NCT01987765|249432|P1|COMPLETED|Overall Study||745
102317|NCT01987765|249432|P1|STARTED|Overall Study||847
102318|NCT01987752|249437|P1|NOT COMPLETED|Overall Study||0
102319|NCT01987752|249437|P1|COMPLETED|Overall Study||732
102320|NCT01987752|249437|P1|STARTED|Overall Study||732
102321|NCT01987609|249442|P1|NOT COMPLETED|Overall Study||1
102322|NCT01987609|249442|P1|COMPLETED|Overall Study||6
102323|NCT01987609|249442|P1|Normal Saline Injected in Arm|Overall Study||6
102324|NCT01987609|249442|P1|Hylenex Injected in Arm|Overall Study||6
102325|NCT01987609|249442|P1|STARTED|Overall Study|one arm on one patient|7
102326|NCT01987583|249475|P2|NOT COMPLETED|Overall Study||2
102327|NCT01987583|249476|P1|NOT COMPLETED|Overall Study||3
102328|NCT01987583|249475|P2|COMPLETED|Overall Study||38
102329|NCT01987583|249476|P1|COMPLETED|Overall Study||37
102330|NCT01987583|249475|P2|STARTED|Overall Study||40
102331|NCT01987583|249476|P1|STARTED|Overall Study||40
102332|NCT01987557|249487|P3|NOT COMPLETED|Overall Study||3
102333|NCT01987557|249488|P2|NOT COMPLETED|Overall Study||3
102334|NCT01987557|249489|P1|NOT COMPLETED|Overall Study||3
102335|NCT01987557|249487|P3|COMPLETED|Overall Study||13
102336|NCT01987557|249488|P2|COMPLETED|Overall Study||13
102337|NCT01987557|249489|P1|COMPLETED|Overall Study||13
102338|NCT01987557|249487|P3|STARTED|Overall Study||16
102339|NCT01987557|249488|P2|STARTED|Overall Study||16
102340|NCT01987557|249489|P1|STARTED|Overall Study||16
102341|NCT01987505|249499|P1|NOT COMPLETED|Overall Study||34
102342|NCT01987505|249499|P1|COMPLETED|Overall Study||106
102343|NCT01987505|249499|P1|STARTED|Overall Study||140
102344|NCT01987479|249529|P1|NOT COMPLETED|Overall Study||17
102345|NCT01987479|249529|P1|COMPLETED|Overall Study||133
102346|NCT01987479|249529|P1|STARTED|Overall Study||150
102347|NCT01987453|249557|P3|NOT COMPLETED|Overall Study||1
102348|NCT01987453|249558|P2|NOT COMPLETED|Overall Study||12
102349|NCT01987453|249559|P1|NOT COMPLETED|Overall Study||1
102350|NCT01987453|249557|P3|COMPLETED|Overall Study||7
102351|NCT01987453|249558|P2|COMPLETED|Overall Study||29
102352|NCT01987453|249559|P1|COMPLETED|Overall Study||50
102353|NCT01987453|249557|P3|STARTED|Overall Study||8
102354|NCT01987453|249558|P2|STARTED|Overall Study||41
102355|NCT01987453|249559|P1|STARTED|Overall Study||51
102356|NCT01987427|249585|P3|NOT COMPLETED|Overall Study||20
102357|NCT01987427|249586|P2|NOT COMPLETED|Overall Study||10
102358|NCT01987427|249587|P1|NOT COMPLETED|Overall Study||14
102359|NCT01987427|249585|P3|COMPLETED|Overall Study||59
102360|NCT01987427|249586|P2|COMPLETED|Overall Study||68
102361|NCT01987427|249587|P1|COMPLETED|Overall Study||64
102362|NCT01987427|249585|P3|STARTED|Overall Study||79
102363|NCT01987427|249586|P2|STARTED|Overall Study||78
102364|NCT01987427|249587|P1|STARTED|Overall Study||78
102365|NCT01987414|249618|P2|NOT COMPLETED|Overall Study||2
102366|NCT01987414|249619|P1|NOT COMPLETED|Overall Study||2
102367|NCT01987414|249618|P2|COMPLETED|Overall Study||6
102368|NCT01987414|249619|P1|COMPLETED|Overall Study||8
102369|NCT01987414|249618|P2|STARTED|Overall Study||8
102370|NCT01987414|249619|P1|STARTED|Overall Study||10
102371|NCT01987401|249668|P3|NOT COMPLETED|Overall Study||44
102372|NCT01987401|249669|P2|NOT COMPLETED|Overall Study||470
102373|NCT01987401|249670|P1|NOT COMPLETED|Overall Study||454
102374|NCT01987401|249668|P3|COMPLETED|Overall Study||16
102375|NCT01987401|249669|P2|COMPLETED|Overall Study||121
102376|NCT01987401|249670|P1|COMPLETED|Overall Study||137
102377|NCT01987401|249668|P3|STARTED|Overall Study||60
102378|NCT01987401|249669|P2|STARTED|Overall Study||591
102379|NCT01987401|249670|P1|STARTED|Overall Study||591
102380|NCT01987349|249686|P8|NOT COMPLETED|Overall Study||1
102381|NCT01987349|249687|P7|NOT COMPLETED|Overall Study||0
102382|NCT01987349|249688|P6|NOT COMPLETED|Overall Study||0
102383|NCT01987349|249689|P5|NOT COMPLETED|Overall Study||0
102384|NCT01987349|249690|P4|NOT COMPLETED|Overall Study||0
102385|NCT01987349|249691|P3|NOT COMPLETED|Overall Study||0
102386|NCT01987349|249692|P2|NOT COMPLETED|Overall Study||0
102387|NCT01987349|249693|P1|NOT COMPLETED|Overall Study||0
102388|NCT01987349|249686|P8|COMPLETED|Overall Study||24
102389|NCT01987349|249687|P7|COMPLETED|Overall Study||10
102390|NCT01987349|249688|P6|COMPLETED|Overall Study||6
102391|NCT01987349|249689|P5|COMPLETED|Overall Study||6
102392|NCT01987349|249690|P4|COMPLETED|Overall Study||6
102393|NCT01987349|249691|P3|COMPLETED|Overall Study||8
102394|NCT01987349|249692|P2|COMPLETED|Overall Study||6
102395|NCT01987349|249693|P1|COMPLETED|Overall Study||6
102396|NCT01987349|249686|P8|STARTED|Overall Study||25
102397|NCT01987349|249687|P7|STARTED|Overall Study||10
102398|NCT01987349|249688|P6|STARTED|Overall Study||6
102399|NCT01987349|249689|P5|STARTED|Overall Study||6
102400|NCT01987349|249690|P4|STARTED|Overall Study||6
102401|NCT01987349|249691|P3|STARTED|Overall Study||8
102402|NCT01987349|249692|P2|STARTED|Overall Study||6
102403|NCT01987349|249693|P1|STARTED|Overall Study||6
102404|NCT01987232|249724|P5|NOT COMPLETED|Overall Study||0
102405|NCT01987232|249725|P4|NOT COMPLETED|Overall Study||1
102406|NCT01987232|249726|P3|NOT COMPLETED|Overall Study||0
102407|NCT01987232|249727|P2|NOT COMPLETED|Overall Study||0
102408|NCT01987232|249728|P1|NOT COMPLETED|Overall Study||0
102409|NCT01987232|249724|P5|COMPLETED|Overall Study||6
102410|NCT01987232|249725|P4|COMPLETED|Overall Study||14
102411|NCT01987232|249726|P3|COMPLETED|Overall Study||3
102412|NCT01987232|249727|P2|COMPLETED|Overall Study||3
102413|NCT01987232|249728|P1|COMPLETED|Overall Study||5
102414|NCT01987232|249724|P5|STARTED|Overall Study||6
102415|NCT01987232|249725|P4|STARTED|Overall Study||15
102416|NCT01987232|249726|P3|STARTED|Overall Study||3
102417|NCT01987232|249727|P2|STARTED|Overall Study||3
102418|NCT01987232|249728|P1|STARTED|Overall Study||5
102419|NCT01987219|249793|P6|NOT COMPLETED|Overall Study||0
102420|NCT01987219|249794|P5|NOT COMPLETED|Overall Study||0
102421|NCT01987219|249795|P4|NOT COMPLETED|Overall Study||0
102422|NCT01987219|249796|P3|NOT COMPLETED|Overall Study||1
102423|NCT01987219|249797|P2|NOT COMPLETED|Overall Study||0
102424|NCT01987219|249798|P1|NOT COMPLETED|Overall Study||0
102425|NCT01987219|249793|P6|COMPLETED|Overall Study||1
102426|NCT01987219|249794|P5|COMPLETED|Overall Study||1
102427|NCT01987219|249795|P4|COMPLETED|Overall Study||2
102428|NCT01987219|249796|P3|COMPLETED|Overall Study||6
102429|NCT01987219|249797|P2|COMPLETED|Overall Study||2
102430|NCT01987219|249798|P1|COMPLETED|Overall Study||2
102431|NCT01987219|249793|P6|STARTED|Overall Study||1
102432|NCT01987219|249794|P5|STARTED|Overall Study||1
102433|NCT01987219|249795|P4|STARTED|Overall Study||2
102434|NCT01987219|249796|P3|STARTED|Overall Study||7
102435|NCT01987219|249797|P2|STARTED|Overall Study||2
102436|NCT01987219|249798|P1|STARTED|Overall Study||2
102437|NCT01987102|249817|P2|NOT COMPLETED|2 Courses of HDMTX With MOD Rescue||1
102438|NCT01987102|249818|P1|NOT COMPLETED|2 Courses of HDMTX With MOD Rescue||0
102439|NCT01987102|249817|P2|COMPLETED|2 Courses of HDMTX With MOD Rescue||3
102440|NCT01987102|249818|P1|COMPLETED|2 Courses of HDMTX With MOD Rescue||4
102441|NCT01987102|249817|P2|STARTED|2 Courses of HDMTX With MOD Rescue||4
102442|NCT01987102|249818|P1|STARTED|2 Courses of HDMTX With MOD Rescue||4
102443|NCT01987102|249817|P2|NOT COMPLETED|2 Courses of HDMTX With SOC Rescue||6
102444|NCT01987102|249818|P1|NOT COMPLETED|2 Courses of HDMTX With SOC Rescue||4
102445|NCT01987102|249817|P2|COMPLETED|2 Courses of HDMTX With SOC Rescue||4
102446|NCT01987102|249818|P1|COMPLETED|2 Courses of HDMTX With SOC Rescue||4
102447|NCT01987102|249817|P2|STARTED|2 Courses of HDMTX With SOC Rescue||10
102448|NCT01987102|249818|P1|STARTED|2 Courses of HDMTX With SOC Rescue||8
102449|NCT01986985|249850|P1|NOT COMPLETED|Overall Study||7
102450|NCT01986985|249850|P1|COMPLETED|Overall Study||51
102451|NCT01986985|249850|P1|STARTED|Overall Study||58
102452|NCT01986946|249856|P2|NOT COMPLETED|Overall Study||0
102453|NCT01986946|249857|P1|NOT COMPLETED|Overall Study||0
102454|NCT01986946|249856|P2|COMPLETED|Overall Study||9
102455|NCT01986946|249857|P1|COMPLETED|Overall Study||5
102456|NCT01986946|249856|P2|STARTED|Overall Study||9
102457|NCT01986946|249857|P1|STARTED|Overall Study||5
102458|NCT01986920|249887|P4|NOT COMPLETED|Placebo||1
102459|NCT01986920|249888|P3|NOT COMPLETED|Placebo||0
102460|NCT01986920|249889|P2|NOT COMPLETED|Placebo||0
102461|NCT01986920|249890|P1|NOT COMPLETED|Placebo||0
102462|NCT01986920|249887|P4|COMPLETED|Placebo||34
102463|NCT01986920|249888|P3|COMPLETED|Placebo||0
102464|NCT01986920|249889|P2|COMPLETED|Placebo||0
102465|NCT01986920|249890|P1|COMPLETED|Placebo||0
102466|NCT01986920|249887|P4|STARTED|Placebo||35
102467|NCT01986920|249888|P3|STARTED|Placebo||0
102468|NCT01986920|249889|P2|STARTED|Placebo||0
102469|NCT01986920|249890|P1|STARTED|Placebo||0
102470|NCT01986920|249887|P4|NOT COMPLETED|A-101 40%||0
102471|NCT01986920|249888|P3|NOT COMPLETED|A-101 40%||1
102472|NCT01986920|249889|P2|NOT COMPLETED|A-101 40%||0
102473|NCT01986920|249890|P1|NOT COMPLETED|A-101 40%||0
102474|NCT01986920|249887|P4|COMPLETED|A-101 40%||0
102475|NCT01986920|249888|P3|COMPLETED|A-101 40%||34
102476|NCT01986920|249889|P2|COMPLETED|A-101 40%||0
102477|NCT01986920|249890|P1|COMPLETED|A-101 40%||0
102478|NCT01986920|249887|P4|STARTED|A-101 40%||0
102479|NCT01986920|249888|P3|STARTED|A-101 40%||35
102480|NCT01986920|249889|P2|STARTED|A-101 40%||0
102481|NCT01986920|249890|P1|STARTED|A-101 40%||0
102482|NCT01986920|249887|P4|NOT COMPLETED|A-101 32.5%||0
102483|NCT01986920|249888|P3|NOT COMPLETED|A-101 32.5%||0
102484|NCT01986920|249889|P2|NOT COMPLETED|A-101 32.5%||1
102485|NCT01986920|249890|P1|NOT COMPLETED|A-101 32.5%||0
102486|NCT01986920|249887|P4|COMPLETED|A-101 32.5%||0
102487|NCT01986920|249888|P3|COMPLETED|A-101 32.5%||0
102488|NCT01986920|249889|P2|COMPLETED|A-101 32.5%||34
102489|NCT01986920|249890|P1|COMPLETED|A-101 32.5%||0
102490|NCT01986920|249887|P4|STARTED|A-101 32.5%||0
102491|NCT01986920|249888|P3|STARTED|A-101 32.5%||0
102492|NCT01986920|249889|P2|STARTED|A-101 32.5%||35
102493|NCT01986920|249890|P1|STARTED|A-101 32.5%||0
102494|NCT01986920|249887|P4|NOT COMPLETED|A- 101 25%||0
102495|NCT01986920|249888|P3|NOT COMPLETED|A- 101 25%||0
102496|NCT01986920|249889|P2|NOT COMPLETED|A- 101 25%||0
102497|NCT01986920|249890|P1|NOT COMPLETED|A- 101 25%||1
102498|NCT01986920|249887|P4|COMPLETED|A- 101 25%||0
102499|NCT01986920|249888|P3|COMPLETED|A- 101 25%||0
102500|NCT01986920|249889|P2|COMPLETED|A- 101 25%||0
102501|NCT01986920|249890|P1|COMPLETED|A- 101 25%||34
102502|NCT01986920|249887|P4|STARTED|A- 101 25%||0
102503|NCT01986920|249888|P3|STARTED|A- 101 25%||0
102504|NCT01986920|249889|P2|STARTED|A- 101 25%||0
102505|NCT01986920|249890|P1|STARTED|A- 101 25%||35
102506|NCT01986907|249904|P1|NOT COMPLETED|Overall Study||162
102507|NCT01986907|249904|P1|COMPLETED|Overall Study||774
102508|NCT01986907|249904|P1|STARTED|Overall Study||936
102509|NCT01986855|249917|P3|NOT COMPLETED|Overall Study||11
102510|NCT01986855|249918|P2|NOT COMPLETED|Overall Study||14
102511|NCT01986855|249919|P1|NOT COMPLETED|Overall Study||13
102512|NCT01986855|249917|P3|COMPLETED|Overall Study||143
102513|NCT01986855|249918|P2|COMPLETED|Overall Study||142
102514|NCT01986855|249919|P1|COMPLETED|Overall Study||145
102515|NCT01986855|249917|P3|Treated|Overall Study||154
102516|NCT01986855|249918|P2|Treated|Overall Study||155
102517|NCT01986855|249919|P1|Treated|Overall Study||158
102518|NCT01986855|249917|P3|STARTED|Overall Study||154
102519|NCT01986855|249918|P2|STARTED|Overall Study||156
102520|NCT01986855|249919|P1|STARTED|Overall Study||158
102521|NCT01986829|249948|P1|NOT COMPLETED|Overall Study||1
102522|NCT01986829|249948|P1|COMPLETED|Overall Study||8
102523|NCT01986829|249948|P1|STARTED|Overall Study||9
102524|NCT01986790|249978|P3|NOT COMPLETED|Overall Study||0
102525|NCT01986790|249979|P2|NOT COMPLETED|Overall Study||0
102526|NCT01986790|249980|P1|NOT COMPLETED|Overall Study||0
102527|NCT01986790|249978|P3|COMPLETED|Overall Study||98
102528|NCT01986790|249979|P2|COMPLETED|Overall Study||154
102529|NCT01986790|249980|P1|COMPLETED|Overall Study||91
102530|NCT01986790|249978|P3|STARTED|Overall Study||98
102531|NCT01986790|249979|P2|STARTED|Overall Study||154
102532|NCT01986790|249980|P1|STARTED|Overall Study||91
102533|NCT01986751|249996|P2|NOT COMPLETED|Overall Study||2
102534|NCT01986751|249997|P1|NOT COMPLETED|Overall Study||10
102535|NCT01986751|249996|P2|COMPLETED|Overall Study||2
102536|NCT01986751|249997|P1|COMPLETED|Overall Study||0
102537|NCT01986751|249996|P2|STARTED|Overall Study||4
102538|NCT01986751|249997|P1|STARTED|Overall Study||10
102539|NCT01986686|250019|P2|NOT COMPLETED|Overall Study||0
102540|NCT01986686|250020|P1|NOT COMPLETED|Overall Study||0
102541|NCT01986686|250019|P2|COMPLETED|Overall Study||26
102542|NCT01986686|250020|P1|COMPLETED|Overall Study||81
102543|NCT01986686|250019|P2|STARTED|Overall Study||26
102544|NCT01986686|250020|P1|STARTED|Overall Study||81
102545|NCT01986647|250030|P4|NOT COMPLETED|Overall Study||11
102546|NCT01986647|250031|P3|NOT COMPLETED|Overall Study||12
102547|NCT01986647|250032|P2|NOT COMPLETED|Overall Study||7
102548|NCT01986647|250033|P1|NOT COMPLETED|Overall Study||10
102549|NCT01986647|250030|P4|COMPLETED|Overall Study||66
102550|NCT01986647|250031|P3|COMPLETED|Overall Study||37
102551|NCT01986647|250032|P2|COMPLETED|Overall Study||139
102552|NCT01986647|250033|P1|COMPLETED|Overall Study||142
102553|NCT01986647|250030|P4|STARTED|Overall Study||77
102554|NCT01986647|250031|P3|STARTED|Overall Study||49
102555|NCT01986647|250032|P2|STARTED|Overall Study||146
102556|NCT01986647|250033|P1|STARTED|Overall Study||152
102557|NCT01986361|250105|P2|NOT COMPLETED|Overall Study||0
102558|NCT01986361|250106|P1|NOT COMPLETED|Overall Study||0
102559|NCT01986361|250105|P2|COMPLETED|Overall Study||21
102560|NCT01986361|250106|P1|COMPLETED|Overall Study||101
102561|NCT01986361|250105|P2|STARTED|Overall Study||21
102562|NCT01986361|250106|P1|STARTED|Overall Study||101
102563|NCT01986231|250128|P1|NOT COMPLETED|Overall Study||1
102564|NCT01986231|250128|P1|COMPLETED|Overall Study||11
102565|NCT01986231|250128|P1|STARTED|Overall Study||12
102566|NCT01986140|250135|P2|NOT COMPLETED|Overall Study||28
102567|NCT01986140|250136|P1|NOT COMPLETED|Overall Study||35
102568|NCT01986140|250135|P2|COMPLETED|Overall Study||51
102569|NCT01986140|250136|P1|COMPLETED|Overall Study||122
102570|NCT01986140|250135|P2|STARTED|Overall Study||79
102571|NCT01986140|250136|P1|STARTED|Overall Study||157
102572|NCT01986114|250142|P1|NOT COMPLETED|Overall Study||156
102573|NCT01986114|250142|P1|COMPLETED|Overall Study||339
102574|NCT01986114|250142|P1|STARTED|Overall Study||495
102575|NCT01986101|250157|P3|NOT COMPLETED|Overall Study||32
102576|NCT01986101|250158|P2|NOT COMPLETED|Overall Study||27
102577|NCT01986101|250159|P1|NOT COMPLETED|Overall Study||33
102578|NCT01986101|250157|P3|COMPLETED|Overall Study||137
102579|NCT01986101|250158|P2|COMPLETED|Overall Study||157
102580|NCT01986101|250159|P1|COMPLETED|Overall Study||139
102581|NCT01986101|250157|P3|Safety Population|Overall Study||169
102582|NCT01986101|250158|P2|Safety Population|Overall Study||184
102583|NCT01986101|250159|P1|Safety Population|Overall Study||172
102584|NCT01986101|250157|P3|Intent-to-Treat Population|Overall Study||169
102585|NCT01986101|250158|P2|Intent-to-Treat Population|Overall Study||182
102586|NCT01986101|250159|P1|Intent-to-Treat Population|Overall Study||171
102587|NCT01986101|250157|P3|STARTED|Overall Study||169
102588|NCT01986101|250158|P2|STARTED|Overall Study||184
102589|NCT01986101|250159|P1|STARTED|Overall Study||172
102590|NCT01986062|250181|P2|NOT COMPLETED|Overall Study||1
102591|NCT01986062|250182|P1|NOT COMPLETED|Overall Study||1
102592|NCT01986062|250181|P2|COMPLETED|Overall Study||49
102593|NCT01986062|250182|P1|COMPLETED|Overall Study||46
102594|NCT01986062|250181|P2|STARTED|Overall Study||50
102595|NCT01986062|250182|P1|STARTED|Overall Study||47
102596|NCT01985958|250198|P1|NOT COMPLETED|Overall Study||1
102597|NCT01985958|250198|P1|COMPLETED|Overall Study||3
102598|NCT01985958|250198|P1|STARTED|Overall Study||4
102599|NCT01985932|250202|P1|NOT COMPLETED|Overall Study||0
102600|NCT01985932|250202|P1|COMPLETED|Overall Study||15
102601|NCT01985932|250202|P1|STARTED|Overall Study||15
102602|NCT01985763|250206|P1|NOT COMPLETED|Overall Study||0
102603|NCT01985763|250206|P1|COMPLETED|Overall Study||13
102604|NCT01985763|250206|P1|STARTED|Overall Study||13
102605|NCT01985685|250221|P2|NOT COMPLETED|Overall Study||0
102606|NCT01985685|250222|P1|NOT COMPLETED|Overall Study||0
102607|NCT01985685|250221|P2|COMPLETED|Overall Study||29
102608|NCT01985685|250222|P1|COMPLETED|Overall Study||27
102609|NCT01985685|250221|P2|STARTED|Overall Study||29
102610|NCT01985685|250222|P1|STARTED|Overall Study||27
102611|NCT01985581|250234|P2|NOT COMPLETED|Second Intervention||4
102612|NCT01985581|250235|P1|NOT COMPLETED|Second Intervention||2
102613|NCT01985581|250234|P2|COMPLETED|Second Intervention||19
102614|NCT01985581|250235|P1|COMPLETED|Second Intervention||20
102615|NCT01985581|250234|P2|STARTED|Second Intervention||23
102616|NCT01985581|250235|P1|STARTED|Second Intervention||22
102617|NCT01985581|250234|P2|NOT COMPLETED|First Intervention||2
102618|NCT01985581|250235|P1|NOT COMPLETED|First Intervention||3
102619|NCT01985581|250234|P2|COMPLETED|First Intervention||23
102620|NCT01985581|250235|P1|COMPLETED|First Intervention||22
102621|NCT01985581|250234|P2|STARTED|First Intervention||25
102622|NCT01985581|250235|P1|STARTED|First Intervention||25
102623|NCT01985425|250255|P2|NOT COMPLETED|Overall Study||0
102624|NCT01985425|250256|P1|NOT COMPLETED|Overall Study||0
102625|NCT01985425|250255|P2|COMPLETED|Overall Study||51
102626|NCT01985425|250256|P1|COMPLETED|Overall Study||49
102627|NCT01985425|250255|P2|STARTED|Overall Study||51
102628|NCT01985425|250256|P1|STARTED|Overall Study||49
102629|NCT01985334|250282|P8|NOT COMPLETED|Overall Study||121
102630|NCT01985334|250283|P7|NOT COMPLETED|Overall Study||37
102631|NCT01985334|250284|P6|NOT COMPLETED|Overall Study||156
102632|NCT01985334|250285|P5|NOT COMPLETED|Overall Study||40
102633|NCT01985334|250286|P4|NOT COMPLETED|Overall Study||229
102634|NCT01985334|250287|P3|NOT COMPLETED|Overall Study||53
102635|NCT01985334|250288|P2|NOT COMPLETED|Overall Study||84
102636|NCT01985334|250289|P1|NOT COMPLETED|Overall Study||23
102637|NCT01985334|250282|P8|COMPLETED|Overall Study||699
102638|NCT01985334|250283|P7|COMPLETED|Overall Study||237
102639|NCT01985334|250284|P6|COMPLETED|Overall Study||666
102640|NCT01985334|250285|P5|COMPLETED|Overall Study||234
102641|NCT01985334|250286|P4|COMPLETED|Overall Study||1033
102642|NCT01985334|250287|P3|COMPLETED|Overall Study||367
102643|NCT01985334|250288|P2|COMPLETED|Overall Study||303
102644|NCT01985334|250289|P1|COMPLETED|Overall Study||107
102645|NCT01985334|250282|P8|The Intention-to-treat (ITT) Population|Overall Study||811
102646|NCT01985334|250283|P7|The Intention-to-treat (ITT) Population|Overall Study||268
102647|NCT01985334|250284|P6|The Intention-to-treat (ITT) Population|Overall Study||811
102648|NCT01985334|250285|P5|The Intention-to-treat (ITT) Population|Overall Study||269
102649|NCT01985334|250286|P4|The Intention-to-treat (ITT) Population|Overall Study||1254
102650|NCT01985334|250287|P3|The Intention-to-treat (ITT) Population|Overall Study||420
102651|NCT01985334|250288|P2|The Intention-to-treat (ITT) Population|Overall Study||369
102652|NCT01985334|250289|P1|The Intention-to-treat (ITT) Population|Overall Study||122
102653|NCT01985334|250282|P8|STARTED|Overall Study||820
102654|NCT01985334|250283|P7|STARTED|Overall Study||274
102655|NCT01985334|250284|P6|STARTED|Overall Study||822
102656|NCT01985334|250285|P5|STARTED|Overall Study||274
102657|NCT01985334|250286|P4|STARTED|Overall Study||1262
102658|NCT01985334|250287|P3|STARTED|Overall Study||420
102659|NCT01985334|250288|P2|STARTED|Overall Study||387
102660|NCT01985334|250289|P1|STARTED|Overall Study||130
102661|NCT01985321|250357|P2|NOT COMPLETED|Overall Study||5
102662|NCT01985321|250358|P1|NOT COMPLETED|Overall Study||11
102663|NCT01985321|250357|P2|COMPLETED|Overall Study||78
102664|NCT01985321|250358|P1|COMPLETED|Overall Study||79
102665|NCT01985321|250357|P2|STARTED|Overall Study|This is treatment eligible subjects only|83
102666|NCT01985321|250358|P1|STARTED|Overall Study|This is Treatment Eligible Subjects only|90
102667|NCT01985126|250368|P2|NOT COMPLETED|Overall Study||106
102668|NCT01985126|250369|P1|NOT COMPLETED|Overall Study||18
102669|NCT01985126|250368|P2|COMPLETED|Overall Study||0
102670|NCT01985126|250369|P1|COMPLETED|Overall Study||0
102671|NCT01985126|250368|P2|STARTED|Overall Study||106
102672|NCT01985126|250369|P1|STARTED|Overall Study||18
102673|NCT01984892|250387|P1|NOT COMPLETED|Overall Study||7
102674|NCT01984892|250387|P1|COMPLETED|Overall Study|1 completed all study visits up until the termination of the study, last study visit not done.|1
102675|NCT01984892|250387|P1|STARTED|Overall Study||8
102676|NCT01984697|250398|P5|NOT COMPLETED|Overall Study||35
102677|NCT01984697|250399|P4|NOT COMPLETED|Overall Study||21
102678|NCT01984697|250400|P3|NOT COMPLETED|Overall Study||29
102679|NCT01984697|250401|P2|NOT COMPLETED|Overall Study||31
102680|NCT01984697|250402|P1|NOT COMPLETED|Overall Study||43
102681|NCT01984697|250398|P5|COMPLETED|Overall Study||279
102682|NCT01984697|250399|P4|COMPLETED|Overall Study||280
102683|NCT01984697|250400|P3|COMPLETED|Overall Study||272
102684|NCT01984697|250401|P2|COMPLETED|Overall Study||270
102685|NCT01984697|250402|P1|COMPLETED|Overall Study||258
102686|NCT01984697|250398|P5|Month 36 Vaccination|Overall Study||31
102687|NCT01984697|250399|P4|Month 36 Vaccination|Overall Study||9
102688|NCT01984697|250400|P3|Month 36 Vaccination|Overall Study||280
102689|NCT01984697|250401|P2|Month 36 Vaccination|Overall Study||281
102690|NCT01984697|250402|P1|Month 36 Vaccination|Overall Study||270
102691|NCT01984697|250398|P5|Vaccination 3|Overall Study||311
102692|NCT01984697|250399|P4|Vaccination 3|Overall Study||293
102693|NCT01984697|250400|P3|Vaccination 3|Overall Study||0
102694|NCT01984697|250401|P2|Vaccination 3|Overall Study||0
102695|NCT01984697|250402|P1|Vaccination 3|Overall Study||0
102696|NCT01984697|250398|P5|Vaccination 2|Overall Study||313
102697|NCT01984697|250399|P4|Vaccination 2|Overall Study||298
102698|NCT01984697|250400|P3|Vaccination 2|Overall Study||291
102699|NCT01984697|250401|P2|Vaccination 2|Overall Study||296
102700|NCT01984697|250402|P1|Vaccination 2|Overall Study||293
102701|NCT01984697|250398|P5|Vaccination 1|Overall Study||314
102702|NCT01984697|250399|P4|Vaccination 1|Overall Study||300
102703|NCT01984697|250400|P3|Vaccination 1|Overall Study||300
102704|NCT01984697|250401|P2|Vaccination 1|Overall Study||301
102705|NCT01984697|250402|P1|Vaccination 1|Overall Study||301
102706|NCT01984697|250398|P5|STARTED|Overall Study||314
102707|NCT01984697|250399|P4|STARTED|Overall Study||301
102708|NCT01984697|250400|P3|STARTED|Overall Study||301
102709|NCT01984697|250401|P2|STARTED|Overall Study||301
102710|NCT01984697|250402|P1|STARTED|Overall Study||301
102711|NCT01984684|250521|P2|NOT COMPLETED|Overall Study||59
102712|NCT01984684|250522|P1|NOT COMPLETED|Overall Study||57
102713|NCT01984684|250521|P2|COMPLETED|Overall Study||368
102714|NCT01984684|250522|P1|COMPLETED|Overall Study||366
102715|NCT01984684|250521|P2|STARTED|Overall Study||427
102716|NCT01984684|250522|P1|STARTED|Overall Study||423
102717|NCT01984515|250532|P1|NOT COMPLETED|Overall Study||19
102718|NCT01984515|250532|P1|COMPLETED|Overall Study||40
102719|NCT01984515|250532|P1|Received CBT Session|Overall Study||40
102720|NCT01984515|250532|P1|STARTED|Overall Study||59
102721|NCT01984424|250540|P2|NOT COMPLETED|Overall Study||7
102722|NCT01984424|250541|P1|NOT COMPLETED|Overall Study||3
102723|NCT01984424|250540|P2|COMPLETED|Overall Study||138
102724|NCT01984424|250541|P1|COMPLETED|Overall Study||70
102725|NCT01984424|250540|P2|STARTED|Overall Study||145
102726|NCT01984424|250541|P1|STARTED|Overall Study||73
102727|NCT01984398|250595|P4|NOT COMPLETED|Treatment Period 2||0
102728|NCT01984398|250596|P3|NOT COMPLETED|Treatment Period 2||0
102729|NCT01984398|250597|P2|NOT COMPLETED|Treatment Period 2||0
102730|NCT01984398|250598|P1|NOT COMPLETED|Treatment Period 2||0
102731|NCT01984398|250595|P4|COMPLETED|Treatment Period 2||4
102732|NCT01984398|250596|P3|COMPLETED|Treatment Period 2||4
102733|NCT01984398|250597|P2|COMPLETED|Treatment Period 2||4
102734|NCT01984398|250598|P1|COMPLETED|Treatment Period 2||4
102735|NCT01984398|250595|P4|STARTED|Treatment Period 2||4
102736|NCT01984398|250596|P3|STARTED|Treatment Period 2||4
102737|NCT01984398|250597|P2|STARTED|Treatment Period 2||4
102738|NCT01984398|250598|P1|STARTED|Treatment Period 2||4
102739|NCT01984398|250595|P4|NOT COMPLETED|Washout Period of 5 to 7 Days||0
102740|NCT01984398|250596|P3|NOT COMPLETED|Washout Period of 5 to 7 Days||0
102741|NCT01984398|250597|P2|NOT COMPLETED|Washout Period of 5 to 7 Days||0
102742|NCT01984398|250598|P1|NOT COMPLETED|Washout Period of 5 to 7 Days||0
102743|NCT01984398|250595|P4|COMPLETED|Washout Period of 5 to 7 Days||4
102744|NCT01984398|250596|P3|COMPLETED|Washout Period of 5 to 7 Days||4
102745|NCT01984398|250597|P2|COMPLETED|Washout Period of 5 to 7 Days||4
102746|NCT01984398|250598|P1|COMPLETED|Washout Period of 5 to 7 Days||4
102747|NCT01984398|250595|P4|STARTED|Washout Period of 5 to 7 Days||4
102748|NCT01984398|250596|P3|STARTED|Washout Period of 5 to 7 Days||4
102749|NCT01984398|250597|P2|STARTED|Washout Period of 5 to 7 Days||4
102750|NCT01984398|250598|P1|STARTED|Washout Period of 5 to 7 Days||4
102751|NCT01984398|250595|P4|NOT COMPLETED|Treatment Period 1||0
102752|NCT01984398|250596|P3|NOT COMPLETED|Treatment Period 1||0
102753|NCT01984398|250597|P2|NOT COMPLETED|Treatment Period 1||0
102754|NCT01984398|250598|P1|NOT COMPLETED|Treatment Period 1||0
102755|NCT01984398|250595|P4|COMPLETED|Treatment Period 1||4
102756|NCT01984398|250596|P3|COMPLETED|Treatment Period 1||4
102757|NCT01984398|250597|P2|COMPLETED|Treatment Period 1||4
102758|NCT01984398|250598|P1|COMPLETED|Treatment Period 1||4
102759|NCT01984398|250595|P4|STARTED|Treatment Period 1||4
102760|NCT01984398|250596|P3|STARTED|Treatment Period 1||4
102761|NCT01984398|250597|P2|STARTED|Treatment Period 1||4
102762|NCT01984398|250598|P1|STARTED|Treatment Period 1||4
102763|NCT01984294|250611|P3|NOT COMPLETED|Overall Study||7
102764|NCT01984294|250612|P2|NOT COMPLETED|Overall Study||3
102765|NCT01984294|250613|P1|NOT COMPLETED|Overall Study||4
102766|NCT01984294|250611|P3|COMPLETED|Overall Study||27
102767|NCT01984294|250612|P2|COMPLETED|Overall Study||29
102768|NCT01984294|250613|P1|COMPLETED|Overall Study||31
102769|NCT01984294|250611|P3|STARTED|Overall Study||34
102770|NCT01984294|250612|P2|STARTED|Overall Study||32
102771|NCT01984294|250613|P1|STARTED|Overall Study||35
102772|NCT01984242|250636|P3|NOT COMPLETED|Overall Study||101
102773|NCT01984242|250637|P2|NOT COMPLETED|Overall Study||103
102774|NCT01984242|250638|P1|NOT COMPLETED|Overall Study||101
102775|NCT01984242|250636|P3|COMPLETED|Overall Study||0
102776|NCT01984242|250637|P2|COMPLETED|Overall Study||0
102777|NCT01984242|250638|P1|COMPLETED|Overall Study||0
102778|NCT01984242|250636|P3|Crossover Population|Overall Study||57
102779|NCT01984242|250637|P2|Crossover Population|Overall Study||44
102780|NCT01984242|250638|P1|Crossover Population|Overall Study||0
102781|NCT01984242|250636|P3|Treated|Overall Study||100
102782|NCT01984242|250637|P2|Treated|Overall Study||103
102783|NCT01984242|250638|P1|Treated|Overall Study||101
102784|NCT01984242|250636|P3|STARTED|Overall Study||101
102785|NCT01984242|250637|P2|STARTED|Overall Study||103
102786|NCT01984242|250638|P1|STARTED|Overall Study||101
102787|NCT01984229|250788|P2|NOT COMPLETED|Safety Follow-up Period||1
102788|NCT01984229|250789|P1|NOT COMPLETED|Safety Follow-up Period||2
102789|NCT01984229|250788|P2|COMPLETED|Safety Follow-up Period||16
102790|NCT01984229|250789|P1|COMPLETED|Safety Follow-up Period||4
102791|NCT01984229|250788|P2|STARTED|Safety Follow-up Period||17
102792|NCT01984229|250789|P1|STARTED|Safety Follow-up Period||6
102793|NCT01984229|250788|P2|NOT COMPLETED|Period 3||0
102794|NCT01984229|250789|P1|NOT COMPLETED|Period 3||0
102795|NCT01984229|250788|P2|COMPLETED|Period 3||17
102796|NCT01984229|250789|P1|COMPLETED|Period 3||6
102797|NCT01984229|250788|P2|STARTED|Period 3||17
102798|NCT01984229|250789|P1|STARTED|Period 3||6
102799|NCT01984229|250788|P2|NOT COMPLETED|Period 2||0
102800|NCT01984229|250789|P1|NOT COMPLETED|Period 2||0
102801|NCT01984229|250788|P2|COMPLETED|Period 2||17
102802|NCT01984229|250789|P1|COMPLETED|Period 2||6
102803|NCT01984229|250788|P2|STARTED|Period 2||17
102804|NCT01984229|250789|P1|STARTED|Period 2||6
102805|NCT01984229|250788|P2|NOT COMPLETED|Period 1||0
102806|NCT01984229|250789|P1|NOT COMPLETED|Period 1||0
102807|NCT01984229|250788|P2|COMPLETED|Period 1||17
102808|NCT01984229|250789|P1|COMPLETED|Period 1||6
102809|NCT01984229|250788|P2|STARTED|Period 1||17
102810|NCT01984229|250789|P1|STARTED|Period 1||6
102811|NCT01983930|250841|P2|NOT COMPLETED|Overall Study||9
102812|NCT01983930|250842|P1|NOT COMPLETED|Overall Study||9
102813|NCT01983930|250841|P2|COMPLETED|Overall Study||29
102814|NCT01983930|250842|P1|COMPLETED|Overall Study||32
102815|NCT01983930|250841|P2|STARTED|Overall Study||38
102816|NCT01983930|250842|P1|STARTED|Overall Study||41
102817|NCT01983878|250854|P1|NOT COMPLETED|Overall Study||0
102818|NCT01983878|250854|P1|COMPLETED|Overall Study||36
102819|NCT01983878|250854|P1|Received At Least One Dose of Study Drug|Overall Study||36
102820|NCT01983878|250854|P1|STARTED|Overall Study||36
102821|NCT01983839|250865|P1|NOT COMPLETED|Overall Study||0
102822|NCT01983839|250865|P1|COMPLETED|Overall Study||18
102823|NCT01983839|250865|P1|STARTED|Overall Study||18
102824|NCT01983826|250872|P2|NOT COMPLETED|Overall Study||0
102825|NCT01983826|250873|P1|NOT COMPLETED|Overall Study||0
102826|NCT01983826|250872|P2|COMPLETED|Overall Study||8
102827|NCT01983826|250873|P1|COMPLETED|Overall Study||13
102828|NCT01983826|250872|P2|STARTED|Overall Study||8
102829|NCT01983826|250873|P1|STARTED|Overall Study||13
102830|NCT01983787|250891|P1|NOT COMPLETED|Overall Study||0
102831|NCT01983787|250891|P1|COMPLETED|Overall Study||10
102832|NCT01983787|250891|P1|STARTED|Overall Study||10
102833|NCT01983683|250916|P2|NOT COMPLETED|Overall Study||51
102834|NCT01983683|250917|P1|NOT COMPLETED|Overall Study||38
102835|NCT01983683|250916|P2|COMPLETED|Overall Study||260
102836|NCT01983683|250917|P1|COMPLETED|Overall Study||260
102837|NCT01983683|250916|P2|STARTED|Overall Study||311
102838|NCT01983683|250917|P1|STARTED|Overall Study||298
102839|NCT01983566|250945|P4|NOT COMPLETED|Test Period 4||0
102840|NCT01983566|250946|P3|NOT COMPLETED|Test Period 4||0
102841|NCT01983566|250947|P2|NOT COMPLETED|Test Period 4||0
102842|NCT01983566|250948|P1|NOT COMPLETED|Test Period 4||0
102843|NCT01983566|250945|P4|COMPLETED|Test Period 4||0
102844|NCT01983566|250946|P3|COMPLETED|Test Period 4||0
102845|NCT01983566|250947|P2|COMPLETED|Test Period 4||0
102846|NCT01983566|250948|P1|COMPLETED|Test Period 4||0
102847|NCT01983566|250945|P4|STARTED|Test Period 4||0
102848|NCT01983566|250946|P3|STARTED|Test Period 4||0
102849|NCT01983566|250947|P2|STARTED|Test Period 4||0
102850|NCT01983566|250948|P1|STARTED|Test Period 4||0
102851|NCT01983566|250945|P4|NOT COMPLETED|Wash-Out 3||0
102852|NCT01983566|250946|P3|NOT COMPLETED|Wash-Out 3||0
102853|NCT01983566|250947|P2|NOT COMPLETED|Wash-Out 3||0
102854|NCT01983566|250948|P1|NOT COMPLETED|Wash-Out 3||0
102855|NCT01983566|250945|P4|COMPLETED|Wash-Out 3||0
102856|NCT01983566|250946|P3|COMPLETED|Wash-Out 3||0
102857|NCT01983566|250947|P2|COMPLETED|Wash-Out 3||0
102858|NCT01983566|250948|P1|COMPLETED|Wash-Out 3||0
102859|NCT01983566|250945|P4|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
102860|NCT01983566|250946|P3|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
102861|NCT01983566|250947|P2|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
102862|NCT01983566|250948|P1|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
102863|NCT01983566|250945|P4|NOT COMPLETED|Test Period 3||0
102864|NCT01983566|250946|P3|NOT COMPLETED|Test Period 3||0
102865|NCT01983566|250947|P2|NOT COMPLETED|Test Period 3||0
102866|NCT01983566|250948|P1|NOT COMPLETED|Test Period 3||0
102867|NCT01983566|250945|P4|COMPLETED|Test Period 3||4
102868|NCT01983566|250946|P3|COMPLETED|Test Period 3||2
102869|NCT01983566|250947|P2|COMPLETED|Test Period 3||3
102870|NCT01983566|250948|P1|COMPLETED|Test Period 3||2
102871|NCT01983566|250945|P4|STARTED|Test Period 3||4
102872|NCT01983566|250946|P3|STARTED|Test Period 3||2
102873|NCT01983566|250947|P2|STARTED|Test Period 3||3
102874|NCT01983566|250948|P1|STARTED|Test Period 3||2
102875|NCT01983566|250945|P4|NOT COMPLETED|Wash-Out 2||0
102876|NCT01983566|250946|P3|NOT COMPLETED|Wash-Out 2||0
102877|NCT01983566|250947|P2|NOT COMPLETED|Wash-Out 2||0
102878|NCT01983566|250948|P1|NOT COMPLETED|Wash-Out 2||0
102879|NCT01983566|250945|P4|COMPLETED|Wash-Out 2||4
102880|NCT01983566|250946|P3|COMPLETED|Wash-Out 2||2
102881|NCT01983566|250947|P2|COMPLETED|Wash-Out 2||3
102882|NCT01983566|250948|P1|COMPLETED|Wash-Out 2||2
102883|NCT01983566|250945|P4|STARTED|Wash-Out 2||4
102884|NCT01983566|250946|P3|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
102885|NCT01983566|250947|P2|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|3
102886|NCT01983566|250948|P1|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
102887|NCT01983566|250945|P4|NOT COMPLETED|Test Period 2||0
102888|NCT01983566|250946|P3|NOT COMPLETED|Test Period 2||0
102889|NCT01983566|250947|P2|NOT COMPLETED|Test Period 2||0
102890|NCT01983566|250948|P1|NOT COMPLETED|Test Period 2||0
102891|NCT01983566|250945|P4|COMPLETED|Test Period 2||4
102892|NCT01983566|250946|P3|COMPLETED|Test Period 2||4
102893|NCT01983566|250947|P2|COMPLETED|Test Period 2||4
102894|NCT01983566|250948|P1|COMPLETED|Test Period 2||4
102895|NCT01983566|250945|P4|STARTED|Test Period 2||4
102896|NCT01983566|250946|P3|STARTED|Test Period 2||4
102897|NCT01983566|250947|P2|STARTED|Test Period 2||4
102898|NCT01983566|250948|P1|STARTED|Test Period 2||4
102899|NCT01983566|250945|P4|NOT COMPLETED|Wash-Out 1||0
102900|NCT01983566|250946|P3|NOT COMPLETED|Wash-Out 1||0
102901|NCT01983566|250947|P2|NOT COMPLETED|Wash-Out 1||0
102902|NCT01983566|250948|P1|NOT COMPLETED|Wash-Out 1||0
102903|NCT01983566|250945|P4|COMPLETED|Wash-Out 1||4
102904|NCT01983566|250946|P3|COMPLETED|Wash-Out 1||4
102905|NCT01983566|250947|P2|COMPLETED|Wash-Out 1||4
102906|NCT01983566|250948|P1|COMPLETED|Wash-Out 1||4
102907|NCT01983566|250945|P4|STARTED|Wash-Out 1||4
102908|NCT01983566|250946|P3|STARTED|Wash-Out 1||4
102909|NCT01983566|250947|P2|STARTED|Wash-Out 1||4
102910|NCT01983566|250948|P1|STARTED|Wash-Out 1||4
102911|NCT01983566|250945|P4|NOT COMPLETED|Test Period 1||0
102912|NCT01983566|250946|P3|NOT COMPLETED|Test Period 1||0
102913|NCT01983566|250947|P2|NOT COMPLETED|Test Period 1||0
102914|NCT01983566|250948|P1|NOT COMPLETED|Test Period 1||0
102915|NCT01983566|250945|P4|COMPLETED|Test Period 1||4
102916|NCT01983566|250946|P3|COMPLETED|Test Period 1||4
102917|NCT01983566|250947|P2|COMPLETED|Test Period 1||4
102918|NCT01983566|250948|P1|COMPLETED|Test Period 1||4
102919|NCT01983566|250945|P4|STARTED|Test Period 1||4
102920|NCT01983566|250946|P3|STARTED|Test Period 1||4
102921|NCT01983566|250947|P2|STARTED|Test Period 1||4
102922|NCT01983566|250948|P1|STARTED|Test Period 1||4
102923|NCT01983553|250969|P2|NOT COMPLETED|Overall Study||0
102924|NCT01983553|250970|P1|NOT COMPLETED|Overall Study||0
102925|NCT01983553|250969|P2|COMPLETED|Overall Study||1072
102926|NCT01983553|250970|P1|COMPLETED|Overall Study||2131
102927|NCT01983553|250969|P2|STARTED|Overall Study||1072
102928|NCT01983553|250970|P1|STARTED|Overall Study||2131
102929|NCT01983293|251004|P2|NOT COMPLETED|Overall Study||19
102930|NCT01983293|251005|P1|NOT COMPLETED|Overall Study||33
102931|NCT01983293|251004|P2|COMPLETED|Overall Study||62
102932|NCT01983293|251005|P1|COMPLETED|Overall Study||128
102933|NCT01983293|251004|P2|STARTED|Overall Study||81
102934|NCT01983293|251005|P1|STARTED|Overall Study||161
102935|NCT01983254|251013|P2|NOT COMPLETED|Overall Study||30
102936|NCT01983254|251014|P1|NOT COMPLETED|Overall Study||34
102937|NCT01983254|251013|P2|COMPLETED|Overall Study|69 patients, 37 caregivers|106
102938|NCT01983254|251014|P1|COMPLETED|Overall Study|62 patients, 29 caregivers|91
102939|NCT01983254|251013|P2|Interview 3|Overall Study|69 patients, 37 caregivers|106
102940|NCT01983254|251014|P1|Interview 3|Overall Study|62 patients, 29 caregivers|91
102941|NCT01983254|251013|P2|Interview 2|Overall Study|71 patients, 39 caregivers|110
102942|NCT01983254|251014|P1|Interview 2|Overall Study|65 patients, 30 caregivers|95
102943|NCT01983254|251013|P2|Interview 1|Overall Study|89 patients, 47 caregivers|136
102944|NCT01983254|251014|P1|Interview 1|Overall Study|86 patients, 39 caregivers|125
102945|NCT01983254|251013|P2|STARTED|Overall Study|89 patients, 47 caregivers|136
102946|NCT01983254|251014|P1|STARTED|Overall Study|86 patients, 39 caregivers|125
102947|NCT01983111|251026|P2|NOT COMPLETED|Overall Study||7
102948|NCT01983111|251027|P1|NOT COMPLETED|Overall Study||12
102949|NCT01983111|251026|P2|COMPLETED|Overall Study||59
102950|NCT01983111|251027|P1|COMPLETED|Overall Study||58
102951|NCT01983111|251026|P2|STARTED|Overall Study||66
102952|NCT01983111|251027|P1|STARTED|Overall Study||70
102953|NCT01983020|251047|P4|NOT COMPLETED|Overall Study||0
102954|NCT01983020|251048|P3|NOT COMPLETED|Overall Study||0
102955|NCT01983020|251049|P2|NOT COMPLETED|Overall Study||0
102956|NCT01983020|251050|P1|NOT COMPLETED|Overall Study||0
102957|NCT01983020|251047|P4|COMPLETED|Overall Study||11
102958|NCT01983020|251048|P3|COMPLETED|Overall Study||12
102959|NCT01983020|251049|P2|COMPLETED|Overall Study||11
102960|NCT01983020|251050|P1|COMPLETED|Overall Study||12
102961|NCT01983020|251047|P4|STARTED|Overall Study||11
102962|NCT01983020|251048|P3|STARTED|Overall Study||12
102963|NCT01983020|251049|P2|STARTED|Overall Study||11
102964|NCT01983020|251050|P1|STARTED|Overall Study||12
102965|NCT01982812|251062|P2|NOT COMPLETED|Overall Study||10
102966|NCT01982812|251063|P1|NOT COMPLETED|Overall Study||1
102967|NCT01982812|251062|P2|COMPLETED|Overall Study||11
102968|NCT01982812|251063|P1|COMPLETED|Overall Study||22
102969|NCT01982812|251062|P2|STARTED|Overall Study||21
102970|NCT01982812|251063|P1|STARTED|Overall Study||23
102971|NCT01982773|251077|P2|NOT COMPLETED|Overall Study||4
102972|NCT01982773|251078|P1|NOT COMPLETED|Overall Study||8
102973|NCT01982773|251077|P2|COMPLETED|Overall Study||56
102974|NCT01982773|251078|P1|COMPLETED|Overall Study||50
102975|NCT01982773|251077|P2|STARTED|Overall Study||60
102976|NCT01982773|251078|P1|STARTED|Overall Study||58
102977|NCT01982695|251092|P2|NOT COMPLETED|Overall Study||1
102978|NCT01982695|251093|P1|NOT COMPLETED|Overall Study||0
102979|NCT01982695|251092|P2|COMPLETED|Overall Study||10
102980|NCT01982695|251093|P1|COMPLETED|Overall Study||12
102981|NCT01982695|251092|P2|STARTED|Overall Study||11
102982|NCT01982695|251093|P1|STARTED|Overall Study||12
102983|NCT01982682|251099|P1|NOT COMPLETED|Overall Study||1
102984|NCT01982682|251099|P1|COMPLETED|Overall Study||40
102985|NCT01982682|251099|P1|STARTED|Overall Study||41
102986|NCT01982539|251107|P1|NOT COMPLETED|Overall Study||0
102987|NCT01982539|251107|P1|COMPLETED|Overall Study||25
102988|NCT01982539|251107|P1|STARTED|Overall Study||25
102989|NCT01982435|251113|P2|NOT COMPLETED|Overall Study||0
102990|NCT01982435|251114|P1|NOT COMPLETED|Overall Study||1
102991|NCT01982435|251113|P2|COMPLETED|Overall Study||12
102992|NCT01982435|251114|P1|COMPLETED|Overall Study||14
102993|NCT01982435|251113|P2|STARTED|Overall Study||12
102994|NCT01982435|251114|P1|STARTED|Overall Study||15
102995|NCT01982383|251144|P2|NOT COMPLETED|Overall Study||0
102996|NCT01982383|251145|P1|NOT COMPLETED|Overall Study||0
102997|NCT01982383|251144|P2|COMPLETED|Overall Study||0
102998|NCT01982383|251145|P1|COMPLETED|Overall Study||2
102999|NCT01982383|251144|P2|STARTED|Overall Study||0
103000|NCT01982383|251145|P1|STARTED|Overall Study||2
103001|NCT01982331|251153|P2|NOT COMPLETED|Completed Study (Day 112)||0
103002|NCT01982331|251154|P1|NOT COMPLETED|Completed Study (Day 112)||2
103003|NCT01982331|251153|P2|COMPLETED|Completed Study (Day 112)||7
103004|NCT01982331|251154|P1|COMPLETED|Completed Study (Day 112)||25
103005|NCT01982331|251153|P2|STARTED|Completed Study (Day 112)||7
103006|NCT01982331|251154|P1|STARTED|Completed Study (Day 112)||27
103007|NCT01982331|251153|P2|NOT COMPLETED|Received Vaccination 2||3
103008|NCT01982331|251154|P1|NOT COMPLETED|Received Vaccination 2||1
103009|NCT01982331|251153|P2|COMPLETED|Received Vaccination 2||7
103010|NCT01982331|251154|P1|COMPLETED|Received Vaccination 2||27
103011|NCT01982331|251153|P2|STARTED|Received Vaccination 2||10
103012|NCT01982331|251154|P1|STARTED|Received Vaccination 2||28
103013|NCT01982331|251153|P2|NOT COMPLETED|Received Vaccination 1||0
103014|NCT01982331|251154|P1|NOT COMPLETED|Received Vaccination 1||0
103015|NCT01982331|251153|P2|COMPLETED|Received Vaccination 1||10
103016|NCT01982331|251154|P1|COMPLETED|Received Vaccination 1||28
103017|NCT01982331|251153|P2|STARTED|Received Vaccination 1||10
103018|NCT01982331|251154|P1|STARTED|Received Vaccination 1||28
103019|NCT01982292|251190|P2|NOT COMPLETED|Overall Study||1
103020|NCT01982292|251191|P1|NOT COMPLETED|Overall Study||12
103021|NCT01982292|251190|P2|COMPLETED|Overall Study||107
103022|NCT01982292|251191|P1|COMPLETED|Overall Study||203
103023|NCT01982292|251190|P2|Safety Set|Overall Study||108
103024|NCT01982292|251191|P1|Safety Set|Overall Study||212
103025|NCT01982292|251190|P2|Full Analaysis Set (FAS)|Overall Study||108
103026|NCT01982292|251191|P1|Full Analaysis Set (FAS)|Overall Study|FAS excludes mis-randomized patients|213
103027|NCT01982292|251190|P2|STARTED|Overall Study||108
103028|NCT01982292|251191|P1|STARTED|Overall Study|"Started indicates Randomized set"|215
103029|NCT01982253|251212|P3|NOT COMPLETED|Overall Study||4
103030|NCT01982253|251213|P2|NOT COMPLETED|Overall Study||4
103031|NCT01982253|251214|P1|NOT COMPLETED|Overall Study||2
103032|NCT01982253|251212|P3|COMPLETED|Overall Study||0
103033|NCT01982253|251213|P2|COMPLETED|Overall Study||0
103034|NCT01982253|251214|P1|COMPLETED|Overall Study||0
103035|NCT01982253|251212|P3|STARTED|Overall Study||4
103036|NCT01982253|251213|P2|STARTED|Overall Study||4
103037|NCT01982253|251214|P1|STARTED|Overall Study||2
103038|NCT01982240|251228|P3|NOT COMPLETED|Overall Study||70
103039|NCT01982240|251229|P2|NOT COMPLETED|Overall Study||69
103040|NCT01982240|251230|P1|NOT COMPLETED|Overall Study||67
103041|NCT01982240|251228|P3|COMPLETED|Overall Study||371
103042|NCT01982240|251229|P2|COMPLETED|Overall Study||384
103043|NCT01982240|251230|P1|COMPLETED|Overall Study||385
103044|NCT01982240|251228|P3|STARTED|Overall Study||441
103045|NCT01982240|251229|P2|STARTED|Overall Study||453
103046|NCT01982240|251230|P1|STARTED|Overall Study||452
103047|NCT01982123|251250|P1|NOT COMPLETED|Overall Study||0
103048|NCT01982123|251250|P1|COMPLETED|Overall Study||12
103049|NCT01982123|251250|P1|STARTED|Overall Study||12
103050|NCT01981967|251257|P2|NOT COMPLETED|Overall Study||0
103051|NCT01981967|251258|P1|NOT COMPLETED|Overall Study||0
103052|NCT01981967|251257|P2|COMPLETED|Overall Study||3149
103053|NCT01981967|251258|P1|COMPLETED|Overall Study||6851
103054|NCT01981967|251257|P2|STARTED|Overall Study||3149
103055|NCT01981967|251258|P1|STARTED|Overall Study||6851
103056|NCT01981954|251268|P1|NOT COMPLETED|Fixed-Dose Assessment Period||1
103057|NCT01981954|251268|P1|COMPLETED|Fixed-Dose Assessment Period||21
103058|NCT01981954|251268|P1|Treated|Fixed-Dose Assessment Period||22
103059|NCT01981954|251268|P1|STARTED|Fixed-Dose Assessment Period||22
103060|NCT01981954|251268|P1|NOT COMPLETED|Titration Period||1
103061|NCT01981954|251268|P1|COMPLETED|Titration Period||22
103062|NCT01981954|251268|P1|Treated|Titration Period||23
103063|NCT01981954|251268|P1|STARTED|Titration Period||23
103064|NCT01981863|251315|P2|NOT COMPLETED|Overall Study||0
103065|NCT01981863|251316|P1|NOT COMPLETED|Overall Study||0
103066|NCT01981863|251315|P2|COMPLETED|Overall Study||20
103067|NCT01981863|251316|P1|COMPLETED|Overall Study||20
103068|NCT01981863|251315|P2|STARTED|Overall Study||20
103069|NCT01981863|251316|P1|STARTED|Overall Study||20
103070|NCT01981759|251328|P2|NOT COMPLETED|Overall Study||11
103071|NCT01981759|251329|P1|NOT COMPLETED|Overall Study||7
103072|NCT01981759|251328|P2|COMPLETED|Overall Study||19
103073|NCT01981759|251329|P1|COMPLETED|Overall Study||21
103074|NCT01981759|251328|P2|Completed Week 12|Overall Study||22
103075|NCT01981759|251329|P1|Completed Week 12|Overall Study||22
103076|NCT01981759|251328|P2|Randomization (Week 3)|Overall Study||30
103077|NCT01981759|251329|P1|Randomization (Week 3)|Overall Study||28
103078|NCT01981759|251328|P2|Baseline (Week 1)|Overall Study||30
103079|NCT01981759|251329|P1|Baseline (Week 1)|Overall Study||28
103080|NCT01981759|251328|P2|STARTED|Overall Study||30
103081|NCT01981759|251329|P1|STARTED|Overall Study||28
103082|NCT01981616|251341|P2|NOT COMPLETED|Overall Study||1
103083|NCT01981616|251342|P1|NOT COMPLETED|Overall Study||1
103084|NCT01981616|251341|P2|COMPLETED|Overall Study||62
103085|NCT01981616|251342|P1|COMPLETED|Overall Study||63
103086|NCT01981616|251341|P2|STARTED|Overall Study||63
103087|NCT01981616|251342|P1|STARTED|Overall Study||64
103088|NCT01981564|251356|P2|NOT COMPLETED|Overall Study||9
103089|NCT01981564|251357|P1|NOT COMPLETED|Overall Study||9
103090|NCT01981564|251356|P2|COMPLETED|Overall Study||106
103091|NCT01981564|251357|P1|COMPLETED|Overall Study||98
103092|NCT01981564|251356|P2|STARTED|Overall Study||115
103093|NCT01981564|251357|P1|STARTED|Overall Study||107
103094|NCT01981473|251368|P3|NOT COMPLETED|Overall Study||8
103095|NCT01981473|251369|P2|NOT COMPLETED|Overall Study||0
103096|NCT01981473|251370|P1|NOT COMPLETED|Overall Study||2
103097|NCT01981473|251368|P3|COMPLETED|Overall Study||196
103098|NCT01981473|251369|P2|COMPLETED|Overall Study||199
103099|NCT01981473|251370|P1|COMPLETED|Overall Study||200
103100|NCT01981473|251368|P3|STARTED|Overall Study||204
103101|NCT01981473|251369|P2|STARTED|Overall Study||199
103102|NCT01981473|251370|P1|STARTED|Overall Study||202
103103|NCT01981356|251411|P2|NOT COMPLETED|Overall Study||2
103104|NCT01981356|251412|P1|NOT COMPLETED|Overall Study||7
103105|NCT01981356|251411|P2|COMPLETED|Overall Study||4
103106|NCT01981356|251412|P1|COMPLETED|Overall Study||5
103107|NCT01981356|251411|P2|STARTED|Overall Study||6
103108|NCT01981356|251412|P1|STARTED|Overall Study||12
103109|NCT01981122|251439|P2|NOT COMPLETED|Overall Study||20
103110|NCT01981122|251440|P1|NOT COMPLETED|Overall Study||14
103111|NCT01981122|251439|P2|COMPLETED|Overall Study||7
103112|NCT01981122|251440|P1|COMPLETED|Overall Study||11
103113|NCT01981122|251439|P2|STARTED|Overall Study||27
103114|NCT01981122|251440|P1|STARTED|Overall Study||25
103115|NCT01981109|251446|P1|NOT COMPLETED|Overall Study||224
103116|NCT01981109|251446|P1|COMPLETED|Overall Study||1
103117|NCT01981109|251446|P1|STARTED|Overall Study||225
103118|NCT01981096|251453|P2|NOT COMPLETED|Overall Study||1
103119|NCT01981096|251454|P1|NOT COMPLETED|Overall Study||3
103120|NCT01981096|251453|P2|COMPLETED|Overall Study||19
103121|NCT01981096|251454|P1|COMPLETED|Overall Study||17
103122|NCT01981096|251453|P2|Post-treatment|Overall Study||19
103123|NCT01981096|251454|P1|Post-treatment|Overall Study||17
103124|NCT01981096|251453|P2|STARTED|Overall Study||20
103125|NCT01981096|251454|P1|STARTED|Overall Study||20
103126|NCT01981057|251466|P2|NOT COMPLETED|Overall Study||0
103127|NCT01981057|251467|P1|NOT COMPLETED|Overall Study||0
103128|NCT01981057|251466|P2|COMPLETED|Overall Study||50
103129|NCT01981057|251467|P1|COMPLETED|Overall Study||50
103130|NCT01981057|251466|P2|STARTED|Overall Study||50
103131|NCT01981057|251467|P1|STARTED|Overall Study||50
103132|NCT01980992|251475|P2|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||1
103133|NCT01980992|251476|P1|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||3
103134|NCT01980992|251475|P2|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
103135|NCT01980992|251476|P1|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
103136|NCT01980992|251475|P2|STARTED|52 Weeks Open Label Active Wheat OIT||19
103137|NCT01980992|251476|P1|STARTED|52 Weeks Open Label Active Wheat OIT||21
103138|NCT01980992|251475|P2|NOT COMPLETED|52 Weeks Blinded Study Treatment||4
103139|NCT01980992|251476|P1|NOT COMPLETED|52 Weeks Blinded Study Treatment||2
103140|NCT01980992|251475|P2|COMPLETED|52 Weeks Blinded Study Treatment||19
103141|NCT01980992|251476|P1|COMPLETED|52 Weeks Blinded Study Treatment||21
103142|NCT01980992|251475|P2|STARTED|52 Weeks Blinded Study Treatment||23
103143|NCT01980992|251476|P1|STARTED|52 Weeks Blinded Study Treatment||23
103144|NCT01980940|251501|P8|NOT COMPLETED|Overall Study||0
103145|NCT01980940|251502|P7|NOT COMPLETED|Overall Study||0
103146|NCT01980940|251503|P6|NOT COMPLETED|Overall Study||2
103147|NCT01980940|251504|P5|NOT COMPLETED|Overall Study||0
103148|NCT01980940|251505|P4|NOT COMPLETED|Overall Study||0
103149|NCT01980940|251506|P3|NOT COMPLETED|Overall Study||0
103150|NCT01980940|251507|P2|NOT COMPLETED|Overall Study||0
103151|NCT01980940|251508|P1|NOT COMPLETED|Overall Study||0
103152|NCT01980940|251501|P8|COMPLETED|Overall Study||24
103153|NCT01980940|251502|P7|COMPLETED|Overall Study||24
103154|NCT01980940|251503|P6|COMPLETED|Overall Study||0
103155|NCT01980940|251504|P5|COMPLETED|Overall Study||2
103156|NCT01980940|251505|P4|COMPLETED|Overall Study||3
103157|NCT01980940|251506|P3|COMPLETED|Overall Study||5
103158|NCT01980940|251507|P2|COMPLETED|Overall Study||5
103159|NCT01980940|251508|P1|COMPLETED|Overall Study||5
103160|NCT01980940|251501|P8|Treated|Overall Study||24
103161|NCT01980940|251502|P7|Treated|Overall Study||24
103162|NCT01980940|251503|P6|Treated|Overall Study||2
103163|NCT01980940|251504|P5|Treated|Overall Study||2
103164|NCT01980940|251505|P4|Treated|Overall Study||3
103165|NCT01980940|251506|P3|Treated|Overall Study||5
103166|NCT01980940|251507|P2|Treated|Overall Study||5
103167|NCT01980940|251508|P1|Treated|Overall Study||5
103168|NCT01980940|251501|P8|STARTED|Overall Study||24
103169|NCT01980940|251502|P7|STARTED|Overall Study||24
103170|NCT01980940|251503|P6|STARTED|Overall Study||2
103171|NCT01980940|251504|P5|STARTED|Overall Study||2
103172|NCT01980940|251505|P4|STARTED|Overall Study||3
103173|NCT01980940|251506|P3|STARTED|Overall Study||5
103174|NCT01980940|251507|P2|STARTED|Overall Study||5
103175|NCT01980940|251508|P1|STARTED|Overall Study||5
103176|NCT01980888|251562|P2|NOT COMPLETED|Overall Study||133
103177|NCT01980888|251563|P1|NOT COMPLETED|Overall Study||144
103178|NCT01980888|251562|P2|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|21
103179|NCT01980888|251563|P1|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|13
103180|NCT01980888|251562|P2|STARTED|Overall Study||154
103181|NCT01980888|251563|P1|STARTED|Overall Study||157
103182|NCT01980875|251582|P3|NOT COMPLETED|Overall Study||24
103183|NCT01980875|251583|P2|NOT COMPLETED|Overall Study||25
103184|NCT01980875|251584|P1|NOT COMPLETED|Overall Study||8
103185|NCT01980875|251582|P3|COMPLETED|Overall Study||0
103186|NCT01980875|251583|P2|COMPLETED|Overall Study||0
103187|NCT01980875|251584|P1|COMPLETED|Overall Study||0
103188|NCT01980875|251582|P3|STARTED|Overall Study||24
103189|NCT01980875|251583|P2|STARTED|Overall Study||25
103190|NCT01980875|251584|P1|STARTED|Overall Study||8
103191|NCT01980771|251609|P2|NOT COMPLETED|Overall Study||119
103192|NCT01980771|251610|P1|NOT COMPLETED|Overall Study||84
103193|NCT01980771|251609|P2|COMPLETED|Overall Study||305
103194|NCT01980771|251610|P1|COMPLETED|Overall Study||352
103195|NCT01980771|251609|P2|STARTED|Overall Study||424
103196|NCT01980771|251610|P1|STARTED|Overall Study||436
103197|NCT01980706|251619|P3|NOT COMPLETED|Overall Study||13
103198|NCT01980706|251620|P2|NOT COMPLETED|Overall Study||17
103199|NCT01980706|251621|P1|NOT COMPLETED|Overall Study||17
103200|NCT01980706|251619|P3|COMPLETED|Overall Study||24
103201|NCT01980706|251620|P2|COMPLETED|Overall Study||26
103202|NCT01980706|251621|P1|COMPLETED|Overall Study||23
103203|NCT01980706|251619|P3|STARTED|Overall Study||37
103204|NCT01980706|251620|P2|STARTED|Overall Study||43
103205|NCT01980706|251621|P1|STARTED|Overall Study||40
103206|NCT01980654|251646|P2|NOT COMPLETED|Overall Study||0
103207|NCT01980654|251647|P1|NOT COMPLETED|Overall Study||0
103208|NCT01980654|251646|P2|COMPLETED|Overall Study||20
103209|NCT01980654|251647|P1|COMPLETED|Overall Study||60
103210|NCT01980654|251646|P2|STARTED|Overall Study||20
103211|NCT01980654|251647|P1|STARTED|Overall Study||60
103212|NCT01980628|251661|P1|NOT COMPLETED|Overall Study||63
103213|NCT01980628|251661|P1|COMPLETED|Overall Study|Participants who remain on treatment at Final Analysis.|0
103214|NCT01980628|251661|P1|STARTED|Overall Study|Total number of patients enrolled to the study and received study treatment|63
103215|NCT01980589|251669|P3|NOT COMPLETED|Overall Study||0
103216|NCT01980589|251670|P2|NOT COMPLETED|Overall Study||0
103217|NCT01980589|251671|P1|NOT COMPLETED|Overall Study||0
103218|NCT01980589|251669|P3|COMPLETED|Overall Study||16
103219|NCT01980589|251670|P2|COMPLETED|Overall Study||3
103220|NCT01980589|251671|P1|COMPLETED|Overall Study||3
103221|NCT01980589|251669|P3|STARTED|Overall Study||16
103222|NCT01980589|251670|P2|STARTED|Overall Study||3
103223|NCT01980589|251671|P1|STARTED|Overall Study||3
103224|NCT01980524|251688|P2|NOT COMPLETED|Study Day 2||0
103225|NCT01980524|251689|P1|NOT COMPLETED|Study Day 2||0
103226|NCT01980524|251688|P2|COMPLETED|Study Day 2||4
103227|NCT01980524|251689|P1|COMPLETED|Study Day 2||4
103228|NCT01980524|251688|P2|STARTED|Study Day 2||4
103229|NCT01980524|251689|P1|STARTED|Study Day 2||4
103230|NCT01980524|251688|P2|NOT COMPLETED|Washout (at Least 2 Weeks)||0
103231|NCT01980524|251689|P1|NOT COMPLETED|Washout (at Least 2 Weeks)||0
103232|NCT01980524|251688|P2|COMPLETED|Washout (at Least 2 Weeks)||4
103233|NCT01980524|251689|P1|COMPLETED|Washout (at Least 2 Weeks)||4
103234|NCT01980524|251688|P2|STARTED|Washout (at Least 2 Weeks)||4
103235|NCT01980524|251689|P1|STARTED|Washout (at Least 2 Weeks)||4
103236|NCT01980524|251688|P2|NOT COMPLETED|Study Day 1||0
103237|NCT01980524|251689|P1|NOT COMPLETED|Study Day 1||0
103238|NCT01980524|251688|P2|COMPLETED|Study Day 1||4
103239|NCT01980524|251689|P1|COMPLETED|Study Day 1||4
103240|NCT01980524|251688|P2|STARTED|Study Day 1||4
103241|NCT01980524|251689|P1|STARTED|Study Day 1||4
103242|NCT01980485|251701|P2|NOT COMPLETED|Overall Study||25
103243|NCT01980485|251702|P1|NOT COMPLETED|Overall Study||36
103244|NCT01980485|251701|P2|COMPLETED|Overall Study||80
103245|NCT01980485|251702|P1|COMPLETED|Overall Study||84
103246|NCT01980485|251701|P2|STARTED|Overall Study||105
103247|NCT01980485|251702|P1|STARTED|Overall Study||120
103248|NCT01980342|251710|P1|NOT COMPLETED|Overall Study||1
103249|NCT01980342|251710|P1|COMPLETED|Overall Study||0
103250|NCT01980342|251710|P1|STARTED|Overall Study||1
103251|NCT01980095|251720|P2|NOT COMPLETED|Overall Study||11
103252|NCT01980095|251721|P1|NOT COMPLETED|Overall Study||15
103253|NCT01980095|251720|P2|COMPLETED|Overall Study||30
103254|NCT01980095|251721|P1|COMPLETED|Overall Study||63
103255|NCT01980095|251720|P2|Treated|Overall Study||41
103256|NCT01980095|251721|P1|Treated|Overall Study|Of 78 patients randomized, 1 patient erroneously randomized and not treated|77
103257|NCT01980095|251720|P2|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|41
103258|NCT01980095|251721|P1|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|78
103259|NCT01980056|251732|P3|NOT COMPLETED|Overall Study||0
103260|NCT01980056|251733|P2|NOT COMPLETED|Overall Study||1
103261|NCT01980056|251734|P1|NOT COMPLETED|Overall Study||1
103262|NCT01980056|251732|P3|COMPLETED|Overall Study||2
103263|NCT01980056|251733|P2|COMPLETED|Overall Study||3
103264|NCT01980056|251734|P1|COMPLETED|Overall Study||3
103265|NCT01980056|251732|P3|STARTED|Overall Study||2
103266|NCT01980056|251733|P2|STARTED|Overall Study||4
103267|NCT01980056|251734|P1|STARTED|Overall Study||4
103268|NCT01979952|251748|P2|NOT COMPLETED|Overall Study||6
103269|NCT01979952|251749|P1|NOT COMPLETED|Overall Study||8
103270|NCT01979952|251748|P2|COMPLETED|Overall Study||51
103271|NCT01979952|251749|P1|COMPLETED|Overall Study||48
103272|NCT01979952|251748|P2|STARTED|Overall Study||57
103273|NCT01979952|251749|P1|STARTED|Overall Study||56
103274|NCT01979614|251779|P2|NOT COMPLETED|Overall Study||1
103275|NCT01979614|251780|P1|NOT COMPLETED|Overall Study||1
103276|NCT01979614|251779|P2|COMPLETED|Overall Study||27
103277|NCT01979614|251780|P1|COMPLETED|Overall Study||29
103278|NCT01979614|251779|P2|PD Analysis Set|Overall Study||26
103279|NCT01979614|251780|P1|PD Analysis Set|Overall Study||25
103280|NCT01979614|251779|P2|PK Analysis Set|Overall Study||0
103281|NCT01979614|251780|P1|PK Analysis Set|Overall Study||30
103282|NCT01979614|251779|P2|Safety Analysis Set|Overall Study||28
103283|NCT01979614|251780|P1|Safety Analysis Set|Overall Study||30
103284|NCT01979614|251779|P2|STARTED|Overall Study||28
103285|NCT01979614|251780|P1|STARTED|Overall Study||30
103286|NCT01979445|251802|P4|NOT COMPLETED|Overall Study||0
103287|NCT01979445|251803|P3|NOT COMPLETED|Overall Study||0
103288|NCT01979445|251804|P2|NOT COMPLETED|Overall Study||0
103289|NCT01979445|251805|P1|NOT COMPLETED|Overall Study||0
103290|NCT01979445|251802|P4|COMPLETED|Overall Study||3
103291|NCT01979445|251803|P3|COMPLETED|Overall Study||6
103292|NCT01979445|251804|P2|COMPLETED|Overall Study||3
103293|NCT01979445|251805|P1|COMPLETED|Overall Study||3
103294|NCT01979445|251802|P4|ITT Population|Overall Study||3
103295|NCT01979445|251803|P3|ITT Population|Overall Study||6
103296|NCT01979445|251804|P2|ITT Population|Overall Study||3
103297|NCT01979445|251805|P1|ITT Population|Overall Study||3
103298|NCT01979445|251802|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
103299|NCT01979445|251803|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
103300|NCT01979445|251804|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
103301|NCT01979445|251805|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
103302|NCT01979445|251802|P4|STARTED|Overall Study||3
103303|NCT01979445|251803|P3|STARTED|Overall Study||6
103304|NCT01979445|251804|P2|STARTED|Overall Study||3
103305|NCT01979445|251805|P1|STARTED|Overall Study||3
103306|NCT01979276|251831|P1|NOT COMPLETED|Overall Study||0
103307|NCT01979276|251831|P1|COMPLETED|Overall Study||2
103308|NCT01979276|251831|P1|STARTED|Overall Study||2
103309|NCT01979185|251839|P2|NOT COMPLETED|Period 2||1
103310|NCT01979185|251840|P1|NOT COMPLETED|Period 2||0
103311|NCT01979185|251839|P2|COMPLETED|Period 2|1 subject discontinued due to a positive drug test prior to receiving Simvastatin alone in Period 2.|14
103312|NCT01979185|251840|P1|COMPLETED|Period 2||15
103313|NCT01979185|251839|P2|STARTED|Period 2||15
103314|NCT01979185|251840|P1|STARTED|Period 2||15
103315|NCT01979185|251839|P2|NOT COMPLETED|Period 1||0
103316|NCT01979185|251840|P1|NOT COMPLETED|Period 1||0
103317|NCT01979185|251839|P2|COMPLETED|Period 1||15
103318|NCT01979185|251840|P1|COMPLETED|Period 1||15
103319|NCT01979185|251839|P2|STARTED|Period 1||15
103320|NCT01979185|251840|P1|STARTED|Period 1||15
103321|NCT01979159|251850|P1|NOT COMPLETED|Overall Study||0
103322|NCT01979159|251850|P1|COMPLETED|Overall Study||4
103323|NCT01979159|251850|P1|STARTED|Overall Study||4
103324|NCT01979133|251856|P1|NOT COMPLETED|Overall Study||3
103325|NCT01979133|251856|P1|COMPLETED|Overall Study||7
103326|NCT01979133|251856|P1|STARTED|Overall Study||10
103327|NCT01979029|251875|P2|NOT COMPLETED|Overall Study||0
103328|NCT01979029|251876|P1|NOT COMPLETED|Overall Study||0
103329|NCT01979029|251875|P2|COMPLETED|Overall Study||28
103330|NCT01979029|251876|P1|COMPLETED|Overall Study||29
103331|NCT01979029|251875|P2|STARTED|Overall Study||28
103332|NCT01979029|251876|P1|STARTED|Overall Study||29
103333|NCT01978938|251888|P2|NOT COMPLETED|Overall Study||14
103334|NCT01978938|251889|P1|NOT COMPLETED|Overall Study||23
103335|NCT01978938|251888|P2|COMPLETED|Overall Study||439
103336|NCT01978938|251889|P1|COMPLETED|Overall Study||432
103337|NCT01978938|251888|P2|Received at Least 1 Dose of Study Drug|Overall Study||451
103338|NCT01978938|251889|P1|Received at Least 1 Dose of Study Drug|Overall Study||454
103339|NCT01978938|251888|P2|STARTED|Overall Study||453
103340|NCT01978938|251889|P1|STARTED|Overall Study||455
103341|NCT01978743|251899|P1|NOT COMPLETED|Overall Study||0
103342|NCT01978743|251899|P1|COMPLETED|Overall Study||10
103343|NCT01978743|251899|P1|STARTED|Overall Study||10
103344|NCT01978600|251913|P2|NOT COMPLETED|Overall Study||0
103345|NCT01978600|251914|P1|NOT COMPLETED|Overall Study||0
103346|NCT01978600|251913|P2|COMPLETED|Overall Study||42
103347|NCT01978600|251914|P1|COMPLETED|Overall Study||44
103348|NCT01978600|251913|P2|STARTED|Overall Study||42
103349|NCT01978600|251914|P1|STARTED|Overall Study||44
103350|NCT01978535|251926|P2|NOT COMPLETED|Overall Study||0
103351|NCT01978535|251927|P1|NOT COMPLETED|Overall Study||0
103352|NCT01978535|251926|P2|COMPLETED|Overall Study||2
103353|NCT01978535|251927|P1|COMPLETED|Overall Study||1
103354|NCT01978535|251926|P2|STARTED|Overall Study||2
103355|NCT01978535|251927|P1|STARTED|Overall Study||1
103356|NCT01978314|251938|P5|NOT COMPLETED|Overall Study||0
103357|NCT01978314|251939|P4|NOT COMPLETED|Overall Study||0
103358|NCT01978314|251940|P3|NOT COMPLETED|Overall Study||0
103359|NCT01978314|251941|P2|NOT COMPLETED|Overall Study||0
103360|NCT01978314|251942|P1|NOT COMPLETED|Overall Study||0
103361|NCT01978314|251938|P5|COMPLETED|Overall Study||8
103362|NCT01978314|251939|P4|COMPLETED|Overall Study||1
103363|NCT01978314|251940|P3|COMPLETED|Overall Study||8
103364|NCT01978314|251941|P2|COMPLETED|Overall Study||8
103365|NCT01978314|251942|P1|COMPLETED|Overall Study||8
103366|NCT01978314|251938|P5|STARTED|Overall Study||8
103367|NCT01978314|251939|P4|STARTED|Overall Study||1
103368|NCT01978314|251940|P3|STARTED|Overall Study||8
103369|NCT01978314|251941|P2|STARTED|Overall Study||8
103370|NCT01978314|251942|P1|STARTED|Overall Study||8
103371|NCT01978262|252024|P1|NOT COMPLETED|Overall Study||11
103372|NCT01978262|252024|P1|COMPLETED|Overall Study||92
103373|NCT01978262|252024|P1|STARTED|Overall Study||103
103374|NCT01978236|252029|P1|NOT COMPLETED|Overall Study||2
103375|NCT01978236|252029|P1|COMPLETED|Overall Study||4
103376|NCT01978236|252029|P1|STARTED|Overall Study||6
103377|NCT01978184|252050|P2|NOT COMPLETED|Overall Study||20
103378|NCT01978184|252051|P1|NOT COMPLETED|Overall Study||13
103379|NCT01978184|252050|P2|COMPLETED|Overall Study||41
103380|NCT01978184|252051|P1|COMPLETED|Overall Study||30
103381|NCT01978184|252050|P2|STARTED|Overall Study||61
103382|NCT01978184|252051|P1|STARTED|Overall Study||43
103383|NCT01978145|252077|P2|NOT COMPLETED|Treatment Period 2||14
103384|NCT01978145|252078|P1|NOT COMPLETED|Treatment Period 2||19
103385|NCT01978145|252077|P2|COMPLETED|Treatment Period 2||179
103386|NCT01978145|252078|P1|COMPLETED|Treatment Period 2||185
103387|NCT01978145|252077|P2|STARTED|Treatment Period 2||193
103388|NCT01978145|252078|P1|STARTED|Treatment Period 2||204
103389|NCT01978145|252077|P2|NOT COMPLETED|Washout Period 1||3
103390|NCT01978145|252078|P1|NOT COMPLETED|Washout Period 1||1
103391|NCT01978145|252077|P2|COMPLETED|Washout Period 1||193
103392|NCT01978145|252078|P1|COMPLETED|Washout Period 1||204
103393|NCT01978145|252077|P2|STARTED|Washout Period 1||196
103394|NCT01978145|252078|P1|STARTED|Washout Period 1||205
103395|NCT01978145|252077|P2|NOT COMPLETED|Treatment Period 1||16
103396|NCT01978145|252078|P1|NOT COMPLETED|Treatment Period 1||9
103397|NCT01978145|252077|P2|COMPLETED|Treatment Period 1||196
103398|NCT01978145|252078|P1|COMPLETED|Treatment Period 1||205
103399|NCT01978145|252077|P2|STARTED|Treatment Period 1||212
103400|NCT01978145|252078|P1|STARTED|Treatment Period 1||214
103401|NCT01978119|252094|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||2
103402|NCT01978119|252095|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||0
103403|NCT01978119|252094|P2|COMPLETED|Treatment Period 2 (12 Weeks)||40
103404|NCT01978119|252095|P1|COMPLETED|Treatment Period 2 (12 Weeks)||38
103405|NCT01978119|252094|P2|STARTED|Treatment Period 2 (12 Weeks)||42
103406|NCT01978119|252095|P1|STARTED|Treatment Period 2 (12 Weeks)||38
103407|NCT01978119|252094|P2|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
103408|NCT01978119|252095|P1|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
103409|NCT01978119|252094|P2|COMPLETED|Washout Period 1 (3 Weeks)||42
103410|NCT01978119|252095|P1|COMPLETED|Washout Period 1 (3 Weeks)||38
103411|NCT01978119|252094|P2|STARTED|Washout Period 1 (3 Weeks)||42
103412|NCT01978119|252095|P1|STARTED|Washout Period 1 (3 Weeks)||38
103413|NCT01978119|252094|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||0
103414|NCT01978119|252095|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
103415|NCT01978119|252094|P2|COMPLETED|Treatment Period 1 (12 Weeks)||42
103416|NCT01978119|252095|P1|COMPLETED|Treatment Period 1 (12 Weeks)||38
103417|NCT01978119|252094|P2|STARTED|Treatment Period 1 (12 Weeks)||42
103418|NCT01978119|252095|P1|STARTED|Treatment Period 1 (12 Weeks)||40
103419|NCT01978093|252121|P2|NOT COMPLETED|Overall Study||73
103420|NCT01978093|252122|P1|NOT COMPLETED|Overall Study||65
103421|NCT01978093|252121|P2|COMPLETED|Overall Study||230
103422|NCT01978093|252122|P1|COMPLETED|Overall Study||232
103423|NCT01978093|252121|P2|STARTED|Overall Study||303
103424|NCT01978093|252122|P1|STARTED|Overall Study||297
103425|NCT01977937|252166|P2|NOT COMPLETED|Overall Study||2
103426|NCT01977937|252167|P1|NOT COMPLETED|Overall Study||3
103427|NCT01977937|252166|P2|COMPLETED|Overall Study||26
103428|NCT01977937|252167|P1|COMPLETED|Overall Study||24
103429|NCT01977937|252166|P2|STARTED|Overall Study||28
103430|NCT01977937|252167|P1|STARTED|Overall Study||27
103431|NCT01977846|252177|P2|NOT COMPLETED|Total Study - Prospective||29
103432|NCT01977846|252178|P1|NOT COMPLETED|Total Study - Prospective||0
103433|NCT01977846|252177|P2|COMPLETED|Total Study - Prospective||230
103434|NCT01977846|252178|P1|COMPLETED|Total Study - Prospective||0
103435|NCT01977846|252177|P2|STARTED|Total Study - Prospective||259
103436|NCT01977846|252178|P1|STARTED|Total Study - Prospective||0
103437|NCT01977846|252177|P2|NOT COMPLETED|Total Study - Retrospective||0
103438|NCT01977846|252178|P1|NOT COMPLETED|Total Study - Retrospective||0
103439|NCT01977846|252177|P2|COMPLETED|Total Study - Retrospective||0
103440|NCT01977846|252178|P1|COMPLETED|Total Study - Retrospective||251
103441|NCT01977846|252177|P2|STARTED|Total Study - Retrospective||0
103442|NCT01977846|252178|P1|STARTED|Total Study - Retrospective||251
103443|NCT01977820|252196|P2|NOT COMPLETED|Overall Study||1
103444|NCT01977820|252197|P1|NOT COMPLETED|Overall Study||1
103445|NCT01977820|252196|P2|COMPLETED|Overall Study||0
103446|NCT01977820|252197|P1|COMPLETED|Overall Study||0
103447|NCT01977820|252196|P2|STARTED|Overall Study||1
103448|NCT01977820|252197|P1|STARTED|Overall Study||1
103449|NCT01977794|252205|P2|NOT COMPLETED|Overall Study||6
103450|NCT01977794|252206|P1|NOT COMPLETED|Overall Study||8
103451|NCT01977794|252205|P2|COMPLETED|Overall Study||94
103452|NCT01977794|252206|P1|COMPLETED|Overall Study||92
103453|NCT01977794|252205|P2|STARTED|Overall Study||100
103454|NCT01977794|252206|P1|STARTED|Overall Study||100
103455|NCT01977781|252222|P2|NOT COMPLETED|Overall Study||1
103456|NCT01977781|252223|P1|NOT COMPLETED|Overall Study||6
103457|NCT01977781|252222|P2|COMPLETED|Overall Study||15
103458|NCT01977781|252223|P1|COMPLETED|Overall Study||18
103459|NCT01977781|252222|P2|STARTED|Overall Study||16
103460|NCT01977781|252223|P1|STARTED|Overall Study||24
103461|NCT01977729|252241|P1|NOT COMPLETED|Overall Study||1
103462|NCT01977729|252241|P1|COMPLETED|Overall Study||0
103463|NCT01977729|252241|P1|STARTED|Overall Study||1
103464|NCT01977690|252253|P2|NOT COMPLETED|Overall Study||4
103465|NCT01977690|252254|P1|NOT COMPLETED|Overall Study||0
103466|NCT01977690|252253|P2|COMPLETED|Overall Study||11
103467|NCT01977690|252254|P1|COMPLETED|Overall Study||15
103468|NCT01977690|252253|P2|STARTED|Overall Study||15
103469|NCT01977690|252254|P1|STARTED|Overall Study||15
103470|NCT01977677|252263|P3|NOT COMPLETED|Overall Study||1
103471|NCT01977677|252264|P2|NOT COMPLETED|Overall Study||0
103472|NCT01977677|252265|P1|NOT COMPLETED|Overall Study||0
103473|NCT01977677|252263|P3|COMPLETED|Overall Study||20
103474|NCT01977677|252264|P2|COMPLETED|Overall Study||6
103475|NCT01977677|252265|P1|COMPLETED|Overall Study||3
103476|NCT01977677|252263|P3|STARTED|Overall Study||21
103477|NCT01977677|252264|P2|STARTED|Overall Study||6
103478|NCT01977677|252265|P1|STARTED|Overall Study||3
103479|NCT01977625|252276|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
103480|NCT01977625|252277|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
103481|NCT01977625|252276|P2|COMPLETED|Second Intervention (4 Weeks)||7
103482|NCT01977625|252277|P1|COMPLETED|Second Intervention (4 Weeks)||7
103483|NCT01977625|252276|P2|STARTED|Second Intervention (4 Weeks)||7
103484|NCT01977625|252277|P1|STARTED|Second Intervention (4 Weeks)||8
103485|NCT01977625|252276|P2|NOT COMPLETED|Washout (2 Weeks)||0
103486|NCT01977625|252277|P1|NOT COMPLETED|Washout (2 Weeks)||0
103487|NCT01977625|252276|P2|COMPLETED|Washout (2 Weeks)||7
103488|NCT01977625|252277|P1|COMPLETED|Washout (2 Weeks)||8
103489|NCT01977625|252276|P2|STARTED|Washout (2 Weeks)||7
103490|NCT01977625|252277|P1|STARTED|Washout (2 Weeks)||8
103491|NCT01977625|252276|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
103492|NCT01977625|252277|P1|NOT COMPLETED|First Intervention (4 Weeks)||3
103493|NCT01977625|252276|P2|COMPLETED|First Intervention (4 Weeks)||7
103494|NCT01977625|252277|P1|COMPLETED|First Intervention (4 Weeks)||8
103495|NCT01977625|252276|P2|STARTED|First Intervention (4 Weeks)||7
103496|NCT01977625|252277|P1|STARTED|First Intervention (4 Weeks)||11
103497|NCT01977612|252287|P2|NOT COMPLETED|Overall Study||1
103498|NCT01977612|252288|P1|NOT COMPLETED|Overall Study||1
103499|NCT01977612|252287|P2|COMPLETED|Overall Study||79
103500|NCT01977612|252288|P1|COMPLETED|Overall Study||84
103501|NCT01977612|252287|P2|STARTED|Overall Study||80
103502|NCT01977612|252288|P1|STARTED|Overall Study||85
103503|NCT01977573|252310|P4|NOT COMPLETED|Overall Study||3
103504|NCT01977573|252311|P3|NOT COMPLETED|Overall Study||4
103505|NCT01977573|252312|P2|NOT COMPLETED|Overall Study||3
103506|NCT01977573|252313|P1|NOT COMPLETED|Overall Study||20
103507|NCT01977573|252310|P4|COMPLETED|Overall Study||33
103508|NCT01977573|252311|P3|COMPLETED|Overall Study||32
103509|NCT01977573|252312|P2|COMPLETED|Overall Study||41
103510|NCT01977573|252313|P1|COMPLETED|Overall Study||116
103511|NCT01977573|252310|P4|STARTED|Overall Study||36
103512|NCT01977573|252311|P3|STARTED|Overall Study||36
103513|NCT01977573|252312|P2|STARTED|Overall Study||44
103514|NCT01977573|252313|P1|STARTED|Overall Study||136
103515|NCT01977482|252427|P6|NOT COMPLETED|Overall Study||5
103516|NCT01977482|252428|P5|NOT COMPLETED|Overall Study||3
103517|NCT01977482|252429|P4|NOT COMPLETED|Overall Study||4
103518|NCT01977482|252430|P3|NOT COMPLETED|Overall Study||5
103519|NCT01977482|252431|P2|NOT COMPLETED|Overall Study||9
103520|NCT01977482|252432|P1|NOT COMPLETED|Overall Study||3
103521|NCT01977482|252427|P6|COMPLETED|Overall Study||14
103522|NCT01977482|252428|P5|COMPLETED|Overall Study||37
103523|NCT01977482|252429|P4|COMPLETED|Overall Study||35
103524|NCT01977482|252430|P3|COMPLETED|Overall Study||35
103525|NCT01977482|252431|P2|COMPLETED|Overall Study||30
103526|NCT01977482|252432|P1|COMPLETED|Overall Study||36
103527|NCT01977482|252427|P6|STARTED|Overall Study||19
103528|NCT01977482|252428|P5|STARTED|Overall Study||40
103529|NCT01977482|252429|P4|STARTED|Overall Study||39
103530|NCT01977482|252430|P3|STARTED|Overall Study||40
103531|NCT01977482|252431|P2|STARTED|Overall Study||39
103532|NCT01977482|252432|P1|STARTED|Overall Study||39
103533|NCT01977456|252547|P1|NOT COMPLETED|Overall Study||5
103534|NCT01977456|252547|P1|COMPLETED|Overall Study||22
103535|NCT01977456|252547|P1|STARTED|Overall Study||27
103536|NCT01977352|252556|P2|NOT COMPLETED|Overall Study||2
103537|NCT01977352|252557|P1|NOT COMPLETED|Overall Study||1
103538|NCT01977352|252556|P2|COMPLETED|Overall Study||19
103539|NCT01977352|252557|P1|COMPLETED|Overall Study||20
103540|NCT01977352|252556|P2|STARTED|Overall Study||21
103541|NCT01977352|252557|P1|STARTED|Overall Study||21
103542|NCT01977222|252575|P1|NOT COMPLETED|Overall Study||1
103543|NCT01977222|252575|P1|COMPLETED|Overall Study||11
103544|NCT01977222|252575|P1|STARTED|Overall Study||12
103545|NCT01977092|252588|P2|NOT COMPLETED|Overall Study||30
103546|NCT01977092|252589|P1|NOT COMPLETED|Overall Study||31
103547|NCT01977092|252588|P2|COMPLETED|Overall Study||151
103548|NCT01977092|252589|P1|COMPLETED|Overall Study||118
103549|NCT01977092|252588|P2|STARTED|Overall Study||181
103550|NCT01977092|252589|P1|STARTED|Overall Study||149
103551|NCT01977040|252599|P1|NOT COMPLETED|Overall Study||2
103552|NCT01977040|252599|P1|COMPLETED|Overall Study||66
103553|NCT01977040|252599|P1|STARTED|Overall Study||68
103554|NCT01976988|252611|P2|NOT COMPLETED|Overall Study||18
103555|NCT01976988|252612|P1|NOT COMPLETED|Overall Study||16
103556|NCT01976988|252611|P2|COMPLETED|Overall Study||184
103557|NCT01976988|252612|P1|COMPLETED|Overall Study||192
103558|NCT01976988|252611|P2|STARTED|Overall Study||202
103559|NCT01976988|252612|P1|STARTED|Overall Study||208
103560|NCT01976975|252630|P2|NOT COMPLETED|Overall Study||12
103561|NCT01976975|252631|P1|NOT COMPLETED|Overall Study||147
103562|NCT01976975|252630|P2|COMPLETED|Overall Study||32
103563|NCT01976975|252631|P1|COMPLETED|Overall Study||79
103564|NCT01976975|252630|P2|STARTED|Overall Study||44
103565|NCT01976975|252631|P1|STARTED|Overall Study||226
103566|NCT01976871|252641|P1|NOT COMPLETED|Overall Study||1
103567|NCT01976871|252641|P1|COMPLETED|Overall Study||20
103568|NCT01976871|252641|P1|STARTED|Overall Study||21
103569|NCT01976845|252653|P3|NOT COMPLETED|Overall Study||3
103570|NCT01976845|252654|P2|NOT COMPLETED|Overall Study||8
103571|NCT01976845|252655|P1|NOT COMPLETED|Overall Study||8
103572|NCT01976845|252653|P3|COMPLETED|Overall Study||40
103573|NCT01976845|252654|P2|COMPLETED|Overall Study||40
103574|NCT01976845|252655|P1|COMPLETED|Overall Study||40
103575|NCT01976845|252653|P3|STARTED|Overall Study||43
103576|NCT01976845|252654|P2|STARTED|Overall Study||48
103577|NCT01976845|252655|P1|STARTED|Overall Study||48
103578|NCT01976819|252669|P1|NOT COMPLETED|Overall Study||5
103579|NCT01976819|252669|P1|COMPLETED|Overall Study||11
103580|NCT01976819|252669|P1|STARTED|Overall Study||16
103581|NCT01976806|252680|P2|NOT COMPLETED|Overall Study||6
103582|NCT01976806|252681|P1|NOT COMPLETED|Overall Study||3
103583|NCT01976806|252680|P2|COMPLETED|Overall Study||22
103584|NCT01976806|252681|P1|COMPLETED|Overall Study||24
103585|NCT01976806|252680|P2|STARTED|Overall Study||28
103586|NCT01976806|252681|P1|STARTED|Overall Study||27
103587|NCT01976663|252709|P1|NOT COMPLETED|Overall Study||42
103588|NCT01976663|252709|P1|COMPLETED|Overall Study||84
103589|NCT01976663|252709|P1|Received Repeat Treatment|Overall Study||85
103590|NCT01976663|252709|P1|Received Asymmetry Correction|Overall Study||45
103591|NCT01976663|252709|P1|Received Touch-up Treatment|Overall Study||63
103592|NCT01976663|252709|P1|STARTED|Overall Study||126
103593|NCT01976650|252723|P1|NOT COMPLETED|Overall Study||6
103594|NCT01976650|252723|P1|COMPLETED|Overall Study||718
103595|NCT01976650|252723|P1|STARTED|Overall Study||724
103596|NCT01976624|252728|P1|NOT COMPLETED|Overall Study||14
103597|NCT01976624|252728|P1|COMPLETED|Overall Study||742
103598|NCT01976624|252728|P1|STARTED|Overall Study||756
103599|NCT01976572|252733|P3|NOT COMPLETED|Overall Study||0
103600|NCT01976572|252734|P2|NOT COMPLETED|Overall Study||0
103601|NCT01976572|252735|P1|NOT COMPLETED|Overall Study||0
103602|NCT01976572|252733|P3|COMPLETED|Overall Study||6
103603|NCT01976572|252734|P2|COMPLETED|Overall Study||6
103604|NCT01976572|252735|P1|COMPLETED|Overall Study||6
103605|NCT01976572|252733|P3|STARTED|Overall Study||6
103606|NCT01976572|252734|P2|STARTED|Overall Study||6
103607|NCT01976572|252735|P1|STARTED|Overall Study||6
103608|NCT01976507|252756|P1|NOT COMPLETED|Overall Study||7
103609|NCT01976507|252756|P1|COMPLETED|Overall Study||94
103610|NCT01976507|252756|P1|Received Initial Dose of Dabigatran|Overall Study||100
103611|NCT01976507|252756|P1|STARTED|Overall Study||101
103612|NCT01976442|252765|P2|NOT COMPLETED|Overall Study||0
103613|NCT01976442|252766|P1|NOT COMPLETED|Overall Study||0
103614|NCT01976442|252765|P2|COMPLETED|Overall Study||31
103615|NCT01976442|252766|P1|COMPLETED|Overall Study||69
103616|NCT01976442|252765|P2|STARTED|Overall Study||31
103617|NCT01976442|252766|P1|STARTED|Overall Study||69
103618|NCT01976416|252780|P2|NOT COMPLETED|Overall Study||2
103619|NCT01976416|252781|P1|NOT COMPLETED|Overall Study||2
103620|NCT01976416|252780|P2|COMPLETED|Overall Study||102
103621|NCT01976416|252781|P1|COMPLETED|Overall Study||102
103622|NCT01976416|252780|P2|STARTED|Overall Study||104
103623|NCT01976416|252781|P1|STARTED|Overall Study||104
103624|NCT01976338|252789|P2|NOT COMPLETED|Overall Study||4
103625|NCT01976338|252790|P1|NOT COMPLETED|Overall Study||13
103626|NCT01976338|252789|P2|COMPLETED|Overall Study|12 months|89
103627|NCT01976338|252790|P1|COMPLETED|Overall Study|12 months|177
103628|NCT01976338|252789|P2|Discontinued Study Prior to 6 Months|Overall Study||2
103629|NCT01976338|252790|P1|Discontinued Study Prior to 6 Months|Overall Study||5
103630|NCT01976338|252789|P2|Completed 6 Months|Overall Study||91
103631|NCT01976338|252790|P1|Completed 6 Months|Overall Study||185
103632|NCT01976338|252789|P2|STARTED|Overall Study||93
103633|NCT01976338|252790|P1|STARTED|Overall Study||190
103634|NCT01976312|252817|P2|NOT COMPLETED|Overall Study||9
103635|NCT01976312|252818|P1|NOT COMPLETED|Overall Study||17
103636|NCT01976312|252817|P2|COMPLETED|Overall Study|Completed study at 12 months|53
103637|NCT01976312|252818|P1|COMPLETED|Overall Study|Completed study at 12 months|173
103638|NCT01976312|252817|P2|Discontinued Study Prior to 3 Months|Overall Study||2
103639|NCT01976312|252818|P1|Discontinued Study Prior to 3 Months|Overall Study||4
103640|NCT01976312|252817|P2|Completed 3 Months|Overall Study||60
103641|NCT01976312|252818|P1|Completed 3 Months|Overall Study||186
103642|NCT01976312|252817|P2|STARTED|Overall Study||62
103643|NCT01976312|252818|P1|STARTED|Overall Study||190
103644|NCT01976299|252839|P2|NOT COMPLETED|Overall Study||6
103645|NCT01976299|252840|P1|NOT COMPLETED|Overall Study||23
103646|NCT01976299|252839|P2|COMPLETED|Overall Study|2 subjects did not proceed onto procedure in this arm.|280
103647|NCT01976299|252840|P1|COMPLETED|Overall Study|9 subjects did not proceed onto procedure in this arm.|269
103648|NCT01976299|252839|P2|Completed Procedure|Overall Study||284
103649|NCT01976299|252840|P1|Completed Procedure|Overall Study||283
103650|NCT01976299|252839|P2|STARTED|Overall Study||286
103651|NCT01976299|252840|P1|STARTED|Overall Study||292
103652|NCT01976273|252856|P2|NOT COMPLETED|Overall Study||1
103653|NCT01976273|252857|P1|NOT COMPLETED|Overall Study||1
103654|NCT01976273|252856|P2|COMPLETED|Overall Study||9
103655|NCT01976273|252857|P1|COMPLETED|Overall Study||9
103656|NCT01976273|252856|P2|STARTED|Overall Study||10
103657|NCT01976273|252857|P1|STARTED|Overall Study||10
103658|NCT01976104|252867|P4|NOT COMPLETED|Overall Study||3
103659|NCT01976104|252868|P3|NOT COMPLETED|Overall Study||2
103660|NCT01976104|252869|P2|NOT COMPLETED|Overall Study||2
103661|NCT01976104|252870|P1|NOT COMPLETED|Overall Study||6
103662|NCT01976104|252867|P4|COMPLETED|Overall Study||55
103663|NCT01976104|252868|P3|COMPLETED|Overall Study||31
103664|NCT01976104|252869|P2|COMPLETED|Overall Study||68
103665|NCT01976104|252870|P1|COMPLETED|Overall Study||37
103666|NCT01976104|252867|P4|STARTED|Overall Study||58
103667|NCT01976104|252868|P3|STARTED|Overall Study||33
103668|NCT01976104|252869|P2|STARTED|Overall Study||70
103669|NCT01976104|252870|P1|STARTED|Overall Study||43
103670|NCT01975974|252896|P1|NOT COMPLETED|Overall Study||0
103671|NCT01975974|252896|P1|COMPLETED|Overall Study||100
103672|NCT01975974|252896|P1|STARTED|Overall Study||100
103673|NCT01975948|252904|P4|NOT COMPLETED|Overall Study||6
103674|NCT01975948|252905|P3|NOT COMPLETED|Overall Study||7
103675|NCT01975948|252906|P2|NOT COMPLETED|Overall Study||21
103676|NCT01975948|252907|P1|NOT COMPLETED|Overall Study||17
103677|NCT01975948|252904|P4|COMPLETED|Overall Study||51
103678|NCT01975948|252905|P3|COMPLETED|Overall Study||65
103679|NCT01975948|252906|P2|COMPLETED|Overall Study||34
103680|NCT01975948|252907|P1|COMPLETED|Overall Study||39
103681|NCT01975948|252904|P4|STARTED|Overall Study||57
103682|NCT01975948|252905|P3|STARTED|Overall Study||72
103683|NCT01975948|252906|P2|STARTED|Overall Study||55
103684|NCT01975948|252907|P1|STARTED|Overall Study||56
103685|NCT01975935|252933|P2|NOT COMPLETED|Overall Study||1
103686|NCT01975935|252934|P1|NOT COMPLETED|Overall Study||3
103687|NCT01975935|252933|P2|COMPLETED|Overall Study||20
103688|NCT01975935|252934|P1|COMPLETED|Overall Study||18
103689|NCT01975935|252933|P2|STARTED|Overall Study||21
103690|NCT01975935|252934|P1|STARTED|Overall Study||21
103691|NCT01975922|252946|P2|NOT COMPLETED|Overall Study||9
103692|NCT01975922|252947|P1|NOT COMPLETED|Overall Study||0
103693|NCT01975922|252946|P2|COMPLETED|Overall Study||43
103694|NCT01975922|252947|P1|COMPLETED|Overall Study||45
103695|NCT01975922|252946|P2|STARTED|Overall Study||52
103696|NCT01975922|252947|P1|STARTED|Overall Study||45
103697|NCT01975909|252957|P2|NOT COMPLETED|Overall Study||0
103698|NCT01975909|252958|P1|NOT COMPLETED|Overall Study||0
103699|NCT01975909|252957|P2|COMPLETED|Overall Study||10
103700|NCT01975909|252958|P1|COMPLETED|Overall Study||10
103701|NCT01975909|252957|P2|STARTED|Overall Study||10
103702|NCT01975909|252958|P1|STARTED|Overall Study||10
103703|NCT01975675|252978|P4|NOT COMPLETED|Overall Study||0
103704|NCT01975675|252979|P3|NOT COMPLETED|Overall Study||0
103705|NCT01975675|252980|P2|NOT COMPLETED|Overall Study||1
103706|NCT01975675|252981|P1|NOT COMPLETED|Overall Study||0
103707|NCT01975675|252978|P4|COMPLETED|Overall Study||87
103708|NCT01975675|252979|P3|COMPLETED|Overall Study||88
103709|NCT01975675|252980|P2|COMPLETED|Overall Study||82
103710|NCT01975675|252981|P1|COMPLETED|Overall Study||83
103711|NCT01975675|252978|P4|STARTED|Overall Study||87
103712|NCT01975675|252979|P3|STARTED|Overall Study||88
103713|NCT01975675|252980|P2|STARTED|Overall Study||83
103714|NCT01975675|252981|P1|STARTED|Overall Study||83
103715|NCT01975467|253003|P2|NOT COMPLETED|Overall Study||0
103716|NCT01975467|253004|P1|NOT COMPLETED|Overall Study||0
103717|NCT01975467|253003|P2|COMPLETED|Overall Study||0
103718|NCT01975467|253004|P1|COMPLETED|Overall Study||0
103719|NCT01975467|253003|P2|STARTED|Overall Study|Study terminated before enrollment|0
103720|NCT01975467|253004|P1|STARTED|Overall Study|Study terminated before enrollment|0
103721|NCT01975389|253014|P2|NOT COMPLETED|Overall Study||236
103722|NCT01975389|253015|P1|NOT COMPLETED|Overall Study||252
103723|NCT01975389|253014|P2|COMPLETED|Overall Study||5045
103724|NCT01975389|253015|P1|COMPLETED|Overall Study||5031
103725|NCT01975389|253014|P2|Treated|Overall Study||5276
103726|NCT01975389|253015|P1|Treated|Overall Study||5279
103727|NCT01975389|253014|P2|STARTED|Overall Study||5281
103728|NCT01975389|253015|P1|STARTED|Overall Study||5283
103729|NCT01975376|253075|P2|NOT COMPLETED|Overall Study||217
103730|NCT01975376|253076|P1|NOT COMPLETED|Overall Study||226
103731|NCT01975376|253075|P2|COMPLETED|Overall Study||8177
103732|NCT01975376|253076|P1|COMPLETED|Overall Study||8164
103733|NCT01975376|253075|P2|Treated|Overall Study||8386
103734|NCT01975376|253076|P1|Treated|Overall Study||8374
103735|NCT01975376|253075|P2|STARTED|Overall Study||8394
103736|NCT01975376|253076|P1|STARTED|Overall Study||8390
103737|NCT01975285|253136|P2|NOT COMPLETED|Overall Study||2
103738|NCT01975285|253137|P1|NOT COMPLETED|Overall Study||2
103739|NCT01975285|253136|P2|COMPLETED|Overall Study||28
103740|NCT01975285|253137|P1|COMPLETED|Overall Study||28
103741|NCT01975285|253136|P2|STARTED|Overall Study||30
103742|NCT01975285|253137|P1|STARTED|Overall Study||30
103743|NCT01975246|253153|P2|NOT COMPLETED|Overall Study||2
103744|NCT01975246|253154|P1|NOT COMPLETED|Overall Study||4
103745|NCT01975246|253153|P2|COMPLETED|Overall Study||158
103746|NCT01975246|253154|P1|COMPLETED|Overall Study||145
103747|NCT01975246|253153|P2|STARTED|Overall Study||160
103748|NCT01975246|253154|P1|STARTED|Overall Study||149
103749|NCT01975220|253167|P6|NOT COMPLETED|Test Period 2||0
103750|NCT01975220|253168|P5|NOT COMPLETED|Test Period 2||0
103751|NCT01975220|253169|P4|NOT COMPLETED|Test Period 2||0
103752|NCT01975220|253170|P3|NOT COMPLETED|Test Period 2||0
103753|NCT01975220|253171|P2|NOT COMPLETED|Test Period 2||0
103754|NCT01975220|253172|P1|NOT COMPLETED|Test Period 2||0
103755|NCT01975220|253167|P6|COMPLETED|Test Period 2||12
103756|NCT01975220|253168|P5|COMPLETED|Test Period 2||12
103757|NCT01975220|253169|P4|COMPLETED|Test Period 2||12
103758|NCT01975220|253170|P3|COMPLETED|Test Period 2||12
103759|NCT01975220|253171|P2|COMPLETED|Test Period 2||11
103760|NCT01975220|253172|P1|COMPLETED|Test Period 2||12
103761|NCT01975220|253167|P6|STARTED|Test Period 2||12
103762|NCT01975220|253168|P5|STARTED|Test Period 2||12
103763|NCT01975220|253169|P4|STARTED|Test Period 2||12
103764|NCT01975220|253170|P3|STARTED|Test Period 2||12
103765|NCT01975220|253171|P2|STARTED|Test Period 2||11
103766|NCT01975220|253172|P1|STARTED|Test Period 2||12
103767|NCT01975220|253167|P6|NOT COMPLETED|Test Period 1||0
103768|NCT01975220|253168|P5|NOT COMPLETED|Test Period 1||0
103769|NCT01975220|253169|P4|NOT COMPLETED|Test Period 1||0
103770|NCT01975220|253170|P3|NOT COMPLETED|Test Period 1||0
103771|NCT01975220|253171|P2|NOT COMPLETED|Test Period 1||1
103772|NCT01975220|253172|P1|NOT COMPLETED|Test Period 1||0
103773|NCT01975220|253167|P6|COMPLETED|Test Period 1||12
103774|NCT01975220|253168|P5|COMPLETED|Test Period 1||12
103775|NCT01975220|253169|P4|COMPLETED|Test Period 1||12
103776|NCT01975220|253170|P3|COMPLETED|Test Period 1||12
103777|NCT01975220|253171|P2|COMPLETED|Test Period 1||11
103778|NCT01975220|253172|P1|COMPLETED|Test Period 1||12
103779|NCT01975220|253167|P6|STARTED|Test Period 1||12
103780|NCT01975220|253168|P5|STARTED|Test Period 1||12
103781|NCT01975220|253169|P4|STARTED|Test Period 1||12
103782|NCT01975220|253170|P3|STARTED|Test Period 1||12
103783|NCT01975220|253171|P2|STARTED|Test Period 1||12
103784|NCT01975220|253172|P1|STARTED|Test Period 1||12
103785|NCT01975090|253216|P1|NOT COMPLETED|Overall Study||12
103786|NCT01975090|253216|P1|COMPLETED|Overall Study||117
103787|NCT01975090|253216|P1|6-month Follow-up|Overall Study||117
103788|NCT01975090|253216|P1|STARTED|Overall Study||129
103789|NCT01974895|253228|P2|NOT COMPLETED|Overall Study||15
103790|NCT01974895|253229|P1|NOT COMPLETED|Overall Study||15
103791|NCT01974895|253228|P2|COMPLETED|Overall Study||141
103792|NCT01974895|253229|P1|COMPLETED|Overall Study||143
103793|NCT01974895|253228|P2|STARTED|Overall Study||156
103794|NCT01974895|253229|P1|STARTED|Overall Study||158
103795|NCT01974817|253259|P1|NOT COMPLETED|Overall Study||8
103796|NCT01974817|253259|P1|COMPLETED|Overall Study||17
103797|NCT01974817|253259|P1|STARTED|Overall Study||25
103798|NCT01974752|253265|P2|NOT COMPLETED|Overall Study||15
103799|NCT01974752|253266|P1|NOT COMPLETED|Overall Study||37
103800|NCT01974752|253265|P2|COMPLETED|Overall Study||17
103801|NCT01974752|253266|P1|COMPLETED|Overall Study||60
103802|NCT01974752|253265|P2|STARTED|Overall Study||32
103803|NCT01974752|253266|P1|STARTED|Overall Study||97
103804|NCT01974700|253280|P2|NOT COMPLETED|Overall Study||0
103805|NCT01974700|253281|P1|NOT COMPLETED|Overall Study||0
103806|NCT01974700|253280|P2|COMPLETED|Overall Study||3
103807|NCT01974700|253281|P1|COMPLETED|Overall Study||5
103808|NCT01974700|253280|P2|STARTED|Overall Study||3
103809|NCT01974700|253281|P1|STARTED|Overall Study||5
103810|NCT01974687|253316|P25|NOT COMPLETED|Overall Study||0
103811|NCT01974687|253317|P24|NOT COMPLETED|Overall Study||0
103812|NCT01974687|253318|P23|NOT COMPLETED|Overall Study||0
103813|NCT01974687|253319|P22|NOT COMPLETED|Overall Study||0
103814|NCT01974687|253320|P21|NOT COMPLETED|Overall Study||0
103815|NCT01974687|253321|P20|NOT COMPLETED|Overall Study||0
103816|NCT01974687|253322|P19|NOT COMPLETED|Overall Study||0
103817|NCT01974687|253323|P18|NOT COMPLETED|Overall Study||3
103818|NCT01974687|253324|P17|NOT COMPLETED|Overall Study||1
103819|NCT01974687|253325|P16|NOT COMPLETED|Overall Study||1
103820|NCT01974687|253326|P15|NOT COMPLETED|Overall Study||1
103821|NCT01974687|253327|P14|NOT COMPLETED|Overall Study||2
103822|NCT01974687|253328|P13|NOT COMPLETED|Overall Study||3
103823|NCT01974687|253329|P12|NOT COMPLETED|Overall Study||2
103824|NCT01974687|253330|P11|NOT COMPLETED|Overall Study||0
103825|NCT01974687|253331|P10|NOT COMPLETED|Overall Study||0
103826|NCT01974687|253332|P9|NOT COMPLETED|Overall Study||0
103827|NCT01974687|253333|P8|NOT COMPLETED|Overall Study||0
103828|NCT01974687|253334|P7|NOT COMPLETED|Overall Study||0
103829|NCT01974687|253335|P6|NOT COMPLETED|Overall Study||0
103830|NCT01974687|253336|P5|NOT COMPLETED|Overall Study||0
103831|NCT01974687|253337|P4|NOT COMPLETED|Overall Study||0
103832|NCT01974687|253338|P3|NOT COMPLETED|Overall Study||0
103833|NCT01974687|253339|P2|NOT COMPLETED|Overall Study||0
103834|NCT01974687|253340|P1|NOT COMPLETED|Overall Study||0
103835|NCT01974687|253316|P25|COMPLETED|Overall Study||10
103836|NCT01974687|253317|P24|COMPLETED|Overall Study||6
103837|NCT01974687|253318|P23|COMPLETED|Overall Study||8
103838|NCT01974687|253319|P22|COMPLETED|Overall Study||8
103839|NCT01974687|253320|P21|COMPLETED|Overall Study||3
103840|NCT01974687|253321|P20|COMPLETED|Overall Study||3
103841|NCT01974687|253322|P19|COMPLETED|Overall Study||9
103842|NCT01974687|253323|P18|COMPLETED|Overall Study||8
103843|NCT01974687|253324|P17|COMPLETED|Overall Study||8
103844|NCT01974687|253325|P16|COMPLETED|Overall Study||8
103845|NCT01974687|253326|P15|COMPLETED|Overall Study||18
103846|NCT01974687|253327|P14|COMPLETED|Overall Study||8
103847|NCT01974687|253328|P13|COMPLETED|Overall Study||10
103848|NCT01974687|253329|P12|COMPLETED|Overall Study||11
103849|NCT01974687|253330|P11|COMPLETED|Overall Study||3
103850|NCT01974687|253331|P10|COMPLETED|Overall Study||3
103851|NCT01974687|253332|P9|COMPLETED|Overall Study||3
103852|NCT01974687|253333|P8|COMPLETED|Overall Study||3
103853|NCT01974687|253334|P7|COMPLETED|Overall Study||3
103854|NCT01974687|253335|P6|COMPLETED|Overall Study||6
103855|NCT01974687|253336|P5|COMPLETED|Overall Study||2
103856|NCT01974687|253337|P4|COMPLETED|Overall Study||6
103857|NCT01974687|253338|P3|COMPLETED|Overall Study||6
103858|NCT01974687|253339|P2|COMPLETED|Overall Study||6
103859|NCT01974687|253340|P1|COMPLETED|Overall Study||6
103860|NCT01974687|253316|P25|Treated|Overall Study||10
103861|NCT01974687|253317|P24|Treated|Overall Study||6
103862|NCT01974687|253318|P23|Treated|Overall Study||8
103863|NCT01974687|253319|P22|Treated|Overall Study||8
103864|NCT01974687|253320|P21|Treated|Overall Study||3
103865|NCT01974687|253321|P20|Treated|Overall Study||3
103866|NCT01974687|253322|P19|Treated|Overall Study||9
103867|NCT01974687|253323|P18|Treated|Overall Study|3 participants discontinued prior to receiving study drug|8
103868|NCT01974687|253324|P17|Treated|Overall Study|1 participant discontinued prior to receiving study drug|8
103869|NCT01974687|253325|P16|Treated|Overall Study|1 participant discontinued prior to receiving study drug|8
103870|NCT01974687|253326|P15|Treated|Overall Study|1 participant discontinued prior to receiving study drug|18
103871|NCT01974687|253327|P14|Treated|Overall Study|2 participants discontinued prior to receiving study drug|8
103872|NCT01974687|253328|P13|Treated|Overall Study|3 participants discontinued prior to receiving study drug|10
103873|NCT01974687|253329|P12|Treated|Overall Study|2 participants discontinued prior to receiving study drug|11
103874|NCT01974687|253330|P11|Treated|Overall Study||3
103875|NCT01974687|253331|P10|Treated|Overall Study||3
103876|NCT01974687|253332|P9|Treated|Overall Study||3
103877|NCT01974687|253333|P8|Treated|Overall Study||3
103878|NCT01974687|253334|P7|Treated|Overall Study||3
103879|NCT01974687|253335|P6|Treated|Overall Study||6
103880|NCT01974687|253336|P5|Treated|Overall Study||2
103881|NCT01974687|253337|P4|Treated|Overall Study||6
103882|NCT01974687|253338|P3|Treated|Overall Study||6
103883|NCT01974687|253339|P2|Treated|Overall Study||6
103884|NCT01974687|253340|P1|Treated|Overall Study||6
103885|NCT01974687|253316|P25|STARTED|Overall Study||10
103886|NCT01974687|253317|P24|STARTED|Overall Study||6
103887|NCT01974687|253318|P23|STARTED|Overall Study||8
103888|NCT01974687|253319|P22|STARTED|Overall Study||8
103889|NCT01974687|253320|P21|STARTED|Overall Study||3
103890|NCT01974687|253321|P20|STARTED|Overall Study||3
103891|NCT01974687|253322|P19|STARTED|Overall Study||9
103892|NCT01974687|253323|P18|STARTED|Overall Study||11
103893|NCT01974687|253324|P17|STARTED|Overall Study||9
103894|NCT01974687|253325|P16|STARTED|Overall Study||9
103895|NCT01974687|253326|P15|STARTED|Overall Study||19
103896|NCT01974687|253327|P14|STARTED|Overall Study||10
103897|NCT01974687|253328|P13|STARTED|Overall Study||13
103898|NCT01974687|253329|P12|STARTED|Overall Study||13
103899|NCT01974687|253330|P11|STARTED|Overall Study||3
103900|NCT01974687|253331|P10|STARTED|Overall Study||3
103901|NCT01974687|253332|P9|STARTED|Overall Study||3
103902|NCT01974687|253333|P8|STARTED|Overall Study||3
103903|NCT01974687|253334|P7|STARTED|Overall Study||3
103904|NCT01974687|253335|P6|STARTED|Overall Study||6
103905|NCT01974687|253336|P5|STARTED|Overall Study||2
103906|NCT01974687|253337|P4|STARTED|Overall Study||6
103907|NCT01974687|253338|P3|STARTED|Overall Study||6
103908|NCT01974687|253339|P2|STARTED|Overall Study||6
103909|NCT01974687|253340|P1|STARTED|Overall Study||6
103910|NCT01974635|253687|P1|NOT COMPLETED|Overall Study||0
103911|NCT01974635|253687|P1|COMPLETED|Overall Study||2
103912|NCT01974635|253687|P1|STARTED|Overall Study||2
103913|NCT01974323|253694|P2|NOT COMPLETED|Overall Study||93
103914|NCT01974323|253695|P1|NOT COMPLETED|Overall Study||92
103915|NCT01974323|253694|P2|COMPLETED|Overall Study||1027
103916|NCT01974323|253695|P1|COMPLETED|Overall Study||1026
103917|NCT01974323|253694|P2|STARTED|Overall Study||1120
103918|NCT01974323|253695|P1|STARTED|Overall Study||1118
103919|NCT01974284|253717|P1|NOT COMPLETED|Overall Study||7
103920|NCT01974284|253717|P1|COMPLETED|Overall Study||0
103921|NCT01974284|253717|P1|STARTED|Overall Study||7
103922|NCT01974245|253726|P2|NOT COMPLETED|Overall Study||8
103923|NCT01974245|253727|P1|NOT COMPLETED|Overall Study||9
103924|NCT01974245|253726|P2|COMPLETED|Overall Study||20
103925|NCT01974245|253727|P1|COMPLETED|Overall Study||18
103926|NCT01974245|253726|P2|STARTED|Overall Study||28
103927|NCT01974245|253727|P1|STARTED|Overall Study||27
103928|NCT01974141|253735|P2|NOT COMPLETED|Overall Study||82
103929|NCT01974141|253736|P1|NOT COMPLETED|Overall Study||96
103930|NCT01974141|253735|P2|COMPLETED|Overall Study||976
103931|NCT01974141|253736|P1|COMPLETED|Overall Study||948
103932|NCT01974141|253735|P2|STARTED|Overall Study||1058
103933|NCT01974141|253736|P1|STARTED|Overall Study||1044
103934|NCT01974089|253760|P2|NOT COMPLETED|Overall Study||0
103935|NCT01974089|253761|P1|NOT COMPLETED|Overall Study||0
103936|NCT01974089|253760|P2|COMPLETED|Overall Study||101
103937|NCT01974089|253761|P1|COMPLETED|Overall Study||53
103938|NCT01974089|253760|P2|STARTED|Overall Study||101
103939|NCT01974089|253761|P1|STARTED|Overall Study||53
103940|NCT01974050|253771|P1|NOT COMPLETED|Overall Study||25
103941|NCT01974050|253771|P1|COMPLETED|Overall Study||141
103942|NCT01974050|253771|P1|STARTED|Overall Study||166
103943|NCT01973972|253780|P2|NOT COMPLETED|Overall Study||19
103944|NCT01973972|253781|P1|NOT COMPLETED|Overall Study||18
103945|NCT01973972|253780|P2|COMPLETED|Overall Study||117
103946|NCT01973972|253781|P1|COMPLETED|Overall Study||109
103947|NCT01973972|253780|P2|STARTED|Overall Study||136
103948|NCT01973972|253781|P1|STARTED|Overall Study||127
103949|NCT01973777|253795|P1|NOT COMPLETED|Overall Study||7
103950|NCT01973777|253795|P1|COMPLETED|Overall Study||44
103951|NCT01973777|253795|P1|One Year Follow-up|Overall Study||44
103952|NCT01973777|253795|P1|STARTED|Overall Study|January 2014|51
103953|NCT01973608|253805|P4|NOT COMPLETED|Overall Study||0
103954|NCT01973608|253806|P3|NOT COMPLETED|Overall Study||0
103955|NCT01973608|253807|P2|NOT COMPLETED|Overall Study||0
103956|NCT01973608|253808|P1|NOT COMPLETED|Overall Study||0
103957|NCT01973608|253805|P4|COMPLETED|Overall Study||2
103958|NCT01973608|253806|P3|COMPLETED|Overall Study||6
103959|NCT01973608|253807|P2|COMPLETED|Overall Study||2
103960|NCT01973608|253808|P1|COMPLETED|Overall Study||2
103961|NCT01973608|253805|P4|STARTED|Overall Study||2
103962|NCT01973608|253806|P3|STARTED|Overall Study||6
103963|NCT01973608|253807|P2|STARTED|Overall Study||2
103964|NCT01973608|253808|P1|STARTED|Overall Study||2
103965|NCT01973595|253830|P4|NOT COMPLETED|Intervention Phase 2||0
103966|NCT01973595|253831|P3|NOT COMPLETED|Intervention Phase 2||0
103967|NCT01973595|253832|P2|NOT COMPLETED|Intervention Phase 2||0
103968|NCT01973595|253833|P1|NOT COMPLETED|Intervention Phase 2||0
103969|NCT01973595|253830|P4|COMPLETED|Intervention Phase 2||14
103970|NCT01973595|253831|P3|COMPLETED|Intervention Phase 2||14
103971|NCT01973595|253832|P2|COMPLETED|Intervention Phase 2||14
103972|NCT01973595|253833|P1|COMPLETED|Intervention Phase 2||14
103973|NCT01973595|253830|P4|STARTED|Intervention Phase 2||14
103974|NCT01973595|253831|P3|STARTED|Intervention Phase 2||14
103975|NCT01973595|253832|P2|STARTED|Intervention Phase 2||14
103976|NCT01973595|253833|P1|STARTED|Intervention Phase 2||14
103977|NCT01973595|253830|P4|NOT COMPLETED|Washout||0
103978|NCT01973595|253831|P3|NOT COMPLETED|Washout||1
103979|NCT01973595|253832|P2|NOT COMPLETED|Washout||0
103980|NCT01973595|253833|P1|NOT COMPLETED|Washout||1
103981|NCT01973595|253830|P4|COMPLETED|Washout||14
103982|NCT01973595|253831|P3|COMPLETED|Washout||14
103983|NCT01973595|253832|P2|COMPLETED|Washout||14
103984|NCT01973595|253833|P1|COMPLETED|Washout||14
103985|NCT01973595|253830|P4|STARTED|Washout||14
103986|NCT01973595|253831|P3|STARTED|Washout||15
103987|NCT01973595|253832|P2|STARTED|Washout||14
103988|NCT01973595|253833|P1|STARTED|Washout||15
103989|NCT01973595|253830|P4|NOT COMPLETED|Intervention Phase 1||0
103990|NCT01973595|253831|P3|NOT COMPLETED|Intervention Phase 1||0
103991|NCT01973595|253832|P2|NOT COMPLETED|Intervention Phase 1||0
103992|NCT01973595|253833|P1|NOT COMPLETED|Intervention Phase 1||0
103993|NCT01973595|253830|P4|COMPLETED|Intervention Phase 1||14
103994|NCT01973595|253831|P3|COMPLETED|Intervention Phase 1||15
103995|NCT01973595|253832|P2|COMPLETED|Intervention Phase 1||14
103996|NCT01973595|253833|P1|COMPLETED|Intervention Phase 1||15
103997|NCT01973595|253830|P4|STARTED|Intervention Phase 1||14
103998|NCT01973595|253831|P3|STARTED|Intervention Phase 1||15
103999|NCT01973595|253832|P2|STARTED|Intervention Phase 1||14
104000|NCT01973595|253833|P1|STARTED|Intervention Phase 1||15
104001|NCT01973491|253847|P1|NOT COMPLETED|Treatment Period (16 Weeks)||1
104002|NCT01973491|253847|P1|COMPLETED|Treatment Period (16 Weeks)||18
104003|NCT01973491|253847|P1|STARTED|Treatment Period (16 Weeks)||19
104004|NCT01973491|253847|P1|NOT COMPLETED|Titration Period(4 Weeks)||0
104005|NCT01973491|253847|P1|COMPLETED|Titration Period(4 Weeks)||19
104006|NCT01973491|253847|P1|STARTED|Titration Period(4 Weeks)||19
104007|NCT01973491|253847|P1|NOT COMPLETED|Baseline Control Period (8 Weeks)||18
104008|NCT01973491|253847|P1|COMPLETED|Baseline Control Period (8 Weeks)||19
104009|NCT01973491|253847|P1|STARTED|Baseline Control Period (8 Weeks)||37
104010|NCT01973439|253863|P1|NOT COMPLETED|Overall Study||5
104011|NCT01973439|253863|P1|COMPLETED|Overall Study||18
104012|NCT01973439|253863|P1|One Evaluable PK Day Only|Overall Study|5 children had only one evaluable PK day.|5
104013|NCT01973439|253863|P1|Two Evaluable PK Days|Overall Study|18 Children had two evaluable PK days|18
104014|NCT01973439|253863|P1|STARTED|Overall Study||23
104015|NCT01973413|253872|P2|NOT COMPLETED|Overall Study||0
104016|NCT01973413|253873|P1|NOT COMPLETED|Overall Study||1
104017|NCT01973413|253872|P2|COMPLETED|Overall Study||20
104018|NCT01973413|253873|P1|COMPLETED|Overall Study||11
104019|NCT01973413|253872|P2|STARTED|Overall Study||20
104020|NCT01973413|253873|P1|STARTED|Overall Study||12
104021|NCT01973387|253885|P2|NOT COMPLETED|Overall Study||18
104022|NCT01973387|253886|P1|NOT COMPLETED|Overall Study||106
104023|NCT01973387|253885|P2|COMPLETED|Overall Study||36
104024|NCT01973387|253886|P1|COMPLETED|Overall Study||0
104025|NCT01973387|253885|P2|Treated|Overall Study||52
104026|NCT01973387|253886|P1|Treated|Overall Study||104
104027|NCT01973387|253885|P2|STARTED|Overall Study||54
104028|NCT01973387|253886|P1|STARTED|Overall Study||106
104029|NCT01973348|253904|P4|NOT COMPLETED|Overall Study||0
104030|NCT01973348|253905|P3|NOT COMPLETED|Overall Study||0
104031|NCT01973348|253906|P2|NOT COMPLETED|Overall Study||3
104032|NCT01973348|253907|P1|NOT COMPLETED|Overall Study||8
104033|NCT01973348|253904|P4|COMPLETED|Overall Study||0
104034|NCT01973348|253905|P3|COMPLETED|Overall Study||0
104035|NCT01973348|253906|P2|COMPLETED|Overall Study||15
104036|NCT01973348|253907|P1|COMPLETED|Overall Study||19
104037|NCT01973348|253904|P4|STARTED|Overall Study||0
104038|NCT01973348|253905|P3|STARTED|Overall Study||0
104039|NCT01973348|253906|P2|STARTED|Overall Study||18
104040|NCT01973348|253907|P1|STARTED|Overall Study||27
104041|NCT01973335|253929|P4|NOT COMPLETED|Overall Study||0
104042|NCT01973335|253930|P3|NOT COMPLETED|Overall Study||0
104043|NCT01973335|253931|P2|NOT COMPLETED|Overall Study||0
104044|NCT01973335|253932|P1|NOT COMPLETED|Overall Study||0
104045|NCT01973335|253929|P4|COMPLETED|Overall Study||9
104046|NCT01973335|253930|P3|COMPLETED|Overall Study||9
104047|NCT01973335|253931|P2|COMPLETED|Overall Study||7
104048|NCT01973335|253932|P1|COMPLETED|Overall Study||9
104049|NCT01973335|253929|P4|STARTED|Overall Study||9
104050|NCT01973335|253930|P3|STARTED|Overall Study||9
104051|NCT01973335|253931|P2|STARTED|Overall Study||7
104052|NCT01973335|253932|P1|STARTED|Overall Study||9
104053|NCT01973231|253968|P2|NOT COMPLETED|Overall Study||12
104054|NCT01973231|253969|P1|NOT COMPLETED|Overall Study||11
104055|NCT01973231|253968|P2|COMPLETED|Overall Study||190
104056|NCT01973231|253969|P1|COMPLETED|Overall Study||191
104057|NCT01973231|253968|P2|STARTED|Overall Study||202
104058|NCT01973231|253969|P1|STARTED|Overall Study||202
104059|NCT01973218|253989|P2|NOT COMPLETED|Overall Study||0
104060|NCT01973218|253990|P1|NOT COMPLETED|Overall Study||2
104061|NCT01973218|253989|P2|COMPLETED|Overall Study||88
104062|NCT01973218|253990|P1|COMPLETED|Overall Study||174
104063|NCT01973218|253989|P2|STARTED|Overall Study||88
104064|NCT01973218|253990|P1|STARTED|Overall Study||176
104065|NCT01973205|254013|P2|NOT COMPLETED|Overall Study||22
104066|NCT01973205|254014|P1|NOT COMPLETED|Overall Study||30
104067|NCT01973205|254013|P2|COMPLETED|Overall Study||425
104068|NCT01973205|254014|P1|COMPLETED|Overall Study||423
104069|NCT01973205|254013|P2|STARTED|Overall Study||447
104070|NCT01973205|254014|P1|STARTED|Overall Study||453
104071|NCT01973062|254026|P1|NOT COMPLETED|Overall Study||0
104072|NCT01973062|254026|P1|COMPLETED|Overall Study||1
104073|NCT01973062|254026|P1|STARTED|Overall Study||1
104074|NCT01973036|254036|P2|NOT COMPLETED|Overall Study||0
104075|NCT01973036|254037|P1|NOT COMPLETED|Overall Study||0
104076|NCT01973036|254036|P2|COMPLETED|Overall Study||93
104077|NCT01973036|254037|P1|COMPLETED|Overall Study||108
104078|NCT01973036|254036|P2|Received Assigned Intervention|Overall Study||88
104079|NCT01973036|254037|P1|Received Assigned Intervention|Overall Study||113
104080|NCT01973036|254036|P2|STARTED|Overall Study||93
104081|NCT01973036|254037|P1|STARTED|Overall Study||108
104082|NCT01972841|254083|P6|NOT COMPLETED|Overall Study||85
104083|NCT01972841|254084|P5|NOT COMPLETED|Overall Study||83
104084|NCT01972841|254085|P4|NOT COMPLETED|Overall Study||37
104085|NCT01972841|254086|P3|NOT COMPLETED|Overall Study||50
104086|NCT01972841|254087|P2|NOT COMPLETED|Overall Study||44
104087|NCT01972841|254088|P1|NOT COMPLETED|Overall Study||43
104088|NCT01972841|254083|P6|COMPLETED|Overall Study||798
104089|NCT01972841|254084|P5|COMPLETED|Overall Study||802
104090|NCT01972841|254085|P4|COMPLETED|Overall Study||397
104091|NCT01972841|254086|P3|COMPLETED|Overall Study||387
104092|NCT01972841|254087|P2|COMPLETED|Overall Study||397
104093|NCT01972841|254088|P1|COMPLETED|Overall Study||404
104094|NCT01972841|254083|P6|STARTED|Overall Study||883
104095|NCT01972841|254084|P5|STARTED|Overall Study||885
104096|NCT01972841|254085|P4|STARTED|Overall Study||434
104097|NCT01972841|254086|P3|STARTED|Overall Study||437
104098|NCT01972841|254087|P2|STARTED|Overall Study||441
104099|NCT01972841|254088|P1|STARTED|Overall Study||447
104100|NCT01972789|254518|P2|NOT COMPLETED|Overall Study||30
104101|NCT01972789|254519|P1|NOT COMPLETED|Overall Study||40
104102|NCT01972789|254518|P2|COMPLETED|Overall Study||145
104103|NCT01972789|254519|P1|COMPLETED|Overall Study||134
104104|NCT01972789|254518|P2|STARTED|Overall Study||175
104105|NCT01972789|254519|P1|STARTED|Overall Study||174
104106|NCT01972776|254553|P6|NOT COMPLETED|Part 2||7
104107|NCT01972776|254554|P5|NOT COMPLETED|Part 2||13
104108|NCT01972776|254555|P4|NOT COMPLETED|Part 2||0
104109|NCT01972776|254556|P3|NOT COMPLETED|Part 2||0
104110|NCT01972776|254557|P2|NOT COMPLETED|Part 2||0
104111|NCT01972776|254558|P1|NOT COMPLETED|Part 2||0
104112|NCT01972776|254553|P6|COMPLETED|Part 2||0
104113|NCT01972776|254554|P5|COMPLETED|Part 2||1
104114|NCT01972776|254555|P4|COMPLETED|Part 2||0
104115|NCT01972776|254556|P3|COMPLETED|Part 2||0
104116|NCT01972776|254557|P2|COMPLETED|Part 2||0
104117|NCT01972776|254558|P1|COMPLETED|Part 2||0
104118|NCT01972776|254553|P6|STARTED|Part 2||7
104119|NCT01972776|254554|P5|STARTED|Part 2||14
104120|NCT01972776|254555|P4|STARTED|Part 2||0
104121|NCT01972776|254556|P3|STARTED|Part 2||0
104122|NCT01972776|254557|P2|STARTED|Part 2||0
104123|NCT01972776|254558|P1|STARTED|Part 2||0
104124|NCT01972776|254553|P6|NOT COMPLETED|Part 1||0
104125|NCT01972776|254554|P5|NOT COMPLETED|Part 1||0
104126|NCT01972776|254555|P4|NOT COMPLETED|Part 1||1
104127|NCT01972776|254556|P3|NOT COMPLETED|Part 1||2
104128|NCT01972776|254557|P2|NOT COMPLETED|Part 1||0
104129|NCT01972776|254558|P1|NOT COMPLETED|Part 1||0
104130|NCT01972776|254553|P6|COMPLETED|Part 1||0
104131|NCT01972776|254554|P5|COMPLETED|Part 1||0
104132|NCT01972776|254555|P4|COMPLETED|Part 1||6
104133|NCT01972776|254556|P3|COMPLETED|Part 1||6
104134|NCT01972776|254557|P2|COMPLETED|Part 1||6
104135|NCT01972776|254558|P1|COMPLETED|Part 1||6
104136|NCT01972776|254553|P6|STARTED|Part 1||0
104137|NCT01972776|254554|P5|STARTED|Part 1||0
104138|NCT01972776|254555|P4|STARTED|Part 1||7
104139|NCT01972776|254556|P3|STARTED|Part 1||8
104140|NCT01972776|254557|P2|STARTED|Part 1||6
104141|NCT01972776|254558|P1|STARTED|Part 1||6
104142|NCT01972724|254629|P3|NOT COMPLETED|Open-Label||5
104143|NCT01972724|254630|P2|NOT COMPLETED|Open-Label||0
104144|NCT01972724|254631|P1|NOT COMPLETED|Open-Label||0
104145|NCT01972724|254629|P3|COMPLETED|Open-Label||72
104146|NCT01972724|254630|P2|COMPLETED|Open-Label||0
104147|NCT01972724|254631|P1|COMPLETED|Open-Label||0
104148|NCT01972724|254629|P3|STARTED|Open-Label||77
104149|NCT01972724|254630|P2|STARTED|Open-Label||0
104150|NCT01972724|254631|P1|STARTED|Open-Label||0
104151|NCT01972724|254629|P3|NOT COMPLETED|Double-Blind||0
104152|NCT01972724|254630|P2|NOT COMPLETED|Double-Blind||9
104153|NCT01972724|254631|P1|NOT COMPLETED|Double-Blind||9
104154|NCT01972724|254629|P3|COMPLETED|Double-Blind||0
104155|NCT01972724|254630|P2|COMPLETED|Double-Blind||9
104156|NCT01972724|254631|P1|COMPLETED|Double-Blind||10
104157|NCT01972724|254629|P3|Intent-to-treat:Received Study Drug|Double-Blind||0
104158|NCT01972724|254630|P2|Intent-to-treat:Received Study Drug|Double-Blind||17
104159|NCT01972724|254631|P1|Intent-to-treat:Received Study Drug|Double-Blind||17
104160|NCT01972724|254629|P3|STARTED|Double-Blind||0
104161|NCT01972724|254630|P2|STARTED|Double-Blind||18
104162|NCT01972724|254631|P1|STARTED|Double-Blind||19
104163|NCT01972659|254644|P2|NOT COMPLETED|Overall Study||3
104164|NCT01972659|254645|P1|NOT COMPLETED|Overall Study||4
104165|NCT01972659|254644|P2|COMPLETED|Overall Study||37
104166|NCT01972659|254645|P1|COMPLETED|Overall Study||36
104167|NCT01972659|254644|P2|STARTED|Overall Study||40
104168|NCT01972659|254645|P1|STARTED|Overall Study||40
104169|NCT01972568|254654|P3|NOT COMPLETED|Overall Study||16
104170|NCT01972568|254655|P2|NOT COMPLETED|Overall Study||12
104171|NCT01972568|254656|P1|NOT COMPLETED|Overall Study||16
104172|NCT01972568|254654|P3|COMPLETED|Overall Study||84
104173|NCT01972568|254655|P2|COMPLETED|Overall Study||92
104174|NCT01972568|254656|P1|COMPLETED|Overall Study||86
104175|NCT01972568|254654|P3|STARTED|Overall Study||100
104176|NCT01972568|254655|P2|STARTED|Overall Study||104
104177|NCT01972568|254656|P1|STARTED|Overall Study||102
104178|NCT01972529|254695|P4|NOT COMPLETED|Overall Study||4
104179|NCT01972529|254696|P3|NOT COMPLETED|Overall Study||2
104180|NCT01972529|254697|P2|NOT COMPLETED|Overall Study||5
104181|NCT01972529|254698|P1|NOT COMPLETED|Overall Study||2
104182|NCT01972529|254695|P4|COMPLETED|Overall Study||55
104183|NCT01972529|254696|P3|COMPLETED|Overall Study||32
104184|NCT01972529|254697|P2|COMPLETED|Overall Study||85
104185|NCT01972529|254698|P1|COMPLETED|Overall Study||46
104186|NCT01972529|254695|P4|STARTED|Overall Study||59
104187|NCT01972529|254696|P3|STARTED|Overall Study||34
104188|NCT01972529|254697|P2|STARTED|Overall Study||90
104189|NCT01972529|254698|P1|STARTED|Overall Study||48
104190|NCT01972516|254726|P2|NOT COMPLETED|Overall Study||0
104191|NCT01972516|254727|P1|NOT COMPLETED|Overall Study||0
104192|NCT01972516|254726|P2|COMPLETED|Overall Study||1
104193|NCT01972516|254727|P1|COMPLETED|Overall Study||3
104194|NCT01972516|254726|P2|STARTED|Overall Study||1
104195|NCT01972516|254727|P1|STARTED|Overall Study||3
104196|NCT01972464|254743|P2|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
104197|NCT01972464|254744|P1|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
104198|NCT01972464|254743|P2|COMPLETED|3-Month Follow-Up (Week 20)||17
104199|NCT01972464|254744|P1|COMPLETED|3-Month Follow-Up (Week 20)||15
104200|NCT01972464|254743|P2|STARTED|3-Month Follow-Up (Week 20)||18
104201|NCT01972464|254744|P1|STARTED|3-Month Follow-Up (Week 20)||16
104202|NCT01972464|254743|P2|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||4
104203|NCT01972464|254744|P1|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||3
104204|NCT01972464|254743|P2|COMPLETED|Treatment Period (Week 1 Through Week 8)||18
104205|NCT01972464|254744|P1|COMPLETED|Treatment Period (Week 1 Through Week 8)||16
104206|NCT01972464|254743|P2|STARTED|Treatment Period (Week 1 Through Week 8)||22
104207|NCT01972464|254744|P1|STARTED|Treatment Period (Week 1 Through Week 8)||19
104208|NCT01972438|254760|P2|NOT COMPLETED|Post Month 12 Study Period||4
104209|NCT01972438|254761|P1|NOT COMPLETED|Post Month 12 Study Period||3
104210|NCT01972438|254760|P2|COMPLETED|Post Month 12 Study Period||0
104211|NCT01972438|254761|P1|COMPLETED|Post Month 12 Study Period||0
104212|NCT01972438|254760|P2|STARTED|Post Month 12 Study Period||4
104213|NCT01972438|254761|P1|STARTED|Post Month 12 Study Period||3
104214|NCT01972438|254760|P2|NOT COMPLETED|Months 6-12 Study Period||2
104215|NCT01972438|254761|P1|NOT COMPLETED|Months 6-12 Study Period||3
104216|NCT01972438|254760|P2|COMPLETED|Months 6-12 Study Period||4
104217|NCT01972438|254761|P1|COMPLETED|Months 6-12 Study Period||3
104218|NCT01972438|254760|P2|STARTED|Months 6-12 Study Period||6
104219|NCT01972438|254761|P1|STARTED|Months 6-12 Study Period||6
104220|NCT01972438|254760|P2|NOT COMPLETED|Months 3-6 Crossover Period||1
104221|NCT01972438|254761|P1|NOT COMPLETED|Months 3-6 Crossover Period||0
104222|NCT01972438|254760|P2|COMPLETED|Months 3-6 Crossover Period||6
104223|NCT01972438|254761|P1|COMPLETED|Months 3-6 Crossover Period||6
104224|NCT01972438|254760|P2|STARTED|Months 3-6 Crossover Period|Two participants who missed Month 3 visit completed this pd but one who completed Month 3 didn't|7
104225|NCT01972438|254761|P1|STARTED|Months 3-6 Crossover Period||6
104226|NCT01972438|254760|P2|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
104227|NCT01972438|254761|P1|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
104228|NCT01972438|254760|P2|COMPLETED|Baseline-Month 3 Crossover Period||6
104229|NCT01972438|254761|P1|COMPLETED|Baseline-Month 3 Crossover Period||6
104230|NCT01972438|254760|P2|STARTED|Baseline-Month 3 Crossover Period|One participant never started IP, as unable to donate blood for preparation of ASEDs|9
104231|NCT01972438|254761|P1|STARTED|Baseline-Month 3 Crossover Period|Two participants never started IP: one died and one did not meet the inclusion criteria|9
104232|NCT01972308|254815|P2|NOT COMPLETED|Overall Study||8
104233|NCT01972308|254816|P1|NOT COMPLETED|Overall Study||8
104234|NCT01972308|254815|P2|COMPLETED|Overall Study||148
104235|NCT01972308|254816|P1|COMPLETED|Overall Study||148
104236|NCT01972308|254815|P2|STARTED|Overall Study||156
104237|NCT01972308|254816|P1|STARTED|Overall Study||156
104238|NCT01972282|254832|P1|NOT COMPLETED|Overall Study||15
104239|NCT01972282|254832|P1|COMPLETED|Overall Study||1005
104240|NCT01972282|254832|P1|STARTED|Overall Study||1020
104241|NCT01972217|254842|P4|NOT COMPLETED|Part B Double-blind, Randomised Period||47
104242|NCT01972217|254843|P3|NOT COMPLETED|Part B Double-blind, Randomised Period||46
104243|NCT01972217|254844|P2|NOT COMPLETED|Part B Double-blind, Randomised Period||0
104244|NCT01972217|254845|P1|NOT COMPLETED|Part B Double-blind, Randomised Period||0
104245|NCT01972217|254842|P4|COMPLETED|Part B Double-blind, Randomised Period||24
104246|NCT01972217|254843|P3|COMPLETED|Part B Double-blind, Randomised Period||25
104247|NCT01972217|254844|P2|COMPLETED|Part B Double-blind, Randomised Period||0
104248|NCT01972217|254845|P1|COMPLETED|Part B Double-blind, Randomised Period||0
104249|NCT01972217|254842|P4|Received Abiraterone|Part B Double-blind, Randomised Period||71
104250|NCT01972217|254843|P3|Received Abiraterone|Part B Double-blind, Randomised Period||71
104251|NCT01972217|254844|P2|Received Abiraterone|Part B Double-blind, Randomised Period||0
104252|NCT01972217|254845|P1|Received Abiraterone|Part B Double-blind, Randomised Period||0
104253|NCT01972217|254842|P4|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71
104254|NCT01972217|254843|P3|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71
104255|NCT01972217|254844|P2|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0
104256|NCT01972217|254845|P1|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0
104257|NCT01972217|254842|P4|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part B did not participate in Part A.|71
104258|NCT01972217|254843|P3|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part B did not participate in Part A.|71
104259|NCT01972217|254844|P2|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part A did not participate in Part B.|0
104260|NCT01972217|254845|P1|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part A did not participate in Part B.|0
104261|NCT01972217|254842|P4|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0
104262|NCT01972217|254843|P3|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0
104263|NCT01972217|254844|P2|NOT COMPLETED|Part A: Open-label Safety Run-in Period||12
104264|NCT01972217|254845|P1|NOT COMPLETED|Part A: Open-label Safety Run-in Period||1
104265|NCT01972217|254842|P4|COMPLETED|Part A: Open-label Safety Run-in Period||0
104266|NCT01972217|254843|P3|COMPLETED|Part A: Open-label Safety Run-in Period||0
104267|NCT01972217|254844|P2|COMPLETED|Part A: Open-label Safety Run-in Period||1
104268|NCT01972217|254845|P1|COMPLETED|Part A: Open-label Safety Run-in Period||2
104269|NCT01972217|254842|P4|STARTED|Part A: Open-label Safety Run-in Period||0
104270|NCT01972217|254843|P3|STARTED|Part A: Open-label Safety Run-in Period||0
104271|NCT01972217|254844|P2|STARTED|Part A: Open-label Safety Run-in Period||13
104272|NCT01972217|254845|P1|STARTED|Part A: Open-label Safety Run-in Period||3
104273|NCT01972204|254893|P2|NOT COMPLETED|Overall Study||4
104274|NCT01972204|254894|P1|NOT COMPLETED|Overall Study||4
104275|NCT01972204|254893|P2|COMPLETED|Overall Study||59
104276|NCT01972204|254894|P1|COMPLETED|Overall Study||58
104277|NCT01972204|254893|P2|STARTED|Overall Study||63
104278|NCT01972204|254894|P1|STARTED|Overall Study||62
104279|NCT01972152|254906|P6|NOT COMPLETED|Third Treatment Visit||0
104280|NCT01972152|254907|P5|NOT COMPLETED|Third Treatment Visit||0
104281|NCT01972152|254908|P4|NOT COMPLETED|Third Treatment Visit||0
104282|NCT01972152|254909|P3|NOT COMPLETED|Third Treatment Visit||0
104283|NCT01972152|254910|P2|NOT COMPLETED|Third Treatment Visit||0
104284|NCT01972152|254911|P1|NOT COMPLETED|Third Treatment Visit||0
104285|NCT01972152|254906|P6|COMPLETED|Third Treatment Visit||5
104286|NCT01972152|254907|P5|COMPLETED|Third Treatment Visit||5
104287|NCT01972152|254908|P4|COMPLETED|Third Treatment Visit||5
104288|NCT01972152|254909|P3|COMPLETED|Third Treatment Visit||5
104289|NCT01972152|254910|P2|COMPLETED|Third Treatment Visit||3
104290|NCT01972152|254911|P1|COMPLETED|Third Treatment Visit||5
104291|NCT01972152|254906|P6|STARTED|Third Treatment Visit||5
104292|NCT01972152|254907|P5|STARTED|Third Treatment Visit||5
104293|NCT01972152|254908|P4|STARTED|Third Treatment Visit||5
104294|NCT01972152|254909|P3|STARTED|Third Treatment Visit||5
104295|NCT01972152|254910|P2|STARTED|Third Treatment Visit||3
104296|NCT01972152|254911|P1|STARTED|Third Treatment Visit||5
104297|NCT01972152|254906|P6|NOT COMPLETED|Second Treatment Visit||0
104298|NCT01972152|254907|P5|NOT COMPLETED|Second Treatment Visit||0
104299|NCT01972152|254908|P4|NOT COMPLETED|Second Treatment Visit||0
104300|NCT01972152|254909|P3|NOT COMPLETED|Second Treatment Visit||0
104301|NCT01972152|254910|P2|NOT COMPLETED|Second Treatment Visit||1
104302|NCT01972152|254911|P1|NOT COMPLETED|Second Treatment Visit||0
104303|NCT01972152|254906|P6|COMPLETED|Second Treatment Visit||5
104304|NCT01972152|254907|P5|COMPLETED|Second Treatment Visit||5
104305|NCT01972152|254908|P4|COMPLETED|Second Treatment Visit||5
104306|NCT01972152|254909|P3|COMPLETED|Second Treatment Visit||5
104307|NCT01972152|254910|P2|COMPLETED|Second Treatment Visit||3
104308|NCT01972152|254911|P1|COMPLETED|Second Treatment Visit||5
104309|NCT01972152|254906|P6|STARTED|Second Treatment Visit||5
104310|NCT01972152|254907|P5|STARTED|Second Treatment Visit||5
104311|NCT01972152|254908|P4|STARTED|Second Treatment Visit||5
104312|NCT01972152|254909|P3|STARTED|Second Treatment Visit||5
104313|NCT01972152|254910|P2|STARTED|Second Treatment Visit||4
104314|NCT01972152|254911|P1|STARTED|Second Treatment Visit||5
104315|NCT01972152|254906|P6|NOT COMPLETED|First Treatment Visit||0
104316|NCT01972152|254907|P5|NOT COMPLETED|First Treatment Visit||0
104317|NCT01972152|254908|P4|NOT COMPLETED|First Treatment Visit||0
104318|NCT01972152|254909|P3|NOT COMPLETED|First Treatment Visit||0
104319|NCT01972152|254910|P2|NOT COMPLETED|First Treatment Visit||1
104320|NCT01972152|254911|P1|NOT COMPLETED|First Treatment Visit||0
104321|NCT01972152|254906|P6|COMPLETED|First Treatment Visit||5
104322|NCT01972152|254907|P5|COMPLETED|First Treatment Visit||5
104323|NCT01972152|254908|P4|COMPLETED|First Treatment Visit||5
104324|NCT01972152|254909|P3|COMPLETED|First Treatment Visit||5
104325|NCT01972152|254910|P2|COMPLETED|First Treatment Visit||4
104326|NCT01972152|254911|P1|COMPLETED|First Treatment Visit||5
104327|NCT01972152|254906|P6|STARTED|First Treatment Visit||5
104328|NCT01972152|254907|P5|STARTED|First Treatment Visit||5
104329|NCT01972152|254908|P4|STARTED|First Treatment Visit||5
104330|NCT01972152|254909|P3|STARTED|First Treatment Visit||5
104331|NCT01972152|254910|P2|STARTED|First Treatment Visit||5
104332|NCT01972152|254911|P1|STARTED|First Treatment Visit||5
104333|NCT01972074|254949|P3|NOT COMPLETED|Overall Study||3
104334|NCT01972074|254950|P2|NOT COMPLETED|Overall Study||4
104335|NCT01972074|254951|P1|NOT COMPLETED|Overall Study||6
104336|NCT01972074|254949|P3|COMPLETED|Overall Study||15
104337|NCT01972074|254950|P2|COMPLETED|Overall Study||17
104338|NCT01972074|254951|P1|COMPLETED|Overall Study||16
104339|NCT01972074|254949|P3|STARTED|Overall Study||18
104340|NCT01972074|254950|P2|STARTED|Overall Study||21
104341|NCT01972074|254951|P1|STARTED|Overall Study||22
104342|NCT01971723|254960|P2|NOT COMPLETED|Overall Study||3
104343|NCT01971723|254961|P1|NOT COMPLETED|Overall Study||2
104344|NCT01971723|254960|P2|COMPLETED|Overall Study||13
104345|NCT01971723|254961|P1|COMPLETED|Overall Study||14
104346|NCT01971723|254960|P2|STARTED|Overall Study||16
104347|NCT01971723|254961|P1|STARTED|Overall Study||16
104348|NCT01971645|254994|P3|NOT COMPLETED|Overall Study||2
104349|NCT01971645|254995|P2|NOT COMPLETED|Overall Study||0
104350|NCT01971645|254996|P1|NOT COMPLETED|Overall Study||2
104351|NCT01971645|254994|P3|COMPLETED|Overall Study||23
104352|NCT01971645|254995|P2|COMPLETED|Overall Study||27
104353|NCT01971645|254996|P1|COMPLETED|Overall Study||23
104354|NCT01971645|254994|P3|STARTED|Overall Study||25
104355|NCT01971645|254995|P2|STARTED|Overall Study||27
104356|NCT01971645|254996|P1|STARTED|Overall Study||25
104357|NCT01971593|255007|P2|NOT COMPLETED|Overall Study||4
104358|NCT01971593|255008|P1|NOT COMPLETED|Overall Study||5
104359|NCT01971593|255007|P2|COMPLETED|Overall Study||8
104360|NCT01971593|255008|P1|COMPLETED|Overall Study||9
104361|NCT01971593|255007|P2|STARTED|Overall Study||12
104362|NCT01971593|255008|P1|STARTED|Overall Study||14
104363|NCT01971580|255019|P2|NOT COMPLETED|Overall Study||5
104364|NCT01971580|255020|P1|NOT COMPLETED|Overall Study||4
104365|NCT01971580|255019|P2|COMPLETED|Overall Study||9
104366|NCT01971580|255020|P1|COMPLETED|Overall Study||10
104367|NCT01971580|255019|P2|STARTED|Overall Study||14
104368|NCT01971580|255020|P1|STARTED|Overall Study||14
104369|NCT01971567|255030|P2|NOT COMPLETED|Overall Study||2
104370|NCT01971567|255031|P1|NOT COMPLETED|Overall Study||4
104371|NCT01971567|255030|P2|COMPLETED|Overall Study||49
104372|NCT01971567|255031|P1|COMPLETED|Overall Study||52
104373|NCT01971567|255030|P2|STARTED|Overall Study||51
104374|NCT01971567|255031|P1|STARTED|Overall Study||56
104375|NCT01971554|255057|P4|NOT COMPLETED|Overall Study||0
104376|NCT01971554|255058|P3|NOT COMPLETED|Overall Study||0
104377|NCT01971554|255059|P2|NOT COMPLETED|Overall Study||0
104378|NCT01971554|255060|P1|NOT COMPLETED|Overall Study||1
104379|NCT01971554|255057|P4|COMPLETED|Overall Study||18
104380|NCT01971554|255058|P3|COMPLETED|Overall Study||18
104381|NCT01971554|255059|P2|COMPLETED|Overall Study||18
104382|NCT01971554|255060|P1|COMPLETED|Overall Study||8
104383|NCT01971554|255057|P4|STARTED|Overall Study||18
104384|NCT01971554|255058|P3|STARTED|Overall Study||18
104385|NCT01971554|255059|P2|STARTED|Overall Study||18
104386|NCT01971554|255060|P1|STARTED|Overall Study||9
104387|NCT01971476|255097|P3|NOT COMPLETED|Cohort 2: 12 to <18 Years||0
104388|NCT01971476|255098|P2|NOT COMPLETED|Cohort 2: 12 to <18 Years||4
104389|NCT01971476|255099|P1|NOT COMPLETED|Cohort 2: 12 to <18 Years||6
104390|NCT01971476|255097|P3|COMPLETED|Cohort 2: 12 to <18 Years||0
104391|NCT01971476|255098|P2|COMPLETED|Cohort 2: 12 to <18 Years||0
104392|NCT01971476|255099|P1|COMPLETED|Cohort 2: 12 to <18 Years||0
104393|NCT01971476|255097|P3|STARTED|Cohort 2: 12 to <18 Years||0
104394|NCT01971476|255098|P2|STARTED|Cohort 2: 12 to <18 Years||4
104395|NCT01971476|255099|P1|STARTED|Cohort 2: 12 to <18 Years||6
104396|NCT01971476|255097|P3|NOT COMPLETED|Cohort 1: 2 to <12 Years||6
104397|NCT01971476|255098|P2|NOT COMPLETED|Cohort 1: 2 to <12 Years||3
104398|NCT01971476|255099|P1|NOT COMPLETED|Cohort 1: 2 to <12 Years||3
104399|NCT01971476|255097|P3|COMPLETED|Cohort 1: 2 to <12 Years||0
104400|NCT01971476|255098|P2|COMPLETED|Cohort 1: 2 to <12 Years||0
104401|NCT01971476|255099|P1|COMPLETED|Cohort 1: 2 to <12 Years||0
104402|NCT01971476|255097|P3|STARTED|Cohort 1: 2 to <12 Years||6
104403|NCT01971476|255098|P2|STARTED|Cohort 1: 2 to <12 Years||3
104404|NCT01971476|255099|P1|STARTED|Cohort 1: 2 to <12 Years||3
104405|NCT01971385|255179|P3|NOT COMPLETED|Overall Study||4
104406|NCT01971385|255180|P2|NOT COMPLETED|Overall Study||5
104407|NCT01971385|255181|P1|NOT COMPLETED|Overall Study||3
104408|NCT01971385|255179|P3|COMPLETED|Overall Study||15
104409|NCT01971385|255180|P2|COMPLETED|Overall Study||13
104410|NCT01971385|255181|P1|COMPLETED|Overall Study||14
104411|NCT01971385|255179|P3|STARTED|Overall Study||19
104412|NCT01971385|255180|P2|STARTED|Overall Study||18
104413|NCT01971385|255181|P1|STARTED|Overall Study||17
104414|NCT01971346|255188|P1|NOT COMPLETED|Overall Study||8
104415|NCT01971346|255188|P1|COMPLETED|Overall Study||42
104416|NCT01971346|255188|P1|STARTED|Overall Study|Four subjects signed the informed consent and terminated the study before beginning.|50
104417|NCT01971255|255202|P2|NOT COMPLETED|Overall Study||2
104418|NCT01971255|255203|P1|NOT COMPLETED|Overall Study||1
104419|NCT01971255|255202|P2|COMPLETED|Overall Study||40
104420|NCT01971255|255203|P1|COMPLETED|Overall Study||31
104421|NCT01971255|255202|P2|STARTED|Overall Study||42
104422|NCT01971255|255203|P1|STARTED|Overall Study||32
104423|NCT01971203|255221|P2|NOT COMPLETED|Overall Study||8
104424|NCT01971203|255222|P1|NOT COMPLETED|Overall Study||9
104425|NCT01971203|255221|P2|COMPLETED|Overall Study||21
104426|NCT01971203|255222|P1|COMPLETED|Overall Study||17
104427|NCT01971203|255221|P2|STARTED|Overall Study||29
104428|NCT01971203|255222|P1|STARTED|Overall Study||26
104429|NCT01971086|255234|P1|NOT COMPLETED|Overall Study||0
104430|NCT01971086|255234|P1|COMPLETED|Overall Study||300
104431|NCT01971086|255234|P1|STARTED|Overall Study||300
104432|NCT01970995|255249|P3|NOT COMPLETED|End of Study (Population at Day 90)||1
104433|NCT01970995|255250|P2|NOT COMPLETED|End of Study (Population at Day 90)||0
104434|NCT01970995|255251|P1|NOT COMPLETED|End of Study (Population at Day 90)||1
104435|NCT01970995|255249|P3|COMPLETED|End of Study (Population at Day 90)||38
104436|NCT01970995|255250|P2|COMPLETED|End of Study (Population at Day 90)||41
104437|NCT01970995|255251|P1|COMPLETED|End of Study (Population at Day 90)||76
104438|NCT01970995|255249|P3|STARTED|End of Study (Population at Day 90)||39
104439|NCT01970995|255250|P2|STARTED|End of Study (Population at Day 90)||41
104440|NCT01970995|255251|P1|STARTED|End of Study (Population at Day 90)||77
104441|NCT01970995|255249|P3|NOT COMPLETED|Confinement Period (Population at Day 5)||1
104442|NCT01970995|255250|P2|NOT COMPLETED|Confinement Period (Population at Day 5)||1
104443|NCT01970995|255251|P1|NOT COMPLETED|Confinement Period (Population at Day 5)||1
104444|NCT01970995|255249|P3|COMPLETED|Confinement Period (Population at Day 5)||39
104445|NCT01970995|255250|P2|COMPLETED|Confinement Period (Population at Day 5)||41
104446|NCT01970995|255251|P1|COMPLETED|Confinement Period (Population at Day 5)||77
104447|NCT01970995|255249|P3|STARTED|Confinement Period (Population at Day 5)||40
104448|NCT01970995|255250|P2|STARTED|Confinement Period (Population at Day 5)||42
104449|NCT01970995|255251|P1|STARTED|Confinement Period (Population at Day 5)||78
104450|NCT01970982|255274|P3|NOT COMPLETED|Overall Study||2
104451|NCT01970982|255275|P2|NOT COMPLETED|Overall Study||0
104452|NCT01970982|255276|P1|NOT COMPLETED|Overall Study||0
104453|NCT01970982|255274|P3|COMPLETED|Overall Study||38
104454|NCT01970982|255275|P2|COMPLETED|Overall Study||40
104455|NCT01970982|255276|P1|COMPLETED|Overall Study||80
104456|NCT01970982|255274|P3|STARTED|Overall Study||40
104457|NCT01970982|255275|P2|STARTED|Overall Study||40
104458|NCT01970982|255276|P1|STARTED|Overall Study||80
104459|NCT01970943|255294|P2|NOT COMPLETED|Overall Study||1
104460|NCT01970943|255295|P1|NOT COMPLETED|Overall Study||3
104461|NCT01970943|255294|P2|COMPLETED|Overall Study||11
104462|NCT01970943|255295|P1|COMPLETED|Overall Study||8
104463|NCT01970943|255294|P2|STARTED|Overall Study||12
104464|NCT01970943|255295|P1|STARTED|Overall Study||11
104465|NCT01970878|255311|P4|NOT COMPLETED|Overall Study||24
104466|NCT01970878|255312|P3|NOT COMPLETED|Overall Study||26
104467|NCT01970878|255313|P2|NOT COMPLETED|Overall Study||27
104468|NCT01970878|255314|P1|NOT COMPLETED|Overall Study||37
104469|NCT01970878|255311|P4|COMPLETED|Overall Study||147
104470|NCT01970878|255312|P3|COMPLETED|Overall Study||187
104471|NCT01970878|255313|P2|COMPLETED|Overall Study||191
104472|NCT01970878|255314|P1|COMPLETED|Overall Study||253
104473|NCT01970878|255311|P4|STARTED|Overall Study||171
104474|NCT01970878|255312|P3|STARTED|Overall Study||213
104475|NCT01970878|255313|P2|STARTED|Overall Study|218 subjects were reported in the CSR, 1 had no completion status|218
104476|NCT01970878|255314|P1|STARTED|Overall Study||290
104477|NCT01970865|255357|P17|NOT COMPLETED|Overall Study||3
104478|NCT01970865|255358|P16|NOT COMPLETED|Overall Study||47
104479|NCT01970865|255359|P15|NOT COMPLETED|Overall Study||46
104480|NCT01970865|255360|P14|NOT COMPLETED|Overall Study||66
104481|NCT01970865|255361|P13|NOT COMPLETED|Overall Study||60
104482|NCT01970865|255362|P12|NOT COMPLETED|Overall Study||27
104483|NCT01970865|255363|P11|NOT COMPLETED|Overall Study||30
104484|NCT01970865|255364|P10|NOT COMPLETED|Overall Study||4
104485|NCT01970865|255365|P9|NOT COMPLETED|Overall Study||3
104486|NCT01970865|255366|P8|NOT COMPLETED|Overall Study||3
104487|NCT01970865|255367|P7|NOT COMPLETED|Overall Study||3
104488|NCT01970865|255368|P6|NOT COMPLETED|Overall Study||3
104489|NCT01970865|255369|P5|NOT COMPLETED|Overall Study||17
104490|NCT01970865|255370|P4|NOT COMPLETED|Overall Study||13
104491|NCT01970865|255371|P3|NOT COMPLETED|Overall Study||3
104492|NCT01970865|255372|P2|NOT COMPLETED|Overall Study||3
104493|NCT01970865|255373|P1|NOT COMPLETED|Overall Study||3
104494|NCT01970865|255357|P17|COMPLETED|Overall Study||0
104495|NCT01970865|255358|P16|COMPLETED|Overall Study||0
104496|NCT01970865|255359|P15|COMPLETED|Overall Study||0
104497|NCT01970865|255360|P14|COMPLETED|Overall Study||0
104498|NCT01970865|255361|P13|COMPLETED|Overall Study||0
104499|NCT01970865|255362|P12|COMPLETED|Overall Study||0
104500|NCT01970865|255363|P11|COMPLETED|Overall Study||0
104501|NCT01970865|255364|P10|COMPLETED|Overall Study||0
104502|NCT01970865|255365|P9|COMPLETED|Overall Study||0
104503|NCT01970865|255366|P8|COMPLETED|Overall Study||0
104504|NCT01970865|255367|P7|COMPLETED|Overall Study||0
104505|NCT01970865|255368|P6|COMPLETED|Overall Study||0
104506|NCT01970865|255369|P5|COMPLETED|Overall Study||0
104507|NCT01970865|255370|P4|COMPLETED|Overall Study||0
104508|NCT01970865|255371|P3|COMPLETED|Overall Study||0
104509|NCT01970865|255372|P2|COMPLETED|Overall Study||0
104510|NCT01970865|255373|P1|COMPLETED|Overall Study||0
104511|NCT01970865|255357|P17|Received Treatment|Overall Study||3
104512|NCT01970865|255358|P16|Received Treatment|Overall Study||47
104513|NCT01970865|255359|P15|Received Treatment|Overall Study||46
104514|NCT01970865|255360|P14|Received Treatment|Overall Study||65
104515|NCT01970865|255361|P13|Received Treatment|Overall Study||60
104516|NCT01970865|255362|P12|Received Treatment|Overall Study||27
104517|NCT01970865|255363|P11|Received Treatment|Overall Study||30
104518|NCT01970865|255364|P10|Received Treatment|Overall Study||4
104519|NCT01970865|255365|P9|Received Treatment|Overall Study||3
104520|NCT01970865|255366|P8|Received Treatment|Overall Study||3
104521|NCT01970865|255367|P7|Received Treatment|Overall Study||3
104522|NCT01970865|255368|P6|Received Treatment|Overall Study||3
104523|NCT01970865|255369|P5|Received Treatment|Overall Study||17
104524|NCT01970865|255370|P4|Received Treatment|Overall Study||12
104525|NCT01970865|255371|P3|Received Treatment|Overall Study||3
104526|NCT01970865|255372|P2|Received Treatment|Overall Study||3
104527|NCT01970865|255373|P1|Received Treatment|Overall Study||3
104528|NCT01970865|255357|P17|STARTED|Overall Study||3
104529|NCT01970865|255358|P16|STARTED|Overall Study||47
104530|NCT01970865|255359|P15|STARTED|Overall Study||46
104531|NCT01970865|255360|P14|STARTED|Overall Study||66
104532|NCT01970865|255361|P13|STARTED|Overall Study||60
104533|NCT01970865|255362|P12|STARTED|Overall Study||27
104534|NCT01970865|255363|P11|STARTED|Overall Study||30
104535|NCT01970865|255364|P10|STARTED|Overall Study||4
104536|NCT01970865|255365|P9|STARTED|Overall Study||3
104537|NCT01970865|255366|P8|STARTED|Overall Study||3
104538|NCT01970865|255367|P7|STARTED|Overall Study||3
104539|NCT01970865|255368|P6|STARTED|Overall Study||3
104540|NCT01970865|255369|P5|STARTED|Overall Study||17
104541|NCT01970865|255370|P4|STARTED|Overall Study||13
104542|NCT01970865|255371|P3|STARTED|Overall Study||3
104543|NCT01970865|255372|P2|STARTED|Overall Study||3
104544|NCT01970865|255373|P1|STARTED|Overall Study||3
104545|NCT01970787|255797|P1|NOT COMPLETED|Overall Study||1
104546|NCT01970787|255797|P1|COMPLETED|Overall Study||21
104547|NCT01970787|255797|P1|STARTED|Overall Study||22
104548|NCT01970488|255807|P5|NOT COMPLETED|Part 2: Post Week 16||8
104549|NCT01970488|255808|P4|NOT COMPLETED|Part 2: Post Week 16||8
104550|NCT01970488|255809|P3|NOT COMPLETED|Part 2: Post Week 16||17
104551|NCT01970488|255810|P2|NOT COMPLETED|Part 2: Post Week 16||0
104552|NCT01970488|255811|P1|NOT COMPLETED|Part 2: Post Week 16||0
104553|NCT01970488|255807|P5|COMPLETED|Part 2: Post Week 16||69
104554|NCT01970488|255808|P4|COMPLETED|Part 2: Post Week 16||71
104555|NCT01970488|255809|P3|COMPLETED|Part 2: Post Week 16||135
104556|NCT01970488|255810|P2|COMPLETED|Part 2: Post Week 16||0
104557|NCT01970488|255811|P1|COMPLETED|Part 2: Post Week 16||0
104558|NCT01970488|255807|P5|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|77
104559|NCT01970488|255808|P4|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|79
104560|NCT01970488|255809|P3|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|152
104561|NCT01970488|255810|P2|STARTED|Part 2: Post Week 16||0
104562|NCT01970488|255811|P1|STARTED|Part 2: Post Week 16||0
104563|NCT01970488|255807|P5|NOT COMPLETED|Part 1: Through Week 16||0
104564|NCT01970488|255808|P4|NOT COMPLETED|Part 1: Through Week 16||0
104565|NCT01970488|255809|P3|NOT COMPLETED|Part 1: Through Week 16||0
104566|NCT01970488|255810|P2|NOT COMPLETED|Part 1: Through Week 16||13
104567|NCT01970488|255811|P1|NOT COMPLETED|Part 1: Through Week 16||11
104568|NCT01970488|255807|P5|COMPLETED|Part 1: Through Week 16||0
104569|NCT01970488|255808|P4|COMPLETED|Part 1: Through Week 16||0
104570|NCT01970488|255809|P3|COMPLETED|Part 1: Through Week 16||0
104571|NCT01970488|255810|P2|COMPLETED|Part 1: Through Week 16||162
104572|NCT01970488|255811|P1|COMPLETED|Part 1: Through Week 16||164
104573|NCT01970488|255807|P5|Received Treatment|Part 1: Through Week 16||0
104574|NCT01970488|255808|P4|Received Treatment|Part 1: Through Week 16||0
104575|NCT01970488|255809|P3|Received Treatment|Part 1: Through Week 16||0
104576|NCT01970488|255810|P2|Received Treatment|Part 1: Through Week 16||173
104577|NCT01970488|255811|P1|Received Treatment|Part 1: Through Week 16||174
104578|NCT01970488|255807|P5|STARTED|Part 1: Through Week 16||0
104579|NCT01970488|255808|P4|STARTED|Part 1: Through Week 16||0
104580|NCT01970488|255809|P3|STARTED|Part 1: Through Week 16||0
104581|NCT01970488|255810|P2|STARTED|Part 1: Through Week 16||175
104582|NCT01970488|255811|P1|STARTED|Part 1: Through Week 16||175
104583|NCT01970475|255878|P2|NOT COMPLETED|Overall Study||11
104584|NCT01970475|255879|P1|NOT COMPLETED|Overall Study||21
104585|NCT01970475|255878|P2|COMPLETED|Overall Study||251
104586|NCT01970475|255879|P1|COMPLETED|Overall Study||243
104587|NCT01970475|255878|P2|STARTED|Overall Study||262
104588|NCT01970475|255879|P1|STARTED|Overall Study||264
104589|NCT01970462|255899|P2|NOT COMPLETED|Overall Study||2
104590|NCT01970462|255900|P1|NOT COMPLETED|Overall Study||0
104591|NCT01970462|255899|P2|COMPLETED|Overall Study||2
104592|NCT01970462|255900|P1|COMPLETED|Overall Study||1
104593|NCT01970462|255899|P2|STARTED|Overall Study||4
104594|NCT01970462|255900|P1|STARTED|Overall Study||1
104595|NCT01970397|255914|P2|NOT COMPLETED|Overall Study||5
104596|NCT01970397|255915|P1|NOT COMPLETED|Overall Study||2
104597|NCT01970397|255914|P2|COMPLETED|Overall Study||64
104598|NCT01970397|255915|P1|COMPLETED|Overall Study||67
104599|NCT01970397|255914|P2|STARTED|Overall Study||69
104600|NCT01970397|255915|P1|STARTED|Overall Study||69
104601|NCT01970371|255928|P3|NOT COMPLETED|Overall Study||13
104602|NCT01970371|255929|P2|NOT COMPLETED|Overall Study||13
104603|NCT01970371|255930|P1|NOT COMPLETED|Overall Study||8
104604|NCT01970371|255928|P3|COMPLETED|Overall Study||17
104605|NCT01970371|255929|P2|COMPLETED|Overall Study||8
104606|NCT01970371|255930|P1|COMPLETED|Overall Study||10
104607|NCT01970371|255928|P3|STARTED|Overall Study||30
104608|NCT01970371|255929|P2|STARTED|Overall Study||21
104609|NCT01970371|255930|P1|STARTED|Overall Study||18
104610|NCT01970241|255955|P2|NOT COMPLETED|Overall Study||8
104611|NCT01970241|255956|P1|NOT COMPLETED|Overall Study||17
104612|NCT01970241|255955|P2|COMPLETED|Overall Study||31
104613|NCT01970241|255956|P1|COMPLETED|Overall Study||29
104614|NCT01970241|255955|P2|STARTED|Overall Study||39
104615|NCT01970241|255956|P1|STARTED|Overall Study||46
104616|NCT01969916|255996|P1|NOT COMPLETED|Overall Study||45
104617|NCT01969916|255996|P1|COMPLETED|Overall Study||105
104618|NCT01969916|255996|P1|STARTED|Overall Study||150
104619|NCT01969851|256003|P3|NOT COMPLETED|Overall Study||7
104620|NCT01969851|256004|P2|NOT COMPLETED|Overall Study||3
104621|NCT01969851|256005|P1|NOT COMPLETED|Overall Study||1
104622|NCT01969851|256003|P3|COMPLETED|Overall Study||14
104623|NCT01969851|256004|P2|COMPLETED|Overall Study||21
104624|NCT01969851|256005|P1|COMPLETED|Overall Study||9
104625|NCT01969851|256003|P3|STARTED|Overall Study||21
104626|NCT01969851|256004|P2|STARTED|Overall Study||24
104627|NCT01969851|256005|P1|STARTED|Overall Study||10
104628|NCT01969799|256027|P2|NOT COMPLETED|Overall Study||14
104629|NCT01969799|256028|P1|NOT COMPLETED|Overall Study||17
104630|NCT01969799|256027|P2|COMPLETED|Overall Study||58
104631|NCT01969799|256028|P1|COMPLETED|Overall Study||54
104632|NCT01969799|256027|P2|STARTED|Overall Study||72
104633|NCT01969799|256028|P1|STARTED|Overall Study||71
104634|NCT01969747|256052|P4|NOT COMPLETED|Overall Study||0
104635|NCT01969747|256053|P3|NOT COMPLETED|Overall Study||0
104636|NCT01969747|256054|P2|NOT COMPLETED|Overall Study||0
104637|NCT01969747|256055|P1|NOT COMPLETED|Overall Study||0
104638|NCT01969747|256052|P4|COMPLETED|Overall Study||18
104639|NCT01969747|256053|P3|COMPLETED|Overall Study||19
104640|NCT01969747|256054|P2|COMPLETED|Overall Study||19
104641|NCT01969747|256055|P1|COMPLETED|Overall Study||19
104642|NCT01969747|256052|P4|STARTED|Overall Study||18
104643|NCT01969747|256053|P3|STARTED|Overall Study||19
104644|NCT01969747|256054|P2|STARTED|Overall Study||19
104645|NCT01969747|256055|P1|STARTED|Overall Study||19
104646|NCT01969721|256065|P4|NOT COMPLETED|Overall Study||6
104647|NCT01969721|256066|P3|NOT COMPLETED|Overall Study||5
104648|NCT01969721|256067|P2|NOT COMPLETED|Overall Study||12
104649|NCT01969721|256068|P1|NOT COMPLETED|Overall Study||4
104650|NCT01969721|256065|P4|COMPLETED|Overall Study||46
104651|NCT01969721|256066|P3|COMPLETED|Overall Study||45
104652|NCT01969721|256067|P2|COMPLETED|Overall Study||57
104653|NCT01969721|256068|P1|COMPLETED|Overall Study||54
104654|NCT01969721|256065|P4|STARTED|Overall Study||52
104655|NCT01969721|256066|P3|STARTED|Overall Study||50
104656|NCT01969721|256067|P2|STARTED|Overall Study||69
104657|NCT01969721|256068|P1|STARTED|Overall Study||58
104658|NCT01969708|256096|P2|NOT COMPLETED|Overall Study||9
104659|NCT01969708|256097|P1|NOT COMPLETED|Overall Study||5
104660|NCT01969708|256096|P2|COMPLETED|Overall Study||173
104661|NCT01969708|256097|P1|COMPLETED|Overall Study||175
104662|NCT01969708|256096|P2|STARTED|Overall Study||182
104663|NCT01969708|256097|P1|STARTED|Overall Study||180
104664|NCT01969565|256113|P1|NOT COMPLETED|Overall Study||1
104665|NCT01969565|256113|P1|COMPLETED|Overall Study||0
104666|NCT01969565|256113|P1|STARTED|Overall Study||1
104667|NCT01969539|256119|P1|NOT COMPLETED|Overall Study||0
104668|NCT01969539|256119|P1|COMPLETED|Overall Study||11
104669|NCT01969539|256119|P1|STARTED|Overall Study||11
104670|NCT01969500|256127|P2|NOT COMPLETED|Overall Study||2
104671|NCT01969500|256128|P1|NOT COMPLETED|Overall Study||1
104672|NCT01969500|256127|P2|COMPLETED|Overall Study||24
104673|NCT01969500|256128|P1|COMPLETED|Overall Study||24
104674|NCT01969500|256127|P2|STARTED|Overall Study||26
104675|NCT01969500|256128|P1|STARTED|Overall Study||25
104676|NCT01969448|256143|P3|NOT COMPLETED|Overall Study||0
104677|NCT01969448|256144|P2|NOT COMPLETED|Overall Study||0
104678|NCT01969448|256145|P1|NOT COMPLETED|Overall Study||0
104679|NCT01969448|256143|P3|COMPLETED|Overall Study||0
104680|NCT01969448|256144|P2|COMPLETED|Overall Study||24
104681|NCT01969448|256145|P1|COMPLETED|Overall Study||55
104682|NCT01969448|256143|P3|STARTED|Overall Study||0
104683|NCT01969448|256144|P2|STARTED|Overall Study||24
104684|NCT01969448|256145|P1|STARTED|Overall Study||55
104685|NCT01969435|256168|P1|NOT COMPLETED|Overall Study||0
104686|NCT01969435|256168|P1|COMPLETED|Overall Study||50
104687|NCT01969435|256168|P1|STARTED|Overall Study||50
104688|NCT01969240|256184|P2|NOT COMPLETED|Overall Study||0
104689|NCT01969240|256185|P1|NOT COMPLETED|Overall Study||0
104690|NCT01969240|256184|P2|COMPLETED|Overall Study||447
104691|NCT01969240|256185|P1|COMPLETED|Overall Study||451
104692|NCT01969240|256184|P2|STARTED|Overall Study||447
104693|NCT01969240|256185|P1|STARTED|Overall Study||451
104694|NCT01969201|256205|P2|NOT COMPLETED|Overall Study||45
104695|NCT01969201|256206|P1|NOT COMPLETED|Overall Study||45
104696|NCT01969201|256205|P2|COMPLETED|Overall Study||313
104697|NCT01969201|256206|P1|COMPLETED|Overall Study||307
104698|NCT01969201|256205|P2|STARTED|Overall Study||358
104699|NCT01969201|256206|P1|STARTED|Overall Study||352
104700|NCT01969162|256226|P1|NOT COMPLETED|Overall Study||0
104701|NCT01969162|256226|P1|COMPLETED|Overall Study||35
104702|NCT01969162|256226|P1|STARTED|Overall Study||35
104703|NCT01969084|256232|P2|NOT COMPLETED|Overall Study||1
104704|NCT01969084|256233|P1|NOT COMPLETED|Overall Study||0
104705|NCT01969084|256232|P2|COMPLETED|Overall Study|One subject withdrew due to unrelated serious adverse event|21
104706|NCT01969084|256233|P1|COMPLETED|Overall Study||19
104707|NCT01969084|256232|P2|STARTED|Overall Study||22
104708|NCT01969084|256233|P1|STARTED|Overall Study||19
104709|NCT01969058|256249|P2|NOT COMPLETED|Overall Study||0
104710|NCT01969058|256250|P1|NOT COMPLETED|Overall Study||3
104711|NCT01969058|256249|P2|COMPLETED|Overall Study||26
104712|NCT01969058|256250|P1|COMPLETED|Overall Study||47
104713|NCT01969058|256249|P2|STARTED|Overall Study||26
104714|NCT01969058|256250|P1|STARTED|Overall Study||50
104715|NCT01968980|256294|P2|NOT COMPLETED|Overall Study||14
104716|NCT01968980|256295|P1|NOT COMPLETED|Overall Study||16
104717|NCT01968980|256294|P2|COMPLETED|Overall Study||171
104718|NCT01968980|256295|P1|COMPLETED|Overall Study||169
104719|NCT01968980|256294|P2|STARTED|Overall Study||185
104720|NCT01968980|256295|P1|STARTED|Overall Study||185
104721|NCT01968967|256357|P5|NOT COMPLETED|Extension Period||5
104722|NCT01968967|256358|P4|NOT COMPLETED|Extension Period||0
104723|NCT01968967|256359|P3|NOT COMPLETED|Extension Period||2
104724|NCT01968967|256360|P2|NOT COMPLETED|Extension Period||0
104725|NCT01968967|256361|P1|NOT COMPLETED|Extension Period||0
104726|NCT01968967|256357|P5|COMPLETED|Extension Period||34
104727|NCT01968967|256358|P4|COMPLETED|Extension Period||19
104728|NCT01968967|256359|P3|COMPLETED|Extension Period||45
104729|NCT01968967|256360|P2|COMPLETED|Extension Period||0
104730|NCT01968967|256361|P1|COMPLETED|Extension Period||0
104731|NCT01968967|256357|P5|STARTED|Extension Period||39
104732|NCT01968967|256358|P4|STARTED|Extension Period||19
104733|NCT01968967|256359|P3|STARTED|Extension Period||47
104734|NCT01968967|256360|P2|STARTED|Extension Period||0
104735|NCT01968967|256361|P1|STARTED|Extension Period||0
104736|NCT01968967|256357|P5|NOT COMPLETED|Treatment Period||0
104737|NCT01968967|256358|P4|NOT COMPLETED|Treatment Period||0
104738|NCT01968967|256359|P3|NOT COMPLETED|Treatment Period||0
104739|NCT01968967|256360|P2|NOT COMPLETED|Treatment Period||134
104740|NCT01968967|256361|P1|NOT COMPLETED|Treatment Period||146
104741|NCT01968967|256357|P5|COMPLETED|Treatment Period||0
104742|NCT01968967|256358|P4|COMPLETED|Treatment Period||0
104743|NCT01968967|256359|P3|COMPLETED|Treatment Period||0
104744|NCT01968967|256360|P2|COMPLETED|Treatment Period||934
104745|NCT01968967|256361|P1|COMPLETED|Treatment Period||925
104746|NCT01968967|256357|P5|Treated|Treatment Period||0
104747|NCT01968967|256358|P4|Treated|Treatment Period||0
104748|NCT01968967|256359|P3|Treated|Treatment Period||0
104749|NCT01968967|256360|P2|Treated|Treatment Period||1063
104750|NCT01968967|256361|P1|Treated|Treatment Period||1065
104751|NCT01968967|256357|P5|STARTED|Treatment Period||0
104752|NCT01968967|256358|P4|STARTED|Treatment Period||0
104753|NCT01968967|256359|P3|STARTED|Treatment Period||0
104754|NCT01968967|256360|P2|STARTED|Treatment Period||1068
104755|NCT01968967|256361|P1|STARTED|Treatment Period||1071
104756|NCT01968954|256430|P2|NOT COMPLETED|Overall Study||43
104757|NCT01968954|256431|P1|NOT COMPLETED|Overall Study||40
104758|NCT01968954|256430|P2|COMPLETED|Overall Study||314
104759|NCT01968954|256431|P1|COMPLETED|Overall Study||314
104760|NCT01968954|256430|P2|Treated|Overall Study||356
104761|NCT01968954|256431|P1|Treated|Overall Study||353
104762|NCT01968954|256430|P2|STARTED|Overall Study||357
104763|NCT01968954|256431|P1|STARTED|Overall Study||354
104764|NCT01968811|256495|P1|NOT COMPLETED|Overall Study||5
104765|NCT01968811|256495|P1|COMPLETED|Overall Study||5
104766|NCT01968811|256495|P1|STARTED|Overall Study||10
104767|NCT01968694|256502|P2|NOT COMPLETED|Visit 2 (1 Day)||0
104768|NCT01968694|256503|P1|NOT COMPLETED|Visit 2 (1 Day)||0
104769|NCT01968694|256502|P2|COMPLETED|Visit 2 (1 Day)||8
104770|NCT01968694|256503|P1|COMPLETED|Visit 2 (1 Day)||10
104771|NCT01968694|256502|P2|STARTED|Visit 2 (1 Day)||8
104772|NCT01968694|256503|P1|STARTED|Visit 2 (1 Day)||10
104773|NCT01968694|256502|P2|NOT COMPLETED|Washout (1 Month)||1
104774|NCT01968694|256503|P1|NOT COMPLETED|Washout (1 Month)||0
104775|NCT01968694|256502|P2|COMPLETED|Washout (1 Month)||8
104776|NCT01968694|256503|P1|COMPLETED|Washout (1 Month)||10
104777|NCT01968694|256502|P2|STARTED|Washout (1 Month)||9
104778|NCT01968694|256503|P1|STARTED|Washout (1 Month)||10
104779|NCT01968694|256502|P2|NOT COMPLETED|Visit 1 (1 Day)||0
104780|NCT01968694|256503|P1|NOT COMPLETED|Visit 1 (1 Day)||0
104781|NCT01968694|256502|P2|COMPLETED|Visit 1 (1 Day)||9
104782|NCT01968694|256503|P1|COMPLETED|Visit 1 (1 Day)||10
104783|NCT01968694|256502|P2|STARTED|Visit 1 (1 Day)||9
104784|NCT01968694|256503|P1|STARTED|Visit 1 (1 Day)||10
104785|NCT01968551|256520|P3|NOT COMPLETED|Extension Phase||4
104786|NCT01968551|256521|P2|NOT COMPLETED|Extension Phase||1
104787|NCT01968551|256522|P1|NOT COMPLETED|Extension Phase||1
104788|NCT01968551|256520|P3|COMPLETED|Extension Phase||30
104789|NCT01968551|256521|P2|COMPLETED|Extension Phase||86
104790|NCT01968551|256522|P1|COMPLETED|Extension Phase||19
104791|NCT01968551|256520|P3|STARTED|Extension Phase|7 participant completed the Open-Label Phase, but did not enter in the Extension Phase|34
104792|NCT01968551|256521|P2|STARTED|Extension Phase||87
104793|NCT01968551|256522|P1|STARTED|Extension Phase||20
104794|NCT01968551|256520|P3|NOT COMPLETED|Open Label Phase (48 Weeks)||5
104795|NCT01968551|256521|P2|NOT COMPLETED|Open Label Phase (48 Weeks)||3
104796|NCT01968551|256522|P1|NOT COMPLETED|Open Label Phase (48 Weeks)||2
104797|NCT01968551|256520|P3|COMPLETED|Open Label Phase (48 Weeks)||41
104798|NCT01968551|256521|P2|COMPLETED|Open Label Phase (48 Weeks)||87
104799|NCT01968551|256522|P1|COMPLETED|Open Label Phase (48 Weeks)||20
104800|NCT01968551|256520|P3|STARTED|Open Label Phase (48 Weeks)||46
104801|NCT01968551|256521|P2|STARTED|Open Label Phase (48 Weeks)||90
104802|NCT01968551|256522|P1|STARTED|Open Label Phase (48 Weeks)||22
104803|NCT01968434|256538|P2|NOT COMPLETED|Overall Study||6
104804|NCT01968434|256539|P1|NOT COMPLETED|Overall Study||3
104805|NCT01968434|256538|P2|COMPLETED|Overall Study||66
104806|NCT01968434|256539|P1|COMPLETED|Overall Study||75
104807|NCT01968434|256538|P2|STARTED|Overall Study||72
104808|NCT01968434|256539|P1|STARTED|Overall Study||78
104809|NCT01968226|256549|P1|NOT COMPLETED|Overall Study||2
104810|NCT01968226|256549|P1|COMPLETED|Overall Study||1
104811|NCT01968226|256549|P1|STARTED|Overall Study||3
104812|NCT01968213|256555|P2|NOT COMPLETED|Overall Study||9
104813|NCT01968213|256556|P1|NOT COMPLETED|Overall Study||90
104814|NCT01968213|256555|P2|COMPLETED|Overall Study||180
104815|NCT01968213|256556|P1|COMPLETED|Overall Study||285
104816|NCT01968213|256555|P2|STARTED|Overall Study||189
104817|NCT01968213|256556|P1|STARTED|Overall Study||375
104818|NCT01968135|256567|P2|NOT COMPLETED|Overall Study||0
104819|NCT01968135|256568|P1|NOT COMPLETED|Overall Study||0
104820|NCT01968135|256567|P2|COMPLETED|Overall Study||16
104821|NCT01968135|256568|P1|COMPLETED|Overall Study||16
104822|NCT01968135|256567|P2|STARTED|Overall Study||16
104823|NCT01968135|256568|P1|STARTED|Overall Study||16
104824|NCT01968070|256598|P18|NOT COMPLETED|Period 3||0
104825|NCT01968070|256599|P17|NOT COMPLETED|Period 3||0
104826|NCT01968070|256600|P16|NOT COMPLETED|Period 3||0
104827|NCT01968070|256601|P15|NOT COMPLETED|Period 3||0
104828|NCT01968070|256602|P14|NOT COMPLETED|Period 3||0
104829|NCT01968070|256603|P13|NOT COMPLETED|Period 3||0
104830|NCT01968070|256604|P12|NOT COMPLETED|Period 3||0
104831|NCT01968070|256605|P11|NOT COMPLETED|Period 3||0
104832|NCT01968070|256606|P10|NOT COMPLETED|Period 3||0
104833|NCT01968070|256607|P9|NOT COMPLETED|Period 3||0
104834|NCT01968070|256608|P8|NOT COMPLETED|Period 3||0
104835|NCT01968070|256609|P7|NOT COMPLETED|Period 3||0
104836|NCT01968070|256610|P6|NOT COMPLETED|Period 3||0
104837|NCT01968070|256611|P5|NOT COMPLETED|Period 3||0
104838|NCT01968070|256612|P4|NOT COMPLETED|Period 3||0
104839|NCT01968070|256613|P3|NOT COMPLETED|Period 3||0
104840|NCT01968070|256614|P2|NOT COMPLETED|Period 3||0
104841|NCT01968070|256615|P1|NOT COMPLETED|Period 3||0
104842|NCT01968070|256598|P18|COMPLETED|Period 3||0
104843|NCT01968070|256599|P17|COMPLETED|Period 3||0
104844|NCT01968070|256600|P16|COMPLETED|Period 3||0
104845|NCT01968070|256601|P15|COMPLETED|Period 3||0
104846|NCT01968070|256602|P14|COMPLETED|Period 3||0
104847|NCT01968070|256603|P13|COMPLETED|Period 3||0
104848|NCT01968070|256604|P12|COMPLETED|Period 3||0
104849|NCT01968070|256605|P11|COMPLETED|Period 3||0
104850|NCT01968070|256606|P10|COMPLETED|Period 3||0
104851|NCT01968070|256607|P9|COMPLETED|Period 3||0
104852|NCT01968070|256608|P8|COMPLETED|Period 3||0
104853|NCT01968070|256609|P7|COMPLETED|Period 3||0
104854|NCT01968070|256610|P6|COMPLETED|Period 3||4
104855|NCT01968070|256611|P5|COMPLETED|Period 3||3
104856|NCT01968070|256612|P4|COMPLETED|Period 3||4
104857|NCT01968070|256613|P3|COMPLETED|Period 3||4
104858|NCT01968070|256614|P2|COMPLETED|Period 3||4
104859|NCT01968070|256615|P1|COMPLETED|Period 3||4
104860|NCT01968070|256598|P18|STARTED|Period 3||0
104861|NCT01968070|256599|P17|STARTED|Period 3||0
104862|NCT01968070|256600|P16|STARTED|Period 3||0
104863|NCT01968070|256601|P15|STARTED|Period 3||0
104864|NCT01968070|256602|P14|STARTED|Period 3||0
104865|NCT01968070|256603|P13|STARTED|Period 3||0
104866|NCT01968070|256604|P12|STARTED|Period 3||0
104867|NCT01968070|256605|P11|STARTED|Period 3||0
104868|NCT01968070|256606|P10|STARTED|Period 3||0
104869|NCT01968070|256607|P9|STARTED|Period 3||0
104870|NCT01968070|256608|P8|STARTED|Period 3||0
104871|NCT01968070|256609|P7|STARTED|Period 3||0
104872|NCT01968070|256610|P6|STARTED|Period 3||4
104873|NCT01968070|256611|P5|STARTED|Period 3||3
104874|NCT01968070|256612|P4|STARTED|Period 3||4
104875|NCT01968070|256613|P3|STARTED|Period 3||4
104876|NCT01968070|256614|P2|STARTED|Period 3||4
104877|NCT01968070|256615|P1|STARTED|Period 3||4
104878|NCT01968070|256598|P18|NOT COMPLETED|Period 2||0
104879|NCT01968070|256599|P17|NOT COMPLETED|Period 2||0
104880|NCT01968070|256600|P16|NOT COMPLETED|Period 2||0
104881|NCT01968070|256601|P15|NOT COMPLETED|Period 2||0
104882|NCT01968070|256602|P14|NOT COMPLETED|Period 2||0
104883|NCT01968070|256603|P13|NOT COMPLETED|Period 2||0
104884|NCT01968070|256604|P12|NOT COMPLETED|Period 2||0
104885|NCT01968070|256605|P11|NOT COMPLETED|Period 2||0
104886|NCT01968070|256606|P10|NOT COMPLETED|Period 2||0
104887|NCT01968070|256607|P9|NOT COMPLETED|Period 2||0
104888|NCT01968070|256608|P8|NOT COMPLETED|Period 2||0
104889|NCT01968070|256609|P7|NOT COMPLETED|Period 2||0
104890|NCT01968070|256610|P6|NOT COMPLETED|Period 2||0
104891|NCT01968070|256611|P5|NOT COMPLETED|Period 2||1
104892|NCT01968070|256612|P4|NOT COMPLETED|Period 2||0
104893|NCT01968070|256613|P3|NOT COMPLETED|Period 2||0
104894|NCT01968070|256614|P2|NOT COMPLETED|Period 2||0
104895|NCT01968070|256615|P1|NOT COMPLETED|Period 2||0
104896|NCT01968070|256598|P18|COMPLETED|Period 2||0
104897|NCT01968070|256599|P17|COMPLETED|Period 2||0
104898|NCT01968070|256600|P16|COMPLETED|Period 2||0
104899|NCT01968070|256601|P15|COMPLETED|Period 2||0
104900|NCT01968070|256602|P14|COMPLETED|Period 2||0
104901|NCT01968070|256603|P13|COMPLETED|Period 2||0
104902|NCT01968070|256604|P12|COMPLETED|Period 2||0
104903|NCT01968070|256605|P11|COMPLETED|Period 2||0
104904|NCT01968070|256606|P10|COMPLETED|Period 2||0
104905|NCT01968070|256607|P9|COMPLETED|Period 2||0
104906|NCT01968070|256608|P8|COMPLETED|Period 2||0
104907|NCT01968070|256609|P7|COMPLETED|Period 2||0
104908|NCT01968070|256610|P6|COMPLETED|Period 2||4
104909|NCT01968070|256611|P5|COMPLETED|Period 2||2
104910|NCT01968070|256612|P4|COMPLETED|Period 2||4
104911|NCT01968070|256613|P3|COMPLETED|Period 2||4
104912|NCT01968070|256614|P2|COMPLETED|Period 2||4
104913|NCT01968070|256615|P1|COMPLETED|Period 2||4
104914|NCT01968070|256598|P18|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
104915|NCT01968070|256599|P17|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
104916|NCT01968070|256600|P16|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
104917|NCT01968070|256601|P15|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
104918|NCT01968070|256602|P14|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
104919|NCT01968070|256603|P13|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
104920|NCT01968070|256604|P12|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
104921|NCT01968070|256605|P11|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
104922|NCT01968070|256606|P10|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
104923|NCT01968070|256607|P9|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
104924|NCT01968070|256608|P8|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
104925|NCT01968070|256609|P7|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
104926|NCT01968070|256610|P6|STARTED|Period 2||4
104927|NCT01968070|256611|P5|STARTED|Period 2||3
104928|NCT01968070|256612|P4|STARTED|Period 2|2 participants were added to replace the 2 participants who discontinued the period 1.|4
104929|NCT01968070|256613|P3|STARTED|Period 2||4
104930|NCT01968070|256614|P2|STARTED|Period 2|1 participant was added to replace the participant who discontinued the period 1.|4
104931|NCT01968070|256615|P1|STARTED|Period 2||4
104932|NCT01968070|256598|P18|NOT COMPLETED|Period 1||0
104933|NCT01968070|256599|P17|NOT COMPLETED|Period 1||0
104934|NCT01968070|256600|P16|NOT COMPLETED|Period 1||1
104935|NCT01968070|256601|P15|NOT COMPLETED|Period 1||0
104936|NCT01968070|256602|P14|NOT COMPLETED|Period 1||0
104937|NCT01968070|256603|P13|NOT COMPLETED|Period 1||0
104938|NCT01968070|256604|P12|NOT COMPLETED|Period 1||1
104939|NCT01968070|256605|P11|NOT COMPLETED|Period 1||0
104940|NCT01968070|256606|P10|NOT COMPLETED|Period 1||0
104941|NCT01968070|256607|P9|NOT COMPLETED|Period 1||0
104942|NCT01968070|256608|P8|NOT COMPLETED|Period 1||0
104943|NCT01968070|256609|P7|NOT COMPLETED|Period 1||2
104944|NCT01968070|256610|P6|NOT COMPLETED|Period 1||0
104945|NCT01968070|256611|P5|NOT COMPLETED|Period 1||1
104946|NCT01968070|256612|P4|NOT COMPLETED|Period 1||2
104947|NCT01968070|256613|P3|NOT COMPLETED|Period 1||0
104948|NCT01968070|256614|P2|NOT COMPLETED|Period 1||1
104949|NCT01968070|256615|P1|NOT COMPLETED|Period 1||0
104950|NCT01968070|256598|P18|COMPLETED|Period 1||2
104951|NCT01968070|256599|P17|COMPLETED|Period 1||2
104952|NCT01968070|256600|P16|COMPLETED|Period 1||8
104953|NCT01968070|256601|P15|COMPLETED|Period 1||2
104954|NCT01968070|256602|P14|COMPLETED|Period 1||2
104955|NCT01968070|256603|P13|COMPLETED|Period 1||9
104956|NCT01968070|256604|P12|COMPLETED|Period 1||1
104957|NCT01968070|256605|P11|COMPLETED|Period 1||2
104958|NCT01968070|256606|P10|COMPLETED|Period 1||9
104959|NCT01968070|256607|P9|COMPLETED|Period 1||2
104960|NCT01968070|256608|P8|COMPLETED|Period 1||2
104961|NCT01968070|256609|P7|COMPLETED|Period 1||8
104962|NCT01968070|256610|P6|COMPLETED|Period 1||4
104963|NCT01968070|256611|P5|COMPLETED|Period 1||3
104964|NCT01968070|256612|P4|COMPLETED|Period 1||2
104965|NCT01968070|256613|P3|COMPLETED|Period 1||4
104966|NCT01968070|256614|P2|COMPLETED|Period 1||3
104967|NCT01968070|256615|P1|COMPLETED|Period 1||4
104968|NCT01968070|256598|P18|STARTED|Period 1||2
104969|NCT01968070|256599|P17|STARTED|Period 1||2
104970|NCT01968070|256600|P16|STARTED|Period 1||9
104971|NCT01968070|256601|P15|STARTED|Period 1||2
104972|NCT01968070|256602|P14|STARTED|Period 1||2
104973|NCT01968070|256603|P13|STARTED|Period 1||9
104974|NCT01968070|256604|P12|STARTED|Period 1||2
104975|NCT01968070|256605|P11|STARTED|Period 1||2
104976|NCT01968070|256606|P10|STARTED|Period 1||9
104977|NCT01968070|256607|P9|STARTED|Period 1||2
104978|NCT01968070|256608|P8|STARTED|Period 1||2
104979|NCT01968070|256609|P7|STARTED|Period 1||10
104980|NCT01968070|256610|P6|STARTED|Period 1||4
104981|NCT01968070|256611|P5|STARTED|Period 1||4
104982|NCT01968070|256612|P4|STARTED|Period 1||4
104983|NCT01968070|256613|P3|STARTED|Period 1||4
104984|NCT01968070|256614|P2|STARTED|Period 1||4
104985|NCT01968070|256615|P1|STARTED|Period 1||4
104986|NCT01968057|256673|P1|NOT COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||0
104987|NCT01968057|256673|P1|COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||18
104988|NCT01968057|256673|P1|Received Baricitinib + Ciclosporin|Period 2 (At Dosing Day 4 to Day 7)||18
104989|NCT01968057|256673|P1|STARTED|Period 2 (At Dosing Day 4 to Day 7)||18
104990|NCT01968057|256673|P1|NOT COMPLETED|Period 1 (Day 1 to Predosing Day 4)||0
104991|NCT01968057|256673|P1|COMPLETED|Period 1 (Day 1 to Predosing Day 4)||18
104992|NCT01968057|256673|P1|Received Baricitinib|Period 1 (Day 1 to Predosing Day 4)||18
104993|NCT01968057|256673|P1|STARTED|Period 1 (Day 1 to Predosing Day 4)||18
104994|NCT01967940|256686|P4|NOT COMPLETED|Part 2||3
104995|NCT01967940|256687|P3|NOT COMPLETED|Part 2||0
104996|NCT01967940|256688|P2|NOT COMPLETED|Part 2||0
104997|NCT01967940|256689|P1|NOT COMPLETED|Part 2||0
104998|NCT01967940|256686|P4|COMPLETED|Part 2||35
104999|NCT01967940|256687|P3|COMPLETED|Part 2||0
105000|NCT01967940|256688|P2|COMPLETED|Part 2||0
105001|NCT01967940|256689|P1|COMPLETED|Part 2||0
105002|NCT01967940|256686|P4|STARTED|Part 2|38 participants from the Part 1 groups moved to this Part 2 E/C/F/TAF + ATV group|38
105003|NCT01967940|256687|P3|STARTED|Part 2|1 participant completed Part 1 and did not enter Part 2; 14 participants moved to the Part 2 group|0
105004|NCT01967940|256688|P2|STARTED|Part 2|12 participants completed Part 1 and did not enter Part 2; 16 participants moved to the Part 2 group|0
105005|NCT01967940|256689|P1|STARTED|Part 2|4 participants completed Part 1 and did not enter Part 2; 8 participants moved to the Part 2 group|0
105006|NCT01967940|256686|P4|NOT COMPLETED|Part 1||0
105007|NCT01967940|256687|P3|NOT COMPLETED|Part 1||0
105008|NCT01967940|256688|P2|NOT COMPLETED|Part 1||0
105009|NCT01967940|256689|P1|NOT COMPLETED|Part 1||0
105010|NCT01967940|256686|P4|COMPLETED|Part 1||0
105011|NCT01967940|256687|P3|COMPLETED|Part 1||15
105012|NCT01967940|256688|P2|COMPLETED|Part 1||28
105013|NCT01967940|256689|P1|COMPLETED|Part 1||12
105014|NCT01967940|256686|P4|STARTED|Part 1||0
105015|NCT01967940|256687|P3|STARTED|Part 1||15
105016|NCT01967940|256688|P2|STARTED|Part 1||28
105017|NCT01967940|256689|P1|STARTED|Part 1||12
105018|NCT01967888|256717|P2|NOT COMPLETED|Overall Study||7
105019|NCT01967888|256718|P1|NOT COMPLETED|Overall Study||10
105020|NCT01967888|256717|P2|COMPLETED|Overall Study||45
105021|NCT01967888|256718|P1|COMPLETED|Overall Study||42
105022|NCT01967888|256717|P2|STARTED|Overall Study||52
105023|NCT01967888|256718|P1|STARTED|Overall Study||52
105024|NCT01967836|256786|P1|NOT COMPLETED|Overall Study||9
105025|NCT01967836|256786|P1|COMPLETED|Overall Study||11
105026|NCT01967836|256786|P1|STARTED|Overall Study||20
105027|NCT01967784|256792|P1|NOT COMPLETED|Overall Study||0
105028|NCT01967784|256792|P1|COMPLETED|Overall Study||100
105029|NCT01967784|256792|P1|STARTED|Overall Study||100
105030|NCT01967732|256802|P4|NOT COMPLETED|Second Intervention (Day 3)||0
105031|NCT01967732|256803|P3|NOT COMPLETED|Second Intervention (Day 3)||0
105032|NCT01967732|256804|P2|NOT COMPLETED|Second Intervention (Day 3)||0
105033|NCT01967732|256805|P1|NOT COMPLETED|Second Intervention (Day 3)||0
105034|NCT01967732|256802|P4|COMPLETED|Second Intervention (Day 3)||9
105035|NCT01967732|256803|P3|COMPLETED|Second Intervention (Day 3)||9
105036|NCT01967732|256804|P2|COMPLETED|Second Intervention (Day 3)||20
105037|NCT01967732|256805|P1|COMPLETED|Second Intervention (Day 3)||22
105038|NCT01967732|256802|P4|STARTED|Second Intervention (Day 3)||9
105039|NCT01967732|256803|P3|STARTED|Second Intervention (Day 3)||9
105040|NCT01967732|256804|P2|STARTED|Second Intervention (Day 3)||20
105041|NCT01967732|256805|P1|STARTED|Second Intervention (Day 3)||22
105042|NCT01967732|256802|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
105043|NCT01967732|256803|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
105044|NCT01967732|256804|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
105045|NCT01967732|256805|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
105046|NCT01967732|256802|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
105047|NCT01967732|256803|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
105048|NCT01967732|256804|P2|COMPLETED|Washout Period of 1 Day (Day 2)||20
105049|NCT01967732|256805|P1|COMPLETED|Washout Period of 1 Day (Day 2)||22
105050|NCT01967732|256802|P4|STARTED|Washout Period of 1 Day (Day 2)||9
105051|NCT01967732|256803|P3|STARTED|Washout Period of 1 Day (Day 2)||9
105052|NCT01967732|256804|P2|STARTED|Washout Period of 1 Day (Day 2)||20
105053|NCT01967732|256805|P1|STARTED|Washout Period of 1 Day (Day 2)||22
105054|NCT01967732|256802|P4|NOT COMPLETED|First Intervention (Day 1)||0
105055|NCT01967732|256803|P3|NOT COMPLETED|First Intervention (Day 1)||0
105056|NCT01967732|256804|P2|NOT COMPLETED|First Intervention (Day 1)||1
105057|NCT01967732|256805|P1|NOT COMPLETED|First Intervention (Day 1)||0
105058|NCT01967732|256802|P4|COMPLETED|First Intervention (Day 1)||9
105059|NCT01967732|256803|P3|COMPLETED|First Intervention (Day 1)||9
105060|NCT01967732|256804|P2|COMPLETED|First Intervention (Day 1)|Subject discontinued from the study prior to product use|20
105061|NCT01967732|256805|P1|COMPLETED|First Intervention (Day 1)||22
105062|NCT01967732|256802|P4|STARTED|First Intervention (Day 1)||9
105063|NCT01967732|256803|P3|STARTED|First Intervention (Day 1)||9
105064|NCT01967732|256804|P2|STARTED|First Intervention (Day 1)||21
105065|NCT01967732|256805|P1|STARTED|First Intervention (Day 1)||22
105066|NCT01967732|256802|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
105067|NCT01967732|256803|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
105068|NCT01967732|256804|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||1
105069|NCT01967732|256805|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
105070|NCT01967732|256802|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
105071|NCT01967732|256803|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
105072|NCT01967732|256804|P2|COMPLETED|Washout Period of 1 Day (Day 0)||21
105073|NCT01967732|256805|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
105074|NCT01967732|256802|P4|STARTED|Washout Period of 1 Day (Day 0)||9
105075|NCT01967732|256803|P3|STARTED|Washout Period of 1 Day (Day 0)||9
105076|NCT01967732|256804|P2|STARTED|Washout Period of 1 Day (Day 0)||22
105077|NCT01967732|256805|P1|STARTED|Washout Period of 1 Day (Day 0)||22
105078|NCT01967719|256819|P4|NOT COMPLETED|Second Intervention (Day 3)||0
105079|NCT01967719|256820|P3|NOT COMPLETED|Second Intervention (Day 3)||0
105080|NCT01967719|256821|P2|NOT COMPLETED|Second Intervention (Day 3)||1
105081|NCT01967719|256822|P1|NOT COMPLETED|Second Intervention (Day 3)||0
105082|NCT01967719|256819|P4|COMPLETED|Second Intervention (Day 3)||8
105083|NCT01967719|256820|P3|COMPLETED|Second Intervention (Day 3)||9
105084|NCT01967719|256821|P2|COMPLETED|Second Intervention (Day 3)||20
105085|NCT01967719|256822|P1|COMPLETED|Second Intervention (Day 3)||22
105086|NCT01967719|256819|P4|STARTED|Second Intervention (Day 3)||8
105087|NCT01967719|256820|P3|STARTED|Second Intervention (Day 3)||9
105088|NCT01967719|256821|P2|STARTED|Second Intervention (Day 3)||21
105089|NCT01967719|256822|P1|STARTED|Second Intervention (Day 3)||22
105090|NCT01967719|256819|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
105091|NCT01967719|256820|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
105092|NCT01967719|256821|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
105093|NCT01967719|256822|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
105094|NCT01967719|256819|P4|COMPLETED|Washout Period of 1 Day (Day 2)||8
105095|NCT01967719|256820|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
105096|NCT01967719|256821|P2|COMPLETED|Washout Period of 1 Day (Day 2)||21
105097|NCT01967719|256822|P1|COMPLETED|Washout Period of 1 Day (Day 2)||22
105098|NCT01967719|256819|P4|STARTED|Washout Period of 1 Day (Day 2)||8
105099|NCT01967719|256820|P3|STARTED|Washout Period of 1 Day (Day 2)||9
105100|NCT01967719|256821|P2|STARTED|Washout Period of 1 Day (Day 2)||21
105101|NCT01967719|256822|P1|STARTED|Washout Period of 1 Day (Day 2)||22
105102|NCT01967719|256819|P4|NOT COMPLETED|First Intervention (Day 1)||1
105103|NCT01967719|256820|P3|NOT COMPLETED|First Intervention (Day 1)||0
105104|NCT01967719|256821|P2|NOT COMPLETED|First Intervention (Day 1)||1
105105|NCT01967719|256822|P1|NOT COMPLETED|First Intervention (Day 1)||0
105106|NCT01967719|256819|P4|COMPLETED|First Intervention (Day 1)||8
105107|NCT01967719|256820|P3|COMPLETED|First Intervention (Day 1)||9
105108|NCT01967719|256821|P2|COMPLETED|First Intervention (Day 1)||21
105109|NCT01967719|256822|P1|COMPLETED|First Intervention (Day 1)||22
105110|NCT01967719|256819|P4|STARTED|First Intervention (Day 1)||9
105111|NCT01967719|256820|P3|STARTED|First Intervention (Day 1)||9
105112|NCT01967719|256821|P2|STARTED|First Intervention (Day 1)||22
105113|NCT01967719|256822|P1|STARTED|First Intervention (Day 1)||22
105114|NCT01967719|256819|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
105115|NCT01967719|256820|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
105116|NCT01967719|256821|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
105117|NCT01967719|256822|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
105118|NCT01967719|256819|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
105119|NCT01967719|256820|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
105120|NCT01967719|256821|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
105121|NCT01967719|256822|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
105122|NCT01967719|256819|P4|STARTED|Washout Period of 1 Day (Day 0)||9
105123|NCT01967719|256820|P3|STARTED|Washout Period of 1 Day (Day 0)||9
105124|NCT01967719|256821|P2|STARTED|Washout Period of 1 Day (Day 0)||22
105125|NCT01967719|256822|P1|STARTED|Washout Period of 1 Day (Day 0)||22
105126|NCT01967706|256837|P4|NOT COMPLETED|Second Intervention (Day 3)||0
105127|NCT01967706|256838|P3|NOT COMPLETED|Second Intervention (Day 3)||0
105128|NCT01967706|256839|P2|NOT COMPLETED|Second Intervention (Day 3)||0
105129|NCT01967706|256840|P1|NOT COMPLETED|Second Intervention (Day 3)||0
105130|NCT01967706|256837|P4|COMPLETED|Second Intervention (Day 3)||9
105131|NCT01967706|256838|P3|COMPLETED|Second Intervention (Day 3)||9
105132|NCT01967706|256839|P2|COMPLETED|Second Intervention (Day 3)||22
105133|NCT01967706|256840|P1|COMPLETED|Second Intervention (Day 3)||21
105134|NCT01967706|256837|P4|STARTED|Second Intervention (Day 3)||9
105135|NCT01967706|256838|P3|STARTED|Second Intervention (Day 3)||9
105136|NCT01967706|256839|P2|STARTED|Second Intervention (Day 3)||22
105137|NCT01967706|256840|P1|STARTED|Second Intervention (Day 3)||21
105138|NCT01967706|256837|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
105139|NCT01967706|256838|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
105140|NCT01967706|256839|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
105141|NCT01967706|256840|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
105142|NCT01967706|256837|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
105143|NCT01967706|256838|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
105144|NCT01967706|256839|P2|COMPLETED|Washout Period of 1 Day (Day 2)||22
105145|NCT01967706|256840|P1|COMPLETED|Washout Period of 1 Day (Day 2)||21
105146|NCT01967706|256837|P4|STARTED|Washout Period of 1 Day (Day 2)||9
105147|NCT01967706|256838|P3|STARTED|Washout Period of 1 Day (Day 2)||9
105148|NCT01967706|256839|P2|STARTED|Washout Period of 1 Day (Day 2)||22
105149|NCT01967706|256840|P1|STARTED|Washout Period of 1 Day (Day 2)||21
105150|NCT01967706|256837|P4|NOT COMPLETED|First Intervention (Day 1)||0
105151|NCT01967706|256838|P3|NOT COMPLETED|First Intervention (Day 1)||0
105152|NCT01967706|256839|P2|NOT COMPLETED|First Intervention (Day 1)||0
105153|NCT01967706|256840|P1|NOT COMPLETED|First Intervention (Day 1)||1
105154|NCT01967706|256837|P4|COMPLETED|First Intervention (Day 1)||9
105155|NCT01967706|256838|P3|COMPLETED|First Intervention (Day 1)||9
105156|NCT01967706|256839|P2|COMPLETED|First Intervention (Day 1)||22
105157|NCT01967706|256840|P1|COMPLETED|First Intervention (Day 1)||21
105158|NCT01967706|256837|P4|STARTED|First Intervention (Day 1)||9
105159|NCT01967706|256838|P3|STARTED|First Intervention (Day 1)||9
105160|NCT01967706|256839|P2|STARTED|First Intervention (Day 1)||22
105161|NCT01967706|256840|P1|STARTED|First Intervention (Day 1)||22
105162|NCT01967706|256837|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
105163|NCT01967706|256838|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
105164|NCT01967706|256839|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
105165|NCT01967706|256840|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
105166|NCT01967706|256837|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
105167|NCT01967706|256838|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
105168|NCT01967706|256839|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
105169|NCT01967706|256840|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
105170|NCT01967706|256837|P4|STARTED|Washout Period of 1 Day (Day 0)||9
105171|NCT01967706|256838|P3|STARTED|Washout Period of 1 Day (Day 0)||9
105172|NCT01967706|256839|P2|STARTED|Washout Period of 1 Day (Day 0)||22
105173|NCT01967706|256840|P1|STARTED|Washout Period of 1 Day (Day 0)||22
105174|NCT01967641|256853|P1|NOT COMPLETED|12-week Outpatient Phase||13
105175|NCT01967641|256853|P1|COMPLETED|12-week Outpatient Phase|Completed week 12 of outpatient phase|18
105176|NCT01967641|256853|P1|STARTED|12-week Outpatient Phase||31
105177|NCT01967641|256853|P1|NOT COMPLETED|Admission to Inpatient Phase||12
105178|NCT01967641|256853|P1|COMPLETED|Admission to Inpatient Phase|Completed 7 week inpatient phase|31
105179|NCT01967641|256853|P1|STARTED|Admission to Inpatient Phase||43
105180|NCT01967641|256853|P1|NOT COMPLETED|Randomized||8
105181|NCT01967641|256853|P1|COMPLETED|Randomized|Completed week 12|43
105182|NCT01967641|256853|P1|STARTED|Randomized||51
105183|NCT01967628|256861|P2|NOT COMPLETED|Overall Study||31
105184|NCT01967628|256862|P1|NOT COMPLETED|Overall Study||27
105185|NCT01967628|256861|P2|COMPLETED|Overall Study||19
105186|NCT01967628|256862|P1|COMPLETED|Overall Study||21
105187|NCT01967628|256861|P2|STARTED|Overall Study||50
105188|NCT01967628|256862|P1|STARTED|Overall Study||48
105189|NCT01967550|256870|P2|NOT COMPLETED|Overall Study||2
105190|NCT01967550|256871|P1|NOT COMPLETED|Overall Study||5
105191|NCT01967550|256870|P2|COMPLETED|Overall Study||149
105192|NCT01967550|256871|P1|COMPLETED|Overall Study||148
105193|NCT01967550|256870|P2|STARTED|Overall Study||151
105194|NCT01967550|256871|P1|STARTED|Overall Study||153
105195|NCT01967537|256877|P1|NOT COMPLETED|Overall Study||60
105196|NCT01967537|256877|P1|COMPLETED|Overall Study||281
105197|NCT01967537|256877|P1|STARTED|Overall Study||341
105198|NCT01967342|256889|P3|NOT COMPLETED|Overall Study||29
105199|NCT01967342|256890|P2|NOT COMPLETED|Overall Study||25
105200|NCT01967342|256891|P1|NOT COMPLETED|Overall Study||27
105201|NCT01967342|256889|P3|COMPLETED|Overall Study||68
105202|NCT01967342|256890|P2|COMPLETED|Overall Study||70
105203|NCT01967342|256891|P1|COMPLETED|Overall Study||71
105204|NCT01967342|256889|P3|10-week Follow-up|Overall Study||80
105205|NCT01967342|256890|P2|10-week Follow-up|Overall Study||83
105206|NCT01967342|256891|P1|10-week Follow-up|Overall Study||78
105207|NCT01967342|256889|P3|5-week Follow-up|Overall Study||76
105208|NCT01967342|256890|P2|5-week Follow-up|Overall Study||78
105209|NCT01967342|256891|P1|5-week Follow-up|Overall Study||83
105210|NCT01967342|256889|P3|STARTED|Overall Study||97
105211|NCT01967342|256890|P2|STARTED|Overall Study||95
105212|NCT01967342|256891|P1|STARTED|Overall Study||98
105213|NCT01967277|256910|P2|NOT COMPLETED|Overall Study||3
105214|NCT01967277|256911|P1|NOT COMPLETED|Overall Study||1
105215|NCT01967277|256910|P2|COMPLETED|Overall Study||19
105216|NCT01967277|256911|P1|COMPLETED|Overall Study||21
105217|NCT01967277|256910|P2|STARTED|Overall Study||22
105218|NCT01967277|256911|P1|STARTED|Overall Study||22
105219|NCT01967225|256923|P2|NOT COMPLETED|Overall Study||3
105220|NCT01967225|256924|P1|NOT COMPLETED|Overall Study||12
105221|NCT01967225|256923|P2|COMPLETED|Overall Study||38
105222|NCT01967225|256924|P1|COMPLETED|Overall Study||72
105223|NCT01967225|256923|P2|Participants Received Treatment|Overall Study||41
105224|NCT01967225|256924|P1|Participants Received Treatment|Overall Study||83
105225|NCT01967225|256923|P2|STARTED|Overall Study||41
105226|NCT01967225|256924|P1|STARTED|Overall Study||84
105227|NCT01967173|256956|P8|NOT COMPLETED|Overall Study||24
105228|NCT01967173|256957|P7|NOT COMPLETED|Overall Study||18
105229|NCT01967173|256958|P6|NOT COMPLETED|Overall Study||23
105230|NCT01967173|256959|P5|NOT COMPLETED|Overall Study||17
105231|NCT01967173|256960|P4|NOT COMPLETED|Overall Study||14
105232|NCT01967173|256961|P3|NOT COMPLETED|Overall Study||16
105233|NCT01967173|256962|P2|NOT COMPLETED|Overall Study||17
105234|NCT01967173|256963|P1|NOT COMPLETED|Overall Study||24
105235|NCT01967173|256956|P8|COMPLETED|Overall Study||50
105236|NCT01967173|256957|P7|COMPLETED|Overall Study||57
105237|NCT01967173|256958|P6|COMPLETED|Overall Study||49
105238|NCT01967173|256959|P5|COMPLETED|Overall Study||56
105239|NCT01967173|256960|P4|COMPLETED|Overall Study||57
105240|NCT01967173|256961|P3|COMPLETED|Overall Study||55
105241|NCT01967173|256962|P2|COMPLETED|Overall Study||52
105242|NCT01967173|256963|P1|COMPLETED|Overall Study||45
105243|NCT01967173|256956|P8|Completed 4th Period|Overall Study||50
105244|NCT01967173|256957|P7|Completed 4th Period|Overall Study||57
105245|NCT01967173|256958|P6|Completed 4th Period|Overall Study||49
105246|NCT01967173|256959|P5|Completed 4th Period|Overall Study||56
105247|NCT01967173|256960|P4|Completed 4th Period|Overall Study||57
105248|NCT01967173|256961|P3|Completed 4th Period|Overall Study||55
105249|NCT01967173|256962|P2|Completed 4th Period|Overall Study||52
105250|NCT01967173|256963|P1|Completed 4th Period|Overall Study||45
105251|NCT01967173|256956|P8|Completed 3rd Period|Overall Study||56
105252|NCT01967173|256957|P7|Completed 3rd Period|Overall Study||59
105253|NCT01967173|256958|P6|Completed 3rd Period|Overall Study||56
105254|NCT01967173|256959|P5|Completed 3rd Period|Overall Study||59
105255|NCT01967173|256960|P4|Completed 3rd Period|Overall Study||61
105256|NCT01967173|256961|P3|Completed 3rd Period|Overall Study||60
105257|NCT01967173|256962|P2|Completed 3rd Period|Overall Study||54
105258|NCT01967173|256963|P1|Completed 3rd Period|Overall Study||48
105259|NCT01967173|256956|P8|Completed 2nd Period|Overall Study||61
105260|NCT01967173|256957|P7|Completed 2nd Period|Overall Study||63
105261|NCT01967173|256958|P6|Completed 2nd Period|Overall Study||57
105262|NCT01967173|256959|P5|Completed 2nd Period|Overall Study||63
105263|NCT01967173|256960|P4|Completed 2nd Period|Overall Study||62
105264|NCT01967173|256961|P3|Completed 2nd Period|Overall Study||63
105265|NCT01967173|256962|P2|Completed 2nd Period|Overall Study||58
105266|NCT01967173|256963|P1|Completed 2nd Period|Overall Study||52
105267|NCT01967173|256956|P8|Completed 1st Period|Overall Study||69
105268|NCT01967173|256957|P7|Completed 1st Period|Overall Study||67
105269|NCT01967173|256958|P6|Completed 1st Period|Overall Study||62
105270|NCT01967173|256959|P5|Completed 1st Period|Overall Study||64
105271|NCT01967173|256960|P4|Completed 1st Period|Overall Study||65
105272|NCT01967173|256961|P3|Completed 1st Period|Overall Study||67
105273|NCT01967173|256962|P2|Completed 1st Period|Overall Study||60
105274|NCT01967173|256963|P1|Completed 1st Period|Overall Study||58
105275|NCT01967173|256956|P8|STARTED|Overall Study||74
105276|NCT01967173|256957|P7|STARTED|Overall Study||75
105277|NCT01967173|256958|P6|STARTED|Overall Study||72
105278|NCT01967173|256959|P5|STARTED|Overall Study||73
105279|NCT01967173|256960|P4|STARTED|Overall Study||71
105280|NCT01967173|256961|P3|STARTED|Overall Study||71
105281|NCT01967173|256962|P2|STARTED|Overall Study||69
105282|NCT01967173|256963|P1|STARTED|Overall Study||69
105283|NCT01967147|256977|P2|NOT COMPLETED|Overall Study||20
105284|NCT01967147|256978|P1|NOT COMPLETED|Overall Study||13
105285|NCT01967147|256977|P2|COMPLETED|Overall Study||82
105286|NCT01967147|256978|P1|COMPLETED|Overall Study||99
105287|NCT01967147|256977|P2|STARTED|Overall Study||102
105288|NCT01967147|256978|P1|STARTED|Overall Study||112
105289|NCT01967134|256996|P3|NOT COMPLETED|Overall Study||0
105290|NCT01967134|256997|P2|NOT COMPLETED|Overall Study||1
105291|NCT01967134|256998|P1|NOT COMPLETED|Overall Study||0
105292|NCT01967134|256996|P3|COMPLETED|Overall Study||9
105293|NCT01967134|256997|P2|COMPLETED|Overall Study||7
105294|NCT01967134|256998|P1|COMPLETED|Overall Study||8
105295|NCT01967134|256996|P3|STARTED|Overall Study||9
105296|NCT01967134|256997|P2|STARTED|Overall Study||8
105297|NCT01967134|256998|P1|STARTED|Overall Study||8
105298|NCT01967121|257021|P3|NOT COMPLETED|Overall Study||0
105299|NCT01967121|257022|P2|NOT COMPLETED|Overall Study||0
105300|NCT01967121|257023|P1|NOT COMPLETED|Overall Study||0
105301|NCT01967121|257021|P3|COMPLETED|Overall Study||25
105302|NCT01967121|257022|P2|COMPLETED|Overall Study||25
105303|NCT01967121|257023|P1|COMPLETED|Overall Study||25
105304|NCT01967121|257021|P3|STARTED|Overall Study||25
105305|NCT01967121|257022|P2|STARTED|Overall Study||25
105306|NCT01967121|257023|P1|STARTED|Overall Study||25
105307|NCT01967069|257033|P2|NOT COMPLETED|Overall Study||8
105308|NCT01967069|257034|P1|NOT COMPLETED|Overall Study||8
105309|NCT01967069|257033|P2|COMPLETED|Overall Study||87
105310|NCT01967069|257034|P1|COMPLETED|Overall Study||174
105311|NCT01967069|257033|P2|STARTED|Overall Study||95
105312|NCT01967069|257034|P1|STARTED|Overall Study||182
105313|NCT01966978|257042|P2|NOT COMPLETED|Overall Study||13
105314|NCT01966978|257043|P1|NOT COMPLETED|Overall Study||17
105315|NCT01966978|257042|P2|COMPLETED|Overall Study||46
105316|NCT01966978|257043|P1|COMPLETED|Overall Study||44
105317|NCT01966978|257042|P2|STARTED|Overall Study||59
105318|NCT01966978|257043|P1|STARTED|Overall Study||61
105319|NCT01966926|257065|P2|NOT COMPLETED|Overall Study||0
105320|NCT01966926|257066|P1|NOT COMPLETED|Overall Study||0
105321|NCT01966926|257065|P2|COMPLETED|Overall Study||15
105322|NCT01966926|257066|P1|COMPLETED|Overall Study||15
105323|NCT01966926|257065|P2|STARTED|Overall Study||15
105324|NCT01966926|257066|P1|STARTED|Overall Study||15
105325|NCT01966900|257084|P2|NOT COMPLETED|Overall Study||0
105326|NCT01966900|257085|P1|NOT COMPLETED|Overall Study||2
105327|NCT01966900|257084|P2|COMPLETED|Overall Study||6
105328|NCT01966900|257085|P1|COMPLETED|Overall Study||6
105329|NCT01966900|257084|P2|STARTED|Overall Study||6
105330|NCT01966900|257085|P1|STARTED|Overall Study||8
105331|NCT01966809|257095|P1|NOT COMPLETED|Overall Study||0
105332|NCT01966809|257095|P1|COMPLETED|Overall Study||1
105333|NCT01966809|257095|P1|STARTED|Overall Study||1
105334|NCT01966770|257102|P1|NOT COMPLETED|Overall Study||0
105335|NCT01966770|257102|P1|COMPLETED|Overall Study||20
105336|NCT01966770|257102|P1|STARTED|Overall Study||20
105337|NCT01966718|257211|P1|NOT COMPLETED|Overall Study||0
105338|NCT01966718|257211|P1|COMPLETED|Overall Study||8
105339|NCT01966718|257211|P1|STARTED|Overall Study||8
105340|NCT01966458|257221|P2|NOT COMPLETED|Overall Study||2
105341|NCT01966458|257222|P1|NOT COMPLETED|Overall Study||4
105342|NCT01966458|257221|P2|COMPLETED|Overall Study||155
105343|NCT01966458|257222|P1|COMPLETED|Overall Study||304
105344|NCT01966458|257221|P2|STARTED|Overall Study||157
105345|NCT01966458|257222|P1|STARTED|Overall Study||308
105346|NCT01966445|257237|P7|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||5
105347|NCT01966445|257238|P6|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
105348|NCT01966445|257239|P5|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
105349|NCT01966445|257240|P4|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
105350|NCT01966445|257241|P3|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
105351|NCT01966445|257242|P2|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
105352|NCT01966445|257243|P1|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
105353|NCT01966445|257237|P7|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||4
105354|NCT01966445|257238|P6|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
105355|NCT01966445|257239|P5|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
105356|NCT01966445|257240|P4|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
105357|NCT01966445|257241|P3|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
105358|NCT01966445|257242|P2|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
105359|NCT01966445|257243|P1|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
105360|NCT01966445|257237|P7|STARTED|Part2 (Median Exposure of 7.143 Weeks)||9
105361|NCT01966445|257238|P6|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
105362|NCT01966445|257239|P5|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
105363|NCT01966445|257240|P4|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
105364|NCT01966445|257241|P3|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
105365|NCT01966445|257242|P2|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
105366|NCT01966445|257243|P1|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
105367|NCT01966445|257237|P7|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
105368|NCT01966445|257238|P6|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
105369|NCT01966445|257239|P5|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||3
105370|NCT01966445|257240|P4|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||3
105371|NCT01966445|257241|P3|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
105372|NCT01966445|257242|P2|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||2
105373|NCT01966445|257243|P1|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
105374|NCT01966445|257237|P7|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
105375|NCT01966445|257238|P6|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||4
105376|NCT01966445|257239|P5|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
105377|NCT01966445|257240|P4|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||2
105378|NCT01966445|257241|P3|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
105379|NCT01966445|257242|P2|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
105380|NCT01966445|257243|P1|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
105381|NCT01966445|257237|P7|STARTED|Part1 (Median Exposure of 6.143 Weeks)||0
105382|NCT01966445|257238|P6|STARTED|Part1 (Median Exposure of 6.143 Weeks)||5
105383|NCT01966445|257239|P5|STARTED|Part1 (Median Exposure of 6.143 Weeks)||4
105384|NCT01966445|257240|P4|STARTED|Part1 (Median Exposure of 6.143 Weeks)||5
105385|NCT01966445|257241|P3|STARTED|Part1 (Median Exposure of 6.143 Weeks)||2
105386|NCT01966445|257242|P2|STARTED|Part1 (Median Exposure of 6.143 Weeks)||3
105387|NCT01966445|257243|P1|STARTED|Part1 (Median Exposure of 6.143 Weeks)||1
105388|NCT01966432|257353|P3|NOT COMPLETED|Overall Study||26
105389|NCT01966432|257354|P2|NOT COMPLETED|Overall Study||13
105390|NCT01966432|257355|P1|NOT COMPLETED|Overall Study||5
105391|NCT01966432|257353|P3|COMPLETED|Overall Study||28
105392|NCT01966432|257354|P2|COMPLETED|Overall Study||21
105393|NCT01966432|257355|P1|COMPLETED|Overall Study||5
105394|NCT01966432|257353|P3|STARTED|Overall Study||54
105395|NCT01966432|257354|P2|STARTED|Overall Study||34
105396|NCT01966432|257355|P1|STARTED|Overall Study||10
105397|NCT01966380|257375|P2|NOT COMPLETED|Overall Study||1
105398|NCT01966380|257376|P1|NOT COMPLETED|Overall Study||0
105399|NCT01966380|257375|P2|COMPLETED|Overall Study||2
105400|NCT01966380|257376|P1|COMPLETED|Overall Study||3
105401|NCT01966380|257375|P2|STARTED|Overall Study||3
105402|NCT01966380|257376|P1|STARTED|Overall Study||3
105403|NCT01966354|257385|P3|NOT COMPLETED|Overall Study||0
105404|NCT01966354|257386|P2|NOT COMPLETED|Overall Study||0
105405|NCT01966354|257387|P1|NOT COMPLETED|Overall Study||0
105406|NCT01966354|257385|P3|COMPLETED|Overall Study||72
105407|NCT01966354|257386|P2|COMPLETED|Overall Study||73
105408|NCT01966354|257387|P1|COMPLETED|Overall Study||75
105409|NCT01966354|257385|P3|STARTED|Overall Study||72
105410|NCT01966354|257386|P2|STARTED|Overall Study||73
105411|NCT01966354|257387|P1|STARTED|Overall Study||75
105412|NCT01966159|257412|P2|NOT COMPLETED|Overall Study||0
105413|NCT01966159|257413|P1|NOT COMPLETED|Overall Study||0
105414|NCT01966159|257412|P2|COMPLETED|Overall Study||207
105415|NCT01966159|257413|P1|COMPLETED|Overall Study||205
105416|NCT01966159|257412|P2|STARTED|Overall Study||207
105417|NCT01966159|257413|P1|STARTED|Overall Study||205
105418|NCT01966120|257425|P2|NOT COMPLETED|Overall Study||6
105419|NCT01966120|257426|P1|NOT COMPLETED|Overall Study||1
105420|NCT01966120|257425|P2|COMPLETED|Overall Study||26
105421|NCT01966120|257426|P1|COMPLETED|Overall Study||54
105422|NCT01966120|257425|P2|STARTED|Overall Study||32
105423|NCT01966120|257426|P1|STARTED|Overall Study||55
105424|NCT01966107|257450|P2|NOT COMPLETED|Overall Study||881
105425|NCT01966107|257451|P1|NOT COMPLETED|Overall Study||802
105426|NCT01966107|257450|P2|COMPLETED|Overall Study||937
105427|NCT01966107|257451|P1|COMPLETED|Overall Study||1010
105428|NCT01966107|257450|P2|Full Analysis Set|Overall Study||1798
105429|NCT01966107|257451|P1|Full Analysis Set|Overall Study||1791
105430|NCT01966107|257450|P2|STARTED|Overall Study||1818
105431|NCT01966107|257451|P1|STARTED|Overall Study||1812
105432|NCT01966068|257465|P1|NOT COMPLETED|Overall Study||138
105433|NCT01966068|257465|P1|COMPLETED|Overall Study||156
105434|NCT01966068|257465|P1|Use the MyAsthma Portal More Than Once|Overall Study||156
105435|NCT01966068|257465|P1|Used the MyAsthma Portal at Least Once|Overall Study||237
105436|NCT01966068|257465|P1|STARTED|Overall Study||294
105437|NCT01966042|257470|P1|NOT COMPLETED|Overall Study||2
105438|NCT01966042|257470|P1|COMPLETED|Overall Study||11
105439|NCT01966042|257470|P1|STARTED|Overall Study||13
105440|NCT01966003|257479|P2|NOT COMPLETED|Overall Study||270
105441|NCT01966003|257480|P1|NOT COMPLETED|Overall Study||270
105442|NCT01966003|257479|P2|COMPLETED|Overall Study||44
105443|NCT01966003|257480|P1|COMPLETED|Overall Study||58
105444|NCT01966003|257479|P2|Received Study Drug|Overall Study||309
105445|NCT01966003|257480|P1|Received Study Drug|Overall Study||324
105446|NCT01966003|257479|P2|STARTED|Overall Study||314
105447|NCT01966003|257480|P1|STARTED|Overall Study||328
105448|NCT01965938|257498|P2|NOT COMPLETED|Overall Study||0
105449|NCT01965938|257499|P1|NOT COMPLETED|Overall Study||1
105450|NCT01965938|257498|P2|COMPLETED|Overall Study||20
105451|NCT01965938|257499|P1|COMPLETED|Overall Study||20
105452|NCT01965938|257498|P2|STARTED|Overall Study||20
105453|NCT01965938|257499|P1|STARTED|Overall Study||21
105454|NCT01965899|257519|P1|NOT COMPLETED|Overall Study||6
105455|NCT01965899|257519|P1|COMPLETED|Overall Study||145
105456|NCT01965899|257519|P1|STARTED|Overall Study||151
105457|NCT01965834|257530|P1|NOT COMPLETED|Overall Study||4
105458|NCT01965834|257530|P1|COMPLETED|Overall Study||2
105459|NCT01965834|257530|P1|STARTED|Overall Study||6
105460|NCT01965782|257536|P1|NOT COMPLETED|Overall Study||0
105461|NCT01965782|257536|P1|COMPLETED|Overall Study||0
105462|NCT01965782|257536|P1|STARTED|Overall Study||0
105463|NCT01965756|257548|P2|NOT COMPLETED|Overall Study||0
105464|NCT01965756|257549|P1|NOT COMPLETED|Overall Study||0
105465|NCT01965756|257548|P2|COMPLETED|Overall Study||10
105466|NCT01965756|257549|P1|COMPLETED|Overall Study||10
105467|NCT01965756|257548|P2|STARTED|Overall Study||10
105468|NCT01965756|257549|P1|STARTED|Overall Study||10
105469|NCT01965665|257563|P1|NOT COMPLETED|Overall Study||1
105470|NCT01965665|257563|P1|COMPLETED|Overall Study||19
105471|NCT01965665|257563|P1|STARTED|Overall Study||20
105472|NCT01965652|257571|P2|NOT COMPLETED|Overall Study||210
105473|NCT01965652|257572|P1|NOT COMPLETED|Overall Study||210
105474|NCT01965652|257571|P2|COMPLETED|Overall Study||413
105475|NCT01965652|257572|P1|COMPLETED|Overall Study||413
105476|NCT01965652|257571|P2|Received Treatment|Overall Study||623
105477|NCT01965652|257572|P1|Received Treatment|Overall Study||622
105478|NCT01965652|257571|P2|STARTED|Overall Study|Includes three participants who each enrolled at two different sites|623
105479|NCT01965652|257572|P1|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|623
105480|NCT01965600|257602|P4|NOT COMPLETED|Second Intervention||2
105481|NCT01965600|257603|P3|NOT COMPLETED|Second Intervention||2
105482|NCT01965600|257604|P2|NOT COMPLETED|Second Intervention||0
105483|NCT01965600|257605|P1|NOT COMPLETED|Second Intervention||0
105484|NCT01965600|257602|P4|COMPLETED|Second Intervention||0
105485|NCT01965600|257603|P3|COMPLETED|Second Intervention||1
105486|NCT01965600|257604|P2|COMPLETED|Second Intervention||4
105487|NCT01965600|257605|P1|COMPLETED|Second Intervention||4
105488|NCT01965600|257602|P4|STARTED|Second Intervention||2
105489|NCT01965600|257603|P3|STARTED|Second Intervention||3
105490|NCT01965600|257604|P2|STARTED|Second Intervention||4
105491|NCT01965600|257605|P1|STARTED|Second Intervention||4
105492|NCT01965600|257602|P4|NOT COMPLETED|Washout Period of Approximately 15 Days||2
105493|NCT01965600|257603|P3|NOT COMPLETED|Washout Period of Approximately 15 Days||2
105494|NCT01965600|257604|P2|NOT COMPLETED|Washout Period of Approximately 15 Days||4
105495|NCT01965600|257605|P1|NOT COMPLETED|Washout Period of Approximately 15 Days||2
105496|NCT01965600|257602|P4|COMPLETED|Washout Period of Approximately 15 Days||2
105497|NCT01965600|257603|P3|COMPLETED|Washout Period of Approximately 15 Days||3
105498|NCT01965600|257604|P2|COMPLETED|Washout Period of Approximately 15 Days||4
105499|NCT01965600|257605|P1|COMPLETED|Washout Period of Approximately 15 Days||4
105500|NCT01965600|257602|P4|STARTED|Washout Period of Approximately 15 Days||4
105501|NCT01965600|257603|P3|STARTED|Washout Period of Approximately 15 Days||5
105502|NCT01965600|257604|P2|STARTED|Washout Period of Approximately 15 Days||8
105503|NCT01965600|257605|P1|STARTED|Washout Period of Approximately 15 Days||6
105504|NCT01965600|257602|P4|NOT COMPLETED|First Intervention||0
105505|NCT01965600|257603|P3|NOT COMPLETED|First Intervention||0
105506|NCT01965600|257604|P2|NOT COMPLETED|First Intervention||0
105507|NCT01965600|257605|P1|NOT COMPLETED|First Intervention||0
105508|NCT01965600|257602|P4|COMPLETED|First Intervention||4
105509|NCT01965600|257603|P3|COMPLETED|First Intervention||5
105510|NCT01965600|257604|P2|COMPLETED|First Intervention||8
105511|NCT01965600|257605|P1|COMPLETED|First Intervention||6
105512|NCT01965600|257602|P4|Received at Least One Dose of Drug|First Intervention||4
105513|NCT01965600|257603|P3|Received at Least One Dose of Drug|First Intervention||5
105514|NCT01965600|257604|P2|Received at Least One Dose of Drug|First Intervention||8
105515|NCT01965600|257605|P1|Received at Least One Dose of Drug|First Intervention||6
105516|NCT01965600|257602|P4|STARTED|First Intervention||4
105517|NCT01965600|257603|P3|STARTED|First Intervention||5
105518|NCT01965600|257604|P2|STARTED|First Intervention||8
105519|NCT01965600|257605|P1|STARTED|First Intervention||6
105520|NCT01965561|257649|P1|NOT COMPLETED|Overall Study||0
105521|NCT01965561|257649|P1|COMPLETED|Overall Study||10
105522|NCT01965561|257649|P1|STARTED|Overall Study||10
105523|NCT01965535|257662|P2|NOT COMPLETED|Overall Study||1
105524|NCT01965535|257663|P1|NOT COMPLETED|Overall Study||2
105525|NCT01965535|257662|P2|COMPLETED|Overall Study||76
105526|NCT01965535|257663|P1|COMPLETED|Overall Study||76
105527|NCT01965535|257662|P2|STARTED|Overall Study||77
105528|NCT01965535|257663|P1|STARTED|Overall Study||78
105529|NCT01965431|257677|P6|NOT COMPLETED|Overall Study||6
105530|NCT01965431|257678|P5|NOT COMPLETED|Overall Study||6
105531|NCT01965431|257679|P4|NOT COMPLETED|Overall Study||6
105532|NCT01965431|257680|P3|NOT COMPLETED|Overall Study||6
105533|NCT01965431|257681|P2|NOT COMPLETED|Overall Study||6
105534|NCT01965431|257682|P1|NOT COMPLETED|Overall Study||6
105535|NCT01965431|257677|P6|COMPLETED|Overall Study||2
105536|NCT01965431|257678|P5|COMPLETED|Overall Study||2
105537|NCT01965431|257679|P4|COMPLETED|Overall Study||2
105538|NCT01965431|257680|P3|COMPLETED|Overall Study||2
105539|NCT01965431|257681|P2|COMPLETED|Overall Study||2
105540|NCT01965431|257682|P1|COMPLETED|Overall Study||2
105541|NCT01965431|257677|P6|STARTED|Overall Study||8
105542|NCT01965431|257678|P5|STARTED|Overall Study||8
105543|NCT01965431|257679|P4|STARTED|Overall Study||8
105544|NCT01965431|257680|P3|STARTED|Overall Study||8
105545|NCT01965431|257681|P2|STARTED|Overall Study||8
105546|NCT01965431|257682|P1|STARTED|Overall Study|Started are actually Treated subjects|8
105547|NCT01965366|257697|P2|NOT COMPLETED|Overall Study||5
105548|NCT01965366|257698|P1|NOT COMPLETED|Overall Study||10
105549|NCT01965366|257697|P2|COMPLETED|Overall Study||9
105550|NCT01965366|257698|P1|COMPLETED|Overall Study||3
105551|NCT01965366|257697|P2|STARTED|Overall Study||14
105552|NCT01965366|257698|P1|STARTED|Overall Study||13
105553|NCT01965327|257706|P1|NOT COMPLETED|Overall Study||2
105554|NCT01965327|257706|P1|COMPLETED|Overall Study|Prior to completion, 2 subjects were withdrawn by the PI for failure to adhere to study protocol.|10
105555|NCT01965327|257706|P1|STARTED|Overall Study||12
105556|NCT01965288|257713|P2|NOT COMPLETED|Overall Study||0
105557|NCT01965288|257714|P1|NOT COMPLETED|Overall Study||0
105558|NCT01965288|257713|P2|COMPLETED|Overall Study||30
105559|NCT01965288|257714|P1|COMPLETED|Overall Study||30
105560|NCT01965288|257713|P2|STARTED|Overall Study||30
105561|NCT01965288|257714|P1|STARTED|Overall Study||30
105562|NCT01965262|257920|P2|NOT COMPLETED|Second Intervention (7 Days)||10
105563|NCT01965262|257921|P1|NOT COMPLETED|Second Intervention (7 Days)||1
105564|NCT01965262|257920|P2|COMPLETED|Second Intervention (7 Days)||5
105565|NCT01965262|257921|P1|COMPLETED|Second Intervention (7 Days)||14
105566|NCT01965262|257920|P2|STARTED|Second Intervention (7 Days)||15
105567|NCT01965262|257921|P1|STARTED|Second Intervention (7 Days)||15
105568|NCT01965262|257920|P2|NOT COMPLETED|First Intervention (7 Days)||0
105569|NCT01965262|257921|P1|NOT COMPLETED|First Intervention (7 Days)||0
105570|NCT01965262|257920|P2|COMPLETED|First Intervention (7 Days)||15
105571|NCT01965262|257921|P1|COMPLETED|First Intervention (7 Days)||15
105572|NCT01965262|257920|P2|STARTED|First Intervention (7 Days)||15
105573|NCT01965262|257921|P1|STARTED|First Intervention (7 Days)||15
105574|NCT01965158|257985|P2|NOT COMPLETED|Overall Study||35
105575|NCT01965158|257986|P1|NOT COMPLETED|Overall Study||41
105576|NCT01965158|257985|P2|COMPLETED|Overall Study||238
105577|NCT01965158|257986|P1|COMPLETED|Overall Study||233
105578|NCT01965158|257985|P2|Received Treatment|Overall Study||273
105579|NCT01965158|257986|P1|Received Treatment|Overall Study||272
105580|NCT01965158|257985|P2|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|273
105581|NCT01965158|257986|P1|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|274
105582|NCT01965067|258002|P2|NOT COMPLETED|Overall Study||0
105583|NCT01965067|258003|P1|NOT COMPLETED|Overall Study||0
105584|NCT01965067|258002|P2|COMPLETED|Overall Study||30
105585|NCT01965067|258003|P1|COMPLETED|Overall Study||30
105586|NCT01965067|258002|P2|STARTED|Overall Study||30
105587|NCT01965067|258003|P1|STARTED|Overall Study||30
105588|NCT01965002|258019|P1|NOT COMPLETED|Overall Study||0
105589|NCT01965002|258019|P1|COMPLETED|Overall Study||5
105590|NCT01965002|258019|P1|STARTED|Overall Study||5
105591|NCT01964976|258027|P1|NOT COMPLETED|Overall Study||31
105592|NCT01964976|258027|P1|COMPLETED|Overall Study||1065
105593|NCT01964976|258027|P1|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1096
105594|NCT01964963|258039|P1|NOT COMPLETED|Overall Study||943
105595|NCT01964963|258039|P1|COMPLETED|Overall Study||18249
105596|NCT01964963|258039|P1|STARTED|Overall Study||19192
105597|NCT01964950|258047|P1|NOT COMPLETED|Overall Study||25
105598|NCT01964950|258047|P1|COMPLETED|Overall Study||1076
105599|NCT01964950|258047|P1|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1101
105600|NCT01964924|258059|P2|NOT COMPLETED|Trametinib + GSK2141||0
105601|NCT01964924|258060|P1|NOT COMPLETED|Trametinib + GSK2141||0
105602|NCT01964924|258059|P2|COMPLETED|Trametinib + GSK2141||19
105603|NCT01964924|258060|P1|COMPLETED|Trametinib + GSK2141||0
105604|NCT01964924|258059|P2|STARTED|Trametinib + GSK2141|Progressed in Part 1 and therefore initiated combination treatment in Part 2|19
105605|NCT01964924|258060|P1|STARTED|Trametinib + GSK2141||0
105606|NCT01964924|258059|P2|NOT COMPLETED|Trametinib Monotherapy||0
105607|NCT01964924|258060|P1|NOT COMPLETED|Trametinib Monotherapy||19
105608|NCT01964924|258059|P2|COMPLETED|Trametinib Monotherapy||0
105609|NCT01964924|258060|P1|COMPLETED|Trametinib Monotherapy||18
105610|NCT01964924|258059|P2|STARTED|Trametinib Monotherapy||0
105611|NCT01964924|258060|P1|STARTED|Trametinib Monotherapy||37
105612|NCT01964898|258084|P2|NOT COMPLETED|Overall Study||7
105613|NCT01964898|258085|P1|NOT COMPLETED|Overall Study||7
105614|NCT01964898|258084|P2|COMPLETED|Overall Study||26
105615|NCT01964898|258085|P1|COMPLETED|Overall Study||24
105616|NCT01964898|258084|P2|12 Week Assessment|Overall Study||30
105617|NCT01964898|258085|P1|12 Week Assessment|Overall Study||25
105618|NCT01964898|258084|P2|STARTED|Overall Study||33
105619|NCT01964898|258085|P1|STARTED|Overall Study||31
105620|NCT01964755|258105|P1|NOT COMPLETED|Overall Study||2
105621|NCT01964755|258105|P1|COMPLETED|Overall Study||4
105622|NCT01964755|258105|P1|Cycle 5|Overall Study||4
105623|NCT01964755|258105|P1|Cycle 4|Overall Study||4
105624|NCT01964755|258105|P1|Cycle 3|Overall Study||4
105625|NCT01964755|258105|P1|Cycle 2|Overall Study||5
105626|NCT01964755|258105|P1|STARTED|Overall Study||6
105627|NCT01964716|258120|P2|NOT COMPLETED|Overall Study||6
105628|NCT01964716|258121|P1|NOT COMPLETED|Overall Study||5
105629|NCT01964716|258120|P2|COMPLETED|Overall Study||244
105630|NCT01964716|258121|P1|COMPLETED|Overall Study||245
105631|NCT01964716|258120|P2|Vaccinated Dose 3|Overall Study||244
105632|NCT01964716|258121|P1|Vaccinated Dose 3|Overall Study||247
105633|NCT01964716|258120|P2|Vaccinated Dose 2|Overall Study||248
105634|NCT01964716|258121|P1|Vaccinated Dose 2|Overall Study||249
105635|NCT01964716|258120|P2|Vaccinated Dose 1|Overall Study||250
105636|NCT01964716|258121|P1|Vaccinated Dose 1|Overall Study||250
105637|NCT01964716|258120|P2|STARTED|Overall Study||250
105638|NCT01964716|258121|P1|STARTED|Overall Study||250
105639|NCT01964547|258159|P2|NOT COMPLETED|Overall Study||11
105640|NCT01964547|258160|P1|NOT COMPLETED|Overall Study||12
105641|NCT01964547|258159|P2|COMPLETED|Overall Study||48
105642|NCT01964547|258160|P1|COMPLETED|Overall Study||50
105643|NCT01964547|258159|P2|STARTED|Overall Study||59
105644|NCT01964547|258160|P1|STARTED|Overall Study||62
105645|NCT01964521|258184|P1|NOT COMPLETED|Overall Study||4
105646|NCT01964521|258184|P1|COMPLETED|Overall Study||20
105647|NCT01964521|258184|P1|STARTED|Overall Study||24
105648|NCT01964352|258193|P4|NOT COMPLETED|Overall Study||8
105649|NCT01964352|258194|P3|NOT COMPLETED|Overall Study||6
105650|NCT01964352|258195|P2|NOT COMPLETED|Overall Study||11
105651|NCT01964352|258196|P1|NOT COMPLETED|Overall Study||26
105652|NCT01964352|258193|P4|COMPLETED|Overall Study||195
105653|NCT01964352|258194|P3|COMPLETED|Overall Study||196
105654|NCT01964352|258195|P2|COMPLETED|Overall Study||192
105655|NCT01964352|258196|P1|COMPLETED|Overall Study||178
105656|NCT01964352|258193|P4|STARTED|Overall Study||203
105657|NCT01964352|258194|P3|STARTED|Overall Study||202
105658|NCT01964352|258195|P2|STARTED|Overall Study||203
105659|NCT01964352|258196|P1|STARTED|Overall Study||204
105660|NCT01964326|258226|P1|NOT COMPLETED|Overall Study||297
105661|NCT01964326|258226|P1|COMPLETED|Overall Study||1014
105662|NCT01964326|258226|P1|STARTED|Overall Study||1311
105663|NCT01964222|258235|P2|NOT COMPLETED|Overall Study||11
105664|NCT01964222|258236|P1|NOT COMPLETED|Overall Study||15
105665|NCT01964222|258235|P2|COMPLETED|Overall Study||89
105666|NCT01964222|258236|P1|COMPLETED|Overall Study||86
105667|NCT01964222|258235|P2|STARTED|Overall Study||100
105668|NCT01964222|258236|P1|STARTED|Overall Study||101
105669|NCT01964105|258253|P3|NOT COMPLETED|Overall Study||0
105670|NCT01964105|258254|P2|NOT COMPLETED|Overall Study||13
105671|NCT01964105|258255|P1|NOT COMPLETED|Overall Study||2
105672|NCT01964105|258253|P3|COMPLETED|Overall Study||10
105673|NCT01964105|258254|P2|COMPLETED|Overall Study||62
105674|NCT01964105|258255|P1|COMPLETED|Overall Study||13
105675|NCT01964105|258253|P3|STARTED|Overall Study||10
105676|NCT01964105|258254|P2|STARTED|Overall Study||75
105677|NCT01964105|258255|P1|STARTED|Overall Study||15
105678|NCT01963845|258265|P2|NOT COMPLETED|Overall Study||0
105679|NCT01963845|258266|P1|NOT COMPLETED|Overall Study||0
105680|NCT01963845|258265|P2|COMPLETED|Overall Study||25
105681|NCT01963845|258266|P1|COMPLETED|Overall Study||25
105682|NCT01963845|258265|P2|STARTED|Overall Study||25
105683|NCT01963845|258266|P1|STARTED|Overall Study||25
105684|NCT01963767|258282|P2|NOT COMPLETED|Overall Study||2
105685|NCT01963767|258283|P1|NOT COMPLETED|Overall Study||6
105686|NCT01963767|258282|P2|COMPLETED|Overall Study||53
105687|NCT01963767|258283|P1|COMPLETED|Overall Study||52
105688|NCT01963767|258282|P2|STARTED|Overall Study||55
105689|NCT01963767|258283|P1|STARTED|Overall Study||58
105690|NCT01963676|258293|P2|NOT COMPLETED|Overall Study||0
105691|NCT01963676|258294|P1|NOT COMPLETED|Overall Study||1
105692|NCT01963676|258293|P2|COMPLETED|Overall Study||13
105693|NCT01963676|258294|P1|COMPLETED|Overall Study||13
105694|NCT01963676|258293|P2|STARTED|Overall Study||13
105695|NCT01963676|258294|P1|STARTED|Overall Study||14
105696|NCT01963611|258307|P5|NOT COMPLETED|Overall Study||51
105697|NCT01963611|258308|P4|NOT COMPLETED|Overall Study||52
105698|NCT01963611|258309|P3|NOT COMPLETED|Overall Study||52
105699|NCT01963611|258310|P2|NOT COMPLETED|Overall Study||49
105700|NCT01963611|258311|P1|NOT COMPLETED|Overall Study||51
105701|NCT01963611|258307|P5|COMPLETED|Overall Study||0
105702|NCT01963611|258308|P4|COMPLETED|Overall Study||0
105703|NCT01963611|258309|P3|COMPLETED|Overall Study||0
105704|NCT01963611|258310|P2|COMPLETED|Overall Study||0
105705|NCT01963611|258311|P1|COMPLETED|Overall Study||0
105706|NCT01963611|258307|P5|Safety Analysis Set|Overall Study||50
105707|NCT01963611|258308|P4|Safety Analysis Set|Overall Study||52
105708|NCT01963611|258309|P3|Safety Analysis Set|Overall Study||52
105709|NCT01963611|258310|P2|Safety Analysis Set|Overall Study||49
105710|NCT01963611|258311|P1|Safety Analysis Set|Overall Study||51
105711|NCT01963611|258307|P5|STARTED|Overall Study||51
105712|NCT01963611|258308|P4|STARTED|Overall Study||52
105713|NCT01963611|258309|P3|STARTED|Overall Study||52
105714|NCT01963611|258310|P2|STARTED|Overall Study||49
105715|NCT01963611|258311|P1|STARTED|Overall Study||51
105716|NCT01963403|258370|P2|NOT COMPLETED|Overall Study||4
105717|NCT01963403|258371|P1|NOT COMPLETED|Overall Study||2
105718|NCT01963403|258370|P2|COMPLETED|Overall Study|Follow-up over three months|9
105719|NCT01963403|258371|P1|COMPLETED|Overall Study|Follow-up over three months|11
105720|NCT01963403|258370|P2|STARTED|Overall Study||13
105721|NCT01963403|258371|P1|STARTED|Overall Study||13
105722|NCT01963260|258393|P10|NOT COMPLETED|Overall Study||0
105723|NCT01963260|258394|P9|NOT COMPLETED|Overall Study||0
105724|NCT01963260|258395|P8|NOT COMPLETED|Overall Study||0
105725|NCT01963260|258396|P7|NOT COMPLETED|Overall Study||0
105726|NCT01963260|258397|P6|NOT COMPLETED|Overall Study||0
105727|NCT01963260|258398|P5|NOT COMPLETED|Overall Study||2
105728|NCT01963260|258399|P4|NOT COMPLETED|Overall Study||1
105729|NCT01963260|258400|P3|NOT COMPLETED|Overall Study||0
105730|NCT01963260|258401|P2|NOT COMPLETED|Overall Study||0
105731|NCT01963260|258402|P1|NOT COMPLETED|Overall Study||2
105732|NCT01963260|258393|P10|COMPLETED|Overall Study||4
105733|NCT01963260|258394|P9|COMPLETED|Overall Study||1
105734|NCT01963260|258395|P8|COMPLETED|Overall Study||2
105735|NCT01963260|258396|P7|COMPLETED|Overall Study||3
105736|NCT01963260|258397|P6|COMPLETED|Overall Study||10
105737|NCT01963260|258398|P5|COMPLETED|Overall Study||4
105738|NCT01963260|258399|P4|COMPLETED|Overall Study||5
105739|NCT01963260|258400|P3|COMPLETED|Overall Study||6
105740|NCT01963260|258401|P2|COMPLETED|Overall Study||6
105741|NCT01963260|258402|P1|COMPLETED|Overall Study||4
105742|NCT01963260|258393|P10|Treated|Overall Study||4
105743|NCT01963260|258394|P9|Treated|Overall Study||1
105744|NCT01963260|258395|P8|Treated|Overall Study||2
105745|NCT01963260|258396|P7|Treated|Overall Study||3
105746|NCT01963260|258397|P6|Treated|Overall Study||10
105747|NCT01963260|258398|P5|Treated|Overall Study||6
105748|NCT01963260|258399|P4|Treated|Overall Study||6
105749|NCT01963260|258400|P3|Treated|Overall Study||6
105750|NCT01963260|258401|P2|Treated|Overall Study||6
105751|NCT01963260|258402|P1|Treated|Overall Study||6
105752|NCT01963260|258393|P10|STARTED|Overall Study||4
105753|NCT01963260|258394|P9|STARTED|Overall Study||1
105754|NCT01963260|258395|P8|STARTED|Overall Study||2
105755|NCT01963260|258396|P7|STARTED|Overall Study||3
105756|NCT01963260|258397|P6|STARTED|Overall Study||10
105757|NCT01963260|258398|P5|STARTED|Overall Study||6
105758|NCT01963260|258399|P4|STARTED|Overall Study||6
105759|NCT01963260|258400|P3|STARTED|Overall Study||6
105760|NCT01963260|258401|P2|STARTED|Overall Study||6
105761|NCT01963260|258402|P1|STARTED|Overall Study||6
105762|NCT01963234|258457|P2|NOT COMPLETED|Overall Study||0
105763|NCT01963234|258458|P1|NOT COMPLETED|Overall Study||61
105764|NCT01963234|258457|P2|COMPLETED|Overall Study||171
105765|NCT01963234|258458|P1|COMPLETED|Overall Study||207
105766|NCT01963234|258457|P2|STARTED|Overall Study||171
105767|NCT01963234|258458|P1|STARTED|Overall Study||268
105768|NCT01963143|258485|P3|NOT COMPLETED|Overall Study||1
105769|NCT01963143|258486|P2|NOT COMPLETED|Overall Study||1
105770|NCT01963143|258487|P1|NOT COMPLETED|Overall Study||0
105771|NCT01963143|258485|P3|COMPLETED|Overall Study||14
105772|NCT01963143|258486|P2|COMPLETED|Overall Study||18
105773|NCT01963143|258487|P1|COMPLETED|Overall Study||14
105774|NCT01963143|258485|P3|STARTED|Overall Study||15
105775|NCT01963143|258486|P2|STARTED|Overall Study||19
105776|NCT01963143|258487|P1|STARTED|Overall Study||14
105777|NCT01963091|258499|P2|NOT COMPLETED|Overall Study||0
105778|NCT01963091|258500|P1|NOT COMPLETED|Overall Study||0
105779|NCT01963091|258499|P2|COMPLETED|Overall Study||16
105780|NCT01963091|258500|P1|COMPLETED|Overall Study||17
105781|NCT01963091|258499|P2|STARTED|Overall Study||16
105782|NCT01963091|258500|P1|STARTED|Overall Study||17
105783|NCT01963078|258514|P4|NOT COMPLETED|Overall Study||2
105784|NCT01963078|258515|P3|NOT COMPLETED|Overall Study||1
105785|NCT01963078|258516|P2|NOT COMPLETED|Overall Study||1
105786|NCT01963078|258517|P1|NOT COMPLETED|Overall Study||1
105787|NCT01963078|258514|P4|COMPLETED|Overall Study||7
105788|NCT01963078|258515|P3|COMPLETED|Overall Study||9
105789|NCT01963078|258516|P2|COMPLETED|Overall Study||9
105790|NCT01963078|258517|P1|COMPLETED|Overall Study||8
105791|NCT01963078|258514|P4|STARTED|Overall Study||9
105792|NCT01963078|258515|P3|STARTED|Overall Study||10
105793|NCT01963078|258516|P2|STARTED|Overall Study||10
105794|NCT01963078|258517|P1|STARTED|Overall Study||9
105795|NCT01962974|258527|P1|NOT COMPLETED|Overall Study||7
105796|NCT01962974|258527|P1|COMPLETED|Overall Study||0
105797|NCT01962974|258527|P1|STARTED|Overall Study||7
105798|NCT01962961|258536|P3|NOT COMPLETED|Overall Study||1
105799|NCT01962961|258537|P2|NOT COMPLETED|Overall Study||1
105800|NCT01962961|258538|P1|NOT COMPLETED|Overall Study||0
105801|NCT01962961|258536|P3|COMPLETED|Overall Study||6
105802|NCT01962961|258537|P2|COMPLETED|Overall Study||7
105803|NCT01962961|258538|P1|COMPLETED|Overall Study||9
105804|NCT01962961|258536|P3|STARTED|Overall Study||7
105805|NCT01962961|258537|P2|STARTED|Overall Study||8
105806|NCT01962961|258538|P1|STARTED|Overall Study||9
105807|NCT01962922|258554|P2|NOT COMPLETED|Extendion Portion (up to Month 6)||3
105808|NCT01962922|258555|P1|NOT COMPLETED|Extendion Portion (up to Month 6)||5
105809|NCT01962922|258554|P2|COMPLETED|Extendion Portion (up to Month 6)||20
105810|NCT01962922|258555|P1|COMPLETED|Extendion Portion (up to Month 6)||18
105811|NCT01962922|258554|P2|STARTED|Extendion Portion (up to Month 6)||23
105812|NCT01962922|258555|P1|STARTED|Extendion Portion (up to Month 6)||23
105813|NCT01962922|258554|P2|NOT COMPLETED|PK Portion Day 21||0
105814|NCT01962922|258555|P1|NOT COMPLETED|PK Portion Day 21||0
105815|NCT01962922|258554|P2|COMPLETED|PK Portion Day 21||23
105816|NCT01962922|258555|P1|COMPLETED|PK Portion Day 21||23
105817|NCT01962922|258554|P2|STARTED|PK Portion Day 21||23
105818|NCT01962922|258555|P1|STARTED|PK Portion Day 21||23
105819|NCT01962922|258554|P2|NOT COMPLETED|PK Portion Day 14||0
105820|NCT01962922|258555|P1|NOT COMPLETED|PK Portion Day 14||0
105821|NCT01962922|258554|P2|COMPLETED|PK Portion Day 14||23
105822|NCT01962922|258555|P1|COMPLETED|PK Portion Day 14||23
105823|NCT01962922|258554|P2|STARTED|PK Portion Day 14||23
105824|NCT01962922|258555|P1|STARTED|PK Portion Day 14||23
105825|NCT01962922|258554|P2|NOT COMPLETED|PK Portion Day 7||0
105826|NCT01962922|258555|P1|NOT COMPLETED|PK Portion Day 7||4
105827|NCT01962922|258554|P2|COMPLETED|PK Portion Day 7||23
105828|NCT01962922|258555|P1|COMPLETED|PK Portion Day 7||23
105829|NCT01962922|258554|P2|STARTED|PK Portion Day 7||23
105830|NCT01962922|258555|P1|STARTED|PK Portion Day 7||27
105831|NCT01962896|258577|P1|NOT COMPLETED|Overall Study||4
105832|NCT01962896|258577|P1|COMPLETED|Overall Study||0
105833|NCT01962896|258577|P1|STARTED|Overall Study||4
105834|NCT01962870|258586|P2|NOT COMPLETED|Overall Study||0
105835|NCT01962870|258587|P1|NOT COMPLETED|Overall Study||0
105836|NCT01962870|258586|P2|COMPLETED|Overall Study||17
105837|NCT01962870|258587|P1|COMPLETED|Overall Study||13
105838|NCT01962870|258586|P2|STARTED|Overall Study||17
105839|NCT01962870|258587|P1|STARTED|Overall Study||13
105840|NCT01962688|258635|P2|NOT COMPLETED|Overall Study||0
105841|NCT01962688|258636|P1|NOT COMPLETED|Overall Study||0
105842|NCT01962688|258635|P2|COMPLETED|Overall Study||18
105843|NCT01962688|258636|P1|COMPLETED|Overall Study||19
105844|NCT01962688|258635|P2|STARTED|Overall Study||18
105845|NCT01962688|258636|P1|STARTED|Overall Study||19
105846|NCT01962675|258654|P2|NOT COMPLETED|Overall Study||0
105847|NCT01962675|258655|P1|NOT COMPLETED|Overall Study||0
105848|NCT01962675|258654|P2|COMPLETED|Overall Study||7
105849|NCT01962675|258655|P1|COMPLETED|Overall Study||7
105850|NCT01962675|258654|P2|STARTED|Overall Study||7
105851|NCT01962675|258655|P1|STARTED|Overall Study||7
105852|NCT01962558|258669|P2|NOT COMPLETED|Overall Study||0
105853|NCT01962558|258670|P1|NOT COMPLETED|Overall Study||0
105854|NCT01962558|258669|P2|COMPLETED|Overall Study||14
105855|NCT01962558|258670|P1|COMPLETED|Overall Study||16
105856|NCT01962558|258669|P2|12-Weeks|Overall Study||14
105857|NCT01962558|258670|P1|12-Weeks|Overall Study||16
105858|NCT01962558|258669|P2|Acute Study|Overall Study||14
105859|NCT01962558|258670|P1|Acute Study|Overall Study||16
105860|NCT01962558|258669|P2|STARTED|Overall Study||14
105861|NCT01962558|258670|P1|STARTED|Overall Study||16
105862|NCT01962493|258688|P2|NOT COMPLETED|Overall Study||5
105863|NCT01962493|258689|P1|NOT COMPLETED|Overall Study||5
105864|NCT01962493|258688|P2|COMPLETED|Overall Study||77
105865|NCT01962493|258689|P1|COMPLETED|Overall Study||73
105866|NCT01962493|258688|P2|STARTED|Overall Study||82
105867|NCT01962493|258689|P1|STARTED|Overall Study||78
105868|NCT01962441|258712|P3|NOT COMPLETED|Retreatment Substudy||0
105869|NCT01962441|258713|P2|NOT COMPLETED|Retreatment Substudy||0
105870|NCT01962441|258714|P1|NOT COMPLETED|Retreatment Substudy||2
105871|NCT01962441|258712|P3|COMPLETED|Retreatment Substudy||0
105872|NCT01962441|258713|P2|COMPLETED|Retreatment Substudy||10
105873|NCT01962441|258714|P1|COMPLETED|Retreatment Substudy||18
105874|NCT01962441|258712|P3|STARTED|Retreatment Substudy|Participants in the SOF+RBV+Peg-IFN group were not eligible to enroll in the Retreatment Substudy.|0
105875|NCT01962441|258713|P2|STARTED|Retreatment Substudy|10 participants who experienced virologic failure enrolled into the Retreatment Substudy.|10
105876|NCT01962441|258714|P1|STARTED|Retreatment Substudy|20 participants who experienced virologic failure enrolled into the Retreatment Substudy.|20
105877|NCT01962441|258712|P3|NOT COMPLETED|Randomized Period||11
105878|NCT01962441|258713|P2|NOT COMPLETED|Randomized Period||11
105879|NCT01962441|258714|P1|NOT COMPLETED|Randomized Period||10
105880|NCT01962441|258712|P3|COMPLETED|Randomized Period||189
105881|NCT01962441|258713|P2|COMPLETED|Randomized Period||190
105882|NCT01962441|258714|P1|COMPLETED|Randomized Period||190
105883|NCT01962441|258712|P3|STARTED|Randomized Period||200
105884|NCT01962441|258713|P2|STARTED|Randomized Period||201
105885|NCT01962441|258714|P1|STARTED|Randomized Period||200
105886|NCT01962428|258746|P2|NOT COMPLETED|Overall Study||6
105887|NCT01962428|258747|P1|NOT COMPLETED|Overall Study||10
105888|NCT01962428|258746|P2|COMPLETED|Overall Study||133
105889|NCT01962428|258747|P1|COMPLETED|Overall Study||129
105890|NCT01962428|258746|P2|STARTED|Overall Study||139
105891|NCT01962428|258747|P1|STARTED|Overall Study||139
105892|NCT01962298|258758|P5|NOT COMPLETED|Overall Study||6
105893|NCT01962298|258759|P4|NOT COMPLETED|Overall Study||2
105894|NCT01962298|258760|P3|NOT COMPLETED|Overall Study||5
105895|NCT01962298|258761|P2|NOT COMPLETED|Overall Study||4
105896|NCT01962298|258762|P1|NOT COMPLETED|Overall Study||3
105897|NCT01962298|258758|P5|COMPLETED|Overall Study||9
105898|NCT01962298|258759|P4|COMPLETED|Overall Study||13
105899|NCT01962298|258760|P3|COMPLETED|Overall Study||10
105900|NCT01962298|258761|P2|COMPLETED|Overall Study||11
105901|NCT01962298|258762|P1|COMPLETED|Overall Study||12
105902|NCT01962298|258758|P5|Received Intervention|Overall Study||15
105903|NCT01962298|258759|P4|Received Intervention|Overall Study||15
105904|NCT01962298|258760|P3|Received Intervention|Overall Study||15
105905|NCT01962298|258761|P2|Received Intervention|Overall Study||15
105906|NCT01962298|258762|P1|Received Intervention|Overall Study|1 subject did not receive the planned intervention and received a different one for clinical reasons|14
105907|NCT01962298|258758|P5|STARTED|Overall Study||15
105908|NCT01962298|258759|P4|STARTED|Overall Study||15
105909|NCT01962298|258760|P3|STARTED|Overall Study||15
105910|NCT01962298|258761|P2|STARTED|Overall Study||15
105911|NCT01962298|258762|P1|STARTED|Overall Study||15
105912|NCT01962207|258783|P4|NOT COMPLETED|Booster Phase (6 Months)||0
105913|NCT01962207|258784|P3|NOT COMPLETED|Booster Phase (6 Months)||0
105914|NCT01962207|258785|P2|NOT COMPLETED|Booster Phase (6 Months)||0
105915|NCT01962207|258786|P1|NOT COMPLETED|Booster Phase (6 Months)||0
105916|NCT01962207|258783|P4|COMPLETED|Booster Phase (6 Months)||21
105917|NCT01962207|258784|P3|COMPLETED|Booster Phase (6 Months)||77
105918|NCT01962207|258785|P2|COMPLETED|Booster Phase (6 Months)||16
105919|NCT01962207|258786|P1|COMPLETED|Booster Phase (6 Months)||67
105920|NCT01962207|258783|P4|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|21
105921|NCT01962207|258784|P3|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|77
105922|NCT01962207|258785|P2|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|16
105923|NCT01962207|258786|P1|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|67
105924|NCT01962207|258783|P4|NOT COMPLETED|Persistence Phase (5 Years)||12
105925|NCT01962207|258784|P3|NOT COMPLETED|Persistence Phase (5 Years)||44
105926|NCT01962207|258785|P2|NOT COMPLETED|Persistence Phase (5 Years)||13
105927|NCT01962207|258786|P1|NOT COMPLETED|Persistence Phase (5 Years)||29
105928|NCT01962207|258783|P4|COMPLETED|Persistence Phase (5 Years)||17
105929|NCT01962207|258784|P3|COMPLETED|Persistence Phase (5 Years)||71
105930|NCT01962207|258785|P2|COMPLETED|Persistence Phase (5 Years)||10
105931|NCT01962207|258786|P1|COMPLETED|Persistence Phase (5 Years)||47
105932|NCT01962207|258783|P4|STARTED|Persistence Phase (5 Years)||29
105933|NCT01962207|258784|P3|STARTED|Persistence Phase (5 Years)||115
105934|NCT01962207|258785|P2|STARTED|Persistence Phase (5 Years)||23
105935|NCT01962207|258786|P1|STARTED|Persistence Phase (5 Years)||76
105936|NCT01962103|258897|P9|NOT COMPLETED|Phase 2||14
105937|NCT01962103|258898|P8|NOT COMPLETED|Phase 2||14
105938|NCT01962103|258899|P7|NOT COMPLETED|Phase 2||14
105939|NCT01962103|258900|P6|NOT COMPLETED|Phase 2||0
105940|NCT01962103|258901|P5|NOT COMPLETED|Phase 2||0
105941|NCT01962103|258902|P4|NOT COMPLETED|Phase 2||0
105942|NCT01962103|258903|P3|NOT COMPLETED|Phase 2||0
105943|NCT01962103|258904|P2|NOT COMPLETED|Phase 2||0
105944|NCT01962103|258905|P1|NOT COMPLETED|Phase 2||0
105945|NCT01962103|258897|P9|COMPLETED|Phase 2|completed treatment|0
105946|NCT01962103|258898|P8|COMPLETED|Phase 2|completed treatment|0
105947|NCT01962103|258899|P7|COMPLETED|Phase 2|completed treatment|0
105948|NCT01962103|258900|P6|COMPLETED|Phase 2||0
105949|NCT01962103|258901|P5|COMPLETED|Phase 2||0
105950|NCT01962103|258902|P4|COMPLETED|Phase 2||0
105951|NCT01962103|258903|P3|COMPLETED|Phase 2||0
105952|NCT01962103|258904|P2|COMPLETED|Phase 2||0
105953|NCT01962103|258905|P1|COMPLETED|Phase 2||0
105954|NCT01962103|258897|P9|STARTED|Phase 2||14
105955|NCT01962103|258898|P8|STARTED|Phase 2||14
105956|NCT01962103|258899|P7|STARTED|Phase 2||14
105957|NCT01962103|258900|P6|STARTED|Phase 2||0
105958|NCT01962103|258901|P5|STARTED|Phase 2||0
105959|NCT01962103|258902|P4|STARTED|Phase 2||0
105960|NCT01962103|258903|P3|STARTED|Phase 2||0
105961|NCT01962103|258904|P2|STARTED|Phase 2||0
105962|NCT01962103|258905|P1|STARTED|Phase 2||0
105963|NCT01962103|258897|P9|NOT COMPLETED|Phase 1||0
105964|NCT01962103|258898|P8|NOT COMPLETED|Phase 1||0
105965|NCT01962103|258899|P7|NOT COMPLETED|Phase 1||0
105966|NCT01962103|258900|P6|NOT COMPLETED|Phase 1||7
105967|NCT01962103|258901|P5|NOT COMPLETED|Phase 1||8
105968|NCT01962103|258902|P4|NOT COMPLETED|Phase 1||11
105969|NCT01962103|258903|P3|NOT COMPLETED|Phase 1||14
105970|NCT01962103|258904|P2|NOT COMPLETED|Phase 1||8
105971|NCT01962103|258905|P1|NOT COMPLETED|Phase 1||16
105972|NCT01962103|258897|P9|COMPLETED|Phase 1||0
105973|NCT01962103|258898|P8|COMPLETED|Phase 1||0
105974|NCT01962103|258899|P7|COMPLETED|Phase 1||0
105975|NCT01962103|258900|P6|COMPLETED|Phase 1||0
105976|NCT01962103|258901|P5|COMPLETED|Phase 1||0
105977|NCT01962103|258902|P4|COMPLETED|Phase 1||0
105978|NCT01962103|258903|P3|COMPLETED|Phase 1||0
105979|NCT01962103|258904|P2|COMPLETED|Phase 1||0
105980|NCT01962103|258905|P1|COMPLETED|Phase 1||0
105981|NCT01962103|258897|P9|STARTED|Phase 1||0
105982|NCT01962103|258898|P8|STARTED|Phase 1||0
105983|NCT01962103|258899|P7|STARTED|Phase 1||0
105984|NCT01962103|258900|P6|STARTED|Phase 1||7
105985|NCT01962103|258901|P5|STARTED|Phase 1||8
105986|NCT01962103|258902|P4|STARTED|Phase 1||11
105987|NCT01962103|258903|P3|STARTED|Phase 1||14
105988|NCT01962103|258904|P2|STARTED|Phase 1||8
105989|NCT01962103|258905|P1|STARTED|Phase 1||16
105990|NCT01961921|259005|P1|NOT COMPLETED|Overall Study||2
105991|NCT01961921|259005|P1|COMPLETED|Overall Study||25
105992|NCT01961921|259005|P1|STARTED|Overall Study||27
105993|NCT01961609|259017|P4|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||7
105994|NCT01961609|259018|P3|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||4
105995|NCT01961609|259019|P2|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||6
105996|NCT01961609|259020|P1|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||12
105997|NCT01961609|259017|P4|COMPLETED|Maintanence 2 (Weeks 49 - 72)||17
105998|NCT01961609|259018|P3|COMPLETED|Maintanence 2 (Weeks 49 - 72)||12
105999|NCT01961609|259019|P2|COMPLETED|Maintanence 2 (Weeks 49 - 72)||25
106000|NCT01961609|259020|P1|COMPLETED|Maintanence 2 (Weeks 49 - 72)||71
106001|NCT01961609|259017|P4|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||24
106002|NCT01961609|259018|P3|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||16
106003|NCT01961609|259019|P2|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||31
106004|NCT01961609|259020|P1|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||83
106005|NCT01961609|259017|P4|Safety Set|Maintanence 2 (Weeks 49 - 72)||24
106006|NCT01961609|259018|P3|Safety Set|Maintanence 2 (Weeks 49 - 72)||16
106007|NCT01961609|259019|P2|Safety Set|Maintanence 2 (Weeks 49 - 72)||31
106008|NCT01961609|259020|P1|Safety Set|Maintanence 2 (Weeks 49 - 72)||83
106009|NCT01961609|259017|P4|STARTED|Maintanence 2 (Weeks 49 - 72)||24
106010|NCT01961609|259018|P3|STARTED|Maintanence 2 (Weeks 49 - 72)||16
106011|NCT01961609|259019|P2|STARTED|Maintanence 2 (Weeks 49 - 72)||31
106012|NCT01961609|259020|P1|STARTED|Maintanence 2 (Weeks 49 - 72)||83
106013|NCT01961609|259017|P4|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||0
106014|NCT01961609|259018|P3|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||19
106015|NCT01961609|259019|P2|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||11
106016|NCT01961609|259020|P1|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||23
106017|NCT01961609|259017|P4|COMPLETED|Maintenance 1 (Weeks 17 - 48)||0
106018|NCT01961609|259018|P3|COMPLETED|Maintenance 1 (Weeks 17 - 48)||18
106019|NCT01961609|259019|P2|COMPLETED|Maintenance 1 (Weeks 17 - 48)||55
106020|NCT01961609|259020|P1|COMPLETED|Maintenance 1 (Weeks 17 - 48)||84
106021|NCT01961609|259017|P4|Safety Set|Maintenance 1 (Weeks 17 - 48)||0
106022|NCT01961609|259018|P3|Safety Set|Maintenance 1 (Weeks 17 - 48)||37
106023|NCT01961609|259019|P2|Safety Set|Maintenance 1 (Weeks 17 - 48)||66
106024|NCT01961609|259020|P1|Safety Set|Maintenance 1 (Weeks 17 - 48)||107
106025|NCT01961609|259017|P4|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||0
106026|NCT01961609|259018|P3|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||37
106027|NCT01961609|259019|P2|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||66
106028|NCT01961609|259020|P1|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||107
106029|NCT01961609|259017|P4|STARTED|Maintenance 1 (Weeks 17 - 48)||0
106030|NCT01961609|259018|P3|STARTED|Maintenance 1 (Weeks 17 - 48)||37
106031|NCT01961609|259019|P2|STARTED|Maintenance 1 (Weeks 17 - 48)||66
106032|NCT01961609|259020|P1|STARTED|Maintenance 1 (Weeks 17 - 48)||107
106033|NCT01961609|259017|P4|NOT COMPLETED|Initiation||0
106034|NCT01961609|259018|P3|NOT COMPLETED|Initiation||0
106035|NCT01961609|259019|P2|NOT COMPLETED|Initiation||13
106036|NCT01961609|259020|P1|NOT COMPLETED|Initiation||12
106037|NCT01961609|259017|P4|COMPLETED|Initiation||0
106038|NCT01961609|259018|P3|COMPLETED|Initiation||0
106039|NCT01961609|259019|P2|COMPLETED|Initiation||103
106040|NCT01961609|259020|P1|COMPLETED|Initiation||107
106041|NCT01961609|259017|P4|Full Analysis Set|Initiation||0
106042|NCT01961609|259018|P3|Full Analysis Set|Initiation||0
106043|NCT01961609|259019|P2|Full Analysis Set|Initiation||115
106044|NCT01961609|259020|P1|Full Analysis Set|Initiation||118
106045|NCT01961609|259017|P4|Safety Set|Initiation||0
106046|NCT01961609|259018|P3|Safety Set|Initiation||0
106047|NCT01961609|259019|P2|Safety Set|Initiation||115
106048|NCT01961609|259020|P1|Safety Set|Initiation||118
106049|NCT01961609|259017|P4|STARTED|Initiation||0
106050|NCT01961609|259018|P3|STARTED|Initiation||0
106051|NCT01961609|259019|P2|STARTED|Initiation||116
106052|NCT01961609|259020|P1|STARTED|Initiation||119
106053|NCT01961544|259072|P1|NOT COMPLETED|Overall Study||13
106054|NCT01961544|259072|P1|COMPLETED|Overall Study||88
106055|NCT01961544|259072|P1|STARTED|Overall Study||101
106056|NCT01961349|259080|P3|NOT COMPLETED|Overall Study||2
106057|NCT01961349|259081|P2|NOT COMPLETED|Overall Study||6
106058|NCT01961349|259082|P1|NOT COMPLETED|Overall Study||3
106059|NCT01961349|259080|P3|COMPLETED|Overall Study||109
106060|NCT01961349|259081|P2|COMPLETED|Overall Study||101
106061|NCT01961349|259082|P1|COMPLETED|Overall Study||51
106062|NCT01961349|259080|P3|STARTED|Overall Study||111
106063|NCT01961349|259081|P2|STARTED|Overall Study||107
106064|NCT01961349|259082|P1|STARTED|Overall Study||54
106065|NCT01961323|259093|P1|NOT COMPLETED|Overall Study||49
106066|NCT01961323|259093|P1|COMPLETED|Overall Study||21
106067|NCT01961323|259093|P1|STARTED|Overall Study||70
106068|NCT01961297|259101|P2|NOT COMPLETED|Overall Study||1
106069|NCT01961297|259102|P1|NOT COMPLETED|Overall Study||2
106070|NCT01961297|259101|P2|COMPLETED|Overall Study||22
106071|NCT01961297|259102|P1|COMPLETED|Overall Study||28
106072|NCT01961297|259101|P2|STARTED|Overall Study||23
106073|NCT01961297|259102|P1|STARTED|Overall Study||30
106074|NCT01961271|259116|P1|NOT COMPLETED|Overall Study||50
106075|NCT01961271|259116|P1|COMPLETED|Overall Study||64
106076|NCT01961271|259116|P1|STARTED|Overall Study||114
106077|NCT01961167|259125|P1|NOT COMPLETED|Overall Study||0
106078|NCT01961167|259125|P1|COMPLETED|Overall Study||27
106079|NCT01961167|259125|P1|STARTED|Overall Study||27
106080|NCT01961115|259166|P3|NOT COMPLETED|Overall Study||4
106081|NCT01961115|259167|P2|NOT COMPLETED|Overall Study||0
106082|NCT01961115|259168|P1|NOT COMPLETED|Overall Study||2
106083|NCT01961115|259166|P3|COMPLETED|Overall Study||5
106084|NCT01961115|259167|P2|COMPLETED|Overall Study||0
106085|NCT01961115|259168|P1|COMPLETED|Overall Study||0
106086|NCT01961115|259166|P3|STARTED|Overall Study||9
106087|NCT01961115|259167|P2|STARTED|Overall Study||0
106088|NCT01961115|259168|P1|STARTED|Overall Study||2
106089|NCT01961089|259203|P1|NOT COMPLETED|Overall Study||0
106090|NCT01961089|259203|P1|COMPLETED|Overall Study||40
106091|NCT01961089|259203|P1|STARTED|Overall Study||40
106092|NCT01960907|259211|P2|NOT COMPLETED|Overall Study||45
106093|NCT01960907|259212|P1|NOT COMPLETED|Overall Study||36
106094|NCT01960907|259211|P2|COMPLETED|Overall Study||109
106095|NCT01960907|259212|P1|COMPLETED|Overall Study||122
106096|NCT01960907|259211|P2|STARTED|Overall Study||154
106097|NCT01960907|259212|P1|STARTED|Overall Study||158
106098|NCT01960855|259227|P5|NOT COMPLETED|Overall Study||5
106099|NCT01960855|259228|P4|NOT COMPLETED|Overall Study||4
106100|NCT01960855|259229|P3|NOT COMPLETED|Overall Study||9
106101|NCT01960855|259230|P2|NOT COMPLETED|Overall Study||4
106102|NCT01960855|259231|P1|NOT COMPLETED|Overall Study||11
106103|NCT01960855|259227|P5|COMPLETED|Overall Study||50
106104|NCT01960855|259228|P4|COMPLETED|Overall Study||51
106105|NCT01960855|259229|P3|COMPLETED|Overall Study||46
106106|NCT01960855|259230|P2|COMPLETED|Overall Study||51
106107|NCT01960855|259231|P1|COMPLETED|Overall Study||45
106108|NCT01960855|259227|P5|STARTED|Overall Study||55
106109|NCT01960855|259228|P4|STARTED|Overall Study||55
106110|NCT01960855|259229|P3|STARTED|Overall Study||55
106111|NCT01960855|259230|P2|STARTED|Overall Study||55
106112|NCT01960855|259231|P1|STARTED|Overall Study||56
106113|NCT01960842|259263|P1|NOT COMPLETED|Overall Study||3
106114|NCT01960842|259263|P1|COMPLETED|Overall Study||28
106115|NCT01960842|259263|P1|STARTED|Overall Study||31
106116|NCT01960816|259286|P1|NOT COMPLETED|Overall Study||1
106117|NCT01960816|259286|P1|COMPLETED|Overall Study||32
106118|NCT01960816|259286|P1|STARTED|Overall Study||33
106119|NCT01960790|259292|P1|NOT COMPLETED|Overall Study||11
106120|NCT01960790|259292|P1|COMPLETED|Overall Study||462
106121|NCT01960790|259292|P1|STARTED|Overall Study||473
106122|NCT01960725|259304|P2|NOT COMPLETED|Overall Study||5
106123|NCT01960725|259305|P1|NOT COMPLETED|Overall Study||6
106124|NCT01960725|259304|P2|COMPLETED|Overall Study||28
106125|NCT01960725|259305|P1|COMPLETED|Overall Study||27
106126|NCT01960725|259304|P2|Received Third Vaccine|Overall Study||32
106127|NCT01960725|259305|P1|Received Third Vaccine|Overall Study||32
106128|NCT01960725|259304|P2|Recieved Second Vaccine|Overall Study||33
106129|NCT01960725|259305|P1|Recieved Second Vaccine|Overall Study||33
106130|NCT01960725|259304|P2|Received First Vaccine|Overall Study||33
106131|NCT01960725|259305|P1|Received First Vaccine|Overall Study||33
106132|NCT01960725|259304|P2|STARTED|Overall Study||33
106133|NCT01960725|259305|P1|STARTED|Overall Study||33
106134|NCT01960530|259327|P1|NOT COMPLETED|Overall Study||0
106135|NCT01960530|259327|P1|COMPLETED|Overall Study||14
106136|NCT01960530|259327|P1|STARTED|Overall Study||14
106137|NCT01960413|259362|P2|NOT COMPLETED|Overall Study||1
106138|NCT01960413|259363|P1|NOT COMPLETED|Overall Study||4
106139|NCT01960413|259362|P2|COMPLETED|Overall Study||21
106140|NCT01960413|259363|P1|COMPLETED|Overall Study||20
106141|NCT01960413|259362|P2|STARTED|Overall Study||22
106142|NCT01960413|259363|P1|STARTED|Overall Study||24
106143|NCT01960400|259371|P2|NOT COMPLETED|Overall Study||0
106144|NCT01960400|259372|P1|NOT COMPLETED|Overall Study||0
106145|NCT01960400|259371|P2|COMPLETED|Overall Study||11
106146|NCT01960400|259372|P1|COMPLETED|Overall Study||11
106147|NCT01960400|259371|P2|STARTED|Overall Study||11
106148|NCT01960400|259372|P1|STARTED|Overall Study||11
106149|NCT01960387|259384|P1|NOT COMPLETED|Overall Study||0
106150|NCT01960387|259384|P1|COMPLETED|Overall Study||2
106151|NCT01960387|259384|P1|STARTED|Overall Study||2
106152|NCT01960348|259393|P2|NOT COMPLETED|Overall Study||22
106153|NCT01960348|259394|P1|NOT COMPLETED|Overall Study||10
106154|NCT01960348|259393|P2|COMPLETED|Overall Study||55
106155|NCT01960348|259394|P1|COMPLETED|Overall Study||138
106156|NCT01960348|259393|P2|STARTED|Overall Study||77
106157|NCT01960348|259394|P1|STARTED|Overall Study||148
106158|NCT01960296|259414|P2|NOT COMPLETED|Overall Study||3
106159|NCT01960296|259415|P1|NOT COMPLETED|Overall Study||2
106160|NCT01960296|259414|P2|COMPLETED|Overall Study||22
106161|NCT01960296|259415|P1|COMPLETED|Overall Study||21
106162|NCT01960296|259414|P2|STARTED|Overall Study||25
106163|NCT01960296|259415|P1|STARTED|Overall Study||23
106164|NCT01960140|259435|P1|NOT COMPLETED|Period 2 (Days 3-18)||2
106165|NCT01960140|259435|P1|COMPLETED|Period 2 (Days 3-18)||38
106166|NCT01960140|259435|P1|Received Simvastatin|Period 2 (Days 3-18)||38
106167|NCT01960140|259435|P1|Received At Least 1 Dose of Baricitinib|Period 2 (Days 3-18)||40
106168|NCT01960140|259435|P1|STARTED|Period 2 (Days 3-18)||40
106169|NCT01960140|259435|P1|NOT COMPLETED|Period 1 (Days 1-2)||0
106170|NCT01960140|259435|P1|COMPLETED|Period 1 (Days 1-2)||40
106171|NCT01960140|259435|P1|Received Simvastatin|Period 1 (Days 1-2)||40
106172|NCT01960140|259435|P1|STARTED|Period 1 (Days 1-2)||40
106173|NCT01960114|259446|P2|NOT COMPLETED|Overall Study||1
106174|NCT01960114|259447|P1|NOT COMPLETED|Overall Study||1
106175|NCT01960114|259446|P2|COMPLETED|Overall Study||268
106176|NCT01960114|259447|P1|COMPLETED|Overall Study||133
106177|NCT01960114|259446|P2|STARTED|Overall Study||269
106178|NCT01960114|259447|P1|STARTED|Overall Study||134
106179|NCT01959945|259465|P4|NOT COMPLETED|Overall Study||16
106180|NCT01959945|259466|P3|NOT COMPLETED|Overall Study||19
106181|NCT01959945|259467|P2|NOT COMPLETED|Overall Study||3
106182|NCT01959945|259468|P1|NOT COMPLETED|Overall Study||4
106183|NCT01959945|259465|P4|COMPLETED|Overall Study||15
106184|NCT01959945|259466|P3|COMPLETED|Overall Study||9
106185|NCT01959945|259467|P2|COMPLETED|Overall Study||75
106186|NCT01959945|259468|P1|COMPLETED|Overall Study||76
106187|NCT01959945|259465|P4|STARTED|Overall Study||31
106188|NCT01959945|259466|P3|STARTED|Overall Study||28
106189|NCT01959945|259467|P2|STARTED|Overall Study||78
106190|NCT01959945|259468|P1|STARTED|Overall Study||80
106191|NCT01959932|259493|P3|NOT COMPLETED|Overall Study||0
106192|NCT01959932|259494|P2|NOT COMPLETED|Overall Study||0
106193|NCT01959932|259495|P1|NOT COMPLETED|Overall Study||1
106194|NCT01959932|259493|P3|COMPLETED|Overall Study||39
106195|NCT01959932|259494|P2|COMPLETED|Overall Study||41
106196|NCT01959932|259495|P1|COMPLETED|Overall Study||79
106197|NCT01959932|259493|P3|STARTED|Overall Study||39
106198|NCT01959932|259494|P2|STARTED|Overall Study||41
106199|NCT01959932|259495|P1|STARTED|Overall Study||80
106200|NCT01959919|259513|P1|NOT COMPLETED|Overall Study||2
106201|NCT01959919|259513|P1|COMPLETED|Overall Study||84
106202|NCT01959919|259513|P1|STARTED|Overall Study||86
106203|NCT01959880|259527|P4|NOT COMPLETED|Overall Study||181
106204|NCT01959880|259528|P3|NOT COMPLETED|Overall Study||208
106205|NCT01959880|259529|P2|NOT COMPLETED|Overall Study||369
106206|NCT01959880|259530|P1|NOT COMPLETED|Overall Study||1132
106207|NCT01959880|259527|P4|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
106208|NCT01959880|259528|P3|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|1
106209|NCT01959880|259529|P2|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
106210|NCT01959880|259530|P1|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
106211|NCT01959880|259527|P4|STARTED|Overall Study||181
106212|NCT01959880|259528|P3|STARTED|Overall Study||209
106213|NCT01959880|259529|P2|STARTED|Overall Study||369
106214|NCT01959880|259530|P1|STARTED|Overall Study||1132
106215|NCT01959841|259555|P3|NOT COMPLETED|Overall Study||43
106216|NCT01959841|259556|P2|NOT COMPLETED|Overall Study||57
106217|NCT01959841|259557|P1|NOT COMPLETED|Overall Study||43
106218|NCT01959841|259555|P3|COMPLETED|Overall Study||206
106219|NCT01959841|259556|P2|COMPLETED|Overall Study||193
106220|NCT01959841|259557|P1|COMPLETED|Overall Study||209
106221|NCT01959841|259555|P3|Reason FAS Excluding 3|Overall Study||0
106222|NCT01959841|259556|P2|Reason FAS Excluding 3|Overall Study||1
106223|NCT01959841|259557|P1|Reason FAS Excluding 3|Overall Study||0
106224|NCT01959841|259555|P3|Reason FAS Excluding 2|Overall Study||0
106225|NCT01959841|259556|P2|Reason FAS Excluding 2|Overall Study||1
106226|NCT01959841|259557|P1|Reason FAS Excluding 2|Overall Study||0
106227|NCT01959841|259555|P3|Reason FAS Excluding 1|Overall Study||4
106228|NCT01959841|259556|P2|Reason FAS Excluding 1|Overall Study||5
106229|NCT01959841|259557|P1|Reason FAS Excluding 1|Overall Study||5
106230|NCT01959841|259555|P3|Full Analysis Set Excluded|Overall Study||4
106231|NCT01959841|259556|P2|Full Analysis Set Excluded|Overall Study||7
106232|NCT01959841|259557|P1|Full Analysis Set Excluded|Overall Study||5
106233|NCT01959841|259555|P3|Full Analysis Set Included|Overall Study||245
106234|NCT01959841|259556|P2|Full Analysis Set Included|Overall Study||243
106235|NCT01959841|259557|P1|Full Analysis Set Included|Overall Study||247
106236|NCT01959841|259555|P3|STARTED|Overall Study||249
106237|NCT01959841|259556|P2|STARTED|Overall Study||250
106238|NCT01959841|259557|P1|STARTED|Overall Study||252
106239|NCT01959685|259580|P1|NOT COMPLETED|Overall Study||0
106240|NCT01959685|259580|P1|COMPLETED|Overall Study||9
106241|NCT01959685|259580|P1|STARTED|Overall Study||9
106242|NCT01959672|259585|P1|NOT COMPLETED|Overall Study||1
106243|NCT01959672|259585|P1|COMPLETED|Overall Study||10
106244|NCT01959672|259585|P1|STARTED|Overall Study||11
106245|NCT01959607|259591|P4|NOT COMPLETED|Second Intervention (Day 3)||0
106246|NCT01959607|259592|P3|NOT COMPLETED|Second Intervention (Day 3)||0
106247|NCT01959607|259593|P2|NOT COMPLETED|Second Intervention (Day 3)||0
106248|NCT01959607|259594|P1|NOT COMPLETED|Second Intervention (Day 3)||0
106249|NCT01959607|259591|P4|COMPLETED|Second Intervention (Day 3)||9
106250|NCT01959607|259592|P3|COMPLETED|Second Intervention (Day 3)||9
106251|NCT01959607|259593|P2|COMPLETED|Second Intervention (Day 3)||21
106252|NCT01959607|259594|P1|COMPLETED|Second Intervention (Day 3)||21
106253|NCT01959607|259591|P4|STARTED|Second Intervention (Day 3)||9
106254|NCT01959607|259592|P3|STARTED|Second Intervention (Day 3)||9
106255|NCT01959607|259593|P2|STARTED|Second Intervention (Day 3)||21
106256|NCT01959607|259594|P1|STARTED|Second Intervention (Day 3)||21
106257|NCT01959607|259591|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
106258|NCT01959607|259592|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
106259|NCT01959607|259593|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
106260|NCT01959607|259594|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
106261|NCT01959607|259591|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
106262|NCT01959607|259592|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
106263|NCT01959607|259593|P2|COMPLETED|Washout Period of 1 Day (Day 2)||21
106264|NCT01959607|259594|P1|COMPLETED|Washout Period of 1 Day (Day 2)||21
106265|NCT01959607|259591|P4|STARTED|Washout Period of 1 Day (Day 2)||9
106266|NCT01959607|259592|P3|STARTED|Washout Period of 1 Day (Day 2)||9
106267|NCT01959607|259593|P2|STARTED|Washout Period of 1 Day (Day 2)||21
106268|NCT01959607|259594|P1|STARTED|Washout Period of 1 Day (Day 2)||21
106269|NCT01959607|259591|P4|NOT COMPLETED|First Intervention (Day 1)||0
106270|NCT01959607|259592|P3|NOT COMPLETED|First Intervention (Day 1)||0
106271|NCT01959607|259593|P2|NOT COMPLETED|First Intervention (Day 1)||1
106272|NCT01959607|259594|P1|NOT COMPLETED|First Intervention (Day 1)||1
106273|NCT01959607|259591|P4|COMPLETED|First Intervention (Day 1)||9
106274|NCT01959607|259592|P3|COMPLETED|First Intervention (Day 1)||9
106275|NCT01959607|259593|P2|COMPLETED|First Intervention (Day 1)||21
106276|NCT01959607|259594|P1|COMPLETED|First Intervention (Day 1)||21
106277|NCT01959607|259591|P4|STARTED|First Intervention (Day 1)||9
106278|NCT01959607|259592|P3|STARTED|First Intervention (Day 1)||9
106279|NCT01959607|259593|P2|STARTED|First Intervention (Day 1)||22
106280|NCT01959607|259594|P1|STARTED|First Intervention (Day 1)||22
106281|NCT01959607|259591|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
106282|NCT01959607|259592|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
106283|NCT01959607|259593|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
106284|NCT01959607|259594|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
106285|NCT01959607|259591|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
106286|NCT01959607|259592|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
106287|NCT01959607|259593|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
106288|NCT01959607|259594|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
106289|NCT01959607|259591|P4|STARTED|Washout Period of 1 Day (Day 0)||9
106290|NCT01959607|259592|P3|STARTED|Washout Period of 1 Day (Day 0)||9
106291|NCT01959607|259593|P2|STARTED|Washout Period of 1 Day (Day 0)||22
106292|NCT01959607|259594|P1|STARTED|Washout Period of 1 Day (Day 0)||22
106293|NCT01959581|259607|P1|NOT COMPLETED|Overall Study||5
106294|NCT01959581|259607|P1|COMPLETED|Overall Study||25
106295|NCT01959581|259607|P1|STARTED|Overall Study||30
106296|NCT01959529|259613|P2|NOT COMPLETED|Overall Study||72
106297|NCT01959529|259614|P1|NOT COMPLETED|Overall Study||76
106298|NCT01959529|259613|P2|COMPLETED|Overall Study||3747
106299|NCT01959529|259614|P1|COMPLETED|Overall Study||3742
106300|NCT01959529|259613|P2|Exposed|Overall Study||3806
106301|NCT01959529|259614|P1|Exposed|Overall Study||3809
106302|NCT01959529|259613|P2|STARTED|Overall Study||3819
106303|NCT01959529|259614|P1|STARTED|Overall Study||3818
106304|NCT01959516|259626|P2|NOT COMPLETED|Epoch 2||1
106305|NCT01959516|259627|P1|NOT COMPLETED|Epoch 2||2
106306|NCT01959516|259626|P2|COMPLETED|Epoch 2||62
106307|NCT01959516|259627|P1|COMPLETED|Epoch 2||61
106308|NCT01959516|259626|P2|STARTED|Epoch 2||63
106309|NCT01959516|259627|P1|STARTED|Epoch 2||63
106310|NCT01959516|259626|P2|NOT COMPLETED|Epoch 1||5
106311|NCT01959516|259627|P1|NOT COMPLETED|Epoch 1||10
106312|NCT01959516|259626|P2|COMPLETED|Epoch 1||58
106313|NCT01959516|259627|P1|COMPLETED|Epoch 1||53
106314|NCT01959516|259626|P2|ITT Population|Epoch 1||62
106315|NCT01959516|259627|P1|ITT Population|Epoch 1||62
106316|NCT01959516|259626|P2|Safety Population|Epoch 1||62
106317|NCT01959516|259627|P1|Safety Population|Epoch 1||62
106318|NCT01959516|259626|P2|STARTED|Epoch 1||63
106319|NCT01959516|259627|P1|STARTED|Epoch 1||63
106320|NCT01959503|259637|P2|NOT COMPLETED|Overall Study||2
106321|NCT01959503|259638|P1|NOT COMPLETED|Overall Study||3
106322|NCT01959503|259637|P2|COMPLETED|Overall Study||49
106323|NCT01959503|259638|P1|COMPLETED|Overall Study||104
106324|NCT01959503|259637|P2|STARTED|Overall Study||51
106325|NCT01959503|259638|P1|STARTED|Overall Study||107
106326|NCT01959490|259661|P3|NOT COMPLETED|Overall Study||0
106327|NCT01959490|259662|P2|NOT COMPLETED|Overall Study||0
106328|NCT01959490|259663|P1|NOT COMPLETED|Overall Study||0
106329|NCT01959490|259661|P3|COMPLETED|Overall Study||5
106330|NCT01959490|259662|P2|COMPLETED|Overall Study||6
106331|NCT01959490|259663|P1|COMPLETED|Overall Study||5
106332|NCT01959490|259661|P3|STARTED|Overall Study||5
106333|NCT01959490|259662|P2|STARTED|Overall Study||6
106334|NCT01959490|259663|P1|STARTED|Overall Study||5
106335|NCT01959412|259689|P6|NOT COMPLETED|Overall Study||0
106336|NCT01959412|259690|P5|NOT COMPLETED|Overall Study||3
106337|NCT01959412|259691|P4|NOT COMPLETED|Overall Study||2
106338|NCT01959412|259692|P3|NOT COMPLETED|Overall Study||0
106339|NCT01959412|259693|P2|NOT COMPLETED|Overall Study||1
106340|NCT01959412|259694|P1|NOT COMPLETED|Overall Study||1
106341|NCT01959412|259689|P6|COMPLETED|Overall Study||15
106342|NCT01959412|259690|P5|COMPLETED|Overall Study||13
106343|NCT01959412|259691|P4|COMPLETED|Overall Study||13
106344|NCT01959412|259692|P3|COMPLETED|Overall Study||15
106345|NCT01959412|259693|P2|COMPLETED|Overall Study||14
106346|NCT01959412|259694|P1|COMPLETED|Overall Study||14
106347|NCT01959412|259689|P6|STARTED|Overall Study||15
106348|NCT01959412|259690|P5|STARTED|Overall Study||16
106349|NCT01959412|259691|P4|STARTED|Overall Study||15
106350|NCT01959412|259692|P3|STARTED|Overall Study||15
106351|NCT01959412|259693|P2|STARTED|Overall Study||15
106352|NCT01959412|259694|P1|STARTED|Overall Study||15
106353|NCT01959334|259734|P2|NOT COMPLETED|Third Dose||1
106354|NCT01959334|259735|P1|NOT COMPLETED|Third Dose||0
106355|NCT01959334|259734|P2|COMPLETED|Third Dose||48
106356|NCT01959334|259735|P1|COMPLETED|Third Dose||25
106357|NCT01959334|259734|P2|STARTED|Third Dose||49
106358|NCT01959334|259735|P1|STARTED|Third Dose||25
106359|NCT01959334|259734|P2|NOT COMPLETED|Second Dose||0
106360|NCT01959334|259735|P1|NOT COMPLETED|Second Dose||1
106361|NCT01959334|259734|P2|COMPLETED|Second Dose||49
106362|NCT01959334|259735|P1|COMPLETED|Second Dose||25
106363|NCT01959334|259734|P2|STARTED|Second Dose||49
106364|NCT01959334|259735|P1|STARTED|Second Dose||26
106365|NCT01959334|259734|P2|NOT COMPLETED|First Dose||0
106366|NCT01959334|259735|P1|NOT COMPLETED|First Dose||0
106367|NCT01959334|259734|P2|COMPLETED|First Dose|Each Dosing Period is separated by at least 7 calendar days.|49
106368|NCT01959334|259735|P1|COMPLETED|First Dose|Each Dosing Period separated by at least 7 calendar days.|26
106369|NCT01959334|259734|P2|STARTED|First Dose||49
106370|NCT01959334|259735|P1|STARTED|First Dose||26
106371|NCT01959243|259747|P2|NOT COMPLETED|Overall Study||4
106372|NCT01959243|259748|P1|NOT COMPLETED|Overall Study||13
106373|NCT01959243|259747|P2|COMPLETED|Overall Study||166
106374|NCT01959243|259748|P1|COMPLETED|Overall Study||324
106375|NCT01959243|259747|P2|Received at Least 1 Dose of Study Drug|Overall Study||170
106376|NCT01959243|259748|P1|Received at Least 1 Dose of Study Drug|Overall Study||337
106377|NCT01959243|259747|P2|STARTED|Overall Study||170
106378|NCT01959243|259748|P1|STARTED|Overall Study||337
106379|NCT01959230|259760|P2|NOT COMPLETED|Overall Study||1
106380|NCT01959230|259761|P1|NOT COMPLETED|Overall Study||4
106381|NCT01959230|259760|P2|COMPLETED|Overall Study||19
106382|NCT01959230|259761|P1|COMPLETED|Overall Study||36
106383|NCT01959230|259760|P2|Received at Least 1 Dose of Study Drug|Overall Study||20
106384|NCT01959230|259761|P1|Received at Least 1 Dose of Study Drug|Overall Study||40
106385|NCT01959230|259760|P2|STARTED|Overall Study||20
106386|NCT01959230|259761|P1|STARTED|Overall Study||40
106387|NCT01959165|259775|P4|NOT COMPLETED|Overall Study||2
106388|NCT01959165|259776|P3|NOT COMPLETED|Overall Study||0
106389|NCT01959165|259777|P2|NOT COMPLETED|Overall Study||1
106390|NCT01959165|259778|P1|NOT COMPLETED|Overall Study||1
106391|NCT01959165|259775|P4|COMPLETED|Overall Study||7
106392|NCT01959165|259776|P3|COMPLETED|Overall Study||12
106393|NCT01959165|259777|P2|COMPLETED|Overall Study||10
106394|NCT01959165|259778|P1|COMPLETED|Overall Study||12
106395|NCT01959165|259775|P4|STARTED|Overall Study||9
106396|NCT01959165|259776|P3|STARTED|Overall Study||12
106397|NCT01959165|259777|P2|STARTED|Overall Study|1 patient discontinued the study without any treatment out of 11 patients.|11
106398|NCT01959165|259778|P1|STARTED|Overall Study||13
106399|NCT01959048|259800|P1|NOT COMPLETED|Overall Study||0
106400|NCT01959048|259800|P1|COMPLETED|Overall Study||3
106401|NCT01959048|259800|P1|STARTED|Overall Study||3
106402|NCT01959035|259808|P1|NOT COMPLETED|Overall Study||11
106403|NCT01959035|259808|P1|COMPLETED|Overall Study||77
106404|NCT01959035|259808|P1|STARTED|Overall Study||88
106405|NCT01958918|259836|P2|NOT COMPLETED|Overall Study||42
106406|NCT01958918|259837|P1|NOT COMPLETED|Overall Study||43
106407|NCT01958918|259836|P2|COMPLETED|Overall Study||314
106408|NCT01958918|259837|P1|COMPLETED|Overall Study||313
106409|NCT01958918|259836|P2|Full Analysis Set|Overall Study||354
106410|NCT01958918|259837|P1|Full Analysis Set|Overall Study||353
106411|NCT01958918|259836|P2|STARTED|Overall Study||356
106412|NCT01958918|259837|P1|STARTED|Overall Study||356
106413|NCT01958827|259851|P1|NOT COMPLETED|Overall Study||10
106414|NCT01958827|259851|P1|COMPLETED|Overall Study||18
106415|NCT01958827|259851|P1|STARTED|Overall Study||28
106416|NCT01958788|259869|P1|NOT COMPLETED|Overall Study||0
106417|NCT01958788|259869|P1|COMPLETED|Overall Study||7
106418|NCT01958788|259869|P1|STARTED|Overall Study||7
106419|NCT01958671|259882|P3|NOT COMPLETED|Overall Study||32
106420|NCT01958671|259883|P2|NOT COMPLETED|Overall Study||24
106421|NCT01958671|259884|P1|NOT COMPLETED|Overall Study||19
106422|NCT01958671|259882|P3|COMPLETED|Overall Study||121
106423|NCT01958671|259883|P2|COMPLETED|Overall Study||128
106424|NCT01958671|259884|P1|COMPLETED|Overall Study||137
106425|NCT01958671|259882|P3|STARTED|Overall Study||153
106426|NCT01958671|259883|P2|STARTED|Overall Study||152
106427|NCT01958671|259884|P1|STARTED|Overall Study||156
106428|NCT01958645|259928|P3|NOT COMPLETED|Overall Study||0
106429|NCT01958645|259929|P2|NOT COMPLETED|Overall Study||0
106430|NCT01958645|259930|P1|NOT COMPLETED|Overall Study||0
106431|NCT01958645|259928|P3|COMPLETED|Overall Study||4
106432|NCT01958645|259929|P2|COMPLETED|Overall Study||4
106433|NCT01958645|259930|P1|COMPLETED|Overall Study||4
106434|NCT01958645|259928|P3|STARTED|Overall Study||4
106435|NCT01958645|259929|P2|STARTED|Overall Study||4
106436|NCT01958645|259930|P1|STARTED|Overall Study||4
106437|NCT01958619|259958|P4|NOT COMPLETED|Overall Study||0
106438|NCT01958619|259959|P3|NOT COMPLETED|Overall Study||1
106439|NCT01958619|259960|P2|NOT COMPLETED|Overall Study||0
106440|NCT01958619|259961|P1|NOT COMPLETED|Overall Study||2
106441|NCT01958619|259958|P4|COMPLETED|Overall Study||12
106442|NCT01958619|259959|P3|COMPLETED|Overall Study||13
106443|NCT01958619|259960|P2|COMPLETED|Overall Study||14
106444|NCT01958619|259961|P1|COMPLETED|Overall Study||13
106445|NCT01958619|259958|P4|STARTED|Overall Study||12
106446|NCT01958619|259959|P3|STARTED|Overall Study||14
106447|NCT01958619|259960|P2|STARTED|Overall Study||14
106448|NCT01958619|259961|P1|STARTED|Overall Study||15
106449|NCT01958606|259983|P2|NOT COMPLETED|Overall Study||0
106450|NCT01958606|259984|P1|NOT COMPLETED|Overall Study||2
106451|NCT01958606|259983|P2|COMPLETED|Overall Study||5
106452|NCT01958606|259984|P1|COMPLETED|Overall Study||11
106453|NCT01958606|259983|P2|STARTED|Overall Study||5
106454|NCT01958606|259984|P1|STARTED|Overall Study||13
106455|NCT01958489|260022|P2|NOT COMPLETED|Period 2||1
106456|NCT01958489|260023|P1|NOT COMPLETED|Period 2||0
106457|NCT01958489|260022|P2|COMPLETED|Period 2||23
106458|NCT01958489|260023|P1|COMPLETED|Period 2||0
106459|NCT01958489|260022|P2|Received at Least 1 Dose of Study Drug|Period 2||24
106460|NCT01958489|260023|P1|Received at Least 1 Dose of Study Drug|Period 2||0
106461|NCT01958489|260022|P2|STARTED|Period 2|Participants who started Period 2 treatment crossed over from Period 1 treatment|24
106462|NCT01958489|260023|P1|STARTED|Period 2|Participants who completed Period 1 treatment crossed over to Period 2 treatment|0
106463|NCT01958489|260022|P2|NOT COMPLETED|Period 1||0
106464|NCT01958489|260023|P1|NOT COMPLETED|Period 1||0
106465|NCT01958489|260022|P2|COMPLETED|Period 1||0
106466|NCT01958489|260023|P1|COMPLETED|Period 1||24
106467|NCT01958489|260022|P2|Received at Least 1 Dose of Study Drug|Period 1||0
106468|NCT01958489|260023|P1|Received at Least 1 Dose of Study Drug|Period 1||24
106469|NCT01958489|260022|P2|STARTED|Period 1||0
106470|NCT01958489|260023|P1|STARTED|Period 1||24
106471|NCT01958476|260039|P2|NOT COMPLETED|Overall Study||0
106472|NCT01958476|260040|P1|NOT COMPLETED|Overall Study||1
106473|NCT01958476|260039|P2|COMPLETED|Overall Study||58
106474|NCT01958476|260040|P1|COMPLETED|Overall Study||58
106475|NCT01958476|260039|P2|STARTED|Overall Study||58
106476|NCT01958476|260040|P1|STARTED|Overall Study||59
106477|NCT01958437|260070|P4|NOT COMPLETED|Overall Study||1
106478|NCT01958437|260071|P3|NOT COMPLETED|Overall Study||1
106479|NCT01958437|260072|P2|NOT COMPLETED|Overall Study||0
106480|NCT01958437|260073|P1|NOT COMPLETED|Overall Study||0
106481|NCT01958437|260070|P4|COMPLETED|Overall Study||10
106482|NCT01958437|260071|P3|COMPLETED|Overall Study||10
106483|NCT01958437|260072|P2|COMPLETED|Overall Study||11
106484|NCT01958437|260073|P1|COMPLETED|Overall Study||11
106485|NCT01958437|260070|P4|STARTED|Overall Study||11
106486|NCT01958437|260071|P3|STARTED|Overall Study||11
106487|NCT01958437|260072|P2|STARTED|Overall Study||11
106488|NCT01958437|260073|P1|STARTED|Overall Study||11
106489|NCT01958346|260097|P2|NOT COMPLETED|Overall Study||0
106490|NCT01958346|260098|P1|NOT COMPLETED|Overall Study||0
106491|NCT01958346|260097|P2|COMPLETED|Overall Study||39
106492|NCT01958346|260098|P1|COMPLETED|Overall Study||39
106493|NCT01958346|260097|P2|STARTED|Overall Study||39
106494|NCT01958346|260098|P1|STARTED|Overall Study||39
106495|NCT01958320|260108|P2|NOT COMPLETED|Overall Study||0
106496|NCT01958320|260109|P1|NOT COMPLETED|Overall Study||0
106497|NCT01958320|260108|P2|COMPLETED|Overall Study||98
106498|NCT01958320|260109|P1|COMPLETED|Overall Study||104
106499|NCT01958320|260108|P2|STARTED|Overall Study||98
106500|NCT01958320|260109|P1|STARTED|Overall Study||104
106501|NCT01958281|260140|P3|NOT COMPLETED|Overall Study||0
106502|NCT01958281|260141|P2|NOT COMPLETED|Overall Study||4
106503|NCT01958281|260142|P1|NOT COMPLETED|Overall Study||6
106504|NCT01958281|260140|P3|COMPLETED|Overall Study||18
106505|NCT01958281|260141|P2|COMPLETED|Overall Study||6
106506|NCT01958281|260142|P1|COMPLETED|Overall Study||4
106507|NCT01958281|260140|P3|STARTED|Overall Study||18
106508|NCT01958281|260141|P2|STARTED|Overall Study||10
106509|NCT01958281|260142|P1|STARTED|Overall Study||10
106510|NCT01958164|260218|P2|NOT COMPLETED|Overall Study||5
106511|NCT01958164|260219|P1|NOT COMPLETED|Overall Study||2
106512|NCT01958164|260218|P2|COMPLETED|Overall Study||5
106513|NCT01958164|260219|P1|COMPLETED|Overall Study||4
106514|NCT01958164|260218|P2|STARTED|Overall Study|Randomised and treated|10
106515|NCT01958164|260219|P1|STARTED|Overall Study|Randomised and treated|6
106516|NCT01958125|260234|P2|NOT COMPLETED|Overall Study||8
106517|NCT01958125|260235|P1|NOT COMPLETED|Overall Study||2
106518|NCT01958125|260234|P2|COMPLETED|Overall Study||44
106519|NCT01958125|260235|P1|COMPLETED|Overall Study||48
106520|NCT01958125|260234|P2|STARTED|Overall Study||52
106521|NCT01958125|260235|P1|STARTED|Overall Study||50
106522|NCT01958112|260249|P1|NOT COMPLETED|Overall Study||0
106523|NCT01958112|260249|P1|COMPLETED|Overall Study||14
106524|NCT01958112|260249|P1|STARTED|Overall Study||14
106525|NCT01958060|260263|P6|NOT COMPLETED|Overall Study||0
106526|NCT01958060|260264|P5|NOT COMPLETED|Overall Study||1
106527|NCT01958060|260265|P4|NOT COMPLETED|Overall Study||0
106528|NCT01958060|260266|P3|NOT COMPLETED|Overall Study||0
106529|NCT01958060|260267|P2|NOT COMPLETED|Overall Study||0
106530|NCT01958060|260268|P1|NOT COMPLETED|Overall Study||2
106531|NCT01958060|260263|P6|COMPLETED|Overall Study|One subject in the 100 mg iv dose group did not receive complete dose of trial medication.|1
106532|NCT01958060|260264|P5|COMPLETED|Overall Study|One subject in the 50 mg iv dose group did not receive complete dose of trial medication.|6
106533|NCT01958060|260265|P4|COMPLETED|Overall Study||5
106534|NCT01958060|260266|P3|COMPLETED|Overall Study||6
106535|NCT01958060|260267|P2|COMPLETED|Overall Study||6
106536|NCT01958060|260268|P1|COMPLETED|Overall Study||8
106537|NCT01958060|260263|P6|STARTED|Overall Study||1
106538|NCT01958060|260264|P5|STARTED|Overall Study||7
106539|NCT01958060|260265|P4|STARTED|Overall Study||5
106540|NCT01958060|260266|P3|STARTED|Overall Study||6
106541|NCT01958060|260267|P2|STARTED|Overall Study||6
106542|NCT01958060|260268|P1|STARTED|Overall Study||10
106543|NCT01958021|260293|P2|NOT COMPLETED|Overall Study||180
106544|NCT01958021|260294|P1|NOT COMPLETED|Overall Study||139
106545|NCT01958021|260293|P2|COMPLETED|Overall Study|Completed = Treatment ongoing|154
106546|NCT01958021|260294|P1|COMPLETED|Overall Study|Completed = Treatment ongoing|195
106547|NCT01958021|260293|P2|Patients Treated|Overall Study||330
106548|NCT01958021|260294|P1|Patients Treated|Overall Study||334
106549|NCT01958021|260293|P2|Patients Untreated|Overall Study||4
106550|NCT01958021|260294|P1|Patients Untreated|Overall Study||0
106551|NCT01958021|260293|P2|STARTED|Overall Study||334
106552|NCT01958021|260294|P1|STARTED|Overall Study||334
106553|NCT01958008|260306|P4|NOT COMPLETED|Overall Study||0
106554|NCT01958008|260307|P3|NOT COMPLETED|Overall Study||1
106555|NCT01958008|260308|P2|NOT COMPLETED|Overall Study||0
106556|NCT01958008|260309|P1|NOT COMPLETED|Overall Study||1
106557|NCT01958008|260306|P4|COMPLETED|Overall Study||21
106558|NCT01958008|260307|P3|COMPLETED|Overall Study||20
106559|NCT01958008|260308|P2|COMPLETED|Overall Study||21
106560|NCT01958008|260309|P1|COMPLETED|Overall Study||20
106561|NCT01958008|260306|P4|STARTED|Overall Study||21
106562|NCT01958008|260307|P3|STARTED|Overall Study||21
106563|NCT01958008|260308|P2|STARTED|Overall Study||21
106564|NCT01958008|260309|P1|STARTED|Overall Study||21
106565|NCT01957930|260339|P2|NOT COMPLETED|Overall Study||0
106566|NCT01957930|260340|P1|NOT COMPLETED|Overall Study||0
106567|NCT01957930|260339|P2|COMPLETED|Overall Study||37
106568|NCT01957930|260340|P1|COMPLETED|Overall Study||35
106569|NCT01957930|260339|P2|STARTED|Overall Study||37
106570|NCT01957930|260340|P1|STARTED|Overall Study||35
106571|NCT01957865|260349|P3|NOT COMPLETED|Overall Study||3
106572|NCT01957865|260350|P2|NOT COMPLETED|Overall Study||2
106573|NCT01957865|260351|P1|NOT COMPLETED|Overall Study||0
106574|NCT01957865|260349|P3|COMPLETED|Overall Study||19
106575|NCT01957865|260350|P2|COMPLETED|Overall Study||18
106576|NCT01957865|260351|P1|COMPLETED|Overall Study||21
106577|NCT01957865|260349|P3|STARTED|Overall Study||22
106578|NCT01957865|260350|P2|STARTED|Overall Study||20
106579|NCT01957865|260351|P1|STARTED|Overall Study||21
106580|NCT01957787|260362|P1|NOT COMPLETED|Overall Study||36
106581|NCT01957787|260362|P1|COMPLETED|Overall Study||95
106582|NCT01957787|260362|P1|Modified ITT (mITT) Population|Overall Study||128
106583|NCT01957787|260362|P1|Intent-to-Treat (ITT) Population|Overall Study||130
106584|NCT01957787|260362|P1|STARTED|Overall Study|Participant who was withdrawn prior to study treatment was not included in Number of Index Tumors.|131
106585|NCT01957761|260377|P1|NOT COMPLETED|Overall Study||0
106586|NCT01957761|260377|P1|COMPLETED|Overall Study||189
106587|NCT01957761|260377|P1|STARTED|Overall Study||189
106588|NCT01957709|260381|P1|NOT COMPLETED|Overall Study||1
106589|NCT01957709|260381|P1|COMPLETED|Overall Study||7
106590|NCT01957709|260381|P1|STARTED|Overall Study||8
106591|NCT01957657|260387|P1|NOT COMPLETED|Overall Study||0
106592|NCT01957657|260387|P1|COMPLETED|Overall Study||4
106593|NCT01957657|260387|P1|STARTED|Overall Study||4
106594|NCT01957644|260406|P5|NOT COMPLETED|Overall Study||1
106595|NCT01957644|260407|P4|NOT COMPLETED|Overall Study||2
106596|NCT01957644|260408|P3|NOT COMPLETED|Overall Study||1
106597|NCT01957644|260409|P2|NOT COMPLETED|Overall Study||6
106598|NCT01957644|260410|P1|NOT COMPLETED|Overall Study||6
106599|NCT01957644|260406|P5|COMPLETED|Overall Study||0
106600|NCT01957644|260407|P4|COMPLETED|Overall Study||0
106601|NCT01957644|260408|P3|COMPLETED|Overall Study||0
106602|NCT01957644|260409|P2|COMPLETED|Overall Study||0
106603|NCT01957644|260410|P1|COMPLETED|Overall Study||0
106604|NCT01957644|260406|P5|STARTED|Overall Study||1
106605|NCT01957644|260407|P4|STARTED|Overall Study||2
106606|NCT01957644|260408|P3|STARTED|Overall Study||1
106607|NCT01957644|260409|P2|STARTED|Overall Study||6
106608|NCT01957644|260410|P1|STARTED|Overall Study||6
106609|NCT01957579|260434|P4|NOT COMPLETED|Overall Study||0
106610|NCT01957579|260435|P3|NOT COMPLETED|Overall Study||2
106611|NCT01957579|260436|P2|NOT COMPLETED|Overall Study||1
106612|NCT01957579|260437|P1|NOT COMPLETED|Overall Study||0
106613|NCT01957579|260434|P4|COMPLETED|Overall Study||6
106614|NCT01957579|260435|P3|COMPLETED|Overall Study||2
106615|NCT01957579|260436|P2|COMPLETED|Overall Study||6
106616|NCT01957579|260437|P1|COMPLETED|Overall Study||3
106617|NCT01957579|260434|P4|STARTED|Overall Study||6
106618|NCT01957579|260435|P3|STARTED|Overall Study||4
106619|NCT01957579|260436|P2|STARTED|Overall Study||7
106620|NCT01957579|260437|P1|STARTED|Overall Study||3
106621|NCT01957553|260504|P2|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||7
106622|NCT01957553|260505|P1|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||3
106623|NCT01957553|260504|P2|COMPLETED|Test Period 2 (21 +- 1 Days)||56
106624|NCT01957553|260505|P1|COMPLETED|Test Period 2 (21 +- 1 Days)||51
106625|NCT01957553|260504|P2|STARTED|Test Period 2 (21 +- 1 Days)||63
106626|NCT01957553|260505|P1|STARTED|Test Period 2 (21 +- 1 Days)||54
106627|NCT01957553|260504|P2|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||3
106628|NCT01957553|260505|P1|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||7
106629|NCT01957553|260504|P2|COMPLETED|Test Period 1 (21 +- 1 Days)||63
106630|NCT01957553|260505|P1|COMPLETED|Test Period 1 (21 +- 1 Days)||54
106631|NCT01957553|260504|P2|STARTED|Test Period 1 (21 +- 1 Days)||66
106632|NCT01957553|260505|P1|STARTED|Test Period 1 (21 +- 1 Days)||61
106633|NCT01957488|260511|P6|NOT COMPLETED|Test Period 3||0
106634|NCT01957488|260512|P5|NOT COMPLETED|Test Period 3||0
106635|NCT01957488|260513|P4|NOT COMPLETED|Test Period 3||0
106636|NCT01957488|260514|P3|NOT COMPLETED|Test Period 3||0
106637|NCT01957488|260515|P2|NOT COMPLETED|Test Period 3||1
106638|NCT01957488|260516|P1|NOT COMPLETED|Test Period 3||1
106639|NCT01957488|260511|P6|COMPLETED|Test Period 3||23
106640|NCT01957488|260512|P5|COMPLETED|Test Period 3||25
106641|NCT01957488|260513|P4|COMPLETED|Test Period 3||28
106642|NCT01957488|260514|P3|COMPLETED|Test Period 3||25
106643|NCT01957488|260515|P2|COMPLETED|Test Period 3||26
106644|NCT01957488|260516|P1|COMPLETED|Test Period 3||23
106645|NCT01957488|260511|P6|STARTED|Test Period 3||23
106646|NCT01957488|260512|P5|STARTED|Test Period 3||25
106647|NCT01957488|260513|P4|STARTED|Test Period 3||28
106648|NCT01957488|260514|P3|STARTED|Test Period 3||25
106649|NCT01957488|260515|P2|STARTED|Test Period 3||27
106650|NCT01957488|260516|P1|STARTED|Test Period 3||24
106651|NCT01957488|260511|P6|NOT COMPLETED|Test Period 2||1
106652|NCT01957488|260512|P5|NOT COMPLETED|Test Period 2||2
106653|NCT01957488|260513|P4|NOT COMPLETED|Test Period 2||1
106654|NCT01957488|260514|P3|NOT COMPLETED|Test Period 2||1
106655|NCT01957488|260515|P2|NOT COMPLETED|Test Period 2||1
106656|NCT01957488|260516|P1|NOT COMPLETED|Test Period 2||3
106657|NCT01957488|260511|P6|COMPLETED|Test Period 2||23
106658|NCT01957488|260512|P5|COMPLETED|Test Period 2||25
106659|NCT01957488|260513|P4|COMPLETED|Test Period 2||28
106660|NCT01957488|260514|P3|COMPLETED|Test Period 2||25
106661|NCT01957488|260515|P2|COMPLETED|Test Period 2||27
106662|NCT01957488|260516|P1|COMPLETED|Test Period 2||24
106663|NCT01957488|260511|P6|STARTED|Test Period 2||24
106664|NCT01957488|260512|P5|STARTED|Test Period 2||27
106665|NCT01957488|260513|P4|STARTED|Test Period 2||29
106666|NCT01957488|260514|P3|STARTED|Test Period 2||26
106667|NCT01957488|260515|P2|STARTED|Test Period 2||28
106668|NCT01957488|260516|P1|STARTED|Test Period 2||27
106669|NCT01957488|260511|P6|NOT COMPLETED|Test Period 1||6
106670|NCT01957488|260512|P5|NOT COMPLETED|Test Period 1||3
106671|NCT01957488|260513|P4|NOT COMPLETED|Test Period 1||3
106672|NCT01957488|260514|P3|NOT COMPLETED|Test Period 1||4
106673|NCT01957488|260515|P2|NOT COMPLETED|Test Period 1||3
106674|NCT01957488|260516|P1|NOT COMPLETED|Test Period 1||3
106675|NCT01957488|260511|P6|COMPLETED|Test Period 1||24
106676|NCT01957488|260512|P5|COMPLETED|Test Period 1||27
106677|NCT01957488|260513|P4|COMPLETED|Test Period 1||29
106678|NCT01957488|260514|P3|COMPLETED|Test Period 1||26
106679|NCT01957488|260515|P2|COMPLETED|Test Period 1||28
106680|NCT01957488|260516|P1|COMPLETED|Test Period 1||27
106681|NCT01957488|260511|P6|STARTED|Test Period 1||30
106682|NCT01957488|260512|P5|STARTED|Test Period 1||30
106683|NCT01957488|260513|P4|STARTED|Test Period 1||32
106684|NCT01957488|260514|P3|STARTED|Test Period 1||30
106685|NCT01957488|260515|P2|STARTED|Test Period 1||31
106686|NCT01957488|260516|P1|STARTED|Test Period 1||30
106687|NCT01957475|260524|P2|NOT COMPLETED|Test Period 2||0
106688|NCT01957475|260525|P1|NOT COMPLETED|Test Period 2||1
106689|NCT01957475|260524|P2|COMPLETED|Test Period 2||8
106690|NCT01957475|260525|P1|COMPLETED|Test Period 2||8
106691|NCT01957475|260524|P2|STARTED|Test Period 2||8
106692|NCT01957475|260525|P1|STARTED|Test Period 2||9
106693|NCT01957475|260524|P2|NOT COMPLETED|Test Period 1||1
106694|NCT01957475|260525|P1|NOT COMPLETED|Test Period 1||2
106695|NCT01957475|260524|P2|COMPLETED|Test Period 1||9
106696|NCT01957475|260525|P1|COMPLETED|Test Period 1||8
106697|NCT01957475|260524|P2|STARTED|Test Period 1||10
106698|NCT01957475|260525|P1|STARTED|Test Period 1||10
106699|NCT01957462|260531|P2|NOT COMPLETED|Test Period 2||0
106700|NCT01957462|260532|P1|NOT COMPLETED|Test Period 2||0
106701|NCT01957462|260531|P2|COMPLETED|Test Period 2||15
106702|NCT01957462|260532|P1|COMPLETED|Test Period 2||14
106703|NCT01957462|260531|P2|STARTED|Test Period 2||15
106704|NCT01957462|260532|P1|STARTED|Test Period 2||14
106705|NCT01957462|260531|P2|NOT COMPLETED|Test Period 1||0
106706|NCT01957462|260532|P1|NOT COMPLETED|Test Period 1||2
106707|NCT01957462|260531|P2|COMPLETED|Test Period 1||15
106708|NCT01957462|260532|P1|COMPLETED|Test Period 1||14
106709|NCT01957462|260531|P2|STARTED|Test Period 1||15
106710|NCT01957462|260532|P1|STARTED|Test Period 1||16
106711|NCT01957410|260538|P1|NOT COMPLETED|Optional Open Label||0
106712|NCT01957410|260538|P1|COMPLETED|Optional Open Label||13
106713|NCT01957410|260538|P1|STARTED|Optional Open Label||13
106714|NCT01957410|260538|P1|NOT COMPLETED|Open Label||0
106715|NCT01957410|260538|P1|COMPLETED|Open Label||13
106716|NCT01957410|260538|P1|STARTED|Open Label||13
106717|NCT01957397|260543|P2|NOT COMPLETED|Test Period 3||2
106718|NCT01957397|260544|P1|NOT COMPLETED|Test Period 3||2
106719|NCT01957397|260543|P2|COMPLETED|Test Period 3||9
106720|NCT01957397|260544|P1|COMPLETED|Test Period 3||9
106721|NCT01957397|260543|P2|STARTED|Test Period 3||11
106722|NCT01957397|260544|P1|STARTED|Test Period 3||11
106723|NCT01957397|260543|P2|NOT COMPLETED|Test Period 2||1
106724|NCT01957397|260544|P1|NOT COMPLETED|Test Period 2||0
106725|NCT01957397|260543|P2|COMPLETED|Test Period 2||11
106726|NCT01957397|260544|P1|COMPLETED|Test Period 2||11
106727|NCT01957397|260543|P2|STARTED|Test Period 2||12
106728|NCT01957397|260544|P1|STARTED|Test Period 2||11
106729|NCT01957397|260543|P2|NOT COMPLETED|Test Period 1||1
106730|NCT01957397|260544|P1|NOT COMPLETED|Test Period 1||2
106731|NCT01957397|260543|P2|COMPLETED|Test Period 1||12
106732|NCT01957397|260544|P1|COMPLETED|Test Period 1||11
106733|NCT01957397|260543|P2|STARTED|Test Period 1||13
106734|NCT01957397|260544|P1|STARTED|Test Period 1||13
106735|NCT01957397|260543|P2|NOT COMPLETED|Baseline Own Product||0
106736|NCT01957397|260544|P1|NOT COMPLETED|Baseline Own Product||0
106737|NCT01957397|260543|P2|COMPLETED|Baseline Own Product||13
106738|NCT01957397|260544|P1|COMPLETED|Baseline Own Product||13
106739|NCT01957397|260543|P2|STARTED|Baseline Own Product||13
106740|NCT01957397|260544|P1|STARTED|Baseline Own Product||13
106741|NCT01957384|260554|P6|NOT COMPLETED|Test Period 3 (14 Days)||0
106742|NCT01957384|260555|P5|NOT COMPLETED|Test Period 3 (14 Days)||0
106743|NCT01957384|260556|P4|NOT COMPLETED|Test Period 3 (14 Days)||0
106744|NCT01957384|260557|P3|NOT COMPLETED|Test Period 3 (14 Days)||0
106745|NCT01957384|260558|P2|NOT COMPLETED|Test Period 3 (14 Days)||0
106746|NCT01957384|260559|P1|NOT COMPLETED|Test Period 3 (14 Days)||0
106747|NCT01957384|260554|P6|COMPLETED|Test Period 3 (14 Days)||3
106748|NCT01957384|260555|P5|COMPLETED|Test Period 3 (14 Days)||3
106749|NCT01957384|260556|P4|COMPLETED|Test Period 3 (14 Days)||4
106750|NCT01957384|260557|P3|COMPLETED|Test Period 3 (14 Days)||4
106751|NCT01957384|260558|P2|COMPLETED|Test Period 3 (14 Days)||4
106752|NCT01957384|260559|P1|COMPLETED|Test Period 3 (14 Days)||4
106753|NCT01957384|260554|P6|STARTED|Test Period 3 (14 Days)||3
106754|NCT01957384|260555|P5|STARTED|Test Period 3 (14 Days)||3
106755|NCT01957384|260556|P4|STARTED|Test Period 3 (14 Days)||4
106756|NCT01957384|260557|P3|STARTED|Test Period 3 (14 Days)||4
106757|NCT01957384|260558|P2|STARTED|Test Period 3 (14 Days)||4
106758|NCT01957384|260559|P1|STARTED|Test Period 3 (14 Days)||4
106759|NCT01957384|260554|P6|NOT COMPLETED|Test Period 2 (14 Days)||0
106760|NCT01957384|260555|P5|NOT COMPLETED|Test Period 2 (14 Days)||0
106761|NCT01957384|260556|P4|NOT COMPLETED|Test Period 2 (14 Days)||0
106762|NCT01957384|260557|P3|NOT COMPLETED|Test Period 2 (14 Days)||0
106763|NCT01957384|260558|P2|NOT COMPLETED|Test Period 2 (14 Days)||0
106764|NCT01957384|260559|P1|NOT COMPLETED|Test Period 2 (14 Days)||0
106765|NCT01957384|260554|P6|COMPLETED|Test Period 2 (14 Days)||3
106766|NCT01957384|260555|P5|COMPLETED|Test Period 2 (14 Days)||3
106767|NCT01957384|260556|P4|COMPLETED|Test Period 2 (14 Days)||4
106768|NCT01957384|260557|P3|COMPLETED|Test Period 2 (14 Days)||4
106769|NCT01957384|260558|P2|COMPLETED|Test Period 2 (14 Days)||4
106770|NCT01957384|260559|P1|COMPLETED|Test Period 2 (14 Days)||4
106771|NCT01957384|260554|P6|STARTED|Test Period 2 (14 Days)||3
106772|NCT01957384|260555|P5|STARTED|Test Period 2 (14 Days)||3
106773|NCT01957384|260556|P4|STARTED|Test Period 2 (14 Days)||4
106774|NCT01957384|260557|P3|STARTED|Test Period 2 (14 Days)||4
106775|NCT01957384|260558|P2|STARTED|Test Period 2 (14 Days)||4
106776|NCT01957384|260559|P1|STARTED|Test Period 2 (14 Days)||4
106777|NCT01957384|260554|P6|NOT COMPLETED|Test Period 1 (14 Days)||0
106778|NCT01957384|260555|P5|NOT COMPLETED|Test Period 1 (14 Days)||0
106779|NCT01957384|260556|P4|NOT COMPLETED|Test Period 1 (14 Days)||0
106780|NCT01957384|260557|P3|NOT COMPLETED|Test Period 1 (14 Days)||0
106781|NCT01957384|260558|P2|NOT COMPLETED|Test Period 1 (14 Days)||0
106782|NCT01957384|260559|P1|NOT COMPLETED|Test Period 1 (14 Days)||0
106783|NCT01957384|260554|P6|COMPLETED|Test Period 1 (14 Days)||3
106784|NCT01957384|260555|P5|COMPLETED|Test Period 1 (14 Days)||3
106785|NCT01957384|260556|P4|COMPLETED|Test Period 1 (14 Days)||4
106786|NCT01957384|260557|P3|COMPLETED|Test Period 1 (14 Days)||4
106787|NCT01957384|260558|P2|COMPLETED|Test Period 1 (14 Days)||4
106788|NCT01957384|260559|P1|COMPLETED|Test Period 1 (14 Days)||4
106789|NCT01957384|260554|P6|STARTED|Test Period 1 (14 Days)||3
106790|NCT01957384|260555|P5|STARTED|Test Period 1 (14 Days)||3
106791|NCT01957384|260556|P4|STARTED|Test Period 1 (14 Days)||4
106792|NCT01957384|260557|P3|STARTED|Test Period 1 (14 Days)||4
106793|NCT01957384|260558|P2|STARTED|Test Period 1 (14 Days)||4
106794|NCT01957384|260559|P1|STARTED|Test Period 1 (14 Days)||4
106795|NCT01957215|260569|P2|NOT COMPLETED|Overall Study||12
106796|NCT01957215|260570|P1|NOT COMPLETED|Overall Study||13
106797|NCT01957215|260569|P2|COMPLETED|Overall Study||123
106798|NCT01957215|260570|P1|COMPLETED|Overall Study||122
106799|NCT01957215|260569|P2|STARTED|Overall Study||135
106800|NCT01957215|260570|P1|STARTED|Overall Study||135
106801|NCT01957202|260598|P18|NOT COMPLETED|Treatment Period 3 (8 Days)||0
106802|NCT01957202|260599|P17|NOT COMPLETED|Treatment Period 3 (8 Days)||1
106803|NCT01957202|260600|P16|NOT COMPLETED|Treatment Period 3 (8 Days)||0
106804|NCT01957202|260601|P15|NOT COMPLETED|Treatment Period 3 (8 Days)||0
106805|NCT01957202|260602|P14|NOT COMPLETED|Treatment Period 3 (8 Days)||0
106806|NCT01957202|260603|P13|NOT COMPLETED|Treatment Period 3 (8 Days)||0
106807|NCT01957202|260604|P12|NOT COMPLETED|Treatment Period 3 (8 Days)||0
106808|NCT01957202|260605|P11|NOT COMPLETED|Treatment Period 3 (8 Days)||0
106809|NCT01957202|260606|P10|NOT COMPLETED|Treatment Period 3 (8 Days)||0
106810|NCT01957202|260607|P9|NOT COMPLETED|Treatment Period 3 (8 Days)||0
106811|NCT01957202|260608|P8|NOT COMPLETED|Treatment Period 3 (8 Days)||0
106812|NCT01957202|260609|P7|NOT COMPLETED|Treatment Period 3 (8 Days)||0
106813|NCT01957202|260610|P6|NOT COMPLETED|Treatment Period 3 (8 Days)||0
106814|NCT01957202|260611|P5|NOT COMPLETED|Treatment Period 3 (8 Days)||0
106815|NCT01957202|260612|P4|NOT COMPLETED|Treatment Period 3 (8 Days)||0
106816|NCT01957202|260613|P3|NOT COMPLETED|Treatment Period 3 (8 Days)||0
106817|NCT01957202|260614|P2|NOT COMPLETED|Treatment Period 3 (8 Days)||0
106818|NCT01957202|260615|P1|NOT COMPLETED|Treatment Period 3 (8 Days)||0
106819|NCT01957202|260598|P18|COMPLETED|Treatment Period 3 (8 Days)||3
106820|NCT01957202|260599|P17|COMPLETED|Treatment Period 3 (8 Days)||4
106821|NCT01957202|260600|P16|COMPLETED|Treatment Period 3 (8 Days)||3
106822|NCT01957202|260601|P15|COMPLETED|Treatment Period 3 (8 Days)||6
106823|NCT01957202|260602|P14|COMPLETED|Treatment Period 3 (8 Days)||3
106824|NCT01957202|260603|P13|COMPLETED|Treatment Period 3 (8 Days)||3
106825|NCT01957202|260604|P12|COMPLETED|Treatment Period 3 (8 Days)||6
106826|NCT01957202|260605|P11|COMPLETED|Treatment Period 3 (8 Days)||3
106827|NCT01957202|260606|P10|COMPLETED|Treatment Period 3 (8 Days)||6
106828|NCT01957202|260607|P9|COMPLETED|Treatment Period 3 (8 Days)||3
106829|NCT01957202|260608|P8|COMPLETED|Treatment Period 3 (8 Days)||3
106830|NCT01957202|260609|P7|COMPLETED|Treatment Period 3 (8 Days)||3
106831|NCT01957202|260610|P6|COMPLETED|Treatment Period 3 (8 Days)||2
106832|NCT01957202|260611|P5|COMPLETED|Treatment Period 3 (8 Days)||3
106833|NCT01957202|260612|P4|COMPLETED|Treatment Period 3 (8 Days)||3
106834|NCT01957202|260613|P3|COMPLETED|Treatment Period 3 (8 Days)||6
106835|NCT01957202|260614|P2|COMPLETED|Treatment Period 3 (8 Days)||5
106836|NCT01957202|260615|P1|COMPLETED|Treatment Period 3 (8 Days)||3
106837|NCT01957202|260598|P18|STARTED|Treatment Period 3 (8 Days)||3
106838|NCT01957202|260599|P17|STARTED|Treatment Period 3 (8 Days)||5
106839|NCT01957202|260600|P16|STARTED|Treatment Period 3 (8 Days)||3
106840|NCT01957202|260601|P15|STARTED|Treatment Period 3 (8 Days)||6
106841|NCT01957202|260602|P14|STARTED|Treatment Period 3 (8 Days)||3
106842|NCT01957202|260603|P13|STARTED|Treatment Period 3 (8 Days)||3
106843|NCT01957202|260604|P12|STARTED|Treatment Period 3 (8 Days)||6
106844|NCT01957202|260605|P11|STARTED|Treatment Period 3 (8 Days)||3
106845|NCT01957202|260606|P10|STARTED|Treatment Period 3 (8 Days)||6
106846|NCT01957202|260607|P9|STARTED|Treatment Period 3 (8 Days)||3
106847|NCT01957202|260608|P8|STARTED|Treatment Period 3 (8 Days)||3
106848|NCT01957202|260609|P7|STARTED|Treatment Period 3 (8 Days)||3
106849|NCT01957202|260610|P6|STARTED|Treatment Period 3 (8 Days)||2
106850|NCT01957202|260611|P5|STARTED|Treatment Period 3 (8 Days)||3
106851|NCT01957202|260612|P4|STARTED|Treatment Period 3 (8 Days)||3
106852|NCT01957202|260613|P3|STARTED|Treatment Period 3 (8 Days)||6
106853|NCT01957202|260614|P2|STARTED|Treatment Period 3 (8 Days)||5
106854|NCT01957202|260615|P1|STARTED|Treatment Period 3 (8 Days)||3
106855|NCT01957202|260598|P18|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
106856|NCT01957202|260599|P17|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
106857|NCT01957202|260600|P16|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
106858|NCT01957202|260601|P15|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
106859|NCT01957202|260602|P14|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
106860|NCT01957202|260603|P13|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
106861|NCT01957202|260604|P12|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
106862|NCT01957202|260605|P11|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
106863|NCT01957202|260606|P10|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
106864|NCT01957202|260607|P9|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
106865|NCT01957202|260608|P8|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
106866|NCT01957202|260609|P7|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
106867|NCT01957202|260610|P6|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
106868|NCT01957202|260611|P5|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
106869|NCT01957202|260612|P4|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
106870|NCT01957202|260613|P3|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
106871|NCT01957202|260614|P2|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
106872|NCT01957202|260615|P1|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
106873|NCT01957202|260598|P18|COMPLETED|Washout Period 2 (14 to 28 Days)||3
106874|NCT01957202|260599|P17|COMPLETED|Washout Period 2 (14 to 28 Days)||5
106875|NCT01957202|260600|P16|COMPLETED|Washout Period 2 (14 to 28 Days)||3
106876|NCT01957202|260601|P15|COMPLETED|Washout Period 2 (14 to 28 Days)||6
106877|NCT01957202|260602|P14|COMPLETED|Washout Period 2 (14 to 28 Days)||3
106878|NCT01957202|260603|P13|COMPLETED|Washout Period 2 (14 to 28 Days)||3
106879|NCT01957202|260604|P12|COMPLETED|Washout Period 2 (14 to 28 Days)||6
106880|NCT01957202|260605|P11|COMPLETED|Washout Period 2 (14 to 28 Days)||3
106881|NCT01957202|260606|P10|COMPLETED|Washout Period 2 (14 to 28 Days)||6
106882|NCT01957202|260607|P9|COMPLETED|Washout Period 2 (14 to 28 Days)||3
106883|NCT01957202|260608|P8|COMPLETED|Washout Period 2 (14 to 28 Days)||3
106884|NCT01957202|260609|P7|COMPLETED|Washout Period 2 (14 to 28 Days)||3
106885|NCT01957202|260610|P6|COMPLETED|Washout Period 2 (14 to 28 Days)||2
106886|NCT01957202|260611|P5|COMPLETED|Washout Period 2 (14 to 28 Days)||3
106887|NCT01957202|260612|P4|COMPLETED|Washout Period 2 (14 to 28 Days)||3
106888|NCT01957202|260613|P3|COMPLETED|Washout Period 2 (14 to 28 Days)||6
106889|NCT01957202|260614|P2|COMPLETED|Washout Period 2 (14 to 28 Days)||5
106890|NCT01957202|260615|P1|COMPLETED|Washout Period 2 (14 to 28 Days)||3
106891|NCT01957202|260598|P18|STARTED|Washout Period 2 (14 to 28 Days)||3
106892|NCT01957202|260599|P17|STARTED|Washout Period 2 (14 to 28 Days)||5
106893|NCT01957202|260600|P16|STARTED|Washout Period 2 (14 to 28 Days)||3
106894|NCT01957202|260601|P15|STARTED|Washout Period 2 (14 to 28 Days)||6
106895|NCT01957202|260602|P14|STARTED|Washout Period 2 (14 to 28 Days)||3
106896|NCT01957202|260603|P13|STARTED|Washout Period 2 (14 to 28 Days)||3
106897|NCT01957202|260604|P12|STARTED|Washout Period 2 (14 to 28 Days)||6
106898|NCT01957202|260605|P11|STARTED|Washout Period 2 (14 to 28 Days)||3
106899|NCT01957202|260606|P10|STARTED|Washout Period 2 (14 to 28 Days)||6
106900|NCT01957202|260607|P9|STARTED|Washout Period 2 (14 to 28 Days)||3
106901|NCT01957202|260608|P8|STARTED|Washout Period 2 (14 to 28 Days)||3
106902|NCT01957202|260609|P7|STARTED|Washout Period 2 (14 to 28 Days)||3
106903|NCT01957202|260610|P6|STARTED|Washout Period 2 (14 to 28 Days)||2
106904|NCT01957202|260611|P5|STARTED|Washout Period 2 (14 to 28 Days)||3
106905|NCT01957202|260612|P4|STARTED|Washout Period 2 (14 to 28 Days)||3
106906|NCT01957202|260613|P3|STARTED|Washout Period 2 (14 to 28 Days)||6
106907|NCT01957202|260614|P2|STARTED|Washout Period 2 (14 to 28 Days)||5
106908|NCT01957202|260615|P1|STARTED|Washout Period 2 (14 to 28 Days)||3
106909|NCT01957202|260598|P18|NOT COMPLETED|Treatment Period 2 (8 Days)||0
106910|NCT01957202|260599|P17|NOT COMPLETED|Treatment Period 2 (8 Days)||1
106911|NCT01957202|260600|P16|NOT COMPLETED|Treatment Period 2 (8 Days)||0
106912|NCT01957202|260601|P15|NOT COMPLETED|Treatment Period 2 (8 Days)||0
106913|NCT01957202|260602|P14|NOT COMPLETED|Treatment Period 2 (8 Days)||0
106914|NCT01957202|260603|P13|NOT COMPLETED|Treatment Period 2 (8 Days)||0
106915|NCT01957202|260604|P12|NOT COMPLETED|Treatment Period 2 (8 Days)||0
106916|NCT01957202|260605|P11|NOT COMPLETED|Treatment Period 2 (8 Days)||0
106917|NCT01957202|260606|P10|NOT COMPLETED|Treatment Period 2 (8 Days)||0
106918|NCT01957202|260607|P9|NOT COMPLETED|Treatment Period 2 (8 Days)||0
106919|NCT01957202|260608|P8|NOT COMPLETED|Treatment Period 2 (8 Days)||0
106920|NCT01957202|260609|P7|NOT COMPLETED|Treatment Period 2 (8 Days)||0
106921|NCT01957202|260610|P6|NOT COMPLETED|Treatment Period 2 (8 Days)||0
106922|NCT01957202|260611|P5|NOT COMPLETED|Treatment Period 2 (8 Days)||0
106923|NCT01957202|260612|P4|NOT COMPLETED|Treatment Period 2 (8 Days)||0
106924|NCT01957202|260613|P3|NOT COMPLETED|Treatment Period 2 (8 Days)||0
106925|NCT01957202|260614|P2|NOT COMPLETED|Treatment Period 2 (8 Days)||1
106926|NCT01957202|260615|P1|NOT COMPLETED|Treatment Period 2 (8 Days)||0
106927|NCT01957202|260598|P18|COMPLETED|Treatment Period 2 (8 Days)||3
106928|NCT01957202|260599|P17|COMPLETED|Treatment Period 2 (8 Days)||5
106929|NCT01957202|260600|P16|COMPLETED|Treatment Period 2 (8 Days)||3
106930|NCT01957202|260601|P15|COMPLETED|Treatment Period 2 (8 Days)||6
106931|NCT01957202|260602|P14|COMPLETED|Treatment Period 2 (8 Days)||3
106932|NCT01957202|260603|P13|COMPLETED|Treatment Period 2 (8 Days)||3
106933|NCT01957202|260604|P12|COMPLETED|Treatment Period 2 (8 Days)||6
106934|NCT01957202|260605|P11|COMPLETED|Treatment Period 2 (8 Days)||3
106935|NCT01957202|260606|P10|COMPLETED|Treatment Period 2 (8 Days)||6
106936|NCT01957202|260607|P9|COMPLETED|Treatment Period 2 (8 Days)||3
106937|NCT01957202|260608|P8|COMPLETED|Treatment Period 2 (8 Days)||3
106938|NCT01957202|260609|P7|COMPLETED|Treatment Period 2 (8 Days)||3
106939|NCT01957202|260610|P6|COMPLETED|Treatment Period 2 (8 Days)||2
106940|NCT01957202|260611|P5|COMPLETED|Treatment Period 2 (8 Days)||3
106941|NCT01957202|260612|P4|COMPLETED|Treatment Period 2 (8 Days)||3
106942|NCT01957202|260613|P3|COMPLETED|Treatment Period 2 (8 Days)||6
106943|NCT01957202|260614|P2|COMPLETED|Treatment Period 2 (8 Days)||5
106944|NCT01957202|260615|P1|COMPLETED|Treatment Period 2 (8 Days)||3
106945|NCT01957202|260598|P18|STARTED|Treatment Period 2 (8 Days)||3
106946|NCT01957202|260599|P17|STARTED|Treatment Period 2 (8 Days)||6
106947|NCT01957202|260600|P16|STARTED|Treatment Period 2 (8 Days)||3
106948|NCT01957202|260601|P15|STARTED|Treatment Period 2 (8 Days)||6
106949|NCT01957202|260602|P14|STARTED|Treatment Period 2 (8 Days)||3
106950|NCT01957202|260603|P13|STARTED|Treatment Period 2 (8 Days)||3
106951|NCT01957202|260604|P12|STARTED|Treatment Period 2 (8 Days)||6
106952|NCT01957202|260605|P11|STARTED|Treatment Period 2 (8 Days)||3
106953|NCT01957202|260606|P10|STARTED|Treatment Period 2 (8 Days)||6
106954|NCT01957202|260607|P9|STARTED|Treatment Period 2 (8 Days)||3
106955|NCT01957202|260608|P8|STARTED|Treatment Period 2 (8 Days)||3
106956|NCT01957202|260609|P7|STARTED|Treatment Period 2 (8 Days)||3
106957|NCT01957202|260610|P6|STARTED|Treatment Period 2 (8 Days)||2
106958|NCT01957202|260611|P5|STARTED|Treatment Period 2 (8 Days)||3
106959|NCT01957202|260612|P4|STARTED|Treatment Period 2 (8 Days)||3
106960|NCT01957202|260613|P3|STARTED|Treatment Period 2 (8 Days)||6
106961|NCT01957202|260614|P2|STARTED|Treatment Period 2 (8 Days)||6
106962|NCT01957202|260615|P1|STARTED|Treatment Period 2 (8 Days)||3
106963|NCT01957202|260598|P18|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
106964|NCT01957202|260599|P17|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
106965|NCT01957202|260600|P16|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
106966|NCT01957202|260601|P15|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
106967|NCT01957202|260602|P14|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
106968|NCT01957202|260603|P13|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
106969|NCT01957202|260604|P12|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
106970|NCT01957202|260605|P11|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
106971|NCT01957202|260606|P10|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
106972|NCT01957202|260607|P9|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
106973|NCT01957202|260608|P8|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
106974|NCT01957202|260609|P7|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
106975|NCT01957202|260610|P6|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
106976|NCT01957202|260611|P5|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
106977|NCT01957202|260612|P4|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
106978|NCT01957202|260613|P3|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
106979|NCT01957202|260614|P2|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
106980|NCT01957202|260615|P1|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
106981|NCT01957202|260598|P18|COMPLETED|Washout Period 1 (14 to 28 Days)||3
106982|NCT01957202|260599|P17|COMPLETED|Washout Period 1 (14 to 28 Days)||6
106983|NCT01957202|260600|P16|COMPLETED|Washout Period 1 (14 to 28 Days)||3
106984|NCT01957202|260601|P15|COMPLETED|Washout Period 1 (14 to 28 Days)||6
106985|NCT01957202|260602|P14|COMPLETED|Washout Period 1 (14 to 28 Days)||3
106986|NCT01957202|260603|P13|COMPLETED|Washout Period 1 (14 to 28 Days)||3
106987|NCT01957202|260604|P12|COMPLETED|Washout Period 1 (14 to 28 Days)||6
106988|NCT01957202|260605|P11|COMPLETED|Washout Period 1 (14 to 28 Days)||3
106989|NCT01957202|260606|P10|COMPLETED|Washout Period 1 (14 to 28 Days)||6
106990|NCT01957202|260607|P9|COMPLETED|Washout Period 1 (14 to 28 Days)||3
106991|NCT01957202|260608|P8|COMPLETED|Washout Period 1 (14 to 28 Days)||3
106992|NCT01957202|260609|P7|COMPLETED|Washout Period 1 (14 to 28 Days)||3
106993|NCT01957202|260610|P6|COMPLETED|Washout Period 1 (14 to 28 Days)||2
106994|NCT01957202|260611|P5|COMPLETED|Washout Period 1 (14 to 28 Days)||3
106995|NCT01957202|260612|P4|COMPLETED|Washout Period 1 (14 to 28 Days)||3
106996|NCT01957202|260613|P3|COMPLETED|Washout Period 1 (14 to 28 Days)||6
106997|NCT01957202|260614|P2|COMPLETED|Washout Period 1 (14 to 28 Days)||6
106998|NCT01957202|260615|P1|COMPLETED|Washout Period 1 (14 to 28 Days)||3
106999|NCT01957202|260598|P18|STARTED|Washout Period 1 (14 to 28 Days)||3
107000|NCT01957202|260599|P17|STARTED|Washout Period 1 (14 to 28 Days)||6
107001|NCT01957202|260600|P16|STARTED|Washout Period 1 (14 to 28 Days)||3
107002|NCT01957202|260601|P15|STARTED|Washout Period 1 (14 to 28 Days)||6
107003|NCT01957202|260602|P14|STARTED|Washout Period 1 (14 to 28 Days)||3
107004|NCT01957202|260603|P13|STARTED|Washout Period 1 (14 to 28 Days)||3
107005|NCT01957202|260604|P12|STARTED|Washout Period 1 (14 to 28 Days)||6
107006|NCT01957202|260605|P11|STARTED|Washout Period 1 (14 to 28 Days)||3
107007|NCT01957202|260606|P10|STARTED|Washout Period 1 (14 to 28 Days)||6
107008|NCT01957202|260607|P9|STARTED|Washout Period 1 (14 to 28 Days)||3
107009|NCT01957202|260608|P8|STARTED|Washout Period 1 (14 to 28 Days)||3
107010|NCT01957202|260609|P7|STARTED|Washout Period 1 (14 to 28 Days)||3
107011|NCT01957202|260610|P6|STARTED|Washout Period 1 (14 to 28 Days)||2
107012|NCT01957202|260611|P5|STARTED|Washout Period 1 (14 to 28 Days)||3
107013|NCT01957202|260612|P4|STARTED|Washout Period 1 (14 to 28 Days)||3
107014|NCT01957202|260613|P3|STARTED|Washout Period 1 (14 to 28 Days)||6
107015|NCT01957202|260614|P2|STARTED|Washout Period 1 (14 to 28 Days)||6
107016|NCT01957202|260615|P1|STARTED|Washout Period 1 (14 to 28 Days)||3
107017|NCT01957202|260598|P18|NOT COMPLETED|Treatment Period 1 (8 Days)||0
107018|NCT01957202|260599|P17|NOT COMPLETED|Treatment Period 1 (8 Days)||0
107019|NCT01957202|260600|P16|NOT COMPLETED|Treatment Period 1 (8 Days)||0
107020|NCT01957202|260601|P15|NOT COMPLETED|Treatment Period 1 (8 Days)||0
107021|NCT01957202|260602|P14|NOT COMPLETED|Treatment Period 1 (8 Days)||0
107022|NCT01957202|260603|P13|NOT COMPLETED|Treatment Period 1 (8 Days)||0
107023|NCT01957202|260604|P12|NOT COMPLETED|Treatment Period 1 (8 Days)||0
107024|NCT01957202|260605|P11|NOT COMPLETED|Treatment Period 1 (8 Days)||0
107025|NCT01957202|260606|P10|NOT COMPLETED|Treatment Period 1 (8 Days)||0
107026|NCT01957202|260607|P9|NOT COMPLETED|Treatment Period 1 (8 Days)||0
107027|NCT01957202|260608|P8|NOT COMPLETED|Treatment Period 1 (8 Days)||0
107028|NCT01957202|260609|P7|NOT COMPLETED|Treatment Period 1 (8 Days)||0
107029|NCT01957202|260610|P6|NOT COMPLETED|Treatment Period 1 (8 Days)||0
107030|NCT01957202|260611|P5|NOT COMPLETED|Treatment Period 1 (8 Days)||0
107031|NCT01957202|260612|P4|NOT COMPLETED|Treatment Period 1 (8 Days)||0
107032|NCT01957202|260613|P3|NOT COMPLETED|Treatment Period 1 (8 Days)||0
107033|NCT01957202|260614|P2|NOT COMPLETED|Treatment Period 1 (8 Days)||0
107034|NCT01957202|260615|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
107035|NCT01957202|260598|P18|COMPLETED|Treatment Period 1 (8 Days)||3
107036|NCT01957202|260599|P17|COMPLETED|Treatment Period 1 (8 Days)||6
107037|NCT01957202|260600|P16|COMPLETED|Treatment Period 1 (8 Days)||3
107038|NCT01957202|260601|P15|COMPLETED|Treatment Period 1 (8 Days)||6
107039|NCT01957202|260602|P14|COMPLETED|Treatment Period 1 (8 Days)||3
107040|NCT01957202|260603|P13|COMPLETED|Treatment Period 1 (8 Days)||3
107041|NCT01957202|260604|P12|COMPLETED|Treatment Period 1 (8 Days)||6
107042|NCT01957202|260605|P11|COMPLETED|Treatment Period 1 (8 Days)||3
107043|NCT01957202|260606|P10|COMPLETED|Treatment Period 1 (8 Days)||6
107044|NCT01957202|260607|P9|COMPLETED|Treatment Period 1 (8 Days)||3
107045|NCT01957202|260608|P8|COMPLETED|Treatment Period 1 (8 Days)||3
107046|NCT01957202|260609|P7|COMPLETED|Treatment Period 1 (8 Days)||3
107047|NCT01957202|260610|P6|COMPLETED|Treatment Period 1 (8 Days)||2
107048|NCT01957202|260611|P5|COMPLETED|Treatment Period 1 (8 Days)||3
107049|NCT01957202|260612|P4|COMPLETED|Treatment Period 1 (8 Days)||3
107050|NCT01957202|260613|P3|COMPLETED|Treatment Period 1 (8 Days)||6
107051|NCT01957202|260614|P2|COMPLETED|Treatment Period 1 (8 Days)||6
107052|NCT01957202|260615|P1|COMPLETED|Treatment Period 1 (8 Days)||3
107053|NCT01957202|260598|P18|STARTED|Treatment Period 1 (8 Days)||3
107054|NCT01957202|260599|P17|STARTED|Treatment Period 1 (8 Days)||6
107055|NCT01957202|260600|P16|STARTED|Treatment Period 1 (8 Days)||3
107056|NCT01957202|260601|P15|STARTED|Treatment Period 1 (8 Days)||6
107057|NCT01957202|260602|P14|STARTED|Treatment Period 1 (8 Days)||3
107058|NCT01957202|260603|P13|STARTED|Treatment Period 1 (8 Days)||3
107059|NCT01957202|260604|P12|STARTED|Treatment Period 1 (8 Days)||6
107060|NCT01957202|260605|P11|STARTED|Treatment Period 1 (8 Days)||3
107061|NCT01957202|260606|P10|STARTED|Treatment Period 1 (8 Days)||6
107062|NCT01957202|260607|P9|STARTED|Treatment Period 1 (8 Days)||3
107063|NCT01957202|260608|P8|STARTED|Treatment Period 1 (8 Days)||3
107064|NCT01957202|260609|P7|STARTED|Treatment Period 1 (8 Days)||3
107065|NCT01957202|260610|P6|STARTED|Treatment Period 1 (8 Days)||2
107066|NCT01957202|260611|P5|STARTED|Treatment Period 1 (8 Days)||3
107067|NCT01957202|260612|P4|STARTED|Treatment Period 1 (8 Days)||3
107068|NCT01957202|260613|P3|STARTED|Treatment Period 1 (8 Days)||6
107069|NCT01957202|260614|P2|STARTED|Treatment Period 1 (8 Days)||6
107070|NCT01957202|260615|P1|STARTED|Treatment Period 1 (8 Days)||3
107071|NCT01957163|260640|P3|NOT COMPLETED|Overall Study||18
107072|NCT01957163|260641|P2|NOT COMPLETED|Overall Study||11
107073|NCT01957163|260642|P1|NOT COMPLETED|Overall Study||15
107074|NCT01957163|260640|P3|COMPLETED|Overall Study||189
107075|NCT01957163|260641|P2|COMPLETED|Overall Study||195
107076|NCT01957163|260642|P1|COMPLETED|Overall Study||191
107077|NCT01957163|260640|P3|STARTED|Overall Study||207
107078|NCT01957163|260641|P2|STARTED|Overall Study||206
107079|NCT01957163|260642|P1|STARTED|Overall Study||206
107080|NCT01957150|260655|P2|NOT COMPLETED|Overall Study||58
107081|NCT01957150|260656|P1|NOT COMPLETED|Overall Study||55
107082|NCT01957150|260655|P2|COMPLETED|Overall Study||83
107083|NCT01957150|260656|P1|COMPLETED|Overall Study||87
107084|NCT01957150|260655|P2|STARTED|Overall Study||141
107085|NCT01957150|260656|P1|STARTED|Overall Study||142
107086|NCT01957137|260672|P1|NOT COMPLETED|No Stimulation||0
107087|NCT01957137|260672|P1|COMPLETED|No Stimulation||28
107088|NCT01957137|260672|P1|STARTED|No Stimulation|Following randomized portion, all subjects went through no stimulation for approximately 4 weeks.|28
107089|NCT01957137|260672|P1|NOT COMPLETED|Randomized Portion||2
107090|NCT01957137|260672|P1|COMPLETED|Randomized Portion||28
107091|NCT01957137|260672|P1|Cycling Parameter #3|Randomized Portion|Subjects received Cycling Parameter #3 for approximately 4 weeks.|28
107092|NCT01957137|260672|P1|Cycling Parameter #2|Randomized Portion|Subjects received Cycling Parameter #2 for approximately 4 weeks.|28
107093|NCT01957137|260672|P1|Cycling Parameter #1|Randomized Portion|Subjects received Cycling Parameter #1 for approximately 4 weeks.|30
107094|NCT01957137|260672|P1|Continuous Stimulation|Randomized Portion|Subjects received continuous stimulation for approximately 4 weeks.|29
107095|NCT01957137|260672|P1|STARTED|Randomized Portion||30
107096|NCT01957111|260702|P2|NOT COMPLETED|Overall Study||1
107097|NCT01957111|260703|P1|NOT COMPLETED|Overall Study||1
107098|NCT01957111|260702|P2|COMPLETED|Overall Study||15
107099|NCT01957111|260703|P1|COMPLETED|Overall Study||15
107100|NCT01957111|260702|P2|STARTED|Overall Study||16
107101|NCT01957111|260703|P1|STARTED|Overall Study||16
107102|NCT01956773|260713|P2|NOT COMPLETED|Overall Study||1
107103|NCT01956773|260714|P1|NOT COMPLETED|Overall Study||628
107104|NCT01956773|260713|P2|COMPLETED|Overall Study||99
107105|NCT01956773|260714|P1|COMPLETED|Overall Study||1892
107106|NCT01956773|260713|P2|STARTED|Overall Study||100
107107|NCT01956773|260714|P1|STARTED|Overall Study||2520
107108|NCT01956435|260725|P2|NOT COMPLETED|Overall Study||0
107109|NCT01956435|260726|P1|NOT COMPLETED|Overall Study||0
107110|NCT01956435|260725|P2|COMPLETED|Overall Study||3
107111|NCT01956435|260726|P1|COMPLETED|Overall Study||3
107112|NCT01956435|260725|P2|STARTED|Overall Study||3
107113|NCT01956435|260726|P1|STARTED|Overall Study||3
107114|NCT01956240|260735|P2|NOT COMPLETED|Overall Study||24
107115|NCT01956240|260736|P1|NOT COMPLETED|Overall Study||23
107116|NCT01956240|260735|P2|COMPLETED|Overall Study||25
107117|NCT01956240|260736|P1|COMPLETED|Overall Study||25
107118|NCT01956240|260735|P2|STARTED|Overall Study||49
107119|NCT01956240|260736|P1|STARTED|Overall Study||48
107120|NCT01956123|260746|P4|NOT COMPLETED|COS Cycle 3||2
107121|NCT01956123|260747|P3|NOT COMPLETED|COS Cycle 3||6
107122|NCT01956123|260748|P2|NOT COMPLETED|COS Cycle 3||0
107123|NCT01956123|260749|P1|NOT COMPLETED|COS Cycle 3||0
107124|NCT01956123|260746|P4|COMPLETED|COS Cycle 3||91
107125|NCT01956123|260747|P3|COMPLETED|COS Cycle 3||89
107126|NCT01956123|260748|P2|COMPLETED|COS Cycle 3||0
107127|NCT01956123|260749|P1|COMPLETED|COS Cycle 3||0
107128|NCT01956123|260746|P4|STARTED|COS Cycle 3|Subjects in COS cycle 2 who failed to achieve an ongoing pregnancy could undergo COS cycle 3|93
107129|NCT01956123|260747|P3|STARTED|COS Cycle 3|Subjects in COS cycle 2 who failed to achieve an ongoing pregnancy could undergo COS cycle 3|95
107130|NCT01956123|260748|P2|STARTED|COS Cycle 3||0
107131|NCT01956123|260749|P1|STARTED|COS Cycle 3||0
107132|NCT01956123|260746|P4|NOT COMPLETED|COS Cycle 2||0
107133|NCT01956123|260747|P3|NOT COMPLETED|COS Cycle 2||0
107134|NCT01956123|260748|P2|NOT COMPLETED|COS Cycle 2||7
107135|NCT01956123|260749|P1|NOT COMPLETED|COS Cycle 2||14
107136|NCT01956123|260746|P4|COMPLETED|COS Cycle 2||0
107137|NCT01956123|260747|P3|COMPLETED|COS Cycle 2||0
107138|NCT01956123|260748|P2|COMPLETED|COS Cycle 2||254
107139|NCT01956123|260749|P1|COMPLETED|COS Cycle 2||238
107140|NCT01956123|260746|P4|STARTED|COS Cycle 2||0
107141|NCT01956123|260747|P3|STARTED|COS Cycle 2||0
107142|NCT01956123|260748|P2|STARTED|COS Cycle 2||261
107143|NCT01956123|260749|P1|STARTED|COS Cycle 2||252
107144|NCT01956110|260801|P2|NOT COMPLETED|Overall Study||22
107145|NCT01956110|260802|P1|NOT COMPLETED|Overall Study||35
107146|NCT01956110|260801|P2|COMPLETED|Overall Study||639
107147|NCT01956110|260802|P1|COMPLETED|Overall Study||630
107148|NCT01956110|260801|P2|STARTED|Overall Study||661
107149|NCT01956110|260802|P1|STARTED|Overall Study||665
107150|NCT01956097|260855|P3|NOT COMPLETED|Overall Study||0
107151|NCT01956097|260856|P2|NOT COMPLETED|Overall Study||2
107152|NCT01956097|260857|P1|NOT COMPLETED|Overall Study||6
107153|NCT01956097|260855|P3|COMPLETED|Overall Study||15
107154|NCT01956097|260856|P2|COMPLETED|Overall Study||28
107155|NCT01956097|260857|P1|COMPLETED|Overall Study||24
107156|NCT01956097|260855|P3|STARTED|Overall Study||15
107157|NCT01956097|260856|P2|STARTED|Overall Study||30
107158|NCT01956097|260857|P1|STARTED|Overall Study||30
107159|NCT01956071|260874|P1|NOT COMPLETED|Overall Study||0
107160|NCT01956071|260874|P1|COMPLETED|Overall Study||44
107161|NCT01956071|260874|P1|STARTED|Overall Study||44
107162|NCT01956032|260878|P1|NOT COMPLETED|Overall Study||0
107163|NCT01956032|260878|P1|COMPLETED|Overall Study||15
107164|NCT01956032|260878|P1|STARTED|Overall Study||15
107165|NCT01955954|260925|P1|NOT COMPLETED|Overall Study||36
107166|NCT01955954|260925|P1|COMPLETED|Overall Study|12-months|33
107167|NCT01955954|260925|P1|Completed 6-month Assessement|Overall Study||42
107168|NCT01955954|260925|P1|Completed 2-month Assessment|Overall Study|Primary endpoint|46
107169|NCT01955954|260925|P1|Completed Post-treatment Assessement|Overall Study||48
107170|NCT01955954|260925|P1|Completed Treatment|Overall Study||53
107171|NCT01955954|260925|P1|Received Treatment|Overall Study||66
107172|NCT01955954|260925|P1|STARTED|Overall Study||69
107173|NCT01955733|260937|P3|NOT COMPLETED|Period 2||21
107174|NCT01955733|260938|P2|NOT COMPLETED|Period 2||19
107175|NCT01955733|260939|P1|NOT COMPLETED|Period 2||12
107176|NCT01955733|260937|P3|COMPLETED|Period 2||8
107177|NCT01955733|260938|P2|COMPLETED|Period 2||10
107178|NCT01955733|260939|P1|COMPLETED|Period 2||20
107179|NCT01955733|260937|P3|STARTED|Period 2||29
107180|NCT01955733|260938|P2|STARTED|Period 2||29
107181|NCT01955733|260939|P1|STARTED|Period 2||32
107182|NCT01955733|260937|P3|NOT COMPLETED|Period 1||0
107183|NCT01955733|260938|P2|NOT COMPLETED|Period 1||0
107184|NCT01955733|260939|P1|NOT COMPLETED|Period 1||1
107185|NCT01955733|260937|P3|COMPLETED|Period 1||29
107186|NCT01955733|260938|P2|COMPLETED|Period 1||29
107187|NCT01955733|260939|P1|COMPLETED|Period 1||32
107188|NCT01955733|260937|P3|STARTED|Period 1||29
107189|NCT01955733|260938|P2|STARTED|Period 1||29
107190|NCT01955733|260939|P1|STARTED|Period 1||33
107191|NCT01955720|260959|P6|NOT COMPLETED|Overall Study||0
107192|NCT01955720|260960|P5|NOT COMPLETED|Overall Study||0
107193|NCT01955720|260961|P4|NOT COMPLETED|Overall Study||0
107194|NCT01955720|260962|P3|NOT COMPLETED|Overall Study||0
107195|NCT01955720|260963|P2|NOT COMPLETED|Overall Study||0
107196|NCT01955720|260964|P1|NOT COMPLETED|Overall Study||0
107197|NCT01955720|260959|P6|COMPLETED|Overall Study||7
107198|NCT01955720|260960|P5|COMPLETED|Overall Study||7
107199|NCT01955720|260961|P4|COMPLETED|Overall Study||3
107200|NCT01955720|260962|P3|COMPLETED|Overall Study||3
107201|NCT01955720|260963|P2|COMPLETED|Overall Study||13
107202|NCT01955720|260964|P1|COMPLETED|Overall Study||13
107203|NCT01955720|260959|P6|Subjects With Moderate Renal Impairment|Overall Study||0
107204|NCT01955720|260960|P5|Subjects With Moderate Renal Impairment|Overall Study||0
107205|NCT01955720|260961|P4|Subjects With Moderate Renal Impairment|Overall Study||0
107206|NCT01955720|260962|P3|Subjects With Moderate Renal Impairment|Overall Study||0
107207|NCT01955720|260963|P2|Subjects With Moderate Renal Impairment|Overall Study||3
107208|NCT01955720|260964|P1|Subjects With Moderate Renal Impairment|Overall Study||3
107209|NCT01955720|260959|P6|Subjects With Mild Renal Impairment|Overall Study||3
107210|NCT01955720|260960|P5|Subjects With Mild Renal Impairment|Overall Study||3
107211|NCT01955720|260961|P4|Subjects With Mild Renal Impairment|Overall Study||0
107212|NCT01955720|260962|P3|Subjects With Mild Renal Impairment|Overall Study||0
107213|NCT01955720|260963|P2|Subjects With Mild Renal Impairment|Overall Study||3
107214|NCT01955720|260964|P1|Subjects With Mild Renal Impairment|Overall Study||3
107215|NCT01955720|260959|P6|Healthy Subjects Aged 65-80|Overall Study||4
107216|NCT01955720|260960|P5|Healthy Subjects Aged 65-80|Overall Study||4
107217|NCT01955720|260961|P4|Healthy Subjects Aged 65-80|Overall Study||0
107218|NCT01955720|260962|P3|Healthy Subjects Aged 65-80|Overall Study||0
107219|NCT01955720|260963|P2|Healthy Subjects Aged 65-80|Overall Study||4
107220|NCT01955720|260964|P1|Healthy Subjects Aged 65-80|Overall Study||4
107221|NCT01955720|260959|P6|Healthy Subjects Aged 45-64|Overall Study||0
107222|NCT01955720|260960|P5|Healthy Subjects Aged 45-64|Overall Study||0
107223|NCT01955720|260961|P4|Healthy Subjects Aged 45-64|Overall Study||3
107224|NCT01955720|260962|P3|Healthy Subjects Aged 45-64|Overall Study||3
107225|NCT01955720|260963|P2|Healthy Subjects Aged 45-64|Overall Study||3
107226|NCT01955720|260964|P1|Healthy Subjects Aged 45-64|Overall Study||3
107227|NCT01955720|260959|P6|STARTED|Overall Study||7
107228|NCT01955720|260960|P5|STARTED|Overall Study||7
107229|NCT01955720|260961|P4|STARTED|Overall Study||3
107230|NCT01955720|260962|P3|STARTED|Overall Study||3
107231|NCT01955720|260963|P2|STARTED|Overall Study||13
107232|NCT01955720|260964|P1|STARTED|Overall Study||13
107233|NCT01955707|261032|P2|NOT COMPLETED|Overall Study||22
107234|NCT01955707|261033|P1|NOT COMPLETED|Overall Study||20
107235|NCT01955707|261032|P2|COMPLETED|Overall Study||57
107236|NCT01955707|261033|P1|COMPLETED|Overall Study||62
107237|NCT01955707|261032|P2|Received Total Volume of Study Drug|Overall Study||77
107238|NCT01955707|261033|P1|Received Total Volume of Study Drug|Overall Study||82
107239|NCT01955707|261032|P2|Dosed|Overall Study||78
107240|NCT01955707|261033|P1|Dosed|Overall Study||82
107241|NCT01955707|261032|P2|Withdrew Prior to Dosing|Overall Study||1
107242|NCT01955707|261033|P1|Withdrew Prior to Dosing|Overall Study||0
107243|NCT01955707|261032|P2|STARTED|Overall Study||79
107244|NCT01955707|261033|P1|STARTED|Overall Study||82
107245|NCT01955629|261057|P1|NOT COMPLETED|Overall Study||0
107246|NCT01955629|261057|P1|COMPLETED|Overall Study|1 participant with DP and 3 with unacceptable toxicity were considered completed as per protocol.|4
107247|NCT01955629|261057|P1|STARTED|Overall Study||4
107248|NCT01955564|261076|P7|NOT COMPLETED|Overall Study||0
107249|NCT01955564|261077|P6|NOT COMPLETED|Overall Study||0
107250|NCT01955564|261078|P5|NOT COMPLETED|Overall Study||0
107251|NCT01955564|261079|P4|NOT COMPLETED|Overall Study||0
107252|NCT01955564|261080|P3|NOT COMPLETED|Overall Study||0
107253|NCT01955564|261081|P2|NOT COMPLETED|Overall Study||0
107254|NCT01955564|261082|P1|NOT COMPLETED|Overall Study||0
107255|NCT01955564|261076|P7|COMPLETED|Overall Study||6
107256|NCT01955564|261077|P6|COMPLETED|Overall Study||6
107257|NCT01955564|261078|P5|COMPLETED|Overall Study||6
107258|NCT01955564|261079|P4|COMPLETED|Overall Study||6
107259|NCT01955564|261080|P3|COMPLETED|Overall Study||6
107260|NCT01955564|261081|P2|COMPLETED|Overall Study||6
107261|NCT01955564|261082|P1|COMPLETED|Overall Study||18
107262|NCT01955564|261076|P7|STARTED|Overall Study||6
107263|NCT01955564|261077|P6|STARTED|Overall Study||6
107264|NCT01955564|261078|P5|STARTED|Overall Study||6
107265|NCT01955564|261079|P4|STARTED|Overall Study||6
107266|NCT01955564|261080|P3|STARTED|Overall Study||6
107267|NCT01955564|261081|P2|STARTED|Overall Study||6
107268|NCT01955564|261082|P1|STARTED|Overall Study||18
107269|NCT01955473|261115|P5|NOT COMPLETED|Overall Study||0
107270|NCT01955473|261116|P4|NOT COMPLETED|Overall Study||0
107271|NCT01955473|261117|P3|NOT COMPLETED|Overall Study||0
107272|NCT01955473|261118|P2|NOT COMPLETED|Overall Study||0
107273|NCT01955473|261119|P1|NOT COMPLETED|Overall Study||0
107274|NCT01955473|261115|P5|COMPLETED|Overall Study||30
107275|NCT01955473|261116|P4|COMPLETED|Overall Study||6
107276|NCT01955473|261117|P3|COMPLETED|Overall Study||6
107277|NCT01955473|261118|P2|COMPLETED|Overall Study||6
107278|NCT01955473|261119|P1|COMPLETED|Overall Study||3
107279|NCT01955473|261115|P5|STARTED|Overall Study||30
107280|NCT01955473|261116|P4|STARTED|Overall Study||6
107281|NCT01955473|261117|P3|STARTED|Overall Study||6
107282|NCT01955473|261118|P2|STARTED|Overall Study||6
107283|NCT01955473|261119|P1|STARTED|Overall Study||3
107284|NCT01955434|261273|P1|NOT COMPLETED|Overall Study||0
107285|NCT01955434|261273|P1|COMPLETED|Overall Study||25
107286|NCT01955434|261273|P1|STARTED|Overall Study||25
107287|NCT01955382|261283|P2|NOT COMPLETED|Overall Study||0
107288|NCT01955382|261284|P1|NOT COMPLETED|Overall Study||0
107289|NCT01955382|261283|P2|COMPLETED|Overall Study||35
107290|NCT01955382|261284|P1|COMPLETED|Overall Study||35
107291|NCT01955382|261283|P2|STARTED|Overall Study||35
107292|NCT01955382|261284|P1|STARTED|Overall Study||35
107293|NCT01955369|261292|P1|NOT COMPLETED|Overall Study||0
107294|NCT01955369|261292|P1|COMPLETED|Overall Study||200
107295|NCT01955369|261292|P1|STARTED|Overall Study||200
107296|NCT01955161|261301|P3|NOT COMPLETED|Overall Study||35
107297|NCT01955161|261302|P2|NOT COMPLETED|Overall Study||25
107298|NCT01955161|261303|P1|NOT COMPLETED|Overall Study||27
107299|NCT01955161|261301|P3|COMPLETED|Overall Study||275
107300|NCT01955161|261302|P2|COMPLETED|Overall Study||288
107301|NCT01955161|261303|P1|COMPLETED|Overall Study||283
107302|NCT01955161|261301|P3|Treated|Overall Study||309
107303|NCT01955161|261302|P2|Treated|Overall Study||313
107304|NCT01955161|261303|P1|Treated|Overall Study||308
107305|NCT01955161|261301|P3|STARTED|Overall Study||310
107306|NCT01955161|261302|P2|STARTED|Overall Study||313
107307|NCT01955161|261303|P1|STARTED|Overall Study||310
107308|NCT01955122|261343|P2|NOT COMPLETED|Overall Study||5
107309|NCT01955122|261344|P1|NOT COMPLETED|Overall Study||5
107310|NCT01955122|261343|P2|COMPLETED|Overall Study||57
107311|NCT01955122|261344|P1|COMPLETED|Overall Study||59
107312|NCT01955122|261343|P2|No. Patients Completed Double Procedure|Overall Study||57
107313|NCT01955122|261344|P1|No. Patients Completed Double Procedure|Overall Study||59
107314|NCT01955122|261343|P2|No.Patients Enrolled|Overall Study||62
107315|NCT01955122|261344|P1|No.Patients Enrolled|Overall Study||64
107316|NCT01955122|261343|P2|STARTED|Overall Study|"Excluded (n = 5)~Included in analysis (n = 57)"|62
107317|NCT01955122|261344|P1|STARTED|Overall Study|"Excluded (n = 5)~Included in analysis (n = 59)"|64
107318|NCT01955083|261364|P2|NOT COMPLETED|Overall Study||1
107319|NCT01955083|261365|P1|NOT COMPLETED|Overall Study||1
107320|NCT01955083|261364|P2|COMPLETED|Overall Study||14
107321|NCT01955083|261365|P1|COMPLETED|Overall Study||14
107322|NCT01955083|261364|P2|STARTED|Overall Study||15
107323|NCT01955083|261365|P1|STARTED|Overall Study||15
107324|NCT01955044|261398|P3|NOT COMPLETED|Overall Study||0
107325|NCT01955044|261399|P2|NOT COMPLETED|Overall Study||1
107326|NCT01955044|261400|P1|NOT COMPLETED|Overall Study||1
107327|NCT01955044|261398|P3|COMPLETED|Overall Study||10
107328|NCT01955044|261399|P2|COMPLETED|Overall Study||9
107329|NCT01955044|261400|P1|COMPLETED|Overall Study||9
107330|NCT01955044|261398|P3|STARTED|Overall Study||10
107331|NCT01955044|261399|P2|STARTED|Overall Study||10
107332|NCT01955044|261400|P1|STARTED|Overall Study||10
107333|NCT01955005|261413|P2|NOT COMPLETED|Overall Study||5
107334|NCT01955005|261414|P1|NOT COMPLETED|Overall Study||3
107335|NCT01955005|261413|P2|COMPLETED|Overall Study||25
107336|NCT01955005|261414|P1|COMPLETED|Overall Study||27
107337|NCT01955005|261413|P2|STARTED|Overall Study||30
107338|NCT01955005|261414|P1|STARTED|Overall Study||30
107339|NCT01954927|261426|P2|NOT COMPLETED|Overall Study||1
107340|NCT01954927|261427|P1|NOT COMPLETED|Overall Study||3
107341|NCT01954927|261426|P2|COMPLETED|Overall Study||44
107342|NCT01954927|261427|P1|COMPLETED|Overall Study||42
107343|NCT01954927|261426|P2|STARTED|Overall Study||45
107344|NCT01954927|261427|P1|STARTED|Overall Study||45
107345|NCT01954771|261448|P3|NOT COMPLETED|Overall Study||3
107346|NCT01954771|261449|P2|NOT COMPLETED|Overall Study||3
107347|NCT01954771|261450|P1|NOT COMPLETED|Overall Study||7
107348|NCT01954771|261448|P3|COMPLETED|Overall Study||25
107349|NCT01954771|261449|P2|COMPLETED|Overall Study||29
107350|NCT01954771|261450|P1|COMPLETED|Overall Study||22
107351|NCT01954771|261448|P3|STARTED|Overall Study||28
107352|NCT01954771|261449|P2|STARTED|Overall Study||32
107353|NCT01954771|261450|P1|STARTED|Overall Study||29
107354|NCT01954745|261467|P1|NOT COMPLETED|Overall Study||19
107355|NCT01954745|261467|P1|COMPLETED|Overall Study||0
107356|NCT01954745|261467|P1|STARTED|Overall Study||19
107357|NCT01954628|261476|P2|NOT COMPLETED|Overall Study||27
107358|NCT01954628|261477|P1|NOT COMPLETED|Overall Study||31
107359|NCT01954628|261476|P2|COMPLETED|Overall Study||173
107360|NCT01954628|261477|P1|COMPLETED|Overall Study||169
107361|NCT01954628|261476|P2|US 6 Month Ophthalmology Safety Visit|Overall Study||32
107362|NCT01954628|261477|P1|US 6 Month Ophthalmology Safety Visit|Overall Study||37
107363|NCT01954628|261476|P2|Pharmacokinetic Population|Overall Study||0
107364|NCT01954628|261477|P1|Pharmacokinetic Population|Overall Study||181
107365|NCT01954628|261476|P2|Safety Set|Overall Study||200
107366|NCT01954628|261477|P1|Safety Set|Overall Study||200
107367|NCT01954628|261476|P2|Full Analysis Set (FAS)|Overall Study||198
107368|NCT01954628|261477|P1|Full Analysis Set (FAS)|Overall Study||200
107369|NCT01954628|261476|P2|STARTED|Overall Study||200
107370|NCT01954628|261477|P1|STARTED|Overall Study||200
107371|NCT01954394|261498|P2|NOT COMPLETED|Overall Study||57
107372|NCT01954394|261499|P1|NOT COMPLETED|Overall Study||30
107373|NCT01954394|261498|P2|COMPLETED|Overall Study||598
107374|NCT01954394|261499|P1|COMPLETED|Overall Study||301
107375|NCT01954394|261498|P2|Treated|Overall Study|Safety population|655
107376|NCT01954394|261499|P1|Treated|Overall Study|Safety population|330
107377|NCT01954394|261498|P2|STARTED|Overall Study|Enrolled|655
107378|NCT01954394|261499|P1|STARTED|Overall Study|Enrolled|331
107379|NCT01954264|261549|P1|NOT COMPLETED|Overall Study||0
107380|NCT01954264|261549|P1|COMPLETED|Overall Study||2421
107381|NCT01954264|261549|P1|STARTED|Overall Study||2421
107382|NCT01954251|261601|P2|NOT COMPLETED|Overall Study||19
107383|NCT01954251|261602|P1|NOT COMPLETED|Overall Study||13
107384|NCT01954251|261601|P2|COMPLETED|Overall Study||396
107385|NCT01954251|261602|P1|COMPLETED|Overall Study||400
107386|NCT01954251|261601|P2|STARTED|Overall Study||415
107387|NCT01954251|261602|P1|STARTED|Overall Study||413
107388|NCT01954160|261638|P2|NOT COMPLETED|Overall Study||0
107389|NCT01954160|261639|P1|NOT COMPLETED|Overall Study||5
107390|NCT01954160|261638|P2|COMPLETED|Overall Study||0
107391|NCT01954160|261639|P1|COMPLETED|Overall Study|Only 4 subjects completed the first early denervation. No subjects completed the late denervation.|0
107392|NCT01954160|261638|P2|STARTED|Overall Study|Not started|0
107393|NCT01954160|261639|P1|STARTED|Overall Study||5
107394|NCT01954121|261699|P2|NOT COMPLETED|Overall Study||91
107395|NCT01954121|261700|P1|NOT COMPLETED|Overall Study||127
107396|NCT01954121|261699|P2|COMPLETED|Overall Study||125
107397|NCT01954121|261700|P1|COMPLETED|Overall Study||93
107398|NCT01954121|261699|P2|STARTED|Overall Study||216
107399|NCT01954121|261700|P1|STARTED|Overall Study||220
107400|NCT01954082|261716|P2|NOT COMPLETED|Overall Study||57
107401|NCT01954082|261717|P1|NOT COMPLETED|Overall Study||68
107402|NCT01954082|261716|P2|COMPLETED|Overall Study|There were 27 infants that received more doses than intended per protocol.|264
107403|NCT01954082|261717|P1|COMPLETED|Overall Study|There were 22 infants that received more doses than intended per protocol.|249
107404|NCT01954082|261716|P2|Treated|Overall Study|The 2 participants who were not treated died before treatment start.|319
107405|NCT01954082|261717|P1|Treated|Overall Study|The 4 participants who were not treated either died (3) or withdrew before treatment start (1).|313
107406|NCT01954082|261716|P2|STARTED|Overall Study||321
107407|NCT01954082|261717|P1|STARTED|Overall Study||317
107408|NCT01954056|261737|P2|NOT COMPLETED|Birth to 22-26 Mos. Corrected GA||0
107409|NCT01954056|261738|P1|NOT COMPLETED|Birth to 22-26 Mos. Corrected GA||1
107410|NCT01954056|261737|P2|COMPLETED|Birth to 22-26 Mos. Corrected GA||6
107411|NCT01954056|261738|P1|COMPLETED|Birth to 22-26 Mos. Corrected GA||5
107412|NCT01954056|261737|P2|STARTED|Birth to 22-26 Mos. Corrected GA||6
107413|NCT01954056|261738|P1|STARTED|Birth to 22-26 Mos. Corrected GA||6
107414|NCT01954056|261737|P2|NOT COMPLETED|Birth to 60 Days of Life||0
107415|NCT01954056|261738|P1|NOT COMPLETED|Birth to 60 Days of Life||0
107416|NCT01954056|261737|P2|COMPLETED|Birth to 60 Days of Life||6
107417|NCT01954056|261738|P1|COMPLETED|Birth to 60 Days of Life||6
107418|NCT01954056|261737|P2|STARTED|Birth to 60 Days of Life||6
107419|NCT01954056|261738|P1|STARTED|Birth to 60 Days of Life||6
107420|NCT01953913|261780|P1|NOT COMPLETED|Overall Study||542
107421|NCT01953913|261780|P1|COMPLETED|Overall Study||0
107422|NCT01953913|261780|P1|Treated|Overall Study||541
107423|NCT01953913|261780|P1|STARTED|Overall Study||542
107424|NCT01953874|261788|P2|NOT COMPLETED|Overall Study||0
107425|NCT01953874|261789|P1|NOT COMPLETED|Overall Study||0
107426|NCT01953874|261788|P2|COMPLETED|Overall Study||61
107427|NCT01953874|261789|P1|COMPLETED|Overall Study||65
107428|NCT01953874|261788|P2|STARTED|Overall Study||61
107429|NCT01953874|261789|P1|STARTED|Overall Study||65
107430|NCT01953601|261835|P3|NOT COMPLETED|Part 2 (Extension Study)||204
107431|NCT01953601|261836|P2|NOT COMPLETED|Part 2 (Extension Study)||191
107432|NCT01953601|261837|P1|NOT COMPLETED|Part 2 (Extension Study)||198
107433|NCT01953601|261835|P3|COMPLETED|Part 2 (Extension Study)||0
107434|NCT01953601|261836|P2|COMPLETED|Part 2 (Extension Study)||0
107435|NCT01953601|261837|P1|COMPLETED|Part 2 (Extension Study)||0
107436|NCT01953601|261835|P3|Treated|Part 2 (Extension Study)||204
107437|NCT01953601|261836|P2|Treated|Part 2 (Extension Study)||191
107438|NCT01953601|261837|P1|Treated|Part 2 (Extension Study)||197
107439|NCT01953601|261835|P3|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|204
107532|NCT01952665|262221|P1|NOT COMPLETED|Overall Study||6
107533|NCT01952665|262220|P2|COMPLETED|Overall Study||20
107440|NCT01953601|261836|P2|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|191
107441|NCT01953601|261837|P1|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|198
107442|NCT01953601|261835|P3|NOT COMPLETED|Part 1 (Base Study)||246
107443|NCT01953601|261836|P2|NOT COMPLETED|Part 1 (Base Study)||253
107444|NCT01953601|261837|P1|NOT COMPLETED|Part 1 (Base Study)||251
107445|NCT01953601|261835|P3|COMPLETED|Part 1 (Base Study)||239
107446|NCT01953601|261836|P2|COMPLETED|Part 1 (Base Study)||231
107447|NCT01953601|261837|P1|COMPLETED|Part 1 (Base Study)||234
107448|NCT01953601|261835|P3|Treated|Part 1 (Base Study)||484
107449|NCT01953601|261836|P2|Treated|Part 1 (Base Study)||484
107450|NCT01953601|261837|P1|Treated|Part 1 (Base Study)||483
107451|NCT01953601|261835|P3|STARTED|Part 1 (Base Study)||485
107452|NCT01953601|261836|P2|STARTED|Part 1 (Base Study)||484
107453|NCT01953601|261837|P1|STARTED|Part 1 (Base Study)||485
107454|NCT01953354|261886|P2|NOT COMPLETED|Overall Study||2
107455|NCT01953354|261887|P1|NOT COMPLETED|Overall Study||1
107456|NCT01953354|261886|P2|COMPLETED|Overall Study||5
107457|NCT01953354|261887|P1|COMPLETED|Overall Study||8
107458|NCT01953354|261886|P2|STARTED|Overall Study||7
107459|NCT01953354|261887|P1|STARTED|Overall Study||9
107460|NCT01953328|261915|P8|NOT COMPLETED|Overall Study||0
107461|NCT01953328|261916|P7|NOT COMPLETED|Overall Study||0
107462|NCT01953328|261917|P6|NOT COMPLETED|Overall Study||0
107463|NCT01953328|261918|P5|NOT COMPLETED|Overall Study||2
107464|NCT01953328|261919|P4|NOT COMPLETED|Overall Study||0
107465|NCT01953328|261920|P3|NOT COMPLETED|Overall Study||0
107466|NCT01953328|261921|P2|NOT COMPLETED|Overall Study||0
107467|NCT01953328|261922|P1|NOT COMPLETED|Overall Study||0
107468|NCT01953328|261915|P8|COMPLETED|Overall Study||51
107469|NCT01953328|261916|P7|COMPLETED|Overall Study||51
107470|NCT01953328|261917|P6|COMPLETED|Overall Study||51
107471|NCT01953328|261918|P5|COMPLETED|Overall Study||50
107472|NCT01953328|261919|P4|COMPLETED|Overall Study||50
107473|NCT01953328|261920|P3|COMPLETED|Overall Study||50
107474|NCT01953328|261921|P2|COMPLETED|Overall Study||50
107475|NCT01953328|261922|P1|COMPLETED|Overall Study||49
107476|NCT01953328|261915|P8|Received Treatment|Overall Study||51
107477|NCT01953328|261916|P7|Received Treatment|Overall Study||51
107478|NCT01953328|261917|P6|Received Treatment|Overall Study||51
107479|NCT01953328|261918|P5|Received Treatment|Overall Study||52
107480|NCT01953328|261919|P4|Received Treatment|Overall Study||50
107481|NCT01953328|261920|P3|Received Treatment|Overall Study||50
107482|NCT01953328|261921|P2|Received Treatment|Overall Study||50
107483|NCT01953328|261922|P1|Received Treatment|Overall Study||49
107484|NCT01953328|261915|P8|STARTED|Overall Study||51
107485|NCT01953328|261916|P7|STARTED|Overall Study||51
107486|NCT01953328|261917|P6|STARTED|Overall Study||51
107487|NCT01953328|261918|P5|STARTED|Overall Study||52
107488|NCT01953328|261919|P4|STARTED|Overall Study||50
107489|NCT01953328|261920|P3|STARTED|Overall Study||50
107490|NCT01953328|261921|P2|STARTED|Overall Study||50
107491|NCT01953328|261922|P1|STARTED|Overall Study||49
107492|NCT01953237|262126|P2|NOT COMPLETED|Overall Study||0
107493|NCT01953237|262127|P1|NOT COMPLETED|Overall Study||0
107494|NCT01953237|262126|P2|COMPLETED|Overall Study||21
107495|NCT01953237|262127|P1|COMPLETED|Overall Study||10
107496|NCT01953237|262126|P2|STARTED|Overall Study||21
107497|NCT01953237|262127|P1|STARTED|Overall Study||10
107498|NCT01953224|262135|P2|NOT COMPLETED|Overall Study||3
107499|NCT01953224|262136|P1|NOT COMPLETED|Overall Study||2
107500|NCT01953224|262135|P2|COMPLETED|Overall Study||17
107501|NCT01953224|262136|P1|COMPLETED|Overall Study||18
107502|NCT01953224|262135|P2|STARTED|Overall Study||20
107503|NCT01953224|262136|P1|STARTED|Overall Study||20
107504|NCT01953211|262152|P1|NOT COMPLETED|Overall Study||0
107505|NCT01953211|262152|P1|COMPLETED|Overall Study|completed prior to clinical trials submission|64
107506|NCT01953211|262152|P1|STARTED|Overall Study|completed prior to clinical trials submission|64
107507|NCT01953081|262160|P2|NOT COMPLETED|Overall Study||3
107508|NCT01953081|262161|P1|NOT COMPLETED|Overall Study||2
107509|NCT01953081|262160|P2|COMPLETED|Overall Study||3
107510|NCT01953081|262161|P1|COMPLETED|Overall Study||5
107511|NCT01953081|262160|P2|STARTED|Overall Study||6
107512|NCT01953081|262161|P1|STARTED|Overall Study||7
107513|NCT01953003|262179|P2|NOT COMPLETED|Overall Study||55
107514|NCT01953003|262180|P1|NOT COMPLETED|Overall Study||56
107515|NCT01953003|262179|P2|COMPLETED|Overall Study||1
107516|NCT01953003|262180|P1|COMPLETED|Overall Study||0
107517|NCT01953003|262179|P2|STARTED|Overall Study||56
107518|NCT01953003|262180|P1|STARTED|Overall Study||56
107519|NCT01952834|262186|P1|NOT COMPLETED|Overall Study||1
107520|NCT01952834|262186|P1|COMPLETED|Overall Study||20
107521|NCT01952834|262186|P1|STARTED|Overall Study||21
107522|NCT01952691|262193|P1|NOT COMPLETED|Overall Study||2
107523|NCT01952691|262193|P1|COMPLETED|Overall Study||20
107524|NCT01952691|262193|P1|STARTED|Overall Study||22
107525|NCT01952678|262201|P2|NOT COMPLETED|Overall Study||0
107526|NCT01952678|262202|P1|NOT COMPLETED|Overall Study||0
107527|NCT01952678|262201|P2|COMPLETED|Overall Study||102
107528|NCT01952678|262202|P1|COMPLETED|Overall Study||102
107529|NCT01952678|262201|P2|STARTED|Overall Study||102
107530|NCT01952678|262202|P1|STARTED|Overall Study||102
107531|NCT01952665|262220|P2|NOT COMPLETED|Overall Study||6
107534|NCT01952665|262221|P1|COMPLETED|Overall Study||31
107535|NCT01952665|262220|P2|STARTED|Overall Study||26
107536|NCT01952665|262221|P1|STARTED|Overall Study||37
107537|NCT01952600|262362|P3|NOT COMPLETED|Overall Study||7
107538|NCT01952600|262363|P2|NOT COMPLETED|Overall Study||13
107539|NCT01952600|262364|P1|NOT COMPLETED|Overall Study||15
107540|NCT01952600|262362|P3|COMPLETED|Overall Study||38
107541|NCT01952600|262363|P2|COMPLETED|Overall Study||77
107542|NCT01952600|262364|P1|COMPLETED|Overall Study||65
107543|NCT01952600|262362|P3|STARTED|Overall Study||45
107544|NCT01952600|262363|P2|STARTED|Overall Study||90
107545|NCT01952600|262364|P1|STARTED|Overall Study||80
107546|NCT01952574|262376|P4|NOT COMPLETED|Overall Study||6
107547|NCT01952574|262377|P3|NOT COMPLETED|Overall Study||9
107548|NCT01952574|262378|P2|NOT COMPLETED|Overall Study||3
107549|NCT01952574|262379|P1|NOT COMPLETED|Overall Study||17
107550|NCT01952574|262376|P4|COMPLETED|Overall Study||101
107551|NCT01952574|262377|P3|COMPLETED|Overall Study||99
107552|NCT01952574|262378|P2|COMPLETED|Overall Study||105
107553|NCT01952574|262379|P1|COMPLETED|Overall Study||143
107554|NCT01952574|262376|P4|Received Study Drug|Overall Study||106
107555|NCT01952574|262377|P3|Received Study Drug|Overall Study||105
107556|NCT01952574|262378|P2|Received Study Drug|Overall Study||108
107557|NCT01952574|262379|P1|Received Study Drug|Overall Study||153
107558|NCT01952574|262376|P4|STARTED|Overall Study||107
107559|NCT01952574|262377|P3|STARTED|Overall Study||108
107560|NCT01952574|262378|P2|STARTED|Overall Study||108
107561|NCT01952574|262379|P1|STARTED|Overall Study||160
107562|NCT01952470|262399|P2|NOT COMPLETED|Overall Study||3
107563|NCT01952470|262400|P1|NOT COMPLETED|Overall Study||3
107564|NCT01952470|262399|P2|COMPLETED|Overall Study||13
107565|NCT01952470|262400|P1|COMPLETED|Overall Study||13
107566|NCT01952470|262399|P2|Missing 3 Month LCI 2% Data.|Overall Study||0
107567|NCT01952470|262400|P1|Missing 3 Month LCI 2% Data.|Overall Study||1
107568|NCT01952470|262399|P2|Missing 1+3 Month LCI 2% Data.|Overall Study||1
107569|NCT01952470|262400|P1|Missing 1+3 Month LCI 2% Data.|Overall Study||2
107570|NCT01952470|262399|P2|Missing Baseline LCI 2% Data.|Overall Study||2
107571|NCT01952470|262400|P1|Missing Baseline LCI 2% Data.|Overall Study||0
107572|NCT01952470|262399|P2|Death|Overall Study||1
107573|NCT01952470|262400|P1|Death|Overall Study||1
107574|NCT01952470|262399|P2|Discontinued Intervention|Overall Study||1
107575|NCT01952470|262400|P1|Discontinued Intervention|Overall Study||2
107576|NCT01952470|262399|P2|ITT Analysis|Overall Study||16
107577|NCT01952470|262400|P1|ITT Analysis|Overall Study||16
107578|NCT01952470|262399|P2|STARTED|Overall Study||16
107579|NCT01952470|262400|P1|STARTED|Overall Study||16
107580|NCT01952444|262438|P2|NOT COMPLETED|Overall Study||1
107581|NCT01952444|262439|P1|NOT COMPLETED|Overall Study||0
107582|NCT01952444|262438|P2|COMPLETED|Overall Study||19
107583|NCT01952444|262439|P1|COMPLETED|Overall Study||20
107584|NCT01952444|262438|P2|STARTED|Overall Study||20
107585|NCT01952444|262439|P1|STARTED|Overall Study||20
107586|NCT01952418|262465|P2|NOT COMPLETED|Overall Study||0
107587|NCT01952418|262466|P1|NOT COMPLETED|Overall Study||0
107588|NCT01952418|262465|P2|COMPLETED|Overall Study||895
107589|NCT01952418|262466|P1|COMPLETED|Overall Study||910
107590|NCT01952418|262465|P2|STARTED|Overall Study||895
107591|NCT01952418|262466|P1|STARTED|Overall Study||910
107592|NCT01952366|262478|P1|NOT COMPLETED|Overall Study||31
107593|NCT01952366|262478|P1|COMPLETED|Overall Study||138
107594|NCT01952366|262478|P1|STARTED|Overall Study||169
107595|NCT01952301|262485|P1|NOT COMPLETED|Overall Study||0
107596|NCT01952301|262485|P1|COMPLETED|Overall Study||30
107597|NCT01952301|262485|P1|STARTED|Overall Study|We designed and implemented a single-blind, randomized, controlled, split-mouth study of 30 subjects|30
107598|NCT01952145|262493|P2|NOT COMPLETED|Overall Study||14
107599|NCT01952145|262494|P1|NOT COMPLETED|Overall Study||28
107600|NCT01952145|262493|P2|COMPLETED|Overall Study||265
107601|NCT01952145|262494|P1|COMPLETED|Overall Study||250
107602|NCT01952145|262493|P2|STARTED|Overall Study||279
107603|NCT01952145|262494|P1|STARTED|Overall Study||278
107604|NCT01952080|262508|P4|NOT COMPLETED|Overall Study||1
107605|NCT01952080|262509|P3|NOT COMPLETED|Overall Study||0
107606|NCT01952080|262510|P2|NOT COMPLETED|Overall Study||1
107607|NCT01952080|262511|P1|NOT COMPLETED|Overall Study||0
107608|NCT01952080|262508|P4|COMPLETED|Overall Study||14
107609|NCT01952080|262509|P3|COMPLETED|Overall Study||14
107610|NCT01952080|262510|P2|COMPLETED|Overall Study||7
107611|NCT01952080|262511|P1|COMPLETED|Overall Study||5
107612|NCT01952080|262508|P4|Treated|Overall Study||15
107613|NCT01952080|262509|P3|Treated|Overall Study||14
107614|NCT01952080|262510|P2|Treated|Overall Study||8
107615|NCT01952080|262511|P1|Treated|Overall Study||5
107616|NCT01952080|262508|P4|STARTED|Overall Study||15
107617|NCT01952080|262509|P3|STARTED|Overall Study||14
107618|NCT01952080|262510|P2|STARTED|Overall Study||8
107619|NCT01952080|262511|P1|STARTED|Overall Study||5
107620|NCT01952054|262557|P1|NOT COMPLETED|Overall Study||1
107621|NCT01952054|262557|P1|COMPLETED|Overall Study||5
107622|NCT01952054|262557|P1|STARTED|Overall Study||6
107623|NCT01952041|262565|P2|NOT COMPLETED|Overall Study||21
107624|NCT01952041|262566|P1|NOT COMPLETED|Overall Study||17
107625|NCT01952041|262565|P2|COMPLETED|Overall Study||43
107626|NCT01952041|262566|P1|COMPLETED|Overall Study||45
107627|NCT01952041|262565|P2|STARTED|Overall Study||64
107628|NCT01952041|262566|P1|STARTED|Overall Study||62
107629|NCT01952015|262580|P1|NOT COMPLETED|Treatment Period 3||9
107630|NCT01952015|262580|P1|COMPLETED|Treatment Period 3||0
107631|NCT01952015|262580|P1|STARTED|Treatment Period 3||9
107632|NCT01952015|262580|P1|NOT COMPLETED|Maintenance||2
107633|NCT01952015|262580|P1|COMPLETED|Maintenance||9
107634|NCT01952015|262580|P1|STARTED|Maintenance||11
107635|NCT01952015|262580|P1|NOT COMPLETED|Induction||1
107636|NCT01952015|262580|P1|COMPLETED|Induction||11
107637|NCT01952015|262580|P1|STARTED|Induction||12
107638|NCT01951963|262603|P2|NOT COMPLETED|Overall Study||0
107639|NCT01951963|262604|P1|NOT COMPLETED|Overall Study||0
107640|NCT01951963|262603|P2|COMPLETED|Overall Study||32
107641|NCT01951963|262604|P1|COMPLETED|Overall Study||31
107642|NCT01951963|262603|P2|STARTED|Overall Study||32
107643|NCT01951963|262604|P1|STARTED|Overall Study||31
107644|NCT01951950|262616|P2|NOT COMPLETED|Overall Study||6
107645|NCT01951950|262617|P1|NOT COMPLETED|Overall Study||6
107646|NCT01951950|262616|P2|COMPLETED|Overall Study||20
107647|NCT01951950|262617|P1|COMPLETED|Overall Study||20
107648|NCT01951950|262616|P2|STARTED|Overall Study||26
107649|NCT01951950|262617|P1|STARTED|Overall Study||26
107650|NCT01951820|262625|P2|NOT COMPLETED|Overall Study||0
107651|NCT01951820|262626|P1|NOT COMPLETED|Overall Study||0
107652|NCT01951820|262625|P2|COMPLETED|Overall Study||30
107653|NCT01951820|262626|P1|COMPLETED|Overall Study||34
107654|NCT01951820|262625|P2|STARTED|Overall Study||30
107655|NCT01951820|262626|P1|STARTED|Overall Study||34
107656|NCT01951768|262634|P2|NOT COMPLETED|Overall Study||0
107657|NCT01951768|262635|P1|NOT COMPLETED|Overall Study||0
107658|NCT01951768|262634|P2|COMPLETED|Overall Study|45 patients|45
107659|NCT01951768|262635|P1|COMPLETED|Overall Study|43 patients|43
107660|NCT01951768|262634|P2|STARTED|Overall Study||45
107661|NCT01951768|262635|P1|STARTED|Overall Study||43
107662|NCT01951703|262647|P2|NOT COMPLETED|Second Intervention||2
107663|NCT01951703|262648|P1|NOT COMPLETED|Second Intervention||0
107664|NCT01951703|262647|P2|COMPLETED|Second Intervention||60
107665|NCT01951703|262648|P1|COMPLETED|Second Intervention||61
107666|NCT01951703|262647|P2|STARTED|Second Intervention||62
107667|NCT01951703|262648|P1|STARTED|Second Intervention||61
107668|NCT01951703|262647|P2|NOT COMPLETED|First Intervention||1
107669|NCT01951703|262648|P1|NOT COMPLETED|First Intervention||3
107670|NCT01951703|262647|P2|COMPLETED|First Intervention||62
107671|NCT01951703|262648|P1|COMPLETED|First Intervention||61
107672|NCT01951703|262647|P2|STARTED|First Intervention||63
107673|NCT01951703|262648|P1|STARTED|First Intervention||64
107674|NCT01951651|262658|P2|NOT COMPLETED|Overall Study||2
107675|NCT01951651|262659|P1|NOT COMPLETED|Overall Study||4
107676|NCT01951651|262658|P2|COMPLETED|Overall Study||10
107677|NCT01951651|262659|P1|COMPLETED|Overall Study||8
107678|NCT01951651|262658|P2|STARTED|Overall Study||12
107679|NCT01951651|262659|P1|STARTED|Overall Study||12
107680|NCT01951586|262673|P2|NOT COMPLETED|Overall Study||148
107681|NCT01951586|262674|P1|NOT COMPLETED|Overall Study||78
107682|NCT01951586|262673|P2|COMPLETED|Overall Study||0
107683|NCT01951586|262674|P1|COMPLETED|Overall Study||0
107684|NCT01951586|262673|P2|Received Study Drug|Overall Study||145
107685|NCT01951586|262674|P1|Received Study Drug|Overall Study||76
107686|NCT01951586|262673|P2|STARTED|Overall Study||148
107687|NCT01951586|262674|P1|STARTED|Overall Study||78
107688|NCT01951573|262698|P2|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
107689|NCT01951573|262699|P1|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
107690|NCT01951573|262698|P2|COMPLETED|Period 2, Second 9 Hours of Wear||16
107691|NCT01951573|262699|P1|COMPLETED|Period 2, Second 9 Hours of Wear||17
107692|NCT01951573|262698|P2|STARTED|Period 2, Second 9 Hours of Wear||16
107693|NCT01951573|262699|P1|STARTED|Period 2, Second 9 Hours of Wear||17
107694|NCT01951573|262698|P2|NOT COMPLETED|Washout Period||1
107695|NCT01951573|262699|P1|NOT COMPLETED|Washout Period||0
107696|NCT01951573|262698|P2|COMPLETED|Washout Period||16
107697|NCT01951573|262699|P1|COMPLETED|Washout Period||17
107698|NCT01951573|262698|P2|STARTED|Washout Period||17
107699|NCT01951573|262699|P1|STARTED|Washout Period||17
107700|NCT01951573|262698|P2|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
107701|NCT01951573|262699|P1|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
107702|NCT01951573|262698|P2|COMPLETED|Period 1, First 9 Hours of Wear||17
107703|NCT01951573|262699|P1|COMPLETED|Period 1, First 9 Hours of Wear||17
107704|NCT01951573|262698|P2|STARTED|Period 1, First 9 Hours of Wear||17
107705|NCT01951573|262699|P1|STARTED|Period 1, First 9 Hours of Wear||17
107706|NCT01951417|262709|P1|NOT COMPLETED|Overall Study||9
107707|NCT01951417|262709|P1|COMPLETED|Overall Study||72
107708|NCT01951417|262709|P1|STARTED|Overall Study||81
107709|NCT01951352|262732|P1|NOT COMPLETED|Overall Study||0
107710|NCT01951352|262732|P1|COMPLETED|Overall Study||10
107711|NCT01951352|262732|P1|STARTED|Overall Study||10
107712|NCT01951339|262741|P2|NOT COMPLETED|Overall Study||1
107713|NCT01951339|262742|P1|NOT COMPLETED|Overall Study||2
107714|NCT01951339|262741|P2|COMPLETED|Overall Study||14
107715|NCT01951339|262742|P1|COMPLETED|Overall Study||13
107716|NCT01951339|262741|P2|STARTED|Overall Study||15
107717|NCT01951339|262742|P1|STARTED|Overall Study||15
107718|NCT01951170|262764|P1|NOT COMPLETED|Overall Study||1
107719|NCT01951170|262764|P1|COMPLETED|Overall Study||51
107720|NCT01951170|262764|P1|STARTED|Overall Study||52
107721|NCT01951157|262790|P3|NOT COMPLETED|Overall Study||25
107722|NCT01951157|262791|P2|NOT COMPLETED|Overall Study||22
107723|NCT01951157|262792|P1|NOT COMPLETED|Overall Study||22
107724|NCT01951157|262790|P3|COMPLETED|Overall Study||0
107725|NCT01951157|262791|P2|COMPLETED|Overall Study||0
107726|NCT01951157|262792|P1|COMPLETED|Overall Study||0
107727|NCT01951157|262790|P3|STARTED|Overall Study||25
107728|NCT01951157|262791|P2|STARTED|Overall Study||22
107729|NCT01951157|262792|P1|STARTED|Overall Study||22
107730|NCT01951105|262824|P3|NOT COMPLETED|Overall Study||2
107731|NCT01951105|262825|P2|NOT COMPLETED|Overall Study||10
107732|NCT01951105|262826|P1|NOT COMPLETED|Overall Study||1
107733|NCT01951105|262824|P3|COMPLETED|Overall Study||28
107734|NCT01951105|262825|P2|COMPLETED|Overall Study||21
107735|NCT01951105|262826|P1|COMPLETED|Overall Study||10
107736|NCT01951105|262824|P3|Completed 12 Weeks Treatment|Overall Study||28
107737|NCT01951105|262825|P2|Completed 12 Weeks Treatment|Overall Study||24
107738|NCT01951105|262826|P1|Completed 12 Weeks Treatment|Overall Study||10
107739|NCT01951105|262824|P3|STARTED|Overall Study||30
107740|NCT01951105|262825|P2|STARTED|Overall Study||31
107741|NCT01951105|262826|P1|STARTED|Overall Study||11
107742|NCT01951092|262840|P1|NOT COMPLETED|Overall Study||12
107743|NCT01951092|262840|P1|COMPLETED|Overall Study||20
107744|NCT01951092|262840|P1|STARTED|Overall Study||32
107745|NCT01951066|262845|P2|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
107746|NCT01951066|262846|P1|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
107747|NCT01951066|262845|P2|COMPLETED|Second Intervention (Week 16 to Week 32)||10
107748|NCT01951066|262846|P1|COMPLETED|Second Intervention (Week 16 to Week 32)||10
107749|NCT01951066|262845|P2|STARTED|Second Intervention (Week 16 to Week 32)||10
107750|NCT01951066|262846|P1|STARTED|Second Intervention (Week 16 to Week 32)||10
107751|NCT01951066|262845|P2|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
107752|NCT01951066|262846|P1|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
107753|NCT01951066|262845|P2|COMPLETED|First Intervention (Baseline to Week 16)||10
107754|NCT01951066|262846|P1|COMPLETED|First Intervention (Baseline to Week 16)||10
107755|NCT01951066|262845|P2|STARTED|First Intervention (Baseline to Week 16)||10
107756|NCT01951066|262846|P1|STARTED|First Intervention (Baseline to Week 16)||10
107757|NCT01950819|262853|P2|NOT COMPLETED|Overall Study||134
107758|NCT01950819|262854|P1|NOT COMPLETED|Overall Study||129
107759|NCT01950819|262853|P2|COMPLETED|Overall Study||881
107760|NCT01950819|262854|P1|COMPLETED|Overall Study||893
107761|NCT01950819|262853|P2|STARTED|Overall Study||1015
107762|NCT01950819|262854|P1|STARTED|Overall Study||1022
107763|NCT01950780|262902|P1|NOT COMPLETED|Overall Study||0
107764|NCT01950780|262902|P1|COMPLETED|Overall Study||12
107765|NCT01950780|262902|P1|STARTED|Overall Study||12
107766|NCT01950741|262907|P1|NOT COMPLETED|Overall Study||3
107767|NCT01950741|262907|P1|COMPLETED|Overall Study||45
107768|NCT01950741|262907|P1|STARTED|Overall Study||48
107769|NCT01950663|262916|P1|NOT COMPLETED|Overall Study||1
107770|NCT01950663|262916|P1|COMPLETED|Overall Study||467
107771|NCT01950663|262916|P1|STARTED|Overall Study||468
107772|NCT01950364|262922|P2|NOT COMPLETED|Overall Study||10
107773|NCT01950364|262923|P1|NOT COMPLETED|Overall Study||10
107774|NCT01950364|262922|P2|COMPLETED|Overall Study||0
107775|NCT01950364|262923|P1|COMPLETED|Overall Study||0
107776|NCT01950364|262922|P2|STARTED|Overall Study||10
107777|NCT01950364|262923|P1|STARTED|Overall Study||10
107778|NCT01950273|263023|P2|NOT COMPLETED|Overall Study||0
107779|NCT01950273|263024|P1|NOT COMPLETED|Overall Study||4
107780|NCT01950273|263023|P2|COMPLETED|Overall Study||46
107781|NCT01950273|263024|P1|COMPLETED|Overall Study||45
107782|NCT01950273|263023|P2|STARTED|Overall Study||46
107783|NCT01950273|263024|P1|STARTED|Overall Study||49
107784|NCT01950260|263046|P2|NOT COMPLETED|Overall Study||0
107785|NCT01950260|263047|P1|NOT COMPLETED|Overall Study||0
107786|NCT01950260|263046|P2|COMPLETED|Overall Study||31
107787|NCT01950260|263047|P1|COMPLETED|Overall Study||30
107788|NCT01950260|263046|P2|STARTED|Overall Study||31
107789|NCT01950260|263047|P1|STARTED|Overall Study||30
107790|NCT01950078|263059|P2|NOT COMPLETED|Overall Study||12
107791|NCT01950078|263060|P1|NOT COMPLETED|Overall Study||20
107792|NCT01950078|263059|P2|COMPLETED|Overall Study||496
107793|NCT01950078|263060|P1|COMPLETED|Overall Study||1005
107794|NCT01950078|263059|P2|STARTED|Overall Study||508
107795|NCT01950078|263060|P1|STARTED|Overall Study||1025
107796|NCT01950013|263071|P3|NOT COMPLETED|Overall Study||0
107797|NCT01950013|263072|P2|NOT COMPLETED|Overall Study||2
107798|NCT01950013|263073|P1|NOT COMPLETED|Overall Study||0
107799|NCT01950013|263071|P3|COMPLETED|Overall Study||15
107800|NCT01950013|263072|P2|COMPLETED|Overall Study||13
107801|NCT01950013|263073|P1|COMPLETED|Overall Study||15
107802|NCT01950013|263071|P3|STARTED|Overall Study||15
107803|NCT01950013|263072|P2|STARTED|Overall Study||15
107804|NCT01950013|263073|P1|STARTED|Overall Study||15
107805|NCT01949870|263084|P1|NOT COMPLETED|Overall Study||6
107806|NCT01949870|263084|P1|COMPLETED|Overall Study||0
107807|NCT01949870|263084|P1|Received Treatment|Overall Study||4
107808|NCT01949870|263084|P1|STARTED|Overall Study||6
107809|NCT01949844|263088|P1|NOT COMPLETED|Overall Study||0
107810|NCT01949844|263088|P1|COMPLETED|Overall Study||44
107811|NCT01949844|263088|P1|STARTED|Overall Study||44
107812|NCT01949779|263092|P1|NOT COMPLETED|Overall Study||2
107813|NCT01949779|263092|P1|COMPLETED|Overall Study||79
107814|NCT01949779|263092|P1|STARTED|Overall Study||81
107815|NCT01949545|263102|P4|NOT COMPLETED|Overall Study||0
107816|NCT01949545|263103|P3|NOT COMPLETED|Overall Study||0
107817|NCT01949545|263104|P2|NOT COMPLETED|Overall Study||0
107818|NCT01949545|263105|P1|NOT COMPLETED|Overall Study||0
107819|NCT01949545|263102|P4|COMPLETED|Overall Study||4
107820|NCT01949545|263103|P3|COMPLETED|Overall Study||14
107821|NCT01949545|263104|P2|COMPLETED|Overall Study||17
107822|NCT01949545|263105|P1|COMPLETED|Overall Study||11
107823|NCT01949545|263102|P4|STARTED|Overall Study||4
107824|NCT01949545|263103|P3|STARTED|Overall Study||14
107825|NCT01949545|263104|P2|STARTED|Overall Study||17
107826|NCT01949545|263105|P1|STARTED|Overall Study||11
107827|NCT01949532|263253|P2|NOT COMPLETED|Overall Study||3
107828|NCT01949532|263254|P1|NOT COMPLETED|Overall Study||3
107829|NCT01949532|263253|P2|COMPLETED|Overall Study||8
107830|NCT01949532|263254|P1|COMPLETED|Overall Study||12
107831|NCT01949532|263253|P2|STARTED|Overall Study||11
107832|NCT01949532|263254|P1|STARTED|Overall Study||15
107833|NCT01949480|263324|P2|NOT COMPLETED|Overall Study||8
107834|NCT01949480|263325|P1|NOT COMPLETED|Overall Study||5
107835|NCT01949480|263324|P2|COMPLETED|Overall Study||14
107836|NCT01949480|263325|P1|COMPLETED|Overall Study||15
107837|NCT01949480|263324|P2|STARTED|Overall Study||22
107838|NCT01949480|263325|P1|STARTED|Overall Study||20
107839|NCT01949389|263353|P1|NOT COMPLETED|Overall Study||0
107840|NCT01949389|263353|P1|COMPLETED|Overall Study||51
107841|NCT01949389|263353|P1|STARTED|Overall Study||51
107842|NCT01949155|263360|P2|NOT COMPLETED|Overall Study||0
107843|NCT01949155|263361|P1|NOT COMPLETED|Overall Study||2
107844|NCT01949155|263360|P2|COMPLETED|Overall Study||88
107845|NCT01949155|263361|P1|COMPLETED|Overall Study||176
107846|NCT01949155|263360|P2|STARTED|Overall Study||88
107847|NCT01949155|263361|P1|STARTED|Overall Study||178
107848|NCT01949142|263373|P2|NOT COMPLETED|Overall Study||1
107849|NCT01949142|263374|P1|NOT COMPLETED|Overall Study||3
107850|NCT01949142|263373|P2|COMPLETED|Overall Study||86
107851|NCT01949142|263374|P1|COMPLETED|Overall Study||176
107852|NCT01949142|263373|P2|STARTED|Overall Study||87
107853|NCT01949142|263374|P1|STARTED|Overall Study||179
107854|NCT01949116|263386|P2|NOT COMPLETED|Overall Study||6
107855|NCT01949116|263387|P1|NOT COMPLETED|Overall Study||8
107856|NCT01949116|263386|P2|COMPLETED|Overall Study||84
107857|NCT01949116|263387|P1|COMPLETED|Overall Study||78
107858|NCT01949116|263386|P2|STARTED|Overall Study||90
107859|NCT01949116|263387|P1|STARTED|Overall Study||86
107860|NCT01949090|263424|P5|NOT COMPLETED|Overall Study||4
107861|NCT01949090|263425|P4|NOT COMPLETED|Overall Study||1
107862|NCT01949090|263426|P3|NOT COMPLETED|Overall Study||2
107863|NCT01949090|263427|P2|NOT COMPLETED|Overall Study||2
107864|NCT01949090|263428|P1|NOT COMPLETED|Overall Study||4
107865|NCT01949090|263424|P5|COMPLETED|Overall Study||116
107866|NCT01949090|263425|P4|COMPLETED|Overall Study||59
107867|NCT01949090|263426|P3|COMPLETED|Overall Study||58
107868|NCT01949090|263427|P2|COMPLETED|Overall Study||58
107869|NCT01949090|263428|P1|COMPLETED|Overall Study||56
107870|NCT01949090|263424|P5|STARTED|Overall Study||120
107871|NCT01949090|263425|P4|STARTED|Overall Study||60
107872|NCT01949090|263426|P3|STARTED|Overall Study||60
107873|NCT01949090|263427|P2|STARTED|Overall Study||60
107874|NCT01949090|263428|P1|STARTED|Overall Study||60
107875|NCT01949051|263605|P6|NOT COMPLETED|Treatment Period 3 (7 Days)||0
107876|NCT01949051|263606|P5|NOT COMPLETED|Treatment Period 3 (7 Days)||0
107877|NCT01949051|263607|P4|NOT COMPLETED|Treatment Period 3 (7 Days)||0
107878|NCT01949051|263608|P3|NOT COMPLETED|Treatment Period 3 (7 Days)||0
107879|NCT01949051|263609|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||0
107880|NCT01949051|263610|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
107881|NCT01949051|263605|P6|COMPLETED|Treatment Period 3 (7 Days)||12
107882|NCT01949051|263606|P5|COMPLETED|Treatment Period 3 (7 Days)||13
107883|NCT01949051|263607|P4|COMPLETED|Treatment Period 3 (7 Days)||12
107884|NCT01949051|263608|P3|COMPLETED|Treatment Period 3 (7 Days)||12
107885|NCT01949051|263609|P2|COMPLETED|Treatment Period 3 (7 Days)||12
107886|NCT01949051|263610|P1|COMPLETED|Treatment Period 3 (7 Days)||11
107887|NCT01949051|263605|P6|STARTED|Treatment Period 3 (7 Days)||12
107888|NCT01949051|263606|P5|STARTED|Treatment Period 3 (7 Days)||13
107889|NCT01949051|263607|P4|STARTED|Treatment Period 3 (7 Days)||12
107890|NCT01949051|263608|P3|STARTED|Treatment Period 3 (7 Days)||12
107891|NCT01949051|263609|P2|STARTED|Treatment Period 3 (7 Days)||12
107892|NCT01949051|263610|P1|STARTED|Treatment Period 3 (7 Days)||11
107893|NCT01949051|263605|P6|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
107894|NCT01949051|263606|P5|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
107895|NCT01949051|263607|P4|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
107896|NCT01949051|263608|P3|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
107897|NCT01949051|263609|P2|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
107898|NCT01949051|263610|P1|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
107899|NCT01949051|263605|P6|COMPLETED|Washout Period 2 (14 to 20 Days)||12
107900|NCT01949051|263606|P5|COMPLETED|Washout Period 2 (14 to 20 Days)||13
107901|NCT01949051|263607|P4|COMPLETED|Washout Period 2 (14 to 20 Days)||12
107902|NCT01949051|263608|P3|COMPLETED|Washout Period 2 (14 to 20 Days)||12
107903|NCT01949051|263609|P2|COMPLETED|Washout Period 2 (14 to 20 Days)||12
107904|NCT01949051|263610|P1|COMPLETED|Washout Period 2 (14 to 20 Days)||11
107905|NCT01949051|263605|P6|STARTED|Washout Period 2 (14 to 20 Days)||12
107906|NCT01949051|263606|P5|STARTED|Washout Period 2 (14 to 20 Days)||13
107907|NCT01949051|263607|P4|STARTED|Washout Period 2 (14 to 20 Days)||12
107908|NCT01949051|263608|P3|STARTED|Washout Period 2 (14 to 20 Days)||12
107909|NCT01949051|263609|P2|STARTED|Washout Period 2 (14 to 20 Days)||12
107910|NCT01949051|263610|P1|STARTED|Washout Period 2 (14 to 20 Days)||11
107911|NCT01949051|263605|P6|NOT COMPLETED|Treatment Period 2 (7 Days)||1
107912|NCT01949051|263606|P5|NOT COMPLETED|Treatment Period 2 (7 Days)||0
107913|NCT01949051|263607|P4|NOT COMPLETED|Treatment Period 2 (7 Days)||0
107914|NCT01949051|263608|P3|NOT COMPLETED|Treatment Period 2 (7 Days)||1
107915|NCT01949051|263609|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||1
107916|NCT01949051|263610|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
107917|NCT01949051|263605|P6|COMPLETED|Treatment Period 2 (7 Days)||12
107918|NCT01949051|263606|P5|COMPLETED|Treatment Period 2 (7 Days)||13
107919|NCT01949051|263607|P4|COMPLETED|Treatment Period 2 (7 Days)||12
107920|NCT01949051|263608|P3|COMPLETED|Treatment Period 2 (7 Days)||12
107921|NCT01949051|263609|P2|COMPLETED|Treatment Period 2 (7 Days)||12
107922|NCT01949051|263610|P1|COMPLETED|Treatment Period 2 (7 Days)||11
107923|NCT01949051|263605|P6|STARTED|Treatment Period 2 (7 Days)||13
107924|NCT01949051|263606|P5|STARTED|Treatment Period 2 (7 Days)||13
107925|NCT01949051|263607|P4|STARTED|Treatment Period 2 (7 Days)||12
107926|NCT01949051|263608|P3|STARTED|Treatment Period 2 (7 Days)||13
107927|NCT01949051|263609|P2|STARTED|Treatment Period 2 (7 Days)||13
107928|NCT01949051|263610|P1|STARTED|Treatment Period 2 (7 Days)||11
107929|NCT01949051|263605|P6|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
107930|NCT01949051|263606|P5|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
107931|NCT01949051|263607|P4|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
107932|NCT01949051|263608|P3|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
107933|NCT01949051|263609|P2|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
107934|NCT01949051|263610|P1|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
107935|NCT01949051|263605|P6|COMPLETED|Washout Period 1 (14 to 20 Days)||13
107936|NCT01949051|263606|P5|COMPLETED|Washout Period 1 (14 to 20 Days)||13
107937|NCT01949051|263607|P4|COMPLETED|Washout Period 1 (14 to 20 Days)||12
107938|NCT01949051|263608|P3|COMPLETED|Washout Period 1 (14 to 20 Days)||13
107939|NCT01949051|263609|P2|COMPLETED|Washout Period 1 (14 to 20 Days)||13
107940|NCT01949051|263610|P1|COMPLETED|Washout Period 1 (14 to 20 Days)||11
107941|NCT01949051|263605|P6|STARTED|Washout Period 1 (14 to 20 Days)||13
107942|NCT01949051|263606|P5|STARTED|Washout Period 1 (14 to 20 Days)||13
107943|NCT01949051|263607|P4|STARTED|Washout Period 1 (14 to 20 Days)||12
107944|NCT01949051|263608|P3|STARTED|Washout Period 1 (14 to 20 Days)||13
107945|NCT01949051|263609|P2|STARTED|Washout Period 1 (14 to 20 Days)||13
107946|NCT01949051|263610|P1|STARTED|Washout Period 1 (14 to 20 Days)||11
107947|NCT01949051|263605|P6|NOT COMPLETED|Treatment Period 1 (7 Days)||0
107948|NCT01949051|263606|P5|NOT COMPLETED|Treatment Period 1 (7 Days)||0
107949|NCT01949051|263607|P4|NOT COMPLETED|Treatment Period 1 (7 Days)||1
107950|NCT01949051|263608|P3|NOT COMPLETED|Treatment Period 1 (7 Days)||0
107951|NCT01949051|263609|P2|NOT COMPLETED|Treatment Period 1 (7 Days)||0
107952|NCT01949051|263610|P1|NOT COMPLETED|Treatment Period 1 (7 Days)||2
107953|NCT01949051|263605|P6|COMPLETED|Treatment Period 1 (7 Days)||13
107954|NCT01949051|263606|P5|COMPLETED|Treatment Period 1 (7 Days)||13
107955|NCT01949051|263607|P4|COMPLETED|Treatment Period 1 (7 Days)||12
107956|NCT01949051|263608|P3|COMPLETED|Treatment Period 1 (7 Days)||13
107957|NCT01949051|263609|P2|COMPLETED|Treatment Period 1 (7 Days)||13
107958|NCT01949051|263610|P1|COMPLETED|Treatment Period 1 (7 Days)||11
107959|NCT01949051|263605|P6|STARTED|Treatment Period 1 (7 Days)||13
107960|NCT01949051|263606|P5|STARTED|Treatment Period 1 (7 Days)||13
107961|NCT01949051|263607|P4|STARTED|Treatment Period 1 (7 Days)||13
107962|NCT01949051|263608|P3|STARTED|Treatment Period 1 (7 Days)||13
107963|NCT01949051|263609|P2|STARTED|Treatment Period 1 (7 Days)||13
107964|NCT01949051|263610|P1|STARTED|Treatment Period 1 (7 Days)||13
107965|NCT01948986|263626|P5|NOT COMPLETED|Overall Study||0
107966|NCT01948986|263627|P4|NOT COMPLETED|Overall Study||0
107967|NCT01948986|263628|P3|NOT COMPLETED|Overall Study||0
107968|NCT01948986|263629|P2|NOT COMPLETED|Overall Study||0
107969|NCT01948986|263630|P1|NOT COMPLETED|Overall Study||0
107970|NCT01948986|263626|P5|COMPLETED|Overall Study||8
107971|NCT01948986|263627|P4|COMPLETED|Overall Study||6
107972|NCT01948986|263628|P3|COMPLETED|Overall Study||8
107973|NCT01948986|263629|P2|COMPLETED|Overall Study||8
107974|NCT01948986|263630|P1|COMPLETED|Overall Study||6
107975|NCT01948986|263626|P5|STARTED|Overall Study||8
107976|NCT01948986|263627|P4|STARTED|Overall Study||6
107977|NCT01948986|263628|P3|STARTED|Overall Study||8
107978|NCT01948986|263629|P2|STARTED|Overall Study||8
107979|NCT01948986|263630|P1|STARTED|Overall Study||6
107980|NCT01948947|263789|P2|NOT COMPLETED|Overall Study||0
107981|NCT01948947|263790|P1|NOT COMPLETED|Overall Study||0
107982|NCT01948947|263789|P2|COMPLETED|Overall Study||15
107983|NCT01948947|263790|P1|COMPLETED|Overall Study||14
107984|NCT01948947|263789|P2|STARTED|Overall Study||15
107985|NCT01948947|263790|P1|STARTED|Overall Study||14
107986|NCT01948908|263805|P3|NOT COMPLETED|Overall Study||2
107987|NCT01948908|263806|P2|NOT COMPLETED|Overall Study||0
107988|NCT01948908|263807|P1|NOT COMPLETED|Overall Study||1
107989|NCT01948908|263805|P3|COMPLETED|Overall Study||31
107990|NCT01948908|263806|P2|COMPLETED|Overall Study||33
107991|NCT01948908|263807|P1|COMPLETED|Overall Study||32
107992|NCT01948908|263805|P3|STARTED|Overall Study||33
107993|NCT01948908|263806|P2|STARTED|Overall Study||33
107994|NCT01948908|263807|P1|STARTED|Overall Study||33
107995|NCT01948830|263823|P2|NOT COMPLETED|Overall Study||32
107996|NCT01948830|263824|P1|NOT COMPLETED|Overall Study||33
107997|NCT01948830|263823|P2|COMPLETED|Overall Study||295
107998|NCT01948830|263824|P1|COMPLETED|Overall Study||290
107999|NCT01948830|263823|P2|Safety Set|Overall Study||326
108000|NCT01948830|263824|P1|Safety Set|Overall Study||323
108001|NCT01948830|263823|P2|STARTED|Overall Study||327
108002|NCT01948830|263824|P1|STARTED|Overall Study||323
108003|NCT01948791|263856|P1|NOT COMPLETED|Overall Study||71
108004|NCT01948791|263856|P1|COMPLETED|Overall Study||151
108005|NCT01948791|263856|P1|STARTED|Overall Study||222
108006|NCT01948518|263864|P1|NOT COMPLETED|Overall Study||0
108007|NCT01948518|263864|P1|COMPLETED|Overall Study||15
108008|NCT01948518|263864|P1|STARTED|Overall Study||15
108009|NCT01948388|263871|P2|NOT COMPLETED|Overall Study||1
108010|NCT01948388|263872|P1|NOT COMPLETED|Overall Study||2
108011|NCT01948388|263871|P2|COMPLETED|Overall Study||9
108012|NCT01948388|263872|P1|COMPLETED|Overall Study||8
108013|NCT01948388|263871|P2|STARTED|Overall Study||10
108014|NCT01948388|263872|P1|STARTED|Overall Study||10
108015|NCT01948375|263888|P2|NOT COMPLETED|Overall Study||0
108016|NCT01948375|263889|P1|NOT COMPLETED|Overall Study||0
108017|NCT01948375|263888|P2|COMPLETED|Overall Study||30
108018|NCT01948375|263889|P1|COMPLETED|Overall Study||30
108019|NCT01948375|263888|P2|STARTED|Overall Study||30
108020|NCT01948375|263889|P1|STARTED|Overall Study||30
108021|NCT01948310|263905|P2|NOT COMPLETED|Overall Study||5
108022|NCT01948310|263906|P1|NOT COMPLETED|Overall Study||3
108023|NCT01948310|263905|P2|COMPLETED|Overall Study||13
108024|NCT01948310|263906|P1|COMPLETED|Overall Study||16
108025|NCT01948310|263905|P2|STARTED|Overall Study||18
108026|NCT01948310|263906|P1|STARTED|Overall Study||19
108027|NCT01948258|263916|P1|NOT COMPLETED|Overall Study||162
108028|NCT01948258|263916|P1|COMPLETED|Overall Study||233
108029|NCT01948258|263916|P1|STARTED|Overall Study||395
108030|NCT01948193|263922|P1|NOT COMPLETED|Overall Study||9
108031|NCT01948193|263922|P1|COMPLETED|Overall Study||168
108032|NCT01948193|263922|P1|STARTED|Overall Study||177
108033|NCT01948141|263931|P1|NOT COMPLETED|Overall Study||0
108034|NCT01948141|263931|P1|COMPLETED|Overall Study||6
108035|NCT01948141|263931|P1|STARTED|Overall Study||6
108036|NCT01948076|263944|P2|NOT COMPLETED|Overall Study||1
108037|NCT01948076|263945|P1|NOT COMPLETED|Overall Study||0
108038|NCT01948076|263944|P2|COMPLETED|Overall Study||19
108039|NCT01948076|263945|P1|COMPLETED|Overall Study||20
108040|NCT01948076|263944|P2|STARTED|Overall Study||20
108041|NCT01948076|263945|P1|STARTED|Overall Study||20
108042|NCT01948063|263955|P2|NOT COMPLETED|Overall Study||2
108043|NCT01948063|263956|P1|NOT COMPLETED|Overall Study||1
108044|NCT01948063|263955|P2|COMPLETED|Overall Study||19
108045|NCT01948063|263956|P1|COMPLETED|Overall Study||19
108046|NCT01948063|263955|P2|STARTED|Overall Study||21
108047|NCT01948063|263956|P1|STARTED|Overall Study||20
108048|NCT01948050|263964|P2|NOT COMPLETED|Overall Study||1
108049|NCT01948050|263965|P1|NOT COMPLETED|Overall Study||0
108050|NCT01948050|263964|P2|COMPLETED|Overall Study||7
108051|NCT01948050|263965|P1|COMPLETED|Overall Study||16
108052|NCT01948050|263964|P2|STARTED|Overall Study||8
108053|NCT01948050|263965|P1|STARTED|Overall Study||16
108054|NCT01947946|263974|P3|NOT COMPLETED|Overall Study||5
108055|NCT01947946|263975|P2|NOT COMPLETED|Overall Study||5
108056|NCT01947946|263976|P1|NOT COMPLETED|Overall Study||3
108057|NCT01947946|263974|P3|COMPLETED|Overall Study||0
108058|NCT01947946|263975|P2|COMPLETED|Overall Study||0
108059|NCT01947946|263976|P1|COMPLETED|Overall Study|Study Stopped|0
108060|NCT01947946|263974|P3|STARTED|Overall Study||5
108061|NCT01947946|263975|P2|STARTED|Overall Study||5
108062|NCT01947946|263976|P1|STARTED|Overall Study||3
108063|NCT01947907|263988|P4|NOT COMPLETED|Overall Study||0
108064|NCT01947907|263989|P3|NOT COMPLETED|Overall Study||0
108065|NCT01947907|263990|P2|NOT COMPLETED|Overall Study||0
108066|NCT01947907|263991|P1|NOT COMPLETED|Overall Study||0
108067|NCT01947907|263988|P4|COMPLETED|Overall Study||13
108068|NCT01947907|263989|P3|COMPLETED|Overall Study||14
108069|NCT01947907|263990|P2|COMPLETED|Overall Study||14
108070|NCT01947907|263991|P1|COMPLETED|Overall Study||12
108071|NCT01947907|263988|P4|STARTED|Overall Study||13
108072|NCT01947907|263989|P3|STARTED|Overall Study||14
108073|NCT01947907|263990|P2|STARTED|Overall Study||14
108074|NCT01947907|263991|P1|STARTED|Overall Study||12
108075|NCT01947894|264033|P3|NOT COMPLETED|Overall Study||27
108076|NCT01947894|264034|P2|NOT COMPLETED|Overall Study||18
108077|NCT01947894|264035|P1|NOT COMPLETED|Overall Study||87
108078|NCT01947894|264033|P3|COMPLETED|Overall Study||61
108079|NCT01947894|264034|P2|COMPLETED|Overall Study||24
108080|NCT01947894|264035|P1|COMPLETED|Overall Study||160
108081|NCT01947894|264033|P3|Treated|Overall Study||87
108082|NCT01947894|264034|P2|Treated|Overall Study||41
108083|NCT01947894|264035|P1|Treated|Overall Study||246
108084|NCT01947894|264033|P3|STARTED|Overall Study||88
108085|NCT01947894|264034|P2|STARTED|Overall Study||42
108086|NCT01947894|264035|P1|STARTED|Overall Study||247
108087|NCT01947855|264100|P3|NOT COMPLETED|Overall Study||0
108088|NCT01947855|264101|P2|NOT COMPLETED|Overall Study||0
108089|NCT01947855|264102|P1|NOT COMPLETED|Overall Study||1
108090|NCT01947855|264100|P3|COMPLETED|Overall Study||19
108091|NCT01947855|264101|P2|COMPLETED|Overall Study||20
108092|NCT01947855|264102|P1|COMPLETED|Overall Study||20
108093|NCT01947855|264100|P3|STARTED|Overall Study||19
108094|NCT01947855|264101|P2|STARTED|Overall Study||20
108095|NCT01947855|264102|P1|STARTED|Overall Study||21
108096|NCT01947816|264110|P1|NOT COMPLETED|Overall Study||70
108097|NCT01947816|264110|P1|COMPLETED|Overall Study||1523
108098|NCT01947816|264110|P1|STARTED|Overall Study||1593
108099|NCT01947647|264120|P2|NOT COMPLETED|6-month Followup Phase||8
108100|NCT01947647|264121|P1|NOT COMPLETED|6-month Followup Phase||9
108101|NCT01947647|264120|P2|COMPLETED|6-month Followup Phase||13
108102|NCT01947647|264121|P1|COMPLETED|6-month Followup Phase||20
108103|NCT01947647|264120|P2|STARTED|6-month Followup Phase||21
108104|NCT01947647|264121|P1|STARTED|6-month Followup Phase||29
108105|NCT01947647|264120|P2|NOT COMPLETED|Treatment Phase||26
108106|NCT01947647|264121|P1|NOT COMPLETED|Treatment Phase||17
108107|NCT01947647|264120|P2|COMPLETED|Treatment Phase||21
108108|NCT01947647|264121|P1|COMPLETED|Treatment Phase||29
108109|NCT01947647|264120|P2|STARTED|Treatment Phase||47
108110|NCT01947647|264121|P1|STARTED|Treatment Phase||46
108111|NCT01947582|264137|P1|NOT COMPLETED|Overall Study||1
108112|NCT01947582|264137|P1|COMPLETED|Overall Study||1
108113|NCT01947582|264137|P1|STARTED|Overall Study||2
108114|NCT01947517|264146|P2|NOT COMPLETED|Overall Study||1
108115|NCT01947517|264147|P1|NOT COMPLETED|Overall Study||1
108116|NCT01947517|264146|P2|COMPLETED|Overall Study||25
108117|NCT01947517|264147|P1|COMPLETED|Overall Study||25
108118|NCT01947517|264146|P2|STARTED|Overall Study||26
108119|NCT01947517|264147|P1|STARTED|Overall Study||26
108120|NCT01947491|264165|P4|NOT COMPLETED|Overall Study||5
108121|NCT01947491|264166|P3|NOT COMPLETED|Overall Study||2
108122|NCT01947491|264167|P2|NOT COMPLETED|Overall Study||6
108123|NCT01947491|264168|P1|NOT COMPLETED|Overall Study||8
108124|NCT01947491|264165|P4|COMPLETED|Overall Study||38
108125|NCT01947491|264166|P3|COMPLETED|Overall Study||88
108126|NCT01947491|264167|P2|COMPLETED|Overall Study||81
108127|NCT01947491|264168|P1|COMPLETED|Overall Study||166
108128|NCT01947491|264165|P4|STARTED|Overall Study||43
108129|NCT01947491|264166|P3|STARTED|Overall Study||90
108130|NCT01947491|264167|P2|STARTED|Overall Study||87
108131|NCT01947491|264168|P1|STARTED|Overall Study||174
108132|NCT01947335|264180|P2|NOT COMPLETED|Overall Study||0
108133|NCT01947335|264181|P1|NOT COMPLETED|Overall Study||0
108134|NCT01947335|264180|P2|COMPLETED|Overall Study||41
108135|NCT01947335|264181|P1|COMPLETED|Overall Study||42
108136|NCT01947335|264180|P2|STARTED|Overall Study||41
108137|NCT01947335|264181|P1|STARTED|Overall Study||42
108138|NCT01947283|264198|P7|NOT COMPLETED|Overall Study||8
108139|NCT01947283|264199|P6|NOT COMPLETED|Overall Study||7
108140|NCT01947283|264200|P5|NOT COMPLETED|Overall Study||0
108141|NCT01947283|264201|P4|NOT COMPLETED|Overall Study||17
108142|NCT01947283|264202|P3|NOT COMPLETED|Overall Study||21
108143|NCT01947283|264203|P2|NOT COMPLETED|Overall Study||23
108144|NCT01947283|264204|P1|NOT COMPLETED|Overall Study||29
108145|NCT01947283|264198|P7|COMPLETED|Overall Study||32
108146|NCT01947283|264199|P6|COMPLETED|Overall Study||27
108147|NCT01947283|264200|P5|COMPLETED|Overall Study||95
108148|NCT01947283|264201|P4|COMPLETED|Overall Study||55
108149|NCT01947283|264202|P3|COMPLETED|Overall Study||62
108150|NCT01947283|264203|P2|COMPLETED|Overall Study||45
108151|NCT01947283|264204|P1|COMPLETED|Overall Study||60
108152|NCT01947283|264198|P7|Completed NRCT Baseline Assessment|Overall Study||0
108153|NCT01947283|264199|P6|Completed NRCT Baseline Assessment|Overall Study||0
108154|NCT01947283|264200|P5|Completed NRCT Baseline Assessment|Overall Study||95
108155|NCT01947283|264201|P4|Completed NRCT Baseline Assessment|Overall Study||0
108156|NCT01947283|264202|P3|Completed NRCT Baseline Assessment|Overall Study||0
108157|NCT01947283|264203|P2|Completed NRCT Baseline Assessment|Overall Study||0
108158|NCT01947283|264204|P1|Completed NRCT Baseline Assessment|Overall Study||0
108159|NCT01947283|264198|P7|In Analysis|Overall Study||38
108160|NCT01947283|264199|P6|In Analysis|Overall Study||30
108161|NCT01947283|264200|P5|In Analysis|Overall Study||95
108162|NCT01947283|264201|P4|In Analysis|Overall Study||72
108163|NCT01947283|264202|P3|In Analysis|Overall Study||83
108164|NCT01947283|264203|P2|In Analysis|Overall Study||68
108165|NCT01947283|264204|P1|In Analysis|Overall Study||89
108166|NCT01947283|264198|P7|End-of-Intervention Assessment|Overall Study||33
108167|NCT01947283|264199|P6|End-of-Intervention Assessment|Overall Study||32
108168|NCT01947283|264200|P5|End-of-Intervention Assessment|Overall Study||0
108169|NCT01947283|264201|P4|End-of-Intervention Assessment|Overall Study||66
108170|NCT01947283|264202|P3|End-of-Intervention Assessment|Overall Study||73
108171|NCT01947283|264203|P2|End-of-Intervention Assessment|Overall Study||53
108172|NCT01947283|264204|P1|End-of-Intervention Assessment|Overall Study||74
108173|NCT01947283|264198|P7|Clinical Recording|Overall Study||0
108174|NCT01947283|264199|P6|Clinical Recording|Overall Study||0
108175|NCT01947283|264200|P5|Clinical Recording|Overall Study||0
108176|NCT01947283|264201|P4|Clinical Recording|Overall Study||57
108177|NCT01947283|264202|P3|Clinical Recording|Overall Study||68
108178|NCT01947283|264203|P2|Clinical Recording|Overall Study||54
108179|NCT01947283|264204|P1|Clinical Recording|Overall Study||65
108180|NCT01947283|264198|P7|Follow-up Assessment|Overall Study||36
108181|NCT01947283|264199|P6|Follow-up Assessment|Overall Study||27
108182|NCT01947283|264200|P5|Follow-up Assessment|Overall Study||0
108183|NCT01947283|264201|P4|Follow-up Assessment|Overall Study||59
108184|NCT01947283|264202|P3|Follow-up Assessment|Overall Study||65
108185|NCT01947283|264203|P2|Follow-up Assessment|Overall Study||51
108186|NCT01947283|264204|P1|Follow-up Assessment|Overall Study||64
108187|NCT01947283|264198|P7|Baseline Assessment|Overall Study||40
108188|NCT01947283|264199|P6|Baseline Assessment|Overall Study||34
108189|NCT01947283|264200|P5|Baseline Assessment|Overall Study||0
108190|NCT01947283|264201|P4|Baseline Assessment|Overall Study||72
108191|NCT01947283|264202|P3|Baseline Assessment|Overall Study||83
108192|NCT01947283|264203|P2|Baseline Assessment|Overall Study||68
108193|NCT01947283|264204|P1|Baseline Assessment|Overall Study||89
108194|NCT01947283|264198|P7|STARTED|Overall Study||40
108195|NCT01947283|264199|P6|STARTED|Overall Study||34
108196|NCT01947283|264200|P5|STARTED|Overall Study||95
108197|NCT01947283|264201|P4|STARTED|Overall Study||72
108198|NCT01947283|264202|P3|STARTED|Overall Study||83
108199|NCT01947283|264203|P2|STARTED|Overall Study||68
108200|NCT01947283|264204|P1|STARTED|Overall Study||89
108201|NCT01947153|264255|P2|NOT COMPLETED|Test Period 2||0
108202|NCT01947153|264256|P1|NOT COMPLETED|Test Period 2||0
108203|NCT01947153|264255|P2|COMPLETED|Test Period 2||18
108204|NCT01947153|264256|P1|COMPLETED|Test Period 2||18
108205|NCT01947153|264255|P2|STARTED|Test Period 2||18
108206|NCT01947153|264256|P1|STARTED|Test Period 2||18
108207|NCT01947153|264255|P2|NOT COMPLETED|Test Period 1||0
108208|NCT01947153|264256|P1|NOT COMPLETED|Test Period 1||0
108209|NCT01947153|264255|P2|COMPLETED|Test Period 1||18
108210|NCT01947153|264256|P1|COMPLETED|Test Period 1||18
108211|NCT01947153|264255|P2|STARTED|Test Period 1||18
108212|NCT01947153|264256|P1|STARTED|Test Period 1||18
108213|NCT01947127|264276|P2|NOT COMPLETED|Overall Study||43
108214|NCT01947127|264277|P1|NOT COMPLETED|Overall Study||23
108215|NCT01947127|264276|P2|COMPLETED|Overall Study||249
108216|NCT01947127|264277|P1|COMPLETED|Overall Study||143
108217|NCT01947127|264276|P2|STARTED|Overall Study||292
108218|NCT01947127|264277|P1|STARTED|Overall Study||166
108219|NCT01946542|264289|P2|NOT COMPLETED|Testing Visit 2||0
108220|NCT01946542|264290|P1|NOT COMPLETED|Testing Visit 2||0
108221|NCT01946542|264289|P2|COMPLETED|Testing Visit 2||1
108222|NCT01946542|264290|P1|COMPLETED|Testing Visit 2||1
108223|NCT01946542|264289|P2|STARTED|Testing Visit 2||1
108224|NCT01946542|264290|P1|STARTED|Testing Visit 2||1
108225|NCT01946542|264289|P2|NOT COMPLETED|Testing Visit 1||0
108226|NCT01946542|264290|P1|NOT COMPLETED|Testing Visit 1||0
108227|NCT01946542|264289|P2|COMPLETED|Testing Visit 1||1
108228|NCT01946542|264290|P1|COMPLETED|Testing Visit 1||1
108229|NCT01946542|264289|P2|STARTED|Testing Visit 1||1
108230|NCT01946542|264290|P1|STARTED|Testing Visit 1||1
108231|NCT01946529|264301|P3|NOT COMPLETED|Completion of All Therapy||6
108232|NCT01946529|264302|P2|NOT COMPLETED|Completion of All Therapy||16
108233|NCT01946529|264303|P1|NOT COMPLETED|Completion of All Therapy||1
108234|NCT01946529|264301|P3|COMPLETED|Completion of All Therapy||0
108235|NCT01946529|264302|P2|COMPLETED|Completion of All Therapy||0
108236|NCT01946529|264303|P1|COMPLETED|Completion of All Therapy||0
108237|NCT01946529|264301|P3|STARTED|Completion of All Therapy||6
108238|NCT01946529|264302|P2|STARTED|Completion of All Therapy||16
108239|NCT01946529|264303|P1|STARTED|Completion of All Therapy||1
108240|NCT01946529|264301|P3|NOT COMPLETED|End of Window Therapy (2 Courses)||0
108241|NCT01946529|264302|P2|NOT COMPLETED|End of Window Therapy (2 Courses)||1
108242|NCT01946529|264303|P1|NOT COMPLETED|End of Window Therapy (2 Courses)||0
108243|NCT01946529|264301|P3|COMPLETED|End of Window Therapy (2 Courses)||6
108244|NCT01946529|264302|P2|COMPLETED|End of Window Therapy (2 Courses)||16
108245|NCT01946529|264303|P1|COMPLETED|End of Window Therapy (2 Courses)||1
108246|NCT01946529|264301|P3|STARTED|End of Window Therapy (2 Courses)||6
108247|NCT01946529|264302|P2|STARTED|End of Window Therapy (2 Courses)||17
108248|NCT01946529|264303|P1|STARTED|End of Window Therapy (2 Courses)||1
108249|NCT01946438|264314|P4|NOT COMPLETED|Overall Study||1
108250|NCT01946438|264315|P3|NOT COMPLETED|Overall Study||1
108251|NCT01946438|264316|P2|NOT COMPLETED|Overall Study||0
108252|NCT01946438|264317|P1|NOT COMPLETED|Overall Study||2
108253|NCT01946438|264314|P4|COMPLETED|Overall Study||51
108254|NCT01946438|264315|P3|COMPLETED|Overall Study||51
108255|NCT01946438|264316|P2|COMPLETED|Overall Study||52
108256|NCT01946438|264317|P1|COMPLETED|Overall Study||50
108257|NCT01946438|264314|P4|STARTED|Overall Study||52
108258|NCT01946438|264315|P3|STARTED|Overall Study||52
108259|NCT01946438|264316|P2|STARTED|Overall Study||52
108260|NCT01946438|264317|P1|STARTED|Overall Study||52
108261|NCT01946425|264345|P2|NOT COMPLETED|Overall Study||0
108262|NCT01946425|264346|P1|NOT COMPLETED|Overall Study||2
108263|NCT01946425|264345|P2|COMPLETED|Overall Study||30
108264|NCT01946425|264346|P1|COMPLETED|Overall Study||28
108265|NCT01946425|264345|P2|STARTED|Overall Study||30
108266|NCT01946425|264346|P1|STARTED|Overall Study||30
108267|NCT01946412|264360|P1|NOT COMPLETED|Overall Study||5
108268|NCT01946412|264360|P1|COMPLETED|Overall Study||28
108269|NCT01946412|264360|P1|STARTED|Overall Study||33
108270|NCT01946243|264382|P1|NOT COMPLETED|Overall Study||0
108271|NCT01946243|264382|P1|COMPLETED|Overall Study||96
108272|NCT01946243|264382|P1|STARTED|Overall Study||96
108273|NCT01946204|264405|P2|NOT COMPLETED|Overall Study||806
108274|NCT01946204|264406|P1|NOT COMPLETED|Overall Study||401
108275|NCT01946204|264405|P2|COMPLETED|Overall Study||0
108276|NCT01946204|264406|P1|COMPLETED|Overall Study||0
108277|NCT01946204|264405|P2|Treated|Overall Study||803
108278|NCT01946204|264406|P1|Treated|Overall Study||398
108279|NCT01946204|264405|P2|STARTED|Overall Study||806
108280|NCT01946204|264406|P1|STARTED|Overall Study||401
108281|NCT01946178|264422|P1|NOT COMPLETED|Overall Study||2
108282|NCT01946178|264422|P1|COMPLETED|Overall Study||71
108283|NCT01946178|264422|P1|STARTED|Overall Study||73
108284|NCT01946126|264432|P2|NOT COMPLETED|Overall Study||0
108285|NCT01946126|264433|P1|NOT COMPLETED|Overall Study||0
108286|NCT01946126|264432|P2|COMPLETED|Overall Study||275
108287|NCT01946126|264433|P1|COMPLETED|Overall Study||184
108288|NCT01946126|264432|P2|STARTED|Overall Study||275
108289|NCT01946126|264433|P1|STARTED|Overall Study||184
108290|NCT01945996|264449|P2|NOT COMPLETED|Overall Study||5
108291|NCT01945996|264450|P1|NOT COMPLETED|Overall Study||3
108292|NCT01945996|264449|P2|COMPLETED|Overall Study||17
108293|NCT01945996|264450|P1|COMPLETED|Overall Study||19
108294|NCT01945996|264449|P2|STARTED|Overall Study||22
108295|NCT01945996|264450|P1|STARTED|Overall Study||22
108296|NCT01945970|264482|P6|NOT COMPLETED|Overall Study||0
108297|NCT01945970|264483|P5|NOT COMPLETED|Overall Study||0
108298|NCT01945970|264484|P4|NOT COMPLETED|Overall Study||0
108299|NCT01945970|264485|P3|NOT COMPLETED|Overall Study||0
108300|NCT01945970|264486|P2|NOT COMPLETED|Overall Study||0
108301|NCT01945970|264487|P1|NOT COMPLETED|Overall Study||0
108302|NCT01945970|264482|P6|COMPLETED|Overall Study||5
108303|NCT01945970|264483|P5|COMPLETED|Overall Study||5
108304|NCT01945970|264484|P4|COMPLETED|Overall Study||5
108305|NCT01945970|264485|P3|COMPLETED|Overall Study||5
108306|NCT01945970|264486|P2|COMPLETED|Overall Study||5
108307|NCT01945970|264487|P1|COMPLETED|Overall Study||5
108308|NCT01945970|264482|P6|STARTED|Overall Study||5
108309|NCT01945970|264483|P5|STARTED|Overall Study||5
108310|NCT01945970|264484|P4|STARTED|Overall Study||5
108311|NCT01945970|264485|P3|STARTED|Overall Study||5
108312|NCT01945970|264486|P2|STARTED|Overall Study||5
108313|NCT01945970|264487|P1|STARTED|Overall Study||5
108314|NCT01945944|264526|P2|NOT COMPLETED|Overall Study||3
108315|NCT01945944|264527|P1|NOT COMPLETED|Overall Study||1
108316|NCT01945944|264526|P2|COMPLETED|Overall Study||6
108317|NCT01945944|264527|P1|COMPLETED|Overall Study||8
108318|NCT01945944|264526|P2|STARTED|Overall Study||9
108319|NCT01945944|264527|P1|STARTED|Overall Study||9
108320|NCT01945866|264551|P2|NOT COMPLETED|Overall Study||0
108321|NCT01945866|264552|P1|NOT COMPLETED|Overall Study||2
108322|NCT01945866|264551|P2|COMPLETED|Overall Study||64
108323|NCT01945866|264552|P1|COMPLETED|Overall Study||63
108324|NCT01945866|264551|P2|STARTED|Overall Study||64
108325|NCT01945866|264552|P1|STARTED|Overall Study||65
108326|NCT01945775|264573|P2|NOT COMPLETED|Overall Study||144
108327|NCT01945775|264574|P1|NOT COMPLETED|Overall Study||287
108328|NCT01945775|264573|P2|COMPLETED|Overall Study||0
108329|NCT01945775|264574|P1|COMPLETED|Overall Study||0
108330|NCT01945775|264573|P2|Treated|Overall Study||126
108331|NCT01945775|264574|P1|Treated|Overall Study||286
108332|NCT01945775|264573|P2|STARTED|Overall Study||144
108333|NCT01945775|264574|P1|STARTED|Overall Study||287
108334|NCT01945710|264610|P7|NOT COMPLETED|Overall Study||23
108335|NCT01945710|264611|P6|NOT COMPLETED|Overall Study||3
108336|NCT01945710|264612|P5|NOT COMPLETED|Overall Study||9
108337|NCT01945710|264613|P4|NOT COMPLETED|Overall Study||3
108338|NCT01945710|264614|P3|NOT COMPLETED|Overall Study||7
108339|NCT01945710|264615|P2|NOT COMPLETED|Overall Study||6
108340|NCT01945710|264616|P1|NOT COMPLETED|Overall Study||7
108341|NCT01945710|264610|P7|COMPLETED|Overall Study||0
108342|NCT01945710|264611|P6|COMPLETED|Overall Study||0
108343|NCT01945710|264612|P5|COMPLETED|Overall Study||0
108344|NCT01945710|264613|P4|COMPLETED|Overall Study||0
108345|NCT01945710|264614|P3|COMPLETED|Overall Study||0
108346|NCT01945710|264615|P2|COMPLETED|Overall Study||0
108347|NCT01945710|264616|P1|COMPLETED|Overall Study||0
108348|NCT01945710|264610|P7|STARTED|Overall Study||23
108349|NCT01945710|264611|P6|STARTED|Overall Study||3
108350|NCT01945710|264612|P5|STARTED|Overall Study||9
108351|NCT01945710|264613|P4|STARTED|Overall Study||3
108352|NCT01945710|264614|P3|STARTED|Overall Study||7
108353|NCT01945710|264615|P2|STARTED|Overall Study||6
108354|NCT01945710|264616|P1|STARTED|Overall Study||7
108355|NCT01945593|264735|P4|NOT COMPLETED|Overall Study||20
108356|NCT01945593|264736|P3|NOT COMPLETED|Overall Study||3
108357|NCT01945593|264737|P2|NOT COMPLETED|Overall Study||8
108358|NCT01945593|264738|P1|NOT COMPLETED|Overall Study||0
108359|NCT01945593|264735|P4|COMPLETED|Overall Study||105
108360|NCT01945593|264736|P3|COMPLETED|Overall Study||23
108361|NCT01945593|264737|P2|COMPLETED|Overall Study||56
108362|NCT01945593|264738|P1|COMPLETED|Overall Study||3
108363|NCT01945593|264735|P4|STARTED|Overall Study||125
108364|NCT01945593|264736|P3|STARTED|Overall Study||26
108365|NCT01945593|264737|P2|STARTED|Overall Study||64
108366|NCT01945593|264738|P1|STARTED|Overall Study||3
108367|NCT01945489|264820|P2|NOT COMPLETED|Cycle 2||1
108368|NCT01945489|264821|P1|NOT COMPLETED|Cycle 2||1
108369|NCT01945489|264820|P2|COMPLETED|Cycle 2||106
108370|NCT01945489|264821|P1|COMPLETED|Cycle 2||87
108371|NCT01945489|264820|P2|STARTED|Cycle 2||107
108372|NCT01945489|264821|P1|STARTED|Cycle 2|Not all participants participated in Cycle 2.|88
108373|NCT01945489|264820|P2|NOT COMPLETED|Cycle 1||4
108374|NCT01945489|264821|P1|NOT COMPLETED|Cycle 1||13
108375|NCT01945489|264820|P2|COMPLETED|Cycle 1||121
108376|NCT01945489|264821|P1|COMPLETED|Cycle 1||116
108377|NCT01945489|264820|P2|STARTED|Cycle 1||125
108378|NCT01945489|264821|P1|STARTED|Cycle 1||129
108379|NCT01945294|264841|P4|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||6
108380|NCT01945294|264842|P3|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||8
108381|NCT01945294|264843|P2|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||5
108382|NCT01945294|264844|P1|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
108383|NCT01945294|264841|P4|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||23
108384|NCT01945294|264842|P3|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
108385|NCT01945294|264843|P2|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
108386|NCT01945294|264844|P1|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
108387|NCT01945294|264841|P4|STARTED|Period 2: BOC+ PR Treatment & Follow-up||29
108388|NCT01945294|264842|P3|STARTED|Period 2: BOC+ PR Treatment & Follow-up||105
108389|NCT01945294|264843|P2|STARTED|Period 2: BOC+ PR Treatment & Follow-up||102
108390|NCT01945294|264844|P1|STARTED|Period 2: BOC+ PR Treatment & Follow-up|Participants were assigned to 1 of the 3 arms after upon the 12-week BOC + PR lead-in.|0
108391|NCT01945294|264841|P4|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
108392|NCT01945294|264842|P3|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
108393|NCT01945294|264843|P2|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
108394|NCT01945294|264844|P1|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||21
108395|NCT01945294|264841|P4|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
108396|NCT01945294|264842|P3|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
108397|NCT01945294|264843|P2|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
108398|NCT01945294|264844|P1|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||236
108399|NCT01945294|264841|P4|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
108400|NCT01945294|264842|P3|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
108401|NCT01945294|264843|P2|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
108402|NCT01945294|264844|P1|STARTED|Period 1: 12-Week PR + BOC Lead-In||257
108403|NCT01945281|264875|P2|NOT COMPLETED|Overall Study||4
108404|NCT01945281|264876|P1|NOT COMPLETED|Overall Study||6
108405|NCT01945281|264875|P2|COMPLETED|Overall Study||13
108406|NCT01945281|264876|P1|COMPLETED|Overall Study||28
108407|NCT01945281|264875|P2|Treated|Overall Study||16
108408|NCT01945281|264876|P1|Treated|Overall Study||33
108409|NCT01945281|264875|P2|STARTED|Overall Study||17
108410|NCT01945281|264876|P1|STARTED|Overall Study||34
108411|NCT01945242|264888|P2|NOT COMPLETED|Overall Study||3
108412|NCT01945242|264889|P1|NOT COMPLETED|Overall Study||3
108413|NCT01945242|264888|P2|COMPLETED|Overall Study||120
108414|NCT01945242|264889|P1|COMPLETED|Overall Study||1248
108415|NCT01945242|264888|P2|STARTED|Overall Study||123
108416|NCT01945242|264889|P1|STARTED|Overall Study||1251
108417|NCT01945216|264904|P1|NOT COMPLETED|Overall Study||99
108418|NCT01945216|264904|P1|COMPLETED|Overall Study||3218
108419|NCT01945216|264904|P1|STARTED|Overall Study||3317
108420|NCT01945138|264918|P2|NOT COMPLETED|Overall Study||0
108421|NCT01945138|264919|P1|NOT COMPLETED|Overall Study||0
108422|NCT01945138|264918|P2|COMPLETED|Overall Study||7
108423|NCT01945138|264919|P1|COMPLETED|Overall Study||7
108424|NCT01945138|264918|P2|STARTED|Overall Study||7
108425|NCT01945138|264919|P1|STARTED|Overall Study||7
108426|NCT01945112|264953|P2|NOT COMPLETED|Overall Study||0
108427|NCT01945112|264954|P1|NOT COMPLETED|Overall Study||0
108428|NCT01945112|264953|P2|COMPLETED|Overall Study||51
108429|NCT01945112|264954|P1|COMPLETED|Overall Study||77
108430|NCT01945112|264953|P2|STARTED|Overall Study|total number of sites where tape was applied|51
108431|NCT01945112|264954|P1|STARTED|Overall Study|total number of sites where tape was applied|77
108432|NCT01945086|264962|P3|NOT COMPLETED|Overall Study||2
108433|NCT01945086|264963|P2|NOT COMPLETED|Overall Study||0
108434|NCT01945086|264964|P1|NOT COMPLETED|Overall Study||1
108435|NCT01945086|264962|P3|COMPLETED|Overall Study||26
108436|NCT01945086|264963|P2|COMPLETED|Overall Study||24
108437|NCT01945086|264964|P1|COMPLETED|Overall Study||26
108438|NCT01945086|264962|P3|STARTED|Overall Study||28
108439|NCT01945086|264963|P2|STARTED|Overall Study||24
108440|NCT01945086|264964|P1|STARTED|Overall Study||27
108441|NCT01945034|265008|P3|NOT COMPLETED|Overall Study||7
108442|NCT01945034|265009|P2|NOT COMPLETED|Overall Study||5
108443|NCT01945034|265010|P1|NOT COMPLETED|Overall Study||1
108444|NCT01945034|265008|P3|COMPLETED|Overall Study||145
108445|NCT01945034|265009|P2|COMPLETED|Overall Study||80
108446|NCT01945034|265010|P1|COMPLETED|Overall Study||66
108447|NCT01945034|265008|P3|STARTED|Overall Study||152
108448|NCT01945034|265009|P2|STARTED|Overall Study||85
108449|NCT01945034|265010|P1|STARTED|Overall Study||67
108450|NCT01945021|265060|P1|NOT COMPLETED|Overall Study||47
108451|NCT01945021|265060|P1|COMPLETED|Overall Study|Completed is defined as patients who continued crizotinib at the time of final analysis (ongoing)|80
108541|NCT01943799|265321|P4|COMPLETED|Overall Study||50
108542|NCT01943799|265322|P3|COMPLETED|Overall Study||49
108452|NCT01945021|265060|P1|Patient Reported Outcome -Evaluable|Overall Study|All patients from the safety population who completed a baseline and >/= 1 post-baseline assessment.|123
108453|NCT01945021|265060|P1|Response Evaluable Population|Overall Study|All patients in the safety population who had an adequate baseline tumor assessment|127
108454|NCT01945021|265060|P1|Safety Population|Overall Study|All enrolled patients who received at least 1 dose of study medication.|127
108455|NCT01945021|265060|P1|STARTED|Overall Study|127 pts with ROS1+ & ALK negative tumors were consented and started study (2 more were screen fails)|127
108456|NCT01944969|265074|P1|NOT COMPLETED|Overall Study||26
108457|NCT01944969|265074|P1|COMPLETED|Overall Study||0
108458|NCT01944969|265074|P1|STARTED|Overall Study||26
108459|NCT01944878|265087|P2|NOT COMPLETED|Overall Study||0
108460|NCT01944878|265088|P1|NOT COMPLETED|Overall Study||0
108461|NCT01944878|265087|P2|COMPLETED|Overall Study||328
108462|NCT01944878|265088|P1|COMPLETED|Overall Study||127
108463|NCT01944878|265087|P2|STARTED|Overall Study||328
108464|NCT01944878|265088|P1|STARTED|Overall Study||127
108465|NCT01944839|265098|P2|NOT COMPLETED|Overall Study||28
108466|NCT01944839|265099|P1|NOT COMPLETED|Overall Study||22
108467|NCT01944839|265098|P2|COMPLETED|Overall Study||282
108468|NCT01944839|265099|P1|COMPLETED|Overall Study||287
108469|NCT01944839|265098|P2|STARTED|Overall Study||310
108470|NCT01944839|265099|P1|STARTED|Overall Study||309
108471|NCT01944774|265108|P3|NOT COMPLETED|Overall Study||8
108472|NCT01944774|265109|P2|NOT COMPLETED|Overall Study||8
108473|NCT01944774|265110|P1|NOT COMPLETED|Overall Study||6
108474|NCT01944774|265108|P3|COMPLETED|Overall Study||62
108475|NCT01944774|265109|P2|COMPLETED|Overall Study||60
108476|NCT01944774|265110|P1|COMPLETED|Overall Study||63
108477|NCT01944774|265108|P3|Received Treatment|Overall Study||70
108478|NCT01944774|265109|P2|Received Treatment|Overall Study||67
108479|NCT01944774|265110|P1|Received Treatment|Overall Study||68
108480|NCT01944774|265108|P3|STARTED|Overall Study||70
108481|NCT01944774|265109|P2|STARTED|Overall Study||68
108482|NCT01944774|265110|P1|STARTED|Overall Study||69
108483|NCT01944722|265153|P1|NOT COMPLETED|Overall Study||9515
108484|NCT01944722|265153|P1|COMPLETED|Overall Study||24343
108485|NCT01944722|265153|P1|STARTED|Overall Study||33858
108486|NCT01944670|265187|P1|NOT COMPLETED|Overall Study||2
108487|NCT01944670|265187|P1|COMPLETED|Overall Study||24
108488|NCT01944670|265187|P1|STARTED|Overall Study||26
108489|NCT01944644|265194|P2|NOT COMPLETED|Overall Study||0
108490|NCT01944644|265195|P1|NOT COMPLETED|Overall Study||0
108491|NCT01944644|265194|P2|COMPLETED|Overall Study||32
108492|NCT01944644|265195|P1|COMPLETED|Overall Study||34
108493|NCT01944644|265194|P2|STARTED|Overall Study||32
108494|NCT01944644|265195|P1|STARTED|Overall Study||34
108495|NCT01944631|265209|P2|NOT COMPLETED|Overall Study||2
108496|NCT01944631|265210|P1|NOT COMPLETED|Overall Study||4
108497|NCT01944631|265209|P2|COMPLETED|Overall Study||98
108498|NCT01944631|265210|P1|COMPLETED|Overall Study||96
108499|NCT01944631|265209|P2|STARTED|Overall Study||100
108500|NCT01944631|265210|P1|STARTED|Overall Study||100
108501|NCT01944462|265226|P1|NOT COMPLETED|Optional Vaccination||0
108502|NCT01944462|265226|P1|COMPLETED|Optional Vaccination||20
108503|NCT01944462|265226|P1|STARTED|Optional Vaccination||20
108504|NCT01944462|265226|P1|NOT COMPLETED|PPPP Educational Program||60
108505|NCT01944462|265226|P1|COMPLETED|PPPP Educational Program||143
108506|NCT01944462|265226|P1|3 Month Follow-Up|PPPP Educational Program||143
108507|NCT01944462|265226|P1|Post-Test|PPPP Educational Program||187
108508|NCT01944462|265226|P1|Baseline|PPPP Educational Program||203
108509|NCT01944462|265226|P1|STARTED|PPPP Educational Program||203
108510|NCT01944345|265235|P1|NOT COMPLETED|Overall Study||0
108511|NCT01944345|265235|P1|COMPLETED|Overall Study||69
108512|NCT01944345|265235|P1|STARTED|Overall Study||69
108513|NCT01944319|265243|P2|NOT COMPLETED|Overall Study||0
108514|NCT01944319|265244|P1|NOT COMPLETED|Overall Study||0
108515|NCT01944319|265243|P2|COMPLETED|Overall Study||39
108516|NCT01944319|265244|P1|COMPLETED|Overall Study||40
108517|NCT01944319|265243|P2|STARTED|Overall Study||39
108518|NCT01944319|265244|P1|STARTED|Overall Study||40
108519|NCT01944293|265256|P2|NOT COMPLETED|Overall Study||0
108520|NCT01944293|265257|P1|NOT COMPLETED|Overall Study||0
108521|NCT01944293|265256|P2|COMPLETED|Overall Study||9
108522|NCT01944293|265257|P1|COMPLETED|Overall Study||7
108523|NCT01944293|265256|P2|STARTED|Overall Study||9
108524|NCT01944293|265257|P1|STARTED|Overall Study||7
108525|NCT01944098|265267|P2|NOT COMPLETED|Overall Study||0
108526|NCT01944098|265268|P1|NOT COMPLETED|Overall Study||1
108527|NCT01944098|265267|P2|COMPLETED|Overall Study||10
108528|NCT01944098|265268|P1|COMPLETED|Overall Study||9
108529|NCT01944098|265267|P2|STARTED|Overall Study||10
108530|NCT01944098|265268|P1|STARTED|Overall Study||10
108531|NCT01944059|265280|P1|NOT COMPLETED|Overall Study||7
108532|NCT01944059|265280|P1|COMPLETED|Overall Study||24
108533|NCT01944059|265280|P1|STARTED|Overall Study||31
108534|NCT01943864|265289|P1|NOT COMPLETED|Overall Study||0
108535|NCT01943864|265289|P1|COMPLETED|Overall Study|Death or 1 year from randomization after progression was considered completion; 20 participants died|20
108536|NCT01943864|265289|P1|STARTED|Overall Study||20
108537|NCT01943799|265321|P4|NOT COMPLETED|Overall Study||0
108538|NCT01943799|265322|P3|NOT COMPLETED|Overall Study||2
108539|NCT01943799|265323|P2|NOT COMPLETED|Overall Study||3
108540|NCT01943799|265324|P1|NOT COMPLETED|Overall Study||5
108543|NCT01943799|265323|P2|COMPLETED|Overall Study||47
108544|NCT01943799|265324|P1|COMPLETED|Overall Study||22
108545|NCT01943799|265321|P4|STARTED|Overall Study||50
108546|NCT01943799|265322|P3|STARTED|Overall Study|1 participant was randomized to OAV + GS-4774 2 YU but received OAV + GS-4774 10 YU.|51
108547|NCT01943799|265323|P2|STARTED|Overall Study||50
108548|NCT01943799|265324|P1|STARTED|Overall Study||27
108549|NCT01943565|265365|P3|NOT COMPLETED|Overall Study||0
108550|NCT01943565|265366|P2|NOT COMPLETED|Overall Study||0
108551|NCT01943565|265367|P1|NOT COMPLETED|Overall Study||0
108552|NCT01943565|265365|P3|COMPLETED|Overall Study||9
108553|NCT01943565|265366|P2|COMPLETED|Overall Study||9
108554|NCT01943565|265367|P1|COMPLETED|Overall Study||11
108555|NCT01943565|265365|P3|STARTED|Overall Study||9
108556|NCT01943565|265366|P2|STARTED|Overall Study||9
108557|NCT01943565|265367|P1|STARTED|Overall Study||11
108558|NCT01943552|265398|P2|NOT COMPLETED|Overall Study||25
108559|NCT01943552|265399|P1|NOT COMPLETED|Overall Study||25
108560|NCT01943552|265398|P2|COMPLETED|Overall Study||69
108561|NCT01943552|265399|P1|COMPLETED|Overall Study||71
108562|NCT01943552|265398|P2|STARTED|Overall Study||94
108563|NCT01943552|265399|P1|STARTED|Overall Study|One patient was randomised to the placebo group, but received nebulized ipratropium bromide.|96
108564|NCT01943539|265415|P2|NOT COMPLETED|Overall Study||0
108565|NCT01943539|265416|P1|NOT COMPLETED|Overall Study||4
108566|NCT01943539|265415|P2|COMPLETED|Overall Study||40
108567|NCT01943539|265416|P1|COMPLETED|Overall Study||40
108568|NCT01943539|265415|P2|STARTED|Overall Study||40
108569|NCT01943539|265416|P1|STARTED|Overall Study||44
108570|NCT01943474|265427|P2|NOT COMPLETED|Overall Study||0
108571|NCT01943474|265428|P1|NOT COMPLETED|Overall Study||0
108572|NCT01943474|265427|P2|COMPLETED|Overall Study||125
108573|NCT01943474|265428|P1|COMPLETED|Overall Study||123
108574|NCT01943474|265427|P2|STARTED|Overall Study||125
108575|NCT01943474|265428|P1|STARTED|Overall Study||123
108576|NCT01943435|265452|P3|NOT COMPLETED|6 Month Follow up||15
108577|NCT01943435|265453|P2|NOT COMPLETED|6 Month Follow up||7
108578|NCT01943435|265454|P1|NOT COMPLETED|6 Month Follow up||12
108579|NCT01943435|265452|P3|COMPLETED|6 Month Follow up||65
108580|NCT01943435|265453|P2|COMPLETED|6 Month Follow up||59
108581|NCT01943435|265454|P1|COMPLETED|6 Month Follow up||67
108582|NCT01943435|265452|P3|STARTED|6 Month Follow up||80
108583|NCT01943435|265453|P2|STARTED|6 Month Follow up||66
108584|NCT01943435|265454|P1|STARTED|6 Month Follow up||79
108585|NCT01943435|265452|P3|NOT COMPLETED|2 Month Follow up||0
108586|NCT01943435|265453|P2|NOT COMPLETED|2 Month Follow up||3
108587|NCT01943435|265454|P1|NOT COMPLETED|2 Month Follow up||2
108588|NCT01943435|265452|P3|COMPLETED|2 Month Follow up||80
108589|NCT01943435|265453|P2|COMPLETED|2 Month Follow up||66
108590|NCT01943435|265454|P1|COMPLETED|2 Month Follow up||79
108591|NCT01943435|265452|P3|STARTED|2 Month Follow up||80
108592|NCT01943435|265453|P2|STARTED|2 Month Follow up||69
108593|NCT01943435|265454|P1|STARTED|2 Month Follow up||81
108594|NCT01943435|265452|P3|NOT COMPLETED|Intervention Period||4
108595|NCT01943435|265453|P2|NOT COMPLETED|Intervention Period||3
108596|NCT01943435|265454|P1|NOT COMPLETED|Intervention Period||3
108597|NCT01943435|265452|P3|COMPLETED|Intervention Period||80
108598|NCT01943435|265453|P2|COMPLETED|Intervention Period||69
108599|NCT01943435|265454|P1|COMPLETED|Intervention Period||81
108600|NCT01943435|265452|P3|STARTED|Intervention Period||84
108601|NCT01943435|265453|P2|STARTED|Intervention Period||72
108602|NCT01943435|265454|P1|STARTED|Intervention Period||84
108603|NCT01943435|265452|P3|NOT COMPLETED|Baseline Eligibility and Randomization||3
108604|NCT01943435|265453|P2|NOT COMPLETED|Baseline Eligibility and Randomization||12
108605|NCT01943435|265454|P1|NOT COMPLETED|Baseline Eligibility and Randomization||4
108606|NCT01943435|265452|P3|COMPLETED|Baseline Eligibility and Randomization||84
108607|NCT01943435|265453|P2|COMPLETED|Baseline Eligibility and Randomization||72
108608|NCT01943435|265454|P1|COMPLETED|Baseline Eligibility and Randomization||84
108609|NCT01943435|265452|P3|STARTED|Baseline Eligibility and Randomization||87
108610|NCT01943435|265453|P2|STARTED|Baseline Eligibility and Randomization||84
108611|NCT01943435|265454|P1|STARTED|Baseline Eligibility and Randomization||88
108612|NCT01943344|265468|P1|NOT COMPLETED|Overall Study||3
108613|NCT01943344|265468|P1|COMPLETED|Overall Study||9
108614|NCT01943344|265468|P1|STARTED|Overall Study||12
108615|NCT01943292|265477|P3|NOT COMPLETED|Overall Study||0
108616|NCT01943292|265478|P2|NOT COMPLETED|Overall Study||0
108617|NCT01943292|265479|P1|NOT COMPLETED|Overall Study||1
108618|NCT01943292|265477|P3|COMPLETED|Overall Study||3
108619|NCT01943292|265478|P2|COMPLETED|Overall Study||3
108620|NCT01943292|265479|P1|COMPLETED|Overall Study||2
108621|NCT01943292|265477|P3|Completed Follow-Up|Overall Study||3
108622|NCT01943292|265478|P2|Completed Follow-Up|Overall Study||3
108623|NCT01943292|265479|P1|Completed Follow-Up|Overall Study||2
108624|NCT01943292|265477|P3|Completed Treatment|Overall Study||3
108625|NCT01943292|265478|P2|Completed Treatment|Overall Study||3
108626|NCT01943292|265479|P1|Completed Treatment|Overall Study||3
108627|NCT01943292|265477|P3|Completed Cycle 1|Overall Study||3
108628|NCT01943292|265478|P2|Completed Cycle 1|Overall Study||3
108629|NCT01943292|265479|P1|Completed Cycle 1|Overall Study||3
108630|NCT01943292|265477|P3|STARTED|Overall Study||3
108631|NCT01943292|265478|P2|STARTED|Overall Study||3
108632|NCT01943292|265479|P1|STARTED|Overall Study||3
108633|NCT01943227|265492|P2|NOT COMPLETED|Overall Study||0
108634|NCT01943227|265493|P1|NOT COMPLETED|Overall Study||0
108635|NCT01943227|265492|P2|COMPLETED|Overall Study||10
108636|NCT01943227|265493|P1|COMPLETED|Overall Study||10
108637|NCT01943227|265492|P2|STARTED|Overall Study||10
108638|NCT01943227|265493|P1|STARTED|Overall Study||10
108639|NCT01943110|265499|P1|NOT COMPLETED|Overall Study||0
108640|NCT01943110|265499|P1|COMPLETED|Overall Study||30
108641|NCT01943110|265499|P1|STARTED|Overall Study||30
108642|NCT01942785|265515|P1|NOT COMPLETED|Overall Study||4
108643|NCT01942785|265515|P1|COMPLETED|Overall Study||50
108644|NCT01942785|265515|P1|STARTED|Overall Study||54
108645|NCT01942733|265544|P1|NOT COMPLETED|Overall Study||3
108646|NCT01942733|265544|P1|COMPLETED|Overall Study||41
108647|NCT01942733|265544|P1|STARTED|Overall Study||44
108648|NCT01942720|265573|P1|NOT COMPLETED|Overall Study||21
108649|NCT01942720|265573|P1|COMPLETED|Overall Study||53
108650|NCT01942720|265573|P1|STARTED|Overall Study||74
108651|NCT01942707|265583|P2|NOT COMPLETED|Overall Study||0
108652|NCT01942707|265584|P1|NOT COMPLETED|Overall Study||0
108653|NCT01942707|265583|P2|COMPLETED|Overall Study||23
108654|NCT01942707|265584|P1|COMPLETED|Overall Study||23
108655|NCT01942707|265583|P2|STARTED|Overall Study||23
108656|NCT01942707|265584|P1|STARTED|Overall Study||23
108657|NCT01942668|265599|P5|NOT COMPLETED|Overall Study||59
108658|NCT01942668|265600|P4|NOT COMPLETED|Overall Study||146
108659|NCT01942668|265601|P3|NOT COMPLETED|Overall Study||110
108660|NCT01942668|265602|P2|NOT COMPLETED|Overall Study||121
108661|NCT01942668|265603|P1|NOT COMPLETED|Overall Study||134
108662|NCT01942668|265599|P5|COMPLETED|Overall Study||93
108663|NCT01942668|265600|P4|COMPLETED|Overall Study||281
108664|NCT01942668|265601|P3|COMPLETED|Overall Study||312
108665|NCT01942668|265602|P2|COMPLETED|Overall Study||305
108666|NCT01942668|265603|P1|COMPLETED|Overall Study||284
108667|NCT01942668|265599|P5|STARTED|Overall Study||152
108668|NCT01942668|265600|P4|STARTED|Overall Study||427
108669|NCT01942668|265601|P3|STARTED|Overall Study||422
108670|NCT01942668|265602|P2|STARTED|Overall Study||426
108671|NCT01942668|265603|P1|STARTED|Overall Study||418
108672|NCT01942590|266662|P2|NOT COMPLETED|Overall Study||1
108673|NCT01942590|266663|P1|NOT COMPLETED|Overall Study||1
108674|NCT01942590|266662|P2|COMPLETED|Overall Study||4
108675|NCT01942590|266663|P1|COMPLETED|Overall Study||7
108676|NCT01942590|266662|P2|STARTED|Overall Study||5
108677|NCT01942590|266663|P1|STARTED|Overall Study||8
108678|NCT01942161|266696|P3|NOT COMPLETED|Overall Study||6
108679|NCT01942161|266697|P2|NOT COMPLETED|Overall Study||6
108680|NCT01942161|266698|P1|NOT COMPLETED|Overall Study||8
108681|NCT01942161|266696|P3|COMPLETED|Overall Study||35
108682|NCT01942161|266697|P2|COMPLETED|Overall Study||24
108683|NCT01942161|266698|P1|COMPLETED|Overall Study||27
108684|NCT01942161|266696|P3|STARTED|Overall Study||41
108685|NCT01942161|266697|P2|STARTED|Overall Study||30
108686|NCT01942161|266698|P1|STARTED|Overall Study||35
108687|NCT01942148|266718|P1|NOT COMPLETED|Overall Study||27
108688|NCT01942148|266718|P1|COMPLETED|Overall Study||41
108689|NCT01942148|266718|P1|STARTED|Overall Study||68
108690|NCT01942135|266726|P2|NOT COMPLETED|Overall Study||174
108691|NCT01942135|266727|P1|NOT COMPLETED|Overall Study||347
108692|NCT01942135|266726|P2|COMPLETED|Overall Study||0
108693|NCT01942135|266727|P1|COMPLETED|Overall Study||0
108694|NCT01942135|266726|P2|STARTED|Overall Study||174
108695|NCT01942135|266727|P1|STARTED|Overall Study||347
108696|NCT01941940|266764|P1|NOT COMPLETED|Overall Study||33
108697|NCT01941940|266764|P1|COMPLETED|Overall Study||194
108698|NCT01941940|266764|P1|STARTED|Overall Study||227
108699|NCT01941745|266808|P4|NOT COMPLETED|Overall Study||0
108700|NCT01941745|266809|P3|NOT COMPLETED|Overall Study||0
108701|NCT01941745|266810|P2|NOT COMPLETED|Overall Study||0
108702|NCT01941745|266811|P1|NOT COMPLETED|Overall Study||0
108703|NCT01941745|266808|P4|COMPLETED|Overall Study||23
108704|NCT01941745|266809|P3|COMPLETED|Overall Study||21
108705|NCT01941745|266810|P2|COMPLETED|Overall Study||22
108706|NCT01941745|266811|P1|COMPLETED|Overall Study||22
108707|NCT01941745|266808|P4|STARTED|Overall Study||23
108708|NCT01941745|266809|P3|STARTED|Overall Study||21
108709|NCT01941745|266810|P2|STARTED|Overall Study||22
108710|NCT01941745|266811|P1|STARTED|Overall Study||22
108711|NCT01941628|266835|P2|NOT COMPLETED|Overall Study||0
108712|NCT01941628|266836|P1|NOT COMPLETED|Overall Study||1
108713|NCT01941628|266835|P2|COMPLETED|Overall Study||45
108714|NCT01941628|266836|P1|COMPLETED|Overall Study||45
108715|NCT01941628|266835|P2|STARTED|Overall Study||45
108716|NCT01941628|266836|P1|STARTED|Overall Study||46
108717|NCT01941615|266846|P1|NOT COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
108718|NCT01941615|266846|P1|COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
108719|NCT01941615|266846|P1|STARTED|Microgynon® Plus Deleobuvir+Faldaprevir||0
108720|NCT01941615|266846|P1|NOT COMPLETED|Reference Treatment: Microgynon®||0
108721|NCT01941615|266846|P1|COMPLETED|Reference Treatment: Microgynon®||0
108722|NCT01941615|266846|P1|STARTED|Reference Treatment: Microgynon®||0
108723|NCT01941615|266846|P1|NOT COMPLETED|Run in Treatment: Microgynon®||0
108724|NCT01941615|266846|P1|COMPLETED|Run in Treatment: Microgynon®||16
108725|NCT01941615|266846|P1|STARTED|Run in Treatment: Microgynon®||16
108726|NCT01941537|266857|P2|NOT COMPLETED|Overall Study||3
108727|NCT01941537|266858|P1|NOT COMPLETED|Overall Study||4
108728|NCT01941537|266857|P2|COMPLETED|Overall Study||17
108729|NCT01941537|266858|P1|COMPLETED|Overall Study||36
108730|NCT01941537|266857|P2|STARTED|Overall Study||20
108731|NCT01941537|266858|P1|STARTED|Overall Study||40
108732|NCT01941498|266870|P1|NOT COMPLETED|Overall Study||1
108733|NCT01941498|266870|P1|COMPLETED|Overall Study||96
108734|NCT01941498|266870|P1|STARTED|Overall Study||97
108735|NCT01941485|266916|P1|NOT COMPLETED|Overall Study||0
108736|NCT01941485|266916|P1|COMPLETED|Overall Study||59
108737|NCT01941485|266916|P1|STARTED|Overall Study||59
108738|NCT01941472|266982|P1|NOT COMPLETED|Overall Study||0
108739|NCT01941472|266982|P1|COMPLETED|Overall Study||40
108740|NCT01941472|266982|P1|STARTED|Overall Study||40
108741|NCT01941186|266988|P2|NOT COMPLETED|Follow-up||0
108742|NCT01941186|266989|P1|NOT COMPLETED|Follow-up||1
108743|NCT01941186|266988|P2|COMPLETED|Follow-up||33
108744|NCT01941186|266989|P1|COMPLETED|Follow-up||30
108745|NCT01941186|266988|P2|STARTED|Follow-up||33
108746|NCT01941186|266989|P1|STARTED|Follow-up||31
108747|NCT01941186|266988|P2|NOT COMPLETED|Randomization/Allocation to Study Group||0
108748|NCT01941186|266989|P1|NOT COMPLETED|Randomization/Allocation to Study Group||0
108749|NCT01941186|266988|P2|COMPLETED|Randomization/Allocation to Study Group||33
108750|NCT01941186|266989|P1|COMPLETED|Randomization/Allocation to Study Group||31
108751|NCT01941186|266988|P2|STARTED|Randomization/Allocation to Study Group||33
108752|NCT01941186|266989|P1|STARTED|Randomization/Allocation to Study Group||31
108753|NCT01941095|267015|P1|NOT COMPLETED|Overall Study||56
108754|NCT01941095|267015|P1|COMPLETED|Overall Study||41
108755|NCT01941095|267015|P1|STARTED|Overall Study||97
108756|NCT01941030|267040|P2|NOT COMPLETED|Overall Study||13
108757|NCT01941030|267041|P1|NOT COMPLETED|Overall Study||13
108758|NCT01941030|267040|P2|COMPLETED|Overall Study||13
108759|NCT01941030|267041|P1|COMPLETED|Overall Study||12
108760|NCT01941030|267040|P2|STARTED|Overall Study||26
108761|NCT01941030|267041|P1|STARTED|Overall Study||25
108762|NCT01940939|267063|P2|NOT COMPLETED|Overall Study||8
108763|NCT01940939|267064|P1|NOT COMPLETED|Overall Study||2
108764|NCT01940939|267063|P2|COMPLETED|Overall Study||27
108765|NCT01940939|267064|P1|COMPLETED|Overall Study||33
108766|NCT01940939|267063|P2|STARTED|Overall Study||35
108767|NCT01940939|267064|P1|STARTED|Overall Study||35
108768|NCT01940900|267076|P2|NOT COMPLETED|Overall Study||31
108769|NCT01940900|267077|P1|NOT COMPLETED|Overall Study||29
108770|NCT01940900|267076|P2|COMPLETED|Overall Study||284
108771|NCT01940900|267077|P1|COMPLETED|Overall Study||282
108772|NCT01940900|267076|P2|STARTED|Overall Study||315
108773|NCT01940900|267077|P1|STARTED|Overall Study||311
108774|NCT01940705|267087|P4|NOT COMPLETED|Overall Study||4
108775|NCT01940705|267088|P3|NOT COMPLETED|Overall Study||8
108776|NCT01940705|267089|P2|NOT COMPLETED|Overall Study||8
108777|NCT01940705|267090|P1|NOT COMPLETED|Overall Study||4
108778|NCT01940705|267087|P4|COMPLETED|Overall Study||63
108779|NCT01940705|267088|P3|COMPLETED|Overall Study||61
108780|NCT01940705|267089|P2|COMPLETED|Overall Study||59
108781|NCT01940705|267090|P1|COMPLETED|Overall Study||62
108782|NCT01940705|267087|P4|STARTED|Overall Study||67
108783|NCT01940705|267088|P3|STARTED|Overall Study||69
108784|NCT01940705|267089|P2|STARTED|Overall Study||67
108785|NCT01940705|267090|P1|STARTED|Overall Study||66
108786|NCT01940523|267110|P2|NOT COMPLETED|Overall Study||0
108787|NCT01940523|267111|P1|NOT COMPLETED|Overall Study||0
108788|NCT01940523|267110|P2|COMPLETED|Overall Study||320
108789|NCT01940523|267111|P1|COMPLETED|Overall Study||320
108790|NCT01940523|267110|P2|STARTED|Overall Study||320
108791|NCT01940523|267111|P1|STARTED|Overall Study||320
108792|NCT01940510|267121|P1|NOT COMPLETED|Overall Study||0
108793|NCT01940510|267121|P1|COMPLETED|Overall Study||24
108794|NCT01940510|267121|P1|STARTED|Overall Study||24
108795|NCT01940497|267154|P2|NOT COMPLETED|Overall Study||118
108796|NCT01940497|267155|P1|NOT COMPLETED|Overall Study||120
108797|NCT01940497|267154|P2|COMPLETED|Overall Study||1
108798|NCT01940497|267155|P1|COMPLETED|Overall Study||1
108799|NCT01940497|267154|P2|Treated: Neoadjuvant|Overall Study||21
108800|NCT01940497|267155|P1|Treated: Neoadjuvant|Overall Study||20
108801|NCT01940497|267154|P2|Treated: Adjuvant|Overall Study||92
108802|NCT01940497|267155|P1|Treated: Adjuvant|Overall Study||95
108803|NCT01940497|267154|P2|Treated|Overall Study||113
108804|NCT01940497|267155|P1|Treated|Overall Study||115
108805|NCT01940497|267154|P2|STARTED|Overall Study||119
108806|NCT01940497|267155|P1|STARTED|Overall Study||121
108807|NCT01940484|267194|P1|NOT COMPLETED|Overall Study||10
108808|NCT01940484|267194|P1|COMPLETED|Overall Study||88
108809|NCT01940484|267194|P1|STARTED|Overall Study||98
108810|NCT01940471|267214|P2|NOT COMPLETED|Open-Label Extension||8
108811|NCT01940471|267215|P1|NOT COMPLETED|Open-Label Extension||14
108812|NCT01940471|267214|P2|COMPLETED|Open-Label Extension||0
108813|NCT01940471|267215|P1|COMPLETED|Open-Label Extension||0
108814|NCT01940471|267214|P2|STARTED|Open-Label Extension||8
108815|NCT01940471|267215|P1|STARTED|Open-Label Extension||14
108816|NCT01940471|267214|P2|NOT COMPLETED|Double-Blind Phase||285
108817|NCT01940471|267215|P1|NOT COMPLETED|Double-Blind Phase||568
108818|NCT01940471|267214|P2|COMPLETED|Double-Blind Phase||8
108819|NCT01940471|267215|P1|COMPLETED|Double-Blind Phase||14
108820|NCT01940471|267214|P2|STARTED|Double-Blind Phase||293
108821|NCT01940471|267215|P1|STARTED|Double-Blind Phase||582
108822|NCT01940354|267233|P2|NOT COMPLETED|Overall Study||2
108823|NCT01940354|267234|P1|NOT COMPLETED|Overall Study||4
108824|NCT01940354|267233|P2|COMPLETED|Overall Study||108
108825|NCT01940354|267234|P1|COMPLETED|Overall Study||106
108826|NCT01940354|267233|P2|STARTED|Overall Study||110
108827|NCT01940354|267234|P1|STARTED|Overall Study||110
108828|NCT01940341|267246|P2|NOT COMPLETED|Open-label Extension Phase||1
108829|NCT01940341|267247|P1|NOT COMPLETED|Open-label Extension Phase||4
108830|NCT01940341|267246|P2|COMPLETED|Open-label Extension Phase||0
108831|NCT01940341|267247|P1|COMPLETED|Open-label Extension Phase||0
108832|NCT01940341|267246|P2|STARTED|Open-label Extension Phase||1
108833|NCT01940341|267247|P1|STARTED|Open-label Extension Phase||4
108834|NCT01940341|267246|P2|NOT COMPLETED|Double-Blind Phase||140
108835|NCT01940341|267247|P1|NOT COMPLETED|Double-Blind Phase||281
108836|NCT01940341|267246|P2|COMPLETED|Double-Blind Phase||1
108837|NCT01940341|267247|P1|COMPLETED|Double-Blind Phase||4
108838|NCT01940341|267246|P2|STARTED|Double-Blind Phase||141
108839|NCT01940341|267247|P1|STARTED|Double-Blind Phase||285
108840|NCT01940146|267265|P4|NOT COMPLETED|Overall Study||2
108841|NCT01940146|267266|P3|NOT COMPLETED|Overall Study||1
108842|NCT01940146|267267|P2|NOT COMPLETED|Overall Study||0
108843|NCT01940146|267268|P1|NOT COMPLETED|Overall Study||1
108844|NCT01940146|267265|P4|COMPLETED|Overall Study||53
108845|NCT01940146|267266|P3|COMPLETED|Overall Study||55
108846|NCT01940146|267267|P2|COMPLETED|Overall Study||55
108847|NCT01940146|267268|P1|COMPLETED|Overall Study||55
108848|NCT01940146|267265|P4|STARTED|Overall Study||55
108849|NCT01940146|267266|P3|STARTED|Overall Study||56
108850|NCT01940146|267267|P2|STARTED|Overall Study||55
108851|NCT01940146|267268|P1|STARTED|Overall Study||56
108852|NCT01940120|267278|P1|NOT COMPLETED|Overall Study||48
108853|NCT01940120|267278|P1|COMPLETED|Overall Study||30
108854|NCT01940120|267278|P1|STARTED|Overall Study||78
108855|NCT01939977|267434|P2|NOT COMPLETED|Overall Study||7
108856|NCT01939977|267435|P1|NOT COMPLETED|Overall Study||9
108857|NCT01939977|267434|P2|COMPLETED|Overall Study||41
108858|NCT01939977|267435|P1|COMPLETED|Overall Study||37
108859|NCT01939977|267434|P2|STARTED|Overall Study|48 patients randomized but 1 did not meet inclusion criteria. 47 patients analyzed.|48
108860|NCT01939977|267435|P1|STARTED|Overall Study||46
108861|NCT01939938|267471|P1|NOT COMPLETED|Overall Study||0
108862|NCT01939938|267471|P1|COMPLETED|Overall Study||10
108863|NCT01939938|267471|P1|STARTED|Overall Study||10
108864|NCT01939899|267482|P5|NOT COMPLETED|Phase 2||1
108865|NCT01939899|267483|P4|NOT COMPLETED|Phase 2||11
108866|NCT01939899|267484|P3|NOT COMPLETED|Phase 2||0
108867|NCT01939899|267485|P2|NOT COMPLETED|Phase 2||0
108868|NCT01939899|267486|P1|NOT COMPLETED|Phase 2||0
108869|NCT01939899|267482|P5|COMPLETED|Phase 2||0
108870|NCT01939899|267483|P4|COMPLETED|Phase 2||1
108871|NCT01939899|267484|P3|COMPLETED|Phase 2||0
108872|NCT01939899|267485|P2|COMPLETED|Phase 2||0
108873|NCT01939899|267486|P1|COMPLETED|Phase 2||0
108874|NCT01939899|267482|P5|STARTED|Phase 2||1
108875|NCT01939899|267483|P4|STARTED|Phase 2||12
108876|NCT01939899|267484|P3|STARTED|Phase 2||0
108877|NCT01939899|267485|P2|STARTED|Phase 2||0
108878|NCT01939899|267486|P1|STARTED|Phase 2||0
108879|NCT01939899|267482|P5|NOT COMPLETED|Lead-in Dose Finding Phase||0
108880|NCT01939899|267483|P4|NOT COMPLETED|Lead-in Dose Finding Phase||0
108881|NCT01939899|267484|P3|NOT COMPLETED|Lead-in Dose Finding Phase||5
108882|NCT01939899|267485|P2|NOT COMPLETED|Lead-in Dose Finding Phase||7
108883|NCT01939899|267486|P1|NOT COMPLETED|Lead-in Dose Finding Phase||2
108884|NCT01939899|267482|P5|COMPLETED|Lead-in Dose Finding Phase||0
108885|NCT01939899|267483|P4|COMPLETED|Lead-in Dose Finding Phase||0
108886|NCT01939899|267484|P3|COMPLETED|Lead-in Dose Finding Phase||1
108887|NCT01939899|267485|P2|COMPLETED|Lead-in Dose Finding Phase||0
108888|NCT01939899|267486|P1|COMPLETED|Lead-in Dose Finding Phase||1
108889|NCT01939899|267482|P5|STARTED|Lead-in Dose Finding Phase||0
108890|NCT01939899|267483|P4|STARTED|Lead-in Dose Finding Phase||0
108891|NCT01939899|267484|P3|STARTED|Lead-in Dose Finding Phase||6
108892|NCT01939899|267485|P2|STARTED|Lead-in Dose Finding Phase||7
108893|NCT01939899|267486|P1|STARTED|Lead-in Dose Finding Phase||3
108894|NCT01939548|267533|P3|NOT COMPLETED|Overall Study||30
108895|NCT01939548|267534|P2|NOT COMPLETED|Overall Study||49
108896|NCT01939548|267535|P1|NOT COMPLETED|Overall Study||37
108897|NCT01939548|267533|P3|COMPLETED|Overall Study||50
108898|NCT01939548|267534|P2|COMPLETED|Overall Study||33
108899|NCT01939548|267535|P1|COMPLETED|Overall Study||41
108900|NCT01939548|267533|P3|STARTED|Overall Study||80
108901|NCT01939548|267534|P2|STARTED|Overall Study||82
108902|NCT01939548|267535|P1|STARTED|Overall Study||78
108903|NCT01939496|267609|P3|NOT COMPLETED|Overall Study||2
108904|NCT01939496|267610|P2|NOT COMPLETED|Overall Study||3
108905|NCT01939496|267611|P1|NOT COMPLETED|Overall Study||9
108906|NCT01939496|267609|P3|COMPLETED|Overall Study||54
108907|NCT01939496|267610|P2|COMPLETED|Overall Study||54
108908|NCT01939496|267611|P1|COMPLETED|Overall Study||47
108909|NCT01939496|267609|P3|STARTED|Overall Study||56
108910|NCT01939496|267610|P2|STARTED|Overall Study||57
108911|NCT01939496|267611|P1|STARTED|Overall Study||56
108912|NCT01939405|267663|P2|NOT COMPLETED|Overall Study||2
108913|NCT01939405|267664|P1|NOT COMPLETED|Overall Study||3
108914|NCT01939405|267663|P2|COMPLETED|Overall Study||28
108915|NCT01939405|267664|P1|COMPLETED|Overall Study||27
108916|NCT01939405|267663|P2|STARTED|Overall Study||30
108917|NCT01939405|267664|P1|STARTED|Overall Study||30
108918|NCT01939314|267678|P2|NOT COMPLETED|Overall Study||8
108919|NCT01939314|267679|P1|NOT COMPLETED|Overall Study||9
108920|NCT01939314|267678|P2|COMPLETED|Overall Study||40
108921|NCT01939314|267679|P1|COMPLETED|Overall Study||36
108922|NCT01939314|267678|P2|24 Hour Endpoint|Overall Study||40
108923|NCT01939314|267679|P1|24 Hour Endpoint|Overall Study||36
108924|NCT01939314|267678|P2|15 Minute Endpoint|Overall Study||46
108925|NCT01939314|267679|P1|15 Minute Endpoint|Overall Study||41
108926|NCT01939314|267678|P2|STARTED|Overall Study||48
108927|NCT01939314|267679|P1|STARTED|Overall Study||45
108928|NCT01939301|267691|P2|NOT COMPLETED|Overall Study||1
108929|NCT01939301|267692|P1|NOT COMPLETED|Overall Study||1
108930|NCT01939301|267691|P2|COMPLETED|Overall Study||38
108931|NCT01939301|267692|P1|COMPLETED|Overall Study||38
108932|NCT01939301|267691|P2|STARTED|Overall Study||39
108933|NCT01939301|267692|P1|STARTED|Overall Study||39
108934|NCT01939288|267700|P2|NOT COMPLETED|Overall Study||0
108935|NCT01939288|267701|P1|NOT COMPLETED|Overall Study||0
108936|NCT01939288|267700|P2|COMPLETED|Overall Study||5
108937|NCT01939288|267701|P1|COMPLETED|Overall Study||5
108938|NCT01939288|267700|P2|STARTED|Overall Study||5
108939|NCT01939288|267701|P1|STARTED|Overall Study||5
108940|NCT01939275|267707|P1|NOT COMPLETED|Overall Study||0
108941|NCT01939275|267707|P1|COMPLETED|Overall Study||8
108942|NCT01939275|267707|P1|STARTED|Overall Study||8
108943|NCT01939223|267713|P2|NOT COMPLETED|Overall Study||11
108944|NCT01939223|267714|P1|NOT COMPLETED|Overall Study||13
108945|NCT01939223|267713|P2|COMPLETED|Overall Study||0
108946|NCT01939223|267714|P1|COMPLETED|Overall Study||1
108947|NCT01939223|267713|P2|Participants Received Treatment|Overall Study||11
108948|NCT01939223|267714|P1|Participants Received Treatment|Overall Study||14
108949|NCT01939223|267713|P2|STARTED|Overall Study||11
108950|NCT01939223|267714|P1|STARTED|Overall Study||14
108951|NCT01939197|267729|P7|NOT COMPLETED|Overall Study||2
108952|NCT01939197|267730|P6|NOT COMPLETED|Overall Study||1
108953|NCT01939197|267731|P5|NOT COMPLETED|Overall Study||4
108954|NCT01939197|267732|P4|NOT COMPLETED|Overall Study||1
108955|NCT01939197|267733|P3|NOT COMPLETED|Overall Study||0
108956|NCT01939197|267734|P2|NOT COMPLETED|Overall Study||1
108957|NCT01939197|267735|P1|NOT COMPLETED|Overall Study||1
108958|NCT01939197|267729|P7|COMPLETED|Overall Study||26
108959|NCT01939197|267730|P6|COMPLETED|Overall Study||4
108960|NCT01939197|267731|P5|COMPLETED|Overall Study||196
108961|NCT01939197|267732|P4|COMPLETED|Overall Study||11
108962|NCT01939197|267733|P3|COMPLETED|Overall Study||10
108963|NCT01939197|267734|P2|COMPLETED|Overall Study||31
108964|NCT01939197|267735|P1|COMPLETED|Overall Study||30
108965|NCT01939197|267729|P7|STARTED|Overall Study||28
108966|NCT01939197|267730|P6|STARTED|Overall Study||5
108967|NCT01939197|267731|P5|STARTED|Overall Study||200
108968|NCT01939197|267732|P4|STARTED|Overall Study||12
108969|NCT01939197|267733|P3|STARTED|Overall Study||10
108970|NCT01939197|267734|P2|STARTED|Overall Study||32
108971|NCT01939197|267735|P1|STARTED|Overall Study||31
108972|NCT01939145|267795|P2|NOT COMPLETED|Overall Study||7
108973|NCT01939145|267796|P1|NOT COMPLETED|Overall Study||2
108974|NCT01939145|267795|P2|COMPLETED|Overall Study||44
108975|NCT01939145|267796|P1|COMPLETED|Overall Study||47
108976|NCT01939145|267795|P2|STARTED|Overall Study||51
108977|NCT01939145|267796|P1|STARTED|Overall Study||49
108978|NCT01939002|267806|P2|NOT COMPLETED|Overall Study||18
108979|NCT01939002|267807|P1|NOT COMPLETED|Overall Study||19
108980|NCT01939002|267806|P2|COMPLETED|Overall Study||80
108981|NCT01939002|267807|P1|COMPLETED|Overall Study||84
108982|NCT01939002|267806|P2|STARTED|Overall Study||98
108983|NCT01939002|267807|P1|STARTED|Overall Study||103
108984|NCT01938989|267873|P2|NOT COMPLETED|Overall Study||0
108985|NCT01938989|267874|P1|NOT COMPLETED|Overall Study||0
108986|NCT01938989|267873|P2|COMPLETED|Overall Study||77
108987|NCT01938989|267874|P1|COMPLETED|Overall Study||77
108988|NCT01938989|267873|P2|STARTED|Overall Study||77
108989|NCT01938989|267874|P1|STARTED|Overall Study||77
108990|NCT01938846|267883|P3|NOT COMPLETED|Overall Study||24
108991|NCT01938846|267884|P2|NOT COMPLETED|Overall Study||25
108992|NCT01938846|267885|P1|NOT COMPLETED|Overall Study||41
108993|NCT01938846|267883|P3|COMPLETED|Overall Study||0
108994|NCT01938846|267884|P2|COMPLETED|Overall Study||0
108995|NCT01938846|267885|P1|COMPLETED|Overall Study||0
108996|NCT01938846|267883|P3|STARTED|Overall Study||24
108997|NCT01938846|267884|P2|STARTED|Overall Study||25
108998|NCT01938846|267885|P1|STARTED|Overall Study||41
108999|NCT01938833|268077|P1|NOT COMPLETED|Overall Study||0
109000|NCT01938833|268077|P1|COMPLETED|Overall Study||9
109001|NCT01938833|268077|P1|STARTED|Overall Study||9
109002|NCT01938664|268087|P2|NOT COMPLETED|Overall Study||10
109003|NCT01938664|268088|P1|NOT COMPLETED|Overall Study||15
109004|NCT01938664|268087|P2|COMPLETED|Overall Study||0
109005|NCT01938664|268088|P1|COMPLETED|Overall Study||5
109006|NCT01938664|268087|P2|STARTED|Overall Study||10
109007|NCT01938664|268088|P1|STARTED|Overall Study||20
109008|NCT01938625|268100|P2|NOT COMPLETED|Overall Study||2
109009|NCT01938625|268101|P1|NOT COMPLETED|Overall Study||0
109010|NCT01938625|268100|P2|COMPLETED|Overall Study||23
109011|NCT01938625|268101|P1|COMPLETED|Overall Study||10
109012|NCT01938625|268100|P2|STARTED|Overall Study||25
109013|NCT01938625|268101|P1|STARTED|Overall Study||10
109014|NCT01938573|268121|P2|NOT COMPLETED|Overall Study||0
109015|NCT01938573|268122|P1|NOT COMPLETED|Overall Study||2
109016|NCT01938573|268121|P2|COMPLETED|Overall Study||6
109017|NCT01938573|268122|P1|COMPLETED|Overall Study||13
109018|NCT01938573|268121|P2|STARTED|Overall Study||6
109019|NCT01938573|268122|P1|STARTED|Overall Study||15
109020|NCT01938430|268142|P14|NOT COMPLETED|Overall Study||1
109021|NCT01938430|268143|P13|NOT COMPLETED|Overall Study||0
109022|NCT01938430|268144|P12|NOT COMPLETED|Overall Study||1
109023|NCT01938430|268145|P11|NOT COMPLETED|Overall Study||3
109024|NCT01938430|268146|P10|NOT COMPLETED|Overall Study||3
109025|NCT01938430|268147|P9|NOT COMPLETED|Overall Study||4
109026|NCT01938430|268148|P8|NOT COMPLETED|Overall Study||1
109027|NCT01938430|268149|P7|NOT COMPLETED|Overall Study||2
109028|NCT01938430|268150|P6|NOT COMPLETED|Overall Study||1
109029|NCT01938430|268151|P5|NOT COMPLETED|Overall Study||0
109030|NCT01938430|268152|P4|NOT COMPLETED|Overall Study||2
109031|NCT01938430|268153|P3|NOT COMPLETED|Overall Study||5
109032|NCT01938430|268154|P2|NOT COMPLETED|Overall Study||3
109033|NCT01938430|268155|P1|NOT COMPLETED|Overall Study||4
109034|NCT01938430|268142|P14|COMPLETED|Overall Study||2
109035|NCT01938430|268143|P13|COMPLETED|Overall Study||4
109036|NCT01938430|268144|P12|COMPLETED|Overall Study||3
109037|NCT01938430|268145|P11|COMPLETED|Overall Study||3
109038|NCT01938430|268146|P10|COMPLETED|Overall Study||23
109039|NCT01938430|268147|P9|COMPLETED|Overall Study||22
109040|NCT01938430|268148|P8|COMPLETED|Overall Study||24
109041|NCT01938430|268149|P7|COMPLETED|Overall Study||24
109042|NCT01938430|268150|P6|COMPLETED|Overall Study||55
109043|NCT01938430|268151|P5|COMPLETED|Overall Study||55
109044|NCT01938430|268152|P4|COMPLETED|Overall Study||24
109045|NCT01938430|268153|P3|COMPLETED|Overall Study||18
109046|NCT01938430|268154|P2|COMPLETED|Overall Study||26
109047|NCT01938430|268155|P1|COMPLETED|Overall Study||26
109048|NCT01938430|268142|P14|STARTED|Overall Study||3
109049|NCT01938430|268143|P13|STARTED|Overall Study||4
109050|NCT01938430|268144|P12|STARTED|Overall Study||4
109051|NCT01938430|268145|P11|STARTED|Overall Study||6
109052|NCT01938430|268146|P10|STARTED|Overall Study||26
109053|NCT01938430|268147|P9|STARTED|Overall Study||26
109054|NCT01938430|268148|P8|STARTED|Overall Study||25
109055|NCT01938430|268149|P7|STARTED|Overall Study||26
109056|NCT01938430|268150|P6|STARTED|Overall Study||56
109057|NCT01938430|268151|P5|STARTED|Overall Study||55
109058|NCT01938430|268152|P4|STARTED|Overall Study||26
109059|NCT01938430|268153|P3|STARTED|Overall Study||23
109060|NCT01938430|268154|P2|STARTED|Overall Study||29
109061|NCT01938430|268155|P1|STARTED|Overall Study||30
109062|NCT01938391|268480|P1|NOT COMPLETED|12 Month Follow up||2
109063|NCT01938391|268480|P1|COMPLETED|12 Month Follow up||22
109064|NCT01938391|268480|P1|STARTED|12 Month Follow up||24
109065|NCT01938391|268480|P1|NOT COMPLETED|6 Month Follow up||1
109066|NCT01938391|268480|P1|COMPLETED|6 Month Follow up||24
109067|NCT01938391|268480|P1|STARTED|6 Month Follow up||25
109068|NCT01938391|268480|P1|NOT COMPLETED|2 Week Follow up||0
109069|NCT01938391|268480|P1|COMPLETED|2 Week Follow up||25
109070|NCT01938391|268480|P1|STARTED|2 Week Follow up||25
109071|NCT01938391|268480|P1|NOT COMPLETED|Baseline||0
109072|NCT01938391|268480|P1|COMPLETED|Baseline||25
109073|NCT01938391|268480|P1|STARTED|Baseline||25
109074|NCT01938170|268490|P1|NOT COMPLETED|Overall Study||0
109075|NCT01938170|268490|P1|COMPLETED|Overall Study||41
109076|NCT01938170|268490|P1|STARTED|Overall Study||41
109077|NCT01938079|268497|P2|NOT COMPLETED|Overall Study||0
109078|NCT01938079|268498|P1|NOT COMPLETED|Overall Study||0
109079|NCT01938079|268497|P2|COMPLETED|Overall Study||10
109080|NCT01938079|268498|P1|COMPLETED|Overall Study||10
109081|NCT01938079|268497|P2|STARTED|Overall Study||10
109082|NCT01938079|268498|P1|STARTED|Overall Study||10
109083|NCT01938066|268506|P2|NOT COMPLETED|Overall Study||2
109084|NCT01938066|268507|P1|NOT COMPLETED|Overall Study||1
109085|NCT01938066|268506|P2|COMPLETED|Overall Study||13
109086|NCT01938066|268507|P1|COMPLETED|Overall Study||14
109087|NCT01938066|268506|P2|STARTED|Overall Study||15
109088|NCT01938066|268507|P1|STARTED|Overall Study||15
109089|NCT01938040|268517|P2|NOT COMPLETED|Overall Study||0
109090|NCT01938040|268518|P1|NOT COMPLETED|Overall Study||0
109091|NCT01938040|268517|P2|COMPLETED|Overall Study||27
109092|NCT01938040|268518|P1|COMPLETED|Overall Study||28
109093|NCT01938040|268517|P2|Behavior Metrics|Overall Study||27
109094|NCT01938040|268518|P1|Behavior Metrics|Overall Study||28
109095|NCT01938040|268517|P2|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|25
109096|NCT01938040|268518|P1|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|24
109097|NCT01938040|268517|P2|STARTED|Overall Study||27
109098|NCT01938040|268518|P1|STARTED|Overall Study||28
109099|NCT01938001|268546|P2|NOT COMPLETED|Overall Study||47
109100|NCT01938001|268547|P1|NOT COMPLETED|Overall Study||43
109101|NCT01938001|268546|P2|COMPLETED|Overall Study||133
109102|NCT01938001|268547|P1|COMPLETED|Overall Study||135
109103|NCT01938001|268546|P2|Completed Treatment|Overall Study||110
109104|NCT01938001|268547|P1|Completed Treatment|Overall Study||124
109105|NCT01938001|268546|P2|Participants Received Treatment|Overall Study||180
109106|NCT01938001|268547|P1|Participants Received Treatment|Overall Study||176
109107|NCT01938001|268546|P2|STARTED|Overall Study||180
109108|NCT01938001|268547|P1|STARTED|Overall Study||178
109109|NCT01937975|268574|P3|NOT COMPLETED|Overall Study||0
109110|NCT01937975|268575|P2|NOT COMPLETED|Overall Study||0
109111|NCT01937975|268576|P1|NOT COMPLETED|Overall Study||0
109112|NCT01937975|268574|P3|COMPLETED|Overall Study||8
109113|NCT01937975|268575|P2|COMPLETED|Overall Study||8
109114|NCT01937975|268576|P1|COMPLETED|Overall Study||8
109115|NCT01937975|268574|P3|STARTED|Overall Study||8
109116|NCT01937975|268575|P2|STARTED|Overall Study||8
109117|NCT01937975|268576|P1|STARTED|Overall Study||8
109118|NCT01937871|268626|P3|NOT COMPLETED|Overall Study||11
109119|NCT01937871|268627|P2|NOT COMPLETED|Overall Study||17
109120|NCT01937871|268628|P1|NOT COMPLETED|Overall Study||24
109121|NCT01937871|268626|P3|COMPLETED|Overall Study||174
109122|NCT01937871|268627|P2|COMPLETED|Overall Study||346
109123|NCT01937871|268628|P1|COMPLETED|Overall Study||337
109124|NCT01937871|268626|P3|Received at Least One Dose of Study Drug|Overall Study||185
109125|NCT01937871|268627|P2|Received at Least One Dose of Study Drug|Overall Study||362
109126|NCT01937871|268628|P1|Received at Least One Dose of Study Drug|Overall Study||361
109127|NCT01937871|268626|P3|STARTED|Overall Study||185
109128|NCT01937871|268627|P2|STARTED|Overall Study||363
109129|NCT01937871|268628|P1|STARTED|Overall Study||361
109130|NCT01937715|268704|P5|NOT COMPLETED|Overall Study||2
109131|NCT01937715|268705|P4|NOT COMPLETED|Overall Study||4
109132|NCT01937715|268706|P3|NOT COMPLETED|Overall Study||0
109133|NCT01937715|268707|P2|NOT COMPLETED|Overall Study||1
109134|NCT01937715|268708|P1|NOT COMPLETED|Overall Study||0
109135|NCT01937715|268704|P5|COMPLETED|Overall Study||1
109136|NCT01937715|268705|P4|COMPLETED|Overall Study||1
109137|NCT01937715|268706|P3|COMPLETED|Overall Study||3
109138|NCT01937715|268707|P2|COMPLETED|Overall Study||3
109139|NCT01937715|268708|P1|COMPLETED|Overall Study||3
109140|NCT01937715|268704|P5|STARTED|Overall Study||3
109141|NCT01937715|268705|P4|STARTED|Overall Study||5
109142|NCT01937715|268706|P3|STARTED|Overall Study||3
109143|NCT01937715|268707|P2|STARTED|Overall Study||4
109144|NCT01937715|268708|P1|STARTED|Overall Study||3
109145|NCT01937624|268830|P1|NOT COMPLETED|Overall Study||0
109146|NCT01937624|268830|P1|COMPLETED|Overall Study||51
109147|NCT01937624|268830|P1|STARTED|Overall Study||51
109148|NCT01937598|268834|P2|NOT COMPLETED|Overall Study||0
109149|NCT01937598|268835|P1|NOT COMPLETED|Overall Study||0
109150|NCT01937598|268834|P2|COMPLETED|Overall Study||8
109151|NCT01937598|268835|P1|COMPLETED|Overall Study||8
109152|NCT01937598|268834|P2|STARTED|Overall Study||8
109153|NCT01937598|268835|P1|STARTED|Overall Study||8
109154|NCT01937520|268859|P2|NOT COMPLETED|Overall Study||0
109155|NCT01937520|268860|P1|NOT COMPLETED|Overall Study||0
109156|NCT01937520|268859|P2|COMPLETED|Overall Study||9
109157|NCT01937520|268860|P1|COMPLETED|Overall Study||11
109158|NCT01937520|268859|P2|STARTED|Overall Study||9
109159|NCT01937520|268860|P1|STARTED|Overall Study||11
109160|NCT01937507|268896|P1|NOT COMPLETED|Overall Study||2
109161|NCT01937507|268896|P1|COMPLETED|Overall Study||0
109162|NCT01937507|268896|P1|STARTED|Overall Study||2
109163|NCT01937390|268903|P1|NOT COMPLETED|Overall Study||35
109164|NCT01937390|268903|P1|COMPLETED|Overall Study||550
109165|NCT01937390|268903|P1|STARTED|Overall Study||585
109166|NCT01937364|268913|P2|NOT COMPLETED|Overall Study||1
109167|NCT01937364|268914|P1|NOT COMPLETED|Overall Study||2
109168|NCT01937364|268913|P2|COMPLETED|Overall Study||7
109169|NCT01937364|268914|P1|COMPLETED|Overall Study||7
109170|NCT01937364|268913|P2|STARTED|Overall Study||8
109171|NCT01937364|268914|P1|STARTED|Overall Study||9
109172|NCT01937351|268926|P2|NOT COMPLETED|Overall Study||2
109173|NCT01937351|268927|P1|NOT COMPLETED|Overall Study||9
109174|NCT01937351|268926|P2|COMPLETED|Overall Study||26
109175|NCT01937351|268927|P1|COMPLETED|Overall Study||125
109176|NCT01937351|268926|P2|6-Month Follow-up|Overall Study||26
109177|NCT01937351|268927|P1|6-Month Follow-up|Overall Study||125
109178|NCT01937351|268926|P2|30-Day Follow-up|Overall Study||27
109179|NCT01937351|268927|P1|30-Day Follow-up|Overall Study||128
109180|NCT01937351|268926|P2|Treated w Study Device|Overall Study||28
109181|NCT01937351|268927|P1|Treated w Study Device|Overall Study||130
109182|NCT01937351|268926|P2|STARTED|Overall Study||28
109183|NCT01937351|268927|P1|STARTED|Overall Study||134
109184|NCT01937312|268935|P2|NOT COMPLETED|Overall Study||3
109185|NCT01937312|268936|P1|NOT COMPLETED|Overall Study||11
109186|NCT01937312|268935|P2|COMPLETED|Overall Study||92
109187|NCT01937312|268936|P1|COMPLETED|Overall Study||83
109188|NCT01937312|268935|P2|Treated|Overall Study||95
109189|NCT01937312|268936|P1|Treated|Overall Study||93
109190|NCT01937312|268935|P2|STARTED|Overall Study||95
109191|NCT01937312|268936|P1|STARTED|Overall Study||94
109192|NCT01937299|268951|P2|NOT COMPLETED|Overall Study||4
109193|NCT01937299|268952|P1|NOT COMPLETED|Overall Study||14
109194|NCT01937299|268951|P2|COMPLETED|Overall Study||112
109195|NCT01937299|268952|P1|COMPLETED|Overall Study||103
109196|NCT01937299|268951|P2|STARTED|Overall Study||116
109197|NCT01937299|268952|P1|STARTED|Overall Study||117
109198|NCT01937260|268965|P2|NOT COMPLETED|Overall Study||0
109199|NCT01937260|268966|P1|NOT COMPLETED|Overall Study||1
109200|NCT01937260|268965|P2|COMPLETED|Overall Study||10
109201|NCT01937260|268966|P1|COMPLETED|Overall Study||20
109202|NCT01937260|268965|P2|STARTED|Overall Study||10
109203|NCT01937260|268966|P1|STARTED|Overall Study||21
109204|NCT01937195|268973|P1|NOT COMPLETED|Overall Study||0
109205|NCT01937195|268973|P1|COMPLETED|Overall Study||95
109206|NCT01937195|268973|P1|STARTED|Overall Study||95
109207|NCT01937130|268987|P4|NOT COMPLETED|Overall Study||2
109208|NCT01937130|268988|P3|NOT COMPLETED|Overall Study||3
109209|NCT01937130|268989|P2|NOT COMPLETED|Overall Study||4
109210|NCT01937130|268990|P1|NOT COMPLETED|Overall Study||5
109211|NCT01937130|268987|P4|COMPLETED|Overall Study||2
109212|NCT01937130|268988|P3|COMPLETED|Overall Study||2
109213|NCT01937130|268989|P2|COMPLETED|Overall Study||3
109214|NCT01937130|268990|P1|COMPLETED|Overall Study||0
109215|NCT01937130|268987|P4|STARTED|Overall Study||4
109216|NCT01937130|268988|P3|STARTED|Overall Study||5
109217|NCT01937130|268989|P2|STARTED|Overall Study||7
109218|NCT01937130|268990|P1|STARTED|Overall Study||5
109219|NCT01937117|269017|P1|NOT COMPLETED|Overall Study||13
109220|NCT01937117|269017|P1|COMPLETED|Overall Study||75
109221|NCT01937117|269017|P1|STARTED|Overall Study||88
109222|NCT01937026|269021|P1|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||0
109223|NCT01937026|269021|P1|COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||18
109224|NCT01937026|269021|P1|Received Probenecid on Days 3 Through 7|Period 2 (At Dosing Day 3 Through Day 8)||18
109225|NCT01937026|269021|P1|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day 8)||18
109226|NCT01937026|269021|P1|STARTED|Period 2 (At Dosing Day 3 Through Day 8)||18
109227|NCT01937026|269021|P1|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
109228|NCT01937026|269021|P1|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||18
109229|NCT01937026|269021|P1|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||18
109230|NCT01937026|269021|P1|STARTED|Period 1 (Day 1 Through Predose Day 3)||18
109231|NCT01936974|269032|P2|NOT COMPLETED|Overall Study||5
109232|NCT01936974|269033|P1|NOT COMPLETED|Overall Study||2
109233|NCT01936974|269032|P2|COMPLETED|Overall Study||0
109234|NCT01936974|269033|P1|COMPLETED|Overall Study||0
109235|NCT01936974|269032|P2|STARTED|Overall Study||5
109236|NCT01936974|269033|P1|STARTED|Overall Study||2
109237|NCT01936909|269042|P3|NOT COMPLETED|Overall Study||6
109238|NCT01936909|269043|P2|NOT COMPLETED|Overall Study||8
109239|NCT01936909|269044|P1|NOT COMPLETED|Overall Study||10
109240|NCT01936909|269042|P3|COMPLETED|Overall Study||14
109241|NCT01936909|269043|P2|COMPLETED|Overall Study||12
109242|NCT01936909|269044|P1|COMPLETED|Overall Study||10
109243|NCT01936909|269042|P3|STARTED|Overall Study||20
109244|NCT01936909|269043|P2|STARTED|Overall Study||20
109245|NCT01936909|269044|P1|STARTED|Overall Study||20
109246|NCT01936896|269058|P1|NOT COMPLETED|Overall Study||0
109247|NCT01936896|269058|P1|COMPLETED|Overall Study||10
109248|NCT01936896|269058|P1|STARTED|Overall Study||10
109249|NCT01936870|269063|P1|NOT COMPLETED|Overall Study||189
109250|NCT01936870|269063|P1|COMPLETED|Overall Study||2303
109251|NCT01936870|269063|P1|STARTED|Overall Study||2492
109252|NCT01936844|269078|P2|NOT COMPLETED|Overall Study||7
109253|NCT01936844|269079|P1|NOT COMPLETED|Overall Study||6
109254|NCT01936844|269078|P2|COMPLETED|Overall Study||8
109255|NCT01936844|269079|P1|COMPLETED|Overall Study||9
109256|NCT01936844|269078|P2|STARTED|Overall Study||15
109257|NCT01936844|269079|P1|STARTED|Overall Study||15
109258|NCT01936662|269091|P2|NOT COMPLETED|Overall Study||0
109259|NCT01936662|269092|P1|NOT COMPLETED|Overall Study||0
109260|NCT01936662|269091|P2|COMPLETED|Overall Study||42
109261|NCT01936662|269092|P1|COMPLETED|Overall Study||42
109262|NCT01936662|269091|P2|STARTED|Overall Study||42
109263|NCT01936662|269092|P1|STARTED|Overall Study||42
109264|NCT01936649|269100|P1|NOT COMPLETED|Overall Study||13
109265|NCT01936649|269100|P1|COMPLETED|Overall Study||50
109266|NCT01936649|269100|P1|Treated|Overall Study||51
109267|NCT01936649|269100|P1|STARTED|Overall Study||63
109268|NCT01936623|269107|P2|NOT COMPLETED|Overall Study||5
109269|NCT01936623|269108|P1|NOT COMPLETED|Overall Study||0
109270|NCT01936623|269107|P2|COMPLETED|Overall Study||35
109271|NCT01936623|269108|P1|COMPLETED|Overall Study||40
109272|NCT01936623|269107|P2|STARTED|Overall Study||40
109273|NCT01936623|269108|P1|STARTED|Overall Study||40
109274|NCT01936467|269122|P2|NOT COMPLETED|Overall Study||0
109275|NCT01936467|269123|P1|NOT COMPLETED|Overall Study||0
109276|NCT01936467|269122|P2|COMPLETED|Overall Study||61
109277|NCT01936467|269123|P1|COMPLETED|Overall Study||60
109278|NCT01936467|269122|P2|STARTED|Overall Study||61
109279|NCT01936467|269123|P1|STARTED|Overall Study||60
109280|NCT01936389|269143|P2|NOT COMPLETED|Overall Study||0
109281|NCT01936389|269144|P1|NOT COMPLETED|Overall Study||1
109282|NCT01936389|269143|P2|COMPLETED|Overall Study||5
109283|NCT01936389|269144|P1|COMPLETED|Overall Study||4
109284|NCT01936389|269143|P2|STARTED|Overall Study||5
109285|NCT01936389|269144|P1|STARTED|Overall Study||5
109286|NCT01936363|269152|P2|NOT COMPLETED|Overall Study||0
109287|NCT01936363|269153|P1|NOT COMPLETED|Overall Study||0
109288|NCT01936363|269152|P2|COMPLETED|Overall Study||33
109289|NCT01936363|269153|P1|COMPLETED|Overall Study||32
109290|NCT01936363|269152|P2|STARTED|Overall Study||33
109291|NCT01936363|269153|P1|STARTED|Overall Study||32
109292|NCT01936324|269180|P3|NOT COMPLETED|Overall Study||5
109293|NCT01936324|269181|P2|NOT COMPLETED|Overall Study||6
109294|NCT01936324|269182|P1|NOT COMPLETED|Overall Study||0
109295|NCT01936324|269180|P3|COMPLETED|Overall Study||50
109296|NCT01936324|269181|P2|COMPLETED|Overall Study||47
109297|NCT01936324|269182|P1|COMPLETED|Overall Study||6
109298|NCT01936324|269180|P3|STARTED|Overall Study||55
109299|NCT01936324|269181|P2|STARTED|Overall Study||53
109300|NCT01936324|269182|P1|STARTED|Overall Study||6
109301|NCT01936181|269195|P4|NOT COMPLETED|Transition-extension||5
109302|NCT01936181|269196|P3|NOT COMPLETED|Transition-extension||6
109303|NCT01936181|269197|P2|NOT COMPLETED|Transition-extension||0
109304|NCT01936181|269198|P1|NOT COMPLETED|Transition-extension||15
109305|NCT01936181|269195|P4|COMPLETED|Transition-extension||96
109306|NCT01936181|269196|P3|COMPLETED|Transition-extension||88
109307|NCT01936181|269197|P2|COMPLETED|Transition-extension||0
109308|NCT01936181|269198|P1|COMPLETED|Transition-extension||186
109309|NCT01936181|269195|P4|STARTED|Transition-extension||101
109310|NCT01936181|269196|P3|STARTED|Transition-extension||94
109311|NCT01936181|269197|P2|STARTED|Transition-extension||0
109312|NCT01936181|269198|P1|STARTED|Transition-extension||201
109313|NCT01936181|269195|P4|NOT COMPLETED|Randomised, Double-blind||0
109314|NCT01936181|269196|P3|NOT COMPLETED|Randomised, Double-blind||0
109315|NCT01936181|269197|P2|NOT COMPLETED|Randomised, Double-blind||68
109316|NCT01936181|269198|P1|NOT COMPLETED|Randomised, Double-blind||64
109317|NCT01936181|269195|P4|COMPLETED|Randomised, Double-blind||0
109318|NCT01936181|269196|P3|COMPLETED|Randomised, Double-blind||0
109319|NCT01936181|269197|P2|COMPLETED|Randomised, Double-blind||225
109320|NCT01936181|269198|P1|COMPLETED|Randomised, Double-blind||227
109321|NCT01936181|269195|P4|STARTED|Randomised, Double-blind||0
109322|NCT01936181|269196|P3|STARTED|Randomised, Double-blind||0
109323|NCT01936181|269197|P2|STARTED|Randomised, Double-blind||293
109324|NCT01936181|269198|P1|STARTED|Randomised, Double-blind||291
109325|NCT01935947|269212|P3|NOT COMPLETED|Overall Study||2
109326|NCT01935947|269213|P2|NOT COMPLETED|Overall Study||4
109327|NCT01935947|269214|P1|NOT COMPLETED|Overall Study||3
109328|NCT01935947|269212|P3|COMPLETED|Overall Study||0
109329|NCT01935947|269213|P2|COMPLETED|Overall Study||0
109330|NCT01935947|269214|P1|COMPLETED|Overall Study||1
109331|NCT01935947|269212|P3|Cytotoxic Therapy|Overall Study||2
109332|NCT01935947|269213|P2|Cytotoxic Therapy|Overall Study||3
109333|NCT01935947|269214|P1|Cytotoxic Therapy|Overall Study||3
109334|NCT01935947|269212|P3|Epigenetic Therapy|Overall Study||0
109335|NCT01935947|269213|P2|Epigenetic Therapy|Overall Study||4
109336|NCT01935947|269214|P1|Epigenetic Therapy|Overall Study||4
109337|NCT01935947|269212|P3|STARTED|Overall Study||2
109338|NCT01935947|269213|P2|STARTED|Overall Study||4
109339|NCT01935947|269214|P1|STARTED|Overall Study||4
109340|NCT01935622|269240|P3|NOT COMPLETED|Overall Study||0
109341|NCT01935622|269241|P2|NOT COMPLETED|Overall Study||2
109342|NCT01935622|269242|P1|NOT COMPLETED|Overall Study||2
109343|NCT01935622|269240|P3|COMPLETED|Overall Study||4
109344|NCT01935622|269241|P2|COMPLETED|Overall Study||1
109345|NCT01935622|269242|P1|COMPLETED|Overall Study||1
109346|NCT01935622|269240|P3|STARTED|Overall Study||4
109347|NCT01935622|269241|P2|STARTED|Overall Study||3
109348|NCT01935622|269242|P1|STARTED|Overall Study||3
109349|NCT01935180|269252|P2|NOT COMPLETED|Overall Study||14
109350|NCT01935180|269253|P1|NOT COMPLETED|Overall Study||21
109351|NCT01935180|269252|P2|COMPLETED|Overall Study||561
109352|NCT01935180|269253|P1|COMPLETED|Overall Study||552
109353|NCT01935180|269252|P2|STARTED|Overall Study||575
109354|NCT01935180|269253|P1|STARTED|Overall Study||573
109355|NCT01934894|269273|P2|NOT COMPLETED|Overall Study||5
109356|NCT01934894|269274|P1|NOT COMPLETED|Overall Study||6
109357|NCT01934894|269273|P2|COMPLETED|Overall Study||0
109358|NCT01934894|269274|P1|COMPLETED|Overall Study||0
109359|NCT01934894|269273|P2|STARTED|Overall Study||5
109360|NCT01934894|269274|P1|STARTED|Overall Study||6
109361|NCT01934790|269289|P1|NOT COMPLETED|Long Term Follow up||0
109362|NCT01934790|269289|P1|COMPLETED|Long Term Follow up||12
109363|NCT01934790|269289|P1|STARTED|Long Term Follow up||12
109364|NCT01934790|269289|P1|NOT COMPLETED|Active Follow up||24
109365|NCT01934790|269289|P1|COMPLETED|Active Follow up||10
109366|NCT01934790|269289|P1|STARTED|Active Follow up||34
109367|NCT01934790|269289|P1|NOT COMPLETED|Treatment||16
109368|NCT01934790|269289|P1|COMPLETED|Treatment||29
109369|NCT01934790|269289|P1|Participants Received Study Treatment|Treatment||44
109370|NCT01934790|269289|P1|STARTED|Treatment|Eligible for treatment|45
109371|NCT01934647|269320|P3|NOT COMPLETED|Overall Study||0
109372|NCT01934647|269321|P2|NOT COMPLETED|Overall Study||0
109373|NCT01934647|269322|P1|NOT COMPLETED|Overall Study||0
109374|NCT01934647|269320|P3|COMPLETED|Overall Study||3
109375|NCT01934647|269321|P2|COMPLETED|Overall Study||2
109376|NCT01934647|269322|P1|COMPLETED|Overall Study||2
109377|NCT01934647|269320|P3|STARTED|Overall Study||3
109378|NCT01934647|269321|P2|STARTED|Overall Study||2
109379|NCT01934647|269322|P1|STARTED|Overall Study||2
109380|NCT01934582|269330|P1|NOT COMPLETED|Overall Study||0
109381|NCT01934582|269330|P1|COMPLETED|Overall Study||13
109382|NCT01934582|269330|P1|STARTED|Overall Study||13
109383|NCT01934517|269344|P1|NOT COMPLETED|Overall Study||0
109384|NCT01934517|269344|P1|COMPLETED|Overall Study||25
109385|NCT01934517|269344|P1|STARTED|Overall Study||25
109386|NCT01934504|269356|P4|NOT COMPLETED|Overall Study||7
109387|NCT01934504|269357|P3|NOT COMPLETED|Overall Study||5
109388|NCT01934504|269358|P2|NOT COMPLETED|Overall Study||0
109389|NCT01934504|269359|P1|NOT COMPLETED|Overall Study||1
109390|NCT01934504|269356|P4|COMPLETED|Overall Study||1
109391|NCT01934504|269357|P3|COMPLETED|Overall Study||11
109392|NCT01934504|269358|P2|COMPLETED|Overall Study||3
109393|NCT01934504|269359|P1|COMPLETED|Overall Study||5
109394|NCT01934504|269356|P4|STARTED|Overall Study||8
109395|NCT01934504|269357|P3|STARTED|Overall Study||16
109396|NCT01934504|269358|P2|STARTED|Overall Study||3
109397|NCT01934504|269359|P1|STARTED|Overall Study||6
109398|NCT01934231|269381|P1|NOT COMPLETED|Overall Study||0
109399|NCT01934231|269381|P1|COMPLETED|Overall Study||27
109400|NCT01934231|269381|P1|STARTED|Overall Study||27
109401|NCT01934218|269392|P2|NOT COMPLETED|Open-Label Phase||24
109402|NCT01934218|269393|P1|NOT COMPLETED|Open-Label Phase||26
109403|NCT01934218|269392|P2|COMPLETED|Open-Label Phase||304
109404|NCT01934218|269393|P1|COMPLETED|Open-Label Phase||290
109405|NCT01934218|269392|P2|STARTED|Open-Label Phase||328
109406|NCT01934218|269393|P1|STARTED|Open-Label Phase||316
109407|NCT01934218|269392|P2|NOT COMPLETED|Double-blind Phase||54
109408|NCT01934218|269393|P1|NOT COMPLETED|Double-blind Phase||48
109409|NCT01934218|269392|P2|COMPLETED|Double-blind Phase||356
109410|NCT01934218|269393|P1|COMPLETED|Double-blind Phase||356
109411|NCT01934218|269392|P2|Analyzed Participants|Double-blind Phase||407
109412|NCT01934218|269393|P1|Analyzed Participants|Double-blind Phase||402
109413|NCT01934218|269392|P2|STARTED|Double-blind Phase||410
109414|NCT01934218|269393|P1|STARTED|Double-blind Phase||404
109415|NCT01934192|269404|P4|NOT COMPLETED|Overall Study||1
109416|NCT01934192|269405|P3|NOT COMPLETED|Overall Study||1
109417|NCT01934192|269406|P2|NOT COMPLETED|Overall Study||7
109418|NCT01934192|269407|P1|NOT COMPLETED|Overall Study||9
109419|NCT01934192|269404|P4|COMPLETED|Overall Study||3
109420|NCT01934192|269405|P3|COMPLETED|Overall Study||3
109421|NCT01934192|269406|P2|COMPLETED|Overall Study||37
109422|NCT01934192|269407|P1|COMPLETED|Overall Study||31
109423|NCT01934192|269404|P4|STARTED|Overall Study||4
109424|NCT01934192|269405|P3|STARTED|Overall Study||4
109425|NCT01934192|269406|P2|STARTED|Overall Study||44
109426|NCT01934192|269407|P1|STARTED|Overall Study||40
109427|NCT01934140|269543|P2|NOT COMPLETED|Booster Phase (6 Months)||3
109428|NCT01934140|269544|P1|NOT COMPLETED|Booster Phase (6 Months)||5
109429|NCT01934140|269543|P2|COMPLETED|Booster Phase (6 Months)||53
109430|NCT01934140|269544|P1|COMPLETED|Booster Phase (6 Months)||159
109431|NCT01934140|269543|P2|Vaccinated|Booster Phase (6 Months)||56
109432|NCT01934140|269544|P1|Vaccinated|Booster Phase (6 Months)||164
109433|NCT01934140|269543|P2|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent, were enrolled in booster phase.|56
109434|NCT01934140|269544|P1|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent, were enrolled in booster phase.|164
109435|NCT01934140|269543|P2|NOT COMPLETED|Persistence Phase (Year 6-10)||25
109436|NCT01934140|269544|P1|NOT COMPLETED|Persistence Phase (Year 6-10)||83
109437|NCT01934140|269543|P2|COMPLETED|Persistence Phase (Year 6-10)|Participants completed all persistence phase visits|51
109438|NCT01934140|269544|P1|COMPLETED|Persistence Phase (Year 6-10)|Participants completed all persistence phase visits|152
109439|NCT01934140|269543|P2|STARTED|Persistence Phase (Year 6-10)||76
109440|NCT01934140|269544|P1|STARTED|Persistence Phase (Year 6-10)||235
109441|NCT01934010|269595|P3|NOT COMPLETED|Overall Study||2
109442|NCT01934010|269596|P2|NOT COMPLETED|Overall Study||11
109443|NCT01934010|269597|P1|NOT COMPLETED|Overall Study||23
109444|NCT01934010|269595|P3|COMPLETED|Overall Study||74
109445|NCT01934010|269596|P2|COMPLETED|Overall Study||56
109446|NCT01934010|269597|P1|COMPLETED|Overall Study||91
109447|NCT01934010|269595|P3|STARTED|Overall Study||76
109448|NCT01934010|269596|P2|STARTED|Overall Study||67
109449|NCT01934010|269597|P1|STARTED|Overall Study||114
109450|NCT01933932|269616|P2|NOT COMPLETED|Overall Study||178
109451|NCT01933932|269617|P1|NOT COMPLETED|Overall Study||184
109452|NCT01933932|269616|P2|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|78
109453|NCT01933932|269617|P1|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|70
109454|NCT01933932|269616|P2|STARTED|Overall Study||256
109455|NCT01933932|269617|P1|STARTED|Overall Study||254
109456|NCT01933919|269635|P2|NOT COMPLETED|Open-label Long-term Phase||6
109457|NCT01933919|269636|P1|NOT COMPLETED|Open-label Long-term Phase||7
109458|NCT01933919|269635|P2|COMPLETED|Open-label Long-term Phase||9
109459|NCT01933919|269636|P1|COMPLETED|Open-label Long-term Phase||12
109460|NCT01933919|269635|P2|STARTED|Open-label Long-term Phase||15
109461|NCT01933919|269636|P1|STARTED|Open-label Long-term Phase||19
109462|NCT01933919|269635|P2|NOT COMPLETED|Double-blind Placebo-controlled Phase||4
109463|NCT01933919|269636|P1|NOT COMPLETED|Double-blind Placebo-controlled Phase||0
109464|NCT01933919|269635|P2|COMPLETED|Double-blind Placebo-controlled Phase||15
109465|NCT01933919|269636|P1|COMPLETED|Double-blind Placebo-controlled Phase||19
109466|NCT01933919|269635|P2|Received Study Drug|Double-blind Placebo-controlled Phase||19
109467|NCT01933919|269636|P1|Received Study Drug|Double-blind Placebo-controlled Phase||19
109468|NCT01933919|269635|P2|STARTED|Double-blind Placebo-controlled Phase||19
109469|NCT01933919|269636|P1|STARTED|Double-blind Placebo-controlled Phase||19
109470|NCT01933880|269672|P2|NOT COMPLETED|Overall Study||1
109471|NCT01933880|269673|P1|NOT COMPLETED|Overall Study||30
109472|NCT01933880|269672|P2|COMPLETED|Overall Study||40
109473|NCT01933880|269673|P1|COMPLETED|Overall Study||123
109474|NCT01933880|269672|P2|STARTED|Overall Study||41
109475|NCT01933880|269673|P1|STARTED|Overall Study||153
109476|NCT01933789|269747|P9|NOT COMPLETED|Overall Study||0
109477|NCT01933789|269748|P8|NOT COMPLETED|Overall Study||14
109478|NCT01933789|269749|P7|NOT COMPLETED|Overall Study||15
109479|NCT01933789|269750|P6|NOT COMPLETED|Overall Study||67
109480|NCT01933789|269751|P5|NOT COMPLETED|Overall Study||59
109481|NCT01933789|269752|P4|NOT COMPLETED|Overall Study||1
109482|NCT01933789|269753|P3|NOT COMPLETED|Overall Study||0
109483|NCT01933789|269754|P2|NOT COMPLETED|Overall Study||1
109484|NCT01933789|269755|P1|NOT COMPLETED|Overall Study||6
109485|NCT01933789|269747|P9|COMPLETED|Overall Study||25
109486|NCT01933789|269748|P8|COMPLETED|Overall Study||47
109487|NCT01933789|269749|P7|COMPLETED|Overall Study||43
109488|NCT01933789|269750|P6|COMPLETED|Overall Study||221
109489|NCT01933789|269751|P5|COMPLETED|Overall Study||190
109490|NCT01933789|269752|P4|COMPLETED|Overall Study||1
109491|NCT01933789|269753|P3|COMPLETED|Overall Study||2
109492|NCT01933789|269754|P2|COMPLETED|Overall Study||66
109493|NCT01933789|269755|P1|COMPLETED|Overall Study||59
109494|NCT01933789|269747|P9|Qualitative Interviews|Overall Study||25
109495|NCT01933789|269748|P8|Qualitative Interviews|Overall Study||0
109496|NCT01933789|269749|P7|Qualitative Interviews|Overall Study||0
109497|NCT01933789|269750|P6|Qualitative Interviews|Overall Study||0
109498|NCT01933789|269751|P5|Qualitative Interviews|Overall Study||0
109499|NCT01933789|269752|P4|Qualitative Interviews|Overall Study||0
109500|NCT01933789|269753|P3|Qualitative Interviews|Overall Study||0
109501|NCT01933789|269754|P2|Qualitative Interviews|Overall Study||0
109502|NCT01933789|269755|P1|Qualitative Interviews|Overall Study||0
109503|NCT01933789|269747|P9|Completed 6-Month Survey|Overall Study||0
109504|NCT01933789|269748|P8|Completed 6-Month Survey|Overall Study||40
109505|NCT01933789|269749|P7|Completed 6-Month Survey|Overall Study||35
109506|NCT01933789|269750|P6|Completed 6-Month Survey|Overall Study||188
109507|NCT01933789|269751|P5|Completed 6-Month Survey|Overall Study||160
109508|NCT01933789|269752|P4|Completed 6-Month Survey|Overall Study||0
109509|NCT01933789|269753|P3|Completed 6-Month Survey|Overall Study||0
109510|NCT01933789|269754|P2|Completed 6-Month Survey|Overall Study||0
109511|NCT01933789|269755|P1|Completed 6-Month Survey|Overall Study||0
109512|NCT01933789|269747|P9|Completed 3-Month Survey|Overall Study||0
109513|NCT01933789|269748|P8|Completed 3-Month Survey|Overall Study||43
109514|NCT01933789|269749|P7|Completed 3-Month Survey|Overall Study||37
109515|NCT01933789|269750|P6|Completed 3-Month Survey|Overall Study||211
109516|NCT01933789|269751|P5|Completed 3-Month Survey|Overall Study||176
109517|NCT01933789|269752|P4|Completed 3-Month Survey|Overall Study||0
109518|NCT01933789|269753|P3|Completed 3-Month Survey|Overall Study||0
109519|NCT01933789|269754|P2|Completed 3-Month Survey|Overall Study||0
109520|NCT01933789|269755|P1|Completed 3-Month Survey|Overall Study||0
109521|NCT01933789|269747|P9|Completed 2-Week Survey|Overall Study||0
109522|NCT01933789|269748|P8|Completed 2-Week Survey|Overall Study||0
109523|NCT01933789|269749|P7|Completed 2-Week Survey|Overall Study||0
109524|NCT01933789|269750|P6|Completed 2-Week Survey|Overall Study||215
109525|NCT01933789|269751|P5|Completed 2-Week Survey|Overall Study||184
109526|NCT01933789|269752|P4|Completed 2-Week Survey|Overall Study||0
109527|NCT01933789|269753|P3|Completed 2-Week Survey|Overall Study||0
109528|NCT01933789|269754|P2|Completed 2-Week Survey|Overall Study||0
109529|NCT01933789|269755|P1|Completed 2-Week Survey|Overall Study||0
109530|NCT01933789|269747|P9|Completed After-visit Survey|Overall Study||0
109531|NCT01933789|269748|P8|Completed After-visit Survey|Overall Study||0
109532|NCT01933789|269749|P7|Completed After-visit Survey|Overall Study||0
109533|NCT01933789|269750|P6|Completed After-visit Survey|Overall Study||0
109534|NCT01933789|269751|P5|Completed After-visit Survey|Overall Study||0
109535|NCT01933789|269752|P4|Completed After-visit Survey|Overall Study|Number reflects individual IP Team members who returned surveys for up to 6 enrolled patients|1
109536|NCT01933789|269753|P3|Completed After-visit Survey|Overall Study|Number reflects individual IP Team members who returned surveys for up to 6 enrolled patients|2
109537|NCT01933789|269754|P2|Completed After-visit Survey|Overall Study|Number reflects individual clinicians who returned surveys for up to 6 enrolled patients|64
109538|NCT01933789|269755|P1|Completed After-visit Survey|Overall Study|Number reflects individual clinicians who returned surveys for up to 6 enrolled patients|57
109539|NCT01933789|269747|P9|Had Target Visit|Overall Study||0
109540|NCT01933789|269748|P8|Had Target Visit|Overall Study||0
109541|NCT01933789|269749|P7|Had Target Visit|Overall Study||0
109542|NCT01933789|269750|P6|Had Target Visit|Overall Study||266
109543|NCT01933789|269751|P5|Had Target Visit|Overall Study||228
109544|NCT01933789|269752|P4|Had Target Visit|Overall Study||2
109545|NCT01933789|269753|P3|Had Target Visit|Overall Study||2
109546|NCT01933789|269754|P2|Had Target Visit|Overall Study|Had target visit(s) completed before clinician or patient withdrawal|65
109547|NCT01933789|269755|P1|Had Target Visit|Overall Study|Had target visit(s) completed before clinician or patient withdrawal|61
109548|NCT01933789|269747|P9|STARTED|Overall Study||25
109549|NCT01933789|269748|P8|STARTED|Overall Study||61
109550|NCT01933789|269749|P7|STARTED|Overall Study||58
109551|NCT01933789|269750|P6|STARTED|Overall Study||288
109552|NCT01933789|269751|P5|STARTED|Overall Study||249
109553|NCT01933789|269752|P4|STARTED|Overall Study||2
109554|NCT01933789|269753|P3|STARTED|Overall Study||2
109555|NCT01933789|269754|P2|STARTED|Overall Study||67
109556|NCT01933789|269755|P1|STARTED|Overall Study||65
109557|NCT01933776|270056|P2|NOT COMPLETED|Overall Study||0
109558|NCT01933776|270057|P1|NOT COMPLETED|Overall Study||0
109559|NCT01933776|270056|P2|COMPLETED|Overall Study||20
109560|NCT01933776|270057|P1|COMPLETED|Overall Study||20
109561|NCT01933776|270056|P2|STARTED|Overall Study||20
109562|NCT01933776|270057|P1|STARTED|Overall Study||20
109563|NCT01933672|270065|P7|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
109564|NCT01933672|270066|P6|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
109565|NCT01933672|270067|P5|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
109566|NCT01933672|270068|P4|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
109567|NCT01933672|270069|P3|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
109568|NCT01933672|270070|P2|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
109569|NCT01933672|270071|P1|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
109570|NCT01933672|270065|P7|COMPLETED|Third Intervention Period (12-16 Days)||6
109571|NCT01933672|270066|P6|COMPLETED|Third Intervention Period (12-16 Days)||4
109572|NCT01933672|270067|P5|COMPLETED|Third Intervention Period (12-16 Days)||6
109573|NCT01933672|270068|P4|COMPLETED|Third Intervention Period (12-16 Days)||4
109574|NCT01933672|270069|P3|COMPLETED|Third Intervention Period (12-16 Days)||1
109575|NCT01933672|270070|P2|COMPLETED|Third Intervention Period (12-16 Days)||5
109576|NCT01933672|270071|P1|COMPLETED|Third Intervention Period (12-16 Days)||0
109577|NCT01933672|270065|P7|STARTED|Third Intervention Period (12-16 Days)||6
109578|NCT01933672|270066|P6|STARTED|Third Intervention Period (12-16 Days)||4
109579|NCT01933672|270067|P5|STARTED|Third Intervention Period (12-16 Days)||6
109580|NCT01933672|270068|P4|STARTED|Third Intervention Period (12-16 Days)||5
109581|NCT01933672|270069|P3|STARTED|Third Intervention Period (12-16 Days)||1
109582|NCT01933672|270070|P2|STARTED|Third Intervention Period (12-16 Days)||6
109583|NCT01933672|270071|P1|STARTED|Third Intervention Period (12-16 Days)||0
109584|NCT01933672|270065|P7|NOT COMPLETED|Second Washout Period (7-14 Days)||0
109585|NCT01933672|270066|P6|NOT COMPLETED|Second Washout Period (7-14 Days)||0
109586|NCT01933672|270067|P5|NOT COMPLETED|Second Washout Period (7-14 Days)||0
109587|NCT01933672|270068|P4|NOT COMPLETED|Second Washout Period (7-14 Days)||0
109588|NCT01933672|270069|P3|NOT COMPLETED|Second Washout Period (7-14 Days)||0
109589|NCT01933672|270070|P2|NOT COMPLETED|Second Washout Period (7-14 Days)||0
109590|NCT01933672|270071|P1|NOT COMPLETED|Second Washout Period (7-14 Days)||0
109591|NCT01933672|270065|P7|COMPLETED|Second Washout Period (7-14 Days)||6
109592|NCT01933672|270066|P6|COMPLETED|Second Washout Period (7-14 Days)||4
109593|NCT01933672|270067|P5|COMPLETED|Second Washout Period (7-14 Days)||6
109594|NCT01933672|270068|P4|COMPLETED|Second Washout Period (7-14 Days)||5
109595|NCT01933672|270069|P3|COMPLETED|Second Washout Period (7-14 Days)||1
109596|NCT01933672|270070|P2|COMPLETED|Second Washout Period (7-14 Days)||6
109597|NCT01933672|270071|P1|COMPLETED|Second Washout Period (7-14 Days)||0
109598|NCT01933672|270065|P7|STARTED|Second Washout Period (7-14 Days)||6
109599|NCT01933672|270066|P6|STARTED|Second Washout Period (7-14 Days)||4
109600|NCT01933672|270067|P5|STARTED|Second Washout Period (7-14 Days)||6
109601|NCT01933672|270068|P4|STARTED|Second Washout Period (7-14 Days)||5
109602|NCT01933672|270069|P3|STARTED|Second Washout Period (7-14 Days)||1
109603|NCT01933672|270070|P2|STARTED|Second Washout Period (7-14 Days)||6
109604|NCT01933672|270071|P1|STARTED|Second Washout Period (7-14 Days)||0
109605|NCT01933672|270065|P7|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
109606|NCT01933672|270066|P6|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
109607|NCT01933672|270067|P5|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
109608|NCT01933672|270068|P4|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
109609|NCT01933672|270069|P3|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
109610|NCT01933672|270070|P2|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
109611|NCT01933672|270071|P1|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
109612|NCT01933672|270065|P7|COMPLETED|Second Intervention Period (12-16 Days)||6
109613|NCT01933672|270066|P6|COMPLETED|Second Intervention Period (12-16 Days)||4
109614|NCT01933672|270067|P5|COMPLETED|Second Intervention Period (12-16 Days)||6
109615|NCT01933672|270068|P4|COMPLETED|Second Intervention Period (12-16 Days)||5
109616|NCT01933672|270069|P3|COMPLETED|Second Intervention Period (12-16 Days)||1
109617|NCT01933672|270070|P2|COMPLETED|Second Intervention Period (12-16 Days)||6
109618|NCT01933672|270071|P1|COMPLETED|Second Intervention Period (12-16 Days)||0
109619|NCT01933672|270065|P7|STARTED|Second Intervention Period (12-16 Days)||6
109620|NCT01933672|270066|P6|STARTED|Second Intervention Period (12-16 Days)||4
109621|NCT01933672|270067|P5|STARTED|Second Intervention Period (12-16 Days)||6
109622|NCT01933672|270068|P4|STARTED|Second Intervention Period (12-16 Days)||5
109623|NCT01933672|270069|P3|STARTED|Second Intervention Period (12-16 Days)||2
109624|NCT01933672|270070|P2|STARTED|Second Intervention Period (12-16 Days)||7
109625|NCT01933672|270071|P1|STARTED|Second Intervention Period (12-16 Days)||0
109626|NCT01933672|270065|P7|NOT COMPLETED|First Washout Period (7-14 Days)||0
109627|NCT01933672|270066|P6|NOT COMPLETED|First Washout Period (7-14 Days)||0
109628|NCT01933672|270067|P5|NOT COMPLETED|First Washout Period (7-14 Days)||0
109629|NCT01933672|270068|P4|NOT COMPLETED|First Washout Period (7-14 Days)||0
109630|NCT01933672|270069|P3|NOT COMPLETED|First Washout Period (7-14 Days)||0
109631|NCT01933672|270070|P2|NOT COMPLETED|First Washout Period (7-14 Days)||0
109632|NCT01933672|270071|P1|NOT COMPLETED|First Washout Period (7-14 Days)||0
109633|NCT01933672|270065|P7|COMPLETED|First Washout Period (7-14 Days)||6
109634|NCT01933672|270066|P6|COMPLETED|First Washout Period (7-14 Days)||4
109635|NCT01933672|270067|P5|COMPLETED|First Washout Period (7-14 Days)||6
109636|NCT01933672|270068|P4|COMPLETED|First Washout Period (7-14 Days)||5
109637|NCT01933672|270069|P3|COMPLETED|First Washout Period (7-14 Days)||2
109638|NCT01933672|270070|P2|COMPLETED|First Washout Period (7-14 Days)||7
109639|NCT01933672|270071|P1|COMPLETED|First Washout Period (7-14 Days)||0
109640|NCT01933672|270065|P7|STARTED|First Washout Period (7-14 Days)||6
109641|NCT01933672|270066|P6|STARTED|First Washout Period (7-14 Days)||4
109642|NCT01933672|270067|P5|STARTED|First Washout Period (7-14 Days)||6
109643|NCT01933672|270068|P4|STARTED|First Washout Period (7-14 Days)||5
109644|NCT01933672|270069|P3|STARTED|First Washout Period (7-14 Days)||2
109645|NCT01933672|270070|P2|STARTED|First Washout Period (7-14 Days)||7
109646|NCT01933672|270071|P1|STARTED|First Washout Period (7-14 Days)||0
109647|NCT01933672|270065|P7|NOT COMPLETED|First Intervention Period (12-16 Days)||0
109648|NCT01933672|270066|P6|NOT COMPLETED|First Intervention Period (12-16 Days)||1
109649|NCT01933672|270067|P5|NOT COMPLETED|First Intervention Period (12-16 Days)||1
109650|NCT01933672|270068|P4|NOT COMPLETED|First Intervention Period (12-16 Days)||0
109651|NCT01933672|270069|P3|NOT COMPLETED|First Intervention Period (12-16 Days)||1
109652|NCT01933672|270070|P2|NOT COMPLETED|First Intervention Period (12-16 Days)||0
109653|NCT01933672|270071|P1|NOT COMPLETED|First Intervention Period (12-16 Days)||0
109654|NCT01933672|270065|P7|COMPLETED|First Intervention Period (12-16 Days)||6
109655|NCT01933672|270066|P6|COMPLETED|First Intervention Period (12-16 Days)||4
109656|NCT01933672|270067|P5|COMPLETED|First Intervention Period (12-16 Days)||6
109657|NCT01933672|270068|P4|COMPLETED|First Intervention Period (12-16 Days)||5
109658|NCT01933672|270069|P3|COMPLETED|First Intervention Period (12-16 Days)||2
109659|NCT01933672|270070|P2|COMPLETED|First Intervention Period (12-16 Days)||7
109660|NCT01933672|270071|P1|COMPLETED|First Intervention Period (12-16 Days)||0
109661|NCT01933672|270065|P7|STARTED|First Intervention Period (12-16 Days)||6
109662|NCT01933672|270066|P6|STARTED|First Intervention Period (12-16 Days)||5
109663|NCT01933672|270067|P5|STARTED|First Intervention Period (12-16 Days)||7
109664|NCT01933672|270068|P4|STARTED|First Intervention Period (12-16 Days)||5
109665|NCT01933672|270069|P3|STARTED|First Intervention Period (12-16 Days)||3
109666|NCT01933672|270070|P2|STARTED|First Intervention Period (12-16 Days)||7
109667|NCT01933672|270071|P1|STARTED|First Intervention Period (12-16 Days)||0
109668|NCT01933672|270065|P7|NOT COMPLETED|Metformin Run-in Period||0
109669|NCT01933672|270066|P6|NOT COMPLETED|Metformin Run-in Period||0
109670|NCT01933672|270067|P5|NOT COMPLETED|Metformin Run-in Period||0
109671|NCT01933672|270068|P4|NOT COMPLETED|Metformin Run-in Period||0
109672|NCT01933672|270069|P3|NOT COMPLETED|Metformin Run-in Period||0
109673|NCT01933672|270070|P2|NOT COMPLETED|Metformin Run-in Period||0
109674|NCT01933672|270071|P1|NOT COMPLETED|Metformin Run-in Period||10
109675|NCT01933672|270065|P7|COMPLETED|Metformin Run-in Period||0
109676|NCT01933672|270066|P6|COMPLETED|Metformin Run-in Period||0
109677|NCT01933672|270067|P5|COMPLETED|Metformin Run-in Period||0
109678|NCT01933672|270068|P4|COMPLETED|Metformin Run-in Period||0
109679|NCT01933672|270069|P3|COMPLETED|Metformin Run-in Period||0
109680|NCT01933672|270070|P2|COMPLETED|Metformin Run-in Period||0
109681|NCT01933672|270071|P1|COMPLETED|Metformin Run-in Period||33
109682|NCT01933672|270065|P7|Received Treatment|Metformin Run-in Period||0
109683|NCT01933672|270066|P6|Received Treatment|Metformin Run-in Period||0
109684|NCT01933672|270067|P5|Received Treatment|Metformin Run-in Period||0
109685|NCT01933672|270068|P4|Received Treatment|Metformin Run-in Period||0
109686|NCT01933672|270069|P3|Received Treatment|Metformin Run-in Period||0
109687|NCT01933672|270070|P2|Received Treatment|Metformin Run-in Period||0
109688|NCT01933672|270071|P1|Received Treatment|Metformin Run-in Period||43
109689|NCT01933672|270065|P7|STARTED|Metformin Run-in Period||0
109690|NCT01933672|270066|P6|STARTED|Metformin Run-in Period||0
109691|NCT01933672|270067|P5|STARTED|Metformin Run-in Period||0
109692|NCT01933672|270068|P4|STARTED|Metformin Run-in Period||0
109693|NCT01933672|270069|P3|STARTED|Metformin Run-in Period||0
109694|NCT01933672|270070|P2|STARTED|Metformin Run-in Period||0
109695|NCT01933672|270071|P1|STARTED|Metformin Run-in Period||43
109696|NCT01933594|270123|P6|NOT COMPLETED|Overall Study||0
109697|NCT01933594|270124|P5|NOT COMPLETED|Overall Study||2
109698|NCT01933594|270125|P4|NOT COMPLETED|Overall Study||0
109699|NCT01933594|270126|P3|NOT COMPLETED|Overall Study||0
109700|NCT01933594|270127|P2|NOT COMPLETED|Overall Study||0
109701|NCT01933594|270128|P1|NOT COMPLETED|Overall Study||1
109702|NCT01933594|270123|P6|COMPLETED|Overall Study||3
109703|NCT01933594|270124|P5|COMPLETED|Overall Study||11
109704|NCT01933594|270125|P4|COMPLETED|Overall Study||7
109705|NCT01933594|270126|P3|COMPLETED|Overall Study||12
109706|NCT01933594|270127|P2|COMPLETED|Overall Study||12
109707|NCT01933594|270128|P1|COMPLETED|Overall Study||11
109708|NCT01933594|270123|P6|STARTED|Overall Study||3
109709|NCT01933594|270124|P5|STARTED|Overall Study||13
109710|NCT01933594|270125|P4|STARTED|Overall Study||7
109711|NCT01933594|270126|P3|STARTED|Overall Study||12
109712|NCT01933594|270127|P2|STARTED|Overall Study||12
109713|NCT01933594|270128|P1|STARTED|Overall Study||12
109714|NCT01933464|270220|P2|NOT COMPLETED|Overall Study||0
109715|NCT01933464|270221|P1|NOT COMPLETED|Overall Study||0
109716|NCT01933464|270220|P2|COMPLETED|Overall Study||5
109717|NCT01933464|270221|P1|COMPLETED|Overall Study||5
109718|NCT01933464|270220|P2|STARTED|Overall Study||5
109719|NCT01933464|270221|P1|STARTED|Overall Study||5
109720|NCT01933425|270233|P2|NOT COMPLETED|Overall Study||0
109721|NCT01933425|270234|P1|NOT COMPLETED|Overall Study||0
109722|NCT01933425|270233|P2|COMPLETED|Overall Study||7
109723|NCT01933425|270234|P1|COMPLETED|Overall Study||7
109724|NCT01933425|270233|P2|STARTED|Overall Study||7
109725|NCT01933425|270234|P1|STARTED|Overall Study||7
109726|NCT01933399|270247|P3|NOT COMPLETED|Overall Study||0
109727|NCT01933399|270248|P2|NOT COMPLETED|Overall Study||0
109728|NCT01933399|270249|P1|NOT COMPLETED|Overall Study||0
109729|NCT01933399|270247|P3|COMPLETED|Overall Study||37
109730|NCT01933399|270248|P2|COMPLETED|Overall Study||32
109731|NCT01933399|270249|P1|COMPLETED|Overall Study||29
109732|NCT01933399|270247|P3|STARTED|Overall Study||37
109733|NCT01933399|270248|P2|STARTED|Overall Study||32
109734|NCT01933399|270249|P1|STARTED|Overall Study||29
109735|NCT01933334|270262|P2|NOT COMPLETED|Overall Study||2
109736|NCT01933334|270263|P1|NOT COMPLETED|Overall Study||5
109737|NCT01933334|270262|P2|COMPLETED|Overall Study||29
109738|NCT01933334|270263|P1|COMPLETED|Overall Study||27
109739|NCT01933334|270262|P2|STARTED|Overall Study||31
109740|NCT01933334|270263|P1|STARTED|Overall Study||32
109741|NCT01933243|270275|P2|NOT COMPLETED|Overall Study||4
109742|NCT01933243|270276|P1|NOT COMPLETED|Overall Study||2
109743|NCT01933243|270275|P2|COMPLETED|Overall Study||8
109744|NCT01933243|270276|P1|COMPLETED|Overall Study||10
109745|NCT01933243|270275|P2|STARTED|Overall Study||12
109746|NCT01933243|270276|P1|STARTED|Overall Study||12
109747|NCT01933230|270286|P1|NOT COMPLETED|Overall Study||0
109748|NCT01933230|270286|P1|COMPLETED|Overall Study||2
109749|NCT01933230|270286|P1|STARTED|Overall Study||2
109750|NCT01933113|270290|P1|NOT COMPLETED|Overall Study||1
109751|NCT01933113|270290|P1|COMPLETED|Overall Study||2
109752|NCT01933113|270290|P1|STARTED|Overall Study||3
109753|NCT01933048|270296|P2|NOT COMPLETED|Overall Study||28
109754|NCT01933048|270297|P1|NOT COMPLETED|Overall Study||25
109755|NCT01933048|270296|P2|COMPLETED|Overall Study||501
109756|NCT01933048|270297|P1|COMPLETED|Overall Study||523
109757|NCT01933048|270296|P2|STARTED|Overall Study||529
109758|NCT01933048|270297|P1|STARTED|Overall Study||548
109759|NCT01932970|270310|P1|NOT COMPLETED|Overall Study||18
109760|NCT01932970|270310|P1|COMPLETED|Overall Study||140
109761|NCT01932970|270310|P1|Received Treatment|Overall Study|Includes participants who completed the washout period and received etelcalcetide|148
109762|NCT01932970|270310|P1|STARTED|Overall Study|Includes all participants who enrolled into the washout period.|158
109763|NCT01932788|270320|P2|NOT COMPLETED|Overall Study||51
109764|NCT01932788|270321|P1|NOT COMPLETED|Overall Study||38
109765|NCT01932788|270320|P2|COMPLETED|Overall Study||118
109766|NCT01932788|270321|P1|COMPLETED|Overall Study||135
109767|NCT01932788|270320|P2|STARTED|Overall Study||169
109768|NCT01932788|270321|P1|STARTED|Overall Study||173
109769|NCT01932762|270331|P4|NOT COMPLETED|Overall Study||1
109770|NCT01932762|270332|P3|NOT COMPLETED|Overall Study||0
109771|NCT01932762|270333|P2|NOT COMPLETED|Overall Study||2
109772|NCT01932762|270334|P1|NOT COMPLETED|Overall Study||6
109773|NCT01932762|270331|P4|COMPLETED|Overall Study||18
109774|NCT01932762|270332|P3|COMPLETED|Overall Study||19
109775|NCT01932762|270333|P2|COMPLETED|Overall Study||28
109776|NCT01932762|270334|P1|COMPLETED|Overall Study||24
109777|NCT01932762|270331|P4|STARTED|Overall Study||19
109778|NCT01932762|270332|P3|STARTED|Overall Study||19
109779|NCT01932762|270333|P2|STARTED|Overall Study||30
109780|NCT01932762|270334|P1|STARTED|Overall Study||30
109781|NCT01932697|270370|P2|NOT COMPLETED|Overall Study||0
109782|NCT01932697|270371|P1|NOT COMPLETED|Overall Study||2
109783|NCT01932697|270370|P2|COMPLETED|Overall Study||43
109784|NCT01932697|270371|P1|COMPLETED|Overall Study||36
109785|NCT01932697|270370|P2|STARTED|Overall Study||43
109786|NCT01932697|270371|P1|STARTED|Overall Study||38
109787|NCT01932606|270385|P2|NOT COMPLETED|Overall Study||0
109788|NCT01932606|270386|P1|NOT COMPLETED|Overall Study||0
109789|NCT01932606|270385|P2|COMPLETED|Overall Study||14
109790|NCT01932606|270386|P1|COMPLETED|Overall Study||14
109791|NCT01932606|270385|P2|STARTED|Overall Study||14
109792|NCT01932606|270386|P1|STARTED|Overall Study||14
109793|NCT01932437|270438|P6|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||1
109794|NCT01932437|270439|P5|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
109795|NCT01932437|270440|P4|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
109796|NCT01932437|270441|P3|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
109797|NCT01932437|270442|P2|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
109798|NCT01932437|270443|P1|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
109799|NCT01932437|270438|P6|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||5
109800|NCT01932437|270439|P5|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
109801|NCT01932437|270440|P4|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
109802|NCT01932437|270441|P3|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
109803|NCT01932437|270442|P2|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
109804|NCT01932437|270443|P1|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||2
109805|NCT01932437|270438|P6|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||6
109806|NCT01932437|270439|P5|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
109807|NCT01932437|270440|P4|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
109808|NCT01932437|270441|P3|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
109809|NCT01932437|270442|P2|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
109810|NCT01932437|270443|P1|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||2
109811|NCT01932437|270438|P6|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
109812|NCT01932437|270439|P5|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
109813|NCT01932437|270440|P4|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
109814|NCT01932437|270441|P3|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
109815|NCT01932437|270442|P2|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
109816|NCT01932437|270443|P1|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
109817|NCT01932437|270438|P6|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
109818|NCT01932437|270439|P5|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||6
109819|NCT01932437|270440|P4|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
109820|NCT01932437|270441|P3|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
109821|NCT01932437|270442|P2|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
109822|NCT01932437|270443|P1|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||2
109823|NCT01932437|270438|P6|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
109824|NCT01932437|270439|P5|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||6
109825|NCT01932437|270440|P4|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
109826|NCT01932437|270441|P3|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
109827|NCT01932437|270442|P2|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
109828|NCT01932437|270443|P1|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||2
109829|NCT01932437|270438|P6|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
109830|NCT01932437|270439|P5|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
109831|NCT01932437|270440|P4|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
109832|NCT01932437|270441|P3|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
109833|NCT01932437|270442|P2|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
109834|NCT01932437|270443|P1|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
109835|NCT01932437|270438|P6|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
109836|NCT01932437|270439|P5|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
109837|NCT01932437|270440|P4|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||6
109838|NCT01932437|270441|P3|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
109839|NCT01932437|270442|P2|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
109840|NCT01932437|270443|P1|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||2
109841|NCT01932437|270438|P6|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
109842|NCT01932437|270439|P5|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
109843|NCT01932437|270440|P4|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||6
109844|NCT01932437|270441|P3|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
109845|NCT01932437|270442|P2|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
109846|NCT01932437|270443|P1|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||2
109847|NCT01932437|270438|P6|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
109848|NCT01932437|270439|P5|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
109849|NCT01932437|270440|P4|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
109850|NCT01932437|270441|P3|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
109851|NCT01932437|270442|P2|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
109852|NCT01932437|270443|P1|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
109853|NCT01932437|270438|P6|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
109854|NCT01932437|270439|P5|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
109855|NCT01932437|270440|P4|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
109856|NCT01932437|270441|P3|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||6
109857|NCT01932437|270442|P2|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
109858|NCT01932437|270443|P1|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||2
109859|NCT01932437|270438|P6|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
109860|NCT01932437|270439|P5|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
109861|NCT01932437|270440|P4|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
109862|NCT01932437|270441|P3|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||6
109863|NCT01932437|270442|P2|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
109864|NCT01932437|270443|P1|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||2
109865|NCT01932437|270438|P6|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
109866|NCT01932437|270439|P5|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
109867|NCT01932437|270440|P4|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
109868|NCT01932437|270441|P3|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
109869|NCT01932437|270442|P2|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
109870|NCT01932437|270443|P1|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
109871|NCT01932437|270438|P6|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
109872|NCT01932437|270439|P5|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
109873|NCT01932437|270440|P4|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
109874|NCT01932437|270441|P3|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
109875|NCT01932437|270442|P2|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||3
109876|NCT01932437|270443|P1|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||1
109877|NCT01932437|270438|P6|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
109878|NCT01932437|270439|P5|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
109879|NCT01932437|270440|P4|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
109880|NCT01932437|270441|P3|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
109881|NCT01932437|270442|P2|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||3
109882|NCT01932437|270443|P1|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||1
109883|NCT01932294|270493|P1|NOT COMPLETED|Overall Study||99
109884|NCT01932294|270493|P1|COMPLETED|Overall Study||72
109885|NCT01932294|270493|P1|STARTED|Overall Study||171
109886|NCT01932242|270501|P2|NOT COMPLETED|Overall Study||5
109887|NCT01932242|270502|P1|NOT COMPLETED|Overall Study||5
109888|NCT01932242|270501|P2|COMPLETED|Overall Study||30
109889|NCT01932242|270502|P1|COMPLETED|Overall Study||30
109890|NCT01932242|270501|P2|STARTED|Overall Study||35
109891|NCT01932242|270502|P1|STARTED|Overall Study||35
109892|NCT01932164|270546|P1|NOT COMPLETED|Overall Study||0
109893|NCT01932164|270546|P1|COMPLETED|Overall Study|In all 5 patients we observed bone formation closing the alveolar cleft after 6 months|5
109894|NCT01932164|270546|P1|Cleft Lip and Palate|Overall Study|The surgeries were performed between december 2013 and june 2014.|5
109895|NCT01932164|270546|P1|Cleft Lip and Palate|Overall Study|Alveolar bone graft surgeries were did using their dental pulp stem cells with biomaterial|5
109896|NCT01932164|270546|P1|Cleft Lip and Palate|Overall Study|Mesenchymal stem cell obtained from dental pulp of 5patients was obtained, caractherized and frozen|5
109897|NCT01932164|270546|P1|Cleft Lip and Palate|Overall Study|Dental pulp was obtained from teeth of 5 different patients (09/2013)|5
109898|NCT01932164|270546|P1|Cleft Lip and Palate|Overall Study|It was performed de extraction of deciduous teeth of 5 cleft lip/palate patients (09/2013)|5
109899|NCT01932164|270546|P1|STARTED|Overall Study|It was performed the selection of 5 patients to participate of these study (08/2013)|5
109900|NCT01932112|270551|P1|NOT COMPLETED|Overall Study||0
109901|NCT01932112|270551|P1|COMPLETED|Overall Study||378
109902|NCT01932112|270551|P1|STARTED|Overall Study||378
109903|NCT01932060|270557|P2|NOT COMPLETED|Overall Study||0
109904|NCT01932060|270558|P1|NOT COMPLETED|Overall Study||0
109905|NCT01932060|270557|P2|COMPLETED|Overall Study||24
109906|NCT01932060|270558|P1|COMPLETED|Overall Study||27
109907|NCT01932060|270557|P2|STARTED|Overall Study||24
109908|NCT01932060|270558|P1|STARTED|Overall Study||27
109909|NCT01931956|270570|P4|NOT COMPLETED|Overall Study||133
109910|NCT01931956|270571|P3|NOT COMPLETED|Overall Study||487
109911|NCT01931956|270572|P2|NOT COMPLETED|Overall Study||7
109912|NCT01931956|270573|P1|NOT COMPLETED|Overall Study||51
109913|NCT01931956|270570|P4|COMPLETED|Overall Study||138
109914|NCT01931956|270571|P3|COMPLETED|Overall Study||141
109915|NCT01931956|270572|P2|COMPLETED|Overall Study||0
109916|NCT01931956|270573|P1|COMPLETED|Overall Study||8
109917|NCT01931956|270570|P4|STARTED|Overall Study||271
109918|NCT01931956|270571|P3|STARTED|Overall Study||628
109919|NCT01931956|270572|P2|STARTED|Overall Study||7
109920|NCT01931956|270573|P1|STARTED|Overall Study||59
109921|NCT01931878|270929|P2|NOT COMPLETED|Second Intervention (After 3 Months)||2
109922|NCT01931878|270930|P1|NOT COMPLETED|Second Intervention (After 3 Months)||0
109923|NCT01931878|270929|P2|COMPLETED|Second Intervention (After 3 Months)||12
109924|NCT01931878|270930|P1|COMPLETED|Second Intervention (After 3 Months)||9
109925|NCT01931878|270929|P2|STARTED|Second Intervention (After 3 Months)||14
109926|NCT01931878|270930|P1|STARTED|Second Intervention (After 3 Months)||9
109927|NCT01931878|270929|P2|NOT COMPLETED|First Intervention||0
109928|NCT01931878|270930|P1|NOT COMPLETED|First Intervention||1
109929|NCT01931878|270929|P2|COMPLETED|First Intervention||14
109930|NCT01931878|270930|P1|COMPLETED|First Intervention||9
109931|NCT01931878|270929|P2|STARTED|First Intervention||14
109932|NCT01931878|270930|P1|STARTED|First Intervention||10
109933|NCT01931865|270940|P1|NOT COMPLETED|Overall Study||4
109934|NCT01931865|270940|P1|COMPLETED|Overall Study||8
109935|NCT01931865|270940|P1|STARTED|Overall Study||12
109936|NCT01931839|270953|P7|NOT COMPLETED|Overall Study||4
109937|NCT01931839|270954|P6|NOT COMPLETED|Overall Study||5
109938|NCT01931839|270955|P5|NOT COMPLETED|Overall Study||1
109939|NCT01931839|270956|P4|NOT COMPLETED|Overall Study||14
109940|NCT01931839|270957|P3|NOT COMPLETED|Overall Study||39
109941|NCT01931839|270958|P2|NOT COMPLETED|Overall Study||26
109942|NCT01931839|270959|P1|NOT COMPLETED|Overall Study||41
109943|NCT01931839|270953|P7|COMPLETED|Overall Study||56
109944|NCT01931839|270954|P6|COMPLETED|Overall Study||50
109945|NCT01931839|270955|P5|COMPLETED|Overall Study||18
109946|NCT01931839|270956|P4|COMPLETED|Overall Study||162
109947|NCT01931839|270957|P3|COMPLETED|Overall Study||301
109948|NCT01931839|270958|P2|COMPLETED|Overall Study||152
109949|NCT01931839|270959|P1|COMPLETED|Overall Study||294
109950|NCT01931839|270953|P7|Safety Analysis Set (As Dosed)|Overall Study||60
109951|NCT01931839|270954|P6|Safety Analysis Set (As Dosed)|Overall Study||55
109952|NCT01931839|270955|P5|Safety Analysis Set (As Dosed)|Overall Study||19
109953|NCT01931839|270956|P4|Safety Analysis Set (As Dosed)|Overall Study||176
109954|NCT01931839|270957|P3|Safety Analysis Set (As Dosed)|Overall Study||340
109955|NCT01931839|270958|P2|Safety Analysis Set (As Dosed)|Overall Study||178
109956|NCT01931839|270959|P1|Safety Analysis Set (As Dosed)|Overall Study||335
109957|NCT01931839|270953|P7|Full Analysis Set (As Randomized)|Overall Study||60
110131|NCT01930487|271351|P1|COMPLETED|First Intervention (30 Days)||19
109958|NCT01931839|270954|P6|Full Analysis Set (As Randomized)|Overall Study||55
109959|NCT01931839|270955|P5|Full Analysis Set (As Randomized)|Overall Study||19
109960|NCT01931839|270956|P4|Full Analysis Set (As Randomized)|Overall Study||176
109961|NCT01931839|270957|P3|Full Analysis Set (As Randomized)|Overall Study||340
109962|NCT01931839|270958|P2|Full Analysis Set (As Randomized)|Overall Study||179
109963|NCT01931839|270959|P1|Full Analysis Set (As Randomized)|Overall Study||334
109964|NCT01931839|270953|P7|STARTED|Overall Study||60
109965|NCT01931839|270954|P6|STARTED|Overall Study||55
109966|NCT01931839|270955|P5|STARTED|Overall Study||19
109967|NCT01931839|270956|P4|STARTED|Overall Study||176
109968|NCT01931839|270957|P3|STARTED|Overall Study||340
109969|NCT01931839|270958|P2|STARTED|Overall Study||178
109970|NCT01931839|270959|P1|STARTED|Overall Study||335
109971|NCT01931735|271031|P4|NOT COMPLETED|Observational Non-Randomized Phase||2
109972|NCT01931735|271032|P3|NOT COMPLETED|Observational Non-Randomized Phase||0
109973|NCT01931735|271033|P2|NOT COMPLETED|Observational Non-Randomized Phase||0
109974|NCT01931735|271034|P1|NOT COMPLETED|Observational Non-Randomized Phase||0
109975|NCT01931735|271031|P4|COMPLETED|Observational Non-Randomized Phase||9
109976|NCT01931735|271032|P3|COMPLETED|Observational Non-Randomized Phase||0
109977|NCT01931735|271033|P2|COMPLETED|Observational Non-Randomized Phase||1
109978|NCT01931735|271034|P1|COMPLETED|Observational Non-Randomized Phase||2
109979|NCT01931735|271031|P4|STARTED|Observational Non-Randomized Phase|Participants recruited post-amendment|11
109980|NCT01931735|271032|P3|STARTED|Observational Non-Randomized Phase||0
109981|NCT01931735|271033|P2|STARTED|Observational Non-Randomized Phase|Participants continued from the randomized phase|1
109982|NCT01931735|271034|P1|STARTED|Observational Non-Randomized Phase|Participants continued from the randomized phase|2
109983|NCT01931735|271031|P4|NOT COMPLETED|Randomized Phase||0
109984|NCT01931735|271032|P3|NOT COMPLETED|Randomized Phase||5
109985|NCT01931735|271033|P2|NOT COMPLETED|Randomized Phase||2
109986|NCT01931735|271034|P1|NOT COMPLETED|Randomized Phase||2
109987|NCT01931735|271031|P4|COMPLETED|Randomized Phase||0
109988|NCT01931735|271032|P3|COMPLETED|Randomized Phase||4
109989|NCT01931735|271033|P2|COMPLETED|Randomized Phase||1
109990|NCT01931735|271034|P1|COMPLETED|Randomized Phase||2
109991|NCT01931735|271031|P4|STARTED|Randomized Phase||0
109992|NCT01931735|271032|P3|STARTED|Randomized Phase||9
109993|NCT01931735|271033|P2|STARTED|Randomized Phase||3
109994|NCT01931735|271034|P1|STARTED|Randomized Phase||4
109995|NCT01931709|271068|P1|NOT COMPLETED|Overall Study||0
109996|NCT01931709|271068|P1|COMPLETED|Overall Study||35
109997|NCT01931709|271068|P1|STARTED|Overall Study||35
109998|NCT01931670|271081|P3|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||21
109999|NCT01931670|271082|P2|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||12
110000|NCT01931670|271083|P1|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||19
110001|NCT01931670|271081|P3|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||33
110002|NCT01931670|271082|P2|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||28
110003|NCT01931670|271083|P1|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||42
110004|NCT01931670|271081|P3|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||15
110005|NCT01931670|271082|P2|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||4
110006|NCT01931670|271083|P1|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||0
110007|NCT01931670|271081|P3|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||18
110008|NCT01931670|271082|P2|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||24
110009|NCT01931670|271083|P1|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||42
110010|NCT01931670|271081|P3|STARTED|Post-Treatment Follow-Up (PTFU) Period||54
110011|NCT01931670|271082|P2|STARTED|Post-Treatment Follow-Up (PTFU) Period||40
110012|NCT01931670|271083|P1|STARTED|Post-Treatment Follow-Up (PTFU) Period||61
110013|NCT01931670|271081|P3|NOT COMPLETED|Treatment Period||45
110014|NCT01931670|271082|P2|NOT COMPLETED|Treatment Period||48
110015|NCT01931670|271083|P1|NOT COMPLETED|Treatment Period||90
110016|NCT01931670|271081|P3|COMPLETED|Treatment Period||184
110017|NCT01931670|271082|P2|COMPLETED|Treatment Period||178
110018|NCT01931670|271083|P1|COMPLETED|Treatment Period||270
110019|NCT01931670|271081|P3|STARTED|Treatment Period||229
110020|NCT01931670|271082|P2|STARTED|Treatment Period||226
110021|NCT01931670|271083|P1|STARTED|Treatment Period||360
110022|NCT01931566|271184|P3|NOT COMPLETED|Overall Study||1506
110023|NCT01931566|271185|P2|NOT COMPLETED|Overall Study||1476
110024|NCT01931566|271186|P1|NOT COMPLETED|Overall Study||429
110025|NCT01931566|271184|P3|COMPLETED|Overall Study||39
110026|NCT01931566|271185|P2|COMPLETED|Overall Study||40
110027|NCT01931566|271186|P1|COMPLETED|Overall Study||4
110028|NCT01931566|271184|P3|Treated|Overall Study||1531
110029|NCT01931566|271185|P2|Treated|Overall Study||1507
110030|NCT01931566|271186|P1|Treated|Overall Study||427
110031|NCT01931566|271184|P3|STARTED|Overall Study||1545
110032|NCT01931566|271185|P2|STARTED|Overall Study||1516
110033|NCT01931566|271186|P1|STARTED|Overall Study||433
110034|NCT01931527|271201|P2|NOT COMPLETED|Overall Study||0
110035|NCT01931527|271202|P1|NOT COMPLETED|Overall Study||0
110036|NCT01931527|271201|P2|COMPLETED|Overall Study||15
110037|NCT01931527|271202|P1|COMPLETED|Overall Study||16
110038|NCT01931527|271201|P2|STARTED|Overall Study||15
110039|NCT01931527|271202|P1|STARTED|Overall Study||16
110040|NCT01931475|271224|P2|NOT COMPLETED|Period 2: Extension Treatment Phase||19
110132|NCT01930487|271350|P2|STARTED|First Intervention (30 Days)||25
110041|NCT01931475|271225|P1|NOT COMPLETED|Period 2: Extension Treatment Phase||4
110042|NCT01931475|271224|P2|COMPLETED|Period 2: Extension Treatment Phase||157
110043|NCT01931475|271225|P1|COMPLETED|Period 2: Extension Treatment Phase||162
110044|NCT01931475|271224|P2|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||175
110045|NCT01931475|271225|P1|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||166
110046|NCT01931475|271224|P2|STARTED|Period 2: Extension Treatment Phase||176
110047|NCT01931475|271225|P1|STARTED|Period 2: Extension Treatment Phase||166
110048|NCT01931475|271224|P2|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||26
110049|NCT01931475|271225|P1|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||39
110050|NCT01931475|271224|P2|COMPLETED|Period 1: Double-Blind Treatment Phase||176
110051|NCT01931475|271225|P1|COMPLETED|Period 1: Double-Blind Treatment Phase||166
110052|NCT01931475|271224|P2|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||198
110053|NCT01931475|271225|P1|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||199
110054|NCT01931475|271224|P2|STARTED|Period 1: Double-Blind Treatment Phase||202
110055|NCT01931475|271225|P1|STARTED|Period 1: Double-Blind Treatment Phase||205
110056|NCT01931462|271252|P1|NOT COMPLETED|Overall Study||1
110057|NCT01931462|271252|P1|COMPLETED|Overall Study||1
110058|NCT01931462|271252|P1|STARTED|Overall Study||2
110059|NCT01931397|271263|P1|NOT COMPLETED|Overall Study||11
110060|NCT01931397|271263|P1|COMPLETED|Overall Study||19
110061|NCT01931397|271263|P1|STARTED|Overall Study||30
110062|NCT01931150|271274|P2|NOT COMPLETED|Overall Study||2
110063|NCT01931150|271275|P1|NOT COMPLETED|Overall Study||1
110064|NCT01931150|271274|P2|COMPLETED|Overall Study||4
110065|NCT01931150|271275|P1|COMPLETED|Overall Study||4
110066|NCT01931150|271274|P2|STARTED|Overall Study||6
110067|NCT01931150|271275|P1|STARTED|Overall Study||5
110068|NCT01931059|271283|P2|NOT COMPLETED|Day3||0
110069|NCT01931059|271284|P1|NOT COMPLETED|Day3||1
110070|NCT01931059|271283|P2|COMPLETED|Day3||4
110071|NCT01931059|271284|P1|COMPLETED|Day3||5
110072|NCT01931059|271283|P2|STARTED|Day3||4
110073|NCT01931059|271284|P1|STARTED|Day3||6
110074|NCT01931059|271283|P2|NOT COMPLETED|Day2||0
110075|NCT01931059|271284|P1|NOT COMPLETED|Day2||0
110076|NCT01931059|271283|P2|COMPLETED|Day2||4
110077|NCT01931059|271284|P1|COMPLETED|Day2||6
110078|NCT01931059|271283|P2|STARTED|Day2||4
110079|NCT01931059|271284|P1|STARTED|Day2||6
110080|NCT01931059|271283|P2|NOT COMPLETED|Day 1||1
110081|NCT01931059|271284|P1|NOT COMPLETED|Day 1||0
110082|NCT01931059|271283|P2|COMPLETED|Day 1||4
110083|NCT01931059|271284|P1|COMPLETED|Day 1||6
110084|NCT01931059|271283|P2|STARTED|Day 1||5
110085|NCT01931059|271284|P1|STARTED|Day 1||6
110086|NCT01930890|271300|P4|NOT COMPLETED|Overall Study||27
110087|NCT01930890|271301|P3|NOT COMPLETED|Overall Study||13
110088|NCT01930890|271302|P2|NOT COMPLETED|Overall Study||33
110089|NCT01930890|271303|P1|NOT COMPLETED|Overall Study||14
110090|NCT01930890|271300|P4|COMPLETED|Overall Study||0
110091|NCT01930890|271301|P3|COMPLETED|Overall Study||0
110092|NCT01930890|271302|P2|COMPLETED|Overall Study||0
110093|NCT01930890|271303|P1|COMPLETED|Overall Study||0
110094|NCT01930890|271300|P4|STARTED|Overall Study||27
110095|NCT01930890|271301|P3|STARTED|Overall Study||13
110096|NCT01930890|271302|P2|STARTED|Overall Study||33
110097|NCT01930890|271303|P1|STARTED|Overall Study||14
110098|NCT01930799|271317|P1|NOT COMPLETED|Overall Study||8
110099|NCT01930799|271317|P1|COMPLETED|Overall Study||112
110100|NCT01930799|271317|P1|STARTED|Overall Study||120
110101|NCT01930747|271325|P3|NOT COMPLETED|Overall Study||0
110102|NCT01930747|271326|P2|NOT COMPLETED|Overall Study||0
110103|NCT01930747|271327|P1|NOT COMPLETED|Overall Study||0
110104|NCT01930747|271325|P3|COMPLETED|Overall Study||12
110105|NCT01930747|271326|P2|COMPLETED|Overall Study||14
110106|NCT01930747|271327|P1|COMPLETED|Overall Study||16
110107|NCT01930747|271325|P3|STARTED|Overall Study||12
110108|NCT01930747|271326|P2|STARTED|Overall Study||14
110109|NCT01930747|271327|P1|STARTED|Overall Study||16
110110|NCT01930643|271343|P2|NOT COMPLETED|Overall Study||0
110111|NCT01930643|271344|P1|NOT COMPLETED|Overall Study||0
110112|NCT01930643|271343|P2|COMPLETED|Overall Study||6
110113|NCT01930643|271344|P1|COMPLETED|Overall Study||7
110114|NCT01930643|271343|P2|STARTED|Overall Study||6
110115|NCT01930643|271344|P1|STARTED|Overall Study||7
110116|NCT01930487|271350|P2|NOT COMPLETED|Second Intervention (30 Days)||0
110117|NCT01930487|271351|P1|NOT COMPLETED|Second Intervention (30 Days)||0
110118|NCT01930487|271350|P2|COMPLETED|Second Intervention (30 Days)||23
110119|NCT01930487|271351|P1|COMPLETED|Second Intervention (30 Days)||19
110120|NCT01930487|271350|P2|STARTED|Second Intervention (30 Days)||23
110121|NCT01930487|271351|P1|STARTED|Second Intervention (30 Days)||19
110122|NCT01930487|271350|P2|NOT COMPLETED|Washout Period (3 Weeks)||0
110123|NCT01930487|271351|P1|NOT COMPLETED|Washout Period (3 Weeks)||0
110124|NCT01930487|271350|P2|COMPLETED|Washout Period (3 Weeks)||23
110125|NCT01930487|271351|P1|COMPLETED|Washout Period (3 Weeks)||19
110126|NCT01930487|271350|P2|STARTED|Washout Period (3 Weeks)||23
110127|NCT01930487|271351|P1|STARTED|Washout Period (3 Weeks)||19
110128|NCT01930487|271350|P2|NOT COMPLETED|First Intervention (30 Days)||2
110129|NCT01930487|271351|P1|NOT COMPLETED|First Intervention (30 Days)||2
110130|NCT01930487|271350|P2|COMPLETED|First Intervention (30 Days)||23
110133|NCT01930487|271351|P1|STARTED|First Intervention (30 Days)||21
110134|NCT01930435|271445|P1|NOT COMPLETED|Overall Study||0
110135|NCT01930435|271445|P1|COMPLETED|Overall Study||20
110136|NCT01930435|271445|P1|STARTED|Overall Study||20
110137|NCT01930214|271456|P3|NOT COMPLETED|Overall Study||25
110138|NCT01930214|271457|P2|NOT COMPLETED|Overall Study||21
110139|NCT01930214|271458|P1|NOT COMPLETED|Overall Study||20
110140|NCT01930214|271456|P3|COMPLETED|Overall Study||108
110141|NCT01930214|271457|P2|COMPLETED|Overall Study||96
110142|NCT01930214|271458|P1|COMPLETED|Overall Study||80
110143|NCT01930214|271456|P3|STARTED|Overall Study||133
110144|NCT01930214|271457|P2|STARTED|Overall Study||117
110145|NCT01930214|271458|P1|STARTED|Overall Study||100
110146|NCT01930188|271478|P3|NOT COMPLETED|Overall Study||19
110147|NCT01930188|271479|P2|NOT COMPLETED|Overall Study||21
110148|NCT01930188|271480|P1|NOT COMPLETED|Overall Study||22
110149|NCT01930188|271478|P3|COMPLETED|Overall Study||388
110150|NCT01930188|271479|P2|COMPLETED|Overall Study||388
110151|NCT01930188|271480|P1|COMPLETED|Overall Study||387
110152|NCT01930188|271478|P3|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|32
110153|NCT01930188|271479|P2|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|61
110154|NCT01930188|271480|P1|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|53
110155|NCT01930188|271478|P3|STARTED|Overall Study||407
110156|NCT01930188|271479|P2|STARTED|Overall Study||409
110157|NCT01930188|271480|P1|STARTED|Overall Study||409
110158|NCT01930162|271504|P1|NOT COMPLETED|Overall Study||5
110159|NCT01930162|271504|P1|COMPLETED|Overall Study||4
110160|NCT01930162|271504|P1|STARTED|Overall Study||9
110161|NCT01930058|271516|P3|NOT COMPLETED|Overall Study||0
110162|NCT01930058|271517|P2|NOT COMPLETED|Overall Study||0
110163|NCT01930058|271518|P1|NOT COMPLETED|Overall Study||0
110164|NCT01930058|271516|P3|COMPLETED|Overall Study||3
110165|NCT01930058|271517|P2|COMPLETED|Overall Study||3
110166|NCT01930058|271518|P1|COMPLETED|Overall Study||3
110167|NCT01930058|271516|P3|STARTED|Overall Study||3
110168|NCT01930058|271517|P2|STARTED|Overall Study||3
110169|NCT01930058|271518|P1|STARTED|Overall Study||3
110170|NCT01930045|271540|P6|NOT COMPLETED|Part 2 - Period 5||0
110171|NCT01930045|271541|P5|NOT COMPLETED|Part 2 - Period 5||0
110172|NCT01930045|271542|P4|NOT COMPLETED|Part 2 - Period 5||0
110173|NCT01930045|271543|P3|NOT COMPLETED|Part 2 - Period 5||0
110174|NCT01930045|271544|P2|NOT COMPLETED|Part 2 - Period 5||0
110175|NCT01930045|271545|P1|NOT COMPLETED|Part 2 - Period 5||0
110176|NCT01930045|271540|P6|COMPLETED|Part 2 - Period 5||1
110177|NCT01930045|271541|P5|COMPLETED|Part 2 - Period 5||3
110178|NCT01930045|271542|P4|COMPLETED|Part 2 - Period 5||3
110179|NCT01930045|271543|P3|COMPLETED|Part 2 - Period 5||3
110180|NCT01930045|271544|P2|COMPLETED|Part 2 - Period 5||3
110181|NCT01930045|271545|P1|COMPLETED|Part 2 - Period 5||3
110182|NCT01930045|271540|P6|STARTED|Part 2 - Period 5||1
110183|NCT01930045|271541|P5|STARTED|Part 2 - Period 5||3
110184|NCT01930045|271542|P4|STARTED|Part 2 - Period 5||3
110185|NCT01930045|271543|P3|STARTED|Part 2 - Period 5||3
110186|NCT01930045|271544|P2|STARTED|Part 2 - Period 5||3
110187|NCT01930045|271545|P1|STARTED|Part 2 - Period 5||3
110188|NCT01930045|271540|P6|NOT COMPLETED|Part 2 - Period 4||0
110189|NCT01930045|271541|P5|NOT COMPLETED|Part 2 - Period 4||0
110190|NCT01930045|271542|P4|NOT COMPLETED|Part 2 - Period 4||0
110191|NCT01930045|271543|P3|NOT COMPLETED|Part 2 - Period 4||0
110192|NCT01930045|271544|P2|NOT COMPLETED|Part 2 - Period 4||0
110193|NCT01930045|271545|P1|NOT COMPLETED|Part 2 - Period 4||0
110194|NCT01930045|271540|P6|COMPLETED|Part 2 - Period 4||1
110195|NCT01930045|271541|P5|COMPLETED|Part 2 - Period 4||3
110196|NCT01930045|271542|P4|COMPLETED|Part 2 - Period 4||3
110197|NCT01930045|271543|P3|COMPLETED|Part 2 - Period 4||3
110198|NCT01930045|271544|P2|COMPLETED|Part 2 - Period 4||3
110199|NCT01930045|271545|P1|COMPLETED|Part 2 - Period 4||3
110200|NCT01930045|271540|P6|STARTED|Part 2 - Period 4||1
110201|NCT01930045|271541|P5|STARTED|Part 2 - Period 4||3
110202|NCT01930045|271542|P4|STARTED|Part 2 - Period 4||3
110203|NCT01930045|271543|P3|STARTED|Part 2 - Period 4||3
110204|NCT01930045|271544|P2|STARTED|Part 2 - Period 4||3
110205|NCT01930045|271545|P1|STARTED|Part 2 - Period 4||3
110206|NCT01930045|271540|P6|NOT COMPLETED|Pause (up to 37 Days)||2
110207|NCT01930045|271541|P5|NOT COMPLETED|Pause (up to 37 Days)||0
110208|NCT01930045|271542|P4|NOT COMPLETED|Pause (up to 37 Days)||0
110209|NCT01930045|271543|P3|NOT COMPLETED|Pause (up to 37 Days)||0
110210|NCT01930045|271544|P2|NOT COMPLETED|Pause (up to 37 Days)||0
110211|NCT01930045|271545|P1|NOT COMPLETED|Pause (up to 37 Days)||0
110212|NCT01930045|271540|P6|COMPLETED|Pause (up to 37 Days)||1
110213|NCT01930045|271541|P5|COMPLETED|Pause (up to 37 Days)||3
110214|NCT01930045|271542|P4|COMPLETED|Pause (up to 37 Days)||3
110215|NCT01930045|271543|P3|COMPLETED|Pause (up to 37 Days)||3
110216|NCT01930045|271544|P2|COMPLETED|Pause (up to 37 Days)||3
110217|NCT01930045|271545|P1|COMPLETED|Pause (up to 37 Days)||3
110218|NCT01930045|271540|P6|STARTED|Pause (up to 37 Days)||3
110219|NCT01930045|271541|P5|STARTED|Pause (up to 37 Days)||3
110220|NCT01930045|271542|P4|STARTED|Pause (up to 37 Days)||3
110221|NCT01930045|271543|P3|STARTED|Pause (up to 37 Days)|The participant who missed treatment in Period 3, resumed the study|3
110222|NCT01930045|271544|P2|STARTED|Pause (up to 37 Days)||3
110223|NCT01930045|271545|P1|STARTED|Pause (up to 37 Days)||3
110224|NCT01930045|271540|P6|NOT COMPLETED|Part 1 - Period 3||0
110225|NCT01930045|271541|P5|NOT COMPLETED|Part 1 - Period 3||0
110226|NCT01930045|271542|P4|NOT COMPLETED|Part 1 - Period 3||0
110227|NCT01930045|271543|P3|NOT COMPLETED|Part 1 - Period 3||0
110228|NCT01930045|271544|P2|NOT COMPLETED|Part 1 - Period 3||0
110229|NCT01930045|271545|P1|NOT COMPLETED|Part 1 - Period 3||0
110230|NCT01930045|271540|P6|COMPLETED|Part 1 - Period 3||3
110231|NCT01930045|271541|P5|COMPLETED|Part 1 - Period 3||3
110232|NCT01930045|271542|P4|COMPLETED|Part 1 - Period 3||3
110233|NCT01930045|271543|P3|COMPLETED|Part 1 - Period 3||2
110234|NCT01930045|271544|P2|COMPLETED|Part 1 - Period 3||3
110235|NCT01930045|271545|P1|COMPLETED|Part 1 - Period 3||3
110236|NCT01930045|271540|P6|STARTED|Part 1 - Period 3||3
110237|NCT01930045|271541|P5|STARTED|Part 1 - Period 3||3
110238|NCT01930045|271542|P4|STARTED|Part 1 - Period 3||3
110239|NCT01930045|271543|P3|STARTED|Part 1 - Period 3|One participant missed treatment during Period 3 only.|2
110240|NCT01930045|271544|P2|STARTED|Part 1 - Period 3||3
110241|NCT01930045|271545|P1|STARTED|Part 1 - Period 3||3
110242|NCT01930045|271540|P6|NOT COMPLETED|Part 1 - Period 2||0
110243|NCT01930045|271541|P5|NOT COMPLETED|Part 1 - Period 2||0
110244|NCT01930045|271542|P4|NOT COMPLETED|Part 1 - Period 2||0
110245|NCT01930045|271543|P3|NOT COMPLETED|Part 1 - Period 2||0
110246|NCT01930045|271544|P2|NOT COMPLETED|Part 1 - Period 2||0
110247|NCT01930045|271545|P1|NOT COMPLETED|Part 1 - Period 2||0
110248|NCT01930045|271540|P6|COMPLETED|Part 1 - Period 2||3
110249|NCT01930045|271541|P5|COMPLETED|Part 1 - Period 2||3
110250|NCT01930045|271542|P4|COMPLETED|Part 1 - Period 2||3
110251|NCT01930045|271543|P3|COMPLETED|Part 1 - Period 2||3
110252|NCT01930045|271544|P2|COMPLETED|Part 1 - Period 2||3
110253|NCT01930045|271545|P1|COMPLETED|Part 1 - Period 2||3
110254|NCT01930045|271540|P6|STARTED|Part 1 - Period 2||3
110255|NCT01930045|271541|P5|STARTED|Part 1 - Period 2||3
110256|NCT01930045|271542|P4|STARTED|Part 1 - Period 2||3
110257|NCT01930045|271543|P3|STARTED|Part 1 - Period 2||3
110258|NCT01930045|271544|P2|STARTED|Part 1 - Period 2||3
110259|NCT01930045|271545|P1|STARTED|Part 1 - Period 2||3
110260|NCT01930045|271540|P6|NOT COMPLETED|Part 1 - Period 1||0
110261|NCT01930045|271541|P5|NOT COMPLETED|Part 1 - Period 1||0
110262|NCT01930045|271542|P4|NOT COMPLETED|Part 1 - Period 1||0
110263|NCT01930045|271543|P3|NOT COMPLETED|Part 1 - Period 1||0
110264|NCT01930045|271544|P2|NOT COMPLETED|Part 1 - Period 1||0
110265|NCT01930045|271545|P1|NOT COMPLETED|Part 1 - Period 1||0
110266|NCT01930045|271540|P6|COMPLETED|Part 1 - Period 1||3
110267|NCT01930045|271541|P5|COMPLETED|Part 1 - Period 1||3
110268|NCT01930045|271542|P4|COMPLETED|Part 1 - Period 1||3
110269|NCT01930045|271543|P3|COMPLETED|Part 1 - Period 1||3
110270|NCT01930045|271544|P2|COMPLETED|Part 1 - Period 1||3
110271|NCT01930045|271545|P1|COMPLETED|Part 1 - Period 1||3
110272|NCT01930045|271540|P6|STARTED|Part 1 - Period 1||3
110273|NCT01930045|271541|P5|STARTED|Part 1 - Period 1||3
110274|NCT01930045|271542|P4|STARTED|Part 1 - Period 1||3
110275|NCT01930045|271543|P3|STARTED|Part 1 - Period 1||3
110276|NCT01930045|271544|P2|STARTED|Part 1 - Period 1||3
110277|NCT01930045|271545|P1|STARTED|Part 1 - Period 1||3
110278|NCT01929993|271572|P2|NOT COMPLETED|Overall Study||28
110279|NCT01929993|271573|P1|NOT COMPLETED|Overall Study||30
110280|NCT01929993|271572|P2|COMPLETED|Overall Study||54
110281|NCT01929993|271573|P1|COMPLETED|Overall Study||52
110282|NCT01929993|271572|P2|STARTED|Overall Study||82
110283|NCT01929993|271573|P1|STARTED|Overall Study||82
110284|NCT01929980|271579|P1|NOT COMPLETED|Overall Study||1
110285|NCT01929980|271579|P1|COMPLETED|Overall Study||3
110286|NCT01929980|271579|P1|STARTED|Overall Study||4
110287|NCT01929889|271583|P1|NOT COMPLETED|Overall Study||5
110288|NCT01929889|271583|P1|COMPLETED|Overall Study|3 subjects completed the study.|3
110289|NCT01929889|271583|P1|STARTED|Overall Study|Target enrollment goal was 20 completed subjects.|8
110290|NCT01929876|271587|P1|NOT COMPLETED|Period 2||1
110291|NCT01929876|271587|P1|COMPLETED|Period 2||15
110292|NCT01929876|271587|P1|STARTED|Period 2||16
110293|NCT01929876|271587|P1|NOT COMPLETED|Period 1||0
110294|NCT01929876|271587|P1|COMPLETED|Period 1||16
110295|NCT01929876|271587|P1|STARTED|Period 1||16
110296|NCT01929863|271600|P2|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
110297|NCT01929863|271601|P1|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
110298|NCT01929863|271600|P2|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
110299|NCT01929863|271601|P1|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
110300|NCT01929863|271600|P2|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
110301|NCT01929863|271601|P1|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
110302|NCT01929863|271600|P2|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||1
110303|NCT01929863|271601|P1|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||0
110304|NCT01929863|271600|P2|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
110305|NCT01929863|271601|P1|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
110306|NCT01929863|271600|P2|STARTED|Period 3:Intervention Period 2 (7 Days)||7
110307|NCT01929863|271601|P1|STARTED|Period 3:Intervention Period 2 (7 Days)||6
110308|NCT01929863|271600|P2|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
110309|NCT01929863|271601|P1|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
110310|NCT01929863|271600|P2|COMPLETED|Period 2:Washout Period (13-15 Days)||7
110311|NCT01929863|271601|P1|COMPLETED|Period 2:Washout Period (13-15 Days)||6
110312|NCT01929863|271600|P2|STARTED|Period 2:Washout Period (13-15 Days)||7
110313|NCT01929863|271601|P1|STARTED|Period 2:Washout Period (13-15 Days)||6
110314|NCT01929863|271600|P2|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
110315|NCT01929863|271601|P1|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
110316|NCT01929863|271600|P2|COMPLETED|Period 1:Intervention Period 1 (7 Days)||7
110317|NCT01929863|271601|P1|COMPLETED|Period 1:Intervention Period 1 (7 Days)||6
110318|NCT01929863|271600|P2|STARTED|Period 1:Intervention Period 1 (7 Days)||8
110319|NCT01929863|271601|P1|STARTED|Period 1:Intervention Period 1 (7 Days)||7
110320|NCT01929759|271644|P1|NOT COMPLETED|Overall Study||0
110321|NCT01929759|271644|P1|COMPLETED|Overall Study||10
110322|NCT01929759|271644|P1|STARTED|Overall Study||10
110323|NCT01929707|271656|P8|NOT COMPLETED|Intervention Period 2||0
110324|NCT01929707|271657|P7|NOT COMPLETED|Intervention Period 2||0
110325|NCT01929707|271658|P6|NOT COMPLETED|Intervention Period 2||2
110326|NCT01929707|271659|P5|NOT COMPLETED|Intervention Period 2||0
110327|NCT01929707|271660|P4|NOT COMPLETED|Intervention Period 2||0
110328|NCT01929707|271661|P3|NOT COMPLETED|Intervention Period 2||0
110329|NCT01929707|271662|P2|NOT COMPLETED|Intervention Period 2||0
110330|NCT01929707|271663|P1|NOT COMPLETED|Intervention Period 2||0
110331|NCT01929707|271656|P8|COMPLETED|Intervention Period 2||4
110332|NCT01929707|271657|P7|COMPLETED|Intervention Period 2||12
110333|NCT01929707|271658|P6|COMPLETED|Intervention Period 2||6
110334|NCT01929707|271659|P5|COMPLETED|Intervention Period 2||6
110335|NCT01929707|271660|P4|COMPLETED|Intervention Period 2||5
110336|NCT01929707|271661|P3|COMPLETED|Intervention Period 2||0
110337|NCT01929707|271662|P2|COMPLETED|Intervention Period 2||0
110338|NCT01929707|271663|P1|COMPLETED|Intervention Period 2||0
110339|NCT01929707|271656|P8|STARTED|Intervention Period 2|Incomplete-crossover design|4
110340|NCT01929707|271657|P7|STARTED|Intervention Period 2|Incomplete-crossover design|12
110341|NCT01929707|271658|P6|STARTED|Intervention Period 2|Incomplete-crossover design|8
110342|NCT01929707|271659|P5|STARTED|Intervention Period 2|Incomplete-crossover design|6
110343|NCT01929707|271660|P4|STARTED|Intervention Period 2|Incomplete-crossover design|5
110344|NCT01929707|271661|P3|STARTED|Intervention Period 2|Incomplete-crossover design|0
110345|NCT01929707|271662|P2|STARTED|Intervention Period 2|Incomplete-crossover design|0
110346|NCT01929707|271663|P1|STARTED|Intervention Period 2|Incomplete-crossover design|0
110347|NCT01929707|271656|P8|NOT COMPLETED|Washout Period ≥7 Days||0
110348|NCT01929707|271657|P7|NOT COMPLETED|Washout Period ≥7 Days||0
110349|NCT01929707|271658|P6|NOT COMPLETED|Washout Period ≥7 Days||0
110350|NCT01929707|271659|P5|NOT COMPLETED|Washout Period ≥7 Days||0
110351|NCT01929707|271660|P4|NOT COMPLETED|Washout Period ≥7 Days||0
110352|NCT01929707|271661|P3|NOT COMPLETED|Washout Period ≥7 Days||0
110353|NCT01929707|271662|P2|NOT COMPLETED|Washout Period ≥7 Days||0
110354|NCT01929707|271663|P1|NOT COMPLETED|Washout Period ≥7 Days||0
110355|NCT01929707|271656|P8|COMPLETED|Washout Period ≥7 Days||0
110356|NCT01929707|271657|P7|COMPLETED|Washout Period ≥7 Days||0
110357|NCT01929707|271658|P6|COMPLETED|Washout Period ≥7 Days||0
110358|NCT01929707|271659|P5|COMPLETED|Washout Period ≥7 Days||0
110359|NCT01929707|271660|P4|COMPLETED|Washout Period ≥7 Days||7
110360|NCT01929707|271661|P3|COMPLETED|Washout Period ≥7 Days||12
110361|NCT01929707|271662|P2|COMPLETED|Washout Period ≥7 Days||8
110362|NCT01929707|271663|P1|COMPLETED|Washout Period ≥7 Days||6
110363|NCT01929707|271656|P8|STARTED|Washout Period ≥7 Days||0
110364|NCT01929707|271657|P7|STARTED|Washout Period ≥7 Days||0
110365|NCT01929707|271658|P6|STARTED|Washout Period ≥7 Days||0
110366|NCT01929707|271659|P5|STARTED|Washout Period ≥7 Days||0
110367|NCT01929707|271660|P4|STARTED|Washout Period ≥7 Days||7
110368|NCT01929707|271661|P3|STARTED|Washout Period ≥7 Days||12
110369|NCT01929707|271662|P2|STARTED|Washout Period ≥7 Days||8
110370|NCT01929707|271663|P1|STARTED|Washout Period ≥7 Days||6
110371|NCT01929707|271656|P8|NOT COMPLETED|Intervention Period 1||0
110372|NCT01929707|271657|P7|NOT COMPLETED|Intervention Period 1||0
110373|NCT01929707|271658|P6|NOT COMPLETED|Intervention Period 1||0
110374|NCT01929707|271659|P5|NOT COMPLETED|Intervention Period 1||0
110375|NCT01929707|271660|P4|NOT COMPLETED|Intervention Period 1||3
110376|NCT01929707|271661|P3|NOT COMPLETED|Intervention Period 1||0
110377|NCT01929707|271662|P2|NOT COMPLETED|Intervention Period 1||0
110378|NCT01929707|271663|P1|NOT COMPLETED|Intervention Period 1||0
110379|NCT01929707|271656|P8|COMPLETED|Intervention Period 1||0
110380|NCT01929707|271657|P7|COMPLETED|Intervention Period 1||0
110381|NCT01929707|271658|P6|COMPLETED|Intervention Period 1||0
110382|NCT01929707|271659|P5|COMPLETED|Intervention Period 1||0
110383|NCT01929707|271660|P4|COMPLETED|Intervention Period 1|Two discontinued participants were replaced in Period 2|7
110384|NCT01929707|271661|P3|COMPLETED|Intervention Period 1||12
110385|NCT01929707|271662|P2|COMPLETED|Intervention Period 1||8
110386|NCT01929707|271663|P1|COMPLETED|Intervention Period 1||6
110387|NCT01929707|271656|P8|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
110388|NCT01929707|271657|P7|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
110389|NCT01929707|271658|P6|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
110390|NCT01929707|271659|P5|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
110391|NCT01929707|271660|P4|Received at Least 1 Dose of Study Drug|Intervention Period 1||10
110479|NCT01929109|271885|P4|COMPLETED|Period 1 (All Groups)||8
110392|NCT01929707|271661|P3|Received at Least 1 Dose of Study Drug|Intervention Period 1||12
110393|NCT01929707|271662|P2|Received at Least 1 Dose of Study Drug|Intervention Period 1||8
110394|NCT01929707|271663|P1|Received at Least 1 Dose of Study Drug|Intervention Period 1||6
110395|NCT01929707|271656|P8|STARTED|Intervention Period 1||0
110396|NCT01929707|271657|P7|STARTED|Intervention Period 1||0
110397|NCT01929707|271658|P6|STARTED|Intervention Period 1||0
110398|NCT01929707|271659|P5|STARTED|Intervention Period 1||0
110399|NCT01929707|271660|P4|STARTED|Intervention Period 1||10
110400|NCT01929707|271661|P3|STARTED|Intervention Period 1||12
110401|NCT01929707|271662|P2|STARTED|Intervention Period 1||8
110402|NCT01929707|271663|P1|STARTED|Intervention Period 1||6
110403|NCT01929681|271695|P2|NOT COMPLETED|Overall Study||1
110404|NCT01929681|271696|P1|NOT COMPLETED|Overall Study||2
110405|NCT01929681|271695|P2|COMPLETED|Overall Study||24
110406|NCT01929681|271696|P1|COMPLETED|Overall Study||26
110407|NCT01929681|271695|P2|STARTED|Overall Study||25
110408|NCT01929681|271696|P1|STARTED|Overall Study||28
110409|NCT01929473|271710|P1|NOT COMPLETED|Overall Study||587
110410|NCT01929473|271710|P1|COMPLETED|Overall Study||3243
110411|NCT01929473|271710|P1|365 Day|Overall Study||3589
110412|NCT01929473|271710|P1|STARTED|Overall Study|0 day|3830
110413|NCT01929460|271716|P2|NOT COMPLETED|Overall Study||0
110414|NCT01929460|271717|P1|NOT COMPLETED|Overall Study||0
110415|NCT01929460|271716|P2|COMPLETED|Overall Study||13
110416|NCT01929460|271717|P1|COMPLETED|Overall Study||13
110417|NCT01929460|271716|P2|STARTED|Overall Study||13
110418|NCT01929460|271717|P1|STARTED|Overall Study||13
110419|NCT01929408|271739|P1|NOT COMPLETED|Overall Study||8
110420|NCT01929408|271739|P1|COMPLETED|Overall Study||695
110421|NCT01929408|271739|P1|STARTED|Overall Study||703
110422|NCT01929395|271747|P3|NOT COMPLETED|Overall Study||1
110423|NCT01929395|271748|P2|NOT COMPLETED|Overall Study||1
110424|NCT01929395|271749|P1|NOT COMPLETED|Overall Study||1
110425|NCT01929395|271747|P3|COMPLETED|Overall Study||69
110426|NCT01929395|271748|P2|COMPLETED|Overall Study||69
110427|NCT01929395|271749|P1|COMPLETED|Overall Study||18
110428|NCT01929395|271747|P3|STARTED|Overall Study||70
110429|NCT01929395|271748|P2|STARTED|Overall Study||70
110430|NCT01929395|271749|P1|STARTED|Overall Study||19
110431|NCT01929317|271761|P2|NOT COMPLETED|Long-term Phase||4
110432|NCT01929317|271762|P1|NOT COMPLETED|Long-term Phase||19
110433|NCT01929317|271761|P2|COMPLETED|Long-term Phase||14
110434|NCT01929317|271762|P1|COMPLETED|Long-term Phase||25
110435|NCT01929317|271761|P2|STARTED|Long-term Phase||18
110436|NCT01929317|271762|P1|STARTED|Long-term Phase||44
110437|NCT01929317|271761|P2|NOT COMPLETED|Dose Increase Effect Verification Phase||1
110438|NCT01929317|271762|P1|NOT COMPLETED|Dose Increase Effect Verification Phase||9
110439|NCT01929317|271761|P2|COMPLETED|Dose Increase Effect Verification Phase||19
110440|NCT01929317|271762|P1|COMPLETED|Dose Increase Effect Verification Phase||52
110441|NCT01929317|271761|P2|STARTED|Dose Increase Effect Verification Phase||20
110442|NCT01929317|271762|P1|STARTED|Dose Increase Effect Verification Phase||61
110443|NCT01929291|271829|P1|NOT COMPLETED|Overall Study||0
110444|NCT01929291|271829|P1|COMPLETED|Overall Study||672
110445|NCT01929291|271829|P1|STARTED|Overall Study||672
110446|NCT01929226|271837|P2|NOT COMPLETED|Overall Study||1
110447|NCT01929226|271838|P1|NOT COMPLETED|Overall Study||5
110448|NCT01929226|271837|P2|COMPLETED|Overall Study||69
110449|NCT01929226|271838|P1|COMPLETED|Overall Study||205
110450|NCT01929226|271837|P2|STARTED|Overall Study||70
110451|NCT01929226|271838|P1|STARTED|Overall Study||210
110452|NCT01929135|271864|P2|NOT COMPLETED|Overall Study||1
110453|NCT01929135|271865|P1|NOT COMPLETED|Overall Study||1
110454|NCT01929135|271864|P2|COMPLETED|Overall Study||18
110455|NCT01929135|271865|P1|COMPLETED|Overall Study||18
110456|NCT01929135|271864|P2|STARTED|Overall Study||19
110457|NCT01929135|271865|P1|STARTED|Overall Study||19
110458|NCT01929109|271884|P5|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
110459|NCT01929109|271885|P4|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
110460|NCT01929109|271886|P3|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
110461|NCT01929109|271887|P2|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
110462|NCT01929109|271888|P1|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
110463|NCT01929109|271884|P5|COMPLETED|Period 2 (End Stage Renal Disease Only)||8
110464|NCT01929109|271885|P4|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
110465|NCT01929109|271886|P3|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
110466|NCT01929109|271887|P2|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
110467|NCT01929109|271888|P1|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
110468|NCT01929109|271884|P5|STARTED|Period 2 (End Stage Renal Disease Only)||8
110469|NCT01929109|271885|P4|STARTED|Period 2 (End Stage Renal Disease Only)||0
110470|NCT01929109|271886|P3|STARTED|Period 2 (End Stage Renal Disease Only)||0
110471|NCT01929109|271887|P2|STARTED|Period 2 (End Stage Renal Disease Only)||0
110472|NCT01929109|271888|P1|STARTED|Period 2 (End Stage Renal Disease Only)||0
110473|NCT01929109|271884|P5|NOT COMPLETED|Period 1 (All Groups)||0
110474|NCT01929109|271885|P4|NOT COMPLETED|Period 1 (All Groups)||0
110475|NCT01929109|271886|P3|NOT COMPLETED|Period 1 (All Groups)||1
110476|NCT01929109|271887|P2|NOT COMPLETED|Period 1 (All Groups)||0
110477|NCT01929109|271888|P1|NOT COMPLETED|Period 1 (All Groups)||0
110478|NCT01929109|271884|P5|COMPLETED|Period 1 (All Groups)||8
110480|NCT01929109|271886|P3|COMPLETED|Period 1 (All Groups)||8
110481|NCT01929109|271887|P2|COMPLETED|Period 1 (All Groups)||8
110482|NCT01929109|271888|P1|COMPLETED|Period 1 (All Groups)||14
110483|NCT01929109|271884|P5|STARTED|Period 1 (All Groups)||8
110484|NCT01929109|271885|P4|STARTED|Period 1 (All Groups)||8
110485|NCT01929109|271886|P3|STARTED|Period 1 (All Groups)||9
110486|NCT01929109|271887|P2|STARTED|Period 1 (All Groups)||8
110487|NCT01929109|271888|P1|STARTED|Period 1 (All Groups)||14
110488|NCT01929083|271907|P2|NOT COMPLETED|Intervention 2||1
110489|NCT01929083|271908|P1|NOT COMPLETED|Intervention 2||0
110490|NCT01929083|271907|P2|COMPLETED|Intervention 2||8
110491|NCT01929083|271908|P1|COMPLETED|Intervention 2||7
110492|NCT01929083|271907|P2|Returned for 2nd Ibutilide Administratio|Intervention 2||8
110493|NCT01929083|271908|P1|Returned for 2nd Ibutilide Administratio|Intervention 2||7
110494|NCT01929083|271907|P2|STARTED|Intervention 2||9
110495|NCT01929083|271908|P1|STARTED|Intervention 2||7
110496|NCT01929083|271907|P2|NOT COMPLETED|Intervention 1||0
110497|NCT01929083|271908|P1|NOT COMPLETED|Intervention 1||3
110498|NCT01929083|271907|P2|COMPLETED|Intervention 1||9
110499|NCT01929083|271908|P1|COMPLETED|Intervention 1||7
110500|NCT01929083|271907|P2|Returned for 1st Ibutilide Administratio|Intervention 1||9
110501|NCT01929083|271908|P1|Returned for 1st Ibutilide Administratio|Intervention 1||7
110502|NCT01929083|271907|P2|STARTED|Intervention 1||9
110503|NCT01929083|271908|P1|STARTED|Intervention 1|Number of patients randomized to receive progesterone first|10
110504|NCT01929057|271934|P2|NOT COMPLETED|Overall Study||0
110505|NCT01929057|271935|P1|NOT COMPLETED|Overall Study||0
110506|NCT01929057|271934|P2|COMPLETED|Overall Study||3
110507|NCT01929057|271935|P1|COMPLETED|Overall Study||31
110508|NCT01929057|271934|P2|STARTED|Overall Study||3
110509|NCT01929057|271935|P1|STARTED|Overall Study||31
110510|NCT01929044|271945|P2|NOT COMPLETED|Overall Study||17
110511|NCT01929044|271946|P1|NOT COMPLETED|Overall Study||11
110512|NCT01929044|271945|P2|COMPLETED|Overall Study||129
110513|NCT01929044|271946|P1|COMPLETED|Overall Study||142
110514|NCT01929044|271945|P2|STARTED|Overall Study||146
110515|NCT01929044|271946|P1|STARTED|Overall Study||153
110516|NCT01929031|271968|P6|NOT COMPLETED|Overall Study||1
110517|NCT01929031|271969|P5|NOT COMPLETED|Overall Study||1
110518|NCT01929031|271970|P4|NOT COMPLETED|Overall Study||0
110519|NCT01929031|271971|P3|NOT COMPLETED|Overall Study||1
110520|NCT01929031|271972|P2|NOT COMPLETED|Overall Study||2
110521|NCT01929031|271973|P1|NOT COMPLETED|Overall Study||4
110522|NCT01929031|271968|P6|COMPLETED|Overall Study||35
110523|NCT01929031|271969|P5|COMPLETED|Overall Study||33
110524|NCT01929031|271970|P4|COMPLETED|Overall Study||35
110525|NCT01929031|271971|P3|COMPLETED|Overall Study||34
110526|NCT01929031|271972|P2|COMPLETED|Overall Study||207
110527|NCT01929031|271973|P1|COMPLETED|Overall Study||209
110528|NCT01929031|271968|P6|STARTED|Overall Study||36
110529|NCT01929031|271969|P5|STARTED|Overall Study||34
110530|NCT01929031|271970|P4|STARTED|Overall Study||35
110531|NCT01929031|271971|P3|STARTED|Overall Study||35
110532|NCT01929031|271972|P2|STARTED|Overall Study||209
110533|NCT01929031|271973|P1|STARTED|Overall Study||213
110534|NCT01929018|271997|P2|NOT COMPLETED|Overall Study||1
110535|NCT01929018|271998|P1|NOT COMPLETED|Overall Study||1
110536|NCT01929018|271997|P2|COMPLETED|Overall Study||18
110537|NCT01929018|271998|P1|COMPLETED|Overall Study||18
110538|NCT01929018|271997|P2|STARTED|Overall Study||19
110539|NCT01929018|271998|P1|STARTED|Overall Study||19
110540|NCT01928940|272022|P2|NOT COMPLETED|Overall Study||1
110541|NCT01928940|272023|P1|NOT COMPLETED|Overall Study||0
110542|NCT01928940|272022|P2|COMPLETED|Overall Study||5
110543|NCT01928940|272023|P1|COMPLETED|Overall Study||6
110544|NCT01928940|272022|P2|STARTED|Overall Study||6
110545|NCT01928940|272023|P1|STARTED|Overall Study||6
110546|NCT01928927|272066|P2|NOT COMPLETED|Overall Study||1
110547|NCT01928927|272067|P1|NOT COMPLETED|Overall Study||2
110548|NCT01928927|272066|P2|COMPLETED|Overall Study||14
110549|NCT01928927|272067|P1|COMPLETED|Overall Study||27
110550|NCT01928927|272066|P2|STARTED|Overall Study||15
110551|NCT01928927|272067|P1|STARTED|Overall Study||29
110552|NCT01928862|272194|P5|NOT COMPLETED|Overall Study||1
110553|NCT01928862|272195|P4|NOT COMPLETED|Overall Study||0
110554|NCT01928862|272196|P3|NOT COMPLETED|Overall Study||0
110555|NCT01928862|272197|P2|NOT COMPLETED|Overall Study||0
110556|NCT01928862|272198|P1|NOT COMPLETED|Overall Study||1
110557|NCT01928862|272194|P5|COMPLETED|Overall Study||13
110558|NCT01928862|272195|P4|COMPLETED|Overall Study||16
110559|NCT01928862|272196|P3|COMPLETED|Overall Study||16
110560|NCT01928862|272197|P2|COMPLETED|Overall Study||16
110561|NCT01928862|272198|P1|COMPLETED|Overall Study||15
110562|NCT01928862|272194|P5|STARTED|Overall Study||14
110563|NCT01928862|272195|P4|STARTED|Overall Study||16
110564|NCT01928862|272196|P3|STARTED|Overall Study||16
110565|NCT01928862|272197|P2|STARTED|Overall Study||16
110566|NCT01928862|272198|P1|STARTED|Overall Study||16
110567|NCT01928849|272237|P2|NOT COMPLETED|Overall Study||7
110568|NCT01928849|272238|P1|NOT COMPLETED|Overall Study||14
110569|NCT01928849|272237|P2|COMPLETED|Overall Study||55
110570|NCT01928849|272238|P1|COMPLETED|Overall Study||52
110571|NCT01928849|272237|P2|STARTED|Overall Study||62
110572|NCT01928849|272238|P1|STARTED|Overall Study||66
110573|NCT01928797|272258|P2|NOT COMPLETED|Overall Study||0
110574|NCT01928797|272259|P1|NOT COMPLETED|Overall Study||0
110575|NCT01928797|272258|P2|COMPLETED|Overall Study||30
110576|NCT01928797|272259|P1|COMPLETED|Overall Study||30
110577|NCT01928797|272258|P2|STARTED|Overall Study||30
110578|NCT01928797|272259|P1|STARTED|Overall Study||30
110579|NCT01928771|272272|P3|NOT COMPLETED|Overall Study||40
110580|NCT01928771|272273|P2|NOT COMPLETED|Overall Study||40
110581|NCT01928771|272274|P1|NOT COMPLETED|Overall Study||46
110582|NCT01928771|272272|P3|COMPLETED|Overall Study||367
110583|NCT01928771|272273|P2|COMPLETED|Overall Study||358
110584|NCT01928771|272274|P1|COMPLETED|Overall Study||354
110585|NCT01928771|272272|P3|Received Treatment|Overall Study||407
110586|NCT01928771|272273|P2|Received Treatment|Overall Study||398
110587|NCT01928771|272274|P1|Received Treatment|Overall Study||399
110588|NCT01928771|272272|P3|STARTED|Overall Study||407
110589|NCT01928771|272273|P2|STARTED|Overall Study||398
110590|NCT01928771|272274|P1|STARTED|Overall Study||400
110591|NCT01928758|272353|P2|NOT COMPLETED|Overall Study||20
110592|NCT01928758|272354|P1|NOT COMPLETED|Overall Study||25
110593|NCT01928758|272353|P2|COMPLETED|Overall Study||74
110594|NCT01928758|272354|P1|COMPLETED|Overall Study||69
110595|NCT01928758|272353|P2|STARTED|Overall Study||94
110596|NCT01928758|272354|P1|STARTED|Overall Study||94
110597|NCT01928719|272372|P2|NOT COMPLETED|Overall Study||19
110598|NCT01928719|272373|P1|NOT COMPLETED|Overall Study||52
110599|NCT01928719|272372|P2|COMPLETED|Overall Study||104
110600|NCT01928719|272373|P1|COMPLETED|Overall Study||70
110601|NCT01928719|272372|P2|STARTED|Overall Study||123
110602|NCT01928719|272373|P1|STARTED|Overall Study||122
110603|NCT01928693|272393|P3|NOT COMPLETED|Overall Study||0
110604|NCT01928693|272394|P2|NOT COMPLETED|Overall Study||0
110605|NCT01928693|272395|P1|NOT COMPLETED|Overall Study||0
110606|NCT01928693|272393|P3|COMPLETED|Overall Study||1
110607|NCT01928693|272394|P2|COMPLETED|Overall Study||1
110608|NCT01928693|272395|P1|COMPLETED|Overall Study||0
110609|NCT01928693|272393|P3|STARTED|Overall Study||1
110610|NCT01928693|272394|P2|STARTED|Overall Study||1
110611|NCT01928693|272395|P1|STARTED|Overall Study||0
110612|NCT01928680|272421|P1|NOT COMPLETED|Overall Study||0
110613|NCT01928680|272421|P1|COMPLETED|Overall Study||33
110614|NCT01928680|272421|P1|STARTED|Overall Study||33
110615|NCT01928615|272425|P1|NOT COMPLETED|Overall Study||2
110616|NCT01928615|272425|P1|COMPLETED|Overall Study||0
110617|NCT01928615|272425|P1|STARTED|Overall Study||2
110618|NCT01928472|272444|P4|NOT COMPLETED|Overall Study||2
110619|NCT01928472|272445|P3|NOT COMPLETED|Overall Study||7
110620|NCT01928472|272446|P2|NOT COMPLETED|Overall Study||8
110621|NCT01928472|272447|P1|NOT COMPLETED|Overall Study||8
110622|NCT01928472|272444|P4|COMPLETED|Overall Study||100
110623|NCT01928472|272445|P3|COMPLETED|Overall Study||91
110624|NCT01928472|272446|P2|COMPLETED|Overall Study||96
110625|NCT01928472|272447|P1|COMPLETED|Overall Study||90
110626|NCT01928472|272444|P4|STARTED|Overall Study||102
110627|NCT01928472|272445|P3|STARTED|Overall Study||98
110628|NCT01928472|272446|P2|STARTED|Overall Study||104
110629|NCT01928472|272447|P1|STARTED|Overall Study||98
110630|NCT01928433|272517|P3|NOT COMPLETED|Overall Study||28
110631|NCT01928433|272518|P2|NOT COMPLETED|Overall Study||21
110632|NCT01928433|272519|P1|NOT COMPLETED|Overall Study||20
110633|NCT01928433|272517|P3|COMPLETED|Overall Study||46
110634|NCT01928433|272518|P2|COMPLETED|Overall Study||54
110635|NCT01928433|272519|P1|COMPLETED|Overall Study||56
110636|NCT01928433|272517|P3|STARTED|Overall Study||74
110637|NCT01928433|272518|P2|STARTED|Overall Study||75
110638|NCT01928433|272519|P1|STARTED|Overall Study||76
110639|NCT01928381|272542|P7|NOT COMPLETED|Part 2 - Post Third Intervention||0
110640|NCT01928381|272543|P6|NOT COMPLETED|Part 2 - Post Third Intervention||0
110641|NCT01928381|272544|P5|NOT COMPLETED|Part 2 - Post Third Intervention||0
110642|NCT01928381|272545|P4|NOT COMPLETED|Part 2 - Post Third Intervention||0
110643|NCT01928381|272546|P3|NOT COMPLETED|Part 2 - Post Third Intervention||1
110644|NCT01928381|272547|P2|NOT COMPLETED|Part 2 - Post Third Intervention||0
110645|NCT01928381|272548|P1|NOT COMPLETED|Part 2 - Post Third Intervention||0
110646|NCT01928381|272542|P7|COMPLETED|Part 2 - Post Third Intervention||5
110647|NCT01928381|272543|P6|COMPLETED|Part 2 - Post Third Intervention||5
110648|NCT01928381|272544|P5|COMPLETED|Part 2 - Post Third Intervention||3
110649|NCT01928381|272545|P4|COMPLETED|Part 2 - Post Third Intervention||4
110650|NCT01928381|272546|P3|COMPLETED|Part 2 - Post Third Intervention||3
110651|NCT01928381|272547|P2|COMPLETED|Part 2 - Post Third Intervention||5
110652|NCT01928381|272548|P1|COMPLETED|Part 2 - Post Third Intervention||0
110653|NCT01928381|272542|P7|STARTED|Part 2 - Post Third Intervention||5
110654|NCT01928381|272543|P6|STARTED|Part 2 - Post Third Intervention||5
110655|NCT01928381|272544|P5|STARTED|Part 2 - Post Third Intervention||3
110656|NCT01928381|272545|P4|STARTED|Part 2 - Post Third Intervention||4
110657|NCT01928381|272546|P3|STARTED|Part 2 - Post Third Intervention||4
110658|NCT01928381|272547|P2|STARTED|Part 2 - Post Third Intervention||5
110659|NCT01928381|272548|P1|STARTED|Part 2 - Post Third Intervention||0
110660|NCT01928381|272542|P7|NOT COMPLETED|Part 2 - Third Intervention||0
110661|NCT01928381|272543|P6|NOT COMPLETED|Part 2 - Third Intervention||0
110662|NCT01928381|272544|P5|NOT COMPLETED|Part 2 - Third Intervention||0
110663|NCT01928381|272545|P4|NOT COMPLETED|Part 2 - Third Intervention||0
110664|NCT01928381|272546|P3|NOT COMPLETED|Part 2 - Third Intervention||0
110665|NCT01928381|272547|P2|NOT COMPLETED|Part 2 - Third Intervention||0
110666|NCT01928381|272548|P1|NOT COMPLETED|Part 2 - Third Intervention||0
110667|NCT01928381|272542|P7|COMPLETED|Part 2 - Third Intervention||5
110668|NCT01928381|272543|P6|COMPLETED|Part 2 - Third Intervention||5
110669|NCT01928381|272544|P5|COMPLETED|Part 2 - Third Intervention||3
110670|NCT01928381|272545|P4|COMPLETED|Part 2 - Third Intervention||4
110671|NCT01928381|272546|P3|COMPLETED|Part 2 - Third Intervention||4
110672|NCT01928381|272547|P2|COMPLETED|Part 2 - Third Intervention||5
110673|NCT01928381|272548|P1|COMPLETED|Part 2 - Third Intervention||0
110674|NCT01928381|272542|P7|STARTED|Part 2 - Third Intervention||5
110675|NCT01928381|272543|P6|STARTED|Part 2 - Third Intervention||5
110676|NCT01928381|272544|P5|STARTED|Part 2 - Third Intervention||3
110677|NCT01928381|272545|P4|STARTED|Part 2 - Third Intervention||4
110678|NCT01928381|272546|P3|STARTED|Part 2 - Third Intervention||4
110679|NCT01928381|272547|P2|STARTED|Part 2 - Third Intervention||5
110680|NCT01928381|272548|P1|STARTED|Part 2 - Third Intervention||0
110681|NCT01928381|272542|P7|NOT COMPLETED|Washout Second Intervention||0
110682|NCT01928381|272543|P6|NOT COMPLETED|Washout Second Intervention||0
110683|NCT01928381|272544|P5|NOT COMPLETED|Washout Second Intervention||0
110684|NCT01928381|272545|P4|NOT COMPLETED|Washout Second Intervention||0
110685|NCT01928381|272546|P3|NOT COMPLETED|Washout Second Intervention||0
110686|NCT01928381|272547|P2|NOT COMPLETED|Washout Second Intervention||0
110687|NCT01928381|272548|P1|NOT COMPLETED|Washout Second Intervention||0
110688|NCT01928381|272542|P7|COMPLETED|Washout Second Intervention||5
110689|NCT01928381|272543|P6|COMPLETED|Washout Second Intervention||5
110690|NCT01928381|272544|P5|COMPLETED|Washout Second Intervention||3
110691|NCT01928381|272545|P4|COMPLETED|Washout Second Intervention||4
110692|NCT01928381|272546|P3|COMPLETED|Washout Second Intervention||4
110693|NCT01928381|272547|P2|COMPLETED|Washout Second Intervention||5
110694|NCT01928381|272548|P1|COMPLETED|Washout Second Intervention||0
110695|NCT01928381|272542|P7|STARTED|Washout Second Intervention||5
110696|NCT01928381|272543|P6|STARTED|Washout Second Intervention||5
110697|NCT01928381|272544|P5|STARTED|Washout Second Intervention||3
110698|NCT01928381|272545|P4|STARTED|Washout Second Intervention||4
110699|NCT01928381|272546|P3|STARTED|Washout Second Intervention||4
110700|NCT01928381|272547|P2|STARTED|Washout Second Intervention||5
110701|NCT01928381|272548|P1|STARTED|Washout Second Intervention||0
110702|NCT01928381|272542|P7|NOT COMPLETED|Part 2 - Second Intervention||0
110703|NCT01928381|272543|P6|NOT COMPLETED|Part 2 - Second Intervention||0
110704|NCT01928381|272544|P5|NOT COMPLETED|Part 2 - Second Intervention||0
110705|NCT01928381|272545|P4|NOT COMPLETED|Part 2 - Second Intervention||1
110706|NCT01928381|272546|P3|NOT COMPLETED|Part 2 - Second Intervention||0
110707|NCT01928381|272547|P2|NOT COMPLETED|Part 2 - Second Intervention||1
110708|NCT01928381|272548|P1|NOT COMPLETED|Part 2 - Second Intervention||0
110709|NCT01928381|272542|P7|COMPLETED|Part 2 - Second Intervention||5
110710|NCT01928381|272543|P6|COMPLETED|Part 2 - Second Intervention||5
110711|NCT01928381|272544|P5|COMPLETED|Part 2 - Second Intervention||3
110712|NCT01928381|272545|P4|COMPLETED|Part 2 - Second Intervention||4
110713|NCT01928381|272546|P3|COMPLETED|Part 2 - Second Intervention||4
110714|NCT01928381|272547|P2|COMPLETED|Part 2 - Second Intervention||5
110715|NCT01928381|272548|P1|COMPLETED|Part 2 - Second Intervention||0
110716|NCT01928381|272542|P7|STARTED|Part 2 - Second Intervention||5
110717|NCT01928381|272543|P6|STARTED|Part 2 - Second Intervention||5
110718|NCT01928381|272544|P5|STARTED|Part 2 - Second Intervention||3
110719|NCT01928381|272545|P4|STARTED|Part 2 - Second Intervention||5
110720|NCT01928381|272546|P3|STARTED|Part 2 - Second Intervention||4
110721|NCT01928381|272547|P2|STARTED|Part 2 - Second Intervention||6
110722|NCT01928381|272548|P1|STARTED|Part 2 - Second Intervention||0
110723|NCT01928381|272542|P7|NOT COMPLETED|Washout First Intervention||0
110724|NCT01928381|272543|P6|NOT COMPLETED|Washout First Intervention||0
110725|NCT01928381|272544|P5|NOT COMPLETED|Washout First Intervention||1
110726|NCT01928381|272545|P4|NOT COMPLETED|Washout First Intervention||0
110727|NCT01928381|272546|P3|NOT COMPLETED|Washout First Intervention||0
110728|NCT01928381|272547|P2|NOT COMPLETED|Washout First Intervention||0
110729|NCT01928381|272548|P1|NOT COMPLETED|Washout First Intervention||0
110730|NCT01928381|272542|P7|COMPLETED|Washout First Intervention||5
110731|NCT01928381|272543|P6|COMPLETED|Washout First Intervention||5
110732|NCT01928381|272544|P5|COMPLETED|Washout First Intervention||3
110733|NCT01928381|272545|P4|COMPLETED|Washout First Intervention||5
110734|NCT01928381|272546|P3|COMPLETED|Washout First Intervention||4
110735|NCT01928381|272547|P2|COMPLETED|Washout First Intervention||6
110736|NCT01928381|272548|P1|COMPLETED|Washout First Intervention||0
110737|NCT01928381|272542|P7|STARTED|Washout First Intervention||5
110738|NCT01928381|272543|P6|STARTED|Washout First Intervention||5
110739|NCT01928381|272544|P5|STARTED|Washout First Intervention||4
110740|NCT01928381|272545|P4|STARTED|Washout First Intervention||5
110741|NCT01928381|272546|P3|STARTED|Washout First Intervention||4
110742|NCT01928381|272547|P2|STARTED|Washout First Intervention||6
110743|NCT01928381|272548|P1|STARTED|Washout First Intervention||0
110744|NCT01928381|272542|P7|NOT COMPLETED|Part 2 - First Intervention||1
110745|NCT01928381|272543|P6|NOT COMPLETED|Part 2 - First Intervention||1
110746|NCT01928381|272544|P5|NOT COMPLETED|Part 2 - First Intervention||0
110747|NCT01928381|272545|P4|NOT COMPLETED|Part 2 - First Intervention||1
110748|NCT01928381|272546|P3|NOT COMPLETED|Part 2 - First Intervention||2
110749|NCT01928381|272547|P2|NOT COMPLETED|Part 2 - First Intervention||0
110750|NCT01928381|272548|P1|NOT COMPLETED|Part 2 - First Intervention||0
110751|NCT01928381|272542|P7|COMPLETED|Part 2 - First Intervention||5
110752|NCT01928381|272543|P6|COMPLETED|Part 2 - First Intervention||5
110753|NCT01928381|272544|P5|COMPLETED|Part 2 - First Intervention||4
110754|NCT01928381|272545|P4|COMPLETED|Part 2 - First Intervention||5
110755|NCT01928381|272546|P3|COMPLETED|Part 2 - First Intervention||4
110756|NCT01928381|272547|P2|COMPLETED|Part 2 - First Intervention||6
110757|NCT01928381|272548|P1|COMPLETED|Part 2 - First Intervention||0
110758|NCT01928381|272542|P7|STARTED|Part 2 - First Intervention||6
110759|NCT01928381|272543|P6|STARTED|Part 2 - First Intervention||6
110760|NCT01928381|272544|P5|STARTED|Part 2 - First Intervention||4
110761|NCT01928381|272545|P4|STARTED|Part 2 - First Intervention||6
110762|NCT01928381|272546|P3|STARTED|Part 2 - First Intervention||6
110763|NCT01928381|272547|P2|STARTED|Part 2 - First Intervention||6
110764|NCT01928381|272548|P1|STARTED|Part 2 - First Intervention||0
110765|NCT01928381|272542|P7|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
110766|NCT01928381|272543|P6|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
110767|NCT01928381|272544|P5|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
110768|NCT01928381|272545|P4|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
110769|NCT01928381|272546|P3|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
110770|NCT01928381|272547|P2|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
110771|NCT01928381|272548|P1|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||14
110772|NCT01928381|272542|P7|COMPLETED|Placebo run-in & Part 2 Eligibility||0
110773|NCT01928381|272543|P6|COMPLETED|Placebo run-in & Part 2 Eligibility||0
110774|NCT01928381|272544|P5|COMPLETED|Placebo run-in & Part 2 Eligibility||0
110775|NCT01928381|272545|P4|COMPLETED|Placebo run-in & Part 2 Eligibility||0
110776|NCT01928381|272546|P3|COMPLETED|Placebo run-in & Part 2 Eligibility||0
110777|NCT01928381|272547|P2|COMPLETED|Placebo run-in & Part 2 Eligibility||0
110778|NCT01928381|272548|P1|COMPLETED|Placebo run-in & Part 2 Eligibility||34
110779|NCT01928381|272542|P7|STARTED|Placebo run-in & Part 2 Eligibility||0
110780|NCT01928381|272543|P6|STARTED|Placebo run-in & Part 2 Eligibility||0
110781|NCT01928381|272544|P5|STARTED|Placebo run-in & Part 2 Eligibility||0
110782|NCT01928381|272545|P4|STARTED|Placebo run-in & Part 2 Eligibility||0
110783|NCT01928381|272546|P3|STARTED|Placebo run-in & Part 2 Eligibility||0
110784|NCT01928381|272547|P2|STARTED|Placebo run-in & Part 2 Eligibility||0
110785|NCT01928381|272548|P1|STARTED|Placebo run-in & Part 2 Eligibility||48
110786|NCT01928381|272542|P7|NOT COMPLETED|Part 1 - Pain Training||0
110787|NCT01928381|272543|P6|NOT COMPLETED|Part 1 - Pain Training||0
110788|NCT01928381|272544|P5|NOT COMPLETED|Part 1 - Pain Training||0
110789|NCT01928381|272545|P4|NOT COMPLETED|Part 1 - Pain Training||0
110790|NCT01928381|272546|P3|NOT COMPLETED|Part 1 - Pain Training||0
110791|NCT01928381|272547|P2|NOT COMPLETED|Part 1 - Pain Training||0
110792|NCT01928381|272548|P1|NOT COMPLETED|Part 1 - Pain Training||35
110793|NCT01928381|272542|P7|COMPLETED|Part 1 - Pain Training||0
110794|NCT01928381|272543|P6|COMPLETED|Part 1 - Pain Training||0
110795|NCT01928381|272544|P5|COMPLETED|Part 1 - Pain Training||0
110796|NCT01928381|272545|P4|COMPLETED|Part 1 - Pain Training||0
110797|NCT01928381|272546|P3|COMPLETED|Part 1 - Pain Training||0
110798|NCT01928381|272547|P2|COMPLETED|Part 1 - Pain Training||0
110799|NCT01928381|272548|P1|COMPLETED|Part 1 - Pain Training||48
110800|NCT01928381|272542|P7|STARTED|Part 1 - Pain Training||0
110801|NCT01928381|272543|P6|STARTED|Part 1 - Pain Training||0
110802|NCT01928381|272544|P5|STARTED|Part 1 - Pain Training||0
110803|NCT01928381|272545|P4|STARTED|Part 1 - Pain Training||0
110804|NCT01928381|272546|P3|STARTED|Part 1 - Pain Training||0
110805|NCT01928381|272547|P2|STARTED|Part 1 - Pain Training||0
110806|NCT01928381|272548|P1|STARTED|Part 1 - Pain Training||83
110807|NCT01928381|272542|P7|NOT COMPLETED|Screening for Pain Training||0
110808|NCT01928381|272543|P6|NOT COMPLETED|Screening for Pain Training||0
110809|NCT01928381|272544|P5|NOT COMPLETED|Screening for Pain Training||0
110810|NCT01928381|272545|P4|NOT COMPLETED|Screening for Pain Training||0
110811|NCT01928381|272546|P3|NOT COMPLETED|Screening for Pain Training||0
110812|NCT01928381|272547|P2|NOT COMPLETED|Screening for Pain Training||0
110813|NCT01928381|272548|P1|NOT COMPLETED|Screening for Pain Training||60
110814|NCT01928381|272542|P7|COMPLETED|Screening for Pain Training||0
110815|NCT01928381|272543|P6|COMPLETED|Screening for Pain Training||0
110816|NCT01928381|272544|P5|COMPLETED|Screening for Pain Training||0
110817|NCT01928381|272545|P4|COMPLETED|Screening for Pain Training||0
110818|NCT01928381|272546|P3|COMPLETED|Screening for Pain Training||0
110819|NCT01928381|272547|P2|COMPLETED|Screening for Pain Training||0
110820|NCT01928381|272548|P1|COMPLETED|Screening for Pain Training||83
110821|NCT01928381|272542|P7|STARTED|Screening for Pain Training||0
110822|NCT01928381|272543|P6|STARTED|Screening for Pain Training||0
110823|NCT01928381|272544|P5|STARTED|Screening for Pain Training||0
110824|NCT01928381|272545|P4|STARTED|Screening for Pain Training||0
110825|NCT01928381|272546|P3|STARTED|Screening for Pain Training||0
110826|NCT01928381|272547|P2|STARTED|Screening for Pain Training||0
110827|NCT01928381|272548|P1|STARTED|Screening for Pain Training||143
110828|NCT01928329|272563|P2|NOT COMPLETED|Overall Study||14
110829|NCT01928329|272564|P1|NOT COMPLETED|Overall Study||12
110830|NCT01928329|272563|P2|COMPLETED|Overall Study||25
110831|NCT01928329|272564|P1|COMPLETED|Overall Study||28
110832|NCT01928329|272563|P2|STARTED|Overall Study||39
110833|NCT01928329|272564|P1|STARTED|Overall Study||40
110834|NCT01928186|272576|P1|NOT COMPLETED|Overall Study||0
110835|NCT01928186|272576|P1|COMPLETED|Overall Study||28
110836|NCT01928186|272576|P1|STARTED|Overall Study||28
110837|NCT01928082|272590|P1|NOT COMPLETED|Overall Study||1
110838|NCT01928082|272590|P1|COMPLETED|Overall Study||0
110839|NCT01928082|272590|P1|STARTED|Overall Study||1
110840|NCT01928030|272608|P3|NOT COMPLETED|Overall Study||0
110841|NCT01928030|272609|P2|NOT COMPLETED|Overall Study||0
110842|NCT01928030|272610|P1|NOT COMPLETED|Overall Study||0
110843|NCT01928030|272608|P3|COMPLETED|Overall Study||0
110844|NCT01928030|272609|P2|COMPLETED|Overall Study||0
110845|NCT01928030|272610|P1|COMPLETED|Overall Study||3
110846|NCT01928030|272608|P3|STARTED|Overall Study||0
110847|NCT01928030|272609|P2|STARTED|Overall Study||0
110848|NCT01928030|272610|P1|STARTED|Overall Study||3
110849|NCT01927887|272617|P1|NOT COMPLETED|Overall Study||0
110850|NCT01927887|272617|P1|COMPLETED|Overall Study||12
110851|NCT01927887|272617|P1|STARTED|Overall Study||12
110852|NCT01927861|272624|P2|NOT COMPLETED|Extended Treatment Phase (26 Weeks)||0
110853|NCT01927861|272625|P1|NOT COMPLETED|Extended Treatment Phase (26 Weeks)||0
110854|NCT01927861|272624|P2|COMPLETED|Extended Treatment Phase (26 Weeks)||14
110855|NCT01927861|272625|P1|COMPLETED|Extended Treatment Phase (26 Weeks)||15
110856|NCT01927861|272624|P2|STARTED|Extended Treatment Phase (26 Weeks)|14 participants agreed to continue the treatment for 26 weeks in the extended treatment phase.|14
110857|NCT01927861|272625|P1|STARTED|Extended Treatment Phase (26 Weeks)|15 participants agreed to continue the treatment for 26 weeks in the extended treatment phase.|15
110858|NCT01927861|272624|P2|NOT COMPLETED|Extension Phase (104 Weeks)||3
110859|NCT01927861|272625|P1|NOT COMPLETED|Extension Phase (104 Weeks)||0
110860|NCT01927861|272624|P2|COMPLETED|Extension Phase (104 Weeks)||23
110861|NCT01927861|272625|P1|COMPLETED|Extension Phase (104 Weeks)||25
110862|NCT01927861|272624|P2|STARTED|Extension Phase (104 Weeks)||26
110863|NCT01927861|272625|P1|STARTED|Extension Phase (104 Weeks)||25
110864|NCT01927861|272624|P2|NOT COMPLETED|Pivotal Phase (104 Weeks)||0
110865|NCT01927861|272625|P1|NOT COMPLETED|Pivotal Phase (104 Weeks)||0
110866|NCT01927861|272624|P2|COMPLETED|Pivotal Phase (104 Weeks)||26
110867|NCT01927861|272625|P1|COMPLETED|Pivotal Phase (104 Weeks)||25
110868|NCT01927861|272624|P2|STARTED|Pivotal Phase (104 Weeks)||26
110869|NCT01927861|272625|P1|STARTED|Pivotal Phase (104 Weeks)||25
110870|NCT01927757|272763|P1|NOT COMPLETED|Overall Study||23
110871|NCT01927757|272763|P1|COMPLETED|Overall Study||67
110872|NCT01927757|272763|P1|Received Etanercept|Overall Study||88
110873|NCT01927757|272763|P1|STARTED|Overall Study||90
110874|NCT01927718|272781|P1|NOT COMPLETED|Overall Study||0
110875|NCT01927718|272781|P1|COMPLETED|Overall Study||10
110876|NCT01927718|272781|P1|STARTED|Overall Study||10
110877|NCT01927627|272785|P1|NOT COMPLETED|Overall Study||5
110878|NCT01927627|272785|P1|COMPLETED|Overall Study||37
110879|NCT01927627|272785|P1|STARTED|Overall Study||42
110880|NCT01927575|272790|P1|NOT COMPLETED|Overall Study||0
110881|NCT01927575|272790|P1|COMPLETED|Overall Study||1
110882|NCT01927575|272790|P1|STARTED|Overall Study||1
110883|NCT01927419|272800|P2|NOT COMPLETED|Overall Study||28
110884|NCT01927419|272801|P1|NOT COMPLETED|Overall Study||70
110885|NCT01927419|272800|P2|COMPLETED|Overall Study|All participants who did not discontinue study drug during treatment period (Parts 1 and 2)|19
110886|NCT01927419|272801|P1|COMPLETED|Overall Study|All participants who did not discontinue study drug during treatment period (Parts 1 and 2)|25
110887|NCT01927419|272800|P2|Received Treatment|Overall Study||46
110888|NCT01927419|272801|P1|Received Treatment|Overall Study||94
110889|NCT01927419|272800|P2|STARTED|Overall Study||47
110890|NCT01927419|272801|P1|STARTED|Overall Study||95
110891|NCT01927120|272817|P1|NOT COMPLETED|Overall Study||10
110892|NCT01927120|272817|P1|COMPLETED|Overall Study||10
110893|NCT01927120|272817|P1|STARTED|Overall Study||20
110894|NCT01927055|272835|P3|NOT COMPLETED|Double-Blind||13
110895|NCT01927055|272836|P2|NOT COMPLETED|Double-Blind||11
110896|NCT01927055|272837|P1|NOT COMPLETED|Double-Blind||0
110897|NCT01927055|272835|P3|COMPLETED|Double-Blind||10
110898|NCT01927055|272836|P2|COMPLETED|Double-Blind||11
110899|NCT01927055|272837|P1|COMPLETED|Double-Blind||0
110900|NCT01927055|272835|P3|STARTED|Double-Blind||23
110901|NCT01927055|272836|P2|STARTED|Double-Blind||22
110902|NCT01927055|272837|P1|STARTED|Double-Blind||0
110903|NCT01927055|272835|P3|NOT COMPLETED|Open-label||0
110904|NCT01927055|272836|P2|NOT COMPLETED|Open-label||0
110905|NCT01927055|272837|P1|NOT COMPLETED|Open-label||16
110906|NCT01927055|272835|P3|COMPLETED|Open-label||0
110907|NCT01927055|272836|P2|COMPLETED|Open-label||0
110908|NCT01927055|272837|P1|COMPLETED|Open-label||45
110909|NCT01927055|272835|P3|STARTED|Open-label||0
110910|NCT01927055|272836|P2|STARTED|Open-label||0
110911|NCT01927055|272837|P1|STARTED|Open-label||61
110912|NCT01926977|272846|P2|NOT COMPLETED|Overall Study||0
110913|NCT01926977|272847|P1|NOT COMPLETED|Overall Study||0
110914|NCT01926977|272846|P2|COMPLETED|Overall Study||53
110915|NCT01926977|272847|P1|COMPLETED|Overall Study||47
110916|NCT01926977|272846|P2|STARTED|Overall Study||53
110917|NCT01926977|272847|P1|STARTED|Overall Study||47
110918|NCT01926886|272855|P2|NOT COMPLETED|Overall Study||0
110919|NCT01926886|272856|P1|NOT COMPLETED|Overall Study||32
110920|NCT01926886|272855|P2|COMPLETED|Overall Study|Partcipants were HCPs included for polling purposes. HCPs were not enrolled in the study.|21
110921|NCT01926886|272856|P1|COMPLETED|Overall Study||70
110922|NCT01926886|272855|P2|Received at Least 1 Dose of Study Drug|Overall Study|Partcipants were HCPs included for polling purposes. HCPs were not enrolled in the study.|0
110923|NCT01926886|272856|P1|Received at Least 1 Dose of Study Drug|Overall Study||101
110924|NCT01926886|272855|P2|STARTED|Overall Study|HCPs were not enrolled in the study. No baseline data were collected for these participants.|21
110925|NCT01926886|272856|P1|STARTED|Overall Study||102
110926|NCT01926782|272875|P6|NOT COMPLETED|Overall Study||41
110927|NCT01926782|272876|P5|NOT COMPLETED|Overall Study||8
110928|NCT01926782|272877|P4|NOT COMPLETED|Overall Study||20
110929|NCT01926782|272878|P3|NOT COMPLETED|Overall Study||40
110930|NCT01926782|272879|P2|NOT COMPLETED|Overall Study||13
110931|NCT01926782|272880|P1|NOT COMPLETED|Overall Study||28
110932|NCT01926782|272875|P6|COMPLETED|Overall Study||105
110933|NCT01926782|272876|P5|COMPLETED|Overall Study||29
110934|NCT01926782|272877|P4|COMPLETED|Overall Study||53
110935|NCT01926782|272878|P3|COMPLETED|Overall Study||272
110936|NCT01926782|272879|P2|COMPLETED|Overall Study||65
110937|NCT01926782|272880|P1|COMPLETED|Overall Study||129
110938|NCT01926782|272875|P6|Completed 24 Weeks Treatment Period|Overall Study||120
110939|NCT01926782|272876|P5|Completed 24 Weeks Treatment Period|Overall Study||31
110940|NCT01926782|272877|P4|Completed 24 Weeks Treatment Period|Overall Study||58
110941|NCT01926782|272878|P3|Completed 24 Weeks Treatment Period|Overall Study||285
110942|NCT01926782|272879|P2|Completed 24 Weeks Treatment Period|Overall Study||68
110943|NCT01926782|272880|P1|Completed 24 Weeks Treatment Period|Overall Study||137
110944|NCT01926782|272875|P6|Treated|Overall Study||146
110945|NCT01926782|272876|P5|Treated|Overall Study||37
110946|NCT01926782|272877|P4|Treated|Overall Study||72
110947|NCT01926782|272878|P3|Treated|Overall Study||312
110948|NCT01926782|272879|P2|Treated|Overall Study||78
110949|NCT01926782|272880|P1|Treated|Overall Study||157
110950|NCT01926782|272875|P6|STARTED|Overall Study||146
110951|NCT01926782|272876|P5|STARTED|Overall Study||37
110952|NCT01926782|272877|P4|STARTED|Overall Study||73
110953|NCT01926782|272878|P3|STARTED|Overall Study||312
110954|NCT01926782|272879|P2|STARTED|Overall Study||78
110955|NCT01926782|272880|P1|STARTED|Overall Study||157
110956|NCT01926626|273029|P1|NOT COMPLETED|Overall Study||22
110957|NCT01926626|273029|P1|COMPLETED|Overall Study||16
110958|NCT01926626|273029|P1|Received Moclobemide|Overall Study||37
110959|NCT01926626|273029|P1|STARTED|Overall Study||38
110960|NCT01926509|273043|P4|NOT COMPLETED|Overall Study||0
110961|NCT01926509|273044|P3|NOT COMPLETED|Overall Study||0
110962|NCT01926509|273045|P2|NOT COMPLETED|Overall Study||0
110963|NCT01926509|273046|P1|NOT COMPLETED|Overall Study||1
110964|NCT01926509|273043|P4|COMPLETED|Overall Study||6
110965|NCT01926509|273044|P3|COMPLETED|Overall Study||5
110966|NCT01926509|273045|P2|COMPLETED|Overall Study||6
110967|NCT01926509|273046|P1|COMPLETED|Overall Study||5
110968|NCT01926509|273043|P4|STARTED|Overall Study||6
110969|NCT01926509|273044|P3|STARTED|Overall Study||5
110970|NCT01926509|273045|P2|STARTED|Overall Study||6
110971|NCT01926509|273046|P1|STARTED|Overall Study||6
110972|NCT01926444|273067|P4|NOT COMPLETED|Overall Study||2
110973|NCT01926444|273068|P3|NOT COMPLETED|Overall Study||4
110974|NCT01926444|273069|P2|NOT COMPLETED|Overall Study||0
110975|NCT01926444|273070|P1|NOT COMPLETED|Overall Study||0
110976|NCT01926444|273067|P4|COMPLETED|Overall Study||101
110977|NCT01926444|273068|P3|COMPLETED|Overall Study||53
110978|NCT01926444|273069|P2|COMPLETED|Overall Study||52
110979|NCT01926444|273070|P1|COMPLETED|Overall Study||56
110980|NCT01926444|273067|P4|STARTED|Overall Study||103
110981|NCT01926444|273068|P3|STARTED|Overall Study||57
110982|NCT01926444|273069|P2|STARTED|Overall Study||52
110983|NCT01926444|273070|P1|STARTED|Overall Study||56
110984|NCT01926119|273112|P1|NOT COMPLETED|Overall Study||1
110985|NCT01926119|273112|P1|COMPLETED|Overall Study||3
110986|NCT01926119|273112|P1|STARTED|Overall Study||4
110987|NCT01926028|273125|P3|NOT COMPLETED|Overall Study||2
110988|NCT01926028|273126|P2|NOT COMPLETED|Overall Study||22
110989|NCT01926028|273127|P1|NOT COMPLETED|Overall Study||21
110990|NCT01926028|273125|P3|COMPLETED|Overall Study||12
110991|NCT01926028|273126|P2|COMPLETED|Overall Study||67
110992|NCT01926028|273127|P1|COMPLETED|Overall Study||64
110993|NCT01926028|273125|P3|STARTED|Overall Study||14
110994|NCT01926028|273126|P2|STARTED|Overall Study||89
110995|NCT01926028|273127|P1|STARTED|Overall Study||85
110996|NCT01926015|273163|P2|NOT COMPLETED|Overall Study||1
110997|NCT01926015|273164|P1|NOT COMPLETED|Overall Study||2
110998|NCT01926015|273163|P2|COMPLETED|Overall Study||95
110999|NCT01926015|273164|P1|COMPLETED|Overall Study||94
111000|NCT01926015|273163|P2|Received >=1 Vaccination|Overall Study||96
111001|NCT01926015|273164|P1|Received >=1 Vaccination|Overall Study||94
111002|NCT01926015|273163|P2|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
111003|NCT01926015|273164|P1|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
111004|NCT01925989|273196|P3|NOT COMPLETED|Period 2||0
111005|NCT01925989|273197|P2|NOT COMPLETED|Period 2||0
111006|NCT01925989|273198|P1|NOT COMPLETED|Period 2||0
111007|NCT01925989|273196|P3|COMPLETED|Period 2||12
111008|NCT01925989|273197|P2|COMPLETED|Period 2||6
111009|NCT01925989|273198|P1|COMPLETED|Period 2||6
111010|NCT01925989|273196|P3|STARTED|Period 2||12
111011|NCT01925989|273197|P2|STARTED|Period 2||6
111012|NCT01925989|273198|P1|STARTED|Period 2||6
111013|NCT01925989|273196|P3|NOT COMPLETED|Period 1||0
111014|NCT01925989|273197|P2|NOT COMPLETED|Period 1||2
111015|NCT01925989|273198|P1|NOT COMPLETED|Period 1||1
111016|NCT01925989|273196|P3|COMPLETED|Period 1||12
111017|NCT01925989|273197|P2|COMPLETED|Period 1||6
111018|NCT01925989|273198|P1|COMPLETED|Period 1||6
111019|NCT01925989|273196|P3|Received at Least 1 Dose of Study Drug|Period 1||0
111020|NCT01925989|273197|P2|Received at Least 1 Dose of Study Drug|Period 1||8
111021|NCT01925989|273198|P1|Received at Least 1 Dose of Study Drug|Period 1||7
111022|NCT01925989|273196|P3|STARTED|Period 1||12
111023|NCT01925989|273197|P2|STARTED|Period 1||8
111024|NCT01925989|273198|P1|STARTED|Period 1||7
111025|NCT01925950|273218|P2|NOT COMPLETED|Part 2||0
111026|NCT01925950|273219|P1|NOT COMPLETED|Part 2||1
111027|NCT01925950|273218|P2|COMPLETED|Part 2||0
111028|NCT01925950|273219|P1|COMPLETED|Part 2||0
111029|NCT01925950|273218|P2|STARTED|Part 2|The 1 orBec subject completed Part 1 but did not meet the criteria of a CR to continue to Part 2|0
111030|NCT01925950|273219|P1|STARTED|Part 2||1
111031|NCT01925950|273218|P2|NOT COMPLETED|Part 1||0
111032|NCT01925950|273219|P1|NOT COMPLETED|Part 1||0
111033|NCT01925950|273218|P2|COMPLETED|Part 1||1
111034|NCT01925950|273219|P1|COMPLETED|Part 1||1
111035|NCT01925950|273218|P2|STARTED|Part 1||1
111036|NCT01925950|273219|P1|STARTED|Part 1||1
111037|NCT01925781|273227|P2|NOT COMPLETED|Overall Study||4
111038|NCT01925781|273228|P1|NOT COMPLETED|Overall Study||2
111039|NCT01925781|273227|P2|COMPLETED|Overall Study||1
111040|NCT01925781|273228|P1|COMPLETED|Overall Study||3
111041|NCT01925781|273227|P2|STARTED|Overall Study||5
111042|NCT01925781|273228|P1|STARTED|Overall Study||5
111043|NCT01925768|273238|P2|NOT COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||18
111044|NCT01925768|273239|P1|NOT COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||20
111045|NCT01925768|273238|P2|COMPLETED|ActiveTreatment/Extension (Weeks 24-104)|Completed Apremilast treatment at Week 104|67
111046|NCT01925768|273239|P1|COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||75
111047|NCT01925768|273238|P2|STARTED|ActiveTreatment/Extension (Weeks 24-104)||85
111048|NCT01925768|273239|P1|STARTED|ActiveTreatment/Extension (Weeks 24-104)||95
111049|NCT01925768|273238|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
111050|NCT01925768|273239|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||11
111051|NCT01925768|273238|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|2 participants who completed Week 24 did not enter the active treatment phase|87
111052|NCT01925768|273239|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|3 participants who completed Week 24 did not enter the active treatment phase|98
111053|NCT01925768|273238|P2|Escaped Early (EE)|Placebo-controlled Phase (Week 0 - 24)||13
111054|NCT01925768|273239|P1|Escaped Early (EE)|Placebo-controlled Phase (Week 0 - 24)||35
111055|NCT01925768|273238|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||91
111056|NCT01925768|273239|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||101
111057|NCT01925768|273238|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||109
111058|NCT01925768|273239|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||109
111059|NCT01925768|273238|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||110
111060|NCT01925768|273239|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||109
111061|NCT01925703|273287|P1|NOT COMPLETED|Overall Study||4
111062|NCT01925703|273287|P1|COMPLETED|Overall Study||9
111063|NCT01925703|273287|P1|Follow-up Completed|Overall Study||9
111064|NCT01925703|273287|P1|Full Iron Repletion Achieved|Overall Study||11
111065|NCT01925703|273287|P1|Dosing Regimen Completed|Overall Study||12
111066|NCT01925703|273287|P1|STARTED|Overall Study||13
111067|NCT01925677|273293|P1|NOT COMPLETED|Overall Study||0
111068|NCT01925677|273293|P1|COMPLETED|Overall Study||3
111069|NCT01925677|273293|P1|STARTED|Overall Study||3
111070|NCT01925612|273305|P5|NOT COMPLETED|Overall Study||2
111071|NCT01925612|273306|P4|NOT COMPLETED|Overall Study||1
111072|NCT01925612|273307|P3|NOT COMPLETED|Overall Study||1
111073|NCT01925612|273308|P2|NOT COMPLETED|Overall Study||4
111074|NCT01925612|273309|P1|NOT COMPLETED|Overall Study||4
111075|NCT01925612|273305|P5|COMPLETED|Overall Study||10
111076|NCT01925612|273306|P4|COMPLETED|Overall Study||10
111077|NCT01925612|273307|P3|COMPLETED|Overall Study||10
111078|NCT01925612|273308|P2|COMPLETED|Overall Study||18
111079|NCT01925612|273309|P1|COMPLETED|Overall Study||25
111080|NCT01925612|273305|P5|STARTED|Overall Study||12
111081|NCT01925612|273306|P4|STARTED|Overall Study||11
111082|NCT01925612|273307|P3|STARTED|Overall Study||11
111083|NCT01925612|273308|P2|STARTED|Overall Study||22
111084|NCT01925612|273309|P1|STARTED|Overall Study||29
111085|NCT01925469|273348|P2|NOT COMPLETED|Overall Study||0
111086|NCT01925469|273349|P1|NOT COMPLETED|Overall Study||1
111087|NCT01925469|273348|P2|COMPLETED|Overall Study||15
111088|NCT01925469|273349|P1|COMPLETED|Overall Study||14
111089|NCT01925469|273348|P2|STARTED|Overall Study||15
111090|NCT01925469|273349|P1|STARTED|Overall Study||15
111091|NCT01925417|273359|P1|NOT COMPLETED|Overall Study||3
111092|NCT01925417|273359|P1|COMPLETED|Overall Study||31
111093|NCT01925417|273359|P1|STARTED|Overall Study||34
111094|NCT01925404|273371|P4|NOT COMPLETED|Overall Study||0
111095|NCT01925404|273372|P3|NOT COMPLETED|Overall Study||0
111096|NCT01925404|273373|P2|NOT COMPLETED|Overall Study||0
111097|NCT01925404|273374|P1|NOT COMPLETED|Overall Study||0
111098|NCT01925404|273371|P4|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
111099|NCT01925404|273372|P3|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
111100|NCT01925404|273373|P2|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
111101|NCT01925404|273374|P1|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
111102|NCT01925404|273371|P4|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|0
111103|NCT01925404|273372|P3|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|0
111104|NCT01925404|273373|P2|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|0
111105|NCT01925404|273374|P1|STARTED|Overall Study|"The primary outcome of this study is at the level of a park.~The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users"|0
111106|NCT01925339|273390|P2|NOT COMPLETED|Overall Study||0
111107|NCT01925339|273391|P1|NOT COMPLETED|Overall Study||2
111108|NCT01925339|273390|P2|COMPLETED|Overall Study||20
111109|NCT01925339|273391|P1|COMPLETED|Overall Study||18
111110|NCT01925339|273390|P2|STARTED|Overall Study||20
111111|NCT01925339|273391|P1|STARTED|Overall Study||20
111112|NCT01925274|273402|P3|NOT COMPLETED|Overall Study||6
111113|NCT01925274|273403|P2|NOT COMPLETED|Overall Study||6
111114|NCT01925274|273404|P1|NOT COMPLETED|Overall Study||7
111115|NCT01925274|273402|P3|COMPLETED|Overall Study||0
111116|NCT01925274|273403|P2|COMPLETED|Overall Study||0
111117|NCT01925274|273404|P1|COMPLETED|Overall Study||0
111118|NCT01925274|273402|P3|STARTED|Overall Study||6
111119|NCT01925274|273403|P2|STARTED|Overall Study||6
111120|NCT01925274|273404|P1|STARTED|Overall Study||7
111121|NCT01925209|273485|P4|NOT COMPLETED|Follow-up||4
111122|NCT01925209|273486|P3|NOT COMPLETED|Follow-up||1
111123|NCT01925209|273487|P2|NOT COMPLETED|Follow-up||6
111124|NCT01925209|273488|P1|NOT COMPLETED|Follow-up||1
111125|NCT01925209|273485|P4|COMPLETED|Follow-up||54
111126|NCT01925209|273486|P3|COMPLETED|Follow-up||55
111127|NCT01925209|273487|P2|COMPLETED|Follow-up||55
111128|NCT01925209|273488|P1|COMPLETED|Follow-up||56
111129|NCT01925209|273485|P4|STARTED|Follow-up||58
111130|NCT01925209|273486|P3|STARTED|Follow-up||56
111131|NCT01925209|273487|P2|STARTED|Follow-up||61
111132|NCT01925209|273488|P1|STARTED|Follow-up||57
111133|NCT01925209|273485|P4|NOT COMPLETED|Maintenance Treatment Epoch||2
111134|NCT01925209|273486|P3|NOT COMPLETED|Maintenance Treatment Epoch||2
111135|NCT01925209|273487|P2|NOT COMPLETED|Maintenance Treatment Epoch||1
111136|NCT01925209|273488|P1|NOT COMPLETED|Maintenance Treatment Epoch||0
111137|NCT01925209|273485|P4|COMPLETED|Maintenance Treatment Epoch||48
111138|NCT01925209|273486|P3|COMPLETED|Maintenance Treatment Epoch||50
111139|NCT01925209|273487|P2|COMPLETED|Maintenance Treatment Epoch||45
111140|NCT01925209|273488|P1|COMPLETED|Maintenance Treatment Epoch||49
111141|NCT01925209|273485|P4|STARTED|Maintenance Treatment Epoch||50
111142|NCT01925209|273486|P3|STARTED|Maintenance Treatment Epoch||52
111143|NCT01925209|273487|P2|STARTED|Maintenance Treatment Epoch||46
111144|NCT01925209|273488|P1|STARTED|Maintenance Treatment Epoch||49
111145|NCT01925209|273485|P4|NOT COMPLETED|Treatment Epoch||5
111146|NCT01925209|273486|P3|NOT COMPLETED|Treatment Epoch||7
111147|NCT01925209|273487|P2|NOT COMPLETED|Treatment Epoch||8
111148|NCT01925209|273488|P1|NOT COMPLETED|Treatment Epoch||9
111149|NCT01925209|273485|P4|COMPLETED|Treatment Epoch||57
111150|NCT01925209|273486|P3|COMPLETED|Treatment Epoch||56
111151|NCT01925209|273487|P2|COMPLETED|Treatment Epoch||55
111152|NCT01925209|273488|P1|COMPLETED|Treatment Epoch||54
111153|NCT01925209|273485|P4|Full Analysis Set|Treatment Epoch||62
111154|NCT01925209|273486|P3|Full Analysis Set|Treatment Epoch||63
111155|NCT01925209|273487|P2|Full Analysis Set|Treatment Epoch||63
111156|NCT01925209|273488|P1|Full Analysis Set|Treatment Epoch||63
111157|NCT01925209|273485|P4|STARTED|Treatment Epoch||62
111158|NCT01925209|273486|P3|STARTED|Treatment Epoch||63
111159|NCT01925209|273487|P2|STARTED|Treatment Epoch||63
111160|NCT01925209|273488|P1|STARTED|Treatment Epoch||63
111161|NCT01925183|273520|P2|NOT COMPLETED|Overall Study||0
111162|NCT01925183|273521|P1|NOT COMPLETED|Overall Study||1
111163|NCT01925183|273520|P2|COMPLETED|Overall Study||3
111164|NCT01925183|273521|P1|COMPLETED|Overall Study||2
111165|NCT01925183|273520|P2|STARTED|Overall Study||3
111166|NCT01925183|273521|P1|STARTED|Overall Study||3
111167|NCT01925170|273529|P1|NOT COMPLETED|Overall Study||53
111168|NCT01925170|273529|P1|COMPLETED|Overall Study||1585
111169|NCT01925170|273529|P1|STARTED|Overall Study||1638
111170|NCT01925144|273547|P1|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||0
111171|NCT01925144|273547|P1|COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||30
111172|NCT01925144|273547|P1|Received 8 Doses of Omeprazole|Period 2 (At Dosing Day 3 Through Day12)||30
111173|NCT01925144|273547|P1|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day12)||30
111174|NCT01925144|273547|P1|STARTED|Period 2 (At Dosing Day 3 Through Day12)||30
111175|NCT01925144|273547|P1|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
111176|NCT01925144|273547|P1|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||30
111177|NCT01925144|273547|P1|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||30
111178|NCT01925144|273547|P1|STARTED|Period 1 (Day 1 Through Predose Day 3)||30
111179|NCT01925014|273560|P2|NOT COMPLETED|Overall Study||19
111180|NCT01925014|273561|P1|NOT COMPLETED|Overall Study||9
111181|NCT01925014|273560|P2|COMPLETED|Overall Study||1520
111182|NCT01925014|273561|P1|COMPLETED|Overall Study||1526
111183|NCT01925014|273560|P2|STARTED|Overall Study||1539
111184|NCT01925014|273561|P1|STARTED|Overall Study||1535
111185|NCT01924988|273595|P1|NOT COMPLETED|Overall Study||0
111186|NCT01924988|273595|P1|COMPLETED|Overall Study||15
111187|NCT01924988|273595|P1|STARTED|Overall Study||15
111188|NCT01924975|273607|P2|NOT COMPLETED|Overall Study||0
111189|NCT01924975|273608|P1|NOT COMPLETED|Overall Study||0
111190|NCT01924975|273607|P2|COMPLETED|Overall Study||51
111191|NCT01924975|273608|P1|COMPLETED|Overall Study||51
111192|NCT01924975|273607|P2|STARTED|Overall Study||51
111193|NCT01924975|273608|P1|STARTED|Overall Study||51
111194|NCT01924949|273618|P1|NOT COMPLETED|Overall Study||0
111195|NCT01924949|273618|P1|COMPLETED|Overall Study||5
111196|NCT01924949|273618|P1|STARTED|Overall Study||5
111197|NCT01924871|273629|P2|NOT COMPLETED|Overall Study||2
111198|NCT01924871|273630|P1|NOT COMPLETED|Overall Study||6
111199|NCT01924871|273629|P2|COMPLETED|Overall Study||29
111200|NCT01924871|273630|P1|COMPLETED|Overall Study||25
111201|NCT01924871|273629|P2|STARTED|Overall Study||31
111202|NCT01924871|273630|P1|STARTED|Overall Study||31
111203|NCT01924845|273636|P1|NOT COMPLETED|Overall Study||6
111204|NCT01924845|273636|P1|COMPLETED|Overall Study||18
111205|NCT01924845|273636|P1|STARTED|Overall Study||24
111206|NCT01924767|273649|P5|NOT COMPLETED|Overall Study||0
111207|NCT01924767|273650|P4|NOT COMPLETED|Overall Study||0
111208|NCT01924767|273651|P3|NOT COMPLETED|Overall Study||1
111209|NCT01924767|273652|P2|NOT COMPLETED|Overall Study||0
111210|NCT01924767|273653|P1|NOT COMPLETED|Overall Study||1
111211|NCT01924767|273649|P5|COMPLETED|Overall Study||9
111212|NCT01924767|273650|P4|COMPLETED|Overall Study||9
111213|NCT01924767|273651|P3|COMPLETED|Overall Study||8
111214|NCT01924767|273652|P2|COMPLETED|Overall Study||9
111215|NCT01924767|273653|P1|COMPLETED|Overall Study||11
111216|NCT01924767|273649|P5|STARTED|Overall Study||9
111217|NCT01924767|273650|P4|STARTED|Overall Study||9
111218|NCT01924767|273651|P3|STARTED|Overall Study||9
111219|NCT01924767|273652|P2|STARTED|Overall Study||9
111220|NCT01924767|273653|P1|STARTED|Overall Study||12
111221|NCT01924689|273759|P6|NOT COMPLETED|Overall Study||2
111222|NCT01924689|273760|P5|NOT COMPLETED|Overall Study||6
111223|NCT01924689|273761|P4|NOT COMPLETED|Overall Study||6
111224|NCT01924689|273762|P3|NOT COMPLETED|Overall Study||4
111225|NCT01924689|273763|P2|NOT COMPLETED|Overall Study||3
111226|NCT01924689|273764|P1|NOT COMPLETED|Overall Study||3
111227|NCT01924689|273759|P6|COMPLETED|Overall Study||0
111228|NCT01924689|273760|P5|COMPLETED|Overall Study||0
111229|NCT01924689|273761|P4|COMPLETED|Overall Study||0
111230|NCT01924689|273762|P3|COMPLETED|Overall Study||0
111231|NCT01924689|273763|P2|COMPLETED|Overall Study||0
111232|NCT01924689|273764|P1|COMPLETED|Overall Study||0
111233|NCT01924689|273759|P6|STARTED|Overall Study||2
111234|NCT01924689|273760|P5|STARTED|Overall Study||6
111235|NCT01924689|273761|P4|STARTED|Overall Study||6
111236|NCT01924689|273762|P3|STARTED|Overall Study||4
111237|NCT01924689|273763|P2|STARTED|Overall Study||3
111238|NCT01924689|273764|P1|STARTED|Overall Study||3
111239|NCT01924559|273822|P1|NOT COMPLETED|Overall Study||0
111240|NCT01924559|273822|P1|COMPLETED|Overall Study|The order in which subjects started scenarios (in biohazard gear vs street clothing) was randomized|37
111241|NCT01924559|273822|P1|STARTED|Overall Study|All 37 participants were scored under the same six scenarios, resulting in 222 observations.|37
111242|NCT01924533|273838|P2|NOT COMPLETED|Overall Study||205
111243|NCT01924533|273839|P1|NOT COMPLETED|Overall Study||189
111244|NCT01924533|273838|P2|COMPLETED|Overall Study||57
111245|NCT01924533|273839|P1|COMPLETED|Overall Study||74
111246|NCT01924533|273838|P2|STARTED|Overall Study||262
111247|NCT01924533|273839|P1|STARTED|Overall Study||263
111248|NCT01924442|273869|P2|NOT COMPLETED|Overall Study||137
111249|NCT01924442|273870|P1|NOT COMPLETED|Overall Study||40
111250|NCT01924442|273869|P2|COMPLETED|Overall Study||967
111251|NCT01924442|273870|P1|COMPLETED|Overall Study||1059
111252|NCT01924442|273869|P2|STARTED|Overall Study||1104
111253|NCT01924442|273870|P1|STARTED|Overall Study||1099
111254|NCT01924429|273880|P2|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0
111255|NCT01924429|273881|P1|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0
111256|NCT01924429|273880|P2|COMPLETED|Period 2 - Second Intervention (4 Weeks)||11
111257|NCT01924429|273881|P1|COMPLETED|Period 2 - Second Intervention (4 Weeks)||14
111258|NCT01924429|273880|P2|STARTED|Period 2 - Second Intervention (4 Weeks)||11
111259|NCT01924429|273881|P1|STARTED|Period 2 - Second Intervention (4 Weeks)||14
111260|NCT01924429|273880|P2|NOT COMPLETED|Washout Period (2 Weeks)||2
111261|NCT01924429|273881|P1|NOT COMPLETED|Washout Period (2 Weeks)||3
111262|NCT01924429|273880|P2|COMPLETED|Washout Period (2 Weeks)||11
111263|NCT01924429|273881|P1|COMPLETED|Washout Period (2 Weeks)||14
111264|NCT01924429|273880|P2|STARTED|Washout Period (2 Weeks)||13
111265|NCT01924429|273881|P1|STARTED|Washout Period (2 Weeks)||17
111266|NCT01924429|273880|P2|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0
111267|NCT01924429|273881|P1|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0
111268|NCT01924429|273880|P2|COMPLETED|Period 1 - First Intervention (4 Weeks)||13
111269|NCT01924429|273881|P1|COMPLETED|Period 1 - First Intervention (4 Weeks)||17
111270|NCT01924429|273880|P2|STARTED|Period 1 - First Intervention (4 Weeks)||13
111271|NCT01924429|273881|P1|STARTED|Period 1 - First Intervention (4 Weeks)||17
111272|NCT01924390|273913|P2|NOT COMPLETED|Overall Study||1
111273|NCT01924390|273914|P1|NOT COMPLETED|Overall Study||1
111274|NCT01924390|273913|P2|COMPLETED|Overall Study||21
111275|NCT01924390|273914|P1|COMPLETED|Overall Study||21
111276|NCT01924390|273913|P2|STARTED|Overall Study||22
111277|NCT01924390|273914|P1|STARTED|Overall Study||22
111278|NCT01924364|273924|P1|NOT COMPLETED|Overall Study||3
111279|NCT01924364|273924|P1|COMPLETED|Overall Study||4
111280|NCT01924364|273924|P1|STARTED|Overall Study||7
111281|NCT01924299|273941|P2|NOT COMPLETED|Period 2||1
111282|NCT01924299|273942|P1|NOT COMPLETED|Period 2||1
111283|NCT01924299|273941|P2|COMPLETED|Period 2||17
111284|NCT01924299|273942|P1|COMPLETED|Period 2||17
111285|NCT01924299|273941|P2|Received Baricitinib|Period 2||17
111286|NCT01924299|273942|P1|Received Baricitinib|Period 2||17
111287|NCT01924299|273941|P2|Received at Least 1 Dose of Study Drug|Period 2||18
111288|NCT01924299|273942|P1|Received at Least 1 Dose of Study Drug|Period 2||18
111289|NCT01924299|273941|P2|STARTED|Period 2||18
111290|NCT01924299|273942|P1|STARTED|Period 2||18
111291|NCT01924299|273941|P2|NOT COMPLETED|Period 1||0
111292|NCT01924299|273942|P1|NOT COMPLETED|Period 1||0
111293|NCT01924299|273941|P2|COMPLETED|Period 1||18
111294|NCT01924299|273942|P1|COMPLETED|Period 1||18
111295|NCT01924299|273941|P2|Received Baricitinib|Period 1||18
111296|NCT01924299|273942|P1|Received Baricitinib|Period 1||18
111297|NCT01924299|273941|P2|STARTED|Period 1||18
111298|NCT01924299|273942|P1|STARTED|Period 1||18
111299|NCT01924182|273964|P2|NOT COMPLETED|Overall Study||0
111300|NCT01924182|273965|P1|NOT COMPLETED|Overall Study||1
111301|NCT01924182|273964|P2|COMPLETED|Overall Study||0
111302|NCT01924182|273965|P1|COMPLETED|Overall Study||2
111303|NCT01924182|273964|P2|STARTED|Overall Study||0
111304|NCT01924182|273965|P1|STARTED|Overall Study||3
111305|NCT01924169|273977|P1|NOT COMPLETED|Overall Study||0
111306|NCT01924169|273977|P1|COMPLETED|Overall Study||3
111307|NCT01924169|273977|P1|STARTED|Overall Study||3
111308|NCT01923961|273985|P3|NOT COMPLETED|Third Intervention||0
111309|NCT01923961|273986|P2|NOT COMPLETED|Third Intervention||0
111310|NCT01923961|273987|P1|NOT COMPLETED|Third Intervention||0
111311|NCT01923961|273985|P3|COMPLETED|Third Intervention||2
111312|NCT01923961|273986|P2|COMPLETED|Third Intervention||3
111313|NCT01923961|273987|P1|COMPLETED|Third Intervention||3
111314|NCT01923961|273985|P3|STARTED|Third Intervention||2
111315|NCT01923961|273986|P2|STARTED|Third Intervention||3
111316|NCT01923961|273987|P1|STARTED|Third Intervention||3
111317|NCT01923961|273985|P3|NOT COMPLETED|Washout (1 Week)||0
111318|NCT01923961|273986|P2|NOT COMPLETED|Washout (1 Week)||0
111319|NCT01923961|273987|P1|NOT COMPLETED|Washout (1 Week)||0
111320|NCT01923961|273985|P3|COMPLETED|Washout (1 Week)||2
111321|NCT01923961|273986|P2|COMPLETED|Washout (1 Week)||3
111322|NCT01923961|273987|P1|COMPLETED|Washout (1 Week)||3
111323|NCT01923961|273985|P3|STARTED|Washout (1 Week)||2
111324|NCT01923961|273986|P2|STARTED|Washout (1 Week)||3
111325|NCT01923961|273987|P1|STARTED|Washout (1 Week)||3
111326|NCT01923961|273985|P3|NOT COMPLETED|Second Intervention||0
111327|NCT01923961|273986|P2|NOT COMPLETED|Second Intervention||0
111328|NCT01923961|273987|P1|NOT COMPLETED|Second Intervention||0
111329|NCT01923961|273985|P3|COMPLETED|Second Intervention||2
111330|NCT01923961|273986|P2|COMPLETED|Second Intervention||3
111331|NCT01923961|273987|P1|COMPLETED|Second Intervention||3
111332|NCT01923961|273985|P3|STARTED|Second Intervention||2
111333|NCT01923961|273986|P2|STARTED|Second Intervention||3
111334|NCT01923961|273987|P1|STARTED|Second Intervention||3
111335|NCT01923961|273985|P3|NOT COMPLETED|Washout (1 Week)||0
111336|NCT01923961|273986|P2|NOT COMPLETED|Washout (1 Week)||0
111337|NCT01923961|273987|P1|NOT COMPLETED|Washout (1 Week)||0
111338|NCT01923961|273985|P3|COMPLETED|Washout (1 Week)||2
111339|NCT01923961|273986|P2|COMPLETED|Washout (1 Week)||3
111340|NCT01923961|273987|P1|COMPLETED|Washout (1 Week)||3
111341|NCT01923961|273985|P3|STARTED|Washout (1 Week)||2
111342|NCT01923961|273986|P2|STARTED|Washout (1 Week)||3
111343|NCT01923961|273987|P1|STARTED|Washout (1 Week)||3
111344|NCT01923961|273985|P3|NOT COMPLETED|First Intervention||0
111345|NCT01923961|273986|P2|NOT COMPLETED|First Intervention||0
111346|NCT01923961|273987|P1|NOT COMPLETED|First Intervention||0
111347|NCT01923961|273985|P3|COMPLETED|First Intervention||2
111348|NCT01923961|273986|P2|COMPLETED|First Intervention||3
111349|NCT01923961|273987|P1|COMPLETED|First Intervention||3
111350|NCT01923961|273985|P3|STARTED|First Intervention||2
111351|NCT01923961|273986|P2|STARTED|First Intervention||3
111352|NCT01923961|273987|P1|STARTED|First Intervention||3
111353|NCT01923896|274006|P2|NOT COMPLETED|Overall Study||0
111354|NCT01923896|274007|P1|NOT COMPLETED|Overall Study||1
111355|NCT01923896|274006|P2|COMPLETED|Overall Study||8
111356|NCT01923896|274007|P1|COMPLETED|Overall Study||7
111357|NCT01923896|274006|P2|STARTED|Overall Study||8
111358|NCT01923896|274007|P1|STARTED|Overall Study||8
111359|NCT01923805|274021|P2|NOT COMPLETED|Overall Study||5
111360|NCT01923805|274022|P1|NOT COMPLETED|Overall Study||3
111361|NCT01923805|274021|P2|COMPLETED|Overall Study||0
111362|NCT01923805|274022|P1|COMPLETED|Overall Study||0
111363|NCT01923805|274021|P2|STARTED|Overall Study|early termination|5
111364|NCT01923805|274022|P1|STARTED|Overall Study|early termination|3
111365|NCT01923740|274030|P2|NOT COMPLETED|3 Year Clinical Follow-up||0
111366|NCT01923740|274031|P1|NOT COMPLETED|3 Year Clinical Follow-up||1
111367|NCT01923740|274030|P2|COMPLETED|3 Year Clinical Follow-up||225
111368|NCT01923740|274031|P1|COMPLETED|3 Year Clinical Follow-up||223
111369|NCT01923740|274030|P2|STARTED|3 Year Clinical Follow-up||225
111370|NCT01923740|274031|P1|STARTED|3 Year Clinical Follow-up||224
111371|NCT01923740|274030|P2|NOT COMPLETED|2 Year Clinical Follow-up||3
111372|NCT01923740|274031|P1|NOT COMPLETED|2 Year Clinical Follow-up||2
111373|NCT01923740|274030|P2|COMPLETED|2 Year Clinical Follow-up||225
111374|NCT01923740|274031|P1|COMPLETED|2 Year Clinical Follow-up||224
111375|NCT01923740|274030|P2|STARTED|2 Year Clinical Follow-up||228
111376|NCT01923740|274031|P1|STARTED|2 Year Clinical Follow-up||226
111377|NCT01923740|274030|P2|NOT COMPLETED|1 Year Clinical Follow-up||0
111378|NCT01923740|274031|P1|NOT COMPLETED|1 Year Clinical Follow-up||1
111379|NCT01923740|274030|P2|COMPLETED|1 Year Clinical Follow-up||228
111380|NCT01923740|274031|P1|COMPLETED|1 Year Clinical Follow-up||226
111381|NCT01923740|274030|P2|STARTED|1 Year Clinical Follow-up||228
111382|NCT01923740|274031|P1|STARTED|1 Year Clinical Follow-up||227
111383|NCT01923740|274030|P2|NOT COMPLETED|270-day Clinical Follow-up||4
111384|NCT01923740|274031|P1|NOT COMPLETED|270-day Clinical Follow-up||0
111385|NCT01923740|274030|P2|COMPLETED|270-day Clinical Follow-up||228
111386|NCT01923740|274031|P1|COMPLETED|270-day Clinical Follow-up||227
111387|NCT01923740|274030|P2|STARTED|270-day Clinical Follow-up||232
111388|NCT01923740|274031|P1|STARTED|270-day Clinical Follow-up||227
111389|NCT01923740|274030|P2|NOT COMPLETED|180-day Clinical Follow-up||0
111390|NCT01923740|274031|P1|NOT COMPLETED|180-day Clinical Follow-up||0
111391|NCT01923740|274030|P2|COMPLETED|180-day Clinical Follow-up||232
111392|NCT01923740|274031|P1|COMPLETED|180-day Clinical Follow-up||227
111393|NCT01923740|274030|P2|STARTED|180-day Clinical Follow-up||232
111394|NCT01923740|274031|P1|STARTED|180-day Clinical Follow-up||227
111395|NCT01923740|274030|P2|NOT COMPLETED|30-day Clinical Follow-up||0
111396|NCT01923740|274031|P1|NOT COMPLETED|30-day Clinical Follow-up||0
111397|NCT01923740|274030|P2|COMPLETED|30-day Clinical Follow-up||232
111398|NCT01923740|274031|P1|COMPLETED|30-day Clinical Follow-up||227
111399|NCT01923740|274030|P2|STARTED|30-day Clinical Follow-up|Per-treatment-evaluable (PTE) population|232
111400|NCT01923740|274031|P1|STARTED|30-day Clinical Follow-up|Per-treatment-evaluable (PTE) population|227
111401|NCT01923480|274248|P6|NOT COMPLETED|Period 2 (Hours 1-7)||0
111402|NCT01923480|274249|P5|NOT COMPLETED|Period 2 (Hours 1-7)||0
111403|NCT01923480|274250|P4|NOT COMPLETED|Period 2 (Hours 1-7)||0
111404|NCT01923480|274251|P3|NOT COMPLETED|Period 2 (Hours 1-7)||0
111405|NCT01923480|274252|P2|NOT COMPLETED|Period 2 (Hours 1-7)||0
111406|NCT01923480|274253|P1|NOT COMPLETED|Period 2 (Hours 1-7)||0
111407|NCT01923480|274248|P6|COMPLETED|Period 2 (Hours 1-7)||2
111408|NCT01923480|274249|P5|COMPLETED|Period 2 (Hours 1-7)||2
111409|NCT01923480|274250|P4|COMPLETED|Period 2 (Hours 1-7)||2
111410|NCT01923480|274251|P3|COMPLETED|Period 2 (Hours 1-7)||2
111411|NCT01923480|274252|P2|COMPLETED|Period 2 (Hours 1-7)||1
111412|NCT01923480|274253|P1|COMPLETED|Period 2 (Hours 1-7)||1
111413|NCT01923480|274248|P6|STARTED|Period 2 (Hours 1-7)||2
111414|NCT01923480|274249|P5|STARTED|Period 2 (Hours 1-7)||2
111415|NCT01923480|274250|P4|STARTED|Period 2 (Hours 1-7)||2
111416|NCT01923480|274251|P3|STARTED|Period 2 (Hours 1-7)||2
111417|NCT01923480|274252|P2|STARTED|Period 2 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|1
111418|NCT01923480|274253|P1|STARTED|Period 2 (Hours 1-7)||1
111419|NCT01923480|274248|P6|NOT COMPLETED|Period 1 (Hours 1-7)||0
111420|NCT01923480|274249|P5|NOT COMPLETED|Period 1 (Hours 1-7)||0
111421|NCT01923480|274250|P4|NOT COMPLETED|Period 1 (Hours 1-7)||0
111422|NCT01923480|274251|P3|NOT COMPLETED|Period 1 (Hours 1-7)||0
111423|NCT01923480|274252|P2|NOT COMPLETED|Period 1 (Hours 1-7)||0
111424|NCT01923480|274253|P1|NOT COMPLETED|Period 1 (Hours 1-7)||0
111425|NCT01923480|274248|P6|COMPLETED|Period 1 (Hours 1-7)||2
111426|NCT01923480|274249|P5|COMPLETED|Period 1 (Hours 1-7)||2
111427|NCT01923480|274250|P4|COMPLETED|Period 1 (Hours 1-7)||2
111428|NCT01923480|274251|P3|COMPLETED|Period 1 (Hours 1-7)||2
111429|NCT01923480|274252|P2|COMPLETED|Period 1 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|2
111430|NCT01923480|274253|P1|COMPLETED|Period 1 (Hours 1-7)||1
111431|NCT01923480|274248|P6|STARTED|Period 1 (Hours 1-7)||2
111432|NCT01923480|274249|P5|STARTED|Period 1 (Hours 1-7)||2
111433|NCT01923480|274250|P4|STARTED|Period 1 (Hours 1-7)||2
111434|NCT01923480|274251|P3|STARTED|Period 1 (Hours 1-7)||2
111435|NCT01923480|274252|P2|STARTED|Period 1 (Hours 1-7)||2
111436|NCT01923480|274253|P1|STARTED|Period 1 (Hours 1-7)||1
111437|NCT01923467|274408|P1|NOT COMPLETED|Overall Study||541
111438|NCT01923467|274408|P1|COMPLETED|Overall Study|Completed 3-month follow up survey|226
111439|NCT01923467|274408|P1|Baseline Completed, Enrolled|Overall Study||288
111440|NCT01923467|274408|P1|STARTED|Overall Study|Offered stop smoking program|767
111441|NCT01923389|274414|P2|NOT COMPLETED|Overall Study||0
111442|NCT01923389|274415|P1|NOT COMPLETED|Overall Study||1
111443|NCT01923389|274414|P2|COMPLETED|Overall Study||2
111444|NCT01923389|274415|P1|COMPLETED|Overall Study||1
111445|NCT01923389|274414|P2|STARTED|Overall Study||2
111446|NCT01923389|274415|P1|STARTED|Overall Study||2
111447|NCT01923363|274437|P1|NOT COMPLETED|Overall Study||1
111448|NCT01923363|274437|P1|COMPLETED|Overall Study||28
111449|NCT01923363|274437|P1|STARTED|Overall Study||29
111450|NCT01923311|274446|P2|NOT COMPLETED|Overall Study||1
111451|NCT01923311|274447|P1|NOT COMPLETED|Overall Study||17
111452|NCT01923311|274446|P2|COMPLETED|Overall Study||13
111453|NCT01923311|274447|P1|COMPLETED|Overall Study||0
111454|NCT01923311|274446|P2|STARTED|Overall Study||14
111455|NCT01923311|274447|P1|STARTED|Overall Study||17
111456|NCT01923181|274499|P9|NOT COMPLETED|Overall Study||3
111457|NCT01923181|274500|P8|NOT COMPLETED|Overall Study||9
111458|NCT01923181|274501|P7|NOT COMPLETED|Overall Study||8
111459|NCT01923181|274502|P6|NOT COMPLETED|Overall Study||4
111460|NCT01923181|274503|P5|NOT COMPLETED|Overall Study||8
111461|NCT01923181|274504|P4|NOT COMPLETED|Overall Study||5
111462|NCT01923181|274505|P3|NOT COMPLETED|Overall Study||3
111463|NCT01923181|274506|P2|NOT COMPLETED|Overall Study||6
111464|NCT01923181|274507|P1|NOT COMPLETED|Overall Study||3
111465|NCT01923181|274499|P9|COMPLETED|Overall Study||68
111466|NCT01923181|274500|P8|COMPLETED|Overall Study||61
111467|NCT01923181|274501|P7|COMPLETED|Overall Study||62
111468|NCT01923181|274502|P6|COMPLETED|Overall Study||66
111469|NCT01923181|274503|P5|COMPLETED|Overall Study||63
111470|NCT01923181|274504|P4|COMPLETED|Overall Study||65
111471|NCT01923181|274505|P3|COMPLETED|Overall Study||67
111472|NCT01923181|274506|P2|COMPLETED|Overall Study||64
111473|NCT01923181|274507|P1|COMPLETED|Overall Study||67
111474|NCT01923181|274499|P9|STARTED|Overall Study||71
111475|NCT01923181|274500|P8|STARTED|Overall Study||70
111476|NCT01923181|274501|P7|STARTED|Overall Study||70
111477|NCT01923181|274502|P6|STARTED|Overall Study||70
111478|NCT01923181|274503|P5|STARTED|Overall Study||71
111479|NCT01923181|274504|P4|STARTED|Overall Study||70
111480|NCT01923181|274505|P3|STARTED|Overall Study||70
111481|NCT01923181|274506|P2|STARTED|Overall Study||70
111482|NCT01923181|274507|P1|STARTED|Overall Study||70
111483|NCT01923168|274585|P3|NOT COMPLETED|Overall Study||17
111484|NCT01923168|274586|P2|NOT COMPLETED|Overall Study||39
111485|NCT01923168|274587|P1|NOT COMPLETED|Overall Study||37
111486|NCT01923168|274585|P3|COMPLETED|Overall Study||109
111487|NCT01923168|274586|P2|COMPLETED|Overall Study||44
111488|NCT01923168|274587|P1|COMPLETED|Overall Study||94
111489|NCT01923168|274585|P3|STARTED|Overall Study||126
111490|NCT01923168|274586|P2|STARTED|Overall Study||83
111491|NCT01923168|274587|P1|STARTED|Overall Study||131
111492|NCT01923129|274646|P2|NOT COMPLETED|Overall Study||0
111493|NCT01923129|274647|P1|NOT COMPLETED|Overall Study||0
111494|NCT01923129|274646|P2|COMPLETED|Overall Study||71
111495|NCT01923129|274647|P1|COMPLETED|Overall Study||71
111496|NCT01923129|274646|P2|STARTED|Overall Study||71
111497|NCT01923129|274647|P1|STARTED|Overall Study||71
111498|NCT01922986|274657|P2|NOT COMPLETED|Overall Study||0
111499|NCT01922986|274658|P1|NOT COMPLETED|Overall Study||0
111500|NCT01922986|274657|P2|COMPLETED|Overall Study||2
111501|NCT01922986|274658|P1|COMPLETED|Overall Study||2
111502|NCT01922986|274657|P2|STARTED|Overall Study||2
111503|NCT01922986|274658|P1|STARTED|Overall Study||2
111504|NCT01922934|274670|P2|NOT COMPLETED|Visit 12 / Final Visits||290
111505|NCT01922934|274671|P1|NOT COMPLETED|Visit 12 / Final Visits||6
111506|NCT01922934|274670|P2|COMPLETED|Visit 12 / Final Visits|290 patients did not have a second weight recorded at one year (+/- 6months) of first weight|2640
111507|NCT01922934|274671|P1|COMPLETED|Visit 12 / Final Visits|6 patients did not return for final visit and weight measure|113
111508|NCT01922934|274670|P2|STARTED|Visit 12 / Final Visits||2930
111509|NCT01922934|274671|P1|STARTED|Visit 12 / Final Visits||119
111510|NCT01922934|274670|P2|NOT COMPLETED|Visit 1- Weight Measured||1284
111511|NCT01922934|274671|P1|NOT COMPLETED|Visit 1- Weight Measured||21
111512|NCT01922934|274670|P2|COMPLETED|Visit 1- Weight Measured|1284 patients did not have any weights recorded in EMR during study timeframe|2930
111513|NCT01922934|274671|P1|COMPLETED|Visit 1- Weight Measured|Patients first received tool and were weighed at Visit 1|119
111514|NCT01922934|274670|P2|STARTED|Visit 1- Weight Measured||4214
111515|NCT01922934|274671|P1|STARTED|Visit 1- Weight Measured|21 patients did not return for Visit 1 to receive tool or have weight measured.|140
111516|NCT01922934|274670|P2|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||0
111517|NCT01922934|274671|P1|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||235
111518|NCT01922934|274670|P2|COMPLETED|Visit 0 - Patient Contacted & Consented||4214
111519|NCT01922934|274671|P1|COMPLETED|Visit 0 - Patient Contacted & Consented|reflects number of patients that were contacted and agreed to attend Visit 0|140
111520|NCT01922934|274670|P2|STARTED|Visit 0 - Patient Contacted & Consented|Control group patients were not contacted or offered intervention|4214
111521|NCT01922934|274671|P1|STARTED|Visit 0 - Patient Contacted & Consented||375
111522|NCT01922934|274670|P2|NOT COMPLETED|Eligible Patients||88
111523|NCT01922934|274671|P1|NOT COMPLETED|Eligible Patients||53
111524|NCT01922934|274670|P2|COMPLETED|Eligible Patients|81 patients did not meet inclusion criteria as they were 80 years or older. 7 patients had died.|4214
111525|NCT01922934|274671|P1|COMPLETED|Eligible Patients|375 patients determined eligible after original random selection from DHHA data warehouse.|375
111526|NCT01922934|274670|P2|STARTED|Eligible Patients||4302
111527|NCT01922934|274671|P1|STARTED|Eligible Patients||428
111528|NCT01922739|274683|P1|NOT COMPLETED|Open-label Treatment Period||34
111529|NCT01922739|274683|P1|COMPLETED|Open-label Treatment Period||136
111530|NCT01922739|274683|P1|Treatment SAS and FAS|Open-label Treatment Period|SAS = safety analysis set FAS = full analysis set|170
111531|NCT01922739|274683|P1|STARTED|Open-label Treatment Period||170
111532|NCT01922739|274683|P1|NOT COMPLETED|Titration/Adjustment Period||12
111533|NCT01922739|274683|P1|COMPLETED|Titration/Adjustment Period||170
111534|NCT01922739|274683|P1|Safety Analysis Set|Titration/Adjustment Period||182
111535|NCT01922739|274683|P1|STARTED|Titration/Adjustment Period||182
111536|NCT01922349|274712|P4|NOT COMPLETED|Multiple Rising Dose (MRD) Period||1
111537|NCT01922349|274713|P3|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
111538|NCT01922349|274714|P2|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
111539|NCT01922349|274715|P1|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
111540|NCT01922349|274712|P4|COMPLETED|Multiple Rising Dose (MRD) Period||26
111541|NCT01922349|274713|P3|COMPLETED|Multiple Rising Dose (MRD) Period||18
111542|NCT01922349|274714|P2|COMPLETED|Multiple Rising Dose (MRD) Period||27
111543|NCT01922349|274715|P1|COMPLETED|Multiple Rising Dose (MRD) Period||24
111544|NCT01922349|274712|P4|STARTED|Multiple Rising Dose (MRD) Period||27
111545|NCT01922349|274713|P3|STARTED|Multiple Rising Dose (MRD) Period||18
111546|NCT01922349|274714|P2|STARTED|Multiple Rising Dose (MRD) Period||27
111547|NCT01922349|274715|P1|STARTED|Multiple Rising Dose (MRD) Period|One subject discontinued the trial after the SRD period due to non-compliance with the protocol.|24
111548|NCT01922349|274712|P4|NOT COMPLETED|Single Rising Dose (SRD) Period||0
111549|NCT01922349|274713|P3|NOT COMPLETED|Single Rising Dose (SRD) Period||0
111550|NCT01922349|274714|P2|NOT COMPLETED|Single Rising Dose (SRD) Period||0
111551|NCT01922349|274715|P1|NOT COMPLETED|Single Rising Dose (SRD) Period||0
111552|NCT01922349|274712|P4|COMPLETED|Single Rising Dose (SRD) Period||27
111553|NCT01922349|274713|P3|COMPLETED|Single Rising Dose (SRD) Period||18
111554|NCT01922349|274714|P2|COMPLETED|Single Rising Dose (SRD) Period||27
111555|NCT01922349|274715|P1|COMPLETED|Single Rising Dose (SRD) Period||25
111556|NCT01922349|274712|P4|STARTED|Single Rising Dose (SRD) Period||27
111557|NCT01922349|274713|P3|STARTED|Single Rising Dose (SRD) Period||18
111558|NCT01922349|274714|P2|STARTED|Single Rising Dose (SRD) Period||27
111559|NCT01922349|274715|P1|STARTED|Single Rising Dose (SRD) Period||25
111560|NCT01922336|274823|P3|NOT COMPLETED|Overall Study||0
111561|NCT01922336|274824|P2|NOT COMPLETED|Overall Study||0
111562|NCT01922336|274825|P1|NOT COMPLETED|Overall Study||0
111563|NCT01922336|274823|P3|COMPLETED|Overall Study||53
111564|NCT01922336|274824|P2|COMPLETED|Overall Study||53
111565|NCT01922336|274825|P1|COMPLETED|Overall Study||53
111566|NCT01922336|274823|P3|STARTED|Overall Study||53
111567|NCT01922336|274824|P2|STARTED|Overall Study||53
111568|NCT01922336|274825|P1|STARTED|Overall Study||53
111569|NCT01922271|274844|P2|NOT COMPLETED|PERIOD 2||0
111570|NCT01922271|274845|P1|NOT COMPLETED|PERIOD 2||0
111571|NCT01922271|274844|P2|COMPLETED|PERIOD 2||76
111572|NCT01922271|274845|P1|COMPLETED|PERIOD 2||75
111573|NCT01922271|274844|P2|STARTED|PERIOD 2||76
111574|NCT01922271|274845|P1|STARTED|PERIOD 2||75
111575|NCT01922271|274844|P2|NOT COMPLETED|WASHOUT Period||0
111576|NCT01922271|274845|P1|NOT COMPLETED|WASHOUT Period||1
111577|NCT01922271|274844|P2|COMPLETED|WASHOUT Period||76
111578|NCT01922271|274845|P1|COMPLETED|WASHOUT Period||75
111579|NCT01922271|274844|P2|STARTED|WASHOUT Period||76
111580|NCT01922271|274845|P1|STARTED|WASHOUT Period||76
111581|NCT01922271|274844|P2|NOT COMPLETED|PERIOD 1||0
111582|NCT01922271|274845|P1|NOT COMPLETED|PERIOD 1||0
111583|NCT01922271|274844|P2|COMPLETED|PERIOD 1||76
111584|NCT01922271|274845|P1|COMPLETED|PERIOD 1||76
111585|NCT01922271|274844|P2|STARTED|PERIOD 1||76
111586|NCT01922271|274845|P1|STARTED|PERIOD 1||76
111587|NCT01922219|274863|P1|NOT COMPLETED|Overall Study||9
111588|NCT01922219|274863|P1|COMPLETED|Overall Study||28
111589|NCT01922219|274863|P1|STARTED|Overall Study||37
111590|NCT01922115|274871|P2|NOT COMPLETED|Overall Study||7
111591|NCT01922115|274872|P1|NOT COMPLETED|Overall Study||7
111592|NCT01922115|274871|P2|COMPLETED|Overall Study||24
111593|NCT01922115|274872|P1|COMPLETED|Overall Study||21
111594|NCT01922115|274871|P2|STARTED|Overall Study||31
111595|NCT01922115|274872|P1|STARTED|Overall Study||28
111596|NCT01922102|274887|P3|NOT COMPLETED|Overall Study||8
111597|NCT01922102|274888|P2|NOT COMPLETED|Overall Study||9
111598|NCT01922102|274889|P1|NOT COMPLETED|Overall Study||9
111599|NCT01922102|274887|P3|COMPLETED|Overall Study||83
111600|NCT01922102|274888|P2|COMPLETED|Overall Study||175
111601|NCT01922102|274889|P1|COMPLETED|Overall Study||173
111602|NCT01922102|274887|P3|STARTED|Overall Study||91
111603|NCT01922102|274888|P2|STARTED|Overall Study||184
111604|NCT01922102|274889|P1|STARTED|Overall Study||182
111605|NCT01922089|274925|P2|NOT COMPLETED|Overall Study||30
111606|NCT01922089|274926|P1|NOT COMPLETED|Overall Study||39
111607|NCT01922089|274925|P2|COMPLETED|Overall Study||221
111608|NCT01922089|274926|P1|COMPLETED|Overall Study||208
111609|NCT01922089|274925|P2|Safety Set|Overall Study||251
111610|NCT01922089|274926|P1|Safety Set|Overall Study||246
111611|NCT01922089|274925|P2|STARTED|Overall Study||251
111612|NCT01922089|274926|P1|STARTED|Overall Study||247
111613|NCT01922050|274950|P14|NOT COMPLETED|Part 2 Double-blind Phase||3
111614|NCT01922050|274951|P13|NOT COMPLETED|Part 2 Double-blind Phase||0
111615|NCT01922050|274952|P12|NOT COMPLETED|Part 2 Double-blind Phase||2
111616|NCT01922050|274953|P11|NOT COMPLETED|Part 2 Double-blind Phase||1
111617|NCT01922050|274954|P10|NOT COMPLETED|Part 2 Double-blind Phase||0
111618|NCT01922050|274955|P9|NOT COMPLETED|Part 2 Double-blind Phase||0
111619|NCT01922050|274956|P8|NOT COMPLETED|Part 2 Double-blind Phase||0
111620|NCT01922050|274957|P7|NOT COMPLETED|Part 2 Double-blind Phase||0
111621|NCT01922050|274958|P6|NOT COMPLETED|Part 2 Double-blind Phase||0
111622|NCT01922050|274959|P5|NOT COMPLETED|Part 2 Double-blind Phase||0
111623|NCT01922050|274960|P4|NOT COMPLETED|Part 2 Double-blind Phase||0
111624|NCT01922050|274961|P3|NOT COMPLETED|Part 2 Double-blind Phase||0
111625|NCT01922050|274962|P2|NOT COMPLETED|Part 2 Double-blind Phase||0
111626|NCT01922050|274963|P1|NOT COMPLETED|Part 2 Double-blind Phase||0
111627|NCT01922050|274950|P14|COMPLETED|Part 2 Double-blind Phase||56
111628|NCT01922050|274951|P13|COMPLETED|Part 2 Double-blind Phase||62
111629|NCT01922050|274952|P12|COMPLETED|Part 2 Double-blind Phase||58
111630|NCT01922050|274953|P11|COMPLETED|Part 2 Double-blind Phase||61
111631|NCT01922050|274954|P10|COMPLETED|Part 2 Double-blind Phase||0
111632|NCT01922050|274955|P9|COMPLETED|Part 2 Double-blind Phase||0
111633|NCT01922050|274956|P8|COMPLETED|Part 2 Double-blind Phase||0
111634|NCT01922050|274957|P7|COMPLETED|Part 2 Double-blind Phase||0
111635|NCT01922050|274958|P6|COMPLETED|Part 2 Double-blind Phase||0
111636|NCT01922050|274959|P5|COMPLETED|Part 2 Double-blind Phase||0
111637|NCT01922050|274960|P4|COMPLETED|Part 2 Double-blind Phase||0
111638|NCT01922050|274961|P3|COMPLETED|Part 2 Double-blind Phase||0
111639|NCT01922050|274962|P2|COMPLETED|Part 2 Double-blind Phase||0
111640|NCT01922050|274963|P1|COMPLETED|Part 2 Double-blind Phase||0
111641|NCT01922050|274950|P14|STARTED|Part 2 Double-blind Phase||59
111642|NCT01922050|274951|P13|STARTED|Part 2 Double-blind Phase||62
111643|NCT01922050|274952|P12|STARTED|Part 2 Double-blind Phase||60
111644|NCT01922050|274953|P11|STARTED|Part 2 Double-blind Phase||62
111645|NCT01922050|274954|P10|STARTED|Part 2 Double-blind Phase||0
111646|NCT01922050|274955|P9|STARTED|Part 2 Double-blind Phase||0
111647|NCT01922050|274956|P8|STARTED|Part 2 Double-blind Phase||0
111648|NCT01922050|274957|P7|STARTED|Part 2 Double-blind Phase||0
111649|NCT01922050|274958|P6|STARTED|Part 2 Double-blind Phase||0
111650|NCT01922050|274959|P5|STARTED|Part 2 Double-blind Phase||0
111651|NCT01922050|274960|P4|STARTED|Part 2 Double-blind Phase||0
111652|NCT01922050|274961|P3|STARTED|Part 2 Double-blind Phase||0
111653|NCT01922050|274962|P2|STARTED|Part 2 Double-blind Phase||0
111654|NCT01922050|274963|P1|STARTED|Part 2 Double-blind Phase||0
111655|NCT01922050|274950|P14|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
111656|NCT01922050|274951|P13|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
111657|NCT01922050|274952|P12|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
111658|NCT01922050|274953|P11|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
111659|NCT01922050|274954|P10|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
111660|NCT01922050|274955|P9|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
111661|NCT01922050|274956|P8|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
111662|NCT01922050|274957|P7|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
111663|NCT01922050|274958|P6|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
111664|NCT01922050|274959|P5|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
111665|NCT01922050|274960|P4|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
111666|NCT01922050|274961|P3|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
111667|NCT01922050|274962|P2|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
111668|NCT01922050|274963|P1|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
111669|NCT01922050|274950|P14|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
111670|NCT01922050|274951|P13|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
111671|NCT01922050|274952|P12|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
111672|NCT01922050|274953|P11|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
111673|NCT01922050|274954|P10|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
111674|NCT01922050|274955|P9|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
111675|NCT01922050|274956|P8|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
111676|NCT01922050|274957|P7|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
111677|NCT01922050|274958|P6|COMPLETED|Part 1 Open-label, Dose-escalation Phase||18
111678|NCT01922050|274959|P5|COMPLETED|Part 1 Open-label, Dose-escalation Phase||17
111679|NCT01922050|274960|P4|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
111680|NCT01922050|274961|P3|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
111681|NCT01922050|274962|P2|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
111682|NCT01922050|274963|P1|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
111683|NCT01922050|274950|P14|STARTED|Part 1 Open-label, Dose-escalation Phase||0
111684|NCT01922050|274951|P13|STARTED|Part 1 Open-label, Dose-escalation Phase||0
111685|NCT01922050|274952|P12|STARTED|Part 1 Open-label, Dose-escalation Phase||0
111686|NCT01922050|274953|P11|STARTED|Part 1 Open-label, Dose-escalation Phase||0
111687|NCT01922050|274954|P10|STARTED|Part 1 Open-label, Dose-escalation Phase||12
111688|NCT01922050|274955|P9|STARTED|Part 1 Open-label, Dose-escalation Phase||6
111689|NCT01922050|274956|P8|STARTED|Part 1 Open-label, Dose-escalation Phase||3
111690|NCT01922050|274957|P7|STARTED|Part 1 Open-label, Dose-escalation Phase||3
111691|NCT01922050|274958|P6|STARTED|Part 1 Open-label, Dose-escalation Phase||18
111692|NCT01922050|274959|P5|STARTED|Part 1 Open-label, Dose-escalation Phase||17
111693|NCT01922050|274960|P4|STARTED|Part 1 Open-label, Dose-escalation Phase||6
111694|NCT01922050|274961|P3|STARTED|Part 1 Open-label, Dose-escalation Phase||6
111695|NCT01922050|274962|P2|STARTED|Part 1 Open-label, Dose-escalation Phase||3
111696|NCT01922050|274963|P1|STARTED|Part 1 Open-label, Dose-escalation Phase||3
111697|NCT01922037|275003|P2|NOT COMPLETED|Overall Study||174
111698|NCT01922037|275004|P1|NOT COMPLETED|Overall Study||10
111699|NCT01922037|275003|P2|COMPLETED|Overall Study||563
111700|NCT01922037|275004|P1|COMPLETED|Overall Study||59
111701|NCT01922037|275003|P2|Treated|Overall Study||732
111702|NCT01922037|275004|P1|Treated|Overall Study||69
111703|NCT01922037|275003|P2|STARTED|Overall Study||737
111704|NCT01922037|275004|P1|STARTED|Overall Study||69
111705|NCT01922024|275098|P2|NOT COMPLETED|Overall Study||0
111706|NCT01922024|275099|P1|NOT COMPLETED|Overall Study||0
111707|NCT01922024|275098|P2|COMPLETED|Overall Study||471
111708|NCT01922024|275099|P1|COMPLETED|Overall Study||1653
111709|NCT01922024|275098|P2|STARTED|Overall Study||471
111710|NCT01922024|275099|P1|STARTED|Overall Study||1653
111711|NCT01922011|275107|P2|NOT COMPLETED|Overall Study||5
111712|NCT01922011|275108|P1|NOT COMPLETED|Overall Study||6
111713|NCT01922011|275107|P2|COMPLETED|Overall Study||69
111714|NCT01922011|275108|P1|COMPLETED|Overall Study||69
111715|NCT01922011|275107|P2|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|72
111716|NCT01922011|275108|P1|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|74
111717|NCT01922011|275107|P2|Treated|Overall Study|Treated Participants|73
111718|NCT01922011|275108|P1|Treated|Overall Study|Treated Participants|73
111719|NCT01922011|275107|P2|STARTED|Overall Study|Randomized participants|74
111720|NCT01922011|275108|P1|STARTED|Overall Study|Randomized participants|75
111721|NCT01921894|275151|P3|NOT COMPLETED|Overall Study||0
111722|NCT01921894|275152|P2|NOT COMPLETED|Overall Study||0
111723|NCT01921894|275153|P1|NOT COMPLETED|Overall Study||0
111724|NCT01921894|275151|P3|COMPLETED|Overall Study||8
111725|NCT01921894|275152|P2|COMPLETED|Overall Study||8
111726|NCT01921894|275153|P1|COMPLETED|Overall Study||8
111727|NCT01921894|275151|P3|STARTED|Overall Study||8
111728|NCT01921894|275152|P2|STARTED|Overall Study||8
111729|NCT01921894|275153|P1|STARTED|Overall Study||8
111730|NCT01921829|275175|P2|NOT COMPLETED|Overall Study||1
111731|NCT01921829|275176|P1|NOT COMPLETED|Overall Study||0
111732|NCT01921829|275175|P2|COMPLETED|Overall Study||8
111733|NCT01921829|275176|P1|COMPLETED|Overall Study||10
111734|NCT01921829|275175|P2|STARTED|Overall Study||9
111735|NCT01921829|275176|P1|STARTED|Overall Study||10
111736|NCT01921751|275225|P3|NOT COMPLETED|Overall Study||0
111737|NCT01921751|275226|P2|NOT COMPLETED|Overall Study||0
111738|NCT01921751|275227|P1|NOT COMPLETED|Overall Study||0
111739|NCT01921751|275225|P3|COMPLETED|Overall Study|All randomized patients are reported here.|5
111740|NCT01921751|275226|P2|COMPLETED|Overall Study|All randomized patients are reported here.|4
111741|NCT01921751|275227|P1|COMPLETED|Overall Study|All randomized patients are reported here.|4
111742|NCT01921751|275225|P3|STARTED|Overall Study||5
111743|NCT01921751|275226|P2|STARTED|Overall Study||4
111744|NCT01921751|275227|P1|STARTED|Overall Study||4
111745|NCT01921517|275247|P2|NOT COMPLETED|Overall Study||9
111746|NCT01921517|275248|P1|NOT COMPLETED|Overall Study||15
111747|NCT01921517|275247|P2|COMPLETED|Overall Study||29
111748|NCT01921517|275248|P1|COMPLETED|Overall Study||27
111749|NCT01921517|275247|P2|STARTED|Overall Study||38
111750|NCT01921517|275248|P1|STARTED|Overall Study||42
111751|NCT01921452|275254|P1|NOT COMPLETED|Overall Study||0
111752|NCT01921452|275254|P1|COMPLETED|Overall Study||283
111753|NCT01921452|275254|P1|STARTED|Overall Study||283
111754|NCT01921387|275259|P1|NOT COMPLETED|Overall Study||1
111755|NCT01921387|275259|P1|COMPLETED|Overall Study||19
111756|NCT01921387|275259|P1|STARTED|Overall Study||20
111757|NCT01921348|275268|P2|NOT COMPLETED|Overall Study||2
111758|NCT01921348|275269|P1|NOT COMPLETED|Overall Study||1
111759|NCT01921348|275268|P2|COMPLETED|Overall Study||7
111760|NCT01921348|275269|P1|COMPLETED|Overall Study||8
111761|NCT01921348|275268|P2|STARTED|Overall Study||9
111762|NCT01921348|275269|P1|STARTED|Overall Study||9
111763|NCT01921322|275281|P2|NOT COMPLETED|Overall Study||17
111764|NCT01921322|275282|P1|NOT COMPLETED|Overall Study||15
111765|NCT01921322|275281|P2|COMPLETED|Overall Study||44
111766|NCT01921322|275282|P1|COMPLETED|Overall Study||42
111767|NCT01921322|275281|P2|STARTED|Overall Study||61
111768|NCT01921322|275282|P1|STARTED|Overall Study||57
111769|NCT01921296|275290|P1|NOT COMPLETED|Overall Study||0
111770|NCT01921296|275290|P1|COMPLETED|Overall Study||2
111771|NCT01921296|275290|P1|STARTED|Overall Study||2
111772|NCT01921270|275298|P1|NOT COMPLETED|Overall Study||1
111773|NCT01921270|275298|P1|COMPLETED|Overall Study||17
111774|NCT01921270|275298|P1|STARTED|Overall Study||18
111775|NCT01921257|275314|P1|NOT COMPLETED|Overall Study||3
111776|NCT01921257|275314|P1|COMPLETED|Overall Study||13
111777|NCT01921257|275314|P1|Active Treatment|Overall Study||13
111778|NCT01921257|275314|P1|Placebo run-in|Overall Study||16
111779|NCT01921257|275314|P1|STARTED|Overall Study||16
111780|NCT01921205|275321|P2|NOT COMPLETED|Overall Study||20
111781|NCT01921205|275322|P1|NOT COMPLETED|Overall Study||21
111782|NCT01921205|275321|P2|COMPLETED|Overall Study||151
111783|NCT01921205|275322|P1|COMPLETED|Overall Study||151
111784|NCT01921205|275321|P2|STARTED|Overall Study||171
111785|NCT01921205|275322|P1|STARTED|Overall Study||172
111786|NCT01921166|275352|P2|NOT COMPLETED|Overall Study||0
111787|NCT01921166|275353|P1|NOT COMPLETED|Overall Study||0
111788|NCT01921166|275352|P2|COMPLETED|Overall Study||15
111789|NCT01921166|275353|P1|COMPLETED|Overall Study||8
111790|NCT01921166|275352|P2|STARTED|Overall Study||15
111791|NCT01921166|275353|P1|STARTED|Overall Study||8
111792|NCT01921114|275363|P2|NOT COMPLETED|Overall Study||0
111793|NCT01921114|275364|P1|NOT COMPLETED|Overall Study||0
111794|NCT01921114|275363|P2|COMPLETED|Overall Study||0
111795|NCT01921114|275364|P1|COMPLETED|Overall Study||0
111796|NCT01921114|275363|P2|STARTED|Overall Study||0
111797|NCT01921114|275364|P1|STARTED|Overall Study||0
111798|NCT01921101|275374|P2|NOT COMPLETED|Overall Study||6
111799|NCT01921101|275375|P1|NOT COMPLETED|Overall Study||16
111800|NCT01921101|275374|P2|COMPLETED|Overall Study||32
111801|NCT01921101|275375|P1|COMPLETED|Overall Study||24
111802|NCT01921101|275374|P2|STARTED|Overall Study||38
111803|NCT01921101|275375|P1|STARTED|Overall Study||40
111804|NCT01920958|275383|P1|NOT COMPLETED|Overall Study||5
111805|NCT01920958|275383|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|228
111806|NCT01920958|275383|P1|STARTED|Overall Study||233
111807|NCT01920893|275401|P2|NOT COMPLETED|Overall Study||2
111808|NCT01920893|275402|P1|NOT COMPLETED|Overall Study||7
111809|NCT01920893|275401|P2|COMPLETED|Overall Study||28
111810|NCT01920893|275402|P1|COMPLETED|Overall Study||23
111811|NCT01920893|275401|P2|Treated (Safety Population)|Overall Study||30
111812|NCT01920893|275402|P1|Treated (Safety Population)|Overall Study||30
111813|NCT01920893|275401|P2|STARTED|Overall Study||30
111814|NCT01920893|275402|P1|STARTED|Overall Study||30
111815|NCT01920854|275435|P7|NOT COMPLETED|Overall Study||1
111816|NCT01920854|275436|P6|NOT COMPLETED|Overall Study||0
111817|NCT01920854|275437|P5|NOT COMPLETED|Overall Study||1
111818|NCT01920854|275438|P4|NOT COMPLETED|Overall Study||0
111819|NCT01920854|275439|P3|NOT COMPLETED|Overall Study||0
111820|NCT01920854|275440|P2|NOT COMPLETED|Overall Study||0
111821|NCT01920854|275441|P1|NOT COMPLETED|Overall Study||1
111822|NCT01920854|275435|P7|COMPLETED|Overall Study||5
111823|NCT01920854|275436|P6|COMPLETED|Overall Study||6
111824|NCT01920854|275437|P5|COMPLETED|Overall Study||5
111825|NCT01920854|275438|P4|COMPLETED|Overall Study||6
111826|NCT01920854|275439|P3|COMPLETED|Overall Study||6
111827|NCT01920854|275440|P2|COMPLETED|Overall Study||6
111828|NCT01920854|275441|P1|COMPLETED|Overall Study||11
111829|NCT01920854|275435|P7|STARTED|Overall Study||6
111830|NCT01920854|275436|P6|STARTED|Overall Study||6
111831|NCT01920854|275437|P5|STARTED|Overall Study||6
111832|NCT01920854|275438|P4|STARTED|Overall Study||6
111833|NCT01920854|275439|P3|STARTED|Overall Study||6
111834|NCT01920854|275440|P2|STARTED|Overall Study||6
111835|NCT01920854|275441|P1|STARTED|Overall Study||12
111836|NCT01920802|275568|P3|NOT COMPLETED|Overall Study||1
111837|NCT01920802|275569|P2|NOT COMPLETED|Overall Study||2
111838|NCT01920802|275570|P1|NOT COMPLETED|Overall Study||4
111839|NCT01920802|275568|P3|COMPLETED|Overall Study||10
111840|NCT01920802|275569|P2|COMPLETED|Overall Study||7
111841|NCT01920802|275570|P1|COMPLETED|Overall Study||7
111842|NCT01920802|275568|P3|STARTED|Overall Study||11
111843|NCT01920802|275569|P2|STARTED|Overall Study||9
111844|NCT01920802|275570|P1|STARTED|Overall Study||11
111845|NCT01920594|275601|P2|NOT COMPLETED|Overall Study||3
111846|NCT01920594|275602|P1|NOT COMPLETED|Overall Study||7
111847|NCT01920594|275601|P2|COMPLETED|Overall Study||25
111848|NCT01920594|275602|P1|COMPLETED|Overall Study||20
111849|NCT01920594|275601|P2|STARTED|Overall Study||28
111850|NCT01920594|275602|P1|STARTED|Overall Study||27
111851|NCT01920568|275652|P2|NOT COMPLETED|Overall Study||84
111852|NCT01920568|275653|P1|NOT COMPLETED|Overall Study||151
111853|NCT01920568|275652|P2|COMPLETED|Overall Study||75
111854|NCT01920568|275653|P1|COMPLETED|Overall Study||175
111855|NCT01920568|275652|P2|STARTED|Overall Study||159
111856|NCT01920568|275653|P1|STARTED|Overall Study||326
111857|NCT01920555|275679|P5|NOT COMPLETED|Overall Study||1
111858|NCT01920555|275680|P4|NOT COMPLETED|Overall Study||3
111859|NCT01920555|275681|P3|NOT COMPLETED|Overall Study||1
111860|NCT01920555|275682|P2|NOT COMPLETED|Overall Study||4
111861|NCT01920555|275683|P1|NOT COMPLETED|Overall Study||4
111862|NCT01920555|275679|P5|COMPLETED|Overall Study||18
111863|NCT01920555|275680|P4|COMPLETED|Overall Study||17
111864|NCT01920555|275681|P3|COMPLETED|Overall Study||21
111865|NCT01920555|275682|P2|COMPLETED|Overall Study||16
111866|NCT01920555|275683|P1|COMPLETED|Overall Study||14
111867|NCT01920555|275679|P5|STARTED|Overall Study||19
111868|NCT01920555|275680|P4|STARTED|Overall Study||20
111869|NCT01920555|275681|P3|STARTED|Overall Study||22
111870|NCT01920555|275682|P2|STARTED|Overall Study||20
111871|NCT01920555|275683|P1|STARTED|Overall Study||18
111872|NCT01920477|275742|P2|NOT COMPLETED|Overall Study||17
111873|NCT01920477|275743|P1|NOT COMPLETED|Overall Study||15
111874|NCT01920477|275742|P2|COMPLETED|Overall Study||1
111875|NCT01920477|275743|P1|COMPLETED|Overall Study||2
111876|NCT01920477|275742|P2|Requiried Individualized Follow-up|Overall Study||0
111972|NCT01919216|276002|P1|NOT COMPLETED|Overall Study||2
111877|NCT01920477|275743|P1|Requiried Individualized Follow-up|Overall Study||1
111878|NCT01920477|275742|P2|STARTED|Overall Study||18
111879|NCT01920477|275743|P1|STARTED|Overall Study||17
111880|NCT01920282|275777|P3|NOT COMPLETED|Overall Study||0
111881|NCT01920282|275778|P2|NOT COMPLETED|Overall Study||0
111882|NCT01920282|275779|P1|NOT COMPLETED|Overall Study||0
111883|NCT01920282|275777|P3|COMPLETED|Overall Study||15
111884|NCT01920282|275778|P2|COMPLETED|Overall Study||15
111885|NCT01920282|275779|P1|COMPLETED|Overall Study||15
111886|NCT01920282|275777|P3|STARTED|Overall Study||15
111887|NCT01920282|275778|P2|STARTED|Overall Study||15
111888|NCT01920282|275779|P1|STARTED|Overall Study||15
111889|NCT01920178|275792|P2|NOT COMPLETED|Overall Study||1
111890|NCT01920178|275793|P1|NOT COMPLETED|Overall Study||2
111891|NCT01920178|275792|P2|COMPLETED|Overall Study||1
111892|NCT01920178|275793|P1|COMPLETED|Overall Study||3
111893|NCT01920178|275792|P2|STARTED|Overall Study||2
111894|NCT01920178|275793|P1|STARTED|Overall Study||5
111895|NCT01919996|275803|P1|NOT COMPLETED|Overall Study||0
111896|NCT01919996|275803|P1|COMPLETED|Overall Study||8
111897|NCT01919996|275803|P1|STARTED|Overall Study||8
111898|NCT01919970|275811|P2|NOT COMPLETED|Overall Study||0
111899|NCT01919970|275812|P1|NOT COMPLETED|Overall Study||3
111900|NCT01919970|275811|P2|COMPLETED|Overall Study||18
111901|NCT01919970|275812|P1|COMPLETED|Overall Study||11
111902|NCT01919970|275811|P2|STARTED|Overall Study||18
111903|NCT01919970|275812|P1|STARTED|Overall Study||14
111904|NCT01919814|275820|P2|NOT COMPLETED|Overall Study||0
111905|NCT01919814|275821|P1|NOT COMPLETED|Overall Study||3
111906|NCT01919814|275820|P2|COMPLETED|Overall Study||30
111907|NCT01919814|275821|P1|COMPLETED|Overall Study||27
111908|NCT01919814|275820|P2|STARTED|Overall Study||30
111909|NCT01919814|275821|P1|STARTED|Overall Study||30
111910|NCT01919801|275833|P2|NOT COMPLETED|Overall Study||3
111911|NCT01919801|275834|P1|NOT COMPLETED|Overall Study||1
111912|NCT01919801|275833|P2|COMPLETED|Overall Study||57
111913|NCT01919801|275834|P1|COMPLETED|Overall Study||60
111914|NCT01919801|275833|P2|STARTED|Overall Study||60
111915|NCT01919801|275834|P1|STARTED|Overall Study||61
111916|NCT01919723|275859|P2|NOT COMPLETED|Overall Study||2
111917|NCT01919723|275860|P1|NOT COMPLETED|Overall Study||2
111918|NCT01919723|275859|P2|COMPLETED|Overall Study||33
111919|NCT01919723|275860|P1|COMPLETED|Overall Study||33
111920|NCT01919723|275859|P2|STARTED|Overall Study||35
111921|NCT01919723|275860|P1|STARTED|Overall Study||35
111922|NCT01919697|275874|P2|NOT COMPLETED|Overall Study||385
111923|NCT01919697|275875|P1|NOT COMPLETED|Overall Study||53
111924|NCT01919697|275874|P2|COMPLETED|Overall Study||1761
111925|NCT01919697|275875|P1|COMPLETED|Overall Study||171
111926|NCT01919697|275874|P2|STARTED|Overall Study||2146
111927|NCT01919697|275875|P1|STARTED|Overall Study||224
111928|NCT01919606|275905|P2|NOT COMPLETED|Overall Study||0
111929|NCT01919606|275906|P1|NOT COMPLETED|Overall Study||0
111930|NCT01919606|275905|P2|COMPLETED|Overall Study||0
111931|NCT01919606|275906|P1|COMPLETED|Overall Study||1
111932|NCT01919606|275905|P2|STARTED|Overall Study||0
111933|NCT01919606|275906|P1|STARTED|Overall Study||1
111934|NCT01919450|275918|P4|NOT COMPLETED|Overall Study||1
111935|NCT01919450|275919|P3|NOT COMPLETED|Overall Study||0
111936|NCT01919450|275920|P2|NOT COMPLETED|Overall Study||0
111937|NCT01919450|275921|P1|NOT COMPLETED|Overall Study||0
111938|NCT01919450|275918|P4|COMPLETED|Overall Study||19
111939|NCT01919450|275919|P3|COMPLETED|Overall Study||20
111940|NCT01919450|275920|P2|COMPLETED|Overall Study||20
111941|NCT01919450|275921|P1|COMPLETED|Overall Study||20
111942|NCT01919450|275918|P4|STARTED|Overall Study||20
111943|NCT01919450|275919|P3|STARTED|Overall Study||20
111944|NCT01919450|275920|P2|STARTED|Overall Study||20
111945|NCT01919450|275921|P1|STARTED|Overall Study||20
111946|NCT01919398|275934|P3|NOT COMPLETED|Overall Study||4
111947|NCT01919398|275935|P2|NOT COMPLETED|Overall Study||0
111948|NCT01919398|275936|P1|NOT COMPLETED|Overall Study||0
111949|NCT01919398|275934|P3|COMPLETED|Overall Study||9
111950|NCT01919398|275935|P2|COMPLETED|Overall Study||3
111951|NCT01919398|275936|P1|COMPLETED|Overall Study||3
111952|NCT01919398|275934|P3|Received at Least One Dose of Study Drug|Overall Study||13
111953|NCT01919398|275935|P2|Received at Least One Dose of Study Drug|Overall Study||3
111954|NCT01919398|275936|P1|Received at Least One Dose of Study Drug|Overall Study||3
111955|NCT01919398|275934|P3|STARTED|Overall Study||13
111956|NCT01919398|275935|P2|STARTED|Overall Study||3
111957|NCT01919398|275936|P1|STARTED|Overall Study||3
111958|NCT01919307|275956|P1|NOT COMPLETED|Overall Study||9
111959|NCT01919307|275956|P1|COMPLETED|Overall Study||20
111960|NCT01919307|275956|P1|STARTED|Overall Study||29
111961|NCT01919229|275966|P3|NOT COMPLETED|Overall Study||1
111962|NCT01919229|275967|P2|NOT COMPLETED|Overall Study||0
111963|NCT01919229|275968|P1|NOT COMPLETED|Overall Study||0
111964|NCT01919229|275966|P3|COMPLETED|Overall Study||3
111965|NCT01919229|275967|P2|COMPLETED|Overall Study||6
111966|NCT01919229|275968|P1|COMPLETED|Overall Study||4
111967|NCT01919229|275966|P3|STARTED|Overall Study||4
111968|NCT01919229|275967|P2|STARTED|Overall Study||6
111969|NCT01919229|275968|P1|STARTED|Overall Study||4
111970|NCT01919216|276000|P3|NOT COMPLETED|Overall Study||1
111971|NCT01919216|276001|P2|NOT COMPLETED|Overall Study||1
111973|NCT01919216|276000|P3|COMPLETED|Overall Study||4
111974|NCT01919216|276001|P2|COMPLETED|Overall Study||20
111975|NCT01919216|276002|P1|COMPLETED|Overall Study||26
111976|NCT01919216|276000|P3|STARTED|Overall Study||5
111977|NCT01919216|276001|P2|STARTED|Overall Study||21
111978|NCT01919216|276002|P1|STARTED|Overall Study||28
111979|NCT01918800|276012|P2|NOT COMPLETED|Overall Study||5
111980|NCT01918800|276013|P1|NOT COMPLETED|Overall Study||9
111981|NCT01918800|276012|P2|COMPLETED|Overall Study||104
111982|NCT01918800|276013|P1|COMPLETED|Overall Study||100
111983|NCT01918800|276012|P2|STARTED|Overall Study||109
111984|NCT01918800|276013|P1|STARTED|Overall Study||109
111985|NCT01918774|276031|P1|NOT COMPLETED|Overall Study||5
111986|NCT01918774|276031|P1|COMPLETED|Overall Study||52
111987|NCT01918774|276031|P1|STARTED|Overall Study||57
111988|NCT01918371|276048|P2|NOT COMPLETED|Overall Study||1
111989|NCT01918371|276049|P1|NOT COMPLETED|Overall Study||1
111990|NCT01918371|276048|P2|COMPLETED|Overall Study||156
111991|NCT01918371|276049|P1|COMPLETED|Overall Study||165
111992|NCT01918371|276048|P2|Participants With Complete Data|Overall Study||156
111993|NCT01918371|276049|P1|Participants With Complete Data|Overall Study||165
111994|NCT01918371|276048|P2|STARTED|Overall Study||157
111995|NCT01918371|276049|P1|STARTED|Overall Study||166
111996|NCT01918332|276127|P4|NOT COMPLETED|Overall Study||7
111997|NCT01918332|276128|P3|NOT COMPLETED|Overall Study||9
111998|NCT01918332|276129|P2|NOT COMPLETED|Overall Study||5
111999|NCT01918332|276130|P1|NOT COMPLETED|Overall Study||8
112000|NCT01918332|276127|P4|COMPLETED|Overall Study||38
112001|NCT01918332|276128|P3|COMPLETED|Overall Study||30
112002|NCT01918332|276129|P2|COMPLETED|Overall Study||36
112003|NCT01918332|276130|P1|COMPLETED|Overall Study||35
112004|NCT01918332|276127|P4|STARTED|Overall Study||45
112005|NCT01918332|276128|P3|STARTED|Overall Study||39
112006|NCT01918332|276129|P2|STARTED|Overall Study||41
112007|NCT01918332|276130|P1|STARTED|Overall Study||43
112008|NCT01918306|276142|P4|NOT COMPLETED|Overall Study||3
112009|NCT01918306|276143|P3|NOT COMPLETED|Overall Study||2
112010|NCT01918306|276144|P2|NOT COMPLETED|Overall Study||0
112011|NCT01918306|276145|P1|NOT COMPLETED|Overall Study||6
112012|NCT01918306|276142|P4|COMPLETED|Overall Study||0
112013|NCT01918306|276143|P3|COMPLETED|Overall Study||0
112014|NCT01918306|276144|P2|COMPLETED|Overall Study||0
112015|NCT01918306|276145|P1|COMPLETED|Overall Study||0
112016|NCT01918306|276142|P4|STARTED|Overall Study||3
112017|NCT01918306|276143|P3|STARTED|Overall Study|1 participant Crossed-over to ARM 2|2
112018|NCT01918306|276144|P2|STARTED|Overall Study|No patients enrolled|0
112019|NCT01918306|276145|P1|STARTED|Overall Study||6
112020|NCT01918189|276165|P1|NOT COMPLETED|Overall Study||18
112021|NCT01918189|276165|P1|COMPLETED|Overall Study||41
112022|NCT01918189|276165|P1|Completed Follow-up Assessment|Overall Study||41
112023|NCT01918189|276165|P1|Completed Baseline Assessment|Overall Study||58
112024|NCT01918189|276165|P1|STARTED|Overall Study||59
112025|NCT01918085|276176|P2|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
112026|NCT01918085|276177|P1|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
112027|NCT01918085|276176|P2|COMPLETED|Test Period 2: Hydrocolloid Strip||11
112028|NCT01918085|276177|P1|COMPLETED|Test Period 2: Hydrocolloid Strip||10
112029|NCT01918085|276176|P2|STARTED|Test Period 2: Hydrocolloid Strip||11
112030|NCT01918085|276177|P1|STARTED|Test Period 2: Hydrocolloid Strip||10
112031|NCT01918085|276176|P2|NOT COMPLETED|Test Period 2: Strata Strip||0
112032|NCT01918085|276177|P1|NOT COMPLETED|Test Period 2: Strata Strip||0
112033|NCT01918085|276176|P2|COMPLETED|Test Period 2: Strata Strip||11
112034|NCT01918085|276177|P1|COMPLETED|Test Period 2: Strata Strip||10
112035|NCT01918085|276176|P2|STARTED|Test Period 2: Strata Strip||11
112036|NCT01918085|276177|P1|STARTED|Test Period 2: Strata Strip||10
112037|NCT01918085|276176|P2|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
112038|NCT01918085|276177|P1|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
112039|NCT01918085|276176|P2|COMPLETED|Test Period 1: Hydrocolloid Strip||11
112040|NCT01918085|276177|P1|COMPLETED|Test Period 1: Hydrocolloid Strip||10
112041|NCT01918085|276176|P2|STARTED|Test Period 1: Hydrocolloid Strip||11
112042|NCT01918085|276177|P1|STARTED|Test Period 1: Hydrocolloid Strip||10
112043|NCT01918085|276176|P2|NOT COMPLETED|Test Period 1: Strata Strip||1
112044|NCT01918085|276177|P1|NOT COMPLETED|Test Period 1: Strata Strip||0
112045|NCT01918085|276176|P2|COMPLETED|Test Period 1: Strata Strip||11
112046|NCT01918085|276177|P1|COMPLETED|Test Period 1: Strata Strip||10
112047|NCT01918085|276176|P2|STARTED|Test Period 1: Strata Strip||12
112048|NCT01918085|276177|P1|STARTED|Test Period 1: Strata Strip||10
112049|NCT01918072|276185|P3|NOT COMPLETED|Quality Assessment Period||0
112050|NCT01918072|276186|P2|NOT COMPLETED|Quality Assessment Period||0
112051|NCT01918072|276187|P1|NOT COMPLETED|Quality Assessment Period||0
112052|NCT01918072|276185|P3|COMPLETED|Quality Assessment Period||202
112053|NCT01918072|276186|P2|COMPLETED|Quality Assessment Period||0
112054|NCT01918072|276187|P1|COMPLETED|Quality Assessment Period||0
112055|NCT01918072|276185|P3|STARTED|Quality Assessment Period||202
112056|NCT01918072|276186|P2|STARTED|Quality Assessment Period||0
112057|NCT01918072|276187|P1|STARTED|Quality Assessment Period||0
112058|NCT01918072|276185|P3|NOT COMPLETED|E-consult Assessment Period||0
112059|NCT01918072|276186|P2|NOT COMPLETED|E-consult Assessment Period||0
112060|NCT01918072|276187|P1|NOT COMPLETED|E-consult Assessment Period||0
112061|NCT01918072|276185|P3|COMPLETED|E-consult Assessment Period||0
112062|NCT01918072|276186|P2|COMPLETED|E-consult Assessment Period||42
112063|NCT01918072|276187|P1|COMPLETED|E-consult Assessment Period||0
112064|NCT01918072|276185|P3|STARTED|E-consult Assessment Period||0
112065|NCT01918072|276186|P2|STARTED|E-consult Assessment Period||42
112066|NCT01918072|276187|P1|STARTED|E-consult Assessment Period||0
112067|NCT01918072|276185|P3|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
112068|NCT01918072|276186|P2|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
112069|NCT01918072|276187|P1|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
112070|NCT01918072|276185|P3|COMPLETED|Controlled Trial Step Five - Four Months||0
112071|NCT01918072|276186|P2|COMPLETED|Controlled Trial Step Five - Four Months||0
112072|NCT01918072|276187|P1|COMPLETED|Controlled Trial Step Five - Four Months||11
112073|NCT01918072|276185|P3|Control|Controlled Trial Step Five - Four Months||0
112074|NCT01918072|276186|P2|Control|Controlled Trial Step Five - Four Months||0
112075|NCT01918072|276187|P1|Control|Controlled Trial Step Five - Four Months||0
112076|NCT01918072|276185|P3|Intervention|Controlled Trial Step Five - Four Months||0
112077|NCT01918072|276186|P2|Intervention|Controlled Trial Step Five - Four Months||0
112078|NCT01918072|276187|P1|Intervention|Controlled Trial Step Five - Four Months||11
112079|NCT01918072|276185|P3|STARTED|Controlled Trial Step Five - Four Months||0
112080|NCT01918072|276186|P2|STARTED|Controlled Trial Step Five - Four Months||0
112081|NCT01918072|276187|P1|STARTED|Controlled Trial Step Five - Four Months||11
112082|NCT01918072|276185|P3|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
112083|NCT01918072|276186|P2|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
112084|NCT01918072|276187|P1|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
112085|NCT01918072|276185|P3|COMPLETED|Controlled Trial Step Four - Six Months||0
112086|NCT01918072|276186|P2|COMPLETED|Controlled Trial Step Four - Six Months||0
112087|NCT01918072|276187|P1|COMPLETED|Controlled Trial Step Four - Six Months||11
112088|NCT01918072|276185|P3|Control|Controlled Trial Step Four - Six Months||0
112089|NCT01918072|276186|P2|Control|Controlled Trial Step Four - Six Months||0
112090|NCT01918072|276187|P1|Control|Controlled Trial Step Four - Six Months||0
112091|NCT01918072|276185|P3|Intervention|Controlled Trial Step Four - Six Months||0
112092|NCT01918072|276186|P2|Intervention|Controlled Trial Step Four - Six Months||0
112093|NCT01918072|276187|P1|Intervention|Controlled Trial Step Four - Six Months||11
112094|NCT01918072|276185|P3|STARTED|Controlled Trial Step Four - Six Months||0
112095|NCT01918072|276186|P2|STARTED|Controlled Trial Step Four - Six Months||0
112096|NCT01918072|276187|P1|STARTED|Controlled Trial Step Four - Six Months||11
112097|NCT01918072|276185|P3|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
112098|NCT01918072|276186|P2|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
112099|NCT01918072|276187|P1|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
112100|NCT01918072|276185|P3|COMPLETED|Controlled Trial Step Three - Six Months||0
112101|NCT01918072|276186|P2|COMPLETED|Controlled Trial Step Three - Six Months||0
112102|NCT01918072|276187|P1|COMPLETED|Controlled Trial Step Three - Six Months||11
112103|NCT01918072|276185|P3|Control|Controlled Trial Step Three - Six Months||0
112104|NCT01918072|276186|P2|Control|Controlled Trial Step Three - Six Months||0
112105|NCT01918072|276187|P1|Control|Controlled Trial Step Three - Six Months||2
112106|NCT01918072|276185|P3|Intervention|Controlled Trial Step Three - Six Months||0
112107|NCT01918072|276186|P2|Intervention|Controlled Trial Step Three - Six Months||0
112108|NCT01918072|276187|P1|Intervention|Controlled Trial Step Three - Six Months||9
112109|NCT01918072|276185|P3|STARTED|Controlled Trial Step Three - Six Months||0
112110|NCT01918072|276186|P2|STARTED|Controlled Trial Step Three - Six Months||0
112111|NCT01918072|276187|P1|STARTED|Controlled Trial Step Three - Six Months||11
112112|NCT01918072|276185|P3|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
112113|NCT01918072|276186|P2|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
112114|NCT01918072|276187|P1|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
112115|NCT01918072|276185|P3|COMPLETED|Controlled Trial Step Two - Six Months||0
112116|NCT01918072|276186|P2|COMPLETED|Controlled Trial Step Two - Six Months||0
112117|NCT01918072|276187|P1|COMPLETED|Controlled Trial Step Two - Six Months||11
112118|NCT01918072|276185|P3|Control|Controlled Trial Step Two - Six Months||0
112119|NCT01918072|276186|P2|Control|Controlled Trial Step Two - Six Months||0
112120|NCT01918072|276187|P1|Control|Controlled Trial Step Two - Six Months||4
112121|NCT01918072|276185|P3|Intervention|Controlled Trial Step Two - Six Months||0
112122|NCT01918072|276186|P2|Intervention|Controlled Trial Step Two - Six Months||0
112123|NCT01918072|276187|P1|Intervention|Controlled Trial Step Two - Six Months||7
112124|NCT01918072|276185|P3|STARTED|Controlled Trial Step Two - Six Months||0
112125|NCT01918072|276186|P2|STARTED|Controlled Trial Step Two - Six Months||0
112126|NCT01918072|276187|P1|STARTED|Controlled Trial Step Two - Six Months||11
112127|NCT01918072|276185|P3|NOT COMPLETED|Controlled Trial Step One - Six Months||0
112128|NCT01918072|276186|P2|NOT COMPLETED|Controlled Trial Step One - Six Months||0
112129|NCT01918072|276187|P1|NOT COMPLETED|Controlled Trial Step One - Six Months||0
112130|NCT01918072|276185|P3|COMPLETED|Controlled Trial Step One - Six Months||0
112131|NCT01918072|276186|P2|COMPLETED|Controlled Trial Step One - Six Months||0
112132|NCT01918072|276187|P1|COMPLETED|Controlled Trial Step One - Six Months||11
112133|NCT01918072|276185|P3|Control|Controlled Trial Step One - Six Months||0
112134|NCT01918072|276186|P2|Control|Controlled Trial Step One - Six Months||0
112135|NCT01918072|276187|P1|Control|Controlled Trial Step One - Six Months||10
112136|NCT01918072|276185|P3|Intervention|Controlled Trial Step One - Six Months||0
112137|NCT01918072|276186|P2|Intervention|Controlled Trial Step One - Six Months||0
112138|NCT01918072|276187|P1|Intervention|Controlled Trial Step One - Six Months||1
112139|NCT01918072|276185|P3|STARTED|Controlled Trial Step One - Six Months||0
112140|NCT01918072|276186|P2|STARTED|Controlled Trial Step One - Six Months||0
112141|NCT01918072|276187|P1|STARTED|Controlled Trial Step One - Six Months||11
112142|NCT01918033|276201|P3|NOT COMPLETED|Overall Study||3
112143|NCT01918033|276202|P2|NOT COMPLETED|Overall Study||2
112144|NCT01918033|276203|P1|NOT COMPLETED|Overall Study||5
112145|NCT01918033|276201|P3|COMPLETED|Overall Study||199
112146|NCT01918033|276202|P2|COMPLETED|Overall Study||201
112147|NCT01918033|276203|P1|COMPLETED|Overall Study||198
112148|NCT01918033|276201|P3|Treated|Overall Study|One randomized participant did not receive study drug.|201
112149|NCT01918033|276202|P2|Treated|Overall Study||203
112150|NCT01918033|276203|P1|Treated|Overall Study|One randomized participant did not receive study drug.|202
112151|NCT01918033|276201|P3|STARTED|Overall Study||202
112152|NCT01918033|276202|P2|STARTED|Overall Study||203
112153|NCT01918033|276203|P1|STARTED|Overall Study||203
112154|NCT01917812|276244|P3|NOT COMPLETED|Overall Study||0
112155|NCT01917812|276245|P2|NOT COMPLETED|Overall Study||0
112156|NCT01917812|276246|P1|NOT COMPLETED|Overall Study||1
112157|NCT01917812|276244|P3|COMPLETED|Overall Study||16
112158|NCT01917812|276245|P2|COMPLETED|Overall Study||16
112159|NCT01917812|276246|P1|COMPLETED|Overall Study||15
112160|NCT01917812|276244|P3|STARTED|Overall Study||16
112161|NCT01917812|276245|P2|STARTED|Overall Study||16
112162|NCT01917812|276246|P1|STARTED|Overall Study||16
112163|NCT01917773|276266|P1|NOT COMPLETED|Overall Study||0
112164|NCT01917773|276266|P1|COMPLETED|Overall Study||13
112165|NCT01917773|276266|P1|STARTED|Overall Study||13
112166|NCT01917656|276274|P2|NOT COMPLETED|Overall Study||24
112167|NCT01917656|276275|P1|NOT COMPLETED|Overall Study||26
112168|NCT01917656|276274|P2|COMPLETED|Overall Study||147
112169|NCT01917656|276275|P1|COMPLETED|Overall Study||146
112170|NCT01917656|276274|P2|Exposed During Ramadan (Fasting)|Overall Study||163
112171|NCT01917656|276275|P1|Exposed During Ramadan (Fasting)|Overall Study||152
112172|NCT01917656|276274|P2|Exposed|Overall Study|1 subject was withdrawn prior to exposure to first SU dose after randomisation|170
112173|NCT01917656|276275|P1|Exposed|Overall Study|1 subject was withdrawn prior to exposure to trial products|171
112174|NCT01917656|276274|P2|STARTED|Overall Study||171
112175|NCT01917656|276275|P1|STARTED|Overall Study||172
112176|NCT01917526|276301|P2|NOT COMPLETED|Overall Study||1
112177|NCT01917526|276302|P1|NOT COMPLETED|Overall Study||1
112178|NCT01917526|276301|P2|COMPLETED|Overall Study|1 patient in oxygen cannula group receive oxygen mask|249
112179|NCT01917526|276302|P1|COMPLETED|Overall Study|One patient in oxygen mask received oxygen cannula|249
112180|NCT01917526|276301|P2|STARTED|Overall Study||250
112181|NCT01917526|276302|P1|STARTED|Overall Study||250
112182|NCT01917513|276312|P2|NOT COMPLETED|Overall Study||102
112183|NCT01917513|276313|P1|NOT COMPLETED|Overall Study||95
112184|NCT01917513|276312|P2|COMPLETED|Overall Study||396
112185|NCT01917513|276313|P1|COMPLETED|Overall Study||407
112186|NCT01917513|276312|P2|STARTED|Overall Study||498
112187|NCT01917513|276313|P1|STARTED|Overall Study||502
112188|NCT01917344|276319|P1|NOT COMPLETED|Overall Study||1
112189|NCT01917344|276319|P1|COMPLETED|Overall Study||9
112190|NCT01917344|276319|P1|STARTED|Overall Study||10
112191|NCT01917214|276323|P1|NOT COMPLETED|Overall Study||0
112192|NCT01917214|276323|P1|COMPLETED|Overall Study||212
112193|NCT01917214|276323|P1|STARTED|Overall Study||212
112194|NCT01917188|276335|P3|NOT COMPLETED|Overall Study||9
112195|NCT01917188|276336|P2|NOT COMPLETED|Overall Study||6
112196|NCT01917188|276337|P1|NOT COMPLETED|Overall Study||12
112197|NCT01917188|276335|P3|COMPLETED|Overall Study||11
112198|NCT01917188|276336|P2|COMPLETED|Overall Study||17
112199|NCT01917188|276337|P1|COMPLETED|Overall Study||17
112200|NCT01917188|276335|P3|STARTED|Overall Study||20
112201|NCT01917188|276336|P2|STARTED|Overall Study||23
112202|NCT01917188|276337|P1|STARTED|Overall Study||29
112203|NCT01917136|276345|P1|NOT COMPLETED|Overall Study||0
112204|NCT01917136|276345|P1|COMPLETED|Overall Study||21
112205|NCT01917136|276345|P1|STARTED|Overall Study||21
112206|NCT01917006|276356|P8|NOT COMPLETED|Open-label Period||2
112207|NCT01917006|276357|P7|NOT COMPLETED|Open-label Period||0
112208|NCT01917006|276358|P6|NOT COMPLETED|Open-label Period||0
112209|NCT01917006|276359|P5|NOT COMPLETED|Open-label Period||0
112210|NCT01917006|276360|P4|NOT COMPLETED|Open-label Period||0
112211|NCT01917006|276361|P3|NOT COMPLETED|Open-label Period||0
112212|NCT01917006|276362|P2|NOT COMPLETED|Open-label Period||0
112213|NCT01917006|276363|P1|NOT COMPLETED|Open-label Period||0
112214|NCT01917006|276356|P8|COMPLETED|Open-label Period||6
112215|NCT01917006|276357|P7|COMPLETED|Open-label Period||0
112216|NCT01917006|276358|P6|COMPLETED|Open-label Period||0
112217|NCT01917006|276359|P5|COMPLETED|Open-label Period||0
112218|NCT01917006|276360|P4|COMPLETED|Open-label Period||0
112219|NCT01917006|276361|P3|COMPLETED|Open-label Period||0
112220|NCT01917006|276362|P2|COMPLETED|Open-label Period||0
112221|NCT01917006|276363|P1|COMPLETED|Open-label Period||0
112222|NCT01917006|276356|P8|STARTED|Open-label Period||8
112223|NCT01917006|276357|P7|STARTED|Open-label Period||0
112224|NCT01917006|276358|P6|STARTED|Open-label Period||0
112225|NCT01917006|276359|P5|STARTED|Open-label Period||0
112226|NCT01917006|276360|P4|STARTED|Open-label Period||0
112227|NCT01917006|276361|P3|STARTED|Open-label Period||0
112228|NCT01917006|276362|P2|STARTED|Open-label Period||0
112229|NCT01917006|276363|P1|STARTED|Open-label Period||0
112230|NCT01917006|276356|P8|NOT COMPLETED|Randomized-treatment Period||0
112231|NCT01917006|276357|P7|NOT COMPLETED|Randomized-treatment Period||1
112232|NCT01917006|276358|P6|NOT COMPLETED|Randomized-treatment Period||1
112233|NCT01917006|276359|P5|NOT COMPLETED|Randomized-treatment Period||0
112234|NCT01917006|276360|P4|NOT COMPLETED|Randomized-treatment Period||1
112235|NCT01917006|276361|P3|NOT COMPLETED|Randomized-treatment Period||0
112236|NCT01917006|276362|P2|NOT COMPLETED|Randomized-treatment Period||0
112237|NCT01917006|276363|P1|NOT COMPLETED|Randomized-treatment Period||2
112238|NCT01917006|276356|P8|COMPLETED|Randomized-treatment Period||0
112239|NCT01917006|276357|P7|COMPLETED|Randomized-treatment Period||14
112240|NCT01917006|276358|P6|COMPLETED|Randomized-treatment Period||7
112241|NCT01917006|276359|P5|COMPLETED|Randomized-treatment Period||8
112242|NCT01917006|276360|P4|COMPLETED|Randomized-treatment Period||7
112243|NCT01917006|276361|P3|COMPLETED|Randomized-treatment Period||8
112244|NCT01917006|276362|P2|COMPLETED|Randomized-treatment Period||7
112245|NCT01917006|276363|P1|COMPLETED|Randomized-treatment Period||3
112246|NCT01917006|276356|P8|STARTED|Randomized-treatment Period||0
112247|NCT01917006|276357|P7|STARTED|Randomized-treatment Period||15
112248|NCT01917006|276358|P6|STARTED|Randomized-treatment Period||8
112249|NCT01917006|276359|P5|STARTED|Randomized-treatment Period||8
112250|NCT01917006|276360|P4|STARTED|Randomized-treatment Period||8
112251|NCT01917006|276361|P3|STARTED|Randomized-treatment Period||8
112252|NCT01917006|276362|P2|STARTED|Randomized-treatment Period||7
112253|NCT01917006|276363|P1|STARTED|Randomized-treatment Period||5
112254|NCT01916980|276396|P2|NOT COMPLETED|Overall Study||4
112255|NCT01916980|276397|P1|NOT COMPLETED|Overall Study||7
112256|NCT01916980|276396|P2|COMPLETED|Overall Study||25
112257|NCT01916980|276397|P1|COMPLETED|Overall Study||58
112258|NCT01916980|276396|P2|STARTED|Overall Study||29
112259|NCT01916980|276397|P1|STARTED|Overall Study||65
112260|NCT01916967|276416|P3|NOT COMPLETED|Overall Study||9
112261|NCT01916967|276417|P2|NOT COMPLETED|Overall Study||1
112262|NCT01916967|276418|P1|NOT COMPLETED|Overall Study||0
112263|NCT01916967|276416|P3|COMPLETED|Overall Study||71
112264|NCT01916967|276417|P2|COMPLETED|Overall Study||78
112265|NCT01916967|276418|P1|COMPLETED|Overall Study||80
112266|NCT01916967|276416|P3|STARTED|Overall Study||80
112267|NCT01916967|276417|P2|STARTED|Overall Study||79
112268|NCT01916967|276418|P1|STARTED|Overall Study||80
112269|NCT01916941|276461|P2|NOT COMPLETED|Overall Study||4
112270|NCT01916941|276462|P1|NOT COMPLETED|Overall Study||5
112271|NCT01916941|276461|P2|COMPLETED|Overall Study||14
112272|NCT01916941|276462|P1|COMPLETED|Overall Study||13
112273|NCT01916941|276461|P2|STARTED|Overall Study||18
112274|NCT01916941|276462|P1|STARTED|Overall Study||18
112275|NCT01916928|276468|P1|NOT COMPLETED|Overall Study||0
112276|NCT01916928|276468|P1|COMPLETED|Overall Study||50
112277|NCT01916928|276468|P1|STARTED|Overall Study||50
112278|NCT01916824|276474|P2|NOT COMPLETED|Overall Study||9
112279|NCT01916824|276475|P1|NOT COMPLETED|Overall Study||7
112280|NCT01916824|276474|P2|COMPLETED|Overall Study||20
112281|NCT01916824|276475|P1|COMPLETED|Overall Study||17
112282|NCT01916824|276474|P2|STARTED|Overall Study||29
112283|NCT01916824|276475|P1|STARTED|Overall Study||24
112284|NCT01916681|276485|P4|NOT COMPLETED|Overall Study||0
112285|NCT01916681|276486|P3|NOT COMPLETED|Overall Study||0
112286|NCT01916681|276487|P2|NOT COMPLETED|Overall Study||0
112287|NCT01916681|276488|P1|NOT COMPLETED|Overall Study||0
112288|NCT01916681|276485|P4|COMPLETED|Overall Study||125
112289|NCT01916681|276486|P3|COMPLETED|Overall Study||123
112290|NCT01916681|276487|P2|COMPLETED|Overall Study||120
112291|NCT01916681|276488|P1|COMPLETED|Overall Study||123
112292|NCT01916681|276485|P4|STARTED|Overall Study||125
112293|NCT01916681|276486|P3|STARTED|Overall Study||123
112294|NCT01916681|276487|P2|STARTED|Overall Study||120
112295|NCT01916681|276488|P1|STARTED|Overall Study||123
112296|NCT01916655|276529|P3|NOT COMPLETED|Overall Study||29
112297|NCT01916655|276530|P2|NOT COMPLETED|Overall Study||20
112298|NCT01916655|276531|P1|NOT COMPLETED|Overall Study||15
112299|NCT01916655|276529|P3|COMPLETED|Overall Study||91
112300|NCT01916655|276530|P2|COMPLETED|Overall Study||89
112301|NCT01916655|276531|P1|COMPLETED|Overall Study||116
112302|NCT01916655|276529|P3|STARTED|Overall Study||120
112303|NCT01916655|276530|P2|STARTED|Overall Study||109
112304|NCT01916655|276531|P1|STARTED|Overall Study||131
112305|NCT01916629|276541|P2|NOT COMPLETED|Overall Study||0
112306|NCT01916629|276542|P1|NOT COMPLETED|Overall Study||0
112307|NCT01916629|276541|P2|COMPLETED|Overall Study||5
112308|NCT01916629|276542|P1|COMPLETED|Overall Study||7
112309|NCT01916629|276541|P2|STARTED|Overall Study||5
112310|NCT01916629|276542|P1|STARTED|Overall Study||7
112311|NCT01916590|276550|P2|NOT COMPLETED|Overall Study||0
112312|NCT01916590|276551|P1|NOT COMPLETED|Overall Study||0
112313|NCT01916590|276550|P2|COMPLETED|Overall Study||3
112314|NCT01916590|276551|P1|COMPLETED|Overall Study||4
112315|NCT01916590|276550|P2|STARTED|Overall Study||3
112316|NCT01916590|276551|P1|STARTED|Overall Study||4
112317|NCT01916304|276557|P1|NOT COMPLETED|Overall Study||17
112318|NCT01916304|276557|P1|COMPLETED|Overall Study||84
112319|NCT01916304|276557|P1|Intent-to-Treat Set|Overall Study||84
112320|NCT01916304|276557|P1|Safety Set|Overall Study||101
112321|NCT01916304|276557|P1|STARTED|Overall Study||101
112322|NCT01916226|276569|P4|NOT COMPLETED|Overall Study||4
112323|NCT01916226|276570|P3|NOT COMPLETED|Overall Study||3
112324|NCT01916226|276571|P2|NOT COMPLETED|Overall Study||1
112325|NCT01916226|276572|P1|NOT COMPLETED|Overall Study||1
112326|NCT01916226|276569|P4|COMPLETED|Overall Study||167
112327|NCT01916226|276570|P3|COMPLETED|Overall Study||168
112328|NCT01916226|276571|P2|COMPLETED|Overall Study||169
112329|NCT01916226|276572|P1|COMPLETED|Overall Study||169
112330|NCT01916226|276569|P4|STARTED|Overall Study||171
112331|NCT01916226|276570|P3|STARTED|Overall Study||171
112332|NCT01916226|276571|P2|STARTED|Overall Study||170
112333|NCT01916226|276572|P1|STARTED|Overall Study||170
112334|NCT01916109|276606|P1|NOT COMPLETED|Overall Study||1
112335|NCT01916109|276606|P1|COMPLETED|Overall Study||3
112336|NCT01916109|276606|P1|STARTED|Overall Study||4
112337|NCT01915940|276612|P3|NOT COMPLETED|Treatment Period||4
112338|NCT01915940|276613|P2|NOT COMPLETED|Treatment Period||11
112339|NCT01915940|276614|P1|NOT COMPLETED|Treatment Period||0
112340|NCT01915940|276612|P3|COMPLETED|Treatment Period||62
112341|NCT01915940|276613|P2|COMPLETED|Treatment Period||53
112342|NCT01915940|276614|P1|COMPLETED|Treatment Period||0
112343|NCT01915940|276612|P3|STARTED|Treatment Period||66
112344|NCT01915940|276613|P2|STARTED|Treatment Period||64
112345|NCT01915940|276614|P1|STARTED|Treatment Period||0
112346|NCT01915940|276612|P3|NOT COMPLETED|Pre-randomization Washout Period||0
112347|NCT01915940|276613|P2|NOT COMPLETED|Pre-randomization Washout Period||0
112348|NCT01915940|276614|P1|NOT COMPLETED|Pre-randomization Washout Period||39
112349|NCT01915940|276612|P3|COMPLETED|Pre-randomization Washout Period||0
112350|NCT01915940|276613|P2|COMPLETED|Pre-randomization Washout Period||0
112351|NCT01915940|276614|P1|COMPLETED|Pre-randomization Washout Period||130
112352|NCT01915940|276612|P3|STARTED|Pre-randomization Washout Period||0
112353|NCT01915940|276613|P2|STARTED|Pre-randomization Washout Period||0
112354|NCT01915940|276614|P1|STARTED|Pre-randomization Washout Period||169
112355|NCT01915914|276630|P4|NOT COMPLETED|Follow-up Phase||2
112356|NCT01915914|276631|P3|NOT COMPLETED|Follow-up Phase||0
112357|NCT01915914|276632|P2|NOT COMPLETED|Follow-up Phase||0
112358|NCT01915914|276633|P1|NOT COMPLETED|Follow-up Phase||0
112359|NCT01915914|276630|P4|COMPLETED|Follow-up Phase||64
112360|NCT01915914|276631|P3|COMPLETED|Follow-up Phase||0
112361|NCT01915914|276632|P2|COMPLETED|Follow-up Phase||0
112362|NCT01915914|276633|P1|COMPLETED|Follow-up Phase||0
112363|NCT01915914|276630|P4|STARTED|Follow-up Phase||66
112364|NCT01915914|276631|P3|STARTED|Follow-up Phase||0
112365|NCT01915914|276632|P2|STARTED|Follow-up Phase||0
112366|NCT01915914|276633|P1|STARTED|Follow-up Phase||0
112367|NCT01915914|276630|P4|NOT COMPLETED|Maintenance Phase||0
112368|NCT01915914|276631|P3|NOT COMPLETED|Maintenance Phase||2
112369|NCT01915914|276632|P2|NOT COMPLETED|Maintenance Phase||6
112370|NCT01915914|276633|P1|NOT COMPLETED|Maintenance Phase||0
112371|NCT01915914|276630|P4|COMPLETED|Maintenance Phase||0
112372|NCT01915914|276631|P3|COMPLETED|Maintenance Phase||51
112373|NCT01915914|276632|P2|COMPLETED|Maintenance Phase||48
112374|NCT01915914|276633|P1|COMPLETED|Maintenance Phase||0
112375|NCT01915914|276630|P4|STARTED|Maintenance Phase||0
112376|NCT01915914|276631|P3|STARTED|Maintenance Phase||53
112377|NCT01915914|276632|P2|STARTED|Maintenance Phase||54
112378|NCT01915914|276633|P1|STARTED|Maintenance Phase||0
112379|NCT01915914|276630|P4|NOT COMPLETED|Acute Phase||0
112380|NCT01915914|276631|P3|NOT COMPLETED|Acute Phase||0
112381|NCT01915914|276632|P2|NOT COMPLETED|Acute Phase||0
112382|NCT01915914|276633|P1|NOT COMPLETED|Acute Phase||12
112383|NCT01915914|276630|P4|COMPLETED|Acute Phase||0
112384|NCT01915914|276631|P3|COMPLETED|Acute Phase||0
112385|NCT01915914|276632|P2|COMPLETED|Acute Phase||0
112386|NCT01915914|276633|P1|COMPLETED|Acute Phase||111
112387|NCT01915914|276630|P4|Completed–Not Entered Maintenance Phase|Acute Phase||0
112388|NCT01915914|276631|P3|Completed–Not Entered Maintenance Phase|Acute Phase||0
112389|NCT01915914|276632|P2|Completed–Not Entered Maintenance Phase|Acute Phase||0
112390|NCT01915914|276633|P1|Completed–Not Entered Maintenance Phase|Acute Phase||4
112391|NCT01915914|276630|P4|STARTED|Acute Phase||0
112392|NCT01915914|276631|P3|STARTED|Acute Phase||0
112393|NCT01915914|276632|P2|STARTED|Acute Phase||0
112394|NCT01915914|276633|P1|STARTED|Acute Phase||123
112395|NCT01915849|276665|P4|NOT COMPLETED|Treatment Period 4 (4 Days)||0
112396|NCT01915849|276666|P3|NOT COMPLETED|Treatment Period 4 (4 Days)||0
112397|NCT01915849|276667|P2|NOT COMPLETED|Treatment Period 4 (4 Days)||0
112398|NCT01915849|276668|P1|NOT COMPLETED|Treatment Period 4 (4 Days)||0
112399|NCT01915849|276665|P4|COMPLETED|Treatment Period 4 (4 Days)||3
112400|NCT01915849|276666|P3|COMPLETED|Treatment Period 4 (4 Days)||3
112401|NCT01915849|276667|P2|COMPLETED|Treatment Period 4 (4 Days)||3
112402|NCT01915849|276668|P1|COMPLETED|Treatment Period 4 (4 Days)||3
112403|NCT01915849|276665|P4|STARTED|Treatment Period 4 (4 Days)||3
112404|NCT01915849|276666|P3|STARTED|Treatment Period 4 (4 Days)||3
112405|NCT01915849|276667|P2|STARTED|Treatment Period 4 (4 Days)||3
112406|NCT01915849|276668|P1|STARTED|Treatment Period 4 (4 Days)||3
112407|NCT01915849|276665|P4|NOT COMPLETED|Treatment Period 3 (4 Days)||0
112408|NCT01915849|276666|P3|NOT COMPLETED|Treatment Period 3 (4 Days)||0
112409|NCT01915849|276667|P2|NOT COMPLETED|Treatment Period 3 (4 Days)||0
112410|NCT01915849|276668|P1|NOT COMPLETED|Treatment Period 3 (4 Days)||0
112411|NCT01915849|276665|P4|COMPLETED|Treatment Period 3 (4 Days)||3
112412|NCT01915849|276666|P3|COMPLETED|Treatment Period 3 (4 Days)||3
112413|NCT01915849|276667|P2|COMPLETED|Treatment Period 3 (4 Days)||3
112414|NCT01915849|276668|P1|COMPLETED|Treatment Period 3 (4 Days)||3
112415|NCT01915849|276665|P4|STARTED|Treatment Period 3 (4 Days)||3
112416|NCT01915849|276666|P3|STARTED|Treatment Period 3 (4 Days)||3
112417|NCT01915849|276667|P2|STARTED|Treatment Period 3 (4 Days)||3
112418|NCT01915849|276668|P1|STARTED|Treatment Period 3 (4 Days)||3
112419|NCT01915849|276665|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
112420|NCT01915849|276666|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
112421|NCT01915849|276667|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
112422|NCT01915849|276668|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
112423|NCT01915849|276665|P4|COMPLETED|Treatment Period 2 (4 Days)||3
112424|NCT01915849|276666|P3|COMPLETED|Treatment Period 2 (4 Days)||3
112425|NCT01915849|276667|P2|COMPLETED|Treatment Period 2 (4 Days)||3
112426|NCT01915849|276668|P1|COMPLETED|Treatment Period 2 (4 Days)||3
112427|NCT01915849|276665|P4|STARTED|Treatment Period 2 (4 Days)||3
112428|NCT01915849|276666|P3|STARTED|Treatment Period 2 (4 Days)||3
112429|NCT01915849|276667|P2|STARTED|Treatment Period 2 (4 Days)||3
112430|NCT01915849|276668|P1|STARTED|Treatment Period 2 (4 Days)||3
112431|NCT01915849|276665|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
112432|NCT01915849|276666|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
112433|NCT01915849|276667|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
112434|NCT01915849|276668|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||2
112435|NCT01915849|276665|P4|COMPLETED|Treatment Period 1 (4 Days)||3
112436|NCT01915849|276666|P3|COMPLETED|Treatment Period 1 (4 Days)||3
112437|NCT01915849|276667|P2|COMPLETED|Treatment Period 1 (4 Days)||3
112438|NCT01915849|276668|P1|COMPLETED|Treatment Period 1 (4 Days)||3
112439|NCT01915849|276665|P4|STARTED|Treatment Period 1 (4 Days)||3
112440|NCT01915849|276666|P3|STARTED|Treatment Period 1 (4 Days)||3
112441|NCT01915849|276667|P2|STARTED|Treatment Period 1 (4 Days)||3
112442|NCT01915849|276668|P1|STARTED|Treatment Period 1 (4 Days)||5
112443|NCT01915823|276680|P2|NOT COMPLETED|Overall Study||2
112444|NCT01915823|276681|P1|NOT COMPLETED|Overall Study||2
112445|NCT01915823|276680|P2|COMPLETED|Overall Study||173
112446|NCT01915823|276681|P1|COMPLETED|Overall Study||171
112447|NCT01915823|276680|P2|STARTED|Overall Study||175
112448|NCT01915823|276681|P1|STARTED|Overall Study||173
112449|NCT01915732|276693|P2|NOT COMPLETED|Overall Study||71
112450|NCT01915732|276694|P1|NOT COMPLETED|Overall Study||70
112451|NCT01915732|276693|P2|COMPLETED|Overall Study||445
112452|NCT01915732|276694|P1|COMPLETED|Overall Study||430
112453|NCT01915732|276693|P2|STARTED|Overall Study||516
112454|NCT01915732|276694|P1|STARTED|Overall Study||500
112455|NCT01915563|276720|P2|NOT COMPLETED|Overall Study||0
112456|NCT01915563|276721|P1|NOT COMPLETED|Overall Study||0
112457|NCT01915563|276720|P2|COMPLETED|Overall Study||227
112458|NCT01915563|276721|P1|COMPLETED|Overall Study||243
112459|NCT01915563|276720|P2|STARTED|Overall Study||227
112460|NCT01915563|276721|P1|STARTED|Overall Study||243
112461|NCT01915173|276733|P4|NOT COMPLETED|Overall Study||0
112462|NCT01915173|276734|P3|NOT COMPLETED|Overall Study||0
112463|NCT01915173|276735|P2|NOT COMPLETED|Overall Study||0
112464|NCT01915173|276736|P1|NOT COMPLETED|Overall Study||0
112465|NCT01915173|276733|P4|COMPLETED|Overall Study||6
112466|NCT01915173|276734|P3|COMPLETED|Overall Study||6
112467|NCT01915173|276735|P2|COMPLETED|Overall Study||6
112468|NCT01915173|276736|P1|COMPLETED|Overall Study||6
112469|NCT01915173|276733|P4|STARTED|Overall Study||6
112470|NCT01915173|276734|P3|STARTED|Overall Study||6
112471|NCT01915173|276735|P2|STARTED|Overall Study||6
112472|NCT01915173|276736|P1|STARTED|Overall Study||6
112473|NCT01915108|276758|P4|NOT COMPLETED|Overall Study||2
112474|NCT01915108|276759|P3|NOT COMPLETED|Overall Study||1
112475|NCT01915108|276760|P2|NOT COMPLETED|Overall Study||3
112476|NCT01915108|276761|P1|NOT COMPLETED|Overall Study||2
112477|NCT01915108|276758|P4|COMPLETED|Overall Study|two patients were excluded from the study|30
112478|NCT01915108|276759|P3|COMPLETED|Overall Study|one patients were excluded from the study|31
112479|NCT01915108|276760|P2|COMPLETED|Overall Study|three patients were excluded from the study|29
112480|NCT01915108|276761|P1|COMPLETED|Overall Study|two patients were excluded from the study|30
112481|NCT01915108|276758|P4|STARTED|Overall Study||32
112482|NCT01915108|276759|P3|STARTED|Overall Study||32
112483|NCT01915108|276760|P2|STARTED|Overall Study||32
112484|NCT01915108|276761|P1|STARTED|Overall Study||32
112485|NCT01914926|276773|P2|NOT COMPLETED|Overall Study||1
112486|NCT01914926|276774|P1|NOT COMPLETED|Overall Study||1
112487|NCT01914926|276773|P2|COMPLETED|Overall Study||24
112488|NCT01914926|276774|P1|COMPLETED|Overall Study||28
112489|NCT01914926|276773|P2|STARTED|Overall Study||25
112490|NCT01914926|276774|P1|STARTED|Overall Study||29
112491|NCT01914757|276783|P3|NOT COMPLETED|Overall Study||38
112492|NCT01914757|276784|P2|NOT COMPLETED|Overall Study||51
112493|NCT01914757|276785|P1|NOT COMPLETED|Overall Study||36
112494|NCT01914757|276783|P3|COMPLETED|Overall Study||402
112495|NCT01914757|276784|P2|COMPLETED|Overall Study||390
112496|NCT01914757|276785|P1|COMPLETED|Overall Study||389
112497|NCT01914757|276783|P3|STARTED|Overall Study||440
112498|NCT01914757|276784|P2|STARTED|Overall Study||441
112499|NCT01914757|276785|P1|STARTED|Overall Study||425
112500|NCT01914679|276859|P1|NOT COMPLETED|Overall Study||5
112501|NCT01914679|276859|P1|COMPLETED|Overall Study||12
112502|NCT01914679|276859|P1|Began 12 Week Actual RINCE Treatment|Overall Study||17
112503|NCT01914679|276859|P1|STARTED|Overall Study||17
112504|NCT01914666|276866|P3|NOT COMPLETED|Tapering Period||0
112505|NCT01914666|276867|P2|NOT COMPLETED|Tapering Period||0
112506|NCT01914666|276868|P1|NOT COMPLETED|Tapering Period||0
112507|NCT01914666|276866|P3|COMPLETED|Tapering Period||40
112508|NCT01914666|276867|P2|COMPLETED|Tapering Period||39
112509|NCT01914666|276868|P1|COMPLETED|Tapering Period||59
112510|NCT01914666|276866|P3|STARTED|Tapering Period|7 Pts who discontinued, and 33 Pts who completed Treatment Period entered Tapering Period.|40
112511|NCT01914666|276867|P2|STARTED|Tapering Period|3 Pts who discontinued, and 36 Pts who completed Treatment Period entered Tapering Period.|39
112512|NCT01914666|276868|P1|STARTED|Tapering Period|4 Pts who discontinued, and 55 Pts who completed Treatment Period entered Tapering Period.|59
112513|NCT01914666|276866|P3|NOT COMPLETED|Treatment Period||8
112514|NCT01914666|276867|P2|NOT COMPLETED|Treatment Period||6
112515|NCT01914666|276868|P1|NOT COMPLETED|Treatment Period||13
112516|NCT01914666|276866|P3|COMPLETED|Treatment Period||33
112517|NCT01914666|276867|P2|COMPLETED|Treatment Period||36
112518|NCT01914666|276868|P1|COMPLETED|Treatment Period||55
112519|NCT01914666|276866|P3|Received at Least 1 Dose of Study Drug|Treatment Period||41
112520|NCT01914666|276867|P2|Received at Least 1 Dose of Study Drug|Treatment Period||42
112521|NCT01914666|276868|P1|Received at Least 1 Dose of Study Drug|Treatment Period||68
112522|NCT01914666|276866|P3|STARTED|Treatment Period||41
112523|NCT01914666|276867|P2|STARTED|Treatment Period||42
112524|NCT01914666|276868|P1|STARTED|Treatment Period||68
112525|NCT01914159|276901|P1|NOT COMPLETED|Overall Study||3
112526|NCT01914159|276901|P1|COMPLETED|Overall Study||21
112527|NCT01914159|276901|P1|STARTED|Overall Study||24
112528|NCT01914003|276909|P2|NOT COMPLETED|Overall Study||12
112529|NCT01914003|276910|P1|NOT COMPLETED|Overall Study||8
112530|NCT01914003|276909|P2|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|14
112531|NCT01914003|276910|P1|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|19
112532|NCT01914003|276909|P2|STARTED|Overall Study||26
112533|NCT01914003|276910|P1|STARTED|Overall Study||27
112534|NCT01913795|276920|P4|NOT COMPLETED|Overall Study||1
112535|NCT01913795|276921|P3|NOT COMPLETED|Overall Study||0
112536|NCT01913795|276922|P2|NOT COMPLETED|Overall Study||3
112537|NCT01913795|276923|P1|NOT COMPLETED|Overall Study||0
112538|NCT01913795|276920|P4|COMPLETED|Overall Study||5
112539|NCT01913795|276921|P3|COMPLETED|Overall Study||9
112540|NCT01913795|276922|P2|COMPLETED|Overall Study||7
112541|NCT01913795|276923|P1|COMPLETED|Overall Study||4
112542|NCT01913795|276920|P4|STARTED|Overall Study||6
112543|NCT01913795|276921|P3|STARTED|Overall Study||9
112544|NCT01913795|276922|P2|STARTED|Overall Study||10
112545|NCT01913795|276923|P1|STARTED|Overall Study||4
112546|NCT01913600|276937|P1|NOT COMPLETED|Overall Study||1
112547|NCT01913600|276937|P1|COMPLETED|Overall Study||55
112548|NCT01913600|276937|P1|STARTED|Overall Study||56
112549|NCT01913535|276959|P5|NOT COMPLETED|Phase 2 (Days 3-5)||0
112550|NCT01913535|276960|P4|NOT COMPLETED|Phase 2 (Days 3-5)||0
112551|NCT01913535|276961|P3|NOT COMPLETED|Phase 2 (Days 3-5)||0
112552|NCT01913535|276962|P2|NOT COMPLETED|Phase 2 (Days 3-5)||0
112553|NCT01913535|276963|P1|NOT COMPLETED|Phase 2 (Days 3-5)||0
112554|NCT01913535|276959|P5|COMPLETED|Phase 2 (Days 3-5)||1
112555|NCT01913535|276960|P4|COMPLETED|Phase 2 (Days 3-5)||2
112556|NCT01913535|276961|P3|COMPLETED|Phase 2 (Days 3-5)||1
112557|NCT01913535|276962|P2|COMPLETED|Phase 2 (Days 3-5)||2
112558|NCT01913535|276963|P1|COMPLETED|Phase 2 (Days 3-5)||2
112559|NCT01913535|276959|P5|STARTED|Phase 2 (Days 3-5)||1
112560|NCT01913535|276960|P4|STARTED|Phase 2 (Days 3-5)||2
112561|NCT01913535|276961|P3|STARTED|Phase 2 (Days 3-5)||1
112562|NCT01913535|276962|P2|STARTED|Phase 2 (Days 3-5)||2
112563|NCT01913535|276963|P1|STARTED|Phase 2 (Days 3-5)||2
112564|NCT01913535|276959|P5|NOT COMPLETED|Phase 1 (Days 0-2)||0
112565|NCT01913535|276960|P4|NOT COMPLETED|Phase 1 (Days 0-2)||0
112566|NCT01913535|276961|P3|NOT COMPLETED|Phase 1 (Days 0-2)||0
112567|NCT01913535|276962|P2|NOT COMPLETED|Phase 1 (Days 0-2)||0
112568|NCT01913535|276963|P1|NOT COMPLETED|Phase 1 (Days 0-2)||0
112569|NCT01913535|276959|P5|COMPLETED|Phase 1 (Days 0-2)||1
112570|NCT01913535|276960|P4|COMPLETED|Phase 1 (Days 0-2)||2
112571|NCT01913535|276961|P3|COMPLETED|Phase 1 (Days 0-2)||1
112572|NCT01913535|276962|P2|COMPLETED|Phase 1 (Days 0-2)||2
112573|NCT01913535|276963|P1|COMPLETED|Phase 1 (Days 0-2)||2
112574|NCT01913535|276959|P5|STARTED|Phase 1 (Days 0-2)||1
112575|NCT01913535|276960|P4|STARTED|Phase 1 (Days 0-2)||2
112576|NCT01913535|276961|P3|STARTED|Phase 1 (Days 0-2)||1
112577|NCT01913535|276962|P2|STARTED|Phase 1 (Days 0-2)||2
112578|NCT01913535|276963|P1|STARTED|Phase 1 (Days 0-2)||2
112579|NCT01913483|276996|P2|NOT COMPLETED|Overall Study||22
112580|NCT01913483|276997|P1|NOT COMPLETED|Overall Study||21
112581|NCT01913483|276996|P2|COMPLETED|Overall Study||343
112582|NCT01913483|276997|P1|COMPLETED|Overall Study||346
112583|NCT01913483|276996|P2|Received at Least 1 Dose of Study Drug|Overall Study||321
112584|NCT01913483|276997|P1|Received at Least 1 Dose of Study Drug|Overall Study||335
112585|NCT01913483|276996|P2|STARTED|Overall Study||365
112586|NCT01913483|276997|P1|STARTED|Overall Study||367
112587|NCT01913470|277009|P2|NOT COMPLETED|Overall Study||3
112588|NCT01913470|277010|P1|NOT COMPLETED|Overall Study||0
112589|NCT01913470|277009|P2|COMPLETED|Overall Study||4
112590|NCT01913470|277010|P1|COMPLETED|Overall Study||5
112591|NCT01913470|277009|P2|STARTED|Overall Study||7
112592|NCT01913470|277010|P1|STARTED|Overall Study||5
112593|NCT01913405|277028|P1|NOT COMPLETED|Overall Study||2
112594|NCT01913405|277028|P1|COMPLETED|Overall Study||20
112595|NCT01913405|277028|P1|STARTED|Overall Study||22
112596|NCT01913314|277082|P1|NOT COMPLETED|Overall Study||0
112597|NCT01913314|277082|P1|COMPLETED|Overall Study||6
112598|NCT01913314|277082|P1|Received Study Drug|Overall Study||6
112599|NCT01913314|277082|P1|STARTED|Overall Study||6
112600|NCT01913041|277095|P1|NOT COMPLETED|Overall Study||39
112601|NCT01913041|277095|P1|COMPLETED|Overall Study||830
112602|NCT01913041|277095|P1|STARTED|Overall Study||869
112603|NCT01912963|277102|P3|NOT COMPLETED|Overall Study||7
112604|NCT01912963|277103|P2|NOT COMPLETED|Overall Study||19
112605|NCT01912963|277104|P1|NOT COMPLETED|Overall Study||6
112606|NCT01912963|277102|P3|COMPLETED|Overall Study||0
112607|NCT01912963|277103|P2|COMPLETED|Overall Study||0
112608|NCT01912963|277104|P1|COMPLETED|Overall Study||0
112609|NCT01912963|277102|P3|STARTED|Overall Study||7
112610|NCT01912963|277103|P2|STARTED|Overall Study||19
112611|NCT01912963|277104|P1|STARTED|Overall Study||6
112612|NCT01912872|277127|P4|NOT COMPLETED|Overall Study||12
112613|NCT01912872|277128|P3|NOT COMPLETED|Overall Study||10
112614|NCT01912872|277129|P2|NOT COMPLETED|Overall Study||4
112615|NCT01912872|277130|P1|NOT COMPLETED|Overall Study||5
112616|NCT01912872|277127|P4|COMPLETED|Overall Study||27
112617|NCT01912872|277128|P3|COMPLETED|Overall Study||30
112618|NCT01912872|277129|P2|COMPLETED|Overall Study||13
112619|NCT01912872|277130|P1|COMPLETED|Overall Study||11
112620|NCT01912872|277127|P4|Discontinued Treatment Prior to Month 12|Overall Study||11
112621|NCT01912872|277128|P3|Discontinued Treatment Prior to Month 12|Overall Study||10
112622|NCT01912872|277129|P2|Discontinued Treatment Prior to Month 12|Overall Study||4
112623|NCT01912872|277130|P1|Discontinued Treatment Prior to Month 12|Overall Study||5
112624|NCT01912872|277127|P4|Completed Study Treatment at Month 12|Overall Study||27
112625|NCT01912872|277128|P3|Completed Study Treatment at Month 12|Overall Study||30
112626|NCT01912872|277129|P2|Completed Study Treatment at Month 12|Overall Study||13
112627|NCT01912872|277130|P1|Completed Study Treatment at Month 12|Overall Study||11
112628|NCT01912872|277127|P4|STARTED|Overall Study||39
112629|NCT01912872|277128|P3|STARTED|Overall Study||40
112630|NCT01912872|277129|P2|STARTED|Overall Study||17
112631|NCT01912872|277130|P1|STARTED|Overall Study||16
112632|NCT01912781|277174|P2|NOT COMPLETED|Overall Study||0
112633|NCT01912781|277175|P1|NOT COMPLETED|Overall Study||2
112634|NCT01912781|277174|P2|COMPLETED|Overall Study||35
112635|NCT01912781|277175|P1|COMPLETED|Overall Study||69
112636|NCT01912781|277174|P2|STARTED|Overall Study||35
112637|NCT01912781|277175|P1|STARTED|Overall Study||71
112638|NCT01912768|277206|P2|NOT COMPLETED|Overall Study||4
112639|NCT01912768|277207|P1|NOT COMPLETED|Overall Study||10
112640|NCT01912768|277206|P2|COMPLETED|Overall Study||109
112641|NCT01912768|277207|P1|COMPLETED|Overall Study||229
112642|NCT01912768|277206|P2|STARTED|Overall Study||113
112643|NCT01912768|277207|P1|STARTED|Overall Study||239
112644|NCT01912729|277238|P2|NOT COMPLETED|Overall Study||1
112645|NCT01912729|277239|P1|NOT COMPLETED|Overall Study||0
112646|NCT01912729|277238|P2|COMPLETED|Overall Study||19
112647|NCT01912729|277239|P1|COMPLETED|Overall Study||20
112648|NCT01912729|277238|P2|STARTED|Overall Study||20
112649|NCT01912729|277239|P1|STARTED|Overall Study||20
112650|NCT01912716|277251|P2|NOT COMPLETED|Overall Study||0
112651|NCT01912716|277252|P1|NOT COMPLETED|Overall Study||0
112652|NCT01912716|277251|P2|COMPLETED|Overall Study||515
112653|NCT01912716|277252|P1|COMPLETED|Overall Study||522
112654|NCT01912716|277251|P2|3-day Follow-up|Overall Study||513
112655|NCT01912716|277252|P1|3-day Follow-up|Overall Study||521
112656|NCT01912716|277251|P2|5-day Follow-up|Overall Study||515
112657|NCT01912716|277252|P1|5-day Follow-up|Overall Study||522
112658|NCT01912716|277251|P2|Receipt of 2nd Dose|Overall Study||503
112659|NCT01912716|277252|P1|Receipt of 2nd Dose|Overall Study||511
112660|NCT01912716|277251|P2|STARTED|Overall Study||515
112661|NCT01912716|277252|P1|STARTED|Overall Study|receipt of 1st dose of indomethacin|522
112662|NCT01912599|277262|P2|NOT COMPLETED|Overall Study||1
112663|NCT01912599|277263|P1|NOT COMPLETED|Overall Study||0
112664|NCT01912599|277262|P2|COMPLETED|Overall Study||15
112665|NCT01912599|277263|P1|COMPLETED|Overall Study||20
112666|NCT01912599|277262|P2|STARTED|Overall Study||16
112667|NCT01912599|277263|P1|STARTED|Overall Study||20
112668|NCT01912495|277277|P1|NOT COMPLETED|Overall Study||0
112669|NCT01912495|277277|P1|COMPLETED|Overall Study||57
112670|NCT01912495|277277|P1|STARTED|Overall Study|8 patients had only screening visit, total enrollment: 65|57
112671|NCT01912404|277288|P2|NOT COMPLETED|Overall Study||0
112672|NCT01912404|277289|P1|NOT COMPLETED|Overall Study||1
112673|NCT01912404|277288|P2|COMPLETED|Overall Study||2
112674|NCT01912404|277289|P1|COMPLETED|Overall Study||2
112675|NCT01912404|277288|P2|STARTED|Overall Study||2
112676|NCT01912404|277289|P1|STARTED|Overall Study||3
112677|NCT01912352|277295|P1|NOT COMPLETED|Overall Study||5
112678|NCT01912352|277295|P1|COMPLETED|Overall Study||78
112679|NCT01912352|277295|P1|STARTED|Overall Study||83
112680|NCT01912339|277302|P3|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||53
112681|NCT01912339|277303|P2|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
112682|NCT01912339|277304|P1|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||133
112683|NCT01912339|277302|P3|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
112684|NCT01912339|277303|P2|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
112685|NCT01912339|277304|P1|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
112686|NCT01912339|277302|P3|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|Control subjects that have crossed over.|53
112687|NCT01912339|277303|P2|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|All subjects for the control group either completed study or crossed over.|0
112688|NCT01912339|277304|P1|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)||133
112689|NCT01912339|277302|P3|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
112690|NCT01912339|277303|P2|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
112691|NCT01912339|277304|P1|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||1
112692|NCT01912339|277302|P3|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|0
112693|NCT01912339|277303|P2|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Of the 61 subjects, there were 53 crossover subjects and 8 that completed their study participation.|61
112694|NCT01912339|277304|P1|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|133
112695|NCT01912339|277302|P3|STARTED|Unblinded (3 to 6 Months/Crossover)||0
112696|NCT01912339|277303|P2|STARTED|Unblinded (3 to 6 Months/Crossover)||61
112697|NCT01912339|277304|P1|STARTED|Unblinded (3 to 6 Months/Crossover)||134
112698|NCT01912339|277302|P3|NOT COMPLETED|Blinded (0 to 3 Months)||0
112699|NCT01912339|277303|P2|NOT COMPLETED|Blinded (0 to 3 Months)||0
112700|NCT01912339|277304|P1|NOT COMPLETED|Blinded (0 to 3 Months)||2
112701|NCT01912339|277302|P3|COMPLETED|Blinded (0 to 3 Months)||0
112702|NCT01912339|277303|P2|COMPLETED|Blinded (0 to 3 Months)||61
112703|NCT01912339|277304|P1|COMPLETED|Blinded (0 to 3 Months)||134
112704|NCT01912339|277302|P3|STARTED|Blinded (0 to 3 Months)||0
112705|NCT01912339|277303|P2|STARTED|Blinded (0 to 3 Months)||61
112706|NCT01912339|277304|P1|STARTED|Blinded (0 to 3 Months)||136
112707|NCT01912222|277321|P3|NOT COMPLETED|Part B: Treatment Period||20
112708|NCT01912222|277322|P2|NOT COMPLETED|Part B: Treatment Period||15
112709|NCT01912222|277323|P1|NOT COMPLETED|Part B: Treatment Period||13
112710|NCT01912222|277321|P3|COMPLETED|Part B: Treatment Period||0
112711|NCT01912222|277322|P2|COMPLETED|Part B: Treatment Period||0
112712|NCT01912222|277323|P1|COMPLETED|Part B: Treatment Period||0
112713|NCT01912222|277321|P3|STARTED|Part B: Treatment Period||20
112714|NCT01912222|277322|P2|STARTED|Part B: Treatment Period||15
112715|NCT01912222|277323|P1|STARTED|Part B: Treatment Period||13
112716|NCT01912222|277321|P3|NOT COMPLETED|Part A: Pharmacokinetic Period||2
112717|NCT01912222|277322|P2|NOT COMPLETED|Part A: Pharmacokinetic Period||2
112718|NCT01912222|277323|P1|NOT COMPLETED|Part A: Pharmacokinetic Period||1
112719|NCT01912222|277321|P3|COMPLETED|Part A: Pharmacokinetic Period||18
112720|NCT01912222|277322|P2|COMPLETED|Part A: Pharmacokinetic Period||13
112721|NCT01912222|277323|P1|COMPLETED|Part A: Pharmacokinetic Period||12
112722|NCT01912222|277321|P3|STARTED|Part A: Pharmacokinetic Period||20
112723|NCT01912222|277322|P2|STARTED|Part A: Pharmacokinetic Period||15
112724|NCT01912222|277323|P1|STARTED|Part A: Pharmacokinetic Period||13
112725|NCT01911845|277346|P1|NOT COMPLETED|Overall Study||6
112726|NCT01911845|277346|P1|COMPLETED|Overall Study||32
112727|NCT01911845|277346|P1|Completed Study Drug|Overall Study||37
112728|NCT01911845|277346|P1|STARTED|Overall Study||38
112729|NCT01911819|277363|P3|NOT COMPLETED|Overall Study||0
112730|NCT01911819|277364|P2|NOT COMPLETED|Overall Study||2
112731|NCT01911819|277365|P1|NOT COMPLETED|Overall Study||1
112732|NCT01911819|277363|P3|COMPLETED|Overall Study||10
112733|NCT01911819|277364|P2|COMPLETED|Overall Study||9
112734|NCT01911819|277365|P1|COMPLETED|Overall Study||9
112735|NCT01911819|277363|P3|STARTED|Overall Study||10
112736|NCT01911819|277364|P2|STARTED|Overall Study|One of 10 sinuses was replaced to another sinus due to infection.|11
112737|NCT01911819|277365|P1|STARTED|Overall Study||10
112738|NCT01911793|277378|P2|NOT COMPLETED|Overall Study||5
112739|NCT01911793|277379|P1|NOT COMPLETED|Overall Study||1
112740|NCT01911793|277378|P2|COMPLETED|Overall Study||0
112741|NCT01911793|277379|P1|COMPLETED|Overall Study||0
112742|NCT01911793|277378|P2|STARTED|Overall Study||5
112743|NCT01911793|277379|P1|STARTED|Overall Study||1
112744|NCT01911780|277403|P2|NOT COMPLETED|Extension Period (52 Weeks)||3
112745|NCT01911780|277404|P1|NOT COMPLETED|Extension Period (52 Weeks)||4
112746|NCT01911780|277403|P2|COMPLETED|Extension Period (52 Weeks)||58
112747|NCT01911780|277404|P1|COMPLETED|Extension Period (52 Weeks)||61
112748|NCT01911780|277403|P2|STARTED|Extension Period (52 Weeks)||61
112749|NCT01911780|277404|P1|STARTED|Extension Period (52 Weeks)||65
112750|NCT01911780|277403|P2|NOT COMPLETED|Double-blind Period (8 Weeks)||3
112751|NCT01911780|277404|P1|NOT COMPLETED|Double-blind Period (8 Weeks)||3
112752|NCT01911780|277403|P2|COMPLETED|Double-blind Period (8 Weeks)||61
112753|NCT01911780|277404|P1|COMPLETED|Double-blind Period (8 Weeks)||65
112754|NCT01911780|277403|P2|STARTED|Double-blind Period (8 Weeks)||64
112755|NCT01911780|277404|P1|STARTED|Double-blind Period (8 Weeks)||68
112756|NCT01911689|277424|P2|NOT COMPLETED|Overall Study||0
112757|NCT01911689|277425|P1|NOT COMPLETED|Overall Study||0
112758|NCT01911689|277424|P2|COMPLETED|Overall Study||51
112759|NCT01911689|277425|P1|COMPLETED|Overall Study||117
112760|NCT01911689|277424|P2|STARTED|Overall Study||51
112761|NCT01911689|277425|P1|STARTED|Overall Study||117
112762|NCT01911546|277438|P1|NOT COMPLETED|Overall Study||6
112763|NCT01911546|277438|P1|COMPLETED|Overall Study||14
112764|NCT01911546|277438|P1|STARTED|Overall Study||20
112765|NCT01911442|277448|P3|NOT COMPLETED|Overall Study||12
112766|NCT01911442|277449|P2|NOT COMPLETED|Overall Study||4
112767|NCT01911442|277450|P1|NOT COMPLETED|Overall Study||6
112768|NCT01911442|277448|P3|COMPLETED|Overall Study||38
112769|NCT01911442|277449|P2|COMPLETED|Overall Study||47
112770|NCT01911442|277450|P1|COMPLETED|Overall Study||43
112771|NCT01911442|277448|P3|STARTED|Overall Study||50
112772|NCT01911442|277449|P2|STARTED|Overall Study||51
112773|NCT01911442|277450|P1|STARTED|Overall Study||49
112774|NCT01911429|277479|P3|NOT COMPLETED|Overall Study||20
112775|NCT01911429|277480|P2|NOT COMPLETED|Overall Study||10
112776|NCT01911429|277481|P1|NOT COMPLETED|Overall Study||12
112777|NCT01911429|277479|P3|COMPLETED|Overall Study||93
112778|NCT01911429|277480|P2|COMPLETED|Overall Study||96
112779|NCT01911429|277481|P1|COMPLETED|Overall Study||96
112780|NCT01911429|277479|P3|STARTED|Overall Study|one subject randomized to Placebo group was never dosed for study medication, making the total 112|113
112781|NCT01911429|277480|P2|STARTED|Overall Study|Subjects received lurasidone 40/mg day from Days 1-3, and 80mg/day from days 4 to Week 6 visit|106
112782|NCT01911429|277481|P1|STARTED|Overall Study||108
112783|NCT01911403|277515|P2|NOT COMPLETED|Overall Study||3
112784|NCT01911403|277516|P1|NOT COMPLETED|Overall Study||9
112785|NCT01911403|277515|P2|COMPLETED|Overall Study||59
112786|NCT01911403|277516|P1|COMPLETED|Overall Study||52
112787|NCT01911403|277515|P2|STARTED|Overall Study||62
112788|NCT01911403|277516|P1|STARTED|Overall Study||61
112789|NCT01911390|277537|P4|NOT COMPLETED|Overall Study||1
112790|NCT01911390|277538|P3|NOT COMPLETED|Overall Study||1
112791|NCT01911390|277539|P2|NOT COMPLETED|Overall Study||0
112792|NCT01911390|277540|P1|NOT COMPLETED|Overall Study||1
112793|NCT01911390|277537|P4|COMPLETED|Overall Study||10
112794|NCT01911390|277538|P3|COMPLETED|Overall Study||9
112795|NCT01911390|277539|P2|COMPLETED|Overall Study||10
112796|NCT01911390|277540|P1|COMPLETED|Overall Study||9
112797|NCT01911390|277537|P4|STARTED|Overall Study||11
112798|NCT01911390|277538|P3|STARTED|Overall Study||10
112799|NCT01911390|277539|P2|STARTED|Overall Study||10
112800|NCT01911390|277540|P1|STARTED|Overall Study||10
112801|NCT01911351|277556|P2|NOT COMPLETED|Overall Study||0
112802|NCT01911351|277557|P1|NOT COMPLETED|Overall Study||0
112803|NCT01911351|277556|P2|COMPLETED|Overall Study||43
112804|NCT01911351|277557|P1|COMPLETED|Overall Study||39
112805|NCT01911351|277556|P2|STARTED|Overall Study||43
112806|NCT01911351|277557|P1|STARTED|Overall Study||39
112807|NCT01911273|277573|P2|NOT COMPLETED|Overall Study||2
112808|NCT01911273|277574|P1|NOT COMPLETED|Overall Study||1
112809|NCT01911273|277573|P2|COMPLETED|Overall Study||0
112810|NCT01911273|277574|P1|COMPLETED|Overall Study||0
112811|NCT01911273|277573|P2|STARTED|Overall Study||2
112812|NCT01911273|277574|P1|STARTED|Overall Study||1
112813|NCT01911260|277608|P4|NOT COMPLETED|Follow-up Period||12
112814|NCT01911260|277609|P3|NOT COMPLETED|Follow-up Period||15
112815|NCT01911260|277610|P2|NOT COMPLETED|Follow-up Period||20
112816|NCT01911260|277611|P1|NOT COMPLETED|Follow-up Period||13
112817|NCT01911260|277608|P4|COMPLETED|Follow-up Period||30
112818|NCT01911260|277609|P3|COMPLETED|Follow-up Period||24
112819|NCT01911260|277610|P2|COMPLETED|Follow-up Period||18
112820|NCT01911260|277611|P1|COMPLETED|Follow-up Period||27
112821|NCT01911260|277608|P4|STARTED|Follow-up Period||42
112822|NCT01911260|277609|P3|STARTED|Follow-up Period||39
112823|NCT01911260|277610|P2|STARTED|Follow-up Period||38
112824|NCT01911260|277611|P1|STARTED|Follow-up Period||40
112825|NCT01911260|277608|P4|NOT COMPLETED|Supplementation Period||8
112826|NCT01911260|277609|P3|NOT COMPLETED|Supplementation Period||10
112827|NCT01911260|277610|P2|NOT COMPLETED|Supplementation Period||12
112828|NCT01911260|277611|P1|NOT COMPLETED|Supplementation Period||10
112829|NCT01911260|277608|P4|COMPLETED|Supplementation Period||42
112830|NCT01911260|277609|P3|COMPLETED|Supplementation Period||39
112831|NCT01911260|277610|P2|COMPLETED|Supplementation Period||38
112832|NCT01911260|277611|P1|COMPLETED|Supplementation Period||40
112833|NCT01911260|277608|P4|STARTED|Supplementation Period||50
112834|NCT01911260|277609|P3|STARTED|Supplementation Period||49
112835|NCT01911260|277610|P2|STARTED|Supplementation Period||50
112836|NCT01911260|277611|P1|STARTED|Supplementation Period||50
112837|NCT01911221|277621|P1|NOT COMPLETED|Overall Study||0
112838|NCT01911221|277621|P1|COMPLETED|Overall Study||13
112839|NCT01911221|277621|P1|STARTED|Overall Study||13
112840|NCT01911169|277637|P2|NOT COMPLETED|Overall Study||0
112841|NCT01911169|277638|P1|NOT COMPLETED|Overall Study||0
112842|NCT01911169|277637|P2|COMPLETED|Overall Study||3
112843|NCT01911169|277638|P1|COMPLETED|Overall Study||6
112844|NCT01911169|277637|P2|STARTED|Overall Study||3
112845|NCT01911169|277638|P1|STARTED|Overall Study||6
112846|NCT01911065|277648|P2|NOT COMPLETED|Overall Study||0
112847|NCT01911065|277649|P1|NOT COMPLETED|Overall Study||0
112848|NCT01911065|277648|P2|COMPLETED|Overall Study||9
112849|NCT01911065|277649|P1|COMPLETED|Overall Study||45
112850|NCT01911065|277648|P2|STARTED|Overall Study||9
112851|NCT01911065|277649|P1|STARTED|Overall Study||45
112852|NCT01910831|277657|P1|NOT COMPLETED|Overall Study||1
112853|NCT01910831|277657|P1|COMPLETED|Overall Study||19
112854|NCT01910831|277657|P1|STARTED|Overall Study||20
112855|NCT01910792|277666|P2|NOT COMPLETED|Overall Study||0
112856|NCT01910792|277667|P1|NOT COMPLETED|Overall Study||0
112857|NCT01910792|277666|P2|COMPLETED|Overall Study||10
112858|NCT01910792|277667|P1|COMPLETED|Overall Study||9
112859|NCT01910792|277666|P2|STARTED|Overall Study||10
112860|NCT01910792|277667|P1|STARTED|Overall Study||9
112861|NCT01910688|277673|P1|NOT COMPLETED|Overall Study||5
112862|NCT01910688|277673|P1|COMPLETED|Overall Study||20
112863|NCT01910688|277673|P1|12months|Overall Study||22
112864|NCT01910688|277673|P1|3rd RFA Treatment|Overall Study||18
112865|NCT01910688|277673|P1|7.5months|Overall Study||24
112866|NCT01910688|277673|P1|2nd RFA Treatment|Overall Study||22
112867|NCT01910688|277673|P1|3.5month|Overall Study||25
112868|NCT01910688|277673|P1|STARTED|Overall Study||25
112869|NCT01910636|277682|P2|NOT COMPLETED|Overall Study||0
112870|NCT01910636|277683|P1|NOT COMPLETED|Overall Study||0
112871|NCT01910636|277682|P2|COMPLETED|Overall Study||63
112872|NCT01910636|277683|P1|COMPLETED|Overall Study||90
112873|NCT01910636|277682|P2|STARTED|Overall Study||63
112874|NCT01910636|277683|P1|STARTED|Overall Study||90
112875|NCT01910519|277697|P2|NOT COMPLETED|Overall Study||0
112876|NCT01910519|277698|P1|NOT COMPLETED|Overall Study||4
112877|NCT01910519|277697|P2|COMPLETED|Overall Study||15
112878|NCT01910519|277698|P1|COMPLETED|Overall Study||31
112879|NCT01910519|277697|P2|STARTED|Overall Study||15
112880|NCT01910519|277698|P1|STARTED|Overall Study||35
112881|NCT01910441|277724|P2|NOT COMPLETED|Overall Study||10
112882|NCT01910441|277725|P1|NOT COMPLETED|Overall Study||7
112883|NCT01910441|277724|P2|COMPLETED|Overall Study||37
112884|NCT01910441|277725|P1|COMPLETED|Overall Study||41
112885|NCT01910441|277724|P2|STARTED|Overall Study||47
112886|NCT01910441|277725|P1|STARTED|Overall Study||48
112887|NCT01910402|277733|P2|NOT COMPLETED|Continuation Phase||0
112888|NCT01910402|277734|P1|NOT COMPLETED|Continuation Phase||90
112889|NCT01910402|277733|P2|COMPLETED|Continuation Phase||0
112890|NCT01910402|277734|P1|COMPLETED|Continuation Phase||30
112891|NCT01910402|277733|P2|STARTED|Continuation Phase||0
112892|NCT01910402|277734|P1|STARTED|Continuation Phase||120
112893|NCT01910402|277733|P2|NOT COMPLETED|Randomized Phase||55
112894|NCT01910402|277734|P1|NOT COMPLETED|Randomized Phase||42
112895|NCT01910402|277733|P2|COMPLETED|Randomized Phase||192
112896|NCT01910402|277734|P1|COMPLETED|Randomized Phase||206
112897|NCT01910402|277733|P2|STARTED|Randomized Phase||247
112898|NCT01910402|277734|P1|STARTED|Randomized Phase||248
112899|NCT01910389|277804|P2|NOT COMPLETED|Overall Study||8
112900|NCT01910389|277805|P1|NOT COMPLETED|Overall Study||15
112901|NCT01910389|277804|P2|COMPLETED|Overall Study||0
112902|NCT01910389|277805|P1|COMPLETED|Overall Study||0
112903|NCT01910389|277804|P2|STARTED|Overall Study||8
112904|NCT01910389|277805|P1|STARTED|Overall Study||15
112905|NCT01910311|277835|P1|NOT COMPLETED|Period 2 (Days 3-32)||0
112906|NCT01910311|277835|P1|COMPLETED|Period 2 (Days 3-32)||18
112907|NCT01910311|277835|P1|Received At Least 1 Dose of Rifampicin|Period 2 (Days 3-32)||18
112908|NCT01910311|277835|P1|Received Baricitinib|Period 2 (Days 3-32)||18
112909|NCT01910311|277835|P1|STARTED|Period 2 (Days 3-32)||18
112910|NCT01910311|277835|P1|NOT COMPLETED|Period 1 (Days 1-2)||0
112911|NCT01910311|277835|P1|COMPLETED|Period 1 (Days 1-2)||18
112912|NCT01910311|277835|P1|Received Baricitinib|Period 1 (Days 1-2)||18
112913|NCT01910311|277835|P1|STARTED|Period 1 (Days 1-2)||18
112914|NCT01910181|277846|P1|NOT COMPLETED|Overall Study||46
112915|NCT01910181|277846|P1|COMPLETED|Overall Study||0
112916|NCT01910181|277846|P1|Expansion Cohort|Overall Study||26
112917|NCT01910181|277846|P1|PK Cohort|Overall Study||20
112918|NCT01910181|277846|P1|STARTED|Overall Study||46
112919|NCT01910129|277873|P3|NOT COMPLETED|Randomized Phase 3||0
112920|NCT01910129|277874|P2|NOT COMPLETED|Randomized Phase 3||1
112921|NCT01910129|277875|P1|NOT COMPLETED|Randomized Phase 3||0
112922|NCT01910129|277873|P3|COMPLETED|Randomized Phase 3||0
112923|NCT01910129|277874|P2|COMPLETED|Randomized Phase 3||4
112924|NCT01910129|277875|P1|COMPLETED|Randomized Phase 3||5
112925|NCT01910129|277873|P3|STARTED|Randomized Phase 3||0
112926|NCT01910129|277874|P2|STARTED|Randomized Phase 3||5
112927|NCT01910129|277875|P1|STARTED|Randomized Phase 3||5
112928|NCT01910129|277873|P3|NOT COMPLETED|Randomized Phase 2||0
112929|NCT01910129|277874|P2|NOT COMPLETED|Randomized Phase 2||1
112930|NCT01910129|277875|P1|NOT COMPLETED|Randomized Phase 2||2
112931|NCT01910129|277873|P3|COMPLETED|Randomized Phase 2||0
112932|NCT01910129|277874|P2|COMPLETED|Randomized Phase 2||5
112933|NCT01910129|277875|P1|COMPLETED|Randomized Phase 2||5
112934|NCT01910129|277873|P3|STARTED|Randomized Phase 2||0
112935|NCT01910129|277874|P2|STARTED|Randomized Phase 2||6
112936|NCT01910129|277875|P1|STARTED|Randomized Phase 2||7
112937|NCT01910129|277873|P3|NOT COMPLETED|Run-in Period Phase 1||0
112938|NCT01910129|277874|P2|NOT COMPLETED|Run-in Period Phase 1||0
112939|NCT01910129|277875|P1|NOT COMPLETED|Run-in Period Phase 1||0
112940|NCT01910129|277873|P3|COMPLETED|Run-in Period Phase 1||13
112941|NCT01910129|277874|P2|COMPLETED|Run-in Period Phase 1||0
112942|NCT01910129|277875|P1|COMPLETED|Run-in Period Phase 1||0
112943|NCT01910129|277873|P3|STARTED|Run-in Period Phase 1||13
112944|NCT01910129|277874|P2|STARTED|Run-in Period Phase 1||0
112945|NCT01910129|277875|P1|STARTED|Run-in Period Phase 1||0
112946|NCT01910116|277899|P2|NOT COMPLETED|Overall Study||16
112947|NCT01910116|277900|P1|NOT COMPLETED|Overall Study||14
112948|NCT01910116|277899|P2|COMPLETED|Overall Study||94
112949|NCT01910116|277900|P1|COMPLETED|Overall Study||96
112950|NCT01910116|277899|P2|Week 16|Overall Study||94
112951|NCT01910116|277900|P1|Week 16|Overall Study||96
112952|NCT01910116|277899|P2|Week 12|Overall Study||96
112953|NCT01910116|277900|P1|Week 12|Overall Study||97
112954|NCT01910116|277899|P2|Week 8|Overall Study||99
112955|NCT01910116|277900|P1|Week 8|Overall Study||98
112956|NCT01910116|277899|P2|Week 4|Overall Study||102
112957|NCT01910116|277900|P1|Week 4|Overall Study||106
112958|NCT01910116|277899|P2|STARTED|Overall Study||110
112959|NCT01910116|277900|P1|STARTED|Overall Study||110
112960|NCT01910064|277976|P1|NOT COMPLETED|Overall Study||45
112961|NCT01910064|277976|P1|COMPLETED|Overall Study||391
112962|NCT01910064|277976|P1|STARTED|Overall Study||436
112963|NCT01909973|277987|P2|NOT COMPLETED|Overall Study||0
112964|NCT01909973|277988|P1|NOT COMPLETED|Overall Study||1
112965|NCT01909973|277987|P2|COMPLETED|Overall Study||7
112966|NCT01909973|277988|P1|COMPLETED|Overall Study||7
112967|NCT01909973|277987|P2|STARTED|Overall Study||7
112968|NCT01909973|277988|P1|STARTED|Overall Study||8
112969|NCT01909804|278008|P12|NOT COMPLETED|Overall Study||3
112970|NCT01909804|278009|P11|NOT COMPLETED|Overall Study||1
112971|NCT01909804|278010|P10|NOT COMPLETED|Overall Study||1
112972|NCT01909804|278011|P9|NOT COMPLETED|Overall Study||0
112973|NCT01909804|278012|P8|NOT COMPLETED|Overall Study||1
112974|NCT01909804|278013|P7|NOT COMPLETED|Overall Study||2
112975|NCT01909804|278014|P6|NOT COMPLETED|Overall Study||4
112976|NCT01909804|278015|P5|NOT COMPLETED|Overall Study||8
112977|NCT01909804|278016|P4|NOT COMPLETED|Overall Study||0
112978|NCT01909804|278017|P3|NOT COMPLETED|Overall Study||0
112979|NCT01909804|278018|P2|NOT COMPLETED|Overall Study||1
112980|NCT01909804|278019|P1|NOT COMPLETED|Overall Study||4
112981|NCT01909804|278008|P12|COMPLETED|Overall Study||26
112982|NCT01909804|278009|P11|COMPLETED|Overall Study||26
112983|NCT01909804|278010|P10|COMPLETED|Overall Study||28
112984|NCT01909804|278011|P9|COMPLETED|Overall Study||27
112985|NCT01909804|278012|P8|COMPLETED|Overall Study||25
112986|NCT01909804|278013|P7|COMPLETED|Overall Study||25
112987|NCT01909804|278014|P6|COMPLETED|Overall Study||21
112988|NCT01909804|278015|P5|COMPLETED|Overall Study||18
112989|NCT01909804|278016|P4|COMPLETED|Overall Study||26
112990|NCT01909804|278017|P3|COMPLETED|Overall Study||27
112991|NCT01909804|278018|P2|COMPLETED|Overall Study||27
112992|NCT01909804|278019|P1|COMPLETED|Overall Study||22
112993|NCT01909804|278008|P12|STARTED|Overall Study||29
112994|NCT01909804|278009|P11|STARTED|Overall Study||27
112995|NCT01909804|278010|P10|STARTED|Overall Study||29
112996|NCT01909804|278011|P9|STARTED|Overall Study||27
112997|NCT01909804|278012|P8|STARTED|Overall Study||26
112998|NCT01909804|278013|P7|STARTED|Overall Study||27
112999|NCT01909804|278014|P6|STARTED|Overall Study||25
113000|NCT01909804|278015|P5|STARTED|Overall Study||26
113001|NCT01909804|278016|P4|STARTED|Overall Study||26
113002|NCT01909804|278017|P3|STARTED|Overall Study||27
113003|NCT01909804|278018|P2|STARTED|Overall Study||28
113004|NCT01909804|278019|P1|STARTED|Overall Study||26
113005|NCT01909778|278065|P1|NOT COMPLETED|Overall Study||1
113006|NCT01909778|278065|P1|COMPLETED|Overall Study||1
113007|NCT01909778|278065|P1|STARTED|Overall Study||2
113008|NCT01909713|278089|P1|NOT COMPLETED|Overall Study||0
113009|NCT01909713|278089|P1|COMPLETED|Overall Study||35
113010|NCT01909713|278089|P1|STARTED|Overall Study||35
113011|NCT01909674|278144|P2|NOT COMPLETED|Overall Study||2
113012|NCT01909674|278145|P1|NOT COMPLETED|Overall Study||5
113013|NCT01909674|278144|P2|COMPLETED|Overall Study||7
113014|NCT01909674|278145|P1|COMPLETED|Overall Study||7
113015|NCT01909674|278144|P2|STARTED|Overall Study||9
113016|NCT01909674|278145|P1|STARTED|Overall Study||12
113017|NCT01909570|278153|P2|NOT COMPLETED|Overall Study||27
113018|NCT01909570|278154|P1|NOT COMPLETED|Overall Study||27
113019|NCT01909570|278153|P2|COMPLETED|Overall Study||64
113020|NCT01909570|278154|P1|COMPLETED|Overall Study||57
113021|NCT01909570|278153|P2|STARTED|Overall Study||91
113022|NCT01909570|278154|P1|STARTED|Overall Study||84
113023|NCT01909466|278164|P2|NOT COMPLETED|Overall Study||23
113024|NCT01909466|278165|P1|NOT COMPLETED|Overall Study||22
113025|NCT01909466|278164|P2|COMPLETED|Overall Study||50
113026|NCT01909466|278165|P1|COMPLETED|Overall Study||46
113027|NCT01909466|278164|P2|STARTED|Overall Study||73
113028|NCT01909466|278165|P1|STARTED|Overall Study||68
113029|NCT01909336|278188|P3|NOT COMPLETED|Overall Study||3
113030|NCT01909336|278189|P2|NOT COMPLETED|Overall Study||3
113031|NCT01909336|278190|P1|NOT COMPLETED|Overall Study||4
113032|NCT01909336|278188|P3|COMPLETED|Overall Study||52
113033|NCT01909336|278189|P2|COMPLETED|Overall Study||50
113034|NCT01909336|278190|P1|COMPLETED|Overall Study||49
113035|NCT01909336|278188|P3|STARTED|Overall Study||55
113036|NCT01909336|278189|P2|STARTED|Overall Study||53
113037|NCT01909336|278190|P1|STARTED|Overall Study||53
113038|NCT01909180|278204|P1|NOT COMPLETED|Overall Study||0
113039|NCT01909180|278204|P1|COMPLETED|Overall Study||49
113040|NCT01909180|278204|P1|STARTED|Overall Study||49
113041|NCT01909154|278210|P1|NOT COMPLETED|Overall Study||0
113042|NCT01909154|278210|P1|COMPLETED|Overall Study||12
113043|NCT01909154|278210|P1|STARTED|Overall Study||12
113044|NCT01909141|278221|P2|NOT COMPLETED|Overall Study||0
113045|NCT01909141|278222|P1|NOT COMPLETED|Overall Study||0
113046|NCT01909141|278221|P2|COMPLETED|Overall Study||50
113047|NCT01909141|278222|P1|COMPLETED|Overall Study||50
113048|NCT01909141|278221|P2|STARTED|Overall Study||50
113049|NCT01909141|278222|P1|STARTED|Overall Study||50
113050|NCT01909011|278238|P2|NOT COMPLETED|Overall Study||0
113051|NCT01909011|278239|P1|NOT COMPLETED|Overall Study||0
113052|NCT01909011|278238|P2|COMPLETED|Overall Study||9
113053|NCT01909011|278239|P1|COMPLETED|Overall Study||7
113054|NCT01909011|278238|P2|STARTED|Overall Study||9
113055|NCT01909011|278239|P1|STARTED|Overall Study||7
113056|NCT01908972|278251|P2|NOT COMPLETED|Overall Study||0
113057|NCT01908972|278252|P1|NOT COMPLETED|Overall Study||2
113058|NCT01908972|278251|P2|COMPLETED|Overall Study||17
113059|NCT01908972|278252|P1|COMPLETED|Overall Study||15
113060|NCT01908972|278251|P2|STARTED|Overall Study||17
113061|NCT01908972|278252|P1|STARTED|Overall Study||17
113062|NCT01908907|278288|P2|NOT COMPLETED|Overall Study||0
113063|NCT01908907|278289|P1|NOT COMPLETED|Overall Study||2
113064|NCT01908907|278288|P2|COMPLETED|Overall Study||29
113065|NCT01908907|278289|P1|COMPLETED|Overall Study||29
113066|NCT01908907|278288|P2|STARTED|Overall Study||29
113067|NCT01908907|278289|P1|STARTED|Overall Study||31
113068|NCT01908842|278311|P2|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||17
113069|NCT01908842|278312|P1|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||25
113070|NCT01908842|278311|P2|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
113071|NCT01908842|278312|P1|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
113072|NCT01908842|278311|P2|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||279
113073|NCT01908842|278312|P1|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||287
113074|NCT01908842|278311|P2|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||65
113075|NCT01908842|278312|P1|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||70
113076|NCT01908842|278311|P2|COMPLETED|Switch to Other BNX Formulation (Day 15)||279
113077|NCT01908842|278312|P1|COMPLETED|Switch to Other BNX Formulation (Day 15)||287
113078|NCT01908842|278311|P2|STARTED|Switch to Other BNX Formulation (Day 15)||344
113079|NCT01908842|278312|P1|STARTED|Switch to Other BNX Formulation (Day 15)||357
113080|NCT01908842|278311|P2|NOT COMPLETED|Induction||31
113081|NCT01908842|278312|P1|NOT COMPLETED|Induction||26
113082|NCT01908842|278311|P2|COMPLETED|Induction||344
113083|NCT01908842|278312|P1|COMPLETED|Induction||357
113084|NCT01908842|278311|P2|STARTED|Induction||375
113085|NCT01908842|278312|P1|STARTED|Induction||383
113086|NCT01908829|278333|P3|NOT COMPLETED|Overall Study||39
113087|NCT01908829|278334|P2|NOT COMPLETED|Overall Study||49
113088|NCT01908829|278335|P1|NOT COMPLETED|Overall Study||49
113089|NCT01908829|278333|P3|COMPLETED|Overall Study||680
113090|NCT01908829|278334|P2|COMPLETED|Overall Study||679
113091|NCT01908829|278335|P1|COMPLETED|Overall Study||678
113092|NCT01908829|278333|P3|Treated With Double-blind Drug|Overall Study||719
113093|NCT01908829|278334|P2|Treated With Double-blind Drug|Overall Study||728
113094|NCT01908829|278335|P1|Treated With Double-blind Drug|Overall Study||725
113095|NCT01908829|278333|P3|STARTED|Overall Study||719
113096|NCT01908829|278334|P2|STARTED|Overall Study||728
113097|NCT01908829|278335|P1|STARTED|Overall Study||727
113098|NCT01908816|278452|P4|NOT COMPLETED|Overall Study||35
113099|NCT01908816|278453|P3|NOT COMPLETED|Overall Study||58
113100|NCT01908816|278454|P2|NOT COMPLETED|Overall Study||84
113101|NCT01908816|278455|P1|NOT COMPLETED|Overall Study||93
113102|NCT01908816|278452|P4|COMPLETED|Overall Study||0
113103|NCT01908816|278453|P3|COMPLETED|Overall Study||0
113104|NCT01908816|278454|P2|COMPLETED|Overall Study||0
113105|NCT01908816|278455|P1|COMPLETED|Overall Study||0
113106|NCT01908816|278452|P4|STARTED|Overall Study||35
113107|NCT01908816|278453|P3|STARTED|Overall Study||58
113108|NCT01908816|278454|P2|STARTED|Overall Study||84
113109|NCT01908816|278455|P1|STARTED|Overall Study||93
113110|NCT01908803|278480|P2|NOT COMPLETED|Overall Study||1
113111|NCT01908803|278481|P1|NOT COMPLETED|Overall Study||4
113112|NCT01908803|278480|P2|COMPLETED|Overall Study||23
113113|NCT01908803|278481|P1|COMPLETED|Overall Study||42
113114|NCT01908803|278480|P2|Treated|Overall Study||24
113115|NCT01908803|278481|P1|Treated|Overall Study|Two randomized subjects discontinued prior to receiving investigational product.|44
113116|NCT01908803|278480|P2|STARTED|Overall Study||24
113117|NCT01908803|278481|P1|STARTED|Overall Study||46
113118|NCT01908582|278492|P1|NOT COMPLETED|Period 2||2
113119|NCT01908582|278492|P1|COMPLETED|Period 2||24
113120|NCT01908582|278492|P1|STARTED|Period 2||26
113121|NCT01908582|278492|P1|NOT COMPLETED|Period 1||0
113122|NCT01908582|278492|P1|COMPLETED|Period 1||26
113123|NCT01908582|278492|P1|Received at Least One Dose of Study Drug|Period 1||26
113124|NCT01908582|278492|P1|STARTED|Period 1||26
113125|NCT01908530|278506|P3|NOT COMPLETED|Overall Study||0
113126|NCT01908530|278507|P2|NOT COMPLETED|Overall Study||0
113127|NCT01908530|278508|P1|NOT COMPLETED|Overall Study||0
113128|NCT01908530|278506|P3|COMPLETED|Overall Study||10
113129|NCT01908530|278507|P2|COMPLETED|Overall Study||8
113130|NCT01908530|278508|P1|COMPLETED|Overall Study||8
113131|NCT01908530|278506|P3|STARTED|Overall Study||10
113132|NCT01908530|278507|P2|STARTED|Overall Study||8
113133|NCT01908530|278508|P1|STARTED|Overall Study||8
113134|NCT01908426|278536|P2|NOT COMPLETED|Overall Study||211
113135|NCT01908426|278537|P1|NOT COMPLETED|Overall Study||397
113136|NCT01908426|278536|P2|COMPLETED|Overall Study||26
113137|NCT01908426|278537|P1|COMPLETED|Overall Study||73
113138|NCT01908426|278536|P2|STARTED|Overall Study||237
113139|NCT01908426|278537|P1|STARTED|Overall Study||470
113140|NCT01908140|278549|P2|NOT COMPLETED|Overall Study||79
113141|NCT01908140|278550|P1|NOT COMPLETED|Overall Study||66
113142|NCT01908140|278549|P2|COMPLETED|Overall Study||386
113143|NCT01908140|278550|P1|COMPLETED|Overall Study||402
113144|NCT01908140|278549|P2|STARTED|Overall Study||465
113145|NCT01908140|278550|P1|STARTED|Overall Study||468
113146|NCT01908127|278560|P2|NOT COMPLETED|Overall Study||0
113147|NCT01908127|278561|P1|NOT COMPLETED|Overall Study||1
113148|NCT01908127|278560|P2|COMPLETED|Overall Study||23
113149|NCT01908127|278561|P1|COMPLETED|Overall Study||22
113150|NCT01908127|278560|P2|STARTED|Overall Study||23
113151|NCT01908127|278561|P1|STARTED|Overall Study||23
113152|NCT01908062|278571|P2|NOT COMPLETED|Overall Study||3
113153|NCT01908062|278572|P1|NOT COMPLETED|Overall Study||2
113154|NCT01908062|278571|P2|COMPLETED|Overall Study||22
113155|NCT01908062|278572|P1|COMPLETED|Overall Study||24
113156|NCT01908062|278571|P2|STARTED|Overall Study||25
113157|NCT01908062|278572|P1|STARTED|Overall Study||26
113158|NCT01907906|278599|P2|NOT COMPLETED|Overall Study||1
113159|NCT01907906|278600|P1|NOT COMPLETED|Overall Study||4
113160|NCT01907906|278599|P2|COMPLETED|Overall Study||12
113161|NCT01907906|278600|P1|COMPLETED|Overall Study||12
113162|NCT01907906|278599|P2|STARTED|Overall Study||13
113163|NCT01907906|278600|P1|STARTED|Overall Study||16
113164|NCT01907854|278680|P2|NOT COMPLETED|Overall Study||13
113165|NCT01907854|278681|P1|NOT COMPLETED|Overall Study||16
113166|NCT01907854|278680|P2|COMPLETED|Overall Study||191
113167|NCT01907854|278681|P1|COMPLETED|Overall Study||187
113168|NCT01907854|278680|P2|Exposed|Overall Study||204
113169|NCT01907854|278681|P1|Exposed|Overall Study|One subject in lira arm was not exposed (Reason: withdrawal by subject)|202
113170|NCT01907854|278680|P2|STARTED|Overall Study||204
113171|NCT01907854|278681|P1|STARTED|Overall Study||203
113172|NCT01907815|278701|P2|NOT COMPLETED|Overall Study||0
113173|NCT01907815|278702|P1|NOT COMPLETED|Overall Study||1
113174|NCT01907815|278701|P2|COMPLETED|Overall Study||7
113175|NCT01907815|278702|P1|COMPLETED|Overall Study||16
113176|NCT01907815|278701|P2|STARTED|Overall Study||7
113177|NCT01907815|278702|P1|STARTED|Overall Study||17
113178|NCT01907737|278716|P1|NOT COMPLETED|Overall Study||1
113179|NCT01907737|278716|P1|COMPLETED|Overall Study||21
113180|NCT01907737|278716|P1|STARTED|Overall Study||22
113181|NCT01907516|278728|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
113182|NCT01907516|278729|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
113183|NCT01907516|278728|P2|COMPLETED|Second Intervention (3 Weeks)||34
113184|NCT01907516|278729|P1|COMPLETED|Second Intervention (3 Weeks)||40
113185|NCT01907516|278728|P2|STARTED|Second Intervention (3 Weeks)||34
113186|NCT01907516|278729|P1|STARTED|Second Intervention (3 Weeks)||40
113187|NCT01907516|278728|P2|NOT COMPLETED|First Intervention (3 Weeks)||16
113188|NCT01907516|278729|P1|NOT COMPLETED|First Intervention (3 Weeks)||10
113189|NCT01907516|278728|P2|COMPLETED|First Intervention (3 Weeks)||34
113190|NCT01907516|278729|P1|COMPLETED|First Intervention (3 Weeks)||40
113191|NCT01907516|278728|P2|STARTED|First Intervention (3 Weeks)||50
113192|NCT01907516|278729|P1|STARTED|First Intervention (3 Weeks)||50
113193|NCT01907490|278736|P1|NOT COMPLETED|Overall Study||0
113194|NCT01907490|278736|P1|COMPLETED|Overall Study||38
113195|NCT01907490|278736|P1|STARTED|Overall Study||38
113196|NCT01907334|278740|P2|NOT COMPLETED|Overall Study||0
113197|NCT01907334|278741|P1|NOT COMPLETED|Overall Study||0
113198|NCT01907334|278740|P2|COMPLETED|Overall Study||4
113199|NCT01907334|278741|P1|COMPLETED|Overall Study||6
113200|NCT01907334|278740|P2|STARTED|Overall Study||4
113201|NCT01907334|278741|P1|STARTED|Overall Study||6
113202|NCT01907321|278746|P1|NOT COMPLETED|Overall Study||2
113203|NCT01907321|278746|P1|COMPLETED|Overall Study||12
113204|NCT01907321|278746|P1|STARTED|Overall Study||14
113205|NCT01907269|278753|P2|NOT COMPLETED|18 Month Outcome Measures Post-intervent||280
113206|NCT01907269|278754|P1|NOT COMPLETED|18 Month Outcome Measures Post-intervent||319
113207|NCT01907269|278753|P2|COMPLETED|18 Month Outcome Measures Post-intervent||970
113208|NCT01907269|278754|P1|COMPLETED|18 Month Outcome Measures Post-intervent||859
113209|NCT01907269|278753|P2|STARTED|18 Month Outcome Measures Post-intervent||1250
113210|NCT01907269|278754|P1|STARTED|18 Month Outcome Measures Post-intervent||1178
113211|NCT01907269|278753|P2|NOT COMPLETED|6 Month Outcome Measures Post-interventi||289
113212|NCT01907269|278754|P1|NOT COMPLETED|6 Month Outcome Measures Post-interventi||389
113213|NCT01907269|278753|P2|COMPLETED|6 Month Outcome Measures Post-interventi||1053
113214|NCT01907269|278754|P1|COMPLETED|6 Month Outcome Measures Post-interventi||953
113215|NCT01907269|278753|P2|STARTED|6 Month Outcome Measures Post-interventi||1342
113216|NCT01907269|278754|P1|STARTED|6 Month Outcome Measures Post-interventi||1342
113217|NCT01907217|278770|P2|NOT COMPLETED|Overall Study||2
113218|NCT01907217|278771|P1|NOT COMPLETED|Overall Study||0
113219|NCT01907217|278770|P2|COMPLETED|Overall Study||67
113220|NCT01907217|278771|P1|COMPLETED|Overall Study||69
113221|NCT01907217|278770|P2|STARTED|Overall Study||69
113222|NCT01907217|278771|P1|STARTED|Overall Study||69
113223|NCT01907113|278788|P5|NOT COMPLETED|Overall Study||0
113224|NCT01907113|278789|P4|NOT COMPLETED|Overall Study||0
113225|NCT01907113|278790|P3|NOT COMPLETED|Overall Study||0
113226|NCT01907113|278791|P2|NOT COMPLETED|Overall Study||0
113227|NCT01907113|278792|P1|NOT COMPLETED|Overall Study||0
113228|NCT01907113|278788|P5|COMPLETED|Overall Study||8
113229|NCT01907113|278789|P4|COMPLETED|Overall Study||8
113230|NCT01907113|278790|P3|COMPLETED|Overall Study||7
113231|NCT01907113|278791|P2|COMPLETED|Overall Study||9
113232|NCT01907113|278792|P1|COMPLETED|Overall Study||8
113233|NCT01907113|278788|P5|STARTED|Overall Study||8
113234|NCT01907113|278789|P4|STARTED|Overall Study||8
113235|NCT01907113|278790|P3|STARTED|Overall Study||7
113236|NCT01907113|278791|P2|STARTED|Overall Study||9
113237|NCT01907113|278792|P1|STARTED|Overall Study||8
113238|NCT01907100|278883|P4|NOT COMPLETED|Overall Study||146
113239|NCT01907100|278884|P3|NOT COMPLETED|Overall Study||147
113240|NCT01907100|278885|P2|NOT COMPLETED|Overall Study||40
113241|NCT01907100|278886|P1|NOT COMPLETED|Overall Study||42
113242|NCT01907100|278883|P4|COMPLETED|Overall Study||83
113243|NCT01907100|278884|P3|COMPLETED|Overall Study||82
113244|NCT01907100|278885|P2|COMPLETED|Overall Study||4
113245|NCT01907100|278886|P1|COMPLETED|Overall Study||1
113246|NCT01907100|278883|P4|Treated Patients|Overall Study||227
113247|NCT01907100|278884|P3|Treated Patients|Overall Study||228
113248|NCT01907100|278885|P2|Treated Patients|Overall Study||44
113249|NCT01907100|278886|P1|Treated Patients|Overall Study||41
113250|NCT01907100|278883|P4|STARTED|Overall Study||229
113251|NCT01907100|278884|P3|STARTED|Overall Study||229
113252|NCT01907100|278885|P2|STARTED|Overall Study||44
113253|NCT01907100|278886|P1|STARTED|Overall Study||43
113254|NCT01907087|278900|P1|NOT COMPLETED|Overall Study||1
113255|NCT01907087|278900|P1|COMPLETED|Overall Study||23
113256|NCT01907087|278900|P1|STARTED|Overall Study||24
113257|NCT01906866|278911|P2|NOT COMPLETED|Overall Study||21
113258|NCT01906866|278912|P1|NOT COMPLETED|Overall Study||9
113259|NCT01906866|278911|P2|COMPLETED|Overall Study||44
113260|NCT01906866|278912|P1|COMPLETED|Overall Study||51
113261|NCT01906866|278911|P2|STARTED|Overall Study||65
113262|NCT01906866|278912|P1|STARTED|Overall Study||60
113263|NCT01906658|278925|P4|NOT COMPLETED|Overall Study||0
113264|NCT01906658|278926|P3|NOT COMPLETED|Overall Study||3
113265|NCT01906658|278927|P2|NOT COMPLETED|Overall Study||1
113266|NCT01906658|278928|P1|NOT COMPLETED|Overall Study||2
113267|NCT01906658|278925|P4|COMPLETED|Overall Study||11
113268|NCT01906658|278926|P3|COMPLETED|Overall Study||7
113269|NCT01906658|278927|P2|COMPLETED|Overall Study||10
113270|NCT01906658|278928|P1|COMPLETED|Overall Study||9
113271|NCT01906658|278925|P4|STARTED|Overall Study||11
113272|NCT01906658|278926|P3|STARTED|Overall Study||10
113273|NCT01906658|278927|P2|STARTED|Overall Study||11
113274|NCT01906658|278928|P1|STARTED|Overall Study||11
113275|NCT01906515|278952|P2|NOT COMPLETED|Overall Study||0
113276|NCT01906515|278953|P1|NOT COMPLETED|Overall Study||0
113277|NCT01906515|278952|P2|COMPLETED|Overall Study||61
113278|NCT01906515|278953|P1|COMPLETED|Overall Study||45
113279|NCT01906515|278952|P2|STARTED|Overall Study||61
113280|NCT01906515|278953|P1|STARTED|Overall Study||45
113281|NCT01906372|278961|P1|NOT COMPLETED|Overall Study||2
113282|NCT01906372|278961|P1|COMPLETED|Overall Study||10
113283|NCT01906372|278961|P1|Visit 10: Follow up Phase Completed|Overall Study||8
113284|NCT01906372|278961|P1|Visit 7: Treatment Phase Completed|Overall Study||10
113285|NCT01906372|278961|P1|STARTED|Overall Study||12
113286|NCT01906346|278966|P1|NOT COMPLETED|Overall Study||1
113287|NCT01906346|278966|P1|COMPLETED|Overall Study||8
113288|NCT01906346|278966|P1|STARTED|Overall Study||9
113289|NCT01905956|278974|P2|NOT COMPLETED|Overall Study||11
113290|NCT01905956|278975|P1|NOT COMPLETED|Overall Study||6
113291|NCT01905956|278974|P2|COMPLETED|Overall Study|Per-protocol population|48
113292|NCT01905956|278975|P1|COMPLETED|Overall Study|Per-protocol population|54
113293|NCT01905956|278974|P2|Intention-to-treat Population|Overall Study|Intention-to-treat population|54
113294|NCT01905956|278975|P1|Intention-to-treat Population|Overall Study|Intention-to-treat population|57
113295|NCT01905956|278974|P2|STARTED|Overall Study|Randomized|59
113296|NCT01905956|278975|P1|STARTED|Overall Study|Randomized|60
113297|NCT01905943|278997|P1|NOT COMPLETED|Overall Study||314
113298|NCT01905943|278997|P1|COMPLETED|Overall Study|All patients provide reason at final analysis|658
113299|NCT01905943|278997|P1|STARTED|Overall Study||972
113300|NCT01905683|279114|P1|NOT COMPLETED|Overall Study||51
113301|NCT01905683|279114|P1|COMPLETED|Overall Study||319
113302|NCT01905683|279114|P1|STARTED|Overall Study||370
113303|NCT01905657|279130|P3|NOT COMPLETED|Overall Study||328
113304|NCT01905657|279131|P2|NOT COMPLETED|Overall Study||346
113305|NCT01905657|279132|P1|NOT COMPLETED|Overall Study||345
113306|NCT01905657|279130|P3|COMPLETED|Overall Study||15
113307|NCT01905657|279131|P2|COMPLETED|Overall Study||0
113308|NCT01905657|279132|P1|COMPLETED|Overall Study||0
113309|NCT01905657|279130|P3|Treated|Overall Study||309
113310|NCT01905657|279131|P2|Treated|Overall Study||343
113311|NCT01905657|279132|P1|Treated|Overall Study||339
113312|NCT01905657|279130|P3|STARTED|Overall Study||343
113313|NCT01905657|279131|P2|STARTED|Overall Study||346
113314|NCT01905657|279132|P1|STARTED|Overall Study||345
113315|NCT01905553|279157|P2|NOT COMPLETED|Period 2||0
113316|NCT01905553|279158|P1|NOT COMPLETED|Period 2||1
113317|NCT01905553|279157|P2|COMPLETED|Period 2||4
113318|NCT01905553|279158|P1|COMPLETED|Period 2||4
113319|NCT01905553|279157|P2|STARTED|Period 2||4
113320|NCT01905553|279158|P1|STARTED|Period 2||5
113321|NCT01905553|279157|P2|NOT COMPLETED|Period 1||0
113322|NCT01905553|279158|P1|NOT COMPLETED|Period 1||0
113323|NCT01905553|279157|P2|COMPLETED|Period 1||4
113324|NCT01905553|279158|P1|COMPLETED|Period 1||5
113325|NCT01905553|279157|P2|STARTED|Period 1||4
113326|NCT01905553|279158|P1|STARTED|Period 1||5
113327|NCT01905540|279172|P4|NOT COMPLETED|Period 3||1
113328|NCT01905540|279173|P3|NOT COMPLETED|Period 3||1
113329|NCT01905540|279174|P2|NOT COMPLETED|Period 3||0
113330|NCT01905540|279175|P1|NOT COMPLETED|Period 3||1
113331|NCT01905540|279172|P4|COMPLETED|Period 3||6
113332|NCT01905540|279173|P3|COMPLETED|Period 3||6
113333|NCT01905540|279174|P2|COMPLETED|Period 3||7
113334|NCT01905540|279175|P1|COMPLETED|Period 3||6
113335|NCT01905540|279172|P4|STARTED|Period 3||7
113336|NCT01905540|279173|P3|STARTED|Period 3||7
113337|NCT01905540|279174|P2|STARTED|Period 3||7
113338|NCT01905540|279175|P1|STARTED|Period 3||7
113339|NCT01905540|279172|P4|NOT COMPLETED|Period 2||0
113340|NCT01905540|279173|P3|NOT COMPLETED|Period 2||0
113341|NCT01905540|279174|P2|NOT COMPLETED|Period 2||0
113342|NCT01905540|279175|P1|NOT COMPLETED|Period 2||0
113343|NCT01905540|279172|P4|COMPLETED|Period 2||7
113344|NCT01905540|279173|P3|COMPLETED|Period 2||7
113345|NCT01905540|279174|P2|COMPLETED|Period 2||7
113346|NCT01905540|279175|P1|COMPLETED|Period 2||7
113347|NCT01905540|279172|P4|STARTED|Period 2||7
113348|NCT01905540|279173|P3|STARTED|Period 2||7
113349|NCT01905540|279174|P2|STARTED|Period 2||7
113350|NCT01905540|279175|P1|STARTED|Period 2||7
113351|NCT01905540|279172|P4|NOT COMPLETED|Period 1||0
113352|NCT01905540|279173|P3|NOT COMPLETED|Period 1||0
113353|NCT01905540|279174|P2|NOT COMPLETED|Period 1||0
113354|NCT01905540|279175|P1|NOT COMPLETED|Period 1||0
113355|NCT01905540|279172|P4|COMPLETED|Period 1||7
113356|NCT01905540|279173|P3|COMPLETED|Period 1||7
113357|NCT01905540|279174|P2|COMPLETED|Period 1||7
113358|NCT01905540|279175|P1|COMPLETED|Period 1||7
113359|NCT01905540|279172|P4|STARTED|Period 1||7
113360|NCT01905540|279173|P3|STARTED|Period 1||7
113361|NCT01905540|279174|P2|STARTED|Period 1||7
113362|NCT01905540|279175|P1|STARTED|Period 1||7
113363|NCT01905423|279197|P4|NOT COMPLETED|Overall Study||0
113364|NCT01905423|279198|P3|NOT COMPLETED|Overall Study||0
113365|NCT01905423|279199|P2|NOT COMPLETED|Overall Study||0
113366|NCT01905423|279200|P1|NOT COMPLETED|Overall Study||0
113367|NCT01905423|279197|P4|COMPLETED|Overall Study||3324
113368|NCT01905423|279198|P3|COMPLETED|Overall Study||4119
113369|NCT01905423|279199|P2|COMPLETED|Overall Study||4111
113370|NCT01905423|279200|P1|COMPLETED|Overall Study||7753
113371|NCT01905423|279197|P4|Year 3 Follow-up|Overall Study||0
113372|NCT01905423|279198|P3|Year 3 Follow-up|Overall Study||0
113373|NCT01905423|279199|P2|Year 3 Follow-up|Overall Study||1028
113374|NCT01905423|279200|P1|Year 3 Follow-up|Overall Study||1776
113375|NCT01905423|279197|P4|Year 2 Follow-up|Overall Study||0
113376|NCT01905423|279198|P3|Year 2 Follow-up|Overall Study||0
113377|NCT01905423|279199|P2|Year 2 Follow-up|Overall Study||1043
113378|NCT01905423|279200|P1|Year 2 Follow-up|Overall Study||1972
113379|NCT01905423|279197|P4|Year 1 Follow-up|Overall Study||1690
113380|NCT01905423|279198|P3|Year 1 Follow-up|Overall Study||2037
113381|NCT01905423|279199|P2|Year 1 Follow-up|Overall Study||1007
113382|NCT01905423|279200|P1|Year 1 Follow-up|Overall Study||1840
113383|NCT01905423|279197|P4|Baseline|Overall Study||1634
113384|NCT01905423|279198|P3|Baseline|Overall Study||2082
113385|NCT01905423|279199|P2|Baseline|Overall Study||1033
113386|NCT01905423|279200|P1|Baseline|Overall Study||2165
113387|NCT01905423|279197|P4|STARTED|Overall Study||3324
113388|NCT01905423|279198|P3|STARTED|Overall Study||4119
113389|NCT01905423|279199|P2|STARTED|Overall Study||4111
113390|NCT01905423|279200|P1|STARTED|Overall Study||7753
113391|NCT01905267|279210|P2|NOT COMPLETED|Overall Study||2
113392|NCT01905267|279211|P1|NOT COMPLETED|Overall Study||2
113393|NCT01905267|279210|P2|COMPLETED|Overall Study||14
113394|NCT01905267|279211|P1|COMPLETED|Overall Study||15
113395|NCT01905267|279210|P2|STARTED|Overall Study||16
113396|NCT01905267|279211|P1|STARTED|Overall Study||17
113397|NCT01905254|279219|P1|NOT COMPLETED|Overall Study||0
113398|NCT01905254|279219|P1|COMPLETED|Overall Study||34
113399|NCT01905254|279219|P1|STARTED|Overall Study||34
113400|NCT01904864|279225|P2|NOT COMPLETED|Overall Study||12
113401|NCT01904864|279226|P1|NOT COMPLETED|Overall Study||9
113402|NCT01904864|279225|P2|COMPLETED|Overall Study||28
113403|NCT01904864|279226|P1|COMPLETED|Overall Study||31
113404|NCT01904864|279225|P2|STARTED|Overall Study||40
113405|NCT01904864|279226|P1|STARTED|Overall Study||40
113406|NCT01904773|279232|P9|NOT COMPLETED|Sixth Intervention||0
113407|NCT01904773|279233|P8|NOT COMPLETED|Sixth Intervention||0
113408|NCT01904773|279234|P7|NOT COMPLETED|Sixth Intervention||0
113409|NCT01904773|279235|P6|NOT COMPLETED|Sixth Intervention||0
113410|NCT01904773|279236|P5|NOT COMPLETED|Sixth Intervention||0
113411|NCT01904773|279237|P4|NOT COMPLETED|Sixth Intervention||0
113412|NCT01904773|279238|P3|NOT COMPLETED|Sixth Intervention||0
113413|NCT01904773|279239|P2|NOT COMPLETED|Sixth Intervention||0
113414|NCT01904773|279240|P1|NOT COMPLETED|Sixth Intervention||0
113415|NCT01904773|279232|P9|COMPLETED|Sixth Intervention||4
113416|NCT01904773|279233|P8|COMPLETED|Sixth Intervention||2
113417|NCT01904773|279234|P7|COMPLETED|Sixth Intervention||3
113418|NCT01904773|279235|P6|COMPLETED|Sixth Intervention||4
113419|NCT01904773|279236|P5|COMPLETED|Sixth Intervention||3
113420|NCT01904773|279237|P4|COMPLETED|Sixth Intervention||2
113421|NCT01904773|279238|P3|COMPLETED|Sixth Intervention||1
113422|NCT01904773|279239|P2|COMPLETED|Sixth Intervention||0
113423|NCT01904773|279240|P1|COMPLETED|Sixth Intervention||0
113424|NCT01904773|279232|P9|STARTED|Sixth Intervention||4
113425|NCT01904773|279233|P8|STARTED|Sixth Intervention||2
113426|NCT01904773|279234|P7|STARTED|Sixth Intervention||3
113427|NCT01904773|279235|P6|STARTED|Sixth Intervention||4
113428|NCT01904773|279236|P5|STARTED|Sixth Intervention||3
113429|NCT01904773|279237|P4|STARTED|Sixth Intervention||2
113430|NCT01904773|279238|P3|STARTED|Sixth Intervention||1
113431|NCT01904773|279239|P2|STARTED|Sixth Intervention||0
113432|NCT01904773|279240|P1|STARTED|Sixth Intervention||0
113433|NCT01904773|279232|P9|NOT COMPLETED|Placebo Washout Fifth Intervention||0
113434|NCT01904773|279233|P8|NOT COMPLETED|Placebo Washout Fifth Intervention||0
113435|NCT01904773|279234|P7|NOT COMPLETED|Placebo Washout Fifth Intervention||0
113436|NCT01904773|279235|P6|NOT COMPLETED|Placebo Washout Fifth Intervention||0
113437|NCT01904773|279236|P5|NOT COMPLETED|Placebo Washout Fifth Intervention||0
113438|NCT01904773|279237|P4|NOT COMPLETED|Placebo Washout Fifth Intervention||0
113439|NCT01904773|279238|P3|NOT COMPLETED|Placebo Washout Fifth Intervention||0
113440|NCT01904773|279239|P2|NOT COMPLETED|Placebo Washout Fifth Intervention||1
113441|NCT01904773|279240|P1|NOT COMPLETED|Placebo Washout Fifth Intervention||0
113442|NCT01904773|279232|P9|COMPLETED|Placebo Washout Fifth Intervention||4
113443|NCT01904773|279233|P8|COMPLETED|Placebo Washout Fifth Intervention||2
113444|NCT01904773|279234|P7|COMPLETED|Placebo Washout Fifth Intervention||3
113445|NCT01904773|279235|P6|COMPLETED|Placebo Washout Fifth Intervention||4
113446|NCT01904773|279236|P5|COMPLETED|Placebo Washout Fifth Intervention||3
113447|NCT01904773|279237|P4|COMPLETED|Placebo Washout Fifth Intervention||2
113448|NCT01904773|279238|P3|COMPLETED|Placebo Washout Fifth Intervention||1
113449|NCT01904773|279239|P2|COMPLETED|Placebo Washout Fifth Intervention||0
113450|NCT01904773|279240|P1|COMPLETED|Placebo Washout Fifth Intervention||0
113451|NCT01904773|279232|P9|STARTED|Placebo Washout Fifth Intervention||4
113452|NCT01904773|279233|P8|STARTED|Placebo Washout Fifth Intervention||2
113453|NCT01904773|279234|P7|STARTED|Placebo Washout Fifth Intervention||3
113454|NCT01904773|279235|P6|STARTED|Placebo Washout Fifth Intervention||4
113455|NCT01904773|279236|P5|STARTED|Placebo Washout Fifth Intervention||3
113456|NCT01904773|279237|P4|STARTED|Placebo Washout Fifth Intervention||2
113457|NCT01904773|279238|P3|STARTED|Placebo Washout Fifth Intervention||1
113458|NCT01904773|279239|P2|STARTED|Placebo Washout Fifth Intervention||1
113459|NCT01904773|279240|P1|STARTED|Placebo Washout Fifth Intervention||0
113460|NCT01904773|279232|P9|NOT COMPLETED|Fifth Intervention||0
113461|NCT01904773|279233|P8|NOT COMPLETED|Fifth Intervention||1
113462|NCT01904773|279234|P7|NOT COMPLETED|Fifth Intervention||0
113463|NCT01904773|279235|P6|NOT COMPLETED|Fifth Intervention||0
113464|NCT01904773|279236|P5|NOT COMPLETED|Fifth Intervention||0
113465|NCT01904773|279237|P4|NOT COMPLETED|Fifth Intervention||0
113466|NCT01904773|279238|P3|NOT COMPLETED|Fifth Intervention||0
113467|NCT01904773|279239|P2|NOT COMPLETED|Fifth Intervention||0
113468|NCT01904773|279240|P1|NOT COMPLETED|Fifth Intervention||0
113469|NCT01904773|279232|P9|COMPLETED|Fifth Intervention||4
113470|NCT01904773|279233|P8|COMPLETED|Fifth Intervention||2
113471|NCT01904773|279234|P7|COMPLETED|Fifth Intervention||3
113472|NCT01904773|279235|P6|COMPLETED|Fifth Intervention||4
113473|NCT01904773|279236|P5|COMPLETED|Fifth Intervention||3
113474|NCT01904773|279237|P4|COMPLETED|Fifth Intervention||2
113475|NCT01904773|279238|P3|COMPLETED|Fifth Intervention||1
113476|NCT01904773|279239|P2|COMPLETED|Fifth Intervention||1
113477|NCT01904773|279240|P1|COMPLETED|Fifth Intervention||0
113478|NCT01904773|279232|P9|STARTED|Fifth Intervention||4
113479|NCT01904773|279233|P8|STARTED|Fifth Intervention||3
113480|NCT01904773|279234|P7|STARTED|Fifth Intervention||3
113481|NCT01904773|279235|P6|STARTED|Fifth Intervention||4
113482|NCT01904773|279236|P5|STARTED|Fifth Intervention||3
113483|NCT01904773|279237|P4|STARTED|Fifth Intervention||2
113484|NCT01904773|279238|P3|STARTED|Fifth Intervention||1
113485|NCT01904773|279239|P2|STARTED|Fifth Intervention||1
113486|NCT01904773|279240|P1|STARTED|Fifth Intervention||0
113487|NCT01904773|279232|P9|NOT COMPLETED|Placebo Washout Fourth Intervention||0
113488|NCT01904773|279233|P8|NOT COMPLETED|Placebo Washout Fourth Intervention||0
113489|NCT01904773|279234|P7|NOT COMPLETED|Placebo Washout Fourth Intervention||0
113490|NCT01904773|279235|P6|NOT COMPLETED|Placebo Washout Fourth Intervention||0
113491|NCT01904773|279236|P5|NOT COMPLETED|Placebo Washout Fourth Intervention||0
113492|NCT01904773|279237|P4|NOT COMPLETED|Placebo Washout Fourth Intervention||0
113493|NCT01904773|279238|P3|NOT COMPLETED|Placebo Washout Fourth Intervention||0
113494|NCT01904773|279239|P2|NOT COMPLETED|Placebo Washout Fourth Intervention||0
113495|NCT01904773|279240|P1|NOT COMPLETED|Placebo Washout Fourth Intervention||0
113496|NCT01904773|279232|P9|COMPLETED|Placebo Washout Fourth Intervention||4
113497|NCT01904773|279233|P8|COMPLETED|Placebo Washout Fourth Intervention||3
113498|NCT01904773|279234|P7|COMPLETED|Placebo Washout Fourth Intervention||3
113499|NCT01904773|279235|P6|COMPLETED|Placebo Washout Fourth Intervention||4
113500|NCT01904773|279236|P5|COMPLETED|Placebo Washout Fourth Intervention||3
113501|NCT01904773|279237|P4|COMPLETED|Placebo Washout Fourth Intervention||2
113502|NCT01904773|279238|P3|COMPLETED|Placebo Washout Fourth Intervention||1
113503|NCT01904773|279239|P2|COMPLETED|Placebo Washout Fourth Intervention||1
113504|NCT01904773|279240|P1|COMPLETED|Placebo Washout Fourth Intervention||0
113505|NCT01904773|279232|P9|STARTED|Placebo Washout Fourth Intervention||4
113506|NCT01904773|279233|P8|STARTED|Placebo Washout Fourth Intervention||3
113507|NCT01904773|279234|P7|STARTED|Placebo Washout Fourth Intervention||3
113508|NCT01904773|279235|P6|STARTED|Placebo Washout Fourth Intervention||4
113509|NCT01904773|279236|P5|STARTED|Placebo Washout Fourth Intervention||3
113510|NCT01904773|279237|P4|STARTED|Placebo Washout Fourth Intervention||2
113511|NCT01904773|279238|P3|STARTED|Placebo Washout Fourth Intervention||1
113512|NCT01904773|279239|P2|STARTED|Placebo Washout Fourth Intervention||1
113513|NCT01904773|279240|P1|STARTED|Placebo Washout Fourth Intervention||0
113514|NCT01904773|279232|P9|NOT COMPLETED|Fourth Intervention||0
113515|NCT01904773|279233|P8|NOT COMPLETED|Fourth Intervention||0
113516|NCT01904773|279234|P7|NOT COMPLETED|Fourth Intervention||0
113517|NCT01904773|279235|P6|NOT COMPLETED|Fourth Intervention||0
113518|NCT01904773|279236|P5|NOT COMPLETED|Fourth Intervention||0
113519|NCT01904773|279237|P4|NOT COMPLETED|Fourth Intervention||0
113520|NCT01904773|279238|P3|NOT COMPLETED|Fourth Intervention||0
113521|NCT01904773|279239|P2|NOT COMPLETED|Fourth Intervention||0
113522|NCT01904773|279240|P1|NOT COMPLETED|Fourth Intervention||0
113523|NCT01904773|279232|P9|COMPLETED|Fourth Intervention||4
113524|NCT01904773|279233|P8|COMPLETED|Fourth Intervention||3
113525|NCT01904773|279234|P7|COMPLETED|Fourth Intervention||3
113526|NCT01904773|279235|P6|COMPLETED|Fourth Intervention||4
113527|NCT01904773|279236|P5|COMPLETED|Fourth Intervention||3
113528|NCT01904773|279237|P4|COMPLETED|Fourth Intervention||2
113529|NCT01904773|279238|P3|COMPLETED|Fourth Intervention||1
113530|NCT01904773|279239|P2|COMPLETED|Fourth Intervention||1
113531|NCT01904773|279240|P1|COMPLETED|Fourth Intervention||0
113532|NCT01904773|279232|P9|STARTED|Fourth Intervention||4
113533|NCT01904773|279233|P8|STARTED|Fourth Intervention||3
113534|NCT01904773|279234|P7|STARTED|Fourth Intervention||3
113535|NCT01904773|279235|P6|STARTED|Fourth Intervention||4
113536|NCT01904773|279236|P5|STARTED|Fourth Intervention||3
113537|NCT01904773|279237|P4|STARTED|Fourth Intervention||2
113538|NCT01904773|279238|P3|STARTED|Fourth Intervention||1
113539|NCT01904773|279239|P2|STARTED|Fourth Intervention||1
113540|NCT01904773|279240|P1|STARTED|Fourth Intervention||0
113541|NCT01904773|279232|P9|NOT COMPLETED|Placebo Washout Third Intervention||0
113542|NCT01904773|279233|P8|NOT COMPLETED|Placebo Washout Third Intervention||0
113543|NCT01904773|279234|P7|NOT COMPLETED|Placebo Washout Third Intervention||0
113544|NCT01904773|279235|P6|NOT COMPLETED|Placebo Washout Third Intervention||0
113545|NCT01904773|279236|P5|NOT COMPLETED|Placebo Washout Third Intervention||0
113546|NCT01904773|279237|P4|NOT COMPLETED|Placebo Washout Third Intervention||0
113547|NCT01904773|279238|P3|NOT COMPLETED|Placebo Washout Third Intervention||0
113548|NCT01904773|279239|P2|NOT COMPLETED|Placebo Washout Third Intervention||0
113549|NCT01904773|279240|P1|NOT COMPLETED|Placebo Washout Third Intervention||0
113550|NCT01904773|279232|P9|COMPLETED|Placebo Washout Third Intervention||4
113551|NCT01904773|279233|P8|COMPLETED|Placebo Washout Third Intervention||3
113552|NCT01904773|279234|P7|COMPLETED|Placebo Washout Third Intervention||3
113553|NCT01904773|279235|P6|COMPLETED|Placebo Washout Third Intervention||4
113554|NCT01904773|279236|P5|COMPLETED|Placebo Washout Third Intervention||3
113555|NCT01904773|279237|P4|COMPLETED|Placebo Washout Third Intervention||2
113556|NCT01904773|279238|P3|COMPLETED|Placebo Washout Third Intervention||1
113557|NCT01904773|279239|P2|COMPLETED|Placebo Washout Third Intervention||1
113558|NCT01904773|279240|P1|COMPLETED|Placebo Washout Third Intervention||0
113559|NCT01904773|279232|P9|STARTED|Placebo Washout Third Intervention||4
113560|NCT01904773|279233|P8|STARTED|Placebo Washout Third Intervention||3
113561|NCT01904773|279234|P7|STARTED|Placebo Washout Third Intervention||3
113562|NCT01904773|279235|P6|STARTED|Placebo Washout Third Intervention||4
113563|NCT01904773|279236|P5|STARTED|Placebo Washout Third Intervention||3
113564|NCT01904773|279237|P4|STARTED|Placebo Washout Third Intervention||2
113565|NCT01904773|279238|P3|STARTED|Placebo Washout Third Intervention||1
113566|NCT01904773|279239|P2|STARTED|Placebo Washout Third Intervention||1
113567|NCT01904773|279240|P1|STARTED|Placebo Washout Third Intervention||0
113568|NCT01904773|279232|P9|NOT COMPLETED|Third Intervention||0
113569|NCT01904773|279233|P8|NOT COMPLETED|Third Intervention||0
113570|NCT01904773|279234|P7|NOT COMPLETED|Third Intervention||0
113571|NCT01904773|279235|P6|NOT COMPLETED|Third Intervention||0
113572|NCT01904773|279236|P5|NOT COMPLETED|Third Intervention||0
113573|NCT01904773|279237|P4|NOT COMPLETED|Third Intervention||0
113574|NCT01904773|279238|P3|NOT COMPLETED|Third Intervention||0
113575|NCT01904773|279239|P2|NOT COMPLETED|Third Intervention||0
113576|NCT01904773|279240|P1|NOT COMPLETED|Third Intervention||0
113577|NCT01904773|279232|P9|COMPLETED|Third Intervention||4
113578|NCT01904773|279233|P8|COMPLETED|Third Intervention||3
113579|NCT01904773|279234|P7|COMPLETED|Third Intervention||3
113580|NCT01904773|279235|P6|COMPLETED|Third Intervention||4
113581|NCT01904773|279236|P5|COMPLETED|Third Intervention||3
113582|NCT01904773|279237|P4|COMPLETED|Third Intervention||2
113583|NCT01904773|279238|P3|COMPLETED|Third Intervention||1
113584|NCT01904773|279239|P2|COMPLETED|Third Intervention||1
113585|NCT01904773|279240|P1|COMPLETED|Third Intervention||0
113586|NCT01904773|279232|P9|STARTED|Third Intervention||4
113587|NCT01904773|279233|P8|STARTED|Third Intervention||3
113588|NCT01904773|279234|P7|STARTED|Third Intervention||3
113589|NCT01904773|279235|P6|STARTED|Third Intervention||4
113590|NCT01904773|279236|P5|STARTED|Third Intervention||3
113591|NCT01904773|279237|P4|STARTED|Third Intervention||2
113592|NCT01904773|279238|P3|STARTED|Third Intervention||1
113593|NCT01904773|279239|P2|STARTED|Third Intervention||1
113594|NCT01904773|279240|P1|STARTED|Third Intervention||0
113595|NCT01904773|279232|P9|NOT COMPLETED|Placebo Washout Second Intervention||0
113596|NCT01904773|279233|P8|NOT COMPLETED|Placebo Washout Second Intervention||0
113597|NCT01904773|279234|P7|NOT COMPLETED|Placebo Washout Second Intervention||0
113598|NCT01904773|279235|P6|NOT COMPLETED|Placebo Washout Second Intervention||0
113599|NCT01904773|279236|P5|NOT COMPLETED|Placebo Washout Second Intervention||0
113600|NCT01904773|279237|P4|NOT COMPLETED|Placebo Washout Second Intervention||0
113601|NCT01904773|279238|P3|NOT COMPLETED|Placebo Washout Second Intervention||0
113602|NCT01904773|279239|P2|NOT COMPLETED|Placebo Washout Second Intervention||0
113603|NCT01904773|279240|P1|NOT COMPLETED|Placebo Washout Second Intervention||0
113604|NCT01904773|279232|P9|COMPLETED|Placebo Washout Second Intervention||4
113605|NCT01904773|279233|P8|COMPLETED|Placebo Washout Second Intervention||3
113606|NCT01904773|279234|P7|COMPLETED|Placebo Washout Second Intervention||3
113607|NCT01904773|279235|P6|COMPLETED|Placebo Washout Second Intervention||4
113608|NCT01904773|279236|P5|COMPLETED|Placebo Washout Second Intervention||3
113609|NCT01904773|279237|P4|COMPLETED|Placebo Washout Second Intervention||2
113610|NCT01904773|279238|P3|COMPLETED|Placebo Washout Second Intervention||1
113611|NCT01904773|279239|P2|COMPLETED|Placebo Washout Second Intervention||1
113612|NCT01904773|279240|P1|COMPLETED|Placebo Washout Second Intervention||0
113613|NCT01904773|279232|P9|STARTED|Placebo Washout Second Intervention||4
113614|NCT01904773|279233|P8|STARTED|Placebo Washout Second Intervention||3
113615|NCT01904773|279234|P7|STARTED|Placebo Washout Second Intervention||3
113616|NCT01904773|279235|P6|STARTED|Placebo Washout Second Intervention||4
113617|NCT01904773|279236|P5|STARTED|Placebo Washout Second Intervention||3
113618|NCT01904773|279237|P4|STARTED|Placebo Washout Second Intervention||2
113619|NCT01904773|279238|P3|STARTED|Placebo Washout Second Intervention||1
113620|NCT01904773|279239|P2|STARTED|Placebo Washout Second Intervention||1
113621|NCT01904773|279240|P1|STARTED|Placebo Washout Second Intervention||0
113622|NCT01904773|279232|P9|NOT COMPLETED|Second Intervention||0
113623|NCT01904773|279233|P8|NOT COMPLETED|Second Intervention||0
113624|NCT01904773|279234|P7|NOT COMPLETED|Second Intervention||0
113625|NCT01904773|279235|P6|NOT COMPLETED|Second Intervention||0
113626|NCT01904773|279236|P5|NOT COMPLETED|Second Intervention||0
113627|NCT01904773|279237|P4|NOT COMPLETED|Second Intervention||0
113628|NCT01904773|279238|P3|NOT COMPLETED|Second Intervention||0
113629|NCT01904773|279239|P2|NOT COMPLETED|Second Intervention||0
113630|NCT01904773|279240|P1|NOT COMPLETED|Second Intervention||0
113631|NCT01904773|279232|P9|COMPLETED|Second Intervention||4
113632|NCT01904773|279233|P8|COMPLETED|Second Intervention||3
113633|NCT01904773|279234|P7|COMPLETED|Second Intervention||3
113634|NCT01904773|279235|P6|COMPLETED|Second Intervention||4
113635|NCT01904773|279236|P5|COMPLETED|Second Intervention||3
113636|NCT01904773|279237|P4|COMPLETED|Second Intervention||2
113637|NCT01904773|279238|P3|COMPLETED|Second Intervention||1
113638|NCT01904773|279239|P2|COMPLETED|Second Intervention||1
113639|NCT01904773|279240|P1|COMPLETED|Second Intervention||0
113640|NCT01904773|279232|P9|STARTED|Second Intervention||4
113641|NCT01904773|279233|P8|STARTED|Second Intervention||3
113642|NCT01904773|279234|P7|STARTED|Second Intervention||3
113643|NCT01904773|279235|P6|STARTED|Second Intervention||4
113644|NCT01904773|279236|P5|STARTED|Second Intervention||3
113645|NCT01904773|279237|P4|STARTED|Second Intervention||2
113646|NCT01904773|279238|P3|STARTED|Second Intervention||1
113647|NCT01904773|279239|P2|STARTED|Second Intervention||1
113648|NCT01904773|279240|P1|STARTED|Second Intervention||0
113649|NCT01904773|279232|P9|NOT COMPLETED|Placebo Washout First Intervention||0
113650|NCT01904773|279233|P8|NOT COMPLETED|Placebo Washout First Intervention||0
113651|NCT01904773|279234|P7|NOT COMPLETED|Placebo Washout First Intervention||0
113652|NCT01904773|279235|P6|NOT COMPLETED|Placebo Washout First Intervention||0
113653|NCT01904773|279236|P5|NOT COMPLETED|Placebo Washout First Intervention||0
113654|NCT01904773|279237|P4|NOT COMPLETED|Placebo Washout First Intervention||0
113655|NCT01904773|279238|P3|NOT COMPLETED|Placebo Washout First Intervention||0
113656|NCT01904773|279239|P2|NOT COMPLETED|Placebo Washout First Intervention||1
113657|NCT01904773|279240|P1|NOT COMPLETED|Placebo Washout First Intervention||0
113658|NCT01904773|279232|P9|COMPLETED|Placebo Washout First Intervention||4
113659|NCT01904773|279233|P8|COMPLETED|Placebo Washout First Intervention||3
113660|NCT01904773|279234|P7|COMPLETED|Placebo Washout First Intervention||3
113661|NCT01904773|279235|P6|COMPLETED|Placebo Washout First Intervention||4
113662|NCT01904773|279236|P5|COMPLETED|Placebo Washout First Intervention||3
113663|NCT01904773|279237|P4|COMPLETED|Placebo Washout First Intervention||2
113664|NCT01904773|279238|P3|COMPLETED|Placebo Washout First Intervention||1
113665|NCT01904773|279239|P2|COMPLETED|Placebo Washout First Intervention||1
113666|NCT01904773|279240|P1|COMPLETED|Placebo Washout First Intervention||0
113667|NCT01904773|279232|P9|STARTED|Placebo Washout First Intervention||4
113668|NCT01904773|279233|P8|STARTED|Placebo Washout First Intervention||3
113669|NCT01904773|279234|P7|STARTED|Placebo Washout First Intervention||3
113670|NCT01904773|279235|P6|STARTED|Placebo Washout First Intervention||4
113671|NCT01904773|279236|P5|STARTED|Placebo Washout First Intervention||3
113672|NCT01904773|279237|P4|STARTED|Placebo Washout First Intervention||2
113673|NCT01904773|279238|P3|STARTED|Placebo Washout First Intervention||1
113674|NCT01904773|279239|P2|STARTED|Placebo Washout First Intervention||2
113675|NCT01904773|279240|P1|STARTED|Placebo Washout First Intervention||0
113676|NCT01904773|279232|P9|NOT COMPLETED|First Intervention||0
113677|NCT01904773|279233|P8|NOT COMPLETED|First Intervention||0
113678|NCT01904773|279234|P7|NOT COMPLETED|First Intervention||1
113679|NCT01904773|279235|P6|NOT COMPLETED|First Intervention||0
113680|NCT01904773|279236|P5|NOT COMPLETED|First Intervention||0
113681|NCT01904773|279237|P4|NOT COMPLETED|First Intervention||0
113682|NCT01904773|279238|P3|NOT COMPLETED|First Intervention||0
113683|NCT01904773|279239|P2|NOT COMPLETED|First Intervention||0
113684|NCT01904773|279240|P1|NOT COMPLETED|First Intervention||0
113685|NCT01904773|279232|P9|COMPLETED|First Intervention||4
113686|NCT01904773|279233|P8|COMPLETED|First Intervention||3
113687|NCT01904773|279234|P7|COMPLETED|First Intervention||3
113688|NCT01904773|279235|P6|COMPLETED|First Intervention||4
113689|NCT01904773|279236|P5|COMPLETED|First Intervention||3
113690|NCT01904773|279237|P4|COMPLETED|First Intervention||2
113691|NCT01904773|279238|P3|COMPLETED|First Intervention||1
113692|NCT01904773|279239|P2|COMPLETED|First Intervention||2
113693|NCT01904773|279240|P1|COMPLETED|First Intervention||0
113694|NCT01904773|279232|P9|STARTED|First Intervention||4
113695|NCT01904773|279233|P8|STARTED|First Intervention||3
113696|NCT01904773|279234|P7|STARTED|First Intervention||4
113697|NCT01904773|279235|P6|STARTED|First Intervention||4
113698|NCT01904773|279236|P5|STARTED|First Intervention||3
113699|NCT01904773|279237|P4|STARTED|First Intervention||2
113700|NCT01904773|279238|P3|STARTED|First Intervention||1
113701|NCT01904773|279239|P2|STARTED|First Intervention||2
113702|NCT01904773|279240|P1|STARTED|First Intervention||0
113703|NCT01904773|279232|P9|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113704|NCT01904773|279233|P8|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113705|NCT01904773|279234|P7|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113706|NCT01904773|279235|P6|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113707|NCT01904773|279236|P5|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113708|NCT01904773|279237|P4|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113709|NCT01904773|279238|P3|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113710|NCT01904773|279239|P2|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113711|NCT01904773|279240|P1|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||1
113712|NCT01904773|279232|P9|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113713|NCT01904773|279233|P8|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113714|NCT01904773|279234|P7|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113715|NCT01904773|279235|P6|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113716|NCT01904773|279236|P5|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113717|NCT01904773|279237|P4|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113718|NCT01904773|279238|P3|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113719|NCT01904773|279239|P2|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113720|NCT01904773|279240|P1|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||23
113721|NCT01904773|279232|P9|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113722|NCT01904773|279233|P8|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113723|NCT01904773|279234|P7|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113724|NCT01904773|279235|P6|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113725|NCT01904773|279236|P5|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113726|NCT01904773|279237|P4|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113727|NCT01904773|279238|P3|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113728|NCT01904773|279239|P2|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113729|NCT01904773|279240|P1|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||4
113730|NCT01904773|279232|P9|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113731|NCT01904773|279233|P8|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113732|NCT01904773|279234|P7|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113733|NCT01904773|279235|P6|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113734|NCT01904773|279236|P5|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113735|NCT01904773|279237|P4|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113736|NCT01904773|279238|P3|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113737|NCT01904773|279239|P2|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113738|NCT01904773|279240|P1|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||20
113739|NCT01904773|279232|P9|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113740|NCT01904773|279233|P8|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113741|NCT01904773|279234|P7|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113742|NCT01904773|279235|P6|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113743|NCT01904773|279236|P5|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113744|NCT01904773|279237|P4|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113745|NCT01904773|279238|P3|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113746|NCT01904773|279239|P2|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
113747|NCT01904773|279240|P1|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||24
113748|NCT01904773|279232|P9|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
113749|NCT01904773|279233|P8|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
113750|NCT01904773|279234|P7|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
113751|NCT01904773|279235|P6|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
113752|NCT01904773|279236|P5|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
113753|NCT01904773|279237|P4|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
113754|NCT01904773|279238|P3|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
113755|NCT01904773|279239|P2|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
113756|NCT01904773|279240|P1|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
113757|NCT01904773|279232|P9|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
113758|NCT01904773|279233|P8|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
113759|NCT01904773|279234|P7|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
113760|NCT01904773|279235|P6|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
113761|NCT01904773|279236|P5|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
113762|NCT01904773|279237|P4|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
113763|NCT01904773|279238|P3|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
113764|NCT01904773|279239|P2|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
113765|NCT01904773|279240|P1|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||24
113766|NCT01904773|279232|P9|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
113767|NCT01904773|279233|P8|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
113768|NCT01904773|279234|P7|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
113769|NCT01904773|279235|P6|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
113770|NCT01904773|279236|P5|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
113771|NCT01904773|279237|P4|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
113772|NCT01904773|279238|P3|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
113773|NCT01904773|279239|P2|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
113774|NCT01904773|279240|P1|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||24
113775|NCT01904773|279232|P9|NOT COMPLETED|Screen||0
113776|NCT01904773|279233|P8|NOT COMPLETED|Screen||0
113777|NCT01904773|279234|P7|NOT COMPLETED|Screen||0
113778|NCT01904773|279235|P6|NOT COMPLETED|Screen||0
113779|NCT01904773|279236|P5|NOT COMPLETED|Screen||0
113780|NCT01904773|279237|P4|NOT COMPLETED|Screen||0
113781|NCT01904773|279238|P3|NOT COMPLETED|Screen||0
113782|NCT01904773|279239|P2|NOT COMPLETED|Screen||0
113783|NCT01904773|279240|P1|NOT COMPLETED|Screen||4
113784|NCT01904773|279232|P9|COMPLETED|Screen||0
113785|NCT01904773|279233|P8|COMPLETED|Screen||0
113786|NCT01904773|279234|P7|COMPLETED|Screen||0
113787|NCT01904773|279235|P6|COMPLETED|Screen||0
113788|NCT01904773|279236|P5|COMPLETED|Screen||0
113789|NCT01904773|279237|P4|COMPLETED|Screen||0
113790|NCT01904773|279238|P3|COMPLETED|Screen||0
113791|NCT01904773|279239|P2|COMPLETED|Screen||0
113792|NCT01904773|279240|P1|COMPLETED|Screen||24
113793|NCT01904773|279232|P9|STARTED|Screen||0
113794|NCT01904773|279233|P8|STARTED|Screen||0
113795|NCT01904773|279234|P7|STARTED|Screen||0
113796|NCT01904773|279235|P6|STARTED|Screen||0
113797|NCT01904773|279236|P5|STARTED|Screen||0
113798|NCT01904773|279237|P4|STARTED|Screen||0
113799|NCT01904773|279238|P3|STARTED|Screen||0
113800|NCT01904773|279239|P2|STARTED|Screen||0
113801|NCT01904773|279240|P1|STARTED|Screen||28
113802|NCT01904760|279257|P2|NOT COMPLETED|Overall Study||0
113803|NCT01904760|279258|P1|NOT COMPLETED|Overall Study||1
113804|NCT01904760|279257|P2|COMPLETED|Overall Study||40
113805|NCT01904760|279258|P1|COMPLETED|Overall Study||39
113806|NCT01904760|279257|P2|STARTED|Overall Study||40
113807|NCT01904760|279258|P1|STARTED|Overall Study||40
113808|NCT01904721|279273|P7|NOT COMPLETED|Overall Study||7
113809|NCT01904721|279274|P6|NOT COMPLETED|Overall Study||9
113810|NCT01904721|279275|P5|NOT COMPLETED|Overall Study||8
113811|NCT01904721|279276|P4|NOT COMPLETED|Overall Study||1
113812|NCT01904721|279277|P3|NOT COMPLETED|Overall Study||1
113813|NCT01904721|279278|P2|NOT COMPLETED|Overall Study||0
113814|NCT01904721|279279|P1|NOT COMPLETED|Overall Study||0
113815|NCT01904721|279273|P7|COMPLETED|Overall Study||57
113816|NCT01904721|279274|P6|COMPLETED|Overall Study||56
113817|NCT01904721|279275|P5|COMPLETED|Overall Study||57
113818|NCT01904721|279276|P4|COMPLETED|Overall Study||11
113819|NCT01904721|279277|P3|COMPLETED|Overall Study||11
113820|NCT01904721|279278|P2|COMPLETED|Overall Study||13
113821|NCT01904721|279279|P1|COMPLETED|Overall Study||13
113822|NCT01904721|279273|P7|STARTED|Overall Study||64
113823|NCT01904721|279274|P6|STARTED|Overall Study||65
113824|NCT01904721|279275|P5|STARTED|Overall Study||65
113825|NCT01904721|279276|P4|STARTED|Overall Study||12
113826|NCT01904721|279277|P3|STARTED|Overall Study||12
113827|NCT01904721|279278|P2|STARTED|Overall Study||13
113828|NCT01904721|279279|P1|STARTED|Overall Study||13
113829|NCT01904604|279309|P3|NOT COMPLETED|Overall Study||2
113830|NCT01904604|279310|P2|NOT COMPLETED|Overall Study||7
113831|NCT01904604|279311|P1|NOT COMPLETED|Overall Study||7
113832|NCT01904604|279309|P3|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|23
113833|NCT01904604|279310|P2|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|18
113834|NCT01904604|279311|P1|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|18
113835|NCT01904604|279309|P3|Completed Week 130 OFC|Overall Study||23
113836|NCT01904604|279310|P2|Completed Week 130 OFC|Overall Study||18
113837|NCT01904604|279311|P1|Completed Week 130 OFC|Overall Study||18
113838|NCT01904604|279309|P3|Began Crossover Treatment|Overall Study|Per protocol, this treatment group did not crossover.|0
113839|NCT01904604|279310|P2|Began Crossover Treatment|Overall Study||21
113840|NCT01904604|279311|P1|Began Crossover Treatment|Overall Study|2 participants who completed the Week 52 OFC did not crossover; 1 passed the OFC and 1 relocated.|20
113841|NCT01904604|279309|P3|Completed Week 52 OFC|Overall Study||25
113842|NCT01904604|279310|P2|Completed Week 52 OFC|Overall Study||21
113843|NCT01904604|279311|P1|Completed Week 52 OFC|Overall Study||22
113844|NCT01904604|279309|P3|STARTED|Overall Study||25
113845|NCT01904604|279310|P2|STARTED|Overall Study||25
113846|NCT01904604|279311|P1|STARTED|Overall Study||25
113847|NCT01904526|279340|P1|NOT COMPLETED|Overall Study||0
113848|NCT01904526|279340|P1|COMPLETED|Overall Study||5
113849|NCT01904526|279340|P1|STARTED|Overall Study||5
113850|NCT01904448|279354|P1|NOT COMPLETED|Overall Study||0
113851|NCT01904448|279354|P1|COMPLETED|Overall Study||5
113852|NCT01904448|279354|P1|STARTED|Overall Study||5
113853|NCT01904383|279376|P1|NOT COMPLETED|Overall Study||1774
113854|NCT01904383|279376|P1|COMPLETED|Overall Study||2283
113855|NCT01904383|279376|P1|Treated|Overall Study||3940
113856|NCT01904383|279376|P1|STARTED|Overall Study||4057
113857|NCT01904279|279383|P2|NOT COMPLETED|Overall Study||3
113858|NCT01904279|279384|P1|NOT COMPLETED|Overall Study||3
113859|NCT01904279|279383|P2|COMPLETED|Overall Study||22
113860|NCT01904279|279384|P1|COMPLETED|Overall Study||24
113861|NCT01904279|279383|P2|STARTED|Overall Study||25
113862|NCT01904279|279384|P1|STARTED|Overall Study||27
113863|NCT01904149|279410|P6|NOT COMPLETED|Overall Study||3
113864|NCT01904149|279411|P5|NOT COMPLETED|Overall Study||5
113865|NCT01904149|279412|P4|NOT COMPLETED|Overall Study||4
113866|NCT01904149|279413|P3|NOT COMPLETED|Overall Study||2
113867|NCT01904149|279414|P2|NOT COMPLETED|Overall Study||11
113868|NCT01904149|279415|P1|NOT COMPLETED|Overall Study||5
113869|NCT01904149|279410|P6|COMPLETED|Overall Study||48
113870|NCT01904149|279411|P5|COMPLETED|Overall Study||46
113871|NCT01904149|279412|P4|COMPLETED|Overall Study||47
113872|NCT01904149|279413|P3|COMPLETED|Overall Study||148
113873|NCT01904149|279414|P2|COMPLETED|Overall Study||140
113874|NCT01904149|279415|P1|COMPLETED|Overall Study||147
113875|NCT01904149|279410|P6|Multiple-dose Phase|Overall Study||49
113876|NCT01904149|279411|P5|Multiple-dose Phase|Overall Study||48
113877|NCT01904149|279412|P4|Multiple-dose Phase|Overall Study||48
113878|NCT01904149|279413|P3|Multiple-dose Phase|Overall Study||149
113879|NCT01904149|279414|P2|Multiple-dose Phase|Overall Study||146
113880|NCT01904149|279415|P1|Multiple-dose Phase|Overall Study||150
113881|NCT01904149|279410|P6|Single-dose Phase|Overall Study||51
113882|NCT01904149|279411|P5|Single-dose Phase|Overall Study||51
113883|NCT01904149|279412|P4|Single-dose Phase|Overall Study||51
113884|NCT01904149|279413|P3|Single-dose Phase|Overall Study||150
113885|NCT01904149|279414|P2|Single-dose Phase|Overall Study||151
113886|NCT01904149|279415|P1|Single-dose Phase|Overall Study||152
113887|NCT01904149|279410|P6|STARTED|Overall Study||51
113888|NCT01904149|279411|P5|STARTED|Overall Study||51
113889|NCT01904149|279412|P4|STARTED|Overall Study||51
113890|NCT01904149|279413|P3|STARTED|Overall Study||150
113891|NCT01904149|279414|P2|STARTED|Overall Study||151
113892|NCT01904149|279415|P1|STARTED|Overall Study||152
113893|NCT01904071|279440|P3|NOT COMPLETED|Overall Study||0
113894|NCT01904071|279441|P2|NOT COMPLETED|Overall Study||0
113895|NCT01904071|279442|P1|NOT COMPLETED|Overall Study||0
113896|NCT01904071|279440|P3|COMPLETED|Overall Study||20
113897|NCT01904071|279441|P2|COMPLETED|Overall Study||20
113898|NCT01904071|279442|P1|COMPLETED|Overall Study||24
113899|NCT01904071|279440|P3|STARTED|Overall Study||20
113900|NCT01904071|279441|P2|STARTED|Overall Study||20
113901|NCT01904071|279442|P1|STARTED|Overall Study||24
113902|NCT01904058|279466|P4|NOT COMPLETED|Overall Study||1
113903|NCT01904058|279467|P3|NOT COMPLETED|Overall Study||1
113904|NCT01904058|279468|P2|NOT COMPLETED|Overall Study||0
113905|NCT01904058|279469|P1|NOT COMPLETED|Overall Study||3
113906|NCT01904058|279466|P4|COMPLETED|Overall Study||12
113907|NCT01904058|279467|P3|COMPLETED|Overall Study||10
113908|NCT01904058|279468|P2|COMPLETED|Overall Study||21
113909|NCT01904058|279469|P1|COMPLETED|Overall Study||18
113910|NCT01904058|279466|P4|STARTED|Overall Study||13
113911|NCT01904058|279467|P3|STARTED|Overall Study||11
113912|NCT01904058|279468|P2|STARTED|Overall Study||21
113913|NCT01904058|279469|P1|STARTED|Overall Study||21
113914|NCT01903993|279509|P2|NOT COMPLETED|Overall Study||144
113915|NCT01903993|279510|P1|NOT COMPLETED|Overall Study||143
113916|NCT01903993|279509|P2|COMPLETED|Overall Study||0
113917|NCT01903993|279510|P1|COMPLETED|Overall Study||0
113918|NCT01903993|279509|P2|Received Treatment|Overall Study||142
113919|NCT01903993|279510|P1|Received Treatment|Overall Study||135
113920|NCT01903993|279509|P2|STARTED|Overall Study||144
113921|NCT01903993|279510|P1|STARTED|Overall Study||143
113922|NCT01903876|279527|P2|NOT COMPLETED|Six-Month Follow-up Period||145
113923|NCT01903876|279528|P1|NOT COMPLETED|Six-Month Follow-up Period||91
113924|NCT01903876|279527|P2|COMPLETED|Six-Month Follow-up Period||123
113925|NCT01903876|279528|P1|COMPLETED|Six-Month Follow-up Period||92
113926|NCT01903876|279527|P2|STARTED|Six-Month Follow-up Period||268
113927|NCT01903876|279528|P1|STARTED|Six-Month Follow-up Period||183
113928|NCT01903876|279527|P2|NOT COMPLETED|Baseline to Post-Intervention Period||108
113929|NCT01903876|279528|P1|NOT COMPLETED|Baseline to Post-Intervention Period||184
113930|NCT01903876|279527|P2|COMPLETED|Baseline to Post-Intervention Period||268
113931|NCT01903876|279528|P1|COMPLETED|Baseline to Post-Intervention Period||183
113932|NCT01903876|279527|P2|STARTED|Baseline to Post-Intervention Period||376
113933|NCT01903876|279528|P1|STARTED|Baseline to Post-Intervention Period||367
113934|NCT01903863|279538|P2|NOT COMPLETED|Overall Study||0
113935|NCT01903863|279539|P1|NOT COMPLETED|Overall Study||2
113936|NCT01903863|279538|P2|COMPLETED|Overall Study||16
113937|NCT01903863|279539|P1|COMPLETED|Overall Study||13
113938|NCT01903863|279538|P2|STARTED|Overall Study||16
113939|NCT01903863|279539|P1|STARTED|Overall Study||15
113940|NCT01903811|279561|P2|NOT COMPLETED|Overall Study||14
113941|NCT01903811|279562|P1|NOT COMPLETED|Overall Study||8
113942|NCT01903811|279561|P2|COMPLETED|Overall Study||57
113943|NCT01903811|279562|P1|COMPLETED|Overall Study||64
113944|NCT01903811|279561|P2|Crossover to Arm II|Overall Study||0
113945|NCT01903811|279562|P1|Crossover to Arm II|Overall Study|Following disease progression on Arm I. Note: these patients are also counted in 'Completed'.|16
113946|NCT01903811|279561|P2|STARTED|Overall Study||71
113947|NCT01903811|279562|P1|STARTED|Overall Study||72
113948|NCT01903798|279579|P4|NOT COMPLETED|Overall Study||0
113949|NCT01903798|279580|P3|NOT COMPLETED|Overall Study||0
113950|NCT01903798|279581|P2|NOT COMPLETED|Overall Study||0
113951|NCT01903798|279582|P1|NOT COMPLETED|Overall Study||0
113952|NCT01903798|279579|P4|COMPLETED|Overall Study||1
113953|NCT01903798|279580|P3|COMPLETED|Overall Study||1
113954|NCT01903798|279581|P2|COMPLETED|Overall Study||0
113955|NCT01903798|279582|P1|COMPLETED|Overall Study||2
113956|NCT01903798|279579|P4|STARTED|Overall Study||1
113957|NCT01903798|279580|P3|STARTED|Overall Study||1
113958|NCT01903798|279581|P2|STARTED|Overall Study||0
113959|NCT01903798|279582|P1|STARTED|Overall Study||2
113960|NCT01903720|279596|P1|NOT COMPLETED|Overall Study||12
113961|NCT01903720|279596|P1|COMPLETED|Overall Study||59
113962|NCT01903720|279596|P1|STARTED|Overall Study||71
113963|NCT01903564|279613|P2|NOT COMPLETED|Overall Study||0
113964|NCT01903564|279614|P1|NOT COMPLETED|Overall Study||0
113965|NCT01903564|279613|P2|COMPLETED|Overall Study||29
113966|NCT01903564|279614|P1|COMPLETED|Overall Study||10
113967|NCT01903564|279613|P2|STARTED|Overall Study||29
113968|NCT01903564|279614|P1|STARTED|Overall Study||10
113969|NCT01903460|279634|P4|NOT COMPLETED|Overall Study||1
113970|NCT01903460|279635|P3|NOT COMPLETED|Overall Study||0
113971|NCT01903460|279636|P2|NOT COMPLETED|Overall Study||0
113972|NCT01903460|279637|P1|NOT COMPLETED|Overall Study||0
113973|NCT01903460|279634|P4|COMPLETED|Overall Study||2
113974|NCT01903460|279635|P3|COMPLETED|Overall Study||3
113975|NCT01903460|279636|P2|COMPLETED|Overall Study||8
113976|NCT01903460|279637|P1|COMPLETED|Overall Study||6
113977|NCT01903460|279634|P4|STARTED|Overall Study||3
113978|NCT01903460|279635|P3|STARTED|Overall Study||3
113979|NCT01903460|279636|P2|STARTED|Overall Study||8
113980|NCT01903460|279637|P1|STARTED|Overall Study||6
113981|NCT01903434|279654|P2|NOT COMPLETED|Treatment Period 3||0
113982|NCT01903434|279655|P1|NOT COMPLETED|Treatment Period 3||0
113983|NCT01903434|279654|P2|COMPLETED|Treatment Period 3||28
113984|NCT01903434|279655|P1|COMPLETED|Treatment Period 3||29
113985|NCT01903434|279654|P2|Received at Least 1 Dose of Study Drug|Treatment Period 3||28
113986|NCT01903434|279655|P1|Received at Least 1 Dose of Study Drug|Treatment Period 3||29
113987|NCT01903434|279654|P2|STARTED|Treatment Period 3||28
113988|NCT01903434|279655|P1|STARTED|Treatment Period 3||29
113989|NCT01903434|279654|P2|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
113990|NCT01903434|279655|P1|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
113991|NCT01903434|279654|P2|COMPLETED|Washout Period 1 (at Least 14 Days)||28
113992|NCT01903434|279655|P1|COMPLETED|Washout Period 1 (at Least 14 Days)||29
113993|NCT01903434|279654|P2|STARTED|Washout Period 1 (at Least 14 Days)||28
113994|NCT01903434|279655|P1|STARTED|Washout Period 1 (at Least 14 Days)||29
113995|NCT01903434|279654|P2|NOT COMPLETED|Treatment Period 2||0
113996|NCT01903434|279655|P1|NOT COMPLETED|Treatment Period 2||0
113997|NCT01903434|279654|P2|COMPLETED|Treatment Period 2||28
113998|NCT01903434|279655|P1|COMPLETED|Treatment Period 2||29
113999|NCT01903434|279654|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||28
114000|NCT01903434|279655|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||29
114001|NCT01903434|279654|P2|STARTED|Treatment Period 2||28
114002|NCT01903434|279655|P1|STARTED|Treatment Period 2||29
114003|NCT01903434|279654|P2|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||2
114004|NCT01903434|279655|P1|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||1
114005|NCT01903434|279654|P2|COMPLETED|Washout Period 1 (at Least 14 Days)||28
114006|NCT01903434|279655|P1|COMPLETED|Washout Period 1 (at Least 14 Days)||29
114007|NCT01903434|279654|P2|STARTED|Washout Period 1 (at Least 14 Days)||30
114008|NCT01903434|279655|P1|STARTED|Washout Period 1 (at Least 14 Days)||30
114009|NCT01903434|279654|P2|NOT COMPLETED|Treatment Period 1||0
114010|NCT01903434|279655|P1|NOT COMPLETED|Treatment Period 1||0
114011|NCT01903434|279654|P2|COMPLETED|Treatment Period 1||30
114012|NCT01903434|279655|P1|COMPLETED|Treatment Period 1||30
114013|NCT01903434|279654|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||30
114014|NCT01903434|279655|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||30
114015|NCT01903434|279654|P2|STARTED|Treatment Period 1||30
114016|NCT01903434|279655|P1|STARTED|Treatment Period 1||30
114017|NCT01903356|279663|P1|NOT COMPLETED|Overall Study||15
114018|NCT01903356|279663|P1|COMPLETED|Overall Study||709
114019|NCT01903356|279663|P1|STARTED|Overall Study||724
114020|NCT01903265|279673|P2|NOT COMPLETED|Overall Study||17
114021|NCT01903265|279674|P1|NOT COMPLETED|Overall Study||14
114022|NCT01903265|279673|P2|COMPLETED|Overall Study||85
114023|NCT01903265|279674|P1|COMPLETED|Overall Study||89
114024|NCT01903265|279673|P2|STARTED|Overall Study||102
114025|NCT01903265|279674|P1|STARTED|Overall Study||103
114026|NCT01903252|279690|P6|NOT COMPLETED|Maintenance, Open-Label||18
114027|NCT01903252|279691|P5|NOT COMPLETED|Maintenance, Open-Label||21
114028|NCT01903252|279692|P4|NOT COMPLETED|Maintenance, Open-Label||6
114029|NCT01903252|279693|P3|NOT COMPLETED|Maintenance, Open-Label||0
114030|NCT01903252|279694|P2|NOT COMPLETED|Maintenance, Open-Label||0
114031|NCT01903252|279695|P1|NOT COMPLETED|Maintenance, Open-Label||0
114032|NCT01903252|279690|P6|COMPLETED|Maintenance, Open-Label||181
114033|NCT01903252|279691|P5|COMPLETED|Maintenance, Open-Label||253
114034|NCT01903252|279692|P4|COMPLETED|Maintenance, Open-Label||196
114035|NCT01903252|279693|P3|COMPLETED|Maintenance, Open-Label||0
114036|NCT01903252|279694|P2|COMPLETED|Maintenance, Open-Label||0
114037|NCT01903252|279695|P1|COMPLETED|Maintenance, Open-Label||0
114038|NCT01903252|279690|P6|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|199
114039|NCT01903252|279691|P5|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|274
114040|NCT01903252|279692|P4|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|202
114041|NCT01903252|279693|P3|STARTED|Maintenance, Open-Label|Period 2 (extended induction) is completed, subjects are newly allocated to Period 3, maintenance.|0
114042|NCT01903252|279694|P2|STARTED|Maintenance, Open-Label||0
114043|NCT01903252|279695|P1|STARTED|Maintenance, Open-Label||0
114044|NCT01903252|279690|P6|NOT COMPLETED|Extended Induction, Open-Label||0
114045|NCT01903252|279691|P5|NOT COMPLETED|Extended Induction, Open-Label||0
114046|NCT01903252|279692|P4|NOT COMPLETED|Extended Induction, Open-Label||0
114047|NCT01903252|279693|P3|NOT COMPLETED|Extended Induction, Open-Label||23
114048|NCT01903252|279694|P2|NOT COMPLETED|Extended Induction, Open-Label||0
114049|NCT01903252|279695|P1|NOT COMPLETED|Extended Induction, Open-Label||0
114050|NCT01903252|279690|P6|COMPLETED|Extended Induction, Open-Label||0
114051|NCT01903252|279691|P5|COMPLETED|Extended Induction, Open-Label||0
114052|NCT01903252|279692|P4|COMPLETED|Extended Induction, Open-Label||0
114053|NCT01903252|279693|P3|COMPLETED|Extended Induction, Open-Label||220
114054|NCT01903252|279694|P2|COMPLETED|Extended Induction, Open-Label||0
114055|NCT01903252|279695|P1|COMPLETED|Extended Induction, Open-Label||0
114056|NCT01903252|279690|P6|STARTED|Extended Induction, Open-Label||0
114057|NCT01903252|279691|P5|STARTED|Extended Induction, Open-Label||0
114058|NCT01903252|279692|P4|STARTED|Extended Induction, Open-Label||0
114059|NCT01903252|279693|P3|STARTED|Extended Induction, Open-Label|The subjects in this phase were non-responders at week 8 and discontinued the double-blind phase.|243
114060|NCT01903252|279694|P2|STARTED|Extended Induction, Open-Label|This treatment arm was only used in Period 1, double-blind induction phase.|0
114061|NCT01903252|279695|P1|STARTED|Extended Induction, Open-Label||0
114062|NCT01903252|279690|P6|NOT COMPLETED|Double-Blind Induction||0
114063|NCT01903252|279691|P5|NOT COMPLETED|Double-Blind Induction||0
114064|NCT01903252|279692|P4|NOT COMPLETED|Double-Blind Induction||0
114065|NCT01903252|279693|P3|NOT COMPLETED|Double-Blind Induction||0
114066|NCT01903252|279694|P2|NOT COMPLETED|Double-Blind Induction||41
114067|NCT01903252|279695|P1|NOT COMPLETED|Double-Blind Induction||39
114068|NCT01903252|279690|P6|COMPLETED|Double-Blind Induction||0
114069|NCT01903252|279691|P5|COMPLETED|Double-Blind Induction||0
114070|NCT01903252|279692|P4|COMPLETED|Double-Blind Induction||0
114071|NCT01903252|279693|P3|COMPLETED|Double-Blind Induction||0
114072|NCT01903252|279694|P2|COMPLETED|Double-Blind Induction||367
114073|NCT01903252|279695|P1|COMPLETED|Double-Blind Induction||370
114074|NCT01903252|279690|P6|STARTED|Double-Blind Induction||0
114075|NCT01903252|279691|P5|STARTED|Double-Blind Induction||0
114076|NCT01903252|279692|P4|STARTED|Double-Blind Induction||0
114077|NCT01903252|279693|P3|STARTED|Double-Blind Induction||0
114078|NCT01903252|279694|P2|STARTED|Double-Blind Induction||408
114079|NCT01903252|279695|P1|STARTED|Double-Blind Induction||409
114080|NCT01903187|279774|P2|NOT COMPLETED|12 Month||0
114081|NCT01903187|279775|P1|NOT COMPLETED|12 Month||0
114082|NCT01903187|279774|P2|COMPLETED|12 Month||0
114083|NCT01903187|279775|P1|COMPLETED|12 Month||2
114084|NCT01903187|279774|P2|STARTED|12 Month||0
114085|NCT01903187|279775|P1|STARTED|12 Month||2
114086|NCT01903187|279774|P2|NOT COMPLETED|6 Month||0
114087|NCT01903187|279775|P1|NOT COMPLETED|6 Month||0
114088|NCT01903187|279774|P2|COMPLETED|6 Month||0
114089|NCT01903187|279775|P1|COMPLETED|6 Month||2
114090|NCT01903187|279774|P2|STARTED|6 Month||0
114091|NCT01903187|279775|P1|STARTED|6 Month||2
114092|NCT01903187|279774|P2|NOT COMPLETED|3 Month||0
114093|NCT01903187|279775|P1|NOT COMPLETED|3 Month||0
114094|NCT01903187|279774|P2|COMPLETED|3 Month||0
114095|NCT01903187|279775|P1|COMPLETED|3 Month||2
114096|NCT01903187|279774|P2|STARTED|3 Month||0
114097|NCT01903187|279775|P1|STARTED|3 Month||2
114098|NCT01903187|279774|P2|NOT COMPLETED|1 Month||0
114099|NCT01903187|279775|P1|NOT COMPLETED|1 Month||0
114100|NCT01903187|279774|P2|COMPLETED|1 Month||2
114101|NCT01903187|279775|P1|COMPLETED|1 Month||2
114102|NCT01903187|279774|P2|STARTED|1 Month||2
114103|NCT01903187|279775|P1|STARTED|1 Month||2
114104|NCT01903187|279774|P2|NOT COMPLETED|Procedure||0
114105|NCT01903187|279775|P1|NOT COMPLETED|Procedure||0
114106|NCT01903187|279774|P2|COMPLETED|Procedure||2
114107|NCT01903187|279775|P1|COMPLETED|Procedure||2
114108|NCT01903187|279774|P2|STARTED|Procedure||2
114109|NCT01903187|279775|P1|STARTED|Procedure||2
114110|NCT01903148|279789|P1|NOT COMPLETED|Overall Study||0
114111|NCT01903148|279789|P1|COMPLETED|Overall Study||441
114112|NCT01903148|279789|P1|STARTED|Overall Study||441
114113|NCT01903031|279808|P3|NOT COMPLETED|Overall Study||5
114114|NCT01903031|279809|P2|NOT COMPLETED|Overall Study||3
114115|NCT01903031|279810|P1|NOT COMPLETED|Overall Study||2
114116|NCT01903031|279808|P3|COMPLETED|Overall Study||24
114117|NCT01903031|279809|P2|COMPLETED|Overall Study||25
114118|NCT01903031|279810|P1|COMPLETED|Overall Study||25
114119|NCT01903031|279808|P3|STARTED|Overall Study||29
114120|NCT01903031|279809|P2|STARTED|Overall Study||28
114121|NCT01903031|279810|P1|STARTED|Overall Study||27
114122|NCT01903005|279852|P1|NOT COMPLETED|Overall Study||373
114123|NCT01903005|279852|P1|COMPLETED|Overall Study|Primary study OX219-006 (n=194); Primary study OX219-007 (n=98)|292
114124|NCT01903005|279852|P1|STARTED|Overall Study|Primary study OX219-006 (n=475); Primary study OX219-007 (n=190)|665
114125|NCT01902901|279868|P2|NOT COMPLETED|Overall Study||2
114126|NCT01902901|279869|P1|NOT COMPLETED|Overall Study||0
114127|NCT01902901|279868|P2|COMPLETED|Overall Study||201
114128|NCT01902901|279869|P1|COMPLETED|Overall Study||180
114129|NCT01902901|279868|P2|STARTED|Overall Study||203
114130|NCT01902901|279869|P1|STARTED|Overall Study||180
114131|NCT01902888|279879|P1|NOT COMPLETED|Overall Study||3
114132|NCT01902888|279879|P1|COMPLETED|Overall Study||0
114133|NCT01902888|279879|P1|STARTED|Overall Study||3
114134|NCT01902758|279886|P2|NOT COMPLETED|Overall Study||0
114135|NCT01902758|279887|P1|NOT COMPLETED|Overall Study||0
114136|NCT01902758|279886|P2|COMPLETED|Overall Study||14
114137|NCT01902758|279887|P1|COMPLETED|Overall Study||14
114138|NCT01902758|279886|P2|STARTED|Overall Study||14
114139|NCT01902758|279887|P1|STARTED|Overall Study||14
114140|NCT01902628|279893|P1|NOT COMPLETED|Overall Study||83
114141|NCT01902628|279893|P1|COMPLETED|Overall Study||354
114142|NCT01902628|279893|P1|STARTED|Overall Study||437
114143|NCT01902459|279902|P2|NOT COMPLETED|Overall Study||0
114144|NCT01902459|279903|P1|NOT COMPLETED|Overall Study||0
114145|NCT01902459|279902|P2|COMPLETED|Overall Study||75
114146|NCT01902459|279903|P1|COMPLETED|Overall Study||75
114147|NCT01902459|279902|P2|STARTED|Overall Study||75
114148|NCT01902459|279903|P1|STARTED|Overall Study||75
114149|NCT01902303|279921|P2|NOT COMPLETED|Overall Study||24
114150|NCT01902303|279922|P1|NOT COMPLETED|Overall Study||23
114151|NCT01902303|279921|P2|COMPLETED|Overall Study|19 not treated /did not use medication as they did not develop a cold sore|57
114152|NCT01902303|279922|P1|COMPLETED|Overall Study|21 not treated - did not use placebo medication as they did not develop cold sore|54
114153|NCT01902303|279921|P2|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|62
114154|NCT01902303|279922|P1|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|56
114155|NCT01902303|279921|P2|STARTED|Overall Study|Allocated to active treatment|81
114156|NCT01902303|279922|P1|STARTED|Overall Study|Allocated to placebo|77
114157|NCT01902134|279936|P6|NOT COMPLETED|Overall Study||9
114158|NCT01902134|279937|P5|NOT COMPLETED|Overall Study||7
114159|NCT01902134|279938|P4|NOT COMPLETED|Overall Study||2
114160|NCT01902134|279939|P3|NOT COMPLETED|Overall Study||15
114161|NCT01902134|279940|P2|NOT COMPLETED|Overall Study||11
114162|NCT01902134|279941|P1|NOT COMPLETED|Overall Study||8
114163|NCT01902134|279936|P6|COMPLETED|Overall Study||45
114164|NCT01902134|279937|P5|COMPLETED|Overall Study||46
114165|NCT01902134|279938|P4|COMPLETED|Overall Study||52
114166|NCT01902134|279939|P3|COMPLETED|Overall Study||145
114167|NCT01902134|279940|P2|COMPLETED|Overall Study||150
114168|NCT01902134|279941|P1|COMPLETED|Overall Study||151
114169|NCT01902134|279936|P6|Multiple-dose Phase|Overall Study||52
114170|NCT01902134|279937|P5|Multiple-dose Phase|Overall Study||53
114171|NCT01902134|279938|P4|Multiple-dose Phase|Overall Study||54
114172|NCT01902134|279939|P3|Multiple-dose Phase|Overall Study||160
114173|NCT01902134|279940|P2|Multiple-dose Phase|Overall Study||160
114174|NCT01902134|279941|P1|Multiple-dose Phase|Overall Study||159
114175|NCT01902134|279936|P6|Single-dose Phase|Overall Study||54
114176|NCT01902134|279937|P5|Single-dose Phase|Overall Study||53
114177|NCT01902134|279938|P4|Single-dose Phase|Overall Study||54
114178|NCT01902134|279939|P3|Single-dose Phase|Overall Study||160
114179|NCT01902134|279940|P2|Single-dose Phase|Overall Study||161
114180|NCT01902134|279941|P1|Single-dose Phase|Overall Study||159
114181|NCT01902134|279936|P6|STARTED|Overall Study||54
114182|NCT01902134|279937|P5|STARTED|Overall Study||53
114183|NCT01902134|279938|P4|STARTED|Overall Study||54
114184|NCT01902134|279939|P3|STARTED|Overall Study||160
114185|NCT01902134|279940|P2|STARTED|Overall Study||161
114186|NCT01902134|279941|P1|STARTED|Overall Study||159
114187|NCT01902004|279965|P2|NOT COMPLETED|Overall Study||18
114188|NCT01902004|279966|P1|NOT COMPLETED|Overall Study||15
114189|NCT01902004|279965|P2|COMPLETED|Overall Study||29
114190|NCT01902004|279966|P1|COMPLETED|Overall Study||33
114191|NCT01902004|279965|P2|STARTED|Overall Study||47
114192|NCT01902004|279966|P1|STARTED|Overall Study||48
114193|NCT01901874|279978|P1|NOT COMPLETED|1-Year (365-Day) MAE Evaluation||20
114194|NCT01901874|279978|P1|COMPLETED|1-Year (365-Day) MAE Evaluation||244
114195|NCT01901874|279978|P1|STARTED|1-Year (365-Day) MAE Evaluation||264
114196|NCT01901874|279978|P1|NOT COMPLETED|30-Day MAE Evaluation||1
114197|NCT01901874|279978|P1|COMPLETED|30-Day MAE Evaluation||264
114198|NCT01901874|279978|P1|STARTED|30-Day MAE Evaluation||265
114199|NCT01901874|279978|P1|NOT COMPLETED|Screening Committee Retrospective Review||47
114200|NCT01901874|279978|P1|COMPLETED|Screening Committee Retrospective Review||265
114201|NCT01901874|279978|P1|STARTED|Screening Committee Retrospective Review||312
114202|NCT01901874|279978|P1|NOT COMPLETED|Procedure||0
114203|NCT01901874|279978|P1|COMPLETED|Procedure||312
114204|NCT01901874|279978|P1|STARTED|Procedure||312
114205|NCT01901848|279993|P2|NOT COMPLETED|Removed From Analyses||0
114206|NCT01901848|279994|P1|NOT COMPLETED|Removed From Analyses||10
114207|NCT01901848|279993|P2|COMPLETED|Removed From Analyses||19
114208|NCT01901848|279994|P1|COMPLETED|Removed From Analyses||12
114209|NCT01901848|279993|P2|STARTED|Removed From Analyses||19
114210|NCT01901848|279994|P1|STARTED|Removed From Analyses||22
114211|NCT01901848|279993|P2|NOT COMPLETED|Randomized and Treated||6
114212|NCT01901848|279994|P1|NOT COMPLETED|Randomized and Treated||3
114213|NCT01901848|279993|P2|COMPLETED|Randomized and Treated||19
114214|NCT01901848|279994|P1|COMPLETED|Randomized and Treated|Ten cases were practice cases used to establish fidelity to CPT, and were removed from analyses.|22
114215|NCT01901848|279993|P2|STARTED|Randomized and Treated||25
114216|NCT01901848|279994|P1|STARTED|Randomized and Treated||25
114217|NCT01901809|280006|P4|NOT COMPLETED|Overall Study||2
114218|NCT01901809|280007|P3|NOT COMPLETED|Overall Study||3
114219|NCT01901809|280008|P2|NOT COMPLETED|Overall Study||0
114220|NCT01901809|280009|P1|NOT COMPLETED|Overall Study||0
114221|NCT01901809|280006|P4|COMPLETED|Overall Study||22
114222|NCT01901809|280007|P3|COMPLETED|Overall Study||21
114223|NCT01901809|280008|P2|COMPLETED|Overall Study||23
114224|NCT01901809|280009|P1|COMPLETED|Overall Study||19
114225|NCT01901809|280006|P4|STARTED|Overall Study||24
114226|NCT01901809|280007|P3|STARTED|Overall Study||24
114227|NCT01901809|280008|P2|STARTED|Overall Study||23
114228|NCT01901809|280009|P1|STARTED|Overall Study||19
114229|NCT01901653|280036|P13|NOT COMPLETED|Overall Study||5
114230|NCT01901653|280037|P12|NOT COMPLETED|Overall Study||16
114231|NCT01901653|280038|P11|NOT COMPLETED|Overall Study||2
114232|NCT01901653|280039|P10|NOT COMPLETED|Overall Study||18
114233|NCT01901653|280040|P9|NOT COMPLETED|Overall Study||1
114234|NCT01901653|280041|P8|NOT COMPLETED|Overall Study||10
114235|NCT01901653|280042|P7|NOT COMPLETED|Overall Study||7
114236|NCT01901653|280043|P6|NOT COMPLETED|Overall Study||3
114237|NCT01901653|280044|P5|NOT COMPLETED|Overall Study||2
114238|NCT01901653|280045|P4|NOT COMPLETED|Overall Study||3
114239|NCT01901653|280046|P3|NOT COMPLETED|Overall Study||11
114240|NCT01901653|280047|P2|NOT COMPLETED|Overall Study||1
114241|NCT01901653|280048|P1|NOT COMPLETED|Overall Study||3
114242|NCT01901653|280036|P13|COMPLETED|Overall Study||0
114243|NCT01901653|280037|P12|COMPLETED|Overall Study||0
114244|NCT01901653|280038|P11|COMPLETED|Overall Study||0
114245|NCT01901653|280039|P10|COMPLETED|Overall Study||0
114246|NCT01901653|280040|P9|COMPLETED|Overall Study||0
114247|NCT01901653|280041|P8|COMPLETED|Overall Study||0
114248|NCT01901653|280042|P7|COMPLETED|Overall Study||0
114249|NCT01901653|280043|P6|COMPLETED|Overall Study||0
114250|NCT01901653|280044|P5|COMPLETED|Overall Study||0
114251|NCT01901653|280045|P4|COMPLETED|Overall Study||0
114252|NCT01901653|280046|P3|COMPLETED|Overall Study||0
114253|NCT01901653|280047|P2|COMPLETED|Overall Study||0
114254|NCT01901653|280048|P1|COMPLETED|Overall Study||0
114255|NCT01901653|280036|P13|STARTED|Overall Study||5
114256|NCT01901653|280037|P12|STARTED|Overall Study||16
114257|NCT01901653|280038|P11|STARTED|Overall Study||2
114258|NCT01901653|280039|P10|STARTED|Overall Study||18
114259|NCT01901653|280040|P9|STARTED|Overall Study||1
114260|NCT01901653|280041|P8|STARTED|Overall Study||10
114261|NCT01901653|280042|P7|STARTED|Overall Study||7
114262|NCT01901653|280043|P6|STARTED|Overall Study||3
114263|NCT01901653|280044|P5|STARTED|Overall Study||2
114264|NCT01901653|280045|P4|STARTED|Overall Study||3
114265|NCT01901653|280046|P3|STARTED|Overall Study||11
114266|NCT01901653|280047|P2|STARTED|Overall Study||1
114267|NCT01901653|280048|P1|STARTED|Overall Study||3
114268|NCT01901614|280092|P2|NOT COMPLETED|Overall Study||1
114269|NCT01901614|280093|P1|NOT COMPLETED|Overall Study||2
114270|NCT01901614|280092|P2|COMPLETED|Overall Study||1
114271|NCT01901614|280093|P1|COMPLETED|Overall Study||1
114272|NCT01901614|280092|P2|STARTED|Overall Study||2
114273|NCT01901614|280093|P1|STARTED|Overall Study||3
114274|NCT01901588|280101|P2|NOT COMPLETED|Overall Study||0
114275|NCT01901588|280102|P1|NOT COMPLETED|Overall Study||0
114276|NCT01901588|280101|P2|COMPLETED|Overall Study||31
114277|NCT01901588|280102|P1|COMPLETED|Overall Study||32
114278|NCT01901588|280101|P2|STARTED|Overall Study||31
114279|NCT01901588|280102|P1|STARTED|Overall Study||32
114280|NCT01901575|280118|P1|NOT COMPLETED|Overall Study||0
114281|NCT01901575|280118|P1|COMPLETED|Overall Study||16
114282|NCT01901575|280118|P1|STARTED|Overall Study|enrolled patients with PVC's present prior to sedation with remifentanil IVPCA|16
114283|NCT01901432|280128|P5|NOT COMPLETED|Overall Study||9
114284|NCT01901432|280129|P4|NOT COMPLETED|Overall Study||0
114285|NCT01901432|280130|P3|NOT COMPLETED|Overall Study||2
114286|NCT01901432|280131|P2|NOT COMPLETED|Overall Study||1
114287|NCT01901432|280132|P1|NOT COMPLETED|Overall Study||0
114288|NCT01901432|280128|P5|COMPLETED|Overall Study||27
114289|NCT01901432|280129|P4|COMPLETED|Overall Study||3
114290|NCT01901432|280130|P3|COMPLETED|Overall Study||1
114291|NCT01901432|280131|P2|COMPLETED|Overall Study||2
114292|NCT01901432|280132|P1|COMPLETED|Overall Study||3
114293|NCT01901432|280128|P5|Received Study Drug|Overall Study||35
114294|NCT01901432|280129|P4|Received Study Drug|Overall Study||3
114295|NCT01901432|280130|P3|Received Study Drug|Overall Study||3
114296|NCT01901432|280131|P2|Received Study Drug|Overall Study||3
114297|NCT01901432|280132|P1|Received Study Drug|Overall Study||3
114298|NCT01901432|280128|P5|STARTED|Overall Study||36
114299|NCT01901432|280129|P4|STARTED|Overall Study||3
114300|NCT01901432|280130|P3|STARTED|Overall Study||3
114301|NCT01901432|280131|P2|STARTED|Overall Study||3
114302|NCT01901432|280132|P1|STARTED|Overall Study||3
114303|NCT01901393|280184|P2|NOT COMPLETED|Overall Study||0
114304|NCT01901393|280185|P1|NOT COMPLETED|Overall Study||1
114305|NCT01901393|280184|P2|COMPLETED|Overall Study||49
114306|NCT01901393|280185|P1|COMPLETED|Overall Study||50
114307|NCT01901393|280184|P2|STARTED|Overall Study||49
114308|NCT01901393|280185|P1|STARTED|Overall Study||51
114309|NCT01901341|280203|P2|NOT COMPLETED|Overall Study||21
114310|NCT01901341|280204|P1|NOT COMPLETED|Overall Study||20
114311|NCT01901341|280203|P2|COMPLETED|Overall Study||1
114312|NCT01901341|280204|P1|COMPLETED|Overall Study||2
114313|NCT01901341|280203|P2|Received at Least 1 Dose of Study Drug|Overall Study||22
114314|NCT01901341|280204|P1|Received at Least 1 Dose of Study Drug|Overall Study||22
114315|NCT01901341|280203|P2|STARTED|Overall Study||22
114316|NCT01901341|280204|P1|STARTED|Overall Study||22
114317|NCT01901328|280218|P2|NOT COMPLETED|Overall Study||21
114318|NCT01901328|280219|P1|NOT COMPLETED|Overall Study||22
114319|NCT01901328|280218|P2|COMPLETED|Overall Study||2
114320|NCT01901328|280219|P1|COMPLETED|Overall Study||4
114321|NCT01901328|280218|P2|Received at Least 1 Dose of Study Drug|Overall Study||23
114322|NCT01901328|280219|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
114323|NCT01901328|280218|P2|STARTED|Overall Study||23
114324|NCT01901328|280219|P1|STARTED|Overall Study||26
114325|NCT01901302|280233|P2|NOT COMPLETED|Overall Study||23
114326|NCT01901302|280234|P1|NOT COMPLETED|Overall Study||27
114327|NCT01901302|280233|P2|COMPLETED|Overall Study||7
114328|NCT01901302|280234|P1|COMPLETED|Overall Study||4
114329|NCT01901302|280233|P2|Received at Least 1 Dose of Study Drug|Overall Study||30
114330|NCT01901302|280234|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
114331|NCT01901302|280233|P2|STARTED|Overall Study||30
114332|NCT01901302|280234|P1|STARTED|Overall Study||31
114333|NCT01901289|280246|P1|NOT COMPLETED|Overall Study||200
114334|NCT01901289|280246|P1|COMPLETED|Overall Study||0
114335|NCT01901289|280246|P1|12-Month Follow-up|Overall Study||175
114336|NCT01901289|280246|P1|STARTED|Overall Study||200
114337|NCT01901250|280252|P2|NOT COMPLETED|Overall Study||126
114338|NCT01901250|280253|P1|NOT COMPLETED|Overall Study||138
114339|NCT01901250|280252|P2|COMPLETED|Overall Study||139
114340|NCT01901250|280253|P1|COMPLETED|Overall Study||122
114341|NCT01901250|280252|P2|End of 1st Grade|Overall Study||151
114342|NCT01901250|280253|P1|End of 1st Grade|Overall Study||143
114343|NCT01901250|280252|P2|Start of 1st Grade|Overall Study||176
114344|NCT01901250|280253|P1|Start of 1st Grade|Overall Study||173
114345|NCT01901250|280252|P2|End of Kidergarten|Overall Study||212
114346|NCT01901250|280253|P1|End of Kidergarten|Overall Study||215
114347|NCT01901250|280252|P2|STARTED|Overall Study||265
114348|NCT01901250|280253|P1|STARTED|Overall Study||260
114349|NCT01901224|280259|P1|NOT COMPLETED|Overall Study||2
114350|NCT01901224|280259|P1|COMPLETED|Overall Study||0
114351|NCT01901224|280259|P1|STARTED|Overall Study||2
114352|NCT01901211|280270|P2|NOT COMPLETED|Second Ten-week Period||0
114353|NCT01901211|280271|P1|NOT COMPLETED|Second Ten-week Period||0
114354|NCT01901211|280270|P2|COMPLETED|Second Ten-week Period||5
114355|NCT01901211|280271|P1|COMPLETED|Second Ten-week Period||6
114356|NCT01901211|280270|P2|STARTED|Second Ten-week Period||5
114357|NCT01901211|280271|P1|STARTED|Second Ten-week Period||6
114358|NCT01901211|280270|P2|NOT COMPLETED|Washout (6 Weeks)||0
114359|NCT01901211|280271|P1|NOT COMPLETED|Washout (6 Weeks)||0
114360|NCT01901211|280270|P2|COMPLETED|Washout (6 Weeks)||5
114361|NCT01901211|280271|P1|COMPLETED|Washout (6 Weeks)||6
114362|NCT01901211|280270|P2|STARTED|Washout (6 Weeks)||5
114363|NCT01901211|280271|P1|STARTED|Washout (6 Weeks)||6
114364|NCT01901211|280270|P2|NOT COMPLETED|First Ten-week Period||0
114365|NCT01901211|280271|P1|NOT COMPLETED|First Ten-week Period||0
114366|NCT01901211|280270|P2|COMPLETED|First Ten-week Period||5
114367|NCT01901211|280271|P1|COMPLETED|First Ten-week Period||6
114368|NCT01901211|280270|P2|STARTED|First Ten-week Period||5
114369|NCT01901211|280271|P1|STARTED|First Ten-week Period||6
114370|NCT01901185|280294|P1|NOT COMPLETED|Overall Study||2
114371|NCT01901185|280294|P1|COMPLETED|Overall Study||75
114372|NCT01901185|280294|P1|Received Etanercept With Autoinjector A|Overall Study||75
114373|NCT01901185|280294|P1|STARTED|Overall Study||77
114374|NCT01901146|280303|P5|NOT COMPLETED|Adjuvant Phase||14
114375|NCT01901146|280304|P4|NOT COMPLETED|Adjuvant Phase||7
114376|NCT01901146|280305|P3|NOT COMPLETED|Adjuvant Phase||26
114377|NCT01901146|280306|P2|NOT COMPLETED|Adjuvant Phase||0
114378|NCT01901146|280307|P1|NOT COMPLETED|Adjuvant Phase||0
114379|NCT01901146|280303|P5|COMPLETED|Adjuvant Phase||157
114380|NCT01901146|280304|P4|COMPLETED|Adjuvant Phase||164
114381|NCT01901146|280305|P3|COMPLETED|Adjuvant Phase||323
114382|NCT01901146|280306|P2|COMPLETED|Adjuvant Phase||0
114383|NCT01901146|280307|P1|COMPLETED|Adjuvant Phase||0
114384|NCT01901146|280303|P5|STARTED|Adjuvant Phase|Three participants discontinued the study after surgery but before entering adjuvant phase.|171
114385|NCT01901146|280304|P4|STARTED|Adjuvant Phase|Two participants discontinued the study after surgery but before entering adjuvant phase.|171
114386|NCT01901146|280305|P3|STARTED|Adjuvant Phase|Nine participants discontinued the study after surgery but before entering adjuvant phase.|349
114387|NCT01901146|280306|P2|STARTED|Adjuvant Phase||0
114388|NCT01901146|280307|P1|STARTED|Adjuvant Phase||0
114389|NCT01901146|280303|P5|NOT COMPLETED|Neoadjuvant Phase||0
114390|NCT01901146|280304|P4|NOT COMPLETED|Neoadjuvant Phase||0
114391|NCT01901146|280305|P3|NOT COMPLETED|Neoadjuvant Phase||0
114392|NCT01901146|280306|P2|NOT COMPLETED|Neoadjuvant Phase||14
114393|NCT01901146|280307|P1|NOT COMPLETED|Neoadjuvant Phase||6
114394|NCT01901146|280303|P5|COMPLETED|Neoadjuvant Phase||0
114395|NCT01901146|280304|P4|COMPLETED|Neoadjuvant Phase||0
114396|NCT01901146|280305|P3|COMPLETED|Neoadjuvant Phase||0
114397|NCT01901146|280306|P2|COMPLETED|Neoadjuvant Phase|Indicates participants who completed surgery|347
114398|NCT01901146|280307|P1|COMPLETED|Neoadjuvant Phase|Indicates participants who completed surgery|358
114399|NCT01901146|280303|P5|STARTED|Neoadjuvant Phase||0
114400|NCT01901146|280304|P4|STARTED|Neoadjuvant Phase||0
114401|NCT01901146|280305|P3|STARTED|Neoadjuvant Phase||0
114402|NCT01901146|280306|P2|STARTED|Neoadjuvant Phase||361
114403|NCT01901146|280307|P1|STARTED|Neoadjuvant Phase||364
114404|NCT01900899|280322|P2|NOT COMPLETED|Overall Study||1
114405|NCT01900899|280323|P1|NOT COMPLETED|Overall Study||9
114406|NCT01900899|280322|P2|COMPLETED|Overall Study||24
114407|NCT01900899|280323|P1|COMPLETED|Overall Study||150
114408|NCT01900899|280322|P2|STARTED|Overall Study||25
114409|NCT01900899|280323|P1|STARTED|Overall Study||159
114410|NCT01900665|280349|P2|NOT COMPLETED|Open Label Period||859
114411|NCT01900665|280350|P1|NOT COMPLETED|Open Label Period||881
114412|NCT01900665|280349|P2|COMPLETED|Open Label Period||0
114413|NCT01900665|280350|P1|COMPLETED|Open Label Period||0
114414|NCT01900665|280349|P2|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|859
114415|NCT01900665|280350|P1|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|881
114416|NCT01900665|280349|P2|NOT COMPLETED|Placebo Controlled Period||164
114417|NCT01900665|280350|P1|NOT COMPLETED|Placebo Controlled Period||143
114418|NCT01900665|280349|P2|COMPLETED|Placebo Controlled Period||908
114419|NCT01900665|280350|P1|COMPLETED|Placebo Controlled Period||914
114420|NCT01900665|280349|P2|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1067
114421|NCT01900665|280350|P1|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1054
114422|NCT01900665|280349|P2|STARTED|Placebo Controlled Period||1072
114423|NCT01900665|280350|P1|STARTED|Placebo Controlled Period||1057
114424|NCT01900652|280393|P2|NOT COMPLETED|Overall Study||3
114425|NCT01900652|280394|P1|NOT COMPLETED|Overall Study||8
114426|NCT01900652|280393|P2|COMPLETED|Overall Study||25
114427|NCT01900652|280394|P1|COMPLETED|Overall Study||75
114428|NCT01900652|280393|P2|Post-Erlotinib Progression Tumor Sample|Overall Study||23
114429|NCT01900652|280394|P1|Post-Erlotinib Progression Tumor Sample|Overall Study||66
114430|NCT01900652|280393|P2|STARTED|Overall Study||28
114431|NCT01900652|280394|P1|STARTED|Overall Study||83
114432|NCT01900626|280430|P2|NOT COMPLETED|Overall Study||1
114433|NCT01900626|280431|P1|NOT COMPLETED|Overall Study||1
114434|NCT01900626|280430|P2|COMPLETED|Overall Study||0
114435|NCT01900626|280431|P1|COMPLETED|Overall Study||0
114436|NCT01900626|280430|P2|STARTED|Overall Study||1
114437|NCT01900626|280431|P1|STARTED|Overall Study||1
114438|NCT01900561|280449|P2|NOT COMPLETED|Overall Study||9
114439|NCT01900561|280450|P1|NOT COMPLETED|Overall Study||17
114440|NCT01900561|280449|P2|COMPLETED|Overall Study||269
114441|NCT01900561|280450|P1|COMPLETED|Overall Study||261
114442|NCT01900561|280449|P2|STARTED|Overall Study||278
114443|NCT01900561|280450|P1|STARTED|Overall Study||278
114444|NCT01900444|280510|P1|NOT COMPLETED|Overall Study||3
114445|NCT01900444|280510|P1|COMPLETED|Overall Study||116
114446|NCT01900444|280510|P1|STARTED|Overall Study||119
114447|NCT01900431|280523|P3|NOT COMPLETED|Open-Label Treatment Period (Part C)||8
114448|NCT01900431|280524|P2|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
114449|NCT01900431|280525|P1|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
114450|NCT01900431|280523|P3|COMPLETED|Open-Label Treatment Period (Part C)||13
114451|NCT01900431|280524|P2|COMPLETED|Open-Label Treatment Period (Part C)||0
114452|NCT01900431|280525|P1|COMPLETED|Open-Label Treatment Period (Part C)||0
114453|NCT01900431|280523|P3|STARTED|Open-Label Treatment Period (Part C)|10 non-responders (5 Placebo, 5 Sarilumab) & 11 non-completers (6 Placebo, 5 Sarilumab) from Part A.|21
114454|NCT01900431|280524|P2|STARTED|Open-Label Treatment Period (Part C)||0
114455|NCT01900431|280525|P1|STARTED|Open-Label Treatment Period (Part C)||0
114456|NCT01900431|280523|P3|NOT COMPLETED|Extended Treatment Period (Part B)||0
114457|NCT01900431|280524|P2|NOT COMPLETED|Extended Treatment Period (Part B)||10
114458|NCT01900431|280525|P1|NOT COMPLETED|Extended Treatment Period (Part B)||1
114459|NCT01900431|280523|P3|COMPLETED|Extended Treatment Period (Part B)||0
114460|NCT01900431|280524|P2|COMPLETED|Extended Treatment Period (Part B)||12
114461|NCT01900431|280525|P1|COMPLETED|Extended Treatment Period (Part B)||7
114462|NCT01900431|280523|P3|STARTED|Extended Treatment Period (Part B)||0
114463|NCT01900431|280524|P2|STARTED|Extended Treatment Period (Part B)||22
114464|NCT01900431|280525|P1|STARTED|Extended Treatment Period (Part B)||8
114465|NCT01900431|280523|P3|NOT COMPLETED|Principal Treatment Period (Part A)||0
114466|NCT01900431|280524|P2|NOT COMPLETED|Principal Treatment Period (Part A)||10
114467|NCT01900431|280525|P1|NOT COMPLETED|Principal Treatment Period (Part A)||7
114468|NCT01900431|280523|P3|COMPLETED|Principal Treatment Period (Part A)||0
114469|NCT01900431|280524|P2|COMPLETED|Principal Treatment Period (Part A)|22 responders entered Part B, 5 non-responders entered Part C, 1 discontinued the study.|28
114470|NCT01900431|280525|P1|COMPLETED|Principal Treatment Period (Part A)|8 responders entered Part B and 5 non-responders entered Part C.|13
114471|NCT01900431|280523|P3|STARTED|Principal Treatment Period (Part A)||0
114472|NCT01900431|280524|P2|STARTED|Principal Treatment Period (Part A)||38
114473|NCT01900431|280525|P1|STARTED|Principal Treatment Period (Part A)||20
114474|NCT01900392|280552|P3|NOT COMPLETED|Overall Study||0
114475|NCT01900392|280553|P2|NOT COMPLETED|Overall Study||1
114476|NCT01900392|280554|P1|NOT COMPLETED|Overall Study||1
114477|NCT01900392|280552|P3|COMPLETED|Overall Study||77
114478|NCT01900392|280553|P2|COMPLETED|Overall Study||74
114479|NCT01900392|280554|P1|COMPLETED|Overall Study||38
114480|NCT01900392|280552|P3|STARTED|Overall Study||77
114481|NCT01900392|280553|P2|STARTED|Overall Study||75
114482|NCT01900392|280554|P1|STARTED|Overall Study||39
114483|NCT01900314|280567|P2|NOT COMPLETED|Overall Study||4
114484|NCT01900314|280568|P1|NOT COMPLETED|Overall Study||4
114485|NCT01900314|280567|P2|COMPLETED|Overall Study|1 patient had 4 TMS Tx, but missed too many for protocol requirements,|16
114486|NCT01900314|280568|P1|COMPLETED|Overall Study|1 patient had MRI, then moved away after 5 TMS treatments|16
114487|NCT01900314|280567|P2|Completed MRI#1|Overall Study|2 withdrew consent, 1 patient was unable to tolerate MRI|17
114488|NCT01900314|280568|P1|Completed MRI#1|Overall Study|2 withdrew consent prior to MRI, 1 had MRI technical failure|17
114489|NCT01900314|280567|P2|STARTED|Overall Study||20
114490|NCT01900314|280568|P1|STARTED|Overall Study||20
114491|NCT01900249|280579|P3|NOT COMPLETED|Overall Study||4
114492|NCT01900249|280580|P2|NOT COMPLETED|Overall Study||5
114493|NCT01900249|280581|P1|NOT COMPLETED|Overall Study||3
114494|NCT01900249|280579|P3|COMPLETED|Overall Study||65
114495|NCT01900249|280580|P2|COMPLETED|Overall Study||63
114496|NCT01900249|280581|P1|COMPLETED|Overall Study||64
114497|NCT01900249|280579|P3|STARTED|Overall Study||69
114498|NCT01900249|280580|P2|STARTED|Overall Study||68
114499|NCT01900249|280581|P1|STARTED|Overall Study||67
114500|NCT01900067|280591|P2|NOT COMPLETED|Overall Study||13
114501|NCT01900067|280592|P1|NOT COMPLETED|Overall Study||12
114502|NCT01900067|280591|P2|COMPLETED|Overall Study||124
114503|NCT01900067|280592|P1|COMPLETED|Overall Study||122
114504|NCT01900067|280591|P2|STARTED|Overall Study||137
114505|NCT01900067|280592|P1|STARTED|Overall Study||134
114506|NCT01900054|280598|P1|NOT COMPLETED|Overall Study||2
114507|NCT01900054|280598|P1|COMPLETED|Overall Study||56
114508|NCT01900054|280598|P1|STARTED|Overall Study||58
114509|NCT01899911|280603|P1|NOT COMPLETED|Overall Study||0
114510|NCT01899911|280603|P1|COMPLETED|Overall Study||12
114511|NCT01899911|280603|P1|STARTED|Overall Study||12
114512|NCT01899768|280607|P1|NOT COMPLETED|Part C||0
114513|NCT01899768|280607|P1|COMPLETED|Part C||11
114514|NCT01899768|280607|P1|STARTED|Part C||11
114515|NCT01899768|280607|P1|NOT COMPLETED|Part B||2
114516|NCT01899768|280607|P1|COMPLETED|Part B||11
114517|NCT01899768|280607|P1|STARTED|Part B||13
114518|NCT01899768|280607|P1|NOT COMPLETED|Part A||3
114519|NCT01899768|280607|P1|COMPLETED|Part A||13
114520|NCT01899768|280607|P1|STARTED|Part A||16
114521|NCT01899742|280681|P2|NOT COMPLETED|Overall Study||16
114522|NCT01899742|280682|P1|NOT COMPLETED|Overall Study||17
114523|NCT01899742|280681|P2|COMPLETED|Overall Study||231
114524|NCT01899742|280682|P1|COMPLETED|Overall Study||230
114525|NCT01899742|280681|P2|STARTED|Overall Study||247
114526|NCT01899742|280682|P1|STARTED|Overall Study||247
114527|NCT01899729|280695|P5|NOT COMPLETED|Overall Study||2
114528|NCT01899729|280696|P4|NOT COMPLETED|Overall Study||0
114529|NCT01899729|280697|P3|NOT COMPLETED|Overall Study||2
114530|NCT01899729|280698|P2|NOT COMPLETED|Overall Study||2
114531|NCT01899729|280699|P1|NOT COMPLETED|Overall Study||2
114532|NCT01899729|280695|P5|COMPLETED|Overall Study||9
114533|NCT01899729|280696|P4|COMPLETED|Overall Study||9
114534|NCT01899729|280697|P3|COMPLETED|Overall Study||6
114535|NCT01899729|280698|P2|COMPLETED|Overall Study||7
114536|NCT01899729|280699|P1|COMPLETED|Overall Study||7
114537|NCT01899729|280695|P5|STARTED|Overall Study||11
114538|NCT01899729|280696|P4|STARTED|Overall Study||9
114539|NCT01899729|280697|P3|STARTED|Overall Study||8
114540|NCT01899729|280698|P2|STARTED|Overall Study||9
114541|NCT01899729|280699|P1|STARTED|Overall Study||9
114542|NCT01899677|280713|P2|NOT COMPLETED|Overall Study||7
114543|NCT01899677|280714|P1|NOT COMPLETED|Overall Study||10
114544|NCT01899677|280713|P2|COMPLETED|Overall Study||28
114545|NCT01899677|280714|P1|COMPLETED|Overall Study||25
114546|NCT01899677|280713|P2|STARTED|Overall Study||35
114547|NCT01899677|280714|P1|STARTED|Overall Study||35
114548|NCT01899144|280742|P1|NOT COMPLETED|Treatment Period 5||1
114549|NCT01899144|280742|P1|COMPLETED|Treatment Period 5|Last treatment taken by the patient who discontinued was ABS Spiromax 180 mcg.|57
114550|NCT01899144|280742|P1|STARTED|Treatment Period 5||58
114551|NCT01899144|280742|P1|NOT COMPLETED|Treatment Period 4||0
114552|NCT01899144|280742|P1|COMPLETED|Treatment Period 4||58
114553|NCT01899144|280742|P1|STARTED|Treatment Period 4||58
114554|NCT01899144|280742|P1|NOT COMPLETED|Treatment Period 3||2
114555|NCT01899144|280742|P1|COMPLETED|Treatment Period 3|Last treatment taken by patients who discontinued were ABS Spiromax 180 mcg and ABS Spiromax 90 mcg.|58
114556|NCT01899144|280742|P1|STARTED|Treatment Period 3||60
114557|NCT01899144|280742|P1|NOT COMPLETED|Treatment Period 2||1
114558|NCT01899144|280742|P1|COMPLETED|Treatment Period 2|Last treatment taken by the patient who discontinued was placebo.|60
114559|NCT01899144|280742|P1|STARTED|Treatment Period 2||61
114560|NCT01899144|280742|P1|NOT COMPLETED|Treatment Period 1||0
114561|NCT01899144|280742|P1|COMPLETED|Treatment Period 1||61
114562|NCT01899144|280742|P1|STARTED|Treatment Period 1||61
114563|NCT01899053|280778|P14|NOT COMPLETED|Overall Study||20
114564|NCT01899053|280779|P13|NOT COMPLETED|Overall Study||14
114565|NCT01899053|280780|P12|NOT COMPLETED|Overall Study||7
114566|NCT01899053|280781|P11|NOT COMPLETED|Overall Study||16
114567|NCT01899053|280782|P10|NOT COMPLETED|Overall Study||3
114568|NCT01899053|280783|P9|NOT COMPLETED|Overall Study||6
114569|NCT01899053|280784|P8|NOT COMPLETED|Overall Study||3
114570|NCT01899053|280785|P7|NOT COMPLETED|Overall Study||3
114571|NCT01899053|280786|P6|NOT COMPLETED|Overall Study||3
114572|NCT01899053|280787|P5|NOT COMPLETED|Overall Study||6
114573|NCT01899053|280788|P4|NOT COMPLETED|Overall Study||3
114574|NCT01899053|280789|P3|NOT COMPLETED|Overall Study||7
114575|NCT01899053|280790|P2|NOT COMPLETED|Overall Study||3
114576|NCT01899053|280791|P1|NOT COMPLETED|Overall Study||7
114577|NCT01899053|280778|P14|COMPLETED|Overall Study||0
114578|NCT01899053|280779|P13|COMPLETED|Overall Study||0
114579|NCT01899053|280780|P12|COMPLETED|Overall Study||0
114580|NCT01899053|280781|P11|COMPLETED|Overall Study||0
114581|NCT01899053|280782|P10|COMPLETED|Overall Study||0
114582|NCT01899053|280783|P9|COMPLETED|Overall Study||0
114583|NCT01899053|280784|P8|COMPLETED|Overall Study||0
114584|NCT01899053|280785|P7|COMPLETED|Overall Study||0
114585|NCT01899053|280786|P6|COMPLETED|Overall Study||0
114586|NCT01899053|280787|P5|COMPLETED|Overall Study||0
114587|NCT01899053|280788|P4|COMPLETED|Overall Study||0
114588|NCT01899053|280789|P3|COMPLETED|Overall Study||0
114589|NCT01899053|280790|P2|COMPLETED|Overall Study||0
114590|NCT01899053|280791|P1|COMPLETED|Overall Study||0
114591|NCT01899053|280778|P14|STARTED|Overall Study||20
114592|NCT01899053|280779|P13|STARTED|Overall Study||14
114593|NCT01899053|280780|P12|STARTED|Overall Study||7
114594|NCT01899053|280781|P11|STARTED|Overall Study||16
114595|NCT01899053|280782|P10|STARTED|Overall Study||3
114596|NCT01899053|280783|P9|STARTED|Overall Study||6
114597|NCT01899053|280784|P8|STARTED|Overall Study||3
114598|NCT01899053|280785|P7|STARTED|Overall Study||3
114599|NCT01899053|280786|P6|STARTED|Overall Study||3
114600|NCT01899053|280787|P5|STARTED|Overall Study||6
114601|NCT01899053|280788|P4|STARTED|Overall Study||3
114602|NCT01899053|280789|P3|STARTED|Overall Study||7
114603|NCT01899053|280790|P2|STARTED|Overall Study||3
114604|NCT01899053|280791|P1|STARTED|Overall Study||7
114605|NCT01898884|281048|P9|NOT COMPLETED|Multiple Dose Period||1
114606|NCT01898884|281049|P8|NOT COMPLETED|Multiple Dose Period||0
114607|NCT01898884|281050|P7|NOT COMPLETED|Multiple Dose Period||1
114608|NCT01898884|281051|P6|NOT COMPLETED|Multiple Dose Period||0
114609|NCT01898884|281052|P5|NOT COMPLETED|Multiple Dose Period||0
114610|NCT01898884|281053|P4|NOT COMPLETED|Multiple Dose Period||0
114611|NCT01898884|281054|P3|NOT COMPLETED|Multiple Dose Period||0
114612|NCT01898884|281055|P2|NOT COMPLETED|Multiple Dose Period||0
114613|NCT01898884|281056|P1|NOT COMPLETED|Multiple Dose Period||0
114614|NCT01898884|281048|P9|COMPLETED|Multiple Dose Period||5
114615|NCT01898884|281049|P8|COMPLETED|Multiple Dose Period||6
114616|NCT01898884|281050|P7|COMPLETED|Multiple Dose Period||5
114617|NCT01898884|281051|P6|COMPLETED|Multiple Dose Period||6
114618|NCT01898884|281052|P5|COMPLETED|Multiple Dose Period||0
114619|NCT01898884|281053|P4|COMPLETED|Multiple Dose Period||0
114620|NCT01898884|281054|P3|COMPLETED|Multiple Dose Period||0
114621|NCT01898884|281055|P2|COMPLETED|Multiple Dose Period||0
114622|NCT01898884|281056|P1|COMPLETED|Multiple Dose Period||0
114623|NCT01898884|281048|P9|Treated|Multiple Dose Period||5
114624|NCT01898884|281049|P8|Treated|Multiple Dose Period||6
114625|NCT01898884|281050|P7|Treated|Multiple Dose Period||6
114626|NCT01898884|281051|P6|Treated|Multiple Dose Period||6
114627|NCT01898884|281052|P5|Treated|Multiple Dose Period||0
114628|NCT01898884|281053|P4|Treated|Multiple Dose Period||0
114629|NCT01898884|281054|P3|Treated|Multiple Dose Period||0
114630|NCT01898884|281055|P2|Treated|Multiple Dose Period||0
114631|NCT01898884|281056|P1|Treated|Multiple Dose Period||0
114632|NCT01898884|281048|P9|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
114633|NCT01898884|281049|P8|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
114634|NCT01898884|281050|P7|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
114635|NCT01898884|281051|P6|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
114636|NCT01898884|281052|P5|STARTED|Multiple Dose Period||0
114637|NCT01898884|281053|P4|STARTED|Multiple Dose Period||0
114638|NCT01898884|281054|P3|STARTED|Multiple Dose Period||0
114639|NCT01898884|281055|P2|STARTED|Multiple Dose Period||0
114640|NCT01898884|281056|P1|STARTED|Multiple Dose Period||0
114641|NCT01898884|281048|P9|NOT COMPLETED|Single Dose Period||0
114642|NCT01898884|281049|P8|NOT COMPLETED|Single Dose Period||0
114643|NCT01898884|281050|P7|NOT COMPLETED|Single Dose Period||0
114644|NCT01898884|281051|P6|NOT COMPLETED|Single Dose Period||0
114645|NCT01898884|281052|P5|NOT COMPLETED|Single Dose Period||0
114646|NCT01898884|281053|P4|NOT COMPLETED|Single Dose Period||0
114647|NCT01898884|281054|P3|NOT COMPLETED|Single Dose Period||0
114648|NCT01898884|281055|P2|NOT COMPLETED|Single Dose Period||0
114649|NCT01898884|281056|P1|NOT COMPLETED|Single Dose Period||0
114650|NCT01898884|281048|P9|COMPLETED|Single Dose Period||0
114651|NCT01898884|281049|P8|COMPLETED|Single Dose Period||0
114652|NCT01898884|281050|P7|COMPLETED|Single Dose Period||0
114653|NCT01898884|281051|P6|COMPLETED|Single Dose Period||0
114654|NCT01898884|281052|P5|COMPLETED|Single Dose Period||6
114655|NCT01898884|281053|P4|COMPLETED|Single Dose Period||6
114656|NCT01898884|281054|P3|COMPLETED|Single Dose Period||6
114657|NCT01898884|281055|P2|COMPLETED|Single Dose Period||6
114658|NCT01898884|281056|P1|COMPLETED|Single Dose Period||8
114659|NCT01898884|281048|P9|STARTED|Single Dose Period||0
114660|NCT01898884|281049|P8|STARTED|Single Dose Period||0
114661|NCT01898884|281050|P7|STARTED|Single Dose Period||0
114662|NCT01898884|281051|P6|STARTED|Single Dose Period||0
114663|NCT01898884|281052|P5|STARTED|Single Dose Period||6
114664|NCT01898884|281053|P4|STARTED|Single Dose Period||6
114665|NCT01898884|281054|P3|STARTED|Single Dose Period||6
114666|NCT01898884|281055|P2|STARTED|Single Dose Period||6
114667|NCT01898884|281056|P1|STARTED|Single Dose Period||8
114668|NCT01898806|281206|P1|NOT COMPLETED|Overall Study||3
114669|NCT01898806|281206|P1|COMPLETED|Overall Study||8
114670|NCT01898806|281206|P1|STARTED|Overall Study||11
114671|NCT01898611|281213|P2|NOT COMPLETED|Overall Study||1
114672|NCT01898611|281214|P1|NOT COMPLETED|Overall Study||0
114673|NCT01898611|281213|P2|COMPLETED|Overall Study||10
114674|NCT01898611|281214|P1|COMPLETED|Overall Study||5
114675|NCT01898611|281213|P2|STARTED|Overall Study||11
114676|NCT01898611|281214|P1|STARTED|Overall Study||5
114677|NCT01898598|281236|P2|NOT COMPLETED|Overall Study||2
114678|NCT01898598|281237|P1|NOT COMPLETED|Overall Study||4
114679|NCT01898598|281236|P2|COMPLETED|Overall Study||4
114680|NCT01898598|281237|P1|COMPLETED|Overall Study||8
114681|NCT01898598|281236|P2|Treated|Overall Study||5
114682|NCT01898598|281237|P1|Treated|Overall Study||11
114683|NCT01898598|281236|P2|STARTED|Overall Study||6
114684|NCT01898598|281237|P1|STARTED|Overall Study||12
114685|NCT01898442|281256|P3|NOT COMPLETED|Overall Study||3
114686|NCT01898442|281257|P2|NOT COMPLETED|Overall Study||2
114687|NCT01898442|281258|P1|NOT COMPLETED|Overall Study||1
114688|NCT01898442|281256|P3|COMPLETED|Overall Study||15
114689|NCT01898442|281257|P2|COMPLETED|Overall Study||15
114690|NCT01898442|281258|P1|COMPLETED|Overall Study||16
114691|NCT01898442|281256|P3|STARTED|Overall Study||18
114692|NCT01898442|281257|P2|STARTED|Overall Study||17
114693|NCT01898442|281258|P1|STARTED|Overall Study||17
114694|NCT01898429|281281|P3|NOT COMPLETED|Phase 3||0
114695|NCT01898429|281282|P2|NOT COMPLETED|Phase 3||0
114696|NCT01898429|281283|P1|NOT COMPLETED|Phase 3||0
114697|NCT01898429|281281|P3|COMPLETED|Phase 3||5
114698|NCT01898429|281282|P2|COMPLETED|Phase 3||0
114699|NCT01898429|281283|P1|COMPLETED|Phase 3||0
114700|NCT01898429|281281|P3|STARTED|Phase 3||5
114701|NCT01898429|281282|P2|STARTED|Phase 3||0
114702|NCT01898429|281283|P1|STARTED|Phase 3||0
114703|NCT01898429|281281|P3|NOT COMPLETED|Phase 2||0
114704|NCT01898429|281282|P2|NOT COMPLETED|Phase 2||0
114705|NCT01898429|281283|P1|NOT COMPLETED|Phase 2||0
114706|NCT01898429|281281|P3|COMPLETED|Phase 2||0
114707|NCT01898429|281282|P2|COMPLETED|Phase 2||5
114708|NCT01898429|281283|P1|COMPLETED|Phase 2||0
114709|NCT01898429|281281|P3|STARTED|Phase 2||0
114710|NCT01898429|281282|P2|STARTED|Phase 2||5
114711|NCT01898429|281283|P1|STARTED|Phase 2||0
114712|NCT01898429|281281|P3|NOT COMPLETED|Phase 1||0
114713|NCT01898429|281282|P2|NOT COMPLETED|Phase 1||0
114714|NCT01898429|281283|P1|NOT COMPLETED|Phase 1||0
114715|NCT01898429|281281|P3|COMPLETED|Phase 1||0
114716|NCT01898429|281282|P2|COMPLETED|Phase 1||0
114717|NCT01898429|281283|P1|COMPLETED|Phase 1||5
114718|NCT01898429|281281|P3|STARTED|Phase 1||0
114719|NCT01898429|281282|P2|STARTED|Phase 1||0
114720|NCT01898429|281283|P1|STARTED|Phase 1||5
114721|NCT01898403|281287|P1|NOT COMPLETED|Overall Study||0
114722|NCT01898403|281287|P1|COMPLETED|Overall Study||50
114723|NCT01898403|281287|P1|STARTED|Overall Study||50
114724|NCT01898286|281293|P1|NOT COMPLETED|Overall Study||3
114725|NCT01898286|281293|P1|COMPLETED|Overall Study|"For this study completed is defined as completing the Early Termination visit"|35
114726|NCT01898286|281293|P1|STARTED|Overall Study||38
114727|NCT01898208|281303|P3|NOT COMPLETED|Overall Study||37
114728|NCT01898208|281304|P2|NOT COMPLETED|Overall Study||49
114729|NCT01898208|281305|P1|NOT COMPLETED|Overall Study||40
114730|NCT01898208|281303|P3|COMPLETED|Overall Study||212
114731|NCT01898208|281304|P2|COMPLETED|Overall Study||198
114732|NCT01898208|281305|P1|COMPLETED|Overall Study||207
114733|NCT01898208|281303|P3|STARTED|Overall Study||249
114734|NCT01898208|281304|P2|STARTED|Overall Study||247
114735|NCT01898208|281305|P1|STARTED|Overall Study||247
114736|NCT01898195|281352|P3|NOT COMPLETED|Smoking Abstinence||36
114737|NCT01898195|281353|P2|NOT COMPLETED|Smoking Abstinence||38
114738|NCT01898195|281354|P1|NOT COMPLETED|Smoking Abstinence||35
114739|NCT01898195|281352|P3|COMPLETED|Smoking Abstinence||15
114740|NCT01898195|281353|P2|COMPLETED|Smoking Abstinence||16
114741|NCT01898195|281354|P1|COMPLETED|Smoking Abstinence||18
114742|NCT01898195|281352|P3|STARTED|Smoking Abstinence||51
114743|NCT01898195|281353|P2|STARTED|Smoking Abstinence||54
114744|NCT01898195|281354|P1|STARTED|Smoking Abstinence||53
114745|NCT01898195|281352|P3|NOT COMPLETED|Varenicline Adherence||36
114746|NCT01898195|281353|P2|NOT COMPLETED|Varenicline Adherence||38
114747|NCT01898195|281354|P1|NOT COMPLETED|Varenicline Adherence||35
114748|NCT01898195|281352|P3|COMPLETED|Varenicline Adherence||15
114749|NCT01898195|281353|P2|COMPLETED|Varenicline Adherence||16
114750|NCT01898195|281354|P1|COMPLETED|Varenicline Adherence||18
114751|NCT01898195|281352|P3|STARTED|Varenicline Adherence||51
114752|NCT01898195|281353|P2|STARTED|Varenicline Adherence||54
114753|NCT01898195|281354|P1|STARTED|Varenicline Adherence||53
114754|NCT01898130|281365|P1|NOT COMPLETED|Follow up Until PD or Death||1
114755|NCT01898130|281365|P1|COMPLETED|Follow up Until PD or Death||26
114756|NCT01898130|281365|P1|STARTED|Follow up Until PD or Death|All patients treated on study go into follow up period for survival data.|27
114757|NCT01898130|281365|P1|NOT COMPLETED|Treatment||6
114758|NCT01898130|281365|P1|COMPLETED|Treatment||21
114759|NCT01898130|281365|P1|Went on to Start Cycle 3|Treatment||21
114760|NCT01898130|281365|P1|Reached 1st Response/2 Cycles|Treatment||24
114761|NCT01898130|281365|P1|STARTED|Treatment||27
114762|NCT01898091|281380|P2|NOT COMPLETED|Overall Study||6
114763|NCT01898091|281381|P1|NOT COMPLETED|Overall Study||2
114764|NCT01898091|281380|P2|COMPLETED|Overall Study||19
114765|NCT01898091|281381|P1|COMPLETED|Overall Study||23
114766|NCT01898091|281380|P2|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
114767|NCT01898091|281381|P1|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
114768|NCT01898078|281389|P2|NOT COMPLETED|Overall Study||8
114769|NCT01898078|281390|P1|NOT COMPLETED|Overall Study||6
114770|NCT01898078|281389|P2|COMPLETED|Overall Study|Completed treatment|5
114771|NCT01898078|281390|P1|COMPLETED|Overall Study|Completed treatment|7
114772|NCT01898078|281389|P2|STARTED|Overall Study||13
114773|NCT01898078|281390|P1|STARTED|Overall Study||13
114774|NCT01898013|281408|P2|NOT COMPLETED|Visit 6||5
114775|NCT01898013|281409|P1|NOT COMPLETED|Visit 6||3
114776|NCT01898013|281408|P2|COMPLETED|Visit 6||42
114777|NCT01898013|281409|P1|COMPLETED|Visit 6||41
114778|NCT01898013|281408|P2|STARTED|Visit 6||47
114779|NCT01898013|281409|P1|STARTED|Visit 6||44
114780|NCT01898013|281408|P2|NOT COMPLETED|Visit 5||1
114781|NCT01898013|281409|P1|NOT COMPLETED|Visit 5||1
114782|NCT01898013|281408|P2|COMPLETED|Visit 5||47
114783|NCT01898013|281409|P1|COMPLETED|Visit 5||44
114784|NCT01898013|281408|P2|STARTED|Visit 5||48
114785|NCT01898013|281409|P1|STARTED|Visit 5||45
114786|NCT01898013|281408|P2|NOT COMPLETED|Visit 4||1
114787|NCT01898013|281409|P1|NOT COMPLETED|Visit 4||0
114788|NCT01898013|281408|P2|COMPLETED|Visit 4||48
114789|NCT01898013|281409|P1|COMPLETED|Visit 4||45
114790|NCT01898013|281408|P2|STARTED|Visit 4||49
114791|NCT01898013|281409|P1|STARTED|Visit 4||45
114792|NCT01898013|281408|P2|NOT COMPLETED|Visit 3 (Randomization Visit)||0
114793|NCT01898013|281409|P1|NOT COMPLETED|Visit 3 (Randomization Visit)||0
114794|NCT01898013|281408|P2|COMPLETED|Visit 3 (Randomization Visit)||49
114795|NCT01898013|281409|P1|COMPLETED|Visit 3 (Randomization Visit)||45
114796|NCT01898013|281408|P2|STARTED|Visit 3 (Randomization Visit)||49
114797|NCT01898013|281409|P1|STARTED|Visit 3 (Randomization Visit)||45
114798|NCT01897896|281427|P2|NOT COMPLETED|Overall Study||12
114799|NCT01897896|281428|P1|NOT COMPLETED|Overall Study||26
114800|NCT01897896|281427|P2|COMPLETED|Overall Study||25
114801|NCT01897896|281428|P1|COMPLETED|Overall Study||56
114802|NCT01897896|281427|P2|STARTED|Overall Study||37
114803|NCT01897896|281428|P1|STARTED|Overall Study||82
114804|NCT01897792|281510|P2|NOT COMPLETED|Overall Study||0
114805|NCT01897792|281511|P1|NOT COMPLETED|Overall Study||0
114806|NCT01897792|281510|P2|COMPLETED|Overall Study||5
114807|NCT01897792|281511|P1|COMPLETED|Overall Study||6
114808|NCT01897792|281510|P2|STARTED|Overall Study||5
114809|NCT01897792|281511|P1|STARTED|Overall Study||6
114810|NCT01897727|281537|P2|NOT COMPLETED|Overall Study||1
114811|NCT01897727|281538|P1|NOT COMPLETED|Overall Study||0
114812|NCT01897727|281537|P2|COMPLETED|Overall Study||8
114813|NCT01897727|281538|P1|COMPLETED|Overall Study||8
114814|NCT01897727|281537|P2|STARTED|Overall Study||9
114815|NCT01897727|281538|P1|STARTED|Overall Study||8
114816|NCT01897532|281546|P2|NOT COMPLETED|Discontinuation From Trial||41
114817|NCT01897532|281547|P1|NOT COMPLETED|Discontinuation From Trial||62
114818|NCT01897532|281546|P2|COMPLETED|Discontinuation From Trial||3458
114819|NCT01897532|281547|P1|COMPLETED|Discontinuation From Trial||3430
114820|NCT01897532|281546|P2|Treated|Discontinuation From Trial||3494
114821|NCT01897532|281547|P1|Treated|Discontinuation From Trial||3485
114822|NCT01897532|281546|P2|STARTED|Discontinuation From Trial||3499
114823|NCT01897532|281547|P1|STARTED|Discontinuation From Trial||3492
114824|NCT01897532|281546|P2|NOT COMPLETED|Discontinuation From Treatment||839
114825|NCT01897532|281547|P1|NOT COMPLETED|Discontinuation From Treatment||962
114826|NCT01897532|281546|P2|COMPLETED|Discontinuation From Treatment||2660
114827|NCT01897532|281547|P1|COMPLETED|Discontinuation From Treatment||2530
114828|NCT01897532|281546|P2|Treated|Discontinuation From Treatment||3494
114829|NCT01897532|281547|P1|Treated|Discontinuation From Treatment||3485
114830|NCT01897532|281546|P2|STARTED|Discontinuation From Treatment||3499
114831|NCT01897532|281547|P1|STARTED|Discontinuation From Treatment||3492
114832|NCT01897493|281555|P1|NOT COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||0
114833|NCT01897493|281555|P1|COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||15
114834|NCT01897493|281555|P1|Received at Least 1 Dose of Study Drug|Period 2 (Day 6 Postdose Through Day 20)||15
114835|NCT01897493|281555|P1|STARTED|Period 2 (Day 6 Postdose Through Day 20)||15
114836|NCT01897493|281555|P1|NOT COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||1
114837|NCT01897493|281555|P1|COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||15
114838|NCT01897493|281555|P1|Received at Least 1 Dose of Study Drug|Period 1 (Day 1 Through Day 6 Predose)||16
114839|NCT01897493|281555|P1|STARTED|Period 1 (Day 1 Through Day 6 Predose)||16
114840|NCT01897402|281570|P2|NOT COMPLETED|Overall Study||16
114841|NCT01897402|281571|P1|NOT COMPLETED|Overall Study||19
114842|NCT01897402|281570|P2|COMPLETED|Overall Study||244
114843|NCT01897402|281571|P1|COMPLETED|Overall Study||246
114844|NCT01897402|281570|P2|STARTED|Overall Study||260
114845|NCT01897402|281571|P1|STARTED|Overall Study||265
114846|NCT01897285|281583|P1|NOT COMPLETED|Overall Study||0
114847|NCT01897285|281583|P1|COMPLETED|Overall Study||20
114848|NCT01897285|281583|P1|STARTED|Overall Study|All 20 participants received original AND test adhesive dressings on upper arms and lower back.|20
114849|NCT01897233|281591|P1|NOT COMPLETED|Part B (24 Weeks)||4
114850|NCT01897233|281591|P1|COMPLETED|Part B (24 Weeks)||54
114851|NCT01897233|281591|P1|STARTED|Part B (24 Weeks)|6 participants from Part A also participated in Part B of the study.|58
114852|NCT01897233|281591|P1|NOT COMPLETED|Part A (14 Days)||0
114853|NCT01897233|281591|P1|COMPLETED|Part A (14 Days)||10
114854|NCT01897233|281591|P1|Part A Cohort 2 (9 to 11 Years)|Part A (14 Days)||5
114855|NCT01897233|281591|P1|Part A Cohort 1 (6 to 8 Years)|Part A (14 Days)||5
114856|NCT01897233|281591|P1|STARTED|Part A (14 Days)||10
114857|NCT01897077|281615|P2|NOT COMPLETED|Overall Study||0
114858|NCT01897077|281616|P1|NOT COMPLETED|Overall Study||0
114859|NCT01897077|281615|P2|COMPLETED|Overall Study||5
114860|NCT01897077|281616|P1|COMPLETED|Overall Study||0
114861|NCT01897077|281615|P2|STARTED|Overall Study||5
114862|NCT01897077|281616|P1|STARTED|Overall Study||0
114863|NCT01897025|281634|P2|NOT COMPLETED|Overall Study||0
114864|NCT01897025|281635|P1|NOT COMPLETED|Overall Study||0
114865|NCT01897025|281634|P2|COMPLETED|Overall Study||9
114866|NCT01897025|281635|P1|COMPLETED|Overall Study||10
114867|NCT01897025|281634|P2|STARTED|Overall Study||9
114868|NCT01897025|281635|P1|STARTED|Overall Study||10
114869|NCT01896986|281643|P2|NOT COMPLETED|Overall Study||23
114870|NCT01896986|281644|P1|NOT COMPLETED|Overall Study||14
114871|NCT01896986|281643|P2|COMPLETED|Overall Study||0
114872|NCT01896986|281644|P1|COMPLETED|Overall Study||0
114873|NCT01896986|281643|P2|STARTED|Overall Study||23
114874|NCT01896986|281644|P1|STARTED|Overall Study||14
114875|NCT01896934|281650|P1|NOT COMPLETED|Overall Study||2
114876|NCT01896934|281650|P1|COMPLETED|Overall Study||19
114877|NCT01896934|281650|P1|STARTED|Overall Study||21
114878|NCT01896921|281656|P1|NOT COMPLETED|Overall Study||2
114879|NCT01896921|281656|P1|COMPLETED|Overall Study||5
114880|NCT01896921|281656|P1|STARTED|Overall Study||7
114881|NCT01896895|281663|P4|NOT COMPLETED|OLEX Period||0
114882|NCT01896895|281664|P3|NOT COMPLETED|OLEX Period||0
114883|NCT01896895|281665|P2|NOT COMPLETED|OLEX Period||0
114884|NCT01896895|281666|P1|NOT COMPLETED|OLEX Period||0
114885|NCT01896895|281663|P4|COMPLETED|OLEX Period||39
114886|NCT01896895|281664|P3|COMPLETED|OLEX Period||0
114887|NCT01896895|281665|P2|COMPLETED|OLEX Period||0
114888|NCT01896895|281666|P1|COMPLETED|OLEX Period||0
114889|NCT01896895|281663|P4|STARTED|OLEX Period|Not all participants who completed double-blind MP fulfilled the inclusion criteria for OLEX period.|39
114890|NCT01896895|281664|P3|STARTED|OLEX Period||0
114891|NCT01896895|281665|P2|STARTED|OLEX Period||0
114892|NCT01896895|281666|P1|STARTED|OLEX Period||0
114893|NCT01896895|281663|P4|NOT COMPLETED|Double-blind MP||0
114894|NCT01896895|281664|P3|NOT COMPLETED|Double-blind MP||3
114895|NCT01896895|281665|P2|NOT COMPLETED|Double-blind MP||2
114896|NCT01896895|281666|P1|NOT COMPLETED|Double-blind MP||1
114897|NCT01896895|281663|P4|COMPLETED|Double-blind MP||0
114898|NCT01896895|281664|P3|COMPLETED|Double-blind MP||16
114899|NCT01896895|281665|P2|COMPLETED|Double-blind MP||20
114900|NCT01896895|281666|P1|COMPLETED|Double-blind MP||19
114901|NCT01896895|281663|P4|STARTED|Double-blind MP||0
114902|NCT01896895|281664|P3|STARTED|Double-blind MP||19
114903|NCT01896895|281665|P2|STARTED|Double-blind MP||22
114904|NCT01896895|281666|P1|STARTED|Double-blind MP||20
114905|NCT01896726|281681|P1|NOT COMPLETED|Treatment Period 2 (Days 23-31)||2
114906|NCT01896726|281681|P1|COMPLETED|Treatment Period 2 (Days 23-31)||18
114907|NCT01896726|281681|P1|Received Microgynon|Treatment Period 2 (Days 23-31)||18
114908|NCT01896726|281681|P1|Received at Least 1 Dose of Baricitinib|Treatment Period 2 (Days 23-31)||20
114909|NCT01896726|281681|P1|STARTED|Treatment Period 2 (Days 23-31)||20
114910|NCT01896726|281681|P1|NOT COMPLETED|Treatment Period 1 (Days 1-22)||0
114911|NCT01896726|281681|P1|COMPLETED|Treatment Period 1 (Days 1-22)||20
114912|NCT01896726|281681|P1|Received Microgynon|Treatment Period 1 (Days 1-22)||20
114913|NCT01896726|281681|P1|STARTED|Treatment Period 1 (Days 1-22)||20
114914|NCT01896700|281696|P2|NOT COMPLETED|Overall Study||6
114915|NCT01896700|281697|P1|NOT COMPLETED|Overall Study||4
114916|NCT01896700|281696|P2|COMPLETED|Overall Study||6
114917|NCT01896700|281697|P1|COMPLETED|Overall Study||8
114918|NCT01896700|281696|P2|STARTED|Overall Study||12
114919|NCT01896700|281697|P1|STARTED|Overall Study||12
114920|NCT01896687|281719|P2|NOT COMPLETED|Overall Study||0
114921|NCT01896687|281720|P1|NOT COMPLETED|Overall Study||0
114922|NCT01896687|281719|P2|COMPLETED|Overall Study||15
114923|NCT01896687|281720|P1|COMPLETED|Overall Study||15
114924|NCT01896687|281719|P2|STARTED|Overall Study||15
114925|NCT01896687|281720|P1|STARTED|Overall Study||15
114926|NCT01896557|281728|P2|NOT COMPLETED|Clopidogrel + GI Protector||4
114927|NCT01896557|281729|P1|NOT COMPLETED|Clopidogrel + GI Protector||2
114928|NCT01896557|281728|P2|COMPLETED|Clopidogrel + GI Protector||44
114929|NCT01896557|281729|P1|COMPLETED|Clopidogrel + GI Protector||41
114930|NCT01896557|281728|P2|STARTED|Clopidogrel + GI Protector||48
114931|NCT01896557|281729|P1|STARTED|Clopidogrel + GI Protector||43
114932|NCT01896557|281728|P2|NOT COMPLETED|Clopidogrel Alone||0
114933|NCT01896557|281729|P1|NOT COMPLETED|Clopidogrel Alone||1
114934|NCT01896557|281728|P2|COMPLETED|Clopidogrel Alone||48
114935|NCT01896557|281729|P1|COMPLETED|Clopidogrel Alone||43
114936|NCT01896557|281728|P2|STARTED|Clopidogrel Alone||48
114937|NCT01896557|281729|P1|STARTED|Clopidogrel Alone||44
114938|NCT01896544|281744|P3|NOT COMPLETED|Overall Study||0
114939|NCT01896544|281745|P2|NOT COMPLETED|Overall Study||0
114940|NCT01896544|281746|P1|NOT COMPLETED|Overall Study||0
114941|NCT01896544|281744|P3|COMPLETED|Overall Study||10
114942|NCT01896544|281745|P2|COMPLETED|Overall Study||10
114943|NCT01896544|281746|P1|COMPLETED|Overall Study||10
114944|NCT01896544|281744|P3|STARTED|Overall Study||10
114945|NCT01896544|281745|P2|STARTED|Overall Study||10
114946|NCT01896544|281746|P1|STARTED|Overall Study||10
114947|NCT01896297|281766|P1|NOT COMPLETED|Overall Study||1
114948|NCT01896297|281766|P1|COMPLETED|Overall Study||59
114949|NCT01896297|281766|P1|STARTED|Overall Study||60
114950|NCT01896232|281773|P2|NOT COMPLETED|Overall Study||53
114951|NCT01896232|281774|P1|NOT COMPLETED|Overall Study||49
114952|NCT01896232|281773|P2|COMPLETED|Overall Study||287
114953|NCT01896232|281774|P1|COMPLETED|Overall Study||294
114954|NCT01896232|281773|P2|Received Treatment|Overall Study||338
114955|NCT01896232|281774|P1|Received Treatment|Overall Study||341
114956|NCT01896232|281773|P2|STARTED|Overall Study||340
114957|NCT01896232|281774|P1|STARTED|Overall Study||343
114958|NCT01896206|281794|P1|NOT COMPLETED|Overall Study||0
114959|NCT01896206|281794|P1|COMPLETED|Overall Study||21
114960|NCT01896206|281794|P1|STARTED|Overall Study||21
114961|NCT01896193|281802|P2|NOT COMPLETED|Overall Study||12
114962|NCT01896193|281803|P1|NOT COMPLETED|Overall Study||21
114963|NCT01896193|281802|P2|COMPLETED|Overall Study||53
114964|NCT01896193|281803|P1|COMPLETED|Overall Study||41
114965|NCT01896193|281802|P2|STARTED|Overall Study||65
114966|NCT01896193|281803|P1|STARTED|Overall Study||62
114967|NCT01896128|281829|P2|NOT COMPLETED|Overall Study||3
114968|NCT01896128|281830|P1|NOT COMPLETED|Overall Study||3
114969|NCT01896128|281829|P2|COMPLETED|Overall Study||8
114970|NCT01896128|281830|P1|COMPLETED|Overall Study||5
114971|NCT01896128|281829|P2|STARTED|Overall Study||11
114972|NCT01896128|281830|P1|STARTED|Overall Study||8
114973|NCT01896115|281846|P2|NOT COMPLETED|Overall Study||0
114974|NCT01896115|281847|P1|NOT COMPLETED|Overall Study||1
114975|NCT01896115|281846|P2|COMPLETED|Overall Study||24
114976|NCT01896115|281847|P1|COMPLETED|Overall Study||15
114977|NCT01896115|281846|P2|Phase 2 Steering|Overall Study||24
114978|NCT01896115|281847|P1|Phase 2 Steering|Overall Study||0
114979|NCT01896115|281846|P2|Phase 2 Single Contact|Overall Study||24
114980|NCT01896115|281847|P1|Phase 2 Single Contact|Overall Study||0
114981|NCT01896115|281846|P2|Phase 1 Ventral Steering|Overall Study||0
114982|NCT01896115|281847|P1|Phase 1 Ventral Steering|Overall Study||15
114983|NCT01896115|281846|P2|Phase 1 Dorsal Steering|Overall Study||0
114984|NCT01896115|281847|P1|Phase 1 Dorsal Steering|Overall Study||15
114985|NCT01896115|281846|P2|Phase 1 Conventional PW|Overall Study||0
114986|NCT01896115|281847|P1|Phase 1 Conventional PW|Overall Study||15
114987|NCT01896115|281846|P2|Phase 1 Short PW|Overall Study||0
114988|NCT01896115|281847|P1|Phase 1 Short PW|Overall Study||15
114989|NCT01896115|281846|P2|STARTED|Overall Study||24
114990|NCT01896115|281847|P1|STARTED|Overall Study||16
114991|NCT01896050|281872|P2|NOT COMPLETED|Overall Study||2
114992|NCT01896050|281873|P1|NOT COMPLETED|Overall Study||38
114993|NCT01896050|281872|P2|COMPLETED|Overall Study||20
114994|NCT01896050|281873|P1|COMPLETED|Overall Study|This includes only patients who remained on the same aromatase inhibitor medication for 12 months|55
114995|NCT01896050|281872|P2|STARTED|Overall Study||22
114996|NCT01896050|281873|P1|STARTED|Overall Study||93
114997|NCT01895972|281883|P1|NOT COMPLETED|Overall Study||9
114998|NCT01895972|281883|P1|COMPLETED|Overall Study||121
114999|NCT01895972|281883|P1|STARTED|Overall Study||130
115000|NCT01895946|281890|P2|NOT COMPLETED|Overall Study||0
115001|NCT01895946|281891|P1|NOT COMPLETED|Overall Study||0
115002|NCT01895946|281890|P2|COMPLETED|Overall Study||12
115003|NCT01895946|281891|P1|COMPLETED|Overall Study||18
115004|NCT01895946|281890|P2|STARTED|Overall Study||12
115005|NCT01895946|281891|P1|STARTED|Overall Study||18
115006|NCT01895647|281912|P3|NOT COMPLETED|Overall Study||0
115007|NCT01895647|281913|P2|NOT COMPLETED|Overall Study||0
115008|NCT01895647|281914|P1|NOT COMPLETED|Overall Study||0
115009|NCT01895647|281912|P3|COMPLETED|Overall Study||7
115010|NCT01895647|281913|P2|COMPLETED|Overall Study||10
115011|NCT01895647|281914|P1|COMPLETED|Overall Study||8
115012|NCT01895647|281912|P3|STARTED|Overall Study||7
115013|NCT01895647|281913|P2|STARTED|Overall Study||10
115014|NCT01895647|281914|P1|STARTED|Overall Study||8
115015|NCT01895634|281928|P1|NOT COMPLETED|Overall Study||3
115016|NCT01895634|281928|P1|COMPLETED|Overall Study||46
115017|NCT01895634|281928|P1|STARTED|Overall Study||49
115018|NCT01895608|281940|P4|NOT COMPLETED|Overall Study||0
115019|NCT01895608|281941|P3|NOT COMPLETED|Overall Study||3
115020|NCT01895608|281942|P2|NOT COMPLETED|Overall Study||1
115021|NCT01895608|281943|P1|NOT COMPLETED|Overall Study||0
115022|NCT01895608|281940|P4|COMPLETED|Overall Study||6
115023|NCT01895608|281941|P3|COMPLETED|Overall Study||8
115024|NCT01895608|281942|P2|COMPLETED|Overall Study||6
115025|NCT01895608|281943|P1|COMPLETED|Overall Study||10
115026|NCT01895608|281940|P4|STARTED|Overall Study||6
115027|NCT01895608|281941|P3|STARTED|Overall Study||11
115028|NCT01895608|281942|P2|STARTED|Overall Study||7
115029|NCT01895608|281943|P1|STARTED|Overall Study||10
115030|NCT01895543|281973|P1|NOT COMPLETED|Overall Study||129
115031|NCT01895543|281973|P1|COMPLETED|Overall Study||282
115032|NCT01895543|281973|P1|Per Protocol Analysis Set|Overall Study|Set included all enrolled patients who had no major protocol deviations.|380
115033|NCT01895543|281973|P1|Safety Analysis Set|Overall Study|Set included all enrolled patients who took at least one dose of Investigational Medicinal Product.|409
115034|NCT01895543|281973|P1|STARTED|Overall Study||411
115035|NCT01895452|281989|P2|NOT COMPLETED|Overall Study||28
115036|NCT01895452|281990|P1|NOT COMPLETED|Overall Study||4
115037|NCT01895452|281989|P2|COMPLETED|Overall Study||198
115038|NCT01895452|281990|P1|COMPLETED|Overall Study||61
115039|NCT01895452|281989|P2|STARTED|Overall Study||226
115040|NCT01895452|281990|P1|STARTED|Overall Study||65
115041|NCT01895335|282000|P1|NOT COMPLETED|Overall Study||215
115042|NCT01895335|282000|P1|COMPLETED|Overall Study||786
115043|NCT01895335|282000|P1|Treated|Overall Study||1000
115044|NCT01895335|282000|P1|STARTED|Overall Study||1001
115045|NCT01895322|282017|P1|NOT COMPLETED|Overall Study||13
115046|NCT01895322|282017|P1|COMPLETED|Overall Study||7
115047|NCT01895322|282017|P1|STARTED|Overall Study||20
115048|NCT01895309|282026|P2|NOT COMPLETED|Overall Study||51
115049|NCT01895309|282027|P1|NOT COMPLETED|Overall Study||40
115050|NCT01895309|282026|P2|COMPLETED|Overall Study||246
115051|NCT01895309|282027|P1|COMPLETED|Overall Study||259
115052|NCT01895309|282026|P2|STARTED|Overall Study||297
115053|NCT01895309|282027|P1|STARTED|Overall Study||299
115054|NCT01895270|282041|P2|NOT COMPLETED|Isradipine Taper (W7-8)||2
115055|NCT01895270|282042|P1|NOT COMPLETED|Isradipine Taper (W7-8)||0
115056|NCT01895270|282041|P2|COMPLETED|Isradipine Taper (W7-8)||0
115057|NCT01895270|282042|P1|COMPLETED|Isradipine Taper (W7-8)||2
115058|NCT01895270|282041|P2|STARTED|Isradipine Taper (W7-8)||2
115059|NCT01895270|282042|P1|STARTED|Isradipine Taper (W7-8)||2
115060|NCT01895270|282041|P2|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||5
115061|NCT01895270|282042|P1|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||3
115062|NCT01895270|282041|P2|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
115063|NCT01895270|282042|P1|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
115064|NCT01895270|282041|P2|STARTED|Buprenorphine Taper (W5 to W6D3)|1 subject missed meds prior to bup taper so did not start this phase|7
115065|NCT01895270|282042|P1|STARTED|Buprenorphine Taper (W5 to W6D3)||5
115066|NCT01895270|282041|P2|NOT COMPLETED|Study Medications Induction (W1-4)||6
115067|NCT01895270|282042|P1|NOT COMPLETED|Study Medications Induction (W1-4)||6
115068|NCT01895270|282041|P2|COMPLETED|Study Medications Induction (W1-4)||8
115069|NCT01895270|282042|P1|COMPLETED|Study Medications Induction (W1-4)||5
115070|NCT01895270|282041|P2|STARTED|Study Medications Induction (W1-4)||14
115071|NCT01895270|282042|P1|STARTED|Study Medications Induction (W1-4)||11
115072|NCT01895127|282050|P2|NOT COMPLETED|Long Term Follow-up (Month 3-12)||3
115073|NCT01895127|282051|P1|NOT COMPLETED|Long Term Follow-up (Month 3-12)||2
115074|NCT01895127|282050|P2|COMPLETED|Long Term Follow-up (Month 3-12)||4
115075|NCT01895127|282051|P1|COMPLETED|Long Term Follow-up (Month 3-12)||1
115076|NCT01895127|282050|P2|STARTED|Long Term Follow-up (Month 3-12)||7
115077|NCT01895127|282051|P1|STARTED|Long Term Follow-up (Month 3-12)||3
115078|NCT01895127|282050|P2|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
115079|NCT01895127|282051|P1|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
115080|NCT01895127|282050|P2|COMPLETED|Month 3 Follow-up & Biopsy||7
115081|NCT01895127|282051|P1|COMPLETED|Month 3 Follow-up & Biopsy||3
115082|NCT01895127|282050|P2|STARTED|Month 3 Follow-up & Biopsy||7
115083|NCT01895127|282051|P1|STARTED|Month 3 Follow-up & Biopsy||3
115084|NCT01895127|282050|P2|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
115085|NCT01895127|282051|P1|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
115086|NCT01895127|282050|P2|COMPLETED|Treatment Period (Week 0-Month 3)||7
115087|NCT01895127|282051|P1|COMPLETED|Treatment Period (Week 0-Month 3)||3
115088|NCT01895127|282050|P2|STARTED|Treatment Period (Week 0-Month 3)||7
115089|NCT01895127|282051|P1|STARTED|Treatment Period (Week 0-Month 3)||3
115090|NCT01895127|282050|P2|NOT COMPLETED|Screening||0
115091|NCT01895127|282051|P1|NOT COMPLETED|Screening||0
115092|NCT01895127|282050|P2|COMPLETED|Screening||7
115093|NCT01895127|282051|P1|COMPLETED|Screening|One subject was found to be pregnant at screening so was withdrawn from the study prior to treatment|4
115094|NCT01895127|282050|P2|STARTED|Screening||7
115095|NCT01895127|282051|P1|STARTED|Screening||4
115096|NCT01895101|282061|P3|NOT COMPLETED|Overall Study||5
115097|NCT01895101|282062|P2|NOT COMPLETED|Overall Study||5
115098|NCT01895101|282063|P1|NOT COMPLETED|Overall Study||1
115099|NCT01895101|282061|P3|COMPLETED|Overall Study||245
115100|NCT01895101|282062|P2|COMPLETED|Overall Study||245
115101|NCT01895101|282063|P1|COMPLETED|Overall Study||249
115102|NCT01895101|282061|P3|STARTED|Overall Study||250
115103|NCT01895101|282062|P2|STARTED|Overall Study||250
115104|NCT01895101|282063|P1|STARTED|Overall Study||250
115105|NCT01895088|282077|P1|NOT COMPLETED|Overall Study||18
115106|NCT01895088|282077|P1|COMPLETED|Overall Study||253
115107|NCT01895088|282077|P1|STARTED|Overall Study|1 subject consented for monitoring after device removal (not included in cohort), per FDA request.|271
115108|NCT01895062|282083|P2|NOT COMPLETED|Overall Study||0
115109|NCT01895062|282084|P1|NOT COMPLETED|Overall Study||0
115110|NCT01895062|282083|P2|COMPLETED|Overall Study||24
115111|NCT01895062|282084|P1|COMPLETED|Overall Study||30
115112|NCT01895062|282083|P2|STARTED|Overall Study||24
115113|NCT01895062|282084|P1|STARTED|Overall Study||30
115114|NCT01895036|282092|P1|NOT COMPLETED|Overall Study||0
115115|NCT01895036|282092|P1|COMPLETED|Overall Study||6
115116|NCT01895036|282092|P1|STARTED|Overall Study||6
115117|NCT01894984|282098|P2|NOT COMPLETED|Overall Study||175
115118|NCT01894984|282099|P1|NOT COMPLETED|Overall Study||314
115119|NCT01894984|282098|P2|COMPLETED|Overall Study||69
115120|NCT01894984|282099|P1|COMPLETED|Overall Study||82
115121|NCT01894984|282098|P2|STARTED|Overall Study||244
115122|NCT01894984|282099|P1|STARTED|Overall Study||396
115123|NCT01894919|282128|P13|NOT COMPLETED|Overall Study||0
115124|NCT01894919|282129|P12|NOT COMPLETED|Overall Study||0
115125|NCT01894919|282130|P11|NOT COMPLETED|Overall Study||2
115126|NCT01894919|282131|P10|NOT COMPLETED|Overall Study||1
115127|NCT01894919|282132|P9|NOT COMPLETED|Overall Study||0
115128|NCT01894919|282133|P8|NOT COMPLETED|Overall Study||0
115129|NCT01894919|282134|P7|NOT COMPLETED|Overall Study||0
115130|NCT01894919|282135|P6|NOT COMPLETED|Overall Study||0
115131|NCT01894919|282136|P5|NOT COMPLETED|Overall Study||3
115132|NCT01894919|282137|P4|NOT COMPLETED|Overall Study||0
115133|NCT01894919|282138|P3|NOT COMPLETED|Overall Study||0
115134|NCT01894919|282139|P2|NOT COMPLETED|Overall Study||0
115135|NCT01894919|282140|P1|NOT COMPLETED|Overall Study||2
115136|NCT01894919|282128|P13|COMPLETED|Overall Study||50
115137|NCT01894919|282129|P12|COMPLETED|Overall Study||55
115138|NCT01894919|282130|P11|COMPLETED|Overall Study||98
115139|NCT01894919|282131|P10|COMPLETED|Overall Study||89
115140|NCT01894919|282132|P9|COMPLETED|Overall Study||91
115141|NCT01894919|282133|P8|COMPLETED|Overall Study||36
115142|NCT01894919|282134|P7|COMPLETED|Overall Study||32
115143|NCT01894919|282135|P6|COMPLETED|Overall Study||39
115144|NCT01894919|282136|P5|COMPLETED|Overall Study||78
115145|NCT01894919|282137|P4|COMPLETED|Overall Study||43
115146|NCT01894919|282138|P3|COMPLETED|Overall Study||89
115147|NCT01894919|282139|P2|COMPLETED|Overall Study||47
115148|NCT01894919|282140|P1|COMPLETED|Overall Study||96
115149|NCT01894919|282128|P13|STARTED|Overall Study||50
115150|NCT01894919|282129|P12|STARTED|Overall Study||55
115151|NCT01894919|282130|P11|STARTED|Overall Study||100
115152|NCT01894919|282131|P10|STARTED|Overall Study||90
115153|NCT01894919|282132|P9|STARTED|Overall Study||91
115154|NCT01894919|282133|P8|STARTED|Overall Study||36
115155|NCT01894919|282134|P7|STARTED|Overall Study||32
115156|NCT01894919|282135|P6|STARTED|Overall Study||39
115157|NCT01894919|282136|P5|STARTED|Overall Study||81
115158|NCT01894919|282137|P4|STARTED|Overall Study||43
115159|NCT01894919|282138|P3|STARTED|Overall Study||89
115160|NCT01894919|282139|P2|STARTED|Overall Study||47
115161|NCT01894919|282140|P1|STARTED|Overall Study||98
115162|NCT01894906|282262|P2|NOT COMPLETED|Overall Study||0
115163|NCT01894906|282263|P1|NOT COMPLETED|Overall Study||0
115164|NCT01894906|282262|P2|COMPLETED|Overall Study||6
115165|NCT01894906|282263|P1|COMPLETED|Overall Study||6
115166|NCT01894906|282262|P2|Treatment F|Overall Study||6
115167|NCT01894906|282263|P1|Treatment F|Overall Study||6
115168|NCT01894906|282262|P2|Treatment E|Overall Study||6
115169|NCT01894906|282263|P1|Treatment E|Overall Study||6
115170|NCT01894906|282262|P2|Treatment D|Overall Study||6
115171|NCT01894906|282263|P1|Treatment D|Overall Study||6
115172|NCT01894906|282262|P2|Treatment C|Overall Study||6
115173|NCT01894906|282263|P1|Treatment C|Overall Study||6
115174|NCT01894906|282262|P2|Treatment B|Overall Study||6
115175|NCT01894906|282263|P1|Treatment B|Overall Study||6
115176|NCT01894906|282262|P2|Treatment A|Overall Study||6
115177|NCT01894906|282263|P1|Treatment A|Overall Study||6
115178|NCT01894906|282262|P2|STARTED|Overall Study||6
115179|NCT01894906|282263|P1|STARTED|Overall Study||6
115180|NCT01894672|282293|P1|NOT COMPLETED|Overall Study||0
115181|NCT01894672|282293|P1|COMPLETED|Overall Study||7
115182|NCT01894672|282293|P1|STARTED|Overall Study||7
115183|NCT01894620|282301|P2|NOT COMPLETED|Overall Study||1
115184|NCT01894620|282302|P1|NOT COMPLETED|Overall Study||0
115185|NCT01894620|282301|P2|COMPLETED|Overall Study||4
115186|NCT01894620|282302|P1|COMPLETED|Overall Study||6
115187|NCT01894620|282301|P2|STARTED|Overall Study||5
115188|NCT01894620|282302|P1|STARTED|Overall Study||6
115189|NCT01894607|282310|P1|NOT COMPLETED|Overall Study||1
115190|NCT01894607|282310|P1|COMPLETED|Overall Study||10
115191|NCT01894607|282310|P1|STARTED|Overall Study||11
115192|NCT01894581|282317|P2|NOT COMPLETED|Overall Study||7
115193|NCT01894581|282318|P1|NOT COMPLETED|Overall Study||5
115194|NCT01894581|282317|P2|COMPLETED|Overall Study||12
115195|NCT01894581|282318|P1|COMPLETED|Overall Study||15
115196|NCT01894581|282317|P2|STARTED|Overall Study||19
115197|NCT01894581|282318|P1|STARTED|Overall Study||20
115198|NCT01894568|282326|P2|NOT COMPLETED|Overall Study||10
115199|NCT01894568|282327|P1|NOT COMPLETED|Overall Study||10
115200|NCT01894568|282326|P2|COMPLETED|Overall Study||186
115201|NCT01894568|282327|P1|COMPLETED|Overall Study||182
115202|NCT01894568|282326|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
115203|NCT01894568|282327|P1|Received at Least 1 Dose of Study Drug|Overall Study||192
115204|NCT01894568|282326|P2|STARTED|Overall Study||196
115205|NCT01894568|282327|P1|STARTED|Overall Study||192
115206|NCT01894555|282367|P1|NOT COMPLETED|Overall Study||0
115207|NCT01894555|282367|P1|COMPLETED|Overall Study||33
115208|NCT01894555|282367|P1|STARTED|Overall Study||33
115209|NCT01894503|282371|P1|NOT COMPLETED|Overall Study||0
115210|NCT01894503|282371|P1|COMPLETED|Overall Study||5
115211|NCT01894503|282371|P1|STARTED|Overall Study||5
115212|NCT01894477|282378|P2|NOT COMPLETED|Overall Study||2
115213|NCT01894477|282379|P1|NOT COMPLETED|Overall Study||0
115214|NCT01894477|282378|P2|COMPLETED|Overall Study||65
115215|NCT01894477|282379|P1|COMPLETED|Overall Study||35
115216|NCT01894477|282378|P2|STARTED|Overall Study||67
115217|NCT01894477|282379|P1|STARTED|Overall Study||35
115218|NCT01894256|282390|P3|NOT COMPLETED|Part B||14
115219|NCT01894256|282391|P2|NOT COMPLETED|Part B||14
115220|NCT01894256|282392|P1|NOT COMPLETED|Part B||15
115221|NCT01894256|282390|P3|COMPLETED|Part B||0
115222|NCT01894256|282391|P2|COMPLETED|Part B||0
115223|NCT01894256|282392|P1|COMPLETED|Part B||0
115224|NCT01894256|282390|P3|STARTED|Part B||14
115225|NCT01894256|282391|P2|STARTED|Part B||14
115226|NCT01894256|282392|P1|STARTED|Part B||15
115227|NCT01894256|282390|P3|NOT COMPLETED|Part A||0
115228|NCT01894256|282391|P2|NOT COMPLETED|Part A||1
115229|NCT01894256|282392|P1|NOT COMPLETED|Part A||0
115230|NCT01894256|282390|P3|COMPLETED|Part A||14
115231|NCT01894256|282391|P2|COMPLETED|Part A||14
115232|NCT01894256|282392|P1|COMPLETED|Part A||15
115233|NCT01894256|282390|P3|STARTED|Part A||14
115234|NCT01894256|282391|P2|STARTED|Part A||15
115235|NCT01894256|282392|P1|STARTED|Part A||15
115236|NCT01894243|282439|P3|NOT COMPLETED|Overall Study||8
115237|NCT01894243|282440|P2|NOT COMPLETED|Overall Study||10
115238|NCT01894243|282441|P1|NOT COMPLETED|Overall Study||13
115239|NCT01894243|282439|P3|COMPLETED|Overall Study||0
115240|NCT01894243|282440|P2|COMPLETED|Overall Study||0
115241|NCT01894243|282441|P1|COMPLETED|Overall Study||0
115242|NCT01894243|282439|P3|Ongoing Into Part B|Overall Study||8
115243|NCT01894243|282440|P2|Ongoing Into Part B|Overall Study||10
115244|NCT01894243|282441|P1|Ongoing Into Part B|Overall Study||13
115245|NCT01894243|282439|P3|Completed Treatment in Part A|Overall Study||8
115246|NCT01894243|282440|P2|Completed Treatment in Part A|Overall Study||10
115247|NCT01894243|282441|P1|Completed Treatment in Part A|Overall Study||13
115248|NCT01894243|282439|P3|STARTED|Overall Study||8
115249|NCT01894243|282440|P2|STARTED|Overall Study||10
115250|NCT01894243|282441|P1|STARTED|Overall Study||13
115251|NCT01894230|282480|P2|NOT COMPLETED|Overall Study||7
115252|NCT01894230|282481|P1|NOT COMPLETED|Overall Study||7
115253|NCT01894230|282480|P2|COMPLETED|Overall Study||69
115254|NCT01894230|282481|P1|COMPLETED|Overall Study||76
115255|NCT01894230|282480|P2|STARTED|Overall Study||76
115256|NCT01894230|282481|P1|STARTED|Overall Study||83
115257|NCT01894178|282507|P2|NOT COMPLETED|Overall Study||0
115258|NCT01894178|282508|P1|NOT COMPLETED|Overall Study||0
115259|NCT01894178|282507|P2|COMPLETED|Overall Study||30
115260|NCT01894178|282508|P1|COMPLETED|Overall Study||30
115261|NCT01894178|282507|P2|STARTED|Overall Study||30
115262|NCT01894178|282508|P1|STARTED|Overall Study||30
115263|NCT01894152|282516|P1|NOT COMPLETED|Overall Study||143
115264|NCT01894152|282516|P1|COMPLETED|Overall Study||1859
115265|NCT01894152|282516|P1|STARTED|Overall Study||2002
115266|NCT01894100|282565|P2|NOT COMPLETED|Overall Study||1
115267|NCT01894100|282566|P1|NOT COMPLETED|Overall Study||3
115268|NCT01894100|282565|P2|COMPLETED|Overall Study||14
115269|NCT01894100|282566|P1|COMPLETED|Overall Study||12
115270|NCT01894100|282565|P2|STARTED|Overall Study||15
115271|NCT01894100|282566|P1|STARTED|Overall Study||15
115272|NCT01894087|282576|P2|NOT COMPLETED|Overall Study||0
115273|NCT01894087|282577|P1|NOT COMPLETED|Overall Study||6
115274|NCT01894087|282576|P2|COMPLETED|Overall Study||102
115275|NCT01894087|282577|P1|COMPLETED|Overall Study||96
115276|NCT01894087|282576|P2|STARTED|Overall Study||102
115277|NCT01894087|282577|P1|STARTED|Overall Study||102
115278|NCT01894022|282591|P2|NOT COMPLETED|Overall Study||10
115279|NCT01894022|282592|P1|NOT COMPLETED|Overall Study||9
115280|NCT01894022|282591|P2|COMPLETED|Overall Study||0
115281|NCT01894022|282592|P1|COMPLETED|Overall Study||0
115282|NCT01894022|282591|P2|STARTED|Overall Study||10
115283|NCT01894022|282592|P1|STARTED|Overall Study||9
115284|NCT01893983|282646|P2|NOT COMPLETED|Overall Study||6
115285|NCT01893983|282647|P1|NOT COMPLETED|Overall Study||10
115286|NCT01893983|282646|P2|COMPLETED|Overall Study||134
115287|NCT01893983|282647|P1|COMPLETED|Overall Study||130
115288|NCT01893983|282646|P2|STARTED|Overall Study||140
115289|NCT01893983|282647|P1|STARTED|Overall Study||140
115290|NCT01893905|282661|P2|NOT COMPLETED|Overall Study||14
115291|NCT01893905|282662|P1|NOT COMPLETED|Overall Study||25
115292|NCT01893905|282661|P2|COMPLETED|Overall Study||64
115293|NCT01893905|282662|P1|COMPLETED|Overall Study||55
115294|NCT01893905|282661|P2|STARTED|Overall Study||78
115295|NCT01893905|282662|P1|STARTED|Overall Study||80
115296|NCT01893879|282670|P2|NOT COMPLETED|Overall Study||3
115297|NCT01893879|282671|P1|NOT COMPLETED|Overall Study||2
115298|NCT01893879|282670|P2|COMPLETED|Overall Study||4
115299|NCT01893879|282671|P1|COMPLETED|Overall Study||5
115300|NCT01893879|282670|P2|STARTED|Overall Study||7
115301|NCT01893879|282671|P1|STARTED|Overall Study||7
115302|NCT01893801|282677|P1|NOT COMPLETED|Overall Study||0
115303|NCT01893801|282677|P1|COMPLETED|Overall Study||25
115304|NCT01893801|282677|P1|STARTED|Overall Study||25
115305|NCT01893632|282687|P2|NOT COMPLETED|Overall Study||0
115306|NCT01893632|282688|P1|NOT COMPLETED|Overall Study||0
115307|NCT01893632|282687|P2|COMPLETED|Overall Study||1
115308|NCT01893632|282688|P1|COMPLETED|Overall Study||1
115309|NCT01893632|282687|P2|STARTED|Overall Study||1
115310|NCT01893632|282688|P1|STARTED|Overall Study||1
115311|NCT01893567|282694|P1|NOT COMPLETED|Overall Study||0
115312|NCT01893567|282694|P1|COMPLETED|Overall Study||28
115313|NCT01893567|282694|P1|STARTED|Overall Study||28
115314|NCT01893411|282701|P3|NOT COMPLETED|Overall Study||9
115315|NCT01893411|282702|P2|NOT COMPLETED|Overall Study||7
115316|NCT01893411|282703|P1|NOT COMPLETED|Overall Study||17
115317|NCT01893411|282701|P3|COMPLETED|Overall Study||69
115318|NCT01893411|282702|P2|COMPLETED|Overall Study||70
115319|NCT01893411|282703|P1|COMPLETED|Overall Study||139
115320|NCT01893411|282701|P3|STARTED|Overall Study||78
115321|NCT01893411|282702|P2|STARTED|Overall Study||77
115322|NCT01893411|282703|P1|STARTED|Overall Study||156
115323|NCT01893359|282768|P3|NOT COMPLETED|Overall Study||0
115324|NCT01893359|282769|P2|NOT COMPLETED|Overall Study||0
115325|NCT01893359|282770|P1|NOT COMPLETED|Overall Study||0
115326|NCT01893359|282768|P3|COMPLETED|Overall Study||0
115327|NCT01893359|282769|P2|COMPLETED|Overall Study||2
115328|NCT01893359|282770|P1|COMPLETED|Overall Study||0
115329|NCT01893359|282768|P3|STARTED|Overall Study||0
115330|NCT01893359|282769|P2|STARTED|Overall Study||2
115331|NCT01893359|282770|P1|STARTED|Overall Study||0
115332|NCT01893346|282785|P4|NOT COMPLETED|Overall Study||0
115333|NCT01893346|282786|P3|NOT COMPLETED|Overall Study||0
115334|NCT01893346|282787|P2|NOT COMPLETED|Overall Study||1
115335|NCT01893346|282788|P1|NOT COMPLETED|Overall Study||3
115336|NCT01893346|282785|P4|COMPLETED|Overall Study||8
115337|NCT01893346|282786|P3|COMPLETED|Overall Study||8
115338|NCT01893346|282787|P2|COMPLETED|Overall Study||7
115339|NCT01893346|282788|P1|COMPLETED|Overall Study||8
115340|NCT01893346|282785|P4|Patients Who Received Full Infusion|Overall Study||8
115341|NCT01893346|282786|P3|Patients Who Received Full Infusion|Overall Study||8
115342|NCT01893346|282787|P2|Patients Who Received Full Infusion|Overall Study||8
115343|NCT01893346|282788|P1|Patients Who Received Full Infusion|Overall Study||8
115344|NCT01893346|282785|P4|STARTED|Overall Study||8
115345|NCT01893346|282786|P3|STARTED|Overall Study||8
115346|NCT01893346|282787|P2|STARTED|Overall Study||8
115347|NCT01893346|282788|P1|STARTED|Overall Study||11
115348|NCT01893281|282802|P1|NOT COMPLETED|Overall Study||3
115349|NCT01893281|282802|P1|COMPLETED|Overall Study||75
115350|NCT01893281|282802|P1|Received at Least 1 Dose of Study Drug|Overall Study||78
115351|NCT01893281|282802|P1|STARTED|Overall Study||78
115352|NCT01893203|282809|P1|NOT COMPLETED|Overall Study||1
115353|NCT01893203|282809|P1|COMPLETED|Overall Study||13
115354|NCT01893203|282809|P1|STARTED|Overall Study||14
115355|NCT01892865|282818|P2|NOT COMPLETED|Overall Study||0
115356|NCT01892865|282819|P1|NOT COMPLETED|Overall Study||0
115357|NCT01892865|282818|P2|COMPLETED|Overall Study||379
115358|NCT01892865|282819|P1|COMPLETED|Overall Study||356
115359|NCT01892865|282818|P2|STARTED|Overall Study|100 operative days scheduled with the Predictive Modeling System method were included|379
115360|NCT01892865|282819|P1|STARTED|Overall Study|107 operative days scheduled with the Historical Means method were included|356
115361|NCT01892722|282833|P2|NOT COMPLETED|Overall Study||20
115362|NCT01892722|282834|P1|NOT COMPLETED|Overall Study||7
115363|NCT01892722|282833|P2|COMPLETED|Overall Study||88
115364|NCT01892722|282834|P1|COMPLETED|Overall Study||100
115365|NCT01892722|282833|P2|Full Analysis Set|Overall Study||107
115366|NCT01892722|282834|P1|Full Analysis Set|Overall Study||107
115367|NCT01892722|282833|P2|STARTED|Overall Study||108
115368|NCT01892722|282834|P1|STARTED|Overall Study||107
115369|NCT01892709|282840|P1|NOT COMPLETED|Overall Study||0
115370|NCT01892709|282840|P1|COMPLETED|Overall Study||215
115371|NCT01892709|282840|P1|STARTED|Overall Study||215
115372|NCT01892657|282850|P1|NOT COMPLETED|Overall Study||18
115373|NCT01892657|282850|P1|COMPLETED|Overall Study||110
115374|NCT01892657|282850|P1|STARTED|Overall Study||128
115375|NCT01892436|282870|P4|NOT COMPLETED|Overall Study||14
115376|NCT01892436|282871|P3|NOT COMPLETED|Overall Study||11
115377|NCT01892436|282872|P2|NOT COMPLETED|Overall Study||29
115378|NCT01892436|282873|P1|NOT COMPLETED|Overall Study||23
115379|NCT01892436|282870|P4|COMPLETED|Overall Study||61
115380|NCT01892436|282871|P3|COMPLETED|Overall Study||63
115381|NCT01892436|282872|P2|COMPLETED|Overall Study||132
115382|NCT01892436|282873|P1|COMPLETED|Overall Study||124
115383|NCT01892436|282870|P4|STARTED|Overall Study||75
115384|NCT01892436|282871|P3|STARTED|Overall Study||74
115385|NCT01892436|282872|P2|STARTED|Overall Study||161
115386|NCT01892436|282873|P1|STARTED|Overall Study||147
115387|NCT01892345|282913|P2|NOT COMPLETED|Overall Study||3
115388|NCT01892345|282914|P1|NOT COMPLETED|Overall Study||16
115389|NCT01892345|282913|P2|COMPLETED|Overall Study||44
115390|NCT01892345|282914|P1|COMPLETED|Overall Study||80
115391|NCT01892345|282913|P2|Received At Least 1 Dose Of Study Drug|Overall Study||47
115392|NCT01892345|282914|P1|Received At Least 1 Dose Of Study Drug|Overall Study||96
115393|NCT01892345|282913|P2|STARTED|Overall Study||47
115394|NCT01892345|282914|P1|STARTED|Overall Study||96
115395|NCT01892306|282934|P2|NOT COMPLETED|Overall Study||6
115396|NCT01892306|282935|P1|NOT COMPLETED|Overall Study||5
115397|NCT01892306|282934|P2|COMPLETED|Overall Study||10
115398|NCT01892306|282935|P1|COMPLETED|Overall Study||8
115399|NCT01892306|282934|P2|STARTED|Overall Study||16
115400|NCT01892306|282935|P1|STARTED|Overall Study||13
115401|NCT01892293|282955|P1|NOT COMPLETED|Overall Study||4
115402|NCT01892293|282955|P1|COMPLETED|Overall Study||2
115403|NCT01892293|282955|P1|Received T-cell|Overall Study||2
115404|NCT01892293|282955|P1|STARTED|Overall Study||6
115405|NCT01892267|282963|P2|NOT COMPLETED|Overall Study||0
115406|NCT01892267|282964|P1|NOT COMPLETED|Overall Study||0
115407|NCT01892267|282963|P2|COMPLETED|Overall Study||10
115408|NCT01892267|282964|P1|COMPLETED|Overall Study||9
115409|NCT01892267|282963|P2|STARTED|Overall Study||10
115410|NCT01892267|282964|P1|STARTED|Overall Study||9
115411|NCT01892189|282999|P9|NOT COMPLETED|Third Intervention Period (1 Day)||0
115412|NCT01892189|283000|P8|NOT COMPLETED|Third Intervention Period (1 Day)||0
115413|NCT01892189|283001|P7|NOT COMPLETED|Third Intervention Period (1 Day)||0
115414|NCT01892189|283002|P6|NOT COMPLETED|Third Intervention Period (1 Day)||0
115415|NCT01892189|283003|P5|NOT COMPLETED|Third Intervention Period (1 Day)||0
115416|NCT01892189|283004|P4|NOT COMPLETED|Third Intervention Period (1 Day)||0
115417|NCT01892189|283005|P3|NOT COMPLETED|Third Intervention Period (1 Day)||0
115418|NCT01892189|283006|P2|NOT COMPLETED|Third Intervention Period (1 Day)||0
115419|NCT01892189|283007|P1|NOT COMPLETED|Third Intervention Period (1 Day)||0
115420|NCT01892189|282999|P9|COMPLETED|Third Intervention Period (1 Day)||1
115421|NCT01892189|283000|P8|COMPLETED|Third Intervention Period (1 Day)||3
115422|NCT01892189|283001|P7|COMPLETED|Third Intervention Period (1 Day)||2
115423|NCT01892189|283002|P6|COMPLETED|Third Intervention Period (1 Day)||2
115424|NCT01892189|283003|P5|COMPLETED|Third Intervention Period (1 Day)||3
115425|NCT01892189|283004|P4|COMPLETED|Third Intervention Period (1 Day)||2
115426|NCT01892189|283005|P3|COMPLETED|Third Intervention Period (1 Day)||1
115427|NCT01892189|283006|P2|COMPLETED|Third Intervention Period (1 Day)||3
115428|NCT01892189|283007|P1|COMPLETED|Third Intervention Period (1 Day)||3
115429|NCT01892189|282999|P9|STARTED|Third Intervention Period (1 Day)||1
115430|NCT01892189|283000|P8|STARTED|Third Intervention Period (1 Day)||3
115431|NCT01892189|283001|P7|STARTED|Third Intervention Period (1 Day)||2
115432|NCT01892189|283002|P6|STARTED|Third Intervention Period (1 Day)||2
115433|NCT01892189|283003|P5|STARTED|Third Intervention Period (1 Day)||3
115434|NCT01892189|283004|P4|STARTED|Third Intervention Period (1 Day)||2
115435|NCT01892189|283005|P3|STARTED|Third Intervention Period (1 Day)||1
115436|NCT01892189|283006|P2|STARTED|Third Intervention Period (1 Day)||3
115437|NCT01892189|283007|P1|STARTED|Third Intervention Period (1 Day)||3
115438|NCT01892189|282999|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
115439|NCT01892189|283000|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
115440|NCT01892189|283001|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
115441|NCT01892189|283002|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
115442|NCT01892189|283003|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
115443|NCT01892189|283004|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
115444|NCT01892189|283005|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
115445|NCT01892189|283006|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
115446|NCT01892189|283007|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
115447|NCT01892189|282999|P9|COMPLETED|Washout Period 2 (7 Days)||1
115448|NCT01892189|283000|P8|COMPLETED|Washout Period 2 (7 Days)||3
115449|NCT01892189|283001|P7|COMPLETED|Washout Period 2 (7 Days)||2
115450|NCT01892189|283002|P6|COMPLETED|Washout Period 2 (7 Days)||2
115451|NCT01892189|283003|P5|COMPLETED|Washout Period 2 (7 Days)||3
115452|NCT01892189|283004|P4|COMPLETED|Washout Period 2 (7 Days)||2
115453|NCT01892189|283005|P3|COMPLETED|Washout Period 2 (7 Days)||1
115454|NCT01892189|283006|P2|COMPLETED|Washout Period 2 (7 Days)||3
115455|NCT01892189|283007|P1|COMPLETED|Washout Period 2 (7 Days)||3
115456|NCT01892189|282999|P9|STARTED|Washout Period 2 (7 Days)||1
115457|NCT01892189|283000|P8|STARTED|Washout Period 2 (7 Days)||3
115458|NCT01892189|283001|P7|STARTED|Washout Period 2 (7 Days)||2
115459|NCT01892189|283002|P6|STARTED|Washout Period 2 (7 Days)||2
115460|NCT01892189|283003|P5|STARTED|Washout Period 2 (7 Days)||3
115461|NCT01892189|283004|P4|STARTED|Washout Period 2 (7 Days)||2
115462|NCT01892189|283005|P3|STARTED|Washout Period 2 (7 Days)||1
115463|NCT01892189|283006|P2|STARTED|Washout Period 2 (7 Days)||3
115464|NCT01892189|283007|P1|STARTED|Washout Period 2 (7 Days)||3
115465|NCT01892189|282999|P9|NOT COMPLETED|Second Intervention Period (1 Day)||0
115466|NCT01892189|283000|P8|NOT COMPLETED|Second Intervention Period (1 Day)||0
115467|NCT01892189|283001|P7|NOT COMPLETED|Second Intervention Period (1 Day)||0
115468|NCT01892189|283002|P6|NOT COMPLETED|Second Intervention Period (1 Day)||0
115469|NCT01892189|283003|P5|NOT COMPLETED|Second Intervention Period (1 Day)||0
115470|NCT01892189|283004|P4|NOT COMPLETED|Second Intervention Period (1 Day)||0
115471|NCT01892189|283005|P3|NOT COMPLETED|Second Intervention Period (1 Day)||0
115472|NCT01892189|283006|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
115473|NCT01892189|283007|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
115474|NCT01892189|282999|P9|COMPLETED|Second Intervention Period (1 Day)||1
115475|NCT01892189|283000|P8|COMPLETED|Second Intervention Period (1 Day)||3
115476|NCT01892189|283001|P7|COMPLETED|Second Intervention Period (1 Day)||2
115477|NCT01892189|283002|P6|COMPLETED|Second Intervention Period (1 Day)||2
115478|NCT01892189|283003|P5|COMPLETED|Second Intervention Period (1 Day)||3
115479|NCT01892189|283004|P4|COMPLETED|Second Intervention Period (1 Day)||2
115480|NCT01892189|283005|P3|COMPLETED|Second Intervention Period (1 Day)||1
115481|NCT01892189|283006|P2|COMPLETED|Second Intervention Period (1 Day)||3
115482|NCT01892189|283007|P1|COMPLETED|Second Intervention Period (1 Day)||3
115483|NCT01892189|282999|P9|STARTED|Second Intervention Period (1 Day)||1
115484|NCT01892189|283000|P8|STARTED|Second Intervention Period (1 Day)||3
115485|NCT01892189|283001|P7|STARTED|Second Intervention Period (1 Day)||2
115486|NCT01892189|283002|P6|STARTED|Second Intervention Period (1 Day)||2
115487|NCT01892189|283003|P5|STARTED|Second Intervention Period (1 Day)||3
115488|NCT01892189|283004|P4|STARTED|Second Intervention Period (1 Day)||2
115489|NCT01892189|283005|P3|STARTED|Second Intervention Period (1 Day)||1
115490|NCT01892189|283006|P2|STARTED|Second Intervention Period (1 Day)||3
115491|NCT01892189|283007|P1|STARTED|Second Intervention Period (1 Day)||3
115492|NCT01892189|282999|P9|NOT COMPLETED|Washout Period 1 (7 Days)||2
115493|NCT01892189|283000|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
115494|NCT01892189|283001|P7|NOT COMPLETED|Washout Period 1 (7 Days)||1
115495|NCT01892189|283002|P6|NOT COMPLETED|Washout Period 1 (7 Days)||1
115496|NCT01892189|283003|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
115497|NCT01892189|283004|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
115498|NCT01892189|283005|P3|NOT COMPLETED|Washout Period 1 (7 Days)||2
115499|NCT01892189|283006|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
115500|NCT01892189|283007|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
115501|NCT01892189|282999|P9|COMPLETED|Washout Period 1 (7 Days)||1
115502|NCT01892189|283000|P8|COMPLETED|Washout Period 1 (7 Days)||3
115503|NCT01892189|283001|P7|COMPLETED|Washout Period 1 (7 Days)||2
115504|NCT01892189|283002|P6|COMPLETED|Washout Period 1 (7 Days)||2
115505|NCT01892189|283003|P5|COMPLETED|Washout Period 1 (7 Days)||3
115506|NCT01892189|283004|P4|COMPLETED|Washout Period 1 (7 Days)||2
115507|NCT01892189|283005|P3|COMPLETED|Washout Period 1 (7 Days)||1
115508|NCT01892189|283006|P2|COMPLETED|Washout Period 1 (7 Days)||3
115509|NCT01892189|283007|P1|COMPLETED|Washout Period 1 (7 Days)||3
115510|NCT01892189|282999|P9|STARTED|Washout Period 1 (7 Days)||3
115511|NCT01892189|283000|P8|STARTED|Washout Period 1 (7 Days)||3
115512|NCT01892189|283001|P7|STARTED|Washout Period 1 (7 Days)||3
115513|NCT01892189|283002|P6|STARTED|Washout Period 1 (7 Days)||3
115514|NCT01892189|283003|P5|STARTED|Washout Period 1 (7 Days)||3
115515|NCT01892189|283004|P4|STARTED|Washout Period 1 (7 Days)||3
115516|NCT01892189|283005|P3|STARTED|Washout Period 1 (7 Days)||3
115517|NCT01892189|283006|P2|STARTED|Washout Period 1 (7 Days)||3
115518|NCT01892189|283007|P1|STARTED|Washout Period 1 (7 Days)||3
115519|NCT01892189|282999|P9|NOT COMPLETED|First Intervention Period (1 Day)||0
115520|NCT01892189|283000|P8|NOT COMPLETED|First Intervention Period (1 Day)||0
115521|NCT01892189|283001|P7|NOT COMPLETED|First Intervention Period (1 Day)||0
115522|NCT01892189|283002|P6|NOT COMPLETED|First Intervention Period (1 Day)||0
115523|NCT01892189|283003|P5|NOT COMPLETED|First Intervention Period (1 Day)||0
115524|NCT01892189|283004|P4|NOT COMPLETED|First Intervention Period (1 Day)||0
115525|NCT01892189|283005|P3|NOT COMPLETED|First Intervention Period (1 Day)||0
115526|NCT01892189|283006|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
115527|NCT01892189|283007|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
115528|NCT01892189|282999|P9|COMPLETED|First Intervention Period (1 Day)||3
115529|NCT01892189|283000|P8|COMPLETED|First Intervention Period (1 Day)||3
115530|NCT01892189|283001|P7|COMPLETED|First Intervention Period (1 Day)||3
115531|NCT01892189|283002|P6|COMPLETED|First Intervention Period (1 Day)||3
115532|NCT01892189|283003|P5|COMPLETED|First Intervention Period (1 Day)||3
115533|NCT01892189|283004|P4|COMPLETED|First Intervention Period (1 Day)||3
115534|NCT01892189|283005|P3|COMPLETED|First Intervention Period (1 Day)||3
115535|NCT01892189|283006|P2|COMPLETED|First Intervention Period (1 Day)||3
115536|NCT01892189|283007|P1|COMPLETED|First Intervention Period (1 Day)||3
115537|NCT01892189|282999|P9|STARTED|First Intervention Period (1 Day)||3
115538|NCT01892189|283000|P8|STARTED|First Intervention Period (1 Day)||3
115539|NCT01892189|283001|P7|STARTED|First Intervention Period (1 Day)||3
115540|NCT01892189|283002|P6|STARTED|First Intervention Period (1 Day)||3
115541|NCT01892189|283003|P5|STARTED|First Intervention Period (1 Day)||3
115542|NCT01892189|283004|P4|STARTED|First Intervention Period (1 Day)||3
115543|NCT01892189|283005|P3|STARTED|First Intervention Period (1 Day)||3
115544|NCT01892189|283006|P2|STARTED|First Intervention Period (1 Day)||3
115545|NCT01892189|283007|P1|STARTED|First Intervention Period (1 Day)||3
115546|NCT01892163|283049|P2|NOT COMPLETED|Overall Study||1
115547|NCT01892163|283050|P1|NOT COMPLETED|Overall Study||2
115548|NCT01892163|283049|P2|COMPLETED|Overall Study||49
115549|NCT01892163|283050|P1|COMPLETED|Overall Study||48
115550|NCT01892163|283049|P2|STARTED|Overall Study||50
115551|NCT01892163|283050|P1|STARTED|Overall Study||50
115552|NCT01892020|283062|P2|NOT COMPLETED|Period 2||0
115553|NCT01892020|283063|P1|NOT COMPLETED|Period 2||1
115554|NCT01892020|283062|P2|COMPLETED|Period 2||74
115555|NCT01892020|283063|P1|COMPLETED|Period 2||77
115556|NCT01892020|283062|P2|STARTED|Period 2||74
115557|NCT01892020|283063|P1|STARTED|Period 2||78
115558|NCT01892020|283062|P2|NOT COMPLETED|Period 1||6
115559|NCT01892020|283063|P1|NOT COMPLETED|Period 1||3
115560|NCT01892020|283062|P2|COMPLETED|Period 1||74
115561|NCT01892020|283063|P1|COMPLETED|Period 1||78
115562|NCT01892020|283062|P2|STARTED|Period 1||80
115563|NCT01892020|283063|P1|STARTED|Period 1||81
115564|NCT01891994|283081|P1|NOT COMPLETED|Overall Study||0
115565|NCT01891994|283081|P1|COMPLETED|Overall Study||40
115566|NCT01891994|283081|P1|STARTED|Overall Study||40
115567|NCT01891968|283085|P1|NOT COMPLETED|Overall Study||0
115568|NCT01891968|283085|P1|COMPLETED|Overall Study||15
115569|NCT01891968|283085|P1|STARTED|Overall Study||15
115570|NCT01891890|283092|P3|NOT COMPLETED|Overall Study||7
115571|NCT01891890|283093|P2|NOT COMPLETED|Overall Study||3
115572|NCT01891890|283094|P1|NOT COMPLETED|Overall Study||7
115573|NCT01891890|283092|P3|COMPLETED|Overall Study||14
115574|NCT01891890|283093|P2|COMPLETED|Overall Study||24
115575|NCT01891890|283094|P1|COMPLETED|Overall Study||17
115576|NCT01891890|283092|P3|STARTED|Overall Study||21
115577|NCT01891890|283093|P2|STARTED|Overall Study||27
115578|NCT01891890|283094|P1|STARTED|Overall Study||24
115579|NCT01891864|283137|P6|NOT COMPLETED|Extension Period||0
115580|NCT01891864|283138|P5|NOT COMPLETED|Extension Period||7
115581|NCT01891864|283139|P4|NOT COMPLETED|Extension Period||5
115582|NCT01891864|283140|P3|NOT COMPLETED|Extension Period||8
115583|NCT01891864|283141|P2|NOT COMPLETED|Extension Period||0
115584|NCT01891864|283142|P1|NOT COMPLETED|Extension Period||0
115585|NCT01891864|283137|P6|COMPLETED|Extension Period||90
115586|NCT01891864|283138|P5|COMPLETED|Extension Period||88
115587|NCT01891864|283139|P4|COMPLETED|Extension Period||137
115588|NCT01891864|283140|P3|COMPLETED|Extension Period||132
115589|NCT01891864|283141|P2|COMPLETED|Extension Period||0
115590|NCT01891864|283142|P1|COMPLETED|Extension Period||0
115591|NCT01891864|283137|P6|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to an adverse event|90
115592|NCT01891864|283138|P5|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to lack of efficacy|95
115593|NCT01891864|283139|P4|STARTED|Extension Period||142
115594|NCT01891864|283140|P3|STARTED|Extension Period|2 patients withdrew consent 1 patient lost to FU between Treatment Period 2 and the Extension period|140
115595|NCT01891864|283141|P2|STARTED|Extension Period||0
115596|NCT01891864|283142|P1|STARTED|Extension Period||0
115597|NCT01891864|283137|P6|NOT COMPLETED|Treatment Period 2||5
115598|NCT01891864|283138|P5|NOT COMPLETED|Treatment Period 2||4
115599|NCT01891864|283139|P4|NOT COMPLETED|Treatment Period 2||9
115600|NCT01891864|283140|P3|NOT COMPLETED|Treatment Period 2||7
115601|NCT01891864|283141|P2|NOT COMPLETED|Treatment Period 2||0
115602|NCT01891864|283142|P1|NOT COMPLETED|Treatment Period 2||0
115603|NCT01891864|283137|P6|COMPLETED|Treatment Period 2||91
115604|NCT01891864|283138|P5|COMPLETED|Treatment Period 2||96
115605|NCT01891864|283139|P4|COMPLETED|Treatment Period 2||142
115606|NCT01891864|283140|P3|COMPLETED|Treatment Period 2||143
115607|NCT01891864|283141|P2|COMPLETED|Treatment Period 2||0
115608|NCT01891864|283142|P1|COMPLETED|Treatment Period 2||0
115609|NCT01891864|283137|P6|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|96
115610|NCT01891864|283138|P5|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|100
115611|NCT01891864|283139|P4|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|151
115612|NCT01891864|283140|P3|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|150
115613|NCT01891864|283141|P2|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
115614|NCT01891864|283142|P1|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
115615|NCT01891864|283137|P6|NOT COMPLETED|Treatment Period 1||0
115616|NCT01891864|283138|P5|NOT COMPLETED|Treatment Period 1||0
115617|NCT01891864|283139|P4|NOT COMPLETED|Treatment Period 1||0
115618|NCT01891864|283140|P3|NOT COMPLETED|Treatment Period 1||0
115619|NCT01891864|283141|P2|NOT COMPLETED|Treatment Period 1||12
115620|NCT01891864|283142|P1|NOT COMPLETED|Treatment Period 1||8
115621|NCT01891864|283137|P6|COMPLETED|Treatment Period 1||0
115622|NCT01891864|283138|P5|COMPLETED|Treatment Period 1||0
115623|NCT01891864|283139|P4|COMPLETED|Treatment Period 1||0
115624|NCT01891864|283140|P3|COMPLETED|Treatment Period 1||0
115625|NCT01891864|283141|P2|COMPLETED|Treatment Period 1|8 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|255
115626|NCT01891864|283142|P1|COMPLETED|Treatment Period 1|6 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|256
115627|NCT01891864|283137|P6|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
115628|NCT01891864|283138|P5|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
115629|NCT01891864|283139|P4|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
115630|NCT01891864|283140|P3|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
115631|NCT01891864|283141|P2|STARTED|Treatment Period 1||267
115632|NCT01891864|283142|P1|STARTED|Treatment Period 1||264
115633|NCT01891734|283164|P2|NOT COMPLETED|Overall Study||3
115634|NCT01891734|283165|P1|NOT COMPLETED|Overall Study||3
115635|NCT01891734|283164|P2|COMPLETED|Overall Study||13
115636|NCT01891734|283165|P1|COMPLETED|Overall Study||14
115637|NCT01891734|283164|P2|STARTED|Overall Study||16
115638|NCT01891734|283165|P1|STARTED|Overall Study||17
115639|NCT01891721|283178|P3|NOT COMPLETED|Overall Study||1
115640|NCT01891721|283179|P2|NOT COMPLETED|Overall Study||5
115641|NCT01891721|283180|P1|NOT COMPLETED|Overall Study||10
115642|NCT01891721|283178|P3|COMPLETED|Overall Study||19
115643|NCT01891721|283179|P2|COMPLETED|Overall Study||35
115644|NCT01891721|283180|P1|COMPLETED|Overall Study||29
115645|NCT01891721|283178|P3|STARTED|Overall Study||20
115646|NCT01891721|283179|P2|STARTED|Overall Study||40
115647|NCT01891721|283180|P1|STARTED|Overall Study||39
115648|NCT01891669|283204|P10|NOT COMPLETED|Overall Study||2
115649|NCT01891669|283205|P9|NOT COMPLETED|Overall Study||1
115650|NCT01891669|283206|P8|NOT COMPLETED|Overall Study||4
115651|NCT01891669|283207|P7|NOT COMPLETED|Overall Study||1
115652|NCT01891669|283208|P6|NOT COMPLETED|Overall Study||0
115653|NCT01891669|283209|P5|NOT COMPLETED|Overall Study||0
115654|NCT01891669|283210|P4|NOT COMPLETED|Overall Study||0
115655|NCT01891669|283211|P3|NOT COMPLETED|Overall Study||0
115656|NCT01891669|283212|P2|NOT COMPLETED|Overall Study||1
115657|NCT01891669|283213|P1|NOT COMPLETED|Overall Study||2
115658|NCT01891669|283204|P10|COMPLETED|Overall Study||1
115659|NCT01891669|283205|P9|COMPLETED|Overall Study||2
115660|NCT01891669|283206|P8|COMPLETED|Overall Study||2
115661|NCT01891669|283207|P7|COMPLETED|Overall Study||1
115662|NCT01891669|283208|P6|COMPLETED|Overall Study||2
115663|NCT01891669|283209|P5|COMPLETED|Overall Study||2
115664|NCT01891669|283210|P4|COMPLETED|Overall Study||2
115665|NCT01891669|283211|P3|COMPLETED|Overall Study||2
115666|NCT01891669|283212|P2|COMPLETED|Overall Study||1
115667|NCT01891669|283213|P1|COMPLETED|Overall Study||0
115668|NCT01891669|283204|P10|STARTED|Overall Study||3
115669|NCT01891669|283205|P9|STARTED|Overall Study||3
115670|NCT01891669|283206|P8|STARTED|Overall Study||6
115671|NCT01891669|283207|P7|STARTED|Overall Study||2
115672|NCT01891669|283208|P6|STARTED|Overall Study||2
115673|NCT01891669|283209|P5|STARTED|Overall Study||2
115674|NCT01891669|283210|P4|STARTED|Overall Study||2
115675|NCT01891669|283211|P3|STARTED|Overall Study||2
115676|NCT01891669|283212|P2|STARTED|Overall Study||2
115677|NCT01891669|283213|P1|STARTED|Overall Study||2
115678|NCT01891357|283364|P1|NOT COMPLETED|Overall Study||3
115679|NCT01891357|283364|P1|COMPLETED|Overall Study||61
115680|NCT01891357|283364|P1|STARTED|Overall Study||64
115681|NCT01891331|283375|P4|NOT COMPLETED|Overall Study||2
115682|NCT01891331|283376|P3|NOT COMPLETED|Overall Study||1
115683|NCT01891331|283377|P2|NOT COMPLETED|Overall Study||2
115684|NCT01891331|283378|P1|NOT COMPLETED|Overall Study||2
115685|NCT01891331|283375|P4|COMPLETED|Overall Study||13
115686|NCT01891331|283376|P3|COMPLETED|Overall Study||13
115687|NCT01891331|283377|P2|COMPLETED|Overall Study||10
115688|NCT01891331|283378|P1|COMPLETED|Overall Study||12
115689|NCT01891331|283375|P4|STARTED|Overall Study||15
115690|NCT01891331|283376|P3|STARTED|Overall Study||14
115691|NCT01891331|283377|P2|STARTED|Overall Study||12
115692|NCT01891331|283378|P1|STARTED|Overall Study||14
115693|NCT01891305|283392|P4|NOT COMPLETED|Overall Study||0
115694|NCT01891305|283393|P3|NOT COMPLETED|Overall Study||3
115695|NCT01891305|283394|P2|NOT COMPLETED|Overall Study||1
115696|NCT01891305|283395|P1|NOT COMPLETED|Overall Study||3
115697|NCT01891305|283392|P4|COMPLETED|Overall Study||12
115698|NCT01891305|283393|P3|COMPLETED|Overall Study||11
115699|NCT01891305|283394|P2|COMPLETED|Overall Study||11
115700|NCT01891305|283395|P1|COMPLETED|Overall Study||9
115701|NCT01891305|283392|P4|STARTED|Overall Study||12
115702|NCT01891305|283393|P3|STARTED|Overall Study||14
115703|NCT01891305|283394|P2|STARTED|Overall Study||12
115704|NCT01891305|283395|P1|STARTED|Overall Study||12
115705|NCT01890967|283411|P6|NOT COMPLETED|Overall Study||13
115706|NCT01890967|283412|P5|NOT COMPLETED|Overall Study||10
115707|NCT01890967|283413|P4|NOT COMPLETED|Overall Study||11
115708|NCT01890967|283414|P3|NOT COMPLETED|Overall Study||10
115709|NCT01890967|283415|P2|NOT COMPLETED|Overall Study||11
115710|NCT01890967|283416|P1|NOT COMPLETED|Overall Study||10
115711|NCT01890967|283411|P6|COMPLETED|Overall Study||75
115712|NCT01890967|283412|P5|COMPLETED|Overall Study||77
115713|NCT01890967|283413|P4|COMPLETED|Overall Study||77
115714|NCT01890967|283414|P3|COMPLETED|Overall Study||78
115715|NCT01890967|283415|P2|COMPLETED|Overall Study||77
115716|NCT01890967|283416|P1|COMPLETED|Overall Study||78
115717|NCT01890967|283411|P6|Received at Least One Dose of Study Drug|Overall Study||87
115718|NCT01890967|283412|P5|Received at Least One Dose of Study Drug|Overall Study||86
115719|NCT01890967|283413|P4|Received at Least One Dose of Study Drug|Overall Study||86
115720|NCT01890967|283414|P3|Received at Least One Dose of Study Drug|Overall Study||86
115721|NCT01890967|283415|P2|Received at Least One Dose of Study Drug|Overall Study||87
115722|NCT01890967|283416|P1|Received at Least One Dose of Study Drug|Overall Study||87
115723|NCT01890967|283411|P6|STARTED|Overall Study||88
115724|NCT01890967|283412|P5|STARTED|Overall Study||87
115725|NCT01890967|283413|P4|STARTED|Overall Study||88
115726|NCT01890967|283414|P3|STARTED|Overall Study||88
115727|NCT01890967|283415|P2|STARTED|Overall Study||88
115728|NCT01890967|283416|P1|STARTED|Overall Study||88
115729|NCT01890954|283485|P2|NOT COMPLETED|Overall Study||0
115730|NCT01890954|283486|P1|NOT COMPLETED|Overall Study||1
115731|NCT01890954|283485|P2|COMPLETED|Overall Study||8
115732|NCT01890954|283486|P1|COMPLETED|Overall Study||8
115733|NCT01890954|283485|P2|STARTED|Overall Study||8
115734|NCT01890954|283486|P1|STARTED|Overall Study||9
115735|NCT01890915|283494|P2|NOT COMPLETED|Overall Study||1
115736|NCT01890915|283495|P1|NOT COMPLETED|Overall Study||3
115737|NCT01890915|283494|P2|COMPLETED|Overall Study||9
115738|NCT01890915|283495|P1|COMPLETED|Overall Study||8
115739|NCT01890915|283494|P2|STARTED|Overall Study||10
115740|NCT01890915|283495|P1|STARTED|Overall Study||11
115741|NCT01890785|283511|P6|NOT COMPLETED|Third Intervention||0
115742|NCT01890785|283512|P5|NOT COMPLETED|Third Intervention||0
115743|NCT01890785|283513|P4|NOT COMPLETED|Third Intervention||0
115744|NCT01890785|283514|P3|NOT COMPLETED|Third Intervention||0
115745|NCT01890785|283515|P2|NOT COMPLETED|Third Intervention||1
115746|NCT01890785|283516|P1|NOT COMPLETED|Third Intervention||0
115747|NCT01890785|283511|P6|COMPLETED|Third Intervention||5
115748|NCT01890785|283512|P5|COMPLETED|Third Intervention||5
115749|NCT01890785|283513|P4|COMPLETED|Third Intervention||5
115750|NCT01890785|283514|P3|COMPLETED|Third Intervention||5
115751|NCT01890785|283515|P2|COMPLETED|Third Intervention||4
115752|NCT01890785|283516|P1|COMPLETED|Third Intervention||5
115753|NCT01890785|283511|P6|STARTED|Third Intervention||5
115754|NCT01890785|283512|P5|STARTED|Third Intervention||5
115755|NCT01890785|283513|P4|STARTED|Third Intervention||5
115756|NCT01890785|283514|P3|STARTED|Third Intervention||5
115757|NCT01890785|283515|P2|STARTED|Third Intervention||5
115758|NCT01890785|283516|P1|STARTED|Third Intervention||5
115759|NCT01890785|283511|P6|NOT COMPLETED|Second Intervention||0
115760|NCT01890785|283512|P5|NOT COMPLETED|Second Intervention||0
115761|NCT01890785|283513|P4|NOT COMPLETED|Second Intervention||0
115762|NCT01890785|283514|P3|NOT COMPLETED|Second Intervention||0
115763|NCT01890785|283515|P2|NOT COMPLETED|Second Intervention||0
115764|NCT01890785|283516|P1|NOT COMPLETED|Second Intervention||0
115765|NCT01890785|283511|P6|COMPLETED|Second Intervention||5
115766|NCT01890785|283512|P5|COMPLETED|Second Intervention||5
115767|NCT01890785|283513|P4|COMPLETED|Second Intervention||5
115768|NCT01890785|283514|P3|COMPLETED|Second Intervention||5
115769|NCT01890785|283515|P2|COMPLETED|Second Intervention||5
115770|NCT01890785|283516|P1|COMPLETED|Second Intervention||5
115771|NCT01890785|283511|P6|STARTED|Second Intervention||5
115772|NCT01890785|283512|P5|STARTED|Second Intervention||5
115773|NCT01890785|283513|P4|STARTED|Second Intervention||5
115774|NCT01890785|283514|P3|STARTED|Second Intervention||5
115775|NCT01890785|283515|P2|STARTED|Second Intervention||5
115776|NCT01890785|283516|P1|STARTED|Second Intervention||5
115777|NCT01890785|283511|P6|NOT COMPLETED|First Intervention||0
115778|NCT01890785|283512|P5|NOT COMPLETED|First Intervention||0
115779|NCT01890785|283513|P4|NOT COMPLETED|First Intervention||0
115780|NCT01890785|283514|P3|NOT COMPLETED|First Intervention||0
115781|NCT01890785|283515|P2|NOT COMPLETED|First Intervention||0
115782|NCT01890785|283516|P1|NOT COMPLETED|First Intervention||0
115783|NCT01890785|283511|P6|COMPLETED|First Intervention||5
115784|NCT01890785|283512|P5|COMPLETED|First Intervention||5
115785|NCT01890785|283513|P4|COMPLETED|First Intervention||5
115786|NCT01890785|283514|P3|COMPLETED|First Intervention||5
115787|NCT01890785|283515|P2|COMPLETED|First Intervention||5
115788|NCT01890785|283516|P1|COMPLETED|First Intervention||5
115789|NCT01890785|283511|P6|STARTED|First Intervention||5
115790|NCT01890785|283512|P5|STARTED|First Intervention||5
115791|NCT01890785|283513|P4|STARTED|First Intervention||5
115792|NCT01890785|283514|P3|STARTED|First Intervention||5
115793|NCT01890785|283515|P2|STARTED|First Intervention||5
115794|NCT01890785|283516|P1|STARTED|First Intervention||5
115795|NCT01890759|283535|P2|NOT COMPLETED|Overall Study||12
115796|NCT01890759|283536|P1|NOT COMPLETED|Overall Study||2
115797|NCT01890759|283535|P2|COMPLETED|Overall Study||188
115798|NCT01890759|283536|P1|COMPLETED|Overall Study||98
115799|NCT01890759|283535|P2|STARTED|Overall Study||200
115800|NCT01890759|283536|P1|STARTED|Overall Study||100
115801|NCT01890746|283570|P2|NOT COMPLETED|Overall Study||41
115802|NCT01890746|283571|P1|NOT COMPLETED|Overall Study||52
115803|NCT01890746|283570|P2|COMPLETED|Overall Study||33
115804|NCT01890746|283571|P1|COMPLETED|Overall Study||22
115805|NCT01890746|283570|P2|STARTED|Overall Study||74
115806|NCT01890746|283571|P1|STARTED|Overall Study||74
115807|NCT01890694|283657|P2|NOT COMPLETED|Overall Study||1
115808|NCT01890694|283658|P1|NOT COMPLETED|Overall Study||1
115809|NCT01890694|283657|P2|COMPLETED|Overall Study||0
115810|NCT01890694|283658|P1|COMPLETED|Overall Study||0
115811|NCT01890694|283657|P2|STARTED|Overall Study||1
115812|NCT01890694|283658|P1|STARTED|Overall Study||1
115813|NCT01890642|283693|P3|NOT COMPLETED|Overall Study||0
115814|NCT01890642|283694|P2|NOT COMPLETED|Overall Study||0
115815|NCT01890642|283695|P1|NOT COMPLETED|Overall Study||0
115816|NCT01890642|283693|P3|COMPLETED|Overall Study||96
115817|NCT01890642|283694|P2|COMPLETED|Overall Study||53
115818|NCT01890642|283695|P1|COMPLETED|Overall Study||56
115819|NCT01890642|283693|P3|STARTED|Overall Study||96
115820|NCT01890642|283694|P2|STARTED|Overall Study||53
115821|NCT01890642|283695|P1|STARTED|Overall Study||56
115822|NCT01890577|283715|P1|NOT COMPLETED|Overall Study||28
115823|NCT01890577|283715|P1|COMPLETED|Overall Study||0
115824|NCT01890577|283715|P1|STARTED|Overall Study||28
115825|NCT01890512|283728|P1|NOT COMPLETED|Overall Study||3
115826|NCT01890512|283728|P1|COMPLETED|Overall Study||17
115827|NCT01890512|283728|P1|STARTED|Overall Study||20
115828|NCT01890473|283734|P2|NOT COMPLETED|Overall Study||0
115829|NCT01890473|283735|P1|NOT COMPLETED|Overall Study||2
115830|NCT01890473|283734|P2|COMPLETED|Overall Study||113
115831|NCT01890473|283735|P1|COMPLETED|Overall Study||109
115832|NCT01890473|283734|P2|STARTED|Overall Study||113
115833|NCT01890473|283735|P1|STARTED|Overall Study||111
115834|NCT01890434|283761|P1|NOT COMPLETED|Overall Study||20
115835|NCT01890434|283761|P1|COMPLETED|Overall Study||458
115836|NCT01890434|283761|P1|Evaluated for Efficacy|Overall Study||389
115837|NCT01890434|283761|P1|STARTED|Overall Study||478
115838|NCT01890421|283791|P1|NOT COMPLETED|Overall Study||11
115839|NCT01890421|283791|P1|COMPLETED|Overall Study||415
115840|NCT01890421|283791|P1|STARTED|Overall Study||426
115841|NCT01890343|283817|P3|NOT COMPLETED|Overall Study||0
115842|NCT01890343|283818|P2|NOT COMPLETED|Overall Study||0
115843|NCT01890343|283819|P1|NOT COMPLETED|Overall Study||0
115844|NCT01890343|283817|P3|COMPLETED|Overall Study||10
115845|NCT01890343|283818|P2|COMPLETED|Overall Study||10
115846|NCT01890343|283819|P1|COMPLETED|Overall Study||8
115847|NCT01890343|283817|P3|STARTED|Overall Study||10
115848|NCT01890343|283818|P2|STARTED|Overall Study||10
115849|NCT01890343|283819|P1|STARTED|Overall Study||8
115850|NCT01890148|283830|P1|NOT COMPLETED|Overall Study||1
115851|NCT01890148|283830|P1|COMPLETED|Overall Study||4
115852|NCT01890148|283830|P1|STARTED|Overall Study||5
115853|NCT01890122|283850|P4|NOT COMPLETED|Overall Study||59
115854|NCT01890122|283851|P3|NOT COMPLETED|Overall Study||13
115855|NCT01890122|283852|P2|NOT COMPLETED|Overall Study||37
115856|NCT01890122|283853|P1|NOT COMPLETED|Overall Study||27
115857|NCT01890122|283850|P4|COMPLETED|Overall Study||104
115858|NCT01890122|283851|P3|COMPLETED|Overall Study||146
115859|NCT01890122|283852|P2|COMPLETED|Overall Study||126
115860|NCT01890122|283853|P1|COMPLETED|Overall Study||135
115861|NCT01890122|283850|P4|Treated|Overall Study||163
115862|NCT01890122|283851|P3|Treated|Overall Study||159
115863|NCT01890122|283852|P2|Treated|Overall Study||162
115864|NCT01890122|283853|P1|Treated|Overall Study|Treated = Randomized participants who received at least one dose of study drug.|161
115865|NCT01890122|283850|P4|STARTED|Overall Study||163
115866|NCT01890122|283851|P3|STARTED|Overall Study||159
115867|NCT01890122|283852|P2|STARTED|Overall Study||163
115868|NCT01890122|283853|P1|STARTED|Overall Study|Started = Enrolled set which included all participants who signed informed consent.|162
115869|NCT01890109|283917|P2|NOT COMPLETED|Overall Study||5
115870|NCT01890109|283918|P1|NOT COMPLETED|Overall Study||1
115871|NCT01890109|283917|P2|COMPLETED|Overall Study||46
115872|NCT01890109|283918|P1|COMPLETED|Overall Study||51
115873|NCT01890109|283917|P2|Received Study Treatment|Overall Study||50
115874|NCT01890109|283918|P1|Received Study Treatment|Overall Study||52
115875|NCT01890109|283917|P2|STARTED|Overall Study||51
115876|NCT01890109|283918|P1|STARTED|Overall Study||52
115877|NCT01890031|283942|P5|NOT COMPLETED|Overall Study||0
115878|NCT01890031|283943|P4|NOT COMPLETED|Overall Study||0
115879|NCT01890031|283944|P3|NOT COMPLETED|Overall Study||0
115880|NCT01890031|283945|P2|NOT COMPLETED|Overall Study||0
115881|NCT01890031|283946|P1|NOT COMPLETED|Overall Study||0
115882|NCT01890031|283942|P5|COMPLETED|Overall Study||8
115883|NCT01890031|283943|P4|COMPLETED|Overall Study||11
115884|NCT01890031|283944|P3|COMPLETED|Overall Study||12
115885|NCT01890031|283945|P2|COMPLETED|Overall Study||50
115886|NCT01890031|283946|P1|COMPLETED|Overall Study||50
115887|NCT01890031|283942|P5|STARTED|Overall Study||8
115888|NCT01890031|283943|P4|STARTED|Overall Study||11
115889|NCT01890031|283944|P3|STARTED|Overall Study||12
115890|NCT01890031|283945|P2|STARTED|Overall Study||50
115891|NCT01890031|283946|P1|STARTED|Overall Study||50
115892|NCT01889862|283967|P4|NOT COMPLETED|Overall Study||0
115893|NCT01889862|283968|P3|NOT COMPLETED|Overall Study||1
115894|NCT01889862|283969|P2|NOT COMPLETED|Overall Study||0
115895|NCT01889862|283970|P1|NOT COMPLETED|Overall Study||0
115896|NCT01889862|283967|P4|COMPLETED|Overall Study||14
115897|NCT01889862|283968|P3|COMPLETED|Overall Study||31
115898|NCT01889862|283969|P2|COMPLETED|Overall Study||15
115899|NCT01889862|283970|P1|COMPLETED|Overall Study||34
115900|NCT01889862|283967|P4|STARTED|Overall Study||14
115901|NCT01889862|283968|P3|STARTED|Overall Study||32
115902|NCT01889862|283969|P2|STARTED|Overall Study||15
115903|NCT01889862|283970|P1|STARTED|Overall Study||34
115904|NCT01889797|283982|P2|NOT COMPLETED|Overall Study||0
115905|NCT01889797|283983|P1|NOT COMPLETED|Overall Study||0
115906|NCT01889797|283982|P2|COMPLETED|Overall Study||16
115907|NCT01889797|283983|P1|COMPLETED|Overall Study||16
115908|NCT01889797|283982|P2|STARTED|Overall Study||16
115909|NCT01889797|283983|P1|STARTED|Overall Study||16
115910|NCT01889667|283998|P3|NOT COMPLETED|Overall Study||0
115911|NCT01889667|283999|P2|NOT COMPLETED|Overall Study||0
115912|NCT01889667|284000|P1|NOT COMPLETED|Overall Study||0
115913|NCT01889667|283998|P3|COMPLETED|Overall Study||10
115914|NCT01889667|283999|P2|COMPLETED|Overall Study||10
115915|NCT01889667|284000|P1|COMPLETED|Overall Study||10
115916|NCT01889667|283998|P3|STARTED|Overall Study||10
115917|NCT01889667|283999|P2|STARTED|Overall Study||10
115918|NCT01889667|284000|P1|STARTED|Overall Study||10
115919|NCT01889563|284022|P2|NOT COMPLETED|Overall Study||5
115920|NCT01889563|284023|P1|NOT COMPLETED|Overall Study||7
115921|NCT01889563|284022|P2|COMPLETED|Overall Study||10
115922|NCT01889563|284023|P1|COMPLETED|Overall Study||10
115923|NCT01889563|284022|P2|STARTED|Overall Study||15
115924|NCT01889563|284023|P1|STARTED|Overall Study||17
115925|NCT01889420|284031|P1|NOT COMPLETED|Overall Study||0
115926|NCT01889420|284031|P1|COMPLETED|Overall Study||1
115927|NCT01889420|284031|P1|STARTED|Overall Study||1
115928|NCT01889355|284037|P1|NOT COMPLETED|Overall Study||2
115929|NCT01889355|284037|P1|COMPLETED|Overall Study||113
115930|NCT01889355|284037|P1|STARTED|Overall Study||115
115931|NCT01889251|284043|P2|NOT COMPLETED|Overall Study||0
115932|NCT01889251|284044|P1|NOT COMPLETED|Overall Study||1
115933|NCT01889251|284043|P2|COMPLETED|Overall Study||57
115934|NCT01889251|284044|P1|COMPLETED|Overall Study||114
115935|NCT01889251|284043|P2|STARTED|Overall Study||57
115936|NCT01889251|284044|P1|STARTED|Overall Study||115
115937|NCT01889238|284050|P1|NOT COMPLETED|Overall Study||9
115938|NCT01889238|284050|P1|COMPLETED|Overall Study|DP, AE, death, treatment withdrawal were considered completed (defined in protocol).|109
115939|NCT01889238|284050|P1|STARTED|Overall Study||118
115940|NCT01888965|284067|P1|NOT COMPLETED|Overall Study||9
115941|NCT01888965|284067|P1|COMPLETED|Overall Study||0
115942|NCT01888965|284067|P1|STARTED|Overall Study||9
115943|NCT01888952|284073|P1|NOT COMPLETED|Overall Study||0
115944|NCT01888952|284073|P1|COMPLETED|Overall Study||10
115945|NCT01888952|284073|P1|STARTED|Overall Study||10
115946|NCT01888900|284079|P2|NOT COMPLETED|Overall Study||2
115947|NCT01888900|284080|P1|NOT COMPLETED|Overall Study||0
115948|NCT01888900|284079|P2|COMPLETED|Overall Study||11
115949|NCT01888900|284080|P1|COMPLETED|Overall Study||22
115950|NCT01888900|284079|P2|STARTED|Overall Study||13
115951|NCT01888900|284080|P1|STARTED|Overall Study||22
115952|NCT01888640|284103|P3|NOT COMPLETED|Overall Study||5
115953|NCT01888640|284104|P2|NOT COMPLETED|Overall Study||31
115954|NCT01888640|284105|P1|NOT COMPLETED|Overall Study||27
115955|NCT01888640|284103|P3|COMPLETED|Overall Study||94
115956|NCT01888640|284104|P2|COMPLETED|Overall Study||68
115957|NCT01888640|284105|P1|COMPLETED|Overall Study||76
115958|NCT01888640|284103|P3|STARTED|Overall Study||99
115959|NCT01888640|284104|P2|STARTED|Overall Study||99
115960|NCT01888640|284105|P1|STARTED|Overall Study||103
115961|NCT01888432|284161|P2|NOT COMPLETED|36-month Analysis (Extension)||0
115962|NCT01888432|284162|P1|NOT COMPLETED|36-month Analysis (Extension)||1
115963|NCT01888432|284161|P2|COMPLETED|36-month Analysis (Extension)||5
115964|NCT01888432|284162|P1|COMPLETED|36-month Analysis (Extension)||12
115965|NCT01888432|284161|P2|STARTED|36-month Analysis (Extension)||5
115966|NCT01888432|284162|P1|STARTED|36-month Analysis (Extension)||13
115967|NCT01888432|284161|P2|NOT COMPLETED|24-month Analysis (FAS)||17
115968|NCT01888432|284162|P1|NOT COMPLETED|24-month Analysis (FAS)||17
115969|NCT01888432|284161|P2|COMPLETED|24-month Analysis (FAS)||125
115970|NCT01888432|284162|P1|COMPLETED|24-month Analysis (FAS)||125
115971|NCT01888432|284161|P2|STARTED|24-month Analysis (FAS)||142
115972|NCT01888432|284162|P1|STARTED|24-month Analysis (FAS)||142
115973|NCT01888432|284161|P2|NOT COMPLETED|12-month Analysis (FAS)||9
115974|NCT01888432|284162|P1|NOT COMPLETED|12-month Analysis (FAS)||11
115975|NCT01888432|284161|P2|COMPLETED|12-month Analysis (FAS)||133
115976|NCT01888432|284162|P1|COMPLETED|12-month Analysis (FAS)||131
115977|NCT01888432|284161|P2|STARTED|12-month Analysis (FAS)||142
115978|NCT01888432|284162|P1|STARTED|12-month Analysis (FAS)||142
115979|NCT01888367|284203|P3|NOT COMPLETED|Overall Study||5
115980|NCT01888367|284204|P2|NOT COMPLETED|Overall Study||5
115981|NCT01888367|284205|P1|NOT COMPLETED|Overall Study||8
115982|NCT01888367|284203|P3|COMPLETED|Overall Study||73
115983|NCT01888367|284204|P2|COMPLETED|Overall Study||66
115984|NCT01888367|284205|P1|COMPLETED|Overall Study||288
115985|NCT01888367|284203|P3|STARTED|Overall Study||78
115986|NCT01888367|284204|P2|STARTED|Overall Study||71
115987|NCT01888367|284205|P1|STARTED|Overall Study||296
115988|NCT01888003|284225|P3|NOT COMPLETED|Overall Study||40
115989|NCT01888003|284226|P2|NOT COMPLETED|Overall Study||6
115990|NCT01888003|284227|P1|NOT COMPLETED|Overall Study||5
115991|NCT01888003|284225|P3|COMPLETED|Overall Study||0
115992|NCT01888003|284226|P2|COMPLETED|Overall Study||0
115993|NCT01888003|284227|P1|COMPLETED|Overall Study||0
115994|NCT01888003|284225|P3|STARTED|Overall Study||40
115995|NCT01888003|284226|P2|STARTED|Overall Study||6
115996|NCT01888003|284227|P1|STARTED|Overall Study||5
115997|NCT01887990|284248|P4|NOT COMPLETED|Overall Study||0
115998|NCT01887990|284249|P3|NOT COMPLETED|Overall Study||0
115999|NCT01887990|284250|P2|NOT COMPLETED|Overall Study||0
116000|NCT01887990|284251|P1|NOT COMPLETED|Overall Study||0
116001|NCT01887990|284248|P4|COMPLETED|Overall Study||2
116002|NCT01887990|284249|P3|COMPLETED|Overall Study||2
116003|NCT01887990|284250|P2|COMPLETED|Overall Study||7
116004|NCT01887990|284251|P1|COMPLETED|Overall Study||7
116005|NCT01887990|284248|P4|STARTED|Overall Study||2
116006|NCT01887990|284249|P3|STARTED|Overall Study||2
116007|NCT01887990|284250|P2|STARTED|Overall Study||7
116008|NCT01887990|284251|P1|STARTED|Overall Study||7
116009|NCT01887912|284267|P2|NOT COMPLETED|Overall Study||731
116010|NCT01887912|284268|P1|NOT COMPLETED|Overall Study||1392
116011|NCT01887912|284267|P2|COMPLETED|Overall Study||2370
116012|NCT01887912|284268|P1|COMPLETED|Overall Study||4809
116013|NCT01887912|284267|P2|Safety Population|Overall Study||3057
116014|NCT01887912|284268|P1|Safety Population|Overall Study||6113
116015|NCT01887912|284267|P2|STARTED|Overall Study||3101
116016|NCT01887912|284268|P1|STARTED|Overall Study||6201
116017|NCT01887717|284296|P2|NOT COMPLETED|Overall Study||11
116018|NCT01887717|284297|P1|NOT COMPLETED|Overall Study||6
116019|NCT01887717|284296|P2|COMPLETED|Overall Study||8
116020|NCT01887717|284297|P1|COMPLETED|Overall Study||11
116021|NCT01887717|284296|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
116022|NCT01887717|284297|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
116023|NCT01887717|284296|P2|STARTED|Overall Study||19
116024|NCT01887717|284297|P1|STARTED|Overall Study||17
116025|NCT01887678|284319|P2|NOT COMPLETED|Overall Study||28
116026|NCT01887678|284320|P1|NOT COMPLETED|Overall Study||17
116027|NCT01887678|284319|P2|COMPLETED|Overall Study||85
116028|NCT01887678|284320|P1|COMPLETED|Overall Study||102
116029|NCT01887678|284319|P2|STARTED|Overall Study||113
116030|NCT01887678|284320|P1|STARTED|Overall Study||119
116031|NCT01887470|284366|P4|NOT COMPLETED|Overall Study||0
116032|NCT01887470|284367|P3|NOT COMPLETED|Overall Study||0
116033|NCT01887470|284368|P2|NOT COMPLETED|Overall Study||0
116034|NCT01887470|284369|P1|NOT COMPLETED|Overall Study||0
116035|NCT01887470|284366|P4|COMPLETED|Overall Study||10
116036|NCT01887470|284367|P3|COMPLETED|Overall Study||10
116037|NCT01887470|284368|P2|COMPLETED|Overall Study||10
116038|NCT01887470|284369|P1|COMPLETED|Overall Study||10
116039|NCT01887470|284366|P4|STARTED|Overall Study||10
116040|NCT01887470|284367|P3|STARTED|Overall Study||10
116041|NCT01887470|284368|P2|STARTED|Overall Study||10
116042|NCT01887470|284369|P1|STARTED|Overall Study||10
116043|NCT01887418|284388|P3|NOT COMPLETED|Overall Study||1
116044|NCT01887418|284389|P2|NOT COMPLETED|Overall Study||0
116045|NCT01887418|284390|P1|NOT COMPLETED|Overall Study||0
116046|NCT01887418|284388|P3|COMPLETED|Overall Study||9
116047|NCT01887418|284389|P2|COMPLETED|Overall Study||14
116048|NCT01887418|284390|P1|COMPLETED|Overall Study||15
116049|NCT01887418|284388|P3|STARTED|Overall Study||10
116050|NCT01887418|284389|P2|STARTED|Overall Study||14
116051|NCT01887418|284390|P1|STARTED|Overall Study||15
116052|NCT01887353|284409|P2|NOT COMPLETED|Overall Study||3
116053|NCT01887353|284410|P1|NOT COMPLETED|Overall Study||4
116054|NCT01887353|284409|P2|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|1
116055|NCT01887353|284410|P1|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|0
116056|NCT01887353|284409|P2|STARTED|Overall Study||4
116057|NCT01887353|284410|P1|STARTED|Overall Study||4
116058|NCT01887327|284419|P3|NOT COMPLETED|Overall Study||3
116059|NCT01887327|284420|P2|NOT COMPLETED|Overall Study||4
116060|NCT01887327|284421|P1|NOT COMPLETED|Overall Study||1
116061|NCT01887327|284419|P3|COMPLETED|Overall Study||27
116062|NCT01887327|284420|P2|COMPLETED|Overall Study||27
116063|NCT01887327|284421|P1|COMPLETED|Overall Study||29
116064|NCT01887327|284419|P3|STARTED|Overall Study||30
116065|NCT01887327|284420|P2|STARTED|Overall Study||31
116066|NCT01887327|284421|P1|STARTED|Overall Study||30
116067|NCT01887288|284438|P1|NOT COMPLETED|Overall Study||16
116068|NCT01887288|284438|P1|COMPLETED|Overall Study||0
116069|NCT01887288|284438|P1|STARTED|Overall Study||16
116070|NCT01887210|284445|P2|NOT COMPLETED|Overall Study||4
116071|NCT01887210|284446|P1|NOT COMPLETED|Overall Study||1
116072|NCT01887210|284445|P2|COMPLETED|Overall Study||29
116073|NCT01887210|284446|P1|COMPLETED|Overall Study||32
116074|NCT01887210|284445|P2|STARTED|Overall Study||33
116075|NCT01887210|284446|P1|STARTED|Overall Study||33
116076|NCT01887171|284460|P2|NOT COMPLETED|Overall Study||0
116077|NCT01887171|284461|P1|NOT COMPLETED|Overall Study||0
116078|NCT01887171|284460|P2|COMPLETED|Overall Study||43
116079|NCT01887171|284461|P1|COMPLETED|Overall Study||43
116080|NCT01887171|284460|P2|STARTED|Overall Study||43
116081|NCT01887171|284461|P1|STARTED|Overall Study||43
116082|NCT01887132|284467|P1|NOT COMPLETED|Overall Study||0
116083|NCT01887132|284467|P1|COMPLETED|Overall Study||4
116084|NCT01887132|284467|P1|STARTED|Overall Study||4
116085|NCT01886963|284474|P2|NOT COMPLETED|Overall Study||4
116086|NCT01886963|284475|P1|NOT COMPLETED|Overall Study||5
116087|NCT01886963|284474|P2|COMPLETED|Overall Study||49
116088|NCT01886963|284475|P1|COMPLETED|Overall Study||46
116089|NCT01886963|284474|P2|12 Week Follow Up|Overall Study||22
116090|NCT01886963|284475|P1|12 Week Follow Up|Overall Study||24
116091|NCT01886963|284474|P2|4 Week Follow Up|Overall Study||26
116092|NCT01886963|284475|P1|4 Week Follow Up|Overall Study||24
116093|NCT01886963|284474|P2|2 Week Follow Up|Overall Study||35
116094|NCT01886963|284475|P1|2 Week Follow Up|Overall Study||38
116095|NCT01886963|284474|P2|STARTED|Overall Study||53
116096|NCT01886963|284475|P1|STARTED|Overall Study||51
116097|NCT01886937|284483|P2|NOT COMPLETED|Overall Study||0
116098|NCT01886937|284484|P1|NOT COMPLETED|Overall Study||0
116099|NCT01886937|284483|P2|COMPLETED|Overall Study||6
116100|NCT01886937|284484|P1|COMPLETED|Overall Study||7
116101|NCT01886937|284483|P2|STARTED|Overall Study||6
116102|NCT01886937|284484|P1|STARTED|Overall Study||7
116103|NCT01886833|284490|P1|NOT COMPLETED|Overall Study||204
116104|NCT01886833|284490|P1|COMPLETED|Overall Study||216
116105|NCT01886833|284490|P1|STARTED|Overall Study||420
116106|NCT01886807|284501|P3|NOT COMPLETED|Overall Study||10
116107|NCT01886807|284502|P2|NOT COMPLETED|Overall Study||10
116108|NCT01886807|284503|P1|NOT COMPLETED|Overall Study||5
116109|NCT01886807|284501|P3|COMPLETED|Overall Study||153
116110|NCT01886807|284502|P2|COMPLETED|Overall Study||145
116111|NCT01886807|284503|P1|COMPLETED|Overall Study||159
116112|NCT01886807|284501|P3|STARTED|Overall Study||163
116113|NCT01886807|284502|P2|STARTED|Overall Study||155
116114|NCT01886807|284503|P1|STARTED|Overall Study||164
116115|NCT01886781|284522|P2|NOT COMPLETED|Overall Study||2
116116|NCT01886781|284523|P1|NOT COMPLETED|Overall Study||14
116117|NCT01886781|284522|P2|COMPLETED|Overall Study||25
116118|NCT01886781|284523|P1|COMPLETED|Overall Study||40
116119|NCT01886781|284522|P2|STARTED|Overall Study||27
116120|NCT01886781|284523|P1|STARTED|Overall Study||54
116121|NCT01886716|284533|P4|NOT COMPLETED|1-Month Post Follow-Up||0
116122|NCT01886716|284534|P3|NOT COMPLETED|1-Month Post Follow-Up||0
116123|NCT01886716|284535|P2|NOT COMPLETED|1-Month Post Follow-Up||0
116124|NCT01886716|284536|P1|NOT COMPLETED|1-Month Post Follow-Up||0
116125|NCT01886716|284533|P4|COMPLETED|1-Month Post Follow-Up||14
116126|NCT01886716|284534|P3|COMPLETED|1-Month Post Follow-Up||19
116127|NCT01886716|284535|P2|COMPLETED|1-Month Post Follow-Up||17
116128|NCT01886716|284536|P1|COMPLETED|1-Month Post Follow-Up||20
116129|NCT01886716|284533|P4|STARTED|1-Month Post Follow-Up||14
116130|NCT01886716|284534|P3|STARTED|1-Month Post Follow-Up||19
116131|NCT01886716|284535|P2|STARTED|1-Month Post Follow-Up||17
116132|NCT01886716|284536|P1|STARTED|1-Month Post Follow-Up||20
116133|NCT01886716|284533|P4|NOT COMPLETED|1-Week Post Follow-Up||0
116134|NCT01886716|284534|P3|NOT COMPLETED|1-Week Post Follow-Up||0
116135|NCT01886716|284535|P2|NOT COMPLETED|1-Week Post Follow-Up||0
116136|NCT01886716|284536|P1|NOT COMPLETED|1-Week Post Follow-Up||0
116137|NCT01886716|284533|P4|COMPLETED|1-Week Post Follow-Up||14
116138|NCT01886716|284534|P3|COMPLETED|1-Week Post Follow-Up||19
116139|NCT01886716|284535|P2|COMPLETED|1-Week Post Follow-Up||17
116140|NCT01886716|284536|P1|COMPLETED|1-Week Post Follow-Up||20
116141|NCT01886716|284533|P4|STARTED|1-Week Post Follow-Up||14
116142|NCT01886716|284534|P3|STARTED|1-Week Post Follow-Up||19
116143|NCT01886716|284535|P2|STARTED|1-Week Post Follow-Up||17
116144|NCT01886716|284536|P1|STARTED|1-Week Post Follow-Up||20
116145|NCT01886716|284533|P4|NOT COMPLETED|Week 4||0
116146|NCT01886716|284534|P3|NOT COMPLETED|Week 4||0
116147|NCT01886716|284535|P2|NOT COMPLETED|Week 4||0
116148|NCT01886716|284536|P1|NOT COMPLETED|Week 4||0
116149|NCT01886716|284533|P4|COMPLETED|Week 4||14
116150|NCT01886716|284534|P3|COMPLETED|Week 4||19
116151|NCT01886716|284535|P2|COMPLETED|Week 4||17
116152|NCT01886716|284536|P1|COMPLETED|Week 4||20
116153|NCT01886716|284533|P4|STARTED|Week 4||14
116154|NCT01886716|284534|P3|STARTED|Week 4||19
116155|NCT01886716|284535|P2|STARTED|Week 4||17
116156|NCT01886716|284536|P1|STARTED|Week 4||20
116157|NCT01886716|284533|P4|NOT COMPLETED|Week 3||1
116158|NCT01886716|284534|P3|NOT COMPLETED|Week 3||0
116159|NCT01886716|284535|P2|NOT COMPLETED|Week 3||1
116160|NCT01886716|284536|P1|NOT COMPLETED|Week 3||1
116161|NCT01886716|284533|P4|COMPLETED|Week 3||14
116162|NCT01886716|284534|P3|COMPLETED|Week 3||19
116163|NCT01886716|284535|P2|COMPLETED|Week 3||17
116164|NCT01886716|284536|P1|COMPLETED|Week 3||20
116165|NCT01886716|284533|P4|STARTED|Week 3||15
116166|NCT01886716|284534|P3|STARTED|Week 3||19
116167|NCT01886716|284535|P2|STARTED|Week 3||18
116168|NCT01886716|284536|P1|STARTED|Week 3||21
116169|NCT01886716|284533|P4|NOT COMPLETED|Week 2||3
116170|NCT01886716|284534|P3|NOT COMPLETED|Week 2||1
116171|NCT01886716|284535|P2|NOT COMPLETED|Week 2||2
116172|NCT01886716|284536|P1|NOT COMPLETED|Week 2||3
116173|NCT01886716|284533|P4|COMPLETED|Week 2||15
116174|NCT01886716|284534|P3|COMPLETED|Week 2||19
116175|NCT01886716|284535|P2|COMPLETED|Week 2||18
116176|NCT01886716|284536|P1|COMPLETED|Week 2||21
116177|NCT01886716|284533|P4|STARTED|Week 2||18
116178|NCT01886716|284534|P3|STARTED|Week 2||20
116179|NCT01886716|284535|P2|STARTED|Week 2||20
116180|NCT01886716|284536|P1|STARTED|Week 2||24
116181|NCT01886716|284533|P4|NOT COMPLETED|Week 1||2
116182|NCT01886716|284534|P3|NOT COMPLETED|Week 1||2
116183|NCT01886716|284535|P2|NOT COMPLETED|Week 1||0
116184|NCT01886716|284536|P1|NOT COMPLETED|Week 1||0
116185|NCT01886716|284533|P4|COMPLETED|Week 1||18
116186|NCT01886716|284534|P3|COMPLETED|Week 1||20
116187|NCT01886716|284535|P2|COMPLETED|Week 1||20
116188|NCT01886716|284536|P1|COMPLETED|Week 1||24
116189|NCT01886716|284533|P4|STARTED|Week 1||20
116190|NCT01886716|284534|P3|STARTED|Week 1||22
116191|NCT01886716|284535|P2|STARTED|Week 1||20
116192|NCT01886716|284536|P1|STARTED|Week 1||24
116193|NCT01886690|284552|P2|NOT COMPLETED|Overall Study||2
116194|NCT01886690|284553|P1|NOT COMPLETED|Overall Study||0
116195|NCT01886690|284552|P2|COMPLETED|Overall Study||71
116196|NCT01886690|284553|P1|COMPLETED|Overall Study||75
116197|NCT01886690|284552|P2|STARTED|Overall Study||73
116198|NCT01886690|284553|P1|STARTED|Overall Study||75
116199|NCT01886313|284569|P2|NOT COMPLETED|Overall Study||1
116200|NCT01886313|284570|P1|NOT COMPLETED|Overall Study||1
116201|NCT01886313|284569|P2|COMPLETED|Overall Study||4
116202|NCT01886313|284570|P1|COMPLETED|Overall Study||5
116203|NCT01886313|284569|P2|STARTED|Overall Study||5
116204|NCT01886313|284570|P1|STARTED|Overall Study||6
116205|NCT01886300|284576|P1|NOT COMPLETED|Overall Study||16
116206|NCT01886300|284576|P1|COMPLETED|Overall Study||0
116207|NCT01886300|284576|P1|STARTED|Overall Study||16
116208|NCT01886287|284587|P1|NOT COMPLETED|Overall Study||2
116209|NCT01886287|284587|P1|COMPLETED|Overall Study||0
116210|NCT01886287|284587|P1|STARTED|Overall Study||2
116211|NCT01886235|284592|P1|NOT COMPLETED|Overall Study||0
116212|NCT01886235|284592|P1|COMPLETED|Overall Study||10
116213|NCT01886235|284592|P1|STARTED|Overall Study||10
116214|NCT01886105|284603|P1|NOT COMPLETED|Overall Study||3
116215|NCT01886105|284603|P1|COMPLETED|Overall Study||1
116216|NCT01886105|284603|P1|STARTED|Overall Study||4
116217|NCT01885936|284610|P2|NOT COMPLETED|Overall Study||0
116218|NCT01885936|284611|P1|NOT COMPLETED|Overall Study||1
116219|NCT01885936|284610|P2|COMPLETED|Overall Study||5
116220|NCT01885936|284611|P1|COMPLETED|Overall Study||7
116221|NCT01885936|284610|P2|STARTED|Overall Study||5
116222|NCT01885936|284611|P1|STARTED|Overall Study||8
116223|NCT01885910|284621|P1|NOT COMPLETED|Overall Study||8
116224|NCT01885910|284621|P1|COMPLETED|Overall Study||24
116225|NCT01885910|284621|P1|STARTED|Overall Study||32
116226|NCT01885871|284635|P1|NOT COMPLETED|Overall Study||0
116227|NCT01885871|284635|P1|COMPLETED|Overall Study||20
116228|NCT01885871|284635|P1|STARTED|Overall Study||20
116229|NCT01885559|284645|P2|NOT COMPLETED|Overall Study||36
116230|NCT01885559|284646|P1|NOT COMPLETED|Overall Study||24
116231|NCT01885559|284645|P2|COMPLETED|Overall Study||208
116232|NCT01885559|284646|P1|COMPLETED|Overall Study||218
116233|NCT01885559|284645|P2|STARTED|Overall Study||244
116234|NCT01885559|284646|P1|STARTED|Overall Study||242
116235|NCT01885208|284668|P2|NOT COMPLETED|Overall Study||38
116236|NCT01885208|284669|P1|NOT COMPLETED|Overall Study||32
116237|NCT01885208|284668|P2|COMPLETED|Overall Study||369
116238|NCT01885208|284669|P1|COMPLETED|Overall Study||374
116239|NCT01885208|284668|P2|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|85
116240|NCT01885208|284669|P1|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|82
116241|NCT01885208|284668|P2|Exposed|Overall Study||405
116242|NCT01885208|284669|P1|Exposed|Overall Study||404
116243|NCT01885208|284668|P2|STARTED|Overall Study||407
116244|NCT01885208|284669|P1|STARTED|Overall Study||406
116245|NCT01885182|284687|P2|NOT COMPLETED|Overall Study||22
116246|NCT01885182|284688|P1|NOT COMPLETED|Overall Study||34
116247|NCT01885182|284687|P2|COMPLETED|Overall Study||93
116248|NCT01885182|284688|P1|COMPLETED|Overall Study||83
116249|NCT01885182|284687|P2|FAP Population|Overall Study||106
116250|NCT01885182|284688|P1|FAP Population|Overall Study||107
116251|NCT01885182|284687|P2|Safety Population|Overall Study||111
116252|NCT01885182|284688|P1|Safety Population|Overall Study||114
116253|NCT01885182|284687|P2|STARTED|Overall Study||115
116254|NCT01885182|284688|P1|STARTED|Overall Study||117
116255|NCT01885117|284712|P2|NOT COMPLETED|Overall Study||0
116256|NCT01885117|284713|P1|NOT COMPLETED|Overall Study||0
116257|NCT01885117|284712|P2|COMPLETED|Overall Study||64
116258|NCT01885117|284713|P1|COMPLETED|Overall Study||61
116259|NCT01885117|284712|P2|STARTED|Overall Study||64
116260|NCT01885117|284713|P1|STARTED|Overall Study||61
116261|NCT01885104|284735|P2|NOT COMPLETED|Overall Study||1
116262|NCT01885104|284736|P1|NOT COMPLETED|Overall Study||2
116263|NCT01885104|284735|P2|COMPLETED|Overall Study||33
116264|NCT01885104|284736|P1|COMPLETED|Overall Study||29
116265|NCT01885104|284735|P2|STARTED|Overall Study||34
116266|NCT01885104|284736|P1|STARTED|Overall Study||31
116267|NCT01885000|284746|P2|NOT COMPLETED|Overall Study||2
116268|NCT01885000|284747|P1|NOT COMPLETED|Overall Study||2
116269|NCT01885000|284746|P2|COMPLETED|Overall Study||42
116270|NCT01885000|284747|P1|COMPLETED|Overall Study||46
116271|NCT01885000|284746|P2|STARTED|Overall Study||44
116272|NCT01885000|284747|P1|STARTED|Overall Study||48
116273|NCT01884844|284761|P2|NOT COMPLETED|Overall Study||5
116274|NCT01884844|284762|P1|NOT COMPLETED|Overall Study||3
116275|NCT01884844|284761|P2|COMPLETED|Overall Study||12
116276|NCT01884844|284762|P1|COMPLETED|Overall Study||13
116277|NCT01884844|284761|P2|STARTED|Overall Study||17
116278|NCT01884844|284762|P1|STARTED|Overall Study||16
116279|NCT01884688|284768|P1|NOT COMPLETED|Overall Study||2
116280|NCT01884688|284768|P1|COMPLETED|Overall Study||1
116281|NCT01884688|284768|P1|STARTED|Overall Study||3
116282|NCT01884675|284774|P2|NOT COMPLETED|Overall Study||2
116283|NCT01884675|284775|P1|NOT COMPLETED|Overall Study||3
116284|NCT01884675|284774|P2|COMPLETED|Overall Study||15
116285|NCT01884675|284775|P1|COMPLETED|Overall Study||13
116286|NCT01884675|284774|P2|STARTED|Overall Study||17
116287|NCT01884675|284775|P1|STARTED|Overall Study||16
116288|NCT01884597|284818|P3|NOT COMPLETED|Overall Study||1
116289|NCT01884597|284819|P2|NOT COMPLETED|Overall Study||1
116290|NCT01884597|284820|P1|NOT COMPLETED|Overall Study||1
116291|NCT01884597|284818|P3|COMPLETED|Overall Study||15
116292|NCT01884597|284819|P2|COMPLETED|Overall Study||2
116293|NCT01884597|284820|P1|COMPLETED|Overall Study||4
116294|NCT01884597|284818|P3|STARTED|Overall Study||16
116295|NCT01884597|284819|P2|STARTED|Overall Study||3
116296|NCT01884597|284820|P1|STARTED|Overall Study||5
116297|NCT01884571|284849|P1|NOT COMPLETED|Overall Study||8
116298|NCT01884571|284849|P1|COMPLETED|Overall Study||23
116299|NCT01884571|284849|P1|STARTED|Overall Study||31
116300|NCT01884545|284864|P4|NOT COMPLETED|Overall Study||9
116301|NCT01884545|284865|P3|NOT COMPLETED|Overall Study||14
116302|NCT01884545|284866|P2|NOT COMPLETED|Overall Study||18
116303|NCT01884545|284867|P1|NOT COMPLETED|Overall Study||13
116304|NCT01884545|284864|P4|COMPLETED|Overall Study||43
116305|NCT01884545|284865|P3|COMPLETED|Overall Study||35
116306|NCT01884545|284866|P2|COMPLETED|Overall Study||31
116307|NCT01884545|284867|P1|COMPLETED|Overall Study||37
116308|NCT01884545|284864|P4|STARTED|Overall Study||52
116309|NCT01884545|284865|P3|STARTED|Overall Study||49
116310|NCT01884545|284866|P2|STARTED|Overall Study||49
116311|NCT01884545|284867|P1|STARTED|Overall Study||50
116312|NCT01884519|284975|P2|NOT COMPLETED|Overall Study||0
116313|NCT01884519|284976|P1|NOT COMPLETED|Overall Study||0
116314|NCT01884519|284975|P2|COMPLETED|Overall Study||60
116315|NCT01884519|284976|P1|COMPLETED|Overall Study||60
116316|NCT01884519|284975|P2|STARTED|Overall Study||60
116317|NCT01884519|284976|P1|STARTED|Overall Study||60
116318|NCT01884350|285020|P3|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||11
116319|NCT01884350|285021|P2|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||13
116320|NCT01884350|285022|P1|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||80
116321|NCT01884350|285020|P3|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||250
116322|NCT01884350|285021|P2|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||250
116323|NCT01884350|285022|P1|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||503
116324|NCT01884350|285020|P3|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||223
116325|NCT01884350|285021|P2|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||308
116326|NCT01884350|285022|P1|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||604
116327|NCT01884350|285020|P3|STARTED|Primary Efficacy Analysis Set (48 Weeks)|After 24 weeks participants were randomized to continue AEP or stop AEP and revert to SOC.|261
116328|NCT01884350|285021|P2|STARTED|Primary Efficacy Analysis Set (48 Weeks)|After 24 weeks participants were randomized to continue AEP or stop AEP and revert to SOC.|263
116329|NCT01884350|285022|P1|STARTED|Primary Efficacy Analysis Set (48 Weeks)||583
116330|NCT01884350|285020|P3|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||0
116331|NCT01884350|285021|P2|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||54
116332|NCT01884350|285022|P1|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||54
116333|NCT01884350|285020|P3|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||0
116334|NCT01884350|285021|P2|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||525
116335|NCT01884350|285022|P1|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||529
116336|NCT01884350|285020|P3|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||0
116337|NCT01884350|285021|P2|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||558
116338|NCT01884350|285022|P1|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||604
116339|NCT01884350|285020|P3|STARTED|Primary Efficacy Analysis Set (24 Weeks)|Participants were not randomized to this arm until after initial 24-week period|0
116340|NCT01884350|285021|P2|STARTED|Primary Efficacy Analysis Set (24 Weeks)||579
116341|NCT01884350|285022|P1|STARTED|Primary Efficacy Analysis Set (24 Weeks)||583
116342|NCT01884337|285045|P2|NOT COMPLETED|Follow-up Period||1
116343|NCT01884337|285046|P1|NOT COMPLETED|Follow-up Period||1
116344|NCT01884337|285045|P2|COMPLETED|Follow-up Period||170
116345|NCT01884337|285046|P1|COMPLETED|Follow-up Period||323
116346|NCT01884337|285045|P2|STARTED|Follow-up Period||171
116347|NCT01884337|285046|P1|STARTED|Follow-up Period||324
116348|NCT01884337|285045|P2|NOT COMPLETED|Treatment||2
116349|NCT01884337|285046|P1|NOT COMPLETED|Treatment||4
116350|NCT01884337|285045|P2|COMPLETED|Treatment||170
116351|NCT01884337|285046|P1|COMPLETED|Treatment||322
116352|NCT01884337|285045|P2|Continuing Into Follow-up Period|Treatment||171
116353|NCT01884337|285046|P1|Continuing Into Follow-up Period|Treatment||324
116354|NCT01884337|285045|P2|STARTED|Treatment||172
116355|NCT01884337|285046|P1|STARTED|Treatment||326
116356|NCT01884311|285054|P1|NOT COMPLETED|Overall Study||5
116357|NCT01884311|285054|P1|COMPLETED|Overall Study||33
116358|NCT01884311|285054|P1|STARTED|Overall Study||38
116359|NCT01884077|285064|P2|NOT COMPLETED|Overall Study||10
116360|NCT01884077|285065|P1|NOT COMPLETED|Overall Study||8
116361|NCT01884077|285064|P2|COMPLETED|Overall Study||1
116362|NCT01884077|285065|P1|COMPLETED|Overall Study||0
116363|NCT01884077|285064|P2|STARTED|Overall Study||11
116364|NCT01884077|285065|P1|STARTED|Overall Study||8
116365|NCT01884064|285077|P2|NOT COMPLETED|Overall Study||0
116366|NCT01884064|285078|P1|NOT COMPLETED|Overall Study||0
116367|NCT01884064|285077|P2|COMPLETED|Overall Study||5
116368|NCT01884064|285078|P1|COMPLETED|Overall Study||12
116369|NCT01884064|285077|P2|STARTED|Overall Study||5
116370|NCT01884064|285078|P1|STARTED|Overall Study||12
116371|NCT01884025|285086|P2|NOT COMPLETED|Overall Study||4
116372|NCT01884025|285087|P1|NOT COMPLETED|Overall Study||3
116373|NCT01884025|285086|P2|COMPLETED|Overall Study||10
116374|NCT01884025|285087|P1|COMPLETED|Overall Study||10
116375|NCT01884025|285086|P2|STARTED|Overall Study||14
116376|NCT01884025|285087|P1|STARTED|Overall Study||13
116377|NCT01883999|285115|P1|NOT COMPLETED|Overall Study||3
116378|NCT01883999|285115|P1|COMPLETED|Overall Study||61
116379|NCT01883999|285115|P1|STARTED|Overall Study||64
116380|NCT01883986|285123|P2|NOT COMPLETED|Overall Study||1
116381|NCT01883986|285124|P1|NOT COMPLETED|Overall Study||3
116382|NCT01883986|285123|P2|COMPLETED|Overall Study|Completed study|19
116383|NCT01883986|285124|P1|COMPLETED|Overall Study|Received allocated intervention|17
116384|NCT01883986|285123|P2|Did Not Complete Study|Overall Study|Did not completed study|1
116385|NCT01883986|285124|P1|Did Not Complete Study|Overall Study||3
116386|NCT01883986|285123|P2|STARTED|Overall Study|Allocated to usual care arm|20
116387|NCT01883986|285124|P1|STARTED|Overall Study|Allocated to intervention arm|20
116388|NCT01883908|285138|P2|NOT COMPLETED|Overall Study||0
116389|NCT01883908|285139|P1|NOT COMPLETED|Overall Study||0
116390|NCT01883908|285138|P2|COMPLETED|Overall Study||1
116391|NCT01883908|285139|P1|COMPLETED|Overall Study||3
116392|NCT01883908|285138|P2|STARTED|Overall Study||1
116393|NCT01883908|285139|P1|STARTED|Overall Study||3
116394|NCT01883895|285147|P1|NOT COMPLETED|Overall Study||2
116395|NCT01883895|285147|P1|COMPLETED|Overall Study||32
116396|NCT01883895|285147|P1|STARTED|Overall Study||34
116397|NCT01883804|285152|P1|NOT COMPLETED|Overall Study||5
116398|NCT01883804|285152|P1|COMPLETED|Overall Study||20
116399|NCT01883804|285152|P1|STARTED|Overall Study||25
116400|NCT01883635|285161|P2|NOT COMPLETED|Overall Study||0
116401|NCT01883635|285162|P1|NOT COMPLETED|Overall Study||4
116402|NCT01883635|285161|P2|COMPLETED|Overall Study||20
116403|NCT01883635|285162|P1|COMPLETED|Overall Study||20
116404|NCT01883635|285161|P2|STARTED|Overall Study||20
116405|NCT01883635|285162|P1|STARTED|Overall Study||24
116406|NCT01883453|285176|P2|NOT COMPLETED|Overall Study||23
116407|NCT01883453|285177|P1|NOT COMPLETED|Overall Study||25
116408|NCT01883453|285176|P2|COMPLETED|Overall Study||50
116409|NCT01883453|285177|P1|COMPLETED|Overall Study||48
116410|NCT01883453|285176|P2|STARTED|Overall Study||73
116411|NCT01883453|285177|P1|STARTED|Overall Study||73
116412|NCT01883440|285185|P2|NOT COMPLETED|Overall Study||0
116413|NCT01883440|285186|P1|NOT COMPLETED|Overall Study||3
116414|NCT01883440|285185|P2|COMPLETED|Overall Study||45
116415|NCT01883440|285186|P1|COMPLETED|Overall Study||42
116416|NCT01883440|285185|P2|STARTED|Overall Study||45
116417|NCT01883440|285186|P1|STARTED|Overall Study||45
116418|NCT01883427|285196|P2|NOT COMPLETED|Overall Study||0
116419|NCT01883427|285197|P1|NOT COMPLETED|Overall Study||0
116420|NCT01883427|285196|P2|COMPLETED|Overall Study||20
116421|NCT01883427|285197|P1|COMPLETED|Overall Study||20
116422|NCT01883427|285196|P2|STARTED|Overall Study||20
116423|NCT01883427|285197|P1|STARTED|Overall Study||20
116424|NCT01883141|285203|P1|NOT COMPLETED|Overall Study||0
116425|NCT01883141|285203|P1|COMPLETED|Overall Study|Exit form with exit reason available|31
116426|NCT01883141|285203|P1|Multivein|Overall Study||23
116427|NCT01883141|285203|P1|Biv Pacing-Posterior|Overall Study||22
116428|NCT01883141|285203|P1|BiV Pacing-Anterior|Overall Study||23
116429|NCT01883141|285203|P1|Multispot-pacing|Overall Study||24
116430|NCT01883141|285203|P1|BiV Pacing-Standard Therapy|Overall Study||26
116431|NCT01883141|285203|P1|BiV Pacing-Mid|Overall Study||25
116432|NCT01883141|285203|P1|BiV Pacing-Distal|Overall Study||24
116433|NCT01883141|285203|P1|Usable EP Data|Overall Study||26
116434|NCT01883141|285203|P1|EP Study Performed|Overall Study||30
116435|NCT01883141|285203|P1|Passing Eligibility|Overall Study||30
116436|NCT01883141|285203|P1|STARTED|Overall Study||31
116437|NCT01882985|285212|P1|NOT COMPLETED|Overall Study||2
116438|NCT01882985|285212|P1|COMPLETED|Overall Study||12
116439|NCT01882985|285212|P1|STARTED|Overall Study||14
116440|NCT01882907|285221|P2|NOT COMPLETED|Overall Study||28
116441|NCT01882907|285222|P1|NOT COMPLETED|Overall Study||14
116442|NCT01882907|285221|P2|COMPLETED|Overall Study||83
116443|NCT01882907|285222|P1|COMPLETED|Overall Study||103
116444|NCT01882907|285221|P2|STARTED|Overall Study||111
116445|NCT01882907|285222|P1|STARTED|Overall Study||117
116446|NCT01882868|285238|P1|NOT COMPLETED|Overall Study||0
116447|NCT01882868|285238|P1|COMPLETED|Overall Study||62
116448|NCT01882868|285238|P1|STARTED|Overall Study||62
116449|NCT01882829|285268|P1|NOT COMPLETED|Overall Study||6
116450|NCT01882829|285268|P1|COMPLETED|Overall Study||14
116451|NCT01882829|285268|P1|STARTED|Overall Study||20
116452|NCT01882803|285282|P1|NOT COMPLETED|Overall Study||94
116453|NCT01882803|285282|P1|COMPLETED|Overall Study|Subject received treatment in 28-day cycles until disease progression or unacceptable toxicity.|35
116454|NCT01882803|285282|P1|STARTED|Overall Study||129
116455|NCT01882725|285293|P1|NOT COMPLETED|Overall Study||0
116456|NCT01882725|285293|P1|COMPLETED|Overall Study||14
116457|NCT01882725|285293|P1|STARTED|Overall Study||14
116458|NCT01882647|285300|P2|NOT COMPLETED|Overall Study||6
116459|NCT01882647|285301|P1|NOT COMPLETED|Overall Study||2
116460|NCT01882647|285300|P2|COMPLETED|Overall Study||106
116461|NCT01882647|285301|P1|COMPLETED|Overall Study||108
116462|NCT01882647|285300|P2|STARTED|Overall Study||112
116463|NCT01882647|285301|P1|STARTED|Overall Study||110
116464|NCT01882543|285319|P2|NOT COMPLETED|Overall Study||3
116465|NCT01882543|285320|P1|NOT COMPLETED|Overall Study||4
116466|NCT01882543|285319|P2|COMPLETED|Overall Study||29
116467|NCT01882543|285320|P1|COMPLETED|Overall Study||33
116468|NCT01882543|285319|P2|STARTED|Overall Study||32
116469|NCT01882543|285320|P1|STARTED|Overall Study||37
116470|NCT01882465|285341|P7|NOT COMPLETED|Period 3||0
116471|NCT01882465|285342|P6|NOT COMPLETED|Period 3||0
116472|NCT01882465|285343|P5|NOT COMPLETED|Period 3||0
116473|NCT01882465|285344|P4|NOT COMPLETED|Period 3||0
116474|NCT01882465|285345|P3|NOT COMPLETED|Period 3||0
116475|NCT01882465|285346|P2|NOT COMPLETED|Period 3||0
116476|NCT01882465|285347|P1|NOT COMPLETED|Period 3||0
116477|NCT01882465|285341|P7|COMPLETED|Period 3||0
116478|NCT01882465|285342|P6|COMPLETED|Period 3||5
116479|NCT01882465|285343|P5|COMPLETED|Period 3||4
116480|NCT01882465|285344|P4|COMPLETED|Period 3||5
116481|NCT01882465|285345|P3|COMPLETED|Period 3||5
116482|NCT01882465|285346|P2|COMPLETED|Period 3||6
116483|NCT01882465|285347|P1|COMPLETED|Period 3||6
116484|NCT01882465|285341|P7|STARTED|Period 3||0
116485|NCT01882465|285342|P6|STARTED|Period 3||5
116486|NCT01882465|285343|P5|STARTED|Period 3||4
116487|NCT01882465|285344|P4|STARTED|Period 3||5
116488|NCT01882465|285345|P3|STARTED|Period 3||5
116489|NCT01882465|285346|P2|STARTED|Period 3||6
116490|NCT01882465|285347|P1|STARTED|Period 3||6
116491|NCT01882465|285341|P7|NOT COMPLETED|Period 2||0
116492|NCT01882465|285342|P6|NOT COMPLETED|Period 2||0
116493|NCT01882465|285343|P5|NOT COMPLETED|Period 2||1
116494|NCT01882465|285344|P4|NOT COMPLETED|Period 2||0
116495|NCT01882465|285345|P3|NOT COMPLETED|Period 2||0
116496|NCT01882465|285346|P2|NOT COMPLETED|Period 2||0
116497|NCT01882465|285347|P1|NOT COMPLETED|Period 2||0
116498|NCT01882465|285341|P7|COMPLETED|Period 2||0
116499|NCT01882465|285342|P6|COMPLETED|Period 2||5
116500|NCT01882465|285343|P5|COMPLETED|Period 2||4
116501|NCT01882465|285344|P4|COMPLETED|Period 2||5
116502|NCT01882465|285345|P3|COMPLETED|Period 2||5
116503|NCT01882465|285346|P2|COMPLETED|Period 2||6
116504|NCT01882465|285347|P1|COMPLETED|Period 2||6
116505|NCT01882465|285341|P7|STARTED|Period 2||0
116506|NCT01882465|285342|P6|STARTED|Period 2||5
116507|NCT01882465|285343|P5|STARTED|Period 2||5
116508|NCT01882465|285344|P4|STARTED|Period 2||5
116509|NCT01882465|285345|P3|STARTED|Period 2||5
116510|NCT01882465|285346|P2|STARTED|Period 2||6
116511|NCT01882465|285347|P1|STARTED|Period 2||6
116512|NCT01882465|285341|P7|NOT COMPLETED|Period 1||1
116513|NCT01882465|285342|P6|NOT COMPLETED|Period 1||0
116514|NCT01882465|285343|P5|NOT COMPLETED|Period 1||0
116515|NCT01882465|285344|P4|NOT COMPLETED|Period 1||1
116516|NCT01882465|285345|P3|NOT COMPLETED|Period 1||0
116517|NCT01882465|285346|P2|NOT COMPLETED|Period 1||0
116518|NCT01882465|285347|P1|NOT COMPLETED|Period 1||0
116519|NCT01882465|285341|P7|COMPLETED|Period 1||0
116520|NCT01882465|285342|P6|COMPLETED|Period 1||5
116521|NCT01882465|285343|P5|COMPLETED|Period 1||5
116522|NCT01882465|285344|P4|COMPLETED|Period 1||5
116523|NCT01882465|285345|P3|COMPLETED|Period 1||5
116524|NCT01882465|285346|P2|COMPLETED|Period 1||6
116525|NCT01882465|285347|P1|COMPLETED|Period 1||6
116526|NCT01882465|285341|P7|STARTED|Period 1||1
116527|NCT01882465|285342|P6|STARTED|Period 1||5
116528|NCT01882465|285343|P5|STARTED|Period 1||5
116529|NCT01882465|285344|P4|STARTED|Period 1||6
116530|NCT01882465|285345|P3|STARTED|Period 1||5
116531|NCT01882465|285346|P2|STARTED|Period 1||6
116532|NCT01882465|285347|P1|STARTED|Period 1||6
116533|NCT01882439|285359|P4|NOT COMPLETED|Overall Study||9
116534|NCT01882439|285360|P3|NOT COMPLETED|Overall Study||10
116535|NCT01882439|285361|P2|NOT COMPLETED|Overall Study||21
116536|NCT01882439|285362|P1|NOT COMPLETED|Overall Study||9
116537|NCT01882439|285359|P4|COMPLETED|Overall Study||56
116538|NCT01882439|285360|P3|COMPLETED|Overall Study||56
116539|NCT01882439|285361|P2|COMPLETED|Overall Study||111
116540|NCT01882439|285362|P1|COMPLETED|Overall Study||122
116541|NCT01882439|285359|P4|STARTED|Overall Study|Received treatment|65
116542|NCT01882439|285360|P3|STARTED|Overall Study|Received treatment|66
116543|NCT01882439|285361|P2|STARTED|Overall Study|Received treatment|132
116544|NCT01882439|285362|P1|STARTED|Overall Study|Received treatment|131
116545|NCT01882413|285542|P1|NOT COMPLETED|Overall Study||0
116546|NCT01882413|285542|P1|COMPLETED|Overall Study||204
116547|NCT01882413|285542|P1|STARTED|Overall Study||204
116548|NCT01882257|285559|P3|NOT COMPLETED|Therapy Portion of Study (12 Months)||4
116549|NCT01882257|285560|P2|NOT COMPLETED|Therapy Portion of Study (12 Months)||11
116550|NCT01882257|285561|P1|NOT COMPLETED|Therapy Portion of Study (12 Months)||0
116551|NCT01882257|285559|P3|COMPLETED|Therapy Portion of Study (12 Months)||18
116552|NCT01882257|285560|P2|COMPLETED|Therapy Portion of Study (12 Months)||27
116553|NCT01882257|285561|P1|COMPLETED|Therapy Portion of Study (12 Months)||11
116554|NCT01882257|285559|P3|STARTED|Therapy Portion of Study (12 Months)||22
116555|NCT01882257|285560|P2|STARTED|Therapy Portion of Study (12 Months)||38
116556|NCT01882257|285561|P1|STARTED|Therapy Portion of Study (12 Months)||11
116557|NCT01882257|285559|P3|NOT COMPLETED|Study Origination to Beginning Therapy||1
116558|NCT01882257|285560|P2|NOT COMPLETED|Study Origination to Beginning Therapy||2
116559|NCT01882257|285561|P1|NOT COMPLETED|Study Origination to Beginning Therapy||0
116560|NCT01882257|285559|P3|COMPLETED|Study Origination to Beginning Therapy||22
116561|NCT01882257|285560|P2|COMPLETED|Study Origination to Beginning Therapy||38
116562|NCT01882257|285561|P1|COMPLETED|Study Origination to Beginning Therapy||11
116563|NCT01882257|285559|P3|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 23 who were given the device, 1 chose not to begin the actual therapy|22
116564|NCT01882257|285560|P2|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 40 who were given the device, 2 chose not to begin the actual therapy|38
116565|NCT01882257|285561|P1|Started Therapy Using Device|Study Origination to Beginning Therapy||11
116566|NCT01882257|285559|P3|STARTED|Study Origination to Beginning Therapy||23
116567|NCT01882257|285560|P2|STARTED|Study Origination to Beginning Therapy||40
116568|NCT01882257|285561|P1|STARTED|Study Origination to Beginning Therapy||11
116569|NCT01882088|285568|P1|NOT COMPLETED|Overall Study||5
116570|NCT01882088|285568|P1|COMPLETED|Overall Study||30
116571|NCT01882088|285568|P1|STARTED|Overall Study|35 patients were provided with psyllium in 5.0 sachets, 3 sachets per day for 10 days|35
116572|NCT01882062|285581|P1|NOT COMPLETED|Overall Study||0
116573|NCT01882062|285581|P1|COMPLETED|Overall Study|18th of july 2013|10
116574|NCT01882062|285581|P1|STARTED|Overall Study|16th of may 2013|10
116575|NCT01881984|285585|P1|NOT COMPLETED|Overall Study||0
116576|NCT01881984|285585|P1|COMPLETED|Overall Study||4
116577|NCT01881984|285585|P1|STARTED|Overall Study||4
116578|NCT01881932|285593|P3|NOT COMPLETED|Overall Study||0
116579|NCT01881932|285594|P2|NOT COMPLETED|Overall Study||0
116580|NCT01881932|285595|P1|NOT COMPLETED|Overall Study||0
116581|NCT01881932|285593|P3|COMPLETED|Overall Study||13
116582|NCT01881932|285594|P2|COMPLETED|Overall Study||4
116583|NCT01881932|285595|P1|COMPLETED|Overall Study||2
116584|NCT01881932|285593|P3|STARTED|Overall Study||13
116585|NCT01881932|285594|P2|STARTED|Overall Study||4
116586|NCT01881932|285595|P1|STARTED|Overall Study||2
116587|NCT01881867|285605|P2|NOT COMPLETED|Overall Study||13
116588|NCT01881867|285606|P1|NOT COMPLETED|Overall Study||12
116589|NCT01881867|285605|P2|COMPLETED|Overall Study||15
116590|NCT01881867|285606|P1|COMPLETED|Overall Study||14
116591|NCT01881867|285605|P2|STARTED|Overall Study||28
116592|NCT01881867|285606|P1|STARTED|Overall Study||26
116593|NCT01881828|285626|P2|NOT COMPLETED|Overall Study||0
116594|NCT01881828|285627|P1|NOT COMPLETED|Overall Study||0
116595|NCT01881828|285626|P2|COMPLETED|Overall Study||69
116596|NCT01881828|285627|P1|COMPLETED|Overall Study||71
116597|NCT01881828|285626|P2|STARTED|Overall Study|23 excluded from randomization from enrollment|69
116598|NCT01881828|285627|P1|STARTED|Overall Study|23 excluded at randomization from enrollment|71
116599|NCT01881776|285650|P3|NOT COMPLETED|Overall Study||2
116600|NCT01881776|285651|P2|NOT COMPLETED|Overall Study||4
116601|NCT01881776|285652|P1|NOT COMPLETED|Overall Study||1
116602|NCT01881776|285650|P3|COMPLETED|Overall Study||20
116603|NCT01881776|285651|P2|COMPLETED|Overall Study||20
116604|NCT01881776|285652|P1|COMPLETED|Overall Study||23
116605|NCT01881776|285650|P3|STARTED|Overall Study||22
116606|NCT01881776|285651|P2|STARTED|Overall Study||24
116607|NCT01881776|285652|P1|STARTED|Overall Study||24
116608|NCT01881750|285680|P2|NOT COMPLETED|Overall Study||4
116609|NCT01881750|285681|P1|NOT COMPLETED|Overall Study||2
116610|NCT01881750|285680|P2|COMPLETED|Overall Study||22
116611|NCT01881750|285681|P1|COMPLETED|Overall Study||25
116612|NCT01881750|285680|P2|STARTED|Overall Study||26
116613|NCT01881750|285681|P1|STARTED|Overall Study||27
116614|NCT01881737|285699|P1|NOT COMPLETED|Overall Study||5
116615|NCT01881737|285699|P1|COMPLETED|Overall Study||10
116616|NCT01881737|285699|P1|Number Screened|Overall Study||15
116617|NCT01881737|285699|P1|STARTED|Overall Study|This is a pilot study|15
116618|NCT01881620|285708|P1|NOT COMPLETED|Overall Study||4
116619|NCT01881620|285708|P1|COMPLETED|Overall Study|Eligible patients with PET-CT scanner performed AND interpretation of 2 pairs of observors available|105
116620|NCT01881620|285708|P1|STARTED|Overall Study||109
116621|NCT01881230|285720|P3|NOT COMPLETED|Overall Study||66
116622|NCT01881230|285721|P2|NOT COMPLETED|Overall Study||64
116623|NCT01881230|285722|P1|NOT COMPLETED|Overall Study||61
116624|NCT01881230|285720|P3|COMPLETED|Overall Study|Not applicable according to the study design|0
116625|NCT01881230|285721|P2|COMPLETED|Overall Study|Not applicable according to the study design|0
116626|NCT01881230|285722|P1|COMPLETED|Overall Study|Not applicable according to the study design|0
116627|NCT01881230|285720|P3|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
116628|NCT01881230|285721|P2|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
116629|NCT01881230|285722|P1|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|60
116630|NCT01881230|285720|P3|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
116631|NCT01881230|285721|P2|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
116632|NCT01881230|285722|P1|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of Investigational Product (IP)|60
116633|NCT01881230|285720|P3|STARTED|Overall Study||66
116634|NCT01881230|285721|P2|STARTED|Overall Study||64
116635|NCT01881230|285722|P1|STARTED|Overall Study||61
116636|NCT01881126|285750|P2|NOT COMPLETED|Overall Study||2
116637|NCT01881126|285751|P1|NOT COMPLETED|Overall Study||1
116638|NCT01881126|285750|P2|COMPLETED|Overall Study||44
116639|NCT01881126|285751|P1|COMPLETED|Overall Study||46
116640|NCT01881126|285750|P2|STARTED|Overall Study||46
116641|NCT01881126|285751|P1|STARTED|Overall Study||47
116642|NCT01881113|285759|P2|NOT COMPLETED|Overall Study||6
116643|NCT01881113|285760|P1|NOT COMPLETED|Overall Study||8
116644|NCT01881113|285759|P2|COMPLETED|Overall Study||44
116645|NCT01881113|285760|P1|COMPLETED|Overall Study||43
116646|NCT01881113|285759|P2|STARTED|Overall Study||50
116647|NCT01881113|285760|P1|STARTED|Overall Study||51
116648|NCT01881087|285817|P3|NOT COMPLETED|Overall Study||2
116649|NCT01881087|285818|P2|NOT COMPLETED|Overall Study||0
116650|NCT01881087|285819|P1|NOT COMPLETED|Overall Study||1
116651|NCT01881087|285817|P3|COMPLETED|Overall Study||60
116652|NCT01881087|285818|P2|COMPLETED|Overall Study||61
116653|NCT01881087|285819|P1|COMPLETED|Overall Study||59
116654|NCT01881087|285817|P3|STARTED|Overall Study||62
116655|NCT01881087|285818|P2|STARTED|Overall Study||61
116656|NCT01881087|285819|P1|STARTED|Overall Study||60
116657|NCT01881009|285832|P2|NOT COMPLETED|Summer Camp Session (6 Days)||1
116658|NCT01881009|285833|P1|NOT COMPLETED|Summer Camp Session (6 Days)||0
116659|NCT01881009|285832|P2|COMPLETED|Summer Camp Session (6 Days)||21
116660|NCT01881009|285833|P1|COMPLETED|Summer Camp Session (6 Days)||0
116661|NCT01881009|285832|P2|STARTED|Summer Camp Session (6 Days)||22
116662|NCT01881009|285833|P1|STARTED|Summer Camp Session (6 Days)||0
116663|NCT01881009|285832|P2|NOT COMPLETED|Inpatient Safety Testing (22 Hours)||0
116664|NCT01881009|285833|P1|NOT COMPLETED|Inpatient Safety Testing (22 Hours)||0
116665|NCT01881009|285832|P2|COMPLETED|Inpatient Safety Testing (22 Hours)||0
116666|NCT01881009|285833|P1|COMPLETED|Inpatient Safety Testing (22 Hours)||16
116667|NCT01881009|285832|P2|STARTED|Inpatient Safety Testing (22 Hours)||0
116668|NCT01881009|285833|P1|STARTED|Inpatient Safety Testing (22 Hours)||16
116669|NCT01880840|285844|P2|NOT COMPLETED|Overall Study||5
116670|NCT01880840|285845|P1|NOT COMPLETED|Overall Study||8
116671|NCT01880840|285844|P2|COMPLETED|Overall Study||91
116672|NCT01880840|285845|P1|COMPLETED|Overall Study||87
116673|NCT01880840|285844|P2|STARTED|Overall Study||96
116674|NCT01880840|285845|P1|STARTED|Overall Study||95
116675|NCT01880736|285855|P4|NOT COMPLETED|Overall Study||6
116676|NCT01880736|285856|P3|NOT COMPLETED|Overall Study||1
116677|NCT01880736|285857|P2|NOT COMPLETED|Overall Study||2
116678|NCT01880736|285858|P1|NOT COMPLETED|Overall Study||1
116679|NCT01880736|285855|P4|COMPLETED|Overall Study||108
116680|NCT01880736|285856|P3|COMPLETED|Overall Study||114
116681|NCT01880736|285857|P2|COMPLETED|Overall Study||113
116682|NCT01880736|285858|P1|COMPLETED|Overall Study||113
116683|NCT01880736|285855|P4|STARTED|Overall Study||114
116684|NCT01880736|285856|P3|STARTED|Overall Study||115
116685|NCT01880736|285857|P2|STARTED|Overall Study||115
116686|NCT01880736|285858|P1|STARTED|Overall Study||114
116687|NCT01880723|285902|P2|NOT COMPLETED|Overall Study||0
116688|NCT01880723|285903|P1|NOT COMPLETED|Overall Study||0
116689|NCT01880723|285902|P2|COMPLETED|Overall Study||16
116690|NCT01880723|285903|P1|COMPLETED|Overall Study||16
116691|NCT01880723|285902|P2|STARTED|Overall Study||16
116692|NCT01880723|285903|P1|STARTED|Overall Study||16
116693|NCT01880697|285919|P2|NOT COMPLETED|Overall Study||1
116694|NCT01880697|285920|P1|NOT COMPLETED|Overall Study||0
116695|NCT01880697|285919|P2|COMPLETED|Overall Study||62
116696|NCT01880697|285920|P1|COMPLETED|Overall Study||63
116697|NCT01880697|285919|P2|STARTED|Overall Study||63
116698|NCT01880697|285920|P1|STARTED|Overall Study||63
116699|NCT01880593|285942|P2|NOT COMPLETED|Overall Study||6
116700|NCT01880593|285943|P1|NOT COMPLETED|Overall Study||8
116701|NCT01880593|285942|P2|COMPLETED|Overall Study||10
116702|NCT01880593|285943|P1|COMPLETED|Overall Study||10
116703|NCT01880593|285942|P2|STARTED|Overall Study||16
116704|NCT01880593|285943|P1|STARTED|Overall Study||18
116705|NCT01880528|285963|P2|NOT COMPLETED|Overall Study||1
116706|NCT01880528|285964|P1|NOT COMPLETED|Overall Study||1
116707|NCT01880528|285963|P2|COMPLETED|Overall Study||10
116708|NCT01880528|285964|P1|COMPLETED|Overall Study||11
116709|NCT01880528|285963|P2|STARTED|Overall Study||11
116710|NCT01880528|285964|P1|STARTED|Overall Study||12
116711|NCT01880515|285980|P2|NOT COMPLETED|Overall Study||9
116712|NCT01880515|285981|P1|NOT COMPLETED|Overall Study||8
116713|NCT01880515|285980|P2|COMPLETED|Overall Study||45
116714|NCT01880515|285981|P1|COMPLETED|Overall Study||45
116715|NCT01880515|285980|P2|STARTED|Overall Study||54
116716|NCT01880515|285981|P1|STARTED|Overall Study||53
116717|NCT01880437|285992|P3|NOT COMPLETED|Overall Study||19
116718|NCT01880437|285993|P2|NOT COMPLETED|Overall Study||4
116719|NCT01880437|285994|P1|NOT COMPLETED|Overall Study||15
116720|NCT01880437|285992|P3|COMPLETED|Overall Study||0
116721|NCT01880437|285993|P2|COMPLETED|Overall Study||0
116722|NCT01880437|285994|P1|COMPLETED|Overall Study||0
116723|NCT01880437|285992|P3|STARTED|Overall Study||19
116724|NCT01880437|285993|P2|STARTED|Overall Study||4
116725|NCT01880437|285994|P1|STARTED|Overall Study||15
116726|NCT01880424|286020|P2|NOT COMPLETED|Overall Study||55
116727|NCT01880424|286021|P1|NOT COMPLETED|Overall Study||33
116728|NCT01880424|286020|P2|COMPLETED|Overall Study||367
116729|NCT01880424|286021|P1|COMPLETED|Overall Study||384
116730|NCT01880424|286020|P2|STARTED|Overall Study||422
116731|NCT01880424|286021|P1|STARTED|Overall Study||417
116732|NCT01880320|286046|P3|NOT COMPLETED|Overall Study||8
116733|NCT01880320|286047|P2|NOT COMPLETED|Overall Study||25
116734|NCT01880320|286048|P1|NOT COMPLETED|Overall Study||20
116735|NCT01880320|286046|P3|COMPLETED|Overall Study||61
116736|NCT01880320|286047|P2|COMPLETED|Overall Study||192
116737|NCT01880320|286048|P1|COMPLETED|Overall Study||197
116738|NCT01880320|286046|P3|STARTED|Overall Study||69
116739|NCT01880320|286047|P2|STARTED|Overall Study||217
116740|NCT01880320|286048|P1|STARTED|Overall Study||217
116741|NCT01880099|286065|P3|NOT COMPLETED|Overall Study||7
116742|NCT01880099|286066|P2|NOT COMPLETED|Overall Study||10
116743|NCT01880099|286067|P1|NOT COMPLETED|Overall Study||8
116744|NCT01880099|286065|P3|COMPLETED|Overall Study||15
116745|NCT01880099|286066|P2|COMPLETED|Overall Study||11
116746|NCT01880099|286067|P1|COMPLETED|Overall Study||9
116747|NCT01880099|286065|P3|STARTED|Overall Study||22
116748|NCT01880099|286066|P2|STARTED|Overall Study||21
116749|NCT01880099|286067|P1|STARTED|Overall Study||17
116750|NCT01880086|286077|P2|NOT COMPLETED|Overall Study||1
116751|NCT01880086|286078|P1|NOT COMPLETED|Overall Study||1
116752|NCT01880086|286077|P2|COMPLETED|Overall Study||6
116753|NCT01880086|286078|P1|COMPLETED|Overall Study||5
116754|NCT01880086|286077|P2|STARTED|Overall Study||7
116755|NCT01880086|286078|P1|STARTED|Overall Study||6
116756|NCT01880047|286100|P4|NOT COMPLETED|Extension Phase - 18 Months||2
116757|NCT01880047|286101|P3|NOT COMPLETED|Extension Phase - 18 Months||1
116758|NCT01880047|286102|P2|NOT COMPLETED|Extension Phase - 18 Months||3
116759|NCT01880047|286103|P1|NOT COMPLETED|Extension Phase - 18 Months||9
116760|NCT01880047|286100|P4|COMPLETED|Extension Phase - 18 Months||0
116761|NCT01880047|286101|P3|COMPLETED|Extension Phase - 18 Months||3
116762|NCT01880047|286102|P2|COMPLETED|Extension Phase - 18 Months||3
116763|NCT01880047|286103|P1|COMPLETED|Extension Phase - 18 Months||6
116764|NCT01880047|286100|P4|STARTED|Extension Phase - 18 Months|2 subjects went into extension phase, were followed for variable periods of time|2
116765|NCT01880047|286101|P3|STARTED|Extension Phase - 18 Months|4 subjects went into extension phase, were followed for variable periods of time|4
116766|NCT01880047|286102|P2|STARTED|Extension Phase - 18 Months|6 subjects went into extension phase, were followed for variable periods of time|6
116767|NCT01880047|286103|P1|STARTED|Extension Phase - 18 Months|15 subjects went into extension phase, were followed for variable periods of time|15
116768|NCT01880047|286100|P4|NOT COMPLETED|Weeks 5-8||0
116769|NCT01880047|286101|P3|NOT COMPLETED|Weeks 5-8||0
116770|NCT01880047|286102|P2|NOT COMPLETED|Weeks 5-8||1
116771|NCT01880047|286103|P1|NOT COMPLETED|Weeks 5-8||2
116772|NCT01880047|286100|P4|COMPLETED|Weeks 5-8||2
116773|NCT01880047|286101|P3|COMPLETED|Weeks 5-8||4
116774|NCT01880047|286102|P2|COMPLETED|Weeks 5-8||6
116775|NCT01880047|286103|P1|COMPLETED|Weeks 5-8||15
116776|NCT01880047|286100|P4|STARTED|Weeks 5-8||2
116777|NCT01880047|286101|P3|STARTED|Weeks 5-8||4
116778|NCT01880047|286102|P2|STARTED|Weeks 5-8||7
116779|NCT01880047|286103|P1|STARTED|Weeks 5-8||17
116780|NCT01880047|286100|P4|NOT COMPLETED|Weeks 3-4||0
116781|NCT01880047|286101|P3|NOT COMPLETED|Weeks 3-4||0
116782|NCT01880047|286102|P2|NOT COMPLETED|Weeks 3-4||1
116783|NCT01880047|286103|P1|NOT COMPLETED|Weeks 3-4||0
116784|NCT01880047|286100|P4|COMPLETED|Weeks 3-4||2
116785|NCT01880047|286101|P3|COMPLETED|Weeks 3-4||4
116786|NCT01880047|286102|P2|COMPLETED|Weeks 3-4||7
116787|NCT01880047|286103|P1|COMPLETED|Weeks 3-4||17
116788|NCT01880047|286100|P4|STARTED|Weeks 3-4||2
116789|NCT01880047|286101|P3|STARTED|Weeks 3-4||4
116790|NCT01880047|286102|P2|STARTED|Weeks 3-4||8
116791|NCT01880047|286103|P1|STARTED|Weeks 3-4||17
116792|NCT01880047|286100|P4|NOT COMPLETED|Weeks 0-2||1
116793|NCT01880047|286101|P3|NOT COMPLETED|Weeks 0-2||1
116794|NCT01880047|286102|P2|NOT COMPLETED|Weeks 0-2||1
116795|NCT01880047|286103|P1|NOT COMPLETED|Weeks 0-2||0
116796|NCT01880047|286100|P4|COMPLETED|Weeks 0-2||2
116797|NCT01880047|286101|P3|COMPLETED|Weeks 0-2||4
116798|NCT01880047|286102|P2|COMPLETED|Weeks 0-2||8
116799|NCT01880047|286103|P1|COMPLETED|Weeks 0-2||17
116800|NCT01880047|286100|P4|STARTED|Weeks 0-2||3
116801|NCT01880047|286101|P3|STARTED|Weeks 0-2||5
116802|NCT01880047|286102|P2|STARTED|Weeks 0-2||9
116803|NCT01880047|286103|P1|STARTED|Weeks 0-2||17
116804|NCT01879852|286126|P2|NOT COMPLETED|Overall Study||0
116805|NCT01879852|286127|P1|NOT COMPLETED|Overall Study||2
116806|NCT01879852|286126|P2|COMPLETED|Overall Study||13
116807|NCT01879852|286127|P1|COMPLETED|Overall Study||12
116808|NCT01879852|286126|P2|STARTED|Overall Study||13
116809|NCT01879852|286127|P1|STARTED|Overall Study||14
116810|NCT01879800|286141|P2|NOT COMPLETED|Overall Study||4
116811|NCT01879800|286142|P1|NOT COMPLETED|Overall Study||0
116812|NCT01879800|286141|P2|COMPLETED|Overall Study||26
116813|NCT01879800|286142|P1|COMPLETED|Overall Study||14
116814|NCT01879800|286141|P2|STARTED|Overall Study||30
116815|NCT01879800|286142|P1|STARTED|Overall Study||14
116816|NCT01879735|286154|P2|NOT COMPLETED|Overall Study||0
116817|NCT01879735|286155|P1|NOT COMPLETED|Overall Study||0
116818|NCT01879735|286154|P2|COMPLETED|Overall Study||16
116819|NCT01879735|286155|P1|COMPLETED|Overall Study||6
116820|NCT01879735|286154|P2|STARTED|Overall Study||16
116821|NCT01879735|286155|P1|STARTED|Overall Study||6
116822|NCT01879722|286171|P10|NOT COMPLETED|Overall Study||0
116823|NCT01879722|286172|P9|NOT COMPLETED|Overall Study||2
116824|NCT01879722|286173|P8|NOT COMPLETED|Overall Study||1
116825|NCT01879722|286174|P7|NOT COMPLETED|Overall Study||0
116826|NCT01879722|286175|P6|NOT COMPLETED|Overall Study||0
116827|NCT01879722|286176|P5|NOT COMPLETED|Overall Study||1
116828|NCT01879722|286177|P4|NOT COMPLETED|Overall Study||1
116829|NCT01879722|286178|P3|NOT COMPLETED|Overall Study||0
116830|NCT01879722|286179|P2|NOT COMPLETED|Overall Study||1
116831|NCT01879722|286180|P1|NOT COMPLETED|Overall Study||0
116832|NCT01879722|286171|P10|COMPLETED|Overall Study||6
116833|NCT01879722|286172|P9|COMPLETED|Overall Study||6
116834|NCT01879722|286173|P8|COMPLETED|Overall Study||7
116835|NCT01879722|286174|P7|COMPLETED|Overall Study||8
116836|NCT01879722|286175|P6|COMPLETED|Overall Study||9
116837|NCT01879722|286176|P5|COMPLETED|Overall Study||7
116838|NCT01879722|286177|P4|COMPLETED|Overall Study||7
116839|NCT01879722|286178|P3|COMPLETED|Overall Study||7
116840|NCT01879722|286179|P2|COMPLETED|Overall Study||7
116841|NCT01879722|286180|P1|COMPLETED|Overall Study||7
116842|NCT01879722|286171|P10|STARTED|Overall Study||6
116843|NCT01879722|286172|P9|STARTED|Overall Study||8
116844|NCT01879722|286173|P8|STARTED|Overall Study||8
116845|NCT01879722|286174|P7|STARTED|Overall Study||8
116846|NCT01879722|286175|P6|STARTED|Overall Study||9
116847|NCT01879722|286176|P5|STARTED|Overall Study||8
116848|NCT01879722|286177|P4|STARTED|Overall Study||8
116849|NCT01879722|286178|P3|STARTED|Overall Study||7
116850|NCT01879722|286179|P2|STARTED|Overall Study||8
116851|NCT01879722|286180|P1|STARTED|Overall Study||7
116852|NCT01879683|286328|P1|NOT COMPLETED|Overall Study||1
116853|NCT01879683|286328|P1|COMPLETED|Overall Study||9
116854|NCT01879683|286328|P1|STARTED|Overall Study||10
116855|NCT01879618|286335|P1|NOT COMPLETED|Overall Study||21
116856|NCT01879618|286335|P1|COMPLETED|Overall Study||131
116857|NCT01879618|286335|P1|STARTED|Overall Study||152
116858|NCT01879579|286342|P2|NOT COMPLETED|Overall Study||2
116859|NCT01879579|286343|P1|NOT COMPLETED|Overall Study||5
116860|NCT01879579|286342|P2|COMPLETED|Overall Study||26
116861|NCT01879579|286343|P1|COMPLETED|Overall Study||28
116862|NCT01879579|286342|P2|STARTED|Overall Study||28
116863|NCT01879579|286343|P1|STARTED|Overall Study||33
116864|NCT01879553|286373|P2|NOT COMPLETED|Overall Study||0
116865|NCT01879553|286374|P1|NOT COMPLETED|Overall Study||1
116866|NCT01879553|286373|P2|COMPLETED|Overall Study||63
116867|NCT01879553|286374|P1|COMPLETED|Overall Study||62
116868|NCT01879553|286373|P2|STARTED|Overall Study||63
116869|NCT01879553|286374|P1|STARTED|Overall Study||63
116870|NCT01879540|286395|P1|NOT COMPLETED|Overall Study||0
116871|NCT01879540|286395|P1|COMPLETED|Overall Study||63
116872|NCT01879540|286395|P1|STARTED|Overall Study||63
116873|NCT01879410|286408|P2|NOT COMPLETED|Overall Study||38
116874|NCT01879410|286409|P1|NOT COMPLETED|Overall Study||24
116875|NCT01879410|286408|P2|COMPLETED|Overall Study||312
116876|NCT01879410|286409|P1|COMPLETED|Overall Study||326
116877|NCT01879410|286408|P2|Intent-to-Treat Population|Overall Study||348
116878|NCT01879410|286409|P1|Intent-to-Treat Population|Overall Study||349
116879|NCT01879410|286408|P2|STARTED|Overall Study||350
116880|NCT01879410|286409|P1|STARTED|Overall Study||350
116881|NCT01879371|286423|P6|NOT COMPLETED|Overall Study||0
116882|NCT01879371|286424|P5|NOT COMPLETED|Overall Study||0
116883|NCT01879371|286425|P4|NOT COMPLETED|Overall Study||0
116884|NCT01879371|286426|P3|NOT COMPLETED|Overall Study||0
116885|NCT01879371|286427|P2|NOT COMPLETED|Overall Study||0
116886|NCT01879371|286428|P1|NOT COMPLETED|Overall Study||0
116887|NCT01879371|286423|P6|COMPLETED|Overall Study||6
116888|NCT01879371|286424|P5|COMPLETED|Overall Study||6
116889|NCT01879371|286425|P4|COMPLETED|Overall Study||6
116890|NCT01879371|286426|P3|COMPLETED|Overall Study||6
116891|NCT01879371|286427|P2|COMPLETED|Overall Study||6
116892|NCT01879371|286428|P1|COMPLETED|Overall Study||6
116893|NCT01879371|286423|P6|STARTED|Overall Study||6
116894|NCT01879371|286424|P5|STARTED|Overall Study||6
116895|NCT01879371|286425|P4|STARTED|Overall Study||6
116896|NCT01879371|286426|P3|STARTED|Overall Study||6
116897|NCT01879371|286427|P2|STARTED|Overall Study||6
116898|NCT01879371|286428|P1|STARTED|Overall Study||6
116899|NCT01879345|286445|P3|NOT COMPLETED|7-day Multiple-dose Period||0
116900|NCT01879345|286446|P2|NOT COMPLETED|7-day Multiple-dose Period||0
116901|NCT01879345|286447|P1|NOT COMPLETED|7-day Multiple-dose Period||0
116902|NCT01879345|286445|P3|COMPLETED|7-day Multiple-dose Period||6
116903|NCT01879345|286446|P2|COMPLETED|7-day Multiple-dose Period||6
116904|NCT01879345|286447|P1|COMPLETED|7-day Multiple-dose Period||6
116905|NCT01879345|286445|P3|STARTED|7-day Multiple-dose Period||6
116906|NCT01879345|286446|P2|STARTED|7-day Multiple-dose Period||6
116907|NCT01879345|286447|P1|STARTED|7-day Multiple-dose Period||6
116908|NCT01879345|286445|P3|NOT COMPLETED|Single-dose Period||0
116909|NCT01879345|286446|P2|NOT COMPLETED|Single-dose Period||0
116910|NCT01879345|286447|P1|NOT COMPLETED|Single-dose Period||0
116911|NCT01879345|286445|P3|COMPLETED|Single-dose Period||6
116912|NCT01879345|286446|P2|COMPLETED|Single-dose Period||6
116913|NCT01879345|286447|P1|COMPLETED|Single-dose Period||6
116914|NCT01879345|286445|P3|STARTED|Single-dose Period||6
116915|NCT01879345|286446|P2|STARTED|Single-dose Period||6
116916|NCT01879345|286447|P1|STARTED|Single-dose Period||6
116917|NCT01879332|286464|P3|NOT COMPLETED|Overall Study||4
116918|NCT01879332|286465|P2|NOT COMPLETED|Overall Study||6
116919|NCT01879332|286466|P1|NOT COMPLETED|Overall Study||6
116920|NCT01879332|286464|P3|COMPLETED|Overall Study||0
116921|NCT01879332|286465|P2|COMPLETED|Overall Study||0
116922|NCT01879332|286466|P1|COMPLETED|Overall Study||0
116923|NCT01879332|286464|P3|STARTED|Overall Study||4
116924|NCT01879332|286465|P2|STARTED|Overall Study||6
116925|NCT01879332|286466|P1|STARTED|Overall Study||6
116926|NCT01879319|286476|P2|NOT COMPLETED|Overall Study||5
116927|NCT01879319|286477|P1|NOT COMPLETED|Overall Study||2
116928|NCT01879319|286476|P2|COMPLETED|Overall Study||77
116929|NCT01879319|286477|P1|COMPLETED|Overall Study||80
116930|NCT01879319|286476|P2|Received Treatment|Overall Study||82
116931|NCT01879319|286477|P1|Received Treatment|Overall Study||82
116932|NCT01879319|286476|P2|STARTED|Overall Study||82
116933|NCT01879319|286477|P1|STARTED|Overall Study||82
116934|NCT01879176|286487|P2|NOT COMPLETED|Overall Study||6
116935|NCT01879176|286488|P1|NOT COMPLETED|Overall Study||8
116936|NCT01879176|286487|P2|COMPLETED|Overall Study||16
116937|NCT01879176|286488|P1|COMPLETED|Overall Study||16
116938|NCT01879176|286487|P2|STARTED|Overall Study||22
116939|NCT01879176|286488|P1|STARTED|Overall Study||24
116940|NCT01879072|286494|P1|NOT COMPLETED|Overall Study||151
116941|NCT01879072|286494|P1|COMPLETED|Overall Study||1709
116942|NCT01879072|286494|P1|STARTED|Overall Study||1860
116943|NCT01879059|286498|P1|NOT COMPLETED|Overall Study||0
116944|NCT01879059|286498|P1|COMPLETED|Overall Study||13
116945|NCT01879059|286498|P1|STARTED|Overall Study||13
116946|NCT01878825|286504|P2|NOT COMPLETED|Overall Study||0
116947|NCT01878825|286505|P1|NOT COMPLETED|Overall Study||0
116948|NCT01878825|286504|P2|COMPLETED|Overall Study||60
116949|NCT01878825|286505|P1|COMPLETED|Overall Study||60
116950|NCT01878825|286504|P2|STARTED|Overall Study||60
116951|NCT01878825|286505|P1|STARTED|Overall Study||60
116952|NCT01878812|286543|P2|NOT COMPLETED|Overall Study||0
116953|NCT01878812|286544|P1|NOT COMPLETED|Overall Study||0
116954|NCT01878812|286543|P2|COMPLETED|Overall Study||57
116955|NCT01878812|286544|P1|COMPLETED|Overall Study||60
116956|NCT01878812|286543|P2|STARTED|Overall Study||57
116957|NCT01878812|286544|P1|STARTED|Overall Study||60
116958|NCT01878799|286580|P2|NOT COMPLETED|Overall Study||0
116959|NCT01878799|286581|P1|NOT COMPLETED|Overall Study||1
116960|NCT01878799|286580|P2|COMPLETED|Overall Study||13
116961|NCT01878799|286581|P1|COMPLETED|Overall Study||36
116962|NCT01878799|286580|P2|STARTED|Overall Study||13
116963|NCT01878799|286581|P1|STARTED|Overall Study||37
116964|NCT01878786|286590|P3|NOT COMPLETED|Overall Study||7
116965|NCT01878786|286591|P2|NOT COMPLETED|Overall Study||9
116966|NCT01878786|286592|P1|NOT COMPLETED|Overall Study||9
116967|NCT01878786|286590|P3|COMPLETED|Overall Study|Study closed prematurely; 1 patient was a screen fail|0
116968|NCT01878786|286591|P2|COMPLETED|Overall Study|Study closed prematurely|0
116969|NCT01878786|286592|P1|COMPLETED|Overall Study|Study closed prematurely|0
116970|NCT01878786|286590|P3|STARTED|Overall Study||7
116971|NCT01878786|286591|P2|STARTED|Overall Study||9
116972|NCT01878786|286592|P1|STARTED|Overall Study||9
116973|NCT01878656|286608|P2|NOT COMPLETED|Overall Study||0
116974|NCT01878656|286609|P1|NOT COMPLETED|Overall Study||0
116975|NCT01878656|286608|P2|COMPLETED|Overall Study||72
116976|NCT01878656|286609|P1|COMPLETED|Overall Study||72
116977|NCT01878656|286608|P2|STARTED|Overall Study||72
116978|NCT01878656|286609|P1|STARTED|Overall Study||72
116979|NCT01878604|286615|P1|NOT COMPLETED|Overall Study||0
116980|NCT01878604|286615|P1|COMPLETED|Overall Study||5
116981|NCT01878604|286615|P1|STARTED|Overall Study||5
116982|NCT01878526|286622|P2|NOT COMPLETED|Overall Study||2
116983|NCT01878526|286623|P1|NOT COMPLETED|Overall Study||3
116984|NCT01878526|286622|P2|COMPLETED|Overall Study||38
116985|NCT01878526|286623|P1|COMPLETED|Overall Study||37
116986|NCT01878526|286622|P2|STARTED|Overall Study||40
116987|NCT01878526|286623|P1|STARTED|Overall Study||40
116988|NCT01878253|286636|P1|NOT COMPLETED|Overall Study||9
116989|NCT01878253|286636|P1|COMPLETED|Overall Study||86
116990|NCT01878253|286636|P1|2 Year|Overall Study||86
116991|NCT01878253|286636|P1|1 Year|Overall Study||88
116992|NCT01878253|286636|P1|6 Months|Overall Study||90
116993|NCT01878253|286636|P1|6 Weeks|Overall Study||95
116994|NCT01878253|286636|P1|Pre-Operative|Overall Study||95
116995|NCT01878253|286636|P1|STARTED|Overall Study||95
116996|NCT01878214|286647|P2|NOT COMPLETED|Overall Study||44
116997|NCT01878214|286648|P1|NOT COMPLETED|Overall Study||53
116998|NCT01878214|286647|P2|COMPLETED|Overall Study||175
116999|NCT01878214|286648|P1|COMPLETED|Overall Study||170
117000|NCT01878214|286647|P2|STARTED|Overall Study||219
117001|NCT01878214|286648|P1|STARTED|Overall Study||223
117002|NCT01878175|286662|P1|NOT COMPLETED|Overall Study||2
117003|NCT01878175|286662|P1|COMPLETED|Overall Study||13
117004|NCT01878175|286662|P1|STARTED|Overall Study||15
117005|NCT01878149|286681|P2|NOT COMPLETED|Overall Study||2
117006|NCT01878149|286682|P1|NOT COMPLETED|Overall Study||2
117007|NCT01878149|286681|P2|COMPLETED|Overall Study||15
117008|NCT01878149|286682|P1|COMPLETED|Overall Study||19
117009|NCT01878149|286681|P2|STARTED|Overall Study||17
117010|NCT01878149|286682|P1|STARTED|Overall Study||21
117011|NCT01878097|286690|P2|NOT COMPLETED|Implementation Year 4||3007
117012|NCT01878097|286691|P1|NOT COMPLETED|Implementation Year 4||3604
117013|NCT01878097|286690|P2|COMPLETED|Implementation Year 4||6607
117014|NCT01878097|286691|P1|COMPLETED|Implementation Year 4||6981
117015|NCT01878097|286690|P2|STARTED|Implementation Year 4||9614
117016|NCT01878097|286691|P1|STARTED|Implementation Year 4||10585
117017|NCT01878097|286690|P2|NOT COMPLETED|Implementation Year 3||2980
117018|NCT01878097|286691|P1|NOT COMPLETED|Implementation Year 3||3494
117019|NCT01878097|286690|P2|COMPLETED|Implementation Year 3||6770
117020|NCT01878097|286691|P1|COMPLETED|Implementation Year 3||7046
117021|NCT01878097|286690|P2|STARTED|Implementation Year 3||9750
117022|NCT01878097|286691|P1|STARTED|Implementation Year 3||10540
117023|NCT01878097|286690|P2|NOT COMPLETED|Implementation Year 2||2841
117024|NCT01878097|286691|P1|NOT COMPLETED|Implementation Year 2||3281
117025|NCT01878097|286690|P2|COMPLETED|Implementation Year 2||6770
117026|NCT01878097|286691|P1|COMPLETED|Implementation Year 2||8286
117027|NCT01878097|286690|P2|STARTED|Implementation Year 2||9611
117028|NCT01878097|286691|P1|STARTED|Implementation Year 2||11567
117029|NCT01878097|286690|P2|NOT COMPLETED|Implementation Year 1||2549
117030|NCT01878097|286691|P1|NOT COMPLETED|Implementation Year 1||3202
117031|NCT01878097|286690|P2|COMPLETED|Implementation Year 1||7317
117032|NCT01878097|286691|P1|COMPLETED|Implementation Year 1||8540
117033|NCT01878097|286690|P2|STARTED|Implementation Year 1||9866
117034|NCT01878097|286691|P1|STARTED|Implementation Year 1||11742
117035|NCT01878097|286690|P2|NOT COMPLETED|Baseline||1800
117036|NCT01878097|286691|P1|NOT COMPLETED|Baseline||2497
117037|NCT01878097|286690|P2|COMPLETED|Baseline|Anonymous surveys; sum of all completed surveys.|8281
117038|NCT01878097|286691|P1|COMPLETED|Baseline|Anonymous surveys so only last year data provided as annual completed.|8228
117039|NCT01878097|286690|P2|STARTED|Baseline|number of students in 13 control schools completing anonymous surveys with non missing data|10081
117040|NCT01878097|286691|P1|STARTED|Baseline|number of students in 13 intervention schools completing anonymous surveys with non missing data|10725
117041|NCT01878006|286699|P2|NOT COMPLETED|Study Session 2||0
117042|NCT01878006|286700|P1|NOT COMPLETED|Study Session 2||0
117043|NCT01878006|286699|P2|COMPLETED|Study Session 2||5
117044|NCT01878006|286700|P1|COMPLETED|Study Session 2||5
117045|NCT01878006|286699|P2|STARTED|Study Session 2||5
117046|NCT01878006|286700|P1|STARTED|Study Session 2||5
117047|NCT01878006|286699|P2|NOT COMPLETED|Study Session 1||0
117048|NCT01878006|286700|P1|NOT COMPLETED|Study Session 1||0
117049|NCT01878006|286699|P2|COMPLETED|Study Session 1||5
117050|NCT01878006|286700|P1|COMPLETED|Study Session 1||5
117051|NCT01878006|286699|P2|STARTED|Study Session 1||5
117052|NCT01878006|286700|P1|STARTED|Study Session 1||5
117053|NCT01877941|286720|P1|NOT COMPLETED|Overall Study||0
117054|NCT01877941|286720|P1|COMPLETED|Overall Study||39
117055|NCT01877941|286720|P1|STARTED|Overall Study||39
117056|NCT01877915|286728|P2|NOT COMPLETED|Overall Study||68
117057|NCT01877915|286729|P1|NOT COMPLETED|Overall Study||54
117058|NCT01877915|286728|P2|COMPLETED|Overall Study||2447
117059|NCT01877915|286729|P1|COMPLETED|Overall Study||2453
117060|NCT01877915|286728|P2|STARTED|Overall Study||2515
117061|NCT01877915|286729|P1|STARTED|Overall Study||2507
117062|NCT01877720|286751|P2|NOT COMPLETED|Overall Study||0
117063|NCT01877720|286752|P1|NOT COMPLETED|Overall Study||1
117064|NCT01877720|286751|P2|COMPLETED|Overall Study||8
117065|NCT01877720|286752|P1|COMPLETED|Overall Study||7
117066|NCT01877720|286751|P2|2nd Intervention|Overall Study||8
117067|NCT01877720|286752|P1|2nd Intervention|Overall Study||7
117068|NCT01877720|286751|P2|1st Intervention|Overall Study||8
117069|NCT01877720|286752|P1|1st Intervention|Overall Study||7
117070|NCT01877720|286751|P2|STARTED|Overall Study||8
117071|NCT01877720|286752|P1|STARTED|Overall Study||8
117072|NCT01877668|286781|P5|NOT COMPLETED|Overall Study||10
117073|NCT01877668|286782|P4|NOT COMPLETED|Overall Study||8
117074|NCT01877668|286783|P3|NOT COMPLETED|Overall Study||12
117075|NCT01877668|286784|P2|NOT COMPLETED|Overall Study||8
117076|NCT01877668|286785|P1|NOT COMPLETED|Overall Study||11
117077|NCT01877668|286781|P5|COMPLETED|Overall Study||43
117078|NCT01877668|286782|P4|COMPLETED|Overall Study||44
117079|NCT01877668|286783|P3|COMPLETED|Overall Study||94
117080|NCT01877668|286784|P2|COMPLETED|Overall Study||96
117081|NCT01877668|286785|P1|COMPLETED|Overall Study||96
117082|NCT01877668|286781|P5|STARTED|Overall Study|Received treatment|53
117083|NCT01877668|286782|P4|STARTED|Overall Study|Received treatment|52
117084|NCT01877668|286783|P3|STARTED|Overall Study|Received treatment|106
117085|NCT01877668|286784|P2|STARTED|Overall Study|Received treatment|104
117086|NCT01877668|286785|P1|STARTED|Overall Study|Received treatment|107
117087|NCT01877655|287016|P2|NOT COMPLETED|Overall Study||97
117088|NCT01877655|287017|P1|NOT COMPLETED|Overall Study||98
117089|NCT01877655|287016|P2|COMPLETED|Overall Study||154
117090|NCT01877655|287017|P1|COMPLETED|Overall Study||165
117091|NCT01877655|287016|P2|Received Treatment|Overall Study||246
117092|NCT01877655|287017|P1|Received Treatment|Overall Study||255
117093|NCT01877655|287016|P2|STARTED|Overall Study||251
117094|NCT01877655|287017|P1|STARTED|Overall Study||263
117095|NCT01877642|287035|P7|NOT COMPLETED|Overall Study||0
117096|NCT01877642|287036|P6|NOT COMPLETED|Overall Study||0
117097|NCT01877642|287037|P5|NOT COMPLETED|Overall Study||0
117098|NCT01877642|287038|P4|NOT COMPLETED|Overall Study||0
117099|NCT01877642|287039|P3|NOT COMPLETED|Overall Study||0
117100|NCT01877642|287040|P2|NOT COMPLETED|Overall Study||0
117101|NCT01877642|287041|P1|NOT COMPLETED|Overall Study||0
117102|NCT01877642|287035|P7|COMPLETED|Overall Study||3
117103|NCT01877642|287036|P6|COMPLETED|Overall Study||3
117104|NCT01877642|287037|P5|COMPLETED|Overall Study||3
117105|NCT01877642|287038|P4|COMPLETED|Overall Study||3
117106|NCT01877642|287039|P3|COMPLETED|Overall Study||3
117107|NCT01877642|287040|P2|COMPLETED|Overall Study||3
117108|NCT01877642|287041|P1|COMPLETED|Overall Study||4
117109|NCT01877642|287035|P7|STARTED|Overall Study||3
117110|NCT01877642|287036|P6|STARTED|Overall Study||3
117111|NCT01877642|287037|P5|STARTED|Overall Study||3
117112|NCT01877642|287038|P4|STARTED|Overall Study||3
117113|NCT01877642|287039|P3|STARTED|Overall Study||3
117114|NCT01877642|287040|P2|STARTED|Overall Study||3
117115|NCT01877642|287041|P1|STARTED|Overall Study||4
117116|NCT01877564|287064|P2|NOT COMPLETED|Overall Study||0
117117|NCT01877564|287065|P1|NOT COMPLETED|Overall Study||0
117118|NCT01877564|287064|P2|COMPLETED|Overall Study||4
117119|NCT01877564|287065|P1|COMPLETED|Overall Study||6
117120|NCT01877564|287064|P2|STARTED|Overall Study||4
117121|NCT01877564|287065|P1|STARTED|Overall Study||6
117122|NCT01877538|287071|P1|NOT COMPLETED|Overall Study||0
117123|NCT01877538|287071|P1|COMPLETED|Overall Study||7
117124|NCT01877538|287071|P1|STARTED|Overall Study||7
117125|NCT01877421|287108|P18|NOT COMPLETED|Phase 2||0
117126|NCT01877421|287109|P17|NOT COMPLETED|Phase 2||0
117127|NCT01877421|287110|P16|NOT COMPLETED|Phase 2||1
117128|NCT01877421|287111|P15|NOT COMPLETED|Phase 2||0
117129|NCT01877421|287112|P14|NOT COMPLETED|Phase 2||0
117130|NCT01877421|287113|P13|NOT COMPLETED|Phase 2||1
117131|NCT01877421|287114|P12|NOT COMPLETED|Phase 2||0
117132|NCT01877421|287115|P11|NOT COMPLETED|Phase 2||2
117133|NCT01877421|287116|P10|NOT COMPLETED|Phase 2||0
117134|NCT01877421|287117|P9|NOT COMPLETED|Phase 2||1
117135|NCT01877421|287118|P8|NOT COMPLETED|Phase 2||0
117136|NCT01877421|287119|P7|NOT COMPLETED|Phase 2||1
117137|NCT01877421|287120|P6|NOT COMPLETED|Phase 2||0
117138|NCT01877421|287121|P5|NOT COMPLETED|Phase 2||0
117139|NCT01877421|287122|P4|NOT COMPLETED|Phase 2||0
117140|NCT01877421|287123|P3|NOT COMPLETED|Phase 2||0
117141|NCT01877421|287124|P2|NOT COMPLETED|Phase 2||0
117142|NCT01877421|287125|P1|NOT COMPLETED|Phase 2||0
117143|NCT01877421|287108|P18|COMPLETED|Phase 2||0
117144|NCT01877421|287109|P17|COMPLETED|Phase 2||0
117145|NCT01877421|287110|P16|COMPLETED|Phase 2||2
117146|NCT01877421|287111|P15|COMPLETED|Phase 2||7
117147|NCT01877421|287112|P14|COMPLETED|Phase 2||3
117148|NCT01877421|287113|P13|COMPLETED|Phase 2||6
117149|NCT01877421|287114|P12|COMPLETED|Phase 2||3
117150|NCT01877421|287115|P11|COMPLETED|Phase 2||5
117151|NCT01877421|287116|P10|COMPLETED|Phase 2||3
117152|NCT01877421|287117|P9|COMPLETED|Phase 2||5
117153|NCT01877421|287118|P8|COMPLETED|Phase 2||2
117154|NCT01877421|287119|P7|COMPLETED|Phase 2||6
117155|NCT01877421|287120|P6|COMPLETED|Phase 2||3
117156|NCT01877421|287121|P5|COMPLETED|Phase 2||7
117157|NCT01877421|287122|P4|COMPLETED|Phase 2||2
117158|NCT01877421|287123|P3|COMPLETED|Phase 2||4
117159|NCT01877421|287124|P2|COMPLETED|Phase 2||0
117160|NCT01877421|287125|P1|COMPLETED|Phase 2||0
117161|NCT01877421|287108|P18|STARTED|Phase 2||0
117162|NCT01877421|287109|P17|STARTED|Phase 2||0
117163|NCT01877421|287110|P16|STARTED|Phase 2||3
117164|NCT01877421|287111|P15|STARTED|Phase 2||7
117165|NCT01877421|287112|P14|STARTED|Phase 2||3
117166|NCT01877421|287113|P13|STARTED|Phase 2||7
117167|NCT01877421|287114|P12|STARTED|Phase 2||3
117168|NCT01877421|287115|P11|STARTED|Phase 2||7
117169|NCT01877421|287116|P10|STARTED|Phase 2||3
117170|NCT01877421|287117|P9|STARTED|Phase 2||6
117171|NCT01877421|287118|P8|STARTED|Phase 2||2
117172|NCT01877421|287119|P7|STARTED|Phase 2||7
117173|NCT01877421|287120|P6|STARTED|Phase 2||3
117174|NCT01877421|287121|P5|STARTED|Phase 2||7
117175|NCT01877421|287122|P4|STARTED|Phase 2||2
117176|NCT01877421|287123|P3|STARTED|Phase 2||4
117177|NCT01877421|287124|P2|STARTED|Phase 2||0
117178|NCT01877421|287125|P1|STARTED|Phase 2||0
117179|NCT01877421|287108|P18|NOT COMPLETED|Phase 1||0
117180|NCT01877421|287109|P17|NOT COMPLETED|Phase 1||0
117181|NCT01877421|287110|P16|NOT COMPLETED|Phase 1||0
117182|NCT01877421|287111|P15|NOT COMPLETED|Phase 1||0
117183|NCT01877421|287112|P14|NOT COMPLETED|Phase 1||0
117184|NCT01877421|287113|P13|NOT COMPLETED|Phase 1||0
117185|NCT01877421|287114|P12|NOT COMPLETED|Phase 1||0
117186|NCT01877421|287115|P11|NOT COMPLETED|Phase 1||0
117187|NCT01877421|287116|P10|NOT COMPLETED|Phase 1||0
117188|NCT01877421|287117|P9|NOT COMPLETED|Phase 1||0
117189|NCT01877421|287118|P8|NOT COMPLETED|Phase 1||0
117190|NCT01877421|287119|P7|NOT COMPLETED|Phase 1||0
117191|NCT01877421|287120|P6|NOT COMPLETED|Phase 1||0
117192|NCT01877421|287121|P5|NOT COMPLETED|Phase 1||0
117193|NCT01877421|287122|P4|NOT COMPLETED|Phase 1||0
117194|NCT01877421|287123|P3|NOT COMPLETED|Phase 1||0
117195|NCT01877421|287124|P2|NOT COMPLETED|Phase 1||0
117196|NCT01877421|287125|P1|NOT COMPLETED|Phase 1||0
117197|NCT01877421|287108|P18|COMPLETED|Phase 1||3
117198|NCT01877421|287109|P17|COMPLETED|Phase 1||7
117199|NCT01877421|287110|P16|COMPLETED|Phase 1||3
117200|NCT01877421|287111|P15|COMPLETED|Phase 1||7
117201|NCT01877421|287112|P14|COMPLETED|Phase 1||3
117202|NCT01877421|287113|P13|COMPLETED|Phase 1||7
117203|NCT01877421|287114|P12|COMPLETED|Phase 1||3
117204|NCT01877421|287115|P11|COMPLETED|Phase 1||7
117205|NCT01877421|287116|P10|COMPLETED|Phase 1||3
117206|NCT01877421|287117|P9|COMPLETED|Phase 1||7
117207|NCT01877421|287118|P8|COMPLETED|Phase 1||2
117208|NCT01877421|287119|P7|COMPLETED|Phase 1||4
117209|NCT01877421|287120|P6|COMPLETED|Phase 1||2
117210|NCT01877421|287121|P5|COMPLETED|Phase 1||4
117211|NCT01877421|287122|P4|COMPLETED|Phase 1||2
117212|NCT01877421|287123|P3|COMPLETED|Phase 1||4
117213|NCT01877421|287124|P2|COMPLETED|Phase 1||1
117214|NCT01877421|287125|P1|COMPLETED|Phase 1||2
117215|NCT01877421|287108|P18|STARTED|Phase 1||3
117216|NCT01877421|287109|P17|STARTED|Phase 1||7
117217|NCT01877421|287110|P16|STARTED|Phase 1||3
117218|NCT01877421|287111|P15|STARTED|Phase 1||7
117219|NCT01877421|287112|P14|STARTED|Phase 1||3
117220|NCT01877421|287113|P13|STARTED|Phase 1||7
117221|NCT01877421|287114|P12|STARTED|Phase 1||3
117222|NCT01877421|287115|P11|STARTED|Phase 1||7
117223|NCT01877421|287116|P10|STARTED|Phase 1||3
117224|NCT01877421|287117|P9|STARTED|Phase 1||7
117225|NCT01877421|287118|P8|STARTED|Phase 1||2
117226|NCT01877421|287119|P7|STARTED|Phase 1||4
117227|NCT01877421|287120|P6|STARTED|Phase 1||2
117228|NCT01877421|287121|P5|STARTED|Phase 1||4
117229|NCT01877421|287122|P4|STARTED|Phase 1||2
117230|NCT01877421|287123|P3|STARTED|Phase 1||4
117231|NCT01877421|287124|P2|STARTED|Phase 1||1
117232|NCT01877421|287125|P1|STARTED|Phase 1||2
117233|NCT01877408|287235|P2|NOT COMPLETED|Overall Study||2
117234|NCT01877408|287236|P1|NOT COMPLETED|Overall Study||0
117235|NCT01877408|287235|P2|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|98
117236|NCT01877408|287236|P1|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|50
117237|NCT01877408|287235|P2|STARTED|Overall Study||100
117238|NCT01877408|287236|P1|STARTED|Overall Study||50
117239|NCT01877343|287256|P7|NOT COMPLETED|Overall Study||0
117240|NCT01877343|287257|P6|NOT COMPLETED|Overall Study||0
117241|NCT01877343|287258|P5|NOT COMPLETED|Overall Study||0
117242|NCT01877343|287259|P4|NOT COMPLETED|Overall Study||0
117243|NCT01877343|287260|P3|NOT COMPLETED|Overall Study||0
117244|NCT01877343|287261|P2|NOT COMPLETED|Overall Study||0
117245|NCT01877343|287262|P1|NOT COMPLETED|Overall Study||0
117246|NCT01877343|287256|P7|COMPLETED|Overall Study||0
117247|NCT01877343|287257|P6|COMPLETED|Overall Study||5
117248|NCT01877343|287258|P5|COMPLETED|Overall Study||0
117249|NCT01877343|287259|P4|COMPLETED|Overall Study||0
117250|NCT01877343|287260|P3|COMPLETED|Overall Study||0
117251|NCT01877343|287261|P2|COMPLETED|Overall Study||3
117252|NCT01877343|287262|P1|COMPLETED|Overall Study||2
117253|NCT01877343|287256|P7|STARTED|Overall Study||0
117254|NCT01877343|287257|P6|STARTED|Overall Study||5
117255|NCT01877343|287258|P5|STARTED|Overall Study||0
117256|NCT01877343|287259|P4|STARTED|Overall Study||0
117257|NCT01877343|287260|P3|STARTED|Overall Study||0
117258|NCT01877343|287261|P2|STARTED|Overall Study||3
117259|NCT01877343|287262|P1|STARTED|Overall Study||2
117260|NCT01877278|287269|P2|NOT COMPLETED|Overall Study||3
117261|NCT01877278|287270|P1|NOT COMPLETED|Overall Study||3
117262|NCT01877278|287269|P2|COMPLETED|Overall Study||30
117263|NCT01877278|287270|P1|COMPLETED|Overall Study||30
117264|NCT01877278|287269|P2|STARTED|Overall Study||33
117265|NCT01877278|287270|P1|STARTED|Overall Study||33
117266|NCT01877265|287278|P6|NOT COMPLETED|Treatment Period 3||0
117267|NCT01877265|287279|P5|NOT COMPLETED|Treatment Period 3||0
117268|NCT01877265|287280|P4|NOT COMPLETED|Treatment Period 3||0
117269|NCT01877265|287281|P3|NOT COMPLETED|Treatment Period 3||0
117270|NCT01877265|287282|P2|NOT COMPLETED|Treatment Period 3||0
117271|NCT01877265|287283|P1|NOT COMPLETED|Treatment Period 3||1
117272|NCT01877265|287278|P6|COMPLETED|Treatment Period 3||2
117273|NCT01877265|287279|P5|COMPLETED|Treatment Period 3||3
117274|NCT01877265|287280|P4|COMPLETED|Treatment Period 3||3
117275|NCT01877265|287281|P3|COMPLETED|Treatment Period 3||2
117276|NCT01877265|287282|P2|COMPLETED|Treatment Period 3||3
117277|NCT01877265|287283|P1|COMPLETED|Treatment Period 3||2
117278|NCT01877265|287278|P6|Received at Least One Dose of Study Drug|Treatment Period 3||2
117279|NCT01877265|287279|P5|Received at Least One Dose of Study Drug|Treatment Period 3||3
117280|NCT01877265|287280|P4|Received at Least One Dose of Study Drug|Treatment Period 3||3
117281|NCT01877265|287281|P3|Received at Least One Dose of Study Drug|Treatment Period 3||2
117282|NCT01877265|287282|P2|Received at Least One Dose of Study Drug|Treatment Period 3||3
117283|NCT01877265|287283|P1|Received at Least One Dose of Study Drug|Treatment Period 3||3
117284|NCT01877265|287278|P6|STARTED|Treatment Period 3||2
117285|NCT01877265|287279|P5|STARTED|Treatment Period 3||3
117286|NCT01877265|287280|P4|STARTED|Treatment Period 3||3
117287|NCT01877265|287281|P3|STARTED|Treatment Period 3||2
117288|NCT01877265|287282|P2|STARTED|Treatment Period 3||3
117289|NCT01877265|287283|P1|STARTED|Treatment Period 3||3
117290|NCT01877265|287278|P6|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||1
117291|NCT01877265|287279|P5|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
117292|NCT01877265|287280|P4|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
117293|NCT01877265|287281|P3|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
117294|NCT01877265|287282|P2|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
117295|NCT01877265|287283|P1|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
117296|NCT01877265|287278|P6|COMPLETED|Washout Period 2 (at Least 14 Days)||2
117297|NCT01877265|287279|P5|COMPLETED|Washout Period 2 (at Least 14 Days)||3
117298|NCT01877265|287280|P4|COMPLETED|Washout Period 2 (at Least 14 Days)||3
117299|NCT01877265|287281|P3|COMPLETED|Washout Period 2 (at Least 14 Days)||2
117300|NCT01877265|287282|P2|COMPLETED|Washout Period 2 (at Least 14 Days)||3
117301|NCT01877265|287283|P1|COMPLETED|Washout Period 2 (at Least 14 Days)||3
117302|NCT01877265|287278|P6|STARTED|Washout Period 2 (at Least 14 Days)||3
117303|NCT01877265|287279|P5|STARTED|Washout Period 2 (at Least 14 Days)||3
117304|NCT01877265|287280|P4|STARTED|Washout Period 2 (at Least 14 Days)||3
117305|NCT01877265|287281|P3|STARTED|Washout Period 2 (at Least 14 Days)||2
117306|NCT01877265|287282|P2|STARTED|Washout Period 2 (at Least 14 Days)||3
117307|NCT01877265|287283|P1|STARTED|Washout Period 2 (at Least 14 Days)||3
117308|NCT01877265|287278|P6|NOT COMPLETED|Treatment Period 2||0
117309|NCT01877265|287279|P5|NOT COMPLETED|Treatment Period 2||0
117310|NCT01877265|287280|P4|NOT COMPLETED|Treatment Period 2||0
117311|NCT01877265|287281|P3|NOT COMPLETED|Treatment Period 2||0
117312|NCT01877265|287282|P2|NOT COMPLETED|Treatment Period 2||0
117313|NCT01877265|287283|P1|NOT COMPLETED|Treatment Period 2||0
117314|NCT01877265|287278|P6|COMPLETED|Treatment Period 2||3
117315|NCT01877265|287279|P5|COMPLETED|Treatment Period 2||3
117316|NCT01877265|287280|P4|COMPLETED|Treatment Period 2||3
117317|NCT01877265|287281|P3|COMPLETED|Treatment Period 2||2
117318|NCT01877265|287282|P2|COMPLETED|Treatment Period 2||3
117319|NCT01877265|287283|P1|COMPLETED|Treatment Period 2||3
117320|NCT01877265|287278|P6|Received at Least One Dose of Study Drug|Treatment Period 2||3
117321|NCT01877265|287279|P5|Received at Least One Dose of Study Drug|Treatment Period 2||3
117322|NCT01877265|287280|P4|Received at Least One Dose of Study Drug|Treatment Period 2||3
117323|NCT01877265|287281|P3|Received at Least One Dose of Study Drug|Treatment Period 2||2
117324|NCT01877265|287282|P2|Received at Least One Dose of Study Drug|Treatment Period 2||3
117325|NCT01877265|287283|P1|Received at Least One Dose of Study Drug|Treatment Period 2||3
117326|NCT01877265|287278|P6|STARTED|Treatment Period 2||3
117327|NCT01877265|287279|P5|STARTED|Treatment Period 2||3
117328|NCT01877265|287280|P4|STARTED|Treatment Period 2||3
117329|NCT01877265|287281|P3|STARTED|Treatment Period 2||2
117330|NCT01877265|287282|P2|STARTED|Treatment Period 2||3
117331|NCT01877265|287283|P1|STARTED|Treatment Period 2||3
117332|NCT01877265|287278|P6|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
117333|NCT01877265|287279|P5|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
117334|NCT01877265|287280|P4|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
117335|NCT01877265|287281|P3|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
117336|NCT01877265|287282|P2|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
117337|NCT01877265|287283|P1|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
117338|NCT01877265|287278|P6|COMPLETED|Washout Period 1 (at Least 14 Days)||3
117339|NCT01877265|287279|P5|COMPLETED|Washout Period 1 (at Least 14 Days)||3
117340|NCT01877265|287280|P4|COMPLETED|Washout Period 1 (at Least 14 Days)||3
117341|NCT01877265|287281|P3|COMPLETED|Washout Period 1 (at Least 14 Days)||2
117342|NCT01877265|287282|P2|COMPLETED|Washout Period 1 (at Least 14 Days)||3
117343|NCT01877265|287283|P1|COMPLETED|Washout Period 1 (at Least 14 Days)||3
117344|NCT01877265|287278|P6|STARTED|Washout Period 1 (at Least 14 Days)||3
117345|NCT01877265|287279|P5|STARTED|Washout Period 1 (at Least 14 Days)||3
117346|NCT01877265|287280|P4|STARTED|Washout Period 1 (at Least 14 Days)||3
117347|NCT01877265|287281|P3|STARTED|Washout Period 1 (at Least 14 Days)||2
117348|NCT01877265|287282|P2|STARTED|Washout Period 1 (at Least 14 Days)||3
117349|NCT01877265|287283|P1|STARTED|Washout Period 1 (at Least 14 Days)||3
117350|NCT01877265|287278|P6|NOT COMPLETED|Treatment Period 1||0
117351|NCT01877265|287279|P5|NOT COMPLETED|Treatment Period 1||0
117352|NCT01877265|287280|P4|NOT COMPLETED|Treatment Period 1||0
117353|NCT01877265|287281|P3|NOT COMPLETED|Treatment Period 1||1
117354|NCT01877265|287282|P2|NOT COMPLETED|Treatment Period 1||0
117355|NCT01877265|287283|P1|NOT COMPLETED|Treatment Period 1||0
117356|NCT01877265|287278|P6|COMPLETED|Treatment Period 1||3
117357|NCT01877265|287279|P5|COMPLETED|Treatment Period 1||3
117358|NCT01877265|287280|P4|COMPLETED|Treatment Period 1||3
117359|NCT01877265|287281|P3|COMPLETED|Treatment Period 1||2
117360|NCT01877265|287282|P2|COMPLETED|Treatment Period 1||3
117361|NCT01877265|287283|P1|COMPLETED|Treatment Period 1||3
117362|NCT01877265|287278|P6|Received at Least One Dose of Study Drug|Treatment Period 1||3
117363|NCT01877265|287279|P5|Received at Least One Dose of Study Drug|Treatment Period 1||3
117364|NCT01877265|287280|P4|Received at Least One Dose of Study Drug|Treatment Period 1||3
117365|NCT01877265|287281|P3|Received at Least One Dose of Study Drug|Treatment Period 1||3
117366|NCT01877265|287282|P2|Received at Least One Dose of Study Drug|Treatment Period 1||3
117367|NCT01877265|287283|P1|Received at Least One Dose of Study Drug|Treatment Period 1||3
117368|NCT01877265|287278|P6|STARTED|Treatment Period 1||3
117369|NCT01877265|287279|P5|STARTED|Treatment Period 1||3
117370|NCT01877265|287280|P4|STARTED|Treatment Period 1||3
117371|NCT01877265|287281|P3|STARTED|Treatment Period 1||3
117372|NCT01877265|287282|P2|STARTED|Treatment Period 1||3
117373|NCT01877265|287283|P1|STARTED|Treatment Period 1||3
117374|NCT01877239|287300|P1|NOT COMPLETED|Overall Study||50
117375|NCT01877239|287300|P1|COMPLETED|Overall Study||61
117376|NCT01877239|287300|P1|Treated|Overall Study||76
117377|NCT01877239|287300|P1|STARTED|Overall Study||111
117378|NCT01877161|287306|P1|NOT COMPLETED|Third Session of Stimulation||0
117379|NCT01877161|287306|P1|COMPLETED|Third Session of Stimulation||12
117380|NCT01877161|287306|P1|STARTED|Third Session of Stimulation||12
117381|NCT01877161|287306|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
117382|NCT01877161|287306|P1|COMPLETED|Washout (at Least 3 Days)||12
117383|NCT01877161|287306|P1|STARTED|Washout (at Least 3 Days)||12
117384|NCT01877161|287306|P1|NOT COMPLETED|Second Session of Stimulation||0
117385|NCT01877161|287306|P1|COMPLETED|Second Session of Stimulation||12
117386|NCT01877161|287306|P1|STARTED|Second Session of Stimulation||12
117387|NCT01877161|287306|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
117388|NCT01877161|287306|P1|COMPLETED|Washout (at Least 3 Days)||12
117389|NCT01877161|287306|P1|STARTED|Washout (at Least 3 Days)||12
117390|NCT01877161|287306|P1|NOT COMPLETED|First Session of Stimulation||0
117391|NCT01877161|287306|P1|COMPLETED|First Session of Stimulation||12
117392|NCT01877161|287306|P1|STARTED|First Session of Stimulation||12
117393|NCT01877148|287316|P2|NOT COMPLETED|Overall Study||1
117394|NCT01877148|287317|P1|NOT COMPLETED|Overall Study||1
117395|NCT01877148|287316|P2|COMPLETED|Overall Study||5
117396|NCT01877148|287317|P1|COMPLETED|Overall Study||5
117397|NCT01877148|287316|P2|STARTED|Overall Study||6
117398|NCT01877148|287317|P1|STARTED|Overall Study||6
117399|NCT01877083|287329|P1|NOT COMPLETED|Extension Phase||5
117400|NCT01877083|287329|P1|COMPLETED|Extension Phase||0
117401|NCT01877083|287329|P1|STARTED|Extension Phase||5
117402|NCT01877083|287329|P1|NOT COMPLETED|Treatment Phase||20
117403|NCT01877083|287329|P1|COMPLETED|Treatment Phase||5
117404|NCT01877083|287329|P1|STARTED|Treatment Phase||25
117405|NCT01876992|287338|P2|NOT COMPLETED|Overall Study||0
117406|NCT01876992|287339|P1|NOT COMPLETED|Overall Study||0
117407|NCT01876992|287338|P2|COMPLETED|Overall Study||5
117408|NCT01876992|287339|P1|COMPLETED|Overall Study||5
117409|NCT01876992|287338|P2|STARTED|Overall Study||5
117410|NCT01876992|287339|P1|STARTED|Overall Study||5
117411|NCT01876979|287353|P2|NOT COMPLETED|Overall Study||3
117412|NCT01876979|287354|P1|NOT COMPLETED|Overall Study||2
117413|NCT01876979|287353|P2|COMPLETED|Overall Study||0
117414|NCT01876979|287354|P1|COMPLETED|Overall Study||0
117415|NCT01876979|287353|P2|STARTED|Overall Study||3
117416|NCT01876979|287354|P1|STARTED|Overall Study||2
117417|NCT01876823|287360|P1|NOT COMPLETED|Overall Study||9
117418|NCT01876823|287360|P1|COMPLETED|Overall Study||26
117419|NCT01876823|287360|P1|STARTED|Overall Study||35
117420|NCT01876810|287373|P2|NOT COMPLETED|Overall Study||1
117421|NCT01876810|287374|P1|NOT COMPLETED|Overall Study||0
117422|NCT01876810|287373|P2|COMPLETED|Overall Study||13
117423|NCT01876810|287374|P1|COMPLETED|Overall Study||14
117424|NCT01876810|287373|P2|STARTED|Overall Study||14
117425|NCT01876810|287374|P1|STARTED|Overall Study||14
117426|NCT01876784|287386|P2|NOT COMPLETED|Overall Study||119
117427|NCT01876784|287387|P1|NOT COMPLETED|Overall Study||119
117428|NCT01876784|287386|P2|COMPLETED|Overall Study||0
117429|NCT01876784|287387|P1|COMPLETED|Overall Study||0
117430|NCT01876784|287386|P2|Treated|Overall Study||118
117431|NCT01876784|287387|P1|Treated|Overall Study||117
117432|NCT01876784|287386|P2|STARTED|Overall Study||119
117433|NCT01876784|287387|P1|STARTED|Overall Study||119
117434|NCT01876732|287393|P1|NOT COMPLETED|Overall Study||75
117435|NCT01876732|287393|P1|COMPLETED|Overall Study||57
117436|NCT01876732|287393|P1|STARTED|Overall Study||132
117437|NCT01876706|287398|P1|NOT COMPLETED|Overall Study||25
117438|NCT01876706|287398|P1|COMPLETED|Overall Study||26
117439|NCT01876706|287398|P1|60 Months|Overall Study||26
117440|NCT01876706|287398|P1|48 Months|Overall Study||31
117441|NCT01876706|287398|P1|36 Months|Overall Study||32
117442|NCT01876706|287398|P1|24 Months|Overall Study||35
117443|NCT01876706|287398|P1|12 Months|Overall Study||42
117444|NCT01876706|287398|P1|6 Months|Overall Study||46
117445|NCT01876706|287398|P1|3 Months|Overall Study||51
117446|NCT01876706|287398|P1|1 Month|Overall Study||51
117447|NCT01876706|287398|P1|STARTED|Overall Study||51
117448|NCT01876485|287417|P2|NOT COMPLETED|Overall Study||26
117449|NCT01876485|287418|P1|NOT COMPLETED|Overall Study||24
117450|NCT01876485|287417|P2|COMPLETED|Overall Study||114
117451|NCT01876485|287418|P1|COMPLETED|Overall Study||116
117452|NCT01876485|287417|P2|Maintenance|Overall Study||114
117453|NCT01876485|287418|P1|Maintenance|Overall Study||116
117454|NCT01876485|287417|P2|Post-Intervention|Overall Study||129
117455|NCT01876485|287418|P1|Post-Intervention|Overall Study||125
117456|NCT01876485|287417|P2|STARTED|Overall Study||140
117457|NCT01876485|287418|P1|STARTED|Overall Study||140
117458|NCT01876446|287428|P2|NOT COMPLETED|Overall Study||6
117459|NCT01876446|287429|P1|NOT COMPLETED|Overall Study||2
117460|NCT01876446|287428|P2|COMPLETED|Overall Study||12
117461|NCT01876446|287429|P1|COMPLETED|Overall Study||18
117462|NCT01876446|287428|P2|STARTED|Overall Study||18
117463|NCT01876446|287429|P1|STARTED|Overall Study||20
117464|NCT01876420|287445|P1|NOT COMPLETED|Overall Study||1
117465|NCT01876420|287445|P1|COMPLETED|Overall Study||59
117466|NCT01876420|287445|P1|STARTED|Overall Study||60
117467|NCT01876381|287457|P1|NOT COMPLETED|Overall Study||7
117468|NCT01876381|287457|P1|COMPLETED|Overall Study||16
117469|NCT01876381|287457|P1|STARTED|Overall Study||23
117470|NCT01876368|287464|P2|NOT COMPLETED|Overall Study||13
117471|NCT01876368|287465|P1|NOT COMPLETED|Overall Study||9
117472|NCT01876368|287464|P2|COMPLETED|Overall Study||175
117473|NCT01876368|287465|P1|COMPLETED|Overall Study||179
117474|NCT01876368|287464|P2|Safety Set (SAF)|Overall Study||187
117475|NCT01876368|287465|P1|Safety Set (SAF)|Overall Study||188
117476|NCT01876368|287464|P2|Full Analysis Set (FAS)|Overall Study|One patient was not included in the SAF and FAS due to mis-randomization.|187
117477|NCT01876368|287465|P1|Full Analysis Set (FAS)|Overall Study||188
117478|NCT01876368|287464|P2|STARTED|Overall Study||188
117479|NCT01876368|287465|P1|STARTED|Overall Study||188
117480|NCT01876329|287494|P3|NOT COMPLETED|Overall Study||0
117481|NCT01876329|287495|P2|NOT COMPLETED|Overall Study||0
117482|NCT01876329|287496|P1|NOT COMPLETED|Overall Study||0
117483|NCT01876329|287494|P3|COMPLETED|Overall Study||44
117484|NCT01876329|287495|P2|COMPLETED|Overall Study||36
117485|NCT01876329|287496|P1|COMPLETED|Overall Study||45
117486|NCT01876329|287494|P3|STARTED|Overall Study||44
117487|NCT01876329|287495|P2|STARTED|Overall Study||36
117488|NCT01876329|287496|P1|STARTED|Overall Study||45
117489|NCT01876251|287510|P3|NOT COMPLETED|Overall Study||11
117490|NCT01876251|287511|P2|NOT COMPLETED|Overall Study||3
117491|NCT01876251|287512|P1|NOT COMPLETED|Overall Study||15
117492|NCT01876251|287510|P3|COMPLETED|Overall Study||0
117493|NCT01876251|287511|P2|COMPLETED|Overall Study||0
117494|NCT01876251|287512|P1|COMPLETED|Overall Study||0
117495|NCT01876251|287510|P3|STARTED|Overall Study||11
117496|NCT01876251|287511|P2|STARTED|Overall Study||3
117497|NCT01876251|287512|P1|STARTED|Overall Study||15
117498|NCT01876212|287571|P2|NOT COMPLETED|Overall Study||0
117499|NCT01876212|287572|P1|NOT COMPLETED|Overall Study||0
117500|NCT01876212|287571|P2|COMPLETED|Overall Study||6
117501|NCT01876212|287572|P1|COMPLETED|Overall Study||9
117502|NCT01876212|287571|P2|STARTED|Overall Study||6
117503|NCT01876212|287572|P1|STARTED|Overall Study||9
117504|NCT01876043|287616|P1|NOT COMPLETED|Overall Study||2
117505|NCT01876043|287616|P1|COMPLETED|Overall Study||22
117506|NCT01876043|287616|P1|Interim Analysis Population|Overall Study||17
117507|NCT01876043|287616|P1|STARTED|Overall Study||24
117508|NCT01875991|287628|P2|NOT COMPLETED|Overall Study||6
117509|NCT01875991|287629|P1|NOT COMPLETED|Overall Study||7
117510|NCT01875991|287628|P2|COMPLETED|Overall Study||103
117511|NCT01875991|287629|P1|COMPLETED|Overall Study||101
117512|NCT01875991|287628|P2|Received Etanercept in Period 2|Overall Study||103
117513|NCT01875991|287629|P1|Received Etanercept in Period 2|Overall Study||102
117514|NCT01875991|287628|P2|Received Etanercept in Period 1|Overall Study||108
117515|NCT01875991|287629|P1|Received Etanercept in Period 1|Overall Study||108
117516|NCT01875991|287628|P2|STARTED|Overall Study||109
117517|NCT01875991|287629|P1|STARTED|Overall Study||108
117518|NCT01875978|287652|P2|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
117519|NCT01875978|287653|P1|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
117520|NCT01875978|287652|P2|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
117521|NCT01875978|287653|P1|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
117522|NCT01875978|287652|P2|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
117523|NCT01875978|287653|P1|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
117524|NCT01875978|287652|P2|NOT COMPLETED|Study 4weeks||0
117525|NCT01875978|287653|P1|NOT COMPLETED|Study 4weeks||0
117526|NCT01875978|287652|P2|COMPLETED|Study 4weeks||20
117527|NCT01875978|287653|P1|COMPLETED|Study 4weeks||20
117528|NCT01875978|287652|P2|STARTED|Study 4weeks||20
117529|NCT01875978|287653|P1|STARTED|Study 4weeks||20
117530|NCT01875874|287665|P1|NOT COMPLETED|Overall Study||3
117531|NCT01875874|287665|P1|COMPLETED|Overall Study||5
117532|NCT01875874|287665|P1|STARTED|Overall Study||8
117533|NCT01875861|287672|P2|NOT COMPLETED|Sustainability||0
117534|NCT01875861|287673|P1|NOT COMPLETED|Sustainability||0
117535|NCT01875861|287672|P2|COMPLETED|Sustainability||3444
117536|NCT01875861|287673|P1|COMPLETED|Sustainability||4306
117537|NCT01875861|287672|P2|STARTED|Sustainability||3444
117538|NCT01875861|287673|P1|STARTED|Sustainability||4306
117539|NCT01875861|287672|P2|NOT COMPLETED|Implementation||0
117540|NCT01875861|287673|P1|NOT COMPLETED|Implementation||0
117541|NCT01875861|287672|P2|COMPLETED|Implementation||3444
117542|NCT01875861|287673|P1|COMPLETED|Implementation||4546
117543|NCT01875861|287672|P2|STARTED|Implementation||3444
117544|NCT01875861|287673|P1|STARTED|Implementation||4546
117545|NCT01875861|287672|P2|NOT COMPLETED|Pre-implementation||0
117546|NCT01875861|287673|P1|NOT COMPLETED|Pre-implementation||0
117547|NCT01875861|287672|P2|COMPLETED|Pre-implementation||3714
117548|NCT01875861|287673|P1|COMPLETED|Pre-implementation||4779
117549|NCT01875861|287672|P2|STARTED|Pre-implementation||3714
117550|NCT01875861|287673|P1|STARTED|Pre-implementation||4779
117551|NCT01875848|287685|P2|NOT COMPLETED|Overall Study||0
117552|NCT01875848|287686|P1|NOT COMPLETED|Overall Study||2
117553|NCT01875848|287685|P2|COMPLETED|Overall Study|4 patients completed the opioid dose escalation arm of the study|4
117554|NCT01875848|287686|P1|COMPLETED|Overall Study|1 patient completed the Buprenorphine arm of the study. 2 patients withdrew|1
117555|NCT01875848|287685|P2|STARTED|Overall Study|4 patients were enrolled in the opioid dose escalation arm of the study|4
117556|NCT01875848|287686|P1|STARTED|Overall Study|3 patients were enrolled in the Buprenorphine arm of the study|3
117557|NCT01875783|287694|P1|NOT COMPLETED|Overall Study||0
117558|NCT01875783|287694|P1|COMPLETED|Overall Study||385
117559|NCT01875783|287694|P1|STARTED|Overall Study||385
117560|NCT01875731|287703|P2|NOT COMPLETED|Overall Study||0
117561|NCT01875731|287704|P1|NOT COMPLETED|Overall Study||1
117562|NCT01875731|287703|P2|COMPLETED|Overall Study||32
117563|NCT01875731|287704|P1|COMPLETED|Overall Study||33
117564|NCT01875731|287703|P2|STARTED|Overall Study||32
117565|NCT01875731|287704|P1|STARTED|Overall Study||34
117566|NCT01875510|287714|P2|NOT COMPLETED|Overall Study||0
117567|NCT01875510|287715|P1|NOT COMPLETED|Overall Study||0
117568|NCT01875510|287714|P2|COMPLETED|Overall Study||40
117569|NCT01875510|287715|P1|COMPLETED|Overall Study||40
117570|NCT01875510|287714|P2|STARTED|Overall Study||40
117571|NCT01875510|287715|P1|STARTED|Overall Study||40
117572|NCT01875471|287723|P2|NOT COMPLETED|Overall Study||1
117573|NCT01875471|287724|P1|NOT COMPLETED|Overall Study||1
117574|NCT01875471|287723|P2|COMPLETED|Overall Study||137
117575|NCT01875471|287724|P1|COMPLETED|Overall Study||136
117576|NCT01875471|287723|P2|Completed Per Protocol|Overall Study||123
117577|NCT01875471|287724|P1|Completed Per Protocol|Overall Study||127
117578|NCT01875471|287723|P2|STARTED|Overall Study||138
117579|NCT01875471|287724|P1|STARTED|Overall Study||137
117580|NCT01875445|287732|P2|NOT COMPLETED|Overall Study||0
117581|NCT01875445|287733|P1|NOT COMPLETED|Overall Study||7
117582|NCT01875445|287732|P2|COMPLETED|Overall Study||19
117583|NCT01875445|287733|P1|COMPLETED|Overall Study||12
117584|NCT01875445|287732|P2|STARTED|Overall Study||19
117585|NCT01875445|287733|P1|STARTED|Overall Study||19
117586|NCT01875237|287743|P2|NOT COMPLETED|Overall Study||0
117587|NCT01875237|287744|P1|NOT COMPLETED|Overall Study||2
117588|NCT01875237|287743|P2|COMPLETED|Overall Study||1
117589|NCT01875237|287744|P1|COMPLETED|Overall Study||0
117590|NCT01875237|287743|P2|STARTED|Overall Study||1
117591|NCT01875237|287744|P1|STARTED|Overall Study||2
117592|NCT01875185|287770|P2|NOT COMPLETED|Overall Study||48
117593|NCT01875185|287771|P1|NOT COMPLETED|Overall Study||52
117594|NCT01875185|287770|P2|COMPLETED|Overall Study||0
117595|NCT01875185|287771|P1|COMPLETED|Overall Study||0
117596|NCT01875185|287770|P2|STARTED|Overall Study||48
117597|NCT01875185|287771|P1|STARTED|Overall Study||52
117598|NCT01875159|287785|P2|NOT COMPLETED|Overall Study||0
117599|NCT01875159|287786|P1|NOT COMPLETED|Overall Study||3
117600|NCT01875159|287785|P2|COMPLETED|Overall Study||53
117601|NCT01875159|287786|P1|COMPLETED|Overall Study||42
117602|NCT01875159|287785|P2|STARTED|Overall Study||53
117603|NCT01875159|287786|P1|STARTED|Overall Study||45
117604|NCT01874951|287796|P2|NOT COMPLETED|Overall Study||0
117605|NCT01874951|287797|P1|NOT COMPLETED|Overall Study||0
117606|NCT01874951|287796|P2|COMPLETED|Overall Study||6
117607|NCT01874951|287797|P1|COMPLETED|Overall Study||6
117608|NCT01874951|287796|P2|STARTED|Overall Study||6
117609|NCT01874951|287797|P1|STARTED|Overall Study||6
117610|NCT01874756|287821|P4|NOT COMPLETED|Overall Study||6
117611|NCT01874756|287822|P3|NOT COMPLETED|Overall Study||2
117612|NCT01874756|287823|P2|NOT COMPLETED|Overall Study||0
117613|NCT01874756|287824|P1|NOT COMPLETED|Overall Study||1
117614|NCT01874756|287821|P4|COMPLETED|Overall Study||21
117615|NCT01874756|287822|P3|COMPLETED|Overall Study||27
117616|NCT01874756|287823|P2|COMPLETED|Overall Study||10
117617|NCT01874756|287824|P1|COMPLETED|Overall Study||28
117618|NCT01874756|287821|P4|STARTED|Overall Study||27
117619|NCT01874756|287822|P3|STARTED|Overall Study||29
117620|NCT01874756|287823|P2|STARTED|Overall Study||10
117621|NCT01874756|287824|P1|STARTED|Overall Study||29
117622|NCT01874665|287856|P2|NOT COMPLETED|Overall Study||15
117623|NCT01874665|287857|P1|NOT COMPLETED|Overall Study||30
117624|NCT01874665|287856|P2|COMPLETED|Overall Study||0
117625|NCT01874665|287857|P1|COMPLETED|Overall Study||0
117626|NCT01874665|287856|P2|STARTED|Overall Study||15
117627|NCT01874665|287857|P1|STARTED|Overall Study||30
117628|NCT01874535|287885|P2|NOT COMPLETED|Overall Study||44
117629|NCT01874535|287886|P1|NOT COMPLETED|Overall Study||55
117630|NCT01874535|287885|P2|COMPLETED|Overall Study||157
117631|NCT01874535|287886|P1|COMPLETED|Overall Study||152
117632|NCT01874535|287885|P2|STARTED|Overall Study||201
117633|NCT01874535|287886|P1|STARTED|Overall Study||207
117634|NCT01874353|287894|P2|NOT COMPLETED|Overall Study||37
117635|NCT01874353|287895|P1|NOT COMPLETED|Overall Study||55
117636|NCT01874353|287894|P2|COMPLETED|Overall Study||62
117637|NCT01874353|287895|P1|COMPLETED|Overall Study||141
117638|NCT01874353|287894|P2|STARTED|Overall Study||99
117639|NCT01874353|287895|P1|STARTED|Overall Study||196
117640|NCT01874340|287922|P4|NOT COMPLETED|Overall Study||5
117641|NCT01874340|287923|P3|NOT COMPLETED|Overall Study||8
117642|NCT01874340|287924|P2|NOT COMPLETED|Overall Study||8
117643|NCT01874340|287925|P1|NOT COMPLETED|Overall Study||6
117644|NCT01874340|287922|P4|COMPLETED|Overall Study||1
117645|NCT01874340|287923|P3|COMPLETED|Overall Study||0
117646|NCT01874340|287924|P2|COMPLETED|Overall Study||0
117647|NCT01874340|287925|P1|COMPLETED|Overall Study||0
117648|NCT01874340|287922|P4|STARTED|Overall Study||6
117649|NCT01874340|287923|P3|STARTED|Overall Study||8
117650|NCT01874340|287924|P2|STARTED|Overall Study||8
117651|NCT01874340|287925|P1|STARTED|Overall Study||6
117652|NCT01874275|287953|P2|NOT COMPLETED|Overall Study||0
117653|NCT01874275|287954|P1|NOT COMPLETED|Overall Study||1
117654|NCT01874275|287953|P2|COMPLETED|Overall Study||2
117655|NCT01874275|287954|P1|COMPLETED|Overall Study||3
117656|NCT01874275|287953|P2|STARTED|Overall Study||2
117657|NCT01874275|287954|P1|STARTED|Overall Study||4
117658|NCT01874262|287968|P2|NOT COMPLETED|Overall Study||3
117659|NCT01874262|287969|P1|NOT COMPLETED|Overall Study||5
117660|NCT01874262|287968|P2|COMPLETED|Overall Study||80
117661|NCT01874262|287969|P1|COMPLETED|Overall Study||86
117662|NCT01874262|287968|P2|Not Included Due to Tehnical Issues|Overall Study||3
117663|NCT01874262|287969|P1|Not Included Due to Tehnical Issues|Overall Study||3
117664|NCT01874262|287968|P2|Not Correctly Randomised|Overall Study||0
117665|NCT01874262|287969|P1|Not Correctly Randomised|Overall Study||2
117666|NCT01874262|287968|P2|STARTED|Overall Study||83
117667|NCT01874262|287969|P1|STARTED|Overall Study||91
117668|NCT01874145|287977|P2|NOT COMPLETED|Extension Period||4
117669|NCT01874145|287978|P1|NOT COMPLETED|Extension Period||6
117670|NCT01874145|287977|P2|COMPLETED|Extension Period||97
117671|NCT01874145|287978|P1|COMPLETED|Extension Period||91
117672|NCT01874145|287977|P2|Full Analysis Set|Extension Period||101
117673|NCT01874145|287978|P1|Full Analysis Set|Extension Period||95
117674|NCT01874145|287977|P2|STARTED|Extension Period|Non-Switchers|101
117675|NCT01874145|287978|P1|STARTED|Extension Period|Switchers|97
117676|NCT01874145|287977|P2|NOT COMPLETED|Core Period||7
117677|NCT01874145|287978|P1|NOT COMPLETED|Core Period||3
117678|NCT01874145|287977|P2|COMPLETED|Core Period||101
117679|NCT01874145|287978|P1|COMPLETED|Core Period||98
117680|NCT01874145|287977|P2|Full Analysis Set|Core Period||108
117681|NCT01874145|287978|P1|Full Analysis Set|Core Period||100
117682|NCT01874145|287977|P2|STARTED|Core Period||108
117683|NCT01874145|287978|P1|STARTED|Core Period||101
117684|NCT01874132|288017|P3|NOT COMPLETED|Overall Study||3
117685|NCT01874132|288018|P2|NOT COMPLETED|Overall Study||4
117686|NCT01874132|288019|P1|NOT COMPLETED|Overall Study||4
117687|NCT01874132|288017|P3|COMPLETED|Overall Study||19
117688|NCT01874132|288018|P2|COMPLETED|Overall Study||18
117689|NCT01874132|288019|P1|COMPLETED|Overall Study||18
117690|NCT01874132|288017|P3|STARTED|Overall Study||22
117691|NCT01874132|288018|P2|STARTED|Overall Study||22
117692|NCT01874132|288019|P1|STARTED|Overall Study||22
117693|NCT01874119|288030|P2|NOT COMPLETED|Second Intervention (6 Days)||0
117694|NCT01874119|288031|P1|NOT COMPLETED|Second Intervention (6 Days)||0
117695|NCT01874119|288030|P2|COMPLETED|Second Intervention (6 Days)||3
117696|NCT01874119|288031|P1|COMPLETED|Second Intervention (6 Days)||4
117697|NCT01874119|288030|P2|STARTED|Second Intervention (6 Days)||3
117698|NCT01874119|288031|P1|STARTED|Second Intervention (6 Days)||4
117699|NCT01874119|288030|P2|NOT COMPLETED|Washout (7 Days)||2
117700|NCT01874119|288031|P1|NOT COMPLETED|Washout (7 Days)||3
117701|NCT01874119|288030|P2|COMPLETED|Washout (7 Days)||3
117702|NCT01874119|288031|P1|COMPLETED|Washout (7 Days)||4
117703|NCT01874119|288030|P2|STARTED|Washout (7 Days)||5
117704|NCT01874119|288031|P1|STARTED|Washout (7 Days)||7
117705|NCT01874119|288030|P2|NOT COMPLETED|First Intervention (6 Days)||0
117706|NCT01874119|288031|P1|NOT COMPLETED|First Intervention (6 Days)||1
117707|NCT01874119|288030|P2|COMPLETED|First Intervention (6 Days)||5
117708|NCT01874119|288031|P1|COMPLETED|First Intervention (6 Days)||7
117709|NCT01874119|288030|P2|STARTED|First Intervention (6 Days)||5
117710|NCT01874119|288031|P1|STARTED|First Intervention (6 Days)||8
117711|NCT01874054|288037|P1|NOT COMPLETED|Overall Study||55
117712|NCT01874054|288037|P1|COMPLETED|Overall Study||0
117713|NCT01874054|288037|P1|Completed 16 Cycles of BV Treatment|Overall Study||17
117714|NCT01874054|288037|P1|Completed ≥2 Cycles of Combo Treatment|Overall Study||53
117715|NCT01874054|288037|P1|STARTED|Overall Study||55
117716|NCT01873989|288048|P2|NOT COMPLETED|Overall Study||1
117717|NCT01873989|288049|P1|NOT COMPLETED|Overall Study||1
117718|NCT01873989|288048|P2|COMPLETED|Overall Study||6
117719|NCT01873989|288049|P1|COMPLETED|Overall Study||7
117720|NCT01873989|288048|P2|STARTED|Overall Study||7
117721|NCT01873989|288049|P1|STARTED|Overall Study||8
117722|NCT01873950|288059|P5|NOT COMPLETED|Period 5||0
117723|NCT01873950|288060|P4|NOT COMPLETED|Period 5||1
117724|NCT01873950|288061|P3|NOT COMPLETED|Period 5||0
117725|NCT01873950|288062|P2|NOT COMPLETED|Period 5||0
117726|NCT01873950|288063|P1|NOT COMPLETED|Period 5||0
117727|NCT01873950|288059|P5|COMPLETED|Period 5||4
117728|NCT01873950|288060|P4|COMPLETED|Period 5||3
117729|NCT01873950|288061|P3|COMPLETED|Period 5||4
117730|NCT01873950|288062|P2|COMPLETED|Period 5||5
117731|NCT01873950|288063|P1|COMPLETED|Period 5||4
117732|NCT01873950|288059|P5|STARTED|Period 5||4
117733|NCT01873950|288060|P4|STARTED|Period 5||4
117734|NCT01873950|288061|P3|STARTED|Period 5||4
117735|NCT01873950|288062|P2|STARTED|Period 5||5
117736|NCT01873950|288063|P1|STARTED|Period 5||4
117737|NCT01873950|288059|P5|NOT COMPLETED|Period 4||0
117738|NCT01873950|288060|P4|NOT COMPLETED|Period 4||0
117739|NCT01873950|288061|P3|NOT COMPLETED|Period 4||0
117740|NCT01873950|288062|P2|NOT COMPLETED|Period 4||0
117741|NCT01873950|288063|P1|NOT COMPLETED|Period 4||0
117742|NCT01873950|288059|P5|COMPLETED|Period 4||5
117743|NCT01873950|288060|P4|COMPLETED|Period 4||4
117744|NCT01873950|288061|P3|COMPLETED|Period 4||4
117745|NCT01873950|288062|P2|COMPLETED|Period 4||5
117746|NCT01873950|288063|P1|COMPLETED|Period 4||4
117747|NCT01873950|288059|P5|STARTED|Period 4||5
117748|NCT01873950|288060|P4|STARTED|Period 4||4
117749|NCT01873950|288061|P3|STARTED|Period 4||4
117750|NCT01873950|288062|P2|STARTED|Period 4||5
117751|NCT01873950|288063|P1|STARTED|Period 4||4
117752|NCT01873950|288059|P5|NOT COMPLETED|Period 3||0
117753|NCT01873950|288060|P4|NOT COMPLETED|Period 3||0
117754|NCT01873950|288061|P3|NOT COMPLETED|Period 3||0
117755|NCT01873950|288062|P2|NOT COMPLETED|Period 3||0
117756|NCT01873950|288063|P1|NOT COMPLETED|Period 3||0
117757|NCT01873950|288059|P5|COMPLETED|Period 3||4
117758|NCT01873950|288060|P4|COMPLETED|Period 3||5
117759|NCT01873950|288061|P3|COMPLETED|Period 3||5
117760|NCT01873950|288062|P2|COMPLETED|Period 3||4
117761|NCT01873950|288063|P1|COMPLETED|Period 3||4
117762|NCT01873950|288059|P5|STARTED|Period 3||4
117763|NCT01873950|288060|P4|STARTED|Period 3||5
117764|NCT01873950|288061|P3|STARTED|Period 3||5
117765|NCT01873950|288062|P2|STARTED|Period 3||4
117766|NCT01873950|288063|P1|STARTED|Period 3||4
117767|NCT01873950|288059|P5|NOT COMPLETED|Period 2||0
117768|NCT01873950|288060|P4|NOT COMPLETED|Period 2||0
117769|NCT01873950|288061|P3|NOT COMPLETED|Period 2||0
117770|NCT01873950|288062|P2|NOT COMPLETED|Period 2||0
117771|NCT01873950|288063|P1|NOT COMPLETED|Period 2||0
117772|NCT01873950|288059|P5|COMPLETED|Period 2||5
117773|NCT01873950|288060|P4|COMPLETED|Period 2||4
117774|NCT01873950|288061|P3|COMPLETED|Period 2||4
117775|NCT01873950|288062|P2|COMPLETED|Period 2||4
117776|NCT01873950|288063|P1|COMPLETED|Period 2||5
117777|NCT01873950|288059|P5|STARTED|Period 2||5
117778|NCT01873950|288060|P4|STARTED|Period 2||4
117779|NCT01873950|288061|P3|STARTED|Period 2||4
117780|NCT01873950|288062|P2|STARTED|Period 2||4
117781|NCT01873950|288063|P1|STARTED|Period 2||5
117782|NCT01873950|288059|P5|NOT COMPLETED|Period 1||0
117783|NCT01873950|288060|P4|NOT COMPLETED|Period 1||0
117784|NCT01873950|288061|P3|NOT COMPLETED|Period 1||0
117785|NCT01873950|288062|P2|NOT COMPLETED|Period 1||0
117786|NCT01873950|288063|P1|NOT COMPLETED|Period 1||0
117787|NCT01873950|288059|P5|COMPLETED|Period 1||4
117788|NCT01873950|288060|P4|COMPLETED|Period 1||4
117789|NCT01873950|288061|P3|COMPLETED|Period 1||5
117790|NCT01873950|288062|P2|COMPLETED|Period 1||4
117791|NCT01873950|288063|P1|COMPLETED|Period 1||5
117792|NCT01873950|288059|P5|STARTED|Period 1||4
117793|NCT01873950|288060|P4|STARTED|Period 1||4
117794|NCT01873950|288061|P3|STARTED|Period 1||5
117795|NCT01873950|288062|P2|STARTED|Period 1||4
117796|NCT01873950|288063|P1|STARTED|Period 1||5
117797|NCT01873859|288100|P2|NOT COMPLETED|Overall Study||4
117798|NCT01873859|288101|P1|NOT COMPLETED|Overall Study||0
117799|NCT01873859|288100|P2|COMPLETED|Overall Study||79
117800|NCT01873859|288101|P1|COMPLETED|Overall Study||83
117801|NCT01873859|288100|P2|STARTED|Overall Study||83
117802|NCT01873859|288101|P1|STARTED|Overall Study||83
117803|NCT01873846|288109|P1|NOT COMPLETED|Overall Study||12
117804|NCT01873846|288109|P1|COMPLETED|Overall Study||388
117805|NCT01873846|288109|P1|Eligble Participants Dispensed Lenses|Overall Study||396
117806|NCT01873846|288109|P1|STARTED|Overall Study||400
117807|NCT01873729|288117|P1|NOT COMPLETED|Overall Study||1
117808|NCT01873729|288117|P1|COMPLETED|Overall Study||2
117809|NCT01873729|288117|P1|STARTED|Overall Study||3
117810|NCT01873586|288122|P1|NOT COMPLETED|Overall Study||3
117811|NCT01873586|288122|P1|COMPLETED|Overall Study||26
117812|NCT01873586|288122|P1|STARTED|Overall Study||29
117813|NCT01873495|288135|P1|NOT COMPLETED|Overall Study||7
117814|NCT01873495|288135|P1|COMPLETED|Overall Study||0
117815|NCT01873495|288135|P1|STARTED|Overall Study||7
117816|NCT01873417|288143|P1|NOT COMPLETED|Overall Study||35
117817|NCT01873417|288143|P1|COMPLETED|Overall Study||202
117818|NCT01873417|288143|P1|Safety Population|Overall Study|Participants who received at least 1 dose of dimethyl fumarate (DMF), recorded in diary data.|233
117819|NCT01873417|288143|P1|STARTED|Overall Study||237
117820|NCT01873287|288156|P2|NOT COMPLETED|Overall Study||174
117821|NCT01873287|288157|P1|NOT COMPLETED|Overall Study||305
117822|NCT01873287|288156|P2|COMPLETED|Overall Study||883
117823|NCT01873287|288157|P1|COMPLETED|Overall Study||1701
117824|NCT01873287|288156|P2|STARTED|Overall Study||1057
117825|NCT01873287|288157|P1|STARTED|Overall Study||2006
117826|NCT01872910|288171|P6|NOT COMPLETED|Overall Study||0
117827|NCT01872910|288172|P5|NOT COMPLETED|Overall Study||0
117828|NCT01872910|288173|P4|NOT COMPLETED|Overall Study||0
117829|NCT01872910|288174|P3|NOT COMPLETED|Overall Study||2
117830|NCT01872910|288175|P2|NOT COMPLETED|Overall Study||0
117831|NCT01872910|288176|P1|NOT COMPLETED|Overall Study||2
117832|NCT01872910|288171|P6|COMPLETED|Overall Study||3
117833|NCT01872910|288172|P5|COMPLETED|Overall Study||15
117834|NCT01872910|288173|P4|COMPLETED|Overall Study||15
117835|NCT01872910|288174|P3|COMPLETED|Overall Study||28
117836|NCT01872910|288175|P2|COMPLETED|Overall Study||31
117837|NCT01872910|288176|P1|COMPLETED|Overall Study||28
117838|NCT01872910|288171|P6|Received Any Study Drug|Overall Study||3
117839|NCT01872910|288172|P5|Received Any Study Drug|Overall Study||15
117840|NCT01872910|288173|P4|Received Any Study Drug|Overall Study||15
117841|NCT01872910|288174|P3|Received Any Study Drug|Overall Study||30
117842|NCT01872910|288175|P2|Received Any Study Drug|Overall Study||31
117843|NCT01872910|288176|P1|Received Any Study Drug|Overall Study||30
117844|NCT01872910|288171|P6|STARTED|Overall Study||3
117845|NCT01872910|288172|P5|STARTED|Overall Study||15
117846|NCT01872910|288173|P4|STARTED|Overall Study||15
117847|NCT01872910|288174|P3|STARTED|Overall Study||30
117848|NCT01872910|288175|P2|STARTED|Overall Study||31
117849|NCT01872910|288176|P1|STARTED|Overall Study||30
117850|NCT01872819|288216|P1|NOT COMPLETED|Overall Study||0
117851|NCT01872819|288216|P1|COMPLETED|Overall Study||14
117852|NCT01872819|288216|P1|STARTED|Overall Study||14
117853|NCT01872715|288221|P1|NOT COMPLETED|Overall Study||4
117854|NCT01872715|288221|P1|COMPLETED|Overall Study||20
117855|NCT01872715|288221|P1|STARTED|Overall Study||24
117856|NCT01872689|288240|P4|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0
117857|NCT01872689|288241|P3|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0
117858|NCT01872689|288242|P2|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||23
117859|NCT01872689|288243|P1|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||21
117860|NCT01872689|288240|P4|COMPLETED|Open-Label Period (Only For Monotherapy)||0
117861|NCT01872689|288241|P3|COMPLETED|Open-Label Period (Only For Monotherapy)||0
117862|NCT01872689|288242|P2|COMPLETED|Open-Label Period (Only For Monotherapy)||33
117863|NCT01872689|288243|P1|COMPLETED|Open-Label Period (Only For Monotherapy)||31
117864|NCT01872689|288240|P4|STARTED|Open-Label Period (Only For Monotherapy)|As per study design, Period 2 was not intended for this arm.|0
117865|NCT01872689|288241|P3|STARTED|Open-Label Period (Only For Monotherapy)|As per study design, Period 2 was not intended for this arm.|0
117866|NCT01872689|288242|P2|STARTED|Open-Label Period (Only For Monotherapy)|Of the 58 participants who completed Period 1, only 56 started Period 2.|56
117867|NCT01872689|288243|P1|STARTED|Open-Label Period (Only For Monotherapy)|Of the 56 participants who completed Period 1, only 52 started Period 2.|52
117868|NCT01872689|288240|P4|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||38
117869|NCT01872689|288241|P3|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||48
117870|NCT01872689|288242|P2|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20
117871|NCT01872689|288243|P1|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20
117872|NCT01872689|288240|P4|COMPLETED|Double-Blind/Placebo-Controlled Period||136
117873|NCT01872689|288241|P3|COMPLETED|Double-Blind/Placebo-Controlled Period||129
117874|NCT01872689|288242|P2|COMPLETED|Double-Blind/Placebo-Controlled Period||58
117875|NCT01872689|288243|P1|COMPLETED|Double-Blind/Placebo-Controlled Period||56
117876|NCT01872689|288240|P4|STARTED|Double-Blind/Placebo-Controlled Period||174
117877|NCT01872689|288241|P3|STARTED|Double-Blind/Placebo-Controlled Period||177
117878|NCT01872689|288242|P2|STARTED|Double-Blind/Placebo-Controlled Period||78
117879|NCT01872689|288243|P1|STARTED|Double-Blind/Placebo-Controlled Period||76
117880|NCT01872611|288319|P2|NOT COMPLETED|Overall Study||12
117881|NCT01872611|288320|P1|NOT COMPLETED|Overall Study||24
117882|NCT01872611|288319|P2|COMPLETED|Overall Study||292
117883|NCT01872611|288320|P1|COMPLETED|Overall Study||277
117884|NCT01872611|288319|P2|Full Analysis Set|Overall Study||293
117885|NCT01872611|288320|P1|Full Analysis Set|Overall Study||289
117886|NCT01872611|288319|P2|Treated (Safety Analysis Set)|Overall Study||295
117887|NCT01872611|288320|P1|Treated (Safety Analysis Set)|Overall Study||293
117888|NCT01872611|288319|P2|Randomized|Overall Study||304
117889|NCT01872611|288320|P1|Randomized|Overall Study||301
117890|NCT01872611|288319|P2|STARTED|Overall Study||304
117891|NCT01872611|288320|P1|STARTED|Overall Study||301
117892|NCT01872078|288342|P4|NOT COMPLETED|Overall Study||2
117893|NCT01872078|288343|P3|NOT COMPLETED|Overall Study||3
117894|NCT01872078|288344|P2|NOT COMPLETED|Overall Study||0
117895|NCT01872078|288345|P1|NOT COMPLETED|Overall Study||0
117896|NCT01872078|288342|P4|COMPLETED|Overall Study||15
117897|NCT01872078|288343|P3|COMPLETED|Overall Study||14
117898|NCT01872078|288344|P2|COMPLETED|Overall Study||15
117899|NCT01872078|288345|P1|COMPLETED|Overall Study||16
117900|NCT01872078|288342|P4|STARTED|Overall Study||17
117901|NCT01872078|288343|P3|STARTED|Overall Study||17
117902|NCT01872078|288344|P2|STARTED|Overall Study||15
117903|NCT01872078|288345|P1|STARTED|Overall Study||16
117904|NCT01871870|288355|P1|NOT COMPLETED|Overall Study||9
117905|NCT01871870|288355|P1|COMPLETED|Overall Study||11
117906|NCT01871870|288355|P1|STARTED|Overall Study||20
117907|NCT01871805|288366|P6|NOT COMPLETED|Phase II||87
117908|NCT01871805|288367|P5|NOT COMPLETED|Phase II||0
117909|NCT01871805|288368|P4|NOT COMPLETED|Phase II||0
117910|NCT01871805|288369|P3|NOT COMPLETED|Phase II||0
117911|NCT01871805|288370|P2|NOT COMPLETED|Phase II||0
117912|NCT01871805|288371|P1|NOT COMPLETED|Phase II||0
117913|NCT01871805|288366|P6|COMPLETED|Phase II||0
117914|NCT01871805|288367|P5|COMPLETED|Phase II||0
117915|NCT01871805|288368|P4|COMPLETED|Phase II||0
117916|NCT01871805|288369|P3|COMPLETED|Phase II||0
117917|NCT01871805|288370|P2|COMPLETED|Phase II||0
117918|NCT01871805|288371|P1|COMPLETED|Phase II||0
117919|NCT01871805|288366|P6|STARTED|Phase II||87
117920|NCT01871805|288367|P5|STARTED|Phase II||0
117921|NCT01871805|288368|P4|STARTED|Phase II||0
117922|NCT01871805|288369|P3|STARTED|Phase II||0
117923|NCT01871805|288370|P2|STARTED|Phase II||0
117924|NCT01871805|288371|P1|STARTED|Phase II||0
117925|NCT01871805|288366|P6|NOT COMPLETED|Phase I||0
117926|NCT01871805|288367|P5|NOT COMPLETED|Phase I||13
117927|NCT01871805|288368|P4|NOT COMPLETED|Phase I||7
117928|NCT01871805|288369|P3|NOT COMPLETED|Phase I||13
117929|NCT01871805|288370|P2|NOT COMPLETED|Phase I||7
117930|NCT01871805|288371|P1|NOT COMPLETED|Phase I||7
117931|NCT01871805|288366|P6|COMPLETED|Phase I||0
117932|NCT01871805|288367|P5|COMPLETED|Phase I||0
117933|NCT01871805|288368|P4|COMPLETED|Phase I||0
117934|NCT01871805|288369|P3|COMPLETED|Phase I||0
117935|NCT01871805|288370|P2|COMPLETED|Phase I||0
117936|NCT01871805|288371|P1|COMPLETED|Phase I||0
117937|NCT01871805|288366|P6|STARTED|Phase I||0
117938|NCT01871805|288367|P5|STARTED|Phase I||13
117939|NCT01871805|288368|P4|STARTED|Phase I||7
117940|NCT01871805|288369|P3|STARTED|Phase I||13
117941|NCT01871805|288370|P2|STARTED|Phase I||7
117942|NCT01871805|288371|P1|STARTED|Phase I||7
117943|NCT01871558|288443|P2|NOT COMPLETED|Overall Study||2
117944|NCT01871558|288444|P1|NOT COMPLETED|Overall Study||3
117945|NCT01871558|288443|P2|COMPLETED|Overall Study||19
117946|NCT01871558|288444|P1|COMPLETED|Overall Study||18
117947|NCT01871558|288443|P2|STARTED|Overall Study||21
117948|NCT01871558|288444|P1|STARTED|Overall Study||21
117949|NCT01871532|288464|P2|NOT COMPLETED|Overall Study||2
117950|NCT01871532|288465|P1|NOT COMPLETED|Overall Study||1
117951|NCT01871532|288464|P2|COMPLETED|Overall Study||10
117952|NCT01871532|288465|P1|COMPLETED|Overall Study||11
117953|NCT01871532|288464|P2|Subjects Received hCG Treatment|Overall Study||9
117954|NCT01871532|288465|P1|Subjects Received hCG Treatment|Overall Study||11
117955|NCT01871532|288464|P2|STARTED|Overall Study||12
117956|NCT01871532|288465|P1|STARTED|Overall Study||12
117957|NCT01871519|288499|P1|NOT COMPLETED|Overall Study||90
117958|NCT01871519|288499|P1|COMPLETED|Overall Study||260
117959|NCT01871519|288499|P1|STARTED|Overall Study||350
117960|NCT01871506|288522|P2|NOT COMPLETED|Overall Study||0
117961|NCT01871506|288523|P1|NOT COMPLETED|Overall Study||0
117962|NCT01871506|288522|P2|COMPLETED|Overall Study||153
117963|NCT01871506|288523|P1|COMPLETED|Overall Study||150
117964|NCT01871506|288522|P2|STARTED|Overall Study||153
117965|NCT01871506|288523|P1|STARTED|Overall Study||150
117966|NCT01871441|288547|P1|NOT COMPLETED|Overall Study||0
117967|NCT01871441|288547|P1|COMPLETED|Overall Study||4
117968|NCT01871441|288547|P1|STARTED|Overall Study||4
117969|NCT01871402|288556|P2|NOT COMPLETED|Overall Study||3
117970|NCT01871402|288557|P1|NOT COMPLETED|Overall Study||1
117971|NCT01871402|288556|P2|COMPLETED|Overall Study||108
117972|NCT01871402|288557|P1|COMPLETED|Overall Study||109
117973|NCT01871402|288556|P2|STARTED|Overall Study||111
117974|NCT01871402|288557|P1|STARTED|Overall Study||110
117975|NCT01871285|288575|P4|NOT COMPLETED|Second Intervention (1 Day)||0
117976|NCT01871285|288576|P3|NOT COMPLETED|Second Intervention (1 Day)||0
117977|NCT01871285|288577|P2|NOT COMPLETED|Second Intervention (1 Day)||0
117978|NCT01871285|288578|P1|NOT COMPLETED|Second Intervention (1 Day)||0
117979|NCT01871285|288575|P4|COMPLETED|Second Intervention (1 Day)||2
117980|NCT01871285|288576|P3|COMPLETED|Second Intervention (1 Day)||3
117981|NCT01871285|288577|P2|COMPLETED|Second Intervention (1 Day)||14
117982|NCT01871285|288578|P1|COMPLETED|Second Intervention (1 Day)||17
117983|NCT01871285|288575|P4|STARTED|Second Intervention (1 Day)||2
117984|NCT01871285|288576|P3|STARTED|Second Intervention (1 Day)||3
117985|NCT01871285|288577|P2|STARTED|Second Intervention (1 Day)||14
117986|NCT01871285|288578|P1|STARTED|Second Intervention (1 Day)||17
117987|NCT01871285|288575|P4|NOT COMPLETED|First Intervention (1 Day)||0
117988|NCT01871285|288576|P3|NOT COMPLETED|First Intervention (1 Day)||1
117989|NCT01871285|288577|P2|NOT COMPLETED|First Intervention (1 Day)||1
117990|NCT01871285|288578|P1|NOT COMPLETED|First Intervention (1 Day)||1
117991|NCT01871285|288575|P4|COMPLETED|First Intervention (1 Day)||2
117992|NCT01871285|288576|P3|COMPLETED|First Intervention (1 Day)||3
117993|NCT01871285|288577|P2|COMPLETED|First Intervention (1 Day)||14
117994|NCT01871285|288578|P1|COMPLETED|First Intervention (1 Day)||17
117995|NCT01871285|288575|P4|STARTED|First Intervention (1 Day)||2
117996|NCT01871285|288576|P3|STARTED|First Intervention (1 Day)||4
117997|NCT01871285|288577|P2|STARTED|First Intervention (1 Day)||15
117998|NCT01871285|288578|P1|STARTED|First Intervention (1 Day)||18
117999|NCT01871142|288604|P1|NOT COMPLETED|Overall Study||1
118000|NCT01871142|288604|P1|COMPLETED|Overall Study||11
118001|NCT01871142|288604|P1|Received 3000mg Aes-103 + Hypoxia|Overall Study||12
118002|NCT01871142|288604|P1|Received 1000mg Aes 103+ Hypoxia|Overall Study||11
118003|NCT01871142|288604|P1|Received Placebo + Hypoxia|Overall Study||12
118004|NCT01871142|288604|P1|Received Placebo + Normoixa|Overall Study||11
118005|NCT01871142|288604|P1|STARTED|Overall Study||12
118006|NCT01871090|288620|P2|NOT COMPLETED|Overall Study||23
118007|NCT01871090|288621|P1|NOT COMPLETED|Overall Study||2
118008|NCT01871090|288620|P2|COMPLETED|Overall Study||25
118009|NCT01871090|288621|P1|COMPLETED|Overall Study||33
118010|NCT01871090|288620|P2|STARTED|Overall Study||48
118011|NCT01871090|288621|P1|STARTED|Overall Study||35
118012|NCT01871077|288631|P1|NOT COMPLETED|Overall Study||0
118013|NCT01871077|288631|P1|COMPLETED|Overall Study||30
118014|NCT01871077|288631|P1|STARTED|Overall Study||30
118015|NCT01870999|288641|P3|NOT COMPLETED|Overall Study||7
118016|NCT01870999|288642|P2|NOT COMPLETED|Overall Study||8
118017|NCT01870999|288643|P1|NOT COMPLETED|Overall Study||4
118018|NCT01870999|288641|P3|COMPLETED|Overall Study||4
118019|NCT01870999|288642|P2|COMPLETED|Overall Study||8
118020|NCT01870999|288643|P1|COMPLETED|Overall Study||10
118021|NCT01870999|288641|P3|Safety Population; Received Study Drug|Overall Study||10
118022|NCT01870999|288642|P2|Safety Population; Received Study Drug|Overall Study||15
118023|NCT01870999|288643|P1|Safety Population; Received Study Drug|Overall Study||14
118024|NCT01870999|288641|P3|STARTED|Overall Study||11
118025|NCT01870999|288642|P2|STARTED|Overall Study||16
118026|NCT01870999|288643|P1|STARTED|Overall Study||14
118027|NCT01870973|288701|P2|NOT COMPLETED|Overall Study||3
118028|NCT01870973|288702|P1|NOT COMPLETED|Overall Study||10
118029|NCT01870973|288701|P2|COMPLETED|Overall Study||49
118030|NCT01870973|288702|P1|COMPLETED|Overall Study||46
118031|NCT01870973|288701|P2|STARTED|Overall Study||52
118032|NCT01870973|288702|P1|STARTED|Overall Study||56
118033|NCT01870921|288708|P1|NOT COMPLETED|Overall Study||90
118034|NCT01870921|288708|P1|COMPLETED|Overall Study||1914
118035|NCT01870921|288708|P1|STARTED|Overall Study||2004
118036|NCT01870856|288716|P2|NOT COMPLETED|Overall Study||0
118037|NCT01870856|288717|P1|NOT COMPLETED|Overall Study||0
118038|NCT01870856|288716|P2|COMPLETED|Overall Study||27
118039|NCT01870856|288717|P1|COMPLETED|Overall Study||25
118040|NCT01870856|288716|P2|STARTED|Overall Study||27
118041|NCT01870856|288717|P1|STARTED|Overall Study||25
118042|NCT01870843|288727|P1|NOT COMPLETED|Overall Study||53
118043|NCT01870843|288727|P1|COMPLETED|Overall Study||208
118044|NCT01870843|288727|P1|STARTED|Overall Study||261
118045|NCT01870778|288742|P2|NOT COMPLETED|Overall Study||9
118046|NCT01870778|288743|P1|NOT COMPLETED|Overall Study||8
118047|NCT01870778|288742|P2|COMPLETED|Overall Study||3262
118048|NCT01870778|288743|P1|COMPLETED|Overall Study||3266
118049|NCT01870778|288742|P2|Biomarker Analysis Set|Overall Study||510
118050|NCT01870778|288743|P1|Biomarker Analysis Set|Overall Study||521
118051|NCT01870778|288742|P2|Full Analysis Set|Overall Study||3271
118052|NCT01870778|288743|P1|Full Analysis Set|Overall Study||3274
118053|NCT01870778|288742|P2|Safety Set|Overall Study||3248
118054|NCT01870778|288743|P1|Safety Set|Overall Study||3257
118055|NCT01870778|288742|P2|STARTED|Overall Study||3271
118056|NCT01870778|288743|P1|STARTED|Overall Study||3274
118057|NCT01870739|288769|P2|NOT COMPLETED|Add-on Period (40 Weeks)||2
118058|NCT01870739|288770|P1|NOT COMPLETED|Add-on Period (40 Weeks)||3
118059|NCT01870739|288769|P2|COMPLETED|Add-on Period (40 Weeks)||51
118060|NCT01870739|288770|P1|COMPLETED|Add-on Period (40 Weeks)||51
118061|NCT01870739|288769|P2|STARTED|Add-on Period (40 Weeks)||53
118062|NCT01870739|288770|P1|STARTED|Add-on Period (40 Weeks)||54
118063|NCT01870739|288769|P2|NOT COMPLETED|Single Drug Treatment (12 Weeks)||4
118064|NCT01870739|288770|P1|NOT COMPLETED|Single Drug Treatment (12 Weeks)||3
118065|NCT01870739|288769|P2|COMPLETED|Single Drug Treatment (12 Weeks)||53
118066|NCT01870739|288770|P1|COMPLETED|Single Drug Treatment (12 Weeks)|"Completed indicates maintenance dose complete"|54
118067|NCT01870739|288769|P2|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||56
118068|NCT01870739|288770|P1|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||57
118069|NCT01870739|288769|P2|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||56
118070|NCT01870739|288770|P1|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||57
118071|NCT01870739|288769|P2|STARTED|Single Drug Treatment (12 Weeks)||57
118072|NCT01870739|288770|P1|STARTED|Single Drug Treatment (12 Weeks)|"Start = Safety/Pharmacokinetic/Pharmacodynamic analysis set"|57
118073|NCT01870726|288809|P7|NOT COMPLETED|Overall Study||10
118074|NCT01870726|288810|P6|NOT COMPLETED|Overall Study||5
118075|NCT01870726|288811|P5|NOT COMPLETED|Overall Study||7
118076|NCT01870726|288812|P4|NOT COMPLETED|Overall Study||6
118077|NCT01870726|288813|P3|NOT COMPLETED|Overall Study||4
118078|NCT01870726|288814|P2|NOT COMPLETED|Overall Study||6
118079|NCT01870726|288815|P1|NOT COMPLETED|Overall Study||5
118080|NCT01870726|288809|P7|COMPLETED|Overall Study||0
118081|NCT01870726|288810|P6|COMPLETED|Overall Study||0
118082|NCT01870726|288811|P5|COMPLETED|Overall Study||0
118083|NCT01870726|288812|P4|COMPLETED|Overall Study||0
118084|NCT01870726|288813|P3|COMPLETED|Overall Study||0
118085|NCT01870726|288814|P2|COMPLETED|Overall Study||0
118086|NCT01870726|288815|P1|COMPLETED|Overall Study||0
118087|NCT01870726|288809|P7|STARTED|Overall Study||10
118088|NCT01870726|288810|P6|STARTED|Overall Study||5
118089|NCT01870726|288811|P5|STARTED|Overall Study||7
118090|NCT01870726|288812|P4|STARTED|Overall Study||6
118091|NCT01870726|288813|P3|STARTED|Overall Study||4
118092|NCT01870726|288814|P2|STARTED|Overall Study||6
118093|NCT01870726|288815|P1|STARTED|Overall Study||5
118094|NCT01870596|288900|P2|NOT COMPLETED|Overall Study||0
118095|NCT01870596|288901|P1|NOT COMPLETED|Overall Study||0
118096|NCT01870596|288900|P2|COMPLETED|Overall Study||18
118097|NCT01870596|288901|P1|COMPLETED|Overall Study||14
118098|NCT01870596|288900|P2|STARTED|Overall Study||18
118099|NCT01870596|288901|P1|STARTED|Overall Study||14
118100|NCT01870583|288910|P3|NOT COMPLETED|Overall Study||8
118101|NCT01870583|288911|P2|NOT COMPLETED|Overall Study||18
118102|NCT01870583|288912|P1|NOT COMPLETED|Overall Study||11
118103|NCT01870583|288910|P3|COMPLETED|Overall Study||455
118104|NCT01870583|288911|P2|COMPLETED|Overall Study||456
118105|NCT01870583|288912|P1|COMPLETED|Overall Study||456
118106|NCT01870583|288910|P3|STARTED|Overall Study||463
118107|NCT01870583|288911|P2|STARTED|Overall Study||474
118108|NCT01870583|288912|P1|STARTED|Overall Study||467
118109|NCT01870388|288922|P2|NOT COMPLETED|Overall Study||0
118110|NCT01870388|288923|P1|NOT COMPLETED|Overall Study||0
118111|NCT01870388|288922|P2|COMPLETED|Overall Study||8
118112|NCT01870388|288923|P1|COMPLETED|Overall Study||8
118113|NCT01870388|288922|P2|Received 1 Dose of Study Drug|Overall Study||8
118114|NCT01870388|288923|P1|Received 1 Dose of Study Drug|Overall Study||8
118115|NCT01870388|288922|P2|STARTED|Overall Study||8
118116|NCT01870388|288923|P1|STARTED|Overall Study||8
118117|NCT01870297|288938|P7|NOT COMPLETED|Overall Study||2
118118|NCT01870297|288939|P6|NOT COMPLETED|Overall Study||1
118119|NCT01870297|288940|P5|NOT COMPLETED|Overall Study||3
118120|NCT01870297|288941|P4|NOT COMPLETED|Overall Study||0
118121|NCT01870297|288942|P3|NOT COMPLETED|Overall Study||1
118122|NCT01870297|288943|P2|NOT COMPLETED|Overall Study||7
118123|NCT01870297|288944|P1|NOT COMPLETED|Overall Study||0
118124|NCT01870297|288938|P7|COMPLETED|Overall Study||8
118125|NCT01870297|288939|P6|COMPLETED|Overall Study||8
118126|NCT01870297|288940|P5|COMPLETED|Overall Study||7
118127|NCT01870297|288941|P4|COMPLETED|Overall Study||9
118128|NCT01870297|288942|P3|COMPLETED|Overall Study||7
118129|NCT01870297|288943|P2|COMPLETED|Overall Study||8
118130|NCT01870297|288944|P1|COMPLETED|Overall Study||11
118131|NCT01870297|288938|P7|STARTED|Overall Study||10
118132|NCT01870297|288939|P6|STARTED|Overall Study||9
118133|NCT01870297|288940|P5|STARTED|Overall Study||10
118134|NCT01870297|288941|P4|STARTED|Overall Study||9
118135|NCT01870297|288942|P3|STARTED|Overall Study||8
118136|NCT01870297|288943|P2|STARTED|Overall Study||15
118137|NCT01870297|288944|P1|STARTED|Overall Study||11
118138|NCT01870076|288988|P4|NOT COMPLETED|Overall Study||0
118139|NCT01870076|288989|P3|NOT COMPLETED|Overall Study||1
118140|NCT01870076|288990|P2|NOT COMPLETED|Overall Study||0
118141|NCT01870076|288991|P1|NOT COMPLETED|Overall Study||1
118142|NCT01870076|288988|P4|COMPLETED|Overall Study||11
118143|NCT01870076|288989|P3|COMPLETED|Overall Study||7
118144|NCT01870076|288990|P2|COMPLETED|Overall Study||12
118145|NCT01870076|288991|P1|COMPLETED|Overall Study||9
118146|NCT01870076|288988|P4|STARTED|Overall Study||11
118147|NCT01870076|288989|P3|STARTED|Overall Study||8
118148|NCT01870076|288990|P2|STARTED|Overall Study||12
118149|NCT01870076|288991|P1|STARTED|Overall Study||10
118150|NCT01869959|289009|P5|NOT COMPLETED|Treatment Period||0
118151|NCT01869959|289010|P4|NOT COMPLETED|Treatment Period||2
118152|NCT01869959|289011|P3|NOT COMPLETED|Treatment Period||3
118153|NCT01869959|289012|P2|NOT COMPLETED|Treatment Period||2
118154|NCT01869959|289013|P1|NOT COMPLETED|Treatment Period||1
118155|NCT01869959|289009|P5|COMPLETED|Treatment Period||0
118156|NCT01869959|289010|P4|COMPLETED|Treatment Period||8
118157|NCT01869959|289011|P3|COMPLETED|Treatment Period||12
118158|NCT01869959|289012|P2|COMPLETED|Treatment Period||8
118159|NCT01869959|289013|P1|COMPLETED|Treatment Period||10
118160|NCT01869959|289009|P5|Received at Least 1 Dose of Study Drug|Treatment Period||0
118161|NCT01869959|289010|P4|Received at Least 1 Dose of Study Drug|Treatment Period||10
118162|NCT01869959|289011|P3|Received at Least 1 Dose of Study Drug|Treatment Period||15
118163|NCT01869959|289012|P2|Received at Least 1 Dose of Study Drug|Treatment Period||10
118164|NCT01869959|289013|P1|Received at Least 1 Dose of Study Drug|Treatment Period||11
118165|NCT01869959|289009|P5|STARTED|Treatment Period|Participants were randomized to treatment groups for the Treatment Period.|0
118166|NCT01869959|289010|P4|STARTED|Treatment Period||10
118167|NCT01869959|289011|P3|STARTED|Treatment Period||15
118168|NCT01869959|289012|P2|STARTED|Treatment Period||10
118169|NCT01869959|289013|P1|STARTED|Treatment Period||11
118170|NCT01869959|289009|P5|NOT COMPLETED|Randomization Period||1
118171|NCT01869959|289010|P4|NOT COMPLETED|Randomization Period||0
118172|NCT01869959|289011|P3|NOT COMPLETED|Randomization Period||0
118173|NCT01869959|289012|P2|NOT COMPLETED|Randomization Period||0
118174|NCT01869959|289013|P1|NOT COMPLETED|Randomization Period||0
118175|NCT01869959|289009|P5|COMPLETED|Randomization Period|One participant discontinued after randomization but did not receive study drug.|46
118176|NCT01869959|289010|P4|COMPLETED|Randomization Period||0
118177|NCT01869959|289011|P3|COMPLETED|Randomization Period||0
118178|NCT01869959|289012|P2|COMPLETED|Randomization Period||0
118179|NCT01869959|289013|P1|COMPLETED|Randomization Period||0
118180|NCT01869959|289009|P5|STARTED|Randomization Period||47
118181|NCT01869959|289010|P4|STARTED|Randomization Period||0
118182|NCT01869959|289011|P3|STARTED|Randomization Period||0
118183|NCT01869959|289012|P2|STARTED|Randomization Period||0
118184|NCT01869959|289013|P1|STARTED|Randomization Period||0
118185|NCT01869764|289083|P2|NOT COMPLETED|Overall Study||2
118186|NCT01869764|289084|P1|NOT COMPLETED|Overall Study||0
118187|NCT01869764|289083|P2|COMPLETED|Overall Study||27
118188|NCT01869764|289084|P1|COMPLETED|Overall Study||28
118189|NCT01869764|289083|P2|STARTED|Overall Study||29
118190|NCT01869764|289084|P1|STARTED|Overall Study||28
118191|NCT01869699|289102|P2|NOT COMPLETED|Overall Study||0
118192|NCT01869699|289103|P1|NOT COMPLETED|Overall Study||1
118193|NCT01869699|289102|P2|COMPLETED|Overall Study||20
118194|NCT01869699|289103|P1|COMPLETED|Overall Study||20
118195|NCT01869699|289102|P2|STARTED|Overall Study||20
118196|NCT01869699|289103|P1|STARTED|Overall Study||21
118197|NCT01869686|289121|P1|NOT COMPLETED|Overall Study||0
118198|NCT01869686|289121|P1|COMPLETED|Overall Study||12
118199|NCT01869686|289121|P1|STARTED|Overall Study||12
118200|NCT01869647|289136|P3|NOT COMPLETED|Overall Study||0
118201|NCT01869647|289137|P2|NOT COMPLETED|Overall Study||6
118202|NCT01869647|289138|P1|NOT COMPLETED|Overall Study||1
118203|NCT01869647|289136|P3|COMPLETED|Overall Study||62
118204|NCT01869647|289137|P2|COMPLETED|Overall Study||130
118205|NCT01869647|289138|P1|COMPLETED|Overall Study||65
118206|NCT01869647|289136|P3|STARTED|Overall Study||62
118207|NCT01869647|289137|P2|STARTED|Overall Study||136
118208|NCT01869647|289138|P1|STARTED|Overall Study||66
118209|NCT01869478|289151|P2|NOT COMPLETED|Overall Study||0
118210|NCT01869478|289152|P1|NOT COMPLETED|Overall Study||0
118211|NCT01869478|289151|P2|COMPLETED|Overall Study||1
118212|NCT01869478|289152|P1|COMPLETED|Overall Study||0
118213|NCT01869478|289151|P2|STARTED|Overall Study||1
118214|NCT01869478|289152|P1|STARTED|Overall Study||0
118215|NCT01869439|289160|P1|NOT COMPLETED|Overall Study||0
118216|NCT01869439|289160|P1|COMPLETED|Overall Study||40
118217|NCT01869439|289160|P1|STARTED|Overall Study||40
118218|NCT01869348|289166|P2|NOT COMPLETED|Overall Study||1
118219|NCT01869348|289167|P1|NOT COMPLETED|Overall Study||1
118220|NCT01869348|289166|P2|COMPLETED|Overall Study||19
118221|NCT01869348|289167|P1|COMPLETED|Overall Study||19
118222|NCT01869348|289166|P2|STARTED|Overall Study||20
118223|NCT01869348|289167|P1|STARTED|Overall Study||20
118224|NCT01869192|289175|P2|NOT COMPLETED|Postoperative Chemotherapy||2
118225|NCT01869192|289176|P1|NOT COMPLETED|Postoperative Chemotherapy||0
118226|NCT01869192|289175|P2|COMPLETED|Postoperative Chemotherapy||31
118227|NCT01869192|289176|P1|COMPLETED|Postoperative Chemotherapy||32
118228|NCT01869192|289175|P2|STARTED|Postoperative Chemotherapy||33
118229|NCT01869192|289176|P1|STARTED|Postoperative Chemotherapy|3 did not start postop chemotherapy|32
118230|NCT01869192|289175|P2|NOT COMPLETED|Preoperative Chemotherapy to Surgery||1
118231|NCT01869192|289176|P1|NOT COMPLETED|Preoperative Chemotherapy to Surgery||2
118232|NCT01869192|289175|P2|COMPLETED|Preoperative Chemotherapy to Surgery|one never got treatment on study|34
118233|NCT01869192|289176|P1|COMPLETED|Preoperative Chemotherapy to Surgery||35
118234|NCT01869192|289175|P2|STARTED|Preoperative Chemotherapy to Surgery||35
118235|NCT01869192|289176|P1|STARTED|Preoperative Chemotherapy to Surgery||37
118236|NCT01869075|289190|P6|NOT COMPLETED|Phase 2||0
118237|NCT01869075|289191|P5|NOT COMPLETED|Phase 2||0
118238|NCT01869075|289192|P4|NOT COMPLETED|Phase 2||0
118239|NCT01869075|289193|P3|NOT COMPLETED|Phase 2||0
118240|NCT01869075|289194|P2|NOT COMPLETED|Phase 2||0
118241|NCT01869075|289195|P1|NOT COMPLETED|Phase 2||0
118242|NCT01869075|289190|P6|COMPLETED|Phase 2||45
118243|NCT01869075|289191|P5|COMPLETED|Phase 2||75
118244|NCT01869075|289192|P4|COMPLETED|Phase 2||45
118245|NCT01869075|289193|P3|COMPLETED|Phase 2||75
118246|NCT01869075|289194|P2|COMPLETED|Phase 2||30
118247|NCT01869075|289195|P1|COMPLETED|Phase 2||90
118248|NCT01869075|289190|P6|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
118249|NCT01869075|289191|P5|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
118250|NCT01869075|289192|P4|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
118251|NCT01869075|289193|P3|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
118252|NCT01869075|289194|P2|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|30
118253|NCT01869075|289195|P1|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|90
118254|NCT01869075|289190|P6|NOT COMPLETED|Phase 1||0
118255|NCT01869075|289191|P5|NOT COMPLETED|Phase 1||0
118256|NCT01869075|289192|P4|NOT COMPLETED|Phase 1||0
118257|NCT01869075|289193|P3|NOT COMPLETED|Phase 1||0
118258|NCT01869075|289194|P2|NOT COMPLETED|Phase 1||0
118259|NCT01869075|289195|P1|NOT COMPLETED|Phase 1||0
118260|NCT01869075|289190|P6|COMPLETED|Phase 1||90
118261|NCT01869075|289191|P5|COMPLETED|Phase 1||30
118262|NCT01869075|289192|P4|COMPLETED|Phase 1||75
118263|NCT01869075|289193|P3|COMPLETED|Phase 1||45
118264|NCT01869075|289194|P2|COMPLETED|Phase 1||75
118265|NCT01869075|289195|P1|COMPLETED|Phase 1||45
118266|NCT01869075|289190|P6|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|90
118267|NCT01869075|289191|P5|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|30
118268|NCT01869075|289192|P4|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
118449|NCT01867658|289784|P1|COMPLETED|Overall Study||103
118269|NCT01869075|289193|P3|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
118270|NCT01869075|289194|P2|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
118271|NCT01869075|289195|P1|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
118272|NCT01869075|289190|P6|NOT COMPLETED|Phase 0 (Baseline)||0
118273|NCT01869075|289191|P5|NOT COMPLETED|Phase 0 (Baseline)||0
118274|NCT01869075|289192|P4|NOT COMPLETED|Phase 0 (Baseline)||0
118275|NCT01869075|289193|P3|NOT COMPLETED|Phase 0 (Baseline)||0
118276|NCT01869075|289194|P2|NOT COMPLETED|Phase 0 (Baseline)||0
118277|NCT01869075|289195|P1|NOT COMPLETED|Phase 0 (Baseline)||0
118278|NCT01869075|289190|P6|COMPLETED|Phase 0 (Baseline)||341
118279|NCT01869075|289191|P5|COMPLETED|Phase 0 (Baseline)||0
118280|NCT01869075|289192|P4|COMPLETED|Phase 0 (Baseline)||416
118281|NCT01869075|289193|P3|COMPLETED|Phase 0 (Baseline)||0
118282|NCT01869075|289194|P2|COMPLETED|Phase 0 (Baseline)||418
118283|NCT01869075|289195|P1|COMPLETED|Phase 0 (Baseline)||0
118284|NCT01869075|289190|P6|STARTED|Phase 0 (Baseline)||341
118285|NCT01869075|289191|P5|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
118286|NCT01869075|289192|P4|STARTED|Phase 0 (Baseline)||416
118287|NCT01869075|289193|P3|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
118288|NCT01869075|289194|P2|STARTED|Phase 0 (Baseline)||418
118289|NCT01869075|289195|P1|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
118290|NCT01868997|289211|P2|NOT COMPLETED|Overall Study||6
118291|NCT01868997|289212|P1|NOT COMPLETED|Overall Study||7
118292|NCT01868997|289211|P2|COMPLETED|Overall Study||36
118293|NCT01868997|289212|P1|COMPLETED|Overall Study||38
118294|NCT01868997|289211|P2|STARTED|Overall Study|randomized and treated|42
118295|NCT01868997|289212|P1|STARTED|Overall Study|randomized and treated|45
118296|NCT01868893|289228|P1|NOT COMPLETED|Overall Study||20
118297|NCT01868893|289228|P1|COMPLETED|Overall Study||0
118298|NCT01868893|289228|P1|STARTED|Overall Study||20
118299|NCT01868789|289237|P2|NOT COMPLETED|Overall Study||2
118300|NCT01868789|289238|P1|NOT COMPLETED|Overall Study||2
118301|NCT01868789|289237|P2|COMPLETED|Overall Study||12
118302|NCT01868789|289238|P1|COMPLETED|Overall Study||7
118303|NCT01868789|289237|P2|STARTED|Overall Study||14
118304|NCT01868789|289238|P1|STARTED|Overall Study||9
118305|NCT01868776|289248|P2|NOT COMPLETED|Overall Study||0
118306|NCT01868776|289249|P1|NOT COMPLETED|Overall Study||0
118307|NCT01868776|289248|P2|COMPLETED|Overall Study||50
118308|NCT01868776|289249|P1|COMPLETED|Overall Study||50
118309|NCT01868776|289248|P2|STARTED|Overall Study||50
118310|NCT01868776|289249|P1|STARTED|Overall Study||50
118311|NCT01868646|289257|P2|NOT COMPLETED|Overall Study||5
118312|NCT01868646|289258|P1|NOT COMPLETED|Overall Study||3
118313|NCT01868646|289257|P2|COMPLETED|Overall Study||67
118314|NCT01868646|289258|P1|COMPLETED|Overall Study||73
118315|NCT01868646|289257|P2|STARTED|Overall Study||72
118316|NCT01868646|289258|P1|STARTED|Overall Study||76
118317|NCT01868633|289286|P2|NOT COMPLETED|Overall Study||0
118318|NCT01868633|289287|P1|NOT COMPLETED|Overall Study||0
118319|NCT01868633|289286|P2|COMPLETED|Overall Study||26
118320|NCT01868633|289287|P1|COMPLETED|Overall Study||26
118321|NCT01868633|289286|P2|STARTED|Overall Study||26
118322|NCT01868633|289287|P1|STARTED|Overall Study||26
118323|NCT01868594|289303|P2|NOT COMPLETED|Overall Study||3
118324|NCT01868594|289304|P1|NOT COMPLETED|Overall Study||4
118325|NCT01868594|289303|P2|COMPLETED|Overall Study||72
118326|NCT01868594|289304|P1|COMPLETED|Overall Study||72
118327|NCT01868594|289303|P2|STARTED|Overall Study||75
118328|NCT01868594|289304|P1|STARTED|Overall Study||76
118329|NCT01868542|289324|P2|NOT COMPLETED|Overall Study||2
118330|NCT01868542|289325|P1|NOT COMPLETED|Overall Study||0
118331|NCT01868542|289324|P2|COMPLETED|Overall Study||21
118332|NCT01868542|289325|P1|COMPLETED|Overall Study||23
118333|NCT01868542|289324|P2|STARTED|Overall Study||23
118334|NCT01868542|289325|P1|STARTED|Overall Study||23
118335|NCT01868503|289343|P1|NOT COMPLETED|Overall Study||2
118336|NCT01868503|289343|P1|COMPLETED|Overall Study||5
118337|NCT01868503|289343|P1|STARTED|Overall Study||7
118338|NCT01868477|289353|P2|NOT COMPLETED|Overall Study||5
118339|NCT01868477|289354|P1|NOT COMPLETED|Overall Study||4
118340|NCT01868477|289353|P2|COMPLETED|Overall Study||6
118341|NCT01868477|289354|P1|COMPLETED|Overall Study||8
118342|NCT01868477|289353|P2|Not Switched to EPO+DFX|Overall Study||0
118343|NCT01868477|289354|P1|Not Switched to EPO+DFX|Overall Study||7
118344|NCT01868477|289353|P2|Switched to EPO+DFX|Overall Study||0
118345|NCT01868477|289354|P1|Switched to EPO+DFX|Overall Study||5
118346|NCT01868477|289353|P2|STARTED|Overall Study||11
118347|NCT01868477|289354|P1|STARTED|Overall Study||12
118348|NCT01868334|289382|P4|NOT COMPLETED|Year 2 Pre-post Study||0
118349|NCT01868334|289383|P3|NOT COMPLETED|Year 2 Pre-post Study||0
118350|NCT01868334|289384|P2|NOT COMPLETED|Year 2 Pre-post Study||0
118351|NCT01868334|289385|P1|NOT COMPLETED|Year 2 Pre-post Study||0
118352|NCT01868334|289382|P4|COMPLETED|Year 2 Pre-post Study||19274
118353|NCT01868334|289383|P3|COMPLETED|Year 2 Pre-post Study||20904
118354|NCT01868334|289384|P2|COMPLETED|Year 2 Pre-post Study||8047
118355|NCT01868334|289385|P1|COMPLETED|Year 2 Pre-post Study||22324
118356|NCT01868334|289382|P4|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Intervention sites who chose not to actively engage Year 2|19274
118357|NCT01868334|289383|P3|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Control sites who became active in the intervention during Year 2|20904
118358|NCT01868334|289384|P2|STARTED|Year 2 Pre-post Study|Reflects: the six Year 1 Intervention sites who chose not to actively engage Year 2|8047
118359|NCT01868334|289385|P1|STARTED|Year 2 Pre-post Study|Reflects: control sites from Year 1 (N=8) and Year 1 Intervention sites who continued in Y2 (N=4)|22324
118360|NCT01868334|289382|P4|NOT COMPLETED|Year 1 RCCT Study||0
118361|NCT01868334|289383|P3|NOT COMPLETED|Year 1 RCCT Study||0
118362|NCT01868334|289384|P2|NOT COMPLETED|Year 1 RCCT Study||0
118363|NCT01868334|289385|P1|NOT COMPLETED|Year 1 RCCT Study||0
118364|NCT01868334|289382|P4|COMPLETED|Year 1 RCCT Study||20904
118365|NCT01868334|289383|P3|COMPLETED|Year 1 RCCT Study||19274
118366|NCT01868334|289384|P2|COMPLETED|Year 1 RCCT Study||17185
118367|NCT01868334|289385|P1|COMPLETED|Year 1 RCCT Study||13186
118368|NCT01868334|289382|P4|STARTED|Year 1 RCCT Study||20904
118369|NCT01868334|289383|P3|STARTED|Year 1 RCCT Study||19274
118370|NCT01868334|289384|P2|STARTED|Year 1 RCCT Study||17185
118371|NCT01868334|289385|P1|STARTED|Year 1 RCCT Study||13186
118372|NCT01868243|289425|P2|NOT COMPLETED|Overall Study||1
118373|NCT01868243|289426|P1|NOT COMPLETED|Overall Study||0
118374|NCT01868243|289425|P2|COMPLETED|Overall Study||11
118375|NCT01868243|289426|P1|COMPLETED|Overall Study||15
118376|NCT01868243|289425|P2|STARTED|Overall Study||12
118377|NCT01868243|289426|P1|STARTED|Overall Study||15
118378|NCT01868165|289434|P1|NOT COMPLETED|Overall Study||45
118379|NCT01868165|289434|P1|COMPLETED|Overall Study||292
118380|NCT01868165|289434|P1|STARTED|Overall Study||337
118381|NCT01868139|289438|P1|NOT COMPLETED|Overall Study||1
118382|NCT01868139|289438|P1|COMPLETED|Overall Study||0
118383|NCT01868139|289438|P1|STARTED|Overall Study||1
118384|NCT01868074|289450|P2|NOT COMPLETED|Overall Study||4
118385|NCT01868074|289451|P1|NOT COMPLETED|Overall Study||7
118386|NCT01868074|289450|P2|COMPLETED|Overall Study||32
118387|NCT01868074|289451|P1|COMPLETED|Overall Study||29
118388|NCT01868074|289450|P2|STARTED|Overall Study||36
118389|NCT01868074|289451|P1|STARTED|Overall Study||36
118390|NCT01868035|289461|P1|NOT COMPLETED|Overall Study||7
118391|NCT01868035|289461|P1|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|8
118392|NCT01868035|289461|P1|STARTED|Overall Study||15
118393|NCT01868022|289486|P9|NOT COMPLETED|Overall Study||2
118394|NCT01868022|289487|P8|NOT COMPLETED|Overall Study||9
118395|NCT01868022|289488|P7|NOT COMPLETED|Overall Study||0
118396|NCT01868022|289489|P6|NOT COMPLETED|Overall Study||1
118397|NCT01868022|289490|P5|NOT COMPLETED|Overall Study||2
118398|NCT01868022|289491|P4|NOT COMPLETED|Overall Study||1
118399|NCT01868022|289492|P3|NOT COMPLETED|Overall Study||1
118400|NCT01868022|289493|P2|NOT COMPLETED|Overall Study||0
118401|NCT01868022|289494|P1|NOT COMPLETED|Overall Study||0
118402|NCT01868022|289486|P9|COMPLETED|Overall Study||6
118403|NCT01868022|289487|P8|COMPLETED|Overall Study||16
118404|NCT01868022|289488|P7|COMPLETED|Overall Study||3
118405|NCT01868022|289489|P6|COMPLETED|Overall Study||2
118406|NCT01868022|289490|P5|COMPLETED|Overall Study||1
118407|NCT01868022|289491|P4|COMPLETED|Overall Study||2
118408|NCT01868022|289492|P3|COMPLETED|Overall Study||13
118409|NCT01868022|289493|P2|COMPLETED|Overall Study||3
118410|NCT01868022|289494|P1|COMPLETED|Overall Study||3
118411|NCT01868022|289486|P9|STARTED|Overall Study||8
118412|NCT01868022|289487|P8|STARTED|Overall Study||25
118413|NCT01868022|289488|P7|STARTED|Overall Study||3
118414|NCT01868022|289489|P6|STARTED|Overall Study||3
118415|NCT01868022|289490|P5|STARTED|Overall Study||3
118416|NCT01868022|289491|P4|STARTED|Overall Study||3
118417|NCT01868022|289492|P3|STARTED|Overall Study||14
118418|NCT01868022|289493|P2|STARTED|Overall Study||3
118419|NCT01868022|289494|P1|STARTED|Overall Study||3
118420|NCT01868009|289700|P2|NOT COMPLETED|Period 2 (5-9 Days)||0
118421|NCT01868009|289701|P1|NOT COMPLETED|Period 2 (5-9 Days)||2
118422|NCT01868009|289700|P2|COMPLETED|Period 2 (5-9 Days)||142
118423|NCT01868009|289701|P1|COMPLETED|Period 2 (5-9 Days)||141
118424|NCT01868009|289700|P2|STARTED|Period 2 (5-9 Days)||142
118425|NCT01868009|289701|P1|STARTED|Period 2 (5-9 Days)||143
118426|NCT01868009|289700|P2|NOT COMPLETED|Period 1 (5-9 Days)||2
118427|NCT01868009|289701|P1|NOT COMPLETED|Period 1 (5-9 Days)||0
118428|NCT01868009|289700|P2|COMPLETED|Period 1 (5-9 Days)||142
118429|NCT01868009|289701|P1|COMPLETED|Period 1 (5-9 Days)||143
118430|NCT01868009|289700|P2|STARTED|Period 1 (5-9 Days)||144
118431|NCT01868009|289701|P1|STARTED|Period 1 (5-9 Days)||143
118432|NCT01867710|289715|P4|NOT COMPLETED|Overall Study||42
118433|NCT01867710|289716|P3|NOT COMPLETED|Overall Study||40
118434|NCT01867710|289717|P2|NOT COMPLETED|Overall Study||41
118435|NCT01867710|289718|P1|NOT COMPLETED|Overall Study||41
118436|NCT01867710|289715|P4|COMPLETED|Overall Study||0
118437|NCT01867710|289716|P3|COMPLETED|Overall Study||0
118438|NCT01867710|289717|P2|COMPLETED|Overall Study||0
118439|NCT01867710|289718|P1|COMPLETED|Overall Study||0
118440|NCT01867710|289715|P4|Treated|Overall Study||42
118441|NCT01867710|289716|P3|Treated|Overall Study||39
118442|NCT01867710|289717|P2|Treated|Overall Study||41
118443|NCT01867710|289718|P1|Treated|Overall Study||41
118444|NCT01867710|289715|P4|STARTED|Overall Study||42
118445|NCT01867710|289716|P3|STARTED|Overall Study||40
118446|NCT01867710|289717|P2|STARTED|Overall Study||41
118447|NCT01867710|289718|P1|STARTED|Overall Study||41
118448|NCT01867658|289784|P1|NOT COMPLETED|Overall Study||9
118450|NCT01867658|289784|P1|STARTED|Overall Study||112
118451|NCT01867632|289797|P2|NOT COMPLETED|Overall Study||0
118452|NCT01867632|289798|P1|NOT COMPLETED|Overall Study||0
118453|NCT01867632|289797|P2|COMPLETED|Overall Study||66
118454|NCT01867632|289798|P1|COMPLETED|Overall Study||65
118455|NCT01867632|289797|P2|STARTED|Overall Study||66
118456|NCT01867632|289798|P1|STARTED|Overall Study||65
118457|NCT01867580|289808|P2|NOT COMPLETED|Overall Study||24
118458|NCT01867580|289809|P1|NOT COMPLETED|Overall Study||28
118459|NCT01867580|289808|P2|COMPLETED|Overall Study||64
118460|NCT01867580|289809|P1|COMPLETED|Overall Study||65
118461|NCT01867580|289808|P2|STARTED|Overall Study||88
118462|NCT01867580|289809|P1|STARTED|Overall Study||93
118463|NCT01867515|289822|P3|NOT COMPLETED|Overall Study||11
118464|NCT01867515|289823|P2|NOT COMPLETED|Overall Study||1
118465|NCT01867515|289824|P1|NOT COMPLETED|Overall Study||0
118466|NCT01867515|289822|P3|COMPLETED|Overall Study||14
118467|NCT01867515|289823|P2|COMPLETED|Overall Study||11
118468|NCT01867515|289824|P1|COMPLETED|Overall Study||13
118469|NCT01867515|289822|P3|STARTED|Overall Study||25
118470|NCT01867515|289823|P2|STARTED|Overall Study||12
118471|NCT01867515|289824|P1|STARTED|Overall Study||13
118472|NCT01867424|289834|P2|NOT COMPLETED|Overall Study||1
118473|NCT01867424|289835|P1|NOT COMPLETED|Overall Study||2
118474|NCT01867424|289834|P2|COMPLETED|Overall Study||11
118475|NCT01867424|289835|P1|COMPLETED|Overall Study||10
118476|NCT01867424|289834|P2|STARTED|Overall Study||12
118477|NCT01867424|289835|P1|STARTED|Overall Study||12
118478|NCT01867307|289849|P2|NOT COMPLETED|Overall Study||3
118479|NCT01867307|289850|P1|NOT COMPLETED|Overall Study||3
118480|NCT01867307|289849|P2|COMPLETED|Overall Study||16
118481|NCT01867307|289850|P1|COMPLETED|Overall Study||15
118482|NCT01867307|289849|P2|STARTED|Overall Study|Started are the treated patients|19
118483|NCT01867307|289850|P1|STARTED|Overall Study|Started are the treated patients|18
118484|NCT01867216|289863|P7|NOT COMPLETED|Overall Study||1
118485|NCT01867216|289864|P6|NOT COMPLETED|Overall Study||0
118486|NCT01867216|289865|P5|NOT COMPLETED|Overall Study||1
118487|NCT01867216|289866|P4|NOT COMPLETED|Overall Study||0
118488|NCT01867216|289867|P3|NOT COMPLETED|Overall Study||0
118489|NCT01867216|289868|P2|NOT COMPLETED|Overall Study||0
118490|NCT01867216|289869|P1|NOT COMPLETED|Overall Study||4
118491|NCT01867216|289863|P7|COMPLETED|Overall Study||8
118492|NCT01867216|289864|P6|COMPLETED|Overall Study||8
118493|NCT01867216|289865|P5|COMPLETED|Overall Study||8
118494|NCT01867216|289866|P4|COMPLETED|Overall Study||8
118495|NCT01867216|289867|P3|COMPLETED|Overall Study||8
118496|NCT01867216|289868|P2|COMPLETED|Overall Study||8
118497|NCT01867216|289869|P1|COMPLETED|Overall Study||12
118498|NCT01867216|289863|P7|Received Study Drug|Overall Study||9
118499|NCT01867216|289864|P6|Received Study Drug|Overall Study||8
118500|NCT01867216|289865|P5|Received Study Drug|Overall Study||9
118501|NCT01867216|289866|P4|Received Study Drug|Overall Study||8
118502|NCT01867216|289867|P3|Received Study Drug|Overall Study||8
118503|NCT01867216|289868|P2|Received Study Drug|Overall Study||8
118504|NCT01867216|289869|P1|Received Study Drug|Overall Study||14
118505|NCT01867216|289863|P7|STARTED|Overall Study||9
118506|NCT01867216|289864|P6|STARTED|Overall Study||8
118507|NCT01867216|289865|P5|STARTED|Overall Study||9
118508|NCT01867216|289866|P4|STARTED|Overall Study||8
118509|NCT01867216|289867|P3|STARTED|Overall Study||8
118510|NCT01867216|289868|P2|STARTED|Overall Study||8
118511|NCT01867216|289869|P1|STARTED|Overall Study||16
118512|NCT01867164|289926|P2|NOT COMPLETED|Overall Study||0
118513|NCT01867164|289927|P1|NOT COMPLETED|Overall Study||0
118514|NCT01867164|289926|P2|COMPLETED|Overall Study||79
118515|NCT01867164|289927|P1|COMPLETED|Overall Study||81
118516|NCT01867164|289926|P2|STARTED|Overall Study||79
118517|NCT01867164|289927|P1|STARTED|Overall Study||81
118518|NCT01867086|289941|P1|NOT COMPLETED|Overall Study||1
118519|NCT01867086|289941|P1|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses."|0
118520|NCT01867086|289941|P1|STARTED|Overall Study||1
118521|NCT01867047|289950|P2|NOT COMPLETED|Overall Study||5
118522|NCT01867047|289951|P1|NOT COMPLETED|Overall Study||8
118523|NCT01867047|289950|P2|COMPLETED|Overall Study||23
118524|NCT01867047|289951|P1|COMPLETED|Overall Study||23
118525|NCT01867047|289950|P2|STARTED|Overall Study||28
118526|NCT01867047|289951|P1|STARTED|Overall Study||31
118527|NCT01867021|289971|P2|NOT COMPLETED|Overall Study||10
118528|NCT01867021|289972|P1|NOT COMPLETED|Overall Study||2
118529|NCT01867021|289971|P2|COMPLETED|Overall Study||1440
118530|NCT01867021|289972|P1|COMPLETED|Overall Study||1450
118531|NCT01867021|289971|P2|STARTED|Overall Study||1450
118532|NCT01867021|289972|P1|STARTED|Overall Study||1452
118533|NCT01866943|289991|P2|NOT COMPLETED|Overall Study||22
118534|NCT01866943|289992|P1|NOT COMPLETED|Overall Study||19
118535|NCT01866943|289991|P2|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
118536|NCT01866943|289992|P1|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
118537|NCT01866943|289991|P2|STARTED|Overall Study||22
118538|NCT01866943|289992|P1|STARTED|Overall Study||19
118539|NCT01866709|290003|P2|NOT COMPLETED|Overall Study||0
118540|NCT01866709|290004|P1|NOT COMPLETED|Overall Study||1
118541|NCT01866709|290003|P2|COMPLETED|Overall Study||17
118542|NCT01866709|290004|P1|COMPLETED|Overall Study||14
118543|NCT01866709|290003|P2|STARTED|Overall Study||17
118544|NCT01866709|290004|P1|STARTED|Overall Study||15
118545|NCT01866592|290012|P1|NOT COMPLETED|Overall Study||23
118546|NCT01866592|290012|P1|COMPLETED|Overall Study||58
118547|NCT01866592|290012|P1|STARTED|Overall Study||81
118548|NCT01866423|290045|P1|NOT COMPLETED|Overall Study||4
118549|NCT01866423|290045|P1|COMPLETED|Overall Study||0
118550|NCT01866423|290045|P1|STARTED|Overall Study||4
118551|NCT01866410|290055|P1|NOT COMPLETED|Overall Study||0
118552|NCT01866410|290055|P1|COMPLETED|Overall Study||37
118553|NCT01866410|290055|P1|STARTED|Overall Study||37
118554|NCT01866319|290073|P3|NOT COMPLETED|Overall Study||277
118555|NCT01866319|290074|P2|NOT COMPLETED|Overall Study||279
118556|NCT01866319|290075|P1|NOT COMPLETED|Overall Study||277
118557|NCT01866319|290073|P3|COMPLETED|Overall Study||0
118558|NCT01866319|290074|P2|COMPLETED|Overall Study||0
118559|NCT01866319|290075|P1|COMPLETED|Overall Study||1
118560|NCT01866319|290073|P3|Treated|Overall Study||277
118561|NCT01866319|290074|P2|Treated|Overall Study||278
118562|NCT01866319|290075|P1|Treated|Overall Study||256
118563|NCT01866319|290073|P3|STARTED|Overall Study||277
118564|NCT01866319|290074|P2|STARTED|Overall Study||279
118565|NCT01866319|290075|P1|STARTED|Overall Study||278
118566|NCT01866306|290096|P7|NOT COMPLETED|Overall Study||0
118567|NCT01866306|290097|P6|NOT COMPLETED|Overall Study||0
118568|NCT01866306|290098|P5|NOT COMPLETED|Overall Study||0
118569|NCT01866306|290099|P4|NOT COMPLETED|Overall Study||0
118570|NCT01866306|290100|P3|NOT COMPLETED|Overall Study||0
118571|NCT01866306|290101|P2|NOT COMPLETED|Overall Study||0
118572|NCT01866306|290102|P1|NOT COMPLETED|Overall Study||0
118573|NCT01866306|290096|P7|COMPLETED|Overall Study||23
118574|NCT01866306|290097|P6|COMPLETED|Overall Study||6
118575|NCT01866306|290098|P5|COMPLETED|Overall Study||6
118576|NCT01866306|290099|P4|COMPLETED|Overall Study||6
118577|NCT01866306|290100|P3|COMPLETED|Overall Study||6
118578|NCT01866306|290101|P2|COMPLETED|Overall Study||6
118579|NCT01866306|290102|P1|COMPLETED|Overall Study||6
118580|NCT01866306|290096|P7|STARTED|Overall Study||23
118581|NCT01866306|290097|P6|STARTED|Overall Study||6
118582|NCT01866306|290098|P5|STARTED|Overall Study||6
118583|NCT01866306|290099|P4|STARTED|Overall Study||6
118584|NCT01866306|290100|P3|STARTED|Overall Study||6
118585|NCT01866306|290101|P2|STARTED|Overall Study||6
118586|NCT01866306|290102|P1|STARTED|Overall Study||6
118587|NCT01866293|290174|P1|NOT COMPLETED|Overall Study||2
118588|NCT01866293|290174|P1|COMPLETED|Overall Study||9
118589|NCT01866293|290174|P1|STARTED|Overall Study||11
118590|NCT01866163|290184|P2|NOT COMPLETED|Overall Study||4
118591|NCT01866163|290185|P1|NOT COMPLETED|Overall Study||10
118592|NCT01866163|290184|P2|COMPLETED|Overall Study||99
118593|NCT01866163|290185|P1|COMPLETED|Overall Study||313
118594|NCT01866163|290184|P2|STARTED|Overall Study||103
118595|NCT01866163|290185|P1|STARTED|Overall Study||323
118596|NCT01866150|290195|P1|NOT COMPLETED|Overall Study||0
118597|NCT01866150|290195|P1|COMPLETED|Overall Study||450
118598|NCT01866150|290195|P1|STARTED|Overall Study||450
118599|NCT01865812|290216|P1|NOT COMPLETED|Overall Study||2
118600|NCT01865812|290216|P1|COMPLETED|Overall Study||24
118601|NCT01865812|290216|P1|STARTED|Overall Study||26
118602|NCT01865747|290224|P2|NOT COMPLETED|Primary Intent to Treat (PITT)||152
118603|NCT01865747|290225|P1|NOT COMPLETED|Primary Intent to Treat (PITT)||131
118604|NCT01865747|290224|P2|COMPLETED|Primary Intent to Treat (PITT)||36
118605|NCT01865747|290225|P1|COMPLETED|Primary Intent to Treat (PITT)||56
118606|NCT01865747|290224|P2|STARTED|Primary Intent to Treat (PITT)|Three subjects in the everolimus arm were randomized but not treated.|188
118607|NCT01865747|290225|P1|STARTED|Primary Intent to Treat (PITT)||187
118608|NCT01865747|290224|P2|NOT COMPLETED|Overall Study (ITT)||255
118609|NCT01865747|290225|P1|NOT COMPLETED|Overall Study (ITT)||198
118610|NCT01865747|290224|P2|COMPLETED|Overall Study (ITT)|Five subjects were randomized but not treated|73
118611|NCT01865747|290225|P1|COMPLETED|Overall Study (ITT)|One subject randomized to everolimus arm received cabozantinib discontd due to clin. deterioration|132
118612|NCT01865747|290224|P2|STARTED|Overall Study (ITT)||328
118613|NCT01865747|290225|P1|STARTED|Overall Study (ITT)||330
118614|NCT01865708|290235|P1|NOT COMPLETED|Overall Study||0
118615|NCT01865708|290235|P1|COMPLETED|Overall Study||10
118616|NCT01865708|290235|P1|STARTED|Overall Study||10
118617|NCT01865552|290246|P6|NOT COMPLETED|Period 2||0
118618|NCT01865552|290247|P5|NOT COMPLETED|Period 2||0
118619|NCT01865552|290248|P4|NOT COMPLETED|Period 2||0
118620|NCT01865552|290249|P3|NOT COMPLETED|Period 2||0
118621|NCT01865552|290250|P2|NOT COMPLETED|Period 2||0
118622|NCT01865552|290251|P1|NOT COMPLETED|Period 2||0
118623|NCT01865552|290246|P6|COMPLETED|Period 2||22
118624|NCT01865552|290247|P5|COMPLETED|Period 2||20
118625|NCT01865552|290248|P4|COMPLETED|Period 2||22
118626|NCT01865552|290249|P3|COMPLETED|Period 2||23
118627|NCT01865552|290250|P2|COMPLETED|Period 2||23
118628|NCT01865552|290251|P1|COMPLETED|Period 2||22
118629|NCT01865552|290246|P6|STARTED|Period 2||22
118630|NCT01865552|290247|P5|STARTED|Period 2||20
118631|NCT01865552|290248|P4|STARTED|Period 2||22
118632|NCT01865552|290249|P3|STARTED|Period 2||23
118633|NCT01865552|290250|P2|STARTED|Period 2||23
118634|NCT01865552|290251|P1|STARTED|Period 2||22
118635|NCT01865552|290246|P6|NOT COMPLETED|Period 1||1
118636|NCT01865552|290247|P5|NOT COMPLETED|Period 1||3
118637|NCT01865552|290248|P4|NOT COMPLETED|Period 1||1
118638|NCT01865552|290249|P3|NOT COMPLETED|Period 1||0
118639|NCT01865552|290250|P2|NOT COMPLETED|Period 1||0
118640|NCT01865552|290251|P1|NOT COMPLETED|Period 1||1
118641|NCT01865552|290246|P6|COMPLETED|Period 1||22
118642|NCT01865552|290247|P5|COMPLETED|Period 1||20
118643|NCT01865552|290248|P4|COMPLETED|Period 1||22
118644|NCT01865552|290249|P3|COMPLETED|Period 1||23
118645|NCT01865552|290250|P2|COMPLETED|Period 1||23
118646|NCT01865552|290251|P1|COMPLETED|Period 1||22
118647|NCT01865552|290246|P6|Discontinued From Period 1|Period 1||1
118648|NCT01865552|290247|P5|Discontinued From Period 1|Period 1||3
118649|NCT01865552|290248|P4|Discontinued From Period 1|Period 1||1
118650|NCT01865552|290249|P3|Discontinued From Period 1|Period 1||0
118651|NCT01865552|290250|P2|Discontinued From Period 1|Period 1||0
118652|NCT01865552|290251|P1|Discontinued From Period 1|Period 1||1
118653|NCT01865552|290246|P6|STARTED|Period 1||23
118654|NCT01865552|290247|P5|STARTED|Period 1||23
118655|NCT01865552|290248|P4|STARTED|Period 1||23
118656|NCT01865552|290249|P3|STARTED|Period 1||23
118657|NCT01865552|290250|P2|STARTED|Period 1||23
118658|NCT01865552|290251|P1|STARTED|Period 1||23
118659|NCT01865448|290285|P2|NOT COMPLETED|Overall Study||3
118660|NCT01865448|290286|P1|NOT COMPLETED|Overall Study||2
118661|NCT01865448|290285|P2|COMPLETED|Overall Study||14
118662|NCT01865448|290286|P1|COMPLETED|Overall Study||15
118663|NCT01865448|290285|P2|STARTED|Overall Study||17
118664|NCT01865448|290286|P1|STARTED|Overall Study||17
118665|NCT01865084|290397|P3|NOT COMPLETED|Open Label Extension (OLE) Period||7
118666|NCT01865084|290398|P2|NOT COMPLETED|Open Label Extension (OLE) Period||11
118667|NCT01865084|290399|P1|NOT COMPLETED|Open Label Extension (OLE) Period||0
118668|NCT01865084|290397|P3|COMPLETED|Open Label Extension (OLE) Period||158
118669|NCT01865084|290398|P2|COMPLETED|Open Label Extension (OLE) Period||139
118670|NCT01865084|290399|P1|COMPLETED|Open Label Extension (OLE) Period||0
118671|NCT01865084|290397|P3|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|165
118672|NCT01865084|290398|P2|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|150
118673|NCT01865084|290399|P1|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|0
118674|NCT01865084|290397|P3|NOT COMPLETED|Double Blind Period (DB)||6
118675|NCT01865084|290398|P2|NOT COMPLETED|Double Blind Period (DB)||4
118676|NCT01865084|290399|P1|NOT COMPLETED|Double Blind Period (DB)||5
118677|NCT01865084|290397|P3|COMPLETED|Double Blind Period (DB)||107
118678|NCT01865084|290398|P2|COMPLETED|Double Blind Period (DB)|One participant stopped therapy during the DB period but remained in the study for follow-up.|98
118679|NCT01865084|290399|P1|COMPLETED|Double Blind Period (DB)||111
118680|NCT01865084|290397|P3|Received at Least One Dose of Study Drug|Double Blind Period (DB)||112
118681|NCT01865084|290398|P2|Received at Least One Dose of Study Drug|Double Blind Period (DB)||102
118682|NCT01865084|290399|P1|Received at Least One Dose of Study Drug|Double Blind Period (DB)||116
118683|NCT01865084|290397|P3|STARTED|Double Blind Period (DB)||113
118684|NCT01865084|290398|P2|STARTED|Double Blind Period (DB)||102
118685|NCT01865084|290399|P1|STARTED|Double Blind Period (DB)||116
118686|NCT01864538|290425|P1|NOT COMPLETED|Overall Study||11
118687|NCT01864538|290425|P1|COMPLETED|Overall Study||0
118688|NCT01864538|290425|P1|STARTED|Overall Study||11
118689|NCT01864525|290431|P2|NOT COMPLETED|Overall Study||0
118690|NCT01864525|290432|P1|NOT COMPLETED|Overall Study||1
118691|NCT01864525|290431|P2|COMPLETED|Overall Study||7
118692|NCT01864525|290432|P1|COMPLETED|Overall Study||9
118693|NCT01864525|290431|P2|STARTED|Overall Study||7
118694|NCT01864525|290432|P1|STARTED|Overall Study||10
118695|NCT01864434|290442|P2|NOT COMPLETED|Overall Study||0
118696|NCT01864434|290443|P1|NOT COMPLETED|Overall Study||0
118697|NCT01864434|290442|P2|COMPLETED|Overall Study||25
118698|NCT01864434|290443|P1|COMPLETED|Overall Study||25
118699|NCT01864434|290442|P2|STARTED|Overall Study||25
118700|NCT01864434|290443|P1|STARTED|Overall Study||25
118701|NCT01864200|290455|P2|NOT COMPLETED|Overall Study||3
118702|NCT01864200|290456|P1|NOT COMPLETED|Overall Study||2
118703|NCT01864200|290455|P2|COMPLETED|Overall Study||26
118704|NCT01864200|290456|P1|COMPLETED|Overall Study||43
118705|NCT01864200|290455|P2|STARTED|Overall Study||29
118706|NCT01864200|290456|P1|STARTED|Overall Study||45
118707|NCT01864174|290464|P2|NOT COMPLETED|Off Treatment Follow-Up||0
118708|NCT01864174|290465|P1|NOT COMPLETED|Off Treatment Follow-Up||3
118709|NCT01864174|290464|P2|COMPLETED|Off Treatment Follow-Up||1
118710|NCT01864174|290465|P1|COMPLETED|Off Treatment Follow-Up||6
118711|NCT01864174|290464|P2|STARTED|Off Treatment Follow-Up||1
118712|NCT01864174|290465|P1|STARTED|Off Treatment Follow-Up||9
118713|NCT01864174|290464|P2|NOT COMPLETED|Double Blind - Compliant Randomized||26
118714|NCT01864174|290465|P1|NOT COMPLETED|Double Blind - Compliant Randomized||23
118715|NCT01864174|290464|P2|COMPLETED|Double Blind - Compliant Randomized||245
118716|NCT01864174|290465|P1|COMPLETED|Double Blind - Compliant Randomized||245
118717|NCT01864174|290464|P2|STARTED|Double Blind - Compliant Randomized||271
118718|NCT01864174|290465|P1|STARTED|Double Blind - Compliant Randomized||268
118719|NCT01864174|290464|P2|NOT COMPLETED|Double Blind Treatment - All Treated||14
118720|NCT01864174|290465|P1|NOT COMPLETED|Double Blind Treatment - All Treated||15
118721|NCT01864174|290464|P2|COMPLETED|Double Blind Treatment - All Treated||271
118722|NCT01864174|290465|P1|COMPLETED|Double Blind Treatment - All Treated||268
118723|NCT01864174|290464|P2|STARTED|Double Blind Treatment - All Treated||285
118724|NCT01864174|290465|P1|STARTED|Double Blind Treatment - All Treated||283
118725|NCT01864148|290484|P5|NOT COMPLETED|Overall Study||23
118726|NCT01864148|290485|P4|NOT COMPLETED|Overall Study||26
118727|NCT01864148|290486|P3|NOT COMPLETED|Overall Study||11
118728|NCT01864148|290487|P2|NOT COMPLETED|Overall Study||5
118729|NCT01864148|290488|P1|NOT COMPLETED|Overall Study||20
118730|NCT01864148|290484|P5|COMPLETED|Overall Study||69
118731|NCT01864148|290485|P4|COMPLETED|Overall Study||68
118732|NCT01864148|290486|P3|COMPLETED|Overall Study||84
118733|NCT01864148|290487|P2|COMPLETED|Overall Study||40
118734|NCT01864148|290488|P1|COMPLETED|Overall Study||73
118735|NCT01864148|290484|P5|Randomized and Dosed|Overall Study||92
118736|NCT01864148|290485|P4|Randomized and Dosed|Overall Study||93
118737|NCT01864148|290486|P3|Randomized and Dosed|Overall Study||95
118738|NCT01864148|290487|P2|Randomized and Dosed|Overall Study||45
118739|NCT01864148|290488|P1|Randomized and Dosed|Overall Study||93
118740|NCT01864148|290484|P5|STARTED|Overall Study||92
118741|NCT01864148|290485|P4|STARTED|Overall Study||94
118742|NCT01864148|290486|P3|STARTED|Overall Study||95
118743|NCT01864148|290487|P2|STARTED|Overall Study||45
118744|NCT01864148|290488|P1|STARTED|Overall Study||93
118745|NCT01864005|290517|P2|NOT COMPLETED|Overall Study||6
118746|NCT01864005|290518|P1|NOT COMPLETED|Overall Study||3
118747|NCT01864005|290517|P2|COMPLETED|Overall Study||25
118748|NCT01864005|290518|P1|COMPLETED|Overall Study||26
118749|NCT01864005|290517|P2|STARTED|Overall Study||31
118750|NCT01864005|290518|P1|STARTED|Overall Study||29
118751|NCT01863953|290535|P3|NOT COMPLETED|Overall Study||1
118752|NCT01863953|290536|P2|NOT COMPLETED|Overall Study||0
118753|NCT01863953|290537|P1|NOT COMPLETED|Overall Study||0
118754|NCT01863953|290535|P3|COMPLETED|Overall Study||37
118755|NCT01863953|290536|P2|COMPLETED|Overall Study||36
118756|NCT01863953|290537|P1|COMPLETED|Overall Study||38
118757|NCT01863953|290535|P3|STARTED|Overall Study||38
118758|NCT01863953|290536|P2|STARTED|Overall Study||36
118759|NCT01863953|290537|P1|STARTED|Overall Study||38
118760|NCT01863771|290551|P4|NOT COMPLETED|Maintenance Phase||43
118761|NCT01863771|290552|P3|NOT COMPLETED|Maintenance Phase||12
118762|NCT01863771|290553|P2|NOT COMPLETED|Maintenance Phase||5
118763|NCT01863771|290554|P1|NOT COMPLETED|Maintenance Phase||0
118764|NCT01863771|290551|P4|COMPLETED|Maintenance Phase||17
118765|NCT01863771|290552|P3|COMPLETED|Maintenance Phase||19
118766|NCT01863771|290553|P2|COMPLETED|Maintenance Phase||27
118767|NCT01863771|290554|P1|COMPLETED|Maintenance Phase||0
118768|NCT01863771|290551|P4|STARTED|Maintenance Phase||60
118769|NCT01863771|290552|P3|STARTED|Maintenance Phase||31
118770|NCT01863771|290553|P2|STARTED|Maintenance Phase||32
118771|NCT01863771|290554|P1|STARTED|Maintenance Phase||0
118772|NCT01863771|290551|P4|NOT COMPLETED|Induction Phase||0
118773|NCT01863771|290552|P3|NOT COMPLETED|Induction Phase||0
118774|NCT01863771|290553|P2|NOT COMPLETED|Induction Phase||0
118775|NCT01863771|290554|P1|NOT COMPLETED|Induction Phase||21
118776|NCT01863771|290551|P4|COMPLETED|Induction Phase||0
118777|NCT01863771|290552|P3|COMPLETED|Induction Phase||0
118778|NCT01863771|290553|P2|COMPLETED|Induction Phase||0
118779|NCT01863771|290554|P1|COMPLETED|Induction Phase|Same participants who completed the induction phase participated in the maintenance phase.|123
118780|NCT01863771|290551|P4|STARTED|Induction Phase||0
118781|NCT01863771|290552|P3|STARTED|Induction Phase||0
118782|NCT01863771|290553|P2|STARTED|Induction Phase||0
118783|NCT01863771|290554|P1|STARTED|Induction Phase||144
118784|NCT01863758|290566|P1|NOT COMPLETED|Prophylactic Treatment-Phase II||2
118785|NCT01863758|290566|P1|COMPLETED|Prophylactic Treatment-Phase II||64
118786|NCT01863758|290566|P1|STARTED|Prophylactic Treatment-Phase II||66
118787|NCT01863758|290566|P1|NOT COMPLETED|Prophylactic Treatment-Phase I||0
118788|NCT01863758|290566|P1|COMPLETED|Prophylactic Treatment-Phase I||66
118789|NCT01863758|290566|P1|STARTED|Prophylactic Treatment-Phase I||66
118790|NCT01863758|290566|P1|NOT COMPLETED|Pharmacokinetic Assessment||0
118791|NCT01863758|290566|P1|COMPLETED|Pharmacokinetic Assessment||66
118792|NCT01863758|290566|P1|STARTED|Pharmacokinetic Assessment||66
118793|NCT01863732|290578|P4|NOT COMPLETED|Overall Study||8
118794|NCT01863732|290579|P3|NOT COMPLETED|Overall Study||11
118795|NCT01863732|290580|P2|NOT COMPLETED|Overall Study||12
118796|NCT01863732|290581|P1|NOT COMPLETED|Overall Study||13
118797|NCT01863732|290578|P4|COMPLETED|Overall Study||33
118798|NCT01863732|290579|P3|COMPLETED|Overall Study||35
118799|NCT01863732|290580|P2|COMPLETED|Overall Study||75
118800|NCT01863732|290581|P1|COMPLETED|Overall Study||87
118801|NCT01863732|290578|P4|STARTED|Overall Study||41
118802|NCT01863732|290579|P3|STARTED|Overall Study||46
118803|NCT01863732|290580|P2|STARTED|Overall Study||87
118804|NCT01863732|290581|P1|STARTED|Overall Study||100
118805|NCT01863680|290594|P1|NOT COMPLETED|Overall Study||57
118806|NCT01863680|290594|P1|COMPLETED|Overall Study||121
118807|NCT01863680|290594|P1|Subjects Who Have Undergone IVF/ET|Overall Study||123
118808|NCT01863680|290594|P1|Subjects Received Study Drug|Overall Study||149
118809|NCT01863680|290594|P1|Subjects Received hCG Injection|Overall Study||162
118810|NCT01863680|290594|P1|Subjects Started COS Treatment|Overall Study||169
118811|NCT01863680|290594|P1|STARTED|Overall Study||178
118812|NCT01863667|290602|P2|NOT COMPLETED|Overall Study||32
118813|NCT01863667|290603|P1|NOT COMPLETED|Overall Study||33
118814|NCT01863667|290602|P2|COMPLETED|Overall Study||0
118815|NCT01863667|290603|P1|COMPLETED|Overall Study||0
118816|NCT01863667|290602|P2|STARTED|Overall Study||32
118817|NCT01863667|290603|P1|STARTED|Overall Study||33
118818|NCT01863563|290623|P1|NOT COMPLETED|Overall Study||0
118819|NCT01863563|290623|P1|COMPLETED|Overall Study||100
118820|NCT01863563|290623|P1|STARTED|Overall Study||100
118821|NCT01863433|290627|P1|NOT COMPLETED|Overall Study||1
118822|NCT01863433|290627|P1|COMPLETED|Overall Study|1 subject was withdrawn from the study due to evidence of substance abuse.|119
118823|NCT01863433|290627|P1|STARTED|Overall Study||120
118824|NCT01863368|290637|P2|NOT COMPLETED|Phase II, Day 35 to Day 90||0
118825|NCT01863368|290638|P1|NOT COMPLETED|Phase II, Day 35 to Day 90||2
118826|NCT01863368|290637|P2|COMPLETED|Phase II, Day 35 to Day 90||41
118827|NCT01863368|290638|P1|COMPLETED|Phase II, Day 35 to Day 90||41
118828|NCT01863368|290637|P2|STARTED|Phase II, Day 35 to Day 90||41
118829|NCT01863368|290638|P1|STARTED|Phase II, Day 35 to Day 90||43
118830|NCT01863368|290637|P2|NOT COMPLETED|Phase I, Day 0 to Day 35||7
118831|NCT01863368|290638|P1|NOT COMPLETED|Phase I, Day 0 to Day 35||3
118832|NCT01863368|290637|P2|COMPLETED|Phase I, Day 0 to Day 35||41
118833|NCT01863368|290638|P1|COMPLETED|Phase I, Day 0 to Day 35||43
118834|NCT01863368|290637|P2|Treated|Phase I, Day 0 to Day 35||47
118835|NCT01863368|290638|P1|Treated|Phase I, Day 0 to Day 35||46
118836|NCT01863368|290637|P2|STARTED|Phase I, Day 0 to Day 35||48
118837|NCT01863368|290638|P1|STARTED|Phase I, Day 0 to Day 35||46
118838|NCT01863134|290653|P2|NOT COMPLETED|Overall Study||0
118839|NCT01863134|290654|P1|NOT COMPLETED|Overall Study||0
118840|NCT01863134|290653|P2|COMPLETED|Overall Study||68
118841|NCT01863134|290654|P1|COMPLETED|Overall Study||72
118842|NCT01863134|290653|P2|STARTED|Overall Study||68
118843|NCT01863134|290654|P1|STARTED|Overall Study||72
118844|NCT01863017|290662|P2|NOT COMPLETED|Overall Study||0
118845|NCT01863017|290663|P1|NOT COMPLETED|Overall Study||0
118846|NCT01863017|290662|P2|COMPLETED|Overall Study||19
118847|NCT01863017|290663|P1|COMPLETED|Overall Study||12
118848|NCT01863017|290662|P2|Participants With PWS|Overall Study||7
118849|NCT01863017|290663|P1|Participants With PWS|Overall Study||3
118850|NCT01863017|290662|P2|Obese Participants|Overall Study||7
118851|NCT01863017|290663|P1|Obese Participants|Overall Study||4
118852|NCT01863017|290662|P2|Normal Weight Participants|Overall Study||5
118853|NCT01863017|290663|P1|Normal Weight Participants|Overall Study||5
118854|NCT01863017|290662|P2|STARTED|Overall Study||19
118855|NCT01863017|290663|P1|STARTED|Overall Study||12
118856|NCT01862991|290676|P3|NOT COMPLETED|Overall Study||1
118857|NCT01862991|290677|P2|NOT COMPLETED|Overall Study||1
118858|NCT01862991|290678|P1|NOT COMPLETED|Overall Study||3
118859|NCT01862991|290676|P3|COMPLETED|Overall Study||27
118860|NCT01862991|290677|P2|COMPLETED|Overall Study||27
118861|NCT01862991|290678|P1|COMPLETED|Overall Study||21
118862|NCT01862991|290676|P3|STARTED|Overall Study||28
118863|NCT01862991|290677|P2|STARTED|Overall Study||28
118864|NCT01862991|290678|P1|STARTED|Overall Study||24
118865|NCT01862874|290691|P2|NOT COMPLETED|Overall Study||77
118866|NCT01862874|290692|P1|NOT COMPLETED|Overall Study||79
118867|NCT01862874|290691|P2|COMPLETED|Overall Study||485
118868|NCT01862874|290692|P1|COMPLETED|Overall Study||483
118869|NCT01862874|290691|P2|Vaccination 3|Overall Study||532
118870|NCT01862874|290692|P1|Vaccination 3|Overall Study||530
118871|NCT01862874|290691|P2|Vaccination 2|Overall Study||542
118872|NCT01862874|290692|P1|Vaccination 2|Overall Study||539
118873|NCT01862874|290691|P2|Vaccination 1|Overall Study||562
118874|NCT01862874|290692|P1|Vaccination 1|Overall Study||561
118875|NCT01862874|290691|P2|STARTED|Overall Study|Randomized participants|562
118876|NCT01862874|290692|P1|STARTED|Overall Study|Randomized participants|562
118877|NCT01862796|290711|P3|NOT COMPLETED|Overall Study||1
118878|NCT01862796|290712|P2|NOT COMPLETED|Overall Study||0
118879|NCT01862796|290713|P1|NOT COMPLETED|Overall Study||0
118880|NCT01862796|290711|P3|COMPLETED|Overall Study||23
118881|NCT01862796|290712|P2|COMPLETED|Overall Study||18
118882|NCT01862796|290713|P1|COMPLETED|Overall Study||19
118883|NCT01862796|290711|P3|STARTED|Overall Study||24
118884|NCT01862796|290712|P2|STARTED|Overall Study||18
118885|NCT01862796|290713|P1|STARTED|Overall Study||19
118886|NCT01862484|290726|P2|NOT COMPLETED|Overall Study||8
118887|NCT01862484|290727|P1|NOT COMPLETED|Overall Study||2
118888|NCT01862484|290726|P2|COMPLETED|Overall Study||6
118889|NCT01862484|290727|P1|COMPLETED|Overall Study||13
118890|NCT01862484|290726|P2|STARTED|Overall Study||14
118891|NCT01862484|290727|P1|STARTED|Overall Study||15
118892|NCT01862419|290735|P2|NOT COMPLETED|Overall Study||0
118893|NCT01862419|290736|P1|NOT COMPLETED|Overall Study||0
118894|NCT01862419|290735|P2|COMPLETED|Overall Study||1192
118895|NCT01862419|290736|P1|COMPLETED|Overall Study||1201
118896|NCT01862419|290735|P2|STARTED|Overall Study||1192
118897|NCT01862419|290736|P1|STARTED|Overall Study||1201
118898|NCT01862250|290746|P1|NOT COMPLETED|Overall Study||4
118899|NCT01862250|290746|P1|COMPLETED|Overall Study||8
118900|NCT01862250|290746|P1|STARTED|Overall Study||12
118901|NCT01862159|290753|P1|NOT COMPLETED|Overall Study||0
118902|NCT01862159|290753|P1|COMPLETED|Overall Study||25038
118903|NCT01862159|290753|P1|STARTED|Overall Study||25038
118904|NCT01862133|290760|P2|NOT COMPLETED|Overall Study||0
118905|NCT01862133|290761|P1|NOT COMPLETED|Overall Study||0
118906|NCT01862133|290760|P2|COMPLETED|Overall Study||31
118907|NCT01862133|290761|P1|COMPLETED|Overall Study|All 105 patients recorded preferences; 92 (88%) returned to the study clinic during the 6 mo. study|105
118908|NCT01862133|290760|P2|Returned During 6 mo Study|Overall Study||31
118909|NCT01862133|290761|P1|Returned During 6 mo Study|Overall Study||92
118910|NCT01862133|290760|P2|STARTED|Overall Study||31
118911|NCT01862133|290761|P1|STARTED|Overall Study||105
118912|NCT01862029|290767|P1|NOT COMPLETED|Overall Study||1
118913|NCT01862029|290767|P1|COMPLETED|Overall Study||8
118914|NCT01862029|290767|P1|STARTED|Overall Study||9
118915|NCT01861925|290775|P3|NOT COMPLETED|Overall Study||0
118916|NCT01861925|290776|P2|NOT COMPLETED|Overall Study||0
118917|NCT01861925|290777|P1|NOT COMPLETED|Overall Study||0
118918|NCT01861925|290775|P3|COMPLETED|Overall Study||8
118919|NCT01861925|290776|P2|COMPLETED|Overall Study||8
118920|NCT01861925|290777|P1|COMPLETED|Overall Study||34
118921|NCT01861925|290775|P3|STARTED|Overall Study||8
118922|NCT01861925|290776|P2|STARTED|Overall Study||8
118923|NCT01861925|290777|P1|STARTED|Overall Study||34
118924|NCT01861756|290800|P2|NOT COMPLETED|Overall Study||18
118925|NCT01861756|290801|P1|NOT COMPLETED|Overall Study||13
118926|NCT01861756|290800|P2|COMPLETED|Overall Study||85
118927|NCT01861756|290801|P1|COMPLETED|Overall Study||88
118928|NCT01861756|290800|P2|STARTED|Overall Study||103
118929|NCT01861756|290801|P1|STARTED|Overall Study||101
118930|NCT01861704|290809|P2|NOT COMPLETED|Overall Study||3
118931|NCT01861704|290810|P1|NOT COMPLETED|Overall Study||3
118932|NCT01861704|290809|P2|COMPLETED|Overall Study||104
118933|NCT01861704|290810|P1|COMPLETED|Overall Study||67
118934|NCT01861704|290809|P2|STARTED|Overall Study||107
118935|NCT01861704|290810|P1|STARTED|Overall Study||70
118936|NCT01861665|290818|P2|NOT COMPLETED|Overall Study||0
118937|NCT01861665|290819|P1|NOT COMPLETED|Overall Study||0
118938|NCT01861665|290818|P2|COMPLETED|Overall Study||17
118939|NCT01861665|290819|P1|COMPLETED|Overall Study||10
118940|NCT01861665|290818|P2|STARTED|Overall Study||17
118941|NCT01861665|290819|P1|STARTED|Overall Study||10
118942|NCT01861587|290827|P2|NOT COMPLETED|Overall Study||0
118943|NCT01861587|290828|P1|NOT COMPLETED|Overall Study||0
118944|NCT01861587|290827|P2|COMPLETED|Overall Study||13
118945|NCT01861587|290828|P1|COMPLETED|Overall Study||14
118946|NCT01861587|290827|P2|STARTED|Overall Study||13
118947|NCT01861587|290828|P1|STARTED|Overall Study||14
118948|NCT01861574|290844|P4|NOT COMPLETED|Overall Study||0
118949|NCT01861574|290845|P3|NOT COMPLETED|Overall Study||0
118950|NCT01861574|290846|P2|NOT COMPLETED|Overall Study||0
118951|NCT01861574|290847|P1|NOT COMPLETED|Overall Study||0
118952|NCT01861574|290844|P4|COMPLETED|Overall Study||28
118953|NCT01861574|290845|P3|COMPLETED|Overall Study||27
118954|NCT01861574|290846|P2|COMPLETED|Overall Study||25
118955|NCT01861574|290847|P1|COMPLETED|Overall Study||28
118956|NCT01861574|290844|P4|STARTED|Overall Study||28
118957|NCT01861574|290845|P3|STARTED|Overall Study||27
118958|NCT01861574|290846|P2|STARTED|Overall Study||25
118959|NCT01861574|290847|P1|STARTED|Overall Study||28
118960|NCT01861522|290870|P2|NOT COMPLETED|Overall Study||0
118961|NCT01861522|290871|P1|NOT COMPLETED|Overall Study||3
118962|NCT01861522|290870|P2|COMPLETED|Overall Study||232
118963|NCT01861522|290871|P1|COMPLETED|Overall Study||237
118964|NCT01861522|290870|P2|STARTED|Overall Study|One subject who did not receive any study drug was excluded from the FAS and the Safety Analysis Set|232
118965|NCT01861522|290871|P1|STARTED|Overall Study||240
118966|NCT01861457|290879|P2|NOT COMPLETED|Overall Study||0
118967|NCT01861457|290880|P1|NOT COMPLETED|Overall Study||0
118968|NCT01861457|290879|P2|COMPLETED|Overall Study||19
118969|NCT01861457|290880|P1|COMPLETED|Overall Study||20
118970|NCT01861457|290879|P2|STARTED|Overall Study||19
118971|NCT01861457|290880|P1|STARTED|Overall Study||20
118972|NCT01861301|290888|P1|NOT COMPLETED|Overall Study||0
118973|NCT01861301|290888|P1|COMPLETED|Overall Study||18
118974|NCT01861301|290888|P1|STARTED|Overall Study||18
118975|NCT01860989|290895|P1|NOT COMPLETED|Overall Study||5
118976|NCT01860989|290895|P1|COMPLETED|Overall Study||6
118977|NCT01860989|290895|P1|STARTED|Overall Study||11
118978|NCT01860976|290901|P2|NOT COMPLETED|Long Term Extension||107
118979|NCT01860976|290902|P1|NOT COMPLETED|Long Term Extension||113
118980|NCT01860976|290901|P2|COMPLETED|Long Term Extension||8
118981|NCT01860976|290902|P1|COMPLETED|Long Term Extension||0
118982|NCT01860976|290901|P2|STARTED|Long Term Extension||115
118983|NCT01860976|290902|P1|STARTED|Long Term Extension||113
118984|NCT01860976|290901|P2|NOT COMPLETED|Open-Label||64
118985|NCT01860976|290902|P1|NOT COMPLETED|Open-Label||74
118986|NCT01860976|290901|P2|COMPLETED|Open-Label||121
118987|NCT01860976|290902|P1|COMPLETED|Open-Label||123
118988|NCT01860976|290901|P2|STARTED|Open-Label||185
118989|NCT01860976|290902|P1|STARTED|Open-Label||197
118990|NCT01860976|290901|P2|NOT COMPLETED|Blinded Treatment||113
118991|NCT01860976|290902|P1|NOT COMPLETED|Blinded Treatment||88
118992|NCT01860976|290901|P2|COMPLETED|Blinded Treatment||98
118993|NCT01860976|290902|P1|COMPLETED|Blinded Treatment||125
118994|NCT01860976|290901|P2|STARTED|Blinded Treatment||211
118995|NCT01860976|290902|P1|STARTED|Blinded Treatment||213
118996|NCT01860950|290930|P6|NOT COMPLETED|Overall Study||0
118997|NCT01860950|290931|P5|NOT COMPLETED|Overall Study||0
118998|NCT01860950|290932|P4|NOT COMPLETED|Overall Study||0
118999|NCT01860950|290933|P3|NOT COMPLETED|Overall Study||0
119000|NCT01860950|290934|P2|NOT COMPLETED|Overall Study||0
119001|NCT01860950|290935|P1|NOT COMPLETED|Overall Study||0
119002|NCT01860950|290930|P6|COMPLETED|Overall Study||13
119003|NCT01860950|290931|P5|COMPLETED|Overall Study||14
119004|NCT01860950|290932|P4|COMPLETED|Overall Study||13
119005|NCT01860950|290933|P3|COMPLETED|Overall Study||10
119006|NCT01860950|290934|P2|COMPLETED|Overall Study||15
119007|NCT01860950|290935|P1|COMPLETED|Overall Study||14
119008|NCT01860950|290930|P6|STARTED|Overall Study||13
119009|NCT01860950|290931|P5|STARTED|Overall Study||14
119010|NCT01860950|290932|P4|STARTED|Overall Study||13
119011|NCT01860950|290933|P3|STARTED|Overall Study||10
119012|NCT01860950|290934|P2|STARTED|Overall Study||15
119013|NCT01860950|290935|P1|STARTED|Overall Study||14
119014|NCT01860846|290956|P1|NOT COMPLETED|Overall Study||33
119015|NCT01860846|290956|P1|COMPLETED|Overall Study||73
119016|NCT01860846|290956|P1|Month 12|Overall Study||73
119017|NCT01860846|290956|P1|Month 6|Overall Study||85
119018|NCT01860846|290956|P1|Month 4|Overall Study||82
119019|NCT01860846|290956|P1|Month 2|Overall Study||83
119020|NCT01860846|290956|P1|Month 1|Overall Study||97
119021|NCT01860846|290956|P1|STARTED|Overall Study||106
119022|NCT01860807|290969|P2|NOT COMPLETED|Overall Study||29
119023|NCT01860807|290970|P1|NOT COMPLETED|Overall Study||30
119024|NCT01860807|290969|P2|COMPLETED|Overall Study||32
119025|NCT01860807|290970|P1|COMPLETED|Overall Study||34
119026|NCT01860807|290969|P2|STARTED|Overall Study||61
119027|NCT01860807|290970|P1|STARTED|Overall Study||64
119028|NCT01860703|290976|P4|NOT COMPLETED|Overall Study||2
119029|NCT01860703|290977|P3|NOT COMPLETED|Overall Study||1
119030|NCT01860703|290978|P2|NOT COMPLETED|Overall Study||5
119031|NCT01860703|290979|P1|NOT COMPLETED|Overall Study||2
119032|NCT01860703|290976|P4|COMPLETED|Overall Study||10
119033|NCT01860703|290977|P3|COMPLETED|Overall Study||11
119034|NCT01860703|290978|P2|COMPLETED|Overall Study||8
119035|NCT01860703|290979|P1|COMPLETED|Overall Study||11
119036|NCT01860703|290976|P4|STARTED|Overall Study||12
119037|NCT01860703|290977|P3|STARTED|Overall Study||12
119038|NCT01860703|290978|P2|STARTED|Overall Study||13
119039|NCT01860703|290979|P1|STARTED|Overall Study||13
119040|NCT01860677|291011|P2|NOT COMPLETED|Second Intervention (1 Day)||0
119041|NCT01860677|291012|P1|NOT COMPLETED|Second Intervention (1 Day)||7
119042|NCT01860677|291011|P2|COMPLETED|Second Intervention (1 Day)||0
119043|NCT01860677|291012|P1|COMPLETED|Second Intervention (1 Day)||1
119044|NCT01860677|291011|P2|STARTED|Second Intervention (1 Day)||0
119045|NCT01860677|291012|P1|STARTED|Second Intervention (1 Day)||8
119046|NCT01860677|291011|P2|NOT COMPLETED|First Intervention (1 Day)||0
119047|NCT01860677|291012|P1|NOT COMPLETED|First Intervention (1 Day)||0
119048|NCT01860677|291011|P2|COMPLETED|First Intervention (1 Day)||0
119049|NCT01860677|291012|P1|COMPLETED|First Intervention (1 Day)||8
119050|NCT01860677|291011|P2|STARTED|First Intervention (1 Day)||0
119051|NCT01860677|291012|P1|STARTED|First Intervention (1 Day)||8
119052|NCT01860651|291023|P2|NOT COMPLETED|Overall Study||8
119053|NCT01860651|291024|P1|NOT COMPLETED|Overall Study||25
119054|NCT01860651|291023|P2|COMPLETED|Overall Study||39
119055|NCT01860651|291024|P1|COMPLETED|Overall Study||31
119056|NCT01860651|291023|P2|STARTED|Overall Study||47
119057|NCT01860651|291024|P1|STARTED|Overall Study||56
119058|NCT01860586|291040|P1|NOT COMPLETED|Overall Study||0
119059|NCT01860586|291040|P1|COMPLETED|Overall Study||20
119060|NCT01860586|291040|P1|STARTED|Overall Study||20
119061|NCT01860573|291048|P2|NOT COMPLETED|Overall Study||0
119062|NCT01860573|291049|P1|NOT COMPLETED|Overall Study||0
119063|NCT01860573|291048|P2|COMPLETED|Overall Study||85
119064|NCT01860573|291049|P1|COMPLETED|Overall Study||83
119065|NCT01860573|291048|P2|STARTED|Overall Study||85
119066|NCT01860573|291049|P1|STARTED|Overall Study||83
119067|NCT01860534|291069|P2|NOT COMPLETED|ROP #2||0
119068|NCT01860534|291070|P1|NOT COMPLETED|ROP #2||1
119069|NCT01860534|291069|P2|COMPLETED|ROP #2||13
119070|NCT01860534|291070|P1|COMPLETED|ROP #2||13
119071|NCT01860534|291069|P2|STARTED|ROP #2||13
119072|NCT01860534|291070|P1|STARTED|ROP #2||14
119073|NCT01860534|291069|P2|NOT COMPLETED|ROP #1||1
119074|NCT01860534|291070|P1|NOT COMPLETED|ROP #1||0
119075|NCT01860534|291069|P2|COMPLETED|ROP #1||13
119076|NCT01860534|291070|P1|COMPLETED|ROP #1||14
119077|NCT01860534|291069|P2|STARTED|ROP #1||14
119078|NCT01860534|291070|P1|STARTED|ROP #1||14
119079|NCT01860521|291084|P2|NOT COMPLETED|Overall Study||0
119080|NCT01860521|291085|P1|NOT COMPLETED|Overall Study||0
119081|NCT01860521|291084|P2|COMPLETED|Overall Study|June 2013|52
119082|NCT01860521|291085|P1|COMPLETED|Overall Study|June 2013|52
119083|NCT01860521|291084|P2|STARTED|Overall Study|September 2011|52
119084|NCT01860521|291085|P1|STARTED|Overall Study|September 2011|52
119085|NCT01860287|291100|P3|NOT COMPLETED|Overall Study||0
119086|NCT01860287|291101|P2|NOT COMPLETED|Overall Study||0
119087|NCT01860287|291102|P1|NOT COMPLETED|Overall Study||0
119088|NCT01860287|291100|P3|COMPLETED|Overall Study||15
119089|NCT01860287|291101|P2|COMPLETED|Overall Study||15
119090|NCT01860287|291102|P1|COMPLETED|Overall Study||18
119091|NCT01860287|291100|P3|STARTED|Overall Study||15
119092|NCT01860287|291101|P2|STARTED|Overall Study||15
119093|NCT01860287|291102|P1|STARTED|Overall Study||18
119094|NCT01860170|291113|P3|NOT COMPLETED|Overall Study||0
119095|NCT01860170|291114|P2|NOT COMPLETED|Overall Study||0
119096|NCT01860170|291115|P1|NOT COMPLETED|Overall Study||0
119097|NCT01860170|291113|P3|COMPLETED|Overall Study||22
119098|NCT01860170|291114|P2|COMPLETED|Overall Study||3
119099|NCT01860170|291115|P1|COMPLETED|Overall Study||3
119100|NCT01860170|291113|P3|STARTED|Overall Study||22
119101|NCT01860170|291114|P2|STARTED|Overall Study||3
119102|NCT01860170|291115|P1|STARTED|Overall Study||3
119103|NCT01860079|291131|P2|NOT COMPLETED|Overall Study||22
119104|NCT01860079|291132|P1|NOT COMPLETED|Overall Study||14
119105|NCT01860079|291131|P2|COMPLETED|Overall Study||363
119106|NCT01860079|291132|P1|COMPLETED|Overall Study||370
119107|NCT01860079|291131|P2|STARTED|Overall Study||385
119108|NCT01860079|291132|P1|STARTED|Overall Study||384
119109|NCT01860040|291140|P2|NOT COMPLETED|Overall Study||0
119110|NCT01860040|291141|P1|NOT COMPLETED|Overall Study||1
119111|NCT01860040|291140|P2|COMPLETED|Overall Study|did not meet recruitment goal|0
119112|NCT01860040|291141|P1|COMPLETED|Overall Study|did not meet recruitment goal|0
119113|NCT01860040|291140|P2|STARTED|Overall Study|did not meet recruitment goal|0
119114|NCT01860040|291141|P1|STARTED|Overall Study|did not meet recruitment goal|1
119115|NCT01859988|291152|P6|NOT COMPLETED|Overall Study||19
119116|NCT01859988|291153|P5|NOT COMPLETED|Overall Study||23
119117|NCT01859988|291154|P4|NOT COMPLETED|Overall Study||10
119118|NCT01859988|291155|P3|NOT COMPLETED|Overall Study||28
119119|NCT01859988|291156|P2|NOT COMPLETED|Overall Study||12
119120|NCT01859988|291157|P1|NOT COMPLETED|Overall Study||11
119121|NCT01859988|291152|P6|COMPLETED|Overall Study||42
119122|NCT01859988|291153|P5|COMPLETED|Overall Study||42
119123|NCT01859988|291154|P4|COMPLETED|Overall Study||55
119124|NCT01859988|291155|P3|COMPLETED|Overall Study||34
119125|NCT01859988|291156|P2|COMPLETED|Overall Study||52
119126|NCT01859988|291157|P1|COMPLETED|Overall Study||52
119127|NCT01859988|291152|P6|Treated|Overall Study||61
119128|NCT01859988|291153|P5|Treated|Overall Study||65
119129|NCT01859988|291154|P4|Treated|Overall Study||65
119130|NCT01859988|291155|P3|Treated|Overall Study||61
119131|NCT01859988|291156|P2|Treated|Overall Study||64
119132|NCT01859988|291157|P1|Treated|Overall Study||63
119133|NCT01859988|291152|P6|STARTED|Overall Study||61
119134|NCT01859988|291153|P5|STARTED|Overall Study||65
119135|NCT01859988|291154|P4|STARTED|Overall Study||65
119136|NCT01859988|291155|P3|STARTED|Overall Study||62
119137|NCT01859988|291156|P2|STARTED|Overall Study||64
119138|NCT01859988|291157|P1|STARTED|Overall Study||63
119139|NCT01859949|291251|P2|NOT COMPLETED|Overall Study||17
119140|NCT01859949|291252|P1|NOT COMPLETED|Overall Study||14
119141|NCT01859949|291251|P2|COMPLETED|Overall Study||15
119142|NCT01859949|291252|P1|COMPLETED|Overall Study||15
119143|NCT01859949|291251|P2|STARTED|Overall Study|Treated participants|32
119144|NCT01859949|291252|P1|STARTED|Overall Study|Treated participants|29
119145|NCT01859793|291270|P2|NOT COMPLETED|2nd Intervention Period||0
119146|NCT01859793|291271|P1|NOT COMPLETED|2nd Intervention Period||0
119147|NCT01859793|291270|P2|COMPLETED|2nd Intervention Period||16
119148|NCT01859793|291271|P1|COMPLETED|2nd Intervention Period||14
119149|NCT01859793|291270|P2|STARTED|2nd Intervention Period||16
119150|NCT01859793|291271|P1|STARTED|2nd Intervention Period||14
119151|NCT01859793|291270|P2|NOT COMPLETED|Washout Period (4 Weeks)||1
119152|NCT01859793|291271|P1|NOT COMPLETED|Washout Period (4 Weeks)||1
119153|NCT01859793|291270|P2|COMPLETED|Washout Period (4 Weeks)||16
119154|NCT01859793|291271|P1|COMPLETED|Washout Period (4 Weeks)||14
119155|NCT01859793|291270|P2|STARTED|Washout Period (4 Weeks)||17
119156|NCT01859793|291271|P1|STARTED|Washout Period (4 Weeks)||15
119157|NCT01859793|291270|P2|NOT COMPLETED|First Intervention (8 Weeks)||1
119158|NCT01859793|291271|P1|NOT COMPLETED|First Intervention (8 Weeks)||5
119159|NCT01859793|291270|P2|COMPLETED|First Intervention (8 Weeks)||17
119160|NCT01859793|291271|P1|COMPLETED|First Intervention (8 Weeks)||15
119161|NCT01859793|291270|P2|STARTED|First Intervention (8 Weeks)||18
119162|NCT01859793|291271|P1|STARTED|First Intervention (8 Weeks)||20
119163|NCT01859741|291289|P8|NOT COMPLETED|Overall Study||70
119164|NCT01859741|291290|P7|NOT COMPLETED|Overall Study||70
119165|NCT01859741|291291|P6|NOT COMPLETED|Overall Study||6
119166|NCT01859741|291292|P5|NOT COMPLETED|Overall Study||6
119167|NCT01859741|291293|P4|NOT COMPLETED|Overall Study||3
119168|NCT01859741|291294|P3|NOT COMPLETED|Overall Study||6
119169|NCT01859741|291295|P2|NOT COMPLETED|Overall Study||3
119170|NCT01859741|291296|P1|NOT COMPLETED|Overall Study||3
119171|NCT01859741|291289|P8|COMPLETED|Overall Study||3
119172|NCT01859741|291290|P7|COMPLETED|Overall Study||2
119173|NCT01859741|291291|P6|COMPLETED|Overall Study||0
119174|NCT01859741|291292|P5|COMPLETED|Overall Study||0
119175|NCT01859741|291293|P4|COMPLETED|Overall Study||0
119176|NCT01859741|291294|P3|COMPLETED|Overall Study||0
119177|NCT01859741|291295|P2|COMPLETED|Overall Study||0
119178|NCT01859741|291296|P1|COMPLETED|Overall Study||0
119179|NCT01859741|291289|P8|STARTED|Overall Study||73
119180|NCT01859741|291290|P7|STARTED|Overall Study||72
119181|NCT01859741|291291|P6|STARTED|Overall Study||6
119182|NCT01859741|291292|P5|STARTED|Overall Study||6
119183|NCT01859741|291293|P4|STARTED|Overall Study||3
119184|NCT01859741|291294|P3|STARTED|Overall Study||6
119185|NCT01859741|291295|P2|STARTED|Overall Study||3
119186|NCT01859741|291296|P1|STARTED|Overall Study||3
119187|NCT01859715|291325|P3|NOT COMPLETED|Overall Study||23
119188|NCT01859715|291326|P2|NOT COMPLETED|Overall Study||8
119189|NCT01859715|291327|P1|NOT COMPLETED|Overall Study||16
119190|NCT01859715|291325|P3|COMPLETED|Overall Study||93
119191|NCT01859715|291326|P2|COMPLETED|Overall Study||83
119192|NCT01859715|291327|P1|COMPLETED|Overall Study||125
119193|NCT01859715|291325|P3|STARTED|Overall Study||116
119194|NCT01859715|291326|P2|STARTED|Overall Study||91
119195|NCT01859715|291327|P1|STARTED|Overall Study||141
119196|NCT01859702|291338|P1|NOT COMPLETED|Overall Study||5
119197|NCT01859702|291338|P1|COMPLETED|Overall Study||31
119198|NCT01859702|291338|P1|STARTED|Overall Study||36
119199|NCT01859637|291342|P1|NOT COMPLETED|Overall Study||0
119200|NCT01859637|291342|P1|COMPLETED|Overall Study||6
119201|NCT01859637|291342|P1|STARTED|Overall Study||6
119202|NCT01859611|291348|P1|NOT COMPLETED|Overall Study||8
119203|NCT01859611|291348|P1|COMPLETED|Overall Study||43
119204|NCT01859611|291348|P1|STARTED|Overall Study||51
119205|NCT01859598|291352|P1|NOT COMPLETED|Visit 3 at 6 Months||912
119206|NCT01859598|291352|P1|COMPLETED|Visit 3 at 6 Months|Loss to follow-up, N=1517; Come back at visit 3, N=605;|16341
119207|NCT01859598|291352|P1|STARTED|Visit 3 at 6 Months||17253
119208|NCT01859598|291352|P1|NOT COMPLETED|Visit 2 at 3 Months||1742
119209|NCT01859598|291352|P1|COMPLETED|Visit 2 at 3 Months||17253
119210|NCT01859598|291352|P1|STARTED|Visit 2 at 3 Months|At visit 1, patients remained at baseline, N=18995|18995
119211|NCT01859507|291360|P1|NOT COMPLETED|Overall Study||4
119212|NCT01859507|291360|P1|COMPLETED|Overall Study||28
119213|NCT01859507|291360|P1|STARTED|Overall Study||32
119214|NCT01859494|291365|P1|NOT COMPLETED|Overall Study||1
119215|NCT01859494|291365|P1|COMPLETED|Overall Study||218
119216|NCT01859494|291365|P1|STARTED|Overall Study||219
119217|NCT01859390|291376|P2|NOT COMPLETED|Overall Study||7
119218|NCT01859390|291377|P1|NOT COMPLETED|Overall Study||1
119219|NCT01859390|291376|P2|COMPLETED|Overall Study||30
119220|NCT01859390|291377|P1|COMPLETED|Overall Study||35
119221|NCT01859390|291376|P2|Withdrawals|Overall Study||2
119222|NCT01859390|291377|P1|Withdrawals|Overall Study||2
119223|NCT01859390|291376|P2|STARTED|Overall Study||37
119224|NCT01859390|291377|P1|STARTED|Overall Study||36
119225|NCT01859325|291401|P3|NOT COMPLETED|Overall Study||0
119226|NCT01859325|291402|P2|NOT COMPLETED|Overall Study||4
119227|NCT01859325|291403|P1|NOT COMPLETED|Overall Study||3
119228|NCT01859325|291401|P3|COMPLETED|Overall Study||2
119229|NCT01859325|291402|P2|COMPLETED|Overall Study||12
119230|NCT01859325|291403|P1|COMPLETED|Overall Study||12
119231|NCT01859325|291401|P3|STARTED|Overall Study||2
119232|NCT01859325|291402|P2|STARTED|Overall Study||16
119233|NCT01859325|291403|P1|STARTED|Overall Study||15
119234|NCT01859312|291411|P1|NOT COMPLETED|Overall Study||0
119235|NCT01859312|291411|P1|COMPLETED|Overall Study|Based on medication & supply accountability, one participant was found to be partially non-compliant|8
119236|NCT01859312|291411|P1|STARTED|Overall Study||8
119237|NCT01859247|291466|P8|NOT COMPLETED|Overall Study||0
119238|NCT01859247|291467|P7|NOT COMPLETED|Overall Study||0
119239|NCT01859247|291468|P6|NOT COMPLETED|Overall Study||0
119240|NCT01859247|291469|P5|NOT COMPLETED|Overall Study||0
119241|NCT01859247|291470|P4|NOT COMPLETED|Overall Study||0
119242|NCT01859247|291471|P3|NOT COMPLETED|Overall Study||0
119243|NCT01859247|291472|P2|NOT COMPLETED|Overall Study||0
119244|NCT01859247|291473|P1|NOT COMPLETED|Overall Study||0
119245|NCT01859247|291466|P8|COMPLETED|Overall Study||1
119246|NCT01859247|291467|P7|COMPLETED|Overall Study||1
119247|NCT01859247|291468|P6|COMPLETED|Overall Study||1
119248|NCT01859247|291469|P5|COMPLETED|Overall Study||1
119249|NCT01859247|291470|P4|COMPLETED|Overall Study||1
119250|NCT01859247|291471|P3|COMPLETED|Overall Study||1
119251|NCT01859247|291472|P2|COMPLETED|Overall Study||1
119252|NCT01859247|291473|P1|COMPLETED|Overall Study||1
119253|NCT01859247|291466|P8|STARTED|Overall Study||1
119254|NCT01859247|291467|P7|STARTED|Overall Study||1
119255|NCT01859247|291468|P6|STARTED|Overall Study||1
119256|NCT01859247|291469|P5|STARTED|Overall Study||1
119257|NCT01859247|291470|P4|STARTED|Overall Study||1
119258|NCT01859247|291471|P3|STARTED|Overall Study||1
119259|NCT01859247|291472|P2|STARTED|Overall Study||1
119260|NCT01859247|291473|P1|STARTED|Overall Study||1
119261|NCT01859195|291500|P2|NOT COMPLETED|Overall Study||0
119262|NCT01859195|291501|P1|NOT COMPLETED|Overall Study||0
119263|NCT01859195|291500|P2|COMPLETED|Overall Study||12
119264|NCT01859195|291501|P1|COMPLETED|Overall Study||24
119265|NCT01859195|291500|P2|STARTED|Overall Study||12
119266|NCT01859195|291501|P1|STARTED|Overall Study||24
119267|NCT01859143|291511|P2|NOT COMPLETED|Overall Study||0
119268|NCT01859143|291512|P1|NOT COMPLETED|Overall Study||2
119269|NCT01859143|291511|P2|COMPLETED|Overall Study||60
119270|NCT01859143|291512|P1|COMPLETED|Overall Study||238
119271|NCT01859143|291511|P2|STARTED|Overall Study|One participant in this group received trivalent influenza vaccine on Day 1.|60
119272|NCT01859143|291512|P1|STARTED|Overall Study||240
119273|NCT01859078|291526|P1|NOT COMPLETED|Overall Study||0
119274|NCT01859078|291526|P1|COMPLETED|Overall Study||28
119275|NCT01859078|291526|P1|STARTED|Overall Study||28
119276|NCT01859013|291542|P2|NOT COMPLETED|Overall Study||5
119277|NCT01859013|291543|P1|NOT COMPLETED|Overall Study||4
119278|NCT01859013|291542|P2|COMPLETED|Overall Study||9
119279|NCT01859013|291543|P1|COMPLETED|Overall Study||12
119280|NCT01859013|291542|P2|STARTED|Overall Study||14
119281|NCT01859013|291543|P1|STARTED|Overall Study||16
119282|NCT01858766|291568|P19|NOT COMPLETED|Overall Study||4
119283|NCT01858766|291569|P18|NOT COMPLETED|Overall Study||4
119284|NCT01858766|291570|P17|NOT COMPLETED|Overall Study||3
119285|NCT01858766|291571|P16|NOT COMPLETED|Overall Study||6
119286|NCT01858766|291572|P15|NOT COMPLETED|Overall Study||8
119287|NCT01858766|291573|P14|NOT COMPLETED|Overall Study||3
119288|NCT01858766|291574|P13|NOT COMPLETED|Overall Study||5
119289|NCT01858766|291575|P12|NOT COMPLETED|Overall Study||5
119290|NCT01858766|291576|P11|NOT COMPLETED|Overall Study||0
119291|NCT01858766|291577|P10|NOT COMPLETED|Overall Study||0
119292|NCT01858766|291578|P9|NOT COMPLETED|Overall Study||0
119293|NCT01858766|291579|P8|NOT COMPLETED|Overall Study||2
119294|NCT01858766|291580|P7|NOT COMPLETED|Overall Study||0
119295|NCT01858766|291581|P6|NOT COMPLETED|Overall Study||4
119296|NCT01858766|291582|P5|NOT COMPLETED|Overall Study||1
119297|NCT01858766|291583|P4|NOT COMPLETED|Overall Study||0
119298|NCT01858766|291584|P3|NOT COMPLETED|Overall Study||1
119299|NCT01858766|291585|P2|NOT COMPLETED|Overall Study||0
119300|NCT01858766|291586|P1|NOT COMPLETED|Overall Study||1
119301|NCT01858766|291568|P19|COMPLETED|Overall Study||22
119302|NCT01858766|291569|P18|COMPLETED|Overall Study||23
119303|NCT01858766|291570|P17|COMPLETED|Overall Study||22
119304|NCT01858766|291571|P16|COMPLETED|Overall Study||20
119305|NCT01858766|291572|P15|COMPLETED|Overall Study||23
119306|NCT01858766|291573|P14|COMPLETED|Overall Study||26
119307|NCT01858766|291574|P13|COMPLETED|Overall Study||25
119308|NCT01858766|291575|P12|COMPLETED|Overall Study||25
119309|NCT01858766|291576|P11|COMPLETED|Overall Study||5
119310|NCT01858766|291577|P10|COMPLETED|Overall Study||4
119311|NCT01858766|291578|P9|COMPLETED|Overall Study||1
119312|NCT01858766|291579|P8|COMPLETED|Overall Study||5
119313|NCT01858766|291580|P7|COMPLETED|Overall Study||7
119314|NCT01858766|291581|P6|COMPLETED|Overall Study||24
119315|NCT01858766|291582|P5|COMPLETED|Overall Study||26
119316|NCT01858766|291583|P4|COMPLETED|Overall Study||10
119317|NCT01858766|291584|P3|COMPLETED|Overall Study||10
119318|NCT01858766|291585|P2|COMPLETED|Overall Study||28
119319|NCT01858766|291586|P1|COMPLETED|Overall Study||26
119320|NCT01858766|291568|P19|STARTED|Overall Study||26
119321|NCT01858766|291569|P18|STARTED|Overall Study||27
119322|NCT01858766|291570|P17|STARTED|Overall Study||25
119323|NCT01858766|291571|P16|STARTED|Overall Study||26
119324|NCT01858766|291572|P15|STARTED|Overall Study||31
119325|NCT01858766|291573|P14|STARTED|Overall Study||29
119326|NCT01858766|291574|P13|STARTED|Overall Study||30
119327|NCT01858766|291575|P12|STARTED|Overall Study||30
119328|NCT01858766|291576|P11|STARTED|Overall Study||5
119329|NCT01858766|291577|P10|STARTED|Overall Study||4
119330|NCT01858766|291578|P9|STARTED|Overall Study||1
119331|NCT01858766|291579|P8|STARTED|Overall Study||7
119332|NCT01858766|291580|P7|STARTED|Overall Study||7
119333|NCT01858766|291581|P6|STARTED|Overall Study||28
119334|NCT01858766|291582|P5|STARTED|Overall Study||27
119335|NCT01858766|291583|P4|STARTED|Overall Study||10
119336|NCT01858766|291584|P3|STARTED|Overall Study||11
119337|NCT01858766|291585|P2|STARTED|Overall Study||28
119338|NCT01858766|291586|P1|STARTED|Overall Study||27
119339|NCT01858701|291657|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
119340|NCT01858701|291658|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
119341|NCT01858701|291657|P2|COMPLETED|Period 2, Second 30 Days of Wear||16
119342|NCT01858701|291658|P1|COMPLETED|Period 2, Second 30 Days of Wear||18
119343|NCT01858701|291657|P2|STARTED|Period 2, Second 30 Days of Wear||17
119344|NCT01858701|291658|P1|STARTED|Period 2, Second 30 Days of Wear||18
119345|NCT01858701|291657|P2|NOT COMPLETED|Washout Period, 1-13 Days||2
119346|NCT01858701|291658|P1|NOT COMPLETED|Washout Period, 1-13 Days||2
119347|NCT01858701|291657|P2|COMPLETED|Washout Period, 1-13 Days||17
119348|NCT01858701|291658|P1|COMPLETED|Washout Period, 1-13 Days||18
119349|NCT01858701|291657|P2|STARTED|Washout Period, 1-13 Days||19
119350|NCT01858701|291658|P1|STARTED|Washout Period, 1-13 Days||20
119351|NCT01858701|291657|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||1
119352|NCT01858701|291658|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
119353|NCT01858701|291657|P2|COMPLETED|Period 1, First 30 Days of Wear||19
119354|NCT01858701|291658|P1|COMPLETED|Period 1, First 30 Days of Wear||20
119355|NCT01858701|291657|P2|STARTED|Period 1, First 30 Days of Wear||20
119356|NCT01858701|291658|P1|STARTED|Period 1, First 30 Days of Wear||20
119357|NCT01858636|291664|P1|NOT COMPLETED|Overall Study||28
119358|NCT01858636|291664|P1|COMPLETED|Overall Study||207
119359|NCT01858636|291664|P1|Device Deployment|Overall Study||211
119360|NCT01858636|291664|P1|STARTED|Overall Study|Subjects consented|235
119361|NCT01858545|291671|P2|NOT COMPLETED|Overall Study||6
119362|NCT01858545|291672|P1|NOT COMPLETED|Overall Study||4
119363|NCT01858545|291671|P2|COMPLETED|Overall Study||23
119364|NCT01858545|291672|P1|COMPLETED|Overall Study||23
119365|NCT01858545|291671|P2|STARTED|Overall Study||29
119366|NCT01858545|291672|P1|STARTED|Overall Study||27
119367|NCT01858532|291682|P4|NOT COMPLETED|Overall Study||93
119368|NCT01858532|291683|P3|NOT COMPLETED|Overall Study||98
119369|NCT01858532|291684|P2|NOT COMPLETED|Overall Study||192
119370|NCT01858532|291685|P1|NOT COMPLETED|Overall Study||181
119371|NCT01858532|291682|P4|COMPLETED|Overall Study||418
119372|NCT01858532|291683|P3|COMPLETED|Overall Study||411
119373|NCT01858532|291684|P2|COMPLETED|Overall Study||1131
119374|NCT01858532|291685|P1|COMPLETED|Overall Study||1144
119375|NCT01858532|291682|P4|STARTED|Overall Study||511
119376|NCT01858532|291683|P3|STARTED|Overall Study||509
119377|NCT01858532|291684|P2|STARTED|Overall Study||1323
119378|NCT01858532|291685|P1|STARTED|Overall Study||1325
119379|NCT01858428|291702|P2|NOT COMPLETED|Overall Study||10
119380|NCT01858428|291703|P1|NOT COMPLETED|Overall Study||1
119381|NCT01858428|291702|P2|COMPLETED|Overall Study||190
119382|NCT01858428|291703|P1|COMPLETED|Overall Study||99
119383|NCT01858428|291702|P2|STARTED|Overall Study||200
119384|NCT01858428|291703|P1|STARTED|Overall Study|EverCross™ Balloon Catheter now a product of Medtronic|100
119385|NCT01858389|291739|P2|NOT COMPLETED|Overall Study||25
119386|NCT01858389|291740|P1|NOT COMPLETED|Overall Study||16
119387|NCT01858389|291739|P2|COMPLETED|Overall Study||0
119388|NCT01858389|291740|P1|COMPLETED|Overall Study||0
119389|NCT01858389|291739|P2|Received Treatment|Overall Study||22
119390|NCT01858389|291740|P1|Received Treatment|Overall Study||16
119391|NCT01858389|291739|P2|STARTED|Overall Study|Enrolled|25
119392|NCT01858389|291740|P1|STARTED|Overall Study|Enrolled|16
119393|NCT01858376|291755|P1|NOT COMPLETED|Overall Study||4
119394|NCT01858376|291755|P1|COMPLETED|Overall Study||20
119395|NCT01858376|291755|P1|STARTED|Overall Study||24
119396|NCT01857986|291764|P2|NOT COMPLETED|Overall Study||7
119397|NCT01857986|291765|P1|NOT COMPLETED|Overall Study||5
119398|NCT01857986|291764|P2|COMPLETED|Overall Study||30
119399|NCT01857986|291765|P1|COMPLETED|Overall Study||34
119400|NCT01857986|291764|P2|STARTED|Overall Study||37
119401|NCT01857986|291765|P1|STARTED|Overall Study||39
119402|NCT01857973|291775|P1|NOT COMPLETED|Overall Study||5
119403|NCT01857973|291775|P1|COMPLETED|Overall Study||73
119404|NCT01857973|291775|P1|Phase 7|Overall Study||4
119405|NCT01857973|291775|P1|Phase 6|Overall Study||4
119406|NCT01857973|291775|P1|Phase 4|Overall Study||10
119407|NCT01857973|291775|P1|Phase 3|Overall Study||10
119408|NCT01857973|291775|P1|Phase 2|Overall Study||14
119409|NCT01857973|291775|P1|Phase 1|Overall Study||17
119410|NCT01857973|291775|P1|Xploratory B Phase|Overall Study||9
119411|NCT01857973|291775|P1|Exploratory A Phase|Overall Study||9
119412|NCT01857973|291775|P1|STARTED|Overall Study||78
119413|NCT01857882|291788|P2|NOT COMPLETED|Overall Study||0
119414|NCT01857882|291789|P1|NOT COMPLETED|Overall Study||0
119415|NCT01857882|291788|P2|COMPLETED|Overall Study||20
119416|NCT01857882|291789|P1|COMPLETED|Overall Study||21
119417|NCT01857882|291788|P2|STARTED|Overall Study||20
119418|NCT01857882|291789|P1|STARTED|Overall Study||21
119419|NCT01857869|291805|P10|NOT COMPLETED|Booster/Rechallenge Phase||0
119420|NCT01857869|291806|P9|NOT COMPLETED|Booster/Rechallenge Phase||0
119421|NCT01857869|291807|P8|NOT COMPLETED|Booster/Rechallenge Phase||0
119422|NCT01857869|291808|P7|NOT COMPLETED|Booster/Rechallenge Phase||0
119423|NCT01857869|291809|P6|NOT COMPLETED|Booster/Rechallenge Phase||0
119424|NCT01857869|291810|P5|NOT COMPLETED|Booster/Rechallenge Phase||0
119425|NCT01857869|291811|P4|NOT COMPLETED|Booster/Rechallenge Phase||2
119426|NCT01857869|291812|P3|NOT COMPLETED|Booster/Rechallenge Phase||0
119427|NCT01857869|291813|P2|NOT COMPLETED|Booster/Rechallenge Phase||0
119428|NCT01857869|291814|P1|NOT COMPLETED|Booster/Rechallenge Phase||0
119429|NCT01857869|291805|P10|COMPLETED|Booster/Rechallenge Phase||6
119430|NCT01857869|291806|P9|COMPLETED|Booster/Rechallenge Phase||3
119431|NCT01857869|291807|P8|COMPLETED|Booster/Rechallenge Phase||4
119432|NCT01857869|291808|P7|COMPLETED|Booster/Rechallenge Phase||5
119433|NCT01857869|291809|P6|COMPLETED|Booster/Rechallenge Phase||2
119434|NCT01857869|291810|P5|COMPLETED|Booster/Rechallenge Phase||10
119435|NCT01857869|291811|P4|COMPLETED|Booster/Rechallenge Phase||7
119436|NCT01857869|291812|P3|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
119437|NCT01857869|291813|P2|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
119438|NCT01857869|291814|P1|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
119439|NCT01857869|291805|P10|STARTED|Booster/Rechallenge Phase||6
119440|NCT01857869|291806|P9|STARTED|Booster/Rechallenge Phase||3
119441|NCT01857869|291807|P8|STARTED|Booster/Rechallenge Phase||4
119442|NCT01857869|291808|P7|STARTED|Booster/Rechallenge Phase||5
119443|NCT01857869|291809|P6|STARTED|Booster/Rechallenge Phase||2
119444|NCT01857869|291810|P5|STARTED|Booster/Rechallenge Phase||10
119445|NCT01857869|291811|P4|STARTED|Booster/Rechallenge Phase||9
119446|NCT01857869|291812|P3|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
119447|NCT01857869|291813|P2|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
119448|NCT01857869|291814|P1|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
119449|NCT01857869|291805|P10|NOT COMPLETED|Primary/Challenge Phase||0
119450|NCT01857869|291806|P9|NOT COMPLETED|Primary/Challenge Phase||0
119451|NCT01857869|291807|P8|NOT COMPLETED|Primary/Challenge Phase||0
119452|NCT01857869|291808|P7|NOT COMPLETED|Primary/Challenge Phase||0
119453|NCT01857869|291809|P6|NOT COMPLETED|Primary/Challenge Phase||0
119454|NCT01857869|291810|P5|NOT COMPLETED|Primary/Challenge Phase||0
119455|NCT01857869|291811|P4|NOT COMPLETED|Primary/Challenge Phase||0
119456|NCT01857869|291812|P3|NOT COMPLETED|Primary/Challenge Phase||0
119457|NCT01857869|291813|P2|NOT COMPLETED|Primary/Challenge Phase||1
119458|NCT01857869|291814|P1|NOT COMPLETED|Primary/Challenge Phase||5
119459|NCT01857869|291805|P10|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
119460|NCT01857869|291806|P9|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
119461|NCT01857869|291807|P8|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
119462|NCT01857869|291808|P7|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
119463|NCT01857869|291809|P6|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
119464|NCT01857869|291810|P5|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
119465|NCT01857869|291811|P4|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
119466|NCT01857869|291812|P3|COMPLETED|Primary/Challenge Phase||12
119467|NCT01857869|291813|P2|COMPLETED|Primary/Challenge Phase||16
119468|NCT01857869|291814|P1|COMPLETED|Primary/Challenge Phase||29
119469|NCT01857869|291805|P10|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
119470|NCT01857869|291806|P9|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
119471|NCT01857869|291807|P8|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
119472|NCT01857869|291808|P7|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
119473|NCT01857869|291809|P6|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
119474|NCT01857869|291810|P5|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
119475|NCT01857869|291811|P4|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
119476|NCT01857869|291812|P3|STARTED|Primary/Challenge Phase||12
119477|NCT01857869|291813|P2|STARTED|Primary/Challenge Phase||17
119478|NCT01857869|291814|P1|STARTED|Primary/Challenge Phase||34
119479|NCT01857713|291894|P1|NOT COMPLETED|Overall Study||6
119480|NCT01857713|291894|P1|COMPLETED|Overall Study||89
119481|NCT01857713|291894|P1|STARTED|Overall Study||95
119482|NCT01857622|291904|P3|NOT COMPLETED|Overall Study||2
119483|NCT01857622|291905|P2|NOT COMPLETED|Overall Study||1
119484|NCT01857622|291906|P1|NOT COMPLETED|Overall Study||11
119485|NCT01857622|291904|P3|COMPLETED|Overall Study||19
119486|NCT01857622|291905|P2|COMPLETED|Overall Study||21
119487|NCT01857622|291906|P1|COMPLETED|Overall Study||39
119488|NCT01857622|291904|P3|STARTED|Overall Study||21
119489|NCT01857622|291905|P2|STARTED|Overall Study||22
119490|NCT01857622|291906|P1|STARTED|Overall Study||50
119491|NCT01857583|291918|P4|NOT COMPLETED|Overall Study||4
119492|NCT01857583|291919|P3|NOT COMPLETED|Overall Study||3
119493|NCT01857583|291920|P2|NOT COMPLETED|Overall Study||1
119494|NCT01857583|291921|P1|NOT COMPLETED|Overall Study||1
119495|NCT01857583|291918|P4|COMPLETED|Overall Study||17
119496|NCT01857583|291919|P3|COMPLETED|Overall Study||19
119497|NCT01857583|291920|P2|COMPLETED|Overall Study||6
119498|NCT01857583|291921|P1|COMPLETED|Overall Study||29
119499|NCT01857583|291918|P4|Safety Analysis Population|Overall Study||20
119500|NCT01857583|291919|P3|Safety Analysis Population|Overall Study||22
119501|NCT01857583|291920|P2|Safety Analysis Population|Overall Study||7
119502|NCT01857583|291921|P1|Safety Analysis Population|Overall Study||30
119503|NCT01857583|291918|P4|STARTED|Overall Study||21
119504|NCT01857583|291919|P3|STARTED|Overall Study||22
119505|NCT01857583|291920|P2|STARTED|Overall Study||7
119506|NCT01857583|291921|P1|STARTED|Overall Study||30
119507|NCT01857531|291931|P1|NOT COMPLETED|Overall Study||4
119508|NCT01857531|291931|P1|COMPLETED|Overall Study||12
119509|NCT01857531|291931|P1|STARTED|Overall Study||16
119510|NCT01857362|291940|P2|NOT COMPLETED|Overall Study||0
119511|NCT01857362|291941|P1|NOT COMPLETED|Overall Study||0
119512|NCT01857362|291940|P2|COMPLETED|Overall Study||6
119513|NCT01857362|291941|P1|COMPLETED|Overall Study||6
119514|NCT01857362|291940|P2|STARTED|Overall Study||6
119515|NCT01857362|291941|P1|STARTED|Overall Study||6
119516|NCT01857323|291949|P1|NOT COMPLETED|Overall Study||64
119517|NCT01857323|291949|P1|COMPLETED|Overall Study||253
119518|NCT01857323|291949|P1|Safety Population|Overall Study|One enrolled participant was lost to follow-up.|316
119519|NCT01857323|291949|P1|STARTED|Overall Study|36 day treatment cohort: 45 participants 50 day treatment cohort: 272 participants|317
119520|NCT01857297|291960|P2|NOT COMPLETED|Overall Study||0
119521|NCT01857297|291961|P1|NOT COMPLETED|Overall Study||0
119522|NCT01857297|291960|P2|COMPLETED|Overall Study||60
119523|NCT01857297|291961|P1|COMPLETED|Overall Study||60
119524|NCT01857297|291960|P2|STARTED|Overall Study||60
119525|NCT01857297|291961|P1|STARTED|Overall Study||60
119526|NCT01857258|291975|P2|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
119527|NCT01857258|291976|P1|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
119528|NCT01857258|291975|P2|COMPLETED|Second Intervention (3 h Postprandially)||7
119529|NCT01857258|291976|P1|COMPLETED|Second Intervention (3 h Postprandially)||8
119530|NCT01857258|291975|P2|STARTED|Second Intervention (3 h Postprandially)||7
119531|NCT01857258|291976|P1|STARTED|Second Intervention (3 h Postprandially)||8
119532|NCT01857258|291975|P2|NOT COMPLETED|Wash-out Period (7 Days)||0
119533|NCT01857258|291976|P1|NOT COMPLETED|Wash-out Period (7 Days)||0
119534|NCT01857258|291975|P2|COMPLETED|Wash-out Period (7 Days)||7
119535|NCT01857258|291976|P1|COMPLETED|Wash-out Period (7 Days)||8
119536|NCT01857258|291975|P2|STARTED|Wash-out Period (7 Days)||7
119537|NCT01857258|291976|P1|STARTED|Wash-out Period (7 Days)||8
119538|NCT01857258|291975|P2|NOT COMPLETED|First Intervention (3 h Postprandially)||0
119539|NCT01857258|291976|P1|NOT COMPLETED|First Intervention (3 h Postprandially)||0
119540|NCT01857258|291975|P2|COMPLETED|First Intervention (3 h Postprandially)||7
119541|NCT01857258|291976|P1|COMPLETED|First Intervention (3 h Postprandially)||8
119542|NCT01857258|291975|P2|STARTED|First Intervention (3 h Postprandially)||7
119543|NCT01857258|291976|P1|STARTED|First Intervention (3 h Postprandially)||8
119544|NCT01857232|292001|P5|NOT COMPLETED|Overall Study||6
119545|NCT01857232|292002|P4|NOT COMPLETED|Overall Study||2
119546|NCT01857232|292003|P3|NOT COMPLETED|Overall Study||4
119547|NCT01857232|292004|P2|NOT COMPLETED|Overall Study||2
119548|NCT01857232|292005|P1|NOT COMPLETED|Overall Study||8
119549|NCT01857232|292001|P5|COMPLETED|Overall Study||63
119550|NCT01857232|292002|P4|COMPLETED|Overall Study||68
119551|NCT01857232|292003|P3|COMPLETED|Overall Study||63
119552|NCT01857232|292004|P2|COMPLETED|Overall Study||65
119553|NCT01857232|292005|P1|COMPLETED|Overall Study||61
119554|NCT01857232|292001|P5|Evaluable ITT|Overall Study||65
119555|NCT01857232|292002|P4|Evaluable ITT|Overall Study||68
119556|NCT01857232|292003|P3|Evaluable ITT|Overall Study||63
119557|NCT01857232|292004|P2|Evaluable ITT|Overall Study||66
119558|NCT01857232|292005|P1|Evaluable ITT|Overall Study||66
119559|NCT01857232|292001|P5|STARTED|Overall Study||69
119560|NCT01857232|292002|P4|STARTED|Overall Study||70
119561|NCT01857232|292003|P3|STARTED|Overall Study||67
119562|NCT01857232|292004|P2|STARTED|Overall Study||67
119563|NCT01857232|292005|P1|STARTED|Overall Study||69
119564|NCT01857206|292024|P2|NOT COMPLETED|Overall Study||10
119565|NCT01857206|292025|P1|NOT COMPLETED|Overall Study||13
119566|NCT01857206|292024|P2|COMPLETED|Overall Study||673
119567|NCT01857206|292025|P1|COMPLETED|Overall Study||1359
119568|NCT01857206|292024|P2|STARTED|Overall Study||683
119569|NCT01857206|292025|P1|STARTED|Overall Study||1372
119570|NCT01857102|292043|P2|NOT COMPLETED|Period 2||0
119571|NCT01857102|292044|P1|NOT COMPLETED|Period 2||2
119572|NCT01857102|292043|P2|COMPLETED|Period 2||51
119573|NCT01857102|292044|P1|COMPLETED|Period 2||53
119574|NCT01857102|292043|P2|Neophytes|Period 2||4
119575|NCT01857102|292044|P1|Neophytes|Period 2||7
119576|NCT01857102|292043|P2|Habitual Users|Period 2||47
119577|NCT01857102|292044|P1|Habitual Users|Period 2||48
119578|NCT01857102|292043|P2|STARTED|Period 2||51
119579|NCT01857102|292044|P1|STARTED|Period 2||55
119580|NCT01857102|292043|P2|NOT COMPLETED|Period 1||5
119581|NCT01857102|292044|P1|NOT COMPLETED|Period 1||3
119582|NCT01857102|292043|P2|COMPLETED|Period 1||51
119583|NCT01857102|292044|P1|COMPLETED|Period 1||55
119584|NCT01857102|292043|P2|Neophtyes|Period 1||4
119585|NCT01857102|292044|P1|Neophtyes|Period 1||7
119586|NCT01857102|292043|P2|Habitual Users|Period 1||52
119587|NCT01857102|292044|P1|Habitual Users|Period 1||51
119588|NCT01857102|292043|P2|STARTED|Period 1||56
119589|NCT01857102|292044|P1|STARTED|Period 1||58
119590|NCT01857063|292054|P2|NOT COMPLETED|Period 2 (7 Days)||2
119591|NCT01857063|292055|P1|NOT COMPLETED|Period 2 (7 Days)||4
119592|NCT01857063|292054|P2|COMPLETED|Period 2 (7 Days)||104
119593|NCT01857063|292055|P1|COMPLETED|Period 2 (7 Days)||104
119594|NCT01857063|292054|P2|STARTED|Period 2 (7 Days)||106
119595|NCT01857063|292055|P1|STARTED|Period 2 (7 Days)||108
119596|NCT01857063|292054|P2|NOT COMPLETED|Period 1 (7 Days)||4
119597|NCT01857063|292055|P1|NOT COMPLETED|Period 1 (7 Days)||2
119598|NCT01857063|292054|P2|COMPLETED|Period 1 (7 Days)||106
119599|NCT01857063|292055|P1|COMPLETED|Period 1 (7 Days)||108
119600|NCT01857063|292054|P2|STARTED|Period 1 (7 Days)||110
119601|NCT01857063|292055|P1|STARTED|Period 1 (7 Days)||110
119602|NCT01856933|292081|P1|NOT COMPLETED|Overall Study||0
119603|NCT01856933|292081|P1|COMPLETED|Overall Study||6
119604|NCT01856933|292081|P1|STARTED|Overall Study||6
119605|NCT01856907|292089|P3|NOT COMPLETED|Overall Study||0
119606|NCT01856907|292090|P2|NOT COMPLETED|Overall Study||3
119607|NCT01856907|292091|P1|NOT COMPLETED|Overall Study||0
119608|NCT01856907|292089|P3|COMPLETED|Overall Study||12
119609|NCT01856907|292090|P2|COMPLETED|Overall Study||9
119610|NCT01856907|292091|P1|COMPLETED|Overall Study||12
119611|NCT01856907|292089|P3|STARTED|Overall Study||12
119612|NCT01856907|292090|P2|STARTED|Overall Study||12
119613|NCT01856907|292091|P1|STARTED|Overall Study||12
119614|NCT01856764|292131|P2|NOT COMPLETED|Overall Study||0
119615|NCT01856764|292132|P1|NOT COMPLETED|Overall Study||0
119616|NCT01856764|292131|P2|COMPLETED|Overall Study||20
119617|NCT01856764|292132|P1|COMPLETED|Overall Study||20
119618|NCT01856764|292131|P2|STARTED|Overall Study||20
119619|NCT01856764|292132|P1|STARTED|Overall Study||20
119620|NCT01856712|292144|P2|NOT COMPLETED|Overall Study||3
119621|NCT01856712|292145|P1|NOT COMPLETED|Overall Study||7
119622|NCT01856712|292144|P2|COMPLETED|Overall Study||19
119623|NCT01856712|292145|P1|COMPLETED|Overall Study||16
119624|NCT01856712|292144|P2|Lost to 45 Day Follow up|Overall Study||1
119625|NCT01856712|292145|P1|Lost to 45 Day Follow up|Overall Study||1
119626|NCT01856712|292144|P2|Lost to 14 Day Follow up|Overall Study||2
119627|NCT01856712|292145|P1|Lost to 14 Day Follow up|Overall Study||6
119628|NCT01856712|292144|P2|STARTED|Overall Study|1 received oral in error thus randomized.|22
119629|NCT01856712|292145|P1|STARTED|Overall Study||23
119630|NCT01856686|292159|P2|NOT COMPLETED|Overall Study||11
119631|NCT01856686|292160|P1|NOT COMPLETED|Overall Study||5
119632|NCT01856686|292159|P2|COMPLETED|Overall Study||22
119633|NCT01856686|292160|P1|COMPLETED|Overall Study||26
119634|NCT01856686|292159|P2|STARTED|Overall Study||33
119635|NCT01856686|292160|P1|STARTED|Overall Study||31
119636|NCT01856673|292203|P3|NOT COMPLETED|Overall Study||34
119637|NCT01856673|292204|P2|NOT COMPLETED|Overall Study||85
119638|NCT01856673|292205|P1|NOT COMPLETED|Overall Study||98
119639|NCT01856673|292203|P3|COMPLETED|Overall Study||137
119640|NCT01856673|292204|P2|COMPLETED|Overall Study|A percentage of 80.9% completed the follow-up (exit survey)|90
119641|NCT01856673|292205|P1|COMPLETED|Overall Study|A percentage of 75.1% completed the follow-up (exit survey)|77
119642|NCT01856673|292203|P3|Quibdó Participants|Overall Study||83
119643|NCT01856673|292204|P2|Quibdó Participants|Overall Study||86
119644|NCT01856673|292205|P1|Quibdó Participants|Overall Study||83
119645|NCT01856673|292203|P3|Buenaventura Participants|Overall Study||88
119646|NCT01856673|292204|P2|Buenaventura Participants|Overall Study||89
119647|NCT01856673|292205|P1|Buenaventura Participants|Overall Study||92
119648|NCT01856673|292203|P3|STARTED|Overall Study||171
119649|NCT01856673|292204|P2|STARTED|Overall Study||175
119650|NCT01856673|292205|P1|STARTED|Overall Study||175
119651|NCT01856595|292225|P9|NOT COMPLETED|Overall Study||0
119652|NCT01856595|292226|P8|NOT COMPLETED|Overall Study||0
119653|NCT01856595|292227|P7|NOT COMPLETED|Overall Study||1
119654|NCT01856595|292228|P6|NOT COMPLETED|Overall Study||0
119655|NCT01856595|292229|P5|NOT COMPLETED|Overall Study||0
119656|NCT01856595|292230|P4|NOT COMPLETED|Overall Study||0
119657|NCT01856595|292231|P3|NOT COMPLETED|Overall Study||0
119658|NCT01856595|292232|P2|NOT COMPLETED|Overall Study||1
119659|NCT01856595|292233|P1|NOT COMPLETED|Overall Study||0
119660|NCT01856595|292225|P9|COMPLETED|Overall Study||14
119661|NCT01856595|292226|P8|COMPLETED|Overall Study||10
119662|NCT01856595|292227|P7|COMPLETED|Overall Study||12
119663|NCT01856595|292228|P6|COMPLETED|Overall Study||12
119664|NCT01856595|292229|P5|COMPLETED|Overall Study||14
119665|NCT01856595|292230|P4|COMPLETED|Overall Study||12
119666|NCT01856595|292231|P3|COMPLETED|Overall Study||12
119667|NCT01856595|292232|P2|COMPLETED|Overall Study||11
119668|NCT01856595|292233|P1|COMPLETED|Overall Study||18
119669|NCT01856595|292225|P9|STARTED|Overall Study||14
119670|NCT01856595|292226|P8|STARTED|Overall Study||10
119671|NCT01856595|292227|P7|STARTED|Overall Study||13
119672|NCT01856595|292228|P6|STARTED|Overall Study||12
119673|NCT01856595|292229|P5|STARTED|Overall Study||14
119674|NCT01856595|292230|P4|STARTED|Overall Study||12
119675|NCT01856595|292231|P3|STARTED|Overall Study||12
119676|NCT01856595|292232|P2|STARTED|Overall Study||12
119677|NCT01856595|292233|P1|STARTED|Overall Study||18
119678|NCT01856582|292466|P1|NOT COMPLETED|Overall Study||1
119679|NCT01856582|292466|P1|COMPLETED|Overall Study||22
119680|NCT01856582|292466|P1|STARTED|Overall Study||23
119681|NCT01856569|292470|P1|NOT COMPLETED|Overall Study||13
119682|NCT01856569|292470|P1|COMPLETED|Overall Study||139
119683|NCT01856569|292470|P1|Full Analysis Set|Overall Study||144
119684|NCT01856569|292470|P1|STARTED|Overall Study||152
119685|NCT01856543|292481|P2|NOT COMPLETED|Overall Study||6
119686|NCT01856543|292482|P1|NOT COMPLETED|Overall Study||13
119687|NCT01856543|292481|P2|COMPLETED|Overall Study||64
119688|NCT01856543|292482|P1|COMPLETED|Overall Study||60
119689|NCT01856543|292481|P2|STARTED|Overall Study||70
119690|NCT01856543|292482|P1|STARTED|Overall Study||73
119691|NCT01856530|292494|P2|NOT COMPLETED|Overall Study||0
119692|NCT01856530|292495|P1|NOT COMPLETED|Overall Study||0
119693|NCT01856530|292494|P2|COMPLETED|Overall Study||27
119694|NCT01856530|292495|P1|COMPLETED|Overall Study||27
119695|NCT01856530|292494|P2|STARTED|Overall Study||27
119696|NCT01856530|292495|P1|STARTED|Overall Study||27
119697|NCT01856491|292511|P1|NOT COMPLETED|Overall Study||15
119698|NCT01856491|292511|P1|COMPLETED|Overall Study||152
119699|NCT01856491|292511|P1|STARTED|Overall Study||167
119700|NCT01856361|292522|P2|NOT COMPLETED|Overall Study||0
119701|NCT01856361|292523|P1|NOT COMPLETED|Overall Study||0
119702|NCT01856361|292522|P2|COMPLETED|Overall Study||1
119703|NCT01856361|292523|P1|COMPLETED|Overall Study||1
119704|NCT01856361|292522|P2|STARTED|Overall Study||1
119705|NCT01856361|292523|P1|STARTED|Overall Study||1
119706|NCT01856322|292540|P3|NOT COMPLETED|Overall Study||3
119707|NCT01856322|292541|P2|NOT COMPLETED|Overall Study||0
119708|NCT01856322|292542|P1|NOT COMPLETED|Overall Study||0
119709|NCT01856322|292540|P3|COMPLETED|Overall Study||0
119710|NCT01856322|292541|P2|COMPLETED|Overall Study||0
119711|NCT01856322|292542|P1|COMPLETED|Overall Study||0
119712|NCT01856322|292540|P3|STARTED|Overall Study||3
119713|NCT01856322|292541|P2|STARTED|Overall Study||0
119714|NCT01856322|292542|P1|STARTED|Overall Study||0
119715|NCT01856309|292553|P4|NOT COMPLETED|Overall Study||609
119716|NCT01856309|292554|P3|NOT COMPLETED|Overall Study||595
119717|NCT01856309|292555|P2|NOT COMPLETED|Overall Study||288
119718|NCT01856309|292556|P1|NOT COMPLETED|Overall Study||299
119719|NCT01856309|292553|P4|COMPLETED|Overall Study||9
119720|NCT01856309|292554|P3|COMPLETED|Overall Study||11
119721|NCT01856309|292555|P2|COMPLETED|Overall Study||3
119722|NCT01856309|292556|P1|COMPLETED|Overall Study||6
119723|NCT01856309|292553|P4|Treated Partcipants|Overall Study||618
119724|NCT01856309|292554|P3|Treated Partcipants|Overall Study||605
119725|NCT01856309|292555|P2|Treated Partcipants|Overall Study||290
119726|NCT01856309|292556|P1|Treated Partcipants|Overall Study||305
119727|NCT01856309|292553|P4|Participants From Study CNTO136ARA3003|Overall Study||206
119728|NCT01856309|292554|P3|Participants From Study CNTO136ARA3003|Overall Study||201
119729|NCT01856309|292555|P2|Participants From Study CNTO136ARA3003|Overall Study||104
119730|NCT01856309|292556|P1|Participants From Study CNTO136ARA3003|Overall Study||108
119731|NCT01856309|292553|P4|Participants From Study CNTO136ARA3002|Overall Study||412
119732|NCT01856309|292554|P3|Participants From Study CNTO136ARA3002|Overall Study||405
119733|NCT01856309|292555|P2|Participants From Study CNTO136ARA3002|Overall Study||187
119734|NCT01856309|292556|P1|Participants From Study CNTO136ARA3002|Overall Study||197
119735|NCT01856309|292553|P4|STARTED|Overall Study||618
119736|NCT01856309|292554|P3|STARTED|Overall Study||606
119737|NCT01856309|292555|P2|STARTED|Overall Study||291
119738|NCT01856309|292556|P1|STARTED|Overall Study||305
119739|NCT01856270|292656|P2|NOT COMPLETED|Overall Study||12
119740|NCT01856270|292657|P1|NOT COMPLETED|Overall Study||11
119741|NCT01856270|292656|P2|COMPLETED|Overall Study||14
119742|NCT01856270|292657|P1|COMPLETED|Overall Study||13
119743|NCT01856270|292656|P2|STARTED|Overall Study||26
119744|NCT01856270|292657|P1|STARTED|Overall Study||24
119745|NCT01856257|292680|P4|NOT COMPLETED|Overall Study||2
119746|NCT01856257|292681|P3|NOT COMPLETED|Overall Study||0
119747|NCT01856257|292682|P2|NOT COMPLETED|Overall Study||1
119748|NCT01856257|292683|P1|NOT COMPLETED|Overall Study||3
119749|NCT01856257|292680|P4|COMPLETED|Overall Study||0
119750|NCT01856257|292681|P3|COMPLETED|Overall Study||11
119751|NCT01856257|292682|P2|COMPLETED|Overall Study||28
119752|NCT01856257|292683|P1|COMPLETED|Overall Study||26
119753|NCT01856257|292680|P4|STARTED|Overall Study||2
119754|NCT01856257|292681|P3|STARTED|Overall Study||11
119755|NCT01856257|292682|P2|STARTED|Overall Study||29
119756|NCT01856257|292683|P1|STARTED|Overall Study||29
119757|NCT01856218|292782|P1|NOT COMPLETED|Long-Term Extension Phase||0
119758|NCT01856218|292782|P1|COMPLETED|Long-Term Extension Phase||3
119759|NCT01856218|292782|P1|STARTED|Long-Term Extension Phase||3
119760|NCT01856218|292782|P1|NOT COMPLETED|First Phase||0
119761|NCT01856218|292782|P1|COMPLETED|First Phase||3
119762|NCT01856218|292782|P1|STARTED|First Phase||3
119763|NCT01855997|292796|P1|NOT COMPLETED|Overall Study||0
119764|NCT01855997|292796|P1|COMPLETED|Overall Study||1669
119765|NCT01855997|292796|P1|STARTED|Overall Study||1669
119766|NCT01855958|292851|P2|NOT COMPLETED|Overall Study||0
119767|NCT01855958|292852|P1|NOT COMPLETED|Overall Study||1
119768|NCT01855958|292851|P2|COMPLETED|Overall Study||13
119769|NCT01855958|292852|P1|COMPLETED|Overall Study||12
119770|NCT01855958|292851|P2|STARTED|Overall Study||13
119771|NCT01855958|292852|P1|STARTED|Overall Study||13
119772|NCT01855945|292882|P12|NOT COMPLETED|Overall Study||3
119773|NCT01855945|292883|P11|NOT COMPLETED|Overall Study||5
119774|NCT01855945|292884|P10|NOT COMPLETED|Overall Study||2
119775|NCT01855945|292885|P9|NOT COMPLETED|Overall Study||2
119776|NCT01855945|292886|P8|NOT COMPLETED|Overall Study||8
119777|NCT01855945|292887|P7|NOT COMPLETED|Overall Study||10
119778|NCT01855945|292888|P6|NOT COMPLETED|Overall Study||3
119779|NCT01855945|292889|P5|NOT COMPLETED|Overall Study||1
119780|NCT01855945|292890|P4|NOT COMPLETED|Overall Study||4
119781|NCT01855945|292891|P3|NOT COMPLETED|Overall Study||12
119782|NCT01855945|292892|P2|NOT COMPLETED|Overall Study||11
119783|NCT01855945|292893|P1|NOT COMPLETED|Overall Study||16
119784|NCT01855945|292882|P12|COMPLETED|Overall Study||49
119785|NCT01855945|292883|P11|COMPLETED|Overall Study||46
119786|NCT01855945|292884|P10|COMPLETED|Overall Study||49
119787|NCT01855945|292885|P9|COMPLETED|Overall Study||46
119788|NCT01855945|292886|P8|COMPLETED|Overall Study||47
119789|NCT01855945|292887|P7|COMPLETED|Overall Study||43
119790|NCT01855945|292888|P6|COMPLETED|Overall Study||50
119791|NCT01855945|292889|P5|COMPLETED|Overall Study||50
119792|NCT01855945|292890|P4|COMPLETED|Overall Study||49
119793|NCT01855945|292891|P3|COMPLETED|Overall Study||39
119794|NCT01855945|292892|P2|COMPLETED|Overall Study||44
119795|NCT01855945|292893|P1|COMPLETED|Overall Study||38
119796|NCT01855945|292882|P12|STARTED|Overall Study||52
119797|NCT01855945|292883|P11|STARTED|Overall Study||51
119798|NCT01855945|292884|P10|STARTED|Overall Study||51
119799|NCT01855945|292885|P9|STARTED|Overall Study||48
119800|NCT01855945|292886|P8|STARTED|Overall Study||55
119801|NCT01855945|292887|P7|STARTED|Overall Study||53
119802|NCT01855945|292888|P6|STARTED|Overall Study||53
119803|NCT01855945|292889|P5|STARTED|Overall Study||51
119804|NCT01855945|292890|P4|STARTED|Overall Study||53
119805|NCT01855945|292891|P3|STARTED|Overall Study||51
119806|NCT01855945|292892|P2|STARTED|Overall Study||55
119807|NCT01855945|292893|P1|STARTED|Overall Study||54
119808|NCT01855919|293029|P2|NOT COMPLETED|Overall Study||26
119809|NCT01855919|293030|P1|NOT COMPLETED|Overall Study||23
119810|NCT01855919|293029|P2|COMPLETED|Overall Study||200
119811|NCT01855919|293030|P1|COMPLETED|Overall Study||209
119812|NCT01855919|293029|P2|Received at Least 1 Dose of Study Drug|Overall Study||226
119813|NCT01855919|293030|P1|Received at Least 1 Dose of Study Drug|Overall Study||232
119814|NCT01855919|293029|P2|STARTED|Overall Study||226
119815|NCT01855919|293030|P1|STARTED|Overall Study||232
119816|NCT01855789|293062|P4|NOT COMPLETED|2) Week 24 up to End of Study||58
119817|NCT01855789|293063|P3|NOT COMPLETED|2) Week 24 up to End of Study||18
119818|NCT01855789|293064|P2|NOT COMPLETED|2) Week 24 up to End of Study||15
119819|NCT01855789|293065|P1|NOT COMPLETED|2) Week 24 up to End of Study||0
119820|NCT01855789|293062|P4|COMPLETED|2) Week 24 up to End of Study||250
119821|NCT01855789|293063|P3|COMPLETED|2) Week 24 up to End of Study||129
119822|NCT01855789|293064|P2|COMPLETED|2) Week 24 up to End of Study||132
119823|NCT01855789|293065|P1|COMPLETED|2) Week 24 up to End of Study||0
119824|NCT01855789|293062|P4|STARTED|2) Week 24 up to End of Study||308
119825|NCT01855789|293063|P3|STARTED|2) Week 24 up to End of Study||147
119826|NCT01855789|293064|P2|STARTED|2) Week 24 up to End of Study||147
119827|NCT01855789|293065|P1|STARTED|2) Week 24 up to End of Study||0
119828|NCT01855789|293062|P4|NOT COMPLETED|1) Baseline up to Week 24||0
119829|NCT01855789|293063|P3|NOT COMPLETED|1) Baseline up to Week 24||0
119830|NCT01855789|293064|P2|NOT COMPLETED|1) Baseline up to Week 24||0
119831|NCT01855789|293065|P1|NOT COMPLETED|1) Baseline up to Week 24||116
119832|NCT01855789|293062|P4|COMPLETED|1) Baseline up to Week 24||0
119833|NCT01855789|293063|P3|COMPLETED|1) Baseline up to Week 24||0
119834|NCT01855789|293064|P2|COMPLETED|1) Baseline up to Week 24||0
119835|NCT01855789|293065|P1|COMPLETED|1) Baseline up to Week 24||602
119836|NCT01855789|293062|P4|STARTED|1) Baseline up to Week 24||0
119837|NCT01855789|293063|P3|STARTED|1) Baseline up to Week 24||0
119838|NCT01855789|293064|P2|STARTED|1) Baseline up to Week 24||0
119839|NCT01855789|293065|P1|STARTED|1) Baseline up to Week 24||718
119840|NCT01855750|293089|P2|NOT COMPLETED|Overall Study||106
119841|NCT01855750|293090|P1|NOT COMPLETED|Overall Study||107
119842|NCT01855750|293089|P2|COMPLETED|Overall Study||313
119843|NCT01855750|293090|P1|COMPLETED|Overall Study||312
119844|NCT01855750|293089|P2|Treated|Overall Study|1 participant not treated: withdrew consent.|418
119845|NCT01855750|293090|P1|Treated|Overall Study|3 participants not treated:2 withdrew consent and 1 not treated per Sponsor/investigator's decision.|416
119846|NCT01855750|293089|P2|STARTED|Overall Study||419
119847|NCT01855750|293090|P1|STARTED|Overall Study||419
119848|NCT01855425|293106|P1|NOT COMPLETED|Overall Study||20
119849|NCT01855425|293106|P1|COMPLETED|Overall Study||76
119850|NCT01855425|293106|P1|STARTED|Overall Study||96
119851|NCT01855399|293112|P2|NOT COMPLETED|12 Month||11
119852|NCT01855399|293113|P1|NOT COMPLETED|12 Month||7
119853|NCT01855399|293112|P2|COMPLETED|12 Month||118
119854|NCT01855399|293113|P1|COMPLETED|12 Month||119
119855|NCT01855399|293112|P2|STARTED|12 Month||129
119856|NCT01855399|293113|P1|STARTED|12 Month||126
119857|NCT01855399|293112|P2|NOT COMPLETED|6 Month||15
119858|NCT01855399|293113|P1|NOT COMPLETED|6 Month||20
119859|NCT01855399|293112|P2|COMPLETED|6 Month||129
119860|NCT01855399|293113|P1|COMPLETED|6 Month||126
119861|NCT01855399|293112|P2|STARTED|6 Month||144
119862|NCT01855399|293113|P1|STARTED|6 Month||146
119863|NCT01855243|293122|P3|NOT COMPLETED|Overall Study||0
119864|NCT01855243|293123|P2|NOT COMPLETED|Overall Study||0
119865|NCT01855243|293124|P1|NOT COMPLETED|Overall Study||1
119866|NCT01855243|293122|P3|COMPLETED|Overall Study||22
119867|NCT01855243|293123|P2|COMPLETED|Overall Study||21
119868|NCT01855243|293124|P1|COMPLETED|Overall Study||19
119869|NCT01855243|293122|P3|STARTED|Overall Study||22
119870|NCT01855243|293123|P2|STARTED|Overall Study||21
119871|NCT01855243|293124|P1|STARTED|Overall Study||20
119872|NCT01855126|293146|P2|NOT COMPLETED|Second Intervention (8 Weeks)||2
119873|NCT01855126|293147|P1|NOT COMPLETED|Second Intervention (8 Weeks)||2
119874|NCT01855126|293146|P2|COMPLETED|Second Intervention (8 Weeks)||14
119875|NCT01855126|293147|P1|COMPLETED|Second Intervention (8 Weeks)||18
119876|NCT01855126|293146|P2|STARTED|Second Intervention (8 Weeks)||16
119877|NCT01855126|293147|P1|STARTED|Second Intervention (8 Weeks)||20
119878|NCT01855126|293146|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
119879|NCT01855126|293147|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
119880|NCT01855126|293146|P2|COMPLETED|Washout Period (2 Weeks)||16
119881|NCT01855126|293147|P1|COMPLETED|Washout Period (2 Weeks)||20
119882|NCT01855126|293146|P2|STARTED|Washout Period (2 Weeks)||16
119883|NCT01855126|293147|P1|STARTED|Washout Period (2 Weeks)||20
119884|NCT01855126|293146|P2|NOT COMPLETED|First Intervention (8 Weeks)||6
119885|NCT01855126|293147|P1|NOT COMPLETED|First Intervention (8 Weeks)||4
119886|NCT01855126|293146|P2|COMPLETED|First Intervention (8 Weeks)||16
119887|NCT01855126|293147|P1|COMPLETED|First Intervention (8 Weeks)||20
119888|NCT01855126|293146|P2|STARTED|First Intervention (8 Weeks)||22
119889|NCT01855126|293147|P1|STARTED|First Intervention (8 Weeks)||24
119890|NCT01855074|293159|P1|NOT COMPLETED|Overall Study||14
119891|NCT01855074|293159|P1|COMPLETED|Overall Study||66
119892|NCT01855074|293159|P1|Treated|Overall Study||79
119893|NCT01855074|293159|P1|STARTED|Overall Study||80
119894|NCT01854944|293171|P3|NOT COMPLETED|Overall Study||1
119895|NCT01854944|293172|P2|NOT COMPLETED|Overall Study||0
119896|NCT01854944|293173|P1|NOT COMPLETED|Overall Study||0
119897|NCT01854944|293171|P3|COMPLETED|Overall Study||3
119898|NCT01854944|293172|P2|COMPLETED|Overall Study||4
119899|NCT01854944|293173|P1|COMPLETED|Overall Study||4
119900|NCT01854944|293171|P3|STARTED|Overall Study||4
119901|NCT01854944|293172|P2|STARTED|Overall Study||4
119902|NCT01854944|293173|P1|STARTED|Overall Study||4
119903|NCT01854918|293225|P2|NOT COMPLETED|All-IP Period (Years 2 and 3)||195
119904|NCT01854918|293226|P1|NOT COMPLETED|All-IP Period (Years 2 and 3)||118
119905|NCT01854918|293225|P2|COMPLETED|All-IP Period (Years 2 and 3)||2196
119906|NCT01854918|293226|P1|COMPLETED|All-IP Period (Years 2 and 3)||1079
119907|NCT01854918|293225|P2|Received Evolocumab|All-IP Period (Years 2 and 3)||2291
119908|NCT01854918|293226|P1|Received Evolocumab|All-IP Period (Years 2 and 3)||1152
119909|NCT01854918|293225|P2|STARTED|All-IP Period (Years 2 and 3)||2391
119910|NCT01854918|293226|P1|STARTED|All-IP Period (Years 2 and 3)||1197
119911|NCT01854918|293225|P2|NOT COMPLETED|SOC-controlled Period (Year 1)||63
119912|NCT01854918|293226|P1|NOT COMPLETED|SOC-controlled Period (Year 1)||30
119913|NCT01854918|293225|P2|COMPLETED|SOC-controlled Period (Year 1)||2391
119914|NCT01854918|293226|P1|COMPLETED|SOC-controlled Period (Year 1)||1197
119915|NCT01854918|293225|P2|Received Evolocumab|SOC-controlled Period (Year 1)||2452
119916|NCT01854918|293226|P1|Received Evolocumab|SOC-controlled Period (Year 1)|5 participants received evolocumab in error|5
119917|NCT01854918|293225|P2|STARTED|SOC-controlled Period (Year 1)||2454
119918|NCT01854918|293226|P1|STARTED|SOC-controlled Period (Year 1)||1227
119919|NCT01854905|293241|P1|NOT COMPLETED|Overall Study||0
119920|NCT01854905|293241|P1|COMPLETED|Overall Study||400
119921|NCT01854905|293241|P1|STARTED|Overall Study||400
119922|NCT01854827|293245|P1|NOT COMPLETED|Overall Study||1
119923|NCT01854827|293245|P1|COMPLETED|Overall Study||29
119924|NCT01854827|293245|P1|STARTED|Overall Study||30
119925|NCT01854710|293257|P6|NOT COMPLETED|Overall Study||2
119926|NCT01854710|293258|P5|NOT COMPLETED|Overall Study||2
119927|NCT01854710|293259|P4|NOT COMPLETED|Overall Study||2
119928|NCT01854710|293260|P3|NOT COMPLETED|Overall Study||2
119929|NCT01854710|293261|P2|NOT COMPLETED|Overall Study||3
119930|NCT01854710|293262|P1|NOT COMPLETED|Overall Study||4
119931|NCT01854710|293257|P6|COMPLETED|Overall Study||8
119932|NCT01854710|293258|P5|COMPLETED|Overall Study||8
119933|NCT01854710|293259|P4|COMPLETED|Overall Study||8
119934|NCT01854710|293260|P3|COMPLETED|Overall Study||8
119935|NCT01854710|293261|P2|COMPLETED|Overall Study||7
119936|NCT01854710|293262|P1|COMPLETED|Overall Study||6
119937|NCT01854710|293257|P6|STARTED|Overall Study||10
119938|NCT01854710|293258|P5|STARTED|Overall Study||10
119939|NCT01854710|293259|P4|STARTED|Overall Study||10
119940|NCT01854710|293260|P3|STARTED|Overall Study||10
119941|NCT01854710|293261|P2|STARTED|Overall Study||10
119942|NCT01854710|293262|P1|STARTED|Overall Study||10
119943|NCT01854697|293283|P5|NOT COMPLETED|Overall Study||2
119944|NCT01854697|293284|P4|NOT COMPLETED|Overall Study||3
119945|NCT01854697|293285|P3|NOT COMPLETED|Overall Study||2
119946|NCT01854697|293286|P2|NOT COMPLETED|Overall Study||3
119947|NCT01854697|293287|P1|NOT COMPLETED|Overall Study||6
119948|NCT01854697|293283|P5|COMPLETED|Overall Study||39
119949|NCT01854697|293284|P4|COMPLETED|Overall Study||80
119950|NCT01854697|293285|P3|COMPLETED|Overall Study||82
119951|NCT01854697|293286|P2|COMPLETED|Overall Study||31
119952|NCT01854697|293287|P1|COMPLETED|Overall Study||63
119953|NCT01854697|293283|P5|STARTED|Overall Study||41
119954|NCT01854697|293284|P4|STARTED|Overall Study||83
119955|NCT01854697|293285|P3|STARTED|Overall Study||84
119956|NCT01854697|293286|P2|STARTED|Overall Study||34
119957|NCT01854697|293287|P1|STARTED|Overall Study||69
119958|NCT01854658|293331|P4|NOT COMPLETED|Overall Study||59
119959|NCT01854658|293332|P3|NOT COMPLETED|Overall Study||80
119960|NCT01854658|293333|P2|NOT COMPLETED|Overall Study||75
119961|NCT01854658|293334|P1|NOT COMPLETED|Overall Study||93
119962|NCT01854658|293331|P4|COMPLETED|Overall Study||165
119963|NCT01854658|293332|P3|COMPLETED|Overall Study||432
119964|NCT01854658|293333|P2|COMPLETED|Overall Study||365
119965|NCT01854658|293334|P1|COMPLETED|Overall Study||346
119966|NCT01854658|293331|P4|STARTED|Overall Study||224
119967|NCT01854658|293332|P3|STARTED|Overall Study||512
119968|NCT01854658|293333|P2|STARTED|Overall Study||440
119969|NCT01854658|293334|P1|STARTED|Overall Study||439
119970|NCT01854645|293369|P5|NOT COMPLETED|Overall Study||60
119971|NCT01854645|293370|P4|NOT COMPLETED|Overall Study||62
119972|NCT01854645|293371|P3|NOT COMPLETED|Overall Study||82
119973|NCT01854645|293372|P2|NOT COMPLETED|Overall Study||106
119974|NCT01854645|293373|P1|NOT COMPLETED|Overall Study||98
119975|NCT01854645|293369|P5|COMPLETED|Overall Study||160
119976|NCT01854645|293370|P4|COMPLETED|Overall Study||391
119977|NCT01854645|293371|P3|COMPLETED|Overall Study||370
119978|NCT01854645|293372|P2|COMPLETED|Overall Study||345
119979|NCT01854645|293373|P1|COMPLETED|Overall Study||429
119980|NCT01854645|293369|P5|STARTED|Overall Study||220
119981|NCT01854645|293370|P4|STARTED|Overall Study||453
119982|NCT01854645|293371|P3|STARTED|Overall Study||452
119983|NCT01854645|293372|P2|STARTED|Overall Study||451
119984|NCT01854645|293373|P1|STARTED|Overall Study||527
119985|NCT01854632|293412|P2|NOT COMPLETED|Overall Study||13
119986|NCT01854632|293413|P1|NOT COMPLETED|Overall Study||26
119987|NCT01854632|293412|P2|COMPLETED|Overall Study||574
119988|NCT01854632|293413|P1|COMPLETED|Overall Study||1148
119989|NCT01854632|293412|P2|STARTED|Overall Study||587
119990|NCT01854632|293413|P1|STARTED|Overall Study||1174
119991|NCT01854593|293421|P2|NOT COMPLETED|Overall Study||1
119992|NCT01854593|293422|P1|NOT COMPLETED|Overall Study||2
119993|NCT01854593|293421|P2|COMPLETED|Overall Study||34
119994|NCT01854593|293422|P1|COMPLETED|Overall Study||32
119995|NCT01854593|293421|P2|STARTED|Overall Study||35
119996|NCT01854593|293422|P1|STARTED|Overall Study||34
119997|NCT01854528|293454|P2|NOT COMPLETED|Overall Study||15
119998|NCT01854528|293455|P1|NOT COMPLETED|Overall Study||0
119999|NCT01854528|293454|P2|COMPLETED|Overall Study||32
120000|NCT01854528|293455|P1|COMPLETED|Overall Study||101
120001|NCT01854528|293454|P2|STARTED|Overall Study||47
120002|NCT01854528|293455|P1|STARTED|Overall Study||101
120003|NCT01854281|293475|P4|NOT COMPLETED|Overall Study||0
120004|NCT01854281|293476|P3|NOT COMPLETED|Overall Study||0
120005|NCT01854281|293477|P2|NOT COMPLETED|Overall Study||0
120006|NCT01854281|293478|P1|NOT COMPLETED|Overall Study||0
120007|NCT01854281|293475|P4|COMPLETED|Overall Study||8
120008|NCT01854281|293476|P3|COMPLETED|Overall Study||5
120009|NCT01854281|293477|P2|COMPLETED|Overall Study||19
120010|NCT01854281|293478|P1|COMPLETED|Overall Study||15
120011|NCT01854281|293475|P4|STARTED|Overall Study||8
120012|NCT01854281|293476|P3|STARTED|Overall Study||5
120013|NCT01854281|293477|P2|STARTED|Overall Study||19
120014|NCT01854281|293478|P1|STARTED|Overall Study||15
120015|NCT01854268|293488|P1|NOT COMPLETED|Overall Study||0
120016|NCT01854268|293488|P1|COMPLETED|Overall Study||25
120017|NCT01854268|293488|P1|STARTED|Overall Study||25
120018|NCT01854242|293494|P1|NOT COMPLETED|Overall Study||0
120019|NCT01854242|293494|P1|COMPLETED|Overall Study||50
120020|NCT01854242|293494|P1|STARTED|Overall Study||50
120021|NCT01854177|293498|P1|NOT COMPLETED|Overall Study||0
120022|NCT01854177|293498|P1|COMPLETED|Overall Study||10
120023|NCT01854177|293498|P1|STARTED|Overall Study||10
120024|NCT01854138|293508|P2|NOT COMPLETED|Overall Study||52
120025|NCT01854138|293509|P1|NOT COMPLETED|Overall Study||0
120026|NCT01854138|293508|P2|COMPLETED|Overall Study||196
120027|NCT01854138|293509|P1|COMPLETED|Overall Study||400
120028|NCT01854138|293508|P2|STARTED|Overall Study||248
120029|NCT01854138|293509|P1|STARTED|Overall Study|historical control with waiver of authorization; no informed consent signed|400
120030|NCT01854047|293526|P5|NOT COMPLETED|Overall Study||19
120031|NCT01854047|293527|P4|NOT COMPLETED|Overall Study||15
120032|NCT01854047|293528|P3|NOT COMPLETED|Overall Study||13
120033|NCT01854047|293529|P2|NOT COMPLETED|Overall Study||8
120034|NCT01854047|293530|P1|NOT COMPLETED|Overall Study||12
120035|NCT01854047|293526|P5|COMPLETED|Overall Study||135
120036|NCT01854047|293527|P4|COMPLETED|Overall Study||142
120037|NCT01854047|293528|P3|COMPLETED|Overall Study||137
120038|NCT01854047|293529|P2|COMPLETED|Overall Study||149
120039|NCT01854047|293530|P1|COMPLETED|Overall Study||146
120040|NCT01854047|293526|P5|Completed 12-week Study Treatment|Overall Study||143
120041|NCT01854047|293527|P4|Completed 12-week Study Treatment|Overall Study||146
120042|NCT01854047|293528|P3|Completed 12-week Study Treatment|Overall Study||141
120043|NCT01854047|293529|P2|Completed 12-week Study Treatment|Overall Study||149
120044|NCT01854047|293530|P1|Completed 12-week Study Treatment|Overall Study||153
120045|NCT01854047|293526|P5|Treated|Overall Study||150
120046|NCT01854047|293527|P4|Treated|Overall Study||157
120047|NCT01854047|293528|P3|Treated|Overall Study||148
120048|NCT01854047|293529|P2|Treated|Overall Study||156
120049|NCT01854047|293530|P1|Treated|Overall Study||158
120050|NCT01854047|293526|P5|STARTED|Overall Study||154
120051|NCT01854047|293527|P4|STARTED|Overall Study||157
120052|NCT01854047|293528|P3|STARTED|Overall Study||150
120053|NCT01854047|293529|P2|STARTED|Overall Study||157
120054|NCT01854047|293530|P1|STARTED|Overall Study||158
120055|NCT01854034|293652|P1|NOT COMPLETED|Overall Study||0
120056|NCT01854034|293652|P1|COMPLETED|Overall Study||29
120057|NCT01854034|293652|P1|STARTED|Overall Study||29
120058|NCT01853982|293661|P2|NOT COMPLETED|Overall Study||1
120059|NCT01853982|293662|P1|NOT COMPLETED|Overall Study||2
120060|NCT01853982|293661|P2|COMPLETED|Overall Study||1
120061|NCT01853982|293662|P1|COMPLETED|Overall Study||0
120062|NCT01853982|293661|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
120063|NCT01853982|293662|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
120064|NCT01853982|293661|P2|STARTED|Overall Study||2
120065|NCT01853982|293662|P1|STARTED|Overall Study||2
120066|NCT01853930|293670|P2|NOT COMPLETED|Overall Study||0
120067|NCT01853930|293671|P1|NOT COMPLETED|Overall Study||0
120068|NCT01853930|293670|P2|COMPLETED|Overall Study||8
120069|NCT01853930|293671|P1|COMPLETED|Overall Study||25
120070|NCT01853930|293670|P2|STARTED|Overall Study||8
120071|NCT01853930|293671|P1|STARTED|Overall Study||25
120072|NCT01853878|293679|P2|NOT COMPLETED|Overall Study||44
120073|NCT01853878|293680|P1|NOT COMPLETED|Overall Study||63
120074|NCT01853878|293679|P2|COMPLETED|Overall Study||3
120075|NCT01853878|293680|P1|COMPLETED|Overall Study||23
120076|NCT01853878|293679|P2|STARTED|Overall Study||47
120077|NCT01853878|293680|P1|STARTED|Overall Study||86
120078|NCT01853839|293704|P1|NOT COMPLETED|Overall Study||429
120079|NCT01853839|293704|P1|COMPLETED|Overall Study||1663
120080|NCT01853839|293704|P1|STARTED|Overall Study||2092
120081|NCT01853696|293726|P2|NOT COMPLETED|Overall Study||5
120082|NCT01853696|293727|P1|NOT COMPLETED|Overall Study||6
120083|NCT01853696|293726|P2|COMPLETED|Overall Study||78
120084|NCT01853696|293727|P1|COMPLETED|Overall Study||78
120085|NCT01853696|293726|P2|STARTED|Overall Study||83
120086|NCT01853696|293727|P1|STARTED|Overall Study||84
120087|NCT01853605|293739|P4|NOT COMPLETED|Overall Study||0
120088|NCT01853605|293740|P3|NOT COMPLETED|Overall Study||0
120089|NCT01853605|293741|P2|NOT COMPLETED|Overall Study||0
120090|NCT01853605|293742|P1|NOT COMPLETED|Overall Study||0
120091|NCT01853605|293739|P4|COMPLETED|Overall Study||428
120092|NCT01853605|293740|P3|COMPLETED|Overall Study||751
120093|NCT01853605|293741|P2|COMPLETED|Overall Study||693
120094|NCT01853605|293742|P1|COMPLETED|Overall Study||1939
120095|NCT01853605|293739|P4|STARTED|Overall Study||428
120096|NCT01853605|293740|P3|STARTED|Overall Study||751
120097|NCT01853605|293741|P2|STARTED|Overall Study||693
120098|NCT01853605|293742|P1|STARTED|Overall Study||1939
120099|NCT01853553|293762|P2|NOT COMPLETED|Overall Study||0
120100|NCT01853553|293763|P1|NOT COMPLETED|Overall Study||1
120101|NCT01853553|293762|P2|COMPLETED|Overall Study||32
120102|NCT01853553|293763|P1|COMPLETED|Overall Study||28
120103|NCT01853553|293762|P2|STARTED|Overall Study||32
120104|NCT01853553|293763|P1|STARTED|Overall Study||29
120105|NCT01853475|293774|P3|NOT COMPLETED|Overall Study||0
120106|NCT01853475|293775|P2|NOT COMPLETED|Overall Study||1
120107|NCT01853475|293776|P1|NOT COMPLETED|Overall Study||0
120108|NCT01853475|293774|P3|COMPLETED|Overall Study||8
120109|NCT01853475|293775|P2|COMPLETED|Overall Study||7
120110|NCT01853475|293776|P1|COMPLETED|Overall Study||8
120111|NCT01853475|293774|P3|STARTED|Overall Study||8
120112|NCT01853475|293775|P2|STARTED|Overall Study||8
120113|NCT01853475|293776|P1|STARTED|Overall Study||8
120114|NCT01853462|293795|P2|NOT COMPLETED|Overall Study||1
120115|NCT01853462|293796|P1|NOT COMPLETED|Overall Study||1
120116|NCT01853462|293795|P2|COMPLETED|Overall Study||10
120117|NCT01853462|293796|P1|COMPLETED|Overall Study||10
120118|NCT01853462|293795|P2|STARTED|Overall Study||11
120119|NCT01853462|293796|P1|STARTED|Overall Study||11
120120|NCT01853397|293866|P4|NOT COMPLETED|Overall Study||2
120121|NCT01853397|293867|P3|NOT COMPLETED|Overall Study||0
120122|NCT01853397|293868|P2|NOT COMPLETED|Overall Study||0
120123|NCT01853397|293869|P1|NOT COMPLETED|Overall Study||0
120124|NCT01853397|293866|P4|COMPLETED|Overall Study||15
120125|NCT01853397|293867|P3|COMPLETED|Overall Study||17
120126|NCT01853397|293868|P2|COMPLETED|Overall Study||20
120127|NCT01853397|293869|P1|COMPLETED|Overall Study||18
120128|NCT01853397|293866|P4|STARTED|Overall Study||17
120129|NCT01853397|293867|P3|STARTED|Overall Study||17
120130|NCT01853397|293868|P2|STARTED|Overall Study||20
120131|NCT01853397|293869|P1|STARTED|Overall Study||18
120132|NCT01853384|293897|P2|NOT COMPLETED|Completed Follow up Visit 2||3
120133|NCT01853384|293898|P1|NOT COMPLETED|Completed Follow up Visit 2||3
120134|NCT01853384|293897|P2|COMPLETED|Completed Follow up Visit 2||91
120135|NCT01853384|293898|P1|COMPLETED|Completed Follow up Visit 2||93
120136|NCT01853384|293897|P2|STARTED|Completed Follow up Visit 2||94
120137|NCT01853384|293898|P1|STARTED|Completed Follow up Visit 2||96
120138|NCT01853384|293897|P2|NOT COMPLETED|Completed Follow up Visit 1||9
120139|NCT01853384|293898|P1|NOT COMPLETED|Completed Follow up Visit 1||14
120140|NCT01853384|293897|P2|COMPLETED|Completed Follow up Visit 1||85
120141|NCT01853384|293898|P1|COMPLETED|Completed Follow up Visit 1||82
120142|NCT01853384|293897|P2|STARTED|Completed Follow up Visit 1||94
120143|NCT01853384|293898|P1|STARTED|Completed Follow up Visit 1||96
120144|NCT01853384|293897|P2|NOT COMPLETED|Enrolled in Follow up Period||0
120145|NCT01853384|293898|P1|NOT COMPLETED|Enrolled in Follow up Period||0
120146|NCT01853384|293897|P2|COMPLETED|Enrolled in Follow up Period||94
120147|NCT01853384|293898|P1|COMPLETED|Enrolled in Follow up Period||96
120148|NCT01853384|293897|P2|Not Enrolled in Follow-up|Enrolled in Follow up Period||27
120149|NCT01853384|293898|P1|Not Enrolled in Follow-up|Enrolled in Follow up Period||35
120150|NCT01853384|293897|P2|STARTED|Enrolled in Follow up Period||94
120151|NCT01853384|293898|P1|STARTED|Enrolled in Follow up Period||96
120152|NCT01853384|293897|P2|NOT COMPLETED|Randomized||46
120153|NCT01853384|293898|P1|NOT COMPLETED|Randomized||62
120154|NCT01853384|293897|P2|COMPLETED|Randomized||75
120155|NCT01853384|293898|P1|COMPLETED|Randomized||69
120156|NCT01853384|293897|P2|STARTED|Randomized||121
120157|NCT01853384|293898|P1|STARTED|Randomized||131
120158|NCT01853371|293918|P2|NOT COMPLETED|Overall Study||2
120159|NCT01853371|293919|P1|NOT COMPLETED|Overall Study||0
120160|NCT01853371|293918|P2|COMPLETED|Overall Study||8
120161|NCT01853371|293919|P1|COMPLETED|Overall Study||10
120162|NCT01853371|293918|P2|STARTED|Overall Study||10
120163|NCT01853371|293919|P1|STARTED|Overall Study||10
120164|NCT01853332|293927|P1|NOT COMPLETED|Overall Study||59
120165|NCT01853332|293927|P1|COMPLETED|Overall Study||151
120166|NCT01853332|293927|P1|STARTED|Overall Study||210
120167|NCT01853280|293938|P2|NOT COMPLETED|Overall Study||6
120168|NCT01853280|293939|P1|NOT COMPLETED|Overall Study||2
120169|NCT01853280|293938|P2|COMPLETED|Overall Study||16
120170|NCT01853280|293939|P1|COMPLETED|Overall Study||20
120171|NCT01853280|293938|P2|STARTED|Overall Study||22
120172|NCT01853280|293939|P1|STARTED|Overall Study||22
120173|NCT01853254|293945|P1|NOT COMPLETED|Overall Study||104
120174|NCT01853254|293945|P1|COMPLETED|Overall Study||168
120175|NCT01853254|293945|P1|STARTED|Overall Study||272
120176|NCT01853228|293949|P2|NOT COMPLETED|Phase 2||8
120177|NCT01853228|293950|P1|NOT COMPLETED|Phase 2||0
120178|NCT01853228|293949|P2|COMPLETED|Phase 2||0
120179|NCT01853228|293950|P1|COMPLETED|Phase 2||0
120180|NCT01853228|293949|P2|STARTED|Phase 2|1 additional participant was enrolled, making total of 8 participants evaluable in Phase 2.|8
120181|NCT01853228|293950|P1|STARTED|Phase 2||0
120182|NCT01853228|293949|P2|NOT COMPLETED|Phase 1||0
120183|NCT01853228|293950|P1|NOT COMPLETED|Phase 1||9
120184|NCT01853228|293949|P2|COMPLETED|Phase 1|Participants who completed Phase 1 moved to Phase 2.|7
120185|NCT01853228|293950|P1|COMPLETED|Phase 1||0
120186|NCT01853228|293949|P2|STARTED|Phase 1||7
120187|NCT01853228|293950|P1|STARTED|Phase 1||9
120188|NCT01853215|293967|P1|NOT COMPLETED|Overall Study||0
120189|NCT01853215|293967|P1|COMPLETED|Overall Study||24
120190|NCT01853215|293967|P1|STARTED|Overall Study||24
120191|NCT01853176|293980|P2|NOT COMPLETED|Overall Study||0
120192|NCT01853176|293981|P1|NOT COMPLETED|Overall Study||4
120193|NCT01853176|293980|P2|COMPLETED|Overall Study||0
120194|NCT01853176|293981|P1|COMPLETED|Overall Study||0
120195|NCT01853176|293980|P2|STARTED|Overall Study||0
120196|NCT01853176|293981|P1|STARTED|Overall Study||4
120197|NCT01853085|293987|P1|NOT COMPLETED|Overall Study||235
120198|NCT01853085|293987|P1|COMPLETED|Overall Study||1595
120199|NCT01853085|293987|P1|STARTED|Overall Study||1830
120200|NCT01853072|294000|P2|NOT COMPLETED|Overall Study||21
120201|NCT01853072|294001|P1|NOT COMPLETED|Overall Study||12
120202|NCT01853072|294000|P2|COMPLETED|Overall Study||286
120203|NCT01853072|294001|P1|COMPLETED|Overall Study||296
120204|NCT01853072|294000|P2|Full Analysis Set|Overall Study||300
120205|NCT01853072|294001|P1|Full Analysis Set|Overall Study||298
120206|NCT01853072|294000|P2|Treated (Safety Analysis Set)|Overall Study||302
120207|NCT01853072|294001|P1|Treated (Safety Analysis Set)|Overall Study||301
120208|NCT01853072|294000|P2|Randomized|Overall Study||307
120209|NCT01853072|294001|P1|Randomized|Overall Study||308
120210|NCT01853072|294000|P2|STARTED|Overall Study||307
120211|NCT01853072|294001|P1|STARTED|Overall Study||308
120212|NCT01853046|294021|P2|NOT COMPLETED|Overall Study||6
120213|NCT01853046|294022|P1|NOT COMPLETED|Overall Study||18
120214|NCT01853046|294021|P2|COMPLETED|Overall Study||0
120215|NCT01853046|294022|P1|COMPLETED|Overall Study||0
120216|NCT01853046|294021|P2|Received Treatment|Overall Study||6
120217|NCT01853046|294022|P1|Received Treatment|Overall Study||18
120218|NCT01853046|294021|P2|STARTED|Overall Study||6
120219|NCT01853046|294022|P1|STARTED|Overall Study||18
120220|NCT01852955|294076|P2|NOT COMPLETED|Overall Study||3
120221|NCT01852955|294077|P1|NOT COMPLETED|Overall Study||2
120222|NCT01852955|294076|P2|COMPLETED|Overall Study||32
120223|NCT01852955|294077|P1|COMPLETED|Overall Study||33
120224|NCT01852955|294076|P2|STARTED|Overall Study||35
120225|NCT01852955|294077|P1|STARTED|Overall Study||35
120226|NCT01852825|294090|P3|NOT COMPLETED|Overall Study||0
120227|NCT01852825|294091|P2|NOT COMPLETED|Overall Study||0
120228|NCT01852825|294092|P1|NOT COMPLETED|Overall Study||2
120229|NCT01852825|294090|P3|COMPLETED|Overall Study||3
120230|NCT01852825|294091|P2|COMPLETED|Overall Study||7
120231|NCT01852825|294092|P1|COMPLETED|Overall Study||14
120232|NCT01852825|294090|P3|STARTED|Overall Study||3
120233|NCT01852825|294091|P2|STARTED|Overall Study||7
120234|NCT01852825|294092|P1|STARTED|Overall Study||16
120235|NCT01852812|294118|P3|NOT COMPLETED|Overall Study||1
120236|NCT01852812|294119|P2|NOT COMPLETED|Overall Study||1
120237|NCT01852812|294120|P1|NOT COMPLETED|Overall Study||0
120238|NCT01852812|294118|P3|COMPLETED|Overall Study||17
120239|NCT01852812|294119|P2|COMPLETED|Overall Study||17
120240|NCT01852812|294120|P1|COMPLETED|Overall Study||51
120241|NCT01852812|294118|P3|STARTED|Overall Study||18
120242|NCT01852812|294119|P2|STARTED|Overall Study||18
120243|NCT01852812|294120|P1|STARTED|Overall Study||51
120244|NCT01852799|294140|P1|NOT COMPLETED|Overall Study||18
120245|NCT01852799|294140|P1|COMPLETED|Overall Study||0
120246|NCT01852799|294140|P1|STARTED|Overall Study||18
120247|NCT01852669|294151|P2|NOT COMPLETED|Overall Study||1
120248|NCT01852669|294152|P1|NOT COMPLETED|Overall Study||0
120249|NCT01852669|294151|P2|COMPLETED|Overall Study|Randomisation error. Patient has protocol violation which necessitated exclusion from analysis|68
120250|NCT01852669|294152|P1|COMPLETED|Overall Study||71
120251|NCT01852669|294151|P2|STARTED|Overall Study||69
120252|NCT01852669|294152|P1|STARTED|Overall Study||71
120253|NCT01852591|294158|P1|NOT COMPLETED|Overall Study||3
120254|NCT01852591|294158|P1|COMPLETED|Overall Study||5
120255|NCT01852591|294158|P1|STARTED|Overall Study||8
120256|NCT01852383|294165|P1|NOT COMPLETED|Overall Study||11
120257|NCT01852383|294165|P1|COMPLETED|Overall Study||19
120258|NCT01852383|294165|P1|STARTED|Overall Study||30
120259|NCT01852344|294176|P4|NOT COMPLETED|Overall Study||0
120260|NCT01852344|294177|P3|NOT COMPLETED|Overall Study||0
120261|NCT01852344|294178|P2|NOT COMPLETED|Overall Study||0
120262|NCT01852344|294179|P1|NOT COMPLETED|Overall Study||0
120263|NCT01852344|294176|P4|COMPLETED|Overall Study||27
120264|NCT01852344|294177|P3|COMPLETED|Overall Study||27
120265|NCT01852344|294178|P2|COMPLETED|Overall Study||27
120266|NCT01852344|294179|P1|COMPLETED|Overall Study||27
120267|NCT01852344|294176|P4|Actual Participation in First Assignment|Overall Study||27
120268|NCT01852344|294177|P3|Actual Participation in First Assignment|Overall Study||27
120269|NCT01852344|294178|P2|Actual Participation in First Assignment|Overall Study||27
120270|NCT01852344|294179|P1|Actual Participation in First Assignment|Overall Study||27
120271|NCT01852344|294176|P4|STARTED|Overall Study||27
120272|NCT01852344|294177|P3|STARTED|Overall Study||27
120273|NCT01852344|294178|P2|STARTED|Overall Study||27
120274|NCT01852344|294179|P1|STARTED|Overall Study||27
120275|NCT01852292|294199|P2|NOT COMPLETED|Overall Study||79
120276|NCT01852292|294200|P1|NOT COMPLETED|Overall Study||79
120277|NCT01852292|294199|P2|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0
120278|NCT01852292|294200|P1|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0
120279|NCT01852292|294199|P2|STARTED|Overall Study||79
120280|NCT01852292|294200|P1|STARTED|Overall Study||79
120281|NCT01852214|294224|P2|NOT COMPLETED|Period 2||0
120282|NCT01852214|294225|P1|NOT COMPLETED|Period 2||0
120283|NCT01852214|294224|P2|COMPLETED|Period 2||20
120284|NCT01852214|294225|P1|COMPLETED|Period 2||25
120285|NCT01852214|294224|P2|STARTED|Period 2||20
120286|NCT01852214|294225|P1|STARTED|Period 2||25
120287|NCT01852214|294224|P2|NOT COMPLETED|Washout Period||1
120288|NCT01852214|294225|P1|NOT COMPLETED|Washout Period||0
120289|NCT01852214|294224|P2|COMPLETED|Washout Period||20
120290|NCT01852214|294225|P1|COMPLETED|Washout Period||25
120291|NCT01852214|294224|P2|STARTED|Washout Period||21
120292|NCT01852214|294225|P1|STARTED|Washout Period||25
120293|NCT01852214|294224|P2|NOT COMPLETED|Period 1||3
120294|NCT01852214|294225|P1|NOT COMPLETED|Period 1||1
120295|NCT01852214|294224|P2|COMPLETED|Period 1||21
120296|NCT01852214|294225|P1|COMPLETED|Period 1||25
120297|NCT01852214|294224|P2|STARTED|Period 1||24
120298|NCT01852214|294225|P1|STARTED|Period 1||26
120299|NCT01852201|294239|P2|NOT COMPLETED|Overall Study||0
120300|NCT01852201|294240|P1|NOT COMPLETED|Overall Study||0
120301|NCT01852201|294239|P2|COMPLETED|Overall Study||12
120302|NCT01852201|294240|P1|COMPLETED|Overall Study||21
120303|NCT01852201|294239|P2|STARTED|Overall Study||12
120304|NCT01852201|294240|P1|STARTED|Overall Study||21
120305|NCT01852175|294264|P2|NOT COMPLETED|Overall Study||0
120306|NCT01852175|294265|P1|NOT COMPLETED|Overall Study||0
120307|NCT01852175|294264|P2|COMPLETED|Overall Study||55
120308|NCT01852175|294265|P1|COMPLETED|Overall Study||55
120309|NCT01852175|294264|P2|STARTED|Overall Study||55
120310|NCT01852175|294265|P1|STARTED|Overall Study||55
120311|NCT01852162|294277|P2|NOT COMPLETED|Overall Study||1
120312|NCT01852162|294278|P1|NOT COMPLETED|Overall Study||4
120313|NCT01852162|294277|P2|COMPLETED|Overall Study||16
120314|NCT01852162|294278|P1|COMPLETED|Overall Study||14
120315|NCT01852162|294277|P2|STARTED|Overall Study||17
120316|NCT01852162|294278|P1|STARTED|Overall Study||18
120317|NCT01852110|294294|P6|NOT COMPLETED|Overall Study||0
120318|NCT01852110|294295|P5|NOT COMPLETED|Overall Study||0
120319|NCT01852110|294296|P4|NOT COMPLETED|Overall Study||0
120320|NCT01852110|294297|P3|NOT COMPLETED|Overall Study||0
120321|NCT01852110|294298|P2|NOT COMPLETED|Overall Study||46
120322|NCT01852110|294299|P1|NOT COMPLETED|Overall Study||50
120323|NCT01852110|294294|P6|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
120324|NCT01852110|294295|P5|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
120325|NCT01852110|294296|P4|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
120326|NCT01852110|294297|P3|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
120327|NCT01852110|294298|P2|COMPLETED|Overall Study||74
120328|NCT01852110|294299|P1|COMPLETED|Overall Study||70
120329|NCT01852110|294294|P6|Treated|Overall Study||0
120330|NCT01852110|294295|P5|Treated|Overall Study||0
120331|NCT01852110|294296|P4|Treated|Overall Study||0
120332|NCT01852110|294297|P3|Treated|Overall Study||0
120333|NCT01852110|294298|P2|Treated|Overall Study||120
120334|NCT01852110|294299|P1|Treated|Overall Study||119
120335|NCT01852110|294294|P6|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
120336|NCT01852110|294295|P5|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
120337|NCT01852110|294296|P4|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
120338|NCT01852110|294297|P3|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
120339|NCT01852110|294298|P2|STARTED|Overall Study||120
120340|NCT01852110|294299|P1|STARTED|Overall Study||120
120341|NCT01852045|294330|P3|NOT COMPLETED|Overall Study||4
120342|NCT01852045|294331|P2|NOT COMPLETED|Overall Study||4
120343|NCT01852045|294332|P1|NOT COMPLETED|Overall Study||6
120344|NCT01852045|294330|P3|COMPLETED|Overall Study||26
120345|NCT01852045|294331|P2|COMPLETED|Overall Study||41
120346|NCT01852045|294332|P1|COMPLETED|Overall Study||33
120347|NCT01852045|294330|P3|Safety Population|Overall Study||30
120348|NCT01852045|294331|P2|Safety Population|Overall Study||45
120349|NCT01852045|294332|P1|Safety Population|Overall Study||38
120350|NCT01852045|294330|P3|mITT Population|Overall Study||30
120351|NCT01852045|294331|P2|mITT Population|Overall Study||45
120352|NCT01852045|294332|P1|mITT Population|Overall Study||38
120353|NCT01852045|294330|P3|STARTED|Overall Study||30
120354|NCT01852045|294331|P2|STARTED|Overall Study||45
120355|NCT01852045|294332|P1|STARTED|Overall Study||39
120356|NCT01852032|294370|P1|NOT COMPLETED|Overall Study||0
120357|NCT01852032|294370|P1|COMPLETED|Overall Study||23
120358|NCT01852032|294370|P1|STARTED|Overall Study||23
120359|NCT01852019|294380|P5|NOT COMPLETED|Day 8||0
120360|NCT01852019|294381|P4|NOT COMPLETED|Day 8||0
120361|NCT01852019|294382|P3|NOT COMPLETED|Day 8||0
120362|NCT01852019|294383|P2|NOT COMPLETED|Day 8||0
120363|NCT01852019|294384|P1|NOT COMPLETED|Day 8||0
120364|NCT01852019|294380|P5|COMPLETED|Day 8||6
120365|NCT01852019|294381|P4|COMPLETED|Day 8||6
120366|NCT01852019|294382|P3|COMPLETED|Day 8||0
120367|NCT01852019|294383|P2|COMPLETED|Day 8||0
120368|NCT01852019|294384|P1|COMPLETED|Day 8||0
120369|NCT01852019|294380|P5|STARTED|Day 8||6
120370|NCT01852019|294381|P4|STARTED|Day 8||6
120371|NCT01852019|294382|P3|STARTED|Day 8||0
120372|NCT01852019|294383|P2|STARTED|Day 8||0
120373|NCT01852019|294384|P1|STARTED|Day 8||0
120374|NCT01852019|294380|P5|NOT COMPLETED|Day 1||0
120375|NCT01852019|294381|P4|NOT COMPLETED|Day 1||0
120376|NCT01852019|294382|P3|NOT COMPLETED|Day 1||0
120377|NCT01852019|294383|P2|NOT COMPLETED|Day 1||0
120378|NCT01852019|294384|P1|NOT COMPLETED|Day 1||0
120379|NCT01852019|294380|P5|COMPLETED|Day 1||0
120380|NCT01852019|294381|P4|COMPLETED|Day 1||0
120381|NCT01852019|294382|P3|COMPLETED|Day 1||6
120382|NCT01852019|294383|P2|COMPLETED|Day 1||3
120383|NCT01852019|294384|P1|COMPLETED|Day 1||3
120384|NCT01852019|294380|P5|STARTED|Day 1||0
120385|NCT01852019|294381|P4|STARTED|Day 1||0
120386|NCT01852019|294382|P3|STARTED|Day 1||6
120387|NCT01852019|294383|P2|STARTED|Day 1||3
120388|NCT01852019|294384|P1|STARTED|Day 1||3
120389|NCT01851876|294405|P2|NOT COMPLETED|Overall Study||0
120390|NCT01851876|294406|P1|NOT COMPLETED|Overall Study||0
120391|NCT01851876|294405|P2|COMPLETED|Overall Study||62
120392|NCT01851876|294406|P1|COMPLETED|Overall Study||56
120393|NCT01851876|294405|P2|STARTED|Overall Study||62
120394|NCT01851876|294406|P1|STARTED|Overall Study||56
120395|NCT01851863|294416|P4|NOT COMPLETED|Overall Study||3
120396|NCT01851863|294417|P3|NOT COMPLETED|Overall Study||5
120397|NCT01851863|294418|P2|NOT COMPLETED|Overall Study||9
120398|NCT01851863|294419|P1|NOT COMPLETED|Overall Study||5
120399|NCT01851863|294416|P4|COMPLETED|Overall Study||63
120400|NCT01851863|294417|P3|COMPLETED|Overall Study||60
120401|NCT01851863|294418|P2|COMPLETED|Overall Study||57
120402|NCT01851863|294419|P1|COMPLETED|Overall Study||60
120403|NCT01851863|294416|P4|STARTED|Overall Study||66
120404|NCT01851863|294417|P3|STARTED|Overall Study||65
120405|NCT01851863|294418|P2|STARTED|Overall Study||66
120406|NCT01851863|294419|P1|STARTED|Overall Study||65
120407|NCT01851772|294440|P1|NOT COMPLETED|Overall Study||0
120408|NCT01851772|294440|P1|COMPLETED|Overall Study||3
120409|NCT01851772|294440|P1|STARTED|Overall Study||3
120410|NCT01851720|294448|P2|NOT COMPLETED|Overall Study||1
120411|NCT01851720|294449|P1|NOT COMPLETED|Overall Study||0
120412|NCT01851720|294448|P2|COMPLETED|Overall Study||0
120413|NCT01851720|294449|P1|COMPLETED|Overall Study||0
120414|NCT01851720|294448|P2|STARTED|Overall Study||1
120415|NCT01851720|294449|P1|STARTED|Overall Study||0
120416|NCT01851655|294457|P2|NOT COMPLETED|Overall Study||0
120417|NCT01851655|294458|P1|NOT COMPLETED|Overall Study||0
120418|NCT01851655|294457|P2|COMPLETED|Overall Study||12
120419|NCT01851655|294458|P1|COMPLETED|Overall Study||12
120420|NCT01851655|294457|P2|STARTED|Overall Study||12
120421|NCT01851655|294458|P1|STARTED|Overall Study||12
120422|NCT01851590|294479|P3|NOT COMPLETED|Overall Study||3
120423|NCT01851590|294480|P2|NOT COMPLETED|Overall Study||1
120424|NCT01851590|294481|P1|NOT COMPLETED|Overall Study||0
120425|NCT01851590|294479|P3|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|22
120426|NCT01851590|294480|P2|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|24
120427|NCT01851590|294481|P1|COMPLETED|Overall Study|All patients (23) were included in the ITT population and final outcome analyses.|23
120428|NCT01851590|294479|P3|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|22
120429|NCT01851590|294480|P2|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|24
120430|NCT01851590|294481|P1|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|23
120431|NCT01851590|294479|P3|At 9 Month: End of Topical Treatments|Overall Study|Washout period of the Terbinafine treatment arm continues.|22
120432|NCT01851590|294480|P2|At 9 Month: End of Topical Treatments|Overall Study|End of topical Amorolfine Lacquer treatment. Washout period of the Amorolfine treatment arm begins.|24
120433|NCT01851590|294481|P1|At 9 Month: End of Topical Treatments|Overall Study|End of topical Resin Lacquer treatment. Washout period of the Resin Lacquer treatment arm begins.|23
120434|NCT01851590|294479|P3|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|22
120435|NCT01851590|294480|P2|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|24
120436|NCT01851590|294481|P1|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|23
120437|NCT01851590|294479|P3|At 3 Month: End of Terbinafine Treatment|Overall Study|End of oral Terbinafine treatment. Washout period of the Terbinafine treatment arm begins.|22
120438|NCT01851590|294480|P2|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Amorolfine Lacquer Treatment continues ->|24
120531|NCT01849692|294757|P6|NOT COMPLETED|Overall Study||0
120439|NCT01851590|294481|P1|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Resin Lacquer treatment continues ->|23
120440|NCT01851590|294479|P3|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
120441|NCT01851590|294480|P2|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
120442|NCT01851590|294481|P1|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|23
120443|NCT01851330|294504|P3|NOT COMPLETED|Overall Study||12
120444|NCT01851330|294505|P2|NOT COMPLETED|Overall Study||16
120445|NCT01851330|294506|P1|NOT COMPLETED|Overall Study||13
120446|NCT01851330|294504|P3|COMPLETED|Overall Study||204
120447|NCT01851330|294505|P2|COMPLETED|Overall Study||200
120448|NCT01851330|294506|P1|COMPLETED|Overall Study||202
120449|NCT01851330|294504|P3|STARTED|Overall Study||216
120450|NCT01851330|294505|P2|STARTED|Overall Study||216
120451|NCT01851330|294506|P1|STARTED|Overall Study||215
120452|NCT01851174|294541|P1|NOT COMPLETED|Overall Study||0
120453|NCT01851174|294541|P1|COMPLETED|Overall Study||15
120454|NCT01851174|294541|P1|STARTED|Overall Study||15
120455|NCT01850745|294549|P3|NOT COMPLETED|Overall Study||0
120456|NCT01850745|294550|P2|NOT COMPLETED|Overall Study||0
120457|NCT01850745|294551|P1|NOT COMPLETED|Overall Study||0
120458|NCT01850745|294549|P3|COMPLETED|Overall Study||131
120459|NCT01850745|294550|P2|COMPLETED|Overall Study||169
120460|NCT01850745|294551|P1|COMPLETED|Overall Study||147
120461|NCT01850745|294549|P3|STARTED|Overall Study||131
120462|NCT01850745|294550|P2|STARTED|Overall Study||169
120463|NCT01850745|294551|P1|STARTED|Overall Study||147
120464|NCT01850641|294559|P1|NOT COMPLETED|Overall Study||5
120465|NCT01850641|294559|P1|COMPLETED|Overall Study||30
120466|NCT01850641|294559|P1|STARTED|Overall Study||35
120467|NCT01850615|294573|P2|NOT COMPLETED|Overall Study||5
120468|NCT01850615|294574|P1|NOT COMPLETED|Overall Study||9
120469|NCT01850615|294573|P2|COMPLETED|Overall Study||115
120470|NCT01850615|294574|P1|COMPLETED|Overall Study||107
120471|NCT01850615|294573|P2|Exposed|Overall Study||120
120472|NCT01850615|294574|P1|Exposed|Overall Study||115
120473|NCT01850615|294573|P2|STARTED|Overall Study||120
120474|NCT01850615|294574|P1|STARTED|Overall Study||116
120475|NCT01850602|294592|P2|NOT COMPLETED|Overall Study||18
120476|NCT01850602|294593|P1|NOT COMPLETED|Overall Study||14
120477|NCT01850602|294592|P2|COMPLETED|Overall Study||87
120478|NCT01850602|294593|P1|COMPLETED|Overall Study||94
120479|NCT01850602|294592|P2|STARTED|Overall Study||105
120480|NCT01850602|294593|P1|STARTED|Overall Study||108
120481|NCT01850589|294607|P2|NOT COMPLETED|Overall Study||0
120482|NCT01850589|294608|P1|NOT COMPLETED|Overall Study||8
120483|NCT01850589|294607|P2|COMPLETED|Overall Study||22
120484|NCT01850589|294608|P1|COMPLETED|Overall Study||14
120485|NCT01850589|294607|P2|STARTED|Overall Study||22
120486|NCT01850589|294608|P1|STARTED|Overall Study||22
120487|NCT01850550|294616|P2|NOT COMPLETED|Overall Study||3
120488|NCT01850550|294617|P1|NOT COMPLETED|Overall Study||0
120489|NCT01850550|294616|P2|COMPLETED|Overall Study||37
120490|NCT01850550|294617|P1|COMPLETED|Overall Study||40
120491|NCT01850550|294616|P2|STARTED|Overall Study||40
120492|NCT01850550|294617|P1|STARTED|Overall Study||40
120493|NCT01850485|294627|P2|NOT COMPLETED|Overall Study||0
120494|NCT01850485|294628|P1|NOT COMPLETED|Overall Study||0
120495|NCT01850485|294627|P2|COMPLETED|Overall Study||13
120496|NCT01850485|294628|P1|COMPLETED|Overall Study||9
120497|NCT01850485|294627|P2|STARTED|Overall Study||13
120498|NCT01850485|294628|P1|STARTED|Overall Study||9
120499|NCT01850394|294649|P3|NOT COMPLETED|Overall Study||0
120500|NCT01850394|294650|P2|NOT COMPLETED|Overall Study||0
120501|NCT01850394|294651|P1|NOT COMPLETED|Overall Study||0
120502|NCT01850394|294649|P3|COMPLETED|Overall Study||45
120503|NCT01850394|294650|P2|COMPLETED|Overall Study||45
120504|NCT01850394|294651|P1|COMPLETED|Overall Study||45
120505|NCT01850394|294649|P3|STARTED|Overall Study||45
120506|NCT01850394|294650|P2|STARTED|Overall Study||45
120507|NCT01850394|294651|P1|STARTED|Overall Study||45
120508|NCT01850030|294673|P2|NOT COMPLETED|Overall Study||369
120509|NCT01850030|294674|P1|NOT COMPLETED|Overall Study||347
120510|NCT01850030|294673|P2|COMPLETED|Overall Study||142
120511|NCT01850030|294674|P1|COMPLETED|Overall Study||173
120512|NCT01850030|294673|P2|STARTED|Overall Study||511
120513|NCT01850030|294674|P1|STARTED|Overall Study||520
120514|NCT01850004|294686|P1|NOT COMPLETED|Overall Study||8
120515|NCT01850004|294686|P1|COMPLETED|Overall Study||76
120516|NCT01850004|294686|P1|STARTED|Overall Study||84
120517|NCT01849848|294693|P1|NOT COMPLETED|Overall Study||4
120518|NCT01849848|294693|P1|COMPLETED|Overall Study||13
120519|NCT01849848|294693|P1|STARTED|Overall Study||17
120520|NCT01849770|294710|P3|NOT COMPLETED|Overall Study||1
120521|NCT01849770|294711|P2|NOT COMPLETED|Overall Study||4
120522|NCT01849770|294712|P1|NOT COMPLETED|Overall Study||0
120523|NCT01849770|294710|P3|COMPLETED|Overall Study||19
120524|NCT01849770|294711|P2|COMPLETED|Overall Study||15
120525|NCT01849770|294712|P1|COMPLETED|Overall Study||20
120526|NCT01849770|294710|P3|STARTED|Overall Study||20
120527|NCT01849770|294711|P2|STARTED|Overall Study||19
120528|NCT01849770|294712|P1|STARTED|Overall Study||20
120529|NCT01849692|294755|P8|NOT COMPLETED|Overall Study||0
120530|NCT01849692|294756|P7|NOT COMPLETED|Overall Study||0
120532|NCT01849692|294758|P5|NOT COMPLETED|Overall Study||0
120533|NCT01849692|294759|P4|NOT COMPLETED|Overall Study||0
120534|NCT01849692|294760|P3|NOT COMPLETED|Overall Study||0
120535|NCT01849692|294761|P2|NOT COMPLETED|Overall Study||0
120536|NCT01849692|294762|P1|NOT COMPLETED|Overall Study||0
120537|NCT01849692|294755|P8|COMPLETED|Overall Study||3
120538|NCT01849692|294756|P7|COMPLETED|Overall Study||10
120539|NCT01849692|294757|P6|COMPLETED|Overall Study||3
120540|NCT01849692|294758|P5|COMPLETED|Overall Study||10
120541|NCT01849692|294759|P4|COMPLETED|Overall Study||3
120542|NCT01849692|294760|P3|COMPLETED|Overall Study||10
120543|NCT01849692|294761|P2|COMPLETED|Overall Study||3
120544|NCT01849692|294762|P1|COMPLETED|Overall Study||10
120545|NCT01849692|294755|P8|STARTED|Overall Study||3
120546|NCT01849692|294756|P7|STARTED|Overall Study||10
120547|NCT01849692|294757|P6|STARTED|Overall Study||3
120548|NCT01849692|294758|P5|STARTED|Overall Study||10
120549|NCT01849692|294759|P4|STARTED|Overall Study||3
120550|NCT01849692|294760|P3|STARTED|Overall Study||10
120551|NCT01849692|294761|P2|STARTED|Overall Study||3
120552|NCT01849692|294762|P1|STARTED|Overall Study||10
120553|NCT01849588|294791|P1|NOT COMPLETED|Overall Study||3
120554|NCT01849588|294791|P1|COMPLETED|Overall Study||0
120555|NCT01849588|294791|P1|STARTED|Overall Study||3
120556|NCT01849562|294801|P3|NOT COMPLETED|Overall Study||0
120557|NCT01849562|294802|P2|NOT COMPLETED|Overall Study||0
120558|NCT01849562|294803|P1|NOT COMPLETED|Overall Study||2
120559|NCT01849562|294801|P3|COMPLETED|Overall Study||10
120560|NCT01849562|294802|P2|COMPLETED|Overall Study||10
120561|NCT01849562|294803|P1|COMPLETED|Overall Study||8
120562|NCT01849562|294801|P3|STARTED|Overall Study||10
120563|NCT01849562|294802|P2|STARTED|Overall Study||10
120564|NCT01849562|294803|P1|STARTED|Overall Study||10
120565|NCT01849497|294816|P2|NOT COMPLETED|Overall Study||4
120566|NCT01849497|294817|P1|NOT COMPLETED|Overall Study||1
120567|NCT01849497|294816|P2|COMPLETED|Overall Study||70
120568|NCT01849497|294817|P1|COMPLETED|Overall Study||74
120569|NCT01849497|294816|P2|Received Treatment|Overall Study||74
120570|NCT01849497|294817|P1|Received Treatment|Overall Study||75
120571|NCT01849497|294816|P2|STARTED|Overall Study||74
120572|NCT01849497|294817|P1|STARTED|Overall Study||75
120573|NCT01849458|294825|P1|NOT COMPLETED|Overall Study||4
120574|NCT01849458|294825|P1|COMPLETED|Overall Study||46
120575|NCT01849458|294825|P1|6 Months Follow-up|Overall Study||50
120576|NCT01849458|294825|P1|STARTED|Overall Study||50
120577|NCT01849419|294835|P1|NOT COMPLETED|Overall Study||0
120578|NCT01849419|294835|P1|COMPLETED|Overall Study||65
120579|NCT01849419|294835|P1|STARTED|Overall Study||65
120580|NCT01849289|294864|P2|NOT COMPLETED|Overall Study||24
120581|NCT01849289|294865|P1|NOT COMPLETED|Overall Study||32
120582|NCT01849289|294864|P2|COMPLETED|Overall Study||254
120583|NCT01849289|294865|P1|COMPLETED|Overall Study||523
120584|NCT01849289|294864|P2|Exposed|Overall Study||278
120585|NCT01849289|294865|P1|Exposed|Overall Study|2 subjects withdrew prior to exposure of trial products|553
120586|NCT01849289|294864|P2|STARTED|Overall Study||278
120587|NCT01849289|294865|P1|STARTED|Overall Study||555
120588|NCT01849276|294881|P1|NOT COMPLETED|Followed for Survival for 5 Years||2
120589|NCT01849276|294881|P1|COMPLETED|Followed for Survival for 5 Years||0
120590|NCT01849276|294881|P1|STARTED|Followed for Survival for 5 Years||2
120591|NCT01849276|294881|P1|NOT COMPLETED|Completed Treatment||0
120592|NCT01849276|294881|P1|COMPLETED|Completed Treatment||2
120593|NCT01849276|294881|P1|STARTED|Completed Treatment||2
120594|NCT01849276|294881|P1|NOT COMPLETED|Registered to the Study||0
120595|NCT01849276|294881|P1|COMPLETED|Registered to the Study||2
120596|NCT01849276|294881|P1|STARTED|Registered to the Study||2
120597|NCT01849263|294893|P1|NOT COMPLETED|Overall Study||0
120598|NCT01849263|294893|P1|COMPLETED|Overall Study||40
120599|NCT01849263|294893|P1|STARTED|Overall Study||40
120600|NCT01849172|294905|P2|NOT COMPLETED|Overall Study||6
120601|NCT01849172|294906|P1|NOT COMPLETED|Overall Study||7
120602|NCT01849172|294905|P2|COMPLETED|Overall Study||174
120603|NCT01849172|294906|P1|COMPLETED|Overall Study||173
120604|NCT01849172|294905|P2|STARTED|Overall Study||180
120605|NCT01849172|294906|P1|STARTED|Overall Study||180
120606|NCT01849068|294944|P2|NOT COMPLETED|Overall Study||0
120607|NCT01849068|294945|P1|NOT COMPLETED|Overall Study||0
120608|NCT01849068|294944|P2|COMPLETED|Overall Study||10
120609|NCT01849068|294945|P1|COMPLETED|Overall Study||10
120610|NCT01849068|294944|P2|STARTED|Overall Study||10
120611|NCT01849068|294945|P1|STARTED|Overall Study||10
120612|NCT01849055|294963|P6|NOT COMPLETED|Overall Study||0
120613|NCT01849055|294964|P5|NOT COMPLETED|Overall Study||0
120614|NCT01849055|294965|P4|NOT COMPLETED|Overall Study||0
120615|NCT01849055|294966|P3|NOT COMPLETED|Overall Study||1
120616|NCT01849055|294967|P2|NOT COMPLETED|Overall Study||0
120617|NCT01849055|294968|P1|NOT COMPLETED|Overall Study||0
120618|NCT01849055|294963|P6|COMPLETED|Overall Study||8
120619|NCT01849055|294964|P5|COMPLETED|Overall Study||8
120620|NCT01849055|294965|P4|COMPLETED|Overall Study||8
120621|NCT01849055|294966|P3|COMPLETED|Overall Study||7
120622|NCT01849055|294967|P2|COMPLETED|Overall Study||8
120623|NCT01849055|294968|P1|COMPLETED|Overall Study||8
120624|NCT01849055|294963|P6|STARTED|Overall Study||8
120625|NCT01849055|294964|P5|STARTED|Overall Study||8
120626|NCT01849055|294965|P4|STARTED|Overall Study||8
120627|NCT01849055|294966|P3|STARTED|Overall Study||8
120628|NCT01849055|294967|P2|STARTED|Overall Study||8
120629|NCT01849055|294968|P1|STARTED|Overall Study||8
120630|NCT01848990|295003|P3|NOT COMPLETED|Overall Study||16
120631|NCT01848990|295004|P2|NOT COMPLETED|Overall Study||20
120632|NCT01848990|295005|P1|NOT COMPLETED|Overall Study||46
120633|NCT01848990|295003|P3|COMPLETED|Overall Study||98
120634|NCT01848990|295004|P2|COMPLETED|Overall Study||95
120635|NCT01848990|295005|P1|COMPLETED|Overall Study||181
120636|NCT01848990|295003|P3|Completed Month 6|Overall Study||103
120637|NCT01848990|295004|P2|Completed Month 6|Overall Study||106
120638|NCT01848990|295005|P1|Completed Month 6|Overall Study||194
120639|NCT01848990|295003|P3|Received at Least 1 Dose of Study Drug|Overall Study||113
120640|NCT01848990|295004|P2|Received at Least 1 Dose of Study Drug|Overall Study||115
120641|NCT01848990|295005|P1|Received at Least 1 Dose of Study Drug|Overall Study||227
120642|NCT01848990|295003|P3|STARTED|Overall Study|One participant was randomized and withdrew consent before start of study treatment.|114
120643|NCT01848990|295004|P2|STARTED|Overall Study||115
120644|NCT01848990|295005|P1|STARTED|Overall Study||227
120645|NCT01848977|295064|P1|NOT COMPLETED|Overall Study||0
120646|NCT01848977|295064|P1|COMPLETED|Overall Study||20
120647|NCT01848977|295064|P1|STARTED|Overall Study||20
120648|NCT01848938|295075|P2|NOT COMPLETED|Overall Study||1
120649|NCT01848938|295076|P1|NOT COMPLETED|Overall Study||1
120650|NCT01848938|295075|P2|COMPLETED|Overall Study||60
120651|NCT01848938|295076|P1|COMPLETED|Overall Study||61
120652|NCT01848938|295075|P2|STARTED|Overall Study||61
120653|NCT01848938|295076|P1|STARTED|Overall Study||62
120654|NCT01848899|295094|P2|NOT COMPLETED|Overall Study||0
120655|NCT01848899|295095|P1|NOT COMPLETED|Overall Study||0
120656|NCT01848899|295094|P2|COMPLETED|Overall Study||50
120657|NCT01848899|295095|P1|COMPLETED|Overall Study||50
120658|NCT01848899|295094|P2|STARTED|Overall Study||50
120659|NCT01848899|295095|P1|STARTED|Overall Study||50
120660|NCT01848847|295111|P2|NOT COMPLETED|Overall Study||3
120661|NCT01848847|295112|P1|NOT COMPLETED|Overall Study||2
120662|NCT01848847|295111|P2|COMPLETED|Overall Study||48
120663|NCT01848847|295112|P1|COMPLETED|Overall Study||49
120664|NCT01848847|295111|P2|STARTED|Overall Study||51
120665|NCT01848847|295112|P1|STARTED|Overall Study||51
120666|NCT01848834|295125|P5|NOT COMPLETED|Overall Study||132
120667|NCT01848834|295126|P4|NOT COMPLETED|Overall Study||37
120668|NCT01848834|295127|P3|NOT COMPLETED|Overall Study||32
120669|NCT01848834|295128|P2|NOT COMPLETED|Overall Study||60
120670|NCT01848834|295129|P1|NOT COMPLETED|Overall Study||30
120671|NCT01848834|295125|P5|COMPLETED|Overall Study|Completed means two-year treatment completed|0
120672|NCT01848834|295126|P4|COMPLETED|Overall Study|Completed means two-year treatment completed|2
120673|NCT01848834|295127|P3|COMPLETED|Overall Study|Completed means two-year treatment completed|1
120674|NCT01848834|295128|P2|COMPLETED|Overall Study|Completed means two-year treatment completed|1
120675|NCT01848834|295129|P1|COMPLETED|Overall Study|Completed means two-year treatment completed|2
120676|NCT01848834|295125|P5|Treated|Overall Study||132
120677|NCT01848834|295126|P4|Treated|Overall Study||39
120678|NCT01848834|295127|P3|Treated|Overall Study||33
120679|NCT01848834|295128|P2|Treated|Overall Study||60
120680|NCT01848834|295129|P1|Treated|Overall Study||32
120681|NCT01848834|295125|P5|STARTED|Overall Study||132
120682|NCT01848834|295126|P4|STARTED|Overall Study||39
120683|NCT01848834|295127|P3|STARTED|Overall Study||33
120684|NCT01848834|295128|P2|STARTED|Overall Study||61
120685|NCT01848834|295129|P1|STARTED|Overall Study||32
120686|NCT01848821|295166|P2|NOT COMPLETED|Overall Study||0
120687|NCT01848821|295167|P1|NOT COMPLETED|Overall Study||0
120688|NCT01848821|295166|P2|COMPLETED|Overall Study||7
120689|NCT01848821|295167|P1|COMPLETED|Overall Study||7
120690|NCT01848821|295166|P2|STARTED|Overall Study||7
120691|NCT01848821|295167|P1|STARTED|Overall Study||7
120692|NCT01848756|295177|P1|NOT COMPLETED|Overall Study||3
120693|NCT01848756|295177|P1|COMPLETED|Overall Study|Cycle 1|12
120694|NCT01848756|295177|P1|STARTED|Overall Study||15
120695|NCT01848366|295187|P1|NOT COMPLETED|Overall Study||0
120696|NCT01848366|295187|P1|COMPLETED|Overall Study||8
120697|NCT01848366|295187|P1|STARTED|Overall Study||8
120698|NCT01848353|295195|P4|NOT COMPLETED|Phase 3||0
120699|NCT01848353|295196|P3|NOT COMPLETED|Phase 3||0
120700|NCT01848353|295197|P2|NOT COMPLETED|Phase 3||1
120701|NCT01848353|295198|P1|NOT COMPLETED|Phase 3||1
120702|NCT01848353|295195|P4|COMPLETED|Phase 3||0
120703|NCT01848353|295196|P3|COMPLETED|Phase 3||0
120704|NCT01848353|295197|P2|COMPLETED|Phase 3||9
120705|NCT01848353|295198|P1|COMPLETED|Phase 3||4
120706|NCT01848353|295195|P4|STARTED|Phase 3|Normal weight participants only completed baseline testing in Phase 1.|0
120707|NCT01848353|295196|P3|STARTED|Phase 3|Normal weight participants only completed baseline testing in Phase 1.|0
120708|NCT01848353|295197|P2|STARTED|Phase 3|31 participants from Phase 2 intervention (both groups) withdrew and did not complete Phase 3|10
120709|NCT01848353|295198|P1|STARTED|Phase 3|31 participants from Phase 2 intervention (both groups) withdrew and did not complete Phase 3|5
120710|NCT01848353|295195|P4|NOT COMPLETED|Phase 2||0
120711|NCT01848353|295196|P3|NOT COMPLETED|Phase 2||0
120712|NCT01848353|295197|P2|NOT COMPLETED|Phase 2||2
120713|NCT01848353|295198|P1|NOT COMPLETED|Phase 2||3
120714|NCT01848353|295195|P4|COMPLETED|Phase 2||0
120715|NCT01848353|295196|P3|COMPLETED|Phase 2||0
120716|NCT01848353|295197|P2|COMPLETED|Phase 2||26
120717|NCT01848353|295198|P1|COMPLETED|Phase 2||20
120718|NCT01848353|295195|P4|STARTED|Phase 2|Normal weight participants only completed baseline testing in Phase 1.|0
120719|NCT01848353|295196|P3|STARTED|Phase 2|Normal weight participants only completed baseline testing in Phase 1.|0
120720|NCT01848353|295197|P2|STARTED|Phase 2|26 participants from Phase 1 intervention (both groups) withdrew and did not complete Phase 2|28
120721|NCT01848353|295198|P1|STARTED|Phase 2|26 participants from Phase 1 intervention (both groups) withdrew and did not complete Phase 2|23
120722|NCT01848353|295195|P4|NOT COMPLETED|Phase 1||0
120723|NCT01848353|295196|P3|NOT COMPLETED|Phase 1||0
120724|NCT01848353|295197|P2|NOT COMPLETED|Phase 1||1
120725|NCT01848353|295198|P1|NOT COMPLETED|Phase 1||3
120726|NCT01848353|295195|P4|COMPLETED|Phase 1||19
120727|NCT01848353|295196|P3|COMPLETED|Phase 1||20
120728|NCT01848353|295197|P2|COMPLETED|Phase 1||42
120729|NCT01848353|295198|P1|COMPLETED|Phase 1||35
120730|NCT01848353|295195|P4|STARTED|Phase 1||19
120731|NCT01848353|295196|P3|STARTED|Phase 1||20
120732|NCT01848353|295197|P2|STARTED|Phase 1||43
120733|NCT01848353|295198|P1|STARTED|Phase 1||38
120734|NCT01848288|295254|P1|NOT COMPLETED|Overall Study||3
120735|NCT01848288|295254|P1|COMPLETED|Overall Study|Two subjects were discontinued prior to undergoing surgery.|97
120736|NCT01848288|295254|P1|STARTED|Overall Study||100
120737|NCT01848210|295265|P2|NOT COMPLETED|Overall Study||78
120738|NCT01848210|295266|P1|NOT COMPLETED|Overall Study||88
120739|NCT01848210|295265|P2|COMPLETED|Overall Study||340
120740|NCT01848210|295266|P1|COMPLETED|Overall Study||323
120741|NCT01848210|295265|P2|Per Protocol Population|Overall Study||245
120742|NCT01848210|295266|P1|Per Protocol Population|Overall Study||222
120743|NCT01848210|295265|P2|Intent-to-Treat (ITT) Population|Overall Study||388
120744|NCT01848210|295266|P1|Intent-to-Treat (ITT) Population|Overall Study||383
120745|NCT01848210|295265|P2|Safety Population-Received Study Drug|Overall Study||398
120746|NCT01848210|295266|P1|Safety Population-Received Study Drug|Overall Study||394
120747|NCT01848210|295265|P2|STARTED|Overall Study||418
120748|NCT01848210|295266|P1|STARTED|Overall Study||411
120749|NCT01848184|295278|P1|NOT COMPLETED|Overall Study||26
120750|NCT01848184|295278|P1|COMPLETED|Overall Study||100
120751|NCT01848184|295278|P1|STARTED|Overall Study||126
120752|NCT01848145|295288|P1|NOT COMPLETED|Subsequent Infusions: Weeks 3-8||10
120753|NCT01848145|295288|P1|COMPLETED|Subsequent Infusions: Weeks 3-8||20
120754|NCT01848145|295288|P1|STARTED|Subsequent Infusions: Weeks 3-8||30
120755|NCT01848145|295288|P1|NOT COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||1
120756|NCT01848145|295288|P1|COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||30
120757|NCT01848145|295288|P1|Completed Within 15min of Infusion Time|Infusion 3: Week 2, Day 1 - 120 Minutes||26
120758|NCT01848145|295288|P1|STARTED|Infusion 3: Week 2, Day 1 - 120 Minutes||31
120759|NCT01848145|295288|P1|NOT COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes||2
120760|NCT01848145|295288|P1|COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes|Includes participants that completed Infusion 2 and proceeded to the next infusion, Infusion 3.|31
120761|NCT01848145|295288|P1|Completed Within 15min of Infusion Time|Infusion 2: Week 1, Day 3 - 167 Minutes||24
120762|NCT01848145|295288|P1|STARTED|Infusion 2: Week 1, Day 3 - 167 Minutes||33
120763|NCT01848145|295288|P1|NOT COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes||1
120764|NCT01848145|295288|P1|COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes|Includes participants that completed Infusion 1 and proceeded to the next infusion, Infusion 2.|33
120765|NCT01848145|295288|P1|Completed Within 15min of Infusion Time|Infusion 1: Week 1, Day 1 - 226 Minutes|Number of patients who completed within 15 minutes (min) of infusion time.|1
120766|NCT01848145|295288|P1|STARTED|Infusion 1: Week 1, Day 1 - 226 Minutes||34
120767|NCT01848067|295297|P1|NOT COMPLETED|Overall Study||0
120768|NCT01848067|295297|P1|COMPLETED|Overall Study||9
120769|NCT01848067|295297|P1|STARTED|Overall Study||9
120770|NCT01848054|295305|P2|NOT COMPLETED|Stabilization/Maintenance||40
120771|NCT01848054|295306|P1|NOT COMPLETED|Stabilization/Maintenance||40
120772|NCT01848054|295305|P2|COMPLETED|Stabilization/Maintenance||107
120773|NCT01848054|295306|P1|COMPLETED|Stabilization/Maintenance||92
120774|NCT01848054|295305|P2|STARTED|Stabilization/Maintenance||147
120775|NCT01848054|295306|P1|STARTED|Stabilization/Maintenance||132
120776|NCT01848054|295305|P2|NOT COMPLETED|Induction Phase||8
120777|NCT01848054|295306|P1|NOT COMPLETED|Induction Phase||23
120778|NCT01848054|295305|P2|COMPLETED|Induction Phase||147
120779|NCT01848054|295306|P1|COMPLETED|Induction Phase||132
120780|NCT01848054|295305|P2|STARTED|Induction Phase||155
120781|NCT01848054|295306|P1|STARTED|Induction Phase||155
120782|NCT01847885|295328|P3|NOT COMPLETED|Randomization||2
120783|NCT01847885|295329|P2|NOT COMPLETED|Randomization||4
120784|NCT01847885|295330|P1|NOT COMPLETED|Randomization||0
120785|NCT01847885|295328|P3|COMPLETED|Randomization||13
120786|NCT01847885|295329|P2|COMPLETED|Randomization||27
120787|NCT01847885|295330|P1|COMPLETED|Randomization||0
120788|NCT01847885|295328|P3|Per Protocol Set|Randomization||13
120789|NCT01847885|295329|P2|Per Protocol Set|Randomization||27
120790|NCT01847885|295330|P1|Per Protocol Set|Randomization||0
120791|NCT01847885|295328|P3|Safety Set|Randomization||13
120792|NCT01847885|295329|P2|Safety Set|Randomization||28
120793|NCT01847885|295330|P1|Safety Set|Randomization||0
120794|NCT01847885|295328|P3|Full Analysis Set|Randomization||15
120795|NCT01847885|295329|P2|Full Analysis Set|Randomization||28
120796|NCT01847885|295330|P1|Full Analysis Set|Randomization||0
120797|NCT01847885|295328|P3|STARTED|Randomization||15
120798|NCT01847885|295329|P2|STARTED|Randomization||31
120799|NCT01847885|295330|P1|STARTED|Randomization||0
120800|NCT01847885|295328|P3|NOT COMPLETED|Initial Enrollment (Consented)||0
120801|NCT01847885|295329|P2|NOT COMPLETED|Initial Enrollment (Consented)||0
120802|NCT01847885|295330|P1|NOT COMPLETED|Initial Enrollment (Consented)||48
120803|NCT01847885|295328|P3|COMPLETED|Initial Enrollment (Consented)||0
120804|NCT01847885|295329|P2|COMPLETED|Initial Enrollment (Consented)||0
120805|NCT01847885|295330|P1|COMPLETED|Initial Enrollment (Consented)||40
120806|NCT01847885|295328|P3|Per Protocol Set|Initial Enrollment (Consented)||0
120807|NCT01847885|295329|P2|Per Protocol Set|Initial Enrollment (Consented)||0
120808|NCT01847885|295330|P1|Per Protocol Set|Initial Enrollment (Consented)||40
120809|NCT01847885|295328|P3|Safety Set|Initial Enrollment (Consented)||0
120810|NCT01847885|295329|P2|Safety Set|Initial Enrollment (Consented)||0
120811|NCT01847885|295330|P1|Safety Set|Initial Enrollment (Consented)||41
120812|NCT01847885|295328|P3|Full Analysis Set|Initial Enrollment (Consented)||0
120813|NCT01847885|295329|P2|Full Analysis Set|Initial Enrollment (Consented)||0
120814|NCT01847885|295330|P1|Full Analysis Set|Initial Enrollment (Consented)||43
120815|NCT01847885|295328|P3|Randomized|Initial Enrollment (Consented)||0
120816|NCT01847885|295329|P2|Randomized|Initial Enrollment (Consented)||0
120817|NCT01847885|295330|P1|Randomized|Initial Enrollment (Consented)||46
120818|NCT01847885|295328|P3|STARTED|Initial Enrollment (Consented)||0
120819|NCT01847885|295329|P2|STARTED|Initial Enrollment (Consented)||0
120820|NCT01847885|295330|P1|STARTED|Initial Enrollment (Consented)||88
120821|NCT01847638|295364|P2|NOT COMPLETED|Overall Study||0
120822|NCT01847638|295365|P1|NOT COMPLETED|Overall Study||0
120823|NCT01847638|295364|P2|COMPLETED|Overall Study||25
120824|NCT01847638|295365|P1|COMPLETED|Overall Study||25
120825|NCT01847638|295364|P2|STARTED|Overall Study||25
120826|NCT01847638|295365|P1|STARTED|Overall Study||25
120827|NCT01847560|295385|P10|NOT COMPLETED|Overall Study||0
120828|NCT01847560|295386|P9|NOT COMPLETED|Overall Study||0
120829|NCT01847560|295387|P8|NOT COMPLETED|Overall Study||0
120830|NCT01847560|295388|P7|NOT COMPLETED|Overall Study||0
120831|NCT01847560|295389|P6|NOT COMPLETED|Overall Study||0
120832|NCT01847560|295390|P5|NOT COMPLETED|Overall Study||0
120833|NCT01847560|295391|P4|NOT COMPLETED|Overall Study||0
120834|NCT01847560|295392|P3|NOT COMPLETED|Overall Study||0
120835|NCT01847560|295393|P2|NOT COMPLETED|Overall Study||0
120836|NCT01847560|295394|P1|NOT COMPLETED|Overall Study||0
120837|NCT01847560|295385|P10|COMPLETED|Overall Study||39438
120838|NCT01847560|295386|P9|COMPLETED|Overall Study||77547
120839|NCT01847560|295387|P8|COMPLETED|Overall Study||19829
120840|NCT01847560|295388|P7|COMPLETED|Overall Study||40971
120841|NCT01847560|295389|P6|COMPLETED|Overall Study||28343
120842|NCT01847560|295390|P5|COMPLETED|Overall Study||27731
120843|NCT01847560|295391|P4|COMPLETED|Overall Study||56655
120844|NCT01847560|295392|P3|COMPLETED|Overall Study||9731
120845|NCT01847560|295393|P2|COMPLETED|Overall Study||19955
120846|NCT01847560|295394|P1|COMPLETED|Overall Study||13464
120847|NCT01847560|295385|P10|STARTED|Overall Study||39438
120848|NCT01847560|295386|P9|STARTED|Overall Study||77547
120849|NCT01847560|295387|P8|STARTED|Overall Study||19829
120850|NCT01847560|295388|P7|STARTED|Overall Study||40971
120851|NCT01847560|295389|P6|STARTED|Overall Study||28343
120852|NCT01847560|295390|P5|STARTED|Overall Study||27731
120853|NCT01847560|295391|P4|STARTED|Overall Study||56655
120854|NCT01847560|295392|P3|STARTED|Overall Study||9731
120855|NCT01847560|295393|P2|STARTED|Overall Study||19955
120856|NCT01847560|295394|P1|STARTED|Overall Study||13464
120857|NCT01847547|295438|P2|NOT COMPLETED|Overall Study||0
120858|NCT01847547|295439|P1|NOT COMPLETED|Overall Study||0
120859|NCT01847547|295438|P2|COMPLETED|Overall Study||2991
120860|NCT01847547|295439|P1|COMPLETED|Overall Study||2991
120861|NCT01847547|295438|P2|STARTED|Overall Study||2991
120862|NCT01847547|295439|P1|STARTED|Overall Study||2991
120863|NCT01847443|295481|P4|NOT COMPLETED|Study Period 4||0
120864|NCT01847443|295482|P3|NOT COMPLETED|Study Period 4||0
120865|NCT01847443|295483|P2|NOT COMPLETED|Study Period 4||0
120866|NCT01847443|295484|P1|NOT COMPLETED|Study Period 4||0
120867|NCT01847443|295481|P4|COMPLETED|Study Period 4||21
120868|NCT01847443|295482|P3|COMPLETED|Study Period 4||21
120869|NCT01847443|295483|P2|COMPLETED|Study Period 4||19
120870|NCT01847443|295484|P1|COMPLETED|Study Period 4||16
120871|NCT01847443|295481|P4|STARTED|Study Period 4||21
120872|NCT01847443|295482|P3|STARTED|Study Period 4||21
120873|NCT01847443|295483|P2|STARTED|Study Period 4||19
120874|NCT01847443|295484|P1|STARTED|Study Period 4||16
120875|NCT01847443|295481|P4|NOT COMPLETED|Washout Period Before Study Period 4||0
120876|NCT01847443|295482|P3|NOT COMPLETED|Washout Period Before Study Period 4||0
120877|NCT01847443|295483|P2|NOT COMPLETED|Washout Period Before Study Period 4||0
120878|NCT01847443|295484|P1|NOT COMPLETED|Washout Period Before Study Period 4||2
120879|NCT01847443|295481|P4|COMPLETED|Washout Period Before Study Period 4||21
120880|NCT01847443|295482|P3|COMPLETED|Washout Period Before Study Period 4||21
120881|NCT01847443|295483|P2|COMPLETED|Washout Period Before Study Period 4||19
120882|NCT01847443|295484|P1|COMPLETED|Washout Period Before Study Period 4||16
120883|NCT01847443|295481|P4|STARTED|Washout Period Before Study Period 4||21
120884|NCT01847443|295482|P3|STARTED|Washout Period Before Study Period 4||21
120885|NCT01847443|295483|P2|STARTED|Washout Period Before Study Period 4||19
120886|NCT01847443|295484|P1|STARTED|Washout Period Before Study Period 4||18
120887|NCT01847443|295481|P4|NOT COMPLETED|Study Period 3||0
120888|NCT01847443|295482|P3|NOT COMPLETED|Study Period 3||0
120889|NCT01847443|295483|P2|NOT COMPLETED|Study Period 3||0
120890|NCT01847443|295484|P1|NOT COMPLETED|Study Period 3||0
120891|NCT01847443|295481|P4|COMPLETED|Study Period 3||21
120892|NCT01847443|295482|P3|COMPLETED|Study Period 3||21
120893|NCT01847443|295483|P2|COMPLETED|Study Period 3||19
120894|NCT01847443|295484|P1|COMPLETED|Study Period 3||18
120895|NCT01847443|295481|P4|STARTED|Study Period 3||21
120896|NCT01847443|295482|P3|STARTED|Study Period 3||21
120897|NCT01847443|295483|P2|STARTED|Study Period 3||19
120898|NCT01847443|295484|P1|STARTED|Study Period 3||18
120899|NCT01847443|295481|P4|NOT COMPLETED|Washout Period Before Study Period 3||0
120900|NCT01847443|295482|P3|NOT COMPLETED|Washout Period Before Study Period 3||0
120901|NCT01847443|295483|P2|NOT COMPLETED|Washout Period Before Study Period 3||0
120902|NCT01847443|295484|P1|NOT COMPLETED|Washout Period Before Study Period 3||1
120903|NCT01847443|295481|P4|COMPLETED|Washout Period Before Study Period 3||21
120904|NCT01847443|295482|P3|COMPLETED|Washout Period Before Study Period 3||21
120905|NCT01847443|295483|P2|COMPLETED|Washout Period Before Study Period 3||19
120906|NCT01847443|295484|P1|COMPLETED|Washout Period Before Study Period 3||18
120907|NCT01847443|295481|P4|STARTED|Washout Period Before Study Period 3||21
120908|NCT01847443|295482|P3|STARTED|Washout Period Before Study Period 3||21
120909|NCT01847443|295483|P2|STARTED|Washout Period Before Study Period 3||19
120910|NCT01847443|295484|P1|STARTED|Washout Period Before Study Period 3||19
120911|NCT01847443|295481|P4|NOT COMPLETED|Study Period 2||0
120912|NCT01847443|295482|P3|NOT COMPLETED|Study Period 2||0
120913|NCT01847443|295483|P2|NOT COMPLETED|Study Period 2||0
120914|NCT01847443|295484|P1|NOT COMPLETED|Study Period 2||0
120915|NCT01847443|295481|P4|COMPLETED|Study Period 2||21
120916|NCT01847443|295482|P3|COMPLETED|Study Period 2||21
120917|NCT01847443|295483|P2|COMPLETED|Study Period 2||19
120918|NCT01847443|295484|P1|COMPLETED|Study Period 2||19
120919|NCT01847443|295481|P4|STARTED|Study Period 2||21
120920|NCT01847443|295482|P3|STARTED|Study Period 2||21
120921|NCT01847443|295483|P2|STARTED|Study Period 2||19
120922|NCT01847443|295484|P1|STARTED|Study Period 2||19
120923|NCT01847443|295481|P4|NOT COMPLETED|Washout Period Before Study Period 2||0
120924|NCT01847443|295482|P3|NOT COMPLETED|Washout Period Before Study Period 2||0
120925|NCT01847443|295483|P2|NOT COMPLETED|Washout Period Before Study Period 2||1
120926|NCT01847443|295484|P1|NOT COMPLETED|Washout Period Before Study Period 2||2
120927|NCT01847443|295481|P4|COMPLETED|Washout Period Before Study Period 2||21
120928|NCT01847443|295482|P3|COMPLETED|Washout Period Before Study Period 2||21
120929|NCT01847443|295483|P2|COMPLETED|Washout Period Before Study Period 2||19
120930|NCT01847443|295484|P1|COMPLETED|Washout Period Before Study Period 2||19
120931|NCT01847443|295481|P4|STARTED|Washout Period Before Study Period 2||21
120932|NCT01847443|295482|P3|STARTED|Washout Period Before Study Period 2||21
120933|NCT01847443|295483|P2|STARTED|Washout Period Before Study Period 2||20
120934|NCT01847443|295484|P1|STARTED|Washout Period Before Study Period 2||21
120935|NCT01847443|295481|P4|NOT COMPLETED|Study Period 1||0
120936|NCT01847443|295482|P3|NOT COMPLETED|Study Period 1||0
120937|NCT01847443|295483|P2|NOT COMPLETED|Study Period 1||1
120938|NCT01847443|295484|P1|NOT COMPLETED|Study Period 1||0
120939|NCT01847443|295481|P4|COMPLETED|Study Period 1||21
120940|NCT01847443|295482|P3|COMPLETED|Study Period 1||21
120941|NCT01847443|295483|P2|COMPLETED|Study Period 1||20
120942|NCT01847443|295484|P1|COMPLETED|Study Period 1||21
120943|NCT01847443|295481|P4|STARTED|Study Period 1||21
120944|NCT01847443|295482|P3|STARTED|Study Period 1||21
120945|NCT01847443|295483|P2|STARTED|Study Period 1||21
120946|NCT01847443|295484|P1|STARTED|Study Period 1||21
120947|NCT01847430|295514|P1|NOT COMPLETED|Overall Study||0
120948|NCT01847430|295514|P1|COMPLETED|Overall Study||302
120949|NCT01847430|295514|P1|STARTED|Overall Study||302
120950|NCT01847313|295527|P2|NOT COMPLETED|Overall Study||2
120951|NCT01847313|295528|P1|NOT COMPLETED|Overall Study||0
120952|NCT01847313|295527|P2|COMPLETED|Overall Study||8
120953|NCT01847313|295528|P1|COMPLETED|Overall Study||10
120954|NCT01847313|295527|P2|STARTED|Overall Study||10
120955|NCT01847313|295528|P1|STARTED|Overall Study||10
120956|NCT01847274|295544|P4|NOT COMPLETED|Overall Study||104
120957|NCT01847274|295545|P3|NOT COMPLETED|Overall Study||188
120958|NCT01847274|295546|P2|NOT COMPLETED|Overall Study||61
120959|NCT01847274|295547|P1|NOT COMPLETED|Overall Study||91
120960|NCT01847274|295544|P4|COMPLETED|Overall Study||12
120961|NCT01847274|295545|P3|COMPLETED|Overall Study||46
120962|NCT01847274|295546|P2|COMPLETED|Overall Study||4
120963|NCT01847274|295547|P1|COMPLETED|Overall Study||47
120964|NCT01847274|295544|P4|STARTED|Overall Study||116
120965|NCT01847274|295545|P3|STARTED|Overall Study||234
120966|NCT01847274|295546|P2|STARTED|Overall Study||65
120967|NCT01847274|295547|P1|STARTED|Overall Study||138
120968|NCT01847209|295601|P1|NOT COMPLETED|Overall Study||2
120969|NCT01847209|295601|P1|COMPLETED|Overall Study||23
120970|NCT01847209|295601|P1|STARTED|Overall Study||25
120971|NCT01847196|295606|P1|NOT COMPLETED|Overall Study||0
120972|NCT01847196|295606|P1|COMPLETED|Overall Study||5
120973|NCT01847196|295606|P1|STARTED|Overall Study|Includes all subjects in which Angel Catheter placement was attempted.|5
120974|NCT01847131|295613|P2|NOT COMPLETED|Overall Study||0
120975|NCT01847131|295614|P1|NOT COMPLETED|Overall Study||0
120976|NCT01847131|295613|P2|COMPLETED|Overall Study||25
120977|NCT01847131|295614|P1|COMPLETED|Overall Study||25
120978|NCT01847131|295613|P2|STARTED|Overall Study||25
120979|NCT01847131|295614|P1|STARTED|Overall Study||25
120980|NCT01847027|295624|P2|NOT COMPLETED|Overall Study||2
120981|NCT01847027|295625|P1|NOT COMPLETED|Overall Study||1
120982|NCT01847027|295624|P2|COMPLETED|Overall Study||10
120983|NCT01847027|295625|P1|COMPLETED|Overall Study||10
120984|NCT01847027|295624|P2|STARTED|Overall Study||12
120985|NCT01847027|295625|P1|STARTED|Overall Study||11
120986|NCT01847014|295635|P1|NOT COMPLETED|Completion of Extension Study||4
120987|NCT01847014|295635|P1|COMPLETED|Completion of Extension Study||0
120988|NCT01847014|295635|P1|STARTED|Completion of Extension Study||4
120989|NCT01847014|295635|P1|NOT COMPLETED|Baseline Extension Visit||0
120990|NCT01847014|295635|P1|COMPLETED|Baseline Extension Visit||4
120991|NCT01847014|295635|P1|STARTED|Baseline Extension Visit||4
120992|NCT01846871|295639|P1|NOT COMPLETED|Overall Study||0
120993|NCT01846871|295639|P1|COMPLETED|Overall Study||10
120994|NCT01846871|295639|P1|STARTED|Overall Study||10
120995|NCT01846741|295664|P1|NOT COMPLETED|Implantation to 18-Month/End of Study||0
120996|NCT01846741|295664|P1|COMPLETED|Implantation to 18-Month/End of Study||20
120997|NCT01846741|295664|P1|STARTED|Implantation to 18-Month/End of Study||20
120998|NCT01846741|295664|P1|NOT COMPLETED|Baseline Visit||2
120999|NCT01846741|295664|P1|COMPLETED|Baseline Visit||20
121000|NCT01846741|295664|P1|STARTED|Baseline Visit||22
121001|NCT01846728|295720|P1|NOT COMPLETED|Overall Study||0
121002|NCT01846728|295720|P1|COMPLETED|Overall Study||6
121003|NCT01846728|295720|P1|STARTED|Overall Study||6
121004|NCT01846702|295735|P7|NOT COMPLETED|Overall Study||0
121005|NCT01846702|295736|P6|NOT COMPLETED|Overall Study||0
121006|NCT01846702|295737|P5|NOT COMPLETED|Overall Study||0
121007|NCT01846702|295738|P4|NOT COMPLETED|Overall Study||0
121008|NCT01846702|295739|P3|NOT COMPLETED|Overall Study||1
121009|NCT01846702|295740|P2|NOT COMPLETED|Overall Study||0
121010|NCT01846702|295741|P1|NOT COMPLETED|Overall Study||0
121011|NCT01846702|295735|P7|COMPLETED|Overall Study||6
121012|NCT01846702|295736|P6|COMPLETED|Overall Study||6
121013|NCT01846702|295737|P5|COMPLETED|Overall Study||6
121014|NCT01846702|295738|P4|COMPLETED|Overall Study||6
121015|NCT01846702|295739|P3|COMPLETED|Overall Study||6
121016|NCT01846702|295740|P2|COMPLETED|Overall Study||6
121017|NCT01846702|295741|P1|COMPLETED|Overall Study||6
121018|NCT01846702|295735|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
121019|NCT01846702|295736|P6|Received at Least 1 Dose of Study Drug|Overall Study||6
121020|NCT01846702|295737|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
121021|NCT01846702|295738|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
121022|NCT01846702|295739|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
121023|NCT01846702|295740|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
121024|NCT01846702|295741|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
121025|NCT01846702|295735|P7|STARTED|Overall Study||6
121026|NCT01846702|295736|P6|STARTED|Overall Study||6
121027|NCT01846702|295737|P5|STARTED|Overall Study||6
121028|NCT01846702|295738|P4|STARTED|Overall Study||6
121029|NCT01846702|295739|P3|STARTED|Overall Study||7
121030|NCT01846702|295740|P2|STARTED|Overall Study||6
121031|NCT01846702|295741|P1|STARTED|Overall Study||6
121032|NCT01846624|295820|P1|NOT COMPLETED|Overall Study||1
121033|NCT01846624|295820|P1|COMPLETED|Overall Study||12
121034|NCT01846624|295820|P1|STARTED|Overall Study||13
121035|NCT01846611|295830|P2|NOT COMPLETED|Overall Study||43
121036|NCT01846611|295831|P1|NOT COMPLETED|Overall Study||38
121037|NCT01846611|295830|P2|COMPLETED|Overall Study||244
121038|NCT01846611|295831|P1|COMPLETED|Overall Study||251
121039|NCT01846611|295830|P2|Treated|Overall Study||282
121040|NCT01846611|295831|P1|Treated|Overall Study||286
121041|NCT01846611|295830|P2|STARTED|Overall Study||287
121042|NCT01846611|295831|P1|STARTED|Overall Study||289
121043|NCT01846507|295841|P1|NOT COMPLETED|Overall Study||7
121044|NCT01846507|295841|P1|COMPLETED|Overall Study||25
121045|NCT01846507|295841|P1|STARTED|Overall Study||32
121046|NCT01846494|295860|P2|NOT COMPLETED|Overall Study||38
121047|NCT01846494|295861|P1|NOT COMPLETED|Overall Study||30
121048|NCT01846494|295860|P2|COMPLETED|Overall Study||25
121049|NCT01846494|295861|P1|COMPLETED|Overall Study||20
121050|NCT01846494|295860|P2|STARTED|Overall Study||63
121051|NCT01846494|295861|P1|STARTED|Overall Study||50
121052|NCT01846455|295874|P5|NOT COMPLETED|Overall Study||0
121053|NCT01846455|295875|P4|NOT COMPLETED|Overall Study||0
121054|NCT01846455|295876|P3|NOT COMPLETED|Overall Study||0
121055|NCT01846455|295877|P2|NOT COMPLETED|Overall Study||0
121056|NCT01846455|295878|P1|NOT COMPLETED|Overall Study||0
121057|NCT01846455|295874|P5|COMPLETED|Overall Study||8
121058|NCT01846455|295875|P4|COMPLETED|Overall Study||10
121059|NCT01846455|295876|P3|COMPLETED|Overall Study||8
121060|NCT01846455|295877|P2|COMPLETED|Overall Study||8
121061|NCT01846455|295878|P1|COMPLETED|Overall Study||9
121062|NCT01846455|295874|P5|PK Population|Overall Study||8
121063|NCT01846455|295875|P4|PK Population|Overall Study||6
121064|NCT01846455|295876|P3|PK Population|Overall Study||6
121065|NCT01846455|295877|P2|PK Population|Overall Study||7
121066|NCT01846455|295878|P1|PK Population|Overall Study||6
121067|NCT01846455|295874|P5|STARTED|Overall Study||8
121068|NCT01846455|295875|P4|STARTED|Overall Study||10
121069|NCT01846455|295876|P3|STARTED|Overall Study||8
121070|NCT01846455|295877|P2|STARTED|Overall Study||8
121071|NCT01846455|295878|P1|STARTED|Overall Study||9
121072|NCT01846442|295939|P4|NOT COMPLETED|Overall Study||3
121073|NCT01846442|295940|P3|NOT COMPLETED|Overall Study||4
121074|NCT01846442|295941|P2|NOT COMPLETED|Overall Study||6
121075|NCT01846442|295942|P1|NOT COMPLETED|Overall Study||6
121076|NCT01846442|295939|P4|COMPLETED|Overall Study||51
121077|NCT01846442|295940|P3|COMPLETED|Overall Study||52
121078|NCT01846442|295941|P2|COMPLETED|Overall Study||48
121079|NCT01846442|295942|P1|COMPLETED|Overall Study||48
121080|NCT01846442|295939|P4|ITT Population|Overall Study||54
121081|NCT01846442|295940|P3|ITT Population|Overall Study||56
121082|NCT01846442|295941|P2|ITT Population|Overall Study||53
121083|NCT01846442|295942|P1|ITT Population|Overall Study||53
121084|NCT01846442|295939|P4|Safety Population|Overall Study||54
121085|NCT01846442|295940|P3|Safety Population|Overall Study||56
121086|NCT01846442|295941|P2|Safety Population|Overall Study||53
121087|NCT01846442|295942|P1|Safety Population|Overall Study||54
121088|NCT01846442|295939|P4|STARTED|Overall Study||54
121089|NCT01846442|295940|P3|STARTED|Overall Study||56
121090|NCT01846442|295941|P2|STARTED|Overall Study||54
121091|NCT01846442|295942|P1|STARTED|Overall Study||54
121092|NCT01846416|295983|P3|NOT COMPLETED|Survival Follow-up||12
121093|NCT01846416|295984|P2|NOT COMPLETED|Survival Follow-up||80
121094|NCT01846416|295985|P1|NOT COMPLETED|Survival Follow-up||28
121095|NCT01846416|295983|P3|COMPLETED|Survival Follow-up||0
121096|NCT01846416|295984|P2|COMPLETED|Survival Follow-up||0
121097|NCT01846416|295985|P1|COMPLETED|Survival Follow-up||0
121098|NCT01846416|295983|P3|STARTED|Survival Follow-up||12
121099|NCT01846416|295984|P2|STARTED|Survival Follow-up||80
121100|NCT01846416|295985|P1|STARTED|Survival Follow-up||28
121101|NCT01846416|295983|P3|NOT COMPLETED|Treatment Phase||13
121102|NCT01846416|295984|P2|NOT COMPLETED|Treatment Phase||93
121103|NCT01846416|295985|P1|NOT COMPLETED|Treatment Phase||31
121104|NCT01846416|295983|P3|COMPLETED|Treatment Phase||0
121105|NCT01846416|295984|P2|COMPLETED|Treatment Phase||0
121106|NCT01846416|295985|P1|COMPLETED|Treatment Phase||0
121107|NCT01846416|295983|P3|STARTED|Treatment Phase||13
121108|NCT01846416|295984|P2|STARTED|Treatment Phase||93
121109|NCT01846416|295985|P1|STARTED|Treatment Phase||31
121110|NCT01846299|296030|P2|NOT COMPLETED|Overall Study||10
121111|NCT01846299|296031|P1|NOT COMPLETED|Overall Study||12
121112|NCT01846299|296030|P2|COMPLETED|Overall Study||50
121113|NCT01846299|296031|P1|COMPLETED|Overall Study||106
121114|NCT01846299|296030|P2|Safety Set|Overall Study||58
121115|NCT01846299|296031|P1|Safety Set|Overall Study|Two participants randomized to sham received ranibizumab at Month 1.|119
121116|NCT01846299|296030|P2|Full Analysis Set|Overall Study||60
121117|NCT01846299|296031|P1|Full Analysis Set|Overall Study|One participant did not receive study treatment prior to discontinuation.|117
121118|NCT01846299|296030|P2|STARTED|Overall Study||60
121119|NCT01846299|296031|P1|STARTED|Overall Study||118
121120|NCT01846273|296070|P3|NOT COMPLETED|Overall Study||0
121121|NCT01846273|296071|P2|NOT COMPLETED|Overall Study||26
121122|NCT01846273|296072|P1|NOT COMPLETED|Overall Study||22
121123|NCT01846273|296070|P3|COMPLETED|Overall Study||41
121124|NCT01846273|296071|P2|COMPLETED|Overall Study||87
121125|NCT01846273|296072|P1|COMPLETED|Overall Study||146
121126|NCT01846273|296070|P3|Safety Analysis Set|Overall Study||14
121127|NCT01846273|296071|P2|Safety Analysis Set|Overall Study||135
121128|NCT01846273|296072|P1|Safety Analysis Set|Overall Study||172
121129|NCT01846273|296070|P3|STARTED|Overall Study||41
121130|NCT01846273|296071|P2|STARTED|Overall Study||113
121131|NCT01846273|296072|P1|STARTED|Overall Study||168
121132|NCT01846221|296128|P2|NOT COMPLETED|Overall Study||0
121133|NCT01846221|296129|P1|NOT COMPLETED|Overall Study||3
121134|NCT01846221|296128|P2|COMPLETED|Overall Study||51
121135|NCT01846221|296129|P1|COMPLETED|Overall Study||47
121136|NCT01846221|296128|P2|STARTED|Overall Study||51
121137|NCT01846221|296129|P1|STARTED|Overall Study||50
121138|NCT01846208|296146|P3|NOT COMPLETED|Overall Study||8
121139|NCT01846208|296147|P2|NOT COMPLETED|Overall Study||4
121140|NCT01846208|296148|P1|NOT COMPLETED|Overall Study||9
121141|NCT01846208|296146|P3|COMPLETED|Overall Study||32
121142|NCT01846208|296147|P2|COMPLETED|Overall Study||20
121143|NCT01846208|296148|P1|COMPLETED|Overall Study||19
121144|NCT01846208|296146|P3|Year 2 Sustained Unresponsiveness OFC|Overall Study||21
121145|NCT01846208|296147|P2|Year 2 Sustained Unresponsiveness OFC|Overall Study||18
121146|NCT01846208|296148|P1|Year 2 Sustained Unresponsiveness OFC|Overall Study||4
121147|NCT01846208|296146|P3|Year 2 Desensitization OFC|Overall Study||33
121148|NCT01846208|296147|P2|Year 2 Desensitization OFC|Overall Study||20
121149|NCT01846208|296148|P1|Year 2 Desensitization OFC|Overall Study||19
121150|NCT01846208|296146|P3|Year 1 Desensitization OFC|Overall Study||34
121151|NCT01846208|296147|P2|Year 1 Desensitization OFC|Overall Study||20
121152|NCT01846208|296148|P1|Year 1 Desensitization OFC|Overall Study||23
121153|NCT01846208|296146|P3|Initiatiated Treatment|Overall Study||39
121154|NCT01846208|296147|P2|Initiatiated Treatment|Overall Study||23
121155|NCT01846208|296148|P1|Initiatiated Treatment|Overall Study||27
121156|NCT01846208|296146|P3|STARTED|Overall Study||40
121157|NCT01846208|296147|P2|STARTED|Overall Study||24
121158|NCT01846208|296148|P1|STARTED|Overall Study||28
121159|NCT01846104|296168|P1|NOT COMPLETED|Overall Study||1
121160|NCT01846104|296168|P1|COMPLETED|Overall Study||3
121161|NCT01846104|296168|P1|STARTED|Overall Study||4
121162|NCT01846039|296174|P1|NOT COMPLETED|Overall Study||2
121163|NCT01846039|296174|P1|COMPLETED|Overall Study||27
121164|NCT01846039|296174|P1|STARTED|Overall Study||29
121165|NCT01845974|296186|P2|NOT COMPLETED|Overall Study||0
121166|NCT01845974|296187|P1|NOT COMPLETED|Overall Study||1
121167|NCT01845974|296186|P2|COMPLETED|Overall Study||9
121168|NCT01845974|296187|P1|COMPLETED|Overall Study||3
121169|NCT01845974|296186|P2|STARTED|Overall Study||9
121170|NCT01845974|296187|P1|STARTED|Overall Study||4
121171|NCT01845831|296195|P5|NOT COMPLETED|Outpatient Phase||0
121172|NCT01845831|296196|P4|NOT COMPLETED|Outpatient Phase||0
121173|NCT01845831|296197|P3|NOT COMPLETED|Outpatient Phase||0
121174|NCT01845831|296198|P2|NOT COMPLETED|Outpatient Phase||0
121175|NCT01845831|296199|P1|NOT COMPLETED|Outpatient Phase||0
121176|NCT01845831|296195|P5|COMPLETED|Outpatient Phase||87
121177|NCT01845831|296196|P4|COMPLETED|Outpatient Phase||98
121178|NCT01845831|296197|P3|COMPLETED|Outpatient Phase||68
121179|NCT01845831|296198|P2|COMPLETED|Outpatient Phase||0
121180|NCT01845831|296199|P1|COMPLETED|Outpatient Phase||0
121181|NCT01845831|296195|P5|STARTED|Outpatient Phase||87
121182|NCT01845831|296196|P4|STARTED|Outpatient Phase||98
121183|NCT01845831|296197|P3|STARTED|Outpatient Phase||68
121184|NCT01845831|296198|P2|STARTED|Outpatient Phase||0
121185|NCT01845831|296199|P1|STARTED|Outpatient Phase||0
121186|NCT01845831|296195|P5|NOT COMPLETED|Inpatient Phase||0
121187|NCT01845831|296196|P4|NOT COMPLETED|Inpatient Phase||0
121188|NCT01845831|296197|P3|NOT COMPLETED|Inpatient Phase||0
121189|NCT01845831|296198|P2|NOT COMPLETED|Inpatient Phase||1
121190|NCT01845831|296199|P1|NOT COMPLETED|Inpatient Phase||1
121191|NCT01845831|296195|P5|COMPLETED|Inpatient Phase||0
121192|NCT01845831|296196|P4|COMPLETED|Inpatient Phase||0
121193|NCT01845831|296197|P3|COMPLETED|Inpatient Phase||0
121194|NCT01845831|296198|P2|COMPLETED|Inpatient Phase||138
121195|NCT01845831|296199|P1|COMPLETED|Inpatient Phase||139
121196|NCT01845831|296195|P5|STARTED|Inpatient Phase||0
121197|NCT01845831|296196|P4|STARTED|Inpatient Phase||0
121198|NCT01845831|296197|P3|STARTED|Inpatient Phase||0
121199|NCT01845831|296198|P2|STARTED|Inpatient Phase||139
121200|NCT01845831|296199|P1|STARTED|Inpatient Phase||140
121201|NCT01845818|296228|P2|NOT COMPLETED|Overall Study||17
121202|NCT01845818|296229|P1|NOT COMPLETED|Overall Study||45
121203|NCT01845818|296228|P2|COMPLETED|Overall Study||40
121204|NCT01845818|296229|P1|COMPLETED|Overall Study||81
121205|NCT01845818|296228|P2|STARTED|Overall Study||57
121206|NCT01845818|296229|P1|STARTED|Overall Study||126
121207|NCT01845792|296270|P2|NOT COMPLETED|Overall Study||0
121208|NCT01845792|296271|P1|NOT COMPLETED|Overall Study||0
121209|NCT01845792|296270|P2|COMPLETED|Overall Study||2
121210|NCT01845792|296271|P1|COMPLETED|Overall Study||5
121211|NCT01845792|296270|P2|STARTED|Overall Study||2
121212|NCT01845792|296271|P1|STARTED|Overall Study||5
121213|NCT01845636|296279|P1|NOT COMPLETED|Overall Study||4
121214|NCT01845636|296279|P1|COMPLETED|Overall Study||37
121215|NCT01845636|296279|P1|STARTED|Overall Study||41
121216|NCT01845220|296287|P2|NOT COMPLETED|Overall Study||0
121217|NCT01845220|296288|P1|NOT COMPLETED|Overall Study||0
121218|NCT01845220|296287|P2|COMPLETED|Overall Study||30
121219|NCT01845220|296288|P1|COMPLETED|Overall Study||30
121220|NCT01845220|296287|P2|STARTED|Overall Study||30
121221|NCT01845220|296288|P1|STARTED|Overall Study||30
121222|NCT01845155|296296|P2|NOT COMPLETED|Overall Study||0
121223|NCT01845155|296297|P1|NOT COMPLETED|Overall Study||1
121224|NCT01845155|296296|P2|COMPLETED|Overall Study||144
121225|NCT01845155|296297|P1|COMPLETED|Overall Study||145
121226|NCT01845155|296296|P2|STARTED|Overall Study||144
121227|NCT01845155|296297|P1|STARTED|Overall Study||146
121228|NCT01845103|296305|P1|NOT COMPLETED|Overall Study||0
121229|NCT01845103|296305|P1|COMPLETED|Overall Study||1
121230|NCT01845103|296305|P1|STARTED|Overall Study||1
121231|NCT01845077|296313|P6|NOT COMPLETED|Treatment Period 2||0
121232|NCT01845077|296314|P5|NOT COMPLETED|Treatment Period 2||0
121233|NCT01845077|296315|P4|NOT COMPLETED|Treatment Period 2||0
121234|NCT01845077|296316|P3|NOT COMPLETED|Treatment Period 2||0
121235|NCT01845077|296317|P2|NOT COMPLETED|Treatment Period 2||0
121236|NCT01845077|296318|P1|NOT COMPLETED|Treatment Period 2||0
121237|NCT01845077|296313|P6|COMPLETED|Treatment Period 2||11
121238|NCT01845077|296314|P5|COMPLETED|Treatment Period 2||11
121239|NCT01845077|296315|P4|COMPLETED|Treatment Period 2||10
121240|NCT01845077|296316|P3|COMPLETED|Treatment Period 2||11
121241|NCT01845077|296317|P2|COMPLETED|Treatment Period 2||11
121242|NCT01845077|296318|P1|COMPLETED|Treatment Period 2||11
121243|NCT01845077|296313|P6|STARTED|Treatment Period 2||11
121244|NCT01845077|296314|P5|STARTED|Treatment Period 2||11
121245|NCT01845077|296315|P4|STARTED|Treatment Period 2||10
121246|NCT01845077|296316|P3|STARTED|Treatment Period 2||11
121247|NCT01845077|296317|P2|STARTED|Treatment Period 2||11
121248|NCT01845077|296318|P1|STARTED|Treatment Period 2||11
121249|NCT01845077|296313|P6|NOT COMPLETED|Washout Period||1
121250|NCT01845077|296314|P5|NOT COMPLETED|Washout Period||1
121251|NCT01845077|296315|P4|NOT COMPLETED|Washout Period||2
121252|NCT01845077|296316|P3|NOT COMPLETED|Washout Period||1
121253|NCT01845077|296317|P2|NOT COMPLETED|Washout Period||1
121254|NCT01845077|296318|P1|NOT COMPLETED|Washout Period||1
121255|NCT01845077|296313|P6|COMPLETED|Washout Period||11
121256|NCT01845077|296314|P5|COMPLETED|Washout Period||11
121257|NCT01845077|296315|P4|COMPLETED|Washout Period||10
121258|NCT01845077|296316|P3|COMPLETED|Washout Period||11
121259|NCT01845077|296317|P2|COMPLETED|Washout Period||11
121260|NCT01845077|296318|P1|COMPLETED|Washout Period||11
121261|NCT01845077|296313|P6|STARTED|Washout Period||12
121262|NCT01845077|296314|P5|STARTED|Washout Period||12
121263|NCT01845077|296315|P4|STARTED|Washout Period||12
121264|NCT01845077|296316|P3|STARTED|Washout Period||12
121265|NCT01845077|296317|P2|STARTED|Washout Period||12
121266|NCT01845077|296318|P1|STARTED|Washout Period||12
121267|NCT01845077|296313|P6|NOT COMPLETED|Treatment Period 1||0
121268|NCT01845077|296314|P5|NOT COMPLETED|Treatment Period 1||0
121269|NCT01845077|296315|P4|NOT COMPLETED|Treatment Period 1||0
121270|NCT01845077|296316|P3|NOT COMPLETED|Treatment Period 1||0
121271|NCT01845077|296317|P2|NOT COMPLETED|Treatment Period 1||0
121272|NCT01845077|296318|P1|NOT COMPLETED|Treatment Period 1||0
121273|NCT01845077|296313|P6|COMPLETED|Treatment Period 1||12
121274|NCT01845077|296314|P5|COMPLETED|Treatment Period 1||12
121275|NCT01845077|296315|P4|COMPLETED|Treatment Period 1||12
121276|NCT01845077|296316|P3|COMPLETED|Treatment Period 1||12
121277|NCT01845077|296317|P2|COMPLETED|Treatment Period 1||12
121278|NCT01845077|296318|P1|COMPLETED|Treatment Period 1||12
121279|NCT01845077|296313|P6|STARTED|Treatment Period 1||12
121280|NCT01845077|296314|P5|STARTED|Treatment Period 1||12
121281|NCT01845077|296315|P4|STARTED|Treatment Period 1||12
121282|NCT01845077|296316|P3|STARTED|Treatment Period 1||12
121283|NCT01845077|296317|P2|STARTED|Treatment Period 1||12
121284|NCT01845077|296318|P1|STARTED|Treatment Period 1||12
121285|NCT01845025|296364|P2|NOT COMPLETED|Overall Study||77
121286|NCT01845025|296365|P1|NOT COMPLETED|Overall Study||85
121287|NCT01845025|296364|P2|COMPLETED|Overall Study||332
121288|NCT01845025|296365|P1|COMPLETED|Overall Study||326
121289|NCT01845025|296364|P2|STARTED|Overall Study||409
121290|NCT01845025|296365|P1|STARTED|Overall Study||411
121291|NCT01844986|296389|P2|NOT COMPLETED|Overall Study||40
121292|NCT01844986|296390|P1|NOT COMPLETED|Overall Study||77
121293|NCT01844986|296389|P2|COMPLETED|Overall Study||91
121294|NCT01844986|296390|P1|COMPLETED|Overall Study||183
121295|NCT01844986|296389|P2|STARTED|Overall Study||131
121296|NCT01844986|296390|P1|STARTED|Overall Study||260
121297|NCT01844895|296412|P1|NOT COMPLETED|Day 29 - Day113 - Autoinjector||6
121298|NCT01844895|296412|P1|COMPLETED|Day 29 - Day113 - Autoinjector||111
121299|NCT01844895|296412|P1|STARTED|Day 29 - Day113 - Autoinjector||117
121300|NCT01844895|296412|P1|NOT COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||3
121301|NCT01844895|296412|P1|COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||117
121302|NCT01844895|296412|P1|STARTED|Day 1 to Day 28 - Pre-filled Syringe||120
121303|NCT01844856|296430|P2|NOT COMPLETED|Overall Study||16
121304|NCT01844856|296431|P1|NOT COMPLETED|Overall Study||24
121305|NCT01844856|296430|P2|COMPLETED|Overall Study||255
121306|NCT01844856|296431|P1|COMPLETED|Overall Study||246
121307|NCT01844856|296430|P2|Received at Least 1 Dose of Study Drug|Overall Study||268
121308|NCT01844856|296431|P1|Received at Least 1 Dose of Study Drug|Overall Study||270
121309|NCT01844856|296430|P2|STARTED|Overall Study||271
121310|NCT01844856|296431|P1|STARTED|Overall Study||270
121311|NCT01844830|296443|P2|NOT COMPLETED|Overall Study||0
121312|NCT01844830|296444|P1|NOT COMPLETED|Overall Study||1
121313|NCT01844830|296443|P2|COMPLETED|Overall Study||30
121314|NCT01844830|296444|P1|COMPLETED|Overall Study||59
121315|NCT01844830|296443|P2|400 µL Dose|Overall Study||10
121316|NCT01844830|296444|P1|400 µL Dose|Overall Study||20
121317|NCT01844830|296443|P2|200 µL Dose|Overall Study||12
121318|NCT01844830|296444|P1|200 µL Dose|Overall Study||24
121319|NCT01844830|296443|P2|100 µL Dose|Overall Study||8
121320|NCT01844830|296444|P1|100 µL Dose|Overall Study||16
121321|NCT01844830|296443|P2|STARTED|Overall Study||30
121322|NCT01844830|296444|P1|STARTED|Overall Study||60
121323|NCT01844817|296474|P2|NOT COMPLETED|Treatment||63
121324|NCT01844817|296475|P1|NOT COMPLETED|Treatment||64
121325|NCT01844817|296474|P2|COMPLETED|Treatment||0
121326|NCT01844817|296475|P1|COMPLETED|Treatment||0
121327|NCT01844817|296474|P2|STARTED|Treatment||63
121328|NCT01844817|296475|P1|STARTED|Treatment||64
121329|NCT01844817|296474|P2|NOT COMPLETED|Enrolled and Randomized||3
121330|NCT01844817|296475|P1|NOT COMPLETED|Enrolled and Randomized||2
121331|NCT01844817|296474|P2|COMPLETED|Enrolled and Randomized||63
121332|NCT01844817|296475|P1|COMPLETED|Enrolled and Randomized||64
121333|NCT01844817|296474|P2|STARTED|Enrolled and Randomized||66
121334|NCT01844817|296475|P1|STARTED|Enrolled and Randomized||66
121335|NCT01844778|296488|P3|NOT COMPLETED|Overall Study||4
121336|NCT01844778|296489|P2|NOT COMPLETED|Overall Study||3
121337|NCT01844778|296490|P1|NOT COMPLETED|Overall Study||2
121338|NCT01844778|296488|P3|COMPLETED|Overall Study||14
121339|NCT01844778|296489|P2|COMPLETED|Overall Study||25
121340|NCT01844778|296490|P1|COMPLETED|Overall Study||12
121341|NCT01844778|296488|P3|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||15
121342|NCT01844778|296489|P2|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||25
121343|NCT01844778|296490|P1|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||12
121344|NCT01844778|296488|P3|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||18
121345|NCT01844778|296489|P2|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||28
121346|NCT01844778|296490|P1|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||14
121347|NCT01844778|296488|P3|STARTED|Overall Study||18
121348|NCT01844778|296489|P2|STARTED|Overall Study||28
121349|NCT01844778|296490|P1|STARTED|Overall Study||14
121350|NCT01844765|296516|P2|NOT COMPLETED|Overall Study||6
121351|NCT01844765|296517|P1|NOT COMPLETED|Overall Study||9
121352|NCT01844765|296516|P2|COMPLETED|Overall Study|Completed = patients ongoing treatment at time of data cut-off|19
121353|NCT01844765|296517|P1|COMPLETED|Overall Study|Completed = patients ongoing treatment at time of data cut-off|25
121354|NCT01844765|296516|P2|Untreated|Overall Study||0
121355|NCT01844765|296517|P1|Untreated|Overall Study|Did not receive study drug due to adverse event (AE).|1
121356|NCT01844765|296516|P2|Treated|Overall Study||25
121357|NCT01844765|296517|P1|Treated|Overall Study||33
121358|NCT01844765|296516|P2|STARTED|Overall Study||25
121359|NCT01844765|296517|P1|STARTED|Overall Study||34
121360|NCT01844700|296537|P2|NOT COMPLETED|Overall Study||1
121361|NCT01844700|296538|P1|NOT COMPLETED|Overall Study||3
121362|NCT01844700|296537|P2|COMPLETED|Overall Study||2
121363|NCT01844700|296538|P1|COMPLETED|Overall Study||1
121364|NCT01844700|296537|P2|STARTED|Overall Study||3
121365|NCT01844700|296538|P1|STARTED|Overall Study||4
121366|NCT01844687|296550|P1|NOT COMPLETED|Visit 8||0
121367|NCT01844687|296550|P1|COMPLETED|Visit 8||31
121368|NCT01844687|296550|P1|STARTED|Visit 8||31
121369|NCT01844687|296550|P1|NOT COMPLETED|Visit 7||0
121370|NCT01844687|296550|P1|COMPLETED|Visit 7||31
121371|NCT01844687|296550|P1|STARTED|Visit 7||31
121372|NCT01844687|296550|P1|NOT COMPLETED|Visit 6||0
121373|NCT01844687|296550|P1|COMPLETED|Visit 6||31
121374|NCT01844687|296550|P1|STARTED|Visit 6||31
121375|NCT01844687|296550|P1|NOT COMPLETED|Visit 5||0
121376|NCT01844687|296550|P1|COMPLETED|Visit 5||31
121377|NCT01844687|296550|P1|STARTED|Visit 5||31
121378|NCT01844687|296550|P1|NOT COMPLETED|Visit 4||4
121379|NCT01844687|296550|P1|COMPLETED|Visit 4||31
121380|NCT01844687|296550|P1|STARTED|Visit 4||35
121381|NCT01844687|296550|P1|NOT COMPLETED|Visit 3||5
121382|NCT01844687|296550|P1|COMPLETED|Visit 3||35
121383|NCT01844687|296550|P1|STARTED|Visit 3||40
121384|NCT01844687|296550|P1|NOT COMPLETED|Visit 2||2
121385|NCT01844687|296550|P1|COMPLETED|Visit 2||40
121386|NCT01844687|296550|P1|STARTED|Visit 2||42
121387|NCT01844687|296550|P1|NOT COMPLETED|Visit 1||8
121388|NCT01844687|296550|P1|COMPLETED|Visit 1||42
121389|NCT01844687|296550|P1|STARTED|Visit 1||50
121390|NCT01844583|296611|P2|NOT COMPLETED|Overall Study||10
121391|NCT01844583|296612|P1|NOT COMPLETED|Overall Study||8
121392|NCT01844583|296611|P2|COMPLETED|Overall Study||19
121393|NCT01844583|296612|P1|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK/ECG assessment.|18
121394|NCT01844583|296611|P2|STARTED|Overall Study||29
121395|NCT01844583|296612|P1|STARTED|Overall Study||26
121396|NCT01844531|296644|P4|NOT COMPLETED|Overall Study||0
121397|NCT01844531|296645|P3|NOT COMPLETED|Overall Study||0
121398|NCT01844531|296646|P2|NOT COMPLETED|Overall Study||1
121399|NCT01844531|296647|P1|NOT COMPLETED|Overall Study||0
121400|NCT01844531|296644|P4|COMPLETED|Overall Study||6
121401|NCT01844531|296645|P3|COMPLETED|Overall Study||6
121402|NCT01844531|296646|P2|COMPLETED|Overall Study||5
121403|NCT01844531|296647|P1|COMPLETED|Overall Study||6
121404|NCT01844531|296644|P4|STARTED|Overall Study||6
121405|NCT01844531|296645|P3|STARTED|Overall Study||6
121406|NCT01844531|296646|P2|STARTED|Overall Study||6
121407|NCT01844531|296647|P1|STARTED|Overall Study||6
121408|NCT01844518|296677|P1|NOT COMPLETED|Long-Term Extension||157
121409|NCT01844518|296677|P1|COMPLETED|Long-Term Extension|Study is on-going|0
121410|NCT01844518|296677|P1|STARTED|Long-Term Extension|7 participants completed ST but did not continue in study.|157
121411|NCT01844518|296677|P1|NOT COMPLETED|Short-Term (ST) Period||9
121412|NCT01844518|296677|P1|COMPLETED|Short-Term (ST) Period||164
121413|NCT01844518|296677|P1|STARTED|Short-Term (ST) Period||173
121414|NCT01844505|296694|P3|NOT COMPLETED|Overall Study||295
121415|NCT01844505|296695|P2|NOT COMPLETED|Overall Study||269
121416|NCT01844505|296696|P1|NOT COMPLETED|Overall Study||249
121417|NCT01844505|296694|P3|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|16
121418|NCT01844505|296695|P2|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|44
121419|NCT01844505|296696|P1|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|64
121420|NCT01844505|296694|P3|STARTED|Overall Study||311
121421|NCT01844505|296695|P2|STARTED|Overall Study||313
121422|NCT01844505|296696|P1|STARTED|Overall Study||313
121423|NCT01844479|296746|P2|NOT COMPLETED|Second Intervention up to 30 Minutes||0
121424|NCT01844479|296747|P1|NOT COMPLETED|Second Intervention up to 30 Minutes||0
121425|NCT01844479|296746|P2|COMPLETED|Second Intervention up to 30 Minutes||13
121426|NCT01844479|296747|P1|COMPLETED|Second Intervention up to 30 Minutes||14
121427|NCT01844479|296746|P2|STARTED|Second Intervention up to 30 Minutes||13
121428|NCT01844479|296747|P1|STARTED|Second Intervention up to 30 Minutes||14
121429|NCT01844479|296746|P2|NOT COMPLETED|First Intervention up to 30 Minutes||0
121430|NCT01844479|296747|P1|NOT COMPLETED|First Intervention up to 30 Minutes||0
121431|NCT01844479|296746|P2|COMPLETED|First Intervention up to 30 Minutes||13
121432|NCT01844479|296747|P1|COMPLETED|First Intervention up to 30 Minutes||14
121433|NCT01844479|296746|P2|STARTED|First Intervention up to 30 Minutes||13
121434|NCT01844479|296747|P1|STARTED|First Intervention up to 30 Minutes||14
121435|NCT01844388|296777|P2|NOT COMPLETED|Overall Study||7
121436|NCT01844388|296778|P1|NOT COMPLETED|Overall Study||8
121437|NCT01844388|296777|P2|COMPLETED|Overall Study||114
121438|NCT01844388|296778|P1|COMPLETED|Overall Study||236
121439|NCT01844388|296777|P2|STARTED|Overall Study||121
121440|NCT01844388|296778|P1|STARTED|Overall Study||244
121441|NCT01844375|296790|P2|NOT COMPLETED|Overall Study||1
121442|NCT01844375|296791|P1|NOT COMPLETED|Overall Study||1
121443|NCT01844375|296790|P2|COMPLETED|Overall Study||34
121444|NCT01844375|296791|P1|COMPLETED|Overall Study||34
121445|NCT01844375|296790|P2|STARTED|Overall Study||35
121446|NCT01844375|296791|P1|STARTED|Overall Study||35
121447|NCT01844284|296803|P2|NOT COMPLETED|Overall Study||7
121448|NCT01844284|296804|P1|NOT COMPLETED|Overall Study||12
121449|NCT01844284|296803|P2|COMPLETED|Overall Study||127
121450|NCT01844284|296804|P1|COMPLETED|Overall Study||254
121451|NCT01844284|296803|P2|STARTED|Overall Study|Intent-to-treat (ITT) population|134
121452|NCT01844284|296804|P1|STARTED|Overall Study|Intent-to-treat (ITT) population|266
121453|NCT01844206|297014|P2|NOT COMPLETED|Overall Study||1
121454|NCT01844206|297015|P1|NOT COMPLETED|Overall Study||0
121455|NCT01844206|297014|P2|COMPLETED|Overall Study|One patient requested that epidural catheter be removed during the first post-operative day.|2
121456|NCT01844206|297015|P1|COMPLETED|Overall Study||2
121457|NCT01844206|297014|P2|STARTED|Overall Study||3
121458|NCT01844206|297015|P1|STARTED|Overall Study||2
121459|NCT01843972|297031|P10|NOT COMPLETED|Overall Study||0
121460|NCT01843972|297032|P9|NOT COMPLETED|Overall Study||0
121461|NCT01843972|297033|P8|NOT COMPLETED|Overall Study||0
121462|NCT01843972|297034|P7|NOT COMPLETED|Overall Study||0
121463|NCT01843972|297035|P6|NOT COMPLETED|Overall Study||0
121464|NCT01843972|297036|P5|NOT COMPLETED|Overall Study||1
121465|NCT01843972|297037|P4|NOT COMPLETED|Overall Study||0
121466|NCT01843972|297038|P3|NOT COMPLETED|Overall Study||0
121467|NCT01843972|297039|P2|NOT COMPLETED|Overall Study||0
121468|NCT01843972|297040|P1|NOT COMPLETED|Overall Study||0
121469|NCT01843972|297031|P10|COMPLETED|Overall Study||12
121470|NCT01843972|297032|P9|COMPLETED|Overall Study||17
121471|NCT01843972|297033|P8|COMPLETED|Overall Study||5
121472|NCT01843972|297034|P7|COMPLETED|Overall Study||5
121473|NCT01843972|297035|P6|COMPLETED|Overall Study||6
121474|NCT01843972|297036|P5|COMPLETED|Overall Study||5
121475|NCT01843972|297037|P4|COMPLETED|Overall Study||6
121476|NCT01843972|297038|P3|COMPLETED|Overall Study||5
121477|NCT01843972|297039|P2|COMPLETED|Overall Study||6
121478|NCT01843972|297040|P1|COMPLETED|Overall Study||13
121479|NCT01843972|297031|P10|STARTED|Overall Study||12
121480|NCT01843972|297032|P9|STARTED|Overall Study||17
121481|NCT01843972|297033|P8|STARTED|Overall Study||5
121482|NCT01843972|297034|P7|STARTED|Overall Study||5
121483|NCT01843972|297035|P6|STARTED|Overall Study||6
121484|NCT01843972|297036|P5|STARTED|Overall Study||6
121485|NCT01843972|297037|P4|STARTED|Overall Study||6
121486|NCT01843972|297038|P3|STARTED|Overall Study||5
121487|NCT01843972|297039|P2|STARTED|Overall Study||6
121488|NCT01843972|297040|P1|STARTED|Overall Study||13
121489|NCT01843933|297110|P2|NOT COMPLETED|Overall Study||4
121490|NCT01843933|297111|P1|NOT COMPLETED|Overall Study||6
121491|NCT01843933|297110|P2|COMPLETED|Overall Study||103
121492|NCT01843933|297111|P1|COMPLETED|Overall Study||98
121493|NCT01843933|297110|P2|STARTED|Overall Study||107
121494|NCT01843933|297111|P1|STARTED|Overall Study||104
121495|NCT01843920|297119|P2|NOT COMPLETED|Overall Study||0
121496|NCT01843920|297120|P1|NOT COMPLETED|Overall Study||0
121497|NCT01843920|297119|P2|COMPLETED|Overall Study||9
121498|NCT01843920|297120|P1|COMPLETED|Overall Study||12
121499|NCT01843920|297119|P2|STARTED|Overall Study||9
121500|NCT01843920|297120|P1|STARTED|Overall Study||12
121501|NCT01843842|297130|P2|NOT COMPLETED|Overall Study||1
121502|NCT01843842|297131|P1|NOT COMPLETED|Overall Study||1
121503|NCT01843842|297130|P2|COMPLETED|Overall Study||151
121504|NCT01843842|297131|P1|COMPLETED|Overall Study||153
121505|NCT01843842|297130|P2|STARTED|Overall Study||152
121506|NCT01843842|297131|P1|STARTED|Overall Study||154
121507|NCT01843803|297153|P2|NOT COMPLETED|Overall Study||3
121508|NCT01843803|297154|P1|NOT COMPLETED|Overall Study||1
121509|NCT01843803|297153|P2|COMPLETED|Overall Study||136
121510|NCT01843803|297154|P1|COMPLETED|Overall Study||136
121511|NCT01843803|297153|P2|STARTED|Overall Study||139
121512|NCT01843803|297154|P1|STARTED|Overall Study||137
121513|NCT01843777|297168|P2|NOT COMPLETED|Overall Study||0
121514|NCT01843777|297169|P1|NOT COMPLETED|Overall Study||1
121515|NCT01843777|297168|P2|COMPLETED|Overall Study|Number of subjects who received the treatment that completed collection of outcome measures|10
121516|NCT01843777|297169|P1|COMPLETED|Overall Study|Final number of standard-of-care participants.|10
121517|NCT01843777|297168|P2|Per Protocol Population|Overall Study|A subject was randomized to treatment but received standard of care and is not in the analyses.|9
121518|NCT01843777|297169|P1|Per Protocol Population|Overall Study||11
121519|NCT01843777|297168|P2|STARTED|Overall Study|Number of participants randomized to treatment.|10
121520|NCT01843777|297169|P1|STARTED|Overall Study|Number of participants randomized to standard-of-care.|11
121521|NCT01843751|297179|P2|NOT COMPLETED|Overall Study||7
121522|NCT01843751|297180|P1|NOT COMPLETED|Overall Study||11
121523|NCT01843751|297179|P2|COMPLETED|Overall Study||3
121524|NCT01843751|297180|P1|COMPLETED|Overall Study||0
121525|NCT01843751|297179|P2|STARTED|Overall Study||10
121526|NCT01843751|297180|P1|STARTED|Overall Study||11
121527|NCT01843673|297194|P1|NOT COMPLETED|Overall Study||6
121528|NCT01843673|297194|P1|COMPLETED|Overall Study||10
121529|NCT01843673|297194|P1|STARTED|Overall Study||16
121530|NCT01843660|297206|P1|NOT COMPLETED|Overall Study||30
121531|NCT01843660|297206|P1|COMPLETED|Overall Study||1029
121532|NCT01843660|297206|P1|STARTED|Overall Study||1059
121533|NCT01843621|297224|P1|NOT COMPLETED|Overall Study||0
121534|NCT01843621|297224|P1|COMPLETED|Overall Study||7
121535|NCT01843621|297224|P1|STARTED|Overall Study||7
121536|NCT01843465|297241|P1|NOT COMPLETED|Overall Study||0
121537|NCT01843465|297241|P1|COMPLETED|Overall Study||34
121538|NCT01843465|297241|P1|STARTED|Overall Study|This study had no follow-up. It focused in the acute setting of cryoballoon ablation.|34
121539|NCT01843374|297247|P2|NOT COMPLETED|Overall Study||379
121540|NCT01843374|297248|P1|NOT COMPLETED|Overall Study||189
121541|NCT01843374|297247|P2|COMPLETED|Overall Study||3
121542|NCT01843374|297248|P1|COMPLETED|Overall Study||0
121543|NCT01843374|297247|P2|RANDOMIZED|Overall Study||382
121544|NCT01843374|297248|P1|RANDOMIZED|Overall Study||189
121545|NCT01843374|297247|P2|STARTED|Overall Study||382
121546|NCT01843374|297248|P1|STARTED|Overall Study||189
121547|NCT01843348|297275|P3|NOT COMPLETED|Overall Study||41
121548|NCT01843348|297276|P2|NOT COMPLETED|Overall Study||40
121549|NCT01843348|297277|P1|NOT COMPLETED|Overall Study||23
121550|NCT01843348|297275|P3|COMPLETED|Overall Study||158
121551|NCT01843348|297276|P2|COMPLETED|Overall Study||168
121552|NCT01843348|297277|P1|COMPLETED|Overall Study||182
121553|NCT01843348|297275|P3|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|80
121554|NCT01843348|297276|P2|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|111
121555|NCT01843348|297277|P1|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|147
121556|NCT01843348|297275|P3|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|199
121557|NCT01843348|297276|P2|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|208
121558|NCT01843348|297277|P1|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|205
121559|NCT01843348|297275|P3|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|198
121560|NCT01843348|297276|P2|Safety Analysis Set (SAS)|Overall Study|Two participants received TAC + Certican in other arms in errorr - analyzed with TAC + Certican arm|210
121561|NCT01843348|297277|P1|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|204
121562|NCT01843348|297275|P3|STARTED|Overall Study||199
121563|NCT01843348|297276|P2|STARTED|Overall Study||208
121564|NCT01843348|297277|P1|STARTED|Overall Study||205
121565|NCT01843205|297317|P2|NOT COMPLETED|Second Treatment (11 Days)||0
121566|NCT01843205|297318|P1|NOT COMPLETED|Second Treatment (11 Days)||0
121567|NCT01843205|297317|P2|COMPLETED|Second Treatment (11 Days)||4
121568|NCT01843205|297318|P1|COMPLETED|Second Treatment (11 Days)||4
121569|NCT01843205|297317|P2|STARTED|Second Treatment (11 Days)||4
121570|NCT01843205|297318|P1|STARTED|Second Treatment (11 Days)||4
121571|NCT01843205|297317|P2|NOT COMPLETED|First Treatment (11 Days)||0
121572|NCT01843205|297318|P1|NOT COMPLETED|First Treatment (11 Days)||1
121573|NCT01843205|297317|P2|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to placebo for Condition 2.|4
121574|NCT01843205|297318|P1|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to buspirone for Condition 2.|4
121575|NCT01843205|297317|P2|STARTED|First Treatment (11 Days)||4
121576|NCT01843205|297318|P1|STARTED|First Treatment (11 Days)||5
121577|NCT01843192|297379|P3|NOT COMPLETED|Overall Study||2
121578|NCT01843192|297380|P2|NOT COMPLETED|Overall Study||6
121579|NCT01843192|297381|P1|NOT COMPLETED|Overall Study||2
121580|NCT01843192|297379|P3|COMPLETED|Overall Study||9
121581|NCT01843192|297380|P2|COMPLETED|Overall Study||28
121582|NCT01843192|297381|P1|COMPLETED|Overall Study||24
121583|NCT01843192|297379|P3|STARTED|Overall Study||11
121584|NCT01843192|297380|P2|STARTED|Overall Study||34
121585|NCT01843192|297381|P1|STARTED|Overall Study||26
121586|NCT01843062|297412|P2|NOT COMPLETED|Overall Study||9
121587|NCT01843062|297413|P1|NOT COMPLETED|Overall Study||22
121588|NCT01843062|297412|P2|COMPLETED|Overall Study||69
121589|NCT01843062|297413|P1|COMPLETED|Overall Study||133
121590|NCT01843062|297412|P2|Ongoing at Primary Analysis Data Cut-off|Overall Study||71
121591|NCT01843062|297413|P1|Ongoing at Primary Analysis Data Cut-off|Overall Study||134
121592|NCT01843062|297412|P2|BRAF/NRAS Mutation Positive Analysis Set|Overall Study||51
121593|NCT01843062|297413|P1|BRAF/NRAS Mutation Positive Analysis Set|Overall Study||91
121594|NCT01843062|297412|P2|Safety Analysis Set|Overall Study||77
121595|NCT01843062|297413|P1|Safety Analysis Set|Overall Study||154
121596|NCT01843062|297412|P2|Intention to Treat (ITT) Analysis Set|Overall Study||78
121597|NCT01843062|297413|P1|Intention to Treat (ITT) Analysis Set|Overall Study||155
121598|NCT01843062|297412|P2|STARTED|Overall Study||78
121599|NCT01843062|297413|P1|STARTED|Overall Study||155
121600|NCT01842958|297427|P2|NOT COMPLETED|Overall Study||1
121601|NCT01842958|297428|P1|NOT COMPLETED|Overall Study||1
121602|NCT01842958|297427|P2|COMPLETED|Overall Study||24
121603|NCT01842958|297428|P1|COMPLETED|Overall Study||24
121604|NCT01842958|297427|P2|Randomized|Overall Study||25
121605|NCT01842958|297428|P1|Randomized|Overall Study|One subject was randomized to 3.3 mm implant, but received the 4.1 mm implant.|25
121606|NCT01842958|297427|P2|STARTED|Overall Study||25
121607|NCT01842958|297428|P1|STARTED|Overall Study||25
121608|NCT01842906|297448|P2|NOT COMPLETED|Overall Study||0
121609|NCT01842906|297449|P1|NOT COMPLETED|Overall Study||0
121610|NCT01842906|297448|P2|COMPLETED|Overall Study||104
121611|NCT01842906|297449|P1|COMPLETED|Overall Study||115
121612|NCT01842906|297448|P2|STARTED|Overall Study||104
121613|NCT01842906|297449|P1|STARTED|Overall Study||115
121614|NCT01842841|297461|P1|NOT COMPLETED|Overall Study||0
121615|NCT01842841|297461|P1|COMPLETED|Overall Study||5
121616|NCT01842841|297461|P1|STARTED|Overall Study||5
121617|NCT01842789|297482|P2|NOT COMPLETED|Overall Study||0
121618|NCT01842789|297483|P1|NOT COMPLETED|Overall Study||0
121619|NCT01842789|297482|P2|COMPLETED|Overall Study||8
121620|NCT01842789|297483|P1|COMPLETED|Overall Study||10
121621|NCT01842789|297482|P2|STARTED|Overall Study||8
121622|NCT01842789|297483|P1|STARTED|Overall Study||10
121623|NCT01842646|297492|P1|NOT COMPLETED|Overall Study||0
121624|NCT01842646|297492|P1|COMPLETED|Overall Study||35
121625|NCT01842646|297492|P1|STARTED|Overall Study||35
121626|NCT01842633|297503|P3|NOT COMPLETED|Overall Study||0
121627|NCT01842633|297504|P2|NOT COMPLETED|Overall Study||2
121628|NCT01842633|297505|P1|NOT COMPLETED|Overall Study||3
121629|NCT01842633|297503|P3|COMPLETED|Overall Study||34
121630|NCT01842633|297504|P2|COMPLETED|Overall Study||64
121631|NCT01842633|297505|P1|COMPLETED|Overall Study||62
121632|NCT01842633|297503|P3|STARTED|Overall Study||34
121633|NCT01842633|297504|P2|STARTED|Overall Study||66
121634|NCT01842633|297505|P1|STARTED|Overall Study||65
121635|NCT01842620|297552|P2|NOT COMPLETED|Period 2||0
121636|NCT01842620|297553|P1|NOT COMPLETED|Period 2||0
121637|NCT01842620|297552|P2|COMPLETED|Period 2||12
121638|NCT01842620|297553|P1|COMPLETED|Period 2||12
121639|NCT01842620|297552|P2|STARTED|Period 2||12
121640|NCT01842620|297553|P1|STARTED|Period 2||12
121641|NCT01842620|297552|P2|NOT COMPLETED|Washout Period||0
121642|NCT01842620|297553|P1|NOT COMPLETED|Washout Period||0
121643|NCT01842620|297552|P2|COMPLETED|Washout Period||12
121644|NCT01842620|297553|P1|COMPLETED|Washout Period||12
121645|NCT01842620|297552|P2|STARTED|Washout Period||12
121646|NCT01842620|297553|P1|STARTED|Washout Period||12
121647|NCT01842620|297552|P2|NOT COMPLETED|Period 1||0
121648|NCT01842620|297553|P1|NOT COMPLETED|Period 1||1
121649|NCT01842620|297552|P2|COMPLETED|Period 1||12
121650|NCT01842620|297553|P1|COMPLETED|Period 1||12
121651|NCT01842620|297552|P2|STARTED|Period 1||12
121652|NCT01842620|297553|P1|STARTED|Period 1||13
121653|NCT01842607|297569|P1|NOT COMPLETED|Overall Study||66
121654|NCT01842607|297569|P1|COMPLETED|Overall Study||585
121655|NCT01842607|297569|P1|STARTED|Overall Study||651
121656|NCT01842594|297588|P1|NOT COMPLETED|Overall Study||3
121657|NCT01842594|297588|P1|COMPLETED|Overall Study||10
121658|NCT01842594|297588|P1|STARTED|Overall Study||13
121659|NCT01842581|297595|P2|NOT COMPLETED|Overall Study||30
121660|NCT01842581|297596|P1|NOT COMPLETED|Overall Study||44
121661|NCT01842581|297595|P2|COMPLETED|Overall Study||79
121662|NCT01842581|297596|P1|COMPLETED|Overall Study||69
121663|NCT01842581|297595|P2|Received at Least 1 Dose of Study Drug|Overall Study||108
121664|NCT01842581|297596|P1|Received at Least 1 Dose of Study Drug|Overall Study||113
121665|NCT01842581|297595|P2|STARTED|Overall Study||109
121666|NCT01842581|297596|P1|STARTED|Overall Study||113
121667|NCT01842464|297612|P1|NOT COMPLETED|Overall Study||0
121668|NCT01842464|297612|P1|COMPLETED|Overall Study||44
121669|NCT01842464|297612|P1|STARTED|Overall Study||44
121670|NCT01842438|297620|P2|NOT COMPLETED|T2: 6month Follow-up||4
121671|NCT01842438|297621|P1|NOT COMPLETED|T2: 6month Follow-up||4
121672|NCT01842438|297620|P2|COMPLETED|T2: 6month Follow-up||32
121673|NCT01842438|297621|P1|COMPLETED|T2: 6month Follow-up||32
121674|NCT01842438|297620|P2|STARTED|T2: 6month Follow-up||36
121675|NCT01842438|297621|P1|STARTED|T2: 6month Follow-up||36
121676|NCT01842438|297620|P2|NOT COMPLETED|T1: Immediately After the Intervention||8
121677|NCT01842438|297621|P1|NOT COMPLETED|T1: Immediately After the Intervention||6
121678|NCT01842438|297620|P2|COMPLETED|T1: Immediately After the Intervention||36
121679|NCT01842438|297621|P1|COMPLETED|T1: Immediately After the Intervention||36
121680|NCT01842438|297620|P2|STARTED|T1: Immediately After the Intervention||44
121681|NCT01842438|297621|P1|STARTED|T1: Immediately After the Intervention||42
121682|NCT01842334|297635|P2|NOT COMPLETED|Overall Study||4
121683|NCT01842334|297636|P1|NOT COMPLETED|Overall Study||3
121684|NCT01842334|297635|P2|COMPLETED|Overall Study||3
121685|NCT01842334|297636|P1|COMPLETED|Overall Study||2
121686|NCT01842334|297635|P2|STARTED|Overall Study||7
121687|NCT01842334|297636|P1|STARTED|Overall Study||5
121688|NCT01841970|297642|P1|NOT COMPLETED|Overall Study||11
121689|NCT01841970|297642|P1|COMPLETED|Overall Study||9
121690|NCT01841970|297642|P1|STARTED|Overall Study||20
121691|NCT01841931|297658|P1|NOT COMPLETED|Overall Study||4
121692|NCT01841931|297658|P1|COMPLETED|Overall Study|As the PI left the institution the study was terminated|0
121693|NCT01841931|297658|P1|STARTED|Overall Study||4
121694|NCT01841762|297666|P1|NOT COMPLETED|Post-Treatment Safety Follow-Up Period||15
121695|NCT01841762|297666|P1|COMPLETED|Post-Treatment Safety Follow-Up Period||269
121696|NCT01841762|297666|P1|STARTED|Post-Treatment Safety Follow-Up Period||284
121697|NCT01841762|297666|P1|NOT COMPLETED|Treatment Period||32
121698|NCT01841762|297666|P1|COMPLETED|Treatment Period||252
121699|NCT01841762|297666|P1|STARTED|Treatment Period||284
121700|NCT01841762|297666|P1|NOT COMPLETED|Screening Period||51
121701|NCT01841762|297666|P1|COMPLETED|Screening Period||284
121702|NCT01841762|297666|P1|STARTED|Screening Period||335
121703|NCT01841697|297676|P2|NOT COMPLETED|Overall Study||18
121704|NCT01841697|297677|P1|NOT COMPLETED|Overall Study||20
121705|NCT01841697|297676|P2|COMPLETED|Overall Study||302
121706|NCT01841697|297677|P1|COMPLETED|Overall Study||302
121707|NCT01841697|297676|P2|STARTED|Overall Study||320
121708|NCT01841697|297677|P1|STARTED|Overall Study||322
121709|NCT01841632|297693|P1|NOT COMPLETED|Overall Study||0
121710|NCT01841632|297693|P1|COMPLETED|Overall Study||3
121711|NCT01841632|297693|P1|STARTED|Overall Study||3
121712|NCT01841619|297698|P1|NOT COMPLETED|Overall Study||0
121713|NCT01841619|297698|P1|COMPLETED|Overall Study||16
121714|NCT01841619|297698|P1|STARTED|Overall Study||16
121715|NCT01841606|297708|P2|NOT COMPLETED|Overall Study||0
121716|NCT01841606|297709|P1|NOT COMPLETED|Overall Study||0
121717|NCT01841606|297708|P2|COMPLETED|Overall Study||27
121718|NCT01841606|297709|P1|COMPLETED|Overall Study||25
121719|NCT01841606|297708|P2|STARTED|Overall Study||27
121720|NCT01841606|297709|P1|STARTED|Overall Study||25
121721|NCT01841593|297717|P2|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
121722|NCT01841593|297718|P1|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
121723|NCT01841593|297717|P2|COMPLETED|Third Intervention (Days 15 to 21)||6
121724|NCT01841593|297718|P1|COMPLETED|Third Intervention (Days 15 to 21)||11
121725|NCT01841593|297717|P2|STARTED|Third Intervention (Days 15 to 21)||6
121726|NCT01841593|297718|P1|STARTED|Third Intervention (Days 15 to 21)||11
121727|NCT01841593|297717|P2|NOT COMPLETED|Second Intervention (Days 8 to 14)||0
121728|NCT01841593|297718|P1|NOT COMPLETED|Second Intervention (Days 8 to 14)||1
121729|NCT01841593|297717|P2|COMPLETED|Second Intervention (Days 8 to 14)||6
121730|NCT01841593|297718|P1|COMPLETED|Second Intervention (Days 8 to 14)||11
121731|NCT01841593|297717|P2|STARTED|Second Intervention (Days 8 to 14)||6
121732|NCT01841593|297718|P1|STARTED|Second Intervention (Days 8 to 14)||12
121733|NCT01841593|297717|P2|NOT COMPLETED|First Intervention (Days 1 to 7)||1
121734|NCT01841593|297718|P1|NOT COMPLETED|First Intervention (Days 1 to 7)||0
121735|NCT01841593|297717|P2|COMPLETED|First Intervention (Days 1 to 7)||6
121736|NCT01841593|297718|P1|COMPLETED|First Intervention (Days 1 to 7)||12
121737|NCT01841593|297717|P2|STARTED|First Intervention (Days 1 to 7)||7
121738|NCT01841593|297718|P1|STARTED|First Intervention (Days 1 to 7)||12
121739|NCT01841567|297734|P1|NOT COMPLETED|Overall Study||3
121740|NCT01841567|297734|P1|COMPLETED|Overall Study||57
121741|NCT01841567|297734|P1|STARTED|Overall Study||60
121742|NCT01841216|297741|P2|NOT COMPLETED|Overall Study||0
121743|NCT01841216|297742|P1|NOT COMPLETED|Overall Study||0
121744|NCT01841216|297741|P2|COMPLETED|Overall Study||15
121745|NCT01841216|297742|P1|COMPLETED|Overall Study||15
121746|NCT01841216|297741|P2|STARTED|Overall Study||15
121747|NCT01841216|297742|P1|STARTED|Overall Study||15
121748|NCT01841073|297752|P2|NOT COMPLETED|Overall Study||3
121749|NCT01841073|297753|P1|NOT COMPLETED|Overall Study||2
121750|NCT01841073|297752|P2|COMPLETED|Overall Study||19
121751|NCT01841073|297753|P1|COMPLETED|Overall Study||20
121752|NCT01841073|297752|P2|STARTED|Overall Study||22
121753|NCT01841073|297753|P1|STARTED|Overall Study||22
121754|NCT01841021|297763|P1|NOT COMPLETED|Overall Study||0
121755|NCT01841021|297763|P1|COMPLETED|Overall Study||1
121756|NCT01841021|297763|P1|STARTED|Overall Study||1
121757|NCT01840943|297775|P2|NOT COMPLETED|Overall Study||12
121758|NCT01840943|297776|P1|NOT COMPLETED|Overall Study||13
121759|NCT01840943|297775|P2|COMPLETED|Overall Study||0
121760|NCT01840943|297776|P1|COMPLETED|Overall Study||1
121761|NCT01840943|297775|P2|STARTED|Overall Study||12
121762|NCT01840943|297776|P1|STARTED|Overall Study||14
121763|NCT01840722|297812|P2|NOT COMPLETED|Overall Study||69
121764|NCT01840722|297813|P1|NOT COMPLETED|Overall Study||0
121765|NCT01840722|297812|P2|COMPLETED|Overall Study||130
121766|NCT01840722|297813|P1|COMPLETED|Overall Study||201
121767|NCT01840722|297812|P2|STARTED|Overall Study||199
121768|NCT01840722|297813|P1|STARTED|Overall Study||201
121769|NCT01840605|297825|P2|NOT COMPLETED|Overall Study||2
121770|NCT01840605|297826|P1|NOT COMPLETED|Overall Study||2
121771|NCT01840605|297825|P2|COMPLETED|Overall Study||150
121772|NCT01840605|297826|P1|COMPLETED|Overall Study||149
121773|NCT01840605|297825|P2|STARTED|Overall Study||152
121774|NCT01840605|297826|P1|STARTED|Overall Study||151
121775|NCT01840410|297840|P2|NOT COMPLETED|Overall Study||4
121776|NCT01840410|297841|P1|NOT COMPLETED|Overall Study||7
121777|NCT01840410|297840|P2|COMPLETED|Overall Study||55
121778|NCT01840410|297841|P1|COMPLETED|Overall Study||112
121779|NCT01840410|297840|P2|Full Analysis Set|Overall Study||59
121780|NCT01840410|297841|P1|Full Analysis Set|Overall Study||119
121781|NCT01840410|297840|P2|Safety Set|Overall Study|52 received ranibizumab at or after Month 2;7 did not receive ranibizumab any time during the study|59
121782|NCT01840410|297841|P1|Safety Set|Overall Study||119
121783|NCT01840410|297840|P2|STARTED|Overall Study||59
121784|NCT01840410|297841|P1|STARTED|Overall Study||119
121785|NCT01840345|297877|P1|NOT COMPLETED|Overall Study||1
121786|NCT01840345|297877|P1|COMPLETED|Overall Study||10
121787|NCT01840345|297877|P1|STARTED|Overall Study||11
121788|NCT01840319|297884|P1|NOT COMPLETED|Overall Study||0
121789|NCT01840319|297884|P1|COMPLETED|Overall Study||156
121790|NCT01840319|297884|P1|STARTED|Overall Study||156
121791|NCT01840228|297890|P2|NOT COMPLETED|Overall Study||1
121792|NCT01840228|297891|P1|NOT COMPLETED|Overall Study||1
121793|NCT01840228|297890|P2|COMPLETED|Overall Study||18
121794|NCT01840228|297891|P1|COMPLETED|Overall Study||18
121795|NCT01840228|297890|P2|STARTED|Overall Study||19
121796|NCT01840228|297891|P1|STARTED|Overall Study||19
121797|NCT01840163|297919|P2|NOT COMPLETED|Systemic Follow Up-secondary Outcome||75
121798|NCT01840163|297920|P1|NOT COMPLETED|Systemic Follow Up-secondary Outcome||91
121799|NCT01840163|297919|P2|COMPLETED|Systemic Follow Up-secondary Outcome||191
121800|NCT01840163|297920|P1|COMPLETED|Systemic Follow Up-secondary Outcome||174
121801|NCT01840163|297919|P2|STARTED|Systemic Follow Up-secondary Outcome|4 participants became unreachable and lost to follow up before sending 9 mo follow up|266
121802|NCT01840163|297920|P1|STARTED|Systemic Follow Up-secondary Outcome|From primary outcome to secondary outcome prd 1 participant withdrew and 1 became deceased|265
121803|NCT01840163|297919|P2|NOT COMPLETED|First Follow up -Primary Outcome||16
121804|NCT01840163|297920|P1|NOT COMPLETED|First Follow up -Primary Outcome||19
121805|NCT01840163|297919|P2|COMPLETED|First Follow up -Primary Outcome||254
121806|NCT01840163|297920|P1|COMPLETED|First Follow up -Primary Outcome||248
121807|NCT01840163|297919|P2|STARTED|First Follow up -Primary Outcome||270
121808|NCT01840163|297920|P1|STARTED|First Follow up -Primary Outcome||267
121809|NCT01840072|297942|P2|NOT COMPLETED|Overall Study||47
121810|NCT01840072|297943|P1|NOT COMPLETED|Overall Study||7
121811|NCT01840072|297942|P2|COMPLETED|Overall Study||1986
121812|NCT01840072|297943|P1|COMPLETED|Overall Study||2031
121813|NCT01840072|297942|P2|STARTED|Overall Study||2033
121814|NCT01840072|297943|P1|STARTED|Overall Study||2038
121815|NCT01839916|297965|P1|NOT COMPLETED|Overall Study||41
121816|NCT01839916|297965|P1|COMPLETED|Overall Study||36
121817|NCT01839916|297965|P1|STARTED|Overall Study||77
121818|NCT01839708|297976|P2|NOT COMPLETED|Overall Study||67
121819|NCT01839708|297977|P1|NOT COMPLETED|Overall Study||76
121820|NCT01839708|297976|P2|COMPLETED|Overall Study||115
121821|NCT01839708|297977|P1|COMPLETED|Overall Study||311
121822|NCT01839708|297976|P2|STARTED|Overall Study||182
121823|NCT01839708|297977|P1|STARTED|Overall Study||387
121824|NCT01839695|298009|P1|NOT COMPLETED|Overall Study||0
121825|NCT01839695|298009|P1|COMPLETED|Overall Study||9
121826|NCT01839695|298009|P1|STARTED|Overall Study||9
121827|NCT01839656|298016|P2|NOT COMPLETED|Overall Study||16
121828|NCT01839656|298017|P1|NOT COMPLETED|Overall Study||3
121829|NCT01839656|298016|P2|COMPLETED|Overall Study||0
121830|NCT01839656|298017|P1|COMPLETED|Overall Study||2
121831|NCT01839656|298016|P2|Completed Loading Dose Period|Overall Study||15
121832|NCT01839656|298017|P1|Completed Loading Dose Period|Overall Study||4
121833|NCT01839656|298016|P2|STARTED|Overall Study||16
121834|NCT01839656|298017|P1|STARTED|Overall Study||5
121835|NCT01839604|298044|P5|NOT COMPLETED|Overall Study||0
121836|NCT01839604|298045|P4|NOT COMPLETED|Overall Study||0
121837|NCT01839604|298046|P3|NOT COMPLETED|Overall Study||0
121838|NCT01839604|298047|P2|NOT COMPLETED|Overall Study||0
121839|NCT01839604|298048|P1|NOT COMPLETED|Overall Study||0
121840|NCT01839604|298044|P5|COMPLETED|Overall Study||15
121841|NCT01839604|298045|P4|COMPLETED|Overall Study||5
121842|NCT01839604|298046|P3|COMPLETED|Overall Study||7
121843|NCT01839604|298047|P2|COMPLETED|Overall Study||6
121844|NCT01839604|298048|P1|COMPLETED|Overall Study||6
121845|NCT01839604|298044|P5|STARTED|Overall Study||15
121846|NCT01839604|298045|P4|STARTED|Overall Study||5
121847|NCT01839604|298046|P3|STARTED|Overall Study||7
121848|NCT01839604|298047|P2|STARTED|Overall Study||6
121849|NCT01839604|298048|P1|STARTED|Overall Study||6
121850|NCT01839396|298077|P2|NOT COMPLETED|Overall Study||0
121851|NCT01839396|298078|P1|NOT COMPLETED|Overall Study||0
121852|NCT01839396|298077|P2|COMPLETED|Overall Study||39
121853|NCT01839396|298078|P1|COMPLETED|Overall Study||121
121854|NCT01839396|298077|P2|STARTED|Overall Study||39
121855|NCT01839396|298078|P1|STARTED|Overall Study||121
121856|NCT01839318|298086|P6|NOT COMPLETED|Period 3, Third Day of Wear||0
121857|NCT01839318|298087|P5|NOT COMPLETED|Period 3, Third Day of Wear||0
121858|NCT01839318|298088|P4|NOT COMPLETED|Period 3, Third Day of Wear||0
121859|NCT01839318|298089|P3|NOT COMPLETED|Period 3, Third Day of Wear||0
121860|NCT01839318|298090|P2|NOT COMPLETED|Period 3, Third Day of Wear||0
121861|NCT01839318|298091|P1|NOT COMPLETED|Period 3, Third Day of Wear||0
121862|NCT01839318|298086|P6|COMPLETED|Period 3, Third Day of Wear||2
121863|NCT01839318|298087|P5|COMPLETED|Period 3, Third Day of Wear||7
121864|NCT01839318|298088|P4|COMPLETED|Period 3, Third Day of Wear||6
121865|NCT01839318|298089|P3|COMPLETED|Period 3, Third Day of Wear||5
121866|NCT01839318|298090|P2|COMPLETED|Period 3, Third Day of Wear||4
121867|NCT01839318|298091|P1|COMPLETED|Period 3, Third Day of Wear||4
121868|NCT01839318|298086|P6|STARTED|Period 3, Third Day of Wear||2
121869|NCT01839318|298087|P5|STARTED|Period 3, Third Day of Wear||7
121870|NCT01839318|298088|P4|STARTED|Period 3, Third Day of Wear||6
121871|NCT01839318|298089|P3|STARTED|Period 3, Third Day of Wear||5
121872|NCT01839318|298090|P2|STARTED|Period 3, Third Day of Wear||4
121873|NCT01839318|298091|P1|STARTED|Period 3, Third Day of Wear||4
121874|NCT01839318|298086|P6|NOT COMPLETED|Period 2, Second Day of Wear||0
121875|NCT01839318|298087|P5|NOT COMPLETED|Period 2, Second Day of Wear||0
121876|NCT01839318|298088|P4|NOT COMPLETED|Period 2, Second Day of Wear||0
121877|NCT01839318|298089|P3|NOT COMPLETED|Period 2, Second Day of Wear||0
121878|NCT01839318|298090|P2|NOT COMPLETED|Period 2, Second Day of Wear||0
121879|NCT01839318|298091|P1|NOT COMPLETED|Period 2, Second Day of Wear||0
121880|NCT01839318|298086|P6|COMPLETED|Period 2, Second Day of Wear||2
121881|NCT01839318|298087|P5|COMPLETED|Period 2, Second Day of Wear||7
121882|NCT01839318|298088|P4|COMPLETED|Period 2, Second Day of Wear||6
121883|NCT01839318|298089|P3|COMPLETED|Period 2, Second Day of Wear||5
121884|NCT01839318|298090|P2|COMPLETED|Period 2, Second Day of Wear||4
121885|NCT01839318|298091|P1|COMPLETED|Period 2, Second Day of Wear||4
121886|NCT01839318|298086|P6|STARTED|Period 2, Second Day of Wear||2
121887|NCT01839318|298087|P5|STARTED|Period 2, Second Day of Wear||7
121888|NCT01839318|298088|P4|STARTED|Period 2, Second Day of Wear||6
121889|NCT01839318|298089|P3|STARTED|Period 2, Second Day of Wear||5
121890|NCT01839318|298090|P2|STARTED|Period 2, Second Day of Wear||4
121891|NCT01839318|298091|P1|STARTED|Period 2, Second Day of Wear||4
121892|NCT01839318|298086|P6|NOT COMPLETED|Period 1, First Day of Wear||0
121893|NCT01839318|298087|P5|NOT COMPLETED|Period 1, First Day of Wear||0
121894|NCT01839318|298088|P4|NOT COMPLETED|Period 1, First Day of Wear||0
121895|NCT01839318|298089|P3|NOT COMPLETED|Period 1, First Day of Wear||0
121896|NCT01839318|298090|P2|NOT COMPLETED|Period 1, First Day of Wear||0
121897|NCT01839318|298091|P1|NOT COMPLETED|Period 1, First Day of Wear||0
121898|NCT01839318|298086|P6|COMPLETED|Period 1, First Day of Wear||2
121899|NCT01839318|298087|P5|COMPLETED|Period 1, First Day of Wear||7
121900|NCT01839318|298088|P4|COMPLETED|Period 1, First Day of Wear||6
121901|NCT01839318|298089|P3|COMPLETED|Period 1, First Day of Wear||5
121902|NCT01839318|298090|P2|COMPLETED|Period 1, First Day of Wear||4
121903|NCT01839318|298091|P1|COMPLETED|Period 1, First Day of Wear||4
121904|NCT01839318|298086|P6|STARTED|Period 1, First Day of Wear||2
121905|NCT01839318|298087|P5|STARTED|Period 1, First Day of Wear||7
121906|NCT01839318|298088|P4|STARTED|Period 1, First Day of Wear||6
121907|NCT01839318|298089|P3|STARTED|Period 1, First Day of Wear||5
121908|NCT01839318|298090|P2|STARTED|Period 1, First Day of Wear||4
121909|NCT01839318|298091|P1|STARTED|Period 1, First Day of Wear||4
121910|NCT01839279|298105|P3|NOT COMPLETED|Overall Study||2
121911|NCT01839279|298106|P2|NOT COMPLETED|Overall Study||2
121912|NCT01839279|298107|P1|NOT COMPLETED|Overall Study||13
121913|NCT01839279|298105|P3|COMPLETED|Overall Study||30
121914|NCT01839279|298106|P2|COMPLETED|Overall Study||30
121915|NCT01839279|298107|P1|COMPLETED|Overall Study||59
121916|NCT01839279|298105|P3|PK/QTc Analysis Set|Overall Study||0
121917|NCT01839279|298106|P2|PK/QTc Analysis Set|Overall Study||0
121918|NCT01839279|298107|P1|PK/QTc Analysis Set|Overall Study||70
121919|NCT01839279|298105|P3|Moxifloxacin/Placebo Analysis Set|Overall Study||30
121920|NCT01839279|298106|P2|Moxifloxacin/Placebo Analysis Set|Overall Study||31
121921|NCT01839279|298107|P1|Moxifloxacin/Placebo Analysis Set|Overall Study||0
121922|NCT01839279|298105|P3|PK Analysis Set|Overall Study||0
121923|NCT01839279|298106|P2|PK Analysis Set|Overall Study||0
121924|NCT01839279|298107|P1|PK Analysis Set|Overall Study||70
121925|NCT01839279|298105|P3|QT/QTc Analysis Set|Overall Study||32
121926|NCT01839279|298106|P2|QT/QTc Analysis Set|Overall Study||32
121927|NCT01839279|298107|P1|QT/QTc Analysis Set|Overall Study||72
121928|NCT01839279|298105|P3|STARTED|Overall Study||32
121929|NCT01839279|298106|P2|STARTED|Overall Study||32
121930|NCT01839279|298107|P1|STARTED|Overall Study||72
121931|NCT01839188|298126|P1|NOT COMPLETED|Overall Study||1
121932|NCT01839188|298126|P1|COMPLETED|Overall Study|N=1 treated participant withdrew before receiving V3|384
121933|NCT01839188|298126|P1|Treated|Overall Study||385
121934|NCT01839188|298126|P1|STARTED|Overall Study||385
121935|NCT01839110|298169|P3|NOT COMPLETED|Overall Study||3
121936|NCT01839110|298170|P2|NOT COMPLETED|Overall Study||2
121937|NCT01839110|298171|P1|NOT COMPLETED|Overall Study||3
121938|NCT01839110|298169|P3|COMPLETED|Overall Study||6
121939|NCT01839110|298170|P2|COMPLETED|Overall Study||4
121940|NCT01839110|298171|P1|COMPLETED|Overall Study||4
121941|NCT01839110|298169|P3|STARTED|Overall Study||9
121942|NCT01839110|298170|P2|STARTED|Overall Study||6
121943|NCT01839110|298171|P1|STARTED|Overall Study||7
121944|NCT01839058|298181|P2|NOT COMPLETED|Overall Study||3
121945|NCT01839058|298182|P1|NOT COMPLETED|Overall Study||4
121946|NCT01839058|298181|P2|COMPLETED|Overall Study||16
121947|NCT01839058|298182|P1|COMPLETED|Overall Study||17
121948|NCT01839058|298181|P2|STARTED|Overall Study||19
121949|NCT01839058|298182|P1|STARTED|Overall Study||21
121950|NCT01838980|298194|P1|NOT COMPLETED|Overall Study||0
121951|NCT01838980|298194|P1|COMPLETED|Overall Study||15
121952|NCT01838980|298194|P1|STARTED|Overall Study||15
121953|NCT01838941|298198|P1|NOT COMPLETED|Overall Study||2
121954|NCT01838941|298198|P1|COMPLETED|Overall Study||10
121955|NCT01838941|298198|P1|STARTED|Overall Study||12
121956|NCT01838876|298203|P1|NOT COMPLETED|Overall Study||233
121957|NCT01838876|298203|P1|COMPLETED|Overall Study||209
121958|NCT01838876|298203|P1|Entered Safety Follow-up Period|Overall Study||287
122051|NCT01838447|298557|P1|NOT COMPLETED|Overall Study||2
121959|NCT01838876|298203|P1|Safety Population; Received Study Drug|Overall Study||345
121960|NCT01838876|298203|P1|STARTED|Overall Study||442
121961|NCT01838863|298218|P2|NOT COMPLETED|Overall Study||9
121962|NCT01838863|298219|P1|NOT COMPLETED|Overall Study||10
121963|NCT01838863|298218|P2|COMPLETED|Overall Study||60
121964|NCT01838863|298219|P1|COMPLETED|Overall Study||65
121965|NCT01838863|298218|P2|STARTED|Overall Study||69
121966|NCT01838863|298219|P1|STARTED|Overall Study||75
121967|NCT01838785|298305|P1|NOT COMPLETED|Overall Study||0
121968|NCT01838785|298305|P1|COMPLETED|Overall Study||25
121969|NCT01838785|298305|P1|STARTED|Overall Study||25
121970|NCT01838694|298312|P2|NOT COMPLETED|Overall Study||1
121971|NCT01838694|298313|P1|NOT COMPLETED|Overall Study||0
121972|NCT01838694|298312|P2|COMPLETED|Overall Study||21
121973|NCT01838694|298313|P1|COMPLETED|Overall Study||8
121974|NCT01838694|298312|P2|STARTED|Overall Study||22
121975|NCT01838694|298313|P1|STARTED|Overall Study||8
121976|NCT01838681|298322|P4|NOT COMPLETED|Period B/A+||117
121977|NCT01838681|298323|P3|NOT COMPLETED|Period B/A+||95
121978|NCT01838681|298324|P2|NOT COMPLETED|Period B/A+||62
121979|NCT01838681|298325|P1|NOT COMPLETED|Period B/A+||0
121980|NCT01838681|298322|P4|COMPLETED|Period B/A+||653
121981|NCT01838681|298323|P3|COMPLETED|Period B/A+||349
121982|NCT01838681|298324|P2|COMPLETED|Period B/A+||380
121983|NCT01838681|298325|P1|COMPLETED|Period B/A+||0
121984|NCT01838681|298322|P4|STARTED|Period B/A+||770
121985|NCT01838681|298323|P3|STARTED|Period B/A+||444
121986|NCT01838681|298324|P2|STARTED|Period B/A+||442
121987|NCT01838681|298325|P1|STARTED|Period B/A+||0
121988|NCT01838681|298322|P4|NOT COMPLETED|Period A||0
121989|NCT01838681|298323|P3|NOT COMPLETED|Period A||0
121990|NCT01838681|298324|P2|NOT COMPLETED|Period A||0
121991|NCT01838681|298325|P1|NOT COMPLETED|Period A||325
121992|NCT01838681|298322|P4|COMPLETED|Period A||0
121993|NCT01838681|298323|P3|COMPLETED|Period A||0
121994|NCT01838681|298324|P2|COMPLETED|Period A||0
121995|NCT01838681|298325|P1|COMPLETED|Period A||1661
121996|NCT01838681|298322|P4|STARTED|Period A||0
121997|NCT01838681|298323|P3|STARTED|Period A||0
121998|NCT01838681|298324|P2|STARTED|Period A||0
121999|NCT01838681|298325|P1|STARTED|Period A||1986
122000|NCT01838655|298365|P1|NOT COMPLETED|Overall Study||0
122001|NCT01838655|298365|P1|COMPLETED|Overall Study||5
122002|NCT01838655|298365|P1|STARTED|Overall Study||5
122003|NCT01838642|298433|P1|NOT COMPLETED|Overall Study||1
122004|NCT01838642|298433|P1|COMPLETED|Overall Study||2
122005|NCT01838642|298433|P1|STARTED|Overall Study||3
122006|NCT01838616|298446|P2|NOT COMPLETED|Pick-up Arm||0
122007|NCT01838616|298447|P1|NOT COMPLETED|Pick-up Arm||15
122008|NCT01838616|298446|P2|COMPLETED|Pick-up Arm||0
122009|NCT01838616|298447|P1|COMPLETED|Pick-up Arm|Participants completed the tapentadol pick-up arm after initially on oxycodone/naloxone PR treatment|35
122010|NCT01838616|298446|P2|Full Analysis Set|Pick-up Arm||0
122011|NCT01838616|298447|P1|Full Analysis Set|Pick-up Arm||49
122012|NCT01838616|298446|P2|STARTED|Pick-up Arm||0
122013|NCT01838616|298447|P1|STARTED|Pick-up Arm|Switch to Tapentadol (PR) after Oxycodone/Naloxone (PR) treatment discontinuation.|50
122014|NCT01838616|298446|P2|NOT COMPLETED|Continuation Period||14
122015|NCT01838616|298447|P1|NOT COMPLETED|Continuation Period||14
122016|NCT01838616|298446|P2|COMPLETED|Continuation Period||48
122017|NCT01838616|298447|P1|COMPLETED|Continuation Period||86
122018|NCT01838616|298446|P2|Switched to Pick-up Arm|Continuation Period||7
122019|NCT01838616|298447|P1|Switched to Pick-up Arm|Continuation Period||0
122020|NCT01838616|298446|P2|STARTED|Continuation Period||62
122021|NCT01838616|298447|P1|STARTED|Continuation Period||100
122022|NCT01838616|298446|P2|NOT COMPLETED|Titration Period||66
122023|NCT01838616|298447|P1|NOT COMPLETED|Titration Period||30
122024|NCT01838616|298446|P2|COMPLETED|Titration Period||62
122025|NCT01838616|298447|P1|COMPLETED|Titration Period||100
122026|NCT01838616|298446|P2|Per Protocol Set|Titration Period||112
122027|NCT01838616|298447|P1|Per Protocol Set|Titration Period||117
122028|NCT01838616|298446|P2|Full Analysis Set|Titration Period||128
122029|NCT01838616|298447|P1|Full Analysis Set|Titration Period||130
122030|NCT01838616|298446|P2|Switched to Pick-up Arm|Titration Period||43
122031|NCT01838616|298447|P1|Switched to Pick-up Arm|Titration Period||0
122032|NCT01838616|298446|P2|Major Protocol Deviations|Titration Period||16
122033|NCT01838616|298447|P1|Major Protocol Deviations|Titration Period||13
122034|NCT01838616|298446|P2|No Post Baseline Pain Intensity Values|Titration Period||2
122035|NCT01838616|298447|P1|No Post Baseline Pain Intensity Values|Titration Period||0
122036|NCT01838616|298446|P2|STARTED|Titration Period||128
122037|NCT01838616|298447|P1|STARTED|Titration Period||130
122038|NCT01838590|298518|P2|NOT COMPLETED|Overall Study||5
122039|NCT01838590|298519|P1|NOT COMPLETED|Overall Study||12
122040|NCT01838590|298518|P2|COMPLETED|Overall Study||46
122041|NCT01838590|298519|P1|COMPLETED|Overall Study||40
122042|NCT01838590|298518|P2|STARTED|Overall Study||51
122043|NCT01838590|298519|P1|STARTED|Overall Study||52
122044|NCT01838499|298543|P2|NOT COMPLETED|Overall Study||17
122045|NCT01838499|298544|P1|NOT COMPLETED|Overall Study||24
122046|NCT01838499|298543|P2|COMPLETED|Overall Study||37
122047|NCT01838499|298544|P1|COMPLETED|Overall Study||31
122048|NCT01838499|298543|P2|STARTED|Overall Study||54
122049|NCT01838499|298544|P1|STARTED|Overall Study||55
122050|NCT01838447|298556|P2|NOT COMPLETED|Overall Study||3
122052|NCT01838447|298556|P2|COMPLETED|Overall Study||21
122053|NCT01838447|298557|P1|COMPLETED|Overall Study||20
122054|NCT01838447|298556|P2|STARTED|Overall Study||24
122055|NCT01838447|298557|P1|STARTED|Overall Study||22
122056|NCT01838304|298577|P2|NOT COMPLETED|Overall Study||0
122057|NCT01838304|298578|P1|NOT COMPLETED|Overall Study||1
122058|NCT01838304|298577|P2|COMPLETED|Overall Study||20
122059|NCT01838304|298578|P1|COMPLETED|Overall Study||19
122060|NCT01838304|298577|P2|STARTED|Overall Study||20
122061|NCT01838304|298578|P1|STARTED|Overall Study||20
122062|NCT01838213|298592|P2|NOT COMPLETED|Overall Study||191
122063|NCT01838213|298593|P1|NOT COMPLETED|Overall Study||166
122064|NCT01838213|298592|P2|COMPLETED|Overall Study||262
122065|NCT01838213|298593|P1|COMPLETED|Overall Study||81
122066|NCT01838213|298592|P2|STARTED|Overall Study||453
122067|NCT01838213|298593|P1|STARTED|Overall Study||247
122068|NCT01838200|298601|P2|NOT COMPLETED|Overall Study||2
122069|NCT01838200|298602|P1|NOT COMPLETED|Overall Study||3
122070|NCT01838200|298601|P2|COMPLETED|Overall Study||0
122071|NCT01838200|298602|P1|COMPLETED|Overall Study||0
122072|NCT01838200|298601|P2|STARTED|Overall Study||2
122073|NCT01838200|298602|P1|STARTED|Overall Study||3
122074|NCT01838044|298614|P2|NOT COMPLETED|Overall Study||16
122075|NCT01838044|298615|P1|NOT COMPLETED|Overall Study||8
122076|NCT01838044|298614|P2|COMPLETED|Overall Study||75
122077|NCT01838044|298615|P1|COMPLETED|Overall Study||81
122078|NCT01838044|298614|P2|STARTED|Overall Study||91
122079|NCT01838044|298615|P1|STARTED|Overall Study||89
122080|NCT01837966|298648|P2|NOT COMPLETED|Overall Study||1
122081|NCT01837966|298649|P1|NOT COMPLETED|Overall Study||2
122082|NCT01837966|298648|P2|COMPLETED|Overall Study||45
122083|NCT01837966|298649|P1|COMPLETED|Overall Study||45
122084|NCT01837966|298648|P2|STARTED|Overall Study||46
122085|NCT01837966|298649|P1|STARTED|Overall Study||47
122086|NCT01837823|298655|P1|NOT COMPLETED|Overall Study||6
122087|NCT01837823|298655|P1|COMPLETED|Overall Study||85
122088|NCT01837823|298655|P1|STARTED|Overall Study||91
122089|NCT01837797|298686|P5|NOT COMPLETED|Period 3||23
122090|NCT01837797|298687|P4|NOT COMPLETED|Period 3||0
122091|NCT01837797|298688|P3|NOT COMPLETED|Period 3||0
122092|NCT01837797|298689|P2|NOT COMPLETED|Period 3||0
122093|NCT01837797|298690|P1|NOT COMPLETED|Period 3||0
122094|NCT01837797|298686|P5|COMPLETED|Period 3||24
122095|NCT01837797|298687|P4|COMPLETED|Period 3||0
122096|NCT01837797|298688|P3|COMPLETED|Period 3||0
122097|NCT01837797|298689|P2|COMPLETED|Period 3||0
122098|NCT01837797|298690|P1|COMPLETED|Period 3||0
122099|NCT01837797|298686|P5|STARTED|Period 3||47
122100|NCT01837797|298687|P4|STARTED|Period 3||0
122101|NCT01837797|298688|P3|STARTED|Period 3||0
122102|NCT01837797|298689|P2|STARTED|Period 3||0
122103|NCT01837797|298690|P1|STARTED|Period 3||0
122104|NCT01837797|298686|P5|NOT COMPLETED|Period 2||0
122105|NCT01837797|298687|P4|NOT COMPLETED|Period 2||5
122106|NCT01837797|298688|P3|NOT COMPLETED|Period 2||2
122107|NCT01837797|298689|P2|NOT COMPLETED|Period 2||5
122108|NCT01837797|298690|P1|NOT COMPLETED|Period 2||0
122109|NCT01837797|298686|P5|COMPLETED|Period 2||0
122110|NCT01837797|298687|P4|COMPLETED|Period 2||1
122111|NCT01837797|298688|P3|COMPLETED|Period 2||1
122112|NCT01837797|298689|P2|COMPLETED|Period 2||1
122113|NCT01837797|298690|P1|COMPLETED|Period 2||0
122114|NCT01837797|298686|P5|STARTED|Period 2||0
122115|NCT01837797|298687|P4|STARTED|Period 2||6
122116|NCT01837797|298688|P3|STARTED|Period 2||3
122117|NCT01837797|298689|P2|STARTED|Period 2||6
122118|NCT01837797|298690|P1|STARTED|Period 2||0
122119|NCT01837797|298686|P5|NOT COMPLETED|Period 1||0
122120|NCT01837797|298687|P4|NOT COMPLETED|Period 1||0
122121|NCT01837797|298688|P3|NOT COMPLETED|Period 1||0
122122|NCT01837797|298689|P2|NOT COMPLETED|Period 1||0
122123|NCT01837797|298690|P1|NOT COMPLETED|Period 1||102
122124|NCT01837797|298686|P5|COMPLETED|Period 1||0
122125|NCT01837797|298687|P4|COMPLETED|Period 1||0
122126|NCT01837797|298688|P3|COMPLETED|Period 1||0
122127|NCT01837797|298689|P2|COMPLETED|Period 1||0
122128|NCT01837797|298690|P1|COMPLETED|Period 1||27
122129|NCT01837797|298686|P5|STARTED|Period 1||0
122130|NCT01837797|298687|P4|STARTED|Period 1||0
122131|NCT01837797|298688|P3|STARTED|Period 1||0
122132|NCT01837797|298689|P2|STARTED|Period 1||0
122133|NCT01837797|298690|P1|STARTED|Period 1||129
122134|NCT01837719|298725|P1|NOT COMPLETED|Period 5: Days 29-31 (Treatment E)||1
122135|NCT01837719|298725|P1|COMPLETED|Period 5: Days 29-31 (Treatment E)||30
122136|NCT01837719|298725|P1|STARTED|Period 5: Days 29-31 (Treatment E)|Reflects the 31 patients remaining after 32 were discharged at the end of Period 4, as per protocol|31
122137|NCT01837719|298725|P1|NOT COMPLETED|Period 4: Days 22-28 (Treatment D or C)||0
122138|NCT01837719|298725|P1|COMPLETED|Period 4: Days 22-28 (Treatment D or C)|Number finishing period; 32 patients were discharged following Period 4, as per protocol|63
122139|NCT01837719|298725|P1|STARTED|Period 4: Days 22-28 (Treatment D or C)||63
122140|NCT01837719|298725|P1|NOT COMPLETED|Period 3: Days 15-21 (Treatment C or D)||0
122141|NCT01837719|298725|P1|COMPLETED|Period 3: Days 15-21 (Treatment C or D)||63
122142|NCT01837719|298725|P1|STARTED|Period 3: Days 15-21 (Treatment C or D)||63
122143|NCT01837719|298725|P1|NOT COMPLETED|Period 2: Days 8-14 (Treatment B or A)||1
122144|NCT01837719|298725|P1|COMPLETED|Period 2: Days 8-14 (Treatment B or A)||63
122145|NCT01837719|298725|P1|STARTED|Period 2: Days 8-14 (Treatment B or A)||64
122146|NCT01837719|298725|P1|NOT COMPLETED|Period 1: Days 1-7 (Treatment A or B)||0
122147|NCT01837719|298725|P1|COMPLETED|Period 1: Days 1-7 (Treatment A or B)||64
122148|NCT01837719|298725|P1|STARTED|Period 1: Days 1-7 (Treatment A or B)|Received treatment|64
122149|NCT01837680|298794|P2|NOT COMPLETED|Overall Study||8
122150|NCT01837680|298795|P1|NOT COMPLETED|Overall Study||10
122151|NCT01837680|298794|P2|COMPLETED|Overall Study||45
122152|NCT01837680|298795|P1|COMPLETED|Overall Study||42
122153|NCT01837680|298794|P2|STARTED|Overall Study||53
122154|NCT01837680|298795|P1|STARTED|Overall Study||52
122155|NCT01837654|298833|P2|NOT COMPLETED|Overall Study||0
122156|NCT01837654|298834|P1|NOT COMPLETED|Overall Study||0
122157|NCT01837654|298833|P2|COMPLETED|Overall Study||11
122158|NCT01837654|298834|P1|COMPLETED|Overall Study||11
122159|NCT01837654|298833|P2|STARTED|Overall Study||11
122160|NCT01837654|298834|P1|STARTED|Overall Study||11
122161|NCT01837550|298844|P2|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
122162|NCT01837550|298845|P1|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
122163|NCT01837550|298844|P2|COMPLETED|T0-T2, 6 Months Follow-up||37
122164|NCT01837550|298845|P1|COMPLETED|T0-T2, 6 Months Follow-up||37
122165|NCT01837550|298844|P2|STARTED|T0-T2, 6 Months Follow-up||37
122166|NCT01837550|298845|P1|STARTED|T0-T2, 6 Months Follow-up||37
122167|NCT01837550|298844|P2|NOT COMPLETED|T0-T1, 5 Weeks||0
122168|NCT01837550|298845|P1|NOT COMPLETED|T0-T1, 5 Weeks||0
122169|NCT01837550|298844|P2|COMPLETED|T0-T1, 5 Weeks||37
122170|NCT01837550|298845|P1|COMPLETED|T0-T1, 5 Weeks||37
122171|NCT01837550|298844|P2|STARTED|T0-T1, 5 Weeks||37
122172|NCT01837550|298845|P1|STARTED|T0-T1, 5 Weeks||37
122173|NCT01837537|298857|P1|NOT COMPLETED|Overall Study||0
122174|NCT01837537|298857|P1|COMPLETED|Overall Study||90
122175|NCT01837537|298857|P1|STARTED|Overall Study||90
122176|NCT01837524|298864|P2|NOT COMPLETED|Overall Study||2
122177|NCT01837524|298865|P1|NOT COMPLETED|Overall Study||3
122178|NCT01837524|298864|P2|COMPLETED|Overall Study||25
122179|NCT01837524|298865|P1|COMPLETED|Overall Study||25
122180|NCT01837524|298864|P2|STARTED|Overall Study||27
122181|NCT01837524|298865|P1|STARTED|Overall Study||28
122182|NCT01836809|298875|P4|NOT COMPLETED|Overall Study||2
122183|NCT01836809|298876|P3|NOT COMPLETED|Overall Study||0
122184|NCT01836809|298877|P2|NOT COMPLETED|Overall Study||0
122185|NCT01836809|298878|P1|NOT COMPLETED|Overall Study||0
122186|NCT01836809|298875|P4|COMPLETED|Overall Study||0
122187|NCT01836809|298876|P3|COMPLETED|Overall Study||0
122188|NCT01836809|298877|P2|COMPLETED|Overall Study||0
122189|NCT01836809|298878|P1|COMPLETED|Overall Study||0
122190|NCT01836809|298875|P4|STARTED|Overall Study||2
122191|NCT01836809|298876|P3|STARTED|Overall Study||0
122192|NCT01836809|298877|P2|STARTED|Overall Study||0
122193|NCT01836809|298878|P1|STARTED|Overall Study||0
122194|NCT01836549|298914|P7|NOT COMPLETED|Overall Study||1
122195|NCT01836549|298915|P6|NOT COMPLETED|Overall Study||0
122196|NCT01836549|298916|P5|NOT COMPLETED|Overall Study||0
122197|NCT01836549|298917|P4|NOT COMPLETED|Overall Study||1
122198|NCT01836549|298918|P3|NOT COMPLETED|Overall Study||1
122199|NCT01836549|298919|P2|NOT COMPLETED|Overall Study||0
122200|NCT01836549|298920|P1|NOT COMPLETED|Overall Study||0
122201|NCT01836549|298914|P7|COMPLETED|Overall Study||8
122202|NCT01836549|298915|P6|COMPLETED|Overall Study||4
122203|NCT01836549|298916|P5|COMPLETED|Overall Study||18
122204|NCT01836549|298917|P4|COMPLETED|Overall Study||8
122205|NCT01836549|298918|P3|COMPLETED|Overall Study||0
122206|NCT01836549|298919|P2|COMPLETED|Overall Study||1
122207|NCT01836549|298920|P1|COMPLETED|Overall Study||1
122208|NCT01836549|298914|P7|STARTED|Overall Study||9
122209|NCT01836549|298915|P6|STARTED|Overall Study||4
122210|NCT01836549|298916|P5|STARTED|Overall Study||18
122211|NCT01836549|298917|P4|STARTED|Overall Study||9
122212|NCT01836549|298918|P3|STARTED|Overall Study||1
122213|NCT01836549|298919|P2|STARTED|Overall Study||1
122214|NCT01836549|298920|P1|STARTED|Overall Study||1
122215|NCT01836523|298944|P4|NOT COMPLETED|Overall Study||74
122216|NCT01836523|298945|P3|NOT COMPLETED|Overall Study||91
122217|NCT01836523|298946|P2|NOT COMPLETED|Overall Study||85
122218|NCT01836523|298947|P1|NOT COMPLETED|Overall Study||51
122219|NCT01836523|298944|P4|COMPLETED|Overall Study||274
122220|NCT01836523|298945|P3|COMPLETED|Overall Study||258
122221|NCT01836523|298946|P2|COMPLETED|Overall Study||265
122222|NCT01836523|298947|P1|COMPLETED|Overall Study||300
122223|NCT01836523|298944|P4|Exposed|Overall Study||348
122224|NCT01836523|298945|P3|Exposed|Overall Study||347
122225|NCT01836523|298946|P2|Exposed|Overall Study||348
122226|NCT01836523|298947|P1|Exposed|Overall Study||350
122227|NCT01836523|298944|P4|STARTED|Overall Study||348
122228|NCT01836523|298945|P3|STARTED|Overall Study||349
122229|NCT01836523|298946|P2|STARTED|Overall Study||350
122230|NCT01836523|298947|P1|STARTED|Overall Study||351
122231|NCT01836471|298974|P5|NOT COMPLETED|Overall Study||5
122232|NCT01836471|298975|P4|NOT COMPLETED|Overall Study||2
122233|NCT01836471|298976|P3|NOT COMPLETED|Overall Study||2
122234|NCT01836471|298977|P2|NOT COMPLETED|Overall Study||9
122235|NCT01836471|298978|P1|NOT COMPLETED|Overall Study||11
122236|NCT01836471|298974|P5|COMPLETED|Overall Study||49
122237|NCT01836471|298975|P4|COMPLETED|Overall Study||40
122238|NCT01836471|298976|P3|COMPLETED|Overall Study||49
122239|NCT01836471|298977|P2|COMPLETED|Overall Study||85
122240|NCT01836471|298978|P1|COMPLETED|Overall Study||82
122241|NCT01836471|298974|P5|STARTED|Overall Study||54
122242|NCT01836471|298975|P4|STARTED|Overall Study||42
122243|NCT01836471|298976|P3|STARTED|Overall Study||51
122244|NCT01836471|298977|P2|STARTED|Overall Study||94
122245|NCT01836471|298978|P1|STARTED|Overall Study||93
122246|NCT01836458|299007|P4|NOT COMPLETED|Overall Study||6
122247|NCT01836458|299008|P3|NOT COMPLETED|Overall Study||5
122248|NCT01836458|299009|P2|NOT COMPLETED|Overall Study||2
122249|NCT01836458|299010|P1|NOT COMPLETED|Overall Study||3
122250|NCT01836458|299007|P4|COMPLETED|Overall Study||1
122251|NCT01836458|299008|P3|COMPLETED|Overall Study||2
122252|NCT01836458|299009|P2|COMPLETED|Overall Study||2
122253|NCT01836458|299010|P1|COMPLETED|Overall Study||4
122254|NCT01836458|299007|P4|STARTED|Overall Study||7
122255|NCT01836458|299008|P3|STARTED|Overall Study||7
122256|NCT01836458|299009|P2|STARTED|Overall Study||4
122257|NCT01836458|299010|P1|STARTED|Overall Study||7
122258|NCT01836445|299034|P2|NOT COMPLETED|12 Month STI Testing||77
122259|NCT01836445|299035|P1|NOT COMPLETED|12 Month STI Testing||80
122260|NCT01836445|299034|P2|COMPLETED|12 Month STI Testing||378
122261|NCT01836445|299035|P1|COMPLETED|12 Month STI Testing||365
122262|NCT01836445|299034|P2|STARTED|12 Month STI Testing|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
122263|NCT01836445|299035|P1|STARTED|12 Month STI Testing|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
122264|NCT01836445|299034|P2|NOT COMPLETED|12 Month Follow-up Assessment||64
122265|NCT01836445|299035|P1|NOT COMPLETED|12 Month Follow-up Assessment||75
122266|NCT01836445|299034|P2|COMPLETED|12 Month Follow-up Assessment||391
122267|NCT01836445|299035|P1|COMPLETED|12 Month Follow-up Assessment||370
122268|NCT01836445|299034|P2|STARTED|12 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
122269|NCT01836445|299035|P1|STARTED|12 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
122270|NCT01836445|299034|P2|NOT COMPLETED|6 Month Follow-up Assessment||75
122271|NCT01836445|299035|P1|NOT COMPLETED|6 Month Follow-up Assessment||103
122272|NCT01836445|299034|P2|COMPLETED|6 Month Follow-up Assessment||380
122273|NCT01836445|299035|P1|COMPLETED|6 Month Follow-up Assessment||342
122274|NCT01836445|299034|P2|STARTED|6 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
122275|NCT01836445|299035|P1|STARTED|6 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
122276|NCT01836445|299034|P2|NOT COMPLETED|3 Month Follow-up Assessment||47
122277|NCT01836445|299035|P1|NOT COMPLETED|3 Month Follow-up Assessment||97
122278|NCT01836445|299034|P2|COMPLETED|3 Month Follow-up Assessment||409
122279|NCT01836445|299035|P1|COMPLETED|3 Month Follow-up Assessment||348
122280|NCT01836445|299034|P2|STARTED|3 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|456
122281|NCT01836445|299035|P1|STARTED|3 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
122282|NCT01836445|299034|P2|NOT COMPLETED|Intervention Modules||22
122283|NCT01836445|299035|P1|NOT COMPLETED|Intervention Modules||70
122284|NCT01836445|299034|P2|COMPLETED|Intervention Modules||434
122285|NCT01836445|299035|P1|COMPLETED|Intervention Modules||375
122286|NCT01836445|299034|P2|STARTED|Intervention Modules||456
122287|NCT01836445|299035|P1|STARTED|Intervention Modules||445
122288|NCT01836276|299095|P2|NOT COMPLETED|Overall Study||51
122289|NCT01836276|299096|P1|NOT COMPLETED|Overall Study||28
122290|NCT01836276|299095|P2|COMPLETED|Overall Study||174
122291|NCT01836276|299096|P1|COMPLETED|Overall Study||196
122292|NCT01836276|299095|P2|Week 12|Overall Study||165
122293|NCT01836276|299096|P1|Week 12|Overall Study||183
122294|NCT01836276|299095|P2|Week 4|Overall Study||186
122295|NCT01836276|299096|P1|Week 4|Overall Study||198
122296|NCT01836276|299095|P2|STARTED|Overall Study||225
122297|NCT01836276|299096|P1|STARTED|Overall Study||224
122298|NCT01836198|299104|P3|NOT COMPLETED|Part B||0
122299|NCT01836198|299105|P2|NOT COMPLETED|Part B||0
122300|NCT01836198|299106|P1|NOT COMPLETED|Part B||0
122301|NCT01836198|299104|P3|COMPLETED|Part B||12
122302|NCT01836198|299105|P2|COMPLETED|Part B||0
122303|NCT01836198|299106|P1|COMPLETED|Part B||0
122304|NCT01836198|299104|P3|Received at Least 1 Dose of Study Drug|Part B||12
122305|NCT01836198|299105|P2|Received at Least 1 Dose of Study Drug|Part B||0
122306|NCT01836198|299106|P1|Received at Least 1 Dose of Study Drug|Part B||0
122307|NCT01836198|299104|P3|STARTED|Part B||12
122308|NCT01836198|299105|P2|STARTED|Part B||0
122309|NCT01836198|299106|P1|STARTED|Part B||0
122310|NCT01836198|299104|P3|NOT COMPLETED|Part A, Period 2||0
122311|NCT01836198|299105|P2|NOT COMPLETED|Part A, Period 2||1
122312|NCT01836198|299106|P1|NOT COMPLETED|Part A, Period 2||0
122313|NCT01836198|299104|P3|COMPLETED|Part A, Period 2||0
122314|NCT01836198|299105|P2|COMPLETED|Part A, Period 2||14
122315|NCT01836198|299106|P1|COMPLETED|Part A, Period 2||15
122316|NCT01836198|299104|P3|Completed Part A, Entered Part B|Part A, Period 2||0
122317|NCT01836198|299105|P2|Completed Part A, Entered Part B|Part A, Period 2||6
122318|NCT01836198|299106|P1|Completed Part A, Entered Part B|Part A, Period 2||6
122319|NCT01836198|299104|P3|STARTED|Part A, Period 2||0
122320|NCT01836198|299105|P2|STARTED|Part A, Period 2||15
122321|NCT01836198|299106|P1|STARTED|Part A, Period 2||15
122322|NCT01836198|299104|P3|NOT COMPLETED|Part A, Period 1||0
122323|NCT01836198|299105|P2|NOT COMPLETED|Part A, Period 1||0
122324|NCT01836198|299106|P1|NOT COMPLETED|Part A, Period 1||0
122325|NCT01836198|299104|P3|COMPLETED|Part A, Period 1||0
122326|NCT01836198|299105|P2|COMPLETED|Part A, Period 1||15
122327|NCT01836198|299106|P1|COMPLETED|Part A, Period 1||15
122328|NCT01836198|299104|P3|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
122329|NCT01836198|299105|P2|Received at Least 1 Dose of Study Drug|Part A, Period 1||15
122330|NCT01836198|299106|P1|Received at Least 1 Dose of Study Drug|Part A, Period 1||15
122331|NCT01836198|299104|P3|STARTED|Part A, Period 1||0
122332|NCT01836198|299105|P2|STARTED|Part A, Period 1||15
122333|NCT01836198|299106|P1|STARTED|Part A, Period 1||15
122334|NCT01836185|299132|P4|NOT COMPLETED|Overall Study||0
122335|NCT01836185|299133|P3|NOT COMPLETED|Overall Study||0
122336|NCT01836185|299134|P2|NOT COMPLETED|Overall Study||0
122337|NCT01836185|299135|P1|NOT COMPLETED|Overall Study||0
122338|NCT01836185|299132|P4|COMPLETED|Overall Study||6
122339|NCT01836185|299133|P3|COMPLETED|Overall Study||8
122340|NCT01836185|299134|P2|COMPLETED|Overall Study||8
122341|NCT01836185|299135|P1|COMPLETED|Overall Study||10
122342|NCT01836185|299132|P4|Received Single Dose of Study Treatment|Overall Study||6
122343|NCT01836185|299133|P3|Received Single Dose of Study Treatment|Overall Study||8
122344|NCT01836185|299134|P2|Received Single Dose of Study Treatment|Overall Study||8
122345|NCT01836185|299135|P1|Received Single Dose of Study Treatment|Overall Study||10
122346|NCT01836185|299132|P4|STARTED|Overall Study||6
122347|NCT01836185|299133|P3|STARTED|Overall Study||8
122348|NCT01836185|299134|P2|STARTED|Overall Study||8
122349|NCT01836185|299135|P1|STARTED|Overall Study||10
122350|NCT01836133|299153|P1|NOT COMPLETED|Overall Study||0
122351|NCT01836133|299153|P1|COMPLETED|Overall Study||70
122352|NCT01836133|299153|P1|STARTED|Overall Study||70
122353|NCT01836042|299162|P3|NOT COMPLETED|Overall Study||0
122354|NCT01836042|299163|P2|NOT COMPLETED|Overall Study||0
122355|NCT01836042|299164|P1|NOT COMPLETED|Overall Study||0
122356|NCT01836042|299162|P3|COMPLETED|Overall Study||22
122357|NCT01836042|299163|P2|COMPLETED|Overall Study||35
122358|NCT01836042|299164|P1|COMPLETED|Overall Study||51
122359|NCT01836042|299162|P3|STARTED|Overall Study||22
122360|NCT01836042|299163|P2|STARTED|Overall Study||35
122361|NCT01836042|299164|P1|STARTED|Overall Study||51
122362|NCT01836029|299174|P2|NOT COMPLETED|Overall Study||0
122363|NCT01836029|299175|P1|NOT COMPLETED|Overall Study||0
122364|NCT01836029|299174|P2|COMPLETED|Overall Study||95
122365|NCT01836029|299175|P1|COMPLETED|Overall Study||100
122366|NCT01836029|299174|P2|STARTED|Overall Study||95
122367|NCT01836029|299175|P1|STARTED|Overall Study||100
122368|NCT01835912|299187|P1|NOT COMPLETED|Overall Study||0
122369|NCT01835912|299187|P1|COMPLETED|Overall Study||10
122370|NCT01835912|299187|P1|Chronic Placebo|Overall Study||10
122371|NCT01835912|299187|P1|Chronic|Overall Study||10
122372|NCT01835912|299187|P1|Acute Placebo|Overall Study||10
122373|NCT01835912|299187|P1|Acute|Overall Study||10
122374|NCT01835912|299187|P1|STARTED|Overall Study||10
122375|NCT01835899|299208|P3|NOT COMPLETED|Overall Study||1
122376|NCT01835899|299209|P2|NOT COMPLETED|Overall Study||1
122377|NCT01835899|299210|P1|NOT COMPLETED|Overall Study||0
122378|NCT01835899|299208|P3|COMPLETED|Overall Study||8
122379|NCT01835899|299209|P2|COMPLETED|Overall Study||8
122380|NCT01835899|299210|P1|COMPLETED|Overall Study||6
122381|NCT01835899|299208|P3|STARTED|Overall Study||9
122382|NCT01835899|299209|P2|STARTED|Overall Study||9
122383|NCT01835899|299210|P1|STARTED|Overall Study||6
122384|NCT01835756|299230|P2|NOT COMPLETED|Overall Study||0
122385|NCT01835756|299231|P1|NOT COMPLETED|Overall Study||0
122386|NCT01835756|299230|P2|COMPLETED|Overall Study||31
122387|NCT01835756|299231|P1|COMPLETED|Overall Study||31
122388|NCT01835756|299230|P2|STARTED|Overall Study||31
122389|NCT01835756|299231|P1|STARTED|Overall Study||31
122390|NCT01835743|299243|P2|NOT COMPLETED|Overall Study||0
122391|NCT01835743|299244|P1|NOT COMPLETED|Overall Study||0
122392|NCT01835743|299243|P2|COMPLETED|Overall Study||32
122393|NCT01835743|299244|P1|COMPLETED|Overall Study||37
122394|NCT01835743|299243|P2|STARTED|Overall Study||32
122395|NCT01835743|299244|P1|STARTED|Overall Study||37
122396|NCT01835587|299256|P4|NOT COMPLETED|Overall Study||9
122397|NCT01835587|299257|P3|NOT COMPLETED|Overall Study||2
122398|NCT01835587|299258|P2|NOT COMPLETED|Overall Study||4
122399|NCT01835587|299259|P1|NOT COMPLETED|Overall Study||2
122400|NCT01835587|299256|P4|COMPLETED|Overall Study||10
122401|NCT01835587|299257|P3|COMPLETED|Overall Study||2
122402|NCT01835587|299258|P2|COMPLETED|Overall Study||0
122403|NCT01835587|299259|P1|COMPLETED|Overall Study||1
122404|NCT01835587|299256|P4|STARTED|Overall Study||19
122405|NCT01835587|299257|P3|STARTED|Overall Study||4
122406|NCT01835587|299258|P2|STARTED|Overall Study||4
122407|NCT01835587|299259|P1|STARTED|Overall Study||3
122408|NCT01835548|299320|P3|NOT COMPLETED|Double-Blind Treatment Period||0
122409|NCT01835548|299321|P2|NOT COMPLETED|Double-Blind Treatment Period||2
122410|NCT01835548|299322|P1|NOT COMPLETED|Double-Blind Treatment Period||0
122411|NCT01835548|299320|P3|COMPLETED|Double-Blind Treatment Period||0
122412|NCT01835548|299321|P2|COMPLETED|Double-Blind Treatment Period||39
122413|NCT01835548|299322|P1|COMPLETED|Double-Blind Treatment Period||44
122414|NCT01835548|299320|P3|STARTED|Double-Blind Treatment Period||0
122415|NCT01835548|299321|P2|STARTED|Double-Blind Treatment Period||41
122416|NCT01835548|299322|P1|STARTED|Double-Blind Treatment Period||44
122417|NCT01835548|299320|P3|NOT COMPLETED|Dose Stabilization Period||0
122418|NCT01835548|299321|P2|NOT COMPLETED|Dose Stabilization Period||0
122419|NCT01835548|299322|P1|NOT COMPLETED|Dose Stabilization Period||0
122420|NCT01835548|299320|P3|COMPLETED|Dose Stabilization Period||85
122421|NCT01835548|299321|P2|COMPLETED|Dose Stabilization Period||0
122422|NCT01835548|299322|P1|COMPLETED|Dose Stabilization Period||0
122423|NCT01835548|299320|P3|STARTED|Dose Stabilization Period||85
122424|NCT01835548|299321|P2|STARTED|Dose Stabilization Period||0
122425|NCT01835548|299322|P1|STARTED|Dose Stabilization Period||0
122426|NCT01835548|299320|P3|NOT COMPLETED|Dose Optimization Period||2
122427|NCT01835548|299321|P2|NOT COMPLETED|Dose Optimization Period||0
122428|NCT01835548|299322|P1|NOT COMPLETED|Dose Optimization Period||0
122429|NCT01835548|299320|P3|COMPLETED|Dose Optimization Period||85
122430|NCT01835548|299321|P2|COMPLETED|Dose Optimization Period||0
122431|NCT01835548|299322|P1|COMPLETED|Dose Optimization Period||0
122432|NCT01835548|299320|P3|STARTED|Dose Optimization Period||87
122433|NCT01835548|299321|P2|STARTED|Dose Optimization Period||0
122434|NCT01835548|299322|P1|STARTED|Dose Optimization Period||0
122435|NCT01835548|299320|P3|NOT COMPLETED|Screening/Washout Period||0
122436|NCT01835548|299321|P2|NOT COMPLETED|Screening/Washout Period||0
122437|NCT01835548|299322|P1|NOT COMPLETED|Screening/Washout Period||0
122438|NCT01835548|299320|P3|COMPLETED|Screening/Washout Period||87
122439|NCT01835548|299321|P2|COMPLETED|Screening/Washout Period||0
122440|NCT01835548|299322|P1|COMPLETED|Screening/Washout Period||0
122441|NCT01835548|299320|P3|STARTED|Screening/Washout Period||87
122442|NCT01835548|299321|P2|STARTED|Screening/Washout Period||0
122443|NCT01835548|299322|P1|STARTED|Screening/Washout Period||0
122444|NCT01835496|299342|P1|NOT COMPLETED|Overall Study||0
122445|NCT01835496|299342|P1|COMPLETED|Overall Study||8
122446|NCT01835496|299342|P1|STARTED|Overall Study||8
122447|NCT01835470|299351|P1|NOT COMPLETED|Long Term Treatment Period||4
122448|NCT01835470|299351|P1|COMPLETED|Long Term Treatment Period|Completed LT period|16
122449|NCT01835470|299351|P1|STARTED|Long Term Treatment Period||20
122450|NCT01835470|299351|P1|NOT COMPLETED|Short Term Treatment Period (to Week 16)||0
122451|NCT01835470|299351|P1|COMPLETED|Short Term Treatment Period (to Week 16)||20
122452|NCT01835470|299351|P1|STARTED|Short Term Treatment Period (to Week 16)||20
122453|NCT01835431|299363|P2|NOT COMPLETED|Overall Study||12
122454|NCT01835431|299364|P1|NOT COMPLETED|Overall Study||8
122455|NCT01835431|299363|P2|COMPLETED|Overall Study||168
122456|NCT01835431|299364|P1|COMPLETED|Overall Study||174
122457|NCT01835431|299363|P2|Exposed|Overall Study|One subject was withdrawn before exposure|179
122458|NCT01835431|299364|P1|Exposed|Overall Study|One subject was withdrawn before exposure.|181
122459|NCT01835431|299363|P2|STARTED|Overall Study||180
122460|NCT01835431|299364|P1|STARTED|Overall Study||182
122461|NCT01835379|299384|P2|NOT COMPLETED|Overall Study||0
122462|NCT01835379|299385|P1|NOT COMPLETED|Overall Study||0
122463|NCT01835379|299384|P2|COMPLETED|Overall Study||41
122464|NCT01835379|299385|P1|COMPLETED|Overall Study||41
122465|NCT01835379|299384|P2|STARTED|Overall Study||41
122466|NCT01835379|299385|P1|STARTED|Overall Study||41
122467|NCT01835262|299395|P2|NOT COMPLETED|Overall Study||0
122468|NCT01835262|299396|P1|NOT COMPLETED|Overall Study||0
122469|NCT01835262|299395|P2|COMPLETED|Overall Study||45
122470|NCT01835262|299396|P1|COMPLETED|Overall Study||45
122471|NCT01835262|299395|P2|STARTED|Overall Study||45
122472|NCT01835262|299396|P1|STARTED|Overall Study||45
122473|NCT01835158|299404|P2|NOT COMPLETED|Overall Study||6
122474|NCT01835158|299405|P1|NOT COMPLETED|Overall Study||1
122475|NCT01835158|299404|P2|COMPLETED|Overall Study||72
122476|NCT01835158|299405|P1|COMPLETED|Overall Study||78
122477|NCT01835158|299404|P2|STARTED|Overall Study||78
122478|NCT01835158|299405|P1|STARTED|Overall Study||79
122479|NCT01835145|299417|P2|NOT COMPLETED|Overall Study||0
122480|NCT01835145|299418|P1|NOT COMPLETED|Overall Study||1
122481|NCT01835145|299417|P2|COMPLETED|Overall Study||15
122482|NCT01835145|299418|P1|COMPLETED|Overall Study||31
122483|NCT01835145|299417|P2|STARTED|Overall Study||15
122484|NCT01835145|299418|P1|STARTED|Overall Study||32
122485|NCT01835132|299425|P1|NOT COMPLETED|2nd Extension Phase - As Needed (PRN)||0
122486|NCT01835132|299425|P1|COMPLETED|2nd Extension Phase - As Needed (PRN)||3
122487|NCT01835132|299425|P1|STARTED|2nd Extension Phase - As Needed (PRN)|PRN extension - Participants starting this phase may not equal those who completed the 1st extension|3
122488|NCT01835132|299425|P1|NOT COMPLETED|1st Extension Phase||0
122489|NCT01835132|299425|P1|COMPLETED|1st Extension Phase|Completed 52 Weeks|6
122490|NCT01835132|299425|P1|STARTED|1st Extension Phase||6
122491|NCT01835132|299425|P1|NOT COMPLETED|Initial Phase||2
122492|NCT01835132|299425|P1|COMPLETED|Initial Phase||6
122493|NCT01835132|299425|P1|STARTED|Initial Phase||8
122494|NCT01835015|299470|P5|NOT COMPLETED|Overall Study||0
122495|NCT01835015|299471|P4|NOT COMPLETED|Overall Study||0
122496|NCT01835015|299472|P3|NOT COMPLETED|Overall Study||1
122497|NCT01835015|299473|P2|NOT COMPLETED|Overall Study||0
122498|NCT01835015|299474|P1|NOT COMPLETED|Overall Study||0
122499|NCT01835015|299470|P5|COMPLETED|Overall Study||6
122500|NCT01835015|299471|P4|COMPLETED|Overall Study||6
122501|NCT01835015|299472|P3|COMPLETED|Overall Study||6
122502|NCT01835015|299473|P2|COMPLETED|Overall Study||6
122503|NCT01835015|299474|P1|COMPLETED|Overall Study||6
122504|NCT01835015|299470|P5|STARTED|Overall Study||6
122505|NCT01835015|299471|P4|STARTED|Overall Study||6
122506|NCT01835015|299472|P3|STARTED|Overall Study||7
122507|NCT01835015|299473|P2|STARTED|Overall Study||6
122508|NCT01835015|299474|P1|STARTED|Overall Study||6
122509|NCT01834729|299551|P4|NOT COMPLETED|Overall Study||2
122510|NCT01834729|299552|P3|NOT COMPLETED|Overall Study||3
122511|NCT01834729|299553|P2|NOT COMPLETED|Overall Study||1
122512|NCT01834729|299554|P1|NOT COMPLETED|Overall Study||1
122513|NCT01834729|299551|P4|COMPLETED|Overall Study||16
122514|NCT01834729|299552|P3|COMPLETED|Overall Study||15
122515|NCT01834729|299553|P2|COMPLETED|Overall Study||19
122516|NCT01834729|299554|P1|COMPLETED|Overall Study||17
122517|NCT01834729|299551|P4|STARTED|Overall Study||18
122518|NCT01834729|299552|P3|STARTED|Overall Study||18
122519|NCT01834729|299553|P2|STARTED|Overall Study||20
122520|NCT01834729|299554|P1|STARTED|Overall Study||18
122521|NCT01834716|299570|P2|NOT COMPLETED|Overall Study||1
122522|NCT01834716|299571|P1|NOT COMPLETED|Overall Study||0
122523|NCT01834716|299570|P2|COMPLETED|Overall Study||11
122524|NCT01834716|299571|P1|COMPLETED|Overall Study||4
122525|NCT01834716|299570|P2|STARTED|Overall Study||12
122526|NCT01834716|299571|P1|STARTED|Overall Study||4
122527|NCT01834651|299577|P1|NOT COMPLETED|Overall Study||1
122528|NCT01834651|299577|P1|COMPLETED|Overall Study|Evaluable for primary outcome assessment at 12 weeks|16
122529|NCT01834651|299577|P1|STARTED|Overall Study||17
122530|NCT01834586|299587|P1|NOT COMPLETED|Overall Study||1
122531|NCT01834586|299587|P1|COMPLETED|Overall Study||29
122532|NCT01834586|299587|P1|STARTED|Overall Study||30
122533|NCT01834404|299594|P2|NOT COMPLETED|Overall Study||0
122534|NCT01834404|299595|P1|NOT COMPLETED|Overall Study||0
122535|NCT01834404|299594|P2|COMPLETED|Overall Study||12
122536|NCT01834404|299595|P1|COMPLETED|Overall Study||12
122537|NCT01834404|299594|P2|STARTED|Overall Study||12
122538|NCT01834404|299595|P1|STARTED|Overall Study||12
122539|NCT01834274|299627|P2|NOT COMPLETED|Overall Study||41
122540|NCT01834274|299628|P1|NOT COMPLETED|Overall Study||47
122541|NCT01834274|299627|P2|COMPLETED|Overall Study||5
122542|NCT01834274|299628|P1|COMPLETED|Overall Study||3
122543|NCT01834274|299627|P2|STARTED|Overall Study||46
122544|NCT01834274|299628|P1|STARTED|Overall Study||50
122545|NCT01834261|299640|P2|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
122546|NCT01834261|299641|P1|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
122547|NCT01834261|299640|P2|COMPLETED|MGH Rest + Nueroeconomic Task fMRI||10
122548|NCT01834261|299641|P1|COMPLETED|MGH Rest + Nueroeconomic Task fMRI|Enrollment completed in May 2015.|10
122549|NCT01834261|299640|P2|STARTED|MGH Rest + Nueroeconomic Task fMRI||10
122550|NCT01834261|299641|P1|STARTED|MGH Rest + Nueroeconomic Task fMRI|Subjects who dropped out/were excluded (10), did so before they received either Oxytocin or Placebo.|10
122551|NCT01834261|299640|P2|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
122552|NCT01834261|299641|P1|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
122553|NCT01834261|299640|P2|COMPLETED|MIT fMRI and MEG Resting State Study||9
122554|NCT01834261|299641|P1|COMPLETED|MIT fMRI and MEG Resting State Study|Enrollment completed in March 2014.|10
122555|NCT01834261|299640|P2|STARTED|MIT fMRI and MEG Resting State Study||10
122556|NCT01834261|299641|P1|STARTED|MIT fMRI and MEG Resting State Study||11
122557|NCT01834222|299651|P1|NOT COMPLETED|Overall Study||1
122558|NCT01834222|299651|P1|COMPLETED|Overall Study||658
122559|NCT01834222|299651|P1|Treated|Overall Study||658
122560|NCT01834222|299651|P1|STARTED|Overall Study||659
122561|NCT01834144|299662|P2|NOT COMPLETED|Overall Study||1
122562|NCT01834144|299663|P1|NOT COMPLETED|Overall Study||0
122563|NCT01834144|299662|P2|COMPLETED|Overall Study||2
122564|NCT01834144|299663|P1|COMPLETED|Overall Study||1
122565|NCT01834144|299662|P2|STARTED|Overall Study||3
122566|NCT01834144|299663|P1|STARTED|Overall Study||1
122567|NCT01834027|299671|P2|NOT COMPLETED|Overall Study||0
122568|NCT01834027|299672|P1|NOT COMPLETED|Overall Study||0
122569|NCT01834027|299671|P2|COMPLETED|Overall Study||28
122570|NCT01834027|299672|P1|COMPLETED|Overall Study||28
122571|NCT01834027|299671|P2|STARTED|Overall Study||28
122572|NCT01834027|299672|P1|STARTED|Overall Study||28
122573|NCT01833988|299682|P2|NOT COMPLETED|Overall Study||0
122574|NCT01833988|299683|P1|NOT COMPLETED|Overall Study||0
122575|NCT01833988|299682|P2|COMPLETED|Overall Study||16
122576|NCT01833988|299683|P1|COMPLETED|Overall Study||16
122577|NCT01833988|299682|P2|STARTED|Overall Study||16
122578|NCT01833988|299683|P1|STARTED|Overall Study||16
122579|NCT01833936|299739|P2|NOT COMPLETED|Overall Study||2
122580|NCT01833936|299740|P1|NOT COMPLETED|Overall Study||4
122581|NCT01833936|299739|P2|COMPLETED|Overall Study||18
122582|NCT01833936|299740|P1|COMPLETED|Overall Study||16
122583|NCT01833936|299739|P2|STARTED|Overall Study||20
122584|NCT01833936|299740|P1|STARTED|Overall Study||20
122585|NCT01833897|299746|P1|NOT COMPLETED|Overall Study||1
122586|NCT01833897|299746|P1|COMPLETED|Overall Study||7
122587|NCT01833897|299746|P1|STARTED|Overall Study||8
122588|NCT01833845|299754|P1|NOT COMPLETED|Overall Study||0
122589|NCT01833845|299754|P1|COMPLETED|Overall Study||4
122590|NCT01833845|299754|P1|STARTED|Overall Study||4
122591|NCT01833832|299758|P1|NOT COMPLETED|Overall Study||1
122592|NCT01833832|299758|P1|COMPLETED|Overall Study||10
122593|NCT01833832|299758|P1|STARTED|Overall Study||11
122594|NCT01833754|299769|P3|NOT COMPLETED|Overall Study||0
122595|NCT01833754|299770|P2|NOT COMPLETED|Overall Study||0
122596|NCT01833754|299771|P1|NOT COMPLETED|Overall Study||0
122597|NCT01833754|299769|P3|COMPLETED|Overall Study||8
122598|NCT01833754|299770|P2|COMPLETED|Overall Study||8
122599|NCT01833754|299771|P1|COMPLETED|Overall Study||8
122600|NCT01833754|299769|P3|STARTED|Overall Study||8
122601|NCT01833754|299770|P2|STARTED|Overall Study||8
122602|NCT01833754|299771|P1|STARTED|Overall Study||8
122603|NCT01833741|299800|P1|NOT COMPLETED|Overall Study||140
122604|NCT01833741|299800|P1|COMPLETED|Overall Study||997
122605|NCT01833741|299800|P1|STARTED|Overall Study||1137
122606|NCT01833546|299817|P4|NOT COMPLETED|Overall Study||0
122607|NCT01833546|299818|P3|NOT COMPLETED|Overall Study||0
122608|NCT01833546|299819|P2|NOT COMPLETED|Overall Study||0
122609|NCT01833546|299820|P1|NOT COMPLETED|Overall Study||0
122610|NCT01833546|299817|P4|COMPLETED|Overall Study||6
122611|NCT01833546|299818|P3|COMPLETED|Overall Study||8
122612|NCT01833546|299819|P2|COMPLETED|Overall Study||3
122613|NCT01833546|299820|P1|COMPLETED|Overall Study||3
122614|NCT01833546|299817|P4|STARTED|Overall Study||6
122615|NCT01833546|299818|P3|STARTED|Overall Study||8
122616|NCT01833546|299819|P2|STARTED|Overall Study||3
122617|NCT01833546|299820|P1|STARTED|Overall Study||3
122618|NCT01833533|299913|P2|NOT COMPLETED|Overall Study||21
122619|NCT01833533|299914|P1|NOT COMPLETED|Overall Study||6
122620|NCT01833533|299913|P2|COMPLETED|Overall Study||184
122621|NCT01833533|299914|P1|COMPLETED|Overall Study||94
122622|NCT01833533|299913|P2|STARTED|Overall Study||205
122623|NCT01833533|299914|P1|STARTED|Overall Study||100
122624|NCT01833494|299928|P1|NOT COMPLETED|Overall Study||45
122625|NCT01833494|299928|P1|COMPLETED|Overall Study||116
122626|NCT01833494|299928|P1|STARTED|Overall Study||161
122627|NCT01833481|299938|P3|NOT COMPLETED|Overall Study||0
122628|NCT01833481|299939|P2|NOT COMPLETED|Overall Study||0
122629|NCT01833481|299940|P1|NOT COMPLETED|Overall Study||0
122630|NCT01833481|299938|P3|COMPLETED|Overall Study||10
122631|NCT01833481|299939|P2|COMPLETED|Overall Study||10
122632|NCT01833481|299940|P1|COMPLETED|Overall Study||10
122633|NCT01833481|299938|P3|STARTED|Overall Study||10
122634|NCT01833481|299939|P2|STARTED|Overall Study||10
122635|NCT01833481|299940|P1|STARTED|Overall Study||10
122636|NCT01833455|299956|P2|NOT COMPLETED|Overall Study||0
122637|NCT01833455|299957|P1|NOT COMPLETED|Overall Study||1
122638|NCT01833455|299956|P2|COMPLETED|Overall Study||4
122639|NCT01833455|299957|P1|COMPLETED|Overall Study||3
122640|NCT01833455|299956|P2|Completed 2nd Baseline (Washout)|Overall Study||4
122641|NCT01833455|299957|P1|Completed 2nd Baseline (Washout)|Overall Study||3
122642|NCT01833455|299956|P2|Completed 1st Intervention|Overall Study||4
122643|NCT01833455|299957|P1|Completed 1st Intervention|Overall Study||3
122644|NCT01833455|299956|P2|Completed 1st Baseline|Overall Study||4
122645|NCT01833455|299957|P1|Completed 1st Baseline|Overall Study||4
122646|NCT01833455|299956|P2|STARTED|Overall Study||4
122647|NCT01833455|299957|P1|STARTED|Overall Study||4
122648|NCT01833403|299975|P1|NOT COMPLETED|Overall Study||0
122649|NCT01833403|299975|P1|COMPLETED|Overall Study||4
122650|NCT01833403|299975|P1|STARTED|Overall Study||4
122651|NCT01833247|299980|P1|NOT COMPLETED|Overall Study||0
122652|NCT01833247|299980|P1|COMPLETED|Overall Study||12
122653|NCT01833247|299980|P1|STARTED|Overall Study||12
122654|NCT01833169|299986|P1|NOT COMPLETED|Overall Study||146
122655|NCT01833169|299986|P1|COMPLETED|Overall Study||0
122656|NCT01833169|299986|P1|Consented to be Followed for Survival|Overall Study||128
122657|NCT01833169|299986|P1|STARTED|Overall Study||146
122658|NCT01833130|299999|P2|NOT COMPLETED|Overall Study||19
122659|NCT01833130|300000|P1|NOT COMPLETED|Overall Study||10
122660|NCT01833130|299999|P2|COMPLETED|Overall Study||8
122661|NCT01833130|300000|P1|COMPLETED|Overall Study||15
122662|NCT01833130|299999|P2|STARTED|Overall Study||27
122663|NCT01833130|300000|P1|STARTED|Overall Study||25
122664|NCT01833117|300038|P2|NOT COMPLETED|Overall Study||0
122665|NCT01833117|300039|P1|NOT COMPLETED|Overall Study||0
122666|NCT01833117|300038|P2|COMPLETED|Overall Study||19
122667|NCT01833117|300039|P1|COMPLETED|Overall Study||43
122668|NCT01833117|300038|P2|STARTED|Overall Study||19
122669|NCT01833117|300039|P1|STARTED|Overall Study||43
122670|NCT01833078|300047|P1|NOT COMPLETED|Overall Study||0
122671|NCT01833078|300047|P1|COMPLETED|Overall Study||5
122672|NCT01833078|300047|P1|STARTED|Overall Study||5
122673|NCT01833065|300055|P5|NOT COMPLETED|Overall Study||36
122674|NCT01833065|300056|P4|NOT COMPLETED|Overall Study||9
122675|NCT01833065|300057|P3|NOT COMPLETED|Overall Study||12
122676|NCT01833065|300058|P2|NOT COMPLETED|Overall Study||13
122677|NCT01833065|300059|P1|NOT COMPLETED|Overall Study||24
122678|NCT01833065|300055|P5|COMPLETED|Overall Study||74
122679|NCT01833065|300056|P4|COMPLETED|Overall Study||41
122680|NCT01833065|300057|P3|COMPLETED|Overall Study||23
122681|NCT01833065|300058|P2|COMPLETED|Overall Study||40
122682|NCT01833065|300059|P1|COMPLETED|Overall Study||41
122683|NCT01833065|300055|P5|Intention-to-treat Analysis Set|Overall Study|Randomized patients|111
122684|NCT01833065|300056|P4|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
122685|NCT01833065|300057|P3|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
122686|NCT01833065|300058|P2|Intention-to-treat Analysis Set|Overall Study|Randomized patients|53
122687|NCT01833065|300059|P1|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
122688|NCT01833065|300055|P5|STARTED|Overall Study|Randomized patients - As treated|110
122689|NCT01833065|300056|P4|STARTED|Overall Study|Randomized patients - As treated|50
122690|NCT01833065|300057|P3|STARTED|Overall Study|Randomized patients - As treated|35
122691|NCT01833065|300058|P2|STARTED|Overall Study|Randomized patients - As treated|53
122692|NCT01833065|300059|P1|STARTED|Overall Study|Randomized patients - As treated|65
122693|NCT01832818|300090|P1|NOT COMPLETED|Overall Study||6
122694|NCT01832818|300090|P1|COMPLETED|Overall Study||8
122695|NCT01832818|300090|P1|STARTED|Overall Study||14
122696|NCT01832766|300099|P2|NOT COMPLETED|Second Intervention||0
122697|NCT01832766|300100|P1|NOT COMPLETED|Second Intervention||0
122698|NCT01832766|300099|P2|COMPLETED|Second Intervention||5
122699|NCT01832766|300100|P1|COMPLETED|Second Intervention||7
122700|NCT01832766|300099|P2|STARTED|Second Intervention||5
122701|NCT01832766|300100|P1|STARTED|Second Intervention||7
122702|NCT01832766|300099|P2|NOT COMPLETED|Washout||1
122703|NCT01832766|300100|P1|NOT COMPLETED|Washout||0
122704|NCT01832766|300099|P2|COMPLETED|Washout||5
122705|NCT01832766|300100|P1|COMPLETED|Washout||7
122706|NCT01832766|300099|P2|STARTED|Washout||6
122707|NCT01832766|300100|P1|STARTED|Washout||7
122708|NCT01832766|300099|P2|NOT COMPLETED|First Intervention||0
122709|NCT01832766|300100|P1|NOT COMPLETED|First Intervention||0
122710|NCT01832766|300099|P2|COMPLETED|First Intervention|one participant did not return for cross over visit|6
122711|NCT01832766|300100|P1|COMPLETED|First Intervention||7
122712|NCT01832766|300099|P2|STARTED|First Intervention||6
122713|NCT01832766|300100|P1|STARTED|First Intervention||7
122714|NCT01832753|300113|P3|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
122715|NCT01832753|300114|P2|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
122716|NCT01832753|300115|P1|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
122717|NCT01832753|300113|P3|COMPLETED|Open Label Dose Phase (Months 12-18)||0
122718|NCT01832753|300114|P2|COMPLETED|Open Label Dose Phase (Months 12-18)||3
122719|NCT01832753|300115|P1|COMPLETED|Open Label Dose Phase (Months 12-18)||3
122720|NCT01832753|300113|P3|STARTED|Open Label Dose Phase (Months 12-18)||0
122721|NCT01832753|300114|P2|STARTED|Open Label Dose Phase (Months 12-18)||3
122722|NCT01832753|300115|P1|STARTED|Open Label Dose Phase (Months 12-18)||3
122723|NCT01832753|300113|P3|NOT COMPLETED|Randomization Phase (Months 6-12)||0
122724|NCT01832753|300114|P2|NOT COMPLETED|Randomization Phase (Months 6-12)||1
122725|NCT01832753|300115|P1|NOT COMPLETED|Randomization Phase (Months 6-12)||1
122726|NCT01832753|300113|P3|COMPLETED|Randomization Phase (Months 6-12)||0
122727|NCT01832753|300114|P2|COMPLETED|Randomization Phase (Months 6-12)||3
122728|NCT01832753|300115|P1|COMPLETED|Randomization Phase (Months 6-12)||4
122729|NCT01832753|300113|P3|STARTED|Randomization Phase (Months 6-12)|1 subject was not randomized as they did not meet inclusion criteria at the end of observation phase|0
122730|NCT01832753|300114|P2|STARTED|Randomization Phase (Months 6-12)||4
122731|NCT01832753|300115|P1|STARTED|Randomization Phase (Months 6-12)||5
122732|NCT01832753|300113|P3|NOT COMPLETED|Observation Phase (Months 0-6)||2
122733|NCT01832753|300114|P2|NOT COMPLETED|Observation Phase (Months 0-6)||0
122734|NCT01832753|300115|P1|NOT COMPLETED|Observation Phase (Months 0-6)||0
122735|NCT01832753|300113|P3|COMPLETED|Observation Phase (Months 0-6)||1
122736|NCT01832753|300114|P2|COMPLETED|Observation Phase (Months 0-6)||4
122737|NCT01832753|300115|P1|COMPLETED|Observation Phase (Months 0-6)||5
122738|NCT01832753|300113|P3|STARTED|Observation Phase (Months 0-6)||3
122739|NCT01832753|300114|P2|STARTED|Observation Phase (Months 0-6)||4
122740|NCT01832753|300115|P1|STARTED|Observation Phase (Months 0-6)||5
122741|NCT01832610|300127|P1|NOT COMPLETED|Overall Study||4
122742|NCT01832610|300127|P1|COMPLETED|Overall Study||97
122743|NCT01832610|300127|P1|STARTED|Overall Study||101
122744|NCT01832506|300141|P3|NOT COMPLETED|Overall Study||0
122745|NCT01832506|300142|P2|NOT COMPLETED|Overall Study||0
122746|NCT01832506|300143|P1|NOT COMPLETED|Overall Study||0
122747|NCT01832506|300141|P3|COMPLETED|Overall Study||6
122748|NCT01832506|300142|P2|COMPLETED|Overall Study||3
122749|NCT01832506|300143|P1|COMPLETED|Overall Study||3
122750|NCT01832506|300141|P3|STARTED|Overall Study||6
122751|NCT01832506|300142|P2|STARTED|Overall Study||3
122752|NCT01832506|300143|P1|STARTED|Overall Study||3
122753|NCT01832493|300194|P1|NOT COMPLETED|Overall Study||8
122754|NCT01832493|300194|P1|COMPLETED|Overall Study||42
122755|NCT01832493|300194|P1|STARTED|Overall Study||50
122756|NCT01832480|300203|P2|NOT COMPLETED|Overall Study||42
122757|NCT01832480|300204|P1|NOT COMPLETED|Overall Study||41
122758|NCT01832480|300203|P2|COMPLETED|Overall Study||270
122759|NCT01832480|300204|P1|COMPLETED|Overall Study||270
122760|NCT01832480|300203|P2|STARTED|Overall Study||312
122761|NCT01832480|300204|P1|STARTED|Overall Study||311
122762|NCT01832259|300212|P2|NOT COMPLETED|Overall Study||0
122763|NCT01832259|300213|P1|NOT COMPLETED|Overall Study||0
122764|NCT01832259|300212|P2|COMPLETED|Overall Study||15
122765|NCT01832259|300213|P1|COMPLETED|Overall Study||15
122766|NCT01832259|300212|P2|STARTED|Overall Study||15
122767|NCT01832259|300213|P1|STARTED|Overall Study||15
122768|NCT01832155|300225|P2|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
122769|NCT01832155|300226|P1|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
122770|NCT01832155|300225|P2|COMPLETED|End of Study: 4 - 8 Weeks||18
122771|NCT01832155|300226|P1|COMPLETED|End of Study: 4 - 8 Weeks||16
122772|NCT01832155|300225|P2|STARTED|End of Study: 4 - 8 Weeks||18
122773|NCT01832155|300226|P1|STARTED|End of Study: 4 - 8 Weeks||16
122774|NCT01832155|300225|P2|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||0
122775|NCT01832155|300226|P1|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||1
122776|NCT01832155|300225|P2|COMPLETED|Mid-point of Study: 0 - 4 Weeks||18
122777|NCT01832155|300226|P1|COMPLETED|Mid-point of Study: 0 - 4 Weeks||16
122778|NCT01832155|300225|P2|STARTED|Mid-point of Study: 0 - 4 Weeks||18
122779|NCT01832155|300226|P1|STARTED|Mid-point of Study: 0 - 4 Weeks||17
122780|NCT01832155|300225|P2|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||0
122781|NCT01832155|300226|P1|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||1
122782|NCT01832155|300225|P2|COMPLETED|Beginning of Study: Baseline at 0 Week||18
122783|NCT01832155|300226|P1|COMPLETED|Beginning of Study: Baseline at 0 Week||17
122784|NCT01832155|300225|P2|STARTED|Beginning of Study: Baseline at 0 Week||18
122785|NCT01832155|300226|P1|STARTED|Beginning of Study: Baseline at 0 Week||18
122786|NCT01832090|300249|P2|NOT COMPLETED|Overall Study||1
122787|NCT01832090|300250|P1|NOT COMPLETED|Overall Study||6
122788|NCT01832090|300249|P2|COMPLETED|Overall Study||28
122789|NCT01832090|300250|P1|COMPLETED|Overall Study||83
122790|NCT01832090|300249|P2|STARTED|Overall Study||29
122791|NCT01832090|300250|P1|STARTED|Overall Study||89
122792|NCT01831934|300295|P2|NOT COMPLETED|Overall Study||0
122793|NCT01831934|300296|P1|NOT COMPLETED|Overall Study||1
122794|NCT01831934|300295|P2|COMPLETED|Overall Study||10
122795|NCT01831934|300296|P1|COMPLETED|Overall Study|Volunteer consented but not enrolled after reporting a prior bad reaction to influenza vaccine.|11
122796|NCT01831934|300295|P2|STARTED|Overall Study||10
122797|NCT01831934|300296|P1|STARTED|Overall Study||12
122798|NCT01831921|300304|P2|NOT COMPLETED|Overall Study||39
122799|NCT01831921|300305|P1|NOT COMPLETED|Overall Study||84
122800|NCT01831921|300304|P2|COMPLETED|Overall Study|Of 42 eligible for this visit.|36
122801|NCT01831921|300305|P1|COMPLETED|Overall Study|Of 85 eligible for this visit.|66
122802|NCT01831921|300304|P2|18 Months|Overall Study|Of 59 eligible for this visit.|49
122803|NCT01831921|300305|P1|18 Months|Overall Study|Of 118 eligible for this visit.|90
122804|NCT01831921|300304|P2|12 Months|Overall Study||62
122805|NCT01831921|300305|P1|12 Months|Overall Study|All participants were followed for 12 months to 24 months, depending on date of randomization.|120
122806|NCT01831921|300304|P2|6 Months|Overall Study||63
122807|NCT01831921|300305|P1|6 Months|Overall Study||122
122808|NCT01831921|300304|P2|STARTED|Overall Study||75
122809|NCT01831921|300305|P1|STARTED|Overall Study||150
122810|NCT01831856|300329|P2|NOT COMPLETED|Overall Study||37
122811|NCT01831856|300330|P1|NOT COMPLETED|Overall Study||34
122812|NCT01831856|300329|P2|COMPLETED|Overall Study||30
122813|NCT01831856|300330|P1|COMPLETED|Overall Study||33
122814|NCT01831856|300329|P2|STARTED|Overall Study||67
122815|NCT01831856|300330|P1|STARTED|Overall Study||67
122816|NCT01831817|300340|P4|NOT COMPLETED|Overall Study||0
122817|NCT01831817|300341|P3|NOT COMPLETED|Overall Study||0
122818|NCT01831817|300342|P2|NOT COMPLETED|Overall Study||0
122819|NCT01831817|300343|P1|NOT COMPLETED|Overall Study||4
122820|NCT01831817|300340|P4|COMPLETED|Overall Study||36
122821|NCT01831817|300341|P3|COMPLETED|Overall Study||35
122822|NCT01831817|300342|P2|COMPLETED|Overall Study||34
122823|NCT01831817|300343|P1|COMPLETED|Overall Study||31
122824|NCT01831817|300340|P4|STARTED|Overall Study||36
122825|NCT01831817|300341|P3|STARTED|Overall Study||35
122826|NCT01831817|300342|P2|STARTED|Overall Study||34
122827|NCT01831817|300343|P1|STARTED|Overall Study||35
122828|NCT01831804|300390|P9|NOT COMPLETED|Overall Study||2
122829|NCT01831804|300391|P8|NOT COMPLETED|Overall Study||3
122830|NCT01831804|300392|P7|NOT COMPLETED|Overall Study||1
122831|NCT01831804|300393|P6|NOT COMPLETED|Overall Study||0
122832|NCT01831804|300394|P5|NOT COMPLETED|Overall Study||2
122833|NCT01831804|300395|P4|NOT COMPLETED|Overall Study||0
122834|NCT01831804|300396|P3|NOT COMPLETED|Overall Study||6
122835|NCT01831804|300397|P2|NOT COMPLETED|Overall Study||2
122836|NCT01831804|300398|P1|NOT COMPLETED|Overall Study||1
122837|NCT01831804|300390|P9|COMPLETED|Overall Study||2
122838|NCT01831804|300391|P8|COMPLETED|Overall Study||23
122839|NCT01831804|300392|P7|COMPLETED|Overall Study||3
122840|NCT01831804|300393|P6|COMPLETED|Overall Study||3
122841|NCT01831804|300394|P5|COMPLETED|Overall Study||3
122842|NCT01831804|300395|P4|COMPLETED|Overall Study||5
122843|NCT01831804|300396|P3|COMPLETED|Overall Study||3
122844|NCT01831804|300397|P2|COMPLETED|Overall Study||1
122845|NCT01831804|300398|P1|COMPLETED|Overall Study||3
122846|NCT01831804|300390|P9|STARTED|Overall Study||4
122847|NCT01831804|300391|P8|STARTED|Overall Study||26
122848|NCT01831804|300392|P7|STARTED|Overall Study||4
122849|NCT01831804|300393|P6|STARTED|Overall Study||3
122850|NCT01831804|300394|P5|STARTED|Overall Study||5
122851|NCT01831804|300395|P4|STARTED|Overall Study||5
122852|NCT01831804|300396|P3|STARTED|Overall Study||9
122853|NCT01831804|300397|P2|STARTED|Overall Study||3
122854|NCT01831804|300398|P1|STARTED|Overall Study||4
122855|NCT01831791|300493|P1|NOT COMPLETED|Overall Study||10
122856|NCT01831791|300493|P1|COMPLETED|Overall Study||110
122857|NCT01831791|300493|P1|STARTED|Overall Study||120
122858|NCT01831765|300522|P3|NOT COMPLETED|Overall Study||42
122859|NCT01831765|300523|P2|NOT COMPLETED|Overall Study||27
122860|NCT01831765|300524|P1|NOT COMPLETED|Overall Study||44
122861|NCT01831765|300522|P3|COMPLETED|Overall Study||338
122862|NCT01831765|300523|P2|COMPLETED|Overall Study||355
122863|NCT01831765|300524|P1|COMPLETED|Overall Study||337
122864|NCT01831765|300522|P3|Completed 52 Weeks|Overall Study||338
122865|NCT01831765|300523|P2|Completed 52 Weeks|Overall Study|This arm did not continue in the trial after 26 weeks ( 26 to 52 weeks).|0
122866|NCT01831765|300524|P1|Completed 52 Weeks|Overall Study||337
122867|NCT01831765|300522|P3|Completed 26 Weeks|Overall Study||356
122868|NCT01831765|300523|P2|Completed 26 Weeks|Overall Study||355
122869|NCT01831765|300524|P1|Completed 26 Weeks|Overall Study||351
122870|NCT01831765|300522|P3|STARTED|Overall Study||380
122871|NCT01831765|300523|P2|STARTED|Overall Study||382
122872|NCT01831765|300524|P1|STARTED|Overall Study||381
122873|NCT01831726|300550|P1|NOT COMPLETED|Overall Study||80
122874|NCT01831726|300550|P1|COMPLETED|Overall Study||0
122875|NCT01831726|300550|P1|STARTED|Overall Study||80
122876|NCT01831466|300569|P12|NOT COMPLETED|Overall Study||4
122877|NCT01831466|300570|P11|NOT COMPLETED|Overall Study||2
122878|NCT01831466|300571|P10|NOT COMPLETED|Overall Study||5
122879|NCT01831466|300572|P9|NOT COMPLETED|Overall Study||3
122880|NCT01831466|300573|P8|NOT COMPLETED|Overall Study||2
122881|NCT01831466|300574|P7|NOT COMPLETED|Overall Study||1
122882|NCT01831466|300575|P6|NOT COMPLETED|Overall Study||26
122883|NCT01831466|300576|P5|NOT COMPLETED|Overall Study||17
122884|NCT01831466|300577|P4|NOT COMPLETED|Overall Study||19
122885|NCT01831466|300578|P3|NOT COMPLETED|Overall Study||23
122886|NCT01831466|300579|P2|NOT COMPLETED|Overall Study||18
122887|NCT01831466|300580|P1|NOT COMPLETED|Overall Study||16
122888|NCT01831466|300569|P12|COMPLETED|Overall Study||3
122889|NCT01831466|300570|P11|COMPLETED|Overall Study||4
122890|NCT01831466|300571|P10|COMPLETED|Overall Study||2
122891|NCT01831466|300572|P9|COMPLETED|Overall Study||4
122892|NCT01831466|300573|P8|COMPLETED|Overall Study||5
122893|NCT01831466|300574|P7|COMPLETED|Overall Study||6
122894|NCT01831466|300575|P6|COMPLETED|Overall Study||48
122895|NCT01831466|300576|P5|COMPLETED|Overall Study||57
122896|NCT01831466|300577|P4|COMPLETED|Overall Study||51
122897|NCT01831466|300578|P3|COMPLETED|Overall Study||48
122898|NCT01831466|300579|P2|COMPLETED|Overall Study||52
122899|NCT01831466|300580|P1|COMPLETED|Overall Study||55
122900|NCT01831466|300569|P12|STARTED|Overall Study|Treated|7
122901|NCT01831466|300570|P11|STARTED|Overall Study|Treated|6
122902|NCT01831466|300571|P10|STARTED|Overall Study|Treated|7
122903|NCT01831466|300572|P9|STARTED|Overall Study|Treated|7
122904|NCT01831466|300573|P8|STARTED|Overall Study|Treated|7
122905|NCT01831466|300574|P7|STARTED|Overall Study|Treated|7
122906|NCT01831466|300575|P6|STARTED|Overall Study|Treated|74
122907|NCT01831466|300576|P5|STARTED|Overall Study|Treated|74
122908|NCT01831466|300577|P4|STARTED|Overall Study|Treated|70
122909|NCT01831466|300578|P3|STARTED|Overall Study|Treated|71
122910|NCT01831466|300579|P2|STARTED|Overall Study|Treated|70
122911|NCT01831466|300580|P1|STARTED|Overall Study|Treated|71
122912|NCT01831258|300702|P2|NOT COMPLETED|Overall Study||3
122913|NCT01831258|300703|P1|NOT COMPLETED|Overall Study||5
122914|NCT01831258|300702|P2|COMPLETED|Overall Study||32
122915|NCT01831258|300703|P1|COMPLETED|Overall Study||30
122916|NCT01831258|300702|P2|STARTED|Overall Study||35
122917|NCT01831258|300703|P1|STARTED|Overall Study||35
122918|NCT01831232|300729|P1|NOT COMPLETED|Overall Study||0
122919|NCT01831232|300729|P1|COMPLETED|Overall Study||24
122920|NCT01831232|300729|P1|STARTED|Overall Study||24
122921|NCT01831219|300740|P2|NOT COMPLETED|Overall Study||24
122922|NCT01831219|300741|P1|NOT COMPLETED|Overall Study||33
122923|NCT01831219|300740|P2|COMPLETED|Overall Study||21
122924|NCT01831219|300741|P1|COMPLETED|Overall Study||40
122925|NCT01831219|300740|P2|STARTED|Overall Study||45
122926|NCT01831219|300741|P1|STARTED|Overall Study||73
122927|NCT01831154|300762|P3|NOT COMPLETED|Overall Study||0
122928|NCT01831154|300763|P2|NOT COMPLETED|Overall Study||0
122929|NCT01831154|300764|P1|NOT COMPLETED|Overall Study||0
122930|NCT01831154|300762|P3|COMPLETED|Overall Study||11
122931|NCT01831154|300763|P2|COMPLETED|Overall Study||11
122932|NCT01831154|300764|P1|COMPLETED|Overall Study||15
122933|NCT01831154|300762|P3|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
122934|NCT01831154|300763|P2|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
122935|NCT01831154|300764|P1|STARTED|Overall Study|Study Institutional Review Board (IRB) approval 11-11-2009, first subjects enrolled 6-7-2010|15
122936|NCT01831076|300789|P2|NOT COMPLETED|Overall Study||1
122937|NCT01831076|300790|P1|NOT COMPLETED|Overall Study||1
122938|NCT01831076|300789|P2|COMPLETED|Overall Study||4
122939|NCT01831076|300790|P1|COMPLETED|Overall Study||30
122940|NCT01831076|300789|P2|STARTED|Overall Study||5
122941|NCT01831076|300790|P1|STARTED|Overall Study||31
122942|NCT01830972|300798|P2|NOT COMPLETED|Part IV||1
122943|NCT01830972|300799|P1|NOT COMPLETED|Part IV||3
122944|NCT01830972|300798|P2|COMPLETED|Part IV||10
122945|NCT01830972|300799|P1|COMPLETED|Part IV||39
122946|NCT01830972|300798|P2|STARTED|Part IV||11
122947|NCT01830972|300799|P1|STARTED|Part IV||42
122948|NCT01830972|300798|P2|NOT COMPLETED|Part III||0
122949|NCT01830972|300799|P1|NOT COMPLETED|Part III||2
122950|NCT01830972|300798|P2|COMPLETED|Part III||11
122951|NCT01830972|300799|P1|COMPLETED|Part III||42
122952|NCT01830972|300798|P2|STARTED|Part III||11
123045|NCT01830621|301106|P1|COMPLETED|Overall Study||138
122953|NCT01830972|300799|P1|STARTED|Part III|2 participants withdrew consent and did not enter Part 3|44
122954|NCT01830972|300798|P2|NOT COMPLETED|Part II||2
122955|NCT01830972|300799|P1|NOT COMPLETED|Part II||2
122956|NCT01830972|300798|P2|COMPLETED|Part II||11
122957|NCT01830972|300799|P1|COMPLETED|Part II||44
122958|NCT01830972|300798|P2|STARTED|Part II|Entered study at Part 2|13
122959|NCT01830972|300799|P1|STARTED|Part II||46
122960|NCT01830972|300798|P2|NOT COMPLETED|Part I||0
122961|NCT01830972|300799|P1|NOT COMPLETED|Part I||0
122962|NCT01830972|300798|P2|COMPLETED|Part I|Not applicable; participants in this arm entered during Part 2.|0
122963|NCT01830972|300799|P1|COMPLETED|Part I||46
122964|NCT01830972|300798|P2|STARTED|Part I|Not applicable; participants in this arm entered during Part 2.|0
122965|NCT01830972|300799|P1|STARTED|Part I||46
122966|NCT01830933|300825|P2|NOT COMPLETED|Overall Study||232
122967|NCT01830933|300826|P1|NOT COMPLETED|Overall Study||168
122968|NCT01830933|300825|P2|COMPLETED|Overall Study||580
122969|NCT01830933|300826|P1|COMPLETED|Overall Study||655
122970|NCT01830933|300825|P2|Completed Meet-up|Overall Study||603
122971|NCT01830933|300826|P1|Completed Meet-up|Overall Study||675
122972|NCT01830933|300825|P2|STARTED|Overall Study||812
122973|NCT01830933|300826|P1|STARTED|Overall Study||823
122974|NCT01830920|300843|P5|NOT COMPLETED|Overall Study||8
122975|NCT01830920|300844|P4|NOT COMPLETED|Overall Study||16
122976|NCT01830920|300845|P3|NOT COMPLETED|Overall Study||8
122977|NCT01830920|300846|P2|NOT COMPLETED|Overall Study||6
122978|NCT01830920|300847|P1|NOT COMPLETED|Overall Study||21
122979|NCT01830920|300843|P5|COMPLETED|Overall Study||99
122980|NCT01830920|300844|P4|COMPLETED|Overall Study||109
122981|NCT01830920|300845|P3|COMPLETED|Overall Study||40
122982|NCT01830920|300846|P2|COMPLETED|Overall Study||40
122983|NCT01830920|300847|P1|COMPLETED|Overall Study||105
122984|NCT01830920|300843|P5|Received Allocated Drug|Overall Study||105
122985|NCT01830920|300844|P4|Received Allocated Drug|Overall Study||119
122986|NCT01830920|300845|P3|Received Allocated Drug|Overall Study||47
122987|NCT01830920|300846|P2|Received Allocated Drug|Overall Study||45
122988|NCT01830920|300847|P1|Received Allocated Drug|Overall Study||115
122989|NCT01830920|300843|P5|STARTED|Overall Study||107
122990|NCT01830920|300844|P4|STARTED|Overall Study||125
122991|NCT01830920|300845|P3|STARTED|Overall Study||48
122992|NCT01830920|300846|P2|STARTED|Overall Study||46
122993|NCT01830920|300847|P1|STARTED|Overall Study||126
122994|NCT01830881|300886|P2|NOT COMPLETED|Overall Study||1
122995|NCT01830881|300887|P1|NOT COMPLETED|Overall Study||0
122996|NCT01830881|300886|P2|COMPLETED|Overall Study||61
122997|NCT01830881|300887|P1|COMPLETED|Overall Study||62
122998|NCT01830881|300886|P2|STARTED|Overall Study||62
122999|NCT01830881|300887|P1|STARTED|Overall Study||62
123000|NCT01830855|300935|P4|NOT COMPLETED|Overall Study||82
123001|NCT01830855|300936|P3|NOT COMPLETED|Overall Study||66
123002|NCT01830855|300937|P2|NOT COMPLETED|Overall Study||61
123003|NCT01830855|300938|P1|NOT COMPLETED|Overall Study||155
123004|NCT01830855|300935|P4|COMPLETED|Overall Study||815
123005|NCT01830855|300936|P3|COMPLETED|Overall Study||521
123006|NCT01830855|300937|P2|COMPLETED|Overall Study||537
123007|NCT01830855|300938|P1|COMPLETED|Overall Study||1353
123008|NCT01830855|300935|P4|STARTED|Overall Study||897
123009|NCT01830855|300936|P3|STARTED|Overall Study||587
123010|NCT01830855|300937|P2|STARTED|Overall Study||598
123011|NCT01830855|300938|P1|STARTED|Overall Study||1508
123012|NCT01830842|301044|P2|NOT COMPLETED|Overall Study||2
123013|NCT01830842|301045|P1|NOT COMPLETED|Overall Study||5
123014|NCT01830842|301044|P2|COMPLETED|Overall Study||22
123015|NCT01830842|301045|P1|COMPLETED|Overall Study||25
123016|NCT01830842|301044|P2|STARTED|Overall Study||24
123017|NCT01830842|301045|P1|STARTED|Overall Study||30
123018|NCT01830816|301054|P3|NOT COMPLETED|Overall Study||7
123019|NCT01830816|301055|P2|NOT COMPLETED|Overall Study||14
123020|NCT01830816|301056|P1|NOT COMPLETED|Overall Study||20
123021|NCT01830816|301054|P3|COMPLETED|Overall Study||0
123022|NCT01830816|301055|P2|COMPLETED|Overall Study||0
123023|NCT01830816|301056|P1|COMPLETED|Overall Study||0
123024|NCT01830816|301054|P3|Pharmacokinetic-Evaluable Population|Overall Study||6
123025|NCT01830816|301055|P2|Pharmacokinetic-Evaluable Population|Overall Study||14
123026|NCT01830816|301056|P1|Pharmacokinetic-Evaluable Population|Overall Study|Participants are considered to have completed study treatment if they are PK evaluable.|18
123027|NCT01830816|301054|P3|STARTED|Overall Study||7
123028|NCT01830816|301055|P2|STARTED|Overall Study||14
123029|NCT01830816|301056|P1|STARTED|Overall Study||20
123030|NCT01830790|301081|P2|NOT COMPLETED|Overall Study||0
123031|NCT01830790|301082|P1|NOT COMPLETED|Overall Study||0
123032|NCT01830790|301081|P2|COMPLETED|Overall Study||10
123033|NCT01830790|301082|P1|COMPLETED|Overall Study||0
123034|NCT01830790|301081|P2|STARTED|Overall Study||10
123035|NCT01830790|301082|P1|STARTED|Overall Study||0
123036|NCT01830699|301092|P2|NOT COMPLETED|Overall Study||0
123037|NCT01830699|301093|P1|NOT COMPLETED|Overall Study||0
123038|NCT01830699|301092|P2|COMPLETED|Overall Study||20
123039|NCT01830699|301093|P1|COMPLETED|Overall Study||13
123040|NCT01830699|301092|P2|STARTED|Overall Study||20
123041|NCT01830699|301093|P1|STARTED|Overall Study||13
123042|NCT01830621|301105|P2|NOT COMPLETED|Overall Study||0
123043|NCT01830621|301106|P1|NOT COMPLETED|Overall Study||0
123044|NCT01830621|301105|P2|COMPLETED|Overall Study||144
123046|NCT01830621|301105|P2|STARTED|Overall Study||144
123047|NCT01830621|301106|P1|STARTED|Overall Study||138
123048|NCT01830595|301120|P2|NOT COMPLETED|Second Period||0
123049|NCT01830595|301121|P1|NOT COMPLETED|Second Period||0
123050|NCT01830595|301120|P2|COMPLETED|Second Period||23
123051|NCT01830595|301121|P1|COMPLETED|Second Period||23
123052|NCT01830595|301120|P2|STARTED|Second Period||23
123053|NCT01830595|301121|P1|STARTED|Second Period||23
123054|NCT01830595|301120|P2|NOT COMPLETED|Washout||2
123055|NCT01830595|301121|P1|NOT COMPLETED|Washout||2
123056|NCT01830595|301120|P2|COMPLETED|Washout||23
123057|NCT01830595|301121|P1|COMPLETED|Washout||23
123058|NCT01830595|301120|P2|STARTED|Washout||25
123059|NCT01830595|301121|P1|STARTED|Washout||25
123060|NCT01830595|301120|P2|NOT COMPLETED|First Period||3
123061|NCT01830595|301121|P1|NOT COMPLETED|First Period||1
123062|NCT01830595|301120|P2|COMPLETED|First Period||25
123063|NCT01830595|301121|P1|COMPLETED|First Period||25
123064|NCT01830595|301120|P2|Received at Least One Dose|First Period||28
123065|NCT01830595|301121|P1|Received at Least One Dose|First Period||26
123066|NCT01830595|301120|P2|STARTED|First Period||28
123067|NCT01830595|301121|P1|STARTED|First Period||26
123068|NCT01830543|301138|P3|NOT COMPLETED|Overall Study||214
123069|NCT01830543|301139|P2|NOT COMPLETED|Overall Study||152
123070|NCT01830543|301140|P1|NOT COMPLETED|Overall Study||159
123071|NCT01830543|301138|P3|COMPLETED|Overall Study||492
123072|NCT01830543|301139|P2|COMPLETED|Overall Study||557
123073|NCT01830543|301140|P1|COMPLETED|Overall Study||550
123074|NCT01830543|301138|P3|Treated|Overall Study||697
123075|NCT01830543|301139|P2|Treated|Overall Study||706
123076|NCT01830543|301140|P1|Treated|Overall Study||696
123077|NCT01830543|301138|P3|STARTED|Overall Study||706
123078|NCT01830543|301139|P2|STARTED|Overall Study||709
123079|NCT01830543|301140|P1|STARTED|Overall Study||709
123080|NCT01830205|301176|P4|NOT COMPLETED|Overall Study||0
123081|NCT01830205|301177|P3|NOT COMPLETED|Overall Study||0
123082|NCT01830205|301178|P2|NOT COMPLETED|Overall Study||0
123083|NCT01830205|301179|P1|NOT COMPLETED|Overall Study||0
123084|NCT01830205|301176|P4|COMPLETED|Overall Study||12
123085|NCT01830205|301177|P3|COMPLETED|Overall Study||6
123086|NCT01830205|301178|P2|COMPLETED|Overall Study||6
123087|NCT01830205|301179|P1|COMPLETED|Overall Study||12
123088|NCT01830205|301176|P4|STARTED|Overall Study||12
123089|NCT01830205|301177|P3|STARTED|Overall Study||6
123090|NCT01830205|301178|P2|STARTED|Overall Study||6
123091|NCT01830205|301179|P1|STARTED|Overall Study||12
123092|NCT01830140|301263|P2|NOT COMPLETED|Overall Study||4
123093|NCT01830140|301264|P1|NOT COMPLETED|Overall Study||7
123094|NCT01830140|301263|P2|COMPLETED|Overall Study||229
123095|NCT01830140|301264|P1|COMPLETED|Overall Study||226
123096|NCT01830140|301263|P2|STARTED|Overall Study||233
123097|NCT01830140|301264|P1|STARTED|Overall Study||233
123098|NCT01830127|301272|P2|NOT COMPLETED|Overall Study||9
123099|NCT01830127|301273|P1|NOT COMPLETED|Overall Study||5
123100|NCT01830127|301272|P2|COMPLETED|Overall Study||8
123101|NCT01830127|301273|P1|COMPLETED|Overall Study||13
123102|NCT01830127|301272|P2|STARTED|Overall Study||17
123103|NCT01830127|301273|P1|STARTED|Overall Study||18
123104|NCT01829997|301281|P1|NOT COMPLETED|Overall Study||6
123105|NCT01829997|301281|P1|COMPLETED|Overall Study||16
123106|NCT01829997|301281|P1|STARTED|Overall Study||22
123107|NCT01829919|301290|P1|NOT COMPLETED|Overall Study||0
123108|NCT01829919|301290|P1|COMPLETED|Overall Study||24
123109|NCT01829919|301290|P1|STARTED|Overall Study||24
123110|NCT01829711|301306|P1|NOT COMPLETED|Overall Study||80
123111|NCT01829711|301306|P1|COMPLETED|Overall Study||0
123112|NCT01829711|301306|P1|STARTED|Overall Study||80
123113|NCT01829516|301336|P2|NOT COMPLETED|2nd Intervention||0
123114|NCT01829516|301337|P1|NOT COMPLETED|2nd Intervention||0
123115|NCT01829516|301336|P2|COMPLETED|2nd Intervention||14
123116|NCT01829516|301337|P1|COMPLETED|2nd Intervention||18
123117|NCT01829516|301336|P2|STARTED|2nd Intervention||14
123118|NCT01829516|301337|P1|STARTED|2nd Intervention||18
123119|NCT01829516|301336|P2|NOT COMPLETED|Washout Period - 1 Week||0
123120|NCT01829516|301337|P1|NOT COMPLETED|Washout Period - 1 Week||0
123121|NCT01829516|301336|P2|COMPLETED|Washout Period - 1 Week||14
123122|NCT01829516|301337|P1|COMPLETED|Washout Period - 1 Week||18
123123|NCT01829516|301336|P2|STARTED|Washout Period - 1 Week||14
123124|NCT01829516|301337|P1|STARTED|Washout Period - 1 Week||18
123125|NCT01829516|301336|P2|NOT COMPLETED|First Intervention||0
123126|NCT01829516|301337|P1|NOT COMPLETED|First Intervention||0
123127|NCT01829516|301336|P2|COMPLETED|First Intervention||14
123128|NCT01829516|301337|P1|COMPLETED|First Intervention||18
123129|NCT01829516|301336|P2|STARTED|First Intervention||14
123130|NCT01829516|301337|P1|STARTED|First Intervention||18
123131|NCT01829503|301345|P1|NOT COMPLETED|Overall Study||0
123132|NCT01829503|301345|P1|COMPLETED|Overall Study||44
123133|NCT01829503|301345|P1|STARTED|Overall Study||44
123134|NCT01829477|301362|P2|NOT COMPLETED|Overall Study||15
123135|NCT01829477|301363|P1|NOT COMPLETED|Overall Study||16
123136|NCT01829477|301362|P2|COMPLETED|Overall Study||1
123137|NCT01829477|301363|P1|COMPLETED|Overall Study||1
123138|NCT01829477|301362|P2|STARTED|Overall Study||16
123139|NCT01829477|301363|P1|STARTED|Overall Study||17
123140|NCT01829464|301376|P3|NOT COMPLETED|Overall Study||26
123141|NCT01829464|301377|P2|NOT COMPLETED|Overall Study||29
123142|NCT01829464|301378|P1|NOT COMPLETED|Overall Study||28
123143|NCT01829464|301376|P3|COMPLETED|Overall Study||3
123144|NCT01829464|301377|P2|COMPLETED|Overall Study||2
123145|NCT01829464|301378|P1|COMPLETED|Overall Study||2
123146|NCT01829464|301376|P3|STARTED|Overall Study||29
123147|NCT01829464|301377|P2|STARTED|Overall Study||31
123148|NCT01829464|301378|P1|STARTED|Overall Study||30
123149|NCT01829425|301394|P2|NOT COMPLETED|Overall Study||4
123150|NCT01829425|301395|P1|NOT COMPLETED|Overall Study||6
123151|NCT01829425|301394|P2|COMPLETED|Overall Study|completed primary outcome 2 month f/u N=70|70
123152|NCT01829425|301395|P1|COMPLETED|Overall Study|completed primary outcome 2 month f/u N=72|72
123153|NCT01829425|301394|P2|STARTED|Overall Study||74
123154|NCT01829425|301395|P1|STARTED|Overall Study||78
123155|NCT01829399|301425|P2|NOT COMPLETED|Visit 2 (One Month Later)||0
123156|NCT01829399|301426|P1|NOT COMPLETED|Visit 2 (One Month Later)||0
123157|NCT01829399|301425|P2|COMPLETED|Visit 2 (One Month Later)||12
123158|NCT01829399|301426|P1|COMPLETED|Visit 2 (One Month Later)||12
123159|NCT01829399|301425|P2|STARTED|Visit 2 (One Month Later)||12
123160|NCT01829399|301426|P1|STARTED|Visit 2 (One Month Later)||12
123161|NCT01829399|301425|P2|NOT COMPLETED|Visit 1||0
123162|NCT01829399|301426|P1|NOT COMPLETED|Visit 1||0
123163|NCT01829399|301425|P2|COMPLETED|Visit 1||12
123164|NCT01829399|301426|P1|COMPLETED|Visit 1||12
123165|NCT01829399|301425|P2|STARTED|Visit 1||12
123166|NCT01829399|301426|P1|STARTED|Visit 1||12
123167|NCT01829360|301438|P4|NOT COMPLETED|Overall Study||0
123168|NCT01829360|301439|P3|NOT COMPLETED|Overall Study||1
123169|NCT01829360|301440|P2|NOT COMPLETED|Overall Study||0
123170|NCT01829360|301441|P1|NOT COMPLETED|Overall Study||0
123171|NCT01829360|301438|P4|COMPLETED|Overall Study||8
123172|NCT01829360|301439|P3|COMPLETED|Overall Study||9
123173|NCT01829360|301440|P2|COMPLETED|Overall Study||9
123174|NCT01829360|301441|P1|COMPLETED|Overall Study||8
123175|NCT01829360|301438|P4|STARTED|Overall Study||8
123176|NCT01829360|301439|P3|STARTED|Overall Study||10
123177|NCT01829360|301440|P2|STARTED|Overall Study||9
123178|NCT01829360|301441|P1|STARTED|Overall Study||8
123179|NCT01829347|301461|P2|NOT COMPLETED|VTI-210E||6
123180|NCT01829347|301462|P1|NOT COMPLETED|VTI-210E||3
123181|NCT01829347|301461|P2|COMPLETED|VTI-210E||0
123182|NCT01829347|301462|P1|COMPLETED|VTI-210E||0
123183|NCT01829347|301461|P2|STARTED|VTI-210E||6
123184|NCT01829347|301462|P1|STARTED|VTI-210E||3
123185|NCT01829347|301461|P2|NOT COMPLETED|VTI-210||3
123186|NCT01829347|301462|P1|NOT COMPLETED|VTI-210||6
123187|NCT01829347|301461|P2|COMPLETED|VTI-210||6
123188|NCT01829347|301462|P1|COMPLETED|VTI-210||3
123189|NCT01829347|301461|P2|STARTED|VTI-210||9
123190|NCT01829347|301462|P1|STARTED|VTI-210||9
123191|NCT01829295|301472|P4|NOT COMPLETED|6-12 Months||13
123192|NCT01829295|301473|P3|NOT COMPLETED|6-12 Months||12
123193|NCT01829295|301474|P2|NOT COMPLETED|6-12 Months||2
123194|NCT01829295|301475|P1|NOT COMPLETED|6-12 Months||4
123195|NCT01829295|301472|P4|COMPLETED|6-12 Months||29
123196|NCT01829295|301473|P3|COMPLETED|6-12 Months||20
123197|NCT01829295|301474|P2|COMPLETED|6-12 Months||54
123198|NCT01829295|301475|P1|COMPLETED|6-12 Months||60
123199|NCT01829295|301472|P4|STARTED|6-12 Months|42 patients failed on mycophenolate mofetil within the first 6 months|42
123200|NCT01829295|301473|P3|STARTED|6-12 Months|32 patients failed methotrexate within the first 6 months|32
123201|NCT01829295|301474|P2|STARTED|6-12 Months|56 patients were a treatment success on mycophenolate mofetil at 6 mo and had the option to continue|56
123202|NCT01829295|301475|P1|STARTED|6-12 Months|64 patients were a treatment success on methotrexate at 6 mo and had the option to continue|64
123203|NCT01829295|301472|P4|NOT COMPLETED|0-6 Months||0
123204|NCT01829295|301473|P3|NOT COMPLETED|0-6 Months||0
123205|NCT01829295|301474|P2|NOT COMPLETED|0-6 Months||11
123206|NCT01829295|301475|P1|NOT COMPLETED|0-6 Months||11
123207|NCT01829295|301472|P4|COMPLETED|0-6 Months||0
123208|NCT01829295|301473|P3|COMPLETED|0-6 Months||0
123209|NCT01829295|301474|P2|COMPLETED|0-6 Months||98
123210|NCT01829295|301475|P1|COMPLETED|0-6 Months||96
123211|NCT01829295|301472|P4|STARTED|0-6 Months||0
123212|NCT01829295|301473|P3|STARTED|0-6 Months||0
123213|NCT01829295|301474|P2|STARTED|0-6 Months||109
123214|NCT01829295|301475|P1|STARTED|0-6 Months||107
123215|NCT01829243|301485|P2|NOT COMPLETED|Second Intervention||0
123216|NCT01829243|301486|P1|NOT COMPLETED|Second Intervention||0
123217|NCT01829243|301485|P2|COMPLETED|Second Intervention||13
123218|NCT01829243|301486|P1|COMPLETED|Second Intervention||7
123219|NCT01829243|301485|P2|STARTED|Second Intervention||13
123220|NCT01829243|301486|P1|STARTED|Second Intervention||7
123221|NCT01829243|301485|P2|NOT COMPLETED|Washout Period of 1 Week||0
123222|NCT01829243|301486|P1|NOT COMPLETED|Washout Period of 1 Week||0
123223|NCT01829243|301485|P2|COMPLETED|Washout Period of 1 Week||13
123224|NCT01829243|301486|P1|COMPLETED|Washout Period of 1 Week||7
123225|NCT01829243|301485|P2|STARTED|Washout Period of 1 Week||13
123226|NCT01829243|301486|P1|STARTED|Washout Period of 1 Week||7
123227|NCT01829243|301485|P2|NOT COMPLETED|First Intervention||2
123228|NCT01829243|301486|P1|NOT COMPLETED|First Intervention||4
123229|NCT01829243|301485|P2|COMPLETED|First Intervention||13
123230|NCT01829243|301486|P1|COMPLETED|First Intervention||7
123231|NCT01829243|301485|P2|STARTED|First Intervention||15
123232|NCT01829243|301486|P1|STARTED|First Intervention||11
123233|NCT01829230|301500|P2|NOT COMPLETED|Overall Study||4
123234|NCT01829230|301501|P1|NOT COMPLETED|Overall Study||1
123235|NCT01829230|301500|P2|COMPLETED|Overall Study||38
123236|NCT01829230|301501|P1|COMPLETED|Overall Study||39
123237|NCT01829230|301500|P2|STARTED|Overall Study||42
123238|NCT01829230|301501|P1|STARTED|Overall Study||40
123239|NCT01829217|301509|P1|NOT COMPLETED|Overall Study||0
123240|NCT01829217|301509|P1|COMPLETED|Overall Study||13
123241|NCT01829217|301509|P1|STARTED|Overall Study||13
123242|NCT01829191|301515|P2|NOT COMPLETED|Overall Study||14
123243|NCT01829191|301516|P1|NOT COMPLETED|Overall Study||7
123244|NCT01829191|301515|P2|COMPLETED|Overall Study||50
123245|NCT01829191|301516|P1|COMPLETED|Overall Study||56
123246|NCT01829191|301515|P2|STARTED|Overall Study||64
123247|NCT01829191|301516|P1|STARTED|Overall Study||63
123248|NCT01829165|301525|P2|NOT COMPLETED|Overall Study||0
123249|NCT01829165|301526|P1|NOT COMPLETED|Overall Study||2
123250|NCT01829165|301525|P2|COMPLETED|Overall Study||13
123251|NCT01829165|301526|P1|COMPLETED|Overall Study||18
123252|NCT01829165|301525|P2|STARTED|Overall Study||13
123253|NCT01829165|301526|P1|STARTED|Overall Study||20
123254|NCT01829113|301534|P2|NOT COMPLETED|Overall Study||78
123255|NCT01829113|301535|P1|NOT COMPLETED|Overall Study||77
123256|NCT01829113|301534|P2|COMPLETED|Overall Study||0
123257|NCT01829113|301535|P1|COMPLETED|Overall Study||0
123258|NCT01829113|301534|P2|STARTED|Overall Study|Two patients were enrolled and randomized but never received treatment.|78
123259|NCT01829113|301535|P1|STARTED|Overall Study|Three patients were enrolled and randomized but never received treatment.|77
123260|NCT01829048|301552|P5|NOT COMPLETED|Overall Study||0
123261|NCT01829048|301553|P4|NOT COMPLETED|Overall Study||2
123262|NCT01829048|301554|P3|NOT COMPLETED|Overall Study||0
123263|NCT01829048|301555|P2|NOT COMPLETED|Overall Study||0
123264|NCT01829048|301556|P1|NOT COMPLETED|Overall Study||0
123265|NCT01829048|301552|P5|COMPLETED|Overall Study||2
123266|NCT01829048|301553|P4|COMPLETED|Overall Study||12
123267|NCT01829048|301554|P3|COMPLETED|Overall Study||7
123268|NCT01829048|301555|P2|COMPLETED|Overall Study||8
123269|NCT01829048|301556|P1|COMPLETED|Overall Study||6
123270|NCT01829048|301552|P5|STARTED|Overall Study||2
123271|NCT01829048|301553|P4|STARTED|Overall Study||14
123272|NCT01829048|301554|P3|STARTED|Overall Study||7
123273|NCT01829048|301555|P2|STARTED|Overall Study||8
123274|NCT01829048|301556|P1|STARTED|Overall Study||6
123275|NCT01828983|301630|P2|NOT COMPLETED|Overall Study||0
123276|NCT01828983|301631|P1|NOT COMPLETED|Overall Study||0
123277|NCT01828983|301630|P2|COMPLETED|Overall Study||81
123278|NCT01828983|301631|P1|COMPLETED|Overall Study||80
123279|NCT01828983|301630|P2|STARTED|Overall Study||81
123280|NCT01828983|301631|P1|STARTED|Overall Study||80
123281|NCT01828593|301644|P3|NOT COMPLETED|Placebo-Free Phase||6
123282|NCT01828593|301645|P2|NOT COMPLETED|Placebo-Free Phase||6
123283|NCT01828593|301646|P1|NOT COMPLETED|Placebo-Free Phase||0
123284|NCT01828593|301644|P3|COMPLETED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|41
123285|NCT01828593|301645|P2|COMPLETED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|49
123286|NCT01828593|301646|P1|COMPLETED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
123287|NCT01828593|301644|P3|STARTED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|47
123288|NCT01828593|301645|P2|STARTED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|55
123289|NCT01828593|301646|P1|STARTED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
123290|NCT01828593|301644|P3|NOT COMPLETED|Placebo-Controlled Phase||1
123291|NCT01828593|301645|P2|NOT COMPLETED|Placebo-Controlled Phase||0
123292|NCT01828593|301646|P1|NOT COMPLETED|Placebo-Controlled Phase||0
123293|NCT01828593|301644|P3|COMPLETED|Placebo-Controlled Phase||32
123294|NCT01828593|301645|P2|COMPLETED|Placebo-Controlled Phase||34
123295|NCT01828593|301646|P1|COMPLETED|Placebo-Controlled Phase||36
123296|NCT01828593|301644|P3|STARTED|Placebo-Controlled Phase||33
123297|NCT01828593|301645|P2|STARTED|Placebo-Controlled Phase||34
123298|NCT01828593|301646|P1|STARTED|Placebo-Controlled Phase||36
123299|NCT01828567|301669|P2|NOT COMPLETED|Overall Study||10
123300|NCT01828567|301670|P1|NOT COMPLETED|Overall Study||31
123301|NCT01828567|301669|P2|COMPLETED|Overall Study||199
123302|NCT01828567|301670|P1|COMPLETED|Overall Study||177
123303|NCT01828567|301669|P2|1 Month|Overall Study||192
123304|NCT01828567|301670|P1|1 Month|Overall Study||172
123305|NCT01828567|301669|P2|STARTED|Overall Study||209
123306|NCT01828567|301670|P1|STARTED|Overall Study||208
123307|NCT01828554|301686|P1|NOT COMPLETED|Overall Study||0
123308|NCT01828554|301686|P1|COMPLETED|Overall Study||8
123309|NCT01828554|301686|P1|STARTED|Overall Study||8
123310|NCT01828515|301693|P2|NOT COMPLETED|Second Intervention (19 Days)||3
123311|NCT01828515|301694|P1|NOT COMPLETED|Second Intervention (19 Days)||0
123312|NCT01828515|301693|P2|COMPLETED|Second Intervention (19 Days)||5
123313|NCT01828515|301694|P1|COMPLETED|Second Intervention (19 Days)||6
123314|NCT01828515|301693|P2|STARTED|Second Intervention (19 Days)||8
123315|NCT01828515|301694|P1|STARTED|Second Intervention (19 Days)||6
123316|NCT01828515|301693|P2|NOT COMPLETED|Washout (23 Days)||1
123317|NCT01828515|301694|P1|NOT COMPLETED|Washout (23 Days)||5
123318|NCT01828515|301693|P2|COMPLETED|Washout (23 Days)||8
123319|NCT01828515|301694|P1|COMPLETED|Washout (23 Days)||6
123320|NCT01828515|301693|P2|STARTED|Washout (23 Days)||9
123321|NCT01828515|301694|P1|STARTED|Washout (23 Days)||11
123322|NCT01828515|301693|P2|NOT COMPLETED|First Intervention (19 Days)||2
123323|NCT01828515|301694|P1|NOT COMPLETED|First Intervention (19 Days)||2
123324|NCT01828515|301693|P2|COMPLETED|First Intervention (19 Days)||9
123325|NCT01828515|301694|P1|COMPLETED|First Intervention (19 Days)||11
123326|NCT01828515|301693|P2|STARTED|First Intervention (19 Days)||11
123327|NCT01828515|301694|P1|STARTED|First Intervention (19 Days)||13
123328|NCT01828476|301702|P2|NOT COMPLETED|Overall Study||0
123329|NCT01828476|301703|P1|NOT COMPLETED|Overall Study||0
123330|NCT01828476|301702|P2|COMPLETED|Overall Study||0
123331|NCT01828476|301703|P1|COMPLETED|Overall Study||13
123332|NCT01828476|301702|P2|STARTED|Overall Study||0
123333|NCT01828476|301703|P1|STARTED|Overall Study||13
123334|NCT01828281|301725|P2|NOT COMPLETED|Overall Study||0
123335|NCT01828281|301726|P1|NOT COMPLETED|Overall Study||1
123336|NCT01828281|301725|P2|COMPLETED|Overall Study||45
123337|NCT01828281|301726|P1|COMPLETED|Overall Study||44
123338|NCT01828281|301725|P2|STARTED|Overall Study||45
123339|NCT01828281|301726|P1|STARTED|Overall Study||45
123340|NCT01828216|301738|P2|NOT COMPLETED|Overall Study||0
123341|NCT01828216|301739|P1|NOT COMPLETED|Overall Study||0
123342|NCT01828216|301738|P2|COMPLETED|Overall Study||157
123343|NCT01828216|301739|P1|COMPLETED|Overall Study||159
123344|NCT01828216|301738|P2|STARTED|Overall Study||157
123345|NCT01828216|301739|P1|STARTED|Overall Study||159
123346|NCT01828164|301747|P1|NOT COMPLETED|Overall Study||17
123347|NCT01828164|301747|P1|COMPLETED|Overall Study||32
123348|NCT01828164|301747|P1|STARTED|Overall Study|11 out of 60 subjects did not meet inclusion criteria after enrollment.|49
123349|NCT01828112|301759|P2|NOT COMPLETED|Overall Study||108
123350|NCT01828112|301760|P1|NOT COMPLETED|Overall Study||82
123351|NCT01828112|301759|P2|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|8
123352|NCT01828112|301760|P1|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|33
123353|NCT01828112|301759|P2|Treated|Overall Study||113
123354|NCT01828112|301760|P1|Treated|Overall Study||115
123355|NCT01828112|301759|P2|Untreated|Overall Study||3
123356|NCT01828112|301760|P1|Untreated|Overall Study||0
123357|NCT01828112|301759|P2|Untreated Patients|Overall Study|untreated = did not receive study drug|3
123358|NCT01828112|301760|P1|Untreated Patients|Overall Study||0
123359|NCT01828112|301759|P2|Discontinued From Study|Overall Study||10
123360|NCT01828112|301760|P1|Discontinued From Study|Overall Study||14
123361|NCT01828112|301759|P2|Entered Survival Follow-up Phase|Overall Study||19
123362|NCT01828112|301760|P1|Entered Survival Follow-up Phase|Overall Study||61
123363|NCT01828112|301759|P2|Entered Post-treatment Follow-up Phase|Overall Study||5
123364|NCT01828112|301760|P1|Entered Post-treatment Follow-up Phase|Overall Study||7
123365|NCT01828112|301759|P2|Entered Extension Treatment Phase|Overall Study||74
123366|NCT01828112|301760|P1|Entered Extension Treatment Phase|Overall Study||0
123367|NCT01828112|301759|P2|STARTED|Overall Study||116
123368|NCT01828112|301760|P1|STARTED|Overall Study||115
123369|NCT01828099|301768|P2|NOT COMPLETED|Overall Study||157
123370|NCT01828099|301769|P1|NOT COMPLETED|Overall Study||94
123371|NCT01828099|301768|P2|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|30
123372|NCT01828099|301769|P1|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|95
123373|NCT01828099|301768|P2|Discontinued From Study|Overall Study||29
123374|NCT01828099|301769|P1|Discontinued From Study|Overall Study||20
123375|NCT01828099|301768|P2|Entered Survival Follow-up Phase|Overall Study||31
123376|NCT01828099|301769|P1|Entered Survival Follow-up Phase|Overall Study||64
123377|NCT01828099|301768|P2|Entered Post-treatment Follow-up Phase|Overall Study||16
123378|NCT01828099|301769|P1|Entered Post-treatment Follow-up Phase|Overall Study||10
123379|NCT01828099|301768|P2|Entered Extension-treatment Phase|Overall Study||81
123380|NCT01828099|301769|P1|Entered Extension-treatment Phase|Overall Study||0
123381|NCT01828099|301768|P2|Discontinued From Treatment Phase|Overall Study||157
123382|NCT01828099|301769|P1|Discontinued From Treatment Phase|Overall Study||94
123383|NCT01828099|301768|P2|Treated|Overall Study||175
123384|NCT01828099|301769|P1|Treated|Overall Study|discontinued from treatment phase = Not completed|189
123385|NCT01828099|301768|P2|Untreated Patients|Overall Study||12
123386|NCT01828099|301769|P1|Untreated Patients|Overall Study||0
123387|NCT01828099|301768|P2|STARTED|Overall Study||187
123388|NCT01828099|301769|P1|STARTED|Overall Study||189
123389|NCT01828073|301777|P2|NOT COMPLETED|Overall Study||2
123390|NCT01828073|301778|P1|NOT COMPLETED|Overall Study||1
123391|NCT01828073|301777|P2|COMPLETED|Overall Study||16
123392|NCT01828073|301778|P1|COMPLETED|Overall Study||21
123393|NCT01828073|301777|P2|STARTED|Overall Study||18
123394|NCT01828073|301778|P1|STARTED|Overall Study||22
123395|NCT01827839|301798|P1|NOT COMPLETED|Overall Study||3
123396|NCT01827839|301798|P1|COMPLETED|Overall Study||93
123397|NCT01827839|301798|P1|STARTED|Overall Study||96
123398|NCT01827787|301822|P2|NOT COMPLETED|Overall Study||0
123399|NCT01827787|301823|P1|NOT COMPLETED|Overall Study||0
123400|NCT01827787|301822|P2|COMPLETED|Overall Study||38
123401|NCT01827787|301823|P1|COMPLETED|Overall Study||45
123402|NCT01827787|301822|P2|STARTED|Overall Study||38
123403|NCT01827787|301823|P1|STARTED|Overall Study||45
123404|NCT01827670|301843|P2|NOT COMPLETED|Overall Study||3
123405|NCT01827670|301844|P1|NOT COMPLETED|Overall Study||3
123406|NCT01827670|301843|P2|COMPLETED|Overall Study||56
123407|NCT01827670|301844|P1|COMPLETED|Overall Study||57
123408|NCT01827670|301843|P2|STARTED|Overall Study||59
123409|NCT01827670|301844|P1|STARTED|Overall Study||60
123410|NCT01827592|301863|P3|NOT COMPLETED|Overall Study||76
123411|NCT01827592|301864|P2|NOT COMPLETED|Overall Study||80
123412|NCT01827592|301865|P1|NOT COMPLETED|Overall Study||74
123413|NCT01827592|301863|P3|COMPLETED|Overall Study||48
123414|NCT01827592|301864|P2|COMPLETED|Overall Study||46
123415|NCT01827592|301865|P1|COMPLETED|Overall Study||52
123416|NCT01827592|301863|P3|Safety Analysis Set|Overall Study||124
123417|NCT01827592|301864|P2|Safety Analysis Set|Overall Study||126
123418|NCT01827592|301865|P1|Safety Analysis Set|Overall Study|1 patient withdrew consent before getting the treatment.|125
123419|NCT01827592|301863|P3|STARTED|Overall Study|Randomized patients.|124
123420|NCT01827592|301864|P2|STARTED|Overall Study|Randomized patients.|126
123421|NCT01827592|301865|P1|STARTED|Overall Study|Randomized patients.|126
123422|NCT01827475|301897|P3|NOT COMPLETED|Overall Study||0
123423|NCT01827475|301898|P2|NOT COMPLETED|Overall Study||0
123424|NCT01827475|301899|P1|NOT COMPLETED|Overall Study||0
123425|NCT01827475|301897|P3|COMPLETED|Overall Study||30
123426|NCT01827475|301898|P2|COMPLETED|Overall Study||30
123427|NCT01827475|301899|P1|COMPLETED|Overall Study||30
123428|NCT01827475|301897|P3|STARTED|Overall Study||30
123429|NCT01827475|301898|P2|STARTED|Overall Study||30
123430|NCT01827475|301899|P1|STARTED|Overall Study||30
123431|NCT01827462|301913|P3|NOT COMPLETED|Overall Study||28
123432|NCT01827462|301914|P2|NOT COMPLETED|Overall Study||18
123433|NCT01827462|301915|P1|NOT COMPLETED|Overall Study||41
123434|NCT01827462|301913|P3|COMPLETED|Overall Study||12
123435|NCT01827462|301914|P2|COMPLETED|Overall Study||19
123436|NCT01827462|301915|P1|COMPLETED|Overall Study||18
123437|NCT01827462|301913|P3|STARTED|Overall Study||40
123438|NCT01827462|301914|P2|STARTED|Overall Study||37
123439|NCT01827462|301915|P1|STARTED|Overall Study||59
123440|NCT01827371|301930|P4|NOT COMPLETED|Overall Study||23
123441|NCT01827371|301931|P3|NOT COMPLETED|Overall Study||11
123442|NCT01827371|301932|P2|NOT COMPLETED|Overall Study||7
123443|NCT01827371|301933|P1|NOT COMPLETED|Overall Study||13
123444|NCT01827371|301930|P4|COMPLETED|Overall Study||97
123445|NCT01827371|301931|P3|COMPLETED|Overall Study||93
123446|NCT01827371|301932|P2|COMPLETED|Overall Study||89
123447|NCT01827371|301933|P1|COMPLETED|Overall Study||102
123448|NCT01827371|301930|P4|STARTED|Overall Study||120
123449|NCT01827371|301931|P3|STARTED|Overall Study||104
123450|NCT01827371|301932|P2|STARTED|Overall Study||96
123451|NCT01827371|301933|P1|STARTED|Overall Study||115
123452|NCT01827358|301957|P2|NOT COMPLETED|Overall Study||31
123453|NCT01827358|301958|P1|NOT COMPLETED|Overall Study||35
123454|NCT01827358|301957|P2|COMPLETED|Overall Study||44
123455|NCT01827358|301958|P1|COMPLETED|Overall Study||45
123456|NCT01827358|301957|P2|STARTED|Overall Study||75
123457|NCT01827358|301958|P1|STARTED|Overall Study||80
123458|NCT01827332|301992|P2|NOT COMPLETED|Overall Study||1
123459|NCT01827332|301993|P1|NOT COMPLETED|Overall Study||2
123460|NCT01827332|301992|P2|COMPLETED|Overall Study||7
123461|NCT01827332|301993|P1|COMPLETED|Overall Study||6
123462|NCT01827332|301992|P2|STARTED|Overall Study||8
123463|NCT01827332|301993|P1|STARTED|Overall Study||8
123464|NCT01827319|302001|P1|NOT COMPLETED|Overall Study||3
123465|NCT01827319|302001|P1|COMPLETED|Overall Study||200
123466|NCT01827319|302001|P1|STARTED|Overall Study||203
123467|NCT01827306|302009|P2|NOT COMPLETED|Overall Study||5
123468|NCT01827306|302010|P1|NOT COMPLETED|Overall Study||11
123469|NCT01827306|302009|P2|COMPLETED|Overall Study||8
123470|NCT01827306|302010|P1|COMPLETED|Overall Study||10
123471|NCT01827306|302009|P2|STARTED|Overall Study||13
123472|NCT01827306|302010|P1|STARTED|Overall Study||21
123473|NCT01827267|302024|P2|NOT COMPLETED|Overall Study||12
123474|NCT01827267|302025|P1|NOT COMPLETED|Overall Study||5
123475|NCT01827267|302024|P2|COMPLETED|Overall Study||32
123476|NCT01827267|302025|P1|COMPLETED|Overall Study||13
123477|NCT01827267|302024|P2|Crossed Over to Neratinib + Temsirolimus|Overall Study||0
123478|NCT01827267|302025|P1|Crossed Over to Neratinib + Temsirolimus|Overall Study||11
123479|NCT01827267|302024|P2|Received Study Drug|Overall Study||43
123480|NCT01827267|302025|P1|Received Study Drug|Overall Study||17
123481|NCT01827267|302024|P2|STARTED|Overall Study|44 subjects were randomized; 43 subjects were treated.|44
123482|NCT01827267|302025|P1|STARTED|Overall Study|18 subjects were randomized but 17 received treatment.|18
123483|NCT01827254|302040|P1|NOT COMPLETED|Overall Study||59
123484|NCT01827254|302040|P1|COMPLETED|Overall Study||2
123485|NCT01827254|302040|P1|Evaluable Population|Overall Study||52
123486|NCT01827254|302040|P1|STARTED|Overall Study||61
123487|NCT01827046|302052|P2|NOT COMPLETED|Overall Study||9
123488|NCT01827046|302053|P1|NOT COMPLETED|Overall Study||1
123489|NCT01827046|302052|P2|COMPLETED|Overall Study||240
123490|NCT01827046|302053|P1|COMPLETED|Overall Study||249
123491|NCT01827046|302052|P2|STARTED|Overall Study||249
123492|NCT01827046|302053|P1|STARTED|Overall Study||250
123493|NCT01826981|302108|P15|NOT COMPLETED|Overall Study||0
123494|NCT01826981|302109|P14|NOT COMPLETED|Overall Study||5
123495|NCT01826981|302110|P13|NOT COMPLETED|Overall Study||1
123496|NCT01826981|302111|P12|NOT COMPLETED|Overall Study||2
123497|NCT01826981|302112|P11|NOT COMPLETED|Overall Study||2
123498|NCT01826981|302113|P10|NOT COMPLETED|Overall Study||1
123499|NCT01826981|302114|P9|NOT COMPLETED|Overall Study||7
123500|NCT01826981|302115|P8|NOT COMPLETED|Overall Study||11
123501|NCT01826981|302116|P7|NOT COMPLETED|Overall Study||1
123502|NCT01826981|302117|P6|NOT COMPLETED|Overall Study||1
123503|NCT01826981|302118|P5|NOT COMPLETED|Overall Study||7
123504|NCT01826981|302119|P4|NOT COMPLETED|Overall Study||0
123505|NCT01826981|302120|P3|NOT COMPLETED|Overall Study||0
123506|NCT01826981|302121|P2|NOT COMPLETED|Overall Study||1
123507|NCT01826981|302122|P1|NOT COMPLETED|Overall Study||0
123508|NCT01826981|302108|P15|COMPLETED|Overall Study||8
123509|NCT01826981|302109|P14|COMPLETED|Overall Study||15
123510|NCT01826981|302110|P13|COMPLETED|Overall Study||25
123511|NCT01826981|302111|P12|COMPLETED|Overall Study||25
123512|NCT01826981|302112|P11|COMPLETED|Overall Study||22
123513|NCT01826981|302113|P10|COMPLETED|Overall Study||26
123514|NCT01826981|302114|P9|COMPLETED|Overall Study||13
123515|NCT01826981|302115|P8|COMPLETED|Overall Study||40
123516|NCT01826981|302116|P7|COMPLETED|Overall Study||24
123517|NCT01826981|302117|P6|COMPLETED|Overall Study||25
123518|NCT01826981|302118|P5|COMPLETED|Overall Study||18
123519|NCT01826981|302119|P4|COMPLETED|Overall Study||26
123520|NCT01826981|302120|P3|COMPLETED|Overall Study||25
123521|NCT01826981|302121|P2|COMPLETED|Overall Study||9
123522|NCT01826981|302122|P1|COMPLETED|Overall Study||19
123523|NCT01826981|302108|P15|STARTED|Overall Study||8
123524|NCT01826981|302109|P14|STARTED|Overall Study||20
123525|NCT01826981|302110|P13|STARTED|Overall Study||26
123526|NCT01826981|302111|P12|STARTED|Overall Study||27
123527|NCT01826981|302112|P11|STARTED|Overall Study||24
123528|NCT01826981|302113|P10|STARTED|Overall Study||27
123529|NCT01826981|302114|P9|STARTED|Overall Study||20
123530|NCT01826981|302115|P8|STARTED|Overall Study||51
123531|NCT01826981|302116|P7|STARTED|Overall Study||25
123532|NCT01826981|302117|P6|STARTED|Overall Study||26
123533|NCT01826981|302118|P5|STARTED|Overall Study||25
123534|NCT01826981|302119|P4|STARTED|Overall Study||26
123535|NCT01826981|302120|P3|STARTED|Overall Study||25
123536|NCT01826981|302121|P2|STARTED|Overall Study||10
123537|NCT01826981|302122|P1|STARTED|Overall Study||19
123538|NCT01826851|302270|P2|NOT COMPLETED|Overall Study||0
123539|NCT01826851|302271|P1|NOT COMPLETED|Overall Study||0
123540|NCT01826851|302270|P2|COMPLETED|Overall Study||41
123541|NCT01826851|302271|P1|COMPLETED|Overall Study||38
123542|NCT01826851|302270|P2|STARTED|Overall Study||41
123543|NCT01826851|302271|P1|STARTED|Overall Study||38
123544|NCT01826812|302291|P2|NOT COMPLETED|Overall Study||1
123545|NCT01826812|302292|P1|NOT COMPLETED|Overall Study||0
123546|NCT01826812|302291|P2|COMPLETED|Overall Study||32
123547|NCT01826812|302292|P1|COMPLETED|Overall Study||167
123548|NCT01826812|302291|P2|STARTED|Overall Study||33
123549|NCT01826812|302292|P1|STARTED|Overall Study||167
123550|NCT01826604|302308|P2|NOT COMPLETED|Overall Study||9
123551|NCT01826604|302309|P1|NOT COMPLETED|Overall Study||8
123552|NCT01826604|302308|P2|COMPLETED|Overall Study||148
123553|NCT01826604|302309|P1|COMPLETED|Overall Study||136
123554|NCT01826604|302308|P2|STARTED|Overall Study||157
123555|NCT01826604|302309|P1|STARTED|Overall Study||144
123556|NCT01826513|302320|P3|NOT COMPLETED|Overall Study||0
123557|NCT01826513|302321|P2|NOT COMPLETED|Overall Study||0
123558|NCT01826513|302322|P1|NOT COMPLETED|Overall Study||0
123559|NCT01826513|302320|P3|COMPLETED|Overall Study||10
123560|NCT01826513|302321|P2|COMPLETED|Overall Study||10
123561|NCT01826513|302322|P1|COMPLETED|Overall Study||5
123562|NCT01826513|302320|P3|STARTED|Overall Study||10
123563|NCT01826513|302321|P2|STARTED|Overall Study||10
123564|NCT01826513|302322|P1|STARTED|Overall Study||5
123565|NCT01826422|302353|P2|NOT COMPLETED|Overall Study||3
123566|NCT01826422|302354|P1|NOT COMPLETED|Overall Study||1
123567|NCT01826422|302353|P2|COMPLETED|Overall Study||19
123568|NCT01826422|302354|P1|COMPLETED|Overall Study||17
123569|NCT01826422|302353|P2|STARTED|Overall Study||22
123570|NCT01826422|302354|P1|STARTED|Overall Study||18
123571|NCT01826370|302398|P1|NOT COMPLETED|Overall Study||20
123572|NCT01826370|302398|P1|COMPLETED|Overall Study||658
123573|NCT01826370|302398|P1|STARTED|Overall Study||678
123574|NCT01826227|302404|P1|NOT COMPLETED|Overall Study||0
123575|NCT01826227|302404|P1|COMPLETED|Overall Study||5
123576|NCT01826227|302404|P1|STARTED|Overall Study||5
123577|NCT01826214|302410|P2|NOT COMPLETED|Overall Study||34
123578|NCT01826214|302411|P1|NOT COMPLETED|Overall Study||35
123579|NCT01826214|302410|P2|COMPLETED|Overall Study||0
123580|NCT01826214|302411|P1|COMPLETED|Overall Study||0
123581|NCT01826214|302410|P2|Treated|Overall Study|Treated = received at least one dose of study drug|34
123582|NCT01826214|302411|P1|Treated|Overall Study|Treated = received at least one dose of study drug|35
123583|NCT01826214|302410|P2|Untreated|Overall Study|Untreated = did not receive study drug|1
123584|NCT01826214|302411|P1|Untreated|Overall Study|Untreated = did not receive study drug|0
123585|NCT01826214|302410|P2|STARTED|Overall Study|35 patients were randomized but only 34 patients received at least one dose of study drug|34
123586|NCT01826214|302411|P1|STARTED|Overall Study||35
123587|NCT01826201|302429|P1|NOT COMPLETED|Overall Study||4
123588|NCT01826201|302429|P1|COMPLETED|Overall Study||17
123589|NCT01826201|302429|P1|STARTED|Overall Study|Subjects in each arm are same|21
123590|NCT01825941|302437|P2|NOT COMPLETED|Overall Study||1
123591|NCT01825941|302438|P1|NOT COMPLETED|Overall Study||4
123592|NCT01825941|302437|P2|COMPLETED|Overall Study||103
123593|NCT01825941|302438|P1|COMPLETED|Overall Study||100
123594|NCT01825941|302437|P2|STARTED|Overall Study||104
123595|NCT01825941|302438|P1|STARTED|Overall Study||104
123596|NCT01825889|302446|P2|NOT COMPLETED|Overall Study||0
123597|NCT01825889|302447|P1|NOT COMPLETED|Overall Study||0
123598|NCT01825889|302446|P2|COMPLETED|Overall Study||10
123599|NCT01825889|302447|P1|COMPLETED|Overall Study||10
123600|NCT01825889|302446|P2|Received One Dose of Study Drug|Overall Study||10
123601|NCT01825889|302447|P1|Received One Dose of Study Drug|Overall Study||10
123602|NCT01825889|302446|P2|STARTED|Overall Study||10
123603|NCT01825889|302447|P1|STARTED|Overall Study||10
123604|NCT01825876|302457|P2|NOT COMPLETED|Period 2||1
123605|NCT01825876|302458|P1|NOT COMPLETED|Period 2||0
123606|NCT01825876|302457|P2|COMPLETED|Period 2||16
123607|NCT01825876|302458|P1|COMPLETED|Period 2||0
123608|NCT01825876|302457|P2|Received 1 Dose of Study Drug|Period 2||17
123609|NCT01825876|302458|P1|Received 1 Dose of Study Drug|Period 2||0
123610|NCT01825876|302457|P2|STARTED|Period 2|Participants received a different treatment in Period 1.|17
123611|NCT01825876|302458|P1|STARTED|Period 2|Participants received a different treatment in Period 2.|0
123612|NCT01825876|302457|P2|NOT COMPLETED|Period 1||0
123613|NCT01825876|302458|P1|NOT COMPLETED|Period 1||0
123614|NCT01825876|302457|P2|COMPLETED|Period 1||0
123615|NCT01825876|302458|P1|COMPLETED|Period 1||17
123616|NCT01825876|302457|P2|Received 1 Dose of Study Drug|Period 1||0
123617|NCT01825876|302458|P1|Received 1 Dose of Study Drug|Period 1||17
123618|NCT01825876|302457|P2|STARTED|Period 1||0
123619|NCT01825876|302458|P1|STARTED|Period 1||17
123620|NCT01825837|302479|P4|NOT COMPLETED|PART II||0
123621|NCT01825837|302480|P3|NOT COMPLETED|PART II||19
123622|NCT01825837|302481|P2|NOT COMPLETED|PART II||14
123623|NCT01825837|302482|P1|NOT COMPLETED|PART II||19
123624|NCT01825837|302479|P4|COMPLETED|PART II||0
123625|NCT01825837|302480|P3|COMPLETED|PART II||7
123626|NCT01825837|302481|P2|COMPLETED|PART II||12
123627|NCT01825837|302482|P1|COMPLETED|PART II||16
123628|NCT01825837|302479|P4|Per-Protocol Population|PART II||0
123629|NCT01825837|302480|P3|Per-Protocol Population|PART II||24
123630|NCT01825837|302481|P2|Per-Protocol Population|PART II||23
123631|NCT01825837|302482|P1|Per-Protocol Population|PART II||32
123632|NCT01825837|302479|P4|Intent-to-Treat Population|PART II||0
123633|NCT01825837|302480|P3|Intent-to-Treat Population|PART II||26
123634|NCT01825837|302481|P2|Intent-to-Treat Population|PART II||25
123635|NCT01825837|302482|P1|Intent-to-Treat Population|PART II||34
123636|NCT01825837|302479|P4|Safety Population (Double-Blind)|PART II||0
123637|NCT01825837|302480|P3|Safety Population (Double-Blind)|PART II||26
123638|NCT01825837|302481|P2|Safety Population (Double-Blind)|PART II||26
123639|NCT01825837|302482|P1|Safety Population (Double-Blind)|PART II||35
123640|NCT01825837|302479|P4|Randomized Patients|PART II||0
123641|NCT01825837|302480|P3|Randomized Patients|PART II||26
123642|NCT01825837|302481|P2|Randomized Patients|PART II||26
123643|NCT01825837|302482|P1|Randomized Patients|PART II||35
123644|NCT01825837|302479|P4|STARTED|PART II||0
123645|NCT01825837|302480|P3|STARTED|PART II||26
123646|NCT01825837|302481|P2|STARTED|PART II||26
123647|NCT01825837|302482|P1|STARTED|PART II||35
123648|NCT01825837|302479|P4|NOT COMPLETED|PART I||17
123649|NCT01825837|302480|P3|NOT COMPLETED|PART I||0
123650|NCT01825837|302481|P2|NOT COMPLETED|PART I||0
123651|NCT01825837|302482|P1|NOT COMPLETED|PART I||0
123652|NCT01825837|302479|P4|COMPLETED|PART I||87
123653|NCT01825837|302480|P3|COMPLETED|PART I||0
123654|NCT01825837|302481|P2|COMPLETED|PART I||0
123655|NCT01825837|302482|P1|COMPLETED|PART I||0
123656|NCT01825837|302479|P4|Safety Population (Open-Label)|PART I||104
123657|NCT01825837|302480|P3|Safety Population (Open-Label)|PART I||0
123658|NCT01825837|302481|P2|Safety Population (Open-Label)|PART I||0
123659|NCT01825837|302482|P1|Safety Population (Open-Label)|PART I||0
123660|NCT01825837|302479|P4|Enrolled|PART I||104
123661|NCT01825837|302480|P3|Enrolled|PART I||0
123662|NCT01825837|302481|P2|Enrolled|PART I||0
123663|NCT01825837|302482|P1|Enrolled|PART I||0
123664|NCT01825837|302479|P4|STARTED|PART I||104
123665|NCT01825837|302480|P3|STARTED|PART I||0
123666|NCT01825837|302481|P2|STARTED|PART I||0
123667|NCT01825837|302482|P1|STARTED|PART I||0
123668|NCT01825798|302492|P2|NOT COMPLETED|Overall Study||5
123669|NCT01825798|302493|P1|NOT COMPLETED|Overall Study||2
123670|NCT01825798|302492|P2|COMPLETED|Overall Study||23
123671|NCT01825798|302493|P1|COMPLETED|Overall Study||30
123672|NCT01825798|302492|P2|STARTED|Overall Study||28
123673|NCT01825798|302493|P1|STARTED|Overall Study||32
123674|NCT01825785|302528|P7|NOT COMPLETED|Overall Study||0
123675|NCT01825785|302529|P6|NOT COMPLETED|Overall Study||1
123676|NCT01825785|302530|P5|NOT COMPLETED|Overall Study||2
123677|NCT01825785|302531|P4|NOT COMPLETED|Overall Study||0
123678|NCT01825785|302532|P3|NOT COMPLETED|Overall Study||0
123679|NCT01825785|302533|P2|NOT COMPLETED|Overall Study||0
123680|NCT01825785|302534|P1|NOT COMPLETED|Overall Study||0
123681|NCT01825785|302528|P7|COMPLETED|Overall Study||6
123682|NCT01825785|302529|P6|COMPLETED|Overall Study||5
123683|NCT01825785|302530|P5|COMPLETED|Overall Study||4
123684|NCT01825785|302531|P4|COMPLETED|Overall Study||6
123685|NCT01825785|302532|P3|COMPLETED|Overall Study||6
123686|NCT01825785|302533|P2|COMPLETED|Overall Study||6
123687|NCT01825785|302534|P1|COMPLETED|Overall Study||12
123688|NCT01825785|302528|P7|STARTED|Overall Study||6
123689|NCT01825785|302529|P6|STARTED|Overall Study||6
123690|NCT01825785|302530|P5|STARTED|Overall Study||6
123691|NCT01825785|302531|P4|STARTED|Overall Study||6
123692|NCT01825785|302532|P3|STARTED|Overall Study||6
123693|NCT01825785|302533|P2|STARTED|Overall Study||6
123694|NCT01825785|302534|P1|STARTED|Overall Study||12
123695|NCT01825655|302680|P2|NOT COMPLETED|Overall Study||0
123696|NCT01825655|302681|P1|NOT COMPLETED|Overall Study||0
123697|NCT01825655|302680|P2|COMPLETED|Overall Study||2
123698|NCT01825655|302681|P1|COMPLETED|Overall Study||0
123699|NCT01825655|302680|P2|STARTED|Overall Study||2
123700|NCT01825655|302681|P1|STARTED|Overall Study||0
123701|NCT01825577|302687|P1|NOT COMPLETED|Overall Study||8
123702|NCT01825577|302687|P1|COMPLETED|Overall Study||6
123703|NCT01825577|302687|P1|STARTED|Overall Study||14
123704|NCT01825408|302696|P4|NOT COMPLETED|Overall Study||0
123705|NCT01825408|302697|P3|NOT COMPLETED|Overall Study||0
123706|NCT01825408|302698|P2|NOT COMPLETED|Overall Study||0
123707|NCT01825408|302699|P1|NOT COMPLETED|Overall Study||0
123708|NCT01825408|302696|P4|COMPLETED|Overall Study||12
123709|NCT01825408|302697|P3|COMPLETED|Overall Study||14
123710|NCT01825408|302698|P2|COMPLETED|Overall Study||7
123711|NCT01825408|302699|P1|COMPLETED|Overall Study||7
123712|NCT01825408|302696|P4|STARTED|Overall Study||12
123713|NCT01825408|302697|P3|STARTED|Overall Study||14
123714|NCT01825408|302698|P2|STARTED|Overall Study||7
123715|NCT01825408|302699|P1|STARTED|Overall Study||7
123716|NCT01825200|302711|P2|NOT COMPLETED|Overall Study||7
123717|NCT01825200|302712|P1|NOT COMPLETED|Overall Study||5
123718|NCT01825200|302711|P2|COMPLETED|Overall Study||1314
123719|NCT01825200|302712|P1|COMPLETED|Overall Study||1314
123720|NCT01825200|302711|P2|STARTED|Overall Study||1321
123721|NCT01825200|302712|P1|STARTED|Overall Study||1319
123722|NCT01825122|302726|P2|NOT COMPLETED|Overall Study||19
123723|NCT01825122|302727|P1|NOT COMPLETED|Overall Study||10
123724|NCT01825122|302726|P2|COMPLETED|Overall Study||59
123725|NCT01825122|302727|P1|COMPLETED|Overall Study||67
123726|NCT01825122|302726|P2|STARTED|Overall Study||78
123727|NCT01825122|302727|P1|STARTED|Overall Study||77
123728|NCT01824979|302735|P2|NOT COMPLETED|Overall Study||13
123729|NCT01824979|302736|P1|NOT COMPLETED|Overall Study||13
123730|NCT01824979|302735|P2|COMPLETED|Overall Study||37
123731|NCT01824979|302736|P1|COMPLETED|Overall Study||37
123732|NCT01824979|302735|P2|STARTED|Overall Study||50
123733|NCT01824979|302736|P1|STARTED|Overall Study||50
123734|NCT01824901|302744|P4|NOT COMPLETED|Overall Study||0
123735|NCT01824901|302745|P3|NOT COMPLETED|Overall Study||0
123736|NCT01824901|302746|P2|NOT COMPLETED|Overall Study||0
123737|NCT01824901|302747|P1|NOT COMPLETED|Overall Study||0
123738|NCT01824901|302744|P4|COMPLETED|Overall Study||0
123739|NCT01824901|302745|P3|COMPLETED|Overall Study||0
123740|NCT01824901|302746|P2|COMPLETED|Overall Study||0
123741|NCT01824901|302747|P1|COMPLETED|Overall Study||2
123742|NCT01824901|302744|P4|STARTED|Overall Study||0
123743|NCT01824901|302745|P3|STARTED|Overall Study||0
123744|NCT01824901|302746|P2|STARTED|Overall Study||0
123745|NCT01824901|302747|P1|STARTED|Overall Study||2
123746|NCT01824823|302753|P2|NOT COMPLETED|Overall Study||1
123747|NCT01824823|302754|P1|NOT COMPLETED|Overall Study||2
123748|NCT01824823|302753|P2|COMPLETED|Overall Study||0
123749|NCT01824823|302754|P1|COMPLETED|Overall Study||0
123750|NCT01824823|302753|P2|STARTED|Overall Study||1
123751|NCT01824823|302754|P1|STARTED|Overall Study||2
123752|NCT01824693|302763|P3|NOT COMPLETED|Overall Study||15
123753|NCT01824693|302764|P2|NOT COMPLETED|Overall Study||7
123754|NCT01824693|302765|P1|NOT COMPLETED|Overall Study||1
123755|NCT01824693|302763|P3|COMPLETED|Overall Study||0
123756|NCT01824693|302764|P2|COMPLETED|Overall Study||2
123757|NCT01824693|302765|P1|COMPLETED|Overall Study||5
123758|NCT01824693|302763|P3|STARTED|Overall Study||15
123759|NCT01824693|302764|P2|STARTED|Overall Study||9
123760|NCT01824693|302765|P1|STARTED|Overall Study||6
123761|NCT01824602|302782|P4|NOT COMPLETED|Overall Study||5
123762|NCT01824602|302783|P3|NOT COMPLETED|Overall Study||4
123763|NCT01824602|302784|P2|NOT COMPLETED|Overall Study||0
123764|NCT01824602|302785|P1|NOT COMPLETED|Overall Study||1
123765|NCT01824602|302782|P4|COMPLETED|Overall Study||5
123766|NCT01824602|302783|P3|COMPLETED|Overall Study||5
123767|NCT01824602|302784|P2|COMPLETED|Overall Study||8
123768|NCT01824602|302785|P1|COMPLETED|Overall Study||10
123769|NCT01824602|302782|P4|Intent-to-treat Population|Overall Study||9
123770|NCT01824602|302783|P3|Intent-to-treat Population|Overall Study||9
123771|NCT01824602|302784|P2|Intent-to-treat Population|Overall Study||8
123772|NCT01824602|302785|P1|Intent-to-treat Population|Overall Study||11
123773|NCT01824602|302782|P4|Safety Population|Overall Study||10
123774|NCT01824602|302783|P3|Safety Population|Overall Study||9
123775|NCT01824602|302784|P2|Safety Population|Overall Study||8
123776|NCT01824602|302785|P1|Safety Population|Overall Study||11
123777|NCT01824602|302782|P4|STARTED|Overall Study||10
123778|NCT01824602|302783|P3|STARTED|Overall Study||9
123779|NCT01824602|302784|P2|STARTED|Overall Study||8
123780|NCT01824602|302785|P1|STARTED|Overall Study||11
123781|NCT01824589|302799|P4|NOT COMPLETED|Overall Study||0
123782|NCT01824589|302800|P3|NOT COMPLETED|Overall Study||0
123783|NCT01824589|302801|P2|NOT COMPLETED|Overall Study||0
123784|NCT01824589|302802|P1|NOT COMPLETED|Overall Study||0
123785|NCT01824589|302799|P4|COMPLETED|Overall Study||0
123786|NCT01824589|302800|P3|COMPLETED|Overall Study||0
123787|NCT01824589|302801|P2|COMPLETED|Overall Study||0
123788|NCT01824589|302802|P1|COMPLETED|Overall Study||1
123789|NCT01824589|302799|P4|STARTED|Overall Study||0
123790|NCT01824589|302800|P3|STARTED|Overall Study||0
123791|NCT01824589|302801|P2|STARTED|Overall Study||0
123792|NCT01824589|302802|P1|STARTED|Overall Study||1
123793|NCT01824576|302824|P1|NOT COMPLETED|Overall Study||2
123794|NCT01824576|302824|P1|COMPLETED|Overall Study||7
123795|NCT01824576|302824|P1|STARTED|Overall Study||9
123796|NCT01824498|302842|P6|NOT COMPLETED|3rd Intervention (8 Weeks)||0
123797|NCT01824498|302843|P5|NOT COMPLETED|3rd Intervention (8 Weeks)||0
123798|NCT01824498|302844|P4|NOT COMPLETED|3rd Intervention (8 Weeks)||0
123799|NCT01824498|302845|P3|NOT COMPLETED|3rd Intervention (8 Weeks)||0
123800|NCT01824498|302846|P2|NOT COMPLETED|3rd Intervention (8 Weeks)||0
123801|NCT01824498|302847|P1|NOT COMPLETED|3rd Intervention (8 Weeks)||0
123802|NCT01824498|302842|P6|COMPLETED|3rd Intervention (8 Weeks)||4
123803|NCT01824498|302843|P5|COMPLETED|3rd Intervention (8 Weeks)||3
123804|NCT01824498|302844|P4|COMPLETED|3rd Intervention (8 Weeks)||2
123805|NCT01824498|302845|P3|COMPLETED|3rd Intervention (8 Weeks)||4
123806|NCT01824498|302846|P2|COMPLETED|3rd Intervention (8 Weeks)||2
123807|NCT01824498|302847|P1|COMPLETED|3rd Intervention (8 Weeks)||3
123808|NCT01824498|302842|P6|STARTED|3rd Intervention (8 Weeks)||4
123809|NCT01824498|302843|P5|STARTED|3rd Intervention (8 Weeks)||3
123810|NCT01824498|302844|P4|STARTED|3rd Intervention (8 Weeks)||2
123811|NCT01824498|302845|P3|STARTED|3rd Intervention (8 Weeks)||4
123812|NCT01824498|302846|P2|STARTED|3rd Intervention (8 Weeks)||2
123813|NCT01824498|302847|P1|STARTED|3rd Intervention (8 Weeks)||3
123814|NCT01824498|302842|P6|NOT COMPLETED|Washout (8 Weeks)||0
123815|NCT01824498|302843|P5|NOT COMPLETED|Washout (8 Weeks)||0
123816|NCT01824498|302844|P4|NOT COMPLETED|Washout (8 Weeks)||0
123817|NCT01824498|302845|P3|NOT COMPLETED|Washout (8 Weeks)||0
123818|NCT01824498|302846|P2|NOT COMPLETED|Washout (8 Weeks)||0
123819|NCT01824498|302847|P1|NOT COMPLETED|Washout (8 Weeks)||0
123820|NCT01824498|302842|P6|COMPLETED|Washout (8 Weeks)||4
123821|NCT01824498|302843|P5|COMPLETED|Washout (8 Weeks)||3
123822|NCT01824498|302844|P4|COMPLETED|Washout (8 Weeks)||2
123823|NCT01824498|302845|P3|COMPLETED|Washout (8 Weeks)||4
123824|NCT01824498|302846|P2|COMPLETED|Washout (8 Weeks)||2
123825|NCT01824498|302847|P1|COMPLETED|Washout (8 Weeks)||3
123826|NCT01824498|302842|P6|STARTED|Washout (8 Weeks)||4
123827|NCT01824498|302843|P5|STARTED|Washout (8 Weeks)||3
123828|NCT01824498|302844|P4|STARTED|Washout (8 Weeks)||2
123829|NCT01824498|302845|P3|STARTED|Washout (8 Weeks)||4
123830|NCT01824498|302846|P2|STARTED|Washout (8 Weeks)||2
123831|NCT01824498|302847|P1|STARTED|Washout (8 Weeks)||3
123832|NCT01824498|302842|P6|NOT COMPLETED|2nd Intervention (8 Weeks)||0
123833|NCT01824498|302843|P5|NOT COMPLETED|2nd Intervention (8 Weeks)||0
123834|NCT01824498|302844|P4|NOT COMPLETED|2nd Intervention (8 Weeks)||0
123835|NCT01824498|302845|P3|NOT COMPLETED|2nd Intervention (8 Weeks)||0
123836|NCT01824498|302846|P2|NOT COMPLETED|2nd Intervention (8 Weeks)||0
123837|NCT01824498|302847|P1|NOT COMPLETED|2nd Intervention (8 Weeks)||0
123838|NCT01824498|302842|P6|COMPLETED|2nd Intervention (8 Weeks)||4
123839|NCT01824498|302843|P5|COMPLETED|2nd Intervention (8 Weeks)||3
123840|NCT01824498|302844|P4|COMPLETED|2nd Intervention (8 Weeks)||2
123841|NCT01824498|302845|P3|COMPLETED|2nd Intervention (8 Weeks)||4
123842|NCT01824498|302846|P2|COMPLETED|2nd Intervention (8 Weeks)||2
123843|NCT01824498|302847|P1|COMPLETED|2nd Intervention (8 Weeks)||3
123844|NCT01824498|302842|P6|STARTED|2nd Intervention (8 Weeks)||4
123845|NCT01824498|302843|P5|STARTED|2nd Intervention (8 Weeks)||3
123846|NCT01824498|302844|P4|STARTED|2nd Intervention (8 Weeks)||2
123847|NCT01824498|302845|P3|STARTED|2nd Intervention (8 Weeks)||4
123848|NCT01824498|302846|P2|STARTED|2nd Intervention (8 Weeks)||2
123849|NCT01824498|302847|P1|STARTED|2nd Intervention (8 Weeks)||3
123850|NCT01824498|302842|P6|NOT COMPLETED|Washout (8 Weeks)||0
123851|NCT01824498|302843|P5|NOT COMPLETED|Washout (8 Weeks)||1
123852|NCT01824498|302844|P4|NOT COMPLETED|Washout (8 Weeks)||1
123853|NCT01824498|302845|P3|NOT COMPLETED|Washout (8 Weeks)||2
123854|NCT01824498|302846|P2|NOT COMPLETED|Washout (8 Weeks)||0
123855|NCT01824498|302847|P1|NOT COMPLETED|Washout (8 Weeks)||2
123856|NCT01824498|302842|P6|COMPLETED|Washout (8 Weeks)||4
123857|NCT01824498|302843|P5|COMPLETED|Washout (8 Weeks)||3
123858|NCT01824498|302844|P4|COMPLETED|Washout (8 Weeks)||2
123859|NCT01824498|302845|P3|COMPLETED|Washout (8 Weeks)||4
123860|NCT01824498|302846|P2|COMPLETED|Washout (8 Weeks)||2
123861|NCT01824498|302847|P1|COMPLETED|Washout (8 Weeks)||3
123862|NCT01824498|302842|P6|STARTED|Washout (8 Weeks)||4
123863|NCT01824498|302843|P5|STARTED|Washout (8 Weeks)|1 dropped out|4
123864|NCT01824498|302844|P4|STARTED|Washout (8 Weeks)|1 dropped out|3
123865|NCT01824498|302845|P3|STARTED|Washout (8 Weeks)|2 dropped out|6
123866|NCT01824498|302846|P2|STARTED|Washout (8 Weeks)||2
123867|NCT01824498|302847|P1|STARTED|Washout (8 Weeks)|2 dropped out|5
123868|NCT01824498|302842|P6|NOT COMPLETED|1st Intervention (8 Weeks)||0
123869|NCT01824498|302843|P5|NOT COMPLETED|1st Intervention (8 Weeks)||0
123870|NCT01824498|302844|P4|NOT COMPLETED|1st Intervention (8 Weeks)||0
123871|NCT01824498|302845|P3|NOT COMPLETED|1st Intervention (8 Weeks)||0
123872|NCT01824498|302846|P2|NOT COMPLETED|1st Intervention (8 Weeks)||0
123873|NCT01824498|302847|P1|NOT COMPLETED|1st Intervention (8 Weeks)||0
123874|NCT01824498|302842|P6|COMPLETED|1st Intervention (8 Weeks)||4
123875|NCT01824498|302843|P5|COMPLETED|1st Intervention (8 Weeks)||4
123876|NCT01824498|302844|P4|COMPLETED|1st Intervention (8 Weeks)||3
123877|NCT01824498|302845|P3|COMPLETED|1st Intervention (8 Weeks)||6
123878|NCT01824498|302846|P2|COMPLETED|1st Intervention (8 Weeks)||2
123879|NCT01824498|302847|P1|COMPLETED|1st Intervention (8 Weeks)||5
123880|NCT01824498|302842|P6|STARTED|1st Intervention (8 Weeks)||4
123881|NCT01824498|302843|P5|STARTED|1st Intervention (8 Weeks)||4
123882|NCT01824498|302844|P4|STARTED|1st Intervention (8 Weeks)||3
123883|NCT01824498|302845|P3|STARTED|1st Intervention (8 Weeks)||6
123884|NCT01824498|302846|P2|STARTED|1st Intervention (8 Weeks)||2
123885|NCT01824498|302847|P1|STARTED|1st Intervention (8 Weeks)||5
123886|NCT01824446|302855|P1|NOT COMPLETED|Overall Study||0
123887|NCT01824446|302855|P1|COMPLETED|Overall Study||6
123888|NCT01824446|302855|P1|STARTED|Overall Study||6
123889|NCT01824394|302881|P3|NOT COMPLETED|Overall Study||74
123890|NCT01824394|302882|P2|NOT COMPLETED|Overall Study||116
123891|NCT01824394|302883|P1|NOT COMPLETED|Overall Study||119
123892|NCT01824394|302881|P3|COMPLETED|Overall Study||51
123893|NCT01824394|302882|P2|COMPLETED|Overall Study||53
123894|NCT01824394|302883|P1|COMPLETED|Overall Study||55
123895|NCT01824394|302881|P3|Per-Protocol Population|Overall Study|Calibration Roll-in patients are not included in the per protocol population|0
123896|NCT01824394|302882|P2|Per-Protocol Population|Overall Study||148
123897|NCT01824394|302883|P1|Per-Protocol Population|Overall Study||150
123898|NCT01824394|302881|P3|Safety Population|Overall Study|Calibration Roll-in patients are included in the safety population|104
123899|NCT01824394|302882|P2|Safety Population|Overall Study||149
123900|NCT01824394|302883|P1|Safety Population|Overall Study||151
123901|NCT01824394|302881|P3|Intent to Treat Population|Overall Study|Calibration Roll-in patients are not included in the ITT|0
123902|NCT01824394|302882|P2|Intent to Treat Population|Overall Study||149
123903|NCT01824394|302883|P1|Intent to Treat Population|Overall Study||151
123904|NCT01824394|302881|P3|STARTED|Overall Study||125
123905|NCT01824394|302882|P2|STARTED|Overall Study||169
123906|NCT01824394|302883|P1|STARTED|Overall Study||174
123907|NCT01824355|302893|P1|NOT COMPLETED|Overall Study||3
123908|NCT01824355|302893|P1|COMPLETED|Overall Study||110
123909|NCT01824355|302893|P1|STARTED|Overall Study||113
123910|NCT01824342|302904|P2|NOT COMPLETED|Overall Study||5
123911|NCT01824342|302905|P1|NOT COMPLETED|Overall Study||9
123912|NCT01824342|302904|P2|COMPLETED|Overall Study||2
123913|NCT01824342|302905|P1|COMPLETED|Overall Study||2
123914|NCT01824342|302904|P2|STARTED|Overall Study||7
123915|NCT01824342|302905|P1|STARTED|Overall Study||11
123916|NCT01824303|302919|P2|NOT COMPLETED|Open Label Extension||0
123917|NCT01824303|302920|P1|NOT COMPLETED|Open Label Extension||0
123918|NCT01824303|302919|P2|COMPLETED|Open Label Extension||11
123919|NCT01824303|302920|P1|COMPLETED|Open Label Extension||12
123920|NCT01824303|302919|P2|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|11
123921|NCT01824303|302920|P1|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|12
123922|NCT01824303|302919|P2|NOT COMPLETED|Randomized Study||1
123923|NCT01824303|302920|P1|NOT COMPLETED|Randomized Study||2
123924|NCT01824303|302919|P2|COMPLETED|Randomized Study||13
123925|NCT01824303|302920|P1|COMPLETED|Randomized Study||14
123926|NCT01824303|302919|P2|STARTED|Randomized Study||14
123927|NCT01824303|302920|P1|STARTED|Randomized Study||16
123928|NCT01824160|302944|P1|NOT COMPLETED|Overall Study||0
123929|NCT01824160|302944|P1|COMPLETED|Overall Study||50
123930|NCT01824160|302944|P1|STARTED|Overall Study||50
123931|NCT01823991|302950|P2|NOT COMPLETED|Overall Study||5
123932|NCT01823991|302951|P1|NOT COMPLETED|Overall Study||8
123933|NCT01823991|302950|P2|COMPLETED|Overall Study||13
123934|NCT01823991|302951|P1|COMPLETED|Overall Study||10
123935|NCT01823991|302950|P2|STARTED|Overall Study||18
123936|NCT01823991|302951|P1|STARTED|Overall Study||18
123937|NCT01823679|302983|P1|NOT COMPLETED|Overall Study||1
123938|NCT01823679|302983|P1|COMPLETED|Overall Study||1
123939|NCT01823679|302983|P1|STARTED|Overall Study||2
123940|NCT01823653|302991|P1|NOT COMPLETED|Overall Study||0
123941|NCT01823653|302991|P1|COMPLETED|Overall Study||60
123942|NCT01823653|302991|P1|STARTED|Overall Study||60
123943|NCT01823614|303005|P6|NOT COMPLETED|Overall Study||0
123944|NCT01823614|303006|P5|NOT COMPLETED|Overall Study||0
123945|NCT01823614|303007|P4|NOT COMPLETED|Overall Study||0
123946|NCT01823614|303008|P3|NOT COMPLETED|Overall Study||0
123947|NCT01823614|303009|P2|NOT COMPLETED|Overall Study||0
123948|NCT01823614|303010|P1|NOT COMPLETED|Overall Study||0
123949|NCT01823614|303005|P6|COMPLETED|Overall Study||154
123950|NCT01823614|303006|P5|COMPLETED|Overall Study||172
123951|NCT01823614|303007|P4|COMPLETED|Overall Study||122
123952|NCT01823614|303008|P3|COMPLETED|Overall Study||176
123953|NCT01823614|303009|P2|COMPLETED|Overall Study||140
123954|NCT01823614|303010|P1|COMPLETED|Overall Study||179
123955|NCT01823614|303005|P6|STARTED|Overall Study||154
123956|NCT01823614|303006|P5|STARTED|Overall Study||172
123957|NCT01823614|303007|P4|STARTED|Overall Study||122
123958|NCT01823614|303008|P3|STARTED|Overall Study||176
123959|NCT01823614|303009|P2|STARTED|Overall Study||140
123960|NCT01823614|303010|P1|STARTED|Overall Study||179
123961|NCT01823536|303036|P6|NOT COMPLETED|Overall Study||0
123962|NCT01823536|303037|P5|NOT COMPLETED|Overall Study||2
123963|NCT01823536|303038|P4|NOT COMPLETED|Overall Study||2
123964|NCT01823536|303039|P3|NOT COMPLETED|Overall Study||1
123965|NCT01823536|303040|P2|NOT COMPLETED|Overall Study||2
123966|NCT01823536|303041|P1|NOT COMPLETED|Overall Study||2
123967|NCT01823536|303036|P6|COMPLETED|Overall Study||2
123968|NCT01823536|303037|P5|COMPLETED|Overall Study||99
123969|NCT01823536|303038|P4|COMPLETED|Overall Study||64
123970|NCT01823536|303039|P3|COMPLETED|Overall Study||119
123971|NCT01823536|303040|P2|COMPLETED|Overall Study||101
123972|NCT01823536|303041|P1|COMPLETED|Overall Study||71
123973|NCT01823536|303036|P6|STARTED|Overall Study||2
123974|NCT01823536|303037|P5|STARTED|Overall Study||101
123975|NCT01823536|303038|P4|STARTED|Overall Study||66
123976|NCT01823536|303039|P3|STARTED|Overall Study||120
123977|NCT01823536|303040|P2|STARTED|Overall Study||103
123978|NCT01823536|303041|P1|STARTED|Overall Study||73
123979|NCT01823510|303079|P2|NOT COMPLETED|Days 22-28||0
123980|NCT01823510|303080|P1|NOT COMPLETED|Days 22-28||0
123981|NCT01823510|303079|P2|COMPLETED|Days 22-28||10
123982|NCT01823510|303080|P1|COMPLETED|Days 22-28||10
123983|NCT01823510|303079|P2|STARTED|Days 22-28||10
123984|NCT01823510|303080|P1|STARTED|Days 22-28||10
123985|NCT01823510|303079|P2|NOT COMPLETED|Days 8-21||0
123986|NCT01823510|303080|P1|NOT COMPLETED|Days 8-21||0
123987|NCT01823510|303079|P2|COMPLETED|Days 8-21||10
123988|NCT01823510|303080|P1|COMPLETED|Days 8-21||10
123989|NCT01823510|303079|P2|STARTED|Days 8-21||10
123990|NCT01823510|303080|P1|STARTED|Days 8-21||10
123991|NCT01823510|303079|P2|NOT COMPLETED|Days 1-7||0
123992|NCT01823510|303080|P1|NOT COMPLETED|Days 1-7||0
123993|NCT01823510|303079|P2|COMPLETED|Days 1-7||10
123994|NCT01823510|303080|P1|COMPLETED|Days 1-7||10
123995|NCT01823510|303079|P2|STARTED|Days 1-7||10
123996|NCT01823510|303080|P1|STARTED|Days 1-7||10
123997|NCT01823341|303092|P1|NOT COMPLETED|Overall Study||15
123998|NCT01823341|303092|P1|COMPLETED|Overall Study||82
123999|NCT01823341|303092|P1|STARTED|Overall Study||97
124000|NCT01823328|303137|P2|NOT COMPLETED|Overall Study||6
124001|NCT01823328|303138|P1|NOT COMPLETED|Overall Study||8
124002|NCT01823328|303137|P2|COMPLETED|Overall Study||67
124003|NCT01823328|303138|P1|COMPLETED|Overall Study||62
124004|NCT01823328|303137|P2|STARTED|Overall Study||73
124005|NCT01823328|303138|P1|STARTED|Overall Study||70
124006|NCT01823289|303158|P1|NOT COMPLETED|Overall Study||24
124007|NCT01823289|303158|P1|COMPLETED|Overall Study||47
124008|NCT01823289|303158|P1|STARTED|Overall Study||71
124009|NCT01823224|303166|P2|NOT COMPLETED|Overall Study||11
124010|NCT01823224|303167|P1|NOT COMPLETED|Overall Study||6
124011|NCT01823224|303166|P2|COMPLETED|Overall Study||22
124012|NCT01823224|303167|P1|COMPLETED|Overall Study||28
124013|NCT01823224|303166|P2|STARTED|Overall Study||33
124014|NCT01823224|303167|P1|STARTED|Overall Study||34
124015|NCT01823146|303177|P2|NOT COMPLETED|Overall Study||2
124016|NCT01823146|303178|P1|NOT COMPLETED|Overall Study||2
124017|NCT01823146|303177|P2|COMPLETED|Overall Study||49
124018|NCT01823146|303178|P1|COMPLETED|Overall Study||53
124019|NCT01823146|303177|P2|STARTED|Overall Study||51
124020|NCT01823146|303178|P1|STARTED|Overall Study||55
124021|NCT01823107|303188|P1|NOT COMPLETED|Overall Study||1
124022|NCT01823107|303188|P1|COMPLETED|Overall Study||24
124023|NCT01823107|303188|P1|STARTED|Overall Study||25
124024|NCT01822899|303196|P2|NOT COMPLETED|Overall Study||18
124025|NCT01822899|303197|P1|NOT COMPLETED|Overall Study||24
124026|NCT01822899|303196|P2|COMPLETED|Overall Study||340
124027|NCT01822899|303197|P1|COMPLETED|Overall Study||334
124028|NCT01822899|303196|P2|STARTED|Overall Study||358
124029|NCT01822899|303197|P1|STARTED|Overall Study||358
124030|NCT01822886|303205|P1|NOT COMPLETED|Overall Study||15
124031|NCT01822886|303205|P1|COMPLETED|Overall Study||5
124032|NCT01822886|303205|P1|STARTED|Overall Study||20
124033|NCT01822821|303215|P2|NOT COMPLETED|Overall Study||1
124034|NCT01822821|303216|P1|NOT COMPLETED|Overall Study||2
124035|NCT01822821|303215|P2|COMPLETED|Overall Study||74
124036|NCT01822821|303216|P1|COMPLETED|Overall Study||73
124037|NCT01822821|303215|P2|STARTED|Overall Study||75
124038|NCT01822821|303216|P1|STARTED|Overall Study||75
124039|NCT01822756|303245|P5|NOT COMPLETED|Overall Study||7
124040|NCT01822756|303246|P4|NOT COMPLETED|Overall Study||4
124041|NCT01822756|303247|P3|NOT COMPLETED|Overall Study||10
124042|NCT01822756|303248|P2|NOT COMPLETED|Overall Study||4
124043|NCT01822756|303249|P1|NOT COMPLETED|Overall Study||16
124044|NCT01822756|303245|P5|COMPLETED|Overall Study||1
124045|NCT01822756|303246|P4|COMPLETED|Overall Study||0
124046|NCT01822756|303247|P3|COMPLETED|Overall Study||0
124047|NCT01822756|303248|P2|COMPLETED|Overall Study||0
124048|NCT01822756|303249|P1|COMPLETED|Overall Study||0
124049|NCT01822756|303245|P5|Discontinued From the Study|Overall Study||7
124050|NCT01822756|303246|P4|Discontinued From the Study|Overall Study||4
124051|NCT01822756|303247|P3|Discontinued From the Study|Overall Study||10
124052|NCT01822756|303248|P2|Discontinued From the Study|Overall Study||4
124053|NCT01822756|303249|P1|Discontinued From the Study|Overall Study||16
124054|NCT01822756|303245|P5|STARTED|Overall Study||8
124055|NCT01822756|303246|P4|STARTED|Overall Study||4
124056|NCT01822756|303247|P3|STARTED|Overall Study||10
124057|NCT01822756|303248|P2|STARTED|Overall Study||4
124058|NCT01822756|303249|P1|STARTED|Overall Study||16
124059|NCT01822691|303291|P1|NOT COMPLETED|Overall Study||2
124060|NCT01822691|303291|P1|COMPLETED|Overall Study||13
124061|NCT01822691|303291|P1|STARTED|Overall Study||15
124062|NCT01822678|303302|P3|NOT COMPLETED|Overall Study||11
124063|NCT01822678|303303|P2|NOT COMPLETED|Overall Study||15
124064|NCT01822678|303304|P1|NOT COMPLETED|Overall Study||12
124065|NCT01822678|303302|P3|COMPLETED|Overall Study||29
124066|NCT01822678|303303|P2|COMPLETED|Overall Study||49
124067|NCT01822678|303304|P1|COMPLETED|Overall Study||45
124068|NCT01822678|303302|P3|Per Protocol Population|Overall Study||34
124069|NCT01822678|303303|P2|Per Protocol Population|Overall Study||52
124070|NCT01822678|303304|P1|Per Protocol Population|Overall Study||45
124071|NCT01822678|303302|P3|Intention-to-Treat Population (ITT)|Overall Study||40
124072|NCT01822678|303303|P2|Intention-to-Treat Population (ITT)|Overall Study|1 patient was excluded from the ITT population because he did not have post baseline efficacy data|63
124073|NCT01822678|303304|P1|Intention-to-Treat Population (ITT)|Overall Study||57
124074|NCT01822678|303302|P3|Safety Population|Overall Study||40
124075|NCT01822678|303303|P2|Safety Population|Overall Study||64
124076|NCT01822678|303304|P1|Safety Population|Overall Study||57
124077|NCT01822678|303302|P3|Treated|Overall Study||40
124078|NCT01822678|303303|P2|Treated|Overall Study||64
124079|NCT01822678|303304|P1|Treated|Overall Study||57
124080|NCT01822678|303302|P3|STARTED|Overall Study||40
124081|NCT01822678|303303|P2|STARTED|Overall Study||64
124082|NCT01822678|303304|P1|STARTED|Overall Study||57
124083|NCT01822665|303312|P1|NOT COMPLETED|Overall Study||8
124084|NCT01822665|303312|P1|COMPLETED|Overall Study||20
124085|NCT01822665|303312|P1|Received Paracetamol Tablet (1000 mg)|Overall Study||28
124086|NCT01822665|303312|P1|Received Ibuprofen Capsule (400 mg)|Overall Study|Two participants, each in period 3 and period 4 did not complete treatment for 'other reason'.|24
124087|NCT01822665|303312|P1|Received Placebo Tablet|Overall Study|5 participants did not complete; Period 2(1:other reason); Period 4(3:adverse event; 1:other reason)|23
124088|NCT01822665|303312|P1|Received Ibuprofen Tablet (400 mg)|Overall Study|5 participants did not complete; Period 3(2:adverse events;1:other reason); Period 4(2:other reason)|23
124089|NCT01822665|303312|P1|STARTED|Overall Study||28
124090|NCT01822574|303339|P3|NOT COMPLETED|Overall Study||0
124091|NCT01822574|303340|P2|NOT COMPLETED|Overall Study||0
124092|NCT01822574|303341|P1|NOT COMPLETED|Overall Study||0
124093|NCT01822574|303339|P3|COMPLETED|Overall Study||30
124094|NCT01822574|303340|P2|COMPLETED|Overall Study||30
124095|NCT01822574|303341|P1|COMPLETED|Overall Study||30
124096|NCT01822574|303339|P3|STARTED|Overall Study||30
124097|NCT01822574|303340|P2|STARTED|Overall Study||30
124098|NCT01822574|303341|P1|STARTED|Overall Study||30
124099|NCT01822561|303355|P1|NOT COMPLETED|Overall Study||2
124100|NCT01822561|303355|P1|COMPLETED|Overall Study||13
124101|NCT01822561|303355|P1|STARTED|Overall Study||15
124102|NCT01822548|303365|P2|NOT COMPLETED|Overall Study||0
124103|NCT01822548|303366|P1|NOT COMPLETED|Overall Study||0
124104|NCT01822548|303365|P2|COMPLETED|Overall Study||24
124105|NCT01822548|303366|P1|COMPLETED|Overall Study||40
124106|NCT01822548|303365|P2|Discontinued Intervention|Overall Study||5
124107|NCT01822548|303366|P1|Discontinued Intervention|Overall Study||0
124108|NCT01822548|303365|P2|STARTED|Overall Study||24
124109|NCT01822548|303366|P1|STARTED|Overall Study|Received allocated intervention n=38 Did not receive allocated intervention (only metformin) n=2|40
124110|NCT01822535|303376|P2|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
124111|NCT01822535|303377|P1|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||1
124112|NCT01822535|303376|P2|COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
124113|NCT01822535|303377|P1|COMPLETED|Visit 2 - Tetraplegia Only - Drug||10
124114|NCT01822535|303376|P2|STARTED|Visit 2 - Tetraplegia Only - Drug|Able-bodied subjects were not enrolled for a second visit.|0
124115|NCT01822535|303377|P1|STARTED|Visit 2 - Tetraplegia Only - Drug|These subjects were individuals who completed Visit 1 of testing.|11
124116|NCT01822535|303376|P2|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||2
124117|NCT01822535|303377|P1|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||6
124118|NCT01822535|303376|P2|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
124119|NCT01822535|303377|P1|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
124120|NCT01822535|303376|P2|STARTED|Visit 1 - Tetraplegia and Able-Bodied||13
124121|NCT01822535|303377|P1|STARTED|Visit 1 - Tetraplegia and Able-Bodied||17
124122|NCT01822496|303393|P4|NOT COMPLETED|Overall Study||4
124123|NCT01822496|303394|P3|NOT COMPLETED|Overall Study||0
124124|NCT01822496|303395|P2|NOT COMPLETED|Overall Study||2
124125|NCT01822496|303396|P1|NOT COMPLETED|Overall Study||2
124126|NCT01822496|303393|P4|COMPLETED|Overall Study||7
124127|NCT01822496|303394|P3|COMPLETED|Overall Study||9
124128|NCT01822496|303395|P2|COMPLETED|Overall Study||21
124129|NCT01822496|303396|P1|COMPLETED|Overall Study||14
124130|NCT01822496|303393|P4|Eligible and Started Study Treatment|Overall Study||7
124131|NCT01822496|303394|P3|Eligible and Started Study Treatment|Overall Study||9
124132|NCT01822496|303395|P2|Eligible and Started Study Treatment|Overall Study||20
124133|NCT01822496|303396|P1|Eligible and Started Study Treatment|Overall Study||14
124134|NCT01822496|303393|P4|Eligible With Disease Assessment|Overall Study||4
124135|NCT01822496|303394|P3|Eligible With Disease Assessment|Overall Study||6
124136|NCT01822496|303395|P2|Eligible With Disease Assessment|Overall Study||15
124137|NCT01822496|303396|P1|Eligible With Disease Assessment|Overall Study||10
124138|NCT01822496|303393|P4|Eligible|Overall Study||7
124139|NCT01822496|303394|P3|Eligible|Overall Study||9
124140|NCT01822496|303395|P2|Eligible|Overall Study||21
124141|NCT01822496|303396|P1|Eligible|Overall Study||14
124142|NCT01822496|303393|P4|STARTED|Overall Study||11
124143|NCT01822496|303394|P3|STARTED|Overall Study||9
124144|NCT01822496|303395|P2|STARTED|Overall Study||23
124145|NCT01822496|303396|P1|STARTED|Overall Study||16
124146|NCT01822366|303434|P4|NOT COMPLETED|Overall Study||22
124147|NCT01822366|303435|P3|NOT COMPLETED|Overall Study||5
124148|NCT01822366|303436|P2|NOT COMPLETED|Overall Study||22
124149|NCT01822366|303437|P1|NOT COMPLETED|Overall Study||5
124150|NCT01822366|303434|P4|COMPLETED|Overall Study||298
124151|NCT01822366|303435|P3|COMPLETED|Overall Study||315
124152|NCT01822366|303436|P2|COMPLETED|Overall Study||298
124153|NCT01822366|303437|P1|COMPLETED|Overall Study||315
124154|NCT01822366|303434|P4|STARTED|Overall Study||320
124155|NCT01822366|303435|P3|STARTED|Overall Study||320
124156|NCT01822366|303436|P2|STARTED|Overall Study||320
124157|NCT01822366|303437|P1|STARTED|Overall Study||320
124158|NCT01822353|303468|P3|NOT COMPLETED|Overall Study||1
124159|NCT01822353|303469|P2|NOT COMPLETED|Overall Study||5
124160|NCT01822353|303470|P1|NOT COMPLETED|Overall Study||4
124161|NCT01822353|303468|P3|COMPLETED|Overall Study||3
124162|NCT01822353|303469|P2|COMPLETED|Overall Study||4
124163|NCT01822353|303470|P1|COMPLETED|Overall Study||6
124164|NCT01822353|303468|P3|STARTED|Overall Study||4
124165|NCT01822353|303469|P2|STARTED|Overall Study||9
124166|NCT01822353|303470|P1|STARTED|Overall Study||10
124167|NCT01822301|303478|P1|NOT COMPLETED|Overall Study||0
124168|NCT01822301|303478|P1|COMPLETED|Overall Study||5
124169|NCT01822301|303478|P1|STARTED|Overall Study||5
124170|NCT01822223|303490|P2|NOT COMPLETED|Overall Study||1
124171|NCT01822223|303491|P1|NOT COMPLETED|Overall Study||0
124172|NCT01822223|303490|P2|COMPLETED|Overall Study||9
124173|NCT01822223|303491|P1|COMPLETED|Overall Study||10
124174|NCT01822223|303490|P2|STARTED|Overall Study||10
124175|NCT01822223|303491|P1|STARTED|Overall Study||10
124176|NCT01822197|303507|P1|NOT COMPLETED|Overall Study||0
124177|NCT01822197|303507|P1|COMPLETED|Overall Study||30
124178|NCT01822197|303507|P1|STARTED|Overall Study||30
124179|NCT01822132|303515|P2|NOT COMPLETED|Overall Study||2
124180|NCT01822132|303516|P1|NOT COMPLETED|Overall Study||4
124181|NCT01822132|303515|P2|COMPLETED|Overall Study||25
124182|NCT01822132|303516|P1|COMPLETED|Overall Study||21
124183|NCT01822132|303515|P2|STARTED|Overall Study||27
124184|NCT01822132|303516|P1|STARTED|Overall Study||25
124185|NCT01822119|303530|P1|NOT COMPLETED|Overall Study||0
124186|NCT01822119|303530|P1|COMPLETED|Overall Study||27
124187|NCT01822119|303530|P1|STARTED|Overall Study||27
124188|NCT01821963|303553|P1|NOT COMPLETED|Overall Study||1
124189|NCT01821963|303553|P1|COMPLETED|Overall Study||0
124190|NCT01821963|303553|P1|STARTED|Overall Study||1
124191|NCT01821937|303559|P2|NOT COMPLETED|Overall Study||3
124192|NCT01821937|303560|P1|NOT COMPLETED|Overall Study||0
124193|NCT01821937|303559|P2|COMPLETED|Overall Study|2 patients discontinued during Single dose period,1 Patient discontinued during Multiple dose period|12
124194|NCT01821937|303560|P1|COMPLETED|Overall Study||10
124195|NCT01821937|303559|P2|STARTED|Overall Study||15
124196|NCT01821937|303560|P1|STARTED|Overall Study||10
124197|NCT01821859|303578|P1|NOT COMPLETED|Overall Study||5
124198|NCT01821859|303578|P1|COMPLETED|Overall Study||0
124199|NCT01821859|303578|P1|STARTED|Overall Study||5
124200|NCT01821807|303584|P2|NOT COMPLETED|Overall Study||1
124201|NCT01821807|303585|P1|NOT COMPLETED|Overall Study||3
124202|NCT01821807|303584|P2|COMPLETED|Overall Study||109
124203|NCT01821807|303585|P1|COMPLETED|Overall Study||147
124204|NCT01821807|303584|P2|STARTED|Overall Study||110
124205|NCT01821807|303585|P1|STARTED|Overall Study||150
124206|NCT01821729|303593|P1|NOT COMPLETED|Overall Study||1
124207|NCT01821729|303593|P1|COMPLETED|Overall Study||49
124208|NCT01821729|303593|P1|Underwent Attempted Surgery|Overall Study||42
124209|NCT01821729|303593|P1|Received Chemoradiotherapy|Overall Study||45
124210|NCT01821729|303593|P1|STARTED|Overall Study||50
124211|NCT01821625|303598|P1|NOT COMPLETED|Overall Study||6
124212|NCT01821625|303598|P1|COMPLETED|Overall Study||1
124213|NCT01821625|303598|P1|STARTED|Overall Study||7
124214|NCT01821560|303604|P2|NOT COMPLETED|Overall Study||7
124215|NCT01821560|303605|P1|NOT COMPLETED|Overall Study||6
124216|NCT01821560|303604|P2|COMPLETED|Overall Study||15
124217|NCT01821560|303605|P1|COMPLETED|Overall Study||16
124218|NCT01821560|303604|P2|STARTED|Overall Study||22
124219|NCT01821560|303605|P1|STARTED|Overall Study||22
124220|NCT01821534|303611|P1|NOT COMPLETED|Overall Study||0
124221|NCT01821534|303611|P1|COMPLETED|Overall Study||201
124222|NCT01821534|303611|P1|STARTED|Overall Study||201
124223|NCT01821417|303620|P2|NOT COMPLETED|Overall Study||0
124224|NCT01821417|303621|P1|NOT COMPLETED|Overall Study||0
124225|NCT01821417|303620|P2|COMPLETED|Overall Study||31
124226|NCT01821417|303621|P1|COMPLETED|Overall Study||37
124227|NCT01821417|303620|P2|STARTED|Overall Study||31
124228|NCT01821417|303621|P1|STARTED|Overall Study||37
124229|NCT01821378|303634|P3|NOT COMPLETED|Overall Study||42
124230|NCT01821378|303635|P2|NOT COMPLETED|Overall Study||54
124231|NCT01821378|303636|P1|NOT COMPLETED|Overall Study||27
124232|NCT01821378|303634|P3|COMPLETED|Overall Study||70
124233|NCT01821378|303635|P2|COMPLETED|Overall Study||145
124234|NCT01821378|303636|P1|COMPLETED|Overall Study||74
124235|NCT01821378|303634|P3|STARTED|Overall Study||112
124236|NCT01821378|303635|P2|STARTED|Overall Study||199
124237|NCT01821378|303636|P1|STARTED|Overall Study||101
124238|NCT01821352|303674|P2|NOT COMPLETED|Overall Study||0
124239|NCT01821352|303675|P1|NOT COMPLETED|Overall Study||0
124240|NCT01821352|303674|P2|COMPLETED|Overall Study||25
124241|NCT01821352|303675|P1|COMPLETED|Overall Study||28
124242|NCT01821352|303674|P2|STARTED|Overall Study||25
124243|NCT01821352|303675|P1|STARTED|Overall Study||28
124244|NCT01821326|303685|P1|NOT COMPLETED|Overall Study||0
124245|NCT01821326|303685|P1|COMPLETED|Overall Study||339
124246|NCT01821326|303685|P1|STARTED|Overall Study||339
124247|NCT01821300|303691|P2|NOT COMPLETED|Overall Study||0
124248|NCT01821300|303692|P1|NOT COMPLETED|Overall Study||0
124249|NCT01821300|303691|P2|COMPLETED|Overall Study||103
124250|NCT01821300|303692|P1|COMPLETED|Overall Study||154
124251|NCT01821300|303691|P2|STARTED|Overall Study||103
124252|NCT01821300|303692|P1|STARTED|Overall Study||154
124253|NCT01821118|303726|P2|NOT COMPLETED|Overall Study||1
124254|NCT01821118|303727|P1|NOT COMPLETED|Overall Study||0
124255|NCT01821118|303726|P2|COMPLETED|Overall Study||11
124256|NCT01821118|303727|P1|COMPLETED|Overall Study||24
124257|NCT01821118|303726|P2|STARTED|Overall Study||12
124258|NCT01821118|303727|P1|STARTED|Overall Study||24
124259|NCT01821105|303760|P1|NOT COMPLETED|Overall Study||0
124260|NCT01821105|303760|P1|COMPLETED|Overall Study||21
124261|NCT01821105|303760|P1|STARTED|Overall Study||21
124262|NCT01820754|303766|P1|NOT COMPLETED|Overall Study||0
124263|NCT01820754|303766|P1|COMPLETED|Overall Study||24
124264|NCT01820754|303766|P1|STARTED|Overall Study||24
124265|NCT01820637|303774|P1|NOT COMPLETED|Overall Study||3
124266|NCT01820637|303774|P1|COMPLETED|Overall Study||54
124267|NCT01820637|303774|P1|STARTED|Overall Study||57
124268|NCT01820585|303783|P4|NOT COMPLETED|Overall Study||49
124269|NCT01820585|303784|P3|NOT COMPLETED|Overall Study||34
124270|NCT01820585|303785|P2|NOT COMPLETED|Overall Study||32
124271|NCT01820585|303786|P1|NOT COMPLETED|Overall Study||27
124272|NCT01820585|303783|P4|COMPLETED|Overall Study||83
124273|NCT01820585|303784|P3|COMPLETED|Overall Study||101
124274|NCT01820585|303785|P2|COMPLETED|Overall Study||98
124275|NCT01820585|303786|P1|COMPLETED|Overall Study||104
124276|NCT01820585|303783|P4|Completed Maintenance Period|Overall Study||84
124277|NCT01820585|303784|P3|Completed Maintenance Period|Overall Study||101
124278|NCT01820585|303785|P2|Completed Maintenance Period|Overall Study||98
124279|NCT01820585|303786|P1|Completed Maintenance Period|Overall Study||105
124280|NCT01820585|303783|P4|Entered Maintenance Period|Overall Study||123
124281|NCT01820585|303784|P3|Entered Maintenance Period|Overall Study||131
124282|NCT01820585|303785|P2|Entered Maintenance Period|Overall Study||124
124283|NCT01820585|303786|P1|Entered Maintenance Period|Overall Study||128
124284|NCT01820585|303783|P4|Completed Titration Period|Overall Study||126
124285|NCT01820585|303784|P3|Completed Titration Period|Overall Study||131
124286|NCT01820585|303785|P2|Completed Titration Period|Overall Study||125
124287|NCT01820585|303786|P1|Completed Titration Period|Overall Study||128
124288|NCT01820585|303783|P4|Full Analysis Set|Overall Study||129
124289|NCT01820585|303784|P3|Full Analysis Set|Overall Study||135
124290|NCT01820585|303785|P2|Full Analysis Set|Overall Study||130
124291|NCT01820585|303786|P1|Full Analysis Set|Overall Study||131
124292|NCT01820585|303783|P4|Randomized and Treated|Overall Study||132
124293|NCT01820585|303784|P3|Randomized and Treated|Overall Study||135
124294|NCT01820585|303785|P2|Randomized and Treated|Overall Study||130
124295|NCT01820585|303786|P1|Randomized and Treated|Overall Study||131
124296|NCT01820585|303783|P4|STARTED|Overall Study||132
124297|NCT01820585|303784|P3|STARTED|Overall Study||135
124298|NCT01820585|303785|P2|STARTED|Overall Study||130
124299|NCT01820585|303786|P1|STARTED|Overall Study||131
124300|NCT01820559|303799|P3|NOT COMPLETED|Overall Study||29
124301|NCT01820559|303800|P2|NOT COMPLETED|Overall Study||13
124302|NCT01820559|303801|P1|NOT COMPLETED|Overall Study||14
124303|NCT01820559|303799|P3|COMPLETED|Overall Study||110
124304|NCT01820559|303800|P2|COMPLETED|Overall Study||122
124305|NCT01820559|303801|P1|COMPLETED|Overall Study||122
124306|NCT01820559|303799|P3|Completed Maintenance Period|Overall Study||110
124307|NCT01820559|303800|P2|Completed Maintenance Period|Overall Study||123
124308|NCT01820559|303801|P1|Completed Maintenance Period|Overall Study||122
124309|NCT01820559|303799|P3|Entered Maintenance Period|Overall Study||129
124310|NCT01820559|303800|P2|Entered Maintenance Period|Overall Study||133
124311|NCT01820559|303801|P1|Entered Maintenance Period|Overall Study||129
124312|NCT01820559|303799|P3|Completed Tutration Period|Overall Study||131
124313|NCT01820559|303800|P2|Completed Tutration Period|Overall Study||134
124314|NCT01820559|303801|P1|Completed Tutration Period|Overall Study||130
124315|NCT01820559|303799|P3|Randomized and Treated|Overall Study||139
124316|NCT01820559|303800|P2|Randomized and Treated|Overall Study||135
124317|NCT01820559|303801|P1|Randomized and Treated|Overall Study||136
124318|NCT01820559|303799|P3|STARTED|Overall Study||139
124319|NCT01820559|303800|P2|STARTED|Overall Study||135
124320|NCT01820559|303801|P1|STARTED|Overall Study||136
124321|NCT01820416|303812|P3|NOT COMPLETED|Overall Study||0
124322|NCT01820416|303813|P2|NOT COMPLETED|Overall Study||2
124323|NCT01820416|303814|P1|NOT COMPLETED|Overall Study||3
124324|NCT01820416|303812|P3|COMPLETED|Overall Study||11
124325|NCT01820416|303813|P2|COMPLETED|Overall Study||10
124326|NCT01820416|303814|P1|COMPLETED|Overall Study||9
124327|NCT01820416|303812|P3|STARTED|Overall Study||11
124328|NCT01820416|303813|P2|STARTED|Overall Study||12
124329|NCT01820416|303814|P1|STARTED|Overall Study||12
124330|NCT01820364|303822|P2|NOT COMPLETED|Part II: LGX818 + MEK162||1
124331|NCT01820364|303823|P1|NOT COMPLETED|Part II: LGX818 + MEK162||0
124332|NCT01820364|303822|P2|COMPLETED|Part II: LGX818 + MEK162||0
124333|NCT01820364|303823|P1|COMPLETED|Part II: LGX818 + MEK162||0
124334|NCT01820364|303822|P2|STARTED|Part II: LGX818 + MEK162||1
124335|NCT01820364|303823|P1|STARTED|Part II: LGX818 + MEK162||0
124336|NCT01820364|303822|P2|NOT COMPLETED|Part I: LGX818||0
124337|NCT01820364|303823|P1|NOT COMPLETED|Part I: LGX818||14
124338|NCT01820364|303822|P2|COMPLETED|Part I: LGX818||0
124339|NCT01820364|303823|P1|COMPLETED|Part I: LGX818||1
124340|NCT01820364|303822|P2|STARTED|Part I: LGX818||0
124341|NCT01820364|303823|P1|STARTED|Part I: LGX818||15
124342|NCT01819935|303837|P2|NOT COMPLETED|Overall Study||0
124343|NCT01819935|303838|P1|NOT COMPLETED|Overall Study||0
124344|NCT01819935|303837|P2|COMPLETED|Overall Study||4943
124345|NCT01819935|303838|P1|COMPLETED|Overall Study||328
124346|NCT01819935|303837|P2|STARTED|Overall Study||4943
124347|NCT01819935|303838|P1|STARTED|Overall Study||328
124348|NCT01819922|303858|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
124349|NCT01819922|303859|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
124350|NCT01819922|303858|P2|COMPLETED|Second Intervention Period (1 Day)||6
124351|NCT01819922|303859|P1|COMPLETED|Second Intervention Period (1 Day)||6
124352|NCT01819922|303858|P2|STARTED|Second Intervention Period (1 Day)||6
124353|NCT01819922|303859|P1|STARTED|Second Intervention Period (1 Day)||6
124354|NCT01819922|303858|P2|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
124355|NCT01819922|303859|P1|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
124356|NCT01819922|303858|P2|COMPLETED|Washout Period (at Least 7-10 Days)||6
124357|NCT01819922|303859|P1|COMPLETED|Washout Period (at Least 7-10 Days)||6
124358|NCT01819922|303858|P2|STARTED|Washout Period (at Least 7-10 Days)||6
124359|NCT01819922|303859|P1|STARTED|Washout Period (at Least 7-10 Days)||6
124360|NCT01819922|303858|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
124361|NCT01819922|303859|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
124362|NCT01819922|303858|P2|COMPLETED|First Intervention Period (1 Day)||6
124363|NCT01819922|303859|P1|COMPLETED|First Intervention Period (1 Day)||6
124364|NCT01819922|303858|P2|STARTED|First Intervention Period (1 Day)||6
124365|NCT01819922|303859|P1|STARTED|First Intervention Period (1 Day)||6
124366|NCT01819883|303945|P2|NOT COMPLETED|Overall Study||0
124367|NCT01819883|303946|P1|NOT COMPLETED|Overall Study||4
124368|NCT01819883|303945|P2|COMPLETED|Overall Study||20
124369|NCT01819883|303946|P1|COMPLETED|Overall Study||16
124370|NCT01819883|303945|P2|STARTED|Overall Study||20
124371|NCT01819883|303946|P1|STARTED|Overall Study||20
124372|NCT01819844|303952|P1|NOT COMPLETED|Overall Study||0
124373|NCT01819844|303952|P1|COMPLETED|Overall Study||12
124374|NCT01819844|303952|P1|STARTED|Overall Study||12
124375|NCT01819727|303967|P2|NOT COMPLETED|Overall Study||28
124376|NCT01819727|303968|P1|NOT COMPLETED|Overall Study||20
124377|NCT01819727|303967|P2|COMPLETED|Overall Study||102
124378|NCT01819727|303968|P1|COMPLETED|Overall Study||111
124379|NCT01819727|303967|P2|STARTED|Overall Study||130
124380|NCT01819727|303968|P1|STARTED|Overall Study||131
124381|NCT01819597|303978|P1|NOT COMPLETED|Overall Study||0
124382|NCT01819597|303978|P1|COMPLETED|Overall Study||52
124383|NCT01819597|303978|P1|STARTED|Overall Study||52
124384|NCT01819506|303990|P2|NOT COMPLETED|Overall Study||5
124385|NCT01819506|303991|P1|NOT COMPLETED|Overall Study||8
124386|NCT01819506|303990|P2|COMPLETED|Overall Study||47
124387|NCT01819506|303991|P1|COMPLETED|Overall Study||43
124388|NCT01819506|303990|P2|STARTED|Overall Study||52
124389|NCT01819506|303991|P1|STARTED|Overall Study||51
124390|NCT01819415|304005|P4|NOT COMPLETED|Overall Study||2
124391|NCT01819415|304006|P3|NOT COMPLETED|Overall Study||1
124392|NCT01819415|304007|P2|NOT COMPLETED|Overall Study||4
124393|NCT01819415|304008|P1|NOT COMPLETED|Overall Study||3
124394|NCT01819415|304005|P4|COMPLETED|Overall Study||8
124395|NCT01819415|304006|P3|COMPLETED|Overall Study||9
124396|NCT01819415|304007|P2|COMPLETED|Overall Study||6
124397|NCT01819415|304008|P1|COMPLETED|Overall Study||7
124398|NCT01819415|304005|P4|STARTED|Overall Study||10
124399|NCT01819415|304006|P3|STARTED|Overall Study||10
124400|NCT01819415|304007|P2|STARTED|Overall Study||10
124401|NCT01819415|304008|P1|STARTED|Overall Study||10
124402|NCT01819311|304020|P2|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
124403|NCT01819311|304021|P1|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
124404|NCT01819311|304020|P2|COMPLETED|Follow-up Phase (8 Weeks)||23
124405|NCT01819311|304021|P1|COMPLETED|Follow-up Phase (8 Weeks)||24
124406|NCT01819311|304020|P2|STARTED|Follow-up Phase (8 Weeks)||30
124407|NCT01819311|304021|P1|STARTED|Follow-up Phase (8 Weeks)||31
124408|NCT01819311|304020|P2|NOT COMPLETED|Treatment Phase (4 Weeks)||1
124409|NCT01819311|304021|P1|NOT COMPLETED|Treatment Phase (4 Weeks)||2
124410|NCT01819311|304020|P2|COMPLETED|Treatment Phase (4 Weeks)||30
124411|NCT01819311|304021|P1|COMPLETED|Treatment Phase (4 Weeks)||31
124412|NCT01819311|304020|P2|STARTED|Treatment Phase (4 Weeks)||31
124413|NCT01819311|304021|P1|STARTED|Treatment Phase (4 Weeks)||33
124414|NCT01819272|304043|P6|NOT COMPLETED|Overall Study||7
124415|NCT01819272|304044|P5|NOT COMPLETED|Overall Study||4
124416|NCT01819272|304045|P4|NOT COMPLETED|Overall Study||5
124417|NCT01819272|304046|P3|NOT COMPLETED|Overall Study||3
124418|NCT01819272|304047|P2|NOT COMPLETED|Overall Study||3
124419|NCT01819272|304048|P1|NOT COMPLETED|Overall Study||6
124420|NCT01819272|304043|P6|COMPLETED|Overall Study||33
124421|NCT01819272|304044|P5|COMPLETED|Overall Study||36
124422|NCT01819272|304045|P4|COMPLETED|Overall Study||35
124423|NCT01819272|304046|P3|COMPLETED|Overall Study||37
124424|NCT01819272|304047|P2|COMPLETED|Overall Study||36
124425|NCT01819272|304048|P1|COMPLETED|Overall Study||35
124426|NCT01819272|304043|P6|STARTED|Overall Study||40
124427|NCT01819272|304044|P5|STARTED|Overall Study||40
124428|NCT01819272|304045|P4|STARTED|Overall Study||40
124429|NCT01819272|304046|P3|STARTED|Overall Study||40
124430|NCT01819272|304047|P2|STARTED|Overall Study||39
124431|NCT01819272|304048|P1|STARTED|Overall Study||41
124432|NCT01819194|304074|P1|NOT COMPLETED|Overall Study||2
124433|NCT01819194|304074|P1|COMPLETED|Overall Study||60
124434|NCT01819194|304074|P1|STARTED|Overall Study||62
124435|NCT01819129|304081|P2|NOT COMPLETED|Overall Study||39
124436|NCT01819129|304082|P1|NOT COMPLETED|Overall Study||44
124437|NCT01819129|304081|P2|COMPLETED|Overall Study||305
124438|NCT01819129|304082|P1|COMPLETED|Overall Study||301
124439|NCT01819129|304081|P2|Exposed|Overall Study||341
124440|NCT01819129|304082|P1|Exposed|Overall Study||341
124441|NCT01819129|304081|P2|STARTED|Overall Study||344
124442|NCT01819129|304082|P1|STARTED|Overall Study||345
124443|NCT01818765|304094|P1|NOT COMPLETED|Overall Study||2
124444|NCT01818765|304094|P1|COMPLETED|Overall Study||18
124445|NCT01818765|304094|P1|STARTED|Overall Study||20
124446|NCT01818752|304107|P2|NOT COMPLETED|Overall Study||198
124447|NCT01818752|304108|P1|NOT COMPLETED|Overall Study||187
124448|NCT01818752|304107|P2|COMPLETED|Overall Study|Completed treatment|280
124449|NCT01818752|304108|P1|COMPLETED|Overall Study|Completed treatment|290
124450|NCT01818752|304107|P2|Received Treatment|Overall Study||474
124451|NCT01818752|304108|P1|Received Treatment|Overall Study||470
124452|NCT01818752|304107|P2|STARTED|Overall Study||478
124453|NCT01818752|304108|P1|STARTED|Overall Study||477
124454|NCT01818726|304128|P2|NOT COMPLETED|Overall Study||2
124455|NCT01818726|304129|P1|NOT COMPLETED|Overall Study||6
124456|NCT01818726|304128|P2|COMPLETED|Overall Study||3
124457|NCT01818726|304129|P1|COMPLETED|Overall Study||4
124458|NCT01818726|304128|P2|STARTED|Overall Study||5
124459|NCT01818726|304129|P1|STARTED|Overall Study||10
124460|NCT01818700|304139|P1|NOT COMPLETED|Overall Study||104
124461|NCT01818700|304139|P1|COMPLETED|Overall Study|104 subjects dropped out this study prior to study completion.|141
124462|NCT01818700|304139|P1|PP Set|Overall Study|105 subjects excluded from PP set due to various reasons.|105
124463|NCT01818700|304139|P1|FAS Set|Overall Study|31 subjects excluded from FAS due to no assessment of primary efficacy(26) and IC/EC violation(5).|210
124464|NCT01818700|304139|P1|Safety Set|Overall Study|4 subjects were not study drug administered.|241
124465|NCT01818700|304139|P1|STARTED|Overall Study|The No. of enrolled patients|245
124466|NCT01818596|304150|P2|NOT COMPLETED|Overall Study||0
124467|NCT01818596|304151|P1|NOT COMPLETED|Overall Study||31
124468|NCT01818596|304150|P2|COMPLETED|Overall Study||6
124469|NCT01818596|304151|P1|COMPLETED|Overall Study||215
124470|NCT01818596|304150|P2|STARTED|Overall Study||6
124471|NCT01818596|304151|P1|STARTED|Overall Study||246
124472|NCT01818531|304190|P2|NOT COMPLETED|Overall Study||2
124473|NCT01818531|304191|P1|NOT COMPLETED|Overall Study||1
124474|NCT01818531|304190|P2|COMPLETED|Overall Study||73
124475|NCT01818531|304191|P1|COMPLETED|Overall Study||74
124476|NCT01818531|304190|P2|STARTED|Overall Study||75
124477|NCT01818531|304191|P1|STARTED|Overall Study||75
124478|NCT01818518|304211|P6|NOT COMPLETED|Overall Study||0
124479|NCT01818518|304212|P5|NOT COMPLETED|Overall Study||0
124480|NCT01818518|304213|P4|NOT COMPLETED|Overall Study||0
124481|NCT01818518|304214|P3|NOT COMPLETED|Overall Study||0
124482|NCT01818518|304215|P2|NOT COMPLETED|Overall Study||0
124483|NCT01818518|304216|P1|NOT COMPLETED|Overall Study||0
124484|NCT01818518|304211|P6|COMPLETED|Overall Study||37
124485|NCT01818518|304212|P5|COMPLETED|Overall Study||38
124486|NCT01818518|304213|P4|COMPLETED|Overall Study||59
124487|NCT01818518|304214|P3|COMPLETED|Overall Study||288
124488|NCT01818518|304215|P2|COMPLETED|Overall Study||263
124489|NCT01818518|304216|P1|COMPLETED|Overall Study||310
124490|NCT01818518|304211|P6|STARTED|Overall Study||37
124491|NCT01818518|304212|P5|STARTED|Overall Study||38
124492|NCT01818518|304213|P4|STARTED|Overall Study||59
124493|NCT01818518|304214|P3|STARTED|Overall Study||288
124494|NCT01818518|304215|P2|STARTED|Overall Study||263
124495|NCT01818518|304216|P1|STARTED|Overall Study||310
124496|NCT01818427|304232|P2|NOT COMPLETED|Overall Study||13
124497|NCT01818427|304233|P1|NOT COMPLETED|Overall Study||9
124498|NCT01818427|304232|P2|COMPLETED|Overall Study||271
124499|NCT01818427|304233|P1|COMPLETED|Overall Study||230
124500|NCT01818427|304232|P2|STARTED|Overall Study||284
124501|NCT01818427|304233|P1|STARTED|Overall Study||239
124502|NCT01818414|304249|P2|NOT COMPLETED|Overall Study||0
124503|NCT01818414|304250|P1|NOT COMPLETED|Overall Study||0
124504|NCT01818414|304249|P2|COMPLETED|Overall Study||15
124505|NCT01818414|304250|P1|COMPLETED|Overall Study||14
124506|NCT01818414|304249|P2|STARTED|Overall Study||15
124507|NCT01818414|304250|P1|STARTED|Overall Study||14
124508|NCT01818336|304264|P2|NOT COMPLETED|Overall Study||12
124509|NCT01818336|304265|P1|NOT COMPLETED|Overall Study||0
124510|NCT01818336|304264|P2|COMPLETED|Overall Study||47
124511|NCT01818336|304265|P1|COMPLETED|Overall Study||391
124512|NCT01818336|304264|P2|STARTED|Overall Study||59
124513|NCT01818336|304265|P1|STARTED|Overall Study||391
124514|NCT01818297|304273|P2|NOT COMPLETED|Open Label Phase (3-12 Months)||10
124515|NCT01818297|304274|P1|NOT COMPLETED|Open Label Phase (3-12 Months)||18
124516|NCT01818297|304273|P2|COMPLETED|Open Label Phase (3-12 Months)||19
124517|NCT01818297|304274|P1|COMPLETED|Open Label Phase (3-12 Months)||14
124518|NCT01818297|304273|P2|STARTED|Open Label Phase (3-12 Months)||29
124519|NCT01818297|304274|P1|STARTED|Open Label Phase (3-12 Months)||32
124520|NCT01818297|304273|P2|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||1
124521|NCT01818297|304274|P1|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||0
124522|NCT01818297|304273|P2|COMPLETED|Blinded Phase (Randomization - 3 Months)||29
124523|NCT01818297|304274|P1|COMPLETED|Blinded Phase (Randomization - 3 Months)||32
124524|NCT01818297|304273|P2|Week 6|Blinded Phase (Randomization - 3 Months)||29
124525|NCT01818297|304274|P1|Week 6|Blinded Phase (Randomization - 3 Months)||32
124526|NCT01818297|304273|P2|Week 1|Blinded Phase (Randomization - 3 Months)||30
124527|NCT01818297|304274|P1|Week 1|Blinded Phase (Randomization - 3 Months)||32
124528|NCT01818297|304273|P2|STARTED|Blinded Phase (Randomization - 3 Months)||30
124529|NCT01818297|304274|P1|STARTED|Blinded Phase (Randomization - 3 Months)||32
124530|NCT01818284|304292|P2|NOT COMPLETED|Overall Study||6
124531|NCT01818284|304293|P1|NOT COMPLETED|Overall Study||4
124532|NCT01818284|304292|P2|COMPLETED|Overall Study||5
124533|NCT01818284|304293|P1|COMPLETED|Overall Study||7
124534|NCT01818284|304292|P2|STARTED|Overall Study||11
124535|NCT01818284|304293|P1|STARTED|Overall Study||11
124536|NCT01818245|304301|P2|NOT COMPLETED|Intervention C||0
124537|NCT01818245|304302|P1|NOT COMPLETED|Intervention C||0
124538|NCT01818245|304301|P2|COMPLETED|Intervention C||0
124539|NCT01818245|304302|P1|COMPLETED|Intervention C||30
124540|NCT01818245|304301|P2|STARTED|Intervention C||0
124541|NCT01818245|304302|P1|STARTED|Intervention C||30
124542|NCT01818245|304301|P2|NOT COMPLETED|Washout (16-28 Days)||0
124543|NCT01818245|304302|P1|NOT COMPLETED|Washout (16-28 Days)||0
124544|NCT01818245|304301|P2|COMPLETED|Washout (16-28 Days)||0
124545|NCT01818245|304302|P1|COMPLETED|Washout (16-28 Days)||30
124546|NCT01818245|304301|P2|STARTED|Washout (16-28 Days)||0
124547|NCT01818245|304302|P1|STARTED|Washout (16-28 Days)||30
124548|NCT01818245|304301|P2|NOT COMPLETED|Intervention B||0
124549|NCT01818245|304302|P1|NOT COMPLETED|Intervention B||0
124550|NCT01818245|304301|P2|COMPLETED|Intervention B||0
124551|NCT01818245|304302|P1|COMPLETED|Intervention B||30
124552|NCT01818245|304301|P2|STARTED|Intervention B||0
124553|NCT01818245|304302|P1|STARTED|Intervention B||30
124554|NCT01818245|304301|P2|NOT COMPLETED|Washout (16-28 Days)||0
124555|NCT01818245|304302|P1|NOT COMPLETED|Washout (16-28 Days)||0
124556|NCT01818245|304301|P2|COMPLETED|Washout (16-28 Days)||0
124557|NCT01818245|304302|P1|COMPLETED|Washout (16-28 Days)||30
124558|NCT01818245|304301|P2|STARTED|Washout (16-28 Days)||0
124559|NCT01818245|304302|P1|STARTED|Washout (16-28 Days)||30
124560|NCT01818245|304301|P2|NOT COMPLETED|Intervention A||0
124561|NCT01818245|304302|P1|NOT COMPLETED|Intervention A||0
124562|NCT01818245|304301|P2|COMPLETED|Intervention A||22
124563|NCT01818245|304302|P1|COMPLETED|Intervention A||30
124564|NCT01818245|304301|P2|Received One Dose of Study Drug|Intervention A||22
124565|NCT01818245|304302|P1|Received One Dose of Study Drug|Intervention A||30
124566|NCT01818245|304301|P2|STARTED|Intervention A|Participants didn't participate in separate interventions and received 1 dose of LY2605541 on Day 1.|22
124567|NCT01818245|304302|P1|STARTED|Intervention A||30
124568|NCT01818141|304326|P2|NOT COMPLETED|Overall Study||3
124569|NCT01818141|304327|P1|NOT COMPLETED|Overall Study||3
124570|NCT01818141|304326|P2|COMPLETED|Overall Study||13
124571|NCT01818141|304327|P1|COMPLETED|Overall Study||15
124572|NCT01818141|304326|P2|STARTED|Overall Study||16
124573|NCT01818141|304327|P1|STARTED|Overall Study||18
124574|NCT01818063|304337|P2|NOT COMPLETED|Overall Study||0
124575|NCT01818063|304338|P1|NOT COMPLETED|Overall Study||0
124576|NCT01818063|304337|P2|COMPLETED|Overall Study||4
124577|NCT01818063|304338|P1|COMPLETED|Overall Study||5
124578|NCT01818063|304337|P2|STARTED|Overall Study||4
124579|NCT01818063|304338|P1|STARTED|Overall Study||5
124580|NCT01817907|304350|P2|NOT COMPLETED|Second Intervention||0
124581|NCT01817907|304351|P1|NOT COMPLETED|Second Intervention||0
124582|NCT01817907|304350|P2|COMPLETED|Second Intervention||7
124583|NCT01817907|304351|P1|COMPLETED|Second Intervention||8
124584|NCT01817907|304350|P2|STARTED|Second Intervention||7
124585|NCT01817907|304351|P1|STARTED|Second Intervention||8
124586|NCT01817907|304350|P2|NOT COMPLETED|Washout Period||0
124587|NCT01817907|304351|P1|NOT COMPLETED|Washout Period||0
124588|NCT01817907|304350|P2|COMPLETED|Washout Period||7
124589|NCT01817907|304351|P1|COMPLETED|Washout Period||8
124590|NCT01817907|304350|P2|STARTED|Washout Period||7
124591|NCT01817907|304351|P1|STARTED|Washout Period||8
124592|NCT01817907|304350|P2|NOT COMPLETED|First Intervention||0
124593|NCT01817907|304351|P1|NOT COMPLETED|First Intervention||0
124594|NCT01817907|304350|P2|COMPLETED|First Intervention||7
124595|NCT01817907|304351|P1|COMPLETED|First Intervention||8
124596|NCT01817907|304350|P2|STARTED|First Intervention||7
124597|NCT01817907|304351|P1|STARTED|First Intervention||8
124598|NCT01817855|304363|P4|NOT COMPLETED|Overall Study||0
124599|NCT01817855|304364|P3|NOT COMPLETED|Overall Study||2
124600|NCT01817855|304365|P2|NOT COMPLETED|Overall Study||2
124601|NCT01817855|304366|P1|NOT COMPLETED|Overall Study||0
124602|NCT01817855|304363|P4|COMPLETED|Overall Study||5
124603|NCT01817855|304364|P3|COMPLETED|Overall Study||9
124604|NCT01817855|304365|P2|COMPLETED|Overall Study||6
124605|NCT01817855|304366|P1|COMPLETED|Overall Study||23
124606|NCT01817855|304363|P4|STARTED|Overall Study||5
124607|NCT01817855|304364|P3|STARTED|Overall Study||11
124608|NCT01817855|304365|P2|STARTED|Overall Study||8
124609|NCT01817855|304366|P1|STARTED|Overall Study||23
124610|NCT01817790|304396|P2|NOT COMPLETED|Overall Study||8
124611|NCT01817790|304397|P1|NOT COMPLETED|Overall Study||4
124612|NCT01817790|304396|P2|COMPLETED|Overall Study||304
124613|NCT01817790|304397|P1|COMPLETED|Overall Study||310
124614|NCT01817790|304396|P2|STARTED|Overall Study||312
124615|NCT01817790|304397|P1|STARTED|Overall Study||314
124616|NCT01817777|304441|P3|NOT COMPLETED|Interventional Phase (20 Weeks)||5
124617|NCT01817777|304442|P2|NOT COMPLETED|Interventional Phase (20 Weeks)||5
124618|NCT01817777|304443|P1|NOT COMPLETED|Interventional Phase (20 Weeks)||0
124619|NCT01817777|304441|P3|COMPLETED|Interventional Phase (20 Weeks)||10
124620|NCT01817777|304442|P2|COMPLETED|Interventional Phase (20 Weeks)||11
124621|NCT01817777|304443|P1|COMPLETED|Interventional Phase (20 Weeks)||0
124622|NCT01817777|304441|P3|STARTED|Interventional Phase (20 Weeks)||15
124623|NCT01817777|304442|P2|STARTED|Interventional Phase (20 Weeks)||16
124624|NCT01817777|304443|P1|STARTED|Interventional Phase (20 Weeks)||0
124625|NCT01817777|304441|P3|NOT COMPLETED|Observational Phase (8 Weeks)||0
124626|NCT01817777|304442|P2|NOT COMPLETED|Observational Phase (8 Weeks)||0
124627|NCT01817777|304443|P1|NOT COMPLETED|Observational Phase (8 Weeks)||5
124628|NCT01817777|304441|P3|COMPLETED|Observational Phase (8 Weeks)||0
124629|NCT01817777|304442|P2|COMPLETED|Observational Phase (8 Weeks)||0
124630|NCT01817777|304443|P1|COMPLETED|Observational Phase (8 Weeks)||31
124631|NCT01817777|304441|P3|STARTED|Observational Phase (8 Weeks)||0
124632|NCT01817777|304442|P2|STARTED|Observational Phase (8 Weeks)||0
124633|NCT01817777|304443|P1|STARTED|Observational Phase (8 Weeks)||36
124634|NCT01817764|304467|P2|NOT COMPLETED|Overall Study||38
124635|NCT01817764|304468|P1|NOT COMPLETED|Overall Study||34
124636|NCT01817764|304467|P2|COMPLETED|Overall Study||315
124637|NCT01817764|304468|P1|COMPLETED|Overall Study||319
124638|NCT01817764|304467|P2|STARTED|Overall Study||353
124639|NCT01817764|304468|P1|STARTED|Overall Study||353
124640|NCT01817725|304476|P1|NOT COMPLETED|Overall Study||1
124641|NCT01817725|304476|P1|COMPLETED|Overall Study||19
124642|NCT01817725|304476|P1|STARTED|Overall Study||20
124643|NCT01817712|304483|P2|NOT COMPLETED|Overall Study||30
124644|NCT01817712|304484|P1|NOT COMPLETED|Overall Study||21
124645|NCT01817712|304483|P2|COMPLETED|Overall Study|Primary Outcome assessed over 18 months|240
124646|NCT01817712|304484|P1|COMPLETED|Overall Study|Primary Outcome Assessed over 18 months|250
124647|NCT01817712|304483|P2|STARTED|Overall Study||270
124648|NCT01817712|304484|P1|STARTED|Overall Study||271
124649|NCT01817582|304497|P3|NOT COMPLETED|Overall Study||0
124650|NCT01817582|304498|P2|NOT COMPLETED|Overall Study||1
124651|NCT01817582|304499|P1|NOT COMPLETED|Overall Study||2
124652|NCT01817582|304497|P3|COMPLETED|Overall Study||33
124653|NCT01817582|304498|P2|COMPLETED|Overall Study||35
124654|NCT01817582|304499|P1|COMPLETED|Overall Study||31
124655|NCT01817582|304497|P3|Received at Least 1 Dose of Study Drug|Overall Study||33
124656|NCT01817582|304498|P2|Received at Least 1 Dose of Study Drug|Overall Study||36
124657|NCT01817582|304499|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
124658|NCT01817582|304497|P3|STARTED|Overall Study||33
124659|NCT01817582|304498|P2|STARTED|Overall Study||36
124660|NCT01817582|304499|P1|STARTED|Overall Study||33
124661|NCT01817491|304563|P2|NOT COMPLETED|Overall Study||0
124662|NCT01817491|304564|P1|NOT COMPLETED|Overall Study||4
124663|NCT01817491|304563|P2|COMPLETED|Overall Study||28
124664|NCT01817491|304564|P1|COMPLETED|Overall Study||28
124665|NCT01817491|304563|P2|STARTED|Overall Study||28
124666|NCT01817491|304564|P1|STARTED|Overall Study||32
124667|NCT01817374|304610|P1|NOT COMPLETED|Overall Study||0
124668|NCT01817374|304610|P1|COMPLETED|Overall Study||6
124669|NCT01817374|304610|P1|STARTED|Overall Study||6
124670|NCT01816906|304624|P2|NOT COMPLETED|12 Months||5
124671|NCT01816906|304625|P1|NOT COMPLETED|12 Months||4
124672|NCT01816906|304624|P2|COMPLETED|12 Months||14
124673|NCT01816906|304625|P1|COMPLETED|12 Months||16
124674|NCT01816906|304624|P2|STARTED|12 Months||19
124675|NCT01816906|304625|P1|STARTED|12 Months||20
124676|NCT01816906|304624|P2|NOT COMPLETED|Six Months||22
124677|NCT01816906|304625|P1|NOT COMPLETED|Six Months||21
124678|NCT01816906|304624|P2|COMPLETED|Six Months||19
124679|NCT01816906|304625|P1|COMPLETED|Six Months||20
124680|NCT01816906|304624|P2|STARTED|Six Months||41
124681|NCT01816906|304625|P1|STARTED|Six Months||41
124682|NCT01816893|304643|P2|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
124683|NCT01816893|304644|P1|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
124684|NCT01816893|304643|P2|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||11
124685|NCT01816893|304644|P1|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||9
124686|NCT01816893|304643|P2|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||11
124687|NCT01816893|304644|P1|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||9
124688|NCT01816893|304643|P2|NOT COMPLETED|Washout Period||0
124689|NCT01816893|304644|P1|NOT COMPLETED|Washout Period||2
124690|NCT01816893|304643|P2|COMPLETED|Washout Period||11
124691|NCT01816893|304644|P1|COMPLETED|Washout Period||9
124692|NCT01816893|304643|P2|STARTED|Washout Period||11
124693|NCT01816893|304644|P1|STARTED|Washout Period||11
124694|NCT01816893|304643|P2|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
124695|NCT01816893|304644|P1|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
124696|NCT01816893|304643|P2|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
124697|NCT01816893|304644|P1|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
124698|NCT01816893|304643|P2|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
124699|NCT01816893|304644|P1|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
124700|NCT01816776|304656|P2|NOT COMPLETED|Overall Study||8
124701|NCT01816776|304657|P1|NOT COMPLETED|Overall Study||13
124702|NCT01816776|304656|P2|COMPLETED|Overall Study||70
124703|NCT01816776|304657|P1|COMPLETED|Overall Study||60
124704|NCT01816776|304656|P2|6 Month Primary Effectiveness Assessed|Overall Study||73
124705|NCT01816776|304657|P1|6 Month Primary Effectiveness Assessed|Overall Study||68
124706|NCT01816776|304656|P2|STARTED|Overall Study||78
124707|NCT01816776|304657|P1|STARTED|Overall Study||73
124708|NCT01816763|304680|P3|NOT COMPLETED|Overall Study||11
124709|NCT01816763|304681|P2|NOT COMPLETED|Overall Study||15
124710|NCT01816763|304682|P1|NOT COMPLETED|Overall Study||4
124711|NCT01816763|304680|P3|COMPLETED|Overall Study||169
124712|NCT01816763|304681|P2|COMPLETED|Overall Study||179
124713|NCT01816763|304682|P1|COMPLETED|Overall Study||191
124714|NCT01816763|304680|P3|STARTED|Overall Study||180
124715|NCT01816763|304681|P2|STARTED|Overall Study||194
124716|NCT01816763|304682|P1|STARTED|Overall Study||195
124717|NCT01816685|304698|P2|NOT COMPLETED|Overall Study||11
124718|NCT01816685|304699|P1|NOT COMPLETED|Overall Study||10
124719|NCT01816685|304698|P2|COMPLETED|Overall Study||56
124720|NCT01816685|304699|P1|COMPLETED|Overall Study||58
124721|NCT01816685|304698|P2|STARTED|Overall Study||67
124722|NCT01816685|304699|P1|STARTED|Overall Study||68
124723|NCT01816594|304709|P2|NOT COMPLETED|Overall Study||2
124724|NCT01816594|304710|P1|NOT COMPLETED|Overall Study||11
124725|NCT01816594|304709|P2|COMPLETED|Overall Study||23
124726|NCT01816594|304710|P1|COMPLETED|Overall Study||14
124727|NCT01816594|304709|P2|Randomized to the mt Cohort|Overall Study|mt = PIK3CA mutant|4
124728|NCT01816594|304710|P1|Randomized to the mt Cohort|Overall Study|mt = PIK3CA mutant|4
124729|NCT01816594|304709|P2|Randomized to the wt Cohort|Overall Study|wt = PIK3CA wild-type|21
124730|NCT01816594|304710|P1|Randomized to the wt Cohort|Overall Study|wt = PIK3CA wild-type|21
124731|NCT01816594|304709|P2|STARTED|Overall Study||25
124732|NCT01816594|304710|P1|STARTED|Overall Study||25
124733|NCT01816477|304748|P2|NOT COMPLETED|Overall Study||1
124734|NCT01816477|304749|P1|NOT COMPLETED|Overall Study||16
124735|NCT01816477|304748|P2|COMPLETED|Overall Study||41
124736|NCT01816477|304749|P1|COMPLETED|Overall Study||27
124737|NCT01816477|304748|P2|STARTED|Overall Study||42
124738|NCT01816477|304749|P1|STARTED|Overall Study||43
124739|NCT01816451|304762|P3|NOT COMPLETED|Overall Study||0
124740|NCT01816451|304763|P2|NOT COMPLETED|Overall Study||0
124741|NCT01816451|304764|P1|NOT COMPLETED|Overall Study||0
124742|NCT01816451|304762|P3|COMPLETED|Overall Study||8
124743|NCT01816451|304763|P2|COMPLETED|Overall Study||11
124744|NCT01816451|304764|P1|COMPLETED|Overall Study||13
124745|NCT01816451|304762|P3|STARTED|Overall Study||8
124746|NCT01816451|304763|P2|STARTED|Overall Study||11
124747|NCT01816451|304764|P1|STARTED|Overall Study||13
124748|NCT01816295|304803|P2|NOT COMPLETED|OLE Phase||56
124749|NCT01816295|304804|P1|NOT COMPLETED|OLE Phase||53
124750|NCT01816295|304803|P2|COMPLETED|OLE Phase||227
124751|NCT01816295|304804|P1|COMPLETED|OLE Phase||222
124752|NCT01816295|304803|P2|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|283
124753|NCT01816295|304804|P1|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|275
124754|NCT01816295|304803|P2|NOT COMPLETED|Double Blind Phase||56
124755|NCT01816295|304804|P1|NOT COMPLETED|Double Blind Phase||63
124756|NCT01816295|304803|P2|COMPLETED|Double Blind Phase||302
124757|NCT01816295|304804|P1|COMPLETED|Double Blind Phase||294
124758|NCT01816295|304803|P2|Received Study Drug|Double Blind Phase||354
124759|NCT01816295|304804|P1|Received Study Drug|Double Blind Phase||356
124760|NCT01816295|304803|P2|STARTED|Double Blind Phase||358
124761|NCT01816295|304804|P1|STARTED|Double Blind Phase||357
124762|NCT01816243|304819|P1|NOT COMPLETED|Overall Study||12
124763|NCT01816243|304819|P1|COMPLETED|Overall Study||27
124764|NCT01816243|304819|P1|STARTED|Overall Study||39
124765|NCT01816074|304830|P4|NOT COMPLETED|Phase 2||1
124766|NCT01816074|304831|P3|NOT COMPLETED|Phase 2||0
124767|NCT01816074|304832|P2|NOT COMPLETED|Phase 2||2
124768|NCT01816074|304833|P1|NOT COMPLETED|Phase 2||2
124769|NCT01816074|304830|P4|COMPLETED|Phase 2||9
124770|NCT01816074|304831|P3|COMPLETED|Phase 2||10
124771|NCT01816074|304832|P2|COMPLETED|Phase 2||7
124772|NCT01816074|304833|P1|COMPLETED|Phase 2||9
124773|NCT01816074|304830|P4|STARTED|Phase 2||10
124774|NCT01816074|304831|P3|STARTED|Phase 2||10
124775|NCT01816074|304832|P2|STARTED|Phase 2||9
124776|NCT01816074|304833|P1|STARTED|Phase 2||11
124777|NCT01816074|304830|P4|NOT COMPLETED|Phase 1||0
124778|NCT01816074|304831|P3|NOT COMPLETED|Phase 1||1
124779|NCT01816074|304832|P2|NOT COMPLETED|Phase 1||0
124780|NCT01816074|304833|P1|NOT COMPLETED|Phase 1||0
124781|NCT01816074|304830|P4|COMPLETED|Phase 1||10
124782|NCT01816074|304831|P3|COMPLETED|Phase 1||10
124783|NCT01816074|304832|P2|COMPLETED|Phase 1||9
124784|NCT01816074|304833|P1|COMPLETED|Phase 1||11
124785|NCT01816074|304830|P4|STARTED|Phase 1||10
124786|NCT01816074|304831|P3|STARTED|Phase 1||11
124787|NCT01816074|304832|P2|STARTED|Phase 1||9
124788|NCT01816074|304833|P1|STARTED|Phase 1||11
124789|NCT01816061|304863|P2|NOT COMPLETED|Overall Study||24
124790|NCT01816061|304864|P1|NOT COMPLETED|Overall Study||13
124791|NCT01816061|304863|P2|COMPLETED|Overall Study||27
124792|NCT01816061|304864|P1|COMPLETED|Overall Study||27
124793|NCT01816061|304863|P2|STARTED|Overall Study||51
124794|NCT01816061|304864|P1|STARTED|Overall Study||40
124795|NCT01816048|304872|P1|NOT COMPLETED|Overall Study||6
124796|NCT01816048|304872|P1|COMPLETED|Overall Study||2
124797|NCT01816048|304872|P1|STARTED|Overall Study||8
124798|NCT01815918|304887|P2|NOT COMPLETED|Overall Study||19
124799|NCT01815918|304888|P1|NOT COMPLETED|Overall Study||18
124800|NCT01815918|304887|P2|COMPLETED|Overall Study||11
124801|NCT01815918|304888|P1|COMPLETED|Overall Study||12
124802|NCT01815918|304887|P2|STARTED|Overall Study||30
124803|NCT01815918|304888|P1|STARTED|Overall Study||30
124804|NCT01815840|304904|P2|NOT COMPLETED|Overall Study||63
124805|NCT01815840|304905|P1|NOT COMPLETED|Overall Study||59
124806|NCT01815840|304904|P2|COMPLETED|Overall Study||50
124807|NCT01815840|304905|P1|COMPLETED|Overall Study||57
124808|NCT01815840|304904|P2|STARTED|Overall Study||113
124809|NCT01815840|304905|P1|STARTED|Overall Study||116
124810|NCT01815736|304935|P2|NOT COMPLETED|Overall Study||478
124811|NCT01815736|304936|P1|NOT COMPLETED|Overall Study||961
124812|NCT01815736|304935|P2|COMPLETED|Overall Study||2
124813|NCT01815736|304936|P1|COMPLETED|Overall Study||2
124814|NCT01815736|304935|P2|STARTED|Overall Study||480
124815|NCT01815736|304936|P1|STARTED|Overall Study||963
124816|NCT01815671|304952|P2|NOT COMPLETED|Overall Study||0
124817|NCT01815671|304953|P1|NOT COMPLETED|Overall Study||0
124818|NCT01815671|304952|P2|COMPLETED|Overall Study||85
124819|NCT01815671|304953|P1|COMPLETED|Overall Study||88
124820|NCT01815671|304952|P2|STARTED|Overall Study||85
124821|NCT01815671|304953|P1|STARTED|Overall Study||88
124822|NCT01815645|304965|P2|NOT COMPLETED|Overall Study||0
124823|NCT01815645|304966|P1|NOT COMPLETED|Overall Study||0
124824|NCT01815645|304965|P2|COMPLETED|Overall Study||33
124825|NCT01815645|304966|P1|COMPLETED|Overall Study||32
124826|NCT01815645|304965|P2|STARTED|Overall Study||33
124827|NCT01815645|304966|P1|STARTED|Overall Study||32
124828|NCT01815515|304982|P1|NOT COMPLETED|Overall Study||0
124829|NCT01815515|304982|P1|COMPLETED|Overall Study||17
124830|NCT01815515|304982|P1|STARTED|Overall Study||17
124831|NCT01815502|304989|P2|NOT COMPLETED|Overall Study||0
124832|NCT01815502|304990|P1|NOT COMPLETED|Overall Study||0
124833|NCT01815502|304989|P2|COMPLETED|Overall Study||10
124834|NCT01815502|304990|P1|COMPLETED|Overall Study||10
124835|NCT01815502|304989|P2|STARTED|Overall Study||10
124836|NCT01815502|304990|P1|STARTED|Overall Study||10
124837|NCT01815424|305005|P5|NOT COMPLETED|Week 16 to 52||3
124838|NCT01815424|305006|P4|NOT COMPLETED|Week 16 to 52||3
124839|NCT01815424|305007|P3|NOT COMPLETED|Week 16 to 52||0
124840|NCT01815424|305008|P2|NOT COMPLETED|Week 16 to 52||5
124841|NCT01815424|305009|P1|NOT COMPLETED|Week 16 to 52||2
124842|NCT01815424|305005|P5|COMPLETED|Week 16 to 52||36
124843|NCT01815424|305006|P4|COMPLETED|Week 16 to 52||35
124844|NCT01815424|305007|P3|COMPLETED|Week 16 to 52||0
124845|NCT01815424|305008|P2|COMPLETED|Week 16 to 52||79
124846|NCT01815424|305009|P1|COMPLETED|Week 16 to 52||81
124847|NCT01815424|305005|P5|STARTED|Week 16 to 52||39
124848|NCT01815424|305006|P4|STARTED|Week 16 to 52||38
124849|NCT01815424|305007|P3|STARTED|Week 16 to 52||0
124850|NCT01815424|305008|P2|STARTED|Week 16 to 52||84
124851|NCT01815424|305009|P1|STARTED|Week 16 to 52||83
124852|NCT01815424|305005|P5|NOT COMPLETED|Week 0 to 16||0
124853|NCT01815424|305006|P4|NOT COMPLETED|Week 0 to 16||0
124854|NCT01815424|305007|P3|NOT COMPLETED|Week 0 to 16||11
124855|NCT01815424|305008|P2|NOT COMPLETED|Week 0 to 16||4
124856|NCT01815424|305009|P1|NOT COMPLETED|Week 0 to 16||7
124857|NCT01815424|305005|P5|COMPLETED|Week 0 to 16||0
124858|NCT01815424|305006|P4|COMPLETED|Week 0 to 16||0
124859|NCT01815424|305007|P3|COMPLETED|Week 0 to 16||77
124860|NCT01815424|305008|P2|COMPLETED|Week 0 to 16||84
124861|NCT01815424|305009|P1|COMPLETED|Week 0 to 16||83
124862|NCT01815424|305005|P5|STARTED|Week 0 to 16||0
124863|NCT01815424|305006|P4|STARTED|Week 0 to 16||0
124864|NCT01815424|305007|P3|STARTED|Week 0 to 16||88
124865|NCT01815424|305008|P2|STARTED|Week 0 to 16||88
124866|NCT01815424|305009|P1|STARTED|Week 0 to 16||90
124867|NCT01815229|305208|P3|NOT COMPLETED|Overall Study||51
124868|NCT01815229|305209|P2|NOT COMPLETED|Overall Study||0
124869|NCT01815229|305210|P1|NOT COMPLETED|Overall Study||0
124870|NCT01815229|305208|P3|COMPLETED|Overall Study||0
124871|NCT01815229|305209|P2|COMPLETED|Overall Study||18
124872|NCT01815229|305210|P1|COMPLETED|Overall Study||13
124873|NCT01815229|305208|P3|STARTED|Overall Study||51
124874|NCT01815229|305209|P2|STARTED|Overall Study||18
124875|NCT01815229|305210|P1|STARTED|Overall Study||13
124876|NCT01815138|305221|P2|NOT COMPLETED|Overall Study||6
124877|NCT01815138|305222|P1|NOT COMPLETED|Overall Study||8
124878|NCT01815138|305221|P2|COMPLETED|Overall Study||31
124879|NCT01815138|305222|P1|COMPLETED|Overall Study||26
124880|NCT01815138|305221|P2|STARTED|Overall Study||37
124881|NCT01815138|305222|P1|STARTED|Overall Study||34
124882|NCT01815099|305234|P1|NOT COMPLETED|Overall Study||2
124883|NCT01815099|305234|P1|COMPLETED|Overall Study||2
124884|NCT01815099|305234|P1|Began rTMS Treatment|Overall Study||3
124885|NCT01815099|305234|P1|STARTED|Overall Study||4
124886|NCT01815008|305239|P1|NOT COMPLETED|Overall Study||4
124887|NCT01815008|305239|P1|COMPLETED|Overall Study|transcriptomic data was available on 9 participants only|15
124888|NCT01815008|305239|P1|STARTED|Overall Study|Had difficulty in completing enrollment|19
124889|NCT01814878|305248|P2|NOT COMPLETED|Overall Study||30
124890|NCT01814878|305249|P1|NOT COMPLETED|Overall Study||46
124891|NCT01814878|305248|P2|COMPLETED|Overall Study||128
124892|NCT01814878|305249|P1|COMPLETED|Overall Study||116
124893|NCT01814878|305248|P2|STARTED|Overall Study||158
124894|NCT01814878|305249|P1|STARTED|Overall Study||162
124895|NCT01814813|305272|P3|NOT COMPLETED|Overall Study||0
124896|NCT01814813|305273|P2|NOT COMPLETED|Overall Study||0
124897|NCT01814813|305274|P1|NOT COMPLETED|Overall Study||0
124898|NCT01814813|305272|P3|COMPLETED|Overall Study||31
124899|NCT01814813|305273|P2|COMPLETED|Overall Study||30
124900|NCT01814813|305274|P1|COMPLETED|Overall Study||29
124901|NCT01814813|305272|P3|STARTED|Overall Study||31
124902|NCT01814813|305273|P2|STARTED|Overall Study||30
124903|NCT01814813|305274|P1|STARTED|Overall Study||29
124904|NCT01814800|305288|P1|NOT COMPLETED|Overall Study||5
124905|NCT01814800|305288|P1|COMPLETED|Overall Study||54
124906|NCT01814800|305288|P1|STARTED|Overall Study||59
124907|NCT01814787|305327|P2|NOT COMPLETED|Overall Study||0
124908|NCT01814787|305328|P1|NOT COMPLETED|Overall Study||0
124909|NCT01814787|305327|P2|COMPLETED|Overall Study||684
124910|NCT01814787|305328|P1|COMPLETED|Overall Study||685
124911|NCT01814787|305327|P2|STARTED|Overall Study||684
124912|NCT01814787|305328|P1|STARTED|Overall Study||685
124913|NCT01814774|305334|P1|NOT COMPLETED|Overall Study||0
124914|NCT01814774|305334|P1|COMPLETED|Overall Study||48
124915|NCT01814774|305334|P1|STARTED|Overall Study||48
124916|NCT01814761|305348|P2|NOT COMPLETED|Overall Study||30
124917|NCT01814761|305349|P1|NOT COMPLETED|Overall Study||8
124918|NCT01814761|305348|P2|COMPLETED|Overall Study||240
124919|NCT01814761|305349|P1|COMPLETED|Overall Study||34
124920|NCT01814761|305348|P2|STARTED|Overall Study||270
124921|NCT01814761|305349|P1|STARTED|Overall Study||42
124922|NCT01814748|305363|P2|NOT COMPLETED|Overall Study||7
124923|NCT01814748|305364|P1|NOT COMPLETED|Overall Study||8
124924|NCT01814748|305363|P2|COMPLETED|Overall Study||94
124925|NCT01814748|305364|P1|COMPLETED|Overall Study||94
124926|NCT01814748|305363|P2|STARTED|Overall Study||101
124927|NCT01814748|305364|P1|STARTED|Overall Study||102
124928|NCT01814722|305387|P3|NOT COMPLETED|Overall Study||0
124929|NCT01814722|305388|P2|NOT COMPLETED|Overall Study||0
124930|NCT01814722|305389|P1|NOT COMPLETED|Overall Study||0
124931|NCT01814722|305387|P3|COMPLETED|Overall Study||6
124932|NCT01814722|305388|P2|COMPLETED|Overall Study||21
124933|NCT01814722|305389|P1|COMPLETED|Overall Study||36
124934|NCT01814722|305387|P3|STARTED|Overall Study||6
124935|NCT01814722|305388|P2|STARTED|Overall Study||21
124936|NCT01814722|305389|P1|STARTED|Overall Study||36
124937|NCT01814696|305408|P2|NOT COMPLETED|Overall Study||0
124938|NCT01814696|305409|P1|NOT COMPLETED|Overall Study||2
124939|NCT01814696|305408|P2|COMPLETED|Overall Study||11
124940|NCT01814696|305409|P1|COMPLETED|Overall Study||13
124941|NCT01814696|305408|P2|STARTED|Overall Study||11
124942|NCT01814696|305409|P1|STARTED|Overall Study||15
124943|NCT01814670|305427|P1|NOT COMPLETED|Overall Study||12
124944|NCT01814670|305427|P1|COMPLETED|Overall Study||173
124945|NCT01814670|305427|P1|STARTED|Overall Study||185
124946|NCT01814553|305437|P2|NOT COMPLETED|Overall Study||22
124947|NCT01814553|305438|P1|NOT COMPLETED|Overall Study||18
124948|NCT01814553|305437|P2|COMPLETED|Overall Study||0
124949|NCT01814553|305438|P1|COMPLETED|Overall Study||0
124950|NCT01814553|305437|P2|STARTED|Overall Study||22
124951|NCT01814553|305438|P1|STARTED|Overall Study||18
124952|NCT01814397|305452|P1|NOT COMPLETED|Overall Study||14
124953|NCT01814397|305452|P1|COMPLETED|Overall Study||36
124954|NCT01814397|305452|P1|3 Month Evaluation|Overall Study||43
124955|NCT01814397|305452|P1|STARTED|Overall Study||50
124956|NCT01814371|305461|P2|NOT COMPLETED|Overall Study||27
124957|NCT01814371|305462|P1|NOT COMPLETED|Overall Study||30
124958|NCT01814371|305461|P2|COMPLETED|Overall Study||199
124959|NCT01814371|305462|P1|COMPLETED|Overall Study||218
124960|NCT01814371|305461|P2|STARTED|Overall Study||226
124961|NCT01814371|305462|P1|STARTED|Overall Study||248
124962|NCT01814332|305497|P2|NOT COMPLETED|Overall Study||16
124963|NCT01814332|305498|P1|NOT COMPLETED|Overall Study||16
124964|NCT01814332|305497|P2|COMPLETED|Overall Study||49
124965|NCT01814332|305498|P1|COMPLETED|Overall Study||47
124966|NCT01814332|305497|P2|STARTED|Overall Study||65
124967|NCT01814332|305498|P1|STARTED|Overall Study||63
124968|NCT01814241|305510|P1|NOT COMPLETED|Overall Study||4
124969|NCT01814241|305510|P1|COMPLETED|Overall Study||16
124970|NCT01814241|305510|P1|STARTED|Overall Study||20
124971|NCT01814137|305520|P2|NOT COMPLETED|Overall Study||5
124972|NCT01814137|305521|P1|NOT COMPLETED|Overall Study||5
124973|NCT01814137|305520|P2|COMPLETED|Overall Study||15
124974|NCT01814137|305521|P1|COMPLETED|Overall Study||15
124975|NCT01814137|305520|P2|STARTED|Overall Study||20
124976|NCT01814137|305521|P1|STARTED|Overall Study||20
124977|NCT01814046|305537|P3|NOT COMPLETED|Retreatment||0
124978|NCT01814046|305538|P2|NOT COMPLETED|Retreatment||0
124979|NCT01814046|305539|P1|NOT COMPLETED|Retreatment||0
124980|NCT01814046|305537|P3|COMPLETED|Retreatment||3
124981|NCT01814046|305538|P2|COMPLETED|Retreatment||0
124982|NCT01814046|305539|P1|COMPLETED|Retreatment||0
124983|NCT01814046|305537|P3|STARTED|Retreatment||3
124984|NCT01814046|305538|P2|STARTED|Retreatment||0
124985|NCT01814046|305539|P1|STARTED|Retreatment||0
124986|NCT01814046|305537|P3|NOT COMPLETED|Drug Administration||0
124987|NCT01814046|305538|P2|NOT COMPLETED|Drug Administration||0
124988|NCT01814046|305539|P1|NOT COMPLETED|Drug Administration||1
124989|NCT01814046|305537|P3|COMPLETED|Drug Administration||0
124990|NCT01814046|305538|P2|COMPLETED|Drug Administration||2
124991|NCT01814046|305539|P1|COMPLETED|Drug Administration||21
124992|NCT01814046|305537|P3|STARTED|Drug Administration||0
124993|NCT01814046|305538|P2|STARTED|Drug Administration||2
124994|NCT01814046|305539|P1|STARTED|Drug Administration||22
124995|NCT01813890|305553|P3|NOT COMPLETED|Overall Study||6
124996|NCT01813890|305554|P2|NOT COMPLETED|Overall Study||4
124997|NCT01813890|305555|P1|NOT COMPLETED|Overall Study||9
124998|NCT01813890|305553|P3|COMPLETED|Overall Study||13
124999|NCT01813890|305554|P2|COMPLETED|Overall Study||17
125000|NCT01813890|305555|P1|COMPLETED|Overall Study||11
125001|NCT01813890|305553|P3|STARTED|Overall Study||19
125002|NCT01813890|305554|P2|STARTED|Overall Study||21
125003|NCT01813890|305555|P1|STARTED|Overall Study||20
125004|NCT01813721|305584|P1|NOT COMPLETED|Overall Study||64
125005|NCT01813721|305584|P1|COMPLETED|Overall Study||943
125006|NCT01813721|305584|P1|STARTED|Overall Study|Indicates number of participants enrolled|1007
125007|NCT01813474|305639|P3|NOT COMPLETED|Overall Study||11
125008|NCT01813474|305640|P2|NOT COMPLETED|Overall Study||7
125009|NCT01813474|305641|P1|NOT COMPLETED|Overall Study||3
125010|NCT01813474|305639|P3|COMPLETED|Overall Study|ongoing study at final data cut off|1
125011|NCT01813474|305640|P2|COMPLETED|Overall Study||0
125012|NCT01813474|305641|P1|COMPLETED|Overall Study|ongoing study at final data cut off|1
125013|NCT01813474|305639|P3|STARTED|Overall Study||12
125014|NCT01813474|305640|P2|STARTED|Overall Study||7
125015|NCT01813474|305641|P1|STARTED|Overall Study||4
125016|NCT01813435|305665|P2|NOT COMPLETED|Overall Study||1007
125017|NCT01813435|305666|P1|NOT COMPLETED|Overall Study||2170
125018|NCT01813435|305665|P2|COMPLETED|Overall Study||6981
125019|NCT01813435|305666|P1|COMPLETED|Overall Study||5810
125020|NCT01813435|305665|P2|STARTED|Overall Study|11 participants withdrew consent or objected to use further use of data|7988
125021|NCT01813435|305666|P1|STARTED|Overall Study|12 participants withdrew consent or objected to use further use of data|7980
125022|NCT01813422|305690|P2|NOT COMPLETED|Overall Study||16
125023|NCT01813422|305691|P1|NOT COMPLETED|Overall Study||20
125024|NCT01813422|305690|P2|COMPLETED|Overall Study||468
125025|NCT01813422|305691|P1|COMPLETED|Overall Study||466
125026|NCT01813422|305690|P2|Received Treatment|Overall Study||484
125027|NCT01813422|305691|P1|Received Treatment|Overall Study||484
125028|NCT01813422|305690|P2|STARTED|Overall Study||484
125029|NCT01813422|305691|P1|STARTED|Overall Study||486
125030|NCT01813214|305705|P2|NOT COMPLETED|Overall Study||0
125031|NCT01813214|305706|P1|NOT COMPLETED|Overall Study||0
125032|NCT01813214|305705|P2|COMPLETED|Overall Study||2
125033|NCT01813214|305706|P1|COMPLETED|Overall Study||3
125034|NCT01813214|305705|P2|STARTED|Overall Study||2
125035|NCT01813214|305706|P1|STARTED|Overall Study||3
125036|NCT01813110|305716|P2|NOT COMPLETED|Overall Study||1
125037|NCT01813110|305717|P1|NOT COMPLETED|Overall Study||0
125038|NCT01813110|305716|P2|COMPLETED|Overall Study||10
125039|NCT01813110|305717|P1|COMPLETED|Overall Study||10
125040|NCT01813110|305716|P2|STARTED|Overall Study||11
125041|NCT01813110|305717|P1|STARTED|Overall Study||10
125042|NCT01813071|305736|P9|NOT COMPLETED|Overall Study||3
125043|NCT01813071|305737|P8|NOT COMPLETED|Overall Study||5
125044|NCT01813071|305738|P7|NOT COMPLETED|Overall Study||3
125045|NCT01813071|305739|P6|NOT COMPLETED|Overall Study||7
125046|NCT01813071|305740|P5|NOT COMPLETED|Overall Study||1
125047|NCT01813071|305741|P4|NOT COMPLETED|Overall Study||0
125048|NCT01813071|305742|P3|NOT COMPLETED|Overall Study||0
125049|NCT01813071|305743|P2|NOT COMPLETED|Overall Study||0
125050|NCT01813071|305744|P1|NOT COMPLETED|Overall Study||0
125051|NCT01813071|305736|P9|COMPLETED|Overall Study||13
125052|NCT01813071|305737|P8|COMPLETED|Overall Study||7
125053|NCT01813071|305738|P7|COMPLETED|Overall Study||9
125054|NCT01813071|305739|P6|COMPLETED|Overall Study||5
125055|NCT01813071|305740|P5|COMPLETED|Overall Study||11
125056|NCT01813071|305741|P4|COMPLETED|Overall Study||9
125057|NCT01813071|305742|P3|COMPLETED|Overall Study||10
125058|NCT01813071|305743|P2|COMPLETED|Overall Study||10
125059|NCT01813071|305744|P1|COMPLETED|Overall Study||10
125060|NCT01813071|305736|P9|STARTED|Overall Study||16
125061|NCT01813071|305737|P8|STARTED|Overall Study||12
125062|NCT01813071|305738|P7|STARTED|Overall Study||12
125063|NCT01813071|305739|P6|STARTED|Overall Study||12
125064|NCT01813071|305740|P5|STARTED|Overall Study||12
125065|NCT01813071|305741|P4|STARTED|Overall Study||9
125066|NCT01813071|305742|P3|STARTED|Overall Study||10
125067|NCT01813071|305743|P2|STARTED|Overall Study||10
125068|NCT01813071|305744|P1|STARTED|Overall Study||10
125069|NCT01813058|306211|P2|NOT COMPLETED|Overall Study||4
125070|NCT01813058|306212|P1|NOT COMPLETED|Overall Study||5
125071|NCT01813058|306211|P2|COMPLETED|Overall Study||56
125072|NCT01813058|306212|P1|COMPLETED|Overall Study||55
125073|NCT01813058|306211|P2|STARTED|Overall Study||60
125074|NCT01813058|306212|P1|STARTED|Overall Study||60
125075|NCT01813019|306220|P2|NOT COMPLETED|Overall Study||6
125076|NCT01813019|306221|P1|NOT COMPLETED|Overall Study||7
125077|NCT01813019|306220|P2|COMPLETED|Overall Study||20
125078|NCT01813019|306221|P1|COMPLETED|Overall Study||17
125079|NCT01813019|306220|P2|STARTED|Overall Study||26
125080|NCT01813019|306221|P1|STARTED|Overall Study||24
125081|NCT01812837|306232|P3|NOT COMPLETED|Overall Study||0
125082|NCT01812837|306233|P2|NOT COMPLETED|Overall Study||1
125083|NCT01812837|306234|P1|NOT COMPLETED|Overall Study||2
125084|NCT01812837|306232|P3|COMPLETED|Overall Study||17
125085|NCT01812837|306233|P2|COMPLETED|Overall Study||16
125086|NCT01812837|306234|P1|COMPLETED|Overall Study||15
125087|NCT01812837|306232|P3|STARTED|Overall Study||17
125088|NCT01812837|306233|P2|STARTED|Overall Study||17
125089|NCT01812837|306234|P1|STARTED|Overall Study||17
125090|NCT01812707|306246|P4|NOT COMPLETED|Overall Study||2
125091|NCT01812707|306247|P3|NOT COMPLETED|Overall Study||0
125092|NCT01812707|306248|P2|NOT COMPLETED|Overall Study||0
125093|NCT01812707|306249|P1|NOT COMPLETED|Overall Study||2
125094|NCT01812707|306246|P4|COMPLETED|Overall Study||23
125095|NCT01812707|306247|P3|COMPLETED|Overall Study||25
125096|NCT01812707|306248|P2|COMPLETED|Overall Study||25
125097|NCT01812707|306249|P1|COMPLETED|Overall Study||23
125098|NCT01812707|306246|P4|Treated|Overall Study||25
125099|NCT01812707|306247|P3|Treated|Overall Study||25
125100|NCT01812707|306248|P2|Treated|Overall Study||25
125101|NCT01812707|306249|P1|Treated|Overall Study||25
125102|NCT01812707|306246|P4|STARTED|Overall Study||25
125103|NCT01812707|306247|P3|STARTED|Overall Study||25
125104|NCT01812707|306248|P2|STARTED|Overall Study||25
125105|NCT01812707|306249|P1|STARTED|Overall Study||25
125106|NCT01812681|306285|P2|NOT COMPLETED|Overall Study||0
125107|NCT01812681|306286|P1|NOT COMPLETED|Overall Study||3
125108|NCT01812681|306285|P2|COMPLETED|Overall Study||24
125109|NCT01812681|306286|P1|COMPLETED|Overall Study||57
125110|NCT01812681|306285|P2|STARTED|Overall Study||24
125111|NCT01812681|306286|P1|STARTED|Overall Study||60
125112|NCT01812655|306297|P3|NOT COMPLETED|Overall Study||0
125113|NCT01812655|306298|P2|NOT COMPLETED|Overall Study||1
125114|NCT01812655|306299|P1|NOT COMPLETED|Overall Study||1
125115|NCT01812655|306297|P3|COMPLETED|Overall Study||10
125116|NCT01812655|306298|P2|COMPLETED|Overall Study||10
125117|NCT01812655|306299|P1|COMPLETED|Overall Study||8
125118|NCT01812655|306297|P3|STARTED|Overall Study|Nurses provided their usual, standard care throughout the entire burn wound care.|10
125119|NCT01812655|306298|P2|STARTED|Overall Study|Passive Distraction-Patients watched a movie during their burn wound care.|11
125120|NCT01812655|306299|P1|STARTED|Overall Study|Virtual Reality-Patients used an interactive VR program during their burn wound care procedure.|9
125121|NCT01812473|306315|P2|NOT COMPLETED|Overall Study||0
125122|NCT01812473|306316|P1|NOT COMPLETED|Overall Study||0
125123|NCT01812473|306315|P2|COMPLETED|Overall Study||13
125124|NCT01812473|306316|P1|COMPLETED|Overall Study||22
125125|NCT01812473|306315|P2|STARTED|Overall Study||13
125126|NCT01812473|306316|P1|STARTED|Overall Study||22
125127|NCT01812057|306324|P2|NOT COMPLETED|Overall Study||0
125128|NCT01812057|306325|P1|NOT COMPLETED|Overall Study||2
125129|NCT01812057|306324|P2|COMPLETED|Overall Study||24
125130|NCT01812057|306325|P1|COMPLETED|Overall Study||23
125131|NCT01812057|306324|P2|STARTED|Overall Study||24
125132|NCT01812057|306325|P1|STARTED|Overall Study||25
125133|NCT01812044|306366|P3|NOT COMPLETED|Overall Study||0
125134|NCT01812044|306367|P2|NOT COMPLETED|Overall Study||0
125135|NCT01812044|306368|P1|NOT COMPLETED|Overall Study||0
125136|NCT01812044|306366|P3|COMPLETED|Overall Study||16
125137|NCT01812044|306367|P2|COMPLETED|Overall Study||17
125138|NCT01812044|306368|P1|COMPLETED|Overall Study||17
125139|NCT01812044|306366|P3|STARTED|Overall Study||16
125140|NCT01812044|306367|P2|STARTED|Overall Study||17
125141|NCT01812044|306368|P1|STARTED|Overall Study||17
125142|NCT01812005|306399|P2|NOT COMPLETED|Overall Study||0
125143|NCT01812005|306400|P1|NOT COMPLETED|Overall Study||0
125144|NCT01812005|306399|P2|COMPLETED|Overall Study||13
125145|NCT01812005|306400|P1|COMPLETED|Overall Study||1
125146|NCT01812005|306399|P2|STARTED|Overall Study||13
125147|NCT01812005|306400|P1|STARTED|Overall Study||1
125148|NCT01811953|306428|P6|NOT COMPLETED|Overall Study||1
125149|NCT01811953|306429|P5|NOT COMPLETED|Overall Study||1
125150|NCT01811953|306430|P4|NOT COMPLETED|Overall Study||1
125151|NCT01811953|306431|P3|NOT COMPLETED|Overall Study||0
125152|NCT01811953|306432|P2|NOT COMPLETED|Overall Study||0
125153|NCT01811953|306433|P1|NOT COMPLETED|Overall Study||0
125154|NCT01811953|306428|P6|COMPLETED|Overall Study||11
125155|NCT01811953|306429|P5|COMPLETED|Overall Study||11
125156|NCT01811953|306430|P4|COMPLETED|Overall Study||5
125157|NCT01811953|306431|P3|COMPLETED|Overall Study||6
125158|NCT01811953|306432|P2|COMPLETED|Overall Study||6
125159|NCT01811953|306433|P1|COMPLETED|Overall Study||6
125160|NCT01811953|306428|P6|STARTED|Overall Study||12
125161|NCT01811953|306429|P5|STARTED|Overall Study||12
125162|NCT01811953|306430|P4|STARTED|Overall Study||6
125163|NCT01811953|306431|P3|STARTED|Overall Study||6
125164|NCT01811953|306432|P2|STARTED|Overall Study||6
125165|NCT01811953|306433|P1|STARTED|Overall Study||6
125166|NCT01811940|306479|P2|NOT COMPLETED|Overall Study||26
125167|NCT01811940|306480|P1|NOT COMPLETED|Overall Study||22
125168|NCT01811940|306479|P2|COMPLETED|Overall Study||37
125169|NCT01811940|306480|P1|COMPLETED|Overall Study||42
125170|NCT01811940|306479|P2|STARTED|Overall Study||63
125171|NCT01811940|306480|P1|STARTED|Overall Study||64
125172|NCT01811732|306490|P2|NOT COMPLETED|Overall Study||58
125173|NCT01811732|306491|P1|NOT COMPLETED|Overall Study||55
125174|NCT01811732|306490|P2|COMPLETED|Overall Study||271
125175|NCT01811732|306491|P1|COMPLETED|Overall Study||276
125176|NCT01811732|306490|P2|STARTED|Overall Study||329
125177|NCT01811732|306491|P1|STARTED|Overall Study||331
125178|NCT01811706|306501|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
125179|NCT01811706|306502|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
125180|NCT01811706|306501|P2|COMPLETED|Second Intervention (4 Weeks)||10
125181|NCT01811706|306502|P1|COMPLETED|Second Intervention (4 Weeks)||9
125182|NCT01811706|306501|P2|STARTED|Second Intervention (4 Weeks)||10
125183|NCT01811706|306502|P1|STARTED|Second Intervention (4 Weeks)||9
125184|NCT01811706|306501|P2|NOT COMPLETED|Washout ( 2 Weeks)||0
125185|NCT01811706|306502|P1|NOT COMPLETED|Washout ( 2 Weeks)||0
125186|NCT01811706|306501|P2|COMPLETED|Washout ( 2 Weeks)||10
125187|NCT01811706|306502|P1|COMPLETED|Washout ( 2 Weeks)||9
125188|NCT01811706|306501|P2|STARTED|Washout ( 2 Weeks)||10
125189|NCT01811706|306502|P1|STARTED|Washout ( 2 Weeks)||9
125190|NCT01811706|306501|P2|NOT COMPLETED|First Intervention ( 4 Weeks)||0
125191|NCT01811706|306502|P1|NOT COMPLETED|First Intervention ( 4 Weeks)||1
125192|NCT01811706|306501|P2|COMPLETED|First Intervention ( 4 Weeks)||10
125193|NCT01811706|306502|P1|COMPLETED|First Intervention ( 4 Weeks)||9
125194|NCT01811706|306501|P2|STARTED|First Intervention ( 4 Weeks)||10
125195|NCT01811706|306502|P1|STARTED|First Intervention ( 4 Weeks)||10
125196|NCT01811680|306512|P1|NOT COMPLETED|Overall Study||0
125197|NCT01811680|306512|P1|COMPLETED|Overall Study||10
125198|NCT01811680|306512|P1|STARTED|Overall Study||10
125199|NCT01811563|306519|P2|NOT COMPLETED|Overall Study||3
125200|NCT01811563|306520|P1|NOT COMPLETED|Overall Study||5
125201|NCT01811563|306519|P2|COMPLETED|Overall Study||20
125202|NCT01811563|306520|P1|COMPLETED|Overall Study||20
125203|NCT01811563|306519|P2|STARTED|Overall Study||23
125204|NCT01811563|306520|P1|STARTED|Overall Study||25
125205|NCT01811485|306549|P3|NOT COMPLETED|Overall Study||5
125206|NCT01811485|306550|P2|NOT COMPLETED|Overall Study||4
125207|NCT01811485|306551|P1|NOT COMPLETED|Overall Study||2
125208|NCT01811485|306549|P3|COMPLETED|Overall Study||51
125209|NCT01811485|306550|P2|COMPLETED|Overall Study||55
125210|NCT01811485|306551|P1|COMPLETED|Overall Study||54
125211|NCT01811485|306549|P3|STARTED|Overall Study||56
125212|NCT01811485|306550|P2|STARTED|Overall Study||59
125213|NCT01811485|306551|P1|STARTED|Overall Study|"Started indicates randomized patients"|56
125214|NCT01811472|306571|P3|NOT COMPLETED|Overall Study||5
125215|NCT01811472|306572|P2|NOT COMPLETED|Overall Study||0
125216|NCT01811472|306573|P1|NOT COMPLETED|Overall Study||2
125217|NCT01811472|306571|P3|COMPLETED|Overall Study||16
125218|NCT01811472|306572|P2|COMPLETED|Overall Study||11
125219|NCT01811472|306573|P1|COMPLETED|Overall Study||18
125220|NCT01811472|306571|P3|STARTED|Overall Study||21
125221|NCT01811472|306572|P2|STARTED|Overall Study||11
125222|NCT01811472|306573|P1|STARTED|Overall Study||20
125223|NCT01811355|306618|P2|NOT COMPLETED|Second Dose||0
125224|NCT01811355|306619|P1|NOT COMPLETED|Second Dose||0
125225|NCT01811355|306618|P2|COMPLETED|Second Dose||12
125226|NCT01811355|306619|P1|COMPLETED|Second Dose||9
125227|NCT01811355|306618|P2|STARTED|Second Dose||12
125228|NCT01811355|306619|P1|STARTED|Second Dose||9
125229|NCT01811355|306618|P2|NOT COMPLETED|Washout||0
125230|NCT01811355|306619|P1|NOT COMPLETED|Washout||0
125231|NCT01811355|306618|P2|COMPLETED|Washout||12
125232|NCT01811355|306619|P1|COMPLETED|Washout||9
125233|NCT01811355|306618|P2|STARTED|Washout||12
125234|NCT01811355|306619|P1|STARTED|Washout||9
125235|NCT01811355|306618|P2|NOT COMPLETED|First Dose||0
125236|NCT01811355|306619|P1|NOT COMPLETED|First Dose||2
125237|NCT01811355|306618|P2|COMPLETED|First Dose||12
125238|NCT01811355|306619|P1|COMPLETED|First Dose||9
125239|NCT01811355|306618|P2|STARTED|First Dose||12
125240|NCT01811355|306619|P1|STARTED|First Dose||11
125241|NCT01811316|306630|P3|NOT COMPLETED|Overall Study||0
125242|NCT01811316|306631|P2|NOT COMPLETED|Overall Study||0
125243|NCT01811316|306632|P1|NOT COMPLETED|Overall Study||3
125244|NCT01811316|306630|P3|COMPLETED|Overall Study||19
125245|NCT01811316|306631|P2|COMPLETED|Overall Study||22
125246|NCT01811316|306632|P1|COMPLETED|Overall Study||18
125247|NCT01811316|306630|P3|Visit 12 Weeks|Overall Study||19
125248|NCT01811316|306631|P2|Visit 12 Weeks|Overall Study||22
125249|NCT01811316|306632|P1|Visit 12 Weeks|Overall Study||18
125250|NCT01811316|306630|P3|Visit 4 Weeks|Overall Study||19
125251|NCT01811316|306631|P2|Visit 4 Weeks|Overall Study||22
125252|NCT01811316|306632|P1|Visit 4 Weeks|Overall Study||19
125253|NCT01811316|306630|P3|STARTED|Overall Study||19
125254|NCT01811316|306631|P2|STARTED|Overall Study||22
125255|NCT01811316|306632|P1|STARTED|Overall Study||21
125256|NCT01811303|306649|P4|NOT COMPLETED|Fourth Intervention (1 Day)||0
125257|NCT01811303|306650|P3|NOT COMPLETED|Fourth Intervention (1 Day)||0
125258|NCT01811303|306651|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
125259|NCT01811303|306652|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
125260|NCT01811303|306649|P4|COMPLETED|Fourth Intervention (1 Day)||2
125261|NCT01811303|306650|P3|COMPLETED|Fourth Intervention (1 Day)||4
125262|NCT01811303|306651|P2|COMPLETED|Fourth Intervention (1 Day)||4
125263|NCT01811303|306652|P1|COMPLETED|Fourth Intervention (1 Day)||4
125264|NCT01811303|306649|P4|STARTED|Fourth Intervention (1 Day)||2
125265|NCT01811303|306650|P3|STARTED|Fourth Intervention (1 Day)||4
125266|NCT01811303|306651|P2|STARTED|Fourth Intervention (1 Day)||4
125267|NCT01811303|306652|P1|STARTED|Fourth Intervention (1 Day)||4
125268|NCT01811303|306649|P4|NOT COMPLETED|Washout (2 Days or More)||0
125269|NCT01811303|306650|P3|NOT COMPLETED|Washout (2 Days or More)||0
125270|NCT01811303|306651|P2|NOT COMPLETED|Washout (2 Days or More)||0
125271|NCT01811303|306652|P1|NOT COMPLETED|Washout (2 Days or More)||0
125272|NCT01811303|306649|P4|COMPLETED|Washout (2 Days or More)||2
125273|NCT01811303|306650|P3|COMPLETED|Washout (2 Days or More)||4
125274|NCT01811303|306651|P2|COMPLETED|Washout (2 Days or More)||4
125275|NCT01811303|306652|P1|COMPLETED|Washout (2 Days or More)||4
125276|NCT01811303|306649|P4|STARTED|Washout (2 Days or More)||2
125277|NCT01811303|306650|P3|STARTED|Washout (2 Days or More)||4
125278|NCT01811303|306651|P2|STARTED|Washout (2 Days or More)||4
125279|NCT01811303|306652|P1|STARTED|Washout (2 Days or More)||4
125280|NCT01811303|306649|P4|NOT COMPLETED|Third Intervention (1 Day)||0
125281|NCT01811303|306650|P3|NOT COMPLETED|Third Intervention (1 Day)||0
125282|NCT01811303|306651|P2|NOT COMPLETED|Third Intervention (1 Day)||0
125283|NCT01811303|306652|P1|NOT COMPLETED|Third Intervention (1 Day)||0
125284|NCT01811303|306649|P4|COMPLETED|Third Intervention (1 Day)||2
125285|NCT01811303|306650|P3|COMPLETED|Third Intervention (1 Day)||4
125286|NCT01811303|306651|P2|COMPLETED|Third Intervention (1 Day)||4
125287|NCT01811303|306652|P1|COMPLETED|Third Intervention (1 Day)||4
125288|NCT01811303|306649|P4|STARTED|Third Intervention (1 Day)||2
125289|NCT01811303|306650|P3|STARTED|Third Intervention (1 Day)||4
125290|NCT01811303|306651|P2|STARTED|Third Intervention (1 Day)||4
125291|NCT01811303|306652|P1|STARTED|Third Intervention (1 Day)||4
125292|NCT01811303|306649|P4|NOT COMPLETED|Washout (2 Days or More)||0
125293|NCT01811303|306650|P3|NOT COMPLETED|Washout (2 Days or More)||0
125294|NCT01811303|306651|P2|NOT COMPLETED|Washout (2 Days or More)||0
125295|NCT01811303|306652|P1|NOT COMPLETED|Washout (2 Days or More)||0
125296|NCT01811303|306649|P4|COMPLETED|Washout (2 Days or More)||2
125297|NCT01811303|306650|P3|COMPLETED|Washout (2 Days or More)||4
125298|NCT01811303|306651|P2|COMPLETED|Washout (2 Days or More)||4
125299|NCT01811303|306652|P1|COMPLETED|Washout (2 Days or More)||4
125300|NCT01811303|306649|P4|STARTED|Washout (2 Days or More)||2
125301|NCT01811303|306650|P3|STARTED|Washout (2 Days or More)||4
125302|NCT01811303|306651|P2|STARTED|Washout (2 Days or More)||4
125303|NCT01811303|306652|P1|STARTED|Washout (2 Days or More)||4
125304|NCT01811303|306649|P4|NOT COMPLETED|Second Intervention (1 Day)||0
125305|NCT01811303|306650|P3|NOT COMPLETED|Second Intervention (1 Day)||0
125306|NCT01811303|306651|P2|NOT COMPLETED|Second Intervention (1 Day)||0
125307|NCT01811303|306652|P1|NOT COMPLETED|Second Intervention (1 Day)||0
125308|NCT01811303|306649|P4|COMPLETED|Second Intervention (1 Day)||2
125309|NCT01811303|306650|P3|COMPLETED|Second Intervention (1 Day)||4
125310|NCT01811303|306651|P2|COMPLETED|Second Intervention (1 Day)||4
125311|NCT01811303|306652|P1|COMPLETED|Second Intervention (1 Day)||4
125312|NCT01811303|306649|P4|STARTED|Second Intervention (1 Day)||2
125313|NCT01811303|306650|P3|STARTED|Second Intervention (1 Day)||4
125314|NCT01811303|306651|P2|STARTED|Second Intervention (1 Day)||4
125315|NCT01811303|306652|P1|STARTED|Second Intervention (1 Day)||4
125316|NCT01811303|306649|P4|NOT COMPLETED|Washout (2 Days or More)||0
125317|NCT01811303|306650|P3|NOT COMPLETED|Washout (2 Days or More)||0
125318|NCT01811303|306651|P2|NOT COMPLETED|Washout (2 Days or More)||0
125319|NCT01811303|306652|P1|NOT COMPLETED|Washout (2 Days or More)||0
125320|NCT01811303|306649|P4|COMPLETED|Washout (2 Days or More)||2
125321|NCT01811303|306650|P3|COMPLETED|Washout (2 Days or More)||4
125322|NCT01811303|306651|P2|COMPLETED|Washout (2 Days or More)||4
125323|NCT01811303|306652|P1|COMPLETED|Washout (2 Days or More)||4
125324|NCT01811303|306649|P4|STARTED|Washout (2 Days or More)||2
125325|NCT01811303|306650|P3|STARTED|Washout (2 Days or More)||4
125326|NCT01811303|306651|P2|STARTED|Washout (2 Days or More)||4
125327|NCT01811303|306652|P1|STARTED|Washout (2 Days or More)||4
125328|NCT01811303|306649|P4|NOT COMPLETED|First Intervention (1 Day)||0
125329|NCT01811303|306650|P3|NOT COMPLETED|First Intervention (1 Day)||0
125330|NCT01811303|306651|P2|NOT COMPLETED|First Intervention (1 Day)||0
125331|NCT01811303|306652|P1|NOT COMPLETED|First Intervention (1 Day)||0
125332|NCT01811303|306649|P4|COMPLETED|First Intervention (1 Day)||2
125333|NCT01811303|306650|P3|COMPLETED|First Intervention (1 Day)||4
125334|NCT01811303|306651|P2|COMPLETED|First Intervention (1 Day)||4
125335|NCT01811303|306652|P1|COMPLETED|First Intervention (1 Day)||4
125336|NCT01811303|306649|P4|STARTED|First Intervention (1 Day)||2
125337|NCT01811303|306650|P3|STARTED|First Intervention (1 Day)||4
125338|NCT01811303|306651|P2|STARTED|First Intervention (1 Day)||4
125339|NCT01811303|306652|P1|STARTED|First Intervention (1 Day)||4
125340|NCT01811238|306660|P1|NOT COMPLETED|Overall Study||81
125341|NCT01811238|306660|P1|COMPLETED|Overall Study|159 subjects regardless PP set completed study visit.|159
125342|NCT01811238|306660|P1|PP Set|Overall Study|89 subjects excluded from PP set due to various reasons.|120
125343|NCT01811238|306660|P1|ITT Set|Overall Study|11 subjects excluded from ITT set due to no primary efficacy assessment(5) and IC/EC violation(6).|209
125344|NCT01811238|306660|P1|Safety Set|Overall Study|20 subjects excluded from the safety set due to study drug not administered.|220
125345|NCT01811238|306660|P1|STARTED|Overall Study|First patient was recruited on 26 Sep. 2012.|240
125346|NCT01811212|306669|P1|NOT COMPLETED|Overall Study||0
125347|NCT01811212|306669|P1|COMPLETED|Overall Study||25
125348|NCT01811212|306669|P1|STARTED|Overall Study||25
125349|NCT01811186|306684|P2|NOT COMPLETED|Overall Study||62
125350|NCT01811186|306685|P1|NOT COMPLETED|Overall Study||71
125351|NCT01811186|306684|P2|COMPLETED|Overall Study||64
125352|NCT01811186|306685|P1|COMPLETED|Overall Study||61
125353|NCT01811186|306684|P2|STARTED|Overall Study||126
125354|NCT01811186|306685|P1|STARTED|Overall Study||132
125355|NCT01810952|306703|P2|NOT COMPLETED|Overall Study||0
125356|NCT01810952|306704|P1|NOT COMPLETED|Overall Study||0
125357|NCT01810952|306703|P2|COMPLETED|Overall Study||17
125358|NCT01810952|306704|P1|COMPLETED|Overall Study||20
125359|NCT01810952|306703|P2|STARTED|Overall Study||17
125360|NCT01810952|306704|P1|STARTED|Overall Study||20
125361|NCT01810939|306718|P3|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||22
125362|NCT01810939|306719|P2|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||10
125363|NCT01810939|306720|P1|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||0
125364|NCT01810939|306718|P3|COMPLETED|Part B Placebo-Controlled Withdrawal||30
125365|NCT01810939|306719|P2|COMPLETED|Part B Placebo-Controlled Withdrawal||45
125366|NCT01810939|306720|P1|COMPLETED|Part B Placebo-Controlled Withdrawal||0
125367|NCT01810939|306718|P3|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|52
125368|NCT01810939|306719|P2|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|55
125369|NCT01810939|306720|P1|STARTED|Part B Placebo-Controlled Withdrawal||0
125370|NCT01810939|306718|P3|NOT COMPLETED|Part A Treatment Period||0
125371|NCT01810939|306719|P2|NOT COMPLETED|Part A Treatment Period||0
125372|NCT01810939|306720|P1|NOT COMPLETED|Part A Treatment Period||24
125373|NCT01810939|306718|P3|COMPLETED|Part A Treatment Period||0
125374|NCT01810939|306719|P2|COMPLETED|Part A Treatment Period||0
125375|NCT01810939|306720|P1|COMPLETED|Part A Treatment Period||219
125376|NCT01810939|306718|P3|STARTED|Part A Treatment Period||0
125377|NCT01810939|306719|P2|STARTED|Part A Treatment Period||0
125378|NCT01810939|306720|P1|STARTED|Part A Treatment Period||243
125379|NCT01810783|306733|P1|NOT COMPLETED|Overall Study||109
125380|NCT01810783|306733|P1|COMPLETED|Overall Study||101
125381|NCT01810783|306733|P1|STARTED|Overall Study||210
125382|NCT01810692|306739|P2|NOT COMPLETED|Overall Study||0
125383|NCT01810692|306740|P1|NOT COMPLETED|Overall Study||0
125384|NCT01810692|306739|P2|COMPLETED|Overall Study||77
125385|NCT01810692|306740|P1|COMPLETED|Overall Study||77
125386|NCT01810692|306739|P2|STARTED|Overall Study||77
125387|NCT01810692|306740|P1|STARTED|Overall Study||77
125388|NCT01810666|306752|P1|NOT COMPLETED|Overall Study||0
125389|NCT01810666|306752|P1|COMPLETED|Overall Study||30
125390|NCT01810666|306752|P1|STARTED|Overall Study||30
125391|NCT01810432|306758|P2|NOT COMPLETED|Period 2||2
125392|NCT01810432|306759|P1|NOT COMPLETED|Period 2||4
125393|NCT01810432|306758|P2|COMPLETED|Period 2||17
125394|NCT01810432|306759|P1|COMPLETED|Period 2||15
125395|NCT01810432|306758|P2|Received at Least 1 Dose of Study Drug|Period 2||19
125396|NCT01810432|306759|P1|Received at Least 1 Dose of Study Drug|Period 2||19
125397|NCT01810432|306758|P2|STARTED|Period 2||19
125398|NCT01810432|306759|P1|STARTED|Period 2||19
125399|NCT01810432|306758|P2|NOT COMPLETED|Washout||1
125400|NCT01810432|306759|P1|NOT COMPLETED|Washout||1
125401|NCT01810432|306758|P2|COMPLETED|Washout||19
125402|NCT01810432|306759|P1|COMPLETED|Washout||19
125403|NCT01810432|306758|P2|STARTED|Washout||20
125404|NCT01810432|306759|P1|STARTED|Washout||20
125405|NCT01810432|306758|P2|NOT COMPLETED|Period 1||0
125406|NCT01810432|306759|P1|NOT COMPLETED|Period 1||0
125407|NCT01810432|306758|P2|COMPLETED|Period 1||20
125408|NCT01810432|306759|P1|COMPLETED|Period 1||20
125409|NCT01810432|306758|P2|Received at Least 1 Dose of Study Drug|Period 1||20
125410|NCT01810432|306759|P1|Received at Least 1 Dose of Study Drug|Period 1||20
125411|NCT01810432|306758|P2|STARTED|Period 1||20
125412|NCT01810432|306759|P1|STARTED|Period 1||20
125413|NCT01810380|306772|P3|NOT COMPLETED|Overall Study||32
125414|NCT01810380|306773|P2|NOT COMPLETED|Overall Study||38
125415|NCT01810380|306774|P1|NOT COMPLETED|Overall Study||55
125416|NCT01810380|306772|P3|COMPLETED|Overall Study||122
125417|NCT01810380|306773|P2|COMPLETED|Overall Study||113
125418|NCT01810380|306774|P1|COMPLETED|Overall Study||108
125419|NCT01810380|306772|P3|Treated|Overall Study||153
125420|NCT01810380|306773|P2|Treated|Overall Study||150
125421|NCT01810380|306774|P1|Treated|Overall Study||161
125422|NCT01810380|306772|P3|STARTED|Overall Study||154
125423|NCT01810380|306773|P2|STARTED|Overall Study||151
125424|NCT01810380|306774|P1|STARTED|Overall Study||163
125425|NCT01810302|306835|P2|NOT COMPLETED|Overall Study||1
125426|NCT01810302|306836|P1|NOT COMPLETED|Overall Study||1
125427|NCT01810302|306835|P2|COMPLETED|Overall Study||0
125428|NCT01810302|306836|P1|COMPLETED|Overall Study||0
125429|NCT01810302|306835|P2|STARTED|Overall Study||1
125430|NCT01810302|306836|P1|STARTED|Overall Study||1
125431|NCT01810289|306846|P2|NOT COMPLETED|Overall Study||0
125432|NCT01810289|306847|P1|NOT COMPLETED|Overall Study||0
125433|NCT01810289|306846|P2|COMPLETED|Overall Study||4747
125434|NCT01810289|306847|P1|COMPLETED|Overall Study||7277
125435|NCT01810289|306846|P2|STARTED|Overall Study||4747
125436|NCT01810289|306847|P1|STARTED|Overall Study||7277
125437|NCT01810263|306863|P2|NOT COMPLETED|Overall Study||7
125438|NCT01810263|306864|P1|NOT COMPLETED|Overall Study||8
125439|NCT01810263|306863|P2|COMPLETED|Overall Study||11
125440|NCT01810263|306864|P1|COMPLETED|Overall Study|2014 July|8
125441|NCT01810263|306863|P2|STARTED|Overall Study||18
125442|NCT01810263|306864|P1|STARTED|Overall Study||16
125443|NCT01810042|306870|P1|NOT COMPLETED|Overall Study||10
125444|NCT01810042|306870|P1|COMPLETED|Overall Study||39
125445|NCT01810042|306870|P1|STARTED|Overall Study||49
125446|NCT01810016|306880|P3|NOT COMPLETED|Overall Study||1
125447|NCT01810016|306881|P2|NOT COMPLETED|Overall Study||1
125448|NCT01810016|306882|P1|NOT COMPLETED|Overall Study||1
125449|NCT01810016|306880|P3|COMPLETED|Overall Study||0
125450|NCT01810016|306881|P2|COMPLETED|Overall Study||1
125451|NCT01810016|306882|P1|COMPLETED|Overall Study||4
125452|NCT01810016|306880|P3|STARTED|Overall Study||1
125453|NCT01810016|306881|P2|STARTED|Overall Study||2
125454|NCT01810016|306882|P1|STARTED|Overall Study||5
125455|NCT01809938|306893|P2|NOT COMPLETED|Second Intervention (170 Minutes)||0
125456|NCT01809938|306894|P1|NOT COMPLETED|Second Intervention (170 Minutes)||0
125457|NCT01809938|306893|P2|COMPLETED|Second Intervention (170 Minutes)||5
125458|NCT01809938|306894|P1|COMPLETED|Second Intervention (170 Minutes)||5
125459|NCT01809938|306893|P2|STARTED|Second Intervention (170 Minutes)||5
125460|NCT01809938|306894|P1|STARTED|Second Intervention (170 Minutes)||5
125461|NCT01809938|306893|P2|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
125462|NCT01809938|306894|P1|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
125463|NCT01809938|306893|P2|COMPLETED|Washout (Not Less Than 24 Hours)||5
125464|NCT01809938|306894|P1|COMPLETED|Washout (Not Less Than 24 Hours)||5
125465|NCT01809938|306893|P2|STARTED|Washout (Not Less Than 24 Hours)||5
125466|NCT01809938|306894|P1|STARTED|Washout (Not Less Than 24 Hours)||5
125467|NCT01809938|306893|P2|NOT COMPLETED|First Intervention (170 Minutes)||0
125468|NCT01809938|306894|P1|NOT COMPLETED|First Intervention (170 Minutes)||0
125469|NCT01809938|306893|P2|COMPLETED|First Intervention (170 Minutes)||5
125470|NCT01809938|306894|P1|COMPLETED|First Intervention (170 Minutes)||5
125471|NCT01809938|306893|P2|STARTED|First Intervention (170 Minutes)||5
125472|NCT01809938|306894|P1|STARTED|First Intervention (170 Minutes)||5
125473|NCT01809899|306903|P2|NOT COMPLETED|Overall Study||0
125474|NCT01809899|306904|P1|NOT COMPLETED|Overall Study||0
125475|NCT01809899|306903|P2|COMPLETED|Overall Study||4
125476|NCT01809899|306904|P1|COMPLETED|Overall Study||8
125477|NCT01809899|306903|P2|STARTED|Overall Study||4
125478|NCT01809899|306904|P1|STARTED|Overall Study||8
125479|NCT01809834|306912|P1|NOT COMPLETED|Overall Study||0
125480|NCT01809834|306912|P1|COMPLETED|Overall Study||44
125481|NCT01809834|306912|P1|STARTED|Overall Study||44
125482|NCT01809639|306940|P2|NOT COMPLETED|Overall Study||0
125483|NCT01809639|306941|P1|NOT COMPLETED|Overall Study||0
125484|NCT01809639|306940|P2|COMPLETED|Overall Study||7
125485|NCT01809639|306941|P1|COMPLETED|Overall Study||18
125486|NCT01809639|306940|P2|STARTED|Overall Study||7
125487|NCT01809639|306941|P1|STARTED|Overall Study||18
125488|NCT01809327|306952|P5|NOT COMPLETED|Overall Study||25
125489|NCT01809327|306953|P4|NOT COMPLETED|Overall Study||12
125490|NCT01809327|306954|P3|NOT COMPLETED|Overall Study||22
125491|NCT01809327|306955|P2|NOT COMPLETED|Overall Study||26
125492|NCT01809327|306956|P1|NOT COMPLETED|Overall Study||32
125493|NCT01809327|306952|P5|COMPLETED|Overall Study||212
125494|NCT01809327|306953|P4|COMPLETED|Overall Study||225
125495|NCT01809327|306954|P3|COMPLETED|Overall Study||216
125496|NCT01809327|306955|P2|COMPLETED|Overall Study||211
125497|NCT01809327|306956|P1|COMPLETED|Overall Study||205
125498|NCT01809327|306952|P5|STARTED|Overall Study||237
125499|NCT01809327|306953|P4|STARTED|Overall Study||237
125500|NCT01809327|306954|P3|STARTED|Overall Study||238
125501|NCT01809327|306955|P2|STARTED|Overall Study||237
125502|NCT01809327|306956|P1|STARTED|Overall Study||237
125503|NCT01809314|306998|P1|NOT COMPLETED|Overall Study||745
125504|NCT01809314|306998|P1|COMPLETED|Overall Study||422
125505|NCT01809314|306998|P1|STARTED|Overall Study||1167
125506|NCT01809262|307004|P10|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
125507|NCT01809262|307005|P9|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
125508|NCT01809262|307006|P8|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
125509|NCT01809262|307007|P7|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
125510|NCT01809262|307008|P6|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
125511|NCT01809262|307009|P5|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
125512|NCT01809262|307010|P4|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
125513|NCT01809262|307011|P3|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
125514|NCT01809262|307012|P2|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
125515|NCT01809262|307013|P1|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
125516|NCT01809262|307004|P10|COMPLETED|Period 5 (Fifth Dose + Washout)||4
125517|NCT01809262|307005|P9|COMPLETED|Period 5 (Fifth Dose + Washout)||3
125518|NCT01809262|307006|P8|COMPLETED|Period 5 (Fifth Dose + Washout)||4
125519|NCT01809262|307007|P7|COMPLETED|Period 5 (Fifth Dose + Washout)||3
125520|NCT01809262|307008|P6|COMPLETED|Period 5 (Fifth Dose + Washout)||3
125521|NCT01809262|307009|P5|COMPLETED|Period 5 (Fifth Dose + Washout)||3
125522|NCT01809262|307010|P4|COMPLETED|Period 5 (Fifth Dose + Washout)||3
125523|NCT01809262|307011|P3|COMPLETED|Period 5 (Fifth Dose + Washout)||4
125524|NCT01809262|307012|P2|COMPLETED|Period 5 (Fifth Dose + Washout)||3
125525|NCT01809262|307013|P1|COMPLETED|Period 5 (Fifth Dose + Washout)||4
125526|NCT01809262|307004|P10|STARTED|Period 5 (Fifth Dose + Washout)||4
125527|NCT01809262|307005|P9|STARTED|Period 5 (Fifth Dose + Washout)||3
125528|NCT01809262|307006|P8|STARTED|Period 5 (Fifth Dose + Washout)||4
125529|NCT01809262|307007|P7|STARTED|Period 5 (Fifth Dose + Washout)||3
125530|NCT01809262|307008|P6|STARTED|Period 5 (Fifth Dose + Washout)||3
125531|NCT01809262|307009|P5|STARTED|Period 5 (Fifth Dose + Washout)||3
125532|NCT01809262|307010|P4|STARTED|Period 5 (Fifth Dose + Washout)||3
125533|NCT01809262|307011|P3|STARTED|Period 5 (Fifth Dose + Washout)||4
125534|NCT01809262|307012|P2|STARTED|Period 5 (Fifth Dose + Washout)||3
125535|NCT01809262|307013|P1|STARTED|Period 5 (Fifth Dose + Washout)||4
125536|NCT01809262|307004|P10|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
125537|NCT01809262|307005|P9|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
125538|NCT01809262|307006|P8|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
125539|NCT01809262|307007|P7|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
125540|NCT01809262|307008|P6|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
125541|NCT01809262|307009|P5|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
125542|NCT01809262|307010|P4|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
125543|NCT01809262|307011|P3|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
125544|NCT01809262|307012|P2|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
125545|NCT01809262|307013|P1|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
125546|NCT01809262|307004|P10|COMPLETED|Period 4 (Fourth Dose + Washout)||4
125547|NCT01809262|307005|P9|COMPLETED|Period 4 (Fourth Dose + Washout)||3
125548|NCT01809262|307006|P8|COMPLETED|Period 4 (Fourth Dose + Washout)||4
125549|NCT01809262|307007|P7|COMPLETED|Period 4 (Fourth Dose + Washout)||3
125550|NCT01809262|307008|P6|COMPLETED|Period 4 (Fourth Dose + Washout)||3
125551|NCT01809262|307009|P5|COMPLETED|Period 4 (Fourth Dose + Washout)||3
125552|NCT01809262|307010|P4|COMPLETED|Period 4 (Fourth Dose + Washout)||3
125553|NCT01809262|307011|P3|COMPLETED|Period 4 (Fourth Dose + Washout)||4
125554|NCT01809262|307012|P2|COMPLETED|Period 4 (Fourth Dose + Washout)||3
125555|NCT01809262|307013|P1|COMPLETED|Period 4 (Fourth Dose + Washout)||4
125556|NCT01809262|307004|P10|STARTED|Period 4 (Fourth Dose + Washout)||4
125557|NCT01809262|307005|P9|STARTED|Period 4 (Fourth Dose + Washout)||3
125558|NCT01809262|307006|P8|STARTED|Period 4 (Fourth Dose + Washout)||4
125559|NCT01809262|307007|P7|STARTED|Period 4 (Fourth Dose + Washout)||3
125560|NCT01809262|307008|P6|STARTED|Period 4 (Fourth Dose + Washout)||3
125561|NCT01809262|307009|P5|STARTED|Period 4 (Fourth Dose + Washout)||3
125562|NCT01809262|307010|P4|STARTED|Period 4 (Fourth Dose + Washout)||3
125563|NCT01809262|307011|P3|STARTED|Period 4 (Fourth Dose + Washout)||4
125564|NCT01809262|307012|P2|STARTED|Period 4 (Fourth Dose + Washout)||3
125565|NCT01809262|307013|P1|STARTED|Period 4 (Fourth Dose + Washout)||4
125566|NCT01809262|307004|P10|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
125567|NCT01809262|307005|P9|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
125568|NCT01809262|307006|P8|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
125569|NCT01809262|307007|P7|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
125570|NCT01809262|307008|P6|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
125571|NCT01809262|307009|P5|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
125572|NCT01809262|307010|P4|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
125573|NCT01809262|307011|P3|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
125574|NCT01809262|307012|P2|NOT COMPLETED|Period 3 (Third Dose + Washout)||1
125575|NCT01809262|307013|P1|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
125576|NCT01809262|307004|P10|COMPLETED|Period 3 (Third Dose + Washout)||4
125577|NCT01809262|307005|P9|COMPLETED|Period 3 (Third Dose + Washout)||3
125578|NCT01809262|307006|P8|COMPLETED|Period 3 (Third Dose + Washout)||4
125579|NCT01809262|307007|P7|COMPLETED|Period 3 (Third Dose + Washout)||3
125580|NCT01809262|307008|P6|COMPLETED|Period 3 (Third Dose + Washout)||3
125581|NCT01809262|307009|P5|COMPLETED|Period 3 (Third Dose + Washout)||3
125582|NCT01809262|307010|P4|COMPLETED|Period 3 (Third Dose + Washout)||3
125583|NCT01809262|307011|P3|COMPLETED|Period 3 (Third Dose + Washout)||4
125584|NCT01809262|307012|P2|COMPLETED|Period 3 (Third Dose + Washout)||3
125585|NCT01809262|307013|P1|COMPLETED|Period 3 (Third Dose + Washout)||4
125586|NCT01809262|307004|P10|STARTED|Period 3 (Third Dose + Washout)||4
125587|NCT01809262|307005|P9|STARTED|Period 3 (Third Dose + Washout)||3
125588|NCT01809262|307006|P8|STARTED|Period 3 (Third Dose + Washout)||4
125589|NCT01809262|307007|P7|STARTED|Period 3 (Third Dose + Washout)||3
125590|NCT01809262|307008|P6|STARTED|Period 3 (Third Dose + Washout)||3
125591|NCT01809262|307009|P5|STARTED|Period 3 (Third Dose + Washout)||3
125592|NCT01809262|307010|P4|STARTED|Period 3 (Third Dose + Washout)||3
125593|NCT01809262|307011|P3|STARTED|Period 3 (Third Dose + Washout)||4
125594|NCT01809262|307012|P2|STARTED|Period 3 (Third Dose + Washout)||4
125595|NCT01809262|307013|P1|STARTED|Period 3 (Third Dose + Washout)||4
125596|NCT01809262|307004|P10|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
125597|NCT01809262|307005|P9|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
125598|NCT01809262|307006|P8|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
125599|NCT01809262|307007|P7|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
125600|NCT01809262|307008|P6|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
125601|NCT01809262|307009|P5|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
125602|NCT01809262|307010|P4|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
125603|NCT01809262|307011|P3|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
125604|NCT01809262|307012|P2|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
125605|NCT01809262|307013|P1|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
125606|NCT01809262|307004|P10|COMPLETED|Period 2 (Second Dose + Washout)||4
125607|NCT01809262|307005|P9|COMPLETED|Period 2 (Second Dose + Washout)||3
125608|NCT01809262|307006|P8|COMPLETED|Period 2 (Second Dose + Washout)||4
125609|NCT01809262|307007|P7|COMPLETED|Period 2 (Second Dose + Washout)||3
125610|NCT01809262|307008|P6|COMPLETED|Period 2 (Second Dose + Washout)||3
125611|NCT01809262|307009|P5|COMPLETED|Period 2 (Second Dose + Washout)||3
125612|NCT01809262|307010|P4|COMPLETED|Period 2 (Second Dose + Washout)||3
125613|NCT01809262|307011|P3|COMPLETED|Period 2 (Second Dose + Washout)||4
125614|NCT01809262|307012|P2|COMPLETED|Period 2 (Second Dose + Washout)||4
125615|NCT01809262|307013|P1|COMPLETED|Period 2 (Second Dose + Washout)||4
125616|NCT01809262|307004|P10|STARTED|Period 2 (Second Dose + Washout)||4
125617|NCT01809262|307005|P9|STARTED|Period 2 (Second Dose + Washout)||3
125618|NCT01809262|307006|P8|STARTED|Period 2 (Second Dose + Washout)||4
125619|NCT01809262|307007|P7|STARTED|Period 2 (Second Dose + Washout)||3
125620|NCT01809262|307008|P6|STARTED|Period 2 (Second Dose + Washout)||3
125621|NCT01809262|307009|P5|STARTED|Period 2 (Second Dose + Washout)||3
125622|NCT01809262|307010|P4|STARTED|Period 2 (Second Dose + Washout)||3
125623|NCT01809262|307011|P3|STARTED|Period 2 (Second Dose + Washout)||4
125624|NCT01809262|307012|P2|STARTED|Period 2 (Second Dose + Washout)||4
125625|NCT01809262|307013|P1|STARTED|Period 2 (Second Dose + Washout)||4
125626|NCT01809262|307004|P10|NOT COMPLETED|Period 1 (First Dose + Washout)||0
125627|NCT01809262|307005|P9|NOT COMPLETED|Period 1 (First Dose + Washout)||0
125628|NCT01809262|307006|P8|NOT COMPLETED|Period 1 (First Dose + Washout)||0
125629|NCT01809262|307007|P7|NOT COMPLETED|Period 1 (First Dose + Washout)||0
125630|NCT01809262|307008|P6|NOT COMPLETED|Period 1 (First Dose + Washout)||0
125631|NCT01809262|307009|P5|NOT COMPLETED|Period 1 (First Dose + Washout)||1
125632|NCT01809262|307010|P4|NOT COMPLETED|Period 1 (First Dose + Washout)||0
125633|NCT01809262|307011|P3|NOT COMPLETED|Period 1 (First Dose + Washout)||0
125634|NCT01809262|307012|P2|NOT COMPLETED|Period 1 (First Dose + Washout)||0
125635|NCT01809262|307013|P1|NOT COMPLETED|Period 1 (First Dose + Washout)||0
125636|NCT01809262|307004|P10|COMPLETED|Period 1 (First Dose + Washout)||4
125637|NCT01809262|307005|P9|COMPLETED|Period 1 (First Dose + Washout)||3
125638|NCT01809262|307006|P8|COMPLETED|Period 1 (First Dose + Washout)||4
125639|NCT01809262|307007|P7|COMPLETED|Period 1 (First Dose + Washout)||3
125640|NCT01809262|307008|P6|COMPLETED|Period 1 (First Dose + Washout)||3
125641|NCT01809262|307009|P5|COMPLETED|Period 1 (First Dose + Washout)||3
125642|NCT01809262|307010|P4|COMPLETED|Period 1 (First Dose + Washout)||3
125643|NCT01809262|307011|P3|COMPLETED|Period 1 (First Dose + Washout)||4
125644|NCT01809262|307012|P2|COMPLETED|Period 1 (First Dose + Washout)||4
125645|NCT01809262|307013|P1|COMPLETED|Period 1 (First Dose + Washout)||4
125646|NCT01809262|307004|P10|STARTED|Period 1 (First Dose + Washout)||4
125647|NCT01809262|307005|P9|STARTED|Period 1 (First Dose + Washout)||3
125648|NCT01809262|307006|P8|STARTED|Period 1 (First Dose + Washout)||4
125649|NCT01809262|307007|P7|STARTED|Period 1 (First Dose + Washout)||3
125650|NCT01809262|307008|P6|STARTED|Period 1 (First Dose + Washout)||3
125651|NCT01809262|307009|P5|STARTED|Period 1 (First Dose + Washout)||4
125652|NCT01809262|307010|P4|STARTED|Period 1 (First Dose + Washout)||3
125653|NCT01809262|307011|P3|STARTED|Period 1 (First Dose + Washout)||4
125654|NCT01809262|307012|P2|STARTED|Period 1 (First Dose + Washout)||4
125655|NCT01809262|307013|P1|STARTED|Period 1 (First Dose + Washout)||4
125656|NCT01809210|307087|P7|NOT COMPLETED|Overall Study||5
125657|NCT01809210|307088|P6|NOT COMPLETED|Overall Study||3
125658|NCT01809210|307089|P5|NOT COMPLETED|Overall Study||2
125659|NCT01809210|307090|P4|NOT COMPLETED|Overall Study||1
125660|NCT01809210|307091|P3|NOT COMPLETED|Overall Study||3
125661|NCT01809210|307092|P2|NOT COMPLETED|Overall Study||1
125662|NCT01809210|307093|P1|NOT COMPLETED|Overall Study||1
125663|NCT01809210|307087|P7|COMPLETED|Overall Study||7
125664|NCT01809210|307088|P6|COMPLETED|Overall Study||12
125665|NCT01809210|307089|P5|COMPLETED|Overall Study||4
125666|NCT01809210|307090|P4|COMPLETED|Overall Study||2
125667|NCT01809210|307091|P3|COMPLETED|Overall Study||4
125668|NCT01809210|307092|P2|COMPLETED|Overall Study||8
125669|NCT01809210|307093|P1|COMPLETED|Overall Study||2
125670|NCT01809210|307087|P7|STARTED|Overall Study||12
125671|NCT01809210|307088|P6|STARTED|Overall Study||15
125672|NCT01809210|307089|P5|STARTED|Overall Study||6
125673|NCT01809210|307090|P4|STARTED|Overall Study||3
125674|NCT01809210|307091|P3|STARTED|Overall Study||7
125675|NCT01809210|307092|P2|STARTED|Overall Study||9
125676|NCT01809210|307093|P1|STARTED|Overall Study||3
125677|NCT01809197|307167|P2|NOT COMPLETED|Overall Study||8
125678|NCT01809197|307168|P1|NOT COMPLETED|Overall Study||10
125679|NCT01809197|307167|P2|COMPLETED|Overall Study||177
125680|NCT01809197|307168|P1|COMPLETED|Overall Study||177
125681|NCT01809197|307167|P2|STARTED|Overall Study||185
125682|NCT01809197|307168|P1|STARTED|Overall Study||187
125683|NCT01809106|307178|P4|NOT COMPLETED|Overall Study||4
125684|NCT01809106|307179|P3|NOT COMPLETED|Overall Study||3
125685|NCT01809106|307180|P2|NOT COMPLETED|Overall Study||5
125686|NCT01809106|307181|P1|NOT COMPLETED|Overall Study||8
125687|NCT01809106|307178|P4|COMPLETED|Overall Study||124
125688|NCT01809106|307179|P3|COMPLETED|Overall Study||127
125689|NCT01809106|307180|P2|COMPLETED|Overall Study||125
125690|NCT01809106|307181|P1|COMPLETED|Overall Study||122
125691|NCT01809106|307178|P4|STARTED|Overall Study||128
125692|NCT01809106|307179|P3|STARTED|Overall Study||130
125693|NCT01809106|307180|P2|STARTED|Overall Study||130
125694|NCT01809106|307181|P1|STARTED|Overall Study||130
125695|NCT01809054|307201|P2|NOT COMPLETED|Overall Study||0
125696|NCT01809054|307202|P1|NOT COMPLETED|Overall Study||0
125697|NCT01809054|307201|P2|COMPLETED|Overall Study||22
125698|NCT01809054|307202|P1|COMPLETED|Overall Study||27
125699|NCT01809054|307201|P2|STARTED|Overall Study||22
125700|NCT01809054|307202|P1|STARTED|Overall Study||27
125701|NCT01808963|307210|P1|NOT COMPLETED|Overall Study||0
125702|NCT01808963|307210|P1|COMPLETED|Overall Study||13
125703|NCT01808963|307210|P1|STARTED|Overall Study||13
125704|NCT01808950|307217|P3|NOT COMPLETED|Overall Study||0
125705|NCT01808950|307218|P2|NOT COMPLETED|Overall Study||0
125706|NCT01808950|307219|P1|NOT COMPLETED|Overall Study||0
125707|NCT01808950|307217|P3|COMPLETED|Overall Study||0
125708|NCT01808950|307218|P2|COMPLETED|Overall Study||3
125709|NCT01808950|307219|P1|COMPLETED|Overall Study||1
125710|NCT01808950|307217|P3|STARTED|Overall Study||0
125711|NCT01808950|307218|P2|STARTED|Overall Study||3
125712|NCT01808950|307219|P1|STARTED|Overall Study||1
125713|NCT01808755|307230|P2|NOT COMPLETED|Overall Study||0
125714|NCT01808755|307231|P1|NOT COMPLETED|Overall Study||0
125715|NCT01808755|307230|P2|COMPLETED|Overall Study||30
125716|NCT01808755|307231|P1|COMPLETED|Overall Study||30
125717|NCT01808755|307230|P2|STARTED|Overall Study||30
125718|NCT01808755|307231|P1|STARTED|Overall Study||30
125719|NCT01808651|307239|P3|NOT COMPLETED|Study Period 2||0
125720|NCT01808651|307240|P2|NOT COMPLETED|Study Period 2||0
125721|NCT01808651|307241|P1|NOT COMPLETED|Study Period 2||0
125722|NCT01808651|307239|P3|COMPLETED|Study Period 2|3 Pts who DC'd from Study Period 1 and 30 pts who completed Study Period 1 entered Study Period 2.|33
125723|NCT01808651|307240|P2|COMPLETED|Study Period 2|5 Pts who DC'd from Study Period 1 and 47 Pts who completed Study Period 1 entered Study Period 2.|52
125724|NCT01808651|307241|P1|COMPLETED|Study Period 2|9 Pts who DC'd from Study Period 1 and 68 Pts who completed Study Period 1 entered Study Period 2.|77
125725|NCT01808651|307239|P3|STARTED|Study Period 2||33
125726|NCT01808651|307240|P2|STARTED|Study Period 2||52
125727|NCT01808651|307241|P1|STARTED|Study Period 2||77
125728|NCT01808651|307239|P3|NOT COMPLETED|Study Period 1||5
125729|NCT01808651|307240|P2|NOT COMPLETED|Study Period 1||17
125730|NCT01808651|307241|P1|NOT COMPLETED|Study Period 1||26
125731|NCT01808651|307239|P3|COMPLETED|Study Period 1||31
125732|NCT01808651|307240|P2|COMPLETED|Study Period 1||48
125733|NCT01808651|307241|P1|COMPLETED|Study Period 1||73
125734|NCT01808651|307239|P3|Received at Least One Dose of Study Drug|Study Period 1||36
125735|NCT01808651|307240|P2|Received at Least One Dose of Study Drug|Study Period 1||65
125736|NCT01808651|307241|P1|Received at Least One Dose of Study Drug|Study Period 1||98
125737|NCT01808651|307239|P3|STARTED|Study Period 1||36
125738|NCT01808651|307240|P2|STARTED|Study Period 1||65
125739|NCT01808651|307241|P1|STARTED|Study Period 1||99
125740|NCT01808612|307276|P3|NOT COMPLETED|Discontinuation Period||0
125741|NCT01808612|307277|P2|NOT COMPLETED|Discontinuation Period||1
125742|NCT01808612|307278|P1|NOT COMPLETED|Discontinuation Period||2
125743|NCT01808612|307276|P3|COMPLETED|Discontinuation Period||145
125744|NCT01808612|307277|P2|COMPLETED|Discontinuation Period||37
125745|NCT01808612|307278|P1|COMPLETED|Discontinuation Period||85
125746|NCT01808612|307276|P3|STARTED|Discontinuation Period||145
125747|NCT01808612|307277|P2|STARTED|Discontinuation Period||38
125748|NCT01808612|307278|P1|STARTED|Discontinuation Period||87
125749|NCT01808612|307276|P3|NOT COMPLETED|Treatment Period||14
125750|NCT01808612|307277|P2|NOT COMPLETED|Treatment Period||7
125751|NCT01808612|307278|P1|NOT COMPLETED|Treatment Period||15
125752|NCT01808612|307276|P3|COMPLETED|Treatment Period|101 participants who completed the Treatment Period did not enter the Discontinuation Period.|246
125753|NCT01808612|307277|P2|COMPLETED|Treatment Period|39 participants who completed the Treatment Period did not enter the Discontinuation Period.|77
125754|NCT01808612|307278|P1|COMPLETED|Treatment Period|67 participants who completed the Treatment Period did not enter the Discontinuation Period.|154
125755|NCT01808612|307276|P3|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|259
125756|NCT01808612|307277|P2|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|83
125757|NCT01808612|307278|P1|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|168
125758|NCT01808612|307276|P3|STARTED|Treatment Period||260
125759|NCT01808612|307277|P2|STARTED|Treatment Period||84
125760|NCT01808612|307278|P1|STARTED|Treatment Period||169
125761|NCT01808560|307310|P3|NOT COMPLETED|4-Month After Cataract Surgery||0
125762|NCT01808560|307311|P2|NOT COMPLETED|4-Month After Cataract Surgery||0
125763|NCT01808560|307312|P1|NOT COMPLETED|4-Month After Cataract Surgery||0
125764|NCT01808560|307310|P3|COMPLETED|4-Month After Cataract Surgery||13
125765|NCT01808560|307311|P2|COMPLETED|4-Month After Cataract Surgery||0
125766|NCT01808560|307312|P1|COMPLETED|4-Month After Cataract Surgery||0
125767|NCT01808560|307310|P3|STARTED|4-Month After Cataract Surgery||13
125768|NCT01808560|307311|P2|STARTED|4-Month After Cataract Surgery||0
125769|NCT01808560|307312|P1|STARTED|4-Month After Cataract Surgery||0
125770|NCT01808560|307310|P3|NOT COMPLETED|Crossover Treatment||0
125771|NCT01808560|307311|P2|NOT COMPLETED|Crossover Treatment||0
125772|NCT01808560|307312|P1|NOT COMPLETED|Crossover Treatment||0
125773|NCT01808560|307310|P3|COMPLETED|Crossover Treatment||13
125774|NCT01808560|307311|P2|COMPLETED|Crossover Treatment||0
125775|NCT01808560|307312|P1|COMPLETED|Crossover Treatment||0
125776|NCT01808560|307310|P3|STARTED|Crossover Treatment|Post-Treatment Group Received Crossover LipiFlow treatment 3 Months after cataract surgery|13
125777|NCT01808560|307311|P2|STARTED|Crossover Treatment||0
125778|NCT01808560|307312|P1|STARTED|Crossover Treatment||0
125779|NCT01808560|307310|P3|NOT COMPLETED|3-Month After Cataract Surgery||0
125780|NCT01808560|307311|P2|NOT COMPLETED|3-Month After Cataract Surgery||0
125781|NCT01808560|307312|P1|NOT COMPLETED|3-Month After Cataract Surgery||0
125782|NCT01808560|307310|P3|COMPLETED|3-Month After Cataract Surgery||0
125783|NCT01808560|307311|P2|COMPLETED|3-Month After Cataract Surgery||13
125784|NCT01808560|307312|P1|COMPLETED|3-Month After Cataract Surgery||17
125785|NCT01808560|307310|P3|STARTED|3-Month After Cataract Surgery||0
125786|NCT01808560|307311|P2|STARTED|3-Month After Cataract Surgery||13
125787|NCT01808560|307312|P1|STARTED|3-Month After Cataract Surgery||17
125788|NCT01808560|307310|P3|NOT COMPLETED|1-Month After Cataract Surgery||0
125789|NCT01808560|307311|P2|NOT COMPLETED|1-Month After Cataract Surgery||0
125790|NCT01808560|307312|P1|NOT COMPLETED|1-Month After Cataract Surgery||0
125791|NCT01808560|307310|P3|COMPLETED|1-Month After Cataract Surgery||0
125792|NCT01808560|307311|P2|COMPLETED|1-Month After Cataract Surgery||13
125793|NCT01808560|307312|P1|COMPLETED|1-Month After Cataract Surgery||16
125794|NCT01808560|307310|P3|STARTED|1-Month After Cataract Surgery||0
125795|NCT01808560|307311|P2|STARTED|1-Month After Cataract Surgery|ITT: 3 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|13
125796|NCT01808560|307312|P1|STARTED|1-Month After Cataract Surgery|ITT: 2 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|16
125797|NCT01808560|307310|P3|NOT COMPLETED|Randomization and Treatment Allocation||0
125798|NCT01808560|307311|P2|NOT COMPLETED|Randomization and Treatment Allocation||0
125799|NCT01808560|307312|P1|NOT COMPLETED|Randomization and Treatment Allocation||0
125800|NCT01808560|307310|P3|COMPLETED|Randomization and Treatment Allocation||0
125801|NCT01808560|307311|P2|COMPLETED|Randomization and Treatment Allocation||16
125802|NCT01808560|307312|P1|COMPLETED|Randomization and Treatment Allocation||18
125803|NCT01808560|307310|P3|STARTED|Randomization and Treatment Allocation||0
125804|NCT01808560|307311|P2|STARTED|Randomization and Treatment Allocation||16
125805|NCT01808560|307312|P1|STARTED|Randomization and Treatment Allocation||18
125806|NCT01808547|307337|P2|NOT COMPLETED|Overall Study||46
125807|NCT01808547|307338|P1|NOT COMPLETED|Overall Study||37
125808|NCT01808547|307337|P2|COMPLETED|Overall Study||48
125809|NCT01808547|307338|P1|COMPLETED|Overall Study||137
125810|NCT01808547|307337|P2|mITT Population|Overall Study||85
125811|NCT01808547|307338|P1|mITT Population|Overall Study||168
125812|NCT01808547|307337|P2|Safety Population|Overall Study||85
125813|NCT01808547|307338|P1|Safety Population|Overall Study||170
125814|NCT01808547|307337|P2|STARTED|Overall Study||94
125815|NCT01808547|307338|P1|STARTED|Overall Study||174
125816|NCT01808534|307344|P1|NOT COMPLETED|Overall Study||4
125817|NCT01808534|307344|P1|COMPLETED|Overall Study||1
125818|NCT01808534|307344|P1|STARTED|Overall Study||5
125819|NCT01808508|307355|P3|NOT COMPLETED|Overall Study||0
125820|NCT01808508|307356|P2|NOT COMPLETED|Overall Study||0
125821|NCT01808508|307357|P1|NOT COMPLETED|Overall Study||1
125822|NCT01808508|307355|P3|COMPLETED|Overall Study||3
125823|NCT01808508|307356|P2|COMPLETED|Overall Study||9
125824|NCT01808508|307357|P1|COMPLETED|Overall Study||10
125825|NCT01808508|307355|P3|STARTED|Overall Study||3
125826|NCT01808508|307356|P2|STARTED|Overall Study||9
125827|NCT01808508|307357|P1|STARTED|Overall Study||11
125828|NCT01808339|307374|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||0
125829|NCT01808339|307375|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
125830|NCT01808339|307376|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
125831|NCT01808339|307377|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
125832|NCT01808339|307378|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||0
125833|NCT01808339|307379|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
125834|NCT01808339|307374|P6|COMPLETED|Treatment Period 3 (14 Days)||5
125835|NCT01808339|307375|P5|COMPLETED|Treatment Period 3 (14 Days)||4
125836|NCT01808339|307376|P4|COMPLETED|Treatment Period 3 (14 Days)||2
125837|NCT01808339|307377|P3|COMPLETED|Treatment Period 3 (14 Days)||3
125838|NCT01808339|307378|P2|COMPLETED|Treatment Period 3 (14 Days)||3
125839|NCT01808339|307379|P1|COMPLETED|Treatment Period 3 (14 Days)||4
125840|NCT01808339|307374|P6|STARTED|Treatment Period 3 (14 Days)||5
125841|NCT01808339|307375|P5|STARTED|Treatment Period 3 (14 Days)||4
125842|NCT01808339|307376|P4|STARTED|Treatment Period 3 (14 Days)||2
125843|NCT01808339|307377|P3|STARTED|Treatment Period 3 (14 Days)||4
125844|NCT01808339|307378|P2|STARTED|Treatment Period 3 (14 Days)||3
125845|NCT01808339|307379|P1|STARTED|Treatment Period 3 (14 Days)||4
125846|NCT01808339|307374|P6|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
125847|NCT01808339|307375|P5|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
125848|NCT01808339|307376|P4|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
125849|NCT01808339|307377|P3|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
125850|NCT01808339|307378|P2|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
125851|NCT01808339|307379|P1|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
125852|NCT01808339|307374|P6|COMPLETED|Washout Period 2 (14-21 Days)||5
125853|NCT01808339|307375|P5|COMPLETED|Washout Period 2 (14-21 Days)||4
125854|NCT01808339|307376|P4|COMPLETED|Washout Period 2 (14-21 Days)||2
125855|NCT01808339|307377|P3|COMPLETED|Washout Period 2 (14-21 Days)||4
125856|NCT01808339|307378|P2|COMPLETED|Washout Period 2 (14-21 Days)||3
125857|NCT01808339|307379|P1|COMPLETED|Washout Period 2 (14-21 Days)||4
125858|NCT01808339|307374|P6|STARTED|Washout Period 2 (14-21 Days)||5
125859|NCT01808339|307375|P5|STARTED|Washout Period 2 (14-21 Days)||4
125860|NCT01808339|307376|P4|STARTED|Washout Period 2 (14-21 Days)||2
125861|NCT01808339|307377|P3|STARTED|Washout Period 2 (14-21 Days)||4
125862|NCT01808339|307378|P2|STARTED|Washout Period 2 (14-21 Days)||3
125863|NCT01808339|307379|P1|STARTED|Washout Period 2 (14-21 Days)||4
125864|NCT01808339|307374|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
125865|NCT01808339|307375|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
125866|NCT01808339|307376|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||0
125867|NCT01808339|307377|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||0
125868|NCT01808339|307378|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||0
125869|NCT01808339|307379|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
125870|NCT01808339|307374|P6|COMPLETED|Treatment Period 2 (14 Days)||5
125871|NCT01808339|307375|P5|COMPLETED|Treatment Period 2 (14 Days)||4
125872|NCT01808339|307376|P4|COMPLETED|Treatment Period 2 (14 Days)||2
125873|NCT01808339|307377|P3|COMPLETED|Treatment Period 2 (14 Days)||4
125874|NCT01808339|307378|P2|COMPLETED|Treatment Period 2 (14 Days)||3
125875|NCT01808339|307379|P1|COMPLETED|Treatment Period 2 (14 Days)||4
125876|NCT01808339|307374|P6|STARTED|Treatment Period 2 (14 Days)||5
125877|NCT01808339|307375|P5|STARTED|Treatment Period 2 (14 Days)||4
125878|NCT01808339|307376|P4|STARTED|Treatment Period 2 (14 Days)||2
125879|NCT01808339|307377|P3|STARTED|Treatment Period 2 (14 Days)||4
125880|NCT01808339|307378|P2|STARTED|Treatment Period 2 (14 Days)||3
125881|NCT01808339|307379|P1|STARTED|Treatment Period 2 (14 Days)||4
125882|NCT01808339|307374|P6|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
125883|NCT01808339|307375|P5|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
125884|NCT01808339|307376|P4|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
125885|NCT01808339|307377|P3|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
125886|NCT01808339|307378|P2|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
125887|NCT01808339|307379|P1|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
125888|NCT01808339|307374|P6|COMPLETED|Washout Period 1 (14-21 Days)||5
125889|NCT01808339|307375|P5|COMPLETED|Washout Period 1 (14-21 Days)||4
125890|NCT01808339|307376|P4|COMPLETED|Washout Period 1 (14-21 Days)||2
125891|NCT01808339|307377|P3|COMPLETED|Washout Period 1 (14-21 Days)||4
125892|NCT01808339|307378|P2|COMPLETED|Washout Period 1 (14-21 Days)||3
125893|NCT01808339|307379|P1|COMPLETED|Washout Period 1 (14-21 Days)||4
125894|NCT01808339|307374|P6|STARTED|Washout Period 1 (14-21 Days)||5
125895|NCT01808339|307375|P5|STARTED|Washout Period 1 (14-21 Days)||4
125896|NCT01808339|307376|P4|STARTED|Washout Period 1 (14-21 Days)||2
125897|NCT01808339|307377|P3|STARTED|Washout Period 1 (14-21 Days)||4
125898|NCT01808339|307378|P2|STARTED|Washout Period 1 (14-21 Days)||3
125899|NCT01808339|307379|P1|STARTED|Washout Period 1 (14-21 Days)||4
125900|NCT01808339|307374|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||1
125901|NCT01808339|307375|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||2
125902|NCT01808339|307376|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||2
125903|NCT01808339|307377|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||0
125904|NCT01808339|307378|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
125905|NCT01808339|307379|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||0
125906|NCT01808339|307374|P6|COMPLETED|Treatment Period 1 (14 Days)||5
125907|NCT01808339|307375|P5|COMPLETED|Treatment Period 1 (14 Days)||4
125908|NCT01808339|307376|P4|COMPLETED|Treatment Period 1 (14 Days)||2
125909|NCT01808339|307377|P3|COMPLETED|Treatment Period 1 (14 Days)||4
125910|NCT01808339|307378|P2|COMPLETED|Treatment Period 1 (14 Days)||3
125911|NCT01808339|307379|P1|COMPLETED|Treatment Period 1 (14 Days)||4
125912|NCT01808339|307374|P6|STARTED|Treatment Period 1 (14 Days)||6
125913|NCT01808339|307375|P5|STARTED|Treatment Period 1 (14 Days)||6
125914|NCT01808339|307376|P4|STARTED|Treatment Period 1 (14 Days)||4
125915|NCT01808339|307377|P3|STARTED|Treatment Period 1 (14 Days)||4
125916|NCT01808339|307378|P2|STARTED|Treatment Period 1 (14 Days)||4
125917|NCT01808339|307379|P1|STARTED|Treatment Period 1 (14 Days)||4
125918|NCT01808326|307396|P1|NOT COMPLETED|Overall Study||0
125919|NCT01808326|307396|P1|COMPLETED|Overall Study||5
125920|NCT01808326|307396|P1|STARTED|Overall Study||5
125921|NCT01808313|307423|P1|NOT COMPLETED|Overall Study||10
125922|NCT01808313|307423|P1|COMPLETED|Overall Study||123
125923|NCT01808313|307423|P1|STARTED|Overall Study||133
125924|NCT01808261|307453|P2|NOT COMPLETED|Overall Study||33
125925|NCT01808261|307454|P1|NOT COMPLETED|Overall Study||36
125926|NCT01808261|307453|P2|COMPLETED|Overall Study||32
125927|NCT01808261|307454|P1|COMPLETED|Overall Study||32
125928|NCT01808261|307453|P2|STARTED|Overall Study||65
125929|NCT01808261|307454|P1|STARTED|Overall Study||68
125930|NCT01808248|307510|P1|NOT COMPLETED|Overall Study||5
125931|NCT01808248|307510|P1|COMPLETED|Overall Study||42
125932|NCT01808248|307510|P1|Completed Posttreatment Week 12 Visit|Overall Study||45
125933|NCT01808248|307510|P1|STARTED|Overall Study||47
125934|NCT01808222|307522|P1|NOT COMPLETED|Overall Study||1
125935|NCT01808222|307522|P1|COMPLETED|Overall Study||24
125936|NCT01808222|307522|P1|Completed mpMR Scan|Overall Study||24
125937|NCT01808222|307522|P1|Completed Fluciclovine PET-CT Scan|Overall Study||25
125938|NCT01808222|307522|P1|STARTED|Overall Study||25
125939|NCT01808209|307529|P2|NOT COMPLETED|Overall Study||1
125940|NCT01808209|307530|P1|NOT COMPLETED|Overall Study||0
125941|NCT01808209|307529|P2|COMPLETED|Overall Study||26
125942|NCT01808209|307530|P1|COMPLETED|Overall Study||33
125943|NCT01808209|307529|P2|STARTED|Overall Study||27
125944|NCT01808209|307530|P1|STARTED|Overall Study||33
125945|NCT01808144|307574|P2|NOT COMPLETED|Overall Study||48
125946|NCT01808144|307575|P1|NOT COMPLETED|Overall Study||40
125947|NCT01808144|307574|P2|COMPLETED|Overall Study||51
125948|NCT01808144|307575|P1|COMPLETED|Overall Study||57
125949|NCT01808144|307574|P2|STARTED|Overall Study||99
125950|NCT01808144|307575|P1|STARTED|Overall Study||97
125951|NCT01808118|307583|P3|NOT COMPLETED|Period 2||8
125952|NCT01808118|307584|P2|NOT COMPLETED|Period 2||13
125953|NCT01808118|307585|P1|NOT COMPLETED|Period 2||0
125954|NCT01808118|307583|P3|COMPLETED|Period 2||144
125955|NCT01808118|307584|P2|COMPLETED|Period 2||140
125956|NCT01808118|307585|P1|COMPLETED|Period 2||0
125957|NCT01808118|307583|P3|STARTED|Period 2||152
125958|NCT01808118|307584|P2|STARTED|Period 2||153
125959|NCT01808118|307585|P1|STARTED|Period 2||0
125960|NCT01808118|307583|P3|NOT COMPLETED|Period 1||0
125961|NCT01808118|307584|P2|NOT COMPLETED|Period 1||0
125962|NCT01808118|307585|P1|NOT COMPLETED|Period 1||368
125963|NCT01808118|307583|P3|COMPLETED|Period 1||0
125964|NCT01808118|307584|P2|COMPLETED|Period 1||0
125965|NCT01808118|307585|P1|COMPLETED|Period 1||305
125966|NCT01808118|307583|P3|STARTED|Period 1||0
125967|NCT01808118|307584|P2|STARTED|Period 1||0
125968|NCT01808118|307585|P1|STARTED|Period 1||673
125969|NCT01808092|307648|P2|NOT COMPLETED|Overall Study||45
125970|NCT01808092|307649|P1|NOT COMPLETED|Overall Study||54
125971|NCT01808092|307648|P2|COMPLETED|Overall Study||363
125972|NCT01808092|307649|P1|COMPLETED|Overall Study||355
125973|NCT01808092|307648|P2|STARTED|Overall Study||408
125974|NCT01808092|307649|P1|STARTED|Overall Study||409
125975|NCT01808066|307751|P1|NOT COMPLETED|Overall Study||15
125976|NCT01808066|307751|P1|COMPLETED|Overall Study||6
125977|NCT01808066|307751|P1|STARTED|Overall Study||21
125978|NCT01807949|307762|P3|NOT COMPLETED|Overall Study||9
125979|NCT01807949|307763|P2|NOT COMPLETED|Overall Study||7
125980|NCT01807949|307764|P1|NOT COMPLETED|Overall Study||2
125981|NCT01807949|307762|P3|COMPLETED|Overall Study||180
125982|NCT01807949|307763|P2|COMPLETED|Overall Study||180
125983|NCT01807949|307764|P1|COMPLETED|Overall Study||185
125984|NCT01807949|307762|P3|STARTED|Overall Study||189
125985|NCT01807949|307763|P2|STARTED|Overall Study||187
125986|NCT01807949|307764|P1|STARTED|Overall Study||187
125987|NCT01807923|307816|P3|NOT COMPLETED|Overall Study||11
125988|NCT01807923|307817|P2|NOT COMPLETED|Overall Study||6
125989|NCT01807923|307818|P1|NOT COMPLETED|Overall Study||5
125990|NCT01807923|307816|P3|COMPLETED|Overall Study||176
125991|NCT01807923|307817|P2|COMPLETED|Overall Study||179
125992|NCT01807923|307818|P1|COMPLETED|Overall Study||182
125993|NCT01807923|307816|P3|STARTED|Overall Study||187
125994|NCT01807923|307817|P2|STARTED|Overall Study||185
125995|NCT01807923|307818|P1|STARTED|Overall Study||187
125996|NCT01807871|307869|P2|NOT COMPLETED|Overall Study||218
125997|NCT01807871|307870|P1|NOT COMPLETED|Overall Study||178
125998|NCT01807871|307869|P2|COMPLETED|Overall Study||127
125999|NCT01807871|307870|P1|COMPLETED|Overall Study||178
126000|NCT01807871|307869|P2|STARTED|Overall Study||345
126001|NCT01807871|307870|P1|STARTED|Overall Study||356
126002|NCT01807650|307880|P1|NOT COMPLETED|Overall Study||20
126003|NCT01807650|307880|P1|COMPLETED|Overall Study||92
126004|NCT01807650|307880|P1|STARTED|Overall Study||112
126005|NCT01807637|307933|P2|NOT COMPLETED|One Month||0
126006|NCT01807637|307934|P1|NOT COMPLETED|One Month||0
126007|NCT01807637|307933|P2|COMPLETED|One Month||2
126008|NCT01807637|307934|P1|COMPLETED|One Month||4
126009|NCT01807637|307933|P2|STARTED|One Month||2
126010|NCT01807637|307934|P1|STARTED|One Month||4
126011|NCT01807637|307933|P2|NOT COMPLETED|One Week||0
126012|NCT01807637|307934|P1|NOT COMPLETED|One Week||0
126013|NCT01807637|307933|P2|COMPLETED|One Week||2
126014|NCT01807637|307934|P1|COMPLETED|One Week||4
126015|NCT01807637|307933|P2|STARTED|One Week||2
126016|NCT01807637|307934|P1|STARTED|One Week||4
126017|NCT01807637|307933|P2|NOT COMPLETED|Baseline||0
126018|NCT01807637|307934|P1|NOT COMPLETED|Baseline||0
126019|NCT01807637|307933|P2|COMPLETED|Baseline||2
126020|NCT01807637|307934|P1|COMPLETED|Baseline||4
126021|NCT01807637|307933|P2|STARTED|Baseline||2
126022|NCT01807637|307934|P1|STARTED|Baseline||4
126023|NCT01807624|307950|P1|NOT COMPLETED|Overall Study||0
126024|NCT01807624|307950|P1|COMPLETED|Overall Study||24
126025|NCT01807624|307950|P1|STARTED|Overall Study||24
126026|NCT01807598|307966|P1|NOT COMPLETED|Overall Study||6
126027|NCT01807598|307966|P1|COMPLETED|Overall Study||4
126028|NCT01807598|307966|P1|STARTED|Overall Study||10
126029|NCT01807585|307980|P3|NOT COMPLETED|Overall Study||6
126030|NCT01807585|307981|P2|NOT COMPLETED|Overall Study||4
126031|NCT01807585|307982|P1|NOT COMPLETED|Overall Study||1
126032|NCT01807585|307980|P3|COMPLETED|Overall Study||108
126033|NCT01807585|307981|P2|COMPLETED|Overall Study||104
126034|NCT01807585|307982|P1|COMPLETED|Overall Study||19
126035|NCT01807585|307980|P3|3 Mos|Overall Study||113
126036|NCT01807585|307981|P2|3 Mos|Overall Study||108
126037|NCT01807585|307982|P1|3 Mos|Overall Study||20
126038|NCT01807585|307980|P3|STARTED|Overall Study||114
126039|NCT01807585|307981|P2|STARTED|Overall Study||108
126040|NCT01807585|307982|P1|STARTED|Overall Study||20
126041|NCT01807520|307998|P7|NOT COMPLETED|Follow-up Period (132-140 Weeks)||1
126042|NCT01807520|307999|P6|NOT COMPLETED|Follow-up Period (132-140 Weeks)||4
126043|NCT01807520|308000|P5|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
126044|NCT01807520|308001|P4|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
126045|NCT01807520|308002|P3|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
126046|NCT01807520|308003|P2|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
126047|NCT01807520|308004|P1|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
126048|NCT01807520|307998|P7|COMPLETED|Follow-up Period (132-140 Weeks)||75
126049|NCT01807520|307999|P6|COMPLETED|Follow-up Period (132-140 Weeks)||77
126050|NCT01807520|308000|P5|COMPLETED|Follow-up Period (132-140 Weeks)||0
126051|NCT01807520|308001|P4|COMPLETED|Follow-up Period (132-140 Weeks)||0
126052|NCT01807520|308002|P3|COMPLETED|Follow-up Period (132-140 Weeks)||2
126053|NCT01807520|308003|P2|COMPLETED|Follow-up Period (132-140 Weeks)||0
126054|NCT01807520|308004|P1|COMPLETED|Follow-up Period (132-140 Weeks)||0
126055|NCT01807520|307998|P7|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457 300mg during treatment period 1 and/or treatment period 2.|76
126056|NCT01807520|307999|P6|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457150mg during treatment period 1 and/or treatment period 2.|81
126057|NCT01807520|308000|P5|STARTED|Follow-up Period (132-140 Weeks)||0
126058|NCT01807520|308001|P4|STARTED|Follow-up Period (132-140 Weeks)||0
126059|NCT01807520|308002|P3|STARTED|Follow-up Period (132-140 Weeks)|These participants discontinued from Treatment Period 1.|2
126060|NCT01807520|308003|P2|STARTED|Follow-up Period (132-140 Weeks)||0
126061|NCT01807520|308004|P1|STARTED|Follow-up Period (132-140 Weeks)||0
126062|NCT01807520|307998|P7|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
126063|NCT01807520|307999|P6|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
126064|NCT01807520|308000|P5|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||5
126065|NCT01807520|308001|P4|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||7
126066|NCT01807520|308002|P3|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
126067|NCT01807520|308003|P2|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||18
126068|NCT01807520|308004|P1|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||25
126069|NCT01807520|307998|P7|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
126070|NCT01807520|307999|P6|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
126071|NCT01807520|308000|P5|COMPLETED|Treatment Period 2 (16-132 Weeks)||24
126072|NCT01807520|308001|P4|COMPLETED|Treatment Period 2 (16-132 Weeks)||22
126073|NCT01807520|308002|P3|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
126074|NCT01807520|308003|P2|COMPLETED|Treatment Period 2 (16-132 Weeks)||47
126075|NCT01807520|308004|P1|COMPLETED|Treatment Period 2 (16-132 Weeks)||38
126076|NCT01807520|307998|P7|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
126077|NCT01807520|307999|P6|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
126078|NCT01807520|308000|P5|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
126079|NCT01807520|308001|P4|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
126080|NCT01807520|308002|P3|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
126081|NCT01807520|308003|P2|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||66
126082|NCT01807520|308004|P1|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||67
126083|NCT01807520|307998|P7|Safety Set|Treatment Period 2 (16-132 Weeks)||0
126084|NCT01807520|307999|P6|Safety Set|Treatment Period 2 (16-132 Weeks)||0
126085|NCT01807520|308000|P5|Safety Set|Treatment Period 2 (16-132 Weeks)||29
126086|NCT01807520|308001|P4|Safety Set|Treatment Period 2 (16-132 Weeks)||29
126087|NCT01807520|308002|P3|Safety Set|Treatment Period 2 (16-132 Weeks)||0
126088|NCT01807520|308003|P2|Safety Set|Treatment Period 2 (16-132 Weeks)||65
126089|NCT01807520|308004|P1|Safety Set|Treatment Period 2 (16-132 Weeks)||63
126090|NCT01807520|307998|P7|STARTED|Treatment Period 2 (16-132 Weeks)||0
126091|NCT01807520|307999|P6|STARTED|Treatment Period 2 (16-132 Weeks)||0
126092|NCT01807520|308000|P5|STARTED|Treatment Period 2 (16-132 Weeks)||29
126093|NCT01807520|308001|P4|STARTED|Treatment Period 2 (16-132 Weeks)||29
126094|NCT01807520|308002|P3|STARTED|Treatment Period 2 (16-132 Weeks)||0
126095|NCT01807520|308003|P2|STARTED|Treatment Period 2 (16-132 Weeks)||65
126096|NCT01807520|308004|P1|STARTED|Treatment Period 2 (16-132 Weeks)||63
126097|NCT01807520|307998|P7|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
126098|NCT01807520|307999|P6|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
126099|NCT01807520|308000|P5|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
126100|NCT01807520|308001|P4|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
126101|NCT01807520|308002|P3|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||7
126102|NCT01807520|308003|P2|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||1
126103|NCT01807520|308004|P1|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||4
126104|NCT01807520|307998|P7|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
126105|NCT01807520|307999|P6|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
126106|NCT01807520|308000|P5|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
126107|NCT01807520|308001|P4|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
126108|NCT01807520|308002|P3|COMPLETED|Treatment Period 1 (0-16 Weeks)||58
126109|NCT01807520|308003|P2|COMPLETED|Treatment Period 1 (0-16 Weeks)||65
126110|NCT01807520|308004|P1|COMPLETED|Treatment Period 1 (0-16 Weeks)||63
126111|NCT01807520|307998|P7|Safety Set|Treatment Period 1 (0-16 Weeks)||0
126112|NCT01807520|307999|P6|Safety Set|Treatment Period 1 (0-16 Weeks)||0
126113|NCT01807520|308000|P5|Safety Set|Treatment Period 1 (0-16 Weeks)||0
126114|NCT01807520|308001|P4|Safety Set|Treatment Period 1 (0-16 Weeks)||0
126115|NCT01807520|308002|P3|Safety Set|Treatment Period 1 (0-16 Weeks)||65
126116|NCT01807520|308003|P2|Safety Set|Treatment Period 1 (0-16 Weeks)||65
126117|NCT01807520|308004|P1|Safety Set|Treatment Period 1 (0-16 Weeks)||67
126118|NCT01807520|307998|P7|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
126119|NCT01807520|307999|P6|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
126120|NCT01807520|308000|P5|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
126121|NCT01807520|308001|P4|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
126122|NCT01807520|308002|P3|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||65
126123|NCT01807520|308003|P2|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||66
126124|NCT01807520|308004|P1|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||67
126125|NCT01807520|307998|P7|STARTED|Treatment Period 1 (0-16 Weeks)||0
126126|NCT01807520|307999|P6|STARTED|Treatment Period 1 (0-16 Weeks)||0
126127|NCT01807520|308000|P5|STARTED|Treatment Period 1 (0-16 Weeks)||0
126128|NCT01807520|308001|P4|STARTED|Treatment Period 1 (0-16 Weeks)||0
126129|NCT01807520|308002|P3|STARTED|Treatment Period 1 (0-16 Weeks)||65
126130|NCT01807520|308003|P2|STARTED|Treatment Period 1 (0-16 Weeks)||66
126131|NCT01807520|308004|P1|STARTED|Treatment Period 1 (0-16 Weeks)||67
126132|NCT01807455|308023|P1|NOT COMPLETED|Overall Study||0
126133|NCT01807455|308023|P1|COMPLETED|Overall Study||12
126134|NCT01807455|308023|P1|STARTED|Overall Study||12
126135|NCT01807234|308037|P6|NOT COMPLETED|Overall Study||4
126136|NCT01807234|308038|P5|NOT COMPLETED|Overall Study||4
126137|NCT01807234|308039|P4|NOT COMPLETED|Overall Study||2
126138|NCT01807234|308040|P3|NOT COMPLETED|Overall Study||2
126139|NCT01807234|308041|P2|NOT COMPLETED|Overall Study||6
126140|NCT01807234|308042|P1|NOT COMPLETED|Overall Study||5
126141|NCT01807234|308037|P6|COMPLETED|Overall Study||8
126142|NCT01807234|308038|P5|COMPLETED|Overall Study||8
126143|NCT01807234|308039|P4|COMPLETED|Overall Study||10
126144|NCT01807234|308040|P3|COMPLETED|Overall Study||10
126145|NCT01807234|308041|P2|COMPLETED|Overall Study||6
126146|NCT01807234|308042|P1|COMPLETED|Overall Study||7
126147|NCT01807234|308037|P6|Completed Only 1 Attack|Overall Study||1
126148|NCT01807234|308038|P5|Completed Only 1 Attack|Overall Study||0
126149|NCT01807234|308039|P4|Completed Only 1 Attack|Overall Study||1
126150|NCT01807234|308040|P3|Completed Only 1 Attack|Overall Study||0
126151|NCT01807234|308041|P2|Completed Only 1 Attack|Overall Study||1
126152|NCT01807234|308042|P1|Completed Only 1 Attack|Overall Study||2
126153|NCT01807234|308037|P6|Randomized, But Did Not Take Drug|Overall Study||3
126154|NCT01807234|308038|P5|Randomized, But Did Not Take Drug|Overall Study||4
126155|NCT01807234|308039|P4|Randomized, But Did Not Take Drug|Overall Study||1
126156|NCT01807234|308040|P3|Randomized, But Did Not Take Drug|Overall Study||2
126157|NCT01807234|308041|P2|Randomized, But Did Not Take Drug|Overall Study||5
126158|NCT01807234|308042|P1|Randomized, But Did Not Take Drug|Overall Study||3
126159|NCT01807234|308037|P6|STARTED|Overall Study||12
126160|NCT01807234|308038|P5|STARTED|Overall Study||12
126161|NCT01807234|308039|P4|STARTED|Overall Study||12
126162|NCT01807234|308040|P3|STARTED|Overall Study||12
126163|NCT01807234|308041|P2|STARTED|Overall Study||12
126164|NCT01807234|308042|P1|STARTED|Overall Study||12
126165|NCT01807156|308077|P1|NOT COMPLETED|Overall Study||1
126166|NCT01807156|308077|P1|COMPLETED|Overall Study||6
126167|NCT01807156|308077|P1|STARTED|Overall Study||7
126168|NCT01807104|308084|P2|NOT COMPLETED|Overall Study||4
126169|NCT01807104|308085|P1|NOT COMPLETED|Overall Study||4
126170|NCT01807104|308084|P2|COMPLETED|Overall Study||40
126171|NCT01807104|308085|P1|COMPLETED|Overall Study||39
126172|NCT01807104|308084|P2|STARTED|Overall Study||44
126173|NCT01807104|308085|P1|STARTED|Overall Study||43
126174|NCT01807026|308097|P6|NOT COMPLETED|Overall Study||0
126175|NCT01807026|308098|P5|NOT COMPLETED|Overall Study||0
126176|NCT01807026|308099|P4|NOT COMPLETED|Overall Study||0
126177|NCT01807026|308100|P3|NOT COMPLETED|Overall Study||0
126178|NCT01807026|308101|P2|NOT COMPLETED|Overall Study||0
126179|NCT01807026|308102|P1|NOT COMPLETED|Overall Study||0
126180|NCT01807026|308097|P6|COMPLETED|Overall Study||3
126181|NCT01807026|308098|P5|COMPLETED|Overall Study||9
126182|NCT01807026|308099|P4|COMPLETED|Overall Study||2
126183|NCT01807026|308100|P3|COMPLETED|Overall Study||10
126184|NCT01807026|308101|P2|COMPLETED|Overall Study||2
126185|NCT01807026|308102|P1|COMPLETED|Overall Study||10
126186|NCT01807026|308097|P6|Received at Least One Dose of Study Drug|Overall Study||3
126187|NCT01807026|308098|P5|Received at Least One Dose of Study Drug|Overall Study||9
126188|NCT01807026|308099|P4|Received at Least One Dose of Study Drug|Overall Study||2
126189|NCT01807026|308100|P3|Received at Least One Dose of Study Drug|Overall Study||10
126190|NCT01807026|308101|P2|Received at Least One Dose of Study Drug|Overall Study||2
126191|NCT01807026|308102|P1|Received at Least One Dose of Study Drug|Overall Study||10
126192|NCT01807026|308097|P6|STARTED|Overall Study||3
126193|NCT01807026|308098|P5|STARTED|Overall Study||9
126194|NCT01807026|308099|P4|STARTED|Overall Study||2
126195|NCT01807026|308100|P3|STARTED|Overall Study||10
126196|NCT01807026|308101|P2|STARTED|Overall Study||2
126197|NCT01807026|308102|P1|STARTED|Overall Study||10
126198|NCT01807000|308130|P1|NOT COMPLETED|Overall Study||0
126199|NCT01807000|308130|P1|COMPLETED|Overall Study||6
126200|NCT01807000|308130|P1|STARTED|Overall Study||6
126201|NCT01806961|308149|P1|NOT COMPLETED|Overall Study||16
126202|NCT01806961|308149|P1|COMPLETED|Overall Study||0
126203|NCT01806961|308149|P1|STARTED|Overall Study||16
126204|NCT01806896|308155|P2|NOT COMPLETED|Overall Study||0
126205|NCT01806896|308156|P1|NOT COMPLETED|Overall Study||3
126206|NCT01806896|308155|P2|COMPLETED|Overall Study||17
126207|NCT01806896|308156|P1|COMPLETED|Overall Study||17
126208|NCT01806896|308155|P2|Received Treatment|Overall Study||17
126209|NCT01806896|308156|P1|Received Treatment|Overall Study||19
126210|NCT01806896|308155|P2|STARTED|Overall Study||17
126211|NCT01806896|308156|P1|STARTED|Overall Study||20
126212|NCT01806857|308184|P2|NOT COMPLETED|Overall Study||0
126213|NCT01806857|308185|P1|NOT COMPLETED|Overall Study||1
126214|NCT01806857|308184|P2|COMPLETED|Overall Study||29
126215|NCT01806857|308185|P1|COMPLETED|Overall Study||30
126216|NCT01806857|308184|P2|STARTED|Overall Study||29
126217|NCT01806857|308185|P1|STARTED|Overall Study||31
126218|NCT01806779|308223|P3|NOT COMPLETED|Overall Study||23
126219|NCT01806779|308224|P2|NOT COMPLETED|Overall Study||44
126220|NCT01806779|308225|P1|NOT COMPLETED|Overall Study||42
126221|NCT01806779|308223|P3|COMPLETED|Overall Study||0
126222|NCT01806779|308224|P2|COMPLETED|Overall Study||40
126223|NCT01806779|308225|P1|COMPLETED|Overall Study||48
126224|NCT01806779|308223|P3|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|0
126225|NCT01806779|308224|P2|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|83
126226|NCT01806779|308225|P1|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|87
126227|NCT01806779|308223|P3|Randomized at Visit 2|Overall Study||0
126228|NCT01806779|308224|P2|Randomized at Visit 2|Overall Study||84
126229|NCT01806779|308225|P1|Randomized at Visit 2|Overall Study||90
126230|NCT01806779|308223|P3|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|2
126231|NCT01806779|308224|P2|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|84
126232|NCT01806779|308225|P1|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|90
126233|NCT01806779|308223|P3|STARTED|Overall Study|All 197 subjects received nicotine patches but 23 dropped before receiving other study drugs.|23
126234|NCT01806779|308224|P2|STARTED|Overall Study||84
126235|NCT01806779|308225|P1|STARTED|Overall Study||90
126236|NCT01806740|308238|P1|NOT COMPLETED|Overall Study||6
126237|NCT01806740|308238|P1|COMPLETED|Overall Study||31
126238|NCT01806740|308238|P1|STARTED|Overall Study||37
126239|NCT01806714|308249|P2|NOT COMPLETED|Overall Study||170
126240|NCT01806714|308250|P1|NOT COMPLETED|Overall Study||200
126241|NCT01806714|308249|P2|COMPLETED|Overall Study||1919
126242|NCT01806714|308250|P1|COMPLETED|Overall Study||1893
126243|NCT01806714|308249|P2|STARTED|Overall Study||2089
126244|NCT01806714|308250|P1|STARTED|Overall Study||2093
126245|NCT01806675|308263|P3|NOT COMPLETED|Overall Study||0
126246|NCT01806675|308264|P2|NOT COMPLETED|Overall Study||0
126247|NCT01806675|308265|P1|NOT COMPLETED|Overall Study||0
126248|NCT01806675|308263|P3|COMPLETED|Overall Study||8
126249|NCT01806675|308264|P2|COMPLETED|Overall Study||6
126250|NCT01806675|308265|P1|COMPLETED|Overall Study||11
126251|NCT01806675|308263|P3|STARTED|Overall Study||8
126252|NCT01806675|308264|P2|STARTED|Overall Study||6
126253|NCT01806675|308265|P1|STARTED|Overall Study||11
126254|NCT01806662|308285|P2|NOT COMPLETED|Second Intervention (Weeks 16-32)||4
126255|NCT01806662|308286|P1|NOT COMPLETED|Second Intervention (Weeks 16-32)||2
126256|NCT01806662|308285|P2|COMPLETED|Second Intervention (Weeks 16-32)||11
126257|NCT01806662|308286|P1|COMPLETED|Second Intervention (Weeks 16-32)||10
126258|NCT01806662|308285|P2|STARTED|Second Intervention (Weeks 16-32)||15
126259|NCT01806662|308286|P1|STARTED|Second Intervention (Weeks 16-32)||12
126260|NCT01806662|308285|P2|NOT COMPLETED|First Intervention (Weeks 0-16)||1
126261|NCT01806662|308286|P1|NOT COMPLETED|First Intervention (Weeks 0-16)||4
126262|NCT01806662|308285|P2|COMPLETED|First Intervention (Weeks 0-16)||15
126263|NCT01806662|308286|P1|COMPLETED|First Intervention (Weeks 0-16)||12
126264|NCT01806662|308285|P2|Received Intervention|First Intervention (Weeks 0-16)||15
126265|NCT01806662|308286|P1|Received Intervention|First Intervention (Weeks 0-16)||12
126266|NCT01806662|308285|P2|STARTED|First Intervention (Weeks 0-16)||16
126267|NCT01806662|308286|P1|STARTED|First Intervention (Weeks 0-16)||16
126268|NCT01806623|308292|P1|NOT COMPLETED|Overall Study||58
126269|NCT01806623|308292|P1|COMPLETED|Overall Study||99
126270|NCT01806623|308292|P1|STARTED|Overall Study||157
126271|NCT01806597|308312|P6|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||12
126272|NCT01806597|308313|P5|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
126273|NCT01806597|308314|P4|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
126274|NCT01806597|308315|P3|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
126275|NCT01806597|308316|P2|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
126276|NCT01806597|308317|P1|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
126277|NCT01806597|308312|P6|COMPLETED|Follow-up Period (Week 132 to Week 140)||149
126278|NCT01806597|308313|P5|COMPLETED|Follow-up Period (Week 132 to Week 140)||3
126279|NCT01806597|308314|P4|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
126280|NCT01806597|308315|P3|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
126281|NCT01806597|308316|P2|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
126282|NCT01806597|308317|P1|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
126283|NCT01806597|308312|P6|STARTED|Follow-up Period (Week 132 to Week 140)||161
126284|NCT01806597|308313|P5|STARTED|Follow-up Period (Week 132 to Week 140)||3
126285|NCT01806597|308314|P4|STARTED|Follow-up Period (Week 132 to Week 140)||0
126286|NCT01806597|308315|P3|STARTED|Follow-up Period (Week 132 to Week 140)||0
126287|NCT01806597|308316|P2|STARTED|Follow-up Period (Week 132 to Week 140)||0
126288|NCT01806597|308317|P1|STARTED|Follow-up Period (Week 132 to Week 140)||0
126289|NCT01806597|308312|P6|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
126290|NCT01806597|308313|P5|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||1
126291|NCT01806597|308314|P4|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||11
126292|NCT01806597|308315|P3|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||14
126293|NCT01806597|308316|P2|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
126294|NCT01806597|308317|P1|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||39
126295|NCT01806597|308312|P6|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
126296|NCT01806597|308313|P5|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
126297|NCT01806597|308314|P4|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
126298|NCT01806597|308315|P3|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||17
126299|NCT01806597|308316|P2|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||44
126300|NCT01806597|308317|P1|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||24
126301|NCT01806597|308312|P6|STARTED|Treatment Period 2 (Week 16 to Week 132)||0
126302|NCT01806597|308313|P5|STARTED|Treatment Period 2 (Week 16 to Week 132)||1
126303|NCT01806597|308314|P4|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
126304|NCT01806597|308315|P3|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
126305|NCT01806597|308316|P2|STARTED|Treatment Period 2 (Week 16 to Week 132)||64
126306|NCT01806597|308317|P1|STARTED|Treatment Period 2 (Week 16 to Week 132)||63
126307|NCT01806597|308312|P6|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
126308|NCT01806597|308313|P5|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
126309|NCT01806597|308314|P4|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
126310|NCT01806597|308315|P3|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
126311|NCT01806597|308316|P2|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
126312|NCT01806597|308317|P1|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
126313|NCT01806597|308312|P6|COMPLETED|Period 1 (Baseline to Week 16)||0
126314|NCT01806597|308313|P5|COMPLETED|Period 1 (Baseline to Week 16)||63
126315|NCT01806597|308314|P4|COMPLETED|Period 1 (Baseline to Week 16)||0
126316|NCT01806597|308315|P3|COMPLETED|Period 1 (Baseline to Week 16)||0
126317|NCT01806597|308316|P2|COMPLETED|Period 1 (Baseline to Week 16)||64
126318|NCT01806597|308317|P1|COMPLETED|Period 1 (Baseline to Week 16)||63
126319|NCT01806597|308312|P6|STARTED|Period 1 (Baseline to Week 16)||0
126320|NCT01806597|308313|P5|STARTED|Period 1 (Baseline to Week 16)||68
126321|NCT01806597|308314|P4|STARTED|Period 1 (Baseline to Week 16)||0
126322|NCT01806597|308315|P3|STARTED|Period 1 (Baseline to Week 16)||0
126323|NCT01806597|308316|P2|STARTED|Period 1 (Baseline to Week 16)||69
126324|NCT01806597|308317|P1|STARTED|Period 1 (Baseline to Week 16)||68
126325|NCT01806584|308353|P2|NOT COMPLETED|Overall Study||18
126326|NCT01806584|308354|P1|NOT COMPLETED|Overall Study||14
126327|NCT01806584|308353|P2|COMPLETED|Overall Study||0
126328|NCT01806584|308354|P1|COMPLETED|Overall Study||0
126329|NCT01806584|308353|P2|STARTED|Overall Study||18
126330|NCT01806584|308354|P1|STARTED|Overall Study||14
126331|NCT01806571|308366|P1|NOT COMPLETED|Overall Study||0
126332|NCT01806571|308366|P1|COMPLETED|Overall Study||34
126333|NCT01806571|308366|P1|STARTED|Overall Study||34
126334|NCT01806545|308376|P2|NOT COMPLETED|Overall Study||5
126335|NCT01806545|308377|P1|NOT COMPLETED|Overall Study||6
126336|NCT01806545|308376|P2|COMPLETED|Overall Study||30
126337|NCT01806545|308377|P1|COMPLETED|Overall Study||23
126338|NCT01806545|308376|P2|STARTED|Overall Study||35
126339|NCT01806545|308377|P1|STARTED|Overall Study||29
126340|NCT01806506|308401|P2|NOT COMPLETED|Overall Study||1
126341|NCT01806506|308402|P1|NOT COMPLETED|Overall Study||2
126342|NCT01806506|308401|P2|COMPLETED|Overall Study||35
126343|NCT01806506|308402|P1|COMPLETED|Overall Study||34
126344|NCT01806506|308401|P2|9 Months|Overall Study|1 patient (reason - lost contact)|35
126345|NCT01806506|308402|P1|9 Months|Overall Study||34
126346|NCT01806506|308401|P2|6 Months|Overall Study||36
126347|NCT01806506|308402|P1|6 Months|Overall Study|1 patient (reason - lost contact)|34
126348|NCT01806506|308401|P2|3 Months|Overall Study||36
126349|NCT01806506|308402|P1|3 Months|Overall Study|1 patient (reason - lost contact)|35
126350|NCT01806506|308401|P2|1 Month|Overall Study||36
126351|NCT01806506|308402|P1|1 Month|Overall Study||36
126352|NCT01806506|308401|P2|STARTED|Overall Study||36
126353|NCT01806506|308402|P1|STARTED|Overall Study||36
126354|NCT01806389|308408|P1|NOT COMPLETED|Overall Study||4
126355|NCT01806389|308408|P1|COMPLETED|Overall Study||10
126356|NCT01806389|308408|P1|STARTED|Overall Study||14
126357|NCT01806298|308422|P1|NOT COMPLETED|Overall Study||10
126358|NCT01806298|308422|P1|COMPLETED|Overall Study||68
126359|NCT01806298|308422|P1|STARTED|Overall Study||78
126360|NCT01806051|308432|P1|NOT COMPLETED|Overall Study||6
126361|NCT01806051|308432|P1|COMPLETED|Overall Study||0
126362|NCT01806051|308432|P1|STARTED|Overall Study||6
126363|NCT01805895|308440|P2|NOT COMPLETED|Overall Study||0
126364|NCT01805895|308441|P1|NOT COMPLETED|Overall Study||0
126365|NCT01805895|308440|P2|COMPLETED|Overall Study||8
126366|NCT01805895|308441|P1|COMPLETED|Overall Study||8
126367|NCT01805895|308440|P2|STARTED|Overall Study||8
126368|NCT01805895|308441|P1|STARTED|Overall Study||8
126369|NCT01805882|308458|P9|NOT COMPLETED|Overall Study||1
126370|NCT01805882|308459|P8|NOT COMPLETED|Overall Study||0
126371|NCT01805882|308460|P7|NOT COMPLETED|Overall Study||2
126372|NCT01805882|308461|P6|NOT COMPLETED|Overall Study||1
126373|NCT01805882|308462|P5|NOT COMPLETED|Overall Study||0
126374|NCT01805882|308463|P4|NOT COMPLETED|Overall Study||2
126375|NCT01805882|308464|P3|NOT COMPLETED|Overall Study||1
126376|NCT01805882|308465|P2|NOT COMPLETED|Overall Study||0
126377|NCT01805882|308466|P1|NOT COMPLETED|Overall Study||0
126378|NCT01805882|308458|P9|COMPLETED|Overall Study||24
126379|NCT01805882|308459|P8|COMPLETED|Overall Study||25
126380|NCT01805882|308460|P7|COMPLETED|Overall Study||48
126381|NCT01805882|308461|P6|COMPLETED|Overall Study||20
126382|NCT01805882|308462|P5|COMPLETED|Overall Study||14
126383|NCT01805882|308463|P4|COMPLETED|Overall Study||32
126384|NCT01805882|308464|P3|COMPLETED|Overall Study||19
126385|NCT01805882|308465|P2|COMPLETED|Overall Study||20
126386|NCT01805882|308466|P1|COMPLETED|Overall Study||20
126387|NCT01805882|308458|P9|STARTED|Overall Study||25
126388|NCT01805882|308459|P8|STARTED|Overall Study||25
126389|NCT01805882|308460|P7|STARTED|Overall Study||50
126390|NCT01805882|308461|P6|STARTED|Overall Study||21
126391|NCT01805882|308462|P5|STARTED|Overall Study||14
126392|NCT01805882|308463|P4|STARTED|Overall Study||34
126393|NCT01805882|308464|P3|STARTED|Overall Study||20
126394|NCT01805882|308465|P2|STARTED|Overall Study||20
126395|NCT01805882|308466|P1|STARTED|Overall Study||20
126396|NCT01805687|308486|P1|NOT COMPLETED|Overall Study||0
126397|NCT01805687|308486|P1|COMPLETED|Overall Study||25
126398|NCT01805687|308486|P1|STARTED|Overall Study||25
126399|NCT01805440|308493|P3|NOT COMPLETED|Overall Study||0
126400|NCT01805440|308494|P2|NOT COMPLETED|Overall Study||0
126401|NCT01805440|308495|P1|NOT COMPLETED|Overall Study||1
126402|NCT01805440|308493|P3|COMPLETED|Overall Study||26
126403|NCT01805440|308494|P2|COMPLETED|Overall Study||17
126404|NCT01805440|308495|P1|COMPLETED|Overall Study||18
126405|NCT01805440|308493|P3|STARTED|Overall Study||26
126406|NCT01805440|308494|P2|STARTED|Overall Study||17
126407|NCT01805440|308495|P1|STARTED|Overall Study||19
126408|NCT01805323|308508|P1|NOT COMPLETED|Overall Study||0
126409|NCT01805323|308508|P1|COMPLETED|Overall Study||101
126410|NCT01805323|308508|P1|STARTED|Overall Study||101
126411|NCT01805297|308515|P2|NOT COMPLETED|Overall Study||3
126412|NCT01805297|308516|P1|NOT COMPLETED|Overall Study||2
126413|NCT01805297|308515|P2|COMPLETED|Overall Study||3
126414|NCT01805297|308516|P1|COMPLETED|Overall Study||4
126415|NCT01805297|308515|P2|STARTED|Overall Study||6
126416|NCT01805297|308516|P1|STARTED|Overall Study||6
126417|NCT01805180|308530|P3|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
126418|NCT01805180|308531|P2|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
126419|NCT01805180|308532|P1|NOT COMPLETED|Pivotal Randomization Through Study Exit||0
126420|NCT01805180|308530|P3|COMPLETED|Pivotal Randomization Through Study Exit||15
126421|NCT01805180|308531|P2|COMPLETED|Pivotal Randomization Through Study Exit||17
126422|NCT01805180|308532|P1|COMPLETED|Pivotal Randomization Through Study Exit||0
126423|NCT01805180|308530|P3|STARTED|Pivotal Randomization Through Study Exit||20
126424|NCT01805180|308531|P2|STARTED|Pivotal Randomization Through Study Exit||22
126425|NCT01805180|308532|P1|STARTED|Pivotal Randomization Through Study Exit|lead-in donors were not randomized and did not participate in this period.|0
126426|NCT01805180|308530|P3|NOT COMPLETED|Lead-in Donor Phase||0
126427|NCT01805180|308531|P2|NOT COMPLETED|Lead-in Donor Phase||0
126428|NCT01805180|308532|P1|NOT COMPLETED|Lead-in Donor Phase||1
126429|NCT01805180|308530|P3|COMPLETED|Lead-in Donor Phase||0
126430|NCT01805180|308531|P2|COMPLETED|Lead-in Donor Phase||0
126431|NCT01805180|308532|P1|COMPLETED|Lead-in Donor Phase||6
126432|NCT01805180|308530|P3|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
126433|NCT01805180|308531|P2|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
126434|NCT01805180|308532|P1|STARTED|Lead-in Donor Phase||7
126435|NCT01805154|308555|P1|NOT COMPLETED|Overall Study||354
126436|NCT01805154|308555|P1|COMPLETED|Overall Study||1175
126437|NCT01805154|308555|P1|STARTED|Overall Study||1529
126438|NCT01805089|308565|P2|NOT COMPLETED|Overall Study||4
126439|NCT01805089|308566|P1|NOT COMPLETED|Overall Study||5
126440|NCT01805089|308565|P2|COMPLETED|Overall Study||43
126441|NCT01805089|308566|P1|COMPLETED|Overall Study||43
126442|NCT01805089|308565|P2|STARTED|Overall Study||47
126443|NCT01805089|308566|P1|STARTED|Overall Study||48
126444|NCT01805024|308580|P4|NOT COMPLETED|Overall Study||0
126445|NCT01805024|308581|P3|NOT COMPLETED|Overall Study||0
126446|NCT01805024|308582|P2|NOT COMPLETED|Overall Study||0
126447|NCT01805024|308583|P1|NOT COMPLETED|Overall Study||0
126448|NCT01805024|308580|P4|COMPLETED|Overall Study||8
126449|NCT01805024|308581|P3|COMPLETED|Overall Study||4
126450|NCT01805024|308582|P2|COMPLETED|Overall Study||4
126451|NCT01805024|308583|P1|COMPLETED|Overall Study||4
126452|NCT01805024|308580|P4|STARTED|Overall Study||8
126453|NCT01805024|308581|P3|STARTED|Overall Study||4
126454|NCT01805024|308582|P2|STARTED|Overall Study||4
126455|NCT01805024|308583|P1|STARTED|Overall Study||4
126456|NCT01804946|308607|P2|NOT COMPLETED|Overall Study||4
126457|NCT01804946|308608|P1|NOT COMPLETED|Overall Study||2
126458|NCT01804946|308607|P2|COMPLETED|Overall Study||76
126459|NCT01804946|308608|P1|COMPLETED|Overall Study||79
126460|NCT01804946|308607|P2|STARTED|Overall Study||80
126461|NCT01804946|308608|P1|STARTED|Overall Study||81
126462|NCT01804881|308632|P2|NOT COMPLETED|Overall Study||4
126463|NCT01804881|308633|P1|NOT COMPLETED|Overall Study||5
126464|NCT01804881|308632|P2|COMPLETED|Overall Study||10
126465|NCT01804881|308633|P1|COMPLETED|Overall Study||11
126466|NCT01804881|308632|P2|STARTED|Overall Study||14
126467|NCT01804881|308633|P1|STARTED|Overall Study||16
126468|NCT01804842|308646|P3|NOT COMPLETED|Overall Study||1
126469|NCT01804842|308647|P2|NOT COMPLETED|Overall Study||2
126470|NCT01804842|308648|P1|NOT COMPLETED|Overall Study||3
126471|NCT01804842|308646|P3|COMPLETED|Overall Study||8
126472|NCT01804842|308647|P2|COMPLETED|Overall Study||6
126473|NCT01804842|308648|P1|COMPLETED|Overall Study||6
126474|NCT01804842|308646|P3|Completed Treatment C|Overall Study||9
126475|NCT01804842|308647|P2|Completed Treatment C|Overall Study||7
126476|NCT01804842|308648|P1|Completed Treatment C|Overall Study||7
126477|NCT01804842|308646|P3|Completed Treatment B|Overall Study||8
126478|NCT01804842|308647|P2|Completed Treatment B|Overall Study||8
126479|NCT01804842|308648|P1|Completed Treatment B|Overall Study||8
126480|NCT01804842|308646|P3|Completed Treatment A|Overall Study||8
126481|NCT01804842|308647|P2|Completed Treatment A|Overall Study||6
126482|NCT01804842|308648|P1|Completed Treatment A|Overall Study||9
126483|NCT01804842|308646|P3|STARTED|Overall Study||9
126484|NCT01804842|308647|P2|STARTED|Overall Study||8
126485|NCT01804842|308648|P1|STARTED|Overall Study||9
126486|NCT01804816|308665|P1|NOT COMPLETED|Acupuncture (Second 5 Weeks)||1
126487|NCT01804816|308665|P1|COMPLETED|Acupuncture (Second 5 Weeks)||10
126488|NCT01804816|308665|P1|STARTED|Acupuncture (Second 5 Weeks)||11
126489|NCT01804816|308665|P1|NOT COMPLETED|No Acupuncture (Initial 5 Weeks)||3
126490|NCT01804816|308665|P1|COMPLETED|No Acupuncture (Initial 5 Weeks)||11
126491|NCT01804816|308665|P1|STARTED|No Acupuncture (Initial 5 Weeks)||14
126492|NCT01804673|308677|P1|NOT COMPLETED|Overall Study||140
126493|NCT01804673|308677|P1|COMPLETED|Overall Study||34
126494|NCT01804673|308677|P1|Completed Hour 72|Overall Study||36
126495|NCT01804673|308677|P1|Completed Hour 48|Overall Study||79
126496|NCT01804673|308677|P1|Completed Hour 24|Overall Study||170
126497|NCT01804673|308677|P1|STARTED|Overall Study||174
126498|NCT01804582|308695|P2|NOT COMPLETED|Overall Study||56
126499|NCT01804582|308696|P1|NOT COMPLETED|Overall Study||49
126500|NCT01804582|308695|P2|COMPLETED|Overall Study||117
126501|NCT01804582|308696|P1|COMPLETED|Overall Study||128
126502|NCT01804582|308695|P2|STARTED|Overall Study||173
126503|NCT01804582|308696|P1|STARTED|Overall Study||177
126504|NCT01804257|308712|P1|NOT COMPLETED|Overall Study||1
126505|NCT01804257|308712|P1|COMPLETED|Overall Study||27
126506|NCT01804257|308712|P1|STARTED|Overall Study||28
126507|NCT01804140|308716|P1|NOT COMPLETED|Overall Study||114
126508|NCT01804140|308716|P1|COMPLETED|Overall Study|This includes all the participants with mutation results from the sampling or biopsy procedures.|548
126509|NCT01804140|308716|P1|STARTED|Overall Study|This includes all the participants who were enrolled for this study.|662
126510|NCT01804101|308723|P2|NOT COMPLETED|Overall Study||0
126511|NCT01804101|308724|P1|NOT COMPLETED|Overall Study||0
126512|NCT01804101|308723|P2|COMPLETED|Overall Study||10
126513|NCT01804101|308724|P1|COMPLETED|Overall Study||38
126514|NCT01804101|308723|P2|STARTED|Overall Study||10
126515|NCT01804101|308724|P1|STARTED|Overall Study||38
126516|NCT01804075|308734|P2|NOT COMPLETED|Overall Study||0
126517|NCT01804075|308735|P1|NOT COMPLETED|Overall Study||0
126518|NCT01804075|308734|P2|COMPLETED|Overall Study||16
126519|NCT01804075|308735|P1|COMPLETED|Overall Study||15
126520|NCT01804075|308734|P2|STARTED|Overall Study||16
126521|NCT01804075|308735|P1|STARTED|Overall Study||15
126522|NCT01804062|308743|P1|NOT COMPLETED|Overall Study||0
126523|NCT01804062|308743|P1|COMPLETED|Overall Study||30
126524|NCT01804062|308743|P1|STARTED|Overall Study||30
126525|NCT01804036|308750|P2|NOT COMPLETED|Overall Study||20
126526|NCT01804036|308751|P1|NOT COMPLETED|Overall Study||13
126527|NCT01804036|308750|P2|COMPLETED|Overall Study||21
126528|NCT01804036|308751|P1|COMPLETED|Overall Study||18
126529|NCT01804036|308750|P2|STARTED|Overall Study||41
126530|NCT01804036|308751|P1|STARTED|Overall Study||31
126531|NCT01803880|308786|P3|NOT COMPLETED|Overall Study||15
126532|NCT01803880|308787|P2|NOT COMPLETED|Overall Study||10
126533|NCT01803880|308788|P1|NOT COMPLETED|Overall Study||6
126534|NCT01803880|308786|P3|COMPLETED|Overall Study||14
126535|NCT01803880|308787|P2|COMPLETED|Overall Study||18
126536|NCT01803880|308788|P1|COMPLETED|Overall Study||13
126537|NCT01803880|308786|P3|STARTED|Overall Study||29
126538|NCT01803880|308787|P2|STARTED|Overall Study||28
126539|NCT01803880|308788|P1|STARTED|Overall Study||19
126540|NCT01803737|308824|P2|NOT COMPLETED|Overall Study||3
126541|NCT01803737|308825|P1|NOT COMPLETED|Overall Study||1
126542|NCT01803737|308824|P2|COMPLETED|Overall Study||10
126543|NCT01803737|308825|P1|COMPLETED|Overall Study||12
126544|NCT01803737|308824|P2|STARTED|Overall Study||13
126545|NCT01803737|308825|P1|STARTED|Overall Study||13
126546|NCT01803711|308849|P2|NOT COMPLETED|Overall Study||1
126547|NCT01803711|308850|P1|NOT COMPLETED|Overall Study||1
126548|NCT01803711|308849|P2|COMPLETED|Overall Study||2
126549|NCT01803711|308850|P1|COMPLETED|Overall Study||1
126550|NCT01803711|308849|P2|STARTED|Overall Study||3
126551|NCT01803711|308850|P1|STARTED|Overall Study||2
126552|NCT01803646|308868|P2|NOT COMPLETED|Overall Study||10
126553|NCT01803646|308869|P1|NOT COMPLETED|Overall Study||17
126554|NCT01803646|308868|P2|COMPLETED|Overall Study||129
126555|NCT01803646|308869|P1|COMPLETED|Overall Study||187
126556|NCT01803646|308868|P2|STARTED|Overall Study||139
126557|NCT01803646|308869|P1|STARTED|Overall Study||204
126558|NCT01803607|308881|P2|NOT COMPLETED|Overall Study||67
126559|NCT01803607|308882|P1|NOT COMPLETED|Overall Study||68
126560|NCT01803607|308881|P2|COMPLETED|Overall Study||0
126561|NCT01803607|308882|P1|COMPLETED|Overall Study||0
126562|NCT01803607|308881|P2|STARTED|Overall Study||67
126563|NCT01803607|308882|P1|STARTED|Overall Study||68
126564|NCT01803464|308906|P4|NOT COMPLETED|Overall Study||0
126565|NCT01803464|308907|P3|NOT COMPLETED|Overall Study||4
126566|NCT01803464|308908|P2|NOT COMPLETED|Overall Study||0
126567|NCT01803464|308909|P1|NOT COMPLETED|Overall Study||1
126568|NCT01803464|308906|P4|COMPLETED|Overall Study||10
126569|NCT01803464|308907|P3|COMPLETED|Overall Study||6
126570|NCT01803464|308908|P2|COMPLETED|Overall Study||4
126571|NCT01803464|308909|P1|COMPLETED|Overall Study||4
126572|NCT01803464|308906|P4|STARTED|Overall Study||10
126573|NCT01803464|308907|P3|STARTED|Overall Study||10
126574|NCT01803464|308908|P2|STARTED|Overall Study||4
126575|NCT01803464|308909|P1|STARTED|Overall Study||5
126576|NCT01803204|308929|P2|NOT COMPLETED|Overall Study||0
126577|NCT01803204|308930|P1|NOT COMPLETED|Overall Study||0
126578|NCT01803204|308929|P2|COMPLETED|Overall Study||20
126579|NCT01803204|308930|P1|COMPLETED|Overall Study||20
126580|NCT01803204|308929|P2|STARTED|Overall Study||20
126581|NCT01803204|308930|P1|STARTED|Overall Study||20
126582|NCT01803074|308954|P14|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
126583|NCT01803074|308955|P13|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
126584|NCT01803074|308956|P12|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
126585|NCT01803074|308957|P11|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
126586|NCT01803074|308958|P10|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
126587|NCT01803074|308959|P9|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
126588|NCT01803074|308960|P8|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
126589|NCT01803074|308961|P7|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
126590|NCT01803074|308962|P6|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
126591|NCT01803074|308963|P5|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
126592|NCT01803074|308964|P4|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
126593|NCT01803074|308965|P3|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
126594|NCT01803074|308966|P2|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
126595|NCT01803074|308967|P1|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
126596|NCT01803074|308954|P14|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||4
126597|NCT01803074|308955|P13|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||7
126598|NCT01803074|308956|P12|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||8
126599|NCT01803074|308957|P11|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
126600|NCT01803074|308958|P10|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
126601|NCT01803074|308959|P9|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
126602|NCT01803074|308960|P8|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
126603|NCT01803074|308961|P7|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
126604|NCT01803074|308962|P6|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
126605|NCT01803074|308963|P5|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
126606|NCT01803074|308964|P4|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
126607|NCT01803074|308965|P3|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
126608|NCT01803074|308966|P2|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
126609|NCT01803074|308967|P1|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
126610|NCT01803074|308954|P14|STARTED|Period 3: Part C (HIV-1 Clade C Only)||4
126611|NCT01803074|308955|P13|STARTED|Period 3: Part C (HIV-1 Clade C Only)||7
126612|NCT01803074|308956|P12|STARTED|Period 3: Part C (HIV-1 Clade C Only)||8
126613|NCT01803074|308957|P11|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
126614|NCT01803074|308958|P10|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
126615|NCT01803074|308959|P9|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
126616|NCT01803074|308960|P8|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
126617|NCT01803074|308961|P7|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
126618|NCT01803074|308962|P6|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
126619|NCT01803074|308963|P5|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
126620|NCT01803074|308964|P4|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
126621|NCT01803074|308965|P3|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
126622|NCT01803074|308966|P2|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
126623|NCT01803074|308967|P1|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
126624|NCT01803074|308954|P14|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
126625|NCT01803074|308955|P13|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
126626|NCT01803074|308956|P12|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
126627|NCT01803074|308957|P11|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
126628|NCT01803074|308958|P10|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
126629|NCT01803074|308959|P9|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
126630|NCT01803074|308960|P8|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
126631|NCT01803074|308961|P7|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
126632|NCT01803074|308962|P6|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
126633|NCT01803074|308963|P5|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
126634|NCT01803074|308964|P4|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
126635|NCT01803074|308965|P3|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
126636|NCT01803074|308966|P2|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
126637|NCT01803074|308967|P1|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
126638|NCT01803074|308954|P14|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
126639|NCT01803074|308955|P13|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
126640|NCT01803074|308956|P12|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
126641|NCT01803074|308957|P11|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
126642|NCT01803074|308958|P10|COMPLETED|Period 2: Part B (HIV-1 Clade B)||4
126643|NCT01803074|308959|P9|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
126644|NCT01803074|308960|P8|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
126645|NCT01803074|308961|P7|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
126646|NCT01803074|308962|P6|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
126647|NCT01803074|308963|P5|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
126648|NCT01803074|308964|P4|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
126649|NCT01803074|308965|P3|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
126650|NCT01803074|308966|P2|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
126651|NCT01803074|308967|P1|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
126652|NCT01803074|308954|P14|STARTED|Period 2: Part B (HIV-1 Clade B)||0
126653|NCT01803074|308955|P13|STARTED|Period 2: Part B (HIV-1 Clade B)||0
126654|NCT01803074|308956|P12|STARTED|Period 2: Part B (HIV-1 Clade B)||0
126655|NCT01803074|308957|P11|STARTED|Period 2: Part B (HIV-1 Clade B)||8
126656|NCT01803074|308958|P10|STARTED|Period 2: Part B (HIV-1 Clade B)||4
126657|NCT01803074|308959|P9|STARTED|Period 2: Part B (HIV-1 Clade B)||8
126658|NCT01803074|308960|P8|STARTED|Period 2: Part B (HIV-1 Clade B)||8
126659|NCT01803074|308961|P7|STARTED|Period 2: Part B (HIV-1 Clade B)||0
126660|NCT01803074|308962|P6|STARTED|Period 2: Part B (HIV-1 Clade B)||0
126661|NCT01803074|308963|P5|STARTED|Period 2: Part B (HIV-1 Clade B)||0
126662|NCT01803074|308964|P4|STARTED|Period 2: Part B (HIV-1 Clade B)||0
126663|NCT01803074|308965|P3|STARTED|Period 2: Part B (HIV-1 Clade B)||0
126664|NCT01803074|308966|P2|STARTED|Period 2: Part B (HIV-1 Clade B)||0
126665|NCT01803074|308967|P1|STARTED|Period 2: Part B (HIV-1 Clade B)||0
126666|NCT01803074|308954|P14|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
126667|NCT01803074|308955|P13|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
126668|NCT01803074|308956|P12|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
126669|NCT01803074|308957|P11|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
126670|NCT01803074|308958|P10|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
126671|NCT01803074|308959|P9|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
126672|NCT01803074|308960|P8|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
126673|NCT01803074|308961|P7|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
126674|NCT01803074|308962|P6|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
126675|NCT01803074|308963|P5|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
126676|NCT01803074|308964|P4|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
126677|NCT01803074|308965|P3|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
126678|NCT01803074|308966|P2|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
126679|NCT01803074|308967|P1|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
126680|NCT01803074|308954|P14|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
126681|NCT01803074|308955|P13|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
126682|NCT01803074|308956|P12|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
126683|NCT01803074|308957|P11|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
126684|NCT01803074|308958|P10|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
126685|NCT01803074|308959|P9|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
126686|NCT01803074|308960|P8|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
126687|NCT01803074|308961|P7|COMPLETED|Period 1: Part A (HIV-1 Clade B)||12
126688|NCT01803074|308962|P6|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
126689|NCT01803074|308963|P5|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
126690|NCT01803074|308964|P4|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
126691|NCT01803074|308965|P3|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
126692|NCT01803074|308966|P2|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
126693|NCT01803074|308967|P1|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
126694|NCT01803074|308954|P14|STARTED|Period 1: Part A (HIV-1 Clade B)||0
126695|NCT01803074|308955|P13|STARTED|Period 1: Part A (HIV-1 Clade B)||0
126696|NCT01803074|308956|P12|STARTED|Period 1: Part A (HIV-1 Clade B)||0
126697|NCT01803074|308957|P11|STARTED|Period 1: Part A (HIV-1 Clade B)||0
126698|NCT01803074|308958|P10|STARTED|Period 1: Part A (HIV-1 Clade B)||0
126699|NCT01803074|308959|P9|STARTED|Period 1: Part A (HIV-1 Clade B)||0
126700|NCT01803074|308960|P8|STARTED|Period 1: Part A (HIV-1 Clade B)||0
126701|NCT01803074|308961|P7|STARTED|Period 1: Part A (HIV-1 Clade B)||12
126702|NCT01803074|308962|P6|STARTED|Period 1: Part A (HIV-1 Clade B)||8
126703|NCT01803074|308963|P5|STARTED|Period 1: Part A (HIV-1 Clade B)||8
126704|NCT01803074|308964|P4|STARTED|Period 1: Part A (HIV-1 Clade B)||8
126705|NCT01803074|308965|P3|STARTED|Period 1: Part A (HIV-1 Clade B)||8
126706|NCT01803074|308966|P2|STARTED|Period 1: Part A (HIV-1 Clade B)||8
126707|NCT01803074|308967|P1|STARTED|Period 1: Part A (HIV-1 Clade B)||8
126708|NCT01802775|309223|P2|NOT COMPLETED|Overall Study||12
126709|NCT01802775|309224|P1|NOT COMPLETED|Overall Study||6
126710|NCT01802775|309223|P2|COMPLETED|Overall Study||89
126711|NCT01802775|309224|P1|COMPLETED|Overall Study||96
126712|NCT01802775|309223|P2|Received Drug (Safety Analysis Set)|Overall Study||100
126713|NCT01802775|309224|P1|Received Drug (Safety Analysis Set)|Overall Study||101
126714|NCT01802775|309223|P2|STARTED|Overall Study||101
126715|NCT01802775|309224|P1|STARTED|Overall Study||102
126716|NCT01802710|309242|P2|NOT COMPLETED|From T1 to T2||2
126717|NCT01802710|309243|P1|NOT COMPLETED|From T1 to T2||2
126718|NCT01802710|309242|P2|COMPLETED|From T1 to T2||70
126719|NCT01802710|309243|P1|COMPLETED|From T1 to T2||58
126720|NCT01802710|309242|P2|STARTED|From T1 to T2||72
126721|NCT01802710|309243|P1|STARTED|From T1 to T2||60
126722|NCT01802710|309242|P2|NOT COMPLETED|From T0 to T1||10
126723|NCT01802710|309243|P1|NOT COMPLETED|From T0 to T1||16
126724|NCT01802710|309242|P2|COMPLETED|From T0 to T1||72
126725|NCT01802710|309243|P1|COMPLETED|From T0 to T1||60
126726|NCT01802710|309242|P2|STARTED|From T0 to T1||82
126727|NCT01802710|309243|P1|STARTED|From T0 to T1||76
126728|NCT01802632|309259|P6|NOT COMPLETED|Overall Study||28
126729|NCT01802632|309260|P5|NOT COMPLETED|Overall Study||12
126730|NCT01802632|309261|P4|NOT COMPLETED|Overall Study||60
126731|NCT01802632|309262|P3|NOT COMPLETED|Overall Study||271
126732|NCT01802632|309263|P2|NOT COMPLETED|Overall Study||31
126733|NCT01802632|309264|P1|NOT COMPLETED|Overall Study||201
126734|NCT01802632|309259|P6|COMPLETED|Overall Study||0
126735|NCT01802632|309260|P5|COMPLETED|Overall Study||0
126736|NCT01802632|309261|P4|COMPLETED|Overall Study||0
126737|NCT01802632|309262|P3|COMPLETED|Overall Study||0
126738|NCT01802632|309263|P2|COMPLETED|Overall Study||0
126739|NCT01802632|309264|P1|COMPLETED|Overall Study||0
126740|NCT01802632|309259|P6|STARTED|Overall Study||28
126741|NCT01802632|309260|P5|STARTED|Overall Study||12
126742|NCT01802632|309261|P4|STARTED|Overall Study||60
126743|NCT01802632|309262|P3|STARTED|Overall Study||271
126744|NCT01802632|309263|P2|STARTED|Overall Study||31
126745|NCT01802632|309264|P1|STARTED|Overall Study||201
126746|NCT01802580|309280|P2|NOT COMPLETED|Overall Study||11
126747|NCT01802580|309281|P1|NOT COMPLETED|Overall Study||9
126748|NCT01802580|309280|P2|COMPLETED|Overall Study||9
126749|NCT01802580|309281|P1|COMPLETED|Overall Study||11
126750|NCT01802580|309280|P2|STARTED|Overall Study||20
126751|NCT01802580|309281|P1|STARTED|Overall Study||20
126752|NCT01802554|309294|P2|NOT COMPLETED|Overall Study||6
126753|NCT01802554|309295|P1|NOT COMPLETED|Overall Study||8
126754|NCT01802554|309294|P2|COMPLETED|Overall Study||43
126755|NCT01802554|309295|P1|COMPLETED|Overall Study||43
126756|NCT01802554|309294|P2|STARTED|Overall Study||49
126757|NCT01802554|309295|P1|STARTED|Overall Study||51
126758|NCT01802515|309312|P3|NOT COMPLETED|Overall Study||0
126759|NCT01802515|309313|P2|NOT COMPLETED|Overall Study||0
126760|NCT01802515|309314|P1|NOT COMPLETED|Overall Study||3
126761|NCT01802515|309312|P3|COMPLETED|Overall Study||4
126762|NCT01802515|309313|P2|COMPLETED|Overall Study||5
126763|NCT01802515|309314|P1|COMPLETED|Overall Study||2
126764|NCT01802515|309312|P3|STARTED|Overall Study||4
126765|NCT01802515|309313|P2|STARTED|Overall Study||5
126766|NCT01802515|309314|P1|STARTED|Overall Study||5
126767|NCT01802437|309327|P2|NOT COMPLETED|Overall Study||4
126768|NCT01802437|309328|P1|NOT COMPLETED|Overall Study||4
126769|NCT01802437|309327|P2|COMPLETED|Overall Study||16
126770|NCT01802437|309328|P1|COMPLETED|Overall Study||16
126771|NCT01802437|309327|P2|STARTED|Overall Study||20
126772|NCT01802437|309328|P1|STARTED|Overall Study||20
126773|NCT01802333|309341|P3|NOT COMPLETED|Overall Study||63
126774|NCT01802333|309342|P2|NOT COMPLETED|Overall Study||61
126775|NCT01802333|309343|P1|NOT COMPLETED|Overall Study||49
126776|NCT01802333|309341|P3|COMPLETED|Overall Study||161
126777|NCT01802333|309342|P2|COMPLETED|Overall Study||206
126778|NCT01802333|309343|P1|COMPLETED|Overall Study||214
126779|NCT01802333|309341|P3|Known Cytogenetic Risk at Baseline|Overall Study||210
126780|NCT01802333|309342|P2|Known Cytogenetic Risk at Baseline|Overall Study||250
126781|NCT01802333|309343|P1|Known Cytogenetic Risk at Baseline|Overall Study||252
126782|NCT01802333|309341|P3|Known NPM1 Status at Baseline|Overall Study||142
126783|NCT01802333|309342|P2|Known NPM1 Status at Baseline|Overall Study||156
126784|NCT01802333|309343|P1|Known NPM1 Status at Baseline|Overall Study||169
126785|NCT01802333|309341|P3|High Risk Patients Achieved CR/CRi|Overall Study||29
126786|NCT01802333|309342|P2|High Risk Patients Achieved CR/CRi|Overall Study||40
126787|NCT01802333|309343|P1|High Risk Patients Achieved CR/CRi|Overall Study||38
126788|NCT01802333|309341|P3|High Risk Patients|Overall Study||38
126789|NCT01802333|309342|P2|High Risk Patients|Overall Study||61
126790|NCT01802333|309343|P1|High Risk Patients|Overall Study||60
126791|NCT01802333|309341|P3|STARTED|Overall Study||224
126792|NCT01802333|309342|P2|STARTED|Overall Study||267
126793|NCT01802333|309343|P1|STARTED|Overall Study||263
126794|NCT01802320|309370|P1|NOT COMPLETED|Overall Study||2
126795|NCT01802320|309370|P1|COMPLETED|Overall Study||16
126796|NCT01802320|309370|P1|STARTED|Overall Study||18
126797|NCT01802216|309380|P2|NOT COMPLETED|12 Month Visit||4
126798|NCT01802216|309381|P1|NOT COMPLETED|12 Month Visit||3
126799|NCT01802216|309380|P2|COMPLETED|12 Month Visit||30
126800|NCT01802216|309381|P1|COMPLETED|12 Month Visit||14
126801|NCT01802216|309380|P2|STARTED|12 Month Visit||34
126802|NCT01802216|309381|P1|STARTED|12 Month Visit||17
126803|NCT01802216|309380|P2|NOT COMPLETED|8 Month Visit||5
126804|NCT01802216|309381|P1|NOT COMPLETED|8 Month Visit||3
126805|NCT01802216|309380|P2|COMPLETED|8 Month Visit||29
126806|NCT01802216|309381|P1|COMPLETED|8 Month Visit||14
126807|NCT01802216|309380|P2|STARTED|8 Month Visit||34
126808|NCT01802216|309381|P1|STARTED|8 Month Visit||17
126809|NCT01802216|309380|P2|NOT COMPLETED|4 Month Visit||4
126810|NCT01802216|309381|P1|NOT COMPLETED|4 Month Visit||3
126811|NCT01802216|309380|P2|COMPLETED|4 Month Visit||30
126812|NCT01802216|309381|P1|COMPLETED|4 Month Visit||14
126813|NCT01802216|309380|P2|STARTED|4 Month Visit||34
126814|NCT01802216|309381|P1|STARTED|4 Month Visit||17
126815|NCT01802216|309380|P2|NOT COMPLETED|Baseline||0
126816|NCT01802216|309381|P1|NOT COMPLETED|Baseline||0
126817|NCT01802216|309380|P2|COMPLETED|Baseline||34
126818|NCT01802216|309381|P1|COMPLETED|Baseline||17
126819|NCT01802216|309380|P2|STARTED|Baseline||34
126820|NCT01802216|309381|P1|STARTED|Baseline||17
126821|NCT01802151|309393|P4|NOT COMPLETED|Overall Study||0
126822|NCT01802151|309394|P3|NOT COMPLETED|Overall Study||2
126823|NCT01802151|309395|P2|NOT COMPLETED|Overall Study||0
126824|NCT01802151|309396|P1|NOT COMPLETED|Overall Study||0
126825|NCT01802151|309393|P4|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
126826|NCT01802151|309394|P3|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
126827|NCT01802151|309395|P2|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|21
126828|NCT01802151|309396|P1|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
126829|NCT01802151|309393|P4|STARTED|Overall Study||20
126830|NCT01802151|309394|P3|STARTED|Overall Study||22
126831|NCT01802151|309395|P2|STARTED|Overall Study||21
126832|NCT01802151|309396|P1|STARTED|Overall Study||20
126833|NCT01802073|309460|P2|NOT COMPLETED|Overall Study||11
126834|NCT01802073|309461|P1|NOT COMPLETED|Overall Study||5
126835|NCT01802073|309460|P2|COMPLETED|Overall Study||9
126836|NCT01802073|309461|P1|COMPLETED|Overall Study||9
126837|NCT01802073|309460|P2|STARTED|Overall Study||20
126838|NCT01802073|309461|P1|STARTED|Overall Study||14
126839|NCT01801982|309477|P1|NOT COMPLETED|Overall Study||1
126840|NCT01801982|309477|P1|COMPLETED|Overall Study||0
126841|NCT01801982|309477|P1|STARTED|Overall Study||1
126842|NCT01801917|309491|P4|NOT COMPLETED|Extension - All Active||0
126843|NCT01801917|309492|P3|NOT COMPLETED|Extension - All Active||0
126844|NCT01801917|309493|P2|NOT COMPLETED|Extension - All Active||0
126845|NCT01801917|309494|P1|NOT COMPLETED|Extension - All Active||0
126846|NCT01801917|309491|P4|COMPLETED|Extension - All Active||0
126847|NCT01801917|309492|P3|COMPLETED|Extension - All Active||3
126848|NCT01801917|309493|P2|COMPLETED|Extension - All Active||0
126849|NCT01801917|309494|P1|COMPLETED|Extension - All Active||6
126850|NCT01801917|309491|P4|STARTED|Extension - All Active||0
126851|NCT01801917|309492|P3|STARTED|Extension - All Active||3
126852|NCT01801917|309493|P2|STARTED|Extension - All Active||0
126853|NCT01801917|309494|P1|STARTED|Extension - All Active||6
126854|NCT01801917|309491|P4|NOT COMPLETED|Period 1 - Randomized||0
126855|NCT01801917|309492|P3|NOT COMPLETED|Period 1 - Randomized||1
126856|NCT01801917|309493|P2|NOT COMPLETED|Period 1 - Randomized||0
126857|NCT01801917|309494|P1|NOT COMPLETED|Period 1 - Randomized||1
126858|NCT01801917|309491|P4|COMPLETED|Period 1 - Randomized||1
126859|NCT01801917|309492|P3|COMPLETED|Period 1 - Randomized||3
126860|NCT01801917|309493|P2|COMPLETED|Period 1 - Randomized||2
126861|NCT01801917|309494|P1|COMPLETED|Period 1 - Randomized||6
126862|NCT01801917|309491|P4|STARTED|Period 1 - Randomized||1
126863|NCT01801917|309492|P3|STARTED|Period 1 - Randomized||4
126864|NCT01801917|309493|P2|STARTED|Period 1 - Randomized||2
126865|NCT01801917|309494|P1|STARTED|Period 1 - Randomized||7
126866|NCT01801735|309514|P1|NOT COMPLETED|Overall Study||210
126867|NCT01801735|309514|P1|COMPLETED|Overall Study||390
126868|NCT01801735|309514|P1|STARTED|Overall Study||600
126869|NCT01801475|309521|P5|NOT COMPLETED|Overall Study||1
126870|NCT01801475|309522|P4|NOT COMPLETED|Overall Study||0
126871|NCT01801475|309523|P3|NOT COMPLETED|Overall Study||0
126872|NCT01801475|309524|P2|NOT COMPLETED|Overall Study||0
126873|NCT01801475|309525|P1|NOT COMPLETED|Overall Study||0
126874|NCT01801475|309521|P5|COMPLETED|Overall Study||39
126875|NCT01801475|309522|P4|COMPLETED|Overall Study||10
126876|NCT01801475|309523|P3|COMPLETED|Overall Study||10
126877|NCT01801475|309524|P2|COMPLETED|Overall Study||30
126878|NCT01801475|309525|P1|COMPLETED|Overall Study||10
126879|NCT01801475|309521|P5|STARTED|Overall Study||40
126880|NCT01801475|309522|P4|STARTED|Overall Study||10
126881|NCT01801475|309523|P3|STARTED|Overall Study||10
126882|NCT01801475|309524|P2|STARTED|Overall Study||30
126883|NCT01801475|309525|P1|STARTED|Overall Study||10
126884|NCT01801449|309536|P1|NOT COMPLETED|Overall Study||0
126885|NCT01801449|309536|P1|COMPLETED|Overall Study||6
126886|NCT01801449|309536|P1|STARTED|Overall Study||6
126887|NCT01801436|309550|P1|NOT COMPLETED|Overall Study||9
126888|NCT01801436|309550|P1|COMPLETED|Overall Study||5
126889|NCT01801436|309550|P1|STARTED|Overall Study||14
126890|NCT01801358|309588|P6|NOT COMPLETED|Overall Study||8
126891|NCT01801358|309589|P5|NOT COMPLETED|Overall Study||6
126892|NCT01801358|309590|P4|NOT COMPLETED|Overall Study||6
126893|NCT01801358|309591|P3|NOT COMPLETED|Overall Study||6
126894|NCT01801358|309592|P2|NOT COMPLETED|Overall Study||6
126895|NCT01801358|309593|P1|NOT COMPLETED|Overall Study||6
126896|NCT01801358|309588|P6|COMPLETED|Overall Study||0
126897|NCT01801358|309589|P5|COMPLETED|Overall Study||0
126898|NCT01801358|309590|P4|COMPLETED|Overall Study||0
126899|NCT01801358|309591|P3|COMPLETED|Overall Study||0
126900|NCT01801358|309592|P2|COMPLETED|Overall Study||0
126901|NCT01801358|309593|P1|COMPLETED|Overall Study||0
126902|NCT01801358|309588|P6|STARTED|Overall Study||8
126903|NCT01801358|309589|P5|STARTED|Overall Study||6
126904|NCT01801358|309590|P4|STARTED|Overall Study||6
126905|NCT01801358|309591|P3|STARTED|Overall Study||6
126906|NCT01801358|309592|P2|STARTED|Overall Study||6
126907|NCT01801358|309593|P1|STARTED|Overall Study||6
126908|NCT01801280|309715|P4|NOT COMPLETED|Period 4||0
126909|NCT01801280|309716|P3|NOT COMPLETED|Period 4||1
126910|NCT01801280|309717|P2|NOT COMPLETED|Period 4||0
126911|NCT01801280|309718|P1|NOT COMPLETED|Period 4||0
126912|NCT01801280|309715|P4|COMPLETED|Period 4||5
126913|NCT01801280|309716|P3|COMPLETED|Period 4||4
126914|NCT01801280|309717|P2|COMPLETED|Period 4||4
126915|NCT01801280|309718|P1|COMPLETED|Period 4||4
126916|NCT01801280|309715|P4|STARTED|Period 4||5
126917|NCT01801280|309716|P3|STARTED|Period 4||5
126918|NCT01801280|309717|P2|STARTED|Period 4||4
126919|NCT01801280|309718|P1|STARTED|Period 4||4
126920|NCT01801280|309715|P4|NOT COMPLETED|Period 3||0
126921|NCT01801280|309716|P3|NOT COMPLETED|Period 3||0
126922|NCT01801280|309717|P2|NOT COMPLETED|Period 3||0
126923|NCT01801280|309718|P1|NOT COMPLETED|Period 3||0
126924|NCT01801280|309715|P4|COMPLETED|Period 3||5
126925|NCT01801280|309716|P3|COMPLETED|Period 3||5
126926|NCT01801280|309717|P2|COMPLETED|Period 3||4
126927|NCT01801280|309718|P1|COMPLETED|Period 3||4
126928|NCT01801280|309715|P4|STARTED|Period 3||5
126929|NCT01801280|309716|P3|STARTED|Period 3||5
126930|NCT01801280|309717|P2|STARTED|Period 3||4
126931|NCT01801280|309718|P1|STARTED|Period 3||4
126932|NCT01801280|309715|P4|NOT COMPLETED|Period 2||0
126933|NCT01801280|309716|P3|NOT COMPLETED|Period 2||0
126934|NCT01801280|309717|P2|NOT COMPLETED|Period 2||0
126935|NCT01801280|309718|P1|NOT COMPLETED|Period 2||1
126936|NCT01801280|309715|P4|COMPLETED|Period 2||5
126937|NCT01801280|309716|P3|COMPLETED|Period 2||5
126938|NCT01801280|309717|P2|COMPLETED|Period 2||4
126939|NCT01801280|309718|P1|COMPLETED|Period 2||4
126940|NCT01801280|309715|P4|STARTED|Period 2||5
126941|NCT01801280|309716|P3|STARTED|Period 2||5
126942|NCT01801280|309717|P2|STARTED|Period 2||4
126943|NCT01801280|309718|P1|STARTED|Period 2||5
126944|NCT01801280|309715|P4|NOT COMPLETED|Period 1||0
126945|NCT01801280|309716|P3|NOT COMPLETED|Period 1||0
126946|NCT01801280|309717|P2|NOT COMPLETED|Period 1||1
126947|NCT01801280|309718|P1|NOT COMPLETED|Period 1||0
126948|NCT01801280|309715|P4|COMPLETED|Period 1||5
126949|NCT01801280|309716|P3|COMPLETED|Period 1||5
126950|NCT01801280|309717|P2|COMPLETED|Period 1||4
126951|NCT01801280|309718|P1|COMPLETED|Period 1||5
126952|NCT01801280|309715|P4|STARTED|Period 1||5
126953|NCT01801280|309716|P3|STARTED|Period 1||5
126954|NCT01801280|309717|P2|STARTED|Period 1||5
126955|NCT01801280|309718|P1|STARTED|Period 1|Each period lasted 10-14 weeks|5
126956|NCT01801124|309728|P1|NOT COMPLETED|Overall Study||0
126957|NCT01801124|309728|P1|COMPLETED|Overall Study||13
126958|NCT01801124|309728|P1|STARTED|Overall Study||13
126959|NCT01801111|309733|P1|NOT COMPLETED|Overall Study||138
126960|NCT01801111|309733|P1|COMPLETED|Overall Study||0
126961|NCT01801111|309733|P1|STARTED|Overall Study||138
126962|NCT01800968|309774|P2|NOT COMPLETED|Overall Study||32
126963|NCT01800968|309775|P1|NOT COMPLETED|Overall Study||36
126964|NCT01800968|309774|P2|COMPLETED|Overall Study||114
126965|NCT01800968|309775|P1|COMPLETED|Overall Study||118
126966|NCT01800968|309774|P2|STARTED|Overall Study||146
126967|NCT01800968|309775|P1|STARTED|Overall Study||154
126968|NCT01800916|309817|P9|NOT COMPLETED|Test Period 3 (1 Week)||0
126969|NCT01800916|309818|P8|NOT COMPLETED|Test Period 3 (1 Week)||0
126970|NCT01800916|309819|P7|NOT COMPLETED|Test Period 3 (1 Week)||0
126971|NCT01800916|309820|P6|NOT COMPLETED|Test Period 3 (1 Week)||0
126972|NCT01800916|309821|P5|NOT COMPLETED|Test Period 3 (1 Week)||0
126973|NCT01800916|309822|P4|NOT COMPLETED|Test Period 3 (1 Week)||0
126974|NCT01800916|309823|P3|NOT COMPLETED|Test Period 3 (1 Week)||0
126975|NCT01800916|309824|P2|NOT COMPLETED|Test Period 3 (1 Week)||0
126976|NCT01800916|309825|P1|NOT COMPLETED|Test Period 3 (1 Week)||0
126977|NCT01800916|309817|P9|COMPLETED|Test Period 3 (1 Week)||7
126978|NCT01800916|309818|P8|COMPLETED|Test Period 3 (1 Week)||7
126979|NCT01800916|309819|P7|COMPLETED|Test Period 3 (1 Week)||7
126980|NCT01800916|309820|P6|COMPLETED|Test Period 3 (1 Week)||7
126981|NCT01800916|309821|P5|COMPLETED|Test Period 3 (1 Week)||7
126982|NCT01800916|309822|P4|COMPLETED|Test Period 3 (1 Week)||6
126983|NCT01800916|309823|P3|COMPLETED|Test Period 3 (1 Week)||7
126984|NCT01800916|309824|P2|COMPLETED|Test Period 3 (1 Week)||7
126985|NCT01800916|309825|P1|COMPLETED|Test Period 3 (1 Week)||7
126986|NCT01800916|309817|P9|STARTED|Test Period 3 (1 Week)||7
126987|NCT01800916|309818|P8|STARTED|Test Period 3 (1 Week)||7
126988|NCT01800916|309819|P7|STARTED|Test Period 3 (1 Week)||7
126989|NCT01800916|309820|P6|STARTED|Test Period 3 (1 Week)||7
126990|NCT01800916|309821|P5|STARTED|Test Period 3 (1 Week)||7
126991|NCT01800916|309822|P4|STARTED|Test Period 3 (1 Week)||6
126992|NCT01800916|309823|P3|STARTED|Test Period 3 (1 Week)||7
126993|NCT01800916|309824|P2|STARTED|Test Period 3 (1 Week)||7
126994|NCT01800916|309825|P1|STARTED|Test Period 3 (1 Week)||7
126995|NCT01800916|309817|P9|NOT COMPLETED|Test Period 2 (1 Week)||0
126996|NCT01800916|309818|P8|NOT COMPLETED|Test Period 2 (1 Week)||0
126997|NCT01800916|309819|P7|NOT COMPLETED|Test Period 2 (1 Week)||0
126998|NCT01800916|309820|P6|NOT COMPLETED|Test Period 2 (1 Week)||0
126999|NCT01800916|309821|P5|NOT COMPLETED|Test Period 2 (1 Week)||0
127000|NCT01800916|309822|P4|NOT COMPLETED|Test Period 2 (1 Week)||0
127001|NCT01800916|309823|P3|NOT COMPLETED|Test Period 2 (1 Week)||0
127002|NCT01800916|309824|P2|NOT COMPLETED|Test Period 2 (1 Week)||0
127003|NCT01800916|309825|P1|NOT COMPLETED|Test Period 2 (1 Week)||0
127004|NCT01800916|309817|P9|COMPLETED|Test Period 2 (1 Week)||7
127005|NCT01800916|309818|P8|COMPLETED|Test Period 2 (1 Week)||7
127006|NCT01800916|309819|P7|COMPLETED|Test Period 2 (1 Week)||7
127007|NCT01800916|309820|P6|COMPLETED|Test Period 2 (1 Week)||7
127008|NCT01800916|309821|P5|COMPLETED|Test Period 2 (1 Week)||7
127009|NCT01800916|309822|P4|COMPLETED|Test Period 2 (1 Week)||6
127010|NCT01800916|309823|P3|COMPLETED|Test Period 2 (1 Week)||7
127011|NCT01800916|309824|P2|COMPLETED|Test Period 2 (1 Week)||7
127012|NCT01800916|309825|P1|COMPLETED|Test Period 2 (1 Week)||7
127013|NCT01800916|309817|P9|STARTED|Test Period 2 (1 Week)||7
127014|NCT01800916|309818|P8|STARTED|Test Period 2 (1 Week)||7
127015|NCT01800916|309819|P7|STARTED|Test Period 2 (1 Week)||7
127016|NCT01800916|309820|P6|STARTED|Test Period 2 (1 Week)||7
127017|NCT01800916|309821|P5|STARTED|Test Period 2 (1 Week)||7
127018|NCT01800916|309822|P4|STARTED|Test Period 2 (1 Week)||6
127019|NCT01800916|309823|P3|STARTED|Test Period 2 (1 Week)||7
127020|NCT01800916|309824|P2|STARTED|Test Period 2 (1 Week)||7
127021|NCT01800916|309825|P1|STARTED|Test Period 2 (1 Week)||7
127022|NCT01800916|309817|P9|NOT COMPLETED|Test Period 1 (1 Week)||0
127023|NCT01800916|309818|P8|NOT COMPLETED|Test Period 1 (1 Week)||0
127024|NCT01800916|309819|P7|NOT COMPLETED|Test Period 1 (1 Week)||0
127025|NCT01800916|309820|P6|NOT COMPLETED|Test Period 1 (1 Week)||0
127026|NCT01800916|309821|P5|NOT COMPLETED|Test Period 1 (1 Week)||1
127027|NCT01800916|309822|P4|NOT COMPLETED|Test Period 1 (1 Week)||1
127028|NCT01800916|309823|P3|NOT COMPLETED|Test Period 1 (1 Week)||0
127029|NCT01800916|309824|P2|NOT COMPLETED|Test Period 1 (1 Week)||0
127030|NCT01800916|309825|P1|NOT COMPLETED|Test Period 1 (1 Week)||0
127031|NCT01800916|309817|P9|COMPLETED|Test Period 1 (1 Week)||7
127032|NCT01800916|309818|P8|COMPLETED|Test Period 1 (1 Week)||7
127033|NCT01800916|309819|P7|COMPLETED|Test Period 1 (1 Week)||7
127034|NCT01800916|309820|P6|COMPLETED|Test Period 1 (1 Week)||7
127035|NCT01800916|309821|P5|COMPLETED|Test Period 1 (1 Week)||7
127036|NCT01800916|309822|P4|COMPLETED|Test Period 1 (1 Week)||6
127037|NCT01800916|309823|P3|COMPLETED|Test Period 1 (1 Week)||7
127038|NCT01800916|309824|P2|COMPLETED|Test Period 1 (1 Week)||7
127039|NCT01800916|309825|P1|COMPLETED|Test Period 1 (1 Week)||7
127040|NCT01800916|309817|P9|STARTED|Test Period 1 (1 Week)||7
127041|NCT01800916|309818|P8|STARTED|Test Period 1 (1 Week)||7
127042|NCT01800916|309819|P7|STARTED|Test Period 1 (1 Week)||7
127043|NCT01800916|309820|P6|STARTED|Test Period 1 (1 Week)||7
127044|NCT01800916|309821|P5|STARTED|Test Period 1 (1 Week)||8
127045|NCT01800916|309822|P4|STARTED|Test Period 1 (1 Week)||7
127046|NCT01800916|309823|P3|STARTED|Test Period 1 (1 Week)||7
127047|NCT01800916|309824|P2|STARTED|Test Period 1 (1 Week)||7
127048|NCT01800916|309825|P1|STARTED|Test Period 1 (1 Week)||7
127049|NCT01800903|309835|P6|NOT COMPLETED|Third Test Period||0
127050|NCT01800903|309836|P5|NOT COMPLETED|Third Test Period||0
127051|NCT01800903|309837|P4|NOT COMPLETED|Third Test Period||0
127052|NCT01800903|309838|P3|NOT COMPLETED|Third Test Period||0
127053|NCT01800903|309839|P2|NOT COMPLETED|Third Test Period||0
127054|NCT01800903|309840|P1|NOT COMPLETED|Third Test Period||0
127055|NCT01800903|309835|P6|COMPLETED|Third Test Period||6
127056|NCT01800903|309836|P5|COMPLETED|Third Test Period||6
127057|NCT01800903|309837|P4|COMPLETED|Third Test Period||7
127058|NCT01800903|309838|P3|COMPLETED|Third Test Period||4
127059|NCT01800903|309839|P2|COMPLETED|Third Test Period||6
127060|NCT01800903|309840|P1|COMPLETED|Third Test Period||6
127061|NCT01800903|309835|P6|STARTED|Third Test Period||6
127062|NCT01800903|309836|P5|STARTED|Third Test Period||6
127063|NCT01800903|309837|P4|STARTED|Third Test Period||7
127064|NCT01800903|309838|P3|STARTED|Third Test Period||4
127065|NCT01800903|309839|P2|STARTED|Third Test Period||6
127066|NCT01800903|309840|P1|STARTED|Third Test Period||6
127067|NCT01800903|309835|P6|NOT COMPLETED|Second Test Period||0
127068|NCT01800903|309836|P5|NOT COMPLETED|Second Test Period||0
127069|NCT01800903|309837|P4|NOT COMPLETED|Second Test Period||0
127070|NCT01800903|309838|P3|NOT COMPLETED|Second Test Period||0
127071|NCT01800903|309839|P2|NOT COMPLETED|Second Test Period||0
127072|NCT01800903|309840|P1|NOT COMPLETED|Second Test Period||1
127073|NCT01800903|309835|P6|COMPLETED|Second Test Period||6
127074|NCT01800903|309836|P5|COMPLETED|Second Test Period||6
127075|NCT01800903|309837|P4|COMPLETED|Second Test Period||7
127076|NCT01800903|309838|P3|COMPLETED|Second Test Period||4
127077|NCT01800903|309839|P2|COMPLETED|Second Test Period||6
127078|NCT01800903|309840|P1|COMPLETED|Second Test Period||6
127079|NCT01800903|309835|P6|STARTED|Second Test Period||6
127080|NCT01800903|309836|P5|STARTED|Second Test Period||6
127081|NCT01800903|309837|P4|STARTED|Second Test Period||7
127082|NCT01800903|309838|P3|STARTED|Second Test Period||4
127083|NCT01800903|309839|P2|STARTED|Second Test Period||6
127084|NCT01800903|309840|P1|STARTED|Second Test Period||7
127085|NCT01800903|309835|P6|NOT COMPLETED|First Test Period||0
127086|NCT01800903|309836|P5|NOT COMPLETED|First Test Period||0
127087|NCT01800903|309837|P4|NOT COMPLETED|First Test Period||0
127088|NCT01800903|309838|P3|NOT COMPLETED|First Test Period||0
127089|NCT01800903|309839|P2|NOT COMPLETED|First Test Period||0
127090|NCT01800903|309840|P1|NOT COMPLETED|First Test Period||0
127091|NCT01800903|309835|P6|COMPLETED|First Test Period||6
127092|NCT01800903|309836|P5|COMPLETED|First Test Period||6
127093|NCT01800903|309837|P4|COMPLETED|First Test Period||7
127094|NCT01800903|309838|P3|COMPLETED|First Test Period||4
127095|NCT01800903|309839|P2|COMPLETED|First Test Period||6
127096|NCT01800903|309840|P1|COMPLETED|First Test Period||7
127097|NCT01800903|309835|P6|STARTED|First Test Period||6
127098|NCT01800903|309836|P5|STARTED|First Test Period||6
127099|NCT01800903|309837|P4|STARTED|First Test Period||7
127100|NCT01800903|309838|P3|STARTED|First Test Period||4
127101|NCT01800903|309839|P2|STARTED|First Test Period||6
127102|NCT01800903|309840|P1|STARTED|First Test Period||7
127103|NCT01800890|309846|P9|NOT COMPLETED|Test Period 3||0
127104|NCT01800890|309847|P8|NOT COMPLETED|Test Period 3||0
127105|NCT01800890|309848|P7|NOT COMPLETED|Test Period 3||0
127106|NCT01800890|309849|P6|NOT COMPLETED|Test Period 3||0
127107|NCT01800890|309850|P5|NOT COMPLETED|Test Period 3||0
127108|NCT01800890|309851|P4|NOT COMPLETED|Test Period 3||0
127109|NCT01800890|309852|P3|NOT COMPLETED|Test Period 3||0
127110|NCT01800890|309853|P2|NOT COMPLETED|Test Period 3||0
127111|NCT01800890|309854|P1|NOT COMPLETED|Test Period 3||0
127112|NCT01800890|309846|P9|COMPLETED|Test Period 3||3
127113|NCT01800890|309847|P8|COMPLETED|Test Period 3||3
127114|NCT01800890|309848|P7|COMPLETED|Test Period 3||3
127115|NCT01800890|309849|P6|COMPLETED|Test Period 3||4
127116|NCT01800890|309850|P5|COMPLETED|Test Period 3||4
127117|NCT01800890|309851|P4|COMPLETED|Test Period 3||2
127118|NCT01800890|309852|P3|COMPLETED|Test Period 3||3
127119|NCT01800890|309853|P2|COMPLETED|Test Period 3||3
127120|NCT01800890|309854|P1|COMPLETED|Test Period 3||3
127121|NCT01800890|309846|P9|STARTED|Test Period 3||3
127122|NCT01800890|309847|P8|STARTED|Test Period 3||3
127123|NCT01800890|309848|P7|STARTED|Test Period 3||3
127124|NCT01800890|309849|P6|STARTED|Test Period 3||4
127125|NCT01800890|309850|P5|STARTED|Test Period 3||4
127126|NCT01800890|309851|P4|STARTED|Test Period 3||2
127127|NCT01800890|309852|P3|STARTED|Test Period 3||3
127128|NCT01800890|309853|P2|STARTED|Test Period 3||3
127129|NCT01800890|309854|P1|STARTED|Test Period 3||3
127130|NCT01800890|309846|P9|NOT COMPLETED|Test Period 2||0
127131|NCT01800890|309847|P8|NOT COMPLETED|Test Period 2||0
127132|NCT01800890|309848|P7|NOT COMPLETED|Test Period 2||0
127133|NCT01800890|309849|P6|NOT COMPLETED|Test Period 2||0
127134|NCT01800890|309850|P5|NOT COMPLETED|Test Period 2||0
127135|NCT01800890|309851|P4|NOT COMPLETED|Test Period 2||0
127136|NCT01800890|309852|P3|NOT COMPLETED|Test Period 2||0
127137|NCT01800890|309853|P2|NOT COMPLETED|Test Period 2||0
127138|NCT01800890|309854|P1|NOT COMPLETED|Test Period 2||0
127139|NCT01800890|309846|P9|COMPLETED|Test Period 2||3
127140|NCT01800890|309847|P8|COMPLETED|Test Period 2||3
127141|NCT01800890|309848|P7|COMPLETED|Test Period 2||3
127142|NCT01800890|309849|P6|COMPLETED|Test Period 2||4
127143|NCT01800890|309850|P5|COMPLETED|Test Period 2||4
127144|NCT01800890|309851|P4|COMPLETED|Test Period 2||2
127145|NCT01800890|309852|P3|COMPLETED|Test Period 2||3
127146|NCT01800890|309853|P2|COMPLETED|Test Period 2||3
127147|NCT01800890|309854|P1|COMPLETED|Test Period 2||3
127148|NCT01800890|309846|P9|STARTED|Test Period 2||3
127149|NCT01800890|309847|P8|STARTED|Test Period 2||3
127150|NCT01800890|309848|P7|STARTED|Test Period 2||3
127151|NCT01800890|309849|P6|STARTED|Test Period 2||4
127152|NCT01800890|309850|P5|STARTED|Test Period 2||4
127153|NCT01800890|309851|P4|STARTED|Test Period 2||2
127154|NCT01800890|309852|P3|STARTED|Test Period 2||3
127155|NCT01800890|309853|P2|STARTED|Test Period 2||3
127156|NCT01800890|309854|P1|STARTED|Test Period 2||3
127157|NCT01800890|309846|P9|NOT COMPLETED|Test Period 1||0
127158|NCT01800890|309847|P8|NOT COMPLETED|Test Period 1||0
127159|NCT01800890|309848|P7|NOT COMPLETED|Test Period 1||0
127160|NCT01800890|309849|P6|NOT COMPLETED|Test Period 1||0
127161|NCT01800890|309850|P5|NOT COMPLETED|Test Period 1||0
127162|NCT01800890|309851|P4|NOT COMPLETED|Test Period 1||1
127163|NCT01800890|309852|P3|NOT COMPLETED|Test Period 1||0
127164|NCT01800890|309853|P2|NOT COMPLETED|Test Period 1||0
127165|NCT01800890|309854|P1|NOT COMPLETED|Test Period 1||0
127166|NCT01800890|309846|P9|COMPLETED|Test Period 1||3
127167|NCT01800890|309847|P8|COMPLETED|Test Period 1||3
127168|NCT01800890|309848|P7|COMPLETED|Test Period 1||3
127169|NCT01800890|309849|P6|COMPLETED|Test Period 1||4
127170|NCT01800890|309850|P5|COMPLETED|Test Period 1||4
127171|NCT01800890|309851|P4|COMPLETED|Test Period 1||2
127172|NCT01800890|309852|P3|COMPLETED|Test Period 1||3
127173|NCT01800890|309853|P2|COMPLETED|Test Period 1||3
127174|NCT01800890|309854|P1|COMPLETED|Test Period 1||3
127175|NCT01800890|309846|P9|STARTED|Test Period 1||3
127176|NCT01800890|309847|P8|STARTED|Test Period 1||3
127177|NCT01800890|309848|P7|STARTED|Test Period 1||3
127178|NCT01800890|309849|P6|STARTED|Test Period 1||4
127179|NCT01800890|309850|P5|STARTED|Test Period 1||4
127180|NCT01800890|309851|P4|STARTED|Test Period 1||3
127181|NCT01800890|309852|P3|STARTED|Test Period 1||3
127182|NCT01800890|309853|P2|STARTED|Test Period 1||3
127183|NCT01800890|309854|P1|STARTED|Test Period 1||3
127184|NCT01800877|309866|P2|NOT COMPLETED|Overall Study||0
127185|NCT01800877|309867|P1|NOT COMPLETED|Overall Study||2
127186|NCT01800877|309866|P2|COMPLETED|Overall Study||60
127187|NCT01800877|309867|P1|COMPLETED|Overall Study||58
127188|NCT01800877|309866|P2|STARTED|Overall Study||60
127189|NCT01800877|309867|P1|STARTED|Overall Study||60
127190|NCT01800838|309877|P4|NOT COMPLETED|Overall Study||0
127191|NCT01800838|309878|P3|NOT COMPLETED|Overall Study||0
127192|NCT01800838|309879|P2|NOT COMPLETED|Overall Study||0
127193|NCT01800838|309880|P1|NOT COMPLETED|Overall Study||0
127194|NCT01800838|309877|P4|COMPLETED|Overall Study||2
127195|NCT01800838|309878|P3|COMPLETED|Overall Study||7
127196|NCT01800838|309879|P2|COMPLETED|Overall Study||1
127197|NCT01800838|309880|P1|COMPLETED|Overall Study||1
127198|NCT01800838|309877|P4|STARTED|Overall Study||2
127199|NCT01800838|309878|P3|STARTED|Overall Study||7
127200|NCT01800838|309879|P2|STARTED|Overall Study||1
127201|NCT01800838|309880|P1|STARTED|Overall Study||1
127202|NCT01800786|309887|P2|NOT COMPLETED|Overall Study||1
127203|NCT01800786|309888|P1|NOT COMPLETED|Overall Study||2
127204|NCT01800786|309887|P2|COMPLETED|Overall Study||15
127205|NCT01800786|309888|P1|COMPLETED|Overall Study||15
127206|NCT01800786|309887|P2|STARTED|Overall Study||16
127207|NCT01800786|309888|P1|STARTED|Overall Study||17
127208|NCT01800318|309898|P4|NOT COMPLETED|Overall Study||1
127209|NCT01800318|309899|P3|NOT COMPLETED|Overall Study||1
127210|NCT01800318|309900|P2|NOT COMPLETED|Overall Study||5
127211|NCT01800318|309901|P1|NOT COMPLETED|Overall Study||2
127212|NCT01800318|309898|P4|COMPLETED|Overall Study||39
127213|NCT01800318|309899|P3|COMPLETED|Overall Study||40
127214|NCT01800318|309900|P2|COMPLETED|Overall Study||37
127215|NCT01800318|309901|P1|COMPLETED|Overall Study||37
127216|NCT01800318|309898|P4|STARTED|Overall Study||40
127217|NCT01800318|309899|P3|STARTED|Overall Study||41
127218|NCT01800318|309900|P2|STARTED|Overall Study||42
127219|NCT01800318|309901|P1|STARTED|Overall Study||39
127220|NCT01800162|309930|P3|NOT COMPLETED|Overall Study||0
127221|NCT01800162|309931|P2|NOT COMPLETED|Overall Study||0
127222|NCT01800162|309932|P1|NOT COMPLETED|Overall Study||0
127223|NCT01800162|309930|P3|COMPLETED|Overall Study||1
127224|NCT01800162|309931|P2|COMPLETED|Overall Study||0
127225|NCT01800162|309932|P1|COMPLETED|Overall Study||1
127226|NCT01800162|309930|P3|STARTED|Overall Study|1 subject randomized to expectant management on 11/1/2013.|1
127227|NCT01800162|309931|P2|STARTED|Overall Study||0
127228|NCT01800162|309932|P1|STARTED|Overall Study|1 subject was randomized to uterine evacuation on 6/26/2013.|1
127229|NCT01799993|309958|P2|NOT COMPLETED|Overall Study||128
127230|NCT01799993|309959|P1|NOT COMPLETED|Overall Study||133
127231|NCT01799993|309958|P2|COMPLETED|Overall Study||235
127232|NCT01799993|309959|P1|COMPLETED|Overall Study||229
127233|NCT01799993|309958|P2|mITT Population|Overall Study||253
127234|NCT01799993|309959|P1|mITT Population|Overall Study||255
127235|NCT01799993|309958|P2|ITT Population|Overall Study||358
127236|NCT01799993|309959|P1|ITT Population|Overall Study||354
127237|NCT01799993|309958|P2|STARTED|Overall Study||363
127238|NCT01799993|309959|P1|STARTED|Overall Study||362
127239|NCT01799941|309991|P1|NOT COMPLETED|Overall Study||96
127240|NCT01799941|309991|P1|COMPLETED|Overall Study||271
127241|NCT01799941|309991|P1|STARTED|Overall Study||367
127242|NCT01799720|310048|P3|NOT COMPLETED|Overall Study||1
127243|NCT01799720|310049|P2|NOT COMPLETED|Overall Study||1
127244|NCT01799720|310050|P1|NOT COMPLETED|Overall Study||3
127245|NCT01799720|310048|P3|COMPLETED|Overall Study||18
127246|NCT01799720|310049|P2|COMPLETED|Overall Study||17
127247|NCT01799720|310050|P1|COMPLETED|Overall Study||17
127248|NCT01799720|310048|P3|Began the Treatment and Finished it|Overall Study||18
127339|NCT01798550|310426|P1|COMPLETED|Overall Study||28
127249|NCT01799720|310049|P2|Began the Treatment and Finished it|Overall Study||17
127250|NCT01799720|310050|P1|Began the Treatment and Finished it|Overall Study||17
127251|NCT01799720|310048|P3|Began the Treatment|Overall Study||19
127252|NCT01799720|310049|P2|Began the Treatment|Overall Study||18
127253|NCT01799720|310050|P1|Began the Treatment|Overall Study||20
127254|NCT01799720|310048|P3|STARTED|Overall Study||19
127255|NCT01799720|310049|P2|STARTED|Overall Study||18
127256|NCT01799720|310050|P1|STARTED|Overall Study||20
127257|NCT01799590|310088|P3|NOT COMPLETED|Overall Study||14
127258|NCT01799590|310089|P2|NOT COMPLETED|Overall Study||16
127259|NCT01799590|310090|P1|NOT COMPLETED|Overall Study||26
127260|NCT01799590|310088|P3|COMPLETED|Overall Study||77
127261|NCT01799590|310089|P2|COMPLETED|Overall Study||78
127262|NCT01799590|310090|P1|COMPLETED|Overall Study||85
127263|NCT01799590|310088|P3|STARTED|Overall Study||91
127264|NCT01799590|310089|P2|STARTED|Overall Study||94
127265|NCT01799590|310090|P1|STARTED|Overall Study||111
127266|NCT01799278|310125|P1|NOT COMPLETED|Overall Study||0
127267|NCT01799278|310125|P1|COMPLETED|Overall Study||60
127268|NCT01799278|310125|P1|STARTED|Overall Study||60
127269|NCT01799239|310133|P2|NOT COMPLETED|Period 2 (7 Days)||1
127270|NCT01799239|310134|P1|NOT COMPLETED|Period 2 (7 Days)||2
127271|NCT01799239|310133|P2|COMPLETED|Period 2 (7 Days)||14
127272|NCT01799239|310134|P1|COMPLETED|Period 2 (7 Days)||11
127273|NCT01799239|310133|P2|STARTED|Period 2 (7 Days)||15
127274|NCT01799239|310134|P1|STARTED|Period 2 (7 Days)||13
127275|NCT01799239|310133|P2|NOT COMPLETED|Period 1 (7 Days)||1
127276|NCT01799239|310134|P1|NOT COMPLETED|Period 1 (7 Days)||3
127277|NCT01799239|310133|P2|COMPLETED|Period 1 (7 Days)||15
127278|NCT01799239|310134|P1|COMPLETED|Period 1 (7 Days)||12
127279|NCT01799239|310133|P2|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|16
127280|NCT01799239|310134|P1|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|15
127281|NCT01799226|310142|P2|NOT COMPLETED|Overall Study||0
127282|NCT01799226|310143|P1|NOT COMPLETED|Overall Study||2
127283|NCT01799226|310142|P2|COMPLETED|Overall Study||16
127284|NCT01799226|310143|P1|COMPLETED|Overall Study||14
127285|NCT01799226|310142|P2|Left Stent Side|Overall Study||8
127286|NCT01799226|310143|P1|Left Stent Side|Overall Study||8
127287|NCT01799226|310142|P2|Right Stent Side|Overall Study||8
127288|NCT01799226|310143|P1|Right Stent Side|Overall Study||8
127289|NCT01799226|310142|P2|STARTED|Overall Study||16
127290|NCT01799226|310143|P1|STARTED|Overall Study||16
127291|NCT01798992|310155|P4|NOT COMPLETED|Overall Study||1
127292|NCT01798992|310156|P3|NOT COMPLETED|Overall Study||2
127293|NCT01798992|310157|P2|NOT COMPLETED|Overall Study||2
127294|NCT01798992|310158|P1|NOT COMPLETED|Overall Study||0
127295|NCT01798992|310155|P4|COMPLETED|Overall Study||16
127296|NCT01798992|310156|P3|COMPLETED|Overall Study||14
127297|NCT01798992|310157|P2|COMPLETED|Overall Study||17
127298|NCT01798992|310158|P1|COMPLETED|Overall Study||4
127299|NCT01798992|310155|P4|STARTED|Overall Study||17
127300|NCT01798992|310156|P3|STARTED|Overall Study||16
127301|NCT01798992|310157|P2|STARTED|Overall Study||19
127302|NCT01798992|310158|P1|STARTED|Overall Study||4
127303|NCT01798966|310172|P1|NOT COMPLETED|Overall Study||0
127304|NCT01798966|310172|P1|COMPLETED|Overall Study||10
127305|NCT01798966|310172|P1|STARTED|Overall Study||10
127306|NCT01798927|310178|P1|NOT COMPLETED|Overall Study||1
127307|NCT01798927|310178|P1|COMPLETED|Overall Study||3
127308|NCT01798927|310178|P1|STARTED|Overall Study||4
127309|NCT01798849|310187|P3|NOT COMPLETED|Overall Study||1
127310|NCT01798849|310188|P2|NOT COMPLETED|Overall Study||0
127311|NCT01798849|310189|P1|NOT COMPLETED|Overall Study||0
127312|NCT01798849|310187|P3|COMPLETED|Overall Study||8
127313|NCT01798849|310188|P2|COMPLETED|Overall Study||8
127314|NCT01798849|310189|P1|COMPLETED|Overall Study||8
127315|NCT01798849|310187|P3|STARTED|Overall Study|1 participant discontinued after Period 1 and was replaced for Periods 2-4|9
127316|NCT01798849|310188|P2|STARTED|Overall Study||8
127317|NCT01798849|310189|P1|STARTED|Overall Study||8
127318|NCT01798706|310379|P2|NOT COMPLETED|Overall Study||21
127319|NCT01798706|310380|P1|NOT COMPLETED|Overall Study||21
127320|NCT01798706|310379|P2|COMPLETED|Overall Study||153
127321|NCT01798706|310380|P1|COMPLETED|Overall Study||155
127322|NCT01798706|310379|P2|STARTED|Overall Study||174
127323|NCT01798706|310380|P1|STARTED|Overall Study||176
127324|NCT01798641|310408|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
127325|NCT01798641|310409|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
127326|NCT01798641|310408|P2|COMPLETED|Second Intervention (6 Weeks)||19
127327|NCT01798641|310409|P1|COMPLETED|Second Intervention (6 Weeks)||19
127328|NCT01798641|310408|P2|STARTED|Second Intervention (6 Weeks)||19
127329|NCT01798641|310409|P1|STARTED|Second Intervention (6 Weeks)||19
127330|NCT01798641|310408|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
127331|NCT01798641|310409|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
127332|NCT01798641|310408|P2|COMPLETED|First Intervention (6 Weeks)||19
127333|NCT01798641|310409|P1|COMPLETED|First Intervention (6 Weeks)||19
127334|NCT01798641|310408|P2|STARTED|First Intervention (6 Weeks)||19
127335|NCT01798641|310409|P1|STARTED|First Intervention (6 Weeks)||19
127336|NCT01798550|310425|P2|NOT COMPLETED|Overall Study||6
127337|NCT01798550|310426|P1|NOT COMPLETED|Overall Study||2
127338|NCT01798550|310425|P2|COMPLETED|Overall Study||26
127340|NCT01798550|310425|P2|STARTED|Overall Study||32
127341|NCT01798550|310426|P1|STARTED|Overall Study||30
127342|NCT01798485|310442|P2|NOT COMPLETED|Overall Study||290
127343|NCT01798485|310443|P1|NOT COMPLETED|Overall Study||346
127344|NCT01798485|310442|P2|COMPLETED|Overall Study||59
127345|NCT01798485|310443|P1|COMPLETED|Overall Study||1
127346|NCT01798485|310442|P2|Randomized as of 19 October 2015|Overall Study||337
127347|NCT01798485|310443|P1|Randomized as of 19 October 2015|Overall Study||335
127348|NCT01798485|310442|P2|Safety Population as of 23 Dec 2015|Overall Study||342
127349|NCT01798485|310443|P1|Safety Population as of 23 Dec 2015|Overall Study||338
127350|NCT01798485|310442|P2|STARTED|Overall Study||349
127351|NCT01798485|310443|P1|STARTED|Overall Study||347
127352|NCT01798394|310479|P2|NOT COMPLETED|Overall Study||3
127353|NCT01798394|310480|P1|NOT COMPLETED|Overall Study||3
127354|NCT01798394|310479|P2|COMPLETED|Overall Study||19
127355|NCT01798394|310480|P1|COMPLETED|Overall Study||21
127356|NCT01798394|310479|P2|STARTED|Overall Study||22
127357|NCT01798394|310480|P1|STARTED|Overall Study||24
127358|NCT01798316|310500|P2|NOT COMPLETED|Overall Study||0
127359|NCT01798316|310501|P1|NOT COMPLETED|Overall Study||0
127360|NCT01798316|310500|P2|COMPLETED|Overall Study||53
127361|NCT01798316|310501|P1|COMPLETED|Overall Study||52
127362|NCT01798316|310500|P2|STARTED|Overall Study||53
127363|NCT01798316|310501|P1|STARTED|Overall Study||52
127364|NCT01798264|310523|P4|NOT COMPLETED|Overall Study||4
127365|NCT01798264|310524|P3|NOT COMPLETED|Overall Study||0
127366|NCT01798264|310525|P2|NOT COMPLETED|Overall Study||0
127367|NCT01798264|310526|P1|NOT COMPLETED|Overall Study||1
127368|NCT01798264|310523|P4|COMPLETED|Overall Study||7
127369|NCT01798264|310524|P3|COMPLETED|Overall Study||10
127370|NCT01798264|310525|P2|COMPLETED|Overall Study||11
127371|NCT01798264|310526|P1|COMPLETED|Overall Study||11
127372|NCT01798264|310523|P4|STARTED|Overall Study||11
127373|NCT01798264|310524|P3|STARTED|Overall Study||10
127374|NCT01798264|310525|P2|STARTED|Overall Study||11
127375|NCT01798264|310526|P1|STARTED|Overall Study||12
127376|NCT01798225|310550|P2|NOT COMPLETED|Overall Study||3
127377|NCT01798225|310551|P1|NOT COMPLETED|Overall Study||0
127378|NCT01798225|310550|P2|COMPLETED|Overall Study||53
127379|NCT01798225|310551|P1|COMPLETED|Overall Study||57
127380|NCT01798225|310550|P2|STARTED|Overall Study||56
127381|NCT01798225|310551|P1|STARTED|Overall Study||57
127382|NCT01798186|310563|P4|NOT COMPLETED|Overall Study||0
127383|NCT01798186|310564|P3|NOT COMPLETED|Overall Study||0
127384|NCT01798186|310565|P2|NOT COMPLETED|Overall Study||0
127385|NCT01798186|310566|P1|NOT COMPLETED|Overall Study||0
127386|NCT01798186|310563|P4|COMPLETED|Overall Study||8
127387|NCT01798186|310564|P3|COMPLETED|Overall Study||6
127388|NCT01798186|310565|P2|COMPLETED|Overall Study||6
127389|NCT01798186|310566|P1|COMPLETED|Overall Study||6
127390|NCT01798186|310563|P4|STARTED|Overall Study||8
127391|NCT01798186|310564|P3|STARTED|Overall Study||6
127392|NCT01798186|310565|P2|STARTED|Overall Study||6
127393|NCT01798186|310566|P1|STARTED|Overall Study||6
127394|NCT01798134|310580|P1|NOT COMPLETED|Overall Study||16
127395|NCT01798134|310580|P1|COMPLETED|Overall Study||9
127396|NCT01798134|310580|P1|STARTED|Overall Study||25
127397|NCT01798056|310589|P2|NOT COMPLETED|Overall Study||25
127398|NCT01798056|310590|P1|NOT COMPLETED|Overall Study||27
127399|NCT01798056|310589|P2|COMPLETED|Overall Study||90
127400|NCT01798056|310590|P1|COMPLETED|Overall Study||90
127401|NCT01798056|310589|P2|STARTED|Overall Study||115
127402|NCT01798056|310590|P1|STARTED|Overall Study||117
127403|NCT01798004|310624|P1|NOT COMPLETED|Overall Study||87
127404|NCT01798004|310624|P1|COMPLETED|Overall Study||63
127405|NCT01798004|310624|P1|STARTED|Overall Study||150
127406|NCT01797835|310630|P2|NOT COMPLETED|Overall Study||27
127407|NCT01797835|310631|P1|NOT COMPLETED|Overall Study||31
127408|NCT01797835|310630|P2|COMPLETED|Overall Study||114
127409|NCT01797835|310631|P1|COMPLETED|Overall Study||122
127410|NCT01797835|310630|P2|STARTED|Overall Study||141
127411|NCT01797835|310631|P1|STARTED|Overall Study||153
127412|NCT01797783|310641|P2|NOT COMPLETED|Overall Study||1
127413|NCT01797783|310642|P1|NOT COMPLETED|Overall Study||2
127414|NCT01797783|310641|P2|COMPLETED|Overall Study||26
127415|NCT01797783|310642|P1|COMPLETED|Overall Study||50
127416|NCT01797783|310641|P2|STARTED|Overall Study||27
127417|NCT01797783|310642|P1|STARTED|Overall Study||52
127418|NCT01797731|310666|P2|NOT COMPLETED|Overall Study||3
127419|NCT01797731|310667|P1|NOT COMPLETED|Overall Study||3
127420|NCT01797731|310666|P2|COMPLETED|Overall Study|3 excluded due to not having proper radiographs for adequate follow up|47
127421|NCT01797731|310667|P1|COMPLETED|Overall Study|3 were excluded due to not having proper radiographs for adequate follow up|47
127422|NCT01797731|310666|P2|STARTED|Overall Study||50
127423|NCT01797731|310667|P1|STARTED|Overall Study||50
127424|NCT01797705|310675|P1|NOT COMPLETED|Overall Study||5
127425|NCT01797705|310675|P1|COMPLETED|Overall Study||28
127426|NCT01797705|310675|P1|STARTED|Overall Study||33
127427|NCT01797575|310683|P4|NOT COMPLETED|Week 8 Re-Randomization||3
127428|NCT01797575|310684|P3|NOT COMPLETED|Week 8 Re-Randomization||1
127429|NCT01797575|310685|P2|NOT COMPLETED|Week 8 Re-Randomization||0
127430|NCT01797575|310686|P1|NOT COMPLETED|Week 8 Re-Randomization||0
127431|NCT01797575|310683|P4|COMPLETED|Week 8 Re-Randomization||7
127432|NCT01797575|310684|P3|COMPLETED|Week 8 Re-Randomization||4
127433|NCT01797575|310685|P2|COMPLETED|Week 8 Re-Randomization||5
127434|NCT01797575|310686|P1|COMPLETED|Week 8 Re-Randomization||4
127435|NCT01797575|310683|P4|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|10
127436|NCT01797575|310684|P3|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
127437|NCT01797575|310685|P2|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
127438|NCT01797575|310686|P1|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|4
127439|NCT01797575|310683|P4|NOT COMPLETED|Baseline Allocation||7
127440|NCT01797575|310684|P3|NOT COMPLETED|Baseline Allocation||5
127441|NCT01797575|310685|P2|NOT COMPLETED|Baseline Allocation||1
127442|NCT01797575|310686|P1|NOT COMPLETED|Baseline Allocation||1
127443|NCT01797575|310683|P4|COMPLETED|Baseline Allocation||8
127444|NCT01797575|310684|P3|COMPLETED|Baseline Allocation||4
127445|NCT01797575|310685|P2|COMPLETED|Baseline Allocation||8
127446|NCT01797575|310686|P1|COMPLETED|Baseline Allocation||4
127447|NCT01797575|310683|P4|STARTED|Baseline Allocation||15
127448|NCT01797575|310684|P3|STARTED|Baseline Allocation||9
127449|NCT01797575|310685|P2|STARTED|Baseline Allocation||9
127450|NCT01797575|310686|P1|STARTED|Baseline Allocation||5
127451|NCT01797536|310740|P4|NOT COMPLETED|Overall Study||0
127452|NCT01797536|310741|P3|NOT COMPLETED|Overall Study||0
127453|NCT01797536|310742|P2|NOT COMPLETED|Overall Study||1
127454|NCT01797536|310743|P1|NOT COMPLETED|Overall Study||0
127455|NCT01797536|310740|P4|COMPLETED|Overall Study||8
127456|NCT01797536|310741|P3|COMPLETED|Overall Study||7
127457|NCT01797536|310742|P2|COMPLETED|Overall Study||10
127458|NCT01797536|310743|P1|COMPLETED|Overall Study||8
127459|NCT01797536|310740|P4|STARTED|Overall Study||8
127460|NCT01797536|310741|P3|STARTED|Overall Study||7
127461|NCT01797536|310742|P2|STARTED|Overall Study|Includes 3 participants from mild arm who were mistakenly re-enrolled and also dosed in moderate arm|11
127462|NCT01797536|310743|P1|STARTED|Overall Study||8
127463|NCT01797484|310775|P2|NOT COMPLETED|Overall Study||0
127464|NCT01797484|310776|P1|NOT COMPLETED|Overall Study||0
127465|NCT01797484|310775|P2|COMPLETED|Overall Study||10
127466|NCT01797484|310776|P1|COMPLETED|Overall Study||10
127467|NCT01797484|310775|P2|STARTED|Overall Study||10
127468|NCT01797484|310776|P1|STARTED|Overall Study||10
127469|NCT01797471|310782|P1|NOT COMPLETED|Overall Study||0
127470|NCT01797471|310782|P1|COMPLETED|Overall Study||1
127471|NCT01797471|310782|P1|STARTED|Overall Study||1
127472|NCT01797458|310794|P3|NOT COMPLETED|Overall Study||7
127473|NCT01797458|310795|P2|NOT COMPLETED|Overall Study||9
127474|NCT01797458|310796|P1|NOT COMPLETED|Overall Study||12
127475|NCT01797458|310794|P3|COMPLETED|Overall Study||58
127476|NCT01797458|310795|P2|COMPLETED|Overall Study||43
127477|NCT01797458|310796|P1|COMPLETED|Overall Study||40
127478|NCT01797458|310794|P3|STARTED|Overall Study||65
127479|NCT01797458|310795|P2|STARTED|Overall Study||52
127480|NCT01797458|310796|P1|STARTED|Overall Study||52
127481|NCT01797445|310815|P2|NOT COMPLETED|Open-Label Extension Phase||0
127482|NCT01797445|310816|P1|NOT COMPLETED|Open-Label Extension Phase||1
127483|NCT01797445|310815|P2|COMPLETED|Open-Label Extension Phase||119
127484|NCT01797445|310816|P1|COMPLETED|Open-Label Extension Phase||140
127485|NCT01797445|310815|P2|STARTED|Open-Label Extension Phase|229 participants completed the Double-Blind Phase, but did not enter the Open-Label Extension Phase.|119
127486|NCT01797445|310816|P1|STARTED|Open-Label Extension Phase|207 participants completed the Double-Blind Phase, but did not enter the Open-Label Extension Phase.|141
127487|NCT01797445|310815|P2|NOT COMPLETED|Double-Blind Phase||89
127488|NCT01797445|310816|P1|NOT COMPLETED|Double-Blind Phase||87
127489|NCT01797445|310815|P2|COMPLETED|Double-Blind Phase||348
127490|NCT01797445|310816|P1|COMPLETED|Double-Blind Phase||348
127491|NCT01797445|310815|P2|STARTED|Double-Blind Phase||437
127492|NCT01797445|310816|P1|STARTED|Double-Blind Phase||435
127493|NCT01797380|310858|P2|NOT COMPLETED|Overall Study||2
127494|NCT01797380|310859|P1|NOT COMPLETED|Overall Study||3
127495|NCT01797380|310858|P2|COMPLETED|Overall Study||0
127496|NCT01797380|310859|P1|COMPLETED|Overall Study|Terminated due to lack of enrollment|0
127497|NCT01797380|310858|P2|STARTED|Overall Study||2
127498|NCT01797380|310859|P1|STARTED|Overall Study|Terminated due to lack of enrollment|3
127499|NCT01797328|310867|P2|NOT COMPLETED|Overall Study||0
127500|NCT01797328|310868|P1|NOT COMPLETED|Overall Study||2
127501|NCT01797328|310867|P2|COMPLETED|Overall Study||12
127502|NCT01797328|310868|P1|COMPLETED|Overall Study||14
127503|NCT01797328|310867|P2|STARTED|Overall Study||12
127504|NCT01797328|310868|P1|STARTED|Overall Study||16
127505|NCT01797185|310877|P3|NOT COMPLETED|Overall Study||12
127506|NCT01797185|310878|P2|NOT COMPLETED|Overall Study||38
127507|NCT01797185|310879|P1|NOT COMPLETED|Overall Study||28
127508|NCT01797185|310877|P3|COMPLETED|Overall Study||38
127509|NCT01797185|310878|P2|COMPLETED|Overall Study||125
127510|NCT01797185|310879|P1|COMPLETED|Overall Study||134
127511|NCT01797185|310877|P3|STARTED|Overall Study||50
127512|NCT01797185|310878|P2|STARTED|Overall Study||163
127513|NCT01797185|310879|P1|STARTED|Overall Study||162
127514|NCT01797120|310889|P2|NOT COMPLETED|Overall Study||65
127515|NCT01797120|310890|P1|NOT COMPLETED|Overall Study||66
127516|NCT01797120|310889|P2|COMPLETED|Overall Study||0
127517|NCT01797120|310890|P1|COMPLETED|Overall Study||0
127518|NCT01797120|310889|P2|STARTED|Overall Study||65
127519|NCT01797120|310890|P1|STARTED|Overall Study||66
127520|NCT01797094|310904|P2|NOT COMPLETED|Overall Study||2
127521|NCT01797094|310905|P1|NOT COMPLETED|Overall Study||6
127522|NCT01797094|310904|P2|COMPLETED|Overall Study||51
127523|NCT01797094|310905|P1|COMPLETED|Overall Study||42
127524|NCT01797094|310904|P2|STARTED|Overall Study||53
127525|NCT01797094|310905|P1|STARTED|Overall Study||48
127526|NCT01797081|310927|P4|NOT COMPLETED|Overall Study||9
127527|NCT01797081|310928|P3|NOT COMPLETED|Overall Study||5
127528|NCT01797081|310929|P2|NOT COMPLETED|Overall Study||4
127529|NCT01797081|310930|P1|NOT COMPLETED|Overall Study||14
127530|NCT01797081|310927|P4|COMPLETED|Overall Study||40
127531|NCT01797081|310928|P3|COMPLETED|Overall Study||43
127532|NCT01797081|310929|P2|COMPLETED|Overall Study||95
127533|NCT01797081|310930|P1|COMPLETED|Overall Study||90
127534|NCT01797081|310927|P4|STARTED|Overall Study||49
127535|NCT01797081|310928|P3|STARTED|Overall Study||48
127536|NCT01797081|310929|P2|STARTED|Overall Study||99
127537|NCT01797081|310930|P1|STARTED|Overall Study||104
127538|NCT01797029|310949|P2|NOT COMPLETED|Overall Study||61
127539|NCT01797029|310950|P1|NOT COMPLETED|Overall Study||159
127540|NCT01797029|310949|P2|COMPLETED|Overall Study||526
127541|NCT01797029|310950|P1|COMPLETED|Overall Study||1015
127542|NCT01797029|310949|P2|STARTED|Overall Study||587
127543|NCT01797029|310950|P1|STARTED|Overall Study||1174
127544|NCT01796977|310958|P1|NOT COMPLETED|Overall Study||0
127545|NCT01796977|310958|P1|COMPLETED|Overall Study||27
127546|NCT01796977|310958|P1|STARTED|Overall Study||27
127547|NCT01796964|310971|P2|NOT COMPLETED|Overall Study||3
127548|NCT01796964|310972|P1|NOT COMPLETED|Overall Study||3
127549|NCT01796964|310971|P2|COMPLETED|Overall Study||42
127550|NCT01796964|310972|P1|COMPLETED|Overall Study||41
127551|NCT01796964|310971|P2|STARTED|Overall Study||45
127552|NCT01796964|310972|P1|STARTED|Overall Study||44
127553|NCT01796912|310994|P2|NOT COMPLETED|Second Intervention||0
127554|NCT01796912|310995|P1|NOT COMPLETED|Second Intervention||0
127555|NCT01796912|310994|P2|COMPLETED|Second Intervention||10
127556|NCT01796912|310995|P1|COMPLETED|Second Intervention||10
127557|NCT01796912|310994|P2|STARTED|Second Intervention||10
127558|NCT01796912|310995|P1|STARTED|Second Intervention||10
127559|NCT01796912|310994|P2|NOT COMPLETED|Washout||0
127560|NCT01796912|310995|P1|NOT COMPLETED|Washout||0
127561|NCT01796912|310994|P2|COMPLETED|Washout||10
127562|NCT01796912|310995|P1|COMPLETED|Washout||10
127563|NCT01796912|310994|P2|STARTED|Washout||10
127564|NCT01796912|310995|P1|STARTED|Washout||10
127565|NCT01796912|310994|P2|NOT COMPLETED|First Intervention||0
127566|NCT01796912|310995|P1|NOT COMPLETED|First Intervention||0
127567|NCT01796912|310994|P2|COMPLETED|First Intervention||10
127568|NCT01796912|310995|P1|COMPLETED|First Intervention||10
127569|NCT01796912|310994|P2|STARTED|First Intervention||10
127570|NCT01796912|310995|P1|STARTED|First Intervention||10
127571|NCT01796860|311013|P1|NOT COMPLETED|Overall Study||3
127572|NCT01796860|311013|P1|COMPLETED|Overall Study||7
127573|NCT01796860|311013|P1|STARTED|Overall Study||10
127574|NCT01796548|311019|P1|NOT COMPLETED|Overall Study||3
127575|NCT01796548|311019|P1|COMPLETED|Overall Study||14
127576|NCT01796548|311019|P1|Treated|Overall Study||15
127577|NCT01796548|311019|P1|STARTED|Overall Study||17
127578|NCT01796392|311033|P2|NOT COMPLETED|Overall Study||3
127579|NCT01796392|311034|P1|NOT COMPLETED|Overall Study||9
127580|NCT01796392|311033|P2|COMPLETED|Overall Study|59 active subjects at 12-months|59
127581|NCT01796392|311034|P1|COMPLETED|Overall Study|119 active subjects at 12-months|119
127582|NCT01796392|311033|P2|STARTED|Overall Study||62
127583|NCT01796392|311034|P1|STARTED|Overall Study||128
127584|NCT01796301|311048|P2|NOT COMPLETED|Overall Study||20
127585|NCT01796301|311049|P1|NOT COMPLETED|Overall Study||18
127586|NCT01796301|311048|P2|COMPLETED|Overall Study||198
127587|NCT01796301|311049|P1|COMPLETED|Overall Study||200
127588|NCT01796301|311048|P2|Received Treatment|Overall Study||218
127589|NCT01796301|311049|P1|Received Treatment|Overall Study||214
127590|NCT01796301|311048|P2|STARTED|Overall Study||218
127591|NCT01796301|311049|P1|STARTED|Overall Study||218
127592|NCT01796236|311085|P2|NOT COMPLETED|Overall Study||2
127593|NCT01796236|311086|P1|NOT COMPLETED|Overall Study||2
127594|NCT01796236|311085|P2|COMPLETED|Overall Study||50
127595|NCT01796236|311086|P1|COMPLETED|Overall Study||49
127596|NCT01796236|311085|P2|STARTED|Overall Study||52
127597|NCT01796236|311086|P1|STARTED|Overall Study||51
127598|NCT01795937|311135|P3|NOT COMPLETED|Overall Study||0
127599|NCT01795937|311136|P2|NOT COMPLETED|Overall Study||1
127600|NCT01795937|311137|P1|NOT COMPLETED|Overall Study||1
127601|NCT01795937|311135|P3|COMPLETED|Overall Study||17
127602|NCT01795937|311136|P2|COMPLETED|Overall Study||15
127603|NCT01795937|311137|P1|COMPLETED|Overall Study||17
127604|NCT01795937|311135|P3|STARTED|Overall Study||17
127605|NCT01795937|311136|P2|STARTED|Overall Study||16
127606|NCT01795937|311137|P1|STARTED|Overall Study||18
127607|NCT01795898|311166|P1|NOT COMPLETED|Overall Study||60
127608|NCT01795898|311166|P1|COMPLETED|Overall Study||177
127609|NCT01795898|311166|P1|STARTED|Overall Study||237
127610|NCT01795859|311176|P2|NOT COMPLETED|Overall Study||2
127611|NCT01795859|311177|P1|NOT COMPLETED|Overall Study||1
127612|NCT01795859|311176|P2|COMPLETED|Overall Study||43
127613|NCT01795859|311177|P1|COMPLETED|Overall Study||44
127614|NCT01795859|311176|P2|STARTED|Overall Study||45
127615|NCT01795859|311177|P1|STARTED|Overall Study||45
127616|NCT01795833|311195|P2|NOT COMPLETED|Overall Study||149
127617|NCT01795833|311196|P1|NOT COMPLETED|Overall Study||150
127618|NCT01795833|311195|P2|COMPLETED|Overall Study||882
127619|NCT01795833|311196|P1|COMPLETED|Overall Study||881
127620|NCT01795833|311195|P2|STARTED|Overall Study||1031
127621|NCT01795833|311196|P1|STARTED|Overall Study||1031
127622|NCT01795716|311204|P2|NOT COMPLETED|Second Intervention (13 Days)||0
127623|NCT01795716|311205|P1|NOT COMPLETED|Second Intervention (13 Days)||0
127624|NCT01795716|311204|P2|COMPLETED|Second Intervention (13 Days)||11
127625|NCT01795716|311205|P1|COMPLETED|Second Intervention (13 Days)||10
127626|NCT01795716|311204|P2|STARTED|Second Intervention (13 Days)||11
127627|NCT01795716|311205|P1|STARTED|Second Intervention (13 Days)||10
127628|NCT01795716|311204|P2|NOT COMPLETED|Washout (10 Days)||0
127629|NCT01795716|311205|P1|NOT COMPLETED|Washout (10 Days)||0
127630|NCT01795716|311204|P2|COMPLETED|Washout (10 Days)||11
127631|NCT01795716|311205|P1|COMPLETED|Washout (10 Days)||10
127632|NCT01795716|311204|P2|STARTED|Washout (10 Days)||11
127633|NCT01795716|311205|P1|STARTED|Washout (10 Days)||10
127634|NCT01795716|311204|P2|NOT COMPLETED|First Intervention (13 Days)||0
127635|NCT01795716|311205|P1|NOT COMPLETED|First Intervention (13 Days)||0
127636|NCT01795716|311204|P2|COMPLETED|First Intervention (13 Days)||11
127637|NCT01795716|311205|P1|COMPLETED|First Intervention (13 Days)||10
127638|NCT01795716|311204|P2|STARTED|First Intervention (13 Days)||11
127639|NCT01795716|311205|P1|STARTED|First Intervention (13 Days)||10
127640|NCT01795547|311213|P2|NOT COMPLETED|Overall Study||64
127641|NCT01795547|311214|P1|NOT COMPLETED|Overall Study||48
127642|NCT01795547|311213|P2|COMPLETED|Overall Study||83
127643|NCT01795547|311214|P1|COMPLETED|Overall Study||100
127644|NCT01795547|311213|P2|STARTED|Overall Study||147
127645|NCT01795547|311214|P1|STARTED|Overall Study||148
127646|NCT01795534|311236|P2|NOT COMPLETED|Second Intervention (Second Shot)||0
127647|NCT01795534|311237|P1|NOT COMPLETED|Second Intervention (Second Shot)||0
127648|NCT01795534|311236|P2|COMPLETED|Second Intervention (Second Shot)||5
127649|NCT01795534|311237|P1|COMPLETED|Second Intervention (Second Shot)||5
127650|NCT01795534|311236|P2|STARTED|Second Intervention (Second Shot)||5
127651|NCT01795534|311237|P1|STARTED|Second Intervention (Second Shot)||5
127652|NCT01795534|311236|P2|NOT COMPLETED|Wash Out Period (4 Days)||0
127653|NCT01795534|311237|P1|NOT COMPLETED|Wash Out Period (4 Days)||0
127654|NCT01795534|311236|P2|COMPLETED|Wash Out Period (4 Days)||5
127655|NCT01795534|311237|P1|COMPLETED|Wash Out Period (4 Days)||5
127656|NCT01795534|311236|P2|STARTED|Wash Out Period (4 Days)||5
127657|NCT01795534|311237|P1|STARTED|Wash Out Period (4 Days)||5
127658|NCT01795534|311236|P2|NOT COMPLETED|First Intervention (First Shot)||0
127659|NCT01795534|311237|P1|NOT COMPLETED|First Intervention (First Shot)||0
127660|NCT01795534|311236|P2|COMPLETED|First Intervention (First Shot)||5
127661|NCT01795534|311237|P1|COMPLETED|First Intervention (First Shot)||5
127662|NCT01795534|311236|P2|STARTED|First Intervention (First Shot)||5
127663|NCT01795534|311237|P1|STARTED|First Intervention (First Shot)||5
127664|NCT01795495|311246|P3|NOT COMPLETED|Overall Study||2
127665|NCT01795495|311247|P2|NOT COMPLETED|Overall Study||0
127666|NCT01795495|311248|P1|NOT COMPLETED|Overall Study||1
127667|NCT01795495|311246|P3|COMPLETED|Overall Study||19
127668|NCT01795495|311247|P2|COMPLETED|Overall Study||22
127669|NCT01795495|311248|P1|COMPLETED|Overall Study||19
127670|NCT01795495|311246|P3|STARTED|Overall Study||21
127671|NCT01795495|311247|P2|STARTED|Overall Study||22
127672|NCT01795495|311248|P1|STARTED|Overall Study||20
127673|NCT01795105|311259|P1|NOT COMPLETED|Overall Study||44
127674|NCT01795105|311259|P1|COMPLETED|Overall Study||648
127675|NCT01795105|311259|P1|STARTED|Overall Study||692
127676|NCT01794949|311268|P2|NOT COMPLETED|Overall Study||0
127677|NCT01794949|311269|P1|NOT COMPLETED|Overall Study||1
127678|NCT01794949|311268|P2|COMPLETED|Overall Study||1
127679|NCT01794949|311269|P1|COMPLETED|Overall Study||6
127680|NCT01794949|311268|P2|6 Month Follow-up|Overall Study||1
127681|NCT01794949|311269|P1|6 Month Follow-up|Overall Study||6
127682|NCT01794949|311268|P2|STARTED|Overall Study||1
127683|NCT01794949|311269|P1|STARTED|Overall Study||7
127684|NCT01794936|311275|P1|NOT COMPLETED|Overall Study||0
127685|NCT01794936|311275|P1|COMPLETED|Overall Study||9
127686|NCT01794936|311275|P1|STARTED|Overall Study||9
127687|NCT01794845|311280|P1|NOT COMPLETED|Overall Study||1
127688|NCT01794845|311280|P1|COMPLETED|Overall Study||4
127689|NCT01794845|311280|P1|STARTED|Overall Study||5
127690|NCT01794806|311289|P2|NOT COMPLETED|Overall Study||1
127691|NCT01794806|311290|P1|NOT COMPLETED|Overall Study||5
127692|NCT01794806|311289|P2|COMPLETED|Overall Study||27
127693|NCT01794806|311290|P1|COMPLETED|Overall Study||26
127694|NCT01794806|311289|P2|4 Weeks|Overall Study||27
127695|NCT01794806|311290|P1|4 Weeks|Overall Study||26
127696|NCT01794806|311289|P2|1 Week|Overall Study||28
127697|NCT01794806|311290|P1|1 Week|Overall Study||28
127698|NCT01794806|311289|P2|STARTED|Overall Study||28
127699|NCT01794806|311290|P1|STARTED|Overall Study||31
127700|NCT01794780|311308|P8|NOT COMPLETED|Overall Study||9
127701|NCT01794780|311309|P7|NOT COMPLETED|Overall Study||42
127702|NCT01794780|311310|P6|NOT COMPLETED|Overall Study||180
127703|NCT01794780|311311|P5|NOT COMPLETED|Overall Study||3
127704|NCT01794780|311312|P4|NOT COMPLETED|Overall Study||83
127705|NCT01794780|311313|P3|NOT COMPLETED|Overall Study||242
127706|NCT01794780|311314|P2|NOT COMPLETED|Overall Study||96
127707|NCT01794780|311315|P1|NOT COMPLETED|Overall Study||17
127708|NCT01794780|311308|P8|COMPLETED|Overall Study||21
127709|NCT01794780|311309|P7|COMPLETED|Overall Study||112
127710|NCT01794780|311310|P6|COMPLETED|Overall Study||452
127711|NCT01794780|311311|P5|COMPLETED|Overall Study||6
127712|NCT01794780|311312|P4|COMPLETED|Overall Study||200
127713|NCT01794780|311313|P3|COMPLETED|Overall Study||571
127714|NCT01794780|311314|P2|COMPLETED|Overall Study||180
127715|NCT01794780|311315|P1|COMPLETED|Overall Study||15
127716|NCT01794780|311308|P8|STARTED|Overall Study||30
127717|NCT01794780|311309|P7|STARTED|Overall Study||154
127718|NCT01794780|311310|P6|STARTED|Overall Study||632
127719|NCT01794780|311311|P5|STARTED|Overall Study||9
127720|NCT01794780|311312|P4|STARTED|Overall Study||283
127721|NCT01794780|311313|P3|STARTED|Overall Study||813
127722|NCT01794780|311314|P2|STARTED|Overall Study||276
127723|NCT01794780|311315|P1|STARTED|Overall Study||32
127724|NCT01794741|311365|P2|NOT COMPLETED|Overall Study||9
127725|NCT01794741|311366|P1|NOT COMPLETED|Overall Study||19
127726|NCT01794741|311365|P2|COMPLETED|Overall Study||92
127727|NCT01794741|311366|P1|COMPLETED|Overall Study||285
127728|NCT01794741|311365|P2|STARTED|Overall Study||101
127729|NCT01794741|311366|P1|STARTED|Overall Study||304
127730|NCT01794702|311375|P3|NOT COMPLETED|Overall Study||0
127731|NCT01794702|311376|P2|NOT COMPLETED|Overall Study||0
127732|NCT01794702|311377|P1|NOT COMPLETED|Overall Study||0
127733|NCT01794702|311375|P3|COMPLETED|Overall Study||47
127734|NCT01794702|311376|P2|COMPLETED|Overall Study||0
127735|NCT01794702|311377|P1|COMPLETED|Overall Study||18
127736|NCT01794702|311375|P3|STARTED|Overall Study||47
127737|NCT01794702|311376|P2|STARTED|Overall Study||0
127738|NCT01794702|311377|P1|STARTED|Overall Study||18
127739|NCT01794689|311391|P4|NOT COMPLETED|Intervention 2 (2 Nights)||0
127740|NCT01794689|311392|P3|NOT COMPLETED|Intervention 2 (2 Nights)||0
127741|NCT01794689|311393|P2|NOT COMPLETED|Intervention 2 (2 Nights)||0
127742|NCT01794689|311394|P1|NOT COMPLETED|Intervention 2 (2 Nights)||0
127743|NCT01794689|311391|P4|COMPLETED|Intervention 2 (2 Nights)||18
127744|NCT01794689|311392|P3|COMPLETED|Intervention 2 (2 Nights)||21
127745|NCT01794689|311393|P2|COMPLETED|Intervention 2 (2 Nights)||27
127746|NCT01794689|311394|P1|COMPLETED|Intervention 2 (2 Nights)||20
127747|NCT01794689|311391|P4|STARTED|Intervention 2 (2 Nights)||18
127748|NCT01794689|311392|P3|STARTED|Intervention 2 (2 Nights)||21
127749|NCT01794689|311393|P2|STARTED|Intervention 2 (2 Nights)||27
127750|NCT01794689|311394|P1|STARTED|Intervention 2 (2 Nights)||20
127751|NCT01794689|311391|P4|NOT COMPLETED|Washout (2 Weeks)||0
127752|NCT01794689|311392|P3|NOT COMPLETED|Washout (2 Weeks)||0
127753|NCT01794689|311393|P2|NOT COMPLETED|Washout (2 Weeks)||0
127754|NCT01794689|311394|P1|NOT COMPLETED|Washout (2 Weeks)||0
127755|NCT01794689|311391|P4|COMPLETED|Washout (2 Weeks)||18
127756|NCT01794689|311392|P3|COMPLETED|Washout (2 Weeks)||21
127757|NCT01794689|311393|P2|COMPLETED|Washout (2 Weeks)||27
127758|NCT01794689|311394|P1|COMPLETED|Washout (2 Weeks)||20
127759|NCT01794689|311391|P4|STARTED|Washout (2 Weeks)||18
127760|NCT01794689|311392|P3|STARTED|Washout (2 Weeks)||21
127761|NCT01794689|311393|P2|STARTED|Washout (2 Weeks)||27
127762|NCT01794689|311394|P1|STARTED|Washout (2 Weeks)||20
127763|NCT01794689|311391|P4|NOT COMPLETED|Intervention 1 (2 Nights)||4
127764|NCT01794689|311392|P3|NOT COMPLETED|Intervention 1 (2 Nights)||3
127765|NCT01794689|311393|P2|NOT COMPLETED|Intervention 1 (2 Nights)||2
127766|NCT01794689|311394|P1|NOT COMPLETED|Intervention 1 (2 Nights)||5
127767|NCT01794689|311391|P4|COMPLETED|Intervention 1 (2 Nights)||18
127768|NCT01794689|311392|P3|COMPLETED|Intervention 1 (2 Nights)||21
127769|NCT01794689|311393|P2|COMPLETED|Intervention 1 (2 Nights)||27
127770|NCT01794689|311394|P1|COMPLETED|Intervention 1 (2 Nights)||20
127771|NCT01794689|311391|P4|STARTED|Intervention 1 (2 Nights)||22
127772|NCT01794689|311392|P3|STARTED|Intervention 1 (2 Nights)||24
127773|NCT01794689|311393|P2|STARTED|Intervention 1 (2 Nights)||29
127774|NCT01794689|311394|P1|STARTED|Intervention 1 (2 Nights)||25
127775|NCT01794455|311418|P2|NOT COMPLETED|Overall Study||0
127776|NCT01794455|311419|P1|NOT COMPLETED|Overall Study||0
127777|NCT01794455|311418|P2|COMPLETED|Overall Study||1
127778|NCT01794455|311419|P1|COMPLETED|Overall Study||0
127779|NCT01794455|311418|P2|STARTED|Overall Study||1
127780|NCT01794455|311419|P1|STARTED|Overall Study||0
127781|NCT01794312|311437|P2|NOT COMPLETED|Overall Study||11
127782|NCT01794312|311438|P1|NOT COMPLETED|Overall Study||6
127783|NCT01794312|311437|P2|COMPLETED|Overall Study||67
127784|NCT01794312|311438|P1|COMPLETED|Overall Study||68
127785|NCT01794312|311437|P2|STARTED|Overall Study||78
127786|NCT01794312|311438|P1|STARTED|Overall Study||74
127787|NCT01794039|311450|P2|NOT COMPLETED|Overall Study||0
127788|NCT01794039|311451|P1|NOT COMPLETED|Overall Study||0
127789|NCT01794039|311450|P2|COMPLETED|Overall Study||4
127790|NCT01794039|311451|P1|COMPLETED|Overall Study||5
127791|NCT01794039|311450|P2|STARTED|Overall Study||4
127792|NCT01794039|311451|P1|STARTED|Overall Study||5
127793|NCT01794000|311463|P2|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
127794|NCT01794000|311464|P1|NOT COMPLETED|Open-Label Extension Phase (OLE)||3
127795|NCT01794000|311463|P2|COMPLETED|Open-Label Extension Phase (OLE)||0
127796|NCT01794000|311464|P1|COMPLETED|Open-Label Extension Phase (OLE)||0
127797|NCT01794000|311463|P2|STARTED|Open-Label Extension Phase (OLE)|Placebo arm was not applicable to Open-Label Extension Phase|0
127798|NCT01794000|311464|P1|STARTED|Open-Label Extension Phase (OLE)|Pts. who had not permanently discontinued study drug and concluded DBP were eligible to enter OLE|3
127799|NCT01794000|311463|P2|NOT COMPLETED|Double-Blind Phase (DBP)||166
127800|NCT01794000|311464|P1|NOT COMPLETED|Double-Blind Phase (DBP)||169
127801|NCT01794000|311463|P2|COMPLETED|Double-Blind Phase (DBP)||4
127802|NCT01794000|311464|P1|COMPLETED|Double-Blind Phase (DBP)||2
127803|NCT01794000|311463|P2|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||166
127804|NCT01794000|311464|P1|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||169
127805|NCT01794000|311463|P2|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
127806|NCT01794000|311464|P1|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
127807|NCT01794000|311463|P2|STARTED|Double-Blind Phase (DBP)||170
127808|NCT01794000|311464|P1|STARTED|Double-Blind Phase (DBP)||171
127809|NCT01793935|311497|P2|NOT COMPLETED|Overall Study||3
127810|NCT01793935|311498|P1|NOT COMPLETED|Overall Study||6
127811|NCT01793935|311497|P2|COMPLETED|Overall Study||31
127812|NCT01793935|311498|P1|COMPLETED|Overall Study||28
127813|NCT01793935|311497|P2|STARTED|Overall Study||34
127814|NCT01793935|311498|P1|STARTED|Overall Study||34
127815|NCT01793909|311534|P2|NOT COMPLETED|Overall Study||5
127816|NCT01793909|311535|P1|NOT COMPLETED|Overall Study||10
127817|NCT01793909|311534|P2|COMPLETED|Overall Study||20
127818|NCT01793909|311535|P1|COMPLETED|Overall Study||20
127819|NCT01793909|311534|P2|STARTED|Overall Study||25
127820|NCT01793909|311535|P1|STARTED|Overall Study||30
127821|NCT01793883|311544|P3|NOT COMPLETED|Overall Study||8
127822|NCT01793883|311545|P2|NOT COMPLETED|Overall Study||10
127823|NCT01793883|311546|P1|NOT COMPLETED|Overall Study||12
127824|NCT01793883|311544|P3|COMPLETED|Overall Study||204
127825|NCT01793883|311545|P2|COMPLETED|Overall Study||204
127826|NCT01793883|311546|P1|COMPLETED|Overall Study||201
127827|NCT01793883|311544|P3|STARTED|Overall Study||212
127828|NCT01793883|311545|P2|STARTED|Overall Study||214
127829|NCT01793883|311546|P1|STARTED|Overall Study||213
127830|NCT01793792|311554|P1|NOT COMPLETED|Overall Study||12
127831|NCT01793792|311554|P1|COMPLETED|Overall Study||141
127832|NCT01793792|311554|P1|Treated|Overall Study|153 Treated, 152 implanted with device, 1 attempted no device implanted|153
127833|NCT01793792|311554|P1|STARTED|Overall Study|153 treated: 1 attempted no device implanted, 152 device implanted.|153
127834|NCT01793688|311559|P1|NOT COMPLETED|Overall Study||2
127835|NCT01793688|311559|P1|COMPLETED|Overall Study||980
127836|NCT01793688|311559|P1|STARTED|Overall Study||982
127837|NCT01793285|311566|P1|NOT COMPLETED|Overall Study||0
127838|NCT01793285|311566|P1|COMPLETED|Overall Study||85
127839|NCT01793285|311566|P1|STARTED|Overall Study||85
127840|NCT01793142|311586|P1|NOT COMPLETED|Overall Study||7
127841|NCT01793142|311586|P1|COMPLETED|Overall Study||3423
127842|NCT01793142|311586|P1|Treated|Overall Study||3423
127843|NCT01793142|311586|P1|STARTED|Overall Study||3430
127844|NCT01792986|311597|P1|NOT COMPLETED|Overall Study||0
127845|NCT01792986|311597|P1|COMPLETED|Overall Study||12
127846|NCT01792986|311597|P1|STARTED|Overall Study||12
127847|NCT01792830|311616|P11|NOT COMPLETED|Overall Study||3
127848|NCT01792830|311617|P10|NOT COMPLETED|Overall Study||0
127849|NCT01792830|311618|P9|NOT COMPLETED|Overall Study||9
127850|NCT01792830|311619|P8|NOT COMPLETED|Overall Study||1
127851|NCT01792830|311620|P7|NOT COMPLETED|Overall Study||2
127852|NCT01792830|311621|P6|NOT COMPLETED|Overall Study||1
127853|NCT01792830|311622|P5|NOT COMPLETED|Overall Study||1
127854|NCT01792830|311623|P4|NOT COMPLETED|Overall Study||3
127855|NCT01792830|311624|P3|NOT COMPLETED|Overall Study||0
127856|NCT01792830|311625|P2|NOT COMPLETED|Overall Study||0
127857|NCT01792830|311626|P1|NOT COMPLETED|Overall Study||25
127858|NCT01792830|311616|P11|COMPLETED|Overall Study||9
127859|NCT01792830|311617|P10|COMPLETED|Overall Study||4
127860|NCT01792830|311618|P9|COMPLETED|Overall Study||11
127861|NCT01792830|311619|P8|COMPLETED|Overall Study||6
127862|NCT01792830|311620|P7|COMPLETED|Overall Study||12
127863|NCT01792830|311621|P6|COMPLETED|Overall Study||3
127864|NCT01792830|311622|P5|COMPLETED|Overall Study||1
127865|NCT01792830|311623|P4|COMPLETED|Overall Study||18
127866|NCT01792830|311624|P3|COMPLETED|Overall Study||4
127867|NCT01792830|311625|P2|COMPLETED|Overall Study||3
127868|NCT01792830|311626|P1|COMPLETED|Overall Study||59
127869|NCT01792830|311616|P11|STARTED|Overall Study||12
127870|NCT01792830|311617|P10|STARTED|Overall Study||4
127871|NCT01792830|311618|P9|STARTED|Overall Study||20
127872|NCT01792830|311619|P8|STARTED|Overall Study||7
127873|NCT01792830|311620|P7|STARTED|Overall Study||14
127874|NCT01792830|311621|P6|STARTED|Overall Study||4
127875|NCT01792830|311622|P5|STARTED|Overall Study||2
127876|NCT01792830|311623|P4|STARTED|Overall Study||21
127877|NCT01792830|311624|P3|STARTED|Overall Study||4
127878|NCT01792830|311625|P2|STARTED|Overall Study||3
127879|NCT01792830|311626|P1|STARTED|Overall Study||84
127880|NCT01792817|311695|P3|NOT COMPLETED|Phase 2 Open Label||26
127881|NCT01792817|311696|P2|NOT COMPLETED|Phase 2 Open Label||0
127882|NCT01792817|311697|P1|NOT COMPLETED|Phase 2 Open Label||0
127883|NCT01792817|311695|P3|COMPLETED|Phase 2 Open Label||74
127884|NCT01792817|311696|P2|COMPLETED|Phase 2 Open Label||0
127885|NCT01792817|311697|P1|COMPLETED|Phase 2 Open Label||0
127886|NCT01792817|311695|P3|STARTED|Phase 2 Open Label||100
127887|NCT01792817|311696|P2|STARTED|Phase 2 Open Label||0
127888|NCT01792817|311697|P1|STARTED|Phase 2 Open Label||0
127889|NCT01792817|311695|P3|NOT COMPLETED|Phase 1 Double Blind Period||0
127890|NCT01792817|311696|P2|NOT COMPLETED|Phase 1 Double Blind Period||31
127891|NCT01792817|311697|P1|NOT COMPLETED|Phase 1 Double Blind Period||19
127892|NCT01792817|311695|P3|COMPLETED|Phase 1 Double Blind Period||0
127893|NCT01792817|311696|P2|COMPLETED|Phase 1 Double Blind Period||42
127894|NCT01792817|311697|P1|COMPLETED|Phase 1 Double Blind Period||58
127895|NCT01792817|311695|P3|STARTED|Phase 1 Double Blind Period||0
127896|NCT01792817|311696|P2|STARTED|Phase 1 Double Blind Period||73
127897|NCT01792817|311697|P1|STARTED|Phase 1 Double Blind Period||77
127898|NCT01792635|311713|P3|NOT COMPLETED|Part B||4
127899|NCT01792635|311714|P2|NOT COMPLETED|Part B||4
127900|NCT01792635|311715|P1|NOT COMPLETED|Part B||0
127901|NCT01792635|311713|P3|COMPLETED|Part B||3
127902|NCT01792635|311714|P2|COMPLETED|Part B||2
127903|NCT01792635|311715|P1|COMPLETED|Part B||0
127904|NCT01792635|311713|P3|STARTED|Part B||7
127905|NCT01792635|311714|P2|STARTED|Part B||6
127906|NCT01792635|311715|P1|STARTED|Part B||0
127907|NCT01792635|311713|P3|NOT COMPLETED|Part A||0
127908|NCT01792635|311714|P2|NOT COMPLETED|Part A||0
127909|NCT01792635|311715|P1|NOT COMPLETED|Part A||0
127910|NCT01792635|311713|P3|COMPLETED|Part A||0
127911|NCT01792635|311714|P2|COMPLETED|Part A||0
127912|NCT01792635|311715|P1|COMPLETED|Part A||6
127913|NCT01792635|311713|P3|STARTED|Part A||0
127914|NCT01792635|311714|P2|STARTED|Part A||0
127915|NCT01792635|311715|P1|STARTED|Part A||6
127916|NCT01792518|311743|P2|NOT COMPLETED|Overall Study||7
127917|NCT01792518|311744|P1|NOT COMPLETED|Overall Study||8
127918|NCT01792518|311743|P2|COMPLETED|Overall Study||175
127919|NCT01792518|311744|P1|COMPLETED|Overall Study||170
127920|NCT01792518|311743|P2|STARTED|Overall Study||182
127921|NCT01792518|311744|P1|STARTED|Overall Study||178
127922|NCT01792284|311754|P3|NOT COMPLETED|Randomization Period 2||0
127923|NCT01792284|311755|P2|NOT COMPLETED|Randomization Period 2||3
127924|NCT01792284|311756|P1|NOT COMPLETED|Randomization Period 2||0
127925|NCT01792284|311754|P3|COMPLETED|Randomization Period 2||85
127926|NCT01792284|311755|P2|COMPLETED|Randomization Period 2||87
127927|NCT01792284|311756|P1|COMPLETED|Randomization Period 2||0
127928|NCT01792284|311754|P3|Received at Least 1 Dose of Study Drug|Randomization Period 2||85
127929|NCT01792284|311755|P2|Received at Least 1 Dose of Study Drug|Randomization Period 2||90
127930|NCT01792284|311756|P1|Received at Least 1 Dose of Study Drug|Randomization Period 2||0
127931|NCT01792284|311754|P3|STARTED|Randomization Period 2||85
127932|NCT01792284|311755|P2|STARTED|Randomization Period 2||90
127933|NCT01792284|311756|P1|STARTED|Randomization Period 2||0
127934|NCT01792284|311754|P3|NOT COMPLETED|Randomization Period 1||5
127935|NCT01792284|311755|P2|NOT COMPLETED|Randomization Period 1||2
127936|NCT01792284|311756|P1|NOT COMPLETED|Randomization Period 1||0
127937|NCT01792284|311754|P3|COMPLETED|Randomization Period 1||85
127938|NCT01792284|311755|P2|COMPLETED|Randomization Period 1||90
127939|NCT01792284|311756|P1|COMPLETED|Randomization Period 1||0
127940|NCT01792284|311754|P3|Received at Least 1 Dose of Study Drug|Randomization Period 1||90
127941|NCT01792284|311755|P2|Received at Least 1 Dose of Study Drug|Randomization Period 1||92
127942|NCT01792284|311756|P1|Received at Least 1 Dose of Study Drug|Randomization Period 1||0
127943|NCT01792284|311754|P3|STARTED|Randomization Period 1||90
127944|NCT01792284|311755|P2|STARTED|Randomization Period 1||92
127945|NCT01792284|311756|P1|STARTED|Randomization Period 1||0
127946|NCT01792284|311754|P3|NOT COMPLETED|Lead-in Period||0
127947|NCT01792284|311755|P2|NOT COMPLETED|Lead-in Period||0
127948|NCT01792284|311756|P1|NOT COMPLETED|Lead-in Period||30
127949|NCT01792284|311754|P3|COMPLETED|Lead-in Period||0
127950|NCT01792284|311755|P2|COMPLETED|Lead-in Period||0
127951|NCT01792284|311756|P1|COMPLETED|Lead-in Period|Participants that completed the Lead-in Period were randomized and entered Randomization Period 1.|182
127952|NCT01792284|311754|P3|STARTED|Lead-in Period||0
127953|NCT01792284|311755|P2|STARTED|Lead-in Period||0
127954|NCT01792284|311756|P1|STARTED|Lead-in Period||212
127955|NCT01792024|311794|P1|NOT COMPLETED|Overall Study||0
127956|NCT01792024|311794|P1|COMPLETED|Overall Study||27
127957|NCT01792024|311794|P1|STARTED|Overall Study||27
127958|NCT01791972|311804|P2|NOT COMPLETED|Overall Study||0
127959|NCT01791972|311805|P1|NOT COMPLETED|Overall Study||0
127960|NCT01791972|311804|P2|COMPLETED|Overall Study||19
127961|NCT01791972|311805|P1|COMPLETED|Overall Study||19
127962|NCT01791972|311804|P2|STARTED|Overall Study||19
127963|NCT01791972|311805|P1|STARTED|Overall Study||19
127964|NCT01791894|311815|P1|NOT COMPLETED|Overall Study||1
127965|NCT01791894|311815|P1|COMPLETED|Overall Study||4
127966|NCT01791894|311815|P1|STARTED|Overall Study||5
127967|NCT01791803|311826|P4|NOT COMPLETED|Overall Study||5
127968|NCT01791803|311827|P3|NOT COMPLETED|Overall Study||2
127969|NCT01791803|311828|P2|NOT COMPLETED|Overall Study||2
127970|NCT01791803|311829|P1|NOT COMPLETED|Overall Study||0
127971|NCT01791803|311826|P4|COMPLETED|Overall Study||37
127972|NCT01791803|311827|P3|COMPLETED|Overall Study||38
127973|NCT01791803|311828|P2|COMPLETED|Overall Study||39
127974|NCT01791803|311829|P1|COMPLETED|Overall Study||41
127975|NCT01791803|311826|P4|STARTED|Overall Study||42
127976|NCT01791803|311827|P3|STARTED|Overall Study||40
127977|NCT01791803|311828|P2|STARTED|Overall Study||41
127978|NCT01791803|311829|P1|STARTED|Overall Study||41
127979|NCT01791725|311847|P3|NOT COMPLETED|Overall Study||0
127980|NCT01791725|311848|P2|NOT COMPLETED|Overall Study||1
127981|NCT01791725|311849|P1|NOT COMPLETED|Overall Study||0
127982|NCT01791725|311847|P3|COMPLETED|Overall Study||6
127983|NCT01791725|311848|P2|COMPLETED|Overall Study||4
127984|NCT01791725|311849|P1|COMPLETED|Overall Study||12
127985|NCT01791725|311847|P3|STARTED|Overall Study||6
127986|NCT01791725|311848|P2|STARTED|Overall Study||5
127987|NCT01791725|311849|P1|STARTED|Overall Study||12
127988|NCT01791517|311872|P12|NOT COMPLETED|Phase II||1
127989|NCT01791517|311873|P11|NOT COMPLETED|Phase II||1
127990|NCT01791517|311874|P10|NOT COMPLETED|Phase II||3
127991|NCT01791517|311875|P9|NOT COMPLETED|Phase II||2
127992|NCT01791517|311876|P8|NOT COMPLETED|Phase II||3
127993|NCT01791517|311877|P7|NOT COMPLETED|Phase II||2
127994|NCT01791517|311878|P6|NOT COMPLETED|Phase II||4
127995|NCT01791517|311879|P5|NOT COMPLETED|Phase II||2
127996|NCT01791517|311880|P4|NOT COMPLETED|Phase II||0
127997|NCT01791517|311881|P3|NOT COMPLETED|Phase II||1
127998|NCT01791517|311882|P2|NOT COMPLETED|Phase II||0
127999|NCT01791517|311883|P1|NOT COMPLETED|Phase II||2
128000|NCT01791517|311872|P12|COMPLETED|Phase II||17
128001|NCT01791517|311873|P11|COMPLETED|Phase II||15
128002|NCT01791517|311874|P10|COMPLETED|Phase II||15
128003|NCT01791517|311875|P9|COMPLETED|Phase II||17
128004|NCT01791517|311876|P8|COMPLETED|Phase II||17
128005|NCT01791517|311877|P7|COMPLETED|Phase II||17
128006|NCT01791517|311878|P6|COMPLETED|Phase II||14
128007|NCT01791517|311879|P5|COMPLETED|Phase II||16
128008|NCT01791517|311880|P4|COMPLETED|Phase II||15
128009|NCT01791517|311881|P3|COMPLETED|Phase II||15
128010|NCT01791517|311882|P2|COMPLETED|Phase II||14
128011|NCT01791517|311883|P1|COMPLETED|Phase II||15
128012|NCT01791517|311872|P12|STARTED|Phase II||18
128013|NCT01791517|311873|P11|STARTED|Phase II||16
128014|NCT01791517|311874|P10|STARTED|Phase II||18
128015|NCT01791517|311875|P9|STARTED|Phase II||19
128016|NCT01791517|311876|P8|STARTED|Phase II||20
128017|NCT01791517|311877|P7|STARTED|Phase II||19
128018|NCT01791517|311878|P6|STARTED|Phase II||18
128019|NCT01791517|311879|P5|STARTED|Phase II||18
128020|NCT01791517|311880|P4|STARTED|Phase II||15
128021|NCT01791517|311881|P3|STARTED|Phase II||16
128022|NCT01791517|311882|P2|STARTED|Phase II||14
128023|NCT01791517|311883|P1|STARTED|Phase II||17
128024|NCT01791517|311872|P12|NOT COMPLETED|Phase I: Period 4||0
128025|NCT01791517|311873|P11|NOT COMPLETED|Phase I: Period 4||0
128026|NCT01791517|311874|P10|NOT COMPLETED|Phase I: Period 4||0
128027|NCT01791517|311875|P9|NOT COMPLETED|Phase I: Period 4||0
128028|NCT01791517|311876|P8|NOT COMPLETED|Phase I: Period 4||0
128029|NCT01791517|311877|P7|NOT COMPLETED|Phase I: Period 4||0
128030|NCT01791517|311878|P6|NOT COMPLETED|Phase I: Period 4||0
128031|NCT01791517|311879|P5|NOT COMPLETED|Phase I: Period 4||0
128032|NCT01791517|311880|P4|NOT COMPLETED|Phase I: Period 4||0
128033|NCT01791517|311881|P3|NOT COMPLETED|Phase I: Period 4||0
128034|NCT01791517|311882|P2|NOT COMPLETED|Phase I: Period 4||0
128035|NCT01791517|311883|P1|NOT COMPLETED|Phase I: Period 4||0
128036|NCT01791517|311872|P12|COMPLETED|Phase I: Period 4||18
128037|NCT01791517|311873|P11|COMPLETED|Phase I: Period 4||16
128038|NCT01791517|311874|P10|COMPLETED|Phase I: Period 4||18
128039|NCT01791517|311875|P9|COMPLETED|Phase I: Period 4||19
128040|NCT01791517|311876|P8|COMPLETED|Phase I: Period 4||20
128041|NCT01791517|311877|P7|COMPLETED|Phase I: Period 4||19
128042|NCT01791517|311878|P6|COMPLETED|Phase I: Period 4||18
128043|NCT01791517|311879|P5|COMPLETED|Phase I: Period 4||18
128044|NCT01791517|311880|P4|COMPLETED|Phase I: Period 4||15
128045|NCT01791517|311881|P3|COMPLETED|Phase I: Period 4||16
128046|NCT01791517|311882|P2|COMPLETED|Phase I: Period 4||14
128047|NCT01791517|311883|P1|COMPLETED|Phase I: Period 4||17
128048|NCT01791517|311872|P12|STARTED|Phase I: Period 4||18
128049|NCT01791517|311873|P11|STARTED|Phase I: Period 4||16
128050|NCT01791517|311874|P10|STARTED|Phase I: Period 4||18
128051|NCT01791517|311875|P9|STARTED|Phase I: Period 4||19
128052|NCT01791517|311876|P8|STARTED|Phase I: Period 4||20
128053|NCT01791517|311877|P7|STARTED|Phase I: Period 4||19
128054|NCT01791517|311878|P6|STARTED|Phase I: Period 4||18
128055|NCT01791517|311879|P5|STARTED|Phase I: Period 4||18
128056|NCT01791517|311880|P4|STARTED|Phase I: Period 4||15
128057|NCT01791517|311881|P3|STARTED|Phase I: Period 4||16
128058|NCT01791517|311882|P2|STARTED|Phase I: Period 4||14
128059|NCT01791517|311883|P1|STARTED|Phase I: Period 4||17
128060|NCT01791517|311872|P12|NOT COMPLETED|Phase I: Period 3||1
128061|NCT01791517|311873|P11|NOT COMPLETED|Phase I: Period 3||0
128062|NCT01791517|311874|P10|NOT COMPLETED|Phase I: Period 3||0
128063|NCT01791517|311875|P9|NOT COMPLETED|Phase I: Period 3||0
128064|NCT01791517|311876|P8|NOT COMPLETED|Phase I: Period 3||0
128065|NCT01791517|311877|P7|NOT COMPLETED|Phase I: Period 3||0
128066|NCT01791517|311878|P6|NOT COMPLETED|Phase I: Period 3||0
128067|NCT01791517|311879|P5|NOT COMPLETED|Phase I: Period 3||1
128068|NCT01791517|311880|P4|NOT COMPLETED|Phase I: Period 3||1
128069|NCT01791517|311881|P3|NOT COMPLETED|Phase I: Period 3||0
128070|NCT01791517|311882|P2|NOT COMPLETED|Phase I: Period 3||1
128071|NCT01791517|311883|P1|NOT COMPLETED|Phase I: Period 3||0
128072|NCT01791517|311872|P12|COMPLETED|Phase I: Period 3||18
128073|NCT01791517|311873|P11|COMPLETED|Phase I: Period 3||16
128074|NCT01791517|311874|P10|COMPLETED|Phase I: Period 3||18
128075|NCT01791517|311875|P9|COMPLETED|Phase I: Period 3||19
128076|NCT01791517|311876|P8|COMPLETED|Phase I: Period 3||20
128077|NCT01791517|311877|P7|COMPLETED|Phase I: Period 3||19
128078|NCT01791517|311878|P6|COMPLETED|Phase I: Period 3||18
128079|NCT01791517|311879|P5|COMPLETED|Phase I: Period 3||18
128080|NCT01791517|311880|P4|COMPLETED|Phase I: Period 3||15
128081|NCT01791517|311881|P3|COMPLETED|Phase I: Period 3||16
128082|NCT01791517|311882|P2|COMPLETED|Phase I: Period 3||14
128083|NCT01791517|311883|P1|COMPLETED|Phase I: Period 3||17
128084|NCT01791517|311872|P12|STARTED|Phase I: Period 3||19
128085|NCT01791517|311873|P11|STARTED|Phase I: Period 3||16
128086|NCT01791517|311874|P10|STARTED|Phase I: Period 3||18
128087|NCT01791517|311875|P9|STARTED|Phase I: Period 3||19
128088|NCT01791517|311876|P8|STARTED|Phase I: Period 3||20
128089|NCT01791517|311877|P7|STARTED|Phase I: Period 3||19
128090|NCT01791517|311878|P6|STARTED|Phase I: Period 3||18
128091|NCT01791517|311879|P5|STARTED|Phase I: Period 3||19
128092|NCT01791517|311880|P4|STARTED|Phase I: Period 3||16
128093|NCT01791517|311881|P3|STARTED|Phase I: Period 3||16
128094|NCT01791517|311882|P2|STARTED|Phase I: Period 3||15
128095|NCT01791517|311883|P1|STARTED|Phase I: Period 3||17
128096|NCT01791517|311872|P12|NOT COMPLETED|Phase I: Period 2||0
128097|NCT01791517|311873|P11|NOT COMPLETED|Phase I: Period 2||2
128098|NCT01791517|311874|P10|NOT COMPLETED|Phase I: Period 2||1
128099|NCT01791517|311875|P9|NOT COMPLETED|Phase I: Period 2||0
128100|NCT01791517|311876|P8|NOT COMPLETED|Phase I: Period 2||0
128101|NCT01791517|311877|P7|NOT COMPLETED|Phase I: Period 2||0
128102|NCT01791517|311878|P6|NOT COMPLETED|Phase I: Period 2||1
128103|NCT01791517|311879|P5|NOT COMPLETED|Phase I: Period 2||0
128104|NCT01791517|311880|P4|NOT COMPLETED|Phase I: Period 2||1
128105|NCT01791517|311881|P3|NOT COMPLETED|Phase I: Period 2||2
128106|NCT01791517|311882|P2|NOT COMPLETED|Phase I: Period 2||3
128107|NCT01791517|311883|P1|NOT COMPLETED|Phase I: Period 2||1
128108|NCT01791517|311872|P12|COMPLETED|Phase I: Period 2||19
128109|NCT01791517|311873|P11|COMPLETED|Phase I: Period 2||16
128110|NCT01791517|311874|P10|COMPLETED|Phase I: Period 2||18
128111|NCT01791517|311875|P9|COMPLETED|Phase I: Period 2||19
128112|NCT01791517|311876|P8|COMPLETED|Phase I: Period 2||20
128113|NCT01791517|311877|P7|COMPLETED|Phase I: Period 2||19
128114|NCT01791517|311878|P6|COMPLETED|Phase I: Period 2||18
128115|NCT01791517|311879|P5|COMPLETED|Phase I: Period 2||19
128116|NCT01791517|311880|P4|COMPLETED|Phase I: Period 2||16
128117|NCT01791517|311881|P3|COMPLETED|Phase I: Period 2||16
128118|NCT01791517|311882|P2|COMPLETED|Phase I: Period 2||15
128119|NCT01791517|311883|P1|COMPLETED|Phase I: Period 2||17
128120|NCT01791517|311872|P12|STARTED|Phase I: Period 2||19
128121|NCT01791517|311873|P11|STARTED|Phase I: Period 2||18
128122|NCT01791517|311874|P10|STARTED|Phase I: Period 2||19
128123|NCT01791517|311875|P9|STARTED|Phase I: Period 2||19
128124|NCT01791517|311876|P8|STARTED|Phase I: Period 2||20
128125|NCT01791517|311877|P7|STARTED|Phase I: Period 2||19
128126|NCT01791517|311878|P6|STARTED|Phase I: Period 2||19
128127|NCT01791517|311879|P5|STARTED|Phase I: Period 2||19
128128|NCT01791517|311880|P4|STARTED|Phase I: Period 2||17
128129|NCT01791517|311881|P3|STARTED|Phase I: Period 2||18
128130|NCT01791517|311882|P2|STARTED|Phase I: Period 2||18
128131|NCT01791517|311883|P1|STARTED|Phase I: Period 2||18
128132|NCT01791517|311872|P12|NOT COMPLETED|Phase I: Period 1||1
128133|NCT01791517|311873|P11|NOT COMPLETED|Phase I: Period 1||0
128134|NCT01791517|311874|P10|NOT COMPLETED|Phase I: Period 1||1
128135|NCT01791517|311875|P9|NOT COMPLETED|Phase I: Period 1||1
128136|NCT01791517|311876|P8|NOT COMPLETED|Phase I: Period 1||0
128137|NCT01791517|311877|P7|NOT COMPLETED|Phase I: Period 1||1
128138|NCT01791517|311878|P6|NOT COMPLETED|Phase I: Period 1||1
128139|NCT01791517|311879|P5|NOT COMPLETED|Phase I: Period 1||1
128140|NCT01791517|311880|P4|NOT COMPLETED|Phase I: Period 1||2
128141|NCT01791517|311881|P3|NOT COMPLETED|Phase I: Period 1||2
128142|NCT01791517|311882|P2|NOT COMPLETED|Phase I: Period 1||2
128143|NCT01791517|311883|P1|NOT COMPLETED|Phase I: Period 1||1
128144|NCT01791517|311872|P12|COMPLETED|Phase I: Period 1||19
128145|NCT01791517|311873|P11|COMPLETED|Phase I: Period 1||18
128146|NCT01791517|311874|P10|COMPLETED|Phase I: Period 1||19
128147|NCT01791517|311875|P9|COMPLETED|Phase I: Period 1||19
128148|NCT01791517|311876|P8|COMPLETED|Phase I: Period 1||20
128149|NCT01791517|311877|P7|COMPLETED|Phase I: Period 1||19
128150|NCT01791517|311878|P6|COMPLETED|Phase I: Period 1||19
128151|NCT01791517|311879|P5|COMPLETED|Phase I: Period 1||19
128152|NCT01791517|311880|P4|COMPLETED|Phase I: Period 1||17
128153|NCT01791517|311881|P3|COMPLETED|Phase I: Period 1||18
128154|NCT01791517|311882|P2|COMPLETED|Phase I: Period 1||18
128155|NCT01791517|311883|P1|COMPLETED|Phase I: Period 1||18
128156|NCT01791517|311872|P12|STARTED|Phase I: Period 1||20
128157|NCT01791517|311873|P11|STARTED|Phase I: Period 1||18
128158|NCT01791517|311874|P10|STARTED|Phase I: Period 1||20
128159|NCT01791517|311875|P9|STARTED|Phase I: Period 1||20
128160|NCT01791517|311876|P8|STARTED|Phase I: Period 1||20
128161|NCT01791517|311877|P7|STARTED|Phase I: Period 1||20
128162|NCT01791517|311878|P6|STARTED|Phase I: Period 1||20
128163|NCT01791517|311879|P5|STARTED|Phase I: Period 1||20
128164|NCT01791517|311880|P4|STARTED|Phase I: Period 1||19
128165|NCT01791517|311881|P3|STARTED|Phase I: Period 1||20
128166|NCT01791517|311882|P2|STARTED|Phase I: Period 1||20
128167|NCT01791517|311883|P1|STARTED|Phase I: Period 1||19
128168|NCT01791491|311909|P1|NOT COMPLETED|Overall Study||0
128169|NCT01791491|311909|P1|COMPLETED|Overall Study||9
128170|NCT01791491|311909|P1|STARTED|Overall Study|Reasons for enrollment and non-treatment: 1 withdrew consent and 6 no longer met study criteria.|9
128171|NCT01791465|311921|P1|NOT COMPLETED|Overall Study||0
128172|NCT01791465|311921|P1|COMPLETED|Overall Study||6
128173|NCT01791465|311921|P1|STARTED|Overall Study||6
128174|NCT01791413|311947|P2|NOT COMPLETED|Overall Study||1
128175|NCT01791413|311948|P1|NOT COMPLETED|Overall Study||5
128176|NCT01791413|311947|P2|COMPLETED|Overall Study||19
128177|NCT01791413|311948|P1|COMPLETED|Overall Study||15
128178|NCT01791413|311947|P2|STARTED|Overall Study||20
128179|NCT01791413|311948|P1|STARTED|Overall Study||20
128180|NCT01791244|311957|P2|NOT COMPLETED|Overall Study||18
128181|NCT01791244|311958|P1|NOT COMPLETED|Overall Study||15
128182|NCT01791244|311957|P2|COMPLETED|Overall Study||29
128183|NCT01791244|311958|P1|COMPLETED|Overall Study||31
128184|NCT01791244|311957|P2|Intent to Treat (ITT)|Overall Study||39
128185|NCT01791244|311958|P1|Intent to Treat (ITT)|Overall Study||38
128186|NCT01791244|311957|P2|STARTED|Overall Study||47
128187|NCT01791244|311958|P1|STARTED|Overall Study||46
128188|NCT01791205|311994|P2|NOT COMPLETED|Phase II||0
128189|NCT01791205|311995|P1|NOT COMPLETED|Phase II||12
128190|NCT01791205|311994|P2|COMPLETED|Phase II||0
128191|NCT01791205|311995|P1|COMPLETED|Phase II||92
128192|NCT01791205|311994|P2|STARTED|Phase II||0
128193|NCT01791205|311995|P1|STARTED|Phase II|Participants who received tocilizumab monotherapy in Phase I was observed in Phase II.|104
128194|NCT01791205|311994|P2|NOT COMPLETED|Phase I||0
128195|NCT01791205|311995|P1|NOT COMPLETED|Phase I||0
128196|NCT01791205|311994|P2|COMPLETED|Phase I||152
128197|NCT01791205|311995|P1|COMPLETED|Phase I||152
128198|NCT01791205|311994|P2|STARTED|Phase I||152
128199|NCT01791205|311995|P1|STARTED|Phase I||152
128200|NCT01791153|312079|P8|NOT COMPLETED|Part 2: Open-label Period||6
128201|NCT01791153|312080|P7|NOT COMPLETED|Part 2: Open-label Period||6
128202|NCT01791153|312081|P6|NOT COMPLETED|Part 2: Open-label Period||4
128203|NCT01791153|312082|P5|NOT COMPLETED|Part 2: Open-label Period||2
128204|NCT01791153|312083|P4|NOT COMPLETED|Part 2: Open-label Period||0
128205|NCT01791153|312084|P3|NOT COMPLETED|Part 2: Open-label Period||0
128206|NCT01791153|312085|P2|NOT COMPLETED|Part 2: Open-label Period||0
128207|NCT01791153|312086|P1|NOT COMPLETED|Part 2: Open-label Period||0
128208|NCT01791153|312079|P8|COMPLETED|Part 2: Open-label Period||61
128209|NCT01791153|312080|P7|COMPLETED|Part 2: Open-label Period||44
128210|NCT01791153|312081|P6|COMPLETED|Part 2: Open-label Period||54
128211|NCT01791153|312082|P5|COMPLETED|Part 2: Open-label Period||38
128212|NCT01791153|312083|P4|COMPLETED|Part 2: Open-label Period||0
128213|NCT01791153|312084|P3|COMPLETED|Part 2: Open-label Period||0
128214|NCT01791153|312085|P2|COMPLETED|Part 2: Open-label Period||0
128215|NCT01791153|312086|P1|COMPLETED|Part 2: Open-label Period||0
128216|NCT01791153|312079|P8|STARTED|Part 2: Open-label Period||67
128217|NCT01791153|312080|P7|STARTED|Part 2: Open-label Period||50
128218|NCT01791153|312081|P6|STARTED|Part 2: Open-label Period||58
128219|NCT01791153|312082|P5|STARTED|Part 2: Open-label Period||40
128220|NCT01791153|312083|P4|STARTED|Part 2: Open-label Period||0
128221|NCT01791153|312084|P3|STARTED|Part 2: Open-label Period||0
128222|NCT01791153|312085|P2|STARTED|Part 2: Open-label Period||0
128223|NCT01791153|312086|P1|STARTED|Part 2: Open-label Period||0
128224|NCT01791153|312079|P8|NOT COMPLETED|Part 1: Blinded Period||0
128225|NCT01791153|312080|P7|NOT COMPLETED|Part 1: Blinded Period||0
128226|NCT01791153|312081|P6|NOT COMPLETED|Part 1: Blinded Period||0
128227|NCT01791153|312082|P5|NOT COMPLETED|Part 1: Blinded Period||0
128228|NCT01791153|312083|P4|NOT COMPLETED|Part 1: Blinded Period||5
128229|NCT01791153|312084|P3|NOT COMPLETED|Part 1: Blinded Period||6
128230|NCT01791153|312085|P2|NOT COMPLETED|Part 1: Blinded Period||8
128231|NCT01791153|312086|P1|NOT COMPLETED|Part 1: Blinded Period||15
128232|NCT01791153|312079|P8|COMPLETED|Part 1: Blinded Period||0
128233|NCT01791153|312080|P7|COMPLETED|Part 1: Blinded Period||0
128234|NCT01791153|312081|P6|COMPLETED|Part 1: Blinded Period||0
128235|NCT01791153|312082|P5|COMPLETED|Part 1: Blinded Period||0
128236|NCT01791153|312083|P4|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|46
128237|NCT01791153|312084|P3|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|44
128238|NCT01791153|312085|P2|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|41
128239|NCT01791153|312086|P1|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|85
128240|NCT01791153|312079|P8|STARTED|Part 1: Blinded Period||0
128241|NCT01791153|312080|P7|STARTED|Part 1: Blinded Period||0
128242|NCT01791153|312081|P6|STARTED|Part 1: Blinded Period||0
128243|NCT01791153|312082|P5|STARTED|Part 1: Blinded Period||0
128244|NCT01791153|312083|P4|STARTED|Part 1: Blinded Period||51
128245|NCT01791153|312084|P3|STARTED|Part 1: Blinded Period||50
128246|NCT01791153|312085|P2|STARTED|Part 1: Blinded Period||49
128247|NCT01791153|312086|P1|STARTED|Part 1: Blinded Period||100
128248|NCT01790932|312146|P1|NOT COMPLETED|Overall Study||50
128249|NCT01790932|312146|P1|COMPLETED|Overall Study||0
128250|NCT01790932|312146|P1|STARTED|Overall Study||50
128251|NCT01790828|312152|P1|NOT COMPLETED|Overall Study||34
128252|NCT01790828|312152|P1|COMPLETED|Overall Study||8
128253|NCT01790828|312152|P1|STARTED|Overall Study||42
128254|NCT01790750|312175|P1|NOT COMPLETED|Overall Study||0
128255|NCT01790750|312175|P1|COMPLETED|Overall Study||50
128256|NCT01790750|312175|P1|STARTED|Overall Study||50
128257|NCT01790685|312182|P2|NOT COMPLETED|Overall Study||0
128258|NCT01790685|312183|P1|NOT COMPLETED|Overall Study||0
128259|NCT01790685|312182|P2|COMPLETED|Overall Study||17
128260|NCT01790685|312183|P1|COMPLETED|Overall Study||23
128261|NCT01790685|312182|P2|STARTED|Overall Study||17
128262|NCT01790685|312183|P1|STARTED|Overall Study||23
128263|NCT01790659|312191|P2|NOT COMPLETED|Overall Study||6
128264|NCT01790659|312192|P1|NOT COMPLETED|Overall Study||6
128265|NCT01790659|312191|P2|COMPLETED|Overall Study||192
128266|NCT01790659|312192|P1|COMPLETED|Overall Study||195
128267|NCT01790659|312191|P2|STARTED|Overall Study||198
128268|NCT01790659|312192|P1|STARTED|Overall Study||201
128269|NCT01790633|312210|P2|NOT COMPLETED|Overall Study||5
128270|NCT01790633|312211|P1|NOT COMPLETED|Overall Study||48
128271|NCT01790633|312210|P2|COMPLETED|Overall Study||159
128272|NCT01790633|312211|P1|COMPLETED|Overall Study||115
128273|NCT01790633|312210|P2|STARTED|Overall Study||164
128274|NCT01790633|312211|P1|STARTED|Overall Study||163
128275|NCT01790594|312224|P3|NOT COMPLETED|Overall Study||3
128276|NCT01790594|312225|P2|NOT COMPLETED|Overall Study||3
128277|NCT01790594|312226|P1|NOT COMPLETED|Overall Study||5
128278|NCT01790594|312224|P3|COMPLETED|Overall Study||0
128279|NCT01790594|312225|P2|COMPLETED|Overall Study||18
128280|NCT01790594|312226|P1|COMPLETED|Overall Study||17
128281|NCT01790594|312224|P3|STARTED|Overall Study||3
128282|NCT01790594|312225|P2|STARTED|Overall Study||21
128283|NCT01790594|312226|P1|STARTED|Overall Study||22
128284|NCT01790581|312294|P2|NOT COMPLETED|Overall Study||0
128285|NCT01790581|312295|P1|NOT COMPLETED|Overall Study||0
128286|NCT01790581|312294|P2|COMPLETED|Overall Study||12
128287|NCT01790581|312295|P1|COMPLETED|Overall Study||12
128288|NCT01790581|312294|P2|STARTED|Overall Study||12
128289|NCT01790581|312295|P1|STARTED|Overall Study||12
128290|NCT01790568|312303|P2|NOT COMPLETED|Overall Study||1
128291|NCT01790568|312304|P1|NOT COMPLETED|Overall Study||0
128292|NCT01790568|312303|P2|COMPLETED|Overall Study||25
128293|NCT01790568|312304|P1|COMPLETED|Overall Study||12
128294|NCT01790568|312303|P2|STARTED|Overall Study||26
128295|NCT01790568|312304|P1|STARTED|Overall Study||12
128296|NCT01790516|312312|P2|NOT COMPLETED|Overall Study||0
128297|NCT01790516|312313|P1|NOT COMPLETED|Overall Study||1
128298|NCT01790516|312312|P2|COMPLETED|Overall Study||1
128299|NCT01790516|312313|P1|COMPLETED|Overall Study||0
128300|NCT01790516|312312|P2|STARTED|Overall Study||1
128301|NCT01790516|312313|P1|STARTED|Overall Study||1
128302|NCT01790503|312330|P11|NOT COMPLETED|Overall Study||16
128303|NCT01790503|312331|P10|NOT COMPLETED|Overall Study||26
128304|NCT01790503|312332|P9|NOT COMPLETED|Overall Study||3
128305|NCT01790503|312333|P8|NOT COMPLETED|Overall Study||1
128306|NCT01790503|312334|P7|NOT COMPLETED|Overall Study||1
128307|NCT01790503|312335|P6|NOT COMPLETED|Overall Study||5
128308|NCT01790503|312336|P5|NOT COMPLETED|Overall Study||5
128309|NCT01790503|312337|P4|NOT COMPLETED|Overall Study||2
128310|NCT01790503|312338|P3|NOT COMPLETED|Overall Study||1
128311|NCT01790503|312339|P2|NOT COMPLETED|Overall Study||1
128312|NCT01790503|312340|P1|NOT COMPLETED|Overall Study||3
128313|NCT01790503|312330|P11|COMPLETED|Overall Study||0
128314|NCT01790503|312331|P10|COMPLETED|Overall Study||1
128315|NCT01790503|312332|P9|COMPLETED|Overall Study||0
128316|NCT01790503|312333|P8|COMPLETED|Overall Study||0
128317|NCT01790503|312334|P7|COMPLETED|Overall Study||0
128318|NCT01790503|312335|P6|COMPLETED|Overall Study||0
128319|NCT01790503|312336|P5|COMPLETED|Overall Study||0
128320|NCT01790503|312337|P4|COMPLETED|Overall Study||0
128321|NCT01790503|312338|P3|COMPLETED|Overall Study||0
128322|NCT01790503|312339|P2|COMPLETED|Overall Study||0
128323|NCT01790503|312340|P1|COMPLETED|Overall Study||0
128324|NCT01790503|312330|P11|STARTED|Overall Study||16
128325|NCT01790503|312331|P10|STARTED|Overall Study||27
128326|NCT01790503|312332|P9|STARTED|Overall Study||3
128327|NCT01790503|312333|P8|STARTED|Overall Study||1
128328|NCT01790503|312334|P7|STARTED|Overall Study||1
128329|NCT01790503|312335|P6|STARTED|Overall Study||5
128330|NCT01790503|312336|P5|STARTED|Overall Study||5
128331|NCT01790503|312337|P4|STARTED|Overall Study||2
128332|NCT01790503|312338|P3|STARTED|Overall Study||1
128333|NCT01790503|312339|P2|STARTED|Overall Study||1
128334|NCT01790503|312340|P1|STARTED|Overall Study||3
128335|NCT01790490|312395|P3|NOT COMPLETED|Overall Study||0
128336|NCT01790490|312396|P2|NOT COMPLETED|Overall Study||0
128337|NCT01790490|312397|P1|NOT COMPLETED|Overall Study||0
128338|NCT01790490|312395|P3|COMPLETED|Overall Study||2
128339|NCT01790490|312396|P2|COMPLETED|Overall Study||3
128340|NCT01790490|312397|P1|COMPLETED|Overall Study||3
128341|NCT01790490|312395|P3|STARTED|Overall Study||2
128342|NCT01790490|312396|P2|STARTED|Overall Study||3
128343|NCT01790490|312397|P1|STARTED|Overall Study||3
128344|NCT01790438|312410|P2|NOT COMPLETED|Overall Study||11
128345|NCT01790438|312411|P1|NOT COMPLETED|Overall Study||35
128346|NCT01790438|312410|P2|COMPLETED|Overall Study||202
128347|NCT01790438|312411|P1|COMPLETED|Overall Study||393
128348|NCT01790438|312410|P2|Received at Least One Dose of Study Drug|Overall Study||212
128349|NCT01790438|312411|P1|Received at Least One Dose of Study Drug|Overall Study||427
128350|NCT01790438|312410|P2|STARTED|Overall Study||213
128351|NCT01790438|312411|P1|STARTED|Overall Study||428
128352|NCT01790295|312461|P1|NOT COMPLETED|Overall Study||11
128353|NCT01790295|312461|P1|COMPLETED|Overall Study||10
128354|NCT01790295|312461|P1|STARTED|Overall Study||21
128355|NCT01790178|312486|P2|NOT COMPLETED|Overall Study||0
128356|NCT01790178|312487|P1|NOT COMPLETED|Overall Study||0
128357|NCT01790178|312486|P2|COMPLETED|Overall Study||24
128358|NCT01790178|312487|P1|COMPLETED|Overall Study||16
128359|NCT01790178|312486|P2|STARTED|Overall Study||24
128360|NCT01790178|312487|P1|STARTED|Overall Study||16
128361|NCT01790048|312503|P2|NOT COMPLETED|Overall Study||17
128362|NCT01790048|312504|P1|NOT COMPLETED|Overall Study||12
128363|NCT01790048|312503|P2|COMPLETED|Overall Study||1086
128364|NCT01790048|312504|P1|COMPLETED|Overall Study||1144
128365|NCT01790048|312503|P2|STARTED|Overall Study||1103
128366|NCT01790048|312504|P1|STARTED|Overall Study||1156
128367|NCT01789970|312522|P3|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||44
128368|NCT01789970|312523|P2|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||50
128369|NCT01789970|312524|P1|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
128370|NCT01789970|312522|P3|COMPLETED|Double-blind Treatment Period (12 Weeks)||147
128371|NCT01789970|312523|P2|COMPLETED|Double-blind Treatment Period (12 Weeks)||130
128372|NCT01789970|312524|P1|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
128373|NCT01789970|312522|P3|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||191
128374|NCT01789970|312523|P2|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)|One participant was randomized but not treated.|179
128375|NCT01789970|312524|P1|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||0
128376|NCT01789970|312522|P3|STARTED|Double-blind Treatment Period (12 Weeks)||191
128377|NCT01789970|312523|P2|STARTED|Double-blind Treatment Period (12 Weeks)||180
128378|NCT01789970|312524|P1|STARTED|Double-blind Treatment Period (12 Weeks)||0
128379|NCT01789970|312522|P3|NOT COMPLETED|Open-label Titration Period||0
128380|NCT01789970|312523|P2|NOT COMPLETED|Open-label Titration Period||0
128381|NCT01789970|312524|P1|NOT COMPLETED|Open-label Titration Period||254
128382|NCT01789970|312522|P3|COMPLETED|Open-label Titration Period||0
128383|NCT01789970|312523|P2|COMPLETED|Open-label Titration Period||0
128384|NCT01789970|312524|P1|COMPLETED|Open-label Titration Period||371
128385|NCT01789970|312522|P3|Safety Analysis Set|Open-label Titration Period||0
128386|NCT01789970|312523|P2|Safety Analysis Set|Open-label Titration Period||0
128387|NCT01789970|312524|P1|Safety Analysis Set|Open-label Titration Period|Two enrolled patients were not treated|623
128388|NCT01789970|312522|P3|STARTED|Open-label Titration Period||0
128389|NCT01789970|312523|P2|STARTED|Open-label Titration Period||0
128390|NCT01789970|312524|P1|STARTED|Open-label Titration Period||625
128391|NCT01789905|312556|P1|NOT COMPLETED|Overall Study||0
128392|NCT01789905|312556|P1|COMPLETED|Overall Study||116
128393|NCT01789905|312556|P1|STARTED|Overall Study||116
128394|NCT01789814|312564|P2|NOT COMPLETED|Overall Study||0
128395|NCT01789814|312565|P1|NOT COMPLETED|Overall Study||0
128396|NCT01789814|312564|P2|COMPLETED|Overall Study||12
128397|NCT01789814|312565|P1|COMPLETED|Overall Study||12
128398|NCT01789814|312564|P2|STARTED|Overall Study||12
128399|NCT01789814|312565|P1|STARTED|Overall Study||12
128400|NCT01789775|312573|P2|NOT COMPLETED|Overall Study||7
128401|NCT01789775|312574|P1|NOT COMPLETED|Overall Study||2
128402|NCT01789775|312573|P2|COMPLETED|Overall Study||50
128403|NCT01789775|312574|P1|COMPLETED|Overall Study||53
128404|NCT01789775|312573|P2|STARTED|Overall Study||57
128405|NCT01789775|312574|P1|STARTED|Overall Study||55
128406|NCT01789606|312582|P2|NOT COMPLETED|Overall Study||450
128407|NCT01789606|312583|P1|NOT COMPLETED|Overall Study||23
128408|NCT01789606|312582|P2|COMPLETED|Overall Study||382
128409|NCT01789606|312583|P1|COMPLETED|Overall Study||228
128410|NCT01789606|312582|P2|STARTED|Overall Study||832
128411|NCT01789606|312583|P1|STARTED|Overall Study||251
128412|NCT01789567|312601|P1|NOT COMPLETED|Overall Study||6
128413|NCT01789567|312601|P1|COMPLETED|Overall Study||14
128414|NCT01789567|312601|P1|STARTED|Overall Study||20
128415|NCT01789476|312610|P2|NOT COMPLETED|Overall Study||2
128416|NCT01789476|312611|P1|NOT COMPLETED|Overall Study||8
128417|NCT01789476|312610|P2|COMPLETED|Overall Study||15
128418|NCT01789476|312611|P1|COMPLETED|Overall Study||26
128419|NCT01789476|312610|P2|STARTED|Overall Study||17
128420|NCT01789476|312611|P1|STARTED|Overall Study||34
128421|NCT01789255|312621|P1|NOT COMPLETED|Overall Study||0
128422|NCT01789255|312621|P1|COMPLETED|Overall Study||12
128423|NCT01789255|312621|P1|STARTED|Overall Study||12
128424|NCT01789203|312633|P2|NOT COMPLETED|Overall Study||4
128425|NCT01789203|312634|P1|NOT COMPLETED|Overall Study||9
128426|NCT01789203|312633|P2|COMPLETED|Overall Study||63
128427|NCT01789203|312634|P1|COMPLETED|Overall Study||124
128428|NCT01789203|312633|P2|STARTED|Overall Study||67
128429|NCT01789203|312634|P1|STARTED|Overall Study||133
128430|NCT01789138|312664|P2|NOT COMPLETED|Overall Study||52
128431|NCT01789138|312665|P1|NOT COMPLETED|Overall Study||41
128432|NCT01789138|312664|P2|COMPLETED|Overall Study||206
128433|NCT01789138|312665|P1|COMPLETED|Overall Study||213
128434|NCT01789138|312664|P2|STARTED|Overall Study||258
128435|NCT01789138|312665|P1|STARTED|Overall Study||254
128436|NCT01789047|312675|P2|NOT COMPLETED|Overall Study||4
128437|NCT01789047|312676|P1|NOT COMPLETED|Overall Study||4
128438|NCT01789047|312675|P2|COMPLETED|Overall Study||17
128439|NCT01789047|312676|P1|COMPLETED|Overall Study||17
128440|NCT01789047|312675|P2|STARTED|Overall Study||21
128441|NCT01789047|312676|P1|STARTED|Overall Study||21
128442|NCT01788943|312684|P2|NOT COMPLETED|Overall Study||0
128443|NCT01788943|312685|P1|NOT COMPLETED|Overall Study||1
128444|NCT01788943|312684|P2|COMPLETED|Overall Study||12
128445|NCT01788943|312685|P1|COMPLETED|Overall Study|2FA-PET Brain Image Analysis Completion Date|12
128446|NCT01788943|312684|P2|STARTED|Overall Study||12
128447|NCT01788943|312685|P1|STARTED|Overall Study|Recruitment for study began.|13
128448|NCT01788631|312695|P2|NOT COMPLETED|Overall Study||1
128449|NCT01788631|312696|P1|NOT COMPLETED|Overall Study||3
128450|NCT01788631|312695|P2|COMPLETED|Overall Study||43
128451|NCT01788631|312696|P1|COMPLETED|Overall Study||49
128452|NCT01788631|312695|P2|Randomized|Overall Study||47
128453|NCT01788631|312696|P1|Randomized|Overall Study||53
128454|NCT01788631|312695|P2|STARTED|Overall Study||44
128455|NCT01788631|312696|P1|STARTED|Overall Study||52
128456|NCT01788566|312714|P1|NOT COMPLETED|Overall Study||8
128457|NCT01788566|312714|P1|COMPLETED|Overall Study||53
128458|NCT01788566|312714|P1|STARTED|Overall Study||61
128459|NCT01788475|312727|P3|NOT COMPLETED|Overall Study||0
128460|NCT01788475|312728|P2|NOT COMPLETED|Overall Study||0
128461|NCT01788475|312729|P1|NOT COMPLETED|Overall Study||3
128462|NCT01788475|312727|P3|COMPLETED|Overall Study||0
128463|NCT01788475|312728|P2|COMPLETED|Overall Study||0
128464|NCT01788475|312729|P1|COMPLETED|Overall Study||0
128465|NCT01788475|312727|P3|STARTED|Overall Study||0
128466|NCT01788475|312728|P2|STARTED|Overall Study||0
128467|NCT01788475|312729|P1|STARTED|Overall Study||3
128468|NCT01788423|312752|P3|NOT COMPLETED|Overall Study||5
128469|NCT01788423|312753|P2|NOT COMPLETED|Overall Study||4
128470|NCT01788423|312754|P1|NOT COMPLETED|Overall Study||0
128471|NCT01788423|312752|P3|COMPLETED|Overall Study|Three people developed unrelated health problems and two were unable to fit/use hearing aids.|50
128472|NCT01788423|312753|P2|COMPLETED|Overall Study|Four participants were unable to self-select hearing aids.|51
128473|NCT01788423|312754|P1|COMPLETED|Overall Study||53
128474|NCT01788423|312752|P3|STARTED|Overall Study||55
128475|NCT01788423|312753|P2|STARTED|Overall Study||55
128476|NCT01788423|312754|P1|STARTED|Overall Study||53
128477|NCT01788358|312765|P1|NOT COMPLETED|Overall Study||98
128478|NCT01788358|312765|P1|COMPLETED|Overall Study|217 subjects completed the study at Week 28 while the remaining 193 subjects completed at Week 52|410
128479|NCT01788358|312765|P1|Completed Week 52|Overall Study||193
128480|NCT01788358|312765|P1|Entered Extension to Week 52|Overall Study|Only the first 200 subjects who completed Week 28 visit, continued treatment up to 52 weeks.|200
128481|NCT01788358|312765|P1|Completed Week 28|Overall Study||417
128482|NCT01788358|312765|P1|Treated|Overall Study||508
128483|NCT01788358|312765|P1|STARTED|Overall Study||508
128484|NCT01788228|312779|P2|NOT COMPLETED|Overall Study||0
128485|NCT01788228|312780|P1|NOT COMPLETED|Overall Study||1
128486|NCT01788228|312779|P2|COMPLETED|Overall Study||1
128487|NCT01788228|312780|P1|COMPLETED|Overall Study||48
128488|NCT01788228|312779|P2|STARTED|Overall Study||1
128489|NCT01788228|312780|P1|STARTED|Overall Study||49
128490|NCT01788215|312799|P2|NOT COMPLETED|Overall Study||1
128491|NCT01788215|312800|P1|NOT COMPLETED|Overall Study||2
128492|NCT01788215|312799|P2|COMPLETED|Overall Study||4
128493|NCT01788215|312800|P1|COMPLETED|Overall Study||3
128494|NCT01788215|312799|P2|12 Weeks of Doxycycline or Placebo|Overall Study||5
128495|NCT01788215|312800|P1|12 Weeks of Doxycycline or Placebo|Overall Study||5
128496|NCT01788215|312799|P2|STARTED|Overall Study||5
128497|NCT01788215|312800|P1|STARTED|Overall Study||5
128498|NCT01788163|312829|P9|NOT COMPLETED|Overall Study||16
128499|NCT01788163|312830|P8|NOT COMPLETED|Overall Study||48
128500|NCT01788163|312831|P7|NOT COMPLETED|Overall Study||1
128501|NCT01788163|312832|P6|NOT COMPLETED|Overall Study||7
128502|NCT01788163|312833|P5|NOT COMPLETED|Overall Study||0
128503|NCT01788163|312834|P4|NOT COMPLETED|Overall Study||0
128504|NCT01788163|312835|P3|NOT COMPLETED|Overall Study||0
128505|NCT01788163|312836|P2|NOT COMPLETED|Overall Study||0
128506|NCT01788163|312837|P1|NOT COMPLETED|Overall Study||55
128507|NCT01788163|312829|P9|COMPLETED|Overall Study||956
128508|NCT01788163|312830|P8|COMPLETED|Overall Study||254
128509|NCT01788163|312831|P7|COMPLETED|Overall Study||49
128510|NCT01788163|312832|P6|COMPLETED|Overall Study||95
128511|NCT01788163|312833|P5|COMPLETED|Overall Study||94
128512|NCT01788163|312834|P4|COMPLETED|Overall Study||71
128513|NCT01788163|312835|P3|COMPLETED|Overall Study||62
128514|NCT01788163|312836|P2|COMPLETED|Overall Study||271
128515|NCT01788163|312837|P1|COMPLETED|Overall Study||1403
128516|NCT01788163|312829|P9|STARTED|Overall Study||972
128517|NCT01788163|312830|P8|STARTED|Overall Study||302
128518|NCT01788163|312831|P7|STARTED|Overall Study||50
128519|NCT01788163|312832|P6|STARTED|Overall Study||102
128520|NCT01788163|312833|P5|STARTED|Overall Study||94
128521|NCT01788163|312834|P4|STARTED|Overall Study||71
128522|NCT01788163|312835|P3|STARTED|Overall Study||62
128523|NCT01788163|312836|P2|STARTED|Overall Study||271
128524|NCT01788163|312837|P1|STARTED|Overall Study||1458
128525|NCT01788046|313000|P2|NOT COMPLETED|Overall Study||37
128526|NCT01788046|313001|P1|NOT COMPLETED|Overall Study||56
128527|NCT01788046|313000|P2|COMPLETED|Overall Study||218
128528|NCT01788046|313001|P1|COMPLETED|Overall Study||204
128529|NCT01788046|313000|P2|Received Treatment|Overall Study||252
128530|NCT01788046|313001|P1|Received Treatment|Overall Study||259
128531|NCT01788046|313000|P2|STARTED|Overall Study||255
128532|NCT01788046|313001|P1|STARTED|Overall Study||260
128533|NCT01787916|313017|P2|NOT COMPLETED|Second Intervention (24 Weeks)||0
128534|NCT01787916|313018|P1|NOT COMPLETED|Second Intervention (24 Weeks)||0
128535|NCT01787916|313017|P2|COMPLETED|Second Intervention (24 Weeks)||7
128536|NCT01787916|313018|P1|COMPLETED|Second Intervention (24 Weeks)||8
128537|NCT01787916|313017|P2|STARTED|Second Intervention (24 Weeks)||7
128538|NCT01787916|313018|P1|STARTED|Second Intervention (24 Weeks)||8
128539|NCT01787916|313017|P2|NOT COMPLETED|Washout (4 Weeks)||0
128540|NCT01787916|313018|P1|NOT COMPLETED|Washout (4 Weeks)||0
128541|NCT01787916|313017|P2|COMPLETED|Washout (4 Weeks)||7
128542|NCT01787916|313018|P1|COMPLETED|Washout (4 Weeks)||8
128543|NCT01787916|313017|P2|STARTED|Washout (4 Weeks)||7
128544|NCT01787916|313018|P1|STARTED|Washout (4 Weeks)||8
128545|NCT01787916|313017|P2|NOT COMPLETED|First Intervention (24 Weeks)||0
128546|NCT01787916|313018|P1|NOT COMPLETED|First Intervention (24 Weeks)||0
128547|NCT01787916|313017|P2|COMPLETED|First Intervention (24 Weeks)||7
128548|NCT01787916|313018|P1|COMPLETED|First Intervention (24 Weeks)||8
128549|NCT01787916|313017|P2|STARTED|First Intervention (24 Weeks)||7
128550|NCT01787916|313018|P1|STARTED|First Intervention (24 Weeks)||8
128551|NCT01787838|313024|P1|NOT COMPLETED|Overall Study||1413
128552|NCT01787838|313024|P1|COMPLETED|Overall Study|This is the number of patients successfully immunized in a one year period.|1096
128553|NCT01787838|313024|P1|STARTED|Overall Study|This is the number who met Centers for Disease Control and Prevention guidelines for vaccine.|2509
128554|NCT01787825|313028|P2|NOT COMPLETED|Overall Study||1
128555|NCT01787825|313029|P1|NOT COMPLETED|Overall Study||6
128556|NCT01787825|313028|P2|COMPLETED|Overall Study||60
128557|NCT01787825|313029|P1|COMPLETED|Overall Study||54
128558|NCT01787825|313028|P2|STARTED|Overall Study||61
128559|NCT01787825|313029|P1|STARTED|Overall Study||60
128560|NCT01787799|313040|P1|NOT COMPLETED|Overall Study||0
128561|NCT01787799|313040|P1|COMPLETED|Overall Study||100
128562|NCT01787799|313040|P1|STARTED|Overall Study||100
128563|NCT01787760|313047|P3|NOT COMPLETED|Overall Study||5
128564|NCT01787760|313048|P2|NOT COMPLETED|Overall Study||16
128565|NCT01787760|313049|P1|NOT COMPLETED|Overall Study||26
128566|NCT01787760|313047|P3|COMPLETED|Overall Study||46
128567|NCT01787760|313048|P2|COMPLETED|Overall Study||34
128568|NCT01787760|313049|P1|COMPLETED|Overall Study||25
128569|NCT01787760|313047|P3|STARTED|Overall Study||51
128570|NCT01787760|313048|P2|STARTED|Overall Study||50
128571|NCT01787760|313049|P1|STARTED|Overall Study||51
128572|NCT01787604|313063|P2|NOT COMPLETED|Overall Study||4
128573|NCT01787604|313064|P1|NOT COMPLETED|Overall Study||4
128574|NCT01787604|313063|P2|COMPLETED|Overall Study||28
128575|NCT01787604|313064|P1|COMPLETED|Overall Study||28
128576|NCT01787604|313063|P2|STARTED|Overall Study||32
128577|NCT01787604|313064|P1|STARTED|Overall Study||32
128578|NCT01787591|313074|P4|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
128579|NCT01787591|313075|P3|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
128580|NCT01787591|313076|P2|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
128581|NCT01787591|313077|P1|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
128582|NCT01787591|313074|P4|COMPLETED|Period 4 (Cross-over Arm 4)||5
128583|NCT01787591|313075|P3|COMPLETED|Period 4 (Cross-over Arm 4)||5
128584|NCT01787591|313076|P2|COMPLETED|Period 4 (Cross-over Arm 4)||5
128585|NCT01787591|313077|P1|COMPLETED|Period 4 (Cross-over Arm 4)||5
128586|NCT01787591|313074|P4|STARTED|Period 4 (Cross-over Arm 4)||5
128587|NCT01787591|313075|P3|STARTED|Period 4 (Cross-over Arm 4)||5
128588|NCT01787591|313076|P2|STARTED|Period 4 (Cross-over Arm 4)||5
128589|NCT01787591|313077|P1|STARTED|Period 4 (Cross-over Arm 4)||5
128590|NCT01787591|313074|P4|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
128591|NCT01787591|313075|P3|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
128592|NCT01787591|313076|P2|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
128593|NCT01787591|313077|P1|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
128594|NCT01787591|313074|P4|COMPLETED|Period 3 (Cross-over Arm 3)||5
128595|NCT01787591|313075|P3|COMPLETED|Period 3 (Cross-over Arm 3)||5
128596|NCT01787591|313076|P2|COMPLETED|Period 3 (Cross-over Arm 3)||5
128597|NCT01787591|313077|P1|COMPLETED|Period 3 (Cross-over Arm 3)||5
128598|NCT01787591|313074|P4|STARTED|Period 3 (Cross-over Arm 3)||5
128599|NCT01787591|313075|P3|STARTED|Period 3 (Cross-over Arm 3)||5
128600|NCT01787591|313076|P2|STARTED|Period 3 (Cross-over Arm 3)||5
128601|NCT01787591|313077|P1|STARTED|Period 3 (Cross-over Arm 3)||5
128602|NCT01787591|313074|P4|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
128603|NCT01787591|313075|P3|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
128604|NCT01787591|313076|P2|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
128605|NCT01787591|313077|P1|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
128606|NCT01787591|313074|P4|COMPLETED|Period 2 (Cross-over Arm 2)||5
128607|NCT01787591|313075|P3|COMPLETED|Period 2 (Cross-over Arm 2)||5
128608|NCT01787591|313076|P2|COMPLETED|Period 2 (Cross-over Arm 2)||5
128609|NCT01787591|313077|P1|COMPLETED|Period 2 (Cross-over Arm 2)||5
128610|NCT01787591|313074|P4|STARTED|Period 2 (Cross-over Arm 2)||5
128611|NCT01787591|313075|P3|STARTED|Period 2 (Cross-over Arm 2)||5
128612|NCT01787591|313076|P2|STARTED|Period 2 (Cross-over Arm 2)||5
128613|NCT01787591|313077|P1|STARTED|Period 2 (Cross-over Arm 2)||5
128614|NCT01787591|313074|P4|NOT COMPLETED|Period 1 (Cross-over Arm 1)||1
128615|NCT01787591|313075|P3|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
128616|NCT01787591|313076|P2|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
128617|NCT01787591|313077|P1|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
128618|NCT01787591|313074|P4|COMPLETED|Period 1 (Cross-over Arm 1)||5
128619|NCT01787591|313075|P3|COMPLETED|Period 1 (Cross-over Arm 1)||5
128620|NCT01787591|313076|P2|COMPLETED|Period 1 (Cross-over Arm 1)||5
128621|NCT01787591|313077|P1|COMPLETED|Period 1 (Cross-over Arm 1)||5
128622|NCT01787591|313074|P4|STARTED|Period 1 (Cross-over Arm 1)||6
128623|NCT01787591|313075|P3|STARTED|Period 1 (Cross-over Arm 1)||5
128624|NCT01787591|313076|P2|STARTED|Period 1 (Cross-over Arm 1)||5
128625|NCT01787591|313077|P1|STARTED|Period 1 (Cross-over Arm 1)||5
128626|NCT01787461|313105|P2|NOT COMPLETED|Overall Study||9
128627|NCT01787461|313106|P1|NOT COMPLETED|Overall Study||14
128628|NCT01787461|313105|P2|COMPLETED|Overall Study||89
128629|NCT01787461|313106|P1|COMPLETED|Overall Study||82
128630|NCT01787461|313105|P2|STARTED|Overall Study||98
128631|NCT01787461|313106|P1|STARTED|Overall Study||96
128632|NCT01787383|313134|P2|NOT COMPLETED|Overall Study||22
128633|NCT01787383|313135|P1|NOT COMPLETED|Overall Study||9
128634|NCT01787383|313134|P2|COMPLETED|Overall Study||76
128635|NCT01787383|313135|P1|COMPLETED|Overall Study||92
128636|NCT01787383|313134|P2|STARTED|Overall Study||98
128637|NCT01787383|313135|P1|STARTED|Overall Study||101
128638|NCT01787331|313155|P1|NOT COMPLETED|Overall Study||0
128639|NCT01787331|313155|P1|COMPLETED|Overall Study||21
128640|NCT01787331|313155|P1|STARTED|Overall Study||21
128641|NCT01787279|313162|P1|NOT COMPLETED|Overall Study||3
128642|NCT01787279|313162|P1|COMPLETED|Overall Study||56
128643|NCT01787279|313162|P1|STARTED|Overall Study||59
128644|NCT01787240|313173|P2|NOT COMPLETED|Overall Study||1
128645|NCT01787240|313174|P1|NOT COMPLETED|Overall Study||5
128646|NCT01787240|313173|P2|COMPLETED|Overall Study||4
128647|NCT01787240|313174|P1|COMPLETED|Overall Study||10
128648|NCT01787240|313173|P2|STARTED|Overall Study||5
128649|NCT01787240|313174|P1|STARTED|Overall Study||15
128650|NCT01787188|313188|P3|NOT COMPLETED|Overall Study||18
128651|NCT01787188|313189|P2|NOT COMPLETED|Overall Study||18
128652|NCT01787188|313190|P1|NOT COMPLETED|Overall Study||17
128653|NCT01787188|313188|P3|COMPLETED|Overall Study||116
128654|NCT01787188|313189|P2|COMPLETED|Overall Study||112
128655|NCT01787188|313190|P1|COMPLETED|Overall Study||122
128656|NCT01787188|313188|P3|STARTED|Overall Study||134
128657|NCT01787188|313189|P2|STARTED|Overall Study||130
128658|NCT01787188|313190|P1|STARTED|Overall Study||139
128659|NCT01787175|313245|P2|NOT COMPLETED|Overall Study||0
128660|NCT01787175|313246|P1|NOT COMPLETED|Overall Study||0
128661|NCT01787175|313245|P2|COMPLETED|Overall Study||28
128662|NCT01787175|313246|P1|COMPLETED|Overall Study||30
128663|NCT01787175|313245|P2|STARTED|Overall Study||28
128664|NCT01787175|313246|P1|STARTED|Overall Study||30
128665|NCT01787032|313262|P6|NOT COMPLETED|Overall Study||1
128666|NCT01787032|313263|P5|NOT COMPLETED|Overall Study||1
128667|NCT01787032|313264|P4|NOT COMPLETED|Overall Study||0
128668|NCT01787032|313265|P3|NOT COMPLETED|Overall Study||0
128669|NCT01787032|313266|P2|NOT COMPLETED|Overall Study||0
128670|NCT01787032|313267|P1|NOT COMPLETED|Overall Study||0
128671|NCT01787032|313262|P6|COMPLETED|Overall Study||3
128672|NCT01787032|313263|P5|COMPLETED|Overall Study||3
128673|NCT01787032|313264|P4|COMPLETED|Overall Study||3
128674|NCT01787032|313265|P3|COMPLETED|Overall Study||3
128675|NCT01787032|313266|P2|COMPLETED|Overall Study||3
128676|NCT01787032|313267|P1|COMPLETED|Overall Study||3
128677|NCT01787032|313262|P6|Received T2|Overall Study||4
128678|NCT01787032|313263|P5|Received T2|Overall Study||4
128679|NCT01787032|313264|P4|Received T2|Overall Study||3
128680|NCT01787032|313265|P3|Received T2|Overall Study||3
128681|NCT01787032|313266|P2|Received T2|Overall Study||3
128682|NCT01787032|313267|P1|Received T2|Overall Study||3
128683|NCT01787032|313262|P6|Received T1|Overall Study||4
128684|NCT01787032|313263|P5|Received T1|Overall Study||3
128685|NCT01787032|313264|P4|Received T1|Overall Study||3
128686|NCT01787032|313265|P3|Received T1|Overall Study||3
128687|NCT01787032|313266|P2|Received T1|Overall Study||3
128688|NCT01787032|313267|P1|Received T1|Overall Study||3
128689|NCT01787032|313262|P6|Received R|Overall Study||3
128690|NCT01787032|313263|P5|Received R|Overall Study||4
128691|NCT01787032|313264|P4|Received R|Overall Study||3
128692|NCT01787032|313265|P3|Received R|Overall Study||3
128693|NCT01787032|313266|P2|Received R|Overall Study||3
128694|NCT01787032|313267|P1|Received R|Overall Study||3
128695|NCT01787032|313262|P6|STARTED|Overall Study||4
128696|NCT01787032|313263|P5|STARTED|Overall Study||4
128697|NCT01787032|313264|P4|STARTED|Overall Study||3
128698|NCT01787032|313265|P3|STARTED|Overall Study||3
128699|NCT01787032|313266|P2|STARTED|Overall Study||3
128700|NCT01787032|313267|P1|STARTED|Overall Study||3
128701|NCT01786993|313291|P2|NOT COMPLETED|Overall Study||10
128702|NCT01786993|313292|P1|NOT COMPLETED|Overall Study||12
128703|NCT01786993|313291|P2|COMPLETED|Overall Study||170
128704|NCT01786993|313292|P1|COMPLETED|Overall Study||189
128705|NCT01786993|313291|P2|Per Protocol Population at 9 Months|Overall Study||170
128706|NCT01786993|313292|P1|Per Protocol Population at 9 Months|Overall Study||189
128707|NCT01786993|313291|P2|STARTED|Overall Study||180
128708|NCT01786993|313292|P1|STARTED|Overall Study||201
128709|NCT01786967|313299|P1|NOT COMPLETED|Overall Study||0
128710|NCT01786967|313299|P1|COMPLETED|Overall Study||61
128711|NCT01786967|313299|P1|Metabolizer Status Undetermined|Overall Study||3
128712|NCT01786967|313299|P1|Poor Metabolizers|Overall Study||4
128713|NCT01786967|313299|P1|Extensive Metabolizers|Overall Study||54
128714|NCT01786967|313299|P1|STARTED|Overall Study||61
128715|NCT01786954|313308|P2|NOT COMPLETED|Overall Study||0
128716|NCT01786954|313309|P1|NOT COMPLETED|Overall Study||0
128717|NCT01786954|313308|P2|COMPLETED|Overall Study||34
128718|NCT01786954|313309|P1|COMPLETED|Overall Study||34
128719|NCT01786954|313308|P2|STARTED|Overall Study||34
128720|NCT01786954|313309|P1|STARTED|Overall Study||34
128721|NCT01786902|313321|P2|NOT COMPLETED|Overall Study||3
128722|NCT01786902|313322|P1|NOT COMPLETED|Overall Study||4
128723|NCT01786902|313321|P2|COMPLETED|Overall Study||31
128724|NCT01786902|313322|P1|COMPLETED|Overall Study||32
128725|NCT01786902|313321|P2|STARTED|Overall Study||34
128726|NCT01786902|313322|P1|STARTED|Overall Study||36
128727|NCT01786876|313332|P1|NOT COMPLETED|Overall Study||0
128728|NCT01786876|313332|P1|COMPLETED|Overall Study||6
128729|NCT01786876|313332|P1|STARTED|Overall Study||6
128730|NCT01786707|313351|P2|NOT COMPLETED|Overall Study||1
128731|NCT01786707|313352|P1|NOT COMPLETED|Overall Study||1
128732|NCT01786707|313351|P2|COMPLETED|Overall Study||0
128733|NCT01786707|313352|P1|COMPLETED|Overall Study||0
128734|NCT01786707|313351|P2|STARTED|Overall Study||1
128735|NCT01786707|313352|P1|STARTED|Overall Study||1
128736|NCT01786668|313364|P4|NOT COMPLETED|Overall Study||4
128737|NCT01786668|313365|P3|NOT COMPLETED|Overall Study||5
128738|NCT01786668|313366|P2|NOT COMPLETED|Overall Study||1
128739|NCT01786668|313367|P1|NOT COMPLETED|Overall Study||1
128740|NCT01786668|313364|P4|COMPLETED|Overall Study||47
128741|NCT01786668|313365|P3|COMPLETED|Overall Study||47
128742|NCT01786668|313366|P2|COMPLETED|Overall Study||51
128743|NCT01786668|313367|P1|COMPLETED|Overall Study||51
128744|NCT01786668|313364|P4|STARTED|Overall Study||51
128745|NCT01786668|313365|P3|STARTED|Overall Study||52
128746|NCT01786668|313366|P2|STARTED|Overall Study||52
128747|NCT01786668|313367|P1|STARTED|Overall Study||52
128748|NCT01786629|313467|P2|NOT COMPLETED|Overall Study||5
128749|NCT01786629|313468|P1|NOT COMPLETED|Overall Study||0
128750|NCT01786629|313467|P2|COMPLETED|Overall Study||164
128751|NCT01786629|313468|P1|COMPLETED|Overall Study||169
128752|NCT01786629|313467|P2|STARTED|Overall Study||169
128753|NCT01786629|313468|P1|STARTED|Overall Study||169
128754|NCT01786551|313474|P1|NOT COMPLETED|Overall Study||2
128755|NCT01786551|313474|P1|COMPLETED|Overall Study||14
128756|NCT01786551|313474|P1|STARTED|Overall Study||16
128757|NCT01786330|313482|P2|NOT COMPLETED|Overall Study||3
128758|NCT01786330|313483|P1|NOT COMPLETED|Overall Study||1
128759|NCT01786330|313482|P2|COMPLETED|Overall Study||27
128760|NCT01786330|313483|P1|COMPLETED|Overall Study||29
128761|NCT01786330|313482|P2|STARTED|Overall Study||30
128762|NCT01786330|313483|P1|STARTED|Overall Study||30
128763|NCT01786252|313497|P2|NOT COMPLETED|Overall Study||0
128764|NCT01786252|313498|P1|NOT COMPLETED|Overall Study||0
128765|NCT01786252|313497|P2|COMPLETED|Overall Study||8
128766|NCT01786252|313498|P1|COMPLETED|Overall Study||7
128767|NCT01786252|313497|P2|STARTED|Overall Study||8
128768|NCT01786252|313498|P1|STARTED|Overall Study||7
128769|NCT01786239|313512|P2|NOT COMPLETED|Overall Study||11
128770|NCT01786239|313513|P1|NOT COMPLETED|Overall Study||11
128771|NCT01786239|313512|P2|COMPLETED|Overall Study||14
128772|NCT01786239|313513|P1|COMPLETED|Overall Study||14
128773|NCT01786239|313512|P2|STARTED|Overall Study||25
128774|NCT01786239|313513|P1|STARTED|Overall Study||25
128775|NCT01786187|313521|P2|NOT COMPLETED|Overall Study||10
128776|NCT01786187|313522|P1|NOT COMPLETED|Overall Study||5
128777|NCT01786187|313521|P2|COMPLETED|Overall Study||37
128778|NCT01786187|313522|P1|COMPLETED|Overall Study||35
128779|NCT01786187|313521|P2|STARTED|Overall Study||47
128780|NCT01786187|313522|P1|STARTED|Overall Study||40
128781|NCT01786174|313535|P2|NOT COMPLETED|Overall Study||0
128782|NCT01786174|313536|P1|NOT COMPLETED|Overall Study||2
128783|NCT01786174|313535|P2|COMPLETED|Overall Study||10
128784|NCT01786174|313536|P1|COMPLETED|Overall Study||16
128785|NCT01786174|313535|P2|Randomized|Overall Study||11
128786|NCT01786174|313536|P1|Randomized|Overall Study||19
128787|NCT01786174|313535|P2|STARTED|Overall Study||10
128788|NCT01786174|313536|P1|STARTED|Overall Study||18
128789|NCT01786161|313552|P2|NOT COMPLETED|Overall Study||0
128790|NCT01786161|313553|P1|NOT COMPLETED|Overall Study||0
128791|NCT01786161|313552|P2|COMPLETED|Overall Study||22
128792|NCT01786161|313553|P1|COMPLETED|Overall Study||22
128793|NCT01786161|313552|P2|STARTED|Overall Study||22
128794|NCT01786161|313553|P1|STARTED|Overall Study||22
128795|NCT01786148|313565|P2|NOT COMPLETED|Overall Study||22
128796|NCT01786148|313566|P1|NOT COMPLETED|Overall Study||22
128797|NCT01786148|313565|P2|COMPLETED|Overall Study||50
128798|NCT01786148|313566|P1|COMPLETED|Overall Study||55
128799|NCT01786148|313565|P2|STARTED|Overall Study||72
128800|NCT01786148|313566|P1|STARTED|Overall Study||77
128801|NCT01786109|313581|P3|NOT COMPLETED|Overall Study||2
128802|NCT01786109|313582|P2|NOT COMPLETED|Overall Study||0
128803|NCT01786109|313583|P1|NOT COMPLETED|Overall Study||1
128804|NCT01786109|313581|P3|COMPLETED|Overall Study||25
128805|NCT01786109|313582|P2|COMPLETED|Overall Study||24
128806|NCT01786109|313583|P1|COMPLETED|Overall Study||23
128807|NCT01786109|313581|P3|STARTED|Overall Study||27
128808|NCT01786109|313582|P2|STARTED|Overall Study||24
128809|NCT01786109|313583|P1|STARTED|Overall Study||24
128810|NCT01785875|313612|P3|NOT COMPLETED|Overall Study||107
128811|NCT01785875|313613|P2|NOT COMPLETED|Overall Study||289
128812|NCT01785875|313614|P1|NOT COMPLETED|Overall Study||294
128813|NCT01785875|313612|P3|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|16
128814|NCT01785875|313613|P2|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|95
128815|NCT01785875|313614|P1|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|90
128816|NCT01785875|313612|P3|Received Etelcalcetide|Overall Study||123
128817|NCT01785875|313613|P2|Received Etelcalcetide|Overall Study||384
128818|NCT01785875|313614|P1|Received Etelcalcetide|Overall Study||383
128819|NCT01785875|313612|P3|STARTED|Overall Study||123
128820|NCT01785875|313613|P2|STARTED|Overall Study||384
128821|NCT01785875|313614|P1|STARTED|Overall Study||384
128822|NCT01785849|313683|P2|NOT COMPLETED|Overall Study||34
128823|NCT01785849|313684|P1|NOT COMPLETED|Overall Study||61
128824|NCT01785849|313683|P2|COMPLETED|Overall Study||220
128825|NCT01785849|313684|P1|COMPLETED|Overall Study||193
128826|NCT01785849|313683|P2|Received Treatment|Overall Study||251
128827|NCT01785849|313684|P1|Received Treatment|Overall Study||254
128828|NCT01785849|313683|P2|STARTED|Overall Study||254
128829|NCT01785849|313684|P1|STARTED|Overall Study||254
128830|NCT01785628|313702|P2|NOT COMPLETED|Overall Study||3
128831|NCT01785628|313703|P1|NOT COMPLETED|Overall Study||2
128832|NCT01785628|313702|P2|COMPLETED|Overall Study||12
128833|NCT01785628|313703|P1|COMPLETED|Overall Study||13
128834|NCT01785628|313702|P2|STARTED|Overall Study||15
128835|NCT01785628|313703|P1|STARTED|Overall Study||15
128836|NCT01785615|313726|P4|NOT COMPLETED|Atorvastatin Phase||0
128837|NCT01785615|313727|P3|NOT COMPLETED|Atorvastatin Phase||0
128838|NCT01785615|313728|P2|NOT COMPLETED|Atorvastatin Phase||0
128839|NCT01785615|313729|P1|NOT COMPLETED|Atorvastatin Phase||0
128840|NCT01785615|313726|P4|COMPLETED|Atorvastatin Phase||0
128841|NCT01785615|313727|P3|COMPLETED|Atorvastatin Phase||0
128842|NCT01785615|313728|P2|COMPLETED|Atorvastatin Phase||44
128843|NCT01785615|313729|P1|COMPLETED|Atorvastatin Phase||44
128844|NCT01785615|313726|P4|STARTED|Atorvastatin Phase||0
128845|NCT01785615|313727|P3|STARTED|Atorvastatin Phase||0
128846|NCT01785615|313728|P2|STARTED|Atorvastatin Phase||44
128847|NCT01785615|313729|P1|STARTED|Atorvastatin Phase||44
128848|NCT01785615|313726|P4|NOT COMPLETED|Dietary Phase||24
128849|NCT01785615|313727|P3|NOT COMPLETED|Dietary Phase||0
128850|NCT01785615|313728|P2|NOT COMPLETED|Dietary Phase||0
128851|NCT01785615|313729|P1|NOT COMPLETED|Dietary Phase||0
128852|NCT01785615|313726|P4|COMPLETED|Dietary Phase||116
128853|NCT01785615|313727|P3|COMPLETED|Dietary Phase||35
128854|NCT01785615|313728|P2|COMPLETED|Dietary Phase||0
128855|NCT01785615|313729|P1|COMPLETED|Dietary Phase||0
128856|NCT01785615|313726|P4|STARTED|Dietary Phase||140
128857|NCT01785615|313727|P3|STARTED|Dietary Phase||35
128858|NCT01785615|313728|P2|STARTED|Dietary Phase||0
128859|NCT01785615|313729|P1|STARTED|Dietary Phase||0
128860|NCT01785602|313801|P2|NOT COMPLETED|Overall Study||9
128861|NCT01785602|313802|P1|NOT COMPLETED|Overall Study||13
128862|NCT01785602|313801|P2|COMPLETED|Overall Study||18
128863|NCT01785602|313802|P1|COMPLETED|Overall Study||63
128864|NCT01785602|313801|P2|STARTED|Overall Study||27
128865|NCT01785602|313802|P1|STARTED|Overall Study||76
128866|NCT01785524|313812|P2|NOT COMPLETED|Overall Study||2
128867|NCT01785524|313813|P1|NOT COMPLETED|Overall Study||2
128868|NCT01785524|313812|P2|COMPLETED|Overall Study||2
128869|NCT01785524|313813|P1|COMPLETED|Overall Study||5
128870|NCT01785524|313812|P2|STARTED|Overall Study||4
128871|NCT01785524|313813|P1|STARTED|Overall Study||7
128872|NCT01785472|313832|P3|NOT COMPLETED|Overall Study||22
128873|NCT01785472|313833|P2|NOT COMPLETED|Overall Study||19
128874|NCT01785472|313834|P1|NOT COMPLETED|Overall Study||24
128875|NCT01785472|313832|P3|COMPLETED|Overall Study||464
128876|NCT01785472|313833|P2|COMPLETED|Overall Study||454
128877|NCT01785472|313834|P1|COMPLETED|Overall Study||455
128878|NCT01785472|313832|P3|Safety Set (SAF)|Overall Study||484
128879|NCT01785472|313833|P2|Safety Set (SAF)|Overall Study||472
128880|NCT01785472|313834|P1|Safety Set (SAF)|Overall Study||478
128881|NCT01785472|313832|P3|Full Analysis Set (FAS)|Overall Study||484
128882|NCT01785472|313833|P2|Full Analysis Set (FAS)|Overall Study||472
128883|NCT01785472|313834|P1|Full Analysis Set (FAS)|Overall Study||479
128884|NCT01785472|313832|P3|STARTED|Overall Study||486
128885|NCT01785472|313833|P2|STARTED|Overall Study||473
128886|NCT01785472|313834|P1|STARTED|Overall Study||479
128887|NCT01785459|313878|P2|NOT COMPLETED|Overall Study||0
128888|NCT01785459|313879|P1|NOT COMPLETED|Overall Study||0
128889|NCT01785459|313878|P2|COMPLETED|Overall Study||12
128890|NCT01785459|313879|P1|COMPLETED|Overall Study||11
128891|NCT01785459|313878|P2|STARTED|Overall Study||12
128892|NCT01785459|313879|P1|STARTED|Overall Study||11
128893|NCT01785186|313894|P5|NOT COMPLETED|Overall Study||6
128894|NCT01785186|313895|P4|NOT COMPLETED|Overall Study||5
128895|NCT01785186|313896|P3|NOT COMPLETED|Overall Study||5
128896|NCT01785186|313897|P2|NOT COMPLETED|Overall Study||6
128897|NCT01785186|313898|P1|NOT COMPLETED|Overall Study||6
128898|NCT01785186|313894|P5|COMPLETED|Overall Study||117
128899|NCT01785186|313895|P4|COMPLETED|Overall Study||58
128900|NCT01785186|313896|P3|COMPLETED|Overall Study||52
128901|NCT01785186|313897|P2|COMPLETED|Overall Study||57
128902|NCT01785186|313898|P1|COMPLETED|Overall Study||53
128903|NCT01785186|313894|P5|STARTED|Overall Study||123
128904|NCT01785186|313895|P4|STARTED|Overall Study||63
128905|NCT01785186|313896|P3|STARTED|Overall Study||57
128906|NCT01785186|313897|P2|STARTED|Overall Study||63
128907|NCT01785186|313898|P1|STARTED|Overall Study||59
128908|NCT01785160|313920|P1|NOT COMPLETED|Treatment Period 2: Raltegravir + Faldap||0
128909|NCT01785160|313920|P1|COMPLETED|Treatment Period 2: Raltegravir + Faldap||23
128910|NCT01785160|313920|P1|STARTED|Treatment Period 2: Raltegravir + Faldap||23
128911|NCT01785160|313920|P1|NOT COMPLETED|Washout Period of at Least 7 Days||1
128912|NCT01785160|313920|P1|COMPLETED|Washout Period of at Least 7 Days||23
128913|NCT01785160|313920|P1|STARTED|Washout Period of at Least 7 Days||24
128914|NCT01785160|313920|P1|NOT COMPLETED|Treatment Period 1: Raltegravir||1
128915|NCT01785160|313920|P1|COMPLETED|Treatment Period 1: Raltegravir||24
128916|NCT01785160|313920|P1|STARTED|Treatment Period 1: Raltegravir||25
128917|NCT01785134|313930|P2|NOT COMPLETED|Overall Study||7
128918|NCT01785134|313931|P1|NOT COMPLETED|Overall Study||12
128919|NCT01785134|313930|P2|COMPLETED|Overall Study||33
128920|NCT01785134|313931|P1|COMPLETED|Overall Study||29
128921|NCT01785134|313930|P2|STARTED|Overall Study||40
128922|NCT01785134|313931|P1|STARTED|Overall Study||41
128923|NCT01785095|313945|P1|NOT COMPLETED|Overall Study||3
128924|NCT01785095|313945|P1|COMPLETED|Overall Study||24
128925|NCT01785095|313945|P1|STARTED|Overall Study||27
128926|NCT01784965|313955|P2|NOT COMPLETED|Overall Study||11
128927|NCT01784965|313956|P1|NOT COMPLETED|Overall Study||6
128928|NCT01784965|313955|P2|COMPLETED|Overall Study||24
128929|NCT01784965|313956|P1|COMPLETED|Overall Study||27
128930|NCT01784965|313955|P2|STARTED|Overall Study||35
128931|NCT01784965|313956|P1|STARTED|Overall Study||33
128932|NCT01784926|313968|P2|NOT COMPLETED|Overall Study||8
128933|NCT01784926|313969|P1|NOT COMPLETED|Overall Study||11
128934|NCT01784926|313968|P2|COMPLETED|Overall Study||42
128935|NCT01784926|313969|P1|COMPLETED|Overall Study||43
128936|NCT01784926|313968|P2|STARTED|Overall Study||50
128937|NCT01784926|313969|P1|STARTED|Overall Study||54
128938|NCT01784848|313987|P2|NOT COMPLETED|Overall Study||3
128939|NCT01784848|313988|P1|NOT COMPLETED|Overall Study||1
128940|NCT01784848|313987|P2|COMPLETED|Overall Study||47
128941|NCT01784848|313988|P1|COMPLETED|Overall Study||49
128942|NCT01784848|313987|P2|STARTED|Overall Study||50
128943|NCT01784848|313988|P1|STARTED|Overall Study||50
128944|NCT01784796|313996|P2|NOT COMPLETED|Overall Study||23
128945|NCT01784796|313997|P1|NOT COMPLETED|Overall Study||35
128946|NCT01784796|313996|P2|COMPLETED|Overall Study||35
128947|NCT01784796|313997|P1|COMPLETED|Overall Study||39
128948|NCT01784796|313996|P2|8 wk Data Collection|Overall Study||39
128949|NCT01784796|313997|P1|8 wk Data Collection|Overall Study||56
128950|NCT01784796|313996|P2|4 Week Data Collection|Overall Study||43
128951|NCT01784796|313997|P1|4 Week Data Collection|Overall Study||47
128952|NCT01784796|313996|P2|Baseline Data Collected|Overall Study||58
128953|NCT01784796|313997|P1|Baseline Data Collected|Overall Study||68
128954|NCT01784796|313996|P2|STARTED|Overall Study|These are participants who provided informed consent|58
128955|NCT01784796|313997|P1|STARTED|Overall Study|These are participants who provided informed consent|74
128956|NCT01784770|314009|P1|NOT COMPLETED|Overall Study||0
128957|NCT01784770|314009|P1|COMPLETED|Overall Study||21
128958|NCT01784770|314009|P1|STARTED|Overall Study||21
128959|NCT01784666|314017|P3|NOT COMPLETED|Overall Study||0
128960|NCT01784666|314018|P2|NOT COMPLETED|Overall Study||0
128961|NCT01784666|314019|P1|NOT COMPLETED|Overall Study||0
128962|NCT01784666|314017|P3|COMPLETED|Overall Study||1
128963|NCT01784666|314018|P2|COMPLETED|Overall Study||0
128964|NCT01784666|314019|P1|COMPLETED|Overall Study||1
128965|NCT01784666|314017|P3|STARTED|Overall Study||1
128966|NCT01784666|314018|P2|STARTED|Overall Study||0
128967|NCT01784666|314019|P1|STARTED|Overall Study||1
128968|NCT01784614|314027|P8|NOT COMPLETED|Period 4||0
128969|NCT01784614|314028|P7|NOT COMPLETED|Period 4||0
128970|NCT01784614|314029|P6|NOT COMPLETED|Period 4||0
128971|NCT01784614|314030|P5|NOT COMPLETED|Period 4||0
128972|NCT01784614|314031|P4|NOT COMPLETED|Period 4||0
128973|NCT01784614|314032|P3|NOT COMPLETED|Period 4||0
128974|NCT01784614|314033|P2|NOT COMPLETED|Period 4||0
128975|NCT01784614|314034|P1|NOT COMPLETED|Period 4||0
128976|NCT01784614|314027|P8|COMPLETED|Period 4||2
128977|NCT01784614|314028|P7|COMPLETED|Period 4||3
128978|NCT01784614|314029|P6|COMPLETED|Period 4||3
128979|NCT01784614|314030|P5|COMPLETED|Period 4||3
128980|NCT01784614|314031|P4|COMPLETED|Period 4||3
128981|NCT01784614|314032|P3|COMPLETED|Period 4||3
128982|NCT01784614|314033|P2|COMPLETED|Period 4||2
128983|NCT01784614|314034|P1|COMPLETED|Period 4||3
128984|NCT01784614|314027|P8|STARTED|Period 4||2
128985|NCT01784614|314028|P7|STARTED|Period 4||3
128986|NCT01784614|314029|P6|STARTED|Period 4||3
128987|NCT01784614|314030|P5|STARTED|Period 4||3
128988|NCT01784614|314031|P4|STARTED|Period 4||3
128989|NCT01784614|314032|P3|STARTED|Period 4||3
128990|NCT01784614|314033|P2|STARTED|Period 4||2
128991|NCT01784614|314034|P1|STARTED|Period 4||3
128992|NCT01784614|314027|P8|NOT COMPLETED|Period 3||0
128993|NCT01784614|314028|P7|NOT COMPLETED|Period 3||0
128994|NCT01784614|314029|P6|NOT COMPLETED|Period 3||0
128995|NCT01784614|314030|P5|NOT COMPLETED|Period 3||0
128996|NCT01784614|314031|P4|NOT COMPLETED|Period 3||0
128997|NCT01784614|314032|P3|NOT COMPLETED|Period 3||0
128998|NCT01784614|314033|P2|NOT COMPLETED|Period 3||0
128999|NCT01784614|314034|P1|NOT COMPLETED|Period 3||0
129000|NCT01784614|314027|P8|COMPLETED|Period 3||2
129001|NCT01784614|314028|P7|COMPLETED|Period 3||3
129002|NCT01784614|314029|P6|COMPLETED|Period 3||3
129003|NCT01784614|314030|P5|COMPLETED|Period 3||3
129004|NCT01784614|314031|P4|COMPLETED|Period 3||3
129005|NCT01784614|314032|P3|COMPLETED|Period 3||3
129006|NCT01784614|314033|P2|COMPLETED|Period 3||2
129007|NCT01784614|314034|P1|COMPLETED|Period 3||3
129008|NCT01784614|314027|P8|STARTED|Period 3||2
129009|NCT01784614|314028|P7|STARTED|Period 3||3
129010|NCT01784614|314029|P6|STARTED|Period 3||3
129011|NCT01784614|314030|P5|STARTED|Period 3||3
129012|NCT01784614|314031|P4|STARTED|Period 3||3
129013|NCT01784614|314032|P3|STARTED|Period 3||3
129014|NCT01784614|314033|P2|STARTED|Period 3||2
129015|NCT01784614|314034|P1|STARTED|Period 3||3
129016|NCT01784614|314027|P8|NOT COMPLETED|Period 2||0
129017|NCT01784614|314028|P7|NOT COMPLETED|Period 2||0
129018|NCT01784614|314029|P6|NOT COMPLETED|Period 2||0
129019|NCT01784614|314030|P5|NOT COMPLETED|Period 2||0
129020|NCT01784614|314031|P4|NOT COMPLETED|Period 2||0
129021|NCT01784614|314032|P3|NOT COMPLETED|Period 2||0
129022|NCT01784614|314033|P2|NOT COMPLETED|Period 2||0
129023|NCT01784614|314034|P1|NOT COMPLETED|Period 2||0
129024|NCT01784614|314027|P8|COMPLETED|Period 2||2
129025|NCT01784614|314028|P7|COMPLETED|Period 2||3
129026|NCT01784614|314029|P6|COMPLETED|Period 2||3
129027|NCT01784614|314030|P5|COMPLETED|Period 2||3
129028|NCT01784614|314031|P4|COMPLETED|Period 2||3
129029|NCT01784614|314032|P3|COMPLETED|Period 2||3
129030|NCT01784614|314033|P2|COMPLETED|Period 2|One participant withdrew consent after completed Period 2 and did not enter Period 3.|3
129031|NCT01784614|314034|P1|COMPLETED|Period 2||3
129032|NCT01784614|314027|P8|STARTED|Period 2||2
129033|NCT01784614|314028|P7|STARTED|Period 2||3
129034|NCT01784614|314029|P6|STARTED|Period 2||3
129035|NCT01784614|314030|P5|STARTED|Period 2||3
129036|NCT01784614|314031|P4|STARTED|Period 2||3
129037|NCT01784614|314032|P3|STARTED|Period 2||3
129038|NCT01784614|314033|P2|STARTED|Period 2||3
129039|NCT01784614|314034|P1|STARTED|Period 2||3
129040|NCT01784614|314027|P8|NOT COMPLETED|Period 1||0
129041|NCT01784614|314028|P7|NOT COMPLETED|Period 1||0
129042|NCT01784614|314029|P6|NOT COMPLETED|Period 1||0
129043|NCT01784614|314030|P5|NOT COMPLETED|Period 1||0
129044|NCT01784614|314031|P4|NOT COMPLETED|Period 1||0
129045|NCT01784614|314032|P3|NOT COMPLETED|Period 1||0
129046|NCT01784614|314033|P2|NOT COMPLETED|Period 1||0
129047|NCT01784614|314034|P1|NOT COMPLETED|Period 1||0
129048|NCT01784614|314027|P8|COMPLETED|Period 1|One participant withdrew consent after completed Period 1 and did not enter Period 2.|3
129049|NCT01784614|314028|P7|COMPLETED|Period 1||3
129050|NCT01784614|314029|P6|COMPLETED|Period 1||3
129051|NCT01784614|314030|P5|COMPLETED|Period 1||3
129052|NCT01784614|314031|P4|COMPLETED|Period 1||3
129053|NCT01784614|314032|P3|COMPLETED|Period 1||3
129054|NCT01784614|314033|P2|COMPLETED|Period 1||3
129055|NCT01784614|314034|P1|COMPLETED|Period 1||3
129056|NCT01784614|314027|P8|Received at Least 1 Dose of Study Drug|Period 1||3
129057|NCT01784614|314028|P7|Received at Least 1 Dose of Study Drug|Period 1||3
129058|NCT01784614|314029|P6|Received at Least 1 Dose of Study Drug|Period 1||3
129059|NCT01784614|314030|P5|Received at Least 1 Dose of Study Drug|Period 1||3
129060|NCT01784614|314031|P4|Received at Least 1 Dose of Study Drug|Period 1||3
129061|NCT01784614|314032|P3|Received at Least 1 Dose of Study Drug|Period 1||3
129062|NCT01784614|314033|P2|Received at Least 1 Dose of Study Drug|Period 1||3
129063|NCT01784614|314034|P1|Received at Least 1 Dose of Study Drug|Period 1||3
129064|NCT01784614|314027|P8|STARTED|Period 1||3
129065|NCT01784614|314028|P7|STARTED|Period 1||3
129066|NCT01784614|314029|P6|STARTED|Period 1||3
129067|NCT01784614|314030|P5|STARTED|Period 1||3
129068|NCT01784614|314031|P4|STARTED|Period 1||3
129069|NCT01784614|314032|P3|STARTED|Period 1||3
129070|NCT01784614|314033|P2|STARTED|Period 1||3
129071|NCT01784614|314034|P1|STARTED|Period 1||3
129072|NCT01784588|314070|P2|NOT COMPLETED|Overall Study||32
129073|NCT01784588|314071|P1|NOT COMPLETED|Overall Study||37
129074|NCT01784588|314070|P2|COMPLETED|Overall Study||108
129075|NCT01784588|314071|P1|COMPLETED|Overall Study||104
129076|NCT01784588|314070|P2|STARTED|Overall Study||140
129077|NCT01784588|314071|P1|STARTED|Overall Study||141
129078|NCT01784211|314079|P6|NOT COMPLETED|Part B (Days 16-21)||0
129079|NCT01784211|314080|P5|NOT COMPLETED|Part B (Days 16-21)||0
129080|NCT01784211|314081|P4|NOT COMPLETED|Part B (Days 16-21)||0
129081|NCT01784211|314082|P3|NOT COMPLETED|Part B (Days 16-21)||0
129082|NCT01784211|314083|P2|NOT COMPLETED|Part B (Days 16-21)||0
129083|NCT01784211|314084|P1|NOT COMPLETED|Part B (Days 16-21)||0
129084|NCT01784211|314079|P6|COMPLETED|Part B (Days 16-21)||10
129085|NCT01784211|314080|P5|COMPLETED|Part B (Days 16-21)||11
129086|NCT01784211|314081|P4|COMPLETED|Part B (Days 16-21)||9
129087|NCT01784211|314082|P3|COMPLETED|Part B (Days 16-21)||10
129088|NCT01784211|314083|P2|COMPLETED|Part B (Days 16-21)||0
129089|NCT01784211|314084|P1|COMPLETED|Part B (Days 16-21)||0
129090|NCT01784211|314079|P6|STARTED|Part B (Days 16-21)||10
129091|NCT01784211|314080|P5|STARTED|Part B (Days 16-21)||11
129092|NCT01784211|314081|P4|STARTED|Part B (Days 16-21)||9
129093|NCT01784211|314082|P3|STARTED|Part B (Days 16-21)||10
129094|NCT01784211|314083|P2|STARTED|Part B (Days 16-21)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|0
129095|NCT01784211|314084|P1|STARTED|Part B (Days 16-21)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|0
129096|NCT01784211|314079|P6|NOT COMPLETED|Part A (Days 1-15)||0
129097|NCT01784211|314080|P5|NOT COMPLETED|Part A (Days 1-15)||0
129098|NCT01784211|314081|P4|NOT COMPLETED|Part A (Days 1-15)||0
129099|NCT01784211|314082|P3|NOT COMPLETED|Part A (Days 1-15)||0
129100|NCT01784211|314083|P2|NOT COMPLETED|Part A (Days 1-15)||2
129101|NCT01784211|314084|P1|NOT COMPLETED|Part A (Days 1-15)||3
129102|NCT01784211|314079|P6|COMPLETED|Part A (Days 1-15)||0
129103|NCT01784211|314080|P5|COMPLETED|Part A (Days 1-15)||0
129104|NCT01784211|314081|P4|COMPLETED|Part A (Days 1-15)||0
129105|NCT01784211|314082|P3|COMPLETED|Part A (Days 1-15)||0
129106|NCT01784211|314083|P2|COMPLETED|Part A (Days 1-15)||36
129107|NCT01784211|314084|P1|COMPLETED|Part A (Days 1-15)||35
129108|NCT01784211|314079|P6|Entered Part B|Part A (Days 1-15)||0
129109|NCT01784211|314080|P5|Entered Part B|Part A (Days 1-15)||0
129110|NCT01784211|314081|P4|Entered Part B|Part A (Days 1-15)||0
129111|NCT01784211|314082|P3|Entered Part B|Part A (Days 1-15)||0
129112|NCT01784211|314083|P2|Entered Part B|Part A (Days 1-15)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|21
129113|NCT01784211|314084|P1|Entered Part B|Part A (Days 1-15)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|19
129114|NCT01784211|314079|P6|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
129115|NCT01784211|314080|P5|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
129116|NCT01784211|314081|P4|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
129117|NCT01784211|314082|P3|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
129118|NCT01784211|314083|P2|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||38
129119|NCT01784211|314084|P1|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||37
129120|NCT01784211|314079|P6|STARTED|Part A (Days 1-15)||0
129121|NCT01784211|314080|P5|STARTED|Part A (Days 1-15)||0
129122|NCT01784211|314081|P4|STARTED|Part A (Days 1-15)||0
129123|NCT01784211|314082|P3|STARTED|Part A (Days 1-15)||0
129124|NCT01784211|314083|P2|STARTED|Part A (Days 1-15)||38
129125|NCT01784211|314084|P1|STARTED|Part A (Days 1-15)||38
129126|NCT01784055|314102|P1|NOT COMPLETED|Overall Study||26
129127|NCT01784055|314102|P1|COMPLETED|Overall Study||100
129128|NCT01784055|314102|P1|STARTED|Overall Study||126
129129|NCT01784029|314109|P3|NOT COMPLETED|Overall Study||22
129130|NCT01784029|314110|P2|NOT COMPLETED|Overall Study||20
129131|NCT01784029|314111|P1|NOT COMPLETED|Overall Study||19
129132|NCT01784029|314109|P3|COMPLETED|Overall Study||41
129133|NCT01784029|314110|P2|COMPLETED|Overall Study||39
129134|NCT01784029|314111|P1|COMPLETED|Overall Study||42
129135|NCT01784029|314109|P3|STARTED|Overall Study||63
129136|NCT01784029|314110|P2|STARTED|Overall Study||59
129137|NCT01784029|314111|P1|STARTED|Overall Study||61
129138|NCT01783938|314121|P2|NOT COMPLETED|Overall Study||53
129139|NCT01783938|314122|P1|NOT COMPLETED|Overall Study||47
129140|NCT01783938|314121|P2|COMPLETED|Overall Study|Completed=continuing treatment; did not permanently discontinue both study drugs in treatment period|17
129141|NCT01783938|314122|P1|COMPLETED|Overall Study|Completed=continuing treatment; did not permanently discontinue both study drugs in treatment period|21
129142|NCT01783938|314121|P2|STARTED|Overall Study||70
129143|NCT01783938|314122|P1|STARTED|Overall Study||68
129144|NCT01783912|314137|P3|NOT COMPLETED|Overall Study||23
129145|NCT01783912|314138|P2|NOT COMPLETED|Overall Study||46
129146|NCT01783912|314139|P1|NOT COMPLETED|Overall Study||30
129147|NCT01783912|314137|P3|COMPLETED|Overall Study||25
129148|NCT01783912|314138|P2|COMPLETED|Overall Study||58
129149|NCT01783912|314139|P1|COMPLETED|Overall Study||88
129150|NCT01783912|314137|P3|STARTED|Overall Study||48
129151|NCT01783912|314138|P2|STARTED|Overall Study||104
129152|NCT01783912|314139|P1|STARTED|Overall Study||118
129153|NCT01783886|314150|P3|NOT COMPLETED|Overall Study||10
129154|NCT01783886|314151|P2|NOT COMPLETED|Overall Study||11
129155|NCT01783886|314152|P1|NOT COMPLETED|Overall Study||5
129156|NCT01783886|314150|P3|COMPLETED|Overall Study||117
129157|NCT01783886|314151|P2|COMPLETED|Overall Study||116
129158|NCT01783886|314152|P1|COMPLETED|Overall Study||122
129159|NCT01783886|314150|P3|Participants Received Treatment|Overall Study||124
129160|NCT01783886|314151|P2|Participants Received Treatment|Overall Study||127
129161|NCT01783886|314152|P1|Participants Received Treatment|Overall Study||127
129162|NCT01783886|314150|P3|STARTED|Overall Study||127
129163|NCT01783886|314151|P2|STARTED|Overall Study||127
129164|NCT01783886|314152|P1|STARTED|Overall Study||127
129165|NCT01783860|314180|P2|NOT COMPLETED|Overall Study||0
129166|NCT01783860|314181|P1|NOT COMPLETED|Overall Study||0
129167|NCT01783860|314180|P2|COMPLETED|Overall Study||50
129168|NCT01783860|314181|P1|COMPLETED|Overall Study||50
129169|NCT01783860|314180|P2|STARTED|Overall Study||50
129170|NCT01783860|314181|P1|STARTED|Overall Study||50
129171|NCT01783847|314200|P3|NOT COMPLETED|Overall Study||0
129172|NCT01783847|314201|P2|NOT COMPLETED|Overall Study||1
129173|NCT01783847|314202|P1|NOT COMPLETED|Overall Study||16
129174|NCT01783847|314200|P3|COMPLETED|Overall Study||16
129175|NCT01783847|314201|P2|COMPLETED|Overall Study||15
129176|NCT01783847|314202|P1|COMPLETED|Overall Study||69
129177|NCT01783847|314200|P3|STARTED|Overall Study||16
129178|NCT01783847|314201|P2|STARTED|Overall Study||16
129179|NCT01783847|314202|P1|STARTED|Overall Study||85
129180|NCT01783821|314215|P2|NOT COMPLETED|Overall Study||1
129181|NCT01783821|314216|P1|NOT COMPLETED|Overall Study||1
129182|NCT01783821|314215|P2|COMPLETED|Overall Study||30
129183|NCT01783821|314216|P1|COMPLETED|Overall Study||29
129184|NCT01783821|314215|P2|STARTED|Overall Study||31
129185|NCT01783821|314216|P1|STARTED|Overall Study||30
129186|NCT01783743|314234|P2|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10920
129187|NCT01783743|314235|P1|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10896
129188|NCT01783743|314234|P2|COMPLETED|Rescreening of Subjects by Senior Grader||3044
129189|NCT01783743|314235|P1|COMPLETED|Rescreening of Subjects by Senior Grader||2613
129190|NCT01783743|314234|P2|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||849
129191|NCT01783743|314235|P1|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||846
129192|NCT01783743|314234|P2|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1786
129193|NCT01783743|314235|P1|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1721
129194|NCT01783743|314234|P2|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||409
129195|NCT01783743|314235|P1|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||46
129196|NCT01783743|314234|P2|STARTED|Rescreening of Subjects by Senior Grader||13964
129197|NCT01783743|314235|P1|STARTED|Rescreening of Subjects by Senior Grader||13509
129198|NCT01783743|314234|P2|NOT COMPLETED|Screening of Subjects by CTA During MDA||4439
129199|NCT01783743|314235|P1|NOT COMPLETED|Screening of Subjects by CTA During MDA||3427
129200|NCT01783743|314234|P2|COMPLETED|Screening of Subjects by CTA During MDA||9525
129201|NCT01783743|314235|P1|COMPLETED|Screening of Subjects by CTA During MDA||10082
129202|NCT01783743|314234|P2|STARTED|Screening of Subjects by CTA During MDA||13964
129203|NCT01783743|314235|P1|STARTED|Screening of Subjects by CTA During MDA||13509
129204|NCT01783730|314249|P1|NOT COMPLETED|Overall Study||6
129205|NCT01783730|314249|P1|COMPLETED|Overall Study||157
129206|NCT01783730|314249|P1|STARTED|Overall Study||163
129207|NCT01783678|314274|P6|NOT COMPLETED|Overall Study||5
129208|NCT01783678|314275|P5|NOT COMPLETED|Overall Study||7
129209|NCT01783678|314276|P4|NOT COMPLETED|Overall Study||8
129210|NCT01783678|314277|P3|NOT COMPLETED|Overall Study||1
129211|NCT01783678|314278|P2|NOT COMPLETED|Overall Study||18
129212|NCT01783678|314279|P1|NOT COMPLETED|Overall Study||2
129213|NCT01783678|314274|P6|COMPLETED|Overall Study||26
129214|NCT01783678|314275|P5|COMPLETED|Overall Study||42
129215|NCT01783678|314276|P4|COMPLETED|Overall Study||50
129216|NCT01783678|314277|P3|COMPLETED|Overall Study||5
129217|NCT01783678|314278|P2|COMPLETED|Overall Study||94
129218|NCT01783678|314279|P1|COMPLETED|Overall Study||17
129219|NCT01783678|314274|P6|STARTED|Overall Study||31
129220|NCT01783678|314275|P5|STARTED|Overall Study||49
129221|NCT01783678|314276|P4|STARTED|Overall Study||58
129222|NCT01783678|314277|P3|STARTED|Overall Study||6
129223|NCT01783678|314278|P2|STARTED|Overall Study||112
129224|NCT01783678|314279|P1|STARTED|Overall Study||19
129225|NCT01783639|314351|P1|NOT COMPLETED|Overall Study||0
129226|NCT01783639|314351|P1|COMPLETED|Overall Study||120
129227|NCT01783639|314351|P1|STARTED|Overall Study||120
129228|NCT01783574|314357|P2|NOT COMPLETED|Overall Study||9
129229|NCT01783574|314358|P1|NOT COMPLETED|Overall Study||5
129230|NCT01783574|314357|P2|COMPLETED|Overall Study||41
129231|NCT01783574|314358|P1|COMPLETED|Overall Study||46
129232|NCT01783574|314357|P2|STARTED|Overall Study||50
129233|NCT01783574|314358|P1|STARTED|Overall Study||51
129234|NCT01783561|314370|P2|NOT COMPLETED|Overall Study||0
129235|NCT01783561|314371|P1|NOT COMPLETED|Overall Study||0
129236|NCT01783561|314370|P2|COMPLETED|Overall Study||10
129237|NCT01783561|314371|P1|COMPLETED|Overall Study||11
129238|NCT01783561|314370|P2|STARTED|Overall Study||10
129239|NCT01783561|314371|P1|STARTED|Overall Study||11
129240|NCT01783548|314383|P2|NOT COMPLETED|Overall Study||18
129241|NCT01783548|314384|P1|NOT COMPLETED|Overall Study||34
129242|NCT01783548|314383|P2|COMPLETED|Overall Study||167
129243|NCT01783548|314384|P1|COMPLETED|Overall Study||328
129244|NCT01783548|314383|P2|Full Analysis Set (FAS)|Overall Study||184
129245|NCT01783548|314384|P1|Full Analysis Set (FAS)|Overall Study||358
129246|NCT01783548|314383|P2|STARTED|Overall Study|Randomized|185
129247|NCT01783548|314384|P1|STARTED|Overall Study|Randomized|362
129248|NCT01783522|314398|P2|NOT COMPLETED|Overall Study||0
129249|NCT01783522|314399|P1|NOT COMPLETED|Overall Study||0
129250|NCT01783522|314398|P2|COMPLETED|Overall Study||5
129251|NCT01783522|314399|P1|COMPLETED|Overall Study||4
129252|NCT01783522|314398|P2|STARTED|Overall Study||5
129253|NCT01783522|314399|P1|STARTED|Overall Study||4
129254|NCT01783496|314417|P6|NOT COMPLETED|Overall Study||1
129255|NCT01783496|314418|P5|NOT COMPLETED|Overall Study||0
129256|NCT01783496|314419|P4|NOT COMPLETED|Overall Study||2
129257|NCT01783496|314420|P3|NOT COMPLETED|Overall Study||0
129258|NCT01783496|314421|P2|NOT COMPLETED|Overall Study||0
129259|NCT01783496|314422|P1|NOT COMPLETED|Overall Study||1
129260|NCT01783496|314417|P6|COMPLETED|Overall Study||4
129261|NCT01783496|314418|P5|COMPLETED|Overall Study||5
129262|NCT01783496|314419|P4|COMPLETED|Overall Study||8
129263|NCT01783496|314420|P3|COMPLETED|Overall Study||10
129264|NCT01783496|314421|P2|COMPLETED|Overall Study||10
129265|NCT01783496|314422|P1|COMPLETED|Overall Study||9
129266|NCT01783496|314417|P6|STARTED|Overall Study||5
129267|NCT01783496|314418|P5|STARTED|Overall Study||5
129268|NCT01783496|314419|P4|STARTED|Overall Study||10
129269|NCT01783496|314420|P3|STARTED|Overall Study||10
129270|NCT01783496|314421|P2|STARTED|Overall Study||10
129271|NCT01783496|314422|P1|STARTED|Overall Study||10
129272|NCT01783483|314450|P2|NOT COMPLETED|Overall Study||15
129273|NCT01783483|314451|P1|NOT COMPLETED|Overall Study||20
129274|NCT01783483|314450|P2|COMPLETED|Overall Study||101
129275|NCT01783483|314451|P1|COMPLETED|Overall Study||100
129276|NCT01783483|314450|P2|STARTED|Overall Study||116
129277|NCT01783483|314451|P1|STARTED|Overall Study||120
129278|NCT01783470|314479|P2|NOT COMPLETED|Overall Study||0
129279|NCT01783470|314480|P1|NOT COMPLETED|Overall Study||0
129280|NCT01783470|314479|P2|COMPLETED|Overall Study||6
129281|NCT01783470|314480|P1|COMPLETED|Overall Study||6
129282|NCT01783470|314479|P2|STARTED|Overall Study|Single-dose|6
129283|NCT01783470|314480|P1|STARTED|Overall Study||6
129284|NCT01783418|314489|P2|NOT COMPLETED|Overall Study||0
129285|NCT01783418|314490|P1|NOT COMPLETED|Overall Study||1
129286|NCT01783418|314489|P2|COMPLETED|Overall Study||6
129287|NCT01783418|314490|P1|COMPLETED|Overall Study||7
129288|NCT01783418|314489|P2|STARTED|Overall Study||6
129289|NCT01783418|314490|P1|STARTED|Overall Study||8
129290|NCT01783236|314510|P2|NOT COMPLETED|Overall Study||0
129291|NCT01783236|314511|P1|NOT COMPLETED|Overall Study||2
129292|NCT01783236|314510|P2|COMPLETED|Overall Study||8
129293|NCT01783236|314511|P1|COMPLETED|Overall Study||6
129294|NCT01783236|314510|P2|STARTED|Overall Study||8
129295|NCT01783236|314511|P1|STARTED|Overall Study||8
129296|NCT01783080|314525|P1|NOT COMPLETED|Overall Study||0
129297|NCT01783080|314525|P1|COMPLETED|Overall Study||16
129298|NCT01783080|314525|P1|STARTED|Overall Study||16
129299|NCT01783054|314532|P1|NOT COMPLETED|Overall Study||0
129300|NCT01783054|314532|P1|COMPLETED|Overall Study||2
129301|NCT01783054|314532|P1|STARTED|Overall Study||2
129302|NCT01783015|314543|P3|NOT COMPLETED|Open Label Treatment||6
129303|NCT01783015|314544|P2|NOT COMPLETED|Open Label Treatment||0
129304|NCT01783015|314545|P1|NOT COMPLETED|Open Label Treatment||0
129305|NCT01783015|314543|P3|COMPLETED|Open Label Treatment||5
129306|NCT01783015|314544|P2|COMPLETED|Open Label Treatment||0
129307|NCT01783015|314545|P1|COMPLETED|Open Label Treatment||0
129308|NCT01783015|314543|P3|STARTED|Open Label Treatment||11
129309|NCT01783015|314544|P2|STARTED|Open Label Treatment||0
129310|NCT01783015|314545|P1|STARTED|Open Label Treatment||0
129311|NCT01783015|314543|P3|NOT COMPLETED|Blinded Treatment||0
129312|NCT01783015|314544|P2|NOT COMPLETED|Blinded Treatment||3
129313|NCT01783015|314545|P1|NOT COMPLETED|Blinded Treatment||2
129314|NCT01783015|314543|P3|COMPLETED|Blinded Treatment||0
129315|NCT01783015|314544|P2|COMPLETED|Blinded Treatment||2
129316|NCT01783015|314545|P1|COMPLETED|Blinded Treatment||9
129317|NCT01783015|314543|P3|Treated|Blinded Treatment||0
129318|NCT01783015|314544|P2|Treated|Blinded Treatment||5
129319|NCT01783015|314545|P1|Treated|Blinded Treatment||11
129320|NCT01783015|314543|P3|STARTED|Blinded Treatment||0
129321|NCT01783015|314544|P2|STARTED|Blinded Treatment||5
129322|NCT01783015|314545|P1|STARTED|Blinded Treatment||11
129323|NCT01782963|314630|P1|NOT COMPLETED|Overall Study||0
129324|NCT01782963|314630|P1|COMPLETED|Overall Study||50
129325|NCT01782963|314630|P1|STARTED|Overall Study||50
129326|NCT01782898|314645|P2|NOT COMPLETED|Overall Study||6
129327|NCT01782898|314646|P1|NOT COMPLETED|Overall Study||6
129328|NCT01782898|314645|P2|COMPLETED|Overall Study||29
129329|NCT01782898|314646|P1|COMPLETED|Overall Study||29
129330|NCT01782898|314645|P2|STARTED|Overall Study||35
129331|NCT01782898|314646|P1|STARTED|Overall Study||35
129332|NCT01782885|314658|P2|NOT COMPLETED|Overall Study||6
129333|NCT01782885|314659|P1|NOT COMPLETED|Overall Study||4
129334|NCT01782885|314658|P2|COMPLETED|Overall Study||33
129335|NCT01782885|314659|P1|COMPLETED|Overall Study||32
129336|NCT01782885|314658|P2|STARTED|Overall Study||39
129337|NCT01782885|314659|P1|STARTED|Overall Study||36
129338|NCT01782872|314685|P4|NOT COMPLETED|Overall Study||1
129339|NCT01782872|314686|P3|NOT COMPLETED|Overall Study||0
129340|NCT01782872|314687|P2|NOT COMPLETED|Overall Study||1
129341|NCT01782872|314688|P1|NOT COMPLETED|Overall Study||0
129342|NCT01782872|314685|P4|COMPLETED|Overall Study||19
129343|NCT01782872|314686|P3|COMPLETED|Overall Study||20
129344|NCT01782872|314687|P2|COMPLETED|Overall Study||19
129345|NCT01782872|314688|P1|COMPLETED|Overall Study||20
129346|NCT01782872|314685|P4|STARTED|Overall Study||20
129347|NCT01782872|314686|P3|STARTED|Overall Study||20
129348|NCT01782872|314687|P2|STARTED|Overall Study||20
129349|NCT01782872|314688|P1|STARTED|Overall Study||20
129350|NCT01782859|314712|P2|NOT COMPLETED|Overall Study||7
129351|NCT01782859|314713|P1|NOT COMPLETED|Overall Study||6
129352|NCT01782859|314712|P2|COMPLETED|Overall Study||13
129353|NCT01782859|314713|P1|COMPLETED|Overall Study||14
129354|NCT01782859|314712|P2|STARTED|Overall Study||20
129355|NCT01782859|314713|P1|STARTED|Overall Study||20
129356|NCT01782833|314727|P1|NOT COMPLETED|Overall Study||270
129357|NCT01782833|314727|P1|COMPLETED|Overall Study||3365
129358|NCT01782833|314727|P1|STARTED|Overall Study||3635
129359|NCT01782742|314735|P2|NOT COMPLETED|Open Label Phase||0
129360|NCT01782742|314736|P1|NOT COMPLETED|Open Label Phase||0
129361|NCT01782742|314735|P2|COMPLETED|Open Label Phase||0
129362|NCT01782742|314736|P1|COMPLETED|Open Label Phase||19
129363|NCT01782742|314735|P2|STARTED|Open Label Phase||0
129364|NCT01782742|314736|P1|STARTED|Open Label Phase||19
129365|NCT01782742|314735|P2|NOT COMPLETED|Double-blind Treatment Phase||0
129366|NCT01782742|314736|P1|NOT COMPLETED|Double-blind Treatment Phase||1
129367|NCT01782742|314735|P2|COMPLETED|Double-blind Treatment Phase||4
129368|NCT01782742|314736|P1|COMPLETED|Double-blind Treatment Phase||15
129369|NCT01782742|314735|P2|STARTED|Double-blind Treatment Phase||4
129370|NCT01782742|314736|P1|STARTED|Double-blind Treatment Phase||16
129371|NCT01782690|314769|P1|NOT COMPLETED|Overall Study||299
129372|NCT01782690|314769|P1|COMPLETED|Overall Study||39
129373|NCT01782690|314769|P1|STARTED|Overall Study||338
129374|NCT01782664|314791|P6|NOT COMPLETED|Overall Study||0
129375|NCT01782664|314792|P5|NOT COMPLETED|Overall Study||0
129376|NCT01782664|314793|P4|NOT COMPLETED|Overall Study||5
129377|NCT01782664|314794|P3|NOT COMPLETED|Overall Study||4
129378|NCT01782664|314795|P2|NOT COMPLETED|Overall Study||5
129379|NCT01782664|314796|P1|NOT COMPLETED|Overall Study||6
129380|NCT01782664|314791|P6|COMPLETED|Overall Study||2
129381|NCT01782664|314792|P5|COMPLETED|Overall Study||6
129382|NCT01782664|314793|P4|COMPLETED|Overall Study||9
129383|NCT01782664|314794|P3|COMPLETED|Overall Study||12
129384|NCT01782664|314795|P2|COMPLETED|Overall Study||10
129385|NCT01782664|314796|P1|COMPLETED|Overall Study||8
129386|NCT01782664|314791|P6|STARTED|Overall Study||2
129387|NCT01782664|314792|P5|STARTED|Overall Study||6
129388|NCT01782664|314793|P4|STARTED|Overall Study||14
129389|NCT01782664|314794|P3|STARTED|Overall Study||16
129390|NCT01782664|314795|P2|STARTED|Overall Study||15
129391|NCT01782664|314796|P1|STARTED|Overall Study||14
129392|NCT01782495|314953|P11|NOT COMPLETED|Overall Study||0
129393|NCT01782495|314954|P10|NOT COMPLETED|Overall Study||0
129394|NCT01782495|314955|P9|NOT COMPLETED|Overall Study||0
129395|NCT01782495|314956|P8|NOT COMPLETED|Overall Study||3
129396|NCT01782495|314957|P7|NOT COMPLETED|Overall Study||0
129397|NCT01782495|314958|P6|NOT COMPLETED|Overall Study||0
129398|NCT01782495|314959|P5|NOT COMPLETED|Overall Study||0
129399|NCT01782495|314960|P4|NOT COMPLETED|Overall Study||0
129400|NCT01782495|314961|P3|NOT COMPLETED|Overall Study||0
129401|NCT01782495|314962|P2|NOT COMPLETED|Overall Study||1
129402|NCT01782495|314963|P1|NOT COMPLETED|Overall Study||0
129403|NCT01782495|314953|P11|COMPLETED|Overall Study||1
129404|NCT01782495|314954|P10|COMPLETED|Overall Study||2
129405|NCT01782495|314955|P9|COMPLETED|Overall Study||3
129406|NCT01782495|314956|P8|COMPLETED|Overall Study||6
129407|NCT01782495|314957|P7|COMPLETED|Overall Study||12
129408|NCT01782495|314958|P6|COMPLETED|Overall Study||22
129409|NCT01782495|314959|P5|COMPLETED|Overall Study||2
129410|NCT01782495|314960|P4|COMPLETED|Overall Study||4
129411|NCT01782495|314961|P3|COMPLETED|Overall Study||13
129412|NCT01782495|314962|P2|COMPLETED|Overall Study||26
129413|NCT01782495|314963|P1|COMPLETED|Overall Study||34
129414|NCT01782495|314953|P11|STARTED|Overall Study||1
129415|NCT01782495|314954|P10|STARTED|Overall Study||2
129416|NCT01782495|314955|P9|STARTED|Overall Study||3
129417|NCT01782495|314956|P8|STARTED|Overall Study||9
129418|NCT01782495|314957|P7|STARTED|Overall Study||12
129419|NCT01782495|314958|P6|STARTED|Overall Study||22
129420|NCT01782495|314959|P5|STARTED|Overall Study||2
129421|NCT01782495|314960|P4|STARTED|Overall Study||4
129422|NCT01782495|314961|P3|STARTED|Overall Study||13
129423|NCT01782495|314962|P2|STARTED|Overall Study||27
129424|NCT01782495|314963|P1|STARTED|Overall Study||34
129425|NCT01782482|315022|P2|NOT COMPLETED|Overall Study||10
129426|NCT01782482|315023|P1|NOT COMPLETED|Overall Study||10
129427|NCT01782482|315022|P2|COMPLETED|Overall Study||270
129428|NCT01782482|315023|P1|COMPLETED|Overall Study||271
129429|NCT01782482|315022|P2|STARTED|Overall Study||280
129430|NCT01782482|315023|P1|STARTED|Overall Study||281
129431|NCT01782469|315031|P1|NOT COMPLETED|Overall Study||1
129432|NCT01782469|315031|P1|COMPLETED|Overall Study||15
129433|NCT01782469|315031|P1|STARTED|Overall Study||16
129434|NCT01782326|315041|P2|NOT COMPLETED|Double-blind Treatment||320
129435|NCT01782326|315042|P1|NOT COMPLETED|Double-blind Treatment||278
129436|NCT01782326|315041|P2|COMPLETED|Double-blind Treatment||1360
129437|NCT01782326|315042|P1|COMPLETED|Double-blind Treatment||1400
129438|NCT01782326|315041|P2|STARTED|Double-blind Treatment||1680
129439|NCT01782326|315042|P1|STARTED|Double-blind Treatment||1678
129440|NCT01782326|315041|P2|NOT COMPLETED|Planned Treatment Epoch||208
129441|NCT01782326|315042|P1|NOT COMPLETED|Planned Treatment Epoch||202
129442|NCT01782326|315041|P2|COMPLETED|Planned Treatment Epoch||1474
129443|NCT01782326|315042|P1|COMPLETED|Planned Treatment Epoch||1478
129444|NCT01782326|315041|P2|Urine Cortisol Set|Planned Treatment Epoch||269
129445|NCT01782326|315042|P1|Urine Cortisol Set|Planned Treatment Epoch||266
129446|NCT01782326|315041|P2|Safety Set (SAF)|Planned Treatment Epoch||1680
129447|NCT01782326|315042|P1|Safety Set (SAF)|Planned Treatment Epoch||1678
129448|NCT01782326|315041|P2|Serial Spirometry Set|Planned Treatment Epoch||279
129449|NCT01782326|315042|P1|Serial Spirometry Set|Planned Treatment Epoch||280
129450|NCT01782326|315041|P2|Per-protocol Set (PPS)|Planned Treatment Epoch||1556
129451|NCT01782326|315042|P1|Per-protocol Set (PPS)|Planned Treatment Epoch||1528
129452|NCT01782326|315041|P2|Full Analysis Set (FAS)|Planned Treatment Epoch||1679
129453|NCT01782326|315042|P1|Full Analysis Set (FAS)|Planned Treatment Epoch||1675
129454|NCT01782326|315041|P2|STARTED|Planned Treatment Epoch||1682
129455|NCT01782326|315042|P1|STARTED|Planned Treatment Epoch||1680
129456|NCT01782313|315102|P1|NOT COMPLETED|Survival Follow up||1
129457|NCT01782313|315102|P1|COMPLETED|Survival Follow up||57
129458|NCT01782313|315102|P1|STARTED|Survival Follow up||58
129459|NCT01782313|315102|P1|NOT COMPLETED|Continued Treatment After 16 Weeks||7
129460|NCT01782313|315102|P1|COMPLETED|Continued Treatment After 16 Weeks||18
129461|NCT01782313|315102|P1|STARTED|Continued Treatment After 16 Weeks||25
129462|NCT01782313|315102|P1|NOT COMPLETED|Treated Cycle 4/Reached 16 Week Response||6
129463|NCT01782313|315102|P1|COMPLETED|Treated Cycle 4/Reached 16 Week Response||25
129464|NCT01782313|315102|P1|STARTED|Treated Cycle 4/Reached 16 Week Response||31
129465|NCT01782313|315102|P1|NOT COMPLETED|Treated Cycle 3||21
129466|NCT01782313|315102|P1|COMPLETED|Treated Cycle 3||31
129467|NCT01782313|315102|P1|STARTED|Treated Cycle 3||52
129468|NCT01782313|315102|P1|NOT COMPLETED|Reached First Response/Completed 2 Cycle||6
129469|NCT01782313|315102|P1|COMPLETED|Reached First Response/Completed 2 Cycle||52
129470|NCT01782313|315102|P1|STARTED|Reached First Response/Completed 2 Cycle||58
129471|NCT01782222|315116|P3|NOT COMPLETED|Overall Study||4
129472|NCT01782222|315117|P2|NOT COMPLETED|Overall Study||11
129473|NCT01782222|315118|P1|NOT COMPLETED|Overall Study||8
129474|NCT01782222|315116|P3|COMPLETED|Overall Study||37
129475|NCT01782222|315117|P2|COMPLETED|Overall Study||30
129476|NCT01782222|315118|P1|COMPLETED|Overall Study||32
129477|NCT01782222|315116|P3|STARTED|Overall Study||41
129478|NCT01782222|315117|P2|STARTED|Overall Study||41
129479|NCT01782222|315118|P1|STARTED|Overall Study||40
129480|NCT01781975|315152|P2|NOT COMPLETED|Overall Study||1
129481|NCT01781975|315153|P1|NOT COMPLETED|Overall Study||2
129482|NCT01781975|315152|P2|COMPLETED|Overall Study||21
129483|NCT01781975|315153|P1|COMPLETED|Overall Study||43
129484|NCT01781975|315152|P2|Follow-Up Period|Overall Study||21
129485|NCT01781975|315153|P1|Follow-Up Period|Overall Study||43
129486|NCT01781975|315152|P2|Treatment Period|Overall Study||22
129487|NCT01781975|315153|P1|Treatment Period|Overall Study||44
129488|NCT01781975|315152|P2|STARTED|Overall Study||22
129489|NCT01781975|315153|P1|STARTED|Overall Study||45
129490|NCT01781962|315159|P1|NOT COMPLETED|Overall Study||5
129491|NCT01781962|315159|P1|COMPLETED|Overall Study||201
129492|NCT01781962|315159|P1|STARTED|Overall Study||206
129493|NCT01781832|315165|P1|NOT COMPLETED|Overall Study||1
129494|NCT01781832|315165|P1|COMPLETED|Overall Study||25
129495|NCT01781832|315165|P1|STARTED|Overall Study||26
129496|NCT01781806|315172|P2|NOT COMPLETED|Overall Study||3
129497|NCT01781806|315173|P1|NOT COMPLETED|Overall Study||79
129498|NCT01781806|315172|P2|COMPLETED|Overall Study||1
129499|NCT01781806|315173|P1|COMPLETED|Overall Study||218
129500|NCT01781806|315172|P2|Week 48|Overall Study||1
129501|NCT01781806|315173|P1|Week 48|Overall Study||222
129502|NCT01781806|315172|P2|Week 36|Overall Study||1
129503|NCT01781806|315173|P1|Week 36|Overall Study||247
129504|NCT01781806|315172|P2|Week 24|Overall Study||1
129505|NCT01781806|315173|P1|Week 24|Overall Study||260
129506|NCT01781806|315172|P2|Week 12|Overall Study||2
129507|NCT01781806|315173|P1|Week 12|Overall Study||272
129508|NCT01781806|315172|P2|Week 8|Overall Study||4
129509|NCT01781806|315173|P1|Week 8|Overall Study||278
129510|NCT01781806|315172|P2|Week 4|Overall Study||4
129511|NCT01781806|315173|P1|Week 4|Overall Study||284
129512|NCT01781806|315172|P2|Week 0|Overall Study||4
129513|NCT01781806|315173|P1|Week 0|Overall Study||297
129514|NCT01781806|315172|P2|STARTED|Overall Study||4
129515|NCT01781806|315173|P1|STARTED|Overall Study||297
129516|NCT01781637|315185|P2|NOT COMPLETED|Overall Study||6
129517|NCT01781637|315186|P1|NOT COMPLETED|Overall Study||4
129518|NCT01781637|315185|P2|COMPLETED|Overall Study||2
129519|NCT01781637|315186|P1|COMPLETED|Overall Study||24
129520|NCT01781637|315185|P2|STARTED|Overall Study||8
129521|NCT01781637|315186|P1|STARTED|Overall Study||28
129522|NCT01781481|315194|P1|NOT COMPLETED|Overall Study||0
129523|NCT01781481|315194|P1|COMPLETED|Overall Study||148
129524|NCT01781481|315194|P1|STARTED|Overall Study||148
129525|NCT01781403|315253|P3|NOT COMPLETED|Overall Study||0
129526|NCT01781403|315254|P2|NOT COMPLETED|Overall Study||0
129527|NCT01781403|315255|P1|NOT COMPLETED|Overall Study||0
129528|NCT01781403|315253|P3|COMPLETED|Overall Study||18
129529|NCT01781403|315254|P2|COMPLETED|Overall Study||2
129530|NCT01781403|315255|P1|COMPLETED|Overall Study||2
129531|NCT01781403|315253|P3|STARTED|Overall Study||18
129532|NCT01781403|315254|P2|STARTED|Overall Study||2
129533|NCT01781403|315255|P1|STARTED|Overall Study||2
129534|NCT01781299|315273|P2|NOT COMPLETED|Overall Study||1
129535|NCT01781299|315274|P1|NOT COMPLETED|Overall Study||0
129536|NCT01781299|315273|P2|COMPLETED|Overall Study||4
129537|NCT01781299|315274|P1|COMPLETED|Overall Study||4
129538|NCT01781299|315273|P2|STARTED|Overall Study||5
129539|NCT01781299|315274|P1|STARTED|Overall Study||4
129540|NCT01781286|315282|P6|NOT COMPLETED|Overall Study||1
129541|NCT01781286|315283|P5|NOT COMPLETED|Overall Study||0
129542|NCT01781286|315284|P4|NOT COMPLETED|Overall Study||1
129543|NCT01781286|315285|P3|NOT COMPLETED|Overall Study||2
129544|NCT01781286|315286|P2|NOT COMPLETED|Overall Study||0
129545|NCT01781286|315287|P1|NOT COMPLETED|Overall Study||2
129546|NCT01781286|315282|P6|COMPLETED|Overall Study||2
129547|NCT01781286|315283|P5|COMPLETED|Overall Study||6
129548|NCT01781286|315284|P4|COMPLETED|Overall Study||7
129549|NCT01781286|315285|P3|COMPLETED|Overall Study||7
129550|NCT01781286|315286|P2|COMPLETED|Overall Study||4
129551|NCT01781286|315287|P1|COMPLETED|Overall Study||5
129552|NCT01781286|315282|P6|Started 3rd Intervention|Overall Study||2
129553|NCT01781286|315283|P5|Started 3rd Intervention|Overall Study||6
129554|NCT01781286|315284|P4|Started 3rd Intervention|Overall Study||7
129555|NCT01781286|315285|P3|Started 3rd Intervention|Overall Study||7
129556|NCT01781286|315286|P2|Started 3rd Intervention|Overall Study||4
129557|NCT01781286|315287|P1|Started 3rd Intervention|Overall Study||5
129558|NCT01781286|315282|P6|Started 2nd Intervention|Overall Study||2
129559|NCT01781286|315283|P5|Started 2nd Intervention|Overall Study||6
129560|NCT01781286|315284|P4|Started 2nd Intervention|Overall Study||8
129561|NCT01781286|315285|P3|Started 2nd Intervention|Overall Study||9
129562|NCT01781286|315286|P2|Started 2nd Intervention|Overall Study||4
129563|NCT01781286|315287|P1|Started 2nd Intervention|Overall Study||5
129564|NCT01781286|315282|P6|Started 1st Intervention|Overall Study||2
129565|NCT01781286|315283|P5|Started 1st Intervention|Overall Study||6
129566|NCT01781286|315284|P4|Started 1st Intervention|Overall Study||8
129567|NCT01781286|315285|P3|Started 1st Intervention|Overall Study||9
129568|NCT01781286|315286|P2|Started 1st Intervention|Overall Study||4
129569|NCT01781286|315287|P1|Started 1st Intervention|Overall Study||6
129570|NCT01781286|315282|P6|STARTED|Overall Study||3
129571|NCT01781286|315283|P5|STARTED|Overall Study||6
129572|NCT01781286|315284|P4|STARTED|Overall Study||8
129573|NCT01781286|315285|P3|STARTED|Overall Study||9
129574|NCT01781286|315286|P2|STARTED|Overall Study||4
129575|NCT01781286|315287|P1|STARTED|Overall Study||7
129576|NCT01781234|315312|P2|NOT COMPLETED|Overall Study||3
129577|NCT01781234|315313|P1|NOT COMPLETED|Overall Study||9
129578|NCT01781234|315312|P2|COMPLETED|Overall Study||21
129579|NCT01781234|315313|P1|COMPLETED|Overall Study||18
129580|NCT01781234|315312|P2|STARTED|Overall Study||24
129581|NCT01781234|315313|P1|STARTED|Overall Study||27
129582|NCT01781208|315323|P1|NOT COMPLETED|Overall Study||0
129583|NCT01781208|315323|P1|COMPLETED|Overall Study||62
129584|NCT01781208|315323|P1|Overall Study|Overall Study||62
129585|NCT01781208|315323|P1|STARTED|Overall Study||62
129586|NCT01781169|315330|P2|NOT COMPLETED|Overall Study||0
129587|NCT01781169|315331|P1|NOT COMPLETED|Overall Study||1
129588|NCT01781169|315330|P2|COMPLETED|Overall Study||21
129589|NCT01781169|315331|P1|COMPLETED|Overall Study||21
129590|NCT01781169|315330|P2|STARTED|Overall Study||21
129591|NCT01781169|315331|P1|STARTED|Overall Study||22
129592|NCT01781078|315339|P3|NOT COMPLETED|Overall Study||16
129593|NCT01781078|315340|P2|NOT COMPLETED|Overall Study||5
129594|NCT01781078|315341|P1|NOT COMPLETED|Overall Study||12
129595|NCT01781078|315339|P3|COMPLETED|Overall Study||0
129596|NCT01781078|315340|P2|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|113
129597|NCT01781078|315341|P1|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|217
129598|NCT01781078|315339|P3|STARTED|Overall Study||16
129599|NCT01781078|315340|P2|STARTED|Overall Study|Randomized post implantation|118
129600|NCT01781078|315341|P1|STARTED|Overall Study|Randomized post implantation|229
129601|NCT01781026|315351|P1|NOT COMPLETED|Overall Study||2
129602|NCT01781026|315351|P1|COMPLETED|Overall Study||0
129603|NCT01781026|315351|P1|STARTED|Overall Study||2
129604|NCT01780987|315357|P2|NOT COMPLETED|Overall Study||6
129605|NCT01780987|315358|P1|NOT COMPLETED|Overall Study||3
129606|NCT01780987|315357|P2|COMPLETED|Overall Study||34
129607|NCT01780987|315358|P1|COMPLETED|Overall Study||37
129608|NCT01780987|315357|P2|STARTED|Overall Study|Including one participant who withdrew from the study prior to receiving any study medication.|40
129609|NCT01780987|315358|P1|STARTED|Overall Study||40
129610|NCT01780974|315376|P2|NOT COMPLETED|Overall Study||3
129611|NCT01780974|315377|P1|NOT COMPLETED|Overall Study||2
129612|NCT01780974|315376|P2|COMPLETED|Overall Study||18
129613|NCT01780974|315377|P1|COMPLETED|Overall Study||19
129614|NCT01780974|315376|P2|STARTED|Overall Study||21
129615|NCT01780974|315377|P1|STARTED|Overall Study||21
129616|NCT01780935|315387|P2|NOT COMPLETED|Overall Study||336
129617|NCT01780935|315388|P1|NOT COMPLETED|Overall Study||335
129618|NCT01780935|315387|P2|COMPLETED|Overall Study||0
129619|NCT01780935|315388|P1|COMPLETED|Overall Study||0
129620|NCT01780935|315387|P2|Safety Set|Overall Study||336
129621|NCT01780935|315388|P1|Safety Set|Overall Study||334
129622|NCT01780935|315387|P2|STARTED|Overall Study||336
129623|NCT01780935|315388|P1|STARTED|Overall Study||335
129624|NCT01780922|315418|P6|NOT COMPLETED|Third Intervention (1 Day)||0
129625|NCT01780922|315419|P5|NOT COMPLETED|Third Intervention (1 Day)||0
129626|NCT01780922|315420|P4|NOT COMPLETED|Third Intervention (1 Day)||0
129627|NCT01780922|315421|P3|NOT COMPLETED|Third Intervention (1 Day)||0
129628|NCT01780922|315422|P2|NOT COMPLETED|Third Intervention (1 Day)||0
129629|NCT01780922|315423|P1|NOT COMPLETED|Third Intervention (1 Day)||0
129630|NCT01780922|315418|P6|COMPLETED|Third Intervention (1 Day)||2
129631|NCT01780922|315419|P5|COMPLETED|Third Intervention (1 Day)||2
129632|NCT01780922|315420|P4|COMPLETED|Third Intervention (1 Day)||2
129633|NCT01780922|315421|P3|COMPLETED|Third Intervention (1 Day)||2
129634|NCT01780922|315422|P2|COMPLETED|Third Intervention (1 Day)||2
129635|NCT01780922|315423|P1|COMPLETED|Third Intervention (1 Day)||2
129636|NCT01780922|315418|P6|STARTED|Third Intervention (1 Day)||2
129637|NCT01780922|315419|P5|STARTED|Third Intervention (1 Day)||2
129638|NCT01780922|315420|P4|STARTED|Third Intervention (1 Day)||2
129639|NCT01780922|315421|P3|STARTED|Third Intervention (1 Day)||2
129640|NCT01780922|315422|P2|STARTED|Third Intervention (1 Day)||2
129641|NCT01780922|315423|P1|STARTED|Third Intervention (1 Day)||2
129642|NCT01780922|315418|P6|NOT COMPLETED|Washout (7 Days)||0
129643|NCT01780922|315419|P5|NOT COMPLETED|Washout (7 Days)||0
129644|NCT01780922|315420|P4|NOT COMPLETED|Washout (7 Days)||0
129645|NCT01780922|315421|P3|NOT COMPLETED|Washout (7 Days)||0
129646|NCT01780922|315422|P2|NOT COMPLETED|Washout (7 Days)||0
129647|NCT01780922|315423|P1|NOT COMPLETED|Washout (7 Days)||0
129648|NCT01780922|315418|P6|COMPLETED|Washout (7 Days)||2
129649|NCT01780922|315419|P5|COMPLETED|Washout (7 Days)||2
129650|NCT01780922|315420|P4|COMPLETED|Washout (7 Days)||2
129651|NCT01780922|315421|P3|COMPLETED|Washout (7 Days)||2
129652|NCT01780922|315422|P2|COMPLETED|Washout (7 Days)||2
129653|NCT01780922|315423|P1|COMPLETED|Washout (7 Days)||2
129654|NCT01780922|315418|P6|STARTED|Washout (7 Days)||2
129655|NCT01780922|315419|P5|STARTED|Washout (7 Days)||2
129656|NCT01780922|315420|P4|STARTED|Washout (7 Days)||2
129657|NCT01780922|315421|P3|STARTED|Washout (7 Days)||2
129658|NCT01780922|315422|P2|STARTED|Washout (7 Days)||2
129659|NCT01780922|315423|P1|STARTED|Washout (7 Days)||2
129660|NCT01780922|315418|P6|NOT COMPLETED|Second Intervention (1 Day)||0
129661|NCT01780922|315419|P5|NOT COMPLETED|Second Intervention (1 Day)||0
129662|NCT01780922|315420|P4|NOT COMPLETED|Second Intervention (1 Day)||0
129663|NCT01780922|315421|P3|NOT COMPLETED|Second Intervention (1 Day)||0
129664|NCT01780922|315422|P2|NOT COMPLETED|Second Intervention (1 Day)||0
129665|NCT01780922|315423|P1|NOT COMPLETED|Second Intervention (1 Day)||0
129666|NCT01780922|315418|P6|COMPLETED|Second Intervention (1 Day)||2
129667|NCT01780922|315419|P5|COMPLETED|Second Intervention (1 Day)||2
129668|NCT01780922|315420|P4|COMPLETED|Second Intervention (1 Day)||2
129669|NCT01780922|315421|P3|COMPLETED|Second Intervention (1 Day)||2
129670|NCT01780922|315422|P2|COMPLETED|Second Intervention (1 Day)||2
129671|NCT01780922|315423|P1|COMPLETED|Second Intervention (1 Day)||2
129672|NCT01780922|315418|P6|STARTED|Second Intervention (1 Day)||2
129673|NCT01780922|315419|P5|STARTED|Second Intervention (1 Day)||2
129674|NCT01780922|315420|P4|STARTED|Second Intervention (1 Day)||2
129675|NCT01780922|315421|P3|STARTED|Second Intervention (1 Day)||2
129676|NCT01780922|315422|P2|STARTED|Second Intervention (1 Day)||2
129677|NCT01780922|315423|P1|STARTED|Second Intervention (1 Day)||2
129678|NCT01780922|315418|P6|NOT COMPLETED|Washout (7 Days)||0
129679|NCT01780922|315419|P5|NOT COMPLETED|Washout (7 Days)||0
129680|NCT01780922|315420|P4|NOT COMPLETED|Washout (7 Days)||0
129681|NCT01780922|315421|P3|NOT COMPLETED|Washout (7 Days)||0
129682|NCT01780922|315422|P2|NOT COMPLETED|Washout (7 Days)||0
129683|NCT01780922|315423|P1|NOT COMPLETED|Washout (7 Days)||0
129684|NCT01780922|315418|P6|COMPLETED|Washout (7 Days)||2
129685|NCT01780922|315419|P5|COMPLETED|Washout (7 Days)||2
129686|NCT01780922|315420|P4|COMPLETED|Washout (7 Days)||2
129687|NCT01780922|315421|P3|COMPLETED|Washout (7 Days)||2
129688|NCT01780922|315422|P2|COMPLETED|Washout (7 Days)||2
129689|NCT01780922|315423|P1|COMPLETED|Washout (7 Days)||2
129690|NCT01780922|315418|P6|STARTED|Washout (7 Days)||2
129691|NCT01780922|315419|P5|STARTED|Washout (7 Days)||2
129692|NCT01780922|315420|P4|STARTED|Washout (7 Days)||2
129693|NCT01780922|315421|P3|STARTED|Washout (7 Days)||2
129694|NCT01780922|315422|P2|STARTED|Washout (7 Days)||2
129695|NCT01780922|315423|P1|STARTED|Washout (7 Days)||2
129696|NCT01780922|315418|P6|NOT COMPLETED|First Intervention (1 Day)||0
129697|NCT01780922|315419|P5|NOT COMPLETED|First Intervention (1 Day)||0
129698|NCT01780922|315420|P4|NOT COMPLETED|First Intervention (1 Day)||0
129699|NCT01780922|315421|P3|NOT COMPLETED|First Intervention (1 Day)||0
129700|NCT01780922|315422|P2|NOT COMPLETED|First Intervention (1 Day)||0
129701|NCT01780922|315423|P1|NOT COMPLETED|First Intervention (1 Day)||0
129702|NCT01780922|315418|P6|COMPLETED|First Intervention (1 Day)||2
129703|NCT01780922|315419|P5|COMPLETED|First Intervention (1 Day)||2
129704|NCT01780922|315420|P4|COMPLETED|First Intervention (1 Day)||2
129705|NCT01780922|315421|P3|COMPLETED|First Intervention (1 Day)||2
129706|NCT01780922|315422|P2|COMPLETED|First Intervention (1 Day)||2
129707|NCT01780922|315423|P1|COMPLETED|First Intervention (1 Day)||2
129708|NCT01780922|315418|P6|STARTED|First Intervention (1 Day)||2
129709|NCT01780922|315419|P5|STARTED|First Intervention (1 Day)||2
129710|NCT01780922|315420|P4|STARTED|First Intervention (1 Day)||2
129711|NCT01780922|315421|P3|STARTED|First Intervention (1 Day)||2
129712|NCT01780922|315422|P2|STARTED|First Intervention (1 Day)||2
129713|NCT01780922|315423|P1|STARTED|First Intervention (1 Day)||2
129714|NCT01780870|315478|P2|NOT COMPLETED|Overall Study||0
129715|NCT01780870|315479|P1|NOT COMPLETED|Overall Study||0
129716|NCT01780870|315478|P2|COMPLETED|Overall Study||5
129717|NCT01780870|315479|P1|COMPLETED|Overall Study||0
129718|NCT01780870|315478|P2|STARTED|Overall Study||5
129719|NCT01780870|315479|P1|STARTED|Overall Study||0
129720|NCT01780662|315492|P3|NOT COMPLETED|Overall Study||10
129721|NCT01780662|315493|P2|NOT COMPLETED|Overall Study||6
129722|NCT01780662|315494|P1|NOT COMPLETED|Overall Study||1
129723|NCT01780662|315492|P3|COMPLETED|Overall Study||20
129724|NCT01780662|315493|P2|COMPLETED|Overall Study||7
129725|NCT01780662|315494|P1|COMPLETED|Overall Study||2
129726|NCT01780662|315492|P3|STARTED|Overall Study||30
129727|NCT01780662|315493|P2|STARTED|Overall Study||13
129728|NCT01780662|315494|P1|STARTED|Overall Study||3
129729|NCT01780584|315511|P3|NOT COMPLETED|Overall Study||2
129730|NCT01780584|315512|P2|NOT COMPLETED|Overall Study||1
129731|NCT01780584|315513|P1|NOT COMPLETED|Overall Study||1
129732|NCT01780584|315511|P3|COMPLETED|Overall Study||13
129733|NCT01780584|315512|P2|COMPLETED|Overall Study||14
129734|NCT01780584|315513|P1|COMPLETED|Overall Study||14
129735|NCT01780584|315511|P3|STARTED|Overall Study||15
129736|NCT01780584|315512|P2|STARTED|Overall Study||15
129737|NCT01780584|315513|P1|STARTED|Overall Study||15
129738|NCT01780545|315535|P2|NOT COMPLETED|Overall Study||2
129739|NCT01780545|315536|P1|NOT COMPLETED|Overall Study||4
129740|NCT01780545|315535|P2|COMPLETED|Overall Study||99
129741|NCT01780545|315536|P1|COMPLETED|Overall Study||95
129742|NCT01780545|315535|P2|STARTED|Overall Study||101
129743|NCT01780545|315536|P1|STARTED|Overall Study||99
129744|NCT01780506|315554|P2|NOT COMPLETED|Open-Label Extension Phase||1
129745|NCT01780506|315555|P1|NOT COMPLETED|Open-Label Extension Phase||0
129746|NCT01780506|315554|P2|COMPLETED|Open-Label Extension Phase||94
129747|NCT01780506|315555|P1|COMPLETED|Open-Label Extension Phase||90
129748|NCT01780506|315554|P2|STARTED|Open-Label Extension Phase|261 participants completed the Double-Blind Phase but did not enter the Open-Label Extension Phase|95
129749|NCT01780506|315555|P1|STARTED|Open-Label Extension Phase|278 participants completed the Double-Blind Phase but did not enter the Open-Label Extension Phase|90
129750|NCT01780506|315554|P2|NOT COMPLETED|Double-Blind Phase||78
129751|NCT01780506|315555|P1|NOT COMPLETED|Double-Blind Phase||70
129752|NCT01780506|315554|P2|COMPLETED|Double-Blind Phase||356
129753|NCT01780506|315555|P1|COMPLETED|Double-Blind Phase||368
129754|NCT01780506|315554|P2|STARTED|Double-Blind Phase||434
129755|NCT01780506|315555|P1|STARTED|Double-Blind Phase||438
129756|NCT01780389|315609|P1|NOT COMPLETED|Overall Study||1
129757|NCT01780389|315609|P1|COMPLETED|Overall Study|One patient discontinued due to adverse event.|4
129758|NCT01780389|315609|P1|STARTED|Overall Study||5
129759|NCT01780350|315620|P1|NOT COMPLETED|Overall Study||0
129760|NCT01780350|315620|P1|COMPLETED|Overall Study||200
129761|NCT01780350|315620|P1|STARTED|Overall Study||200
129762|NCT01780337|315627|P2|NOT COMPLETED|Overall Study||0
129763|NCT01780337|315628|P1|NOT COMPLETED|Overall Study||0
129764|NCT01780337|315627|P2|COMPLETED|Overall Study||6
129765|NCT01780337|315628|P1|COMPLETED|Overall Study||6
129766|NCT01780337|315627|P2|STARTED|Overall Study||6
129767|NCT01780337|315628|P1|STARTED|Overall Study||6
129768|NCT01780324|315640|P2|NOT COMPLETED|Overall Study||6
129769|NCT01780324|315641|P1|NOT COMPLETED|Overall Study||1
129770|NCT01780324|315640|P2|COMPLETED|Overall Study||33
129771|NCT01780324|315641|P1|COMPLETED|Overall Study||40
129772|NCT01780324|315640|P2|STARTED|Overall Study||39
129773|NCT01780324|315641|P1|STARTED|Overall Study||41
129774|NCT01779869|315647|P1|NOT COMPLETED|Overall Study||2
129775|NCT01779869|315647|P1|COMPLETED|Overall Study||14
129776|NCT01779869|315647|P1|STARTED|Overall Study||16
129777|NCT01779700|315653|P2|NOT COMPLETED|Overall Study||5
129778|NCT01779700|315654|P1|NOT COMPLETED|Overall Study||4
129779|NCT01779700|315653|P2|COMPLETED|Overall Study||17
129780|NCT01779700|315654|P1|COMPLETED|Overall Study||14
129781|NCT01779700|315653|P2|STARTED|Overall Study||22
129782|NCT01779700|315654|P1|STARTED|Overall Study||18
129783|NCT01779648|315694|P2|NOT COMPLETED|Overall Study||0
129784|NCT01779648|315695|P1|NOT COMPLETED|Overall Study||1
129785|NCT01779648|315694|P2|COMPLETED|Overall Study||27
129786|NCT01779648|315695|P1|COMPLETED|Overall Study||27
129787|NCT01779648|315694|P2|STARTED|Overall Study||27
129788|NCT01779648|315695|P1|STARTED|Overall Study||28
129789|NCT01779440|315725|P2|NOT COMPLETED|Overall Study||5
129790|NCT01779440|315726|P1|NOT COMPLETED|Overall Study||3
129791|NCT01779440|315725|P2|COMPLETED|Overall Study||23
129792|NCT01779440|315726|P1|COMPLETED|Overall Study||27
129793|NCT01779440|315725|P2|STARTED|Overall Study||28
129794|NCT01779440|315726|P1|STARTED|Overall Study||30
129795|NCT01779375|315736|P2|NOT COMPLETED|Overall Study||3
129796|NCT01779375|315737|P1|NOT COMPLETED|Overall Study||2
129797|NCT01779375|315736|P2|COMPLETED|Overall Study||41
129798|NCT01779375|315737|P1|COMPLETED|Overall Study||45
129799|NCT01779375|315736|P2|STARTED|Overall Study||44
129800|NCT01779375|315737|P1|STARTED|Overall Study||47
129801|NCT01779219|315753|P2|NOT COMPLETED|Overall Study||0
129802|NCT01779219|315754|P1|NOT COMPLETED|Overall Study||0
129803|NCT01779219|315753|P2|COMPLETED|Overall Study|First interim analysis|21
129804|NCT01779219|315754|P1|COMPLETED|Overall Study|First interim analysis|21
129805|NCT01779219|315753|P2|STARTED|Overall Study|First interim analysis|21
129806|NCT01779219|315754|P1|STARTED|Overall Study|First interim analysis|21
129807|NCT01779167|315766|P1|NOT COMPLETED|Overall Study||1
129808|NCT01779167|315766|P1|COMPLETED|Overall Study||3
129809|NCT01779167|315766|P1|STARTED|Overall Study||4
129810|NCT01779141|315775|P1|NOT COMPLETED|Overall Study||181
129811|NCT01779141|315775|P1|COMPLETED|Overall Study||300
129812|NCT01779141|315775|P1|STARTED|Overall Study||481
129813|NCT01779024|315782|P2|NOT COMPLETED|2nd Visit - Functional MRI||0
129814|NCT01779024|315783|P1|NOT COMPLETED|2nd Visit - Functional MRI||0
129815|NCT01779024|315782|P2|COMPLETED|2nd Visit - Functional MRI||6
129816|NCT01779024|315783|P1|COMPLETED|2nd Visit - Functional MRI||5
129817|NCT01779024|315782|P2|STARTED|2nd Visit - Functional MRI||6
129818|NCT01779024|315783|P1|STARTED|2nd Visit - Functional MRI||5
129819|NCT01779024|315782|P2|NOT COMPLETED|1st Visit - Functional MRI||2
129820|NCT01779024|315783|P1|NOT COMPLETED|1st Visit - Functional MRI||2
129821|NCT01779024|315782|P2|COMPLETED|1st Visit - Functional MRI||5
129822|NCT01779024|315783|P1|COMPLETED|1st Visit - Functional MRI||4
129823|NCT01779024|315782|P2|STARTED|1st Visit - Functional MRI||7
129824|NCT01779024|315783|P1|STARTED|1st Visit - Functional MRI||6
129825|NCT01779024|315782|P2|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||0
129826|NCT01779024|315783|P1|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||2
129827|NCT01779024|315782|P2|COMPLETED|2nd Visit - Alcohol Self-Administration||9
129828|NCT01779024|315783|P1|COMPLETED|2nd Visit - Alcohol Self-Administration||6
129829|NCT01779024|315782|P2|STARTED|2nd Visit - Alcohol Self-Administration||9
129830|NCT01779024|315783|P1|STARTED|2nd Visit - Alcohol Self-Administration||8
129831|NCT01779024|315782|P2|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0
129832|NCT01779024|315783|P1|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0
129833|NCT01779024|315782|P2|COMPLETED|1st Visit - Alcohol Self-Administration||9
129834|NCT01779024|315783|P1|COMPLETED|1st Visit - Alcohol Self-Administration||8
129835|NCT01779024|315782|P2|STARTED|1st Visit - Alcohol Self-Administration||9
129836|NCT01779024|315783|P1|STARTED|1st Visit - Alcohol Self-Administration||8
129837|NCT01778985|315791|P2|NOT COMPLETED|Overall Study||3
129838|NCT01778985|315792|P1|NOT COMPLETED|Overall Study||7
129839|NCT01778985|315791|P2|COMPLETED|Overall Study||12
129840|NCT01778985|315792|P1|COMPLETED|Overall Study||8
129841|NCT01778985|315791|P2|STARTED|Overall Study||15
129842|NCT01778985|315792|P1|STARTED|Overall Study||15
129843|NCT01778855|315838|P2|NOT COMPLETED|Overall Study||1
129844|NCT01778855|315839|P1|NOT COMPLETED|Overall Study||0
129845|NCT01778855|315838|P2|COMPLETED|Overall Study||3
129846|NCT01778855|315839|P1|COMPLETED|Overall Study||2
129847|NCT01778855|315838|P2|STARTED|Overall Study||4
129848|NCT01778855|315839|P1|STARTED|Overall Study||2
129849|NCT01778751|315847|P2|NOT COMPLETED|Overall Study||2
129850|NCT01778751|315848|P1|NOT COMPLETED|Overall Study||2
129851|NCT01778751|315847|P2|COMPLETED|Overall Study||23
129852|NCT01778751|315848|P1|COMPLETED|Overall Study||23
129853|NCT01778751|315847|P2|STARTED|Overall Study||25
129854|NCT01778751|315848|P1|STARTED|Overall Study||25
129855|NCT01778634|315862|P2|NOT COMPLETED|Overall Study||0
129856|NCT01778634|315863|P1|NOT COMPLETED|Overall Study||0
129857|NCT01778634|315862|P2|COMPLETED|Overall Study||60
129858|NCT01778634|315863|P1|COMPLETED|Overall Study||61
129859|NCT01778634|315862|P2|STARTED|Overall Study||60
129860|NCT01778634|315863|P1|STARTED|Overall Study||61
129861|NCT01778556|315901|P2|NOT COMPLETED|Long-term Follow-up||0
129862|NCT01778556|315902|P1|NOT COMPLETED|Long-term Follow-up||1
129863|NCT01778556|315901|P2|COMPLETED|Long-term Follow-up|no long-term follow-up period in on-leptin arm|0
129864|NCT01778556|315902|P1|COMPLETED|Long-term Follow-up||14
129865|NCT01778556|315901|P2|STARTED|Long-term Follow-up|no long-term follow-up period in on-leptin arm|0
129866|NCT01778556|315902|P1|STARTED|Long-term Follow-up||15
129867|NCT01778556|315901|P2|NOT COMPLETED|Intervention 2 (14 Days)||0
129868|NCT01778556|315902|P1|NOT COMPLETED|Intervention 2 (14 Days)||1
129869|NCT01778556|315901|P2|COMPLETED|Intervention 2 (14 Days)||8
129870|NCT01778556|315902|P1|COMPLETED|Intervention 2 (14 Days)||14
129871|NCT01778556|315901|P2|STARTED|Intervention 2 (14 Days)||8
129872|NCT01778556|315902|P1|STARTED|Intervention 2 (14 Days)||15
129873|NCT01778556|315901|P2|NOT COMPLETED|Intervention 1 (5 Days)||2
129874|NCT01778556|315902|P1|NOT COMPLETED|Intervention 1 (5 Days)||0
129875|NCT01778556|315901|P2|COMPLETED|Intervention 1 (5 Days)||8
129876|NCT01778556|315902|P1|COMPLETED|Intervention 1 (5 Days)||15
129877|NCT01778556|315901|P2|STARTED|Intervention 1 (5 Days)||10
129878|NCT01778556|315902|P1|STARTED|Intervention 1 (5 Days)||15
129879|NCT01778530|315915|P1|NOT COMPLETED|Overall Study||2
129880|NCT01778530|315915|P1|COMPLETED|Overall Study||0
129881|NCT01778530|315915|P1|STARTED|Overall Study||2
129882|NCT01778426|315922|P2|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0
129883|NCT01778426|315923|P1|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0
129884|NCT01778426|315922|P2|COMPLETED|Intention-To-Treat (ITT) - Completer|Not applicable: ITT-completer contains only primo-implant subjects.|0
129885|NCT01778426|315923|P1|COMPLETED|Intention-To-Treat (ITT) - Completer||198
129886|NCT01778426|315922|P2|STARTED|Intention-To-Treat (ITT) - Completer|Not applicable: ITT-completer contains only primo-implant subjects.|0
129887|NCT01778426|315923|P1|STARTED|Intention-To-Treat (ITT) - Completer||198
129888|NCT01778426|315922|P2|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||25
129889|NCT01778426|315923|P1|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||56
129890|NCT01778426|315922|P2|COMPLETED|Overall Study - Full Analysis Set (FAS)||113
129891|NCT01778426|315923|P1|COMPLETED|Overall Study - Full Analysis Set (FAS)||208
129892|NCT01778426|315922|P2|STARTED|Overall Study - Full Analysis Set (FAS)||138
129893|NCT01778426|315923|P1|STARTED|Overall Study - Full Analysis Set (FAS)||264
129894|NCT01778296|315939|P1|NOT COMPLETED|Overall Study||0
129895|NCT01778296|315939|P1|COMPLETED|Overall Study|No patient was lost to follow-up.|12
129896|NCT01778296|315939|P1|STARTED|Overall Study|There were 12 patients included in the study in the initial stage.|12
129897|NCT01778127|315946|P3|NOT COMPLETED|Overall Study||6
129898|NCT01778127|315947|P2|NOT COMPLETED|Overall Study||2
129899|NCT01778127|315948|P1|NOT COMPLETED|Overall Study||8
129900|NCT01778127|315946|P3|COMPLETED|Overall Study||26
129901|NCT01778127|315947|P2|COMPLETED|Overall Study||31
129902|NCT01778127|315948|P1|COMPLETED|Overall Study||25
129903|NCT01778127|315946|P3|STARTED|Overall Study||32
129904|NCT01778127|315947|P2|STARTED|Overall Study||33
129905|NCT01778127|315948|P1|STARTED|Overall Study||33
129906|NCT01778062|315991|P2|NOT COMPLETED|Overall Study||11
129907|NCT01778062|315992|P1|NOT COMPLETED|Overall Study||6
129908|NCT01778062|315991|P2|COMPLETED|Overall Study||57
129909|NCT01778062|315992|P1|COMPLETED|Overall Study||62
129910|NCT01778062|315991|P2|Intent to Treat (ITT)|Overall Study|One failed to perform primary efficacy evaluation and was excluded, 135 were included in the ITT set|67
129911|NCT01778062|315992|P1|Intent to Treat (ITT)|Overall Study||68
129912|NCT01778062|315991|P2|Safety Set|Overall Study||68
129913|NCT01778062|315992|P1|Safety Set|Overall Study||68
129914|NCT01778062|315991|P2|STARTED|Overall Study||68
129915|NCT01778062|315992|P1|STARTED|Overall Study||68
129916|NCT01778049|316006|P6|NOT COMPLETED|Double Blind Treatment Period||7
129917|NCT01778049|316007|P5|NOT COMPLETED|Double Blind Treatment Period||12
129918|NCT01778049|316008|P4|NOT COMPLETED|Double Blind Treatment Period||12
129919|NCT01778049|316009|P3|NOT COMPLETED|Double Blind Treatment Period||15
129920|NCT01778049|316010|P2|NOT COMPLETED|Double Blind Treatment Period||0
129921|NCT01778049|316011|P1|NOT COMPLETED|Double Blind Treatment Period||0
129922|NCT01778049|316006|P6|COMPLETED|Double Blind Treatment Period||105
129923|NCT01778049|316007|P5|COMPLETED|Double Blind Treatment Period||102
129924|NCT01778049|316008|P4|COMPLETED|Double Blind Treatment Period||118
129925|NCT01778049|316009|P3|COMPLETED|Double Blind Treatment Period||111
129926|NCT01778049|316010|P2|COMPLETED|Double Blind Treatment Period||0
129927|NCT01778049|316011|P1|COMPLETED|Double Blind Treatment Period||0
129928|NCT01778049|316006|P6|STARTED|Double Blind Treatment Period||112
129929|NCT01778049|316007|P5|STARTED|Double Blind Treatment Period||114
129930|NCT01778049|316008|P4|STARTED|Double Blind Treatment Period||130
129931|NCT01778049|316009|P3|STARTED|Double Blind Treatment Period||126
129932|NCT01778049|316010|P2|STARTED|Double Blind Treatment Period||0
129933|NCT01778049|316011|P1|STARTED|Double Blind Treatment Period||0
129934|NCT01778049|316006|P6|NOT COMPLETED|Open Label Treatment Period||0
129935|NCT01778049|316007|P5|NOT COMPLETED|Open Label Treatment Period||0
129936|NCT01778049|316008|P4|NOT COMPLETED|Open Label Treatment Period||0
129937|NCT01778049|316009|P3|NOT COMPLETED|Open Label Treatment Period||0
129938|NCT01778049|316010|P2|NOT COMPLETED|Open Label Treatment Period||129
129939|NCT01778049|316011|P1|NOT COMPLETED|Open Label Treatment Period||98
129940|NCT01778049|316006|P6|COMPLETED|Open Label Treatment Period||0
129941|NCT01778049|316007|P5|COMPLETED|Open Label Treatment Period||0
129942|NCT01778049|316008|P4|COMPLETED|Open Label Treatment Period||0
129943|NCT01778049|316009|P3|COMPLETED|Open Label Treatment Period||0
129944|NCT01778049|316010|P2|COMPLETED|Open Label Treatment Period||226
129945|NCT01778049|316011|P1|COMPLETED|Open Label Treatment Period||256
129946|NCT01778049|316006|P6|STARTED|Open Label Treatment Period||0
129947|NCT01778049|316007|P5|STARTED|Open Label Treatment Period||0
129948|NCT01778049|316008|P4|STARTED|Open Label Treatment Period||0
129949|NCT01778049|316009|P3|STARTED|Open Label Treatment Period||0
129950|NCT01778049|316010|P2|STARTED|Open Label Treatment Period||355
129951|NCT01778049|316011|P1|STARTED|Open Label Treatment Period||354
129952|NCT01778023|316029|P2|NOT COMPLETED|Overall Study||3
129953|NCT01778023|316030|P1|NOT COMPLETED|Overall Study||0
129954|NCT01778023|316029|P2|COMPLETED|Overall Study||15
129955|NCT01778023|316030|P1|COMPLETED|Overall Study||36
129956|NCT01778023|316029|P2|Exposed|Overall Study||15
129957|NCT01778023|316030|P1|Exposed|Overall Study||36
129958|NCT01778023|316029|P2|STARTED|Overall Study||18
129959|NCT01778023|316030|P1|STARTED|Overall Study||36
129960|NCT01778010|316047|P1|NOT COMPLETED|Overall Study||5
129961|NCT01778010|316047|P1|COMPLETED|Overall Study||8
129962|NCT01778010|316047|P1|STARTED|Overall Study||13
129963|NCT01777997|316088|P1|NOT COMPLETED|Weeks 48 to 72/96 on ART||2
129964|NCT01777997|316088|P1|COMPLETED|Weeks 48 to 72/96 on ART||26
129965|NCT01777997|316088|P1|STARTED|Weeks 48 to 72/96 on ART||28
129966|NCT01777997|316088|P1|NOT COMPLETED|Weeks 0 to 24/48 on ART||1
129967|NCT01777997|316088|P1|COMPLETED|Weeks 0 to 24/48 on ART|7 of these participants opted not to continue ART into next period|35
129968|NCT01777997|316088|P1|STARTED|Weeks 0 to 24/48 on ART||36
129969|NCT01777997|316088|P1|NOT COMPLETED|12 Week lead-in of no ART||2
129970|NCT01777997|316088|P1|COMPLETED|12 Week lead-in of no ART||36
129971|NCT01777997|316088|P1|STARTED|12 Week lead-in of no ART||38
129972|NCT01777945|316100|P1|NOT COMPLETED|Overall Study||0
129973|NCT01777945|316100|P1|COMPLETED|Overall Study||46
129974|NCT01777945|316100|P1|Evaluable Participants|Overall Study||45
129975|NCT01777945|316100|P1|STARTED|Overall Study||46
129976|NCT01777932|316110|P1|NOT COMPLETED|Overall Study||205
129977|NCT01777932|316110|P1|COMPLETED|Overall Study||15
129978|NCT01777932|316110|P1|STARTED|Overall Study||220
129979|NCT01777854|316124|P2|NOT COMPLETED|Overall Study||3
129980|NCT01777854|316125|P1|NOT COMPLETED|Overall Study||3
129981|NCT01777854|316124|P2|COMPLETED|Overall Study||0
129982|NCT01777854|316125|P1|COMPLETED|Overall Study||0
129983|NCT01777854|316124|P2|STARTED|Overall Study||3
129984|NCT01777854|316125|P1|STARTED|Overall Study||3
129985|NCT01777776|316133|P4|NOT COMPLETED|Overall Study||4
129986|NCT01777776|316134|P3|NOT COMPLETED|Overall Study||6
129987|NCT01777776|316135|P2|NOT COMPLETED|Overall Study||12
129988|NCT01777776|316136|P1|NOT COMPLETED|Overall Study||6
129989|NCT01777776|316133|P4|COMPLETED|Overall Study||0
129990|NCT01777776|316134|P3|COMPLETED|Overall Study||0
129991|NCT01777776|316135|P2|COMPLETED|Overall Study||0
129992|NCT01777776|316136|P1|COMPLETED|Overall Study||0
129993|NCT01777776|316133|P4|STARTED|Overall Study||4
129994|NCT01777776|316134|P3|STARTED|Overall Study||6
129995|NCT01777776|316135|P2|STARTED|Overall Study||12
129996|NCT01777776|316136|P1|STARTED|Overall Study||6
129997|NCT01777763|316195|P2|NOT COMPLETED|Overall Study||47
129998|NCT01777763|316196|P1|NOT COMPLETED|Overall Study||4
129999|NCT01777763|316195|P2|COMPLETED|Overall Study||163
130000|NCT01777763|316196|P1|COMPLETED|Overall Study||16
130001|NCT01777763|316195|P2|STARTED|Overall Study||210
130002|NCT01777763|316196|P1|STARTED|Overall Study||20
130003|NCT01777620|316220|P2|NOT COMPLETED|Overall Study||0
130004|NCT01777620|316221|P1|NOT COMPLETED|Overall Study||1
130005|NCT01777620|316220|P2|COMPLETED|Overall Study||62
130006|NCT01777620|316221|P1|COMPLETED|Overall Study||62
130007|NCT01777620|316220|P2|STARTED|Overall Study||62
130008|NCT01777620|316221|P1|STARTED|Overall Study||63
130009|NCT01777581|316247|P2|NOT COMPLETED|Overall Study||2
130010|NCT01777581|316248|P1|NOT COMPLETED|Overall Study||3
130011|NCT01777581|316247|P2|COMPLETED|Overall Study||3
130012|NCT01777581|316248|P1|COMPLETED|Overall Study||5
130013|NCT01777581|316247|P2|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|5
130014|NCT01777581|316248|P1|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|8
130015|NCT01777568|316268|P2|NOT COMPLETED|Overall Study||0
130016|NCT01777568|316269|P1|NOT COMPLETED|Overall Study||0
130017|NCT01777568|316268|P2|COMPLETED|Overall Study||2896
130018|NCT01777568|316269|P1|COMPLETED|Overall Study||2853
130019|NCT01777568|316268|P2|STARTED|Overall Study||2896
130020|NCT01777568|316269|P1|STARTED|Overall Study||2853
130021|NCT01777542|316277|P2|NOT COMPLETED|Second Intervention (20 Weeks)||1
130022|NCT01777542|316278|P1|NOT COMPLETED|Second Intervention (20 Weeks)||0
130023|NCT01777542|316277|P2|COMPLETED|Second Intervention (20 Weeks)||14
130024|NCT01777542|316278|P1|COMPLETED|Second Intervention (20 Weeks)||15
130025|NCT01777542|316277|P2|STARTED|Second Intervention (20 Weeks)||15
130026|NCT01777542|316278|P1|STARTED|Second Intervention (20 Weeks)||15
130027|NCT01777542|316277|P2|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
130028|NCT01777542|316278|P1|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
130029|NCT01777542|316277|P2|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
130030|NCT01777542|316278|P1|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
130031|NCT01777542|316277|P2|STARTED|Washout Period (28 +/- 2 Weeks)||15
130032|NCT01777542|316278|P1|STARTED|Washout Period (28 +/- 2 Weeks)||15
130033|NCT01777542|316277|P2|NOT COMPLETED|First Intervention (20 Weeks)||0
130034|NCT01777542|316278|P1|NOT COMPLETED|First Intervention (20 Weeks)||0
130035|NCT01777542|316277|P2|COMPLETED|First Intervention (20 Weeks)||15
130036|NCT01777542|316278|P1|COMPLETED|First Intervention (20 Weeks)||15
130037|NCT01777542|316277|P2|STARTED|First Intervention (20 Weeks)||15
130038|NCT01777542|316278|P1|STARTED|First Intervention (20 Weeks)||15
130039|NCT01777490|316321|P4|NOT COMPLETED|Overall Study||1
130040|NCT01777490|316322|P3|NOT COMPLETED|Overall Study||1
130041|NCT01777490|316323|P2|NOT COMPLETED|Overall Study||0
130042|NCT01777490|316324|P1|NOT COMPLETED|Overall Study||0
130043|NCT01777490|316321|P4|COMPLETED|Overall Study||118
130044|NCT01777490|316322|P3|COMPLETED|Overall Study||118
130045|NCT01777490|316323|P2|COMPLETED|Overall Study||123
130046|NCT01777490|316324|P1|COMPLETED|Overall Study||123
130047|NCT01777490|316321|P4|STARTED|Overall Study||119
130048|NCT01777490|316322|P3|STARTED|Overall Study||119
130049|NCT01777490|316323|P2|STARTED|Overall Study||123
130050|NCT01777490|316324|P1|STARTED|Overall Study||123
130051|NCT01777438|316342|P2|NOT COMPLETED|Overall Study||0
130052|NCT01777438|316343|P1|NOT COMPLETED|Overall Study||0
130053|NCT01777438|316342|P2|COMPLETED|Overall Study||82
130054|NCT01777438|316343|P1|COMPLETED|Overall Study||352
130055|NCT01777438|316342|P2|STARTED|Overall Study||82
130056|NCT01777438|316343|P1|STARTED|Overall Study||352
130057|NCT01777425|316355|P1|NOT COMPLETED|Overall Study||0
130058|NCT01777425|316355|P1|COMPLETED|Overall Study||389
130059|NCT01777425|316355|P1|STARTED|Overall Study||389
130060|NCT01777412|316361|P1|NOT COMPLETED|Overall Study||0
130061|NCT01777412|316361|P1|COMPLETED|Overall Study||10
130062|NCT01777412|316361|P1|STARTED|Overall Study||10
130063|NCT01777334|316369|P2|NOT COMPLETED|Overall Study||63
130064|NCT01777334|316370|P1|NOT COMPLETED|Overall Study||53
130065|NCT01777334|316369|P2|COMPLETED|Overall Study||388
130066|NCT01777334|316370|P1|COMPLETED|Overall Study||401
130067|NCT01777334|316369|P2|STARTED|Overall Study||451
130068|NCT01777334|316370|P1|STARTED|Overall Study||454
130069|NCT01777321|316380|P2|NOT COMPLETED|Overall Study||1
130070|NCT01777321|316381|P1|NOT COMPLETED|Overall Study||0
130071|NCT01777321|316380|P2|COMPLETED|Overall Study||29
130072|NCT01777321|316381|P1|COMPLETED|Overall Study||30
130073|NCT01777321|316380|P2|STARTED|Overall Study||30
130074|NCT01777321|316381|P1|STARTED|Overall Study||30
130075|NCT01777308|316419|P2|NOT COMPLETED|Overall Study||3
130076|NCT01777308|316420|P1|NOT COMPLETED|Overall Study||14
130077|NCT01777308|316419|P2|COMPLETED|Overall Study||34
130078|NCT01777308|316420|P1|COMPLETED|Overall Study||105
130079|NCT01777308|316419|P2|Completed up to Month 73|Overall Study||37
130080|NCT01777308|316420|P1|Completed up to Month 73|Overall Study||118
130081|NCT01777308|316419|P2|STARTED|Overall Study||37
130082|NCT01777308|316420|P1|STARTED|Overall Study||119
130083|NCT01777295|316452|P2|NOT COMPLETED|Overall Study||3
130084|NCT01777295|316453|P1|NOT COMPLETED|Overall Study||4
130085|NCT01777295|316452|P2|COMPLETED|Overall Study||38
130086|NCT01777295|316453|P1|COMPLETED|Overall Study||36
130087|NCT01777295|316452|P2|STARTED|Overall Study||41
130088|NCT01777295|316453|P1|STARTED|Overall Study||40
130089|NCT01777282|316660|P5|NOT COMPLETED|Overall Study||7
130090|NCT01777282|316661|P4|NOT COMPLETED|Overall Study||2
130091|NCT01777282|316662|P3|NOT COMPLETED|Overall Study||6
130092|NCT01777282|316663|P2|NOT COMPLETED|Overall Study||4
130093|NCT01777282|316664|P1|NOT COMPLETED|Overall Study||11
130094|NCT01777282|316660|P5|COMPLETED|Overall Study||54
130095|NCT01777282|316661|P4|COMPLETED|Overall Study||59
130096|NCT01777282|316662|P3|COMPLETED|Overall Study||59
130097|NCT01777282|316663|P2|COMPLETED|Overall Study||63
130098|NCT01777282|316664|P1|COMPLETED|Overall Study||109
130099|NCT01777282|316660|P5|Completing Follow-up Period|Overall Study||54
130100|NCT01777282|316661|P4|Completing Follow-up Period|Overall Study||59
130101|NCT01777282|316662|P3|Completing Follow-up Period|Overall Study||59
130102|NCT01777282|316663|P2|Completing Follow-up Period|Overall Study||63
130103|NCT01777282|316664|P1|Completing Follow-up Period|Overall Study||109
130104|NCT01777282|316660|P5|Completing Treatment Period|Overall Study||54
130105|NCT01777282|316661|P4|Completing Treatment Period|Overall Study||59
130106|NCT01777282|316662|P3|Completing Treatment Period|Overall Study||59
130107|NCT01777282|316663|P2|Completing Treatment Period|Overall Study||63
130108|NCT01777282|316664|P1|Completing Treatment Period|Overall Study||109
130109|NCT01777282|316660|P5|STARTED|Overall Study||61
130110|NCT01777282|316661|P4|STARTED|Overall Study||61
130111|NCT01777282|316662|P3|STARTED|Overall Study||65
130112|NCT01777282|316663|P2|STARTED|Overall Study||67
130113|NCT01777282|316664|P1|STARTED|Overall Study||120
130114|NCT01777269|316708|P2|NOT COMPLETED|Overall Study||59
130115|NCT01777269|316709|P1|NOT COMPLETED|Overall Study||55
130116|NCT01777269|316708|P2|COMPLETED|Overall Study||184
130117|NCT01777269|316709|P1|COMPLETED|Overall Study||191
130118|NCT01777269|316708|P2|STARTED|Overall Study||243
130119|NCT01777269|316709|P1|STARTED|Overall Study||246
130120|NCT01777217|316737|P2|NOT COMPLETED|Overall Study||0
130121|NCT01777217|316738|P1|NOT COMPLETED|Overall Study||0
130122|NCT01777217|316737|P2|COMPLETED|Overall Study||4
130123|NCT01777217|316738|P1|COMPLETED|Overall Study||4
130124|NCT01777217|316737|P2|STARTED|Overall Study||4
130125|NCT01777217|316738|P1|STARTED|Overall Study||4
130126|NCT01777191|316746|P2|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||13
130127|NCT01777191|316747|P1|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||9
130128|NCT01777191|316746|P2|COMPLETED|Safety Extension Per (Week 12-Week 48)||78
130129|NCT01777191|316747|P1|COMPLETED|Safety Extension Per (Week 12-Week 48)||85
130130|NCT01777191|316746|P2|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|91
130131|NCT01777191|316747|P1|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|94
130132|NCT01777191|316746|P2|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||8
130133|NCT01777191|316747|P1|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||6
130134|NCT01777191|316746|P2|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||94
130135|NCT01777191|316747|P1|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||96
130136|NCT01777191|316746|P2|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
130137|NCT01777191|316747|P1|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
130138|NCT01777152|316777|P2|NOT COMPLETED|Overall Study||226
130139|NCT01777152|316778|P1|NOT COMPLETED|Overall Study||226
130140|NCT01777152|316777|P2|COMPLETED|Overall Study||0
130141|NCT01777152|316778|P1|COMPLETED|Overall Study||0
130142|NCT01777152|316777|P2|STARTED|Overall Study||226
130143|NCT01777152|316778|P1|STARTED|Overall Study||226
130144|NCT01777139|316794|P2|NOT COMPLETED|SFUCP (Up to 1.4 Years)||4
130145|NCT01777139|316795|P1|NOT COMPLETED|SFUCP (Up to 1.4 Years)||0
130146|NCT01777139|316794|P2|COMPLETED|SFUCP (Up to 1.4 Years)||0
130147|NCT01777139|316795|P1|COMPLETED|SFUCP (Up to 1.4 Years)||0
130148|NCT01777139|316794|P2|STARTED|SFUCP (Up to 1.4 Years)||4
130149|NCT01777139|316795|P1|STARTED|SFUCP (Up to 1.4 Years)||0
130150|NCT01777139|316794|P2|NOT COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
130151|NCT01777139|316795|P1|NOT COMPLETED|Primary Reporting Phase (Up to 4 Years)||30
130152|NCT01777139|316794|P2|COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
130153|NCT01777139|316795|P1|COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
130154|NCT01777139|316794|P2|STARTED|Primary Reporting Phase (Up to 4 Years)||0
130155|NCT01777139|316795|P1|STARTED|Primary Reporting Phase (Up to 4 Years)||30
130156|NCT01777126|316836|P2|NOT COMPLETED|Overall Study||0
130157|NCT01777126|316837|P1|NOT COMPLETED|Overall Study||0
130158|NCT01777126|316836|P2|COMPLETED|Overall Study||46
130159|NCT01777126|316837|P1|COMPLETED|Overall Study||48
130160|NCT01777126|316836|P2|STARTED|Overall Study||46
130161|NCT01777126|316837|P1|STARTED|Overall Study||48
130162|NCT01776645|316860|P2|NOT COMPLETED|Overall Study||14
130163|NCT01776645|316861|P1|NOT COMPLETED|Overall Study||14
130164|NCT01776645|316860|P2|COMPLETED|Overall Study||14
130165|NCT01776645|316861|P1|COMPLETED|Overall Study||14
130166|NCT01776645|316860|P2|STARTED|Overall Study||28
130167|NCT01776645|316861|P1|STARTED|Overall Study||28
130168|NCT01776632|316869|P2|NOT COMPLETED|Overall Study||29
130169|NCT01776632|316870|P1|NOT COMPLETED|Overall Study||27
130170|NCT01776632|316869|P2|COMPLETED|Overall Study||190
130171|NCT01776632|316870|P1|COMPLETED|Overall Study||190
130172|NCT01776632|316869|P2|STARTED|Overall Study||219
130173|NCT01776632|316870|P1|STARTED|Overall Study||217
130174|NCT01776554|316884|P2|NOT COMPLETED|Overall Study||23
130175|NCT01776554|316885|P1|NOT COMPLETED|Overall Study||17
130176|NCT01776554|316884|P2|COMPLETED|Overall Study||307
130177|NCT01776554|316885|P1|COMPLETED|Overall Study||315
130178|NCT01776554|316884|P2|STARTED|Overall Study||330
130179|NCT01776554|316885|P1|STARTED|Overall Study||332
130180|NCT01776541|316928|P2|NOT COMPLETED|Overall Study||75
130181|NCT01776541|316929|P1|NOT COMPLETED|Overall Study||56
130182|NCT01776541|316928|P2|COMPLETED|Overall Study||416
130183|NCT01776541|316929|P1|COMPLETED|Overall Study||432
130184|NCT01776541|316928|P2|STARTED|Overall Study||491
130185|NCT01776541|316929|P1|STARTED|Overall Study||488
130186|NCT01776424|316951|P3|NOT COMPLETED|Overall Study||24
130187|NCT01776424|316952|P2|NOT COMPLETED|Overall Study||19
130188|NCT01776424|316953|P1|NOT COMPLETED|Overall Study||20
130189|NCT01776424|316951|P3|COMPLETED|Overall Study||9102
130190|NCT01776424|316952|P2|COMPLETED|Overall Study||9098
130191|NCT01776424|316953|P1|COMPLETED|Overall Study||9132
130192|NCT01776424|316951|P3|Treated|Overall Study||9107
130193|NCT01776424|316952|P2|Treated|Overall Study||9110
130194|NCT01776424|316953|P1|Treated|Overall Study||9134
130195|NCT01776424|316951|P3|STARTED|Overall Study||9126
130196|NCT01776424|316952|P2|STARTED|Overall Study||9117
130197|NCT01776424|316953|P1|STARTED|Overall Study||9152
130198|NCT01776268|316975|P2|NOT COMPLETED|Overall Study||0
130199|NCT01776268|316976|P1|NOT COMPLETED|Overall Study||0
130200|NCT01776268|316975|P2|COMPLETED|Overall Study||51
130201|NCT01776268|316976|P1|COMPLETED|Overall Study||48
130202|NCT01776268|316975|P2|STARTED|Overall Study||51
130203|NCT01776268|316976|P1|STARTED|Overall Study||48
130204|NCT01776008|316984|P1|NOT COMPLETED|Overall Study||2
130205|NCT01776008|316984|P1|COMPLETED|Overall Study||14
130206|NCT01776008|316984|P1|STARTED|Overall Study||16
130207|NCT01775995|316998|P2|NOT COMPLETED|Overall Study||1
130208|NCT01775995|316999|P1|NOT COMPLETED|Overall Study||1
130209|NCT01775995|316998|P2|COMPLETED|Overall Study|One control participant was unable to reach at 26 week follow up|13
130210|NCT01775995|316999|P1|COMPLETED|Overall Study|One experimental participant was unable to reach at 26 week follow up|20
130211|NCT01775995|316998|P2|STARTED|Overall Study||14
130212|NCT01775995|316999|P1|STARTED|Overall Study||21
130213|NCT01775904|317059|P1|NOT COMPLETED|LY2886721 ODT (Water, Fasting)||1
130214|NCT01775904|317059|P1|COMPLETED|LY2886721 ODT (Water, Fasting)||24
130215|NCT01775904|317059|P1|Received at Least One Dose of Drug|LY2886721 ODT (Water, Fasting)|One participant was not dosed in this period due to an adverse event (AE).|24
130216|NCT01775904|317059|P1|STARTED|LY2886721 ODT (Water, Fasting)||25
130217|NCT01775904|317059|P1|NOT COMPLETED|Third Washout (7 Days)||0
130218|NCT01775904|317059|P1|COMPLETED|Third Washout (7 Days)||25
130219|NCT01775904|317059|P1|STARTED|Third Washout (7 Days)||25
130220|NCT01775904|317059|P1|NOT COMPLETED|LY2886721 ODT (Water, Fed)||0
130221|NCT01775904|317059|P1|COMPLETED|LY2886721 ODT (Water, Fed)||25
130222|NCT01775904|317059|P1|Received at Least One Dose of Drug|LY2886721 ODT (Water, Fed)||25
130223|NCT01775904|317059|P1|STARTED|LY2886721 ODT (Water, Fed)||25
130224|NCT01775904|317059|P1|NOT COMPLETED|Second Washout (7 Days)||0
130225|NCT01775904|317059|P1|COMPLETED|Second Washout (7 Days)||25
130226|NCT01775904|317059|P1|STARTED|Second Washout (7 Days)||25
130227|NCT01775904|317059|P1|NOT COMPLETED|LY2886721 Capsule (Water, Fasting)||1
130228|NCT01775904|317059|P1|COMPLETED|LY2886721 Capsule (Water, Fasting)||25
130229|NCT01775904|317059|P1|Received at Least One Dose of Drug|LY2886721 Capsule (Water, Fasting)||26
130230|NCT01775904|317059|P1|STARTED|LY2886721 Capsule (Water, Fasting)||26
130231|NCT01775904|317059|P1|NOT COMPLETED|First Washout (7 Days)||0
130232|NCT01775904|317059|P1|COMPLETED|First Washout (7 Days)||26
130233|NCT01775904|317059|P1|STARTED|First Washout (7 Days)||26
130234|NCT01775904|317059|P1|NOT COMPLETED|LY2886721 ODT (no Water, Fasting)||0
130235|NCT01775904|317059|P1|COMPLETED|LY2886721 ODT (no Water, Fasting)||26
130236|NCT01775904|317059|P1|Received at Least One Dose of Drug|LY2886721 ODT (no Water, Fasting)||26
130237|NCT01775904|317059|P1|STARTED|LY2886721 ODT (no Water, Fasting)||26
130238|NCT01775865|317084|P3|NOT COMPLETED|Overall Study||0
130239|NCT01775865|317085|P2|NOT COMPLETED|Overall Study||1
130240|NCT01775865|317086|P1|NOT COMPLETED|Overall Study||3
130241|NCT01775865|317084|P3|COMPLETED|Overall Study||17
130242|NCT01775865|317085|P2|COMPLETED|Overall Study||13
130243|NCT01775865|317086|P1|COMPLETED|Overall Study||11
130244|NCT01775865|317084|P3|STARTED|Overall Study||17
130245|NCT01775865|317085|P2|STARTED|Overall Study||14
130246|NCT01775865|317086|P1|STARTED|Overall Study||14
130247|NCT01775852|317102|P2|NOT COMPLETED|Overall Study||1
130248|NCT01775852|317103|P1|NOT COMPLETED|Overall Study||0
130249|NCT01775852|317102|P2|COMPLETED|Overall Study||13
130250|NCT01775852|317103|P1|COMPLETED|Overall Study||31
130251|NCT01775852|317102|P2|STARTED|Overall Study||14
130252|NCT01775852|317103|P1|STARTED|Overall Study||31
130253|NCT01775800|317117|P2|NOT COMPLETED|Overall Study||0
130254|NCT01775800|317118|P1|NOT COMPLETED|Overall Study||0
130255|NCT01775800|317117|P2|COMPLETED|Overall Study||8
130256|NCT01775800|317118|P1|COMPLETED|Overall Study||8
130257|NCT01775800|317117|P2|STARTED|Overall Study||8
130258|NCT01775800|317118|P1|STARTED|Overall Study||8
130259|NCT01775787|317125|P2|NOT COMPLETED|Second 7-10 Days||2
130260|NCT01775787|317126|P1|NOT COMPLETED|Second 7-10 Days||0
130261|NCT01775787|317125|P2|COMPLETED|Second 7-10 Days||6
130262|NCT01775787|317126|P1|COMPLETED|Second 7-10 Days||12
130263|NCT01775787|317125|P2|STARTED|Second 7-10 Days||8
130264|NCT01775787|317126|P1|STARTED|Second 7-10 Days||12
130265|NCT01775787|317125|P2|NOT COMPLETED|First 7-10 Days||6
130266|NCT01775787|317126|P1|NOT COMPLETED|First 7-10 Days||1
130267|NCT01775787|317125|P2|COMPLETED|First 7-10 Days||8
130268|NCT01775787|317126|P1|COMPLETED|First 7-10 Days||12
130269|NCT01775787|317125|P2|STARTED|First 7-10 Days||14
130270|NCT01775787|317126|P1|STARTED|First 7-10 Days||13
130271|NCT01775774|317137|P3|NOT COMPLETED|Overall Study||0
130272|NCT01775774|317138|P2|NOT COMPLETED|Overall Study||0
130273|NCT01775774|317139|P1|NOT COMPLETED|Overall Study||0
130274|NCT01775774|317137|P3|COMPLETED|Overall Study||3
130275|NCT01775774|317138|P2|COMPLETED|Overall Study||3
130276|NCT01775774|317139|P1|COMPLETED|Overall Study||3
130277|NCT01775774|317137|P3|STARTED|Overall Study||3
130278|NCT01775774|317138|P2|STARTED|Overall Study||3
130279|NCT01775774|317139|P1|STARTED|Overall Study||3
130280|NCT01775735|317167|P2|NOT COMPLETED|Open Label (24 Months)||4
130281|NCT01775735|317168|P1|NOT COMPLETED|Open Label (24 Months)||1
130282|NCT01775735|317167|P2|COMPLETED|Open Label (24 Months)||3
130283|NCT01775735|317168|P1|COMPLETED|Open Label (24 Months)||7
130284|NCT01775735|317167|P2|STARTED|Open Label (24 Months)||7
130285|NCT01775735|317168|P1|STARTED|Open Label (24 Months)||8
130286|NCT01775735|317167|P2|NOT COMPLETED|Intervention (6 Months)||0
130287|NCT01775735|317168|P1|NOT COMPLETED|Intervention (6 Months)||0
130288|NCT01775735|317167|P2|COMPLETED|Intervention (6 Months)||7
130289|NCT01775735|317168|P1|COMPLETED|Intervention (6 Months)||8
130290|NCT01775735|317167|P2|STARTED|Intervention (6 Months)||7
130291|NCT01775735|317168|P1|STARTED|Intervention (6 Months)||8
130292|NCT01775722|317174|P1|NOT COMPLETED|Overall Study||2
130293|NCT01775722|317174|P1|COMPLETED|Overall Study||20
130294|NCT01775722|317174|P1|STARTED|Overall Study||22
130295|NCT01775670|317182|P2|NOT COMPLETED|Overall Study||1
130296|NCT01775670|317183|P1|NOT COMPLETED|Overall Study||1
130297|NCT01775670|317182|P2|COMPLETED|Overall Study||2
130298|NCT01775670|317183|P1|COMPLETED|Overall Study||0
130299|NCT01775670|317182|P2|STARTED|Overall Study||3
130300|NCT01775670|317183|P1|STARTED|Overall Study||1
130301|NCT01775553|317209|P1|NOT COMPLETED|Overall Study||13
130302|NCT01775553|317209|P1|COMPLETED|Overall Study||0
130303|NCT01775553|317209|P1|STARTED|Overall Study||13
130304|NCT01775189|317217|P7|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
130305|NCT01775189|317218|P6|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
130306|NCT01775189|317219|P5|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
130307|NCT01775189|317220|P4|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
130308|NCT01775189|317221|P3|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
130309|NCT01775189|317222|P2|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
130310|NCT01775189|317223|P1|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
130311|NCT01775189|317217|P7|COMPLETED|Treatment Phase: Fourth Intervention||7
130312|NCT01775189|317218|P6|COMPLETED|Treatment Phase: Fourth Intervention||7
130313|NCT01775189|317219|P5|COMPLETED|Treatment Phase: Fourth Intervention||8
130314|NCT01775189|317220|P4|COMPLETED|Treatment Phase: Fourth Intervention||6
130315|NCT01775189|317221|P3|COMPLETED|Treatment Phase: Fourth Intervention||0
130316|NCT01775189|317222|P2|COMPLETED|Treatment Phase: Fourth Intervention||0
130317|NCT01775189|317223|P1|COMPLETED|Treatment Phase: Fourth Intervention||0
130318|NCT01775189|317217|P7|STARTED|Treatment Phase: Fourth Intervention||7
130319|NCT01775189|317218|P6|STARTED|Treatment Phase: Fourth Intervention||7
130320|NCT01775189|317219|P5|STARTED|Treatment Phase: Fourth Intervention||8
130321|NCT01775189|317220|P4|STARTED|Treatment Phase: Fourth Intervention||6
130322|NCT01775189|317221|P3|STARTED|Treatment Phase: Fourth Intervention||0
130323|NCT01775189|317222|P2|STARTED|Treatment Phase: Fourth Intervention||0
130324|NCT01775189|317223|P1|STARTED|Treatment Phase: Fourth Intervention||0
130325|NCT01775189|317217|P7|NOT COMPLETED|Treatment Phase: Washout Period 3||1
130326|NCT01775189|317218|P6|NOT COMPLETED|Treatment Phase: Washout Period 3||0
130327|NCT01775189|317219|P5|NOT COMPLETED|Treatment Phase: Washout Period 3||0
130328|NCT01775189|317220|P4|NOT COMPLETED|Treatment Phase: Washout Period 3||1
130329|NCT01775189|317221|P3|NOT COMPLETED|Treatment Phase: Washout Period 3||0
130330|NCT01775189|317222|P2|NOT COMPLETED|Treatment Phase: Washout Period 3||0
130331|NCT01775189|317223|P1|NOT COMPLETED|Treatment Phase: Washout Period 3||0
130332|NCT01775189|317217|P7|COMPLETED|Treatment Phase: Washout Period 3||7
130333|NCT01775189|317218|P6|COMPLETED|Treatment Phase: Washout Period 3||7
130334|NCT01775189|317219|P5|COMPLETED|Treatment Phase: Washout Period 3||8
130335|NCT01775189|317220|P4|COMPLETED|Treatment Phase: Washout Period 3||6
130336|NCT01775189|317221|P3|COMPLETED|Treatment Phase: Washout Period 3||0
130337|NCT01775189|317222|P2|COMPLETED|Treatment Phase: Washout Period 3||0
130338|NCT01775189|317223|P1|COMPLETED|Treatment Phase: Washout Period 3||0
130339|NCT01775189|317217|P7|STARTED|Treatment Phase: Washout Period 3||8
130340|NCT01775189|317218|P6|STARTED|Treatment Phase: Washout Period 3||7
130341|NCT01775189|317219|P5|STARTED|Treatment Phase: Washout Period 3||8
130342|NCT01775189|317220|P4|STARTED|Treatment Phase: Washout Period 3||7
130343|NCT01775189|317221|P3|STARTED|Treatment Phase: Washout Period 3||0
130344|NCT01775189|317222|P2|STARTED|Treatment Phase: Washout Period 3||0
130345|NCT01775189|317223|P1|STARTED|Treatment Phase: Washout Period 3||0
130346|NCT01775189|317217|P7|NOT COMPLETED|Treatment Phase: Third Intervention||0
130347|NCT01775189|317218|P6|NOT COMPLETED|Treatment Phase: Third Intervention||0
130348|NCT01775189|317219|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
130349|NCT01775189|317220|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
130350|NCT01775189|317221|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
130351|NCT01775189|317222|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
130352|NCT01775189|317223|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
130353|NCT01775189|317217|P7|COMPLETED|Treatment Phase: Third Intervention||8
130354|NCT01775189|317218|P6|COMPLETED|Treatment Phase: Third Intervention||7
130355|NCT01775189|317219|P5|COMPLETED|Treatment Phase: Third Intervention||8
130356|NCT01775189|317220|P4|COMPLETED|Treatment Phase: Third Intervention||7
130357|NCT01775189|317221|P3|COMPLETED|Treatment Phase: Third Intervention||0
130358|NCT01775189|317222|P2|COMPLETED|Treatment Phase: Third Intervention||0
130359|NCT01775189|317223|P1|COMPLETED|Treatment Phase: Third Intervention||0
130360|NCT01775189|317217|P7|STARTED|Treatment Phase: Third Intervention||8
130361|NCT01775189|317218|P6|STARTED|Treatment Phase: Third Intervention||7
130362|NCT01775189|317219|P5|STARTED|Treatment Phase: Third Intervention||8
130363|NCT01775189|317220|P4|STARTED|Treatment Phase: Third Intervention||7
130364|NCT01775189|317221|P3|STARTED|Treatment Phase: Third Intervention||0
130365|NCT01775189|317222|P2|STARTED|Treatment Phase: Third Intervention||0
130366|NCT01775189|317223|P1|STARTED|Treatment Phase: Third Intervention||0
130367|NCT01775189|317217|P7|NOT COMPLETED|Treatment Phase: Washout Period 2||0
130368|NCT01775189|317218|P6|NOT COMPLETED|Treatment Phase: Washout Period 2||0
130369|NCT01775189|317219|P5|NOT COMPLETED|Treatment Phase: Washout Period 2||0
130370|NCT01775189|317220|P4|NOT COMPLETED|Treatment Phase: Washout Period 2||1
130371|NCT01775189|317221|P3|NOT COMPLETED|Treatment Phase: Washout Period 2||0
130372|NCT01775189|317222|P2|NOT COMPLETED|Treatment Phase: Washout Period 2||0
130373|NCT01775189|317223|P1|NOT COMPLETED|Treatment Phase: Washout Period 2||0
130374|NCT01775189|317217|P7|COMPLETED|Treatment Phase: Washout Period 2||8
130375|NCT01775189|317218|P6|COMPLETED|Treatment Phase: Washout Period 2||7
130376|NCT01775189|317219|P5|COMPLETED|Treatment Phase: Washout Period 2||8
130377|NCT01775189|317220|P4|COMPLETED|Treatment Phase: Washout Period 2||7
130378|NCT01775189|317221|P3|COMPLETED|Treatment Phase: Washout Period 2||0
130379|NCT01775189|317222|P2|COMPLETED|Treatment Phase: Washout Period 2||0
130380|NCT01775189|317223|P1|COMPLETED|Treatment Phase: Washout Period 2||0
130381|NCT01775189|317217|P7|STARTED|Treatment Phase: Washout Period 2||8
130382|NCT01775189|317218|P6|STARTED|Treatment Phase: Washout Period 2||7
130383|NCT01775189|317219|P5|STARTED|Treatment Phase: Washout Period 2||8
130384|NCT01775189|317220|P4|STARTED|Treatment Phase: Washout Period 2||8
130385|NCT01775189|317221|P3|STARTED|Treatment Phase: Washout Period 2||0
130386|NCT01775189|317222|P2|STARTED|Treatment Phase: Washout Period 2||0
130387|NCT01775189|317223|P1|STARTED|Treatment Phase: Washout Period 2||0
130388|NCT01775189|317217|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
130389|NCT01775189|317218|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
130390|NCT01775189|317219|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
130391|NCT01775189|317220|P4|NOT COMPLETED|Treatment Phase: Second Intervention||0
130392|NCT01775189|317221|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
130393|NCT01775189|317222|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
130394|NCT01775189|317223|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
130395|NCT01775189|317217|P7|COMPLETED|Treatment Phase: Second Intervention||8
130396|NCT01775189|317218|P6|COMPLETED|Treatment Phase: Second Intervention||7
130397|NCT01775189|317219|P5|COMPLETED|Treatment Phase: Second Intervention||8
130398|NCT01775189|317220|P4|COMPLETED|Treatment Phase: Second Intervention||8
130399|NCT01775189|317221|P3|COMPLETED|Treatment Phase: Second Intervention||0
130400|NCT01775189|317222|P2|COMPLETED|Treatment Phase: Second Intervention||0
130401|NCT01775189|317223|P1|COMPLETED|Treatment Phase: Second Intervention||0
130402|NCT01775189|317217|P7|STARTED|Treatment Phase: Second Intervention||8
130403|NCT01775189|317218|P6|STARTED|Treatment Phase: Second Intervention||7
130404|NCT01775189|317219|P5|STARTED|Treatment Phase: Second Intervention||8
130405|NCT01775189|317220|P4|STARTED|Treatment Phase: Second Intervention||8
130406|NCT01775189|317221|P3|STARTED|Treatment Phase: Second Intervention||0
130407|NCT01775189|317222|P2|STARTED|Treatment Phase: Second Intervention||0
130408|NCT01775189|317223|P1|STARTED|Treatment Phase: Second Intervention||0
130409|NCT01775189|317217|P7|NOT COMPLETED|Treatment Phase: Washout Period 1||0
130410|NCT01775189|317218|P6|NOT COMPLETED|Treatment Phase: Washout Period 1||1
130411|NCT01775189|317219|P5|NOT COMPLETED|Treatment Phase: Washout Period 1||0
130412|NCT01775189|317220|P4|NOT COMPLETED|Treatment Phase: Washout Period 1||0
130413|NCT01775189|317221|P3|NOT COMPLETED|Treatment Phase: Washout Period 1||0
130414|NCT01775189|317222|P2|NOT COMPLETED|Treatment Phase: Washout Period 1||0
130415|NCT01775189|317223|P1|NOT COMPLETED|Treatment Phase: Washout Period 1||0
130416|NCT01775189|317217|P7|COMPLETED|Treatment Phase: Washout Period 1||8
130417|NCT01775189|317218|P6|COMPLETED|Treatment Phase: Washout Period 1||7
130418|NCT01775189|317219|P5|COMPLETED|Treatment Phase: Washout Period 1||8
130419|NCT01775189|317220|P4|COMPLETED|Treatment Phase: Washout Period 1||8
130420|NCT01775189|317221|P3|COMPLETED|Treatment Phase: Washout Period 1||0
130421|NCT01775189|317222|P2|COMPLETED|Treatment Phase: Washout Period 1||0
130422|NCT01775189|317223|P1|COMPLETED|Treatment Phase: Washout Period 1||0
130423|NCT01775189|317217|P7|STARTED|Treatment Phase: Washout Period 1||8
130424|NCT01775189|317218|P6|STARTED|Treatment Phase: Washout Period 1||8
130425|NCT01775189|317219|P5|STARTED|Treatment Phase: Washout Period 1||8
130426|NCT01775189|317220|P4|STARTED|Treatment Phase: Washout Period 1||8
130427|NCT01775189|317221|P3|STARTED|Treatment Phase: Washout Period 1||0
130428|NCT01775189|317222|P2|STARTED|Treatment Phase: Washout Period 1||0
130429|NCT01775189|317223|P1|STARTED|Treatment Phase: Washout Period 1||0
130430|NCT01775189|317217|P7|NOT COMPLETED|Treatment Phase: First Intervention||0
130431|NCT01775189|317218|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
130432|NCT01775189|317219|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
130433|NCT01775189|317220|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
130434|NCT01775189|317221|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
130435|NCT01775189|317222|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
130436|NCT01775189|317223|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
130437|NCT01775189|317217|P7|COMPLETED|Treatment Phase: First Intervention||8
130438|NCT01775189|317218|P6|COMPLETED|Treatment Phase: First Intervention||8
130439|NCT01775189|317219|P5|COMPLETED|Treatment Phase: First Intervention||8
130440|NCT01775189|317220|P4|COMPLETED|Treatment Phase: First Intervention||8
130441|NCT01775189|317221|P3|COMPLETED|Treatment Phase: First Intervention||0
130442|NCT01775189|317222|P2|COMPLETED|Treatment Phase: First Intervention||0
130443|NCT01775189|317223|P1|COMPLETED|Treatment Phase: First Intervention||0
130444|NCT01775189|317217|P7|STARTED|Treatment Phase: First Intervention||8
130445|NCT01775189|317218|P6|STARTED|Treatment Phase: First Intervention||8
130446|NCT01775189|317219|P5|STARTED|Treatment Phase: First Intervention||8
130447|NCT01775189|317220|P4|STARTED|Treatment Phase: First Intervention||8
130448|NCT01775189|317221|P3|STARTED|Treatment Phase: First Intervention||0
130449|NCT01775189|317222|P2|STARTED|Treatment Phase: First Intervention||0
130450|NCT01775189|317223|P1|STARTED|Treatment Phase: First Intervention||0
130451|NCT01775189|317217|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
130452|NCT01775189|317218|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
130453|NCT01775189|317219|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
130454|NCT01775189|317220|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
130455|NCT01775189|317221|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||7
130456|NCT01775189|317222|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||3
130457|NCT01775189|317223|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
130458|NCT01775189|317217|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
130459|NCT01775189|317218|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
130460|NCT01775189|317219|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
130461|NCT01775189|317220|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
130462|NCT01775189|317221|P3|COMPLETED|Drug Discrimination Phase: Day 2||16
130463|NCT01775189|317222|P2|COMPLETED|Drug Discrimination Phase: Day 2||16
130464|NCT01775189|317223|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
130465|NCT01775189|317217|P7|STARTED|Drug Discrimination Phase: Day 2||0
130466|NCT01775189|317218|P6|STARTED|Drug Discrimination Phase: Day 2||0
130467|NCT01775189|317219|P5|STARTED|Drug Discrimination Phase: Day 2||0
130468|NCT01775189|317220|P4|STARTED|Drug Discrimination Phase: Day 2||0
130469|NCT01775189|317221|P3|STARTED|Drug Discrimination Phase: Day 2||23
130470|NCT01775189|317222|P2|STARTED|Drug Discrimination Phase: Day 2||19
130471|NCT01775189|317223|P1|STARTED|Drug Discrimination Phase: Day 2||0
130472|NCT01775189|317217|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
130473|NCT01775189|317218|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
130474|NCT01775189|317219|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
130475|NCT01775189|317220|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
130476|NCT01775189|317221|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
130477|NCT01775189|317222|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
130478|NCT01775189|317223|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
130479|NCT01775189|317217|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
130480|NCT01775189|317218|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
130481|NCT01775189|317219|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
130482|NCT01775189|317220|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
130483|NCT01775189|317221|P3|COMPLETED|Drug Discrimination Phase: Day 1||23
130484|NCT01775189|317222|P2|COMPLETED|Drug Discrimination Phase: Day 1||19
130485|NCT01775189|317223|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
130486|NCT01775189|317217|P7|STARTED|Drug Discrimination Phase: Day 1||0
130487|NCT01775189|317218|P6|STARTED|Drug Discrimination Phase: Day 1||0
130488|NCT01775189|317219|P5|STARTED|Drug Discrimination Phase: Day 1||0
130489|NCT01775189|317220|P4|STARTED|Drug Discrimination Phase: Day 1||0
130490|NCT01775189|317221|P3|STARTED|Drug Discrimination Phase: Day 1||23
130491|NCT01775189|317222|P2|STARTED|Drug Discrimination Phase: Day 1||22
130492|NCT01775189|317223|P1|STARTED|Drug Discrimination Phase: Day 1||0
130493|NCT01775189|317217|P7|NOT COMPLETED|Naloxone Challenge Phase||0
130494|NCT01775189|317218|P6|NOT COMPLETED|Naloxone Challenge Phase||0
130495|NCT01775189|317219|P5|NOT COMPLETED|Naloxone Challenge Phase||0
130496|NCT01775189|317220|P4|NOT COMPLETED|Naloxone Challenge Phase||0
130497|NCT01775189|317221|P3|NOT COMPLETED|Naloxone Challenge Phase||0
130498|NCT01775189|317222|P2|NOT COMPLETED|Naloxone Challenge Phase||0
130499|NCT01775189|317223|P1|NOT COMPLETED|Naloxone Challenge Phase||0
130500|NCT01775189|317217|P7|COMPLETED|Naloxone Challenge Phase||0
130501|NCT01775189|317218|P6|COMPLETED|Naloxone Challenge Phase||0
130502|NCT01775189|317219|P5|COMPLETED|Naloxone Challenge Phase||0
130503|NCT01775189|317220|P4|COMPLETED|Naloxone Challenge Phase||0
130504|NCT01775189|317221|P3|COMPLETED|Naloxone Challenge Phase||0
130505|NCT01775189|317222|P2|COMPLETED|Naloxone Challenge Phase||0
130506|NCT01775189|317223|P1|COMPLETED|Naloxone Challenge Phase||45
130507|NCT01775189|317217|P7|STARTED|Naloxone Challenge Phase||0
130508|NCT01775189|317218|P6|STARTED|Naloxone Challenge Phase||0
130509|NCT01775189|317219|P5|STARTED|Naloxone Challenge Phase||0
130510|NCT01775189|317220|P4|STARTED|Naloxone Challenge Phase||0
130511|NCT01775189|317221|P3|STARTED|Naloxone Challenge Phase||0
130512|NCT01775189|317222|P2|STARTED|Naloxone Challenge Phase||0
130513|NCT01775189|317223|P1|STARTED|Naloxone Challenge Phase||45
130514|NCT01775137|317442|P1|NOT COMPLETED|Overall Study||11
130515|NCT01775137|317442|P1|COMPLETED|Overall Study||34
130516|NCT01775137|317442|P1|STARTED|Overall Study||45
130517|NCT01775124|317469|P2|NOT COMPLETED|Extension Period||18
130518|NCT01775124|317470|P1|NOT COMPLETED|Extension Period||12
130519|NCT01775124|317469|P2|COMPLETED|Extension Period||138
130520|NCT01775124|317470|P1|COMPLETED|Extension Period||145
130521|NCT01775124|317469|P2|STARTED|Extension Period||156
130522|NCT01775124|317470|P1|STARTED|Extension Period||157
130523|NCT01775124|317469|P2|NOT COMPLETED|Core Period||10
130524|NCT01775124|317470|P1|NOT COMPLETED|Core Period||11
130525|NCT01775124|317469|P2|COMPLETED|Core Period||156
130526|NCT01775124|317470|P1|COMPLETED|Core Period||157
130527|NCT01775124|317469|P2|Safety Set|Core Period||166
130528|NCT01775124|317470|P1|Safety Set|Core Period|1 patient was mis-randomized & 1 patient discontinued due to AE. No treatment given|166
130529|NCT01775124|317469|P2|Per Protocol Set|Core Period||155
130530|NCT01775124|317470|P1|Per Protocol Set|Core Period||157
130531|NCT01775124|317469|P2|Full Analysis Set|Core Period||166
130532|NCT01775124|317470|P1|Full Analysis Set|Core Period||167
130533|NCT01775124|317469|P2|STARTED|Core Period||166
130534|NCT01775124|317470|P1|STARTED|Core Period||168
130535|NCT01774981|317505|P8|NOT COMPLETED|Overall Study||1
130536|NCT01774981|317506|P7|NOT COMPLETED|Overall Study||0
130537|NCT01774981|317507|P6|NOT COMPLETED|Overall Study||1
130538|NCT01774981|317508|P5|NOT COMPLETED|Overall Study||1
130539|NCT01774981|317509|P4|NOT COMPLETED|Overall Study||0
130540|NCT01774981|317510|P3|NOT COMPLETED|Overall Study||0
130541|NCT01774981|317511|P2|NOT COMPLETED|Overall Study||0
130542|NCT01774981|317512|P1|NOT COMPLETED|Overall Study||0
130543|NCT01774981|317505|P8|COMPLETED|Overall Study||11
130544|NCT01774981|317506|P7|COMPLETED|Overall Study||13
130545|NCT01774981|317507|P6|COMPLETED|Overall Study||13
130546|NCT01774981|317508|P5|COMPLETED|Overall Study||5
130547|NCT01774981|317509|P4|COMPLETED|Overall Study||4
130548|NCT01774981|317510|P3|COMPLETED|Overall Study||4
130549|NCT01774981|317511|P2|COMPLETED|Overall Study||4
130550|NCT01774981|317512|P1|COMPLETED|Overall Study||3
130551|NCT01774981|317505|P8|Received at Least 1 Dose of Study Drug|Overall Study||12
130552|NCT01774981|317506|P7|Received at Least 1 Dose of Study Drug|Overall Study||13
130553|NCT01774981|317507|P6|Received at Least 1 Dose of Study Drug|Overall Study||14
130554|NCT01774981|317508|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
130555|NCT01774981|317509|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
130556|NCT01774981|317510|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
130557|NCT01774981|317511|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
130558|NCT01774981|317512|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
130559|NCT01774981|317505|P8|STARTED|Overall Study||12
130560|NCT01774981|317506|P7|STARTED|Overall Study||13
130561|NCT01774981|317507|P6|STARTED|Overall Study||14
130562|NCT01774981|317508|P5|STARTED|Overall Study||6
130563|NCT01774981|317509|P4|STARTED|Overall Study||4
130564|NCT01774981|317510|P3|STARTED|Overall Study||4
130565|NCT01774981|317511|P2|STARTED|Overall Study||4
130566|NCT01774981|317512|P1|STARTED|Overall Study||3
130567|NCT01774968|317544|P2|NOT COMPLETED|Overall Study||35
130568|NCT01774968|317545|P1|NOT COMPLETED|Overall Study||30
130569|NCT01774968|317544|P2|COMPLETED|Overall Study||128
130570|NCT01774968|317545|P1|COMPLETED|Overall Study||132
130571|NCT01774968|317544|P2|Received at Least 1 Dose of Study Drug|Overall Study||161
130572|NCT01774968|317545|P1|Received at Least 1 Dose of Study Drug|Overall Study||162
130573|NCT01774968|317544|P2|STARTED|Overall Study||163
130574|NCT01774968|317545|P1|STARTED|Overall Study||162
130575|NCT01774929|317579|P1|NOT COMPLETED|Overall Study||3
130576|NCT01774929|317579|P1|COMPLETED|Overall Study||32
130577|NCT01774929|317579|P1|STARTED|Overall Study||35
130578|NCT01774903|317585|P1|NOT COMPLETED|Overall Study||11
130579|NCT01774903|317585|P1|COMPLETED|Overall Study||34
130580|NCT01774903|317585|P1|STARTED|Overall Study||45
130581|NCT01774851|317594|P2|NOT COMPLETED|Overall Study||0
130582|NCT01774851|317595|P1|NOT COMPLETED|Overall Study||0
130583|NCT01774851|317594|P2|COMPLETED|Overall Study||42
130584|NCT01774851|317595|P1|COMPLETED|Overall Study||42
130585|NCT01774851|317594|P2|STARTED|Overall Study||42
130586|NCT01774851|317595|P1|STARTED|Overall Study||42
130587|NCT01774799|317605|P4|NOT COMPLETED|Overall Study||0
130588|NCT01774799|317606|P3|NOT COMPLETED|Overall Study||0
130589|NCT01774799|317607|P2|NOT COMPLETED|Overall Study||1
130590|NCT01774799|317608|P1|NOT COMPLETED|Overall Study||1
130591|NCT01774799|317605|P4|COMPLETED|Overall Study||190
130592|NCT01774799|317606|P3|COMPLETED|Overall Study||212
130593|NCT01774799|317607|P2|COMPLETED|Overall Study||189
130594|NCT01774799|317608|P1|COMPLETED|Overall Study||211
130595|NCT01774799|317605|P4|STARTED|Overall Study||190
130596|NCT01774799|317606|P3|STARTED|Overall Study||212
130597|NCT01774799|317607|P2|STARTED|Overall Study||190
130598|NCT01774799|317608|P1|STARTED|Overall Study||212
130599|NCT01774786|317624|P2|NOT COMPLETED|Overall Study||392
130600|NCT01774786|317625|P1|NOT COMPLETED|Overall Study||388
130601|NCT01774786|317624|P2|COMPLETED|Overall Study||0
130602|NCT01774786|317625|P1|COMPLETED|Overall Study||0
130603|NCT01774786|317624|P2|Received at Least One Dose of Placebo|Overall Study||388
130604|NCT01774786|317625|P1|Received at Least One Dose of Placebo|Overall Study||0
130605|NCT01774786|317624|P2|Received at Least One Dose of Pertuzumab|Overall Study|One participant randomized to placebo arm received 1 dose of pertuzumab by error.|1
130606|NCT01774786|317625|P1|Received at Least One Dose of Pertuzumab|Overall Study||384
130607|NCT01774786|317624|P2|Did Not Receive Study Drug|Overall Study||3
130608|NCT01774786|317625|P1|Did Not Receive Study Drug|Overall Study||4
130609|NCT01774786|317624|P2|STARTED|Overall Study||392
130610|NCT01774786|317625|P1|STARTED|Overall Study||388
130611|NCT01774760|317653|P1|NOT COMPLETED|Overall Study||0
130612|NCT01774760|317653|P1|COMPLETED|Overall Study||10
130613|NCT01774760|317653|P1|STARTED|Overall Study||10
130614|NCT01774721|317659|P2|NOT COMPLETED|Overall Study||225
130615|NCT01774721|317660|P1|NOT COMPLETED|Overall Study||227
130616|NCT01774721|317659|P2|COMPLETED|Overall Study||0
130617|NCT01774721|317660|P1|COMPLETED|Overall Study||0
130618|NCT01774721|317659|P2|Treated|Overall Study||224
130619|NCT01774721|317660|P1|Treated|Overall Study||227
130620|NCT01774721|317659|P2|STARTED|Overall Study||225
130621|NCT01774721|317660|P1|STARTED|Overall Study||227
130622|NCT01774604|317704|P2|NOT COMPLETED|Overall Study||0
130623|NCT01774604|317705|P1|NOT COMPLETED|Overall Study||0
130624|NCT01774604|317704|P2|COMPLETED|Overall Study||226
130625|NCT01774604|317705|P1|COMPLETED|Overall Study||223
130626|NCT01774604|317704|P2|STARTED|Overall Study||226
130627|NCT01774604|317705|P1|STARTED|Overall Study||223
130628|NCT01774591|317725|P2|NOT COMPLETED|Overall Study||4
130629|NCT01774591|317726|P1|NOT COMPLETED|Overall Study||1
130630|NCT01774591|317725|P2|COMPLETED|Overall Study||7
130631|NCT01774591|317726|P1|COMPLETED|Overall Study||9
130632|NCT01774591|317725|P2|STARTED|Overall Study||11
130633|NCT01774591|317726|P1|STARTED|Overall Study||10
130634|NCT01774370|317736|P1|NOT COMPLETED|Overall Study||129
130635|NCT01774370|317736|P1|COMPLETED|Overall Study||3053
130636|NCT01774370|317736|P1|STARTED|Overall Study||3182
130637|NCT01774344|317744|P2|NOT COMPLETED|Overall Study||148
130638|NCT01774344|317745|P1|NOT COMPLETED|Overall Study||32
130639|NCT01774344|317744|P2|COMPLETED|Overall Study||231
130640|NCT01774344|317745|P1|COMPLETED|Overall Study||162
130641|NCT01774344|317744|P2|Treated|Overall Study||374
130642|NCT01774344|317745|P1|Treated|Overall Study||193
130643|NCT01774344|317744|P2|STARTED|Overall Study||379
130644|NCT01774344|317745|P1|STARTED|Overall Study||194
130645|NCT01774305|317761|P2|NOT COMPLETED|Overall Study||0
130646|NCT01774305|317762|P1|NOT COMPLETED|Overall Study||1
130647|NCT01774305|317761|P2|COMPLETED|Overall Study||71
130648|NCT01774305|317762|P1|COMPLETED|Overall Study||70
130649|NCT01774305|317761|P2|STARTED|Overall Study||71
130650|NCT01774305|317762|P1|STARTED|Overall Study||71
130651|NCT01774253|317770|P1|NOT COMPLETED|Overall Study||9
130652|NCT01774253|317770|P1|COMPLETED|Overall Study||0
130653|NCT01774253|317770|P1|STARTED|Overall Study||9
130654|NCT01774149|317780|P2|NOT COMPLETED|Overall Study||3
130655|NCT01774149|317781|P1|NOT COMPLETED|Overall Study||1
130656|NCT01774149|317780|P2|COMPLETED|Overall Study||12
130657|NCT01774149|317781|P1|COMPLETED|Overall Study||14
130658|NCT01774149|317780|P2|STARTED|Overall Study||15
130659|NCT01774149|317781|P1|STARTED|Overall Study||15
130660|NCT01774110|317789|P1|NOT COMPLETED|Overall Study||7
130661|NCT01774110|317789|P1|COMPLETED|Overall Study||5
130662|NCT01774110|317789|P1|STARTED|Overall Study||12
130663|NCT01774097|317797|P2|NOT COMPLETED|Overall Study||2
130664|NCT01774097|317798|P1|NOT COMPLETED|Overall Study||2
130665|NCT01774097|317797|P2|COMPLETED|Overall Study||40
130666|NCT01774097|317798|P1|COMPLETED|Overall Study||38
130667|NCT01774097|317797|P2|STARTED|Overall Study||42
130668|NCT01774097|317798|P1|STARTED|Overall Study||40
130669|NCT01774084|317828|P2|NOT COMPLETED|Overall Study||0
130670|NCT01774084|317829|P1|NOT COMPLETED|Overall Study||1
130671|NCT01774084|317828|P2|COMPLETED|Overall Study||12
130672|NCT01774084|317829|P1|COMPLETED|Overall Study||10
130673|NCT01774084|317828|P2|STARTED|Overall Study||12
130674|NCT01774084|317829|P1|STARTED|Overall Study||11
130675|NCT01774045|317839|P2|NOT COMPLETED|Overall Study||0
130676|NCT01774045|317840|P1|NOT COMPLETED|Overall Study||0
130677|NCT01774045|317839|P2|COMPLETED|Overall Study||7
130678|NCT01774045|317840|P1|COMPLETED|Overall Study||23
130679|NCT01774045|317839|P2|STARTED|Overall Study||7
130680|NCT01774045|317840|P1|STARTED|Overall Study||23
130681|NCT01773993|317854|P1|NOT COMPLETED|Overall Study||35
130682|NCT01773993|317854|P1|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|499
130683|NCT01773993|317854|P1|STARTED|Overall Study||534
130684|NCT01773967|317873|P2|NOT COMPLETED|Overall Study||13
130685|NCT01773967|317874|P1|NOT COMPLETED|Overall Study||15
130686|NCT01773967|317873|P2|COMPLETED|Overall Study||475
130687|NCT01773967|317874|P1|COMPLETED|Overall Study||468
130688|NCT01773967|317873|P2|STARTED|Overall Study||488
130689|NCT01773967|317874|P1|STARTED|Overall Study||483
130690|NCT01773954|317884|P1|NOT COMPLETED|Overall Study||9
130691|NCT01773954|317884|P1|COMPLETED|Overall Study||31
130692|NCT01773954|317884|P1|STARTED|Overall Study||40
130693|NCT01773889|317889|P1|NOT COMPLETED|Overall Study||2
130694|NCT01773889|317889|P1|COMPLETED|Overall Study||0
130695|NCT01773889|317889|P1|STARTED|Overall Study||2
130696|NCT01773473|317895|P2|NOT COMPLETED|Overall Study||19
130697|NCT01773473|317896|P1|NOT COMPLETED|Overall Study||16
130698|NCT01773473|317895|P2|COMPLETED|Overall Study||177
130699|NCT01773473|317896|P1|COMPLETED|Overall Study||191
130700|NCT01773473|317895|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
130701|NCT01773473|317896|P1|Received at Least 1 Dose of Study Drug|Overall Study||207
130702|NCT01773473|317895|P2|STARTED|Overall Study||196
130703|NCT01773473|317896|P1|STARTED|Overall Study||207
130704|NCT01773291|317917|P3|NOT COMPLETED|Overall Study||1
130705|NCT01773291|317918|P2|NOT COMPLETED|Overall Study||0
130706|NCT01773291|317919|P1|NOT COMPLETED|Overall Study||1
130707|NCT01773291|317917|P3|COMPLETED|Overall Study||6
130708|NCT01773291|317918|P2|COMPLETED|Overall Study||9
130709|NCT01773291|317919|P1|COMPLETED|Overall Study||7
130710|NCT01773291|317917|P3|STARTED|Overall Study||7
130711|NCT01773291|317918|P2|STARTED|Overall Study||9
130712|NCT01773291|317919|P1|STARTED|Overall Study||8
130713|NCT01773226|317930|P1|NOT COMPLETED|Overall Study||1
130714|NCT01773226|317930|P1|COMPLETED|Overall Study|Withdrawal of one subject after one-month assessment due to persistent OA symptoms|10
130715|NCT01773226|317930|P1|STARTED|Overall Study||11
130716|NCT01773135|317940|P1|NOT COMPLETED|Overall Study||0
130717|NCT01773135|317940|P1|COMPLETED|Overall Study||262
130718|NCT01773135|317940|P1|STARTED|Overall Study||262
130719|NCT01773122|317949|P4|NOT COMPLETED|Overall Study||1
130720|NCT01773122|317950|P3|NOT COMPLETED|Overall Study||0
130721|NCT01773122|317951|P2|NOT COMPLETED|Overall Study||1
130722|NCT01773122|317952|P1|NOT COMPLETED|Overall Study||3
130723|NCT01773122|317949|P4|COMPLETED|Overall Study||18
130724|NCT01773122|317950|P3|COMPLETED|Overall Study||19
130725|NCT01773122|317951|P2|COMPLETED|Overall Study||18
130726|NCT01773122|317952|P1|COMPLETED|Overall Study||17
130727|NCT01773122|317949|P4|STARTED|Overall Study||19
130728|NCT01773122|317950|P3|STARTED|Overall Study||19
130729|NCT01773122|317951|P2|STARTED|Overall Study||19
130730|NCT01773122|317952|P1|STARTED|Overall Study||20
130731|NCT01773070|317966|P1|NOT COMPLETED|Overall Study||81
130732|NCT01773070|317966|P1|COMPLETED|Overall Study||397
130733|NCT01773070|317966|P1|STARTED|Overall Study||478
130734|NCT01772823|317976|P2|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||9
130735|NCT01772823|317977|P1|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||10
130736|NCT01772823|317976|P2|COMPLETED|Extension Phase (Visits 24,48wks Post tx||33
130737|NCT01772823|317977|P1|COMPLETED|Extension Phase (Visits 24,48wks Post tx||53
130738|NCT01772823|317976|P2|STARTED|Extension Phase (Visits 24,48wks Post tx|10 of the 52 subjects that completed the Treatment Phase were not eligible for the Extension Phase|42
130739|NCT01772823|317977|P1|STARTED|Extension Phase (Visits 24,48wks Post tx|25 of the 88 subjects that completed the Treatment Phase were not eligible for the Extension Phase|63
130740|NCT01772823|317976|P2|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||18
130741|NCT01772823|317977|P1|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||28
130742|NCT01772823|317976|P2|COMPLETED|Treatment Phase (Week 0- Week 48)||52
130743|NCT01772823|317977|P1|COMPLETED|Treatment Phase (Week 0- Week 48)||88
130744|NCT01772823|317976|P2|STARTED|Treatment Phase (Week 0- Week 48)||70
130745|NCT01772823|317977|P1|STARTED|Treatment Phase (Week 0- Week 48)||116
130746|NCT01772823|317976|P2|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||2
130747|NCT01772823|317977|P1|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||12
130748|NCT01772823|317976|P2|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||70
130749|NCT01772823|317977|P1|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||116
130750|NCT01772823|317976|P2|STARTED|Behavioral Intervention (BL -3MV or PCC)||72
130751|NCT01772823|317977|P1|STARTED|Behavioral Intervention (BL -3MV or PCC)||128
130752|NCT01772758|318077|P4|NOT COMPLETED|Overall Study||0
130753|NCT01772758|318078|P3|NOT COMPLETED|Overall Study||0
130754|NCT01772758|318079|P2|NOT COMPLETED|Overall Study||0
130755|NCT01772758|318080|P1|NOT COMPLETED|Overall Study||0
130756|NCT01772758|318077|P4|COMPLETED|Overall Study||17
130757|NCT01772758|318078|P3|COMPLETED|Overall Study||12
130758|NCT01772758|318079|P2|COMPLETED|Overall Study||17
130759|NCT01772758|318080|P1|COMPLETED|Overall Study||18
130760|NCT01772758|318077|P4|STARTED|Overall Study||17
130761|NCT01772758|318078|P3|STARTED|Overall Study||12
130762|NCT01772758|318079|P2|STARTED|Overall Study||17
130763|NCT01772758|318080|P1|STARTED|Overall Study||18
130764|NCT01772719|318090|P1|NOT COMPLETED|Overall Study||7
130765|NCT01772719|318090|P1|COMPLETED|Overall Study||0
130766|NCT01772719|318090|P1|STARTED|Overall Study||7
130767|NCT01772654|318103|P2|NOT COMPLETED|Overall Study||0
130768|NCT01772654|318104|P1|NOT COMPLETED|Overall Study||0
130769|NCT01772654|318103|P2|COMPLETED|Overall Study||15
130770|NCT01772654|318104|P1|COMPLETED|Overall Study||2
130771|NCT01772654|318103|P2|STARTED|Overall Study||15
130772|NCT01772654|318104|P1|STARTED|Overall Study||2
130773|NCT01772576|318110|P1|NOT COMPLETED|Overall Study||34
130774|NCT01772576|318110|P1|COMPLETED|Overall Study||133
130775|NCT01772576|318110|P1|STARTED|Overall Study||167
130776|NCT01772550|318122|P3|NOT COMPLETED|Overall Study||6
130777|NCT01772550|318123|P2|NOT COMPLETED|Overall Study||1
130778|NCT01772550|318124|P1|NOT COMPLETED|Overall Study||1
130779|NCT01772550|318122|P3|COMPLETED|Overall Study||27
130780|NCT01772550|318123|P2|COMPLETED|Overall Study||102
130781|NCT01772550|318124|P1|COMPLETED|Overall Study||101
130782|NCT01772550|318122|P3|CT Cardiac|Overall Study||1
130783|NCT01772550|318123|P2|CT Cardiac|Overall Study||7
130784|NCT01772550|318124|P1|CT Cardiac|Overall Study||7
130785|NCT01772550|318122|P3|CT Kidney|Overall Study||6
130786|NCT01772550|318123|P2|CT Kidney|Overall Study||19
130787|NCT01772550|318124|P1|CT Kidney|Overall Study||12
130788|NCT01772550|318122|P3|CT Liver|Overall Study||8
130789|NCT01772550|318123|P2|CT Liver|Overall Study||14
130790|NCT01772550|318124|P1|CT Liver|Overall Study||18
130791|NCT01772550|318122|P3|CT Angiogram|Overall Study||4
130792|NCT01772550|318123|P2|CT Angiogram|Overall Study||25
130793|NCT01772550|318124|P1|CT Angiogram|Overall Study||24
130794|NCT01772550|318122|P3|CT Pancreas|Overall Study||8
130795|NCT01772550|318123|P2|CT Pancreas|Overall Study||36
130796|NCT01772550|318124|P1|CT Pancreas|Overall Study||40
130797|NCT01772550|318122|P3|STARTED|Overall Study||33
130798|NCT01772550|318123|P2|STARTED|Overall Study||103
130799|NCT01772550|318124|P1|STARTED|Overall Study||102
130800|NCT01772537|318165|P3|NOT COMPLETED|Overall Study||0
130801|NCT01772537|318166|P2|NOT COMPLETED|Overall Study||0
130802|NCT01772537|318167|P1|NOT COMPLETED|Overall Study||1
130803|NCT01772537|318165|P3|COMPLETED|Overall Study||6
130804|NCT01772537|318166|P2|COMPLETED|Overall Study||3
130805|NCT01772537|318167|P1|COMPLETED|Overall Study||4
130806|NCT01772537|318165|P3|STARTED|Overall Study||6
130807|NCT01772537|318166|P2|STARTED|Overall Study||3
130808|NCT01772537|318167|P1|STARTED|Overall Study||5
130809|NCT01772472|318183|P2|NOT COMPLETED|Overall Study||743
130810|NCT01772472|318184|P1|NOT COMPLETED|Overall Study||743
130811|NCT01772472|318183|P2|COMPLETED|Overall Study||0
130812|NCT01772472|318184|P1|COMPLETED|Overall Study||0
130813|NCT01772472|318183|P2|STARTED|Overall Study||743
130814|NCT01772472|318184|P1|STARTED|Overall Study||743
130815|NCT01772368|318196|P1|NOT COMPLETED|Overall Study||7
130816|NCT01772368|318196|P1|COMPLETED|Overall Study||65
130817|NCT01772368|318196|P1|Received Advair Diskus 100/50 mcg|Overall Study||66
130818|NCT01772368|318196|P1|Received FS MDPI 100/50 mcg|Overall Study||68
130819|NCT01772368|318196|P1|Received FS MDPI 100/25 mcg|Overall Study||67
130820|NCT01772368|318196|P1|Received FS MDPI 100/12.5mcg|Overall Study||69
130821|NCT01772368|318196|P1|Received FS MDPI 100/6.25 mcg|Overall Study||68
130822|NCT01772368|318196|P1|Received Fp MDPI 100 mcg|Overall Study||67
130823|NCT01772368|318196|P1|STARTED|Overall Study||72
130824|NCT01772316|318242|P1|NOT COMPLETED|Overall Study||7
130825|NCT01772316|318242|P1|COMPLETED|Overall Study||40
130826|NCT01772316|318242|P1|STARTED|Overall Study||47
130827|NCT01772147|318263|P3|NOT COMPLETED|Overall Study||18
130828|NCT01772147|318264|P2|NOT COMPLETED|Overall Study||25
130829|NCT01772147|318265|P1|NOT COMPLETED|Overall Study||31
130830|NCT01772147|318263|P3|COMPLETED|Overall Study||184
130831|NCT01772147|318264|P2|COMPLETED|Overall Study||178
130832|NCT01772147|318265|P1|COMPLETED|Overall Study||170
130833|NCT01772147|318263|P3|STARTED|Overall Study||202
130834|NCT01772147|318264|P2|STARTED|Overall Study||203
130835|NCT01772147|318265|P1|STARTED|Overall Study||201
130836|NCT01772134|318285|P3|NOT COMPLETED|Overall Study||22
130837|NCT01772134|318286|P2|NOT COMPLETED|Overall Study||14
130838|NCT01772134|318287|P1|NOT COMPLETED|Overall Study||29
130839|NCT01772134|318285|P3|COMPLETED|Overall Study||184
130840|NCT01772134|318286|P2|COMPLETED|Overall Study||190
130841|NCT01772134|318287|P1|COMPLETED|Overall Study||178
130842|NCT01772134|318285|P3|Received Randomized Study Medication|Overall Study||205
130843|NCT01772134|318286|P2|Received Randomized Study Medication|Overall Study||204
130844|NCT01772134|318287|P1|Received Randomized Study Medication|Overall Study||205
130845|NCT01772134|318285|P3|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|206
130846|NCT01772134|318286|P2|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|204
130847|NCT01772134|318287|P1|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|207
130848|NCT01771991|318306|P2|NOT COMPLETED|Overall Study||6
130849|NCT01771991|318307|P1|NOT COMPLETED|Overall Study||8
130850|NCT01771991|318306|P2|COMPLETED|Overall Study||30
130851|NCT01771991|318307|P1|COMPLETED|Overall Study||30
130852|NCT01771991|318306|P2|Started Treatment|Overall Study||34
130853|NCT01771991|318307|P1|Started Treatment|Overall Study||37
130854|NCT01771991|318306|P2|STARTED|Overall Study||36
130855|NCT01771991|318307|P1|STARTED|Overall Study||38
130856|NCT01771965|318321|P2|NOT COMPLETED|Overall Study||5
130857|NCT01771965|318322|P1|NOT COMPLETED|Overall Study||3
130858|NCT01771965|318321|P2|COMPLETED|Overall Study||4
130859|NCT01771965|318322|P1|COMPLETED|Overall Study||7
130860|NCT01771965|318321|P2|STARTED|Overall Study||9
130861|NCT01771965|318322|P1|STARTED|Overall Study||10
130862|NCT01771913|318330|P2|NOT COMPLETED|Overall Study||0
130863|NCT01771913|318331|P1|NOT COMPLETED|Overall Study||1
130864|NCT01771913|318330|P2|COMPLETED|Overall Study||11
130865|NCT01771913|318331|P1|COMPLETED|Overall Study||8
130866|NCT01771913|318330|P2|STARTED|Overall Study||11
130867|NCT01771913|318331|P1|STARTED|Overall Study||9
130868|NCT01771809|318343|P2|NOT COMPLETED|Overall Study||83
130869|NCT01771809|318344|P1|NOT COMPLETED|Overall Study||71
130870|NCT01771809|318343|P2|COMPLETED|Overall Study||83
130871|NCT01771809|318344|P1|COMPLETED|Overall Study||93
130872|NCT01771809|318343|P2|STARTED|Overall Study||166
130873|NCT01771809|318344|P1|STARTED|Overall Study||164
130874|NCT01771666|318358|P1|NOT COMPLETED|Overall Study||0
130875|NCT01771666|318358|P1|COMPLETED|Overall Study||23
130876|NCT01771666|318358|P1|STARTED|Overall Study||23
130877|NCT01771250|318363|P2|NOT COMPLETED|Period 2||0
130878|NCT01771250|318364|P1|NOT COMPLETED|Period 2||0
130879|NCT01771250|318363|P2|COMPLETED|Period 2||7
130880|NCT01771250|318364|P1|COMPLETED|Period 2||7
130881|NCT01771250|318363|P2|STARTED|Period 2||7
130882|NCT01771250|318364|P1|STARTED|Period 2||7
130883|NCT01771250|318363|P2|NOT COMPLETED|Period 1||0
130884|NCT01771250|318364|P1|NOT COMPLETED|Period 1||1
130885|NCT01771250|318363|P2|COMPLETED|Period 1||7
130886|NCT01771250|318364|P1|COMPLETED|Period 1||7
130887|NCT01771250|318363|P2|Received at Least One Dose of Study Drug|Period 1||7
130888|NCT01771250|318364|P1|Received at Least One Dose of Study Drug|Period 1||7
130889|NCT01771250|318363|P2|STARTED|Period 1||7
130890|NCT01771250|318364|P1|STARTED|Period 1||8
130891|NCT01771172|318376|P1|NOT COMPLETED|Overall Study||2
130892|NCT01771172|318376|P1|COMPLETED|Overall Study||46
130893|NCT01771172|318376|P1|STARTED|Overall Study||48
130894|NCT01770860|318380|P1|NOT COMPLETED|Overall Study||6
130895|NCT01770860|318380|P1|COMPLETED|Overall Study||40
130896|NCT01770860|318380|P1|Randomization|Overall Study|One participant withdrew before randomization|45
130897|NCT01770860|318380|P1|STARTED|Overall Study|Forty-six subjects were enrolled but one subject withdrew before randomization.|46
130898|NCT01770743|318428|P5|NOT COMPLETED|Overall Study||2
130899|NCT01770743|318429|P4|NOT COMPLETED|Overall Study||2
130900|NCT01770743|318430|P3|NOT COMPLETED|Overall Study||1
130901|NCT01770743|318431|P2|NOT COMPLETED|Overall Study||3
130902|NCT01770743|318432|P1|NOT COMPLETED|Overall Study||2
130903|NCT01770743|318428|P5|COMPLETED|Overall Study||21
130904|NCT01770743|318429|P4|COMPLETED|Overall Study||42
130905|NCT01770743|318430|P3|COMPLETED|Overall Study||22
130906|NCT01770743|318431|P2|COMPLETED|Overall Study||31
130907|NCT01770743|318432|P1|COMPLETED|Overall Study||42
130908|NCT01770743|318428|P5|Treated|Overall Study||23
130909|NCT01770743|318429|P4|Treated|Overall Study||44
130910|NCT01770743|318430|P3|Treated|Overall Study||23
130911|NCT01770743|318431|P2|Treated|Overall Study||34
130912|NCT01770743|318432|P1|Treated|Overall Study||44
130913|NCT01770743|318428|P5|STARTED|Overall Study||23
130914|NCT01770743|318429|P4|STARTED|Overall Study||44
130915|NCT01770743|318430|P3|STARTED|Overall Study||23
130916|NCT01770743|318431|P2|STARTED|Overall Study||34
130917|NCT01770743|318432|P1|STARTED|Overall Study||44
130918|NCT01770691|318484|P1|NOT COMPLETED|Overall Study||0
130919|NCT01770691|318484|P1|COMPLETED|Overall Study||7
130920|NCT01770691|318484|P1|STARTED|Overall Study||7
130921|NCT01770652|318495|P4|NOT COMPLETED|Overall Study||0
130922|NCT01770652|318496|P3|NOT COMPLETED|Overall Study||0
130923|NCT01770652|318497|P2|NOT COMPLETED|Overall Study||0
130924|NCT01770652|318498|P1|NOT COMPLETED|Overall Study||0
130925|NCT01770652|318495|P4|COMPLETED|Overall Study||8
130926|NCT01770652|318496|P3|COMPLETED|Overall Study||8
130927|NCT01770652|318497|P2|COMPLETED|Overall Study||8
130928|NCT01770652|318498|P1|COMPLETED|Overall Study||8
130929|NCT01770652|318495|P4|STARTED|Overall Study||8
130930|NCT01770652|318496|P3|STARTED|Overall Study||8
130931|NCT01770652|318497|P2|STARTED|Overall Study||8
130932|NCT01770652|318498|P1|STARTED|Overall Study||8
130933|NCT01770509|318534|P2|NOT COMPLETED|Overall Study||3
130934|NCT01770509|318535|P1|NOT COMPLETED|Overall Study||1
130935|NCT01770509|318534|P2|COMPLETED|Overall Study||14
130936|NCT01770509|318535|P1|COMPLETED|Overall Study||11
130937|NCT01770509|318534|P2|STARTED|Overall Study||17
130938|NCT01770509|318535|P1|STARTED|Overall Study||12
130939|NCT01770483|318551|P2|NOT COMPLETED|Overall Study||0
130940|NCT01770483|318552|P1|NOT COMPLETED|Overall Study||0
130941|NCT01770483|318551|P2|COMPLETED|Overall Study||33
130942|NCT01770483|318552|P1|COMPLETED|Overall Study||33
130943|NCT01770483|318551|P2|STARTED|Overall Study||33
130944|NCT01770483|318552|P1|STARTED|Overall Study||33
130945|NCT01770431|318562|P2|NOT COMPLETED|Overall Study||32
130946|NCT01770431|318563|P1|NOT COMPLETED|Overall Study||10
130947|NCT01770431|318562|P2|COMPLETED|Overall Study||316
130948|NCT01770431|318563|P1|COMPLETED|Overall Study||686
130949|NCT01770431|318562|P2|STARTED|Overall Study||348
130950|NCT01770431|318563|P1|STARTED|Overall Study||696
130951|NCT01770392|318571|P1|NOT COMPLETED|Nintedanib+ Rifampicin||0
130952|NCT01770392|318571|P1|COMPLETED|Nintedanib+ Rifampicin||25
130953|NCT01770392|318571|P1|STARTED|Nintedanib+ Rifampicin||25
130954|NCT01770392|318571|P1|NOT COMPLETED|Washout Period of at Least 14 Days||1
130955|NCT01770392|318571|P1|COMPLETED|Washout Period of at Least 14 Days||25
130956|NCT01770392|318571|P1|STARTED|Washout Period of at Least 14 Days||26
130957|NCT01770392|318571|P1|NOT COMPLETED|Nintedanib||0
130958|NCT01770392|318571|P1|COMPLETED|Nintedanib||26
130959|NCT01770392|318571|P1|STARTED|Nintedanib||26
130960|NCT01770379|318586|P3|NOT COMPLETED|Overall Study||42
130961|NCT01770379|318587|P2|NOT COMPLETED|Overall Study||44
130962|NCT01770379|318588|P1|NOT COMPLETED|Overall Study||39
130963|NCT01770379|318586|P3|COMPLETED|Overall Study||39
130964|NCT01770379|318587|P2|COMPLETED|Overall Study||37
130965|NCT01770379|318588|P1|COMPLETED|Overall Study||41
130966|NCT01770379|318586|P3|STARTED|Overall Study||81
130967|NCT01770379|318587|P2|STARTED|Overall Study||81
130968|NCT01770379|318588|P1|STARTED|Overall Study||80
130969|NCT01770366|318607|P2|NOT COMPLETED|Overall Study||2
130970|NCT01770366|318608|P1|NOT COMPLETED|Overall Study||2
130971|NCT01770366|318607|P2|COMPLETED|Overall Study||4
130972|NCT01770366|318608|P1|COMPLETED|Overall Study||2
130973|NCT01770366|318607|P2|STARTED|Overall Study||6
130974|NCT01770366|318608|P1|STARTED|Overall Study||4
130975|NCT01770353|318616|P2|NOT COMPLETED|Overall Study||12
130976|NCT01770353|318617|P1|NOT COMPLETED|Overall Study||6
130977|NCT01770353|318616|P2|COMPLETED|Overall Study||18
130978|NCT01770353|318617|P1|COMPLETED|Overall Study||9
130979|NCT01770353|318616|P2|Received FMX and MM-398|Overall Study||29
130980|NCT01770353|318617|P1|Received FMX and MM-398|Overall Study||13
130981|NCT01770353|318616|P2|Received FMX|Overall Study|1 subject excluded from MM-398 safety population.|30
130982|NCT01770353|318617|P1|Received FMX|Overall Study|2 subjects excluded from MM-398 safety population.|15
130983|NCT01770353|318616|P2|STARTED|Overall Study||30
130984|NCT01770353|318617|P1|STARTED|Overall Study||15
130985|NCT01770314|318667|P2|NOT COMPLETED|Overall Study||0
130986|NCT01770314|318668|P1|NOT COMPLETED|Overall Study||0
130987|NCT01770314|318667|P2|COMPLETED|Overall Study||90
130988|NCT01770314|318668|P1|COMPLETED|Overall Study||86
130989|NCT01770314|318667|P2|Contributed Data to One-month Follow-up|Overall Study||66
130990|NCT01770314|318668|P1|Contributed Data to One-month Follow-up|Overall Study||61
130991|NCT01770314|318667|P2|Contributed Data to Post-test|Overall Study||67
130992|NCT01770314|318668|P1|Contributed Data to Post-test|Overall Study||65
130993|NCT01770314|318667|P2|Contributed Data to Baseline|Overall Study||72
130994|NCT01770314|318668|P1|Contributed Data to Baseline|Overall Study||68
130995|NCT01770314|318667|P2|STARTED|Overall Study||90
130996|NCT01770314|318668|P1|STARTED|Overall Study||86
130997|NCT01770145|318676|P1|NOT COMPLETED|Treatment||4
130998|NCT01770145|318676|P1|COMPLETED|Treatment||97
130999|NCT01770145|318676|P1|STARTED|Treatment||101
131000|NCT01770145|318676|P1|NOT COMPLETED|Baseline||26
131001|NCT01770145|318676|P1|COMPLETED|Baseline||101
131002|NCT01770145|318676|P1|STARTED|Baseline||127
131003|NCT01769612|318681|P1|NOT COMPLETED|Overall Study||0
131004|NCT01769612|318681|P1|COMPLETED|Overall Study||168
131005|NCT01769612|318681|P1|STARTED|Overall Study||168
131006|NCT01769586|318689|P2|NOT COMPLETED|Overall Study||0
131007|NCT01769586|318690|P1|NOT COMPLETED|Overall Study||0
131008|NCT01769586|318689|P2|COMPLETED|Overall Study||100
131009|NCT01769586|318690|P1|COMPLETED|Overall Study||100
131010|NCT01769586|318689|P2|STARTED|Overall Study||100
131011|NCT01769586|318690|P1|STARTED|Overall Study||100
131012|NCT01769573|318701|P5|NOT COMPLETED|Overall Study||0
131013|NCT01769573|318702|P4|NOT COMPLETED|Overall Study||0
131014|NCT01769573|318703|P3|NOT COMPLETED|Overall Study||0
131015|NCT01769573|318704|P2|NOT COMPLETED|Overall Study||0
131016|NCT01769573|318705|P1|NOT COMPLETED|Overall Study||0
131017|NCT01769573|318701|P5|COMPLETED|Overall Study||10
131018|NCT01769573|318702|P4|COMPLETED|Overall Study||0
131019|NCT01769573|318703|P3|COMPLETED|Overall Study||10
131020|NCT01769573|318704|P2|COMPLETED|Overall Study||6
131021|NCT01769573|318705|P1|COMPLETED|Overall Study||10
131022|NCT01769573|318701|P5|STARTED|Overall Study||10
131023|NCT01769573|318702|P4|STARTED|Overall Study||0
131024|NCT01769573|318703|P3|STARTED|Overall Study||10
131025|NCT01769573|318704|P2|STARTED|Overall Study||6
131026|NCT01769573|318705|P1|STARTED|Overall Study||10
131027|NCT01769508|318732|P1|NOT COMPLETED|Overall Study||6
131028|NCT01769508|318732|P1|COMPLETED|Overall Study||6
131029|NCT01769508|318732|P1|STARTED|Overall Study||12
131030|NCT01769469|318741|P1|NOT COMPLETED|Overall Study||35
131031|NCT01769469|318741|P1|COMPLETED|Overall Study||66
131032|NCT01769469|318741|P1|STARTED|Overall Study||101
131033|NCT01769456|318901|P1|NOT COMPLETED|Overall Study||37
131034|NCT01769456|318901|P1|COMPLETED|Overall Study||41
131035|NCT01769456|318901|P1|STARTED|Overall Study|1 subject inadvertently enrolled, discontin'd after baseline, re-enrolled later and completed study|78
131036|NCT01769443|318922|P2|NOT COMPLETED|Overall Study||0
131037|NCT01769443|318923|P1|NOT COMPLETED|Overall Study||1
131038|NCT01769443|318922|P2|COMPLETED|Overall Study||1
131039|NCT01769443|318923|P1|COMPLETED|Overall Study||0
131040|NCT01769443|318922|P2|STARTED|Overall Study||1
131041|NCT01769443|318923|P1|STARTED|Overall Study||1
131042|NCT01769404|318965|P2|NOT COMPLETED|Treatment Period 2||0
131043|NCT01769404|318966|P1|NOT COMPLETED|Treatment Period 2||7
131044|NCT01769404|318965|P2|COMPLETED|Treatment Period 2||13
131045|NCT01769404|318966|P1|COMPLETED|Treatment Period 2||0
131046|NCT01769404|318965|P2|STARTED|Treatment Period 2||13
131047|NCT01769404|318966|P1|STARTED|Treatment Period 2||7
131048|NCT01769404|318965|P2|NOT COMPLETED|Treatment Period 1||0
131049|NCT01769404|318966|P1|NOT COMPLETED|Treatment Period 1||5
131050|NCT01769404|318965|P2|COMPLETED|Treatment Period 1||13
131051|NCT01769404|318966|P1|COMPLETED|Treatment Period 1||7
131052|NCT01769404|318965|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||13
131053|NCT01769404|318966|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
131054|NCT01769404|318965|P2|STARTED|Treatment Period 1||13
131055|NCT01769404|318966|P1|STARTED|Treatment Period 1||12
131056|NCT01769391|318988|P2|NOT COMPLETED|Overall Study||9
131057|NCT01769391|318989|P1|NOT COMPLETED|Overall Study||17
131058|NCT01769391|318988|P2|COMPLETED|Overall Study||48
131059|NCT01769391|318989|P1|COMPLETED|Overall Study||93
131060|NCT01769391|318988|P2|Received at Least One Dose of Study Drug|Overall Study||55
131061|NCT01769391|318989|P1|Received at Least One Dose of Study Drug|Overall Study||106
131062|NCT01769391|318988|P2|STARTED|Overall Study||57
131063|NCT01769391|318989|P1|STARTED|Overall Study||110
131064|NCT01769378|319008|P2|NOT COMPLETED|Overall Study||4
131065|NCT01769378|319009|P1|NOT COMPLETED|Overall Study||25
131066|NCT01769378|319008|P2|COMPLETED|Overall Study|Completed the study on study treatment|56
131067|NCT01769378|319009|P1|COMPLETED|Overall Study|Completed the study on study treatment|215
131068|NCT01769378|319008|P2|Received at Least 1 Dose of Study Drug|Overall Study||60
131069|NCT01769378|319009|P1|Received at Least 1 Dose of Study Drug|Overall Study||239
131070|NCT01769378|319008|P2|STARTED|Overall Study||60
131071|NCT01769378|319009|P1|STARTED|Overall Study||240
131072|NCT01769365|319047|P3|NOT COMPLETED|Overall Study||2
131073|NCT01769365|319048|P2|NOT COMPLETED|Overall Study||2
131074|NCT01769365|319049|P1|NOT COMPLETED|Overall Study||0
131075|NCT01769365|319047|P3|COMPLETED|Overall Study||101
131076|NCT01769365|319048|P2|COMPLETED|Overall Study||100
131077|NCT01769365|319049|P1|COMPLETED|Overall Study||102
131078|NCT01769365|319047|P3|STARTED|Overall Study||103
131079|NCT01769365|319048|P2|STARTED|Overall Study||102
131080|NCT01769365|319049|P1|STARTED|Overall Study||102
131081|NCT01769352|319061|P4|NOT COMPLETED|Overall Study||0
131082|NCT01769352|319062|P3|NOT COMPLETED|Overall Study||0
131083|NCT01769352|319063|P2|NOT COMPLETED|Overall Study||0
131084|NCT01769352|319064|P1|NOT COMPLETED|Overall Study||0
131085|NCT01769352|319061|P4|COMPLETED|Overall Study||8
131086|NCT01769352|319062|P3|COMPLETED|Overall Study||9
131087|NCT01769352|319063|P2|COMPLETED|Overall Study||12
131088|NCT01769352|319064|P1|COMPLETED|Overall Study||13
131089|NCT01769352|319061|P4|STARTED|Overall Study||8
131090|NCT01769352|319062|P3|STARTED|Overall Study||9
131091|NCT01769352|319063|P2|STARTED|Overall Study||12
131092|NCT01769352|319064|P1|STARTED|Overall Study||13
131093|NCT01769339|319089|P1|NOT COMPLETED|Overall Study||43
131094|NCT01769339|319089|P1|COMPLETED|Overall Study||72
131095|NCT01769339|319089|P1|STARTED|Overall Study||115
131096|NCT01769326|319100|P4|NOT COMPLETED|Overall Study||0
131097|NCT01769326|319101|P3|NOT COMPLETED|Overall Study||1
131098|NCT01769326|319102|P2|NOT COMPLETED|Overall Study||4
131099|NCT01769326|319103|P1|NOT COMPLETED|Overall Study||2
131100|NCT01769326|319100|P4|COMPLETED|Overall Study||8
131101|NCT01769326|319101|P3|COMPLETED|Overall Study||8
131102|NCT01769326|319102|P2|COMPLETED|Overall Study||8
131103|NCT01769326|319103|P1|COMPLETED|Overall Study||9
131104|NCT01769326|319100|P4|STARTED|Overall Study||8
131105|NCT01769326|319101|P3|STARTED|Overall Study||9
131106|NCT01769326|319102|P2|STARTED|Overall Study||12
131107|NCT01769326|319103|P1|STARTED|Overall Study||11
131108|NCT01769274|319113|P3|NOT COMPLETED|Part B:Treatment Session2-Period4||0
131109|NCT01769274|319114|P2|NOT COMPLETED|Part B:Treatment Session2-Period4||0
131110|NCT01769274|319115|P1|NOT COMPLETED|Part B:Treatment Session2-Period4||0
131111|NCT01769274|319113|P3|COMPLETED|Part B:Treatment Session2-Period4||3
131112|NCT01769274|319114|P2|COMPLETED|Part B:Treatment Session2-Period4||2
131113|NCT01769274|319115|P1|COMPLETED|Part B:Treatment Session2-Period4||0
131114|NCT01769274|319113|P3|STARTED|Part B:Treatment Session2-Period4||3
131115|NCT01769274|319114|P2|STARTED|Part B:Treatment Session2-Period4||2
131116|NCT01769274|319115|P1|STARTED|Part B:Treatment Session2-Period4||0
131117|NCT01769274|319113|P3|NOT COMPLETED|Washout Period||0
131118|NCT01769274|319114|P2|NOT COMPLETED|Washout Period||0
131119|NCT01769274|319115|P1|NOT COMPLETED|Washout Period||0
131120|NCT01769274|319113|P3|COMPLETED|Washout Period||3
131121|NCT01769274|319114|P2|COMPLETED|Washout Period||2
131122|NCT01769274|319115|P1|COMPLETED|Washout Period||0
131123|NCT01769274|319113|P3|STARTED|Washout Period||3
131124|NCT01769274|319114|P2|STARTED|Washout Period||2
131125|NCT01769274|319115|P1|STARTED|Washout Period||0
131126|NCT01769274|319113|P3|NOT COMPLETED|Part B:Treatment Session2-Period3||0
131127|NCT01769274|319114|P2|NOT COMPLETED|Part B:Treatment Session2-Period3||0
131128|NCT01769274|319115|P1|NOT COMPLETED|Part B:Treatment Session2-Period3||0
131129|NCT01769274|319113|P3|COMPLETED|Part B:Treatment Session2-Period3||3
131130|NCT01769274|319114|P2|COMPLETED|Part B:Treatment Session2-Period3||2
131131|NCT01769274|319115|P1|COMPLETED|Part B:Treatment Session2-Period3||0
131132|NCT01769274|319113|P3|STARTED|Part B:Treatment Session2-Period3||3
131133|NCT01769274|319114|P2|STARTED|Part B:Treatment Session2-Period3||2
131134|NCT01769274|319115|P1|STARTED|Part B:Treatment Session2-Period3||0
131135|NCT01769274|319113|P3|NOT COMPLETED|Washout Period||0
131136|NCT01769274|319114|P2|NOT COMPLETED|Washout Period||0
131137|NCT01769274|319115|P1|NOT COMPLETED|Washout Period||0
131138|NCT01769274|319113|P3|COMPLETED|Washout Period||3
131139|NCT01769274|319114|P2|COMPLETED|Washout Period||2
131140|NCT01769274|319115|P1|COMPLETED|Washout Period||0
131141|NCT01769274|319113|P3|STARTED|Washout Period||3
131142|NCT01769274|319114|P2|STARTED|Washout Period||2
131143|NCT01769274|319115|P1|STARTED|Washout Period||0
131144|NCT01769274|319113|P3|NOT COMPLETED|Part B:Treatment Session1-Period2||0
131145|NCT01769274|319114|P2|NOT COMPLETED|Part B:Treatment Session1-Period2||0
131146|NCT01769274|319115|P1|NOT COMPLETED|Part B:Treatment Session1-Period2||0
131147|NCT01769274|319113|P3|COMPLETED|Part B:Treatment Session1-Period2||3
131148|NCT01769274|319114|P2|COMPLETED|Part B:Treatment Session1-Period2||2
131149|NCT01769274|319115|P1|COMPLETED|Part B:Treatment Session1-Period2||0
131150|NCT01769274|319113|P3|STARTED|Part B:Treatment Session1-Period2||3
131151|NCT01769274|319114|P2|STARTED|Part B:Treatment Session1-Period2||2
131152|NCT01769274|319115|P1|STARTED|Part B:Treatment Session1-Period2||0
131153|NCT01769274|319113|P3|NOT COMPLETED|Washout Period||0
131154|NCT01769274|319114|P2|NOT COMPLETED|Washout Period||0
131155|NCT01769274|319115|P1|NOT COMPLETED|Washout Period||0
131156|NCT01769274|319113|P3|COMPLETED|Washout Period||3
131157|NCT01769274|319114|P2|COMPLETED|Washout Period||2
131158|NCT01769274|319115|P1|COMPLETED|Washout Period||0
131159|NCT01769274|319113|P3|STARTED|Washout Period||3
131160|NCT01769274|319114|P2|STARTED|Washout Period||2
131161|NCT01769274|319115|P1|STARTED|Washout Period||0
131162|NCT01769274|319113|P3|NOT COMPLETED|Part B:Treatment Session1-Period1||0
131163|NCT01769274|319114|P2|NOT COMPLETED|Part B:Treatment Session1-Period1||0
131164|NCT01769274|319115|P1|NOT COMPLETED|Part B:Treatment Session1-Period1||0
131165|NCT01769274|319113|P3|COMPLETED|Part B:Treatment Session1-Period1||3
131166|NCT01769274|319114|P2|COMPLETED|Part B:Treatment Session1-Period1||2
131167|NCT01769274|319115|P1|COMPLETED|Part B:Treatment Session1-Period1||0
131168|NCT01769274|319113|P3|STARTED|Part B:Treatment Session1-Period1||3
131169|NCT01769274|319114|P2|STARTED|Part B:Treatment Session1-Period1||2
131170|NCT01769274|319115|P1|STARTED|Part B:Treatment Session1-Period1||0
131171|NCT01769274|319113|P3|NOT COMPLETED|Part A||0
131172|NCT01769274|319114|P2|NOT COMPLETED|Part A||0
131173|NCT01769274|319115|P1|NOT COMPLETED|Part A||0
131174|NCT01769274|319113|P3|COMPLETED|Part A||0
131175|NCT01769274|319114|P2|COMPLETED|Part A||0
131176|NCT01769274|319115|P1|COMPLETED|Part A||5
131177|NCT01769274|319113|P3|STARTED|Part A||0
131178|NCT01769274|319114|P2|STARTED|Part A||0
131179|NCT01769274|319115|P1|STARTED|Part A||5
131180|NCT01769248|319207|P2|NOT COMPLETED|Overall Study||12
131181|NCT01769248|319208|P1|NOT COMPLETED|Overall Study||28
131182|NCT01769248|319207|P2|COMPLETED|Overall Study||58
131183|NCT01769248|319208|P1|COMPLETED|Overall Study||42
131184|NCT01769248|319207|P2|Participants Who Crossed-over|Overall Study||12
131185|NCT01769248|319208|P1|Participants Who Crossed-over|Overall Study||28
131186|NCT01769248|319207|P2|STARTED|Overall Study||70
131187|NCT01769248|319208|P1|STARTED|Overall Study||70
131188|NCT01769222|319220|P2|NOT COMPLETED|Overall Study||0
131189|NCT01769222|319221|P1|NOT COMPLETED|Overall Study||0
131190|NCT01769222|319220|P2|COMPLETED|Overall Study||0
131191|NCT01769222|319221|P1|COMPLETED|Overall Study||3
131192|NCT01769222|319220|P2|STARTED|Overall Study||0
131193|NCT01769222|319221|P1|STARTED|Overall Study||3
131194|NCT01769209|319235|P1|NOT COMPLETED|Overall Study||0
131195|NCT01769209|319235|P1|COMPLETED|Overall Study||18
131196|NCT01769209|319235|P1|STARTED|Overall Study||18
131197|NCT01769196|319248|P2|NOT COMPLETED|Overall Study||272
131198|NCT01769196|319249|P1|NOT COMPLETED|Overall Study||272
131199|NCT01769196|319248|P2|COMPLETED|Overall Study||0
131200|NCT01769196|319249|P1|COMPLETED|Overall Study||0
131201|NCT01769196|319248|P2|STARTED|Overall Study||272
131202|NCT01769196|319249|P1|STARTED|Overall Study||272
131203|NCT01769105|319279|P2|NOT COMPLETED|Cross-over||0
131204|NCT01769105|319280|P1|NOT COMPLETED|Cross-over||5
131205|NCT01769105|319279|P2|COMPLETED|Cross-over|Was not intended by the study protocol|0
131206|NCT01769105|319280|P1|COMPLETED|Cross-over||9
131207|NCT01769105|319279|P2|STARTED|Cross-over|Cross-over was only intended for the Lid margin hygiene group|0
131208|NCT01769105|319280|P1|STARTED|Cross-over||14
131209|NCT01769105|319279|P2|NOT COMPLETED|First Intervention||2
131210|NCT01769105|319280|P1|NOT COMPLETED|First Intervention||2
131211|NCT01769105|319279|P2|COMPLETED|First Intervention||17
131212|NCT01769105|319280|P1|COMPLETED|First Intervention||14
131213|NCT01769105|319279|P2|STARTED|First Intervention||19
131214|NCT01769105|319280|P1|STARTED|First Intervention||16
131215|NCT01768858|319299|P1|NOT COMPLETED|Overall Study||22
131216|NCT01768858|319299|P1|COMPLETED|Overall Study||74
131217|NCT01768858|319299|P1|STARTED|Overall Study||96
131218|NCT01768832|319314|P3|NOT COMPLETED|Overall Study||9
131219|NCT01768832|319315|P2|NOT COMPLETED|Overall Study||4
131220|NCT01768832|319316|P1|NOT COMPLETED|Overall Study||10
131221|NCT01768832|319314|P3|COMPLETED|Overall Study||26
131222|NCT01768832|319315|P2|COMPLETED|Overall Study||39
131223|NCT01768832|319316|P1|COMPLETED|Overall Study||31
131224|NCT01768832|319314|P3|STARTED|Overall Study||35
131225|NCT01768832|319315|P2|STARTED|Overall Study||43
131226|NCT01768832|319316|P1|STARTED|Overall Study||41
131227|NCT01768676|319350|P2|NOT COMPLETED|Overall Study||31
131228|NCT01768676|319351|P1|NOT COMPLETED|Overall Study||24
131229|NCT01768676|319350|P2|COMPLETED|Overall Study||60
131230|NCT01768676|319351|P1|COMPLETED|Overall Study||66
131231|NCT01768676|319350|P2|STARTED|Overall Study||91
131232|NCT01768676|319351|P1|STARTED|Overall Study||90
131233|NCT01768637|319367|P2|NOT COMPLETED|Overall Study||7
131234|NCT01768637|319368|P1|NOT COMPLETED|Overall Study||3
131235|NCT01768637|319367|P2|COMPLETED|Overall Study||12
131236|NCT01768637|319368|P1|COMPLETED|Overall Study||26
131237|NCT01768637|319367|P2|Completed Visit 2|Overall Study||13
131238|NCT01768637|319368|P1|Completed Visit 2|Overall Study||26
131239|NCT01768637|319367|P2|Completed Visit 1|Overall Study||16
131240|NCT01768637|319368|P1|Completed Visit 1|Overall Study||28
131241|NCT01768637|319367|P2|STARTED|Overall Study||19
131242|NCT01768637|319368|P1|STARTED|Overall Study||29
131243|NCT01768572|319381|P3|NOT COMPLETED|Overall Study||6
131244|NCT01768572|319382|P2|NOT COMPLETED|Overall Study||12
131245|NCT01768572|319383|P1|NOT COMPLETED|Overall Study||9
131246|NCT01768572|319381|P3|COMPLETED|Overall Study||96
131247|NCT01768572|319382|P2|COMPLETED|Overall Study||39
131248|NCT01768572|319383|P1|COMPLETED|Overall Study||40
131249|NCT01768572|319381|P3|STARTED|Overall Study||102
131250|NCT01768572|319382|P2|STARTED|Overall Study||51
131251|NCT01768572|319383|P1|STARTED|Overall Study||49
131252|NCT01768559|319394|P3|NOT COMPLETED|Overall Study||13
131253|NCT01768559|319395|P2|NOT COMPLETED|Overall Study||17
131254|NCT01768559|319396|P1|NOT COMPLETED|Overall Study||30
131255|NCT01768559|319394|P3|COMPLETED|Overall Study||285
131256|NCT01768559|319395|P2|COMPLETED|Overall Study||281
131257|NCT01768559|319396|P1|COMPLETED|Overall Study||268
131258|NCT01768559|319394|P3|Treated|Overall Study|4 participants received Insulin Glulisine QD (for more than 50%)|297
131259|NCT01768559|319395|P2|Treated|Overall Study|1 participant received Insulin Glulisine TID (for more than 50%)|298
131260|NCT01768559|319396|P1|Treated|Overall Study||298
131261|NCT01768559|319394|P3|STARTED|Overall Study||298
131262|NCT01768559|319395|P2|STARTED|Overall Study||298
131263|NCT01768559|319396|P1|STARTED|Overall Study||298
131264|NCT01768520|319447|P3|NOT COMPLETED|Overall Study||9
131265|NCT01768520|319448|P2|NOT COMPLETED|Overall Study||26
131266|NCT01768520|319449|P1|NOT COMPLETED|Overall Study||32
131267|NCT01768520|319447|P3|COMPLETED|Overall Study||30
131268|NCT01768520|319448|P2|COMPLETED|Overall Study||121
131269|NCT01768520|319449|P1|COMPLETED|Overall Study||120
131270|NCT01768520|319447|P3|STARTED|Overall Study||39
131271|NCT01768520|319448|P2|STARTED|Overall Study||147
131272|NCT01768520|319449|P1|STARTED|Overall Study||152
131273|NCT01768325|319462|P2|NOT COMPLETED|Overall Study||0
131274|NCT01768325|319463|P1|NOT COMPLETED|Overall Study||0
131275|NCT01768325|319462|P2|COMPLETED|Overall Study||41
131276|NCT01768325|319463|P1|COMPLETED|Overall Study||37
131277|NCT01768325|319462|P2|STARTED|Overall Study||41
131278|NCT01768325|319463|P1|STARTED|Overall Study||37
131279|NCT01768286|319477|P4|NOT COMPLETED|Overall Study||1
131280|NCT01768286|319478|P3|NOT COMPLETED|Overall Study||2
131281|NCT01768286|319479|P2|NOT COMPLETED|Overall Study||4
131282|NCT01768286|319480|P1|NOT COMPLETED|Overall Study||7
131283|NCT01768286|319477|P4|COMPLETED|Overall Study||110
131284|NCT01768286|319478|P3|COMPLETED|Overall Study||108
131285|NCT01768286|319479|P2|COMPLETED|Overall Study||107
131286|NCT01768286|319480|P1|COMPLETED|Overall Study||102
131287|NCT01768286|319477|P4|STARTED|Overall Study||111
131288|NCT01768286|319478|P3|STARTED|Overall Study||110
131289|NCT01768286|319479|P2|STARTED|Overall Study||111
131290|NCT01768286|319480|P1|STARTED|Overall Study||109
131291|NCT01768117|319542|P1|NOT COMPLETED|Overall Study||6
131292|NCT01768117|319542|P1|COMPLETED|Overall Study||7
131293|NCT01768117|319542|P1|STARTED|Overall Study||13
131294|NCT01768013|319550|P1|NOT COMPLETED|Overall Study||0
131295|NCT01768013|319550|P1|COMPLETED|Overall Study||13
131296|NCT01768013|319550|P1|STARTED|Overall Study||13
131297|NCT01768000|319583|P4|NOT COMPLETED|Overall Study||2
131298|NCT01768000|319584|P3|NOT COMPLETED|Overall Study||1
131299|NCT01768000|319585|P2|NOT COMPLETED|Overall Study||2
131300|NCT01768000|319586|P1|NOT COMPLETED|Overall Study||1
131301|NCT01768000|319583|P4|COMPLETED|Overall Study||8
131302|NCT01768000|319584|P3|COMPLETED|Overall Study||9
131303|NCT01768000|319585|P2|COMPLETED|Overall Study||8
131304|NCT01768000|319586|P1|COMPLETED|Overall Study||9
131305|NCT01768000|319583|P4|STARTED|Overall Study||10
131306|NCT01768000|319584|P3|STARTED|Overall Study||10
131307|NCT01768000|319585|P2|STARTED|Overall Study||10
131308|NCT01768000|319586|P1|STARTED|Overall Study||10
131309|NCT01767987|319606|P2|NOT COMPLETED|Overall Study||1
131310|NCT01767987|319607|P1|NOT COMPLETED|Overall Study||4
131311|NCT01767987|319606|P2|COMPLETED|Overall Study||1
131312|NCT01767987|319607|P1|COMPLETED|Overall Study||0
131313|NCT01767987|319606|P2|STARTED|Overall Study||2
131314|NCT01767987|319607|P1|STARTED|Overall Study||4
131315|NCT01767935|319629|P1|NOT COMPLETED|Overall Study||0
131316|NCT01767935|319629|P1|COMPLETED|Overall Study||1
131317|NCT01767935|319629|P1|STARTED|Overall Study||1
131318|NCT01767701|319637|P1|NOT COMPLETED|Overall Study||0
131319|NCT01767701|319637|P1|COMPLETED|Overall Study||20
131320|NCT01767701|319637|P1|STARTED|Overall Study|All 20 patients who entered the treatment phase completed the six months trial period.|20
131321|NCT01767688|319650|P2|NOT COMPLETED|Overall Study||0
131322|NCT01767688|319651|P1|NOT COMPLETED|Overall Study||0
131323|NCT01767688|319650|P2|COMPLETED|Overall Study||8
131324|NCT01767688|319651|P1|COMPLETED|Overall Study||8
131325|NCT01767688|319650|P2|STARTED|Overall Study||8
131326|NCT01767688|319651|P1|STARTED|Overall Study||8
131327|NCT01767597|319673|P2|NOT COMPLETED|Overall Study||1
131328|NCT01767597|319674|P1|NOT COMPLETED|Overall Study||4
131329|NCT01767597|319673|P2|COMPLETED|Overall Study||499
131330|NCT01767597|319674|P1|COMPLETED|Overall Study||496
131331|NCT01767597|319673|P2|STARTED|Overall Study||500
131332|NCT01767597|319674|P1|STARTED|Overall Study||500
131333|NCT01767519|319683|P3|NOT COMPLETED|Overall Study||5
131334|NCT01767519|319684|P2|NOT COMPLETED|Overall Study||13
131335|NCT01767519|319685|P1|NOT COMPLETED|Overall Study||14
131336|NCT01767519|319683|P3|COMPLETED|Overall Study||55
131337|NCT01767519|319684|P2|COMPLETED|Overall Study||138
131338|NCT01767519|319685|P1|COMPLETED|Overall Study||131
131339|NCT01767519|319683|P3|STARTED|Overall Study||60
131340|NCT01767519|319684|P2|STARTED|Overall Study||151
131341|NCT01767519|319685|P1|STARTED|Overall Study||145
131342|NCT01767506|319713|P2|NOT COMPLETED|Overall Study||0
131343|NCT01767506|319714|P1|NOT COMPLETED|Overall Study||0
131344|NCT01767506|319713|P2|COMPLETED|Overall Study|The study was conducted at the community level.|0
131345|NCT01767506|319714|P1|COMPLETED|Overall Study|The study was conducted at the community level.|0
131346|NCT01767506|319713|P2|STARTED|Overall Study|"26 communities were randomized to control group~The study was conducted at the community level."|0
131347|NCT01767506|319714|P1|STARTED|Overall Study|"26 communities were randomized to intervention group~The study was conducted at the community level."|0
131348|NCT01767467|319726|P2|NOT COMPLETED|End of Study Phase (up to Month 13)||63
131349|NCT01767467|319727|P1|NOT COMPLETED|End of Study Phase (up to Month 13)||47
131350|NCT01767467|319726|P2|COMPLETED|End of Study Phase (up to Month 13)||216
131351|NCT01767467|319727|P1|COMPLETED|End of Study Phase (up to Month 13)||236
131352|NCT01767467|319726|P2|STARTED|End of Study Phase (up to Month 13)||279
131353|NCT01767467|319727|P1|STARTED|End of Study Phase (up to Month 13)||283
131354|NCT01767467|319726|P2|NOT COMPLETED|Vaccination Phase (up to Month 2)||20
131355|NCT01767467|319727|P1|NOT COMPLETED|Vaccination Phase (up to Month 2)||17
131356|NCT01767467|319726|P2|COMPLETED|Vaccination Phase (up to Month 2)||259
131357|NCT01767467|319727|P1|COMPLETED|Vaccination Phase (up to Month 2)||266
131358|NCT01767467|319726|P2|STARTED|Vaccination Phase (up to Month 2)||279
131359|NCT01767467|319727|P1|STARTED|Vaccination Phase (up to Month 2)||283
131360|NCT01767415|319775|P1|NOT COMPLETED|Overall Study||0
131361|NCT01767415|319775|P1|COMPLETED|Overall Study||10
131362|NCT01767415|319775|P1|STARTED|Overall Study||10
131363|NCT01767376|319783|P3|NOT COMPLETED|Overall Study||0
131364|NCT01767376|319784|P2|NOT COMPLETED|Overall Study||3
131365|NCT01767376|319785|P1|NOT COMPLETED|Overall Study||4
131366|NCT01767376|319783|P3|COMPLETED|Overall Study||232
131367|NCT01767376|319784|P2|COMPLETED|Overall Study||225
131368|NCT01767376|319785|P1|COMPLETED|Overall Study||227
131369|NCT01767376|319783|P3|STARTED|Overall Study||232
131370|NCT01767376|319784|P2|STARTED|Overall Study||228
131371|NCT01767376|319785|P1|STARTED|Overall Study||231
131372|NCT01767285|319832|P2|NOT COMPLETED|Overall Study||6
131373|NCT01767285|319833|P1|NOT COMPLETED|Overall Study||7
131374|NCT01767285|319832|P2|COMPLETED|Overall Study||24
131375|NCT01767285|319833|P1|COMPLETED|Overall Study||22
131376|NCT01767285|319832|P2|STARTED|Overall Study||30
131377|NCT01767285|319833|P1|STARTED|Overall Study||29
131378|NCT01767194|319851|P2|NOT COMPLETED|Overall Study||43
131379|NCT01767194|319852|P1|NOT COMPLETED|Overall Study||18
131380|NCT01767194|319851|P2|COMPLETED|Overall Study||11
131381|NCT01767194|319852|P1|COMPLETED|Overall Study||1
131382|NCT01767194|319851|P2|STARTED|Overall Study||54
131383|NCT01767194|319852|P1|STARTED|Overall Study||19
131384|NCT01767155|319861|P2|NOT COMPLETED|Overall Study||15
131385|NCT01767155|319862|P1|NOT COMPLETED|Overall Study||13
131386|NCT01767155|319861|P2|COMPLETED|Overall Study||240
131387|NCT01767155|319862|P1|COMPLETED|Overall Study||243
131388|NCT01767155|319861|P2|Safety Population (SAF)|Overall Study||249
131389|NCT01767155|319862|P1|Safety Population (SAF)|Overall Study||252
131390|NCT01767155|319861|P2|Modified ITT (mITT)|Overall Study||249
131391|NCT01767155|319862|P1|Modified ITT (mITT)|Overall Study||252
131392|NCT01767155|319861|P2|STARTED|Overall Study|Patients allocated to doxorubicin|255
131393|NCT01767155|319862|P1|STARTED|Overall Study|Patients allocated to AEZS-108|256
131394|NCT01767116|319876|P2|NOT COMPLETED|Overall Study||2
131395|NCT01767116|319877|P1|NOT COMPLETED|Overall Study||2
131396|NCT01767116|319876|P2|COMPLETED|Overall Study||207
131397|NCT01767116|319877|P1|COMPLETED|Overall Study||208
131398|NCT01767116|319876|P2|STARTED|Overall Study||209
131399|NCT01767116|319877|P1|STARTED|Overall Study||210
131400|NCT01767103|319896|P3|NOT COMPLETED|Overall Study||0
131401|NCT01767103|319897|P2|NOT COMPLETED|Overall Study||0
131402|NCT01767103|319898|P1|NOT COMPLETED|Overall Study||0
131403|NCT01767103|319896|P3|COMPLETED|Overall Study||7
131404|NCT01767103|319897|P2|COMPLETED|Overall Study||7
131405|NCT01767103|319898|P1|COMPLETED|Overall Study||7
131406|NCT01767103|319896|P3|STARTED|Overall Study||7
131407|NCT01767103|319897|P2|STARTED|Overall Study||7
131408|NCT01767103|319898|P1|STARTED|Overall Study||7
131409|NCT01767064|319926|P2|NOT COMPLETED|Overall Study||0
131410|NCT01767064|319927|P1|NOT COMPLETED|Overall Study||0
131411|NCT01767064|319926|P2|COMPLETED|Overall Study||7
131412|NCT01767064|319927|P1|COMPLETED|Overall Study||7
131413|NCT01767064|319926|P2|STARTED|Overall Study||7
131414|NCT01767064|319927|P1|STARTED|Overall Study||7
131415|NCT01766921|319935|P2|NOT COMPLETED|Overall Study||17
131416|NCT01766921|319936|P1|NOT COMPLETED|Overall Study||24
131417|NCT01766921|319935|P2|COMPLETED|Overall Study||676
131418|NCT01766921|319936|P1|COMPLETED|Overall Study||676
131419|NCT01766921|319935|P2|STARTED|Overall Study||693
131420|NCT01766921|319936|P1|STARTED|Overall Study||700
131421|NCT01766817|319958|P3|NOT COMPLETED|Overall Study||13
131422|NCT01766817|319959|P2|NOT COMPLETED|Overall Study||11
131423|NCT01766817|319960|P1|NOT COMPLETED|Overall Study||11
131424|NCT01766817|319958|P3|COMPLETED|Overall Study||34
131425|NCT01766817|319959|P2|COMPLETED|Overall Study||37
131426|NCT01766817|319960|P1|COMPLETED|Overall Study||37
131427|NCT01766817|319958|P3|STARTED|Overall Study||47
131428|NCT01766817|319959|P2|STARTED|Overall Study||48
131429|NCT01766817|319960|P1|STARTED|Overall Study||48
131430|NCT01766778|320011|P2|NOT COMPLETED|Overall Study||4
131431|NCT01766778|320012|P1|NOT COMPLETED|Overall Study||5
131432|NCT01766778|320011|P2|COMPLETED|Overall Study||57
131433|NCT01766778|320012|P1|COMPLETED|Overall Study||51
131434|NCT01766778|320011|P2|STARTED|Overall Study||61
131435|NCT01766778|320012|P1|STARTED|Overall Study|Intent to treat population|56
131436|NCT01766713|320030|P2|NOT COMPLETED|Overall Study||2
131437|NCT01766713|320031|P1|NOT COMPLETED|Overall Study||2
131438|NCT01766713|320030|P2|COMPLETED|Overall Study||23
131439|NCT01766713|320031|P1|COMPLETED|Overall Study||23
131440|NCT01766713|320030|P2|STARTED|Overall Study||25
131441|NCT01766713|320031|P1|STARTED|Overall Study||25
131442|NCT01766466|320039|P4|NOT COMPLETED|Day 5||0
131443|NCT01766466|320040|P3|NOT COMPLETED|Day 5||0
131444|NCT01766466|320041|P2|NOT COMPLETED|Day 5||0
131445|NCT01766466|320042|P1|NOT COMPLETED|Day 5||0
131446|NCT01766466|320039|P4|COMPLETED|Day 5||6
131447|NCT01766466|320040|P3|COMPLETED|Day 5||0
131448|NCT01766466|320041|P2|COMPLETED|Day 5||6
131449|NCT01766466|320042|P1|COMPLETED|Day 5||0
131450|NCT01766466|320039|P4|STARTED|Day 5||6
131451|NCT01766466|320040|P3|STARTED|Day 5||0
131452|NCT01766466|320041|P2|STARTED|Day 5||6
131453|NCT01766466|320042|P1|STARTED|Day 5||0
131454|NCT01766466|320039|P4|NOT COMPLETED|Day 1||0
131455|NCT01766466|320040|P3|NOT COMPLETED|Day 1||0
131456|NCT01766466|320041|P2|NOT COMPLETED|Day 1||0
131457|NCT01766466|320042|P1|NOT COMPLETED|Day 1||0
131458|NCT01766466|320039|P4|COMPLETED|Day 1||0
131459|NCT01766466|320040|P3|COMPLETED|Day 1||6
131460|NCT01766466|320041|P2|COMPLETED|Day 1||0
131461|NCT01766466|320042|P1|COMPLETED|Day 1||6
131462|NCT01766466|320039|P4|STARTED|Day 1||0
131463|NCT01766466|320040|P3|STARTED|Day 1||6
131464|NCT01766466|320041|P2|STARTED|Day 1||0
131465|NCT01766466|320042|P1|STARTED|Day 1||6
131466|NCT01766440|320055|P1|NOT COMPLETED|Overall Study||1
131467|NCT01766440|320055|P1|COMPLETED|Overall Study||17
131468|NCT01766440|320055|P1|STARTED|Overall Study||18
131469|NCT01766336|320066|P2|NOT COMPLETED|Overall Study||75
131470|NCT01766336|320067|P1|NOT COMPLETED|Overall Study||90
131471|NCT01766336|320066|P2|COMPLETED|Overall Study||71
131472|NCT01766336|320067|P1|COMPLETED|Overall Study||60
131473|NCT01766336|320066|P2|STARTED|Overall Study||146
131474|NCT01766336|320067|P1|STARTED|Overall Study||150
131475|NCT01766310|320075|P2|NOT COMPLETED|Overall Study||3
131476|NCT01766310|320076|P1|NOT COMPLETED|Overall Study||1
131477|NCT01766310|320075|P2|COMPLETED|Overall Study||23
131478|NCT01766310|320076|P1|COMPLETED|Overall Study||23
131479|NCT01766310|320075|P2|STARTED|Overall Study||26
131480|NCT01766310|320076|P1|STARTED|Overall Study||24
131481|NCT01766219|320087|P3|NOT COMPLETED|Overall Study||0
131482|NCT01766219|320088|P2|NOT COMPLETED|Overall Study||0
131483|NCT01766219|320089|P1|NOT COMPLETED|Overall Study||0
131484|NCT01766219|320087|P3|COMPLETED|Overall Study||11
131485|NCT01766219|320088|P2|COMPLETED|Overall Study||2
131486|NCT01766219|320089|P1|COMPLETED|Overall Study||4
131487|NCT01766219|320087|P3|STARTED|Overall Study||11
131488|NCT01766219|320088|P2|STARTED|Overall Study||2
131489|NCT01766219|320089|P1|STARTED|Overall Study||4
131490|NCT01766206|320106|P1|NOT COMPLETED|Overall Study||51
131491|NCT01766206|320106|P1|COMPLETED|Overall Study||3888
131492|NCT01766206|320106|P1|STARTED|Overall Study||3939
131493|NCT01766102|320115|P2|NOT COMPLETED|Overall Study||0
131494|NCT01766102|320116|P1|NOT COMPLETED|Overall Study||0
131495|NCT01766102|320115|P2|COMPLETED|Overall Study||36
131496|NCT01766102|320116|P1|COMPLETED|Overall Study||36
131497|NCT01766102|320115|P2|STARTED|Overall Study||36
131498|NCT01766102|320116|P1|STARTED|Overall Study||36
131499|NCT01766076|320126|P2|NOT COMPLETED|Overall Study||0
131500|NCT01766076|320127|P1|NOT COMPLETED|Overall Study||0
131501|NCT01766076|320126|P2|COMPLETED|Overall Study||15
131502|NCT01766076|320127|P1|COMPLETED|Overall Study||15
131503|NCT01766076|320126|P2|STARTED|Overall Study||15
131504|NCT01766076|320127|P1|STARTED|Overall Study||15
131505|NCT01766050|320133|P1|NOT COMPLETED|Overall Study||4
131506|NCT01766050|320133|P1|COMPLETED|Overall Study||18
131507|NCT01766050|320133|P1|STARTED|Overall Study||22
131508|NCT01766037|320268|P2|NOT COMPLETED|Overall Study||29
131509|NCT01766037|320269|P1|NOT COMPLETED|Overall Study||29
131510|NCT01766037|320268|P2|COMPLETED|Overall Study||31
131511|NCT01766037|320269|P1|COMPLETED|Overall Study||82
131512|NCT01766037|320268|P2|STARTED|Overall Study||60
131513|NCT01766037|320269|P1|STARTED|Overall Study||111
131514|NCT01766024|320306|P2|NOT COMPLETED|Overall Study||0
131515|NCT01766024|320307|P1|NOT COMPLETED|Overall Study||0
131516|NCT01766024|320306|P2|COMPLETED|Overall Study||16
131517|NCT01766024|320307|P1|COMPLETED|Overall Study||16
131518|NCT01766024|320306|P2|STARTED|Overall Study||16
131519|NCT01766024|320307|P1|STARTED|Overall Study||16
131520|NCT01765972|320317|P4|NOT COMPLETED|Overall Study||0
131521|NCT01765972|320318|P3|NOT COMPLETED|Overall Study||0
131522|NCT01765972|320319|P2|NOT COMPLETED|Overall Study||0
131523|NCT01765972|320320|P1|NOT COMPLETED|Overall Study||0
131524|NCT01765972|320317|P4|COMPLETED|Overall Study||6
131525|NCT01765972|320318|P3|COMPLETED|Overall Study||6
131526|NCT01765972|320319|P2|COMPLETED|Overall Study||6
131527|NCT01765972|320320|P1|COMPLETED|Overall Study||6
131528|NCT01765972|320317|P4|STARTED|Overall Study||6
131529|NCT01765972|320318|P3|STARTED|Overall Study||6
131530|NCT01765972|320319|P2|STARTED|Overall Study||6
131531|NCT01765972|320320|P1|STARTED|Overall Study||6
131532|NCT01765803|320330|P1|NOT COMPLETED|Overall Study||0
131533|NCT01765803|320330|P1|COMPLETED|Overall Study||6
131534|NCT01765803|320330|P1|STARTED|Overall Study||6
131535|NCT01765764|320338|P3|NOT COMPLETED|Post-treatment Period||0
131536|NCT01765764|320339|P2|NOT COMPLETED|Post-treatment Period||0
131537|NCT01765764|320340|P1|NOT COMPLETED|Post-treatment Period||0
131538|NCT01765764|320338|P3|COMPLETED|Post-treatment Period||112
131539|NCT01765764|320339|P2|COMPLETED|Post-treatment Period||107
131540|NCT01765764|320340|P1|COMPLETED|Post-treatment Period||114
131541|NCT01765764|320338|P3|STARTED|Post-treatment Period|3 participants did not enter the Post-treatment Period [1 Personal Reasons,2 LFU].|112
131542|NCT01765764|320339|P2|STARTED|Post-treatment Period|2 participants did not enter the Post-treatment Period [2 Lost-to-Follow-up (LFU)]|107
131543|NCT01765764|320340|P1|STARTED|Post-treatment Period|1 participant did not enter the Post-treatment Period. [Personal Reasons]|114
131544|NCT01765764|320338|P3|NOT COMPLETED|Treatment Period||6
131545|NCT01765764|320339|P2|NOT COMPLETED|Treatment Period||9
131546|NCT01765764|320340|P1|NOT COMPLETED|Treatment Period||3
131547|NCT01765764|320338|P3|COMPLETED|Treatment Period||115
131548|NCT01765764|320339|P2|COMPLETED|Treatment Period||109
131549|NCT01765764|320340|P1|COMPLETED|Treatment Period||115
131550|NCT01765764|320338|P3|STARTED|Treatment Period||121
131551|NCT01765764|320339|P2|STARTED|Treatment Period||118
131552|NCT01765764|320340|P1|STARTED|Treatment Period||118
131553|NCT01765751|320360|P3|NOT COMPLETED|Overall Study||1
131554|NCT01765751|320361|P2|NOT COMPLETED|Overall Study||2
131555|NCT01765751|320362|P1|NOT COMPLETED|Overall Study||0
131556|NCT01765751|320360|P3|COMPLETED|Overall Study||15
131557|NCT01765751|320361|P2|COMPLETED|Overall Study||14
131558|NCT01765751|320362|P1|COMPLETED|Overall Study||16
131559|NCT01765751|320360|P3|STARTED|Overall Study||16
131560|NCT01765751|320361|P2|STARTED|Overall Study||16
131561|NCT01765751|320362|P1|STARTED|Overall Study||16
131562|NCT01765673|320394|P1|NOT COMPLETED|Overall Study||1
131563|NCT01765673|320394|P1|COMPLETED|Overall Study||11
131564|NCT01765673|320394|P1|STARTED|Overall Study||12
131565|NCT01765582|320420|P3|NOT COMPLETED|Overall Study||95
131566|NCT01765582|320421|P2|NOT COMPLETED|Overall Study||92
131567|NCT01765582|320422|P1|NOT COMPLETED|Overall Study||93
131568|NCT01765582|320420|P3|COMPLETED|Overall Study||0
131569|NCT01765582|320421|P2|COMPLETED|Overall Study||0
131570|NCT01765582|320422|P1|COMPLETED|Overall Study||0
131571|NCT01765582|320420|P3|STARTED|Overall Study||95
131572|NCT01765582|320421|P2|STARTED|Overall Study||92
131573|NCT01765582|320422|P1|STARTED|Overall Study||93
131574|NCT01765569|320455|P1|NOT COMPLETED|Period C||1
131575|NCT01765569|320455|P1|COMPLETED|Period C||27
131576|NCT01765569|320455|P1|STARTED|Period C||28
131577|NCT01765569|320455|P1|NOT COMPLETED|Period B||1
131578|NCT01765569|320455|P1|COMPLETED|Period B||28
131579|NCT01765569|320455|P1|STARTED|Period B||29
131580|NCT01765569|320455|P1|NOT COMPLETED|Period A||0
131581|NCT01765569|320455|P1|COMPLETED|Period A||29
131582|NCT01765569|320455|P1|STARTED|Period A||29
131583|NCT01765543|320476|P1|NOT COMPLETED|Overall Study||3
131584|NCT01765543|320476|P1|COMPLETED|Overall Study||24
131585|NCT01765543|320476|P1|STARTED|Overall Study||27
131586|NCT01765530|320500|P2|NOT COMPLETED|Overall Study||1
131587|NCT01765530|320501|P1|NOT COMPLETED|Overall Study||1
131588|NCT01765530|320500|P2|COMPLETED|Overall Study||36
131589|NCT01765530|320501|P1|COMPLETED|Overall Study||36
131590|NCT01765530|320500|P2|STARTED|Overall Study||37
131591|NCT01765530|320501|P1|STARTED|Overall Study||37
131592|NCT01765465|320511|P2|NOT COMPLETED|Overall Study||4
131593|NCT01765465|320512|P1|NOT COMPLETED|Overall Study||7
131594|NCT01765465|320511|P2|COMPLETED|Overall Study||63
131595|NCT01765465|320512|P1|COMPLETED|Overall Study||64
131596|NCT01765465|320511|P2|STARTED|Overall Study||67
131597|NCT01765465|320512|P1|STARTED|Overall Study||71
131598|NCT01765426|320528|P4|NOT COMPLETED|Overall Study||0
131599|NCT01765426|320529|P3|NOT COMPLETED|Overall Study||0
131600|NCT01765426|320530|P2|NOT COMPLETED|Overall Study||1
131601|NCT01765426|320531|P1|NOT COMPLETED|Overall Study||0
131602|NCT01765426|320528|P4|COMPLETED|Overall Study||15
131603|NCT01765426|320529|P3|COMPLETED|Overall Study||17
131604|NCT01765426|320530|P2|COMPLETED|Overall Study||16
131605|NCT01765426|320531|P1|COMPLETED|Overall Study||18
131606|NCT01765426|320528|P4|Completed All Vaccinations|Overall Study||15
131607|NCT01765426|320529|P3|Completed All Vaccinations|Overall Study||17
131608|NCT01765426|320530|P2|Completed All Vaccinations|Overall Study||16
131609|NCT01765426|320531|P1|Completed All Vaccinations|Overall Study||17
131610|NCT01765426|320528|P4|STARTED|Overall Study||15
131611|NCT01765426|320529|P3|STARTED|Overall Study||17
131612|NCT01765426|320530|P2|STARTED|Overall Study||17
131613|NCT01765426|320531|P1|STARTED|Overall Study||18
131614|NCT01765270|320587|P2|NOT COMPLETED|Overall Study||1
131615|NCT01765270|320588|P1|NOT COMPLETED|Overall Study||1
131616|NCT01765270|320587|P2|COMPLETED|Overall Study||6
131617|NCT01765270|320588|P1|COMPLETED|Overall Study||4
131618|NCT01765270|320587|P2|STARTED|Overall Study||7
131619|NCT01765270|320588|P1|STARTED|Overall Study||5
131620|NCT01765192|320610|P2|NOT COMPLETED|End of Treatment Period 2 to Final Visit||1
131621|NCT01765192|320611|P1|NOT COMPLETED|End of Treatment Period 2 to Final Visit||0
131622|NCT01765192|320610|P2|COMPLETED|End of Treatment Period 2 to Final Visit||27
131623|NCT01765192|320611|P1|COMPLETED|End of Treatment Period 2 to Final Visit||30
131624|NCT01765192|320610|P2|STARTED|End of Treatment Period 2 to Final Visit||28
131625|NCT01765192|320611|P1|STARTED|End of Treatment Period 2 to Final Visit||30
131626|NCT01765192|320610|P2|NOT COMPLETED|Treatment Period 2||2
131627|NCT01765192|320611|P1|NOT COMPLETED|Treatment Period 2||0
131628|NCT01765192|320610|P2|COMPLETED|Treatment Period 2||28
131629|NCT01765192|320611|P1|COMPLETED|Treatment Period 2||30
131630|NCT01765192|320610|P2|STARTED|Treatment Period 2||30
131631|NCT01765192|320611|P1|STARTED|Treatment Period 2||30
131632|NCT01765192|320610|P2|NOT COMPLETED|Washout Period||1
131633|NCT01765192|320611|P1|NOT COMPLETED|Washout Period||2
131634|NCT01765192|320610|P2|COMPLETED|Washout Period||30
131635|NCT01765192|320611|P1|COMPLETED|Washout Period||30
131636|NCT01765192|320610|P2|STARTED|Washout Period||31
131637|NCT01765192|320611|P1|STARTED|Washout Period||32
131638|NCT01765192|320610|P2|NOT COMPLETED|Treatment Period 1||1
131639|NCT01765192|320611|P1|NOT COMPLETED|Treatment Period 1||0
131640|NCT01765192|320610|P2|COMPLETED|Treatment Period 1||31
131641|NCT01765192|320611|P1|COMPLETED|Treatment Period 1||32
131642|NCT01765192|320610|P2|STARTED|Treatment Period 1||32
131643|NCT01765192|320611|P1|STARTED|Treatment Period 1||32
131644|NCT01765179|320629|P1|NOT COMPLETED|Overall Study||27
131645|NCT01765179|320629|P1|COMPLETED|Overall Study||117
131646|NCT01765179|320629|P1|STARTED|Overall Study||144
131647|NCT01765153|320636|P2|NOT COMPLETED|Rest Phase 2||1
131648|NCT01765153|320637|P1|NOT COMPLETED|Rest Phase 2||2
131649|NCT01765153|320636|P2|COMPLETED|Rest Phase 2||7
131650|NCT01765153|320637|P1|COMPLETED|Rest Phase 2||8
131651|NCT01765153|320636|P2|STARTED|Rest Phase 2||8
131652|NCT01765153|320637|P1|STARTED|Rest Phase 2||10
131653|NCT01765153|320636|P2|NOT COMPLETED|Training Phase 2||1
131654|NCT01765153|320637|P1|NOT COMPLETED|Training Phase 2||0
131655|NCT01765153|320636|P2|COMPLETED|Training Phase 2||8
131656|NCT01765153|320637|P1|COMPLETED|Training Phase 2||10
131657|NCT01765153|320636|P2|STARTED|Training Phase 2||9
131658|NCT01765153|320637|P1|STARTED|Training Phase 2|1st subject didn't use same training(phase 1) as subsequent participants Phase 1 and 2 data removed.|10
131659|NCT01765153|320636|P2|NOT COMPLETED|Rest Phase 1||1
131660|NCT01765153|320637|P1|NOT COMPLETED|Rest Phase 1||0
131661|NCT01765153|320636|P2|COMPLETED|Rest Phase 1||9
131662|NCT01765153|320637|P1|COMPLETED|Rest Phase 1||9
131663|NCT01765153|320636|P2|STARTED|Rest Phase 1||10
131664|NCT01765153|320637|P1|STARTED|Rest Phase 1||9
131665|NCT01765153|320636|P2|NOT COMPLETED|Training Phase 1||1
131666|NCT01765153|320637|P1|NOT COMPLETED|Training Phase 1||1
131667|NCT01765153|320636|P2|COMPLETED|Training Phase 1||10
131668|NCT01765153|320637|P1|COMPLETED|Training Phase 1||9
131669|NCT01765153|320636|P2|STARTED|Training Phase 1||11
131670|NCT01765153|320637|P1|STARTED|Training Phase 1||10
131671|NCT01764997|320744|P5|NOT COMPLETED|Study Drug Treatment Period||36
131672|NCT01764997|320745|P4|NOT COMPLETED|Study Drug Treatment Period||0
131673|NCT01764997|320746|P3|NOT COMPLETED|Study Drug Treatment Period||0
131674|NCT01764997|320747|P2|NOT COMPLETED|Study Drug Treatment Period||1
131675|NCT01764997|320748|P1|NOT COMPLETED|Study Drug Treatment Period||0
131676|NCT01764997|320744|P5|COMPLETED|Study Drug Treatment Period||286
131677|NCT01764997|320745|P4|COMPLETED|Study Drug Treatment Period||13
131678|NCT01764997|320746|P3|COMPLETED|Study Drug Treatment Period||13
131679|NCT01764997|320747|P2|COMPLETED|Study Drug Treatment Period||16
131680|NCT01764997|320748|P1|COMPLETED|Study Drug Treatment Period||0
131681|NCT01764997|320744|P5|STARTED|Study Drug Treatment Period||322
131682|NCT01764997|320745|P4|STARTED|Study Drug Treatment Period||13
131683|NCT01764997|320746|P3|STARTED|Study Drug Treatment Period||13
131684|NCT01764997|320747|P2|STARTED|Study Drug Treatment Period||17
131685|NCT01764997|320748|P1|STARTED|Study Drug Treatment Period||0
131686|NCT01764997|320744|P5|NOT COMPLETED|Run-in Period||0
131687|NCT01764997|320745|P4|NOT COMPLETED|Run-in Period||0
131688|NCT01764997|320746|P3|NOT COMPLETED|Run-in Period||0
131689|NCT01764997|320747|P2|NOT COMPLETED|Run-in Period||0
131690|NCT01764997|320748|P1|NOT COMPLETED|Run-in Period||38
131691|NCT01764997|320744|P5|COMPLETED|Run-in Period||0
131692|NCT01764997|320745|P4|COMPLETED|Run-in Period||0
131693|NCT01764997|320746|P3|COMPLETED|Run-in Period||0
131694|NCT01764997|320747|P2|COMPLETED|Run-in Period||0
131695|NCT01764997|320748|P1|COMPLETED|Run-in Period|43 participants proceeded to randomized treatment and 322 proceeded to open-label sub-study.|738
131696|NCT01764997|320744|P5|STARTED|Run-in Period||0
131697|NCT01764997|320745|P4|STARTED|Run-in Period||0
131698|NCT01764997|320746|P3|STARTED|Run-in Period||0
131699|NCT01764997|320747|P2|STARTED|Run-in Period||0
131700|NCT01764997|320748|P1|STARTED|Run-in Period||776
131701|NCT01764945|320775|P8|NOT COMPLETED|Overall Study||0
131702|NCT01764945|320776|P7|NOT COMPLETED|Overall Study||1
131703|NCT01764945|320777|P6|NOT COMPLETED|Overall Study||0
131704|NCT01764945|320778|P5|NOT COMPLETED|Overall Study||0
131705|NCT01764945|320779|P4|NOT COMPLETED|Overall Study||0
131706|NCT01764945|320780|P3|NOT COMPLETED|Overall Study||0
131707|NCT01764945|320781|P2|NOT COMPLETED|Overall Study||1
131708|NCT01764945|320782|P1|NOT COMPLETED|Overall Study||0
131709|NCT01764945|320775|P8|COMPLETED|Overall Study||9
131710|NCT01764945|320776|P7|COMPLETED|Overall Study||8
131711|NCT01764945|320777|P6|COMPLETED|Overall Study||8
131712|NCT01764945|320778|P5|COMPLETED|Overall Study||10
131713|NCT01764945|320779|P4|COMPLETED|Overall Study||5
131714|NCT01764945|320780|P3|COMPLETED|Overall Study||5
131715|NCT01764945|320781|P2|COMPLETED|Overall Study||4
131716|NCT01764945|320782|P1|COMPLETED|Overall Study||5
131717|NCT01764945|320775|P8|STARTED|Overall Study||9
131718|NCT01764945|320776|P7|STARTED|Overall Study||9
131719|NCT01764945|320777|P6|STARTED|Overall Study||8
131720|NCT01764945|320778|P5|STARTED|Overall Study||10
131721|NCT01764945|320779|P4|STARTED|Overall Study||5
131722|NCT01764945|320780|P3|STARTED|Overall Study||5
131723|NCT01764945|320781|P2|STARTED|Overall Study||5
131724|NCT01764945|320782|P1|STARTED|Overall Study||5
131725|NCT01764919|320816|P1|NOT COMPLETED|Overall Study||0
131726|NCT01764919|320816|P1|COMPLETED|Overall Study||4
131727|NCT01764919|320816|P1|STARTED|Overall Study||4
131728|NCT01764841|320828|P4|NOT COMPLETED|Overall Study||19
131729|NCT01764841|320829|P3|NOT COMPLETED|Overall Study||14
131730|NCT01764841|320830|P2|NOT COMPLETED|Overall Study||26
131731|NCT01764841|320831|P1|NOT COMPLETED|Overall Study||23
131732|NCT01764841|320828|P4|COMPLETED|Overall Study||49
131733|NCT01764841|320829|P3|COMPLETED|Overall Study||56
131734|NCT01764841|320830|P2|COMPLETED|Overall Study||111
131735|NCT01764841|320831|P1|COMPLETED|Overall Study||118
131736|NCT01764841|320828|P4|Participants Received Treatment|Overall Study|safety population|68
131737|NCT01764841|320829|P3|Participants Received Treatment|Overall Study|safety population|69
131738|NCT01764841|320830|P2|Participants Received Treatment|Overall Study|safety population|136
131739|NCT01764841|320831|P1|Participants Received Treatment|Overall Study|safety population|141
131740|NCT01764841|320828|P4|STARTED|Overall Study||68
131741|NCT01764841|320829|P3|STARTED|Overall Study||70
131742|NCT01764841|320830|P2|STARTED|Overall Study||137
131743|NCT01764841|320831|P1|STARTED|Overall Study||141
131744|NCT01764685|320865|P2|NOT COMPLETED|Overall Study||1
131745|NCT01764685|320866|P1|NOT COMPLETED|Overall Study||0
131746|NCT01764685|320865|P2|COMPLETED|Overall Study||3
131747|NCT01764685|320866|P1|COMPLETED|Overall Study||0
131748|NCT01764685|320865|P2|STARTED|Overall Study||4
131749|NCT01764685|320866|P1|STARTED|Overall Study||0
131750|NCT01764633|320874|P2|NOT COMPLETED|Overall Study||93
131751|NCT01764633|320875|P1|NOT COMPLETED|Overall Study||118
131752|NCT01764633|320874|P2|COMPLETED|Overall Study||13691
131753|NCT01764633|320875|P1|COMPLETED|Overall Study||13662
131754|NCT01764633|320874|P2|Received Treatment|Overall Study||13769
131755|NCT01764633|320875|P1|Received Treatment|Overall Study||13756
131756|NCT01764633|320874|P2|STARTED|Overall Study||13784
131757|NCT01764633|320875|P1|STARTED|Overall Study||13780
131758|NCT01764607|320897|P1|NOT COMPLETED|Overall Study||0
131759|NCT01764607|320897|P1|COMPLETED|Overall Study||1
131760|NCT01764607|320897|P1|STARTED|Overall Study||1
131761|NCT01764464|320904|P2|NOT COMPLETED|Second Intervention (Cross-over)||0
131762|NCT01764464|320905|P1|NOT COMPLETED|Second Intervention (Cross-over)||2
131763|NCT01764464|320904|P2|COMPLETED|Second Intervention (Cross-over)|Completed Gralise|13
131764|NCT01764464|320905|P1|COMPLETED|Second Intervention (Cross-over)|Completed Placebo|12
131765|NCT01764464|320904|P2|STARTED|Second Intervention (Cross-over)|Started Gralise|13
131766|NCT01764464|320905|P1|STARTED|Second Intervention (Cross-over)|Started Placebo|14
131767|NCT01764464|320904|P2|NOT COMPLETED|First Intervention||3
131768|NCT01764464|320905|P1|NOT COMPLETED|First Intervention||2
131769|NCT01764464|320904|P2|COMPLETED|First Intervention|Completed Placebo|13
131770|NCT01764464|320905|P1|COMPLETED|First Intervention|Completed Gralise|14
131771|NCT01764464|320904|P2|STARTED|First Intervention|Started Placebo|16
131772|NCT01764464|320905|P1|STARTED|First Intervention|Started Gralise|16
131773|NCT01764386|320923|P2|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||53
131774|NCT01764386|320924|P1|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||16
131775|NCT01764386|320923|P2|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|28
131776|NCT01764386|320924|P1|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|55
131777|NCT01764386|320923|P2|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||35
131778|NCT01764386|320924|P1|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||61
131779|NCT01764386|320923|P2|STARTED|Uncontrolled Treatment Period (UTP)|One subject completed the 26-week CTP, but did not continue in the UTP.|81
131780|NCT01764386|320924|P1|STARTED|Uncontrolled Treatment Period (UTP)||71
131781|NCT01764386|320923|P2|NOT COMPLETED|Controlled Treatment Period (CTP)||7
131782|NCT01764386|320924|P1|NOT COMPLETED|Controlled Treatment Period (CTP)||82
131783|NCT01764386|320923|P2|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|82
131784|NCT01764386|320924|P1|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|71
131785|NCT01764386|320923|P2|STARTED|Controlled Treatment Period (CTP)||89
131786|NCT01764386|320924|P1|STARTED|Controlled Treatment Period (CTP)||153
131787|NCT01764256|320969|P4|NOT COMPLETED|Completed Study||1
131788|NCT01764256|320970|P3|NOT COMPLETED|Completed Study||0
131789|NCT01764256|320971|P2|NOT COMPLETED|Completed Study||0
131790|NCT01764256|320972|P1|NOT COMPLETED|Completed Study||0
131791|NCT01764256|320969|P4|COMPLETED|Completed Study||11
131792|NCT01764256|320970|P3|COMPLETED|Completed Study||11
131793|NCT01764256|320971|P2|COMPLETED|Completed Study||11
131794|NCT01764256|320972|P1|COMPLETED|Completed Study||10
131795|NCT01764256|320969|P4|STARTED|Completed Study||12
131796|NCT01764256|320970|P3|STARTED|Completed Study||11
131797|NCT01764256|320971|P2|STARTED|Completed Study||11
131798|NCT01764256|320972|P1|STARTED|Completed Study||10
131799|NCT01764256|320969|P4|NOT COMPLETED|Received All Vaccinations||0
131800|NCT01764256|320970|P3|NOT COMPLETED|Received All Vaccinations||1
131801|NCT01764256|320971|P2|NOT COMPLETED|Received All Vaccinations||1
131802|NCT01764256|320972|P1|NOT COMPLETED|Received All Vaccinations||2
131803|NCT01764256|320969|P4|COMPLETED|Received All Vaccinations||12
131804|NCT01764256|320970|P3|COMPLETED|Received All Vaccinations||11
131805|NCT01764256|320971|P2|COMPLETED|Received All Vaccinations||11
131806|NCT01764256|320972|P1|COMPLETED|Received All Vaccinations||10
131807|NCT01764256|320969|P4|STARTED|Received All Vaccinations||12
131808|NCT01764256|320970|P3|STARTED|Received All Vaccinations||12
131809|NCT01764256|320971|P2|STARTED|Received All Vaccinations||12
131810|NCT01764256|320972|P1|STARTED|Received All Vaccinations||12
131811|NCT01764022|321015|P2|NOT COMPLETED|Overall Study||14
131812|NCT01764022|321016|P1|NOT COMPLETED|Overall Study||8
131813|NCT01764022|321015|P2|COMPLETED|Overall Study||96
131814|NCT01764022|321016|P1|COMPLETED|Overall Study||107
131815|NCT01764022|321015|P2|Received at Least 1 Dose of Study Drug|Overall Study||110
131816|NCT01764022|321016|P1|Received at Least 1 Dose of Study Drug|Overall Study||113
131817|NCT01764022|321015|P2|STARTED|Overall Study||110
131818|NCT01764022|321016|P1|STARTED|Overall Study||115
131819|NCT01763996|321048|P2|NOT COMPLETED|Treatment Period 2||1
131820|NCT01763996|321049|P1|NOT COMPLETED|Treatment Period 2||0
131821|NCT01763996|321048|P2|COMPLETED|Treatment Period 2||14
131822|NCT01763996|321049|P1|COMPLETED|Treatment Period 2||15
131823|NCT01763996|321048|P2|STARTED|Treatment Period 2||15
131824|NCT01763996|321049|P1|STARTED|Treatment Period 2||15
131825|NCT01763996|321048|P2|NOT COMPLETED|Treatment Period 1||0
131826|NCT01763996|321049|P1|NOT COMPLETED|Treatment Period 1||0
131827|NCT01763996|321048|P2|COMPLETED|Treatment Period 1||15
131828|NCT01763996|321049|P1|COMPLETED|Treatment Period 1||15
131829|NCT01763996|321048|P2|STARTED|Treatment Period 1||15
131830|NCT01763996|321049|P1|STARTED|Treatment Period 1||15
131831|NCT01763918|321079|P4|NOT COMPLETED|Overall Study||2
131832|NCT01763918|321080|P3|NOT COMPLETED|Overall Study||10
131833|NCT01763918|321081|P2|NOT COMPLETED|Overall Study||1
131834|NCT01763918|321082|P1|NOT COMPLETED|Overall Study||6
131835|NCT01763918|321079|P4|COMPLETED|Overall Study||108
131836|NCT01763918|321080|P3|COMPLETED|Overall Study||101
131837|NCT01763918|321081|P2|COMPLETED|Overall Study||54
131838|NCT01763918|321082|P1|COMPLETED|Overall Study||49
131839|NCT01763918|321079|P4|Received Treatment|Overall Study||110
131840|NCT01763918|321080|P3|Received Treatment|Overall Study||110
131841|NCT01763918|321081|P2|Received Treatment|Overall Study||55
131842|NCT01763918|321082|P1|Received Treatment|Overall Study||54
131843|NCT01763918|321079|P4|STARTED|Overall Study||110
131844|NCT01763918|321080|P3|STARTED|Overall Study||111
131845|NCT01763918|321081|P2|STARTED|Overall Study||55
131846|NCT01763918|321082|P1|STARTED|Overall Study||55
131847|NCT01763905|321180|P4|NOT COMPLETED|Overall Study||1
131848|NCT01763905|321181|P3|NOT COMPLETED|Overall Study||9
131849|NCT01763905|321182|P2|NOT COMPLETED|Overall Study||1
131850|NCT01763905|321183|P1|NOT COMPLETED|Overall Study||6
131851|NCT01763905|321180|P4|COMPLETED|Overall Study||101
131852|NCT01763905|321181|P3|COMPLETED|Overall Study||94
131853|NCT01763905|321182|P2|COMPLETED|Overall Study||50
131854|NCT01763905|321183|P1|COMPLETED|Overall Study||45
131855|NCT01763905|321180|P4|STARTED|Overall Study||102
131856|NCT01763905|321181|P3|STARTED|Overall Study||103
131857|NCT01763905|321182|P2|STARTED|Overall Study||51
131858|NCT01763905|321183|P1|STARTED|Overall Study||51
131859|NCT01763866|321301|P24|NOT COMPLETED|Overall Study||2
131860|NCT01763866|321302|P23|NOT COMPLETED|Overall Study||3
131861|NCT01763866|321303|P22|NOT COMPLETED|Overall Study||1
131862|NCT01763866|321304|P21|NOT COMPLETED|Overall Study||4
131863|NCT01763866|321305|P20|NOT COMPLETED|Overall Study||2
131864|NCT01763866|321306|P19|NOT COMPLETED|Overall Study||6
131865|NCT01763866|321307|P18|NOT COMPLETED|Overall Study||1
131866|NCT01763866|321308|P17|NOT COMPLETED|Overall Study||1
131867|NCT01763866|321309|P16|NOT COMPLETED|Overall Study||3
131868|NCT01763866|321310|P15|NOT COMPLETED|Overall Study||12
131869|NCT01763866|321311|P14|NOT COMPLETED|Overall Study||0
131870|NCT01763866|321312|P13|NOT COMPLETED|Overall Study||4
131871|NCT01763866|321313|P12|NOT COMPLETED|Overall Study||2
131872|NCT01763866|321314|P11|NOT COMPLETED|Overall Study||8
131873|NCT01763866|321315|P10|NOT COMPLETED|Overall Study||1
131874|NCT01763866|321316|P9|NOT COMPLETED|Overall Study||3
131875|NCT01763866|321317|P8|NOT COMPLETED|Overall Study||0
131876|NCT01763866|321318|P7|NOT COMPLETED|Overall Study||7
131877|NCT01763866|321319|P6|NOT COMPLETED|Overall Study||3
131878|NCT01763866|321320|P5|NOT COMPLETED|Overall Study||2
131879|NCT01763866|321321|P4|NOT COMPLETED|Overall Study||0
131880|NCT01763866|321322|P3|NOT COMPLETED|Overall Study||5
131881|NCT01763866|321323|P2|NOT COMPLETED|Overall Study||1
131882|NCT01763866|321324|P1|NOT COMPLETED|Overall Study||2
131883|NCT01763866|321301|P24|COMPLETED|Overall Study||113
131884|NCT01763866|321302|P23|COMPLETED|Overall Study||109
131885|NCT01763866|321303|P22|COMPLETED|Overall Study||54
131886|NCT01763866|321304|P21|COMPLETED|Overall Study||52
131887|NCT01763866|321305|P20|COMPLETED|Overall Study||110
131888|NCT01763866|321306|P19|COMPLETED|Overall Study||105
131889|NCT01763866|321307|P18|COMPLETED|Overall Study||55
131890|NCT01763866|321308|P17|COMPLETED|Overall Study||55
131891|NCT01763866|321309|P16|COMPLETED|Overall Study||112
131892|NCT01763866|321310|P15|COMPLETED|Overall Study||102
131893|NCT01763866|321311|P14|COMPLETED|Overall Study||57
131894|NCT01763866|321312|P13|COMPLETED|Overall Study||54
131895|NCT01763866|321313|P12|COMPLETED|Overall Study||108
131896|NCT01763866|321314|P11|COMPLETED|Overall Study||102
131897|NCT01763866|321315|P10|COMPLETED|Overall Study||53
131898|NCT01763866|321316|P9|COMPLETED|Overall Study||53
131899|NCT01763866|321317|P8|COMPLETED|Overall Study||55
131900|NCT01763866|321318|P7|COMPLETED|Overall Study||48
131901|NCT01763866|321319|P6|COMPLETED|Overall Study||107
131902|NCT01763866|321320|P5|COMPLETED|Overall Study||108
131903|NCT01763866|321321|P4|COMPLETED|Overall Study||55
131904|NCT01763866|321322|P3|COMPLETED|Overall Study||51
131905|NCT01763866|321323|P2|COMPLETED|Overall Study||54
131906|NCT01763866|321324|P1|COMPLETED|Overall Study||54
131907|NCT01763866|321301|P24|Received Treatment|Overall Study||115
131908|NCT01763866|321302|P23|Received Treatment|Overall Study||112
131909|NCT01763866|321303|P22|Received Treatment|Overall Study||55
131910|NCT01763866|321304|P21|Received Treatment|Overall Study||56
131911|NCT01763866|321305|P20|Received Treatment|Overall Study||112
131912|NCT01763866|321306|P19|Received Treatment|Overall Study||111
131913|NCT01763866|321307|P18|Received Treatment|Overall Study||55
131914|NCT01763866|321308|P17|Received Treatment|Overall Study||56
131915|NCT01763866|321309|P16|Received Treatment|Overall Study||115
131916|NCT01763866|321310|P15|Received Treatment|Overall Study||113
131917|NCT01763866|321311|P14|Received Treatment|Overall Study||57
131918|NCT01763866|321312|P13|Received Treatment|Overall Study||58
131919|NCT01763866|321313|P12|Received Treatment|Overall Study||110
131920|NCT01763866|321314|P11|Received Treatment|Overall Study||109
131921|NCT01763866|321315|P10|Received Treatment|Overall Study||54
131922|NCT01763866|321316|P9|Received Treatment|Overall Study||56
131923|NCT01763866|321317|P8|Received Treatment|Overall Study||55
131924|NCT01763866|321318|P7|Received Treatment|Overall Study||55
131925|NCT01763866|321319|P6|Received Treatment|Overall Study||110
131926|NCT01763866|321320|P5|Received Treatment|Overall Study||110
131927|NCT01763866|321321|P4|Received Treatment|Overall Study||55
131928|NCT01763866|321322|P3|Received Treatment|Overall Study||56
131929|NCT01763866|321323|P2|Received Treatment|Overall Study||55
131930|NCT01763866|321324|P1|Received Treatment|Overall Study||56
131931|NCT01763866|321301|P24|STARTED|Overall Study||115
131932|NCT01763866|321302|P23|STARTED|Overall Study||112
131933|NCT01763866|321303|P22|STARTED|Overall Study||55
131934|NCT01763866|321304|P21|STARTED|Overall Study||56
131935|NCT01763866|321305|P20|STARTED|Overall Study||112
131936|NCT01763866|321306|P19|STARTED|Overall Study||111
131937|NCT01763866|321307|P18|STARTED|Overall Study||56
131938|NCT01763866|321308|P17|STARTED|Overall Study||56
131939|NCT01763866|321309|P16|STARTED|Overall Study||115
131940|NCT01763866|321310|P15|STARTED|Overall Study||114
131941|NCT01763866|321311|P14|STARTED|Overall Study||57
131942|NCT01763866|321312|P13|STARTED|Overall Study||58
131943|NCT01763866|321313|P12|STARTED|Overall Study||110
131944|NCT01763866|321314|P11|STARTED|Overall Study||110
131945|NCT01763866|321315|P10|STARTED|Overall Study||54
131946|NCT01763866|321316|P9|STARTED|Overall Study||56
131947|NCT01763866|321317|P8|STARTED|Overall Study||55
131948|NCT01763866|321318|P7|STARTED|Overall Study||55
131949|NCT01763866|321319|P6|STARTED|Overall Study||110
131950|NCT01763866|321320|P5|STARTED|Overall Study||110
131951|NCT01763866|321321|P4|STARTED|Overall Study||55
131952|NCT01763866|321322|P3|STARTED|Overall Study||56
131953|NCT01763866|321323|P2|STARTED|Overall Study||55
131954|NCT01763866|321324|P1|STARTED|Overall Study||56
131955|NCT01763827|321884|P6|NOT COMPLETED|Overall Study||2
131956|NCT01763827|321885|P5|NOT COMPLETED|Overall Study||6
131957|NCT01763827|321886|P4|NOT COMPLETED|Overall Study||1
131958|NCT01763827|321887|P3|NOT COMPLETED|Overall Study||4
131959|NCT01763827|321888|P2|NOT COMPLETED|Overall Study||1
131960|NCT01763827|321889|P1|NOT COMPLETED|Overall Study||3
131961|NCT01763827|321884|P6|COMPLETED|Overall Study||151
131962|NCT01763827|321885|P5|COMPLETED|Overall Study||147
131963|NCT01763827|321886|P4|COMPLETED|Overall Study||76
131964|NCT01763827|321887|P3|COMPLETED|Overall Study||73
131965|NCT01763827|321888|P2|COMPLETED|Overall Study||77
131966|NCT01763827|321889|P1|COMPLETED|Overall Study||74
131967|NCT01763827|321884|P6|Received at Least 1 Dose of Study Drug|Overall Study||153
131968|NCT01763827|321885|P5|Received at Least 1 Dose of Study Drug|Overall Study||153
131969|NCT01763827|321886|P4|Received at Least 1 Dose of Study Drug|Overall Study||77
131970|NCT01763827|321887|P3|Received at Least 1 Dose of Study Drug|Overall Study||77
131971|NCT01763827|321888|P2|Received at Least 1 Dose of Study Drug|Overall Study||78
131972|NCT01763827|321889|P1|Received at Least 1 Dose of Study Drug|Overall Study||76
131973|NCT01763827|321884|P6|STARTED|Overall Study||153
131974|NCT01763827|321885|P5|STARTED|Overall Study||153
131975|NCT01763827|321886|P4|STARTED|Overall Study||77
131976|NCT01763827|321887|P3|STARTED|Overall Study||77
131977|NCT01763827|321888|P2|STARTED|Overall Study||78
131978|NCT01763827|321889|P1|STARTED|Overall Study||77
131979|NCT01763788|322033|P4|NOT COMPLETED|Overall Study||0
131980|NCT01763788|322034|P3|NOT COMPLETED|Overall Study||1
131981|NCT01763788|322035|P2|NOT COMPLETED|Overall Study||0
131982|NCT01763788|322036|P1|NOT COMPLETED|Overall Study||0
131983|NCT01763788|322033|P4|COMPLETED|Overall Study||92
131984|NCT01763788|322034|P3|COMPLETED|Overall Study||90
131985|NCT01763788|322035|P2|COMPLETED|Overall Study||6
131986|NCT01763788|322036|P1|COMPLETED|Overall Study||3
131987|NCT01763788|322033|P4|Received at Least 1dose of Study Drug|Overall Study||91
131988|NCT01763788|322034|P3|Received at Least 1dose of Study Drug|Overall Study||90
131989|NCT01763788|322035|P2|Received at Least 1dose of Study Drug|Overall Study||6
131990|NCT01763788|322036|P1|Received at Least 1dose of Study Drug|Overall Study||3
131991|NCT01763788|322033|P4|STARTED|Overall Study||92
131992|NCT01763788|322034|P3|STARTED|Overall Study||91
131993|NCT01763788|322035|P2|STARTED|Overall Study||6
131994|NCT01763788|322036|P1|STARTED|Overall Study||3
131995|NCT01763645|322072|P2|NOT COMPLETED|Overall Study||24
131996|NCT01763645|322073|P1|NOT COMPLETED|Overall Study||26
131997|NCT01763645|322072|P2|COMPLETED|Overall Study|Completed the study according the protocol.|45
131998|NCT01763645|322073|P1|COMPLETED|Overall Study|Completed the study according the protocol.|43
131999|NCT01763645|322072|P2|Received at Least 1 Dose of Study Drug|Overall Study||66
132000|NCT01763645|322073|P1|Received at Least 1 Dose of Study Drug|Overall Study||68
132001|NCT01763645|322072|P2|STARTED|Overall Study||69
132002|NCT01763645|322073|P1|STARTED|Overall Study||69
132003|NCT01763567|322091|P1|NOT COMPLETED|Overall Study||0
132004|NCT01763567|322091|P1|COMPLETED|Overall Study||19
132005|NCT01763567|322091|P1|STARTED|Overall Study||19
132006|NCT01763346|322101|P2|NOT COMPLETED|Overall Study||8
132007|NCT01763346|322102|P1|NOT COMPLETED|Overall Study||10
132008|NCT01763346|322101|P2|COMPLETED|Overall Study||36
132009|NCT01763346|322102|P1|COMPLETED|Overall Study||34
132010|NCT01763346|322101|P2|Received Intervention|Overall Study||38
132011|NCT01763346|322102|P1|Received Intervention|Overall Study||39
132012|NCT01763346|322101|P2|STARTED|Overall Study|"Six subjects randomized to gastric banding refused the banding surgery and, thus, did not start"|44
132013|NCT01763346|322102|P1|STARTED|Overall Study|"Five subjects who enrolled in the study refused to initiate metformin therapy, thus did not start"|44
132014|NCT01763333|322126|P14|NOT COMPLETED|Overall Study||0
132015|NCT01763333|322127|P13|NOT COMPLETED|Overall Study||0
132016|NCT01763333|322128|P12|NOT COMPLETED|Overall Study||0
132017|NCT01763333|322129|P11|NOT COMPLETED|Overall Study||0
132018|NCT01763333|322130|P10|NOT COMPLETED|Overall Study||0
132019|NCT01763333|322131|P9|NOT COMPLETED|Overall Study||0
132020|NCT01763333|322132|P8|NOT COMPLETED|Overall Study||0
132021|NCT01763333|322133|P7|NOT COMPLETED|Overall Study||0
132022|NCT01763333|322134|P6|NOT COMPLETED|Overall Study||0
132023|NCT01763333|322135|P5|NOT COMPLETED|Overall Study||0
132024|NCT01763333|322136|P4|NOT COMPLETED|Overall Study||0
132025|NCT01763333|322137|P3|NOT COMPLETED|Overall Study||0
132026|NCT01763333|322138|P2|NOT COMPLETED|Overall Study||0
132027|NCT01763333|322139|P1|NOT COMPLETED|Overall Study||0
132028|NCT01763333|322126|P14|COMPLETED|Overall Study||3
132029|NCT01763333|322127|P13|COMPLETED|Overall Study||3
132030|NCT01763333|322128|P12|COMPLETED|Overall Study||3
132031|NCT01763333|322129|P11|COMPLETED|Overall Study||3
132032|NCT01763333|322130|P10|COMPLETED|Overall Study||18
132033|NCT01763333|322131|P9|COMPLETED|Overall Study||5
132034|NCT01763333|322132|P8|COMPLETED|Overall Study||6
132035|NCT01763333|322133|P7|COMPLETED|Overall Study||5
132036|NCT01763333|322134|P6|COMPLETED|Overall Study||6
132037|NCT01763333|322135|P5|COMPLETED|Overall Study||4
132038|NCT01763333|322136|P4|COMPLETED|Overall Study||6
132039|NCT01763333|322137|P3|COMPLETED|Overall Study||6
132040|NCT01763333|322138|P2|COMPLETED|Overall Study||6
132041|NCT01763333|322139|P1|COMPLETED|Overall Study||6
132042|NCT01763333|322126|P14|STARTED|Overall Study||3
132043|NCT01763333|322127|P13|STARTED|Overall Study||3
132044|NCT01763333|322128|P12|STARTED|Overall Study||3
132045|NCT01763333|322129|P11|STARTED|Overall Study||3
132046|NCT01763333|322130|P10|STARTED|Overall Study||18
132047|NCT01763333|322131|P9|STARTED|Overall Study||5
132048|NCT01763333|322132|P8|STARTED|Overall Study||6
132049|NCT01763333|322133|P7|STARTED|Overall Study||5
132050|NCT01763333|322134|P6|STARTED|Overall Study||6
132051|NCT01763333|322135|P5|STARTED|Overall Study||4
132052|NCT01763333|322136|P4|STARTED|Overall Study||6
132053|NCT01763333|322137|P3|STARTED|Overall Study||6
132054|NCT01763333|322138|P2|STARTED|Overall Study||6
132055|NCT01763333|322139|P1|STARTED|Overall Study||6
132056|NCT01763203|322245|P2|NOT COMPLETED|Overall Study||42
132057|NCT01763203|322246|P1|NOT COMPLETED|Overall Study||33
132058|NCT01763203|322245|P2|COMPLETED|Overall Study||204
132059|NCT01763203|322246|P1|COMPLETED|Overall Study||208
132060|NCT01763203|322245|P2|STARTED|Overall Study||246
132061|NCT01763203|322246|P1|STARTED|Overall Study||241
132062|NCT01763047|322292|P2|NOT COMPLETED|Period 2||5
132063|NCT01763047|322293|P1|NOT COMPLETED|Period 2||4
132064|NCT01763047|322292|P2|COMPLETED|Period 2||121
132065|NCT01763047|322293|P1|COMPLETED|Period 2||126
132066|NCT01763047|322292|P2|Hyperopes|Period 2||54
132067|NCT01763047|322293|P1|Hyperopes|Period 2||56
132068|NCT01763047|322292|P2|Myopes|Period 2||72
132069|NCT01763047|322293|P1|Myopes|Period 2||74
132070|NCT01763047|322292|P2|STARTED|Period 2||126
132071|NCT01763047|322293|P1|STARTED|Period 2||130
132072|NCT01763047|322292|P2|NOT COMPLETED|Period 1||11
132073|NCT01763047|322293|P1|NOT COMPLETED|Period 1||9
132074|NCT01763047|322292|P2|COMPLETED|Period 1||126
132075|NCT01763047|322293|P1|COMPLETED|Period 1||130
132076|NCT01763047|322292|P2|Hyperopes|Period 1||61
132077|NCT01763047|322293|P1|Hyperopes|Period 1||62
132078|NCT01763047|322292|P2|Myopes|Period 1||76
132079|NCT01763047|322293|P1|Myopes|Period 1||77
132080|NCT01763047|322292|P2|STARTED|Period 1||137
132081|NCT01763047|322293|P1|STARTED|Period 1||139
132082|NCT01762982|322309|P1|NOT COMPLETED|Overall Study||0
132083|NCT01762982|322309|P1|COMPLETED|Overall Study||36
132084|NCT01762982|322309|P1|Received Empty Finn Chamber|Overall Study||36
132085|NCT01762982|322309|P1|Received SLS|Overall Study||36
132086|NCT01762982|322309|P1|Received Benzalkonium Chloride|Overall Study||36
132087|NCT01762982|322309|P1|Received Saline Water|Overall Study||36
132088|NCT01762982|322309|P1|STARTED|Overall Study||36
132089|NCT01762943|322332|P2|NOT COMPLETED|Overall Study||2
132090|NCT01762943|322333|P1|NOT COMPLETED|Overall Study||4
132091|NCT01762943|322332|P2|COMPLETED|Overall Study||15
132092|NCT01762943|322333|P1|COMPLETED|Overall Study||15
132093|NCT01762943|322332|P2|Withdrawal|Overall Study||15
132094|NCT01762943|322333|P1|Withdrawal|Overall Study||15
132095|NCT01762943|322332|P2|Addback|Overall Study||15
132096|NCT01762943|322333|P1|Addback|Overall Study||16
132097|NCT01762943|322332|P2|Hypogonadism|Overall Study||15
132098|NCT01762943|322333|P1|Hypogonadism|Overall Study||18
132099|NCT01762943|322332|P2|STARTED|Overall Study||17
132100|NCT01762943|322333|P1|STARTED|Overall Study||19
132101|NCT01762904|322341|P1|NOT COMPLETED|Overall Study||0
132102|NCT01762904|322341|P1|COMPLETED|Overall Study|October, 2013|135
132103|NCT01762904|322341|P1|STARTED|Overall Study|January, 2013|135
132104|NCT01762800|322350|P2|NOT COMPLETED|Overall Study||21
132105|NCT01762800|322351|P1|NOT COMPLETED|Overall Study||19
132106|NCT01762800|322350|P2|COMPLETED|Overall Study||183
132107|NCT01762800|322351|P1|COMPLETED|Overall Study||183
132108|NCT01762800|322350|P2|STARTED|Overall Study||204
132109|NCT01762800|322351|P1|STARTED|Overall Study||202
132110|NCT01762761|322425|P2|NOT COMPLETED|Overall Study||4
132111|NCT01762761|322426|P1|NOT COMPLETED|Overall Study||2
132112|NCT01762761|322425|P2|COMPLETED|Overall Study||100
132113|NCT01762761|322426|P1|COMPLETED|Overall Study||49
132114|NCT01762761|322425|P2|STARTED|Overall Study||104
132115|NCT01762761|322426|P1|STARTED|Overall Study||51
132116|NCT01762722|322480|P2|NOT COMPLETED|Overall Study||0
132117|NCT01762722|322481|P1|NOT COMPLETED|Overall Study||0
132118|NCT01762722|322480|P2|COMPLETED|Overall Study||11
132119|NCT01762722|322481|P1|COMPLETED|Overall Study||12
132120|NCT01762722|322480|P2|STARTED|Overall Study||11
132121|NCT01762722|322481|P1|STARTED|Overall Study||12
132122|NCT01762631|322489|P2|NOT COMPLETED|Overall Study||0
132123|NCT01762631|322490|P1|NOT COMPLETED|Overall Study||0
132124|NCT01762631|322489|P2|COMPLETED|Overall Study||22
132125|NCT01762631|322490|P1|COMPLETED|Overall Study||53
132126|NCT01762631|322489|P2|STARTED|Overall Study||22
132127|NCT01762631|322490|P1|STARTED|Overall Study||53
132128|NCT01762501|322508|P2|NOT COMPLETED|Overall Study||23
132129|NCT01762501|322509|P1|NOT COMPLETED|Overall Study||27
132130|NCT01762501|322508|P2|COMPLETED|Overall Study||336
132131|NCT01762501|322509|P1|COMPLETED|Overall Study||332
132132|NCT01762501|322508|P2|STARTED|Overall Study||359
132133|NCT01762501|322509|P1|STARTED|Overall Study||359
132134|NCT01762345|322523|P1|NOT COMPLETED|Overall Study||7
132135|NCT01762345|322523|P1|COMPLETED|Overall Study||76
132136|NCT01762345|322523|P1|STARTED|Overall Study||83
132137|NCT01762059|322533|P1|NOT COMPLETED|Overall Study||0
132138|NCT01762059|322533|P1|COMPLETED|Overall Study||20
132139|NCT01762059|322533|P1|STARTED|Overall Study||20
132140|NCT01761747|322560|P1|NOT COMPLETED|Overall Study||1
132141|NCT01761747|322560|P1|COMPLETED|Overall Study||2
132142|NCT01761747|322560|P1|STARTED|Overall Study||3
132143|NCT01761565|322571|P1|NOT COMPLETED|40 Consecutive Doses of SUF 15 mcg||1
132144|NCT01761565|322571|P1|COMPLETED|40 Consecutive Doses of SUF 15 mcg||38
132145|NCT01761565|322571|P1|STARTED|40 Consecutive Doses of SUF 15 mcg|Subject was withdrawn from the study prior to the second arm/period due to non-compliance|39
132146|NCT01761565|322571|P1|NOT COMPLETED|Single Dose of SUF NT 15 mcg||0
132147|NCT01761565|322571|P1|COMPLETED|Single Dose of SUF NT 15 mcg||40
132148|NCT01761565|322571|P1|STARTED|Single Dose of SUF NT 15 mcg||40
132149|NCT01761279|322580|P1|NOT COMPLETED|Overall Study||0
132150|NCT01761279|322580|P1|COMPLETED|Overall Study||84
132151|NCT01761279|322580|P1|STARTED|Overall Study||84
132152|NCT01761266|322595|P2|NOT COMPLETED|Overall Study||476
132153|NCT01761266|322596|P1|NOT COMPLETED|Overall Study||478
132154|NCT01761266|322595|P2|COMPLETED|Overall Study||0
132155|NCT01761266|322596|P1|COMPLETED|Overall Study||0
132156|NCT01761266|322595|P2|Treated|Overall Study||475
132157|NCT01761266|322596|P1|Treated|Overall Study||476
132158|NCT01761266|322595|P2|STARTED|Overall Study||476
132159|NCT01761266|322596|P1|STARTED|Overall Study||478
132160|NCT01761175|322624|P2|NOT COMPLETED|Overall Study||0
132161|NCT01761175|322625|P1|NOT COMPLETED|Overall Study||0
132162|NCT01761175|322624|P2|COMPLETED|Overall Study||112
132163|NCT01761175|322625|P1|COMPLETED|Overall Study||112
132164|NCT01761175|322624|P2|STARTED|Overall Study||112
132165|NCT01761175|322625|P1|STARTED|Overall Study||112
132166|NCT01761162|322653|P1|NOT COMPLETED|Overall Study||3
132167|NCT01761162|322653|P1|COMPLETED|Overall Study||226
132168|NCT01761162|322653|P1|STARTED|Overall Study||229
132169|NCT01761084|322663|P2|NOT COMPLETED|Overall Study||6
132170|NCT01761084|322664|P1|NOT COMPLETED|Overall Study||5
132171|NCT01761084|322663|P2|COMPLETED|Overall Study||64
132172|NCT01761084|322664|P1|COMPLETED|Overall Study||66
132173|NCT01761084|322663|P2|STARTED|Overall Study||70
132174|NCT01761084|322664|P1|STARTED|Overall Study||71
132175|NCT01761019|322713|P1|NOT COMPLETED|Overall Study||0
132176|NCT01761019|322713|P1|COMPLETED|Overall Study||8
132177|NCT01761019|322713|P1|STARTED|Overall Study||8
132178|NCT01760993|322721|P1|NOT COMPLETED|Overall Study||0
132179|NCT01760993|322721|P1|COMPLETED|Overall Study||0
132180|NCT01760993|322721|P1|STARTED|Overall Study||0
132181|NCT01760954|322742|P4|NOT COMPLETED|Post-treatment Follow-up (12 Months)||20
132182|NCT01760954|322743|P3|NOT COMPLETED|Post-treatment Follow-up (12 Months)||21
132183|NCT01760954|322744|P2|NOT COMPLETED|Post-treatment Follow-up (12 Months)||35
132184|NCT01760954|322745|P1|NOT COMPLETED|Post-treatment Follow-up (12 Months)||30
132185|NCT01760954|322742|P4|COMPLETED|Post-treatment Follow-up (12 Months)||67
132186|NCT01760954|322743|P3|COMPLETED|Post-treatment Follow-up (12 Months)||65
132187|NCT01760954|322744|P2|COMPLETED|Post-treatment Follow-up (12 Months)||83
132188|NCT01760954|322745|P1|COMPLETED|Post-treatment Follow-up (12 Months)||96
132189|NCT01760954|322742|P4|STARTED|Post-treatment Follow-up (12 Months)||87
132190|NCT01760954|322743|P3|STARTED|Post-treatment Follow-up (12 Months)||86
132191|NCT01760954|322744|P2|STARTED|Post-treatment Follow-up (12 Months)||118
132192|NCT01760954|322745|P1|STARTED|Post-treatment Follow-up (12 Months)||126
132193|NCT01760954|322742|P4|NOT COMPLETED|Treatment Period (6 Months)||26
132194|NCT01760954|322743|P3|NOT COMPLETED|Treatment Period (6 Months)||21
132195|NCT01760954|322744|P2|NOT COMPLETED|Treatment Period (6 Months)||28
132196|NCT01760954|322745|P1|NOT COMPLETED|Treatment Period (6 Months)||33
132197|NCT01760954|322742|P4|COMPLETED|Treatment Period (6 Months)||83
132198|NCT01760954|322743|P3|COMPLETED|Treatment Period (6 Months)||87
132199|NCT01760954|322744|P2|COMPLETED|Treatment Period (6 Months)||110
132200|NCT01760954|322745|P1|COMPLETED|Treatment Period (6 Months)||116
132201|NCT01760954|322742|P4|STARTED|Treatment Period (6 Months)||109
132202|NCT01760954|322743|P3|STARTED|Treatment Period (6 Months)||108
132203|NCT01760954|322744|P2|STARTED|Treatment Period (6 Months)||138
132204|NCT01760954|322745|P1|STARTED|Treatment Period (6 Months)||149
132205|NCT01760941|322823|P1|NOT COMPLETED|Overall Study||0
132206|NCT01760941|322823|P1|COMPLETED|Overall Study||1
132207|NCT01760941|322823|P1|STARTED|Overall Study||1
132208|NCT01760889|322833|P3|NOT COMPLETED|Overall Study||0
132209|NCT01760889|322834|P2|NOT COMPLETED|Overall Study||0
132210|NCT01760889|322835|P1|NOT COMPLETED|Overall Study||0
132211|NCT01760889|322833|P3|COMPLETED|Overall Study||0
132212|NCT01760889|322834|P2|COMPLETED|Overall Study||0
132213|NCT01760889|322835|P1|COMPLETED|Overall Study||0
132214|NCT01760889|322833|P3|STARTED|Overall Study||0
132215|NCT01760889|322834|P2|STARTED|Overall Study||0
132216|NCT01760889|322835|P1|STARTED|Overall Study||0
132217|NCT01760876|322882|P1|NOT COMPLETED|Overall Study||6
132218|NCT01760876|322882|P1|COMPLETED|Overall Study|12 months clinical FU of last patient in July 2015.|100
132219|NCT01760876|322882|P1|STARTED|Overall Study||106
132220|NCT01760785|322888|P2|NOT COMPLETED|Overall Study||0
132221|NCT01760785|322889|P1|NOT COMPLETED|Overall Study||0
132222|NCT01760785|322888|P2|COMPLETED|Overall Study||27
132223|NCT01760785|322889|P1|COMPLETED|Overall Study||23
132224|NCT01760785|322888|P2|STARTED|Overall Study||27
132225|NCT01760785|322889|P1|STARTED|Overall Study||23
132226|NCT01760473|322895|P1|NOT COMPLETED|Overall Study||15
132227|NCT01760473|322895|P1|COMPLETED|Overall Study||12
132228|NCT01760473|322895|P1|STARTED|Overall Study||27
132229|NCT01760304|322918|P2|NOT COMPLETED|Overall Study||0
132230|NCT01760304|322919|P1|NOT COMPLETED|Overall Study||0
132231|NCT01760304|322918|P2|COMPLETED|Overall Study||3
132232|NCT01760304|322919|P1|COMPLETED|Overall Study||2
132233|NCT01760304|322918|P2|STARTED|Overall Study||3
132234|NCT01760304|322919|P1|STARTED|Overall Study||2
132235|NCT01760239|322931|P2|NOT COMPLETED|Overall Study||14316
132236|NCT01760239|322932|P1|NOT COMPLETED|Overall Study||16741
132237|NCT01760239|322931|P2|COMPLETED|Overall Study||226
132238|NCT01760239|322932|P1|COMPLETED|Overall Study||296
132239|NCT01760239|322931|P2|STARTED|Overall Study||14542
132240|NCT01760239|322932|P1|STARTED|Overall Study||17037
132241|NCT01760187|322952|P5|NOT COMPLETED|Overall Study||0
132242|NCT01760187|322953|P4|NOT COMPLETED|Overall Study||2
132243|NCT01760187|322954|P3|NOT COMPLETED|Overall Study||0
132244|NCT01760187|322955|P2|NOT COMPLETED|Overall Study||0
132245|NCT01760187|322956|P1|NOT COMPLETED|Overall Study||1
132246|NCT01760187|322952|P5|COMPLETED|Overall Study||16
132247|NCT01760187|322953|P4|COMPLETED|Overall Study||10
132248|NCT01760187|322954|P3|COMPLETED|Overall Study||12
132249|NCT01760187|322955|P2|COMPLETED|Overall Study||12
132250|NCT01760187|322956|P1|COMPLETED|Overall Study||19
132251|NCT01760187|322952|P5|STARTED|Overall Study||16
132252|NCT01760187|322953|P4|STARTED|Overall Study||12
132253|NCT01760187|322954|P3|STARTED|Overall Study||12
132254|NCT01760187|322955|P2|STARTED|Overall Study||12
132255|NCT01760187|322956|P1|STARTED|Overall Study||20
132256|NCT01759862|323186|P2|NOT COMPLETED|Overall Study||2
132257|NCT01759862|323187|P1|NOT COMPLETED|Overall Study||3
132258|NCT01759862|323186|P2|COMPLETED|Overall Study||25
132259|NCT01759862|323187|P1|COMPLETED|Overall Study||20
132260|NCT01759862|323186|P2|STARTED|Overall Study||27
132261|NCT01759862|323187|P1|STARTED|Overall Study||23
132262|NCT01759602|323197|P1|NOT COMPLETED|Overall Study||0
132263|NCT01759602|323197|P1|COMPLETED|Overall Study||10
132264|NCT01759602|323197|P1|STARTED|Overall Study||10
132265|NCT01759511|323205|P1|NOT COMPLETED|Overall Study||34
132266|NCT01759511|323205|P1|COMPLETED|Overall Study||0
132267|NCT01759511|323205|P1|STARTED|Overall Study||34
132268|NCT01759446|323218|P5|NOT COMPLETED|Overall Study||0
132269|NCT01759446|323219|P4|NOT COMPLETED|Overall Study||1
132270|NCT01759446|323220|P3|NOT COMPLETED|Overall Study||1
132271|NCT01759446|323221|P2|NOT COMPLETED|Overall Study||1
132272|NCT01759446|323222|P1|NOT COMPLETED|Overall Study||1
132273|NCT01759446|323218|P5|COMPLETED|Overall Study||8
132274|NCT01759446|323219|P4|COMPLETED|Overall Study||8
132275|NCT01759446|323220|P3|COMPLETED|Overall Study||8
132276|NCT01759446|323221|P2|COMPLETED|Overall Study||8
132277|NCT01759446|323222|P1|COMPLETED|Overall Study||8
132278|NCT01759446|323218|P5|STARTED|Overall Study||8
132279|NCT01759446|323219|P4|STARTED|Overall Study||9
132280|NCT01759446|323220|P3|STARTED|Overall Study||9
132281|NCT01759446|323221|P2|STARTED|Overall Study||9
132282|NCT01759446|323222|P1|STARTED|Overall Study||9
132283|NCT01759420|323234|P1|NOT COMPLETED|Overall Study||6
132284|NCT01759420|323234|P1|COMPLETED|Overall Study||22
132285|NCT01759420|323234|P1|STARTED|Overall Study||28
132286|NCT01759407|323241|P2|NOT COMPLETED|Overall Study||2
132287|NCT01759407|323242|P1|NOT COMPLETED|Overall Study||0
132288|NCT01759407|323241|P2|COMPLETED|Overall Study||7
132289|NCT01759407|323242|P1|COMPLETED|Overall Study||10
132290|NCT01759407|323241|P2|STARTED|Overall Study||9
132291|NCT01759407|323242|P1|STARTED|Overall Study||10
132292|NCT01759381|323254|P2|NOT COMPLETED|Overall Study||0
132293|NCT01759381|323255|P1|NOT COMPLETED|Overall Study||1
132294|NCT01759381|323254|P2|COMPLETED|Overall Study||11
132295|NCT01759381|323255|P1|COMPLETED|Overall Study||7
132296|NCT01759381|323254|P2|STARTED|Overall Study||11
132297|NCT01759381|323255|P1|STARTED|Overall Study||8
132298|NCT01759368|323263|P2|NOT COMPLETED|Overall Study||0
132299|NCT01759368|323264|P1|NOT COMPLETED|Overall Study||1
132300|NCT01759368|323263|P2|COMPLETED|Overall Study||47
132301|NCT01759368|323264|P1|COMPLETED|Overall Study||46
132302|NCT01759368|323263|P2|STARTED|Overall Study||47
132303|NCT01759368|323264|P1|STARTED|Overall Study||47
132304|NCT01759290|323282|P1|NOT COMPLETED|Overall Study||81
132305|NCT01759290|323282|P1|COMPLETED|Overall Study||1719
132306|NCT01759290|323282|P1|STARTED|Overall Study||1800
132307|NCT01759264|323342|P1|NOT COMPLETED|Overall Study||10
132308|NCT01759264|323342|P1|COMPLETED|Overall Study||91
132309|NCT01759264|323342|P1|STARTED|Overall Study||101
132310|NCT01759251|323355|P1|NOT COMPLETED|Follow-up Period||0
132311|NCT01759251|323355|P1|COMPLETED|Follow-up Period||305
132312|NCT01759251|323355|P1|STARTED|Follow-up Period||305
132313|NCT01759251|323355|P1|NOT COMPLETED|60 Days Treatment Period||0
132314|NCT01759251|323355|P1|COMPLETED|60 Days Treatment Period||305
132315|NCT01759251|323355|P1|STARTED|60 Days Treatment Period||305
132316|NCT01759251|323355|P1|NOT COMPLETED|30 Days Treatment Period||4
132317|NCT01759251|323355|P1|COMPLETED|30 Days Treatment Period||305
132318|NCT01759251|323355|P1|STARTED|30 Days Treatment Period||309
132319|NCT01759160|323361|P2|NOT COMPLETED|Overall Study||0
132320|NCT01759160|323362|P1|NOT COMPLETED|Overall Study||0
132321|NCT01759160|323361|P2|COMPLETED|Overall Study||30
132322|NCT01759160|323362|P1|COMPLETED|Overall Study||30
132323|NCT01759160|323361|P2|STARTED|Overall Study||30
132324|NCT01759160|323362|P1|STARTED|Overall Study||30
132325|NCT01758900|323370|P2|NOT COMPLETED|Overall Study||8
132326|NCT01758900|323371|P1|NOT COMPLETED|Overall Study||7
132327|NCT01758900|323370|P2|COMPLETED|Overall Study||100
132328|NCT01758900|323371|P1|COMPLETED|Overall Study||99
132329|NCT01758900|323370|P2|STARTED|Overall Study||108
132330|NCT01758900|323371|P1|STARTED|Overall Study||106
132331|NCT01758731|323389|P1|NOT COMPLETED|Overall Study||1
132332|NCT01758731|323389|P1|COMPLETED|Overall Study||16
132333|NCT01758731|323389|P1|STARTED|Overall Study||17
132334|NCT01758588|323395|P2|NOT COMPLETED|Overall Study||0
132335|NCT01758588|323396|P1|NOT COMPLETED|Overall Study||0
132336|NCT01758588|323395|P2|COMPLETED|Overall Study||3
132337|NCT01758588|323396|P1|COMPLETED|Overall Study||5
132338|NCT01758588|323395|P2|STARTED|Overall Study||3
132339|NCT01758588|323396|P1|STARTED|Overall Study||5
132340|NCT01758523|323408|P2|NOT COMPLETED|Overall Study||14
132341|NCT01758523|323409|P1|NOT COMPLETED|Overall Study||21
132342|NCT01758523|323408|P2|COMPLETED|Overall Study||54
132343|NCT01758523|323409|P1|COMPLETED|Overall Study||53
132344|NCT01758523|323408|P2|Attended >/= 1 Visit Post-randomization|Overall Study||67
132345|NCT01758523|323409|P1|Attended >/= 1 Visit Post-randomization|Overall Study||68
132346|NCT01758523|323408|P2|STARTED|Overall Study||68
132347|NCT01758523|323409|P1|STARTED|Overall Study||74
132348|NCT01758432|323434|P7|NOT COMPLETED|Overall Study||0
132349|NCT01758432|323435|P6|NOT COMPLETED|Overall Study||0
132350|NCT01758432|323436|P5|NOT COMPLETED|Overall Study||0
132351|NCT01758432|323437|P4|NOT COMPLETED|Overall Study||0
132352|NCT01758432|323438|P3|NOT COMPLETED|Overall Study||0
132353|NCT01758432|323439|P2|NOT COMPLETED|Overall Study||0
132354|NCT01758432|323440|P1|NOT COMPLETED|Overall Study||0
132355|NCT01758432|323434|P7|COMPLETED|Overall Study||6
132356|NCT01758432|323435|P6|COMPLETED|Overall Study||6
132357|NCT01758432|323436|P5|COMPLETED|Overall Study||6
132358|NCT01758432|323437|P4|COMPLETED|Overall Study||6
132359|NCT01758432|323438|P3|COMPLETED|Overall Study||6
132360|NCT01758432|323439|P2|COMPLETED|Overall Study||6
132361|NCT01758432|323440|P1|COMPLETED|Overall Study||18
132362|NCT01758432|323434|P7|STARTED|Overall Study||6
132363|NCT01758432|323435|P6|STARTED|Overall Study||6
132364|NCT01758432|323436|P5|STARTED|Overall Study||6
132365|NCT01758432|323437|P4|STARTED|Overall Study||6
132366|NCT01758432|323438|P3|STARTED|Overall Study||6
132367|NCT01758432|323439|P2|STARTED|Overall Study||6
132368|NCT01758432|323440|P1|STARTED|Overall Study||18
132369|NCT01758289|323512|P1|NOT COMPLETED|Overall Study||53
132370|NCT01758289|323512|P1|COMPLETED|Overall Study||52
132371|NCT01758289|323512|P1|STARTED|Overall Study||105
132372|NCT01757964|323531|P2|NOT COMPLETED|Overall Study||0
132373|NCT01757964|323532|P1|NOT COMPLETED|Overall Study||0
132374|NCT01757964|323531|P2|COMPLETED|Overall Study||4
132375|NCT01757964|323532|P1|COMPLETED|Overall Study||9
132376|NCT01757964|323531|P2|STARTED|Overall Study||4
132377|NCT01757964|323532|P1|STARTED|Overall Study||9
132378|NCT01757847|323538|P2|NOT COMPLETED|Overall Study||4
132379|NCT01757847|323539|P1|NOT COMPLETED|Overall Study||3
132380|NCT01757847|323538|P2|COMPLETED|Overall Study||42
132381|NCT01757847|323539|P1|COMPLETED|Overall Study||41
132382|NCT01757847|323538|P2|STARTED|Overall Study||46
132383|NCT01757847|323539|P1|STARTED|Overall Study||44
132384|NCT01757821|323547|P1|NOT COMPLETED|Overall Study||1
132385|NCT01757821|323547|P1|COMPLETED|Overall Study|10 subjects|10
132386|NCT01757821|323547|P1|STARTED|Overall Study|11 subjects|11
132387|NCT01757717|323555|P1|NOT COMPLETED|Overall Study||0
132388|NCT01757717|323555|P1|COMPLETED|Overall Study||3
132389|NCT01757717|323555|P1|STARTED|Overall Study||3
132390|NCT01757704|323562|P2|NOT COMPLETED|Overall Study||3
132391|NCT01757704|323563|P1|NOT COMPLETED|Overall Study||1
132392|NCT01757704|323562|P2|COMPLETED|Overall Study||10
132393|NCT01757704|323563|P1|COMPLETED|Overall Study||10
132394|NCT01757704|323562|P2|STARTED|Overall Study|Two patients excluded intraoperatively due to failure to obtain TCD signals and one due to adhesion.|13
132395|NCT01757704|323563|P1|STARTED|Overall Study|One patient was excluded at start of surgery due to opening of the pleurae during sternotomy.|11
132396|NCT01757691|323581|P2|NOT COMPLETED|Overall Study||0
132397|NCT01757691|323582|P1|NOT COMPLETED|Overall Study||2
132398|NCT01757691|323581|P2|COMPLETED|Overall Study||0
132399|NCT01757691|323582|P1|COMPLETED|Overall Study||0
132400|NCT01757691|323581|P2|STARTED|Overall Study||0
132401|NCT01757691|323582|P1|STARTED|Overall Study||2
132402|NCT01757678|323595|P1|NOT COMPLETED|Overall Study||0
132403|NCT01757678|323595|P1|COMPLETED|Overall Study||276
132404|NCT01757678|323595|P1|STARTED|Overall Study||276
132405|NCT01757561|323611|P4|NOT COMPLETED|Overall Study||9
132406|NCT01757561|323612|P3|NOT COMPLETED|Overall Study||7
132407|NCT01757561|323613|P2|NOT COMPLETED|Overall Study||6
132408|NCT01757561|323614|P1|NOT COMPLETED|Overall Study||6
132409|NCT01757561|323611|P4|COMPLETED|Overall Study||25
132410|NCT01757561|323612|P3|COMPLETED|Overall Study||31
132411|NCT01757561|323613|P2|COMPLETED|Overall Study||28
132412|NCT01757561|323614|P1|COMPLETED|Overall Study||32
132413|NCT01757561|323611|P4|STARTED|Overall Study||34
132414|NCT01757561|323612|P3|STARTED|Overall Study||38
132415|NCT01757561|323613|P2|STARTED|Overall Study||34
132416|NCT01757561|323614|P1|STARTED|Overall Study||38
132417|NCT01757405|323630|P2|NOT COMPLETED|Overall Study||2
132418|NCT01757405|323631|P1|NOT COMPLETED|Overall Study||1
132419|NCT01757405|323630|P2|COMPLETED|Overall Study||18
132420|NCT01757405|323631|P1|COMPLETED|Overall Study||17
132421|NCT01757405|323630|P2|STARTED|Overall Study||20
132422|NCT01757405|323631|P1|STARTED|Overall Study||18
132423|NCT01757301|323649|P2|NOT COMPLETED|Overall Study||14
132424|NCT01757301|323650|P1|NOT COMPLETED|Overall Study||13
132425|NCT01757301|323649|P2|COMPLETED|Overall Study||133
132426|NCT01757301|323650|P1|COMPLETED|Overall Study||134
132427|NCT01757301|323649|P2|STARTED|Overall Study||147
132428|NCT01757301|323650|P1|STARTED|Overall Study||147
132429|NCT01757275|323666|P2|NOT COMPLETED|Overall Study||13
132430|NCT01757275|323667|P1|NOT COMPLETED|Overall Study||9
132431|NCT01757275|323666|P2|COMPLETED|Overall Study||98
132432|NCT01757275|323667|P1|COMPLETED|Overall Study||102
132433|NCT01757275|323666|P2|STARTED|Overall Study||111
132434|NCT01757275|323667|P1|STARTED|Overall Study||111
132435|NCT01757197|323689|P1|NOT COMPLETED|Overall Study||2
132436|NCT01757197|323689|P1|COMPLETED|Overall Study||0
132437|NCT01757197|323689|P1|STARTED|Overall Study||2
132438|NCT01757184|323698|P2|NOT COMPLETED|Open-Label Period||0
132439|NCT01757184|323699|P1|NOT COMPLETED|Open-Label Period||0
132440|NCT01757184|323698|P2|COMPLETED|Open-Label Period|This period is currently ongoing.|30
132441|NCT01757184|323699|P1|COMPLETED|Open-Label Period|This period is currently ongoing.|35
132442|NCT01757184|323698|P2|STARTED|Open-Label Period||30
132443|NCT01757184|323699|P1|STARTED|Open-Label Period||35
132444|NCT01757184|323698|P2|NOT COMPLETED|Double-Blind Period||0
132445|NCT01757184|323699|P1|NOT COMPLETED|Double-Blind Period||1
132446|NCT01757184|323698|P2|COMPLETED|Double-Blind Period||30
132447|NCT01757184|323699|P1|COMPLETED|Double-Blind Period||35
132448|NCT01757184|323698|P2|STARTED|Double-Blind Period||30
132449|NCT01757184|323699|P1|STARTED|Double-Blind Period||36
132450|NCT01757171|323723|P2|NOT COMPLETED|Overall Study||1
132451|NCT01757171|323724|P1|NOT COMPLETED|Overall Study||8
132452|NCT01757171|323723|P2|COMPLETED|Overall Study||23
132453|NCT01757171|323724|P1|COMPLETED|Overall Study||53
132454|NCT01757171|323723|P2|STARTED|Overall Study||24
132455|NCT01757171|323724|P1|STARTED|Overall Study||61
132456|NCT01756976|323738|P2|NOT COMPLETED|Overall Study||0
132457|NCT01756976|323739|P1|NOT COMPLETED|Overall Study||3
132458|NCT01756976|323738|P2|COMPLETED|Overall Study||8
132459|NCT01756976|323739|P1|COMPLETED|Overall Study||73
132460|NCT01756976|323738|P2|STARTED|Overall Study||8
132461|NCT01756976|323739|P1|STARTED|Overall Study||76
132462|NCT01756885|323747|P2|NOT COMPLETED|Overall Study||26
132463|NCT01756885|323748|P1|NOT COMPLETED|Overall Study||23
132464|NCT01756885|323747|P2|COMPLETED|Overall Study||79
132465|NCT01756885|323748|P1|COMPLETED|Overall Study||79
132466|NCT01756885|323747|P2|STARTED|Overall Study||105
132467|NCT01756885|323748|P1|STARTED|Overall Study||102
132468|NCT01756846|323760|P2|NOT COMPLETED|Overall Study||12
132469|NCT01756846|323761|P1|NOT COMPLETED|Overall Study||6
132470|NCT01756846|323760|P2|COMPLETED|Overall Study||1821
132471|NCT01756846|323761|P1|COMPLETED|Overall Study||1827
132472|NCT01756846|323760|P2|STARTED|Overall Study||1833
132473|NCT01756846|323761|P1|STARTED|Overall Study||1833
132474|NCT01756586|323771|P2|NOT COMPLETED|Overall Study||2
132475|NCT01756586|323772|P1|NOT COMPLETED|Overall Study||2
132476|NCT01756586|323771|P2|COMPLETED|Overall Study||0
132477|NCT01756586|323772|P1|COMPLETED|Overall Study||0
132478|NCT01756586|323771|P2|STARTED|Overall Study||2
132479|NCT01756586|323772|P1|STARTED|Overall Study||2
132480|NCT01756573|323781|P3|NOT COMPLETED|Overall Study||0
132481|NCT01756573|323782|P2|NOT COMPLETED|Overall Study||0
132482|NCT01756573|323783|P1|NOT COMPLETED|Overall Study||0
132483|NCT01756573|323781|P3|COMPLETED|Overall Study||1
132484|NCT01756573|323782|P2|COMPLETED|Overall Study||1
132485|NCT01756573|323783|P1|COMPLETED|Overall Study||3
132486|NCT01756573|323781|P3|STARTED|Overall Study||1
132487|NCT01756573|323782|P2|STARTED|Overall Study||1
132488|NCT01756573|323783|P1|STARTED|Overall Study||3
132489|NCT01756560|323793|P2|NOT COMPLETED|Overall Study||0
132490|NCT01756560|323794|P1|NOT COMPLETED|Overall Study||2
132491|NCT01756560|323793|P2|COMPLETED|Overall Study||0
132492|NCT01756560|323794|P1|COMPLETED|Overall Study||0
132493|NCT01756560|323793|P2|STARTED|Overall Study||0
132494|NCT01756560|323794|P1|STARTED|Overall Study||2
132495|NCT01756456|323806|P6|NOT COMPLETED|Follow Up Period Phase I/II||33
132496|NCT01756456|323807|P5|NOT COMPLETED|Follow Up Period Phase I/II||26
132497|NCT01756456|323808|P4|NOT COMPLETED|Follow Up Period Phase I/II||33
132498|NCT01756456|323809|P3|NOT COMPLETED|Follow Up Period Phase I/II||1
132499|NCT01756456|323810|P2|NOT COMPLETED|Follow Up Period Phase I/II||1
132500|NCT01756456|323811|P1|NOT COMPLETED|Follow Up Period Phase I/II||1
132501|NCT01756456|323806|P6|COMPLETED|Follow Up Period Phase I/II||15
132502|NCT01756456|323807|P5|COMPLETED|Follow Up Period Phase I/II||13
132503|NCT01756456|323808|P4|COMPLETED|Follow Up Period Phase I/II||12
132504|NCT01756456|323809|P3|COMPLETED|Follow Up Period Phase I/II||1
132505|NCT01756456|323810|P2|COMPLETED|Follow Up Period Phase I/II||5
132506|NCT01756456|323811|P1|COMPLETED|Follow Up Period Phase I/II||5
132507|NCT01756456|323806|P6|STARTED|Follow Up Period Phase I/II||48
132508|NCT01756456|323807|P5|STARTED|Follow Up Period Phase I/II||39
132509|NCT01756456|323808|P4|STARTED|Follow Up Period Phase I/II||45
132510|NCT01756456|323809|P3|STARTED|Follow Up Period Phase I/II||2
132511|NCT01756456|323810|P2|STARTED|Follow Up Period Phase I/II||6
132512|NCT01756456|323811|P1|STARTED|Follow Up Period Phase I/II||6
132513|NCT01756456|323806|P6|NOT COMPLETED|Treatment Period: Phase I/II||4
132514|NCT01756456|323807|P5|NOT COMPLETED|Treatment Period: Phase I/II||13
132515|NCT01756456|323808|P4|NOT COMPLETED|Treatment Period: Phase I/II||7
132516|NCT01756456|323809|P3|NOT COMPLETED|Treatment Period: Phase I/II||2
132517|NCT01756456|323810|P2|NOT COMPLETED|Treatment Period: Phase I/II||1
132518|NCT01756456|323811|P1|NOT COMPLETED|Treatment Period: Phase I/II||1
132519|NCT01756456|323806|P6|COMPLETED|Treatment Period: Phase I/II||48
132520|NCT01756456|323807|P5|COMPLETED|Treatment Period: Phase I/II||39
132521|NCT01756456|323808|P4|COMPLETED|Treatment Period: Phase I/II||45
132522|NCT01756456|323809|P3|COMPLETED|Treatment Period: Phase I/II||2
132523|NCT01756456|323810|P2|COMPLETED|Treatment Period: Phase I/II||6
132524|NCT01756456|323811|P1|COMPLETED|Treatment Period: Phase I/II||6
132525|NCT01756456|323806|P6|STARTED|Treatment Period: Phase I/II||52
132526|NCT01756456|323807|P5|STARTED|Treatment Period: Phase I/II||52
132527|NCT01756456|323808|P4|STARTED|Treatment Period: Phase I/II||52
132528|NCT01756456|323809|P3|STARTED|Treatment Period: Phase I/II||4
132529|NCT01756456|323810|P2|STARTED|Treatment Period: Phase I/II||7
132530|NCT01756456|323811|P1|STARTED|Treatment Period: Phase I/II||7
132531|NCT01756391|323909|P1|NOT COMPLETED|Overall Study||32
132532|NCT01756391|323909|P1|COMPLETED|Overall Study||319
132533|NCT01756391|323909|P1|STARTED|Overall Study||351
132534|NCT01756352|323913|P1|NOT COMPLETED|Overall Study||1
132535|NCT01756352|323913|P1|COMPLETED|Overall Study||12
132536|NCT01756352|323913|P1|STARTED|Overall Study||13
132537|NCT01756300|323918|P1|NOT COMPLETED|Overall Study||2
132538|NCT01756300|323918|P1|COMPLETED|Overall Study|Subjects with follow up available at 12 months|33
132539|NCT01756300|323918|P1|STARTED|Overall Study|Subjects underwent renal denervation treatment with the study catheter.|35
132540|NCT01756274|323940|P1|NOT COMPLETED|Overall Study||3
132541|NCT01756274|323940|P1|COMPLETED|Overall Study||159
132542|NCT01756274|323940|P1|STARTED|Overall Study||162
132543|NCT01756235|323947|P1|NOT COMPLETED|Overall Study||2
132544|NCT01756235|323947|P1|COMPLETED|Overall Study||460
132545|NCT01756235|323947|P1|STARTED|Overall Study||462
132546|NCT01756157|323968|P2|NOT COMPLETED|Second Intervention Period||0
132547|NCT01756157|323969|P1|NOT COMPLETED|Second Intervention Period||0
132548|NCT01756157|323968|P2|COMPLETED|Second Intervention Period||22
132549|NCT01756157|323969|P1|COMPLETED|Second Intervention Period||22
132550|NCT01756157|323968|P2|STARTED|Second Intervention Period||22
132551|NCT01756157|323969|P1|STARTED|Second Intervention Period||22
132552|NCT01756157|323968|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
132553|NCT01756157|323969|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
132554|NCT01756157|323968|P2|COMPLETED|Washout Period (at Least 7 Days)||22
132555|NCT01756157|323969|P1|COMPLETED|Washout Period (at Least 7 Days)||22
132556|NCT01756157|323968|P2|STARTED|Washout Period (at Least 7 Days)||22
132557|NCT01756157|323969|P1|STARTED|Washout Period (at Least 7 Days)||22
132558|NCT01756157|323968|P2|NOT COMPLETED|First Intervention Period||2
132559|NCT01756157|323969|P1|NOT COMPLETED|First Intervention Period||1
132560|NCT01756157|323968|P2|COMPLETED|First Intervention Period||22
132561|NCT01756157|323969|P1|COMPLETED|First Intervention Period||22
132562|NCT01756157|323968|P2|STARTED|First Intervention Period||24
132563|NCT01756157|323969|P1|STARTED|First Intervention Period||23
132564|NCT01756079|323983|P1|NOT COMPLETED|Treatment / Follow-up: Week 4 to Week 72||35
132565|NCT01756079|323983|P1|COMPLETED|Treatment / Follow-up: Week 4 to Week 72||23
132566|NCT01756079|323983|P1|Treated in Treatment Period|Treatment / Follow-up: Week 4 to Week 72||54
132567|NCT01756079|323983|P1|STARTED|Treatment / Follow-up: Week 4 to Week 72||58
132568|NCT01756079|323983|P1|NOT COMPLETED|Lead-in: Day 0 to Week 4||0
132569|NCT01756079|323983|P1|COMPLETED|Lead-in: Day 0 to Week 4||58
132570|NCT01756079|323983|P1|STARTED|Lead-in: Day 0 to Week 4||58
132571|NCT01756053|323989|P2|NOT COMPLETED|Period 2 (10 Days)||2
132572|NCT01756053|323990|P1|NOT COMPLETED|Period 2 (10 Days)||0
132573|NCT01756053|323989|P2|COMPLETED|Period 2 (10 Days)||6
132574|NCT01756053|323990|P1|COMPLETED|Period 2 (10 Days)||7
132575|NCT01756053|323989|P2|STARTED|Period 2 (10 Days)||8
132576|NCT01756053|323990|P1|STARTED|Period 2 (10 Days)||7
132577|NCT01756053|323989|P2|NOT COMPLETED|Washout Period (~21 Days)||0
132578|NCT01756053|323990|P1|NOT COMPLETED|Washout Period (~21 Days)||0
132579|NCT01756053|323989|P2|COMPLETED|Washout Period (~21 Days)||8
132580|NCT01756053|323990|P1|COMPLETED|Washout Period (~21 Days)||7
132581|NCT01756053|323989|P2|STARTED|Washout Period (~21 Days)||8
132582|NCT01756053|323990|P1|STARTED|Washout Period (~21 Days)||7
132583|NCT01756053|323989|P2|NOT COMPLETED|Period 1 (10 Days)||1
132584|NCT01756053|323990|P1|NOT COMPLETED|Period 1 (10 Days)||1
132585|NCT01756053|323989|P2|COMPLETED|Period 1 (10 Days)||8
132586|NCT01756053|323990|P1|COMPLETED|Period 1 (10 Days)||7
132587|NCT01756053|323989|P2|STARTED|Period 1 (10 Days)||9
132588|NCT01756053|323990|P1|STARTED|Period 1 (10 Days)||8
132589|NCT01755949|324016|P6|NOT COMPLETED|Overall Study||0
132590|NCT01755949|324017|P5|NOT COMPLETED|Overall Study||0
132591|NCT01755949|324018|P4|NOT COMPLETED|Overall Study||0
132592|NCT01755949|324019|P3|NOT COMPLETED|Overall Study||0
132593|NCT01755949|324020|P2|NOT COMPLETED|Overall Study||0
132594|NCT01755949|324021|P1|NOT COMPLETED|Overall Study||0
132595|NCT01755949|324016|P6|COMPLETED|Overall Study||3
132596|NCT01755949|324017|P5|COMPLETED|Overall Study||4
132597|NCT01755949|324018|P4|COMPLETED|Overall Study||5
132598|NCT01755949|324019|P3|COMPLETED|Overall Study||4
132599|NCT01755949|324020|P2|COMPLETED|Overall Study||5
132600|NCT01755949|324021|P1|COMPLETED|Overall Study||5
132601|NCT01755949|324016|P6|STARTED|Overall Study||3
132602|NCT01755949|324017|P5|STARTED|Overall Study||4
132603|NCT01755949|324018|P4|STARTED|Overall Study||5
132604|NCT01755949|324019|P3|STARTED|Overall Study||4
132605|NCT01755949|324020|P2|STARTED|Overall Study||5
132606|NCT01755949|324021|P1|STARTED|Overall Study||5
132607|NCT01755702|324047|P1|NOT COMPLETED|Period III||0
132608|NCT01755702|324047|P1|COMPLETED|Period III||58
132609|NCT01755702|324047|P1|Received Ibuprofen|Period III||18
132610|NCT01755702|324047|P1|Received Paracetamol/Caffeine|Period III||10
132611|NCT01755702|324047|P1|Received Placebo|Period III||13
132612|NCT01755702|324047|P1|Received Paracetamol|Period III||17
132613|NCT01755702|324047|P1|STARTED|Period III||58
132614|NCT01755702|324047|P1|NOT COMPLETED|Washout Period II||5
132615|NCT01755702|324047|P1|COMPLETED|Washout Period II||58
132616|NCT01755702|324047|P1|STARTED|Washout Period II||63
132617|NCT01755702|324047|P1|NOT COMPLETED|Period II||0
132618|NCT01755702|324047|P1|COMPLETED|Period II||63
132619|NCT01755702|324047|P1|Received Paracetamol|Period II||17
132620|NCT01755702|324047|P1|Received Paracetamol/Caffeine|Period II||20
132621|NCT01755702|324047|P1|Received Placebo|Period II||15
132622|NCT01755702|324047|P1|Received Ibuprofen|Period II||11
132623|NCT01755702|324047|P1|STARTED|Period II||63
132624|NCT01755702|324047|P1|NOT COMPLETED|Wash Out Period I||3
132625|NCT01755702|324047|P1|COMPLETED|Wash Out Period I||63
132626|NCT01755702|324047|P1|STARTED|Wash Out Period I||66
132627|NCT01755702|324047|P1|NOT COMPLETED|Period I||0
132628|NCT01755702|324047|P1|COMPLETED|Period I||66
132629|NCT01755702|324047|P1|Received Paracetamol/Caffeine|Period I||17
132630|NCT01755702|324047|P1|Received Ibuprofen|Period I||16
132631|NCT01755702|324047|P1|Received Placebo|Period I||17
132632|NCT01755702|324047|P1|Received Paracetamol|Period I||16
132633|NCT01755702|324047|P1|STARTED|Period I||66
132634|NCT01755689|324094|P5|NOT COMPLETED|Overall Study||6
132635|NCT01755689|324095|P4|NOT COMPLETED|Overall Study||6
132636|NCT01755689|324096|P3|NOT COMPLETED|Overall Study||6
132637|NCT01755689|324097|P2|NOT COMPLETED|Overall Study||5
132638|NCT01755689|324098|P1|NOT COMPLETED|Overall Study||3
132639|NCT01755689|324094|P5|COMPLETED|Overall Study||255
132640|NCT01755689|324095|P4|COMPLETED|Overall Study||254
132641|NCT01755689|324096|P3|COMPLETED|Overall Study||255
132642|NCT01755689|324097|P2|COMPLETED|Overall Study||254
132643|NCT01755689|324098|P1|COMPLETED|Overall Study||256
132644|NCT01755689|324094|P5|STARTED|Overall Study||261
132645|NCT01755689|324095|P4|STARTED|Overall Study||260
132646|NCT01755689|324096|P3|STARTED|Overall Study||261
132647|NCT01755689|324097|P2|STARTED|Overall Study||259
132648|NCT01755689|324098|P1|STARTED|Overall Study||259
132649|NCT01755637|324173|P2|NOT COMPLETED|Period 2||0
132650|NCT01755637|324174|P1|NOT COMPLETED|Period 2||0
132651|NCT01755637|324173|P2|COMPLETED|Period 2||27
132652|NCT01755637|324174|P1|COMPLETED|Period 2||28
132653|NCT01755637|324173|P2|STARTED|Period 2||27
132654|NCT01755637|324174|P1|STARTED|Period 2||28
132655|NCT01755637|324173|P2|NOT COMPLETED|Period 1||1
132656|NCT01755637|324174|P1|NOT COMPLETED|Period 1||0
132657|NCT01755637|324173|P2|COMPLETED|Period 1||27
132658|NCT01755637|324174|P1|COMPLETED|Period 1||28
132659|NCT01755637|324173|P2|STARTED|Period 1||28
132660|NCT01755637|324174|P1|STARTED|Period 1||28
132661|NCT01755546|324192|P1|NOT COMPLETED|Long Term Treatment||121
132662|NCT01755546|324192|P1|COMPLETED|Long Term Treatment||103
132663|NCT01755546|324192|P1|STARTED|Long Term Treatment||224
132664|NCT01755546|324192|P1|NOT COMPLETED|Titration Phase||70
132665|NCT01755546|324192|P1|COMPLETED|Titration Phase||224
132666|NCT01755546|324192|P1|STARTED|Titration Phase||294
132667|NCT01755546|324192|P1|NOT COMPLETED|Screened and Taper (Rollover and DeNovo)||10
132668|NCT01755546|324192|P1|COMPLETED|Screened and Taper (Rollover and DeNovo)||294
132669|NCT01755546|324192|P1|STARTED|Screened and Taper (Rollover and DeNovo)||304
132670|NCT01755455|324196|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
132671|NCT01755455|324197|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
132672|NCT01755455|324196|P2|COMPLETED|Second Intervention (6 Weeks)||11
132673|NCT01755455|324197|P1|COMPLETED|Second Intervention (6 Weeks)||11
132674|NCT01755455|324196|P2|STARTED|Second Intervention (6 Weeks)||11
132675|NCT01755455|324197|P1|STARTED|Second Intervention (6 Weeks)||11
132676|NCT01755455|324196|P2|NOT COMPLETED|Washout (4 Weeks)||0
132677|NCT01755455|324197|P1|NOT COMPLETED|Washout (4 Weeks)||0
132678|NCT01755455|324196|P2|COMPLETED|Washout (4 Weeks)||11
132679|NCT01755455|324197|P1|COMPLETED|Washout (4 Weeks)||11
132680|NCT01755455|324196|P2|STARTED|Washout (4 Weeks)||11
132681|NCT01755455|324197|P1|STARTED|Washout (4 Weeks)||11
132682|NCT01755455|324196|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
132683|NCT01755455|324197|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
132684|NCT01755455|324196|P2|COMPLETED|First Intervention (6 Weeks)||11
132685|NCT01755455|324197|P1|COMPLETED|First Intervention (6 Weeks)||11
132686|NCT01755455|324196|P2|STARTED|First Intervention (6 Weeks)||11
132687|NCT01755455|324197|P1|STARTED|First Intervention (6 Weeks)||11
132688|NCT01755416|324209|P2|NOT COMPLETED|Second Intervention (Upto 2 Days)||0
132689|NCT01755416|324210|P1|NOT COMPLETED|Second Intervention (Upto 2 Days)||0
132690|NCT01755416|324209|P2|COMPLETED|Second Intervention (Upto 2 Days)||7
132691|NCT01755416|324210|P1|COMPLETED|Second Intervention (Upto 2 Days)||8
132692|NCT01755416|324209|P2|STARTED|Second Intervention (Upto 2 Days)||7
132693|NCT01755416|324210|P1|STARTED|Second Intervention (Upto 2 Days)||8
132694|NCT01755416|324209|P2|NOT COMPLETED|First Intervention ( Upto 2 Days)||2
132695|NCT01755416|324210|P1|NOT COMPLETED|First Intervention ( Upto 2 Days)||1
132696|NCT01755416|324209|P2|COMPLETED|First Intervention ( Upto 2 Days)||7
132697|NCT01755416|324210|P1|COMPLETED|First Intervention ( Upto 2 Days)||8
132698|NCT01755416|324209|P2|STARTED|First Intervention ( Upto 2 Days)||9
132699|NCT01755416|324210|P1|STARTED|First Intervention ( Upto 2 Days)||9
132700|NCT01755234|324218|P2|NOT COMPLETED|Overall Study||8
132701|NCT01755234|324219|P1|NOT COMPLETED|Overall Study||15
132702|NCT01755234|324218|P2|COMPLETED|Overall Study||37
132703|NCT01755234|324219|P1|COMPLETED|Overall Study||30
132704|NCT01755234|324218|P2|STARTED|Overall Study||45
132705|NCT01755234|324219|P1|STARTED|Overall Study||45
132706|NCT01755169|324235|P4|NOT COMPLETED|Overall Study||0
132707|NCT01755169|324236|P3|NOT COMPLETED|Overall Study||0
132708|NCT01755169|324237|P2|NOT COMPLETED|Overall Study||0
132709|NCT01755169|324238|P1|NOT COMPLETED|Overall Study||0
132710|NCT01755169|324235|P4|COMPLETED|Overall Study||1
132711|NCT01755169|324236|P3|COMPLETED|Overall Study||0
132712|NCT01755169|324237|P2|COMPLETED|Overall Study||1
132713|NCT01755169|324238|P1|COMPLETED|Overall Study||2
132714|NCT01755169|324235|P4|STARTED|Overall Study||1
132715|NCT01755169|324236|P3|STARTED|Overall Study||0
132716|NCT01755169|324237|P2|STARTED|Overall Study||1
132717|NCT01755169|324238|P1|STARTED|Overall Study||2
132718|NCT01755156|324250|P2|NOT COMPLETED|Phase B (Weeks 24-104)||36
132719|NCT01755156|324251|P1|NOT COMPLETED|Phase B (Weeks 24-104)||39
132720|NCT01755156|324250|P2|COMPLETED|Phase B (Weeks 24-104)||141
132721|NCT01755156|324251|P1|COMPLETED|Phase B (Weeks 24-104)||144
132722|NCT01755156|324250|P2|STARTED|Phase B (Weeks 24-104)||177
132723|NCT01755156|324251|P1|STARTED|Phase B (Weeks 24-104)|1 participant who completed Phase A did not continue to Phase B.|183
132724|NCT01755156|324250|P2|NOT COMPLETED|Phase A (Weeks 0-24)||24
132725|NCT01755156|324251|P1|NOT COMPLETED|Phase A (Weeks 0-24)||17
132726|NCT01755156|324250|P2|COMPLETED|Phase A (Weeks 0-24)||177
132727|NCT01755156|324251|P1|COMPLETED|Phase A (Weeks 0-24)||184
132728|NCT01755156|324250|P2|STARTED|Phase A (Weeks 0-24)||201
132729|NCT01755156|324251|P1|STARTED|Phase A (Weeks 0-24)||201
132730|NCT01755143|324297|P2|NOT COMPLETED|Overall Study||3
132731|NCT01755143|324298|P1|NOT COMPLETED|Overall Study||11
132732|NCT01755143|324297|P2|COMPLETED|Overall Study||86
132733|NCT01755143|324298|P1|COMPLETED|Overall Study||166
132734|NCT01755143|324297|P2|STARTED|Overall Study||89
132735|NCT01755143|324298|P1|STARTED|Overall Study||177
132736|NCT01755091|324315|P3|NOT COMPLETED|Overall Study||7
132737|NCT01755091|324316|P2|NOT COMPLETED|Overall Study||3
132738|NCT01755091|324317|P1|NOT COMPLETED|Overall Study||9
132739|NCT01755091|324315|P3|COMPLETED|Overall Study||20
132740|NCT01755091|324316|P2|COMPLETED|Overall Study||19
132741|NCT01755091|324317|P1|COMPLETED|Overall Study||17
132742|NCT01755091|324315|P3|STARTED|Overall Study||27
132743|NCT01755091|324316|P2|STARTED|Overall Study||22
132744|NCT01755091|324317|P1|STARTED|Overall Study||26
132745|NCT01755026|324342|P2|NOT COMPLETED|Overall Study||1
132746|NCT01755026|324343|P1|NOT COMPLETED|Overall Study||2
132747|NCT01755026|324342|P2|COMPLETED|Overall Study||11
132748|NCT01755026|324343|P1|COMPLETED|Overall Study||9
132749|NCT01755026|324342|P2|STARTED|Overall Study||12
132750|NCT01755026|324343|P1|STARTED|Overall Study||11
132751|NCT01754987|324351|P2|NOT COMPLETED|Overall Study||0
132752|NCT01754987|324352|P1|NOT COMPLETED|Overall Study||0
132753|NCT01754987|324351|P2|COMPLETED|Overall Study||0
132754|NCT01754987|324352|P1|COMPLETED|Overall Study||5
132755|NCT01754987|324351|P2|STARTED|Overall Study||0
132756|NCT01754987|324352|P1|STARTED|Overall Study||5
132757|NCT01754922|324366|P2|NOT COMPLETED|Overall Study||1
132758|NCT01754922|324367|P1|NOT COMPLETED|Overall Study||0
132759|NCT01754922|324366|P2|COMPLETED|Overall Study||17
132760|NCT01754922|324367|P1|COMPLETED|Overall Study||32
132761|NCT01754922|324366|P2|STARTED|Overall Study||18
132762|NCT01754922|324367|P1|STARTED|Overall Study||32
132763|NCT01754909|324379|P2|NOT COMPLETED|Overall Study||0
132764|NCT01754909|324380|P1|NOT COMPLETED|Overall Study||0
132765|NCT01754909|324379|P2|COMPLETED|Overall Study||23
132766|NCT01754909|324380|P1|COMPLETED|Overall Study||20
132767|NCT01754909|324379|P2|STARTED|Overall Study||23
132768|NCT01754909|324380|P1|STARTED|Overall Study||20
132769|NCT01754766|324393|P3|NOT COMPLETED|Overall Study||0
132770|NCT01754766|324394|P2|NOT COMPLETED|Overall Study||1
132771|NCT01754766|324395|P1|NOT COMPLETED|Overall Study||1
132772|NCT01754766|324393|P3|COMPLETED|Overall Study||30
132773|NCT01754766|324394|P2|COMPLETED|Overall Study||28
132774|NCT01754766|324395|P1|COMPLETED|Overall Study||30
132775|NCT01754766|324393|P3|STARTED|Overall Study||30
132776|NCT01754766|324394|P2|STARTED|Overall Study||29
132777|NCT01754766|324395|P1|STARTED|Overall Study||31
132778|NCT01754727|324409|P1|NOT COMPLETED|Overall Study||2
132779|NCT01754727|324409|P1|COMPLETED|Overall Study||450
132780|NCT01754727|324409|P1|STARTED|Overall Study||452
132781|NCT01754714|324427|P4|NOT COMPLETED|Overall Study||1
132782|NCT01754714|324428|P3|NOT COMPLETED|Overall Study||2
132783|NCT01754714|324429|P2|NOT COMPLETED|Overall Study||1
132784|NCT01754714|324430|P1|NOT COMPLETED|Overall Study||0
132785|NCT01754714|324427|P4|COMPLETED|Overall Study||27
132786|NCT01754714|324428|P3|COMPLETED|Overall Study||24
132787|NCT01754714|324429|P2|COMPLETED|Overall Study||26
132788|NCT01754714|324430|P1|COMPLETED|Overall Study||27
132789|NCT01754714|324427|P4|STARTED|Overall Study||28
132790|NCT01754714|324428|P3|STARTED|Overall Study||26
132791|NCT01754714|324429|P2|STARTED|Overall Study||27
132792|NCT01754714|324430|P1|STARTED|Overall Study||27
132793|NCT01754688|324520|P1|NOT COMPLETED|Overall Study||0
132794|NCT01754688|324520|P1|COMPLETED|Overall Study||624
132795|NCT01754688|324520|P1|STARTED|Overall Study||624
132796|NCT01754623|324525|P1|NOT COMPLETED|Overall Study||0
132797|NCT01754623|324525|P1|COMPLETED|Overall Study||9
132798|NCT01754623|324525|P1|STARTED|Overall Study||9
132799|NCT01754519|324532|P1|NOT COMPLETED|Overall Study||0
132800|NCT01754519|324532|P1|COMPLETED|Overall Study||1
132801|NCT01754519|324532|P1|STARTED|Overall Study||1
132802|NCT01754493|324541|P1|NOT COMPLETED|Overall Study||7
132803|NCT01754493|324541|P1|COMPLETED|Overall Study||10
132804|NCT01754493|324541|P1|STARTED|Overall Study||17
132805|NCT01754480|324551|P2|NOT COMPLETED|Primary Part II||11
132806|NCT01754480|324552|P1|NOT COMPLETED|Primary Part II||15
132807|NCT01754480|324551|P2|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|102
132808|NCT01754480|324552|P1|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|96
132809|NCT01754480|324551|P2|Completed Study up to Week 6|Primary Part II||108
132810|NCT01754480|324552|P1|Completed Study up to Week 6|Primary Part II||100
132811|NCT01754480|324551|P2|STARTED|Primary Part II||113
132812|NCT01754480|324552|P1|STARTED|Primary Part II||111
132813|NCT01754480|324551|P2|NOT COMPLETED|Part I + Part II (Overall Study)||23
132814|NCT01754480|324552|P1|NOT COMPLETED|Part I + Part II (Overall Study)||25
132815|NCT01754480|324551|P2|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 3 pediatric subjects)|139
132816|NCT01754480|324552|P1|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 2 pediatric subjects)|138
132817|NCT01754480|324551|P2|Completed Study up to Week 6|Part I + Part II (Overall Study)||153
132818|NCT01754480|324552|P1|Completed Study up to Week 6|Part I + Part II (Overall Study)||147
132819|NCT01754480|324551|P2|STARTED|Part I + Part II (Overall Study)||162
132820|NCT01754480|324552|P1|STARTED|Part I + Part II (Overall Study)||163
132821|NCT01754467|324566|P1|NOT COMPLETED|Overall Study||1
132822|NCT01754467|324566|P1|COMPLETED|Overall Study||8
132823|NCT01754467|324566|P1|STARTED|Overall Study||9
132824|NCT01754402|324576|P3|NOT COMPLETED|Overall Study||4
132825|NCT01754402|324577|P2|NOT COMPLETED|Overall Study||2
132826|NCT01754402|324578|P1|NOT COMPLETED|Overall Study||2
132827|NCT01754402|324576|P3|COMPLETED|Overall Study||26
132828|NCT01754402|324577|P2|COMPLETED|Overall Study||0
132829|NCT01754402|324578|P1|COMPLETED|Overall Study||4
132830|NCT01754402|324576|P3|STARTED|Overall Study||30
132831|NCT01754402|324577|P2|STARTED|Overall Study||2
132832|NCT01754402|324578|P1|STARTED|Overall Study||6
132833|NCT01754389|324590|P3|NOT COMPLETED|Overall Study||0
132834|NCT01754389|324591|P2|NOT COMPLETED|Overall Study||0
132835|NCT01754389|324592|P1|NOT COMPLETED|Overall Study||0
132836|NCT01754389|324590|P3|COMPLETED|Overall Study||47
132837|NCT01754389|324591|P2|COMPLETED|Overall Study||45
132838|NCT01754389|324592|P1|COMPLETED|Overall Study||46
132839|NCT01754389|324590|P3|STARTED|Overall Study||47
132840|NCT01754389|324591|P2|STARTED|Overall Study||45
132841|NCT01754389|324592|P1|STARTED|Overall Study||46
132842|NCT01754376|324612|P1|NOT COMPLETED|Overall Study||3
132843|NCT01754376|324612|P1|COMPLETED|Overall Study||3
132844|NCT01754376|324612|P1|Completed 2-week Lead in of Vemurafenib|Overall Study||6
132845|NCT01754376|324612|P1|STARTED|Overall Study||6
132846|NCT01754259|324623|P2|NOT COMPLETED|Overall Study||6
132847|NCT01754259|324624|P1|NOT COMPLETED|Overall Study||5
132848|NCT01754259|324623|P2|COMPLETED|Overall Study||18
132849|NCT01754259|324624|P1|COMPLETED|Overall Study||18
132850|NCT01754259|324623|P2|STARTED|Overall Study||24
132851|NCT01754259|324624|P1|STARTED|Overall Study||23
132852|NCT01754194|324634|P2|NOT COMPLETED|Overall Study||27
132853|NCT01754194|324635|P1|NOT COMPLETED|Overall Study||52
132854|NCT01754194|324634|P2|COMPLETED|Overall Study||97
132855|NCT01754194|324635|P1|COMPLETED|Overall Study||117
132856|NCT01754194|324634|P2|STARTED|Overall Study||124
132857|NCT01754194|324635|P1|STARTED|Overall Study||169
132858|NCT01754129|324655|P1|NOT COMPLETED|Overall Study||33
132859|NCT01754129|324655|P1|COMPLETED|Overall Study||115
132860|NCT01754129|324655|P1|Visit 3 (Year 2)|Overall Study||115
132861|NCT01754129|324655|P1|Visit 2 (Year 1)|Overall Study||129
132862|NCT01754129|324655|P1|Visit 1 (Enrollment Day)|Overall Study||145
132863|NCT01754129|324655|P1|STARTED|Overall Study||148
132864|NCT01753999|324678|P2|NOT COMPLETED|Period 2 -Cross to Alternate Arm||26
132865|NCT01753999|324679|P1|NOT COMPLETED|Period 2 -Cross to Alternate Arm||17
132866|NCT01753999|324678|P2|COMPLETED|Period 2 -Cross to Alternate Arm||86
132867|NCT01753999|324679|P1|COMPLETED|Period 2 -Cross to Alternate Arm||99
132868|NCT01753999|324678|P2|STARTED|Period 2 -Cross to Alternate Arm||112
132869|NCT01753999|324679|P1|STARTED|Period 2 -Cross to Alternate Arm||116
132870|NCT01753999|324678|P2|NOT COMPLETED|Period 1 - Initial Assignment||50
132871|NCT01753999|324679|P1|NOT COMPLETED|Period 1 - Initial Assignment||39
132872|NCT01753999|324678|P2|COMPLETED|Period 1 - Initial Assignment||112
132873|NCT01753999|324679|P1|COMPLETED|Period 1 - Initial Assignment||116
132874|NCT01753999|324678|P2|STARTED|Period 1 - Initial Assignment||162
132875|NCT01753999|324679|P1|STARTED|Period 1 - Initial Assignment||155
132876|NCT01753856|324689|P2|NOT COMPLETED|Overall Study||2
132877|NCT01753856|324690|P1|NOT COMPLETED|Overall Study||3
132878|NCT01753856|324689|P2|COMPLETED|Overall Study||34
132879|NCT01753856|324690|P1|COMPLETED|Overall Study||30
132880|NCT01753856|324689|P2|Completed 3-Month Bone Biopsy|Overall Study||35
132881|NCT01753856|324690|P1|Completed 3-Month Bone Biopsy|Overall Study||31
132882|NCT01753856|324689|P2|Received at Least 1 Dose of Study Drug|Overall Study||36
132883|NCT01753856|324690|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
132884|NCT01753856|324689|P2|STARTED|Overall Study||36
132885|NCT01753856|324690|P1|STARTED|Overall Study||33
132886|NCT01753713|324742|P2|NOT COMPLETED|Overall Study||0
132887|NCT01753713|324743|P1|NOT COMPLETED|Overall Study||0
132888|NCT01753713|324742|P2|COMPLETED|Overall Study||19
132889|NCT01753713|324743|P1|COMPLETED|Overall Study||14
132890|NCT01753713|324742|P2|STARTED|Overall Study||19
132891|NCT01753713|324743|P1|STARTED|Overall Study||14
132892|NCT01753570|324762|P3|NOT COMPLETED|Overall Study||1
132893|NCT01753570|324763|P2|NOT COMPLETED|Overall Study||5
132894|NCT01753570|324764|P1|NOT COMPLETED|Overall Study||2
132895|NCT01753570|324762|P3|COMPLETED|Overall Study||13
132896|NCT01753570|324763|P2|COMPLETED|Overall Study||25
132897|NCT01753570|324764|P1|COMPLETED|Overall Study||28
132898|NCT01753570|324762|P3|STARTED|Overall Study||14
132899|NCT01753570|324763|P2|STARTED|Overall Study||30
132900|NCT01753570|324764|P1|STARTED|Overall Study||30
132901|NCT01753557|324788|P2|NOT COMPLETED|Overall Study||0
132902|NCT01753557|324789|P1|NOT COMPLETED|Overall Study||0
132903|NCT01753557|324788|P2|COMPLETED|Overall Study||19
132904|NCT01753557|324789|P1|COMPLETED|Overall Study||35
132905|NCT01753557|324788|P2|STARTED|Overall Study||19
132906|NCT01753557|324789|P1|STARTED|Overall Study||35
132907|NCT01753518|324807|P2|NOT COMPLETED|Postpartum Follow-up||15
132908|NCT01753518|324808|P1|NOT COMPLETED|Postpartum Follow-up||22
132909|NCT01753518|324807|P2|COMPLETED|Postpartum Follow-up||88
132910|NCT01753518|324808|P1|COMPLETED|Postpartum Follow-up||81
132911|NCT01753518|324807|P2|STARTED|Postpartum Follow-up||103
132912|NCT01753518|324808|P1|STARTED|Postpartum Follow-up||103
132913|NCT01753518|324807|P2|NOT COMPLETED|Intention-to-Treat Analysis||7
132914|NCT01753518|324808|P1|NOT COMPLETED|Intention-to-Treat Analysis||7
132915|NCT01753518|324807|P2|COMPLETED|Intention-to-Treat Analysis||103
132916|NCT01753518|324808|P1|COMPLETED|Intention-to-Treat Analysis||103
132917|NCT01753518|324807|P2|STARTED|Intention-to-Treat Analysis||110
132918|NCT01753518|324808|P1|STARTED|Intention-to-Treat Analysis||110
132919|NCT01753336|324830|P1|NOT COMPLETED|Overall Study||20
132920|NCT01753336|324830|P1|COMPLETED|Overall Study||92
132921|NCT01753336|324830|P1|Cycle 3|Overall Study||93
132922|NCT01753336|324830|P1|Cycle 2|Overall Study||98
132923|NCT01753336|324830|P1|Cycle 1|Overall Study||112
132924|NCT01753336|324830|P1|STARTED|Overall Study||112
132925|NCT01753323|324842|P3|NOT COMPLETED|Overall Study||9
132926|NCT01753323|324843|P2|NOT COMPLETED|Overall Study||0
132927|NCT01753323|324844|P1|NOT COMPLETED|Overall Study||1
132928|NCT01753323|324842|P3|COMPLETED|Overall Study||13
132929|NCT01753323|324843|P2|COMPLETED|Overall Study||10
132930|NCT01753323|324844|P1|COMPLETED|Overall Study||10
132931|NCT01753323|324842|P3|Intent-to-treat Analysis Set|Overall Study||22
132932|NCT01753323|324843|P2|Intent-to-treat Analysis Set|Overall Study||10
132933|NCT01753323|324844|P1|Intent-to-treat Analysis Set|Overall Study||11
132934|NCT01753323|324842|P3|Safety Set|Overall Study||22
132935|NCT01753323|324843|P2|Safety Set|Overall Study||10
132936|NCT01753323|324844|P1|Safety Set|Overall Study||11
132937|NCT01753323|324842|P3|Pharmacokinetic(PK) Set|Overall Study||21
132938|NCT01753323|324843|P2|Pharmacokinetic(PK) Set|Overall Study||10
132939|NCT01753323|324844|P1|Pharmacokinetic(PK) Set|Overall Study||10
132940|NCT01753323|324842|P3|Pharmacodynamic (PD) Set|Overall Study||21
132941|NCT01753323|324843|P2|Pharmacodynamic (PD) Set|Overall Study||10
132942|NCT01753323|324844|P1|Pharmacodynamic (PD) Set|Overall Study||10
132943|NCT01753323|324842|P3|STARTED|Overall Study||22
132944|NCT01753323|324843|P2|STARTED|Overall Study||10
132945|NCT01753323|324844|P1|STARTED|Overall Study||11
132946|NCT01753310|324882|P2|NOT COMPLETED|Overall Study||24
132947|NCT01753310|324883|P1|NOT COMPLETED|Overall Study||32
132948|NCT01753310|324882|P2|COMPLETED|Overall Study||21
132949|NCT01753310|324883|P1|COMPLETED|Overall Study||57
132950|NCT01753310|324882|P2|STARTED|Overall Study||45
132951|NCT01753310|324883|P1|STARTED|Overall Study||89
132952|NCT01753193|324903|P1|NOT COMPLETED|Overall Study||46
132953|NCT01753193|324903|P1|COMPLETED|Overall Study||172
132954|NCT01753193|324903|P1|STARTED|Overall Study||218
132955|NCT01753115|324918|P3|NOT COMPLETED|Overall Study||14
132956|NCT01753115|324919|P2|NOT COMPLETED|Overall Study||15
132957|NCT01753115|324920|P1|NOT COMPLETED|Overall Study||12
132958|NCT01753115|324918|P3|COMPLETED|Overall Study||56
132959|NCT01753115|324919|P2|COMPLETED|Overall Study||25
132960|NCT01753115|324920|P1|COMPLETED|Overall Study||32
132961|NCT01753115|324918|P3|Treated|Overall Study||67
132962|NCT01753115|324919|P2|Treated|Overall Study||39
132963|NCT01753115|324920|P1|Treated|Overall Study||38
132964|NCT01753115|324918|P3|STARTED|Overall Study||70
132965|NCT01753115|324919|P2|STARTED|Overall Study||40
132966|NCT01753115|324920|P1|STARTED|Overall Study||44
132967|NCT01753076|324930|P2|NOT COMPLETED|Overall Study||46
132968|NCT01753076|324931|P1|NOT COMPLETED|Overall Study||41
132969|NCT01753076|324930|P2|COMPLETED|Overall Study||106
132970|NCT01753076|324931|P1|COMPLETED|Overall Study||110
132971|NCT01753076|324930|P2|STARTED|Overall Study||152
132972|NCT01753076|324931|P1|STARTED|Overall Study||151
132973|NCT01752985|324958|P3|NOT COMPLETED|Follow-up Period||0
132974|NCT01752985|324959|P2|NOT COMPLETED|Follow-up Period||0
132975|NCT01752985|324960|P1|NOT COMPLETED|Follow-up Period||0
132976|NCT01752985|324958|P3|COMPLETED|Follow-up Period||26
132977|NCT01752985|324959|P2|COMPLETED|Follow-up Period||27
132978|NCT01752985|324960|P1|COMPLETED|Follow-up Period||28
132979|NCT01752985|324958|P3|STARTED|Follow-up Period|Includes 24 participants in this period and 2 participants re-joined for follow-up|26
132980|NCT01752985|324959|P2|STARTED|Follow-up Period||27
132981|NCT01752985|324960|P1|STARTED|Follow-up Period|Includes 25 participants in this period and 3 participants re-joined for follow-up|28
132982|NCT01752985|324958|P3|NOT COMPLETED|Treatment Period||5
132983|NCT01752985|324959|P2|NOT COMPLETED|Treatment Period||3
132984|NCT01752985|324960|P1|NOT COMPLETED|Treatment Period||4
132985|NCT01752985|324958|P3|COMPLETED|Treatment Period||24
132986|NCT01752985|324959|P2|COMPLETED|Treatment Period||27
132987|NCT01752985|324960|P1|COMPLETED|Treatment Period||25
132988|NCT01752985|324958|P3|STARTED|Treatment Period||29
132989|NCT01752985|324959|P2|STARTED|Treatment Period||30
132990|NCT01752985|324960|P1|STARTED|Treatment Period||29
132991|NCT01752933|324988|P2|NOT COMPLETED|Overall Study and Follow-up||46
132992|NCT01752933|324989|P1|NOT COMPLETED|Overall Study and Follow-up||4
132993|NCT01752933|324988|P2|COMPLETED|Overall Study and Follow-up|Completion not applicable for this survival study|0
132994|NCT01752933|324989|P1|COMPLETED|Overall Study and Follow-up|Completion not applicable for this survival study|0
132995|NCT01752933|324988|P2|STARTED|Overall Study and Follow-up|Includes all patients who received any treatment|46
132996|NCT01752933|324989|P1|STARTED|Overall Study and Follow-up|Includes all patients who received any treatment|4
132997|NCT01752933|324988|P2|NOT COMPLETED|Treatment||46
132998|NCT01752933|324989|P1|NOT COMPLETED|Treatment||4
132999|NCT01752933|324988|P2|COMPLETED|Treatment|Completion not applicable for this survival study|0
133000|NCT01752933|324989|P1|COMPLETED|Treatment|Completion not applicable for this survival study|0
133001|NCT01752933|324988|P2|STARTED|Treatment|Includes all patients who received any treatment|46
133002|NCT01752933|324989|P1|STARTED|Treatment|Includes all patients who received any treatment|4
133003|NCT01752907|325007|P2|NOT COMPLETED|Overall Study||20
133004|NCT01752907|325008|P1|NOT COMPLETED|Overall Study||12
133005|NCT01752907|325007|P2|COMPLETED|Overall Study||133
133006|NCT01752907|325008|P1|COMPLETED|Overall Study||139
133007|NCT01752907|325007|P2|Received Pegfilgrastim|Overall Study||151
133008|NCT01752907|325008|P1|Received Pegfilgrastim|Overall Study||149
133009|NCT01752907|325007|P2|STARTED|Overall Study||153
133010|NCT01752907|325008|P1|STARTED|Overall Study||151
133011|NCT01752855|325028|P2|NOT COMPLETED|Overall Study||4
133012|NCT01752855|325029|P1|NOT COMPLETED|Overall Study||1
133013|NCT01752855|325028|P2|COMPLETED|Overall Study||40
133014|NCT01752855|325029|P1|COMPLETED|Overall Study||43
133015|NCT01752855|325028|P2|STARTED|Overall Study||44
133016|NCT01752855|325029|P1|STARTED|Overall Study||44
133017|NCT01752842|325045|P2|NOT COMPLETED|Overall Study||2
133018|NCT01752842|325046|P1|NOT COMPLETED|Overall Study||3
133019|NCT01752842|325045|P2|COMPLETED|Overall Study||34
133020|NCT01752842|325046|P1|COMPLETED|Overall Study||31
133021|NCT01752842|325045|P2|STARTED|Overall Study||36
133022|NCT01752842|325046|P1|STARTED|Overall Study||34
133023|NCT01752712|325058|P2|NOT COMPLETED|Overall Study||10
133024|NCT01752712|325059|P1|NOT COMPLETED|Overall Study||9
133025|NCT01752712|325058|P2|COMPLETED|Overall Study||21
133026|NCT01752712|325059|P1|COMPLETED|Overall Study||22
133027|NCT01752712|325058|P2|STARTED|Overall Study||31
133028|NCT01752712|325059|P1|STARTED|Overall Study||31
133029|NCT01752400|325075|P1|NOT COMPLETED|Overall Study||0
133030|NCT01752400|325075|P1|COMPLETED|Overall Study||6
133031|NCT01752400|325075|P1|STARTED|Overall Study||6
133032|NCT01752023|325088|P2|NOT COMPLETED|Overall Study||1
133033|NCT01752023|325089|P1|NOT COMPLETED|Overall Study||2
133034|NCT01752023|325088|P2|COMPLETED|Overall Study||0
133035|NCT01752023|325089|P1|COMPLETED|Overall Study||0
133036|NCT01752023|325088|P2|STARTED|Overall Study||1
133037|NCT01752023|325089|P1|STARTED|Overall Study||2
133038|NCT01751971|325107|P2|NOT COMPLETED|Overall Study||1
133039|NCT01751971|325108|P1|NOT COMPLETED|Overall Study||2
133040|NCT01751971|325107|P2|COMPLETED|Overall Study||24
133041|NCT01751971|325108|P1|COMPLETED|Overall Study||20
133042|NCT01751971|325107|P2|STARTED|Overall Study||25
133043|NCT01751971|325108|P1|STARTED|Overall Study||22
133044|NCT01751906|325125|P2|NOT COMPLETED|Overall Study||47
133045|NCT01751906|325126|P1|NOT COMPLETED|Overall Study||84
133046|NCT01751906|325125|P2|COMPLETED|Overall Study||639
133047|NCT01751906|325126|P1|COMPLETED|Overall Study||1238
133048|NCT01751906|325125|P2|STARTED|Overall Study||686
133049|NCT01751906|325126|P1|STARTED|Overall Study||1322
133050|NCT01751867|325330|P2|NOT COMPLETED|Overall Study||99
133051|NCT01751867|325331|P1|NOT COMPLETED|Overall Study||36
133052|NCT01751867|325330|P2|COMPLETED|Overall Study||0
133053|NCT01751867|325331|P1|COMPLETED|Overall Study||0
133054|NCT01751867|325330|P2|Treated|Overall Study||98
133055|NCT01751867|325331|P1|Treated|Overall Study||34
133056|NCT01751867|325330|P2|STARTED|Overall Study||99
133057|NCT01751867|325331|P1|STARTED|Overall Study||36
133058|NCT01751802|325351|P2|NOT COMPLETED|Overall Study||2
133059|NCT01751802|325352|P1|NOT COMPLETED|Overall Study||4
133060|NCT01751802|325351|P2|COMPLETED|Overall Study||2
133061|NCT01751802|325352|P1|COMPLETED|Overall Study||1
133062|NCT01751802|325351|P2|Completed Period 3|Overall Study||1
133063|NCT01751802|325352|P1|Completed Period 3|Overall Study||2
133064|NCT01751802|325351|P2|Completed Period 2|Overall Study||1
133065|NCT01751802|325352|P1|Completed Period 2|Overall Study||2
133066|NCT01751802|325351|P2|Completed Period 1|Overall Study||4
133067|NCT01751802|325352|P1|Completed Period 1|Overall Study||2
133068|NCT01751802|325351|P2|STARTED|Overall Study||4
133069|NCT01751802|325352|P1|STARTED|Overall Study||5
133070|NCT01751724|325366|P2|NOT COMPLETED|Overall Study||2
133071|NCT01751724|325367|P1|NOT COMPLETED|Overall Study||1
133072|NCT01751724|325366|P2|COMPLETED|Overall Study||42
133073|NCT01751724|325367|P1|COMPLETED|Overall Study||41
133074|NCT01751724|325366|P2|STARTED|Overall Study||44
133075|NCT01751724|325367|P1|STARTED|Overall Study||42
133076|NCT01751646|325395|P2|NOT COMPLETED|Overall Study||18
133077|NCT01751646|325396|P1|NOT COMPLETED|Overall Study||11
133078|NCT01751646|325395|P2|COMPLETED|Overall Study||87
133079|NCT01751646|325396|P1|COMPLETED|Overall Study||98
133080|NCT01751646|325395|P2|STARTED|Overall Study||105
133081|NCT01751646|325396|P1|STARTED|Overall Study||109
133082|NCT01751412|325544|P1|NOT COMPLETED|Overall Study||1
133083|NCT01751412|325544|P1|COMPLETED|Overall Study||11
133084|NCT01751412|325544|P1|STARTED|Overall Study||12
133085|NCT01751399|325558|P4|NOT COMPLETED|Overall Study||0
133086|NCT01751399|325559|P3|NOT COMPLETED|Overall Study||0
133087|NCT01751399|325560|P2|NOT COMPLETED|Overall Study||0
133088|NCT01751399|325561|P1|NOT COMPLETED|Overall Study||0
133089|NCT01751399|325558|P4|COMPLETED|Overall Study||7
133090|NCT01751399|325559|P3|COMPLETED|Overall Study||8
133091|NCT01751399|325560|P2|COMPLETED|Overall Study||8
133092|NCT01751399|325561|P1|COMPLETED|Overall Study||12
133093|NCT01751399|325558|P4|Received 1 Dose of Study Drug|Overall Study||7
133094|NCT01751399|325559|P3|Received 1 Dose of Study Drug|Overall Study||8
133095|NCT01751399|325560|P2|Received 1 Dose of Study Drug|Overall Study||8
133096|NCT01751399|325561|P1|Received 1 Dose of Study Drug|Overall Study||12
133097|NCT01751399|325558|P4|STARTED|Overall Study||7
133098|NCT01751399|325559|P3|STARTED|Overall Study||8
133099|NCT01751399|325560|P2|STARTED|Overall Study||8
133100|NCT01751399|325561|P1|STARTED|Overall Study||12
133101|NCT01751386|325577|P2|NOT COMPLETED|Overall Study||3
133102|NCT01751386|325578|P1|NOT COMPLETED|Overall Study||2
133103|NCT01751386|325577|P2|COMPLETED|Overall Study||16
133104|NCT01751386|325578|P1|COMPLETED|Overall Study||18
133105|NCT01751386|325577|P2|STARTED|Overall Study||19
133106|NCT01751386|325578|P1|STARTED|Overall Study||20
133107|NCT01751308|325589|P5|NOT COMPLETED|Phase 2||0
133108|NCT01751308|325590|P4|NOT COMPLETED|Phase 2||0
133109|NCT01751308|325591|P3|NOT COMPLETED|Phase 2||0
133110|NCT01751308|325592|P2|NOT COMPLETED|Phase 2||0
133111|NCT01751308|325593|P1|NOT COMPLETED|Phase 2||0
133112|NCT01751308|325589|P5|COMPLETED|Phase 2|DP, AE and death were considered as completed (defined in protocol)|16
133113|NCT01751308|325590|P4|COMPLETED|Phase 2||0
133114|NCT01751308|325591|P3|COMPLETED|Phase 2||0
133115|NCT01751308|325592|P2|COMPLETED|Phase 2||0
133116|NCT01751308|325593|P1|COMPLETED|Phase 2||0
133117|NCT01751308|325589|P5|STARTED|Phase 2|Phase 1 and Phase 2 were separate populations.|16
133118|NCT01751308|325590|P4|STARTED|Phase 2||0
133119|NCT01751308|325591|P3|STARTED|Phase 2||0
133120|NCT01751308|325592|P2|STARTED|Phase 2||0
133121|NCT01751308|325593|P1|STARTED|Phase 2||0
133122|NCT01751308|325589|P5|NOT COMPLETED|Phase 1||0
133123|NCT01751308|325590|P4|NOT COMPLETED|Phase 1||0
133124|NCT01751308|325591|P3|NOT COMPLETED|Phase 1||0
133125|NCT01751308|325592|P2|NOT COMPLETED|Phase 1||0
133126|NCT01751308|325593|P1|NOT COMPLETED|Phase 1||0
133127|NCT01751308|325589|P5|COMPLETED|Phase 1||0
133128|NCT01751308|325590|P4|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
133129|NCT01751308|325591|P3|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
133130|NCT01751308|325592|P2|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|3
133131|NCT01751308|325593|P1|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|6
133132|NCT01751308|325589|P5|STARTED|Phase 1|Phase 1 and Phase 2 were separate populations.|0
133133|NCT01751308|325590|P4|STARTED|Phase 1||7
133134|NCT01751308|325591|P3|STARTED|Phase 1||7
133135|NCT01751308|325592|P2|STARTED|Phase 1||3
133136|NCT01751308|325593|P1|STARTED|Phase 1||6
133137|NCT01751230|325632|P2|NOT COMPLETED|Overall Study||4
133138|NCT01751230|325633|P1|NOT COMPLETED|Overall Study||1
133139|NCT01751230|325632|P2|COMPLETED|Overall Study||16
133140|NCT01751230|325633|P1|COMPLETED|Overall Study||19
133141|NCT01751230|325632|P2|STARTED|Overall Study||20
133142|NCT01751230|325633|P1|STARTED|Overall Study||20
133143|NCT01751178|325654|P3|NOT COMPLETED|Overall Study||2
133144|NCT01751178|325655|P2|NOT COMPLETED|Overall Study||0
133145|NCT01751178|325656|P1|NOT COMPLETED|Overall Study||3
133146|NCT01751178|325654|P3|COMPLETED|Overall Study||105
133147|NCT01751178|325655|P2|COMPLETED|Overall Study||109
133148|NCT01751178|325656|P1|COMPLETED|Overall Study||105
133149|NCT01751178|325654|P3|STARTED|Overall Study||107
133150|NCT01751178|325655|P2|STARTED|Overall Study||109
133151|NCT01751178|325656|P1|STARTED|Overall Study||108
133152|NCT01751165|325676|P3|NOT COMPLETED|Overall Study||3
133153|NCT01751165|325677|P2|NOT COMPLETED|Overall Study||3
133154|NCT01751165|325678|P1|NOT COMPLETED|Overall Study||2
133155|NCT01751165|325676|P3|COMPLETED|Overall Study||113
133156|NCT01751165|325677|P2|COMPLETED|Overall Study||116
133157|NCT01751165|325678|P1|COMPLETED|Overall Study||117
133158|NCT01751165|325676|P3|STARTED|Overall Study||116
133159|NCT01751165|325677|P2|STARTED|Overall Study||119
133160|NCT01751165|325678|P1|STARTED|Overall Study||119
133161|NCT01751113|325718|P6|NOT COMPLETED|Treatment Period 3 (4 Weeks)||1
133162|NCT01751113|325719|P5|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
133163|NCT01751113|325720|P4|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
133164|NCT01751113|325721|P3|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
133165|NCT01751113|325722|P2|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
133166|NCT01751113|325723|P1|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
133167|NCT01751113|325718|P6|COMPLETED|Treatment Period 3 (4 Weeks)||9
133168|NCT01751113|325719|P5|COMPLETED|Treatment Period 3 (4 Weeks)||8
133169|NCT01751113|325720|P4|COMPLETED|Treatment Period 3 (4 Weeks)||8
133170|NCT01751113|325721|P3|COMPLETED|Treatment Period 3 (4 Weeks)||9
133171|NCT01751113|325722|P2|COMPLETED|Treatment Period 3 (4 Weeks)||8
133172|NCT01751113|325723|P1|COMPLETED|Treatment Period 3 (4 Weeks)||8
133173|NCT01751113|325718|P6|STARTED|Treatment Period 3 (4 Weeks)||10
133174|NCT01751113|325719|P5|STARTED|Treatment Period 3 (4 Weeks)||8
133175|NCT01751113|325720|P4|STARTED|Treatment Period 3 (4 Weeks)||8
133176|NCT01751113|325721|P3|STARTED|Treatment Period 3 (4 Weeks)||9
133177|NCT01751113|325722|P2|STARTED|Treatment Period 3 (4 Weeks)||8
133178|NCT01751113|325723|P1|STARTED|Treatment Period 3 (4 Weeks)||8
133179|NCT01751113|325718|P6|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
133180|NCT01751113|325719|P5|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
133181|NCT01751113|325720|P4|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
133182|NCT01751113|325721|P3|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
133183|NCT01751113|325722|P2|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
133184|NCT01751113|325723|P1|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
133185|NCT01751113|325718|P6|COMPLETED|Washout Period 2 (2 Weeks)||10
133186|NCT01751113|325719|P5|COMPLETED|Washout Period 2 (2 Weeks)||8
133187|NCT01751113|325720|P4|COMPLETED|Washout Period 2 (2 Weeks)||8
133188|NCT01751113|325721|P3|COMPLETED|Washout Period 2 (2 Weeks)||9
133189|NCT01751113|325722|P2|COMPLETED|Washout Period 2 (2 Weeks)||8
133190|NCT01751113|325723|P1|COMPLETED|Washout Period 2 (2 Weeks)||8
133191|NCT01751113|325718|P6|STARTED|Washout Period 2 (2 Weeks)||10
133192|NCT01751113|325719|P5|STARTED|Washout Period 2 (2 Weeks)||8
133193|NCT01751113|325720|P4|STARTED|Washout Period 2 (2 Weeks)||8
133194|NCT01751113|325721|P3|STARTED|Washout Period 2 (2 Weeks)||9
133195|NCT01751113|325722|P2|STARTED|Washout Period 2 (2 Weeks)||8
133196|NCT01751113|325723|P1|STARTED|Washout Period 2 (2 Weeks)||8
133197|NCT01751113|325718|P6|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
133198|NCT01751113|325719|P5|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
133199|NCT01751113|325720|P4|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
133200|NCT01751113|325721|P3|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
133201|NCT01751113|325722|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
133202|NCT01751113|325723|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
133203|NCT01751113|325718|P6|COMPLETED|Treatment Period 2 (4 Weeks)||10
133204|NCT01751113|325719|P5|COMPLETED|Treatment Period 2 (4 Weeks)||8
133205|NCT01751113|325720|P4|COMPLETED|Treatment Period 2 (4 Weeks)||8
133206|NCT01751113|325721|P3|COMPLETED|Treatment Period 2 (4 Weeks)||9
133207|NCT01751113|325722|P2|COMPLETED|Treatment Period 2 (4 Weeks)||8
133208|NCT01751113|325723|P1|COMPLETED|Treatment Period 2 (4 Weeks)||8
133209|NCT01751113|325718|P6|STARTED|Treatment Period 2 (4 Weeks)||10
133210|NCT01751113|325719|P5|STARTED|Treatment Period 2 (4 Weeks)||8
133211|NCT01751113|325720|P4|STARTED|Treatment Period 2 (4 Weeks)||8
133212|NCT01751113|325721|P3|STARTED|Treatment Period 2 (4 Weeks)||9
133213|NCT01751113|325722|P2|STARTED|Treatment Period 2 (4 Weeks)||8
133214|NCT01751113|325723|P1|STARTED|Treatment Period 2 (4 Weeks)||8
133215|NCT01751113|325718|P6|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
133216|NCT01751113|325719|P5|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
133217|NCT01751113|325720|P4|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
133218|NCT01751113|325721|P3|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
133219|NCT01751113|325722|P2|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
133220|NCT01751113|325723|P1|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
133221|NCT01751113|325718|P6|COMPLETED|Washout Period 1 (2 Weeks)||10
133222|NCT01751113|325719|P5|COMPLETED|Washout Period 1 (2 Weeks)||8
133223|NCT01751113|325720|P4|COMPLETED|Washout Period 1 (2 Weeks)||8
133224|NCT01751113|325721|P3|COMPLETED|Washout Period 1 (2 Weeks)||9
133225|NCT01751113|325722|P2|COMPLETED|Washout Period 1 (2 Weeks)||8
133226|NCT01751113|325723|P1|COMPLETED|Washout Period 1 (2 Weeks)||8
133227|NCT01751113|325718|P6|STARTED|Washout Period 1 (2 Weeks)||10
133228|NCT01751113|325719|P5|STARTED|Washout Period 1 (2 Weeks)||8
133229|NCT01751113|325720|P4|STARTED|Washout Period 1 (2 Weeks)||8
133230|NCT01751113|325721|P3|STARTED|Washout Period 1 (2 Weeks)||9
133231|NCT01751113|325722|P2|STARTED|Washout Period 1 (2 Weeks)||8
133232|NCT01751113|325723|P1|STARTED|Washout Period 1 (2 Weeks)||8
133233|NCT01751113|325718|P6|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
133234|NCT01751113|325719|P5|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
133235|NCT01751113|325720|P4|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
133236|NCT01751113|325721|P3|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
133237|NCT01751113|325722|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
133238|NCT01751113|325723|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
133239|NCT01751113|325718|P6|COMPLETED|Treatment Period 1 (4 Weeks)||10
133240|NCT01751113|325719|P5|COMPLETED|Treatment Period 1 (4 Weeks)||8
133241|NCT01751113|325720|P4|COMPLETED|Treatment Period 1 (4 Weeks)||8
133242|NCT01751113|325721|P3|COMPLETED|Treatment Period 1 (4 Weeks)||9
133243|NCT01751113|325722|P2|COMPLETED|Treatment Period 1 (4 Weeks)||8
133244|NCT01751113|325723|P1|COMPLETED|Treatment Period 1 (4 Weeks)||8
133245|NCT01751113|325718|P6|STARTED|Treatment Period 1 (4 Weeks)||10
133246|NCT01751113|325719|P5|STARTED|Treatment Period 1 (4 Weeks)||9
133247|NCT01751113|325720|P4|STARTED|Treatment Period 1 (4 Weeks)||9
133248|NCT01751113|325721|P3|STARTED|Treatment Period 1 (4 Weeks)||9
133249|NCT01751113|325722|P2|STARTED|Treatment Period 1 (4 Weeks)||8
133250|NCT01751113|325723|P1|STARTED|Treatment Period 1 (4 Weeks)||8
133251|NCT01751087|325764|P3|NOT COMPLETED|Overall Study||1
133252|NCT01751087|325765|P2|NOT COMPLETED|Overall Study||0
133253|NCT01751087|325766|P1|NOT COMPLETED|Overall Study||1
133254|NCT01751087|325764|P3|COMPLETED|Overall Study||99
133255|NCT01751087|325765|P2|COMPLETED|Overall Study||100
133256|NCT01751087|325766|P1|COMPLETED|Overall Study||99
133257|NCT01751087|325764|P3|STARTED|Overall Study||100
133258|NCT01751087|325765|P2|STARTED|Overall Study||100
133259|NCT01751087|325766|P1|STARTED|Overall Study||100
133260|NCT01751061|325800|P2|NOT COMPLETED|Overall Study||34
133261|NCT01751061|325801|P1|NOT COMPLETED|Overall Study||56
133262|NCT01751061|325800|P2|COMPLETED|Overall Study||172
133263|NCT01751061|325801|P1|COMPLETED|Overall Study||154
133264|NCT01751061|325800|P2|STARTED|Overall Study||206
133265|NCT01751061|325801|P1|STARTED|Overall Study||210
133266|NCT01751022|325822|P3|NOT COMPLETED|Overall Study||27
133267|NCT01751022|325823|P2|NOT COMPLETED|Overall Study||44
133268|NCT01751022|325824|P1|NOT COMPLETED|Overall Study||56
133269|NCT01751022|325822|P3|COMPLETED|Overall Study|6 month visit|273
133270|NCT01751022|325823|P2|COMPLETED|Overall Study|6 month visit|282
133271|NCT01751022|325824|P1|COMPLETED|Overall Study|6 month visit|443
133272|NCT01751022|325822|P3|STARTED|Overall Study||300
133273|NCT01751022|325823|P2|STARTED|Overall Study||326
133274|NCT01751022|325824|P1|STARTED|Overall Study||499
133275|NCT01750931|325856|P2|NOT COMPLETED|Period 2||0
133276|NCT01750931|325857|P1|NOT COMPLETED|Period 2||0
133277|NCT01750931|325856|P2|COMPLETED|Period 2||14
133278|NCT01750931|325857|P1|COMPLETED|Period 2||14
133279|NCT01750931|325856|P2|STARTED|Period 2||14
133280|NCT01750931|325857|P1|STARTED|Period 2||14
133281|NCT01750931|325856|P2|NOT COMPLETED|Wash Out||0
133282|NCT01750931|325857|P1|NOT COMPLETED|Wash Out||0
133283|NCT01750931|325856|P2|COMPLETED|Wash Out||14
133284|NCT01750931|325857|P1|COMPLETED|Wash Out||14
133285|NCT01750931|325856|P2|STARTED|Wash Out||14
133286|NCT01750931|325857|P1|STARTED|Wash Out||14
133287|NCT01750931|325856|P2|NOT COMPLETED|Period 1||0
133288|NCT01750931|325857|P1|NOT COMPLETED|Period 1||0
133289|NCT01750931|325856|P2|COMPLETED|Period 1||14
133290|NCT01750931|325857|P1|COMPLETED|Period 1||14
133291|NCT01750931|325856|P2|STARTED|Period 1||14
133292|NCT01750931|325857|P1|STARTED|Period 1||14
133293|NCT01750840|325875|P1|NOT COMPLETED|Overall Study||4
133294|NCT01750840|325875|P1|COMPLETED|Overall Study||4
133295|NCT01750840|325875|P1|STARTED|Overall Study||8
133296|NCT01750697|325880|P1|NOT COMPLETED|Overall Study||9
133297|NCT01750697|325880|P1|COMPLETED|Overall Study|Completed to CCO. 6 participants entered Extended Safety Follow-up, 10 participants completed Study.|16
133298|NCT01750697|325880|P1|Follow-up Phase|Overall Study|Completed required follow-up|24
133299|NCT01750697|325880|P1|Completed|Overall Study||25
133300|NCT01750697|325880|P1|STARTED|Overall Study||25
133301|NCT01750684|325892|P2|NOT COMPLETED|Overall Study||2
133302|NCT01750684|325893|P1|NOT COMPLETED|Overall Study||2
133303|NCT01750684|325892|P2|COMPLETED|Overall Study||5
133304|NCT01750684|325893|P1|COMPLETED|Overall Study||4
133305|NCT01750684|325892|P2|STARTED|Overall Study||7
133306|NCT01750684|325893|P1|STARTED|Overall Study||6
133307|NCT01750502|325903|P2|NOT COMPLETED|Overall Study||0
133308|NCT01750502|325904|P1|NOT COMPLETED|Overall Study||0
133309|NCT01750502|325903|P2|COMPLETED|Overall Study||186
133310|NCT01750502|325904|P1|COMPLETED|Overall Study||70
133311|NCT01750502|325903|P2|STARTED|Overall Study||186
133312|NCT01750502|325904|P1|STARTED|Overall Study||70
133313|NCT01750398|325917|P1|NOT COMPLETED|Bipolar Androgen Thearpy Phase||3
133314|NCT01750398|325917|P1|COMPLETED|Bipolar Androgen Thearpy Phase||26
133315|NCT01750398|325917|P1|STARTED|Bipolar Androgen Thearpy Phase||29
133316|NCT01750398|325917|P1|NOT COMPLETED|ADT Lead In Phase||4
133317|NCT01750398|325917|P1|COMPLETED|ADT Lead In Phase||29
133318|NCT01750398|325917|P1|STARTED|ADT Lead In Phase||33
133319|NCT01750346|325930|P3|NOT COMPLETED|Overall Study||0
133320|NCT01750346|325931|P2|NOT COMPLETED|Overall Study||0
133321|NCT01750346|325932|P1|NOT COMPLETED|Overall Study||1
133322|NCT01750346|325930|P3|COMPLETED|Overall Study||3
133323|NCT01750346|325931|P2|COMPLETED|Overall Study||2
133324|NCT01750346|325932|P1|COMPLETED|Overall Study||2
133325|NCT01750346|325930|P3|STARTED|Overall Study||3
133326|NCT01750346|325931|P2|STARTED|Overall Study||2
133327|NCT01750346|325932|P1|STARTED|Overall Study||3
133328|NCT01750294|325958|P1|NOT COMPLETED|Overall Study||2
133329|NCT01750294|325958|P1|COMPLETED|Overall Study||12
133330|NCT01750294|325958|P1|STARTED|Overall Study||14
133331|NCT01750281|325965|P3|NOT COMPLETED|Overall Study||84
133332|NCT01750281|325966|P2|NOT COMPLETED|Overall Study||85
133333|NCT01750281|325967|P1|NOT COMPLETED|Overall Study||43
133334|NCT01750281|325965|P3|COMPLETED|Overall Study||0
133335|NCT01750281|325966|P2|COMPLETED|Overall Study||0
133336|NCT01750281|325967|P1|COMPLETED|Overall Study||0
133337|NCT01750281|325965|P3|Did Not Receive Treatment|Overall Study||0
133338|NCT01750281|325966|P2|Did Not Receive Treatment|Overall Study||1
133339|NCT01750281|325967|P1|Did Not Receive Treatment|Overall Study||0
133340|NCT01750281|325965|P3|Received Treatment|Overall Study||84
133341|NCT01750281|325966|P2|Received Treatment|Overall Study||84
133342|NCT01750281|325967|P1|Received Treatment|Overall Study||43
133343|NCT01750281|325965|P3|STARTED|Overall Study||84
133344|NCT01750281|325966|P2|STARTED|Overall Study||85
133345|NCT01750281|325967|P1|STARTED|Overall Study||43
133346|NCT01750255|325980|P2|NOT COMPLETED|Overall Study||5
133347|NCT01750255|325981|P1|NOT COMPLETED|Overall Study||6
133348|NCT01750255|325980|P2|COMPLETED|Overall Study||38
133349|NCT01750255|325981|P1|COMPLETED|Overall Study||43
133350|NCT01750255|325980|P2|STARTED|Overall Study||43
133351|NCT01750255|325981|P1|STARTED|Overall Study||49
133352|NCT01750242|325997|P1|NOT COMPLETED|Overall Study||3
133353|NCT01750242|325997|P1|COMPLETED|Overall Study||20
133354|NCT01750242|325997|P1|Readable Images|Overall Study|Subjects with readable images were analyzed and there were 3 subjects with unreadable images.|20
133355|NCT01750242|325997|P1|STARTED|Overall Study||23
133356|NCT01750229|326002|P1|NOT COMPLETED|Long-term Follow-up Phase||3
133357|NCT01750229|326002|P1|COMPLETED|Long-term Follow-up Phase||25
133358|NCT01750229|326002|P1|STARTED|Long-term Follow-up Phase|Four subjects who had protocol violations continued to be followed in long-term follow-up phase.|28
133359|NCT01750229|326002|P1|NOT COMPLETED|Randomized Crossover Phase||2
133360|NCT01750229|326002|P1|COMPLETED|Randomized Crossover Phase||28
133361|NCT01750229|326002|P1|Protocol Violation|Randomized Crossover Phase||4
133362|NCT01750229|326002|P1|Subjects Received 5882 Hz|Randomized Crossover Phase||24
133363|NCT01750229|326002|P1|Subjects Received 3030 Hz|Randomized Crossover Phase||24
133364|NCT01750229|326002|P1|Subjects Received 1200 Hz|Randomized Crossover Phase||24
133365|NCT01750229|326002|P1|Subject Received Sham|Randomized Crossover Phase||24
133366|NCT01750229|326002|P1|STARTED|Randomized Crossover Phase||30
133367|NCT01750086|326014|P2|NOT COMPLETED|Overall Study||1
133368|NCT01750086|326015|P1|NOT COMPLETED|Overall Study||1
133369|NCT01750086|326014|P2|COMPLETED|Overall Study||13
133370|NCT01750086|326015|P1|COMPLETED|Overall Study||12
133371|NCT01750086|326014|P2|STARTED|Overall Study||14
133372|NCT01750086|326015|P1|STARTED|Overall Study||13
133373|NCT01749995|326021|P1|NOT COMPLETED|Overall Study||4
133374|NCT01749995|326021|P1|COMPLETED|Overall Study||196
133375|NCT01749995|326021|P1|STARTED|Overall Study||200
133376|NCT01749982|326029|P4|NOT COMPLETED|Overall Study||3
133377|NCT01749982|326030|P3|NOT COMPLETED|Overall Study||0
133378|NCT01749982|326031|P2|NOT COMPLETED|Overall Study||0
133379|NCT01749982|326032|P1|NOT COMPLETED|Overall Study||0
133380|NCT01749982|326029|P4|COMPLETED|Overall Study||12
133381|NCT01749982|326030|P3|COMPLETED|Overall Study||15
133382|NCT01749982|326031|P2|COMPLETED|Overall Study||15
133383|NCT01749982|326032|P1|COMPLETED|Overall Study||15
133384|NCT01749982|326029|P4|STARTED|Overall Study||15
133385|NCT01749982|326030|P3|STARTED|Overall Study||15
133386|NCT01749982|326031|P2|STARTED|Overall Study||15
133387|NCT01749982|326032|P1|STARTED|Overall Study||15
133388|NCT01749956|326050|P1|NOT COMPLETED|Overall Study||15
133389|NCT01749956|326050|P1|COMPLETED|Overall Study||24
133390|NCT01749956|326050|P1|STARTED|Overall Study||39
133391|NCT01749930|326062|P2|NOT COMPLETED|Overall Study||12
133392|NCT01749930|326063|P1|NOT COMPLETED|Overall Study||30
133393|NCT01749930|326062|P2|COMPLETED|Overall Study|randomized population|125
133394|NCT01749930|326063|P1|COMPLETED|Overall Study|randomized population|253
133395|NCT01749930|326062|P2|STARTED|Overall Study|randomized population|137
133396|NCT01749930|326063|P1|STARTED|Overall Study|randomized population|283
133397|NCT01749904|326079|P2|NOT COMPLETED|Overall Study||11
133398|NCT01749904|326080|P1|NOT COMPLETED|Overall Study||22
133399|NCT01749904|326079|P2|COMPLETED|Overall Study|randomized population|123
133400|NCT01749904|326080|P1|COMPLETED|Overall Study|randomized population|264
133401|NCT01749904|326079|P2|STARTED|Overall Study|randomized population|134
133402|NCT01749904|326080|P1|STARTED|Overall Study|randomized population|286
133403|NCT01749826|326096|P2|NOT COMPLETED|Overall Study||0
133404|NCT01749826|326097|P1|NOT COMPLETED|Overall Study||20
133405|NCT01749826|326096|P2|COMPLETED|Overall Study||0
133406|NCT01749826|326097|P1|COMPLETED|Overall Study||0
133407|NCT01749826|326096|P2|STARTED|Overall Study||0
133408|NCT01749826|326097|P1|STARTED|Overall Study||20
133409|NCT01749800|326112|P3|NOT COMPLETED|Overall Study||0
133410|NCT01749800|326113|P2|NOT COMPLETED|Overall Study||1
133411|NCT01749800|326114|P1|NOT COMPLETED|Overall Study||3
133412|NCT01749800|326112|P3|COMPLETED|Overall Study||0
133413|NCT01749800|326113|P2|COMPLETED|Overall Study||0
133414|NCT01749800|326114|P1|COMPLETED|Overall Study||3
133415|NCT01749800|326112|P3|STARTED|Overall Study||0
133416|NCT01749800|326113|P2|STARTED|Overall Study|1 subject showed significant motor impairments but decided to undergo therapy (exclusion criterion)|1
133417|NCT01749800|326114|P1|STARTED|Overall Study|3 subjects did not show significant attention span deficit (required inclusion criterion)|6
133418|NCT01749735|326124|P2|NOT COMPLETED|Overall Study||0
133419|NCT01749735|326125|P1|NOT COMPLETED|Overall Study||1
133420|NCT01749735|326124|P2|COMPLETED|Overall Study||0
133421|NCT01749735|326125|P1|COMPLETED|Overall Study||1
133422|NCT01749735|326124|P2|STARTED|Overall Study||0
133423|NCT01749735|326125|P1|STARTED|Overall Study||2
133424|NCT01749631|326133|P1|NOT COMPLETED|Overall Study||0
133425|NCT01749631|326133|P1|COMPLETED|Overall Study||97
133426|NCT01749631|326133|P1|STARTED|Overall Study||97
133427|NCT01749605|326145|P2|NOT COMPLETED|Overall Study||3
133428|NCT01749605|326146|P1|NOT COMPLETED|Overall Study||4
133429|NCT01749605|326145|P2|COMPLETED|Overall Study||14
133430|NCT01749605|326146|P1|COMPLETED|Overall Study||14
133431|NCT01749605|326145|P2|STARTED|Overall Study||17
133432|NCT01749605|326146|P1|STARTED|Overall Study||18
133433|NCT01749501|326154|P2|NOT COMPLETED|Overall Study||0
133434|NCT01749501|326155|P1|NOT COMPLETED|Overall Study||0
133435|NCT01749501|326154|P2|COMPLETED|Overall Study||23
133436|NCT01749501|326155|P1|COMPLETED|Overall Study||22
133437|NCT01749501|326154|P2|STARTED|Overall Study||23
133438|NCT01749501|326155|P1|STARTED|Overall Study||22
133439|NCT01749410|326163|P1|NOT COMPLETED|Overall Study||0
133440|NCT01749410|326163|P1|COMPLETED|Overall Study||33
133441|NCT01749410|326163|P1|STARTED|Overall Study||33
133442|NCT01748955|326169|P2|NOT COMPLETED|Overall Study||5
133443|NCT01748955|326170|P1|NOT COMPLETED|Overall Study||3
133444|NCT01748955|326169|P2|COMPLETED|Overall Study||4
133445|NCT01748955|326170|P1|COMPLETED|Overall Study||3
133446|NCT01748955|326169|P2|STARTED|Overall Study||9
133447|NCT01748955|326170|P1|STARTED|Overall Study||6
133448|NCT01748942|326180|P2|NOT COMPLETED|Overall Study||4
133449|NCT01748942|326181|P1|NOT COMPLETED|Overall Study||4
133450|NCT01748942|326180|P2|COMPLETED|Overall Study||33
133451|NCT01748942|326181|P1|COMPLETED|Overall Study||35
133452|NCT01748942|326180|P2|STARTED|Overall Study||37
133453|NCT01748942|326181|P1|STARTED|Overall Study||39
133454|NCT01748916|326201|P6|NOT COMPLETED|Overall Study||0
133455|NCT01748916|326202|P5|NOT COMPLETED|Overall Study||0
133456|NCT01748916|326203|P4|NOT COMPLETED|Overall Study||0
133457|NCT01748916|326204|P3|NOT COMPLETED|Overall Study||0
133458|NCT01748916|326205|P2|NOT COMPLETED|Overall Study||0
133459|NCT01748916|326206|P1|NOT COMPLETED|Overall Study||0
133460|NCT01748916|326201|P6|COMPLETED|Overall Study||3
133461|NCT01748916|326202|P5|COMPLETED|Overall Study||3
133462|NCT01748916|326203|P4|COMPLETED|Overall Study||3
133463|NCT01748916|326204|P3|COMPLETED|Overall Study||2
133464|NCT01748916|326205|P2|COMPLETED|Overall Study||3
133465|NCT01748916|326206|P1|COMPLETED|Overall Study||2
133466|NCT01748916|326201|P6|STARTED|Overall Study||3
133467|NCT01748916|326202|P5|STARTED|Overall Study||3
133468|NCT01748916|326203|P4|STARTED|Overall Study||3
133469|NCT01748916|326204|P3|STARTED|Overall Study||2
133470|NCT01748916|326205|P2|STARTED|Overall Study||3
133471|NCT01748916|326206|P1|STARTED|Overall Study||2
133472|NCT01748890|326214|P1|NOT COMPLETED|Overall Study||4
133473|NCT01748890|326214|P1|COMPLETED|Overall Study|Insufficient recruitment for analysis|0
133474|NCT01748890|326214|P1|STARTED|Overall Study||4
133475|NCT01748799|326226|P8|NOT COMPLETED|Overall Study||0
133476|NCT01748799|326227|P7|NOT COMPLETED|Overall Study||1
133477|NCT01748799|326228|P6|NOT COMPLETED|Overall Study||1
133478|NCT01748799|326229|P5|NOT COMPLETED|Overall Study||0
133479|NCT01748799|326230|P4|NOT COMPLETED|Overall Study||0
133480|NCT01748799|326231|P3|NOT COMPLETED|Overall Study||0
133481|NCT01748799|326232|P2|NOT COMPLETED|Overall Study||0
133482|NCT01748799|326233|P1|NOT COMPLETED|Overall Study||5
133483|NCT01748799|326226|P8|COMPLETED|Overall Study||1
133484|NCT01748799|326227|P7|COMPLETED|Overall Study||1
133485|NCT01748799|326228|P6|COMPLETED|Overall Study||1
133486|NCT01748799|326229|P5|COMPLETED|Overall Study||1
133487|NCT01748799|326230|P4|COMPLETED|Overall Study||2
133488|NCT01748799|326231|P3|COMPLETED|Overall Study||1
133489|NCT01748799|326232|P2|COMPLETED|Overall Study||1
133490|NCT01748799|326233|P1|COMPLETED|Overall Study||1
133491|NCT01748799|326226|P8|Completed Self-titrated Sativex|Overall Study||1
133492|NCT01748799|326227|P7|Completed Self-titrated Sativex|Overall Study||1
133493|NCT01748799|326228|P6|Completed Self-titrated Sativex|Overall Study||1
133494|NCT01748799|326229|P5|Completed Self-titrated Sativex|Overall Study||1
133495|NCT01748799|326230|P4|Completed Self-titrated Sativex|Overall Study||2
133496|NCT01748799|326231|P3|Completed Self-titrated Sativex|Overall Study||1
133497|NCT01748799|326232|P2|Completed Self-titrated Sativex|Overall Study||1
133498|NCT01748799|326233|P1|Completed Self-titrated Sativex|Overall Study||1
133499|NCT01748799|326226|P8|Completed SAU of Self-titrated Sativex|Overall Study||1
133500|NCT01748799|326227|P7|Completed SAU of Self-titrated Sativex|Overall Study||1
133501|NCT01748799|326228|P6|Completed SAU of Self-titrated Sativex|Overall Study||2
133502|NCT01748799|326229|P5|Completed SAU of Self-titrated Sativex|Overall Study||1
133503|NCT01748799|326230|P4|Completed SAU of Self-titrated Sativex|Overall Study||2
133504|NCT01748799|326231|P3|Completed SAU of Self-titrated Sativex|Overall Study||1
133505|NCT01748799|326232|P2|Completed SAU of Self-titrated Sativex|Overall Study||1
133506|NCT01748799|326233|P1|Completed SAU of Self-titrated Sativex|Overall Study||2
133507|NCT01748799|326226|P8|Completed Self-titrated Placebo|Overall Study||1
133508|NCT01748799|326227|P7|Completed Self-titrated Placebo|Overall Study||1
133509|NCT01748799|326228|P6|Completed Self-titrated Placebo|Overall Study||2
133510|NCT01748799|326229|P5|Completed Self-titrated Placebo|Overall Study||1
133511|NCT01748799|326230|P4|Completed Self-titrated Placebo|Overall Study||2
133512|NCT01748799|326231|P3|Completed Self-titrated Placebo|Overall Study||1
133513|NCT01748799|326232|P2|Completed Self-titrated Placebo|Overall Study||1
133514|NCT01748799|326233|P1|Completed Self-titrated Placebo|Overall Study||4
133515|NCT01748799|326226|P8|Completed SAU of Self-titrated Placebo|Overall Study||1
133516|NCT01748799|326227|P7|Completed SAU of Self-titrated Placebo|Overall Study||1
133517|NCT01748799|326228|P6|Completed SAU of Self-titrated Placebo|Overall Study||2
133518|NCT01748799|326229|P5|Completed SAU of Self-titrated Placebo|Overall Study||1
133519|NCT01748799|326230|P4|Completed SAU of Self-titrated Placebo|Overall Study||2
133520|NCT01748799|326231|P3|Completed SAU of Self-titrated Placebo|Overall Study||1
133521|NCT01748799|326232|P2|Completed SAU of Self-titrated Placebo|Overall Study||1
133522|NCT01748799|326233|P1|Completed SAU of Self-titrated Placebo|Overall Study||5
133523|NCT01748799|326226|P8|Completed Fixed Dose Sativex|Overall Study||1
133524|NCT01748799|326227|P7|Completed Fixed Dose Sativex|Overall Study||1
133525|NCT01748799|326228|P6|Completed Fixed Dose Sativex|Overall Study||1
133526|NCT01748799|326229|P5|Completed Fixed Dose Sativex|Overall Study||1
133527|NCT01748799|326230|P4|Completed Fixed Dose Sativex|Overall Study||2
133528|NCT01748799|326231|P3|Completed Fixed Dose Sativex|Overall Study||1
133529|NCT01748799|326232|P2|Completed Fixed Dose Sativex|Overall Study||1
133530|NCT01748799|326233|P1|Completed Fixed Dose Sativex|Overall Study||1
133531|NCT01748799|326226|P8|Completed SAU of Fixed Dose Sativex|Overall Study||1
133532|NCT01748799|326227|P7|Completed SAU of Fixed Dose Sativex|Overall Study||1
133533|NCT01748799|326228|P6|Completed SAU of Fixed Dose Sativex|Overall Study||1
133534|NCT01748799|326229|P5|Completed SAU of Fixed Dose Sativex|Overall Study||1
133535|NCT01748799|326230|P4|Completed SAU of Fixed Dose Sativex|Overall Study||2
133536|NCT01748799|326231|P3|Completed SAU of Fixed Dose Sativex|Overall Study||1
133537|NCT01748799|326232|P2|Completed SAU of Fixed Dose Sativex|Overall Study||1
133538|NCT01748799|326233|P1|Completed SAU of Fixed Dose Sativex|Overall Study||1
133539|NCT01748799|326226|P8|Completed Fixed Dose Placebo|Overall Study||1
133540|NCT01748799|326227|P7|Completed Fixed Dose Placebo|Overall Study||1
133541|NCT01748799|326228|P6|Completed Fixed Dose Placebo|Overall Study||1
133542|NCT01748799|326229|P5|Completed Fixed Dose Placebo|Overall Study||1
133543|NCT01748799|326230|P4|Completed Fixed Dose Placebo|Overall Study||2
133544|NCT01748799|326231|P3|Completed Fixed Dose Placebo|Overall Study||1
133545|NCT01748799|326232|P2|Completed Fixed Dose Placebo|Overall Study||1
133546|NCT01748799|326233|P1|Completed Fixed Dose Placebo|Overall Study||2
133547|NCT01748799|326226|P8|Completed SAU of Fixed Dose Placebo|Overall Study||1
133548|NCT01748799|326227|P7|Completed SAU of Fixed Dose Placebo|Overall Study||1
133549|NCT01748799|326228|P6|Completed SAU of Fixed Dose Placebo|Overall Study||1
133550|NCT01748799|326229|P5|Completed SAU of Fixed Dose Placebo|Overall Study||1
133551|NCT01748799|326230|P4|Completed SAU of Fixed Dose Placebo|Overall Study||2
133552|NCT01748799|326231|P3|Completed SAU of Fixed Dose Placebo|Overall Study||1
133553|NCT01748799|326232|P2|Completed SAU of Fixed Dose Placebo|Overall Study||1
133554|NCT01748799|326233|P1|Completed SAU of Fixed Dose Placebo|Overall Study||2
133555|NCT01748799|326226|P8|STARTED|Overall Study||1
133556|NCT01748799|326227|P7|STARTED|Overall Study||2
133557|NCT01748799|326228|P6|STARTED|Overall Study||2
133558|NCT01748799|326229|P5|STARTED|Overall Study||1
133559|NCT01748799|326230|P4|STARTED|Overall Study||2
133560|NCT01748799|326231|P3|STARTED|Overall Study||1
133561|NCT01748799|326232|P2|STARTED|Overall Study||1
133562|NCT01748799|326233|P1|STARTED|Overall Study||6
133563|NCT01748760|326269|P2|NOT COMPLETED|Overall Study||2
133564|NCT01748760|326270|P1|NOT COMPLETED|Overall Study||6
133565|NCT01748760|326269|P2|COMPLETED|Overall Study||23
133566|NCT01748760|326270|P1|COMPLETED|Overall Study||19
133567|NCT01748760|326269|P2|STARTED|Overall Study||25
133568|NCT01748760|326270|P1|STARTED|Overall Study||25
133569|NCT01748695|326276|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
133570|NCT01748695|326277|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
133571|NCT01748695|326276|P2|COMPLETED|Second Intervention (4 Weeks)||11
133572|NCT01748695|326277|P1|COMPLETED|Second Intervention (4 Weeks)||14
133573|NCT01748695|326276|P2|STARTED|Second Intervention (4 Weeks)||11
133574|NCT01748695|326277|P1|STARTED|Second Intervention (4 Weeks)||14
133575|NCT01748695|326276|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
133576|NCT01748695|326277|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
133577|NCT01748695|326276|P2|COMPLETED|First Intervention (4 Weeks)||11
133578|NCT01748695|326277|P1|COMPLETED|First Intervention (4 Weeks)||14
133579|NCT01748695|326276|P2|STARTED|First Intervention (4 Weeks)||11
133580|NCT01748695|326277|P1|STARTED|First Intervention (4 Weeks)||14
133581|NCT01748643|326287|P2|NOT COMPLETED|Overall Study||0
133582|NCT01748643|326288|P1|NOT COMPLETED|Overall Study||0
133583|NCT01748643|326287|P2|COMPLETED|Overall Study||30
133584|NCT01748643|326288|P1|COMPLETED|Overall Study||30
133585|NCT01748643|326287|P2|STARTED|Overall Study||30
133586|NCT01748643|326288|P1|STARTED|Overall Study||30
133587|NCT01748552|326316|P12|NOT COMPLETED|Intervention Period 3 and Washout||0
133588|NCT01748552|326317|P11|NOT COMPLETED|Intervention Period 3 and Washout||0
133589|NCT01748552|326318|P10|NOT COMPLETED|Intervention Period 3 and Washout||0
133590|NCT01748552|326319|P9|NOT COMPLETED|Intervention Period 3 and Washout||0
133591|NCT01748552|326320|P8|NOT COMPLETED|Intervention Period 3 and Washout||0
133592|NCT01748552|326321|P7|NOT COMPLETED|Intervention Period 3 and Washout||0
133593|NCT01748552|326322|P6|NOT COMPLETED|Intervention Period 3 and Washout||0
133594|NCT01748552|326323|P5|NOT COMPLETED|Intervention Period 3 and Washout||0
133595|NCT01748552|326324|P4|NOT COMPLETED|Intervention Period 3 and Washout||0
133596|NCT01748552|326325|P3|NOT COMPLETED|Intervention Period 3 and Washout||0
133597|NCT01748552|326326|P2|NOT COMPLETED|Intervention Period 3 and Washout||0
133598|NCT01748552|326327|P1|NOT COMPLETED|Intervention Period 3 and Washout||0
133599|NCT01748552|326316|P12|COMPLETED|Intervention Period 3 and Washout||3
133600|NCT01748552|326317|P11|COMPLETED|Intervention Period 3 and Washout||3
133601|NCT01748552|326318|P10|COMPLETED|Intervention Period 3 and Washout||3
133602|NCT01748552|326319|P9|COMPLETED|Intervention Period 3 and Washout||0
133603|NCT01748552|326320|P8|COMPLETED|Intervention Period 3 and Washout||0
133604|NCT01748552|326321|P7|COMPLETED|Intervention Period 3 and Washout||0
133605|NCT01748552|326322|P6|COMPLETED|Intervention Period 3 and Washout||3
133606|NCT01748552|326323|P5|COMPLETED|Intervention Period 3 and Washout||3
133607|NCT01748552|326324|P4|COMPLETED|Intervention Period 3 and Washout||3
133608|NCT01748552|326325|P3|COMPLETED|Intervention Period 3 and Washout||2
133609|NCT01748552|326326|P2|COMPLETED|Intervention Period 3 and Washout||3
133610|NCT01748552|326327|P1|COMPLETED|Intervention Period 3 and Washout||3
133611|NCT01748552|326316|P12|STARTED|Intervention Period 3 and Washout||3
133612|NCT01748552|326317|P11|STARTED|Intervention Period 3 and Washout||3
133613|NCT01748552|326318|P10|STARTED|Intervention Period 3 and Washout||3
133614|NCT01748552|326319|P9|STARTED|Intervention Period 3 and Washout||0
133615|NCT01748552|326320|P8|STARTED|Intervention Period 3 and Washout||0
133616|NCT01748552|326321|P7|STARTED|Intervention Period 3 and Washout||0
133617|NCT01748552|326322|P6|STARTED|Intervention Period 3 and Washout||3
133618|NCT01748552|326323|P5|STARTED|Intervention Period 3 and Washout||3
133619|NCT01748552|326324|P4|STARTED|Intervention Period 3 and Washout||3
133620|NCT01748552|326325|P3|STARTED|Intervention Period 3 and Washout||2
133621|NCT01748552|326326|P2|STARTED|Intervention Period 3 and Washout||3
133622|NCT01748552|326327|P1|STARTED|Intervention Period 3 and Washout||3
133623|NCT01748552|326316|P12|NOT COMPLETED|Intervention Period 2 and Washout||0
133624|NCT01748552|326317|P11|NOT COMPLETED|Intervention Period 2 and Washout||0
133625|NCT01748552|326318|P10|NOT COMPLETED|Intervention Period 2 and Washout||0
133626|NCT01748552|326319|P9|NOT COMPLETED|Intervention Period 2 and Washout||3
133627|NCT01748552|326320|P8|NOT COMPLETED|Intervention Period 2 and Washout||3
133628|NCT01748552|326321|P7|NOT COMPLETED|Intervention Period 2 and Washout||3
133629|NCT01748552|326322|P6|NOT COMPLETED|Intervention Period 2 and Washout||0
133630|NCT01748552|326323|P5|NOT COMPLETED|Intervention Period 2 and Washout||0
133631|NCT01748552|326324|P4|NOT COMPLETED|Intervention Period 2 and Washout||0
133632|NCT01748552|326325|P3|NOT COMPLETED|Intervention Period 2 and Washout||1
133633|NCT01748552|326326|P2|NOT COMPLETED|Intervention Period 2 and Washout||0
133634|NCT01748552|326327|P1|NOT COMPLETED|Intervention Period 2 and Washout||0
133635|NCT01748552|326316|P12|COMPLETED|Intervention Period 2 and Washout||3
133636|NCT01748552|326317|P11|COMPLETED|Intervention Period 2 and Washout||3
133637|NCT01748552|326318|P10|COMPLETED|Intervention Period 2 and Washout||3
133638|NCT01748552|326319|P9|COMPLETED|Intervention Period 2 and Washout||0
133639|NCT01748552|326320|P8|COMPLETED|Intervention Period 2 and Washout||0
133640|NCT01748552|326321|P7|COMPLETED|Intervention Period 2 and Washout||0
133641|NCT01748552|326322|P6|COMPLETED|Intervention Period 2 and Washout||3
133642|NCT01748552|326323|P5|COMPLETED|Intervention Period 2 and Washout||3
133643|NCT01748552|326324|P4|COMPLETED|Intervention Period 2 and Washout||3
133644|NCT01748552|326325|P3|COMPLETED|Intervention Period 2 and Washout||2
133645|NCT01748552|326326|P2|COMPLETED|Intervention Period 2 and Washout||3
133646|NCT01748552|326327|P1|COMPLETED|Intervention Period 2 and Washout||3
133647|NCT01748552|326316|P12|STARTED|Intervention Period 2 and Washout||3
133648|NCT01748552|326317|P11|STARTED|Intervention Period 2 and Washout||3
133649|NCT01748552|326318|P10|STARTED|Intervention Period 2 and Washout||3
133650|NCT01748552|326319|P9|STARTED|Intervention Period 2 and Washout||3
133651|NCT01748552|326320|P8|STARTED|Intervention Period 2 and Washout||3
133652|NCT01748552|326321|P7|STARTED|Intervention Period 2 and Washout||3
133653|NCT01748552|326322|P6|STARTED|Intervention Period 2 and Washout||3
133654|NCT01748552|326323|P5|STARTED|Intervention Period 2 and Washout||3
133655|NCT01748552|326324|P4|STARTED|Intervention Period 2 and Washout||3
133656|NCT01748552|326325|P3|STARTED|Intervention Period 2 and Washout||3
133657|NCT01748552|326326|P2|STARTED|Intervention Period 2 and Washout||3
133658|NCT01748552|326327|P1|STARTED|Intervention Period 2 and Washout||3
133659|NCT01748552|326316|P12|NOT COMPLETED|Intervention Period 1 and Washout||0
133660|NCT01748552|326317|P11|NOT COMPLETED|Intervention Period 1 and Washout||0
133661|NCT01748552|326318|P10|NOT COMPLETED|Intervention Period 1 and Washout||0
133662|NCT01748552|326319|P9|NOT COMPLETED|Intervention Period 1 and Washout||0
133663|NCT01748552|326320|P8|NOT COMPLETED|Intervention Period 1 and Washout||0
133664|NCT01748552|326321|P7|NOT COMPLETED|Intervention Period 1 and Washout||0
133665|NCT01748552|326322|P6|NOT COMPLETED|Intervention Period 1 and Washout||0
133666|NCT01748552|326323|P5|NOT COMPLETED|Intervention Period 1 and Washout||0
133667|NCT01748552|326324|P4|NOT COMPLETED|Intervention Period 1 and Washout||0
133668|NCT01748552|326325|P3|NOT COMPLETED|Intervention Period 1 and Washout||0
133669|NCT01748552|326326|P2|NOT COMPLETED|Intervention Period 1 and Washout||0
133670|NCT01748552|326327|P1|NOT COMPLETED|Intervention Period 1 and Washout||0
133671|NCT01748552|326316|P12|COMPLETED|Intervention Period 1 and Washout||3
133672|NCT01748552|326317|P11|COMPLETED|Intervention Period 1 and Washout||3
133673|NCT01748552|326318|P10|COMPLETED|Intervention Period 1 and Washout||3
133674|NCT01748552|326319|P9|COMPLETED|Intervention Period 1 and Washout||3
133675|NCT01748552|326320|P8|COMPLETED|Intervention Period 1 and Washout||3
133676|NCT01748552|326321|P7|COMPLETED|Intervention Period 1 and Washout||3
133677|NCT01748552|326322|P6|COMPLETED|Intervention Period 1 and Washout||3
133678|NCT01748552|326323|P5|COMPLETED|Intervention Period 1 and Washout||3
133679|NCT01748552|326324|P4|COMPLETED|Intervention Period 1 and Washout||3
133680|NCT01748552|326325|P3|COMPLETED|Intervention Period 1 and Washout||3
133681|NCT01748552|326326|P2|COMPLETED|Intervention Period 1 and Washout||3
133682|NCT01748552|326327|P1|COMPLETED|Intervention Period 1 and Washout||3
133683|NCT01748552|326316|P12|STARTED|Intervention Period 1 and Washout||3
133684|NCT01748552|326317|P11|STARTED|Intervention Period 1 and Washout||3
133685|NCT01748552|326318|P10|STARTED|Intervention Period 1 and Washout||3
133686|NCT01748552|326319|P9|STARTED|Intervention Period 1 and Washout||3
133687|NCT01748552|326320|P8|STARTED|Intervention Period 1 and Washout||3
133688|NCT01748552|326321|P7|STARTED|Intervention Period 1 and Washout||3
133689|NCT01748552|326322|P6|STARTED|Intervention Period 1 and Washout||3
133690|NCT01748552|326323|P5|STARTED|Intervention Period 1 and Washout||3
133691|NCT01748552|326324|P4|STARTED|Intervention Period 1 and Washout||3
133692|NCT01748552|326325|P3|STARTED|Intervention Period 1 and Washout||3
133693|NCT01748552|326326|P2|STARTED|Intervention Period 1 and Washout||3
133694|NCT01748552|326327|P1|STARTED|Intervention Period 1 and Washout||3
133695|NCT01748292|326397|P2|NOT COMPLETED|Overall Study||12
133696|NCT01748292|326398|P1|NOT COMPLETED|Overall Study||2
133697|NCT01748292|326397|P2|COMPLETED|Overall Study||28
133698|NCT01748292|326398|P1|COMPLETED|Overall Study||18
133699|NCT01748292|326397|P2|STARTED|Overall Study||40
133700|NCT01748292|326398|P1|STARTED|Overall Study||20
133701|NCT01748240|326418|P1|NOT COMPLETED|Overall Study||0
133702|NCT01748240|326418|P1|COMPLETED|Overall Study||21
133703|NCT01748240|326418|P1|STARTED|Overall Study||21
133704|NCT01748227|326422|P1|NOT COMPLETED|Overall Study||3
133705|NCT01748227|326422|P1|COMPLETED|Overall Study||17
133706|NCT01748227|326422|P1|STARTED|Overall Study||20
133707|NCT01748162|326432|P2|NOT COMPLETED|Overall Study||5
133708|NCT01748162|326433|P1|NOT COMPLETED|Overall Study||5
133709|NCT01748162|326432|P2|COMPLETED|Overall Study||0
133710|NCT01748162|326433|P1|COMPLETED|Overall Study||0
133711|NCT01748162|326432|P2|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
133712|NCT01748162|326433|P1|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
133713|NCT01748162|326432|P2|Completed 6 Month Initial Treatment|Overall Study||0
133714|NCT01748162|326433|P1|Completed 6 Month Initial Treatment|Overall Study||0
133715|NCT01748162|326432|P2|Started 6 Month Initial Treatment Plan|Overall Study||2
133716|NCT01748162|326433|P1|Started 6 Month Initial Treatment Plan|Overall Study||2
133717|NCT01748162|326432|P2|STARTED|Overall Study||5
133718|NCT01748162|326433|P1|STARTED|Overall Study||5
133719|NCT01748071|326444|P3|NOT COMPLETED|Overall Study||0
133720|NCT01748071|326445|P2|NOT COMPLETED|Overall Study||2
133721|NCT01748071|326446|P1|NOT COMPLETED|Overall Study||2
133722|NCT01748071|326444|P3|COMPLETED|Overall Study||40
133723|NCT01748071|326445|P2|COMPLETED|Overall Study||38
133724|NCT01748071|326446|P1|COMPLETED|Overall Study||38
133725|NCT01748071|326444|P3|STARTED|Overall Study||40
133726|NCT01748071|326445|P2|STARTED|Overall Study||40
133727|NCT01748071|326446|P1|STARTED|Overall Study||40
133728|NCT01748045|326468|P2|NOT COMPLETED|Overall Study||0
133729|NCT01748045|326469|P1|NOT COMPLETED|Overall Study||0
133730|NCT01748045|326468|P2|COMPLETED|Overall Study||1
133731|NCT01748045|326469|P1|COMPLETED|Overall Study||2
133732|NCT01748045|326468|P2|STARTED|Overall Study||1
133733|NCT01748045|326469|P1|STARTED|Overall Study||2
133734|NCT01747928|326495|P8|NOT COMPLETED|Overall Study||0
133735|NCT01747928|326496|P7|NOT COMPLETED|Overall Study||0
133736|NCT01747928|326497|P6|NOT COMPLETED|Overall Study||0
133737|NCT01747928|326498|P5|NOT COMPLETED|Overall Study||0
133738|NCT01747928|326499|P4|NOT COMPLETED|Overall Study||0
133739|NCT01747928|326500|P3|NOT COMPLETED|Overall Study||0
133740|NCT01747928|326501|P2|NOT COMPLETED|Overall Study||0
133741|NCT01747928|326502|P1|NOT COMPLETED|Overall Study||0
133742|NCT01747928|326495|P8|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
133743|NCT01747928|326496|P7|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
133744|NCT01747928|326497|P6|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
133745|NCT01747928|326498|P5|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
133746|NCT01747928|326499|P4|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
133747|NCT01747928|326500|P3|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
133748|NCT01747928|326501|P2|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
133749|NCT01747928|326502|P1|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
133750|NCT01747928|326495|P8|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
133751|NCT01747928|326496|P7|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
133752|NCT01747928|326497|P6|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
133753|NCT01747928|326498|P5|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
133754|NCT01747928|326499|P4|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
133755|NCT01747928|326500|P3|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
133756|NCT01747928|326501|P2|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
133757|NCT01747928|326502|P1|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
133758|NCT01747915|326709|P3|NOT COMPLETED|Overall Study||6
133759|NCT01747915|326710|P2|NOT COMPLETED|Overall Study||11
133760|NCT01747915|326711|P1|NOT COMPLETED|Overall Study||15
133761|NCT01747915|326709|P3|COMPLETED|Overall Study||66
133762|NCT01747915|326710|P2|COMPLETED|Overall Study||61
133763|NCT01747915|326711|P1|COMPLETED|Overall Study||60
133764|NCT01747915|326709|P3|STARTED|Overall Study||72
133765|NCT01747915|326710|P2|STARTED|Overall Study||72
133766|NCT01747915|326711|P1|STARTED|Overall Study||75
133767|NCT01747876|326725|P3|NOT COMPLETED|Overall Study||12
133768|NCT01747876|326726|P2|NOT COMPLETED|Overall Study||15
133769|NCT01747876|326727|P1|NOT COMPLETED|Overall Study||5
133770|NCT01747876|326725|P3|COMPLETED|Overall Study||0
133771|NCT01747876|326726|P2|COMPLETED|Overall Study||0
133772|NCT01747876|326727|P1|COMPLETED|Overall Study||0
133773|NCT01747876|326725|P3|STARTED|Overall Study||12
133774|NCT01747876|326726|P2|STARTED|Overall Study||15
133775|NCT01747876|326727|P1|STARTED|Overall Study||5
133776|NCT01747850|326756|P3|NOT COMPLETED|Overall Study||6
133777|NCT01747850|326757|P2|NOT COMPLETED|Overall Study||7
133778|NCT01747850|326758|P1|NOT COMPLETED|Overall Study||1
133779|NCT01747850|326756|P3|COMPLETED|Overall Study||14
133780|NCT01747850|326757|P2|COMPLETED|Overall Study||13
133781|NCT01747850|326758|P1|COMPLETED|Overall Study||4
133782|NCT01747850|326756|P3|STARTED|Overall Study||20
133783|NCT01747850|326757|P2|STARTED|Overall Study||20
133784|NCT01747850|326758|P1|STARTED|Overall Study||5
133785|NCT01747811|326780|P2|NOT COMPLETED|Overall Study||4
133786|NCT01747811|326781|P1|NOT COMPLETED|Overall Study||2
133787|NCT01747811|326780|P2|COMPLETED|Overall Study||12
133788|NCT01747811|326781|P1|COMPLETED|Overall Study||14
133789|NCT01747811|326780|P2|STARTED|Overall Study||16
133790|NCT01747811|326781|P1|STARTED|Overall Study||16
133791|NCT01747772|326797|P1|NOT COMPLETED|Overall Study||9
133792|NCT01747772|326797|P1|COMPLETED|Overall Study||171
133793|NCT01747772|326797|P1|Analysis Population|Overall Study|All participants who completed the study and had adequate SWE and liver biopsy data.|164
133794|NCT01747772|326797|P1|STARTED|Overall Study||180
133795|NCT01747655|326805|P2|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
133796|NCT01747655|326806|P1|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
133797|NCT01747655|326805|P2|COMPLETED|PEG-J Period (Continued Treatment)||15
133798|NCT01747655|326806|P1|COMPLETED|PEG-J Period (Continued Treatment)||41
133799|NCT01747655|326805|P2|STARTED|PEG-J Period (Continued Treatment)|SoC MAS: 6 SoC participants plus 9 participants who received Duodopa via PEG-J then returned to SoC|15
133800|NCT01747655|326806|P1|STARTED|PEG-J Period (Continued Treatment)||41
133801|NCT01747655|326805|P2|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||0
133802|NCT01747655|326806|P1|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||14
133803|NCT01747655|326805|P2|COMPLETED|PEG-J Period (Duodopa Treatment)||6
133804|NCT01747655|326806|P1|COMPLETED|PEG-J Period (Duodopa Treatment)||44
133805|NCT01747655|326805|P2|STARTED|PEG-J Period (Duodopa Treatment)|Participants in the MAS that returned to SoC (no PEG-J introduced; did not meet selection criteria)|6
133806|NCT01747655|326806|P1|STARTED|PEG-J Period (Duodopa Treatment)|Dudopa MAS: Participants in the MAS that received Duodopa via PEG-J.|58
133807|NCT01747655|326805|P2|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
133808|NCT01747655|326806|P1|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
134055|NCT01746901|326986|P3|STARTED|Treatment Phase: Washout Period 3||0
133809|NCT01747655|326805|P2|COMPLETED|Temporary Naso-jejunal Tube Period||0
133810|NCT01747655|326806|P1|COMPLETED|Temporary Naso-jejunal Tube Period||64
133811|NCT01747655|326805|P2|STARTED|Temporary Naso-jejunal Tube Period||0
133812|NCT01747655|326806|P1|STARTED|Temporary Naso-jejunal Tube Period|Main Analysis Set (MAS): participants with baseline and 1 further visit and ≥ 1 Duodopa treatment|64
133813|NCT01747629|326836|P2|NOT COMPLETED|Overall Study||6
133814|NCT01747629|326837|P1|NOT COMPLETED|Overall Study||8
133815|NCT01747629|326836|P2|COMPLETED|Overall Study||69
133816|NCT01747629|326837|P1|COMPLETED|Overall Study||77
133817|NCT01747629|326836|P2|Treated|Overall Study|Safety set and full analysis set|75
133818|NCT01747629|326837|P1|Treated|Overall Study|Safety set and full analysis set|84
133819|NCT01747629|326836|P2|STARTED|Overall Study||75
133820|NCT01747629|326837|P1|STARTED|Overall Study||85
133821|NCT01747551|326871|P2|NOT COMPLETED|Overall Study||21
133822|NCT01747551|326872|P1|NOT COMPLETED|Overall Study||43
133823|NCT01747551|326871|P2|COMPLETED|Overall Study||0
133824|NCT01747551|326872|P1|COMPLETED|Overall Study||0
133825|NCT01747551|326871|P2|STARTED|Overall Study||21
133826|NCT01747551|326872|P1|STARTED|Overall Study||43
133827|NCT01747499|326889|P5|NOT COMPLETED|Overall Study||15
133828|NCT01747499|326890|P4|NOT COMPLETED|Overall Study||2
133829|NCT01747499|326891|P3|NOT COMPLETED|Overall Study||0
133830|NCT01747499|326892|P2|NOT COMPLETED|Overall Study||1
133831|NCT01747499|326893|P1|NOT COMPLETED|Overall Study||1
133832|NCT01747499|326889|P5|COMPLETED|Overall Study||24
133833|NCT01747499|326890|P4|COMPLETED|Overall Study||4
133834|NCT01747499|326891|P3|COMPLETED|Overall Study||3
133835|NCT01747499|326892|P2|COMPLETED|Overall Study||2
133836|NCT01747499|326893|P1|COMPLETED|Overall Study||2
133837|NCT01747499|326889|P5|STARTED|Overall Study||39
133838|NCT01747499|326890|P4|STARTED|Overall Study||6
133839|NCT01747499|326891|P3|STARTED|Overall Study||3
133840|NCT01747499|326892|P2|STARTED|Overall Study||3
133841|NCT01747499|326893|P1|STARTED|Overall Study||3
133842|NCT01747486|326929|P2|NOT COMPLETED|Stage 2||0
133843|NCT01747486|326930|P1|NOT COMPLETED|Stage 2||9
133844|NCT01747486|326929|P2|COMPLETED|Stage 2||0
133845|NCT01747486|326930|P1|COMPLETED|Stage 2||3
133846|NCT01747486|326929|P2|STARTED|Stage 2||0
133847|NCT01747486|326930|P1|STARTED|Stage 2||12
133848|NCT01747486|326929|P2|NOT COMPLETED|Stage 1||13
133849|NCT01747486|326930|P1|NOT COMPLETED|Stage 1||12
133850|NCT01747486|326929|P2|COMPLETED|Stage 1||2
133851|NCT01747486|326930|P1|COMPLETED|Stage 1||3
133852|NCT01747486|326929|P2|STARTED|Stage 1||15
133853|NCT01747486|326930|P1|STARTED|Stage 1||15
133854|NCT01747343|326936|P1|NOT COMPLETED|Underwear/Differential Reinforcement||0
133855|NCT01747343|326936|P1|COMPLETED|Underwear/Differential Reinforcement||4
133856|NCT01747343|326936|P1|STARTED|Underwear/Differential Reinforcement||4
133857|NCT01747343|326936|P1|NOT COMPLETED|Underwear||0
133858|NCT01747343|326936|P1|COMPLETED|Underwear||4
133859|NCT01747343|326936|P1|STARTED|Underwear||4
133860|NCT01747343|326936|P1|NOT COMPLETED|Baseline||0
133861|NCT01747343|326936|P1|COMPLETED|Baseline||4
133862|NCT01747343|326936|P1|STARTED|Baseline||4
133863|NCT01747330|326942|P1|NOT COMPLETED|Overall Study||0
133864|NCT01747330|326942|P1|COMPLETED|Overall Study||40
133865|NCT01747330|326942|P1|STARTED|Overall Study||40
133866|NCT01746979|326956|P2|NOT COMPLETED|Overall Study||347
133867|NCT01746979|326957|P1|NOT COMPLETED|Overall Study||346
133868|NCT01746979|326956|P2|COMPLETED|Overall Study||0
133869|NCT01746979|326957|P1|COMPLETED|Overall Study||0
133870|NCT01746979|326956|P2|STARTED|Overall Study||347
133871|NCT01746979|326957|P1|STARTED|Overall Study||346
133872|NCT01746940|326969|P4|NOT COMPLETED|Safety Second Phase||0
133873|NCT01746940|326970|P3|NOT COMPLETED|Safety Second Phase||0
133874|NCT01746940|326971|P2|NOT COMPLETED|Safety Second Phase||0
133875|NCT01746940|326972|P1|NOT COMPLETED|Safety Second Phase||0
133876|NCT01746940|326969|P4|COMPLETED|Safety Second Phase||0
133877|NCT01746940|326970|P3|COMPLETED|Safety Second Phase||0
133878|NCT01746940|326971|P2|COMPLETED|Safety Second Phase||18
133879|NCT01746940|326972|P1|COMPLETED|Safety Second Phase||18
133880|NCT01746940|326969|P4|STARTED|Safety Second Phase||0
133881|NCT01746940|326970|P3|STARTED|Safety Second Phase||0
133882|NCT01746940|326971|P2|STARTED|Safety Second Phase||18
133883|NCT01746940|326972|P1|STARTED|Safety Second Phase||18
133884|NCT01746940|326969|P4|NOT COMPLETED|Safety and Efficacy First Phase||3
133885|NCT01746940|326970|P3|NOT COMPLETED|Safety and Efficacy First Phase||0
133886|NCT01746940|326971|P2|NOT COMPLETED|Safety and Efficacy First Phase||0
133887|NCT01746940|326972|P1|NOT COMPLETED|Safety and Efficacy First Phase||0
133888|NCT01746940|326969|P4|COMPLETED|Safety and Efficacy First Phase||0
133889|NCT01746940|326970|P3|COMPLETED|Safety and Efficacy First Phase||40
133890|NCT01746940|326971|P2|COMPLETED|Safety and Efficacy First Phase||41
133891|NCT01746940|326972|P1|COMPLETED|Safety and Efficacy First Phase||39
133892|NCT01746940|326969|P4|STARTED|Safety and Efficacy First Phase||3
133893|NCT01746940|326970|P3|STARTED|Safety and Efficacy First Phase||40
133894|NCT01746940|326971|P2|STARTED|Safety and Efficacy First Phase||41
133895|NCT01746940|326972|P1|STARTED|Safety and Efficacy First Phase||39
133896|NCT01746901|326980|P9|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
133897|NCT01746901|326981|P8|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
133898|NCT01746901|326982|P7|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
133899|NCT01746901|326983|P6|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
133900|NCT01746901|326984|P5|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
133901|NCT01746901|326985|P4|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
133902|NCT01746901|326986|P3|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
133903|NCT01746901|326987|P2|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
133904|NCT01746901|326988|P1|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
133905|NCT01746901|326980|P9|COMPLETED|Treatment Phase: Sixth Intervention||5
133906|NCT01746901|326981|P8|COMPLETED|Treatment Phase: Sixth Intervention||6
133907|NCT01746901|326982|P7|COMPLETED|Treatment Phase: Sixth Intervention||5
133908|NCT01746901|326983|P6|COMPLETED|Treatment Phase: Sixth Intervention||5
133909|NCT01746901|326984|P5|COMPLETED|Treatment Phase: Sixth Intervention||6
133910|NCT01746901|326985|P4|COMPLETED|Treatment Phase: Sixth Intervention||5
133911|NCT01746901|326986|P3|COMPLETED|Treatment Phase: Sixth Intervention||0
133912|NCT01746901|326987|P2|COMPLETED|Treatment Phase: Sixth Intervention||0
133913|NCT01746901|326988|P1|COMPLETED|Treatment Phase: Sixth Intervention||0
133914|NCT01746901|326980|P9|STARTED|Treatment Phase: Sixth Intervention||5
133915|NCT01746901|326981|P8|STARTED|Treatment Phase: Sixth Intervention||6
133916|NCT01746901|326982|P7|STARTED|Treatment Phase: Sixth Intervention||5
133917|NCT01746901|326983|P6|STARTED|Treatment Phase: Sixth Intervention||5
133918|NCT01746901|326984|P5|STARTED|Treatment Phase: Sixth Intervention||6
133919|NCT01746901|326985|P4|STARTED|Treatment Phase: Sixth Intervention||5
133920|NCT01746901|326986|P3|STARTED|Treatment Phase: Sixth Intervention||0
133921|NCT01746901|326987|P2|STARTED|Treatment Phase: Sixth Intervention||0
133922|NCT01746901|326988|P1|STARTED|Treatment Phase: Sixth Intervention||0
133923|NCT01746901|326980|P9|NOT COMPLETED|Treatment Phase: Washout Period 5||0
133924|NCT01746901|326981|P8|NOT COMPLETED|Treatment Phase: Washout Period 5||0
133925|NCT01746901|326982|P7|NOT COMPLETED|Treatment Phase: Washout Period 5||0
133926|NCT01746901|326983|P6|NOT COMPLETED|Treatment Phase: Washout Period 5||0
133927|NCT01746901|326984|P5|NOT COMPLETED|Treatment Phase: Washout Period 5||0
133928|NCT01746901|326985|P4|NOT COMPLETED|Treatment Phase: Washout Period 5||0
133929|NCT01746901|326986|P3|NOT COMPLETED|Treatment Phase: Washout Period 5||0
133930|NCT01746901|326987|P2|NOT COMPLETED|Treatment Phase: Washout Period 5||0
133931|NCT01746901|326988|P1|NOT COMPLETED|Treatment Phase: Washout Period 5||0
133932|NCT01746901|326980|P9|COMPLETED|Treatment Phase: Washout Period 5||5
133933|NCT01746901|326981|P8|COMPLETED|Treatment Phase: Washout Period 5||6
133934|NCT01746901|326982|P7|COMPLETED|Treatment Phase: Washout Period 5||5
133935|NCT01746901|326983|P6|COMPLETED|Treatment Phase: Washout Period 5||5
133936|NCT01746901|326984|P5|COMPLETED|Treatment Phase: Washout Period 5||6
133937|NCT01746901|326985|P4|COMPLETED|Treatment Phase: Washout Period 5||5
133938|NCT01746901|326986|P3|COMPLETED|Treatment Phase: Washout Period 5||0
133939|NCT01746901|326987|P2|COMPLETED|Treatment Phase: Washout Period 5||0
133940|NCT01746901|326988|P1|COMPLETED|Treatment Phase: Washout Period 5||0
133941|NCT01746901|326980|P9|STARTED|Treatment Phase: Washout Period 5||5
133942|NCT01746901|326981|P8|STARTED|Treatment Phase: Washout Period 5||6
133943|NCT01746901|326982|P7|STARTED|Treatment Phase: Washout Period 5||5
133944|NCT01746901|326983|P6|STARTED|Treatment Phase: Washout Period 5||5
133945|NCT01746901|326984|P5|STARTED|Treatment Phase: Washout Period 5||6
133946|NCT01746901|326985|P4|STARTED|Treatment Phase: Washout Period 5||5
133947|NCT01746901|326986|P3|STARTED|Treatment Phase: Washout Period 5||0
133948|NCT01746901|326987|P2|STARTED|Treatment Phase: Washout Period 5||0
133949|NCT01746901|326988|P1|STARTED|Treatment Phase: Washout Period 5||0
133950|NCT01746901|326980|P9|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
133951|NCT01746901|326981|P8|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
133952|NCT01746901|326982|P7|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
133953|NCT01746901|326983|P6|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
133954|NCT01746901|326984|P5|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
133955|NCT01746901|326985|P4|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
133956|NCT01746901|326986|P3|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
133957|NCT01746901|326987|P2|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
133958|NCT01746901|326988|P1|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
133959|NCT01746901|326980|P9|COMPLETED|Treatment Phase: Fifth Intervention||5
133960|NCT01746901|326981|P8|COMPLETED|Treatment Phase: Fifth Intervention||6
133961|NCT01746901|326982|P7|COMPLETED|Treatment Phase: Fifth Intervention||5
133962|NCT01746901|326983|P6|COMPLETED|Treatment Phase: Fifth Intervention||5
133963|NCT01746901|326984|P5|COMPLETED|Treatment Phase: Fifth Intervention||6
133964|NCT01746901|326985|P4|COMPLETED|Treatment Phase: Fifth Intervention||5
133965|NCT01746901|326986|P3|COMPLETED|Treatment Phase: Fifth Intervention||0
133966|NCT01746901|326987|P2|COMPLETED|Treatment Phase: Fifth Intervention||0
133967|NCT01746901|326988|P1|COMPLETED|Treatment Phase: Fifth Intervention||0
133968|NCT01746901|326980|P9|STARTED|Treatment Phase: Fifth Intervention||5
133969|NCT01746901|326981|P8|STARTED|Treatment Phase: Fifth Intervention||6
133970|NCT01746901|326982|P7|STARTED|Treatment Phase: Fifth Intervention||5
133971|NCT01746901|326983|P6|STARTED|Treatment Phase: Fifth Intervention||5
133972|NCT01746901|326984|P5|STARTED|Treatment Phase: Fifth Intervention||6
133973|NCT01746901|326985|P4|STARTED|Treatment Phase: Fifth Intervention||5
133974|NCT01746901|326986|P3|STARTED|Treatment Phase: Fifth Intervention||0
133975|NCT01746901|326987|P2|STARTED|Treatment Phase: Fifth Intervention||0
133976|NCT01746901|326988|P1|STARTED|Treatment Phase: Fifth Intervention||0
133977|NCT01746901|326980|P9|NOT COMPLETED|Treatment Phase: Washout Period 4||0
133978|NCT01746901|326981|P8|NOT COMPLETED|Treatment Phase: Washout Period 4||0
133979|NCT01746901|326982|P7|NOT COMPLETED|Treatment Phase: Washout Period 4||0
133980|NCT01746901|326983|P6|NOT COMPLETED|Treatment Phase: Washout Period 4||0
133981|NCT01746901|326984|P5|NOT COMPLETED|Treatment Phase: Washout Period 4||0
133982|NCT01746901|326985|P4|NOT COMPLETED|Treatment Phase: Washout Period 4||0
133983|NCT01746901|326986|P3|NOT COMPLETED|Treatment Phase: Washout Period 4||0
133984|NCT01746901|326987|P2|NOT COMPLETED|Treatment Phase: Washout Period 4||0
133985|NCT01746901|326988|P1|NOT COMPLETED|Treatment Phase: Washout Period 4||0
133986|NCT01746901|326980|P9|COMPLETED|Treatment Phase: Washout Period 4||5
133987|NCT01746901|326981|P8|COMPLETED|Treatment Phase: Washout Period 4||6
133988|NCT01746901|326982|P7|COMPLETED|Treatment Phase: Washout Period 4||5
133989|NCT01746901|326983|P6|COMPLETED|Treatment Phase: Washout Period 4||5
133990|NCT01746901|326984|P5|COMPLETED|Treatment Phase: Washout Period 4||6
133991|NCT01746901|326985|P4|COMPLETED|Treatment Phase: Washout Period 4||5
133992|NCT01746901|326986|P3|COMPLETED|Treatment Phase: Washout Period 4||0
133993|NCT01746901|326987|P2|COMPLETED|Treatment Phase: Washout Period 4||0
133994|NCT01746901|326988|P1|COMPLETED|Treatment Phase: Washout Period 4||0
133995|NCT01746901|326980|P9|STARTED|Treatment Phase: Washout Period 4||5
133996|NCT01746901|326981|P8|STARTED|Treatment Phase: Washout Period 4||6
133997|NCT01746901|326982|P7|STARTED|Treatment Phase: Washout Period 4||5
133998|NCT01746901|326983|P6|STARTED|Treatment Phase: Washout Period 4||5
133999|NCT01746901|326984|P5|STARTED|Treatment Phase: Washout Period 4||6
134000|NCT01746901|326985|P4|STARTED|Treatment Phase: Washout Period 4||5
134001|NCT01746901|326986|P3|STARTED|Treatment Phase: Washout Period 4||0
134002|NCT01746901|326987|P2|STARTED|Treatment Phase: Washout Period 4||0
134003|NCT01746901|326988|P1|STARTED|Treatment Phase: Washout Period 4||0
134004|NCT01746901|326980|P9|NOT COMPLETED|Treatment Phase: Fourth Intervention||2
134005|NCT01746901|326981|P8|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
134006|NCT01746901|326982|P7|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
134007|NCT01746901|326983|P6|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
134008|NCT01746901|326984|P5|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
134009|NCT01746901|326985|P4|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
134010|NCT01746901|326986|P3|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
134011|NCT01746901|326987|P2|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
134012|NCT01746901|326988|P1|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
134013|NCT01746901|326980|P9|COMPLETED|Treatment Phase: Fourth Intervention||5
134014|NCT01746901|326981|P8|COMPLETED|Treatment Phase: Fourth Intervention||6
134015|NCT01746901|326982|P7|COMPLETED|Treatment Phase: Fourth Intervention||5
134016|NCT01746901|326983|P6|COMPLETED|Treatment Phase: Fourth Intervention||5
134017|NCT01746901|326984|P5|COMPLETED|Treatment Phase: Fourth Intervention||6
134018|NCT01746901|326985|P4|COMPLETED|Treatment Phase: Fourth Intervention||5
134019|NCT01746901|326986|P3|COMPLETED|Treatment Phase: Fourth Intervention||0
134020|NCT01746901|326987|P2|COMPLETED|Treatment Phase: Fourth Intervention||0
134021|NCT01746901|326988|P1|COMPLETED|Treatment Phase: Fourth Intervention||0
134022|NCT01746901|326980|P9|STARTED|Treatment Phase: Fourth Intervention||7
134023|NCT01746901|326981|P8|STARTED|Treatment Phase: Fourth Intervention||6
134024|NCT01746901|326982|P7|STARTED|Treatment Phase: Fourth Intervention||6
134025|NCT01746901|326983|P6|STARTED|Treatment Phase: Fourth Intervention||6
134026|NCT01746901|326984|P5|STARTED|Treatment Phase: Fourth Intervention||6
134027|NCT01746901|326985|P4|STARTED|Treatment Phase: Fourth Intervention||6
134028|NCT01746901|326986|P3|STARTED|Treatment Phase: Fourth Intervention||0
134029|NCT01746901|326987|P2|STARTED|Treatment Phase: Fourth Intervention||0
134030|NCT01746901|326988|P1|STARTED|Treatment Phase: Fourth Intervention||0
134031|NCT01746901|326980|P9|NOT COMPLETED|Treatment Phase: Washout Period 3||0
134032|NCT01746901|326981|P8|NOT COMPLETED|Treatment Phase: Washout Period 3||0
134033|NCT01746901|326982|P7|NOT COMPLETED|Treatment Phase: Washout Period 3||0
134034|NCT01746901|326983|P6|NOT COMPLETED|Treatment Phase: Washout Period 3||0
134035|NCT01746901|326984|P5|NOT COMPLETED|Treatment Phase: Washout Period 3||0
134036|NCT01746901|326985|P4|NOT COMPLETED|Treatment Phase: Washout Period 3||0
134037|NCT01746901|326986|P3|NOT COMPLETED|Treatment Phase: Washout Period 3||0
134038|NCT01746901|326987|P2|NOT COMPLETED|Treatment Phase: Washout Period 3||0
134039|NCT01746901|326988|P1|NOT COMPLETED|Treatment Phase: Washout Period 3||0
134040|NCT01746901|326980|P9|COMPLETED|Treatment Phase: Washout Period 3||7
134041|NCT01746901|326981|P8|COMPLETED|Treatment Phase: Washout Period 3||6
134042|NCT01746901|326982|P7|COMPLETED|Treatment Phase: Washout Period 3||6
134043|NCT01746901|326983|P6|COMPLETED|Treatment Phase: Washout Period 3||6
134044|NCT01746901|326984|P5|COMPLETED|Treatment Phase: Washout Period 3||6
134045|NCT01746901|326985|P4|COMPLETED|Treatment Phase: Washout Period 3||6
134046|NCT01746901|326986|P3|COMPLETED|Treatment Phase: Washout Period 3||0
134047|NCT01746901|326987|P2|COMPLETED|Treatment Phase: Washout Period 3||0
134048|NCT01746901|326988|P1|COMPLETED|Treatment Phase: Washout Period 3||0
134049|NCT01746901|326980|P9|STARTED|Treatment Phase: Washout Period 3||7
134050|NCT01746901|326981|P8|STARTED|Treatment Phase: Washout Period 3||6
134051|NCT01746901|326982|P7|STARTED|Treatment Phase: Washout Period 3||6
134052|NCT01746901|326983|P6|STARTED|Treatment Phase: Washout Period 3||6
134053|NCT01746901|326984|P5|STARTED|Treatment Phase: Washout Period 3||6
134054|NCT01746901|326985|P4|STARTED|Treatment Phase: Washout Period 3||6
134056|NCT01746901|326987|P2|STARTED|Treatment Phase: Washout Period 3||0
134057|NCT01746901|326988|P1|STARTED|Treatment Phase: Washout Period 3||0
134058|NCT01746901|326980|P9|NOT COMPLETED|Treatment Phase: Third Intervention||0
134059|NCT01746901|326981|P8|NOT COMPLETED|Treatment Phase: Third Intervention||0
134060|NCT01746901|326982|P7|NOT COMPLETED|Treatment Phase: Third Intervention||1
134061|NCT01746901|326983|P6|NOT COMPLETED|Treatment Phase: Third Intervention||1
134062|NCT01746901|326984|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
134063|NCT01746901|326985|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
134064|NCT01746901|326986|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
134065|NCT01746901|326987|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
134066|NCT01746901|326988|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
134067|NCT01746901|326980|P9|COMPLETED|Treatment Phase: Third Intervention||7
134068|NCT01746901|326981|P8|COMPLETED|Treatment Phase: Third Intervention||6
134069|NCT01746901|326982|P7|COMPLETED|Treatment Phase: Third Intervention||6
134070|NCT01746901|326983|P6|COMPLETED|Treatment Phase: Third Intervention||6
134071|NCT01746901|326984|P5|COMPLETED|Treatment Phase: Third Intervention||6
134072|NCT01746901|326985|P4|COMPLETED|Treatment Phase: Third Intervention||6
134073|NCT01746901|326986|P3|COMPLETED|Treatment Phase: Third Intervention||0
134074|NCT01746901|326987|P2|COMPLETED|Treatment Phase: Third Intervention||0
134075|NCT01746901|326988|P1|COMPLETED|Treatment Phase: Third Intervention||0
134076|NCT01746901|326980|P9|STARTED|Treatment Phase: Third Intervention||7
134077|NCT01746901|326981|P8|STARTED|Treatment Phase: Third Intervention||6
134078|NCT01746901|326982|P7|STARTED|Treatment Phase: Third Intervention||7
134079|NCT01746901|326983|P6|STARTED|Treatment Phase: Third Intervention||7
134080|NCT01746901|326984|P5|STARTED|Treatment Phase: Third Intervention||6
134081|NCT01746901|326985|P4|STARTED|Treatment Phase: Third Intervention||6
134082|NCT01746901|326986|P3|STARTED|Treatment Phase: Third Intervention||0
134083|NCT01746901|326987|P2|STARTED|Treatment Phase: Third Intervention||0
134084|NCT01746901|326988|P1|STARTED|Treatment Phase: Third Intervention||0
134085|NCT01746901|326980|P9|NOT COMPLETED|Treatment Phase: Washout Period 2||0
134086|NCT01746901|326981|P8|NOT COMPLETED|Treatment Phase: Washout Period 2||0
134087|NCT01746901|326982|P7|NOT COMPLETED|Treatment Phase: Washout Period 2||0
134088|NCT01746901|326983|P6|NOT COMPLETED|Treatment Phase: Washout Period 2||0
134089|NCT01746901|326984|P5|NOT COMPLETED|Treatment Phase: Washout Period 2||0
134090|NCT01746901|326985|P4|NOT COMPLETED|Treatment Phase: Washout Period 2||0
134091|NCT01746901|326986|P3|NOT COMPLETED|Treatment Phase: Washout Period 2||0
134092|NCT01746901|326987|P2|NOT COMPLETED|Treatment Phase: Washout Period 2||0
134093|NCT01746901|326988|P1|NOT COMPLETED|Treatment Phase: Washout Period 2||0
134094|NCT01746901|326980|P9|COMPLETED|Treatment Phase: Washout Period 2||7
134095|NCT01746901|326981|P8|COMPLETED|Treatment Phase: Washout Period 2||6
134096|NCT01746901|326982|P7|COMPLETED|Treatment Phase: Washout Period 2||7
134097|NCT01746901|326983|P6|COMPLETED|Treatment Phase: Washout Period 2||7
134098|NCT01746901|326984|P5|COMPLETED|Treatment Phase: Washout Period 2||6
134099|NCT01746901|326985|P4|COMPLETED|Treatment Phase: Washout Period 2||6
134100|NCT01746901|326986|P3|COMPLETED|Treatment Phase: Washout Period 2||0
134101|NCT01746901|326987|P2|COMPLETED|Treatment Phase: Washout Period 2||0
134102|NCT01746901|326988|P1|COMPLETED|Treatment Phase: Washout Period 2||0
134103|NCT01746901|326980|P9|STARTED|Treatment Phase: Washout Period 2||7
134104|NCT01746901|326981|P8|STARTED|Treatment Phase: Washout Period 2||6
134105|NCT01746901|326982|P7|STARTED|Treatment Phase: Washout Period 2||7
134106|NCT01746901|326983|P6|STARTED|Treatment Phase: Washout Period 2||7
134107|NCT01746901|326984|P5|STARTED|Treatment Phase: Washout Period 2||6
134108|NCT01746901|326985|P4|STARTED|Treatment Phase: Washout Period 2||6
134109|NCT01746901|326986|P3|STARTED|Treatment Phase: Washout Period 2||0
134110|NCT01746901|326987|P2|STARTED|Treatment Phase: Washout Period 2||0
134111|NCT01746901|326988|P1|STARTED|Treatment Phase: Washout Period 2||0
134112|NCT01746901|326980|P9|NOT COMPLETED|Treatment Phase: Second Intervention||0
134113|NCT01746901|326981|P8|NOT COMPLETED|Treatment Phase: Second Intervention||1
134114|NCT01746901|326982|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
134115|NCT01746901|326983|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
134116|NCT01746901|326984|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
134117|NCT01746901|326985|P4|NOT COMPLETED|Treatment Phase: Second Intervention||0
134118|NCT01746901|326986|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
134119|NCT01746901|326987|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
134120|NCT01746901|326988|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
134121|NCT01746901|326980|P9|COMPLETED|Treatment Phase: Second Intervention||7
134122|NCT01746901|326981|P8|COMPLETED|Treatment Phase: Second Intervention||6
134123|NCT01746901|326982|P7|COMPLETED|Treatment Phase: Second Intervention||7
134124|NCT01746901|326983|P6|COMPLETED|Treatment Phase: Second Intervention||7
134125|NCT01746901|326984|P5|COMPLETED|Treatment Phase: Second Intervention||6
134126|NCT01746901|326985|P4|COMPLETED|Treatment Phase: Second Intervention||6
134127|NCT01746901|326986|P3|COMPLETED|Treatment Phase: Second Intervention||0
134128|NCT01746901|326987|P2|COMPLETED|Treatment Phase: Second Intervention||0
134129|NCT01746901|326988|P1|COMPLETED|Treatment Phase: Second Intervention||0
134130|NCT01746901|326980|P9|STARTED|Treatment Phase: Second Intervention||7
134131|NCT01746901|326981|P8|STARTED|Treatment Phase: Second Intervention||7
134132|NCT01746901|326982|P7|STARTED|Treatment Phase: Second Intervention||7
134133|NCT01746901|326983|P6|STARTED|Treatment Phase: Second Intervention||7
134134|NCT01746901|326984|P5|STARTED|Treatment Phase: Second Intervention||6
134135|NCT01746901|326985|P4|STARTED|Treatment Phase: Second Intervention||6
134136|NCT01746901|326986|P3|STARTED|Treatment Phase: Second Intervention||0
134137|NCT01746901|326987|P2|STARTED|Treatment Phase: Second Intervention||0
134138|NCT01746901|326988|P1|STARTED|Treatment Phase: Second Intervention||0
134139|NCT01746901|326980|P9|NOT COMPLETED|Treatment Phase: Washout Period 1||0
134140|NCT01746901|326981|P8|NOT COMPLETED|Treatment Phase: Washout Period 1||0
134141|NCT01746901|326982|P7|NOT COMPLETED|Treatment Phase: Washout Period 1||0
134142|NCT01746901|326983|P6|NOT COMPLETED|Treatment Phase: Washout Period 1||0
134143|NCT01746901|326984|P5|NOT COMPLETED|Treatment Phase: Washout Period 1||0
134144|NCT01746901|326985|P4|NOT COMPLETED|Treatment Phase: Washout Period 1||0
134145|NCT01746901|326986|P3|NOT COMPLETED|Treatment Phase: Washout Period 1||0
134146|NCT01746901|326987|P2|NOT COMPLETED|Treatment Phase: Washout Period 1||0
134147|NCT01746901|326988|P1|NOT COMPLETED|Treatment Phase: Washout Period 1||0
134148|NCT01746901|326980|P9|COMPLETED|Treatment Phase: Washout Period 1||7
134149|NCT01746901|326981|P8|COMPLETED|Treatment Phase: Washout Period 1||7
134150|NCT01746901|326982|P7|COMPLETED|Treatment Phase: Washout Period 1||7
134151|NCT01746901|326983|P6|COMPLETED|Treatment Phase: Washout Period 1||7
134152|NCT01746901|326984|P5|COMPLETED|Treatment Phase: Washout Period 1||6
134153|NCT01746901|326985|P4|COMPLETED|Treatment Phase: Washout Period 1||6
134154|NCT01746901|326986|P3|COMPLETED|Treatment Phase: Washout Period 1||0
134155|NCT01746901|326987|P2|COMPLETED|Treatment Phase: Washout Period 1||0
134156|NCT01746901|326988|P1|COMPLETED|Treatment Phase: Washout Period 1||0
134157|NCT01746901|326980|P9|STARTED|Treatment Phase: Washout Period 1||7
134158|NCT01746901|326981|P8|STARTED|Treatment Phase: Washout Period 1||7
134159|NCT01746901|326982|P7|STARTED|Treatment Phase: Washout Period 1||7
134160|NCT01746901|326983|P6|STARTED|Treatment Phase: Washout Period 1||7
134161|NCT01746901|326984|P5|STARTED|Treatment Phase: Washout Period 1||6
134162|NCT01746901|326985|P4|STARTED|Treatment Phase: Washout Period 1||6
134163|NCT01746901|326986|P3|STARTED|Treatment Phase: Washout Period 1||0
134164|NCT01746901|326987|P2|STARTED|Treatment Phase: Washout Period 1||0
134165|NCT01746901|326988|P1|STARTED|Treatment Phase: Washout Period 1||0
134166|NCT01746901|326980|P9|NOT COMPLETED|Treatment Phase: First Intervention||0
134167|NCT01746901|326981|P8|NOT COMPLETED|Treatment Phase: First Intervention||0
134168|NCT01746901|326982|P7|NOT COMPLETED|Treatment Phase: First Intervention||1
134169|NCT01746901|326983|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
134170|NCT01746901|326984|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
134171|NCT01746901|326985|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
134172|NCT01746901|326986|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
134173|NCT01746901|326987|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
134174|NCT01746901|326988|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
134175|NCT01746901|326980|P9|COMPLETED|Treatment Phase: First Intervention||7
134176|NCT01746901|326981|P8|COMPLETED|Treatment Phase: First Intervention||7
134177|NCT01746901|326982|P7|COMPLETED|Treatment Phase: First Intervention||7
134178|NCT01746901|326983|P6|COMPLETED|Treatment Phase: First Intervention||7
134179|NCT01746901|326984|P5|COMPLETED|Treatment Phase: First Intervention||6
134180|NCT01746901|326985|P4|COMPLETED|Treatment Phase: First Intervention||6
134181|NCT01746901|326986|P3|COMPLETED|Treatment Phase: First Intervention||0
134182|NCT01746901|326987|P2|COMPLETED|Treatment Phase: First Intervention||0
134183|NCT01746901|326988|P1|COMPLETED|Treatment Phase: First Intervention||0
134184|NCT01746901|326980|P9|STARTED|Treatment Phase: First Intervention||7
134185|NCT01746901|326981|P8|STARTED|Treatment Phase: First Intervention||7
134186|NCT01746901|326982|P7|STARTED|Treatment Phase: First Intervention||8
134187|NCT01746901|326983|P6|STARTED|Treatment Phase: First Intervention||7
134188|NCT01746901|326984|P5|STARTED|Treatment Phase: First Intervention||6
134189|NCT01746901|326985|P4|STARTED|Treatment Phase: First Intervention||6
134190|NCT01746901|326986|P3|STARTED|Treatment Phase: First Intervention||0
134191|NCT01746901|326987|P2|STARTED|Treatment Phase: First Intervention||0
134192|NCT01746901|326988|P1|STARTED|Treatment Phase: First Intervention||0
134193|NCT01746901|326980|P9|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
134194|NCT01746901|326981|P8|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
134195|NCT01746901|326982|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
134196|NCT01746901|326983|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
134197|NCT01746901|326984|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
134198|NCT01746901|326985|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
134199|NCT01746901|326986|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||14
134200|NCT01746901|326987|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||14
134201|NCT01746901|326988|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
134202|NCT01746901|326980|P9|COMPLETED|Drug Discrimination Phase: Day 2||0
134203|NCT01746901|326981|P8|COMPLETED|Drug Discrimination Phase: Day 2||0
134204|NCT01746901|326982|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
134205|NCT01746901|326983|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
134206|NCT01746901|326984|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
134207|NCT01746901|326985|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
134208|NCT01746901|326986|P3|COMPLETED|Drug Discrimination Phase: Day 2||22
134209|NCT01746901|326987|P2|COMPLETED|Drug Discrimination Phase: Day 2||19
134210|NCT01746901|326988|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
134211|NCT01746901|326980|P9|STARTED|Drug Discrimination Phase: Day 2||0
134212|NCT01746901|326981|P8|STARTED|Drug Discrimination Phase: Day 2||0
134213|NCT01746901|326982|P7|STARTED|Drug Discrimination Phase: Day 2||0
134214|NCT01746901|326983|P6|STARTED|Drug Discrimination Phase: Day 2||0
134215|NCT01746901|326984|P5|STARTED|Drug Discrimination Phase: Day 2||0
134216|NCT01746901|326985|P4|STARTED|Drug Discrimination Phase: Day 2||0
134217|NCT01746901|326986|P3|STARTED|Drug Discrimination Phase: Day 2||36
134218|NCT01746901|326987|P2|STARTED|Drug Discrimination Phase: Day 2||33
134219|NCT01746901|326988|P1|STARTED|Drug Discrimination Phase: Day 2||0
134220|NCT01746901|326980|P9|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
134221|NCT01746901|326981|P8|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
134222|NCT01746901|326982|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
134223|NCT01746901|326983|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
134224|NCT01746901|326984|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
134225|NCT01746901|326985|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
134226|NCT01746901|326986|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
134227|NCT01746901|326987|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
134228|NCT01746901|326988|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
134229|NCT01746901|326980|P9|COMPLETED|Drug Discrimination Phase: Day 1||0
134230|NCT01746901|326981|P8|COMPLETED|Drug Discrimination Phase: Day 1||0
134231|NCT01746901|326982|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
134232|NCT01746901|326983|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
134233|NCT01746901|326984|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
134234|NCT01746901|326985|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
134235|NCT01746901|326986|P3|COMPLETED|Drug Discrimination Phase: Day 1||36
134236|NCT01746901|326987|P2|COMPLETED|Drug Discrimination Phase: Day 1||33
134237|NCT01746901|326988|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
134238|NCT01746901|326980|P9|STARTED|Drug Discrimination Phase: Day 1||0
134239|NCT01746901|326981|P8|STARTED|Drug Discrimination Phase: Day 1||0
134240|NCT01746901|326982|P7|STARTED|Drug Discrimination Phase: Day 1||0
134241|NCT01746901|326983|P6|STARTED|Drug Discrimination Phase: Day 1||0
134242|NCT01746901|326984|P5|STARTED|Drug Discrimination Phase: Day 1||0
134243|NCT01746901|326985|P4|STARTED|Drug Discrimination Phase: Day 1||0
134244|NCT01746901|326986|P3|STARTED|Drug Discrimination Phase: Day 1||36
134245|NCT01746901|326987|P2|STARTED|Drug Discrimination Phase: Day 1||36
134246|NCT01746901|326988|P1|STARTED|Drug Discrimination Phase: Day 1||0
134247|NCT01746901|326980|P9|NOT COMPLETED|Naloxone Challenge Phase||0
134248|NCT01746901|326981|P8|NOT COMPLETED|Naloxone Challenge Phase||0
134249|NCT01746901|326982|P7|NOT COMPLETED|Naloxone Challenge Phase||0
134250|NCT01746901|326983|P6|NOT COMPLETED|Naloxone Challenge Phase||0
134251|NCT01746901|326984|P5|NOT COMPLETED|Naloxone Challenge Phase||0
134252|NCT01746901|326985|P4|NOT COMPLETED|Naloxone Challenge Phase||0
134253|NCT01746901|326986|P3|NOT COMPLETED|Naloxone Challenge Phase||0
134254|NCT01746901|326987|P2|NOT COMPLETED|Naloxone Challenge Phase||0
134255|NCT01746901|326988|P1|NOT COMPLETED|Naloxone Challenge Phase||3
134256|NCT01746901|326980|P9|COMPLETED|Naloxone Challenge Phase||0
134257|NCT01746901|326981|P8|COMPLETED|Naloxone Challenge Phase||0
134258|NCT01746901|326982|P7|COMPLETED|Naloxone Challenge Phase||0
134259|NCT01746901|326983|P6|COMPLETED|Naloxone Challenge Phase||0
134260|NCT01746901|326984|P5|COMPLETED|Naloxone Challenge Phase||0
134261|NCT01746901|326985|P4|COMPLETED|Naloxone Challenge Phase||0
134262|NCT01746901|326986|P3|COMPLETED|Naloxone Challenge Phase||0
134263|NCT01746901|326987|P2|COMPLETED|Naloxone Challenge Phase||0
134264|NCT01746901|326988|P1|COMPLETED|Naloxone Challenge Phase||72
134265|NCT01746901|326980|P9|STARTED|Naloxone Challenge Phase||0
134266|NCT01746901|326981|P8|STARTED|Naloxone Challenge Phase||0
134267|NCT01746901|326982|P7|STARTED|Naloxone Challenge Phase||0
134268|NCT01746901|326983|P6|STARTED|Naloxone Challenge Phase||0
134269|NCT01746901|326984|P5|STARTED|Naloxone Challenge Phase||0
134270|NCT01746901|326985|P4|STARTED|Naloxone Challenge Phase||0
134271|NCT01746901|326986|P3|STARTED|Naloxone Challenge Phase||0
134272|NCT01746901|326987|P2|STARTED|Naloxone Challenge Phase||0
134273|NCT01746901|326988|P1|STARTED|Naloxone Challenge Phase||75
134274|NCT01746862|327311|P2|NOT COMPLETED|Overall Study||3
134275|NCT01746862|327312|P1|NOT COMPLETED|Overall Study||8
134276|NCT01746862|327311|P2|COMPLETED|Overall Study||27
134277|NCT01746862|327312|P1|COMPLETED|Overall Study||52
134278|NCT01746862|327311|P2|Treated|Overall Study||30
134279|NCT01746862|327312|P1|Treated|Overall Study||59
134280|NCT01746862|327311|P2|STARTED|Overall Study||30
134281|NCT01746862|327312|P1|STARTED|Overall Study||60
134282|NCT01746784|327337|P5|NOT COMPLETED|Overall Study||0
134283|NCT01746784|327338|P4|NOT COMPLETED|Overall Study||0
134284|NCT01746784|327339|P3|NOT COMPLETED|Overall Study||0
134285|NCT01746784|327340|P2|NOT COMPLETED|Overall Study||0
134286|NCT01746784|327341|P1|NOT COMPLETED|Overall Study||0
134287|NCT01746784|327337|P5|COMPLETED|Overall Study||19
134288|NCT01746784|327338|P4|COMPLETED|Overall Study||9
134289|NCT01746784|327339|P3|COMPLETED|Overall Study||9
134290|NCT01746784|327340|P2|COMPLETED|Overall Study||10
134291|NCT01746784|327341|P1|COMPLETED|Overall Study||19
134292|NCT01746784|327337|P5|Enrolled|Overall Study||19
134293|NCT01746784|327338|P4|Enrolled|Overall Study||9
134294|NCT01746784|327339|P3|Enrolled|Overall Study||9
134295|NCT01746784|327340|P2|Enrolled|Overall Study||10
134296|NCT01746784|327341|P1|Enrolled|Overall Study||19
134297|NCT01746784|327337|P5|STARTED|Overall Study||19
134298|NCT01746784|327338|P4|STARTED|Overall Study||9
134299|NCT01746784|327339|P3|STARTED|Overall Study||9
134300|NCT01746784|327340|P2|STARTED|Overall Study||10
134301|NCT01746784|327341|P1|STARTED|Overall Study||19
134302|NCT01746745|327363|P1|NOT COMPLETED|Overall Study||0
134303|NCT01746745|327363|P1|COMPLETED|Overall Study||6
134304|NCT01746745|327363|P1|Received Study Drug|Overall Study||6
134305|NCT01746745|327363|P1|STARTED|Overall Study||6
134306|NCT01746732|327376|P3|NOT COMPLETED|Period 2||4
134307|NCT01746732|327377|P2|NOT COMPLETED|Period 2||0
134308|NCT01746732|327378|P1|NOT COMPLETED|Period 2||0
134309|NCT01746732|327376|P3|COMPLETED|Period 2||7
134310|NCT01746732|327377|P2|COMPLETED|Period 2||10
134311|NCT01746732|327378|P1|COMPLETED|Period 2||0
134312|NCT01746732|327376|P3|STARTED|Period 2||11
134313|NCT01746732|327377|P2|STARTED|Period 2||10
134314|NCT01746732|327378|P1|STARTED|Period 2||0
134315|NCT01746732|327376|P3|NOT COMPLETED|Period 1||0
134316|NCT01746732|327377|P2|NOT COMPLETED|Period 1||1
134317|NCT01746732|327378|P1|NOT COMPLETED|Period 1||0
134318|NCT01746732|327376|P3|COMPLETED|Period 1||11
134319|NCT01746732|327377|P2|COMPLETED|Period 1||10
134320|NCT01746732|327378|P1|COMPLETED|Period 1||0
134321|NCT01746732|327376|P3|STARTED|Period 1||11
134322|NCT01746732|327377|P2|STARTED|Period 1||11
134323|NCT01746732|327378|P1|STARTED|Period 1||0
134324|NCT01746732|327376|P3|NOT COMPLETED|Lead-In Period||0
134325|NCT01746732|327377|P2|NOT COMPLETED|Lead-In Period||0
134326|NCT01746732|327378|P1|NOT COMPLETED|Lead-In Period||1
134327|NCT01746732|327376|P3|COMPLETED|Lead-In Period||0
134328|NCT01746732|327377|P2|COMPLETED|Lead-In Period||0
134329|NCT01746732|327378|P1|COMPLETED|Lead-In Period||22
134330|NCT01746732|327376|P3|Participants Received at Least 1 Dose|Lead-In Period||0
134331|NCT01746732|327377|P2|Participants Received at Least 1 Dose|Lead-In Period||0
134332|NCT01746732|327378|P1|Participants Received at Least 1 Dose|Lead-In Period||22
134333|NCT01746732|327376|P3|STARTED|Lead-In Period||0
134334|NCT01746732|327377|P2|STARTED|Lead-In Period||0
134335|NCT01746732|327378|P1|STARTED|Lead-In Period||23
134336|NCT01746511|327401|P2|NOT COMPLETED|Overall Study||0
134337|NCT01746511|327402|P1|NOT COMPLETED|Overall Study||0
134338|NCT01746511|327401|P2|COMPLETED|Overall Study||39
134339|NCT01746511|327402|P1|COMPLETED|Overall Study||40
134340|NCT01746511|327401|P2|STARTED|Overall Study||39
134341|NCT01746511|327402|P1|STARTED|Overall Study||40
134342|NCT01746420|327421|P5|NOT COMPLETED|Overall Study||0
134343|NCT01746420|327422|P4|NOT COMPLETED|Overall Study||0
134344|NCT01746420|327423|P3|NOT COMPLETED|Overall Study||3
134345|NCT01746420|327424|P2|NOT COMPLETED|Overall Study||2
134346|NCT01746420|327425|P1|NOT COMPLETED|Overall Study||3
134347|NCT01746420|327421|P5|COMPLETED|Overall Study||20
134348|NCT01746420|327422|P4|COMPLETED|Overall Study||20
134349|NCT01746420|327423|P3|COMPLETED|Overall Study||17
134350|NCT01746420|327424|P2|COMPLETED|Overall Study||18
134351|NCT01746420|327425|P1|COMPLETED|Overall Study||17
134352|NCT01746420|327421|P5|STARTED|Overall Study||20
134353|NCT01746420|327422|P4|STARTED|Overall Study||20
134354|NCT01746420|327423|P3|STARTED|Overall Study||20
134355|NCT01746420|327424|P2|STARTED|Overall Study||20
134356|NCT01746420|327425|P1|STARTED|Overall Study||20
134357|NCT01746368|327459|P2|NOT COMPLETED|Overall Study||1
134358|NCT01746368|327460|P1|NOT COMPLETED|Overall Study||2
134359|NCT01746368|327459|P2|COMPLETED|Overall Study||16
134360|NCT01746368|327460|P1|COMPLETED|Overall Study||31
134361|NCT01746368|327459|P2|Analyzed for Satisfaction|Overall Study||16
134362|NCT01746368|327460|P1|Analyzed for Satisfaction|Overall Study||30
134363|NCT01746368|327459|P2|Analyzed for AD Completion Rate|Overall Study||17
134364|NCT01746368|327460|P1|Analyzed for AD Completion Rate|Overall Study||32
134365|NCT01746368|327459|P2|Assessment Completed|Overall Study||16
134366|NCT01746368|327460|P1|Assessment Completed|Overall Study||31
134367|NCT01746368|327459|P2|Recieved Allocated Intervention|Overall Study||8
134368|NCT01746368|327460|P1|Recieved Allocated Intervention|Overall Study||31
134369|NCT01746368|327459|P2|STARTED|Overall Study||17
134370|NCT01746368|327460|P1|STARTED|Overall Study||33
134371|NCT01746264|327468|P1|NOT COMPLETED|Overall Study||0
134372|NCT01746264|327468|P1|COMPLETED|Overall Study||19
134373|NCT01746264|327468|P1|STARTED|Overall Study||19
134374|NCT01746173|327487|P1|NOT COMPLETED|Overall Study||2
134375|NCT01746173|327487|P1|COMPLETED|Overall Study||3
134376|NCT01746173|327487|P1|STARTED|Overall Study||5
134377|NCT01746108|327495|P3|NOT COMPLETED|Overall Study||0
134378|NCT01746108|327496|P2|NOT COMPLETED|Overall Study||4
134379|NCT01746108|327497|P1|NOT COMPLETED|Overall Study||0
134380|NCT01746108|327495|P3|COMPLETED|Overall Study||6
134381|NCT01746108|327496|P2|COMPLETED|Overall Study||24
134382|NCT01746108|327497|P1|COMPLETED|Overall Study||18
134383|NCT01746108|327495|P3|STARTED|Overall Study||6
134384|NCT01746108|327496|P2|STARTED|Overall Study||28
134385|NCT01746108|327497|P1|STARTED|Overall Study||18
134386|NCT01746043|327537|P4|NOT COMPLETED|Overall Study||0
134387|NCT01746043|327538|P3|NOT COMPLETED|Overall Study||0
134388|NCT01746043|327539|P2|NOT COMPLETED|Overall Study||0
134389|NCT01746043|327540|P1|NOT COMPLETED|Overall Study||0
134390|NCT01746043|327537|P4|COMPLETED|Overall Study||5
134391|NCT01746043|327538|P3|COMPLETED|Overall Study||5
134392|NCT01746043|327539|P2|COMPLETED|Overall Study||4
134393|NCT01746043|327540|P1|COMPLETED|Overall Study||5
134394|NCT01746043|327537|P4|STARTED|Overall Study||5
134395|NCT01746043|327538|P3|STARTED|Overall Study||5
134396|NCT01746043|327539|P2|STARTED|Overall Study||4
134397|NCT01746043|327540|P1|STARTED|Overall Study||5
134398|NCT01746017|327561|P11|NOT COMPLETED|Period 4||0
134399|NCT01746017|327562|P10|NOT COMPLETED|Period 4||0
134400|NCT01746017|327563|P9|NOT COMPLETED|Period 4||0
134401|NCT01746017|327564|P8|NOT COMPLETED|Period 4||0
134402|NCT01746017|327565|P7|NOT COMPLETED|Period 4||0
134403|NCT01746017|327566|P6|NOT COMPLETED|Period 4||0
134404|NCT01746017|327567|P5|NOT COMPLETED|Period 4||0
134405|NCT01746017|327568|P4|NOT COMPLETED|Period 4||0
134406|NCT01746017|327569|P3|NOT COMPLETED|Period 4||0
134407|NCT01746017|327570|P2|NOT COMPLETED|Period 4||0
134408|NCT01746017|327571|P1|NOT COMPLETED|Period 4||0
134409|NCT01746017|327561|P11|COMPLETED|Period 4||0
134410|NCT01746017|327562|P10|COMPLETED|Period 4||0
134411|NCT01746017|327563|P9|COMPLETED|Period 4||0
134412|NCT01746017|327564|P8|COMPLETED|Period 4||2
134413|NCT01746017|327565|P7|COMPLETED|Period 4||2
134414|NCT01746017|327566|P6|COMPLETED|Period 4||1
134415|NCT01746017|327567|P5|COMPLETED|Period 4||2
134416|NCT01746017|327568|P4|COMPLETED|Period 4||2
134417|NCT01746017|327569|P3|COMPLETED|Period 4||2
134418|NCT01746017|327570|P2|COMPLETED|Period 4||2
134419|NCT01746017|327571|P1|COMPLETED|Period 4||2
134420|NCT01746017|327561|P11|STARTED|Period 4|Part B occurred only for 3 periods.|0
134421|NCT01746017|327562|P10|STARTED|Period 4|Part B occurred only for 3 periods.|0
134422|NCT01746017|327563|P9|STARTED|Period 4|Part B occurred only for 3 periods.|0
134423|NCT01746017|327564|P8|STARTED|Period 4||2
134424|NCT01746017|327565|P7|STARTED|Period 4||2
134425|NCT01746017|327566|P6|STARTED|Period 4||1
134426|NCT01746017|327567|P5|STARTED|Period 4||2
134427|NCT01746017|327568|P4|STARTED|Period 4||2
134428|NCT01746017|327569|P3|STARTED|Period 4||2
134429|NCT01746017|327570|P2|STARTED|Period 4||2
134430|NCT01746017|327571|P1|STARTED|Period 4||2
134431|NCT01746017|327561|P11|NOT COMPLETED|Period 3||0
134432|NCT01746017|327562|P10|NOT COMPLETED|Period 3||0
134433|NCT01746017|327563|P9|NOT COMPLETED|Period 3||0
134434|NCT01746017|327564|P8|NOT COMPLETED|Period 3||0
134435|NCT01746017|327565|P7|NOT COMPLETED|Period 3||0
134436|NCT01746017|327566|P6|NOT COMPLETED|Period 3||1
134437|NCT01746017|327567|P5|NOT COMPLETED|Period 3||0
134438|NCT01746017|327568|P4|NOT COMPLETED|Period 3||0
134439|NCT01746017|327569|P3|NOT COMPLETED|Period 3||0
134440|NCT01746017|327570|P2|NOT COMPLETED|Period 3||0
134441|NCT01746017|327571|P1|NOT COMPLETED|Period 3||0
134442|NCT01746017|327561|P11|COMPLETED|Period 3||3
134443|NCT01746017|327562|P10|COMPLETED|Period 3||3
134444|NCT01746017|327563|P9|COMPLETED|Period 3||3
134445|NCT01746017|327564|P8|COMPLETED|Period 3||2
134446|NCT01746017|327565|P7|COMPLETED|Period 3||2
134447|NCT01746017|327566|P6|COMPLETED|Period 3||1
134448|NCT01746017|327567|P5|COMPLETED|Period 3||2
134449|NCT01746017|327568|P4|COMPLETED|Period 3||2
134450|NCT01746017|327569|P3|COMPLETED|Period 3||2
134451|NCT01746017|327570|P2|COMPLETED|Period 3||2
134452|NCT01746017|327571|P1|COMPLETED|Period 3||2
134453|NCT01746017|327561|P11|STARTED|Period 3||3
134454|NCT01746017|327562|P10|STARTED|Period 3||3
134455|NCT01746017|327563|P9|STARTED|Period 3||3
134456|NCT01746017|327564|P8|STARTED|Period 3||2
134457|NCT01746017|327565|P7|STARTED|Period 3||2
134458|NCT01746017|327566|P6|STARTED|Period 3||2
134459|NCT01746017|327567|P5|STARTED|Period 3||2
134460|NCT01746017|327568|P4|STARTED|Period 3||2
134461|NCT01746017|327569|P3|STARTED|Period 3||2
134462|NCT01746017|327570|P2|STARTED|Period 3||2
134463|NCT01746017|327571|P1|STARTED|Period 3||2
134464|NCT01746017|327561|P11|NOT COMPLETED|Period 2||0
134465|NCT01746017|327562|P10|NOT COMPLETED|Period 2||0
134466|NCT01746017|327563|P9|NOT COMPLETED|Period 2||0
134467|NCT01746017|327564|P8|NOT COMPLETED|Period 2||0
134468|NCT01746017|327565|P7|NOT COMPLETED|Period 2||0
134469|NCT01746017|327566|P6|NOT COMPLETED|Period 2||0
134470|NCT01746017|327567|P5|NOT COMPLETED|Period 2||0
134471|NCT01746017|327568|P4|NOT COMPLETED|Period 2||0
134472|NCT01746017|327569|P3|NOT COMPLETED|Period 2||0
134473|NCT01746017|327570|P2|NOT COMPLETED|Period 2||0
134474|NCT01746017|327571|P1|NOT COMPLETED|Period 2||0
134475|NCT01746017|327561|P11|COMPLETED|Period 2||3
134476|NCT01746017|327562|P10|COMPLETED|Period 2||3
134477|NCT01746017|327563|P9|COMPLETED|Period 2||3
134478|NCT01746017|327564|P8|COMPLETED|Period 2||2
134479|NCT01746017|327565|P7|COMPLETED|Period 2||2
134480|NCT01746017|327566|P6|COMPLETED|Period 2||2
134481|NCT01746017|327567|P5|COMPLETED|Period 2||2
134482|NCT01746017|327568|P4|COMPLETED|Period 2||2
134483|NCT01746017|327569|P3|COMPLETED|Period 2||2
134484|NCT01746017|327570|P2|COMPLETED|Period 2||2
134485|NCT01746017|327571|P1|COMPLETED|Period 2||2
134486|NCT01746017|327561|P11|STARTED|Period 2||3
134487|NCT01746017|327562|P10|STARTED|Period 2||3
134488|NCT01746017|327563|P9|STARTED|Period 2||3
134489|NCT01746017|327564|P8|STARTED|Period 2||2
134490|NCT01746017|327565|P7|STARTED|Period 2||2
134491|NCT01746017|327566|P6|STARTED|Period 2||2
134492|NCT01746017|327567|P5|STARTED|Period 2||2
134493|NCT01746017|327568|P4|STARTED|Period 2||2
134494|NCT01746017|327569|P3|STARTED|Period 2||2
134495|NCT01746017|327570|P2|STARTED|Period 2||2
134496|NCT01746017|327571|P1|STARTED|Period 2||2
134497|NCT01746017|327561|P11|NOT COMPLETED|Period 1||0
134498|NCT01746017|327562|P10|NOT COMPLETED|Period 1||0
134499|NCT01746017|327563|P9|NOT COMPLETED|Period 1||0
134500|NCT01746017|327564|P8|NOT COMPLETED|Period 1||0
134501|NCT01746017|327565|P7|NOT COMPLETED|Period 1||1
134502|NCT01746017|327566|P6|NOT COMPLETED|Period 1||0
134503|NCT01746017|327567|P5|NOT COMPLETED|Period 1||0
134504|NCT01746017|327568|P4|NOT COMPLETED|Period 1||0
134505|NCT01746017|327569|P3|NOT COMPLETED|Period 1||0
134506|NCT01746017|327570|P2|NOT COMPLETED|Period 1||0
134507|NCT01746017|327571|P1|NOT COMPLETED|Period 1||0
134508|NCT01746017|327561|P11|COMPLETED|Period 1||3
134509|NCT01746017|327562|P10|COMPLETED|Period 1||3
134510|NCT01746017|327563|P9|COMPLETED|Period 1||3
134511|NCT01746017|327564|P8|COMPLETED|Period 1||2
134512|NCT01746017|327565|P7|COMPLETED|Period 1||2
134513|NCT01746017|327566|P6|COMPLETED|Period 1||2
134514|NCT01746017|327567|P5|COMPLETED|Period 1||2
134515|NCT01746017|327568|P4|COMPLETED|Period 1||2
134516|NCT01746017|327569|P3|COMPLETED|Period 1||2
134517|NCT01746017|327570|P2|COMPLETED|Period 1||2
134518|NCT01746017|327571|P1|COMPLETED|Period 1||2
134519|NCT01746017|327561|P11|Received at Least 1 Dose of Study Drug|Period 1||3
134520|NCT01746017|327562|P10|Received at Least 1 Dose of Study Drug|Period 1||3
134521|NCT01746017|327563|P9|Received at Least 1 Dose of Study Drug|Period 1||3
134522|NCT01746017|327564|P8|Received at Least 1 Dose of Study Drug|Period 1||2
134523|NCT01746017|327565|P7|Received at Least 1 Dose of Study Drug|Period 1||3
134524|NCT01746017|327566|P6|Received at Least 1 Dose of Study Drug|Period 1||2
134525|NCT01746017|327567|P5|Received at Least 1 Dose of Study Drug|Period 1||2
134526|NCT01746017|327568|P4|Received at Least 1 Dose of Study Drug|Period 1||2
134527|NCT01746017|327569|P3|Received at Least 1 Dose of Study Drug|Period 1||2
134528|NCT01746017|327570|P2|Received at Least 1 Dose of Study Drug|Period 1||2
134529|NCT01746017|327571|P1|Received at Least 1 Dose of Study Drug|Period 1||2
134530|NCT01746017|327561|P11|STARTED|Period 1||3
134531|NCT01746017|327562|P10|STARTED|Period 1||3
134532|NCT01746017|327563|P9|STARTED|Period 1||3
134533|NCT01746017|327564|P8|STARTED|Period 1||2
134534|NCT01746017|327565|P7|STARTED|Period 1||3
134535|NCT01746017|327566|P6|STARTED|Period 1||2
134536|NCT01746017|327567|P5|STARTED|Period 1||2
134537|NCT01746017|327568|P4|STARTED|Period 1||2
134538|NCT01746017|327569|P3|STARTED|Period 1||2
134539|NCT01746017|327570|P2|STARTED|Period 1||2
134540|NCT01746017|327571|P1|STARTED|Period 1||2
134541|NCT01745952|327647|P3|NOT COMPLETED|Overall Study||0
134542|NCT01745952|327648|P2|NOT COMPLETED|Overall Study||1
134543|NCT01745952|327649|P1|NOT COMPLETED|Overall Study||1
134544|NCT01745952|327647|P3|COMPLETED|Overall Study||3
134545|NCT01745952|327648|P2|COMPLETED|Overall Study|data of one patient not used due to no seizure diary entries on multiple occasions|3
134546|NCT01745952|327649|P1|COMPLETED|Overall Study||3
134547|NCT01745952|327647|P3|STARTED|Overall Study||3
134548|NCT01745952|327648|P2|STARTED|Overall Study||4
134549|NCT01745952|327649|P1|STARTED|Overall Study||4
134550|NCT01745913|327675|P2|NOT COMPLETED|Overall Study||1
134551|NCT01745913|327676|P1|NOT COMPLETED|Overall Study||1
134552|NCT01745913|327675|P2|COMPLETED|Overall Study||0
134553|NCT01745913|327676|P1|COMPLETED|Overall Study||0
134554|NCT01745913|327675|P2|STARTED|Overall Study||1
134555|NCT01745913|327676|P1|STARTED|Overall Study||1
134556|NCT01745848|327692|P1|NOT COMPLETED|Overall Study||6
134557|NCT01745848|327692|P1|COMPLETED|Overall Study||20
134558|NCT01745848|327692|P1|STARTED|Overall Study||26
134559|NCT01745393|327699|P2|NOT COMPLETED|12-month Follow-up||5
134560|NCT01745393|327700|P1|NOT COMPLETED|12-month Follow-up||6
134561|NCT01745393|327699|P2|COMPLETED|12-month Follow-up||151
134562|NCT01745393|327700|P1|COMPLETED|12-month Follow-up||136
134563|NCT01745393|327699|P2|STARTED|12-month Follow-up||156
134564|NCT01745393|327700|P1|STARTED|12-month Follow-up||142
134565|NCT01745393|327699|P2|NOT COMPLETED|Treatment to End-of-treatment Assessment||8
134566|NCT01745393|327700|P1|NOT COMPLETED|Treatment to End-of-treatment Assessment||21
134567|NCT01745393|327699|P2|COMPLETED|Treatment to End-of-treatment Assessment||156
134568|NCT01745393|327700|P1|COMPLETED|Treatment to End-of-treatment Assessment||142
134569|NCT01745393|327699|P2|Received Treatment|Treatment to End-of-treatment Assessment|Attention control = nutrition education via telephone|144
134570|NCT01745393|327700|P1|Received Treatment|Treatment to End-of-treatment Assessment|Behavioral counseling = TSE-reduction and cessation counseling via telephone|147
134571|NCT01745393|327699|P2|STARTED|Treatment to End-of-treatment Assessment||164
134572|NCT01745393|327700|P1|STARTED|Treatment to End-of-treatment Assessment||163
134573|NCT01745380|327712|P2|NOT COMPLETED|Overall Study||1
134574|NCT01745380|327713|P1|NOT COMPLETED|Overall Study||1
134575|NCT01745380|327712|P2|COMPLETED|Overall Study||49
134576|NCT01745380|327713|P1|COMPLETED|Overall Study||99
134577|NCT01745380|327712|P2|STARTED|Overall Study||50
134578|NCT01745380|327713|P1|STARTED|Overall Study||100
134579|NCT01745146|327751|P2|NOT COMPLETED|Overall Study||3
134580|NCT01745146|327752|P1|NOT COMPLETED|Overall Study||3
134581|NCT01745146|327751|P2|COMPLETED|Overall Study||57
134582|NCT01745146|327752|P1|COMPLETED|Overall Study||27
134583|NCT01745146|327751|P2|Analysis|Overall Study||57
134584|NCT01745146|327752|P1|Analysis|Overall Study||27
134585|NCT01745146|327751|P2|Primary Outcome Assessment|Overall Study||57
134586|NCT01745146|327752|P1|Primary Outcome Assessment|Overall Study||27
134587|NCT01745146|327751|P2|Allocation to Intervention|Overall Study||60
134588|NCT01745146|327752|P1|Allocation to Intervention|Overall Study||30
134589|NCT01745146|327751|P2|STARTED|Overall Study||60
134590|NCT01745146|327752|P1|STARTED|Overall Study||30
134591|NCT01745133|327762|P3|NOT COMPLETED|Overall Study||4
134592|NCT01745133|327763|P2|NOT COMPLETED|Overall Study||4
134593|NCT01745133|327764|P1|NOT COMPLETED|Overall Study||6
134594|NCT01745133|327762|P3|COMPLETED|Overall Study||15
134595|NCT01745133|327763|P2|COMPLETED|Overall Study||16
134596|NCT01745133|327764|P1|COMPLETED|Overall Study||13
134597|NCT01745133|327762|P3|STARTED|Overall Study||19
134598|NCT01745133|327763|P2|STARTED|Overall Study||20
134599|NCT01745133|327764|P1|STARTED|Overall Study||19
134600|NCT01745120|327774|P2|NOT COMPLETED|Overall Study||0
134601|NCT01745120|327775|P1|NOT COMPLETED|Overall Study||1
134602|NCT01745120|327774|P2|COMPLETED|Overall Study||8
134603|NCT01745120|327775|P1|COMPLETED|Overall Study||10
134604|NCT01745120|327774|P2|STARTED|Overall Study||8
134605|NCT01745120|327775|P1|STARTED|Overall Study||11
134606|NCT01745094|327833|P4|NOT COMPLETED|Overall Study||3
134607|NCT01745094|327834|P3|NOT COMPLETED|Overall Study||12
134608|NCT01745094|327835|P2|NOT COMPLETED|Overall Study||0
134609|NCT01745094|327836|P1|NOT COMPLETED|Overall Study||5
134610|NCT01745094|327833|P4|COMPLETED|Overall Study||90
134611|NCT01745094|327834|P3|COMPLETED|Overall Study||46
134612|NCT01745094|327835|P2|COMPLETED|Overall Study||37
134613|NCT01745094|327836|P1|COMPLETED|Overall Study||30
134614|NCT01745094|327833|P4|STARTED|Overall Study||93
134615|NCT01745094|327834|P3|STARTED|Overall Study||58
134616|NCT01745094|327835|P2|STARTED|Overall Study||37
134617|NCT01745094|327836|P1|STARTED|Overall Study||35
134618|NCT01745055|327902|P1|NOT COMPLETED|Overall Study||0
134619|NCT01745055|327902|P1|COMPLETED|Overall Study||12
134620|NCT01745055|327902|P1|STARTED|Overall Study||12
134621|NCT01744977|327937|P2|NOT COMPLETED|Overall Study||5
134622|NCT01744977|327938|P1|NOT COMPLETED|Overall Study||11
134623|NCT01744977|327937|P2|COMPLETED|Overall Study||115
134624|NCT01744977|327938|P1|COMPLETED|Overall Study||109
134625|NCT01744977|327937|P2|6 Month Completed|Overall Study||115
134626|NCT01744977|327938|P1|6 Month Completed|Overall Study||113
134627|NCT01744977|327937|P2|STARTED|Overall Study||120
134628|NCT01744977|327938|P1|STARTED|Overall Study||120
134629|NCT01744860|327946|P1|NOT COMPLETED|Overall Study||0
134630|NCT01744860|327946|P1|COMPLETED|Overall Study||420
134631|NCT01744860|327946|P1|STARTED|Overall Study||420
134632|NCT01744821|327984|P4|NOT COMPLETED|Overall Study||0
134633|NCT01744821|327985|P3|NOT COMPLETED|Overall Study||0
134634|NCT01744821|327986|P2|NOT COMPLETED|Overall Study||0
134635|NCT01744821|327987|P1|NOT COMPLETED|Overall Study||0
134636|NCT01744821|327984|P4|COMPLETED|Overall Study||1
134637|NCT01744821|327985|P3|COMPLETED|Overall Study||2
134638|NCT01744821|327986|P2|COMPLETED|Overall Study||3
134639|NCT01744821|327987|P1|COMPLETED|Overall Study||1
134640|NCT01744821|327984|P4|STARTED|Overall Study||1
134641|NCT01744821|327985|P3|STARTED|Overall Study||2
134642|NCT01744821|327986|P2|STARTED|Overall Study||3
134643|NCT01744821|327987|P1|STARTED|Overall Study||1
134644|NCT01744782|328009|P1|NOT COMPLETED|Overall Study||1
134645|NCT01744782|328009|P1|COMPLETED|Overall Study||16
134646|NCT01744782|328009|P1|STARTED|Overall Study||17
134647|NCT01744730|328022|P5|NOT COMPLETED|Overall Study||0
134648|NCT01744730|328023|P4|NOT COMPLETED|Overall Study||0
134649|NCT01744730|328024|P3|NOT COMPLETED|Overall Study||0
134650|NCT01744730|328025|P2|NOT COMPLETED|Overall Study||0
134651|NCT01744730|328026|P1|NOT COMPLETED|Overall Study||0
134652|NCT01744730|328022|P5|COMPLETED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
134653|NCT01744730|328023|P4|COMPLETED|Overall Study||11
134654|NCT01744730|328024|P3|COMPLETED|Overall Study||4
134655|NCT01744730|328025|P2|COMPLETED|Overall Study||3
134656|NCT01744730|328026|P1|COMPLETED|Overall Study||4
134657|NCT01744730|328022|P5|STARTED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
134658|NCT01744730|328023|P4|STARTED|Overall Study||11
134659|NCT01744730|328024|P3|STARTED|Overall Study||4
134660|NCT01744730|328025|P2|STARTED|Overall Study||3
134661|NCT01744730|328026|P1|STARTED|Overall Study||4
134662|NCT01744704|328080|P12|NOT COMPLETED|Overall Study||0
134663|NCT01744704|328081|P11|NOT COMPLETED|Overall Study||0
134664|NCT01744704|328082|P10|NOT COMPLETED|Overall Study||0
134665|NCT01744704|328083|P9|NOT COMPLETED|Overall Study||0
134666|NCT01744704|328084|P8|NOT COMPLETED|Overall Study||0
134667|NCT01744704|328085|P7|NOT COMPLETED|Overall Study||0
134668|NCT01744704|328086|P6|NOT COMPLETED|Overall Study||0
134669|NCT01744704|328087|P5|NOT COMPLETED|Overall Study||0
134670|NCT01744704|328088|P4|NOT COMPLETED|Overall Study||0
134671|NCT01744704|328089|P3|NOT COMPLETED|Overall Study||0
134672|NCT01744704|328090|P2|NOT COMPLETED|Overall Study||0
134673|NCT01744704|328091|P1|NOT COMPLETED|Overall Study||0
134674|NCT01744704|328080|P12|COMPLETED|Overall Study||10
134675|NCT01744704|328081|P11|COMPLETED|Overall Study||9
134676|NCT01744704|328082|P10|COMPLETED|Overall Study||9
134677|NCT01744704|328083|P9|COMPLETED|Overall Study||3
134678|NCT01744704|328084|P8|COMPLETED|Overall Study||9
134679|NCT01744704|328085|P7|COMPLETED|Overall Study||6
134680|NCT01744704|328086|P6|COMPLETED|Overall Study||7
134681|NCT01744704|328087|P5|COMPLETED|Overall Study||6
134682|NCT01744704|328088|P4|COMPLETED|Overall Study||6
134683|NCT01744704|328089|P3|COMPLETED|Overall Study||3
134684|NCT01744704|328090|P2|COMPLETED|Overall Study||3
134685|NCT01744704|328091|P1|COMPLETED|Overall Study||3
134686|NCT01744704|328080|P12|STARTED|Overall Study||10
134687|NCT01744704|328081|P11|STARTED|Overall Study||9
134688|NCT01744704|328082|P10|STARTED|Overall Study||9
134689|NCT01744704|328083|P9|STARTED|Overall Study||3
134690|NCT01744704|328084|P8|STARTED|Overall Study||9
134691|NCT01744704|328085|P7|STARTED|Overall Study||6
134692|NCT01744704|328086|P6|STARTED|Overall Study||7
134693|NCT01744704|328087|P5|STARTED|Overall Study||6
134694|NCT01744704|328088|P4|STARTED|Overall Study||6
134695|NCT01744704|328089|P3|STARTED|Overall Study||3
134696|NCT01744704|328090|P2|STARTED|Overall Study||3
134697|NCT01744704|328091|P1|STARTED|Overall Study||3
134698|NCT01744691|328170|P1|NOT COMPLETED|Overall Study||43
134699|NCT01744691|328170|P1|COMPLETED|Overall Study|Participants who were on study treatment at the time of the primary analysis|101
134700|NCT01744691|328170|P1|STARTED|Overall Study|Participants who received study treatment|144
134701|NCT01744574|328179|P4|NOT COMPLETED|Overall Study||11
134702|NCT01744574|328180|P3|NOT COMPLETED|Overall Study||20
134703|NCT01744574|328181|P2|NOT COMPLETED|Overall Study||25
134704|NCT01744574|328182|P1|NOT COMPLETED|Overall Study||24
134705|NCT01744574|328179|P4|COMPLETED|Overall Study||40
134706|NCT01744574|328180|P3|COMPLETED|Overall Study||32
134707|NCT01744574|328181|P2|COMPLETED|Overall Study||31
134708|NCT01744574|328182|P1|COMPLETED|Overall Study||33
134709|NCT01744574|328179|P4|STARTED|Overall Study||51
134710|NCT01744574|328180|P3|STARTED|Overall Study||52
134711|NCT01744574|328181|P2|STARTED|Overall Study||56
134712|NCT01744574|328182|P1|STARTED|Overall Study||57
134713|NCT01744496|328218|P2|NOT COMPLETED|Maintenance Period||4
134714|NCT01744496|328219|P1|NOT COMPLETED|Maintenance Period||4
134715|NCT01744496|328218|P2|COMPLETED|Maintenance Period||29
134716|NCT01744496|328219|P1|COMPLETED|Maintenance Period||27
134717|NCT01744496|328218|P2|STARTED|Maintenance Period||33
134718|NCT01744496|328219|P1|STARTED|Maintenance Period||31
134719|NCT01744496|328218|P2|NOT COMPLETED|Titration Period||2
134720|NCT01744496|328219|P1|NOT COMPLETED|Titration Period||2
134721|NCT01744496|328218|P2|COMPLETED|Titration Period||33
134722|NCT01744496|328219|P1|COMPLETED|Titration Period||31
134723|NCT01744496|328218|P2|STARTED|Titration Period||35
134724|NCT01744496|328219|P1|STARTED|Titration Period||33
134725|NCT01744483|328240|P3|NOT COMPLETED|Overall Study||28
134726|NCT01744483|328241|P2|NOT COMPLETED|Overall Study||22
134727|NCT01744483|328242|P1|NOT COMPLETED|Overall Study||29
134728|NCT01744483|328240|P3|COMPLETED|Overall Study||10
134729|NCT01744483|328241|P2|COMPLETED|Overall Study||13
134730|NCT01744483|328242|P1|COMPLETED|Overall Study||15
134731|NCT01744483|328240|P3|STARTED|Overall Study||38
134732|NCT01744483|328241|P2|STARTED|Overall Study||35
134733|NCT01744483|328242|P1|STARTED|Overall Study||44
134734|NCT01744392|328250|P1|NOT COMPLETED|Overall Study||1
134735|NCT01744392|328250|P1|COMPLETED|Overall Study||22
134736|NCT01744392|328250|P1|STARTED|Overall Study||23
134737|NCT01744353|328266|P3|NOT COMPLETED|Overall Study||0
134738|NCT01744353|328267|P2|NOT COMPLETED|Overall Study||0
134739|NCT01744353|328268|P1|NOT COMPLETED|Overall Study||0
134740|NCT01744353|328266|P3|COMPLETED|Overall Study||3
134741|NCT01744353|328267|P2|COMPLETED|Overall Study||26
134742|NCT01744353|328268|P1|COMPLETED|Overall Study||6
134743|NCT01744353|328266|P3|STARTED|Overall Study||3
134744|NCT01744353|328267|P2|STARTED|Overall Study||26
134745|NCT01744353|328268|P1|STARTED|Overall Study||6
134746|NCT01744340|328279|P2|NOT COMPLETED|Overall Study||0
134747|NCT01744340|328280|P1|NOT COMPLETED|Overall Study||0
134748|NCT01744340|328279|P2|COMPLETED|Overall Study||15
134749|NCT01744340|328280|P1|COMPLETED|Overall Study||8
134750|NCT01744340|328279|P2|STARTED|Overall Study||15
134751|NCT01744340|328280|P1|STARTED|Overall Study||8
134752|NCT01744197|328290|P2|NOT COMPLETED|Overall Study||3
134753|NCT01744197|328291|P1|NOT COMPLETED|Overall Study||4
134754|NCT01744197|328290|P2|COMPLETED|Overall Study||26
134755|NCT01744197|328291|P1|COMPLETED|Overall Study||28
134756|NCT01744197|328290|P2|STARTED|Overall Study||29
134757|NCT01744197|328291|P1|STARTED|Overall Study||32
134758|NCT01744093|328303|P2|NOT COMPLETED|Overall Study||1
134759|NCT01744093|328304|P1|NOT COMPLETED|Overall Study||6
134760|NCT01744093|328303|P2|COMPLETED|Overall Study||8
134761|NCT01744093|328304|P1|COMPLETED|Overall Study||12
134762|NCT01744093|328303|P2|STARTED|Overall Study||9
134763|NCT01744093|328304|P1|STARTED|Overall Study||18
134764|NCT01743963|328314|P2|NOT COMPLETED|Overall Study||0
134765|NCT01743963|328315|P1|NOT COMPLETED|Overall Study||0
134766|NCT01743963|328314|P2|COMPLETED|Overall Study||17
134767|NCT01743963|328315|P1|COMPLETED|Overall Study||21
134768|NCT01743963|328314|P2|STARTED|Overall Study||17
134769|NCT01743963|328315|P1|STARTED|Overall Study||21
134770|NCT01743859|328321|P1|NOT COMPLETED|Overall Study||9
134771|NCT01743859|328321|P1|COMPLETED|Overall Study||28
134772|NCT01743859|328321|P1|STARTED|Overall Study||37
134773|NCT01743729|328333|P2|NOT COMPLETED|Overall Study||12
134774|NCT01743729|328334|P1|NOT COMPLETED|Overall Study||37
134775|NCT01743729|328333|P2|COMPLETED|Overall Study||348
134776|NCT01743729|328334|P1|COMPLETED|Overall Study||321
134777|NCT01743729|328333|P2|STARTED|Overall Study|One placebo participant was considered for Lifitegrast arm; Placebo safety analysis set (N= 359).|360
134778|NCT01743729|328334|P1|STARTED|Overall Study|One participant from placebo arm included in Lifitegrast arm for safety analysis set (N=359).|358
134779|NCT01743560|328342|P1|NOT COMPLETED|Overall Study||43
134780|NCT01743560|328342|P1|COMPLETED|Overall Study||9
134781|NCT01743560|328342|P1|Safety Analysis Set (SAF)|Overall Study|≥ 1 dose study drug +1 post baseline safety assessment|49
134782|NCT01743560|328342|P1|Full Analysis Set (FAS)|Overall Study|≥ 1 dose study drug|49
134783|NCT01743560|328342|P1|STARTED|Overall Study||52
134784|NCT01743521|328369|P4|NOT COMPLETED|Overall Study||0
134785|NCT01743521|328370|P3|NOT COMPLETED|Overall Study||0
134786|NCT01743521|328371|P2|NOT COMPLETED|Overall Study||0
134787|NCT01743521|328372|P1|NOT COMPLETED|Overall Study||0
134788|NCT01743521|328369|P4|COMPLETED|Overall Study||2
134789|NCT01743521|328370|P3|COMPLETED|Overall Study||2
134790|NCT01743521|328371|P2|COMPLETED|Overall Study||3
134791|NCT01743521|328372|P1|COMPLETED|Overall Study||7
134792|NCT01743521|328369|P4|STARTED|Overall Study||2
134793|NCT01743521|328370|P3|STARTED|Overall Study||2
134794|NCT01743521|328371|P2|STARTED|Overall Study||3
134795|NCT01743521|328372|P1|STARTED|Overall Study||7
134796|NCT01743469|328426|P4|NOT COMPLETED|Follow-up Period - Post-Treatment||16
134797|NCT01743469|328427|P3|NOT COMPLETED|Follow-up Period - Post-Treatment||23
134798|NCT01743469|328428|P2|NOT COMPLETED|Follow-up Period - Post-Treatment||48
134799|NCT01743469|328429|P1|NOT COMPLETED|Follow-up Period - Post-Treatment||45
134800|NCT01743469|328426|P4|COMPLETED|Follow-up Period - Post-Treatment||5
134801|NCT01743469|328427|P3|COMPLETED|Follow-up Period - Post-Treatment||14
134802|NCT01743469|328428|P2|COMPLETED|Follow-up Period - Post-Treatment||5
134803|NCT01743469|328429|P1|COMPLETED|Follow-up Period - Post-Treatment||6
134804|NCT01743469|328426|P4|STARTED|Follow-up Period - Post-Treatment||21
134805|NCT01743469|328427|P3|STARTED|Follow-up Period - Post-Treatment||37
134806|NCT01743469|328428|P2|STARTED|Follow-up Period - Post-Treatment||53
134807|NCT01743469|328429|P1|STARTED|Follow-up Period - Post-Treatment||51
134808|NCT01743469|328426|P4|NOT COMPLETED|Active Treatment Phase||21
134809|NCT01743469|328427|P3|NOT COMPLETED|Active Treatment Phase||38
134810|NCT01743469|328428|P2|NOT COMPLETED|Active Treatment Phase||55
134811|NCT01743469|328429|P1|NOT COMPLETED|Active Treatment Phase||53
134812|NCT01743469|328426|P4|COMPLETED|Active Treatment Phase||0
134813|NCT01743469|328427|P3|COMPLETED|Active Treatment Phase||0
134814|NCT01743469|328428|P2|COMPLETED|Active Treatment Phase||0
134815|NCT01743469|328429|P1|COMPLETED|Active Treatment Phase||0
134816|NCT01743469|328426|P4|STARTED|Active Treatment Phase||21
134817|NCT01743469|328427|P3|STARTED|Active Treatment Phase||38
134818|NCT01743469|328428|P2|STARTED|Active Treatment Phase||55
134819|NCT01743469|328429|P1|STARTED|Active Treatment Phase||53
134820|NCT01743092|328469|P2|NOT COMPLETED|Overall Study||15
134821|NCT01743092|328470|P1|NOT COMPLETED|Overall Study||14
134822|NCT01743092|328469|P2|COMPLETED|Overall Study||11
134823|NCT01743092|328470|P1|COMPLETED|Overall Study||19
134824|NCT01743092|328469|P2|STARTED|Overall Study||26
134825|NCT01743092|328470|P1|STARTED|Overall Study||33
134826|NCT01743027|328482|P4|NOT COMPLETED|Overall Study||1
134827|NCT01743027|328483|P3|NOT COMPLETED|Overall Study||9
134828|NCT01743027|328484|P2|NOT COMPLETED|Overall Study||5
134829|NCT01743027|328485|P1|NOT COMPLETED|Overall Study||5
134830|NCT01743027|328482|P4|COMPLETED|Overall Study||48
134831|NCT01743027|328483|P3|COMPLETED|Overall Study||90
134832|NCT01743027|328484|P2|COMPLETED|Overall Study||94
134833|NCT01743027|328485|P1|COMPLETED|Overall Study||93
134834|NCT01743027|328482|P4|STARTED|Overall Study||49
134835|NCT01743027|328483|P3|STARTED|Overall Study||99
134836|NCT01743027|328484|P2|STARTED|Overall Study||99
134837|NCT01743027|328485|P1|STARTED|Overall Study||98
134838|NCT01743001|328525|P2|NOT COMPLETED|Overall Study||0
134839|NCT01743001|328526|P1|NOT COMPLETED|Overall Study||3
134840|NCT01743001|328525|P2|COMPLETED|Overall Study||112
134841|NCT01743001|328526|P1|COMPLETED|Overall Study||111
134842|NCT01743001|328525|P2|STARTED|Overall Study||112
134843|NCT01743001|328526|P1|STARTED|Overall Study||114
134844|NCT01742949|328538|P2|NOT COMPLETED|Overall Study||0
134845|NCT01742949|328539|P1|NOT COMPLETED|Overall Study||0
134846|NCT01742949|328538|P2|COMPLETED|Overall Study||20
134847|NCT01742949|328539|P1|COMPLETED|Overall Study||20
134848|NCT01742949|328538|P2|STARTED|Overall Study||20
134849|NCT01742949|328539|P1|STARTED|Overall Study||20
134850|NCT01742936|328560|P2|NOT COMPLETED|Overall Study||0
134851|NCT01742936|328561|P1|NOT COMPLETED|Overall Study||0
134852|NCT01742936|328560|P2|COMPLETED|Overall Study||50
134853|NCT01742936|328561|P1|COMPLETED|Overall Study||50
134854|NCT01742936|328560|P2|STARTED|Overall Study||50
134855|NCT01742936|328561|P1|STARTED|Overall Study||50
134856|NCT01742897|328569|P1|NOT COMPLETED|Overall Study||5
134857|NCT01742897|328569|P1|COMPLETED|Overall Study||30
134858|NCT01742897|328569|P1|Treated|Overall Study||33
134859|NCT01742897|328569|P1|STARTED|Overall Study||35
134860|NCT01742832|328575|P2|NOT COMPLETED|Overall Study||5
134861|NCT01742832|328576|P1|NOT COMPLETED|Overall Study||1
134862|NCT01742832|328575|P2|COMPLETED|Overall Study||23
134863|NCT01742832|328576|P1|COMPLETED|Overall Study||19
134864|NCT01742832|328575|P2|STARTED|Overall Study||28
134865|NCT01742832|328576|P1|STARTED|Overall Study||20
134866|NCT01742364|328586|P4|NOT COMPLETED|Overall Study||0
134867|NCT01742364|328587|P3|NOT COMPLETED|Overall Study||0
134868|NCT01742364|328588|P2|NOT COMPLETED|Overall Study||0
134869|NCT01742364|328589|P1|NOT COMPLETED|Overall Study||0
134870|NCT01742364|328586|P4|COMPLETED|Overall Study||15
134871|NCT01742364|328587|P3|COMPLETED|Overall Study||15
134872|NCT01742364|328588|P2|COMPLETED|Overall Study||33
134873|NCT01742364|328589|P1|COMPLETED|Overall Study||33
134874|NCT01742364|328586|P4|STARTED|Overall Study||15
134875|NCT01742364|328587|P3|STARTED|Overall Study||15
134876|NCT01742364|328588|P2|STARTED|Overall Study||33
134877|NCT01742364|328589|P1|STARTED|Overall Study||33
134878|NCT01742208|328618|P3|NOT COMPLETED|Overall Study||0
134879|NCT01742208|328619|P2|NOT COMPLETED|Overall Study||0
134880|NCT01742208|328620|P1|NOT COMPLETED|Overall Study||0
134881|NCT01742208|328618|P3|COMPLETED|Overall Study||16
134882|NCT01742208|328619|P2|COMPLETED|Overall Study||17
134883|NCT01742208|328620|P1|COMPLETED|Overall Study||3
134884|NCT01742208|328618|P3|STARTED|Overall Study||16
134885|NCT01742208|328619|P2|STARTED|Overall Study||17
134886|NCT01742208|328620|P1|STARTED|Overall Study||3
134887|NCT01742091|328650|P6|NOT COMPLETED|Overall Study||2
134888|NCT01742091|328651|P5|NOT COMPLETED|Overall Study||1
134889|NCT01742091|328652|P4|NOT COMPLETED|Overall Study||1
134890|NCT01742091|328653|P3|NOT COMPLETED|Overall Study||0
134891|NCT01742091|328654|P2|NOT COMPLETED|Overall Study||0
134892|NCT01742091|328655|P1|NOT COMPLETED|Overall Study||0
134893|NCT01742091|328650|P6|COMPLETED|Overall Study||10
134894|NCT01742091|328651|P5|COMPLETED|Overall Study||7
134895|NCT01742091|328652|P4|COMPLETED|Overall Study||8
134896|NCT01742091|328653|P3|COMPLETED|Overall Study||10
134897|NCT01742091|328654|P2|COMPLETED|Overall Study||11
134898|NCT01742091|328655|P1|COMPLETED|Overall Study||9
134899|NCT01742091|328650|P6|RECEIVED STUDY DRUG|Overall Study||12
134900|NCT01742091|328651|P5|RECEIVED STUDY DRUG|Overall Study||8
134901|NCT01742091|328652|P4|RECEIVED STUDY DRUG|Overall Study||9
134902|NCT01742091|328653|P3|RECEIVED STUDY DRUG|Overall Study||10
134903|NCT01742091|328654|P2|RECEIVED STUDY DRUG|Overall Study||11
134904|NCT01742091|328655|P1|RECEIVED STUDY DRUG|Overall Study||9
134905|NCT01742091|328650|P6|STARTED|Overall Study||12
134906|NCT01742091|328651|P5|STARTED|Overall Study||8
134907|NCT01742091|328652|P4|STARTED|Overall Study||9
134908|NCT01742091|328653|P3|STARTED|Overall Study||10
134909|NCT01742091|328654|P2|STARTED|Overall Study||11
134910|NCT01742091|328655|P1|STARTED|Overall Study||9
134911|NCT01742078|328701|P9|NOT COMPLETED|Overall Study||0
134912|NCT01742078|328702|P8|NOT COMPLETED|Overall Study||0
134913|NCT01742078|328703|P7|NOT COMPLETED|Overall Study||0
134914|NCT01742078|328704|P6|NOT COMPLETED|Overall Study||0
134915|NCT01742078|328705|P5|NOT COMPLETED|Overall Study||0
134916|NCT01742078|328706|P4|NOT COMPLETED|Overall Study||1
134917|NCT01742078|328707|P3|NOT COMPLETED|Overall Study||0
134918|NCT01742078|328708|P2|NOT COMPLETED|Overall Study||0
134919|NCT01742078|328709|P1|NOT COMPLETED|Overall Study||0
134920|NCT01742078|328701|P9|COMPLETED|Overall Study||12
134921|NCT01742078|328702|P8|COMPLETED|Overall Study||6
134922|NCT01742078|328703|P7|COMPLETED|Overall Study||6
134923|NCT01742078|328704|P6|COMPLETED|Overall Study||6
134924|NCT01742078|328705|P5|COMPLETED|Overall Study||6
134925|NCT01742078|328706|P4|COMPLETED|Overall Study||5
134926|NCT01742078|328707|P3|COMPLETED|Overall Study||6
134927|NCT01742078|328708|P2|COMPLETED|Overall Study||6
134928|NCT01742078|328709|P1|COMPLETED|Overall Study||6
134929|NCT01742078|328701|P9|RECEIVED STUDY DRUG|Overall Study||12
134930|NCT01742078|328702|P8|RECEIVED STUDY DRUG|Overall Study||6
134931|NCT01742078|328703|P7|RECEIVED STUDY DRUG|Overall Study||6
134932|NCT01742078|328704|P6|RECEIVED STUDY DRUG|Overall Study||6
134933|NCT01742078|328705|P5|RECEIVED STUDY DRUG|Overall Study||6
134934|NCT01742078|328706|P4|RECEIVED STUDY DRUG|Overall Study||6
134935|NCT01742078|328707|P3|RECEIVED STUDY DRUG|Overall Study||6
134936|NCT01742078|328708|P2|RECEIVED STUDY DRUG|Overall Study||6
134937|NCT01742078|328709|P1|RECEIVED STUDY DRUG|Overall Study||6
134938|NCT01742078|328701|P9|STARTED|Overall Study||12
134939|NCT01742078|328702|P8|STARTED|Overall Study||6
134940|NCT01742078|328703|P7|STARTED|Overall Study||6
134941|NCT01742078|328704|P6|STARTED|Overall Study||6
134942|NCT01742078|328705|P5|STARTED|Overall Study||6
134943|NCT01742078|328706|P4|STARTED|Overall Study||6
134944|NCT01742078|328707|P3|STARTED|Overall Study||6
134945|NCT01742078|328708|P2|STARTED|Overall Study||6
134946|NCT01742078|328709|P1|STARTED|Overall Study||6
134947|NCT01742065|328766|P2|NOT COMPLETED|Overall Study||0
134948|NCT01742065|328767|P1|NOT COMPLETED|Overall Study||0
134949|NCT01742065|328766|P2|COMPLETED|Overall Study|21134 patients were analyzed in 13 clinics.|21134
134950|NCT01742065|328767|P1|COMPLETED|Overall Study|20059 patients were analyzed in 13 clinics.|20059
134951|NCT01742065|328766|P2|STARTED|Overall Study|21134 patients were analyzed in 13 clinics.|21134
134952|NCT01742065|328767|P1|STARTED|Overall Study|20059 patients were analyzed in 13 clinics.|20059
134953|NCT01741792|328778|P3|NOT COMPLETED|Overall Study||12
134954|NCT01741792|328779|P2|NOT COMPLETED|Overall Study||1
134955|NCT01741792|328780|P1|NOT COMPLETED|Overall Study||6
134956|NCT01741792|328778|P3|COMPLETED|Overall Study||2
134957|NCT01741792|328779|P2|COMPLETED|Overall Study||1
134958|NCT01741792|328780|P1|COMPLETED|Overall Study||3
134959|NCT01741792|328778|P3|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|13
134960|NCT01741792|328779|P2|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|1
134961|NCT01741792|328780|P1|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|7
134962|NCT01741792|328778|P3|STARTED|Overall Study||14
134963|NCT01741792|328779|P2|STARTED|Overall Study|Cohort 2 was closed to enrollment on recommendation of the data monitoring committee|2
134964|NCT01741792|328780|P1|STARTED|Overall Study|3 participants were not considered evaluable and were replaced as specified in the protocol.|9
134965|NCT01741701|328847|P2|NOT COMPLETED|Overall Study||2
134966|NCT01741701|328848|P1|NOT COMPLETED|Overall Study||5
134967|NCT01741701|328847|P2|COMPLETED|Overall Study||13
134968|NCT01741701|328848|P1|COMPLETED|Overall Study||13
134969|NCT01741701|328847|P2|STARTED|Overall Study||15
134970|NCT01741701|328848|P1|STARTED|Overall Study||18
134971|NCT01741688|328864|P1|NOT COMPLETED|Overall Study||3
134972|NCT01741688|328864|P1|COMPLETED|Overall Study||13
134973|NCT01741688|328864|P1|STARTED|Overall Study||16
134974|NCT01741545|328883|P2|NOT COMPLETED|Follow-up Period (24 Weeks)||2
134975|NCT01741545|328884|P1|NOT COMPLETED|Follow-up Period (24 Weeks)||1
134976|NCT01741545|328883|P2|COMPLETED|Follow-up Period (24 Weeks)||37
134977|NCT01741545|328884|P1|COMPLETED|Follow-up Period (24 Weeks)||11
134978|NCT01741545|328883|P2|STARTED|Follow-up Period (24 Weeks)|4 participants re-joined Cohort B in follow-up period.|39
134979|NCT01741545|328884|P1|STARTED|Follow-up Period (24 Weeks)|1 participant re-joined Cohort A in follow-up period.|12
134980|NCT01741545|328883|P2|NOT COMPLETED|Treatment Period||4
134981|NCT01741545|328884|P1|NOT COMPLETED|Treatment Period||1
134982|NCT01741545|328883|P2|COMPLETED|Treatment Period||35
134983|NCT01741545|328884|P1|COMPLETED|Treatment Period||11
134984|NCT01741545|328883|P2|STARTED|Treatment Period||39
134985|NCT01741545|328884|P1|STARTED|Treatment Period||12
134986|NCT01741532|328908|P2|NOT COMPLETED|Overall Study||3
134987|NCT01741532|328909|P1|NOT COMPLETED|Overall Study||10
134988|NCT01741532|328908|P2|COMPLETED|Overall Study||27
134989|NCT01741532|328909|P1|COMPLETED|Overall Study||49
134990|NCT01741532|328908|P2|Provided Post-baseline Efficacy Data|Overall Study||28
134991|NCT01741532|328909|P1|Provided Post-baseline Efficacy Data|Overall Study||58
134992|NCT01741532|328908|P2|Exposed|Overall Study||30
134993|NCT01741532|328909|P1|Exposed|Overall Study||58
134994|NCT01741532|328908|P2|STARTED|Overall Study||30
134995|NCT01741532|328909|P1|STARTED|Overall Study||59
134996|NCT01741480|328931|P2|NOT COMPLETED|Overall Study||0
134997|NCT01741480|328932|P1|NOT COMPLETED|Overall Study||0
134998|NCT01741480|328931|P2|COMPLETED|Overall Study||286
134999|NCT01741480|328932|P1|COMPLETED|Overall Study||285
135000|NCT01741480|328931|P2|STARTED|Overall Study||286
135001|NCT01741480|328932|P1|STARTED|Overall Study||285
135002|NCT01741454|328942|P4|NOT COMPLETED|Overall Study||22
135003|NCT01741454|328943|P3|NOT COMPLETED|Overall Study||17
135004|NCT01741454|328944|P2|NOT COMPLETED|Overall Study||6
135005|NCT01741454|328945|P1|NOT COMPLETED|Overall Study||13
135006|NCT01741454|328942|P4|COMPLETED|Overall Study||21
135007|NCT01741454|328943|P3|COMPLETED|Overall Study||22
135008|NCT01741454|328944|P2|COMPLETED|Overall Study||44
135009|NCT01741454|328945|P1|COMPLETED|Overall Study||36
135010|NCT01741454|328942|P4|STARTED|Overall Study||43
135011|NCT01741454|328943|P3|STARTED|Overall Study||39
135012|NCT01741454|328944|P2|STARTED|Overall Study||50
135013|NCT01741454|328945|P1|STARTED|Overall Study||49
135014|NCT01741350|328969|P2|NOT COMPLETED|12-Month Follow-up Assessment||2
135015|NCT01741350|328970|P1|NOT COMPLETED|12-Month Follow-up Assessment||3
135016|NCT01741350|328969|P2|COMPLETED|12-Month Follow-up Assessment||109
135017|NCT01741350|328970|P1|COMPLETED|12-Month Follow-up Assessment||111
135018|NCT01741350|328969|P2|STARTED|12-Month Follow-up Assessment||111
135019|NCT01741350|328970|P1|STARTED|12-Month Follow-up Assessment||114
135020|NCT01741350|328969|P2|NOT COMPLETED|6-Month Follow-up Assessment||8
135021|NCT01741350|328970|P1|NOT COMPLETED|6-Month Follow-up Assessment||15
135022|NCT01741350|328969|P2|COMPLETED|6-Month Follow-up Assessment||111
135023|NCT01741350|328970|P1|COMPLETED|6-Month Follow-up Assessment||114
135024|NCT01741350|328969|P2|STARTED|6-Month Follow-up Assessment||119
135025|NCT01741350|328970|P1|STARTED|6-Month Follow-up Assessment||129
135026|NCT01741350|328969|P2|NOT COMPLETED|3-Month Follow-up Assessment||22
135027|NCT01741350|328970|P1|NOT COMPLETED|3-Month Follow-up Assessment||6
135028|NCT01741350|328969|P2|COMPLETED|3-Month Follow-up Assessment||119
135029|NCT01741350|328970|P1|COMPLETED|3-Month Follow-up Assessment||129
135030|NCT01741350|328969|P2|STARTED|3-Month Follow-up Assessment||141
135031|NCT01741350|328970|P1|STARTED|3-Month Follow-up Assessment||135
135032|NCT01741350|328969|P2|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
135033|NCT01741350|328970|P1|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
135034|NCT01741350|328969|P2|COMPLETED|Post Intervention Assessment (at Week 4)||141
135035|NCT01741350|328970|P1|COMPLETED|Post Intervention Assessment (at Week 4)||135
135036|NCT01741350|328969|P2|STARTED|Post Intervention Assessment (at Week 4)||155
135037|NCT01741350|328970|P1|STARTED|Post Intervention Assessment (at Week 4)||149
135038|NCT01741350|328969|P2|NOT COMPLETED|Study Intervention||0
135039|NCT01741350|328970|P1|NOT COMPLETED|Study Intervention||0
135040|NCT01741350|328969|P2|COMPLETED|Study Intervention||155
135041|NCT01741350|328970|P1|COMPLETED|Study Intervention||149
135042|NCT01741350|328969|P2|STARTED|Study Intervention||155
135043|NCT01741350|328970|P1|STARTED|Study Intervention||149
135044|NCT01741272|329106|P2|NOT COMPLETED|Overall Study||0
135045|NCT01741272|329107|P1|NOT COMPLETED|Overall Study||0
135046|NCT01741272|329106|P2|COMPLETED|Overall Study||97
135047|NCT01741272|329107|P1|COMPLETED|Overall Study||92
135048|NCT01741272|329106|P2|STARTED|Overall Study||97
135049|NCT01741272|329107|P1|STARTED|Overall Study||92
135050|NCT01741259|329123|P2|NOT COMPLETED|Overall Study||6
135051|NCT01741259|329124|P1|NOT COMPLETED|Overall Study||6
135052|NCT01741259|329123|P2|COMPLETED|Overall Study||129
135053|NCT01741259|329124|P1|COMPLETED|Overall Study||127
135054|NCT01741259|329123|P2|STARTED|Overall Study||135
135055|NCT01741259|329124|P1|STARTED|Overall Study||133
135056|NCT01741012|329178|P1|NOT COMPLETED|Overall Study||3
135057|NCT01741012|329178|P1|COMPLETED|Overall Study||34
135058|NCT01741012|329178|P1|STARTED|Overall Study||37
135059|NCT01740817|329185|P2|NOT COMPLETED|Second Intervention (48 h)||0
135060|NCT01740817|329186|P1|NOT COMPLETED|Second Intervention (48 h)||0
135061|NCT01740817|329185|P2|COMPLETED|Second Intervention (48 h)||4
135062|NCT01740817|329186|P1|COMPLETED|Second Intervention (48 h)||8
135063|NCT01740817|329185|P2|STARTED|Second Intervention (48 h)||4
135064|NCT01740817|329186|P1|STARTED|Second Intervention (48 h)||8
135065|NCT01740817|329185|P2|NOT COMPLETED|Washout (4-6 Weeks)||0
135066|NCT01740817|329186|P1|NOT COMPLETED|Washout (4-6 Weeks)||0
135067|NCT01740817|329185|P2|COMPLETED|Washout (4-6 Weeks)||4
135068|NCT01740817|329186|P1|COMPLETED|Washout (4-6 Weeks)||8
135069|NCT01740817|329185|P2|STARTED|Washout (4-6 Weeks)||4
135070|NCT01740817|329186|P1|STARTED|Washout (4-6 Weeks)||8
135071|NCT01740817|329185|P2|NOT COMPLETED|First Intervention (48 h)||0
135072|NCT01740817|329186|P1|NOT COMPLETED|First Intervention (48 h)||0
135073|NCT01740817|329185|P2|COMPLETED|First Intervention (48 h)||4
135074|NCT01740817|329186|P1|COMPLETED|First Intervention (48 h)||8
135075|NCT01740817|329185|P2|STARTED|First Intervention (48 h)||4
135076|NCT01740817|329186|P1|STARTED|First Intervention (48 h)||8
135077|NCT01740726|329198|P2|NOT COMPLETED|Overall Study||0
135078|NCT01740726|329199|P1|NOT COMPLETED|Overall Study||0
135079|NCT01740726|329198|P2|COMPLETED|Overall Study||1
135080|NCT01740726|329199|P1|COMPLETED|Overall Study||0
135081|NCT01740726|329198|P2|STARTED|Overall Study||1
135082|NCT01740726|329199|P1|STARTED|Overall Study||0
135083|NCT01740713|329224|P3|NOT COMPLETED|Overall Study||1
135084|NCT01740713|329225|P2|NOT COMPLETED|Overall Study||2
135085|NCT01740713|329226|P1|NOT COMPLETED|Overall Study||0
135086|NCT01740713|329224|P3|COMPLETED|Overall Study||6
135087|NCT01740713|329225|P2|COMPLETED|Overall Study||6
135088|NCT01740713|329226|P1|COMPLETED|Overall Study||6
135089|NCT01740713|329224|P3|STARTED|Overall Study||7
135090|NCT01740713|329225|P2|STARTED|Overall Study||8
135091|NCT01740713|329226|P1|STARTED|Overall Study||6
135092|NCT01740440|329250|P1|NOT COMPLETED|Overall Study||3
135093|NCT01740440|329250|P1|COMPLETED|Overall Study||27
135094|NCT01740440|329250|P1|STARTED|Overall Study||30
135095|NCT01740427|329258|P2|NOT COMPLETED|Overall Study||222
135096|NCT01740427|329259|P1|NOT COMPLETED|Overall Study||444
135097|NCT01740427|329258|P2|COMPLETED|Overall Study||0
135098|NCT01740427|329259|P1|COMPLETED|Overall Study||0
135099|NCT01740427|329258|P2|STARTED|Overall Study||222
135100|NCT01740427|329259|P1|STARTED|Overall Study||444
135101|NCT01740414|329288|P2|NOT COMPLETED|Overall Study||8
135102|NCT01740414|329289|P1|NOT COMPLETED|Overall Study||9
135103|NCT01740414|329288|P2|COMPLETED|Overall Study||8
135104|NCT01740414|329289|P1|COMPLETED|Overall Study||3
135105|NCT01740414|329288|P2|STARTED|Overall Study||16
135106|NCT01740414|329289|P1|STARTED|Overall Study||12
135107|NCT01740401|329311|P1|NOT COMPLETED|Overall Study||10
135108|NCT01740401|329311|P1|COMPLETED|Overall Study||0
135109|NCT01740401|329311|P1|STARTED|Overall Study||10
135110|NCT01740388|329320|P2|NOT COMPLETED|Overall Study||44
135111|NCT01740388|329321|P1|NOT COMPLETED|Overall Study||46
135112|NCT01740388|329320|P2|COMPLETED|Overall Study||28
135113|NCT01740388|329321|P1|COMPLETED|Overall Study||18
135114|NCT01740388|329320|P2|STARTED|Overall Study||72
135115|NCT01740388|329321|P1|STARTED|Overall Study||64
135116|NCT01740362|329341|P4|NOT COMPLETED|Overall Study||0
135117|NCT01740362|329342|P3|NOT COMPLETED|Overall Study||0
135118|NCT01740362|329343|P2|NOT COMPLETED|Overall Study||0
135119|NCT01740362|329344|P1|NOT COMPLETED|Overall Study||0
135120|NCT01740362|329341|P4|COMPLETED|Overall Study||6
135121|NCT01740362|329342|P3|COMPLETED|Overall Study||6
135122|NCT01740362|329343|P2|COMPLETED|Overall Study||6
135123|NCT01740362|329344|P1|COMPLETED|Overall Study||6
135124|NCT01740362|329341|P4|STARTED|Overall Study||6
135125|NCT01740362|329342|P3|STARTED|Overall Study||6
135126|NCT01740362|329343|P2|STARTED|Overall Study||6
135127|NCT01740362|329344|P1|STARTED|Overall Study||6
135128|NCT01740323|329372|P2|NOT COMPLETED|Overall Study||0
135129|NCT01740323|329373|P1|NOT COMPLETED|Overall Study||2
135130|NCT01740323|329372|P2|COMPLETED|Overall Study||15
135131|NCT01740323|329373|P1|COMPLETED|Overall Study||13
135132|NCT01740323|329372|P2|STARTED|Overall Study||15
135133|NCT01740323|329373|P1|STARTED|Overall Study||15
135134|NCT01740297|329394|P3|NOT COMPLETED|Overall Study||98
135135|NCT01740297|329395|P2|NOT COMPLETED|Overall Study||100
135136|NCT01740297|329396|P1|NOT COMPLETED|Overall Study||19
135137|NCT01740297|329394|P3|COMPLETED|Overall Study||0
135138|NCT01740297|329395|P2|COMPLETED|Overall Study||0
135139|NCT01740297|329396|P1|COMPLETED|Overall Study||0
135140|NCT01740297|329394|P3|Received Ipilimumab|Overall Study||92
135141|NCT01740297|329395|P2|Received Ipilimumab|Overall Study||95
135142|NCT01740297|329396|P1|Received Ipilimumab|Overall Study||18
135143|NCT01740297|329394|P3|Received Talimogene Laherparepvec|Overall Study||95
135144|NCT01740297|329395|P2|Received Talimogene Laherparepvec|Overall Study||0
135145|NCT01740297|329396|P1|Received Talimogene Laherparepvec|Overall Study||19
135146|NCT01740297|329394|P3|STARTED|Overall Study||98
135147|NCT01740297|329395|P2|STARTED|Overall Study||100
135148|NCT01740297|329396|P1|STARTED|Overall Study||19
135149|NCT01740206|329428|P2|NOT COMPLETED|Overall Study||0
135150|NCT01740206|329429|P1|NOT COMPLETED|Overall Study||0
135151|NCT01740206|329428|P2|COMPLETED|Overall Study||34
135152|NCT01740206|329429|P1|COMPLETED|Overall Study||14
135153|NCT01740206|329428|P2|STARTED|Overall Study||34
135154|NCT01740206|329429|P1|STARTED|Overall Study||14
135155|NCT01740154|329445|P1|NOT COMPLETED|Overall Study||1
135156|NCT01740154|329445|P1|COMPLETED|Overall Study||12
135157|NCT01740154|329445|P1|STARTED|Overall Study||13
135158|NCT01740128|329453|P2|NOT COMPLETED|Overall Study||7
135159|NCT01740128|329454|P1|NOT COMPLETED|Overall Study||6
135160|NCT01740128|329453|P2|COMPLETED|Overall Study||4
135161|NCT01740128|329454|P1|COMPLETED|Overall Study||4
135162|NCT01740128|329453|P2|STARTED|Overall Study||11
135163|NCT01740128|329454|P1|STARTED|Overall Study||10
135164|NCT01740089|329483|P3|NOT COMPLETED|After 12 Weeks||11
135165|NCT01740089|329484|P2|NOT COMPLETED|After 12 Weeks||3
135166|NCT01740089|329485|P1|NOT COMPLETED|After 12 Weeks||7
135167|NCT01740089|329483|P3|COMPLETED|After 12 Weeks|"Withdrawn due to:~No EVR (n=4) AE (n=5) Non-attendance of visit (n=1) Withdrawn consent (n=1)"|37
135168|NCT01740089|329484|P2|COMPLETED|After 12 Weeks|"Withdrawn due to:~Withdrawn consent (n=1) No EVR (n=1) Non-compliance (n=1)"|45
135169|NCT01740089|329485|P1|COMPLETED|After 12 Weeks|"Withdrawn due to:~No EVR (n=3) AE (n=2) No EOT (n=1) Non-compliance (n=1)"|43
135170|NCT01740089|329483|P3|STARTED|After 12 Weeks||48
135171|NCT01740089|329484|P2|STARTED|After 12 Weeks||48
135172|NCT01740089|329485|P1|STARTED|After 12 Weeks||50
135173|NCT01740089|329483|P3|NOT COMPLETED|First 12 Weeks of Treatment||2
135174|NCT01740089|329484|P2|NOT COMPLETED|First 12 Weeks of Treatment||2
135175|NCT01740089|329485|P1|NOT COMPLETED|First 12 Weeks of Treatment||0
135176|NCT01740089|329483|P3|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:~AE before W12 (n=2)"|48
135177|NCT01740089|329484|P2|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:~AE before W12 (n=1) Withdrew consent before W12 (n=1)"|48
135178|NCT01740089|329485|P1|COMPLETED|First 12 Weeks of Treatment||50
135179|NCT01740089|329483|P3|STARTED|First 12 Weeks of Treatment||50
135180|NCT01740089|329484|P2|STARTED|First 12 Weeks of Treatment||50
135181|NCT01740089|329485|P1|STARTED|First 12 Weeks of Treatment||50
135182|NCT01739803|329503|P2|NOT COMPLETED|Overall Study||6
135183|NCT01739803|329504|P1|NOT COMPLETED|Overall Study||9
135184|NCT01739803|329503|P2|COMPLETED|Overall Study||68
135185|NCT01739803|329504|P1|COMPLETED|Overall Study||67
135186|NCT01739803|329503|P2|STARTED|Overall Study||74
135187|NCT01739803|329504|P1|STARTED|Overall Study||76
135188|NCT01739790|329516|P2|NOT COMPLETED|Overall Study||4
135189|NCT01739790|329517|P1|NOT COMPLETED|Overall Study||2
135190|NCT01739790|329516|P2|COMPLETED|Overall Study||23
135191|NCT01739790|329517|P1|COMPLETED|Overall Study||22
135192|NCT01739790|329516|P2|STARTED|Overall Study||27
135193|NCT01739790|329517|P1|STARTED|Overall Study||24
135194|NCT01739595|329526|P3|NOT COMPLETED|Overall Study||2
135195|NCT01739595|329527|P2|NOT COMPLETED|Overall Study||1
135196|NCT01739595|329528|P1|NOT COMPLETED|Overall Study||13
135197|NCT01739595|329526|P3|COMPLETED|Overall Study||45
135198|NCT01739595|329527|P2|COMPLETED|Overall Study||21
135199|NCT01739595|329528|P1|COMPLETED|Overall Study||99
135200|NCT01739595|329526|P3|STARTED|Overall Study||47
135201|NCT01739595|329527|P2|STARTED|Overall Study||22
135202|NCT01739595|329528|P1|STARTED|Overall Study||112
135203|NCT01739400|329538|P2|NOT COMPLETED|Overall Study||9
135204|NCT01739400|329539|P1|NOT COMPLETED|Overall Study||17
135205|NCT01739400|329538|P2|COMPLETED|Overall Study||99
135206|NCT01739400|329539|P1|COMPLETED|Overall Study||92
135207|NCT01739400|329538|P2|Treated With 10 mg Macitentan|Overall Study||108
135208|NCT01739400|329539|P1|Treated With 10 mg Macitentan|Overall Study||109
135209|NCT01739400|329538|P2|STARTED|Overall Study||108
135210|NCT01739400|329539|P1|STARTED|Overall Study||109
135211|NCT01739361|329552|P2|NOT COMPLETED|Overall Study||1
135212|NCT01739361|329553|P1|NOT COMPLETED|Overall Study||3
135213|NCT01739361|329552|P2|COMPLETED|Overall Study||22
135214|NCT01739361|329553|P1|COMPLETED|Overall Study||18
135215|NCT01739361|329552|P2|STARTED|Overall Study||23
135216|NCT01739361|329553|P1|STARTED|Overall Study||21
135217|NCT01739348|329567|P4|NOT COMPLETED|Part II (Extension Study)||396
135218|NCT01739348|329568|P3|NOT COMPLETED|Part II (Extension Study)||61
135219|NCT01739348|329569|P2|NOT COMPLETED|Part II (Extension Study)||366
135220|NCT01739348|329570|P1|NOT COMPLETED|Part II (Extension Study)||379
135221|NCT01739348|329567|P4|COMPLETED|Part II (Extension Study)||0
135222|NCT01739348|329568|P3|COMPLETED|Part II (Extension Study)||0
135223|NCT01739348|329569|P2|COMPLETED|Part II (Extension Study)||0
135224|NCT01739348|329570|P1|COMPLETED|Part II (Extension Study)||0
135225|NCT01739348|329567|P4|Treated|Part II (Extension Study)||394
135226|NCT01739348|329568|P3|Treated|Part II (Extension Study)||61
135227|NCT01739348|329569|P2|Treated|Part II (Extension Study)||365
135228|NCT01739348|329570|P1|Treated|Part II (Extension Study)||379
135229|NCT01739348|329567|P4|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|396
135230|NCT01739348|329568|P3|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|61
135231|NCT01739348|329569|P2|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|366
135232|NCT01739348|329570|P1|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|379
135233|NCT01739348|329567|P4|NOT COMPLETED|Part I (Base Study)||189
135234|NCT01739348|329568|P3|NOT COMPLETED|Part I (Base Study)||26
135235|NCT01739348|329569|P2|NOT COMPLETED|Part I (Base Study)||203
135236|NCT01739348|329570|P1|NOT COMPLETED|Part I (Base Study)||202
135237|NCT01739348|329567|P4|COMPLETED|Part I (Base Study)||516
135238|NCT01739348|329568|P3|COMPLETED|Part I (Base Study)||77
135239|NCT01739348|329569|P2|COMPLETED|Part I (Base Study)||497
135240|NCT01739348|329570|P1|COMPLETED|Part I (Base Study)||501
135241|NCT01739348|329567|P4|Treated|Part I (Base Study)||705
135242|NCT01739348|329568|P3|Treated|Part I (Base Study)||103
135243|NCT01739348|329569|P2|Treated|Part I (Base Study)||700
135244|NCT01739348|329570|P1|Treated|Part I (Base Study)||702
135245|NCT01739348|329567|P4|STARTED|Part I (Base Study)||705
135246|NCT01739348|329568|P3|STARTED|Part I (Base Study)||103
135247|NCT01739348|329569|P2|STARTED|Part I (Base Study)||700
135248|NCT01739348|329570|P1|STARTED|Part I (Base Study)||703
135249|NCT01739335|329642|P2|NOT COMPLETED|Overall Study||5
135250|NCT01739335|329643|P1|NOT COMPLETED|Overall Study||7
135251|NCT01739335|329642|P2|COMPLETED|Overall Study||35
135252|NCT01739335|329643|P1|COMPLETED|Overall Study||34
135253|NCT01739335|329642|P2|STARTED|Overall Study||40
135254|NCT01739335|329643|P1|STARTED|Overall Study||41
135255|NCT01739309|329675|P1|NOT COMPLETED|Overall Study||3
135256|NCT01739309|329675|P1|COMPLETED|Overall Study||25
135257|NCT01739309|329675|P1|Alive and on Study, Off Treatment|Overall Study||8
135258|NCT01739309|329675|P1|Death Due to Any Cause|Overall Study||17
135259|NCT01739309|329675|P1|Received at Least One Dose of Study Drug|Overall Study||28
135260|NCT01739309|329675|P1|STARTED|Overall Study||28
135261|NCT01739231|329698|P4|NOT COMPLETED|Part B||2
135262|NCT01739231|329699|P3|NOT COMPLETED|Part B||2
135263|NCT01739231|329700|P2|NOT COMPLETED|Part B||5
135264|NCT01739231|329701|P1|NOT COMPLETED|Part B||7
135265|NCT01739231|329698|P4|COMPLETED|Part B||19
135266|NCT01739231|329699|P3|COMPLETED|Part B||10
135267|NCT01739231|329700|P2|COMPLETED|Part B||12
135268|NCT01739231|329701|P1|COMPLETED|Part B||13
135269|NCT01739231|329698|P4|Challenged|Part B||21
135270|NCT01739231|329699|P3|Challenged|Part B||10
135271|NCT01739231|329700|P2|Challenged|Part B||13
135272|NCT01739231|329701|P1|Challenged|Part B||13
135273|NCT01739231|329698|P4|STARTED|Part B||21
135274|NCT01739231|329699|P3|STARTED|Part B||12
135275|NCT01739231|329700|P2|STARTED|Part B||17
135276|NCT01739231|329701|P1|STARTED|Part B||20
135277|NCT01739231|329698|P4|NOT COMPLETED|Part A||0
135278|NCT01739231|329699|P3|NOT COMPLETED|Part A||0
135279|NCT01739231|329700|P2|NOT COMPLETED|Part A||7
135280|NCT01739231|329701|P1|NOT COMPLETED|Part A||4
135281|NCT01739231|329698|P4|COMPLETED|Part A||0
135282|NCT01739231|329699|P3|COMPLETED|Part A||12
135283|NCT01739231|329700|P2|COMPLETED|Part A||17
135284|NCT01739231|329701|P1|COMPLETED|Part A||20
135285|NCT01739231|329698|P4|Received All 3 Vaccinations|Part A||0
135286|NCT01739231|329699|P3|Received All 3 Vaccinations|Part A||12
135287|NCT01739231|329700|P2|Received All 3 Vaccinations|Part A||20
135288|NCT01739231|329701|P1|Received All 3 Vaccinations|Part A||21
135289|NCT01739231|329698|P4|STARTED|Part A||0
135290|NCT01739231|329699|P3|STARTED|Part A||12
135291|NCT01739231|329700|P2|STARTED|Part A||24
135292|NCT01739231|329701|P1|STARTED|Part A||24
135293|NCT01738984|329870|P2|NOT COMPLETED|Overall Study||39
135294|NCT01738984|329871|P1|NOT COMPLETED|Overall Study||64
135295|NCT01738984|329870|P2|COMPLETED|Overall Study||210
135296|NCT01738984|329871|P1|COMPLETED|Overall Study||186
135297|NCT01738984|329870|P2|STARTED|Overall Study||249
135298|NCT01738984|329871|P1|STARTED|Overall Study||250
135299|NCT01738971|329884|P3|NOT COMPLETED|Overall Study||17
135300|NCT01738971|329885|P2|NOT COMPLETED|Overall Study||30
135301|NCT01738971|329886|P1|NOT COMPLETED|Overall Study||19
135302|NCT01738971|329884|P3|COMPLETED|Overall Study|39 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|39
135303|NCT01738971|329885|P2|COMPLETED|Overall Study|28 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|28
135304|NCT01738971|329886|P1|COMPLETED|Overall Study|35 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|35
135305|NCT01738971|329884|P3|STARTED|Overall Study|56 participants recruited to this arm|56
135306|NCT01738971|329885|P2|STARTED|Overall Study|58 participants recruited to this arm|58
135307|NCT01738971|329886|P1|STARTED|Overall Study|54 participants recruited to this arm|54
135308|NCT01738919|329902|P2|NOT COMPLETED|Overall Study||3
135309|NCT01738919|329903|P1|NOT COMPLETED|Overall Study||1
135310|NCT01738919|329902|P2|COMPLETED|Overall Study||14
135311|NCT01738919|329903|P1|COMPLETED|Overall Study||14
135312|NCT01738919|329902|P2|STARTED|Overall Study||17
135313|NCT01738919|329903|P1|STARTED|Overall Study||15
135314|NCT01738750|329921|P2|NOT COMPLETED|Overall Study||0
135315|NCT01738750|329922|P1|NOT COMPLETED|Overall Study||0
135316|NCT01738750|329921|P2|COMPLETED|Overall Study||51
135317|NCT01738750|329922|P1|COMPLETED|Overall Study||49
135318|NCT01738750|329921|P2|STARTED|Overall Study||51
135319|NCT01738750|329922|P1|STARTED|Overall Study||49
135320|NCT01738737|329935|P5|NOT COMPLETED|Overall Study||4
135321|NCT01738737|329936|P4|NOT COMPLETED|Overall Study||4
135322|NCT01738737|329937|P3|NOT COMPLETED|Overall Study||4
135323|NCT01738737|329938|P2|NOT COMPLETED|Overall Study||4
135324|NCT01738737|329939|P1|NOT COMPLETED|Overall Study||4
135325|NCT01738737|329935|P5|COMPLETED|Overall Study||25
135326|NCT01738737|329936|P4|COMPLETED|Overall Study||25
135327|NCT01738737|329937|P3|COMPLETED|Overall Study||25
135328|NCT01738737|329938|P2|COMPLETED|Overall Study||25
135329|NCT01738737|329939|P1|COMPLETED|Overall Study||25
135330|NCT01738737|329935|P5|STARTED|Overall Study||29
135331|NCT01738737|329936|P4|STARTED|Overall Study||29
135332|NCT01738737|329937|P3|STARTED|Overall Study||29
135333|NCT01738737|329938|P2|STARTED|Overall Study||29
135334|NCT01738737|329939|P1|STARTED|Overall Study||29
135335|NCT01738698|329975|P4|NOT COMPLETED|Overall Study||0
135336|NCT01738698|329976|P3|NOT COMPLETED|Overall Study||0
135337|NCT01738698|329977|P2|NOT COMPLETED|Overall Study||0
135338|NCT01738698|329978|P1|NOT COMPLETED|Overall Study||0
135339|NCT01738698|329975|P4|COMPLETED|Overall Study||0
135340|NCT01738698|329976|P3|COMPLETED|Overall Study||0
135341|NCT01738698|329977|P2|COMPLETED|Overall Study||0
135342|NCT01738698|329978|P1|COMPLETED|Overall Study||0
135343|NCT01738698|329975|P4|STARTED|Overall Study||0
135344|NCT01738698|329976|P3|STARTED|Overall Study||0
135345|NCT01738698|329977|P2|STARTED|Overall Study||0
135346|NCT01738698|329978|P1|STARTED|Overall Study||0
135347|NCT01738672|330044|P1|NOT COMPLETED|Overall Study||5
135348|NCT01738672|330044|P1|COMPLETED|Overall Study||11
135349|NCT01738672|330044|P1|STARTED|Overall Study||16
135350|NCT01738646|330053|P1|NOT COMPLETED|Overall Study||2
135351|NCT01738646|330053|P1|COMPLETED|Overall Study|Participants who discontinued study drug for any reason.|38
135352|NCT01738646|330053|P1|STARTED|Overall Study||40
135353|NCT01738594|330064|P8|NOT COMPLETED|Follow up for 1 Year||0
135354|NCT01738594|330065|P7|NOT COMPLETED|Follow up for 1 Year||0
135355|NCT01738594|330066|P6|NOT COMPLETED|Follow up for 1 Year||3
135356|NCT01738594|330067|P5|NOT COMPLETED|Follow up for 1 Year||0
135357|NCT01738594|330068|P4|NOT COMPLETED|Follow up for 1 Year||0
135358|NCT01738594|330069|P3|NOT COMPLETED|Follow up for 1 Year||0
135359|NCT01738594|330070|P2|NOT COMPLETED|Follow up for 1 Year||0
135360|NCT01738594|330071|P1|NOT COMPLETED|Follow up for 1 Year||0
135361|NCT01738594|330064|P8|COMPLETED|Follow up for 1 Year||0
135362|NCT01738594|330065|P7|COMPLETED|Follow up for 1 Year||0
135363|NCT01738594|330066|P6|COMPLETED|Follow up for 1 Year||0
135364|NCT01738594|330067|P5|COMPLETED|Follow up for 1 Year||1
135365|NCT01738594|330068|P4|COMPLETED|Follow up for 1 Year||0
135366|NCT01738594|330069|P3|COMPLETED|Follow up for 1 Year||0
135367|NCT01738594|330070|P2|COMPLETED|Follow up for 1 Year||2
135368|NCT01738594|330071|P1|COMPLETED|Follow up for 1 Year||0
135369|NCT01738594|330064|P8|STARTED|Follow up for 1 Year||0
135370|NCT01738594|330065|P7|STARTED|Follow up for 1 Year||0
135371|NCT01738594|330066|P6|STARTED|Follow up for 1 Year||3
135372|NCT01738594|330067|P5|STARTED|Follow up for 1 Year||1
135373|NCT01738594|330068|P4|STARTED|Follow up for 1 Year||0
135374|NCT01738594|330069|P3|STARTED|Follow up for 1 Year||0
135375|NCT01738594|330070|P2|STARTED|Follow up for 1 Year||2
135376|NCT01738594|330071|P1|STARTED|Follow up for 1 Year||0
135377|NCT01738594|330064|P8|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
135378|NCT01738594|330065|P7|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
135379|NCT01738594|330066|P6|NOT COMPLETED|Went on to Continue Treatment Cycle 5||1
135380|NCT01738594|330067|P5|NOT COMPLETED|Went on to Continue Treatment Cycle 5||1
135381|NCT01738594|330068|P4|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
135382|NCT01738594|330069|P3|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
135383|NCT01738594|330070|P2|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
135384|NCT01738594|330071|P1|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
135385|NCT01738594|330064|P8|COMPLETED|Went on to Continue Treatment Cycle 5||0
135386|NCT01738594|330065|P7|COMPLETED|Went on to Continue Treatment Cycle 5||0
135387|NCT01738594|330066|P6|COMPLETED|Went on to Continue Treatment Cycle 5||0
135388|NCT01738594|330067|P5|COMPLETED|Went on to Continue Treatment Cycle 5||0
135389|NCT01738594|330068|P4|COMPLETED|Went on to Continue Treatment Cycle 5||0
135390|NCT01738594|330069|P3|COMPLETED|Went on to Continue Treatment Cycle 5||0
135391|NCT01738594|330070|P2|COMPLETED|Went on to Continue Treatment Cycle 5||0
135392|NCT01738594|330071|P1|COMPLETED|Went on to Continue Treatment Cycle 5||0
135393|NCT01738594|330064|P8|STARTED|Went on to Continue Treatment Cycle 5||0
135394|NCT01738594|330065|P7|STARTED|Went on to Continue Treatment Cycle 5||0
135395|NCT01738594|330066|P6|STARTED|Went on to Continue Treatment Cycle 5||1
135396|NCT01738594|330067|P5|STARTED|Went on to Continue Treatment Cycle 5||1
135397|NCT01738594|330068|P4|STARTED|Went on to Continue Treatment Cycle 5||0
135398|NCT01738594|330069|P3|STARTED|Went on to Continue Treatment Cycle 5||0
135399|NCT01738594|330070|P2|STARTED|Went on to Continue Treatment Cycle 5||0
135400|NCT01738594|330071|P1|STARTED|Went on to Continue Treatment Cycle 5||0
135401|NCT01738594|330064|P8|NOT COMPLETED|Completed 4 Cycles of Treatment||0
135402|NCT01738594|330065|P7|NOT COMPLETED|Completed 4 Cycles of Treatment||0
135403|NCT01738594|330066|P6|NOT COMPLETED|Completed 4 Cycles of Treatment||1
135404|NCT01738594|330067|P5|NOT COMPLETED|Completed 4 Cycles of Treatment||0
135405|NCT01738594|330068|P4|NOT COMPLETED|Completed 4 Cycles of Treatment||0
135406|NCT01738594|330069|P3|NOT COMPLETED|Completed 4 Cycles of Treatment||0
135407|NCT01738594|330070|P2|NOT COMPLETED|Completed 4 Cycles of Treatment||2
135408|NCT01738594|330071|P1|NOT COMPLETED|Completed 4 Cycles of Treatment||0
135409|NCT01738594|330064|P8|COMPLETED|Completed 4 Cycles of Treatment||0
135410|NCT01738594|330065|P7|COMPLETED|Completed 4 Cycles of Treatment||0
135411|NCT01738594|330066|P6|COMPLETED|Completed 4 Cycles of Treatment||1
135412|NCT01738594|330067|P5|COMPLETED|Completed 4 Cycles of Treatment||1
135413|NCT01738594|330068|P4|COMPLETED|Completed 4 Cycles of Treatment||0
135414|NCT01738594|330069|P3|COMPLETED|Completed 4 Cycles of Treatment||0
135415|NCT01738594|330070|P2|COMPLETED|Completed 4 Cycles of Treatment||0
135416|NCT01738594|330071|P1|COMPLETED|Completed 4 Cycles of Treatment||0
135417|NCT01738594|330064|P8|STARTED|Completed 4 Cycles of Treatment||0
135418|NCT01738594|330065|P7|STARTED|Completed 4 Cycles of Treatment||0
135419|NCT01738594|330066|P6|STARTED|Completed 4 Cycles of Treatment||2
135420|NCT01738594|330067|P5|STARTED|Completed 4 Cycles of Treatment||1
135421|NCT01738594|330068|P4|STARTED|Completed 4 Cycles of Treatment||0
135422|NCT01738594|330069|P3|STARTED|Completed 4 Cycles of Treatment||0
135423|NCT01738594|330070|P2|STARTED|Completed 4 Cycles of Treatment||2
135424|NCT01738594|330071|P1|STARTED|Completed 4 Cycles of Treatment||0
135425|NCT01738594|330064|P8|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
135426|NCT01738594|330065|P7|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
135427|NCT01738594|330066|P6|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||1
135428|NCT01738594|330067|P5|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
135429|NCT01738594|330068|P4|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
135430|NCT01738594|330069|P3|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
135431|NCT01738594|330070|P2|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
135432|NCT01738594|330071|P1|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
135433|NCT01738594|330064|P8|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
135434|NCT01738594|330065|P7|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
135435|NCT01738594|330066|P6|COMPLETED|Completed 2 Cycles/Reached 1st Response||2
135436|NCT01738594|330067|P5|COMPLETED|Completed 2 Cycles/Reached 1st Response||1
135437|NCT01738594|330068|P4|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
135438|NCT01738594|330069|P3|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
135439|NCT01738594|330070|P2|COMPLETED|Completed 2 Cycles/Reached 1st Response||2
135440|NCT01738594|330071|P1|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
135441|NCT01738594|330064|P8|STARTED|Completed 2 Cycles/Reached 1st Response||0
135442|NCT01738594|330065|P7|STARTED|Completed 2 Cycles/Reached 1st Response||0
135443|NCT01738594|330066|P6|STARTED|Completed 2 Cycles/Reached 1st Response||3
135444|NCT01738594|330067|P5|STARTED|Completed 2 Cycles/Reached 1st Response||1
135445|NCT01738594|330068|P4|STARTED|Completed 2 Cycles/Reached 1st Response||0
135446|NCT01738594|330069|P3|STARTED|Completed 2 Cycles/Reached 1st Response||0
135447|NCT01738594|330070|P2|STARTED|Completed 2 Cycles/Reached 1st Response||2
135448|NCT01738594|330071|P1|STARTED|Completed 2 Cycles/Reached 1st Response||0
135449|NCT01738594|330064|P8|NOT COMPLETED|Registration and Treatment Start||0
135450|NCT01738594|330065|P7|NOT COMPLETED|Registration and Treatment Start||0
135451|NCT01738594|330066|P6|NOT COMPLETED|Registration and Treatment Start||0
135452|NCT01738594|330067|P5|NOT COMPLETED|Registration and Treatment Start||0
135453|NCT01738594|330068|P4|NOT COMPLETED|Registration and Treatment Start||0
135454|NCT01738594|330069|P3|NOT COMPLETED|Registration and Treatment Start||0
135455|NCT01738594|330070|P2|NOT COMPLETED|Registration and Treatment Start||1
135456|NCT01738594|330071|P1|NOT COMPLETED|Registration and Treatment Start||0
135457|NCT01738594|330064|P8|COMPLETED|Registration and Treatment Start||0
135458|NCT01738594|330065|P7|COMPLETED|Registration and Treatment Start||0
135459|NCT01738594|330066|P6|COMPLETED|Registration and Treatment Start||3
135460|NCT01738594|330067|P5|COMPLETED|Registration and Treatment Start||1
135461|NCT01738594|330068|P4|COMPLETED|Registration and Treatment Start||0
135462|NCT01738594|330069|P3|COMPLETED|Registration and Treatment Start||0
135463|NCT01738594|330070|P2|COMPLETED|Registration and Treatment Start||2
135464|NCT01738594|330071|P1|COMPLETED|Registration and Treatment Start||0
135465|NCT01738594|330064|P8|Treatment Started|Registration and Treatment Start||0
135466|NCT01738594|330065|P7|Treatment Started|Registration and Treatment Start||0
135467|NCT01738594|330066|P6|Treatment Started|Registration and Treatment Start||3
135468|NCT01738594|330067|P5|Treatment Started|Registration and Treatment Start||1
135469|NCT01738594|330068|P4|Treatment Started|Registration and Treatment Start||0
135470|NCT01738594|330069|P3|Treatment Started|Registration and Treatment Start||0
135471|NCT01738594|330070|P2|Treatment Started|Registration and Treatment Start||2
135472|NCT01738594|330071|P1|Treatment Started|Registration and Treatment Start||0
135473|NCT01738594|330064|P8|Registered to Study|Registration and Treatment Start||0
135474|NCT01738594|330065|P7|Registered to Study|Registration and Treatment Start||0
135475|NCT01738594|330066|P6|Registered to Study|Registration and Treatment Start||3
135476|NCT01738594|330067|P5|Registered to Study|Registration and Treatment Start||1
135477|NCT01738594|330068|P4|Registered to Study|Registration and Treatment Start||0
135478|NCT01738594|330069|P3|Registered to Study|Registration and Treatment Start||0
135479|NCT01738594|330070|P2|Registered to Study|Registration and Treatment Start||3
135480|NCT01738594|330071|P1|Registered to Study|Registration and Treatment Start||0
135481|NCT01738594|330064|P8|STARTED|Registration and Treatment Start||0
135482|NCT01738594|330065|P7|STARTED|Registration and Treatment Start||0
135483|NCT01738594|330066|P6|STARTED|Registration and Treatment Start||3
135484|NCT01738594|330067|P5|STARTED|Registration and Treatment Start||1
135485|NCT01738594|330068|P4|STARTED|Registration and Treatment Start||0
135486|NCT01738594|330069|P3|STARTED|Registration and Treatment Start||0
135487|NCT01738594|330070|P2|STARTED|Registration and Treatment Start||3
135488|NCT01738594|330071|P1|STARTED|Registration and Treatment Start||0
135489|NCT01738581|330089|P2|NOT COMPLETED|Overall Study||0
135490|NCT01738581|330090|P1|NOT COMPLETED|Overall Study||1
135491|NCT01738581|330089|P2|COMPLETED|Overall Study||4
135492|NCT01738581|330090|P1|COMPLETED|Overall Study||4
135493|NCT01738581|330089|P2|STARTED|Overall Study||4
135494|NCT01738581|330090|P1|STARTED|Overall Study||5
135495|NCT01738503|330114|P7|NOT COMPLETED|PET Imaging Sub-study||1
135496|NCT01738503|330115|P6|NOT COMPLETED|PET Imaging Sub-study||2
135497|NCT01738503|330116|P5|NOT COMPLETED|PET Imaging Sub-study||0
135498|NCT01738503|330117|P4|NOT COMPLETED|PET Imaging Sub-study||0
135499|NCT01738503|330118|P3|NOT COMPLETED|PET Imaging Sub-study||0
135500|NCT01738503|330119|P2|NOT COMPLETED|PET Imaging Sub-study||0
135501|NCT01738503|330120|P1|NOT COMPLETED|PET Imaging Sub-study||0
135502|NCT01738503|330114|P7|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 6 injections plus all PET images|1
135503|NCT01738503|330115|P6|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 12 injections plus all PET images|1
135504|NCT01738503|330116|P5|COMPLETED|PET Imaging Sub-study||0
135505|NCT01738503|330117|P4|COMPLETED|PET Imaging Sub-study||0
135506|NCT01738503|330118|P3|COMPLETED|PET Imaging Sub-study||0
135507|NCT01738503|330119|P2|COMPLETED|PET Imaging Sub-study||0
135508|NCT01738503|330120|P1|COMPLETED|PET Imaging Sub-study||0
135509|NCT01738503|330114|P7|STARTED|PET Imaging Sub-study||2
135510|NCT01738503|330115|P6|STARTED|PET Imaging Sub-study||3
135511|NCT01738503|330116|P5|STARTED|PET Imaging Sub-study||0
135512|NCT01738503|330117|P4|STARTED|PET Imaging Sub-study||0
135513|NCT01738503|330118|P3|STARTED|PET Imaging Sub-study||0
135514|NCT01738503|330119|P2|STARTED|PET Imaging Sub-study||0
135515|NCT01738503|330120|P1|STARTED|PET Imaging Sub-study||0
135516|NCT01738503|330114|P7|NOT COMPLETED|Treatment Period||8
135517|NCT01738503|330115|P6|NOT COMPLETED|Treatment Period||6
135518|NCT01738503|330116|P5|NOT COMPLETED|Treatment Period||8
135519|NCT01738503|330117|P4|NOT COMPLETED|Treatment Period||6
135520|NCT01738503|330118|P3|NOT COMPLETED|Treatment Period||5
135521|NCT01738503|330119|P2|NOT COMPLETED|Treatment Period||5
135522|NCT01738503|330120|P1|NOT COMPLETED|Treatment Period||0
135523|NCT01738503|330114|P7|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|6
135524|NCT01738503|330115|P6|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
135525|NCT01738503|330116|P5|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|7
135526|NCT01738503|330117|P4|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
135527|NCT01738503|330118|P3|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
135528|NCT01738503|330119|P2|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
135529|NCT01738503|330120|P1|COMPLETED|Treatment Period||0
135530|NCT01738503|330114|P7|STARTED|Treatment Period||14
135531|NCT01738503|330115|P6|STARTED|Treatment Period||15
135532|NCT01738503|330116|P5|STARTED|Treatment Period||15
135533|NCT01738503|330117|P4|STARTED|Treatment Period||15
135534|NCT01738503|330118|P3|STARTED|Treatment Period||15
135535|NCT01738503|330119|P2|STARTED|Treatment Period||15
135536|NCT01738503|330120|P1|STARTED|Treatment Period||0
135537|NCT01738503|330114|P7|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
135538|NCT01738503|330115|P6|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
135539|NCT01738503|330116|P5|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
135540|NCT01738503|330117|P4|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
135541|NCT01738503|330118|P3|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
135542|NCT01738503|330119|P2|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
135543|NCT01738503|330120|P1|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||35
135544|NCT01738503|330114|P7|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
135545|NCT01738503|330115|P6|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
135546|NCT01738503|330116|P5|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
135547|NCT01738503|330117|P4|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
135548|NCT01738503|330118|P3|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
135549|NCT01738503|330119|P2|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
135550|NCT01738503|330120|P1|COMPLETED|Induction/Stabilization (Days -14 to -1)||89
135551|NCT01738503|330114|P7|STARTED|Induction/Stabilization (Days -14 to -1)||0
135552|NCT01738503|330115|P6|STARTED|Induction/Stabilization (Days -14 to -1)||0
135553|NCT01738503|330116|P5|STARTED|Induction/Stabilization (Days -14 to -1)||0
135554|NCT01738503|330117|P4|STARTED|Induction/Stabilization (Days -14 to -1)||0
135555|NCT01738503|330118|P3|STARTED|Induction/Stabilization (Days -14 to -1)||0
135556|NCT01738503|330119|P2|STARTED|Induction/Stabilization (Days -14 to -1)||0
135557|NCT01738503|330120|P1|STARTED|Induction/Stabilization (Days -14 to -1)||124
135558|NCT01738477|330318|P2|NOT COMPLETED|Overall Study||4
135559|NCT01738477|330319|P1|NOT COMPLETED|Overall Study||1
135560|NCT01738477|330318|P2|COMPLETED|Overall Study||124
135561|NCT01738477|330319|P1|COMPLETED|Overall Study||36
135562|NCT01738477|330318|P2|STARTED|Overall Study||128
135563|NCT01738477|330319|P1|STARTED|Overall Study||37
135564|NCT01738438|330347|P1|NOT COMPLETED|Overall Study||35
135565|NCT01738438|330347|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
135566|NCT01738438|330347|P1|STARTED|Overall Study||35
135567|NCT01738321|330355|P2|NOT COMPLETED|Overall Study||0
135568|NCT01738321|330356|P1|NOT COMPLETED|Overall Study||0
135569|NCT01738321|330355|P2|COMPLETED|Overall Study||30
135570|NCT01738321|330356|P1|COMPLETED|Overall Study||33
135571|NCT01738321|330355|P2|STARTED|Overall Study||30
135572|NCT01738321|330356|P1|STARTED|Overall Study||33
135573|NCT01738191|330364|P2|NOT COMPLETED|Overall Study||1
135574|NCT01738191|330365|P1|NOT COMPLETED|Overall Study||4
135575|NCT01738191|330364|P2|COMPLETED|Overall Study||14
135576|NCT01738191|330365|P1|COMPLETED|Overall Study||11
135577|NCT01738191|330364|P2|STARTED|Overall Study||15
135578|NCT01738191|330365|P1|STARTED|Overall Study||15
135579|NCT01737996|330388|P3|NOT COMPLETED|Overall Study||2
135580|NCT01737996|330389|P2|NOT COMPLETED|Overall Study||1
135581|NCT01737996|330390|P1|NOT COMPLETED|Overall Study||0
135582|NCT01737996|330388|P3|COMPLETED|Overall Study|One patient withdrew consent after the first dose due to private reasons.|14
135583|NCT01737996|330389|P2|COMPLETED|Overall Study||7
135584|NCT01737996|330390|P1|COMPLETED|Overall Study||8
135585|NCT01737996|330388|P3|STARTED|Overall Study||16
135586|NCT01737996|330389|P2|STARTED|Overall Study||8
135587|NCT01737996|330390|P1|STARTED|Overall Study||8
135588|NCT01737944|330431|P4|NOT COMPLETED|Overall Study||0
135589|NCT01737944|330432|P3|NOT COMPLETED|Overall Study||0
135590|NCT01737944|330433|P2|NOT COMPLETED|Overall Study||0
135591|NCT01737944|330434|P1|NOT COMPLETED|Overall Study||0
135592|NCT01737944|330431|P4|COMPLETED|Overall Study||9
135593|NCT01737944|330432|P3|COMPLETED|Overall Study||9
135594|NCT01737944|330433|P2|COMPLETED|Overall Study||9
135595|NCT01737944|330434|P1|COMPLETED|Overall Study||9
135596|NCT01737944|330431|P4|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
135597|NCT01737944|330432|P3|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
135598|NCT01737944|330433|P2|STARTED|Overall Study||9
135599|NCT01737944|330434|P1|STARTED|Overall Study||9
135600|NCT01737931|330452|P3|NOT COMPLETED|Overall Study||1
135601|NCT01737931|330453|P2|NOT COMPLETED|Overall Study||2
135602|NCT01737931|330454|P1|NOT COMPLETED|Overall Study||0
135603|NCT01737931|330452|P3|COMPLETED|Overall Study||38
135604|NCT01737931|330453|P2|COMPLETED|Overall Study||38
135605|NCT01737931|330454|P1|COMPLETED|Overall Study||38
135606|NCT01737931|330452|P3|STARTED|Overall Study||39
135607|NCT01737931|330453|P2|STARTED|Overall Study||40
135608|NCT01737931|330454|P1|STARTED|Overall Study||38
135609|NCT01737879|330469|P1|NOT COMPLETED|Overall Study||41
135610|NCT01737879|330469|P1|COMPLETED|Overall Study||0
135611|NCT01737879|330469|P1|Transitioned to Epoetin Alfa|Overall Study||0
135612|NCT01737879|330469|P1|Received Peginesatide|Overall Study||34
135613|NCT01737879|330469|P1|STARTED|Overall Study||41
135614|NCT01737840|330478|P2|NOT COMPLETED|Overall Study||2
135615|NCT01737840|330479|P1|NOT COMPLETED|Overall Study||2
135616|NCT01737840|330478|P2|COMPLETED|Overall Study||33
135617|NCT01737840|330479|P1|COMPLETED|Overall Study||33
135618|NCT01737840|330478|P2|STARTED|Overall Study||35
135619|NCT01737840|330479|P1|STARTED|Overall Study||35
135620|NCT01737762|330489|P2|NOT COMPLETED|Overall Study||17
135621|NCT01737762|330490|P1|NOT COMPLETED|Overall Study||20
135622|NCT01737762|330489|P2|COMPLETED|Overall Study||61
135623|NCT01737762|330490|P1|COMPLETED|Overall Study||57
135624|NCT01737762|330489|P2|STARTED|Overall Study||78
135625|NCT01737762|330490|P1|STARTED|Overall Study||77
135626|NCT01737710|330503|P5|NOT COMPLETED|Overall Study||0
135627|NCT01737710|330504|P4|NOT COMPLETED|Overall Study||0
135628|NCT01737710|330505|P3|NOT COMPLETED|Overall Study||3
135629|NCT01737710|330506|P2|NOT COMPLETED|Overall Study||4
135630|NCT01737710|330507|P1|NOT COMPLETED|Overall Study||2
135631|NCT01737710|330503|P5|COMPLETED|Overall Study||21
135632|NCT01737710|330504|P4|COMPLETED|Overall Study||23
135633|NCT01737710|330505|P3|COMPLETED|Overall Study||102
135634|NCT01737710|330506|P2|COMPLETED|Overall Study||101
135635|NCT01737710|330507|P1|COMPLETED|Overall Study||112
135636|NCT01737710|330503|P5|STARTED|Overall Study||21
135637|NCT01737710|330504|P4|STARTED|Overall Study||23
135638|NCT01737710|330505|P3|STARTED|Overall Study||105
135639|NCT01737710|330506|P2|STARTED|Overall Study||105
135640|NCT01737710|330507|P1|STARTED|Overall Study||114
135641|NCT01737697|330549|P15|NOT COMPLETED|Subacute Phase||1
135642|NCT01737697|330550|P14|NOT COMPLETED|Subacute Phase||2
135643|NCT01737697|330551|P13|NOT COMPLETED|Subacute Phase||2
135644|NCT01737697|330552|P12|NOT COMPLETED|Subacute Phase||3
135645|NCT01737697|330553|P11|NOT COMPLETED|Subacute Phase||6
135646|NCT01737697|330554|P10|NOT COMPLETED|Subacute Phase||2
135647|NCT01737697|330555|P9|NOT COMPLETED|Subacute Phase||2
135648|NCT01737697|330556|P8|NOT COMPLETED|Subacute Phase||3
135649|NCT01737697|330557|P7|NOT COMPLETED|Subacute Phase||1
135650|NCT01737697|330558|P6|NOT COMPLETED|Subacute Phase||3
135651|NCT01737697|330559|P5|NOT COMPLETED|Subacute Phase||0
135652|NCT01737697|330560|P4|NOT COMPLETED|Subacute Phase||0
135653|NCT01737697|330561|P3|NOT COMPLETED|Subacute Phase||0
135654|NCT01737697|330562|P2|NOT COMPLETED|Subacute Phase||0
135655|NCT01737697|330563|P1|NOT COMPLETED|Subacute Phase||0
135656|NCT01737697|330549|P15|COMPLETED|Subacute Phase||49
135657|NCT01737697|330550|P14|COMPLETED|Subacute Phase||44
135658|NCT01737697|330551|P13|COMPLETED|Subacute Phase||61
135659|NCT01737697|330552|P12|COMPLETED|Subacute Phase||58
135660|NCT01737697|330553|P11|COMPLETED|Subacute Phase||59
135661|NCT01737697|330554|P10|COMPLETED|Subacute Phase||66
135662|NCT01737697|330555|P9|COMPLETED|Subacute Phase||52
135663|NCT01737697|330556|P8|COMPLETED|Subacute Phase||43
135664|NCT01737697|330557|P7|COMPLETED|Subacute Phase||48
135665|NCT01737697|330558|P6|COMPLETED|Subacute Phase||38
135666|NCT01737697|330559|P5|COMPLETED|Subacute Phase||0
135667|NCT01737697|330560|P4|COMPLETED|Subacute Phase||0
135668|NCT01737697|330561|P3|COMPLETED|Subacute Phase||0
135669|NCT01737697|330562|P2|COMPLETED|Subacute Phase||0
135670|NCT01737697|330563|P1|COMPLETED|Subacute Phase||0
135671|NCT01737697|330549|P15|STARTED|Subacute Phase||50
135672|NCT01737697|330550|P14|STARTED|Subacute Phase||46
135673|NCT01737697|330551|P13|STARTED|Subacute Phase||63
135674|NCT01737697|330552|P12|STARTED|Subacute Phase||61
135675|NCT01737697|330553|P11|STARTED|Subacute Phase||65
135676|NCT01737697|330554|P10|STARTED|Subacute Phase||68
135677|NCT01737697|330555|P9|STARTED|Subacute Phase||54
135678|NCT01737697|330556|P8|STARTED|Subacute Phase||46
135679|NCT01737697|330557|P7|STARTED|Subacute Phase||49
135680|NCT01737697|330558|P6|STARTED|Subacute Phase||41
135681|NCT01737697|330559|P5|STARTED|Subacute Phase||0
135682|NCT01737697|330560|P4|STARTED|Subacute Phase||0
135683|NCT01737697|330561|P3|STARTED|Subacute Phase||0
135684|NCT01737697|330562|P2|STARTED|Subacute Phase||0
135685|NCT01737697|330563|P1|STARTED|Subacute Phase||0
135686|NCT01737697|330549|P15|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
135687|NCT01737697|330550|P14|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
135688|NCT01737697|330551|P13|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
135689|NCT01737697|330552|P12|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
135690|NCT01737697|330553|P11|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
135691|NCT01737697|330554|P10|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
135692|NCT01737697|330555|P9|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
135693|NCT01737697|330556|P8|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
135694|NCT01737697|330557|P7|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
135695|NCT01737697|330558|P6|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
135696|NCT01737697|330559|P5|NOT COMPLETED|Acute Phase-Initial 48 Hours||3
135697|NCT01737697|330560|P4|NOT COMPLETED|Acute Phase-Initial 48 Hours||6
135698|NCT01737697|330561|P3|NOT COMPLETED|Acute Phase-Initial 48 Hours||4
135699|NCT01737697|330562|P2|NOT COMPLETED|Acute Phase-Initial 48 Hours||4
135700|NCT01737697|330563|P1|NOT COMPLETED|Acute Phase-Initial 48 Hours||1
135701|NCT01737697|330549|P15|COMPLETED|Acute Phase-Initial 48 Hours||0
135702|NCT01737697|330550|P14|COMPLETED|Acute Phase-Initial 48 Hours||0
135703|NCT01737697|330551|P13|COMPLETED|Acute Phase-Initial 48 Hours||0
135704|NCT01737697|330552|P12|COMPLETED|Acute Phase-Initial 48 Hours||0
135705|NCT01737697|330553|P11|COMPLETED|Acute Phase-Initial 48 Hours||0
135706|NCT01737697|330554|P10|COMPLETED|Acute Phase-Initial 48 Hours||0
135707|NCT01737697|330555|P9|COMPLETED|Acute Phase-Initial 48 Hours||0
135708|NCT01737697|330556|P8|COMPLETED|Acute Phase-Initial 48 Hours||0
135709|NCT01737697|330557|P7|COMPLETED|Acute Phase-Initial 48 Hours||0
135710|NCT01737697|330558|P6|COMPLETED|Acute Phase-Initial 48 Hours||0
135711|NCT01737697|330559|P5|COMPLETED|Acute Phase-Initial 48 Hours||140
135712|NCT01737697|330560|P4|COMPLETED|Acute Phase-Initial 48 Hours||152
135713|NCT01737697|330561|P3|COMPLETED|Acute Phase-Initial 48 Hours||137
135714|NCT01737697|330562|P2|COMPLETED|Acute Phase-Initial 48 Hours||150
135715|NCT01737697|330563|P1|COMPLETED|Acute Phase-Initial 48 Hours||157
135716|NCT01737697|330549|P15|STARTED|Acute Phase-Initial 48 Hours||0
135717|NCT01737697|330550|P14|STARTED|Acute Phase-Initial 48 Hours||0
135718|NCT01737697|330551|P13|STARTED|Acute Phase-Initial 48 Hours||0
135719|NCT01737697|330552|P12|STARTED|Acute Phase-Initial 48 Hours||0
135720|NCT01737697|330553|P11|STARTED|Acute Phase-Initial 48 Hours||0
135721|NCT01737697|330554|P10|STARTED|Acute Phase-Initial 48 Hours||0
135722|NCT01737697|330555|P9|STARTED|Acute Phase-Initial 48 Hours||0
135723|NCT01737697|330556|P8|STARTED|Acute Phase-Initial 48 Hours||0
135724|NCT01737697|330557|P7|STARTED|Acute Phase-Initial 48 Hours||0
135725|NCT01737697|330558|P6|STARTED|Acute Phase-Initial 48 Hours||0
135726|NCT01737697|330559|P5|STARTED|Acute Phase-Initial 48 Hours||143
135727|NCT01737697|330560|P4|STARTED|Acute Phase-Initial 48 Hours||158
135728|NCT01737697|330561|P3|STARTED|Acute Phase-Initial 48 Hours||141
135729|NCT01737697|330562|P2|STARTED|Acute Phase-Initial 48 Hours||154
135730|NCT01737697|330563|P1|STARTED|Acute Phase-Initial 48 Hours||158
135731|NCT01737684|330652|P3|NOT COMPLETED|Overall Study||0
135732|NCT01737684|330653|P2|NOT COMPLETED|Overall Study||0
135733|NCT01737684|330654|P1|NOT COMPLETED|Overall Study||0
135734|NCT01737684|330652|P3|COMPLETED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
135735|NCT01737684|330653|P2|COMPLETED|Overall Study||8
135736|NCT01737684|330654|P1|COMPLETED|Overall Study||8
135737|NCT01737684|330652|P3|STARTED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
135738|NCT01737684|330653|P2|STARTED|Overall Study||8
135739|NCT01737684|330654|P1|STARTED|Overall Study||8
135740|NCT01737593|330673|P3|NOT COMPLETED|Overall Study||0
135741|NCT01737593|330674|P2|NOT COMPLETED|Overall Study||0
135742|NCT01737593|330675|P1|NOT COMPLETED|Overall Study||0
135743|NCT01737593|330673|P3|COMPLETED|Overall Study||39
135744|NCT01737593|330674|P2|COMPLETED|Overall Study||32
135745|NCT01737593|330675|P1|COMPLETED|Overall Study||37
135746|NCT01737593|330673|P3|STARTED|Overall Study||39
135747|NCT01737593|330674|P2|STARTED|Overall Study||32
135748|NCT01737593|330675|P1|STARTED|Overall Study||37
135749|NCT01737398|330706|P2|NOT COMPLETED|Overall Study||8
135750|NCT01737398|330707|P1|NOT COMPLETED|Overall Study||26
135751|NCT01737398|330706|P2|COMPLETED|Overall Study||52
135752|NCT01737398|330707|P1|COMPLETED|Overall Study||87
135753|NCT01737398|330706|P2|Safety Set|Overall Study||60
135754|NCT01737398|330707|P1|Safety Set|Overall Study||112
135755|NCT01737398|330706|P2|Received at Least 1 Dose of Study Drug|Overall Study||60
135756|NCT01737398|330707|P1|Received at Least 1 Dose of Study Drug|Overall Study||112
135757|NCT01737398|330706|P2|STARTED|Overall Study||60
135758|NCT01737398|330707|P1|STARTED|Overall Study||113
135759|NCT01737281|330751|P2|NOT COMPLETED|Overall Study||280
135760|NCT01737281|330752|P1|NOT COMPLETED|Overall Study||366
135761|NCT01737281|330751|P2|COMPLETED|Overall Study||689
135762|NCT01737281|330752|P1|COMPLETED|Overall Study||603
135763|NCT01737281|330751|P2|STARTED|Overall Study||969
135764|NCT01737281|330752|P1|STARTED|Overall Study||969
135765|NCT01737268|330760|P1|NOT COMPLETED|Overall Study||9
135766|NCT01737268|330760|P1|COMPLETED|Overall Study||11
135767|NCT01737268|330760|P1|Treated|Overall Study||20
135768|NCT01737268|330760|P1|STARTED|Overall Study||20
135769|NCT01737021|330774|P2|NOT COMPLETED|Overall Study||3
135770|NCT01737021|330775|P1|NOT COMPLETED|Overall Study||5
135771|NCT01737021|330774|P2|COMPLETED|Overall Study||6
135772|NCT01737021|330775|P1|COMPLETED|Overall Study||17
135773|NCT01737021|330774|P2|STARTED|Overall Study||9
135774|NCT01737021|330775|P1|STARTED|Overall Study||22
135775|NCT01736930|330781|P1|NOT COMPLETED|Overall Study||1
135776|NCT01736930|330781|P1|COMPLETED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|19
135777|NCT01736930|330781|P1|STARTED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|20
135778|NCT01736917|330821|P1|NOT COMPLETED|Overall Study||11
135779|NCT01736917|330821|P1|COMPLETED|Overall Study||54
135780|NCT01736917|330821|P1|STARTED|Overall Study||65
135781|NCT01736865|330830|P2|NOT COMPLETED|Overall Study||0
135782|NCT01736865|330831|P1|NOT COMPLETED|Overall Study||0
135783|NCT01736865|330830|P2|COMPLETED|Overall Study||66
135784|NCT01736865|330831|P1|COMPLETED|Overall Study||61
135785|NCT01736865|330830|P2|STARTED|Overall Study||66
135786|NCT01736865|330831|P1|STARTED|Overall Study||61
135787|NCT01736696|330850|P7|NOT COMPLETED|Overall Study||0
135788|NCT01736696|330851|P6|NOT COMPLETED|Overall Study||0
135789|NCT01736696|330852|P5|NOT COMPLETED|Overall Study||0
135790|NCT01736696|330853|P4|NOT COMPLETED|Overall Study||0
135791|NCT01736696|330854|P3|NOT COMPLETED|Overall Study||1
135792|NCT01736696|330855|P2|NOT COMPLETED|Overall Study||0
135793|NCT01736696|330856|P1|NOT COMPLETED|Overall Study||0
135794|NCT01736696|330850|P7|COMPLETED|Overall Study||13
135795|NCT01736696|330851|P6|COMPLETED|Overall Study||8
135796|NCT01736696|330852|P5|COMPLETED|Overall Study||9
135797|NCT01736696|330853|P4|COMPLETED|Overall Study||9
135798|NCT01736696|330854|P3|COMPLETED|Overall Study||9
135799|NCT01736696|330855|P2|COMPLETED|Overall Study||5
135800|NCT01736696|330856|P1|COMPLETED|Overall Study||5
135801|NCT01736696|330850|P7|STARTED|Overall Study||13
135802|NCT01736696|330851|P6|STARTED|Overall Study||8
135803|NCT01736696|330852|P5|STARTED|Overall Study||9
135804|NCT01736696|330853|P4|STARTED|Overall Study||9
135805|NCT01736696|330854|P3|STARTED|Overall Study||10
135806|NCT01736696|330855|P2|STARTED|Overall Study||5
135807|NCT01736696|330856|P1|STARTED|Overall Study||5
135808|NCT01736683|331178|P5|NOT COMPLETED|Overall Study||5
135809|NCT01736683|331179|P4|NOT COMPLETED|Overall Study||35
135810|NCT01736683|331180|P3|NOT COMPLETED|Overall Study||21
135811|NCT01736683|331181|P2|NOT COMPLETED|Overall Study||6
135812|NCT01736683|331182|P1|NOT COMPLETED|Overall Study||7
135813|NCT01736683|331178|P5|COMPLETED|Overall Study|# who completed treatment|0
135814|NCT01736683|331179|P4|COMPLETED|Overall Study|# who completed treatment|0
135815|NCT01736683|331180|P3|COMPLETED|Overall Study|# who completed treatment|0
135816|NCT01736683|331181|P2|COMPLETED|Overall Study|# who completed treatment|0
135817|NCT01736683|331182|P1|COMPLETED|Overall Study|# who completed treatment|0
135818|NCT01736683|331178|P5|STARTED|Overall Study||5
135819|NCT01736683|331179|P4|STARTED|Overall Study||35
135820|NCT01736683|331180|P3|STARTED|Overall Study||21
135821|NCT01736683|331181|P2|STARTED|Overall Study||6
135822|NCT01736683|331182|P1|STARTED|Overall Study||7
135823|NCT01736657|331244|P1|NOT COMPLETED|Overall Study||1
135824|NCT01736657|331244|P1|COMPLETED|Overall Study||72
135825|NCT01736657|331244|P1|STARTED|Overall Study||73
135826|NCT01736579|331253|P2|NOT COMPLETED|Overall Study||2
135827|NCT01736579|331254|P1|NOT COMPLETED|Overall Study||2
135828|NCT01736579|331253|P2|COMPLETED|Overall Study||0
135829|NCT01736579|331254|P1|COMPLETED|Overall Study||0
135830|NCT01736579|331253|P2|STARTED|Overall Study||2
135831|NCT01736579|331254|P1|STARTED|Overall Study||2
135832|NCT01736566|331293|P5|NOT COMPLETED|Long Term Follow-up||1
135833|NCT01736566|331294|P4|NOT COMPLETED|Long Term Follow-up||0
135834|NCT01736566|331295|P3|NOT COMPLETED|Long Term Follow-up||49
135835|NCT01736566|331296|P2|NOT COMPLETED|Long Term Follow-up||0
135836|NCT01736566|331297|P1|NOT COMPLETED|Long Term Follow-up||42
135837|NCT01736566|331293|P5|COMPLETED|Long Term Follow-up||0
135838|NCT01736566|331294|P4|COMPLETED|Long Term Follow-up||0
135839|NCT01736566|331295|P3|COMPLETED|Long Term Follow-up||0
135840|NCT01736566|331296|P2|COMPLETED|Long Term Follow-up||0
135841|NCT01736566|331297|P1|COMPLETED|Long Term Follow-up||0
135842|NCT01736566|331293|P5|STARTED|Long Term Follow-up||1
135843|NCT01736566|331294|P4|STARTED|Long Term Follow-up||0
135844|NCT01736566|331295|P3|STARTED|Long Term Follow-up||49
135845|NCT01736566|331296|P2|STARTED|Long Term Follow-up||0
135846|NCT01736566|331297|P1|STARTED|Long Term Follow-up||42
135847|NCT01736566|331293|P5|NOT COMPLETED|Main Study||4
135848|NCT01736566|331294|P4|NOT COMPLETED|Main Study||1
135849|NCT01736566|331295|P3|NOT COMPLETED|Main Study||1
135850|NCT01736566|331296|P2|NOT COMPLETED|Main Study||0
135851|NCT01736566|331297|P1|NOT COMPLETED|Main Study||1
135852|NCT01736566|331293|P5|COMPLETED|Main Study||6
135853|NCT01736566|331294|P4|COMPLETED|Main Study||51
135854|NCT01736566|331295|P3|COMPLETED|Main Study||49
135855|NCT01736566|331296|P2|COMPLETED|Main Study||50
135856|NCT01736566|331297|P1|COMPLETED|Main Study||50
135857|NCT01736566|331293|P5|STARTED|Main Study||10
135858|NCT01736566|331294|P4|STARTED|Main Study||52
135859|NCT01736566|331295|P3|STARTED|Main Study||50
135860|NCT01736566|331296|P2|STARTED|Main Study||50
135861|NCT01736566|331297|P1|STARTED|Main Study||51
135862|NCT01736553|331382|P2|NOT COMPLETED|Overall Study||4
135863|NCT01736553|331383|P1|NOT COMPLETED|Overall Study||19
135864|NCT01736553|331382|P2|COMPLETED|Overall Study||23
135865|NCT01736553|331383|P1|COMPLETED|Overall Study||7
135866|NCT01736553|331382|P2|STARTED|Overall Study||27
135867|NCT01736553|331383|P1|STARTED|Overall Study||26
135868|NCT01736540|331434|P1|NOT COMPLETED|Overall Study||15
135869|NCT01736540|331434|P1|COMPLETED|Overall Study||228
135870|NCT01736540|331434|P1|STARTED|Overall Study||243
135871|NCT01736527|331491|P1|NOT COMPLETED|Overall Study||0
135872|NCT01736527|331491|P1|COMPLETED|Overall Study||12
135873|NCT01736527|331491|P1|STARTED|Overall Study||12
135874|NCT01736475|331500|P2|NOT COMPLETED|Overall Study||0
135875|NCT01736475|331501|P1|NOT COMPLETED|Overall Study||12
135876|NCT01736475|331500|P2|COMPLETED|Overall Study||17
135877|NCT01736475|331501|P1|COMPLETED|Overall Study||109
135878|NCT01736475|331500|P2|STARTED|Overall Study||17
135879|NCT01736475|331501|P1|STARTED|Overall Study||121
135880|NCT01736397|331556|P2|NOT COMPLETED|Overall Study||24
135881|NCT01736397|331557|P1|NOT COMPLETED|Overall Study||14
135882|NCT01736397|331556|P2|COMPLETED|Overall Study||50
135883|NCT01736397|331557|P1|COMPLETED|Overall Study||61
135884|NCT01736397|331556|P2|STARTED|Overall Study||74
135885|NCT01736397|331557|P1|STARTED|Overall Study||75
135886|NCT01736254|331569|P1|NOT COMPLETED|Period 3 (Days 13 to 23)||1
135887|NCT01736254|331569|P1|COMPLETED|Period 3 (Days 13 to 23)||20
135888|NCT01736254|331569|P1|STARTED|Period 3 (Days 13 to 23)||21
135889|NCT01736254|331569|P1|NOT COMPLETED|Period 2 (Days 2 to 12)||3
135890|NCT01736254|331569|P1|COMPLETED|Period 2 (Days 2 to 12)||21
135891|NCT01736254|331569|P1|STARTED|Period 2 (Days 2 to 12)||24
135892|NCT01736254|331569|P1|NOT COMPLETED|Period 1 (Day 1)||0
135893|NCT01736254|331569|P1|COMPLETED|Period 1 (Day 1)||24
135894|NCT01736254|331569|P1|Received at Least One Dose of Study Drug|Period 1 (Day 1)||24
135895|NCT01736254|331569|P1|STARTED|Period 1 (Day 1)||24
135896|NCT01736241|331593|P7|NOT COMPLETED|Overall Study||0
135897|NCT01736241|331594|P6|NOT COMPLETED|Overall Study||0
135898|NCT01736241|331595|P5|NOT COMPLETED|Overall Study||0
135899|NCT01736241|331596|P4|NOT COMPLETED|Overall Study||0
135900|NCT01736241|331597|P3|NOT COMPLETED|Overall Study||0
135901|NCT01736241|331598|P2|NOT COMPLETED|Overall Study||0
135902|NCT01736241|331599|P1|NOT COMPLETED|Overall Study||0
135903|NCT01736241|331593|P7|COMPLETED|Overall Study||6
135904|NCT01736241|331594|P6|COMPLETED|Overall Study||6
135905|NCT01736241|331595|P5|COMPLETED|Overall Study||6
135906|NCT01736241|331596|P4|COMPLETED|Overall Study||5
135907|NCT01736241|331597|P3|COMPLETED|Overall Study||6
135908|NCT01736241|331598|P2|COMPLETED|Overall Study||6
135909|NCT01736241|331599|P1|COMPLETED|Overall Study||6
135910|NCT01736241|331593|P7|Received at Least One Dose of Study Drug|Overall Study||6
135911|NCT01736241|331594|P6|Received at Least One Dose of Study Drug|Overall Study||6
135912|NCT01736241|331595|P5|Received at Least One Dose of Study Drug|Overall Study||6
135913|NCT01736241|331596|P4|Received at Least One Dose of Study Drug|Overall Study||5
135914|NCT01736241|331597|P3|Received at Least One Dose of Study Drug|Overall Study||6
135915|NCT01736241|331598|P2|Received at Least One Dose of Study Drug|Overall Study||6
135916|NCT01736241|331599|P1|Received at Least One Dose of Study Drug|Overall Study||6
135917|NCT01736241|331593|P7|STARTED|Overall Study||6
135918|NCT01736241|331594|P6|STARTED|Overall Study||6
135919|NCT01736241|331595|P5|STARTED|Overall Study||6
135920|NCT01736241|331596|P4|STARTED|Overall Study||5
135921|NCT01736241|331597|P3|STARTED|Overall Study||6
135922|NCT01736241|331598|P2|STARTED|Overall Study||6
135923|NCT01736241|331599|P1|STARTED|Overall Study||6
135924|NCT01736215|331634|P1|NOT COMPLETED|Overall Study||14
135925|NCT01736215|331634|P1|COMPLETED|Overall Study||19
135926|NCT01736215|331634|P1|Treated|Overall Study||25
135927|NCT01736215|331634|P1|STARTED|Overall Study||33
135928|NCT01736189|331646|P1|NOT COMPLETED|Overall Study||46
135929|NCT01736189|331646|P1|COMPLETED|Overall Study||300
135930|NCT01736189|331646|P1|STARTED|Overall Study||346
135931|NCT01736176|331655|P1|NOT COMPLETED|Overall Study||11
135932|NCT01736176|331655|P1|COMPLETED|Overall Study||28
135933|NCT01736176|331655|P1|Received LCIG|Overall Study||38
135934|NCT01736176|331655|P1|STARTED|Overall Study|Enrolled participants who underwent the PEG-J placement procedure|39
135935|NCT01735916|331702|P3|NOT COMPLETED|Overall Study||7
135936|NCT01735916|331703|P2|NOT COMPLETED|Overall Study||19
135937|NCT01735916|331704|P1|NOT COMPLETED|Overall Study||18
135938|NCT01735916|331702|P3|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
135939|NCT01735916|331703|P2|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
135940|NCT01735916|331704|P1|COMPLETED|Overall Study||0
135941|NCT01735916|331702|P3|STARTED|Overall Study||7
135942|NCT01735916|331703|P2|STARTED|Overall Study||19
135943|NCT01735916|331704|P1|STARTED|Overall Study||18
135944|NCT01735877|331725|P2|NOT COMPLETED|Overall Study||0
135945|NCT01735877|331726|P1|NOT COMPLETED|Overall Study||1
135946|NCT01735877|331725|P2|COMPLETED|Overall Study||21
135947|NCT01735877|331726|P1|COMPLETED|Overall Study||26
135948|NCT01735877|331725|P2|STARTED|Overall Study||21
135949|NCT01735877|331726|P1|STARTED|Overall Study||27
135950|NCT01735630|331742|P2|NOT COMPLETED|Overall Study||18
135951|NCT01735630|331743|P1|NOT COMPLETED|Overall Study||18
135952|NCT01735630|331742|P2|COMPLETED|Overall Study||157
135953|NCT01735630|331743|P1|COMPLETED|Overall Study||157
135954|NCT01735630|331742|P2|STARTED|Overall Study||175
135955|NCT01735630|331743|P1|STARTED|Overall Study||175
135956|NCT01735617|331757|P1|NOT COMPLETED|Overall Study||0
135957|NCT01735617|331757|P1|COMPLETED|Overall Study||16
135958|NCT01735617|331757|P1|STARTED|Overall Study||16
135959|NCT01735396|331770|P1|NOT COMPLETED|Overall Study||1
135960|NCT01735396|331770|P1|COMPLETED|Overall Study||10
135961|NCT01735396|331770|P1|STARTED|Overall Study||11
135962|NCT01735214|331779|P1|NOT COMPLETED|Overall Study||0
135963|NCT01735214|331779|P1|COMPLETED|Overall Study||358
135964|NCT01735214|331779|P1|STARTED|Overall Study||358
135965|NCT01735201|331799|P8|NOT COMPLETED|Overall Study||2
135966|NCT01735201|331800|P7|NOT COMPLETED|Overall Study||3
135967|NCT01735201|331801|P6|NOT COMPLETED|Overall Study||5
135968|NCT01735201|331802|P5|NOT COMPLETED|Overall Study||1
135969|NCT01735201|331803|P4|NOT COMPLETED|Overall Study||2
135970|NCT01735201|331804|P3|NOT COMPLETED|Overall Study||0
135971|NCT01735201|331805|P2|NOT COMPLETED|Overall Study||1
135972|NCT01735201|331806|P1|NOT COMPLETED|Overall Study||3
135973|NCT01735201|331799|P8|COMPLETED|Overall Study||42
135974|NCT01735201|331800|P7|COMPLETED|Overall Study||42
135975|NCT01735201|331801|P6|COMPLETED|Overall Study||40
135976|NCT01735201|331802|P5|COMPLETED|Overall Study||44
135977|NCT01735201|331803|P4|COMPLETED|Overall Study||42
135978|NCT01735201|331804|P3|COMPLETED|Overall Study||44
135979|NCT01735201|331805|P2|COMPLETED|Overall Study||43
135980|NCT01735201|331806|P1|COMPLETED|Overall Study||42
135981|NCT01735201|331799|P8|STARTED|Overall Study||44
135982|NCT01735201|331800|P7|STARTED|Overall Study||45
135983|NCT01735201|331801|P6|STARTED|Overall Study||45
135984|NCT01735201|331802|P5|STARTED|Overall Study||45
135985|NCT01735201|331803|P4|STARTED|Overall Study||44
135986|NCT01735201|331804|P3|STARTED|Overall Study||44
135987|NCT01735201|331805|P2|STARTED|Overall Study||44
135988|NCT01735201|331806|P1|STARTED|Overall Study||45
135989|NCT01735175|331842|P2|NOT COMPLETED|Overall Study||13
135990|NCT01735175|331843|P1|NOT COMPLETED|Overall Study||29
135991|NCT01735175|331842|P2|COMPLETED|Overall Study||144
135992|NCT01735175|331843|P1|COMPLETED|Overall Study||130
135993|NCT01735175|331842|P2|Completed the 6-month SFU Visit|Overall Study||138
135994|NCT01735175|331843|P1|Completed the 6-month SFU Visit|Overall Study||120
135995|NCT01735175|331842|P2|Completed All Treatments as Planned|Overall Study||150
135996|NCT01735175|331843|P1|Completed All Treatments as Planned|Overall Study||140
135997|NCT01735175|331842|P2|Completed All Cycles|Overall Study||150
135998|NCT01735175|331843|P1|Completed All Cycles|Overall Study||141
135999|NCT01735175|331842|P2|STARTED|Overall Study||157
136000|NCT01735175|331843|P1|STARTED|Overall Study||159
136001|NCT01734993|331863|P1|NOT COMPLETED|Overall Study||2
136002|NCT01734993|331863|P1|COMPLETED|Overall Study||9
136003|NCT01734993|331863|P1|STARTED|Overall Study||11
136004|NCT01734902|331891|P2|NOT COMPLETED|Overall Study||2
136005|NCT01734902|331892|P1|NOT COMPLETED|Overall Study||0
136006|NCT01734902|331891|P2|COMPLETED|Overall Study||14
136007|NCT01734902|331892|P1|COMPLETED|Overall Study||14
136008|NCT01734902|331891|P2|STARTED|Overall Study||16
136009|NCT01734902|331892|P1|STARTED|Overall Study||14
136010|NCT01734889|331902|P1|NOT COMPLETED|Overall Study||0
136011|NCT01734889|331902|P1|COMPLETED|Overall Study||18
136012|NCT01734889|331902|P1|STARTED|Overall Study||18
136013|NCT01734785|331913|P4|NOT COMPLETED|Double−Blind Period||0
136014|NCT01734785|331914|P3|NOT COMPLETED|Double−Blind Period||5
136015|NCT01734785|331915|P2|NOT COMPLETED|Double−Blind Period||9
136016|NCT01734785|331916|P1|NOT COMPLETED|Double−Blind Period||5
136017|NCT01734785|331913|P4|COMPLETED|Double−Blind Period||0
136018|NCT01734785|331914|P3|COMPLETED|Double−Blind Period||105
136019|NCT01734785|331915|P2|COMPLETED|Double−Blind Period||103
136020|NCT01734785|331916|P1|COMPLETED|Double−Blind Period||106
136021|NCT01734785|331913|P4|STARTED|Double−Blind Period||0
136022|NCT01734785|331914|P3|STARTED|Double−Blind Period||110
136023|NCT01734785|331915|P2|STARTED|Double−Blind Period||112
136024|NCT01734785|331916|P1|STARTED|Double−Blind Period||111
136025|NCT01734785|331913|P4|NOT COMPLETED|Open−Label Period||273
136026|NCT01734785|331914|P3|NOT COMPLETED|Open−Label Period||0
136027|NCT01734785|331915|P2|NOT COMPLETED|Open−Label Period||0
136028|NCT01734785|331916|P1|NOT COMPLETED|Open−Label Period||0
136029|NCT01734785|331913|P4|COMPLETED|Open−Label Period||333
136030|NCT01734785|331914|P3|COMPLETED|Open−Label Period||0
136031|NCT01734785|331915|P2|COMPLETED|Open−Label Period||0
136032|NCT01734785|331916|P1|COMPLETED|Open−Label Period||0
136033|NCT01734785|331913|P4|STARTED|Open−Label Period||606
136034|NCT01734785|331914|P3|STARTED|Open−Label Period||0
136035|NCT01734785|331915|P2|STARTED|Open−Label Period||0
136036|NCT01734785|331916|P1|STARTED|Open−Label Period||0
136037|NCT01734772|331933|P2|NOT COMPLETED|Overall Study||3
136038|NCT01734772|331934|P1|NOT COMPLETED|Overall Study||1
136039|NCT01734772|331933|P2|COMPLETED|Overall Study||21
136040|NCT01734772|331934|P1|COMPLETED|Overall Study||23
136041|NCT01734772|331933|P2|STARTED|Overall Study||24
136042|NCT01734772|331934|P1|STARTED|Overall Study||24
136043|NCT01734746|331951|P1|NOT COMPLETED|Overall Study||1
136044|NCT01734746|331951|P1|COMPLETED|Overall Study||21
136045|NCT01734746|331951|P1|STARTED|Overall Study||22
136046|NCT01734655|331957|P1|NOT COMPLETED|Overall Study||0
136047|NCT01734655|331957|P1|COMPLETED|Overall Study||40
136048|NCT01734655|331957|P1|STARTED|Overall Study||40
136049|NCT01734551|331968|P2|NOT COMPLETED|Overall Study||0
136050|NCT01734551|331969|P1|NOT COMPLETED|Overall Study||0
136051|NCT01734551|331968|P2|COMPLETED|Overall Study||16
136052|NCT01734551|331969|P1|COMPLETED|Overall Study||15
136053|NCT01734551|331968|P2|STARTED|Overall Study||16
136054|NCT01734551|331969|P1|STARTED|Overall Study||15
136055|NCT01734525|331981|P1|NOT COMPLETED|Overall Study||0
136056|NCT01734525|331981|P1|COMPLETED|Overall Study||85
136057|NCT01734525|331981|P1|STARTED|Overall Study||85
136058|NCT01734434|331989|P4|NOT COMPLETED|Overall Study||23
136059|NCT01734434|331990|P3|NOT COMPLETED|Overall Study||129
136060|NCT01734434|331991|P2|NOT COMPLETED|Overall Study||12
136061|NCT01734434|331992|P1|NOT COMPLETED|Overall Study||10
136062|NCT01734434|331989|P4|COMPLETED|Overall Study||228
136063|NCT01734434|331990|P3|COMPLETED|Overall Study||1863
136064|NCT01734434|331991|P2|COMPLETED|Overall Study||488
136065|NCT01734434|331992|P1|COMPLETED|Overall Study||490
136066|NCT01734434|331989|P4|STARTED|Overall Study||251
136067|NCT01734434|331990|P3|STARTED|Overall Study||1992
136068|NCT01734434|331991|P2|STARTED|Overall Study||500
136069|NCT01734434|331992|P1|STARTED|Overall Study||500
136070|NCT01734395|332014|P1|NOT COMPLETED|Overall Study||410
136071|NCT01734395|332014|P1|COMPLETED|Overall Study||1472
136072|NCT01734395|332014|P1|STARTED|Overall Study||1882
136073|NCT01734317|332020|P1|NOT COMPLETED|Overall Study||0
136074|NCT01734317|332020|P1|COMPLETED|Overall Study||10
136075|NCT01734317|332020|P1|STARTED|Overall Study||10
136076|NCT01734239|332026|P2|NOT COMPLETED|Overall Study||0
136077|NCT01734239|332027|P1|NOT COMPLETED|Overall Study||0
136078|NCT01734239|332026|P2|COMPLETED|Overall Study||50
136079|NCT01734239|332027|P1|COMPLETED|Overall Study||52
136080|NCT01734239|332026|P2|STARTED|Overall Study||50
136081|NCT01734239|332027|P1|STARTED|Overall Study||52
136082|NCT01734161|332042|P2|NOT COMPLETED|Overall Study||8
136083|NCT01734161|332043|P1|NOT COMPLETED|Overall Study||6
136084|NCT01734161|332042|P2|COMPLETED|Overall Study||53
136085|NCT01734161|332043|P1|COMPLETED|Overall Study||55
136086|NCT01734161|332042|P2|STARTED|Overall Study||61
136087|NCT01734161|332043|P1|STARTED|Overall Study||61
136088|NCT01733953|332051|P2|NOT COMPLETED|Overall Study||7
136089|NCT01733953|332052|P1|NOT COMPLETED|Overall Study||5
136090|NCT01733953|332051|P2|COMPLETED|Overall Study||6
136091|NCT01733953|332052|P1|COMPLETED|Overall Study||9
136092|NCT01733953|332051|P2|STARTED|Overall Study||13
136093|NCT01733953|332052|P1|STARTED|Overall Study||14
136094|NCT01733758|332072|P4|NOT COMPLETED|Overall Study||8
136095|NCT01733758|332073|P3|NOT COMPLETED|Overall Study||15
136096|NCT01733758|332074|P2|NOT COMPLETED|Overall Study||12
136097|NCT01733758|332075|P1|NOT COMPLETED|Overall Study||15
136098|NCT01733758|332072|P4|COMPLETED|Overall Study||95
136099|NCT01733758|332073|P3|COMPLETED|Overall Study||135
136100|NCT01733758|332074|P2|COMPLETED|Overall Study||148
136101|NCT01733758|332075|P1|COMPLETED|Overall Study||62
136102|NCT01733758|332072|P4|STARTED|Overall Study||103
136103|NCT01733758|332073|P3|STARTED|Overall Study||150
136104|NCT01733758|332074|P2|STARTED|Overall Study||160
136105|NCT01733758|332075|P1|STARTED|Overall Study||77
136106|NCT01733745|332128|P2|NOT COMPLETED|Overall Study||0
136107|NCT01733745|332129|P1|NOT COMPLETED|Overall Study||0
136108|NCT01733745|332128|P2|COMPLETED|Overall Study||13
136109|NCT01733745|332129|P1|COMPLETED|Overall Study||13
136110|NCT01733745|332128|P2|STARTED|Overall Study||13
136111|NCT01733745|332129|P1|STARTED|Overall Study||13
136112|NCT01733732|332141|P2|NOT COMPLETED|Overall Study||0
136113|NCT01733732|332142|P1|NOT COMPLETED|Overall Study||2
136114|NCT01733732|332141|P2|COMPLETED|Overall Study||27
136115|NCT01733732|332142|P1|COMPLETED|Overall Study||25
136116|NCT01733732|332141|P2|STARTED|Overall Study||27
136117|NCT01733732|332142|P1|STARTED|Overall Study||27
136118|NCT01733680|332178|P2|NOT COMPLETED|Overall Study||1
136119|NCT01733680|332179|P1|NOT COMPLETED|Overall Study||0
136120|NCT01733680|332178|P2|COMPLETED|Overall Study||0
136121|NCT01733680|332179|P1|COMPLETED|Overall Study||2
136122|NCT01733680|332178|P2|STARTED|Overall Study||1
136123|NCT01733680|332179|P1|STARTED|Overall Study||2
136124|NCT01733472|332191|P2|NOT COMPLETED|Overall Study||0
136125|NCT01733472|332192|P1|NOT COMPLETED|Overall Study||0
136126|NCT01733472|332191|P2|COMPLETED|Overall Study||60
136127|NCT01733472|332192|P1|COMPLETED|Overall Study||60
136128|NCT01733472|332191|P2|STARTED|Overall Study||60
136129|NCT01733472|332192|P1|STARTED|Overall Study||60
136130|NCT01733407|332204|P2|NOT COMPLETED|Overall Study||0
136131|NCT01733407|332205|P1|NOT COMPLETED|Overall Study||2
136132|NCT01733407|332204|P2|COMPLETED|Overall Study||9
136133|NCT01733407|332205|P1|COMPLETED|Overall Study||7
136134|NCT01733407|332204|P2|STARTED|Overall Study||9
136135|NCT01733407|332205|P1|STARTED|Overall Study||9
136136|NCT01733368|332221|P1|NOT COMPLETED|Overall Study||31
136137|NCT01733368|332221|P1|COMPLETED|Overall Study||167
136138|NCT01733368|332221|P1|STARTED|Overall Study||198
136139|NCT01733329|332231|P2|NOT COMPLETED|Overall Study||1
136140|NCT01733329|332232|P1|NOT COMPLETED|Overall Study||2
136141|NCT01733329|332231|P2|COMPLETED|Overall Study||60
136142|NCT01733329|332232|P1|COMPLETED|Overall Study||60
136143|NCT01733329|332231|P2|STARTED|Overall Study||61
136144|NCT01733329|332232|P1|STARTED|Overall Study||62
136145|NCT01733316|332244|P1|NOT COMPLETED|Long Term Extension Phase||5
136146|NCT01733316|332244|P1|COMPLETED|Long Term Extension Phase||33
136147|NCT01733316|332244|P1|STARTED|Long Term Extension Phase|Two participants did not enter the long term follow up period.|38
136148|NCT01733316|332244|P1|NOT COMPLETED|RP103 Phase||1
136149|NCT01733316|332244|P1|COMPLETED|RP103 Phase||40
136150|NCT01733316|332244|P1|STARTED|RP103 Phase||41
136151|NCT01733316|332244|P1|NOT COMPLETED|Cystagon® Phase||0
136152|NCT01733316|332244|P1|COMPLETED|Cystagon® Phase||41
136153|NCT01733316|332244|P1|STARTED|Cystagon® Phase||41
136154|NCT01733277|332260|P2|NOT COMPLETED|Overall Study||0
136155|NCT01733277|332261|P1|NOT COMPLETED|Overall Study||0
136156|NCT01733277|332260|P2|COMPLETED|Overall Study||25
136157|NCT01733277|332261|P1|COMPLETED|Overall Study||25
136158|NCT01733277|332260|P2|STARTED|Overall Study||25
136159|NCT01733277|332261|P1|STARTED|Overall Study||25
136160|NCT01733212|332273|P2|NOT COMPLETED|Overall Study||0
136161|NCT01733212|332274|P1|NOT COMPLETED|Overall Study||0
136162|NCT01733212|332273|P2|COMPLETED|Overall Study||123
136163|NCT01733212|332274|P1|COMPLETED|Overall Study||116
136164|NCT01733212|332273|P2|STARTED|Overall Study||123
136165|NCT01733212|332274|P1|STARTED|Overall Study||116
136166|NCT01733121|332282|P2|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
136167|NCT01733121|332283|P1|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
136168|NCT01733121|332282|P2|COMPLETED|Follow-Up Period (Week 6 to 8)||46
136169|NCT01733121|332283|P1|COMPLETED|Follow-Up Period (Week 6 to 8)||44
136170|NCT01733121|332282|P2|STARTED|Follow-Up Period (Week 6 to 8)||46
136171|NCT01733121|332283|P1|STARTED|Follow-Up Period (Week 6 to 8)||44
136172|NCT01733121|332282|P2|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||5
136173|NCT01733121|332283|P1|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
136174|NCT01733121|332282|P2|COMPLETED|Double-Blind Period (Week 0 to 6)||46
136175|NCT01733121|332283|P1|COMPLETED|Double-Blind Period (Week 0 to 6)||44
136176|NCT01733121|332282|P2|STARTED|Double-Blind Period (Week 0 to 6)||51
136177|NCT01733121|332283|P1|STARTED|Double-Blind Period (Week 0 to 6)||51
136178|NCT01733069|332297|P2|NOT COMPLETED|Overall Study||0
136179|NCT01733069|332298|P1|NOT COMPLETED|Overall Study||0
136180|NCT01733069|332297|P2|COMPLETED|Overall Study||1598
136181|NCT01733069|332298|P1|COMPLETED|Overall Study||264
136182|NCT01733069|332297|P2|STARTED|Overall Study||1598
136183|NCT01733069|332298|P1|STARTED|Overall Study||264
136184|NCT01733056|332307|P3|NOT COMPLETED|Overall Study||0
136185|NCT01733056|332308|P2|NOT COMPLETED|Overall Study||0
136186|NCT01733056|332309|P1|NOT COMPLETED|Overall Study||0
136187|NCT01733056|332307|P3|COMPLETED|Overall Study||12
136188|NCT01733056|332308|P2|COMPLETED|Overall Study||10
136189|NCT01733056|332309|P1|COMPLETED|Overall Study||21
136190|NCT01733056|332307|P3|STARTED|Overall Study||12
136191|NCT01733056|332308|P2|STARTED|Overall Study||10
136192|NCT01733056|332309|P1|STARTED|Overall Study||21
136193|NCT01732926|332325|P2|NOT COMPLETED|Overall Study||110
136194|NCT01732926|332326|P1|NOT COMPLETED|Overall Study||267
136195|NCT01732926|332325|P2|COMPLETED|Overall Study||45
136196|NCT01732926|332326|P1|COMPLETED|Overall Study||53
136197|NCT01732926|332325|P2|STARTED|Overall Study||155
136198|NCT01732926|332326|P1|STARTED|Overall Study||320
136199|NCT01732913|332342|P2|NOT COMPLETED|Overall Study||69
136200|NCT01732913|332343|P1|NOT COMPLETED|Overall Study||156
136201|NCT01732913|332342|P2|COMPLETED|Overall Study||28
136202|NCT01732913|332343|P1|COMPLETED|Overall Study||42
136203|NCT01732913|332342|P2|STARTED|Overall Study||97
136204|NCT01732913|332343|P1|STARTED|Overall Study||198
136205|NCT01732835|332357|P1|NOT COMPLETED|2-year Extended Follow-up||5
136206|NCT01732835|332357|P1|COMPLETED|2-year Extended Follow-up||39
136207|NCT01732835|332357|P1|STARTED|2-year Extended Follow-up||44
136208|NCT01732835|332357|P1|NOT COMPLETED|6-month Primary Endpoint||24
136209|NCT01732835|332357|P1|COMPLETED|6-month Primary Endpoint||44
136210|NCT01732835|332357|P1|STARTED|6-month Primary Endpoint||68
136211|NCT01732822|332390|P2|NOT COMPLETED|Overall Study||113
136212|NCT01732822|332391|P1|NOT COMPLETED|Overall Study||123
136213|NCT01732822|332390|P2|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6842
136214|NCT01732822|332391|P1|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6807
136215|NCT01732822|332390|P2|STARTED|Overall Study||6955
136216|NCT01732822|332391|P1|STARTED|Overall Study||6930
136217|NCT01732796|332464|P3|NOT COMPLETED|Overall Study||13
136218|NCT01732796|332465|P2|NOT COMPLETED|Overall Study||42
136219|NCT01732796|332466|P1|NOT COMPLETED|Overall Study||46
136220|NCT01732796|332464|P3|COMPLETED|Overall Study||38
136221|NCT01732796|332465|P2|COMPLETED|Overall Study||169
136222|NCT01732796|332466|P1|COMPLETED|Overall Study||162
136223|NCT01732796|332464|P3|STARTED|Overall Study||51
136224|NCT01732796|332465|P2|STARTED|Overall Study||211
136225|NCT01732796|332466|P1|STARTED|Overall Study||208
136226|NCT01732783|332485|P3|NOT COMPLETED|Overall Study||10
136227|NCT01732783|332486|P2|NOT COMPLETED|Overall Study||32
136228|NCT01732783|332487|P1|NOT COMPLETED|Overall Study||135
136229|NCT01732783|332485|P3|COMPLETED|Overall Study|Completed 12-month observation period.|2
136230|NCT01732783|332486|P2|COMPLETED|Overall Study|Completed 12-month observation period.|5
136231|NCT01732783|332487|P1|COMPLETED|Overall Study|Completed 12-month observation period.|29
136232|NCT01732783|332485|P3|STARTED|Overall Study||12
136233|NCT01732783|332486|P2|STARTED|Overall Study||37
136234|NCT01732783|332487|P1|STARTED|Overall Study||164
136235|NCT01732770|332551|P2|NOT COMPLETED|Overall Study||8
136236|NCT01732770|332552|P1|NOT COMPLETED|Overall Study||10
136237|NCT01732770|332551|P2|COMPLETED|Overall Study||313
136238|NCT01732770|332552|P1|COMPLETED|Overall Study||312
136239|NCT01732770|332551|P2|Received Study Treatment|Overall Study||320
136240|NCT01732770|332552|P1|Received Study Treatment|Overall Study||320
136241|NCT01732770|332551|P2|STARTED|Overall Study||321
136242|NCT01732770|332552|P1|STARTED|Overall Study||322
136243|NCT01732757|332567|P3|NOT COMPLETED|Overall Study||0
136244|NCT01732757|332568|P2|NOT COMPLETED|Overall Study||0
136245|NCT01732757|332569|P1|NOT COMPLETED|Overall Study||1
136246|NCT01732757|332567|P3|COMPLETED|Overall Study||52
136247|NCT01732757|332568|P2|COMPLETED|Overall Study||52
136248|NCT01732757|332569|P1|COMPLETED|Overall Study||52
136249|NCT01732757|332567|P3|STARTED|Overall Study||52
136250|NCT01732757|332568|P2|STARTED|Overall Study||52
136251|NCT01732757|332569|P1|STARTED|Overall Study||53
136252|NCT01732718|332607|P2|NOT COMPLETED|Second Intervention||0
136253|NCT01732718|332608|P1|NOT COMPLETED|Second Intervention||0
136254|NCT01732718|332607|P2|COMPLETED|Second Intervention||6
136255|NCT01732718|332608|P1|COMPLETED|Second Intervention||7
136256|NCT01732718|332607|P2|STARTED|Second Intervention||6
136257|NCT01732718|332608|P1|STARTED|Second Intervention||7
136258|NCT01732718|332607|P2|NOT COMPLETED|Washout (4 Weeks)||0
136259|NCT01732718|332608|P1|NOT COMPLETED|Washout (4 Weeks)||0
136260|NCT01732718|332607|P2|COMPLETED|Washout (4 Weeks)||6
136261|NCT01732718|332608|P1|COMPLETED|Washout (4 Weeks)||7
136262|NCT01732718|332607|P2|STARTED|Washout (4 Weeks)||6
136263|NCT01732718|332608|P1|STARTED|Washout (4 Weeks)||7
136264|NCT01732718|332607|P2|NOT COMPLETED|First Intervention||0
136265|NCT01732718|332608|P1|NOT COMPLETED|First Intervention||0
136266|NCT01732718|332607|P2|COMPLETED|First Intervention||6
136267|NCT01732718|332608|P1|COMPLETED|First Intervention||7
136268|NCT01732718|332607|P2|STARTED|First Intervention||6
136269|NCT01732718|332608|P1|STARTED|First Intervention||7
136270|NCT01732692|332646|P2|NOT COMPLETED|Overall Study||1
136271|NCT01732692|332647|P1|NOT COMPLETED|Overall Study||0
136272|NCT01732692|332646|P2|COMPLETED|Overall Study||69
136273|NCT01732692|332647|P1|COMPLETED|Overall Study||70
136274|NCT01732692|332646|P2|STARTED|Overall Study||70
136275|NCT01732692|332647|P1|STARTED|Overall Study||70
136276|NCT01732640|332661|P2|NOT COMPLETED|Overall Study||2
136277|NCT01732640|332662|P1|NOT COMPLETED|Overall Study||0
136278|NCT01732640|332661|P2|COMPLETED|Overall Study||1
136279|NCT01732640|332662|P1|COMPLETED|Overall Study||6
136280|NCT01732640|332661|P2|STARTED|Overall Study||3
136281|NCT01732640|332662|P1|STARTED|Overall Study||6
136282|NCT01732588|332680|P3|NOT COMPLETED|Third Intervention (7 Days)||0
136283|NCT01732588|332681|P2|NOT COMPLETED|Third Intervention (7 Days)||0
136284|NCT01732588|332682|P1|NOT COMPLETED|Third Intervention (7 Days)||0
136285|NCT01732588|332680|P3|COMPLETED|Third Intervention (7 Days)||4
136286|NCT01732588|332681|P2|COMPLETED|Third Intervention (7 Days)||2
136287|NCT01732588|332682|P1|COMPLETED|Third Intervention (7 Days)||4
136288|NCT01732588|332680|P3|STARTED|Third Intervention (7 Days)||4
136289|NCT01732588|332681|P2|STARTED|Third Intervention (7 Days)||2
136290|NCT01732588|332682|P1|STARTED|Third Intervention (7 Days)||4
136291|NCT01732588|332680|P3|NOT COMPLETED|Second Intervention (7 Days)||0
136292|NCT01732588|332681|P2|NOT COMPLETED|Second Intervention (7 Days)||0
136293|NCT01732588|332682|P1|NOT COMPLETED|Second Intervention (7 Days)||0
136294|NCT01732588|332680|P3|COMPLETED|Second Intervention (7 Days)||4
136295|NCT01732588|332681|P2|COMPLETED|Second Intervention (7 Days)||2
136296|NCT01732588|332682|P1|COMPLETED|Second Intervention (7 Days)||4
136297|NCT01732588|332680|P3|STARTED|Second Intervention (7 Days)||4
136298|NCT01732588|332681|P2|STARTED|Second Intervention (7 Days)||2
136299|NCT01732588|332682|P1|STARTED|Second Intervention (7 Days)||4
136300|NCT01732588|332680|P3|NOT COMPLETED|First Intervention (7 Days)||0
136301|NCT01732588|332681|P2|NOT COMPLETED|First Intervention (7 Days)||1
136302|NCT01732588|332682|P1|NOT COMPLETED|First Intervention (7 Days)||0
136303|NCT01732588|332680|P3|COMPLETED|First Intervention (7 Days)||4
136304|NCT01732588|332681|P2|COMPLETED|First Intervention (7 Days)||2
136305|NCT01732588|332682|P1|COMPLETED|First Intervention (7 Days)||4
136306|NCT01732588|332680|P3|STARTED|First Intervention (7 Days)||4
136307|NCT01732588|332681|P2|STARTED|First Intervention (7 Days)||3
136308|NCT01732588|332682|P1|STARTED|First Intervention (7 Days)||4
136309|NCT01732549|332698|P2|NOT COMPLETED|Overall Study||73
136310|NCT01732549|332699|P1|NOT COMPLETED|Overall Study||71
136311|NCT01732549|332698|P2|COMPLETED|Overall Study||0
136312|NCT01732549|332699|P1|COMPLETED|Overall Study||0
136313|NCT01732549|332698|P2|Withdrawn During Treatment:Final Analysi|Overall Study||73
136314|NCT01732549|332699|P1|Withdrawn During Treatment:Final Analysi|Overall Study||71
136315|NCT01732549|332698|P2|Ongoing Treatment Period:Final Analysis|Overall Study||0
136316|NCT01732549|332699|P1|Ongoing Treatment Period:Final Analysis|Overall Study||0
136317|NCT01732549|332698|P2|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 61 (AE 3, Consent withdrawn 6, Disease progression 46, Other 6)|61
136318|NCT01732549|332699|P1|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 59 (AE 13, Consent withdrawn 13, Disease progression 31, Other 2)|59
136319|NCT01732549|332698|P2|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
136320|NCT01732549|332699|P1|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
136321|NCT01732549|332698|P2|STARTED|Overall Study||73
136322|NCT01732549|332699|P1|STARTED|Overall Study||71
136323|NCT01732536|332721|P2|NOT COMPLETED|Overall Study||1
136324|NCT01732536|332722|P1|NOT COMPLETED|Overall Study||1
136325|NCT01732536|332721|P2|COMPLETED|Overall Study||46
136326|NCT01732536|332722|P1|COMPLETED|Overall Study||52
136327|NCT01732536|332721|P2|STARTED|Overall Study||47
136328|NCT01732536|332722|P1|STARTED|Overall Study||53
136329|NCT01732510|332745|P7|NOT COMPLETED|Overall Study||8
136330|NCT01732510|332746|P6|NOT COMPLETED|Overall Study||13
136331|NCT01732510|332747|P5|NOT COMPLETED|Overall Study||5
136332|NCT01732510|332748|P4|NOT COMPLETED|Overall Study||5
136333|NCT01732510|332749|P3|NOT COMPLETED|Overall Study||4
136334|NCT01732510|332750|P2|NOT COMPLETED|Overall Study||5
136335|NCT01732510|332751|P1|NOT COMPLETED|Overall Study||1
136336|NCT01732510|332745|P7|COMPLETED|Overall Study||0
136337|NCT01732510|332746|P6|COMPLETED|Overall Study||0
136338|NCT01732510|332747|P5|COMPLETED|Overall Study||3
136339|NCT01732510|332748|P4|COMPLETED|Overall Study||5
136340|NCT01732510|332749|P3|COMPLETED|Overall Study||4
136341|NCT01732510|332750|P2|COMPLETED|Overall Study||4
136342|NCT01732510|332751|P1|COMPLETED|Overall Study||8
136343|NCT01732510|332745|P7|STARTED|Overall Study||8
136344|NCT01732510|332746|P6|STARTED|Overall Study||13
136345|NCT01732510|332747|P5|STARTED|Overall Study||8
136346|NCT01732510|332748|P4|STARTED|Overall Study||10
136347|NCT01732510|332749|P3|STARTED|Overall Study||8
136348|NCT01732510|332750|P2|STARTED|Overall Study||9
136349|NCT01732510|332751|P1|STARTED|Overall Study||9
136350|NCT01732484|332830|P1|NOT COMPLETED|Overall Study||26
136351|NCT01732484|332830|P1|COMPLETED|Overall Study||74
136352|NCT01732484|332830|P1|Allocation|Overall Study||100
136353|NCT01732484|332830|P1|Randomized|Overall Study|Randomized implantation SN60WF IOL in on eye and iMics NY-60 in the other eye.|100
136354|NCT01732484|332830|P1|STARTED|Overall Study||100
136355|NCT01732471|332838|P1|NOT COMPLETED|Overall Study||1
136356|NCT01732471|332838|P1|COMPLETED|Overall Study||89
136357|NCT01732471|332838|P1|STARTED|Overall Study||90
136358|NCT01732458|332849|P4|NOT COMPLETED|Overall Study||2
136359|NCT01732458|332850|P3|NOT COMPLETED|Overall Study||3
136360|NCT01732458|332851|P2|NOT COMPLETED|Overall Study||5
136361|NCT01732458|332852|P1|NOT COMPLETED|Overall Study||3
136362|NCT01732458|332849|P4|COMPLETED|Overall Study||50
136363|NCT01732458|332850|P3|COMPLETED|Overall Study||55
136364|NCT01732458|332851|P2|COMPLETED|Overall Study||53
136365|NCT01732458|332852|P1|COMPLETED|Overall Study||57
136366|NCT01732458|332849|P4|Treated|Overall Study||52
136367|NCT01732458|332850|P3|Treated|Overall Study||56
136368|NCT01732458|332851|P2|Treated|Overall Study||55
136369|NCT01732458|332852|P1|Treated|Overall Study||57
136370|NCT01732458|332849|P4|STARTED|Overall Study||52
136371|NCT01732458|332850|P3|STARTED|Overall Study||58
136372|NCT01732458|332851|P2|STARTED|Overall Study||58
136373|NCT01732458|332852|P1|STARTED|Overall Study||60
136374|NCT01732445|332914|P1|NOT COMPLETED|Overall Study||0
136375|NCT01732445|332914|P1|COMPLETED|Overall Study||14
136376|NCT01732445|332914|P1|STARTED|Overall Study||14
136377|NCT01732419|332923|P2|NOT COMPLETED|Overall Study||4
136378|NCT01732419|332924|P1|NOT COMPLETED|Overall Study||8
136379|NCT01732419|332923|P2|COMPLETED|Overall Study||41
136380|NCT01732419|332924|P1|COMPLETED|Overall Study||37
136381|NCT01732419|332923|P2|STARTED|Overall Study||45
136382|NCT01732419|332924|P1|STARTED|Overall Study||45
136383|NCT01732406|332941|P3|NOT COMPLETED|Overall Study||0
136384|NCT01732406|332942|P2|NOT COMPLETED|Overall Study||0
136385|NCT01732406|332943|P1|NOT COMPLETED|Overall Study||0
136386|NCT01732406|332941|P3|COMPLETED|Overall Study||35
136387|NCT01732406|332942|P2|COMPLETED|Overall Study||60
136388|NCT01732406|332943|P1|COMPLETED|Overall Study||31
136389|NCT01732406|332941|P3|STARTED|Overall Study||35
136390|NCT01732406|332942|P2|STARTED|Overall Study||60
136391|NCT01732406|332943|P1|STARTED|Overall Study||31
136392|NCT01732263|332962|P2|NOT COMPLETED|Overall Study||0
136393|NCT01732263|332963|P1|NOT COMPLETED|Overall Study||0
136394|NCT01732263|332962|P2|COMPLETED|Overall Study||20
136395|NCT01732263|332963|P1|COMPLETED|Overall Study||23
136396|NCT01732263|332962|P2|STARTED|Overall Study||20
136397|NCT01732263|332963|P1|STARTED|Overall Study||23
136398|NCT01732107|333003|P1|NOT COMPLETED|Overall Study||13
136399|NCT01732107|333003|P1|COMPLETED|Overall Study||0
136400|NCT01732107|333003|P1|STARTED|Overall Study||13
136401|NCT01731990|333020|P2|NOT COMPLETED|Overall Study||8
136402|NCT01731990|333021|P1|NOT COMPLETED|Overall Study||4
136403|NCT01731990|333020|P2|COMPLETED|Overall Study||12
136404|NCT01731990|333021|P1|COMPLETED|Overall Study||14
136405|NCT01731990|333020|P2|STARTED|Overall Study||20
136406|NCT01731990|333021|P1|STARTED|Overall Study|"Started indicates Safety and Pharmacodynamics set ."|18
136407|NCT01731938|333037|P2|NOT COMPLETED|Primary Part II||13
136408|NCT01731938|333038|P1|NOT COMPLETED|Primary Part II||13
136409|NCT01731938|333037|P2|COMPLETED|Primary Part II||95
136410|NCT01731938|333038|P1|COMPLETED|Primary Part II||103
136411|NCT01731938|333037|P2|STARTED|Primary Part II|Subjects from Preliminary Part I were not carried over to Primary Part II to assess safety/efficacy.|108
136412|NCT01731938|333038|P1|STARTED|Primary Part II|Preliminary Part I was for study team familiarization with FS Grifols application.|116
136413|NCT01731938|333037|P2|NOT COMPLETED|Preliminary Part I||8
136414|NCT01731938|333038|P1|NOT COMPLETED|Preliminary Part I||3
136415|NCT01731938|333037|P2|COMPLETED|Preliminary Part I||44
136416|NCT01731938|333038|P1|COMPLETED|Preliminary Part I||48
136417|NCT01731938|333037|P2|STARTED|Preliminary Part I||52
136418|NCT01731938|333038|P1|STARTED|Preliminary Part I||51
136419|NCT01731912|333050|P1|NOT COMPLETED|Overall Study||2
136420|NCT01731912|333050|P1|COMPLETED|Overall Study||14
136421|NCT01731912|333050|P1|STARTED|Overall Study||16
136422|NCT01731886|333057|P2|NOT COMPLETED|Overall Study||1
136423|NCT01731886|333058|P1|NOT COMPLETED|Overall Study||2
136424|NCT01731886|333057|P2|COMPLETED|Overall Study||28
136425|NCT01731886|333058|P1|COMPLETED|Overall Study||29
136426|NCT01731886|333057|P2|STARTED|Overall Study||29
136427|NCT01731886|333058|P1|STARTED|Overall Study||31
136428|NCT01731678|333072|P1|NOT COMPLETED|Overall Study||7
136429|NCT01731678|333072|P1|COMPLETED|Overall Study||32
136430|NCT01731678|333072|P1|STARTED|Overall Study||39
136431|NCT01731600|333078|P2|NOT COMPLETED|Overall Study||0
136432|NCT01731600|333079|P1|NOT COMPLETED|Overall Study||6
136433|NCT01731600|333078|P2|COMPLETED|Overall Study||34
136434|NCT01731600|333079|P1|COMPLETED|Overall Study||28
136435|NCT01731600|333078|P2|STARTED|Overall Study||34
136436|NCT01731600|333079|P1|STARTED|Overall Study||34
136437|NCT01731470|333133|P1|NOT COMPLETED|Overall Study||2
136438|NCT01731470|333133|P1|COMPLETED|Overall Study|Number of patients enrolled in the study|14
136439|NCT01731470|333133|P1|STARTED|Overall Study|Number of patients consented to participate in the study|16
136440|NCT01731171|333140|P2|NOT COMPLETED|Overall Study||7
136441|NCT01731171|333141|P1|NOT COMPLETED|Overall Study||7
136442|NCT01731171|333140|P2|COMPLETED|Overall Study||26
136443|NCT01731171|333141|P1|COMPLETED|Overall Study||26
136444|NCT01731171|333140|P2|STARTED|Overall Study||33
136445|NCT01731171|333141|P1|STARTED|Overall Study||33
136446|NCT01731119|333153|P1|NOT COMPLETED|Overall Study||2
136447|NCT01731119|333153|P1|COMPLETED|Overall Study||7
136448|NCT01731119|333153|P1|STARTED|Overall Study||9
136449|NCT01731041|333163|P2|NOT COMPLETED|Overall Study||0
136450|NCT01731041|333164|P1|NOT COMPLETED|Overall Study||0
136451|NCT01731041|333163|P2|COMPLETED|Overall Study||30
136452|NCT01731041|333164|P1|COMPLETED|Overall Study||30
136453|NCT01731041|333163|P2|STARTED|Overall Study||30
136454|NCT01731041|333164|P1|STARTED|Overall Study||30
136455|NCT01731002|333175|P3|NOT COMPLETED|Overall Study||3
136456|NCT01731002|333176|P2|NOT COMPLETED|Overall Study||4
136457|NCT01731002|333177|P1|NOT COMPLETED|Overall Study||4
136458|NCT01731002|333175|P3|COMPLETED|Overall Study||74
136459|NCT01731002|333176|P2|COMPLETED|Overall Study||68
136460|NCT01731002|333177|P1|COMPLETED|Overall Study||71
136461|NCT01731002|333175|P3|STARTED|Overall Study||77
136462|NCT01731002|333176|P2|STARTED|Overall Study||72
136463|NCT01731002|333177|P1|STARTED|Overall Study||75
136464|NCT01730872|333191|P3|NOT COMPLETED|Overall Study||0
136465|NCT01730872|333192|P2|NOT COMPLETED|Overall Study||0
136466|NCT01730872|333193|P1|NOT COMPLETED|Overall Study||0
136467|NCT01730872|333191|P3|COMPLETED|Overall Study||3
136468|NCT01730872|333192|P2|COMPLETED|Overall Study||5
136469|NCT01730872|333193|P1|COMPLETED|Overall Study||8
136470|NCT01730872|333191|P3|Full Analysis Set|Overall Study||0
136471|NCT01730872|333192|P2|Full Analysis Set|Overall Study|1 subject did not complete the last post-CAE measurement on Day 6 and was excluded from the FAS|4
136472|NCT01730872|333193|P1|Full Analysis Set|Overall Study||8
136473|NCT01730872|333191|P3|STARTED|Overall Study||3
136474|NCT01730872|333192|P2|STARTED|Overall Study||5
136475|NCT01730872|333193|P1|STARTED|Overall Study||8
136476|NCT01730846|333207|P3|NOT COMPLETED|Overall Study||0
136477|NCT01730846|333208|P2|NOT COMPLETED|Overall Study||0
136478|NCT01730846|333209|P1|NOT COMPLETED|Overall Study||0
136479|NCT01730846|333207|P3|COMPLETED|Overall Study||13
136480|NCT01730846|333208|P2|COMPLETED|Overall Study||11
136481|NCT01730846|333209|P1|COMPLETED|Overall Study||11
136482|NCT01730846|333207|P3|STARTED|Overall Study||13
136483|NCT01730846|333208|P2|STARTED|Overall Study||11
136484|NCT01730846|333209|P1|STARTED|Overall Study||11
136485|NCT01730729|333220|P1|NOT COMPLETED|Overall Study||14
136486|NCT01730729|333220|P1|COMPLETED|Overall Study||6
136487|NCT01730729|333220|P1|Treated Cycle 3 and Beyond|Overall Study||6
136488|NCT01730729|333220|P1|Completed 2 Cycles/Reached 1st Response|Overall Study||18
136489|NCT01730729|333220|P1|STARTED|Overall Study||20
136490|NCT01730378|333236|P2|NOT COMPLETED|Overall Study||0
136491|NCT01730378|333237|P1|NOT COMPLETED|Overall Study||1
136492|NCT01730378|333236|P2|COMPLETED|Overall Study||47
136493|NCT01730378|333237|P1|COMPLETED|Overall Study||83
136494|NCT01730378|333236|P2|STARTED|Overall Study||47
136495|NCT01730378|333237|P1|STARTED|Overall Study||84
136496|NCT01730339|333268|P2|NOT COMPLETED|Overall Study||3
136497|NCT01730339|333269|P1|NOT COMPLETED|Overall Study||5
136498|NCT01730339|333268|P2|COMPLETED|Overall Study||52
136499|NCT01730339|333269|P1|COMPLETED|Overall Study||40
136500|NCT01730339|333268|P2|STARTED|Overall Study||55
136501|NCT01730339|333269|P1|STARTED|Overall Study||45
136502|NCT01730053|333309|P6|NOT COMPLETED|Overall Study||13
136503|NCT01730053|333310|P5|NOT COMPLETED|Overall Study||9
136504|NCT01730053|333311|P4|NOT COMPLETED|Overall Study||8
136505|NCT01730053|333312|P3|NOT COMPLETED|Overall Study||11
136506|NCT01730053|333313|P2|NOT COMPLETED|Overall Study||14
136507|NCT01730053|333314|P1|NOT COMPLETED|Overall Study||5
136508|NCT01730053|333309|P6|COMPLETED|Overall Study||41
136509|NCT01730053|333310|P5|COMPLETED|Overall Study||44
136510|NCT01730053|333311|P4|COMPLETED|Overall Study||45
136511|NCT01730053|333312|P3|COMPLETED|Overall Study||38
136512|NCT01730053|333313|P2|COMPLETED|Overall Study||34
136513|NCT01730053|333314|P1|COMPLETED|Overall Study||43
136514|NCT01730053|333309|P6|Treated|Overall Study||54
136515|NCT01730053|333310|P5|Treated|Overall Study||53
136516|NCT01730053|333311|P4|Treated|Overall Study||53
136517|NCT01730053|333312|P3|Treated|Overall Study||49
136518|NCT01730053|333313|P2|Treated|Overall Study||48
136519|NCT01730053|333314|P1|Treated|Overall Study||48
136520|NCT01730053|333309|P6|STARTED|Overall Study||54
136521|NCT01730053|333310|P5|STARTED|Overall Study||53
136522|NCT01730053|333311|P4|STARTED|Overall Study||53
136523|NCT01730053|333312|P3|STARTED|Overall Study||49
136524|NCT01730053|333313|P2|STARTED|Overall Study||48
136525|NCT01730053|333314|P1|STARTED|Overall Study||48
136526|NCT01730040|333473|P7|NOT COMPLETED|Overall Study||9
136527|NCT01730040|333474|P6|NOT COMPLETED|Overall Study||7
136528|NCT01730040|333475|P5|NOT COMPLETED|Overall Study||6
136529|NCT01730040|333476|P4|NOT COMPLETED|Overall Study||8
136530|NCT01730040|333477|P3|NOT COMPLETED|Overall Study||11
136531|NCT01730040|333478|P2|NOT COMPLETED|Overall Study||15
136532|NCT01730040|333479|P1|NOT COMPLETED|Overall Study||13
136533|NCT01730040|333473|P7|COMPLETED|Overall Study||38
136534|NCT01730040|333474|P6|COMPLETED|Overall Study||40
136535|NCT01730040|333475|P5|COMPLETED|Overall Study||39
136536|NCT01730040|333476|P4|COMPLETED|Overall Study||39
136537|NCT01730040|333477|P3|COMPLETED|Overall Study||46
136538|NCT01730040|333478|P2|COMPLETED|Overall Study||40
136539|NCT01730040|333479|P1|COMPLETED|Overall Study||44
136540|NCT01730040|333473|P7|Treated|Overall Study||47
136541|NCT01730040|333474|P6|Treated|Overall Study||46
136542|NCT01730040|333475|P5|Treated|Overall Study||45
136543|NCT01730040|333476|P4|Treated|Overall Study||47
136544|NCT01730040|333477|P3|Treated|Overall Study||57
136545|NCT01730040|333478|P2|Treated|Overall Study||55
136546|NCT01730040|333479|P1|Treated|Overall Study||57
136547|NCT01730040|333473|P7|STARTED|Overall Study||47
136548|NCT01730040|333474|P6|STARTED|Overall Study||47
136549|NCT01730040|333475|P5|STARTED|Overall Study||45
136550|NCT01730040|333476|P4|STARTED|Overall Study||47
136551|NCT01730040|333477|P3|STARTED|Overall Study||57
136552|NCT01730040|333478|P2|STARTED|Overall Study||55
136553|NCT01730040|333479|P1|STARTED|Overall Study||57
136554|NCT01729923|333656|P1|NOT COMPLETED|Overall Study||27
136555|NCT01729923|333656|P1|COMPLETED|Overall Study||0
136556|NCT01729923|333656|P1|STARTED|Overall Study||27
136557|NCT01729871|333668|P2|NOT COMPLETED|Overall Study||23
136558|NCT01729871|333669|P1|NOT COMPLETED|Overall Study||12
136559|NCT01729871|333668|P2|COMPLETED|Overall Study||101
136560|NCT01729871|333669|P1|COMPLETED|Overall Study||112
136561|NCT01729871|333668|P2|STARTED|Overall Study||124
136562|NCT01729871|333669|P1|STARTED|Overall Study||124
136563|NCT01729845|333688|P3|NOT COMPLETED|Efficacy of Dec/MEC||0
136564|NCT01729845|333689|P2|NOT COMPLETED|Efficacy of Dec/MEC||0
136565|NCT01729845|333690|P1|NOT COMPLETED|Efficacy of Dec/MEC||0
136566|NCT01729845|333688|P3|COMPLETED|Efficacy of Dec/MEC||0
136567|NCT01729845|333689|P2|COMPLETED|Efficacy of Dec/MEC||22
136568|NCT01729845|333690|P1|COMPLETED|Efficacy of Dec/MEC||0
136569|NCT01729845|333688|P3|STARTED|Efficacy of Dec/MEC||0
136570|NCT01729845|333689|P2|STARTED|Efficacy of Dec/MEC||22
136571|NCT01729845|333690|P1|STARTED|Efficacy of Dec/MEC||0
136572|NCT01729845|333688|P3|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
136573|NCT01729845|333689|P2|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
136574|NCT01729845|333690|P1|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
136575|NCT01729845|333688|P3|COMPLETED|Safety/Tolerability of Dec/MEC||12
136576|NCT01729845|333689|P2|COMPLETED|Safety/Tolerability of Dec/MEC||34
136577|NCT01729845|333690|P1|COMPLETED|Safety/Tolerability of Dec/MEC||6
136578|NCT01729845|333688|P3|STARTED|Safety/Tolerability of Dec/MEC||12
136579|NCT01729845|333689|P2|STARTED|Safety/Tolerability of Dec/MEC||34
136580|NCT01729845|333690|P1|STARTED|Safety/Tolerability of Dec/MEC||6
136581|NCT01729819|333703|P2|NOT COMPLETED|Overall Study||7
136582|NCT01729819|333704|P1|NOT COMPLETED|Overall Study||6
136583|NCT01729819|333703|P2|COMPLETED|Overall Study||50
136584|NCT01729819|333704|P1|COMPLETED|Overall Study||43
136585|NCT01729819|333703|P2|STARTED|Overall Study||57
136586|NCT01729819|333704|P1|STARTED|Overall Study||49
136587|NCT01729754|333723|P10|NOT COMPLETED|Part 3||7
136588|NCT01729754|333724|P9|NOT COMPLETED|Part 3||1
136589|NCT01729754|333725|P8|NOT COMPLETED|Part 3||3
136590|NCT01729754|333726|P7|NOT COMPLETED|Part 3||0
136591|NCT01729754|333727|P6|NOT COMPLETED|Part 3||13
136592|NCT01729754|333728|P5|NOT COMPLETED|Part 3||4
136593|NCT01729754|333729|P4|NOT COMPLETED|Part 3||0
136594|NCT01729754|333730|P3|NOT COMPLETED|Part 3||5
136595|NCT01729754|333731|P2|NOT COMPLETED|Part 3||5
136596|NCT01729754|333732|P1|NOT COMPLETED|Part 3||0
136597|NCT01729754|333723|P10|COMPLETED|Part 3||114
136598|NCT01729754|333724|P9|COMPLETED|Part 3||65
136599|NCT01729754|333725|P8|COMPLETED|Part 3||66
136600|NCT01729754|333726|P7|COMPLETED|Part 3||0
136601|NCT01729754|333727|P6|COMPLETED|Part 3||224
136602|NCT01729754|333728|P5|COMPLETED|Part 3||17
136603|NCT01729754|333729|P4|COMPLETED|Part 3||0
136604|NCT01729754|333730|P3|COMPLETED|Part 3||105
136605|NCT01729754|333731|P2|COMPLETED|Part 3||165
136606|NCT01729754|333732|P1|COMPLETED|Part 3||0
136607|NCT01729754|333723|P10|STARTED|Part 3|156 participants completed Part 2 but did not enter Part 3|121
136608|NCT01729754|333724|P9|STARTED|Part 3||66
136609|NCT01729754|333725|P8|STARTED|Part 3||69
136610|NCT01729754|333726|P7|STARTED|Part 3||0
136611|NCT01729754|333727|P6|STARTED|Part 3|31 participants completed Part 2 but did not enter Part 3|237
136612|NCT01729754|333728|P5|STARTED|Part 3||21
136613|NCT01729754|333729|P4|STARTED|Part 3||0
136614|NCT01729754|333730|P3|STARTED|Part 3||110
136615|NCT01729754|333731|P2|STARTED|Part 3|14 participants completed Part 2 but did not enter Part 3|170
136616|NCT01729754|333732|P1|STARTED|Part 3||0
136617|NCT01729754|333723|P10|NOT COMPLETED|Part 2||12
136618|NCT01729754|333724|P9|NOT COMPLETED|Part 2||4
136619|NCT01729754|333725|P8|NOT COMPLETED|Part 2||3
136620|NCT01729754|333726|P7|NOT COMPLETED|Part 2||0
136621|NCT01729754|333727|P6|NOT COMPLETED|Part 2||0
136622|NCT01729754|333728|P5|NOT COMPLETED|Part 2||0
136623|NCT01729754|333729|P4|NOT COMPLETED|Part 2||5
136624|NCT01729754|333730|P3|NOT COMPLETED|Part 2||0
136625|NCT01729754|333731|P2|NOT COMPLETED|Part 2||0
136626|NCT01729754|333732|P1|NOT COMPLETED|Part 2||6
136627|NCT01729754|333723|P10|COMPLETED|Part 2||277
136628|NCT01729754|333724|P9|COMPLETED|Part 2||66
136629|NCT01729754|333725|P8|COMPLETED|Part 2||69
136630|NCT01729754|333726|P7|COMPLETED|Part 2||0
136631|NCT01729754|333727|P6|COMPLETED|Part 2||268
136632|NCT01729754|333728|P5|COMPLETED|Part 2||21
136633|NCT01729754|333729|P4|COMPLETED|Part 2||0
136634|NCT01729754|333730|P3|COMPLETED|Part 2||110
136635|NCT01729754|333731|P2|COMPLETED|Part 2||184
136636|NCT01729754|333732|P1|COMPLETED|Part 2||0
136637|NCT01729754|333723|P10|STARTED|Part 2||289
136638|NCT01729754|333724|P9|STARTED|Part 2||70
136639|NCT01729754|333725|P8|STARTED|Part 2||72
136640|NCT01729754|333726|P7|STARTED|Part 2||0
136641|NCT01729754|333727|P6|STARTED|Part 2||268
136642|NCT01729754|333728|P5|STARTED|Part 2||21
136643|NCT01729754|333729|P4|STARTED|Part 2|1 participant completed Part 1 but did not enter Part 2|5
136644|NCT01729754|333730|P3|STARTED|Part 2||110
136645|NCT01729754|333731|P2|STARTED|Part 2||184
136646|NCT01729754|333732|P1|STARTED|Part 2||6
136647|NCT01729754|333723|P10|NOT COMPLETED|Part 1||24
136648|NCT01729754|333724|P9|NOT COMPLETED|Part 1||0
136649|NCT01729754|333725|P8|NOT COMPLETED|Part 1||0
136650|NCT01729754|333726|P7|NOT COMPLETED|Part 1||14
136651|NCT01729754|333727|P6|NOT COMPLETED|Part 1||0
136652|NCT01729754|333728|P5|NOT COMPLETED|Part 1||0
136653|NCT01729754|333729|P4|NOT COMPLETED|Part 1||12
136654|NCT01729754|333730|P3|NOT COMPLETED|Part 1||0
136655|NCT01729754|333731|P2|NOT COMPLETED|Part 1||0
136656|NCT01729754|333732|P1|NOT COMPLETED|Part 1||14
136657|NCT01729754|333723|P10|COMPLETED|Part 1||289
136658|NCT01729754|333724|P9|COMPLETED|Part 1||70
136659|NCT01729754|333725|P8|COMPLETED|Part 1||72
136660|NCT01729754|333726|P7|COMPLETED|Part 1||0
136661|NCT01729754|333727|P6|COMPLETED|Part 1||268
136662|NCT01729754|333728|P5|COMPLETED|Part 1||21
136663|NCT01729754|333729|P4|COMPLETED|Part 1||6
136664|NCT01729754|333730|P3|COMPLETED|Part 1||110
136665|NCT01729754|333731|P2|COMPLETED|Part 1||184
136666|NCT01729754|333732|P1|COMPLETED|Part 1||6
136667|NCT01729754|333723|P10|STARTED|Part 1||313
136668|NCT01729754|333724|P9|STARTED|Part 1||70
136669|NCT01729754|333725|P8|STARTED|Part 1||72
136670|NCT01729754|333726|P7|STARTED|Part 1||14
136671|NCT01729754|333727|P6|STARTED|Part 1||268
136672|NCT01729754|333728|P5|STARTED|Part 1||21
136673|NCT01729754|333729|P4|STARTED|Part 1||18
136674|NCT01729754|333730|P3|STARTED|Part 1||110
136675|NCT01729754|333731|P2|STARTED|Part 1||184
136676|NCT01729754|333732|P1|STARTED|Part 1||20
136677|NCT01729728|333939|P3|NOT COMPLETED|Overall Study||1
136678|NCT01729728|333940|P2|NOT COMPLETED|Overall Study||6
136679|NCT01729728|333941|P1|NOT COMPLETED|Overall Study||1
136680|NCT01729728|333939|P3|COMPLETED|Overall Study||16
136681|NCT01729728|333940|P2|COMPLETED|Overall Study||22
136682|NCT01729728|333941|P1|COMPLETED|Overall Study||20
136683|NCT01729728|333939|P3|STARTED|Overall Study||17
136684|NCT01729728|333940|P2|STARTED|Overall Study||28
136685|NCT01729728|333941|P1|STARTED|Overall Study||21
136686|NCT01729598|334074|P2|NOT COMPLETED|Overall Study||0
136687|NCT01729598|334075|P1|NOT COMPLETED|Overall Study||0
136688|NCT01729598|334074|P2|COMPLETED|Overall Study||4
136689|NCT01729598|334075|P1|COMPLETED|Overall Study||10
136690|NCT01729598|334074|P2|STARTED|Overall Study||4
136691|NCT01729598|334075|P1|STARTED|Overall Study||10
136692|NCT01729559|334091|P2|NOT COMPLETED|Overall Study||28
136693|NCT01729559|334092|P1|NOT COMPLETED|Overall Study||31
136694|NCT01729559|334091|P2|COMPLETED|Overall Study||216
136695|NCT01729559|334092|P1|COMPLETED|Overall Study||220
136696|NCT01729559|334091|P2|STARTED|Overall Study||244
136697|NCT01729559|334092|P1|STARTED|Overall Study||251
136698|NCT01729338|334104|P1|NOT COMPLETED|Overall Study||2
136699|NCT01729338|334104|P1|COMPLETED|Overall Study||14
136700|NCT01729338|334104|P1|STARTED|Overall Study||16
136701|NCT01729247|334119|P1|NOT COMPLETED|Overall Study||0
136702|NCT01729247|334119|P1|COMPLETED|Overall Study||50
136703|NCT01729247|334119|P1|STARTED|Overall Study||50
136704|NCT01729156|334136|P3|NOT COMPLETED|Overall Study||0
136705|NCT01729156|334137|P2|NOT COMPLETED|Overall Study||0
136706|NCT01729156|334138|P1|NOT COMPLETED|Overall Study||1
136707|NCT01729156|334136|P3|COMPLETED|Overall Study||12
136708|NCT01729156|334137|P2|COMPLETED|Overall Study||12
136709|NCT01729156|334138|P1|COMPLETED|Overall Study||11
136710|NCT01729156|334136|P3|STARTED|Overall Study||12
136711|NCT01729156|334137|P2|STARTED|Overall Study||12
136712|NCT01729156|334138|P1|STARTED|Overall Study||12
136713|NCT01729039|334166|P2|NOT COMPLETED|Overall Study||12
136714|NCT01729039|334167|P1|NOT COMPLETED|Overall Study||10
136715|NCT01729039|334166|P2|COMPLETED|Overall Study||14
136716|NCT01729039|334167|P1|COMPLETED|Overall Study||13
136717|NCT01729039|334166|P2|STARTED|Overall Study||26
136718|NCT01729039|334167|P1|STARTED|Overall Study||23
136719|NCT01729026|334183|P2|NOT COMPLETED|3-month to 6-month (Final) Follow-up||2
136720|NCT01729026|334184|P1|NOT COMPLETED|3-month to 6-month (Final) Follow-up||1
136721|NCT01729026|334183|P2|COMPLETED|3-month to 6-month (Final) Follow-up||6
136722|NCT01729026|334184|P1|COMPLETED|3-month to 6-month (Final) Follow-up||6
136723|NCT01729026|334183|P2|STARTED|3-month to 6-month (Final) Follow-up||8
136724|NCT01729026|334184|P1|STARTED|3-month to 6-month (Final) Follow-up||7
136725|NCT01729026|334183|P2|NOT COMPLETED|Randomization to 3-month Follow-up||2
136726|NCT01729026|334184|P1|NOT COMPLETED|Randomization to 3-month Follow-up||2
136727|NCT01729026|334183|P2|COMPLETED|Randomization to 3-month Follow-up||8
136728|NCT01729026|334184|P1|COMPLETED|Randomization to 3-month Follow-up||7
136729|NCT01729026|334183|P2|STARTED|Randomization to 3-month Follow-up||10
136730|NCT01729026|334184|P1|STARTED|Randomization to 3-month Follow-up||9
136731|NCT01728805|334192|P3|NOT COMPLETED|Crossover Period||0
136732|NCT01728805|334193|P2|NOT COMPLETED|Crossover Period||0
136733|NCT01728805|334194|P1|NOT COMPLETED|Crossover Period||0
136734|NCT01728805|334192|P3|COMPLETED|Crossover Period||136
136735|NCT01728805|334193|P2|COMPLETED|Crossover Period||0
136736|NCT01728805|334194|P1|COMPLETED|Crossover Period||0
136737|NCT01728805|334192|P3|STARTED|Crossover Period||136
136738|NCT01728805|334193|P2|STARTED|Crossover Period||0
136739|NCT01728805|334194|P1|STARTED|Crossover Period||0
136740|NCT01728805|334192|P3|NOT COMPLETED|Randomization Period||0
136741|NCT01728805|334193|P2|NOT COMPLETED|Randomization Period||0
136742|NCT01728805|334194|P1|NOT COMPLETED|Randomization Period||0
136743|NCT01728805|334192|P3|COMPLETED|Randomization Period||0
136744|NCT01728805|334193|P2|COMPLETED|Randomization Period||186
136745|NCT01728805|334194|P1|COMPLETED|Randomization Period||186
136746|NCT01728805|334192|P3|STARTED|Randomization Period||0
136747|NCT01728805|334193|P2|STARTED|Randomization Period||186
136748|NCT01728805|334194|P1|STARTED|Randomization Period||186
136749|NCT01728792|334212|P5|NOT COMPLETED|Overall Study||0
136750|NCT01728792|334213|P4|NOT COMPLETED|Overall Study||3
136751|NCT01728792|334214|P3|NOT COMPLETED|Overall Study||4
136752|NCT01728792|334215|P2|NOT COMPLETED|Overall Study||2
136753|NCT01728792|334216|P1|NOT COMPLETED|Overall Study||3
136754|NCT01728792|334212|P5|COMPLETED|Overall Study||16
136755|NCT01728792|334213|P4|COMPLETED|Overall Study||14
136756|NCT01728792|334214|P3|COMPLETED|Overall Study||13
136757|NCT01728792|334215|P2|COMPLETED|Overall Study||14
136758|NCT01728792|334216|P1|COMPLETED|Overall Study||11
136759|NCT01728792|334212|P5|STARTED|Overall Study||16
136760|NCT01728792|334213|P4|STARTED|Overall Study||17
136761|NCT01728792|334214|P3|STARTED|Overall Study||17
136762|NCT01728792|334215|P2|STARTED|Overall Study||16
136763|NCT01728792|334216|P1|STARTED|Overall Study||14
136764|NCT01728584|334267|P4|NOT COMPLETED|Overall Study||1
136765|NCT01728584|334268|P3|NOT COMPLETED|Overall Study||1
136766|NCT01728584|334269|P2|NOT COMPLETED|Overall Study||0
136767|NCT01728584|334270|P1|NOT COMPLETED|Overall Study||8
136768|NCT01728584|334267|P4|COMPLETED|Overall Study||29
136769|NCT01728584|334268|P3|COMPLETED|Overall Study||30
136770|NCT01728584|334269|P2|COMPLETED|Overall Study||30
136771|NCT01728584|334270|P1|COMPLETED|Overall Study||28
136772|NCT01728584|334267|P4|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 5 (all to Deep/Std)|30
136773|NCT01728584|334268|P3|STARTED|Overall Study|Randomized|31
136774|NCT01728584|334269|P2|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 7 (2 to Std/Std, 4 to Deep/Std, 1 to Deep/Low)|30
136775|NCT01728584|334270|P1|STARTED|Overall Study|Randomized|36
136776|NCT01728454|334325|P3|NOT COMPLETED|Stage 3||4
136777|NCT01728454|334326|P2|NOT COMPLETED|Stage 3||4
136778|NCT01728454|334327|P1|NOT COMPLETED|Stage 3||3
136779|NCT01728454|334325|P3|COMPLETED|Stage 3||7
136780|NCT01728454|334326|P2|COMPLETED|Stage 3||1
136781|NCT01728454|334327|P1|COMPLETED|Stage 3||3
136782|NCT01728454|334325|P3|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|11
136783|NCT01728454|334326|P2|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|5
136784|NCT01728454|334327|P1|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|6
136785|NCT01728454|334325|P3|NOT COMPLETED|Stage 1 and 2||4
136786|NCT01728454|334326|P2|NOT COMPLETED|Stage 1 and 2||4
136787|NCT01728454|334327|P1|NOT COMPLETED|Stage 1 and 2||5
136788|NCT01728454|334325|P3|COMPLETED|Stage 1 and 2||19
136789|NCT01728454|334326|P2|COMPLETED|Stage 1 and 2||16
136790|NCT01728454|334327|P1|COMPLETED|Stage 1 and 2||12
136791|NCT01728454|334325|P3|STARTED|Stage 1 and 2||23
136792|NCT01728454|334326|P2|STARTED|Stage 1 and 2||20
136793|NCT01728454|334327|P1|STARTED|Stage 1 and 2||17
136794|NCT01728376|334377|P6|NOT COMPLETED|Overall Study||2
136795|NCT01728376|334378|P5|NOT COMPLETED|Overall Study||2
136796|NCT01728376|334379|P4|NOT COMPLETED|Overall Study||2
136797|NCT01728376|334380|P3|NOT COMPLETED|Overall Study||2
136798|NCT01728376|334381|P2|NOT COMPLETED|Overall Study||2
136799|NCT01728376|334382|P1|NOT COMPLETED|Overall Study||4
136800|NCT01728376|334377|P6|COMPLETED|Overall Study||5
136801|NCT01728376|334378|P5|COMPLETED|Overall Study||12
136802|NCT01728376|334379|P4|COMPLETED|Overall Study||7
136803|NCT01728376|334380|P3|COMPLETED|Overall Study||17
136804|NCT01728376|334381|P2|COMPLETED|Overall Study||9
136805|NCT01728376|334382|P1|COMPLETED|Overall Study||18
136806|NCT01728376|334377|P6|Treated|Overall Study||7
136807|NCT01728376|334378|P5|Treated|Overall Study||14
136808|NCT01728376|334379|P4|Treated|Overall Study||9
136809|NCT01728376|334380|P3|Treated|Overall Study||19
136810|NCT01728376|334381|P2|Treated|Overall Study||10
136811|NCT01728376|334382|P1|Treated|Overall Study||22
136812|NCT01728376|334377|P6|STARTED|Overall Study||7
136813|NCT01728376|334378|P5|STARTED|Overall Study||14
136814|NCT01728376|334379|P4|STARTED|Overall Study||9
136815|NCT01728376|334380|P3|STARTED|Overall Study||19
136816|NCT01728376|334381|P2|STARTED|Overall Study||11
136817|NCT01728376|334382|P1|STARTED|Overall Study||22
136818|NCT01728337|334444|P1|NOT COMPLETED|Overall Study||0
136819|NCT01728337|334444|P1|COMPLETED|Overall Study||80
136820|NCT01728337|334444|P1|STARTED|Overall Study||80
136821|NCT01728324|334455|P3|NOT COMPLETED|Termination of RBV||15
136822|NCT01728324|334456|P2|NOT COMPLETED|Termination of RBV||37
136823|NCT01728324|334457|P1|NOT COMPLETED|Termination of RBV||39
136824|NCT01728324|334455|P3|COMPLETED|Termination of RBV||57
136825|NCT01728324|334456|P2|COMPLETED|Termination of RBV||176
136826|NCT01728324|334457|P1|COMPLETED|Termination of RBV||172
136827|NCT01728324|334455|P3|STARTED|Termination of RBV||72
136828|NCT01728324|334456|P2|STARTED|Termination of RBV||213
136829|NCT01728324|334457|P1|STARTED|Termination of RBV||211
136830|NCT01728324|334455|P3|NOT COMPLETED|Termination of FDV||14
136831|NCT01728324|334456|P2|NOT COMPLETED|Termination of FDV||36
136832|NCT01728324|334457|P1|NOT COMPLETED|Termination of FDV||38
136833|NCT01728324|334455|P3|COMPLETED|Termination of FDV||58
136834|NCT01728324|334456|P2|COMPLETED|Termination of FDV||177
136835|NCT01728324|334457|P1|COMPLETED|Termination of FDV||173
136836|NCT01728324|334455|P3|STARTED|Termination of FDV||72
136837|NCT01728324|334456|P2|STARTED|Termination of FDV||213
136838|NCT01728324|334457|P1|STARTED|Termination of FDV||211
136839|NCT01728324|334455|P3|NOT COMPLETED|Termination of DBV||14
136840|NCT01728324|334456|P2|NOT COMPLETED|Termination of DBV||36
136841|NCT01728324|334457|P1|NOT COMPLETED|Termination of DBV||38
136842|NCT01728324|334455|P3|COMPLETED|Termination of DBV||58
136843|NCT01728324|334456|P2|COMPLETED|Termination of DBV||177
136844|NCT01728324|334457|P1|COMPLETED|Termination of DBV||173
136845|NCT01728324|334455|P3|STARTED|Termination of DBV||72
136846|NCT01728324|334456|P2|STARTED|Termination of DBV||213
136847|NCT01728324|334457|P1|STARTED|Termination of DBV||211
136848|NCT01728246|334478|P2|NOT COMPLETED|Overall Study||36
136849|NCT01728246|334479|P1|NOT COMPLETED|Overall Study||36
136850|NCT01728246|334478|P2|COMPLETED|Overall Study||195
136851|NCT01728246|334479|P1|COMPLETED|Overall Study||206
136852|NCT01728246|334478|P2|STARTED|Overall Study||231
136853|NCT01728246|334479|P1|STARTED|Overall Study||242
136854|NCT01728116|334497|P2|NOT COMPLETED|Overall Study||47
136855|NCT01728116|334498|P1|NOT COMPLETED|Overall Study||161
136856|NCT01728116|334497|P2|COMPLETED|Overall Study|Completed to Week 52|60
136857|NCT01728116|334498|P1|COMPLETED|Overall Study|Completed to Week 78|52
136858|NCT01728116|334497|P2|STARTED|Overall Study|Sham mITT subjects|107
136859|NCT01728116|334498|P1|STARTED|Overall Study|EndoBarrier mITT Subjects|213
136860|NCT01728077|334523|P2|NOT COMPLETED|Overall Study||5
136861|NCT01728077|334524|P1|NOT COMPLETED|Overall Study||8
136862|NCT01728077|334523|P2|COMPLETED|Overall Study||2
136863|NCT01728077|334524|P1|COMPLETED|Overall Study||11
136864|NCT01728077|334523|P2|STARTED|Overall Study||7
136865|NCT01728077|334524|P1|STARTED|Overall Study||19
136866|NCT01727895|334539|P2|NOT COMPLETED|Overall Study||0
136867|NCT01727895|334540|P1|NOT COMPLETED|Overall Study||0
136868|NCT01727895|334539|P2|COMPLETED|Overall Study||5
136869|NCT01727895|334540|P1|COMPLETED|Overall Study||10
136870|NCT01727895|334539|P2|STARTED|Overall Study||5
136871|NCT01727895|334540|P1|STARTED|Overall Study||10
136872|NCT01727791|334546|P1|NOT COMPLETED|Overall Study||0
136873|NCT01727791|334546|P1|COMPLETED|Overall Study||10
136874|NCT01727791|334546|P1|STARTED|Overall Study||10
136875|NCT01727765|334578|P2|NOT COMPLETED|Overall Study||0
136876|NCT01727765|334579|P1|NOT COMPLETED|Overall Study||0
136877|NCT01727765|334578|P2|COMPLETED|Overall Study||8
136878|NCT01727765|334579|P1|COMPLETED|Overall Study||8
136879|NCT01727765|334578|P2|STARTED|Overall Study||8
136880|NCT01727765|334579|P1|STARTED|Overall Study||8
136881|NCT01727726|334588|P3|NOT COMPLETED|Overall Study||20
136882|NCT01727726|334589|P2|NOT COMPLETED|Overall Study||14
136883|NCT01727726|334590|P1|NOT COMPLETED|Overall Study||26
136884|NCT01727726|334588|P3|COMPLETED|Overall Study||186
136885|NCT01727726|334589|P2|COMPLETED|Overall Study||86
136886|NCT01727726|334590|P1|COMPLETED|Overall Study||171
136887|NCT01727726|334588|P3|STARTED|Overall Study||206
136888|NCT01727726|334589|P2|STARTED|Overall Study||100
136889|NCT01727726|334590|P1|STARTED|Overall Study||197
136890|NCT01727713|334622|P1|NOT COMPLETED|Overall Study||35
136891|NCT01727713|334622|P1|COMPLETED|Overall Study||75
136892|NCT01727713|334622|P1|STARTED|Overall Study||110
136893|NCT01727700|334649|P3|NOT COMPLETED|Overall Study||2
136894|NCT01727700|334650|P2|NOT COMPLETED|Overall Study||10
136895|NCT01727700|334651|P1|NOT COMPLETED|Overall Study||2
136896|NCT01727700|334649|P3|COMPLETED|Overall Study||42
136897|NCT01727700|334650|P2|COMPLETED|Overall Study||35
136898|NCT01727700|334651|P1|COMPLETED|Overall Study||42
136899|NCT01727700|334649|P3|STARTED|Overall Study||44
136900|NCT01727700|334650|P2|STARTED|Overall Study||45
136901|NCT01727700|334651|P1|STARTED|Overall Study||44
136902|NCT01727505|334674|P2|NOT COMPLETED|Second 24 Hours||1
136903|NCT01727505|334675|P1|NOT COMPLETED|Second 24 Hours||0
136904|NCT01727505|334674|P2|COMPLETED|Second 24 Hours||10
136905|NCT01727505|334675|P1|COMPLETED|Second 24 Hours||14
136906|NCT01727505|334674|P2|STARTED|Second 24 Hours||11
136907|NCT01727505|334675|P1|STARTED|Second 24 Hours||14
136908|NCT01727505|334674|P2|NOT COMPLETED|First 24 Hours||1
136909|NCT01727505|334675|P1|NOT COMPLETED|First 24 Hours||0
136910|NCT01727505|334674|P2|COMPLETED|First 24 Hours||11
136911|NCT01727505|334675|P1|COMPLETED|First 24 Hours||14
136912|NCT01727505|334674|P2|STARTED|First 24 Hours||12
136913|NCT01727505|334675|P1|STARTED|First 24 Hours||14
136914|NCT01727414|334693|P2|NOT COMPLETED|Overall Study||0
136915|NCT01727414|334694|P1|NOT COMPLETED|Overall Study||3
136916|NCT01727414|334693|P2|COMPLETED|Overall Study||45
136917|NCT01727414|334694|P1|COMPLETED|Overall Study||123
136918|NCT01727414|334693|P2|STARTED|Overall Study||45
136919|NCT01727414|334694|P1|STARTED|Overall Study||126
136920|NCT01727297|334700|P2|NOT COMPLETED|Overall Study||51
136921|NCT01727297|334701|P1|NOT COMPLETED|Overall Study||102
136922|NCT01727297|334700|P2|COMPLETED|Overall Study||0
136923|NCT01727297|334701|P1|COMPLETED|Overall Study||293
136924|NCT01727297|334700|P2|STARTED|Overall Study||51
136925|NCT01727297|334701|P1|STARTED|Overall Study||395
136926|NCT01727258|334717|P3|NOT COMPLETED|Overall Study||1
136927|NCT01727258|334718|P2|NOT COMPLETED|Overall Study||3
136928|NCT01727258|334719|P1|NOT COMPLETED|Overall Study||2
136929|NCT01727258|334717|P3|COMPLETED|Overall Study||50
136930|NCT01727258|334718|P2|COMPLETED|Overall Study||48
136931|NCT01727258|334719|P1|COMPLETED|Overall Study||49
136932|NCT01727258|334717|P3|STARTED|Overall Study||51
136933|NCT01727258|334718|P2|STARTED|Overall Study||51
136934|NCT01727258|334719|P1|STARTED|Overall Study||51
136935|NCT01727180|334742|P1|NOT COMPLETED|Overall Study||0
136936|NCT01727180|334742|P1|COMPLETED|Overall Study||108
136937|NCT01727180|334742|P1|STARTED|Overall Study||108
136938|NCT01727167|334748|P2|NOT COMPLETED|Overall Study||0
136939|NCT01727167|334749|P1|NOT COMPLETED|Overall Study||0
136940|NCT01727167|334748|P2|COMPLETED|Overall Study||0
136941|NCT01727167|334749|P1|COMPLETED|Overall Study||1
136942|NCT01727167|334748|P2|STARTED|Overall Study||0
136943|NCT01727167|334749|P1|STARTED|Overall Study||1
136944|NCT01727154|334757|P1|NOT COMPLETED|Overall Study||59
136945|NCT01727154|334757|P1|COMPLETED|Overall Study||80
136946|NCT01727154|334757|P1|STARTED|Overall Study||139
136947|NCT01727141|334765|P4|NOT COMPLETED|Overall Study||15
136948|NCT01727141|334766|P3|NOT COMPLETED|Overall Study||3
136949|NCT01727141|334767|P2|NOT COMPLETED|Overall Study||9
136950|NCT01727141|334768|P1|NOT COMPLETED|Overall Study||5
136951|NCT01727141|334765|P4|COMPLETED|Overall Study||246
136952|NCT01727141|334766|P3|COMPLETED|Overall Study||258
136953|NCT01727141|334767|P2|COMPLETED|Overall Study||251
136954|NCT01727141|334768|P1|COMPLETED|Overall Study||255
136955|NCT01727141|334765|P4|Full Analysis Set|Overall Study||261
136956|NCT01727141|334766|P3|Full Analysis Set|Overall Study||261
136957|NCT01727141|334767|P2|Full Analysis Set|Overall Study||260
136958|NCT01727141|334768|P1|Full Analysis Set|Overall Study||258
136959|NCT01727141|334765|P4|Safety Set|Overall Study||260
136960|NCT01727141|334766|P3|Safety Set|Overall Study||262
136961|NCT01727141|334767|P2|Safety Set|Overall Study||260
136962|NCT01727141|334768|P1|Safety Set|Overall Study||258
136963|NCT01727141|334765|P4|STARTED|Overall Study||261
136964|NCT01727141|334766|P3|STARTED|Overall Study||261
136965|NCT01727141|334767|P2|STARTED|Overall Study||260
136966|NCT01727141|334768|P1|STARTED|Overall Study||260
136967|NCT01727089|334820|P2|NOT COMPLETED|Overall Study||0
136968|NCT01727089|334821|P1|NOT COMPLETED|Overall Study||0
136969|NCT01727089|334820|P2|COMPLETED|Overall Study||30
136970|NCT01727089|334821|P1|COMPLETED|Overall Study||29
136971|NCT01727089|334820|P2|STARTED|Overall Study||30
136972|NCT01727089|334821|P1|STARTED|Overall Study||29
136973|NCT01727024|334833|P2|NOT COMPLETED|Period 2||0
136974|NCT01727024|334834|P1|NOT COMPLETED|Period 2||0
136975|NCT01727024|334833|P2|COMPLETED|Period 2||64
136976|NCT01727024|334834|P1|COMPLETED|Period 2||68
136977|NCT01727024|334833|P2|STARTED|Period 2||64
136978|NCT01727024|334834|P1|STARTED|Period 2||68
136979|NCT01727024|334833|P2|NOT COMPLETED|Period 1||4
136980|NCT01727024|334834|P1|NOT COMPLETED|Period 1||3
136981|NCT01727024|334833|P2|COMPLETED|Period 1||64
136982|NCT01727024|334834|P1|COMPLETED|Period 1||68
136983|NCT01727024|334833|P2|STARTED|Period 1||68
136984|NCT01727024|334834|P1|STARTED|Period 1||71
136985|NCT01726803|334849|P2|NOT COMPLETED|Overall Study||1
136986|NCT01726803|334850|P1|NOT COMPLETED|Overall Study||7
136987|NCT01726803|334849|P2|COMPLETED|Overall Study||107
136988|NCT01726803|334850|P1|COMPLETED|Overall Study||105
136989|NCT01726803|334849|P2|STARTED|Overall Study||108
136990|NCT01726803|334850|P1|STARTED|Overall Study||112
136991|NCT01726673|334872|P2|NOT COMPLETED|Overall Study||3
136992|NCT01726673|334873|P1|NOT COMPLETED|Overall Study||6
136993|NCT01726673|334872|P2|COMPLETED|Overall Study||21
136994|NCT01726673|334873|P1|COMPLETED|Overall Study||24
136995|NCT01726673|334872|P2|STARTED|Overall Study||24
136996|NCT01726673|334873|P1|STARTED|Overall Study||30
136997|NCT01726621|334883|P1|NOT COMPLETED|Overall Study||4
136998|NCT01726621|334883|P1|COMPLETED|Overall Study||51
136999|NCT01726621|334883|P1|STARTED|Overall Study||55
137000|NCT01726517|334892|P5|NOT COMPLETED|Overall Study||0
137001|NCT01726517|334893|P4|NOT COMPLETED|Overall Study||0
137002|NCT01726517|334894|P3|NOT COMPLETED|Overall Study||1
137003|NCT01726517|334895|P2|NOT COMPLETED|Overall Study||0
137004|NCT01726517|334896|P1|NOT COMPLETED|Overall Study||0
137005|NCT01726517|334892|P5|COMPLETED|Overall Study||21
137006|NCT01726517|334893|P4|COMPLETED|Overall Study||19
137007|NCT01726517|334894|P3|COMPLETED|Overall Study||18
137008|NCT01726517|334895|P2|COMPLETED|Overall Study||21
137009|NCT01726517|334896|P1|COMPLETED|Overall Study||20
137010|NCT01726517|334892|P5|STARTED|Overall Study||21
137011|NCT01726517|334893|P4|STARTED|Overall Study||19
137012|NCT01726517|334894|P3|STARTED|Overall Study||19
137013|NCT01726517|334895|P2|STARTED|Overall Study||21
137014|NCT01726517|334896|P1|STARTED|Overall Study||20
137015|NCT01726504|334925|P2|NOT COMPLETED|Overall Study||28
137016|NCT01726504|334926|P1|NOT COMPLETED|Overall Study||12
137017|NCT01726504|334925|P2|COMPLETED|Overall Study||511
137018|NCT01726504|334926|P1|COMPLETED|Overall Study||524
137019|NCT01726504|334925|P2|STARTED|Overall Study||539
137020|NCT01726504|334926|P1|STARTED|Overall Study||536
137021|NCT01726335|334952|P1|NOT COMPLETED|Overall Study||24
137022|NCT01726335|334952|P1|COMPLETED|Overall Study||29
137023|NCT01726335|334952|P1|STARTED|Overall Study||53
137024|NCT01726049|334970|P2|NOT COMPLETED|Overall Study||4
137025|NCT01726049|334971|P1|NOT COMPLETED|Overall Study||5
137026|NCT01726049|334970|P2|COMPLETED|Overall Study||22
137027|NCT01726049|334971|P1|COMPLETED|Overall Study||21
137028|NCT01726049|334970|P2|STARTED|Overall Study||26
137029|NCT01726049|334971|P1|STARTED|Overall Study||26
137030|NCT01726036|334985|P2|NOT COMPLETED|Overall Study||7
137031|NCT01726036|334986|P1|NOT COMPLETED|Overall Study||16
137032|NCT01726036|334985|P2|COMPLETED|Overall Study||130
137033|NCT01726036|334986|P1|COMPLETED|Overall Study||121
137034|NCT01726036|334985|P2|STARTED|Overall Study||137
137035|NCT01726036|334986|P1|STARTED|Overall Study||137
137036|NCT01726023|334996|P2|NOT COMPLETED|Overall Study||26
137037|NCT01726023|334997|P1|NOT COMPLETED|Overall Study||29
137038|NCT01726023|334996|P2|COMPLETED|Overall Study||196
137039|NCT01726023|334997|P1|COMPLETED|Overall Study||190
137040|NCT01726023|334996|P2|STARTED|Overall Study||222
137041|NCT01726023|334997|P1|STARTED|Overall Study||219
137042|NCT01725984|335089|P2|NOT COMPLETED|Overall Study||0
137043|NCT01725984|335090|P1|NOT COMPLETED|Overall Study||0
137044|NCT01725984|335089|P2|COMPLETED|Overall Study||41
137045|NCT01725984|335090|P1|COMPLETED|Overall Study||39
137046|NCT01725984|335089|P2|STARTED|Overall Study||41
137047|NCT01725984|335090|P1|STARTED|Overall Study||39
137048|NCT01725815|335116|P2|NOT COMPLETED|Overall Study||0
137049|NCT01725815|335117|P1|NOT COMPLETED|Overall Study||0
137050|NCT01725815|335116|P2|COMPLETED|Overall Study||202
137051|NCT01725815|335117|P1|COMPLETED|Overall Study||198
137052|NCT01725815|335116|P2|STARTED|Overall Study||202
137053|NCT01725815|335117|P1|STARTED|Overall Study||198
137054|NCT01725750|335131|P2|NOT COMPLETED|Overall Study||10
137055|NCT01725750|335132|P1|NOT COMPLETED|Overall Study||2
137056|NCT01725750|335131|P2|COMPLETED|Overall Study||34
137057|NCT01725750|335132|P1|COMPLETED|Overall Study||42
137058|NCT01725750|335131|P2|STARTED|Overall Study||44
137059|NCT01725750|335132|P1|STARTED|Overall Study||44
137060|NCT01725529|335165|P3|NOT COMPLETED|Overall Study||10
137061|NCT01725529|335166|P2|NOT COMPLETED|Overall Study||16
137062|NCT01725529|335167|P1|NOT COMPLETED|Overall Study||15
137063|NCT01725529|335165|P3|COMPLETED|Overall Study||142
137064|NCT01725529|335166|P2|COMPLETED|Overall Study||137
137065|NCT01725529|335167|P1|COMPLETED|Overall Study||137
137066|NCT01725529|335165|P3|STARTED|Overall Study||152
137067|NCT01725529|335166|P2|STARTED|Overall Study||153
137068|NCT01725529|335167|P1|STARTED|Overall Study||152
137069|NCT01725451|335193|P4|NOT COMPLETED|Period 6||0
137070|NCT01725451|335194|P3|NOT COMPLETED|Period 6||0
137071|NCT01725451|335195|P2|NOT COMPLETED|Period 6||0
137072|NCT01725451|335196|P1|NOT COMPLETED|Period 6||0
137073|NCT01725451|335193|P4|COMPLETED|Period 6||7
137074|NCT01725451|335194|P3|COMPLETED|Period 6||6
137075|NCT01725451|335195|P2|COMPLETED|Period 6||6
137076|NCT01725451|335196|P1|COMPLETED|Period 6||7
137077|NCT01725451|335193|P4|STARTED|Period 6||7
137078|NCT01725451|335194|P3|STARTED|Period 6||6
137079|NCT01725451|335195|P2|STARTED|Period 6||6
137080|NCT01725451|335196|P1|STARTED|Period 6||7
137081|NCT01725451|335193|P4|NOT COMPLETED|Washout From Period 5||0
137082|NCT01725451|335194|P3|NOT COMPLETED|Washout From Period 5||0
137083|NCT01725451|335195|P2|NOT COMPLETED|Washout From Period 5||0
137084|NCT01725451|335196|P1|NOT COMPLETED|Washout From Period 5||0
137085|NCT01725451|335193|P4|COMPLETED|Washout From Period 5||7
137086|NCT01725451|335194|P3|COMPLETED|Washout From Period 5||6
137087|NCT01725451|335195|P2|COMPLETED|Washout From Period 5||6
137088|NCT01725451|335196|P1|COMPLETED|Washout From Period 5||7
137089|NCT01725451|335193|P4|STARTED|Washout From Period 5||7
137090|NCT01725451|335194|P3|STARTED|Washout From Period 5||6
137091|NCT01725451|335195|P2|STARTED|Washout From Period 5||6
137092|NCT01725451|335196|P1|STARTED|Washout From Period 5||7
137093|NCT01725451|335193|P4|NOT COMPLETED|Period 5||0
137094|NCT01725451|335194|P3|NOT COMPLETED|Period 5||0
137095|NCT01725451|335195|P2|NOT COMPLETED|Period 5||0
137096|NCT01725451|335196|P1|NOT COMPLETED|Period 5||0
137097|NCT01725451|335193|P4|COMPLETED|Period 5||7
137098|NCT01725451|335194|P3|COMPLETED|Period 5||6
137099|NCT01725451|335195|P2|COMPLETED|Period 5||6
137100|NCT01725451|335196|P1|COMPLETED|Period 5||7
137101|NCT01725451|335193|P4|STARTED|Period 5||7
137102|NCT01725451|335194|P3|STARTED|Period 5||6
137103|NCT01725451|335195|P2|STARTED|Period 5||6
137104|NCT01725451|335196|P1|STARTED|Period 5||7
137105|NCT01725451|335193|P4|NOT COMPLETED|Washout From Period 4||0
137106|NCT01725451|335194|P3|NOT COMPLETED|Washout From Period 4||0
137107|NCT01725451|335195|P2|NOT COMPLETED|Washout From Period 4||0
137108|NCT01725451|335196|P1|NOT COMPLETED|Washout From Period 4||0
137109|NCT01725451|335193|P4|COMPLETED|Washout From Period 4||7
137110|NCT01725451|335194|P3|COMPLETED|Washout From Period 4||6
137111|NCT01725451|335195|P2|COMPLETED|Washout From Period 4||6
137112|NCT01725451|335196|P1|COMPLETED|Washout From Period 4||7
137113|NCT01725451|335193|P4|STARTED|Washout From Period 4||7
137114|NCT01725451|335194|P3|STARTED|Washout From Period 4||6
137115|NCT01725451|335195|P2|STARTED|Washout From Period 4||6
137116|NCT01725451|335196|P1|STARTED|Washout From Period 4||7
137117|NCT01725451|335193|P4|NOT COMPLETED|Period 4||0
137118|NCT01725451|335194|P3|NOT COMPLETED|Period 4||1
137119|NCT01725451|335195|P2|NOT COMPLETED|Period 4||0
137120|NCT01725451|335196|P1|NOT COMPLETED|Period 4||0
137121|NCT01725451|335193|P4|COMPLETED|Period 4||7
137122|NCT01725451|335194|P3|COMPLETED|Period 4||6
137123|NCT01725451|335195|P2|COMPLETED|Period 4||6
137124|NCT01725451|335196|P1|COMPLETED|Period 4||7
137125|NCT01725451|335193|P4|STARTED|Period 4||7
137126|NCT01725451|335194|P3|STARTED|Period 4||7
137127|NCT01725451|335195|P2|STARTED|Period 4||6
137128|NCT01725451|335196|P1|STARTED|Period 4||7
137129|NCT01725451|335193|P4|NOT COMPLETED|Washout From Period 3||0
137130|NCT01725451|335194|P3|NOT COMPLETED|Washout From Period 3||1
137131|NCT01725451|335195|P2|NOT COMPLETED|Washout From Period 3||1
137132|NCT01725451|335196|P1|NOT COMPLETED|Washout From Period 3||0
137133|NCT01725451|335193|P4|COMPLETED|Washout From Period 3||7
137134|NCT01725451|335194|P3|COMPLETED|Washout From Period 3||7
137135|NCT01725451|335195|P2|COMPLETED|Washout From Period 3||6
137136|NCT01725451|335196|P1|COMPLETED|Washout From Period 3||7
137137|NCT01725451|335193|P4|STARTED|Washout From Period 3||7
137138|NCT01725451|335194|P3|STARTED|Washout From Period 3||8
137139|NCT01725451|335195|P2|STARTED|Washout From Period 3||7
137140|NCT01725451|335196|P1|STARTED|Washout From Period 3||7
137141|NCT01725451|335193|P4|NOT COMPLETED|Period 3||0
137142|NCT01725451|335194|P3|NOT COMPLETED|Period 3||0
137143|NCT01725451|335195|P2|NOT COMPLETED|Period 3||0
137144|NCT01725451|335196|P1|NOT COMPLETED|Period 3||0
137145|NCT01725451|335193|P4|COMPLETED|Period 3||7
137146|NCT01725451|335194|P3|COMPLETED|Period 3||8
137147|NCT01725451|335195|P2|COMPLETED|Period 3||7
137148|NCT01725451|335196|P1|COMPLETED|Period 3||7
137149|NCT01725451|335193|P4|STARTED|Period 3||7
137150|NCT01725451|335194|P3|STARTED|Period 3||8
137151|NCT01725451|335195|P2|STARTED|Period 3||7
137152|NCT01725451|335196|P1|STARTED|Period 3||7
137153|NCT01725451|335193|P4|NOT COMPLETED|Washout From Period 2||0
137154|NCT01725451|335194|P3|NOT COMPLETED|Washout From Period 2||0
137155|NCT01725451|335195|P2|NOT COMPLETED|Washout From Period 2||0
137156|NCT01725451|335196|P1|NOT COMPLETED|Washout From Period 2||0
137157|NCT01725451|335193|P4|COMPLETED|Washout From Period 2||7
137158|NCT01725451|335194|P3|COMPLETED|Washout From Period 2||8
137159|NCT01725451|335195|P2|COMPLETED|Washout From Period 2||7
137160|NCT01725451|335196|P1|COMPLETED|Washout From Period 2||7
137161|NCT01725451|335193|P4|STARTED|Washout From Period 2||7
137162|NCT01725451|335194|P3|STARTED|Washout From Period 2||8
137163|NCT01725451|335195|P2|STARTED|Washout From Period 2||7
137164|NCT01725451|335196|P1|STARTED|Washout From Period 2||7
137165|NCT01725451|335193|P4|NOT COMPLETED|Period 2||0
137166|NCT01725451|335194|P3|NOT COMPLETED|Period 2||0
137167|NCT01725451|335195|P2|NOT COMPLETED|Period 2||0
137168|NCT01725451|335196|P1|NOT COMPLETED|Period 2||0
137169|NCT01725451|335193|P4|COMPLETED|Period 2||7
137170|NCT01725451|335194|P3|COMPLETED|Period 2||8
137171|NCT01725451|335195|P2|COMPLETED|Period 2||7
137172|NCT01725451|335196|P1|COMPLETED|Period 2||7
137173|NCT01725451|335193|P4|STARTED|Period 2||7
137174|NCT01725451|335194|P3|STARTED|Period 2||8
137175|NCT01725451|335195|P2|STARTED|Period 2||7
137176|NCT01725451|335196|P1|STARTED|Period 2||7
137177|NCT01725451|335193|P4|NOT COMPLETED|Washout From Period 1||0
137178|NCT01725451|335194|P3|NOT COMPLETED|Washout From Period 1||0
137179|NCT01725451|335195|P2|NOT COMPLETED|Washout From Period 1||0
137180|NCT01725451|335196|P1|NOT COMPLETED|Washout From Period 1||0
137181|NCT01725451|335193|P4|COMPLETED|Washout From Period 1||7
137182|NCT01725451|335194|P3|COMPLETED|Washout From Period 1||8
137183|NCT01725451|335195|P2|COMPLETED|Washout From Period 1||7
137184|NCT01725451|335196|P1|COMPLETED|Washout From Period 1||7
137185|NCT01725451|335193|P4|STARTED|Washout From Period 1||7
137186|NCT01725451|335194|P3|STARTED|Washout From Period 1||8
137187|NCT01725451|335195|P2|STARTED|Washout From Period 1||7
137188|NCT01725451|335196|P1|STARTED|Washout From Period 1||7
137189|NCT01725451|335193|P4|NOT COMPLETED|Period 1||0
137190|NCT01725451|335194|P3|NOT COMPLETED|Period 1||0
137191|NCT01725451|335195|P2|NOT COMPLETED|Period 1||0
137192|NCT01725451|335196|P1|NOT COMPLETED|Period 1||1
137193|NCT01725451|335193|P4|COMPLETED|Period 1||7
137194|NCT01725451|335194|P3|COMPLETED|Period 1||8
137195|NCT01725451|335195|P2|COMPLETED|Period 1||7
137196|NCT01725451|335196|P1|COMPLETED|Period 1||7
137197|NCT01725451|335193|P4|STARTED|Period 1||7
137198|NCT01725451|335194|P3|STARTED|Period 1||8
137199|NCT01725451|335195|P2|STARTED|Period 1||7
137200|NCT01725451|335196|P1|STARTED|Period 1||8
137201|NCT01725386|335218|P2|NOT COMPLETED|Overall Study||46
137202|NCT01725386|335219|P1|NOT COMPLETED|Overall Study||175
137203|NCT01725386|335218|P2|COMPLETED|Overall Study||17
137204|NCT01725386|335219|P1|COMPLETED|Overall Study||13
137205|NCT01725386|335218|P2|STARTED|Overall Study||63
137206|NCT01725386|335219|P1|STARTED|Overall Study||188
137207|NCT01725308|335238|P3|NOT COMPLETED|Treatment Period II||64
137208|NCT01725308|335239|P2|NOT COMPLETED|Treatment Period II||29
137209|NCT01725308|335240|P1|NOT COMPLETED|Treatment Period II||55
137210|NCT01725308|335238|P3|COMPLETED|Treatment Period II||74
137211|NCT01725308|335239|P2|COMPLETED|Treatment Period II||31
137212|NCT01725308|335240|P1|COMPLETED|Treatment Period II||79
137213|NCT01725308|335238|P3|Treated|Treatment Period II||130
137214|NCT01725308|335239|P2|Treated|Treatment Period II||53
137215|NCT01725308|335240|P1|Treated|Treatment Period II||120
137216|NCT01725308|335238|P3|STARTED|Treatment Period II||138
137217|NCT01725308|335239|P2|STARTED|Treatment Period II||60
137218|NCT01725308|335240|P1|STARTED|Treatment Period II||134
137219|NCT01725308|335238|P3|NOT COMPLETED|Treatment Period I||41
137220|NCT01725308|335239|P2|NOT COMPLETED|Treatment Period I||14
137221|NCT01725308|335240|P1|NOT COMPLETED|Treatment Period I||44
137222|NCT01725308|335238|P3|COMPLETED|Treatment Period I||138
137223|NCT01725308|335239|P2|COMPLETED|Treatment Period I||60
137224|NCT01725308|335240|P1|COMPLETED|Treatment Period I||134
137225|NCT01725308|335238|P3|Treated|Treatment Period I||179
137226|NCT01725308|335239|P2|Treated|Treatment Period I||74
137227|NCT01725308|335240|P1|Treated|Treatment Period I||177
137228|NCT01725308|335238|P3|STARTED|Treatment Period I||179
137229|NCT01725308|335239|P2|STARTED|Treatment Period I||74
137230|NCT01725308|335240|P1|STARTED|Treatment Period I||178
137231|NCT01725282|335387|P4|NOT COMPLETED|Overall Study||7
137232|NCT01725282|335388|P3|NOT COMPLETED|Overall Study||8
137233|NCT01725282|335389|P2|NOT COMPLETED|Overall Study||5
137234|NCT01725282|335390|P1|NOT COMPLETED|Overall Study||2
137235|NCT01725282|335387|P4|COMPLETED|Overall Study||36
137236|NCT01725282|335388|P3|COMPLETED|Overall Study||33
137237|NCT01725282|335389|P2|COMPLETED|Overall Study||39
137238|NCT01725282|335390|P1|COMPLETED|Overall Study||42
137239|NCT01725282|335387|P4|STARTED|Overall Study||43
137240|NCT01725282|335388|P3|STARTED|Overall Study||41
137241|NCT01725282|335389|P2|STARTED|Overall Study||44
137242|NCT01725282|335390|P1|STARTED|Overall Study||44
137243|NCT01725217|335423|P3|NOT COMPLETED|Overall Study||0
137244|NCT01725217|335424|P2|NOT COMPLETED|Overall Study||0
137245|NCT01725217|335425|P1|NOT COMPLETED|Overall Study||1
137246|NCT01725217|335423|P3|COMPLETED|Overall Study||66
137247|NCT01725217|335424|P2|COMPLETED|Overall Study||66
137248|NCT01725217|335425|P1|COMPLETED|Overall Study||65
137249|NCT01725217|335423|P3|STARTED|Overall Study||66
137250|NCT01725217|335424|P2|STARTED|Overall Study||66
137251|NCT01725217|335425|P1|STARTED|Overall Study||66
137252|NCT01725126|335459|P6|NOT COMPLETED|Overall Study||0
137253|NCT01725126|335460|P5|NOT COMPLETED|Overall Study||0
137254|NCT01725126|335461|P4|NOT COMPLETED|Overall Study||1
137255|NCT01725126|335462|P3|NOT COMPLETED|Overall Study||0
137256|NCT01725126|335463|P2|NOT COMPLETED|Overall Study||1
137257|NCT01725126|335464|P1|NOT COMPLETED|Overall Study||0
137258|NCT01725126|335459|P6|COMPLETED|Overall Study||12
137259|NCT01725126|335460|P5|COMPLETED|Overall Study||6
137260|NCT01725126|335461|P4|COMPLETED|Overall Study||13
137261|NCT01725126|335462|P3|COMPLETED|Overall Study||6
137262|NCT01725126|335463|P2|COMPLETED|Overall Study||10
137263|NCT01725126|335464|P1|COMPLETED|Overall Study||4
137264|NCT01725126|335459|P6|STARTED|Overall Study||12
137265|NCT01725126|335460|P5|STARTED|Overall Study||6
137266|NCT01725126|335461|P4|STARTED|Overall Study||14
137267|NCT01725126|335462|P3|STARTED|Overall Study||6
137268|NCT01725126|335463|P2|STARTED|Overall Study||11
137269|NCT01725126|335464|P1|STARTED|Overall Study||4
137270|NCT01724528|335662|P2|NOT COMPLETED|Overall Study||3
137271|NCT01724528|335663|P1|NOT COMPLETED|Overall Study||4
137272|NCT01724528|335662|P2|COMPLETED|Overall Study||170
137273|NCT01724528|335663|P1|COMPLETED|Overall Study||169
137274|NCT01724528|335662|P2|STARTED|Overall Study||173
137275|NCT01724528|335663|P1|STARTED|Overall Study||173
137276|NCT01724359|335677|P1|NOT COMPLETED|Overall Study||31
137277|NCT01724359|335677|P1|COMPLETED|Overall Study||64
137278|NCT01724359|335677|P1|STARTED|Overall Study||95
137279|NCT01724216|335690|P1|NOT COMPLETED|Overall Study||1
137280|NCT01724216|335690|P1|COMPLETED|Overall Study||10
137281|NCT01724216|335690|P1|STARTED|Overall Study||11
137282|NCT01724177|335694|P1|NOT COMPLETED|Overall Study||26
137283|NCT01724177|335694|P1|COMPLETED|Overall Study||0
137284|NCT01724177|335694|P1|Safety Population|Overall Study|Safety Population includes participants who received at least one dose of lenalidomide|26
137285|NCT01724177|335694|P1|STARTED|Overall Study||26
137286|NCT01724021|335707|P2|NOT COMPLETED|Overall Study||133
137287|NCT01724021|335708|P1|NOT COMPLETED|Overall Study||127
137288|NCT01724021|335707|P2|COMPLETED|Overall Study||236
137289|NCT01724021|335708|P1|COMPLETED|Overall Study||244
137290|NCT01724021|335707|P2|STARTED|Overall Study||369
137291|NCT01724021|335708|P1|STARTED|Overall Study||371
137292|NCT01723904|335740|P1|NOT COMPLETED|Overall Study||11
137293|NCT01723904|335740|P1|COMPLETED|Overall Study||79
137294|NCT01723904|335740|P1|STARTED|Overall Study||90
137295|NCT01723722|335752|P2|NOT COMPLETED|Overall Study||0
137296|NCT01723722|335753|P1|NOT COMPLETED|Overall Study||0
137297|NCT01723722|335752|P2|COMPLETED|Overall Study||20
137298|NCT01723722|335753|P1|COMPLETED|Overall Study||20
137299|NCT01723722|335752|P2|STARTED|Overall Study||20
137300|NCT01723722|335753|P1|STARTED|Overall Study||20
137301|NCT01723696|335761|P2|NOT COMPLETED|Overall Study||13
137302|NCT01723696|335762|P1|NOT COMPLETED|Overall Study||17
137303|NCT01723696|335761|P2|COMPLETED|Overall Study||113
137304|NCT01723696|335762|P1|COMPLETED|Overall Study||109
137305|NCT01723696|335761|P2|STARTED|Overall Study||126
137306|NCT01723696|335762|P1|STARTED|Overall Study||126
137307|NCT01723514|335782|P8|NOT COMPLETED|Overall Study||0
137308|NCT01723514|335783|P7|NOT COMPLETED|Overall Study||0
137309|NCT01723514|335784|P6|NOT COMPLETED|Overall Study||0
137310|NCT01723514|335785|P5|NOT COMPLETED|Overall Study||0
137311|NCT01723514|335786|P4|NOT COMPLETED|Overall Study||0
137312|NCT01723514|335787|P3|NOT COMPLETED|Overall Study||0
137313|NCT01723514|335788|P2|NOT COMPLETED|Overall Study||0
137314|NCT01723514|335789|P1|NOT COMPLETED|Overall Study||0
137315|NCT01723514|335782|P8|COMPLETED|Overall Study||6
137316|NCT01723514|335783|P7|COMPLETED|Overall Study||6
137317|NCT01723514|335784|P6|COMPLETED|Overall Study||4
137318|NCT01723514|335785|P5|COMPLETED|Overall Study||6
137319|NCT01723514|335786|P4|COMPLETED|Overall Study||6
137320|NCT01723514|335787|P3|COMPLETED|Overall Study||6
137321|NCT01723514|335788|P2|COMPLETED|Overall Study||6
137322|NCT01723514|335789|P1|COMPLETED|Overall Study||8
137323|NCT01723514|335782|P8|STARTED|Overall Study||6
137324|NCT01723514|335783|P7|STARTED|Overall Study||6
137325|NCT01723514|335784|P6|STARTED|Overall Study||4
137326|NCT01723514|335785|P5|STARTED|Overall Study||6
137327|NCT01723514|335786|P4|STARTED|Overall Study||6
137328|NCT01723514|335787|P3|STARTED|Overall Study||6
137329|NCT01723514|335788|P2|STARTED|Overall Study||6
137330|NCT01723514|335789|P1|STARTED|Overall Study||8
137331|NCT01723397|335865|P2|NOT COMPLETED|Study Period 2||1
137332|NCT01723397|335866|P1|NOT COMPLETED|Study Period 2||0
137333|NCT01723397|335865|P2|COMPLETED|Study Period 2||5
137334|NCT01723397|335866|P1|COMPLETED|Study Period 2||7
137335|NCT01723397|335865|P2|STARTED|Study Period 2||6
137336|NCT01723397|335866|P1|STARTED|Study Period 2||7
137337|NCT01723397|335865|P2|NOT COMPLETED|Washout||0
137338|NCT01723397|335866|P1|NOT COMPLETED|Washout||0
137339|NCT01723397|335865|P2|COMPLETED|Washout||6
137340|NCT01723397|335866|P1|COMPLETED|Washout||7
137341|NCT01723397|335865|P2|STARTED|Washout||6
137342|NCT01723397|335866|P1|STARTED|Washout||7
137343|NCT01723397|335865|P2|NOT COMPLETED|Study Period 1||1
137344|NCT01723397|335866|P1|NOT COMPLETED|Study Period 1||0
137345|NCT01723397|335865|P2|COMPLETED|Study Period 1||6
137346|NCT01723397|335866|P1|COMPLETED|Study Period 1||7
137347|NCT01723397|335865|P2|STARTED|Study Period 1||7
137348|NCT01723397|335866|P1|STARTED|Study Period 1||7
137349|NCT01723384|335874|P2|NOT COMPLETED|Overall Study||0
137350|NCT01723384|335875|P1|NOT COMPLETED|Overall Study||0
137351|NCT01723384|335874|P2|COMPLETED|Overall Study||15
137352|NCT01723384|335875|P1|COMPLETED|Overall Study||15
137353|NCT01723384|335874|P2|STARTED|Overall Study||15
137354|NCT01723384|335875|P1|STARTED|Overall Study||15
137355|NCT01723254|335893|P8|NOT COMPLETED|Overall Study||3
137356|NCT01723254|335894|P7|NOT COMPLETED|Overall Study||1
137357|NCT01723254|335895|P6|NOT COMPLETED|Overall Study||2
137358|NCT01723254|335896|P5|NOT COMPLETED|Overall Study||2
137359|NCT01723254|335897|P4|NOT COMPLETED|Overall Study||2
137360|NCT01723254|335898|P3|NOT COMPLETED|Overall Study||3
137361|NCT01723254|335899|P2|NOT COMPLETED|Overall Study||3
137362|NCT01723254|335900|P1|NOT COMPLETED|Overall Study||1
137363|NCT01723254|335893|P8|COMPLETED|Overall Study||60
137364|NCT01723254|335894|P7|COMPLETED|Overall Study||19
137365|NCT01723254|335895|P6|COMPLETED|Overall Study||18
137366|NCT01723254|335896|P5|COMPLETED|Overall Study||18
137367|NCT01723254|335897|P4|COMPLETED|Overall Study||18
137368|NCT01723254|335898|P3|COMPLETED|Overall Study||17
137369|NCT01723254|335899|P2|COMPLETED|Overall Study||18
137370|NCT01723254|335900|P1|COMPLETED|Overall Study||5
137371|NCT01723254|335893|P8|STARTED|Overall Study||63
137372|NCT01723254|335894|P7|STARTED|Overall Study||20
137373|NCT01723254|335895|P6|STARTED|Overall Study||20
137374|NCT01723254|335896|P5|STARTED|Overall Study||20
137375|NCT01723254|335897|P4|STARTED|Overall Study||20
137376|NCT01723254|335898|P3|STARTED|Overall Study||20
137377|NCT01723254|335899|P2|STARTED|Overall Study||21
137378|NCT01723254|335900|P1|STARTED|Overall Study||6
137379|NCT01723228|335952|P2|NOT COMPLETED|Overall Study||11
137380|NCT01723228|335953|P1|NOT COMPLETED|Overall Study||8
137381|NCT01723228|335952|P2|COMPLETED|Overall Study||73
137382|NCT01723228|335953|P1|COMPLETED|Overall Study||78
137383|NCT01723228|335952|P2|STARTED|Overall Study||84
137384|NCT01723228|335953|P1|STARTED|Overall Study||86
137385|NCT01723163|335971|P2|NOT COMPLETED|12-Month Follow-up||28
137386|NCT01723163|335972|P1|NOT COMPLETED|12-Month Follow-up||24
137387|NCT01723163|335971|P2|COMPLETED|12-Month Follow-up||119
137388|NCT01723163|335972|P1|COMPLETED|12-Month Follow-up||111
137389|NCT01723163|335971|P2|STARTED|12-Month Follow-up||147
137390|NCT01723163|335972|P1|STARTED|12-Month Follow-up||135
137391|NCT01723163|335971|P2|NOT COMPLETED|6-Month Follow-up||15
137392|NCT01723163|335972|P1|NOT COMPLETED|6-Month Follow-up||18
137393|NCT01723163|335971|P2|COMPLETED|6-Month Follow-up||132
137394|NCT01723163|335972|P1|COMPLETED|6-Month Follow-up||118
137395|NCT01723163|335971|P2|STARTED|6-Month Follow-up||147
137396|NCT01723163|335972|P1|STARTED|6-Month Follow-up||136
137397|NCT01723163|335971|P2|NOT COMPLETED|3-Month Follow-up||19
137398|NCT01723163|335972|P1|NOT COMPLETED|3-Month Follow-up||13
137399|NCT01723163|335971|P2|COMPLETED|3-Month Follow-up||128
137400|NCT01723163|335972|P1|COMPLETED|3-Month Follow-up||124
137401|NCT01723163|335971|P2|STARTED|3-Month Follow-up||147
137402|NCT01723163|335972|P1|STARTED|3-Month Follow-up||137
137403|NCT01723163|335971|P2|NOT COMPLETED|Treatment Phase||7
137404|NCT01723163|335972|P1|NOT COMPLETED|Treatment Phase||19
137405|NCT01723163|335971|P2|COMPLETED|Treatment Phase||147
137406|NCT01723163|335972|P1|COMPLETED|Treatment Phase||137
137407|NCT01723163|335971|P2|STARTED|Treatment Phase||154
137408|NCT01723163|335972|P1|STARTED|Treatment Phase||156
137409|NCT01723163|335971|P2|NOT COMPLETED|Baseline||0
137410|NCT01723163|335972|P1|NOT COMPLETED|Baseline||0
137411|NCT01723163|335971|P2|COMPLETED|Baseline||154
137412|NCT01723163|335972|P1|COMPLETED|Baseline||156
137413|NCT01723163|335971|P2|STARTED|Baseline||154
137414|NCT01723163|335972|P1|STARTED|Baseline||156
137415|NCT01722994|335980|P2|NOT COMPLETED|Overall Study||17
137416|NCT01722994|335981|P1|NOT COMPLETED|Overall Study||25
137417|NCT01722994|335980|P2|COMPLETED|Overall Study||31
137418|NCT01722994|335981|P1|COMPLETED|Overall Study||24
137419|NCT01722994|335980|P2|STARTED|Overall Study||48
137420|NCT01722994|335981|P1|STARTED|Overall Study||49
137421|NCT01722929|335995|P1|NOT COMPLETED|Overall Study||0
137422|NCT01722929|335995|P1|COMPLETED|Overall Study||4
137423|NCT01722929|335995|P1|STARTED|Overall Study||4
137424|NCT01722877|336000|P1|NOT COMPLETED|Overall Study||2
137425|NCT01722877|336000|P1|COMPLETED|Overall Study||27
137426|NCT01722877|336000|P1|STARTED|Overall Study||29
137427|NCT01722734|336010|P3|NOT COMPLETED|Overall Study||2
137428|NCT01722734|336011|P2|NOT COMPLETED|Overall Study||1
137429|NCT01722734|336012|P1|NOT COMPLETED|Overall Study||2
137430|NCT01722734|336010|P3|COMPLETED|Overall Study||307
137431|NCT01722734|336011|P2|COMPLETED|Overall Study||276
137432|NCT01722734|336012|P1|COMPLETED|Overall Study||552
137433|NCT01722734|336010|P3|STARTED|Overall Study||309
137434|NCT01722734|336011|P2|STARTED|Overall Study||277
137435|NCT01722734|336012|P1|STARTED|Overall Study||554
137436|NCT01722643|336022|P2|NOT COMPLETED|Overall Study||1
137437|NCT01722643|336023|P1|NOT COMPLETED|Overall Study||0
137438|NCT01722643|336022|P2|COMPLETED|Overall Study||30
137439|NCT01722643|336023|P1|COMPLETED|Overall Study||30
137440|NCT01722643|336022|P2|STARTED|Overall Study||31
137441|NCT01722643|336023|P1|STARTED|Overall Study||30
137442|NCT01722552|336031|P1|NOT COMPLETED|Overall Study||4
137443|NCT01722552|336031|P1|COMPLETED|Overall Study|Number of subjects who completed the intervention|116
137444|NCT01722552|336031|P1|STARTED|Overall Study|Number of subjects enrolled|120
137445|NCT01722487|336041|P2|NOT COMPLETED|Overall Study||7
137446|NCT01722487|336042|P1|NOT COMPLETED|Overall Study||2
137447|NCT01722487|336041|P2|COMPLETED|Overall Study|Participants who were still on study or died at study closure|126
137448|NCT01722487|336042|P1|COMPLETED|Overall Study|Participants who were still on study or died at study closure|134
137449|NCT01722487|336041|P2|STARTED|Overall Study||133
137450|NCT01722487|336042|P1|STARTED|Overall Study||136
137451|NCT01722435|336060|P1|NOT COMPLETED|Overall Study||0
137452|NCT01722435|336060|P1|COMPLETED|Overall Study||78
137453|NCT01722435|336060|P1|STARTED|Overall Study||78
137454|NCT01722331|336071|P7|NOT COMPLETED|Part 3||2
137455|NCT01722331|336072|P6|NOT COMPLETED|Part 3||3
137456|NCT01722331|336073|P5|NOT COMPLETED|Part 3||0
137457|NCT01722331|336074|P4|NOT COMPLETED|Part 3||1
137458|NCT01722331|336075|P3|NOT COMPLETED|Part 3||0
137459|NCT01722331|336076|P2|NOT COMPLETED|Part 3||17
137460|NCT01722331|336077|P1|NOT COMPLETED|Part 3||15
137461|NCT01722331|336071|P7|COMPLETED|Part 3||65
137462|NCT01722331|336072|P6|COMPLETED|Part 3||59
137463|NCT01722331|336073|P5|COMPLETED|Part 3||0
137464|NCT01722331|336074|P4|COMPLETED|Part 3||18
137465|NCT01722331|336075|P3|COMPLETED|Part 3||0
137466|NCT01722331|336076|P2|COMPLETED|Part 3||232
137467|NCT01722331|336077|P1|COMPLETED|Part 3||264
137468|NCT01722331|336071|P7|STARTED|Part 3||67
137469|NCT01722331|336072|P6|STARTED|Part 3||62
137470|NCT01722331|336073|P5|STARTED|Part 3||0
137471|NCT01722331|336074|P4|STARTED|Part 3||19
137472|NCT01722331|336075|P3|STARTED|Part 3||0
137473|NCT01722331|336076|P2|STARTED|Part 3||249
137474|NCT01722331|336077|P1|STARTED|Part 3||279
137475|NCT01722331|336071|P7|NOT COMPLETED|Part 2||7
137476|NCT01722331|336072|P6|NOT COMPLETED|Part 2||10
137477|NCT01722331|336073|P5|NOT COMPLETED|Part 2||0
137478|NCT01722331|336074|P4|NOT COMPLETED|Part 2||0
137479|NCT01722331|336075|P3|NOT COMPLETED|Part 2||31
137480|NCT01722331|336076|P2|NOT COMPLETED|Part 2||0
137481|NCT01722331|336077|P1|NOT COMPLETED|Part 2||19
137482|NCT01722331|336071|P7|COMPLETED|Part 2||67
137483|NCT01722331|336072|P6|COMPLETED|Part 2||62
137484|NCT01722331|336073|P5|COMPLETED|Part 2||0
137485|NCT01722331|336074|P4|COMPLETED|Part 2||19
137486|NCT01722331|336075|P3|COMPLETED|Part 2||0
137487|NCT01722331|336076|P2|COMPLETED|Part 2||249
137488|NCT01722331|336077|P1|COMPLETED|Part 2||279
137489|NCT01722331|336071|P7|STARTED|Part 2||74
137490|NCT01722331|336072|P6|STARTED|Part 2||72
137491|NCT01722331|336073|P5|STARTED|Part 2||0
137492|NCT01722331|336074|P4|STARTED|Part 2||19
137493|NCT01722331|336075|P3|STARTED|Part 2|1 participant who completed Part 1 did not enter Part 2|31
137494|NCT01722331|336076|P2|STARTED|Part 2||249
137495|NCT01722331|336077|P1|STARTED|Part 2||298
137496|NCT01722331|336071|P7|NOT COMPLETED|Part 1||0
137497|NCT01722331|336072|P6|NOT COMPLETED|Part 1||0
137498|NCT01722331|336073|P5|NOT COMPLETED|Part 1||9
137499|NCT01722331|336074|P4|NOT COMPLETED|Part 1||0
137500|NCT01722331|336075|P3|NOT COMPLETED|Part 1||9
137501|NCT01722331|336076|P2|NOT COMPLETED|Part 1||0
137502|NCT01722331|336077|P1|NOT COMPLETED|Part 1||10
137503|NCT01722331|336071|P7|COMPLETED|Part 1||74
137504|NCT01722331|336072|P6|COMPLETED|Part 1||72
137505|NCT01722331|336073|P5|COMPLETED|Part 1||0
137506|NCT01722331|336074|P4|COMPLETED|Part 1||19
137507|NCT01722331|336075|P3|COMPLETED|Part 1||32
137508|NCT01722331|336076|P2|COMPLETED|Part 1||249
137509|NCT01722331|336077|P1|COMPLETED|Part 1||298
137510|NCT01722331|336071|P7|STARTED|Part 1||74
137511|NCT01722331|336072|P6|STARTED|Part 1||72
137512|NCT01722331|336073|P5|STARTED|Part 1||9
137513|NCT01722331|336074|P4|STARTED|Part 1||19
137514|NCT01722331|336075|P3|STARTED|Part 1||41
137515|NCT01722331|336076|P2|STARTED|Part 1||249
137516|NCT01722331|336077|P1|STARTED|Part 1||308
137517|NCT01722318|336121|P5|NOT COMPLETED|Overall Study||18
137518|NCT01722318|336122|P4|NOT COMPLETED|Overall Study||20
137519|NCT01722318|336123|P3|NOT COMPLETED|Overall Study||20
137520|NCT01722318|336124|P2|NOT COMPLETED|Overall Study||20
137521|NCT01722318|336125|P1|NOT COMPLETED|Overall Study||14
137522|NCT01722318|336121|P5|COMPLETED|Overall Study||68
137523|NCT01722318|336122|P4|COMPLETED|Overall Study||65
137524|NCT01722318|336123|P3|COMPLETED|Overall Study||66
137525|NCT01722318|336124|P2|COMPLETED|Overall Study||65
137526|NCT01722318|336125|P1|COMPLETED|Overall Study||72
137527|NCT01722318|336121|P5|STARTED|Overall Study||86
137528|NCT01722318|336122|P4|STARTED|Overall Study||85
137529|NCT01722318|336123|P3|STARTED|Overall Study||86
137530|NCT01722318|336124|P2|STARTED|Overall Study||85
137531|NCT01722318|336125|P1|STARTED|Overall Study||86
137532|NCT01722292|336155|P3|NOT COMPLETED|Overall Study||0
137533|NCT01722292|336156|P2|NOT COMPLETED|Overall Study||0
137534|NCT01722292|336157|P1|NOT COMPLETED|Overall Study||0
137535|NCT01722292|336155|P3|COMPLETED|Overall Study||14
137536|NCT01722292|336156|P2|COMPLETED|Overall Study||6
137537|NCT01722292|336157|P1|COMPLETED|Overall Study||6
137538|NCT01722292|336155|P3|Received at Least One Dose of Study Drug|Overall Study||14
137539|NCT01722292|336156|P2|Received at Least One Dose of Study Drug|Overall Study||6
137540|NCT01722292|336157|P1|Received at Least One Dose of Study Drug|Overall Study||6
137541|NCT01722292|336155|P3|STARTED|Overall Study||14
137542|NCT01722292|336156|P2|STARTED|Overall Study||6
137543|NCT01722292|336157|P1|STARTED|Overall Study||6
137544|NCT01722266|336193|P4|NOT COMPLETED|Overall Study||0
137545|NCT01722266|336194|P3|NOT COMPLETED|Overall Study||5
137546|NCT01722266|336195|P2|NOT COMPLETED|Overall Study||3
137547|NCT01722266|336196|P1|NOT COMPLETED|Overall Study||1
137548|NCT01722266|336193|P4|COMPLETED|Overall Study|3 subjects randomized to 1.2 mg group and 1 to 1.8 mg group tolerated only 0.6 mg|18
137549|NCT01722266|336194|P3|COMPLETED|Overall Study||13
137550|NCT01722266|336195|P2|COMPLETED|Overall Study||15
137551|NCT01722266|336196|P1|COMPLETED|Overall Study||17
137552|NCT01722266|336193|P4|STARTED|Overall Study|3 withdrew consent; 1 dropped out due to nausea|18
137553|NCT01722266|336194|P3|STARTED|Overall Study||18
137554|NCT01722266|336195|P2|STARTED|Overall Study||18
137555|NCT01722266|336196|P1|STARTED|Overall Study||18
137556|NCT01722162|336224|P2|NOT COMPLETED|Overall Study||6
137557|NCT01722162|336225|P1|NOT COMPLETED|Overall Study||5
137558|NCT01722162|336224|P2|COMPLETED|Overall Study||18
137559|NCT01722162|336225|P1|COMPLETED|Overall Study||18
137560|NCT01722162|336224|P2|STARTED|Overall Study||24
137561|NCT01722162|336225|P1|STARTED|Overall Study||23
137562|NCT01722097|336235|P2|NOT COMPLETED|Overall Study||5
137563|NCT01722097|336236|P1|NOT COMPLETED|Overall Study||6
137564|NCT01722097|336235|P2|COMPLETED|Overall Study||50
137565|NCT01722097|336236|P1|COMPLETED|Overall Study||49
137566|NCT01722097|336235|P2|STARTED|Overall Study||55
137567|NCT01722097|336236|P1|STARTED|Overall Study||55
137568|NCT01722071|336244|P2|NOT COMPLETED|Overall Study||0
137569|NCT01722071|336245|P1|NOT COMPLETED|Overall Study||1
137570|NCT01722071|336244|P2|COMPLETED|Overall Study||10
137571|NCT01722071|336245|P1|COMPLETED|Overall Study||9
137572|NCT01722071|336244|P2|STARTED|Overall Study||10
137573|NCT01722071|336245|P1|STARTED|Overall Study||10
137574|NCT01722045|336251|P1|NOT COMPLETED|Overall Study||28
137575|NCT01722045|336251|P1|COMPLETED|Overall Study||126
137576|NCT01722045|336251|P1|STARTED|Overall Study||154
137577|NCT01721967|336261|P1|NOT COMPLETED|Overall Study||3
137578|NCT01721967|336261|P1|COMPLETED|Overall Study||11
137579|NCT01721967|336261|P1|STARTED|Overall Study||14
137580|NCT01721954|336272|P2|NOT COMPLETED|Overall Study||69
137581|NCT01721954|336273|P1|NOT COMPLETED|Overall Study||70
137582|NCT01721954|336272|P2|COMPLETED|Overall Study||35
137583|NCT01721954|336273|P1|COMPLETED|Overall Study||35
137584|NCT01721954|336272|P2|STARTED|Overall Study||104
137585|NCT01721954|336273|P1|STARTED|Overall Study||105
137586|NCT01721837|336281|P1|NOT COMPLETED|Overall Study||0
137587|NCT01721837|336281|P1|COMPLETED|Overall Study||2120
137588|NCT01721837|336281|P1|STARTED|Overall Study||2120
137589|NCT01721772|336287|P2|NOT COMPLETED|Overall Study||192
137590|NCT01721772|336288|P1|NOT COMPLETED|Overall Study||111
137591|NCT01721772|336287|P2|COMPLETED|Overall Study|Continuing in treatment period|13
137592|NCT01721772|336288|P1|COMPLETED|Overall Study|Continuing in treatment period|95
137593|NCT01721772|336287|P2|STARTED|Overall Study||205
137594|NCT01721772|336288|P1|STARTED|Overall Study||206
137595|NCT01721759|336308|P1|NOT COMPLETED|Overall Study||102
137596|NCT01721759|336308|P1|COMPLETED|Overall Study|Completed=continuing to receive treatment|15
137597|NCT01721759|336308|P1|STARTED|Overall Study||117
137598|NCT01721746|336316|P3|NOT COMPLETED|Follow-Up Period||0
137599|NCT01721746|336317|P2|NOT COMPLETED|Follow-Up Period||0
137600|NCT01721746|336318|P1|NOT COMPLETED|Follow-Up Period||0
137601|NCT01721746|336316|P3|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|19
137602|NCT01721746|336317|P2|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|11
137603|NCT01721746|336318|P1|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|92
137604|NCT01721746|336316|P3|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|19
137605|NCT01721746|336317|P2|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|11
137606|NCT01721746|336318|P1|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|92
137607|NCT01721746|336316|P3|NOT COMPLETED|Treatment Period||57
137608|NCT01721746|336317|P2|NOT COMPLETED|Treatment Period||45
137609|NCT01721746|336318|P1|NOT COMPLETED|Treatment Period||233
137610|NCT01721746|336316|P3|COMPLETED|Treatment Period||0
137611|NCT01721746|336317|P2|COMPLETED|Treatment Period||0
137612|NCT01721746|336318|P1|COMPLETED|Treatment Period|Completed=Continuing in Treatment Period|35
137613|NCT01721746|336316|P3|STARTED|Treatment Period||57
137614|NCT01721746|336317|P2|STARTED|Treatment Period||45
137615|NCT01721746|336318|P1|STARTED|Treatment Period||268
137616|NCT01721681|336334|P1|NOT COMPLETED|Overall Study||0
137617|NCT01721681|336334|P1|COMPLETED|Overall Study||9
137618|NCT01721681|336334|P1|STARTED|Overall Study||9
137619|NCT01721603|336340|P1|NOT COMPLETED|Overall Study||0
137620|NCT01721603|336340|P1|COMPLETED|Overall Study||2
137621|NCT01721603|336340|P1|STARTED|Overall Study||2
137622|NCT01721564|336351|P1|NOT COMPLETED|Overall Study||0
137623|NCT01721564|336351|P1|COMPLETED|Overall Study||8
137624|NCT01721564|336351|P1|STARTED|Overall Study||8
137625|NCT01721486|336358|P2|NOT COMPLETED|Overall Study||1
137626|NCT01721486|336359|P1|NOT COMPLETED|Overall Study||1
137627|NCT01721486|336358|P2|COMPLETED|Overall Study||19
137628|NCT01721486|336359|P1|COMPLETED|Overall Study||20
137629|NCT01721486|336358|P2|STARTED|Overall Study||20
137630|NCT01721486|336359|P1|STARTED|Overall Study||21
137631|NCT01721473|336377|P6|NOT COMPLETED|Overall Study||0
137632|NCT01721473|336378|P5|NOT COMPLETED|Overall Study||0
137633|NCT01721473|336379|P4|NOT COMPLETED|Overall Study||0
137634|NCT01721473|336380|P3|NOT COMPLETED|Overall Study||0
137635|NCT01721473|336381|P2|NOT COMPLETED|Overall Study||0
137636|NCT01721473|336382|P1|NOT COMPLETED|Overall Study||0
137637|NCT01721473|336377|P6|COMPLETED|Overall Study||18
137638|NCT01721473|336378|P5|COMPLETED|Overall Study||22
137639|NCT01721473|336379|P4|COMPLETED|Overall Study||34
137640|NCT01721473|336380|P3|COMPLETED|Overall Study||41
137641|NCT01721473|336381|P2|COMPLETED|Overall Study||22
137642|NCT01721473|336382|P1|COMPLETED|Overall Study||47
137643|NCT01721473|336377|P6|STARTED|Overall Study||18
137644|NCT01721473|336378|P5|STARTED|Overall Study||22
137645|NCT01721473|336379|P4|STARTED|Overall Study||34
137646|NCT01721473|336380|P3|STARTED|Overall Study||41
137647|NCT01721473|336381|P2|STARTED|Overall Study||22
137648|NCT01721473|336382|P1|STARTED|Overall Study||47
137649|NCT01721460|336391|P1|NOT COMPLETED|Overall Study||1
137650|NCT01721460|336391|P1|COMPLETED|Overall Study||5
137651|NCT01721460|336391|P1|STARTED|Overall Study||6
137652|NCT01721447|336398|P1|NOT COMPLETED|Overall Study||0
137653|NCT01721447|336398|P1|COMPLETED|Overall Study||100
137654|NCT01721447|336398|P1|STARTED|Overall Study||100
137655|NCT01721408|336407|P2|NOT COMPLETED|Overall Study||24
137656|NCT01721408|336408|P1|NOT COMPLETED|Overall Study||36
137657|NCT01721408|336407|P2|COMPLETED|Overall Study||207
137658|NCT01721408|336408|P1|COMPLETED|Overall Study||196
137659|NCT01721408|336407|P2|STARTED|Overall Study|Number of participants treated.|231
137660|NCT01721408|336408|P1|STARTED|Overall Study|Number of participants treated.|232
137661|NCT01721330|336424|P2|NOT COMPLETED|Overall Study||1
137662|NCT01721330|336425|P1|NOT COMPLETED|Overall Study||0
137663|NCT01721330|336424|P2|COMPLETED|Overall Study||1
137664|NCT01721330|336425|P1|COMPLETED|Overall Study||1
137665|NCT01721330|336424|P2|STARTED|Overall Study||2
137666|NCT01721330|336425|P1|STARTED|Overall Study||1
137667|NCT01721317|336433|P2|NOT COMPLETED|Overall Study||4
137668|NCT01721317|336434|P1|NOT COMPLETED|Overall Study||2
137669|NCT01721317|336433|P2|COMPLETED|Overall Study||0
137670|NCT01721317|336434|P1|COMPLETED|Overall Study||0
137671|NCT01721317|336433|P2|STARTED|Overall Study||4
137672|NCT01721317|336434|P1|STARTED|Overall Study||2
137673|NCT01721226|336502|P2|NOT COMPLETED|Overall Study||7
137674|NCT01721226|336503|P1|NOT COMPLETED|Overall Study||5
137675|NCT01721226|336502|P2|COMPLETED|Overall Study||50
137676|NCT01721226|336503|P1|COMPLETED|Overall Study||50
137677|NCT01721226|336502|P2|Week 24|Overall Study||50
137678|NCT01721226|336503|P1|Week 24|Overall Study||50
137679|NCT01721226|336502|P2|Week 12|Overall Study||53
137680|NCT01721226|336503|P1|Week 12|Overall Study||48
137681|NCT01721226|336502|P2|Baseline|Overall Study||57
137682|NCT01721226|336503|P1|Baseline|Overall Study||53
137683|NCT01721226|336502|P2|STARTED|Overall Study||57
137684|NCT01721226|336503|P1|STARTED|Overall Study||55
137685|NCT01721200|336513|P2|NOT COMPLETED|Overall Study||5
137686|NCT01721200|336514|P1|NOT COMPLETED|Overall Study||3
137687|NCT01721200|336513|P2|COMPLETED|Overall Study||58
137688|NCT01721200|336514|P1|COMPLETED|Overall Study||59
137689|NCT01721200|336513|P2|Completed 2 Week Follow-up|Overall Study||61
137690|NCT01721200|336514|P1|Completed 2 Week Follow-up|Overall Study||60
137691|NCT01721200|336513|P2|STARTED|Overall Study||63
137692|NCT01721200|336514|P1|STARTED|Overall Study||62
137693|NCT01721161|336539|P2|NOT COMPLETED|Overall Study||7
137694|NCT01721161|336540|P1|NOT COMPLETED|Overall Study||4
137695|NCT01721161|336539|P2|COMPLETED|Overall Study||34
137696|NCT01721161|336540|P1|COMPLETED|Overall Study||37
137697|NCT01721161|336539|P2|STARTED|Overall Study||41
137698|NCT01721161|336540|P1|STARTED|Overall Study||41
137699|NCT01721109|336563|P1|NOT COMPLETED|Overall Study||7
137700|NCT01721109|336563|P1|COMPLETED|Overall Study|34 participants transitioned to commercial Stribild or to an individual patient use (IPU) program|43
137701|NCT01721109|336563|P1|STARTED|Overall Study||50
137702|NCT01721096|336578|P2|NOT COMPLETED|Overall Study||10
137703|NCT01721096|336579|P1|NOT COMPLETED|Overall Study||27
137704|NCT01721096|336578|P2|COMPLETED|Overall Study||203
137705|NCT01721096|336579|P1|COMPLETED|Overall Study||296
137706|NCT01721096|336578|P2|STARTED|Overall Study||213
137707|NCT01721096|336579|P1|STARTED|Overall Study||323
137708|NCT01721070|336728|P1|NOT COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||1
137709|NCT01721070|336728|P1|COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||18
137710|NCT01721070|336728|P1|STARTED|Ketoconazole 400 mg and SUF NT 15 mcg||19
137711|NCT01721070|336728|P1|NOT COMPLETED|SUF NT 15 mcg||0
137712|NCT01721070|336728|P1|COMPLETED|SUF NT 15 mcg||19
137713|NCT01721070|336728|P1|STARTED|SUF NT 15 mcg||19
137714|NCT01721057|336739|P7|NOT COMPLETED|Follow Up||0
137715|NCT01721057|336740|P6|NOT COMPLETED|Follow Up||0
137716|NCT01721057|336741|P5|NOT COMPLETED|Follow Up||0
137717|NCT01721057|336742|P4|NOT COMPLETED|Follow Up||0
137718|NCT01721057|336743|P3|NOT COMPLETED|Follow Up||0
137719|NCT01721057|336744|P2|NOT COMPLETED|Follow Up||0
137720|NCT01721057|336745|P1|NOT COMPLETED|Follow Up||0
137721|NCT01721057|336739|P7|COMPLETED|Follow Up||22
137722|NCT01721057|336740|P6|COMPLETED|Follow Up||19
137723|NCT01721057|336741|P5|COMPLETED|Follow Up||17
137724|NCT01721057|336742|P4|COMPLETED|Follow Up||0
137725|NCT01721057|336743|P3|COMPLETED|Follow Up||0
137726|NCT01721057|336744|P2|COMPLETED|Follow Up||0
137727|NCT01721057|336745|P1|COMPLETED|Follow Up||0
137728|NCT01721057|336739|P7|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|22
137729|NCT01721057|336740|P6|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
137730|NCT01721057|336741|P5|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|17
137731|NCT01721057|336742|P4|STARTED|Follow Up|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4 mg FollowUp|0
137732|NCT01721057|336743|P3|STARTED|Follow Up||0
137733|NCT01721057|336744|P2|STARTED|Follow Up||0
137734|NCT01721057|336745|P1|STARTED|Follow Up||0
137735|NCT01721057|336739|P7|NOT COMPLETED|Rescue Period||0
137736|NCT01721057|336740|P6|NOT COMPLETED|Rescue Period||0
137737|NCT01721057|336741|P5|NOT COMPLETED|Rescue Period||0
137738|NCT01721057|336742|P4|NOT COMPLETED|Rescue Period||3
137739|NCT01721057|336743|P3|NOT COMPLETED|Rescue Period||0
137740|NCT01721057|336744|P2|NOT COMPLETED|Rescue Period||0
137741|NCT01721057|336745|P1|NOT COMPLETED|Rescue Period||0
137742|NCT01721057|336739|P7|COMPLETED|Rescue Period||0
137743|NCT01721057|336740|P6|COMPLETED|Rescue Period||0
137744|NCT01721057|336741|P5|COMPLETED|Rescue Period||0
137745|NCT01721057|336742|P4|COMPLETED|Rescue Period||88
137746|NCT01721057|336743|P3|COMPLETED|Rescue Period||0
137747|NCT01721057|336744|P2|COMPLETED|Rescue Period||0
137748|NCT01721057|336745|P1|COMPLETED|Rescue Period||0
137749|NCT01721057|336739|P7|STARTED|Rescue Period||0
137750|NCT01721057|336740|P6|STARTED|Rescue Period||0
137751|NCT01721057|336741|P5|STARTED|Rescue Period||0
137752|NCT01721057|336742|P4|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|91
137753|NCT01721057|336743|P3|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
137754|NCT01721057|336744|P2|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
137755|NCT01721057|336745|P1|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
137756|NCT01721057|336739|P7|NOT COMPLETED|Treatment Period||0
137757|NCT01721057|336740|P6|NOT COMPLETED|Treatment Period||0
137758|NCT01721057|336741|P5|NOT COMPLETED|Treatment Period||0
137759|NCT01721057|336742|P4|NOT COMPLETED|Treatment Period||0
137760|NCT01721057|336743|P3|NOT COMPLETED|Treatment Period||23
137761|NCT01721057|336744|P2|NOT COMPLETED|Treatment Period||19
137762|NCT01721057|336745|P1|NOT COMPLETED|Treatment Period||28
137763|NCT01721057|336739|P7|COMPLETED|Treatment Period||0
137764|NCT01721057|336740|P6|COMPLETED|Treatment Period||0
137765|NCT01721057|336741|P5|COMPLETED|Treatment Period||0
137766|NCT01721057|336742|P4|COMPLETED|Treatment Period||0
137767|NCT01721057|336743|P3|COMPLETED|Treatment Period|"Completers include rescued participants."|204
137768|NCT01721057|336744|P2|COMPLETED|Treatment Period|"Completers include rescued participants."|210
137769|NCT01721057|336745|P1|COMPLETED|Treatment Period|"Completers include rescued participants."|200
137770|NCT01721057|336739|P7|Rescued|Treatment Period||0
137771|NCT01721057|336740|P6|Rescued|Treatment Period||0
137772|NCT01721057|336741|P5|Rescued|Treatment Period||0
137773|NCT01721057|336742|P4|Rescued|Treatment Period||0
137774|NCT01721057|336743|P3|Rescued|Treatment Period||15
137775|NCT01721057|336744|P2|Rescued|Treatment Period||21
137776|NCT01721057|336745|P1|Rescued|Treatment Period||55
137777|NCT01721057|336739|P7|Received at Least 1 Dose of Study Drug|Treatment Period||0
137778|NCT01721057|336740|P6|Received at Least 1 Dose of Study Drug|Treatment Period||0
137779|NCT01721057|336741|P5|Received at Least 1 Dose of Study Drug|Treatment Period||0
137780|NCT01721057|336742|P4|Received at Least 1 Dose of Study Drug|Treatment Period||0
137781|NCT01721057|336743|P3|Received at Least 1 Dose of Study Drug|Treatment Period||227
137782|NCT01721057|336744|P2|Received at Least 1 Dose of Study Drug|Treatment Period||229
137783|NCT01721057|336745|P1|Received at Least 1 Dose of Study Drug|Treatment Period||228
137784|NCT01721057|336739|P7|STARTED|Treatment Period||0
137785|NCT01721057|336740|P6|STARTED|Treatment Period||0
137786|NCT01721057|336741|P5|STARTED|Treatment Period||0
137787|NCT01721057|336742|P4|STARTED|Treatment Period||0
137788|NCT01721057|336743|P3|STARTED|Treatment Period||227
137789|NCT01721057|336744|P2|STARTED|Treatment Period||229
137790|NCT01721057|336745|P1|STARTED|Treatment Period||228
137791|NCT01721044|336818|P3|NOT COMPLETED|Follow Up||0
137792|NCT01721044|336819|P2|NOT COMPLETED|Follow Up||0
137793|NCT01721044|336820|P1|NOT COMPLETED|Follow Up||0
137794|NCT01721044|336818|P3|COMPLETED|Follow Up||20
137795|NCT01721044|336819|P2|COMPLETED|Follow Up||9
137796|NCT01721044|336820|P1|COMPLETED|Follow Up||19
137797|NCT01721044|336818|P3|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|20
137798|NCT01721044|336819|P2|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|9
137799|NCT01721044|336820|P1|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
137800|NCT01721044|336818|P3|NOT COMPLETED|Treatment Period||19
137801|NCT01721044|336819|P2|NOT COMPLETED|Treatment Period||17
137802|NCT01721044|336820|P1|NOT COMPLETED|Treatment Period||32
137803|NCT01721044|336818|P3|COMPLETED|Treatment Period||158
137804|NCT01721044|336819|P2|COMPLETED|Treatment Period||157
137805|NCT01721044|336820|P1|COMPLETED|Treatment Period||144
137806|NCT01721044|336818|P3|Rescue Week 16-24|Treatment Period||33
137807|NCT01721044|336819|P2|Rescue Week 16-24|Treatment Period||38
137808|NCT01721044|336820|P1|Rescue Week 16-24|Treatment Period||56
137809|NCT01721044|336818|P3|STARTED|Treatment Period||177
137810|NCT01721044|336819|P2|STARTED|Treatment Period|Randomized to 4mg (N=11) but received 2mg due to moderate renal impairment were included in 4mg arm|174
137811|NCT01721044|336820|P1|STARTED|Treatment Period||176
137812|NCT01720797|336893|P2|NOT COMPLETED|Overall Study||0
137813|NCT01720797|336894|P1|NOT COMPLETED|Overall Study||3
137814|NCT01720797|336893|P2|COMPLETED|Overall Study||9
137815|NCT01720797|336894|P1|COMPLETED|Overall Study||9
137816|NCT01720797|336893|P2|STARTED|Overall Study||9
137817|NCT01720797|336894|P1|STARTED|Overall Study||12
137818|NCT01720667|336902|P2|NOT COMPLETED|Overall Study||1
137819|NCT01720667|336903|P1|NOT COMPLETED|Overall Study||4
137820|NCT01720667|336902|P2|COMPLETED|Overall Study||41
137821|NCT01720667|336903|P1|COMPLETED|Overall Study||60
137822|NCT01720667|336902|P2|Modified ITT|Overall Study||30
137823|NCT01720667|336903|P1|Modified ITT|Overall Study||53
137824|NCT01720667|336902|P2|Received 2nd Infusion of Alternate Drug|Overall Study||6
137825|NCT01720667|336903|P1|Received 2nd Infusion of Alternate Drug|Overall Study||27
137826|NCT01720667|336902|P2|Recieved Alternate Intervention|Overall Study||10
137827|NCT01720667|336903|P1|Recieved Alternate Intervention|Overall Study||45
137828|NCT01720667|336902|P2|Recieved Second Infusion of Same Drug|Overall Study||20
137829|NCT01720667|336903|P1|Recieved Second Infusion of Same Drug|Overall Study||50
137830|NCT01720667|336902|P2|STARTED|Overall Study||42
137831|NCT01720667|336903|P1|STARTED|Overall Study||64
137832|NCT01720602|336917|P1|NOT COMPLETED|Overall Study||5
137833|NCT01720602|336917|P1|COMPLETED|Overall Study||10
137834|NCT01720602|336917|P1|STARTED|Overall Study||15
137835|NCT01720446|336929|P4|NOT COMPLETED|Overall Study||20
137836|NCT01720446|336930|P3|NOT COMPLETED|Overall Study||20
137837|NCT01720446|336931|P2|NOT COMPLETED|Overall Study||11
137838|NCT01720446|336932|P1|NOT COMPLETED|Overall Study||14
137839|NCT01720446|336929|P4|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|805
137840|NCT01720446|336930|P3|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|804
137841|NCT01720446|336931|P2|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|811
137842|NCT01720446|336932|P1|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|812
137843|NCT01720446|336929|P4|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|159
137844|NCT01720446|336930|P3|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|151
137845|NCT01720446|336931|P2|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|186
137846|NCT01720446|336932|P1|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|164
137847|NCT01720446|336929|P4|STARTED|Overall Study||825
137848|NCT01720446|336930|P3|STARTED|Overall Study||824
137849|NCT01720446|336931|P2|STARTED|Overall Study||822
137850|NCT01720446|336932|P1|STARTED|Overall Study||826
137851|NCT01720316|336993|P2|NOT COMPLETED|Open-label Glycine||0
137852|NCT01720316|336994|P1|NOT COMPLETED|Open-label Glycine||0
137853|NCT01720316|336993|P2|COMPLETED|Open-label Glycine||1
137854|NCT01720316|336994|P1|COMPLETED|Open-label Glycine||1
137855|NCT01720316|336993|P2|STARTED|Open-label Glycine||1
137856|NCT01720316|336994|P1|STARTED|Open-label Glycine||1
137857|NCT01720316|336993|P2|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
137858|NCT01720316|336994|P1|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
137859|NCT01720316|336993|P2|COMPLETED|Double-Blind Glycine Placebo Crossover||1
137860|NCT01720316|336994|P1|COMPLETED|Double-Blind Glycine Placebo Crossover||1
137861|NCT01720316|336993|P2|STARTED|Double-Blind Glycine Placebo Crossover||1
137862|NCT01720316|336994|P1|STARTED|Double-Blind Glycine Placebo Crossover||1
137863|NCT01720277|337042|P2|NOT COMPLETED|Overall Study||558
137864|NCT01720277|337043|P1|NOT COMPLETED|Overall Study||503
137865|NCT01720277|337042|P2|COMPLETED|Overall Study|intent-to-treat approach|938
137866|NCT01720277|337043|P1|COMPLETED|Overall Study|intent-to-treat approach|958
137867|NCT01720277|337042|P2|STARTED|Overall Study||1496
137868|NCT01720277|337043|P1|STARTED|Overall Study||1461
137869|NCT01720264|337053|P1|NOT COMPLETED|Post-transplant (Day 16) to 1 Year||12
137870|NCT01720264|337053|P1|COMPLETED|Post-transplant (Day 16) to 1 Year||2
137871|NCT01720264|337053|P1|STARTED|Post-transplant (Day 16) to 1 Year||14
137872|NCT01720264|337053|P1|NOT COMPLETED|Transplant With Sitagliptin for 15 Days||1
137873|NCT01720264|337053|P1|COMPLETED|Transplant With Sitagliptin for 15 Days||14
137874|NCT01720264|337053|P1|STARTED|Transplant With Sitagliptin for 15 Days||15
137875|NCT01720251|337063|P3|NOT COMPLETED|Overall Study||0
137876|NCT01720251|337064|P2|NOT COMPLETED|Overall Study||2
137877|NCT01720251|337065|P1|NOT COMPLETED|Overall Study||1
137878|NCT01720251|337063|P3|COMPLETED|Overall Study||82
137879|NCT01720251|337064|P2|COMPLETED|Overall Study||77
137880|NCT01720251|337065|P1|COMPLETED|Overall Study||78
137881|NCT01720251|337063|P3|STARTED|Overall Study||82
137882|NCT01720251|337064|P2|STARTED|Overall Study||79
137883|NCT01720251|337065|P1|STARTED|Overall Study||79
137884|NCT01720173|337073|P1|NOT COMPLETED|Overall Study||0
137885|NCT01720173|337073|P1|COMPLETED|Overall Study||30
137886|NCT01720173|337073|P1|STARTED|Overall Study||30
137887|NCT01720043|337081|P1|NOT COMPLETED|Overall Study||1
137888|NCT01720043|337081|P1|COMPLETED|Overall Study||7
137889|NCT01720043|337081|P1|STARTED|Overall Study||8
137890|NCT01719861|337085|P1|NOT COMPLETED|Cycle 2||1
137891|NCT01719861|337085|P1|COMPLETED|Cycle 2||1
137892|NCT01719861|337085|P1|STARTED|Cycle 2||2
137893|NCT01719861|337085|P1|NOT COMPLETED|Cycle 1||4
137894|NCT01719861|337085|P1|COMPLETED|Cycle 1||2
137895|NCT01719861|337085|P1|STARTED|Cycle 1||6
137896|NCT01719783|337095|P2|NOT COMPLETED|Dose 2||0
137897|NCT01719783|337096|P1|NOT COMPLETED|Dose 2||1
137898|NCT01719783|337095|P2|COMPLETED|Dose 2||10
137899|NCT01719783|337096|P1|COMPLETED|Dose 2||29
137900|NCT01719783|337095|P2|STARTED|Dose 2||10
137901|NCT01719783|337096|P1|STARTED|Dose 2||30
137902|NCT01719783|337095|P2|NOT COMPLETED|Dose 1||0
137903|NCT01719783|337096|P1|NOT COMPLETED|Dose 1||0
137904|NCT01719783|337095|P2|COMPLETED|Dose 1||10
137905|NCT01719783|337096|P1|COMPLETED|Dose 1||30
137906|NCT01719783|337095|P2|STARTED|Dose 1||10
137907|NCT01719783|337096|P1|STARTED|Dose 1||30
137908|NCT01719757|337182|P1|NOT COMPLETED|Overall Study||101
137909|NCT01719757|337182|P1|COMPLETED|Overall Study||258
137910|NCT01719757|337182|P1|STARTED|Overall Study||359
137911|NCT01719744|337190|P1|NOT COMPLETED|Overall Study||0
137912|NCT01719744|337190|P1|COMPLETED|Overall Study||25
137913|NCT01719744|337190|P1|STARTED|Overall Study||25
137914|NCT01719653|337201|P5|NOT COMPLETED|Overall Study||21
137915|NCT01719653|337202|P4|NOT COMPLETED|Overall Study||18
137916|NCT01719653|337203|P3|NOT COMPLETED|Overall Study||18
137917|NCT01719653|337204|P2|NOT COMPLETED|Overall Study||13
137918|NCT01719653|337205|P1|NOT COMPLETED|Overall Study||9
137919|NCT01719653|337201|P5|COMPLETED|Overall Study||200
137920|NCT01719653|337202|P4|COMPLETED|Overall Study||200
137921|NCT01719653|337203|P3|COMPLETED|Overall Study||200
137922|NCT01719653|337204|P2|COMPLETED|Overall Study||200
137923|NCT01719653|337205|P1|COMPLETED|Overall Study||200
137924|NCT01719653|337201|P5|STARTED|Overall Study||221
137925|NCT01719653|337202|P4|STARTED|Overall Study||218
137926|NCT01719653|337203|P3|STARTED|Overall Study||218
137927|NCT01719653|337204|P2|STARTED|Overall Study||213
137928|NCT01719653|337205|P1|STARTED|Overall Study||209
137929|NCT01719367|337227|P2|NOT COMPLETED|Overall Study||0
137930|NCT01719367|337228|P1|NOT COMPLETED|Overall Study||0
137931|NCT01719367|337227|P2|COMPLETED|Overall Study||19
137932|NCT01719367|337228|P1|COMPLETED|Overall Study||19
137933|NCT01719367|337227|P2|STARTED|Overall Study||19
137934|NCT01719367|337228|P1|STARTED|Overall Study||19
137935|NCT01719224|337236|P2|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
137936|NCT01719224|337237|P1|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
137937|NCT01719224|337236|P2|COMPLETED|Intervention 2: Position Change(At 3.5h)||16
137938|NCT01719224|337237|P1|COMPLETED|Intervention 2: Position Change(At 3.5h)||14
137939|NCT01719224|337236|P2|STARTED|Intervention 2: Position Change(At 3.5h)||16
137940|NCT01719224|337237|P1|STARTED|Intervention 2: Position Change(At 3.5h)||14
137941|NCT01719224|337236|P2|NOT COMPLETED|Intervention 1: Sleeping Position 1||2
137942|NCT01719224|337237|P1|NOT COMPLETED|Intervention 1: Sleeping Position 1||4
137943|NCT01719224|337236|P2|COMPLETED|Intervention 1: Sleeping Position 1||16
137944|NCT01719224|337237|P1|COMPLETED|Intervention 1: Sleeping Position 1||14
137945|NCT01719224|337236|P2|STARTED|Intervention 1: Sleeping Position 1||18
137946|NCT01719224|337237|P1|STARTED|Intervention 1: Sleeping Position 1||18
137947|NCT01719172|337246|P1|NOT COMPLETED|Overall Study||2
137948|NCT01719172|337246|P1|COMPLETED|Overall Study||28
137949|NCT01719172|337246|P1|STARTED|Overall Study||30
137950|NCT01719003|337260|P9|NOT COMPLETED|Overall Study||4
137951|NCT01719003|337261|P8|NOT COMPLETED|Overall Study||20
137952|NCT01719003|337262|P7|NOT COMPLETED|Overall Study||20
137953|NCT01719003|337263|P6|NOT COMPLETED|Overall Study||12
137954|NCT01719003|337264|P5|NOT COMPLETED|Overall Study||17
137955|NCT01719003|337265|P4|NOT COMPLETED|Overall Study||13
137956|NCT01719003|337266|P3|NOT COMPLETED|Overall Study||17
137957|NCT01719003|337267|P2|NOT COMPLETED|Overall Study||17
137958|NCT01719003|337268|P1|NOT COMPLETED|Overall Study||9
137959|NCT01719003|337260|P9|COMPLETED|Overall Study||49
137960|NCT01719003|337261|P8|COMPLETED|Overall Study||151
137961|NCT01719003|337262|P7|COMPLETED|Overall Study||150
137962|NCT01719003|337263|P6|COMPLETED|Overall Study||160
137963|NCT01719003|337264|P5|COMPLETED|Overall Study||150
137964|NCT01719003|337265|P4|COMPLETED|Overall Study||156
137965|NCT01719003|337266|P3|COMPLETED|Overall Study||154
137966|NCT01719003|337267|P2|COMPLETED|Overall Study||153
137967|NCT01719003|337268|P1|COMPLETED|Overall Study||161
137968|NCT01719003|337260|P9|STARTED|Overall Study||53
137969|NCT01719003|337261|P8|STARTED|Overall Study||171
137970|NCT01719003|337262|P7|STARTED|Overall Study||170
137971|NCT01719003|337263|P6|STARTED|Overall Study||172
137972|NCT01719003|337264|P5|STARTED|Overall Study||167
137973|NCT01719003|337265|P4|STARTED|Overall Study||169
137974|NCT01719003|337266|P3|STARTED|Overall Study||171
137975|NCT01719003|337267|P2|STARTED|Overall Study||170
137976|NCT01719003|337268|P1|STARTED|Overall Study||170
137977|NCT01718691|337305|P2|NOT COMPLETED|Overall Study||1
137978|NCT01718691|337306|P1|NOT COMPLETED|Overall Study||18
137979|NCT01718691|337305|P2|COMPLETED|Overall Study||9
137980|NCT01718691|337306|P1|COMPLETED|Overall Study||42
137981|NCT01718691|337305|P2|STARTED|Overall Study||10
137982|NCT01718691|337306|P1|STARTED|Overall Study||60
137983|NCT01718535|337349|P10|NOT COMPLETED|Overall Study||0
137984|NCT01718535|337350|P9|NOT COMPLETED|Overall Study||0
137985|NCT01718535|337351|P8|NOT COMPLETED|Overall Study||0
137986|NCT01718535|337352|P7|NOT COMPLETED|Overall Study||0
137987|NCT01718535|337353|P6|NOT COMPLETED|Overall Study||0
137988|NCT01718535|337354|P5|NOT COMPLETED|Overall Study||0
137989|NCT01718535|337355|P4|NOT COMPLETED|Overall Study||1
137990|NCT01718535|337356|P3|NOT COMPLETED|Overall Study||0
137991|NCT01718535|337357|P2|NOT COMPLETED|Overall Study||0
137992|NCT01718535|337358|P1|NOT COMPLETED|Overall Study||1
137993|NCT01718535|337349|P10|COMPLETED|Overall Study||1
137994|NCT01718535|337350|P9|COMPLETED|Overall Study||15
137995|NCT01718535|337351|P8|COMPLETED|Overall Study||6
137996|NCT01718535|337352|P7|COMPLETED|Overall Study||11
137997|NCT01718535|337353|P6|COMPLETED|Overall Study||40
137998|NCT01718535|337354|P5|COMPLETED|Overall Study||1
137999|NCT01718535|337355|P4|COMPLETED|Overall Study||7
138000|NCT01718535|337356|P3|COMPLETED|Overall Study||19
138001|NCT01718535|337357|P2|COMPLETED|Overall Study||95
138002|NCT01718535|337358|P1|COMPLETED|Overall Study||130
138003|NCT01718535|337349|P10|First Pass|Overall Study||1
138004|NCT01718535|337350|P9|First Pass|Overall Study||15
138005|NCT01718535|337351|P8|First Pass|Overall Study||6
138006|NCT01718535|337352|P7|First Pass|Overall Study||11
138007|NCT01718535|337353|P6|First Pass|Overall Study||39
138008|NCT01718535|337354|P5|First Pass|Overall Study||1
138009|NCT01718535|337355|P4|First Pass|Overall Study||7
138010|NCT01718535|337356|P3|First Pass|Overall Study||19
138011|NCT01718535|337357|P2|First Pass|Overall Study||94
138012|NCT01718535|337358|P1|First Pass|Overall Study||128
138013|NCT01718535|337349|P10|STARTED|Overall Study||1
138014|NCT01718535|337350|P9|STARTED|Overall Study||15
138015|NCT01718535|337351|P8|STARTED|Overall Study||6
138016|NCT01718535|337352|P7|STARTED|Overall Study||11
138017|NCT01718535|337353|P6|STARTED|Overall Study||40
138018|NCT01718535|337354|P5|STARTED|Overall Study||1
138019|NCT01718535|337355|P4|STARTED|Overall Study||8
138020|NCT01718535|337356|P3|STARTED|Overall Study||19
138021|NCT01718535|337357|P2|STARTED|Overall Study||95
138022|NCT01718535|337358|P1|STARTED|Overall Study||131
138023|NCT01718522|337380|P1|NOT COMPLETED|Overall Study||8
138024|NCT01718522|337380|P1|COMPLETED|Overall Study||67
138025|NCT01718522|337380|P1|STARTED|Overall Study||75
138026|NCT01718509|337396|P2|NOT COMPLETED|Overall Study||48
138027|NCT01718509|337397|P1|NOT COMPLETED|Overall Study||48
138028|NCT01718509|337396|P2|COMPLETED|Overall Study||147
138029|NCT01718509|337397|P1|COMPLETED|Overall Study||147
138030|NCT01718509|337396|P2|STARTED|Overall Study||195
138031|NCT01718509|337397|P1|STARTED|Overall Study||195
138032|NCT01718483|337443|P2|NOT COMPLETED|Overall Study||34
138033|NCT01718483|337444|P1|NOT COMPLETED|Overall Study||34
138034|NCT01718483|337443|P2|COMPLETED|Overall Study||158
138035|NCT01718483|337444|P1|COMPLETED|Overall Study||157
138036|NCT01718483|337443|P2|Treated|Overall Study||192
138037|NCT01718483|337444|P1|Treated|Overall Study||187
138038|NCT01718483|337443|P2|STARTED|Overall Study||192
138039|NCT01718483|337444|P1|STARTED|Overall Study||191
138040|NCT01718353|337490|P2|NOT COMPLETED|Overall Study||5
138041|NCT01718353|337491|P1|NOT COMPLETED|Overall Study||12
138042|NCT01718353|337490|P2|COMPLETED|Overall Study|Participants at study cut-off, AE, DP and consent withdrawn were considered completed.|17
138043|NCT01718353|337491|P1|COMPLETED|Overall Study|Participants at study cut-off, Adverse Event (AE), DP & consent withdrawn were considered completed.|29
138044|NCT01718353|337490|P2|Treated From Cycle 5|Overall Study|3 participants switched from Treatment B to A & 12 participants switched from Treatment A to B.|25
138045|NCT01718353|337491|P1|Treated From Cycle 5|Overall Study|12 participants switched from Treatment A to B & 3 participants switched from Treatment B to A.|23
138046|NCT01718353|337490|P2|Treated up to End of Cycle 4|Overall Study|6 participants discontinued before Cycle 5|16
138047|NCT01718353|337491|P1|Treated up to End of Cycle 4|Overall Study|7 participants discontinued before Cycle 5|32
138048|NCT01718353|337490|P2|Treated|Overall Study||22
138049|NCT01718353|337491|P1|Treated|Overall Study||39
138050|NCT01718353|337490|P2|STARTED|Overall Study||22
138051|NCT01718353|337491|P1|STARTED|Overall Study||41
138052|NCT01718028|337509|P2|NOT COMPLETED|Overall Study||0
138053|NCT01718028|337510|P1|NOT COMPLETED|Overall Study||0
138054|NCT01718028|337509|P2|COMPLETED|Overall Study||24
138055|NCT01718028|337510|P1|COMPLETED|Overall Study||25
138056|NCT01718028|337509|P2|STARTED|Overall Study||24
138057|NCT01718028|337510|P1|STARTED|Overall Study||25
138058|NCT01717989|337522|P1|NOT COMPLETED|Overall Study||1066
138059|NCT01717989|337522|P1|COMPLETED|Overall Study||1182
138060|NCT01717989|337522|P1|STARTED|Overall Study||2248
138061|NCT01717976|337590|P2|NOT COMPLETED|Overall Study||1
138062|NCT01717976|337591|P1|NOT COMPLETED|Overall Study||0
138063|NCT01717976|337590|P2|COMPLETED|Overall Study||256
138064|NCT01717976|337591|P1|COMPLETED|Overall Study||257
138065|NCT01717976|337590|P2|STARTED|Overall Study||257
138066|NCT01717976|337591|P1|STARTED|Overall Study||257
138067|NCT01717898|337605|P4|NOT COMPLETED|Overall Study||0
138068|NCT01717898|337606|P3|NOT COMPLETED|Overall Study||0
138069|NCT01717898|337607|P2|NOT COMPLETED|Overall Study||0
138070|NCT01717898|337608|P1|NOT COMPLETED|Overall Study||6
138071|NCT01717898|337605|P4|COMPLETED|Overall Study||0
138072|NCT01717898|337606|P3|COMPLETED|Overall Study||0
138073|NCT01717898|337607|P2|COMPLETED|Overall Study||0
138074|NCT01717898|337608|P1|COMPLETED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
138075|NCT01717898|337605|P4|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
138076|NCT01717898|337606|P3|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
138077|NCT01717898|337607|P2|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
138078|NCT01717898|337608|P1|STARTED|Overall Study||6
138079|NCT01717872|337635|P2|NOT COMPLETED|Overall Study||0
138080|NCT01717872|337636|P1|NOT COMPLETED|Overall Study||0
138081|NCT01717872|337635|P2|COMPLETED|Overall Study||25
138082|NCT01717872|337636|P1|COMPLETED|Overall Study||25
138083|NCT01717872|337635|P2|STARTED|Overall Study||25
138084|NCT01717872|337636|P1|STARTED|Overall Study||25
138085|NCT01717859|337646|P1|NOT COMPLETED|Overall Study||10
138086|NCT01717859|337646|P1|COMPLETED|Overall Study||44
138087|NCT01717859|337646|P1|3 Month|Overall Study||50
138088|NCT01717859|337646|P1|STARTED|Overall Study||54
138089|NCT01717768|337667|P12|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
138090|NCT01717768|337668|P11|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
138091|NCT01717768|337669|P10|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||1
138092|NCT01717768|337670|P9|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
138093|NCT01717768|337671|P8|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||2
138094|NCT01717768|337672|P7|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
138095|NCT01717768|337673|P6|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
138096|NCT01717768|337674|P5|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
138097|NCT01717768|337675|P4|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
138098|NCT01717768|337676|P3|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
138099|NCT01717768|337677|P2|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
138100|NCT01717768|337678|P1|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
138101|NCT01717768|337667|P12|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
138102|NCT01717768|337668|P11|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
138103|NCT01717768|337669|P10|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
138104|NCT01717768|337670|P9|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
138105|NCT01717768|337671|P8|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
138106|NCT01717768|337672|P7|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
138107|NCT01717768|337673|P6|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
138108|NCT01717768|337674|P5|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
138109|NCT01717768|337675|P4|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
138110|NCT01717768|337676|P3|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
138111|NCT01717768|337677|P2|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
138112|NCT01717768|337678|P1|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
138113|NCT01717768|337667|P12|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
138114|NCT01717768|337668|P11|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
138115|NCT01717768|337669|P10|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||16
138116|NCT01717768|337670|P9|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
138117|NCT01717768|337671|P8|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||17
138118|NCT01717768|337672|P7|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
138119|NCT01717768|337673|P6|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
138120|NCT01717768|337674|P5|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
138121|NCT01717768|337675|P4|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
138122|NCT01717768|337676|P3|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
138123|NCT01717768|337677|P2|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
138124|NCT01717768|337678|P1|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
138125|NCT01717768|337667|P12|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||1
138126|NCT01717768|337668|P11|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
138127|NCT01717768|337669|P10|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
138128|NCT01717768|337670|P9|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
138129|NCT01717768|337671|P8|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
138130|NCT01717768|337672|P7|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
138131|NCT01717768|337673|P6|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
138132|NCT01717768|337674|P5|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
138133|NCT01717768|337675|P4|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
138134|NCT01717768|337676|P3|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
138135|NCT01717768|337677|P2|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
138136|NCT01717768|337678|P1|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
138137|NCT01717768|337667|P12|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||15
138138|NCT01717768|337668|P11|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
138139|NCT01717768|337669|P10|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
138140|NCT01717768|337670|P9|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
138141|NCT01717768|337671|P8|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
138142|NCT01717768|337672|P7|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||17
138143|NCT01717768|337673|P6|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
138144|NCT01717768|337674|P5|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
138145|NCT01717768|337675|P4|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
138146|NCT01717768|337676|P3|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
138147|NCT01717768|337677|P2|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
138148|NCT01717768|337678|P1|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
138149|NCT01717768|337667|P12|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
138150|NCT01717768|337668|P11|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
138151|NCT01717768|337669|P10|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
138152|NCT01717768|337670|P9|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
138153|NCT01717768|337671|P8|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
138154|NCT01717768|337672|P7|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||17
138155|NCT01717768|337673|P6|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
138156|NCT01717768|337674|P5|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
138157|NCT01717768|337675|P4|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
138158|NCT01717768|337676|P3|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
138159|NCT01717768|337677|P2|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
138160|NCT01717768|337678|P1|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
138161|NCT01717768|337667|P12|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
138162|NCT01717768|337668|P11|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
138163|NCT01717768|337669|P10|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
138164|NCT01717768|337670|P9|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
138165|NCT01717768|337671|P8|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
138166|NCT01717768|337672|P7|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
138167|NCT01717768|337673|P6|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
138168|NCT01717768|337674|P5|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
138169|NCT01717768|337675|P4|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
138170|NCT01717768|337676|P3|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
138171|NCT01717768|337677|P2|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
138172|NCT01717768|337678|P1|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
138173|NCT01717768|337667|P12|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
138174|NCT01717768|337668|P11|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
138175|NCT01717768|337669|P10|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
138176|NCT01717768|337670|P9|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
138177|NCT01717768|337671|P8|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
138178|NCT01717768|337672|P7|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
138179|NCT01717768|337673|P6|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
138180|NCT01717768|337674|P5|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
138181|NCT01717768|337675|P4|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||4
138182|NCT01717768|337676|P3|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
138183|NCT01717768|337677|P2|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
138184|NCT01717768|337678|P1|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
138185|NCT01717768|337667|P12|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
138186|NCT01717768|337668|P11|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
138187|NCT01717768|337669|P10|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
138188|NCT01717768|337670|P9|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
138189|NCT01717768|337671|P8|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
138190|NCT01717768|337672|P7|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
138191|NCT01717768|337673|P6|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
138192|NCT01717768|337674|P5|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
138193|NCT01717768|337675|P4|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||4
138194|NCT01717768|337676|P3|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
138195|NCT01717768|337677|P2|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
138196|NCT01717768|337678|P1|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
138197|NCT01717768|337667|P12|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
138198|NCT01717768|337668|P11|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
138199|NCT01717768|337669|P10|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
138200|NCT01717768|337670|P9|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
138201|NCT01717768|337671|P8|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
138202|NCT01717768|337672|P7|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
138203|NCT01717768|337673|P6|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
138204|NCT01717768|337674|P5|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
138205|NCT01717768|337675|P4|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
138206|NCT01717768|337676|P3|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
138207|NCT01717768|337677|P2|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
138208|NCT01717768|337678|P1|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
138209|NCT01717768|337667|P12|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
138210|NCT01717768|337668|P11|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
138211|NCT01717768|337669|P10|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
138212|NCT01717768|337670|P9|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
138213|NCT01717768|337671|P8|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
138214|NCT01717768|337672|P7|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
138215|NCT01717768|337673|P6|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
138216|NCT01717768|337674|P5|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
138217|NCT01717768|337675|P4|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||4
138218|NCT01717768|337676|P3|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
138219|NCT01717768|337677|P2|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
138220|NCT01717768|337678|P1|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
138221|NCT01717768|337667|P12|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
138222|NCT01717768|337668|P11|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
138223|NCT01717768|337669|P10|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
138224|NCT01717768|337670|P9|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
138225|NCT01717768|337671|P8|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
138226|NCT01717768|337672|P7|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
138227|NCT01717768|337673|P6|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
138228|NCT01717768|337674|P5|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
138229|NCT01717768|337675|P4|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||4
138230|NCT01717768|337676|P3|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
138231|NCT01717768|337677|P2|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
138232|NCT01717768|337678|P1|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
138233|NCT01717768|337667|P12|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
138234|NCT01717768|337668|P11|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
138235|NCT01717768|337669|P10|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
138236|NCT01717768|337670|P9|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
138237|NCT01717768|337671|P8|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
138238|NCT01717768|337672|P7|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
138239|NCT01717768|337673|P6|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
138240|NCT01717768|337674|P5|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
138241|NCT01717768|337675|P4|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
138242|NCT01717768|337676|P3|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
138243|NCT01717768|337677|P2|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
138244|NCT01717768|337678|P1|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
138245|NCT01717768|337667|P12|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
138246|NCT01717768|337668|P11|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
138247|NCT01717768|337669|P10|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
138248|NCT01717768|337670|P9|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
138249|NCT01717768|337671|P8|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
138250|NCT01717768|337672|P7|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
138251|NCT01717768|337673|P6|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
138252|NCT01717768|337674|P5|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
138253|NCT01717768|337675|P4|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||4
138254|NCT01717768|337676|P3|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
138255|NCT01717768|337677|P2|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
138256|NCT01717768|337678|P1|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
138257|NCT01717768|337667|P12|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
138258|NCT01717768|337668|P11|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
138259|NCT01717768|337669|P10|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
138260|NCT01717768|337670|P9|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
138261|NCT01717768|337671|P8|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
138262|NCT01717768|337672|P7|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
138263|NCT01717768|337673|P6|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
138264|NCT01717768|337674|P5|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
138265|NCT01717768|337675|P4|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||4
138266|NCT01717768|337676|P3|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
138267|NCT01717768|337677|P2|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
138268|NCT01717768|337678|P1|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
138269|NCT01717768|337667|P12|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
138270|NCT01717768|337668|P11|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
138271|NCT01717768|337669|P10|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
138272|NCT01717768|337670|P9|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
138273|NCT01717768|337671|P8|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
138274|NCT01717768|337672|P7|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
138275|NCT01717768|337673|P6|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
138276|NCT01717768|337674|P5|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
138277|NCT01717768|337675|P4|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
138278|NCT01717768|337676|P3|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
138279|NCT01717768|337677|P2|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
138280|NCT01717768|337678|P1|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
138281|NCT01717768|337667|P12|COMPLETED|Part 2 (Duration of 15 Days)||0
138282|NCT01717768|337668|P11|COMPLETED|Part 2 (Duration of 15 Days)||0
138283|NCT01717768|337669|P10|COMPLETED|Part 2 (Duration of 15 Days)||0
138284|NCT01717768|337670|P9|COMPLETED|Part 2 (Duration of 15 Days)||0
138285|NCT01717768|337671|P8|COMPLETED|Part 2 (Duration of 15 Days)||0
138286|NCT01717768|337672|P7|COMPLETED|Part 2 (Duration of 15 Days)||0
138287|NCT01717768|337673|P6|COMPLETED|Part 2 (Duration of 15 Days)||0
138288|NCT01717768|337674|P5|COMPLETED|Part 2 (Duration of 15 Days)||0
138289|NCT01717768|337675|P4|COMPLETED|Part 2 (Duration of 15 Days)||0
138290|NCT01717768|337676|P3|COMPLETED|Part 2 (Duration of 15 Days)||17
138291|NCT01717768|337677|P2|COMPLETED|Part 2 (Duration of 15 Days)||0
138292|NCT01717768|337678|P1|COMPLETED|Part 2 (Duration of 15 Days)||0
138293|NCT01717768|337667|P12|STARTED|Part 2 (Duration of 15 Days)||0
138294|NCT01717768|337668|P11|STARTED|Part 2 (Duration of 15 Days)||0
138295|NCT01717768|337669|P10|STARTED|Part 2 (Duration of 15 Days)||0
138296|NCT01717768|337670|P9|STARTED|Part 2 (Duration of 15 Days)||0
138297|NCT01717768|337671|P8|STARTED|Part 2 (Duration of 15 Days)||0
138298|NCT01717768|337672|P7|STARTED|Part 2 (Duration of 15 Days)||0
138299|NCT01717768|337673|P6|STARTED|Part 2 (Duration of 15 Days)||0
138300|NCT01717768|337674|P5|STARTED|Part 2 (Duration of 15 Days)||0
138301|NCT01717768|337675|P4|STARTED|Part 2 (Duration of 15 Days)||0
138302|NCT01717768|337676|P3|STARTED|Part 2 (Duration of 15 Days)||17
138303|NCT01717768|337677|P2|STARTED|Part 2 (Duration of 15 Days)||0
138304|NCT01717768|337678|P1|STARTED|Part 2 (Duration of 15 Days)||0
138305|NCT01717768|337667|P12|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
138306|NCT01717768|337668|P11|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
138307|NCT01717768|337669|P10|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
138308|NCT01717768|337670|P9|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
138309|NCT01717768|337671|P8|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
138310|NCT01717768|337672|P7|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
138311|NCT01717768|337673|P6|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
138312|NCT01717768|337674|P5|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
138313|NCT01717768|337675|P4|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
138314|NCT01717768|337676|P3|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
138315|NCT01717768|337677|P2|NOT COMPLETED|Part 1 (Duration of 15 Days)||1
138316|NCT01717768|337678|P1|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
138317|NCT01717768|337667|P12|COMPLETED|Part 1 (Duration of 15 Days)||0
138318|NCT01717768|337668|P11|COMPLETED|Part 1 (Duration of 15 Days)||0
138319|NCT01717768|337669|P10|COMPLETED|Part 1 (Duration of 15 Days)||0
138320|NCT01717768|337670|P9|COMPLETED|Part 1 (Duration of 15 Days)||0
138321|NCT01717768|337671|P8|COMPLETED|Part 1 (Duration of 15 Days)||0
138322|NCT01717768|337672|P7|COMPLETED|Part 1 (Duration of 15 Days)||0
138323|NCT01717768|337673|P6|COMPLETED|Part 1 (Duration of 15 Days)||0
138324|NCT01717768|337674|P5|COMPLETED|Part 1 (Duration of 15 Days)||0
138325|NCT01717768|337675|P4|COMPLETED|Part 1 (Duration of 15 Days)||0
138326|NCT01717768|337676|P3|COMPLETED|Part 1 (Duration of 15 Days)||0
138327|NCT01717768|337677|P2|COMPLETED|Part 1 (Duration of 15 Days)||16
138328|NCT01717768|337678|P1|COMPLETED|Part 1 (Duration of 15 Days)||17
138329|NCT01717768|337667|P12|STARTED|Part 1 (Duration of 15 Days)||0
138330|NCT01717768|337668|P11|STARTED|Part 1 (Duration of 15 Days)||0
138331|NCT01717768|337669|P10|STARTED|Part 1 (Duration of 15 Days)||0
138332|NCT01717768|337670|P9|STARTED|Part 1 (Duration of 15 Days)||0
138333|NCT01717768|337671|P8|STARTED|Part 1 (Duration of 15 Days)||0
138334|NCT01717768|337672|P7|STARTED|Part 1 (Duration of 15 Days)||0
138335|NCT01717768|337673|P6|STARTED|Part 1 (Duration of 15 Days)||0
138336|NCT01717768|337674|P5|STARTED|Part 1 (Duration of 15 Days)||0
138337|NCT01717768|337675|P4|STARTED|Part 1 (Duration of 15 Days)||0
138338|NCT01717768|337676|P3|STARTED|Part 1 (Duration of 15 Days)||0
138339|NCT01717768|337677|P2|STARTED|Part 1 (Duration of 15 Days)||17
138340|NCT01717768|337678|P1|STARTED|Part 1 (Duration of 15 Days)||17
138341|NCT01717638|337729|P13|NOT COMPLETED|Overall Study||19
138342|NCT01717638|337730|P12|NOT COMPLETED|Overall Study||0
138343|NCT01717638|337731|P11|NOT COMPLETED|Overall Study||0
138344|NCT01717638|337732|P10|NOT COMPLETED|Overall Study||1
138345|NCT01717638|337733|P9|NOT COMPLETED|Overall Study||2
138346|NCT01717638|337734|P8|NOT COMPLETED|Overall Study||1
138347|NCT01717638|337735|P7|NOT COMPLETED|Overall Study||2
138348|NCT01717638|337736|P6|NOT COMPLETED|Overall Study||1
138349|NCT01717638|337737|P5|NOT COMPLETED|Overall Study||1
138350|NCT01717638|337738|P4|NOT COMPLETED|Overall Study||0
138351|NCT01717638|337739|P3|NOT COMPLETED|Overall Study||1
138352|NCT01717638|337740|P2|NOT COMPLETED|Overall Study||1
138353|NCT01717638|337741|P1|NOT COMPLETED|Overall Study||0
138354|NCT01717638|337729|P13|COMPLETED|Overall Study||190
138355|NCT01717638|337730|P12|COMPLETED|Overall Study||12
138356|NCT01717638|337731|P11|COMPLETED|Overall Study||11
138357|NCT01717638|337732|P10|COMPLETED|Overall Study||99
138358|NCT01717638|337733|P9|COMPLETED|Overall Study||26
138359|NCT01717638|337734|P8|COMPLETED|Overall Study||28
138360|NCT01717638|337735|P7|COMPLETED|Overall Study||41
138361|NCT01717638|337736|P6|COMPLETED|Overall Study||54
138362|NCT01717638|337737|P5|COMPLETED|Overall Study||63
138363|NCT01717638|337738|P4|COMPLETED|Overall Study||66
138364|NCT01717638|337739|P3|COMPLETED|Overall Study||59
138365|NCT01717638|337740|P2|COMPLETED|Overall Study||60
138366|NCT01717638|337741|P1|COMPLETED|Overall Study||67
138367|NCT01717638|337729|P13|STARTED|Overall Study||209
138368|NCT01717638|337730|P12|STARTED|Overall Study||12
138369|NCT01717638|337731|P11|STARTED|Overall Study||11
138370|NCT01717638|337732|P10|STARTED|Overall Study||100
138371|NCT01717638|337733|P9|STARTED|Overall Study||28
138372|NCT01717638|337734|P8|STARTED|Overall Study||29
138373|NCT01717638|337735|P7|STARTED|Overall Study||43
138374|NCT01717638|337736|P6|STARTED|Overall Study||55
138375|NCT01717638|337737|P5|STARTED|Overall Study||64
138376|NCT01717638|337738|P4|STARTED|Overall Study||66
138377|NCT01717638|337739|P3|STARTED|Overall Study||60
138378|NCT01717638|337740|P2|STARTED|Overall Study||61
138379|NCT01717638|337741|P1|STARTED|Overall Study||67
138380|NCT01717521|337883|P1|NOT COMPLETED|Overall Study||0
138381|NCT01717521|337883|P1|COMPLETED|Overall Study||20
138382|NCT01717521|337883|P1|STARTED|Overall Study||20
138383|NCT01717482|337902|P2|NOT COMPLETED|Overall Study||0
138384|NCT01717482|337903|P1|NOT COMPLETED|Overall Study||4
138385|NCT01717482|337902|P2|COMPLETED|Overall Study||2
138386|NCT01717482|337903|P1|COMPLETED|Overall Study||0
138387|NCT01717482|337902|P2|STARTED|Overall Study||2
138388|NCT01717482|337903|P1|STARTED|Overall Study||4
138389|NCT01717456|337911|P2|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
138390|NCT01717456|337912|P1|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
138391|NCT01717456|337911|P2|COMPLETED|Follow-Up 6 Months After End of Tx||2
138392|NCT01717456|337912|P1|COMPLETED|Follow-Up 6 Months After End of Tx||7
138393|NCT01717456|337911|P2|STARTED|Follow-Up 6 Months After End of Tx||6
138394|NCT01717456|337912|P1|STARTED|Follow-Up 6 Months After End of Tx||11
138395|NCT01717456|337911|P2|NOT COMPLETED|End of Treatment||2
138396|NCT01717456|337912|P1|NOT COMPLETED|End of Treatment||0
138397|NCT01717456|337911|P2|COMPLETED|End of Treatment||6
138398|NCT01717456|337912|P1|COMPLETED|End of Treatment||11
138399|NCT01717456|337911|P2|STARTED|End of Treatment||8
138400|NCT01717456|337912|P1|STARTED|End of Treatment||11
138401|NCT01717391|337980|P1|NOT COMPLETED|Overall Study||9
138402|NCT01717391|337980|P1|COMPLETED|Overall Study||27
138403|NCT01717391|337980|P1|STARTED|Overall Study||36
138404|NCT01717326|338009|P20|NOT COMPLETED|Overall Study||6
138405|NCT01717326|338010|P19|NOT COMPLETED|Overall Study||4
138406|NCT01717326|338011|P18|NOT COMPLETED|Overall Study||0
138407|NCT01717326|338012|P17|NOT COMPLETED|Overall Study||1
138408|NCT01717326|338013|P16|NOT COMPLETED|Overall Study||3
138409|NCT01717326|338014|P15|NOT COMPLETED|Overall Study||0
138410|NCT01717326|338015|P14|NOT COMPLETED|Overall Study||0
138411|NCT01717326|338016|P13|NOT COMPLETED|Overall Study||1
138412|NCT01717326|338017|P12|NOT COMPLETED|Overall Study||0
138413|NCT01717326|338018|P11|NOT COMPLETED|Overall Study||2
138414|NCT01717326|338019|P10|NOT COMPLETED|Overall Study||2
138415|NCT01717326|338020|P9|NOT COMPLETED|Overall Study||0
138416|NCT01717326|338021|P8|NOT COMPLETED|Overall Study||0
138417|NCT01717326|338022|P7|NOT COMPLETED|Overall Study||1
138418|NCT01717326|338023|P6|NOT COMPLETED|Overall Study||0
138419|NCT01717326|338024|P5|NOT COMPLETED|Overall Study||2
138420|NCT01717326|338025|P4|NOT COMPLETED|Overall Study||2
138421|NCT01717326|338026|P3|NOT COMPLETED|Overall Study||0
138422|NCT01717326|338027|P2|NOT COMPLETED|Overall Study||1
138423|NCT01717326|338028|P1|NOT COMPLETED|Overall Study||3
138424|NCT01717326|338009|P20|COMPLETED|Overall Study||15
138425|NCT01717326|338010|P19|COMPLETED|Overall Study||16
138426|NCT01717326|338011|P18|COMPLETED|Overall Study||31
138427|NCT01717326|338012|P17|COMPLETED|Overall Study||29
138428|NCT01717326|338013|P16|COMPLETED|Overall Study||27
138429|NCT01717326|338014|P15|COMPLETED|Overall Study||29
138430|NCT01717326|338015|P14|COMPLETED|Overall Study||32
138431|NCT01717326|338016|P13|COMPLETED|Overall Study||32
138432|NCT01717326|338017|P12|COMPLETED|Overall Study||33
138433|NCT01717326|338018|P11|COMPLETED|Overall Study||30
138434|NCT01717326|338019|P10|COMPLETED|Overall Study||29
138435|NCT01717326|338020|P9|COMPLETED|Overall Study||32
138436|NCT01717326|338021|P8|COMPLETED|Overall Study||29
138437|NCT01717326|338022|P7|COMPLETED|Overall Study||30
138438|NCT01717326|338023|P6|COMPLETED|Overall Study||31
138439|NCT01717326|338024|P5|COMPLETED|Overall Study||31
138440|NCT01717326|338025|P4|COMPLETED|Overall Study||28
138441|NCT01717326|338026|P3|COMPLETED|Overall Study||13
138442|NCT01717326|338027|P2|COMPLETED|Overall Study||26
138443|NCT01717326|338028|P1|COMPLETED|Overall Study||22
138444|NCT01717326|338009|P20|Treated|Overall Study||21
138445|NCT01717326|338010|P19|Treated|Overall Study||20
138446|NCT01717326|338011|P18|Treated|Overall Study||31
138447|NCT01717326|338012|P17|Treated|Overall Study||30
138448|NCT01717326|338013|P16|Treated|Overall Study||30
138449|NCT01717326|338014|P15|Treated|Overall Study||29
138450|NCT01717326|338015|P14|Treated|Overall Study||32
138451|NCT01717326|338016|P13|Treated|Overall Study||33
138452|NCT01717326|338017|P12|Treated|Overall Study||33
138453|NCT01717326|338018|P11|Treated|Overall Study||32
138454|NCT01717326|338019|P10|Treated|Overall Study||31
138455|NCT01717326|338020|P9|Treated|Overall Study||32
138456|NCT01717326|338021|P8|Treated|Overall Study||29
138457|NCT01717326|338022|P7|Treated|Overall Study||31
138458|NCT01717326|338023|P6|Treated|Overall Study||31
138459|NCT01717326|338024|P5|Treated|Overall Study||33
138460|NCT01717326|338025|P4|Treated|Overall Study||30
138461|NCT01717326|338026|P3|Treated|Overall Study|Number excludes 1 participant randomized to A3 but treated on Arm A2|12
138462|NCT01717326|338027|P2|Treated|Overall Study|Number includes 1 additional participant randomized to A3 but treated on A2|28
138463|NCT01717326|338028|P1|Treated|Overall Study||25
138464|NCT01717326|338009|P20|STARTED|Overall Study||21
138465|NCT01717326|338010|P19|STARTED|Overall Study||20
138466|NCT01717326|338011|P18|STARTED|Overall Study||31
138467|NCT01717326|338012|P17|STARTED|Overall Study||30
138468|NCT01717326|338013|P16|STARTED|Overall Study||30
138469|NCT01717326|338014|P15|STARTED|Overall Study||29
138470|NCT01717326|338015|P14|STARTED|Overall Study||32
138471|NCT01717326|338016|P13|STARTED|Overall Study||33
138472|NCT01717326|338017|P12|STARTED|Overall Study||33
138473|NCT01717326|338018|P11|STARTED|Overall Study||32
138474|NCT01717326|338019|P10|STARTED|Overall Study||31
138475|NCT01717326|338020|P9|STARTED|Overall Study||32
138476|NCT01717326|338021|P8|STARTED|Overall Study||29
138477|NCT01717326|338022|P7|STARTED|Overall Study||31
138478|NCT01717326|338023|P6|STARTED|Overall Study||31
138479|NCT01717326|338024|P5|STARTED|Overall Study||33
138480|NCT01717326|338025|P4|STARTED|Overall Study||30
138481|NCT01717326|338026|P3|STARTED|Overall Study||13
138482|NCT01717326|338027|P2|STARTED|Overall Study||27
138483|NCT01717326|338028|P1|STARTED|Overall Study||25
138484|NCT01717313|338292|P2|NOT COMPLETED|Phase B (Weeks 24 to 54)||16
138485|NCT01717313|338293|P1|NOT COMPLETED|Phase B (Weeks 24 to 54)||12
138486|NCT01717313|338292|P2|COMPLETED|Phase B (Weeks 24 to 54)||135
138487|NCT01717313|338293|P1|COMPLETED|Phase B (Weeks 24 to 54)||134
138488|NCT01717313|338292|P2|STARTED|Phase B (Weeks 24 to 54)||151
138489|NCT01717313|338293|P1|STARTED|Phase B (Weeks 24 to 54)||146
138490|NCT01717313|338292|P2|NOT COMPLETED|Interphase||0
138491|NCT01717313|338293|P1|NOT COMPLETED|Interphase||1
138492|NCT01717313|338292|P2|COMPLETED|Interphase||151
138493|NCT01717313|338293|P1|COMPLETED|Interphase||146
138494|NCT01717313|338292|P2|STARTED|Interphase||151
138495|NCT01717313|338293|P1|STARTED|Interphase||147
138496|NCT01717313|338292|P2|NOT COMPLETED|Phase A (Weeks 0 to 24)||13
138497|NCT01717313|338293|P1|NOT COMPLETED|Phase A (Weeks 0 to 24)||18
138498|NCT01717313|338292|P2|COMPLETED|Phase A (Weeks 0 to 24)||151
138499|NCT01717313|338293|P1|COMPLETED|Phase A (Weeks 0 to 24)||147
138500|NCT01717313|338292|P2|STARTED|Phase A (Weeks 0 to 24)||164
138501|NCT01717313|338293|P1|STARTED|Phase A (Weeks 0 to 24)||165
138502|NCT01717287|338331|P2|NOT COMPLETED|Overall Study||3
138503|NCT01717287|338332|P1|NOT COMPLETED|Overall Study||0
138504|NCT01717287|338331|P2|COMPLETED|Overall Study||25
138505|NCT01717287|338332|P1|COMPLETED|Overall Study||4
138506|NCT01717287|338331|P2|STARTED|Overall Study||28
138507|NCT01717287|338332|P1|STARTED|Overall Study||4
138508|NCT01717209|338354|P1|NOT COMPLETED|Overall Study||0
138509|NCT01717209|338354|P1|COMPLETED|Overall Study||14
138510|NCT01717209|338354|P1|STARTED|Overall Study||14
138511|NCT01717053|338363|P1|NOT COMPLETED|Overall Study||4
138512|NCT01717053|338363|P1|COMPLETED|Overall Study||33
138513|NCT01717053|338363|P1|STARTED|Overall Study||37
138514|NCT01717040|338369|P2|NOT COMPLETED|Overall Study||5
138515|NCT01717040|338370|P1|NOT COMPLETED|Overall Study||5
138516|NCT01717040|338369|P2|COMPLETED|Overall Study||15
138517|NCT01717040|338370|P1|COMPLETED|Overall Study||12
138518|NCT01717040|338369|P2|STARTED|Overall Study||20
138519|NCT01717040|338370|P1|STARTED|Overall Study||17
138520|NCT01717014|338376|P1|NOT COMPLETED|Overall Study||0
138521|NCT01717014|338376|P1|COMPLETED|Overall Study||8
138522|NCT01717014|338376|P1|STARTED|Overall Study||8
138523|NCT01716754|338388|P4|NOT COMPLETED|Overall Study||8
138524|NCT01716754|338389|P3|NOT COMPLETED|Overall Study||14
138525|NCT01716754|338390|P2|NOT COMPLETED|Overall Study||4
138526|NCT01716754|338391|P1|NOT COMPLETED|Overall Study||11
138527|NCT01716754|338388|P4|COMPLETED|Overall Study||89
138528|NCT01716754|338389|P3|COMPLETED|Overall Study||121
138529|NCT01716754|338390|P2|COMPLETED|Overall Study||36
138530|NCT01716754|338391|P1|COMPLETED|Overall Study||188
138531|NCT01716754|338388|P4|Safety Set|Overall Study||96
138532|NCT01716754|338389|P3|Safety Set|Overall Study||131
138533|NCT01716754|338390|P2|Safety Set|Overall Study||40
138534|NCT01716754|338391|P1|Safety Set|Overall Study||199
138535|NCT01716754|338388|P4|FAS|Overall Study||96
138536|NCT01716754|338389|P3|FAS|Overall Study||131
138537|NCT01716754|338390|P2|FAS|Overall Study||40
138538|NCT01716754|338391|P1|FAS|Overall Study||199
138539|NCT01716754|338388|P4|STARTED|Overall Study||97
138540|NCT01716754|338389|P3|STARTED|Overall Study||135
138541|NCT01716754|338390|P2|STARTED|Overall Study||40
138542|NCT01716754|338391|P1|STARTED|Overall Study||199
138543|NCT01716663|338412|P1|NOT COMPLETED|Overall Study||6
138544|NCT01716663|338412|P1|COMPLETED|Overall Study|Effectiveness population = enrolled and treated (study device inserted and RF energy applied)|228
138545|NCT01716663|338412|P1|Safety|Overall Study|Enrolled patients who had a study device inserted.|230
138546|NCT01716663|338412|P1|STARTED|Overall Study|Enrolled = signed informed consent and met eligibility requirements|234
138547|NCT01716585|338422|P2|NOT COMPLETED|Open-label Treatment||7
138548|NCT01716585|338423|P1|NOT COMPLETED|Open-label Treatment||0
138549|NCT01716585|338422|P2|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|150
138550|NCT01716585|338423|P1|COMPLETED|Open-label Treatment|not applicable to this arm|0
138551|NCT01716585|338422|P2|STARTED|Open-label Treatment||157
138552|NCT01716585|338423|P1|STARTED|Open-label Treatment|not applicable to this arm|0
138553|NCT01716585|338422|P2|NOT COMPLETED|Double-blind Treatment||2
138554|NCT01716585|338423|P1|NOT COMPLETED|Double-blind Treatment||13
138555|NCT01716585|338422|P2|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|157
138556|NCT01716585|338423|P1|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|464
138557|NCT01716585|338422|P2|Randomized But Not Treated|Double-blind Treatment||1
138558|NCT01716585|338423|P1|Randomized But Not Treated|Double-blind Treatment||4
138559|NCT01716585|338422|P2|STARTED|Double-blind Treatment||159
138560|NCT01716585|338423|P1|STARTED|Double-blind Treatment||477
138561|NCT01716559|338435|P1|NOT COMPLETED|Overall Study||111
138562|NCT01716559|338435|P1|COMPLETED|Overall Study||49
138563|NCT01716559|338435|P1|STARTED|Overall Study||160
138564|NCT01716533|338447|P4|NOT COMPLETED|Overall Study||8
138565|NCT01716533|338448|P3|NOT COMPLETED|Overall Study||5
138566|NCT01716533|338449|P2|NOT COMPLETED|Overall Study||0
138567|NCT01716533|338450|P1|NOT COMPLETED|Overall Study||0
138568|NCT01716533|338447|P4|COMPLETED|Overall Study||1
138569|NCT01716533|338448|P3|COMPLETED|Overall Study||0
138570|NCT01716533|338449|P2|COMPLETED|Overall Study||25
138571|NCT01716533|338450|P1|COMPLETED|Overall Study||7
138572|NCT01716533|338447|P4|STARTED|Overall Study||9
138573|NCT01716533|338448|P3|STARTED|Overall Study||5
138574|NCT01716533|338449|P2|STARTED|Overall Study||25
138575|NCT01716533|338450|P1|STARTED|Overall Study||7
138576|NCT01716520|338504|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||2
138577|NCT01716520|338505|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
138578|NCT01716520|338506|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
138579|NCT01716520|338507|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
138580|NCT01716520|338508|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||0
138581|NCT01716520|338509|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
138582|NCT01716520|338504|P6|COMPLETED|Treatment Period 3 (14 Days)||23
138583|NCT01716520|338505|P5|COMPLETED|Treatment Period 3 (14 Days)||29
138584|NCT01716520|338506|P4|COMPLETED|Treatment Period 3 (14 Days)||28
138585|NCT01716520|338507|P3|COMPLETED|Treatment Period 3 (14 Days)||25
138586|NCT01716520|338508|P2|COMPLETED|Treatment Period 3 (14 Days)||27
138587|NCT01716520|338509|P1|COMPLETED|Treatment Period 3 (14 Days)||27
138588|NCT01716520|338504|P6|STARTED|Treatment Period 3 (14 Days)||25
138589|NCT01716520|338505|P5|STARTED|Treatment Period 3 (14 Days)||29
138590|NCT01716520|338506|P4|STARTED|Treatment Period 3 (14 Days)||28
138591|NCT01716520|338507|P3|STARTED|Treatment Period 3 (14 Days)||26
138592|NCT01716520|338508|P2|STARTED|Treatment Period 3 (14 Days)||27
138593|NCT01716520|338509|P1|STARTED|Treatment Period 3 (14 Days)||27
138594|NCT01716520|338504|P6|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
138595|NCT01716520|338505|P5|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
138596|NCT01716520|338506|P4|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
138597|NCT01716520|338507|P3|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
138598|NCT01716520|338508|P2|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
138599|NCT01716520|338509|P1|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
138600|NCT01716520|338504|P6|COMPLETED|Washout Period 2 (10 to 14 Days)||25
138601|NCT01716520|338505|P5|COMPLETED|Washout Period 2 (10 to 14 Days)||29
138602|NCT01716520|338506|P4|COMPLETED|Washout Period 2 (10 to 14 Days)||28
138603|NCT01716520|338507|P3|COMPLETED|Washout Period 2 (10 to 14 Days)||26
138604|NCT01716520|338508|P2|COMPLETED|Washout Period 2 (10 to 14 Days)||27
138605|NCT01716520|338509|P1|COMPLETED|Washout Period 2 (10 to 14 Days)||27
138606|NCT01716520|338504|P6|STARTED|Washout Period 2 (10 to 14 Days)||27
138607|NCT01716520|338505|P5|STARTED|Washout Period 2 (10 to 14 Days)||29
138608|NCT01716520|338506|P4|STARTED|Washout Period 2 (10 to 14 Days)||28
138609|NCT01716520|338507|P3|STARTED|Washout Period 2 (10 to 14 Days)||27
138610|NCT01716520|338508|P2|STARTED|Washout Period 2 (10 to 14 Days)||28
138611|NCT01716520|338509|P1|STARTED|Washout Period 2 (10 to 14 Days)||29
138612|NCT01716520|338504|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
138613|NCT01716520|338505|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||2
138614|NCT01716520|338506|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
138615|NCT01716520|338507|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||0
138616|NCT01716520|338508|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||0
138617|NCT01716520|338509|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
138618|NCT01716520|338504|P6|COMPLETED|Treatment Period 2 (14 Days)||27
138619|NCT01716520|338505|P5|COMPLETED|Treatment Period 2 (14 Days)||29
138620|NCT01716520|338506|P4|COMPLETED|Treatment Period 2 (14 Days)||28
138621|NCT01716520|338507|P3|COMPLETED|Treatment Period 2 (14 Days)||27
138622|NCT01716520|338508|P2|COMPLETED|Treatment Period 2 (14 Days)||28
138623|NCT01716520|338509|P1|COMPLETED|Treatment Period 2 (14 Days)||29
138624|NCT01716520|338504|P6|STARTED|Treatment Period 2 (14 Days)||27
138625|NCT01716520|338505|P5|STARTED|Treatment Period 2 (14 Days)||31
138626|NCT01716520|338506|P4|STARTED|Treatment Period 2 (14 Days)||29
138627|NCT01716520|338507|P3|STARTED|Treatment Period 2 (14 Days)||27
138628|NCT01716520|338508|P2|STARTED|Treatment Period 2 (14 Days)||28
138629|NCT01716520|338509|P1|STARTED|Treatment Period 2 (14 Days)||29
138630|NCT01716520|338504|P6|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||2
138631|NCT01716520|338505|P5|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
138632|NCT01716520|338506|P4|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
138633|NCT01716520|338507|P3|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
138634|NCT01716520|338508|P2|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
138635|NCT01716520|338509|P1|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
138636|NCT01716520|338504|P6|COMPLETED|Washout Period 1 (10 to 14 Days)||27
138637|NCT01716520|338505|P5|COMPLETED|Washout Period 1 (10 to 14 Days)||31
138638|NCT01716520|338506|P4|COMPLETED|Washout Period 1 (10 to 14 Days)||29
138639|NCT01716520|338507|P3|COMPLETED|Washout Period 1 (10 to 14 Days)||27
138640|NCT01716520|338508|P2|COMPLETED|Washout Period 1 (10 to 14 Days)||28
138641|NCT01716520|338509|P1|COMPLETED|Washout Period 1 (10 to 14 Days)||29
138642|NCT01716520|338504|P6|STARTED|Washout Period 1 (10 to 14 Days)||29
138643|NCT01716520|338505|P5|STARTED|Washout Period 1 (10 to 14 Days)||31
138644|NCT01716520|338506|P4|STARTED|Washout Period 1 (10 to 14 Days)||29
138645|NCT01716520|338507|P3|STARTED|Washout Period 1 (10 to 14 Days)||28
138646|NCT01716520|338508|P2|STARTED|Washout Period 1 (10 to 14 Days)||29
138647|NCT01716520|338509|P1|STARTED|Washout Period 1 (10 to 14 Days)||29
138648|NCT01716520|338504|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||1
138649|NCT01716520|338505|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||0
138650|NCT01716520|338506|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||1
138651|NCT01716520|338507|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||2
138652|NCT01716520|338508|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
138653|NCT01716520|338509|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
138654|NCT01716520|338504|P6|COMPLETED|Treatment Period 1 (14 Days)||29
138655|NCT01716520|338505|P5|COMPLETED|Treatment Period 1 (14 Days)||31
138656|NCT01716520|338506|P4|COMPLETED|Treatment Period 1 (14 Days)||29
138657|NCT01716520|338507|P3|COMPLETED|Treatment Period 1 (14 Days)||28
138658|NCT01716520|338508|P2|COMPLETED|Treatment Period 1 (14 Days)||29
138659|NCT01716520|338509|P1|COMPLETED|Treatment Period 1 (14 Days)||29
138660|NCT01716520|338504|P6|STARTED|Treatment Period 1 (14 Days)||30
138661|NCT01716520|338505|P5|STARTED|Treatment Period 1 (14 Days)||31
138662|NCT01716520|338506|P4|STARTED|Treatment Period 1 (14 Days)||30
138663|NCT01716520|338507|P3|STARTED|Treatment Period 1 (14 Days)||30
138664|NCT01716520|338508|P2|STARTED|Treatment Period 1 (14 Days)||30
138665|NCT01716520|338509|P1|STARTED|Treatment Period 1 (14 Days)||31
138666|NCT01716468|338525|P1|NOT COMPLETED|Overall Study||6
138667|NCT01716468|338525|P1|COMPLETED|Overall Study||11
138668|NCT01716468|338525|P1|STARTED|Overall Study||17
138669|NCT01716455|338535|P6|NOT COMPLETED|Overall Study||0
138670|NCT01716455|338536|P5|NOT COMPLETED|Overall Study||0
138671|NCT01716455|338537|P4|NOT COMPLETED|Overall Study||0
138672|NCT01716455|338538|P3|NOT COMPLETED|Overall Study||0
138673|NCT01716455|338539|P2|NOT COMPLETED|Overall Study||0
138674|NCT01716455|338540|P1|NOT COMPLETED|Overall Study||0
138675|NCT01716455|338535|P6|COMPLETED|Overall Study||8
138676|NCT01716455|338536|P5|COMPLETED|Overall Study||26
138677|NCT01716455|338537|P4|COMPLETED|Overall Study||8
138678|NCT01716455|338538|P3|COMPLETED|Overall Study||8
138679|NCT01716455|338539|P2|COMPLETED|Overall Study||8
138680|NCT01716455|338540|P1|COMPLETED|Overall Study||8
138681|NCT01716455|338535|P6|STARTED|Overall Study||8
138682|NCT01716455|338536|P5|STARTED|Overall Study||26
138683|NCT01716455|338537|P4|STARTED|Overall Study||8
138684|NCT01716455|338538|P3|STARTED|Overall Study||8
138685|NCT01716455|338539|P2|STARTED|Overall Study||8
138686|NCT01716455|338540|P1|STARTED|Overall Study||8
138687|NCT01716234|338564|P7|NOT COMPLETED|Overall Study||0
138688|NCT01716234|338565|P6|NOT COMPLETED|Overall Study||14
138689|NCT01716234|338566|P5|NOT COMPLETED|Overall Study||5
138690|NCT01716234|338567|P4|NOT COMPLETED|Overall Study||12
138691|NCT01716234|338568|P3|NOT COMPLETED|Overall Study||5
138692|NCT01716234|338569|P2|NOT COMPLETED|Overall Study||10
138693|NCT01716234|338570|P1|NOT COMPLETED|Overall Study||10
138694|NCT01716234|338564|P7|COMPLETED|Overall Study||1
138695|NCT01716234|338565|P6|COMPLETED|Overall Study||18
138696|NCT01716234|338566|P5|COMPLETED|Overall Study||10
138697|NCT01716234|338567|P4|COMPLETED|Overall Study||16
138698|NCT01716234|338568|P3|COMPLETED|Overall Study||15
138699|NCT01716234|338569|P2|COMPLETED|Overall Study||12
138700|NCT01716234|338570|P1|COMPLETED|Overall Study||14
138701|NCT01716234|338564|P7|Treated|Overall Study||1
138702|NCT01716234|338565|P6|Treated|Overall Study||30
138703|NCT01716234|338566|P5|Treated|Overall Study||15
138704|NCT01716234|338567|P4|Treated|Overall Study||28
138705|NCT01716234|338568|P3|Treated|Overall Study||19
138706|NCT01716234|338569|P2|Treated|Overall Study||21
138707|NCT01716234|338570|P1|Treated|Overall Study||22
138708|NCT01716234|338564|P7|STARTED|Overall Study||1
138709|NCT01716234|338565|P6|STARTED|Overall Study||32
138710|NCT01716234|338566|P5|STARTED|Overall Study||15
138711|NCT01716234|338567|P4|STARTED|Overall Study||28
138712|NCT01716234|338568|P3|STARTED|Overall Study||20
138713|NCT01716234|338569|P2|STARTED|Overall Study||22
138714|NCT01716234|338570|P1|STARTED|Overall Study||24
138715|NCT01716221|338607|P1|NOT COMPLETED|Overall Study||0
138716|NCT01716221|338607|P1|COMPLETED|Overall Study||1
138717|NCT01716221|338607|P1|STARTED|Overall Study||1
138718|NCT01716169|338633|P1|NOT COMPLETED|Overall Study||4
138719|NCT01716169|338633|P1|COMPLETED|Overall Study||6
138720|NCT01716169|338633|P1|Standard of Care Dressings Used|Overall Study||7
138721|NCT01716169|338633|P1|STARTED|Overall Study||10
138722|NCT01716156|338642|P3|NOT COMPLETED|Overall Study||2
138723|NCT01716156|338643|P2|NOT COMPLETED|Overall Study||1
138724|NCT01716156|338644|P1|NOT COMPLETED|Overall Study||2
138725|NCT01716156|338642|P3|COMPLETED|Overall Study||11
138726|NCT01716156|338643|P2|COMPLETED|Overall Study||3
138727|NCT01716156|338644|P1|COMPLETED|Overall Study||7
138728|NCT01716156|338642|P3|STARTED|Overall Study||13
138729|NCT01716156|338643|P2|STARTED|Overall Study||4
138730|NCT01716156|338644|P1|STARTED|Overall Study||9
138731|NCT01716117|338670|P2|NOT COMPLETED|Overall Study||2
138732|NCT01716117|338671|P1|NOT COMPLETED|Overall Study||7
138733|NCT01716117|338670|P2|COMPLETED|Overall Study||31
138734|NCT01716117|338671|P1|COMPLETED|Overall Study||173
138735|NCT01716117|338670|P2|6-Month Visit|Overall Study||32
138736|NCT01716117|338671|P1|6-Month Visit|Overall Study||174
138737|NCT01716117|338670|P2|1-Month Visit|Overall Study||33
138738|NCT01716117|338671|P1|1-Month Visit|Overall Study||176
138739|NCT01716117|338670|P2|Discharge|Overall Study||33
138740|NCT01716117|338671|P1|Discharge|Overall Study||177
138741|NCT01716117|338670|P2|STARTED|Overall Study||33
138742|NCT01716117|338671|P1|STARTED|Overall Study||180
138743|NCT01716104|338690|P2|NOT COMPLETED|Overall Study||7
138744|NCT01716104|338691|P1|NOT COMPLETED|Overall Study||6
138745|NCT01716104|338690|P2|COMPLETED|Overall Study||117
138746|NCT01716104|338691|P1|COMPLETED|Overall Study||119
138747|NCT01716104|338690|P2|STARTED|Overall Study||124
138748|NCT01716104|338691|P1|STARTED|Overall Study||125
138749|NCT01716052|338717|P2|NOT COMPLETED|Overall Study||1
138750|NCT01716052|338718|P1|NOT COMPLETED|Overall Study||1
138751|NCT01716052|338717|P2|COMPLETED|Overall Study||0
138752|NCT01716052|338718|P1|COMPLETED|Overall Study||0
138753|NCT01716052|338717|P2|STARTED|Overall Study||1
138754|NCT01716052|338718|P1|STARTED|Overall Study||1
138755|NCT01716013|338726|P2|NOT COMPLETED|Overall Study||0
138756|NCT01716013|338727|P1|NOT COMPLETED|Overall Study||3
138757|NCT01716013|338726|P2|COMPLETED|Overall Study||54
138758|NCT01716013|338727|P1|COMPLETED|Overall Study||105
138759|NCT01716013|338726|P2|STARTED|Overall Study||54
138760|NCT01716013|338727|P1|STARTED|Overall Study||108
138761|NCT01715948|338739|P1|NOT COMPLETED|Overall Study||1
138762|NCT01715948|338739|P1|COMPLETED|Overall Study||8
138763|NCT01715948|338739|P1|STARTED|Overall Study||9
138764|NCT01715896|338760|P2|NOT COMPLETED|Overall Study||11
138765|NCT01715896|338761|P1|NOT COMPLETED|Overall Study||3
138766|NCT01715896|338760|P2|COMPLETED|Overall Study||59
138767|NCT01715896|338761|P1|COMPLETED|Overall Study||65
138768|NCT01715896|338760|P2|STARTED|Overall Study||70
138769|NCT01715896|338761|P1|STARTED|Overall Study||68
138770|NCT01715883|338824|P1|NOT COMPLETED|Overall Study||1
138771|NCT01715883|338824|P1|COMPLETED|Overall Study||2
138772|NCT01715883|338824|P1|STARTED|Overall Study||3
138773|NCT01715857|338834|P1|NOT COMPLETED|Overall Study||96
138774|NCT01715857|338834|P1|COMPLETED|Overall Study||4004
138775|NCT01715857|338834|P1|STARTED|Overall Study||4100
138776|NCT01715831|338844|P1|NOT COMPLETED|Overall Study||1
138777|NCT01715831|338844|P1|COMPLETED|Overall Study||25
138778|NCT01715831|338844|P1|STARTED|Overall Study||26
138779|NCT01715805|338860|P4|NOT COMPLETED|Double-Blind or Continued Treatment||48
138780|NCT01715805|338861|P3|NOT COMPLETED|Double-Blind or Continued Treatment||56
138781|NCT01715805|338862|P2|NOT COMPLETED|Double-Blind or Continued Treatment||39
138782|NCT01715805|338863|P1|NOT COMPLETED|Double-Blind or Continued Treatment||0
138783|NCT01715805|338860|P4|COMPLETED|Double-Blind or Continued Treatment||222
138784|NCT01715805|338861|P3|COMPLETED|Double-Blind or Continued Treatment||213
138785|NCT01715805|338862|P2|COMPLETED|Double-Blind or Continued Treatment||222
138786|NCT01715805|338863|P1|COMPLETED|Double-Blind or Continued Treatment||0
138787|NCT01715805|338860|P4|Double-Blind Safety Population|Double-Blind or Continued Treatment||0
138788|NCT01715805|338861|P3|Double-Blind Safety Population|Double-Blind or Continued Treatment||269
138789|NCT01715805|338862|P2|Double-Blind Safety Population|Double-Blind or Continued Treatment||258
138790|NCT01715805|338863|P1|Double-Blind Safety Population|Double-Blind or Continued Treatment||0
138791|NCT01715805|338860|P4|STARTED|Double-Blind or Continued Treatment||270
138792|NCT01715805|338861|P3|STARTED|Double-Blind or Continued Treatment||269
138793|NCT01715805|338862|P2|STARTED|Double-Blind or Continued Treatment||261
138794|NCT01715805|338863|P1|STARTED|Double-Blind or Continued Treatment||0
138795|NCT01715805|338860|P4|NOT COMPLETED|Placebo + ADT Lead-in Period||0
138796|NCT01715805|338861|P3|NOT COMPLETED|Placebo + ADT Lead-in Period||0
138797|NCT01715805|338862|P2|NOT COMPLETED|Placebo + ADT Lead-in Period||0
138798|NCT01715805|338863|P1|NOT COMPLETED|Placebo + ADT Lead-in Period||215
138799|NCT01715805|338860|P4|COMPLETED|Placebo + ADT Lead-in Period||0
138800|NCT01715805|338861|P3|COMPLETED|Placebo + ADT Lead-in Period||0
138801|NCT01715805|338862|P2|COMPLETED|Placebo + ADT Lead-in Period||0
138802|NCT01715805|338863|P1|COMPLETED|Placebo + ADT Lead-in Period||807
138803|NCT01715805|338860|P4|STARTED|Placebo + ADT Lead-in Period||0
138804|NCT01715805|338861|P3|STARTED|Placebo + ADT Lead-in Period||0
138805|NCT01715805|338862|P2|STARTED|Placebo + ADT Lead-in Period||0
138806|NCT01715805|338863|P1|STARTED|Placebo + ADT Lead-in Period||1022
138807|NCT01715415|338877|P2|NOT COMPLETED|Open-label Treatment||2
138808|NCT01715415|338878|P1|NOT COMPLETED|Open-label Treatment||0
138809|NCT01715415|338877|P2|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|94
138810|NCT01715415|338878|P1|COMPLETED|Open-label Treatment|not applicable to this arm|0
138811|NCT01715415|338877|P2|STARTED|Open-label Treatment||96
138812|NCT01715415|338878|P1|STARTED|Open-label Treatment|not applicable to this arm|0
138813|NCT01715415|338877|P2|NOT COMPLETED|Double-blind Treatment||2
138814|NCT01715415|338878|P1|NOT COMPLETED|Double-blind Treatment||5
138815|NCT01715415|338877|P2|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|96
138816|NCT01715415|338878|P1|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|292
138817|NCT01715415|338877|P2|Randomized But Not Treated|Double-blind Treatment||1
138818|NCT01715415|338878|P1|Randomized But Not Treated|Double-blind Treatment||0
138819|NCT01715415|338877|P2|STARTED|Double-blind Treatment||98
138820|NCT01715415|338878|P1|STARTED|Double-blind Treatment||297
138821|NCT01715298|338892|P2|NOT COMPLETED|Overall Study||11
138822|NCT01715298|338893|P1|NOT COMPLETED|Overall Study||7
138823|NCT01715298|338892|P2|COMPLETED|Overall Study||205
138824|NCT01715298|338893|P1|COMPLETED|Overall Study||209
138825|NCT01715298|338892|P2|Full Analysis Set (FAS)|Overall Study||214
138826|NCT01715298|338893|P1|Full Analysis Set (FAS)|Overall Study|patients were analyzed according to the treatment to which they were randomized|215
138827|NCT01715298|338892|P2|STARTED|Overall Study||216
138828|NCT01715298|338893|P1|STARTED|Overall Study||216
138829|NCT01715285|338931|P3|NOT COMPLETED|Open-label (OL) Extension Phase||72
138830|NCT01715285|338932|P2|NOT COMPLETED|Open-label (OL) Extension Phase||0
138831|NCT01715285|338933|P1|NOT COMPLETED|Open-label (OL) Extension Phase||157
138832|NCT01715285|338931|P3|COMPLETED|Open-label (OL) Extension Phase||0
138833|NCT01715285|338932|P2|COMPLETED|Open-label (OL) Extension Phase||0
138834|NCT01715285|338933|P1|COMPLETED|Open-label (OL) Extension Phase||0
138835|NCT01715285|338931|P3|STARTED|Open-label (OL) Extension Phase||72
138836|NCT01715285|338932|P2|STARTED|Open-label (OL) Extension Phase||0
138837|NCT01715285|338933|P1|STARTED|Open-label (OL) Extension Phase||157
138838|NCT01715285|338931|P3|NOT COMPLETED|Treatment Period||0
138839|NCT01715285|338932|P2|NOT COMPLETED|Treatment Period||602
138840|NCT01715285|338933|P1|NOT COMPLETED|Treatment Period||597
138841|NCT01715285|338931|P3|COMPLETED|Treatment Period||0
138842|NCT01715285|338932|P2|COMPLETED|Treatment Period||0
138843|NCT01715285|338933|P1|COMPLETED|Treatment Period||0
138844|NCT01715285|338931|P3|Safety Population|Treatment Period||0
138845|NCT01715285|338932|P2|Safety Population|Treatment Period||602
138846|NCT01715285|338933|P1|Safety Population|Treatment Period||597
138847|NCT01715285|338931|P3|ITT Population|Treatment Period||0
138848|NCT01715285|338932|P2|ITT Population|Treatment Period||602
138849|NCT01715285|338933|P1|ITT Population|Treatment Period||597
138850|NCT01715285|338931|P3|STARTED|Treatment Period||0
138851|NCT01715285|338932|P2|STARTED|Treatment Period||602
138852|NCT01715285|338933|P1|STARTED|Treatment Period||597
138853|NCT01715233|338952|P1|NOT COMPLETED|Overall Study||0
138854|NCT01715233|338952|P1|COMPLETED|Overall Study||21
138855|NCT01715233|338952|P1|STARTED|Overall Study||21
138856|NCT01715207|338960|P2|NOT COMPLETED|Overall Study||1
138857|NCT01715207|338961|P1|NOT COMPLETED|Overall Study||1
138858|NCT01715207|338960|P2|COMPLETED|Overall Study||14
138859|NCT01715207|338961|P1|COMPLETED|Overall Study||14
138860|NCT01715207|338960|P2|STARTED|Overall Study||15
138861|NCT01715207|338961|P1|STARTED|Overall Study||15
138862|NCT01715129|338969|P1|NOT COMPLETED|Overall Study||9
138863|NCT01715129|338969|P1|COMPLETED|Overall Study||117
138864|NCT01715129|338969|P1|STARTED|Overall Study||126
138865|NCT01715064|338988|P2|NOT COMPLETED|Overall Study||0
138866|NCT01715064|338989|P1|NOT COMPLETED|Overall Study||0
138867|NCT01715064|338988|P2|COMPLETED|Overall Study||18
138868|NCT01715064|338989|P1|COMPLETED|Overall Study||18
138869|NCT01715064|338988|P2|STARTED|Overall Study||18
138870|NCT01715064|338989|P1|STARTED|Overall Study||18
138871|NCT01714947|338995|P1|NOT COMPLETED|Part B||3
138872|NCT01714947|338995|P1|COMPLETED|Part B||0
138873|NCT01714947|338995|P1|STARTED|Part B||3
138874|NCT01714947|338995|P1|NOT COMPLETED|Part A||0
138875|NCT01714947|338995|P1|COMPLETED|Part A||3
138876|NCT01714947|338995|P1|STARTED|Part A||3
138877|NCT01714921|339024|P1|NOT COMPLETED|Overall Study||193
138878|NCT01714921|339024|P1|COMPLETED|Overall Study||311
138879|NCT01714921|339024|P1|STARTED|Overall Study||504
138880|NCT01714817|339036|P2|NOT COMPLETED|Overall Study||42
138881|NCT01714817|339037|P1|NOT COMPLETED|Overall Study||48
138882|NCT01714817|339036|P2|COMPLETED|Overall Study|Completed = continued study through Year 1|161
138883|NCT01714817|339037|P1|COMPLETED|Overall Study|Completed = continued study through Year 1|155
138884|NCT01714817|339036|P2|Treated|Overall Study||203
138885|NCT01714817|339037|P1|Treated|Overall Study||202
138886|NCT01714817|339036|P2|STARTED|Overall Study||203
138887|NCT01714817|339037|P1|STARTED|Overall Study||203
138888|NCT01714804|339058|P2|NOT COMPLETED|Overall Study||0
138889|NCT01714804|339059|P1|NOT COMPLETED|Overall Study||1
138890|NCT01714804|339058|P2|COMPLETED|Overall Study||30
138891|NCT01714804|339059|P1|COMPLETED|Overall Study||29
138892|NCT01714804|339058|P2|STARTED|Overall Study||30
138893|NCT01714804|339059|P1|STARTED|Overall Study||30
138894|NCT01714726|339069|P4|NOT COMPLETED|Open-Label Period||28
138895|NCT01714726|339070|P3|NOT COMPLETED|Open-Label Period||19
138896|NCT01714726|339071|P2|NOT COMPLETED|Open-Label Period||0
138897|NCT01714726|339072|P1|NOT COMPLETED|Open-Label Period||0
138898|NCT01714726|339069|P4|COMPLETED|Open-Label Period||24
138899|NCT01714726|339070|P3|COMPLETED|Open-Label Period||33
138900|NCT01714726|339071|P2|COMPLETED|Open-Label Period||0
138901|NCT01714726|339072|P1|COMPLETED|Open-Label Period||0
138902|NCT01714726|339069|P4|STARTED|Open-Label Period||52
138903|NCT01714726|339070|P3|STARTED|Open-Label Period||52
138904|NCT01714726|339071|P2|STARTED|Open-Label Period||0
138905|NCT01714726|339072|P1|STARTED|Open-Label Period||0
138906|NCT01714726|339069|P4|NOT COMPLETED|Double-Blinded Induction Period||0
138907|NCT01714726|339070|P3|NOT COMPLETED|Double-Blinded Induction Period||0
138908|NCT01714726|339071|P2|NOT COMPLETED|Double-Blinded Induction Period||7
138909|NCT01714726|339072|P1|NOT COMPLETED|Double-Blinded Induction Period||8
138910|NCT01714726|339069|P4|COMPLETED|Double-Blinded Induction Period||0
138911|NCT01714726|339070|P3|COMPLETED|Double-Blinded Induction Period||0
138912|NCT01714726|339071|P2|COMPLETED|Double-Blinded Induction Period||52
138913|NCT01714726|339072|P1|COMPLETED|Double-Blinded Induction Period||52
138914|NCT01714726|339069|P4|STARTED|Double-Blinded Induction Period||0
138915|NCT01714726|339070|P3|STARTED|Double-Blinded Induction Period||0
138916|NCT01714726|339071|P2|STARTED|Double-Blinded Induction Period||59
138917|NCT01714726|339072|P1|STARTED|Double-Blinded Induction Period||60
138918|NCT01714687|339152|P2|NOT COMPLETED|Overall Study||4
138919|NCT01714687|339153|P1|NOT COMPLETED|Overall Study||3
138920|NCT01714687|339152|P2|COMPLETED|Overall Study||26
138921|NCT01714687|339153|P1|COMPLETED|Overall Study||26
138922|NCT01714687|339152|P2|STARTED|Overall Study||30
138923|NCT01714687|339153|P1|STARTED|Overall Study||29
138924|NCT01714635|339177|P3|NOT COMPLETED|Overall Study||2
138925|NCT01714635|339178|P2|NOT COMPLETED|Overall Study||0
138926|NCT01714635|339179|P1|NOT COMPLETED|Overall Study||2
138927|NCT01714635|339177|P3|COMPLETED|Overall Study||146
138928|NCT01714635|339178|P2|COMPLETED|Overall Study||150
138929|NCT01714635|339179|P1|COMPLETED|Overall Study||145
138930|NCT01714635|339177|P3|STARTED|Overall Study||148
138931|NCT01714635|339178|P2|STARTED|Overall Study||150
138932|NCT01714635|339179|P1|STARTED|Overall Study||147
138933|NCT01714609|339195|P2|NOT COMPLETED|Overall Study||0
138934|NCT01714609|339196|P1|NOT COMPLETED|Overall Study||1
138935|NCT01714609|339195|P2|COMPLETED|Overall Study||5
138936|NCT01714609|339196|P1|COMPLETED|Overall Study||4
138937|NCT01714609|339195|P2|STARTED|Overall Study||5
138938|NCT01714609|339196|P1|STARTED|Overall Study||5
138939|NCT01714544|339202|P1|NOT COMPLETED|Overall Study||3
138940|NCT01714544|339202|P1|COMPLETED|Overall Study||57
138941|NCT01714544|339202|P1|STARTED|Overall Study||60
138942|NCT01714505|339206|P2|NOT COMPLETED|Admission 2 (40 Hours)||0
138943|NCT01714505|339207|P1|NOT COMPLETED|Admission 2 (40 Hours)||0
138944|NCT01714505|339206|P2|COMPLETED|Admission 2 (40 Hours)||9
138945|NCT01714505|339207|P1|COMPLETED|Admission 2 (40 Hours)||9
138946|NCT01714505|339206|P2|STARTED|Admission 2 (40 Hours)||9
138947|NCT01714505|339207|P1|STARTED|Admission 2 (40 Hours)||9
138948|NCT01714505|339206|P2|NOT COMPLETED|Admission 1 (40 Hours)||1
138949|NCT01714505|339207|P1|NOT COMPLETED|Admission 1 (40 Hours)||1
138950|NCT01714505|339206|P2|COMPLETED|Admission 1 (40 Hours)||9
138951|NCT01714505|339207|P1|COMPLETED|Admission 1 (40 Hours)||9
138952|NCT01714505|339206|P2|STARTED|Admission 1 (40 Hours)||10
138953|NCT01714505|339207|P1|STARTED|Admission 1 (40 Hours)||10
138954|NCT01714492|339217|P1|NOT COMPLETED|Overall Study||0
138955|NCT01714492|339217|P1|COMPLETED|Overall Study||8
138956|NCT01714492|339217|P1|STARTED|Overall Study||8
138957|NCT01714336|339228|P2|NOT COMPLETED|Overall Study||0
138958|NCT01714336|339229|P1|NOT COMPLETED|Overall Study||0
138959|NCT01714336|339228|P2|COMPLETED|Overall Study||69
138960|NCT01714336|339229|P1|COMPLETED|Overall Study||69
138961|NCT01714336|339228|P2|STARTED|Overall Study||69
138962|NCT01714336|339229|P1|STARTED|Overall Study||69
138963|NCT01714323|339251|P2|NOT COMPLETED|Overall Study||172
138964|NCT01714323|339252|P1|NOT COMPLETED|Overall Study||164
138965|NCT01714323|339251|P2|COMPLETED|Overall Study||508
138966|NCT01714323|339252|P1|COMPLETED|Overall Study||513
138967|NCT01714323|339251|P2|STARTED|Overall Study||680
138968|NCT01714323|339252|P1|STARTED|Overall Study||677
138969|NCT01714310|339273|P3|NOT COMPLETED|Double Blind Adjunctive Treatment||0
138970|NCT01714310|339274|P2|NOT COMPLETED|Double Blind Adjunctive Treatment||3
138971|NCT01714310|339275|P1|NOT COMPLETED|Double Blind Adjunctive Treatment||2
138972|NCT01714310|339273|P3|COMPLETED|Double Blind Adjunctive Treatment||0
138973|NCT01714310|339274|P2|COMPLETED|Double Blind Adjunctive Treatment||11
138974|NCT01714310|339275|P1|COMPLETED|Double Blind Adjunctive Treatment||10
138975|NCT01714310|339273|P3|STARTED|Double Blind Adjunctive Treatment|No one remained on lisdexamfetamine alone in Period 2.|0
138976|NCT01714310|339274|P2|STARTED|Double Blind Adjunctive Treatment|Adjunctive placebo was initiated at beginning of Period 2, at study week 4.|14
138977|NCT01714310|339275|P1|STARTED|Double Blind Adjunctive Treatment|Adjunctive fluoxetine treatment was initiated at beginning of Period 2, at study week 4.|12
138978|NCT01714310|339273|P3|NOT COMPLETED|Open Lisdexamfetamine Titration||4
138979|NCT01714310|339274|P2|NOT COMPLETED|Open Lisdexamfetamine Titration||0
138980|NCT01714310|339275|P1|NOT COMPLETED|Open Lisdexamfetamine Titration||0
138981|NCT01714310|339273|P3|COMPLETED|Open Lisdexamfetamine Titration||30
138982|NCT01714310|339274|P2|COMPLETED|Open Lisdexamfetamine Titration||0
138983|NCT01714310|339275|P1|COMPLETED|Open Lisdexamfetamine Titration||0
138984|NCT01714310|339273|P3|STARTED|Open Lisdexamfetamine Titration||34
138985|NCT01714310|339274|P2|STARTED|Open Lisdexamfetamine Titration||0
138986|NCT01714310|339275|P1|STARTED|Open Lisdexamfetamine Titration||0
138987|NCT01714232|339322|P1|NOT COMPLETED|Overall Study||0
138988|NCT01714232|339322|P1|COMPLETED|Overall Study||106
138989|NCT01714232|339322|P1|STARTED|Overall Study||106
138990|NCT01714063|339328|P1|NOT COMPLETED|Overall Study||2
138991|NCT01714063|339328|P1|COMPLETED|Overall Study||32
138992|NCT01714063|339328|P1|STARTED|Overall Study||34
138993|NCT01714024|339343|P3|NOT COMPLETED|Overall Study||3
138994|NCT01714024|339344|P2|NOT COMPLETED|Overall Study||6
138995|NCT01714024|339345|P1|NOT COMPLETED|Overall Study||1
138996|NCT01714024|339343|P3|COMPLETED|Overall Study||8
138997|NCT01714024|339344|P2|COMPLETED|Overall Study||12
138998|NCT01714024|339345|P1|COMPLETED|Overall Study||12
138999|NCT01714024|339343|P3|STARTED|Overall Study||11
139000|NCT01714024|339344|P2|STARTED|Overall Study||18
139001|NCT01714024|339345|P1|STARTED|Overall Study||13
139002|NCT01713998|339365|P3|NOT COMPLETED|Overall Study||2
139003|NCT01713998|339366|P2|NOT COMPLETED|Overall Study||0
139004|NCT01713998|339367|P1|NOT COMPLETED|Overall Study||3
139005|NCT01713998|339365|P3|COMPLETED|Overall Study||14
139006|NCT01713998|339366|P2|COMPLETED|Overall Study||15
139007|NCT01713998|339367|P1|COMPLETED|Overall Study||13
139008|NCT01713998|339365|P3|STARTED|Overall Study||16
139009|NCT01713998|339366|P2|STARTED|Overall Study||15
139010|NCT01713998|339367|P1|STARTED|Overall Study||16
139011|NCT01713946|339388|P3|NOT COMPLETED|Overall Study||44
139012|NCT01713946|339389|P2|NOT COMPLETED|Overall Study||45
139013|NCT01713946|339390|P1|NOT COMPLETED|Overall Study||43
139014|NCT01713946|339388|P3|COMPLETED|Overall Study||75
139015|NCT01713946|339389|P2|COMPLETED|Overall Study||85
139016|NCT01713946|339390|P1|COMPLETED|Overall Study||74
139017|NCT01713946|339388|P3|Did Not Cont. in Post-Ext Phase|Overall Study||0
139018|NCT01713946|339389|P2|Did Not Cont. in Post-Ext Phase|Overall Study||2
139019|NCT01713946|339390|P1|Did Not Cont. in Post-Ext Phase|Overall Study||1
139020|NCT01713946|339388|P3|Did Not Continue in Ext Phase|Overall Study||0
139021|NCT01713946|339389|P2|Did Not Continue in Ext Phase|Overall Study||3
139022|NCT01713946|339390|P1|Did Not Continue in Ext Phase|Overall Study||0
139023|NCT01713946|339388|P3|Completed Post-Ext Phase|Overall Study||75
139024|NCT01713946|339389|P2|Completed Post-Ext Phase|Overall Study||85
139025|NCT01713946|339390|P1|Completed Post-Ext Phase|Overall Study||74
139026|NCT01713946|339388|P3|Continued in Post-Ext. Phase|Overall Study||81
139027|NCT01713946|339389|P2|Continued in Post-Ext. Phase|Overall Study||90
139028|NCT01713946|339390|P1|Continued in Post-Ext. Phase|Overall Study||78
139029|NCT01713946|339388|P3|Completed Ext. Phase|Overall Study||81
139030|NCT01713946|339389|P2|Completed Ext. Phase|Overall Study||92
139031|NCT01713946|339390|P1|Completed Ext. Phase|Overall Study||79
139032|NCT01713946|339388|P3|Continued in Ext. Phase|Overall Study||114
139033|NCT01713946|339389|P2|Continued in Ext. Phase|Overall Study||119
139034|NCT01713946|339390|P1|Continued in Ext. Phase|Overall Study||110
139035|NCT01713946|339388|P3|Completed Core Phase|Overall Study||114
139036|NCT01713946|339389|P2|Completed Core Phase|Overall Study||122
139037|NCT01713946|339390|P1|Completed Core Phase|Overall Study||110
139038|NCT01713946|339388|P3|STARTED|Overall Study|Of the 119 patients initially randomized to the Placebo arm, 5 patients never switched to everolimus|119
139039|NCT01713946|339389|P2|STARTED|Overall Study||130
139040|NCT01713946|339390|P1|STARTED|Overall Study||117
139041|NCT01713933|339481|P1|NOT COMPLETED|Overall Study||6
139042|NCT01713933|339481|P1|COMPLETED|Overall Study||31
139043|NCT01713933|339481|P1|STARTED|Overall Study||37
139044|NCT01713868|339497|P4|NOT COMPLETED|Overall Study||95
139045|NCT01713868|339498|P3|NOT COMPLETED|Overall Study||80
139046|NCT01713868|339499|P2|NOT COMPLETED|Overall Study||65
139047|NCT01713868|339500|P1|NOT COMPLETED|Overall Study||97
139048|NCT01713868|339497|P4|COMPLETED|Overall Study||305
139049|NCT01713868|339498|P3|COMPLETED|Overall Study||320
139050|NCT01713868|339499|P2|COMPLETED|Overall Study||335
139051|NCT01713868|339500|P1|COMPLETED|Overall Study||303
139052|NCT01713868|339497|P4|STARTED|Overall Study||400
139053|NCT01713868|339498|P3|STARTED|Overall Study||400
139054|NCT01713868|339499|P2|STARTED|Overall Study||400
139055|NCT01713868|339500|P1|STARTED|Overall Study||400
139056|NCT01713686|339530|P1|NOT COMPLETED|Overall Study||15
139057|NCT01713686|339530|P1|COMPLETED|Overall Study||110
139058|NCT01713686|339530|P1|STARTED|Overall Study|129 enrolled, 125 treated. 2 withdrew consent prior to treatment; 2 excluded after enrollment.|125
139059|NCT01713660|339539|P1|NOT COMPLETED|Overall Study||0
139060|NCT01713660|339539|P1|COMPLETED|Overall Study||37
139061|NCT01713660|339539|P1|STARTED|Overall Study||37
139062|NCT01713621|339547|P2|NOT COMPLETED|Overall Study||16
139063|NCT01713621|339548|P1|NOT COMPLETED|Overall Study||7
139064|NCT01713621|339547|P2|COMPLETED|Overall Study||1
139065|NCT01713621|339548|P1|COMPLETED|Overall Study||1
139066|NCT01713621|339547|P2|STARTED|Overall Study||17
139067|NCT01713621|339548|P1|STARTED|Overall Study||8
139068|NCT01713608|339558|P4|NOT COMPLETED|Overall Study||0
139069|NCT01713608|339559|P3|NOT COMPLETED|Overall Study||0
139070|NCT01713608|339560|P2|NOT COMPLETED|Overall Study||0
139071|NCT01713608|339561|P1|NOT COMPLETED|Overall Study||0
139072|NCT01713608|339558|P4|COMPLETED|Overall Study||12
139073|NCT01713608|339559|P3|COMPLETED|Overall Study||8
139074|NCT01713608|339560|P2|COMPLETED|Overall Study||6
139075|NCT01713608|339561|P1|COMPLETED|Overall Study||8
139076|NCT01713608|339558|P4|STARTED|Overall Study||12
139077|NCT01713608|339559|P3|STARTED|Overall Study||8
139078|NCT01713608|339560|P2|STARTED|Overall Study||6
139079|NCT01713608|339561|P1|STARTED|Overall Study||8
139080|NCT01713582|339600|P21|NOT COMPLETED|Overall Study||15
139081|NCT01713582|339601|P20|NOT COMPLETED|Overall Study||5
139082|NCT01713582|339602|P19|NOT COMPLETED|Overall Study||5
139083|NCT01713582|339603|P18|NOT COMPLETED|Overall Study||3
139084|NCT01713582|339604|P17|NOT COMPLETED|Overall Study||7
139085|NCT01713582|339605|P16|NOT COMPLETED|Overall Study||6
139086|NCT01713582|339606|P15|NOT COMPLETED|Overall Study||7
139087|NCT01713582|339607|P14|NOT COMPLETED|Overall Study||4
139088|NCT01713582|339608|P13|NOT COMPLETED|Overall Study||3
139089|NCT01713582|339609|P12|NOT COMPLETED|Overall Study||5
139090|NCT01713582|339610|P11|NOT COMPLETED|Overall Study||16
139091|NCT01713582|339611|P10|NOT COMPLETED|Overall Study||18
139092|NCT01713582|339612|P9|NOT COMPLETED|Overall Study||6
139093|NCT01713582|339613|P8|NOT COMPLETED|Overall Study||6
139094|NCT01713582|339614|P7|NOT COMPLETED|Overall Study||7
139095|NCT01713582|339615|P6|NOT COMPLETED|Overall Study||8
139096|NCT01713582|339616|P5|NOT COMPLETED|Overall Study||4
139097|NCT01713582|339617|P4|NOT COMPLETED|Overall Study||3
139098|NCT01713582|339618|P3|NOT COMPLETED|Overall Study||4
139099|NCT01713582|339619|P2|NOT COMPLETED|Overall Study||3
139100|NCT01713582|339620|P1|NOT COMPLETED|Overall Study||3
139101|NCT01713582|339600|P21|COMPLETED|Overall Study||0
139102|NCT01713582|339601|P20|COMPLETED|Overall Study||0
139103|NCT01713582|339602|P19|COMPLETED|Overall Study||0
139104|NCT01713582|339603|P18|COMPLETED|Overall Study||0
139105|NCT01713582|339604|P17|COMPLETED|Overall Study||0
139106|NCT01713582|339605|P16|COMPLETED|Overall Study||0
139107|NCT01713582|339606|P15|COMPLETED|Overall Study||0
139108|NCT01713582|339607|P14|COMPLETED|Overall Study||0
139109|NCT01713582|339608|P13|COMPLETED|Overall Study||0
139110|NCT01713582|339609|P12|COMPLETED|Overall Study||0
139111|NCT01713582|339610|P11|COMPLETED|Overall Study||0
139112|NCT01713582|339611|P10|COMPLETED|Overall Study||0
139113|NCT01713582|339612|P9|COMPLETED|Overall Study||0
139114|NCT01713582|339613|P8|COMPLETED|Overall Study||0
139115|NCT01713582|339614|P7|COMPLETED|Overall Study||0
139116|NCT01713582|339615|P6|COMPLETED|Overall Study||0
139117|NCT01713582|339616|P5|COMPLETED|Overall Study||0
139118|NCT01713582|339617|P4|COMPLETED|Overall Study||0
139119|NCT01713582|339618|P3|COMPLETED|Overall Study||0
139120|NCT01713582|339619|P2|COMPLETED|Overall Study||0
139121|NCT01713582|339620|P1|COMPLETED|Overall Study||0
139122|NCT01713582|339600|P21|STARTED|Overall Study|Number treated|15
139123|NCT01713582|339601|P20|STARTED|Overall Study|Number treated|5
139124|NCT01713582|339602|P19|STARTED|Overall Study|Number treated|5
139125|NCT01713582|339603|P18|STARTED|Overall Study|Number treated|3
139126|NCT01713582|339604|P17|STARTED|Overall Study|Number treated|7
139127|NCT01713582|339605|P16|STARTED|Overall Study|Number treated|6
139128|NCT01713582|339606|P15|STARTED|Overall Study|Number treated|7
139129|NCT01713582|339607|P14|STARTED|Overall Study|Number treated|4
139130|NCT01713582|339608|P13|STARTED|Overall Study|Number treated|3
139131|NCT01713582|339609|P12|STARTED|Overall Study|Number treated|5
139132|NCT01713582|339610|P11|STARTED|Overall Study|Number treated|16
139133|NCT01713582|339611|P10|STARTED|Overall Study|Number treated|18
139134|NCT01713582|339612|P9|STARTED|Overall Study|Number treated|6
139135|NCT01713582|339613|P8|STARTED|Overall Study|Number treated|6
139136|NCT01713582|339614|P7|STARTED|Overall Study|Number treated|7
139137|NCT01713582|339615|P6|STARTED|Overall Study|Number treated|8
139138|NCT01713582|339616|P5|STARTED|Overall Study|Number treated|4
139139|NCT01713582|339617|P4|STARTED|Overall Study|Number treated|3
139140|NCT01713582|339618|P3|STARTED|Overall Study|Number treated|4
139141|NCT01713582|339619|P2|STARTED|Overall Study|Number treated|3
139142|NCT01713582|339620|P1|STARTED|Overall Study|Number treated|3
139143|NCT01713530|339783|P2|NOT COMPLETED|Overall Study||19
139144|NCT01713530|339784|P1|NOT COMPLETED|Overall Study||25
139145|NCT01713530|339783|P2|COMPLETED|Overall Study||117
139146|NCT01713530|339784|P1|COMPLETED|Overall Study||113
139147|NCT01713530|339783|P2|Exposed|Overall Study|One (1) subject was withdrawn by the investigator|135
139148|NCT01713530|339784|P1|Exposed|Overall Study|One (1) subject was randomised in error and 1 subject withdrew consent|136
139149|NCT01713530|339783|P2|STARTED|Overall Study||136
139150|NCT01713530|339784|P1|STARTED|Overall Study||138
139151|NCT01713400|339802|P2|NOT COMPLETED|Overall Study||0
139152|NCT01713400|339803|P1|NOT COMPLETED|Overall Study||0
139153|NCT01713400|339802|P2|COMPLETED|Overall Study||15
139154|NCT01713400|339803|P1|COMPLETED|Overall Study||15
139155|NCT01713400|339802|P2|STARTED|Overall Study||15
139156|NCT01713400|339803|P1|STARTED|Overall Study||15
139157|NCT01713348|339815|P4|NOT COMPLETED|Overall Study||0
139158|NCT01713348|339816|P3|NOT COMPLETED|Overall Study||2
139159|NCT01713348|339817|P2|NOT COMPLETED|Overall Study||2
139160|NCT01713348|339818|P1|NOT COMPLETED|Overall Study||4
139161|NCT01713348|339815|P4|COMPLETED|Overall Study||15
139162|NCT01713348|339816|P3|COMPLETED|Overall Study||28
139163|NCT01713348|339817|P2|COMPLETED|Overall Study||11
139164|NCT01713348|339818|P1|COMPLETED|Overall Study||25
139165|NCT01713348|339815|P4|STARTED|Overall Study||15
139166|NCT01713348|339816|P3|STARTED|Overall Study||30
139167|NCT01713348|339817|P2|STARTED|Overall Study||13
139168|NCT01713348|339818|P1|STARTED|Overall Study||29
139169|NCT01713283|339848|P2|NOT COMPLETED|Overall Study||3
139170|NCT01713283|339849|P1|NOT COMPLETED|Overall Study||11
139171|NCT01713283|339848|P2|COMPLETED|Overall Study||26
139172|NCT01713283|339849|P1|COMPLETED|Overall Study||20
139173|NCT01713283|339848|P2|STARTED|Overall Study||29
139174|NCT01713283|339849|P1|STARTED|Overall Study||31
139175|NCT01713036|339871|P1|NOT COMPLETED|Overall Study||1
139176|NCT01713036|339871|P1|COMPLETED|Overall Study||5
139177|NCT01713036|339871|P1|STARTED|Overall Study||6
139178|NCT01712984|339911|P3|NOT COMPLETED|Overall Study||10
139179|NCT01712984|339912|P2|NOT COMPLETED|Overall Study||16
139180|NCT01712984|339913|P1|NOT COMPLETED|Overall Study||16
139181|NCT01712984|339911|P3|COMPLETED|Overall Study||836
139182|NCT01712984|339912|P2|COMPLETED|Overall Study||821
139183|NCT01712984|339913|P1|COMPLETED|Overall Study||1656
139184|NCT01712984|339911|P3|STARTED|Overall Study||846
139185|NCT01712984|339912|P2|STARTED|Overall Study||837
139186|NCT01712984|339913|P1|STARTED|Overall Study||1672
139187|NCT01712854|339933|P1|NOT COMPLETED|Overall Study||1
139188|NCT01712854|339933|P1|COMPLETED|Overall Study||8
139189|NCT01712854|339933|P1|STARTED|Overall Study||9
139190|NCT01712776|339940|P2|NOT COMPLETED|Overall Study||0
139191|NCT01712776|339941|P1|NOT COMPLETED|Overall Study||0
139192|NCT01712776|339940|P2|COMPLETED|Overall Study||50
139193|NCT01712776|339941|P1|COMPLETED|Overall Study|trial to enroll 50 in each group for total of 100|50
139194|NCT01712776|339940|P2|STARTED|Overall Study||50
139195|NCT01712776|339941|P1|STARTED|Overall Study||50
139196|NCT01712711|339949|P2|NOT COMPLETED|Overall Study||0
139197|NCT01712711|339950|P1|NOT COMPLETED|Overall Study||0
139198|NCT01712711|339949|P2|COMPLETED|Overall Study||20
139199|NCT01712711|339950|P1|COMPLETED|Overall Study||20
139200|NCT01712711|339949|P2|STARTED|Overall Study||20
139201|NCT01712711|339950|P1|STARTED|Overall Study||20
139202|NCT01712685|339956|P1|NOT COMPLETED|Overall Study||1
139203|NCT01712685|339956|P1|COMPLETED|Overall Study||11
139204|NCT01712685|339956|P1|STARTED|Overall Study||12
139205|NCT01712516|339972|P4|NOT COMPLETED|Overall Study||13
139206|NCT01712516|339973|P3|NOT COMPLETED|Overall Study||6
139207|NCT01712516|339974|P2|NOT COMPLETED|Overall Study||10
139208|NCT01712516|339975|P1|NOT COMPLETED|Overall Study||6
139209|NCT01712516|339972|P4|COMPLETED|Overall Study||236
139210|NCT01712516|339973|P3|COMPLETED|Overall Study||245
139211|NCT01712516|339974|P2|COMPLETED|Overall Study||241
139212|NCT01712516|339975|P1|COMPLETED|Overall Study||244
139213|NCT01712516|339972|P4|Full Analysis Set|Overall Study||247
139214|NCT01712516|339973|P3|Full Analysis Set|Overall Study||250
139215|NCT01712516|339974|P2|Full Analysis Set|Overall Study||251
139216|NCT01712516|339975|P1|Full Analysis Set|Overall Study||250
139217|NCT01712516|339972|P4|Safety Set|Overall Study||248
139218|NCT01712516|339973|P3|Safety Set|Overall Study||251
139219|NCT01712516|339974|P2|Safety Set|Overall Study||251
139220|NCT01712516|339975|P1|Safety Set|Overall Study||250
139221|NCT01712516|339972|P4|STARTED|Overall Study||249
139222|NCT01712516|339973|P3|STARTED|Overall Study||251
139223|NCT01712516|339974|P2|STARTED|Overall Study||251
139224|NCT01712516|339975|P1|STARTED|Overall Study||250
139225|NCT01712490|340027|P2|NOT COMPLETED|Overall Study||670
139226|NCT01712490|340028|P1|NOT COMPLETED|Overall Study||664
139227|NCT01712490|340027|P2|COMPLETED|Overall Study||0
139228|NCT01712490|340028|P1|COMPLETED|Overall Study||0
139229|NCT01712490|340027|P2|Treated|Overall Study||659
139230|NCT01712490|340028|P1|Treated|Overall Study||662
139231|NCT01712490|340027|P2|STARTED|Overall Study||670
139232|NCT01712490|340028|P1|STARTED|Overall Study||664
139233|NCT01712438|340065|P1|NOT COMPLETED|Overall Study||37
139234|NCT01712438|340065|P1|COMPLETED|Overall Study||73
139235|NCT01712438|340065|P1|SURG Population|Overall Study||24
139236|NCT01712438|340065|P1|BLEED Population|Overall Study||94
139237|NCT01712438|340065|P1|PROPH Population|Overall Study||103
139238|NCT01712438|340065|P1|PP Population|Overall Study||95
139239|NCT01712438|340065|P1|ITT Population|Overall Study||108
139240|NCT01712438|340065|P1|SAF Population|Overall Study||108
139241|NCT01712438|340065|P1|STARTED|Overall Study||110
139242|NCT01712399|340075|P1|NOT COMPLETED|Overall Study||397
139243|NCT01712399|340075|P1|COMPLETED|Overall Study||0
139244|NCT01712399|340075|P1|STARTED|Overall Study||397
139245|NCT01712360|340092|P4|NOT COMPLETED|Overall Study||2
139246|NCT01712360|340093|P3|NOT COMPLETED|Overall Study||0
139247|NCT01712360|340094|P2|NOT COMPLETED|Overall Study||1
139248|NCT01712360|340095|P1|NOT COMPLETED|Overall Study||0
139249|NCT01712360|340092|P4|COMPLETED|Overall Study||4
139250|NCT01712360|340093|P3|COMPLETED|Overall Study||6
139251|NCT01712360|340094|P2|COMPLETED|Overall Study||21
139252|NCT01712360|340095|P1|COMPLETED|Overall Study||22
139253|NCT01712360|340092|P4|STARTED|Overall Study||6
139254|NCT01712360|340093|P3|STARTED|Overall Study||6
139255|NCT01712360|340094|P2|STARTED|Overall Study||22
139256|NCT01712360|340095|P1|STARTED|Overall Study||22
139257|NCT01712334|340121|P2|NOT COMPLETED|Treatment Period 2||0
139258|NCT01712334|340122|P1|NOT COMPLETED|Treatment Period 2||0
139259|NCT01712334|340121|P2|COMPLETED|Treatment Period 2||41
139260|NCT01712334|340122|P1|COMPLETED|Treatment Period 2||44
139261|NCT01712334|340121|P2|STARTED|Treatment Period 2||41
139262|NCT01712334|340122|P1|STARTED|Treatment Period 2||44
139263|NCT01712334|340121|P2|NOT COMPLETED|Treatment Period 1||2
139264|NCT01712334|340122|P1|NOT COMPLETED|Treatment Period 1||0
139265|NCT01712334|340121|P2|COMPLETED|Treatment Period 1||41
139266|NCT01712334|340122|P1|COMPLETED|Treatment Period 1||44
139267|NCT01712334|340121|P2|Received Treatment|Treatment Period 1||41
139268|NCT01712334|340122|P1|Received Treatment|Treatment Period 1||44
139269|NCT01712334|340121|P2|STARTED|Treatment Period 1||43
139270|NCT01712334|340122|P1|STARTED|Treatment Period 1||44
139271|NCT01712256|340130|P1|NOT COMPLETED|Overall Study||1
139272|NCT01712256|340130|P1|COMPLETED|Overall Study||32
139273|NCT01712256|340130|P1|STARTED|Overall Study||33
139274|NCT01712230|340142|P3|NOT COMPLETED|Overall Study||7
139275|NCT01712230|340143|P2|NOT COMPLETED|Overall Study||4
139276|NCT01712230|340144|P1|NOT COMPLETED|Overall Study||2
139277|NCT01712230|340142|P3|COMPLETED|Overall Study||11
139278|NCT01712230|340143|P2|COMPLETED|Overall Study||14
139279|NCT01712230|340144|P1|COMPLETED|Overall Study||9
139280|NCT01712230|340142|P3|STARTED|Overall Study||18
139281|NCT01712230|340143|P2|STARTED|Overall Study||18
139282|NCT01712230|340144|P1|STARTED|Overall Study||11
139283|NCT01712204|340160|P2|NOT COMPLETED|Overall Study||5
139284|NCT01712204|340161|P1|NOT COMPLETED|Overall Study||8
139285|NCT01712204|340160|P2|COMPLETED|Overall Study||36
139286|NCT01712204|340161|P1|COMPLETED|Overall Study||33
139287|NCT01712204|340160|P2|STARTED|Overall Study||41
139288|NCT01712204|340161|P1|STARTED|Overall Study||41
139289|NCT01712178|340169|P2|NOT COMPLETED|Overall Study||3
139290|NCT01712178|340170|P1|NOT COMPLETED|Overall Study||1
139291|NCT01712178|340169|P2|COMPLETED|Overall Study||47
139292|NCT01712178|340170|P1|COMPLETED|Overall Study||49
139293|NCT01712178|340169|P2|STARTED|Overall Study||50
139294|NCT01712178|340170|P1|STARTED|Overall Study||50
139295|NCT01712074|340195|P3|NOT COMPLETED|Double Blind Period||8
139296|NCT01712074|340196|P2|NOT COMPLETED|Double Blind Period||14
139297|NCT01712074|340197|P1|NOT COMPLETED|Double Blind Period||0
139298|NCT01712074|340195|P3|COMPLETED|Double Blind Period||86
139299|NCT01712074|340196|P2|COMPLETED|Double Blind Period||77
139300|NCT01712074|340197|P1|COMPLETED|Double Blind Period||0
139301|NCT01712074|340195|P3|STARTED|Double Blind Period||94
139302|NCT01712074|340196|P2|STARTED|Double Blind Period||91
139303|NCT01712074|340197|P1|STARTED|Double Blind Period||0
139304|NCT01712074|340195|P3|NOT COMPLETED|Placebo Run-in Period||0
139305|NCT01712074|340196|P2|NOT COMPLETED|Placebo Run-in Period||0
139306|NCT01712074|340197|P1|NOT COMPLETED|Placebo Run-in Period||10
139307|NCT01712074|340195|P3|COMPLETED|Placebo Run-in Period||0
139308|NCT01712074|340196|P2|COMPLETED|Placebo Run-in Period||0
139309|NCT01712074|340197|P1|COMPLETED|Placebo Run-in Period||185
139310|NCT01712074|340195|P3|STARTED|Placebo Run-in Period||0
139311|NCT01712074|340196|P2|STARTED|Placebo Run-in Period||0
139312|NCT01712074|340197|P1|STARTED|Placebo Run-in Period||195
139313|NCT01712061|340253|P3|NOT COMPLETED|Overall Study||11
139314|NCT01712061|340254|P2|NOT COMPLETED|Overall Study||26
139315|NCT01712061|340255|P1|NOT COMPLETED|Overall Study||10
139316|NCT01712061|340253|P3|COMPLETED|Overall Study||45
139317|NCT01712061|340254|P2|COMPLETED|Overall Study||114
139318|NCT01712061|340255|P1|COMPLETED|Overall Study||20
139319|NCT01712061|340253|P3|STARTED|Overall Study||56
139320|NCT01712061|340254|P2|STARTED|Overall Study||140
139321|NCT01712061|340255|P1|STARTED|Overall Study||30
139322|NCT01712009|340295|P3|NOT COMPLETED|Overall Study||21
139323|NCT01712009|340296|P2|NOT COMPLETED|Overall Study||29
139324|NCT01712009|340297|P1|NOT COMPLETED|Overall Study||38
139325|NCT01712009|340295|P3|COMPLETED|Overall Study||181
139326|NCT01712009|340296|P2|COMPLETED|Overall Study||171
139327|NCT01712009|340297|P1|COMPLETED|Overall Study||160
139328|NCT01712009|340295|P3|Received Naproxen / Loratadine|Overall Study||198
139329|NCT01712009|340296|P2|Received Naproxen / Loratadine|Overall Study||193
139330|NCT01712009|340297|P1|Received Naproxen / Loratadine|Overall Study||0
139331|NCT01712009|340295|P3|Received Pegfilgrastim|Overall Study||200
139332|NCT01712009|340296|P2|Received Pegfilgrastim|Overall Study||196
139333|NCT01712009|340297|P1|Received Pegfilgrastim|Overall Study||191
139334|NCT01712009|340295|P3|STARTED|Overall Study||202
139335|NCT01712009|340296|P2|STARTED|Overall Study||200
139336|NCT01712009|340297|P1|STARTED|Overall Study||198
139337|NCT01711918|340323|P1|NOT COMPLETED|Overall Study||2
139338|NCT01711918|340323|P1|COMPLETED|Overall Study||7
139339|NCT01711918|340323|P1|STARTED|Overall Study||9
139340|NCT01711866|340331|P1|NOT COMPLETED|Overall Study||8
139341|NCT01711866|340331|P1|COMPLETED|Overall Study||79
139342|NCT01711866|340331|P1|STARTED|Overall Study||87
139343|NCT01711853|340336|P1|NOT COMPLETED|Overall Study||3
139344|NCT01711853|340336|P1|COMPLETED|Overall Study||16
139345|NCT01711853|340336|P1|STARTED|Overall Study||19
139346|NCT01711736|340343|P2|NOT COMPLETED|Overall Study||8
139347|NCT01711736|340344|P1|NOT COMPLETED|Overall Study||12
139348|NCT01711736|340343|P2|COMPLETED|Overall Study|Up to Day 180|294
139349|NCT01711736|340344|P1|COMPLETED|Overall Study|Up to Day 180|287
139350|NCT01711736|340343|P2|STARTED|Overall Study||302
139351|NCT01711736|340344|P1|STARTED|Overall Study||299
139352|NCT01711645|340372|P1|NOT COMPLETED|Overall Study||19
139353|NCT01711645|340372|P1|COMPLETED|Overall Study||36
139354|NCT01711645|340372|P1|STARTED|Overall Study||55
139355|NCT01711619|340409|P2|NOT COMPLETED|Overall Study||24
139356|NCT01711619|340410|P1|NOT COMPLETED|Overall Study||18
139357|NCT01711619|340409|P2|COMPLETED|Overall Study||36
139358|NCT01711619|340410|P1|COMPLETED|Overall Study||38
139359|NCT01711619|340409|P2|STARTED|Overall Study||60
139360|NCT01711619|340410|P1|STARTED|Overall Study||56
139361|NCT01711541|340427|P5|NOT COMPLETED|Overall Study||0
139362|NCT01711541|340428|P4|NOT COMPLETED|Overall Study||1
139363|NCT01711541|340429|P3|NOT COMPLETED|Overall Study||0
139364|NCT01711541|340430|P2|NOT COMPLETED|Overall Study||1
139365|NCT01711541|340431|P1|NOT COMPLETED|Overall Study||0
139366|NCT01711541|340427|P5|COMPLETED|Overall Study||7
139367|NCT01711541|340428|P4|COMPLETED|Overall Study||5
139368|NCT01711541|340429|P3|COMPLETED|Overall Study||3
139369|NCT01711541|340430|P2|COMPLETED|Overall Study||3
139370|NCT01711541|340431|P1|COMPLETED|Overall Study||4
139371|NCT01711541|340427|P5|STARTED|Overall Study||7
139372|NCT01711541|340428|P4|STARTED|Overall Study||6
139373|NCT01711541|340429|P3|STARTED|Overall Study||3
139374|NCT01711541|340430|P2|STARTED|Overall Study||4
139375|NCT01711541|340431|P1|STARTED|Overall Study||4
139376|NCT01711424|340460|P1|NOT COMPLETED|Overall Study||0
139377|NCT01711424|340460|P1|COMPLETED|Overall Study||1209
139378|NCT01711424|340460|P1|STARTED|Overall Study||1209
139379|NCT01711359|340470|P3|NOT COMPLETED|Follow Up||28
139380|NCT01711359|340471|P2|NOT COMPLETED|Follow Up||15
139381|NCT01711359|340472|P1|NOT COMPLETED|Follow Up||25
139382|NCT01711359|340470|P3|COMPLETED|Follow Up||0
139383|NCT01711359|340471|P2|COMPLETED|Follow Up||0
139384|NCT01711359|340472|P1|COMPLETED|Follow Up||0
139385|NCT01711359|340470|P3|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|28
139386|NCT01711359|340471|P2|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|15
139387|NCT01711359|340472|P1|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|25
139388|NCT01711359|340470|P3|NOT COMPLETED|Treatment Period||42
139389|NCT01711359|340471|P2|NOT COMPLETED|Treatment Period||24
139390|NCT01711359|340472|P1|NOT COMPLETED|Treatment Period||52
139391|NCT01711359|340470|P3|COMPLETED|Treatment Period||173
139392|NCT01711359|340471|P2|COMPLETED|Treatment Period||136
139393|NCT01711359|340472|P1|COMPLETED|Treatment Period||161
139394|NCT01711359|340470|P3|Rescued|Treatment Period||6
139395|NCT01711359|340471|P2|Rescued|Treatment Period||7
139396|NCT01711359|340472|P1|Rescued|Treatment Period||26
139397|NCT01711359|340470|P3|Received at Least One Dose of Study Drug|Treatment Period||215
139398|NCT01711359|340471|P2|Received at Least One Dose of Study Drug|Treatment Period||159
139399|NCT01711359|340472|P1|Received at Least One Dose of Study Drug|Treatment Period||210
139400|NCT01711359|340470|P3|STARTED|Treatment Period||215
139401|NCT01711359|340471|P2|STARTED|Treatment Period||160
139402|NCT01711359|340472|P1|STARTED|Treatment Period||213
139403|NCT01711216|340543|P1|NOT COMPLETED|Overall Study||217
139404|NCT01711216|340543|P1|COMPLETED|Overall Study||782
139405|NCT01711216|340543|P1|STARTED|Overall Study||999
139406|NCT01711177|340567|P3|NOT COMPLETED|Overall Study||0
139407|NCT01711177|340568|P2|NOT COMPLETED|Overall Study||0
139408|NCT01711177|340569|P1|NOT COMPLETED|Overall Study||0
139409|NCT01711177|340567|P3|COMPLETED|Overall Study||3
139410|NCT01711177|340568|P2|COMPLETED|Overall Study||3
139411|NCT01711177|340569|P1|COMPLETED|Overall Study||10
139412|NCT01711177|340567|P3|STARTED|Overall Study||3
139413|NCT01711177|340568|P2|STARTED|Overall Study||3
139414|NCT01711177|340569|P1|STARTED|Overall Study||10
139415|NCT01710891|340579|P2|NOT COMPLETED|Overall Study||0
139416|NCT01710891|340580|P1|NOT COMPLETED|Overall Study||0
139417|NCT01710891|340579|P2|COMPLETED|Overall Study||103
139418|NCT01710891|340580|P1|COMPLETED|Overall Study||95
139419|NCT01710891|340579|P2|STARTED|Overall Study||103
139420|NCT01710891|340580|P1|STARTED|Overall Study||95
139421|NCT01710839|340598|P2|NOT COMPLETED|Overall Study||6
139422|NCT01710839|340599|P1|NOT COMPLETED|Overall Study||1
139423|NCT01710839|340598|P2|COMPLETED|Overall Study||0
139424|NCT01710839|340599|P1|COMPLETED|Overall Study||23
139425|NCT01710839|340598|P2|STARTED|Overall Study||6
139426|NCT01710839|340599|P1|STARTED|Overall Study||24
139427|NCT01710800|340621|P1|NOT COMPLETED|Overall Study||22
139428|NCT01710800|340621|P1|COMPLETED|Overall Study|22 drop outs(consented but did not participate, refused 2nd intervention)|41
139429|NCT01710800|340621|P1|Received Placebo Intervention|Overall Study||45
139430|NCT01710800|340621|P1|Received PPI Intervention|Overall Study||44
139431|NCT01710800|340621|P1|STARTED|Overall Study|63 patients consented to be part of the study|63
139432|NCT01710787|340630|P3|NOT COMPLETED|Overall Study||0
139433|NCT01710787|340631|P2|NOT COMPLETED|Overall Study||0
139434|NCT01710787|340632|P1|NOT COMPLETED|Overall Study||0
139435|NCT01710787|340630|P3|COMPLETED|Overall Study||22
139436|NCT01710787|340631|P2|COMPLETED|Overall Study||44
139437|NCT01710787|340632|P1|COMPLETED|Overall Study||44
139438|NCT01710787|340630|P3|STARTED|Overall Study||22
139439|NCT01710787|340631|P2|STARTED|Overall Study||44
139440|NCT01710787|340632|P1|STARTED|Overall Study||44
139441|NCT01710709|340685|P1|NOT COMPLETED|Overall Study||173
139442|NCT01710709|340685|P1|COMPLETED|Overall Study||291
139443|NCT01710709|340685|P1|STARTED|Overall Study||464
139444|NCT01710657|340700|P3|NOT COMPLETED|Overall Study||32
139445|NCT01710657|340701|P2|NOT COMPLETED|Overall Study||12
139446|NCT01710657|340702|P1|NOT COMPLETED|Overall Study||18
139447|NCT01710657|340700|P3|COMPLETED|Overall Study||148
139448|NCT01710657|340701|P2|COMPLETED|Overall Study||171
139449|NCT01710657|340702|P1|COMPLETED|Overall Study||166
139450|NCT01710657|340700|P3|Maintenance Period (12 Weeks)|Overall Study||168
139451|NCT01710657|340701|P2|Maintenance Period (12 Weeks)|Overall Study||175
139452|NCT01710657|340702|P1|Maintenance Period (12 Weeks)|Overall Study||176
139453|NCT01710657|340700|P3|Titration Period (4 Weeks)|Overall Study||180
139454|NCT01710657|340701|P2|Titration Period (4 Weeks)|Overall Study||183
139455|NCT01710657|340702|P1|Titration Period (4 Weeks)|Overall Study||184
139456|NCT01710657|340700|P3|STARTED|Overall Study||180
139457|NCT01710657|340701|P2|STARTED|Overall Study||183
139458|NCT01710657|340702|P1|STARTED|Overall Study||184
139459|NCT01710527|340719|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
139460|NCT01710527|340720|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
139461|NCT01710527|340719|P2|COMPLETED|Period 3: Intervention Period 2||15
139462|NCT01710527|340720|P1|COMPLETED|Period 3: Intervention Period 2||16
139463|NCT01710527|340719|P2|STARTED|Period 3: Intervention Period 2||15
139464|NCT01710527|340720|P1|STARTED|Period 3: Intervention Period 2||16
139465|NCT01710527|340719|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||1
139466|NCT01710527|340720|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
139467|NCT01710527|340719|P2|COMPLETED|Period 2: Washout Period (7 Days)||15
139468|NCT01710527|340720|P1|COMPLETED|Period 2: Washout Period (7 Days)||16
139469|NCT01710527|340719|P2|STARTED|Period 2: Washout Period (7 Days)||16
139470|NCT01710527|340720|P1|STARTED|Period 2: Washout Period (7 Days)||16
139471|NCT01710527|340719|P2|NOT COMPLETED|Period 1: Intervention Period 1||0
139472|NCT01710527|340720|P1|NOT COMPLETED|Period 1: Intervention Period 1||0
139473|NCT01710527|340719|P2|COMPLETED|Period 1: Intervention Period 1||16
139474|NCT01710527|340720|P1|COMPLETED|Period 1: Intervention Period 1||16
139475|NCT01710527|340719|P2|STARTED|Period 1: Intervention Period 1||16
139476|NCT01710527|340720|P1|STARTED|Period 1: Intervention Period 1||16
139477|NCT01710514|340746|P2|NOT COMPLETED|Overall Study||7
139478|NCT01710514|340747|P1|NOT COMPLETED|Overall Study||7
139479|NCT01710514|340746|P2|COMPLETED|Overall Study||47
139480|NCT01710514|340747|P1|COMPLETED|Overall Study||47
139481|NCT01710514|340746|P2|Safety Analysis Set|Overall Study|All subjects received at least one dose of IMP.|54
139482|NCT01710514|340747|P1|Safety Analysis Set|Overall Study|All subjects received at least one dose of Investigational Medicinal Product (IMP).|54
139483|NCT01710514|340746|P2|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|47
139484|NCT01710514|340747|P1|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|43
139485|NCT01710514|340746|P2|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|48
139486|NCT01710514|340747|P1|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|46
139487|NCT01710514|340746|P2|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the ITT analysis set.|54
139488|NCT01710514|340747|P1|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the Intent-To-Treat (ITT) analysis set.|54
139489|NCT01710514|340746|P2|STARTED|Overall Study||54
139490|NCT01710514|340747|P1|STARTED|Overall Study||54
139491|NCT01710501|340768|P3|NOT COMPLETED|Overall Study||0
139492|NCT01710501|340769|P2|NOT COMPLETED|Overall Study||0
139493|NCT01710501|340770|P1|NOT COMPLETED|Overall Study||2
139494|NCT01710501|340768|P3|COMPLETED|Overall Study||30
139495|NCT01710501|340769|P2|COMPLETED|Overall Study||28
139496|NCT01710501|340770|P1|COMPLETED|Overall Study||27
139497|NCT01710501|340768|P3|STARTED|Overall Study||30
139498|NCT01710501|340769|P2|STARTED|Overall Study||28
139499|NCT01710501|340770|P1|STARTED|Overall Study||29
139500|NCT01710358|340802|P3|NOT COMPLETED|Follow-up Period||0
139501|NCT01710358|340803|P2|NOT COMPLETED|Follow-up Period||0
139502|NCT01710358|340804|P1|NOT COMPLETED|Follow-up Period||0
139503|NCT01710358|340802|P3|COMPLETED|Follow-up Period||20
139504|NCT01710358|340803|P2|COMPLETED|Follow-up Period||76
139505|NCT01710358|340804|P1|COMPLETED|Follow-up Period||33
139506|NCT01710358|340802|P3|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|20
139579|NCT01710046|340937|P1|NOT COMPLETED|Overall Study||1
139507|NCT01710358|340803|P2|STARTED|Follow-up Period|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4mg follow up.|76
139508|NCT01710358|340804|P1|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|33
139509|NCT01710358|340802|P3|NOT COMPLETED|Rescue Period||0
139510|NCT01710358|340803|P2|NOT COMPLETED|Rescue Period||31
139511|NCT01710358|340804|P1|NOT COMPLETED|Rescue Period||0
139512|NCT01710358|340802|P3|COMPLETED|Rescue Period||0
139513|NCT01710358|340803|P2|COMPLETED|Rescue Period||196
139514|NCT01710358|340804|P1|COMPLETED|Rescue Period||0
139515|NCT01710358|340802|P3|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
139516|NCT01710358|340803|P2|STARTED|Rescue Period|Baricitinib 4 mg administered PO QD through Week 52. Participants continued background MTX therapy.|227
139517|NCT01710358|340804|P1|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
139518|NCT01710358|340802|P3|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||15
139519|NCT01710358|340803|P2|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||22
139520|NCT01710358|340804|P1|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||16
139521|NCT01710358|340802|P3|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|252
139522|NCT01710358|340803|P2|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|402
139523|NCT01710358|340804|P1|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|294
139524|NCT01710358|340802|P3|Rescued|Treatment Period Part B (Weeks 24 to 52)||11
139525|NCT01710358|340803|P2|Rescued|Treatment Period Part B (Weeks 24 to 52)||8
139526|NCT01710358|340804|P1|Rescued|Treatment Period Part B (Weeks 24 to 52)||5
139527|NCT01710358|340802|P3|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||267
139528|NCT01710358|340803|P2|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||424
139529|NCT01710358|340804|P1|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)|Participants originally randomized to placebo received baricitinib during Part B.|306
139530|NCT01710358|340802|P3|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|267
139531|NCT01710358|340803|P2|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|424
139532|NCT01710358|340804|P1|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|310
139533|NCT01710358|340802|P3|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||23
139534|NCT01710358|340803|P2|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||29
139535|NCT01710358|340804|P1|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||51
139536|NCT01710358|340802|P3|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|307
139537|NCT01710358|340803|P2|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|459
139538|NCT01710358|340804|P1|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|438
139539|NCT01710358|340802|P3|Rescued|Treatment Period Part A (Weeks 0 to 24)||40
139540|NCT01710358|340803|P2|Rescued|Treatment Period Part A (Weeks 0 to 24)||35
139541|NCT01710358|340804|P1|Rescued|Treatment Period Part A (Weeks 0 to 24)||128
139542|NCT01710358|340802|P3|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||330
139543|NCT01710358|340803|P2|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||487
139544|NCT01710358|340804|P1|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||488
139545|NCT01710358|340802|P3|STARTED|Treatment Period Part A (Weeks 0 to 24)||330
139546|NCT01710358|340803|P2|STARTED|Treatment Period Part A (Weeks 0 to 24)||488
139547|NCT01710358|340804|P1|STARTED|Treatment Period Part A (Weeks 0 to 24)||489
139548|NCT01710345|340875|P3|NOT COMPLETED|Overall Study||1
139549|NCT01710345|340876|P2|NOT COMPLETED|Overall Study||5
139550|NCT01710345|340877|P1|NOT COMPLETED|Overall Study||3
139551|NCT01710345|340875|P3|COMPLETED|Overall Study||19
139552|NCT01710345|340876|P2|COMPLETED|Overall Study||35
139553|NCT01710345|340877|P1|COMPLETED|Overall Study||37
139554|NCT01710345|340875|P3|STARTED|Overall Study||20
139555|NCT01710345|340876|P2|STARTED|Overall Study||40
139556|NCT01710345|340877|P1|STARTED|Overall Study|41 patients were randomized to sufentanil 20 mcg, one patient not dosed due to damaged medication.|40
139557|NCT01710332|340887|P2|NOT COMPLETED|Overall Study||0
139558|NCT01710332|340888|P1|NOT COMPLETED|Overall Study||0
139559|NCT01710332|340887|P2|COMPLETED|Overall Study||6
139560|NCT01710332|340888|P1|COMPLETED|Overall Study||6
139561|NCT01710332|340887|P2|STARTED|Overall Study||6
139562|NCT01710332|340888|P1|STARTED|Overall Study||6
139563|NCT01710306|340898|P2|NOT COMPLETED|Overall Study||30
139564|NCT01710306|340899|P1|NOT COMPLETED|Overall Study||18
139565|NCT01710306|340898|P2|COMPLETED|Overall Study||55
139566|NCT01710306|340899|P1|COMPLETED|Overall Study||68
139567|NCT01710306|340898|P2|STARTED|Overall Study||85
139568|NCT01710306|340899|P1|STARTED|Overall Study||86
139569|NCT01710254|340907|P1|NOT COMPLETED|Overall Study||0
139570|NCT01710254|340907|P1|COMPLETED|Overall Study||30
139571|NCT01710254|340907|P1|STARTED|Overall Study||30
139572|NCT01710137|340915|P2|NOT COMPLETED|Overall Study||14
139573|NCT01710137|340916|P1|NOT COMPLETED|Overall Study||24
139574|NCT01710137|340915|P2|COMPLETED|Overall Study||76
139575|NCT01710137|340916|P1|COMPLETED|Overall Study||65
139576|NCT01710137|340915|P2|STARTED|Overall Study||90
139577|NCT01710137|340916|P1|STARTED|Overall Study||89
139578|NCT01710046|340936|P2|NOT COMPLETED|Overall Study||0
139580|NCT01710046|340936|P2|COMPLETED|Overall Study||3
139581|NCT01710046|340937|P1|COMPLETED|Overall Study||8
139582|NCT01710046|340936|P2|STARTED|Overall Study||3
139583|NCT01710046|340937|P1|STARTED|Overall Study||9
139584|NCT01710033|340977|P5|NOT COMPLETED|Stage 2||1
139585|NCT01710033|340978|P4|NOT COMPLETED|Stage 2||0
139586|NCT01710033|340979|P3|NOT COMPLETED|Stage 2||0
139587|NCT01710033|340980|P2|NOT COMPLETED|Stage 2||0
139588|NCT01710033|340981|P1|NOT COMPLETED|Stage 2||0
139589|NCT01710033|340977|P5|COMPLETED|Stage 2||3
139590|NCT01710033|340978|P4|COMPLETED|Stage 2||0
139591|NCT01710033|340979|P3|COMPLETED|Stage 2||0
139592|NCT01710033|340980|P2|COMPLETED|Stage 2||0
139593|NCT01710033|340981|P1|COMPLETED|Stage 2||0
139594|NCT01710033|340977|P5|STARTED|Stage 2||4
139595|NCT01710033|340978|P4|STARTED|Stage 2||0
139596|NCT01710033|340979|P3|STARTED|Stage 2||0
139597|NCT01710033|340980|P2|STARTED|Stage 2||0
139598|NCT01710033|340981|P1|STARTED|Stage 2||0
139599|NCT01710033|340977|P5|NOT COMPLETED|Stage 1||0
139600|NCT01710033|340978|P4|NOT COMPLETED|Stage 1||0
139601|NCT01710033|340979|P3|NOT COMPLETED|Stage 1||0
139602|NCT01710033|340980|P2|NOT COMPLETED|Stage 1||0
139603|NCT01710033|340981|P1|NOT COMPLETED|Stage 1||0
139604|NCT01710033|340977|P5|COMPLETED|Stage 1||0
139605|NCT01710033|340978|P4|COMPLETED|Stage 1||6
139606|NCT01710033|340979|P3|COMPLETED|Stage 1||6
139607|NCT01710033|340980|P2|COMPLETED|Stage 1||6
139608|NCT01710033|340981|P1|COMPLETED|Stage 1||6
139609|NCT01710033|340977|P5|STARTED|Stage 1||0
139610|NCT01710033|340978|P4|STARTED|Stage 1||6
139611|NCT01710033|340979|P3|STARTED|Stage 1||6
139612|NCT01710033|340980|P2|STARTED|Stage 1||6
139613|NCT01710033|340981|P1|STARTED|Stage 1||6
139614|NCT01710020|341062|P1|NOT COMPLETED|Period 2||0
139615|NCT01710020|341062|P1|COMPLETED|Period 2||11
139616|NCT01710020|341062|P1|STARTED|Period 2||11
139617|NCT01710020|341062|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
139618|NCT01710020|341062|P1|COMPLETED|Washout Period (at Least 14 Days)||11
139619|NCT01710020|341062|P1|STARTED|Washout Period (at Least 14 Days)||11
139620|NCT01710020|341062|P1|NOT COMPLETED|Period 1||1
139621|NCT01710020|341062|P1|COMPLETED|Period 1||11
139622|NCT01710020|341062|P1|STARTED|Period 1||12
139623|NCT01709903|341081|P2|NOT COMPLETED|Overall Study||39
139624|NCT01709903|341082|P1|NOT COMPLETED|Overall Study||29
139625|NCT01709903|341081|P2|COMPLETED|Overall Study||333
139626|NCT01709903|341082|P1|COMPLETED|Overall Study||343
139627|NCT01709903|341081|P2|STARTED|Overall Study|Randomized set|372
139628|NCT01709903|341082|P1|STARTED|Overall Study|Randomized set|372
139629|NCT01709864|341106|P2|NOT COMPLETED|Overall Study||11
139630|NCT01709864|341107|P1|NOT COMPLETED|Overall Study||7
139631|NCT01709864|341106|P2|COMPLETED|Overall Study||208
139632|NCT01709864|341107|P1|COMPLETED|Overall Study||215
139633|NCT01709864|341106|P2|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|201
139634|NCT01709864|341107|P1|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|204
139635|NCT01709864|341106|P2|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|216
139636|NCT01709864|341107|P1|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|222
139637|NCT01709864|341106|P2|STARTED|Overall Study||219
139638|NCT01709864|341107|P1|STARTED|Overall Study||222
139639|NCT01709838|341141|P1|NOT COMPLETED|Overall Study||67
139640|NCT01709838|341141|P1|COMPLETED|Overall Study||67
139641|NCT01709838|341141|P1|STARTED|Overall Study||134
139642|NCT01709799|341164|P3|NOT COMPLETED|Overall Study||3
139643|NCT01709799|341165|P2|NOT COMPLETED|Overall Study||3
139644|NCT01709799|341166|P1|NOT COMPLETED|Overall Study||3
139645|NCT01709799|341164|P3|COMPLETED|Overall Study||15
139646|NCT01709799|341165|P2|COMPLETED|Overall Study||18
139647|NCT01709799|341166|P1|COMPLETED|Overall Study||22
139648|NCT01709799|341164|P3|STARTED|Overall Study||18
139649|NCT01709799|341165|P2|STARTED|Overall Study||21
139650|NCT01709799|341166|P1|STARTED|Overall Study||25
139651|NCT01709786|341189|P1|NOT COMPLETED|Overall Study||0
139652|NCT01709786|341189|P1|COMPLETED|Overall Study||88
139653|NCT01709786|341189|P1|STARTED|Overall Study||88
139654|NCT01709708|341198|P2|NOT COMPLETED|Overall Study||2
139655|NCT01709708|341199|P1|NOT COMPLETED|Overall Study||1
139656|NCT01709708|341198|P2|COMPLETED|Overall Study||12
139657|NCT01709708|341199|P1|COMPLETED|Overall Study||26
139658|NCT01709708|341198|P2|STARTED|Overall Study||14
139659|NCT01709708|341199|P1|STARTED|Overall Study||27
139660|NCT01709695|341223|P2|NOT COMPLETED|Overall Study||1
139661|NCT01709695|341224|P1|NOT COMPLETED|Overall Study||1
139662|NCT01709695|341223|P2|COMPLETED|Overall Study||13
139663|NCT01709695|341224|P1|COMPLETED|Overall Study||12
139664|NCT01709695|341223|P2|STARTED|Overall Study||14
139665|NCT01709695|341224|P1|STARTED|Overall Study||13
139666|NCT01709578|341249|P3|NOT COMPLETED|Overall Study||51
139667|NCT01709578|341250|P2|NOT COMPLETED|Overall Study||56
139668|NCT01709578|341251|P1|NOT COMPLETED|Overall Study||80
139669|NCT01709578|341249|P3|COMPLETED|Overall Study||133
139670|NCT01709578|341250|P2|COMPLETED|Overall Study||125
139671|NCT01709578|341251|P1|COMPLETED|Overall Study||101
139672|NCT01709578|341249|P3|STARTED|Overall Study||184
139673|NCT01709578|341250|P2|STARTED|Overall Study||181
139674|NCT01709578|341251|P1|STARTED|Overall Study||181
139675|NCT01709513|341382|P3|NOT COMPLETED|Overall Study||30
139676|NCT01709513|341383|P2|NOT COMPLETED|Overall Study||43
139677|NCT01709513|341384|P1|NOT COMPLETED|Overall Study||21
139678|NCT01709513|341382|P3|COMPLETED|Overall Study||96
139679|NCT01709513|341383|P2|COMPLETED|Overall Study||82
139680|NCT01709513|341384|P1|COMPLETED|Overall Study||42
139681|NCT01709513|341382|P3|Treated|Overall Study||126
139682|NCT01709513|341383|P2|Treated|Overall Study||124
139683|NCT01709513|341384|P1|Treated|Overall Study||63
139684|NCT01709513|341382|P3|STARTED|Overall Study||126
139685|NCT01709513|341383|P2|STARTED|Overall Study||125
139686|NCT01709513|341384|P1|STARTED|Overall Study||63
139687|NCT01709500|341445|P2|NOT COMPLETED|Overall Study||82
139688|NCT01709500|341446|P1|NOT COMPLETED|Overall Study||167
139689|NCT01709500|341445|P2|COMPLETED|Overall Study||0
139690|NCT01709500|341446|P1|COMPLETED|Overall Study||0
139691|NCT01709500|341445|P2|Treated|Overall Study||81
139692|NCT01709500|341446|P1|Treated|Overall Study||167
139693|NCT01709500|341445|P2|STARTED|Overall Study||82
139694|NCT01709500|341446|P1|STARTED|Overall Study||167
139695|NCT01709474|341502|P2|NOT COMPLETED|Overall Study||0
139696|NCT01709474|341503|P1|NOT COMPLETED|Overall Study||0
139697|NCT01709474|341502|P2|COMPLETED|Overall Study||4
139698|NCT01709474|341503|P1|COMPLETED|Overall Study||3
139699|NCT01709474|341502|P2|STARTED|Overall Study||4
139700|NCT01709474|341503|P1|STARTED|Overall Study||3
139701|NCT01709422|341513|P2|NOT COMPLETED|Overall Study||0
139702|NCT01709422|341514|P1|NOT COMPLETED|Overall Study||0
139703|NCT01709422|341513|P2|COMPLETED|Overall Study||70
139704|NCT01709422|341514|P1|COMPLETED|Overall Study||70
139705|NCT01709422|341513|P2|STARTED|Overall Study||70
139706|NCT01709422|341514|P1|STARTED|Overall Study||70
139707|NCT01709409|341524|P2|NOT COMPLETED|Overall Study||0
139708|NCT01709409|341525|P1|NOT COMPLETED|Overall Study||1
139709|NCT01709409|341524|P2|COMPLETED|Overall Study||45
139710|NCT01709409|341525|P1|COMPLETED|Overall Study||42
139711|NCT01709409|341524|P2|STARTED|Overall Study||45
139712|NCT01709409|341525|P1|STARTED|Overall Study||43
139713|NCT01709383|341533|P2|NOT COMPLETED|Overall Study||0
139714|NCT01709383|341534|P1|NOT COMPLETED|Overall Study||1
139715|NCT01709383|341533|P2|COMPLETED|Overall Study||14
139716|NCT01709383|341534|P1|COMPLETED|Overall Study||23
139717|NCT01709383|341533|P2|Included in Analysis|Overall Study||13
139718|NCT01709383|341534|P1|Included in Analysis|Overall Study||22
139719|NCT01709383|341533|P2|Completed Follow-ups|Overall Study||14
139720|NCT01709383|341534|P1|Completed Follow-ups|Overall Study||23
139721|NCT01709383|341533|P2|Completed Treatment|Overall Study||14
139722|NCT01709383|341534|P1|Completed Treatment|Overall Study||24
139723|NCT01709383|341533|P2|STARTED|Overall Study||14
139724|NCT01709383|341534|P1|STARTED|Overall Study||24
139725|NCT01709331|341552|P1|NOT COMPLETED|Overall Study||1
139726|NCT01709331|341552|P1|COMPLETED|Overall Study||17
139727|NCT01709331|341552|P1|STARTED|Overall Study||18
139728|NCT01709305|341558|P5|NOT COMPLETED|Phase 2||47
139729|NCT01709305|341559|P4|NOT COMPLETED|Phase 2||48
139730|NCT01709305|341560|P3|NOT COMPLETED|Phase 2||45
139731|NCT01709305|341561|P2|NOT COMPLETED|Phase 2||52
139732|NCT01709305|341562|P1|NOT COMPLETED|Phase 2||0
139733|NCT01709305|341558|P5|COMPLETED|Phase 2||507
139734|NCT01709305|341559|P4|COMPLETED|Phase 2||508
139735|NCT01709305|341560|P3|COMPLETED|Phase 2||505
139736|NCT01709305|341561|P2|COMPLETED|Phase 2||500
139737|NCT01709305|341562|P1|COMPLETED|Phase 2||0
139738|NCT01709305|341558|P5|STARTED|Phase 2||554
139739|NCT01709305|341559|P4|STARTED|Phase 2||556
139740|NCT01709305|341560|P3|STARTED|Phase 2||550
139741|NCT01709305|341561|P2|STARTED|Phase 2||552
139742|NCT01709305|341562|P1|STARTED|Phase 2||0
139743|NCT01709305|341558|P5|NOT COMPLETED|Phase 1||0
139744|NCT01709305|341559|P4|NOT COMPLETED|Phase 1||0
139745|NCT01709305|341560|P3|NOT COMPLETED|Phase 1||0
139746|NCT01709305|341561|P2|NOT COMPLETED|Phase 1||0
139747|NCT01709305|341562|P1|NOT COMPLETED|Phase 1||637
139748|NCT01709305|341558|P5|COMPLETED|Phase 1||0
139749|NCT01709305|341559|P4|COMPLETED|Phase 1||0
139750|NCT01709305|341560|P3|COMPLETED|Phase 1||0
139751|NCT01709305|341561|P2|COMPLETED|Phase 1||0
139752|NCT01709305|341562|P1|COMPLETED|Phase 1||4933
139753|NCT01709305|341558|P5|STARTED|Phase 1||0
139754|NCT01709305|341559|P4|STARTED|Phase 1||0
139755|NCT01709305|341560|P3|STARTED|Phase 1||0
139756|NCT01709305|341561|P2|STARTED|Phase 1||0
139757|NCT01709305|341562|P1|STARTED|Phase 1||5570
139758|NCT01709227|341599|P2|NOT COMPLETED|Overall Study||9
139759|NCT01709227|341600|P1|NOT COMPLETED|Overall Study||1
139760|NCT01709227|341599|P2|COMPLETED|Overall Study||32
139761|NCT01709227|341600|P1|COMPLETED|Overall Study||31
139762|NCT01709227|341599|P2|STARTED|Overall Study||41
139763|NCT01709227|341600|P1|STARTED|Overall Study||32
139764|NCT01709162|341626|P2|NOT COMPLETED|Overall Study||5
139765|NCT01709162|341627|P1|NOT COMPLETED|Overall Study||6
139766|NCT01709162|341626|P2|COMPLETED|Overall Study|Completed treatment as per protocol|0
139767|NCT01709162|341627|P1|COMPLETED|Overall Study|Completed treatment as per protocol|12
139768|NCT01709162|341626|P2|Still Receiving Treatment|Overall Study||0
139769|NCT01709162|341627|P1|Still Receiving Treatment|Overall Study||0
139770|NCT01709162|341626|P2|Received Treatment|Overall Study||4
139771|NCT01709162|341627|P1|Received Treatment|Overall Study||18
139772|NCT01709162|341626|P2|STARTED|Overall Study|Randomized|5
139773|NCT01709162|341627|P1|STARTED|Overall Study|Randomized|18
139774|NCT01709136|341639|P1|NOT COMPLETED|Overall Study||0
139775|NCT01709136|341639|P1|COMPLETED|Overall Study||3
139776|NCT01709136|341639|P1|STARTED|Overall Study||3
139777|NCT01709110|341648|P2|NOT COMPLETED|Overall Study||168
139778|NCT01709110|341649|P1|NOT COMPLETED|Overall Study||185
139779|NCT01709110|341648|P2|COMPLETED|Overall Study||515
139780|NCT01709110|341649|P1|COMPLETED|Overall Study||498
139781|NCT01709110|341648|P2|Received at Least One Dose of Study Drug|Overall Study||680
139782|NCT01709110|341649|P1|Received at Least One Dose of Study Drug|Overall Study||680
139783|NCT01709110|341648|P2|STARTED|Overall Study||683
139784|NCT01709110|341649|P1|STARTED|Overall Study||683
139785|NCT01709084|341679|P2|NOT COMPLETED|Overall Study||15
139786|NCT01709084|341680|P1|NOT COMPLETED|Overall Study||16
139787|NCT01709084|341679|P2|COMPLETED|Overall Study||198
139788|NCT01709084|341680|P1|COMPLETED|Overall Study||197
139789|NCT01709084|341679|P2|Treated|Overall Study||211
139790|NCT01709084|341680|P1|Treated|Overall Study||213
139791|NCT01709084|341679|P2|STARTED|Overall Study||213
139792|NCT01709084|341680|P1|STARTED|Overall Study||213
139793|NCT01709032|341696|P1|NOT COMPLETED|Overall Study||3
139794|NCT01709032|341696|P1|COMPLETED|Overall Study||6
139795|NCT01709032|341696|P1|STARTED|Overall Study||9
139796|NCT01708967|341703|P2|NOT COMPLETED|Overall Study||7
139797|NCT01708967|341704|P1|NOT COMPLETED|Overall Study||0
139798|NCT01708967|341703|P2|COMPLETED|Overall Study||43
139799|NCT01708967|341704|P1|COMPLETED|Overall Study||50
139800|NCT01708967|341703|P2|STARTED|Overall Study||50
139801|NCT01708967|341704|P1|STARTED|Overall Study||50
139802|NCT01708954|341713|P3|NOT COMPLETED|Step 2||0
139803|NCT01708954|341714|P2|NOT COMPLETED|Step 2||7
139804|NCT01708954|341715|P1|NOT COMPLETED|Step 2||13
139805|NCT01708954|341713|P3|COMPLETED|Step 2||0
139806|NCT01708954|341714|P2|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
139807|NCT01708954|341715|P1|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
139808|NCT01708954|341713|P3|STARTED|Step 2|Only patients with disease progression on Arms A and B were allowed to register to Step 2.|0
139809|NCT01708954|341714|P2|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|7
139810|NCT01708954|341715|P1|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|13
139811|NCT01708954|341713|P3|NOT COMPLETED|Step 1||43
139812|NCT01708954|341714|P2|NOT COMPLETED|Step 1||40
139813|NCT01708954|341715|P1|NOT COMPLETED|Step 1||42
139814|NCT01708954|341713|P3|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
139815|NCT01708954|341714|P2|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
139816|NCT01708954|341715|P1|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
139817|NCT01708954|341713|P3|Patients With MET Status Data Available|Step 1||24
139818|NCT01708954|341714|P2|Patients With MET Status Data Available|Step 1||32
139819|NCT01708954|341715|P1|Patients With MET Status Data Available|Step 1||30
139820|NCT01708954|341713|P3|Eligible and Treated|Step 1||35
139821|NCT01708954|341714|P2|Eligible and Treated|Step 1||38
139822|NCT01708954|341715|P1|Eligible and Treated|Step 1||38
139823|NCT01708954|341713|P3|Started Protocol Therapy|Step 1||39
139824|NCT01708954|341714|P2|Started Protocol Therapy|Step 1||40
139825|NCT01708954|341715|P1|Started Protocol Therapy|Step 1||40
139826|NCT01708954|341713|P3|STARTED|Step 1||43
139827|NCT01708954|341714|P2|STARTED|Step 1||40
139828|NCT01708954|341715|P1|STARTED|Step 1||42
139829|NCT01708941|341740|P4|NOT COMPLETED|Overall Study||18
139830|NCT01708941|341741|P3|NOT COMPLETED|Overall Study||19
139831|NCT01708941|341742|P2|NOT COMPLETED|Overall Study||18
139832|NCT01708941|341743|P1|NOT COMPLETED|Overall Study||18
139833|NCT01708941|341740|P4|COMPLETED|Overall Study||4
139834|NCT01708941|341741|P3|COMPLETED|Overall Study||3
139835|NCT01708941|341742|P2|COMPLETED|Overall Study||5
139836|NCT01708941|341743|P1|COMPLETED|Overall Study||3
139837|NCT01708941|341740|P4|Eligible and Started Treatment|Overall Study||22
139838|NCT01708941|341741|P3|Eligible and Started Treatment|Overall Study||19
139839|NCT01708941|341742|P2|Eligible and Started Treatment|Overall Study||22
139840|NCT01708941|341743|P1|Eligible and Started Treatment|Overall Study||18
139841|NCT01708941|341740|P4|STARTED|Overall Study||22
139842|NCT01708941|341741|P3|STARTED|Overall Study||22
139843|NCT01708941|341742|P2|STARTED|Overall Study||23
139844|NCT01708941|341743|P1|STARTED|Overall Study||21
139845|NCT01708915|341761|P4|NOT COMPLETED|Overall Study||33
139846|NCT01708915|341762|P3|NOT COMPLETED|Overall Study||46
139847|NCT01708915|341763|P2|NOT COMPLETED|Overall Study||62
139848|NCT01708915|341764|P1|NOT COMPLETED|Overall Study||86
139849|NCT01708915|341761|P4|COMPLETED|Overall Study||169
139850|NCT01708915|341762|P3|COMPLETED|Overall Study||152
139851|NCT01708915|341763|P2|COMPLETED|Overall Study||139
139852|NCT01708915|341764|P1|COMPLETED|Overall Study||118
139853|NCT01708915|341761|P4|STARTED|Overall Study||202
139854|NCT01708915|341762|P3|STARTED|Overall Study||198
139855|NCT01708915|341763|P2|STARTED|Overall Study||201
139856|NCT01708915|341764|P1|STARTED|Overall Study||204
139857|NCT01708902|341793|P7|NOT COMPLETED|Overall Study||7
139858|NCT01708902|341794|P6|NOT COMPLETED|Overall Study||7
139859|NCT01708902|341795|P5|NOT COMPLETED|Overall Study||16
139860|NCT01708902|341796|P4|NOT COMPLETED|Overall Study||10
139861|NCT01708902|341797|P3|NOT COMPLETED|Overall Study||17
139862|NCT01708902|341798|P2|NOT COMPLETED|Overall Study||8
139863|NCT01708902|341799|P1|NOT COMPLETED|Overall Study||17
139864|NCT01708902|341793|P7|COMPLETED|Overall Study||65
139865|NCT01708902|341794|P6|COMPLETED|Overall Study||64
139866|NCT01708902|341795|P5|COMPLETED|Overall Study||131
139867|NCT01708902|341796|P4|COMPLETED|Overall Study||137
139868|NCT01708902|341797|P3|COMPLETED|Overall Study||127
139869|NCT01708902|341798|P2|COMPLETED|Overall Study||137
139870|NCT01708902|341799|P1|COMPLETED|Overall Study||130
139871|NCT01708902|341793|P7|STARTED|Overall Study||72
139872|NCT01708902|341794|P6|STARTED|Overall Study||71
139873|NCT01708902|341795|P5|STARTED|Overall Study||147
139874|NCT01708902|341796|P4|STARTED|Overall Study||147
139875|NCT01708902|341797|P3|STARTED|Overall Study||144
139876|NCT01708902|341798|P2|STARTED|Overall Study||145
139877|NCT01708902|341799|P1|STARTED|Overall Study||147
139878|NCT01708525|341858|P1|NOT COMPLETED|Overall Study||0
139879|NCT01708525|341858|P1|COMPLETED|Overall Study||2
139880|NCT01708525|341858|P1|STARTED|Overall Study||2
139881|NCT01708317|341863|P1|NOT COMPLETED|Final Education Period||0
139882|NCT01708317|341863|P1|COMPLETED|Final Education Period||909
139883|NCT01708317|341863|P1|STARTED|Final Education Period|# of ED patients eligible for ACASI, had it been available, in final education period|909
139884|NCT01708317|341863|P1|NOT COMPLETED|ACASI + Education Period||0
139885|NCT01708317|341863|P1|COMPLETED|ACASI + Education Period||2601
139886|NCT01708317|341863|P1|STARTED|ACASI + Education Period|# of ED patients eligible for ACASI in the period the ACASI was actually available.|2601
139887|NCT01708317|341863|P1|NOT COMPLETED|Initial Education Period||0
139888|NCT01708317|341863|P1|COMPLETED|Initial Education Period||982
139889|NCT01708317|341863|P1|STARTED|Initial Education Period|# of ED patients eligible for ACASI, had it been available, in initial education period|982
139890|NCT01708317|341863|P1|NOT COMPLETED|2010 Control Period||0
139891|NCT01708317|341863|P1|COMPLETED|2010 Control Period||3929
139892|NCT01708317|341863|P1|STARTED|2010 Control Period|# of ED patients eligible for ACASI, had it been available, in control period|3929
139893|NCT01708291|341872|P2|NOT COMPLETED|Overall Study||1
139894|NCT01708291|341873|P1|NOT COMPLETED|Overall Study||2
139895|NCT01708291|341872|P2|COMPLETED|Overall Study||20
139896|NCT01708291|341873|P1|COMPLETED|Overall Study||19
139897|NCT01708291|341872|P2|STARTED|Overall Study||21
139898|NCT01708291|341873|P1|STARTED|Overall Study||21
139899|NCT01708278|341885|P6|NOT COMPLETED|Overall Study||0
139900|NCT01708278|341886|P5|NOT COMPLETED|Overall Study||0
139901|NCT01708278|341887|P4|NOT COMPLETED|Overall Study||0
139902|NCT01708278|341888|P3|NOT COMPLETED|Overall Study||0
139903|NCT01708278|341889|P2|NOT COMPLETED|Overall Study||0
139904|NCT01708278|341890|P1|NOT COMPLETED|Overall Study||0
139905|NCT01708278|341885|P6|COMPLETED|Overall Study||1
139906|NCT01708278|341886|P5|COMPLETED|Overall Study||1
139907|NCT01708278|341887|P4|COMPLETED|Overall Study||2
139908|NCT01708278|341888|P3|COMPLETED|Overall Study||2
139909|NCT01708278|341889|P2|COMPLETED|Overall Study||2
139910|NCT01708278|341890|P1|COMPLETED|Overall Study||1
139911|NCT01708278|341885|P6|STARTED|Overall Study||1
139912|NCT01708278|341886|P5|STARTED|Overall Study||1
139913|NCT01708278|341887|P4|STARTED|Overall Study||2
139914|NCT01708278|341888|P3|STARTED|Overall Study||2
139915|NCT01708278|341889|P2|STARTED|Overall Study||2
139916|NCT01708278|341890|P1|STARTED|Overall Study||1
139917|NCT01708213|341904|P1|NOT COMPLETED|Overall Study||1
139918|NCT01708213|341904|P1|COMPLETED|Overall Study||71
139919|NCT01708213|341904|P1|STARTED|Overall Study||72
139920|NCT01708187|341912|P2|NOT COMPLETED|Overall Study||1
139921|NCT01708187|341913|P1|NOT COMPLETED|Overall Study||0
139922|NCT01708187|341912|P2|COMPLETED|Overall Study||0
139923|NCT01708187|341913|P1|COMPLETED|Overall Study||1
139924|NCT01708187|341912|P2|STARTED|Overall Study||1
139925|NCT01708187|341913|P1|STARTED|Overall Study||1
139926|NCT01708174|341922|P3|NOT COMPLETED|Survival Follow-up||0
139927|NCT01708174|341923|P2|NOT COMPLETED|Survival Follow-up||0
139928|NCT01708174|341924|P1|NOT COMPLETED|Survival Follow-up||0
139929|NCT01708174|341922|P3|COMPLETED|Survival Follow-up||0
139930|NCT01708174|341923|P2|COMPLETED|Survival Follow-up||10
139931|NCT01708174|341924|P1|COMPLETED|Survival Follow-up||1
139932|NCT01708174|341922|P3|STARTED|Survival Follow-up||0
139933|NCT01708174|341923|P2|STARTED|Survival Follow-up||10
139934|NCT01708174|341924|P1|STARTED|Survival Follow-up||1
139935|NCT01708174|341922|P3|NOT COMPLETED|Treatment Period||1
139936|NCT01708174|341923|P2|NOT COMPLETED|Treatment Period||2
139937|NCT01708174|341924|P1|NOT COMPLETED|Treatment Period||1
139938|NCT01708174|341922|P3|COMPLETED|Treatment Period||3
139939|NCT01708174|341923|P2|COMPLETED|Treatment Period||14
139940|NCT01708174|341924|P1|COMPLETED|Treatment Period||1
139941|NCT01708174|341922|P3|Pharmacokinetic Analysis Set|Treatment Period||0
139942|NCT01708174|341923|P2|Pharmacokinetic Analysis Set|Treatment Period||13
139943|NCT01708174|341924|P1|Pharmacokinetic Analysis Set|Treatment Period||2
139944|NCT01708174|341922|P3|STARTED|Treatment Period||4
139945|NCT01708174|341923|P2|STARTED|Treatment Period||16
139946|NCT01708174|341924|P1|STARTED|Treatment Period||2
139947|NCT01708161|341956|P6|NOT COMPLETED|Overall Study||1
139948|NCT01708161|341957|P5|NOT COMPLETED|Overall Study||6
139949|NCT01708161|341958|P4|NOT COMPLETED|Overall Study||16
139950|NCT01708161|341959|P3|NOT COMPLETED|Overall Study||10
139951|NCT01708161|341960|P2|NOT COMPLETED|Overall Study||10
139952|NCT01708161|341961|P1|NOT COMPLETED|Overall Study||4
139953|NCT01708161|341956|P6|COMPLETED|Overall Study||0
139954|NCT01708161|341957|P5|COMPLETED|Overall Study||0
139955|NCT01708161|341958|P4|COMPLETED|Overall Study||0
139956|NCT01708161|341959|P3|COMPLETED|Overall Study||0
139957|NCT01708161|341960|P2|COMPLETED|Overall Study||0
139958|NCT01708161|341961|P1|COMPLETED|Overall Study||0
139959|NCT01708161|341956|P6|STARTED|Overall Study||1
139960|NCT01708161|341957|P5|STARTED|Overall Study||6
139961|NCT01708161|341958|P4|STARTED|Overall Study||16
139962|NCT01708161|341959|P3|STARTED|Overall Study||10
139963|NCT01708161|341960|P2|STARTED|Overall Study||10
139964|NCT01708161|341961|P1|STARTED|Overall Study||4
139965|NCT01708122|342003|P2|NOT COMPLETED|Overall Study||0
139966|NCT01708122|342004|P1|NOT COMPLETED|Overall Study||0
139967|NCT01708122|342003|P2|COMPLETED|Overall Study||26
139968|NCT01708122|342004|P1|COMPLETED|Overall Study||27
139969|NCT01708122|342003|P2|STARTED|Overall Study||26
139970|NCT01708122|342004|P1|STARTED|Overall Study||27
139971|NCT01708057|342012|P3|NOT COMPLETED|Overall Study||1
139972|NCT01708057|342013|P2|NOT COMPLETED|Overall Study||1
139973|NCT01708057|342014|P1|NOT COMPLETED|Overall Study||1
139974|NCT01708057|342012|P3|COMPLETED|Overall Study||0
139975|NCT01708057|342013|P2|COMPLETED|Overall Study||0
139976|NCT01708057|342014|P1|COMPLETED|Overall Study||0
139977|NCT01708057|342012|P3|STARTED|Overall Study||1
139978|NCT01708057|342013|P2|STARTED|Overall Study||1
139979|NCT01708057|342014|P1|STARTED|Overall Study||1
139980|NCT01707992|342073|P6|NOT COMPLETED|Active Treatment Phase (24 Months)||215
139981|NCT01707992|342074|P5|NOT COMPLETED|Active Treatment Phase (24 Months)||494
139982|NCT01707992|342075|P4|NOT COMPLETED|Active Treatment Phase (24 Months)||884
139983|NCT01707992|342076|P3|NOT COMPLETED|Active Treatment Phase (24 Months)||0
139984|NCT01707992|342077|P2|NOT COMPLETED|Active Treatment Phase (24 Months)||0
139985|NCT01707992|342078|P1|NOT COMPLETED|Active Treatment Phase (24 Months)||0
139986|NCT01707992|342073|P6|COMPLETED|Active Treatment Phase (24 Months)||0
139987|NCT01707992|342074|P5|COMPLETED|Active Treatment Phase (24 Months)||10
139988|NCT01707992|342075|P4|COMPLETED|Active Treatment Phase (24 Months)||7
139989|NCT01707992|342076|P3|COMPLETED|Active Treatment Phase (24 Months)||0
139990|NCT01707992|342077|P2|COMPLETED|Active Treatment Phase (24 Months)||0
139991|NCT01707992|342078|P1|COMPLETED|Active Treatment Phase (24 Months)||0
139992|NCT01707992|342073|P6|STARTED|Active Treatment Phase (24 Months)||215
139993|NCT01707992|342074|P5|STARTED|Active Treatment Phase (24 Months)||504
139994|NCT01707992|342075|P4|STARTED|Active Treatment Phase (24 Months)||891
139995|NCT01707992|342076|P3|STARTED|Active Treatment Phase (24 Months)||0
139996|NCT01707992|342077|P2|STARTED|Active Treatment Phase (24 Months)||0
139997|NCT01707992|342078|P1|STARTED|Active Treatment Phase (24 Months)||0
139998|NCT01707992|342073|P6|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
139999|NCT01707992|342074|P5|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
140000|NCT01707992|342075|P4|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
140001|NCT01707992|342076|P3|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||200
140002|NCT01707992|342077|P2|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||104
140003|NCT01707992|342078|P1|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||144
140004|NCT01707992|342073|P6|COMPLETED|Placebo-Controlled Phase (24 Months)||0
140005|NCT01707992|342074|P5|COMPLETED|Placebo-Controlled Phase (24 Months)||0
140006|NCT01707992|342075|P4|COMPLETED|Placebo-Controlled Phase (24 Months)||0
140007|NCT01707992|342076|P3|COMPLETED|Placebo-Controlled Phase (24 Months)||532
140008|NCT01707992|342077|P2|COMPLETED|Placebo-Controlled Phase (24 Months)||623
140009|NCT01707992|342078|P1|COMPLETED|Placebo-Controlled Phase (24 Months)||596
140010|NCT01707992|342073|P6|STARTED|Placebo-Controlled Phase (24 Months)||0
140011|NCT01707992|342074|P5|STARTED|Placebo-Controlled Phase (24 Months)||0
140012|NCT01707992|342075|P4|STARTED|Placebo-Controlled Phase (24 Months)||0
140013|NCT01707992|342076|P3|STARTED|Placebo-Controlled Phase (24 Months)||732
140014|NCT01707992|342077|P2|STARTED|Placebo-Controlled Phase (24 Months)||727
140015|NCT01707992|342078|P1|STARTED|Placebo-Controlled Phase (24 Months)||740
140016|NCT01707693|342130|P2|NOT COMPLETED|Time 3 Measures @ 6 Mth||5
140017|NCT01707693|342131|P1|NOT COMPLETED|Time 3 Measures @ 6 Mth||0
140018|NCT01707693|342130|P2|COMPLETED|Time 3 Measures @ 6 Mth||49
140019|NCT01707693|342131|P1|COMPLETED|Time 3 Measures @ 6 Mth||46
140020|NCT01707693|342130|P2|STARTED|Time 3 Measures @ 6 Mth||54
140021|NCT01707693|342131|P1|STARTED|Time 3 Measures @ 6 Mth||46
140022|NCT01707693|342130|P2|NOT COMPLETED|Overall Study Allocation||8
140023|NCT01707693|342131|P1|NOT COMPLETED|Overall Study Allocation||13
140024|NCT01707693|342130|P2|COMPLETED|Overall Study Allocation||54
140025|NCT01707693|342131|P1|COMPLETED|Overall Study Allocation||46
140026|NCT01707693|342130|P2|STARTED|Overall Study Allocation||62
140027|NCT01707693|342131|P1|STARTED|Overall Study Allocation||59
140028|NCT01707667|342145|P2|NOT COMPLETED|Period 2||0
140029|NCT01707667|342146|P1|NOT COMPLETED|Period 2||0
140030|NCT01707667|342145|P2|COMPLETED|Period 2||6
140031|NCT01707667|342146|P1|COMPLETED|Period 2||6
140032|NCT01707667|342145|P2|STARTED|Period 2||6
140033|NCT01707667|342146|P1|STARTED|Period 2||6
140034|NCT01707667|342145|P2|NOT COMPLETED|Period 1||0
140035|NCT01707667|342146|P1|NOT COMPLETED|Period 1||1
140036|NCT01707667|342145|P2|COMPLETED|Period 1||6
140037|NCT01707667|342146|P1|COMPLETED|Period 1||6
140038|NCT01707667|342145|P2|STARTED|Period 1||6
140039|NCT01707667|342146|P1|STARTED|Period 1||7
140040|NCT01707654|342164|P1|NOT COMPLETED|Overall Study||0
140041|NCT01707654|342164|P1|COMPLETED|Overall Study||9
140042|NCT01707654|342164|P1|STARTED|Overall Study||9
140043|NCT01707472|342171|P3|NOT COMPLETED|Overall Study||0
140044|NCT01707472|342172|P2|NOT COMPLETED|Overall Study||0
140045|NCT01707472|342173|P1|NOT COMPLETED|Overall Study||0
140046|NCT01707472|342171|P3|COMPLETED|Overall Study||8
140047|NCT01707472|342172|P2|COMPLETED|Overall Study||6
140048|NCT01707472|342173|P1|COMPLETED|Overall Study||4
140049|NCT01707472|342171|P3|STARTED|Overall Study||8
140050|NCT01707472|342172|P2|STARTED|Overall Study||6
140051|NCT01707472|342173|P1|STARTED|Overall Study||4
140052|NCT01707381|342196|P2|NOT COMPLETED|Period 2||0
140053|NCT01707381|342197|P1|NOT COMPLETED|Period 2||0
140054|NCT01707381|342196|P2|COMPLETED|Period 2||11
140055|NCT01707381|342197|P1|COMPLETED|Period 2||10
140056|NCT01707381|342196|P2|STARTED|Period 2||11
140057|NCT01707381|342197|P1|STARTED|Period 2||10
140058|NCT01707381|342196|P2|NOT COMPLETED|Period 1||2
140059|NCT01707381|342197|P1|NOT COMPLETED|Period 1||2
140060|NCT01707381|342196|P2|COMPLETED|Period 1||11
140061|NCT01707381|342197|P1|COMPLETED|Period 1||10
140062|NCT01707381|342196|P2|STARTED|Period 1||13
140063|NCT01707381|342197|P1|STARTED|Period 1||12
140064|NCT01707368|342207|P1|NOT COMPLETED|Overall Study||168
140065|NCT01707368|342207|P1|COMPLETED|Overall Study||393
140066|NCT01707368|342207|P1|STARTED|Overall Study||561
140067|NCT01707290|342216|P2|NOT COMPLETED|Overall Study||1
140068|NCT01707290|342217|P1|NOT COMPLETED|Overall Study||86
140069|NCT01707290|342216|P2|COMPLETED|Overall Study||3
140070|NCT01707290|342217|P1|COMPLETED|Overall Study||35
140071|NCT01707290|342216|P2|STARTED|Overall Study||4
140072|NCT01707290|342217|P1|STARTED|Overall Study||121
140073|NCT01707238|342240|P2|NOT COMPLETED|Overall Study||0
140074|NCT01707238|342241|P1|NOT COMPLETED|Overall Study||0
140075|NCT01707238|342240|P2|COMPLETED|Overall Study||52
140076|NCT01707238|342241|P1|COMPLETED|Overall Study||48
140077|NCT01707238|342240|P2|STARTED|Overall Study||52
140078|NCT01707238|342241|P1|STARTED|Overall Study||48
140079|NCT01707225|342257|P1|NOT COMPLETED|Overall Study||0
140080|NCT01707225|342257|P1|COMPLETED|Overall Study||10
140081|NCT01707225|342257|P1|STARTED|Overall Study||10
140082|NCT01707147|342262|P1|NOT COMPLETED|Overall Study||100
140083|NCT01707147|342262|P1|COMPLETED|Overall Study||3119
140084|NCT01707147|342262|P1|STARTED|Overall Study||3219
140085|NCT01707095|342272|P2|NOT COMPLETED|Overall Study||0
140086|NCT01707095|342273|P1|NOT COMPLETED|Overall Study||0
140087|NCT01707095|342272|P2|COMPLETED|Overall Study||42
140088|NCT01707095|342273|P1|COMPLETED|Overall Study||42
140089|NCT01707095|342272|P2|STARTED|Overall Study||42
140090|NCT01707095|342273|P1|STARTED|Overall Study||42
140091|NCT01707043|342283|P2|NOT COMPLETED|Overall Study||0
140092|NCT01707043|342284|P1|NOT COMPLETED|Overall Study||0
140093|NCT01707043|342283|P2|COMPLETED|Overall Study||10
140094|NCT01707043|342284|P1|COMPLETED|Overall Study||10
140095|NCT01707043|342283|P2|STARTED|Overall Study||10
140096|NCT01707043|342284|P1|STARTED|Overall Study||10
140097|NCT01707030|342294|P2|NOT COMPLETED|Overall Study||17
140098|NCT01707030|342295|P1|NOT COMPLETED|Overall Study||11
140099|NCT01707030|342294|P2|COMPLETED|Overall Study||54
140100|NCT01707030|342295|P1|COMPLETED|Overall Study||56
140101|NCT01707030|342294|P2|STARTED|Overall Study||71
140102|NCT01707030|342295|P1|STARTED|Overall Study||67
140103|NCT01707004|342311|P1|NOT COMPLETED|Overall Study||3
140104|NCT01707004|342311|P1|COMPLETED|Overall Study|3 participants were not eligible to proceed to Bone Marrow Transplant due to significant infections.|17
140105|NCT01707004|342311|P1|STARTED|Overall Study||20
140106|NCT01706965|342325|P2|NOT COMPLETED|Overall Study||1
140107|NCT01706965|342326|P1|NOT COMPLETED|Overall Study||1
140108|NCT01706965|342325|P2|COMPLETED|Overall Study||12
140109|NCT01706965|342326|P1|COMPLETED|Overall Study||13
140110|NCT01706965|342325|P2|STARTED|Overall Study||13
140111|NCT01706965|342326|P1|STARTED|Overall Study||14
140112|NCT01706952|342334|P1|NOT COMPLETED|Overall Study||8
140113|NCT01706952|342334|P1|COMPLETED|Overall Study||37
140114|NCT01706952|342334|P1|STARTED|Overall Study||45
140115|NCT01706926|342350|P4|NOT COMPLETED|Overall Study||5
140116|NCT01706926|342351|P3|NOT COMPLETED|Overall Study||6
140117|NCT01706926|342352|P2|NOT COMPLETED|Overall Study||4
140118|NCT01706926|342353|P1|NOT COMPLETED|Overall Study||6
140119|NCT01706926|342350|P4|COMPLETED|Overall Study||74
140120|NCT01706926|342351|P3|COMPLETED|Overall Study||79
140121|NCT01706926|342352|P2|COMPLETED|Overall Study||77
140122|NCT01706926|342353|P1|COMPLETED|Overall Study||75
140123|NCT01706926|342350|P4|STARTED|Overall Study||79
140124|NCT01706926|342351|P3|STARTED|Overall Study||85
140125|NCT01706926|342352|P2|STARTED|Overall Study||81
140126|NCT01706926|342353|P1|STARTED|Overall Study||81
140127|NCT01706822|342462|P1|NOT COMPLETED|Overall Study||0
140128|NCT01706822|342462|P1|COMPLETED|Overall Study||8
140129|NCT01706822|342462|P1|STARTED|Overall Study||8
140130|NCT01706770|342472|P2|NOT COMPLETED|Overall Study||0
140131|NCT01706770|342473|P1|NOT COMPLETED|Overall Study||2
140132|NCT01706770|342472|P2|COMPLETED|Overall Study||17
140133|NCT01706770|342473|P1|COMPLETED|Overall Study||31
140134|NCT01706770|342472|P2|STARTED|Overall Study||17
140135|NCT01706770|342473|P1|STARTED|Overall Study||33
140136|NCT01706666|342484|P3|NOT COMPLETED|Overall Study||0
140137|NCT01706666|342485|P2|NOT COMPLETED|Overall Study||0
140138|NCT01706666|342486|P1|NOT COMPLETED|Overall Study||0
140139|NCT01706666|342484|P3|COMPLETED|Overall Study||1
140140|NCT01706666|342485|P2|COMPLETED|Overall Study||1
140141|NCT01706666|342486|P1|COMPLETED|Overall Study||1
140142|NCT01706666|342484|P3|STARTED|Overall Study||1
140143|NCT01706666|342485|P2|STARTED|Overall Study||1
140144|NCT01706666|342486|P1|STARTED|Overall Study||1
140145|NCT01706588|342505|P5|NOT COMPLETED|Overall Study||0
140146|NCT01706588|342506|P4|NOT COMPLETED|Overall Study||0
140147|NCT01706588|342507|P3|NOT COMPLETED|Overall Study||0
140148|NCT01706588|342508|P2|NOT COMPLETED|Overall Study||0
140149|NCT01706588|342509|P1|NOT COMPLETED|Overall Study||0
140150|NCT01706588|342505|P5|COMPLETED|Overall Study||16
140151|NCT01706588|342506|P4|COMPLETED|Overall Study||14
140152|NCT01706588|342507|P3|COMPLETED|Overall Study||15
140153|NCT01706588|342508|P2|COMPLETED|Overall Study||15
140154|NCT01706588|342509|P1|COMPLETED|Overall Study||15
140155|NCT01706588|342505|P5|STARTED|Overall Study||16
140156|NCT01706588|342506|P4|STARTED|Overall Study||14
140157|NCT01706588|342507|P3|STARTED|Overall Study||15
140158|NCT01706588|342508|P2|STARTED|Overall Study||15
140159|NCT01706588|342509|P1|STARTED|Overall Study||15
140160|NCT01706575|342521|P1|NOT COMPLETED|Overall Study||12
140161|NCT01706575|342521|P1|COMPLETED|Overall Study||64
140162|NCT01706575|342521|P1|Treated|Overall Study||70
140163|NCT01706575|342521|P1|STARTED|Overall Study||76
140164|NCT01706549|342532|P1|NOT COMPLETED|Overall Study||0
140165|NCT01706549|342532|P1|COMPLETED|Overall Study||16
140166|NCT01706549|342532|P1|STARTED|Overall Study||16
140167|NCT01706536|342542|P5|NOT COMPLETED|Overall Study||2
140168|NCT01706536|342543|P4|NOT COMPLETED|Overall Study||4
140169|NCT01706536|342544|P3|NOT COMPLETED|Overall Study||5
140170|NCT01706536|342545|P2|NOT COMPLETED|Overall Study||4
140171|NCT01706536|342546|P1|NOT COMPLETED|Overall Study||4
140172|NCT01706536|342542|P5|COMPLETED|Overall Study||57
140173|NCT01706536|342543|P4|COMPLETED|Overall Study||53
140174|NCT01706536|342544|P3|COMPLETED|Overall Study||49
140175|NCT01706536|342545|P2|COMPLETED|Overall Study||51
140176|NCT01706536|342546|P1|COMPLETED|Overall Study||53
140177|NCT01706536|342542|P5|STARTED|Overall Study||59
140178|NCT01706536|342543|P4|STARTED|Overall Study||57
140179|NCT01706536|342544|P3|STARTED|Overall Study||54
140180|NCT01706536|342545|P2|STARTED|Overall Study||55
140181|NCT01706536|342546|P1|STARTED|Overall Study||57
140182|NCT01706497|342603|P1|NOT COMPLETED|Overall Study||0
140183|NCT01706497|342603|P1|COMPLETED|Overall Study||177
140184|NCT01706497|342603|P1|STARTED|Overall Study||177
140185|NCT01706458|342613|P2|NOT COMPLETED|Overall Study||4
140186|NCT01706458|342614|P1|NOT COMPLETED|Overall Study||3
140187|NCT01706458|342613|P2|COMPLETED|Overall Study||5
140188|NCT01706458|342614|P1|COMPLETED|Overall Study||6
140189|NCT01706458|342613|P2|STARTED|Overall Study||9
140190|NCT01706458|342614|P1|STARTED|Overall Study||9
140191|NCT01706328|342638|P3|NOT COMPLETED|12-week Double-blind Treatment Period||45
140192|NCT01706328|342639|P2|NOT COMPLETED|12-week Double-blind Treatment Period||46
140193|NCT01706328|342640|P1|NOT COMPLETED|12-week Double-blind Treatment Period||0
140194|NCT01706328|342638|P3|COMPLETED|12-week Double-blind Treatment Period||371
140195|NCT01706328|342639|P2|COMPLETED|12-week Double-blind Treatment Period||366
140196|NCT01706328|342640|P1|COMPLETED|12-week Double-blind Treatment Period||0
140197|NCT01706328|342638|P3|STARTED|12-week Double-blind Treatment Period||416
140198|NCT01706328|342639|P2|STARTED|12-week Double-blind Treatment Period||412
140199|NCT01706328|342640|P1|STARTED|12-week Double-blind Treatment Period||0
140200|NCT01706328|342638|P3|NOT COMPLETED|2-week Run-in Period||0
140201|NCT01706328|342639|P2|NOT COMPLETED|2-week Run-in Period||0
140202|NCT01706328|342640|P1|NOT COMPLETED|2-week Run-in Period||165
140203|NCT01706328|342638|P3|COMPLETED|2-week Run-in Period||0
140204|NCT01706328|342639|P2|COMPLETED|2-week Run-in Period||0
140205|NCT01706328|342640|P1|COMPLETED|2-week Run-in Period||828
140206|NCT01706328|342638|P3|STARTED|2-week Run-in Period||0
140207|NCT01706328|342639|P2|STARTED|2-week Run-in Period||0
140208|NCT01706328|342640|P1|STARTED|2-week Run-in Period||993
140209|NCT01706263|342650|P1|NOT COMPLETED|Overall Study||0
140210|NCT01706263|342650|P1|COMPLETED|Overall Study||28
140211|NCT01706263|342650|P1|STARTED|Overall Study||28
140212|NCT01706250|342659|P1|NOT COMPLETED|Overall Study||2
140213|NCT01706250|342659|P1|COMPLETED|Overall Study||18
140214|NCT01706250|342659|P1|STARTED|Overall Study||20
140215|NCT01706198|342690|P2|NOT COMPLETED|Overall Study||194
140216|NCT01706198|342691|P1|NOT COMPLETED|Overall Study||173
140217|NCT01706198|342690|P2|COMPLETED|Overall Study||1920
140218|NCT01706198|342691|P1|COMPLETED|Overall Study||1946
140219|NCT01706198|342690|P2|STARTED|Overall Study||2114
140220|NCT01706198|342691|P1|STARTED|Overall Study||2119
140221|NCT01706159|342743|P2|NOT COMPLETED|Overall Study||2
140222|NCT01706159|342744|P1|NOT COMPLETED|Overall Study||8
140223|NCT01706159|342743|P2|COMPLETED|Overall Study||4
140224|NCT01706159|342744|P1|COMPLETED|Overall Study||6
140225|NCT01706159|342743|P2|Completers (With Baron Score at Week 8)|Overall Study||3
140226|NCT01706159|342744|P1|Completers (With Baron Score at Week 8)|Overall Study||6
140227|NCT01706159|342743|P2|Exposed|Overall Study|One subject was not exposed to placebo.|5
140228|NCT01706159|342744|P1|Exposed|Overall Study|One subject was not exposed to rFXIII.|13
140229|NCT01706159|342743|P2|STARTED|Overall Study||6
140230|NCT01706159|342744|P1|STARTED|Overall Study||14
140231|NCT01706146|342758|P1|NOT COMPLETED|Overall Study||6
140232|NCT01706146|342758|P1|COMPLETED|Overall Study|1 pt developed permanent AF; 1 pt needed dual antiplatelet therapy; 3 possible TIA; 1 withdraw|53
140233|NCT01706146|342758|P1|STARTED|Overall Study||59
140234|NCT01706081|342765|P2|NOT COMPLETED|Overall Study||0
140235|NCT01706081|342766|P1|NOT COMPLETED|Overall Study||0
140236|NCT01706081|342765|P2|COMPLETED|Overall Study||42
140237|NCT01706081|342766|P1|COMPLETED|Overall Study||40
140238|NCT01706081|342765|P2|STARTED|Overall Study||42
140239|NCT01706081|342766|P1|STARTED|Overall Study||40
140240|NCT01706003|342778|P2|NOT COMPLETED|Overall Study||4
140241|NCT01706003|342779|P1|NOT COMPLETED|Overall Study||11
140242|NCT01706003|342778|P2|COMPLETED|Overall Study||18
140243|NCT01706003|342779|P1|COMPLETED|Overall Study||12
140244|NCT01706003|342778|P2|STARTED|Overall Study||22
140245|NCT01706003|342779|P1|STARTED|Overall Study||23
140246|NCT01705977|342787|P2|NOT COMPLETED|Overall Study||260
140247|NCT01705977|342788|P1|NOT COMPLETED|Overall Study||273
140248|NCT01705977|342787|P2|COMPLETED|Overall Study||1741
140249|NCT01705977|342788|P1|COMPLETED|Overall Study||1729
140250|NCT01705977|342787|P2|STARTED|Overall Study||2001
140251|NCT01705977|342788|P1|STARTED|Overall Study||2002
140252|NCT01705730|342806|P1|NOT COMPLETED|Overall Study||9
140253|NCT01705730|342806|P1|COMPLETED|Overall Study||59
140254|NCT01705730|342806|P1|STARTED|Overall Study|Participants who received study drug|68
140255|NCT01705717|342846|P2|NOT COMPLETED|Overall Study||5
140256|NCT01705717|342847|P1|NOT COMPLETED|Overall Study||2
140257|NCT01705717|342846|P2|COMPLETED|Overall Study||7
140258|NCT01705717|342847|P1|COMPLETED|Overall Study||35
140259|NCT01705717|342846|P2|STARTED|Overall Study||12
140260|NCT01705717|342847|P1|STARTED|Overall Study||37
140261|NCT01705691|342864|P2|NOT COMPLETED|Overall Study||6
140262|NCT01705691|342865|P1|NOT COMPLETED|Overall Study||3
140263|NCT01705691|342864|P2|COMPLETED|Overall Study||24
140264|NCT01705691|342865|P1|COMPLETED|Overall Study||16
140265|NCT01705691|342864|P2|STARTED|Overall Study||30
140266|NCT01705691|342865|P1|STARTED|Overall Study||19
140267|NCT01705652|342885|P2|NOT COMPLETED|Overall Study||3
140268|NCT01705652|342886|P1|NOT COMPLETED|Overall Study||3
140269|NCT01705652|342885|P2|COMPLETED|Overall Study||9
140270|NCT01705652|342886|P1|COMPLETED|Overall Study||6
140271|NCT01705652|342885|P2|STARTED|Overall Study||12
140272|NCT01705652|342886|P1|STARTED|Overall Study||9
140273|NCT01705587|342894|P2|NOT COMPLETED|Overall Study||1
140274|NCT01705587|342895|P1|NOT COMPLETED|Overall Study||0
140275|NCT01705587|342894|P2|COMPLETED|Overall Study||5
140276|NCT01705587|342895|P1|COMPLETED|Overall Study||7
140277|NCT01705587|342894|P2|STARTED|Overall Study||6
140278|NCT01705587|342895|P1|STARTED|Overall Study||7
140279|NCT01705574|342913|P4|NOT COMPLETED|Open-Label Extension Phase||5
140280|NCT01705574|342914|P3|NOT COMPLETED|Open-Label Extension Phase||11
140281|NCT01705574|342915|P2|NOT COMPLETED|Open-Label Extension Phase||0
140282|NCT01705574|342916|P1|NOT COMPLETED|Open-Label Extension Phase||15
140283|NCT01705574|342913|P4|COMPLETED|Open-Label Extension Phase||48
140284|NCT01705574|342914|P3|COMPLETED|Open-Label Extension Phase||148
140285|NCT01705574|342915|P2|COMPLETED|Open-Label Extension Phase||0
140286|NCT01705574|342916|P1|COMPLETED|Open-Label Extension Phase||231
140287|NCT01705574|342913|P4|STARTED|Open-Label Extension Phase|53 participants entered from the DB ATV+ RTV + TVD arm.|53
140288|NCT01705574|342914|P3|STARTED|Open-Label Extension Phase|159 participants entered from the DB ATV+RTV+TVD arm.|159
140289|NCT01705574|342915|P2|STARTED|Open-Label Extension Phase|Participants either entered the OL GEN arm or OL ATV+RTV+TVD arm.|0
140290|NCT01705574|342916|P1|STARTED|Open-Label Extension Phase||246
140291|NCT01705574|342913|P4|NOT COMPLETED|Double-Blind Phase||0
140292|NCT01705574|342914|P3|NOT COMPLETED|Double-Blind Phase||0
140293|NCT01705574|342915|P2|NOT COMPLETED|Double-Blind Phase||41
140294|NCT01705574|342916|P1|NOT COMPLETED|Double-Blind Phase||33
140295|NCT01705574|342913|P4|COMPLETED|Double-Blind Phase||0
140296|NCT01705574|342914|P3|COMPLETED|Double-Blind Phase||0
140297|NCT01705574|342915|P2|COMPLETED|Double-Blind Phase||249
140298|NCT01705574|342916|P1|COMPLETED|Double-Blind Phase||260
140299|NCT01705574|342913|P4|STARTED|Double-Blind Phase||0
140300|NCT01705574|342914|P3|STARTED|Double-Blind Phase||0
140301|NCT01705574|342915|P2|STARTED|Double-Blind Phase||290
140302|NCT01705574|342916|P1|STARTED|Double-Blind Phase||293
140303|NCT01705496|342933|P1|NOT COMPLETED|Overall Study||4
140304|NCT01705496|342933|P1|COMPLETED|Overall Study||19
140305|NCT01705496|342933|P1|STARTED|Overall Study||23
140306|NCT01705145|342943|P1|NOT COMPLETED|Part B||1
140307|NCT01705145|342943|P1|COMPLETED|Part B||33
140308|NCT01705145|342943|P1|STARTED|Part B|Eight participants from Part A continued in Part B of the study.|34
140309|NCT01705145|342943|P1|NOT COMPLETED|Part A||0
140310|NCT01705145|342943|P1|COMPLETED|Part A||9
140311|NCT01705145|342943|P1|STARTED|Part A||9
140312|NCT01705106|342971|P1|NOT COMPLETED|Overall Study||0
140313|NCT01705106|342971|P1|COMPLETED|Overall Study||21
140314|NCT01705106|342971|P1|STARTED|Overall Study||21
140315|NCT01705080|342983|P4|NOT COMPLETED|Overall Study||42
140316|NCT01705080|342984|P3|NOT COMPLETED|Overall Study||5
140317|NCT01705080|342985|P2|NOT COMPLETED|Overall Study||16
140318|NCT01705080|342986|P1|NOT COMPLETED|Overall Study||15
140319|NCT01705080|342983|P4|COMPLETED|Overall Study||9
140320|NCT01705080|342984|P3|COMPLETED|Overall Study||27
140321|NCT01705080|342985|P2|COMPLETED|Overall Study||98
140322|NCT01705080|342986|P1|COMPLETED|Overall Study||142
140323|NCT01705080|342983|P4|1 Month|Overall Study||10
140324|NCT01705080|342984|P3|1 Month|Overall Study||27
140325|NCT01705080|342985|P2|1 Month|Overall Study||97
140326|NCT01705080|342986|P1|1 Month|Overall Study||148
140327|NCT01705080|342983|P4|Procedure|Overall Study||10
140328|NCT01705080|342984|P3|Procedure|Overall Study||29
140329|NCT01705080|342985|P2|Procedure|Overall Study||103
140330|NCT01705080|342986|P1|Procedure|Overall Study||149
140331|NCT01705080|342983|P4|STARTED|Overall Study||51
140332|NCT01705080|342984|P3|STARTED|Overall Study||32
140333|NCT01705080|342985|P2|STARTED|Overall Study||114
140334|NCT01705080|342986|P1|STARTED|Overall Study||157
140335|NCT01704976|342998|P2|NOT COMPLETED|Overall Study||2
140336|NCT01704976|342999|P1|NOT COMPLETED|Overall Study||1
140337|NCT01704976|342998|P2|COMPLETED|Overall Study|2 participants completed < 11 SR-WBV sessions, they were excluded from statistical analysis|11
140338|NCT01704976|342999|P1|COMPLETED|Overall Study|One participant completed < 11 SR-WBV sessions and was excluded from the statistical analysis|13
140339|NCT01704976|342998|P2|STARTED|Overall Study||13
140340|NCT01704976|342999|P1|STARTED|Overall Study||14
140341|NCT01704846|343015|P2|NOT COMPLETED|Treatment Period 4||0
140342|NCT01704846|343016|P1|NOT COMPLETED|Treatment Period 4||0
140343|NCT01704846|343015|P2|COMPLETED|Treatment Period 4||29
140344|NCT01704846|343016|P1|COMPLETED|Treatment Period 4||30
140345|NCT01704846|343015|P2|STARTED|Treatment Period 4||29
140346|NCT01704846|343016|P1|STARTED|Treatment Period 4||30
140347|NCT01704846|343015|P2|NOT COMPLETED|Treatment Period 3||0
140348|NCT01704846|343016|P1|NOT COMPLETED|Treatment Period 3||0
140349|NCT01704846|343015|P2|COMPLETED|Treatment Period 3||29
140350|NCT01704846|343016|P1|COMPLETED|Treatment Period 3||30
140351|NCT01704846|343015|P2|STARTED|Treatment Period 3||29
140352|NCT01704846|343016|P1|STARTED|Treatment Period 3||30
140353|NCT01704846|343015|P2|NOT COMPLETED|Treatment Period 2||1
140354|NCT01704846|343016|P1|NOT COMPLETED|Treatment Period 2||0
140355|NCT01704846|343015|P2|COMPLETED|Treatment Period 2||29
140356|NCT01704846|343016|P1|COMPLETED|Treatment Period 2||30
140357|NCT01704846|343015|P2|STARTED|Treatment Period 2||30
140358|NCT01704846|343016|P1|STARTED|Treatment Period 2||30
140359|NCT01704846|343015|P2|NOT COMPLETED|Treatment Period 1||0
140360|NCT01704846|343016|P1|NOT COMPLETED|Treatment Period 1||0
140361|NCT01704846|343015|P2|COMPLETED|Treatment Period 1||30
140362|NCT01704846|343016|P1|COMPLETED|Treatment Period 1||30
140363|NCT01704846|343015|P2|STARTED|Treatment Period 1||30
140364|NCT01704846|343016|P1|STARTED|Treatment Period 1||30
140365|NCT01704781|343039|P5|NOT COMPLETED|Overall Study||0
140366|NCT01704781|343040|P4|NOT COMPLETED|Overall Study||0
140367|NCT01704781|343041|P3|NOT COMPLETED|Overall Study||0
140368|NCT01704781|343042|P2|NOT COMPLETED|Overall Study||0
140369|NCT01704781|343043|P1|NOT COMPLETED|Overall Study||0
140370|NCT01704781|343039|P5|COMPLETED|Overall Study||12
140371|NCT01704781|343040|P4|COMPLETED|Overall Study||12
140372|NCT01704781|343041|P3|COMPLETED|Overall Study||6
140373|NCT01704781|343042|P2|COMPLETED|Overall Study||3
140374|NCT01704781|343043|P1|COMPLETED|Overall Study||3
140375|NCT01704781|343039|P5|STARTED|Overall Study||12
140376|NCT01704781|343040|P4|STARTED|Overall Study||12
140377|NCT01704781|343041|P3|STARTED|Overall Study||6
140378|NCT01704781|343042|P2|STARTED|Overall Study||3
140379|NCT01704781|343043|P1|STARTED|Overall Study||3
140380|NCT01704755|343071|P2|NOT COMPLETED|Overall Study||7
140381|NCT01704755|343072|P1|NOT COMPLETED|Overall Study||12
140382|NCT01704755|343071|P2|COMPLETED|Overall Study||165
140383|NCT01704755|343072|P1|COMPLETED|Overall Study||196
140384|NCT01704755|343071|P2|Completed Study Drug|Overall Study||163
140385|NCT01704755|343072|P1|Completed Study Drug|Overall Study||204
140386|NCT01704755|343071|P2|STARTED|Overall Study||172
140387|NCT01704755|343072|P1|STARTED|Overall Study||208
140388|NCT01704651|343086|P2|NOT COMPLETED|Overall Study||7
140389|NCT01704651|343087|P1|NOT COMPLETED|Overall Study||5
140390|NCT01704651|343086|P2|COMPLETED|Overall Study||68
140391|NCT01704651|343087|P1|COMPLETED|Overall Study||66
140392|NCT01704651|343086|P2|STARTED|Overall Study||75
140393|NCT01704651|343087|P1|STARTED|Overall Study||71
140394|NCT01704599|343095|P1|NOT COMPLETED|Overall Study||1
140395|NCT01704599|343095|P1|COMPLETED|Overall Study|11 screened 8 entered study 1 terminated.|7
140396|NCT01704599|343095|P1|STARTED|Overall Study|Study was started January 22, 2010|8
140397|NCT01704521|343124|P2|NOT COMPLETED|Overall Study||0
140398|NCT01704521|343125|P1|NOT COMPLETED|Overall Study||0
140399|NCT01704521|343124|P2|COMPLETED|Overall Study||2
140400|NCT01704521|343125|P1|COMPLETED|Overall Study||3
140401|NCT01704521|343124|P2|STARTED|Overall Study||2
140402|NCT01704521|343125|P1|STARTED|Overall Study||3
140403|NCT01704495|343135|P4|NOT COMPLETED|Optional Safety Extension||31
140404|NCT01704495|343136|P3|NOT COMPLETED|Optional Safety Extension||31
140405|NCT01704495|343137|P2|NOT COMPLETED|Optional Safety Extension||33
140406|NCT01704495|343138|P1|NOT COMPLETED|Optional Safety Extension||29
140407|NCT01704495|343135|P4|COMPLETED|Optional Safety Extension||85
140408|NCT01704495|343136|P3|COMPLETED|Optional Safety Extension||83
140409|NCT01704495|343137|P2|COMPLETED|Optional Safety Extension||88
140410|NCT01704495|343138|P1|COMPLETED|Optional Safety Extension||87
140411|NCT01704495|343135|P4|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
140412|NCT01704495|343136|P3|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|114
140413|NCT01704495|343137|P2|STARTED|Optional Safety Extension|35 subjects did not enter safety extension|121
140414|NCT01704495|343138|P1|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
140415|NCT01704495|343135|P4|NOT COMPLETED|Subjects Randomized||17
140416|NCT01704495|343136|P3|NOT COMPLETED|Subjects Randomized||16
140417|NCT01704495|343137|P2|NOT COMPLETED|Subjects Randomized||15
140418|NCT01704495|343138|P1|NOT COMPLETED|Subjects Randomized||22
140419|NCT01704495|343135|P4|COMPLETED|Subjects Randomized||145
140420|NCT01704495|343136|P3|COMPLETED|Subjects Randomized||144
140421|NCT01704495|343137|P2|COMPLETED|Subjects Randomized||141
140422|NCT01704495|343138|P1|COMPLETED|Subjects Randomized||140
140423|NCT01704495|343135|P4|STARTED|Subjects Randomized||162
140424|NCT01704495|343136|P3|STARTED|Subjects Randomized||160
140425|NCT01704495|343137|P2|STARTED|Subjects Randomized||156
140426|NCT01704495|343138|P1|STARTED|Subjects Randomized||162
140427|NCT01704404|343312|P6|NOT COMPLETED|Overall Study||0
140428|NCT01704404|343313|P5|NOT COMPLETED|Overall Study||1
140429|NCT01704404|343314|P4|NOT COMPLETED|Overall Study||3
140430|NCT01704404|343315|P3|NOT COMPLETED|Overall Study||1
140431|NCT01704404|343316|P2|NOT COMPLETED|Overall Study||1
140432|NCT01704404|343317|P1|NOT COMPLETED|Overall Study||1
140433|NCT01704404|343312|P6|COMPLETED|Overall Study||9
140434|NCT01704404|343313|P5|COMPLETED|Overall Study||10
140435|NCT01704404|343314|P4|COMPLETED|Overall Study||8
140436|NCT01704404|343315|P3|COMPLETED|Overall Study||9
140437|NCT01704404|343316|P2|COMPLETED|Overall Study||9
140438|NCT01704404|343317|P1|COMPLETED|Overall Study||10
140439|NCT01704404|343312|P6|STARTED|Overall Study||9
140440|NCT01704404|343313|P5|STARTED|Overall Study||11
140441|NCT01704404|343314|P4|STARTED|Overall Study||11
140442|NCT01704404|343315|P3|STARTED|Overall Study||10
140443|NCT01704404|343316|P2|STARTED|Overall Study||10
140444|NCT01704404|343317|P1|STARTED|Overall Study||11
140445|NCT01704287|343354|P5|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||38
140446|NCT01704287|343355|P4|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||38
140447|NCT01704287|343356|P3|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
140448|NCT01704287|343357|P2|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
140449|NCT01704287|343358|P1|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
140450|NCT01704287|343354|P5|COMPLETED|Switch to Pembrolizumab Treatment Period||7
140451|NCT01704287|343355|P4|COMPLETED|Switch to Pembrolizumab Treatment Period||15
140452|NCT01704287|343356|P3|COMPLETED|Switch to Pembrolizumab Treatment Period||0
140453|NCT01704287|343357|P2|COMPLETED|Switch to Pembrolizumab Treatment Period||0
140454|NCT01704287|343358|P1|COMPLETED|Switch to Pembrolizumab Treatment Period||0
140455|NCT01704287|343354|P5|STARTED|Switch to Pembrolizumab Treatment Period||45
140456|NCT01704287|343355|P4|STARTED|Switch to Pembrolizumab Treatment Period||53
140457|NCT01704287|343356|P3|STARTED|Switch to Pembrolizumab Treatment Period||0
140458|NCT01704287|343357|P2|STARTED|Switch to Pembrolizumab Treatment Period||0
140459|NCT01704287|343358|P1|STARTED|Switch to Pembrolizumab Treatment Period||0
140460|NCT01704287|343354|P5|NOT COMPLETED|Initial Treatment Period||0
140461|NCT01704287|343355|P4|NOT COMPLETED|Initial Treatment Period||0
140462|NCT01704287|343356|P3|NOT COMPLETED|Initial Treatment Period||173
140463|NCT01704287|343357|P2|NOT COMPLETED|Initial Treatment Period||134
140464|NCT01704287|343358|P1|NOT COMPLETED|Initial Treatment Period||147
140465|NCT01704287|343354|P5|COMPLETED|Initial Treatment Period||0
140466|NCT01704287|343355|P4|COMPLETED|Initial Treatment Period||0
140467|NCT01704287|343356|P3|COMPLETED|Initial Treatment Period||6
140468|NCT01704287|343357|P2|COMPLETED|Initial Treatment Period||47
140469|NCT01704287|343358|P1|COMPLETED|Initial Treatment Period||33
140470|NCT01704287|343354|P5|Treated|Initial Treatment Period||0
140471|NCT01704287|343355|P4|Treated|Initial Treatment Period||0
140472|NCT01704287|343356|P3|Treated|Initial Treatment Period||171
140473|NCT01704287|343357|P2|Treated|Initial Treatment Period||179
140474|NCT01704287|343358|P1|Treated|Initial Treatment Period||178
140475|NCT01704287|343354|P5|STARTED|Initial Treatment Period||0
140476|NCT01704287|343355|P4|STARTED|Initial Treatment Period||0
140477|NCT01704287|343356|P3|STARTED|Initial Treatment Period||179
140478|NCT01704287|343357|P2|STARTED|Initial Treatment Period||181
140479|NCT01704287|343358|P1|STARTED|Initial Treatment Period||180
140480|NCT01704261|343406|P2|NOT COMPLETED|Overall Study||15
140481|NCT01704261|343407|P1|NOT COMPLETED|Overall Study||13
140482|NCT01704261|343406|P2|COMPLETED|Overall Study||138
140483|NCT01704261|343407|P1|COMPLETED|Overall Study||141
140484|NCT01704261|343406|P2|STARTED|Overall Study||153
140485|NCT01704261|343407|P1|STARTED|Overall Study||154
140486|NCT01704196|343423|P2|NOT COMPLETED|Overall Study||24
140487|NCT01704196|343424|P1|NOT COMPLETED|Overall Study||19
140488|NCT01704196|343423|P2|COMPLETED|Overall Study||65
140489|NCT01704196|343424|P1|COMPLETED|Overall Study||71
140490|NCT01704196|343423|P2|STARTED|Overall Study||89
140491|NCT01704196|343424|P1|STARTED|Overall Study||90
140492|NCT01704079|343434|P2|NOT COMPLETED|Overall Study||23
140493|NCT01704079|343435|P1|NOT COMPLETED|Overall Study||14
140494|NCT01704079|343434|P2|COMPLETED|Overall Study||121
140495|NCT01704079|343435|P1|COMPLETED|Overall Study||58
140496|NCT01704079|343434|P2|Entered Extension Study|Overall Study||102
140497|NCT01704079|343435|P1|Entered Extension Study|Overall Study||53
140498|NCT01704079|343434|P2|STARTED|Overall Study||144
140499|NCT01704079|343435|P1|STARTED|Overall Study||72
140500|NCT01703988|343451|P4|NOT COMPLETED|Overall Study||1
140501|NCT01703988|343452|P3|NOT COMPLETED|Overall Study||0
140502|NCT01703988|343453|P2|NOT COMPLETED|Overall Study||0
140503|NCT01703988|343454|P1|NOT COMPLETED|Overall Study||0
140504|NCT01703988|343451|P4|COMPLETED|Overall Study||8
140505|NCT01703988|343452|P3|COMPLETED|Overall Study||9
140506|NCT01703988|343453|P2|COMPLETED|Overall Study||8
140507|NCT01703988|343454|P1|COMPLETED|Overall Study||8
140508|NCT01703988|343451|P4|STARTED|Overall Study||9
140509|NCT01703988|343452|P3|STARTED|Overall Study||9
140510|NCT01703988|343453|P2|STARTED|Overall Study||8
140511|NCT01703988|343454|P1|STARTED|Overall Study||8
140512|NCT01703858|343484|P3|NOT COMPLETED|Overall Study||0
140513|NCT01703858|343485|P2|NOT COMPLETED|Overall Study||1
140514|NCT01703858|343486|P1|NOT COMPLETED|Overall Study||0
140515|NCT01703858|343484|P3|COMPLETED|Overall Study||5
140516|NCT01703858|343485|P2|COMPLETED|Overall Study||4
140517|NCT01703858|343486|P1|COMPLETED|Overall Study||5
140518|NCT01703858|343484|P3|STARTED|Overall Study||5
140519|NCT01703858|343485|P2|STARTED|Overall Study||5
140520|NCT01703858|343486|P1|STARTED|Overall Study||5
140521|NCT01703845|343511|P2|NOT COMPLETED|Overall Study||0
140522|NCT01703845|343512|P1|NOT COMPLETED|Overall Study||3
140523|NCT01703845|343511|P2|COMPLETED|Overall Study||16
140524|NCT01703845|343512|P1|COMPLETED|Overall Study||13
140525|NCT01703845|343511|P2|STARTED|Overall Study|started are actually the randomized|16
140526|NCT01703845|343512|P1|STARTED|Overall Study|started are actually the randomized|16
140527|NCT01703832|343549|P2|NOT COMPLETED|Overall Study||0
140528|NCT01703832|343550|P1|NOT COMPLETED|Overall Study||1
140529|NCT01703832|343549|P2|COMPLETED|Overall Study||32
140530|NCT01703832|343550|P1|COMPLETED|Overall Study||32
140531|NCT01703832|343549|P2|STARTED|Overall Study||32
140532|NCT01703832|343550|P1|STARTED|Overall Study||33
140533|NCT01703819|343582|P2|NOT COMPLETED|Overall Study||2
140534|NCT01703819|343583|P1|NOT COMPLETED|Overall Study||0
140535|NCT01703819|343582|P2|COMPLETED|Overall Study||30
140536|NCT01703819|343583|P1|COMPLETED|Overall Study||34
140537|NCT01703819|343582|P2|STARTED|Overall Study||32
140538|NCT01703819|343583|P1|STARTED|Overall Study||34
140539|NCT01703741|343613|P1|NOT COMPLETED|Overall Study||18
140540|NCT01703741|343613|P1|COMPLETED|Overall Study||127
140541|NCT01703741|343613|P1|Per Protocol (PP) Population|Overall Study|Subjects having 24 hr pharmacokinetic (PK) data for testosterone, with no major protocol violations.|106
140542|NCT01703741|343613|P1|STARTED|Overall Study||145
140543|NCT01703702|343631|P2|NOT COMPLETED|Overall Study||22
140544|NCT01703702|343632|P1|NOT COMPLETED|Overall Study||36
140545|NCT01703702|343631|P2|COMPLETED|Overall Study||288
140546|NCT01703702|343632|P1|COMPLETED|Overall Study||272
140547|NCT01703702|343631|P2|STARTED|Overall Study||310
140548|NCT01703702|343632|P1|STARTED|Overall Study||308
140549|NCT01703663|343649|P2|NOT COMPLETED|Second Treatment Period||0
140550|NCT01703663|343650|P1|NOT COMPLETED|Second Treatment Period||0
140551|NCT01703663|343649|P2|COMPLETED|Second Treatment Period||8
140552|NCT01703663|343650|P1|COMPLETED|Second Treatment Period||11
140553|NCT01703663|343649|P2|STARTED|Second Treatment Period||8
140554|NCT01703663|343650|P1|STARTED|Second Treatment Period||11
140555|NCT01703663|343649|P2|NOT COMPLETED|First Treatment Period||0
140556|NCT01703663|343650|P1|NOT COMPLETED|First Treatment Period||0
140557|NCT01703663|343649|P2|COMPLETED|First Treatment Period||20
140558|NCT01703663|343650|P1|COMPLETED|First Treatment Period||20
140559|NCT01703663|343649|P2|STARTED|First Treatment Period||20
140560|NCT01703663|343650|P1|STARTED|First Treatment Period||20
140561|NCT01703598|343656|P1|NOT COMPLETED|Overall Study||0
140562|NCT01703598|343656|P1|COMPLETED|Overall Study||69
140563|NCT01703598|343656|P1|STARTED|Overall Study||69
140564|NCT01703507|343662|P2|NOT COMPLETED|Overall Study||0
140565|NCT01703507|343663|P1|NOT COMPLETED|Overall Study||1
140566|NCT01703507|343662|P2|COMPLETED|Overall Study||11
140567|NCT01703507|343663|P1|COMPLETED|Overall Study||5
140568|NCT01703507|343662|P2|STARTED|Overall Study||11
140569|NCT01703507|343663|P1|STARTED|Overall Study||6
140570|NCT01703286|343679|P6|NOT COMPLETED|Period 3 Including Washout||0
140571|NCT01703286|343680|P5|NOT COMPLETED|Period 3 Including Washout||0
140572|NCT01703286|343681|P4|NOT COMPLETED|Period 3 Including Washout||0
140573|NCT01703286|343682|P3|NOT COMPLETED|Period 3 Including Washout||0
140574|NCT01703286|343683|P2|NOT COMPLETED|Period 3 Including Washout||0
140575|NCT01703286|343684|P1|NOT COMPLETED|Period 3 Including Washout||0
140576|NCT01703286|343679|P6|COMPLETED|Period 3 Including Washout||6
140577|NCT01703286|343680|P5|COMPLETED|Period 3 Including Washout||7
140578|NCT01703286|343681|P4|COMPLETED|Period 3 Including Washout||5
140579|NCT01703286|343682|P3|COMPLETED|Period 3 Including Washout||7
140580|NCT01703286|343683|P2|COMPLETED|Period 3 Including Washout||7
140581|NCT01703286|343684|P1|COMPLETED|Period 3 Including Washout||7
140582|NCT01703286|343679|P6|STARTED|Period 3 Including Washout||6
140583|NCT01703286|343680|P5|STARTED|Period 3 Including Washout||7
140584|NCT01703286|343681|P4|STARTED|Period 3 Including Washout||5
140585|NCT01703286|343682|P3|STARTED|Period 3 Including Washout||7
140586|NCT01703286|343683|P2|STARTED|Period 3 Including Washout||7
140587|NCT01703286|343684|P1|STARTED|Period 3 Including Washout||7
140588|NCT01703286|343679|P6|NOT COMPLETED|Period 2 Including Washout||0
140589|NCT01703286|343680|P5|NOT COMPLETED|Period 2 Including Washout||0
140590|NCT01703286|343681|P4|NOT COMPLETED|Period 2 Including Washout||1
140591|NCT01703286|343682|P3|NOT COMPLETED|Period 2 Including Washout||0
140592|NCT01703286|343683|P2|NOT COMPLETED|Period 2 Including Washout||0
140593|NCT01703286|343684|P1|NOT COMPLETED|Period 2 Including Washout||0
140594|NCT01703286|343679|P6|COMPLETED|Period 2 Including Washout||6
140595|NCT01703286|343680|P5|COMPLETED|Period 2 Including Washout||7
140596|NCT01703286|343681|P4|COMPLETED|Period 2 Including Washout||5
140597|NCT01703286|343682|P3|COMPLETED|Period 2 Including Washout||7
140598|NCT01703286|343683|P2|COMPLETED|Period 2 Including Washout||7
140599|NCT01703286|343684|P1|COMPLETED|Period 2 Including Washout||7
140600|NCT01703286|343679|P6|STARTED|Period 2 Including Washout||6
140601|NCT01703286|343680|P5|STARTED|Period 2 Including Washout||7
140602|NCT01703286|343681|P4|STARTED|Period 2 Including Washout||6
140603|NCT01703286|343682|P3|STARTED|Period 2 Including Washout||7
140604|NCT01703286|343683|P2|STARTED|Period 2 Including Washout||7
140605|NCT01703286|343684|P1|STARTED|Period 2 Including Washout||7
140606|NCT01703286|343679|P6|NOT COMPLETED|Period 1 Including Washout||1
140607|NCT01703286|343680|P5|NOT COMPLETED|Period 1 Including Washout||0
140608|NCT01703286|343681|P4|NOT COMPLETED|Period 1 Including Washout||1
140609|NCT01703286|343682|P3|NOT COMPLETED|Period 1 Including Washout||0
140610|NCT01703286|343683|P2|NOT COMPLETED|Period 1 Including Washout||0
140611|NCT01703286|343684|P1|NOT COMPLETED|Period 1 Including Washout||0
140612|NCT01703286|343679|P6|COMPLETED|Period 1 Including Washout||6
140613|NCT01703286|343680|P5|COMPLETED|Period 1 Including Washout||7
140614|NCT01703286|343681|P4|COMPLETED|Period 1 Including Washout||6
140615|NCT01703286|343682|P3|COMPLETED|Period 1 Including Washout||7
140616|NCT01703286|343683|P2|COMPLETED|Period 1 Including Washout||7
140617|NCT01703286|343684|P1|COMPLETED|Period 1 Including Washout||7
140618|NCT01703286|343679|P6|STARTED|Period 1 Including Washout||7
140619|NCT01703286|343680|P5|STARTED|Period 1 Including Washout||7
140620|NCT01703286|343681|P4|STARTED|Period 1 Including Washout||7
140621|NCT01703286|343682|P3|STARTED|Period 1 Including Washout||7
140622|NCT01703286|343683|P2|STARTED|Period 1 Including Washout||7
140623|NCT01703286|343684|P1|STARTED|Period 1 Including Washout||7
140624|NCT01703260|343707|P3|NOT COMPLETED|Overall Study||3
140625|NCT01703260|343708|P2|NOT COMPLETED|Overall Study||4
140626|NCT01703260|343709|P1|NOT COMPLETED|Overall Study||3
140627|NCT01703260|343707|P3|COMPLETED|Overall Study||3
140628|NCT01703260|343708|P2|COMPLETED|Overall Study||3
140629|NCT01703260|343709|P1|COMPLETED|Overall Study||4
140630|NCT01703260|343707|P3|STARTED|Overall Study||6
140631|NCT01703260|343708|P2|STARTED|Overall Study||7
140632|NCT01703260|343709|P1|STARTED|Overall Study||7
140633|NCT01703221|343735|P3|NOT COMPLETED|Phase B - (Week 25 to 52)||5
140634|NCT01703221|343736|P2|NOT COMPLETED|Phase B - (Week 25 to 52)||14
140635|NCT01703221|343737|P1|NOT COMPLETED|Phase B - (Week 25 to 52)||16
140636|NCT01703221|343735|P3|COMPLETED|Phase B - (Week 25 to 52)||75
140637|NCT01703221|343736|P2|COMPLETED|Phase B - (Week 25 to 52)||147
140638|NCT01703221|343737|P1|COMPLETED|Phase B - (Week 25 to 52)||143
140639|NCT01703221|343735|P3|STARTED|Phase B - (Week 25 to 52)||80
140640|NCT01703221|343736|P2|STARTED|Phase B - (Week 25 to 52)||161
140641|NCT01703221|343737|P1|STARTED|Phase B - (Week 25 to 52)||159
140642|NCT01703221|343735|P3|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
140643|NCT01703221|343736|P2|NOT COMPLETED|Phase A (Up to 24 Weeks)||4
140644|NCT01703221|343737|P1|NOT COMPLETED|Phase A (Up to 24 Weeks)||7
140645|NCT01703221|343735|P3|COMPLETED|Phase A (Up to 24 Weeks)||80
140646|NCT01703221|343736|P2|COMPLETED|Phase A (Up to 24 Weeks)||161
140647|NCT01703221|343737|P1|COMPLETED|Phase A (Up to 24 Weeks)||159
140648|NCT01703221|343735|P3|STARTED|Phase A (Up to 24 Weeks)||83
140649|NCT01703221|343736|P2|STARTED|Phase A (Up to 24 Weeks)||165
140650|NCT01703221|343737|P1|STARTED|Phase A (Up to 24 Weeks)||166
140651|NCT01703208|343768|P2|NOT COMPLETED|Overall Study||2102
140652|NCT01703208|343769|P1|NOT COMPLETED|Overall Study||2100
140653|NCT01703208|343768|P2|COMPLETED|Overall Study||0
140654|NCT01703208|343769|P1|COMPLETED|Overall Study||0
140655|NCT01703208|343768|P2|Treated|Overall Study||2100
140656|NCT01703208|343769|P1|Treated|Overall Study||2092
140657|NCT01703208|343768|P2|STARTED|Overall Study||2102
140658|NCT01703208|343769|P1|STARTED|Overall Study||2100
140659|NCT01703169|343823|P1|NOT COMPLETED|Overall Study||0
140660|NCT01703169|343823|P1|COMPLETED|Overall Study||13
140661|NCT01703169|343823|P1|STARTED|Overall Study||13
140662|NCT01703091|343833|P2|NOT COMPLETED|Overall Study||4
140663|NCT01703091|343834|P1|NOT COMPLETED|Overall Study||9
140664|NCT01703091|343833|P2|COMPLETED|Overall Study||95
140665|NCT01703091|343834|P1|COMPLETED|Overall Study||89
140666|NCT01703091|343833|P2|Received at Least One Dose of Study Drug|Overall Study||98
140667|NCT01703091|343834|P1|Received at Least One Dose of Study Drug|Overall Study||94
140668|NCT01703091|343833|P2|STARTED|Overall Study||99
140669|NCT01703091|343834|P1|STARTED|Overall Study||98
140670|NCT01703065|343852|P2|NOT COMPLETED|Overall Study||0
140671|NCT01703065|343853|P1|NOT COMPLETED|Overall Study||1
140672|NCT01703065|343852|P2|COMPLETED|Overall Study||0
140673|NCT01703065|343853|P1|COMPLETED|Overall Study||8
140674|NCT01703065|343852|P2|STARTED|Overall Study||0
140675|NCT01703065|343853|P1|STARTED|Overall Study||9
140676|NCT01703039|343868|P2|NOT COMPLETED|Overall Study||5
140677|NCT01703039|343869|P1|NOT COMPLETED|Overall Study||3
140678|NCT01703039|343868|P2|COMPLETED|Overall Study||7
140679|NCT01703039|343869|P1|COMPLETED|Overall Study||6
140680|NCT01703039|343868|P2|STARTED|Overall Study||12
140681|NCT01703039|343869|P1|STARTED|Overall Study||9
140682|NCT01703000|343883|P1|NOT COMPLETED|Overall Study||1
140683|NCT01703000|343883|P1|COMPLETED|Overall Study||99
140684|NCT01703000|343883|P1|STARTED|Overall Study||100
140685|NCT01702987|343916|P2|NOT COMPLETED|Overall Study||0
140686|NCT01702987|343917|P1|NOT COMPLETED|Overall Study||1
140687|NCT01702987|343916|P2|COMPLETED|Overall Study||12
140688|NCT01702987|343917|P1|COMPLETED|Overall Study||9
140689|NCT01702987|343916|P2|STARTED|Overall Study||12
140690|NCT01702987|343917|P1|STARTED|Overall Study||10
140691|NCT01702961|343923|P1|NOT COMPLETED|Overall Study||47
140692|NCT01702961|343923|P1|COMPLETED|Overall Study||28
140693|NCT01702961|343923|P1|STARTED|Overall Study||75
140694|NCT01702909|343929|P1|NOT COMPLETED|Overall Study||0
140695|NCT01702909|343929|P1|COMPLETED|Overall Study||7
140696|NCT01702909|343929|P1|STARTED|Overall Study||7
140697|NCT01702896|343935|P1|NOT COMPLETED|Overall Study||8
140698|NCT01702896|343935|P1|COMPLETED|Overall Study||0
140699|NCT01702896|343935|P1|STARTED|Overall Study||8
140700|NCT01702558|343946|P5|NOT COMPLETED|Overall Study||42
140701|NCT01702558|343947|P4|NOT COMPLETED|Overall Study||47
140702|NCT01702558|343948|P3|NOT COMPLETED|Overall Study||5
140703|NCT01702558|343949|P2|NOT COMPLETED|Overall Study||4
140704|NCT01702558|343950|P1|NOT COMPLETED|Overall Study||4
140705|NCT01702558|343946|P5|COMPLETED|Overall Study||38
140706|NCT01702558|343947|P4|COMPLETED|Overall Study||34
140707|NCT01702558|343948|P3|COMPLETED|Overall Study||1
140708|NCT01702558|343949|P2|COMPLETED|Overall Study||1
140709|NCT01702558|343950|P1|COMPLETED|Overall Study||3
140710|NCT01702558|343946|P5|STARTED|Overall Study||80
140711|NCT01702558|343947|P4|STARTED|Overall Study||81
140712|NCT01702558|343948|P3|STARTED|Overall Study||6
140713|NCT01702558|343949|P2|STARTED|Overall Study||5
140714|NCT01702558|343950|P1|STARTED|Overall Study||7
140715|NCT01702532|344015|P2|NOT COMPLETED|Overall Study||1
140716|NCT01702532|344016|P1|NOT COMPLETED|Overall Study||0
140717|NCT01702532|344015|P2|COMPLETED|Overall Study||160
140718|NCT01702532|344016|P1|COMPLETED|Overall Study||161
140719|NCT01702532|344015|P2|Safety Population|Overall Study|One subject randomized but did not receive the study treatment.|160
140720|NCT01702532|344016|P1|Safety Population|Overall Study||161
140721|NCT01702532|344015|P2|STARTED|Overall Study||161
140722|NCT01702532|344016|P1|STARTED|Overall Study||161
140723|NCT01702519|344026|P2|NOT COMPLETED|Period 2||0
140724|NCT01702519|344027|P1|NOT COMPLETED|Period 2||0
140725|NCT01702519|344026|P2|COMPLETED|Period 2||18
140726|NCT01702519|344027|P1|COMPLETED|Period 2||19
140727|NCT01702519|344026|P2|STARTED|Period 2||18
140728|NCT01702519|344027|P1|STARTED|Period 2||19
140729|NCT01702519|344026|P2|NOT COMPLETED|Washout Period||2
140730|NCT01702519|344027|P1|NOT COMPLETED|Washout Period||1
140731|NCT01702519|344026|P2|COMPLETED|Washout Period||18
140732|NCT01702519|344027|P1|COMPLETED|Washout Period||19
140733|NCT01702519|344026|P2|STARTED|Washout Period||20
140734|NCT01702519|344027|P1|STARTED|Washout Period||20
140735|NCT01702519|344026|P2|NOT COMPLETED|Period 1||0
140736|NCT01702519|344027|P1|NOT COMPLETED|Period 1||0
140737|NCT01702519|344026|P2|COMPLETED|Period 1||20
140738|NCT01702519|344027|P1|COMPLETED|Period 1||20
140739|NCT01702519|344026|P2|STARTED|Period 1||20
140740|NCT01702519|344027|P1|STARTED|Period 1||20
140741|NCT01702454|344045|P2|NOT COMPLETED|Overall Study||8
140742|NCT01702454|344046|P1|NOT COMPLETED|Overall Study||3
140743|NCT01702454|344045|P2|COMPLETED|Overall Study||221
140744|NCT01702454|344046|P1|COMPLETED|Overall Study||238
140745|NCT01702454|344045|P2|STARTED|Overall Study||229
140746|NCT01702454|344046|P1|STARTED|Overall Study||241
140747|NCT01702428|344128|P4|NOT COMPLETED|Overall Study||57
140748|NCT01702428|344129|P3|NOT COMPLETED|Overall Study||53
140749|NCT01702428|344130|P2|NOT COMPLETED|Overall Study||70
140750|NCT01702428|344131|P1|NOT COMPLETED|Overall Study||64
140751|NCT01702428|344128|P4|COMPLETED|Overall Study||1232
140752|NCT01702428|344129|P3|COMPLETED|Overall Study||1190
140753|NCT01702428|344130|P2|COMPLETED|Overall Study||1162
140754|NCT01702428|344131|P1|COMPLETED|Overall Study||1175
140755|NCT01702428|344128|P4|STARTED|Overall Study||1289
140756|NCT01702428|344129|P3|STARTED|Overall Study||1243
140757|NCT01702428|344130|P2|STARTED|Overall Study||1232
140758|NCT01702428|344131|P1|STARTED|Overall Study||1239
140759|NCT01702363|344218|P1|NOT COMPLETED|Overall Study||20
140760|NCT01702363|344218|P1|COMPLETED|Overall Study||111
140761|NCT01702363|344218|P1|STARTED|Overall Study||131
140762|NCT01702311|344235|P2|NOT COMPLETED|Overall Study||13
140763|NCT01702311|344236|P1|NOT COMPLETED|Overall Study||16
140764|NCT01702311|344235|P2|COMPLETED|Overall Study||100
140765|NCT01702311|344236|P1|COMPLETED|Overall Study||106
140766|NCT01702311|344235|P2|STARTED|Overall Study||113
140767|NCT01702311|344236|P1|STARTED|Overall Study||122
140768|NCT01702298|344266|P1|NOT COMPLETED|Overall Study||1
140769|NCT01702298|344266|P1|COMPLETED|Overall Study||41
140770|NCT01702298|344266|P1|STARTED|Overall Study||42
140771|NCT01702259|344279|P2|NOT COMPLETED|Overall Study||0
140772|NCT01702259|344280|P1|NOT COMPLETED|Overall Study||0
140773|NCT01702259|344279|P2|COMPLETED|Overall Study||34
140774|NCT01702259|344280|P1|COMPLETED|Overall Study||34
140775|NCT01702259|344279|P2|STARTED|Overall Study||34
140776|NCT01702259|344280|P1|STARTED|Overall Study||34
140777|NCT01702246|344294|P1|NOT COMPLETED|Overall Study||5
140778|NCT01702246|344294|P1|COMPLETED|Overall Study||19
140779|NCT01702246|344294|P1|STARTED|Overall Study||24
140780|NCT01702233|344306|P3|NOT COMPLETED|Overall Study||5
140781|NCT01702233|344307|P2|NOT COMPLETED|Overall Study||3
140782|NCT01702233|344308|P1|NOT COMPLETED|Overall Study||6
140783|NCT01702233|344306|P3|COMPLETED|Overall Study||31
140784|NCT01702233|344307|P2|COMPLETED|Overall Study|One of these Patient completed the Trial but had no valid outcome measure after enrolment|64
140785|NCT01702233|344308|P1|COMPLETED|Overall Study||66
140786|NCT01702233|344306|P3|Per Protocol Set|Overall Study||27
140787|NCT01702233|344307|P2|Per Protocol Set|Overall Study||58
140788|NCT01702233|344308|P1|Per Protocol Set|Overall Study||58
140789|NCT01702233|344306|P3|Full Analysis Set (ITT)|Overall Study||31
140790|NCT01702233|344307|P2|Full Analysis Set (ITT)|Overall Study||63
140791|NCT01702233|344308|P1|Full Analysis Set (ITT)|Overall Study||66
140792|NCT01702233|344306|P3|STARTED|Overall Study||36
140793|NCT01702233|344307|P2|STARTED|Overall Study||67
140794|NCT01702233|344308|P1|STARTED|Overall Study||72
140795|NCT01702025|344348|P4|NOT COMPLETED|Overall Study||0
140796|NCT01702025|344349|P3|NOT COMPLETED|Overall Study||1
140797|NCT01702025|344350|P2|NOT COMPLETED|Overall Study||1
140798|NCT01702025|344351|P1|NOT COMPLETED|Overall Study||2
140799|NCT01702025|344348|P4|COMPLETED|Overall Study||10
140800|NCT01702025|344349|P3|COMPLETED|Overall Study||9
140801|NCT01702025|344350|P2|COMPLETED|Overall Study||9
140802|NCT01702025|344351|P1|COMPLETED|Overall Study||9
140803|NCT01702025|344348|P4|STARTED|Overall Study||10
140804|NCT01702025|344349|P3|STARTED|Overall Study||10
140805|NCT01702025|344350|P2|STARTED|Overall Study||10
140806|NCT01702025|344351|P1|STARTED|Overall Study||11
140807|NCT01701999|344367|P2|NOT COMPLETED|Overall Study||0
140808|NCT01701999|344368|P1|NOT COMPLETED|Overall Study||0
140809|NCT01701999|344367|P2|COMPLETED|Overall Study||37
140810|NCT01701999|344368|P1|COMPLETED|Overall Study||8
140811|NCT01701999|344367|P2|STARTED|Overall Study||37
140812|NCT01701999|344368|P1|STARTED|Overall Study||8
140813|NCT01701973|344380|P8|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
140814|NCT01701973|344381|P7|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
140815|NCT01701973|344382|P6|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
140816|NCT01701973|344383|P5|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
140817|NCT01701973|344384|P4|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
140818|NCT01701973|344385|P3|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
140819|NCT01701973|344386|P2|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
140820|NCT01701973|344387|P1|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
140821|NCT01701973|344380|P8|COMPLETED|Aim 2: Second Intervention (1 Day)||3
140822|NCT01701973|344381|P7|COMPLETED|Aim 2: Second Intervention (1 Day)||5
140823|NCT01701973|344382|P6|COMPLETED|Aim 2: Second Intervention (1 Day)||3
140824|NCT01701973|344383|P5|COMPLETED|Aim 2: Second Intervention (1 Day)||2
140825|NCT01701973|344384|P4|COMPLETED|Aim 2: Second Intervention (1 Day)||4
140826|NCT01701973|344385|P3|COMPLETED|Aim 2: Second Intervention (1 Day)||5
140827|NCT01701973|344386|P2|COMPLETED|Aim 2: Second Intervention (1 Day)||0
140828|NCT01701973|344387|P1|COMPLETED|Aim 2: Second Intervention (1 Day)||0
140829|NCT01701973|344380|P8|STARTED|Aim 2: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 3 and 4.|3
140830|NCT01701973|344381|P7|STARTED|Aim 2: Second Intervention (1 Day)||5
140831|NCT01701973|344382|P6|STARTED|Aim 2: Second Intervention (1 Day)||3
140832|NCT01701973|344383|P5|STARTED|Aim 2: Second Intervention (1 Day)||2
140833|NCT01701973|344384|P4|STARTED|Aim 2: Second Intervention (1 Day)||4
140834|NCT01701973|344385|P3|STARTED|Aim 2: Second Intervention (1 Day)||5
140835|NCT01701973|344386|P2|STARTED|Aim 2: Second Intervention (1 Day)||0
140836|NCT01701973|344387|P1|STARTED|Aim 2: Second Intervention (1 Day)||0
140837|NCT01701973|344380|P8|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
140838|NCT01701973|344381|P7|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
140839|NCT01701973|344382|P6|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
140840|NCT01701973|344383|P5|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
140841|NCT01701973|344384|P4|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
140842|NCT01701973|344385|P3|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
140843|NCT01701973|344386|P2|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
140844|NCT01701973|344387|P1|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
140845|NCT01701973|344380|P8|COMPLETED|Aim 2: First Intervention (1 Day)||4
140846|NCT01701973|344381|P7|COMPLETED|Aim 2: First Intervention (1 Day)||5
140847|NCT01701973|344382|P6|COMPLETED|Aim 2: First Intervention (1 Day)||3
140848|NCT01701973|344383|P5|COMPLETED|Aim 2: First Intervention (1 Day)||2
140849|NCT01701973|344384|P4|COMPLETED|Aim 2: First Intervention (1 Day)||4
140850|NCT01701973|344385|P3|COMPLETED|Aim 2: First Intervention (1 Day)||5
140851|NCT01701973|344386|P2|COMPLETED|Aim 2: First Intervention (1 Day)||0
140852|NCT01701973|344387|P1|COMPLETED|Aim 2: First Intervention (1 Day)||0
140853|NCT01701973|344380|P8|STARTED|Aim 2: First Intervention (1 Day)||4
140854|NCT01701973|344381|P7|STARTED|Aim 2: First Intervention (1 Day)||5
140855|NCT01701973|344382|P6|STARTED|Aim 2: First Intervention (1 Day)||3
140856|NCT01701973|344383|P5|STARTED|Aim 2: First Intervention (1 Day)||2
140857|NCT01701973|344384|P4|STARTED|Aim 2: First Intervention (1 Day)||4
140858|NCT01701973|344385|P3|STARTED|Aim 2: First Intervention (1 Day)||5
140859|NCT01701973|344386|P2|STARTED|Aim 2: First Intervention (1 Day)||0
140860|NCT01701973|344387|P1|STARTED|Aim 2: First Intervention (1 Day)||0
140861|NCT01701973|344380|P8|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
140862|NCT01701973|344381|P7|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
140863|NCT01701973|344382|P6|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
140864|NCT01701973|344383|P5|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
140865|NCT01701973|344384|P4|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
140866|NCT01701973|344385|P3|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
140867|NCT01701973|344386|P2|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
140868|NCT01701973|344387|P1|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
140869|NCT01701973|344380|P8|COMPLETED|Aim 1: Second Intervention (1 Day)||0
140870|NCT01701973|344381|P7|COMPLETED|Aim 1: Second Intervention (1 Day)||0
140871|NCT01701973|344382|P6|COMPLETED|Aim 1: Second Intervention (1 Day)||0
140872|NCT01701973|344383|P5|COMPLETED|Aim 1: Second Intervention (1 Day)||0
140873|NCT01701973|344384|P4|COMPLETED|Aim 1: Second Intervention (1 Day)||0
140874|NCT01701973|344385|P3|COMPLETED|Aim 1: Second Intervention (1 Day)||0
140875|NCT01701973|344386|P2|COMPLETED|Aim 1: Second Intervention (1 Day)||17
140876|NCT01701973|344387|P1|COMPLETED|Aim 1: Second Intervention (1 Day)||22
140877|NCT01701973|344380|P8|STARTED|Aim 1: Second Intervention (1 Day)||0
140878|NCT01701973|344381|P7|STARTED|Aim 1: Second Intervention (1 Day)||0
140879|NCT01701973|344382|P6|STARTED|Aim 1: Second Intervention (1 Day)||0
140880|NCT01701973|344383|P5|STARTED|Aim 1: Second Intervention (1 Day)||0
140881|NCT01701973|344384|P4|STARTED|Aim 1: Second Intervention (1 Day)||0
140882|NCT01701973|344385|P3|STARTED|Aim 1: Second Intervention (1 Day)||0
140883|NCT01701973|344386|P2|STARTED|Aim 1: Second Intervention (1 Day)|3 subjects were lost to follow-up in between Periods 1 and 2.|17
140884|NCT01701973|344387|P1|STARTED|Aim 1: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 1 and 2.|22
140885|NCT01701973|344380|P8|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
140886|NCT01701973|344381|P7|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
140887|NCT01701973|344382|P6|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
140888|NCT01701973|344383|P5|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
140889|NCT01701973|344384|P4|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
140890|NCT01701973|344385|P3|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
140891|NCT01701973|344386|P2|NOT COMPLETED|Aim 1: First Intervention (1 Day)||1
140892|NCT01701973|344387|P1|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
140893|NCT01701973|344380|P8|COMPLETED|Aim 1: First Intervention (1 Day)||0
140894|NCT01701973|344381|P7|COMPLETED|Aim 1: First Intervention (1 Day)||0
140895|NCT01701973|344382|P6|COMPLETED|Aim 1: First Intervention (1 Day)||0
140896|NCT01701973|344383|P5|COMPLETED|Aim 1: First Intervention (1 Day)||0
140897|NCT01701973|344384|P4|COMPLETED|Aim 1: First Intervention (1 Day)||0
140898|NCT01701973|344385|P3|COMPLETED|Aim 1: First Intervention (1 Day)||0
140899|NCT01701973|344386|P2|COMPLETED|Aim 1: First Intervention (1 Day)||20
140900|NCT01701973|344387|P1|COMPLETED|Aim 1: First Intervention (1 Day)||23
140901|NCT01701973|344380|P8|STARTED|Aim 1: First Intervention (1 Day)||0
140902|NCT01701973|344381|P7|STARTED|Aim 1: First Intervention (1 Day)||0
140903|NCT01701973|344382|P6|STARTED|Aim 1: First Intervention (1 Day)||0
140904|NCT01701973|344383|P5|STARTED|Aim 1: First Intervention (1 Day)||0
140905|NCT01701973|344384|P4|STARTED|Aim 1: First Intervention (1 Day)||0
140906|NCT01701973|344385|P3|STARTED|Aim 1: First Intervention (1 Day)||0
140907|NCT01701973|344386|P2|STARTED|Aim 1: First Intervention (1 Day)||21
140908|NCT01701973|344387|P1|STARTED|Aim 1: First Intervention (1 Day)||23
140909|NCT01701674|344434|P1|NOT COMPLETED|Overall Study||1
140910|NCT01701674|344434|P1|COMPLETED|Overall Study||12
140911|NCT01701674|344434|P1|STARTED|Overall Study||13
140912|NCT01701622|344441|P1|NOT COMPLETED|Overall Study||0
140913|NCT01701622|344441|P1|COMPLETED|Overall Study||1
140914|NCT01701622|344441|P1|STARTED|Overall Study||1
140915|NCT01701505|344452|P6|NOT COMPLETED|Overall Study||0
140916|NCT01701505|344453|P5|NOT COMPLETED|Overall Study||0
140917|NCT01701505|344454|P4|NOT COMPLETED|Overall Study||0
140918|NCT01701505|344455|P3|NOT COMPLETED|Overall Study||0
140919|NCT01701505|344456|P2|NOT COMPLETED|Overall Study||0
140920|NCT01701505|344457|P1|NOT COMPLETED|Overall Study||0
140921|NCT01701505|344452|P6|COMPLETED|Overall Study||8
140922|NCT01701505|344453|P5|COMPLETED|Overall Study||8
140923|NCT01701505|344454|P4|COMPLETED|Overall Study||8
140924|NCT01701505|344455|P3|COMPLETED|Overall Study||8
140925|NCT01701505|344456|P2|COMPLETED|Overall Study||8
140926|NCT01701505|344457|P1|COMPLETED|Overall Study||8
140927|NCT01701505|344452|P6|STARTED|Overall Study||8
140928|NCT01701505|344453|P5|STARTED|Overall Study||8
140929|NCT01701505|344454|P4|STARTED|Overall Study||8
140930|NCT01701505|344455|P3|STARTED|Overall Study||8
140931|NCT01701505|344456|P2|STARTED|Overall Study||8
140932|NCT01701505|344457|P1|STARTED|Overall Study||8
140933|NCT01701414|344509|P2|NOT COMPLETED|Overall Study||1
140934|NCT01701414|344510|P1|NOT COMPLETED|Overall Study||1
140935|NCT01701414|344509|P2|COMPLETED|Overall Study||18
140936|NCT01701414|344510|P1|COMPLETED|Overall Study||18
140937|NCT01701414|344509|P2|STARTED|Overall Study||19
140938|NCT01701414|344510|P1|STARTED|Overall Study||19
140939|NCT01701401|344520|P4|NOT COMPLETED|Overall Study||6
140940|NCT01701401|344521|P3|NOT COMPLETED|Overall Study||5
140941|NCT01701401|344522|P2|NOT COMPLETED|Overall Study||9
140942|NCT01701401|344523|P1|NOT COMPLETED|Overall Study||10
140943|NCT01701401|344520|P4|COMPLETED|Overall Study||212
140944|NCT01701401|344521|P3|COMPLETED|Overall Study||212
140945|NCT01701401|344522|P2|COMPLETED|Overall Study||209
140946|NCT01701401|344523|P1|COMPLETED|Overall Study||207
140947|NCT01701401|344520|P4|STARTED|Overall Study||218
140948|NCT01701401|344521|P3|STARTED|Overall Study||217
140949|NCT01701401|344522|P2|STARTED|Overall Study||218
140950|NCT01701401|344523|P1|STARTED|Overall Study||217
140951|NCT01701375|344569|P1|NOT COMPLETED|Overall Study||0
140952|NCT01701375|344569|P1|COMPLETED|Overall Study||2
140953|NCT01701375|344569|P1|STARTED|Overall Study||2
140954|NCT01701362|344575|P2|NOT COMPLETED|Overall Study||56
140955|NCT01701362|344576|P1|NOT COMPLETED|Overall Study||42
140956|NCT01701362|344575|P2|COMPLETED|Overall Study||211
140957|NCT01701362|344576|P1|COMPLETED|Overall Study||233
140958|NCT01701362|344575|P2|TREATED|Overall Study||265
140959|NCT01701362|344576|P1|TREATED|Overall Study||274
140960|NCT01701362|344575|P2|STARTED|Overall Study||267
140961|NCT01701362|344576|P1|STARTED|Overall Study||275
140962|NCT01701271|344604|P1|NOT COMPLETED|Overall Study||0
140963|NCT01701271|344604|P1|COMPLETED|Overall Study||20
140964|NCT01701271|344604|P1|STARTED|Overall Study||20
140965|NCT01701258|344614|P13|NOT COMPLETED|EEG (Session 4)||0
140966|NCT01701258|344615|P12|NOT COMPLETED|EEG (Session 4)||0
140967|NCT01701258|344616|P11|NOT COMPLETED|EEG (Session 4)||0
140968|NCT01701258|344617|P10|NOT COMPLETED|EEG (Session 4)||0
140969|NCT01701258|344618|P9|NOT COMPLETED|EEG (Session 4)||0
140970|NCT01701258|344619|P8|NOT COMPLETED|EEG (Session 4)||0
140971|NCT01701258|344620|P7|NOT COMPLETED|EEG (Session 4)||0
140972|NCT01701258|344621|P6|NOT COMPLETED|EEG (Session 4)||0
140973|NCT01701258|344622|P5|NOT COMPLETED|EEG (Session 4)||0
140974|NCT01701258|344623|P4|NOT COMPLETED|EEG (Session 4)||0
140975|NCT01701258|344624|P3|NOT COMPLETED|EEG (Session 4)||0
140976|NCT01701258|344625|P2|NOT COMPLETED|EEG (Session 4)||0
140977|NCT01701258|344626|P1|NOT COMPLETED|EEG (Session 4)||0
140978|NCT01701258|344614|P13|COMPLETED|EEG (Session 4)||0
140979|NCT01701258|344615|P12|COMPLETED|EEG (Session 4)||0
140980|NCT01701258|344616|P11|COMPLETED|EEG (Session 4)||17
140981|NCT01701258|344617|P10|COMPLETED|EEG (Session 4)||0
140982|NCT01701258|344618|P9|COMPLETED|EEG (Session 4)||0
140983|NCT01701258|344619|P8|COMPLETED|EEG (Session 4)||16
140984|NCT01701258|344620|P7|COMPLETED|EEG (Session 4)||0
140985|NCT01701258|344621|P6|COMPLETED|EEG (Session 4)||0
140986|NCT01701258|344622|P5|COMPLETED|EEG (Session 4)||14
140987|NCT01701258|344623|P4|COMPLETED|EEG (Session 4)||0
140988|NCT01701258|344624|P3|COMPLETED|EEG (Session 4)||0
140989|NCT01701258|344625|P2|COMPLETED|EEG (Session 4)||19
140990|NCT01701258|344626|P1|COMPLETED|EEG (Session 4)||0
140991|NCT01701258|344614|P13|STARTED|EEG (Session 4)||0
140992|NCT01701258|344615|P12|STARTED|EEG (Session 4)||0
140993|NCT01701258|344616|P11|STARTED|EEG (Session 4)||17
140994|NCT01701258|344617|P10|STARTED|EEG (Session 4)||0
140995|NCT01701258|344618|P9|STARTED|EEG (Session 4)||0
140996|NCT01701258|344619|P8|STARTED|EEG (Session 4)||16
140997|NCT01701258|344620|P7|STARTED|EEG (Session 4)||0
140998|NCT01701258|344621|P6|STARTED|EEG (Session 4)||0
140999|NCT01701258|344622|P5|STARTED|EEG (Session 4)||14
141000|NCT01701258|344623|P4|STARTED|EEG (Session 4)||0
141001|NCT01701258|344624|P3|STARTED|EEG (Session 4)||0
141002|NCT01701258|344625|P2|STARTED|EEG (Session 4)||19
141003|NCT01701258|344626|P1|STARTED|EEG (Session 4)||0
141004|NCT01701258|344614|P13|NOT COMPLETED|PET (Session 3)||0
141005|NCT01701258|344615|P12|NOT COMPLETED|PET (Session 3)||0
141006|NCT01701258|344616|P11|NOT COMPLETED|PET (Session 3)||0
141007|NCT01701258|344617|P10|NOT COMPLETED|PET (Session 3)||0
141008|NCT01701258|344618|P9|NOT COMPLETED|PET (Session 3)||0
141009|NCT01701258|344619|P8|NOT COMPLETED|PET (Session 3)||0
141010|NCT01701258|344620|P7|NOT COMPLETED|PET (Session 3)||0
141011|NCT01701258|344621|P6|NOT COMPLETED|PET (Session 3)||0
141012|NCT01701258|344622|P5|NOT COMPLETED|PET (Session 3)||0
141013|NCT01701258|344623|P4|NOT COMPLETED|PET (Session 3)||0
141014|NCT01701258|344624|P3|NOT COMPLETED|PET (Session 3)||0
141015|NCT01701258|344625|P2|NOT COMPLETED|PET (Session 3)||0
141016|NCT01701258|344626|P1|NOT COMPLETED|PET (Session 3)||0
141017|NCT01701258|344614|P13|COMPLETED|PET (Session 3)||0
141018|NCT01701258|344615|P12|COMPLETED|PET (Session 3)||0
141019|NCT01701258|344616|P11|COMPLETED|PET (Session 3)||18
141020|NCT01701258|344617|P10|COMPLETED|PET (Session 3)||0
141021|NCT01701258|344618|P9|COMPLETED|PET (Session 3)||0
141022|NCT01701258|344619|P8|COMPLETED|PET (Session 3)||19
141023|NCT01701258|344620|P7|COMPLETED|PET (Session 3)||0
141024|NCT01701258|344621|P6|COMPLETED|PET (Session 3)||0
141025|NCT01701258|344622|P5|COMPLETED|PET (Session 3)||16
141026|NCT01701258|344623|P4|COMPLETED|PET (Session 3)||0
141027|NCT01701258|344624|P3|COMPLETED|PET (Session 3)||0
141028|NCT01701258|344625|P2|COMPLETED|PET (Session 3)||20
141029|NCT01701258|344626|P1|COMPLETED|PET (Session 3)||0
141030|NCT01701258|344614|P13|STARTED|PET (Session 3)||0
141031|NCT01701258|344615|P12|STARTED|PET (Session 3)||0
141032|NCT01701258|344616|P11|STARTED|PET (Session 3)||18
141033|NCT01701258|344617|P10|STARTED|PET (Session 3)||0
141034|NCT01701258|344618|P9|STARTED|PET (Session 3)||0
141035|NCT01701258|344619|P8|STARTED|PET (Session 3)||19
141036|NCT01701258|344620|P7|STARTED|PET (Session 3)||0
141037|NCT01701258|344621|P6|STARTED|PET (Session 3)||0
141038|NCT01701258|344622|P5|STARTED|PET (Session 3)||16
141039|NCT01701258|344623|P4|STARTED|PET (Session 3)||0
141040|NCT01701258|344624|P3|STARTED|PET (Session 3)||0
141041|NCT01701258|344625|P2|STARTED|PET (Session 3)||20
141042|NCT01701258|344626|P1|STARTED|PET (Session 3)||0
141043|NCT01701258|344614|P13|NOT COMPLETED|Drug+fMRI (Session 2)||0
141044|NCT01701258|344615|P12|NOT COMPLETED|Drug+fMRI (Session 2)||0
141045|NCT01701258|344616|P11|NOT COMPLETED|Drug+fMRI (Session 2)||0
141046|NCT01701258|344617|P10|NOT COMPLETED|Drug+fMRI (Session 2)||0
141047|NCT01701258|344618|P9|NOT COMPLETED|Drug+fMRI (Session 2)||0
141048|NCT01701258|344619|P8|NOT COMPLETED|Drug+fMRI (Session 2)||0
141049|NCT01701258|344620|P7|NOT COMPLETED|Drug+fMRI (Session 2)||0
141050|NCT01701258|344621|P6|NOT COMPLETED|Drug+fMRI (Session 2)||0
141051|NCT01701258|344622|P5|NOT COMPLETED|Drug+fMRI (Session 2)||0
141052|NCT01701258|344623|P4|NOT COMPLETED|Drug+fMRI (Session 2)||0
141053|NCT01701258|344624|P3|NOT COMPLETED|Drug+fMRI (Session 2)||0
141054|NCT01701258|344625|P2|NOT COMPLETED|Drug+fMRI (Session 2)||0
141055|NCT01701258|344626|P1|NOT COMPLETED|Drug+fMRI (Session 2)||0
141056|NCT01701258|344614|P13|COMPLETED|Drug+fMRI (Session 2)||7
141057|NCT01701258|344615|P12|COMPLETED|Drug+fMRI (Session 2)||10
141058|NCT01701258|344616|P11|COMPLETED|Drug+fMRI (Session 2)||0
141059|NCT01701258|344617|P10|COMPLETED|Drug+fMRI (Session 2)||6
141060|NCT01701258|344618|P9|COMPLETED|Drug+fMRI (Session 2)||6
141061|NCT01701258|344619|P8|COMPLETED|Drug+fMRI (Session 2)||0
141062|NCT01701258|344620|P7|COMPLETED|Drug+fMRI (Session 2)||8
141063|NCT01701258|344621|P6|COMPLETED|Drug+fMRI (Session 2)||9
141064|NCT01701258|344622|P5|COMPLETED|Drug+fMRI (Session 2)||0
141065|NCT01701258|344623|P4|COMPLETED|Drug+fMRI (Session 2)||11
141066|NCT01701258|344624|P3|COMPLETED|Drug+fMRI (Session 2)||11
141067|NCT01701258|344625|P2|COMPLETED|Drug+fMRI (Session 2)||0
141068|NCT01701258|344626|P1|COMPLETED|Drug+fMRI (Session 2)||0
141069|NCT01701258|344614|P13|Received Drug Challenge|Drug+fMRI (Session 2)||7
141070|NCT01701258|344615|P12|Received Drug Challenge|Drug+fMRI (Session 2)||10
141071|NCT01701258|344616|P11|Received Drug Challenge|Drug+fMRI (Session 2)||0
141072|NCT01701258|344617|P10|Received Drug Challenge|Drug+fMRI (Session 2)||6
141073|NCT01701258|344618|P9|Received Drug Challenge|Drug+fMRI (Session 2)||6
141074|NCT01701258|344619|P8|Received Drug Challenge|Drug+fMRI (Session 2)||0
141075|NCT01701258|344620|P7|Received Drug Challenge|Drug+fMRI (Session 2)||8
141076|NCT01701258|344621|P6|Received Drug Challenge|Drug+fMRI (Session 2)||9
141077|NCT01701258|344622|P5|Received Drug Challenge|Drug+fMRI (Session 2)||0
141078|NCT01701258|344623|P4|Received Drug Challenge|Drug+fMRI (Session 2)||11
141079|NCT01701258|344624|P3|Received Drug Challenge|Drug+fMRI (Session 2)||11
141080|NCT01701258|344625|P2|Received Drug Challenge|Drug+fMRI (Session 2)||0
141081|NCT01701258|344626|P1|Received Drug Challenge|Drug+fMRI (Session 2)||0
141082|NCT01701258|344614|P13|STARTED|Drug+fMRI (Session 2)||7
141083|NCT01701258|344615|P12|STARTED|Drug+fMRI (Session 2)||10
141084|NCT01701258|344616|P11|STARTED|Drug+fMRI (Session 2)||0
141085|NCT01701258|344617|P10|STARTED|Drug+fMRI (Session 2)||6
141086|NCT01701258|344618|P9|STARTED|Drug+fMRI (Session 2)||6
141087|NCT01701258|344619|P8|STARTED|Drug+fMRI (Session 2)||0
141088|NCT01701258|344620|P7|STARTED|Drug+fMRI (Session 2)||8
141089|NCT01701258|344621|P6|STARTED|Drug+fMRI (Session 2)||9
141090|NCT01701258|344622|P5|STARTED|Drug+fMRI (Session 2)||0
141091|NCT01701258|344623|P4|STARTED|Drug+fMRI (Session 2)||11
141092|NCT01701258|344624|P3|STARTED|Drug+fMRI (Session 2)||11
141093|NCT01701258|344625|P2|STARTED|Drug+fMRI (Session 2)||0
141094|NCT01701258|344626|P1|STARTED|Drug+fMRI (Session 2)||0
141095|NCT01701258|344614|P13|NOT COMPLETED|Assessment and Scheduling||0
141096|NCT01701258|344615|P12|NOT COMPLETED|Assessment and Scheduling||0
141097|NCT01701258|344616|P11|NOT COMPLETED|Assessment and Scheduling||0
141098|NCT01701258|344617|P10|NOT COMPLETED|Assessment and Scheduling||0
141099|NCT01701258|344618|P9|NOT COMPLETED|Assessment and Scheduling||0
141100|NCT01701258|344619|P8|NOT COMPLETED|Assessment and Scheduling||0
141101|NCT01701258|344620|P7|NOT COMPLETED|Assessment and Scheduling||0
141102|NCT01701258|344621|P6|NOT COMPLETED|Assessment and Scheduling||0
141103|NCT01701258|344622|P5|NOT COMPLETED|Assessment and Scheduling||0
141104|NCT01701258|344623|P4|NOT COMPLETED|Assessment and Scheduling||0
141105|NCT01701258|344624|P3|NOT COMPLETED|Assessment and Scheduling||0
141106|NCT01701258|344625|P2|NOT COMPLETED|Assessment and Scheduling||0
141107|NCT01701258|344626|P1|NOT COMPLETED|Assessment and Scheduling||83
141108|NCT01701258|344614|P13|COMPLETED|Assessment and Scheduling||0
141109|NCT01701258|344615|P12|COMPLETED|Assessment and Scheduling||0
141110|NCT01701258|344616|P11|COMPLETED|Assessment and Scheduling||0
141111|NCT01701258|344617|P10|COMPLETED|Assessment and Scheduling||0
141112|NCT01701258|344618|P9|COMPLETED|Assessment and Scheduling||0
141113|NCT01701258|344619|P8|COMPLETED|Assessment and Scheduling||0
141114|NCT01701258|344620|P7|COMPLETED|Assessment and Scheduling||0
141115|NCT01701258|344621|P6|COMPLETED|Assessment and Scheduling||0
141116|NCT01701258|344622|P5|COMPLETED|Assessment and Scheduling||0
141117|NCT01701258|344623|P4|COMPLETED|Assessment and Scheduling||0
141118|NCT01701258|344624|P3|COMPLETED|Assessment and Scheduling||0
141119|NCT01701258|344625|P2|COMPLETED|Assessment and Scheduling||0
141120|NCT01701258|344626|P1|COMPLETED|Assessment and Scheduling||70
141121|NCT01701258|344614|P13|Returned for EEG (Session 4)|Assessment and Scheduling||0
141122|NCT01701258|344615|P12|Returned for EEG (Session 4)|Assessment and Scheduling||0
141123|NCT01701258|344616|P11|Returned for EEG (Session 4)|Assessment and Scheduling||0
141124|NCT01701258|344617|P10|Returned for EEG (Session 4)|Assessment and Scheduling||0
141125|NCT01701258|344618|P9|Returned for EEG (Session 4)|Assessment and Scheduling||0
141126|NCT01701258|344619|P8|Returned for EEG (Session 4)|Assessment and Scheduling||0
141127|NCT01701258|344620|P7|Returned for EEG (Session 4)|Assessment and Scheduling||0
141128|NCT01701258|344621|P6|Returned for EEG (Session 4)|Assessment and Scheduling||0
141129|NCT01701258|344622|P5|Returned for EEG (Session 4)|Assessment and Scheduling||0
141130|NCT01701258|344623|P4|Returned for EEG (Session 4)|Assessment and Scheduling||0
141131|NCT01701258|344624|P3|Returned for EEG (Session 4)|Assessment and Scheduling||0
141132|NCT01701258|344625|P2|Returned for EEG (Session 4)|Assessment and Scheduling||0
141133|NCT01701258|344626|P1|Returned for EEG (Session 4)|Assessment and Scheduling||66
141134|NCT01701258|344614|P13|Returned for PET (Session 3)|Assessment and Scheduling||0
141135|NCT01701258|344615|P12|Returned for PET (Session 3)|Assessment and Scheduling||0
141136|NCT01701258|344616|P11|Returned for PET (Session 3)|Assessment and Scheduling||0
141137|NCT01701258|344617|P10|Returned for PET (Session 3)|Assessment and Scheduling||0
141138|NCT01701258|344618|P9|Returned for PET (Session 3)|Assessment and Scheduling||0
141139|NCT01701258|344619|P8|Returned for PET (Session 3)|Assessment and Scheduling||0
141140|NCT01701258|344620|P7|Returned for PET (Session 3)|Assessment and Scheduling||0
141141|NCT01701258|344621|P6|Returned for PET (Session 3)|Assessment and Scheduling||0
141142|NCT01701258|344622|P5|Returned for PET (Session 3)|Assessment and Scheduling||0
141143|NCT01701258|344623|P4|Returned for PET (Session 3)|Assessment and Scheduling||0
141144|NCT01701258|344624|P3|Returned for PET (Session 3)|Assessment and Scheduling||0
141145|NCT01701258|344625|P2|Returned for PET (Session 3)|Assessment and Scheduling||0
141146|NCT01701258|344626|P1|Returned for PET (Session 3)|Assessment and Scheduling||73
141147|NCT01701258|344614|P13|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
141148|NCT01701258|344615|P12|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
141149|NCT01701258|344616|P11|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
141150|NCT01701258|344617|P10|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
141151|NCT01701258|344618|P9|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
141152|NCT01701258|344619|P8|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
141153|NCT01701258|344620|P7|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
141154|NCT01701258|344621|P6|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
141155|NCT01701258|344622|P5|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
141156|NCT01701258|344623|P4|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
141157|NCT01701258|344624|P3|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
141158|NCT01701258|344625|P2|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
141159|NCT01701258|344626|P1|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||68
141160|NCT01701258|344614|P13|Eligible After Screening Visit|Assessment and Scheduling||0
141161|NCT01701258|344615|P12|Eligible After Screening Visit|Assessment and Scheduling||0
141162|NCT01701258|344616|P11|Eligible After Screening Visit|Assessment and Scheduling||0
141163|NCT01701258|344617|P10|Eligible After Screening Visit|Assessment and Scheduling||0
141164|NCT01701258|344618|P9|Eligible After Screening Visit|Assessment and Scheduling||0
141165|NCT01701258|344619|P8|Eligible After Screening Visit|Assessment and Scheduling||0
141166|NCT01701258|344620|P7|Eligible After Screening Visit|Assessment and Scheduling||0
141167|NCT01701258|344621|P6|Eligible After Screening Visit|Assessment and Scheduling||0
141168|NCT01701258|344622|P5|Eligible After Screening Visit|Assessment and Scheduling||0
141169|NCT01701258|344623|P4|Eligible After Screening Visit|Assessment and Scheduling||0
141170|NCT01701258|344624|P3|Eligible After Screening Visit|Assessment and Scheduling||0
141171|NCT01701258|344625|P2|Eligible After Screening Visit|Assessment and Scheduling||0
141172|NCT01701258|344626|P1|Eligible After Screening Visit|Assessment and Scheduling||96
141173|NCT01701258|344614|P13|STARTED|Assessment and Scheduling||0
141174|NCT01701258|344615|P12|STARTED|Assessment and Scheduling||0
141175|NCT01701258|344616|P11|STARTED|Assessment and Scheduling||0
141176|NCT01701258|344617|P10|STARTED|Assessment and Scheduling||0
141177|NCT01701258|344618|P9|STARTED|Assessment and Scheduling||0
141178|NCT01701258|344619|P8|STARTED|Assessment and Scheduling||0
141179|NCT01701258|344620|P7|STARTED|Assessment and Scheduling||0
141180|NCT01701258|344621|P6|STARTED|Assessment and Scheduling||0
141181|NCT01701258|344622|P5|STARTED|Assessment and Scheduling||0
141182|NCT01701258|344623|P4|STARTED|Assessment and Scheduling||0
141183|NCT01701258|344624|P3|STARTED|Assessment and Scheduling||0
141184|NCT01701258|344625|P2|STARTED|Assessment and Scheduling||0
141185|NCT01701258|344626|P1|STARTED|Assessment and Scheduling||153
141186|NCT01701245|344680|P2|NOT COMPLETED|Overall Study||15
141187|NCT01701245|344681|P1|NOT COMPLETED|Overall Study||12
141188|NCT01701245|344680|P2|COMPLETED|Overall Study||33
141189|NCT01701245|344681|P1|COMPLETED|Overall Study||37
141190|NCT01701245|344680|P2|FAS Matched Data|Overall Study||32
141191|NCT01701245|344681|P1|FAS Matched Data|Overall Study||42
141192|NCT01701245|344680|P2|FAS Unmatched Data|Overall Study|3 patients protocol violation|45
141193|NCT01701245|344681|P1|FAS Unmatched Data|Overall Study|1 patient protocol violation|48
141194|NCT01701245|344680|P2|STARTED|Overall Study||48
141195|NCT01701245|344681|P1|STARTED|Overall Study||49
141196|NCT01701115|344695|P2|NOT COMPLETED|Overall Study||0
141197|NCT01701115|344696|P1|NOT COMPLETED|Overall Study||2
141198|NCT01701115|344695|P2|COMPLETED|Overall Study||77
141199|NCT01701115|344696|P1|COMPLETED|Overall Study||75
141200|NCT01701115|344695|P2|STARTED|Overall Study||77
141201|NCT01701115|344696|P1|STARTED|Overall Study||77
141202|NCT01701102|344712|P4|NOT COMPLETED|Overall Study||0
141203|NCT01701102|344713|P3|NOT COMPLETED|Overall Study||0
141204|NCT01701102|344714|P2|NOT COMPLETED|Overall Study||0
141205|NCT01701102|344715|P1|NOT COMPLETED|Overall Study||0
141206|NCT01701102|344712|P4|COMPLETED|Overall Study||18
141207|NCT01701102|344713|P3|COMPLETED|Overall Study||10
141208|NCT01701102|344714|P2|COMPLETED|Overall Study||6
141209|NCT01701102|344715|P1|COMPLETED|Overall Study||22
141210|NCT01701102|344712|P4|STARTED|Overall Study||18
141211|NCT01701102|344713|P3|STARTED|Overall Study||10
141212|NCT01701102|344714|P2|STARTED|Overall Study||6
141213|NCT01701102|344715|P1|STARTED|Overall Study||22
141214|NCT01701063|344728|P3|NOT COMPLETED|Overall Study||2
141215|NCT01701063|344729|P2|NOT COMPLETED|Overall Study||1
141216|NCT01701063|344730|P1|NOT COMPLETED|Overall Study||0
141217|NCT01701063|344728|P3|COMPLETED|Overall Study||8
141218|NCT01701063|344729|P2|COMPLETED|Overall Study||18
141219|NCT01701063|344730|P1|COMPLETED|Overall Study||13
141220|NCT01701063|344728|P3|STARTED|Overall Study||10
141221|NCT01701063|344729|P2|STARTED|Overall Study||19
141222|NCT01701063|344730|P1|STARTED|Overall Study||13
141223|NCT01701037|344772|P1|NOT COMPLETED|Overall Study||0
141224|NCT01701037|344772|P1|COMPLETED|Overall Study||13
141225|NCT01701037|344772|P1|STARTED|Overall Study||13
141226|NCT01701024|344783|P2|NOT COMPLETED|Overall Study||9
141227|NCT01701024|344784|P1|NOT COMPLETED|Overall Study||10
141228|NCT01701024|344783|P2|COMPLETED|Overall Study||236
141229|NCT01701024|344784|P1|COMPLETED|Overall Study||243
141230|NCT01701024|344783|P2|STARTED|Overall Study||245
141231|NCT01701024|344784|P1|STARTED|Overall Study||253
141232|NCT01701011|344799|P3|NOT COMPLETED|Overall Study||34
141233|NCT01701011|344800|P2|NOT COMPLETED|Overall Study||24
141234|NCT01701011|344801|P1|NOT COMPLETED|Overall Study||35
141235|NCT01701011|344799|P3|COMPLETED|Overall Study||90
141236|NCT01701011|344800|P2|COMPLETED|Overall Study||102
141237|NCT01701011|344801|P1|COMPLETED|Overall Study||92
141238|NCT01701011|344799|P3|STARTED|Overall Study||124
141239|NCT01701011|344800|P2|STARTED|Overall Study||126
141240|NCT01701011|344801|P1|STARTED|Overall Study||127
141241|NCT01700985|344814|P2|NOT COMPLETED|Overall Study||1
141242|NCT01700985|344815|P1|NOT COMPLETED|Overall Study||0
141243|NCT01700985|344814|P2|COMPLETED|Overall Study||20
141244|NCT01700985|344815|P1|COMPLETED|Overall Study||23
141245|NCT01700985|344814|P2|STARTED|Overall Study||21
141246|NCT01700985|344815|P1|STARTED|Overall Study||23
141247|NCT01700959|344837|P6|NOT COMPLETED|Overall Study||25
141248|NCT01700959|344838|P5|NOT COMPLETED|Overall Study||27
141249|NCT01700959|344839|P4|NOT COMPLETED|Overall Study||35
141250|NCT01700959|344840|P3|NOT COMPLETED|Overall Study||40
141251|NCT01700959|344841|P2|NOT COMPLETED|Overall Study||24
141252|NCT01700959|344842|P1|NOT COMPLETED|Overall Study||27
141253|NCT01700959|344837|P6|COMPLETED|Overall Study||72
141254|NCT01700959|344838|P5|COMPLETED|Overall Study||69
141255|NCT01700959|344839|P4|COMPLETED|Overall Study||70
141256|NCT01700959|344840|P3|COMPLETED|Overall Study||65
141257|NCT01700959|344841|P2|COMPLETED|Overall Study||64
141258|NCT01700959|344842|P1|COMPLETED|Overall Study||62
141259|NCT01700959|344837|P6|STARTED|Overall Study||97
141260|NCT01700959|344838|P5|STARTED|Overall Study||96
141261|NCT01700959|344839|P4|STARTED|Overall Study||105
141262|NCT01700959|344840|P3|STARTED|Overall Study||105
141263|NCT01700959|344841|P2|STARTED|Overall Study||88
141264|NCT01700959|344842|P1|STARTED|Overall Study||89
141265|NCT01700907|344866|P2|NOT COMPLETED|Overall Study||0
141266|NCT01700907|344867|P1|NOT COMPLETED|Overall Study||0
141267|NCT01700907|344866|P2|COMPLETED|Overall Study||10
141268|NCT01700907|344867|P1|COMPLETED|Overall Study||10
141269|NCT01700907|344866|P2|STARTED|Overall Study||10
141270|NCT01700907|344867|P1|STARTED|Overall Study||10
141271|NCT01700816|344883|P2|NOT COMPLETED|Overall Study||0
141272|NCT01700816|344884|P1|NOT COMPLETED|Overall Study||0
141273|NCT01700816|344883|P2|COMPLETED|Overall Study||19
141274|NCT01700816|344884|P1|COMPLETED|Overall Study||21
141275|NCT01700816|344883|P2|STARTED|Overall Study||19
141276|NCT01700816|344884|P1|STARTED|Overall Study||21
141277|NCT01700725|344913|P3|NOT COMPLETED|Overall Study||0
141278|NCT01700725|344914|P2|NOT COMPLETED|Overall Study||0
141279|NCT01700725|344915|P1|NOT COMPLETED|Overall Study||0
141280|NCT01700725|344913|P3|COMPLETED|Overall Study||12
141281|NCT01700725|344914|P2|COMPLETED|Overall Study||14
141282|NCT01700725|344915|P1|COMPLETED|Overall Study||14
141283|NCT01700725|344913|P3|STARTED|Overall Study||12
141284|NCT01700725|344914|P2|STARTED|Overall Study||14
141285|NCT01700725|344915|P1|STARTED|Overall Study||14
141286|NCT01700621|344931|P2|NOT COMPLETED|Analyzed for Immunogenicity||7
141287|NCT01700621|344932|P1|NOT COMPLETED|Analyzed for Immunogenicity||13
141288|NCT01700621|344931|P2|COMPLETED|Analyzed for Immunogenicity||233
141289|NCT01700621|344932|P1|COMPLETED|Analyzed for Immunogenicity||227
141290|NCT01700621|344931|P2|STARTED|Analyzed for Immunogenicity||240
141291|NCT01700621|344932|P1|STARTED|Analyzed for Immunogenicity||240
141292|NCT01700621|344931|P2|NOT COMPLETED|Received Study Vaccines||0
141293|NCT01700621|344932|P1|NOT COMPLETED|Received Study Vaccines||0
141294|NCT01700621|344931|P2|COMPLETED|Received Study Vaccines||240
141295|NCT01700621|344932|P1|COMPLETED|Received Study Vaccines||240
141296|NCT01700621|344931|P2|STARTED|Received Study Vaccines||240
141297|NCT01700621|344932|P1|STARTED|Received Study Vaccines||240
141298|NCT01700530|344970|P3|NOT COMPLETED|Overall Study||1
141299|NCT01700530|344971|P2|NOT COMPLETED|Overall Study||3
141300|NCT01700530|344972|P1|NOT COMPLETED|Overall Study||0
141301|NCT01700530|344970|P3|COMPLETED|Overall Study||19
141302|NCT01700530|344971|P2|COMPLETED|Overall Study||18
141303|NCT01700530|344972|P1|COMPLETED|Overall Study||9
141304|NCT01700530|344970|P3|STARTED|Overall Study||20
141305|NCT01700530|344971|P2|STARTED|Overall Study||21
141306|NCT01700530|344972|P1|STARTED|Overall Study||9
141307|NCT01700517|344986|P3|NOT COMPLETED|Overall Study||0
141308|NCT01700517|344987|P2|NOT COMPLETED|Overall Study||0
141309|NCT01700517|344988|P1|NOT COMPLETED|Overall Study||0
141310|NCT01700517|344986|P3|COMPLETED|Overall Study||40
141311|NCT01700517|344987|P2|COMPLETED|Overall Study||40
141312|NCT01700517|344988|P1|COMPLETED|Overall Study||40
141313|NCT01700517|344986|P3|STARTED|Overall Study||40
141314|NCT01700517|344987|P2|STARTED|Overall Study||40
141315|NCT01700517|344988|P1|STARTED|Overall Study||40
141316|NCT01700439|344996|P1|NOT COMPLETED|Overall Study||889
141317|NCT01700439|344996|P1|COMPLETED|Overall Study||0
141318|NCT01700439|344996|P1|2 Year|Overall Study||215
141319|NCT01700439|344996|P1|1 Year|Overall Study||573
141320|NCT01700439|344996|P1|3 Month|Overall Study||778
141321|NCT01700439|344996|P1|Discharge|Overall Study||831
141322|NCT01700439|344996|P1|Study Valve Group|Overall Study|Received the Edwards INTUITY surgical aortic heart valve.|839
141323|NCT01700439|344996|P1|STARTED|Overall Study||889
141324|NCT01700387|345021|P2|NOT COMPLETED|Overall Study||4
141325|NCT01700387|345022|P1|NOT COMPLETED|Overall Study||4
141326|NCT01700387|345021|P2|COMPLETED|Overall Study||6
141327|NCT01700387|345022|P1|COMPLETED|Overall Study||6
141328|NCT01700387|345021|P2|STARTED|Overall Study||10
141329|NCT01700387|345022|P1|STARTED|Overall Study||10
141330|NCT01700348|345032|P1|NOT COMPLETED|Overall Study||23
141331|NCT01700348|345032|P1|COMPLETED|Overall Study||93
141332|NCT01700348|345032|P1|STARTED|Overall Study||116
141333|NCT01700335|345041|P2|NOT COMPLETED|Overall Study||4
141334|NCT01700335|345042|P1|NOT COMPLETED|Overall Study||1
141335|NCT01700335|345041|P2|COMPLETED|Overall Study||2
141336|NCT01700335|345042|P1|COMPLETED|Overall Study||2
141337|NCT01700335|345041|P2|STARTED|Overall Study||6
141338|NCT01700335|345042|P1|STARTED|Overall Study||3
141339|NCT01700205|345055|P2|NOT COMPLETED|Overall Study||15
141340|NCT01700205|345056|P1|NOT COMPLETED|Overall Study||15
141341|NCT01700205|345055|P2|COMPLETED|Overall Study|Mother-Infant Dyads|39
141342|NCT01700205|345056|P1|COMPLETED|Overall Study|Mother-Infant Dyads|44
141343|NCT01700205|345055|P2|STARTED|Overall Study|Mother-Infant Dyads|54
141344|NCT01700205|345056|P1|STARTED|Overall Study|Mother-Infant Dyads|59
141345|NCT01700192|345078|P2|NOT COMPLETED|Overall Study||128
141346|NCT01700192|345079|P1|NOT COMPLETED|Overall Study||180
141347|NCT01700192|345078|P2|COMPLETED|Overall Study||613
141348|NCT01700192|345079|P1|COMPLETED|Overall Study||561
141349|NCT01700192|345078|P2|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|738
141350|NCT01700192|345079|P1|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|743
141351|NCT01700192|345078|P2|Treated|Overall Study||741
141352|NCT01700192|345079|P1|Treated|Overall Study||740
141353|NCT01700192|345078|P2|STARTED|Overall Study||741
141354|NCT01700192|345079|P1|STARTED|Overall Study||741
141355|NCT01700179|345097|P1|NOT COMPLETED|Overall Study||2
141356|NCT01700179|345097|P1|COMPLETED|Overall Study||6
141357|NCT01700179|345097|P1|STARTED|Overall Study||8
141358|NCT01700140|345104|P3|NOT COMPLETED|Overall Study||1
141359|NCT01700140|345105|P2|NOT COMPLETED|Overall Study||9
141360|NCT01700140|345106|P1|NOT COMPLETED|Overall Study||6
141361|NCT01700140|345104|P3|COMPLETED|Overall Study||61
141362|NCT01700140|345105|P2|COMPLETED|Overall Study||57
141363|NCT01700140|345106|P1|COMPLETED|Overall Study||55
141364|NCT01700140|345104|P3|STARTED|Overall Study||62
141365|NCT01700140|345105|P2|STARTED|Overall Study||66
141366|NCT01700140|345106|P1|STARTED|Overall Study||61
141367|NCT01700049|345138|P1|NOT COMPLETED|Overall Study||1
141368|NCT01700049|345138|P1|COMPLETED|Overall Study||27
141369|NCT01700049|345138|P1|STARTED|Overall Study||28
141370|NCT01700036|345144|P1|NOT COMPLETED|Overall Study||0
141371|NCT01700036|345144|P1|COMPLETED|Overall Study||40
141372|NCT01700036|345144|P1|STARTED|Overall Study||40
141373|NCT01699867|345153|P1|NOT COMPLETED|Overall Study||3
141374|NCT01699867|345153|P1|COMPLETED|Overall Study||47
141375|NCT01699867|345153|P1|STARTED|Overall Study||50
141376|NCT01699815|345160|P2|NOT COMPLETED|Overall Study||8
141377|NCT01699815|345161|P1|NOT COMPLETED|Overall Study||5
141378|NCT01699815|345160|P2|COMPLETED|Overall Study||56
141379|NCT01699815|345161|P1|COMPLETED|Overall Study||57
141380|NCT01699815|345160|P2|STARTED|Overall Study||64
141381|NCT01699815|345161|P1|STARTED|Overall Study||62
141382|NCT01699789|345173|P2|NOT COMPLETED|Overall Study||126
141383|NCT01699789|345174|P1|NOT COMPLETED|Overall Study||102
141384|NCT01699789|345173|P2|COMPLETED|Overall Study|Clients in 46 programs with complete or partially complete data at baseline, 6 and 12 mo FU analyzed|514
141385|NCT01699789|345174|P1|COMPLETED|Overall Study|Clients in 44 programs with complete or partially complete data at baseline, 6 and 12 mo FU analyzed|504
141386|NCT01699789|345173|P2|12-Month Follow-Up|Overall Study||369
141387|NCT01699789|345174|P1|12-Month Follow-Up|Overall Study||364
141388|NCT01699789|345173|P2|6-Month Follow-Up|Overall Study||379
141389|NCT01699789|345174|P1|6-Month Follow-Up|Overall Study||380
141390|NCT01699789|345173|P2|Baseline|Overall Study||488
141391|NCT01699789|345174|P1|Baseline|Overall Study||492
141392|NCT01699789|345173|P2|STARTED|Overall Study|640 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in CEP arm|640
141393|NCT01699789|345174|P1|STARTED|Overall Study|606 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in RS arm|606
141394|NCT01699763|345236|P1|NOT COMPLETED|Overall Study||0
141395|NCT01699763|345236|P1|COMPLETED|Overall Study||112
141396|NCT01699763|345236|P1|STARTED|Overall Study||112
141397|NCT01699750|345244|P2|NOT COMPLETED|Overall Study||3
141398|NCT01699750|345245|P1|NOT COMPLETED|Overall Study||0
141399|NCT01699750|345244|P2|COMPLETED|Overall Study||33
141400|NCT01699750|345245|P1|COMPLETED|Overall Study||34
141401|NCT01699750|345244|P2|STARTED|Overall Study||36
141402|NCT01699750|345245|P1|STARTED|Overall Study||34
141403|NCT01699698|345269|P2|NOT COMPLETED|Overall Study||5
141404|NCT01699698|345270|P1|NOT COMPLETED|Overall Study||2
141405|NCT01699698|345269|P2|COMPLETED|Overall Study||56
141406|NCT01699698|345270|P1|COMPLETED|Overall Study||42
141407|NCT01699698|345269|P2|STARTED|Overall Study||61
141408|NCT01699698|345270|P1|STARTED|Overall Study||44
141409|NCT01699685|345280|P2|NOT COMPLETED|Period 2||0
141410|NCT01699685|345281|P1|NOT COMPLETED|Period 2||1
141411|NCT01699685|345280|P2|COMPLETED|Period 2||36
141412|NCT01699685|345281|P1|COMPLETED|Period 2||35
141413|NCT01699685|345280|P2|STARTED|Period 2||36
141414|NCT01699685|345281|P1|STARTED|Period 2||36
141415|NCT01699685|345280|P2|NOT COMPLETED|Period 1||3
141416|NCT01699685|345281|P1|NOT COMPLETED|Period 1||3
141417|NCT01699685|345280|P2|COMPLETED|Period 1||36
141418|NCT01699685|345281|P1|COMPLETED|Period 1||36
141419|NCT01699685|345280|P2|Full Analysis Population (FAS)|Period 1||38
141420|NCT01699685|345281|P1|Full Analysis Population (FAS)|Period 1||38
141421|NCT01699685|345280|P2|Safety Population|Period 1||38
141422|NCT01699685|345281|P1|Safety Population|Period 1||39
141423|NCT01699685|345280|P2|STARTED|Period 1||39
141424|NCT01699685|345281|P1|STARTED|Period 1||39
141425|NCT01699607|345299|P2|NOT COMPLETED|Overall Study||0
141426|NCT01699607|345300|P1|NOT COMPLETED|Overall Study||0
141427|NCT01699607|345299|P2|COMPLETED|Overall Study||4
141428|NCT01699607|345300|P1|COMPLETED|Overall Study||6
141429|NCT01699607|345299|P2|STARTED|Overall Study||4
141430|NCT01699607|345300|P1|STARTED|Overall Study||6
141431|NCT01699503|345307|P2|NOT COMPLETED|Overall Study||1005
141432|NCT01699503|345308|P1|NOT COMPLETED|Overall Study||1000
141433|NCT01699503|345307|P2|COMPLETED|Overall Study||992
141434|NCT01699503|345308|P1|COMPLETED|Overall Study||1008
141435|NCT01699503|345307|P2|6 Month Follow-up|Overall Study||893
141436|NCT01699503|345308|P1|6 Month Follow-up|Overall Study||903
141437|NCT01699503|345307|P2|1 Month Follow-up|Overall Study||1022
141438|NCT01699503|345308|P1|1 Month Follow-up|Overall Study||998
141439|NCT01699503|345307|P2|Baseline|Overall Study||1693
141440|NCT01699503|345308|P1|Baseline|Overall Study||1723
141441|NCT01699503|345307|P2|STARTED|Overall Study||1997
141442|NCT01699503|345308|P1|STARTED|Overall Study||2008
141443|NCT01699373|345324|P2|NOT COMPLETED|Overall Study||0
141444|NCT01699373|345325|P1|NOT COMPLETED|Overall Study||0
141445|NCT01699373|345324|P2|COMPLETED|Overall Study||85
141446|NCT01699373|345325|P1|COMPLETED|Overall Study||85
141447|NCT01699373|345324|P2|STARTED|Overall Study||85
141448|NCT01699373|345325|P1|STARTED|Overall Study||85
141449|NCT01699178|345333|P2|NOT COMPLETED|Overall Study||32
141450|NCT01699178|345334|P1|NOT COMPLETED|Overall Study||19
141451|NCT01699178|345333|P2|COMPLETED|Overall Study||62
141452|NCT01699178|345334|P1|COMPLETED|Overall Study||69
141453|NCT01699178|345333|P2|STARTED|Overall Study||94
141454|NCT01699178|345334|P1|STARTED|Overall Study||88
141455|NCT01699087|345350|P1|NOT COMPLETED|Overall Study||24
141456|NCT01699087|345350|P1|COMPLETED|Overall Study||152
141457|NCT01699087|345350|P1|Treated|Overall Study||161
141458|NCT01699087|345350|P1|STARTED|Overall Study||176
141459|NCT01699022|345364|P1|NOT COMPLETED|Overall Study||3
141460|NCT01699022|345364|P1|COMPLETED|Overall Study||14
141461|NCT01699022|345364|P1|STARTED|Overall Study||17
141462|NCT01698814|345379|P2|NOT COMPLETED|Overall Study||3
141463|NCT01698814|345380|P1|NOT COMPLETED|Overall Study||2
141464|NCT01698814|345379|P2|COMPLETED|Overall Study||166
141465|NCT01698814|345380|P1|COMPLETED|Overall Study||329
141466|NCT01698814|345379|P2|STARTED|Overall Study||169
141467|NCT01698814|345380|P1|STARTED|Overall Study||331
141468|NCT01698801|345386|P1|NOT COMPLETED|Follow Up Phase||5
141469|NCT01698801|345386|P1|COMPLETED|Follow Up Phase|Completed includes participants who remain in follow-up for up to 5 years from start of treatment|6
141470|NCT01698801|345386|P1|STARTED|Follow Up Phase|11 participants did not complete the study and moved into the follow up phase lasting up to 5 years.|11
141471|NCT01698801|345386|P1|NOT COMPLETED|Treatment Phase||11
141472|NCT01698801|345386|P1|COMPLETED|Treatment Phase|Completed includes participants who continued to receive study medication and treatment is ongoing.|15
141473|NCT01698801|345386|P1|STARTED|Treatment Phase||26
141474|NCT01698775|345397|P2|NOT COMPLETED|Phase B||11
141475|NCT01698775|345398|P1|NOT COMPLETED|Phase B||14
141476|NCT01698775|345397|P2|COMPLETED|Phase B||86
141477|NCT01698775|345398|P1|COMPLETED|Phase B||84
141478|NCT01698775|345397|P2|STARTED|Phase B||97
141479|NCT01698775|345398|P1|STARTED|Phase B||98
141480|NCT01698775|345397|P2|NOT COMPLETED|Phase A||9
141481|NCT01698775|345398|P1|NOT COMPLETED|Phase A||9
141482|NCT01698775|345397|P2|COMPLETED|Phase A||97
141483|NCT01698775|345398|P1|COMPLETED|Phase A||98
141484|NCT01698775|345397|P2|STARTED|Phase A||106
141485|NCT01698775|345398|P1|STARTED|Phase A||107
141486|NCT01698710|345424|P1|NOT COMPLETED|Overall Study||0
141487|NCT01698710|345424|P1|COMPLETED|Overall Study||5
141488|NCT01698710|345424|P1|STARTED|Overall Study||5
141489|NCT01698684|345433|P3|NOT COMPLETED|Overall Study||21
141490|NCT01698684|345434|P2|NOT COMPLETED|Overall Study||23
141491|NCT01698684|345435|P1|NOT COMPLETED|Overall Study||29
141492|NCT01698684|345433|P3|COMPLETED|Overall Study||127
141493|NCT01698684|345434|P2|COMPLETED|Overall Study||124
141494|NCT01698684|345435|P1|COMPLETED|Overall Study||116
141495|NCT01698684|345433|P3|Safety Population|Overall Study||146
141496|NCT01698684|345434|P2|Safety Population|Overall Study||146
141497|NCT01698684|345435|P1|Safety Population|Overall Study||143
141498|NCT01698684|345433|P3|ITT Population|Overall Study||139
141499|NCT01698684|345434|P2|ITT Population|Overall Study||139
141500|NCT01698684|345435|P1|ITT Population|Overall Study||136
141501|NCT01698684|345433|P3|STARTED|Overall Study||148
141502|NCT01698684|345434|P2|STARTED|Overall Study||147
141503|NCT01698684|345435|P1|STARTED|Overall Study||145
141504|NCT01698554|345447|P4|NOT COMPLETED|Overall Study||2
141505|NCT01698554|345448|P3|NOT COMPLETED|Overall Study||2
141506|NCT01698554|345449|P2|NOT COMPLETED|Overall Study||10
141507|NCT01698554|345450|P1|NOT COMPLETED|Overall Study||6
141508|NCT01698554|345447|P4|COMPLETED|Overall Study||77
141509|NCT01698554|345448|P3|COMPLETED|Overall Study||73
141510|NCT01698554|345449|P2|COMPLETED|Overall Study||147
141511|NCT01698554|345450|P1|COMPLETED|Overall Study||147
141512|NCT01698554|345447|P4|STARTED|Overall Study||79
141513|NCT01698554|345448|P3|STARTED|Overall Study||75
141514|NCT01698554|345449|P2|STARTED|Overall Study||157
141515|NCT01698554|345450|P1|STARTED|Overall Study||153
141516|NCT01698528|345478|P2|NOT COMPLETED|Overall Study||4
141517|NCT01698528|345479|P1|NOT COMPLETED|Overall Study||1
141518|NCT01698528|345478|P2|COMPLETED|Overall Study||16
141519|NCT01698528|345479|P1|COMPLETED|Overall Study||19
141520|NCT01698528|345478|P2|STARTED|Overall Study||20
141521|NCT01698528|345479|P1|STARTED|Overall Study||20
141522|NCT01698502|345495|P2|NOT COMPLETED|Overall Study||0
141523|NCT01698502|345496|P1|NOT COMPLETED|Overall Study||0
141524|NCT01698502|345495|P2|COMPLETED|Overall Study||10
141525|NCT01698502|345496|P1|COMPLETED|Overall Study||11
141526|NCT01698502|345495|P2|STARTED|Overall Study||10
141527|NCT01698502|345496|P1|STARTED|Overall Study||11
141528|NCT01698463|345504|P1|NOT COMPLETED|Overall Study||0
141529|NCT01698463|345504|P1|COMPLETED|Overall Study||11
141530|NCT01698463|345504|P1|STARTED|Overall Study||11
141531|NCT01698333|345514|P1|NOT COMPLETED|Overall Study||0
141532|NCT01698333|345514|P1|COMPLETED|Overall Study||25
141533|NCT01698333|345514|P1|STARTED|Overall Study||25
141534|NCT01698320|345520|P3|NOT COMPLETED|40-Week Open-Label Period||10
141535|NCT01698320|345521|P2|NOT COMPLETED|40-Week Open-Label Period||19
141536|NCT01698320|345522|P1|NOT COMPLETED|40-Week Open-Label Period||0
141537|NCT01698320|345520|P3|COMPLETED|40-Week Open-Label Period||146
141538|NCT01698320|345521|P2|COMPLETED|40-Week Open-Label Period||146
141539|NCT01698320|345522|P1|COMPLETED|40-Week Open-Label Period||0
141540|NCT01698320|345520|P3|STARTED|40-Week Open-Label Period||156
141541|NCT01698320|345521|P2|STARTED|40-Week Open-Label Period||165
141542|NCT01698320|345522|P1|STARTED|40-Week Open-Label Period||0
141543|NCT01698320|345520|P3|NOT COMPLETED|12-Week Double-Blind Period||12
141544|NCT01698320|345521|P2|NOT COMPLETED|12-Week Double-Blind Period||4
141545|NCT01698320|345522|P1|NOT COMPLETED|12-Week Double-Blind Period||0
141546|NCT01698320|345520|P3|COMPLETED|12-Week Double-Blind Period||156
141547|NCT01698320|345521|P2|COMPLETED|12-Week Double-Blind Period||165
141548|NCT01698320|345522|P1|COMPLETED|12-Week Double-Blind Period||0
141549|NCT01698320|345520|P3|Safety Population|12-Week Double-Blind Period||168
141550|NCT01698320|345521|P2|Safety Population|12-Week Double-Blind Period|One participant took both placebo and albuterol so is counted in both treatment groups for safety.|170
141551|NCT01698320|345522|P1|Safety Population|12-Week Double-Blind Period||0
141552|NCT01698320|345520|P3|STARTED|12-Week Double-Blind Period||168
141553|NCT01698320|345521|P2|STARTED|12-Week Double-Blind Period||169
141554|NCT01698320|345522|P1|STARTED|12-Week Double-Blind Period||0
141555|NCT01698320|345520|P3|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
141556|NCT01698320|345521|P2|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
141557|NCT01698320|345522|P1|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||27
141558|NCT01698320|345520|P3|COMPLETED|Run-In Period (Week -1 to Day 0)||0
141559|NCT01698320|345521|P2|COMPLETED|Run-In Period (Week -1 to Day 0)||0
141560|NCT01698320|345522|P1|COMPLETED|Run-In Period (Week -1 to Day 0)||337
141561|NCT01698320|345520|P3|STARTED|Run-In Period (Week -1 to Day 0)||0
141562|NCT01698320|345521|P2|STARTED|Run-In Period (Week -1 to Day 0)||0
141563|NCT01698320|345522|P1|STARTED|Run-In Period (Week -1 to Day 0)||364
141564|NCT01698268|345542|P2|NOT COMPLETED|Overall Study||1
141565|NCT01698268|345543|P1|NOT COMPLETED|Overall Study||2
141566|NCT01698268|345542|P2|COMPLETED|Overall Study||24
141567|NCT01698268|345543|P1|COMPLETED|Overall Study||23
141568|NCT01698268|345542|P2|STARTED|Overall Study||25
141569|NCT01698268|345543|P1|STARTED|Overall Study||25
141570|NCT01698008|345551|P2|NOT COMPLETED|Overall Study||2
141571|NCT01698008|345552|P1|NOT COMPLETED|Overall Study||1
141572|NCT01698008|345551|P2|COMPLETED|Overall Study||0
141573|NCT01698008|345552|P1|COMPLETED|Overall Study||2
141574|NCT01698008|345551|P2|STARTED|Overall Study||2
141575|NCT01698008|345552|P1|STARTED|Overall Study||3
141576|NCT01697969|345558|P1|NOT COMPLETED|Overall Study||3
141577|NCT01697969|345558|P1|COMPLETED|Overall Study||10
141578|NCT01697969|345558|P1|STARTED|Overall Study||13
141579|NCT01697956|345565|P2|NOT COMPLETED|Overall Study||1
141580|NCT01697956|345566|P1|NOT COMPLETED|Overall Study||1
141581|NCT01697956|345565|P2|COMPLETED|Overall Study||31
141582|NCT01697956|345566|P1|COMPLETED|Overall Study||66
141583|NCT01697956|345565|P2|Per Protocol Population|Overall Study||31
141584|NCT01697956|345566|P1|Per Protocol Population|Overall Study||66
141585|NCT01697956|345565|P2|STARTED|Overall Study|enrolled and randomized|32
141586|NCT01697956|345566|P1|STARTED|Overall Study|enrolled and randomized|67
141587|NCT01697748|345596|P2|NOT COMPLETED|Overall Study||68
141588|NCT01697748|345597|P1|NOT COMPLETED|Overall Study||58
141589|NCT01697748|345596|P2|COMPLETED|Overall Study||260
141590|NCT01697748|345597|P1|COMPLETED|Overall Study||271
141591|NCT01697748|345596|P2|STARTED|Overall Study||328
141592|NCT01697748|345597|P1|STARTED|Overall Study||329
141593|NCT01697709|345615|P2|NOT COMPLETED|Overall Study||28
141594|NCT01697709|345616|P1|NOT COMPLETED|Overall Study||30
141595|NCT01697709|345615|P2|COMPLETED|Overall Study||38
141596|NCT01697709|345616|P1|COMPLETED|Overall Study||34
141597|NCT01697709|345615|P2|STARTED|Overall Study||66
141598|NCT01697709|345616|P1|STARTED|Overall Study||64
141599|NCT01697696|345626|P2|NOT COMPLETED|Overall Study||47
141600|NCT01697696|345627|P1|NOT COMPLETED|Overall Study||47
141601|NCT01697696|345626|P2|COMPLETED|Overall Study||210
141602|NCT01697696|345627|P1|COMPLETED|Overall Study||207
141603|NCT01697696|345626|P2|Full Analysis Set (FAS)|Overall Study||255
141604|NCT01697696|345627|P1|Full Analysis Set (FAS)|Overall Study||251
141605|NCT01697696|345626|P2|Safety Set|Overall Study|Safety set included a patient that was treated, but not randomized|256
141606|NCT01697696|345627|P1|Safety Set|Overall Study||251
141607|NCT01697696|345626|P2|STARTED|Overall Study||257
141608|NCT01697696|345627|P1|STARTED|Overall Study||254
141609|NCT01697592|345659|P10|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
141610|NCT01697592|345660|P9|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
141611|NCT01697592|345661|P8|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
141612|NCT01697592|345662|P7|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
141613|NCT01697592|345663|P6|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
141614|NCT01697592|345664|P5|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
141615|NCT01697592|345665|P4|NOT COMPLETED|Phase B (Week 25 to Week 52)||3
141616|NCT01697592|345666|P3|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
141617|NCT01697592|345667|P2|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
141618|NCT01697592|345668|P1|NOT COMPLETED|Phase B (Week 25 to Week 52)||5
141619|NCT01697592|345659|P10|COMPLETED|Phase B (Week 25 to Week 52)||30
141620|NCT01697592|345660|P9|COMPLETED|Phase B (Week 25 to Week 52)||32
141621|NCT01697592|345661|P8|COMPLETED|Phase B (Week 25 to Week 52)||32
141622|NCT01697592|345662|P7|COMPLETED|Phase B (Week 25 to Week 52)||31
141623|NCT01697592|345663|P6|COMPLETED|Phase B (Week 25 to Week 52)||60
141624|NCT01697592|345664|P5|COMPLETED|Phase B (Week 25 to Week 52)||67
141625|NCT01697592|345665|P4|COMPLETED|Phase B (Week 25 to Week 52)||60
141626|NCT01697592|345666|P3|COMPLETED|Phase B (Week 25 to Week 52)||64
141627|NCT01697592|345667|P2|COMPLETED|Phase B (Week 25 to Week 52)||61
141628|NCT01697592|345668|P1|COMPLETED|Phase B (Week 25 to Week 52)||118
141629|NCT01697592|345659|P10|STARTED|Phase B (Week 25 to Week 52)||30
141630|NCT01697592|345660|P9|STARTED|Phase B (Week 25 to Week 52)||34
141631|NCT01697592|345661|P8|STARTED|Phase B (Week 25 to Week 52)||33
141632|NCT01697592|345662|P7|STARTED|Phase B (Week 25 to Week 52)||32
141633|NCT01697592|345663|P6|STARTED|Phase B (Week 25 to Week 52)||62
141634|NCT01697592|345664|P5|STARTED|Phase B (Week 25 to Week 52)||67
141635|NCT01697592|345665|P4|STARTED|Phase B (Week 25 to Week 52)||63
141636|NCT01697592|345666|P3|STARTED|Phase B (Week 25 to Week 52)||65
141637|NCT01697592|345667|P2|STARTED|Phase B (Week 25 to Week 52)||62
141638|NCT01697592|345668|P1|STARTED|Phase B (Week 25 to Week 52)||123
141639|NCT01697592|345659|P10|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
141640|NCT01697592|345660|P9|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
141641|NCT01697592|345661|P8|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
141642|NCT01697592|345662|P7|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
141643|NCT01697592|345663|P6|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
141644|NCT01697592|345664|P5|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
141645|NCT01697592|345665|P4|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
141646|NCT01697592|345666|P3|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
141647|NCT01697592|345667|P2|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
141648|NCT01697592|345668|P1|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
141649|NCT01697592|345659|P10|COMPLETED|Phase A (Up to 24 Weeks)||30
141650|NCT01697592|345660|P9|COMPLETED|Phase A (Up to 24 Weeks)||34
141651|NCT01697592|345661|P8|COMPLETED|Phase A (Up to 24 Weeks)||33
141652|NCT01697592|345662|P7|COMPLETED|Phase A (Up to 24 Weeks)||32
141653|NCT01697592|345663|P6|COMPLETED|Phase A (Up to 24 Weeks)||62
141654|NCT01697592|345664|P5|COMPLETED|Phase A (Up to 24 Weeks)||67
141655|NCT01697592|345665|P4|COMPLETED|Phase A (Up to 24 Weeks)||63
141656|NCT01697592|345666|P3|COMPLETED|Phase A (Up to 24 Weeks)||65
141657|NCT01697592|345667|P2|COMPLETED|Phase A (Up to 24 Weeks)||62
141658|NCT01697592|345668|P1|COMPLETED|Phase A (Up to 24 Weeks)||123
141659|NCT01697592|345659|P10|STARTED|Phase A (Up to 24 Weeks)||32
141660|NCT01697592|345660|P9|STARTED|Phase A (Up to 24 Weeks)||34
141661|NCT01697592|345661|P8|STARTED|Phase A (Up to 24 Weeks)||33
141662|NCT01697592|345662|P7|STARTED|Phase A (Up to 24 Weeks)||34
141663|NCT01697592|345663|P6|STARTED|Phase A (Up to 24 Weeks)||63
141664|NCT01697592|345664|P5|STARTED|Phase A (Up to 24 Weeks)||67
141665|NCT01697592|345665|P4|STARTED|Phase A (Up to 24 Weeks)||65
141666|NCT01697592|345666|P3|STARTED|Phase A (Up to 24 Weeks)||66
141667|NCT01697592|345667|P2|STARTED|Phase A (Up to 24 Weeks)||65
141668|NCT01697592|345668|P1|STARTED|Phase A (Up to 24 Weeks)||126
141669|NCT01697579|345737|P7|NOT COMPLETED|Optional Extension-Cycles 2-6||69
141670|NCT01697579|345738|P6|NOT COMPLETED|Optional Extension-Cycles 2-6||35
141671|NCT01697579|345739|P5|NOT COMPLETED|Optional Extension-Cycles 2-6||0
141672|NCT01697579|345740|P4|NOT COMPLETED|Optional Extension-Cycles 2-6||0
141673|NCT01697579|345741|P3|NOT COMPLETED|Optional Extension-Cycles 2-6||0
141674|NCT01697579|345742|P2|NOT COMPLETED|Optional Extension-Cycles 2-6||0
141675|NCT01697579|345743|P1|NOT COMPLETED|Optional Extension-Cycles 2-6||0
141676|NCT01697579|345737|P7|COMPLETED|Optional Extension-Cycles 2-6||37
141677|NCT01697579|345738|P6|COMPLETED|Optional Extension-Cycles 2-6||12
141678|NCT01697579|345739|P5|COMPLETED|Optional Extension-Cycles 2-6||0
141679|NCT01697579|345740|P4|COMPLETED|Optional Extension-Cycles 2-6||0
141680|NCT01697579|345741|P3|COMPLETED|Optional Extension-Cycles 2-6||0
141681|NCT01697579|345742|P2|COMPLETED|Optional Extension-Cycles 2-6||0
141682|NCT01697579|345743|P1|COMPLETED|Optional Extension-Cycles 2-6||0
141683|NCT01697579|345737|P7|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|106
141684|NCT01697579|345738|P6|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|47
141685|NCT01697579|345739|P5|STARTED|Optional Extension-Cycles 2-6|21 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
141686|NCT01697579|345740|P4|STARTED|Optional Extension-Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
141687|NCT01697579|345741|P3|STARTED|Optional Extension-Cycles 2-6|25 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
141688|NCT01697579|345742|P2|STARTED|Optional Extension-Cycles 2-6|33 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
141689|NCT01697579|345743|P1|STARTED|Optional Extension-Cycles 2-6|47 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 5 mg/kg|0
141690|NCT01697579|345737|P7|NOT COMPLETED|Base Study-Cycle 1||0
141691|NCT01697579|345738|P6|NOT COMPLETED|Base Study-Cycle 1||0
141692|NCT01697579|345739|P5|NOT COMPLETED|Base Study-Cycle 1||3
141693|NCT01697579|345740|P4|NOT COMPLETED|Base Study-Cycle 1||1
141694|NCT01697579|345741|P3|NOT COMPLETED|Base Study-Cycle 1||1
141695|NCT01697579|345742|P2|NOT COMPLETED|Base Study-Cycle 1||1
141696|NCT01697579|345743|P1|NOT COMPLETED|Base Study-Cycle 1||2
141697|NCT01697579|345737|P7|COMPLETED|Base Study-Cycle 1||0
141698|NCT01697579|345738|P6|COMPLETED|Base Study-Cycle 1||0
141699|NCT01697579|345739|P5|COMPLETED|Base Study-Cycle 1||35
141700|NCT01697579|345740|P4|COMPLETED|Base Study-Cycle 1||40
141701|NCT01697579|345741|P3|COMPLETED|Base Study-Cycle 1||43
141702|NCT01697579|345742|P2|COMPLETED|Base Study-Cycle 1||42
141703|NCT01697579|345743|P1|COMPLETED|Base Study-Cycle 1||72
141704|NCT01697579|345737|P7|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
141705|NCT01697579|345738|P6|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
141706|NCT01697579|345739|P5|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|38
141707|NCT01697579|345740|P4|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|41
141708|NCT01697579|345741|P3|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|44
141709|NCT01697579|345742|P2|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|43
141710|NCT01697579|345743|P1|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|74
141711|NCT01697501|345855|P1|NOT COMPLETED|Overall Study||2
141712|NCT01697501|345855|P1|COMPLETED|Overall Study||86
141713|NCT01697501|345855|P1|STARTED|Overall Study||88
141714|NCT01697462|345898|P1|NOT COMPLETED|Overall Study||77
141715|NCT01697462|345898|P1|COMPLETED|Overall Study||181
141716|NCT01697462|345898|P1|STARTED|Overall Study||258
141717|NCT01697449|345905|P1|NOT COMPLETED|Overall Study||90
141718|NCT01697449|345905|P1|COMPLETED|Overall Study||101
141719|NCT01697449|345905|P1|STARTED|Overall Study||191
141720|NCT01697358|345916|P2|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||55
141721|NCT01697358|345917|P1|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||49
141722|NCT01697358|345916|P2|COMPLETED|Period II: 6-24M Long-term Follow-up||52
141723|NCT01697358|345917|P1|COMPLETED|Period II: 6-24M Long-term Follow-up||48
141724|NCT01697358|345916|P2|STARTED|Period II: 6-24M Long-term Follow-up||107
141725|NCT01697358|345917|P1|STARTED|Period II: 6-24M Long-term Follow-up||97
141726|NCT01697358|345916|P2|NOT COMPLETED|Period I: Randomization to 6 Months||1
141727|NCT01697358|345917|P1|NOT COMPLETED|Period I: Randomization to 6 Months||13
141728|NCT01697358|345916|P2|COMPLETED|Period I: Randomization to 6 Months||107
141729|NCT01697358|345917|P1|COMPLETED|Period I: Randomization to 6 Months||97
141730|NCT01697358|345916|P2|STARTED|Period I: Randomization to 6 Months||108
141731|NCT01697358|345917|P1|STARTED|Period I: Randomization to 6 Months||110
141732|NCT01697345|345933|P1|NOT COMPLETED|Overall Study||1
141733|NCT01697345|345933|P1|COMPLETED|Overall Study|One patient withdrew due to symptoms of recurrent Gardnerella vaginalis.|12
141734|NCT01697345|345933|P1|STARTED|Overall Study||13
141735|NCT01697332|345952|P1|NOT COMPLETED|Overall Study||0
141736|NCT01697332|345952|P1|COMPLETED|Overall Study||1
141737|NCT01697332|345952|P1|STARTED|Overall Study||1
141738|NCT01697319|345958|P1|NOT COMPLETED|Extension Phase||15
141739|NCT01697319|345958|P1|COMPLETED|Extension Phase||0
141740|NCT01697319|345958|P1|STARTED|Extension Phase||15
141741|NCT01697319|345958|P1|NOT COMPLETED|Primary Phase||1
141742|NCT01697319|345958|P1|COMPLETED|Primary Phase||15
141743|NCT01697319|345958|P1|STARTED|Primary Phase|One subject enrolled but did not receive a single dose of study drug|16
141744|NCT01696994|345967|P2|NOT COMPLETED|Overall Study||8437
141745|NCT01696994|345968|P1|NOT COMPLETED|Overall Study||5192
141746|NCT01696994|345967|P2|COMPLETED|Overall Study||30668
141747|NCT01696994|345968|P1|COMPLETED|Overall Study||33919
141748|NCT01696994|345967|P2|STARTED|Overall Study||39105
141749|NCT01696994|345968|P1|STARTED|Overall Study||39111
141750|NCT01696981|345996|P2|NOT COMPLETED|Overall Study||10374
141751|NCT01696981|345997|P1|NOT COMPLETED|Overall Study||1201
141752|NCT01696981|345996|P2|COMPLETED|Overall Study||67071
141753|NCT01696981|345997|P1|COMPLETED|Overall Study||76254
141754|NCT01696981|345996|P2|STARTED|Overall Study||77445
141755|NCT01696981|345997|P1|STARTED|Overall Study||77455
141756|NCT01696968|346017|P2|NOT COMPLETED|Overall Study||6812
141757|NCT01696968|346018|P1|NOT COMPLETED|Overall Study||1201
141758|NCT01696968|346017|P2|COMPLETED|Overall Study||70633
141759|NCT01696968|346018|P1|COMPLETED|Overall Study||76255
141760|NCT01696968|346017|P2|STARTED|Overall Study||77445
141761|NCT01696968|346018|P1|STARTED|Overall Study||77456
141762|NCT01696955|346040|P2|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0
141763|NCT01696955|346041|P1|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0
141764|NCT01696955|346040|P2|COMPLETED|Failure on Cetuximab-Received Tivantinib|23 patients did not cross over|15
141765|NCT01696955|346041|P1|COMPLETED|Failure on Cetuximab-Received Tivantinib||0
141766|NCT01696955|346040|P2|STARTED|Failure on Cetuximab-Received Tivantinib||15
141767|NCT01696955|346041|P1|STARTED|Failure on Cetuximab-Received Tivantinib||0
141768|NCT01696955|346040|P2|NOT COMPLETED|Main Study||1
141769|NCT01696955|346041|P1|NOT COMPLETED|Main Study||2
141770|NCT01696955|346040|P2|COMPLETED|Main Study||38
141771|NCT01696955|346041|P1|COMPLETED|Main Study||40
141772|NCT01696955|346040|P2|STARTED|Main Study||39
141773|NCT01696955|346041|P1|STARTED|Main Study||42
141774|NCT01696942|346066|P2|NOT COMPLETED|Overall Study||3
141775|NCT01696942|346067|P1|NOT COMPLETED|Overall Study||2
141776|NCT01696942|346066|P2|COMPLETED|Overall Study||2
141777|NCT01696942|346067|P1|COMPLETED|Overall Study||3
141778|NCT01696942|346066|P2|STARTED|Overall Study||5
141779|NCT01696942|346067|P1|STARTED|Overall Study||5
141780|NCT01696929|346075|P1|NOT COMPLETED|Overall Study||1
141781|NCT01696929|346075|P1|COMPLETED|Overall Study||5
141782|NCT01696929|346075|P1|STARTED|Overall Study||6
141783|NCT01696877|346082|P2|NOT COMPLETED|Overall Study||1
141784|NCT01696877|346083|P1|NOT COMPLETED|Overall Study||0
141785|NCT01696877|346082|P2|COMPLETED|Overall Study||13
141786|NCT01696877|346083|P1|COMPLETED|Overall Study||15
141787|NCT01696877|346082|P2|STARTED|Overall Study||14
141788|NCT01696877|346083|P1|STARTED|Overall Study||15
141789|NCT01696773|346105|P2|NOT COMPLETED|Day 28, Second Intervention||0
141790|NCT01696773|346106|P1|NOT COMPLETED|Day 28, Second Intervention||0
141791|NCT01696773|346105|P2|COMPLETED|Day 28, Second Intervention||6
141792|NCT01696773|346106|P1|COMPLETED|Day 28, Second Intervention||5
141793|NCT01696773|346105|P2|STARTED|Day 28, Second Intervention||6
141794|NCT01696773|346106|P1|STARTED|Day 28, Second Intervention||5
141795|NCT01696773|346105|P2|NOT COMPLETED|Days 15-27, Washout||0
141796|NCT01696773|346106|P1|NOT COMPLETED|Days 15-27, Washout||1
141797|NCT01696773|346105|P2|COMPLETED|Days 15-27, Washout||6
141798|NCT01696773|346106|P1|COMPLETED|Days 15-27, Washout||5
141799|NCT01696773|346105|P2|STARTED|Days 15-27, Washout||6
141800|NCT01696773|346106|P1|STARTED|Days 15-27, Washout||6
141801|NCT01696773|346105|P2|NOT COMPLETED|Day 14, First Intervention||0
141802|NCT01696773|346106|P1|NOT COMPLETED|Day 14, First Intervention||0
141803|NCT01696773|346105|P2|COMPLETED|Day 14, First Intervention||6
141804|NCT01696773|346106|P1|COMPLETED|Day 14, First Intervention||6
141805|NCT01696773|346105|P2|STARTED|Day 14, First Intervention||6
141806|NCT01696773|346106|P1|STARTED|Day 14, First Intervention||6
141807|NCT01696773|346105|P2|NOT COMPLETED|Days 1-13, Washout||0
141808|NCT01696773|346106|P1|NOT COMPLETED|Days 1-13, Washout||0
141809|NCT01696773|346105|P2|COMPLETED|Days 1-13, Washout||6
141810|NCT01696773|346106|P1|COMPLETED|Days 1-13, Washout||6
141811|NCT01696773|346105|P2|STARTED|Days 1-13, Washout||6
141812|NCT01696773|346106|P1|STARTED|Days 1-13, Washout||6
141813|NCT01696760|346114|P2|NOT COMPLETED|Overall Study||0
141814|NCT01696760|346115|P1|NOT COMPLETED|Overall Study||0
141815|NCT01696760|346114|P2|COMPLETED|Overall Study||3
141816|NCT01696760|346115|P1|COMPLETED|Overall Study||9
141817|NCT01696760|346114|P2|STARTED|Overall Study||3
141818|NCT01696760|346115|P1|STARTED|Overall Study||9
141819|NCT01696695|346133|P1|NOT COMPLETED|Overall Study||882
141820|NCT01696695|346133|P1|COMPLETED|Overall Study||0
141821|NCT01696695|346133|P1|STARTED|Overall Study||882
141822|NCT01696643|346145|P2|NOT COMPLETED|Overall Study||535
141823|NCT01696643|346146|P1|NOT COMPLETED|Overall Study||529
141824|NCT01696643|346145|P2|COMPLETED|Overall Study||169
141825|NCT01696643|346146|P1|COMPLETED|Overall Study||174
141826|NCT01696643|346145|P2|Received at Least 1 Dose of Study Drug|Overall Study|2 participants randomized to placebo took CB-5945. Their results are included in the CB-5945 group.|702
141827|NCT01696643|346146|P1|Received at Least 1 Dose of Study Drug|Overall Study||701
141828|NCT01696643|346145|P2|STARTED|Overall Study||704
141829|NCT01696643|346146|P1|STARTED|Overall Study||703
141830|NCT01696396|346165|P4|NOT COMPLETED|Overall Study||14
141831|NCT01696396|346166|P3|NOT COMPLETED|Overall Study||26
141832|NCT01696396|346167|P2|NOT COMPLETED|Overall Study||7
141833|NCT01696396|346168|P1|NOT COMPLETED|Overall Study||31
141834|NCT01696396|346165|P4|COMPLETED|Overall Study||28
141835|NCT01696396|346166|P3|COMPLETED|Overall Study||59
141836|NCT01696396|346167|P2|COMPLETED|Overall Study||20
141837|NCT01696396|346168|P1|COMPLETED|Overall Study||69
141838|NCT01696396|346165|P4|Entered Open-label Period|Overall Study||37
141839|NCT01696396|346166|P3|Entered Open-label Period|Overall Study||75
141840|NCT01696396|346167|P2|Entered Open-label Period|Overall Study||21
141841|NCT01696396|346168|P1|Entered Open-label Period|Overall Study||84
141842|NCT01696396|346165|P4|Received Study Drug|Overall Study||41
141843|NCT01696396|346166|P3|Received Study Drug|Overall Study||84
141844|NCT01696396|346167|P2|Received Study Drug|Overall Study||26
141845|NCT01696396|346168|P1|Received Study Drug|Overall Study||98
141846|NCT01696396|346165|P4|STARTED|Overall Study||42
141847|NCT01696396|346166|P3|STARTED|Overall Study||85
141848|NCT01696396|346167|P2|STARTED|Overall Study||27
141849|NCT01696396|346168|P1|STARTED|Overall Study||100
141850|NCT01696357|346212|P2|NOT COMPLETED|Overall Study||1
141851|NCT01696357|346213|P1|NOT COMPLETED|Overall Study||2
141852|NCT01696357|346212|P2|COMPLETED|Overall Study||41
141853|NCT01696357|346213|P1|COMPLETED|Overall Study||40
141854|NCT01696357|346212|P2|STARTED|Overall Study||42
141855|NCT01696357|346213|P1|STARTED|Overall Study||42
141856|NCT01696214|346223|P4|NOT COMPLETED|Overall Study||0
141857|NCT01696214|346224|P3|NOT COMPLETED|Overall Study||0
141858|NCT01696214|346225|P2|NOT COMPLETED|Overall Study||0
141859|NCT01696214|346226|P1|NOT COMPLETED|Overall Study||1
141860|NCT01696214|346223|P4|COMPLETED|Overall Study||5
141861|NCT01696214|346224|P3|COMPLETED|Overall Study||5
141862|NCT01696214|346225|P2|COMPLETED|Overall Study||5
141863|NCT01696214|346226|P1|COMPLETED|Overall Study||4
141864|NCT01696214|346223|P4|STARTED|Overall Study||5
141865|NCT01696214|346224|P3|STARTED|Overall Study||5
141866|NCT01696214|346225|P2|STARTED|Overall Study||5
141867|NCT01696214|346226|P1|STARTED|Overall Study||5
141868|NCT01696188|346246|P2|NOT COMPLETED|Overall Study||1
141869|NCT01696188|346247|P1|NOT COMPLETED|Overall Study||1
141870|NCT01696188|346246|P2|COMPLETED|Overall Study||42
141871|NCT01696188|346247|P1|COMPLETED|Overall Study||40
141872|NCT01696188|346246|P2|STARTED|Overall Study||43
141873|NCT01696188|346247|P1|STARTED|Overall Study||41
141874|NCT01696084|346261|P2|NOT COMPLETED|Overall Study||146
141875|NCT01696084|346262|P1|NOT COMPLETED|Overall Study||131
141876|NCT01696084|346261|P2|COMPLETED|Overall Study||10
141877|NCT01696084|346262|P1|COMPLETED|Overall Study||22
141878|NCT01696084|346261|P2|STARTED|Overall Study||156
141879|NCT01696084|346262|P1|STARTED|Overall Study||153
141880|NCT01696071|346278|P2|NOT COMPLETED|Treatment Period 2: 4 Weeks||0
141881|NCT01696071|346279|P1|NOT COMPLETED|Treatment Period 2: 4 Weeks||1
141882|NCT01696071|346278|P2|COMPLETED|Treatment Period 2: 4 Weeks||47
141883|NCT01696071|346279|P1|COMPLETED|Treatment Period 2: 4 Weeks||50
141884|NCT01696071|346278|P2|STARTED|Treatment Period 2: 4 Weeks||47
141885|NCT01696071|346279|P1|STARTED|Treatment Period 2: 4 Weeks||51
141886|NCT01696071|346278|P2|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
141887|NCT01696071|346279|P1|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
141888|NCT01696071|346278|P2|COMPLETED|Treatment Period 1: 4 Weeks||47
141889|NCT01696071|346279|P1|COMPLETED|Treatment Period 1: 4 Weeks||51
141890|NCT01696071|346278|P2|STARTED|Treatment Period 1: 4 Weeks||47
141891|NCT01696071|346279|P1|STARTED|Treatment Period 1: 4 Weeks||51
141892|NCT01696058|346307|P2|NOT COMPLETED|Overall Study||31
141893|NCT01696058|346308|P1|NOT COMPLETED|Overall Study||43
141894|NCT01696058|346307|P2|COMPLETED|Overall Study||538
141895|NCT01696058|346308|P1|COMPLETED|Overall Study||523
141896|NCT01696058|346307|P2|STARTED|Overall Study||569
141897|NCT01696058|346308|P1|STARTED|Overall Study||566
141898|NCT01696045|346336|P2|NOT COMPLETED|Overall Study||7
141899|NCT01696045|346337|P1|NOT COMPLETED|Overall Study||3
141900|NCT01696045|346336|P2|COMPLETED|Overall Study||1
141901|NCT01696045|346337|P1|COMPLETED|Overall Study||1
141902|NCT01696045|346336|P2|STARTED|Overall Study||8
141903|NCT01696045|346337|P1|STARTED|Overall Study||4
141904|NCT01695993|346356|P3|NOT COMPLETED|Overall Study||6
141905|NCT01695993|346357|P2|NOT COMPLETED|Overall Study||5
141906|NCT01695993|346358|P1|NOT COMPLETED|Overall Study||5
141907|NCT01695993|346356|P3|COMPLETED|Overall Study||75
141908|NCT01695993|346357|P2|COMPLETED|Overall Study||75
141909|NCT01695993|346358|P1|COMPLETED|Overall Study||76
141910|NCT01695993|346356|P3|STARTED|Overall Study||81
141911|NCT01695993|346357|P2|STARTED|Overall Study||80
141912|NCT01695993|346358|P1|STARTED|Overall Study||81
141913|NCT01695772|346366|P1|NOT COMPLETED|Overall Study||38
141914|NCT01695772|346366|P1|COMPLETED|Overall Study||12
141915|NCT01695772|346366|P1|STARTED|Overall Study||50
141916|NCT01695746|346378|P1|NOT COMPLETED|Overall Study||12
141917|NCT01695746|346378|P1|COMPLETED|Overall Study||96
141918|NCT01695746|346378|P1|STARTED|Overall Study||108
141919|NCT01695668|346394|P2|NOT COMPLETED|Overall Study||17
141920|NCT01695668|346395|P1|NOT COMPLETED|Overall Study||15
141921|NCT01695668|346394|P2|COMPLETED|Overall Study||20
141922|NCT01695668|346395|P1|COMPLETED|Overall Study||23
141923|NCT01695668|346394|P2|STARTED|Overall Study||37
141924|NCT01695668|346395|P1|STARTED|Overall Study||38
141925|NCT01695369|346401|P1|NOT COMPLETED|Overall Study||0
141926|NCT01695369|346401|P1|COMPLETED|Overall Study||61
141927|NCT01695369|346401|P1|STARTED|Overall Study||61
141928|NCT01695330|346407|P2|NOT COMPLETED|Overall Study||0
141929|NCT01695330|346408|P1|NOT COMPLETED|Overall Study||47
141930|NCT01695330|346407|P2|COMPLETED|Overall Study||0
141931|NCT01695330|346408|P1|COMPLETED|Overall Study||5
141932|NCT01695330|346407|P2|STARTED|Overall Study||0
141933|NCT01695330|346408|P1|STARTED|Overall Study||52
141934|NCT01695304|346414|P2|NOT COMPLETED|Overall Study||0
141935|NCT01695304|346415|P1|NOT COMPLETED|Overall Study||0
141936|NCT01695304|346414|P2|COMPLETED|Overall Study|3 deaths & 2 drop out in the intervention group, contributed some information over the 26 weeks|120
141937|NCT01695304|346415|P1|COMPLETED|Overall Study|2 deaths & 1 drop out in the intervention group, contributed some information over the 26 weeks|120
141938|NCT01695304|346414|P2|STARTED|Overall Study||120
141939|NCT01695304|346415|P1|STARTED|Overall Study||120
141940|NCT01695291|346425|P2|NOT COMPLETED|Overall Study||7
141941|NCT01695291|346426|P1|NOT COMPLETED|Overall Study||2
141942|NCT01695291|346425|P2|COMPLETED|Overall Study||14
141943|NCT01695291|346426|P1|COMPLETED|Overall Study||8
141944|NCT01695291|346425|P2|STARTED|Overall Study||21
141945|NCT01695291|346426|P1|STARTED|Overall Study||10
141946|NCT01695239|346438|P14|NOT COMPLETED|Post-Treatment Follow-Up Period||5
141947|NCT01695239|346439|P13|NOT COMPLETED|Post-Treatment Follow-Up Period||9
141948|NCT01695239|346440|P12|NOT COMPLETED|Post-Treatment Follow-Up Period||1
141949|NCT01695239|346441|P11|NOT COMPLETED|Post-Treatment Follow-Up Period||0
141950|NCT01695239|346442|P10|NOT COMPLETED|Post-Treatment Follow-Up Period||0
141951|NCT01695239|346443|P9|NOT COMPLETED|Post-Treatment Follow-Up Period||0
141952|NCT01695239|346444|P8|NOT COMPLETED|Post-Treatment Follow-Up Period||0
141953|NCT01695239|346445|P7|NOT COMPLETED|Post-Treatment Follow-Up Period||0
141954|NCT01695239|346446|P6|NOT COMPLETED|Post-Treatment Follow-Up Period||0
141955|NCT01695239|346447|P5|NOT COMPLETED|Post-Treatment Follow-Up Period||0
141956|NCT01695239|346448|P4|NOT COMPLETED|Post-Treatment Follow-Up Period||0
141957|NCT01695239|346449|P3|NOT COMPLETED|Post-Treatment Follow-Up Period||0
141958|NCT01695239|346450|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||0
141959|NCT01695239|346451|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||0
141960|NCT01695239|346438|P14|COMPLETED|Post-Treatment Follow-Up Period||166
141961|NCT01695239|346439|P13|COMPLETED|Post-Treatment Follow-Up Period||156
141962|NCT01695239|346440|P12|COMPLETED|Post-Treatment Follow-Up Period||0
141963|NCT01695239|346441|P11|COMPLETED|Post-Treatment Follow-Up Period||20
141964|NCT01695239|346442|P10|COMPLETED|Post-Treatment Follow-Up Period||0
141965|NCT01695239|346443|P9|COMPLETED|Post-Treatment Follow-Up Period||0
141966|NCT01695239|346444|P8|COMPLETED|Post-Treatment Follow-Up Period||0
141967|NCT01695239|346445|P7|COMPLETED|Post-Treatment Follow-Up Period||0
141968|NCT01695239|346446|P6|COMPLETED|Post-Treatment Follow-Up Period||0
141969|NCT01695239|346447|P5|COMPLETED|Post-Treatment Follow-Up Period||0
141970|NCT01695239|346448|P4|COMPLETED|Post-Treatment Follow-Up Period||0
141971|NCT01695239|346449|P3|COMPLETED|Post-Treatment Follow-Up Period||0
141972|NCT01695239|346450|P2|COMPLETED|Post-Treatment Follow-Up Period||0
141973|NCT01695239|346451|P1|COMPLETED|Post-Treatment Follow-Up Period||0
141974|NCT01695239|346438|P14|STARTED|Post-Treatment Follow-Up Period|IxeQ2W participants who entered post-treatment follow-up.|171
141975|NCT01695239|346439|P13|STARTED|Post-Treatment Follow-Up Period|IxeQ4W participants who entered post-treatment follow-up.|165
141976|NCT01695239|346440|P12|STARTED|Post-Treatment Follow-Up Period|Participants who discontinued early and received adalimumab.|1
141977|NCT01695239|346441|P11|STARTED|Post-Treatment Follow-Up Period|Participants who discontinued early and received PBO.|20
142051|NCT01695239|346445|P7|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
141978|NCT01695239|346442|P10|STARTED|Post-Treatment Follow-Up Period|Only included post-treatment follow-up participants.|0
141979|NCT01695239|346443|P9|STARTED|Post-Treatment Follow-Up Period|Only included post-treatment follow-up participants.|0
141980|NCT01695239|346444|P8|STARTED|Post-Treatment Follow-Up Period||0
141981|NCT01695239|346445|P7|STARTED|Post-Treatment Follow-Up Period||0
141982|NCT01695239|346446|P6|STARTED|Post-Treatment Follow-Up Period||0
141983|NCT01695239|346447|P5|STARTED|Post-Treatment Follow-Up Period||0
141984|NCT01695239|346448|P4|STARTED|Post-Treatment Follow-Up Period||0
141985|NCT01695239|346449|P3|STARTED|Post-Treatment Follow-Up Period||0
141986|NCT01695239|346450|P2|STARTED|Post-Treatment Follow-Up Period||0
141987|NCT01695239|346451|P1|STARTED|Post-Treatment Follow-Up Period||0
141988|NCT01695239|346438|P14|NOT COMPLETED|Extension Long-Term Extension Periods||0
141989|NCT01695239|346439|P13|NOT COMPLETED|Extension Long-Term Extension Periods||0
141990|NCT01695239|346440|P12|NOT COMPLETED|Extension Long-Term Extension Periods||0
141991|NCT01695239|346441|P11|NOT COMPLETED|Extension Long-Term Extension Periods||0
141992|NCT01695239|346442|P10|NOT COMPLETED|Extension Long-Term Extension Periods||61
141993|NCT01695239|346443|P9|NOT COMPLETED|Extension Long-Term Extension Periods||66
141994|NCT01695239|346444|P8|NOT COMPLETED|Extension Long-Term Extension Periods||0
141995|NCT01695239|346445|P7|NOT COMPLETED|Extension Long-Term Extension Periods||0
141996|NCT01695239|346446|P6|NOT COMPLETED|Extension Long-Term Extension Periods||0
141997|NCT01695239|346447|P5|NOT COMPLETED|Extension Long-Term Extension Periods||0
141998|NCT01695239|346448|P4|NOT COMPLETED|Extension Long-Term Extension Periods||0
141999|NCT01695239|346449|P3|NOT COMPLETED|Extension Long-Term Extension Periods||0
142000|NCT01695239|346450|P2|NOT COMPLETED|Extension Long-Term Extension Periods||0
142001|NCT01695239|346451|P1|NOT COMPLETED|Extension Long-Term Extension Periods||0
142002|NCT01695239|346438|P14|COMPLETED|Extension Long-Term Extension Periods||0
142003|NCT01695239|346439|P13|COMPLETED|Extension Long-Term Extension Periods||0
142004|NCT01695239|346440|P12|COMPLETED|Extension Long-Term Extension Periods||0
142005|NCT01695239|346441|P11|COMPLETED|Extension Long-Term Extension Periods||0
142006|NCT01695239|346442|P10|COMPLETED|Extension Long-Term Extension Periods||122
142007|NCT01695239|346443|P9|COMPLETED|Extension Long-Term Extension Periods||121
142008|NCT01695239|346444|P8|COMPLETED|Extension Long-Term Extension Periods||0
142009|NCT01695239|346445|P7|COMPLETED|Extension Long-Term Extension Periods||0
142010|NCT01695239|346446|P6|COMPLETED|Extension Long-Term Extension Periods||0
142011|NCT01695239|346447|P5|COMPLETED|Extension Long-Term Extension Periods||0
142012|NCT01695239|346448|P4|COMPLETED|Extension Long-Term Extension Periods||0
142013|NCT01695239|346449|P3|COMPLETED|Extension Long-Term Extension Periods||0
142014|NCT01695239|346450|P2|COMPLETED|Extension Long-Term Extension Periods||0
142015|NCT01695239|346451|P1|COMPLETED|Extension Long-Term Extension Periods||0
142016|NCT01695239|346438|P14|STARTED|Extension Long-Term Extension Periods||0
142017|NCT01695239|346439|P13|STARTED|Extension Long-Term Extension Periods||0
142018|NCT01695239|346440|P12|STARTED|Extension Long-Term Extension Periods||0
142019|NCT01695239|346441|P11|STARTED|Extension Long-Term Extension Periods||0
142020|NCT01695239|346442|P10|STARTED|Extension Long-Term Extension Periods|IxeQ2W who re-randomized to ixeQ2W.|183
142021|NCT01695239|346443|P9|STARTED|Extension Long-Term Extension Periods|IxeQ4W who re-randomized to ixeQ4W.|187
142022|NCT01695239|346444|P8|STARTED|Extension Long-Term Extension Periods|Only included combined extension participants.|0
142023|NCT01695239|346445|P7|STARTED|Extension Long-Term Extension Periods||0
142024|NCT01695239|346446|P6|STARTED|Extension Long-Term Extension Periods||0
142025|NCT01695239|346447|P5|STARTED|Extension Long-Term Extension Periods||0
142026|NCT01695239|346448|P4|STARTED|Extension Long-Term Extension Periods||0
142027|NCT01695239|346449|P3|STARTED|Extension Long-Term Extension Periods||0
142028|NCT01695239|346450|P2|STARTED|Extension Long-Term Extension Periods||0
142029|NCT01695239|346451|P1|STARTED|Extension Long-Term Extension Periods||0
142030|NCT01695239|346438|P14|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
142031|NCT01695239|346439|P13|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
142032|NCT01695239|346440|P12|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
142033|NCT01695239|346441|P11|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
142034|NCT01695239|346442|P10|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
142035|NCT01695239|346443|P9|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
142036|NCT01695239|346444|P8|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||11
142037|NCT01695239|346445|P7|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
142038|NCT01695239|346446|P6|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
142039|NCT01695239|346447|P5|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
142040|NCT01695239|346448|P4|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
142041|NCT01695239|346449|P3|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
142042|NCT01695239|346450|P2|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
142043|NCT01695239|346451|P1|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
142044|NCT01695239|346438|P14|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
142045|NCT01695239|346439|P13|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
142046|NCT01695239|346440|P12|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
142047|NCT01695239|346441|P11|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
142048|NCT01695239|346442|P10|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
142049|NCT01695239|346443|P9|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
142050|NCT01695239|346444|P8|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||77
142052|NCT01695239|346446|P6|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
142053|NCT01695239|346447|P5|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
142054|NCT01695239|346448|P4|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
142055|NCT01695239|346449|P3|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
142056|NCT01695239|346450|P2|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
142057|NCT01695239|346451|P1|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
142058|NCT01695239|346438|P14|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
142059|NCT01695239|346439|P13|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
142060|NCT01695239|346440|P12|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
142061|NCT01695239|346441|P11|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
142062|NCT01695239|346442|P10|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
142063|NCT01695239|346443|P9|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
142064|NCT01695239|346444|P8|STARTED|Placebo Washout (Week 24 Up To Week 32)|Adalimumab Q2W responders who re-randomized to IxeQ2W or IxeQ4W and PBO for ixe and adalimumab.|88
142065|NCT01695239|346445|P7|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
142066|NCT01695239|346446|P6|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
142067|NCT01695239|346447|P5|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
142068|NCT01695239|346448|P4|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
142069|NCT01695239|346449|P3|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
142070|NCT01695239|346450|P2|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
142071|NCT01695239|346451|P1|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
142072|NCT01695239|346438|P14|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
142073|NCT01695239|346439|P13|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
142074|NCT01695239|346440|P12|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
142075|NCT01695239|346441|P11|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
142076|NCT01695239|346442|P10|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
142077|NCT01695239|346443|P9|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
142078|NCT01695239|346444|P8|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
142079|NCT01695239|346445|P7|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
142080|NCT01695239|346446|P6|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
142081|NCT01695239|346447|P5|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
142082|NCT01695239|346448|P4|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
142083|NCT01695239|346449|P3|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
142084|NCT01695239|346450|P2|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
142085|NCT01695239|346451|P1|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
142086|NCT01695239|346438|P14|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
142087|NCT01695239|346439|P13|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
142088|NCT01695239|346440|P12|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
142089|NCT01695239|346441|P11|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
142090|NCT01695239|346442|P10|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
142091|NCT01695239|346443|P9|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
142092|NCT01695239|346444|P8|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
142093|NCT01695239|346445|P7|COMPLETED|IR Participants (Week 16 Up To Week 24)||9
142094|NCT01695239|346446|P6|COMPLETED|IR Participants (Week 16 Up To Week 24)||24
142095|NCT01695239|346447|P5|COMPLETED|IR Participants (Week 16 Up To Week 24)||24
142096|NCT01695239|346448|P4|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
142097|NCT01695239|346449|P3|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
142098|NCT01695239|346450|P2|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
142099|NCT01695239|346451|P1|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
142100|NCT01695239|346438|P14|STARTED|IR Participants (Week 16 Up To Week 24)||0
142101|NCT01695239|346439|P13|STARTED|IR Participants (Week 16 Up To Week 24)||0
142102|NCT01695239|346440|P12|STARTED|IR Participants (Week 16 Up To Week 24)||0
142103|NCT01695239|346441|P11|STARTED|IR Participants (Week 16 Up To Week 24)||0
142104|NCT01695239|346442|P10|STARTED|IR Participants (Week 16 Up To Week 24)||0
142105|NCT01695239|346443|P9|STARTED|IR Participants (Week 16 Up To Week 24)||0
142106|NCT01695239|346444|P8|STARTED|IR Participants (Week 16 Up To Week 24)||0
142107|NCT01695239|346445|P7|STARTED|IR Participants (Week 16 Up To Week 24)|Adalimumab Q2W (IR) who re-randomized to IxeQ2W or IxeQ4W and PBO for ixe and adalimumab.|9
142108|NCT01695239|346446|P6|STARTED|IR Participants (Week 16 Up To Week 24)|IR from placebo who re-randomized to ixeQ2W and IR from ixeQ2W.|24
142109|NCT01695239|346447|P5|STARTED|IR Participants (Week 16 Up To Week 24)|IR from placebo who re-randomized to ixeQ4W and IR from ixeQ4W.|24
142110|NCT01695239|346448|P4|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
142111|NCT01695239|346449|P3|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
142112|NCT01695239|346450|P2|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
142113|NCT01695239|346451|P1|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
142114|NCT01695239|346438|P14|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
142115|NCT01695239|346439|P13|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
142116|NCT01695239|346440|P12|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
142117|NCT01695239|346441|P11|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
142118|NCT01695239|346442|P10|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
142119|NCT01695239|346443|P9|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
142120|NCT01695239|346444|P8|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
142121|NCT01695239|346445|P7|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
142122|NCT01695239|346446|P6|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
142123|NCT01695239|346447|P5|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
142124|NCT01695239|346448|P4|NOT COMPLETED|Double-Blind (DB) Treatment Period||7
142125|NCT01695239|346449|P3|NOT COMPLETED|Double-Blind (DB) Treatment Period||10
142126|NCT01695239|346450|P2|NOT COMPLETED|Double-Blind (DB) Treatment Period||4
142127|NCT01695239|346451|P1|NOT COMPLETED|Double-Blind (DB) Treatment Period||15
142128|NCT01695239|346438|P14|COMPLETED|Double-Blind (DB) Treatment Period||0
142129|NCT01695239|346439|P13|COMPLETED|Double-Blind (DB) Treatment Period||0
142130|NCT01695239|346440|P12|COMPLETED|Double-Blind (DB) Treatment Period||0
142131|NCT01695239|346441|P11|COMPLETED|Double-Blind (DB) Treatment Period||0
142132|NCT01695239|346442|P10|COMPLETED|Double-Blind (DB) Treatment Period||0
142133|NCT01695239|346443|P9|COMPLETED|Double-Blind (DB) Treatment Period||0
142134|NCT01695239|346444|P8|COMPLETED|Double-Blind (DB) Treatment Period||0
142135|NCT01695239|346445|P7|COMPLETED|Double-Blind (DB) Treatment Period||0
142136|NCT01695239|346446|P6|COMPLETED|Double-Blind (DB) Treatment Period||0
142137|NCT01695239|346447|P5|COMPLETED|Double-Blind (DB) Treatment Period||0
142138|NCT01695239|346448|P4|COMPLETED|Double-Blind (DB) Treatment Period||96
142139|NCT01695239|346449|P3|COMPLETED|Double-Blind (DB) Treatment Period||97
142140|NCT01695239|346450|P2|COMPLETED|Double-Blind (DB) Treatment Period||97
142141|NCT01695239|346451|P1|COMPLETED|Double-Blind (DB) Treatment Period||91
142142|NCT01695239|346438|P14|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
142143|NCT01695239|346439|P13|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
142144|NCT01695239|346440|P12|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
142145|NCT01695239|346441|P11|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
142146|NCT01695239|346442|P10|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
142147|NCT01695239|346443|P9|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
142148|NCT01695239|346444|P8|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
142149|NCT01695239|346445|P7|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
142150|NCT01695239|346446|P6|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
142151|NCT01695239|346447|P5|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
142152|NCT01695239|346448|P4|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||10
142153|NCT01695239|346449|P3|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||11
142154|NCT01695239|346450|P2|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||9
142155|NCT01695239|346451|P1|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||27
142156|NCT01695239|346438|P14|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
142157|NCT01695239|346439|P13|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
142158|NCT01695239|346440|P12|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
142159|NCT01695239|346441|P11|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
142160|NCT01695239|346442|P10|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
142161|NCT01695239|346443|P9|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
142162|NCT01695239|346444|P8|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
142163|NCT01695239|346445|P7|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
142164|NCT01695239|346446|P6|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
142165|NCT01695239|346447|P5|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
142166|NCT01695239|346448|P4|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||102
142167|NCT01695239|346449|P3|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||107
142168|NCT01695239|346450|P2|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||101
142169|NCT01695239|346451|P1|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||106
142170|NCT01695239|346438|P14|STARTED|Double-Blind (DB) Treatment Period||0
142171|NCT01695239|346439|P13|STARTED|Double-Blind (DB) Treatment Period||0
142172|NCT01695239|346440|P12|STARTED|Double-Blind (DB) Treatment Period||0
142173|NCT01695239|346441|P11|STARTED|Double-Blind (DB) Treatment Period||0
142174|NCT01695239|346442|P10|STARTED|Double-Blind (DB) Treatment Period||0
142175|NCT01695239|346443|P9|STARTED|Double-Blind (DB) Treatment Period||0
142176|NCT01695239|346444|P8|STARTED|Double-Blind (DB) Treatment Period||0
142177|NCT01695239|346445|P7|STARTED|Double-Blind (DB) Treatment Period||0
142178|NCT01695239|346446|P6|STARTED|Double-Blind (DB) Treatment Period||0
142179|NCT01695239|346447|P5|STARTED|Double-Blind (DB) Treatment Period||0
142180|NCT01695239|346448|P4|STARTED|Double-Blind (DB) Treatment Period||103
142181|NCT01695239|346449|P3|STARTED|Double-Blind (DB) Treatment Period||107
142182|NCT01695239|346450|P2|STARTED|Double-Blind (DB) Treatment Period||101
142183|NCT01695239|346451|P1|STARTED|Double-Blind (DB) Treatment Period||106
142184|NCT01695135|346592|P4|NOT COMPLETED|Open Label Extension Treatment Phase||70
142185|NCT01695135|346593|P3|NOT COMPLETED|Open Label Extension Treatment Phase||40
142186|NCT01695135|346594|P2|NOT COMPLETED|Open Label Extension Treatment Phase||0
142187|NCT01695135|346595|P1|NOT COMPLETED|Open Label Extension Treatment Phase||0
142188|NCT01695135|346592|P4|COMPLETED|Open Label Extension Treatment Phase||10
142189|NCT01695135|346593|P3|COMPLETED|Open Label Extension Treatment Phase||9
142190|NCT01695135|346594|P2|COMPLETED|Open Label Extension Treatment Phase||0
142191|NCT01695135|346595|P1|COMPLETED|Open Label Extension Treatment Phase||0
142192|NCT01695135|346592|P4|STARTED|Open Label Extension Treatment Phase||80
142193|NCT01695135|346593|P3|STARTED|Open Label Extension Treatment Phase||49
142194|NCT01695135|346594|P2|STARTED|Open Label Extension Treatment Phase||0
142195|NCT01695135|346595|P1|STARTED|Open Label Extension Treatment Phase||0
142196|NCT01695135|346592|P4|NOT COMPLETED|Double-blind Treatment Phase||0
142197|NCT01695135|346593|P3|NOT COMPLETED|Double-blind Treatment Phase||0
142198|NCT01695135|346594|P2|NOT COMPLETED|Double-blind Treatment Phase||139
142199|NCT01695135|346595|P1|NOT COMPLETED|Double-blind Treatment Phase||71
142200|NCT01695135|346592|P4|COMPLETED|Double-blind Treatment Phase||0
142201|NCT01695135|346593|P3|COMPLETED|Double-blind Treatment Phase||0
142202|NCT01695135|346594|P2|COMPLETED|Double-blind Treatment Phase||4
142203|NCT01695135|346595|P1|COMPLETED|Double-blind Treatment Phase||0
142204|NCT01695135|346592|P4|STARTED|Double-blind Treatment Phase||0
142205|NCT01695135|346593|P3|STARTED|Double-blind Treatment Phase||0
142206|NCT01695135|346594|P2|STARTED|Double-blind Treatment Phase||143
142207|NCT01695135|346595|P1|STARTED|Double-blind Treatment Phase||71
142208|NCT01695044|346619|P1|NOT COMPLETED|Overall Study||102
142209|NCT01695044|346619|P1|COMPLETED|Overall Study||17
142210|NCT01695044|346619|P1|STARTED|Overall Study||119
142211|NCT01694966|346632|P3|NOT COMPLETED|Overall Study||34
142212|NCT01694966|346633|P2|NOT COMPLETED|Overall Study||15
142213|NCT01694966|346634|P1|NOT COMPLETED|Overall Study||34
142214|NCT01694966|346632|P3|COMPLETED|Overall Study||464
142215|NCT01694966|346633|P2|COMPLETED|Overall Study||232
142216|NCT01694966|346634|P1|COMPLETED|Overall Study||470
142217|NCT01694966|346632|P3|STARTED|Overall Study||498
142218|NCT01694966|346633|P2|STARTED|Overall Study||247
142219|NCT01694966|346634|P1|STARTED|Overall Study||504
142220|NCT01694771|346644|P2|NOT COMPLETED|Overall Study||40
142221|NCT01694771|346645|P1|NOT COMPLETED|Overall Study||40
142222|NCT01694771|346644|P2|COMPLETED|Overall Study||525
142223|NCT01694771|346645|P1|COMPLETED|Overall Study||527
142224|NCT01694771|346644|P2|STARTED|Overall Study||565
142225|NCT01694771|346645|P1|STARTED|Overall Study||567
142226|NCT01694706|346669|P3|NOT COMPLETED|Overall Study||0
142227|NCT01694706|346670|P2|NOT COMPLETED|Overall Study||1
142228|NCT01694706|346671|P1|NOT COMPLETED|Overall Study||1
142229|NCT01694706|346669|P3|COMPLETED|Overall Study||5
142230|NCT01694706|346670|P2|COMPLETED|Overall Study||4
142231|NCT01694706|346671|P1|COMPLETED|Overall Study||4
142232|NCT01694706|346669|P3|Received Faldaprevir Fed|Overall Study||5
142233|NCT01694706|346670|P2|Received Faldaprevir Fed|Overall Study||5
142234|NCT01694706|346671|P1|Received Faldaprevir Fed|Overall Study||4
142235|NCT01694706|346669|P3|Received Faldaprevir +OMP|Overall Study||5
142236|NCT01694706|346670|P2|Received Faldaprevir +OMP|Overall Study||5
142237|NCT01694706|346671|P1|Received Faldaprevir +OMP|Overall Study||5
142238|NCT01694706|346669|P3|Received Faldaprevir|Overall Study||5
142239|NCT01694706|346670|P2|Received Faldaprevir|Overall Study||5
142240|NCT01694706|346671|P1|Received Faldaprevir|Overall Study||5
142241|NCT01694706|346669|P3|STARTED|Overall Study||5
142242|NCT01694706|346670|P2|STARTED|Overall Study||5
142243|NCT01694706|346671|P1|STARTED|Overall Study||5
142244|NCT01694667|346688|P2|NOT COMPLETED|Overall Study||0
142245|NCT01694667|346689|P1|NOT COMPLETED|Overall Study||0
142246|NCT01694667|346688|P2|COMPLETED|Overall Study||28
142247|NCT01694667|346689|P1|COMPLETED|Overall Study||29
142248|NCT01694667|346688|P2|STARTED|Overall Study||28
142249|NCT01694667|346689|P1|STARTED|Overall Study||29
142250|NCT01694641|346707|P2|NOT COMPLETED|Overall Study||10
142251|NCT01694641|346708|P1|NOT COMPLETED|Overall Study||12
142252|NCT01694641|346707|P2|COMPLETED|Overall Study||71
142253|NCT01694641|346708|P1|COMPLETED|Overall Study||68
142254|NCT01694641|346707|P2|STARTED|Overall Study||81
142255|NCT01694641|346708|P1|STARTED|Overall Study||80
142256|NCT01694563|346716|P1|NOT COMPLETED|Overall Study||87
142257|NCT01694563|346716|P1|COMPLETED|Overall Study||278
142258|NCT01694563|346716|P1|STARTED|Overall Study||365
142259|NCT01694485|346728|P5|NOT COMPLETED|Overall Study||25
142260|NCT01694485|346729|P4|NOT COMPLETED|Overall Study||38
142261|NCT01694485|346730|P3|NOT COMPLETED|Overall Study||13
142262|NCT01694485|346731|P2|NOT COMPLETED|Overall Study||7
142263|NCT01694485|346732|P1|NOT COMPLETED|Overall Study||33
142264|NCT01694485|346728|P5|COMPLETED|Overall Study||55
142265|NCT01694485|346729|P4|COMPLETED|Overall Study||62
142266|NCT01694485|346730|P3|COMPLETED|Overall Study||27
142267|NCT01694485|346731|P2|COMPLETED|Overall Study||15
142268|NCT01694485|346732|P1|COMPLETED|Overall Study||84
142269|NCT01694485|346728|P5|Entered Open-label Period|Overall Study||68
142270|NCT01694485|346729|P4|Entered Open-label Period|Overall Study||88
142271|NCT01694485|346730|P3|Entered Open-label Period|Overall Study||36
142272|NCT01694485|346731|P2|Entered Open-label Period|Overall Study||19
142273|NCT01694485|346732|P1|Entered Open-label Period|Overall Study||100
142274|NCT01694485|346728|P5|Completed Week 8 Assessment|Overall Study||76
142275|NCT01694485|346729|P4|Completed Week 8 Assessment|Overall Study||94
142276|NCT01694485|346730|P3|Completed Week 8 Assessment|Overall Study||38
142277|NCT01694485|346731|P2|Completed Week 8 Assessment|Overall Study||18
142278|NCT01694485|346732|P1|Completed Week 8 Assessment|Overall Study||106
142279|NCT01694485|346728|P5|Received Treatment|Overall Study||79
142280|NCT01694485|346729|P4|Received Treatment|Overall Study||98
142281|NCT01694485|346730|P3|Received Treatment|Overall Study||40
142282|NCT01694485|346731|P2|Received Treatment|Overall Study||21
142283|NCT01694485|346732|P1|Received Treatment|Overall Study||116
142284|NCT01694485|346728|P5|STARTED|Overall Study||80
142285|NCT01694485|346729|P4|STARTED|Overall Study||100
142286|NCT01694485|346730|P3|STARTED|Overall Study||40
142287|NCT01694485|346731|P2|STARTED|Overall Study||22
142288|NCT01694485|346732|P1|STARTED|Overall Study||117
142289|NCT01694433|346766|P2|NOT COMPLETED|Overall Study||4
142290|NCT01694433|346767|P1|NOT COMPLETED|Overall Study||11
142291|NCT01694433|346766|P2|COMPLETED|Overall Study||29
142292|NCT01694433|346767|P1|COMPLETED|Overall Study||22
142293|NCT01694433|346766|P2|Baseline Visit|Overall Study||32
142294|NCT01694433|346767|P1|Baseline Visit|Overall Study||33
142295|NCT01694433|346766|P2|STARTED|Overall Study||33
142296|NCT01694433|346767|P1|STARTED|Overall Study||33
142297|NCT01694420|346775|P1|NOT COMPLETED|Overall Study||3
142298|NCT01694420|346775|P1|COMPLETED|Overall Study||30
142299|NCT01694420|346775|P1|STARTED|Overall Study||33
142300|NCT01694199|346786|P2|NOT COMPLETED|Overall Study||0
142301|NCT01694199|346787|P1|NOT COMPLETED|Overall Study||0
142302|NCT01694199|346786|P2|COMPLETED|Overall Study||68
142303|NCT01694199|346787|P1|COMPLETED|Overall Study||71
142304|NCT01694199|346786|P2|STARTED|Overall Study||68
142305|NCT01694199|346787|P1|STARTED|Overall Study||71
142306|NCT01694121|346803|P2|NOT COMPLETED|Overall Study||0
142307|NCT01694121|346804|P1|NOT COMPLETED|Overall Study||1
142308|NCT01694121|346803|P2|COMPLETED|Overall Study||227
142309|NCT01694121|346804|P1|COMPLETED|Overall Study||227
142310|NCT01694121|346803|P2|STARTED|Overall Study||227
142311|NCT01694121|346804|P1|STARTED|Overall Study||228
142312|NCT01694108|346818|P2|NOT COMPLETED|Overall Study||0
142313|NCT01694108|346819|P1|NOT COMPLETED|Overall Study||0
142314|NCT01694108|346818|P2|COMPLETED|Overall Study|100% follow-up|2133
142315|NCT01694108|346819|P1|COMPLETED|Overall Study|100% follow-up|2129
142316|NCT01694108|346818|P2|STARTED|Overall Study||2133
142317|NCT01694108|346819|P1|STARTED|Overall Study||2129
142318|NCT01693900|346875|P2|NOT COMPLETED|Overall Study||0
142319|NCT01693900|346876|P1|NOT COMPLETED|Overall Study||0
142320|NCT01693900|346875|P2|COMPLETED|Overall Study||25
142321|NCT01693900|346876|P1|COMPLETED|Overall Study||25
142322|NCT01693900|346875|P2|STARTED|Overall Study||25
142323|NCT01693900|346876|P1|STARTED|Overall Study||25
142324|NCT01693653|346890|P2|NOT COMPLETED|Overall Study||0
142325|NCT01693653|346891|P1|NOT COMPLETED|Overall Study||0
142326|NCT01693653|346890|P2|COMPLETED|Overall Study||0
142327|NCT01693653|346891|P1|COMPLETED|Overall Study||1
142328|NCT01693653|346890|P2|STARTED|Overall Study||0
142329|NCT01693653|346891|P1|STARTED|Overall Study||1
142330|NCT01693614|346918|P3|NOT COMPLETED|Overall Study||24
142331|NCT01693614|346919|P2|NOT COMPLETED|Overall Study||22
142332|NCT01693614|346920|P1|NOT COMPLETED|Overall Study||26
142333|NCT01693614|346918|P3|COMPLETED|Overall Study||0
142334|NCT01693614|346919|P2|COMPLETED|Overall Study||0
142335|NCT01693614|346920|P1|COMPLETED|Overall Study||0
142336|NCT01693614|346918|P3|STARTED|Overall Study||24
142337|NCT01693614|346919|P2|STARTED|Overall Study||22
142338|NCT01693614|346920|P1|STARTED|Overall Study||26
142339|NCT01693484|346942|P1|NOT COMPLETED|Overall Study||13
142340|NCT01693484|346942|P1|COMPLETED|Overall Study|Study closed by PI|0
142341|NCT01693484|346942|P1|STARTED|Overall Study||13
142342|NCT01693367|346948|P2|NOT COMPLETED|Overall Study||2
142343|NCT01693367|346949|P1|NOT COMPLETED|Overall Study||1
142344|NCT01693367|346948|P2|COMPLETED|Overall Study||1
142345|NCT01693367|346949|P1|COMPLETED|Overall Study||1
142346|NCT01693367|346948|P2|STARTED|Overall Study||3
142347|NCT01693367|346949|P1|STARTED|Overall Study||2
142348|NCT01693250|346967|P2|NOT COMPLETED|Overall Study||2
142349|NCT01693250|346968|P1|NOT COMPLETED|Overall Study||2
142350|NCT01693250|346967|P2|COMPLETED|Overall Study|15 teens completed 6 months post baseline assessment|15
142351|NCT01693250|346968|P1|COMPLETED|Overall Study|21 teens completed 6 months post baseline assessment|21
142352|NCT01693250|346967|P2|STARTED|Overall Study|three month post baseline assessment|17
142353|NCT01693250|346968|P1|STARTED|Overall Study|3 months post baseline assessment|23
142354|NCT01693185|346978|P2|NOT COMPLETED|Overall Study||6
142355|NCT01693185|346979|P1|NOT COMPLETED|Overall Study||0
142356|NCT01693185|346978|P2|COMPLETED|Overall Study||27
142357|NCT01693185|346979|P1|COMPLETED|Overall Study||27
142358|NCT01693185|346978|P2|STARTED|Overall Study||33
142359|NCT01693185|346979|P1|STARTED|Overall Study||27
142360|NCT01693120|346995|P1|NOT COMPLETED|Phased RF Study Procedure and Follow-up||17
142361|NCT01693120|346995|P1|COMPLETED|Phased RF Study Procedure and Follow-up|112 of the 129 subjects with a Phased RF procedure completed the 6-month follow-up visit|112
142362|NCT01693120|346995|P1|STARTED|Phased RF Study Procedure and Follow-up||129
142363|NCT01693120|346995|P1|NOT COMPLETED|Enrollment||70
142364|NCT01693120|346995|P1|COMPLETED|Enrollment|129 of the 199 enrolled subjects underwent a Phased RF study procedure|129
142365|NCT01693120|346995|P1|STARTED|Enrollment|70 subjects exited the study after consent, but prior to undergoing a study ablation procedure.|199
142366|NCT01693068|347004|P3|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||1
142367|NCT01693068|347005|P2|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
142368|NCT01693068|347006|P1|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
142369|NCT01693068|347004|P3|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||40
142370|NCT01693068|347005|P2|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
142371|NCT01693068|347006|P1|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
142372|NCT01693068|347004|P3|Treated|Cross-over (Dacarbazine To Pimasertib)||41
142373|NCT01693068|347005|P2|Treated|Cross-over (Dacarbazine To Pimasertib)||0
142374|NCT01693068|347006|P1|Treated|Cross-over (Dacarbazine To Pimasertib)||0
142375|NCT01693068|347004|P3|STARTED|Cross-over (Dacarbazine To Pimasertib)||41
142376|NCT01693068|347005|P2|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
142377|NCT01693068|347006|P1|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
142378|NCT01693068|347004|P3|NOT COMPLETED|Randomization Period||0
142379|NCT01693068|347005|P2|NOT COMPLETED|Randomization Period||5
142380|NCT01693068|347006|P1|NOT COMPLETED|Randomization Period||2
142381|NCT01693068|347004|P3|COMPLETED|Randomization Period||0
142382|NCT01693068|347005|P2|COMPLETED|Randomization Period||125
142383|NCT01693068|347006|P1|COMPLETED|Randomization Period||62
142384|NCT01693068|347004|P3|Treated|Randomization Period||0
142385|NCT01693068|347005|P2|Treated|Randomization Period||130
142386|NCT01693068|347006|P1|Treated|Randomization Period||61
142387|NCT01693068|347004|P3|STARTED|Randomization Period||0
142388|NCT01693068|347005|P2|STARTED|Randomization Period||130
142389|NCT01693068|347006|P1|STARTED|Randomization Period||64
142390|NCT01693029|347038|P2|NOT COMPLETED|Overall Study||57
142391|NCT01693029|347039|P1|NOT COMPLETED|Overall Study||44
142392|NCT01693029|347038|P2|COMPLETED|Overall Study||161
142393|NCT01693029|347039|P1|COMPLETED|Overall Study||173
142394|NCT01693029|347038|P2|STARTED|Overall Study||218
142395|NCT01693029|347039|P1|STARTED|Overall Study||217
142396|NCT01692951|347055|P4|NOT COMPLETED|Overall Study||0
142397|NCT01692951|347056|P3|NOT COMPLETED|Overall Study||0
142398|NCT01692951|347057|P2|NOT COMPLETED|Overall Study||0
142399|NCT01692951|347058|P1|NOT COMPLETED|Overall Study||0
142400|NCT01692951|347055|P4|COMPLETED|Overall Study||54
142401|NCT01692951|347056|P3|COMPLETED|Overall Study||18
142402|NCT01692951|347057|P2|COMPLETED|Overall Study||111
142403|NCT01692951|347058|P1|COMPLETED|Overall Study||37
142404|NCT01692951|347055|P4|STARTED|Overall Study||54
142405|NCT01692951|347056|P3|STARTED|Overall Study||18
142406|NCT01692951|347057|P2|STARTED|Overall Study||111
142407|NCT01692951|347058|P1|STARTED|Overall Study||37
142408|NCT01692938|347070|P2|NOT COMPLETED|Overall Study||4
142409|NCT01692938|347071|P1|NOT COMPLETED|Overall Study||4
142410|NCT01692938|347070|P2|COMPLETED|Overall Study||12
142411|NCT01692938|347071|P1|COMPLETED|Overall Study||12
142412|NCT01692938|347070|P2|STARTED|Overall Study||16
142413|NCT01692938|347071|P1|STARTED|Overall Study||16
142414|NCT01692782|347082|P3|NOT COMPLETED|Overall Study||10
142415|NCT01692782|347083|P2|NOT COMPLETED|Overall Study||56
142416|NCT01692782|347084|P1|NOT COMPLETED|Overall Study||20
142417|NCT01692782|347082|P3|COMPLETED|Overall Study||100
142418|NCT01692782|347083|P2|COMPLETED|Overall Study||59
142419|NCT01692782|347084|P1|COMPLETED|Overall Study||96
142420|NCT01692782|347082|P3|STARTED|Overall Study||110
142421|NCT01692782|347083|P2|STARTED|Overall Study||115
142422|NCT01692782|347084|P1|STARTED|Overall Study||116
142423|NCT01692756|347111|P4|NOT COMPLETED|Overall Study||0
142424|NCT01692756|347112|P3|NOT COMPLETED|Overall Study||2
142425|NCT01692756|347113|P2|NOT COMPLETED|Overall Study||1
142426|NCT01692756|347114|P1|NOT COMPLETED|Overall Study||1
142427|NCT01692756|347111|P4|COMPLETED|Overall Study||12
142428|NCT01692756|347112|P3|COMPLETED|Overall Study||11
142429|NCT01692756|347113|P2|COMPLETED|Overall Study||11
142430|NCT01692756|347114|P1|COMPLETED|Overall Study||11
142431|NCT01692756|347111|P4|STARTED|Overall Study||12
142432|NCT01692756|347112|P3|STARTED|Overall Study||13
142433|NCT01692756|347113|P2|STARTED|Overall Study||12
142434|NCT01692756|347114|P1|STARTED|Overall Study||12
142435|NCT01692743|347175|P3|NOT COMPLETED|Overall Study||27
142436|NCT01692743|347176|P2|NOT COMPLETED|Overall Study||35
142437|NCT01692743|347177|P1|NOT COMPLETED|Overall Study||27
142438|NCT01692743|347175|P3|COMPLETED|Overall Study||88
142439|NCT01692743|347176|P2|COMPLETED|Overall Study||81
142440|NCT01692743|347177|P1|COMPLETED|Overall Study||90
142441|NCT01692743|347175|P3|STARTED|Overall Study||115
142442|NCT01692743|347176|P2|STARTED|Overall Study||116
142443|NCT01692743|347177|P1|STARTED|Overall Study||117
142444|NCT01692730|347193|P2|NOT COMPLETED|Overall Study||227
142445|NCT01692730|347194|P1|NOT COMPLETED|Overall Study||225
142446|NCT01692730|347193|P2|COMPLETED|Overall Study||502
142447|NCT01692730|347194|P1|COMPLETED|Overall Study||498
142448|NCT01692730|347193|P2|STARTED|Overall Study||729
142449|NCT01692730|347194|P1|STARTED|Overall Study||723
142450|NCT01692691|347202|P1|NOT COMPLETED|Overall Study||0
142451|NCT01692691|347202|P1|COMPLETED|Overall Study||1
142452|NCT01692691|347202|P1|STARTED|Overall Study||1
142453|NCT01692626|347208|P2|NOT COMPLETED|Overall Study||6
142454|NCT01692626|347209|P1|NOT COMPLETED|Overall Study||4
142455|NCT01692626|347208|P2|COMPLETED|Overall Study||1
142456|NCT01692626|347209|P1|COMPLETED|Overall Study||2
142457|NCT01692626|347208|P2|STARTED|Overall Study||7
142458|NCT01692626|347209|P1|STARTED|Overall Study||6
142459|NCT01692340|347217|P3|NOT COMPLETED|Overall Study||0
142460|NCT01692340|347218|P2|NOT COMPLETED|Overall Study||0
142461|NCT01692340|347219|P1|NOT COMPLETED|Overall Study||0
142462|NCT01692340|347217|P3|COMPLETED|Overall Study||0
142463|NCT01692340|347218|P2|COMPLETED|Overall Study||4
142464|NCT01692340|347219|P1|COMPLETED|Overall Study||8
142465|NCT01692340|347217|P3|STARTED|Overall Study||0
142466|NCT01692340|347218|P2|STARTED|Overall Study||4
142467|NCT01692340|347219|P1|STARTED|Overall Study||8
142468|NCT01692301|347234|P2|NOT COMPLETED|Overall Study||42
142469|NCT01692301|347235|P1|NOT COMPLETED|Overall Study||45
142470|NCT01692301|347234|P2|COMPLETED|Overall Study||183
142471|NCT01692301|347235|P1|COMPLETED|Overall Study||184
142472|NCT01692301|347234|P2|STARTED|Overall Study||225
142473|NCT01692301|347235|P1|STARTED|Overall Study|"Started indicates patients in randomized, full analysis and safety set"|229
142474|NCT01692275|347267|P2|NOT COMPLETED|Overall Study||59
142475|NCT01692275|347268|P1|NOT COMPLETED|Overall Study||66
142476|NCT01692275|347267|P2|COMPLETED|Overall Study||316
142477|NCT01692275|347268|P1|COMPLETED|Overall Study||309
142478|NCT01692275|347267|P2|STARTED|Overall Study||375
142479|NCT01692275|347268|P1|STARTED|Overall Study||375
142480|NCT01692197|347328|P1|NOT COMPLETED|Overall Study||3
142481|NCT01692197|347328|P1|COMPLETED|Overall Study||40
142482|NCT01692197|347328|P1|STARTED|Overall Study||43
142483|NCT01691950|347337|P2|NOT COMPLETED|Overall Study||0
142484|NCT01691950|347338|P1|NOT COMPLETED|Overall Study||10
142485|NCT01691950|347337|P2|COMPLETED|Overall Study||10
142486|NCT01691950|347338|P1|COMPLETED|Overall Study||10
142487|NCT01691950|347337|P2|STARTED|Overall Study||10
142488|NCT01691950|347338|P1|STARTED|Overall Study||20
142489|NCT01691898|347350|P6|NOT COMPLETED|Overall Study||40
142490|NCT01691898|347351|P5|NOT COMPLETED|Overall Study||39
142491|NCT01691898|347352|P4|NOT COMPLETED|Overall Study||9
142492|NCT01691898|347353|P3|NOT COMPLETED|Overall Study||18
142493|NCT01691898|347354|P2|NOT COMPLETED|Overall Study||58
142494|NCT01691898|347355|P1|NOT COMPLETED|Overall Study||60
142495|NCT01691898|347350|P6|COMPLETED|Overall Study||0
142496|NCT01691898|347351|P5|COMPLETED|Overall Study||0
142497|NCT01691898|347352|P4|COMPLETED|Overall Study||0
142498|NCT01691898|347353|P3|COMPLETED|Overall Study||2
142499|NCT01691898|347354|P2|COMPLETED|Overall Study||1
142500|NCT01691898|347355|P1|COMPLETED|Overall Study||3
142501|NCT01691898|347350|P6|STARTED|Overall Study||40
142502|NCT01691898|347351|P5|STARTED|Overall Study||39
142503|NCT01691898|347352|P4|STARTED|Overall Study||9
142504|NCT01691898|347353|P3|STARTED|Overall Study||20
142505|NCT01691898|347354|P2|STARTED|Overall Study||59
142506|NCT01691898|347355|P1|STARTED|Overall Study||63
142507|NCT01691885|347501|P2|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
142508|NCT01691885|347502|P1|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
142509|NCT01691885|347501|P2|COMPLETED|Treatment Period 2 (7-14 Days)||21
142510|NCT01691885|347502|P1|COMPLETED|Treatment Period 2 (7-14 Days)||21
142511|NCT01691885|347501|P2|STARTED|Treatment Period 2 (7-14 Days)||21
142512|NCT01691885|347502|P1|STARTED|Treatment Period 2 (7-14 Days)||21
142513|NCT01691885|347501|P2|NOT COMPLETED|Washout Period (7-9 Days)||1
142514|NCT01691885|347502|P1|NOT COMPLETED|Washout Period (7-9 Days)||0
142515|NCT01691885|347501|P2|COMPLETED|Washout Period (7-9 Days)||21
142516|NCT01691885|347502|P1|COMPLETED|Washout Period (7-9 Days)||21
142517|NCT01691885|347501|P2|STARTED|Washout Period (7-9 Days)||22
142518|NCT01691885|347502|P1|STARTED|Washout Period (7-9 Days)||21
142519|NCT01691885|347501|P2|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
142520|NCT01691885|347502|P1|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
142521|NCT01691885|347501|P2|COMPLETED|Treatment Period 1(7-14 Days)||22
142522|NCT01691885|347502|P1|COMPLETED|Treatment Period 1(7-14 Days)||21
142523|NCT01691885|347501|P2|STARTED|Treatment Period 1(7-14 Days)||23
142524|NCT01691885|347502|P1|STARTED|Treatment Period 1(7-14 Days)||22
142525|NCT01691859|347508|P1|NOT COMPLETED|Overall Study||347
142526|NCT01691859|347508|P1|COMPLETED|Overall Study||0
142527|NCT01691859|347508|P1|STARTED|Overall Study||347
142528|NCT01691833|347530|P3|NOT COMPLETED|Overall Study||0
142529|NCT01691833|347531|P2|NOT COMPLETED|Overall Study||1
142530|NCT01691833|347532|P1|NOT COMPLETED|Overall Study||1
142531|NCT01691833|347530|P3|COMPLETED|Overall Study||13
142532|NCT01691833|347531|P2|COMPLETED|Overall Study||49
142533|NCT01691833|347532|P1|COMPLETED|Overall Study||49
142534|NCT01691833|347530|P3|STARTED|Overall Study||13
142535|NCT01691833|347531|P2|STARTED|Overall Study||50
142536|NCT01691833|347532|P1|STARTED|Overall Study||50
142537|NCT01691820|347555|P3|NOT COMPLETED|Overall Study||1
142538|NCT01691820|347556|P2|NOT COMPLETED|Overall Study||34
142539|NCT01691820|347557|P1|NOT COMPLETED|Overall Study||29
142540|NCT01691820|347555|P3|COMPLETED|Overall Study||2
142541|NCT01691820|347556|P2|COMPLETED|Overall Study||110
142542|NCT01691820|347557|P1|COMPLETED|Overall Study||187
142543|NCT01691820|347555|P3|STARTED|Overall Study||3
142544|NCT01691820|347556|P2|STARTED|Overall Study||144
142545|NCT01691820|347557|P1|STARTED|Overall Study||216
142546|NCT01691794|347595|P3|NOT COMPLETED|Overall Study||10
142547|NCT01691794|347596|P2|NOT COMPLETED|Overall Study||18
142548|NCT01691794|347597|P1|NOT COMPLETED|Overall Study||1
142549|NCT01691794|347595|P3|COMPLETED|Overall Study|Completed baseline to End of Study|13
142550|NCT01691794|347596|P2|COMPLETED|Overall Study|Completed baseline to End of Study|15
142551|NCT01691794|347597|P1|COMPLETED|Overall Study|Completed baseline to End of Study|2
142552|NCT01691794|347595|P3|STARTED|Overall Study||23
142553|NCT01691794|347596|P2|STARTED|Overall Study||33
142554|NCT01691794|347597|P1|STARTED|Overall Study||3
142555|NCT01691781|347613|P2|NOT COMPLETED|Overall Study||7
142556|NCT01691781|347614|P1|NOT COMPLETED|Overall Study||7
142557|NCT01691781|347613|P2|COMPLETED|Overall Study||15
142558|NCT01691781|347614|P1|COMPLETED|Overall Study||12
142559|NCT01691781|347613|P2|STARTED|Overall Study||22
142560|NCT01691781|347614|P1|STARTED|Overall Study||19
142561|NCT01691768|347626|P2|NOT COMPLETED|Overall Study||16
142562|NCT01691768|347627|P1|NOT COMPLETED|Overall Study||15
142563|NCT01691768|347626|P2|COMPLETED|Overall Study||167
142564|NCT01691768|347627|P1|COMPLETED|Overall Study||174
142565|NCT01691768|347626|P2|STARTED|Overall Study||183
142566|NCT01691768|347627|P1|STARTED|Overall Study||189
142567|NCT01691690|347651|P2|NOT COMPLETED|Overall Study||4
142568|NCT01691690|347652|P1|NOT COMPLETED|Overall Study||7
142569|NCT01691690|347651|P2|COMPLETED|Overall Study||121
142570|NCT01691690|347652|P1|COMPLETED|Overall Study||118
142571|NCT01691690|347651|P2|STARTED|Overall Study||125
142572|NCT01691690|347652|P1|STARTED|Overall Study||125
142573|NCT01691612|347662|P1|NOT COMPLETED|Overall Study||7
142574|NCT01691612|347662|P1|COMPLETED|Overall Study||7
142575|NCT01691612|347662|P1|Second Visit (Bronchoscopy)|Overall Study||7
142576|NCT01691612|347662|P1|First Visit (Allergen Challenge)|Overall Study||8
142577|NCT01691612|347662|P1|STARTED|Overall Study||14
142578|NCT01691560|347673|P4|NOT COMPLETED|Overall Study||0
142579|NCT01691560|347674|P3|NOT COMPLETED|Overall Study||0
142580|NCT01691560|347675|P2|NOT COMPLETED|Overall Study||0
142581|NCT01691560|347676|P1|NOT COMPLETED|Overall Study||0
142582|NCT01691560|347673|P4|COMPLETED|Overall Study||33
142583|NCT01691560|347674|P3|COMPLETED|Overall Study||34
142584|NCT01691560|347675|P2|COMPLETED|Overall Study||33
142585|NCT01691560|347676|P1|COMPLETED|Overall Study||34
142586|NCT01691560|347673|P4|STARTED|Overall Study||33
142587|NCT01691560|347674|P3|STARTED|Overall Study||34
142588|NCT01691560|347675|P2|STARTED|Overall Study||33
142589|NCT01691560|347676|P1|STARTED|Overall Study||34
142590|NCT01691534|347713|P7|NOT COMPLETED|Overall Study||1
142591|NCT01691534|347714|P6|NOT COMPLETED|Overall Study||1
142592|NCT01691534|347715|P5|NOT COMPLETED|Overall Study||0
142593|NCT01691534|347716|P4|NOT COMPLETED|Overall Study||1
142594|NCT01691534|347717|P3|NOT COMPLETED|Overall Study||1
142595|NCT01691534|347718|P2|NOT COMPLETED|Overall Study||1
142596|NCT01691534|347719|P1|NOT COMPLETED|Overall Study||0
142597|NCT01691534|347713|P7|COMPLETED|Overall Study||14
142598|NCT01691534|347714|P6|COMPLETED|Overall Study||14
142599|NCT01691534|347715|P5|COMPLETED|Overall Study||15
142600|NCT01691534|347716|P4|COMPLETED|Overall Study||14
142601|NCT01691534|347717|P3|COMPLETED|Overall Study||14
142602|NCT01691534|347718|P2|COMPLETED|Overall Study||14
142603|NCT01691534|347719|P1|COMPLETED|Overall Study||15
142604|NCT01691534|347713|P7|STARTED|Overall Study||15
142605|NCT01691534|347714|P6|STARTED|Overall Study||15
142606|NCT01691534|347715|P5|STARTED|Overall Study||15
142607|NCT01691534|347716|P4|STARTED|Overall Study||15
142608|NCT01691534|347717|P3|STARTED|Overall Study||15
142609|NCT01691534|347718|P2|STARTED|Overall Study||15
142610|NCT01691534|347719|P1|STARTED|Overall Study||15
142611|NCT01691521|347773|P3|NOT COMPLETED|Overall Study||9
142612|NCT01691521|347774|P2|NOT COMPLETED|Overall Study||16
142613|NCT01691521|347775|P1|NOT COMPLETED|Overall Study||12
142614|NCT01691521|347773|P3|COMPLETED|Overall Study||185
142615|NCT01691521|347774|P2|COMPLETED|Overall Study||175
142616|NCT01691521|347775|P1|COMPLETED|Overall Study||179
142617|NCT01691521|347773|P3|STARTED|Overall Study||194
142618|NCT01691521|347774|P2|STARTED|Overall Study||191
142619|NCT01691521|347775|P1|STARTED|Overall Study||191
142620|NCT01691508|347797|P2|NOT COMPLETED|Overall Study||3
142621|NCT01691508|347798|P1|NOT COMPLETED|Overall Study||4
142622|NCT01691508|347797|P2|COMPLETED|Overall Study||66
142623|NCT01691508|347798|P1|COMPLETED|Overall Study||62
142624|NCT01691508|347797|P2|STARTED|Overall Study||69
142625|NCT01691508|347798|P1|STARTED|Overall Study||66
142626|NCT01691482|347812|P2|NOT COMPLETED|Treatment Period 2||2
142627|NCT01691482|347813|P1|NOT COMPLETED|Treatment Period 2||1
142628|NCT01691482|347812|P2|COMPLETED|Treatment Period 2||26
142629|NCT01691482|347813|P1|COMPLETED|Treatment Period 2||27
142630|NCT01691482|347812|P2|STARTED|Treatment Period 2||28
142631|NCT01691482|347813|P1|STARTED|Treatment Period 2||28
142632|NCT01691482|347812|P2|NOT COMPLETED|Treatment Period 1||0
142633|NCT01691482|347813|P1|NOT COMPLETED|Treatment Period 1||0
142634|NCT01691482|347812|P2|COMPLETED|Treatment Period 1||28
142635|NCT01691482|347813|P1|COMPLETED|Treatment Period 1||28
142636|NCT01691482|347812|P2|STARTED|Treatment Period 1||28
142637|NCT01691482|347813|P1|STARTED|Treatment Period 1||28
142638|NCT01691430|347831|P2|NOT COMPLETED|Overall Study||20
142639|NCT01691430|347832|P1|NOT COMPLETED|Overall Study||22
142640|NCT01691430|347831|P2|COMPLETED|Overall Study||73
142641|NCT01691430|347832|P1|COMPLETED|Overall Study||70
142642|NCT01691430|347831|P2|Received Medication|Overall Study||93
142643|NCT01691430|347832|P1|Received Medication|Overall Study||92
142644|NCT01691430|347831|P2|STARTED|Overall Study||93
142645|NCT01691430|347832|P1|STARTED|Overall Study||92
142646|NCT01691378|347858|P2|NOT COMPLETED|Overall Study||2
142647|NCT01691378|347859|P1|NOT COMPLETED|Overall Study||7
142648|NCT01691378|347858|P2|COMPLETED|Overall Study||20
142649|NCT01691378|347859|P1|COMPLETED|Overall Study||15
142650|NCT01691378|347858|P2|STARTED|Overall Study||22
142651|NCT01691378|347859|P1|STARTED|Overall Study||22
142652|NCT01691339|347873|P4|NOT COMPLETED|Overall Study||0
142653|NCT01691339|347874|P3|NOT COMPLETED|Overall Study||0
142654|NCT01691339|347875|P2|NOT COMPLETED|Overall Study||0
142655|NCT01691339|347876|P1|NOT COMPLETED|Overall Study||0
142656|NCT01691339|347873|P4|COMPLETED|Overall Study||49
142657|NCT01691339|347874|P3|COMPLETED|Overall Study||51
142658|NCT01691339|347875|P2|COMPLETED|Overall Study||50
142659|NCT01691339|347876|P1|COMPLETED|Overall Study||50
142660|NCT01691339|347873|P4|STARTED|Overall Study||49
142661|NCT01691339|347874|P3|STARTED|Overall Study||51
142662|NCT01691339|347875|P2|STARTED|Overall Study||50
142663|NCT01691339|347876|P1|STARTED|Overall Study||50
142664|NCT01691326|347904|P2|NOT COMPLETED|Overall Study||0
142665|NCT01691326|347905|P1|NOT COMPLETED|Overall Study||0
142666|NCT01691326|347904|P2|COMPLETED|Overall Study||30
142667|NCT01691326|347905|P1|COMPLETED|Overall Study||30
142668|NCT01691326|347904|P2|STARTED|Overall Study||30
142669|NCT01691326|347905|P1|STARTED|Overall Study||30
142670|NCT01691313|347923|P4|NOT COMPLETED|Overall Study||0
142671|NCT01691313|347924|P3|NOT COMPLETED|Overall Study||0
142672|NCT01691313|347925|P2|NOT COMPLETED|Overall Study||0
142673|NCT01691313|347926|P1|NOT COMPLETED|Overall Study||0
142674|NCT01691313|347923|P4|COMPLETED|Overall Study||25
142675|NCT01691313|347924|P3|COMPLETED|Overall Study||25
142676|NCT01691313|347925|P2|COMPLETED|Overall Study||32
142677|NCT01691313|347926|P1|COMPLETED|Overall Study||22
142678|NCT01691313|347923|P4|STARTED|Overall Study||25
142679|NCT01691313|347924|P3|STARTED|Overall Study||25
142680|NCT01691313|347925|P2|STARTED|Overall Study||32
142681|NCT01691313|347926|P1|STARTED|Overall Study||22
142682|NCT01691248|347942|P2|NOT COMPLETED|Overall Study||114
142683|NCT01691248|347943|P1|NOT COMPLETED|Overall Study||111
142684|NCT01691248|347942|P2|COMPLETED|Overall Study||192
142685|NCT01691248|347943|P1|COMPLETED|Overall Study||194
142686|NCT01691248|347942|P2|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
142687|NCT01691248|347943|P1|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
142688|NCT01691248|347942|P2|Treated|Overall Study|Received at least 1 dose of study drug|299
142689|NCT01691248|347943|P1|Treated|Overall Study|Received at least 1 dose of study drug|301
142690|NCT01691248|347942|P2|STARTED|Overall Study|Randomized|306
142691|NCT01691248|347943|P1|STARTED|Overall Study|Randomized|305
142692|NCT01691105|347955|P2|NOT COMPLETED|12 Month Biochemical Verification||502
142693|NCT01691105|347956|P1|NOT COMPLETED|12 Month Biochemical Verification||424
142694|NCT01691105|347955|P2|COMPLETED|12 Month Biochemical Verification||65
142695|NCT01691105|347956|P1|COMPLETED|12 Month Biochemical Verification||53
142696|NCT01691105|347955|P2|STARTED|12 Month Biochemical Verification||567
142697|NCT01691105|347956|P1|STARTED|12 Month Biochemical Verification||477
142698|NCT01691105|347955|P2|NOT COMPLETED|12 Month Follow-up||101
142699|NCT01691105|347956|P1|NOT COMPLETED|12 Month Follow-up||72
142700|NCT01691105|347955|P2|COMPLETED|12 Month Follow-up||466
142701|NCT01691105|347956|P1|COMPLETED|12 Month Follow-up||405
142702|NCT01691105|347955|P2|STARTED|12 Month Follow-up||567
142703|NCT01691105|347956|P1|STARTED|12 Month Follow-up||477
142704|NCT01691105|347955|P2|NOT COMPLETED|6 Month Follow-up||71
142705|NCT01691105|347956|P1|NOT COMPLETED|6 Month Follow-up||52
142706|NCT01691105|347955|P2|COMPLETED|6 Month Follow-up||496
142707|NCT01691105|347956|P1|COMPLETED|6 Month Follow-up||425
142708|NCT01691105|347955|P2|STARTED|6 Month Follow-up||567
142709|NCT01691105|347956|P1|STARTED|6 Month Follow-up||477
142710|NCT01691105|347955|P2|NOT COMPLETED|1 Month Follow-up||41
142711|NCT01691105|347956|P1|NOT COMPLETED|1 Month Follow-up||43
142712|NCT01691105|347955|P2|COMPLETED|1 Month Follow-up||526
142713|NCT01691105|347956|P1|COMPLETED|1 Month Follow-up||434
142714|NCT01691105|347955|P2|STARTED|1 Month Follow-up||567
142715|NCT01691105|347956|P1|STARTED|1 Month Follow-up||477
142716|NCT01691105|347955|P2|NOT COMPLETED|Baseline||0
142717|NCT01691105|347956|P1|NOT COMPLETED|Baseline||0
142718|NCT01691105|347955|P2|COMPLETED|Baseline||567
142719|NCT01691105|347956|P1|COMPLETED|Baseline||477
142720|NCT01691105|347955|P2|STARTED|Baseline||567
142721|NCT01691105|347956|P1|STARTED|Baseline||477
142722|NCT01691092|347976|P1|NOT COMPLETED|Overall Study||41
142723|NCT01691092|347976|P1|COMPLETED|Overall Study||38
142724|NCT01691092|347976|P1|STARTED|Overall Study||79
142725|NCT01691027|347980|P1|NOT COMPLETED|Video Games Training||0
142726|NCT01691027|347980|P1|COMPLETED|Video Games Training|Four subjects were able to complete video games training module|4
142727|NCT01691027|347980|P1|STARTED|Video Games Training|Four subjects started video game training module|4
142728|NCT01691027|347980|P1|NOT COMPLETED|Line and Circle Tracing Training||0
142729|NCT01691027|347980|P1|COMPLETED|Line and Circle Tracing Training|Four subjects were able to complete line and circle tracing training module.|4
142730|NCT01691027|347980|P1|STARTED|Line and Circle Tracing Training|Four subjects started line and circle tracing training module|4
142731|NCT01691027|347980|P1|NOT COMPLETED|Scotoma Awareness||0
142732|NCT01691027|347980|P1|COMPLETED|Scotoma Awareness|Four subjects were able to complete scotoma awareness training module|4
142733|NCT01691027|347980|P1|STARTED|Scotoma Awareness|Four subjects started scotoma awareness training module|4
142734|NCT01691014|347989|P4|NOT COMPLETED|Overall Study||5
142735|NCT01691014|347990|P3|NOT COMPLETED|Overall Study||11
142736|NCT01691014|347991|P2|NOT COMPLETED|Overall Study||15
142737|NCT01691014|347992|P1|NOT COMPLETED|Overall Study||3
142738|NCT01691014|347989|P4|COMPLETED|Overall Study||4
142739|NCT01691014|347990|P3|COMPLETED|Overall Study||25
142740|NCT01691014|347991|P2|COMPLETED|Overall Study||11
142741|NCT01691014|347992|P1|COMPLETED|Overall Study||5
142742|NCT01691014|347989|P4|STARTED|Overall Study||9
142743|NCT01691014|347990|P3|STARTED|Overall Study||36
142744|NCT01691014|347991|P2|STARTED|Overall Study||26
142745|NCT01691014|347992|P1|STARTED|Overall Study||8
142746|NCT01690988|348037|P3|NOT COMPLETED|Overall Study||7
142747|NCT01690988|348038|P2|NOT COMPLETED|Overall Study||5
142748|NCT01690988|348039|P1|NOT COMPLETED|Overall Study||6
142749|NCT01690988|348037|P3|COMPLETED|Overall Study||216
142750|NCT01690988|348038|P2|COMPLETED|Overall Study||217
142751|NCT01690988|348039|P1|COMPLETED|Overall Study||221
142752|NCT01690988|348037|P3|STARTED|Overall Study||223
142753|NCT01690988|348038|P2|STARTED|Overall Study||222
142754|NCT01690988|348039|P1|STARTED|Overall Study||227
142755|NCT01690923|348064|P2|NOT COMPLETED|Overall Study||1
142756|NCT01690923|348065|P1|NOT COMPLETED|Overall Study||0
142757|NCT01690923|348064|P2|COMPLETED|Overall Study||10
142758|NCT01690923|348065|P1|COMPLETED|Overall Study||10
142759|NCT01690923|348064|P2|STARTED|Overall Study|1 participant was withdrawn and excluded due to poor fit with the pillows mask|11
142760|NCT01690923|348065|P1|STARTED|Overall Study||10
142761|NCT01690663|348074|P4|NOT COMPLETED|Overall Study||4
142762|NCT01690663|348075|P3|NOT COMPLETED|Overall Study||3
142763|NCT01690663|348076|P2|NOT COMPLETED|Overall Study||3
142764|NCT01690663|348077|P1|NOT COMPLETED|Overall Study||3
142765|NCT01690663|348074|P4|COMPLETED|Overall Study||20
142766|NCT01690663|348075|P3|COMPLETED|Overall Study||19
142767|NCT01690663|348076|P2|COMPLETED|Overall Study||17
142768|NCT01690663|348077|P1|COMPLETED|Overall Study||20
142769|NCT01690663|348074|P4|STARTED|Overall Study||24
142770|NCT01690663|348075|P3|STARTED|Overall Study||22
142771|NCT01690663|348076|P2|STARTED|Overall Study||20
142772|NCT01690663|348077|P1|STARTED|Overall Study||23
142773|NCT01690546|348091|P1|NOT COMPLETED|Overall Study||9
142774|NCT01690546|348091|P1|COMPLETED|Overall Study||26
142775|NCT01690546|348091|P1|Extended Release Injectable NTX|Overall Study||27
142776|NCT01690546|348091|P1|STARTED|Overall Study||35
142777|NCT01690299|348107|P6|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||30
142778|NCT01690299|348108|P5|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||33
142779|NCT01690299|348109|P4|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||26
142780|NCT01690299|348110|P3|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
142781|NCT01690299|348111|P2|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
142782|NCT01690299|348112|P1|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
142783|NCT01690299|348107|P6|COMPLETED|Apremilast Extension Phase (Weeks16-104)||50
142784|NCT01690299|348108|P5|COMPLETED|Apremilast Extension Phase (Weeks16-104)||41
142785|NCT01690299|348109|P4|COMPLETED|Apremilast Extension Phase (Weeks16-104)||47
142786|NCT01690299|348110|P3|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
142787|NCT01690299|348111|P2|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
142788|NCT01690299|348112|P1|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
142789|NCT01690299|348107|P6|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|79
142790|NCT01690299|348108|P5|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|74
142791|NCT01690299|348109|P4|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|73
142792|NCT01690299|348110|P3|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
142793|NCT01690299|348111|P2|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
142794|NCT01690299|348112|P1|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
142795|NCT01690299|348107|P6|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|80
142796|NCT01690299|348108|P5|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|74
142797|NCT01690299|348109|P4|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|73
142798|NCT01690299|348110|P3|STARTED|Apremilast Extension Phase (Weeks16-104)||0
142799|NCT01690299|348111|P2|STARTED|Apremilast Extension Phase (Weeks16-104)||0
142800|NCT01690299|348112|P1|STARTED|Apremilast Extension Phase (Weeks16-104)||0
142801|NCT01690299|348107|P6|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
142802|NCT01690299|348108|P5|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
142803|NCT01690299|348109|P4|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
142804|NCT01690299|348110|P3|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||2
142805|NCT01690299|348111|P2|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||6
142806|NCT01690299|348112|P1|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||9
142807|NCT01690299|348107|P6|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
142808|NCT01690299|348108|P5|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
142809|NCT01690299|348109|P4|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
142810|NCT01690299|348110|P3|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||81
142811|NCT01690299|348111|P2|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||77
142812|NCT01690299|348112|P1|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||75
142813|NCT01690299|348107|P6|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
142814|NCT01690299|348108|P5|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
142815|NCT01690299|348109|P4|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
142816|NCT01690299|348110|P3|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
142817|NCT01690299|348111|P2|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
142818|NCT01690299|348112|P1|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|84
142819|NCT01690299|348107|P6|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
142820|NCT01690299|348108|P5|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
142821|NCT01690299|348109|P4|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
142822|NCT01690299|348110|P3|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
142823|NCT01690299|348111|P2|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
142824|NCT01690299|348112|P1|STARTED|Placebo-controlled Phase (Weeks 0-16)||84
142825|NCT01690273|348157|P3|NOT COMPLETED|Overall Study||0
142826|NCT01690273|348158|P2|NOT COMPLETED|Overall Study||0
142827|NCT01690273|348159|P1|NOT COMPLETED|Overall Study||0
142828|NCT01690273|348157|P3|COMPLETED|Overall Study||20
142829|NCT01690273|348158|P2|COMPLETED|Overall Study||17
142830|NCT01690273|348159|P1|COMPLETED|Overall Study||18
142831|NCT01690273|348157|P3|STARTED|Overall Study||20
142832|NCT01690273|348158|P2|STARTED|Overall Study||17
142833|NCT01690273|348159|P1|STARTED|Overall Study||18
142834|NCT01690143|348209|P1|NOT COMPLETED|Overall Study||1
142835|NCT01690143|348209|P1|COMPLETED|Overall Study||44
142836|NCT01690143|348209|P1|STARTED|Overall Study||45
142837|NCT01690130|348219|P2|NOT COMPLETED|Overall Study||0
142838|NCT01690130|348220|P1|NOT COMPLETED|Overall Study||1
142839|NCT01690130|348219|P2|COMPLETED|Overall Study||9
142840|NCT01690130|348220|P1|COMPLETED|Overall Study||9
142841|NCT01690130|348219|P2|STARTED|Overall Study||9
142842|NCT01690130|348220|P1|STARTED|Overall Study||10
142843|NCT01690117|348230|P2|NOT COMPLETED|Overall Study||14
142844|NCT01690117|348231|P1|NOT COMPLETED|Overall Study||16
142845|NCT01690117|348230|P2|COMPLETED|Overall Study||31
142846|NCT01690117|348231|P1|COMPLETED|Overall Study||31
142847|NCT01690117|348230|P2|Post-Measurement|Overall Study||40
142848|NCT01690117|348231|P1|Post-Measurement|Overall Study||41
142849|NCT01690117|348230|P2|STARTED|Overall Study||45
142850|NCT01690117|348231|P1|STARTED|Overall Study||47
142851|NCT01690052|348267|P2|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
142852|NCT01690052|348268|P1|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
142853|NCT01690052|348267|P2|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
142854|NCT01690052|348268|P1|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
142855|NCT01690052|348267|P2|STARTED|SECOND INTERVENTION: 4 WEEKS||6
142856|NCT01690052|348268|P1|STARTED|SECOND INTERVENTION: 4 WEEKS||6
142857|NCT01690052|348267|P2|NOT COMPLETED|Washout Period of 1 Week||0
142858|NCT01690052|348268|P1|NOT COMPLETED|Washout Period of 1 Week||0
142859|NCT01690052|348267|P2|COMPLETED|Washout Period of 1 Week||6
142860|NCT01690052|348268|P1|COMPLETED|Washout Period of 1 Week||6
142861|NCT01690052|348267|P2|STARTED|Washout Period of 1 Week||6
142862|NCT01690052|348268|P1|STARTED|Washout Period of 1 Week||6
142863|NCT01690052|348267|P2|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||2
142864|NCT01690052|348268|P1|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||1
142865|NCT01690052|348267|P2|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
142866|NCT01690052|348268|P1|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
142867|NCT01690052|348267|P2|STARTED|FIRST INTERVENTION: 4 WEEKS||8
142868|NCT01690052|348268|P1|STARTED|FIRST INTERVENTION: 4 WEEKS||7
142869|NCT01690000|348276|P2|NOT COMPLETED|Overall Study||6
142870|NCT01690000|348277|P1|NOT COMPLETED|Overall Study||3
142871|NCT01690000|348276|P2|COMPLETED|Overall Study||35
142872|NCT01690000|348277|P1|COMPLETED|Overall Study||37
142873|NCT01690000|348276|P2|STARTED|Overall Study||41
142874|NCT01690000|348277|P1|STARTED|Overall Study||40
142875|NCT01689974|348285|P2|NOT COMPLETED|Overall Study||5
142876|NCT01689974|348286|P1|NOT COMPLETED|Overall Study||5
142877|NCT01689974|348285|P2|COMPLETED|Overall Study||0
142878|NCT01689974|348286|P1|COMPLETED|Overall Study||0
142879|NCT01689974|348285|P2|STARTED|Overall Study||5
142880|NCT01689974|348286|P1|STARTED|Overall Study||5
142881|NCT01689909|348294|P2|NOT COMPLETED|Overall Study||0
142882|NCT01689909|348295|P1|NOT COMPLETED|Overall Study||0
142883|NCT01689909|348294|P2|COMPLETED|Overall Study||52
142884|NCT01689909|348295|P1|COMPLETED|Overall Study||51
142885|NCT01689909|348294|P2|STARTED|Overall Study||52
142886|NCT01689909|348295|P1|STARTED|Overall Study||51
142887|NCT01689857|348317|P2|NOT COMPLETED|Overall Study||2
142888|NCT01689857|348318|P1|NOT COMPLETED|Overall Study||5
142889|NCT01689857|348317|P2|COMPLETED|Overall Study||18
142890|NCT01689857|348318|P1|COMPLETED|Overall Study||15
142891|NCT01689857|348317|P2|STARTED|Overall Study||20
142892|NCT01689857|348318|P1|STARTED|Overall Study||20
142893|NCT01689779|348326|P2|NOT COMPLETED|Overall Study||0
142894|NCT01689779|348327|P1|NOT COMPLETED|Overall Study||0
142895|NCT01689779|348326|P2|COMPLETED|Overall Study||32
142896|NCT01689779|348327|P1|COMPLETED|Overall Study||28
142897|NCT01689779|348326|P2|STARTED|Overall Study||32
142898|NCT01689779|348327|P1|STARTED|Overall Study||28
142899|NCT01689701|348345|P2|NOT COMPLETED|Overall Study||6
142900|NCT01689701|348346|P1|NOT COMPLETED|Overall Study||5
142901|NCT01689701|348345|P2|COMPLETED|Overall Study||21
142902|NCT01689701|348346|P1|COMPLETED|Overall Study||22
142903|NCT01689701|348345|P2|STARTED|Overall Study||27
142904|NCT01689701|348346|P1|STARTED|Overall Study||27
142905|NCT01689649|348366|P1|NOT COMPLETED|Overall Study||22
142906|NCT01689649|348366|P1|COMPLETED|Overall Study||117
142907|NCT01689649|348366|P1|STARTED|Overall Study||139
142908|NCT01689532|348378|P2|NOT COMPLETED|Overall Study||9
142909|NCT01689532|348379|P1|NOT COMPLETED|Overall Study||14
142910|NCT01689532|348378|P2|COMPLETED|Overall Study||52
142911|NCT01689532|348379|P1|COMPLETED|Overall Study||47
142912|NCT01689532|348378|P2|STARTED|Overall Study||61
142913|NCT01689532|348379|P1|STARTED|Overall Study||61
142914|NCT01689519|348443|P2|NOT COMPLETED|Overall Study||138
142915|NCT01689519|348444|P1|NOT COMPLETED|Overall Study||166
142916|NCT01689519|348443|P2|COMPLETED|Overall Study||109
142917|NCT01689519|348444|P1|COMPLETED|Overall Study||82
142918|NCT01689519|348443|P2|Received Treatment|Overall Study||246
142919|NCT01689519|348444|P1|Received Treatment|Overall Study||247
142920|NCT01689519|348443|P2|STARTED|Overall Study||247
142921|NCT01689519|348444|P1|STARTED|Overall Study||248
142922|NCT01689441|348460|P2|NOT COMPLETED|Overall Study||0
142923|NCT01689441|348461|P1|NOT COMPLETED|Overall Study||0
142924|NCT01689441|348460|P2|COMPLETED|Overall Study||31
142925|NCT01689441|348461|P1|COMPLETED|Overall Study||36
142926|NCT01689441|348460|P2|STARTED|Overall Study||31
142927|NCT01689441|348461|P1|STARTED|Overall Study||36
142928|NCT01689363|348471|P8|NOT COMPLETED|Overall Study||0
142929|NCT01689363|348472|P7|NOT COMPLETED|Overall Study||0
142930|NCT01689363|348473|P6|NOT COMPLETED|Overall Study||0
142931|NCT01689363|348474|P5|NOT COMPLETED|Overall Study||0
142932|NCT01689363|348475|P4|NOT COMPLETED|Overall Study||0
142933|NCT01689363|348476|P3|NOT COMPLETED|Overall Study||0
142934|NCT01689363|348477|P2|NOT COMPLETED|Overall Study||1
142935|NCT01689363|348478|P1|NOT COMPLETED|Overall Study||0
142936|NCT01689363|348471|P8|COMPLETED|Overall Study||32
142937|NCT01689363|348472|P7|COMPLETED|Overall Study||32
142938|NCT01689363|348473|P6|COMPLETED|Overall Study||31
142939|NCT01689363|348474|P5|COMPLETED|Overall Study||31
142940|NCT01689363|348475|P4|COMPLETED|Overall Study||31
142941|NCT01689363|348476|P3|COMPLETED|Overall Study||32
142942|NCT01689363|348477|P2|COMPLETED|Overall Study||31
142943|NCT01689363|348478|P1|COMPLETED|Overall Study||32
142944|NCT01689363|348471|P8|STARTED|Overall Study||32
142945|NCT01689363|348472|P7|STARTED|Overall Study||32
142946|NCT01689363|348473|P6|STARTED|Overall Study||31
142947|NCT01689363|348474|P5|STARTED|Overall Study||31
142948|NCT01689363|348475|P4|STARTED|Overall Study||31
142949|NCT01689363|348476|P3|STARTED|Overall Study||32
142950|NCT01689363|348477|P2|STARTED|Overall Study||32
142951|NCT01689363|348478|P1|STARTED|Overall Study||32
142952|NCT01689350|348524|P2|NOT COMPLETED|Overall Study||0
142953|NCT01689350|348525|P1|NOT COMPLETED|Overall Study||0
142954|NCT01689350|348524|P2|COMPLETED|Overall Study||45
142955|NCT01689350|348525|P1|COMPLETED|Overall Study||47
142956|NCT01689350|348524|P2|STARTED|Overall Study||45
142957|NCT01689350|348525|P1|STARTED|Overall Study||47
142958|NCT01689337|348533|P1|NOT COMPLETED|Overall Study||1
142959|NCT01689337|348533|P1|COMPLETED|Overall Study||0
142960|NCT01689337|348533|P1|STARTED|Overall Study||1
142961|NCT01689324|348548|P1|NOT COMPLETED|Overall Study||0
142962|NCT01689324|348548|P1|COMPLETED|Overall Study||43
142963|NCT01689324|348548|P1|STARTED|Overall Study||43
142964|NCT01689207|348572|P11|NOT COMPLETED|Overall Study||0
142965|NCT01689207|348573|P10|NOT COMPLETED|Overall Study||0
142966|NCT01689207|348574|P9|NOT COMPLETED|Overall Study||1
142967|NCT01689207|348575|P8|NOT COMPLETED|Overall Study||0
142968|NCT01689207|348576|P7|NOT COMPLETED|Overall Study||0
142969|NCT01689207|348577|P6|NOT COMPLETED|Overall Study||1
142970|NCT01689207|348578|P5|NOT COMPLETED|Overall Study||2
142971|NCT01689207|348579|P4|NOT COMPLETED|Overall Study||0
142972|NCT01689207|348580|P3|NOT COMPLETED|Overall Study||0
142973|NCT01689207|348581|P2|NOT COMPLETED|Overall Study||1
142974|NCT01689207|348582|P1|NOT COMPLETED|Overall Study||0
142975|NCT01689207|348572|P11|COMPLETED|Overall Study|Subjects completed study|8
142976|NCT01689207|348573|P10|COMPLETED|Overall Study|Subjects completed study|10
142977|NCT01689207|348574|P9|COMPLETED|Overall Study|Subjects completed study|5
142978|NCT01689207|348575|P8|COMPLETED|Overall Study|Subjects completed study|10
142979|NCT01689207|348576|P7|COMPLETED|Overall Study|Subjects completed study|10
142980|NCT01689207|348577|P6|COMPLETED|Overall Study|Subjects completed study|7
142981|NCT01689207|348578|P5|COMPLETED|Overall Study|Subjects completed study|2
142982|NCT01689207|348579|P4|COMPLETED|Overall Study|Subjects completed study|8
142983|NCT01689207|348580|P3|COMPLETED|Overall Study|Subjects completed study|16
142984|NCT01689207|348581|P2|COMPLETED|Overall Study|Subjects completed study|7
142985|NCT01689207|348582|P1|COMPLETED|Overall Study|Subjects completed study|4
142986|NCT01689207|348572|P11|STARTED|Overall Study|Subjects randomised|8
142987|NCT01689207|348573|P10|STARTED|Overall Study|Subjects randomised|10
142988|NCT01689207|348574|P9|STARTED|Overall Study|Subjects randomised|6
142989|NCT01689207|348575|P8|STARTED|Overall Study|Subjects randomised|10
142990|NCT01689207|348576|P7|STARTED|Overall Study|Subjects randomised|10
142991|NCT01689207|348577|P6|STARTED|Overall Study|Subjects randomised|8
142992|NCT01689207|348578|P5|STARTED|Overall Study|Subjects randomised|4
142993|NCT01689207|348579|P4|STARTED|Overall Study|Subjects randomised|8
142994|NCT01689207|348580|P3|STARTED|Overall Study|Subjects randomised|16
142995|NCT01689207|348581|P2|STARTED|Overall Study|Subjects randomised|8
142996|NCT01689207|348582|P1|STARTED|Overall Study|Subjects randomised|4
142997|NCT01689155|348678|P1|NOT COMPLETED|Overall Study||0
142998|NCT01689155|348678|P1|COMPLETED|Overall Study||116
142999|NCT01689155|348678|P1|STARTED|Overall Study||116
143000|NCT01688973|348689|P2|NOT COMPLETED|Overall Study||3
143001|NCT01688973|348690|P1|NOT COMPLETED|Overall Study||2
143002|NCT01688973|348689|P2|COMPLETED|Overall Study||25
143003|NCT01688973|348690|P1|COMPLETED|Overall Study||25
143004|NCT01688973|348689|P2|Eligible/Evaluable Patients|Overall Study||25
143005|NCT01688973|348690|P1|Eligible/Evaluable Patients|Overall Study||25
143006|NCT01688973|348689|P2|STARTED|Overall Study||28
143007|NCT01688973|348690|P1|STARTED|Overall Study||27
143008|NCT01688921|348704|P2|NOT COMPLETED|Overall Study||15
143009|NCT01688921|348705|P1|NOT COMPLETED|Overall Study||16
143010|NCT01688921|348704|P2|COMPLETED|Overall Study||608
143011|NCT01688921|348705|P1|COMPLETED|Overall Study||611
143012|NCT01688921|348704|P2|STARTED|Overall Study||623
143013|NCT01688921|348705|P1|STARTED|Overall Study||627
143014|NCT01688882|348730|P2|NOT COMPLETED|Overall Study||1
143015|NCT01688882|348731|P1|NOT COMPLETED|Overall Study||3
143016|NCT01688882|348730|P2|COMPLETED|Overall Study|The one patient that discontinued was already switched to open-label QGE031 treatment.|6
143017|NCT01688882|348731|P1|COMPLETED|Overall Study||10
143018|NCT01688882|348730|P2|Safety Follow-up|Overall Study||5
143019|NCT01688882|348731|P1|Safety Follow-up|Overall Study||11
143020|NCT01688882|348730|P2|STARTED|Overall Study|4 patients who completed 12 weeks of placebo changed to open-label QGE031 treatment.|7
143021|NCT01688882|348731|P1|STARTED|Overall Study||13
143022|NCT01688843|348745|P1|NOT COMPLETED|Overall Study||0
143023|NCT01688843|348745|P1|COMPLETED|Overall Study||1060
143024|NCT01688843|348745|P1|STARTED|Overall Study||1060
143025|NCT01688830|348776|P21|NOT COMPLETED|Overall Study||0
143026|NCT01688830|348777|P20|NOT COMPLETED|Overall Study||0
143027|NCT01688830|348778|P19|NOT COMPLETED|Overall Study||0
143028|NCT01688830|348779|P18|NOT COMPLETED|Overall Study||0
143029|NCT01688830|348780|P17|NOT COMPLETED|Overall Study||0
143030|NCT01688830|348781|P16|NOT COMPLETED|Overall Study||0
143031|NCT01688830|348782|P15|NOT COMPLETED|Overall Study||0
143032|NCT01688830|348783|P14|NOT COMPLETED|Overall Study||0
143033|NCT01688830|348784|P13|NOT COMPLETED|Overall Study||0
143034|NCT01688830|348785|P12|NOT COMPLETED|Overall Study||0
143035|NCT01688830|348786|P11|NOT COMPLETED|Overall Study||1
143036|NCT01688830|348787|P10|NOT COMPLETED|Overall Study||0
143037|NCT01688830|348788|P9|NOT COMPLETED|Overall Study||0
143038|NCT01688830|348789|P8|NOT COMPLETED|Overall Study||0
143039|NCT01688830|348790|P7|NOT COMPLETED|Overall Study||0
143040|NCT01688830|348791|P6|NOT COMPLETED|Overall Study||0
143041|NCT01688830|348792|P5|NOT COMPLETED|Overall Study||0
143042|NCT01688830|348793|P4|NOT COMPLETED|Overall Study||0
143043|NCT01688830|348794|P3|NOT COMPLETED|Overall Study||0
143044|NCT01688830|348795|P2|NOT COMPLETED|Overall Study||0
143045|NCT01688830|348796|P1|NOT COMPLETED|Overall Study||0
143046|NCT01688830|348776|P21|COMPLETED|Overall Study||9
143047|NCT01688830|348777|P20|COMPLETED|Overall Study||3
143048|NCT01688830|348778|P19|COMPLETED|Overall Study||8
143049|NCT01688830|348779|P18|COMPLETED|Overall Study||9
143050|NCT01688830|348780|P17|COMPLETED|Overall Study||9
143051|NCT01688830|348781|P16|COMPLETED|Overall Study||9
143052|NCT01688830|348782|P15|COMPLETED|Overall Study||6
143053|NCT01688830|348783|P14|COMPLETED|Overall Study||6
143054|NCT01688830|348784|P13|COMPLETED|Overall Study||6
143055|NCT01688830|348785|P12|COMPLETED|Overall Study||6
143056|NCT01688830|348786|P11|COMPLETED|Overall Study||5
143057|NCT01688830|348787|P10|COMPLETED|Overall Study||6
143058|NCT01688830|348788|P9|COMPLETED|Overall Study||6
143059|NCT01688830|348789|P8|COMPLETED|Overall Study||6
143060|NCT01688830|348790|P7|COMPLETED|Overall Study||12
143061|NCT01688830|348791|P6|COMPLETED|Overall Study||6
143062|NCT01688830|348792|P5|COMPLETED|Overall Study||5
143063|NCT01688830|348793|P4|COMPLETED|Overall Study||6
143064|NCT01688830|348794|P3|COMPLETED|Overall Study||6
143065|NCT01688830|348795|P2|COMPLETED|Overall Study||6
143066|NCT01688830|348796|P1|COMPLETED|Overall Study||21
143067|NCT01688830|348776|P21|STARTED|Overall Study||9
143068|NCT01688830|348777|P20|STARTED|Overall Study||3
143069|NCT01688830|348778|P19|STARTED|Overall Study||8
143070|NCT01688830|348779|P18|STARTED|Overall Study||9
143071|NCT01688830|348780|P17|STARTED|Overall Study||9
143072|NCT01688830|348781|P16|STARTED|Overall Study||9
143073|NCT01688830|348782|P15|STARTED|Overall Study||6
143074|NCT01688830|348783|P14|STARTED|Overall Study||6
143075|NCT01688830|348784|P13|STARTED|Overall Study||6
143076|NCT01688830|348785|P12|STARTED|Overall Study||6
143077|NCT01688830|348786|P11|STARTED|Overall Study||6
143078|NCT01688830|348787|P10|STARTED|Overall Study||6
143079|NCT01688830|348788|P9|STARTED|Overall Study||6
143080|NCT01688830|348789|P8|STARTED|Overall Study||6
143081|NCT01688830|348790|P7|STARTED|Overall Study||12
143082|NCT01688830|348791|P6|STARTED|Overall Study||6
143083|NCT01688830|348792|P5|STARTED|Overall Study||5
143084|NCT01688830|348793|P4|STARTED|Overall Study||6
143085|NCT01688830|348794|P3|STARTED|Overall Study||6
143086|NCT01688830|348795|P2|STARTED|Overall Study||6
143087|NCT01688830|348796|P1|STARTED|Overall Study||21
143088|NCT01688739|348950|P10|NOT COMPLETED|Overall Study||0
143089|NCT01688739|348951|P9|NOT COMPLETED|Overall Study||0
143090|NCT01688739|348952|P8|NOT COMPLETED|Overall Study||0
143091|NCT01688739|348953|P7|NOT COMPLETED|Overall Study||0
143092|NCT01688739|348954|P6|NOT COMPLETED|Overall Study||0
143093|NCT01688739|348955|P5|NOT COMPLETED|Overall Study||0
143094|NCT01688739|348956|P4|NOT COMPLETED|Overall Study||0
143095|NCT01688739|348957|P3|NOT COMPLETED|Overall Study||0
143096|NCT01688739|348958|P2|NOT COMPLETED|Overall Study||0
143097|NCT01688739|348959|P1|NOT COMPLETED|Overall Study||1
143098|NCT01688739|348950|P10|COMPLETED|Overall Study||6
143099|NCT01688739|348951|P9|COMPLETED|Overall Study||6
143100|NCT01688739|348952|P8|COMPLETED|Overall Study||6
143101|NCT01688739|348953|P7|COMPLETED|Overall Study||6
143102|NCT01688739|348954|P6|COMPLETED|Overall Study||6
143103|NCT01688739|348955|P5|COMPLETED|Overall Study||6
143104|NCT01688739|348956|P4|COMPLETED|Overall Study||6
143105|NCT01688739|348957|P3|COMPLETED|Overall Study||3
143106|NCT01688739|348958|P2|COMPLETED|Overall Study||3
143107|NCT01688739|348959|P1|COMPLETED|Overall Study||12
143108|NCT01688739|348950|P10|Received Study Drug|Overall Study||6
143109|NCT01688739|348951|P9|Received Study Drug|Overall Study||6
143110|NCT01688739|348952|P8|Received Study Drug|Overall Study||6
143111|NCT01688739|348953|P7|Received Study Drug|Overall Study||6
143112|NCT01688739|348954|P6|Received Study Drug|Overall Study||6
143113|NCT01688739|348955|P5|Received Study Drug|Overall Study||6
143114|NCT01688739|348956|P4|Received Study Drug|Overall Study||6
143115|NCT01688739|348957|P3|Received Study Drug|Overall Study||3
143116|NCT01688739|348958|P2|Received Study Drug|Overall Study||3
143117|NCT01688739|348959|P1|Received Study Drug|Overall Study||12
143118|NCT01688739|348950|P10|STARTED|Overall Study||6
143119|NCT01688739|348951|P9|STARTED|Overall Study||6
143120|NCT01688739|348952|P8|STARTED|Overall Study||6
143121|NCT01688739|348953|P7|STARTED|Overall Study||6
143122|NCT01688739|348954|P6|STARTED|Overall Study||6
143123|NCT01688739|348955|P5|STARTED|Overall Study||6
143124|NCT01688739|348956|P4|STARTED|Overall Study||6
143125|NCT01688739|348957|P3|STARTED|Overall Study||3
143126|NCT01688739|348958|P2|STARTED|Overall Study||3
143127|NCT01688739|348959|P1|STARTED|Overall Study||13
143128|NCT01688726|349035|P2|NOT COMPLETED|Overall Study||1
143129|NCT01688726|349036|P1|NOT COMPLETED|Overall Study||1
143130|NCT01688726|349035|P2|COMPLETED|Overall Study||44
143131|NCT01688726|349036|P1|COMPLETED|Overall Study||45
143132|NCT01688726|349035|P2|STARTED|Overall Study||45
143133|NCT01688726|349036|P1|STARTED|Overall Study||46
143134|NCT01688635|349048|P2|NOT COMPLETED|Period 4||0
143135|NCT01688635|349049|P1|NOT COMPLETED|Period 4||0
143136|NCT01688635|349048|P2|COMPLETED|Period 4||42
143137|NCT01688635|349049|P1|COMPLETED|Period 4||40
143138|NCT01688635|349048|P2|STARTED|Period 4||42
143139|NCT01688635|349049|P1|STARTED|Period 4||40
143140|NCT01688635|349048|P2|NOT COMPLETED|Washout 3||0
143141|NCT01688635|349049|P1|NOT COMPLETED|Washout 3||1
143142|NCT01688635|349048|P2|COMPLETED|Washout 3||42
143143|NCT01688635|349049|P1|COMPLETED|Washout 3||40
143144|NCT01688635|349048|P2|STARTED|Washout 3||42
143145|NCT01688635|349049|P1|STARTED|Washout 3||41
143146|NCT01688635|349048|P2|NOT COMPLETED|Period 3||0
143147|NCT01688635|349049|P1|NOT COMPLETED|Period 3||0
143148|NCT01688635|349048|P2|COMPLETED|Period 3||42
143149|NCT01688635|349049|P1|COMPLETED|Period 3||41
143150|NCT01688635|349048|P2|STARTED|Period 3||42
143151|NCT01688635|349049|P1|STARTED|Period 3||41
143152|NCT01688635|349048|P2|NOT COMPLETED|Washout 2||2
143153|NCT01688635|349049|P1|NOT COMPLETED|Washout 2||3
143154|NCT01688635|349048|P2|COMPLETED|Washout 2||42
143155|NCT01688635|349049|P1|COMPLETED|Washout 2||41
143156|NCT01688635|349048|P2|STARTED|Washout 2||44
143157|NCT01688635|349049|P1|STARTED|Washout 2||44
143158|NCT01688635|349048|P2|NOT COMPLETED|Period 2||0
143159|NCT01688635|349049|P1|NOT COMPLETED|Period 2||0
143160|NCT01688635|349048|P2|COMPLETED|Period 2||44
143161|NCT01688635|349049|P1|COMPLETED|Period 2||44
143162|NCT01688635|349048|P2|STARTED|Period 2||44
143163|NCT01688635|349049|P1|STARTED|Period 2||44
143164|NCT01688635|349048|P2|NOT COMPLETED|Washout 1||2
143165|NCT01688635|349049|P1|NOT COMPLETED|Washout 1||1
143166|NCT01688635|349048|P2|COMPLETED|Washout 1||44
143167|NCT01688635|349049|P1|COMPLETED|Washout 1||44
143168|NCT01688635|349048|P2|STARTED|Washout 1||46
143169|NCT01688635|349049|P1|STARTED|Washout 1||45
143170|NCT01688635|349048|P2|NOT COMPLETED|Period 1||0
143171|NCT01688635|349049|P1|NOT COMPLETED|Period 1||0
143172|NCT01688635|349048|P2|COMPLETED|Period 1||46
143173|NCT01688635|349049|P1|COMPLETED|Period 1||45
143174|NCT01688635|349048|P2|Received at Least 1 Dose of Study Drug|Period 1||46
143175|NCT01688635|349049|P1|Received at Least 1 Dose of Study Drug|Period 1||45
143176|NCT01688635|349048|P2|STARTED|Period 1||46
143177|NCT01688635|349049|P1|STARTED|Period 1||45
143178|NCT01688609|349061|P1|NOT COMPLETED|Overall Study||0
143179|NCT01688609|349061|P1|COMPLETED|Overall Study||18
143180|NCT01688609|349061|P1|STARTED|Overall Study||18
143181|NCT01688596|349071|P2|NOT COMPLETED|Overall Study||9
143182|NCT01688596|349072|P1|NOT COMPLETED|Overall Study||8
143183|NCT01688596|349071|P2|COMPLETED|Overall Study||59
143184|NCT01688596|349072|P1|COMPLETED|Overall Study||59
143185|NCT01688596|349071|P2|STARTED|Overall Study||68
143186|NCT01688596|349072|P1|STARTED|Overall Study||67
143187|NCT01688466|349096|P2|NOT COMPLETED|Overall Study||7
143188|NCT01688466|349097|P1|NOT COMPLETED|Overall Study||2
143189|NCT01688466|349096|P2|COMPLETED|Overall Study||10
143190|NCT01688466|349097|P1|COMPLETED|Overall Study||15
143191|NCT01688466|349096|P2|STARTED|Overall Study||17
143192|NCT01688466|349097|P1|STARTED|Overall Study||17
143193|NCT01688336|349105|P1|NOT COMPLETED|Overall Study||0
143194|NCT01688336|349105|P1|COMPLETED|Overall Study||9
143195|NCT01688336|349105|P1|STARTED|Overall Study||9
143196|NCT01688310|349117|P2|NOT COMPLETED|Overall Study||0
143197|NCT01688310|349118|P1|NOT COMPLETED|Overall Study||0
143198|NCT01688310|349117|P2|COMPLETED|Overall Study||100
143199|NCT01688310|349118|P1|COMPLETED|Overall Study||100
143200|NCT01688310|349117|P2|STARTED|Overall Study||100
143201|NCT01688310|349118|P1|STARTED|Overall Study||100
143202|NCT01688102|349138|P2|NOT COMPLETED|Overall Study||18
143203|NCT01688102|349139|P1|NOT COMPLETED|Overall Study||16
143204|NCT01688102|349138|P2|COMPLETED|Overall Study||40
143205|NCT01688102|349139|P1|COMPLETED|Overall Study||44
143206|NCT01688102|349138|P2|STARTED|Overall Study||58
143207|NCT01688102|349139|P1|STARTED|Overall Study||60
143208|NCT01688050|349167|P1|NOT COMPLETED|Overall Study||50
143209|NCT01688050|349167|P1|COMPLETED|Overall Study||0
143210|NCT01688050|349167|P1|30 Days|Overall Study||50
143211|NCT01688050|349167|P1|STARTED|Overall Study||50
143212|NCT01688037|349176|P3|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
143213|NCT01688037|349177|P2|NOT COMPLETED|Follow-up Period (Week 12 to 16)||1
143214|NCT01688037|349178|P1|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
143215|NCT01688037|349176|P3|COMPLETED|Follow-up Period (Week 12 to 16)||17
143216|NCT01688037|349177|P2|COMPLETED|Follow-up Period (Week 12 to 16)||21
143217|NCT01688037|349178|P1|COMPLETED|Follow-up Period (Week 12 to 16)||42
143218|NCT01688037|349176|P3|STARTED|Follow-up Period (Week 12 to 16)||17
143219|NCT01688037|349177|P2|STARTED|Follow-up Period (Week 12 to 16)||22
143220|NCT01688037|349178|P1|STARTED|Follow-up Period (Week 12 to 16)||42
143221|NCT01688037|349176|P3|NOT COMPLETED|Open-Label Period (Week 6 to 12)||4
143222|NCT01688037|349177|P2|NOT COMPLETED|Open-Label Period (Week 6 to 12)||3
143223|NCT01688037|349178|P1|NOT COMPLETED|Open-Label Period (Week 6 to 12)||5
143224|NCT01688037|349176|P3|COMPLETED|Open-Label Period (Week 6 to 12)||17
143225|NCT01688037|349177|P2|COMPLETED|Open-Label Period (Week 6 to 12)||22
143226|NCT01688037|349178|P1|COMPLETED|Open-Label Period (Week 6 to 12)||42
143227|NCT01688037|349176|P3|STARTED|Open-Label Period (Week 6 to 12)||21
143228|NCT01688037|349177|P2|STARTED|Open-Label Period (Week 6 to 12)||25
143229|NCT01688037|349178|P1|STARTED|Open-Label Period (Week 6 to 12)||47
143230|NCT01688037|349176|P3|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||6
143231|NCT01688037|349177|P2|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||3
143232|NCT01688037|349178|P1|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
143233|NCT01688037|349176|P3|COMPLETED|Double-Blind Period (Week 0 to 6)||21
143234|NCT01688037|349177|P2|COMPLETED|Double-Blind Period (Week 0 to 6)||25
143235|NCT01688037|349178|P1|COMPLETED|Double-Blind Period (Week 0 to 6)||47
143236|NCT01688037|349176|P3|STARTED|Double-Blind Period (Week 0 to 6)||27
143237|NCT01688037|349177|P2|STARTED|Double-Blind Period (Week 0 to 6)||28
143238|NCT01688037|349178|P1|STARTED|Double-Blind Period (Week 0 to 6)||54
143239|NCT01687998|349194|P2|NOT COMPLETED|Overall Study||120
143240|NCT01687998|349195|P1|NOT COMPLETED|Overall Study||112
143241|NCT01687998|349194|P2|COMPLETED|Overall Study||5934
143242|NCT01687998|349195|P1|COMPLETED|Overall Study||5926
143243|NCT01687998|349194|P2|Received at Least One Dose of Study Drug|Overall Study||6052
143244|NCT01687998|349195|P1|Received at Least One Dose of Study Drug|Overall Study||6036
143245|NCT01687998|349194|P2|STARTED|Overall Study||6054
143246|NCT01687998|349195|P1|STARTED|Overall Study||6038
143247|NCT01687972|349213|P2|NOT COMPLETED|Overall Study||0
143248|NCT01687972|349214|P1|NOT COMPLETED|Overall Study||0
143249|NCT01687972|349213|P2|COMPLETED|Overall Study||44
143250|NCT01687972|349214|P1|COMPLETED|Overall Study||44
143251|NCT01687972|349213|P2|STARTED|Overall Study||44
143252|NCT01687972|349214|P1|STARTED|Overall Study||44
143253|NCT01687790|349224|P1|NOT COMPLETED|Overall Study||0
143254|NCT01687790|349224|P1|COMPLETED|Overall Study||60
143255|NCT01687790|349224|P1|STARTED|Overall Study||60
143256|NCT01687712|349231|P2|NOT COMPLETED|Cycle 3||24
143257|NCT01687712|349232|P1|NOT COMPLETED|Cycle 3||24
143258|NCT01687712|349231|P2|COMPLETED|Cycle 3||0
143259|NCT01687712|349232|P1|COMPLETED|Cycle 3||4
143260|NCT01687712|349231|P2|Clinical Pregnancy|Cycle 3||0
143261|NCT01687712|349232|P1|Clinical Pregnancy|Cycle 3||5
143262|NCT01687712|349231|P2|Biochemically Pregnant|Cycle 3||2
143263|NCT01687712|349232|P1|Biochemically Pregnant|Cycle 3||7
143264|NCT01687712|349231|P2|Embryo Transfer|Cycle 3||24
143265|NCT01687712|349232|P1|Embryo Transfer|Cycle 3||26
143266|NCT01687712|349231|P2|Fertilization Performed|Cycle 3||24
143267|NCT01687712|349232|P1|Fertilization Performed|Cycle 3||27
143268|NCT01687712|349231|P2|Ooctye/Ovum Pick-Up|Cycle 3||24
143269|NCT01687712|349232|P1|Ooctye/Ovum Pick-Up|Cycle 3||27
143270|NCT01687712|349231|P2|Received hCG|Cycle 3||24
143271|NCT01687712|349232|P1|Received hCG|Cycle 3||27
143272|NCT01687712|349231|P2|STARTED|Cycle 3||24
143273|NCT01687712|349232|P1|STARTED|Cycle 3||28
143274|NCT01687712|349231|P2|NOT COMPLETED|Cycle 2||95
143275|NCT01687712|349232|P1|NOT COMPLETED|Cycle 2||93
143276|NCT01687712|349231|P2|COMPLETED|Cycle 2||25
143277|NCT01687712|349232|P1|COMPLETED|Cycle 2||16
143278|NCT01687712|349231|P2|Clinical Pregnancy|Cycle 2||26
143279|NCT01687712|349232|P1|Clinical Pregnancy|Cycle 2||17
143280|NCT01687712|349231|P2|Biochemical Pregnancy|Cycle 2||43
143281|NCT01687712|349232|P1|Biochemical Pregnancy|Cycle 2||35
143282|NCT01687712|349231|P2|Embryo Transfer|Cycle 2||117
143283|NCT01687712|349232|P1|Embryo Transfer|Cycle 2||101
143284|NCT01687712|349231|P2|Fertilization Performed|Cycle 2||119
143285|NCT01687712|349232|P1|Fertilization Performed|Cycle 2||106
143286|NCT01687712|349231|P2|Oocyte/Ovum Pick Up|Cycle 2||119
143287|NCT01687712|349232|P1|Oocyte/Ovum Pick Up|Cycle 2||107
143288|NCT01687712|349231|P2|Received hCG|Cycle 2||119
143289|NCT01687712|349232|P1|Received hCG|Cycle 2||107
143290|NCT01687712|349231|P2|STARTED|Cycle 2||120
143291|NCT01687712|349232|P1|STARTED|Cycle 2||109
143292|NCT01687712|349231|P2|NOT COMPLETED|Cycle 1||429
143293|NCT01687712|349232|P1|NOT COMPLETED|Cycle 1||448
143294|NCT01687712|349231|P2|COMPLETED|Cycle 1||122
143295|NCT01687712|349232|P1|COMPLETED|Cycle 1||101
143296|NCT01687712|349231|P2|Clinical Pregnancy|Cycle 1||138
143297|NCT01687712|349232|P1|Clinical Pregnancy|Cycle 1||114
143298|NCT01687712|349231|P2|Biochemical Pregnancy|Cycle 1||203
143299|NCT01687712|349232|P1|Biochemical Pregnancy|Cycle 1||163
143300|NCT01687712|349231|P2|Embryo Transfer|Cycle 1||483
143301|NCT01687712|349232|P1|Embryo Transfer|Cycle 1||466
143302|NCT01687712|349231|P2|Fertilization Performed|Cycle 1||512
143303|NCT01687712|349232|P1|Fertilization Performed|Cycle 1||508
143304|NCT01687712|349231|P2|Oocyte/Ovum Pick Up|Cycle 1||517
143305|NCT01687712|349232|P1|Oocyte/Ovum Pick Up|Cycle 1||513
143306|NCT01687712|349231|P2|Received hCG|Cycle 1||520
143307|NCT01687712|349232|P1|Received hCG|Cycle 1||516
143308|NCT01687712|349231|P2|STARTED|Cycle 1||551
143309|NCT01687712|349232|P1|STARTED|Cycle 1||549
143310|NCT01687478|349272|P2|NOT COMPLETED|Overall Study||39
143311|NCT01687478|349273|P1|NOT COMPLETED|Overall Study||32
143312|NCT01687478|349272|P2|COMPLETED|Overall Study||49
143313|NCT01687478|349273|P1|COMPLETED|Overall Study||56
143314|NCT01687478|349272|P2|Safety Analysis Set|Overall Study||87
143315|NCT01687478|349273|P1|Safety Analysis Set|Overall Study||88
143316|NCT01687478|349272|P2|STARTED|Overall Study||88
143317|NCT01687478|349273|P1|STARTED|Overall Study||88
143318|NCT01687400|349295|P1|NOT COMPLETED|Overall Study||0
143319|NCT01687400|349295|P1|COMPLETED|Overall Study||114
143320|NCT01687400|349295|P1|STARTED|Overall Study||114
143321|NCT01687387|349309|P3|NOT COMPLETED|Overall Study||38
143322|NCT01687387|349310|P2|NOT COMPLETED|Overall Study||38
143323|NCT01687387|349311|P1|NOT COMPLETED|Overall Study||41
143324|NCT01687387|349309|P3|COMPLETED|Overall Study||13
143325|NCT01687387|349310|P2|COMPLETED|Overall Study||12
143326|NCT01687387|349311|P1|COMPLETED|Overall Study||10
143327|NCT01687387|349309|P3|STARTED|Overall Study||51
143328|NCT01687387|349310|P2|STARTED|Overall Study||50
143329|NCT01687387|349311|P1|STARTED|Overall Study||51
143330|NCT01687296|349324|P2|NOT COMPLETED|Overall Study||5
143331|NCT01687296|349325|P1|NOT COMPLETED|Overall Study||7
143332|NCT01687296|349324|P2|COMPLETED|Overall Study||123
143333|NCT01687296|349325|P1|COMPLETED|Overall Study||116
143334|NCT01687296|349324|P2|STARTED|Overall Study||128
143335|NCT01687296|349325|P1|STARTED|Overall Study||123
143336|NCT01687283|349347|P2|NOT COMPLETED|Overall Study||27
143337|NCT01687283|349348|P1|NOT COMPLETED|Overall Study||35
143338|NCT01687283|349347|P2|COMPLETED|Overall Study||130
143339|NCT01687283|349348|P1|COMPLETED|Overall Study||123
143340|NCT01687283|349347|P2|STARTED|Overall Study||157
143341|NCT01687283|349348|P1|STARTED|Overall Study||158
143342|NCT01687270|349371|P1|NOT COMPLETED|Overall Study||12
143343|NCT01687270|349371|P1|COMPLETED|Overall Study||28
143344|NCT01687270|349371|P1|STARTED|Overall Study||40
143345|NCT01687257|349382|P3|NOT COMPLETED|Overall Study||6
143346|NCT01687257|349383|P2|NOT COMPLETED|Overall Study||4
143347|NCT01687257|349384|P1|NOT COMPLETED|Overall Study||8
143348|NCT01687257|349382|P3|COMPLETED|Overall Study||15
143349|NCT01687257|349383|P2|COMPLETED|Overall Study||0
143350|NCT01687257|349384|P1|COMPLETED|Overall Study||17
143351|NCT01687257|349382|P3|STARTED|Overall Study||21
143352|NCT01687257|349383|P2|STARTED|Overall Study||4
143353|NCT01687257|349384|P1|STARTED|Overall Study||25
143354|NCT01687244|349412|P2|NOT COMPLETED|Overall Study||0
143355|NCT01687244|349413|P1|NOT COMPLETED|Overall Study||0
143356|NCT01687244|349412|P2|COMPLETED|Overall Study||19
143357|NCT01687244|349413|P1|COMPLETED|Overall Study||21
143358|NCT01687244|349412|P2|STARTED|Overall Study||19
143359|NCT01687244|349413|P1|STARTED|Overall Study||21
143360|NCT01687218|349449|P6|NOT COMPLETED|Overall Study||0
143361|NCT01687218|349450|P5|NOT COMPLETED|Overall Study||1
143362|NCT01687218|349451|P4|NOT COMPLETED|Overall Study||2
143363|NCT01687218|349452|P3|NOT COMPLETED|Overall Study||1
143364|NCT01687218|349453|P2|NOT COMPLETED|Overall Study||3
143365|NCT01687218|349454|P1|NOT COMPLETED|Overall Study||3
143366|NCT01687218|349449|P6|COMPLETED|Overall Study||32
143367|NCT01687218|349450|P5|COMPLETED|Overall Study||32
143368|NCT01687218|349451|P4|COMPLETED|Overall Study||32
143369|NCT01687218|349452|P3|COMPLETED|Overall Study||30
143370|NCT01687218|349453|P2|COMPLETED|Overall Study||29
143371|NCT01687218|349454|P1|COMPLETED|Overall Study||30
143372|NCT01687218|349449|P6|STARTED|Overall Study||32
143373|NCT01687218|349450|P5|STARTED|Overall Study||33
143374|NCT01687218|349451|P4|STARTED|Overall Study||34
143375|NCT01687218|349452|P3|STARTED|Overall Study||31
143376|NCT01687218|349453|P2|STARTED|Overall Study||32
143377|NCT01687218|349454|P1|STARTED|Overall Study||33
143378|NCT01687179|349474|P2|NOT COMPLETED|Overall Study||4
143379|NCT01687179|349475|P1|NOT COMPLETED|Overall Study||1
143380|NCT01687179|349474|P2|COMPLETED|Overall Study||6
143381|NCT01687179|349475|P1|COMPLETED|Overall Study||2
143382|NCT01687179|349474|P2|STARTED|Overall Study||10
143383|NCT01687179|349475|P1|STARTED|Overall Study||3
143384|NCT01687166|349485|P4|NOT COMPLETED|Overall Study||2
143385|NCT01687166|349486|P3|NOT COMPLETED|Overall Study||14
143386|NCT01687166|349487|P2|NOT COMPLETED|Overall Study||27
143387|NCT01687166|349488|P1|NOT COMPLETED|Overall Study||28
143388|NCT01687166|349485|P4|COMPLETED|Overall Study||1
143389|NCT01687166|349486|P3|COMPLETED|Overall Study||42
143390|NCT01687166|349487|P2|COMPLETED|Overall Study||145
143391|NCT01687166|349488|P1|COMPLETED|Overall Study||139
143392|NCT01687166|349485|P4|STARTED|Overall Study||3
143393|NCT01687166|349486|P3|STARTED|Overall Study||56
143394|NCT01687166|349487|P2|STARTED|Overall Study||172
143395|NCT01687166|349488|P1|STARTED|Overall Study||167
143396|NCT01687114|349500|P1|NOT COMPLETED|Overall Study||0
143397|NCT01687114|349500|P1|COMPLETED|Overall Study||5
143398|NCT01687114|349500|P1|STARTED|Overall Study||5
143399|NCT01687101|349504|P1|NOT COMPLETED|Overall Study||7
143400|NCT01687101|349504|P1|COMPLETED|Overall Study||25
143401|NCT01687101|349504|P1|STARTED|Overall Study||32
143402|NCT01687088|349510|P2|NOT COMPLETED|Overall Study||0
143403|NCT01687088|349511|P1|NOT COMPLETED|Overall Study||0
143404|NCT01687088|349510|P2|COMPLETED|Overall Study||50
143405|NCT01687088|349511|P1|COMPLETED|Overall Study||50
143406|NCT01687088|349510|P2|STARTED|Overall Study||50
143407|NCT01687088|349511|P1|STARTED|Overall Study||50
143408|NCT01687036|349517|P1|NOT COMPLETED|Overall Study||0
143409|NCT01687036|349517|P1|COMPLETED|Overall Study||10
143410|NCT01687036|349517|P1|STARTED|Overall Study||10
143411|NCT01686958|349529|P1|NOT COMPLETED|Overall Study||1
143412|NCT01686958|349529|P1|COMPLETED|Overall Study|No. of patients who completed ALL assessments at 12 months post treatment; 1 pt only had PSA test.|29
143413|NCT01686958|349529|P1|STARTED|Overall Study||30
143414|NCT01686932|349542|P2|NOT COMPLETED|Period 2||0
143415|NCT01686932|349543|P1|NOT COMPLETED|Period 2||0
143416|NCT01686932|349542|P2|COMPLETED|Period 2||25
143417|NCT01686932|349543|P1|COMPLETED|Period 2||24
143418|NCT01686932|349542|P2|STARTED|Period 2||25
143419|NCT01686932|349543|P1|STARTED|Period 2||24
143420|NCT01686932|349542|P2|NOT COMPLETED|Period 1||1
143421|NCT01686932|349543|P1|NOT COMPLETED|Period 1||1
143422|NCT01686932|349542|P2|COMPLETED|Period 1||25
143423|NCT01686932|349543|P1|COMPLETED|Period 1||24
143424|NCT01686932|349542|P2|STARTED|Period 1||26
143425|NCT01686932|349543|P1|STARTED|Period 1||25
143426|NCT01686828|349573|P4|NOT COMPLETED|Overall Study||0
143427|NCT01686828|349574|P3|NOT COMPLETED|Overall Study||1
143428|NCT01686828|349575|P2|NOT COMPLETED|Overall Study||1
143429|NCT01686828|349576|P1|NOT COMPLETED|Overall Study||1
143430|NCT01686828|349573|P4|COMPLETED|Overall Study||13
143431|NCT01686828|349574|P3|COMPLETED|Overall Study||12
143432|NCT01686828|349575|P2|COMPLETED|Overall Study||13
143433|NCT01686828|349576|P1|COMPLETED|Overall Study||12
143434|NCT01686828|349573|P4|STARTED|Overall Study||13
143435|NCT01686828|349574|P3|STARTED|Overall Study||13
143436|NCT01686828|349575|P2|STARTED|Overall Study||14
143437|NCT01686828|349576|P1|STARTED|Overall Study||13
143438|NCT01686750|349596|P2|NOT COMPLETED|Overall Study||0
143439|NCT01686750|349597|P1|NOT COMPLETED|Overall Study||0
143440|NCT01686750|349596|P2|COMPLETED|Overall Study||10725
143441|NCT01686750|349597|P1|COMPLETED|Overall Study||11001
143442|NCT01686750|349596|P2|STARTED|Overall Study||10725
143443|NCT01686750|349597|P1|STARTED|Overall Study||11001
143444|NCT01686646|349637|P4|NOT COMPLETED|Overall Study||0
143445|NCT01686646|349638|P3|NOT COMPLETED|Overall Study||0
143446|NCT01686646|349639|P2|NOT COMPLETED|Overall Study||0
143447|NCT01686646|349640|P1|NOT COMPLETED|Overall Study||0
143448|NCT01686646|349637|P4|COMPLETED|Overall Study||75
143449|NCT01686646|349638|P3|COMPLETED|Overall Study||75
143450|NCT01686646|349639|P2|COMPLETED|Overall Study||45
143451|NCT01686646|349640|P1|COMPLETED|Overall Study||45
143452|NCT01686646|349637|P4|Safety Population|Overall Study||75
143453|NCT01686646|349638|P3|Safety Population|Overall Study||74
143454|NCT01686646|349639|P2|Safety Population|Overall Study||45
143455|NCT01686646|349640|P1|Safety Population|Overall Study|One subject randomized to Paracetamol+Caffeine (500/65) group but received 1000/130 combination.|46
143456|NCT01686646|349637|P4|Intent to Treat Population|Overall Study||75
143457|NCT01686646|349638|P3|Intent to Treat Population|Overall Study||75
143458|NCT01686646|349639|P2|Intent to Treat Population|Overall Study||45
143459|NCT01686646|349640|P1|Intent to Treat Population|Overall Study||45
143460|NCT01686646|349637|P4|STARTED|Overall Study||75
143461|NCT01686646|349638|P3|STARTED|Overall Study||75
143462|NCT01686646|349639|P2|STARTED|Overall Study||45
143463|NCT01686646|349640|P1|STARTED|Overall Study||45
143464|NCT01686633|349689|P3|NOT COMPLETED|Overall Study||25
143465|NCT01686633|349690|P2|NOT COMPLETED|Overall Study||32
143466|NCT01686633|349691|P1|NOT COMPLETED|Overall Study||51
143467|NCT01686633|349689|P3|COMPLETED|Overall Study||321
143468|NCT01686633|349690|P2|COMPLETED|Overall Study||314
143469|NCT01686633|349691|P1|COMPLETED|Overall Study||296
143470|NCT01686633|349689|P3|STARTED|Overall Study||346
143471|NCT01686633|349690|P2|STARTED|Overall Study||346
143472|NCT01686633|349691|P1|STARTED|Overall Study||347
143473|NCT01686581|349714|P1|NOT COMPLETED|Overall Study||177
143474|NCT01686581|349714|P1|COMPLETED|Overall Study||464
143475|NCT01686581|349714|P1|Completed 24 Months|Overall Study||128
143476|NCT01686581|349714|P1|Safety Analysis Set; Received Study Drug|Overall Study||633
143477|NCT01686581|349714|P1|STARTED|Overall Study||641
143478|NCT01686568|349727|P2|NOT COMPLETED|Sub-Study||2
143479|NCT01686568|349728|P1|NOT COMPLETED|Sub-Study||2
143480|NCT01686568|349727|P2|COMPLETED|Sub-Study||9
143481|NCT01686568|349728|P1|COMPLETED|Sub-Study||12
143482|NCT01686568|349727|P2|STARTED|Sub-Study||11
143483|NCT01686568|349728|P1|STARTED|Sub-Study||14
143484|NCT01686568|349727|P2|NOT COMPLETED|Main Study||4
143485|NCT01686568|349728|P1|NOT COMPLETED|Main Study||2
143486|NCT01686568|349727|P2|COMPLETED|Main Study||11
143487|NCT01686568|349728|P1|COMPLETED|Main Study||14
143488|NCT01686568|349727|P2|STARTED|Main Study||15
143489|NCT01686568|349728|P1|STARTED|Main Study||16
143490|NCT01686503|349754|P4|NOT COMPLETED|Overall Study||1
143491|NCT01686503|349755|P3|NOT COMPLETED|Overall Study||2
143492|NCT01686503|349756|P2|NOT COMPLETED|Overall Study||3
143493|NCT01686503|349757|P1|NOT COMPLETED|Overall Study||1
143494|NCT01686503|349754|P4|COMPLETED|Overall Study||32
143495|NCT01686503|349755|P3|COMPLETED|Overall Study||64
143496|NCT01686503|349756|P2|COMPLETED|Overall Study||63
143497|NCT01686503|349757|P1|COMPLETED|Overall Study||65
143498|NCT01686503|349754|P4|STARTED|Overall Study||33
143499|NCT01686503|349755|P3|STARTED|Overall Study||66
143500|NCT01686503|349756|P2|STARTED|Overall Study||66
143501|NCT01686503|349757|P1|STARTED|Overall Study||66
143502|NCT01686451|349773|P2|NOT COMPLETED|Overall Study||0
143503|NCT01686451|349774|P1|NOT COMPLETED|Overall Study||0
143504|NCT01686451|349773|P2|COMPLETED|Overall Study||27
143505|NCT01686451|349774|P1|COMPLETED|Overall Study||33
143506|NCT01686451|349773|P2|STARTED|Overall Study||27
143507|NCT01686451|349774|P1|STARTED|Overall Study||33
143508|NCT01686438|349805|P3|NOT COMPLETED|Overall Study||13
143509|NCT01686438|349806|P2|NOT COMPLETED|Overall Study||9
143510|NCT01686438|349807|P1|NOT COMPLETED|Overall Study||8
143511|NCT01686438|349805|P3|COMPLETED|Overall Study||24
143512|NCT01686438|349806|P2|COMPLETED|Overall Study||26
143513|NCT01686438|349807|P1|COMPLETED|Overall Study||7
143514|NCT01686438|349805|P3|6-Month Follow Up|Overall Study||24
143515|NCT01686438|349806|P2|6-Month Follow Up|Overall Study||26
143516|NCT01686438|349807|P1|6-Month Follow Up|Overall Study||7
143517|NCT01686438|349805|P3|3-Month Follow Up|Overall Study||17
143518|NCT01686438|349806|P2|3-Month Follow Up|Overall Study||21
143519|NCT01686438|349807|P1|3-Month Follow Up|Overall Study||7
143520|NCT01686438|349805|P3|2-Week Follow Up|Overall Study||27
143521|NCT01686438|349806|P2|2-Week Follow Up|Overall Study||31
143522|NCT01686438|349807|P1|2-Week Follow Up|Overall Study||12
143523|NCT01686438|349805|P3|STARTED|Overall Study||37
143524|NCT01686438|349806|P2|STARTED|Overall Study||35
143525|NCT01686438|349807|P1|STARTED|Overall Study||15
143526|NCT01686373|349855|P2|NOT COMPLETED|Overall Study||2
143527|NCT01686373|349856|P1|NOT COMPLETED|Overall Study||3
143528|NCT01686373|349855|P2|COMPLETED|Overall Study||38
143529|NCT01686373|349856|P1|COMPLETED|Overall Study||31
143530|NCT01686373|349855|P2|Received 15 Treatment Sessions|Overall Study||39
143531|NCT01686373|349856|P1|Received 15 Treatment Sessions|Overall Study||33
143532|NCT01686373|349855|P2|STARTED|Overall Study||40
143533|NCT01686373|349856|P1|STARTED|Overall Study||34
143534|NCT01686165|349862|P1|NOT COMPLETED|Overall Study||0
143535|NCT01686165|349862|P1|COMPLETED|Overall Study||5
143536|NCT01686165|349862|P1|STARTED|Overall Study||5
143537|NCT01685996|349871|P2|NOT COMPLETED|Overall Study||13
143538|NCT01685996|349872|P1|NOT COMPLETED|Overall Study||16
143539|NCT01685996|349871|P2|COMPLETED|Overall Study||27
143540|NCT01685996|349872|P1|COMPLETED|Overall Study||18
143541|NCT01685996|349871|P2|STARTED|Overall Study||40
143542|NCT01685996|349872|P1|STARTED|Overall Study||34
143543|NCT01685983|349880|P1|NOT COMPLETED|Overall Study||82
143544|NCT01685983|349880|P1|COMPLETED|Overall Study||0
143545|NCT01685983|349880|P1|STARTED|Overall Study||82
143546|NCT01685840|349892|P2|NOT COMPLETED|Overall Study||332
143547|NCT01685840|349893|P1|NOT COMPLETED|Overall Study||329
143548|NCT01685840|349892|P2|COMPLETED|Overall Study||114
143549|NCT01685840|349893|P1|COMPLETED|Overall Study||119
143550|NCT01685840|349892|P2|STARTED|Overall Study||446
143551|NCT01685840|349893|P1|STARTED|Overall Study||448
143552|NCT01685801|349937|P4|NOT COMPLETED|Open-label Period (8 Weeks)||0
143553|NCT01685801|349938|P3|NOT COMPLETED|Open-label Period (8 Weeks)||0
143554|NCT01685801|349939|P2|NOT COMPLETED|Open-label Period (8 Weeks)||0
143555|NCT01685801|349940|P1|NOT COMPLETED|Open-label Period (8 Weeks)||0
143556|NCT01685801|349937|P4|COMPLETED|Open-label Period (8 Weeks)||4
143557|NCT01685801|349938|P3|COMPLETED|Open-label Period (8 Weeks)||7
143558|NCT01685801|349939|P2|COMPLETED|Open-label Period (8 Weeks)||5
143559|NCT01685801|349940|P1|COMPLETED|Open-label Period (8 Weeks)||5
143560|NCT01685801|349937|P4|STARTED|Open-label Period (8 Weeks)||4
143561|NCT01685801|349938|P3|STARTED|Open-label Period (8 Weeks)||7
143562|NCT01685801|349939|P2|STARTED|Open-label Period (8 Weeks)||5
143563|NCT01685801|349940|P1|STARTED|Open-label Period (8 Weeks)||5
143564|NCT01685801|349937|P4|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
143565|NCT01685801|349938|P3|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
143566|NCT01685801|349939|P2|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
143567|NCT01685801|349940|P1|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
143568|NCT01685801|349937|P4|COMPLETED|Washout Period 2 (4 Weeks)||4
143569|NCT01685801|349938|P3|COMPLETED|Washout Period 2 (4 Weeks)||7
143570|NCT01685801|349939|P2|COMPLETED|Washout Period 2 (4 Weeks)||5
143571|NCT01685801|349940|P1|COMPLETED|Washout Period 2 (4 Weeks)||5
143572|NCT01685801|349937|P4|STARTED|Washout Period 2 (4 Weeks)||4
143573|NCT01685801|349938|P3|STARTED|Washout Period 2 (4 Weeks)||7
143574|NCT01685801|349939|P2|STARTED|Washout Period 2 (4 Weeks)||5
143575|NCT01685801|349940|P1|STARTED|Washout Period 2 (4 Weeks)||5
143576|NCT01685801|349937|P4|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
143577|NCT01685801|349938|P3|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
143578|NCT01685801|349939|P2|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
143579|NCT01685801|349940|P1|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
143580|NCT01685801|349937|P4|COMPLETED|Cycle 2 Period 2 (2 Weeks)||4
143581|NCT01685801|349938|P3|COMPLETED|Cycle 2 Period 2 (2 Weeks)||7
143582|NCT01685801|349939|P2|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
143583|NCT01685801|349940|P1|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
143584|NCT01685801|349937|P4|STARTED|Cycle 2 Period 2 (2 Weeks)||5
143585|NCT01685801|349938|P3|STARTED|Cycle 2 Period 2 (2 Weeks)||7
143586|NCT01685801|349939|P2|STARTED|Cycle 2 Period 2 (2 Weeks)||6
143587|NCT01685801|349940|P1|STARTED|Cycle 2 Period 2 (2 Weeks)||5
143588|NCT01685801|349937|P4|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
143589|NCT01685801|349938|P3|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
143590|NCT01685801|349939|P2|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
143591|NCT01685801|349940|P1|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
143592|NCT01685801|349937|P4|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
143593|NCT01685801|349938|P3|COMPLETED|Cycle 2 Period 1 (2 Weeks)||7
143594|NCT01685801|349939|P2|COMPLETED|Cycle 2 Period 1 (2 Weeks)||6
143595|NCT01685801|349940|P1|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
143596|NCT01685801|349937|P4|STARTED|Cycle 2 Period 1 (2 Weeks)||5
143597|NCT01685801|349938|P3|STARTED|Cycle 2 Period 1 (2 Weeks)||7
143598|NCT01685801|349939|P2|STARTED|Cycle 2 Period 1 (2 Weeks)||6
143599|NCT01685801|349940|P1|STARTED|Cycle 2 Period 1 (2 Weeks)||5
143600|NCT01685801|349937|P4|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
143601|NCT01685801|349938|P3|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
143602|NCT01685801|349939|P2|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
143603|NCT01685801|349940|P1|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
143604|NCT01685801|349937|P4|COMPLETED|Washout Period 1 (4 Weeks)||5
143605|NCT01685801|349938|P3|COMPLETED|Washout Period 1 (4 Weeks)||7
143606|NCT01685801|349939|P2|COMPLETED|Washout Period 1 (4 Weeks)||6
143607|NCT01685801|349940|P1|COMPLETED|Washout Period 1 (4 Weeks)||5
143608|NCT01685801|349937|P4|STARTED|Washout Period 1 (4 Weeks)||5
143609|NCT01685801|349938|P3|STARTED|Washout Period 1 (4 Weeks)||7
143610|NCT01685801|349939|P2|STARTED|Washout Period 1 (4 Weeks)||6
143611|NCT01685801|349940|P1|STARTED|Washout Period 1 (4 Weeks)||5
143612|NCT01685801|349937|P4|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||1
143613|NCT01685801|349938|P3|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
143614|NCT01685801|349939|P2|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
143615|NCT01685801|349940|P1|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
143616|NCT01685801|349937|P4|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
143617|NCT01685801|349938|P3|COMPLETED|Cycle 1 Period 2 (2 Weeks)||7
143618|NCT01685801|349939|P2|COMPLETED|Cycle 1 Period 2 (2 Weeks)||6
143619|NCT01685801|349940|P1|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
143620|NCT01685801|349937|P4|STARTED|Cycle 1 Period 2 (2 Weeks)||6
143621|NCT01685801|349938|P3|STARTED|Cycle 1 Period 2 (2 Weeks)||7
143622|NCT01685801|349939|P2|STARTED|Cycle 1 Period 2 (2 Weeks)||6
143623|NCT01685801|349940|P1|STARTED|Cycle 1 Period 2 (2 Weeks)||5
143624|NCT01685801|349937|P4|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
143625|NCT01685801|349938|P3|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
143626|NCT01685801|349939|P2|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
143627|NCT01685801|349940|P1|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
143628|NCT01685801|349937|P4|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
143629|NCT01685801|349938|P3|COMPLETED|Cycle 1 Period 1 (2 Weeks)||7
143630|NCT01685801|349939|P2|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
143631|NCT01685801|349940|P1|COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
143632|NCT01685801|349937|P4|STARTED|Cycle 1 Period 1 (2 Weeks)||6
143633|NCT01685801|349938|P3|STARTED|Cycle 1 Period 1 (2 Weeks)||7
143634|NCT01685801|349939|P2|STARTED|Cycle 1 Period 1 (2 Weeks)||6
143635|NCT01685801|349940|P1|STARTED|Cycle 1 Period 1 (2 Weeks)||5
143636|NCT01685697|349962|P2|NOT COMPLETED|Overall Study||3
143637|NCT01685697|349963|P1|NOT COMPLETED|Overall Study||3
143638|NCT01685697|349962|P2|COMPLETED|Overall Study||28
143639|NCT01685697|349963|P1|COMPLETED|Overall Study||28
143640|NCT01685697|349962|P2|STARTED|Overall Study||31
143641|NCT01685697|349963|P1|STARTED|Overall Study||31
143642|NCT01685684|349971|P3|NOT COMPLETED|Double-blind Maintenance Phase||96
143643|NCT01685684|349972|P2|NOT COMPLETED|Double-blind Maintenance Phase||71
143644|NCT01685684|349973|P1|NOT COMPLETED|Double-blind Maintenance Phase||0
143645|NCT01685684|349971|P3|COMPLETED|Double-blind Maintenance Phase||100
143646|NCT01685684|349972|P2|COMPLETED|Double-blind Maintenance Phase||122
143647|NCT01685684|349973|P1|COMPLETED|Double-blind Maintenance Phase||0
143648|NCT01685684|349971|P3|STARTED|Double-blind Maintenance Phase||196
143649|NCT01685684|349972|P2|STARTED|Double-blind Maintenance Phase||193
143650|NCT01685684|349973|P1|STARTED|Double-blind Maintenance Phase||0
143651|NCT01685684|349971|P3|NOT COMPLETED|Titration Phase||0
143652|NCT01685684|349972|P2|NOT COMPLETED|Titration Phase||0
143653|NCT01685684|349973|P1|NOT COMPLETED|Titration Phase||351
143654|NCT01685684|349971|P3|COMPLETED|Titration Phase||0
143655|NCT01685684|349972|P2|COMPLETED|Titration Phase||0
143656|NCT01685684|349973|P1|COMPLETED|Titration Phase||389
143657|NCT01685684|349971|P3|STARTED|Titration Phase||0
143658|NCT01685684|349972|P2|STARTED|Titration Phase||0
143659|NCT01685684|349973|P1|STARTED|Titration Phase||740
143660|NCT01685606|349997|P1|NOT COMPLETED|Overall Study||1
143661|NCT01685606|349997|P1|COMPLETED|Overall Study||5
143662|NCT01685606|349997|P1|STARTED|Overall Study||6
143663|NCT01685567|350002|P1|NOT COMPLETED|Overall Study||0
143664|NCT01685567|350002|P1|COMPLETED|Overall Study||219
143665|NCT01685567|350002|P1|STARTED|Overall Study||219
143666|NCT01685463|350012|P2|NOT COMPLETED|Overall Study||0
143667|NCT01685463|350013|P1|NOT COMPLETED|Overall Study||0
143668|NCT01685463|350012|P2|COMPLETED|Overall Study||8
143669|NCT01685463|350013|P1|COMPLETED|Overall Study||10
143670|NCT01685463|350012|P2|STARTED|Overall Study||8
143671|NCT01685463|350013|P1|STARTED|Overall Study||10
143672|NCT01685437|350025|P1|NOT COMPLETED|Overall Study||31
143673|NCT01685437|350025|P1|COMPLETED|Overall Study||158
143674|NCT01685437|350025|P1|STARTED|Overall Study||189
143675|NCT01685372|350039|P2|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
143676|NCT01685372|350040|P1|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||3
143677|NCT01685372|350039|P2|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||5
143678|NCT01685372|350040|P1|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
143679|NCT01685372|350039|P2|STARTED|Timepoint 3 (T3): 3rd Blood Draw||9
143680|NCT01685372|350040|P1|STARTED|Timepoint 3 (T3): 3rd Blood Draw||7
143681|NCT01685372|350039|P2|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
143682|NCT01685372|350040|P1|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
143683|NCT01685372|350039|P2|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||9
143684|NCT01685372|350040|P1|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||7
143685|NCT01685372|350039|P2|STARTED|Timepoint 2 (T2): 2nd Blood Draw||9
143686|NCT01685372|350040|P1|STARTED|Timepoint 2 (T2): 2nd Blood Draw||7
143687|NCT01685372|350039|P2|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
143688|NCT01685372|350040|P1|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
143689|NCT01685372|350039|P2|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
143690|NCT01685372|350040|P1|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
143691|NCT01685372|350039|P2|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
143692|NCT01685372|350040|P1|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
143693|NCT01685320|350062|P2|NOT COMPLETED|Overall Study||0
143694|NCT01685320|350063|P1|NOT COMPLETED|Overall Study||0
143695|NCT01685320|350062|P2|COMPLETED|Overall Study||15
143696|NCT01685320|350063|P1|COMPLETED|Overall Study||15
143697|NCT01685320|350062|P2|STARTED|Overall Study||15
143698|NCT01685320|350063|P1|STARTED|Overall Study||15
143699|NCT01685242|350073|P2|NOT COMPLETED|Overall Study||3
143700|NCT01685242|350074|P1|NOT COMPLETED|Overall Study||1
143701|NCT01685242|350073|P2|COMPLETED|Overall Study||47
143702|NCT01685242|350074|P1|COMPLETED|Overall Study||49
143703|NCT01685242|350073|P2|STARTED|Overall Study||50
143704|NCT01685242|350074|P1|STARTED|Overall Study||50
143705|NCT01685229|350130|P2|NOT COMPLETED|Overall Study||16
143706|NCT01685229|350131|P1|NOT COMPLETED|Overall Study||26
143707|NCT01685229|350130|P2|COMPLETED|Overall Study||36
143708|NCT01685229|350131|P1|COMPLETED|Overall Study||120
143709|NCT01685229|350130|P2|STARTED|Overall Study||52
143710|NCT01685229|350131|P1|STARTED|Overall Study||146
143711|NCT01685216|350157|P1|NOT COMPLETED|Overall Study||1
143712|NCT01685216|350157|P1|COMPLETED|Overall Study||6
143713|NCT01685216|350157|P1|STARTED|Overall Study||7
143714|NCT01685203|350174|P7|NOT COMPLETED|Overall Study||0
143715|NCT01685203|350175|P6|NOT COMPLETED|Overall Study||3
143716|NCT01685203|350176|P5|NOT COMPLETED|Overall Study||0
143717|NCT01685203|350177|P4|NOT COMPLETED|Overall Study||1
143718|NCT01685203|350178|P3|NOT COMPLETED|Overall Study||0
143719|NCT01685203|350179|P2|NOT COMPLETED|Overall Study||3
143720|NCT01685203|350180|P1|NOT COMPLETED|Overall Study||4
143721|NCT01685203|350174|P7|COMPLETED|Overall Study||52
143722|NCT01685203|350175|P6|COMPLETED|Overall Study||44
143723|NCT01685203|350176|P5|COMPLETED|Overall Study||49
143724|NCT01685203|350177|P4|COMPLETED|Overall Study||41
143725|NCT01685203|350178|P3|COMPLETED|Overall Study||40
143726|NCT01685203|350179|P2|COMPLETED|Overall Study||39
143727|NCT01685203|350180|P1|COMPLETED|Overall Study||40
143728|NCT01685203|350174|P7|Completed Study Drug|Overall Study||52
143729|NCT01685203|350175|P6|Completed Study Drug|Overall Study||43
143730|NCT01685203|350176|P5|Completed Study Drug|Overall Study||49
143731|NCT01685203|350177|P4|Completed Study Drug|Overall Study||42
143732|NCT01685203|350178|P3|Completed Study Drug|Overall Study||39
143733|NCT01685203|350179|P2|Completed Study Drug|Overall Study||40
143734|NCT01685203|350180|P1|Completed Study Drug|Overall Study||42
143735|NCT01685203|350174|P7|STARTED|Overall Study||52
143736|NCT01685203|350175|P6|STARTED|Overall Study||47
143737|NCT01685203|350176|P5|STARTED|Overall Study||49
143738|NCT01685203|350177|P4|STARTED|Overall Study||42
143739|NCT01685203|350178|P3|STARTED|Overall Study||40
143740|NCT01685203|350179|P2|STARTED|Overall Study||42
143741|NCT01685203|350180|P1|STARTED|Overall Study||44
143742|NCT01685138|350224|P1|NOT COMPLETED|Overall Study||92
143743|NCT01685138|350224|P1|COMPLETED|Overall Study||32
143744|NCT01685138|350224|P1|Discontinued From Study|Overall Study||51
143745|NCT01685138|350224|P1|Entered Survival Follow-up|Overall Study||63
143746|NCT01685138|350224|P1|Entered Post-treatment Efficacy f/up|Overall Study||10
143747|NCT01685138|350224|P1|Discontinued From Treatment Phase|Overall Study||124
143748|NCT01685138|350224|P1|STARTED|Overall Study||124
143749|NCT01685073|350240|P2|NOT COMPLETED|Overall Study||32
143750|NCT01685073|350241|P1|NOT COMPLETED|Overall Study||30
143751|NCT01685073|350240|P2|COMPLETED|Overall Study|Retained in treatment through 12 weeks|33
143752|NCT01685073|350241|P1|COMPLETED|Overall Study|Retained in treatment through 12 weeks|32
143753|NCT01685073|350240|P2|STARTED|Overall Study|Randomized|65
143754|NCT01685073|350241|P1|STARTED|Overall Study|Randomized|62
143755|NCT01685060|350249|P1|NOT COMPLETED|Overall Study||140
143756|NCT01685060|350249|P1|COMPLETED|Overall Study||0
143757|NCT01685060|350249|P1|Discontinued From Study|Overall Study||35
143758|NCT01685060|350249|P1|Entered Survival Follow up|Overall Study||98
143759|NCT01685060|350249|P1|Entered Post-treatment Efficacy f/u|Overall Study||7
143760|NCT01685060|350249|P1|STARTED|Overall Study||140
143761|NCT01685047|350264|P1|NOT COMPLETED|Overall Study||85
143762|NCT01685047|350264|P1|COMPLETED|Overall Study||396
143763|NCT01685047|350264|P1|STARTED|Overall Study|481 subjects signed the consent. 1 subject was withdrawn prior to the baseline visit.|481
143764|NCT01685021|350268|P1|NOT COMPLETED|Overall Study||16
143765|NCT01685021|350268|P1|COMPLETED|Overall Study|Last patient last visit date. Study was Terminated prematurely.|6
143766|NCT01685021|350268|P1|STARTED|Overall Study||22
143767|NCT01684930|350279|P2|NOT COMPLETED|Overall Study||1
143768|NCT01684930|350280|P1|NOT COMPLETED|Overall Study||3
143769|NCT01684930|350279|P2|COMPLETED|Overall Study||13
143770|NCT01684930|350280|P1|COMPLETED|Overall Study||9
143771|NCT01684930|350279|P2|STARTED|Overall Study||14
143772|NCT01684930|350280|P1|STARTED|Overall Study||12
143773|NCT01684878|350300|P4|NOT COMPLETED|Part 2: Randomized Phase||78
143774|NCT01684878|350301|P3|NOT COMPLETED|Part 2: Randomized Phase||78
143775|NCT01684878|350302|P2|NOT COMPLETED|Part 2: Randomized Phase||0
143776|NCT01684878|350303|P1|NOT COMPLETED|Part 2: Randomized Phase||0
143777|NCT01684878|350300|P4|COMPLETED|Part 2: Randomized Phase||0
143778|NCT01684878|350301|P3|COMPLETED|Part 2: Randomized Phase||0
143779|NCT01684878|350302|P2|COMPLETED|Part 2: Randomized Phase||0
143780|NCT01684878|350303|P1|COMPLETED|Part 2: Randomized Phase||0
143781|NCT01684878|350300|P4|Participants Mis-randomized|Part 2: Randomized Phase||0
143782|NCT01684878|350301|P3|Participants Mis-randomized|Part 2: Randomized Phase||2
143783|NCT01684878|350302|P2|Participants Mis-randomized|Part 2: Randomized Phase||0
143784|NCT01684878|350303|P1|Participants Mis-randomized|Part 2: Randomized Phase||0
143785|NCT01684878|350300|P4|Participants Randomized But Not Treated|Part 2: Randomized Phase||2
143786|NCT01684878|350301|P3|Participants Randomized But Not Treated|Part 2: Randomized Phase||1
143787|NCT01684878|350302|P2|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
143788|NCT01684878|350303|P1|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
143789|NCT01684878|350300|P4|STARTED|Part 2: Randomized Phase||78
143790|NCT01684878|350301|P3|STARTED|Part 2: Randomized Phase||78
143791|NCT01684878|350302|P2|STARTED|Part 2: Randomized Phase||0
143792|NCT01684878|350303|P1|STARTED|Part 2: Randomized Phase||0
143793|NCT01684878|350300|P4|NOT COMPLETED|Part 1: Safety Run in Phase||0
143794|NCT01684878|350301|P3|NOT COMPLETED|Part 1: Safety Run in Phase||0
143795|NCT01684878|350302|P2|NOT COMPLETED|Part 1: Safety Run in Phase||23
143796|NCT01684878|350303|P1|NOT COMPLETED|Part 1: Safety Run in Phase||16
143797|NCT01684878|350300|P4|COMPLETED|Part 1: Safety Run in Phase||0
143798|NCT01684878|350301|P3|COMPLETED|Part 1: Safety Run in Phase||0
143799|NCT01684878|350302|P2|COMPLETED|Part 1: Safety Run in Phase||5
143800|NCT01684878|350303|P1|COMPLETED|Part 1: Safety Run in Phase||6
143801|NCT01684878|350300|P4|STARTED|Part 1: Safety Run in Phase||0
143802|NCT01684878|350301|P3|STARTED|Part 1: Safety Run in Phase||0
143803|NCT01684878|350302|P2|STARTED|Part 1: Safety Run in Phase||28
143804|NCT01684878|350303|P1|STARTED|Part 1: Safety Run in Phase||22
143805|NCT01684839|350327|P1|NOT COMPLETED|Overall Study||0
143806|NCT01684839|350327|P1|COMPLETED|Overall Study||9
143807|NCT01684839|350327|P1|STARTED|Overall Study||9
143808|NCT01684826|350331|P1|NOT COMPLETED|Overall Study||10
143809|NCT01684826|350331|P1|COMPLETED|Overall Study||39
143810|NCT01684826|350331|P1|Collected Dose and Image Information|Overall Study||39
143811|NCT01684826|350331|P1|STARTED|Overall Study||49
143812|NCT01684748|350339|P2|NOT COMPLETED|Second Intervention - 8 Weeks||0
143813|NCT01684748|350340|P1|NOT COMPLETED|Second Intervention - 8 Weeks||0
143814|NCT01684748|350339|P2|COMPLETED|Second Intervention - 8 Weeks||8
143815|NCT01684748|350340|P1|COMPLETED|Second Intervention - 8 Weeks||8
143816|NCT01684748|350339|P2|STARTED|Second Intervention - 8 Weeks||8
143817|NCT01684748|350340|P1|STARTED|Second Intervention - 8 Weeks||8
143818|NCT01684748|350339|P2|NOT COMPLETED|First Intervention - 8 Weeks||2
143819|NCT01684748|350340|P1|NOT COMPLETED|First Intervention - 8 Weeks||2
143820|NCT01684748|350339|P2|COMPLETED|First Intervention - 8 Weeks||8
143821|NCT01684748|350340|P1|COMPLETED|First Intervention - 8 Weeks||8
143822|NCT01684748|350339|P2|STARTED|First Intervention - 8 Weeks||10
143823|NCT01684748|350340|P1|STARTED|First Intervention - 8 Weeks||10
143824|NCT01684592|350349|P2|NOT COMPLETED|Overall Study||24
143825|NCT01684592|350350|P1|NOT COMPLETED|Overall Study||26
143826|NCT01684592|350349|P2|COMPLETED|Overall Study||40
143827|NCT01684592|350350|P1|COMPLETED|Overall Study||38
143828|NCT01684592|350349|P2|STARTED|Overall Study||64
143829|NCT01684592|350350|P1|STARTED|Overall Study||64
143830|NCT01684566|350370|P2|NOT COMPLETED|Overall Study||7
143831|NCT01684566|350371|P1|NOT COMPLETED|Overall Study||16
143832|NCT01684566|350370|P2|COMPLETED|Overall Study||49
143833|NCT01684566|350371|P1|COMPLETED|Overall Study||44
143834|NCT01684566|350370|P2|Treated (ITT)|Overall Study||52
143835|NCT01684566|350371|P1|Treated (ITT)|Overall Study||57
143836|NCT01684566|350370|P2|STARTED|Overall Study||56
143837|NCT01684566|350371|P1|STARTED|Overall Study||60
143838|NCT01684436|350393|P1|NOT COMPLETED|Overall Study||1
143839|NCT01684436|350393|P1|COMPLETED|Overall Study||29
143840|NCT01684436|350393|P1|STARTED|Overall Study||30
143841|NCT01684423|350407|P5|NOT COMPLETED|Overall Study||0
143842|NCT01684423|350408|P4|NOT COMPLETED|Overall Study||0
143843|NCT01684423|350409|P3|NOT COMPLETED|Overall Study||1
143844|NCT01684423|350410|P2|NOT COMPLETED|Overall Study||0
143845|NCT01684423|350411|P1|NOT COMPLETED|Overall Study||0
143846|NCT01684423|350407|P5|COMPLETED|Overall Study||7
143847|NCT01684423|350408|P4|COMPLETED|Overall Study||19
143848|NCT01684423|350409|P3|COMPLETED|Overall Study||12
143849|NCT01684423|350410|P2|COMPLETED|Overall Study||13
143850|NCT01684423|350411|P1|COMPLETED|Overall Study||11
143851|NCT01684423|350407|P5|STARTED|Overall Study||7
143852|NCT01684423|350408|P4|STARTED|Overall Study||19
143853|NCT01684423|350409|P3|STARTED|Overall Study||13
143854|NCT01684423|350410|P2|STARTED|Overall Study||13
143855|NCT01684423|350411|P1|STARTED|Overall Study||11
143856|NCT01684410|350448|P3|NOT COMPLETED|Overall Study||0
143857|NCT01684410|350449|P2|NOT COMPLETED|Overall Study||0
143858|NCT01684410|350450|P1|NOT COMPLETED|Overall Study||0
143859|NCT01684410|350448|P3|COMPLETED|Overall Study||10
143860|NCT01684410|350449|P2|COMPLETED|Overall Study||10
143861|NCT01684410|350450|P1|COMPLETED|Overall Study||10
143862|NCT01684410|350448|P3|STARTED|Overall Study||10
143863|NCT01684410|350449|P2|STARTED|Overall Study||10
143864|NCT01684410|350450|P1|STARTED|Overall Study||10
143865|NCT01684215|350468|P4|NOT COMPLETED|Phase 2||43
143866|NCT01684215|350469|P3|NOT COMPLETED|Phase 2||0
143867|NCT01684215|350470|P2|NOT COMPLETED|Phase 2||0
143868|NCT01684215|350471|P1|NOT COMPLETED|Phase 2||0
143869|NCT01684215|350468|P4|COMPLETED|Phase 2||0
143870|NCT01684215|350469|P3|COMPLETED|Phase 2||0
143871|NCT01684215|350470|P2|COMPLETED|Phase 2||0
143872|NCT01684215|350471|P1|COMPLETED|Phase 2||0
143873|NCT01684215|350468|P4|Treated|Phase 2||42
143874|NCT01684215|350469|P3|Treated|Phase 2||0
143875|NCT01684215|350470|P2|Treated|Phase 2||0
143876|NCT01684215|350471|P1|Treated|Phase 2||0
143877|NCT01684215|350468|P4|STARTED|Phase 2|Eligible participants who consented for Phase 2.|43
143878|NCT01684215|350469|P3|STARTED|Phase 2||0
143879|NCT01684215|350470|P2|STARTED|Phase 2||0
143880|NCT01684215|350471|P1|STARTED|Phase 2||0
143881|NCT01684215|350468|P4|NOT COMPLETED|Phase 1, Part 2||0
143882|NCT01684215|350469|P3|NOT COMPLETED|Phase 1, Part 2||6
143883|NCT01684215|350470|P2|NOT COMPLETED|Phase 1, Part 2||0
143884|NCT01684215|350471|P1|NOT COMPLETED|Phase 1, Part 2||0
143885|NCT01684215|350468|P4|COMPLETED|Phase 1, Part 2||0
143886|NCT01684215|350469|P3|COMPLETED|Phase 1, Part 2||0
143887|NCT01684215|350470|P2|COMPLETED|Phase 1, Part 2||0
143888|NCT01684215|350471|P1|COMPLETED|Phase 1, Part 2||0
143889|NCT01684215|350468|P4|STARTED|Phase 1, Part 2||0
143890|NCT01684215|350469|P3|STARTED|Phase 1, Part 2|Eligible participants who consented for Phase 1 Part 2.|6
143891|NCT01684215|350470|P2|STARTED|Phase 1, Part 2||0
143892|NCT01684215|350471|P1|STARTED|Phase 1, Part 2||0
143893|NCT01684215|350468|P4|NOT COMPLETED|Phase 1, Part 1||0
143894|NCT01684215|350469|P3|NOT COMPLETED|Phase 1, Part 1||0
143895|NCT01684215|350470|P2|NOT COMPLETED|Phase 1, Part 1||6
143896|NCT01684215|350471|P1|NOT COMPLETED|Phase 1, Part 1||6
143897|NCT01684215|350468|P4|COMPLETED|Phase 1, Part 1||0
143898|NCT01684215|350469|P3|COMPLETED|Phase 1, Part 1||0
143899|NCT01684215|350470|P2|COMPLETED|Phase 1, Part 1||0
143900|NCT01684215|350471|P1|COMPLETED|Phase 1, Part 1||0
143901|NCT01684215|350468|P4|Treated|Phase 1, Part 1||0
143902|NCT01684215|350469|P3|Treated|Phase 1, Part 1||0
143903|NCT01684215|350470|P2|Treated|Phase 1, Part 1||6
143904|NCT01684215|350471|P1|Treated|Phase 1, Part 1||6
143905|NCT01684215|350468|P4|STARTED|Phase 1, Part 1||0
143906|NCT01684215|350469|P3|STARTED|Phase 1, Part 1||0
143907|NCT01684215|350470|P2|STARTED|Phase 1, Part 1||6
143908|NCT01684215|350471|P1|STARTED|Phase 1, Part 1||6
143909|NCT01684046|350545|P2|NOT COMPLETED|Period 2, Second 30 Days||0
143910|NCT01684046|350546|P1|NOT COMPLETED|Period 2, Second 30 Days||0
143911|NCT01684046|350545|P2|COMPLETED|Period 2, Second 30 Days||93
143912|NCT01684046|350546|P1|COMPLETED|Period 2, Second 30 Days||97
143913|NCT01684046|350545|P2|STARTED|Period 2, Second 30 Days||93
143914|NCT01684046|350546|P1|STARTED|Period 2, Second 30 Days||97
143915|NCT01684046|350545|P2|NOT COMPLETED|Period 1, First 30 Days||2
143916|NCT01684046|350546|P1|NOT COMPLETED|Period 1, First 30 Days||0
143917|NCT01684046|350545|P2|COMPLETED|Period 1, First 30 Days||93
143918|NCT01684046|350546|P1|COMPLETED|Period 1, First 30 Days||97
143919|NCT01684046|350545|P2|STARTED|Period 1, First 30 Days||95
143920|NCT01684046|350546|P1|STARTED|Period 1, First 30 Days||97
143921|NCT01684033|350552|P2|NOT COMPLETED|Period 2, Second 30 Days||0
143922|NCT01684033|350553|P1|NOT COMPLETED|Period 2, Second 30 Days||1
143923|NCT01684033|350552|P2|COMPLETED|Period 2, Second 30 Days||98
143924|NCT01684033|350553|P1|COMPLETED|Period 2, Second 30 Days||94
143925|NCT01684033|350552|P2|STARTED|Period 2, Second 30 Days||98
143926|NCT01684033|350553|P1|STARTED|Period 2, Second 30 Days||95
143927|NCT01684033|350552|P2|NOT COMPLETED|Period 1, First 30 Days||1
143928|NCT01684033|350553|P1|NOT COMPLETED|Period 1, First 30 Days||4
143929|NCT01684033|350552|P2|COMPLETED|Period 1, First 30 Days||98
143930|NCT01684033|350553|P1|COMPLETED|Period 1, First 30 Days||95
143931|NCT01684033|350552|P2|STARTED|Period 1, First 30 Days||99
143932|NCT01684033|350553|P1|STARTED|Period 1, First 30 Days||99
143933|NCT01684007|350563|P2|NOT COMPLETED|Overall Study||0
143934|NCT01684007|350564|P1|NOT COMPLETED|Overall Study||0
143935|NCT01684007|350563|P2|COMPLETED|Overall Study||50
143936|NCT01684007|350564|P1|COMPLETED|Overall Study||53
143937|NCT01684007|350563|P2|STARTED|Overall Study||50
143938|NCT01684007|350564|P1|STARTED|Overall Study||53
143939|NCT01683994|350577|P5|NOT COMPLETED|Overall Study||1
143940|NCT01683994|350578|P4|NOT COMPLETED|Overall Study||3
143941|NCT01683994|350579|P3|NOT COMPLETED|Overall Study||0
143942|NCT01683994|350580|P2|NOT COMPLETED|Overall Study||0
143943|NCT01683994|350581|P1|NOT COMPLETED|Overall Study||1
143944|NCT01683994|350577|P5|COMPLETED|Overall Study||12
143945|NCT01683994|350578|P4|COMPLETED|Overall Study||10
143946|NCT01683994|350579|P3|COMPLETED|Overall Study||7
143947|NCT01683994|350580|P2|COMPLETED|Overall Study||8
143948|NCT01683994|350581|P1|COMPLETED|Overall Study||3
143949|NCT01683994|350577|P5|# of Patients Who Received Treatment|Overall Study||13
143950|NCT01683994|350578|P4|# of Patients Who Received Treatment|Overall Study||12
143951|NCT01683994|350579|P3|# of Patients Who Received Treatment|Overall Study||7
143952|NCT01683994|350580|P2|# of Patients Who Received Treatment|Overall Study||8
143953|NCT01683994|350581|P1|# of Patients Who Received Treatment|Overall Study||4
143954|NCT01683994|350577|P5|STARTED|Overall Study||13
143955|NCT01683994|350578|P4|STARTED|Overall Study||13
143956|NCT01683994|350579|P3|STARTED|Overall Study||7
143957|NCT01683994|350580|P2|STARTED|Overall Study||8
143958|NCT01683994|350581|P1|STARTED|Overall Study||4
143959|NCT01683864|350610|P3|NOT COMPLETED|Overall Study||0
143960|NCT01683864|350611|P2|NOT COMPLETED|Overall Study||0
143961|NCT01683864|350612|P1|NOT COMPLETED|Overall Study||0
143962|NCT01683864|350610|P3|COMPLETED|Overall Study||0
143963|NCT01683864|350611|P2|COMPLETED|Overall Study||0
143964|NCT01683864|350612|P1|COMPLETED|Overall Study||0
143965|NCT01683864|350610|P3|STARTED|Overall Study||0
143966|NCT01683864|350611|P2|STARTED|Overall Study||0
143967|NCT01683864|350612|P1|STARTED|Overall Study||0
143968|NCT01683838|350622|P2|NOT COMPLETED|Overall Study||12
143969|NCT01683838|350623|P1|NOT COMPLETED|Overall Study||26
143970|NCT01683838|350622|P2|COMPLETED|Overall Study||88
143971|NCT01683838|350623|P1|COMPLETED|Overall Study||78
143972|NCT01683838|350622|P2|Efficacy Population|Overall Study||93
143973|NCT01683838|350623|P1|Efficacy Population|Overall Study||89
143974|NCT01683838|350622|P2|Safety Population|Overall Study||100
143975|NCT01683838|350623|P1|Safety Population|Overall Study||103
143976|NCT01683838|350622|P2|Intent to Treat (ITT) Population|Overall Study||100
143977|NCT01683838|350623|P1|Intent to Treat (ITT) Population|Overall Study||103
143978|NCT01683838|350622|P2|STARTED|Overall Study||100
143979|NCT01683838|350623|P1|STARTED|Overall Study||104
143980|NCT01683812|350645|P1|NOT COMPLETED|Overall Study||0
143981|NCT01683812|350645|P1|COMPLETED|Overall Study||23
143982|NCT01683812|350645|P1|STARTED|Overall Study||23
143983|NCT01683630|350652|P2|NOT COMPLETED|Overall Study||0
143984|NCT01683630|350653|P1|NOT COMPLETED|Overall Study||0
143985|NCT01683630|350652|P2|COMPLETED|Overall Study||445
143986|NCT01683630|350653|P1|COMPLETED|Overall Study||1404
143987|NCT01683630|350652|P2|STARTED|Overall Study||445
143988|NCT01683630|350653|P1|STARTED|Overall Study||1404
143989|NCT01683604|350663|P1|NOT COMPLETED|Overall Study||5
143990|NCT01683604|350663|P1|COMPLETED|Overall Study||32
143991|NCT01683604|350663|P1|STARTED|Overall Study||37
143992|NCT01683565|350828|P2|NOT COMPLETED|Overall Study||1
143993|NCT01683565|350829|P1|NOT COMPLETED|Overall Study||3
143994|NCT01683565|350828|P2|COMPLETED|Overall Study||15
143995|NCT01683565|350829|P1|COMPLETED|Overall Study||12
143996|NCT01683565|350828|P2|STARTED|Overall Study||16
143997|NCT01683565|350829|P1|STARTED|Overall Study||15
143998|NCT01683526|350843|P2|NOT COMPLETED|Overall Study||0
143999|NCT01683526|350844|P1|NOT COMPLETED|Overall Study||0
144000|NCT01683526|350843|P2|COMPLETED|Overall Study||57
144001|NCT01683526|350844|P1|COMPLETED|Overall Study||60
144002|NCT01683526|350843|P2|STARTED|Overall Study||57
144003|NCT01683526|350844|P1|STARTED|Overall Study||60
144004|NCT01683409|350863|P5|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||3
144005|NCT01683409|350864|P4|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
144006|NCT01683409|350865|P3|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||1
144007|NCT01683409|350866|P2|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
144008|NCT01683409|350867|P1|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
144009|NCT01683409|350863|P5|COMPLETED|Washout Period 2 (Weeks 29-32)||9
144010|NCT01683409|350864|P4|COMPLETED|Washout Period 2 (Weeks 29-32)||6
144011|NCT01683409|350865|P3|COMPLETED|Washout Period 2 (Weeks 29-32)||7
144012|NCT01683409|350866|P2|COMPLETED|Washout Period 2 (Weeks 29-32)||6
144013|NCT01683409|350867|P1|COMPLETED|Washout Period 2 (Weeks 29-32)||6
144014|NCT01683409|350863|P5|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 8 participants.|12
144015|NCT01683409|350864|P4|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 16 participants.|6
144016|NCT01683409|350865|P3|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 17 participants.|8
144017|NCT01683409|350866|P2|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 11 participants.|6
144018|NCT01683409|350867|P1|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 18 participants.|6
144019|NCT01683409|350863|P5|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
144020|NCT01683409|350864|P4|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||2
144021|NCT01683409|350865|P3|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||1
144022|NCT01683409|350866|P2|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||4
144023|NCT01683409|350867|P1|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
144024|NCT01683409|350863|P5|COMPLETED|Washout Period 1 (Weeks 25-28)||20
144025|NCT01683409|350864|P4|COMPLETED|Washout Period 1 (Weeks 25-28)||22
144026|NCT01683409|350865|P3|COMPLETED|Washout Period 1 (Weeks 25-28)||25
144027|NCT01683409|350866|P2|COMPLETED|Washout Period 1 (Weeks 25-28)||17
144028|NCT01683409|350867|P1|COMPLETED|Washout Period 1 (Weeks 25-28)||24
144029|NCT01683409|350863|P5|STARTED|Washout Period 1 (Weeks 25-28)||23
144030|NCT01683409|350864|P4|STARTED|Washout Period 1 (Weeks 25-28)||24
144031|NCT01683409|350865|P3|STARTED|Washout Period 1 (Weeks 25-28)||26
144032|NCT01683409|350866|P2|STARTED|Washout Period 1 (Weeks 25-28)||21
144033|NCT01683409|350867|P1|STARTED|Washout Period 1 (Weeks 25-28)||27
144034|NCT01683409|350863|P5|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
144035|NCT01683409|350864|P4|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
144036|NCT01683409|350865|P3|NOT COMPLETED|Treatment Period (Weeks 1-24)||1
144037|NCT01683409|350866|P2|NOT COMPLETED|Treatment Period (Weeks 1-24)||4
144038|NCT01683409|350867|P1|NOT COMPLETED|Treatment Period (Weeks 1-24)||0
144039|NCT01683409|350863|P5|COMPLETED|Treatment Period (Weeks 1-24)||23
144040|NCT01683409|350864|P4|COMPLETED|Treatment Period (Weeks 1-24)||24
144041|NCT01683409|350865|P3|COMPLETED|Treatment Period (Weeks 1-24)||26
144042|NCT01683409|350866|P2|COMPLETED|Treatment Period (Weeks 1-24)||21
144043|NCT01683409|350867|P1|COMPLETED|Treatment Period (Weeks 1-24)||27
144044|NCT01683409|350863|P5|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
144045|NCT01683409|350864|P4|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
144046|NCT01683409|350865|P3|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
144047|NCT01683409|350866|P2|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
144048|NCT01683409|350867|P1|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||27
144049|NCT01683409|350863|P5|STARTED|Treatment Period (Weeks 1-24)||25
144050|NCT01683409|350864|P4|STARTED|Treatment Period (Weeks 1-24)||26
144051|NCT01683409|350865|P3|STARTED|Treatment Period (Weeks 1-24)||27
144052|NCT01683409|350866|P2|STARTED|Treatment Period (Weeks 1-24)||25
144053|NCT01683409|350867|P1|STARTED|Treatment Period (Weeks 1-24)||27
144054|NCT01683383|350910|P2|NOT COMPLETED|Overall Study||0
144055|NCT01683383|350911|P1|NOT COMPLETED|Overall Study||1
144056|NCT01683383|350910|P2|COMPLETED|Overall Study||51
144057|NCT01683383|350911|P1|COMPLETED|Overall Study||49
144058|NCT01683383|350910|P2|Transported and Treated|Overall Study||51
144059|NCT01683383|350911|P1|Transported and Treated|Overall Study||49
144060|NCT01683383|350910|P2|STARTED|Overall Study||51
144061|NCT01683383|350911|P1|STARTED|Overall Study||50
144062|NCT01683331|350927|P2|NOT COMPLETED|Overall Study||0
144063|NCT01683331|350928|P1|NOT COMPLETED|Overall Study||0
144064|NCT01683331|350927|P2|COMPLETED|Overall Study||18
144065|NCT01683331|350928|P1|COMPLETED|Overall Study||18
144066|NCT01683331|350927|P2|24 Months|Overall Study||18
144067|NCT01683331|350928|P1|24 Months|Overall Study||18
144068|NCT01683331|350927|P2|12 Months|Overall Study||18
144069|NCT01683331|350928|P1|12 Months|Overall Study||18
144070|NCT01683331|350927|P2|Began Dosage|Overall Study||18
144071|NCT01683331|350928|P1|Began Dosage|Overall Study||18
144072|NCT01683331|350927|P2|STARTED|Overall Study||18
144073|NCT01683331|350928|P1|STARTED|Overall Study||18
144074|NCT01683266|350938|P2|NOT COMPLETED|Overall Study||50
144075|NCT01683266|350939|P1|NOT COMPLETED|Overall Study||55
144076|NCT01683266|350938|P2|COMPLETED|Overall Study||225
144077|NCT01683266|350939|P1|COMPLETED|Overall Study||219
144078|NCT01683266|350938|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
144079|NCT01683266|350939|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
144080|NCT01683266|350938|P2|STARTED|Overall Study||275
144081|NCT01683266|350939|P1|STARTED|Overall Study||274
144082|NCT01683058|350967|P1|NOT COMPLETED|Overall Study||29
144083|NCT01683058|350967|P1|COMPLETED|Overall Study||45
144084|NCT01683058|350967|P1|STARTED|Overall Study||74
144085|NCT01683019|350998|P3|NOT COMPLETED|Overall Study||4
144086|NCT01683019|350999|P2|NOT COMPLETED|Overall Study||1
144087|NCT01683019|351000|P1|NOT COMPLETED|Overall Study||2
144088|NCT01683019|350998|P3|COMPLETED|Overall Study||15
144089|NCT01683019|350999|P2|COMPLETED|Overall Study||14
144090|NCT01683019|351000|P1|COMPLETED|Overall Study||16
144091|NCT01683019|350998|P3|STARTED|Overall Study||19
144092|NCT01683019|350999|P2|STARTED|Overall Study||15
144093|NCT01683019|351000|P1|STARTED|Overall Study||18
144094|NCT01682954|351010|P2|NOT COMPLETED|Overall Study||5
144095|NCT01682954|351011|P1|NOT COMPLETED|Overall Study||5
144096|NCT01682954|351010|P2|COMPLETED|Overall Study||33
144097|NCT01682954|351011|P1|COMPLETED|Overall Study||35
144098|NCT01682954|351010|P2|STARTED|Overall Study||38
144099|NCT01682954|351011|P1|STARTED|Overall Study||40
144100|NCT01682876|351023|P4|NOT COMPLETED|Overall Study||19
144101|NCT01682876|351024|P3|NOT COMPLETED|Overall Study||11
144102|NCT01682876|351025|P2|NOT COMPLETED|Overall Study||20
144103|NCT01682876|351026|P1|NOT COMPLETED|Overall Study||21
144104|NCT01682876|351023|P4|COMPLETED|Overall Study||157
144105|NCT01682876|351024|P3|COMPLETED|Overall Study||169
144106|NCT01682876|351025|P2|COMPLETED|Overall Study||163
144107|NCT01682876|351026|P1|COMPLETED|Overall Study||155
144108|NCT01682876|351023|P4|STARTED|Overall Study||176
144109|NCT01682876|351024|P3|STARTED|Overall Study||180
144110|NCT01682876|351025|P2|STARTED|Overall Study||183
144111|NCT01682876|351026|P1|STARTED|Overall Study||176
144112|NCT01682863|351072|P3|NOT COMPLETED|Overall Study||24
144113|NCT01682863|351073|P2|NOT COMPLETED|Overall Study||17
144114|NCT01682863|351074|P1|NOT COMPLETED|Overall Study||27
144115|NCT01682863|351072|P3|COMPLETED|Overall Study||183
144116|NCT01682863|351073|P2|COMPLETED|Overall Study||187
144117|NCT01682863|351074|P1|COMPLETED|Overall Study||177
144118|NCT01682863|351072|P3|Randomized Set|Overall Study|1 randomized patient was not treated; experienced an AE prior to receiving any study drug|207
144119|NCT01682863|351073|P2|Randomized Set|Overall Study||204
144120|NCT01682863|351074|P1|Randomized Set|Overall Study||204
144121|NCT01682863|351072|P3|Full Analysis Set (FAS)|Overall Study||206
144122|NCT01682863|351073|P2|Full Analysis Set (FAS)|Overall Study||204
144123|NCT01682863|351074|P1|Full Analysis Set (FAS)|Overall Study|included all randomized patients who received at least one dose of study medication|204
144124|NCT01682863|351072|P3|Safety Set|Overall Study||206
144125|NCT01682863|351073|P2|Safety Set|Overall Study||204
144126|NCT01682863|351074|P1|Safety Set|Overall Study||204
144127|NCT01682863|351072|P3|STARTED|Overall Study||207
144128|NCT01682863|351073|P2|STARTED|Overall Study||204
144129|NCT01682863|351074|P1|STARTED|Overall Study||204
144130|NCT01682837|351103|P1|NOT COMPLETED|Fourth Intervention (4 Weeks)||0
144131|NCT01682837|351103|P1|COMPLETED|Fourth Intervention (4 Weeks)||30
144132|NCT01682837|351103|P1|Received Placebo|Fourth Intervention (4 Weeks)||7
144133|NCT01682837|351103|P1|Received KCl|Fourth Intervention (4 Weeks)||8
144134|NCT01682837|351103|P1|Received KCit|Fourth Intervention (4 Weeks)||9
144135|NCT01682837|351103|P1|Received KMgCit|Fourth Intervention (4 Weeks)||6
144136|NCT01682837|351103|P1|STARTED|Fourth Intervention (4 Weeks)||30
144137|NCT01682837|351103|P1|NOT COMPLETED|Third Intervention (4 Weeks)||0
144138|NCT01682837|351103|P1|COMPLETED|Third Intervention (4 Weeks)||30
144139|NCT01682837|351103|P1|Received Placebo|Third Intervention (4 Weeks)||7
144140|NCT01682837|351103|P1|Received KCl|Third Intervention (4 Weeks)||7
144141|NCT01682837|351103|P1|Received KCit|Third Intervention (4 Weeks)||7
144142|NCT01682837|351103|P1|Received KMgCit|Third Intervention (4 Weeks)||9
144143|NCT01682837|351103|P1|STARTED|Third Intervention (4 Weeks)||30
144144|NCT01682837|351103|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
144145|NCT01682837|351103|P1|COMPLETED|Second Intervention (4 Weeks)||30
144146|NCT01682837|351103|P1|Received Placebo|Second Intervention (4 Weeks)||9
144147|NCT01682837|351103|P1|Received KCl|Second Intervention (4 Weeks)||8
144148|NCT01682837|351103|P1|Received KCit|Second Intervention (4 Weeks)||6
144149|NCT01682837|351103|P1|Received KMgCit|Second Intervention (4 Weeks)||7
144150|NCT01682837|351103|P1|STARTED|Second Intervention (4 Weeks)||30
144151|NCT01682837|351103|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
144152|NCT01682837|351103|P1|COMPLETED|First Intervention (4 Weeks)||30
144153|NCT01682837|351103|P1|Received Placebo|First Intervention (4 Weeks)||7
144154|NCT01682837|351103|P1|Received KCl|First Intervention (4 Weeks)||7
144155|NCT01682837|351103|P1|Received KCit|First Intervention (4 Weeks)||8
144156|NCT01682837|351103|P1|Received KMgCit|First Intervention (4 Weeks)||8
144157|NCT01682837|351103|P1|STARTED|First Intervention (4 Weeks)||30
144158|NCT01682837|351103|P1|NOT COMPLETED|Baseline||5
144159|NCT01682837|351103|P1|COMPLETED|Baseline||30
144160|NCT01682837|351103|P1|STARTED|Baseline||35
144161|NCT01682759|351147|P2|NOT COMPLETED|Overall Study||70
144162|NCT01682759|351148|P1|NOT COMPLETED|Overall Study||69
144163|NCT01682759|351147|P2|COMPLETED|Overall Study||305
144164|NCT01682759|351148|P1|COMPLETED|Overall Study||307
144165|NCT01682759|351147|P2|Treated|Overall Study||375
144166|NCT01682759|351148|P1|Treated|Overall Study||375
144167|NCT01682759|351147|P2|STARTED|Overall Study||375
144168|NCT01682759|351148|P1|STARTED|Overall Study||376
144169|NCT01682720|351172|P4|NOT COMPLETED|Overall Study||39
144170|NCT01682720|351173|P3|NOT COMPLETED|Overall Study||7
144171|NCT01682720|351174|P2|NOT COMPLETED|Overall Study||5
144172|NCT01682720|351175|P1|NOT COMPLETED|Overall Study||85
144173|NCT01682720|351172|P4|COMPLETED|Overall Study||211
144174|NCT01682720|351173|P3|COMPLETED|Overall Study||5
144175|NCT01682720|351174|P2|COMPLETED|Overall Study||69
144176|NCT01682720|351175|P1|COMPLETED|Overall Study||0
144177|NCT01682720|351172|P4|Included in Full Analysis Set|Overall Study||250
144178|NCT01682720|351173|P3|Included in Full Analysis Set|Overall Study||11
144179|NCT01682720|351174|P2|Included in Full Analysis Set|Overall Study||73
144180|NCT01682720|351175|P1|Included in Full Analysis Set|Overall Study||0
144181|NCT01682720|351172|P4|STARTED|Overall Study||250
144182|NCT01682720|351173|P3|STARTED|Overall Study||12
144183|NCT01682720|351174|P2|STARTED|Overall Study||74
144184|NCT01682720|351175|P1|STARTED|Overall Study||85
144185|NCT01682681|351192|P1|NOT COMPLETED|Overall Study||332
144186|NCT01682681|351192|P1|COMPLETED|Overall Study||902
144187|NCT01682681|351192|P1|Treated|Overall Study|2 Participants were not compliant with eligibility criteria|1232
144188|NCT01682681|351192|P1|STARTED|Overall Study||1234
144189|NCT01682642|351202|P2|NOT COMPLETED|Overall Study||1
144190|NCT01682642|351203|P1|NOT COMPLETED|Overall Study||0
144191|NCT01682642|351202|P2|COMPLETED|Overall Study||58
144192|NCT01682642|351203|P1|COMPLETED|Overall Study||61
144193|NCT01682642|351202|P2|STARTED|Overall Study||59
144194|NCT01682642|351203|P1|STARTED|Overall Study||61
144195|NCT01682603|351221|P1|NOT COMPLETED|Overall Study||3
144196|NCT01682603|351221|P1|COMPLETED|Overall Study||34
144197|NCT01682603|351221|P1|STARTED|Overall Study||37
144198|NCT01682538|351235|P1|NOT COMPLETED|Overall Study||0
144199|NCT01682538|351235|P1|COMPLETED|Overall Study||12
144200|NCT01682538|351235|P1|STARTED|Overall Study||12
144201|NCT01682512|351266|P3|NOT COMPLETED|Overall Study||18
144202|NCT01682512|351267|P2|NOT COMPLETED|Overall Study||71
144203|NCT01682512|351268|P1|NOT COMPLETED|Overall Study||72
144204|NCT01682512|351266|P3|COMPLETED|Overall Study||48
144205|NCT01682512|351267|P2|COMPLETED|Overall Study||40
144206|NCT01682512|351268|P1|COMPLETED|Overall Study||44
144207|NCT01682512|351266|P3|Randomized in Part-II|Overall Study||0
144208|NCT01682512|351267|P2|Randomized in Part-II|Overall Study||46
144209|NCT01682512|351268|P1|Randomized in Part-II|Overall Study||50
144210|NCT01682512|351266|P3|Randomized in Part-I|Overall Study||66
144211|NCT01682512|351267|P2|Randomized in Part-I|Overall Study||65
144212|NCT01682512|351268|P1|Randomized in Part-I|Overall Study||66
144213|NCT01682512|351266|P3|STARTED|Overall Study||66
144214|NCT01682512|351267|P2|STARTED|Overall Study||111
144215|NCT01682512|351268|P1|STARTED|Overall Study||116
144216|NCT01682460|351293|P1|NOT COMPLETED|Overall Study||4
144217|NCT01682460|351293|P1|COMPLETED|Overall Study||11
144218|NCT01682460|351293|P1|STARTED|Overall Study||15
144219|NCT01682148|351310|P2|NOT COMPLETED|Overall Study||3
144220|NCT01682148|351311|P1|NOT COMPLETED|Overall Study||4
144221|NCT01682148|351310|P2|COMPLETED|Overall Study||41
144222|NCT01682148|351311|P1|COMPLETED|Overall Study||40
144223|NCT01682148|351310|P2|STARTED|Overall Study||44
144224|NCT01682148|351311|P1|STARTED|Overall Study||44
144225|NCT01682135|351335|P3|NOT COMPLETED|Overall Study||0
144226|NCT01682135|351336|P2|NOT COMPLETED|Overall Study||0
144227|NCT01682135|351337|P1|NOT COMPLETED|Overall Study||0
144228|NCT01682135|351335|P3|COMPLETED|Overall Study||12
144229|NCT01682135|351336|P2|COMPLETED|Overall Study||10
144230|NCT01682135|351337|P1|COMPLETED|Overall Study||6
144231|NCT01682135|351335|P3|Received at Least 1 Dose of Study Drug|Overall Study||12
144232|NCT01682135|351336|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
144233|NCT01682135|351337|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
144234|NCT01682135|351335|P3|STARTED|Overall Study||12
144235|NCT01682135|351336|P2|STARTED|Overall Study||10
144236|NCT01682135|351337|P1|STARTED|Overall Study||6
144237|NCT01682083|351371|P2|NOT COMPLETED|Overall Study||155
144238|NCT01682083|351372|P1|NOT COMPLETED|Overall Study||107
144239|NCT01682083|351371|P2|COMPLETED|Overall Study|Ongoing patients at the time of data cut-off.|277
144240|NCT01682083|351372|P1|COMPLETED|Overall Study|Ongoing patients at the time of data cut-off. 3 patients were untreated|331
144241|NCT01682083|351371|P2|STARTED|Overall Study||432
144242|NCT01682083|351372|P1|STARTED|Overall Study||438
144243|NCT01682044|351384|P1|NOT COMPLETED|Overall Study||4
144244|NCT01682044|351384|P1|COMPLETED|Overall Study||16
144245|NCT01682044|351384|P1|STARTED|Overall Study||20
144246|NCT01682031|351396|P2|NOT COMPLETED|Overall Study||5
144247|NCT01682031|351397|P1|NOT COMPLETED|Overall Study||1
144248|NCT01682031|351396|P2|COMPLETED|Overall Study||5
144249|NCT01682031|351397|P1|COMPLETED|Overall Study||7
144250|NCT01682031|351396|P2|STARTED|Overall Study||10
144251|NCT01682031|351397|P1|STARTED|Overall Study||8
144252|NCT01681992|351420|P3|NOT COMPLETED|Overall Study||83
144253|NCT01681992|351421|P2|NOT COMPLETED|Overall Study||70
144254|NCT01681992|351422|P1|NOT COMPLETED|Overall Study||66
144255|NCT01681992|351420|P3|COMPLETED|Overall Study||1443
144256|NCT01681992|351421|P2|COMPLETED|Overall Study||1427
144257|NCT01681992|351422|P1|COMPLETED|Overall Study||1427
144258|NCT01681992|351420|P3|STARTED|Overall Study||1526
144259|NCT01681992|351421|P2|STARTED|Overall Study||1497
144260|NCT01681992|351422|P1|STARTED|Overall Study||1493
144261|NCT01681849|351511|P3|NOT COMPLETED|Overall Study||39
144262|NCT01681849|351512|P2|NOT COMPLETED|Overall Study||7
144263|NCT01681849|351513|P1|NOT COMPLETED|Overall Study||8
144264|NCT01681849|351511|P3|COMPLETED|Overall Study||17
144265|NCT01681849|351512|P2|COMPLETED|Overall Study||6
144266|NCT01681849|351513|P1|COMPLETED|Overall Study||7
144267|NCT01681849|351511|P3|STARTED|Overall Study||56
144268|NCT01681849|351512|P2|STARTED|Overall Study||13
144269|NCT01681849|351513|P1|STARTED|Overall Study||15
144270|NCT01681836|351522|P2|NOT COMPLETED|Second Intervention||1
144271|NCT01681836|351523|P1|NOT COMPLETED|Second Intervention||0
144272|NCT01681836|351522|P2|COMPLETED|Second Intervention||4
144273|NCT01681836|351523|P1|COMPLETED|Second Intervention||6
144274|NCT01681836|351522|P2|STARTED|Second Intervention||5
144275|NCT01681836|351523|P1|STARTED|Second Intervention||6
144276|NCT01681836|351522|P2|NOT COMPLETED|Washout Period of 3-7 Days||0
144277|NCT01681836|351523|P1|NOT COMPLETED|Washout Period of 3-7 Days||0
144278|NCT01681836|351522|P2|COMPLETED|Washout Period of 3-7 Days||5
144279|NCT01681836|351523|P1|COMPLETED|Washout Period of 3-7 Days||6
144280|NCT01681836|351522|P2|STARTED|Washout Period of 3-7 Days||5
144281|NCT01681836|351523|P1|STARTED|Washout Period of 3-7 Days||6
144282|NCT01681836|351522|P2|NOT COMPLETED|First Intervention||0
144283|NCT01681836|351523|P1|NOT COMPLETED|First Intervention||0
144284|NCT01681836|351522|P2|COMPLETED|First Intervention||5
144285|NCT01681836|351523|P1|COMPLETED|First Intervention||6
144286|NCT01681836|351522|P2|STARTED|First Intervention||5
144287|NCT01681836|351523|P1|STARTED|First Intervention||6
144288|NCT01681810|351547|P1|NOT COMPLETED|Overall Study||0
144289|NCT01681810|351547|P1|COMPLETED|Overall Study||20
144290|NCT01681810|351547|P1|STARTED|Overall Study||20
144291|NCT01681771|351557|P2|NOT COMPLETED|Overall Study||2
144292|NCT01681771|351558|P1|NOT COMPLETED|Overall Study||4
144293|NCT01681771|351557|P2|COMPLETED|Overall Study||23
144294|NCT01681771|351558|P1|COMPLETED|Overall Study||21
144295|NCT01681771|351557|P2|STARTED|Overall Study||25
144296|NCT01681771|351558|P1|STARTED|Overall Study||25
144297|NCT01681628|351566|P2|NOT COMPLETED|19 Months Follow-up||43
144298|NCT01681628|351567|P1|NOT COMPLETED|19 Months Follow-up||62
144299|NCT01681628|351566|P2|COMPLETED|19 Months Follow-up||64
144300|NCT01681628|351567|P1|COMPLETED|19 Months Follow-up||52
144301|NCT01681628|351566|P2|STARTED|19 Months Follow-up||107
144302|NCT01681628|351567|P1|STARTED|19 Months Follow-up||114
144303|NCT01681628|351566|P2|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||15
144304|NCT01681628|351567|P1|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||0
144305|NCT01681628|351566|P2|COMPLETED|Time 2 to Time 3 (One Week Later).||107
144306|NCT01681628|351567|P1|COMPLETED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
144307|NCT01681628|351566|P2|STARTED|Time 2 to Time 3 (One Week Later).||122
144308|NCT01681628|351567|P1|STARTED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
144309|NCT01681628|351566|P2|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||6
144310|NCT01681628|351567|P1|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||14
144311|NCT01681628|351566|P2|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||122
144312|NCT01681628|351567|P1|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||114
144313|NCT01681628|351566|P2|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
144314|NCT01681628|351567|P1|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
144315|NCT01681576|351580|P2|NOT COMPLETED|Period 2||1
144316|NCT01681576|351581|P1|NOT COMPLETED|Period 2||4
144317|NCT01681576|351580|P2|COMPLETED|Period 2||35
144318|NCT01681576|351581|P1|COMPLETED|Period 2||30
144319|NCT01681576|351580|P2|STARTED|Period 2|Period 2: LCZ696 400mg|36
144320|NCT01681576|351581|P1|STARTED|Period 2|Period 2: Valsartan 320mg|34
144321|NCT01681576|351580|P2|NOT COMPLETED|Period 1||0
144322|NCT01681576|351581|P1|NOT COMPLETED|Period 1||2
144323|NCT01681576|351580|P2|COMPLETED|Period 1||36
144324|NCT01681576|351581|P1|COMPLETED|Period 1||34
144325|NCT01681576|351580|P2|STARTED|Period 1||36
144326|NCT01681576|351581|P1|STARTED|Period 1||36
144327|NCT01681511|351597|P2|NOT COMPLETED|Overall Study||14
144328|NCT01681511|351598|P1|NOT COMPLETED|Overall Study||18
144329|NCT01681511|351597|P2|COMPLETED|Overall Study||35
144330|NCT01681511|351598|P1|COMPLETED|Overall Study||28
144331|NCT01681511|351597|P2|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the TIC arm of this population.|14
144332|NCT01681511|351598|P1|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the Lubri-Sil arm of this population.|16
144333|NCT01681511|351597|P2|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the TIC treatment after randomization.|46
144334|NCT01681511|351598|P1|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the Lubri-Sil treatment after randomization.|45
144335|NCT01681511|351597|P2|STARTED|Overall Study|All randomized subjects in the TIC arm.|49
144336|NCT01681511|351598|P1|STARTED|Overall Study|All randomized subjects in the Lubri-Sil arm.|46
144337|NCT01681472|351616|P4|NOT COMPLETED|Overall Study||0
144338|NCT01681472|351617|P3|NOT COMPLETED|Overall Study||0
144339|NCT01681472|351618|P2|NOT COMPLETED|Overall Study||1
144340|NCT01681472|351619|P1|NOT COMPLETED|Overall Study||0
144341|NCT01681472|351616|P4|COMPLETED|Overall Study||8
144342|NCT01681472|351617|P3|COMPLETED|Overall Study||8
144343|NCT01681472|351618|P2|COMPLETED|Overall Study||7
144344|NCT01681472|351619|P1|COMPLETED|Overall Study||8
144345|NCT01681472|351616|P4|STARTED|Overall Study||8
144346|NCT01681472|351617|P3|STARTED|Overall Study||8
144347|NCT01681472|351618|P2|STARTED|Overall Study||8
144348|NCT01681472|351619|P1|STARTED|Overall Study||8
144349|NCT01681433|351799|P2|NOT COMPLETED|Overall Study||33
144350|NCT01681433|351800|P1|NOT COMPLETED|Overall Study||32
144351|NCT01681433|351799|P2|COMPLETED|Overall Study||3
144352|NCT01681433|351800|P1|COMPLETED|Overall Study||4
144353|NCT01681433|351799|P2|STARTED|Overall Study||36
144354|NCT01681433|351800|P1|STARTED|Overall Study||36
144355|NCT01681368|351818|P1|NOT COMPLETED|Overall Study||2
144356|NCT01681368|351818|P1|COMPLETED|Overall Study||9
144357|NCT01681368|351818|P1|STARTED|Overall Study||11
144358|NCT01681277|351835|P5|NOT COMPLETED|Overall Study||0
144359|NCT01681277|351836|P4|NOT COMPLETED|Overall Study||0
144360|NCT01681277|351837|P3|NOT COMPLETED|Overall Study||0
144361|NCT01681277|351838|P2|NOT COMPLETED|Overall Study||0
144362|NCT01681277|351839|P1|NOT COMPLETED|Overall Study||1
144363|NCT01681277|351835|P5|COMPLETED|Overall Study||9
144364|NCT01681277|351836|P4|COMPLETED|Overall Study||9
144365|NCT01681277|351837|P3|COMPLETED|Overall Study||9
144366|NCT01681277|351838|P2|COMPLETED|Overall Study||9
144367|NCT01681277|351839|P1|COMPLETED|Overall Study||11
144368|NCT01681277|351835|P5|STARTED|Overall Study||9
144369|NCT01681277|351836|P4|STARTED|Overall Study||9
144370|NCT01681277|351837|P3|STARTED|Overall Study||9
144371|NCT01681277|351838|P2|STARTED|Overall Study||9
144372|NCT01681277|351839|P1|STARTED|Overall Study||12
144373|NCT01681212|351880|P1|NOT COMPLETED|Overall Study||6
144374|NCT01681212|351880|P1|COMPLETED|Overall Study|Completed=patients who received treatment; not completed=patients who did not receive treatment|15
144375|NCT01681212|351880|P1|Received Treatment|Overall Study||15
144376|NCT01681212|351880|P1|STARTED|Overall Study|Enrolled|21
144377|NCT01681186|351894|P8|NOT COMPLETED|Fourth Intervention||1
144378|NCT01681186|351895|P7|NOT COMPLETED|Fourth Intervention||0
144379|NCT01681186|351896|P6|NOT COMPLETED|Fourth Intervention||0
144380|NCT01681186|351897|P5|NOT COMPLETED|Fourth Intervention||0
144381|NCT01681186|351898|P4|NOT COMPLETED|Fourth Intervention||0
144382|NCT01681186|351899|P3|NOT COMPLETED|Fourth Intervention||0
144383|NCT01681186|351900|P2|NOT COMPLETED|Fourth Intervention||0
144384|NCT01681186|351901|P1|NOT COMPLETED|Fourth Intervention||0
144385|NCT01681186|351894|P8|COMPLETED|Fourth Intervention||5
144386|NCT01681186|351895|P7|COMPLETED|Fourth Intervention||5
144387|NCT01681186|351896|P6|COMPLETED|Fourth Intervention||0
144388|NCT01681186|351897|P5|COMPLETED|Fourth Intervention||0
144389|NCT01681186|351898|P4|COMPLETED|Fourth Intervention||0
144390|NCT01681186|351899|P3|COMPLETED|Fourth Intervention||0
144391|NCT01681186|351900|P2|COMPLETED|Fourth Intervention||0
144392|NCT01681186|351901|P1|COMPLETED|Fourth Intervention||0
144393|NCT01681186|351894|P8|STARTED|Fourth Intervention||6
144394|NCT01681186|351895|P7|STARTED|Fourth Intervention||5
144395|NCT01681186|351896|P6|STARTED|Fourth Intervention||0
144396|NCT01681186|351897|P5|STARTED|Fourth Intervention||0
144397|NCT01681186|351898|P4|STARTED|Fourth Intervention||0
144398|NCT01681186|351899|P3|STARTED|Fourth Intervention||0
144399|NCT01681186|351900|P2|STARTED|Fourth Intervention||0
144400|NCT01681186|351901|P1|STARTED|Fourth Intervention||0
144401|NCT01681186|351894|P8|NOT COMPLETED|Washout Period From Third Intervention||0
144402|NCT01681186|351895|P7|NOT COMPLETED|Washout Period From Third Intervention||1
144403|NCT01681186|351896|P6|NOT COMPLETED|Washout Period From Third Intervention||0
144404|NCT01681186|351897|P5|NOT COMPLETED|Washout Period From Third Intervention||0
144405|NCT01681186|351898|P4|NOT COMPLETED|Washout Period From Third Intervention||0
144406|NCT01681186|351899|P3|NOT COMPLETED|Washout Period From Third Intervention||0
144407|NCT01681186|351900|P2|NOT COMPLETED|Washout Period From Third Intervention||0
144408|NCT01681186|351901|P1|NOT COMPLETED|Washout Period From Third Intervention||0
144409|NCT01681186|351894|P8|COMPLETED|Washout Period From Third Intervention||6
144410|NCT01681186|351895|P7|COMPLETED|Washout Period From Third Intervention||5
144411|NCT01681186|351896|P6|COMPLETED|Washout Period From Third Intervention||0
144412|NCT01681186|351897|P5|COMPLETED|Washout Period From Third Intervention||0
144413|NCT01681186|351898|P4|COMPLETED|Washout Period From Third Intervention||0
144414|NCT01681186|351899|P3|COMPLETED|Washout Period From Third Intervention||0
144415|NCT01681186|351900|P2|COMPLETED|Washout Period From Third Intervention||0
144416|NCT01681186|351901|P1|COMPLETED|Washout Period From Third Intervention||0
144417|NCT01681186|351894|P8|STARTED|Washout Period From Third Intervention||6
144418|NCT01681186|351895|P7|STARTED|Washout Period From Third Intervention||6
144419|NCT01681186|351896|P6|STARTED|Washout Period From Third Intervention||0
144420|NCT01681186|351897|P5|STARTED|Washout Period From Third Intervention||0
144421|NCT01681186|351898|P4|STARTED|Washout Period From Third Intervention||0
144422|NCT01681186|351899|P3|STARTED|Washout Period From Third Intervention||0
144423|NCT01681186|351900|P2|STARTED|Washout Period From Third Intervention||0
144424|NCT01681186|351901|P1|STARTED|Washout Period From Third Intervention||0
144425|NCT01681186|351894|P8|NOT COMPLETED|Third Intervention||0
144426|NCT01681186|351895|P7|NOT COMPLETED|Third Intervention||0
144427|NCT01681186|351896|P6|NOT COMPLETED|Third Intervention||0
144428|NCT01681186|351897|P5|NOT COMPLETED|Third Intervention||0
144429|NCT01681186|351898|P4|NOT COMPLETED|Third Intervention||0
144430|NCT01681186|351899|P3|NOT COMPLETED|Third Intervention||0
144431|NCT01681186|351900|P2|NOT COMPLETED|Third Intervention||0
144432|NCT01681186|351901|P1|NOT COMPLETED|Third Intervention||0
144433|NCT01681186|351894|P8|COMPLETED|Third Intervention||6
144434|NCT01681186|351895|P7|COMPLETED|Third Intervention||6
144435|NCT01681186|351896|P6|COMPLETED|Third Intervention||0
144436|NCT01681186|351897|P5|COMPLETED|Third Intervention||0
144437|NCT01681186|351898|P4|COMPLETED|Third Intervention||0
144438|NCT01681186|351899|P3|COMPLETED|Third Intervention||0
144439|NCT01681186|351900|P2|COMPLETED|Third Intervention||0
144440|NCT01681186|351901|P1|COMPLETED|Third Intervention||0
144441|NCT01681186|351894|P8|STARTED|Third Intervention||6
144442|NCT01681186|351895|P7|STARTED|Third Intervention||6
144443|NCT01681186|351896|P6|STARTED|Third Intervention||0
144444|NCT01681186|351897|P5|STARTED|Third Intervention||0
144445|NCT01681186|351898|P4|STARTED|Third Intervention||0
144446|NCT01681186|351899|P3|STARTED|Third Intervention||0
144447|NCT01681186|351900|P2|STARTED|Third Intervention||0
144448|NCT01681186|351901|P1|STARTED|Third Intervention||0
144449|NCT01681186|351894|P8|NOT COMPLETED|Washout Period From Second Intervention||1
144450|NCT01681186|351895|P7|NOT COMPLETED|Washout Period From Second Intervention||1
144451|NCT01681186|351896|P6|NOT COMPLETED|Washout Period From Second Intervention||0
144452|NCT01681186|351897|P5|NOT COMPLETED|Washout Period From Second Intervention||0
144453|NCT01681186|351898|P4|NOT COMPLETED|Washout Period From Second Intervention||0
144454|NCT01681186|351899|P3|NOT COMPLETED|Washout Period From Second Intervention||0
144455|NCT01681186|351900|P2|NOT COMPLETED|Washout Period From Second Intervention||0
144456|NCT01681186|351901|P1|NOT COMPLETED|Washout Period From Second Intervention||0
144457|NCT01681186|351894|P8|COMPLETED|Washout Period From Second Intervention||6
144458|NCT01681186|351895|P7|COMPLETED|Washout Period From Second Intervention||6
144459|NCT01681186|351896|P6|COMPLETED|Washout Period From Second Intervention||0
144460|NCT01681186|351897|P5|COMPLETED|Washout Period From Second Intervention||0
144461|NCT01681186|351898|P4|COMPLETED|Washout Period From Second Intervention||0
144462|NCT01681186|351899|P3|COMPLETED|Washout Period From Second Intervention||0
144463|NCT01681186|351900|P2|COMPLETED|Washout Period From Second Intervention||0
144464|NCT01681186|351901|P1|COMPLETED|Washout Period From Second Intervention||0
144465|NCT01681186|351894|P8|STARTED|Washout Period From Second Intervention||7
144466|NCT01681186|351895|P7|STARTED|Washout Period From Second Intervention||7
144467|NCT01681186|351896|P6|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
144468|NCT01681186|351897|P5|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
144469|NCT01681186|351898|P4|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
144470|NCT01681186|351899|P3|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
144471|NCT01681186|351900|P2|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
144472|NCT01681186|351901|P1|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
144473|NCT01681186|351894|P8|NOT COMPLETED|Second Intervention||0
144474|NCT01681186|351895|P7|NOT COMPLETED|Second Intervention||0
144475|NCT01681186|351896|P6|NOT COMPLETED|Second Intervention||0
144476|NCT01681186|351897|P5|NOT COMPLETED|Second Intervention||0
144477|NCT01681186|351898|P4|NOT COMPLETED|Second Intervention||0
144478|NCT01681186|351899|P3|NOT COMPLETED|Second Intervention||0
144479|NCT01681186|351900|P2|NOT COMPLETED|Second Intervention||0
144480|NCT01681186|351901|P1|NOT COMPLETED|Second Intervention||0
144481|NCT01681186|351894|P8|COMPLETED|Second Intervention||7
144482|NCT01681186|351895|P7|COMPLETED|Second Intervention||7
144483|NCT01681186|351896|P6|COMPLETED|Second Intervention||2
144484|NCT01681186|351897|P5|COMPLETED|Second Intervention||3
144485|NCT01681186|351898|P4|COMPLETED|Second Intervention||3
144486|NCT01681186|351899|P3|COMPLETED|Second Intervention||2
144487|NCT01681186|351900|P2|COMPLETED|Second Intervention||2
144488|NCT01681186|351901|P1|COMPLETED|Second Intervention||4
144489|NCT01681186|351894|P8|STARTED|Second Intervention||7
144490|NCT01681186|351895|P7|STARTED|Second Intervention||7
144491|NCT01681186|351896|P6|STARTED|Second Intervention||2
144492|NCT01681186|351897|P5|STARTED|Second Intervention||3
144493|NCT01681186|351898|P4|STARTED|Second Intervention||3
144494|NCT01681186|351899|P3|STARTED|Second Intervention||2
144495|NCT01681186|351900|P2|STARTED|Second Intervention||2
144496|NCT01681186|351901|P1|STARTED|Second Intervention||4
144497|NCT01681186|351894|P8|NOT COMPLETED|Washout Period From First Intervention||0
144498|NCT01681186|351895|P7|NOT COMPLETED|Washout Period From First Intervention||0
144499|NCT01681186|351896|P6|NOT COMPLETED|Washout Period From First Intervention||0
144500|NCT01681186|351897|P5|NOT COMPLETED|Washout Period From First Intervention||0
144501|NCT01681186|351898|P4|NOT COMPLETED|Washout Period From First Intervention||0
144502|NCT01681186|351899|P3|NOT COMPLETED|Washout Period From First Intervention||0
144503|NCT01681186|351900|P2|NOT COMPLETED|Washout Period From First Intervention||0
144504|NCT01681186|351901|P1|NOT COMPLETED|Washout Period From First Intervention||0
144505|NCT01681186|351894|P8|COMPLETED|Washout Period From First Intervention||7
144506|NCT01681186|351895|P7|COMPLETED|Washout Period From First Intervention||7
144507|NCT01681186|351896|P6|COMPLETED|Washout Period From First Intervention||2
144508|NCT01681186|351897|P5|COMPLETED|Washout Period From First Intervention||3
144509|NCT01681186|351898|P4|COMPLETED|Washout Period From First Intervention||3
144510|NCT01681186|351899|P3|COMPLETED|Washout Period From First Intervention||2
144511|NCT01681186|351900|P2|COMPLETED|Washout Period From First Intervention||2
144512|NCT01681186|351901|P1|COMPLETED|Washout Period From First Intervention||4
144513|NCT01681186|351894|P8|STARTED|Washout Period From First Intervention||7
144514|NCT01681186|351895|P7|STARTED|Washout Period From First Intervention||7
144515|NCT01681186|351896|P6|STARTED|Washout Period From First Intervention||2
144516|NCT01681186|351897|P5|STARTED|Washout Period From First Intervention||3
144517|NCT01681186|351898|P4|STARTED|Washout Period From First Intervention||3
144518|NCT01681186|351899|P3|STARTED|Washout Period From First Intervention||2
144519|NCT01681186|351900|P2|STARTED|Washout Period From First Intervention||2
144520|NCT01681186|351901|P1|STARTED|Washout Period From First Intervention||4
144521|NCT01681186|351894|P8|NOT COMPLETED|First Intervention||0
144522|NCT01681186|351895|P7|NOT COMPLETED|First Intervention||0
144523|NCT01681186|351896|P6|NOT COMPLETED|First Intervention||0
144524|NCT01681186|351897|P5|NOT COMPLETED|First Intervention||0
144525|NCT01681186|351898|P4|NOT COMPLETED|First Intervention||0
144526|NCT01681186|351899|P3|NOT COMPLETED|First Intervention||0
144527|NCT01681186|351900|P2|NOT COMPLETED|First Intervention||0
144528|NCT01681186|351901|P1|NOT COMPLETED|First Intervention||0
144529|NCT01681186|351894|P8|COMPLETED|First Intervention||7
144530|NCT01681186|351895|P7|COMPLETED|First Intervention||7
144531|NCT01681186|351896|P6|COMPLETED|First Intervention||2
144532|NCT01681186|351897|P5|COMPLETED|First Intervention||3
144533|NCT01681186|351898|P4|COMPLETED|First Intervention||3
144534|NCT01681186|351899|P3|COMPLETED|First Intervention||2
144535|NCT01681186|351900|P2|COMPLETED|First Intervention||2
144536|NCT01681186|351901|P1|COMPLETED|First Intervention||4
144537|NCT01681186|351894|P8|STARTED|First Intervention||7
144538|NCT01681186|351895|P7|STARTED|First Intervention||7
144539|NCT01681186|351896|P6|STARTED|First Intervention||2
144540|NCT01681186|351897|P5|STARTED|First Intervention||3
144541|NCT01681186|351898|P4|STARTED|First Intervention||3
144542|NCT01681186|351899|P3|STARTED|First Intervention||2
144543|NCT01681186|351900|P2|STARTED|First Intervention||2
144544|NCT01681186|351901|P1|STARTED|First Intervention||4
144545|NCT01681121|351954|P2|NOT COMPLETED|Overall Study||11
144546|NCT01681121|351955|P1|NOT COMPLETED|Overall Study||8
144547|NCT01681121|351954|P2|COMPLETED|Overall Study||38
144548|NCT01681121|351955|P1|COMPLETED|Overall Study||36
144549|NCT01681121|351954|P2|STARTED|Overall Study||49
144550|NCT01681121|351955|P1|STARTED|Overall Study||44
144551|NCT01681095|351963|P2|NOT COMPLETED|Overall Study||0
144552|NCT01681095|351964|P1|NOT COMPLETED|Overall Study||0
144553|NCT01681095|351963|P2|COMPLETED|Overall Study||55
144554|NCT01681095|351964|P1|COMPLETED|Overall Study||55
144555|NCT01681095|351963|P2|STARTED|Overall Study||55
144556|NCT01681095|351964|P1|STARTED|Overall Study||55
144557|NCT01681069|352004|P2|NOT COMPLETED|Overall Study||7
144558|NCT01681069|352005|P1|NOT COMPLETED|Overall Study||5
144559|NCT01681069|352004|P2|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|53
144560|NCT01681069|352005|P1|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|55
144561|NCT01681069|352004|P2|Full Analysis Set (FAS)|Overall Study||60
144562|NCT01681069|352005|P1|Full Analysis Set (FAS)|Overall Study||57
144563|NCT01681069|352004|P2|STARTED|Overall Study||60
144564|NCT01681069|352005|P1|STARTED|Overall Study||60
144565|NCT01681030|352018|P3|NOT COMPLETED|Overall Study||0
144566|NCT01681030|352019|P2|NOT COMPLETED|Overall Study||0
144567|NCT01681030|352020|P1|NOT COMPLETED|Overall Study||0
144568|NCT01681030|352018|P3|COMPLETED|Overall Study||11
144569|NCT01681030|352019|P2|COMPLETED|Overall Study||18
144570|NCT01681030|352020|P1|COMPLETED|Overall Study||13
144571|NCT01681030|352018|P3|STARTED|Overall Study||11
144572|NCT01681030|352019|P2|STARTED|Overall Study||18
144573|NCT01681030|352020|P1|STARTED|Overall Study||13
144574|NCT01681004|352042|P2|NOT COMPLETED|Study Completion||8
144575|NCT01681004|352043|P1|NOT COMPLETED|Study Completion||12
144576|NCT01681004|352042|P2|COMPLETED|Study Completion||36
144577|NCT01681004|352043|P1|COMPLETED|Study Completion||89
144578|NCT01681004|352042|P2|STARTED|Study Completion||44
144579|NCT01681004|352043|P1|STARTED|Study Completion||101
144580|NCT01681004|352042|P2|NOT COMPLETED|Primary Endpoint: 6 Months||2
144581|NCT01681004|352043|P1|NOT COMPLETED|Primary Endpoint: 6 Months||1
144582|NCT01681004|352042|P2|COMPLETED|Primary Endpoint: 6 Months||44
144583|NCT01681004|352043|P1|COMPLETED|Primary Endpoint: 6 Months||101
144584|NCT01681004|352042|P2|Crossover to Surgical Treatment|Primary Endpoint: 6 Months|Crossover to surgical treatment allowed per study protocol after the 6-month visit was complete.|39
144585|NCT01681004|352043|P1|Crossover to Surgical Treatment|Primary Endpoint: 6 Months||0
144586|NCT01681004|352042|P2|STARTED|Primary Endpoint: 6 Months||46
144587|NCT01681004|352043|P1|STARTED|Primary Endpoint: 6 Months||102
144588|NCT01680991|352100|P3|NOT COMPLETED|Overall Study||4
144589|NCT01680991|352101|P2|NOT COMPLETED|Overall Study||19
144590|NCT01680991|352102|P1|NOT COMPLETED|Overall Study||8
144591|NCT01680991|352100|P3|COMPLETED|Overall Study||9
144592|NCT01680991|352101|P2|COMPLETED|Overall Study||4
144593|NCT01680991|352102|P1|COMPLETED|Overall Study||4
144594|NCT01680991|352100|P3|STARTED|Overall Study||13
144595|NCT01680991|352101|P2|STARTED|Overall Study||23
144596|NCT01680991|352102|P1|STARTED|Overall Study||12
144597|NCT01680900|352163|P2|NOT COMPLETED|Overall Study||1
144598|NCT01680900|352164|P1|NOT COMPLETED|Overall Study||4
144599|NCT01680900|352163|P2|COMPLETED|Overall Study||11
144600|NCT01680900|352164|P1|COMPLETED|Overall Study||20
144601|NCT01680900|352163|P2|STARTED|Overall Study||12
144602|NCT01680900|352164|P1|STARTED|Overall Study||24
144603|NCT01680887|352182|P2|NOT COMPLETED|Overall Study||24
144604|NCT01680887|352183|P1|NOT COMPLETED|Overall Study||29
144605|NCT01680887|352182|P2|COMPLETED|Overall Study||52
144606|NCT01680887|352183|P1|COMPLETED|Overall Study||51
144607|NCT01680887|352182|P2|STARTED|Overall Study||76
144608|NCT01680887|352183|P1|STARTED|Overall Study||80
144609|NCT01680861|352193|P2|NOT COMPLETED|First 12 Months Post-transplant||0
144610|NCT01680861|352194|P1|NOT COMPLETED|First 12 Months Post-transplant||0
144611|NCT01680861|352193|P2|COMPLETED|First 12 Months Post-transplant||15
144612|NCT01680861|352194|P1|COMPLETED|First 12 Months Post-transplant||15
144613|NCT01680861|352193|P2|STARTED|First 12 Months Post-transplant||15
144614|NCT01680861|352194|P1|STARTED|First 12 Months Post-transplant||15
144615|NCT01680861|352193|P2|NOT COMPLETED|Early Post-transplant Period||1
144616|NCT01680861|352194|P1|NOT COMPLETED|Early Post-transplant Period||1
144617|NCT01680861|352193|P2|COMPLETED|Early Post-transplant Period||15
144618|NCT01680861|352194|P1|COMPLETED|Early Post-transplant Period||15
144619|NCT01680861|352193|P2|STARTED|Early Post-transplant Period|One patient developed immediate DGF (delayed graft function) and was therefore ineligible.|16
144620|NCT01680861|352194|P1|STARTED|Early Post-transplant Period|One patient didn't produce sufficient urine during first 24hr post-transplant (ineligible).|16
144621|NCT01680848|352212|P1|NOT COMPLETED|Overall Study||93
144622|NCT01680848|352212|P1|COMPLETED|Overall Study||189
144623|NCT01680848|352212|P1|STARTED|Overall Study||282
144624|NCT01680783|352218|P2|NOT COMPLETED|Overall Study||0
144625|NCT01680783|352219|P1|NOT COMPLETED|Overall Study||0
144626|NCT01680783|352218|P2|COMPLETED|Overall Study||44
144627|NCT01680783|352219|P1|COMPLETED|Overall Study||39
144628|NCT01680783|352218|P2|STARTED|Overall Study||44
144629|NCT01680783|352219|P1|STARTED|Overall Study||39
144630|NCT01680666|352227|P2|NOT COMPLETED|Overall Study||0
144631|NCT01680666|352228|P1|NOT COMPLETED|Overall Study||0
144632|NCT01680666|352227|P2|COMPLETED|Overall Study||66
144633|NCT01680666|352228|P1|COMPLETED|Overall Study||84
144634|NCT01680666|352227|P2|STARTED|Overall Study||66
144635|NCT01680666|352228|P1|STARTED|Overall Study||84
144636|NCT01680653|352242|P1|NOT COMPLETED|Overall Study||0
144637|NCT01680653|352242|P1|COMPLETED|Overall Study||57
144638|NCT01680653|352242|P1|STARTED|Overall Study||57
144639|NCT01680549|352254|P2|NOT COMPLETED|Overall Study||8
144640|NCT01680549|352255|P1|NOT COMPLETED|Overall Study||5
144641|NCT01680549|352254|P2|COMPLETED|Overall Study||17
144642|NCT01680549|352255|P1|COMPLETED|Overall Study||20
144643|NCT01680549|352254|P2|STARTED|Overall Study||25
144644|NCT01680549|352255|P1|STARTED|Overall Study||25
144645|NCT01680497|352267|P1|NOT COMPLETED|Overall Study||2
144646|NCT01680497|352267|P1|COMPLETED|Overall Study||68
144647|NCT01680497|352267|P1|STARTED|Overall Study||70
144648|NCT01680458|352277|P1|NOT COMPLETED|Overall Study||3
144649|NCT01680458|352277|P1|COMPLETED|Overall Study||27
144650|NCT01680458|352277|P1|STARTED|Overall Study||30
144651|NCT01680341|352288|P2|NOT COMPLETED|Overall Study||17
144652|NCT01680341|352289|P1|NOT COMPLETED|Overall Study||21
144653|NCT01680341|352288|P2|COMPLETED|Overall Study||119
144654|NCT01680341|352289|P1|COMPLETED|Overall Study||115
144655|NCT01680341|352288|P2|Exposed|Overall Study|Two (2) subjects withdrew consent prior to exposure to trial product.|134
144656|NCT01680341|352289|P1|Exposed|Overall Study|One (1) subject withdrew consent prior to exposure to trial product.|135
144657|NCT01680341|352288|P2|STARTED|Overall Study||136
144658|NCT01680341|352289|P1|STARTED|Overall Study||136
144659|NCT01680328|352309|P1|NOT COMPLETED|Overall Study||2
144660|NCT01680328|352309|P1|COMPLETED|Overall Study||80
144661|NCT01680328|352309|P1|Subjects Missing Injections|Overall Study|One missed the [1600 μL, 450 μL/s; thighs]; one missed the [400 μL, 300 μL/s; abdomen]|2
144662|NCT01680328|352309|P1|STARTED|Overall Study||82
144663|NCT01680172|352347|P2|NOT COMPLETED|Overall Study||0
144664|NCT01680172|352348|P1|NOT COMPLETED|Overall Study||0
144665|NCT01680172|352347|P2|COMPLETED|Overall Study||2
144666|NCT01680172|352348|P1|COMPLETED|Overall Study||3
144667|NCT01680172|352347|P2|STARTED|Overall Study||2
144668|NCT01680172|352348|P1|STARTED|Overall Study||3
144669|NCT01680159|352360|P1|NOT COMPLETED|Increased Dose Period||8
144670|NCT01680159|352360|P1|COMPLETED|Increased Dose Period||43
144671|NCT01680159|352360|P1|STARTED|Increased Dose Period||51
144672|NCT01680159|352360|P1|NOT COMPLETED|Screening Period||7
144673|NCT01680159|352360|P1|COMPLETED|Screening Period||39
144674|NCT01680159|352360|P1|STARTED|Screening Period||46
144675|NCT01680016|352387|P4|NOT COMPLETED|Overall Study||5
144676|NCT01680016|352388|P3|NOT COMPLETED|Overall Study||5
144677|NCT01680016|352389|P2|NOT COMPLETED|Overall Study||8
144678|NCT01680016|352390|P1|NOT COMPLETED|Overall Study||6
144679|NCT01680016|352387|P4|COMPLETED|Overall Study||195
144680|NCT01680016|352388|P3|COMPLETED|Overall Study||196
144681|NCT01680016|352389|P2|COMPLETED|Overall Study||114
144682|NCT01680016|352390|P1|COMPLETED|Overall Study||115
144683|NCT01680016|352387|P4|STARTED|Overall Study||200
144684|NCT01680016|352388|P3|STARTED|Overall Study||201
144685|NCT01680016|352389|P2|STARTED|Overall Study||122
144686|NCT01680016|352390|P1|STARTED|Overall Study||121
144687|NCT01679613|352452|P4|NOT COMPLETED|Overall Study||2
144688|NCT01679613|352453|P3|NOT COMPLETED|Overall Study||2
144689|NCT01679613|352454|P2|NOT COMPLETED|Overall Study||1
144690|NCT01679613|352455|P1|NOT COMPLETED|Overall Study||0
144691|NCT01679613|352452|P4|COMPLETED|Overall Study||11
144692|NCT01679613|352453|P3|COMPLETED|Overall Study||11
144693|NCT01679613|352454|P2|COMPLETED|Overall Study||3
144694|NCT01679613|352455|P1|COMPLETED|Overall Study||4
144695|NCT01679613|352452|P4|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
144696|NCT01679613|352453|P3|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
144697|NCT01679613|352454|P2|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
144698|NCT01679613|352455|P1|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
144699|NCT01679613|352452|P4|Received Nintedanib (Main)|Overall Study||11
144700|NCT01679613|352453|P3|Received Nintedanib (Main)|Overall Study||13
144701|NCT01679613|352454|P2|Received Nintedanib (Main)|Overall Study||0
144702|NCT01679613|352455|P1|Received Nintedanib (Main)|Overall Study||0
144703|NCT01679613|352452|P4|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
144704|NCT01679613|352453|P3|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
144705|NCT01679613|352454|P2|Received Nintedanib+Ketoconazole (Pilot)|Overall Study|One subject received only ketoconazole not nintedanib|4
144706|NCT01679613|352455|P1|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||4
144707|NCT01679613|352452|P4|Received Nintedanib (Pilot)|Overall Study||0
144708|NCT01679613|352453|P3|Received Nintedanib (Pilot)|Overall Study||0
144709|NCT01679613|352454|P2|Received Nintedanib (Pilot)|Overall Study||3
144710|NCT01679613|352455|P1|Received Nintedanib (Pilot)|Overall Study||4
144711|NCT01679613|352452|P4|STARTED|Overall Study||13
144712|NCT01679613|352453|P3|STARTED|Overall Study||13
144713|NCT01679613|352454|P2|STARTED|Overall Study||4
144714|NCT01679613|352455|P1|STARTED|Overall Study||4
144715|NCT01679600|352468|P2|NOT COMPLETED|Overall Study||0
144716|NCT01679600|352469|P1|NOT COMPLETED|Overall Study||0
144717|NCT01679600|352468|P2|COMPLETED|Overall Study||7
144718|NCT01679600|352469|P1|COMPLETED|Overall Study||7
144719|NCT01679600|352468|P2|STARTED|Overall Study||7
144720|NCT01679600|352469|P1|STARTED|Overall Study||7
144721|NCT01679405|352477|P2|NOT COMPLETED|Overall Study||5
144722|NCT01679405|352478|P1|NOT COMPLETED|Overall Study||2
144723|NCT01679405|352477|P2|COMPLETED|Overall Study||1
144724|NCT01679405|352478|P1|COMPLETED|Overall Study||1
144725|NCT01679405|352477|P2|STARTED|Overall Study||6
144726|NCT01679405|352478|P1|STARTED|Overall Study||3
144727|NCT01679314|352494|P2|NOT COMPLETED|Overall Study||0
144728|NCT01679314|352495|P1|NOT COMPLETED|Overall Study||2
144729|NCT01679314|352494|P2|COMPLETED|Overall Study||28
144730|NCT01679314|352495|P1|COMPLETED|Overall Study||24
144731|NCT01679314|352494|P2|STARTED|Overall Study||28
144732|NCT01679314|352495|P1|STARTED|Overall Study||26
144733|NCT01679301|352513|P3|NOT COMPLETED|Study Period||0
144734|NCT01679301|352514|P2|NOT COMPLETED|Study Period||0
144735|NCT01679301|352515|P1|NOT COMPLETED|Study Period||0
144736|NCT01679301|352513|P3|COMPLETED|Study Period||4
144737|NCT01679301|352514|P2|COMPLETED|Study Period||4
144738|NCT01679301|352515|P1|COMPLETED|Study Period||0
144739|NCT01679301|352513|P3|STARTED|Study Period||4
144740|NCT01679301|352514|P2|STARTED|Study Period||4
144741|NCT01679301|352515|P1|STARTED|Study Period||0
144742|NCT01679301|352513|P3|NOT COMPLETED|Screening Period||0
144743|NCT01679301|352514|P2|NOT COMPLETED|Screening Period||0
144744|NCT01679301|352515|P1|NOT COMPLETED|Screening Period||3
144745|NCT01679301|352513|P3|COMPLETED|Screening Period||0
144746|NCT01679301|352514|P2|COMPLETED|Screening Period||0
144747|NCT01679301|352515|P1|COMPLETED|Screening Period||8
144748|NCT01679301|352513|P3|STARTED|Screening Period||0
144749|NCT01679301|352514|P2|STARTED|Screening Period||0
144750|NCT01679301|352515|P1|STARTED|Screening Period||11
144751|NCT01679236|352523|P2|NOT COMPLETED|Overall Study||15
144752|NCT01679236|352524|P1|NOT COMPLETED|Overall Study||15
144753|NCT01679236|352523|P2|COMPLETED|Overall Study||10
144754|NCT01679236|352524|P1|COMPLETED|Overall Study||15
144755|NCT01679236|352523|P2|STARTED|Overall Study||25
144756|NCT01679236|352524|P1|STARTED|Overall Study||30
144757|NCT01679197|352530|P1|NOT COMPLETED|Overall Study||4
144758|NCT01679197|352530|P1|COMPLETED|Overall Study||19
144759|NCT01679197|352530|P1|STARTED|Overall Study||23
144760|NCT01679028|352549|P6|NOT COMPLETED|Overall Study||0
144761|NCT01679028|352550|P5|NOT COMPLETED|Overall Study||0
144762|NCT01679028|352551|P4|NOT COMPLETED|Overall Study||0
144763|NCT01679028|352552|P3|NOT COMPLETED|Overall Study||0
144764|NCT01679028|352553|P2|NOT COMPLETED|Overall Study||0
144765|NCT01679028|352554|P1|NOT COMPLETED|Overall Study||0
144766|NCT01679028|352549|P6|COMPLETED|Overall Study||6
144767|NCT01679028|352550|P5|COMPLETED|Overall Study||2
144768|NCT01679028|352551|P4|COMPLETED|Overall Study||4
144769|NCT01679028|352552|P3|COMPLETED|Overall Study||2
144770|NCT01679028|352553|P2|COMPLETED|Overall Study||4
144771|NCT01679028|352554|P1|COMPLETED|Overall Study||2
144772|NCT01679028|352549|P6|STARTED|Overall Study||6
144773|NCT01679028|352550|P5|STARTED|Overall Study||2
144774|NCT01679028|352551|P4|STARTED|Overall Study||4
144775|NCT01679028|352552|P3|STARTED|Overall Study||2
144776|NCT01679028|352553|P2|STARTED|Overall Study||4
144777|NCT01679028|352554|P1|STARTED|Overall Study||2
144778|NCT01679002|352571|P3|NOT COMPLETED|Overall Study||0
144779|NCT01679002|352572|P2|NOT COMPLETED|Overall Study||1
144780|NCT01679002|352573|P1|NOT COMPLETED|Overall Study||1
144781|NCT01679002|352571|P3|COMPLETED|Overall Study||4
144782|NCT01679002|352572|P2|COMPLETED|Overall Study||3
144783|NCT01679002|352573|P1|COMPLETED|Overall Study||3
144784|NCT01679002|352571|P3|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
144785|NCT01679002|352572|P2|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
144786|NCT01679002|352573|P1|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||3
144787|NCT01679002|352571|P3|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
144788|NCT01679002|352572|P2|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
144789|NCT01679002|352573|P1|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
144790|NCT01679002|352571|P3|BIA 2-093 900 mg Once-daily Period|Overall Study||4
144791|NCT01679002|352572|P2|BIA 2-093 900 mg Once-daily Period|Overall Study||3
144792|NCT01679002|352573|P1|BIA 2-093 900 mg Once-daily Period|Overall Study||4
144793|NCT01679002|352571|P3|STARTED|Overall Study||4
144794|NCT01679002|352572|P2|STARTED|Overall Study||4
144795|NCT01679002|352573|P1|STARTED|Overall Study||4
144796|NCT01678976|352589|P2|NOT COMPLETED|Second Period||0
144797|NCT01678976|352590|P1|NOT COMPLETED|Second Period||0
144798|NCT01678976|352589|P2|COMPLETED|Second Period||6
144799|NCT01678976|352590|P1|COMPLETED|Second Period||6
144800|NCT01678976|352589|P2|STARTED|Second Period||6
144801|NCT01678976|352590|P1|STARTED|Second Period||6
144802|NCT01678976|352589|P2|NOT COMPLETED|First Period||1
144803|NCT01678976|352590|P1|NOT COMPLETED|First Period||0
144804|NCT01678976|352589|P2|COMPLETED|First Period||6
144805|NCT01678976|352590|P1|COMPLETED|First Period||6
144806|NCT01678976|352589|P2|STARTED|First Period||7
144807|NCT01678976|352590|P1|STARTED|First Period||6
144808|NCT01678911|352600|P2|NOT COMPLETED|Second Intervention||0
144809|NCT01678911|352601|P1|NOT COMPLETED|Second Intervention||2
144810|NCT01678911|352600|P2|COMPLETED|Second Intervention||1
144811|NCT01678911|352601|P1|COMPLETED|Second Intervention||2
144812|NCT01678911|352600|P2|STARTED|Second Intervention||1
144813|NCT01678911|352601|P1|STARTED|Second Intervention||4
144814|NCT01678911|352600|P2|NOT COMPLETED|First Intervention||0
144815|NCT01678911|352601|P1|NOT COMPLETED|First Intervention||0
144816|NCT01678911|352600|P2|COMPLETED|First Intervention||1
144817|NCT01678911|352601|P1|COMPLETED|First Intervention||4
144818|NCT01678911|352600|P2|Cross Over|First Intervention||1
144819|NCT01678911|352601|P1|Cross Over|First Intervention||4
144820|NCT01678911|352600|P2|STARTED|First Intervention||1
144821|NCT01678911|352601|P1|STARTED|First Intervention||4
144822|NCT01678885|352617|P5|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||17
144823|NCT01678885|352618|P4|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
144824|NCT01678885|352619|P3|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
144825|NCT01678885|352620|P2|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
144826|NCT01678885|352621|P1|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
144827|NCT01678885|352617|P5|COMPLETED|Phase II; 8 Week Low Calorie Diet||70
144828|NCT01678885|352618|P4|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
144829|NCT01678885|352619|P3|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
144830|NCT01678885|352620|P2|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
144831|NCT01678885|352621|P1|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
144832|NCT01678885|352617|P5|STARTED|Phase II; 8 Week Low Calorie Diet||87
144833|NCT01678885|352618|P4|STARTED|Phase II; 8 Week Low Calorie Diet||0
144834|NCT01678885|352619|P3|STARTED|Phase II; 8 Week Low Calorie Diet||0
144835|NCT01678885|352620|P2|STARTED|Phase II; 8 Week Low Calorie Diet||0
144836|NCT01678885|352621|P1|STARTED|Phase II; 8 Week Low Calorie Diet||0
144837|NCT01678885|352617|P5|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
144838|NCT01678885|352618|P4|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
144839|NCT01678885|352619|P3|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||1
144840|NCT01678885|352620|P2|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
144841|NCT01678885|352621|P1|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
144842|NCT01678885|352617|P5|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
144843|NCT01678885|352618|P4|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||21
144844|NCT01678885|352619|P3|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
144845|NCT01678885|352620|P2|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||15
144846|NCT01678885|352621|P1|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
144847|NCT01678885|352617|P5|STARTED|Phase I; 2 Wks Duration, Both Sub-study||0
144848|NCT01678885|352618|P4|STARTED|Phase I; 2 Wks Duration, Both Sub-study||24
144849|NCT01678885|352619|P3|STARTED|Phase I; 2 Wks Duration, Both Sub-study||23
144850|NCT01678885|352620|P2|STARTED|Phase I; 2 Wks Duration, Both Sub-study||18
144851|NCT01678885|352621|P1|STARTED|Phase I; 2 Wks Duration, Both Sub-study||22
144852|NCT01678846|352631|P2|NOT COMPLETED|Overall Study||0
144853|NCT01678846|352632|P1|NOT COMPLETED|Overall Study||0
144854|NCT01678846|352631|P2|COMPLETED|Overall Study||1899
144855|NCT01678846|352632|P1|COMPLETED|Overall Study||1921
144856|NCT01678846|352631|P2|STARTED|Overall Study||1899
144857|NCT01678846|352632|P1|STARTED|Overall Study|Whole school implementation. Started and completed shows number of students in the end-line survey.|1921
144858|NCT01678820|352647|P3|NOT COMPLETED|Overall Study||57
144859|NCT01678820|352648|P2|NOT COMPLETED|Overall Study||63
144860|NCT01678820|352649|P1|NOT COMPLETED|Overall Study||62
144861|NCT01678820|352647|P3|COMPLETED|Overall Study||43
144862|NCT01678820|352648|P2|COMPLETED|Overall Study||36
144863|NCT01678820|352649|P1|COMPLETED|Overall Study||38
144864|NCT01678820|352647|P3|Treated With Double-blind Study Drug|Overall Study||98
144865|NCT01678820|352648|P2|Treated With Double-blind Study Drug|Overall Study||97
144866|NCT01678820|352649|P1|Treated With Double-blind Study Drug|Overall Study||100
144867|NCT01678820|352647|P3|STARTED|Overall Study||100
144868|NCT01678820|352648|P2|STARTED|Overall Study||99
144869|NCT01678820|352649|P1|STARTED|Overall Study||100
144870|NCT01678807|352694|P3|NOT COMPLETED|Overall Study||0
144871|NCT01678807|352695|P2|NOT COMPLETED|Overall Study||5
144872|NCT01678807|352696|P1|NOT COMPLETED|Overall Study||4
144873|NCT01678807|352694|P3|COMPLETED|Overall Study||65
144874|NCT01678807|352695|P2|COMPLETED|Overall Study||60
144875|NCT01678807|352696|P1|COMPLETED|Overall Study||61
144876|NCT01678807|352694|P3|STARTED|Overall Study||65
144877|NCT01678807|352695|P2|STARTED|Overall Study||65
144878|NCT01678807|352696|P1|STARTED|Overall Study||65
144879|NCT01678443|352707|P1|NOT COMPLETED|Overall Study||0
144880|NCT01678443|352707|P1|COMPLETED|Overall Study||2
144881|NCT01678443|352707|P1|STARTED|Overall Study||2
144882|NCT01678313|352714|P2|NOT COMPLETED|Prostate Biopsy at 3 Months||12
144883|NCT01678313|352715|P1|NOT COMPLETED|Prostate Biopsy at 3 Months||11
144884|NCT01678313|352714|P2|COMPLETED|Prostate Biopsy at 3 Months||37
144885|NCT01678313|352715|P1|COMPLETED|Prostate Biopsy at 3 Months||45
144886|NCT01678313|352714|P2|STARTED|Prostate Biopsy at 3 Months||49
144887|NCT01678313|352715|P1|STARTED|Prostate Biopsy at 3 Months||56
144888|NCT01678313|352714|P2|NOT COMPLETED|PSA >4 ng/dL at 3 Months||9
144889|NCT01678313|352715|P1|NOT COMPLETED|PSA >4 ng/dL at 3 Months||8
144890|NCT01678313|352714|P2|COMPLETED|PSA >4 ng/dL at 3 Months||49
144891|NCT01678313|352715|P1|COMPLETED|PSA >4 ng/dL at 3 Months||56
144892|NCT01678313|352714|P2|STARTED|PSA >4 ng/dL at 3 Months||58
144893|NCT01678313|352715|P1|STARTED|PSA >4 ng/dL at 3 Months||64
144894|NCT01678313|352714|P2|NOT COMPLETED|Completed the 3-month Therapy||12
144895|NCT01678313|352715|P1|NOT COMPLETED|Completed the 3-month Therapy||6
144896|NCT01678313|352714|P2|COMPLETED|Completed the 3-month Therapy||58
144897|NCT01678313|352715|P1|COMPLETED|Completed the 3-month Therapy||64
144898|NCT01678313|352714|P2|STARTED|Completed the 3-month Therapy||70
144899|NCT01678313|352715|P1|STARTED|Completed the 3-month Therapy||70
144900|NCT01678196|352733|P2|NOT COMPLETED|Overall Study||0
144901|NCT01678196|352734|P1|NOT COMPLETED|Overall Study||0
144902|NCT01678196|352733|P2|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|32
144903|NCT01678196|352734|P1|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|34
144904|NCT01678196|352733|P2|STARTED|Overall Study||32
144905|NCT01678196|352734|P1|STARTED|Overall Study||34
144906|NCT01678144|352746|P1|NOT COMPLETED|Stage 2: MAR Regular and MAR Expanded||0
144907|NCT01678144|352746|P1|COMPLETED|Stage 2: MAR Regular and MAR Expanded||5
144908|NCT01678144|352746|P1|STARTED|Stage 2: MAR Regular and MAR Expanded||5
144909|NCT01678144|352746|P1|NOT COMPLETED|Stage 1: MAR Classic||1
144910|NCT01678144|352746|P1|COMPLETED|Stage 1: MAR Classic||6
144911|NCT01678144|352746|P1|STARTED|Stage 1: MAR Classic||7
144912|NCT01678131|352765|P3|NOT COMPLETED|Overall Study||2
144913|NCT01678131|352766|P2|NOT COMPLETED|Overall Study||1
144914|NCT01678131|352767|P1|NOT COMPLETED|Overall Study||0
144915|NCT01678131|352765|P3|COMPLETED|Overall Study||9
144916|NCT01678131|352766|P2|COMPLETED|Overall Study||9
144917|NCT01678131|352767|P1|COMPLETED|Overall Study||10
144918|NCT01678131|352765|P3|STARTED|Overall Study||11
144919|NCT01678131|352766|P2|STARTED|Overall Study||10
144920|NCT01678131|352767|P1|STARTED|Overall Study||10
144921|NCT01677988|352775|P1|NOT COMPLETED|Overall Study||2
144922|NCT01677988|352775|P1|COMPLETED|Overall Study||1
144923|NCT01677988|352775|P1|STARTED|Overall Study||3
144924|NCT01677936|352788|P2|NOT COMPLETED|Overall Study||5
144925|NCT01677936|352789|P1|NOT COMPLETED|Overall Study||9
144926|NCT01677936|352788|P2|COMPLETED|Overall Study|Full analysis dataset completers|15
144927|NCT01677936|352789|P1|COMPLETED|Overall Study|Full analysis dataset completers|22
144928|NCT01677936|352788|P2|STARTED|Overall Study|20 randomized to snacks; 1 excluded due to lack of post-baseline evaluation; 19 = full dataset|20
144929|NCT01677936|352789|P1|STARTED|Overall Study|31 randomized to raisins; 4 excluded due to lack of post-baseline evaluation; 27 = full dataset|31
144930|NCT01677910|352800|P4|NOT COMPLETED|Open-Label Extension Period (OLE)||36
144931|NCT01677910|352801|P3|NOT COMPLETED|Open-Label Extension Period (OLE)||0
144932|NCT01677910|352802|P2|NOT COMPLETED|Open-Label Extension Period (OLE)||0
144933|NCT01677910|352803|P1|NOT COMPLETED|Open-Label Extension Period (OLE)||0
144934|NCT01677910|352800|P4|COMPLETED|Open-Label Extension Period (OLE)||79
144935|NCT01677910|352801|P3|COMPLETED|Open-Label Extension Period (OLE)||0
144936|NCT01677910|352802|P2|COMPLETED|Open-Label Extension Period (OLE)||0
144937|NCT01677910|352803|P1|COMPLETED|Open-Label Extension Period (OLE)||0
144938|NCT01677910|352800|P4|STARTED|Open-Label Extension Period (OLE)||115
144939|NCT01677910|352801|P3|STARTED|Open-Label Extension Period (OLE)||0
144940|NCT01677910|352802|P2|STARTED|Open-Label Extension Period (OLE)||0
144941|NCT01677910|352803|P1|STARTED|Open-Label Extension Period (OLE)||0
144942|NCT01677910|352800|P4|NOT COMPLETED|Double-Blind Treatment Period||0
144943|NCT01677910|352801|P3|NOT COMPLETED|Double-Blind Treatment Period||7
144944|NCT01677910|352802|P2|NOT COMPLETED|Double-Blind Treatment Period||3
144945|NCT01677910|352803|P1|NOT COMPLETED|Double-Blind Treatment Period||7
144946|NCT01677910|352800|P4|COMPLETED|Double-Blind Treatment Period||0
144947|NCT01677910|352801|P3|COMPLETED|Double-Blind Treatment Period||38
144948|NCT01677910|352802|P2|COMPLETED|Double-Blind Treatment Period||42
144949|NCT01677910|352803|P1|COMPLETED|Double-Blind Treatment Period||38
144950|NCT01677910|352800|P4|STARTED|Double-Blind Treatment Period||0
144951|NCT01677910|352801|P3|STARTED|Double-Blind Treatment Period||45
144952|NCT01677910|352802|P2|STARTED|Double-Blind Treatment Period||45
144953|NCT01677910|352803|P1|STARTED|Double-Blind Treatment Period||45
144954|NCT01677858|352830|P5|NOT COMPLETED|Overall Study||85
144955|NCT01677858|352831|P4|NOT COMPLETED|Overall Study||6
144956|NCT01677858|352832|P3|NOT COMPLETED|Overall Study||14
144957|NCT01677858|352833|P2|NOT COMPLETED|Overall Study||2
144958|NCT01677858|352834|P1|NOT COMPLETED|Overall Study||3
144959|NCT01677858|352830|P5|COMPLETED|Overall Study|Completed indicates participants ongoing in study|4
144960|NCT01677858|352831|P4|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
144961|NCT01677858|352832|P3|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
144962|NCT01677858|352833|P2|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
144963|NCT01677858|352834|P1|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
144964|NCT01677858|352830|P5|STARTED|Overall Study||89
144965|NCT01677858|352831|P4|STARTED|Overall Study||6
144966|NCT01677858|352832|P3|STARTED|Overall Study||15
144967|NCT01677858|352833|P2|STARTED|Overall Study||3
144968|NCT01677858|352834|P1|STARTED|Overall Study||3
144969|NCT01677767|352907|P1|NOT COMPLETED|Overall Study||22
144970|NCT01677767|352907|P1|COMPLETED|Overall Study||102
144971|NCT01677767|352907|P1|STARTED|Overall Study||124
144972|NCT01677624|352921|P1|NOT COMPLETED|Overall Study||1
144973|NCT01677624|352921|P1|COMPLETED|Overall Study||27
144974|NCT01677624|352921|P1|STARTED|Overall Study||28
144975|NCT01677507|352926|P2|NOT COMPLETED|Second Assigment||5
144976|NCT01677507|352927|P1|NOT COMPLETED|Second Assigment||3
144977|NCT01677507|352926|P2|COMPLETED|Second Assigment||51
144978|NCT01677507|352927|P1|COMPLETED|Second Assigment||60
144979|NCT01677507|352926|P2|STARTED|Second Assigment||56
144980|NCT01677507|352927|P1|STARTED|Second Assigment||63
144981|NCT01677507|352926|P2|NOT COMPLETED|Initial Assignment||2
144982|NCT01677507|352927|P1|NOT COMPLETED|Initial Assignment||0
144983|NCT01677507|352926|P2|COMPLETED|Initial Assignment||56
144984|NCT01677507|352927|P1|COMPLETED|Initial Assignment||63
144985|NCT01677507|352926|P2|STARTED|Initial Assignment||58
144986|NCT01677507|352927|P1|STARTED|Initial Assignment||63
144987|NCT01677377|352940|P3|NOT COMPLETED|Overall Study||6
144988|NCT01677377|352941|P2|NOT COMPLETED|Overall Study||1
144989|NCT01677377|352942|P1|NOT COMPLETED|Overall Study||1
144990|NCT01677377|352940|P3|COMPLETED|Overall Study||9
144991|NCT01677377|352941|P2|COMPLETED|Overall Study||14
144992|NCT01677377|352942|P1|COMPLETED|Overall Study||14
144993|NCT01677377|352940|P3|STARTED|Overall Study||15
144994|NCT01677377|352941|P2|STARTED|Overall Study||15
144995|NCT01677377|352942|P1|STARTED|Overall Study||15
144996|NCT01677299|353143|P4|NOT COMPLETED|Overall Study||1
144997|NCT01677299|353144|P3|NOT COMPLETED|Overall Study||1
144998|NCT01677299|353145|P2|NOT COMPLETED|Overall Study||3
144999|NCT01677299|353146|P1|NOT COMPLETED|Overall Study||0
145000|NCT01677299|353143|P4|COMPLETED|Overall Study||5
145001|NCT01677299|353144|P3|COMPLETED|Overall Study||5
145002|NCT01677299|353145|P2|COMPLETED|Overall Study||3
145003|NCT01677299|353146|P1|COMPLETED|Overall Study||6
145004|NCT01677299|353143|P4|STARTED|Overall Study||6
145005|NCT01677299|353144|P3|STARTED|Overall Study||6
145006|NCT01677299|353145|P2|STARTED|Overall Study||6
145007|NCT01677299|353146|P1|STARTED|Overall Study||6
145008|NCT01677286|353168|P1|NOT COMPLETED|Overall Study||11
145009|NCT01677286|353168|P1|COMPLETED|Overall Study||14
145010|NCT01677286|353168|P1|STARTED|Overall Study||25
145011|NCT01677195|353178|P3|NOT COMPLETED|Overall Study||30
145012|NCT01677195|353179|P2|NOT COMPLETED|Overall Study||32
145013|NCT01677195|353180|P1|NOT COMPLETED|Overall Study||29
145014|NCT01677195|353178|P3|COMPLETED|Overall Study||50
145015|NCT01677195|353179|P2|COMPLETED|Overall Study||51
145016|NCT01677195|353180|P1|COMPLETED|Overall Study||42
145017|NCT01677195|353178|P3|STARTED|Overall Study||80
145018|NCT01677195|353179|P2|STARTED|Overall Study||83
145019|NCT01677195|353180|P1|STARTED|Overall Study||71
145020|NCT01677182|353191|P3|NOT COMPLETED|Overall Study||39
145021|NCT01677182|353192|P2|NOT COMPLETED|Overall Study||28
145022|NCT01677182|353193|P1|NOT COMPLETED|Overall Study||34
145023|NCT01677182|353191|P3|COMPLETED|Overall Study||143
145024|NCT01677182|353192|P2|COMPLETED|Overall Study||141
145025|NCT01677182|353193|P1|COMPLETED|Overall Study||150
145026|NCT01677182|353191|P3|STARTED|Overall Study||182
145027|NCT01677182|353192|P2|STARTED|Overall Study||169
145028|NCT01677182|353193|P1|STARTED|Overall Study||184
145029|NCT01676961|353225|P1|NOT COMPLETED|Overall Study||5
145030|NCT01676961|353225|P1|COMPLETED|Overall Study||0
145031|NCT01676961|353225|P1|STARTED|Overall Study||5
145032|NCT01676909|353232|P2|NOT COMPLETED|Overall Study||14
145033|NCT01676909|353233|P1|NOT COMPLETED|Overall Study||18
145034|NCT01676909|353232|P2|COMPLETED|Overall Study|14 not completed (5 withdrawn, 9 timed out|104
145035|NCT01676909|353233|P1|COMPLETED|Overall Study|18 not completed (3 withdrawn, 15 timed out)|106
145036|NCT01676909|353232|P2|Post-Treatment Assessment|Overall Study|11 not completed (5 withdrawn, 6 timed out)|107
145037|NCT01676909|353233|P1|Post-Treatment Assessment|Overall Study|19 not completed (3 withdrawn, 15 timed out, 1 declined)|105
145038|NCT01676909|353232|P2|STARTED|Overall Study||118
145039|NCT01676909|353233|P1|STARTED|Overall Study||124
145040|NCT01676896|353298|P3|NOT COMPLETED|Overall Study||19
145041|NCT01676896|353299|P2|NOT COMPLETED|Overall Study||7
145042|NCT01676896|353300|P1|NOT COMPLETED|Overall Study||12
145043|NCT01676896|353298|P3|COMPLETED|Overall Study||81
145044|NCT01676896|353299|P2|COMPLETED|Overall Study||89
145045|NCT01676896|353300|P1|COMPLETED|Overall Study||84
145046|NCT01676896|353298|P3|STARTED|Overall Study||100
145047|NCT01676896|353299|P2|STARTED|Overall Study||96
145048|NCT01676896|353300|P1|STARTED|Overall Study||96
145049|NCT01676831|353397|P2|NOT COMPLETED|Overall Study||1
145050|NCT01676831|353398|P1|NOT COMPLETED|Overall Study||0
145051|NCT01676831|353397|P2|COMPLETED|Overall Study||4
145052|NCT01676831|353398|P1|COMPLETED|Overall Study||8
145053|NCT01676831|353397|P2|STARTED|Overall Study||5
145054|NCT01676831|353398|P1|STARTED|Overall Study||8
145055|NCT01676727|353408|P1|NOT COMPLETED|Overall Study||32
145056|NCT01676727|353408|P1|COMPLETED|Overall Study||68
145057|NCT01676727|353408|P1|Implanted|Overall Study||92
145058|NCT01676727|353408|P1|STARTED|Overall Study||100
145059|NCT01676714|353413|P1|NOT COMPLETED|Overall Study||0
145060|NCT01676714|353413|P1|COMPLETED|Overall Study||10
145061|NCT01676714|353413|P1|STARTED|Overall Study||10
145062|NCT01676701|353422|P2|NOT COMPLETED|Overall Study||4
145063|NCT01676701|353423|P1|NOT COMPLETED|Overall Study||4
145064|NCT01676701|353422|P2|COMPLETED|Overall Study||0
145065|NCT01676701|353423|P1|COMPLETED|Overall Study||0
145066|NCT01676701|353422|P2|Completed Post-Treatment Follow-Up|Overall Study||4
145067|NCT01676701|353423|P1|Completed Post-Treatment Follow-Up|Overall Study||4
145068|NCT01676701|353422|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
145069|NCT01676701|353423|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
145070|NCT01676701|353422|P2|STARTED|Overall Study||4
145071|NCT01676701|353423|P1|STARTED|Overall Study||4
145072|NCT01676532|353449|P1|NOT COMPLETED|Overall Study||0
145073|NCT01676532|353449|P1|COMPLETED|Overall Study||127
145074|NCT01676532|353449|P1|STARTED|Overall Study||127
145075|NCT01676415|353460|P2|NOT COMPLETED|Overall Study||0
145076|NCT01676415|353461|P1|NOT COMPLETED|Overall Study||0
145077|NCT01676415|353460|P2|COMPLETED|Overall Study||5
145078|NCT01676415|353461|P1|COMPLETED|Overall Study||4
145079|NCT01676415|353460|P2|STARTED|Overall Study||5
145080|NCT01676415|353461|P1|STARTED|Overall Study||4
145081|NCT01676311|353475|P2|NOT COMPLETED|Overall Study||2
145082|NCT01676311|353476|P1|NOT COMPLETED|Overall Study||0
145083|NCT01676311|353475|P2|COMPLETED|Overall Study||5
145084|NCT01676311|353476|P1|COMPLETED|Overall Study||7
145085|NCT01676311|353475|P2|STARTED|Overall Study||7
145086|NCT01676311|353476|P1|STARTED|Overall Study||7
145087|NCT01676298|353498|P8|NOT COMPLETED|Overall Study||0
145088|NCT01676298|353499|P7|NOT COMPLETED|Overall Study||0
145089|NCT01676298|353500|P6|NOT COMPLETED|Overall Study||0
145090|NCT01676298|353501|P5|NOT COMPLETED|Overall Study||0
145091|NCT01676298|353502|P4|NOT COMPLETED|Overall Study||0
145092|NCT01676298|353503|P3|NOT COMPLETED|Overall Study||0
145093|NCT01676298|353504|P2|NOT COMPLETED|Overall Study||0
145094|NCT01676298|353505|P1|NOT COMPLETED|Overall Study||0
145095|NCT01676298|353498|P8|COMPLETED|Overall Study||1
145096|NCT01676298|353499|P7|COMPLETED|Overall Study||1
145097|NCT01676298|353500|P6|COMPLETED|Overall Study||1
145098|NCT01676298|353501|P5|COMPLETED|Overall Study||1
145099|NCT01676298|353502|P4|COMPLETED|Overall Study||1
145100|NCT01676298|353503|P3|COMPLETED|Overall Study||1
145101|NCT01676298|353504|P2|COMPLETED|Overall Study||1
145102|NCT01676298|353505|P1|COMPLETED|Overall Study||1
145103|NCT01676298|353498|P8|Participated in All Tests|Overall Study||1
145104|NCT01676298|353499|P7|Participated in All Tests|Overall Study||1
145105|NCT01676298|353500|P6|Participated in All Tests|Overall Study||1
145106|NCT01676298|353501|P5|Participated in All Tests|Overall Study||1
145107|NCT01676298|353502|P4|Participated in All Tests|Overall Study||1
145108|NCT01676298|353503|P3|Participated in All Tests|Overall Study||1
145109|NCT01676298|353504|P2|Participated in All Tests|Overall Study||1
145110|NCT01676298|353505|P1|Participated in All Tests|Overall Study||1
145111|NCT01676298|353498|P8|All Genotypes Confirmed With Reference|Overall Study||1
145112|NCT01676298|353499|P7|All Genotypes Confirmed With Reference|Overall Study||1
145113|NCT01676298|353500|P6|All Genotypes Confirmed With Reference|Overall Study||1
145114|NCT01676298|353501|P5|All Genotypes Confirmed With Reference|Overall Study||1
145115|NCT01676298|353502|P4|All Genotypes Confirmed With Reference|Overall Study||1
145116|NCT01676298|353503|P3|All Genotypes Confirmed With Reference|Overall Study||1
145117|NCT01676298|353504|P2|All Genotypes Confirmed With Reference|Overall Study||1
145118|NCT01676298|353505|P1|All Genotypes Confirmed With Reference|Overall Study||1
145119|NCT01676298|353498|P8|STARTED|Overall Study||1
145120|NCT01676298|353499|P7|STARTED|Overall Study||1
145121|NCT01676298|353500|P6|STARTED|Overall Study||1
145122|NCT01676298|353501|P5|STARTED|Overall Study||1
145123|NCT01676298|353502|P4|STARTED|Overall Study||1
145124|NCT01676298|353503|P3|STARTED|Overall Study||1
145125|NCT01676298|353504|P2|STARTED|Overall Study||1
145126|NCT01676298|353505|P1|STARTED|Overall Study||1
145127|NCT01676220|353525|P2|NOT COMPLETED|Overall Study||125
145128|NCT01676220|353526|P1|NOT COMPLETED|Overall Study||102
145129|NCT01676220|353525|P2|COMPLETED|Overall Study||314
145130|NCT01676220|353526|P1|COMPLETED|Overall Study||337
145131|NCT01676220|353525|P2|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post­baseline data|430
145132|NCT01676220|353526|P1|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post­baseline data|432
145133|NCT01676220|353525|P2|Treated|Overall Study||438
145134|NCT01676220|353526|P1|Treated|Overall Study||435
145135|NCT01676220|353525|P2|STARTED|Overall Study||439
145136|NCT01676220|353526|P1|STARTED|Overall Study||439
145137|NCT01676116|353558|P2|NOT COMPLETED|Overall Study||29
145138|NCT01676116|353559|P1|NOT COMPLETED|Overall Study||16
145139|NCT01676116|353558|P2|COMPLETED|Overall Study||117
145140|NCT01676116|353559|P1|COMPLETED|Overall Study||276
145141|NCT01676116|353558|P2|STARTED|Overall Study||146
145142|NCT01676116|353559|P1|STARTED|Overall Study||292
145143|NCT01676012|353581|P1|NOT COMPLETED|Overall Study||3
145144|NCT01676012|353581|P1|COMPLETED|Overall Study||29
145145|NCT01676012|353581|P1|STARTED|Overall Study||32
145146|NCT01675960|353587|P2|NOT COMPLETED|Overall Study||0
145147|NCT01675960|353588|P1|NOT COMPLETED|Overall Study||0
145148|NCT01675960|353587|P2|COMPLETED|Overall Study||0
145149|NCT01675960|353588|P1|COMPLETED|Overall Study||2
145150|NCT01675960|353587|P2|STARTED|Overall Study||0
145151|NCT01675960|353588|P1|STARTED|Overall Study||2
145152|NCT01675830|353596|P1|NOT COMPLETED|Overall Study||0
145153|NCT01675830|353596|P1|COMPLETED|Overall Study||10
145154|NCT01675830|353596|P1|STARTED|Overall Study||10
145155|NCT01675661|353603|P2|NOT COMPLETED|Overall Study||46
145156|NCT01675661|353604|P1|NOT COMPLETED|Overall Study||40
145157|NCT01675661|353603|P2|COMPLETED|Overall Study||103
145158|NCT01675661|353604|P1|COMPLETED|Overall Study||113
145159|NCT01675661|353603|P2|STARTED|Overall Study||149
145160|NCT01675661|353604|P1|STARTED|Overall Study||153
145161|NCT01675635|353612|P2|NOT COMPLETED|Overall Study||0
145162|NCT01675635|353613|P1|NOT COMPLETED|Overall Study||0
145163|NCT01675635|353612|P2|COMPLETED|Overall Study||117
145164|NCT01675635|353613|P1|COMPLETED|Overall Study||117
145165|NCT01675635|353612|P2|STARTED|Overall Study||117
145166|NCT01675635|353613|P1|STARTED|Overall Study||117
145167|NCT01675622|353633|P2|NOT COMPLETED|Overall Study||24
145168|NCT01675622|353634|P1|NOT COMPLETED|Overall Study||26
145169|NCT01675622|353633|P2|COMPLETED|Overall Study||96
145170|NCT01675622|353634|P1|COMPLETED|Overall Study||96
145171|NCT01675622|353633|P2|STARTED|Overall Study||120
145172|NCT01675622|353634|P1|STARTED|Overall Study||122
145173|NCT01675596|353658|P1|NOT COMPLETED|Overall Study||8
145174|NCT01675596|353658|P1|COMPLETED|Overall Study||191
145175|NCT01675596|353658|P1|STARTED|Overall Study|One patient did not receive the study device.|199
145176|NCT01675544|353664|P1|NOT COMPLETED|Overall Study||2
145177|NCT01675544|353664|P1|COMPLETED|Overall Study||44
145178|NCT01675544|353664|P1|STARTED|Overall Study||46
145179|NCT01675531|353669|P1|NOT COMPLETED|Overall Study||25
145180|NCT01675531|353669|P1|COMPLETED|Overall Study||41
145181|NCT01675531|353669|P1|STARTED|Overall Study||66
145182|NCT01675492|353676|P1|NOT COMPLETED|Overall Study||42
145183|NCT01675492|353676|P1|COMPLETED|Overall Study||42
145184|NCT01675492|353676|P1|STARTED|Overall Study||84
145185|NCT01675479|353681|P1|NOT COMPLETED|Overall Study||11
145186|NCT01675479|353681|P1|COMPLETED|Overall Study||58
145187|NCT01675479|353681|P1|STARTED|Overall Study||69
145188|NCT01675453|353688|P2|NOT COMPLETED|Overall Study||0
145189|NCT01675453|353689|P1|NOT COMPLETED|Overall Study||0
145190|NCT01675453|353688|P2|COMPLETED|Overall Study||20
145191|NCT01675453|353689|P1|COMPLETED|Overall Study||20
145192|NCT01675453|353688|P2|STARTED|Overall Study||20
145193|NCT01675453|353689|P1|STARTED|Overall Study||20
145194|NCT01675427|353695|P1|NOT COMPLETED|Overall Study||34
145195|NCT01675427|353695|P1|COMPLETED|Overall Study||4732
145196|NCT01675427|353695|P1|STARTED|Overall Study||4766
145197|NCT01675297|353982|P2|NOT COMPLETED|Overall Study||48
145198|NCT01675297|353983|P1|NOT COMPLETED|Overall Study||164
145199|NCT01675297|353982|P2|COMPLETED|Overall Study||199
145200|NCT01675297|353983|P1|COMPLETED|Overall Study||642
145201|NCT01675297|353982|P2|STARTED|Overall Study||247
145202|NCT01675297|353983|P1|STARTED|Overall Study||806
145203|NCT01675167|353995|P3|NOT COMPLETED|Double-blind Treatment Phase||110
145204|NCT01675167|353996|P2|NOT COMPLETED|Double-blind Treatment Phase||48
145205|NCT01675167|353997|P1|NOT COMPLETED|Double-blind Treatment Phase||0
145206|NCT01675167|353995|P3|COMPLETED|Double-blind Treatment Phase||147
145207|NCT01675167|353996|P2|COMPLETED|Double-blind Treatment Phase||206
145208|NCT01675167|353997|P1|COMPLETED|Double-blind Treatment Phase||0
145209|NCT01675167|353995|P3|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|257
145210|NCT01675167|353996|P2|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|254
145211|NCT01675167|353997|P1|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
145212|NCT01675167|353995|P3|NOT COMPLETED|Open-label Titration Phase||0
145213|NCT01675167|353996|P2|NOT COMPLETED|Open-label Titration Phase||0
145214|NCT01675167|353997|P1|NOT COMPLETED|Open-label Titration Phase||304
145215|NCT01675167|353995|P3|COMPLETED|Open-label Titration Phase||0
145216|NCT01675167|353996|P2|COMPLETED|Open-label Titration Phase||0
145217|NCT01675167|353997|P1|COMPLETED|Open-label Titration Phase||511
145218|NCT01675167|353995|P3|STARTED|Open-label Titration Phase||0
145219|NCT01675167|353996|P2|STARTED|Open-label Titration Phase||0
145220|NCT01675167|353997|P1|STARTED|Open-label Titration Phase||815
145221|NCT01675141|354019|P1|NOT COMPLETED|Overall Study||11
145222|NCT01675141|354019|P1|COMPLETED|Overall Study||0
145223|NCT01675141|354019|P1|STARTED|Overall Study||11
145224|NCT01675128|354032|P3|NOT COMPLETED|Overall Study||1
145225|NCT01675128|354033|P2|NOT COMPLETED|Overall Study||2
145226|NCT01675128|354034|P1|NOT COMPLETED|Overall Study||2
145227|NCT01675128|354032|P3|COMPLETED|Overall Study||9
145228|NCT01675128|354033|P2|COMPLETED|Overall Study||8
145229|NCT01675128|354034|P1|COMPLETED|Overall Study||2
145230|NCT01675128|354032|P3|STARTED|Overall Study||10
145231|NCT01675128|354033|P2|STARTED|Overall Study||10
145232|NCT01675128|354034|P1|STARTED|Overall Study||4
145233|NCT01675063|354056|P1|NOT COMPLETED|Overall Study||0
145234|NCT01675063|354056|P1|COMPLETED|Overall Study||77
145235|NCT01675063|354056|P1|STARTED|Overall Study||77
145236|NCT01675050|354062|P2|NOT COMPLETED|Second Period Treatment||0
145237|NCT01675050|354063|P1|NOT COMPLETED|Second Period Treatment||0
145238|NCT01675050|354062|P2|COMPLETED|Second Period Treatment||2
145239|NCT01675050|354063|P1|COMPLETED|Second Period Treatment||1
145240|NCT01675050|354062|P2|STARTED|Second Period Treatment||2
145241|NCT01675050|354063|P1|STARTED|Second Period Treatment||1
145242|NCT01675050|354062|P2|NOT COMPLETED|Wash Out Period||0
145243|NCT01675050|354063|P1|NOT COMPLETED|Wash Out Period||0
145244|NCT01675050|354062|P2|COMPLETED|Wash Out Period||2
145245|NCT01675050|354063|P1|COMPLETED|Wash Out Period||1
145246|NCT01675050|354062|P2|STARTED|Wash Out Period||2
145247|NCT01675050|354063|P1|STARTED|Wash Out Period||1
145248|NCT01675050|354062|P2|NOT COMPLETED|Period One Treatment||0
145249|NCT01675050|354063|P1|NOT COMPLETED|Period One Treatment||1
145250|NCT01675050|354062|P2|COMPLETED|Period One Treatment||2
145251|NCT01675050|354063|P1|COMPLETED|Period One Treatment||1
145252|NCT01675050|354062|P2|STARTED|Period One Treatment||2
145253|NCT01675050|354063|P1|STARTED|Period One Treatment||2
145254|NCT01675011|354073|P2|NOT COMPLETED|Overall Study||1
145255|NCT01675011|354074|P1|NOT COMPLETED|Overall Study||3
145256|NCT01675011|354073|P2|COMPLETED|Overall Study||0
145257|NCT01675011|354074|P1|COMPLETED|Overall Study||0
145258|NCT01675011|354073|P2|STARTED|Overall Study||1
145259|NCT01675011|354074|P1|STARTED|Overall Study||3
145260|NCT01674725|354082|P2|NOT COMPLETED|Overall Study||1
145261|NCT01674725|354083|P1|NOT COMPLETED|Overall Study||3
145262|NCT01674725|354082|P2|COMPLETED|Overall Study||94
145263|NCT01674725|354083|P1|COMPLETED|Overall Study||89
145264|NCT01674725|354082|P2|STARTED|Overall Study||95
145265|NCT01674725|354083|P1|STARTED|Overall Study||92
145266|NCT01674712|354102|P5|NOT COMPLETED|Overall Study||11
145267|NCT01674712|354103|P4|NOT COMPLETED|Overall Study||8
145268|NCT01674712|354104|P3|NOT COMPLETED|Overall Study||9
145269|NCT01674712|354105|P2|NOT COMPLETED|Overall Study||9
145270|NCT01674712|354106|P1|NOT COMPLETED|Overall Study||10
145271|NCT01674712|354102|P5|COMPLETED|Overall Study||102
145272|NCT01674712|354103|P4|COMPLETED|Overall Study||108
145273|NCT01674712|354104|P3|COMPLETED|Overall Study||106
145274|NCT01674712|354105|P2|COMPLETED|Overall Study||108
145275|NCT01674712|354106|P1|COMPLETED|Overall Study||104
145276|NCT01674712|354102|P5|Safety Subject Sample|Overall Study||112
145277|NCT01674712|354103|P4|Safety Subject Sample|Overall Study||115
145278|NCT01674712|354104|P3|Safety Subject Sample|Overall Study||113
145279|NCT01674712|354105|P2|Safety Subject Sample|Overall Study||117
145280|NCT01674712|354106|P1|Safety Subject Sample|Overall Study||111
145281|NCT01674712|354102|P5|Full Analysis Subject Sample|Overall Study||111
145282|NCT01674712|354103|P4|Full Analysis Subject Sample|Overall Study||112
145283|NCT01674712|354104|P3|Full Analysis Subject Sample|Overall Study||110
145284|NCT01674712|354105|P2|Full Analysis Subject Sample|Overall Study||114
145285|NCT01674712|354106|P1|Full Analysis Subject Sample|Overall Study||109
145286|NCT01674712|354102|P5|STARTED|Overall Study||113
145287|NCT01674712|354103|P4|STARTED|Overall Study||116
145288|NCT01674712|354104|P3|STARTED|Overall Study||115
145289|NCT01674712|354105|P2|STARTED|Overall Study||117
145290|NCT01674712|354106|P1|STARTED|Overall Study||114
145291|NCT01674647|354130|P2|NOT COMPLETED|30-day Safety Follow-up Period||41
145292|NCT01674647|354131|P1|NOT COMPLETED|30-day Safety Follow-up Period||58
145293|NCT01674647|354130|P2|COMPLETED|30-day Safety Follow-up Period||446
145294|NCT01674647|354131|P1|COMPLETED|30-day Safety Follow-up Period||924
145295|NCT01674647|354130|P2|STARTED|30-day Safety Follow-up Period||487
145296|NCT01674647|354131|P1|STARTED|30-day Safety Follow-up Period||982
145297|NCT01674647|354130|P2|NOT COMPLETED|Treatment Period||102
145298|NCT01674647|354131|P1|NOT COMPLETED|Treatment Period||156
145299|NCT01674647|354130|P2|COMPLETED|Treatment Period||400
145300|NCT01674647|354131|P1|COMPLETED|Treatment Period||846
145301|NCT01674647|354130|P2|Subjects Received Treatment|Treatment Period||499
145302|NCT01674647|354131|P1|Subjects Received Treatment|Treatment Period||988
145303|NCT01674647|354130|P2|STARTED|Treatment Period||502
145304|NCT01674647|354131|P1|STARTED|Treatment Period||1002
145305|NCT01674634|354157|P1|NOT COMPLETED|Overall Study||6
145306|NCT01674634|354157|P1|COMPLETED|Overall Study||709
145307|NCT01674634|354157|P1|STARTED|Overall Study||715
145308|NCT01674621|354177|P5|NOT COMPLETED|Overall Study||6
145309|NCT01674621|354178|P4|NOT COMPLETED|Overall Study||7
145310|NCT01674621|354179|P3|NOT COMPLETED|Overall Study||8
145311|NCT01674621|354180|P2|NOT COMPLETED|Overall Study||5
145312|NCT01674621|354181|P1|NOT COMPLETED|Overall Study||6
145313|NCT01674621|354177|P5|COMPLETED|Overall Study||45
145314|NCT01674621|354178|P4|COMPLETED|Overall Study||41
145315|NCT01674621|354179|P3|COMPLETED|Overall Study||43
145316|NCT01674621|354180|P2|COMPLETED|Overall Study||45
145317|NCT01674621|354181|P1|COMPLETED|Overall Study||44
145318|NCT01674621|354177|P5|STARTED|Overall Study||51
145319|NCT01674621|354178|P4|STARTED|Overall Study||48
145320|NCT01674621|354179|P3|STARTED|Overall Study||51
145321|NCT01674621|354180|P2|STARTED|Overall Study||50
145322|NCT01674621|354181|P1|STARTED|Overall Study||50
145323|NCT01674569|354203|P6|NOT COMPLETED|Overall Study||2
145324|NCT01674569|354204|P5|NOT COMPLETED|Overall Study||2
145325|NCT01674569|354205|P4|NOT COMPLETED|Overall Study||1
145326|NCT01674569|354206|P3|NOT COMPLETED|Overall Study||2
145327|NCT01674569|354207|P2|NOT COMPLETED|Overall Study||3
145328|NCT01674569|354208|P1|NOT COMPLETED|Overall Study||0
145329|NCT01674569|354203|P6|COMPLETED|Overall Study||1
145330|NCT01674569|354204|P5|COMPLETED|Overall Study||5
145331|NCT01674569|354205|P4|COMPLETED|Overall Study||9
145332|NCT01674569|354206|P3|COMPLETED|Overall Study||2
145333|NCT01674569|354207|P2|COMPLETED|Overall Study||5
145334|NCT01674569|354208|P1|COMPLETED|Overall Study||3
145335|NCT01674569|354203|P6|STARTED|Overall Study||3
145336|NCT01674569|354204|P5|STARTED|Overall Study||7
145337|NCT01674569|354205|P4|STARTED|Overall Study||10
145338|NCT01674569|354206|P3|STARTED|Overall Study||4
145339|NCT01674569|354207|P2|STARTED|Overall Study||8
145340|NCT01674569|354208|P1|STARTED|Overall Study||3
145341|NCT01674478|354214|P2|NOT COMPLETED|Overall Study||0
145342|NCT01674478|354215|P1|NOT COMPLETED|Overall Study||0
145343|NCT01674478|354214|P2|COMPLETED|Overall Study||9
145344|NCT01674478|354215|P1|COMPLETED|Overall Study||9
145345|NCT01674478|354214|P2|STARTED|Overall Study||9
145346|NCT01674478|354215|P1|STARTED|Overall Study||9
145347|NCT01674062|354229|P2|NOT COMPLETED|Overall Study||29
145348|NCT01674062|354230|P1|NOT COMPLETED|Overall Study||66
145349|NCT01674062|354229|P2|COMPLETED|Overall Study||0
145350|NCT01674062|354230|P1|COMPLETED|Overall Study||0
145351|NCT01674062|354229|P2|STARTED|Overall Study||29
145352|NCT01674062|354230|P1|STARTED|Overall Study||66
145353|NCT01674010|354245|P3|NOT COMPLETED|Randomization Phase 2||61
145354|NCT01674010|354246|P2|NOT COMPLETED|Randomization Phase 2||62
145355|NCT01674010|354247|P1|NOT COMPLETED|Randomization Phase 2||0
145356|NCT01674010|354245|P3|COMPLETED|Randomization Phase 2||3
145357|NCT01674010|354246|P2|COMPLETED|Randomization Phase 2||3
145358|NCT01674010|354247|P1|COMPLETED|Randomization Phase 2||0
145359|NCT01674010|354245|P3|STARTED|Randomization Phase 2||64
145360|NCT01674010|354246|P2|STARTED|Randomization Phase 2||65
145361|NCT01674010|354247|P1|STARTED|Randomization Phase 2||0
145362|NCT01674010|354245|P3|NOT COMPLETED|Open Treatment Phase 1||0
145363|NCT01674010|354246|P2|NOT COMPLETED|Open Treatment Phase 1||0
145364|NCT01674010|354247|P1|NOT COMPLETED|Open Treatment Phase 1||180
145365|NCT01674010|354245|P3|COMPLETED|Open Treatment Phase 1||0
145366|NCT01674010|354246|P2|COMPLETED|Open Treatment Phase 1||0
145367|NCT01674010|354247|P1|COMPLETED|Open Treatment Phase 1||129
145368|NCT01674010|354245|P3|STARTED|Open Treatment Phase 1||0
145369|NCT01674010|354246|P2|STARTED|Open Treatment Phase 1||0
145370|NCT01674010|354247|P1|STARTED|Open Treatment Phase 1||309
145371|NCT01673984|354266|P2|NOT COMPLETED|Overall Study||6
145372|NCT01673984|354267|P1|NOT COMPLETED|Overall Study||10
145373|NCT01673984|354266|P2|COMPLETED|Overall Study||1
145374|NCT01673984|354267|P1|COMPLETED|Overall Study||4
145375|NCT01673984|354266|P2|STARTED|Overall Study||7
145376|NCT01673984|354267|P1|STARTED|Overall Study||14
145377|NCT01673919|354285|P1|NOT COMPLETED|Overall Study||0
145378|NCT01673919|354285|P1|COMPLETED|Overall Study||7
145379|NCT01673919|354285|P1|STARTED|Overall Study||7
145380|NCT01673893|354309|P1|NOT COMPLETED|Overall Study||0
145381|NCT01673893|354309|P1|COMPLETED|Overall Study||59
145382|NCT01673893|354309|P1|STARTED|Overall Study||59
145383|NCT01673867|354317|P2|NOT COMPLETED|Treatment||268
145384|NCT01673867|354318|P1|NOT COMPLETED|Treatment||244
145385|NCT01673867|354317|P2|COMPLETED|Treatment||0
145386|NCT01673867|354318|P1|COMPLETED|Treatment||43
145387|NCT01673867|354317|P2|STARTED|Treatment||268
145388|NCT01673867|354318|P1|STARTED|Treatment||287
145389|NCT01673867|354317|P2|NOT COMPLETED|Randomization||22
145390|NCT01673867|354318|P1|NOT COMPLETED|Randomization||5
145391|NCT01673867|354317|P2|COMPLETED|Randomization||268
145392|NCT01673867|354318|P1|COMPLETED|Randomization||287
145393|NCT01673867|354317|P2|STARTED|Randomization||290
145394|NCT01673867|354318|P1|STARTED|Randomization||292
145395|NCT01673854|354344|P1|NOT COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||19
145396|NCT01673854|354344|P1|COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||0
145397|NCT01673854|354344|P1|STARTED|Vem 2 Phase (Vemurafenib Retreatment)||19
145398|NCT01673854|354344|P1|NOT COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||27
145399|NCT01673854|354344|P1|COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||19
145400|NCT01673854|354344|P1|STARTED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||46
145401|NCT01673854|354344|P1|NOT COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||0
145402|NCT01673854|354344|P1|COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||46
145403|NCT01673854|354344|P1|STARTED|Vem 1 Phase (Vemurafenib, 960 mg)||46
145404|NCT01673828|354354|P2|NOT COMPLETED|Overall Study||0
145405|NCT01673828|354355|P1|NOT COMPLETED|Overall Study||0
145406|NCT01673828|354354|P2|COMPLETED|Overall Study||6
145407|NCT01673828|354355|P1|COMPLETED|Overall Study||7
145408|NCT01673828|354354|P2|STARTED|Overall Study||6
145409|NCT01673828|354355|P1|STARTED|Overall Study||7
145410|NCT01673802|354361|P1|NOT COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||0
145411|NCT01673802|354361|P1|COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||10
145412|NCT01673802|354361|P1|STARTED|Gadoxetate Double Dose 0.050 mmol/kg||10
145413|NCT01673802|354361|P1|NOT COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||0
145414|NCT01673802|354361|P1|COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||8
145415|NCT01673802|354361|P1|STARTED|Gadoxetate Standard Dose 0.025 mmol/kg||8
145416|NCT01673698|354367|P2|NOT COMPLETED|Overall Study||13
145417|NCT01673698|354368|P1|NOT COMPLETED|Overall Study||51
145418|NCT01673698|354367|P2|COMPLETED|Overall Study||126
145419|NCT01673698|354368|P1|COMPLETED|Overall Study||136
145420|NCT01673698|354367|P2|STARTED|Overall Study||139
145421|NCT01673698|354368|P1|STARTED|Overall Study||187
145422|NCT01673646|354379|P3|NOT COMPLETED|Overall Study||4
145423|NCT01673646|354380|P2|NOT COMPLETED|Overall Study||7
145424|NCT01673646|354381|P1|NOT COMPLETED|Overall Study||4
145425|NCT01673646|354379|P3|COMPLETED|Overall Study||7
145426|NCT01673646|354380|P2|COMPLETED|Overall Study||4
145427|NCT01673646|354381|P1|COMPLETED|Overall Study||7
145428|NCT01673646|354379|P3|Discontinued Beyond 24 Months|Overall Study||1
145429|NCT01673646|354380|P2|Discontinued Beyond 24 Months|Overall Study||4
145430|NCT01673646|354381|P1|Discontinued Beyond 24 Months|Overall Study||0
145431|NCT01673646|354379|P3|Treated Beyond 24 Months|Overall Study||8
145432|NCT01673646|354380|P2|Treated Beyond 24 Months|Overall Study||8
145433|NCT01673646|354381|P1|Treated Beyond 24 Months|Overall Study||7
145434|NCT01673646|354379|P3|Did Not Enter Ext. Phase|Overall Study||1
145435|NCT01673646|354380|P2|Did Not Enter Ext. Phase|Overall Study||1
145436|NCT01673646|354381|P1|Did Not Enter Ext. Phase|Overall Study||2
145437|NCT01673646|354379|P3|Entered Ext. Phase|Overall Study||9
145438|NCT01673646|354380|P2|Entered Ext. Phase|Overall Study||9
145439|NCT01673646|354381|P1|Entered Ext. Phase|Overall Study||7
145440|NCT01673646|354379|P3|Completed Core Phase|Overall Study||10
145441|NCT01673646|354380|P2|Completed Core Phase|Overall Study||10
145442|NCT01673646|354381|P1|Completed Core Phase|Overall Study||9
145443|NCT01673646|354379|P3|Entered/Treated in Core Phase|Overall Study||11
145444|NCT01673646|354380|P2|Entered/Treated in Core Phase|Overall Study||11
145445|NCT01673646|354381|P1|Entered/Treated in Core Phase|Overall Study||11
145446|NCT01673646|354379|P3|STARTED|Overall Study||11
145447|NCT01673646|354380|P2|STARTED|Overall Study||11
145448|NCT01673646|354381|P1|STARTED|Overall Study||11
145449|NCT01673620|354420|P2|NOT COMPLETED|Overall Study||0
145450|NCT01673620|354421|P1|NOT COMPLETED|Overall Study||1
145451|NCT01673620|354420|P2|COMPLETED|Overall Study||22
145452|NCT01673620|354421|P1|COMPLETED|Overall Study||46
145453|NCT01673620|354420|P2|STARTED|Overall Study||22
145454|NCT01673620|354421|P1|STARTED|Overall Study||47
145455|NCT01673594|354431|P2|NOT COMPLETED|Overall Study||6
145456|NCT01673594|354432|P1|NOT COMPLETED|Overall Study||6
145457|NCT01673594|354431|P2|COMPLETED|Overall Study||13
145458|NCT01673594|354432|P1|COMPLETED|Overall Study||12
145459|NCT01673594|354431|P2|STARTED|Overall Study||19
145460|NCT01673594|354432|P1|STARTED|Overall Study||18
145461|NCT01673568|354442|P2|NOT COMPLETED|Overall Study||0
145462|NCT01673568|354443|P1|NOT COMPLETED|Overall Study||0
145463|NCT01673568|354442|P2|COMPLETED|Overall Study||28
145464|NCT01673568|354443|P1|COMPLETED|Overall Study||28
145465|NCT01673568|354442|P2|STARTED|Overall Study||28
145466|NCT01673568|354443|P1|STARTED|Overall Study||28
145467|NCT01673490|354451|P1|NOT COMPLETED|Overall Study||7
145468|NCT01673490|354451|P1|COMPLETED|Overall Study||52
145469|NCT01673490|354451|P1|STARTED|Overall Study||59
145470|NCT01673425|354464|P1|NOT COMPLETED|Overall Study||1
145471|NCT01673425|354464|P1|COMPLETED|Overall Study||4
145472|NCT01673425|354464|P1|STARTED|Overall Study||5
145473|NCT01673373|354468|P1|NOT COMPLETED|Overall Study||2
145474|NCT01673373|354468|P1|COMPLETED|Overall Study|Completed primary endpoint follow up.|66
145475|NCT01673373|354468|P1|STARTED|Overall Study||68
145476|NCT01673347|354484|P1|NOT COMPLETED|Overall Study||7
145477|NCT01673347|354484|P1|COMPLETED|Overall Study||17
145478|NCT01673347|354484|P1|STARTED|Overall Study||24
145479|NCT01673282|354493|P2|NOT COMPLETED|Overall Study||26
145480|NCT01673282|354494|P1|NOT COMPLETED|Overall Study||33
145481|NCT01673282|354493|P2|COMPLETED|Overall Study||132
145482|NCT01673282|354494|P1|COMPLETED|Overall Study||120
145483|NCT01673282|354493|P2|STARTED|Overall Study||158
145484|NCT01673282|354494|P1|STARTED|Overall Study||153
145485|NCT01673256|354500|P1|NOT COMPLETED|Overall Study||0
145486|NCT01673256|354500|P1|COMPLETED|Overall Study||90
145487|NCT01673256|354500|P1|STARTED|Overall Study||90
145488|NCT01673191|354506|P2|NOT COMPLETED|Overall Study||0
145489|NCT01673191|354507|P1|NOT COMPLETED|Overall Study||0
145490|NCT01673191|354506|P2|COMPLETED|Overall Study||11
145491|NCT01673191|354507|P1|COMPLETED|Overall Study||26
145492|NCT01673191|354506|P2|STARTED|Overall Study||11
145493|NCT01673191|354507|P1|STARTED|Overall Study||26
145494|NCT01673178|354530|P5|NOT COMPLETED|Overall Study||2
145495|NCT01673178|354531|P4|NOT COMPLETED|Overall Study||8
145496|NCT01673178|354532|P3|NOT COMPLETED|Overall Study||3
145497|NCT01673178|354533|P2|NOT COMPLETED|Overall Study||2
145498|NCT01673178|354534|P1|NOT COMPLETED|Overall Study||3
145499|NCT01673178|354530|P5|COMPLETED|Overall Study||19
145500|NCT01673178|354531|P4|COMPLETED|Overall Study||14
145501|NCT01673178|354532|P3|COMPLETED|Overall Study||18
145502|NCT01673178|354533|P2|COMPLETED|Overall Study||19
145503|NCT01673178|354534|P1|COMPLETED|Overall Study||19
145504|NCT01673178|354530|P5|STARTED|Overall Study||21
145505|NCT01673178|354531|P4|STARTED|Overall Study||22
145506|NCT01673178|354532|P3|STARTED|Overall Study||21
145507|NCT01673178|354533|P2|STARTED|Overall Study||21
145508|NCT01673178|354534|P1|STARTED|Overall Study||22
145509|NCT01673126|354773|P2|NOT COMPLETED|Overall Study||3
145510|NCT01673126|354774|P1|NOT COMPLETED|Overall Study||4
145511|NCT01673126|354773|P2|COMPLETED|Overall Study||23
145512|NCT01673126|354774|P1|COMPLETED|Overall Study||32
145513|NCT01673126|354773|P2|STARTED|Overall Study|First stimulation (20 minutes) Washout (2days) Second stimulation (20 minutes)|26
145514|NCT01673126|354774|P1|STARTED|Overall Study|First stimulation (20 minutes) Washout (2 days) Second stimulation (20 minutes)|36
145515|NCT01673113|354782|P2|NOT COMPLETED|Overall Study||0
145516|NCT01673113|354783|P1|NOT COMPLETED|Overall Study||0
145517|NCT01673113|354782|P2|COMPLETED|Overall Study||11
145518|NCT01673113|354783|P1|COMPLETED|Overall Study||11
145519|NCT01673113|354782|P2|STARTED|Overall Study||11
145520|NCT01673113|354783|P1|STARTED|Overall Study||11
145521|NCT01673022|354790|P1|NOT COMPLETED|Overall Study||8
145522|NCT01673022|354790|P1|COMPLETED|Overall Study||422
145523|NCT01673022|354790|P1|STARTED|Overall Study||430
145524|NCT01673009|354794|P1|NOT COMPLETED|Overall Study||13
145525|NCT01673009|354794|P1|COMPLETED|Overall Study||23
145526|NCT01673009|354794|P1|STARTED|Overall Study||36
145527|NCT01672996|354806|P3|NOT COMPLETED|Overall Study||0
145528|NCT01672996|354807|P2|NOT COMPLETED|Overall Study||0
145529|NCT01672996|354808|P1|NOT COMPLETED|Overall Study||0
145530|NCT01672996|354806|P3|COMPLETED|Overall Study||6
145531|NCT01672996|354807|P2|COMPLETED|Overall Study||30
145532|NCT01672996|354808|P1|COMPLETED|Overall Study||30
145533|NCT01672996|354806|P3|STARTED|Overall Study||6
145534|NCT01672996|354807|P2|STARTED|Overall Study||30
145535|NCT01672996|354808|P1|STARTED|Overall Study||30
145536|NCT01672983|354844|P6|NOT COMPLETED|Overall Study||0
145537|NCT01672983|354845|P5|NOT COMPLETED|Overall Study||0
145538|NCT01672983|354846|P4|NOT COMPLETED|Overall Study||0
145539|NCT01672983|354847|P3|NOT COMPLETED|Overall Study||0
145540|NCT01672983|354848|P2|NOT COMPLETED|Overall Study||0
145541|NCT01672983|354849|P1|NOT COMPLETED|Overall Study||0
145542|NCT01672983|354844|P6|COMPLETED|Overall Study||18
145543|NCT01672983|354845|P5|COMPLETED|Overall Study||19
145544|NCT01672983|354846|P4|COMPLETED|Overall Study||18
145545|NCT01672983|354847|P3|COMPLETED|Overall Study||19
145546|NCT01672983|354848|P2|COMPLETED|Overall Study||18
145547|NCT01672983|354849|P1|COMPLETED|Overall Study||18
145548|NCT01672983|354844|P6|Completed Study Drug|Overall Study||17
145549|NCT01672983|354845|P5|Completed Study Drug|Overall Study||12
145550|NCT01672983|354846|P4|Completed Study Drug|Overall Study||18
145551|NCT01672983|354847|P3|Completed Study Drug|Overall Study||18
145552|NCT01672983|354848|P2|Completed Study Drug|Overall Study||17
145553|NCT01672983|354849|P1|Completed Study Drug|Overall Study||18
145554|NCT01672983|354844|P6|STARTED|Overall Study||18
145555|NCT01672983|354845|P5|STARTED|Overall Study||19
145556|NCT01672983|354846|P4|STARTED|Overall Study||18
145557|NCT01672983|354847|P3|STARTED|Overall Study||19
145558|NCT01672983|354848|P2|STARTED|Overall Study||18
145559|NCT01672983|354849|P1|STARTED|Overall Study||18
145560|NCT01672970|354879|P1|NOT COMPLETED|Overall Study||47
145561|NCT01672970|354879|P1|COMPLETED|Overall Study||244
145562|NCT01672970|354879|P1|Treated|Overall Study||290
145563|NCT01672970|354879|P1|STARTED|Overall Study||291
145564|NCT01672957|354915|P1|NOT COMPLETED|Overall Study||55
145565|NCT01672957|354915|P1|COMPLETED|Overall Study||73
145566|NCT01672957|354915|P1|Intent-to-treat (ITT) Population|Overall Study|All enrolled participants who had no major protocol violation.|123
145567|NCT01672957|354915|P1|STARTED|Overall Study||128
145568|NCT01672892|354930|P2|NOT COMPLETED|Overall Study||3
145569|NCT01672892|354931|P1|NOT COMPLETED|Overall Study||8
145570|NCT01672892|354930|P2|COMPLETED|Overall Study|Eligible subjects available for analysis|149
145571|NCT01672892|354931|P1|COMPLETED|Overall Study|Eligible subjects available for analysis|129
145572|NCT01672892|354930|P2|STARTED|Overall Study||152
145573|NCT01672892|354931|P1|STARTED|Overall Study||137
145574|NCT01672879|354948|P3|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||8
145575|NCT01672879|354949|P2|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||17
145576|NCT01672879|354950|P1|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||15
145577|NCT01672879|354948|P3|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
145578|NCT01672879|354949|P2|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
145579|NCT01672879|354950|P1|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
145580|NCT01672879|354948|P3|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|8
145581|NCT01672879|354949|P2|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|17
145582|NCT01672879|354950|P1|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|15
145583|NCT01672879|354948|P3|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||86
145584|NCT01672879|354949|P2|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||86
145585|NCT01672879|354950|P1|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||87
145586|NCT01672879|354948|P3|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
145587|NCT01672879|354949|P2|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
145588|NCT01672879|354950|P1|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
145589|NCT01672879|354948|P3|STARTED|Blinded Phase (Up to 240 Weeks)||86
145590|NCT01672879|354949|P2|STARTED|Blinded Phase (Up to 240 Weeks)||86
145591|NCT01672879|354950|P1|STARTED|Blinded Phase (Up to 240 Weeks)||87
145592|NCT01672866|354965|P3|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||16
145593|NCT01672866|354966|P2|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||15
145594|NCT01672866|354967|P1|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||11
145595|NCT01672866|354965|P3|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
145596|NCT01672866|354966|P2|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
145597|NCT01672866|354967|P1|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
145598|NCT01672866|354965|P3|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|16
145599|NCT01672866|354966|P2|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|15
145600|NCT01672866|354967|P1|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|11
145601|NCT01672866|354965|P3|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
145602|NCT01672866|354966|P2|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
145603|NCT01672866|354967|P1|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
145604|NCT01672866|354965|P3|COMPLETED|Blinded Phase (up to 240 Weeks)||0
145605|NCT01672866|354966|P2|COMPLETED|Blinded Phase (up to 240 Weeks)||0
145606|NCT01672866|354967|P1|COMPLETED|Blinded Phase (up to 240 Weeks)||0
145607|NCT01672866|354965|P3|STARTED|Blinded Phase (up to 240 Weeks)||74
145608|NCT01672866|354966|P2|STARTED|Blinded Phase (up to 240 Weeks)||74
145609|NCT01672866|354967|P1|STARTED|Blinded Phase (up to 240 Weeks)||74
145610|NCT01672853|354982|P3|NOT COMPLETED|Overall Study||14
145611|NCT01672853|354983|P2|NOT COMPLETED|Overall Study||17
145612|NCT01672853|354984|P1|NOT COMPLETED|Overall Study||10
145613|NCT01672853|354982|P3|COMPLETED|Overall Study||65
145614|NCT01672853|354983|P2|COMPLETED|Overall Study||60
145615|NCT01672853|354984|P1|COMPLETED|Overall Study||69
145616|NCT01672853|354982|P3|STARTED|Overall Study||79
145617|NCT01672853|354983|P2|STARTED|Overall Study||77
145618|NCT01672853|354984|P1|STARTED|Overall Study||79
145619|NCT01672827|355001|P1|NOT COMPLETED|Overall Study||0
145620|NCT01672827|355001|P1|COMPLETED|Overall Study||276
145621|NCT01672827|355001|P1|STARTED|Overall Study||276
145622|NCT01672788|355007|P4|NOT COMPLETED|Treatment Period 4 (3 Days)||0
145623|NCT01672788|355008|P3|NOT COMPLETED|Treatment Period 4 (3 Days)||0
145624|NCT01672788|355009|P2|NOT COMPLETED|Treatment Period 4 (3 Days)||0
145625|NCT01672788|355010|P1|NOT COMPLETED|Treatment Period 4 (3 Days)||0
145626|NCT01672788|355007|P4|COMPLETED|Treatment Period 4 (3 Days)||8
145627|NCT01672788|355008|P3|COMPLETED|Treatment Period 4 (3 Days)||9
145628|NCT01672788|355009|P2|COMPLETED|Treatment Period 4 (3 Days)||9
145629|NCT01672788|355010|P1|COMPLETED|Treatment Period 4 (3 Days)||9
145630|NCT01672788|355007|P4|STARTED|Treatment Period 4 (3 Days)||8
145631|NCT01672788|355008|P3|STARTED|Treatment Period 4 (3 Days)||9
145632|NCT01672788|355009|P2|STARTED|Treatment Period 4 (3 Days)||9
145633|NCT01672788|355010|P1|STARTED|Treatment Period 4 (3 Days)||9
145634|NCT01672788|355007|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
145635|NCT01672788|355008|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
145636|NCT01672788|355009|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
145637|NCT01672788|355010|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
145638|NCT01672788|355007|P4|COMPLETED|Washout Period 3 (7 Days)||8
145639|NCT01672788|355008|P3|COMPLETED|Washout Period 3 (7 Days)||9
145640|NCT01672788|355009|P2|COMPLETED|Washout Period 3 (7 Days)||9
145641|NCT01672788|355010|P1|COMPLETED|Washout Period 3 (7 Days)||9
145642|NCT01672788|355007|P4|STARTED|Washout Period 3 (7 Days)||8
145643|NCT01672788|355008|P3|STARTED|Washout Period 3 (7 Days)||9
145644|NCT01672788|355009|P2|STARTED|Washout Period 3 (7 Days)||9
145645|NCT01672788|355010|P1|STARTED|Washout Period 3 (7 Days)||9
145646|NCT01672788|355007|P4|NOT COMPLETED|Treatment Period 3 (3 Days)||0
145647|NCT01672788|355008|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
145648|NCT01672788|355009|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
145649|NCT01672788|355010|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
145650|NCT01672788|355007|P4|COMPLETED|Treatment Period 3 (3 Days)||8
145651|NCT01672788|355008|P3|COMPLETED|Treatment Period 3 (3 Days)||9
145652|NCT01672788|355009|P2|COMPLETED|Treatment Period 3 (3 Days)||9
145653|NCT01672788|355010|P1|COMPLETED|Treatment Period 3 (3 Days)||9
145654|NCT01672788|355007|P4|STARTED|Treatment Period 3 (3 Days)||8
145655|NCT01672788|355008|P3|STARTED|Treatment Period 3 (3 Days)||9
145656|NCT01672788|355009|P2|STARTED|Treatment Period 3 (3 Days)||9
145657|NCT01672788|355010|P1|STARTED|Treatment Period 3 (3 Days)||9
145658|NCT01672788|355007|P4|NOT COMPLETED|Washout Period 2 (7 Days)||1
145659|NCT01672788|355008|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
145660|NCT01672788|355009|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
145661|NCT01672788|355010|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
145662|NCT01672788|355007|P4|COMPLETED|Washout Period 2 (7 Days)||8
145663|NCT01672788|355008|P3|COMPLETED|Washout Period 2 (7 Days)||9
145664|NCT01672788|355009|P2|COMPLETED|Washout Period 2 (7 Days)||9
145665|NCT01672788|355010|P1|COMPLETED|Washout Period 2 (7 Days)||9
145666|NCT01672788|355007|P4|STARTED|Washout Period 2 (7 Days)||9
145667|NCT01672788|355008|P3|STARTED|Washout Period 2 (7 Days)||9
145668|NCT01672788|355009|P2|STARTED|Washout Period 2 (7 Days)||9
145669|NCT01672788|355010|P1|STARTED|Washout Period 2 (7 Days)||9
145670|NCT01672788|355007|P4|NOT COMPLETED|Treatment Period 2 (3 Days)||0
145671|NCT01672788|355008|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||0
145672|NCT01672788|355009|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||0
145673|NCT01672788|355010|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
145674|NCT01672788|355007|P4|COMPLETED|Treatment Period 2 (3 Days)||9
145675|NCT01672788|355008|P3|COMPLETED|Treatment Period 2 (3 Days)||9
145676|NCT01672788|355009|P2|COMPLETED|Treatment Period 2 (3 Days)||9
145677|NCT01672788|355010|P1|COMPLETED|Treatment Period 2 (3 Days)||9
145678|NCT01672788|355007|P4|STARTED|Treatment Period 2 (3 Days)||9
145679|NCT01672788|355008|P3|STARTED|Treatment Period 2 (3 Days)||9
145680|NCT01672788|355009|P2|STARTED|Treatment Period 2 (3 Days)||9
145681|NCT01672788|355010|P1|STARTED|Treatment Period 2 (3 Days)||9
145682|NCT01672788|355007|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
145683|NCT01672788|355008|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
145684|NCT01672788|355009|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
145685|NCT01672788|355010|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
145686|NCT01672788|355007|P4|COMPLETED|Washout Period 1 (7 Days)||9
145687|NCT01672788|355008|P3|COMPLETED|Washout Period 1 (7 Days)||9
145688|NCT01672788|355009|P2|COMPLETED|Washout Period 1 (7 Days)||9
145689|NCT01672788|355010|P1|COMPLETED|Washout Period 1 (7 Days)||9
145690|NCT01672788|355007|P4|STARTED|Washout Period 1 (7 Days)||9
145691|NCT01672788|355008|P3|STARTED|Washout Period 1 (7 Days)||9
145692|NCT01672788|355009|P2|STARTED|Washout Period 1 (7 Days)||9
145693|NCT01672788|355010|P1|STARTED|Washout Period 1 (7 Days)||9
145694|NCT01672788|355007|P4|NOT COMPLETED|Treatment Period 1 (3 Days)||0
145695|NCT01672788|355008|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||0
145696|NCT01672788|355009|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
145697|NCT01672788|355010|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||0
145698|NCT01672788|355007|P4|COMPLETED|Treatment Period 1 (3 Days)||9
145699|NCT01672788|355008|P3|COMPLETED|Treatment Period 1 (3 Days)||9
145700|NCT01672788|355009|P2|COMPLETED|Treatment Period 1 (3 Days)||9
145701|NCT01672788|355010|P1|COMPLETED|Treatment Period 1 (3 Days)||9
145702|NCT01672788|355007|P4|STARTED|Treatment Period 1 (3 Days)||9
145703|NCT01672788|355008|P3|STARTED|Treatment Period 1 (3 Days)||9
145704|NCT01672788|355009|P2|STARTED|Treatment Period 1 (3 Days)||9
145705|NCT01672788|355010|P1|STARTED|Treatment Period 1 (3 Days)||9
145706|NCT01672736|355040|P1|NOT COMPLETED|Overall Study||3
145707|NCT01672736|355040|P1|COMPLETED|Overall Study|3 patients taken off study due to non-availability of further study (Linsitinib) drug supply.|16
145708|NCT01672736|355040|P1|STARTED|Overall Study|Phase I study part stopped early due to manufacturer's decision to stop further drug development.|19
145709|NCT01672723|355044|P2|NOT COMPLETED|Second Intervention||0
145710|NCT01672723|355045|P1|NOT COMPLETED|Second Intervention||0
145711|NCT01672723|355044|P2|COMPLETED|Second Intervention||15
145712|NCT01672723|355045|P1|COMPLETED|Second Intervention||16
145713|NCT01672723|355044|P2|STARTED|Second Intervention||15
145714|NCT01672723|355045|P1|STARTED|Second Intervention||16
145715|NCT01672723|355044|P2|NOT COMPLETED|Washout Period of 10 Days||0
145716|NCT01672723|355045|P1|NOT COMPLETED|Washout Period of 10 Days||0
145717|NCT01672723|355044|P2|COMPLETED|Washout Period of 10 Days||15
145718|NCT01672723|355045|P1|COMPLETED|Washout Period of 10 Days||16
145719|NCT01672723|355044|P2|STARTED|Washout Period of 10 Days||15
145720|NCT01672723|355045|P1|STARTED|Washout Period of 10 Days||16
145721|NCT01672723|355044|P2|NOT COMPLETED|First Intervention||0
145722|NCT01672723|355045|P1|NOT COMPLETED|First Intervention||3
145723|NCT01672723|355044|P2|COMPLETED|First Intervention||15
145724|NCT01672723|355045|P1|COMPLETED|First Intervention||16
145725|NCT01672723|355044|P2|STARTED|First Intervention||15
145726|NCT01672723|355045|P1|STARTED|First Intervention||19
145727|NCT01672710|355057|P2|NOT COMPLETED|3 Month Follow up||4
145728|NCT01672710|355058|P1|NOT COMPLETED|3 Month Follow up||6
145729|NCT01672710|355057|P2|COMPLETED|3 Month Follow up||5
145730|NCT01672710|355058|P1|COMPLETED|3 Month Follow up||16
145731|NCT01672710|355057|P2|STARTED|3 Month Follow up||9
145732|NCT01672710|355058|P1|STARTED|3 Month Follow up||22
145733|NCT01672710|355057|P2|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||1
145734|NCT01672710|355058|P1|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||0
145735|NCT01672710|355057|P2|COMPLETED|Waitlist Assessed After Sauna Regimen||9
145825|NCT01671085|355225|P2|COMPLETED|Overall Study||2
145736|NCT01672710|355058|P1|COMPLETED|Waitlist Assessed After Sauna Regimen|non applicable, cannot compare the immediate start and waitlist in this period|22
145737|NCT01672710|355057|P2|STARTED|Waitlist Assessed After Sauna Regimen|waitlisted group receive the 4 week intervention and complete 7 day assessments|10
145738|NCT01672710|355058|P1|STARTED|Waitlist Assessed After Sauna Regimen|immediate start group no further assessments until 3 month follow up|22
145739|NCT01672710|355057|P2|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0
145740|NCT01672710|355058|P1|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0
145741|NCT01672710|355057|P2|COMPLETED|Controlled Comparison 5 Week Follow-up|waitlist group repeat baseline assessments after 4 week time period then begin sauna|10
145742|NCT01672710|355058|P1|COMPLETED|Controlled Comparison 5 Week Follow-up|sauna intervention group repeat all assessments 7 days after complete the regimen|22
145743|NCT01672710|355057|P2|STARTED|Controlled Comparison 5 Week Follow-up||10
145744|NCT01672710|355058|P1|STARTED|Controlled Comparison 5 Week Follow-up||22
145745|NCT01672658|355070|P2|NOT COMPLETED|Overall Study||1
145746|NCT01672658|355071|P1|NOT COMPLETED|Overall Study||0
145747|NCT01672658|355070|P2|COMPLETED|Overall Study||14
145748|NCT01672658|355071|P1|COMPLETED|Overall Study||16
145749|NCT01672658|355070|P2|STARTED|Overall Study||15
145750|NCT01672658|355071|P1|STARTED|Overall Study||16
145751|NCT01672294|355095|P4|NOT COMPLETED|Overall Study||13
145752|NCT01672294|355096|P3|NOT COMPLETED|Overall Study||11
145753|NCT01672294|355097|P2|NOT COMPLETED|Overall Study||21
145754|NCT01672294|355098|P1|NOT COMPLETED|Overall Study||6
145755|NCT01672294|355095|P4|COMPLETED|Overall Study||59
145756|NCT01672294|355096|P3|COMPLETED|Overall Study||61
145757|NCT01672294|355097|P2|COMPLETED|Overall Study||50
145758|NCT01672294|355098|P1|COMPLETED|Overall Study||65
145759|NCT01672294|355095|P4|STARTED|Overall Study||72
145760|NCT01672294|355096|P3|STARTED|Overall Study||72
145761|NCT01672294|355097|P2|STARTED|Overall Study||71
145762|NCT01672294|355098|P1|STARTED|Overall Study||71
145763|NCT01672242|355120|P2|NOT COMPLETED|Period 2||0
145764|NCT01672242|355121|P1|NOT COMPLETED|Period 2||0
145765|NCT01672242|355120|P2|COMPLETED|Period 2||2
145766|NCT01672242|355121|P1|COMPLETED|Period 2||4
145767|NCT01672242|355120|P2|STARTED|Period 2||2
145768|NCT01672242|355121|P1|STARTED|Period 2||4
145769|NCT01672242|355120|P2|NOT COMPLETED|Period 1||0
145770|NCT01672242|355121|P1|NOT COMPLETED|Period 1||0
145771|NCT01672242|355120|P2|COMPLETED|Period 1||2
145772|NCT01672242|355121|P1|COMPLETED|Period 1||4
145773|NCT01672242|355120|P2|STARTED|Period 1||2
145774|NCT01672242|355121|P1|STARTED|Period 1||4
145775|NCT01671839|355127|P1|NOT COMPLETED|Overall Study||5
145776|NCT01671839|355127|P1|COMPLETED|Overall Study||50
145777|NCT01671839|355127|P1|STARTED|Overall Study||55
145778|NCT01671748|355138|P2|NOT COMPLETED|12 Week Treatment Phase||0
145779|NCT01671748|355139|P1|NOT COMPLETED|12 Week Treatment Phase||0
145780|NCT01671748|355138|P2|COMPLETED|12 Week Treatment Phase||17
145781|NCT01671748|355139|P1|COMPLETED|12 Week Treatment Phase||19
145782|NCT01671748|355138|P2|STARTED|12 Week Treatment Phase||17
145783|NCT01671748|355139|P1|STARTED|12 Week Treatment Phase||19
145784|NCT01671748|355138|P2|NOT COMPLETED|4 Week run-in Phase||0
145785|NCT01671748|355139|P1|NOT COMPLETED|4 Week run-in Phase||11
145786|NCT01671748|355138|P2|COMPLETED|4 Week run-in Phase||0
145787|NCT01671748|355139|P1|COMPLETED|4 Week run-in Phase||36
145788|NCT01671748|355138|P2|STARTED|4 Week run-in Phase||0
145789|NCT01671748|355139|P1|STARTED|4 Week run-in Phase||47
145790|NCT01671605|355159|P2|NOT COMPLETED|Overall Study||0
145791|NCT01671605|355160|P1|NOT COMPLETED|Overall Study||0
145792|NCT01671605|355159|P2|COMPLETED|Overall Study||31
145793|NCT01671605|355160|P1|COMPLETED|Overall Study||72
145794|NCT01671605|355159|P2|STARTED|Overall Study||31
145795|NCT01671605|355160|P1|STARTED|Overall Study||72
145796|NCT01671488|355166|P1|NOT COMPLETED|Overall Study||1
145797|NCT01671488|355166|P1|COMPLETED|Overall Study||10
145798|NCT01671488|355166|P1|STARTED|Overall Study||11
145799|NCT01671345|355174|P2|NOT COMPLETED|Overall Study||9
145800|NCT01671345|355175|P1|NOT COMPLETED|Overall Study||13
145801|NCT01671345|355174|P2|COMPLETED|Overall Study||83
145802|NCT01671345|355175|P1|COMPLETED|Overall Study||64
145803|NCT01671345|355174|P2|STARTED|Overall Study||92
145804|NCT01671345|355175|P1|STARTED|Overall Study||77
145805|NCT01671319|355187|P1|NOT COMPLETED|Overall Study||1
145806|NCT01671319|355187|P1|COMPLETED|Overall Study||41
145807|NCT01671319|355187|P1|STARTED|Overall Study||42
145808|NCT01671293|355195|P2|NOT COMPLETED|Overall Study||2
145809|NCT01671293|355196|P1|NOT COMPLETED|Overall Study||3
145810|NCT01671293|355195|P2|COMPLETED|Overall Study||32
145811|NCT01671293|355196|P1|COMPLETED|Overall Study||33
145812|NCT01671293|355195|P2|STARTED|Overall Study||34
145813|NCT01671293|355196|P1|STARTED|Overall Study||36
145814|NCT01671280|355202|P1|NOT COMPLETED|Overall Study||2
145815|NCT01671280|355202|P1|COMPLETED|Overall Study||401
145816|NCT01671280|355202|P1|STARTED|Overall Study|The number is enrollment.|403
145817|NCT01671176|355208|P1|NOT COMPLETED|Overall Study||0
145818|NCT01671176|355208|P1|COMPLETED|Overall Study||30
145819|NCT01671176|355208|P1|STARTED|Overall Study||30
145820|NCT01671111|355213|P1|NOT COMPLETED|Overall Study||30
145821|NCT01671111|355213|P1|COMPLETED|Overall Study||0
145822|NCT01671111|355213|P1|STARTED|Overall Study||30
145823|NCT01671085|355225|P2|NOT COMPLETED|Overall Study||0
145824|NCT01671085|355226|P1|NOT COMPLETED|Overall Study||1
145826|NCT01671085|355226|P1|COMPLETED|Overall Study||10
145827|NCT01671085|355225|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
145828|NCT01671085|355226|P1|Received at Least 1 Dose of Study Drug|Overall Study||11
145829|NCT01671085|355225|P2|STARTED|Overall Study||2
145830|NCT01671085|355226|P1|STARTED|Overall Study|1 participant who dropped out was replaced.|11
145831|NCT01671059|355237|P1|NOT COMPLETED|Overall Study||5
145832|NCT01671059|355237|P1|COMPLETED|Overall Study||75
145833|NCT01671059|355237|P1|STARTED|Overall Study||80
145834|NCT01670825|355262|P2|NOT COMPLETED|Overall Study||0
145835|NCT01670825|355263|P1|NOT COMPLETED|Overall Study||0
145836|NCT01670825|355262|P2|COMPLETED|Overall Study||39
145837|NCT01670825|355263|P1|COMPLETED|Overall Study||42
145838|NCT01670825|355262|P2|STARTED|Overall Study||39
145839|NCT01670825|355263|P1|STARTED|Overall Study||42
145840|NCT01670721|355329|P1|NOT COMPLETED|Overall Study||53
145841|NCT01670721|355329|P1|COMPLETED|Overall Study|81 participants with DP and 41 with adverse events were considered as completed.|122
145842|NCT01670721|355329|P1|STARTED|Overall Study||175
145843|NCT01670656|355341|P5|NOT COMPLETED|Overall Study||11
145844|NCT01670656|355342|P4|NOT COMPLETED|Overall Study||6
145845|NCT01670656|355343|P3|NOT COMPLETED|Overall Study||8
145846|NCT01670656|355344|P2|NOT COMPLETED|Overall Study||7
145847|NCT01670656|355345|P1|NOT COMPLETED|Overall Study||3
145848|NCT01670656|355341|P5|COMPLETED|Overall Study||79
145849|NCT01670656|355342|P4|COMPLETED|Overall Study||79
145850|NCT01670656|355343|P3|COMPLETED|Overall Study||79
145851|NCT01670656|355344|P2|COMPLETED|Overall Study||84
145852|NCT01670656|355345|P1|COMPLETED|Overall Study||83
145853|NCT01670656|355341|P5|Treated|Overall Study||90
145854|NCT01670656|355342|P4|Treated|Overall Study||85
145855|NCT01670656|355343|P3|Treated|Overall Study||86
145856|NCT01670656|355344|P2|Treated|Overall Study||91
145857|NCT01670656|355345|P1|Treated|Overall Study||86
145858|NCT01670656|355341|P5|STARTED|Overall Study||90
145859|NCT01670656|355342|P4|STARTED|Overall Study||85
145860|NCT01670656|355343|P3|STARTED|Overall Study||87
145861|NCT01670656|355344|P2|STARTED|Overall Study||91
145862|NCT01670656|355345|P1|STARTED|Overall Study||86
145863|NCT01670526|355374|P2|NOT COMPLETED|Overall Study||6
145864|NCT01670526|355375|P1|NOT COMPLETED|Overall Study||12
145865|NCT01670526|355374|P2|COMPLETED|Overall Study||39
145866|NCT01670526|355375|P1|COMPLETED|Overall Study||37
145867|NCT01670526|355374|P2|STARTED|Overall Study||45
145868|NCT01670526|355375|P1|STARTED|Overall Study||49
145869|NCT01670487|355389|P2|NOT COMPLETED|Overall Study||0
145870|NCT01670487|355390|P1|NOT COMPLETED|Overall Study||0
145871|NCT01670487|355389|P2|COMPLETED|Overall Study||150
145872|NCT01670487|355390|P1|COMPLETED|Overall Study||150
145873|NCT01670487|355389|P2|STARTED|Overall Study||150
145874|NCT01670487|355390|P1|STARTED|Overall Study||150
145875|NCT01670292|355396|P1|NOT COMPLETED|Overall Study||14
145876|NCT01670292|355396|P1|COMPLETED|Overall Study||68
145877|NCT01670292|355396|P1|STARTED|Overall Study||82
145878|NCT01670279|355437|P4|NOT COMPLETED|Overall Study||1
145879|NCT01670279|355438|P3|NOT COMPLETED|Overall Study||0
145880|NCT01670279|355439|P2|NOT COMPLETED|Overall Study||2
145881|NCT01670279|355440|P1|NOT COMPLETED|Overall Study||0
145882|NCT01670279|355437|P4|COMPLETED|Overall Study||4
145883|NCT01670279|355438|P3|COMPLETED|Overall Study||0
145884|NCT01670279|355439|P2|COMPLETED|Overall Study||5
145885|NCT01670279|355440|P1|COMPLETED|Overall Study||6
145886|NCT01670279|355437|P4|STARTED|Overall Study||5
145887|NCT01670279|355438|P3|STARTED|Overall Study||0
145888|NCT01670279|355439|P2|STARTED|Overall Study||7
145889|NCT01670279|355440|P1|STARTED|Overall Study||6
145890|NCT01670201|355475|P1|NOT COMPLETED|Overall Study||0
145891|NCT01670201|355475|P1|COMPLETED|Overall Study||8
145892|NCT01670201|355475|P1|STARTED|Overall Study||8
145893|NCT01670188|355482|P2|NOT COMPLETED|Overall Study||1
145894|NCT01670188|355483|P1|NOT COMPLETED|Overall Study||0
145895|NCT01670188|355482|P2|COMPLETED|Overall Study||39
145896|NCT01670188|355483|P1|COMPLETED|Overall Study||38
145897|NCT01670188|355482|P2|STARTED|Overall Study||40
145898|NCT01670188|355483|P1|STARTED|Overall Study||38
145899|NCT01670045|355489|P1|NOT COMPLETED|Overall Study||16
145900|NCT01670045|355489|P1|COMPLETED|Overall Study||27
145901|NCT01670045|355489|P1|STARTED|Overall Study||43
145902|NCT01670019|355507|P2|NOT COMPLETED|Overall Study||0
145903|NCT01670019|355508|P1|NOT COMPLETED|Overall Study||9
145904|NCT01670019|355507|P2|COMPLETED|Overall Study||23
145905|NCT01670019|355508|P1|COMPLETED|Overall Study||14
145906|NCT01670019|355507|P2|STARTED|Overall Study||23
145907|NCT01670019|355508|P1|STARTED|Overall Study||23
145908|NCT01669902|355522|P1|NOT COMPLETED|Overall Study||29
145909|NCT01669902|355522|P1|COMPLETED|Overall Study||78
145910|NCT01669902|355522|P1|STARTED|Overall Study||107
145911|NCT01669863|355549|P1|NOT COMPLETED|Overall Study||0
145912|NCT01669863|355549|P1|COMPLETED|Overall Study||6
145913|NCT01669863|355549|P1|STARTED|Overall Study||6
145914|NCT01669811|355557|P2|NOT COMPLETED|Overall Study||11
145915|NCT01669811|355558|P1|NOT COMPLETED|Overall Study||3
145916|NCT01669811|355557|P2|COMPLETED|Overall Study||131
145917|NCT01669811|355558|P1|COMPLETED|Overall Study||142
145918|NCT01669811|355557|P2|STARTED|Overall Study||142
145919|NCT01669811|355558|P1|STARTED|Overall Study||145
145920|NCT01669798|355576|P1|NOT COMPLETED|Overall Study||5
145921|NCT01669798|355576|P1|COMPLETED|Overall Study||27
145922|NCT01669798|355576|P1|STARTED|Overall Study||32
145923|NCT01669785|355592|P3|NOT COMPLETED|Overall Study||0
145924|NCT01669785|355593|P2|NOT COMPLETED|Overall Study||0
145925|NCT01669785|355594|P1|NOT COMPLETED|Overall Study||0
145926|NCT01669785|355592|P3|COMPLETED|Overall Study||46
145927|NCT01669785|355593|P2|COMPLETED|Overall Study||48
145928|NCT01669785|355594|P1|COMPLETED|Overall Study||45
145929|NCT01669785|355592|P3|STARTED|Overall Study||46
145930|NCT01669785|355593|P2|STARTED|Overall Study||48
145931|NCT01669785|355594|P1|STARTED|Overall Study||45
145932|NCT01669720|355631|P2|NOT COMPLETED|Overall Study||0
145933|NCT01669720|355632|P1|NOT COMPLETED|Overall Study||0
145934|NCT01669720|355631|P2|COMPLETED|Overall Study||3
145935|NCT01669720|355632|P1|COMPLETED|Overall Study||7
145936|NCT01669720|355631|P2|STARTED|Overall Study||3
145937|NCT01669720|355632|P1|STARTED|Overall Study||7
145938|NCT01669642|355645|P6|NOT COMPLETED|Overall Study||10
145939|NCT01669642|355646|P5|NOT COMPLETED|Overall Study||0
145940|NCT01669642|355647|P4|NOT COMPLETED|Overall Study||1
145941|NCT01669642|355648|P3|NOT COMPLETED|Overall Study||0
145942|NCT01669642|355649|P2|NOT COMPLETED|Overall Study||0
145943|NCT01669642|355650|P1|NOT COMPLETED|Overall Study||0
145944|NCT01669642|355645|P6|COMPLETED|Overall Study||0
145945|NCT01669642|355646|P5|COMPLETED|Overall Study||20
145946|NCT01669642|355647|P4|COMPLETED|Overall Study||20
145947|NCT01669642|355648|P3|COMPLETED|Overall Study||20
145948|NCT01669642|355649|P2|COMPLETED|Overall Study||20
145949|NCT01669642|355650|P1|COMPLETED|Overall Study||20
145950|NCT01669642|355645|P6|STARTED|Overall Study||10
145951|NCT01669642|355646|P5|STARTED|Overall Study||20
145952|NCT01669642|355647|P4|STARTED|Overall Study||21
145953|NCT01669642|355648|P3|STARTED|Overall Study||20
145954|NCT01669642|355649|P2|STARTED|Overall Study||20
145955|NCT01669642|355650|P1|STARTED|Overall Study||20
145956|NCT01669629|355682|P2|NOT COMPLETED|Period 2||0
145957|NCT01669629|355683|P1|NOT COMPLETED|Period 2||0
145958|NCT01669629|355682|P2|COMPLETED|Period 2||89
145959|NCT01669629|355683|P1|COMPLETED|Period 2||91
145960|NCT01669629|355682|P2|STARTED|Period 2||89
145961|NCT01669629|355683|P1|STARTED|Period 2||91
145962|NCT01669629|355682|P2|NOT COMPLETED|Period 1||2
145963|NCT01669629|355683|P1|NOT COMPLETED|Period 1||1
145964|NCT01669629|355682|P2|COMPLETED|Period 1||89
145965|NCT01669629|355683|P1|COMPLETED|Period 1||91
145966|NCT01669629|355682|P2|STARTED|Period 1||91
145967|NCT01669629|355683|P1|STARTED|Period 1||92
145968|NCT01669603|355699|P2|NOT COMPLETED|Overall Study||38
145969|NCT01669603|355700|P1|NOT COMPLETED|Overall Study||37
145970|NCT01669603|355699|P2|COMPLETED|Overall Study||57
145971|NCT01669603|355700|P1|COMPLETED|Overall Study||58
145972|NCT01669603|355699|P2|STARTED|Overall Study||95
145973|NCT01669603|355700|P1|STARTED|Overall Study||95
145974|NCT01669577|355706|P1|NOT COMPLETED|Overall Study||134
145975|NCT01669577|355706|P1|COMPLETED|Overall Study|complete case analysis (data missing completely at random)|200
145976|NCT01669577|355706|P1|STARTED|Overall Study|calculated ISS<16, no informed consent, not enough data(complete case analysis), were excluded|334
145977|NCT01669538|355712|P2|NOT COMPLETED|Overall Study||9
145978|NCT01669538|355713|P1|NOT COMPLETED|Overall Study||12
145979|NCT01669538|355712|P2|COMPLETED|Overall Study||33
145980|NCT01669538|355713|P1|COMPLETED|Overall Study||28
145981|NCT01669538|355712|P2|STARTED|Overall Study||42
145982|NCT01669538|355713|P1|STARTED|Overall Study||40
145983|NCT01669434|355727|P2|NOT COMPLETED|Overall Study||7
145984|NCT01669434|355728|P1|NOT COMPLETED|Overall Study||9
145985|NCT01669434|355727|P2|COMPLETED|Overall Study||138
145986|NCT01669434|355728|P1|COMPLETED|Overall Study||137
145987|NCT01669434|355727|P2|STARTED|Overall Study||145
145988|NCT01669434|355728|P1|STARTED|Overall Study||146
145989|NCT01669421|355744|P1|NOT COMPLETED|Phase 3: Standard Dose Therapy||0
145990|NCT01669421|355744|P1|COMPLETED|Phase 3: Standard Dose Therapy||8
145991|NCT01669421|355744|P1|STARTED|Phase 3: Standard Dose Therapy||8
145992|NCT01669421|355744|P1|NOT COMPLETED|Phase 2: Double Dose Therapy||0
145993|NCT01669421|355744|P1|COMPLETED|Phase 2: Double Dose Therapy||8
145994|NCT01669421|355744|P1|STARTED|Phase 2: Double Dose Therapy||8
145995|NCT01669421|355744|P1|NOT COMPLETED|Phase 1: Standard Dose Therapy||2
145996|NCT01669421|355744|P1|COMPLETED|Phase 1: Standard Dose Therapy||8
145997|NCT01669421|355744|P1|STARTED|Phase 1: Standard Dose Therapy||10
145998|NCT01669174|355763|P2|NOT COMPLETED|Overall Study||6
145999|NCT01669174|355764|P1|NOT COMPLETED|Overall Study||6
146000|NCT01669174|355763|P2|COMPLETED|Overall Study||28
146001|NCT01669174|355764|P1|COMPLETED|Overall Study||27
146002|NCT01669174|355763|P2|STARTED|Overall Study||34
146003|NCT01669174|355764|P1|STARTED|Overall Study||33
146004|NCT01669148|355775|P1|NOT COMPLETED|Overall Study||70
146005|NCT01669148|355775|P1|COMPLETED|Overall Study||426
146006|NCT01669148|355775|P1|STARTED|Overall Study||496
146007|NCT01669122|355780|P1|NOT COMPLETED|Period IV||0
146008|NCT01669122|355780|P1|COMPLETED|Period IV||37
146009|NCT01669122|355780|P1|STARTED|Period IV|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=9, Reference Lozenge=9|37
146010|NCT01669122|355780|P1|NOT COMPLETED|Period III||0
146011|NCT01669122|355780|P1|COMPLETED|Period III||37
146012|NCT01669122|355780|P1|STARTED|Period III|Participants who received Lozenge A=10, Lozenge B=8, Lozenge C=10, Reference Lozenge=9|37
146013|NCT01669122|355780|P1|NOT COMPLETED|Washout Period III||0
146014|NCT01669122|355780|P1|COMPLETED|Washout Period III||37
146015|NCT01669122|355780|P1|STARTED|Washout Period III||37
146016|NCT01669122|355780|P1|NOT COMPLETED|Washout Period II||2
146017|NCT01669122|355780|P1|COMPLETED|Washout Period II||37
146018|NCT01669122|355780|P1|STARTED|Washout Period II||39
146019|NCT01669122|355780|P1|NOT COMPLETED|Period II||0
146020|NCT01669122|355780|P1|COMPLETED|Period II||39
146021|NCT01669122|355780|P1|STARTED|Period II|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|39
146022|NCT01669122|355780|P1|NOT COMPLETED|Washout Period I||0
146023|NCT01669122|355780|P1|COMPLETED|Washout Period I||39
146024|NCT01669122|355780|P1|STARTED|Washout Period I||39
146025|NCT01669122|355780|P1|NOT COMPLETED|Period I||1
146026|NCT01669122|355780|P1|COMPLETED|Period I||39
146027|NCT01669122|355780|P1|Safety Population|Period I||39
146028|NCT01669122|355780|P1|STARTED|Period I|Participants who received Lozenge A=10, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|40
146029|NCT01669096|355810|P1|NOT COMPLETED|Overall Study||0
146030|NCT01669096|355810|P1|COMPLETED|Overall Study||20
146031|NCT01669096|355810|P1|STARTED|Overall Study||20
146032|NCT01668966|355847|P1|NOT COMPLETED|Overall Study||4
146033|NCT01668966|355847|P1|COMPLETED|Overall Study||19
146034|NCT01668966|355847|P1|Treated|Overall Study||21
146035|NCT01668966|355847|P1|STARTED|Overall Study||23
146036|NCT01668836|355867|P4|NOT COMPLETED|Overall Study||0
146037|NCT01668836|355868|P3|NOT COMPLETED|Overall Study||0
146038|NCT01668836|355869|P2|NOT COMPLETED|Overall Study||0
146039|NCT01668836|355870|P1|NOT COMPLETED|Overall Study||0
146040|NCT01668836|355867|P4|COMPLETED|Overall Study||12
146041|NCT01668836|355868|P3|COMPLETED|Overall Study||12
146042|NCT01668836|355869|P2|COMPLETED|Overall Study||12
146043|NCT01668836|355870|P1|COMPLETED|Overall Study||12
146044|NCT01668836|355867|P4|STARTED|Overall Study||12
146045|NCT01668836|355868|P3|STARTED|Overall Study||12
146046|NCT01668836|355869|P2|STARTED|Overall Study||12
146047|NCT01668836|355870|P1|STARTED|Overall Study||12
146048|NCT01668797|355926|P4|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||96
146049|NCT01668797|355927|P3|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||83
146050|NCT01668797|355928|P2|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
146051|NCT01668797|355929|P1|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
146052|NCT01668797|355926|P4|COMPLETED|Phase C (Double-Blind Maintenance Phase)||9
146053|NCT01668797|355927|P3|COMPLETED|Phase C (Double-Blind Maintenance Phase)||14
146054|NCT01668797|355928|P2|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
146055|NCT01668797|355929|P1|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
146056|NCT01668797|355926|P4|STARTED|Phase C (Double-Blind Maintenance Phase)||105
146057|NCT01668797|355927|P3|STARTED|Phase C (Double-Blind Maintenance Phase)|N= 202 rolled over from Phase B|97
146058|NCT01668797|355928|P2|STARTED|Phase C (Double-Blind Maintenance Phase)||0
146059|NCT01668797|355929|P1|STARTED|Phase C (Double-Blind Maintenance Phase)||0
146060|NCT01668797|355926|P4|NOT COMPLETED|Phase B (Stabilization Phase)||0
146061|NCT01668797|355927|P3|NOT COMPLETED|Phase B (Stabilization Phase)||0
146062|NCT01668797|355928|P2|NOT COMPLETED|Phase B (Stabilization Phase)||262
146063|NCT01668797|355929|P1|NOT COMPLETED|Phase B (Stabilization Phase)||0
146064|NCT01668797|355926|P4|COMPLETED|Phase B (Stabilization Phase)||0
146065|NCT01668797|355927|P3|COMPLETED|Phase B (Stabilization Phase)||0
146066|NCT01668797|355928|P2|COMPLETED|Phase B (Stabilization Phase)||202
146067|NCT01668797|355929|P1|COMPLETED|Phase B (Stabilization Phase)||0
146068|NCT01668797|355926|P4|STARTED|Phase B (Stabilization Phase)||0
146069|NCT01668797|355927|P3|STARTED|Phase B (Stabilization Phase)||0
146070|NCT01668797|355928|P2|STARTED|Phase B (Stabilization Phase)|N= 464; 346 rolled over from Phase A and 118 entered directly into Phase B|464
146071|NCT01668797|355929|P1|STARTED|Phase B (Stabilization Phase)||0
146072|NCT01668797|355926|P4|NOT COMPLETED|Phase A (Conversion Phase)||0
146073|NCT01668797|355927|P3|NOT COMPLETED|Phase A (Conversion Phase)||0
146074|NCT01668797|355928|P2|NOT COMPLETED|Phase A (Conversion Phase)||0
146075|NCT01668797|355929|P1|NOT COMPLETED|Phase A (Conversion Phase)||60
146076|NCT01668797|355926|P4|COMPLETED|Phase A (Conversion Phase)||0
146077|NCT01668797|355927|P3|COMPLETED|Phase A (Conversion Phase)||0
146078|NCT01668797|355928|P2|COMPLETED|Phase A (Conversion Phase)||0
146079|NCT01668797|355929|P1|COMPLETED|Phase A (Conversion Phase)||346
146080|NCT01668797|355926|P4|STARTED|Phase A (Conversion Phase)||0
146081|NCT01668797|355927|P3|STARTED|Phase A (Conversion Phase)||0
146082|NCT01668797|355928|P2|STARTED|Phase A (Conversion Phase)||0
146083|NCT01668797|355929|P1|STARTED|Phase A (Conversion Phase)||406
146084|NCT01668784|355994|P2|NOT COMPLETED|Treated (Overall)||369
146085|NCT01668784|355995|P1|NOT COMPLETED|Treated (Overall)||339
146086|NCT01668784|355994|P2|COMPLETED|Treated (Overall)||28
146087|NCT01668784|355995|P1|COMPLETED|Treated (Overall)||67
146088|NCT01668784|355994|P2|STARTED|Treated (Overall)||397
146089|NCT01668784|355995|P1|STARTED|Treated (Overall)||406
146090|NCT01668784|355994|P2|NOT COMPLETED|Randomized (Pre-treatment)||14
146091|NCT01668784|355995|P1|NOT COMPLETED|Randomized (Pre-treatment)||4
146092|NCT01668784|355994|P2|COMPLETED|Randomized (Pre-treatment)||397
146093|NCT01668784|355995|P1|COMPLETED|Randomized (Pre-treatment)||406
146094|NCT01668784|355994|P2|STARTED|Randomized (Pre-treatment)||411
146095|NCT01668784|355995|P1|STARTED|Randomized (Pre-treatment)||410
146096|NCT01668667|356023|P4|NOT COMPLETED|Overall Study||23
146097|NCT01668667|356024|P3|NOT COMPLETED|Overall Study||31
146098|NCT01668667|356025|P2|NOT COMPLETED|Overall Study||26
146099|NCT01668667|356026|P1|NOT COMPLETED|Overall Study||31
146100|NCT01668667|356023|P4|COMPLETED|Overall Study||102
146101|NCT01668667|356024|P3|COMPLETED|Overall Study||94
146102|NCT01668667|356025|P2|COMPLETED|Overall Study||99
146103|NCT01668667|356026|P1|COMPLETED|Overall Study||95
146104|NCT01668667|356023|P4|STARTED|Overall Study||125
146105|NCT01668667|356024|P3|STARTED|Overall Study||125
146106|NCT01668667|356025|P2|STARTED|Overall Study||125
146107|NCT01668667|356026|P1|STARTED|Overall Study||126
146108|NCT01668654|356048|P1|NOT COMPLETED|Overall Study||4
146109|NCT01668654|356048|P1|COMPLETED|Overall Study||0
146110|NCT01668654|356048|P1|STARTED|Overall Study||4
146111|NCT01668628|356091|P3|NOT COMPLETED|Overall Study||0
146112|NCT01668628|356092|P2|NOT COMPLETED|Overall Study||0
146113|NCT01668628|356093|P1|NOT COMPLETED|Overall Study||2
146114|NCT01668628|356091|P3|COMPLETED|Overall Study||367
146115|NCT01668628|356092|P2|COMPLETED|Overall Study||359
146116|NCT01668628|356093|P1|COMPLETED|Overall Study||347
146117|NCT01668628|356091|P3|STARTED|Overall Study|2 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|367
146118|NCT01668628|356092|P2|STARTED|Overall Study||359
146119|NCT01668628|356093|P1|STARTED|Overall Study|5 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|349
146120|NCT01668589|356109|P4|NOT COMPLETED|Overall Study||35
146121|NCT01668589|356110|P3|NOT COMPLETED|Overall Study||35
146122|NCT01668589|356111|P2|NOT COMPLETED|Overall Study||58
146123|NCT01668589|356112|P1|NOT COMPLETED|Overall Study||139
146124|NCT01668589|356109|P4|COMPLETED|Overall Study||266
146125|NCT01668589|356110|P3|COMPLETED|Overall Study||265
146126|NCT01668589|356111|P2|COMPLETED|Overall Study||242
146127|NCT01668589|356112|P1|COMPLETED|Overall Study||461
146128|NCT01668589|356109|P4|Received Denosumab|Overall Study||301
146129|NCT01668589|356110|P3|Received Denosumab|Overall Study||300
146130|NCT01668589|356111|P2|Received Denosumab|Overall Study||300
146131|NCT01668589|356112|P1|Received Denosumab|Overall Study||599
146132|NCT01668589|356109|P4|STARTED|Overall Study||301
146133|NCT01668589|356110|P3|STARTED|Overall Study||300
146134|NCT01668589|356111|P2|STARTED|Overall Study||300
146135|NCT01668589|356112|P1|STARTED|Overall Study||600
146136|NCT01668173|356150|P1|NOT COMPLETED|Overall Study||7
146137|NCT01668173|356150|P1|COMPLETED|Overall Study||0
146138|NCT01668173|356150|P1|STARTED|Overall Study||7
146139|NCT01668030|356154|P2|NOT COMPLETED|Overall Study||0
146140|NCT01668030|356155|P1|NOT COMPLETED|Overall Study||0
146141|NCT01668030|356154|P2|COMPLETED|Overall Study||10
146142|NCT01668030|356155|P1|COMPLETED|Overall Study||10
146143|NCT01668030|356154|P2|STARTED|Overall Study||10
146144|NCT01668030|356155|P1|STARTED|Overall Study||10
146145|NCT01668017|356165|P5|NOT COMPLETED|Overall Study||0
146146|NCT01668017|356166|P4|NOT COMPLETED|Overall Study||0
146147|NCT01668017|356167|P3|NOT COMPLETED|Overall Study||0
146148|NCT01668017|356168|P2|NOT COMPLETED|Overall Study||0
146149|NCT01668017|356169|P1|NOT COMPLETED|Overall Study||0
146150|NCT01668017|356165|P5|COMPLETED|Overall Study||2
146151|NCT01668017|356166|P4|COMPLETED|Overall Study||5
146152|NCT01668017|356167|P3|COMPLETED|Overall Study||6
146153|NCT01668017|356168|P2|COMPLETED|Overall Study||9
146154|NCT01668017|356169|P1|COMPLETED|Overall Study||4
146155|NCT01668017|356165|P5|STARTED|Overall Study||2
146156|NCT01668017|356166|P4|STARTED|Overall Study||5
146157|NCT01668017|356167|P3|STARTED|Overall Study||6
146158|NCT01668017|356168|P2|STARTED|Overall Study||9
146159|NCT01668017|356169|P1|STARTED|Overall Study||4
146160|NCT01668004|356276|P1|NOT COMPLETED|Overall Study||25
146161|NCT01668004|356276|P1|COMPLETED|Overall Study||76
146162|NCT01668004|356276|P1|Treated|Overall Study||101
146163|NCT01668004|356276|P1|STARTED|Overall Study||101
146164|NCT01667978|356289|P2|NOT COMPLETED|Overall Study||0
146165|NCT01667978|356290|P1|NOT COMPLETED|Overall Study||2
146166|NCT01667978|356289|P2|COMPLETED|Overall Study||17
146167|NCT01667978|356290|P1|COMPLETED|Overall Study||16
146168|NCT01667978|356289|P2|STARTED|Overall Study||17
146169|NCT01667978|356290|P1|STARTED|Overall Study||18
146170|NCT01667926|356298|P3|NOT COMPLETED|Overall Study||11
146171|NCT01667926|356299|P2|NOT COMPLETED|Overall Study||4
146172|NCT01667926|356300|P1|NOT COMPLETED|Overall Study||5
146173|NCT01667926|356298|P3|COMPLETED|Overall Study|Participants in the screen fail group were not randomized in the study.|0
146174|NCT01667926|356299|P2|COMPLETED|Overall Study||9
146175|NCT01667926|356300|P1|COMPLETED|Overall Study||8
146176|NCT01667926|356298|P3|STARTED|Overall Study||11
146177|NCT01667926|356299|P2|STARTED|Overall Study||13
146178|NCT01667926|356300|P1|STARTED|Overall Study||13
146179|NCT01667900|356313|P20|NOT COMPLETED|Part B||0
146180|NCT01667900|356314|P19|NOT COMPLETED|Part B||0
146181|NCT01667900|356315|P18|NOT COMPLETED|Part B||0
146182|NCT01667900|356316|P17|NOT COMPLETED|Part B||1
146183|NCT01667900|356317|P16|NOT COMPLETED|Part B||0
146184|NCT01667900|356318|P15|NOT COMPLETED|Part B||0
146185|NCT01667900|356319|P14|NOT COMPLETED|Part B||0
146186|NCT01667900|356320|P13|NOT COMPLETED|Part B||0
146187|NCT01667900|356321|P12|NOT COMPLETED|Part B||0
146188|NCT01667900|356322|P11|NOT COMPLETED|Part B||0
146189|NCT01667900|356323|P10|NOT COMPLETED|Part B||0
146190|NCT01667900|356324|P9|NOT COMPLETED|Part B||0
146191|NCT01667900|356325|P8|NOT COMPLETED|Part B||0
146192|NCT01667900|356326|P7|NOT COMPLETED|Part B||0
146193|NCT01667900|356327|P6|NOT COMPLETED|Part B||0
146194|NCT01667900|356328|P5|NOT COMPLETED|Part B||0
146195|NCT01667900|356329|P4|NOT COMPLETED|Part B||0
146196|NCT01667900|356330|P3|NOT COMPLETED|Part B||0
146197|NCT01667900|356331|P2|NOT COMPLETED|Part B||0
146198|NCT01667900|356332|P1|NOT COMPLETED|Part B||0
146199|NCT01667900|356313|P20|COMPLETED|Part B||10
146200|NCT01667900|356314|P19|COMPLETED|Part B||10
146201|NCT01667900|356315|P18|COMPLETED|Part B||11
146202|NCT01667900|356316|P17|COMPLETED|Part B||10
146203|NCT01667900|356317|P16|COMPLETED|Part B||0
146204|NCT01667900|356318|P15|COMPLETED|Part B||0
146205|NCT01667900|356319|P14|COMPLETED|Part B||0
146206|NCT01667900|356320|P13|COMPLETED|Part B||0
146207|NCT01667900|356321|P12|COMPLETED|Part B||0
146208|NCT01667900|356322|P11|COMPLETED|Part B||0
146209|NCT01667900|356323|P10|COMPLETED|Part B||0
146210|NCT01667900|356324|P9|COMPLETED|Part B||0
146211|NCT01667900|356325|P8|COMPLETED|Part B||0
146212|NCT01667900|356326|P7|COMPLETED|Part B||0
146213|NCT01667900|356327|P6|COMPLETED|Part B||0
146214|NCT01667900|356328|P5|COMPLETED|Part B||0
146215|NCT01667900|356329|P4|COMPLETED|Part B||0
146216|NCT01667900|356330|P3|COMPLETED|Part B||0
146217|NCT01667900|356331|P2|COMPLETED|Part B||0
146218|NCT01667900|356332|P1|COMPLETED|Part B||0
146219|NCT01667900|356313|P20|STARTED|Part B||10
146220|NCT01667900|356314|P19|STARTED|Part B||10
146221|NCT01667900|356315|P18|STARTED|Part B||11
146222|NCT01667900|356316|P17|STARTED|Part B||11
146223|NCT01667900|356317|P16|STARTED|Part B|Part A participants did not participate in Part B.|0
146224|NCT01667900|356318|P15|STARTED|Part B|Part A participants did not participate in Part B.|0
146225|NCT01667900|356319|P14|STARTED|Part B|Part A participants did not participate in Part B.|0
146226|NCT01667900|356320|P13|STARTED|Part B|Part A participants did not participate in Part B.|0
146227|NCT01667900|356321|P12|STARTED|Part B|Part A participants did not participate in Part B.|0
146228|NCT01667900|356322|P11|STARTED|Part B|Part A participants did not participate in Part B.|0
146229|NCT01667900|356323|P10|STARTED|Part B|Part A participants did not participate in Part B.|0
146230|NCT01667900|356324|P9|STARTED|Part B|Part A participants did not participate in Part B.|0
146231|NCT01667900|356325|P8|STARTED|Part B|Part A participants did not participate in Part B.|0
146232|NCT01667900|356326|P7|STARTED|Part B|Part A participants did not participate in Part B.|0
146233|NCT01667900|356327|P6|STARTED|Part B|Part A participants did not participate in Part B.|0
146234|NCT01667900|356328|P5|STARTED|Part B|Part A participants did not participate in Part B.|0
146235|NCT01667900|356329|P4|STARTED|Part B|Part A participants did not participate in Part B.|0
146236|NCT01667900|356330|P3|STARTED|Part B|Part A participants did not participate in Part B.|0
146237|NCT01667900|356331|P2|STARTED|Part B|Part A participants did not participate in Part B.|0
146238|NCT01667900|356332|P1|STARTED|Part B|Part A participants did not participate in Part B.|0
146239|NCT01667900|356313|P20|NOT COMPLETED|Part A, Period 3||0
146240|NCT01667900|356314|P19|NOT COMPLETED|Part A, Period 3||0
146241|NCT01667900|356315|P18|NOT COMPLETED|Part A, Period 3||0
146242|NCT01667900|356316|P17|NOT COMPLETED|Part A, Period 3||0
146243|NCT01667900|356317|P16|NOT COMPLETED|Part A, Period 3||0
146244|NCT01667900|356318|P15|NOT COMPLETED|Part A, Period 3||0
146245|NCT01667900|356319|P14|NOT COMPLETED|Part A, Period 3||0
146246|NCT01667900|356320|P13|NOT COMPLETED|Part A, Period 3||0
146247|NCT01667900|356321|P12|NOT COMPLETED|Part A, Period 3||0
146248|NCT01667900|356322|P11|NOT COMPLETED|Part A, Period 3||0
146249|NCT01667900|356323|P10|NOT COMPLETED|Part A, Period 3||0
146250|NCT01667900|356324|P9|NOT COMPLETED|Part A, Period 3||0
146251|NCT01667900|356325|P8|NOT COMPLETED|Part A, Period 3||0
146252|NCT01667900|356326|P7|NOT COMPLETED|Part A, Period 3||0
146253|NCT01667900|356327|P6|NOT COMPLETED|Part A, Period 3||0
146254|NCT01667900|356328|P5|NOT COMPLETED|Part A, Period 3||0
146255|NCT01667900|356329|P4|NOT COMPLETED|Part A, Period 3||0
146256|NCT01667900|356330|P3|NOT COMPLETED|Part A, Period 3||0
146257|NCT01667900|356331|P2|NOT COMPLETED|Part A, Period 3||0
146258|NCT01667900|356332|P1|NOT COMPLETED|Part A, Period 3||0
146259|NCT01667900|356313|P20|COMPLETED|Part A, Period 3||0
146260|NCT01667900|356314|P19|COMPLETED|Part A, Period 3||0
146261|NCT01667900|356315|P18|COMPLETED|Part A, Period 3||0
146262|NCT01667900|356316|P17|COMPLETED|Part A, Period 3||0
146263|NCT01667900|356317|P16|COMPLETED|Part A, Period 3||1
146264|NCT01667900|356318|P15|COMPLETED|Part A, Period 3||1
146265|NCT01667900|356319|P14|COMPLETED|Part A, Period 3||1
146266|NCT01667900|356320|P13|COMPLETED|Part A, Period 3||1
146267|NCT01667900|356321|P12|COMPLETED|Part A, Period 3||1
146268|NCT01667900|356322|P11|COMPLETED|Part A, Period 3||1
146269|NCT01667900|356323|P10|COMPLETED|Part A, Period 3||1
146270|NCT01667900|356324|P9|COMPLETED|Part A, Period 3||1
146271|NCT01667900|356325|P8|COMPLETED|Part A, Period 3||1
146272|NCT01667900|356326|P7|COMPLETED|Part A, Period 3||1
146273|NCT01667900|356327|P6|COMPLETED|Part A, Period 3||1
146274|NCT01667900|356328|P5|COMPLETED|Part A, Period 3||1
146275|NCT01667900|356329|P4|COMPLETED|Part A, Period 3||1
146276|NCT01667900|356330|P3|COMPLETED|Part A, Period 3||1
146277|NCT01667900|356331|P2|COMPLETED|Part A, Period 3||1
146278|NCT01667900|356332|P1|COMPLETED|Part A, Period 3||1
146279|NCT01667900|356313|P20|STARTED|Part A, Period 3||0
146280|NCT01667900|356314|P19|STARTED|Part A, Period 3||0
146281|NCT01667900|356315|P18|STARTED|Part A, Period 3||0
146282|NCT01667900|356316|P17|STARTED|Part A, Period 3||0
146283|NCT01667900|356317|P16|STARTED|Part A, Period 3||1
146284|NCT01667900|356318|P15|STARTED|Part A, Period 3||1
146285|NCT01667900|356319|P14|STARTED|Part A, Period 3||1
146286|NCT01667900|356320|P13|STARTED|Part A, Period 3||1
146287|NCT01667900|356321|P12|STARTED|Part A, Period 3||1
146288|NCT01667900|356322|P11|STARTED|Part A, Period 3||1
146289|NCT01667900|356323|P10|STARTED|Part A, Period 3||1
146290|NCT01667900|356324|P9|STARTED|Part A, Period 3||1
146291|NCT01667900|356325|P8|STARTED|Part A, Period 3||1
146292|NCT01667900|356326|P7|STARTED|Part A, Period 3||1
146293|NCT01667900|356327|P6|STARTED|Part A, Period 3||1
146294|NCT01667900|356328|P5|STARTED|Part A, Period 3||1
146295|NCT01667900|356329|P4|STARTED|Part A, Period 3||1
146296|NCT01667900|356330|P3|STARTED|Part A, Period 3||1
146297|NCT01667900|356331|P2|STARTED|Part A, Period 3||1
146298|NCT01667900|356332|P1|STARTED|Part A, Period 3||1
146299|NCT01667900|356313|P20|NOT COMPLETED|Part A, Washout 2||0
146300|NCT01667900|356314|P19|NOT COMPLETED|Part A, Washout 2||0
146301|NCT01667900|356315|P18|NOT COMPLETED|Part A, Washout 2||0
146302|NCT01667900|356316|P17|NOT COMPLETED|Part A, Washout 2||0
146303|NCT01667900|356317|P16|NOT COMPLETED|Part A, Washout 2||0
146304|NCT01667900|356318|P15|NOT COMPLETED|Part A, Washout 2||0
146305|NCT01667900|356319|P14|NOT COMPLETED|Part A, Washout 2||0
146306|NCT01667900|356320|P13|NOT COMPLETED|Part A, Washout 2||0
146307|NCT01667900|356321|P12|NOT COMPLETED|Part A, Washout 2||0
146308|NCT01667900|356322|P11|NOT COMPLETED|Part A, Washout 2||0
146309|NCT01667900|356323|P10|NOT COMPLETED|Part A, Washout 2||0
146310|NCT01667900|356324|P9|NOT COMPLETED|Part A, Washout 2||0
146311|NCT01667900|356325|P8|NOT COMPLETED|Part A, Washout 2||0
146312|NCT01667900|356326|P7|NOT COMPLETED|Part A, Washout 2||0
146313|NCT01667900|356327|P6|NOT COMPLETED|Part A, Washout 2||0
146314|NCT01667900|356328|P5|NOT COMPLETED|Part A, Washout 2||0
146315|NCT01667900|356329|P4|NOT COMPLETED|Part A, Washout 2||0
146316|NCT01667900|356330|P3|NOT COMPLETED|Part A, Washout 2||0
146317|NCT01667900|356331|P2|NOT COMPLETED|Part A, Washout 2||0
146318|NCT01667900|356332|P1|NOT COMPLETED|Part A, Washout 2||0
146319|NCT01667900|356313|P20|COMPLETED|Part A, Washout 2||0
146320|NCT01667900|356314|P19|COMPLETED|Part A, Washout 2||0
146321|NCT01667900|356315|P18|COMPLETED|Part A, Washout 2||0
146322|NCT01667900|356316|P17|COMPLETED|Part A, Washout 2||0
146323|NCT01667900|356317|P16|COMPLETED|Part A, Washout 2||1
146324|NCT01667900|356318|P15|COMPLETED|Part A, Washout 2||1
146325|NCT01667900|356319|P14|COMPLETED|Part A, Washout 2||1
146326|NCT01667900|356320|P13|COMPLETED|Part A, Washout 2||1
146327|NCT01667900|356321|P12|COMPLETED|Part A, Washout 2||1
146328|NCT01667900|356322|P11|COMPLETED|Part A, Washout 2||1
146329|NCT01667900|356323|P10|COMPLETED|Part A, Washout 2||1
146330|NCT01667900|356324|P9|COMPLETED|Part A, Washout 2||1
146331|NCT01667900|356325|P8|COMPLETED|Part A, Washout 2||1
146332|NCT01667900|356326|P7|COMPLETED|Part A, Washout 2||1
146333|NCT01667900|356327|P6|COMPLETED|Part A, Washout 2||1
146334|NCT01667900|356328|P5|COMPLETED|Part A, Washout 2||1
146335|NCT01667900|356329|P4|COMPLETED|Part A, Washout 2||1
146336|NCT01667900|356330|P3|COMPLETED|Part A, Washout 2||1
146337|NCT01667900|356331|P2|COMPLETED|Part A, Washout 2||1
146338|NCT01667900|356332|P1|COMPLETED|Part A, Washout 2||1
146339|NCT01667900|356313|P20|STARTED|Part A, Washout 2||0
146340|NCT01667900|356314|P19|STARTED|Part A, Washout 2||0
146341|NCT01667900|356315|P18|STARTED|Part A, Washout 2||0
146342|NCT01667900|356316|P17|STARTED|Part A, Washout 2||0
146343|NCT01667900|356317|P16|STARTED|Part A, Washout 2||1
146344|NCT01667900|356318|P15|STARTED|Part A, Washout 2||1
146345|NCT01667900|356319|P14|STARTED|Part A, Washout 2||1
146346|NCT01667900|356320|P13|STARTED|Part A, Washout 2||1
146347|NCT01667900|356321|P12|STARTED|Part A, Washout 2||1
146348|NCT01667900|356322|P11|STARTED|Part A, Washout 2||1
146349|NCT01667900|356323|P10|STARTED|Part A, Washout 2||1
146350|NCT01667900|356324|P9|STARTED|Part A, Washout 2||1
146351|NCT01667900|356325|P8|STARTED|Part A, Washout 2||1
146352|NCT01667900|356326|P7|STARTED|Part A, Washout 2||1
146353|NCT01667900|356327|P6|STARTED|Part A, Washout 2||1
146354|NCT01667900|356328|P5|STARTED|Part A, Washout 2||1
146355|NCT01667900|356329|P4|STARTED|Part A, Washout 2||1
146356|NCT01667900|356330|P3|STARTED|Part A, Washout 2||1
146357|NCT01667900|356331|P2|STARTED|Part A, Washout 2||1
146358|NCT01667900|356332|P1|STARTED|Part A, Washout 2||1
146359|NCT01667900|356313|P20|NOT COMPLETED|Part A, Period 2||0
146360|NCT01667900|356314|P19|NOT COMPLETED|Part A, Period 2||0
146361|NCT01667900|356315|P18|NOT COMPLETED|Part A, Period 2||0
146362|NCT01667900|356316|P17|NOT COMPLETED|Part A, Period 2||0
146363|NCT01667900|356317|P16|NOT COMPLETED|Part A, Period 2||0
146364|NCT01667900|356318|P15|NOT COMPLETED|Part A, Period 2||0
146365|NCT01667900|356319|P14|NOT COMPLETED|Part A, Period 2||0
146366|NCT01667900|356320|P13|NOT COMPLETED|Part A, Period 2||0
146367|NCT01667900|356321|P12|NOT COMPLETED|Part A, Period 2||0
146368|NCT01667900|356322|P11|NOT COMPLETED|Part A, Period 2||0
146369|NCT01667900|356323|P10|NOT COMPLETED|Part A, Period 2||0
146370|NCT01667900|356324|P9|NOT COMPLETED|Part A, Period 2||0
146371|NCT01667900|356325|P8|NOT COMPLETED|Part A, Period 2||0
146372|NCT01667900|356326|P7|NOT COMPLETED|Part A, Period 2||0
146373|NCT01667900|356327|P6|NOT COMPLETED|Part A, Period 2||0
146374|NCT01667900|356328|P5|NOT COMPLETED|Part A, Period 2||0
146375|NCT01667900|356329|P4|NOT COMPLETED|Part A, Period 2||0
146376|NCT01667900|356330|P3|NOT COMPLETED|Part A, Period 2||0
146377|NCT01667900|356331|P2|NOT COMPLETED|Part A, Period 2||0
146378|NCT01667900|356332|P1|NOT COMPLETED|Part A, Period 2||0
146379|NCT01667900|356313|P20|COMPLETED|Part A, Period 2||0
146380|NCT01667900|356314|P19|COMPLETED|Part A, Period 2||0
146381|NCT01667900|356315|P18|COMPLETED|Part A, Period 2||0
146382|NCT01667900|356316|P17|COMPLETED|Part A, Period 2||0
146383|NCT01667900|356317|P16|COMPLETED|Part A, Period 2||1
146384|NCT01667900|356318|P15|COMPLETED|Part A, Period 2||1
146385|NCT01667900|356319|P14|COMPLETED|Part A, Period 2||1
146386|NCT01667900|356320|P13|COMPLETED|Part A, Period 2||1
146387|NCT01667900|356321|P12|COMPLETED|Part A, Period 2||1
146388|NCT01667900|356322|P11|COMPLETED|Part A, Period 2||1
146389|NCT01667900|356323|P10|COMPLETED|Part A, Period 2||1
146390|NCT01667900|356324|P9|COMPLETED|Part A, Period 2||1
146391|NCT01667900|356325|P8|COMPLETED|Part A, Period 2||1
146392|NCT01667900|356326|P7|COMPLETED|Part A, Period 2||1
146393|NCT01667900|356327|P6|COMPLETED|Part A, Period 2||1
146394|NCT01667900|356328|P5|COMPLETED|Part A, Period 2||1
146395|NCT01667900|356329|P4|COMPLETED|Part A, Period 2||1
146396|NCT01667900|356330|P3|COMPLETED|Part A, Period 2||1
146397|NCT01667900|356331|P2|COMPLETED|Part A, Period 2||1
146398|NCT01667900|356332|P1|COMPLETED|Part A, Period 2||1
146399|NCT01667900|356313|P20|STARTED|Part A, Period 2||0
146400|NCT01667900|356314|P19|STARTED|Part A, Period 2||0
146401|NCT01667900|356315|P18|STARTED|Part A, Period 2||0
146402|NCT01667900|356316|P17|STARTED|Part A, Period 2||0
146403|NCT01667900|356317|P16|STARTED|Part A, Period 2||1
146404|NCT01667900|356318|P15|STARTED|Part A, Period 2||1
146405|NCT01667900|356319|P14|STARTED|Part A, Period 2||1
146406|NCT01667900|356320|P13|STARTED|Part A, Period 2||1
146407|NCT01667900|356321|P12|STARTED|Part A, Period 2||1
146408|NCT01667900|356322|P11|STARTED|Part A, Period 2||1
146409|NCT01667900|356323|P10|STARTED|Part A, Period 2||1
146410|NCT01667900|356324|P9|STARTED|Part A, Period 2||1
146411|NCT01667900|356325|P8|STARTED|Part A, Period 2||1
146412|NCT01667900|356326|P7|STARTED|Part A, Period 2||1
146413|NCT01667900|356327|P6|STARTED|Part A, Period 2||1
146414|NCT01667900|356328|P5|STARTED|Part A, Period 2||1
146415|NCT01667900|356329|P4|STARTED|Part A, Period 2||1
146416|NCT01667900|356330|P3|STARTED|Part A, Period 2||1
146417|NCT01667900|356331|P2|STARTED|Part A, Period 2||1
146418|NCT01667900|356332|P1|STARTED|Part A, Period 2||1
146419|NCT01667900|356313|P20|NOT COMPLETED|Part A, Washout 1||0
146420|NCT01667900|356314|P19|NOT COMPLETED|Part A, Washout 1||0
146421|NCT01667900|356315|P18|NOT COMPLETED|Part A, Washout 1||0
146422|NCT01667900|356316|P17|NOT COMPLETED|Part A, Washout 1||0
146423|NCT01667900|356317|P16|NOT COMPLETED|Part A, Washout 1||0
146424|NCT01667900|356318|P15|NOT COMPLETED|Part A, Washout 1||0
146425|NCT01667900|356319|P14|NOT COMPLETED|Part A, Washout 1||0
146426|NCT01667900|356320|P13|NOT COMPLETED|Part A, Washout 1||0
146427|NCT01667900|356321|P12|NOT COMPLETED|Part A, Washout 1||0
146428|NCT01667900|356322|P11|NOT COMPLETED|Part A, Washout 1||0
146429|NCT01667900|356323|P10|NOT COMPLETED|Part A, Washout 1||0
146430|NCT01667900|356324|P9|NOT COMPLETED|Part A, Washout 1||0
146431|NCT01667900|356325|P8|NOT COMPLETED|Part A, Washout 1||0
146432|NCT01667900|356326|P7|NOT COMPLETED|Part A, Washout 1||0
146433|NCT01667900|356327|P6|NOT COMPLETED|Part A, Washout 1||0
146434|NCT01667900|356328|P5|NOT COMPLETED|Part A, Washout 1||0
146435|NCT01667900|356329|P4|NOT COMPLETED|Part A, Washout 1||0
146436|NCT01667900|356330|P3|NOT COMPLETED|Part A, Washout 1||0
146437|NCT01667900|356331|P2|NOT COMPLETED|Part A, Washout 1||0
146438|NCT01667900|356332|P1|NOT COMPLETED|Part A, Washout 1||0
146439|NCT01667900|356313|P20|COMPLETED|Part A, Washout 1||0
146440|NCT01667900|356314|P19|COMPLETED|Part A, Washout 1||0
146441|NCT01667900|356315|P18|COMPLETED|Part A, Washout 1||0
146442|NCT01667900|356316|P17|COMPLETED|Part A, Washout 1||0
146443|NCT01667900|356317|P16|COMPLETED|Part A, Washout 1||1
146444|NCT01667900|356318|P15|COMPLETED|Part A, Washout 1||1
146445|NCT01667900|356319|P14|COMPLETED|Part A, Washout 1||1
146446|NCT01667900|356320|P13|COMPLETED|Part A, Washout 1||1
146447|NCT01667900|356321|P12|COMPLETED|Part A, Washout 1||1
146448|NCT01667900|356322|P11|COMPLETED|Part A, Washout 1||1
146449|NCT01667900|356323|P10|COMPLETED|Part A, Washout 1||1
146450|NCT01667900|356324|P9|COMPLETED|Part A, Washout 1||1
146451|NCT01667900|356325|P8|COMPLETED|Part A, Washout 1||1
146452|NCT01667900|356326|P7|COMPLETED|Part A, Washout 1||1
146453|NCT01667900|356327|P6|COMPLETED|Part A, Washout 1||1
146454|NCT01667900|356328|P5|COMPLETED|Part A, Washout 1||1
146455|NCT01667900|356329|P4|COMPLETED|Part A, Washout 1||1
146456|NCT01667900|356330|P3|COMPLETED|Part A, Washout 1||1
146457|NCT01667900|356331|P2|COMPLETED|Part A, Washout 1||1
146458|NCT01667900|356332|P1|COMPLETED|Part A, Washout 1||1
146459|NCT01667900|356313|P20|STARTED|Part A, Washout 1||0
146460|NCT01667900|356314|P19|STARTED|Part A, Washout 1||0
146461|NCT01667900|356315|P18|STARTED|Part A, Washout 1||0
146462|NCT01667900|356316|P17|STARTED|Part A, Washout 1||0
146463|NCT01667900|356317|P16|STARTED|Part A, Washout 1||1
146464|NCT01667900|356318|P15|STARTED|Part A, Washout 1||1
146465|NCT01667900|356319|P14|STARTED|Part A, Washout 1||1
146466|NCT01667900|356320|P13|STARTED|Part A, Washout 1||1
146467|NCT01667900|356321|P12|STARTED|Part A, Washout 1||1
146468|NCT01667900|356322|P11|STARTED|Part A, Washout 1||1
146469|NCT01667900|356323|P10|STARTED|Part A, Washout 1||1
146470|NCT01667900|356324|P9|STARTED|Part A, Washout 1||1
146471|NCT01667900|356325|P8|STARTED|Part A, Washout 1||1
146472|NCT01667900|356326|P7|STARTED|Part A, Washout 1||1
146473|NCT01667900|356327|P6|STARTED|Part A, Washout 1||1
146474|NCT01667900|356328|P5|STARTED|Part A, Washout 1||1
146475|NCT01667900|356329|P4|STARTED|Part A, Washout 1||1
146476|NCT01667900|356330|P3|STARTED|Part A, Washout 1||1
146477|NCT01667900|356331|P2|STARTED|Part A, Washout 1||1
146478|NCT01667900|356332|P1|STARTED|Part A, Washout 1||1
146479|NCT01667900|356313|P20|NOT COMPLETED|Part A, Period 1||0
146480|NCT01667900|356314|P19|NOT COMPLETED|Part A, Period 1||0
146481|NCT01667900|356315|P18|NOT COMPLETED|Part A, Period 1||0
146482|NCT01667900|356316|P17|NOT COMPLETED|Part A, Period 1||0
146483|NCT01667900|356317|P16|NOT COMPLETED|Part A, Period 1||0
146484|NCT01667900|356318|P15|NOT COMPLETED|Part A, Period 1||0
146485|NCT01667900|356319|P14|NOT COMPLETED|Part A, Period 1||0
146486|NCT01667900|356320|P13|NOT COMPLETED|Part A, Period 1||0
146487|NCT01667900|356321|P12|NOT COMPLETED|Part A, Period 1||0
146488|NCT01667900|356322|P11|NOT COMPLETED|Part A, Period 1||0
146489|NCT01667900|356323|P10|NOT COMPLETED|Part A, Period 1||0
146490|NCT01667900|356324|P9|NOT COMPLETED|Part A, Period 1||0
146491|NCT01667900|356325|P8|NOT COMPLETED|Part A, Period 1||0
146492|NCT01667900|356326|P7|NOT COMPLETED|Part A, Period 1||0
146493|NCT01667900|356327|P6|NOT COMPLETED|Part A, Period 1||0
146494|NCT01667900|356328|P5|NOT COMPLETED|Part A, Period 1||0
146495|NCT01667900|356329|P4|NOT COMPLETED|Part A, Period 1||0
146496|NCT01667900|356330|P3|NOT COMPLETED|Part A, Period 1||0
146497|NCT01667900|356331|P2|NOT COMPLETED|Part A, Period 1||0
146498|NCT01667900|356332|P1|NOT COMPLETED|Part A, Period 1||0
146499|NCT01667900|356313|P20|COMPLETED|Part A, Period 1||0
146500|NCT01667900|356314|P19|COMPLETED|Part A, Period 1||0
146501|NCT01667900|356315|P18|COMPLETED|Part A, Period 1||0
146502|NCT01667900|356316|P17|COMPLETED|Part A, Period 1||0
146503|NCT01667900|356317|P16|COMPLETED|Part A, Period 1||1
146504|NCT01667900|356318|P15|COMPLETED|Part A, Period 1||1
146505|NCT01667900|356319|P14|COMPLETED|Part A, Period 1||1
146506|NCT01667900|356320|P13|COMPLETED|Part A, Period 1||1
146507|NCT01667900|356321|P12|COMPLETED|Part A, Period 1||1
146508|NCT01667900|356322|P11|COMPLETED|Part A, Period 1||1
146509|NCT01667900|356323|P10|COMPLETED|Part A, Period 1||1
146510|NCT01667900|356324|P9|COMPLETED|Part A, Period 1||1
146511|NCT01667900|356325|P8|COMPLETED|Part A, Period 1||1
146512|NCT01667900|356326|P7|COMPLETED|Part A, Period 1||1
146513|NCT01667900|356327|P6|COMPLETED|Part A, Period 1||1
146514|NCT01667900|356328|P5|COMPLETED|Part A, Period 1||1
146515|NCT01667900|356329|P4|COMPLETED|Part A, Period 1||1
146516|NCT01667900|356330|P3|COMPLETED|Part A, Period 1||1
146517|NCT01667900|356331|P2|COMPLETED|Part A, Period 1||1
146518|NCT01667900|356332|P1|COMPLETED|Part A, Period 1||1
146519|NCT01667900|356313|P20|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
146520|NCT01667900|356314|P19|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
146521|NCT01667900|356315|P18|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
146522|NCT01667900|356316|P17|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
146523|NCT01667900|356317|P16|STARTED|Part A, Period 1||1
146524|NCT01667900|356318|P15|STARTED|Part A, Period 1||1
146525|NCT01667900|356319|P14|STARTED|Part A, Period 1||1
146526|NCT01667900|356320|P13|STARTED|Part A, Period 1||1
146527|NCT01667900|356321|P12|STARTED|Part A, Period 1||1
146528|NCT01667900|356322|P11|STARTED|Part A, Period 1||1
146529|NCT01667900|356323|P10|STARTED|Part A, Period 1||1
146530|NCT01667900|356324|P9|STARTED|Part A, Period 1||1
146531|NCT01667900|356325|P8|STARTED|Part A, Period 1||1
146532|NCT01667900|356326|P7|STARTED|Part A, Period 1||1
146533|NCT01667900|356327|P6|STARTED|Part A, Period 1||1
146534|NCT01667900|356328|P5|STARTED|Part A, Period 1||1
146535|NCT01667900|356329|P4|STARTED|Part A, Period 1||1
146536|NCT01667900|356330|P3|STARTED|Part A, Period 1||1
146537|NCT01667900|356331|P2|STARTED|Part A, Period 1||1
146538|NCT01667900|356332|P1|STARTED|Part A, Period 1||1
146539|NCT01667848|356372|P2|NOT COMPLETED|Overall Study||0
146540|NCT01667848|356373|P1|NOT COMPLETED|Overall Study||0
146541|NCT01667848|356372|P2|COMPLETED|Overall Study||81
146542|NCT01667848|356373|P1|COMPLETED|Overall Study||67
146543|NCT01667848|356372|P2|STARTED|Overall Study||81
146544|NCT01667848|356373|P1|STARTED|Overall Study||67
146545|NCT01667796|356383|P2|NOT COMPLETED|Overall Study||1
146546|NCT01667796|356384|P1|NOT COMPLETED|Overall Study||3
146547|NCT01667796|356383|P2|COMPLETED|Overall Study||29
146548|NCT01667796|356384|P1|COMPLETED|Overall Study||24
146549|NCT01667796|356383|P2|STARTED|Overall Study||30
146550|NCT01667796|356384|P1|STARTED|Overall Study||27
146551|NCT01667731|356402|P5|NOT COMPLETED|Overall Study||28
146552|NCT01667731|356403|P4|NOT COMPLETED|Overall Study||2
146553|NCT01667731|356404|P3|NOT COMPLETED|Overall Study||2
146554|NCT01667731|356405|P2|NOT COMPLETED|Overall Study||16
146555|NCT01667731|356406|P1|NOT COMPLETED|Overall Study||5
146556|NCT01667731|356402|P5|COMPLETED|Overall Study||87
146557|NCT01667731|356403|P4|COMPLETED|Overall Study||15
146558|NCT01667731|356404|P3|COMPLETED|Overall Study||22
146559|NCT01667731|356405|P2|COMPLETED|Overall Study||26
146560|NCT01667731|356406|P1|COMPLETED|Overall Study||21
146561|NCT01667731|356402|P5|STARTED|Overall Study||115
146562|NCT01667731|356403|P4|STARTED|Overall Study||17
146563|NCT01667731|356404|P3|STARTED|Overall Study||24
146564|NCT01667731|356405|P2|STARTED|Overall Study||42
146565|NCT01667731|356406|P1|STARTED|Overall Study||26
146566|NCT01667679|356461|P2|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
146567|NCT01667679|356462|P1|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
146568|NCT01667679|356461|P2|COMPLETED|Treatment Period 2 (<=12 Weeks)||85
146569|NCT01667679|356462|P1|COMPLETED|Treatment Period 2 (<=12 Weeks)||100
146570|NCT01667679|356461|P2|STARTED|Treatment Period 2 (<=12 Weeks)||107
146571|NCT01667679|356462|P1|STARTED|Treatment Period 2 (<=12 Weeks)||122
146572|NCT01667679|356461|P2|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||30
146573|NCT01667679|356462|P1|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||16
146574|NCT01667679|356461|P2|COMPLETED|Treatment Period 1 (<=12 Weeks)||107
146575|NCT01667679|356462|P1|COMPLETED|Treatment Period 1 (<=12 Weeks)||122
146576|NCT01667679|356461|P2|STARTED|Treatment Period 1 (<=12 Weeks)||137
146577|NCT01667679|356462|P1|STARTED|Treatment Period 1 (<=12 Weeks)||138
146578|NCT01667536|356520|P1|NOT COMPLETED|Overall Study||0
146579|NCT01667536|356520|P1|COMPLETED|Overall Study|105 subjects comprised the safety popn, defined as all subjects who received an MIP-1404 injection.|105
146580|NCT01667536|356520|P1|STARTED|Overall Study||105
146581|NCT01667471|356531|P1|NOT COMPLETED|Overall Study||0
146582|NCT01667471|356531|P1|COMPLETED|Overall Study||7
146583|NCT01667471|356531|P1|STARTED|Overall Study||7
146584|NCT01667432|356547|P1|NOT COMPLETED|Overall Study||57
146585|NCT01667432|356547|P1|COMPLETED|Overall Study||84
146586|NCT01667432|356547|P1|STARTED|Overall Study||141
146587|NCT01667419|356556|P4|NOT COMPLETED|Overall Study||39
146588|NCT01667419|356557|P3|NOT COMPLETED|Overall Study||36
146589|NCT01667419|356558|P2|NOT COMPLETED|Overall Study||47
146590|NCT01667419|356559|P1|NOT COMPLETED|Overall Study||43
146591|NCT01667419|356556|P4|COMPLETED|Overall Study||52
146592|NCT01667419|356557|P3|COMPLETED|Overall Study||57
146593|NCT01667419|356558|P2|COMPLETED|Overall Study||110
146594|NCT01667419|356559|P1|COMPLETED|Overall Study||114
146595|NCT01667419|356556|P4|STARTED|Overall Study||91
146596|NCT01667419|356557|P3|STARTED|Overall Study||93
146597|NCT01667419|356558|P2|STARTED|Overall Study||157
146598|NCT01667419|356559|P1|STARTED|Overall Study||157
146599|NCT01667250|356589|P3|NOT COMPLETED|Randomised Period||0
146600|NCT01667250|356590|P2|NOT COMPLETED|Randomised Period||1
146601|NCT01667250|356591|P1|NOT COMPLETED|Randomised Period||1
146602|NCT01667250|356589|P3|COMPLETED|Randomised Period||0
146603|NCT01667250|356590|P2|COMPLETED|Randomised Period||28
146604|NCT01667250|356591|P1|COMPLETED|Randomised Period||29
146605|NCT01667250|356589|P3|STARTED|Randomised Period||0
146606|NCT01667250|356590|P2|STARTED|Randomised Period||29
146607|NCT01667250|356591|P1|STARTED|Randomised Period||30
146608|NCT01667250|356589|P3|NOT COMPLETED|Run-in (no Treatment)||14
146609|NCT01667250|356590|P2|NOT COMPLETED|Run-in (no Treatment)||0
146610|NCT01667250|356591|P1|NOT COMPLETED|Run-in (no Treatment)||0
146611|NCT01667250|356589|P3|COMPLETED|Run-in (no Treatment)||59
146612|NCT01667250|356590|P2|COMPLETED|Run-in (no Treatment)||0
146613|NCT01667250|356591|P1|COMPLETED|Run-in (no Treatment)||0
146614|NCT01667250|356589|P3|STARTED|Run-in (no Treatment)||73
146615|NCT01667250|356590|P2|STARTED|Run-in (no Treatment)||0
146616|NCT01667250|356591|P1|STARTED|Run-in (no Treatment)||0
146617|NCT01667224|356607|P2|NOT COMPLETED|Overall Study||2
146618|NCT01667224|356608|P1|NOT COMPLETED|Overall Study||4
146619|NCT01667224|356607|P2|COMPLETED|Overall Study||38
146620|NCT01667224|356608|P1|COMPLETED|Overall Study||36
146621|NCT01667224|356607|P2|STARTED|Overall Study||40
146622|NCT01667224|356608|P1|STARTED|Overall Study||40
146623|NCT01667107|356622|P2|NOT COMPLETED|Overall Study||7
146624|NCT01667107|356623|P1|NOT COMPLETED|Overall Study||4
146625|NCT01667107|356622|P2|COMPLETED|Overall Study||11
146626|NCT01667107|356623|P1|COMPLETED|Overall Study||4
146627|NCT01667107|356622|P2|STARTED|Overall Study||18
146628|NCT01667107|356623|P1|STARTED|Overall Study||8
146629|NCT01667029|356639|P2|NOT COMPLETED|Overall Study||1
146630|NCT01667029|356640|P1|NOT COMPLETED|Overall Study||1
146631|NCT01667029|356639|P2|COMPLETED|Overall Study||3
146632|NCT01667029|356640|P1|COMPLETED|Overall Study||3
146633|NCT01667029|356639|P2|STARTED|Overall Study||4
146634|NCT01667029|356640|P1|STARTED|Overall Study||4
146635|NCT01666951|356682|P2|NOT COMPLETED|Overall Study||1
146636|NCT01666951|356683|P1|NOT COMPLETED|Overall Study||1
146637|NCT01666951|356682|P2|COMPLETED|Overall Study||17
146638|NCT01666951|356683|P1|COMPLETED|Overall Study||17
146639|NCT01666951|356682|P2|STARTED|Overall Study||18
146640|NCT01666951|356683|P1|STARTED|Overall Study||18
146641|NCT01666912|356721|P2|NOT COMPLETED|Overall Study||11
146642|NCT01666912|356722|P1|NOT COMPLETED|Overall Study||21
146643|NCT01666912|356721|P2|COMPLETED|Overall Study||37
146644|NCT01666912|356722|P1|COMPLETED|Overall Study||27
146645|NCT01666912|356721|P2|STARTED|Overall Study||48
146646|NCT01666912|356722|P1|STARTED|Overall Study||48
146647|NCT01666782|356734|P2|NOT COMPLETED|Overall Study||1
146648|NCT01666782|356735|P1|NOT COMPLETED|Overall Study||4
146649|NCT01666782|356734|P2|COMPLETED|Overall Study||50
146650|NCT01666782|356735|P1|COMPLETED|Overall Study||50
146651|NCT01666782|356734|P2|STARTED|Overall Study||51
146652|NCT01666782|356735|P1|STARTED|Overall Study||54
146653|NCT01666652|356756|P5|NOT COMPLETED|Overall Study||1
146654|NCT01666652|356757|P4|NOT COMPLETED|Overall Study||4
146655|NCT01666652|356758|P3|NOT COMPLETED|Overall Study||1
146656|NCT01666652|356759|P2|NOT COMPLETED|Overall Study||1
146657|NCT01666652|356760|P1|NOT COMPLETED|Overall Study||2
146658|NCT01666652|356756|P5|COMPLETED|Overall Study||19
146659|NCT01666652|356757|P4|COMPLETED|Overall Study||16
146660|NCT01666652|356758|P3|COMPLETED|Overall Study||19
146661|NCT01666652|356759|P2|COMPLETED|Overall Study||19
146662|NCT01666652|356760|P1|COMPLETED|Overall Study||18
146663|NCT01666652|356756|P5|STARTED|Overall Study||20
146664|NCT01666652|356757|P4|STARTED|Overall Study||20
146665|NCT01666652|356758|P3|STARTED|Overall Study||20
146666|NCT01666652|356759|P2|STARTED|Overall Study||20
146667|NCT01666652|356760|P1|STARTED|Overall Study||20
146668|NCT01666444|356809|P2|NOT COMPLETED|Overall Study||1
146669|NCT01666444|356810|P1|NOT COMPLETED|Overall Study||2
146670|NCT01666444|356809|P2|COMPLETED|Overall Study||147
146671|NCT01666444|356810|P1|COMPLETED|Overall Study||147
146672|NCT01666444|356809|P2|STARTED|Overall Study||148
146673|NCT01666444|356810|P1|STARTED|Overall Study||149
146674|NCT01666314|356828|P4|NOT COMPLETED|Overall Study||36
146675|NCT01666314|356829|P3|NOT COMPLETED|Overall Study||36
146676|NCT01666314|356830|P2|NOT COMPLETED|Overall Study||32
146677|NCT01666314|356831|P1|NOT COMPLETED|Overall Study||33
146678|NCT01666314|356828|P4|COMPLETED|Overall Study||0
146679|NCT01666314|356829|P3|COMPLETED|Overall Study||0
146680|NCT01666314|356830|P2|COMPLETED|Overall Study||0
146681|NCT01666314|356831|P1|COMPLETED|Overall Study||0
146682|NCT01666314|356828|P4|STARTED|Overall Study||36
146683|NCT01666314|356829|P3|STARTED|Overall Study||36
146684|NCT01666314|356830|P2|STARTED|Overall Study||32
146685|NCT01666314|356831|P1|STARTED|Overall Study||33
146686|NCT01666210|356942|P2|NOT COMPLETED|Overall Study||1
146687|NCT01666210|356943|P1|NOT COMPLETED|Overall Study||2
146688|NCT01666210|356942|P2|COMPLETED|Overall Study||29
146689|NCT01666210|356943|P1|COMPLETED|Overall Study||28
146690|NCT01666210|356942|P2|STARTED|Overall Study||30
146691|NCT01666210|356943|P1|STARTED|Overall Study||30
146692|NCT01666197|356955|P2|NOT COMPLETED|Overall Study||0
146693|NCT01666197|356956|P1|NOT COMPLETED|Overall Study||0
146694|NCT01666197|356955|P2|COMPLETED|Overall Study||50
146695|NCT01666197|356956|P1|COMPLETED|Overall Study||50
146696|NCT01666197|356955|P2|STARTED|Overall Study||50
146697|NCT01666197|356956|P1|STARTED|Overall Study||50
146698|NCT01666145|356962|P1|NOT COMPLETED|Overall Study||0
146699|NCT01666145|356962|P1|COMPLETED|Overall Study||14
146700|NCT01666145|356962|P1|STARTED|Overall Study||14
146701|NCT01666119|356967|P1|NOT COMPLETED|Overall Study||52
146702|NCT01666119|356967|P1|COMPLETED|Overall Study||197
146703|NCT01666119|356967|P1|STARTED|Overall Study||249
146704|NCT01666002|356974|P2|NOT COMPLETED|Overall Study||0
146705|NCT01666002|356975|P1|NOT COMPLETED|Overall Study||5
146706|NCT01666002|356974|P2|COMPLETED|Overall Study||10
146707|NCT01666002|356975|P1|COMPLETED|Overall Study||12
146708|NCT01666002|356974|P2|STARTED|Overall Study||10
146709|NCT01666002|356975|P1|STARTED|Overall Study||17
146710|NCT01665950|356986|P3|NOT COMPLETED|Overall Study||1
146711|NCT01665950|356987|P2|NOT COMPLETED|Overall Study||0
146712|NCT01665950|356988|P1|NOT COMPLETED|Overall Study||1
146713|NCT01665950|356986|P3|COMPLETED|Overall Study||1
146714|NCT01665950|356987|P2|COMPLETED|Overall Study||0
146715|NCT01665950|356988|P1|COMPLETED|Overall Study||1
146716|NCT01665950|356986|P3|STARTED|Overall Study||2
146717|NCT01665950|356987|P2|STARTED|Overall Study||0
146718|NCT01665950|356988|P1|STARTED|Overall Study||2
146719|NCT01665911|356996|P1|NOT COMPLETED|Overall Study||6
146720|NCT01665911|356996|P1|COMPLETED|Overall Study||22
146721|NCT01665911|356996|P1|3.0 mg Sodium Fluoride in 200 ml Milk|Overall Study||22
146722|NCT01665911|356996|P1|3.0 mg Sodium Fluoride in 100 ml Milk|Overall Study||22
146723|NCT01665911|356996|P1|1.5 mg Sodium Fluoride in 200 ml Milk|Overall Study||25
146724|NCT01665911|356996|P1|1.5 mg Sodium Fluoride in 100 ml Milk|Overall Study||23
146725|NCT01665911|356996|P1|0 mg Fluoride in 200 ml Milk|Overall Study||22
146726|NCT01665911|356996|P1|STARTED|Overall Study||28
146727|NCT01665807|357005|P3|NOT COMPLETED|Overall Study||1
146728|NCT01665807|357006|P2|NOT COMPLETED|Overall Study||0
146729|NCT01665807|357007|P1|NOT COMPLETED|Overall Study||2
146730|NCT01665807|357005|P3|COMPLETED|Overall Study||401
146731|NCT01665807|357006|P2|COMPLETED|Overall Study||58
146732|NCT01665807|357007|P1|COMPLETED|Overall Study||409
146733|NCT01665807|357005|P3|STARTED|Overall Study||402
146734|NCT01665807|357006|P2|STARTED|Overall Study||58
146735|NCT01665807|357007|P1|STARTED|Overall Study||411
146736|NCT01665768|357018|P1|NOT COMPLETED|Overall Study||23
146737|NCT01665768|357018|P1|COMPLETED|Overall Study||26
146738|NCT01665768|357018|P1|STARTED|Overall Study||49
146739|NCT01665599|357023|P1|NOT COMPLETED|Overall Study||8
146740|NCT01665599|357023|P1|COMPLETED|Overall Study||172
146741|NCT01665599|357023|P1|STARTED|Overall Study||180
146742|NCT01665508|357043|P1|NOT COMPLETED|Overall Study||5
146743|NCT01665508|357043|P1|COMPLETED|Overall Study||7
146744|NCT01665508|357043|P1|STARTED|Overall Study||12
146745|NCT01665430|357059|P1|NOT COMPLETED|Overall Study||9
146746|NCT01665430|357059|P1|COMPLETED|Overall Study||29
146747|NCT01665430|357059|P1|STARTED|Overall Study||38
146748|NCT01665170|357075|P2|NOT COMPLETED|Overall Study||0
146749|NCT01665170|357076|P1|NOT COMPLETED|Overall Study||0
146750|NCT01665170|357075|P2|COMPLETED|Overall Study||30
146751|NCT01665170|357076|P1|COMPLETED|Overall Study|Last TSST/ last patient out|30
146752|NCT01665170|357075|P2|After TSST|Overall Study||30
146753|NCT01665170|357076|P1|After TSST|Overall Study||30
146754|NCT01665170|357075|P2|During TSST|Overall Study||30
146755|NCT01665170|357076|P1|During TSST|Overall Study||30
146756|NCT01665170|357075|P2|Bevore TSST|Overall Study||30
146757|NCT01665170|357076|P1|Bevore TSST|Overall Study||30
146758|NCT01665170|357075|P2|STARTED|Overall Study||30
146759|NCT01665170|357076|P1|STARTED|Overall Study|First patient in|30
146760|NCT01665157|357127|P3|NOT COMPLETED|Overall Study||0
146761|NCT01665157|357128|P2|NOT COMPLETED|Overall Study||0
146762|NCT01665157|357129|P1|NOT COMPLETED|Overall Study||0
146763|NCT01665157|357127|P3|COMPLETED|Overall Study||60
146764|NCT01665157|357128|P2|COMPLETED|Overall Study||60
146765|NCT01665157|357129|P1|COMPLETED|Overall Study||60
146766|NCT01665157|357127|P3|STARTED|Overall Study||60
146767|NCT01665157|357128|P2|STARTED|Overall Study||60
146768|NCT01665157|357129|P1|STARTED|Overall Study||60
146769|NCT01665144|357157|P2|NOT COMPLETED|Overall Study||122
146770|NCT01665144|357158|P1|NOT COMPLETED|Overall Study||202
146771|NCT01665144|357157|P2|COMPLETED|Overall Study||424
146772|NCT01665144|357158|P1|COMPLETED|Overall Study||903
146773|NCT01665144|357157|P2|Full Analysis Set|Overall Study||546
146774|NCT01665144|357158|P1|Full Analysis Set|Overall Study||1099
146775|NCT01665144|357157|P2|Safety Set|Overall Study||546
146776|NCT01665144|357158|P1|Safety Set|Overall Study||1099
146777|NCT01665144|357157|P2|STARTED|Overall Study||546
146778|NCT01665144|357158|P1|STARTED|Overall Study||1105
146779|NCT01665092|357168|P4|NOT COMPLETED|Overall Study||1
146780|NCT01665092|357169|P3|NOT COMPLETED|Overall Study||2
146781|NCT01665092|357170|P2|NOT COMPLETED|Overall Study||0
146782|NCT01665092|357171|P1|NOT COMPLETED|Overall Study||0
146783|NCT01665092|357168|P4|COMPLETED|Overall Study||105
146784|NCT01665092|357169|P3|COMPLETED|Overall Study||32
146785|NCT01665092|357170|P2|COMPLETED|Overall Study||35
146786|NCT01665092|357171|P1|COMPLETED|Overall Study||75
146787|NCT01665092|357168|P4|STARTED|Overall Study||106
146788|NCT01665092|357169|P3|STARTED|Overall Study||34
146789|NCT01665092|357170|P2|STARTED|Overall Study||35
146790|NCT01665092|357171|P1|STARTED|Overall Study||75
146791|NCT01665053|357183|P2|NOT COMPLETED|Overall Study||15
146792|NCT01665053|357184|P1|NOT COMPLETED|Overall Study||32
146793|NCT01665053|357183|P2|COMPLETED|Overall Study||831
146794|NCT01665053|357184|P1|COMPLETED|Overall Study||806
146795|NCT01665053|357183|P2|Death With No 12-month Clinical FU|Overall Study||9
146796|NCT01665053|357184|P1|Death With No 12-month Clinical FU|Overall Study||9
146797|NCT01665053|357183|P2|No 12-Month F/U|Overall Study||15
146798|NCT01665053|357184|P1|No 12-Month F/U|Overall Study||32
146799|NCT01665053|357183|P2|Completed 12-Month Clinical F/U|Overall Study||822
146800|NCT01665053|357184|P1|Completed 12-Month Clinical F/U|Overall Study||797
146801|NCT01665053|357183|P2|STARTED|Overall Study||846
146802|NCT01665053|357184|P1|STARTED|Overall Study||838
146803|NCT01665040|357222|P1|NOT COMPLETED|Overall Study||4
146804|NCT01665040|357222|P1|COMPLETED|Overall Study||36
146805|NCT01665040|357222|P1|STARTED|Overall Study||40
146806|NCT01664975|357229|P2|NOT COMPLETED|Overall Study||3
146807|NCT01664975|357230|P1|NOT COMPLETED|Overall Study||5
146808|NCT01664975|357229|P2|COMPLETED|Overall Study||51
146809|NCT01664975|357230|P1|COMPLETED|Overall Study||52
146810|NCT01664975|357229|P2|STARTED|Overall Study||54
146811|NCT01664975|357230|P1|STARTED|Overall Study||57
146812|NCT01664949|357238|P2|NOT COMPLETED|Overall Study||25
146813|NCT01664949|357239|P1|NOT COMPLETED|Overall Study||24
146814|NCT01664949|357238|P2|COMPLETED|Overall Study||211
146815|NCT01664949|357239|P1|COMPLETED|Overall Study||200
146816|NCT01664949|357238|P2|STARTED|Overall Study||236
146817|NCT01664949|357239|P1|STARTED|Overall Study||224
146818|NCT01664923|357255|P2|NOT COMPLETED|Period 2: Open-label Phase-36 Months||23
146819|NCT01664923|357256|P1|NOT COMPLETED|Period 2: Open-label Phase-36 Months||41
146820|NCT01664923|357255|P2|COMPLETED|Period 2: Open-label Phase-36 Months||15
146821|NCT01664923|357256|P1|COMPLETED|Period 2: Open-label Phase-36 Months||52
146822|NCT01664923|357255|P2|Treated|Period 2: Open-label Phase-36 Months||37
146823|NCT01664923|357256|P1|Treated|Period 2: Open-label Phase-36 Months||93
146824|NCT01664923|357255|P2|STARTED|Period 2: Open-label Phase-36 Months||38
146825|NCT01664923|357256|P1|STARTED|Period 2: Open-label Phase-36 Months||93
146826|NCT01664923|357255|P2|NOT COMPLETED|Period1:Double Blind Phase-29 Months||160
146827|NCT01664923|357256|P1|NOT COMPLETED|Period1:Double Blind Phase-29 Months||105
146828|NCT01664923|357255|P2|COMPLETED|Period1:Double Blind Phase-29 Months||38
146829|NCT01664923|357256|P1|COMPLETED|Period1:Double Blind Phase-29 Months||93
146830|NCT01664923|357255|P2|Received Study Treatment|Period1:Double Blind Phase-29 Months||198
146831|NCT01664923|357256|P1|Received Study Treatment|Period1:Double Blind Phase-29 Months||197
146832|NCT01664923|357255|P2|STARTED|Period1:Double Blind Phase-29 Months||198
146833|NCT01664923|357256|P1|STARTED|Period1:Double Blind Phase-29 Months||198
146834|NCT01664858|357279|P3|NOT COMPLETED|Overall Study||6
146835|NCT01664858|357280|P2|NOT COMPLETED|Overall Study||13
146836|NCT01664858|357281|P1|NOT COMPLETED|Overall Study||14
146837|NCT01664858|357279|P3|COMPLETED|Overall Study||234
146838|NCT01664858|357280|P2|COMPLETED|Overall Study||468
146839|NCT01664858|357281|P1|COMPLETED|Overall Study||467
146840|NCT01664858|357279|P3|STARTED|Overall Study||240
146841|NCT01664858|357280|P2|STARTED|Overall Study||481
146842|NCT01664858|357281|P1|STARTED|Overall Study||481
146843|NCT01664806|357297|P2|NOT COMPLETED|Overall Study||0
146844|NCT01664806|357298|P1|NOT COMPLETED|Overall Study||0
146845|NCT01664806|357297|P2|COMPLETED|Overall Study||20
146846|NCT01664806|357298|P1|COMPLETED|Overall Study||20
146847|NCT01664806|357297|P2|STARTED|Overall Study||20
146848|NCT01664806|357298|P1|STARTED|Overall Study||20
146849|NCT01664793|357308|P2|NOT COMPLETED|Overall Study||0
146850|NCT01664793|357309|P1|NOT COMPLETED|Overall Study||0
146851|NCT01664793|357308|P2|COMPLETED|Overall Study||38626
146852|NCT01664793|357309|P1|COMPLETED|Overall Study||49039
146853|NCT01664793|357308|P2|STARTED|Overall Study||38626
146854|NCT01664793|357309|P1|STARTED|Overall Study||49039
146855|NCT01664741|357320|P3|NOT COMPLETED|Overall Study||0
146856|NCT01664741|357321|P2|NOT COMPLETED|Overall Study||0
146857|NCT01664741|357322|P1|NOT COMPLETED|Overall Study||0
146858|NCT01664741|357320|P3|COMPLETED|Overall Study||13
146859|NCT01664741|357321|P2|COMPLETED|Overall Study||6
146860|NCT01664741|357322|P1|COMPLETED|Overall Study||6
146861|NCT01664741|357320|P3|STARTED|Overall Study||13
146862|NCT01664741|357321|P2|STARTED|Overall Study||6
146863|NCT01664741|357322|P1|STARTED|Overall Study||6
146864|NCT01664624|357339|P4|NOT COMPLETED|Overall Study||0
146865|NCT01664624|357340|P3|NOT COMPLETED|Overall Study||0
146866|NCT01664624|357341|P2|NOT COMPLETED|Overall Study||1
146867|NCT01664624|357342|P1|NOT COMPLETED|Overall Study||0
146868|NCT01664624|357339|P4|COMPLETED|Overall Study||9
146869|NCT01664624|357340|P3|COMPLETED|Overall Study||10
146870|NCT01664624|357341|P2|COMPLETED|Overall Study||10
146871|NCT01664624|357342|P1|COMPLETED|Overall Study||10
146872|NCT01664624|357339|P4|STARTED|Overall Study||9
146873|NCT01664624|357340|P3|STARTED|Overall Study||10
146874|NCT01664624|357341|P2|STARTED|Overall Study||11
146875|NCT01664624|357342|P1|STARTED|Overall Study||10
146876|NCT01664559|357374|P2|NOT COMPLETED|Overall Study||0
146877|NCT01664559|357375|P1|NOT COMPLETED|Overall Study||0
146878|NCT01664559|357374|P2|COMPLETED|Overall Study||33
146879|NCT01664559|357375|P1|COMPLETED|Overall Study||34
146880|NCT01664559|357374|P2|STARTED|Overall Study||33
146881|NCT01664559|357375|P1|STARTED|Overall Study||34
146882|NCT01664533|357389|P1|NOT COMPLETED|Overall Study||57
146883|NCT01664533|357389|P1|COMPLETED|Overall Study||0
146884|NCT01664533|357389|P1|STARTED|Overall Study||57
146885|NCT01664494|357397|P1|NOT COMPLETED|Overall Study||193
146886|NCT01664494|357397|P1|COMPLETED|Overall Study||370
146887|NCT01664494|357397|P1|STARTED|Overall Study||563
146888|NCT01664247|357404|P2|NOT COMPLETED|Overall Study||41
146889|NCT01664247|357405|P1|NOT COMPLETED|Overall Study||14
146890|NCT01664247|357404|P2|COMPLETED|Overall Study||131
146891|NCT01664247|357405|P1|COMPLETED|Overall Study||160
146892|NCT01664247|357404|P2|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|170
146893|NCT01664247|357405|P1|Exposed|Overall Study|1 subject was randomised in error and withdrew before exposure to the drug|173
146894|NCT01664247|357404|P2|STARTED|Overall Study||172
146895|NCT01664247|357405|P1|STARTED|Overall Study||174
146896|NCT01664130|357427|P1|NOT COMPLETED|Overall Study||2
146897|NCT01664130|357427|P1|COMPLETED|Overall Study||33
146898|NCT01664130|357427|P1|STARTED|Overall Study||35
146899|NCT01664117|357450|P1|NOT COMPLETED|Overall Study||0
146900|NCT01664117|357450|P1|COMPLETED|Overall Study||209
146901|NCT01664117|357450|P1|STARTED|Overall Study||209
146902|NCT01664104|357505|P1|NOT COMPLETED|Overall Study||16
146903|NCT01664104|357505|P1|COMPLETED|Overall Study||120
146904|NCT01664104|357505|P1|STARTED|Overall Study||136
146905|NCT01664091|357572|P1|NOT COMPLETED|Overall Study||6
146906|NCT01664091|357572|P1|COMPLETED|Overall Study||26
146907|NCT01664091|357572|P1|STARTED|Overall Study||32
146908|NCT01664052|357582|P2|NOT COMPLETED|Phase 2||4
146909|NCT01664052|357583|P1|NOT COMPLETED|Phase 2||0
146910|NCT01664052|357582|P2|COMPLETED|Phase 2||31
146911|NCT01664052|357583|P1|COMPLETED|Phase 2||0
146912|NCT01664052|357582|P2|Repeat HSG and Hysterectomy at 90 Days|Phase 2||10
146913|NCT01664052|357583|P1|Repeat HSG and Hysterectomy at 90 Days|Phase 2||0
146914|NCT01664052|357582|P2|Repeat HSG and Hysterectomy at 60 Days|Phase 2||10
146915|NCT01664052|357583|P1|Repeat HSG and Hysterectomy at 60 Days|Phase 2||0
146916|NCT01664052|357582|P2|Repeat HSG and Hysterectomy at 30 Days|Phase 2||10
146917|NCT01664052|357583|P1|Repeat HSG and Hysterectomy at 30 Days|Phase 2||0
146918|NCT01664052|357582|P2|HSG 1 Hour Post Placement|Phase 2||31
146919|NCT01664052|357583|P1|HSG 1 Hour Post Placement|Phase 2||0
146920|NCT01664052|357582|P2|Insert Placed|Phase 2||31
146921|NCT01664052|357583|P1|Insert Placed|Phase 2||0
146922|NCT01664052|357582|P2|STARTED|Phase 2||35
146923|NCT01664052|357583|P1|STARTED|Phase 2|Screened and enrolled|0
146924|NCT01664052|357582|P2|NOT COMPLETED|Phase 1||0
146925|NCT01664052|357583|P1|NOT COMPLETED|Phase 1||7
146926|NCT01664052|357582|P2|COMPLETED|Phase 1||0
146927|NCT01664052|357583|P1|COMPLETED|Phase 1||24
146928|NCT01664052|357582|P2|Repeat HSG and Hysterectomy at 90 Days|Phase 1||0
146929|NCT01664052|357583|P1|Repeat HSG and Hysterectomy at 90 Days|Phase 1||7
146930|NCT01664052|357582|P2|Repeat HSG and Hysterectomy at 60 Days|Phase 1||0
146931|NCT01664052|357583|P1|Repeat HSG and Hysterectomy at 60 Days|Phase 1||8
146932|NCT01664052|357582|P2|Repeat HSG and Hysterectomy at 30 Days|Phase 1||0
146933|NCT01664052|357583|P1|Repeat HSG and Hysterectomy at 30 Days|Phase 1||9
146934|NCT01664052|357582|P2|HSG 1 Hour Post Placement|Phase 1||0
146935|NCT01664052|357583|P1|HSG 1 Hour Post Placement|Phase 1||24
146936|NCT01664052|357582|P2|Insert Placed in at Least One Tube|Phase 1||0
146937|NCT01664052|357583|P1|Insert Placed in at Least One Tube|Phase 1||25
146938|NCT01664052|357582|P2|STARTED|Phase 1||0
146939|NCT01664052|357583|P1|STARTED|Phase 1|Screening and enrollment|31
146940|NCT01664039|357601|P2|NOT COMPLETED|Overall Study||9
146941|NCT01664039|357602|P1|NOT COMPLETED|Overall Study||6
146942|NCT01664039|357601|P2|COMPLETED|Overall Study||43
146943|NCT01664039|357602|P1|COMPLETED|Overall Study||46
146944|NCT01664039|357601|P2|STARTED|Overall Study||52
146945|NCT01664039|357602|P1|STARTED|Overall Study||52
146946|NCT01663987|357624|P2|NOT COMPLETED|Overall Study||6
146947|NCT01663987|357625|P1|NOT COMPLETED|Overall Study||13
146948|NCT01663987|357624|P2|COMPLETED|Overall Study||34
146949|NCT01663987|357625|P1|COMPLETED|Overall Study||26
146950|NCT01663987|357624|P2|STARTED|Overall Study||40
146951|NCT01663987|357625|P1|STARTED|Overall Study||39
146952|NCT01663935|357653|P1|NOT COMPLETED|Overall Study||0
146953|NCT01663935|357653|P1|COMPLETED|Overall Study||20
146954|NCT01663935|357653|P1|STARTED|Overall Study||20
146955|NCT01663922|357658|P2|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
146956|NCT01663922|357659|P1|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
146957|NCT01663922|357658|P2|COMPLETED|Third Intervention (14 Days or 5 Days)||9
146958|NCT01663922|357659|P1|COMPLETED|Third Intervention (14 Days or 5 Days)||8
146959|NCT01663922|357658|P2|STARTED|Third Intervention (14 Days or 5 Days)||9
146960|NCT01663922|357659|P1|STARTED|Third Intervention (14 Days or 5 Days)||8
146961|NCT01663922|357658|P2|NOT COMPLETED|Washout (7 Days)||0
146962|NCT01663922|357659|P1|NOT COMPLETED|Washout (7 Days)||0
146963|NCT01663922|357658|P2|COMPLETED|Washout (7 Days)||9
146964|NCT01663922|357659|P1|COMPLETED|Washout (7 Days)||8
146965|NCT01663922|357658|P2|STARTED|Washout (7 Days)||9
146966|NCT01663922|357659|P1|STARTED|Washout (7 Days)||8
146967|NCT01663922|357658|P2|NOT COMPLETED|Second Intervention (14 Days)||0
146968|NCT01663922|357659|P1|NOT COMPLETED|Second Intervention (14 Days)||0
146969|NCT01663922|357658|P2|COMPLETED|Second Intervention (14 Days)||9
146970|NCT01663922|357659|P1|COMPLETED|Second Intervention (14 Days)||8
146971|NCT01663922|357658|P2|STARTED|Second Intervention (14 Days)||9
146972|NCT01663922|357659|P1|STARTED|Second Intervention (14 Days)||8
146973|NCT01663922|357658|P2|NOT COMPLETED|Washout (7 Days)||0
146974|NCT01663922|357659|P1|NOT COMPLETED|Washout (7 Days)||0
146975|NCT01663922|357658|P2|COMPLETED|Washout (7 Days)||9
146976|NCT01663922|357659|P1|COMPLETED|Washout (7 Days)||8
146977|NCT01663922|357658|P2|STARTED|Washout (7 Days)||9
146978|NCT01663922|357659|P1|STARTED|Washout (7 Days)||8
146979|NCT01663922|357658|P2|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
146980|NCT01663922|357659|P1|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
146981|NCT01663922|357658|P2|COMPLETED|First Intervention (14 Days or 5 Days)||9
146982|NCT01663922|357659|P1|COMPLETED|First Intervention (14 Days or 5 Days)||8
146983|NCT01663922|357658|P2|STARTED|First Intervention (14 Days or 5 Days)||9
146984|NCT01663922|357659|P1|STARTED|First Intervention (14 Days or 5 Days)||8
146985|NCT01663857|357668|P4|NOT COMPLETED|Overall Study||4
146986|NCT01663857|357669|P3|NOT COMPLETED|Overall Study||10
146987|NCT01663857|357670|P2|NOT COMPLETED|Overall Study||1
146988|NCT01663857|357671|P1|NOT COMPLETED|Overall Study||0
146989|NCT01663857|357668|P4|COMPLETED|Overall Study||48
146990|NCT01663857|357669|P3|COMPLETED|Overall Study||48
146991|NCT01663857|357670|P2|COMPLETED|Overall Study||1
146992|NCT01663857|357671|P1|COMPLETED|Overall Study||6
146993|NCT01663857|357668|P4|Received at Least One Dose of Study Drug|Overall Study||52
146994|NCT01663857|357669|P3|Received at Least One Dose of Study Drug|Overall Study||58
146995|NCT01663857|357670|P2|Received at Least One Dose of Study Drug|Overall Study||2
146996|NCT01663857|357671|P1|Received at Least One Dose of Study Drug|Overall Study||6
146997|NCT01663857|357668|P4|STARTED|Overall Study||52
146998|NCT01663857|357669|P3|STARTED|Overall Study||58
146999|NCT01663857|357670|P2|STARTED|Overall Study||2
147000|NCT01663857|357671|P1|STARTED|Overall Study||6
147001|NCT01663779|357690|P2|NOT COMPLETED|Overall Study||0
147002|NCT01663779|357691|P1|NOT COMPLETED|Overall Study||0
147003|NCT01663779|357690|P2|COMPLETED|Overall Study||23
147004|NCT01663779|357691|P1|COMPLETED|Overall Study||27
147005|NCT01663779|357690|P2|STARTED|Overall Study||23
147006|NCT01663779|357691|P1|STARTED|Overall Study||27
147007|NCT01663740|357699|P2|NOT COMPLETED|Overall Study||8
147008|NCT01663740|357700|P1|NOT COMPLETED|Overall Study||16
147009|NCT01663740|357699|P2|COMPLETED|Overall Study||13
147010|NCT01663740|357700|P1|COMPLETED|Overall Study||22
147011|NCT01663740|357699|P2|STARTED|Overall Study|Safety Population|21
147012|NCT01663740|357700|P1|STARTED|Overall Study|Safety Population|38
147013|NCT01663727|357760|P2|NOT COMPLETED|Overall Study||238
147014|NCT01663727|357761|P1|NOT COMPLETED|Overall Study||242
147015|NCT01663727|357760|P2|COMPLETED|Overall Study||1
147016|NCT01663727|357761|P1|COMPLETED|Overall Study||0
147017|NCT01663727|357760|P2|STARTED|Overall Study||239
147018|NCT01663727|357761|P1|STARTED|Overall Study||242
147019|NCT01663714|357793|P1|NOT COMPLETED|Long-Term Follow-Up||6
147020|NCT01663714|357793|P1|COMPLETED|Long-Term Follow-Up||16
147021|NCT01663714|357793|P1|STARTED|Long-Term Follow-Up|22 of the30 participants withdrawing from Study BEX104514 enrolled in the LTFU study.|22
147022|NCT01663714|357793|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||30
147023|NCT01663714|357793|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
147024|NCT01663714|357793|P1|STARTED|Dosimetric and Therapeutic Treatment||30
147025|NCT01663636|357822|P2|NOT COMPLETED|Parent SMS Acceptability Assessment||0
147026|NCT01663636|357823|P1|NOT COMPLETED|Parent SMS Acceptability Assessment||0
147027|NCT01663636|357822|P2|COMPLETED|Parent SMS Acceptability Assessment||130
147028|NCT01663636|357823|P1|COMPLETED|Parent SMS Acceptability Assessment||135
147029|NCT01663636|357822|P2|STARTED|Parent SMS Acceptability Assessment||130
147030|NCT01663636|357823|P1|STARTED|Parent SMS Acceptability Assessment||135
147031|NCT01663636|357822|P2|NOT COMPLETED|Infant SMS Reminder Feasibility Study||31
147032|NCT01663636|357823|P1|NOT COMPLETED|Infant SMS Reminder Feasibility Study||25
147033|NCT01663636|357822|P2|COMPLETED|Infant SMS Reminder Feasibility Study||130
147034|NCT01663636|357823|P1|COMPLETED|Infant SMS Reminder Feasibility Study||135
147035|NCT01663636|357822|P2|STARTED|Infant SMS Reminder Feasibility Study||161
147036|NCT01663636|357823|P1|STARTED|Infant SMS Reminder Feasibility Study||160
147037|NCT01663623|357831|P2|NOT COMPLETED|Overall Study||20
147038|NCT01663623|357832|P1|NOT COMPLETED|Overall Study||12
147039|NCT01663623|357831|P2|COMPLETED|Overall Study||33
147040|NCT01663623|357832|P1|COMPLETED|Overall Study||40
147041|NCT01663623|357831|P2|STARTED|Overall Study||53
147042|NCT01663623|357832|P1|STARTED|Overall Study||52
147043|NCT01663532|357842|P2|NOT COMPLETED|Overall Study||107
147044|NCT01663532|357843|P1|NOT COMPLETED|Overall Study||74
147045|NCT01663532|357842|P2|COMPLETED|Overall Study||65
147046|NCT01663532|357843|P1|COMPLETED|Overall Study||94
147047|NCT01663532|357842|P2|STARTED|Overall Study||172
147048|NCT01663532|357843|P1|STARTED|Overall Study||168
147049|NCT01663506|357861|P1|NOT COMPLETED|Overall Study||8
147050|NCT01663506|357861|P1|COMPLETED|Overall Study||15
147051|NCT01663506|357861|P1|STARTED|Overall Study||23
147052|NCT01663402|357892|P2|NOT COMPLETED|Overall Study||2084
147053|NCT01663402|357893|P1|NOT COMPLETED|Overall Study||1515
147054|NCT01663402|357892|P2|COMPLETED|Overall Study||7378
147055|NCT01663402|357893|P1|COMPLETED|Overall Study||7947
147056|NCT01663402|357892|P2|Treated|Overall Study||9451
147057|NCT01663402|357893|P1|Treated|Overall Study||9443
147058|NCT01663402|357892|P2|STARTED|Overall Study||9462
147059|NCT01663402|357893|P1|STARTED|Overall Study||9462
147060|NCT01663363|357927|P1|NOT COMPLETED|Overall Study||0
147061|NCT01663363|357927|P1|COMPLETED|Overall Study|334 Eyes were treated among 170 participants|170
147062|NCT01663363|357927|P1|STARTED|Overall Study|334 Eyes were treated among 170 participants|170
147063|NCT01663285|357932|P1|NOT COMPLETED|Overall Study||0
147064|NCT01663285|357932|P1|COMPLETED|Overall Study||1
147065|NCT01663285|357932|P1|STARTED|Overall Study||1
147066|NCT01663272|357938|P3|NOT COMPLETED|Overall Study||0
147067|NCT01663272|357939|P2|NOT COMPLETED|Overall Study||0
147068|NCT01663272|357940|P1|NOT COMPLETED|Overall Study||0
147069|NCT01663272|357938|P3|COMPLETED|Overall Study||1
147070|NCT01663272|357939|P2|COMPLETED|Overall Study||6
147071|NCT01663272|357940|P1|COMPLETED|Overall Study||5
147072|NCT01663272|357938|P3|STARTED|Overall Study||1
147073|NCT01663272|357939|P2|STARTED|Overall Study||6
147074|NCT01663272|357940|P1|STARTED|Overall Study||5
147075|NCT01663233|357947|P2|NOT COMPLETED|Overall Study||7
147076|NCT01663233|357948|P1|NOT COMPLETED|Overall Study||4
147077|NCT01663233|357947|P2|COMPLETED|Overall Study||129
147078|NCT01663233|357948|P1|COMPLETED|Overall Study||126
147079|NCT01663233|357947|P2|STARTED|Overall Study||136
147080|NCT01663233|357948|P1|STARTED|Overall Study||130
147081|NCT01663103|357972|P2|NOT COMPLETED|Overall Study||2
147082|NCT01663103|357973|P1|NOT COMPLETED|Overall Study||3
147083|NCT01663103|357972|P2|COMPLETED|Overall Study||19
147084|NCT01663103|357973|P1|COMPLETED|Overall Study||18
147085|NCT01663103|357972|P2|STARTED|Overall Study||21
147086|NCT01663103|357973|P1|STARTED|Overall Study||21
147087|NCT01663012|357989|P1|NOT COMPLETED|Overall Study||0
147088|NCT01663012|357989|P1|COMPLETED|Overall Study||20
147089|NCT01663012|357989|P1|STARTED|Overall Study||20
147090|NCT01662999|358001|P6|NOT COMPLETED|Period 3||0
147091|NCT01662999|358002|P5|NOT COMPLETED|Period 3||0
147092|NCT01662999|358003|P4|NOT COMPLETED|Period 3||0
147093|NCT01662999|358004|P3|NOT COMPLETED|Period 3||0
147094|NCT01662999|358005|P2|NOT COMPLETED|Period 3||1
147095|NCT01662999|358006|P1|NOT COMPLETED|Period 3||0
147096|NCT01662999|358001|P6|COMPLETED|Period 3||7
147097|NCT01662999|358002|P5|COMPLETED|Period 3||7
147098|NCT01662999|358003|P4|COMPLETED|Period 3||7
147099|NCT01662999|358004|P3|COMPLETED|Period 3||7
147100|NCT01662999|358005|P2|COMPLETED|Period 3|Participant did not provide 36, 48, or 60 hour samples in this period for Treatment B.|6
147101|NCT01662999|358006|P1|COMPLETED|Period 3||7
147102|NCT01662999|358001|P6|STARTED|Period 3||7
147103|NCT01662999|358002|P5|STARTED|Period 3||7
147104|NCT01662999|358003|P4|STARTED|Period 3||7
147105|NCT01662999|358004|P3|STARTED|Period 3||7
147106|NCT01662999|358005|P2|STARTED|Period 3||7
147107|NCT01662999|358006|P1|STARTED|Period 3||7
147108|NCT01662999|358001|P6|NOT COMPLETED|Period 2||0
147109|NCT01662999|358002|P5|NOT COMPLETED|Period 2||0
147110|NCT01662999|358003|P4|NOT COMPLETED|Period 2||0
147111|NCT01662999|358004|P3|NOT COMPLETED|Period 2||0
147112|NCT01662999|358005|P2|NOT COMPLETED|Period 2||0
147113|NCT01662999|358006|P1|NOT COMPLETED|Period 2||0
147114|NCT01662999|358001|P6|COMPLETED|Period 2||7
147115|NCT01662999|358002|P5|COMPLETED|Period 2||7
147116|NCT01662999|358003|P4|COMPLETED|Period 2||7
147117|NCT01662999|358004|P3|COMPLETED|Period 2||7
147118|NCT01662999|358005|P2|COMPLETED|Period 2||7
147119|NCT01662999|358006|P1|COMPLETED|Period 2||7
147120|NCT01662999|358001|P6|STARTED|Period 2||7
147121|NCT01662999|358002|P5|STARTED|Period 2||7
147122|NCT01662999|358003|P4|STARTED|Period 2||7
147123|NCT01662999|358004|P3|STARTED|Period 2||7
147124|NCT01662999|358005|P2|STARTED|Period 2||7
147125|NCT01662999|358006|P1|STARTED|Period 2||7
147126|NCT01662999|358001|P6|NOT COMPLETED|Period 1||0
147127|NCT01662999|358002|P5|NOT COMPLETED|Period 1||0
147128|NCT01662999|358003|P4|NOT COMPLETED|Period 1||0
147129|NCT01662999|358004|P3|NOT COMPLETED|Period 1||0
147130|NCT01662999|358005|P2|NOT COMPLETED|Period 1||0
147131|NCT01662999|358006|P1|NOT COMPLETED|Period 1||0
147132|NCT01662999|358001|P6|COMPLETED|Period 1||7
147133|NCT01662999|358002|P5|COMPLETED|Period 1||7
147134|NCT01662999|358003|P4|COMPLETED|Period 1||7
147135|NCT01662999|358004|P3|COMPLETED|Period 1||7
147136|NCT01662999|358005|P2|COMPLETED|Period 1||7
147137|NCT01662999|358006|P1|COMPLETED|Period 1||7
147138|NCT01662999|358001|P6|STARTED|Period 1||7
147139|NCT01662999|358002|P5|STARTED|Period 1||7
147140|NCT01662999|358003|P4|STARTED|Period 1||7
147141|NCT01662999|358004|P3|STARTED|Period 1||7
147142|NCT01662999|358005|P2|STARTED|Period 1||7
147143|NCT01662999|358006|P1|STARTED|Period 1||7
147144|NCT01662986|358077|P2|NOT COMPLETED|Overall Study||13
147145|NCT01662986|358078|P1|NOT COMPLETED|Overall Study||18
147146|NCT01662986|358077|P2|COMPLETED|Overall Study||26
147147|NCT01662986|358078|P1|COMPLETED|Overall Study||22
147148|NCT01662986|358077|P2|STARTED|Overall Study||39
147149|NCT01662986|358078|P1|STARTED|Overall Study||40
147150|NCT01662960|358114|P4|NOT COMPLETED|3 Month Follow-up||2
147151|NCT01662960|358115|P3|NOT COMPLETED|3 Month Follow-up||3
147152|NCT01662960|358116|P2|NOT COMPLETED|3 Month Follow-up||3
147153|NCT01662960|358117|P1|NOT COMPLETED|3 Month Follow-up||3
147154|NCT01662960|358114|P4|COMPLETED|3 Month Follow-up||13
147155|NCT01662960|358115|P3|COMPLETED|3 Month Follow-up||5
147156|NCT01662960|358116|P2|COMPLETED|3 Month Follow-up||16
147157|NCT01662960|358117|P1|COMPLETED|3 Month Follow-up||21
147158|NCT01662960|358114|P4|STARTED|3 Month Follow-up||15
147159|NCT01662960|358115|P3|STARTED|3 Month Follow-up||8
147160|NCT01662960|358116|P2|STARTED|3 Month Follow-up||19
147161|NCT01662960|358117|P1|STARTED|3 Month Follow-up||24
147162|NCT01662960|358114|P4|NOT COMPLETED|End of 4 Week Treatment Period||0
147163|NCT01662960|358115|P3|NOT COMPLETED|End of 4 Week Treatment Period||1
147164|NCT01662960|358116|P2|NOT COMPLETED|End of 4 Week Treatment Period||4
147165|NCT01662960|358117|P1|NOT COMPLETED|End of 4 Week Treatment Period||1
147166|NCT01662960|358114|P4|COMPLETED|End of 4 Week Treatment Period||15
147167|NCT01662960|358115|P3|COMPLETED|End of 4 Week Treatment Period||8
147168|NCT01662960|358116|P2|COMPLETED|End of 4 Week Treatment Period||19
147169|NCT01662960|358117|P1|COMPLETED|End of 4 Week Treatment Period||24
147170|NCT01662960|358114|P4|STARTED|End of 4 Week Treatment Period||15
147171|NCT01662960|358115|P3|STARTED|End of 4 Week Treatment Period||9
147172|NCT01662960|358116|P2|STARTED|End of 4 Week Treatment Period||23
147173|NCT01662960|358117|P1|STARTED|End of 4 Week Treatment Period||25
147174|NCT01662908|358149|P2|NOT COMPLETED|Overall Study||5
147175|NCT01662908|358150|P1|NOT COMPLETED|Overall Study||6
147176|NCT01662908|358149|P2|COMPLETED|Overall Study||23
147177|NCT01662908|358150|P1|COMPLETED|Overall Study||50
147178|NCT01662908|358149|P2|STARTED|Overall Study||28
147179|NCT01662908|358150|P1|STARTED|Overall Study||56
147180|NCT01662895|358166|P2|NOT COMPLETED|Overall Study||1
147181|NCT01662895|358167|P1|NOT COMPLETED|Overall Study||0
147182|NCT01662895|358166|P2|COMPLETED|Overall Study||20
147183|NCT01662895|358167|P1|COMPLETED|Overall Study||21
147184|NCT01662895|358166|P2|Initiated Study Drug|Overall Study||21
147185|NCT01662895|358167|P1|Initiated Study Drug|Overall Study||21
147186|NCT01662895|358166|P2|STARTED|Overall Study||21
147187|NCT01662895|358167|P1|STARTED|Overall Study||21
147188|NCT01662882|358190|P3|NOT COMPLETED|Overall Study||0
147189|NCT01662882|358191|P2|NOT COMPLETED|Overall Study||0
147190|NCT01662882|358192|P1|NOT COMPLETED|Overall Study||0
147191|NCT01662882|358190|P3|COMPLETED|Overall Study||15
147192|NCT01662882|358191|P2|COMPLETED|Overall Study||18
147193|NCT01662882|358192|P1|COMPLETED|Overall Study||15
147194|NCT01662882|358190|P3|STARTED|Overall Study||15
147195|NCT01662882|358191|P2|STARTED|Overall Study||18
147196|NCT01662882|358192|P1|STARTED|Overall Study||15
147197|NCT01662856|358205|P2|NOT COMPLETED|Primary Part II||2
147198|NCT01662856|358206|P1|NOT COMPLETED|Primary Part II||10
147199|NCT01662856|358205|P2|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|55
147200|NCT01662856|358206|P1|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|99
147201|NCT01662856|358205|P2|Completed Study up to Week 6|Primary Part II||56
147202|NCT01662856|358206|P1|Completed Study up to Week 6|Primary Part II||106
147203|NCT01662856|358205|P2|STARTED|Primary Part II||57
147204|NCT01662856|358206|P1|STARTED|Primary Part II||109
147205|NCT01662856|358205|P2|NOT COMPLETED|Part I + Part II (Overall Study)||2
147206|NCT01662856|358206|P1|NOT COMPLETED|Part I + Part II (Overall Study)||16
147207|NCT01662856|358205|P2|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|55
147208|NCT01662856|358206|P1|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|152
147209|NCT01662856|358205|P2|Completed Study up to Week 6|Part I + Part II (Overall Study)||56
147210|NCT01662856|358206|P1|Completed Study up to Week 6|Part I + Part II (Overall Study)||164
147211|NCT01662856|358205|P2|STARTED|Part I + Part II (Overall Study)||57
147212|NCT01662856|358206|P1|STARTED|Part I + Part II (Overall Study)||168
147213|NCT01662791|358220|P2|NOT COMPLETED|Part 2 - Interventional||0
147214|NCT01662791|358221|P1|NOT COMPLETED|Part 2 - Interventional||0
147215|NCT01662791|358220|P2|COMPLETED|Part 2 - Interventional||0
147216|NCT01662791|358221|P1|COMPLETED|Part 2 - Interventional||8
147217|NCT01662791|358220|P2|STARTED|Part 2 - Interventional|The Control Group did not take part in the second part of the study.|0
147218|NCT01662791|358221|P1|STARTED|Part 2 - Interventional||8
147219|NCT01662791|358220|P2|NOT COMPLETED|Part 1 - Observational||0
147220|NCT01662791|358221|P1|NOT COMPLETED|Part 1 - Observational||0
147221|NCT01662791|358220|P2|COMPLETED|Part 1 - Observational||41
147222|NCT01662791|358221|P1|COMPLETED|Part 1 - Observational||8
147223|NCT01662791|358220|P2|STARTED|Part 1 - Observational||41
147224|NCT01662791|358221|P1|STARTED|Part 1 - Observational||8
147225|NCT01662778|358243|P4|NOT COMPLETED|Period 4||0
147226|NCT01662778|358244|P3|NOT COMPLETED|Period 4||0
147227|NCT01662778|358245|P2|NOT COMPLETED|Period 4||0
147228|NCT01662778|358246|P1|NOT COMPLETED|Period 4||0
147229|NCT01662778|358243|P4|COMPLETED|Period 4||4
147230|NCT01662778|358244|P3|COMPLETED|Period 4||6
147231|NCT01662778|358245|P2|COMPLETED|Period 4||5
147232|NCT01662778|358246|P1|COMPLETED|Period 4||6
147233|NCT01662778|358243|P4|STARTED|Period 4||4
147234|NCT01662778|358244|P3|STARTED|Period 4||6
147235|NCT01662778|358245|P2|STARTED|Period 4||5
147236|NCT01662778|358246|P1|STARTED|Period 4||6
147237|NCT01662778|358243|P4|NOT COMPLETED|Period 3||0
147238|NCT01662778|358244|P3|NOT COMPLETED|Period 3||0
147239|NCT01662778|358245|P2|NOT COMPLETED|Period 3||0
147240|NCT01662778|358246|P1|NOT COMPLETED|Period 3||0
147241|NCT01662778|358243|P4|COMPLETED|Period 3||4
147242|NCT01662778|358244|P3|COMPLETED|Period 3||6
147243|NCT01662778|358245|P2|COMPLETED|Period 3||5
147244|NCT01662778|358246|P1|COMPLETED|Period 3||6
147245|NCT01662778|358243|P4|STARTED|Period 3||4
147246|NCT01662778|358244|P3|STARTED|Period 3||6
147247|NCT01662778|358245|P2|STARTED|Period 3||5
147248|NCT01662778|358246|P1|STARTED|Period 3||6
147249|NCT01662778|358243|P4|NOT COMPLETED|Period 2||0
147250|NCT01662778|358244|P3|NOT COMPLETED|Period 2||0
147251|NCT01662778|358245|P2|NOT COMPLETED|Period 2||0
147252|NCT01662778|358246|P1|NOT COMPLETED|Period 2||0
147253|NCT01662778|358243|P4|COMPLETED|Period 2||4
147254|NCT01662778|358244|P3|COMPLETED|Period 2||6
147255|NCT01662778|358245|P2|COMPLETED|Period 2||5
147256|NCT01662778|358246|P1|COMPLETED|Period 2||6
147257|NCT01662778|358243|P4|STARTED|Period 2||4
147258|NCT01662778|358244|P3|STARTED|Period 2||6
147259|NCT01662778|358245|P2|STARTED|Period 2||5
147260|NCT01662778|358246|P1|STARTED|Period 2||6
147261|NCT01662778|358243|P4|NOT COMPLETED|Period 1||0
147262|NCT01662778|358244|P3|NOT COMPLETED|Period 1||0
147263|NCT01662778|358245|P2|NOT COMPLETED|Period 1||0
147264|NCT01662778|358246|P1|NOT COMPLETED|Period 1||0
147265|NCT01662778|358243|P4|COMPLETED|Period 1||4
147266|NCT01662778|358244|P3|COMPLETED|Period 1||6
147267|NCT01662778|358245|P2|COMPLETED|Period 1||5
147268|NCT01662778|358246|P1|COMPLETED|Period 1||6
147269|NCT01662778|358243|P4|STARTED|Period 1||4
147270|NCT01662778|358244|P3|STARTED|Period 1||6
147271|NCT01662778|358245|P2|STARTED|Period 1||5
147272|NCT01662778|358246|P1|STARTED|Period 1||6
147273|NCT01662765|358270|P2|NOT COMPLETED|Overall Study||2
147274|NCT01662765|358271|P1|NOT COMPLETED|Overall Study||1
147275|NCT01662765|358270|P2|COMPLETED|Overall Study||40
147276|NCT01662765|358271|P1|COMPLETED|Overall Study||41
147277|NCT01662765|358270|P2|STARTED|Overall Study||42
147278|NCT01662765|358271|P1|STARTED|Overall Study||42
147279|NCT01662752|358283|P1|NOT COMPLETED|Overall Study||0
147280|NCT01662752|358283|P1|COMPLETED|Overall Study||30
147281|NCT01662752|358283|P1|STARTED|Overall Study||30
147282|NCT01662648|358291|P2|NOT COMPLETED|Overall Study||178
147283|NCT01662648|358292|P1|NOT COMPLETED|Overall Study||147
147284|NCT01662648|358291|P2|COMPLETED|Overall Study||419
147285|NCT01662648|358292|P1|COMPLETED|Overall Study||373
147286|NCT01662648|358291|P2|STARTED|Overall Study||597
147287|NCT01662648|358292|P1|STARTED|Overall Study||520
147288|NCT01662635|358314|P1|NOT COMPLETED|Overall Study||30
147289|NCT01662635|358314|P1|COMPLETED|Overall Study||200
147290|NCT01662635|358314|P1|STARTED|Overall Study||230
147291|NCT01662583|358323|P3|NOT COMPLETED|Overall Study||0
147292|NCT01662583|358324|P2|NOT COMPLETED|Overall Study||0
147293|NCT01662583|358325|P1|NOT COMPLETED|Overall Study||0
147294|NCT01662583|358323|P3|COMPLETED|Overall Study||219
147295|NCT01662583|358324|P2|COMPLETED|Overall Study||225
147296|NCT01662583|358325|P1|COMPLETED|Overall Study||216
147297|NCT01662583|358323|P3|STARTED|Overall Study||219
147298|NCT01662583|358324|P2|STARTED|Overall Study||225
147299|NCT01662583|358325|P1|STARTED|Overall Study||216
147300|NCT01662531|358338|P1|NOT COMPLETED|Overall Study||0
147301|NCT01662531|358338|P1|COMPLETED|Overall Study||27
147302|NCT01662531|358338|P1|STARTED|Overall Study||27
147303|NCT01662505|358365|P3|NOT COMPLETED|Overall Study||8
147304|NCT01662505|358366|P2|NOT COMPLETED|Overall Study||4
147305|NCT01662505|358367|P1|NOT COMPLETED|Overall Study||7
147306|NCT01662505|358365|P3|COMPLETED|Overall Study||0
147307|NCT01662505|358366|P2|COMPLETED|Overall Study||0
147308|NCT01662505|358367|P1|COMPLETED|Overall Study||0
147309|NCT01662505|358365|P3|STARTED|Overall Study||8
147310|NCT01662505|358366|P2|STARTED|Overall Study||4
147311|NCT01662505|358367|P1|STARTED|Overall Study||7
147312|NCT01662492|358391|P3|NOT COMPLETED|Overall Study||6
147313|NCT01662492|358392|P2|NOT COMPLETED|Overall Study||1
147314|NCT01662492|358393|P1|NOT COMPLETED|Overall Study||3
147315|NCT01662492|358391|P3|COMPLETED|Overall Study||31
147316|NCT01662492|358392|P2|COMPLETED|Overall Study||42
147317|NCT01662492|358393|P1|COMPLETED|Overall Study||42
147318|NCT01662492|358391|P3|STARTED|Overall Study||37
147319|NCT01662492|358392|P2|STARTED|Overall Study||43
147320|NCT01662492|358393|P1|STARTED|Overall Study||45
147321|NCT01662440|358417|P4|NOT COMPLETED|Overall Study||4
147322|NCT01662440|358418|P3|NOT COMPLETED|Overall Study||6
147323|NCT01662440|358419|P2|NOT COMPLETED|Overall Study||6
147324|NCT01662440|358420|P1|NOT COMPLETED|Overall Study||9
147325|NCT01662440|358417|P4|COMPLETED|Overall Study||52
147326|NCT01662440|358418|P3|COMPLETED|Overall Study||215
147327|NCT01662440|358419|P2|COMPLETED|Overall Study||211
147328|NCT01662440|358420|P1|COMPLETED|Overall Study||158
147329|NCT01662440|358417|P4|STARTED|Overall Study||56
147330|NCT01662440|358418|P3|STARTED|Overall Study||221
147331|NCT01662440|358419|P2|STARTED|Overall Study||217
147332|NCT01662440|358420|P1|STARTED|Overall Study||167
147333|NCT01662362|358468|P1|NOT COMPLETED|Overall Study||38
147334|NCT01662362|358468|P1|COMPLETED|Overall Study||25
147335|NCT01662362|358468|P1|STARTED|Overall Study||63
147336|NCT01662336|358473|P1|NOT COMPLETED|Overall Study||66
147337|NCT01662336|358473|P1|COMPLETED|Overall Study||107
147338|NCT01662336|358473|P1|Completed Month 12 Visit|Overall Study||109
147339|NCT01662336|358473|P1|Completed Month 6 Visit|Overall Study||142
147340|NCT01662336|358473|P1|STARTED|Overall Study||173
147341|NCT01662310|358499|P5|NOT COMPLETED|Open-Label Extension Phase||10
147342|NCT01662310|358500|P4|NOT COMPLETED|Open-Label Extension Phase||11
147343|NCT01662310|358501|P3|NOT COMPLETED|Open-Label Extension Phase||0
147344|NCT01662310|358502|P2|NOT COMPLETED|Open-Label Extension Phase||0
147345|NCT01662310|358503|P1|NOT COMPLETED|Open-Label Extension Phase||0
147346|NCT01662310|358499|P5|COMPLETED|Open-Label Extension Phase||49
147347|NCT01662310|358500|P4|COMPLETED|Open-Label Extension Phase||36
147348|NCT01662310|358501|P3|COMPLETED|Open-Label Extension Phase||0
147349|NCT01662310|358502|P2|COMPLETED|Open-Label Extension Phase||0
147350|NCT01662310|358503|P1|COMPLETED|Open-Label Extension Phase||0
147351|NCT01662310|358499|P5|STARTED|Open-Label Extension Phase||59
147352|NCT01662310|358500|P4|STARTED|Open-Label Extension Phase||47
147353|NCT01662310|358501|P3|STARTED|Open-Label Extension Phase||0
147354|NCT01662310|358502|P2|STARTED|Open-Label Extension Phase||0
147355|NCT01662310|358503|P1|STARTED|Open-Label Extension Phase||0
147356|NCT01662310|358499|P5|NOT COMPLETED|Double-Blind Phase||0
147357|NCT01662310|358500|P4|NOT COMPLETED|Double-Blind Phase||0
147358|NCT01662310|358501|P3|NOT COMPLETED|Double-Blind Phase||5
147359|NCT01662310|358502|P2|NOT COMPLETED|Double-Blind Phase||15
147360|NCT01662310|358503|P1|NOT COMPLETED|Double-Blind Phase||0
147361|NCT01662310|358499|P5|COMPLETED|Double-Blind Phase||0
147362|NCT01662310|358500|P4|COMPLETED|Double-Blind Phase||0
147363|NCT01662310|358501|P3|COMPLETED|Double-Blind Phase||66
147364|NCT01662310|358502|P2|COMPLETED|Double-Blind Phase||50
147365|NCT01662310|358503|P1|COMPLETED|Double-Blind Phase||0
147366|NCT01662310|358499|P5|Treated|Double-Blind Phase||0
147367|NCT01662310|358500|P4|Treated|Double-Blind Phase||0
147368|NCT01662310|358501|P3|Treated|Double-Blind Phase||71
147369|NCT01662310|358502|P2|Treated|Double-Blind Phase||64
147370|NCT01662310|358503|P1|Treated|Double-Blind Phase||0
147371|NCT01662310|358499|P5|STARTED|Double-Blind Phase||0
147372|NCT01662310|358500|P4|STARTED|Double-Blind Phase||0
147373|NCT01662310|358501|P3|STARTED|Double-Blind Phase||71
147374|NCT01662310|358502|P2|STARTED|Double-Blind Phase||65
147375|NCT01662310|358503|P1|STARTED|Double-Blind Phase||0
147376|NCT01662310|358499|P5|NOT COMPLETED|Run-In or Stabilization Phase||0
147377|NCT01662310|358500|P4|NOT COMPLETED|Run-In or Stabilization Phase||0
147378|NCT01662310|358501|P3|NOT COMPLETED|Run-In or Stabilization Phase||0
147379|NCT01662310|358502|P2|NOT COMPLETED|Run-In or Stabilization Phase||0
147380|NCT01662310|358503|P1|NOT COMPLETED|Run-In or Stabilization Phase||65
147381|NCT01662310|358499|P5|COMPLETED|Run-In or Stabilization Phase||0
147382|NCT01662310|358500|P4|COMPLETED|Run-In or Stabilization Phase||0
147383|NCT01662310|358501|P3|COMPLETED|Run-In or Stabilization Phase||0
147384|NCT01662310|358502|P2|COMPLETED|Run-In or Stabilization Phase||0
147385|NCT01662310|358503|P1|COMPLETED|Run-In or Stabilization Phase||136
147386|NCT01662310|358499|P5|STARTED|Run-In or Stabilization Phase||0
147387|NCT01662310|358500|P4|STARTED|Run-In or Stabilization Phase||0
147388|NCT01662310|358501|P3|STARTED|Run-In or Stabilization Phase||0
147389|NCT01662310|358502|P2|STARTED|Run-In or Stabilization Phase||0
147390|NCT01662310|358503|P1|STARTED|Run-In or Stabilization Phase||201
147391|NCT01662297|358537|P2|NOT COMPLETED|Overall Study||0
147392|NCT01662297|358538|P1|NOT COMPLETED|Overall Study||0
147393|NCT01662297|358537|P2|COMPLETED|Overall Study||1
147394|NCT01662297|358538|P1|COMPLETED|Overall Study||0
147395|NCT01662297|358537|P2|STARTED|Overall Study||1
147396|NCT01662297|358538|P1|STARTED|Overall Study||0
147397|NCT01662115|358563|P3|NOT COMPLETED|Overall Study||0
147398|NCT01662115|358564|P2|NOT COMPLETED|Overall Study||0
147399|NCT01662115|358565|P1|NOT COMPLETED|Overall Study||0
147400|NCT01662115|358563|P3|COMPLETED|Overall Study||0
147401|NCT01662115|358564|P2|COMPLETED|Overall Study||2
147402|NCT01662115|358565|P1|COMPLETED|Overall Study||2
147403|NCT01662115|358563|P3|STARTED|Overall Study||0
147404|NCT01662115|358564|P2|STARTED|Overall Study||2
147405|NCT01662115|358565|P1|STARTED|Overall Study||2
147406|NCT01662102|358584|P2|NOT COMPLETED|Overall Study||0
147407|NCT01662102|358585|P1|NOT COMPLETED|Overall Study||1
147408|NCT01662102|358584|P2|COMPLETED|Overall Study||0
147409|NCT01662102|358585|P1|COMPLETED|Overall Study||0
147410|NCT01662102|358584|P2|STARTED|Overall Study||0
147411|NCT01662102|358585|P1|STARTED|Overall Study||1
147412|NCT01662063|358593|P3|NOT COMPLETED|Overall Study||1
147413|NCT01662063|358594|P2|NOT COMPLETED|Overall Study||29
147414|NCT01662063|358595|P1|NOT COMPLETED|Overall Study||5
147415|NCT01662063|358593|P3|COMPLETED|Overall Study||0
147416|NCT01662063|358594|P2|COMPLETED|Overall Study||144
147417|NCT01662063|358595|P1|COMPLETED|Overall Study||39
147418|NCT01662063|358593|P3|STARTED|Overall Study||1
147419|NCT01662063|358594|P2|STARTED|Overall Study||173
147420|NCT01662063|358595|P1|STARTED|Overall Study||44
147421|NCT01662024|358674|P1|NOT COMPLETED|Overall Study||5
147422|NCT01662024|358674|P1|COMPLETED|Overall Study||15
147423|NCT01662024|358674|P1|STARTED|Overall Study||20
147424|NCT01661972|358686|P2|NOT COMPLETED|Overall Study||4
147425|NCT01661972|358687|P1|NOT COMPLETED|Overall Study||2
147426|NCT01661972|358686|P2|COMPLETED|Overall Study||46
147427|NCT01661972|358687|P1|COMPLETED|Overall Study||11
147428|NCT01661972|358686|P2|STARTED|Overall Study||50
147429|NCT01661972|358687|P1|STARTED|Overall Study||13
147430|NCT01661946|358699|P2|NOT COMPLETED|Overall Study||0
147431|NCT01661946|358700|P1|NOT COMPLETED|Overall Study||0
147432|NCT01661946|358699|P2|COMPLETED|Overall Study||5
147433|NCT01661946|358700|P1|COMPLETED|Overall Study||5
147434|NCT01661946|358699|P2|STARTED|Overall Study||5
147435|NCT01661946|358700|P1|STARTED|Overall Study||5
147436|NCT01661933|358706|P1|NOT COMPLETED|High-dose Gluten Challenge||2
147437|NCT01661933|358706|P1|COMPLETED|High-dose Gluten Challenge||8
147438|NCT01661933|358706|P1|STARTED|High-dose Gluten Challenge|2 of 10 available after post-GC-1g did not enroll for reasons unrelated to gluten.|10
147439|NCT01661933|358706|P1|NOT COMPLETED|Low-dose Gluten Challenge||2
147440|NCT01661933|358706|P1|COMPLETED|Low-dose Gluten Challenge|Two had challenge interrupted for 1-2 weeks. All completed challenge.|10
147441|NCT01661933|358706|P1|STARTED|Low-dose Gluten Challenge|One was symptomatically intolerant to gluten >25 mg. One had active CeD pre- & post-micro-challenge|12
147442|NCT01661933|358706|P1|NOT COMPLETED|Gluten Micro-challenge||0
147443|NCT01661933|358706|P1|COMPLETED|Gluten Micro-challenge|Two gluten intolerant participants did not proceed to the low-dose challenge.|12
147444|NCT01661933|358706|P1|STARTED|Gluten Micro-challenge|All 12 enrolled completed hookworm inoculation and gluten micro-challenge.|12
147445|NCT01661881|358713|P1|NOT COMPLETED|Overall Study||1
147446|NCT01661881|358713|P1|COMPLETED|Overall Study||22
147447|NCT01661881|358713|P1|STARTED|Overall Study||23
147448|NCT01661790|358721|P2|NOT COMPLETED|Overall Study||2
147449|NCT01661790|358722|P1|NOT COMPLETED|Overall Study||0
147450|NCT01661790|358721|P2|COMPLETED|Overall Study||34
147451|NCT01661790|358722|P1|COMPLETED|Overall Study||36
147452|NCT01661790|358721|P2|STARTED|Overall Study||36
147453|NCT01661790|358722|P1|STARTED|Overall Study||36
147454|NCT01661764|358734|P6|NOT COMPLETED|Overall Study||2
147455|NCT01661764|358735|P5|NOT COMPLETED|Overall Study||3
147456|NCT01661764|358736|P4|NOT COMPLETED|Overall Study||2
147457|NCT01661764|358737|P3|NOT COMPLETED|Overall Study||3
147458|NCT01661764|358738|P2|NOT COMPLETED|Overall Study||5
147459|NCT01661764|358739|P1|NOT COMPLETED|Overall Study||2
147460|NCT01661764|358734|P6|COMPLETED|Overall Study||18
147461|NCT01661764|358735|P5|COMPLETED|Overall Study||16
147462|NCT01661764|358736|P4|COMPLETED|Overall Study||24
147463|NCT01661764|358737|P3|COMPLETED|Overall Study||22
147464|NCT01661764|358738|P2|COMPLETED|Overall Study||20
147465|NCT01661764|358739|P1|COMPLETED|Overall Study||24
147466|NCT01661764|358734|P6|STARTED|Overall Study||20
147467|NCT01661764|358735|P5|STARTED|Overall Study||19
147468|NCT01661764|358736|P4|STARTED|Overall Study||26
147469|NCT01661764|358737|P3|STARTED|Overall Study||25
147470|NCT01661764|358738|P2|STARTED|Overall Study||25
147471|NCT01661764|358739|P1|STARTED|Overall Study||26
147472|NCT01661712|358803|P2|NOT COMPLETED|Overall Study||0
147473|NCT01661712|358804|P1|NOT COMPLETED|Overall Study||0
147474|NCT01661712|358803|P2|COMPLETED|Overall Study|sham stimulation night|18
147475|NCT01661712|358804|P1|COMPLETED|Overall Study|night on transcutaneous electrical stimulation|18
147476|NCT01661712|358803|P2|Washout Period|Overall Study|>Three nights of no stimulation/sham stimulation|18
147477|NCT01661712|358804|P1|Washout Period|Overall Study|>Three nights of no stimulation/sham stimulation|18
147478|NCT01661712|358803|P2|STARTED|Overall Study|initial night on transcutaneous electrical stimulation|18
147479|NCT01661712|358804|P1|STARTED|Overall Study|initial sham stimulation night|18
147480|NCT01661686|358822|P2|NOT COMPLETED|Overall Study||2
147481|NCT01661686|358823|P1|NOT COMPLETED|Overall Study||2
147482|NCT01661686|358822|P2|COMPLETED|Overall Study||47
147483|NCT01661686|358823|P1|COMPLETED|Overall Study||47
147484|NCT01661686|358822|P2|STARTED|Overall Study||49
147485|NCT01661686|358823|P1|STARTED|Overall Study||49
147486|NCT01661621|358839|P2|NOT COMPLETED|Overall Study||0
147487|NCT01661621|358840|P1|NOT COMPLETED|Overall Study||0
147488|NCT01661621|358839|P2|COMPLETED|Overall Study||279
147489|NCT01661621|358840|P1|COMPLETED|Overall Study||116
147490|NCT01661621|358839|P2|STARTED|Overall Study||279
147491|NCT01661621|358840|P1|STARTED|Overall Study||116
147492|NCT01661595|358864|P4|NOT COMPLETED|Phase 2: Week 5-8.||0
147493|NCT01661595|358865|P3|NOT COMPLETED|Phase 2: Week 5-8.||1
147494|NCT01661595|358866|P2|NOT COMPLETED|Phase 2: Week 5-8.||0
147495|NCT01661595|358867|P1|NOT COMPLETED|Phase 2: Week 5-8.||0
147496|NCT01661595|358864|P4|COMPLETED|Phase 2: Week 5-8.||4
147497|NCT01661595|358865|P3|COMPLETED|Phase 2: Week 5-8.||4
147498|NCT01661595|358866|P2|COMPLETED|Phase 2: Week 5-8.||4
147499|NCT01661595|358867|P1|COMPLETED|Phase 2: Week 5-8.||4
147500|NCT01661595|358864|P4|STARTED|Phase 2: Week 5-8.||4
147501|NCT01661595|358865|P3|STARTED|Phase 2: Week 5-8.||5
147502|NCT01661595|358866|P2|STARTED|Phase 2: Week 5-8.||4
147503|NCT01661595|358867|P1|STARTED|Phase 2: Week 5-8.||4
147504|NCT01661595|358864|P4|NOT COMPLETED|Phase 1: Week 0-4||0
147505|NCT01661595|358865|P3|NOT COMPLETED|Phase 1: Week 0-4||0
147506|NCT01661595|358866|P2|NOT COMPLETED|Phase 1: Week 0-4||0
147507|NCT01661595|358867|P1|NOT COMPLETED|Phase 1: Week 0-4||1
147508|NCT01661595|358864|P4|COMPLETED|Phase 1: Week 0-4||4
147509|NCT01661595|358865|P3|COMPLETED|Phase 1: Week 0-4||5
147510|NCT01661595|358866|P2|COMPLETED|Phase 1: Week 0-4||4
147511|NCT01661595|358867|P1|COMPLETED|Phase 1: Week 0-4||4
147512|NCT01661595|358864|P4|STARTED|Phase 1: Week 0-4||4
147513|NCT01661595|358865|P3|STARTED|Phase 1: Week 0-4||5
147514|NCT01661595|358866|P2|STARTED|Phase 1: Week 0-4||4
147515|NCT01661595|358867|P1|STARTED|Phase 1: Week 0-4||5
147516|NCT01661283|358972|P1|NOT COMPLETED|Overall Study||0
147517|NCT01661283|358972|P1|COMPLETED|Overall Study||25
147518|NCT01661283|358972|P1|STARTED|Overall Study|15 patients enrolled in the first stage; 10 patients enrolled in the second stage|25
147519|NCT01661270|358983|P2|NOT COMPLETED|Overall Study||0
147520|NCT01661270|358984|P1|NOT COMPLETED|Overall Study||0
147521|NCT01661270|358983|P2|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|223
147522|NCT01661270|358984|P1|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|109
147523|NCT01661270|358983|P2|Other Reasons|Overall Study||2
147524|NCT01661270|358984|P1|Other Reasons|Overall Study||0
147525|NCT01661270|358983|P2|Participant’s Request|Overall Study|Met EOT criteria|48
147526|NCT01661270|358984|P1|Participant’s Request|Overall Study|Met EOT criteria|15
147527|NCT01661270|358983|P2|Physician Decision|Overall Study|Met EOT criteria|8
147528|NCT01661270|358984|P1|Physician Decision|Overall Study|Met EOT criteria|1
147529|NCT01661270|358983|P2|Disease Progression|Overall Study|Met EOT criteria|118
147530|NCT01661270|358984|P1|Disease Progression|Overall Study|Met EOT criteria|67
147531|NCT01661270|358983|P2|Adverse Event|Overall Study|Met EOT criteria|47
147532|NCT01661270|358984|P1|Adverse Event|Overall Study|Met end of treatment (EOT) criteria.|26
147533|NCT01661270|358983|P2|STARTED|Overall Study||223
147534|NCT01661270|358984|P1|STARTED|Overall Study||109
147535|NCT01661205|358995|P1|NOT COMPLETED|Overall Study||2
147536|NCT01661205|358995|P1|COMPLETED|Overall Study||24
147537|NCT01661205|358995|P1|STARTED|Overall Study||26
147538|NCT01661179|359006|P1|NOT COMPLETED|Overall Study||6
147539|NCT01661179|359006|P1|COMPLETED|Overall Study||8
147540|NCT01661179|359006|P1|STARTED|Overall Study||14
147541|NCT01661140|359010|P3|NOT COMPLETED|Double-Blind Period||50
147542|NCT01661140|359011|P2|NOT COMPLETED|Double-Blind Period||41
147543|NCT01661140|359012|P1|NOT COMPLETED|Double-Blind Period||0
147544|NCT01661140|359010|P3|COMPLETED|Double-Blind Period||86
147545|NCT01661140|359011|P2|COMPLETED|Double-Blind Period||95
147546|NCT01661140|359012|P1|COMPLETED|Double-Blind Period||0
147547|NCT01661140|359010|P3|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
147548|NCT01661140|359011|P2|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
147549|NCT01661140|359012|P1|STARTED|Double-Blind Period|Those with a good/moderate disease response in the initial phase were randomized to the MTX arms.|0
147550|NCT01661140|359010|P3|NOT COMPLETED|Open-Label Period||0
147551|NCT01661140|359011|P2|NOT COMPLETED|Open-Label Period||0
147552|NCT01661140|359012|P1|NOT COMPLETED|Open-Label Period||76
147553|NCT01661140|359010|P3|COMPLETED|Open-Label Period||0
147554|NCT01661140|359011|P2|COMPLETED|Open-Label Period||0
147555|NCT01661140|359012|P1|COMPLETED|Open-Label Period||351
147556|NCT01661140|359010|P3|STARTED|Open-Label Period||0
147557|NCT01661140|359011|P2|STARTED|Open-Label Period||0
147558|NCT01661140|359012|P1|STARTED|Open-Label Period|All participants entered the study in the initial phase for 24 weeks of open label treatment.|427
147559|NCT01661114|359053|P1|NOT COMPLETED|Overall Study||0
147560|NCT01661114|359053|P1|COMPLETED|Overall Study||39
147561|NCT01661114|359053|P1|STARTED|Overall Study||39
147562|NCT01661088|359058|P1|NOT COMPLETED|IMRT With FDR Gemcitabine||2
147563|NCT01661088|359058|P1|COMPLETED|IMRT With FDR Gemcitabine||19
147564|NCT01661088|359058|P1|STARTED|IMRT With FDR Gemcitabine||21
147565|NCT01661088|359058|P1|NOT COMPLETED|FOLFIRINOX||4
147566|NCT01661088|359058|P1|COMPLETED|FOLFIRINOX||21
147567|NCT01661088|359058|P1|STARTED|FOLFIRINOX||25
147568|NCT01661062|359064|P1|NOT COMPLETED|Overall Study||5
147569|NCT01661062|359064|P1|COMPLETED|Overall Study||18
147570|NCT01661062|359064|P1|STARTED|Overall Study||23
147571|NCT01660906|359069|P1|NOT COMPLETED|Overall Study||3
147572|NCT01660906|359069|P1|COMPLETED|Overall Study||36
147573|NCT01660906|359069|P1|STARTED|Overall Study||39
147574|NCT01660893|359081|P3|NOT COMPLETED|Overall Study||0
147575|NCT01660893|359082|P2|NOT COMPLETED|Overall Study||0
147576|NCT01660893|359083|P1|NOT COMPLETED|Overall Study||0
147577|NCT01660893|359081|P3|COMPLETED|Overall Study||6
147578|NCT01660893|359082|P2|COMPLETED|Overall Study||10
147579|NCT01660893|359083|P1|COMPLETED|Overall Study||10
147580|NCT01660893|359081|P3|STARTED|Overall Study||6
147581|NCT01660893|359082|P2|STARTED|Overall Study||10
147582|NCT01660893|359083|P1|STARTED|Overall Study||10
147583|NCT01660815|359130|P1|NOT COMPLETED|Overall Study||0
147584|NCT01660815|359130|P1|COMPLETED|Overall Study||7
147585|NCT01660815|359130|P1|STARTED|Overall Study||7
147586|NCT01660802|359137|P2|NOT COMPLETED|Overall Study||11
147587|NCT01660802|359138|P1|NOT COMPLETED|Overall Study||4
147588|NCT01660802|359137|P2|COMPLETED|Overall Study||121
147589|NCT01660802|359138|P1|COMPLETED|Overall Study||126
147590|NCT01660802|359137|P2|STARTED|Overall Study||132
147591|NCT01660802|359138|P1|STARTED|Overall Study||130
147592|NCT01660763|359152|P2|NOT COMPLETED|Overall Study||61
147593|NCT01660763|359153|P1|NOT COMPLETED|Overall Study||100
147594|NCT01660763|359152|P2|COMPLETED|Overall Study||43
147595|NCT01660763|359153|P1|COMPLETED|Overall Study||215
147596|NCT01660763|359152|P2|STARTED|Overall Study||104
147597|NCT01660763|359153|P1|STARTED|Overall Study||315
147598|NCT01660737|359159|P1|NOT COMPLETED|Overall Study||0
147599|NCT01660737|359159|P1|COMPLETED|Overall Study||123
147600|NCT01660737|359159|P1|STARTED|Overall Study||123
147601|NCT01660698|359176|P2|NOT COMPLETED|Overall Study||0
147602|NCT01660698|359177|P1|NOT COMPLETED|Overall Study||0
147603|NCT01660698|359176|P2|COMPLETED|Overall Study||10
147604|NCT01660698|359177|P1|COMPLETED|Overall Study||10
147605|NCT01660698|359176|P2|STARTED|Overall Study||10
147606|NCT01660698|359177|P1|STARTED|Overall Study||10
147607|NCT01660672|359187|P1|NOT COMPLETED|Overall Study||0
147608|NCT01660672|359187|P1|COMPLETED|Overall Study||7
147609|NCT01660672|359187|P1|STARTED|Overall Study||7
147610|NCT01660451|359201|P3|NOT COMPLETED|Overall Study||105
147611|NCT01660451|359202|P2|NOT COMPLETED|Overall Study||17
147612|NCT01660451|359203|P1|NOT COMPLETED|Overall Study||17
147613|NCT01660451|359201|P3|COMPLETED|Overall Study||37
147614|NCT01660451|359202|P2|COMPLETED|Overall Study||34
147615|NCT01660451|359203|P1|COMPLETED|Overall Study||16
147616|NCT01660451|359201|P3|STARTED|Overall Study||142
147617|NCT01660451|359202|P2|STARTED|Overall Study||51
147618|NCT01660451|359203|P1|STARTED|Overall Study||33
147619|NCT01660412|359231|P2|NOT COMPLETED|Overall Study||3
147620|NCT01660412|359232|P1|NOT COMPLETED|Overall Study||0
147621|NCT01660412|359231|P2|COMPLETED|Overall Study||28
147622|NCT01660412|359232|P1|COMPLETED|Overall Study||29
147623|NCT01660412|359231|P2|Injection 4|Overall Study||31
147624|NCT01660412|359232|P1|Injection 4|Overall Study||29
147625|NCT01660412|359231|P2|Injection 3|Overall Study||31
147626|NCT01660412|359232|P1|Injection 3|Overall Study||29
147627|NCT01660412|359231|P2|Injection 2|Overall Study||31
147628|NCT01660412|359232|P1|Injection 2|Overall Study||29
147629|NCT01660412|359231|P2|Injection 1|Overall Study||31
147630|NCT01660412|359232|P1|Injection 1|Overall Study||29
147631|NCT01660412|359231|P2|Other|Overall Study||4
147632|NCT01660412|359232|P1|Other|Overall Study||2
147633|NCT01660412|359231|P2|Appendicular Structures|Overall Study||11
147634|NCT01660412|359232|P1|Appendicular Structures|Overall Study||17
147635|NCT01660412|359231|P2|Thorax|Overall Study||9
147636|NCT01660412|359232|P1|Thorax|Overall Study||9
147637|NCT01660412|359231|P2|Head|Overall Study||4
147638|NCT01660412|359232|P1|Head|Overall Study||1
147639|NCT01660412|359231|P2|STARTED|Overall Study||31
147640|NCT01660412|359232|P1|STARTED|Overall Study||29
147641|NCT01660334|359238|P1|NOT COMPLETED|Overall Study||1
147642|NCT01660334|359238|P1|COMPLETED|Overall Study||12
147643|NCT01660334|359238|P1|STARTED|Overall Study||13
147644|NCT01660321|359243|P1|NOT COMPLETED|Overall Study||0
147645|NCT01660321|359243|P1|COMPLETED|Overall Study||26
147646|NCT01660321|359243|P1|STARTED|Overall Study||26
147647|NCT01660230|359267|P12|NOT COMPLETED|Overall Study||0
147648|NCT01660230|359268|P11|NOT COMPLETED|Overall Study||0
147649|NCT01660230|359269|P10|NOT COMPLETED|Overall Study||0
147650|NCT01660230|359270|P9|NOT COMPLETED|Overall Study||0
147651|NCT01660230|359271|P8|NOT COMPLETED|Overall Study||0
147652|NCT01660230|359272|P7|NOT COMPLETED|Overall Study||0
147653|NCT01660230|359273|P6|NOT COMPLETED|Overall Study||0
147654|NCT01660230|359274|P5|NOT COMPLETED|Overall Study||0
147655|NCT01660230|359275|P4|NOT COMPLETED|Overall Study||0
147656|NCT01660230|359276|P3|NOT COMPLETED|Overall Study||0
147657|NCT01660230|359277|P2|NOT COMPLETED|Overall Study||0
147658|NCT01660230|359278|P1|NOT COMPLETED|Overall Study||0
147659|NCT01660230|359267|P12|COMPLETED|Overall Study||14
147660|NCT01660230|359268|P11|COMPLETED|Overall Study||6
147661|NCT01660230|359269|P10|COMPLETED|Overall Study||6
147662|NCT01660230|359270|P9|COMPLETED|Overall Study||6
147663|NCT01660230|359271|P8|COMPLETED|Overall Study||6
147664|NCT01660230|359272|P7|COMPLETED|Overall Study||4
147665|NCT01660230|359273|P6|COMPLETED|Overall Study||2
147666|NCT01660230|359274|P5|COMPLETED|Overall Study||4
147667|NCT01660230|359275|P4|COMPLETED|Overall Study||4
147668|NCT01660230|359276|P3|COMPLETED|Overall Study||4
147669|NCT01660230|359277|P2|COMPLETED|Overall Study||4
147670|NCT01660230|359278|P1|COMPLETED|Overall Study||4
147671|NCT01660230|359267|P12|STARTED|Overall Study||14
147672|NCT01660230|359268|P11|STARTED|Overall Study||6
147673|NCT01660230|359269|P10|STARTED|Overall Study||6
147674|NCT01660230|359270|P9|STARTED|Overall Study||6
147675|NCT01660230|359271|P8|STARTED|Overall Study||6
147676|NCT01660230|359272|P7|STARTED|Overall Study||4
147677|NCT01660230|359273|P6|STARTED|Overall Study||2
147678|NCT01660230|359274|P5|STARTED|Overall Study||4
147679|NCT01660230|359275|P4|STARTED|Overall Study||4
147680|NCT01660230|359276|P3|STARTED|Overall Study||4
147681|NCT01660230|359277|P2|STARTED|Overall Study||4
147682|NCT01660230|359278|P1|STARTED|Overall Study||4
147683|NCT01660191|359450|P3|NOT COMPLETED|End of Treatment||1
147684|NCT01660191|359451|P2|NOT COMPLETED|End of Treatment||6
147685|NCT01660191|359452|P1|NOT COMPLETED|End of Treatment||1
147686|NCT01660191|359450|P3|COMPLETED|End of Treatment||43
147687|NCT01660191|359451|P2|COMPLETED|End of Treatment||39
147688|NCT01660191|359452|P1|COMPLETED|End of Treatment||44
147689|NCT01660191|359450|P3|STARTED|End of Treatment||44
147690|NCT01660191|359451|P2|STARTED|End of Treatment||45
147691|NCT01660191|359452|P1|STARTED|End of Treatment||45
147692|NCT01660191|359450|P3|NOT COMPLETED|Randomization||0
147693|NCT01660191|359451|P2|NOT COMPLETED|Randomization||0
147694|NCT01660191|359452|P1|NOT COMPLETED|Randomization||0
147695|NCT01660191|359450|P3|COMPLETED|Randomization||44
147696|NCT01660191|359451|P2|COMPLETED|Randomization||45
147697|NCT01660191|359452|P1|COMPLETED|Randomization||45
147698|NCT01660191|359450|P3|STARTED|Randomization||44
147699|NCT01660191|359451|P2|STARTED|Randomization||45
147700|NCT01660191|359452|P1|STARTED|Randomization||45
147701|NCT01660191|359450|P3|NOT COMPLETED|Enrollment and Washout||0
147702|NCT01660191|359451|P2|NOT COMPLETED|Enrollment and Washout||0
147703|NCT01660191|359452|P1|NOT COMPLETED|Enrollment and Washout||0
147704|NCT01660191|359450|P3|COMPLETED|Enrollment and Washout||44
147705|NCT01660191|359451|P2|COMPLETED|Enrollment and Washout||45
147706|NCT01660191|359452|P1|COMPLETED|Enrollment and Washout||45
147707|NCT01660191|359450|P3|STARTED|Enrollment and Washout||44
147708|NCT01660191|359451|P2|STARTED|Enrollment and Washout||45
147709|NCT01660191|359452|P1|STARTED|Enrollment and Washout||45
147710|NCT01660022|359481|P6|NOT COMPLETED|Second Sequence (42 Days)||0
147711|NCT01660022|359482|P5|NOT COMPLETED|Second Sequence (42 Days)||0
147712|NCT01660022|359483|P4|NOT COMPLETED|Second Sequence (42 Days)||0
147713|NCT01660022|359484|P3|NOT COMPLETED|Second Sequence (42 Days)||0
147714|NCT01660022|359485|P2|NOT COMPLETED|Second Sequence (42 Days)||0
147715|NCT01660022|359486|P1|NOT COMPLETED|Second Sequence (42 Days)||0
147716|NCT01660022|359481|P6|COMPLETED|Second Sequence (42 Days)||16
147717|NCT01660022|359482|P5|COMPLETED|Second Sequence (42 Days)||6
147718|NCT01660022|359483|P4|COMPLETED|Second Sequence (42 Days)||7
147719|NCT01660022|359484|P3|COMPLETED|Second Sequence (42 Days)||8
147720|NCT01660022|359485|P2|COMPLETED|Second Sequence (42 Days)||7
147721|NCT01660022|359486|P1|COMPLETED|Second Sequence (42 Days)||8
147722|NCT01660022|359481|P6|STARTED|Second Sequence (42 Days)||16
147723|NCT01660022|359482|P5|STARTED|Second Sequence (42 Days)||6
147724|NCT01660022|359483|P4|STARTED|Second Sequence (42 Days)||7
147725|NCT01660022|359484|P3|STARTED|Second Sequence (42 Days)||8
147726|NCT01660022|359485|P2|STARTED|Second Sequence (42 Days)||7
147727|NCT01660022|359486|P1|STARTED|Second Sequence (42 Days)||8
147728|NCT01660022|359481|P6|NOT COMPLETED|First Sequence (7 Days)||4
147729|NCT01660022|359482|P5|NOT COMPLETED|First Sequence (7 Days)||1
147730|NCT01660022|359483|P4|NOT COMPLETED|First Sequence (7 Days)||1
147731|NCT01660022|359484|P3|NOT COMPLETED|First Sequence (7 Days)||0
147732|NCT01660022|359485|P2|NOT COMPLETED|First Sequence (7 Days)||1
147733|NCT01660022|359486|P1|NOT COMPLETED|First Sequence (7 Days)||0
147734|NCT01660022|359481|P6|COMPLETED|First Sequence (7 Days)||16
147735|NCT01660022|359482|P5|COMPLETED|First Sequence (7 Days)||6
147736|NCT01660022|359483|P4|COMPLETED|First Sequence (7 Days)||7
147737|NCT01660022|359484|P3|COMPLETED|First Sequence (7 Days)||8
147738|NCT01660022|359485|P2|COMPLETED|First Sequence (7 Days)||7
147739|NCT01660022|359486|P1|COMPLETED|First Sequence (7 Days)||8
147740|NCT01660022|359481|P6|STARTED|First Sequence (7 Days)||20
147741|NCT01660022|359482|P5|STARTED|First Sequence (7 Days)||7
147742|NCT01660022|359483|P4|STARTED|First Sequence (7 Days)||8
147743|NCT01660022|359484|P3|STARTED|First Sequence (7 Days)||8
147744|NCT01660022|359485|P2|STARTED|First Sequence (7 Days)||8
147745|NCT01660022|359486|P1|STARTED|First Sequence (7 Days)||8
147746|NCT01659996|359545|P3|NOT COMPLETED|Overall Study||11
147747|NCT01659996|359546|P2|NOT COMPLETED|Overall Study||7
147748|NCT01659996|359547|P1|NOT COMPLETED|Overall Study||8
147749|NCT01659996|359545|P3|COMPLETED|Overall Study||461
147750|NCT01659996|359546|P2|COMPLETED|Overall Study||388
147751|NCT01659996|359547|P1|COMPLETED|Overall Study||413
147752|NCT01659996|359545|P3|STARTED|Overall Study||472
147753|NCT01659996|359546|P2|STARTED|Overall Study||395
147754|NCT01659996|359547|P1|STARTED|Overall Study||421
147755|NCT01659866|359581|P2|NOT COMPLETED|Overall Study||0
147756|NCT01659866|359582|P1|NOT COMPLETED|Overall Study||0
147757|NCT01659866|359581|P2|COMPLETED|Overall Study||80
147758|NCT01659866|359582|P1|COMPLETED|Overall Study||430
147759|NCT01659866|359581|P2|STARTED|Overall Study||80
147760|NCT01659866|359582|P1|STARTED|Overall Study||430
147761|NCT01659853|359588|P2|NOT COMPLETED|Treatment Period 2||0
147762|NCT01659853|359589|P1|NOT COMPLETED|Treatment Period 2||0
147763|NCT01659853|359588|P2|COMPLETED|Treatment Period 2||35
147764|NCT01659853|359589|P1|COMPLETED|Treatment Period 2||33
147765|NCT01659853|359588|P2|STARTED|Treatment Period 2||35
147766|NCT01659853|359589|P1|STARTED|Treatment Period 2||33
147767|NCT01659853|359588|P2|NOT COMPLETED|Washout , 3 to 7 Days||0
147768|NCT01659853|359589|P1|NOT COMPLETED|Washout , 3 to 7 Days||2
147769|NCT01659853|359588|P2|COMPLETED|Washout , 3 to 7 Days||35
147770|NCT01659853|359589|P1|COMPLETED|Washout , 3 to 7 Days||33
147771|NCT01659853|359588|P2|STARTED|Washout , 3 to 7 Days||35
147772|NCT01659853|359589|P1|STARTED|Washout , 3 to 7 Days||35
147773|NCT01659853|359588|P2|NOT COMPLETED|Treatment Period 1||0
147774|NCT01659853|359589|P1|NOT COMPLETED|Treatment Period 1||0
147775|NCT01659853|359588|P2|COMPLETED|Treatment Period 1||35
147776|NCT01659853|359589|P1|COMPLETED|Treatment Period 1||35
147777|NCT01659853|359588|P2|STARTED|Treatment Period 1||35
147778|NCT01659853|359589|P1|STARTED|Treatment Period 1||35
147779|NCT01659736|359599|P2|NOT COMPLETED|3-month Follow-up||1
147780|NCT01659736|359600|P1|NOT COMPLETED|3-month Follow-up||0
147781|NCT01659736|359599|P2|COMPLETED|3-month Follow-up||9
147782|NCT01659736|359600|P1|COMPLETED|3-month Follow-up||9
147783|NCT01659736|359599|P2|STARTED|3-month Follow-up||10
147784|NCT01659736|359600|P1|STARTED|3-month Follow-up||9
147785|NCT01659736|359599|P2|NOT COMPLETED|Treatment Period||2
147786|NCT01659736|359600|P1|NOT COMPLETED|Treatment Period||5
147787|NCT01659736|359599|P2|COMPLETED|Treatment Period||10
147788|NCT01659736|359600|P1|COMPLETED|Treatment Period|n = 10, but data from one completer was excluded from all analyses due to protocol violation.|9
147789|NCT01659736|359599|P2|STARTED|Treatment Period||12
147790|NCT01659736|359600|P1|STARTED|Treatment Period||14
147791|NCT01659567|359614|P1|NOT COMPLETED|Overall Study||123
147792|NCT01659567|359614|P1|COMPLETED|Overall Study||393
147793|NCT01659567|359614|P1|STARTED|Overall Study||516
147794|NCT01659554|359631|P1|NOT COMPLETED|Overall Study||4
147795|NCT01659554|359631|P1|COMPLETED|Overall Study||0
147796|NCT01659554|359631|P1|STARTED|Overall Study|4 subjects enrolled; 4 subjects treated and 4 did not complete protocol schema|4
147797|NCT01659320|359638|P1|NOT COMPLETED|Overall Study||3
147798|NCT01659320|359638|P1|COMPLETED|Overall Study||13
147799|NCT01659320|359638|P1|STARTED|Overall Study||16
147800|NCT01659268|359644|P2|NOT COMPLETED|Overall Study||0
147801|NCT01659268|359645|P1|NOT COMPLETED|Overall Study||0
147802|NCT01659268|359644|P2|COMPLETED|Overall Study||8
147803|NCT01659268|359645|P1|COMPLETED|Overall Study||9
147804|NCT01659268|359644|P2|STARTED|Overall Study||8
147805|NCT01659268|359645|P1|STARTED|Overall Study||9
147806|NCT01659125|359657|P1|NOT COMPLETED|Overall Study||14
147807|NCT01659125|359657|P1|COMPLETED|Overall Study||12
147808|NCT01659125|359657|P1|Completed 6-month Follow-up|Overall Study||12
147809|NCT01659125|359657|P1|Completed 3-month Follow-up|Overall Study||16
147810|NCT01659125|359657|P1|Completed the Posttreatment Assessment|Overall Study||17
147811|NCT01659125|359657|P1|Initiated Treatment|Overall Study||24
147812|NCT01659125|359657|P1|STARTED|Overall Study||26
147813|NCT01659021|359664|P2|NOT COMPLETED|Long-Term Follow Up||4
147814|NCT01659021|359665|P1|NOT COMPLETED|Long-Term Follow Up||5
147815|NCT01659021|359664|P2|COMPLETED|Long-Term Follow Up||65
147816|NCT01659021|359665|P1|COMPLETED|Long-Term Follow Up||133
147817|NCT01659021|359664|P2|STARTED|Long-Term Follow Up|Participants did not have to complete the main study to enter the Long-Term Follow Up period.|69
147818|NCT01659021|359665|P1|STARTED|Long-Term Follow Up|Participants did not have to complete the main study to enter the Long-Term Follow Up period.|138
147819|NCT01659021|359664|P2|NOT COMPLETED|Main Study||37
147820|NCT01659021|359665|P1|NOT COMPLETED|Main Study||74
147821|NCT01659021|359664|P2|COMPLETED|Main Study||50
147822|NCT01659021|359665|P1|COMPLETED|Main Study||100
147823|NCT01659021|359664|P2|Randomized and Treated|Main Study||86
147824|NCT01659021|359665|P1|Randomized and Treated|Main Study||173
147825|NCT01659021|359664|P2|STARTED|Main Study||87
147826|NCT01659021|359665|P1|STARTED|Main Study||174
147827|NCT01658943|359683|P2|NOT COMPLETED|Overall Study||67
147828|NCT01658943|359684|P1|NOT COMPLETED|Overall Study||70
147829|NCT01658943|359683|P2|COMPLETED|Overall Study||0
147830|NCT01658943|359684|P1|COMPLETED|Overall Study||0
147831|NCT01658943|359683|P2|Eligible and Began Protocol Therapy|Overall Study||58
147832|NCT01658943|359684|P1|Eligible and Began Protocol Therapy|Overall Study||62
147833|NCT01658943|359683|P2|Eligible|Overall Study||58
147834|NCT01658943|359684|P1|Eligible|Overall Study||63
147835|NCT01658943|359683|P2|STARTED|Overall Study||67
147836|NCT01658943|359684|P1|STARTED|Overall Study||70
147837|NCT01658904|359699|P3|NOT COMPLETED|Overall Study||0
147838|NCT01658904|359700|P2|NOT COMPLETED|Overall Study||0
147839|NCT01658904|359701|P1|NOT COMPLETED|Overall Study||2
147840|NCT01658904|359699|P3|COMPLETED|Overall Study||0
147841|NCT01658904|359700|P2|COMPLETED|Overall Study||0
147842|NCT01658904|359701|P1|COMPLETED|Overall Study||1
147843|NCT01658904|359699|P3|STARTED|Overall Study||0
147844|NCT01658904|359700|P2|STARTED|Overall Study||0
147845|NCT01658904|359701|P1|STARTED|Overall Study||3
147846|NCT01658839|359718|P1|NOT COMPLETED|Overall Study||0
147847|NCT01658839|359718|P1|COMPLETED|Overall Study||25
147848|NCT01658839|359718|P1|STARTED|Overall Study||25
147849|NCT01658813|359727|P1|NOT COMPLETED|Overall Study||3
147850|NCT01658813|359727|P1|COMPLETED|Overall Study||15
147851|NCT01658813|359727|P1|Treated|Overall Study||18
147852|NCT01658813|359727|P1|Eligible|Overall Study||18
147853|NCT01658813|359727|P1|STARTED|Overall Study||18
147854|NCT01658735|359738|P3|NOT COMPLETED|Overall Study||4
147855|NCT01658735|359739|P2|NOT COMPLETED|Overall Study||7
147856|NCT01658735|359740|P1|NOT COMPLETED|Overall Study||5
147857|NCT01658735|359738|P3|COMPLETED|Overall Study||34
147858|NCT01658735|359739|P2|COMPLETED|Overall Study||29
147859|NCT01658735|359740|P1|COMPLETED|Overall Study||34
147860|NCT01658735|359738|P3|STARTED|Overall Study||38
147861|NCT01658735|359739|P2|STARTED|Overall Study||36
147862|NCT01658735|359740|P1|STARTED|Overall Study||39
147863|NCT01658657|359771|P2|NOT COMPLETED|Overall Study||3
147864|NCT01658657|359772|P1|NOT COMPLETED|Overall Study||3
147865|NCT01658657|359771|P2|COMPLETED|Overall Study||7
147866|NCT01658657|359772|P1|COMPLETED|Overall Study||4
147867|NCT01658657|359771|P2|STARTED|Overall Study||10
147868|NCT01658657|359772|P1|STARTED|Overall Study||7
147869|NCT01658579|359782|P4|NOT COMPLETED|Treatment Period B||1
147870|NCT01658579|359783|P3|NOT COMPLETED|Treatment Period B||0
147871|NCT01658579|359784|P2|NOT COMPLETED|Treatment Period B||0
147872|NCT01658579|359785|P1|NOT COMPLETED|Treatment Period B||0
147873|NCT01658579|359782|P4|COMPLETED|Treatment Period B||12
147874|NCT01658579|359783|P3|COMPLETED|Treatment Period B||14
147875|NCT01658579|359784|P2|COMPLETED|Treatment Period B||15
147876|NCT01658579|359785|P1|COMPLETED|Treatment Period B||14
147877|NCT01658579|359782|P4|STARTED|Treatment Period B||13
147878|NCT01658579|359783|P3|STARTED|Treatment Period B||14
147879|NCT01658579|359784|P2|STARTED|Treatment Period B||15
147880|NCT01658579|359785|P1|STARTED|Treatment Period B||14
147881|NCT01658579|359782|P4|NOT COMPLETED|Treatment Period A||1
147882|NCT01658579|359783|P3|NOT COMPLETED|Treatment Period A||1
147883|NCT01658579|359784|P2|NOT COMPLETED|Treatment Period A||0
147884|NCT01658579|359785|P1|NOT COMPLETED|Treatment Period A||1
147885|NCT01658579|359782|P4|COMPLETED|Treatment Period A||13
147886|NCT01658579|359783|P3|COMPLETED|Treatment Period A||14
147887|NCT01658579|359784|P2|COMPLETED|Treatment Period A||15
147888|NCT01658579|359785|P1|COMPLETED|Treatment Period A||14
147889|NCT01658579|359782|P4|STARTED|Treatment Period A||14
147890|NCT01658579|359783|P3|STARTED|Treatment Period A||15
147891|NCT01658579|359784|P2|STARTED|Treatment Period A||15
147892|NCT01658579|359785|P1|STARTED|Treatment Period A||15
147893|NCT01658514|359813|P3|NOT COMPLETED|Overall Study||2
147894|NCT01658514|359814|P2|NOT COMPLETED|Overall Study||0
147895|NCT01658514|359815|P1|NOT COMPLETED|Overall Study||1
147896|NCT01658514|359813|P3|COMPLETED|Overall Study||12
147897|NCT01658514|359814|P2|COMPLETED|Overall Study||11
147898|NCT01658514|359815|P1|COMPLETED|Overall Study||13
147899|NCT01658514|359813|P3|Completed - Severe RI Cohort Only|Overall Study||3
147900|NCT01658514|359814|P2|Completed - Severe RI Cohort Only|Overall Study||2
147901|NCT01658514|359815|P1|Completed - Severe RI Cohort Only|Overall Study||3
147902|NCT01658514|359813|P3|Started - Severe RI Cohort Only|Overall Study||3
147903|NCT01658514|359814|P2|Started - Severe RI Cohort Only|Overall Study||2
147904|NCT01658514|359815|P1|Started - Severe RI Cohort Only|Overall Study||3
147905|NCT01658514|359813|P3|Completed - Moderate RI Cohort Only|Overall Study||2
147906|NCT01658514|359814|P2|Completed - Moderate RI Cohort Only|Overall Study||4
147907|NCT01658514|359815|P1|Completed - Moderate RI Cohort Only|Overall Study||3
147908|NCT01658514|359813|P3|Started - Moderate RI Cohort Only|Overall Study||4
147909|NCT01658514|359814|P2|Started - Moderate RI Cohort Only|Overall Study||4
147910|NCT01658514|359815|P1|Started - Moderate RI Cohort Only|Overall Study||4
147911|NCT01658514|359813|P3|Completed - Mild RI Cohort Only|Overall Study||4
147912|NCT01658514|359814|P2|Completed - Mild RI Cohort Only|Overall Study||3
147913|NCT01658514|359815|P1|Completed - Mild RI Cohort Only|Overall Study||4
147914|NCT01658514|359813|P3|Started - Mild RI Cohort Only|Overall Study||4
147915|NCT01658514|359814|P2|Started - Mild RI Cohort Only|Overall Study||3
147916|NCT01658514|359815|P1|Started - Mild RI Cohort Only|Overall Study||4
147917|NCT01658514|359813|P3|Completed - Normal RF Cohort Only|Overall Study||3
147918|NCT01658514|359814|P2|Completed - Normal RF Cohort Only|Overall Study||2
147919|NCT01658514|359815|P1|Completed - Normal RF Cohort Only|Overall Study||3
147920|NCT01658514|359813|P3|Started - Normal RF Cohort Only|Overall Study||3
147921|NCT01658514|359814|P2|Started - Normal RF Cohort Only|Overall Study||2
147922|NCT01658514|359815|P1|Started - Normal RF Cohort Only|Overall Study||3
147923|NCT01658514|359813|P3|Completed Treatment C|Overall Study||12
147924|NCT01658514|359814|P2|Completed Treatment C|Overall Study||11
147925|NCT01658514|359815|P1|Completed Treatment C|Overall Study||13
147926|NCT01658514|359813|P3|Completed Treatment B|Overall Study||14
147927|NCT01658514|359814|P2|Completed Treatment B|Overall Study||11
147928|NCT01658514|359815|P1|Completed Treatment B|Overall Study||13
147929|NCT01658514|359813|P3|Completed Treatment A|Overall Study||12
147930|NCT01658514|359814|P2|Completed Treatment A|Overall Study||11
147931|NCT01658514|359815|P1|Completed Treatment A|Overall Study||14
147932|NCT01658514|359813|P3|STARTED|Overall Study||14
147933|NCT01658514|359814|P2|STARTED|Overall Study||11
147934|NCT01658514|359815|P1|STARTED|Overall Study||14
147935|NCT01658436|359826|P2|NOT COMPLETED|Overall Study||11
147936|NCT01658436|359827|P1|NOT COMPLETED|Overall Study||20
147937|NCT01658436|359826|P2|COMPLETED|Overall Study||0
147938|NCT01658436|359827|P1|COMPLETED|Overall Study||0
147939|NCT01658436|359826|P2|STARTED|Overall Study||11
147940|NCT01658436|359827|P1|STARTED|Overall Study||20
147941|NCT01658228|359836|P2|NOT COMPLETED|Overall Study||8
147942|NCT01658228|359837|P1|NOT COMPLETED|Overall Study||7
147943|NCT01658228|359836|P2|COMPLETED|Overall Study||23
147944|NCT01658228|359837|P1|COMPLETED|Overall Study||23
147945|NCT01658228|359836|P2|STARTED|Overall Study||31
147946|NCT01658228|359837|P1|STARTED|Overall Study||30
147947|NCT01658150|359847|P1|NOT COMPLETED|Overall Study||1
147948|NCT01658150|359847|P1|COMPLETED|Overall Study||10
147949|NCT01658150|359847|P1|STARTED|Overall Study||11
147950|NCT01658072|359869|P2|NOT COMPLETED|Overall Study||2
147951|NCT01658072|359870|P1|NOT COMPLETED|Overall Study||4
147952|NCT01658072|359869|P2|COMPLETED|Overall Study||43
147953|NCT01658072|359870|P1|COMPLETED|Overall Study||41
147954|NCT01658072|359869|P2|STARTED|Overall Study||45
147955|NCT01658072|359870|P1|STARTED|Overall Study||45
147956|NCT01658059|359876|P2|NOT COMPLETED|Second Intervention- 2 Days||0
147957|NCT01658059|359877|P1|NOT COMPLETED|Second Intervention- 2 Days||0
147958|NCT01658059|359876|P2|COMPLETED|Second Intervention- 2 Days||5
147959|NCT01658059|359877|P1|COMPLETED|Second Intervention- 2 Days||6
147960|NCT01658059|359876|P2|STARTED|Second Intervention- 2 Days||5
147961|NCT01658059|359877|P1|STARTED|Second Intervention- 2 Days||6
147962|NCT01658059|359876|P2|NOT COMPLETED|Washout Period- 14 Days||0
147963|NCT01658059|359877|P1|NOT COMPLETED|Washout Period- 14 Days||0
147964|NCT01658059|359876|P2|COMPLETED|Washout Period- 14 Days||5
147965|NCT01658059|359877|P1|COMPLETED|Washout Period- 14 Days||6
147966|NCT01658059|359876|P2|STARTED|Washout Period- 14 Days||5
147967|NCT01658059|359877|P1|STARTED|Washout Period- 14 Days||6
147968|NCT01658059|359876|P2|NOT COMPLETED|First Intervention- 2 Days||5
147969|NCT01658059|359877|P1|NOT COMPLETED|First Intervention- 2 Days||6
147970|NCT01658059|359876|P2|COMPLETED|First Intervention- 2 Days||5
147971|NCT01658059|359877|P1|COMPLETED|First Intervention- 2 Days||6
147972|NCT01658059|359876|P2|STARTED|First Intervention- 2 Days||10
147973|NCT01658059|359877|P1|STARTED|First Intervention- 2 Days||12
147974|NCT01658020|359885|P2|NOT COMPLETED|Overall Study||9
147975|NCT01658020|359886|P1|NOT COMPLETED|Overall Study||8
147976|NCT01658020|359885|P2|COMPLETED|Overall Study||158
147977|NCT01658020|359886|P1|COMPLETED|Overall Study||167
147978|NCT01658020|359885|P2|STARTED|Overall Study||167
147979|NCT01658020|359886|P1|STARTED|Overall Study||175
147980|NCT01657903|359902|P1|NOT COMPLETED|Overall Study||2
147981|NCT01657903|359902|P1|COMPLETED|Overall Study||54
147982|NCT01657903|359902|P1|Received NaF/KNO3 Toothpaste 2|Overall Study||55
147983|NCT01657903|359902|P1|Received NaF/KNO3 Toothpaste 3|Overall Study||54
147984|NCT01657903|359902|P1|Received NaF/KNO3 Toothpaste 1|Overall Study|One participant withdrew consent in study period 3|55
147985|NCT01657903|359902|P1|Received Placebo (No NaF/KNO3)Toothpaste|Overall Study|One participant was lost to follow up in study period 1|56
147986|NCT01657903|359902|P1|STARTED|Overall Study||56
147987|NCT01657877|359924|P1|NOT COMPLETED|Overall Study||14
147988|NCT01657877|359924|P1|COMPLETED|Overall Study||65
147989|NCT01657877|359924|P1|Received 1500ppm Fluoride as SMFP+0% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and 1 withdrawal of consent and AE in P3|71
147990|NCT01657877|359924|P1|Received 0ppm Fluoride+ 0% CSP|Overall Study|Discontinuation: 1 in P4 due to other reasons|69
147991|NCT01657877|359924|P1|Received 0ppm Fluoride+ 5% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and P2 each and 1 withdrawal of consent in P1.|71
147992|NCT01657877|359924|P1|Received 1500ppm Fluoride as SMFP+5% CSP|Overall Study|Discontinuations:2 withdrawal of consent in period (P) 1; 1 AE in P2;1 protocol violation in P3 & P4|75
147993|NCT01657877|359924|P1|Received 500ppm Fluoride as SMFP+ 0% CSP|Overall Study|Discontinuations: 1 due to other reason in P2 and 1 protocol violation in P4|70
147994|NCT01657877|359924|P1|STARTED|Overall Study||79
147995|NCT01657799|359944|P3|NOT COMPLETED|Overall Study||102
147996|NCT01657799|359945|P2|NOT COMPLETED|Overall Study||103
147997|NCT01657799|359946|P1|NOT COMPLETED|Overall Study||102
147998|NCT01657799|359944|P3|COMPLETED|Overall Study||0
147999|NCT01657799|359945|P2|COMPLETED|Overall Study||0
148000|NCT01657799|359946|P1|COMPLETED|Overall Study||0
148001|NCT01657799|359944|P3|Received Treatment|Overall Study||102
148002|NCT01657799|359945|P2|Received Treatment|Overall Study||103
148003|NCT01657799|359946|P1|Received Treatment|Overall Study||101
148004|NCT01657799|359944|P3|STARTED|Overall Study||102
148005|NCT01657799|359945|P2|STARTED|Overall Study||103
148006|NCT01657799|359946|P1|STARTED|Overall Study||102
148007|NCT01657760|359965|P4|NOT COMPLETED|Overall Study||3
148008|NCT01657760|359966|P3|NOT COMPLETED|Overall Study||1
148009|NCT01657760|359967|P2|NOT COMPLETED|Overall Study||1
148010|NCT01657760|359968|P1|NOT COMPLETED|Overall Study||1
148011|NCT01657760|359965|P4|COMPLETED|Overall Study||4
148012|NCT01657760|359966|P3|COMPLETED|Overall Study||6
148013|NCT01657760|359967|P2|COMPLETED|Overall Study||6
148014|NCT01657760|359968|P1|COMPLETED|Overall Study||4
148015|NCT01657760|359965|P4|STARTED|Overall Study||7
148016|NCT01657760|359966|P3|STARTED|Overall Study||7
148017|NCT01657760|359967|P2|STARTED|Overall Study||7
148018|NCT01657760|359968|P1|STARTED|Overall Study||5
148019|NCT01657617|359980|P1|NOT COMPLETED|Overall Study||0
148020|NCT01657617|359980|P1|COMPLETED|Overall Study||35
148021|NCT01657617|359980|P1|STARTED|Overall Study||35
148022|NCT01657461|359987|P2|NOT COMPLETED|Overall Study||20
148023|NCT01657461|359988|P1|NOT COMPLETED|Overall Study||10
148024|NCT01657461|359987|P2|COMPLETED|Overall Study||78
148025|NCT01657461|359988|P1|COMPLETED|Overall Study||88
148026|NCT01657461|359987|P2|STARTED|Overall Study||98
148027|NCT01657461|359988|P1|STARTED|Overall Study||98
148028|NCT01657370|360018|P6|NOT COMPLETED|Overall Study||4
148029|NCT01657370|360019|P5|NOT COMPLETED|Overall Study||7
148030|NCT01657370|360020|P4|NOT COMPLETED|Overall Study||5
148031|NCT01657370|360021|P3|NOT COMPLETED|Overall Study||7
148032|NCT01657370|360022|P2|NOT COMPLETED|Overall Study||4
148033|NCT01657370|360023|P1|NOT COMPLETED|Overall Study||6
148034|NCT01657370|360018|P6|COMPLETED|Overall Study||27
148035|NCT01657370|360019|P5|COMPLETED|Overall Study||27
148036|NCT01657370|360020|P4|COMPLETED|Overall Study||28
148037|NCT01657370|360021|P3|COMPLETED|Overall Study||25
148038|NCT01657370|360022|P2|COMPLETED|Overall Study||28
148039|NCT01657370|360023|P1|COMPLETED|Overall Study||27
148040|NCT01657370|360018|P6|STARTED|Overall Study||31
148041|NCT01657370|360019|P5|STARTED|Overall Study||34
148042|NCT01657370|360020|P4|STARTED|Overall Study||33
148043|NCT01657370|360021|P3|STARTED|Overall Study||32
148044|NCT01657370|360022|P2|STARTED|Overall Study||32
148045|NCT01657370|360023|P1|STARTED|Overall Study||33
148046|NCT01657344|360105|P7|NOT COMPLETED|Overall Study||0
148047|NCT01657344|360106|P6|NOT COMPLETED|Overall Study||0
148048|NCT01657344|360107|P5|NOT COMPLETED|Overall Study||0
148049|NCT01657344|360108|P4|NOT COMPLETED|Overall Study||0
148050|NCT01657344|360109|P3|NOT COMPLETED|Overall Study||0
148051|NCT01657344|360110|P2|NOT COMPLETED|Overall Study||0
148052|NCT01657344|360111|P1|NOT COMPLETED|Overall Study||0
148053|NCT01657344|360105|P7|COMPLETED|Overall Study||140776
148054|NCT01657344|360106|P6|COMPLETED|Overall Study||316477
148055|NCT01657344|360107|P5|COMPLETED|Overall Study||157802
148056|NCT01657344|360108|P4|COMPLETED|Overall Study||376517
148057|NCT01657344|360109|P3|COMPLETED|Overall Study||196300
148058|NCT01657344|360110|P2|COMPLETED|Overall Study||409967
148059|NCT01657344|360111|P1|COMPLETED|Overall Study||421622
148060|NCT01657344|360105|P7|STARTED|Overall Study||140776
148061|NCT01657344|360106|P6|STARTED|Overall Study||316477
148062|NCT01657344|360107|P5|STARTED|Overall Study||157802
148063|NCT01657344|360108|P4|STARTED|Overall Study||376517
148064|NCT01657344|360109|P3|STARTED|Overall Study||196300
148065|NCT01657344|360110|P2|STARTED|Overall Study||409967
148066|NCT01657344|360111|P1|STARTED|Overall Study||421622
148067|NCT01657305|360121|P1|NOT COMPLETED|Overall Study||25
148068|NCT01657305|360121|P1|COMPLETED|Overall Study||82
148069|NCT01657305|360121|P1|STARTED|Overall Study||107
148070|NCT01657292|360171|P1|NOT COMPLETED|Overall Study||10
148071|NCT01657292|360171|P1|COMPLETED|Overall Study||51
148072|NCT01657292|360171|P1|STARTED|Overall Study||61
148073|NCT01657266|360180|P2|NOT COMPLETED|Overall Study||5
148074|NCT01657266|360181|P1|NOT COMPLETED|Overall Study||4
148075|NCT01657266|360180|P2|COMPLETED|Overall Study||70
148076|NCT01657266|360181|P1|COMPLETED|Overall Study||69
148077|NCT01657266|360180|P2|STARTED|Overall Study||75
148078|NCT01657266|360181|P1|STARTED|Overall Study||73
148079|NCT01657253|360203|P2|NOT COMPLETED|Overall Study||18
148080|NCT01657253|360204|P1|NOT COMPLETED|Overall Study||17
148081|NCT01657253|360203|P2|COMPLETED|Overall Study||72
148082|NCT01657253|360204|P1|COMPLETED|Overall Study||76
148083|NCT01657253|360203|P2|STARTED|Overall Study||90
148084|NCT01657253|360204|P1|STARTED|Overall Study||93
148085|NCT01657032|360216|P2|NOT COMPLETED|Overall Study||7
148086|NCT01657032|360217|P1|NOT COMPLETED|Overall Study||0
148087|NCT01657032|360216|P2|COMPLETED|Overall Study||37
148088|NCT01657032|360217|P1|COMPLETED|Overall Study||44
148089|NCT01657032|360216|P2|STARTED|Overall Study||44
148090|NCT01657032|360217|P1|STARTED|Overall Study||44
148091|NCT01657019|360243|P1|NOT COMPLETED|Overall Study||235
148092|NCT01657019|360243|P1|COMPLETED|Overall Study||369
148093|NCT01657019|360243|P1|STARTED|Overall Study||604
148094|NCT01656967|360257|P2|NOT COMPLETED|Overall Study||2
148095|NCT01656967|360258|P1|NOT COMPLETED|Overall Study||4
148096|NCT01656967|360257|P2|COMPLETED|Overall Study||31
148097|NCT01656967|360258|P1|COMPLETED|Overall Study||29
148098|NCT01656967|360257|P2|ETT Insertion|Overall Study||31
148099|NCT01656967|360258|P1|ETT Insertion|Overall Study||29
148100|NCT01656967|360257|P2|SGA Placement|Overall Study||33
148101|NCT01656967|360258|P1|SGA Placement|Overall Study||32
148102|NCT01656967|360257|P2|STARTED|Overall Study||33
148103|NCT01656967|360258|P1|STARTED|Overall Study||33
148104|NCT01656889|360284|P2|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||9
148105|NCT01656889|360285|P1|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||4
148106|NCT01656889|360284|P2|COMPLETED|Post Treatment Follow-Up, 3 Months||204
148107|NCT01656889|360285|P1|COMPLETED|Post Treatment Follow-Up, 3 Months||206
148108|NCT01656889|360284|P2|STARTED|Post Treatment Follow-Up, 3 Months||213
148109|NCT01656889|360285|P1|STARTED|Post Treatment Follow-Up, 3 Months||210
148110|NCT01656889|360284|P2|NOT COMPLETED|Treatment Period, 12 Weeks||11
148111|NCT01656889|360285|P1|NOT COMPLETED|Treatment Period, 12 Weeks||12
148112|NCT01656889|360284|P2|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|214
148113|NCT01656889|360285|P1|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|210
148114|NCT01656889|360284|P2|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|225
148115|NCT01656889|360285|P1|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|222
148116|NCT01656850|360305|P2|NOT COMPLETED|Second Intervention (3 Months)||0
148117|NCT01656850|360306|P1|NOT COMPLETED|Second Intervention (3 Months)||0
148118|NCT01656850|360305|P2|COMPLETED|Second Intervention (3 Months)||16
148119|NCT01656850|360306|P1|COMPLETED|Second Intervention (3 Months)||17
148120|NCT01656850|360305|P2|STARTED|Second Intervention (3 Months)||16
148121|NCT01656850|360306|P1|STARTED|Second Intervention (3 Months)||17
148122|NCT01656850|360305|P2|NOT COMPLETED|Washout (2 Weeks)||0
148123|NCT01656850|360306|P1|NOT COMPLETED|Washout (2 Weeks)||0
148124|NCT01656850|360305|P2|COMPLETED|Washout (2 Weeks)||16
148125|NCT01656850|360306|P1|COMPLETED|Washout (2 Weeks)||17
148126|NCT01656850|360305|P2|STARTED|Washout (2 Weeks)||16
148127|NCT01656850|360306|P1|STARTED|Washout (2 Weeks)||17
148128|NCT01656850|360305|P2|NOT COMPLETED|First Intervention (3 Months)||4
148129|NCT01656850|360306|P1|NOT COMPLETED|First Intervention (3 Months)||3
148130|NCT01656850|360305|P2|COMPLETED|First Intervention (3 Months)||16
148131|NCT01656850|360306|P1|COMPLETED|First Intervention (3 Months)||17
148132|NCT01656850|360305|P2|STARTED|First Intervention (3 Months)||20
148133|NCT01656850|360306|P1|STARTED|First Intervention (3 Months)||20
148134|NCT01656772|360386|P2|NOT COMPLETED|Overall Study||0
148135|NCT01656772|360387|P1|NOT COMPLETED|Overall Study||0
148136|NCT01656772|360386|P2|COMPLETED|Overall Study||77
148137|NCT01656772|360387|P1|COMPLETED|Overall Study||43
148138|NCT01656772|360386|P2|STARTED|Overall Study||77
148139|NCT01656772|360387|P1|STARTED|Overall Study||43
148140|NCT01656759|360397|P2|NOT COMPLETED|Overall Study||3
148141|NCT01656759|360398|P1|NOT COMPLETED|Overall Study||2
148142|NCT01656759|360397|P2|COMPLETED|Overall Study||22
148143|NCT01656759|360398|P1|COMPLETED|Overall Study||25
148144|NCT01656759|360397|P2|STARTED|Overall Study||25
148145|NCT01656759|360398|P1|STARTED|Overall Study||27
148146|NCT01656733|360412|P2|NOT COMPLETED|Overall Study||4
148147|NCT01656733|360413|P1|NOT COMPLETED|Overall Study||0
148148|NCT01656733|360412|P2|COMPLETED|Overall Study||66
148149|NCT01656733|360413|P1|COMPLETED|Overall Study||67
148150|NCT01656733|360412|P2|Visit 8 (6 Months Postpartum)|Overall Study||28
148151|NCT01656733|360413|P1|Visit 8 (6 Months Postpartum)|Overall Study||30
148152|NCT01656733|360412|P2|Visit 7 (1 Month Postpartum) Phone Call|Overall Study||50
148153|NCT01656733|360413|P1|Visit 7 (1 Month Postpartum) Phone Call|Overall Study||47
148154|NCT01656733|360412|P2|Participants With Perinatal Outcomes|Overall Study||66
148155|NCT01656733|360413|P1|Participants With Perinatal Outcomes|Overall Study||67
148156|NCT01656733|360412|P2|Visit 6 ( 32-36 Weeks Gestation)|Overall Study||47
148157|NCT01656733|360413|P1|Visit 6 ( 32-36 Weeks Gestation)|Overall Study||39
148158|NCT01656733|360412|P2|Visit 5 (6 Weeks After Quit Date)|Overall Study||36
148159|NCT01656733|360413|P1|Visit 5 (6 Weeks After Quit Date)|Overall Study||37
148160|NCT01656733|360412|P2|Visit 4 (4 Weeks After Quit Date)|Overall Study||30
148161|NCT01656733|360413|P1|Visit 4 (4 Weeks After Quit Date)|Overall Study||32
148162|NCT01656733|360412|P2|Visit 3 (3 Weeks After Quit Date)|Overall Study||34
148163|NCT01656733|360413|P1|Visit 3 (3 Weeks After Quit Date)|Overall Study||33
148164|NCT01656733|360412|P2|Visit 2 (2 Weeks After Quit Date)|Overall Study||44
148165|NCT01656733|360413|P1|Visit 2 (2 Weeks After Quit Date)|Overall Study||32
148166|NCT01656733|360412|P2|Visit 1 (1 Week After Quit Date)|Overall Study||42
148167|NCT01656733|360413|P1|Visit 1 (1 Week After Quit Date)|Overall Study||45
148168|NCT01656733|360412|P2|STARTED|Overall Study|5 discontinued after BL visit ( lost to follow up)|70
148169|NCT01656733|360413|P1|STARTED|Overall Study|4 discontinued after BL visit (lost to follow up)|67
148170|NCT01656629|360428|P3|NOT COMPLETED|Overall Study||2
148171|NCT01656629|360429|P2|NOT COMPLETED|Overall Study||2
148172|NCT01656629|360430|P1|NOT COMPLETED|Overall Study||5
148173|NCT01656629|360428|P3|COMPLETED|Overall Study||14
148174|NCT01656629|360429|P2|COMPLETED|Overall Study||16
148175|NCT01656629|360430|P1|COMPLETED|Overall Study||16
148176|NCT01656629|360428|P3|STARTED|Overall Study||16
148177|NCT01656629|360429|P2|STARTED|Overall Study||18
148178|NCT01656629|360430|P1|STARTED|Overall Study||21
148179|NCT01656486|360438|P1|NOT COMPLETED|Overall Study||0
148180|NCT01656486|360438|P1|COMPLETED|Overall Study||1
148181|NCT01656486|360438|P1|STARTED|Overall Study||1
148182|NCT01656460|360442|P4|NOT COMPLETED|Overall Study||0
148183|NCT01656460|360443|P3|NOT COMPLETED|Overall Study||0
148184|NCT01656460|360444|P2|NOT COMPLETED|Overall Study||0
148185|NCT01656460|360445|P1|NOT COMPLETED|Overall Study||0
148186|NCT01656460|360442|P4|COMPLETED|Overall Study||3
148187|NCT01656460|360443|P3|COMPLETED|Overall Study||3
148188|NCT01656460|360444|P2|COMPLETED|Overall Study||3
148189|NCT01656460|360445|P1|COMPLETED|Overall Study||3
148190|NCT01656460|360442|P4|STARTED|Overall Study||3
148191|NCT01656460|360443|P3|STARTED|Overall Study||3
148192|NCT01656460|360444|P2|STARTED|Overall Study||3
148193|NCT01656460|360445|P1|STARTED|Overall Study||3
148194|NCT01656434|360457|P2|NOT COMPLETED|Overall Study||580
148195|NCT01656434|360458|P1|NOT COMPLETED|Overall Study||2401
148196|NCT01656434|360457|P2|COMPLETED|Overall Study||40
148197|NCT01656434|360458|P1|COMPLETED|Overall Study||152
148198|NCT01656434|360457|P2|Treated|Overall Study||604
148199|NCT01656434|360458|P1|Treated|Overall Study|One treated participant had incomplete data and was not included in the Safety Analyses.|2466
148200|NCT01656434|360457|P2|STARTED|Overall Study||620
148201|NCT01656434|360458|P1|STARTED|Overall Study||2553
148202|NCT01656408|360484|P10|NOT COMPLETED|Overall Study||3
148203|NCT01656408|360485|P9|NOT COMPLETED|Overall Study||2
148204|NCT01656408|360486|P8|NOT COMPLETED|Overall Study||1
148205|NCT01656408|360487|P7|NOT COMPLETED|Overall Study||1
148206|NCT01656408|360488|P6|NOT COMPLETED|Overall Study||2
148207|NCT01656408|360489|P5|NOT COMPLETED|Overall Study||1
148208|NCT01656408|360490|P4|NOT COMPLETED|Overall Study||0
148209|NCT01656408|360491|P3|NOT COMPLETED|Overall Study||2
148210|NCT01656408|360492|P2|NOT COMPLETED|Overall Study||0
148211|NCT01656408|360493|P1|NOT COMPLETED|Overall Study||1
148212|NCT01656408|360484|P10|COMPLETED|Overall Study||15
148213|NCT01656408|360485|P9|COMPLETED|Overall Study||16
148214|NCT01656408|360486|P8|COMPLETED|Overall Study||7
148215|NCT01656408|360487|P7|COMPLETED|Overall Study||9
148216|NCT01656408|360488|P6|COMPLETED|Overall Study||7
148217|NCT01656408|360489|P5|COMPLETED|Overall Study||8
148218|NCT01656408|360490|P4|COMPLETED|Overall Study||7
148219|NCT01656408|360491|P3|COMPLETED|Overall Study||6
148220|NCT01656408|360492|P2|COMPLETED|Overall Study||8
148221|NCT01656408|360493|P1|COMPLETED|Overall Study||7
148222|NCT01656408|360484|P10|STARTED|Overall Study||18
148223|NCT01656408|360485|P9|STARTED|Overall Study||18
148224|NCT01656408|360486|P8|STARTED|Overall Study||8
148225|NCT01656408|360487|P7|STARTED|Overall Study||10
148226|NCT01656408|360488|P6|STARTED|Overall Study||9
148227|NCT01656408|360489|P5|STARTED|Overall Study||9
148228|NCT01656408|360490|P4|STARTED|Overall Study||7
148229|NCT01656408|360491|P3|STARTED|Overall Study||8
148230|NCT01656408|360492|P2|STARTED|Overall Study||8
148231|NCT01656408|360493|P1|STARTED|Overall Study||8
148232|NCT01656395|360688|P8|NOT COMPLETED|Overall Study||0
148233|NCT01656395|360689|P7|NOT COMPLETED|Overall Study||0
148234|NCT01656395|360690|P6|NOT COMPLETED|Overall Study||40
148235|NCT01656395|360691|P5|NOT COMPLETED|Overall Study||14
148236|NCT01656395|360692|P4|NOT COMPLETED|Overall Study||12
148237|NCT01656395|360693|P3|NOT COMPLETED|Overall Study||36
148238|NCT01656395|360694|P2|NOT COMPLETED|Overall Study||34
148239|NCT01656395|360695|P1|NOT COMPLETED|Overall Study||17
148240|NCT01656395|360688|P8|COMPLETED|Overall Study||0
148241|NCT01656395|360689|P7|COMPLETED|Overall Study||0
148242|NCT01656395|360690|P6|COMPLETED|Overall Study||94
148243|NCT01656395|360691|P5|COMPLETED|Overall Study||46
148244|NCT01656395|360692|P4|COMPLETED|Overall Study||41
148245|NCT01656395|360693|P3|COMPLETED|Overall Study||106
148246|NCT01656395|360694|P2|COMPLETED|Overall Study||93
148247|NCT01656395|360695|P1|COMPLETED|Overall Study||43
148248|NCT01656395|360688|P8|Treated Participants|Overall Study||0
148249|NCT01656395|360689|P7|Treated Participants|Overall Study||0
148250|NCT01656395|360690|P6|Treated Participants|Overall Study||126
148251|NCT01656395|360691|P5|Treated Participants|Overall Study||60
148252|NCT01656395|360692|P4|Treated Participants|Overall Study||52
148253|NCT01656395|360693|P3|Treated Participants|Overall Study||135
148254|NCT01656395|360694|P2|Treated Participants|Overall Study||126
148255|NCT01656395|360695|P1|Treated Participants|Overall Study||58
148256|NCT01656395|360688|P8|STARTED|Overall Study||0
148257|NCT01656395|360689|P7|STARTED|Overall Study||0
148258|NCT01656395|360690|P6|STARTED|Overall Study||134
148259|NCT01656395|360691|P5|STARTED|Overall Study||60
148260|NCT01656395|360692|P4|STARTED|Overall Study||53
148261|NCT01656395|360693|P3|STARTED|Overall Study||142
148262|NCT01656395|360694|P2|STARTED|Overall Study||127
148263|NCT01656395|360695|P1|STARTED|Overall Study||60
148264|NCT01656304|360781|P1|NOT COMPLETED|Overall Study||1
148265|NCT01656304|360781|P1|COMPLETED|Overall Study||15
148266|NCT01656304|360781|P1|STARTED|Overall Study||16
148267|NCT01656252|360790|P1|NOT COMPLETED|Phase II||0
148268|NCT01656252|360790|P1|COMPLETED|Phase II||0
148269|NCT01656252|360790|P1|STARTED|Phase II||0
148270|NCT01656252|360790|P1|NOT COMPLETED|Phase I||0
148271|NCT01656252|360790|P1|COMPLETED|Phase I||14
148272|NCT01656252|360790|P1|STARTED|Phase I||14
148273|NCT01656200|360822|P1|NOT COMPLETED|Overall Study||1
148274|NCT01656200|360822|P1|COMPLETED|Overall Study||16
148275|NCT01656200|360822|P1|STARTED|Overall Study||17
148276|NCT01656187|360830|P2|NOT COMPLETED|Second Intervention (24 Weeks)||3
148277|NCT01656187|360831|P1|NOT COMPLETED|Second Intervention (24 Weeks)||1
148278|NCT01656187|360830|P2|COMPLETED|Second Intervention (24 Weeks)||19
148279|NCT01656187|360831|P1|COMPLETED|Second Intervention (24 Weeks)||13
148280|NCT01656187|360830|P2|STARTED|Second Intervention (24 Weeks)||22
148281|NCT01656187|360831|P1|STARTED|Second Intervention (24 Weeks)||14
148282|NCT01656187|360830|P2|NOT COMPLETED|Washout (4 Weeks)||1
148283|NCT01656187|360831|P1|NOT COMPLETED|Washout (4 Weeks)||0
148284|NCT01656187|360830|P2|COMPLETED|Washout (4 Weeks)||22
148285|NCT01656187|360831|P1|COMPLETED|Washout (4 Weeks)||14
148286|NCT01656187|360830|P2|STARTED|Washout (4 Weeks)||23
148287|NCT01656187|360831|P1|STARTED|Washout (4 Weeks)||14
148288|NCT01656187|360830|P2|NOT COMPLETED|First Intervention (24 Weeks)||3
148289|NCT01656187|360831|P1|NOT COMPLETED|First Intervention (24 Weeks)||6
148290|NCT01656187|360830|P2|COMPLETED|First Intervention (24 Weeks)||23
148291|NCT01656187|360831|P1|COMPLETED|First Intervention (24 Weeks)||14
148292|NCT01656187|360830|P2|STARTED|First Intervention (24 Weeks)||26
148293|NCT01656187|360831|P1|STARTED|First Intervention (24 Weeks)||20
148294|NCT01656161|360837|P1|NOT COMPLETED|Overall Study||7
148295|NCT01656161|360837|P1|COMPLETED|Overall Study|Per protocol analysis set|113
148296|NCT01656161|360837|P1|Received Triptorelin at Day 169|Overall Study||115
148297|NCT01656161|360837|P1|Received Triptorelin at Day 1|Overall Study|Safety analysis set|120
148298|NCT01656161|360837|P1|STARTED|Overall Study|Intention to treat analysis set|120
148299|NCT01656031|360851|P1|NOT COMPLETED|Overall Study||0
148300|NCT01656031|360851|P1|COMPLETED|Overall Study||39
148301|NCT01656031|360851|P1|STARTED|Overall Study||39
148302|NCT01655901|360855|P6|NOT COMPLETED|Third Intervention (Hour 3)||0
148303|NCT01655901|360856|P5|NOT COMPLETED|Third Intervention (Hour 3)||1
148304|NCT01655901|360857|P4|NOT COMPLETED|Third Intervention (Hour 3)||0
148305|NCT01655901|360858|P3|NOT COMPLETED|Third Intervention (Hour 3)||1
148306|NCT01655901|360859|P2|NOT COMPLETED|Third Intervention (Hour 3)||1
148307|NCT01655901|360860|P1|NOT COMPLETED|Third Intervention (Hour 3)||1
148308|NCT01655901|360855|P6|COMPLETED|Third Intervention (Hour 3)||5
148309|NCT01655901|360856|P5|COMPLETED|Third Intervention (Hour 3)||4
148310|NCT01655901|360857|P4|COMPLETED|Third Intervention (Hour 3)||5
148311|NCT01655901|360858|P3|COMPLETED|Third Intervention (Hour 3)||4
148312|NCT01655901|360859|P2|COMPLETED|Third Intervention (Hour 3)||4
148313|NCT01655901|360860|P1|COMPLETED|Third Intervention (Hour 3)||4
148314|NCT01655901|360855|P6|STARTED|Third Intervention (Hour 3)||5
148315|NCT01655901|360856|P5|STARTED|Third Intervention (Hour 3)||5
148316|NCT01655901|360857|P4|STARTED|Third Intervention (Hour 3)||5
148317|NCT01655901|360858|P3|STARTED|Third Intervention (Hour 3)||5
148318|NCT01655901|360859|P2|STARTED|Third Intervention (Hour 3)||5
148319|NCT01655901|360860|P1|STARTED|Third Intervention (Hour 3)||5
148320|NCT01655901|360855|P6|NOT COMPLETED|Washout (1 Week)||0
148321|NCT01655901|360856|P5|NOT COMPLETED|Washout (1 Week)||0
148322|NCT01655901|360857|P4|NOT COMPLETED|Washout (1 Week)||0
148323|NCT01655901|360858|P3|NOT COMPLETED|Washout (1 Week)||0
148324|NCT01655901|360859|P2|NOT COMPLETED|Washout (1 Week)||0
148325|NCT01655901|360860|P1|NOT COMPLETED|Washout (1 Week)||0
148326|NCT01655901|360855|P6|COMPLETED|Washout (1 Week)||5
148327|NCT01655901|360856|P5|COMPLETED|Washout (1 Week)||5
148328|NCT01655901|360857|P4|COMPLETED|Washout (1 Week)||5
148329|NCT01655901|360858|P3|COMPLETED|Washout (1 Week)||5
148330|NCT01655901|360859|P2|COMPLETED|Washout (1 Week)||5
148331|NCT01655901|360860|P1|COMPLETED|Washout (1 Week)||5
148332|NCT01655901|360855|P6|STARTED|Washout (1 Week)||5
148333|NCT01655901|360856|P5|STARTED|Washout (1 Week)||5
148334|NCT01655901|360857|P4|STARTED|Washout (1 Week)||5
148335|NCT01655901|360858|P3|STARTED|Washout (1 Week)||5
148336|NCT01655901|360859|P2|STARTED|Washout (1 Week)||5
148337|NCT01655901|360860|P1|STARTED|Washout (1 Week)||5
148338|NCT01655901|360855|P6|NOT COMPLETED|Second Intervention (Hour 2)||0
148339|NCT01655901|360856|P5|NOT COMPLETED|Second Intervention (Hour 2)||0
148340|NCT01655901|360857|P4|NOT COMPLETED|Second Intervention (Hour 2)||0
148341|NCT01655901|360858|P3|NOT COMPLETED|Second Intervention (Hour 2)||0
148342|NCT01655901|360859|P2|NOT COMPLETED|Second Intervention (Hour 2)||0
148343|NCT01655901|360860|P1|NOT COMPLETED|Second Intervention (Hour 2)||0
148344|NCT01655901|360855|P6|COMPLETED|Second Intervention (Hour 2)||5
148345|NCT01655901|360856|P5|COMPLETED|Second Intervention (Hour 2)||5
148346|NCT01655901|360857|P4|COMPLETED|Second Intervention (Hour 2)||5
148347|NCT01655901|360858|P3|COMPLETED|Second Intervention (Hour 2)||5
148348|NCT01655901|360859|P2|COMPLETED|Second Intervention (Hour 2)||5
148349|NCT01655901|360860|P1|COMPLETED|Second Intervention (Hour 2)||5
148350|NCT01655901|360855|P6|STARTED|Second Intervention (Hour 2)||5
148351|NCT01655901|360856|P5|STARTED|Second Intervention (Hour 2)||5
148352|NCT01655901|360857|P4|STARTED|Second Intervention (Hour 2)||5
148353|NCT01655901|360858|P3|STARTED|Second Intervention (Hour 2)||5
148354|NCT01655901|360859|P2|STARTED|Second Intervention (Hour 2)||5
148355|NCT01655901|360860|P1|STARTED|Second Intervention (Hour 2)||5
148356|NCT01655901|360855|P6|NOT COMPLETED|Washout (1 Week)||0
148357|NCT01655901|360856|P5|NOT COMPLETED|Washout (1 Week)||0
148358|NCT01655901|360857|P4|NOT COMPLETED|Washout (1 Week)||0
148359|NCT01655901|360858|P3|NOT COMPLETED|Washout (1 Week)||0
148360|NCT01655901|360859|P2|NOT COMPLETED|Washout (1 Week)||0
148361|NCT01655901|360860|P1|NOT COMPLETED|Washout (1 Week)||0
148362|NCT01655901|360855|P6|COMPLETED|Washout (1 Week)||5
148363|NCT01655901|360856|P5|COMPLETED|Washout (1 Week)||5
148364|NCT01655901|360857|P4|COMPLETED|Washout (1 Week)||5
148365|NCT01655901|360858|P3|COMPLETED|Washout (1 Week)||5
148366|NCT01655901|360859|P2|COMPLETED|Washout (1 Week)||5
148367|NCT01655901|360860|P1|COMPLETED|Washout (1 Week)||5
148368|NCT01655901|360855|P6|STARTED|Washout (1 Week)||5
148369|NCT01655901|360856|P5|STARTED|Washout (1 Week)||5
148370|NCT01655901|360857|P4|STARTED|Washout (1 Week)||5
148371|NCT01655901|360858|P3|STARTED|Washout (1 Week)||5
148372|NCT01655901|360859|P2|STARTED|Washout (1 Week)||5
148373|NCT01655901|360860|P1|STARTED|Washout (1 Week)||5
148374|NCT01655901|360855|P6|NOT COMPLETED|First Intervention (Hour 1)||0
148375|NCT01655901|360856|P5|NOT COMPLETED|First Intervention (Hour 1)||0
148376|NCT01655901|360857|P4|NOT COMPLETED|First Intervention (Hour 1)||0
148377|NCT01655901|360858|P3|NOT COMPLETED|First Intervention (Hour 1)||0
148378|NCT01655901|360859|P2|NOT COMPLETED|First Intervention (Hour 1)||0
148379|NCT01655901|360860|P1|NOT COMPLETED|First Intervention (Hour 1)||0
148380|NCT01655901|360855|P6|COMPLETED|First Intervention (Hour 1)||5
148381|NCT01655901|360856|P5|COMPLETED|First Intervention (Hour 1)||5
148382|NCT01655901|360857|P4|COMPLETED|First Intervention (Hour 1)||5
148383|NCT01655901|360858|P3|COMPLETED|First Intervention (Hour 1)||5
148384|NCT01655901|360859|P2|COMPLETED|First Intervention (Hour 1)||5
148385|NCT01655901|360860|P1|COMPLETED|First Intervention (Hour 1)||5
148386|NCT01655901|360855|P6|STARTED|First Intervention (Hour 1)||5
148387|NCT01655901|360856|P5|STARTED|First Intervention (Hour 1)||5
148388|NCT01655901|360857|P4|STARTED|First Intervention (Hour 1)||5
148389|NCT01655901|360858|P3|STARTED|First Intervention (Hour 1)||5
148390|NCT01655901|360859|P2|STARTED|First Intervention (Hour 1)||5
148391|NCT01655901|360860|P1|STARTED|First Intervention (Hour 1)||5
148392|NCT01655823|360874|P5|NOT COMPLETED|Overall Study||1
148393|NCT01655823|360875|P4|NOT COMPLETED|Overall Study||1
148394|NCT01655823|360876|P3|NOT COMPLETED|Overall Study||0
148395|NCT01655823|360877|P2|NOT COMPLETED|Overall Study||2
148396|NCT01655823|360878|P1|NOT COMPLETED|Overall Study||0
148397|NCT01655823|360874|P5|COMPLETED|Overall Study||25
148398|NCT01655823|360875|P4|COMPLETED|Overall Study||24
148399|NCT01655823|360876|P3|COMPLETED|Overall Study||24
148400|NCT01655823|360877|P2|COMPLETED|Overall Study||23
148401|NCT01655823|360878|P1|COMPLETED|Overall Study||25
148402|NCT01655823|360874|P5|STARTED|Overall Study||26
148403|NCT01655823|360875|P4|STARTED|Overall Study||25
148404|NCT01655823|360876|P3|STARTED|Overall Study||24
148405|NCT01655823|360877|P2|STARTED|Overall Study||25
148406|NCT01655823|360878|P1|STARTED|Overall Study||25
148407|NCT01655719|360890|P1|NOT COMPLETED|Overall Study||0
148408|NCT01655719|360890|P1|COMPLETED|Overall Study||1
148409|NCT01655719|360890|P1|STARTED|Overall Study||1
148410|NCT01655563|360898|P2|NOT COMPLETED|Overall Study||0
148411|NCT01655563|360899|P1|NOT COMPLETED|Overall Study||0
148412|NCT01655563|360898|P2|COMPLETED|Overall Study||35
148413|NCT01655563|360899|P1|COMPLETED|Overall Study||18
148414|NCT01655563|360898|P2|STARTED|Overall Study||35
148415|NCT01655563|360899|P1|STARTED|Overall Study||18
148416|NCT01655498|360909|P1|NOT COMPLETED|Overall Study||5
148417|NCT01655498|360909|P1|COMPLETED|Overall Study||56
148418|NCT01655498|360909|P1|STARTED|Overall Study||61
148419|NCT01655381|360916|P1|NOT COMPLETED|Overall Study||3
148420|NCT01655381|360916|P1|COMPLETED|Overall Study||12
148421|NCT01655381|360916|P1|STARTED|Overall Study||15
148422|NCT01655329|360936|P1|NOT COMPLETED|Overall Study||0
148423|NCT01655329|360936|P1|COMPLETED|Overall Study||10
148424|NCT01655329|360936|P1|STARTED|Overall Study|The same 10 radiologists are interpreting images in both arms.|10
148425|NCT01655069|360956|P4|NOT COMPLETED|Overall Study||4
148426|NCT01655069|360957|P3|NOT COMPLETED|Overall Study||2
148427|NCT01655069|360958|P2|NOT COMPLETED|Overall Study||12
148428|NCT01655069|360959|P1|NOT COMPLETED|Overall Study||8
148429|NCT01655069|360956|P4|COMPLETED|Overall Study||11
148430|NCT01655069|360957|P3|COMPLETED|Overall Study||12
148431|NCT01655069|360958|P2|COMPLETED|Overall Study||46
148432|NCT01655069|360959|P1|COMPLETED|Overall Study||53
148433|NCT01655069|360956|P4|Full Analysis Set (FAS)|Overall Study||15
148434|NCT01655069|360957|P3|Full Analysis Set (FAS)|Overall Study||14
148435|NCT01655069|360958|P2|Full Analysis Set (FAS)|Overall Study||57
148436|NCT01655069|360959|P1|Full Analysis Set (FAS)|Overall Study||60
148437|NCT01655069|360956|P4|Safety Analysis Set (SAF)|Overall Study||15
148438|NCT01655069|360957|P3|Safety Analysis Set (SAF)|Overall Study||14
148439|NCT01655069|360958|P2|Safety Analysis Set (SAF)|Overall Study||57
148440|NCT01655069|360959|P1|Safety Analysis Set (SAF)|Overall Study||61
148441|NCT01655069|360956|P4|STARTED|Overall Study||15
148442|NCT01655069|360957|P3|STARTED|Overall Study||14
148443|NCT01655069|360958|P2|STARTED|Overall Study||58
148444|NCT01655069|360959|P1|STARTED|Overall Study||61
148445|NCT01655043|360974|P1|NOT COMPLETED|Overall Study||0
148446|NCT01655043|360974|P1|COMPLETED|Overall Study||20
148447|NCT01655043|360974|P1|STARTED|Overall Study||20
148448|NCT01654887|360980|P2|NOT COMPLETED|Overall Study||0
148449|NCT01654887|360981|P1|NOT COMPLETED|Overall Study||0
148450|NCT01654887|360980|P2|COMPLETED|Overall Study||88
148451|NCT01654887|360981|P1|COMPLETED|Overall Study||103
148452|NCT01654887|360980|P2|STARTED|Overall Study||88
148453|NCT01654887|360981|P1|STARTED|Overall Study||103
148454|NCT01654861|360997|P1|NOT COMPLETED|Overall Study||0
148455|NCT01654861|360997|P1|COMPLETED|Overall Study||3
148456|NCT01654861|360997|P1|STARTED|Overall Study||3
148457|NCT01654796|361005|P3|NOT COMPLETED|Overall Study||1
148458|NCT01654796|361006|P2|NOT COMPLETED|Overall Study||3
148459|NCT01654796|361007|P1|NOT COMPLETED|Overall Study||1
148460|NCT01654796|361005|P3|COMPLETED|Overall Study||28
148461|NCT01654796|361006|P2|COMPLETED|Overall Study||26
148462|NCT01654796|361007|P1|COMPLETED|Overall Study||25
148463|NCT01654796|361005|P3|STARTED|Overall Study||29
148464|NCT01654796|361006|P2|STARTED|Overall Study||29
148465|NCT01654796|361007|P1|STARTED|Overall Study||26
148466|NCT01654666|361019|P3|NOT COMPLETED|Overall Study||14
148467|NCT01654666|361020|P2|NOT COMPLETED|Overall Study||13
148468|NCT01654666|361021|P1|NOT COMPLETED|Overall Study||15
148469|NCT01654666|361019|P3|COMPLETED|Overall Study||49
148470|NCT01654666|361020|P2|COMPLETED|Overall Study||50
148471|NCT01654666|361021|P1|COMPLETED|Overall Study||48
148472|NCT01654666|361019|P3|Primary Analysis|Overall Study||54
148473|NCT01654666|361020|P2|Primary Analysis|Overall Study||56
148474|NCT01654666|361021|P1|Primary Analysis|Overall Study||52
148475|NCT01654666|361019|P3|STARTED|Overall Study||63
148476|NCT01654666|361020|P2|STARTED|Overall Study||63
148477|NCT01654666|361021|P1|STARTED|Overall Study||63
148478|NCT01654601|361046|P2|NOT COMPLETED|2nd Administration||1
148479|NCT01654601|361047|P1|NOT COMPLETED|2nd Administration||1
148480|NCT01654601|361046|P2|COMPLETED|2nd Administration||11
148481|NCT01654601|361047|P1|COMPLETED|2nd Administration||11
148482|NCT01654601|361046|P2|STARTED|2nd Administration||12
148483|NCT01654601|361047|P1|STARTED|2nd Administration||12
148484|NCT01654601|361046|P2|NOT COMPLETED|1st Administration||2
148485|NCT01654601|361047|P1|NOT COMPLETED|1st Administration||2
148486|NCT01654601|361046|P2|COMPLETED|1st Administration||12
148487|NCT01654601|361047|P1|COMPLETED|1st Administration||12
148488|NCT01654601|361046|P2|STARTED|1st Administration||14
148489|NCT01654601|361047|P1|STARTED|1st Administration||14
148490|NCT01654549|361061|P2|NOT COMPLETED|Overall Study||1
148491|NCT01654549|361062|P1|NOT COMPLETED|Overall Study||0
148492|NCT01654549|361061|P2|COMPLETED|Overall Study||19
148493|NCT01654549|361062|P1|COMPLETED|Overall Study||20
148494|NCT01654549|361061|P2|STARTED|Overall Study||20
148495|NCT01654549|361062|P1|STARTED|Overall Study||20
148496|NCT01654536|361074|P2|NOT COMPLETED|Overall Study||38
148497|NCT01654536|361075|P1|NOT COMPLETED|Overall Study||44
148498|NCT01654536|361074|P2|COMPLETED|Overall Study||331
148499|NCT01654536|361075|P1|COMPLETED|Overall Study||324
148500|NCT01654536|361074|P2|STARTED|Overall Study||369
148501|NCT01654536|361075|P1|STARTED|Overall Study||368
148502|NCT01654523|361111|P1|NOT COMPLETED|Overall Study||1
148503|NCT01654523|361111|P1|COMPLETED|Overall Study||19
148504|NCT01654523|361111|P1|STARTED|Overall Study||20
148505|NCT01654380|361117|P4|NOT COMPLETED|Part B, Period 4||0
148506|NCT01654380|361118|P3|NOT COMPLETED|Part B, Period 4||0
148507|NCT01654380|361119|P2|NOT COMPLETED|Part B, Period 4||0
148508|NCT01654380|361120|P1|NOT COMPLETED|Part B, Period 4||0
148509|NCT01654380|361117|P4|COMPLETED|Part B, Period 4||7
148510|NCT01654380|361118|P3|COMPLETED|Part B, Period 4||6
148511|NCT01654380|361119|P2|COMPLETED|Part B, Period 4||0
148512|NCT01654380|361120|P1|COMPLETED|Part B, Period 4||0
148513|NCT01654380|361117|P4|STARTED|Part B, Period 4||7
148514|NCT01654380|361118|P3|STARTED|Part B, Period 4||6
148515|NCT01654380|361119|P2|STARTED|Part B, Period 4||0
148516|NCT01654380|361120|P1|STARTED|Part B, Period 4||0
148517|NCT01654380|361117|P4|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
148518|NCT01654380|361118|P3|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
148519|NCT01654380|361119|P2|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
148520|NCT01654380|361120|P1|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
148521|NCT01654380|361117|P4|COMPLETED|Part B, Washout of at Least 6 Days||7
148522|NCT01654380|361118|P3|COMPLETED|Part B, Washout of at Least 6 Days||6
148523|NCT01654380|361119|P2|COMPLETED|Part B, Washout of at Least 6 Days||0
148524|NCT01654380|361120|P1|COMPLETED|Part B, Washout of at Least 6 Days||0
148525|NCT01654380|361117|P4|STARTED|Part B, Washout of at Least 6 Days||7
148526|NCT01654380|361118|P3|STARTED|Part B, Washout of at Least 6 Days||6
148527|NCT01654380|361119|P2|STARTED|Part B, Washout of at Least 6 Days||0
148528|NCT01654380|361120|P1|STARTED|Part B, Washout of at Least 6 Days||0
148529|NCT01654380|361117|P4|NOT COMPLETED|Part B, Period 3||0
148530|NCT01654380|361118|P3|NOT COMPLETED|Part B, Period 3||0
148531|NCT01654380|361119|P2|NOT COMPLETED|Part B, Period 3||0
148532|NCT01654380|361120|P1|NOT COMPLETED|Part B, Period 3||0
148533|NCT01654380|361117|P4|COMPLETED|Part B, Period 3||7
148534|NCT01654380|361118|P3|COMPLETED|Part B, Period 3||6
148535|NCT01654380|361119|P2|COMPLETED|Part B, Period 3||0
148536|NCT01654380|361120|P1|COMPLETED|Part B, Period 3||0
148537|NCT01654380|361117|P4|STARTED|Part B, Period 3||7
148538|NCT01654380|361118|P3|STARTED|Part B, Period 3||6
148539|NCT01654380|361119|P2|STARTED|Part B, Period 3||0
148540|NCT01654380|361120|P1|STARTED|Part B, Period 3||0
148541|NCT01654380|361117|P4|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
148542|NCT01654380|361118|P3|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
148543|NCT01654380|361119|P2|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
148544|NCT01654380|361120|P1|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
148545|NCT01654380|361117|P4|COMPLETED|Part B, Washout of at Least 6 Days||7
148546|NCT01654380|361118|P3|COMPLETED|Part B, Washout of at Least 6 Days||6
148547|NCT01654380|361119|P2|COMPLETED|Part B, Washout of at Least 6 Days||0
148548|NCT01654380|361120|P1|COMPLETED|Part B, Washout of at Least 6 Days||0
148549|NCT01654380|361117|P4|STARTED|Part B, Washout of at Least 6 Days||7
148550|NCT01654380|361118|P3|STARTED|Part B, Washout of at Least 6 Days||6
148551|NCT01654380|361119|P2|STARTED|Part B, Washout of at Least 6 Days||0
148552|NCT01654380|361120|P1|STARTED|Part B, Washout of at Least 6 Days||0
148553|NCT01654380|361117|P4|NOT COMPLETED|Part B, Period 2||0
148554|NCT01654380|361118|P3|NOT COMPLETED|Part B, Period 2||0
148555|NCT01654380|361119|P2|NOT COMPLETED|Part B, Period 2||0
148556|NCT01654380|361120|P1|NOT COMPLETED|Part B, Period 2||0
148557|NCT01654380|361117|P4|COMPLETED|Part B, Period 2||7
148558|NCT01654380|361118|P3|COMPLETED|Part B, Period 2||6
148559|NCT01654380|361119|P2|COMPLETED|Part B, Period 2||0
148560|NCT01654380|361120|P1|COMPLETED|Part B, Period 2||0
148561|NCT01654380|361117|P4|STARTED|Part B, Period 2||7
148562|NCT01654380|361118|P3|STARTED|Part B, Period 2||6
148563|NCT01654380|361119|P2|STARTED|Part B, Period 2||0
148564|NCT01654380|361120|P1|STARTED|Part B, Period 2||0
148565|NCT01654380|361117|P4|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
148566|NCT01654380|361118|P3|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
148567|NCT01654380|361119|P2|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
148568|NCT01654380|361120|P1|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
148569|NCT01654380|361117|P4|COMPLETED|Part B, Washout of at Least 6 Days||7
148570|NCT01654380|361118|P3|COMPLETED|Part B, Washout of at Least 6 Days||6
148571|NCT01654380|361119|P2|COMPLETED|Part B, Washout of at Least 6 Days||0
148572|NCT01654380|361120|P1|COMPLETED|Part B, Washout of at Least 6 Days||0
148573|NCT01654380|361117|P4|STARTED|Part B, Washout of at Least 6 Days||7
148574|NCT01654380|361118|P3|STARTED|Part B, Washout of at Least 6 Days||6
148575|NCT01654380|361119|P2|STARTED|Part B, Washout of at Least 6 Days||0
148576|NCT01654380|361120|P1|STARTED|Part B, Washout of at Least 6 Days||0
148577|NCT01654380|361117|P4|NOT COMPLETED|Part B, Period 1||0
148578|NCT01654380|361118|P3|NOT COMPLETED|Part B, Period 1||1
148579|NCT01654380|361119|P2|NOT COMPLETED|Part B, Period 1||0
148580|NCT01654380|361120|P1|NOT COMPLETED|Part B, Period 1||0
148581|NCT01654380|361117|P4|COMPLETED|Part B, Period 1||7
148582|NCT01654380|361118|P3|COMPLETED|Part B, Period 1|Participant who did not complete received only 1 dose of LY2605541 74.1 mU/min IV for 8 hours|6
148583|NCT01654380|361119|P2|COMPLETED|Part B, Period 1||0
148584|NCT01654380|361120|P1|COMPLETED|Part B, Period 1||0
148585|NCT01654380|361117|P4|Received at Least 1 Dose of Study Drug|Part B, Period 1||7
148586|NCT01654380|361118|P3|Received at Least 1 Dose of Study Drug|Part B, Period 1||7
148587|NCT01654380|361119|P2|Received at Least 1 Dose of Study Drug|Part B, Period 1||0
148588|NCT01654380|361120|P1|Received at Least 1 Dose of Study Drug|Part B, Period 1||0
148589|NCT01654380|361117|P4|STARTED|Part B, Period 1|Participants in Part B were not included in Part A.|7
148590|NCT01654380|361118|P3|STARTED|Part B, Period 1|Participants in Part B were not included in Part A.|7
148591|NCT01654380|361119|P2|STARTED|Part B, Period 1|Participants in Part A were not included in Part B.|0
148592|NCT01654380|361120|P1|STARTED|Part B, Period 1|Participants in Part A were not included in Part B.|0
148593|NCT01654380|361117|P4|NOT COMPLETED|Part A, Period 4||0
148594|NCT01654380|361118|P3|NOT COMPLETED|Part A, Period 4||0
148595|NCT01654380|361119|P2|NOT COMPLETED|Part A, Period 4||0
148596|NCT01654380|361120|P1|NOT COMPLETED|Part A, Period 4||0
148597|NCT01654380|361117|P4|COMPLETED|Part A, Period 4||0
148598|NCT01654380|361118|P3|COMPLETED|Part A, Period 4||0
148599|NCT01654380|361119|P2|COMPLETED|Part A, Period 4||4
148600|NCT01654380|361120|P1|COMPLETED|Part A, Period 4||4
148601|NCT01654380|361117|P4|STARTED|Part A, Period 4||0
148602|NCT01654380|361118|P3|STARTED|Part A, Period 4||0
148603|NCT01654380|361119|P2|STARTED|Part A, Period 4||4
148604|NCT01654380|361120|P1|STARTED|Part A, Period 4||4
148605|NCT01654380|361117|P4|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
148606|NCT01654380|361118|P3|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
148607|NCT01654380|361119|P2|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
148608|NCT01654380|361120|P1|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
148609|NCT01654380|361117|P4|COMPLETED|Part A, Washout of at Least 6 Days||0
148610|NCT01654380|361118|P3|COMPLETED|Part A, Washout of at Least 6 Days||0
148611|NCT01654380|361119|P2|COMPLETED|Part A, Washout of at Least 6 Days||4
148612|NCT01654380|361120|P1|COMPLETED|Part A, Washout of at Least 6 Days||4
148613|NCT01654380|361117|P4|STARTED|Part A, Washout of at Least 6 Days||0
148614|NCT01654380|361118|P3|STARTED|Part A, Washout of at Least 6 Days||0
148615|NCT01654380|361119|P2|STARTED|Part A, Washout of at Least 6 Days||4
148616|NCT01654380|361120|P1|STARTED|Part A, Washout of at Least 6 Days||4
148617|NCT01654380|361117|P4|NOT COMPLETED|Part A, Period 3||0
148618|NCT01654380|361118|P3|NOT COMPLETED|Part A, Period 3||0
148619|NCT01654380|361119|P2|NOT COMPLETED|Part A, Period 3||0
148620|NCT01654380|361120|P1|NOT COMPLETED|Part A, Period 3||0
148621|NCT01654380|361117|P4|COMPLETED|Part A, Period 3||0
148622|NCT01654380|361118|P3|COMPLETED|Part A, Period 3||0
148623|NCT01654380|361119|P2|COMPLETED|Part A, Period 3||4
148624|NCT01654380|361120|P1|COMPLETED|Part A, Period 3||4
148625|NCT01654380|361117|P4|STARTED|Part A, Period 3||0
148626|NCT01654380|361118|P3|STARTED|Part A, Period 3||0
148627|NCT01654380|361119|P2|STARTED|Part A, Period 3||4
148628|NCT01654380|361120|P1|STARTED|Part A, Period 3||4
148629|NCT01654380|361117|P4|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
148630|NCT01654380|361118|P3|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
148631|NCT01654380|361119|P2|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
148632|NCT01654380|361120|P1|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
148633|NCT01654380|361117|P4|COMPLETED|Part A, Washout of at Least 6 Days||0
148634|NCT01654380|361118|P3|COMPLETED|Part A, Washout of at Least 6 Days||0
148635|NCT01654380|361119|P2|COMPLETED|Part A, Washout of at Least 6 Days||4
148636|NCT01654380|361120|P1|COMPLETED|Part A, Washout of at Least 6 Days||4
148637|NCT01654380|361117|P4|STARTED|Part A, Washout of at Least 6 Days||0
148638|NCT01654380|361118|P3|STARTED|Part A, Washout of at Least 6 Days||0
148639|NCT01654380|361119|P2|STARTED|Part A, Washout of at Least 6 Days||4
148640|NCT01654380|361120|P1|STARTED|Part A, Washout of at Least 6 Days||4
148641|NCT01654380|361117|P4|NOT COMPLETED|Part A, Period 2||0
148642|NCT01654380|361118|P3|NOT COMPLETED|Part A, Period 2||0
148643|NCT01654380|361119|P2|NOT COMPLETED|Part A, Period 2||0
148644|NCT01654380|361120|P1|NOT COMPLETED|Part A, Period 2||0
148645|NCT01654380|361117|P4|COMPLETED|Part A, Period 2||0
148646|NCT01654380|361118|P3|COMPLETED|Part A, Period 2||0
148647|NCT01654380|361119|P2|COMPLETED|Part A, Period 2||4
148648|NCT01654380|361120|P1|COMPLETED|Part A, Period 2||4
148649|NCT01654380|361117|P4|STARTED|Part A, Period 2||0
148650|NCT01654380|361118|P3|STARTED|Part A, Period 2||0
148651|NCT01654380|361119|P2|STARTED|Part A, Period 2||4
148652|NCT01654380|361120|P1|STARTED|Part A, Period 2||4
148653|NCT01654380|361117|P4|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
148654|NCT01654380|361118|P3|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
148655|NCT01654380|361119|P2|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
148656|NCT01654380|361120|P1|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
148657|NCT01654380|361117|P4|COMPLETED|Part A, Washout of at Least 6 Days||0
148658|NCT01654380|361118|P3|COMPLETED|Part A, Washout of at Least 6 Days||0
148659|NCT01654380|361119|P2|COMPLETED|Part A, Washout of at Least 6 Days||4
148660|NCT01654380|361120|P1|COMPLETED|Part A, Washout of at Least 6 Days||4
148661|NCT01654380|361117|P4|STARTED|Part A, Washout of at Least 6 Days||0
148662|NCT01654380|361118|P3|STARTED|Part A, Washout of at Least 6 Days||0
148663|NCT01654380|361119|P2|STARTED|Part A, Washout of at Least 6 Days||4
148664|NCT01654380|361120|P1|STARTED|Part A, Washout of at Least 6 Days||4
148665|NCT01654380|361117|P4|NOT COMPLETED|Part A, Period 1||0
148666|NCT01654380|361118|P3|NOT COMPLETED|Part A, Period 1||0
148667|NCT01654380|361119|P2|NOT COMPLETED|Part A, Period 1||0
148668|NCT01654380|361120|P1|NOT COMPLETED|Part A, Period 1||0
148669|NCT01654380|361117|P4|COMPLETED|Part A, Period 1||0
148670|NCT01654380|361118|P3|COMPLETED|Part A, Period 1||0
148671|NCT01654380|361119|P2|COMPLETED|Part A, Period 1||4
148672|NCT01654380|361120|P1|COMPLETED|Part A, Period 1||4
148673|NCT01654380|361117|P4|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
148674|NCT01654380|361118|P3|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
148675|NCT01654380|361119|P2|Received at Least 1 Dose of Study Drug|Part A, Period 1||4
148676|NCT01654380|361120|P1|Received at Least 1 Dose of Study Drug|Part A, Period 1||4
148677|NCT01654380|361117|P4|STARTED|Part A, Period 1||0
148678|NCT01654380|361118|P3|STARTED|Part A, Period 1||0
148679|NCT01654380|361119|P2|STARTED|Part A, Period 1||4
148680|NCT01654380|361120|P1|STARTED|Part A, Period 1||4
148681|NCT01654315|361148|P3|NOT COMPLETED|Overall Study||0
148682|NCT01654315|361149|P2|NOT COMPLETED|Overall Study||0
148683|NCT01654315|361150|P1|NOT COMPLETED|Overall Study||0
148684|NCT01654315|361148|P3|COMPLETED|Overall Study||9
148685|NCT01654315|361149|P2|COMPLETED|Overall Study||10
148686|NCT01654315|361150|P1|COMPLETED|Overall Study||15
148687|NCT01654315|361148|P3|STARTED|Overall Study||9
148688|NCT01654315|361149|P2|STARTED|Overall Study||10
148689|NCT01654315|361150|P1|STARTED|Overall Study||15
148690|NCT01654302|361163|P2|NOT COMPLETED|Second Intervention (Day 7)||1
148691|NCT01654302|361164|P1|NOT COMPLETED|Second Intervention (Day 7)||1
148692|NCT01654302|361163|P2|COMPLETED|Second Intervention (Day 7)||19
148693|NCT01654302|361164|P1|COMPLETED|Second Intervention (Day 7)||19
148694|NCT01654302|361163|P2|STARTED|Second Intervention (Day 7)||20
148695|NCT01654302|361164|P1|STARTED|Second Intervention (Day 7)||20
148696|NCT01654302|361163|P2|NOT COMPLETED|First Intervention (Day 1)||0
148697|NCT01654302|361164|P1|NOT COMPLETED|First Intervention (Day 1)||0
148698|NCT01654302|361163|P2|COMPLETED|First Intervention (Day 1)||20
148699|NCT01654302|361164|P1|COMPLETED|First Intervention (Day 1)||20
148700|NCT01654302|361163|P2|STARTED|First Intervention (Day 1)||20
148701|NCT01654302|361164|P1|STARTED|First Intervention (Day 1)||20
148702|NCT01654289|361173|P3|NOT COMPLETED|Overall Study||5
148703|NCT01654289|361174|P2|NOT COMPLETED|Overall Study||28
148704|NCT01654289|361175|P1|NOT COMPLETED|Overall Study||27
148705|NCT01654289|361173|P3|COMPLETED|Overall Study||133
148706|NCT01654289|361174|P2|COMPLETED|Overall Study||109
148707|NCT01654289|361175|P1|COMPLETED|Overall Study||111
148708|NCT01654289|361173|P3|STARTED|Overall Study||138
148709|NCT01654289|361174|P2|STARTED|Overall Study||137
148710|NCT01654289|361175|P1|STARTED|Overall Study||138
148711|NCT01654276|361213|P1|NOT COMPLETED|Overall Study||6
148712|NCT01654276|361213|P1|COMPLETED|Overall Study||18
148713|NCT01654276|361213|P1|Visit 4 (6months)|Overall Study||18
148714|NCT01654276|361213|P1|Visit 3 (4 Months)|Overall Study||18
148715|NCT01654276|361213|P1|Visit 2 (2 Months)|Overall Study||19
148716|NCT01654276|361213|P1|STARTED|Overall Study||24
148717|NCT01654263|361237|P6|NOT COMPLETED|Overall Study||1
148718|NCT01654263|361238|P5|NOT COMPLETED|Overall Study||1
148719|NCT01654263|361239|P4|NOT COMPLETED|Overall Study||1
148720|NCT01654263|361240|P3|NOT COMPLETED|Overall Study||2
148721|NCT01654263|361241|P2|NOT COMPLETED|Overall Study||0
148722|NCT01654263|361242|P1|NOT COMPLETED|Overall Study||0
148723|NCT01654263|361237|P6|COMPLETED|Overall Study||148
148724|NCT01654263|361238|P5|COMPLETED|Overall Study||139
148725|NCT01654263|361239|P4|COMPLETED|Overall Study||144
148726|NCT01654263|361240|P3|COMPLETED|Overall Study||137
148727|NCT01654263|361241|P2|COMPLETED|Overall Study||147
148728|NCT01654263|361242|P1|COMPLETED|Overall Study||164
148729|NCT01654263|361237|P6|STARTED|Overall Study||149
148730|NCT01654263|361238|P5|STARTED|Overall Study||140
148731|NCT01654263|361239|P4|STARTED|Overall Study||145
148732|NCT01654263|361240|P3|STARTED|Overall Study||139
148733|NCT01654263|361241|P2|STARTED|Overall Study||147
148734|NCT01654263|361242|P1|STARTED|Overall Study||164
148735|NCT01654250|361267|P2|NOT COMPLETED|Overall Study||0
148736|NCT01654250|361268|P1|NOT COMPLETED|Overall Study||1
148737|NCT01654250|361267|P2|COMPLETED|Overall Study||42
148738|NCT01654250|361268|P1|COMPLETED|Overall Study||43
148739|NCT01654250|361267|P2|STARTED|Overall Study||42
148740|NCT01654250|361268|P1|STARTED|Overall Study||44
148741|NCT01654224|361285|P2|NOT COMPLETED|Overall Study||12
148742|NCT01654224|361286|P1|NOT COMPLETED|Overall Study||6
148743|NCT01654224|361285|P2|COMPLETED|Overall Study||98
148744|NCT01654224|361286|P1|COMPLETED|Overall Study||89
148745|NCT01654224|361285|P2|STARTED|Overall Study||110
148746|NCT01654224|361286|P1|STARTED|Overall Study||95
148747|NCT01654107|361298|P2|NOT COMPLETED|Overall Study||8
148748|NCT01654107|361299|P1|NOT COMPLETED|Overall Study||3
148749|NCT01654107|361298|P2|COMPLETED|Overall Study||22
148750|NCT01654107|361299|P1|COMPLETED|Overall Study||25
148751|NCT01654107|361298|P2|STARTED|Overall Study||30
148752|NCT01654107|361299|P1|STARTED|Overall Study||28
148753|NCT01654068|361305|P1|NOT COMPLETED|Overall Study||0
148754|NCT01654068|361305|P1|COMPLETED|Overall Study||14
148755|NCT01654068|361305|P1|STARTED|Overall Study||14
148756|NCT01653964|361311|P1|NOT COMPLETED|Overall Study||0
148757|NCT01653964|361311|P1|COMPLETED|Overall Study||82
148758|NCT01653964|361311|P1|STARTED|Overall Study||82
148759|NCT01653912|361317|P6|NOT COMPLETED|Phase 2: GSK2110183 125 mg||8
148760|NCT01653912|361318|P5|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
148761|NCT01653912|361319|P4|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
148762|NCT01653912|361320|P3|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
148763|NCT01653912|361321|P2|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
148764|NCT01653912|361322|P1|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
148765|NCT01653912|361317|P6|COMPLETED|Phase 2: GSK2110183 125 mg||22
148766|NCT01653912|361318|P5|COMPLETED|Phase 2: GSK2110183 125 mg||0
148767|NCT01653912|361319|P4|COMPLETED|Phase 2: GSK2110183 125 mg||0
148768|NCT01653912|361320|P3|COMPLETED|Phase 2: GSK2110183 125 mg||0
148769|NCT01653912|361321|P2|COMPLETED|Phase 2: GSK2110183 125 mg||0
148770|NCT01653912|361322|P1|COMPLETED|Phase 2: GSK2110183 125 mg||0
148771|NCT01653912|361317|P6|STARTED|Phase 2: GSK2110183 125 mg|Per SAP, Cohort B (n=2) data was summarized in phase 2 total column as cohort B had <10 subjects.|30
148772|NCT01653912|361318|P5|STARTED|Phase 2: GSK2110183 125 mg||0
148773|NCT01653912|361319|P4|STARTED|Phase 2: GSK2110183 125 mg||0
148774|NCT01653912|361320|P3|STARTED|Phase 2: GSK2110183 125 mg||0
148775|NCT01653912|361321|P2|STARTED|Phase 2: GSK2110183 125 mg||0
148776|NCT01653912|361322|P1|STARTED|Phase 2: GSK2110183 125 mg||0
148777|NCT01653912|361317|P6|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
148778|NCT01653912|361318|P5|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
148779|NCT01653912|361319|P4|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
148780|NCT01653912|361320|P3|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
148781|NCT01653912|361321|P2|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
148782|NCT01653912|361322|P1|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
148783|NCT01653912|361317|P6|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
148784|NCT01653912|361318|P5|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||3
148785|NCT01653912|361319|P4|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
148786|NCT01653912|361320|P3|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
148787|NCT01653912|361321|P2|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
148788|NCT01653912|361322|P1|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
148789|NCT01653912|361317|P6|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
148790|NCT01653912|361318|P5|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||3
148791|NCT01653912|361319|P4|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
148792|NCT01653912|361320|P3|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
148793|NCT01653912|361321|P2|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
148794|NCT01653912|361322|P1|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
148795|NCT01653912|361317|P6|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
148796|NCT01653912|361318|P5|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
148797|NCT01653912|361319|P4|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||2
148798|NCT01653912|361320|P3|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
148799|NCT01653912|361321|P2|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
148800|NCT01653912|361322|P1|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
148801|NCT01653912|361317|P6|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
148802|NCT01653912|361318|P5|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
148803|NCT01653912|361319|P4|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||10
148804|NCT01653912|361320|P3|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
148805|NCT01653912|361321|P2|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
148806|NCT01653912|361322|P1|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
148807|NCT01653912|361317|P6|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
148808|NCT01653912|361318|P5|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
148809|NCT01653912|361319|P4|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||12
148810|NCT01653912|361320|P3|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
148811|NCT01653912|361321|P2|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
148812|NCT01653912|361322|P1|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
148813|NCT01653912|361317|P6|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
148814|NCT01653912|361318|P5|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
148815|NCT01653912|361319|P4|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
148816|NCT01653912|361320|P3|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||2
148817|NCT01653912|361321|P2|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
148818|NCT01653912|361322|P1|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
148819|NCT01653912|361317|P6|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
148820|NCT01653912|361318|P5|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
148821|NCT01653912|361319|P4|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
148822|NCT01653912|361320|P3|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||4
148823|NCT01653912|361321|P2|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
148824|NCT01653912|361322|P1|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
148825|NCT01653912|361317|P6|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
148826|NCT01653912|361318|P5|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
148827|NCT01653912|361319|P4|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
148828|NCT01653912|361320|P3|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||6
148829|NCT01653912|361321|P2|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
148830|NCT01653912|361322|P1|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
148831|NCT01653912|361317|P6|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
148832|NCT01653912|361318|P5|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
148833|NCT01653912|361319|P4|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
148834|NCT01653912|361320|P3|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
148835|NCT01653912|361321|P2|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||1
148836|NCT01653912|361322|P1|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
148837|NCT01653912|361317|P6|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
148838|NCT01653912|361318|P5|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
148839|NCT01653912|361319|P4|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
148840|NCT01653912|361320|P3|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
148841|NCT01653912|361321|P2|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||3
148842|NCT01653912|361322|P1|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
148843|NCT01653912|361317|P6|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
148844|NCT01653912|361318|P5|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
148845|NCT01653912|361319|P4|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
148846|NCT01653912|361320|P3|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
148847|NCT01653912|361321|P2|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||4
148848|NCT01653912|361322|P1|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
148849|NCT01653912|361317|P6|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
148850|NCT01653912|361318|P5|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
148851|NCT01653912|361319|P4|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
148852|NCT01653912|361320|P3|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
148853|NCT01653912|361321|P2|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
148854|NCT01653912|361322|P1|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
148855|NCT01653912|361317|P6|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
148856|NCT01653912|361318|P5|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
148857|NCT01653912|361319|P4|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
148858|NCT01653912|361320|P3|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
148859|NCT01653912|361321|P2|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
148860|NCT01653912|361322|P1|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||4
148861|NCT01653912|361317|P6|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
148862|NCT01653912|361318|P5|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
148863|NCT01653912|361319|P4|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
148864|NCT01653912|361320|P3|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
148865|NCT01653912|361321|P2|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
148866|NCT01653912|361322|P1|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||4
148867|NCT01653782|361340|P3|NOT COMPLETED|Overall Study||6
148868|NCT01653782|361341|P2|NOT COMPLETED|Overall Study||18
148869|NCT01653782|361342|P1|NOT COMPLETED|Overall Study||16
148870|NCT01653782|361340|P3|COMPLETED|Overall Study||46
148871|NCT01653782|361341|P2|COMPLETED|Overall Study||37
148872|NCT01653782|361342|P1|COMPLETED|Overall Study||36
148873|NCT01653782|361340|P3|STARTED|Overall Study||52
148874|NCT01653782|361341|P2|STARTED|Overall Study||55
148875|NCT01653782|361342|P1|STARTED|Overall Study||52
148876|NCT01653743|361352|P2|NOT COMPLETED|Overall Study||0
148877|NCT01653743|361353|P1|NOT COMPLETED|Overall Study||4
148878|NCT01653743|361352|P2|COMPLETED|Overall Study||27
148879|NCT01653743|361353|P1|COMPLETED|Overall Study||50
148880|NCT01653743|361352|P2|STARTED|Overall Study||27
148881|NCT01653743|361353|P1|STARTED|Overall Study||54
148882|NCT01653704|361369|P2|NOT COMPLETED|Overall Study||1
148883|NCT01653704|361370|P1|NOT COMPLETED|Overall Study||2
148884|NCT01653704|361369|P2|COMPLETED|Overall Study||20
148885|NCT01653704|361370|P1|COMPLETED|Overall Study||19
148886|NCT01653704|361369|P2|STARTED|Overall Study||21
148887|NCT01653704|361370|P1|STARTED|Overall Study||21
148888|NCT01653587|361378|P2|NOT COMPLETED|Overall Study||0
148889|NCT01653587|361379|P1|NOT COMPLETED|Overall Study||0
148890|NCT01653587|361378|P2|COMPLETED|Overall Study||120
148891|NCT01653587|361379|P1|COMPLETED|Overall Study||120
148892|NCT01653587|361378|P2|STARTED|Overall Study||120
148893|NCT01653587|361379|P1|STARTED|Overall Study||120
148894|NCT01653509|361391|P2|NOT COMPLETED|Overall Study||0
148895|NCT01653509|361392|P1|NOT COMPLETED|Overall Study||0
148896|NCT01653509|361391|P2|COMPLETED|Overall Study||13
148897|NCT01653509|361392|P1|COMPLETED|Overall Study||12
148898|NCT01653509|361391|P2|STARTED|Overall Study||13
148899|NCT01653509|361392|P1|STARTED|Overall Study||12
148900|NCT01653418|361410|P1|NOT COMPLETED|Overall Study||0
148901|NCT01653418|361410|P1|COMPLETED|Overall Study||10
148902|NCT01653418|361410|P1|STARTED|Overall Study||10
148903|NCT01653405|361424|P2|NOT COMPLETED|Overall Study||1068803
148904|NCT01653405|361425|P1|NOT COMPLETED|Overall Study||3765
148905|NCT01653405|361424|P2|COMPLETED|Overall Study|These patients had enough data to calculate TTR.|179979
148906|NCT01653405|361425|P1|COMPLETED|Overall Study|These patients had enough data to calculate TTR.|8029
148907|NCT01653405|361424|P2|STARTED|Overall Study||1248782
148908|NCT01653405|361425|P1|STARTED|Overall Study||11794
148909|NCT01653327|361439|P1|NOT COMPLETED|Overall Study||1
148910|NCT01653327|361439|P1|COMPLETED|Overall Study||10
148911|NCT01653327|361439|P1|STARTED|Overall Study||11
148912|NCT01653288|361449|P2|NOT COMPLETED|Overall Study||1
148913|NCT01653288|361450|P1|NOT COMPLETED|Overall Study||10
148914|NCT01653288|361449|P2|COMPLETED|Overall Study||35
148915|NCT01653288|361450|P1|COMPLETED|Overall Study||26
148916|NCT01653288|361449|P2|STARTED|Overall Study||36
148917|NCT01653288|361450|P1|STARTED|Overall Study||36
148918|NCT01653262|361464|P1|NOT COMPLETED|Overall Study||3
148919|NCT01653262|361464|P1|COMPLETED|Overall Study||26
148920|NCT01653262|361464|P1|STARTED|Overall Study||29
148921|NCT01653158|361477|P8|NOT COMPLETED|Overall Study||15
148922|NCT01653158|361478|P7|NOT COMPLETED|Overall Study||2
148923|NCT01653158|361479|P6|NOT COMPLETED|Overall Study||1
148924|NCT01653158|361480|P5|NOT COMPLETED|Overall Study||1
148925|NCT01653158|361481|P4|NOT COMPLETED|Overall Study||2
148926|NCT01653158|361482|P3|NOT COMPLETED|Overall Study||0
148927|NCT01653158|361483|P2|NOT COMPLETED|Overall Study||0
148928|NCT01653158|361484|P1|NOT COMPLETED|Overall Study||1
148929|NCT01653158|361477|P8|COMPLETED|Overall Study||4
148930|NCT01653158|361478|P7|COMPLETED|Overall Study||7
148931|NCT01653158|361479|P6|COMPLETED|Overall Study||2
148932|NCT01653158|361480|P5|COMPLETED|Overall Study||2
148933|NCT01653158|361481|P4|COMPLETED|Overall Study||1
148934|NCT01653158|361482|P3|COMPLETED|Overall Study||3
148935|NCT01653158|361483|P2|COMPLETED|Overall Study||3
148936|NCT01653158|361484|P1|COMPLETED|Overall Study||2
148937|NCT01653158|361477|P8|STARTED|Overall Study|Six (6) and 13 participants were enrolled in dose escalation and expansion cohorts, respectively.|19
148938|NCT01653158|361478|P7|STARTED|Overall Study||9
148939|NCT01653158|361479|P6|STARTED|Overall Study||3
148940|NCT01653158|361480|P5|STARTED|Overall Study||3
148941|NCT01653158|361481|P4|STARTED|Overall Study||3
148942|NCT01653158|361482|P3|STARTED|Overall Study||3
148943|NCT01653158|361483|P2|STARTED|Overall Study||3
148944|NCT01653158|361484|P1|STARTED|Overall Study||3
148945|NCT01653132|361756|P2|NOT COMPLETED|Second Intervention||0
148946|NCT01653132|361757|P1|NOT COMPLETED|Second Intervention||0
148947|NCT01653132|361756|P2|COMPLETED|Second Intervention||5
148948|NCT01653132|361757|P1|COMPLETED|Second Intervention||4
148949|NCT01653132|361756|P2|STARTED|Second Intervention||5
148950|NCT01653132|361757|P1|STARTED|Second Intervention||4
148951|NCT01653132|361756|P2|NOT COMPLETED|Washout 1-2 Months||0
148952|NCT01653132|361757|P1|NOT COMPLETED|Washout 1-2 Months||0
148953|NCT01653132|361756|P2|COMPLETED|Washout 1-2 Months||5
148954|NCT01653132|361757|P1|COMPLETED|Washout 1-2 Months||4
148955|NCT01653132|361756|P2|STARTED|Washout 1-2 Months||5
148956|NCT01653132|361757|P1|STARTED|Washout 1-2 Months||4
148957|NCT01653132|361756|P2|NOT COMPLETED|First Intervention||0
148958|NCT01653132|361757|P1|NOT COMPLETED|First Intervention||1
148959|NCT01653132|361756|P2|COMPLETED|First Intervention||5
148960|NCT01653132|361757|P1|COMPLETED|First Intervention|one dropped out: wanted to start anticholinergic drug for tremor that could affect saliva volume|4
148961|NCT01653132|361756|P2|STARTED|First Intervention||5
148962|NCT01653132|361757|P1|STARTED|First Intervention||5
148963|NCT01653028|361776|P5|NOT COMPLETED|Overall Study||0
148964|NCT01653028|361777|P4|NOT COMPLETED|Overall Study||0
148965|NCT01653028|361778|P3|NOT COMPLETED|Overall Study||0
148966|NCT01653028|361779|P2|NOT COMPLETED|Overall Study||0
148967|NCT01653028|361780|P1|NOT COMPLETED|Overall Study||0
148968|NCT01653028|361776|P5|COMPLETED|Overall Study||29
148969|NCT01653028|361777|P4|COMPLETED|Overall Study||10
148970|NCT01653028|361778|P3|COMPLETED|Overall Study||11
148971|NCT01653028|361779|P2|COMPLETED|Overall Study||10
148972|NCT01653028|361780|P1|COMPLETED|Overall Study||12
148973|NCT01653028|361776|P5|STARTED|Overall Study||29
148974|NCT01653028|361777|P4|STARTED|Overall Study||10
148975|NCT01653028|361778|P3|STARTED|Overall Study||11
148976|NCT01653028|361779|P2|STARTED|Overall Study||10
148977|NCT01653028|361780|P1|STARTED|Overall Study||12
148978|NCT01652976|361807|P1|NOT COMPLETED|Overall Study||0
148979|NCT01652976|361807|P1|COMPLETED|Overall Study||44
148980|NCT01652976|361807|P1|STARTED|Overall Study||44
148981|NCT01652885|361821|P1|NOT COMPLETED|Overall Study||1
148982|NCT01652885|361821|P1|COMPLETED|Overall Study||22
148983|NCT01652885|361821|P1|STARTED|Overall Study||23
148984|NCT01652872|361848|P2|NOT COMPLETED|Overall Study||153
148985|NCT01652872|361849|P1|NOT COMPLETED|Overall Study||145
148986|NCT01652872|361848|P2|COMPLETED|Overall Study||226
148987|NCT01652872|361849|P1|COMPLETED|Overall Study||232
148988|NCT01652872|361848|P2|Received Investigational Product|Overall Study||377
148989|NCT01652872|361849|P1|Received Investigational Product|Overall Study||377
148990|NCT01652872|361848|P2|STARTED|Overall Study||379
148991|NCT01652872|361849|P1|STARTED|Overall Study||377
148992|NCT01652729|361866|P3|NOT COMPLETED|Overall Study||14
148993|NCT01652729|361867|P2|NOT COMPLETED|Overall Study||13
148994|NCT01652729|361868|P1|NOT COMPLETED|Overall Study||27
148995|NCT01652729|361866|P3|COMPLETED|Overall Study||47
148996|NCT01652729|361867|P2|COMPLETED|Overall Study||109
148997|NCT01652729|361868|P1|COMPLETED|Overall Study|The double-enrolled subject’s reasons for withdrawal were LTFU and PV. Only PV is shown below.|155
148998|NCT01652729|361866|P3|Meal Test Evaluable|Overall Study||15
148999|NCT01652729|361867|P2|Meal Test Evaluable|Overall Study||31
149000|NCT01652729|361868|P1|Meal Test Evaluable|Overall Study|ITT subjects who ate >=75% of meal and did not miss 2-hour postprandial glucose measures at V3 and 8|44
149001|NCT01652729|361866|P3|Meal Test Subjects|Overall Study||20
149002|NCT01652729|361867|P2|Meal Test Subjects|Overall Study||41
149003|NCT01652729|361868|P1|Meal Test Subjects|Overall Study||60
149004|NCT01652729|361866|P3|Evaluable|Overall Study||43
149005|NCT01652729|361867|P2|Evaluable|Overall Study||91
149006|NCT01652729|361868|P1|Evaluable|Overall Study|Subjects who completed study procedures to Week 24 or beyond and had adequate study drug exposure|143
149007|NCT01652729|361866|P3|Treated|Overall Study||61
149008|NCT01652729|361867|P2|Treated|Overall Study||122
149009|NCT01652729|361868|P1|Treated|Overall Study|All subjects who received at least one dose of study medication even if not randomized.|181
149010|NCT01652729|361866|P3|Modified Intent-to-Treat|Overall Study||61
149011|NCT01652729|361867|P2|Modified Intent-to-Treat|Overall Study||122
149012|NCT01652729|361868|P1|Modified Intent-to-Treat|Overall Study|All randomized subjects who received at least one dose of study drug.|181
149013|NCT01652729|361866|P3|STARTED|Overall Study||61
149014|NCT01652729|361867|P2|STARTED|Overall Study||122
149015|NCT01652729|361868|P1|STARTED|Overall Study|One subject was enrolled twice at different sites. He was randomized to exenatide at both sites.|182
149016|NCT01652716|361890|P2|NOT COMPLETED|Overall Study||46
149017|NCT01652716|361891|P1|NOT COMPLETED|Overall Study||56
149018|NCT01652716|361890|P2|COMPLETED|Overall Study|* completed study|102
149019|NCT01652716|361891|P1|COMPLETED|Overall Study|* completed study|173
149020|NCT01652716|361890|P2|Completed 28-week|Overall Study||118
149021|NCT01652716|361891|P1|Completed 28-week|Overall Study||197
149022|NCT01652716|361890|P2|STARTED|Overall Study|Two subjects in the exenatide BID group withdrew from the study before receiving study drug.|148
149023|NCT01652716|361891|P1|STARTED|Overall Study||229
149024|NCT01652703|361911|P6|NOT COMPLETED|Overall Study||2
149025|NCT01652703|361912|P5|NOT COMPLETED|Overall Study||1
149026|NCT01652703|361913|P4|NOT COMPLETED|Overall Study||2
149027|NCT01652703|361914|P3|NOT COMPLETED|Overall Study||3
149028|NCT01652703|361915|P2|NOT COMPLETED|Overall Study||1
149029|NCT01652703|361916|P1|NOT COMPLETED|Overall Study||0
149030|NCT01652703|361911|P6|COMPLETED|Overall Study||51
149031|NCT01652703|361912|P5|COMPLETED|Overall Study||51
149032|NCT01652703|361913|P4|COMPLETED|Overall Study||50
149033|NCT01652703|361914|P3|COMPLETED|Overall Study||47
149034|NCT01652703|361915|P2|COMPLETED|Overall Study||50
149035|NCT01652703|361916|P1|COMPLETED|Overall Study||52
149036|NCT01652703|361911|P6|Received Treatment|Overall Study||53
149037|NCT01652703|361912|P5|Received Treatment|Overall Study||51
149038|NCT01652703|361913|P4|Received Treatment|Overall Study||52
149039|NCT01652703|361914|P3|Received Treatment|Overall Study||49
149040|NCT01652703|361915|P2|Received Treatment|Overall Study||50
149041|NCT01652703|361916|P1|Received Treatment|Overall Study||52
149042|NCT01652703|361911|P6|STARTED|Overall Study||53
149043|NCT01652703|361912|P5|STARTED|Overall Study||52
149044|NCT01652703|361913|P4|STARTED|Overall Study||52
149045|NCT01652703|361914|P3|STARTED|Overall Study||50
149046|NCT01652703|361915|P2|STARTED|Overall Study||51
149047|NCT01652703|361916|P1|STARTED|Overall Study||52
149048|NCT01652690|361974|P2|NOT COMPLETED|Overall Study||21
149049|NCT01652690|361975|P1|NOT COMPLETED|Overall Study||35
149050|NCT01652690|361974|P2|COMPLETED|Overall Study||279
149051|NCT01652690|361975|P1|COMPLETED|Overall Study||265
149052|NCT01652690|361974|P2|STARTED|Overall Study||300
149053|NCT01652690|361975|P1|STARTED|Overall Study||300
149054|NCT01652664|362009|P2|NOT COMPLETED|Overall Study||1
149055|NCT01652664|362010|P1|NOT COMPLETED|Overall Study||6
149056|NCT01652664|362009|P2|COMPLETED|Overall Study||74
149057|NCT01652664|362010|P1|COMPLETED|Overall Study||71
149058|NCT01652664|362009|P2|STARTED|Overall Study||75
149059|NCT01652664|362010|P1|STARTED|Overall Study||77
149060|NCT01652573|362019|P2|NOT COMPLETED|Overall Study||1
149061|NCT01652573|362020|P1|NOT COMPLETED|Overall Study||0
149062|NCT01652573|362019|P2|COMPLETED|Overall Study||10
149063|NCT01652573|362020|P1|COMPLETED|Overall Study||10
149064|NCT01652573|362019|P2|STARTED|Overall Study||11
149065|NCT01652573|362020|P1|STARTED|Overall Study||10
149066|NCT01652534|362062|P2|NOT COMPLETED|Overall Study||0
149067|NCT01652534|362063|P1|NOT COMPLETED|Overall Study||1
149068|NCT01652534|362062|P2|COMPLETED|Overall Study||1
149069|NCT01652534|362063|P1|COMPLETED|Overall Study||1
149070|NCT01652534|362062|P2|STARTED|Overall Study||1
149071|NCT01652534|362063|P1|STARTED|Overall Study||2
149072|NCT01652495|362091|P2|NOT COMPLETED|Overall Study||2
149073|NCT01652495|362092|P1|NOT COMPLETED|Overall Study||2
149074|NCT01652495|362091|P2|COMPLETED|Overall Study||20
149075|NCT01652495|362092|P1|COMPLETED|Overall Study||20
149076|NCT01652495|362091|P2|STARTED|Overall Study||22
149077|NCT01652495|362092|P1|STARTED|Overall Study||22
149078|NCT01652469|362104|P2|NOT COMPLETED|Overall Study||6
149079|NCT01652469|362105|P1|NOT COMPLETED|Overall Study||1
149080|NCT01652469|362104|P2|COMPLETED|Overall Study||36
149081|NCT01652469|362105|P1|COMPLETED|Overall Study||37
149082|NCT01652469|362104|P2|STARTED|Overall Study||42
149083|NCT01652469|362105|P1|STARTED|Overall Study||38
149084|NCT01652287|362121|P2|NOT COMPLETED|Overall Study||0
149085|NCT01652287|362122|P1|NOT COMPLETED|Overall Study||2
149086|NCT01652287|362121|P2|COMPLETED|Overall Study||31
149087|NCT01652287|362122|P1|COMPLETED|Overall Study|• Did not receive allocated intervention (withdrew consent) (n=2)|29
149088|NCT01652287|362121|P2|STARTED|Overall Study||31
149089|NCT01652287|362122|P1|STARTED|Overall Study||31
149090|NCT01652040|362130|P2|NOT COMPLETED|Overall Study||2
149091|NCT01652040|362131|P1|NOT COMPLETED|Overall Study||2
149092|NCT01652040|362130|P2|COMPLETED|Overall Study||11
149093|NCT01652040|362131|P1|COMPLETED|Overall Study||11
149094|NCT01652040|362130|P2|STARTED|Overall Study||13
149095|NCT01652040|362131|P1|STARTED|Overall Study||13
149096|NCT01652001|362141|P2|NOT COMPLETED|Overall Study||6
149097|NCT01652001|362142|P1|NOT COMPLETED|Overall Study||9
149098|NCT01652001|362141|P2|COMPLETED|Overall Study||79
149099|NCT01652001|362142|P1|COMPLETED|Overall Study||91
149100|NCT01652001|362141|P2|STARTED|Overall Study||85
149101|NCT01652001|362142|P1|STARTED|Overall Study||100
149102|NCT01651949|362153|P3|NOT COMPLETED|Overall Study||31
149103|NCT01651949|362154|P2|NOT COMPLETED|Overall Study||86
149104|NCT01651949|362155|P1|NOT COMPLETED|Overall Study||53
149105|NCT01651949|362153|P3|COMPLETED|Overall Study||282
149106|NCT01651949|362154|P2|COMPLETED|Overall Study||1015
149107|NCT01651949|362155|P1|COMPLETED|Overall Study||1053
149108|NCT01651949|362153|P3|Vaccination 3|Overall Study||291
149109|NCT01651949|362154|P2|Vaccination 3|Overall Study||1037
149110|NCT01651949|362155|P1|Vaccination 3|Overall Study||1067
149111|NCT01651949|362153|P3|Vaccination 2|Overall Study||298
149112|NCT01651949|362154|P2|Vaccination 2|Overall Study||1069
149113|NCT01651949|362155|P1|Vaccination 2|Overall Study||1089
149114|NCT01651949|362153|P3|Vaccination 1|Overall Study||313
149115|NCT01651949|362154|P2|Vaccination 1|Overall Study||1099
149116|NCT01651949|362155|P1|Vaccination 1|Overall Study||1103
149117|NCT01651949|362153|P3|STARTED|Overall Study||313
149118|NCT01651949|362154|P2|STARTED|Overall Study||1101
149119|NCT01651949|362155|P1|STARTED|Overall Study||1106
149120|NCT01651936|362175|P3|NOT COMPLETED|Extension Study||14
149121|NCT01651936|362176|P2|NOT COMPLETED|Extension Study||0
149122|NCT01651936|362177|P1|NOT COMPLETED|Extension Study||0
149123|NCT01651936|362175|P3|COMPLETED|Extension Study||0
149124|NCT01651936|362176|P2|COMPLETED|Extension Study||0
149125|NCT01651936|362177|P1|COMPLETED|Extension Study||0
149126|NCT01651936|362175|P3|STARTED|Extension Study|Includes completers and early escapees from the Base Study|14
149127|NCT01651936|362176|P2|STARTED|Extension Study||0
149128|NCT01651936|362177|P1|STARTED|Extension Study||0
149129|NCT01651936|362175|P3|NOT COMPLETED|Base Study||0
149130|NCT01651936|362176|P2|NOT COMPLETED|Base Study||25
149131|NCT01651936|362177|P1|NOT COMPLETED|Base Study||27
149132|NCT01651936|362175|P3|COMPLETED|Base Study||0
149133|NCT01651936|362176|P2|COMPLETED|Base Study||1
149134|NCT01651936|362177|P1|COMPLETED|Base Study||3
149135|NCT01651936|362175|P3|STARTED|Base Study||0
149136|NCT01651936|362176|P2|STARTED|Base Study||26
149137|NCT01651936|362177|P1|STARTED|Base Study||30
149138|NCT01651806|362203|P5|NOT COMPLETED|Overall Study||0
149139|NCT01651806|362204|P4|NOT COMPLETED|Overall Study||0
149140|NCT01651806|362205|P3|NOT COMPLETED|Overall Study||0
149141|NCT01651806|362206|P2|NOT COMPLETED|Overall Study||0
149142|NCT01651806|362207|P1|NOT COMPLETED|Overall Study||0
149143|NCT01651806|362203|P5|COMPLETED|Overall Study||8
149144|NCT01651806|362204|P4|COMPLETED|Overall Study||7
149145|NCT01651806|362205|P3|COMPLETED|Overall Study||25
149146|NCT01651806|362206|P2|COMPLETED|Overall Study||12
149147|NCT01651806|362207|P1|COMPLETED|Overall Study||13
149148|NCT01651806|362203|P5|STARTED|Overall Study||8
149149|NCT01651806|362204|P4|STARTED|Overall Study||7
149150|NCT01651806|362205|P3|STARTED|Overall Study||25
149151|NCT01651806|362206|P2|STARTED|Overall Study||12
149152|NCT01651806|362207|P1|STARTED|Overall Study||13
149153|NCT01651793|362224|P4|NOT COMPLETED|Overall Study||1
149154|NCT01651793|362225|P3|NOT COMPLETED|Overall Study||0
149155|NCT01651793|362226|P2|NOT COMPLETED|Overall Study||0
149156|NCT01651793|362227|P1|NOT COMPLETED|Overall Study||0
149157|NCT01651793|362224|P4|COMPLETED|Overall Study||5
149158|NCT01651793|362225|P3|COMPLETED|Overall Study||6
149159|NCT01651793|362226|P2|COMPLETED|Overall Study||6
149160|NCT01651793|362227|P1|COMPLETED|Overall Study||6
149161|NCT01651793|362224|P4|STARTED|Overall Study||6
149162|NCT01651793|362225|P3|STARTED|Overall Study||6
149163|NCT01651793|362226|P2|STARTED|Overall Study||6
149164|NCT01651793|362227|P1|STARTED|Overall Study||6
149165|NCT01651780|362247|P2|NOT COMPLETED|Overall Study||10
149166|NCT01651780|362248|P1|NOT COMPLETED|Overall Study||11
149167|NCT01651780|362247|P2|COMPLETED|Overall Study||388
149168|NCT01651780|362248|P1|COMPLETED|Overall Study||394
149169|NCT01651780|362247|P2|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|0
149170|NCT01651780|362248|P1|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|65
149171|NCT01651780|362247|P2|Received at Least 1 Dose of Study Drug|Overall Study||394
149172|NCT01651780|362248|P1|Received at Least 1 Dose of Study Drug|Overall Study|All but 1 participant in the bivalirudin group (withdrew consent) comprised the ITT population.|393
149173|NCT01651780|362247|P2|Intent-To-Treat (ITT) Population|Overall Study||398
149174|NCT01651780|362248|P1|Intent-To-Treat (ITT) Population|Overall Study||404
149175|NCT01651780|362247|P2|STARTED|Overall Study||398
149176|NCT01651780|362248|P1|STARTED|Overall Study||405
149177|NCT01651442|362280|P6|NOT COMPLETED|Phase II Treatment||10
149178|NCT01651442|362281|P5|NOT COMPLETED|Phase II Treatment||6
149179|NCT01651442|362282|P4|NOT COMPLETED|Phase II Treatment||12
149180|NCT01651442|362283|P3|NOT COMPLETED|Phase II Treatment||2
149181|NCT01651442|362284|P2|NOT COMPLETED|Phase II Treatment||0
149182|NCT01651442|362285|P1|NOT COMPLETED|Phase II Treatment||0
149183|NCT01651442|362280|P6|COMPLETED|Phase II Treatment||17
149184|NCT01651442|362281|P5|COMPLETED|Phase II Treatment||21
149185|NCT01651442|362282|P4|COMPLETED|Phase II Treatment||15
149186|NCT01651442|362283|P3|COMPLETED|Phase II Treatment||25
149187|NCT01651442|362284|P2|COMPLETED|Phase II Treatment||0
149188|NCT01651442|362285|P1|COMPLETED|Phase II Treatment||0
149189|NCT01651442|362280|P6|STARTED|Phase II Treatment||27
149190|NCT01651442|362281|P5|STARTED|Phase II Treatment||27
149191|NCT01651442|362282|P4|STARTED|Phase II Treatment||27
149192|NCT01651442|362283|P3|STARTED|Phase II Treatment||27
149193|NCT01651442|362284|P2|STARTED|Phase II Treatment||0
149194|NCT01651442|362285|P1|STARTED|Phase II Treatment||0
149195|NCT01651442|362280|P6|NOT COMPLETED|Phase I Treatment||0
149196|NCT01651442|362281|P5|NOT COMPLETED|Phase I Treatment||0
149197|NCT01651442|362282|P4|NOT COMPLETED|Phase I Treatment||0
149198|NCT01651442|362283|P3|NOT COMPLETED|Phase I Treatment||0
149199|NCT01651442|362284|P2|NOT COMPLETED|Phase I Treatment||27
149200|NCT01651442|362285|P1|NOT COMPLETED|Phase I Treatment||16
149201|NCT01651442|362280|P6|COMPLETED|Phase I Treatment||0
149202|NCT01651442|362281|P5|COMPLETED|Phase I Treatment||0
149203|NCT01651442|362282|P4|COMPLETED|Phase I Treatment||0
149204|NCT01651442|362283|P3|COMPLETED|Phase I Treatment||0
149205|NCT01651442|362284|P2|COMPLETED|Phase I Treatment||80
149206|NCT01651442|362285|P1|COMPLETED|Phase I Treatment||88
149207|NCT01651442|362280|P6|STARTED|Phase I Treatment||0
149208|NCT01651442|362281|P5|STARTED|Phase I Treatment||0
149209|NCT01651442|362282|P4|STARTED|Phase I Treatment||0
149210|NCT01651442|362283|P3|STARTED|Phase I Treatment||0
149211|NCT01651442|362284|P2|STARTED|Phase I Treatment||107
149212|NCT01651442|362285|P1|STARTED|Phase I Treatment||104
149213|NCT01651403|362299|P2|NOT COMPLETED|Open-Label TDF Phase (Weeks 49/73-96)||22
149214|NCT01651403|362300|P1|NOT COMPLETED|Open-Label TDF Phase (Weeks 49/73-96)||47
149215|NCT01651403|362299|P2|COMPLETED|Open-Label TDF Phase (Weeks 49/73-96)||3
149216|NCT01651403|362300|P1|COMPLETED|Open-Label TDF Phase (Weeks 49/73-96)||9
149217|NCT01651403|362299|P2|STARTED|Open-Label TDF Phase (Weeks 49/73-96)|1 participant completed the Double-Blind Phase but did not enter the Open-Label TDF Phase.|25
149218|NCT01651403|362300|P1|STARTED|Open-Label TDF Phase (Weeks 49/73-96)||56
149219|NCT01651403|362299|P2|NOT COMPLETED|Double-Blind Period (Through Week 48/72)||4
149220|NCT01651403|362300|P1|NOT COMPLETED|Double-Blind Period (Through Week 48/72)||4
149221|NCT01651403|362299|P2|COMPLETED|Double-Blind Period (Through Week 48/72)||26
149222|NCT01651403|362300|P1|COMPLETED|Double-Blind Period (Through Week 48/72)||56
149223|NCT01651403|362299|P2|STARTED|Double-Blind Period (Through Week 48/72)||30
149224|NCT01651403|362300|P1|STARTED|Double-Blind Period (Through Week 48/72)||60
149225|NCT01651351|362330|P2|NOT COMPLETED|Overall Study||0
149226|NCT01651351|362331|P1|NOT COMPLETED|Overall Study||0
149227|NCT01651351|362330|P2|COMPLETED|Overall Study||15
149228|NCT01651351|362331|P1|COMPLETED|Overall Study||15
149229|NCT01651351|362330|P2|STARTED|Overall Study||15
149230|NCT01651351|362331|P1|STARTED|Overall Study||15
149231|NCT01651260|362348|P1|NOT COMPLETED|Overall Study||3
149232|NCT01651260|362348|P1|COMPLETED|Overall Study||62
149233|NCT01651260|362348|P1|STARTED|Overall Study||65
149234|NCT01651208|362355|P2|NOT COMPLETED|Overall Study||16
149235|NCT01651208|362356|P1|NOT COMPLETED|Overall Study||14
149236|NCT01651208|362355|P2|COMPLETED|Overall Study|16 subjects had no pharmacy claims data to analyze primary outcome|209
149237|NCT01651208|362356|P1|COMPLETED|Overall Study|14 patients had no pharmacy claims data to analyze primary outcome|213
149238|NCT01651208|362355|P2|STARTED|Overall Study||225
149239|NCT01651208|362356|P1|STARTED|Overall Study||227
149240|NCT01651117|362368|P4|NOT COMPLETED|Overall Study||2
149241|NCT01651117|362369|P3|NOT COMPLETED|Overall Study||2
149242|NCT01651117|362370|P2|NOT COMPLETED|Overall Study||3
149243|NCT01651117|362371|P1|NOT COMPLETED|Overall Study||2
149244|NCT01651117|362368|P4|COMPLETED|Overall Study||68
149245|NCT01651117|362369|P3|COMPLETED|Overall Study||47
149246|NCT01651117|362370|P2|COMPLETED|Overall Study||202
149247|NCT01651117|362371|P1|COMPLETED|Overall Study||154
149248|NCT01651117|362368|P4|STARTED|Overall Study||70
149249|NCT01651117|362369|P3|STARTED|Overall Study||49
149250|NCT01651117|362370|P2|STARTED|Overall Study||205
149251|NCT01651117|362371|P1|STARTED|Overall Study||156
149252|NCT01651104|362437|P1|NOT COMPLETED|Overall Study||0
149253|NCT01651104|362437|P1|COMPLETED|Overall Study||63
149254|NCT01651104|362437|P1|STARTED|Overall Study||63
149255|NCT01651078|362444|P1|NOT COMPLETED|Overall Study||26
149256|NCT01651078|362444|P1|COMPLETED|Overall Study||16
149257|NCT01651078|362444|P1|STARTED|Overall Study|Two (2) out of 44 patients were enrolled but did not go on to have the NeuroBlate Procedure.|42
149258|NCT01651052|362451|P1|NOT COMPLETED|Overall Study||26
149259|NCT01651052|362451|P1|COMPLETED|Overall Study||107
149260|NCT01651052|362451|P1|Study Valve Group|Overall Study||133
149261|NCT01651052|362451|P1|STARTED|Overall Study||133
149262|NCT01651039|362471|P1|NOT COMPLETED|Overall Study||30
149263|NCT01651039|362471|P1|COMPLETED|Overall Study||2
149264|NCT01651039|362471|P1|STARTED|Overall Study||32
149265|NCT01651000|362484|P2|NOT COMPLETED|Overall Study||28
149266|NCT01651000|362485|P1|NOT COMPLETED|Overall Study||10
149267|NCT01651000|362484|P2|COMPLETED|Overall Study||113
149268|NCT01651000|362485|P1|COMPLETED|Overall Study||62
149269|NCT01651000|362484|P2|Entered Extension Study|Overall Study||93
149270|NCT01651000|362485|P1|Entered Extension Study|Overall Study||50
149271|NCT01651000|362484|P2|STARTED|Overall Study||141
149272|NCT01651000|362485|P1|STARTED|Overall Study||72
149273|NCT01650844|362499|P2|NOT COMPLETED|Overall Study||4
149274|NCT01650844|362500|P1|NOT COMPLETED|Overall Study||1
149275|NCT01650844|362499|P2|COMPLETED|Overall Study||196
149276|NCT01650844|362500|P1|COMPLETED|Overall Study||199
149277|NCT01650844|362499|P2|STARTED|Overall Study||200
149278|NCT01650844|362500|P1|STARTED|Overall Study||200
149279|NCT01650831|362506|P1|NOT COMPLETED|Overall Study||1
149280|NCT01650831|362506|P1|COMPLETED|Overall Study||112
149281|NCT01650831|362506|P1|STARTED|Overall Study||113
149282|NCT01650805|362516|P2|NOT COMPLETED|Overall Study||0
149283|NCT01650805|362517|P1|NOT COMPLETED|Overall Study||1
149284|NCT01650805|362516|P2|COMPLETED|Overall Study||152
149285|NCT01650805|362517|P1|COMPLETED|Overall Study|Completed means patient initiated and discontinued study treatment.|154
149286|NCT01650805|362516|P2|STARTED|Overall Study||152
149287|NCT01650805|362517|P1|STARTED|Overall Study|Started means patient has been randomized.|155
149288|NCT01650779|362527|P1|NOT COMPLETED|Overall Study||1
149289|NCT01650779|362527|P1|COMPLETED|Overall Study||14
149290|NCT01650779|362527|P1|STARTED|Overall Study||15
149291|NCT01650636|362536|P2|NOT COMPLETED|9 Month Visit||0
149292|NCT01650636|362537|P1|NOT COMPLETED|9 Month Visit||0
149293|NCT01650636|362536|P2|COMPLETED|9 Month Visit||129
149294|NCT01650636|362537|P1|COMPLETED|9 Month Visit||135
149295|NCT01650636|362536|P2|STARTED|9 Month Visit||129
149296|NCT01650636|362537|P1|STARTED|9 Month Visit||135
149297|NCT01650636|362536|P2|NOT COMPLETED|Washout up to 9 Months||3
149298|NCT01650636|362537|P1|NOT COMPLETED|Washout up to 9 Months||6
149299|NCT01650636|362536|P2|COMPLETED|Washout up to 9 Months||129
149300|NCT01650636|362537|P1|COMPLETED|Washout up to 9 Months||135
149301|NCT01650636|362536|P2|STARTED|Washout up to 9 Months||132
149302|NCT01650636|362537|P1|STARTED|Washout up to 9 Months||141
149303|NCT01650636|362536|P2|NOT COMPLETED|5 Month Visit||0
149304|NCT01650636|362537|P1|NOT COMPLETED|5 Month Visit||0
149305|NCT01650636|362536|P2|COMPLETED|5 Month Visit||132
149306|NCT01650636|362537|P1|COMPLETED|5 Month Visit||141
149307|NCT01650636|362536|P2|STARTED|5 Month Visit||132
149308|NCT01650636|362537|P1|STARTED|5 Month Visit||141
149309|NCT01650636|362536|P2|NOT COMPLETED|Washout up to 5 Months||18
149310|NCT01650636|362537|P1|NOT COMPLETED|Washout up to 5 Months||9
149311|NCT01650636|362536|P2|COMPLETED|Washout up to 5 Months||132
149312|NCT01650636|362537|P1|COMPLETED|Washout up to 5 Months||141
149313|NCT01650636|362536|P2|STARTED|Washout up to 5 Months||150
149314|NCT01650636|362537|P1|STARTED|Washout up to 5 Months||150
149315|NCT01650636|362536|P2|NOT COMPLETED|Intervention Phase||0
149316|NCT01650636|362537|P1|NOT COMPLETED|Intervention Phase||0
149317|NCT01650636|362536|P2|COMPLETED|Intervention Phase||150
149318|NCT01650636|362537|P1|COMPLETED|Intervention Phase||150
149319|NCT01650636|362536|P2|STARTED|Intervention Phase||150
149320|NCT01650636|362537|P1|STARTED|Intervention Phase||150
149321|NCT01650545|362557|P2|NOT COMPLETED|Overall Study||0
149322|NCT01650545|362558|P1|NOT COMPLETED|Overall Study||0
149323|NCT01650545|362557|P2|COMPLETED|Overall Study||10
149324|NCT01650545|362558|P1|COMPLETED|Overall Study||11
149325|NCT01650545|362557|P2|STARTED|Overall Study||10
149326|NCT01650545|362558|P1|STARTED|Overall Study||11
149327|NCT01650519|362570|P2|NOT COMPLETED|Overall Study||0
149328|NCT01650519|362571|P1|NOT COMPLETED|Overall Study||1
149329|NCT01650519|362570|P2|COMPLETED|Overall Study||31
149330|NCT01650519|362571|P1|COMPLETED|Overall Study||19
149331|NCT01650519|362570|P2|STARTED|Overall Study||31
149332|NCT01650519|362571|P1|STARTED|Overall Study||20
149333|NCT01650350|362589|P1|NOT COMPLETED|Overall Study||0
149334|NCT01650350|362589|P1|COMPLETED|Overall Study||7
149335|NCT01650350|362589|P1|STARTED|Overall Study||7
149336|NCT01650324|362600|P5|NOT COMPLETED|Overall Study||0
149337|NCT01650324|362601|P4|NOT COMPLETED|Overall Study||0
149338|NCT01650324|362602|P3|NOT COMPLETED|Overall Study||0
149339|NCT01650324|362603|P2|NOT COMPLETED|Overall Study||0
149340|NCT01650324|362604|P1|NOT COMPLETED|Overall Study||0
149341|NCT01650324|362600|P5|COMPLETED|Overall Study||6
149342|NCT01650324|362601|P4|COMPLETED|Overall Study||6
149343|NCT01650324|362602|P3|COMPLETED|Overall Study||6
149344|NCT01650324|362603|P2|COMPLETED|Overall Study||6
149345|NCT01650324|362604|P1|COMPLETED|Overall Study||8
149346|NCT01650324|362600|P5|STARTED|Overall Study||6
149347|NCT01650324|362601|P4|STARTED|Overall Study||6
149348|NCT01650324|362602|P3|STARTED|Overall Study||6
149349|NCT01650324|362603|P2|STARTED|Overall Study||6
149350|NCT01650324|362604|P1|STARTED|Overall Study||8
149351|NCT01650285|362633|P1|NOT COMPLETED|Overall Study||1
149352|NCT01650285|362633|P1|COMPLETED|Overall Study||4
149353|NCT01650285|362633|P1|STARTED|Overall Study||5
149354|NCT01650259|362640|P2|NOT COMPLETED|Overall Study||235
149355|NCT01650259|362641|P1|NOT COMPLETED|Overall Study||1043
149356|NCT01650259|362640|P2|COMPLETED|Overall Study||2128
149357|NCT01650259|362641|P1|COMPLETED|Overall Study||1470
149358|NCT01650259|362640|P2|STARTED|Overall Study|Started are the registered patients|2363
149359|NCT01650259|362641|P1|STARTED|Overall Study|Started are the registered patients|2513
149360|NCT01650246|362646|P1|NOT COMPLETED|Overall Study||143
149361|NCT01650246|362646|P1|COMPLETED|Overall Study||0
149362|NCT01650246|362646|P1|STARTED|Overall Study||143
149363|NCT01650194|362651|P1|NOT COMPLETED|Overall Study||47
149364|NCT01650194|362651|P1|COMPLETED|Overall Study||13
149365|NCT01650194|362651|P1|Treated|Overall Study||60
149366|NCT01650194|362651|P1|STARTED|Overall Study||60
149367|NCT01649947|362676|P2|NOT COMPLETED|Overall Study||18
149368|NCT01649947|362677|P1|NOT COMPLETED|Overall Study||12
149369|NCT01649947|362676|P2|COMPLETED|Overall Study||2
149370|NCT01649947|362677|P1|COMPLETED|Overall Study||0
149371|NCT01649947|362676|P2|STARTED|Overall Study||20
149372|NCT01649947|362677|P1|STARTED|Overall Study||12
149373|NCT01649856|362687|P2|NOT COMPLETED|Overall Study||78
149374|NCT01649856|362688|P1|NOT COMPLETED|Overall Study||139
149375|NCT01649856|362687|P2|COMPLETED|Overall Study||125
149376|NCT01649856|362688|P1|COMPLETED|Overall Study||230
149377|NCT01649856|362687|P2|STARTED|Overall Study||203
149378|NCT01649856|362688|P1|STARTED|Overall Study||369
149379|NCT01649804|362720|P1|NOT COMPLETED|Overall Study||8
149380|NCT01649804|362720|P1|COMPLETED|Overall Study||4
149381|NCT01649804|362720|P1|STARTED|Overall Study||12
149382|NCT01649791|362732|P1|NOT COMPLETED|Overall Study||3
149383|NCT01649791|362732|P1|COMPLETED|Overall Study||5
149384|NCT01649791|362732|P1|STARTED|Overall Study||8
149385|NCT01649765|362741|P2|NOT COMPLETED|Overall Study||8
149386|NCT01649765|362742|P1|NOT COMPLETED|Overall Study||9
149387|NCT01649765|362741|P2|COMPLETED|Overall Study||45
149388|NCT01649765|362742|P1|COMPLETED|Overall Study||31
149389|NCT01649765|362741|P2|STARTED|Overall Study||53
149390|NCT01649765|362742|P1|STARTED|Overall Study||40
149391|NCT01649609|362770|P2|NOT COMPLETED|Overall Study||0
149392|NCT01649609|362771|P1|NOT COMPLETED|Overall Study||0
149393|NCT01649609|362770|P2|COMPLETED|Overall Study||20
149394|NCT01649609|362771|P1|COMPLETED|Overall Study||20
149395|NCT01649609|362770|P2|STARTED|Overall Study||20
149396|NCT01649609|362771|P1|STARTED|Overall Study||20
149397|NCT01649596|362781|P2|NOT COMPLETED|Overall Study||0
149398|NCT01649596|362782|P1|NOT COMPLETED|Overall Study||0
149399|NCT01649596|362781|P2|COMPLETED|Overall Study||48
149400|NCT01649596|362782|P1|COMPLETED|Overall Study||46
149401|NCT01649596|362781|P2|STARTED|Overall Study||48
149402|NCT01649596|362782|P1|STARTED|Overall Study||46
149403|NCT01649557|362793|P3|NOT COMPLETED|Overall Study||9
149404|NCT01649557|362794|P2|NOT COMPLETED|Overall Study||14
149405|NCT01649557|362795|P1|NOT COMPLETED|Overall Study||44
149406|NCT01649557|362793|P3|COMPLETED|Overall Study||15
149407|NCT01649557|362794|P2|COMPLETED|Overall Study||27
149408|NCT01649557|362795|P1|COMPLETED|Overall Study||135
149409|NCT01649557|362793|P3|52-week Enrollers|Overall Study||2
149410|NCT01649557|362794|P2|52-week Enrollers|Overall Study||6
149411|NCT01649557|362795|P1|52-week Enrollers|Overall Study||20
149412|NCT01649557|362793|P3|6-week Enrollers|Overall Study||22
149413|NCT01649557|362794|P2|6-week Enrollers|Overall Study||35
149414|NCT01649557|362795|P1|6-week Enrollers|Overall Study||159
149415|NCT01649557|362793|P3|STARTED|Overall Study||24
149416|NCT01649557|362794|P2|STARTED|Overall Study||41
149417|NCT01649557|362795|P1|STARTED|Overall Study||179
149418|NCT01649505|362832|P2|NOT COMPLETED|Overall Study||1
149419|NCT01649505|362833|P1|NOT COMPLETED|Overall Study||1
149420|NCT01649505|362832|P2|COMPLETED|Overall Study||0
149421|NCT01649505|362833|P1|COMPLETED|Overall Study||0
149422|NCT01649505|362832|P2|STARTED|Overall Study||1
149423|NCT01649505|362833|P1|STARTED|Overall Study||1
149424|NCT01649427|362841|P2|NOT COMPLETED|Overall Study||12
149425|NCT01649427|362842|P1|NOT COMPLETED|Overall Study||11
149426|NCT01649427|362841|P2|COMPLETED|Overall Study||26
149427|NCT01649427|362842|P1|COMPLETED|Overall Study||24
149428|NCT01649427|362841|P2|STARTED|Overall Study||38
149429|NCT01649427|362842|P1|STARTED|Overall Study||35
149430|NCT01649375|362861|P5|NOT COMPLETED|Week 16 up to Week 260||5
149431|NCT01649375|362862|P4|NOT COMPLETED|Week 16 up to Week 260||12
149432|NCT01649375|362863|P3|NOT COMPLETED|Week 16 up to Week 260||0
149433|NCT01649375|362864|P2|NOT COMPLETED|Week 16 up to Week 260||13
149434|NCT01649375|362865|P1|NOT COMPLETED|Week 16 up to Week 260||20
149435|NCT01649375|362861|P5|COMPLETED|Week 16 up to Week 260||29
149436|NCT01649375|362862|P4|COMPLETED|Week 16 up to Week 260||20
149437|NCT01649375|362863|P3|COMPLETED|Week 16 up to Week 260||0
149438|NCT01649375|362864|P2|COMPLETED|Week 16 up to Week 260||53
149439|NCT01649375|362865|P1|COMPLETED|Week 16 up to Week 260||48
149440|NCT01649375|362861|P5|STARTED|Week 16 up to Week 260||34
149441|NCT01649375|362862|P4|STARTED|Week 16 up to Week 260||32
149442|NCT01649375|362863|P3|STARTED|Week 16 up to Week 260||0
149443|NCT01649375|362864|P2|STARTED|Week 16 up to Week 260||66
149444|NCT01649375|362865|P1|STARTED|Week 16 up to Week 260||68
149445|NCT01649375|362861|P5|NOT COMPLETED|Up to Week 16||0
149446|NCT01649375|362862|P4|NOT COMPLETED|Up to Week 16||0
149447|NCT01649375|362863|P3|NOT COMPLETED|Up to Week 16||8
149448|NCT01649375|362864|P2|NOT COMPLETED|Up to Week 16||6
149449|NCT01649375|362865|P1|NOT COMPLETED|Up to Week 16||5
149450|NCT01649375|362861|P5|COMPLETED|Up to Week 16||0
149451|NCT01649375|362862|P4|COMPLETED|Up to Week 16||0
149452|NCT01649375|362863|P3|COMPLETED|Up to Week 16||66
149453|NCT01649375|362864|P2|COMPLETED|Up to Week 16||66
149454|NCT01649375|362865|P1|COMPLETED|Up to Week 16||68
149455|NCT01649375|362861|P5|STARTED|Up to Week 16||0
149456|NCT01649375|362862|P4|STARTED|Up to Week 16||0
149457|NCT01649375|362863|P3|STARTED|Up to Week 16||74
149458|NCT01649375|362864|P2|STARTED|Up to Week 16||72
149459|NCT01649375|362865|P1|STARTED|Up to Week 16||73
149460|NCT01649362|362896|P2|NOT COMPLETED|Overall Study||14
149461|NCT01649362|362897|P1|NOT COMPLETED|Overall Study||1
149462|NCT01649362|362896|P2|COMPLETED|Overall Study||40
149463|NCT01649362|362897|P1|COMPLETED|Overall Study||46
149464|NCT01649362|362896|P2|STARTED|Overall Study||54
149465|NCT01649362|362897|P1|STARTED|Overall Study||47
149466|NCT01649297|362912|P5|NOT COMPLETED|Overall Study||4
149467|NCT01649297|362913|P4|NOT COMPLETED|Overall Study||19
149468|NCT01649297|362914|P3|NOT COMPLETED|Overall Study||17
149469|NCT01649297|362915|P2|NOT COMPLETED|Overall Study||13
149470|NCT01649297|362916|P1|NOT COMPLETED|Overall Study||14
149471|NCT01649297|362912|P5|COMPLETED|Overall Study||103
149472|NCT01649297|362913|P4|COMPLETED|Overall Study||201
149473|NCT01649297|362914|P3|COMPLETED|Overall Study||202
149474|NCT01649297|362915|P2|COMPLETED|Overall Study||205
149475|NCT01649297|362916|P1|COMPLETED|Overall Study||205
149476|NCT01649297|362912|P5|STARTED|Overall Study|randomised|107
149477|NCT01649297|362913|P4|STARTED|Overall Study|randomised|220
149478|NCT01649297|362914|P3|STARTED|Overall Study|randomised|219
149479|NCT01649297|362915|P2|STARTED|Overall Study|randomised|218
149480|NCT01649297|362916|P1|STARTED|Overall Study|randomised|219
149481|NCT01649271|362935|P2|NOT COMPLETED|Overall Study||7
149482|NCT01649271|362936|P1|NOT COMPLETED|Overall Study||6
149483|NCT01649271|362935|P2|COMPLETED|Overall Study||0
149484|NCT01649271|362936|P1|COMPLETED|Overall Study||0
149485|NCT01649271|362935|P2|STARTED|Overall Study||7
149486|NCT01649271|362936|P1|STARTED|Overall Study||6
149487|NCT01649232|362951|P2|NOT COMPLETED|Overall Study||0
149488|NCT01649232|362952|P1|NOT COMPLETED|Overall Study||2
149489|NCT01649232|362951|P2|COMPLETED|Overall Study||30
149490|NCT01649232|362952|P1|COMPLETED|Overall Study|technical problems or excessive artifacts, two data sets were excluded from further analysis.|28
149491|NCT01649232|362951|P2|STARTED|Overall Study||30
149492|NCT01649232|362952|P1|STARTED|Overall Study||30
149493|NCT01649180|362972|P1|NOT COMPLETED|Overall Study||0
149494|NCT01649180|362972|P1|COMPLETED|Overall Study||3
149495|NCT01649180|362972|P1|STARTED|Overall Study||3
149496|NCT01648920|362980|P1|NOT COMPLETED|Overall Study||0
149497|NCT01648920|362980|P1|COMPLETED|Overall Study||50
149498|NCT01648920|362980|P1|STARTED|Overall Study||50
149499|NCT01648790|363004|P5|NOT COMPLETED|Treatment 5||0
149500|NCT01648790|363005|P4|NOT COMPLETED|Treatment 5||0
149501|NCT01648790|363006|P3|NOT COMPLETED|Treatment 5||0
149502|NCT01648790|363007|P2|NOT COMPLETED|Treatment 5||0
149503|NCT01648790|363008|P1|NOT COMPLETED|Treatment 5||0
149504|NCT01648790|363004|P5|COMPLETED|Treatment 5||4
149505|NCT01648790|363005|P4|COMPLETED|Treatment 5||3
149506|NCT01648790|363006|P3|COMPLETED|Treatment 5||4
149507|NCT01648790|363007|P2|COMPLETED|Treatment 5||4
149508|NCT01648790|363008|P1|COMPLETED|Treatment 5||4
149509|NCT01648790|363004|P5|STARTED|Treatment 5||4
149510|NCT01648790|363005|P4|STARTED|Treatment 5||3
149511|NCT01648790|363006|P3|STARTED|Treatment 5||4
149512|NCT01648790|363007|P2|STARTED|Treatment 5||4
149513|NCT01648790|363008|P1|STARTED|Treatment 5||4
149514|NCT01648790|363004|P5|NOT COMPLETED|Treatment 4||0
149515|NCT01648790|363005|P4|NOT COMPLETED|Treatment 4||0
149516|NCT01648790|363006|P3|NOT COMPLETED|Treatment 4||0
149517|NCT01648790|363007|P2|NOT COMPLETED|Treatment 4||0
149518|NCT01648790|363008|P1|NOT COMPLETED|Treatment 4||0
149519|NCT01648790|363004|P5|COMPLETED|Treatment 4||4
149520|NCT01648790|363005|P4|COMPLETED|Treatment 4||3
149521|NCT01648790|363006|P3|COMPLETED|Treatment 4||4
149522|NCT01648790|363007|P2|COMPLETED|Treatment 4||4
149523|NCT01648790|363008|P1|COMPLETED|Treatment 4||4
149524|NCT01648790|363004|P5|STARTED|Treatment 4||4
149525|NCT01648790|363005|P4|STARTED|Treatment 4||3
149526|NCT01648790|363006|P3|STARTED|Treatment 4||4
149527|NCT01648790|363007|P2|STARTED|Treatment 4||4
149528|NCT01648790|363008|P1|STARTED|Treatment 4||4
149529|NCT01648790|363004|P5|NOT COMPLETED|Treatment 3||0
149530|NCT01648790|363005|P4|NOT COMPLETED|Treatment 3||1
149531|NCT01648790|363006|P3|NOT COMPLETED|Treatment 3||0
149532|NCT01648790|363007|P2|NOT COMPLETED|Treatment 3||0
149533|NCT01648790|363008|P1|NOT COMPLETED|Treatment 3||0
149534|NCT01648790|363004|P5|COMPLETED|Treatment 3||4
149535|NCT01648790|363005|P4|COMPLETED|Treatment 3||3
149536|NCT01648790|363006|P3|COMPLETED|Treatment 3||4
149537|NCT01648790|363007|P2|COMPLETED|Treatment 3||4
149538|NCT01648790|363008|P1|COMPLETED|Treatment 3||4
149539|NCT01648790|363004|P5|STARTED|Treatment 3||4
149540|NCT01648790|363005|P4|STARTED|Treatment 3|Withdrew consent prior to dosing on this treatment day.|4
149541|NCT01648790|363006|P3|STARTED|Treatment 3||4
149542|NCT01648790|363007|P2|STARTED|Treatment 3||4
149543|NCT01648790|363008|P1|STARTED|Treatment 3||4
149544|NCT01648790|363004|P5|NOT COMPLETED|Treatment 2||0
149545|NCT01648790|363005|P4|NOT COMPLETED|Treatment 2||0
149546|NCT01648790|363006|P3|NOT COMPLETED|Treatment 2||0
149547|NCT01648790|363007|P2|NOT COMPLETED|Treatment 2||0
149548|NCT01648790|363008|P1|NOT COMPLETED|Treatment 2||0
149549|NCT01648790|363004|P5|COMPLETED|Treatment 2||4
149550|NCT01648790|363005|P4|COMPLETED|Treatment 2||4
149551|NCT01648790|363006|P3|COMPLETED|Treatment 2||4
149552|NCT01648790|363007|P2|COMPLETED|Treatment 2||4
149553|NCT01648790|363008|P1|COMPLETED|Treatment 2||4
149554|NCT01648790|363004|P5|STARTED|Treatment 2||4
149555|NCT01648790|363005|P4|STARTED|Treatment 2||4
149556|NCT01648790|363006|P3|STARTED|Treatment 2||4
149557|NCT01648790|363007|P2|STARTED|Treatment 2||4
149558|NCT01648790|363008|P1|STARTED|Treatment 2||4
149559|NCT01648790|363004|P5|NOT COMPLETED|Treatment 1||0
149560|NCT01648790|363005|P4|NOT COMPLETED|Treatment 1||0
149561|NCT01648790|363006|P3|NOT COMPLETED|Treatment 1||0
149562|NCT01648790|363007|P2|NOT COMPLETED|Treatment 1||0
149563|NCT01648790|363008|P1|NOT COMPLETED|Treatment 1||0
149564|NCT01648790|363004|P5|COMPLETED|Treatment 1||4
149565|NCT01648790|363005|P4|COMPLETED|Treatment 1||4
149566|NCT01648790|363006|P3|COMPLETED|Treatment 1||4
149567|NCT01648790|363007|P2|COMPLETED|Treatment 1||4
149568|NCT01648790|363008|P1|COMPLETED|Treatment 1||4
149569|NCT01648790|363004|P5|Received at Least 1 Dose of Study Drug|Treatment 1||4
149570|NCT01648790|363005|P4|Received at Least 1 Dose of Study Drug|Treatment 1||4
149571|NCT01648790|363006|P3|Received at Least 1 Dose of Study Drug|Treatment 1||4
149572|NCT01648790|363007|P2|Received at Least 1 Dose of Study Drug|Treatment 1||4
149573|NCT01648790|363008|P1|Received at Least 1 Dose of Study Drug|Treatment 1||4
149574|NCT01648790|363004|P5|STARTED|Treatment 1||4
149575|NCT01648790|363005|P4|STARTED|Treatment 1||4
149576|NCT01648790|363006|P3|STARTED|Treatment 1||4
149577|NCT01648790|363007|P2|STARTED|Treatment 1||4
149578|NCT01648790|363008|P1|STARTED|Treatment 1||4
149579|NCT01648764|363043|P14|NOT COMPLETED|Overall Study||3
149580|NCT01648764|363044|P13|NOT COMPLETED|Overall Study||4
149581|NCT01648764|363045|P12|NOT COMPLETED|Overall Study||5
149582|NCT01648764|363046|P11|NOT COMPLETED|Overall Study||0
149583|NCT01648764|363047|P10|NOT COMPLETED|Overall Study||3
149584|NCT01648764|363048|P9|NOT COMPLETED|Overall Study||0
149585|NCT01648764|363049|P8|NOT COMPLETED|Overall Study||0
149586|NCT01648764|363050|P7|NOT COMPLETED|Overall Study||5
149587|NCT01648764|363051|P6|NOT COMPLETED|Overall Study||2
149588|NCT01648764|363052|P5|NOT COMPLETED|Overall Study||0
149589|NCT01648764|363053|P4|NOT COMPLETED|Overall Study||0
149590|NCT01648764|363054|P3|NOT COMPLETED|Overall Study||0
149591|NCT01648764|363055|P2|NOT COMPLETED|Overall Study||1
149592|NCT01648764|363056|P1|NOT COMPLETED|Overall Study||0
149593|NCT01648764|363043|P14|COMPLETED|Overall Study||9
149594|NCT01648764|363044|P13|COMPLETED|Overall Study||3
149595|NCT01648764|363045|P12|COMPLETED|Overall Study||4
149596|NCT01648764|363046|P11|COMPLETED|Overall Study||3
149597|NCT01648764|363047|P10|COMPLETED|Overall Study||4
149598|NCT01648764|363048|P9|COMPLETED|Overall Study||3
149599|NCT01648764|363049|P8|COMPLETED|Overall Study||3
149600|NCT01648764|363050|P7|COMPLETED|Overall Study||4
149601|NCT01648764|363051|P6|COMPLETED|Overall Study||3
149602|NCT01648764|363052|P5|COMPLETED|Overall Study||3
149603|NCT01648764|363053|P4|COMPLETED|Overall Study||3
149604|NCT01648764|363054|P3|COMPLETED|Overall Study||3
149605|NCT01648764|363055|P2|COMPLETED|Overall Study||2
149606|NCT01648764|363056|P1|COMPLETED|Overall Study||3
149607|NCT01648764|363043|P14|Received at Least 1 Dose of Study Drug|Overall Study||12
149608|NCT01648764|363044|P13|Received at Least 1 Dose of Study Drug|Overall Study||7
149609|NCT01648764|363045|P12|Received at Least 1 Dose of Study Drug|Overall Study||9
149610|NCT01648764|363046|P11|Received at Least 1 Dose of Study Drug|Overall Study||3
149611|NCT01648764|363047|P10|Received at Least 1 Dose of Study Drug|Overall Study||7
149612|NCT01648764|363048|P9|Received at Least 1 Dose of Study Drug|Overall Study||3
149613|NCT01648764|363049|P8|Received at Least 1 Dose of Study Drug|Overall Study||3
149614|NCT01648764|363050|P7|Received at Least 1 Dose of Study Drug|Overall Study||9
149615|NCT01648764|363051|P6|Received at Least 1 Dose of Study Drug|Overall Study||5
149616|NCT01648764|363052|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
149617|NCT01648764|363053|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
149618|NCT01648764|363054|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
149619|NCT01648764|363055|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
149620|NCT01648764|363056|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
149621|NCT01648764|363043|P14|STARTED|Overall Study||12
149622|NCT01648764|363044|P13|STARTED|Overall Study||7
149623|NCT01648764|363045|P12|STARTED|Overall Study||9
149624|NCT01648764|363046|P11|STARTED|Overall Study||3
149625|NCT01648764|363047|P10|STARTED|Overall Study||7
149626|NCT01648764|363048|P9|STARTED|Overall Study||3
149627|NCT01648764|363049|P8|STARTED|Overall Study||3
149628|NCT01648764|363050|P7|STARTED|Overall Study||9
149629|NCT01648764|363051|P6|STARTED|Overall Study||5
149630|NCT01648764|363052|P5|STARTED|Overall Study||3
149631|NCT01648764|363053|P4|STARTED|Overall Study||3
149632|NCT01648764|363054|P3|STARTED|Overall Study||3
149633|NCT01648764|363055|P2|STARTED|Overall Study||3
149634|NCT01648764|363056|P1|STARTED|Overall Study||3
149635|NCT01648699|363208|P1|NOT COMPLETED|Overall Study||5
149636|NCT01648699|363208|P1|COMPLETED|Overall Study||15
149637|NCT01648699|363208|P1|STARTED|Overall Study||20
149638|NCT01648582|363237|P3|NOT COMPLETED|Overall Study||32
149639|NCT01648582|363238|P2|NOT COMPLETED|Overall Study||38
149640|NCT01648582|363239|P1|NOT COMPLETED|Overall Study||32
149641|NCT01648582|363237|P3|COMPLETED|Overall Study||227
149642|NCT01648582|363238|P2|COMPLETED|Overall Study||219
149643|NCT01648582|363239|P1|COMPLETED|Overall Study||226
149644|NCT01648582|363237|P3|Modified Intent-to-Treat Population|Overall Study||250
149645|NCT01648582|363238|P2|Modified Intent-to-Treat Population|Overall Study||252
149646|NCT01648582|363239|P1|Modified Intent-to-Treat Population|Overall Study||253
149647|NCT01648582|363237|P3|Received at Least One Dose of Study Drug|Overall Study||259
149648|NCT01648582|363238|P2|Received at Least One Dose of Study Drug|Overall Study||257
149649|NCT01648582|363239|P1|Received at Least One Dose of Study Drug|Overall Study||258
149650|NCT01648582|363237|P3|STARTED|Overall Study||259
149651|NCT01648582|363238|P2|STARTED|Overall Study||257
149652|NCT01648582|363239|P1|STARTED|Overall Study||258
149653|NCT01648530|363308|P1|NOT COMPLETED|Overall Study||10874
149654|NCT01648530|363308|P1|COMPLETED|Overall Study||5915
149655|NCT01648530|363308|P1|STARTED|Overall Study||16789
149656|NCT01648491|363314|P1|NOT COMPLETED|Overall Study||0
149657|NCT01648491|363314|P1|COMPLETED|Overall Study||1
149658|NCT01648491|363314|P1|STARTED|Overall Study||1
149659|NCT01648452|363321|P1|NOT COMPLETED|Overall Study||0
149660|NCT01648452|363321|P1|COMPLETED|Overall Study|One participant was explanted due to an adverse event. Remainder kept implant at study completion.|5
149661|NCT01648452|363321|P1|STARTED|Overall Study||5
149662|NCT01648348|363342|P6|NOT COMPLETED|Overall Study||6
149663|NCT01648348|363343|P5|NOT COMPLETED|Overall Study||3
149664|NCT01648348|363344|P4|NOT COMPLETED|Overall Study||0
149665|NCT01648348|363345|P3|NOT COMPLETED|Overall Study||1
149666|NCT01648348|363346|P2|NOT COMPLETED|Overall Study||0
149667|NCT01648348|363347|P1|NOT COMPLETED|Overall Study||2
149668|NCT01648348|363342|P6|COMPLETED|Overall Study||43
149669|NCT01648348|363343|P5|COMPLETED|Overall Study||49
149670|NCT01648348|363344|P4|COMPLETED|Overall Study||3
149671|NCT01648348|363345|P3|COMPLETED|Overall Study||3
149672|NCT01648348|363346|P2|COMPLETED|Overall Study||3
149673|NCT01648348|363347|P1|COMPLETED|Overall Study||3
149674|NCT01648348|363342|P6|STARTED|Overall Study||49
149675|NCT01648348|363343|P5|STARTED|Overall Study||52
149676|NCT01648348|363344|P4|STARTED|Overall Study||3
149677|NCT01648348|363345|P3|STARTED|Overall Study||4
149678|NCT01648348|363346|P2|STARTED|Overall Study||3
149679|NCT01648348|363347|P1|STARTED|Overall Study||5
149680|NCT01648322|363376|P4|NOT COMPLETED|Overall Study||4
149681|NCT01648322|363377|P3|NOT COMPLETED|Overall Study||5
149682|NCT01648322|363378|P2|NOT COMPLETED|Overall Study||5
149683|NCT01648322|363379|P1|NOT COMPLETED|Overall Study||2
149684|NCT01648322|363376|P4|COMPLETED|Overall Study||61
149685|NCT01648322|363377|P3|COMPLETED|Overall Study||60
149686|NCT01648322|363378|P2|COMPLETED|Overall Study||62
149687|NCT01648322|363379|P1|COMPLETED|Overall Study||33
149688|NCT01648322|363376|P4|STARTED|Overall Study||65
149689|NCT01648322|363377|P3|STARTED|Overall Study||65
149690|NCT01648322|363378|P2|STARTED|Overall Study||67
149691|NCT01648322|363379|P1|STARTED|Overall Study||35
149692|NCT01648296|363425|P2|NOT COMPLETED|Overall Study||0
149693|NCT01648296|363426|P1|NOT COMPLETED|Overall Study||0
149694|NCT01648296|363425|P2|COMPLETED|Overall Study||38
149695|NCT01648296|363426|P1|COMPLETED|Overall Study||12
149696|NCT01648296|363425|P2|STARTED|Overall Study||38
149697|NCT01648296|363426|P1|STARTED|Overall Study||12
149698|NCT01648283|363432|P1|NOT COMPLETED|Overall Study||14
149699|NCT01648283|363432|P1|COMPLETED|Overall Study||64
149700|NCT01648283|363432|P1|STARTED|Overall Study||78
149701|NCT01648166|363440|P2|NOT COMPLETED|Overall Study||100
149702|NCT01648166|363441|P1|NOT COMPLETED|Overall Study||53
149703|NCT01648166|363440|P2|COMPLETED|Overall Study||267
149704|NCT01648166|363441|P1|COMPLETED|Overall Study||100
149705|NCT01648166|363440|P2|STARTED|Overall Study||367
149706|NCT01648166|363441|P1|STARTED|Overall Study||153
149707|NCT01648140|363451|P4|NOT COMPLETED|Overall Study||2
149708|NCT01648140|363452|P3|NOT COMPLETED|Overall Study||8
149709|NCT01648140|363453|P2|NOT COMPLETED|Overall Study||12
149710|NCT01648140|363454|P1|NOT COMPLETED|Overall Study||12
149711|NCT01648140|363451|P4|COMPLETED|Overall Study||11
149712|NCT01648140|363452|P3|COMPLETED|Overall Study||9
149713|NCT01648140|363453|P2|COMPLETED|Overall Study||28
149714|NCT01648140|363454|P1|COMPLETED|Overall Study||29
149715|NCT01648140|363451|P4|STARTED|Overall Study||13
149716|NCT01648140|363452|P3|STARTED|Overall Study||17
149717|NCT01648140|363453|P2|STARTED|Overall Study||40
149718|NCT01648140|363454|P1|STARTED|Overall Study||41
149719|NCT01648101|363619|P3|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
149720|NCT01648101|363620|P2|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
149721|NCT01648101|363621|P1|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
149722|NCT01648101|363619|P3|COMPLETED|Taper/Follow-up Phase (4 Weeks)||3
149723|NCT01648101|363620|P2|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
149724|NCT01648101|363621|P1|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
149725|NCT01648101|363619|P3|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|3
149726|NCT01648101|363620|P2|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|2
149727|NCT01648101|363621|P1|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|1
149728|NCT01648101|363619|P3|NOT COMPLETED|Transition Phase (4 Weeks)||4
149729|NCT01648101|363620|P2|NOT COMPLETED|Transition Phase (4 Weeks)||5
149730|NCT01648101|363621|P1|NOT COMPLETED|Transition Phase (4 Weeks)||5
149731|NCT01648101|363619|P3|COMPLETED|Transition Phase (4 Weeks)||5
149732|NCT01648101|363620|P2|COMPLETED|Transition Phase (4 Weeks)||13
149733|NCT01648101|363621|P1|COMPLETED|Transition Phase (4 Weeks)||12
149734|NCT01648101|363619|P3|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|9
149735|NCT01648101|363620|P2|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|18
149736|NCT01648101|363621|P1|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|17
149737|NCT01648101|363619|P3|NOT COMPLETED|Maintenance Phase (12 Weeks)||6
149738|NCT01648101|363620|P2|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
149739|NCT01648101|363621|P1|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
149740|NCT01648101|363619|P3|COMPLETED|Maintenance Phase (12 Weeks)||12
149741|NCT01648101|363620|P2|COMPLETED|Maintenance Phase (12 Weeks)||20
149742|NCT01648101|363621|P1|COMPLETED|Maintenance Phase (12 Weeks)||20
149743|NCT01648101|363619|P3|STARTED|Maintenance Phase (12 Weeks)||18
149744|NCT01648101|363620|P2|STARTED|Maintenance Phase (12 Weeks)||23
149745|NCT01648101|363621|P1|STARTED|Maintenance Phase (12 Weeks)||23
149746|NCT01648101|363619|P3|NOT COMPLETED|Titration Phase (4 Weeks)||6
149747|NCT01648101|363620|P2|NOT COMPLETED|Titration Phase (4 Weeks)||3
149748|NCT01648101|363621|P1|NOT COMPLETED|Titration Phase (4 Weeks)||2
149749|NCT01648101|363619|P3|COMPLETED|Titration Phase (4 Weeks)||18
149750|NCT01648101|363620|P2|COMPLETED|Titration Phase (4 Weeks)||23
149751|NCT01648101|363621|P1|COMPLETED|Titration Phase (4 Weeks)||23
149752|NCT01648101|363619|P3|STARTED|Titration Phase (4 Weeks)||24
149753|NCT01648101|363620|P2|STARTED|Titration Phase (4 Weeks)||26
149754|NCT01648101|363621|P1|STARTED|Titration Phase (4 Weeks)||25
149755|NCT01647945|363673|P4|NOT COMPLETED|Overall Study||1
149756|NCT01647945|363674|P3|NOT COMPLETED|Overall Study||2
149757|NCT01647945|363675|P2|NOT COMPLETED|Overall Study||0
149758|NCT01647945|363676|P1|NOT COMPLETED|Overall Study||0
149759|NCT01647945|363673|P4|COMPLETED|Overall Study||5
149760|NCT01647945|363674|P3|COMPLETED|Overall Study||3
149761|NCT01647945|363675|P2|COMPLETED|Overall Study||6
149762|NCT01647945|363676|P1|COMPLETED|Overall Study||6
149763|NCT01647945|363673|P4|STARTED|Overall Study||6
149764|NCT01647945|363674|P3|STARTED|Overall Study||5
149765|NCT01647945|363675|P2|STARTED|Overall Study||6
149766|NCT01647945|363676|P1|STARTED|Overall Study||6
149767|NCT01647737|363696|P2|NOT COMPLETED|Overall Study||5
149768|NCT01647737|363697|P1|NOT COMPLETED|Overall Study||4
149769|NCT01647737|363696|P2|COMPLETED|Overall Study||25
149770|NCT01647737|363697|P1|COMPLETED|Overall Study||26
149771|NCT01647737|363696|P2|STARTED|Overall Study||30
149772|NCT01647737|363697|P1|STARTED|Overall Study||30
149773|NCT01647711|363708|P5|NOT COMPLETED|Overall Study||6
149774|NCT01647711|363709|P4|NOT COMPLETED|Overall Study||11
149775|NCT01647711|363710|P3|NOT COMPLETED|Overall Study||9
149776|NCT01647711|363711|P2|NOT COMPLETED|Overall Study||3
149777|NCT01647711|363712|P1|NOT COMPLETED|Overall Study||6
149778|NCT01647711|363708|P5|COMPLETED|Overall Study||0
149779|NCT01647711|363709|P4|COMPLETED|Overall Study||0
149780|NCT01647711|363710|P3|COMPLETED|Overall Study||0
149781|NCT01647711|363711|P2|COMPLETED|Overall Study||0
149782|NCT01647711|363712|P1|COMPLETED|Overall Study||0
149783|NCT01647711|363708|P5|STARTED|Overall Study||6
149784|NCT01647711|363709|P4|STARTED|Overall Study||11
149785|NCT01647711|363710|P3|STARTED|Overall Study||9
149786|NCT01647711|363711|P2|STARTED|Overall Study||3
149787|NCT01647711|363712|P1|STARTED|Overall Study||6
149788|NCT01647581|363739|P2|NOT COMPLETED|Overall Study||31
149789|NCT01647581|363740|P1|NOT COMPLETED|Overall Study||17
149790|NCT01647581|363739|P2|COMPLETED|Overall Study||520
149791|NCT01647581|363740|P1|COMPLETED|Overall Study||530
149792|NCT01647581|363739|P2|STARTED|Overall Study||551
149793|NCT01647581|363740|P1|STARTED|Overall Study||547
149794|NCT01647542|363749|P3|NOT COMPLETED|Overall Study||72
149795|NCT01647542|363750|P2|NOT COMPLETED|Overall Study||73
149796|NCT01647542|363751|P1|NOT COMPLETED|Overall Study||76
149797|NCT01647542|363749|P3|COMPLETED|Overall Study||59
149798|NCT01647542|363750|P2|COMPLETED|Overall Study||58
149799|NCT01647542|363751|P1|COMPLETED|Overall Study||55
149800|NCT01647542|363749|P3|STARTED|Overall Study||131
149801|NCT01647542|363750|P2|STARTED|Overall Study||131
149802|NCT01647542|363751|P1|STARTED|Overall Study||131
149803|NCT01647464|363768|P1|NOT COMPLETED|Overall Study||0
149804|NCT01647464|363768|P1|COMPLETED|Overall Study||10
149805|NCT01647464|363768|P1|STARTED|Overall Study||10
149806|NCT01647438|363774|P2|NOT COMPLETED|Overall Study||0
149807|NCT01647438|363775|P1|NOT COMPLETED|Overall Study||0
149808|NCT01647438|363774|P2|COMPLETED|Overall Study||31
149809|NCT01647438|363775|P1|COMPLETED|Overall Study||32
149810|NCT01647438|363774|P2|STARTED|Overall Study||31
149811|NCT01647438|363775|P1|STARTED|Overall Study||32
149812|NCT01647282|363785|P2|NOT COMPLETED|Overall Study||5
149813|NCT01647282|363786|P1|NOT COMPLETED|Overall Study||7
149814|NCT01647282|363785|P2|COMPLETED|Overall Study||25
149815|NCT01647282|363786|P1|COMPLETED|Overall Study||23
149816|NCT01647282|363785|P2|STARTED|Overall Study||30
149817|NCT01647282|363786|P1|STARTED|Overall Study||30
149818|NCT01647217|363796|P2|NOT COMPLETED|Overall Study||1
149819|NCT01647217|363797|P1|NOT COMPLETED|Overall Study||1
149820|NCT01647217|363796|P2|COMPLETED|Overall Study||8
149821|NCT01647217|363797|P1|COMPLETED|Overall Study||7
149822|NCT01647217|363796|P2|STARTED|Overall Study||9
149823|NCT01647217|363797|P1|STARTED|Overall Study||8
149824|NCT01646827|363807|P2|NOT COMPLETED|Overall Study||5
149825|NCT01646827|363808|P1|NOT COMPLETED|Overall Study||2
149826|NCT01646827|363807|P2|COMPLETED|Overall Study||14
149827|NCT01646827|363808|P1|COMPLETED|Overall Study||16
149828|NCT01646827|363807|P2|STARTED|Overall Study||19
149829|NCT01646827|363808|P1|STARTED|Overall Study||18
149830|NCT01646814|363838|P2|NOT COMPLETED|Overall Study||6
149831|NCT01646814|363839|P1|NOT COMPLETED|Overall Study||11
149832|NCT01646814|363838|P2|COMPLETED|Overall Study||120
149833|NCT01646814|363839|P1|COMPLETED|Overall Study||110
149834|NCT01646814|363838|P2|STARTED|Overall Study||126
149835|NCT01646814|363839|P1|STARTED|Overall Study||121
149836|NCT01646762|363845|P1|NOT COMPLETED|Overall Study||0
149837|NCT01646762|363845|P1|COMPLETED|Overall Study||13
149838|NCT01646762|363845|P1|STARTED|Overall Study||13
149839|NCT01646671|363857|P3|NOT COMPLETED|Overall Study||0
149840|NCT01646671|363858|P2|NOT COMPLETED|Overall Study||0
149841|NCT01646671|363859|P1|NOT COMPLETED|Overall Study||0
149842|NCT01646671|363857|P3|COMPLETED|Overall Study||21
149843|NCT01646671|363858|P2|COMPLETED|Overall Study||11
149844|NCT01646671|363859|P1|COMPLETED|Overall Study||3
149845|NCT01646671|363857|P3|STARTED|Overall Study||21
149846|NCT01646671|363858|P2|STARTED|Overall Study||11
149847|NCT01646671|363859|P1|STARTED|Overall Study||3
149848|NCT01646398|363895|P2|NOT COMPLETED|Overall Study||0
149849|NCT01646398|363896|P1|NOT COMPLETED|Overall Study||1
149850|NCT01646398|363895|P2|COMPLETED|Overall Study||382
149851|NCT01646398|363896|P1|COMPLETED|Overall Study||381
149852|NCT01646398|363895|P2|STARTED|Overall Study||382
149853|NCT01646398|363896|P1|STARTED|Overall Study||382
149854|NCT01646385|363912|P2|NOT COMPLETED|Overall Study||871
149855|NCT01646385|363913|P1|NOT COMPLETED|Overall Study||838
149856|NCT01646385|363912|P2|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|1993
149857|NCT01646385|363913|P1|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|2691
149858|NCT01646385|363912|P2|STARTED|Overall Study||2864
149859|NCT01646385|363913|P1|STARTED|Overall Study||3529
149860|NCT01646346|363944|P1|NOT COMPLETED|Overall Study||0
149861|NCT01646346|363944|P1|COMPLETED|Overall Study||46
149862|NCT01646346|363944|P1|STARTED|Overall Study||46
149863|NCT01646320|363956|P2|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||7
149864|NCT01646320|363957|P1|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||6
149865|NCT01646320|363956|P2|COMPLETED|Long-term Period (Weeks 24 to 52)||140
149866|NCT01646320|363957|P1|COMPLETED|Long-term Period (Weeks 24 to 52)||141
149867|NCT01646320|363956|P2|STARTED|Long-term Period (Weeks 24 to 52)||147
149868|NCT01646320|363957|P1|STARTED|Long-term Period (Weeks 24 to 52)||147
149869|NCT01646320|363956|P2|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||7
149870|NCT01646320|363957|P1|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||12
149871|NCT01646320|363956|P2|COMPLETED|Short-term Period (Day 1 to Week 24)||153
149872|NCT01646320|363957|P1|COMPLETED|Short-term Period (Day 1 to Week 24)||148
149873|NCT01646320|363956|P2|STARTED|Short-term Period (Day 1 to Week 24)||160
149874|NCT01646320|363957|P1|STARTED|Short-term Period (Day 1 to Week 24)||160
149875|NCT01646268|363973|P2|NOT COMPLETED|Overall Study||16
149876|NCT01646268|363974|P1|NOT COMPLETED|Overall Study||11
149877|NCT01646268|363973|P2|COMPLETED|Overall Study||107
149878|NCT01646268|363974|P1|COMPLETED|Overall Study||113
149879|NCT01646268|363973|P2|STARTED|Overall Study||123
149880|NCT01646268|363974|P1|STARTED|Overall Study||124
149881|NCT01646255|363988|P2|NOT COMPLETED|Overall Study||14
149882|NCT01646255|363989|P1|NOT COMPLETED|Overall Study||21
149883|NCT01646255|363988|P2|COMPLETED|Overall Study||160
149884|NCT01646255|363989|P1|COMPLETED|Overall Study||151
149885|NCT01646255|363988|P2|STARTED|Overall Study||174
149886|NCT01646255|363989|P1|STARTED|Overall Study||172
149887|NCT01646216|364021|P2|NOT COMPLETED|Overall Study||13
149888|NCT01646216|364022|P1|NOT COMPLETED|Overall Study||11
149889|NCT01646216|364021|P2|COMPLETED|Overall Study||4
149890|NCT01646216|364022|P1|COMPLETED|Overall Study||6
149891|NCT01646216|364021|P2|STARTED|Overall Study||17
149892|NCT01646216|364022|P1|STARTED|Overall Study||17
149893|NCT01646203|364044|P3|NOT COMPLETED|Overall Study||1
149894|NCT01646203|364045|P2|NOT COMPLETED|Overall Study||2
149895|NCT01646203|364046|P1|NOT COMPLETED|Overall Study||2
149896|NCT01646203|364044|P3|COMPLETED|Overall Study||6
149897|NCT01646203|364045|P2|COMPLETED|Overall Study||3
149898|NCT01646203|364046|P1|COMPLETED|Overall Study||0
149899|NCT01646203|364044|P3|Received at Least One Dose of Study Drug|Overall Study||7
149900|NCT01646203|364045|P2|Received at Least One Dose of Study Drug|Overall Study||5
149901|NCT01646203|364046|P1|Received at Least One Dose of Study Drug|Overall Study||2
149902|NCT01646203|364044|P3|STARTED|Overall Study||7
149903|NCT01646203|364045|P2|STARTED|Overall Study||5
149904|NCT01646203|364046|P1|STARTED|Overall Study||2
149905|NCT01646177|364075|P4|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
149906|NCT01646177|364076|P3|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
149907|NCT01646177|364077|P2|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
149908|NCT01646177|364078|P1|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
149909|NCT01646177|364075|P4|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
149910|NCT01646177|364076|P3|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
149911|NCT01646177|364077|P2|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
149912|NCT01646177|364078|P1|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
149913|NCT01646177|364075|P4|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
149914|NCT01646177|364076|P3|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
149915|NCT01646177|364077|P2|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
149916|NCT01646177|364078|P1|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
149917|NCT01646177|364075|P4|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||22
149918|NCT01646177|364076|P3|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||26
149919|NCT01646177|364077|P2|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||13
149920|NCT01646177|364078|P1|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||10
149921|NCT01646177|364075|P4|COMPLETED|Blinded Induction Dosing (Week 0-12)||363
149922|NCT01646177|364076|P3|COMPLETED|Blinded Induction Dosing (Week 0-12)||360
149923|NCT01646177|364077|P2|COMPLETED|Blinded Induction Dosing (Week 0-12)||369
149924|NCT01646177|364078|P1|COMPLETED|Blinded Induction Dosing (Week 0-12)||183
149925|NCT01646177|364075|P4|STARTED|Blinded Induction Dosing (Week 0-12)||385
149926|NCT01646177|364076|P3|STARTED|Blinded Induction Dosing (Week 0-12)||386
149927|NCT01646177|364077|P2|STARTED|Blinded Induction Dosing (Week 0-12)||382
149928|NCT01646177|364078|P1|STARTED|Blinded Induction Dosing (Week 0-12)||193
149929|NCT01646151|364156|P1|NOT COMPLETED|Overall Study||170
149930|NCT01646151|364156|P1|COMPLETED|Overall Study||2410
149931|NCT01646151|364156|P1|STARTED|Overall Study||2580
149932|NCT01646138|364172|P5|NOT COMPLETED|Overall Study||2
149933|NCT01646138|364173|P4|NOT COMPLETED|Overall Study||0
149934|NCT01646138|364174|P3|NOT COMPLETED|Overall Study||0
149935|NCT01646138|364175|P2|NOT COMPLETED|Overall Study||0
149936|NCT01646138|364176|P1|NOT COMPLETED|Overall Study||0
149937|NCT01646138|364172|P5|COMPLETED|Overall Study||13
149938|NCT01646138|364173|P4|COMPLETED|Overall Study||19
149939|NCT01646138|364174|P3|COMPLETED|Overall Study||5
149940|NCT01646138|364175|P2|COMPLETED|Overall Study||4
149941|NCT01646138|364176|P1|COMPLETED|Overall Study||5
149942|NCT01646138|364172|P5|STARTED|Overall Study||15
149943|NCT01646138|364173|P4|STARTED|Overall Study||19
149944|NCT01646138|364174|P3|STARTED|Overall Study||5
149945|NCT01646138|364175|P2|STARTED|Overall Study||4
149946|NCT01646138|364176|P1|STARTED|Overall Study||5
149947|NCT01646125|364190|P2|NOT COMPLETED|Overall Study||28
149948|NCT01646125|364191|P1|NOT COMPLETED|Overall Study||31
149949|NCT01646125|364190|P2|COMPLETED|Overall Study||0
149950|NCT01646125|364191|P1|COMPLETED|Overall Study||0
149951|NCT01646125|364190|P2|STARTED|Overall Study||28
149952|NCT01646125|364191|P1|STARTED|Overall Study||31
149953|NCT01646073|364216|P2|NOT COMPLETED|Period B (12 Weeks)||13
149954|NCT01646073|364217|P1|NOT COMPLETED|Period B (12 Weeks)||1
149955|NCT01646073|364216|P2|COMPLETED|Period B (12 Weeks)||320
149956|NCT01646073|364217|P1|COMPLETED|Period B (12 Weeks)||84
149957|NCT01646073|364216|P2|STARTED|Period B (12 Weeks)||333
149958|NCT01646073|364217|P1|STARTED|Period B (12 Weeks)||85
149959|NCT01646073|364216|P2|NOT COMPLETED|Period A (12 Weeks)||5
149960|NCT01646073|364217|P1|NOT COMPLETED|Period A (12 Weeks)||2
149961|NCT01646073|364216|P2|COMPLETED|Period A (12 Weeks)||333
149962|NCT01646073|364217|P1|COMPLETED|Period A (12 Weeks)||85
149963|NCT01646073|364216|P2|STARTED|Period A (12 Weeks)||338
149964|NCT01646073|364217|P1|STARTED|Period A (12 Weeks)||87
149965|NCT01646021|364258|P2|NOT COMPLETED|Overall Study||141
149966|NCT01646021|364259|P1|NOT COMPLETED|Overall Study||139
149967|NCT01646021|364258|P2|COMPLETED|Overall Study||0
149968|NCT01646021|364259|P1|COMPLETED|Overall Study||0
149969|NCT01646021|364258|P2|Treated|Overall Study||139
149970|NCT01646021|364259|P1|Treated|Overall Study||139
149971|NCT01646021|364258|P2|STARTED|Overall Study||141
149972|NCT01646021|364259|P1|STARTED|Overall Study||139
149973|NCT01645930|364296|P1|NOT COMPLETED|Overall Study||43
149974|NCT01645930|364296|P1|COMPLETED|Overall Study||0
149975|NCT01645930|364296|P1|STARTED|Overall Study||43
149976|NCT01645735|364313|P2|NOT COMPLETED|Overall Study||1
149977|NCT01645735|364314|P1|NOT COMPLETED|Overall Study||4
149978|NCT01645735|364313|P2|COMPLETED|Overall Study||16
149979|NCT01645735|364314|P1|COMPLETED|Overall Study||28
149980|NCT01645735|364313|P2|STARTED|Overall Study||17
149981|NCT01645735|364314|P1|STARTED|Overall Study||32
149982|NCT01645709|364328|P2|NOT COMPLETED|Overall Study||0
149983|NCT01645709|364329|P1|NOT COMPLETED|Overall Study||0
149984|NCT01645709|364328|P2|COMPLETED|Overall Study|Study was terminated; not made unblind|0
149985|NCT01645709|364329|P1|COMPLETED|Overall Study|Study was terminated; not made unblind|0
149986|NCT01645709|364328|P2|STARTED|Overall Study|Study was terminated; not made unblind|0
149987|NCT01645709|364329|P1|STARTED|Overall Study|Study was terminated; not made unblind|0
149988|NCT01645280|364356|P5|NOT COMPLETED|Overall Study||8
149989|NCT01645280|364357|P4|NOT COMPLETED|Overall Study||6
149990|NCT01645280|364358|P3|NOT COMPLETED|Overall Study||6
149991|NCT01645280|364359|P2|NOT COMPLETED|Overall Study||3
149992|NCT01645280|364360|P1|NOT COMPLETED|Overall Study||6
149993|NCT01645280|364356|P5|COMPLETED|Overall Study||47
149994|NCT01645280|364357|P4|COMPLETED|Overall Study||48
149995|NCT01645280|364358|P3|COMPLETED|Overall Study||49
149996|NCT01645280|364359|P2|COMPLETED|Overall Study||51
149997|NCT01645280|364360|P1|COMPLETED|Overall Study||49
149998|NCT01645280|364356|P5|STARTED|Overall Study||55
149999|NCT01645280|364357|P4|STARTED|Overall Study||54
150000|NCT01645280|364358|P3|STARTED|Overall Study||55
150001|NCT01645280|364359|P2|STARTED|Overall Study||54
150002|NCT01645280|364360|P1|STARTED|Overall Study|16 participants in placebo group early escaped to receive Ustekinmab; included in safety population.|55
150003|NCT01645176|364388|P1|NOT COMPLETED|Overall Study||5
150004|NCT01645176|364388|P1|COMPLETED|Overall Study||16
150005|NCT01645176|364388|P1|STARTED|Overall Study||21
150006|NCT01645111|364392|P1|NOT COMPLETED|Overall Study||15
150007|NCT01645111|364392|P1|COMPLETED|Overall Study||35
150008|NCT01645111|364392|P1|STARTED|Overall Study||50
150009|NCT01645098|364398|P2|NOT COMPLETED|Overall Study||0
150010|NCT01645098|364399|P1|NOT COMPLETED|Overall Study||0
150011|NCT01645098|364398|P2|COMPLETED|Overall Study||29
150012|NCT01645098|364399|P1|COMPLETED|Overall Study||24
150013|NCT01645098|364398|P2|STARTED|Overall Study||29
150014|NCT01645098|364399|P1|STARTED|Overall Study||24
150015|NCT01645059|364413|P1|NOT COMPLETED|Overall Study||0
150016|NCT01645059|364413|P1|COMPLETED|Overall Study||129
150017|NCT01645059|364413|P1|STARTED|Overall Study||129
150018|NCT01644890|364433|P2|NOT COMPLETED|Overall Study||215
150019|NCT01644890|364434|P1|NOT COMPLETED|Overall Study||216
150020|NCT01644890|364433|P2|COMPLETED|Overall Study||3
150021|NCT01644890|364434|P1|COMPLETED|Overall Study||2
150022|NCT01644890|364433|P2|STARTED|Overall Study||218
150023|NCT01644890|364434|P1|STARTED|Overall Study||218
150024|NCT01644734|364444|P1|NOT COMPLETED|Overall Study||266
150025|NCT01644734|364444|P1|COMPLETED|Overall Study||1016
150026|NCT01644734|364444|P1|STARTED|Overall Study|Patients with documentation of treatment.|1282
150027|NCT01644695|364449|P1|NOT COMPLETED|Overall Study||0
150028|NCT01644695|364449|P1|COMPLETED|Overall Study||85
150029|NCT01644695|364449|P1|STARTED|Overall Study||85
150030|NCT01644643|364458|P4|NOT COMPLETED|Overall Study||10
150031|NCT01644643|364459|P3|NOT COMPLETED|Overall Study||5
150032|NCT01644643|364460|P2|NOT COMPLETED|Overall Study||0
150033|NCT01644643|364461|P1|NOT COMPLETED|Overall Study||2
150034|NCT01644643|364458|P4|COMPLETED|Overall Study||143
150035|NCT01644643|364459|P3|COMPLETED|Overall Study||148
150036|NCT01644643|364460|P2|COMPLETED|Overall Study||12
150037|NCT01644643|364461|P1|COMPLETED|Overall Study||13
150038|NCT01644643|364458|P4|STARTED|Overall Study||153
150039|NCT01644643|364459|P3|STARTED|Overall Study||153
150040|NCT01644643|364460|P2|STARTED|Overall Study||12
150041|NCT01644643|364461|P1|STARTED|Overall Study||15
150042|NCT01644617|364626|P3|NOT COMPLETED|Overall Study||7
150043|NCT01644617|364627|P2|NOT COMPLETED|Overall Study||5
150044|NCT01644617|364628|P1|NOT COMPLETED|Overall Study||6
150045|NCT01644617|364626|P3|COMPLETED|Overall Study||34
150046|NCT01644617|364627|P2|COMPLETED|Overall Study||36
150047|NCT01644617|364628|P1|COMPLETED|Overall Study||36
150048|NCT01644617|364626|P3|STARTED|Overall Study||41
150049|NCT01644617|364627|P2|STARTED|Overall Study||41
150050|NCT01644617|364628|P1|STARTED|Overall Study||42
150051|NCT01644565|364678|P9|NOT COMPLETED|Overall Study||1
150052|NCT01644565|364679|P8|NOT COMPLETED|Overall Study||2
150053|NCT01644565|364680|P7|NOT COMPLETED|Overall Study||0
150054|NCT01644565|364681|P6|NOT COMPLETED|Overall Study||0
150055|NCT01644565|364682|P5|NOT COMPLETED|Overall Study||1
150056|NCT01644565|364683|P4|NOT COMPLETED|Overall Study||1
150057|NCT01644565|364684|P3|NOT COMPLETED|Overall Study||0
150058|NCT01644565|364685|P2|NOT COMPLETED|Overall Study||0
150059|NCT01644565|364686|P1|NOT COMPLETED|Overall Study||1
150060|NCT01644565|364678|P9|COMPLETED|Overall Study||7
150061|NCT01644565|364679|P8|COMPLETED|Overall Study||8
150062|NCT01644565|364680|P7|COMPLETED|Overall Study||7
150063|NCT01644565|364681|P6|COMPLETED|Overall Study||7
150064|NCT01644565|364682|P5|COMPLETED|Overall Study||4
150065|NCT01644565|364683|P4|COMPLETED|Overall Study||4
150066|NCT01644565|364684|P3|COMPLETED|Overall Study||5
150067|NCT01644565|364685|P2|COMPLETED|Overall Study||5
150068|NCT01644565|364686|P1|COMPLETED|Overall Study||4
150069|NCT01644565|364678|P9|STARTED|Overall Study||8
150070|NCT01644565|364679|P8|STARTED|Overall Study||10
150071|NCT01644565|364680|P7|STARTED|Overall Study||7
150072|NCT01644565|364681|P6|STARTED|Overall Study||7
150073|NCT01644565|364682|P5|STARTED|Overall Study||5
150074|NCT01644565|364683|P4|STARTED|Overall Study||5
150075|NCT01644565|364684|P3|STARTED|Overall Study||5
150076|NCT01644565|364685|P2|STARTED|Overall Study||5
150077|NCT01644565|364686|P1|STARTED|Overall Study||5
150078|NCT01644500|364727|P3|NOT COMPLETED|Overall Study||15
150079|NCT01644500|364728|P2|NOT COMPLETED|Overall Study||24
150080|NCT01644500|364729|P1|NOT COMPLETED|Overall Study||22
150081|NCT01644500|364727|P3|COMPLETED|Overall Study||230
150082|NCT01644500|364728|P2|COMPLETED|Overall Study||224
150083|NCT01644500|364729|P1|COMPLETED|Overall Study||222
150084|NCT01644500|364727|P3|Modified Intent-to-treat Population|Overall Study||242
150085|NCT01644500|364728|P2|Modified Intent-to-treat Population|Overall Study||239
150086|NCT01644500|364729|P1|Modified Intent-to-treat Population|Overall Study||239
150087|NCT01644500|364727|P3|Received at Least One Dose of Study Drug|Overall Study||243
150088|NCT01644500|364728|P2|Received at Least One Dose of Study Drug|Overall Study||248
150089|NCT01644500|364729|P1|Received at Least One Dose of Study Drug|Overall Study||244
150090|NCT01644500|364727|P3|STARTED|Overall Study||245
150091|NCT01644500|364728|P2|STARTED|Overall Study||248
150092|NCT01644500|364729|P1|STARTED|Overall Study||244
150093|NCT01644474|364799|P2|NOT COMPLETED|Overall Study||8
150094|NCT01644474|364800|P1|NOT COMPLETED|Overall Study||7
150095|NCT01644474|364799|P2|COMPLETED|Overall Study||44
150096|NCT01644474|364800|P1|COMPLETED|Overall Study||44
150097|NCT01644474|364799|P2|Treated|Overall Study||52
150098|NCT01644474|364800|P1|Treated|Overall Study||51
150099|NCT01644474|364799|P2|STARTED|Overall Study|Randomized|52
150100|NCT01644474|364800|P1|STARTED|Overall Study|Randomized|51
150101|NCT01644396|364840|P1|NOT COMPLETED|Overall Study||0
150102|NCT01644396|364840|P1|COMPLETED|Overall Study||50
150103|NCT01644396|364840|P1|STARTED|Overall Study||50
150104|NCT01644331|364884|P2|NOT COMPLETED|Overall Study||10
150105|NCT01644331|364885|P1|NOT COMPLETED|Overall Study||11
150106|NCT01644331|364884|P2|COMPLETED|Overall Study||118
150107|NCT01644331|364885|P1|COMPLETED|Overall Study||118
150108|NCT01644331|364884|P2|STARTED|Overall Study||128
150109|NCT01644331|364885|P1|STARTED|Overall Study||129
150110|NCT01644292|364917|P1|NOT COMPLETED|Overall Study||0
150111|NCT01644292|364917|P1|COMPLETED|Overall Study||2
150112|NCT01644292|364917|P1|STARTED|Overall Study||2
150113|NCT01644240|364924|P3|NOT COMPLETED|Overall Study||0
150114|NCT01644240|364925|P2|NOT COMPLETED|Overall Study||0
150115|NCT01644240|364926|P1|NOT COMPLETED|Overall Study||0
150116|NCT01644240|364924|P3|COMPLETED|Overall Study||6
150117|NCT01644240|364925|P2|COMPLETED|Overall Study||4
150118|NCT01644240|364926|P1|COMPLETED|Overall Study||6
150119|NCT01644240|364924|P3|STARTED|Overall Study||6
150120|NCT01644240|364925|P2|STARTED|Overall Study||4
150121|NCT01644240|364926|P1|STARTED|Overall Study||6
150122|NCT01644188|364984|P2|NOT COMPLETED|Overall Study||75
150123|NCT01644188|364985|P1|NOT COMPLETED|Overall Study||122
150124|NCT01644188|364984|P2|COMPLETED|Overall Study||166
150125|NCT01644188|364985|P1|COMPLETED|Overall Study||357
150126|NCT01644188|364984|P2|Treated|Overall Study||241
150127|NCT01644188|364985|P1|Treated|Overall Study||479
150128|NCT01644188|364984|P2|STARTED|Overall Study|Randomized|241
150129|NCT01644188|364985|P1|STARTED|Overall Study|Randomized|479
150130|NCT01644175|365043|P2|NOT COMPLETED|Overall Study||53
150131|NCT01644175|365044|P1|NOT COMPLETED|Overall Study||32
150132|NCT01644175|365043|P2|COMPLETED|Overall Study||156
150133|NCT01644175|365044|P1|COMPLETED|Overall Study||75
150134|NCT01644175|365043|P2|Treated|Overall Study||207
150135|NCT01644175|365044|P1|Treated|Overall Study||107
150136|NCT01644175|365043|P2|STARTED|Overall Study|Randomized|209
150137|NCT01644175|365044|P1|STARTED|Overall Study|Randomized|107
150138|NCT01644149|365096|P2|NOT COMPLETED|Overall Study||1
150139|NCT01644149|365097|P1|NOT COMPLETED|Overall Study||4
150140|NCT01644149|365096|P2|COMPLETED|Overall Study|28 day serum samples were not obtained from one NS subject.|39
150141|NCT01644149|365097|P1|COMPLETED|Overall Study|One subject discontinued prior to vaccination. 28 day serum samples not obtained from 3 subjects.|39
150142|NCT01644149|365096|P2|STARTED|Overall Study||40
150143|NCT01644149|365097|P1|STARTED|Overall Study||43
150144|NCT01644058|365107|P1|NOT COMPLETED|Overall Study||0
150145|NCT01644058|365107|P1|COMPLETED|Overall Study||18
150146|NCT01644058|365107|P1|STARTED|Overall Study||18
150147|NCT01643928|365117|P5|NOT COMPLETED|Overall Study||2
150148|NCT01643928|365118|P4|NOT COMPLETED|Overall Study||3
150149|NCT01643928|365119|P3|NOT COMPLETED|Overall Study||3
150150|NCT01643928|365120|P2|NOT COMPLETED|Overall Study||2
150151|NCT01643928|365121|P1|NOT COMPLETED|Overall Study||10
150152|NCT01643928|365117|P5|COMPLETED|Overall Study||28
150153|NCT01643928|365118|P4|COMPLETED|Overall Study||27
150154|NCT01643928|365119|P3|COMPLETED|Overall Study||30
150155|NCT01643928|365120|P2|COMPLETED|Overall Study||30
150156|NCT01643928|365121|P1|COMPLETED|Overall Study||48
150157|NCT01643928|365117|P5|STARTED|Overall Study||30
150158|NCT01643928|365118|P4|STARTED|Overall Study||30
150159|NCT01643928|365119|P3|STARTED|Overall Study||33
150160|NCT01643928|365120|P2|STARTED|Overall Study||32
150161|NCT01643928|365121|P1|STARTED|Overall Study||58
150162|NCT01643902|365406|P1|NOT COMPLETED|Overall Study||0
150163|NCT01643902|365406|P1|COMPLETED|Overall Study||20
150164|NCT01643902|365406|P1|STARTED|Overall Study||20
150165|NCT01643876|365411|P1|NOT COMPLETED|Overall Study||0
150166|NCT01643876|365411|P1|COMPLETED|Overall Study||48
150167|NCT01643876|365411|P1|STARTED|Overall Study||48
150168|NCT01643798|365416|P2|NOT COMPLETED|Pretreatment 2 and Stimulation||0
150169|NCT01643798|365417|P1|NOT COMPLETED|Pretreatment 2 and Stimulation||0
150170|NCT01643798|365416|P2|COMPLETED|Pretreatment 2 and Stimulation||8
150171|NCT01643798|365417|P1|COMPLETED|Pretreatment 2 and Stimulation||6
150172|NCT01643798|365416|P2|STARTED|Pretreatment 2 and Stimulation||8
150173|NCT01643798|365417|P1|STARTED|Pretreatment 2 and Stimulation||6
150174|NCT01643798|365416|P2|NOT COMPLETED|Pretreatment 1 and Stimulation||0
150175|NCT01643798|365417|P1|NOT COMPLETED|Pretreatment 1 and Stimulation||1
150176|NCT01643798|365416|P2|COMPLETED|Pretreatment 1 and Stimulation||8
150177|NCT01643798|365417|P1|COMPLETED|Pretreatment 1 and Stimulation||6
150178|NCT01643798|365416|P2|STARTED|Pretreatment 1 and Stimulation||8
150179|NCT01643798|365417|P1|STARTED|Pretreatment 1 and Stimulation||7
150180|NCT01643772|365432|P4|NOT COMPLETED|Overall Study||2
150181|NCT01643772|365433|P3|NOT COMPLETED|Overall Study||0
150182|NCT01643772|365434|P2|NOT COMPLETED|Overall Study||0
150183|NCT01643772|365435|P1|NOT COMPLETED|Overall Study||0
150184|NCT01643772|365432|P4|COMPLETED|Overall Study||14
150185|NCT01643772|365433|P3|COMPLETED|Overall Study||15
150186|NCT01643772|365434|P2|COMPLETED|Overall Study||15
150187|NCT01643772|365435|P1|COMPLETED|Overall Study||15
150188|NCT01643772|365432|P4|STARTED|Overall Study||16
150189|NCT01643772|365433|P3|STARTED|Overall Study||15
150190|NCT01643772|365434|P2|STARTED|Overall Study||15
150191|NCT01643772|365435|P1|STARTED|Overall Study||15
150192|NCT01643668|365475|P1|NOT COMPLETED|Overall Study||1
150193|NCT01643668|365475|P1|COMPLETED|Overall Study||33
150194|NCT01643668|365475|P1|STARTED|Overall Study||34
150195|NCT01643616|365489|P2|NOT COMPLETED|Overall Study||0
150196|NCT01643616|365490|P1|NOT COMPLETED|Overall Study||0
150197|NCT01643616|365489|P2|COMPLETED|Overall Study||125
150198|NCT01643616|365490|P1|COMPLETED|Overall Study||125
150199|NCT01643616|365489|P2|STARTED|Overall Study||125
150200|NCT01643616|365490|P1|STARTED|Overall Study||125
150201|NCT01643525|365500|P1|NOT COMPLETED|Overall Study||0
150202|NCT01643525|365500|P1|COMPLETED|Overall Study||29
150203|NCT01643525|365500|P1|STARTED|Overall Study||29
150204|NCT01643473|365506|P2|NOT COMPLETED|Overall Study||0
150205|NCT01643473|365507|P1|NOT COMPLETED|Overall Study||1
150206|NCT01643473|365506|P2|COMPLETED|Overall Study||21
150207|NCT01643473|365507|P1|COMPLETED|Overall Study||20
150208|NCT01643473|365506|P2|STARTED|Overall Study||21
150209|NCT01643473|365507|P1|STARTED|Overall Study||21
150210|NCT01643213|365521|P2|NOT COMPLETED|Overall Study||0
150211|NCT01643213|365522|P1|NOT COMPLETED|Overall Study||1
150212|NCT01643213|365521|P2|COMPLETED|Overall Study||14
150213|NCT01643213|365522|P1|COMPLETED|Overall Study||12
150214|NCT01643213|365521|P2|STARTED|Overall Study||14
150215|NCT01643213|365522|P1|STARTED|Overall Study||13
150216|NCT01643044|365530|P2|NOT COMPLETED|Overall Study||5
150217|NCT01643044|365531|P1|NOT COMPLETED|Overall Study||4
150218|NCT01643044|365530|P2|COMPLETED|Overall Study||19
150219|NCT01643044|365531|P1|COMPLETED|Overall Study||20
150220|NCT01643044|365530|P2|STARTED|Overall Study||24
150221|NCT01643044|365531|P1|STARTED|Overall Study||24
150222|NCT01642914|365540|P3|NOT COMPLETED|Overall Study||40
150223|NCT01642914|365541|P2|NOT COMPLETED|Overall Study||32
150224|NCT01642914|365542|P1|NOT COMPLETED|Overall Study||46
150225|NCT01642914|365540|P3|COMPLETED|Overall Study||120
150226|NCT01642914|365541|P2|COMPLETED|Overall Study||122
150227|NCT01642914|365542|P1|COMPLETED|Overall Study||127
150228|NCT01642914|365540|P3|STARTED|Overall Study||160
150229|NCT01642914|365541|P2|STARTED|Overall Study||154
150230|NCT01642914|365542|P1|STARTED|Overall Study||173
150231|NCT01642732|365617|P1|NOT COMPLETED|Overall Study||1
150232|NCT01642732|365617|P1|COMPLETED|Overall Study||0
150233|NCT01642732|365617|P1|STARTED|Overall Study||1
150234|NCT01642615|365622|P3|NOT COMPLETED|Double Blind Maintenance Phase||6
150235|NCT01642615|365623|P2|NOT COMPLETED|Double Blind Maintenance Phase||7
150236|NCT01642615|365624|P1|NOT COMPLETED|Double Blind Maintenance Phase||0
150237|NCT01642615|365622|P3|COMPLETED|Double Blind Maintenance Phase||20
150238|NCT01642615|365623|P2|COMPLETED|Double Blind Maintenance Phase||18
150239|NCT01642615|365624|P1|COMPLETED|Double Blind Maintenance Phase||0
150240|NCT01642615|365622|P3|STARTED|Double Blind Maintenance Phase||26
150241|NCT01642615|365623|P2|STARTED|Double Blind Maintenance Phase||25
150242|NCT01642615|365624|P1|STARTED|Double Blind Maintenance Phase||0
150243|NCT01642615|365622|P3|NOT COMPLETED|Open Label Maintenance Phase||0
150244|NCT01642615|365623|P2|NOT COMPLETED|Open Label Maintenance Phase||0
150245|NCT01642615|365624|P1|NOT COMPLETED|Open Label Maintenance Phase||5
150246|NCT01642615|365622|P3|COMPLETED|Open Label Maintenance Phase||0
150247|NCT01642615|365623|P2|COMPLETED|Open Label Maintenance Phase||0
150248|NCT01642615|365624|P1|COMPLETED|Open Label Maintenance Phase||58
150249|NCT01642615|365622|P3|Safety Analysis Set|Open Label Maintenance Phase||0
150250|NCT01642615|365623|P2|Safety Analysis Set|Open Label Maintenance Phase||0
150251|NCT01642615|365624|P1|Safety Analysis Set|Open Label Maintenance Phase||62
150252|NCT01642615|365622|P3|STARTED|Open Label Maintenance Phase||0
150253|NCT01642615|365623|P2|STARTED|Open Label Maintenance Phase||0
150254|NCT01642615|365624|P1|STARTED|Open Label Maintenance Phase||63
150255|NCT01642602|365638|P1|NOT COMPLETED|Overall Study||2
150256|NCT01642602|365638|P1|COMPLETED|Overall Study||102
150257|NCT01642602|365638|P1|STARTED|Overall Study||104
150258|NCT01642589|365645|P2|NOT COMPLETED|Overall Study||1
150259|NCT01642589|365646|P1|NOT COMPLETED|Overall Study||1
150260|NCT01642589|365645|P2|COMPLETED|Overall Study||99
150261|NCT01642589|365646|P1|COMPLETED|Overall Study||199
150262|NCT01642589|365645|P2|STARTED|Overall Study||100
150263|NCT01642589|365646|P1|STARTED|Overall Study||200
150264|NCT01642485|365660|P8|NOT COMPLETED|Period 2, Day 3||0
150265|NCT01642485|365661|P7|NOT COMPLETED|Period 2, Day 3||0
150266|NCT01642485|365662|P6|NOT COMPLETED|Period 2, Day 3||0
150267|NCT01642485|365663|P5|NOT COMPLETED|Period 2, Day 3||0
150268|NCT01642485|365664|P4|NOT COMPLETED|Period 2, Day 3||0
150269|NCT01642485|365665|P3|NOT COMPLETED|Period 2, Day 3||0
150270|NCT01642485|365666|P2|NOT COMPLETED|Period 2, Day 3||0
150271|NCT01642485|365667|P1|NOT COMPLETED|Period 2, Day 3||0
150272|NCT01642485|365660|P8|COMPLETED|Period 2, Day 3||4
150273|NCT01642485|365661|P7|COMPLETED|Period 2, Day 3||4
150274|NCT01642485|365662|P6|COMPLETED|Period 2, Day 3||4
150275|NCT01642485|365663|P5|COMPLETED|Period 2, Day 3||4
150276|NCT01642485|365664|P4|COMPLETED|Period 2, Day 3||4
150277|NCT01642485|365665|P3|COMPLETED|Period 2, Day 3||4
150278|NCT01642485|365666|P2|COMPLETED|Period 2, Day 3||4
150279|NCT01642485|365667|P1|COMPLETED|Period 2, Day 3||4
150280|NCT01642485|365660|P8|STARTED|Period 2, Day 3||4
150281|NCT01642485|365661|P7|STARTED|Period 2, Day 3||4
150282|NCT01642485|365662|P6|STARTED|Period 2, Day 3||4
150283|NCT01642485|365663|P5|STARTED|Period 2, Day 3||4
150284|NCT01642485|365664|P4|STARTED|Period 2, Day 3||4
150285|NCT01642485|365665|P3|STARTED|Period 2, Day 3||4
150286|NCT01642485|365666|P2|STARTED|Period 2, Day 3||4
150287|NCT01642485|365667|P1|STARTED|Period 2, Day 3||4
150288|NCT01642485|365660|P8|NOT COMPLETED|Period 2, Day 2||0
150289|NCT01642485|365661|P7|NOT COMPLETED|Period 2, Day 2||0
150290|NCT01642485|365662|P6|NOT COMPLETED|Period 2, Day 2||0
150291|NCT01642485|365663|P5|NOT COMPLETED|Period 2, Day 2||0
150292|NCT01642485|365664|P4|NOT COMPLETED|Period 2, Day 2||0
150293|NCT01642485|365665|P3|NOT COMPLETED|Period 2, Day 2||0
150294|NCT01642485|365666|P2|NOT COMPLETED|Period 2, Day 2||0
150295|NCT01642485|365667|P1|NOT COMPLETED|Period 2, Day 2||0
150296|NCT01642485|365660|P8|COMPLETED|Period 2, Day 2||4
150297|NCT01642485|365661|P7|COMPLETED|Period 2, Day 2||4
150298|NCT01642485|365662|P6|COMPLETED|Period 2, Day 2||4
150299|NCT01642485|365663|P5|COMPLETED|Period 2, Day 2||4
150300|NCT01642485|365664|P4|COMPLETED|Period 2, Day 2||4
150301|NCT01642485|365665|P3|COMPLETED|Period 2, Day 2||4
150302|NCT01642485|365666|P2|COMPLETED|Period 2, Day 2||4
150303|NCT01642485|365667|P1|COMPLETED|Period 2, Day 2||4
150304|NCT01642485|365660|P8|STARTED|Period 2, Day 2||4
150305|NCT01642485|365661|P7|STARTED|Period 2, Day 2||4
150306|NCT01642485|365662|P6|STARTED|Period 2, Day 2||4
150307|NCT01642485|365663|P5|STARTED|Period 2, Day 2||4
150308|NCT01642485|365664|P4|STARTED|Period 2, Day 2||4
150309|NCT01642485|365665|P3|STARTED|Period 2, Day 2||4
150310|NCT01642485|365666|P2|STARTED|Period 2, Day 2||4
150311|NCT01642485|365667|P1|STARTED|Period 2, Day 2||4
150312|NCT01642485|365660|P8|NOT COMPLETED|Period 2, Day 1||0
150313|NCT01642485|365661|P7|NOT COMPLETED|Period 2, Day 1||0
150314|NCT01642485|365662|P6|NOT COMPLETED|Period 2, Day 1||0
150315|NCT01642485|365663|P5|NOT COMPLETED|Period 2, Day 1||0
150316|NCT01642485|365664|P4|NOT COMPLETED|Period 2, Day 1||0
150317|NCT01642485|365665|P3|NOT COMPLETED|Period 2, Day 1||0
150318|NCT01642485|365666|P2|NOT COMPLETED|Period 2, Day 1||0
150319|NCT01642485|365667|P1|NOT COMPLETED|Period 2, Day 1||0
150320|NCT01642485|365660|P8|COMPLETED|Period 2, Day 1||4
150321|NCT01642485|365661|P7|COMPLETED|Period 2, Day 1||4
150322|NCT01642485|365662|P6|COMPLETED|Period 2, Day 1||4
150323|NCT01642485|365663|P5|COMPLETED|Period 2, Day 1||4
150324|NCT01642485|365664|P4|COMPLETED|Period 2, Day 1||4
150325|NCT01642485|365665|P3|COMPLETED|Period 2, Day 1||4
150326|NCT01642485|365666|P2|COMPLETED|Period 2, Day 1||4
150327|NCT01642485|365667|P1|COMPLETED|Period 2, Day 1||4
150328|NCT01642485|365660|P8|STARTED|Period 2, Day 1||4
150329|NCT01642485|365661|P7|STARTED|Period 2, Day 1||4
150330|NCT01642485|365662|P6|STARTED|Period 2, Day 1||4
150331|NCT01642485|365663|P5|STARTED|Period 2, Day 1||4
150332|NCT01642485|365664|P4|STARTED|Period 2, Day 1||4
150333|NCT01642485|365665|P3|STARTED|Period 2, Day 1||4
150334|NCT01642485|365666|P2|STARTED|Period 2, Day 1||4
150335|NCT01642485|365667|P1|STARTED|Period 2, Day 1||4
150336|NCT01642485|365660|P8|NOT COMPLETED|Period 1, Day 3||0
150337|NCT01642485|365661|P7|NOT COMPLETED|Period 1, Day 3||0
150338|NCT01642485|365662|P6|NOT COMPLETED|Period 1, Day 3||0
150339|NCT01642485|365663|P5|NOT COMPLETED|Period 1, Day 3||0
150340|NCT01642485|365664|P4|NOT COMPLETED|Period 1, Day 3||0
150341|NCT01642485|365665|P3|NOT COMPLETED|Period 1, Day 3||0
150342|NCT01642485|365666|P2|NOT COMPLETED|Period 1, Day 3||0
150343|NCT01642485|365667|P1|NOT COMPLETED|Period 1, Day 3||0
150344|NCT01642485|365660|P8|COMPLETED|Period 1, Day 3||4
150345|NCT01642485|365661|P7|COMPLETED|Period 1, Day 3||4
150346|NCT01642485|365662|P6|COMPLETED|Period 1, Day 3||4
150347|NCT01642485|365663|P5|COMPLETED|Period 1, Day 3||4
150348|NCT01642485|365664|P4|COMPLETED|Period 1, Day 3||4
150349|NCT01642485|365665|P3|COMPLETED|Period 1, Day 3||4
150350|NCT01642485|365666|P2|COMPLETED|Period 1, Day 3||4
150351|NCT01642485|365667|P1|COMPLETED|Period 1, Day 3||4
150352|NCT01642485|365660|P8|STARTED|Period 1, Day 3||4
150353|NCT01642485|365661|P7|STARTED|Period 1, Day 3||4
150354|NCT01642485|365662|P6|STARTED|Period 1, Day 3||4
150355|NCT01642485|365663|P5|STARTED|Period 1, Day 3||4
150356|NCT01642485|365664|P4|STARTED|Period 1, Day 3||4
150357|NCT01642485|365665|P3|STARTED|Period 1, Day 3||4
150358|NCT01642485|365666|P2|STARTED|Period 1, Day 3||4
150359|NCT01642485|365667|P1|STARTED|Period 1, Day 3||4
150360|NCT01642485|365660|P8|NOT COMPLETED|Period 1, Day 2||0
150361|NCT01642485|365661|P7|NOT COMPLETED|Period 1, Day 2||0
150362|NCT01642485|365662|P6|NOT COMPLETED|Period 1, Day 2||0
150363|NCT01642485|365663|P5|NOT COMPLETED|Period 1, Day 2||0
150364|NCT01642485|365664|P4|NOT COMPLETED|Period 1, Day 2||0
150365|NCT01642485|365665|P3|NOT COMPLETED|Period 1, Day 2||0
150366|NCT01642485|365666|P2|NOT COMPLETED|Period 1, Day 2||0
150367|NCT01642485|365667|P1|NOT COMPLETED|Period 1, Day 2||0
150368|NCT01642485|365660|P8|COMPLETED|Period 1, Day 2||4
150369|NCT01642485|365661|P7|COMPLETED|Period 1, Day 2||4
150370|NCT01642485|365662|P6|COMPLETED|Period 1, Day 2||4
150371|NCT01642485|365663|P5|COMPLETED|Period 1, Day 2||4
150372|NCT01642485|365664|P4|COMPLETED|Period 1, Day 2||4
150373|NCT01642485|365665|P3|COMPLETED|Period 1, Day 2||4
150374|NCT01642485|365666|P2|COMPLETED|Period 1, Day 2||4
150375|NCT01642485|365667|P1|COMPLETED|Period 1, Day 2||4
150376|NCT01642485|365660|P8|STARTED|Period 1, Day 2||4
150377|NCT01642485|365661|P7|STARTED|Period 1, Day 2||4
150378|NCT01642485|365662|P6|STARTED|Period 1, Day 2||4
150379|NCT01642485|365663|P5|STARTED|Period 1, Day 2||4
150380|NCT01642485|365664|P4|STARTED|Period 1, Day 2||4
150381|NCT01642485|365665|P3|STARTED|Period 1, Day 2||4
150382|NCT01642485|365666|P2|STARTED|Period 1, Day 2||4
150383|NCT01642485|365667|P1|STARTED|Period 1, Day 2||4
150384|NCT01642485|365660|P8|NOT COMPLETED|Period 1, Day 1||0
150385|NCT01642485|365661|P7|NOT COMPLETED|Period 1, Day 1||0
150386|NCT01642485|365662|P6|NOT COMPLETED|Period 1, Day 1||0
150387|NCT01642485|365663|P5|NOT COMPLETED|Period 1, Day 1||0
150388|NCT01642485|365664|P4|NOT COMPLETED|Period 1, Day 1||0
150389|NCT01642485|365665|P3|NOT COMPLETED|Period 1, Day 1||0
150390|NCT01642485|365666|P2|NOT COMPLETED|Period 1, Day 1||0
150391|NCT01642485|365667|P1|NOT COMPLETED|Period 1, Day 1||0
150392|NCT01642485|365660|P8|COMPLETED|Period 1, Day 1||4
150393|NCT01642485|365661|P7|COMPLETED|Period 1, Day 1||4
150394|NCT01642485|365662|P6|COMPLETED|Period 1, Day 1||4
150395|NCT01642485|365663|P5|COMPLETED|Period 1, Day 1||4
150396|NCT01642485|365664|P4|COMPLETED|Period 1, Day 1||4
150397|NCT01642485|365665|P3|COMPLETED|Period 1, Day 1||4
150398|NCT01642485|365666|P2|COMPLETED|Period 1, Day 1||4
150399|NCT01642485|365667|P1|COMPLETED|Period 1, Day 1||4
150400|NCT01642485|365660|P8|STARTED|Period 1, Day 1||4
150401|NCT01642485|365661|P7|STARTED|Period 1, Day 1||4
150402|NCT01642485|365662|P6|STARTED|Period 1, Day 1||4
150403|NCT01642485|365663|P5|STARTED|Period 1, Day 1||4
150404|NCT01642485|365664|P4|STARTED|Period 1, Day 1||4
150405|NCT01642485|365665|P3|STARTED|Period 1, Day 1||4
150406|NCT01642485|365666|P2|STARTED|Period 1, Day 1||4
150407|NCT01642485|365667|P1|STARTED|Period 1, Day 1|crossover so all subjects had this treatment|4
150408|NCT01642407|365685|P1|NOT COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||2
150409|NCT01642407|365685|P1|COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||1
150410|NCT01642407|365685|P1|STARTED|Part 2(Week17 to Maximum of 119.6 Weeks)||3
150411|NCT01642407|365685|P1|NOT COMPLETED|Part 1 (Screening Till Week 16)||3
150412|NCT01642407|365685|P1|COMPLETED|Part 1 (Screening Till Week 16)||3
150413|NCT01642407|365685|P1|STARTED|Part 1 (Screening Till Week 16)||6
150414|NCT01642277|365732|P2|NOT COMPLETED|Overall Study||0
150415|NCT01642277|365733|P1|NOT COMPLETED|Overall Study||24
150416|NCT01642277|365732|P2|COMPLETED|Overall Study||60
150417|NCT01642277|365733|P1|COMPLETED|Overall Study||50
150418|NCT01642277|365732|P2|STARTED|Overall Study||60
150419|NCT01642277|365733|P1|STARTED|Overall Study||74
150420|NCT01642251|365745|P4|NOT COMPLETED|Overall Study||23
150421|NCT01642251|365746|P3|NOT COMPLETED|Overall Study||22
150422|NCT01642251|365747|P2|NOT COMPLETED|Overall Study||0
150423|NCT01642251|365748|P1|NOT COMPLETED|Overall Study||0
150424|NCT01642251|365745|P4|COMPLETED|Overall Study||49
150425|NCT01642251|365746|P3|COMPLETED|Overall Study||53
150426|NCT01642251|365747|P2|COMPLETED|Overall Study||6
150427|NCT01642251|365748|P1|COMPLETED|Overall Study||3
150428|NCT01642251|365745|P4|Eligible and Treated|Overall Study||64
150429|NCT01642251|365746|P3|Eligible and Treated|Overall Study||64
150430|NCT01642251|365747|P2|Eligible and Treated|Overall Study||6
150431|NCT01642251|365748|P1|Eligible and Treated|Overall Study||3
150432|NCT01642251|365745|P4|Eligible|Overall Study||69
150433|NCT01642251|365746|P3|Eligible|Overall Study||72
150434|NCT01642251|365747|P2|Eligible|Overall Study||6
150435|NCT01642251|365748|P1|Eligible|Overall Study||3
150436|NCT01642251|365745|P4|Started Protocol Therapy|Overall Study||66
150437|NCT01642251|365746|P3|Started Protocol Therapy|Overall Study||66
150438|NCT01642251|365747|P2|Started Protocol Therapy|Overall Study||6
150439|NCT01642251|365748|P1|Started Protocol Therapy|Overall Study||3
150440|NCT01642251|365745|P4|STARTED|Overall Study||72
150441|NCT01642251|365746|P3|STARTED|Overall Study||75
150442|NCT01642251|365747|P2|STARTED|Overall Study||6
150443|NCT01642251|365748|P1|STARTED|Overall Study||3
150444|NCT01642238|365763|P2|NOT COMPLETED|Second Intervention (1 Day)||0
150445|NCT01642238|365764|P1|NOT COMPLETED|Second Intervention (1 Day)||0
150446|NCT01642238|365763|P2|COMPLETED|Second Intervention (1 Day)||8
150447|NCT01642238|365764|P1|COMPLETED|Second Intervention (1 Day)||7
150448|NCT01642238|365763|P2|STARTED|Second Intervention (1 Day)||8
150449|NCT01642238|365764|P1|STARTED|Second Intervention (1 Day)||7
150450|NCT01642238|365763|P2|NOT COMPLETED|Washout (1-2 Weeks)||0
150451|NCT01642238|365764|P1|NOT COMPLETED|Washout (1-2 Weeks)||0
150452|NCT01642238|365763|P2|COMPLETED|Washout (1-2 Weeks)||8
150453|NCT01642238|365764|P1|COMPLETED|Washout (1-2 Weeks)||7
150454|NCT01642238|365763|P2|STARTED|Washout (1-2 Weeks)||8
150455|NCT01642238|365764|P1|STARTED|Washout (1-2 Weeks)||7
150456|NCT01642238|365763|P2|NOT COMPLETED|First Intervention (1 Day)||0
150457|NCT01642238|365764|P1|NOT COMPLETED|First Intervention (1 Day)||0
150458|NCT01642238|365763|P2|COMPLETED|First Intervention (1 Day)||8
150459|NCT01642238|365764|P1|COMPLETED|First Intervention (1 Day)||7
150460|NCT01642238|365763|P2|STARTED|First Intervention (1 Day)||8
150461|NCT01642238|365764|P1|STARTED|First Intervention (1 Day)||7
150462|NCT01642212|365786|P5|NOT COMPLETED|Open-label Extension||8
150463|NCT01642212|365787|P4|NOT COMPLETED|Open-label Extension||10
150464|NCT01642212|365788|P3|NOT COMPLETED|Open-label Extension||0
150465|NCT01642212|365789|P2|NOT COMPLETED|Open-label Extension||0
150466|NCT01642212|365790|P1|NOT COMPLETED|Open-label Extension||0
150467|NCT01642212|365786|P5|COMPLETED|Open-label Extension||37
150468|NCT01642212|365787|P4|COMPLETED|Open-label Extension||27
150469|NCT01642212|365788|P3|COMPLETED|Open-label Extension||0
150470|NCT01642212|365789|P2|COMPLETED|Open-label Extension||0
150471|NCT01642212|365790|P1|COMPLETED|Open-label Extension||0
150472|NCT01642212|365786|P5|STARTED|Open-label Extension|Four participants completed double-blind treatment but did not enter the open-label extension.|45
150473|NCT01642212|365787|P4|STARTED|Open-label Extension|Two participants completed double-blind treatment but did not enter the open-label extension.|37
150474|NCT01642212|365788|P3|STARTED|Open-label Extension||0
150475|NCT01642212|365789|P2|STARTED|Open-label Extension||0
150476|NCT01642212|365790|P1|STARTED|Open-label Extension||0
150477|NCT01642212|365786|P5|NOT COMPLETED|Double-blind Treatment||0
150478|NCT01642212|365787|P4|NOT COMPLETED|Double-blind Treatment||0
150479|NCT01642212|365788|P3|NOT COMPLETED|Double-blind Treatment||2
150480|NCT01642212|365789|P2|NOT COMPLETED|Double-blind Treatment||3
150481|NCT01642212|365790|P1|NOT COMPLETED|Double-blind Treatment||0
150482|NCT01642212|365786|P5|COMPLETED|Double-blind Treatment||0
150483|NCT01642212|365787|P4|COMPLETED|Double-blind Treatment||0
150484|NCT01642212|365788|P3|COMPLETED|Double-blind Treatment||49
150485|NCT01642212|365789|P2|COMPLETED|Double-blind Treatment||39
150486|NCT01642212|365790|P1|COMPLETED|Double-blind Treatment||0
150487|NCT01642212|365786|P5|STARTED|Double-blind Treatment||0
150488|NCT01642212|365787|P4|STARTED|Double-blind Treatment||0
150489|NCT01642212|365788|P3|STARTED|Double-blind Treatment||51
150490|NCT01642212|365789|P2|STARTED|Double-blind Treatment||42
150491|NCT01642212|365790|P1|STARTED|Double-blind Treatment||0
150492|NCT01642212|365786|P5|NOT COMPLETED|Single-blind Baseline||0
150493|NCT01642212|365787|P4|NOT COMPLETED|Single-blind Baseline||0
150494|NCT01642212|365788|P3|NOT COMPLETED|Single-blind Baseline||0
150495|NCT01642212|365789|P2|NOT COMPLETED|Single-blind Baseline||0
150496|NCT01642212|365790|P1|NOT COMPLETED|Single-blind Baseline||26
150497|NCT01642212|365786|P5|COMPLETED|Single-blind Baseline||0
150498|NCT01642212|365787|P4|COMPLETED|Single-blind Baseline||0
150499|NCT01642212|365788|P3|COMPLETED|Single-blind Baseline||0
150500|NCT01642212|365789|P2|COMPLETED|Single-blind Baseline||0
150501|NCT01642212|365790|P1|COMPLETED|Single-blind Baseline||93
150502|NCT01642212|365786|P5|STARTED|Single-blind Baseline||0
150503|NCT01642212|365787|P4|STARTED|Single-blind Baseline||0
150504|NCT01642212|365788|P3|STARTED|Single-blind Baseline||0
150505|NCT01642212|365789|P2|STARTED|Single-blind Baseline||0
150506|NCT01642212|365790|P1|STARTED|Single-blind Baseline||119
150507|NCT01642147|365840|P2|NOT COMPLETED|Overall Study||0
150508|NCT01642147|365841|P1|NOT COMPLETED|Overall Study||0
150509|NCT01642147|365840|P2|COMPLETED|Overall Study||30
150510|NCT01642147|365841|P1|COMPLETED|Overall Study||30
150511|NCT01642147|365840|P2|STARTED|Overall Study||30
150512|NCT01642147|365841|P1|STARTED|Overall Study||30
150513|NCT01642082|365869|P1|NOT COMPLETED|Overall Study||0
150514|NCT01642082|365869|P1|COMPLETED|Overall Study||28
150515|NCT01642082|365869|P1|STARTED|Overall Study||28
150516|NCT01642004|365885|P2|NOT COMPLETED|Treatment||127
150517|NCT01642004|365886|P1|NOT COMPLETED|Treatment||110
150518|NCT01642004|365885|P2|COMPLETED|Treatment||2
150519|NCT01642004|365886|P1|COMPLETED|Treatment||21
150520|NCT01642004|365885|P2|STARTED|Treatment||129
150521|NCT01642004|365886|P1|STARTED|Treatment||131
150522|NCT01642004|365885|P2|NOT COMPLETED|Randomization||8
150523|NCT01642004|365886|P1|NOT COMPLETED|Randomization||4
150524|NCT01642004|365885|P2|COMPLETED|Randomization||129
150525|NCT01642004|365886|P1|COMPLETED|Randomization||131
150526|NCT01642004|365885|P2|STARTED|Randomization||137
150527|NCT01642004|365886|P1|STARTED|Randomization||135
150528|NCT01641991|365920|P4|NOT COMPLETED|Overall Study||16
150529|NCT01641991|365921|P3|NOT COMPLETED|Overall Study||17
150530|NCT01641991|365922|P2|NOT COMPLETED|Overall Study||8
150531|NCT01641991|365923|P1|NOT COMPLETED|Overall Study||9
150532|NCT01641991|365920|P4|COMPLETED|Overall Study||66
150533|NCT01641991|365921|P3|COMPLETED|Overall Study||65
150534|NCT01641991|365922|P2|COMPLETED|Overall Study||74
150535|NCT01641991|365923|P1|COMPLETED|Overall Study||73
150536|NCT01641991|365920|P4|STARTED|Overall Study||82
150537|NCT01641991|365921|P3|STARTED|Overall Study||82
150538|NCT01641991|365922|P2|STARTED|Overall Study||82
150539|NCT01641991|365923|P1|STARTED|Overall Study||82
150540|NCT01641978|365999|P1|NOT COMPLETED|Overall Study||0
150541|NCT01641978|365999|P1|COMPLETED|Overall Study||125
150542|NCT01641978|365999|P1|STARTED|Overall Study||125
150543|NCT01641952|366007|P1|NOT COMPLETED|Overall Study||34
150544|NCT01641952|366007|P1|COMPLETED|Overall Study||471
150545|NCT01641952|366007|P1|Treated|Overall Study||504
150546|NCT01641952|366007|P1|STARTED|Overall Study||505
150547|NCT01641939|366023|P3|NOT COMPLETED|Overall Study||70
150548|NCT01641939|366024|P2|NOT COMPLETED|Overall Study||228
150549|NCT01641939|366025|P1|NOT COMPLETED|Overall Study||117
150550|NCT01641939|366023|P3|COMPLETED|Overall Study||0
150551|NCT01641939|366024|P2|COMPLETED|Overall Study||0
150552|NCT01641939|366025|P1|COMPLETED|Overall Study||0
150553|NCT01641939|366023|P3|Stage 2|Overall Study||0
150554|NCT01641939|366024|P2|Stage 2|Overall Study||153
150555|NCT01641939|366025|P1|Stage 2|Overall Study||80
150556|NCT01641939|366023|P3|Stage 1|Overall Study||70
150557|NCT01641939|366024|P2|Stage 1|Overall Study||75
150558|NCT01641939|366025|P1|Stage 1|Overall Study||37
150559|NCT01641939|366023|P3|STARTED|Overall Study||70
150560|NCT01641939|366024|P2|STARTED|Overall Study||228
150561|NCT01641939|366025|P1|STARTED|Overall Study||117
150562|NCT01641926|366068|P4|NOT COMPLETED|Overall Study||4
150563|NCT01641926|366069|P3|NOT COMPLETED|Overall Study||11
150564|NCT01641926|366070|P2|NOT COMPLETED|Overall Study||15
150565|NCT01641926|366071|P1|NOT COMPLETED|Overall Study||28
150566|NCT01641926|366068|P4|COMPLETED|Overall Study||53
150567|NCT01641926|366069|P3|COMPLETED|Overall Study||46
150568|NCT01641926|366070|P2|COMPLETED|Overall Study||130
150569|NCT01641926|366071|P1|COMPLETED|Overall Study||115
150570|NCT01641926|366068|P4|Treated (All Participants as Treated)|Overall Study||57
150571|NCT01641926|366069|P3|Treated (All Participants as Treated)|Overall Study||56
150572|NCT01641926|366070|P2|Treated (All Participants as Treated)|Overall Study||144
150573|NCT01641926|366071|P1|Treated (All Participants as Treated)|Overall Study||142
150574|NCT01641926|366068|P4|STARTED|Overall Study||57
150575|NCT01641926|366069|P3|STARTED|Overall Study||57
150576|NCT01641926|366070|P2|STARTED|Overall Study||145
150577|NCT01641926|366071|P1|STARTED|Overall Study||143
150578|NCT01641900|366099|P2|NOT COMPLETED|Overall Study||2
150579|NCT01641900|366100|P1|NOT COMPLETED|Overall Study||2
150580|NCT01641900|366099|P2|COMPLETED|Overall Study||29
150581|NCT01641900|366100|P1|COMPLETED|Overall Study||26
150582|NCT01641900|366099|P2|Completed Drug Intervention|Overall Study||29
150583|NCT01641900|366100|P1|Completed Drug Intervention|Overall Study|n=1,assigned to drug intervention first, completed the session and dropped out of the study.|26
150584|NCT01641900|366099|P2|Completed Placebo Intervention|Overall Study|n=2,both assigned to placebo intervention first, completed the session and dropped out of the study.|29
150585|NCT01641900|366100|P1|Completed Placebo Intervention|Overall Study|n=1,assigned to placebo intervention first, completed the session and dropped out of the study.|27
150586|NCT01641900|366099|P2|STARTED|Overall Study||31
150587|NCT01641900|366100|P1|STARTED|Overall Study||28
150588|NCT01641861|366112|P2|NOT COMPLETED|Overall Study||25
150589|NCT01641861|366113|P1|NOT COMPLETED|Overall Study||35
150590|NCT01641861|366112|P2|COMPLETED|Overall Study||217
150591|NCT01641861|366113|P1|COMPLETED|Overall Study||211
150592|NCT01641861|366112|P2|STARTED|Overall Study||242
150593|NCT01641861|366113|P1|STARTED|Overall Study||246
150594|NCT01641835|366127|P1|NOT COMPLETED|Overall Study||0
150595|NCT01641835|366127|P1|COMPLETED|Overall Study||303
150596|NCT01641835|366127|P1|STARTED|Overall Study||303
150597|NCT01641822|366134|P3|NOT COMPLETED|Comparative Phase||10
150598|NCT01641822|366135|P2|NOT COMPLETED|Comparative Phase||6
150599|NCT01641822|366136|P1|NOT COMPLETED|Comparative Phase||0
150600|NCT01641822|366134|P3|COMPLETED|Comparative Phase||37
150601|NCT01641822|366135|P2|COMPLETED|Comparative Phase||37
150602|NCT01641822|366136|P1|COMPLETED|Comparative Phase||0
150603|NCT01641822|366134|P3|Received Randomized Study Drug Treatment|Comparative Phase||46
150604|NCT01641822|366135|P2|Received Randomized Study Drug Treatment|Comparative Phase||42
150605|NCT01641822|366136|P1|Received Randomized Study Drug Treatment|Comparative Phase||0
150606|NCT01641822|366134|P3|STARTED|Comparative Phase||47
150607|NCT01641822|366135|P2|STARTED|Comparative Phase||43
150608|NCT01641822|366136|P1|STARTED|Comparative Phase|Participants continuing into the Comparative Phase were randomized to the AZLI or Placebo group.|0
150609|NCT01641822|366134|P3|NOT COMPLETED|Run-in Phase||0
150610|NCT01641822|366135|P2|NOT COMPLETED|Run-in Phase||0
150611|NCT01641822|366136|P1|NOT COMPLETED|Run-in Phase||14
150612|NCT01641822|366134|P3|COMPLETED|Run-in Phase||0
150613|NCT01641822|366135|P2|COMPLETED|Run-in Phase||0
150614|NCT01641822|366136|P1|COMPLETED|Run-in Phase|3 participants who completed the TIS Run-In Phase did not continue to the Comparative Phase.|93
150615|NCT01641822|366134|P3|STARTED|Run-in Phase||0
150616|NCT01641822|366135|P2|STARTED|Run-in Phase||0
150617|NCT01641822|366136|P1|STARTED|Run-in Phase||107
150618|NCT01641692|366153|P8|NOT COMPLETED|Washout Period 3 or Follow-up||0
150619|NCT01641692|366154|P7|NOT COMPLETED|Washout Period 3 or Follow-up||1
150620|NCT01641692|366155|P6|NOT COMPLETED|Washout Period 3 or Follow-up||2
150621|NCT01641692|366156|P5|NOT COMPLETED|Washout Period 3 or Follow-up||0
150622|NCT01641692|366157|P4|NOT COMPLETED|Washout Period 3 or Follow-up||1
150623|NCT01641692|366158|P3|NOT COMPLETED|Washout Period 3 or Follow-up||1
150624|NCT01641692|366159|P2|NOT COMPLETED|Washout Period 3 or Follow-up||0
150625|NCT01641692|366160|P1|NOT COMPLETED|Washout Period 3 or Follow-up||1
150626|NCT01641692|366153|P8|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|38
150627|NCT01641692|366154|P7|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
150628|NCT01641692|366155|P6|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|37
150629|NCT01641692|366156|P5|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|40
150630|NCT01641692|366157|P4|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|41
150631|NCT01641692|366158|P3|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|36
150632|NCT01641692|366159|P2|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
150633|NCT01641692|366160|P1|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|42
150634|NCT01641692|366153|P8|STARTED|Washout Period 3 or Follow-up||38
150635|NCT01641692|366154|P7|STARTED|Washout Period 3 or Follow-up||33
150636|NCT01641692|366155|P6|STARTED|Washout Period 3 or Follow-up||39
150637|NCT01641692|366156|P5|STARTED|Washout Period 3 or Follow-up||40
150638|NCT01641692|366157|P4|STARTED|Washout Period 3 or Follow-up||42
150639|NCT01641692|366158|P3|STARTED|Washout Period 3 or Follow-up||37
150640|NCT01641692|366159|P2|STARTED|Washout Period 3 or Follow-up||32
150641|NCT01641692|366160|P1|STARTED|Washout Period 3 or Follow-up||43
150642|NCT01641692|366153|P8|NOT COMPLETED|Treatment Period 3||0
150643|NCT01641692|366154|P7|NOT COMPLETED|Treatment Period 3||2
150644|NCT01641692|366155|P6|NOT COMPLETED|Treatment Period 3||0
150645|NCT01641692|366156|P5|NOT COMPLETED|Treatment Period 3||0
150646|NCT01641692|366157|P4|NOT COMPLETED|Treatment Period 3||0
150647|NCT01641692|366158|P3|NOT COMPLETED|Treatment Period 3||1
150648|NCT01641692|366159|P2|NOT COMPLETED|Treatment Period 3||1
150649|NCT01641692|366160|P1|NOT COMPLETED|Treatment Period 3||0
150650|NCT01641692|366153|P8|COMPLETED|Treatment Period 3||38
150651|NCT01641692|366154|P7|COMPLETED|Treatment Period 3||33
150652|NCT01641692|366155|P6|COMPLETED|Treatment Period 3||39
150653|NCT01641692|366156|P5|COMPLETED|Treatment Period 3||40
150654|NCT01641692|366157|P4|COMPLETED|Treatment Period 3||42
150655|NCT01641692|366158|P3|COMPLETED|Treatment Period 3||37
150656|NCT01641692|366159|P2|COMPLETED|Treatment Period 3||32
150657|NCT01641692|366160|P1|COMPLETED|Treatment Period 3||43
150658|NCT01641692|366153|P8|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
150659|NCT01641692|366154|P7|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|35
150660|NCT01641692|366155|P6|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|39
150661|NCT01641692|366156|P5|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|40
150662|NCT01641692|366157|P4|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|42
150663|NCT01641692|366158|P3|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
150664|NCT01641692|366159|P2|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|33
150665|NCT01641692|366160|P1|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|43
150666|NCT01641692|366153|P8|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
150667|NCT01641692|366154|P7|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
150668|NCT01641692|366155|P6|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
150669|NCT01641692|366156|P5|NOT COMPLETED|Washout Period 2 (12-14 Days)||3
150670|NCT01641692|366157|P4|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
150671|NCT01641692|366158|P3|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
150672|NCT01641692|366159|P2|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
150673|NCT01641692|366160|P1|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
150674|NCT01641692|366153|P8|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
150675|NCT01641692|366154|P7|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
150676|NCT01641692|366155|P6|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
150677|NCT01641692|366156|P5|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
150678|NCT01641692|366157|P4|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|41
150679|NCT01641692|366158|P3|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
150680|NCT01641692|366159|P2|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|46
150681|NCT01641692|366160|P1|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|30
150682|NCT01641692|366153|P8|STARTED|Washout Period 2 (12-14 Days)||35
150683|NCT01641692|366154|P7|STARTED|Washout Period 2 (12-14 Days)||43
150684|NCT01641692|366155|P6|STARTED|Washout Period 2 (12-14 Days)||43
150685|NCT01641692|366156|P5|STARTED|Washout Period 2 (12-14 Days)||37
150686|NCT01641692|366157|P4|STARTED|Washout Period 2 (12-14 Days)||41
150687|NCT01641692|366158|P3|STARTED|Washout Period 2 (12-14 Days)||40
150688|NCT01641692|366159|P2|STARTED|Washout Period 2 (12-14 Days)||46
150689|NCT01641692|366160|P1|STARTED|Washout Period 2 (12-14 Days)||30
150690|NCT01641692|366153|P8|NOT COMPLETED|Treatment Period 2||1
150691|NCT01641692|366154|P7|NOT COMPLETED|Treatment Period 2||0
150692|NCT01641692|366155|P6|NOT COMPLETED|Treatment Period 2||2
150693|NCT01641692|366156|P5|NOT COMPLETED|Treatment Period 2||0
150694|NCT01641692|366157|P4|NOT COMPLETED|Treatment Period 2||0
150695|NCT01641692|366158|P3|NOT COMPLETED|Treatment Period 2||0
150696|NCT01641692|366159|P2|NOT COMPLETED|Treatment Period 2||0
150697|NCT01641692|366160|P1|NOT COMPLETED|Treatment Period 2||3
150698|NCT01641692|366153|P8|COMPLETED|Treatment Period 2||35
150699|NCT01641692|366154|P7|COMPLETED|Treatment Period 2||43
150700|NCT01641692|366155|P6|COMPLETED|Treatment Period 2||43
150701|NCT01641692|366156|P5|COMPLETED|Treatment Period 2||37
150702|NCT01641692|366157|P4|COMPLETED|Treatment Period 2||41
150703|NCT01641692|366158|P3|COMPLETED|Treatment Period 2||40
150704|NCT01641692|366159|P2|COMPLETED|Treatment Period 2||46
150705|NCT01641692|366160|P1|COMPLETED|Treatment Period 2||30
150706|NCT01641692|366153|P8|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|36
150707|NCT01641692|366154|P7|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|43
150708|NCT01641692|366155|P6|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|45
150709|NCT01641692|366156|P5|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|37
150710|NCT01641692|366157|P4|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|41
150711|NCT01641692|366158|P3|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|40
150712|NCT01641692|366159|P2|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|46
150713|NCT01641692|366160|P1|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|33
150714|NCT01641692|366153|P8|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
150715|NCT01641692|366154|P7|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
150716|NCT01641692|366155|P6|NOT COMPLETED|Washout Period 1 (12-14 Days)||0
150717|NCT01641692|366156|P5|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
150718|NCT01641692|366157|P4|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
150719|NCT01641692|366158|P3|NOT COMPLETED|Washout Period 1 (12-14 Days)||3
150720|NCT01641692|366159|P2|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
150721|NCT01641692|366160|P1|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
150722|NCT01641692|366153|P8|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
150723|NCT01641692|366154|P7|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
150724|NCT01641692|366155|P6|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|37
150725|NCT01641692|366156|P5|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|35
150726|NCT01641692|366157|P4|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
150727|NCT01641692|366158|P3|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
150728|NCT01641692|366159|P2|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|44
150729|NCT01641692|366160|P1|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
150730|NCT01641692|366153|P8|STARTED|Washout Period 1 (12-14 Days)||48
150731|NCT01641692|366154|P7|STARTED|Washout Period 1 (12-14 Days)||38
150732|NCT01641692|366155|P6|STARTED|Washout Period 1 (12-14 Days)||37
150733|NCT01641692|366156|P5|STARTED|Washout Period 1 (12-14 Days)||39
150734|NCT01641692|366157|P4|STARTED|Washout Period 1 (12-14 Days)||41
150735|NCT01641692|366158|P3|STARTED|Washout Period 1 (12-14 Days)||50
150736|NCT01641692|366159|P2|STARTED|Washout Period 1 (12-14 Days)||45
150737|NCT01641692|366160|P1|STARTED|Washout Period 1 (12-14 Days)||40
150738|NCT01641692|366153|P8|NOT COMPLETED|Treatment Period 1||3
150739|NCT01641692|366154|P7|NOT COMPLETED|Treatment Period 1||0
150740|NCT01641692|366155|P6|NOT COMPLETED|Treatment Period 1||2
150741|NCT01641692|366156|P5|NOT COMPLETED|Treatment Period 1||4
150742|NCT01641692|366157|P4|NOT COMPLETED|Treatment Period 1||0
150743|NCT01641692|366158|P3|NOT COMPLETED|Treatment Period 1||1
150744|NCT01641692|366159|P2|NOT COMPLETED|Treatment Period 1||0
150745|NCT01641692|366160|P1|NOT COMPLETED|Treatment Period 1||2
150746|NCT01641692|366153|P8|COMPLETED|Treatment Period 1||48
150747|NCT01641692|366154|P7|COMPLETED|Treatment Period 1||38
150748|NCT01641692|366155|P6|COMPLETED|Treatment Period 1||37
150749|NCT01641692|366156|P5|COMPLETED|Treatment Period 1||39
150750|NCT01641692|366157|P4|COMPLETED|Treatment Period 1||41
150751|NCT01641692|366158|P3|COMPLETED|Treatment Period 1||50
150752|NCT01641692|366159|P2|COMPLETED|Treatment Period 1||45
150753|NCT01641692|366160|P1|COMPLETED|Treatment Period 1||40
150754|NCT01641692|366153|P8|STARTED|Treatment Period 1||51
150755|NCT01641692|366154|P7|STARTED|Treatment Period 1||38
150756|NCT01641692|366155|P6|STARTED|Treatment Period 1||39
150757|NCT01641692|366156|P5|STARTED|Treatment Period 1||43
150758|NCT01641692|366157|P4|STARTED|Treatment Period 1||41
150759|NCT01641692|366158|P3|STARTED|Treatment Period 1||51
150760|NCT01641692|366159|P2|STARTED|Treatment Period 1||45
150761|NCT01641692|366160|P1|STARTED|Treatment Period 1||42
150762|NCT01641653|366349|P2|NOT COMPLETED|Overall Study||0
150763|NCT01641653|366350|P1|NOT COMPLETED|Overall Study||0
150764|NCT01641653|366349|P2|COMPLETED|Overall Study||30
150765|NCT01641653|366350|P1|COMPLETED|Overall Study||30
150766|NCT01641653|366349|P2|STARTED|Overall Study||30
150767|NCT01641653|366350|P1|STARTED|Overall Study||30
150768|NCT01641640|366360|P1|NOT COMPLETED|Overall Study||36
150769|NCT01641640|366360|P1|COMPLETED|Overall Study||292
150770|NCT01641640|366360|P1|Enrolled and Treated|Overall Study||327
150771|NCT01641640|366360|P1|STARTED|Overall Study||328
150772|NCT01641471|366371|P2|NOT COMPLETED|Overall Study||27
150773|NCT01641471|366372|P1|NOT COMPLETED|Overall Study||23
150774|NCT01641471|366371|P2|COMPLETED|Overall Study||31
150775|NCT01641471|366372|P1|COMPLETED|Overall Study||35
150776|NCT01641471|366371|P2|STARTED|Overall Study||58
150777|NCT01641471|366372|P1|STARTED|Overall Study||58
150778|NCT01641380|366386|P2|NOT COMPLETED|Third Injection Cycle||5
150779|NCT01641380|366387|P1|NOT COMPLETED|Third Injection Cycle||3
150780|NCT01641380|366386|P2|COMPLETED|Third Injection Cycle||33
150781|NCT01641380|366387|P1|COMPLETED|Third Injection Cycle||36
150782|NCT01641380|366386|P2|STARTED|Third Injection Cycle||38
150783|NCT01641380|366387|P1|STARTED|Third Injection Cycle||39
150784|NCT01641380|366386|P2|NOT COMPLETED|Second Injection Cycle||6
150785|NCT01641380|366387|P1|NOT COMPLETED|Second Injection Cycle||4
150786|NCT01641380|366386|P2|COMPLETED|Second Injection Cycle||38
150787|NCT01641380|366387|P1|COMPLETED|Second Injection Cycle||39
150788|NCT01641380|366386|P2|STARTED|Second Injection Cycle||44
150789|NCT01641380|366387|P1|STARTED|Second Injection Cycle||43
150790|NCT01641380|366386|P2|NOT COMPLETED|First Injection Cycle||6
150791|NCT01641380|366387|P1|NOT COMPLETED|First Injection Cycle||7
150792|NCT01641380|366386|P2|COMPLETED|First Injection Cycle||44
150793|NCT01641380|366387|P1|COMPLETED|First Injection Cycle||43
150794|NCT01641380|366386|P2|STARTED|First Injection Cycle||50
150795|NCT01641380|366387|P1|STARTED|First Injection Cycle||50
150796|NCT01641367|366404|P8|NOT COMPLETED|Randomized Adherence Intervention||24
150797|NCT01641367|366405|P7|NOT COMPLETED|Randomized Adherence Intervention||19
150798|NCT01641367|366406|P6|NOT COMPLETED|Randomized Adherence Intervention||0
150799|NCT01641367|366407|P5|NOT COMPLETED|Randomized Adherence Intervention||0
150800|NCT01641367|366408|P4|NOT COMPLETED|Randomized Adherence Intervention||0
150801|NCT01641367|366409|P3|NOT COMPLETED|Randomized Adherence Intervention||0
150802|NCT01641367|366410|P2|NOT COMPLETED|Randomized Adherence Intervention||0
150803|NCT01641367|366411|P1|NOT COMPLETED|Randomized Adherence Intervention||0
150804|NCT01641367|366404|P8|COMPLETED|Randomized Adherence Intervention||240
150805|NCT01641367|366405|P7|COMPLETED|Randomized Adherence Intervention||238
150806|NCT01641367|366406|P6|COMPLETED|Randomized Adherence Intervention||0
150807|NCT01641367|366407|P5|COMPLETED|Randomized Adherence Intervention||0
150808|NCT01641367|366408|P4|COMPLETED|Randomized Adherence Intervention||0
150809|NCT01641367|366409|P3|COMPLETED|Randomized Adherence Intervention||0
150810|NCT01641367|366410|P2|COMPLETED|Randomized Adherence Intervention||0
150811|NCT01641367|366411|P1|COMPLETED|Randomized Adherence Intervention||0
150812|NCT01641367|366404|P8|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||202
150813|NCT01641367|366405|P7|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||196
150814|NCT01641367|366406|P6|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
150815|NCT01641367|366407|P5|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
150816|NCT01641367|366408|P4|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
150817|NCT01641367|366409|P3|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
150818|NCT01641367|366410|P2|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
150819|NCT01641367|366411|P1|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
150820|NCT01641367|366404|P8|STARTED|Randomized Adherence Intervention||264
150821|NCT01641367|366405|P7|STARTED|Randomized Adherence Intervention||257
150822|NCT01641367|366406|P6|STARTED|Randomized Adherence Intervention||0
150823|NCT01641367|366407|P5|STARTED|Randomized Adherence Intervention||0
150824|NCT01641367|366408|P4|STARTED|Randomized Adherence Intervention||0
150825|NCT01641367|366409|P3|STARTED|Randomized Adherence Intervention||0
150826|NCT01641367|366410|P2|STARTED|Randomized Adherence Intervention||0
150827|NCT01641367|366411|P1|STARTED|Randomized Adherence Intervention||0
150828|NCT01641367|366404|P8|NOT COMPLETED|Cohorts||0
150829|NCT01641367|366405|P7|NOT COMPLETED|Cohorts||0
150830|NCT01641367|366406|P6|NOT COMPLETED|Cohorts||1
150831|NCT01641367|366407|P5|NOT COMPLETED|Cohorts||3
150832|NCT01641367|366408|P4|NOT COMPLETED|Cohorts||0
150833|NCT01641367|366409|P3|NOT COMPLETED|Cohorts||4
150834|NCT01641367|366410|P2|NOT COMPLETED|Cohorts||1
150835|NCT01641367|366411|P1|NOT COMPLETED|Cohorts||34
150836|NCT01641367|366404|P8|COMPLETED|Cohorts||0
150837|NCT01641367|366405|P7|COMPLETED|Cohorts||0
150838|NCT01641367|366406|P6|COMPLETED|Cohorts||33
150839|NCT01641367|366407|P5|COMPLETED|Cohorts||67
150840|NCT01641367|366408|P4|COMPLETED|Cohorts||8
150841|NCT01641367|366409|P3|COMPLETED|Cohorts||68
150842|NCT01641367|366410|P2|COMPLETED|Cohorts||73
150843|NCT01641367|366411|P1|COMPLETED|Cohorts||253
150844|NCT01641367|366404|P8|Followed 72 Weeks on Step 1/2|Cohorts||0
150845|NCT01641367|366405|P7|Followed 72 Weeks on Step 1/2|Cohorts||0
150846|NCT01641367|366406|P6|Followed 72 Weeks on Step 1/2|Cohorts||30
150847|NCT01641367|366407|P5|Followed 72 Weeks on Step 1/2|Cohorts||52
150848|NCT01641367|366408|P4|Followed 72 Weeks on Step 1/2|Cohorts||6
150849|NCT01641367|366409|P3|Followed 72 Weeks on Step 1/2|Cohorts||60
150850|NCT01641367|366410|P2|Followed 72 Weeks on Step 1/2|Cohorts||60
150851|NCT01641367|366411|P1|Followed 72 Weeks on Step 1/2|Cohorts||211
150852|NCT01641367|366404|P8|STARTED|Cohorts||0
150853|NCT01641367|366405|P7|STARTED|Cohorts||0
150854|NCT01641367|366406|P6|STARTED|Cohorts||34
150855|NCT01641367|366407|P5|STARTED|Cohorts||70
150856|NCT01641367|366408|P4|STARTED|Cohorts||8
150857|NCT01641367|366409|P3|STARTED|Cohorts||72
150858|NCT01641367|366410|P2|STARTED|Cohorts||74
150859|NCT01641367|366411|P1|STARTED|Cohorts||287
150860|NCT01641237|366662|P4|NOT COMPLETED|Period IV||0
150861|NCT01641237|366663|P3|NOT COMPLETED|Period IV||0
150862|NCT01641237|366664|P2|NOT COMPLETED|Period IV||0
150863|NCT01641237|366665|P1|NOT COMPLETED|Period IV||0
150864|NCT01641237|366662|P4|COMPLETED|Period IV||15
150865|NCT01641237|366663|P3|COMPLETED|Period IV||15
150866|NCT01641237|366664|P2|COMPLETED|Period IV||15
150867|NCT01641237|366665|P1|COMPLETED|Period IV||15
150868|NCT01641237|366662|P4|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
150869|NCT01641237|366663|P3|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
150870|NCT01641237|366664|P2|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
150871|NCT01641237|366665|P1|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
150872|NCT01641237|366662|P4|NOT COMPLETED|Period III||0
150873|NCT01641237|366663|P3|NOT COMPLETED|Period III||0
150874|NCT01641237|366664|P2|NOT COMPLETED|Period III||0
150875|NCT01641237|366665|P1|NOT COMPLETED|Period III||1
150876|NCT01641237|366662|P4|COMPLETED|Period III||16
150877|NCT01641237|366663|P3|COMPLETED|Period III||15
150878|NCT01641237|366664|P2|COMPLETED|Period III||14
150879|NCT01641237|366665|P1|COMPLETED|Period III||15
150880|NCT01641237|366662|P4|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
150881|NCT01641237|366663|P3|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|15
150882|NCT01641237|366664|P2|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
150883|NCT01641237|366665|P1|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
150884|NCT01641237|366662|P4|NOT COMPLETED|Period II||0
150885|NCT01641237|366663|P3|NOT COMPLETED|Period II||0
150886|NCT01641237|366664|P2|NOT COMPLETED|Period II||0
150887|NCT01641237|366665|P1|NOT COMPLETED|Period II||1
150888|NCT01641237|366662|P4|COMPLETED|Period II||15
150889|NCT01641237|366663|P3|COMPLETED|Period II||16
150890|NCT01641237|366664|P2|COMPLETED|Period II||16
150891|NCT01641237|366665|P1|COMPLETED|Period II||14
150892|NCT01641237|366662|P4|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
150893|NCT01641237|366663|P3|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
150894|NCT01641237|366664|P2|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
150895|NCT01641237|366665|P1|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
150896|NCT01641237|366662|P4|NOT COMPLETED|Period I||0
150897|NCT01641237|366663|P3|NOT COMPLETED|Period I||0
150898|NCT01641237|366664|P2|NOT COMPLETED|Period I||0
150899|NCT01641237|366665|P1|NOT COMPLETED|Period I||0
150900|NCT01641237|366662|P4|COMPLETED|Period I||15
150901|NCT01641237|366663|P3|COMPLETED|Period I||15
150902|NCT01641237|366664|P2|COMPLETED|Period I||16
150903|NCT01641237|366665|P1|COMPLETED|Period I||16
150904|NCT01641237|366662|P4|STARTED|Period I||15
150905|NCT01641237|366663|P3|STARTED|Period I||15
150906|NCT01641237|366664|P2|STARTED|Period I||16
150907|NCT01641237|366665|P1|STARTED|Period I||16
150908|NCT01641198|366690|P3|NOT COMPLETED|At 15-20 Years of Function||2
150909|NCT01641198|366691|P2|NOT COMPLETED|At 15-20 Years of Function||1
150910|NCT01641198|366692|P1|NOT COMPLETED|At 15-20 Years of Function||6
150911|NCT01641198|366690|P3|COMPLETED|At 15-20 Years of Function|Participants: 1 interval violation, 1 death|9
150912|NCT01641198|366691|P2|COMPLETED|At 15-20 Years of Function|Participants: 1 interval violation|6
150913|NCT01641198|366692|P1|COMPLETED|At 15-20 Years of Function|Participants: 5 interval violation, 1 death|6
150914|NCT01641198|366690|P3|STARTED|At 15-20 Years of Function||11
150915|NCT01641198|366691|P2|STARTED|At 15-20 Years of Function||7
150916|NCT01641198|366692|P1|STARTED|At 15-20 Years of Function||12
150917|NCT01641198|366690|P3|NOT COMPLETED|After 24 Months of Function||6
150918|NCT01641198|366691|P2|NOT COMPLETED|After 24 Months of Function||9
150919|NCT01641198|366692|P1|NOT COMPLETED|After 24 Months of Function||4
150920|NCT01641198|366690|P3|COMPLETED|After 24 Months of Function|Participants: 6 interval violation. Implants: 2 bone loss not measurable|11
150921|NCT01641198|366691|P2|COMPLETED|After 24 Months of Function|Participants: 9 interval violation|7
150922|NCT01641198|366692|P1|COMPLETED|After 24 Months of Function|Participants: 4 interval violation. Implants: 3 bone loss not measurable|12
150923|NCT01641198|366690|P3|STARTED|After 24 Months of Function||17
150924|NCT01641198|366691|P2|STARTED|After 24 Months of Function||16
150925|NCT01641198|366692|P1|STARTED|After 24 Months of Function||16
150926|NCT01641198|366690|P3|NOT COMPLETED|After 12 Months of Function||2
150927|NCT01641198|366691|P2|NOT COMPLETED|After 12 Months of Function||3
150928|NCT01641198|366692|P1|NOT COMPLETED|After 12 Months of Function||4
150929|NCT01641198|366690|P3|COMPLETED|After 12 Months of Function|Participants: 2 interval violation. Implants: 3 bone loss not measurable|17
150930|NCT01641198|366691|P2|COMPLETED|After 12 Months of Function|Participants: 2 interval violation, 1 adverse event. Implants: 3 bone loss not measurable|16
150931|NCT01641198|366692|P1|COMPLETED|After 12 Months of Function|Participants: 3 interval violation, 1 protocol violation. Implants: 13 bone loss not measurable|16
150932|NCT01641198|366690|P3|STARTED|After 12 Months of Function||19
150933|NCT01641198|366691|P2|STARTED|After 12 Months of Function||19
150934|NCT01641198|366692|P1|STARTED|After 12 Months of Function||20
150935|NCT01641159|366708|P2|NOT COMPLETED|Overall Study||2
150936|NCT01641159|366709|P1|NOT COMPLETED|Overall Study||2
150937|NCT01641159|366708|P2|COMPLETED|Overall Study||25
150938|NCT01641159|366709|P1|COMPLETED|Overall Study||33
150939|NCT01641159|366708|P2|STARTED|Overall Study||27
150940|NCT01641159|366709|P1|STARTED|Overall Study||35
150941|NCT01641133|366720|P3|NOT COMPLETED|Overall Study||8
150942|NCT01641133|366721|P2|NOT COMPLETED|Overall Study||9
150943|NCT01641133|366722|P1|NOT COMPLETED|Overall Study||10
150944|NCT01641133|366720|P3|COMPLETED|Overall Study||90
150945|NCT01641133|366721|P2|COMPLETED|Overall Study||90
150946|NCT01641133|366722|P1|COMPLETED|Overall Study||87
150947|NCT01641133|366720|P3|STARTED|Overall Study||98
150948|NCT01641133|366721|P2|STARTED|Overall Study||99
150949|NCT01641133|366722|P1|STARTED|Overall Study||97
150950|NCT01641120|366763|P1|NOT COMPLETED|30 Gauge Needle Weeks 2 and 3||0
150951|NCT01641120|366763|P1|COMPLETED|30 Gauge Needle Weeks 2 and 3||20
150952|NCT01641120|366763|P1|STARTED|30 Gauge Needle Weeks 2 and 3||20
150953|NCT01641120|366763|P1|NOT COMPLETED|25 Gauge Needle Weeks 1, 4, 5||0
150954|NCT01641120|366763|P1|COMPLETED|25 Gauge Needle Weeks 1, 4, 5||20
150955|NCT01641120|366763|P1|STARTED|25 Gauge Needle Weeks 1, 4, 5||20
150956|NCT01641081|366775|P10|NOT COMPLETED|Period 5||0
150957|NCT01641081|366776|P9|NOT COMPLETED|Period 5||0
150958|NCT01641081|366777|P8|NOT COMPLETED|Period 5||0
150959|NCT01641081|366778|P7|NOT COMPLETED|Period 5||0
150960|NCT01641081|366779|P6|NOT COMPLETED|Period 5||0
150961|NCT01641081|366780|P5|NOT COMPLETED|Period 5||0
150962|NCT01641081|366781|P4|NOT COMPLETED|Period 5||0
150963|NCT01641081|366782|P3|NOT COMPLETED|Period 5||2
150964|NCT01641081|366783|P2|NOT COMPLETED|Period 5||0
150965|NCT01641081|366784|P1|NOT COMPLETED|Period 5||0
150966|NCT01641081|366775|P10|COMPLETED|Period 5||14
150967|NCT01641081|366776|P9|COMPLETED|Period 5||14
150968|NCT01641081|366777|P8|COMPLETED|Period 5||14
150969|NCT01641081|366778|P7|COMPLETED|Period 5||16
150970|NCT01641081|366779|P6|COMPLETED|Period 5||18
150971|NCT01641081|366780|P5|COMPLETED|Period 5||16
150972|NCT01641081|366781|P4|COMPLETED|Period 5||20
150973|NCT01641081|366782|P3|COMPLETED|Period 5||12
150974|NCT01641081|366783|P2|COMPLETED|Period 5||17
150975|NCT01641081|366784|P1|COMPLETED|Period 5||16
150976|NCT01641081|366775|P10|STARTED|Period 5||14
150977|NCT01641081|366776|P9|STARTED|Period 5||14
150978|NCT01641081|366777|P8|STARTED|Period 5||14
150979|NCT01641081|366778|P7|STARTED|Period 5||16
150980|NCT01641081|366779|P6|STARTED|Period 5||18
150981|NCT01641081|366780|P5|STARTED|Period 5||16
150982|NCT01641081|366781|P4|STARTED|Period 5||20
150983|NCT01641081|366782|P3|STARTED|Period 5||14
150984|NCT01641081|366783|P2|STARTED|Period 5||17
150985|NCT01641081|366784|P1|STARTED|Period 5||16
150986|NCT01641081|366775|P10|NOT COMPLETED|Period 4||0
150987|NCT01641081|366776|P9|NOT COMPLETED|Period 4||0
150988|NCT01641081|366777|P8|NOT COMPLETED|Period 4||0
150989|NCT01641081|366778|P7|NOT COMPLETED|Period 4||0
150990|NCT01641081|366779|P6|NOT COMPLETED|Period 4||0
150991|NCT01641081|366780|P5|NOT COMPLETED|Period 4||0
150992|NCT01641081|366781|P4|NOT COMPLETED|Period 4||1
150993|NCT01641081|366782|P3|NOT COMPLETED|Period 4||0
150994|NCT01641081|366783|P2|NOT COMPLETED|Period 4||1
150995|NCT01641081|366784|P1|NOT COMPLETED|Period 4||0
150996|NCT01641081|366775|P10|COMPLETED|Period 4||14
150997|NCT01641081|366776|P9|COMPLETED|Period 4||14
150998|NCT01641081|366777|P8|COMPLETED|Period 4||14
150999|NCT01641081|366778|P7|COMPLETED|Period 4||16
151000|NCT01641081|366779|P6|COMPLETED|Period 4||18
151001|NCT01641081|366780|P5|COMPLETED|Period 4||16
151002|NCT01641081|366781|P4|COMPLETED|Period 4||20
151003|NCT01641081|366782|P3|COMPLETED|Period 4||14
151004|NCT01641081|366783|P2|COMPLETED|Period 4||17
151005|NCT01641081|366784|P1|COMPLETED|Period 4||16
151006|NCT01641081|366775|P10|STARTED|Period 4||14
151007|NCT01641081|366776|P9|STARTED|Period 4||14
151008|NCT01641081|366777|P8|STARTED|Period 4||14
151009|NCT01641081|366778|P7|STARTED|Period 4||16
151010|NCT01641081|366779|P6|STARTED|Period 4||18
151011|NCT01641081|366780|P5|STARTED|Period 4||16
151012|NCT01641081|366781|P4|STARTED|Period 4||21
151013|NCT01641081|366782|P3|STARTED|Period 4||14
151014|NCT01641081|366783|P2|STARTED|Period 4||18
151015|NCT01641081|366784|P1|STARTED|Period 4||16
151016|NCT01641081|366775|P10|NOT COMPLETED|Period 3||0
151017|NCT01641081|366776|P9|NOT COMPLETED|Period 3||1
151018|NCT01641081|366777|P8|NOT COMPLETED|Period 3||0
151019|NCT01641081|366778|P7|NOT COMPLETED|Period 3||0
151020|NCT01641081|366779|P6|NOT COMPLETED|Period 3||0
151021|NCT01641081|366780|P5|NOT COMPLETED|Period 3||0
151022|NCT01641081|366781|P4|NOT COMPLETED|Period 3||0
151023|NCT01641081|366782|P3|NOT COMPLETED|Period 3||1
151024|NCT01641081|366783|P2|NOT COMPLETED|Period 3||0
151025|NCT01641081|366784|P1|NOT COMPLETED|Period 3||0
151026|NCT01641081|366775|P10|COMPLETED|Period 3||14
151027|NCT01641081|366776|P9|COMPLETED|Period 3||14
151028|NCT01641081|366777|P8|COMPLETED|Period 3||14
151029|NCT01641081|366778|P7|COMPLETED|Period 3||16
151030|NCT01641081|366779|P6|COMPLETED|Period 3||18
151031|NCT01641081|366780|P5|COMPLETED|Period 3||16
151032|NCT01641081|366781|P4|COMPLETED|Period 3||21
151033|NCT01641081|366782|P3|COMPLETED|Period 3||14
151034|NCT01641081|366783|P2|COMPLETED|Period 3||18
151035|NCT01641081|366784|P1|COMPLETED|Period 3||16
151036|NCT01641081|366775|P10|STARTED|Period 3||14
151037|NCT01641081|366776|P9|STARTED|Period 3||15
151038|NCT01641081|366777|P8|STARTED|Period 3||14
151039|NCT01641081|366778|P7|STARTED|Period 3||16
151040|NCT01641081|366779|P6|STARTED|Period 3||18
151041|NCT01641081|366780|P5|STARTED|Period 3||16
151042|NCT01641081|366781|P4|STARTED|Period 3||21
151043|NCT01641081|366782|P3|STARTED|Period 3||15
151044|NCT01641081|366783|P2|STARTED|Period 3||18
151045|NCT01641081|366784|P1|STARTED|Period 3||16
151046|NCT01641081|366775|P10|NOT COMPLETED|Period 2||0
151047|NCT01641081|366776|P9|NOT COMPLETED|Period 2||0
151048|NCT01641081|366777|P8|NOT COMPLETED|Period 2||0
151049|NCT01641081|366778|P7|NOT COMPLETED|Period 2||2
151050|NCT01641081|366779|P6|NOT COMPLETED|Period 2||1
151051|NCT01641081|366780|P5|NOT COMPLETED|Period 2||0
151052|NCT01641081|366781|P4|NOT COMPLETED|Period 2||1
151053|NCT01641081|366782|P3|NOT COMPLETED|Period 2||0
151054|NCT01641081|366783|P2|NOT COMPLETED|Period 2||0
151055|NCT01641081|366784|P1|NOT COMPLETED|Period 2||1
151056|NCT01641081|366775|P10|COMPLETED|Period 2||14
151057|NCT01641081|366776|P9|COMPLETED|Period 2||15
151058|NCT01641081|366777|P8|COMPLETED|Period 2||14
151059|NCT01641081|366778|P7|COMPLETED|Period 2||16
151060|NCT01641081|366779|P6|COMPLETED|Period 2||18
151061|NCT01641081|366780|P5|COMPLETED|Period 2||16
151062|NCT01641081|366781|P4|COMPLETED|Period 2||21
151063|NCT01641081|366782|P3|COMPLETED|Period 2||15
151064|NCT01641081|366783|P2|COMPLETED|Period 2||18
151065|NCT01641081|366784|P1|COMPLETED|Period 2||16
151066|NCT01641081|366775|P10|STARTED|Period 2||14
151067|NCT01641081|366776|P9|STARTED|Period 2||15
151068|NCT01641081|366777|P8|STARTED|Period 2||14
151069|NCT01641081|366778|P7|STARTED|Period 2||18
151070|NCT01641081|366779|P6|STARTED|Period 2||19
151071|NCT01641081|366780|P5|STARTED|Period 2||16
151072|NCT01641081|366781|P4|STARTED|Period 2||22
151073|NCT01641081|366782|P3|STARTED|Period 2||15
151074|NCT01641081|366783|P2|STARTED|Period 2||18
151075|NCT01641081|366784|P1|STARTED|Period 2||17
151076|NCT01641081|366775|P10|NOT COMPLETED|Period 1||0
151077|NCT01641081|366776|P9|NOT COMPLETED|Period 1||0
151078|NCT01641081|366777|P8|NOT COMPLETED|Period 1||3
151079|NCT01641081|366778|P7|NOT COMPLETED|Period 1||1
151080|NCT01641081|366779|P6|NOT COMPLETED|Period 1||0
151081|NCT01641081|366780|P5|NOT COMPLETED|Period 1||1
151082|NCT01641081|366781|P4|NOT COMPLETED|Period 1||0
151083|NCT01641081|366782|P3|NOT COMPLETED|Period 1||0
151084|NCT01641081|366783|P2|NOT COMPLETED|Period 1||0
151085|NCT01641081|366784|P1|NOT COMPLETED|Period 1||1
151086|NCT01641081|366775|P10|COMPLETED|Period 1||14
151087|NCT01641081|366776|P9|COMPLETED|Period 1||15
151088|NCT01641081|366777|P8|COMPLETED|Period 1||14
151089|NCT01641081|366778|P7|COMPLETED|Period 1||18
151090|NCT01641081|366779|P6|COMPLETED|Period 1||19
151091|NCT01641081|366780|P5|COMPLETED|Period 1||16
151092|NCT01641081|366781|P4|COMPLETED|Period 1||22
151093|NCT01641081|366782|P3|COMPLETED|Period 1||15
151094|NCT01641081|366783|P2|COMPLETED|Period 1||18
151095|NCT01641081|366784|P1|COMPLETED|Period 1||17
151096|NCT01641081|366775|P10|STARTED|Period 1||14
151097|NCT01641081|366776|P9|STARTED|Period 1||15
151098|NCT01641081|366777|P8|STARTED|Period 1||17
151099|NCT01641081|366778|P7|STARTED|Period 1||19
151100|NCT01641081|366779|P6|STARTED|Period 1||19
151101|NCT01641081|366780|P5|STARTED|Period 1||17
151102|NCT01641081|366781|P4|STARTED|Period 1||22
151103|NCT01641081|366782|P3|STARTED|Period 1||15
151104|NCT01641081|366783|P2|STARTED|Period 1||18
151105|NCT01641081|366784|P1|STARTED|Period 1||18
151106|NCT01641042|366803|P2|NOT COMPLETED|Overall Study||0
151107|NCT01641042|366804|P1|NOT COMPLETED|Overall Study||0
151108|NCT01641042|366803|P2|COMPLETED|Overall Study||43
151109|NCT01641042|366804|P1|COMPLETED|Overall Study||43
151110|NCT01641042|366803|P2|STARTED|Overall Study||43
151111|NCT01641042|366804|P1|STARTED|Overall Study||43
151112|NCT01640964|366853|P3|NOT COMPLETED|Overall Study||3
151113|NCT01640964|366854|P2|NOT COMPLETED|Overall Study||1
151114|NCT01640964|366855|P1|NOT COMPLETED|Overall Study||1
151115|NCT01640964|366853|P3|COMPLETED|Overall Study||3
151116|NCT01640964|366854|P2|COMPLETED|Overall Study||19
151117|NCT01640964|366855|P1|COMPLETED|Overall Study||19
151118|NCT01640964|366853|P3|STARTED|Overall Study||6
151119|NCT01640964|366854|P2|STARTED|Overall Study||20
151120|NCT01640964|366855|P1|STARTED|Overall Study||20
151121|NCT01640951|366878|P8|NOT COMPLETED|Overall Study||16
151122|NCT01640951|366879|P7|NOT COMPLETED|Overall Study||18
151123|NCT01640951|366880|P6|NOT COMPLETED|Overall Study||47
151124|NCT01640951|366881|P5|NOT COMPLETED|Overall Study||13
151125|NCT01640951|366882|P4|NOT COMPLETED|Overall Study||45
151126|NCT01640951|366883|P3|NOT COMPLETED|Overall Study||42
151127|NCT01640951|366884|P2|NOT COMPLETED|Overall Study||15
151128|NCT01640951|366885|P1|NOT COMPLETED|Overall Study||46
151129|NCT01640951|366878|P8|COMPLETED|Overall Study||17
151130|NCT01640951|366879|P7|COMPLETED|Overall Study||94
151131|NCT01640951|366880|P6|COMPLETED|Overall Study||13
151132|NCT01640951|366881|P5|COMPLETED|Overall Study||82
151133|NCT01640951|366882|P4|COMPLETED|Overall Study||10
151134|NCT01640951|366883|P3|COMPLETED|Overall Study||126
151135|NCT01640951|366884|P2|COMPLETED|Overall Study||60
151136|NCT01640951|366885|P1|COMPLETED|Overall Study||31
151137|NCT01640951|366878|P8|STARTED|Overall Study||33
151138|NCT01640951|366879|P7|STARTED|Overall Study||112
151139|NCT01640951|366880|P6|STARTED|Overall Study||60
151140|NCT01640951|366881|P5|STARTED|Overall Study||95
151141|NCT01640951|366882|P4|STARTED|Overall Study||55
151142|NCT01640951|366883|P3|STARTED|Overall Study||168
151143|NCT01640951|366884|P2|STARTED|Overall Study||75
151144|NCT01640951|366885|P1|STARTED|Overall Study||77
151145|NCT01640925|366987|P2|NOT COMPLETED|Overall Study||11
151146|NCT01640925|366988|P1|NOT COMPLETED|Overall Study||14
151147|NCT01640925|366987|P2|COMPLETED|Overall Study||164
151148|NCT01640925|366988|P1|COMPLETED|Overall Study||161
151149|NCT01640925|366987|P2|STARTED|Overall Study||175
151150|NCT01640925|366988|P1|STARTED|Overall Study||175
151151|NCT01640873|367002|P2|NOT COMPLETED|Overall Study||1
151152|NCT01640873|367003|P1|NOT COMPLETED|Overall Study||2
151153|NCT01640873|367002|P2|COMPLETED|Overall Study||10
151154|NCT01640873|367003|P1|COMPLETED|Overall Study||20
151155|NCT01640873|367002|P2|STARTED|Overall Study||11
151156|NCT01640873|367003|P1|STARTED|Overall Study||22
151157|NCT01640834|367022|P3|NOT COMPLETED|Overall Study||0
151158|NCT01640834|367023|P2|NOT COMPLETED|Overall Study||0
151159|NCT01640834|367024|P1|NOT COMPLETED|Overall Study||0
151160|NCT01640834|367022|P3|COMPLETED|Overall Study||4
151161|NCT01640834|367023|P2|COMPLETED|Overall Study||8
151162|NCT01640834|367024|P1|COMPLETED|Overall Study||8
151163|NCT01640834|367022|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
151164|NCT01640834|367023|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
151165|NCT01640834|367024|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
151166|NCT01640834|367022|P3|STARTED|Overall Study||4
151167|NCT01640834|367023|P2|STARTED|Overall Study||8
151168|NCT01640834|367024|P1|STARTED|Overall Study||8
151169|NCT01640548|367051|P1|NOT COMPLETED|Overall Study||0
151170|NCT01640548|367051|P1|COMPLETED|Overall Study||309
151171|NCT01640548|367051|P1|STARTED|Overall Study||309
151172|NCT01640379|367067|P2|NOT COMPLETED|Overall Study||12
151173|NCT01640379|367068|P1|NOT COMPLETED|Overall Study||14
151174|NCT01640379|367067|P2|COMPLETED|Overall Study||125
151175|NCT01640379|367068|P1|COMPLETED|Overall Study||135
151176|NCT01640379|367067|P2|STARTED|Overall Study||137
151177|NCT01640379|367068|P1|STARTED|Overall Study||149
151178|NCT01640353|367076|P1|NOT COMPLETED|Overall Study||45
151179|NCT01640353|367076|P1|COMPLETED|Overall Study||149
151180|NCT01640353|367076|P1|Month 18|Overall Study||150
151181|NCT01640353|367076|P1|Month 12|Overall Study||160
151182|NCT01640353|367076|P1|Month 6|Overall Study||168
151183|NCT01640353|367076|P1|Month 3|Overall Study||169
151184|NCT01640353|367076|P1|Month 1|Overall Study||171
151185|NCT01640353|367076|P1|Treated|Overall Study||172
151186|NCT01640353|367076|P1|STARTED|Overall Study||194
151187|NCT01640340|367088|P2|NOT COMPLETED|Overall Study||0
151188|NCT01640340|367089|P1|NOT COMPLETED|Overall Study||0
151189|NCT01640340|367088|P2|COMPLETED|Overall Study||20
151190|NCT01640340|367089|P1|COMPLETED|Overall Study||20
151191|NCT01640340|367088|P2|Overall Complete Response Rate|Overall Study||20
151192|NCT01640340|367089|P1|Overall Complete Response Rate|Overall Study||20
151193|NCT01640340|367088|P2|STARTED|Overall Study||20
151194|NCT01640340|367089|P1|STARTED|Overall Study||20
151195|NCT01640327|367109|P2|NOT COMPLETED|Overall Study||0
151196|NCT01640327|367110|P1|NOT COMPLETED|Overall Study||0
151197|NCT01640327|367109|P2|COMPLETED|Overall Study||63
151198|NCT01640327|367110|P1|COMPLETED|Overall Study||63
151199|NCT01640327|367109|P2|STARTED|Overall Study||63
151200|NCT01640327|367110|P1|STARTED|Overall Study||63
151201|NCT01640314|367124|P2|NOT COMPLETED|Overall Study||1
151202|NCT01640314|367125|P1|NOT COMPLETED|Overall Study||0
151203|NCT01640314|367124|P2|COMPLETED|Overall Study||62
151204|NCT01640314|367125|P1|COMPLETED|Overall Study||63
151205|NCT01640314|367124|P2|STARTED|Overall Study||63
151206|NCT01640314|367125|P1|STARTED|Overall Study||63
151207|NCT01640249|367146|P7|NOT COMPLETED|Period 3||0
151208|NCT01640249|367147|P6|NOT COMPLETED|Period 3||0
151209|NCT01640249|367148|P5|NOT COMPLETED|Period 3||0
151210|NCT01640249|367149|P4|NOT COMPLETED|Period 3||1
151211|NCT01640249|367150|P3|NOT COMPLETED|Period 3||0
151212|NCT01640249|367151|P2|NOT COMPLETED|Period 3||0
151213|NCT01640249|367152|P1|NOT COMPLETED|Period 3||0
151214|NCT01640249|367146|P7|COMPLETED|Period 3||0
151215|NCT01640249|367147|P6|COMPLETED|Period 3||0
151216|NCT01640249|367148|P5|COMPLETED|Period 3||0
151217|NCT01640249|367149|P4|COMPLETED|Period 3||1
151218|NCT01640249|367150|P3|COMPLETED|Period 3||2
151219|NCT01640249|367151|P2|COMPLETED|Period 3||2
151220|NCT01640249|367152|P1|COMPLETED|Period 3||2
151221|NCT01640249|367146|P7|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
151222|NCT01640249|367147|P6|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
151223|NCT01640249|367148|P5|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
151224|NCT01640249|367149|P4|STARTED|Period 3||2
151225|NCT01640249|367150|P3|STARTED|Period 3||2
151226|NCT01640249|367151|P2|STARTED|Period 3||2
151227|NCT01640249|367152|P1|STARTED|Period 3||2
151228|NCT01640249|367146|P7|NOT COMPLETED|Period 2||0
151229|NCT01640249|367147|P6|NOT COMPLETED|Period 2||0
151230|NCT01640249|367148|P5|NOT COMPLETED|Period 2||0
151231|NCT01640249|367149|P4|NOT COMPLETED|Period 2||0
151232|NCT01640249|367150|P3|NOT COMPLETED|Period 2||0
151233|NCT01640249|367151|P2|NOT COMPLETED|Period 2||0
151234|NCT01640249|367152|P1|NOT COMPLETED|Period 2||0
151235|NCT01640249|367146|P7|COMPLETED|Period 2||2
151236|NCT01640249|367147|P6|COMPLETED|Period 2||4
151237|NCT01640249|367148|P5|COMPLETED|Period 2||2
151238|NCT01640249|367149|P4|COMPLETED|Period 2||2
151239|NCT01640249|367150|P3|COMPLETED|Period 2||2
151240|NCT01640249|367151|P2|COMPLETED|Period 2||2
151241|NCT01640249|367152|P1|COMPLETED|Period 2||2
151242|NCT01640249|367146|P7|STARTED|Period 2||2
151243|NCT01640249|367147|P6|STARTED|Period 2||4
151244|NCT01640249|367148|P5|STARTED|Period 2||2
151245|NCT01640249|367149|P4|STARTED|Period 2||2
151246|NCT01640249|367150|P3|STARTED|Period 2||2
151247|NCT01640249|367151|P2|STARTED|Period 2||2
151248|NCT01640249|367152|P1|STARTED|Period 2||2
151249|NCT01640249|367146|P7|NOT COMPLETED|Period 1||0
151250|NCT01640249|367147|P6|NOT COMPLETED|Period 1||1
151251|NCT01640249|367148|P5|NOT COMPLETED|Period 1||0
151252|NCT01640249|367149|P4|NOT COMPLETED|Period 1||0
151253|NCT01640249|367150|P3|NOT COMPLETED|Period 1||0
151254|NCT01640249|367151|P2|NOT COMPLETED|Period 1||0
151255|NCT01640249|367152|P1|NOT COMPLETED|Period 1||1
151256|NCT01640249|367146|P7|COMPLETED|Period 1||2
151257|NCT01640249|367147|P6|COMPLETED|Period 1||4
151258|NCT01640249|367148|P5|COMPLETED|Period 1||2
151259|NCT01640249|367149|P4|COMPLETED|Period 1||2
151260|NCT01640249|367150|P3|COMPLETED|Period 1||2
151261|NCT01640249|367151|P2|COMPLETED|Period 1||2
151262|NCT01640249|367152|P1|COMPLETED|Period 1||2
151263|NCT01640249|367146|P7|Received at Least 1 Dose of Study Drug|Period 1||2
151264|NCT01640249|367147|P6|Received at Least 1 Dose of Study Drug|Period 1||5
151265|NCT01640249|367148|P5|Received at Least 1 Dose of Study Drug|Period 1||2
151266|NCT01640249|367149|P4|Received at Least 1 Dose of Study Drug|Period 1||2
151267|NCT01640249|367150|P3|Received at Least 1 Dose of Study Drug|Period 1||2
151268|NCT01640249|367151|P2|Received at Least 1 Dose of Study Drug|Period 1||2
151269|NCT01640249|367152|P1|Received at Least 1 Dose of Study Drug|Period 1||3
151270|NCT01640249|367146|P7|STARTED|Period 1||2
151271|NCT01640249|367147|P6|STARTED|Period 1||5
151272|NCT01640249|367148|P5|STARTED|Period 1||2
151273|NCT01640249|367149|P4|STARTED|Period 1||2
151274|NCT01640249|367150|P3|STARTED|Period 1||2
151275|NCT01640249|367151|P2|STARTED|Period 1||2
151276|NCT01640249|367152|P1|STARTED|Period 1||3
151277|NCT01640197|367178|P2|NOT COMPLETED|Overall Study||0
151278|NCT01640197|367179|P1|NOT COMPLETED|Overall Study||0
151279|NCT01640197|367178|P2|COMPLETED|Overall Study||30
151280|NCT01640197|367179|P1|COMPLETED|Overall Study||30
151281|NCT01640197|367178|P2|STARTED|Overall Study||30
151282|NCT01640197|367179|P1|STARTED|Overall Study||30
151283|NCT01640184|367200|P3|NOT COMPLETED|Overall Study||2
151284|NCT01640184|367201|P2|NOT COMPLETED|Overall Study||2
151285|NCT01640184|367202|P1|NOT COMPLETED|Overall Study||8
151286|NCT01640184|367200|P3|COMPLETED|Overall Study||20
151287|NCT01640184|367201|P2|COMPLETED|Overall Study||21
151288|NCT01640184|367202|P1|COMPLETED|Overall Study||26
151289|NCT01640184|367200|P3|STARTED|Overall Study||22
151290|NCT01640184|367201|P2|STARTED|Overall Study||23
151291|NCT01640184|367202|P1|STARTED|Overall Study||34
151292|NCT01640171|367224|P1|NOT COMPLETED|Overall Study||0
151293|NCT01640171|367224|P1|COMPLETED|Overall Study||57
151294|NCT01640171|367224|P1|STARTED|Overall Study||57
151295|NCT01640054|367231|P1|NOT COMPLETED|Overall Study||6
151296|NCT01640054|367231|P1|COMPLETED|Overall Study|Number of patients on treatment when the study was stopped.|109
151297|NCT01640054|367231|P1|Did Not Receive Treatment|Overall Study||0
151298|NCT01640054|367231|P1|STARTED|Overall Study|Patients who received treatment|115
151299|NCT01639833|367241|P2|NOT COMPLETED|Overall Study||4
151300|NCT01639833|367242|P1|NOT COMPLETED|Overall Study||6
151301|NCT01639833|367241|P2|COMPLETED|Overall Study||41
151302|NCT01639833|367242|P1|COMPLETED|Overall Study||39
151303|NCT01639833|367241|P2|STARTED|Overall Study||45
151304|NCT01639833|367242|P1|STARTED|Overall Study||45
151305|NCT01639755|367250|P1|NOT COMPLETED|Overall Study||19
151306|NCT01639755|367250|P1|COMPLETED|Overall Study||0
151307|NCT01639755|367250|P1|STARTED|Overall Study||19
151308|NCT01639742|367258|P1|NOT COMPLETED|Overall Study||18
151309|NCT01639742|367258|P1|COMPLETED|Overall Study||0
151310|NCT01639742|367258|P1|STARTED|Overall Study||18
151311|NCT01639729|367266|P6|NOT COMPLETED|Overall Study||0
151312|NCT01639729|367267|P5|NOT COMPLETED|Overall Study||0
151313|NCT01639729|367268|P4|NOT COMPLETED|Overall Study||1
151314|NCT01639729|367269|P3|NOT COMPLETED|Overall Study||1
151315|NCT01639729|367270|P2|NOT COMPLETED|Overall Study||0
151316|NCT01639729|367271|P1|NOT COMPLETED|Overall Study||1
151317|NCT01639729|367266|P6|COMPLETED|Overall Study||4
151318|NCT01639729|367267|P5|COMPLETED|Overall Study||4
151319|NCT01639729|367268|P4|COMPLETED|Overall Study||4
151320|NCT01639729|367269|P3|COMPLETED|Overall Study||3
151321|NCT01639729|367270|P2|COMPLETED|Overall Study||4
151322|NCT01639729|367271|P1|COMPLETED|Overall Study||3
151323|NCT01639729|367266|P6|STARTED|Overall Study||4
151324|NCT01639729|367267|P5|STARTED|Overall Study||4
151325|NCT01639729|367268|P4|STARTED|Overall Study||5
151326|NCT01639729|367269|P3|STARTED|Overall Study||4
151327|NCT01639729|367270|P2|STARTED|Overall Study||4
151328|NCT01639729|367271|P1|STARTED|Overall Study||4
151329|NCT01639703|367293|P1|NOT COMPLETED|Overall Study||12
151330|NCT01639703|367293|P1|COMPLETED|Overall Study||84
151331|NCT01639703|367293|P1|STARTED|Overall Study||96
151332|NCT01639560|367336|P2|NOT COMPLETED|Overall Study||29
151333|NCT01639560|367337|P1|NOT COMPLETED|Overall Study||19
151334|NCT01639560|367336|P2|COMPLETED|Overall Study||19
151335|NCT01639560|367337|P1|COMPLETED|Overall Study||26
151336|NCT01639560|367336|P2|End of Treatment|Overall Study||20
151337|NCT01639560|367337|P1|End of Treatment|Overall Study||28
151338|NCT01639560|367336|P2|STARTED|Overall Study||48
151339|NCT01639560|367337|P1|STARTED|Overall Study||45
151340|NCT01639495|367349|P1|NOT COMPLETED|Overall Study||16
151341|NCT01639495|367349|P1|COMPLETED|Overall Study||132
151342|NCT01639495|367349|P1|Primary Effectiveness Cohort|Overall Study||138
151343|NCT01639495|367349|P1|Safety Cohort|Overall Study||144
151344|NCT01639495|367349|P1|STARTED|Overall Study|Patients who signed the informed consent.|148
151345|NCT01639469|367359|P2|NOT COMPLETED|Overall Study||3
151346|NCT01639469|367360|P1|NOT COMPLETED|Overall Study||5
151347|NCT01639469|367359|P2|COMPLETED|Overall Study||77
151348|NCT01639469|367360|P1|COMPLETED|Overall Study||84
151349|NCT01639469|367359|P2|STARTED|Overall Study||80
151350|NCT01639469|367360|P1|STARTED|Overall Study||89
151351|NCT01639443|367368|P2|NOT COMPLETED|Overall Study||0
151352|NCT01639443|367369|P1|NOT COMPLETED|Overall Study||0
151353|NCT01639443|367368|P2|COMPLETED|Overall Study|These individuals all booked appointments using typical booking.|4855
151354|NCT01639443|367369|P1|COMPLETED|Overall Study|Intervention is limited to appointment booking, and all completed.|180
151355|NCT01639443|367368|P2|STARTED|Overall Study|These individuals opted to not participate in Fast-tracked group, and were not consented.|4855
151356|NCT01639443|367369|P1|STARTED|Overall Study|These individuals opted into Fast-tracked group and were consented.|180
151357|NCT01639352|367385|P1|NOT COMPLETED|Overall Study||0
151358|NCT01639352|367385|P1|COMPLETED|Overall Study||20
151359|NCT01639352|367385|P1|STARTED|Overall Study||20
151360|NCT01639222|367394|P1|NOT COMPLETED|Overall Study||0
151361|NCT01639222|367394|P1|COMPLETED|Overall Study||55
151362|NCT01639222|367394|P1|STARTED|Overall Study||55
151363|NCT01639157|367404|P2|NOT COMPLETED|Overall Study||0
151364|NCT01639157|367405|P1|NOT COMPLETED|Overall Study||0
151365|NCT01639157|367404|P2|COMPLETED|Overall Study||5
151366|NCT01639157|367405|P1|COMPLETED|Overall Study||4
151367|NCT01639157|367404|P2|STARTED|Overall Study||5
151368|NCT01639157|367405|P1|STARTED|Overall Study||4
151369|NCT01639144|367465|P2|NOT COMPLETED|Overall Study||5
151370|NCT01639144|367466|P1|NOT COMPLETED|Overall Study||10
151371|NCT01639144|367465|P2|COMPLETED|Overall Study||250
151372|NCT01639144|367466|P1|COMPLETED|Overall Study||250
151373|NCT01639144|367465|P2|STARTED|Overall Study||255
151374|NCT01639144|367466|P1|STARTED|Overall Study||260
151375|NCT01639040|367474|P2|NOT COMPLETED|Overall Study||0
151376|NCT01639040|367475|P1|NOT COMPLETED|Overall Study||1
151377|NCT01639040|367474|P2|COMPLETED|Overall Study||21
151378|NCT01639040|367475|P1|COMPLETED|Overall Study||9
151379|NCT01639040|367474|P2|STARTED|Overall Study||21
151380|NCT01639040|367475|P1|STARTED|Overall Study||10
151381|NCT01639001|367493|P2|NOT COMPLETED|Overall Study||103
151382|NCT01639001|367494|P1|NOT COMPLETED|Overall Study||104
151383|NCT01639001|367493|P2|COMPLETED|Overall Study||0
151384|NCT01639001|367494|P1|COMPLETED|Overall Study||0
151385|NCT01639001|367493|P2|Treated|Overall Study||101
151386|NCT01639001|367494|P1|Treated|Overall Study||104
151387|NCT01639001|367493|P2|STARTED|Overall Study||103
151388|NCT01639001|367494|P1|STARTED|Overall Study||104
151389|NCT01638819|367540|P2|NOT COMPLETED|Overall Study||0
151390|NCT01638819|367541|P1|NOT COMPLETED|Overall Study||1
151391|NCT01638819|367540|P2|COMPLETED|Overall Study||15
151392|NCT01638819|367541|P1|COMPLETED|Overall Study||14
151393|NCT01638819|367540|P2|Second Intervention (24 Weeks)|Overall Study||15
151394|NCT01638819|367541|P1|Second Intervention (24 Weeks)|Overall Study||14
151395|NCT01638819|367540|P2|First Intervention (8 Weeks)|Overall Study||15
151396|NCT01638819|367541|P1|First Intervention (8 Weeks)|Overall Study||15
151397|NCT01638819|367540|P2|STARTED|Overall Study||15
151398|NCT01638819|367541|P1|STARTED|Overall Study||15
151399|NCT01638559|367550|P1|NOT COMPLETED|Overall Study||3
151400|NCT01638559|367550|P1|COMPLETED|Overall Study|Completion through the time of the primary endpoint (outcome).|85
151401|NCT01638559|367550|P1|STARTED|Overall Study||88
151402|NCT01638546|367568|P2|NOT COMPLETED|Overall Study||3
151403|NCT01638546|367569|P1|NOT COMPLETED|Overall Study||1
151404|NCT01638546|367568|P2|COMPLETED|Overall Study||42
151405|NCT01638546|367569|P1|COMPLETED|Overall Study||51
151406|NCT01638546|367568|P2|STARTED|Overall Study||45
151407|NCT01638546|367569|P1|STARTED|Overall Study||52
151408|NCT01638507|367581|P1|NOT COMPLETED|Overall Study||6
151409|NCT01638507|367581|P1|COMPLETED|Overall Study||224
151410|NCT01638507|367581|P1|STARTED|Overall Study||230
151411|NCT01638468|367594|P1|NOT COMPLETED|Overall Study||0
151412|NCT01638468|367594|P1|COMPLETED|Overall Study||7
151413|NCT01638468|367594|P1|STARTED|Overall Study||7
151414|NCT01638429|367608|P1|NOT COMPLETED|Overall Study||1
151415|NCT01638429|367608|P1|COMPLETED|Overall Study||11
151416|NCT01638429|367608|P1|Post-treatment Testing|Overall Study||11
151417|NCT01638429|367608|P1|Antibiotic Treatment|Overall Study||11
151418|NCT01638429|367608|P1|Pre-treatment Testing|Overall Study||11
151419|NCT01638429|367608|P1|STARTED|Overall Study||12
151420|NCT01638390|367636|P1|NOT COMPLETED|Overall Study||21
151421|NCT01638390|367636|P1|COMPLETED|Overall Study|treated eyes|336
151422|NCT01638390|367636|P1|STARTED|Overall Study|enrolled|357
151423|NCT01638312|367650|P2|NOT COMPLETED|Overall Study||0
151424|NCT01638312|367651|P1|NOT COMPLETED|Overall Study||0
151425|NCT01638312|367650|P2|COMPLETED|Overall Study||30
151426|NCT01638312|367651|P1|COMPLETED|Overall Study||20
151427|NCT01638312|367650|P2|STARTED|Overall Study||30
151428|NCT01638312|367651|P1|STARTED|Overall Study||20
151429|NCT01638000|367659|P2|NOT COMPLETED|Overall Study||71
151430|NCT01638000|367660|P1|NOT COMPLETED|Overall Study||60
151431|NCT01638000|367659|P2|COMPLETED|Overall Study||873
151432|NCT01638000|367660|P1|COMPLETED|Overall Study||883
151433|NCT01638000|367659|P2|Received at Least 1 Double-Blind Dose|Overall Study||934
151434|NCT01638000|367660|P1|Received at Least 1 Double-Blind Dose|Overall Study||936
151435|NCT01638000|367659|P2|STARTED|Overall Study||944
151436|NCT01638000|367660|P1|STARTED|Overall Study||943
151437|NCT01637961|367758|P1|NOT COMPLETED|Overall Study||2
151438|NCT01637961|367758|P1|COMPLETED|Overall Study|Eligible and treated patients.|21
151439|NCT01637961|367758|P1|STARTED|Overall Study||23
151440|NCT01637935|367773|P2|NOT COMPLETED|Overall Study||0
151441|NCT01637935|367774|P1|NOT COMPLETED|Overall Study||0
151442|NCT01637935|367773|P2|COMPLETED|Overall Study||158918
151443|NCT01637935|367774|P1|COMPLETED|Overall Study||34181
151444|NCT01637935|367773|P2|STARTED|Overall Study||158918
151445|NCT01637935|367774|P1|STARTED|Overall Study||34181
151446|NCT01637922|367790|P2|NOT COMPLETED|Overall Study||5
151447|NCT01637922|367791|P1|NOT COMPLETED|Overall Study||2
151448|NCT01637922|367790|P2|COMPLETED|Overall Study||14
151449|NCT01637922|367791|P1|COMPLETED|Overall Study||13
151450|NCT01637922|367790|P2|STARTED|Overall Study||19
151451|NCT01637922|367791|P1|STARTED|Overall Study||15
151452|NCT01637870|367814|P1|NOT COMPLETED|Overall Study||0
151453|NCT01637870|367814|P1|COMPLETED|Overall Study||110
151454|NCT01637870|367814|P1|STARTED|Overall Study||110
151455|NCT01637584|367820|P2|NOT COMPLETED|Overall Study||3
151456|NCT01637584|367821|P1|NOT COMPLETED|Overall Study||1
151457|NCT01637584|367820|P2|COMPLETED|Overall Study||17
151458|NCT01637584|367821|P1|COMPLETED|Overall Study||19
151459|NCT01637584|367820|P2|STARTED|Overall Study||20
151460|NCT01637584|367821|P1|STARTED|Overall Study||20
151461|NCT01637272|367828|P1|NOT COMPLETED|Overall Study||20
151462|NCT01637272|367828|P1|COMPLETED|Overall Study||23
151463|NCT01637272|367828|P1|Completed Core But Did no Enter Ext..|Overall Study||4
151464|NCT01637272|367828|P1|Entered Extension Phase|Overall Study||27
151465|NCT01637272|367828|P1|Completed Core Phase (sc + LAR)|Overall Study||31
151466|NCT01637272|367828|P1|Completed sc Phase|Overall Study||33
151467|NCT01637272|367828|P1|STARTED|Overall Study||43
151468|NCT01637246|367890|P1|NOT COMPLETED|Overall Study||2139
151469|NCT01637246|367890|P1|COMPLETED|Overall Study||2246
151470|NCT01637246|367890|P1|STARTED|Overall Study||4385
151471|NCT01637090|367898|P1|NOT COMPLETED|Overall Study||3
151472|NCT01637090|367898|P1|COMPLETED|Overall Study||0
151473|NCT01637090|367898|P1|STARTED|Overall Study||3
151474|NCT01637077|367908|P2|NOT COMPLETED|Overall Study||1
151475|NCT01637077|367909|P1|NOT COMPLETED|Overall Study||4
151476|NCT01637077|367908|P2|COMPLETED|Overall Study||22
151477|NCT01637077|367909|P1|COMPLETED|Overall Study||19
151478|NCT01637077|367908|P2|STARTED|Overall Study||23
151479|NCT01637077|367909|P1|STARTED|Overall Study||23
151480|NCT01636986|367937|P2|NOT COMPLETED|Overall Study||2
151481|NCT01636986|367938|P1|NOT COMPLETED|Overall Study||0
151482|NCT01636986|367937|P2|COMPLETED|Overall Study||30
151483|NCT01636986|367938|P1|COMPLETED|Overall Study||30
151484|NCT01636986|367937|P2|STARTED|Overall Study||32
151485|NCT01636986|367938|P1|STARTED|Overall Study||30
151486|NCT01636960|367944|P1|NOT COMPLETED|Maintenance Phase||7
151487|NCT01636960|367944|P1|COMPLETED|Maintenance Phase||0
151488|NCT01636960|367944|P1|STARTED|Maintenance Phase||7
151489|NCT01636960|367944|P1|NOT COMPLETED|Induction Phase||2
151490|NCT01636960|367944|P1|COMPLETED|Induction Phase|Participants continuing into Maintenance Phase|7
151491|NCT01636960|367944|P1|STARTED|Induction Phase||9
151492|NCT01636947|367952|P2|NOT COMPLETED|Overall Study||11
151493|NCT01636947|367953|P1|NOT COMPLETED|Overall Study||12
151494|NCT01636947|367952|P2|COMPLETED|Overall Study||239
151495|NCT01636947|367953|P1|COMPLETED|Overall Study||232
151496|NCT01636947|367952|P2|Treated|Overall Study||248
151497|NCT01636947|367953|P1|Treated|Overall Study||242
151498|NCT01636947|367952|P2|STARTED|Overall Study||250
151499|NCT01636947|367953|P1|STARTED|Overall Study||244
151500|NCT01636882|367973|P1|NOT COMPLETED|Overall Study||0
151501|NCT01636882|367973|P1|COMPLETED|Overall Study||16
151502|NCT01636882|367973|P1|STARTED|Overall Study||16
151503|NCT01636778|367977|P3|NOT COMPLETED|Follow-up Period After Part 2||4
151504|NCT01636778|367978|P2|NOT COMPLETED|Follow-up Period After Part 2||0
151505|NCT01636778|367979|P1|NOT COMPLETED|Follow-up Period After Part 2||0
151506|NCT01636778|367977|P3|COMPLETED|Follow-up Period After Part 2||37
151507|NCT01636778|367978|P2|COMPLETED|Follow-up Period After Part 2||0
151508|NCT01636778|367979|P1|COMPLETED|Follow-up Period After Part 2||0
151509|NCT01636778|367977|P3|STARTED|Follow-up Period After Part 2||41
151510|NCT01636778|367978|P2|STARTED|Follow-up Period After Part 2||0
151511|NCT01636778|367979|P1|STARTED|Follow-up Period After Part 2||0
151512|NCT01636778|367977|P3|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
151513|NCT01636778|367978|P2|NOT COMPLETED|Antiviral Treatment Period (Part 2)||10
151514|NCT01636778|367979|P1|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
151515|NCT01636778|367977|P3|COMPLETED|Antiviral Treatment Period (Part 2)||0
151516|NCT01636778|367978|P2|COMPLETED|Antiviral Treatment Period (Part 2)||31
151517|NCT01636778|367979|P1|COMPLETED|Antiviral Treatment Period (Part 2)||0
151518|NCT01636778|367977|P3|STARTED|Antiviral Treatment Period (Part 2)||0
151519|NCT01636778|367978|P2|STARTED|Antiviral Treatment Period (Part 2)||41
151520|NCT01636778|367979|P1|STARTED|Antiviral Treatment Period (Part 2)||0
151521|NCT01636778|367977|P3|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
151522|NCT01636778|367978|P2|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
151523|NCT01636778|367979|P1|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||4
151524|NCT01636778|367977|P3|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
151525|NCT01636778|367978|P2|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
151526|NCT01636778|367979|P1|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||41
151527|NCT01636778|367977|P3|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
151528|NCT01636778|367978|P2|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
151529|NCT01636778|367979|P1|STARTED|Pre-Antiviral Treatment Period (Part 1)||45
151530|NCT01636765|368042|P1|NOT COMPLETED|Overall Study||0
151531|NCT01636765|368042|P1|COMPLETED|Overall Study||104
151532|NCT01636765|368042|P1|STARTED|Overall Study||104
151533|NCT01636713|368050|P3|NOT COMPLETED|Overall Study||23
151534|NCT01636713|368051|P2|NOT COMPLETED|Overall Study||28
151535|NCT01636713|368052|P1|NOT COMPLETED|Overall Study||32
151536|NCT01636713|368050|P3|COMPLETED|Overall Study||170
151537|NCT01636713|368051|P2|COMPLETED|Overall Study||166
151538|NCT01636713|368052|P1|COMPLETED|Overall Study||161
151539|NCT01636713|368050|P3|STARTED|Overall Study||193
151540|NCT01636713|368051|P2|STARTED|Overall Study||194
151541|NCT01636713|368052|P1|STARTED|Overall Study||193
151542|NCT01636687|368069|P5|NOT COMPLETED|Follow-up Period||1
151543|NCT01636687|368070|P4|NOT COMPLETED|Follow-up Period||0
151544|NCT01636687|368071|P3|NOT COMPLETED|Follow-up Period||0
151545|NCT01636687|368072|P2|NOT COMPLETED|Follow-up Period||0
151546|NCT01636687|368073|P1|NOT COMPLETED|Follow-up Period||1
151547|NCT01636687|368069|P5|COMPLETED|Follow-up Period||1
151548|NCT01636687|368070|P4|COMPLETED|Follow-up Period||20
151549|NCT01636687|368071|P3|COMPLETED|Follow-up Period||21
151550|NCT01636687|368072|P2|COMPLETED|Follow-up Period||45
151551|NCT01636687|368073|P1|COMPLETED|Follow-up Period||37
151552|NCT01636687|368069|P5|STARTED|Follow-up Period||2
151553|NCT01636687|368070|P4|STARTED|Follow-up Period||20
151554|NCT01636687|368071|P3|STARTED|Follow-up Period||21
151555|NCT01636687|368072|P2|STARTED|Follow-up Period||45
151556|NCT01636687|368073|P1|STARTED|Follow-up Period||38
151557|NCT01636687|368069|P5|NOT COMPLETED|Extension Period||0
151558|NCT01636687|368070|P4|NOT COMPLETED|Extension Period||28
151559|NCT01636687|368071|P3|NOT COMPLETED|Extension Period||25
151560|NCT01636687|368072|P2|NOT COMPLETED|Extension Period||54
151561|NCT01636687|368073|P1|NOT COMPLETED|Extension Period||47
151562|NCT01636687|368069|P5|COMPLETED|Extension Period||0
151563|NCT01636687|368070|P4|COMPLETED|Extension Period||0
151564|NCT01636687|368071|P3|COMPLETED|Extension Period||0
151565|NCT01636687|368072|P2|COMPLETED|Extension Period||0
151566|NCT01636687|368073|P1|COMPLETED|Extension Period||0
151567|NCT01636687|368069|P5|STARTED|Extension Period||0
151568|NCT01636687|368070|P4|STARTED|Extension Period||28
151569|NCT01636687|368071|P3|STARTED|Extension Period||25
151570|NCT01636687|368072|P2|STARTED|Extension Period||54
151571|NCT01636687|368073|P1|STARTED|Extension Period||47
151572|NCT01636687|368069|P5|NOT COMPLETED|Maintenance Period||2
151573|NCT01636687|368070|P4|NOT COMPLETED|Maintenance Period||0
151574|NCT01636687|368071|P3|NOT COMPLETED|Maintenance Period||2
151575|NCT01636687|368072|P2|NOT COMPLETED|Maintenance Period||2
151576|NCT01636687|368073|P1|NOT COMPLETED|Maintenance Period||8
151577|NCT01636687|368069|P5|COMPLETED|Maintenance Period||1
151578|NCT01636687|368070|P4|COMPLETED|Maintenance Period||28
151579|NCT01636687|368071|P3|COMPLETED|Maintenance Period||26
151580|NCT01636687|368072|P2|COMPLETED|Maintenance Period||58
151581|NCT01636687|368073|P1|COMPLETED|Maintenance Period||50
151582|NCT01636687|368069|P5|STARTED|Maintenance Period||3
151583|NCT01636687|368070|P4|STARTED|Maintenance Period||28
151584|NCT01636687|368071|P3|STARTED|Maintenance Period||28
151585|NCT01636687|368072|P2|STARTED|Maintenance Period||60
151586|NCT01636687|368073|P1|STARTED|Maintenance Period||58
151587|NCT01636687|368069|P5|NOT COMPLETED|Induction Period||2
151588|NCT01636687|368070|P4|NOT COMPLETED|Induction Period||0
151589|NCT01636687|368071|P3|NOT COMPLETED|Induction Period||0
151590|NCT01636687|368072|P2|NOT COMPLETED|Induction Period||0
151591|NCT01636687|368073|P1|NOT COMPLETED|Induction Period||3
151592|NCT01636687|368069|P5|COMPLETED|Induction Period||59
151593|NCT01636687|368070|P4|COMPLETED|Induction Period||0
151594|NCT01636687|368071|P3|COMPLETED|Induction Period||0
151595|NCT01636687|368072|P2|COMPLETED|Induction Period||60
151596|NCT01636687|368073|P1|COMPLETED|Induction Period||58
151597|NCT01636687|368069|P5|STARTED|Induction Period||61
151598|NCT01636687|368070|P4|STARTED|Induction Period||0
151599|NCT01636687|368071|P3|STARTED|Induction Period||0
151600|NCT01636687|368072|P2|STARTED|Induction Period||60
151601|NCT01636687|368073|P1|STARTED|Induction Period||61
151602|NCT01636661|368162|P2|NOT COMPLETED|Overall Study||0
151603|NCT01636661|368163|P1|NOT COMPLETED|Overall Study||0
151604|NCT01636661|368162|P2|COMPLETED|Overall Study||6
151605|NCT01636661|368163|P1|COMPLETED|Overall Study||5
151606|NCT01636661|368162|P2|STARTED|Overall Study||6
151607|NCT01636661|368163|P1|STARTED|Overall Study||5
151608|NCT01636466|368173|P2|NOT COMPLETED|Overall Study||0
151609|NCT01636466|368174|P1|NOT COMPLETED|Overall Study||1
151610|NCT01636466|368173|P2|COMPLETED|Overall Study||0
151611|NCT01636466|368174|P1|COMPLETED|Overall Study||0
151612|NCT01636466|368173|P2|STARTED|Overall Study||0
151613|NCT01636466|368174|P1|STARTED|Overall Study||1
151614|NCT01636453|368182|P1|NOT COMPLETED|Overall Study||8
151615|NCT01636453|368182|P1|COMPLETED|Overall Study||112
151616|NCT01636453|368182|P1|STARTED|Overall Study||120
151617|NCT01636414|368201|P3|NOT COMPLETED|Overall Study||9
151618|NCT01636414|368202|P2|NOT COMPLETED|Overall Study||6
151619|NCT01636414|368203|P1|NOT COMPLETED|Overall Study||3
151620|NCT01636414|368201|P3|COMPLETED|Overall Study||65
151621|NCT01636414|368202|P2|COMPLETED|Overall Study||60
151622|NCT01636414|368203|P1|COMPLETED|Overall Study||61
151623|NCT01636414|368201|P3|STARTED|Overall Study||74
151624|NCT01636414|368202|P2|STARTED|Overall Study||66
151625|NCT01636414|368203|P1|STARTED|Overall Study||64
151626|NCT01636362|368214|P1|NOT COMPLETED|Overall Study||8
151627|NCT01636362|368214|P1|COMPLETED|Overall Study||37
151628|NCT01636362|368214|P1|STARTED|Overall Study||45
151629|NCT01636297|368223|P3|NOT COMPLETED|Overall Study||1
151630|NCT01636297|368224|P2|NOT COMPLETED|Overall Study||4
151631|NCT01636297|368225|P1|NOT COMPLETED|Overall Study||4
151632|NCT01636297|368223|P3|COMPLETED|Overall Study||19
151633|NCT01636297|368224|P2|COMPLETED|Overall Study||36
151634|NCT01636297|368225|P1|COMPLETED|Overall Study||36
151635|NCT01636297|368223|P3|STARTED|Overall Study||20
151636|NCT01636297|368224|P2|STARTED|Overall Study||40
151637|NCT01636297|368225|P1|STARTED|Overall Study||40
151638|NCT01636258|368241|P2|NOT COMPLETED|Overall Study||0
151639|NCT01636258|368242|P1|NOT COMPLETED|Overall Study||1
151640|NCT01636258|368241|P2|COMPLETED|Overall Study||14
151641|NCT01636258|368242|P1|COMPLETED|Overall Study||12
151642|NCT01636258|368241|P2|STARTED|Overall Study||14
151643|NCT01636258|368242|P1|STARTED|Overall Study||13
151644|NCT01636206|368258|P2|NOT COMPLETED|Overall Study||51
151645|NCT01636206|368259|P1|NOT COMPLETED|Overall Study||19
151646|NCT01636206|368258|P2|COMPLETED|Overall Study||170
151647|NCT01636206|368259|P1|COMPLETED|Overall Study||92
151648|NCT01636206|368258|P2|STARTED|Overall Study||221
151649|NCT01636206|368259|P1|STARTED|Overall Study||111
151650|NCT01636102|368267|P2|NOT COMPLETED|Overall Study||0
151651|NCT01636102|368268|P1|NOT COMPLETED|Overall Study||0
151652|NCT01636102|368267|P2|COMPLETED|Overall Study||63
151653|NCT01636102|368268|P1|COMPLETED|Overall Study||63
151654|NCT01636102|368267|P2|STARTED|Overall Study||63
151655|NCT01636102|368268|P1|STARTED|Overall Study||63
151656|NCT01636076|368282|P2|NOT COMPLETED|Overall Study||25
151657|NCT01636076|368283|P1|NOT COMPLETED|Overall Study||17
151658|NCT01636076|368282|P2|COMPLETED|Overall Study||288
151659|NCT01636076|368283|P1|COMPLETED|Overall Study||299
151660|NCT01636076|368282|P2|STARTED|Overall Study||313
151661|NCT01636076|368283|P1|STARTED|Overall Study||316
151662|NCT01636063|368345|P2|NOT COMPLETED|Overall Study||0
151663|NCT01636063|368346|P1|NOT COMPLETED|Overall Study||0
151664|NCT01636063|368345|P2|COMPLETED|Overall Study||21
151665|NCT01636063|368346|P1|COMPLETED|Overall Study||21
151666|NCT01636063|368345|P2|STARTED|Overall Study||21
151667|NCT01636063|368346|P1|STARTED|Overall Study||21
151668|NCT01635933|368354|P2|NOT COMPLETED|Overall Study||8
151669|NCT01635933|368355|P1|NOT COMPLETED|Overall Study||2
151670|NCT01635933|368354|P2|COMPLETED|Overall Study||177
151671|NCT01635933|368355|P1|COMPLETED|Overall Study||176
151672|NCT01635933|368354|P2|STARTED|Overall Study||185
151673|NCT01635933|368355|P1|STARTED|Overall Study||178
151674|NCT01635920|368367|P2|NOT COMPLETED|Overall Study||1
151675|NCT01635920|368368|P1|NOT COMPLETED|Overall Study||3
151676|NCT01635920|368367|P2|COMPLETED|Overall Study||125
151677|NCT01635920|368368|P1|COMPLETED|Overall Study||122
151678|NCT01635920|368367|P2|STARTED|Overall Study||126
151679|NCT01635920|368368|P1|STARTED|Overall Study||125
151680|NCT01635881|368376|P1|NOT COMPLETED|Overall Study||0
151681|NCT01635881|368376|P1|COMPLETED|Overall Study||60
151682|NCT01635881|368376|P1|STARTED|Overall Study||60
151683|NCT01635855|368381|P1|NOT COMPLETED|Overall Study||4
151684|NCT01635855|368381|P1|COMPLETED|Overall Study||113
151685|NCT01635855|368381|P1|STARTED|Overall Study||117
151686|NCT01635764|368390|P1|NOT COMPLETED|Overall Study||273
151687|NCT01635764|368390|P1|COMPLETED|Overall Study||235
151688|NCT01635764|368390|P1|STARTED|Overall Study||508
151689|NCT01635504|368418|P1|NOT COMPLETED|Overall Study||0
151690|NCT01635504|368418|P1|COMPLETED|Overall Study||5
151691|NCT01635504|368418|P1|STARTED|Overall Study||5
151692|NCT01635439|368425|P2|NOT COMPLETED|Overall Study||0
151693|NCT01635439|368426|P1|NOT COMPLETED|Overall Study||0
151694|NCT01635439|368425|P2|COMPLETED|Overall Study||100
151695|NCT01635439|368426|P1|COMPLETED|Overall Study||100
151696|NCT01635439|368425|P2|STARTED|Overall Study||100
151697|NCT01635439|368426|P1|STARTED|Overall Study||100
151698|NCT01635244|368443|P3|NOT COMPLETED|Overall Study||2
151699|NCT01635244|368444|P2|NOT COMPLETED|Overall Study||1
151700|NCT01635244|368445|P1|NOT COMPLETED|Overall Study||1
151701|NCT01635244|368443|P3|COMPLETED|Overall Study||18
151702|NCT01635244|368444|P2|COMPLETED|Overall Study||21
151703|NCT01635244|368445|P1|COMPLETED|Overall Study||17
151704|NCT01635244|368443|P3|STARTED|Overall Study||20
151705|NCT01635244|368444|P2|STARTED|Overall Study||22
151706|NCT01635244|368445|P1|STARTED|Overall Study||18
151707|NCT01635218|368456|P3|NOT COMPLETED|Overall Study||6
151708|NCT01635218|368457|P2|NOT COMPLETED|Overall Study||7
151709|NCT01635218|368458|P1|NOT COMPLETED|Overall Study||3
151710|NCT01635218|368456|P3|COMPLETED|Overall Study||37
151711|NCT01635218|368457|P2|COMPLETED|Overall Study||39
151712|NCT01635218|368458|P1|COMPLETED|Overall Study||41
151713|NCT01635218|368456|P3|STARTED|Overall Study||43
151714|NCT01635218|368457|P2|STARTED|Overall Study||46
151715|NCT01635218|368458|P1|STARTED|Overall Study||44
151716|NCT01635062|368480|P2|NOT COMPLETED|Overall Study||0
151717|NCT01635062|368481|P1|NOT COMPLETED|Overall Study||0
151718|NCT01635062|368480|P2|COMPLETED|Overall Study||9
151719|NCT01635062|368481|P1|COMPLETED|Overall Study||9
151720|NCT01635062|368480|P2|Post-Randomization Sodium Loaded|Overall Study||9
151721|NCT01635062|368481|P1|Post-Randomization Sodium Loaded|Overall Study||9
151722|NCT01635062|368480|P2|Post-randomization Sodium Restriction|Overall Study||9
151723|NCT01635062|368481|P1|Post-randomization Sodium Restriction|Overall Study||9
151724|NCT01635062|368480|P2|Sodium Loading Baseline Visit|Overall Study||9
151725|NCT01635062|368481|P1|Sodium Loading Baseline Visit|Overall Study||9
151726|NCT01635062|368480|P2|Sodium Restriction Baseline Visit|Overall Study||9
151727|NCT01635062|368481|P1|Sodium Restriction Baseline Visit|Overall Study||9
151728|NCT01635062|368480|P2|STARTED|Overall Study||9
151729|NCT01635062|368481|P1|STARTED|Overall Study||9
151730|NCT01634854|368493|P2|NOT COMPLETED|Overall Study||7
151731|NCT01634854|368494|P1|NOT COMPLETED|Overall Study||2
151732|NCT01634854|368493|P2|COMPLETED|Overall Study||59
151733|NCT01634854|368494|P1|COMPLETED|Overall Study||62
151734|NCT01634854|368493|P2|STARTED|Overall Study||66
151735|NCT01634854|368494|P1|STARTED|Overall Study||64
151736|NCT01634659|368514|P2|NOT COMPLETED|Period 2 - Second 8 Days of Wear||0
151737|NCT01634659|368515|P1|NOT COMPLETED|Period 2 - Second 8 Days of Wear||3
151738|NCT01634659|368514|P2|COMPLETED|Period 2 - Second 8 Days of Wear||158
151739|NCT01634659|368515|P1|COMPLETED|Period 2 - Second 8 Days of Wear||152
151740|NCT01634659|368514|P2|STARTED|Period 2 - Second 8 Days of Wear||158
151741|NCT01634659|368515|P1|STARTED|Period 2 - Second 8 Days of Wear||155
151742|NCT01634659|368514|P2|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
151743|NCT01634659|368515|P1|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
151744|NCT01634659|368514|P2|COMPLETED|Period 1 - First 8 Days of Wear||158
151745|NCT01634659|368515|P1|COMPLETED|Period 1 - First 8 Days of Wear||155
151746|NCT01634659|368514|P2|STARTED|Period 1 - First 8 Days of Wear||158
151747|NCT01634659|368515|P1|STARTED|Period 1 - First 8 Days of Wear||155
151748|NCT01634620|368525|P1|NOT COMPLETED|Overall Study||0
151749|NCT01634620|368525|P1|COMPLETED|Overall Study||200
151750|NCT01634620|368525|P1|STARTED|Overall Study||200
151751|NCT01634555|368545|P1|NOT COMPLETED|Overall Study||4
151752|NCT01634555|368545|P1|COMPLETED|Overall Study|Completed the required treatment and assessment.|25
151753|NCT01634555|368545|P1|Drug-Drug Interaction (DDI) Population|Overall Study|Completed the required treatment in Cycle 1, Day 1 and Cycle 2, Day 1.|25
151754|NCT01634555|368545|P1|Received at Least 1 Dose of Study Drug|Overall Study||29
151755|NCT01634555|368545|P1|STARTED|Overall Study||29
151756|NCT01634360|368556|P2|NOT COMPLETED|Overall Study||136
151757|NCT01634360|368557|P1|NOT COMPLETED|Overall Study||49
151758|NCT01634360|368556|P2|COMPLETED|Overall Study||0
151759|NCT01634360|368557|P1|COMPLETED|Overall Study||0
151760|NCT01634360|368556|P2|STARTED|Overall Study||136
151761|NCT01634360|368557|P1|STARTED|Overall Study||49
151762|NCT01634269|368567|P1|NOT COMPLETED|Overall Study||2
151763|NCT01634269|368567|P1|COMPLETED|Overall Study||18
151764|NCT01634269|368567|P1|24 Month|Overall Study||18
151765|NCT01634269|368567|P1|12 Month|Overall Study||20
151766|NCT01634269|368567|P1|6 Month|Overall Study||20
151767|NCT01634269|368567|P1|30 Days|Overall Study||20
151768|NCT01634269|368567|P1|STARTED|Overall Study||20
151769|NCT01634256|368614|P2|NOT COMPLETED|Overall Study||8
151770|NCT01634256|368615|P1|NOT COMPLETED|Overall Study||4
151771|NCT01634256|368614|P2|COMPLETED|Overall Study||22
151772|NCT01634256|368615|P1|COMPLETED|Overall Study||26
151773|NCT01634256|368614|P2|STARTED|Overall Study||30
151774|NCT01634256|368615|P1|STARTED|Overall Study||30
151775|NCT01634243|368631|P2|NOT COMPLETED|Overall Study||5
151776|NCT01634243|368632|P1|NOT COMPLETED|Overall Study||6
151777|NCT01634243|368631|P2|COMPLETED|Overall Study||38
151778|NCT01634243|368632|P1|COMPLETED|Overall Study||15
151779|NCT01634243|368631|P2|STARTED|Overall Study||43
151780|NCT01634243|368632|P1|STARTED|Overall Study||21
151781|NCT01634165|368658|P4|NOT COMPLETED|Period 4||0
151782|NCT01634165|368659|P3|NOT COMPLETED|Period 4||0
151783|NCT01634165|368660|P2|NOT COMPLETED|Period 4||0
151784|NCT01634165|368661|P1|NOT COMPLETED|Period 4||0
151785|NCT01634165|368658|P4|COMPLETED|Period 4||6
151786|NCT01634165|368659|P3|COMPLETED|Period 4||6
151787|NCT01634165|368660|P2|COMPLETED|Period 4||5
151788|NCT01634165|368661|P1|COMPLETED|Period 4||6
151789|NCT01634165|368658|P4|STARTED|Period 4||6
151790|NCT01634165|368659|P3|STARTED|Period 4||6
151791|NCT01634165|368660|P2|STARTED|Period 4||5
151792|NCT01634165|368661|P1|STARTED|Period 4||6
151793|NCT01634165|368658|P4|NOT COMPLETED|Period 3||0
151794|NCT01634165|368659|P3|NOT COMPLETED|Period 3||0
151795|NCT01634165|368660|P2|NOT COMPLETED|Period 3||0
151796|NCT01634165|368661|P1|NOT COMPLETED|Period 3||0
151797|NCT01634165|368658|P4|COMPLETED|Period 3||6
151798|NCT01634165|368659|P3|COMPLETED|Period 3||6
151799|NCT01634165|368660|P2|COMPLETED|Period 3||5
151800|NCT01634165|368661|P1|COMPLETED|Period 3||6
151801|NCT01634165|368658|P4|STARTED|Period 3||6
151802|NCT01634165|368659|P3|STARTED|Period 3||6
151803|NCT01634165|368660|P2|STARTED|Period 3||5
151804|NCT01634165|368661|P1|STARTED|Period 3||6
151805|NCT01634165|368658|P4|NOT COMPLETED|Period 2||0
151806|NCT01634165|368659|P3|NOT COMPLETED|Period 2||0
151807|NCT01634165|368660|P2|NOT COMPLETED|Period 2||1
151808|NCT01634165|368661|P1|NOT COMPLETED|Period 2||0
151809|NCT01634165|368658|P4|COMPLETED|Period 2||6
151810|NCT01634165|368659|P3|COMPLETED|Period 2||6
151811|NCT01634165|368660|P2|COMPLETED|Period 2||5
151812|NCT01634165|368661|P1|COMPLETED|Period 2||6
151813|NCT01634165|368658|P4|STARTED|Period 2||6
151814|NCT01634165|368659|P3|STARTED|Period 2||6
151815|NCT01634165|368660|P2|STARTED|Period 2||6
151816|NCT01634165|368661|P1|STARTED|Period 2||6
151817|NCT01634165|368658|P4|NOT COMPLETED|Period 1||0
151818|NCT01634165|368659|P3|NOT COMPLETED|Period 1||0
151819|NCT01634165|368660|P2|NOT COMPLETED|Period 1||0
151820|NCT01634165|368661|P1|NOT COMPLETED|Period 1||0
151821|NCT01634165|368658|P4|COMPLETED|Period 1||6
151822|NCT01634165|368659|P3|COMPLETED|Period 1||6
151823|NCT01634165|368660|P2|COMPLETED|Period 1||6
151824|NCT01634165|368661|P1|COMPLETED|Period 1||6
151825|NCT01634165|368658|P4|Received at Least 1 Dose of Study Drug|Period 1||6
151826|NCT01634165|368659|P3|Received at Least 1 Dose of Study Drug|Period 1||6
151827|NCT01634165|368660|P2|Received at Least 1 Dose of Study Drug|Period 1||6
151828|NCT01634165|368661|P1|Received at Least 1 Dose of Study Drug|Period 1||6
151829|NCT01634165|368658|P4|STARTED|Period 1||6
151830|NCT01634165|368659|P3|STARTED|Period 1||6
151831|NCT01634165|368660|P2|STARTED|Period 1||6
151832|NCT01634165|368661|P1|STARTED|Period 1||6
151833|NCT01634152|368694|P3|NOT COMPLETED|Overall Study||4
151834|NCT01634152|368695|P2|NOT COMPLETED|Overall Study||1
151835|NCT01634152|368696|P1|NOT COMPLETED|Overall Study||4
151836|NCT01634152|368694|P3|COMPLETED|Overall Study||126
151837|NCT01634152|368695|P2|COMPLETED|Overall Study||136
151838|NCT01634152|368696|P1|COMPLETED|Overall Study||130
151839|NCT01634152|368694|P3|STARTED|Overall Study||130
151840|NCT01634152|368695|P2|STARTED|Overall Study||137
151841|NCT01634152|368696|P1|STARTED|Overall Study||134
151842|NCT01634139|368779|P3|NOT COMPLETED|Overall Study||5
151843|NCT01634139|368780|P2|NOT COMPLETED|Overall Study||6
151844|NCT01634139|368781|P1|NOT COMPLETED|Overall Study||10
151845|NCT01634139|368779|P3|COMPLETED|Overall Study||130
151846|NCT01634139|368780|P2|COMPLETED|Overall Study||130
151847|NCT01634139|368781|P1|COMPLETED|Overall Study||122
151848|NCT01634139|368779|P3|STARTED|Overall Study||135
151849|NCT01634139|368780|P2|STARTED|Overall Study||136
151850|NCT01634139|368781|P1|STARTED|Overall Study||132
151851|NCT01634113|368882|P3|NOT COMPLETED|Overall Study||1
151852|NCT01634113|368883|P2|NOT COMPLETED|Overall Study||0
151853|NCT01634113|368884|P1|NOT COMPLETED|Overall Study||0
151854|NCT01634113|368882|P3|COMPLETED|Overall Study||31
151855|NCT01634113|368883|P2|COMPLETED|Overall Study||36
151856|NCT01634113|368884|P1|COMPLETED|Overall Study||34
151857|NCT01634113|368882|P3|STARTED|Overall Study||32
151858|NCT01634113|368883|P2|STARTED|Overall Study||36
151859|NCT01634113|368884|P1|STARTED|Overall Study||34
151860|NCT01634100|368928|P6|NOT COMPLETED|Overall Study||0
151861|NCT01634100|368929|P5|NOT COMPLETED|Overall Study||0
151862|NCT01634100|368930|P4|NOT COMPLETED|Overall Study||0
151863|NCT01634100|368931|P3|NOT COMPLETED|Overall Study||1
151864|NCT01634100|368932|P2|NOT COMPLETED|Overall Study||0
151865|NCT01634100|368933|P1|NOT COMPLETED|Overall Study||1
151866|NCT01634100|368928|P6|COMPLETED|Overall Study||3
151867|NCT01634100|368929|P5|COMPLETED|Overall Study||3
151868|NCT01634100|368930|P4|COMPLETED|Overall Study||3
151869|NCT01634100|368931|P3|COMPLETED|Overall Study||2
151870|NCT01634100|368932|P2|COMPLETED|Overall Study||3
151871|NCT01634100|368933|P1|COMPLETED|Overall Study||2
151872|NCT01634100|368928|P6|Received Empa + Probenecid|Overall Study||3
151873|NCT01634100|368929|P5|Received Empa + Probenecid|Overall Study||3
151874|NCT01634100|368930|P4|Received Empa + Probenecid|Overall Study||3
151875|NCT01634100|368931|P3|Received Empa + Probenecid|Overall Study||2
151876|NCT01634100|368932|P2|Received Empa + Probenecid|Overall Study||3
151877|NCT01634100|368933|P1|Received Empa + Probenecid|Overall Study||2
151878|NCT01634100|368928|P6|Received Empa + Rifampicin|Overall Study||3
151879|NCT01634100|368929|P5|Received Empa + Rifampicin|Overall Study||3
151880|NCT01634100|368930|P4|Received Empa + Rifampicin|Overall Study||3
151881|NCT01634100|368931|P3|Received Empa + Rifampicin|Overall Study||3
151882|NCT01634100|368932|P2|Received Empa + Rifampicin|Overall Study||3
151883|NCT01634100|368933|P1|Received Empa + Rifampicin|Overall Study||3
151884|NCT01634100|368928|P6|Received Empa Alone|Overall Study||3
151885|NCT01634100|368929|P5|Received Empa Alone|Overall Study||3
151886|NCT01634100|368930|P4|Received Empa Alone|Overall Study||3
151887|NCT01634100|368931|P3|Received Empa Alone|Overall Study||3
151888|NCT01634100|368932|P2|Received Empa Alone|Overall Study||3
151889|NCT01634100|368933|P1|Received Empa Alone|Overall Study||3
151890|NCT01634100|368928|P6|STARTED|Overall Study||3
151891|NCT01634100|368929|P5|STARTED|Overall Study||3
151892|NCT01634100|368930|P4|STARTED|Overall Study||3
151893|NCT01634100|368931|P3|STARTED|Overall Study||3
151894|NCT01634100|368932|P2|STARTED|Overall Study||3
151895|NCT01634100|368933|P1|STARTED|Overall Study||3
151896|NCT01633944|368949|P3|NOT COMPLETED|Double-blind Treatment Phase||58
151897|NCT01633944|368950|P2|NOT COMPLETED|Double-blind Treatment Phase||54
151898|NCT01633944|368951|P1|NOT COMPLETED|Double-blind Treatment Phase||0
151899|NCT01633944|368949|P3|COMPLETED|Double-blind Treatment Phase||174
151900|NCT01633944|368950|P2|COMPLETED|Double-blind Treatment Phase||176
151901|NCT01633944|368951|P1|COMPLETED|Double-blind Treatment Phase||0
151902|NCT01633944|368949|P3|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|232
151903|NCT01633944|368950|P2|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|230
151904|NCT01633944|368951|P1|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
151905|NCT01633944|368949|P3|NOT COMPLETED|Open-label Titration Phase||0
151906|NCT01633944|368950|P2|NOT COMPLETED|Open-label Titration Phase||0
151907|NCT01633944|368951|P1|NOT COMPLETED|Open-label Titration Phase||290
151908|NCT01633944|368949|P3|COMPLETED|Open-label Titration Phase||0
151909|NCT01633944|368950|P2|COMPLETED|Open-label Titration Phase||0
151910|NCT01633944|368951|P1|COMPLETED|Open-label Titration Phase||462
151911|NCT01633944|368949|P3|STARTED|Open-label Titration Phase||0
151912|NCT01633944|368950|P2|STARTED|Open-label Titration Phase||0
151913|NCT01633944|368951|P1|STARTED|Open-label Titration Phase||752
151914|NCT01633892|368971|P1|NOT COMPLETED|Overall Study||0
151915|NCT01633892|368971|P1|COMPLETED|Overall Study||5
151916|NCT01633892|368971|P1|STARTED|Overall Study||5
151917|NCT01633853|368981|P2|NOT COMPLETED|Overall Study||0
151918|NCT01633853|368982|P1|NOT COMPLETED|Overall Study||0
151919|NCT01633853|368981|P2|COMPLETED|Overall Study||100
151920|NCT01633853|368982|P1|COMPLETED|Overall Study||104
151921|NCT01633853|368981|P2|STARTED|Overall Study||100
151922|NCT01633853|368982|P1|STARTED|Overall Study||104
151923|NCT01633827|368996|P2|NOT COMPLETED|Second Intervention||0
151924|NCT01633827|368997|P1|NOT COMPLETED|Second Intervention||0
151925|NCT01633827|368996|P2|COMPLETED|Second Intervention||11
151926|NCT01633827|368997|P1|COMPLETED|Second Intervention||11
151927|NCT01633827|368996|P2|STARTED|Second Intervention||11
151928|NCT01633827|368997|P1|STARTED|Second Intervention||11
151929|NCT01633827|368996|P2|NOT COMPLETED|Washout Period||0
151930|NCT01633827|368997|P1|NOT COMPLETED|Washout Period||0
151931|NCT01633827|368996|P2|COMPLETED|Washout Period||11
151932|NCT01633827|368997|P1|COMPLETED|Washout Period||11
151933|NCT01633827|368996|P2|STARTED|Washout Period||11
151934|NCT01633827|368997|P1|STARTED|Washout Period||11
151935|NCT01633827|368996|P2|NOT COMPLETED|First Intervention||0
151936|NCT01633827|368997|P1|NOT COMPLETED|First Intervention||0
151937|NCT01633827|368996|P2|COMPLETED|First Intervention||11
151938|NCT01633827|368997|P1|COMPLETED|First Intervention||11
151939|NCT01633827|368996|P2|STARTED|First Intervention||11
151940|NCT01633827|368997|P1|STARTED|First Intervention||11
151941|NCT01633814|369010|P1|NOT COMPLETED|Overall Study||0
151942|NCT01633814|369010|P1|COMPLETED|Overall Study||4
151943|NCT01633814|369010|P1|STARTED|Overall Study||4
151944|NCT01633788|369019|P4|NOT COMPLETED|Overall Study||13
151945|NCT01633788|369020|P3|NOT COMPLETED|Overall Study||10
151946|NCT01633788|369021|P2|NOT COMPLETED|Overall Study||8
151947|NCT01633788|369022|P1|NOT COMPLETED|Overall Study||7
151948|NCT01633788|369019|P4|COMPLETED|Overall Study||45
151949|NCT01633788|369020|P3|COMPLETED|Overall Study||49
151950|NCT01633788|369021|P2|COMPLETED|Overall Study||50
151951|NCT01633788|369022|P1|COMPLETED|Overall Study||50
151952|NCT01633788|369019|P4|STARTED|Overall Study||58
151953|NCT01633788|369020|P3|STARTED|Overall Study||59
151954|NCT01633788|369021|P2|STARTED|Overall Study||58
151955|NCT01633788|369022|P1|STARTED|Overall Study||57
151956|NCT01633320|369042|P2|NOT COMPLETED|Overall Study||0
151957|NCT01633320|369043|P1|NOT COMPLETED|Overall Study||0
151958|NCT01633320|369042|P2|COMPLETED|Overall Study||68
151959|NCT01633320|369043|P1|COMPLETED|Overall Study||132
151960|NCT01633320|369042|P2|STARTED|Overall Study||68
151961|NCT01633320|369043|P1|STARTED|Overall Study||132
151962|NCT01633112|369054|P3|NOT COMPLETED|Overall Study||92
151963|NCT01633112|369055|P2|NOT COMPLETED|Overall Study||60
151964|NCT01633112|369056|P1|NOT COMPLETED|Overall Study||53
151965|NCT01633112|369054|P3|COMPLETED|Overall Study||250
151966|NCT01633112|369055|P2|COMPLETED|Overall Study||310
151967|NCT01633112|369056|P1|COMPLETED|Overall Study||299
151968|NCT01633112|369054|P3|STARTED|Overall Study||342
151969|NCT01633112|369055|P2|STARTED|Overall Study||370
151970|NCT01633112|369056|P1|STARTED|Overall Study||352
151971|NCT01633060|369091|P2|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
151972|NCT01633060|369092|P1|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||16
151973|NCT01633060|369091|P2|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
151974|NCT01633060|369092|P1|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
151975|NCT01633060|369091|P2|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
151976|NCT01633060|369092|P1|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|16
151977|NCT01633060|369091|P2|NOT COMPLETED|Treatment Phase||140
151978|NCT01633060|369092|P1|NOT COMPLETED|Treatment Phase||288
151979|NCT01633060|369091|P2|COMPLETED|Treatment Phase||0
151980|NCT01633060|369092|P1|COMPLETED|Treatment Phase||0
151981|NCT01633060|369091|P2|Pharmacokinetic Analysis Set (PAS)|Treatment Phase||0
151982|NCT01633060|369092|P1|Pharmacokinetic Analysis Set (PAS)|Treatment Phase||63
151983|NCT01633060|369091|P2|Safety Set (SS)|Treatment Phase||140
151984|NCT01633060|369092|P1|Safety Set (SS)|Treatment Phase||288
151985|NCT01633060|369091|P2|FAS - ctDNA PIK3CA Non-mutant|Treatment Phase||81
151986|NCT01633060|369092|P1|FAS - ctDNA PIK3CA Non-mutant|Treatment Phase||132
151987|NCT01633060|369091|P2|FAS - ctDNA PIK3CA Mutant|Treatment Phase||35
151988|NCT01633060|369092|P1|FAS - ctDNA PIK3CA Mutant|Treatment Phase||100
151989|NCT01633060|369091|P2|STARTED|Treatment Phase||140
151990|NCT01633060|369092|P1|STARTED|Treatment Phase||288
151991|NCT01633060|369091|P2|NOT COMPLETED|Randomization Phase||3
151992|NCT01633060|369092|P1|NOT COMPLETED|Randomization Phase||1
151993|NCT01633060|369091|P2|COMPLETED|Randomization Phase||140
151994|NCT01633060|369092|P1|COMPLETED|Randomization Phase||288
151995|NCT01633060|369091|P2|STARTED|Randomization Phase|All randomized patients|143
151996|NCT01633060|369092|P1|STARTED|Randomization Phase|All randomized patients|289
151997|NCT01632995|369117|P1|NOT COMPLETED|Main Study Follow-up Period||120
151998|NCT01632995|369117|P1|COMPLETED|Main Study Follow-up Period||437
151999|NCT01632995|369117|P1|STARTED|Main Study Follow-up Period||557
152000|NCT01632995|369117|P1|NOT COMPLETED|Pre-screening to Enrollment Period||512
152001|NCT01632995|369117|P1|COMPLETED|Pre-screening to Enrollment Period||557
152002|NCT01632995|369117|P1|STARTED|Pre-screening to Enrollment Period||1069
152003|NCT01632904|369132|P2|NOT COMPLETED|Overall Study||6
152004|NCT01632904|369133|P1|NOT COMPLETED|Overall Study||7
152005|NCT01632904|369132|P2|COMPLETED|Overall Study|Patients still in the study as of 27MAR2014, including those who crossed over to ruxolitinib|50
152006|NCT01632904|369133|P1|COMPLETED|Overall Study|Patients still in the study as of data cutoff, 27MAR2014.|47
152007|NCT01632904|369132|P2|STARTED|Overall Study||56
152008|NCT01632904|369133|P1|STARTED|Overall Study||54
152009|NCT01632891|369144|P2|NOT COMPLETED|Overall Study||1
152010|NCT01632891|369145|P1|NOT COMPLETED|Overall Study||1
152011|NCT01632891|369144|P2|COMPLETED|Overall Study||25
152012|NCT01632891|369145|P1|COMPLETED|Overall Study||25
152013|NCT01632891|369144|P2|STARTED|Overall Study||26
152014|NCT01632891|369145|P1|STARTED|Overall Study||26
152015|NCT01632878|369169|P1|NOT COMPLETED|Treatment||158
152016|NCT01632878|369169|P1|COMPLETED|Treatment||1105
152017|NCT01632878|369169|P1|STARTED|Treatment||1263
152018|NCT01632878|369169|P1|NOT COMPLETED|Screening||268
152019|NCT01632878|369169|P1|COMPLETED|Screening||1263
152020|NCT01632878|369169|P1|STARTED|Screening||1531
152021|NCT01632800|369173|P1|NOT COMPLETED|Overall Study||1
152022|NCT01632800|369173|P1|COMPLETED|Overall Study||25
152023|NCT01632800|369173|P1|STARTED|Overall Study||26
152024|NCT01632735|369179|P2|NOT COMPLETED|Overall Study||3
152025|NCT01632735|369180|P1|NOT COMPLETED|Overall Study||4
152026|NCT01632735|369179|P2|COMPLETED|Overall Study||37
152027|NCT01632735|369180|P1|COMPLETED|Overall Study||36
152028|NCT01632735|369179|P2|STARTED|Overall Study||40
152029|NCT01632735|369180|P1|STARTED|Overall Study||40
152030|NCT01632709|369196|P4|NOT COMPLETED|Overall Study||1
152031|NCT01632709|369197|P3|NOT COMPLETED|Overall Study||0
152032|NCT01632709|369198|P2|NOT COMPLETED|Overall Study||1
152033|NCT01632709|369199|P1|NOT COMPLETED|Overall Study||2
152034|NCT01632709|369196|P4|COMPLETED|Overall Study||3
152035|NCT01632709|369197|P3|COMPLETED|Overall Study||5
152036|NCT01632709|369198|P2|COMPLETED|Overall Study||2
152037|NCT01632709|369199|P1|COMPLETED|Overall Study||2
152038|NCT01632709|369196|P4|Completed Visit 2 (Received Injection)|Overall Study||3
152039|NCT01632709|369197|P3|Completed Visit 2 (Received Injection)|Overall Study||5
152040|NCT01632709|369198|P2|Completed Visit 2 (Received Injection)|Overall Study||2
152041|NCT01632709|369199|P1|Completed Visit 2 (Received Injection)|Overall Study||4
152042|NCT01632709|369196|P4|STARTED|Overall Study||4
152043|NCT01632709|369197|P3|STARTED|Overall Study||5
152044|NCT01632709|369198|P2|STARTED|Overall Study||3
152045|NCT01632709|369199|P1|STARTED|Overall Study||4
152046|NCT01632683|369225|P2|NOT COMPLETED|Overall Study||0
152047|NCT01632683|369226|P1|NOT COMPLETED|Overall Study||0
152048|NCT01632683|369225|P2|COMPLETED|Overall Study||552
152049|NCT01632683|369226|P1|COMPLETED|Overall Study||548
152050|NCT01632683|369225|P2|STARTED|Overall Study||552
152051|NCT01632683|369226|P1|STARTED|Overall Study||548
152052|NCT01632579|369240|P9|NOT COMPLETED|Period 3 (Third Intervention)||0
152053|NCT01632579|369241|P8|NOT COMPLETED|Period 3 (Third Intervention)||0
152054|NCT01632579|369242|P7|NOT COMPLETED|Period 3 (Third Intervention)||0
152055|NCT01632579|369243|P6|NOT COMPLETED|Period 3 (Third Intervention)||0
152056|NCT01632579|369244|P5|NOT COMPLETED|Period 3 (Third Intervention)||0
152057|NCT01632579|369245|P4|NOT COMPLETED|Period 3 (Third Intervention)||0
152058|NCT01632579|369246|P3|NOT COMPLETED|Period 3 (Third Intervention)||0
152059|NCT01632579|369247|P2|NOT COMPLETED|Period 3 (Third Intervention)||0
152060|NCT01632579|369248|P1|NOT COMPLETED|Period 3 (Third Intervention)||0
152061|NCT01632579|369240|P9|COMPLETED|Period 3 (Third Intervention)||2
152062|NCT01632579|369241|P8|COMPLETED|Period 3 (Third Intervention)||6
152063|NCT01632579|369242|P7|COMPLETED|Period 3 (Third Intervention)||2
152064|NCT01632579|369243|P6|COMPLETED|Period 3 (Third Intervention)||2
152065|NCT01632579|369244|P5|COMPLETED|Period 3 (Third Intervention)||6
152066|NCT01632579|369245|P4|COMPLETED|Period 3 (Third Intervention)||2
152067|NCT01632579|369246|P3|COMPLETED|Period 3 (Third Intervention)||2
152068|NCT01632579|369247|P2|COMPLETED|Period 3 (Third Intervention)||6
152069|NCT01632579|369248|P1|COMPLETED|Period 3 (Third Intervention)||0
152070|NCT01632579|369240|P9|Received at Least 1 Dose|Period 3 (Third Intervention)||2
152071|NCT01632579|369241|P8|Received at Least 1 Dose|Period 3 (Third Intervention)||6
152072|NCT01632579|369242|P7|Received at Least 1 Dose|Period 3 (Third Intervention)||2
152073|NCT01632579|369243|P6|Received at Least 1 Dose|Period 3 (Third Intervention)||2
152074|NCT01632579|369244|P5|Received at Least 1 Dose|Period 3 (Third Intervention)||6
152075|NCT01632579|369245|P4|Received at Least 1 Dose|Period 3 (Third Intervention)||2
152076|NCT01632579|369246|P3|Received at Least 1 Dose|Period 3 (Third Intervention)||2
152077|NCT01632579|369247|P2|Received at Least 1 Dose|Period 3 (Third Intervention)||6
152078|NCT01632579|369248|P1|Received at Least 1 Dose|Period 3 (Third Intervention)||0
152079|NCT01632579|369240|P9|STARTED|Period 3 (Third Intervention)||2
152080|NCT01632579|369241|P8|STARTED|Period 3 (Third Intervention)||6
152081|NCT01632579|369242|P7|STARTED|Period 3 (Third Intervention)||2
152082|NCT01632579|369243|P6|STARTED|Period 3 (Third Intervention)||2
152083|NCT01632579|369244|P5|STARTED|Period 3 (Third Intervention)||6
152084|NCT01632579|369245|P4|STARTED|Period 3 (Third Intervention)||2
152085|NCT01632579|369246|P3|STARTED|Period 3 (Third Intervention)||2
152086|NCT01632579|369247|P2|STARTED|Period 3 (Third Intervention)||6
152087|NCT01632579|369248|P1|STARTED|Period 3 (Third Intervention)||0
152088|NCT01632579|369240|P9|NOT COMPLETED|Washout Period||0
152089|NCT01632579|369241|P8|NOT COMPLETED|Washout Period||0
152090|NCT01632579|369242|P7|NOT COMPLETED|Washout Period||0
152091|NCT01632579|369243|P6|NOT COMPLETED|Washout Period||0
152092|NCT01632579|369244|P5|NOT COMPLETED|Washout Period||0
152093|NCT01632579|369245|P4|NOT COMPLETED|Washout Period||0
152094|NCT01632579|369246|P3|NOT COMPLETED|Washout Period||0
152095|NCT01632579|369247|P2|NOT COMPLETED|Washout Period||0
152096|NCT01632579|369248|P1|NOT COMPLETED|Washout Period||0
152097|NCT01632579|369240|P9|COMPLETED|Washout Period||2
152098|NCT01632579|369241|P8|COMPLETED|Washout Period||6
152099|NCT01632579|369242|P7|COMPLETED|Washout Period||2
152100|NCT01632579|369243|P6|COMPLETED|Washout Period||2
152101|NCT01632579|369244|P5|COMPLETED|Washout Period||6
152102|NCT01632579|369245|P4|COMPLETED|Washout Period||2
152103|NCT01632579|369246|P3|COMPLETED|Washout Period||2
152104|NCT01632579|369247|P2|COMPLETED|Washout Period||6
152105|NCT01632579|369248|P1|COMPLETED|Washout Period||0
152106|NCT01632579|369240|P9|STARTED|Washout Period||2
152107|NCT01632579|369241|P8|STARTED|Washout Period||6
152108|NCT01632579|369242|P7|STARTED|Washout Period||2
152109|NCT01632579|369243|P6|STARTED|Washout Period||2
152110|NCT01632579|369244|P5|STARTED|Washout Period||6
152111|NCT01632579|369245|P4|STARTED|Washout Period||2
152112|NCT01632579|369246|P3|STARTED|Washout Period||2
152113|NCT01632579|369247|P2|STARTED|Washout Period||6
152114|NCT01632579|369248|P1|STARTED|Washout Period||0
152115|NCT01632579|369240|P9|NOT COMPLETED|Period 2 (Second Intervention)||0
152116|NCT01632579|369241|P8|NOT COMPLETED|Period 2 (Second Intervention)||0
152117|NCT01632579|369242|P7|NOT COMPLETED|Period 2 (Second Intervention)||0
152118|NCT01632579|369243|P6|NOT COMPLETED|Period 2 (Second Intervention)||0
152119|NCT01632579|369244|P5|NOT COMPLETED|Period 2 (Second Intervention)||0
152120|NCT01632579|369245|P4|NOT COMPLETED|Period 2 (Second Intervention)||0
152121|NCT01632579|369246|P3|NOT COMPLETED|Period 2 (Second Intervention)||0
152122|NCT01632579|369247|P2|NOT COMPLETED|Period 2 (Second Intervention)||0
152123|NCT01632579|369248|P1|NOT COMPLETED|Period 2 (Second Intervention)||1
152124|NCT01632579|369240|P9|COMPLETED|Period 2 (Second Intervention)||2
152125|NCT01632579|369241|P8|COMPLETED|Period 2 (Second Intervention)||6
152126|NCT01632579|369242|P7|COMPLETED|Period 2 (Second Intervention)||2
152127|NCT01632579|369243|P6|COMPLETED|Period 2 (Second Intervention)||2
152128|NCT01632579|369244|P5|COMPLETED|Period 2 (Second Intervention)||6
152129|NCT01632579|369245|P4|COMPLETED|Period 2 (Second Intervention)||2
152130|NCT01632579|369246|P3|COMPLETED|Period 2 (Second Intervention)||2
152131|NCT01632579|369247|P2|COMPLETED|Period 2 (Second Intervention)||6
152132|NCT01632579|369248|P1|COMPLETED|Period 2 (Second Intervention)||0
152133|NCT01632579|369240|P9|Received at Least 1 Dose|Period 2 (Second Intervention)||2
152134|NCT01632579|369241|P8|Received at Least 1 Dose|Period 2 (Second Intervention)||6
152135|NCT01632579|369242|P7|Received at Least 1 Dose|Period 2 (Second Intervention)||2
152136|NCT01632579|369243|P6|Received at Least 1 Dose|Period 2 (Second Intervention)||2
152137|NCT01632579|369244|P5|Received at Least 1 Dose|Period 2 (Second Intervention)||6
152138|NCT01632579|369245|P4|Received at Least 1 Dose|Period 2 (Second Intervention)||2
152139|NCT01632579|369246|P3|Received at Least 1 Dose|Period 2 (Second Intervention)||2
152140|NCT01632579|369247|P2|Received at Least 1 Dose|Period 2 (Second Intervention)||6
152141|NCT01632579|369248|P1|Received at Least 1 Dose|Period 2 (Second Intervention)||1
152142|NCT01632579|369240|P9|STARTED|Period 2 (Second Intervention)||2
152143|NCT01632579|369241|P8|STARTED|Period 2 (Second Intervention)||6
152144|NCT01632579|369242|P7|STARTED|Period 2 (Second Intervention)||2
152145|NCT01632579|369243|P6|STARTED|Period 2 (Second Intervention)||2
152146|NCT01632579|369244|P5|STARTED|Period 2 (Second Intervention)||6
152147|NCT01632579|369245|P4|STARTED|Period 2 (Second Intervention)||2
152148|NCT01632579|369246|P3|STARTED|Period 2 (Second Intervention)||2
152149|NCT01632579|369247|P2|STARTED|Period 2 (Second Intervention)||6
152150|NCT01632579|369248|P1|STARTED|Period 2 (Second Intervention)||1
152151|NCT01632579|369240|P9|NOT COMPLETED|Washout Period||0
152152|NCT01632579|369241|P8|NOT COMPLETED|Washout Period||0
152153|NCT01632579|369242|P7|NOT COMPLETED|Washout Period||0
152154|NCT01632579|369243|P6|NOT COMPLETED|Washout Period||0
152155|NCT01632579|369244|P5|NOT COMPLETED|Washout Period||0
152156|NCT01632579|369245|P4|NOT COMPLETED|Washout Period||0
152157|NCT01632579|369246|P3|NOT COMPLETED|Washout Period||0
152158|NCT01632579|369247|P2|NOT COMPLETED|Washout Period||0
152159|NCT01632579|369248|P1|NOT COMPLETED|Washout Period||1
152160|NCT01632579|369240|P9|COMPLETED|Washout Period||2
152161|NCT01632579|369241|P8|COMPLETED|Washout Period||6
152162|NCT01632579|369242|P7|COMPLETED|Washout Period||2
152163|NCT01632579|369243|P6|COMPLETED|Washout Period||2
152164|NCT01632579|369244|P5|COMPLETED|Washout Period||6
152165|NCT01632579|369245|P4|COMPLETED|Washout Period||2
152166|NCT01632579|369246|P3|COMPLETED|Washout Period||2
152167|NCT01632579|369247|P2|COMPLETED|Washout Period||6
152168|NCT01632579|369248|P1|COMPLETED|Washout Period||1
152169|NCT01632579|369240|P9|STARTED|Washout Period||2
152170|NCT01632579|369241|P8|STARTED|Washout Period||6
152171|NCT01632579|369242|P7|STARTED|Washout Period||2
152172|NCT01632579|369243|P6|STARTED|Washout Period||2
152173|NCT01632579|369244|P5|STARTED|Washout Period||6
152174|NCT01632579|369245|P4|STARTED|Washout Period||2
152175|NCT01632579|369246|P3|STARTED|Washout Period||2
152176|NCT01632579|369247|P2|STARTED|Washout Period||6
152177|NCT01632579|369248|P1|STARTED|Washout Period||2
152178|NCT01632579|369240|P9|NOT COMPLETED|Period 1 (First Intervention)||0
152179|NCT01632579|369241|P8|NOT COMPLETED|Period 1 (First Intervention)||0
152180|NCT01632579|369242|P7|NOT COMPLETED|Period 1 (First Intervention)||0
152181|NCT01632579|369243|P6|NOT COMPLETED|Period 1 (First Intervention)||0
152182|NCT01632579|369244|P5|NOT COMPLETED|Period 1 (First Intervention)||0
152183|NCT01632579|369245|P4|NOT COMPLETED|Period 1 (First Intervention)||0
152184|NCT01632579|369246|P3|NOT COMPLETED|Period 1 (First Intervention)||0
152185|NCT01632579|369247|P2|NOT COMPLETED|Period 1 (First Intervention)||0
152186|NCT01632579|369248|P1|NOT COMPLETED|Period 1 (First Intervention)||0
152187|NCT01632579|369240|P9|COMPLETED|Period 1 (First Intervention)||2
152188|NCT01632579|369241|P8|COMPLETED|Period 1 (First Intervention)||6
152189|NCT01632579|369242|P7|COMPLETED|Period 1 (First Intervention)||2
152190|NCT01632579|369243|P6|COMPLETED|Period 1 (First Intervention)||2
152191|NCT01632579|369244|P5|COMPLETED|Period 1 (First Intervention)||6
152192|NCT01632579|369245|P4|COMPLETED|Period 1 (First Intervention)||2
152193|NCT01632579|369246|P3|COMPLETED|Period 1 (First Intervention)||2
152194|NCT01632579|369247|P2|COMPLETED|Period 1 (First Intervention)||6
152195|NCT01632579|369248|P1|COMPLETED|Period 1 (First Intervention)||2
152196|NCT01632579|369240|P9|Received at Least 1 Dose|Period 1 (First Intervention)||2
152197|NCT01632579|369241|P8|Received at Least 1 Dose|Period 1 (First Intervention)||6
152198|NCT01632579|369242|P7|Received at Least 1 Dose|Period 1 (First Intervention)||2
152199|NCT01632579|369243|P6|Received at Least 1 Dose|Period 1 (First Intervention)||2
152200|NCT01632579|369244|P5|Received at Least 1 Dose|Period 1 (First Intervention)||6
152201|NCT01632579|369245|P4|Received at Least 1 Dose|Period 1 (First Intervention)||2
152202|NCT01632579|369246|P3|Received at Least 1 Dose|Period 1 (First Intervention)||2
152203|NCT01632579|369247|P2|Received at Least 1 Dose|Period 1 (First Intervention)||6
152204|NCT01632579|369248|P1|Received at Least 1 Dose|Period 1 (First Intervention)||2
152205|NCT01632579|369240|P9|STARTED|Period 1 (First Intervention)||2
152206|NCT01632579|369241|P8|STARTED|Period 1 (First Intervention)||6
152207|NCT01632579|369242|P7|STARTED|Period 1 (First Intervention)||2
152208|NCT01632579|369243|P6|STARTED|Period 1 (First Intervention)||2
152209|NCT01632579|369244|P5|STARTED|Period 1 (First Intervention)||6
152210|NCT01632579|369245|P4|STARTED|Period 1 (First Intervention)||2
152211|NCT01632579|369246|P3|STARTED|Period 1 (First Intervention)||2
152212|NCT01632579|369247|P2|STARTED|Period 1 (First Intervention)||6
152213|NCT01632579|369248|P1|STARTED|Period 1 (First Intervention)||2
152214|NCT01632566|369315|P5|NOT COMPLETED|Overall Study||2
152215|NCT01632566|369316|P4|NOT COMPLETED|Overall Study||2
152216|NCT01632566|369317|P3|NOT COMPLETED|Overall Study||9
152217|NCT01632566|369318|P2|NOT COMPLETED|Overall Study||3
152218|NCT01632566|369319|P1|NOT COMPLETED|Overall Study||0
152219|NCT01632566|369315|P5|COMPLETED|Overall Study||4
152220|NCT01632566|369316|P4|COMPLETED|Overall Study||4
152221|NCT01632566|369317|P3|COMPLETED|Overall Study||0
152222|NCT01632566|369318|P2|COMPLETED|Overall Study||7
152223|NCT01632566|369319|P1|COMPLETED|Overall Study||8
152224|NCT01632566|369315|P5|Received at Least One Dose Simvastatin|Overall Study||4
152225|NCT01632566|369316|P4|Received at Least One Dose Simvastatin|Overall Study||4
152226|NCT01632566|369317|P3|Received at Least One Dose Simvastatin|Overall Study||9
152227|NCT01632566|369318|P2|Received at Least One Dose Simvastatin|Overall Study||10
152228|NCT01632566|369319|P1|Received at Least One Dose Simvastatin|Overall Study||0
152229|NCT01632566|369315|P5|Received at Least One Dose LY3031207|Overall Study||0
152230|NCT01632566|369316|P4|Received at Least One Dose LY3031207|Overall Study||0
152231|NCT01632566|369317|P3|Received at Least One Dose LY3031207|Overall Study||9
152232|NCT01632566|369318|P2|Received at Least One Dose LY3031207|Overall Study||10
152233|NCT01632566|369319|P1|Received at Least One Dose LY3031207|Overall Study||8
152234|NCT01632566|369315|P5|STARTED|Overall Study||6
152235|NCT01632566|369316|P4|STARTED|Overall Study||6
152236|NCT01632566|369317|P3|STARTED|Overall Study||9
152237|NCT01632566|369318|P2|STARTED|Overall Study||10
152238|NCT01632566|369319|P1|STARTED|Overall Study||8
152239|NCT01632423|369357|P1|NOT COMPLETED|Overall Study||246
152240|NCT01632423|369357|P1|COMPLETED|Overall Study||10091
152241|NCT01632423|369357|P1|STARTED|Overall Study||10337
152242|NCT01632345|369370|P7|NOT COMPLETED|Treatment: Part II||11
152243|NCT01632345|369371|P6|NOT COMPLETED|Treatment: Part II||11
152244|NCT01632345|369372|P5|NOT COMPLETED|Treatment: Part II||0
152245|NCT01632345|369373|P4|NOT COMPLETED|Treatment: Part II||0
152246|NCT01632345|369374|P3|NOT COMPLETED|Treatment: Part II||0
152247|NCT01632345|369375|P2|NOT COMPLETED|Treatment: Part II||0
152248|NCT01632345|369376|P1|NOT COMPLETED|Treatment: Part II||0
152249|NCT01632345|369370|P7|COMPLETED|Treatment: Part II||55
152250|NCT01632345|369371|P6|COMPLETED|Treatment: Part II||55
152251|NCT01632345|369372|P5|COMPLETED|Treatment: Part II||0
152252|NCT01632345|369373|P4|COMPLETED|Treatment: Part II||0
152253|NCT01632345|369374|P3|COMPLETED|Treatment: Part II||0
152254|NCT01632345|369375|P2|COMPLETED|Treatment: Part II||0
152255|NCT01632345|369376|P1|COMPLETED|Treatment: Part II||0
152256|NCT01632345|369370|P7|Treated|Treatment: Part II||66
152257|NCT01632345|369371|P6|Treated|Treatment: Part II||66
152258|NCT01632345|369372|P5|Treated|Treatment: Part II||0
152259|NCT01632345|369373|P4|Treated|Treatment: Part II||0
152260|NCT01632345|369374|P3|Treated|Treatment: Part II||0
152261|NCT01632345|369375|P2|Treated|Treatment: Part II||0
152262|NCT01632345|369376|P1|Treated|Treatment: Part II||0
152263|NCT01632345|369370|P7|STARTED|Treatment: Part II|66 new participants enrolled at efavirenz treatment in Part II.|66
152264|NCT01632345|369371|P6|STARTED|Treatment: Part II|66 new participants enrolled at 100 mg dose in Part II.|66
152265|NCT01632345|369372|P5|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
152266|NCT01632345|369373|P4|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
152267|NCT01632345|369374|P3|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
152357|NCT01632020|369519|P1|NOT COMPLETED|Overall Study||2
152268|NCT01632345|369375|P2|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
152269|NCT01632345|369376|P1|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
152270|NCT01632345|369370|P7|NOT COMPLETED|Treatment: Part I||0
152271|NCT01632345|369371|P6|NOT COMPLETED|Treatment: Part I||0
152272|NCT01632345|369372|P5|NOT COMPLETED|Treatment: Part I||13
152273|NCT01632345|369373|P4|NOT COMPLETED|Treatment: Part I||8
152274|NCT01632345|369374|P3|NOT COMPLETED|Treatment: Part I||10
152275|NCT01632345|369375|P2|NOT COMPLETED|Treatment: Part I||15
152276|NCT01632345|369376|P1|NOT COMPLETED|Treatment: Part I||12
152277|NCT01632345|369370|P7|COMPLETED|Treatment: Part I||0
152278|NCT01632345|369371|P6|COMPLETED|Treatment: Part I||0
152279|NCT01632345|369372|P5|COMPLETED|Treatment: Part I||30
152280|NCT01632345|369373|P4|COMPLETED|Treatment: Part I||33
152281|NCT01632345|369374|P3|COMPLETED|Treatment: Part I||32
152282|NCT01632345|369375|P2|COMPLETED|Treatment: Part I||28
152283|NCT01632345|369376|P1|COMPLETED|Treatment: Part I||29
152284|NCT01632345|369370|P7|Treated|Treatment: Part I||0
152285|NCT01632345|369371|P6|Treated|Treatment: Part I||0
152286|NCT01632345|369372|P5|Treated|Treatment: Part I||43
152287|NCT01632345|369373|P4|Treated|Treatment: Part I||41
152288|NCT01632345|369374|P3|Treated|Treatment: Part I||42
152289|NCT01632345|369375|P2|Treated|Treatment: Part I||43
152290|NCT01632345|369376|P1|Treated|Treatment: Part I||40
152291|NCT01632345|369370|P7|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
152292|NCT01632345|369371|P6|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
152293|NCT01632345|369372|P5|STARTED|Treatment: Part I||43
152294|NCT01632345|369373|P4|STARTED|Treatment: Part I||41
152295|NCT01632345|369374|P3|STARTED|Treatment: Part I||42
152296|NCT01632345|369375|P2|STARTED|Treatment: Part I||43
152297|NCT01632345|369376|P1|STARTED|Treatment: Part I||41
152298|NCT01632345|369370|P7|NOT COMPLETED|Randomized Participants||0
152299|NCT01632345|369371|P6|NOT COMPLETED|Randomized Participants||0
152300|NCT01632345|369372|P5|NOT COMPLETED|Randomized Participants||0
152301|NCT01632345|369373|P4|NOT COMPLETED|Randomized Participants||0
152302|NCT01632345|369374|P3|NOT COMPLETED|Randomized Participants||0
152303|NCT01632345|369375|P2|NOT COMPLETED|Randomized Participants||0
152304|NCT01632345|369376|P1|NOT COMPLETED|Randomized Participants||0
152305|NCT01632345|369370|P7|COMPLETED|Randomized Participants||66
152306|NCT01632345|369371|P6|COMPLETED|Randomized Participants||66
152307|NCT01632345|369372|P5|COMPLETED|Randomized Participants||43
152308|NCT01632345|369373|P4|COMPLETED|Randomized Participants||41
152309|NCT01632345|369374|P3|COMPLETED|Randomized Participants||42
152310|NCT01632345|369375|P2|COMPLETED|Randomized Participants||43
152311|NCT01632345|369376|P1|COMPLETED|Randomized Participants||41
152312|NCT01632345|369370|P7|STARTED|Randomized Participants||66
152313|NCT01632345|369371|P6|STARTED|Randomized Participants||66
152314|NCT01632345|369372|P5|STARTED|Randomized Participants||43
152315|NCT01632345|369373|P4|STARTED|Randomized Participants||41
152316|NCT01632345|369374|P3|STARTED|Randomized Participants||42
152317|NCT01632345|369375|P2|STARTED|Randomized Participants||43
152318|NCT01632345|369376|P1|STARTED|Randomized Participants||41
152319|NCT01632306|369438|P3|NOT COMPLETED|Overall Study||0
152320|NCT01632306|369439|P2|NOT COMPLETED|Overall Study||0
152321|NCT01632306|369440|P1|NOT COMPLETED|Overall Study||1
152322|NCT01632306|369438|P3|COMPLETED|Overall Study||0
152323|NCT01632306|369439|P2|COMPLETED|Overall Study||10
152324|NCT01632306|369440|P1|COMPLETED|Overall Study||2
152325|NCT01632306|369438|P3|Received at Least One Dose of Study Drug|Overall Study||0
152326|NCT01632306|369439|P2|Received at Least One Dose of Study Drug|Overall Study||10
152327|NCT01632306|369440|P1|Received at Least One Dose of Study Drug|Overall Study||3
152328|NCT01632306|369438|P3|STARTED|Overall Study||0
152329|NCT01632306|369439|P2|STARTED|Overall Study||10
152330|NCT01632306|369440|P1|STARTED|Overall Study||3
152331|NCT01632280|369456|P2|NOT COMPLETED|Overall Study||0
152332|NCT01632280|369457|P1|NOT COMPLETED|Overall Study||1
152333|NCT01632280|369456|P2|COMPLETED|Overall Study||6
152334|NCT01632280|369457|P1|COMPLETED|Overall Study||5
152335|NCT01632280|369456|P2|STARTED|Overall Study||6
152336|NCT01632280|369457|P1|STARTED|Overall Study||6
152337|NCT01632267|369467|P1|NOT COMPLETED|Overall Study||7
152338|NCT01632267|369467|P1|COMPLETED|Overall Study||97
152339|NCT01632267|369467|P1|STARTED|Overall Study||104
152340|NCT01632241|369473|P2|NOT COMPLETED|Overall Study||79
152341|NCT01632241|369474|P1|NOT COMPLETED|Overall Study||44
152342|NCT01632241|369473|P2|COMPLETED|Overall Study||252
152343|NCT01632241|369474|P1|COMPLETED|Overall Study||121
152344|NCT01632241|369473|P2|STARTED|Overall Study||331
152345|NCT01632241|369474|P1|STARTED|Overall Study||165
152346|NCT01632215|369500|P2|NOT COMPLETED|Overall Study||1
152347|NCT01632215|369501|P1|NOT COMPLETED|Overall Study||2
152348|NCT01632215|369500|P2|COMPLETED|Overall Study||19
152349|NCT01632215|369501|P1|COMPLETED|Overall Study||18
152350|NCT01632215|369500|P2|STARTED|Overall Study||20
152351|NCT01632215|369501|P1|STARTED|Overall Study||20
152352|NCT01632150|369509|P1|NOT COMPLETED|Overall Study||40
152353|NCT01632150|369509|P1|COMPLETED|Overall Study|Completed=still receiving treatment|0
152354|NCT01632150|369509|P1|Received Cyclophosphamide|Overall Study||11
152355|NCT01632150|369509|P1|STARTED|Overall Study||40
152356|NCT01632020|369518|P2|NOT COMPLETED|Overall Study||0
152358|NCT01632020|369518|P2|COMPLETED|Overall Study||3
152359|NCT01632020|369519|P1|COMPLETED|Overall Study||2
152360|NCT01632020|369518|P2|STARTED|Overall Study||3
152361|NCT01632020|369519|P1|STARTED|Overall Study||4
152362|NCT01631929|369529|P2|NOT COMPLETED|Overall Study||0
152363|NCT01631929|369530|P1|NOT COMPLETED|Overall Study||0
152364|NCT01631929|369529|P2|COMPLETED|Overall Study||6
152365|NCT01631929|369530|P1|COMPLETED|Overall Study||6
152366|NCT01631929|369529|P2|STARTED|Overall Study||6
152367|NCT01631929|369530|P1|STARTED|Overall Study||6
152368|NCT01631864|369538|P2|NOT COMPLETED|Overall Study||4
152369|NCT01631864|369539|P1|NOT COMPLETED|Overall Study||2
152370|NCT01631864|369538|P2|COMPLETED|Overall Study||44
152371|NCT01631864|369539|P1|COMPLETED|Overall Study||48
152372|NCT01631864|369538|P2|STARTED|Overall Study||48
152373|NCT01631864|369539|P1|STARTED|Overall Study||50
152374|NCT01631825|369551|P1|NOT COMPLETED|Overall Study||65
152375|NCT01631825|369551|P1|COMPLETED|Overall Study||256
152376|NCT01631825|369551|P1|STARTED|Overall Study||321
152377|NCT01631812|369571|P1|NOT COMPLETED|Overall Study||37
152378|NCT01631812|369571|P1|COMPLETED|Overall Study||93
152379|NCT01631812|369571|P1|STARTED|Overall Study||130
152380|NCT01631747|369581|P2|NOT COMPLETED|One Year Infant Outcomes||9
152381|NCT01631747|369582|P1|NOT COMPLETED|One Year Infant Outcomes||13
152382|NCT01631747|369581|P2|COMPLETED|One Year Infant Outcomes||130
152383|NCT01631747|369582|P1|COMPLETED|One Year Infant Outcomes||123
152384|NCT01631747|369581|P2|STARTED|One Year Infant Outcomes||139
152385|NCT01631747|369582|P1|STARTED|One Year Infant Outcomes||136
152386|NCT01631747|369581|P2|NOT COMPLETED|Live Birth||1
152387|NCT01631747|369582|P1|NOT COMPLETED|Live Birth||4
152388|NCT01631747|369581|P2|COMPLETED|Live Birth||139
152389|NCT01631747|369582|P1|COMPLETED|Live Birth||136
152390|NCT01631747|369581|P2|STARTED|Live Birth||140
152391|NCT01631747|369582|P1|STARTED|Live Birth||140
152392|NCT01631747|369581|P2|NOT COMPLETED|Randomization Through End of Pregnancy||0
152393|NCT01631747|369582|P1|NOT COMPLETED|Randomization Through End of Pregnancy||1
152394|NCT01631747|369581|P2|COMPLETED|Randomization Through End of Pregnancy||140
152395|NCT01631747|369582|P1|COMPLETED|Randomization Through End of Pregnancy||140
152396|NCT01631747|369581|P2|STARTED|Randomization Through End of Pregnancy||140
152397|NCT01631747|369582|P1|STARTED|Randomization Through End of Pregnancy||141
152398|NCT01631682|369624|P4|NOT COMPLETED|Overall Study||2
152399|NCT01631682|369625|P3|NOT COMPLETED|Overall Study||31
152400|NCT01631682|369626|P2|NOT COMPLETED|Overall Study||45
152401|NCT01631682|369627|P1|NOT COMPLETED|Overall Study||31
152402|NCT01631682|369624|P4|COMPLETED|Overall Study||5
152403|NCT01631682|369625|P3|COMPLETED|Overall Study||13
152404|NCT01631682|369626|P2|COMPLETED|Overall Study||21
152405|NCT01631682|369627|P1|COMPLETED|Overall Study||24
152406|NCT01631682|369624|P4|STARTED|Overall Study||7
152407|NCT01631682|369625|P3|STARTED|Overall Study||44
152408|NCT01631682|369626|P2|STARTED|Overall Study||66
152409|NCT01631682|369627|P1|STARTED|Overall Study||55
152410|NCT01631656|369639|P2|NOT COMPLETED|Overall Study||0
152411|NCT01631656|369640|P1|NOT COMPLETED|Overall Study||0
152412|NCT01631656|369639|P2|COMPLETED|Overall Study||5
152413|NCT01631656|369640|P1|COMPLETED|Overall Study||5
152414|NCT01631656|369639|P2|STARTED|Overall Study||5
152415|NCT01631656|369640|P1|STARTED|Overall Study||5
152416|NCT01631630|369648|P2|NOT COMPLETED|Overall Study||0
152417|NCT01631630|369649|P1|NOT COMPLETED|Overall Study||3
152418|NCT01631630|369648|P2|COMPLETED|Overall Study||8
152419|NCT01631630|369649|P1|COMPLETED|Overall Study||5
152420|NCT01631630|369648|P2|STARTED|Overall Study||8
152421|NCT01631630|369649|P1|STARTED|Overall Study||8
152422|NCT01631435|369759|P1|NOT COMPLETED|Overall Study||9
152423|NCT01631435|369759|P1|COMPLETED|Overall Study||66
152424|NCT01631435|369759|P1|STARTED|Overall Study||75
152425|NCT01631331|369764|P1|NOT COMPLETED|Overall Study||4
152426|NCT01631331|369764|P1|COMPLETED|Overall Study||11
152427|NCT01631331|369764|P1|STARTED|Overall Study||15
152428|NCT01631227|369773|P2|NOT COMPLETED|Overall Study||22
152429|NCT01631227|369774|P1|NOT COMPLETED|Overall Study||30
152430|NCT01631227|369773|P2|COMPLETED|Overall Study||310
152431|NCT01631227|369774|P1|COMPLETED|Overall Study||303
152432|NCT01631227|369773|P2|Full Analysis Set Population|Overall Study|1 patient not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|331
152433|NCT01631227|369774|P1|Full Analysis Set Population|Overall Study|2 patients not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|330
152434|NCT01631227|369773|P2|Safety Subject Sample|Overall Study||332
152435|NCT01631227|369774|P1|Safety Subject Sample|Overall Study|1 patient was randomized by mistake and never received study medication.|332
152436|NCT01631227|369773|P2|STARTED|Overall Study||332
152437|NCT01631227|369774|P1|STARTED|Overall Study||333
152438|NCT01631214|369782|P2|NOT COMPLETED|Overall Study||523
152439|NCT01631214|369783|P1|NOT COMPLETED|Overall Study||544
152440|NCT01631214|369782|P2|COMPLETED|Overall Study||1523
152441|NCT01631214|369783|P1|COMPLETED|Overall Study||1503
152442|NCT01631214|369782|P2|Completed Primary Analysis Period|Overall Study||1574
152443|NCT01631214|369783|P1|Completed Primary Analysis Period|Overall Study||1576
152444|NCT01631214|369782|P2|Completed Double-blind Period|Overall Study||1831
152445|NCT01631214|369783|P1|Completed Double-blind Period|Overall Study||1823
152446|NCT01631214|369782|P2|Received Double-blind Treatment|Overall Study||2038
152447|NCT01631214|369783|P1|Received Double-blind Treatment|Overall Study||2040
152448|NCT01631214|369782|P2|STARTED|Overall Study||2046
152449|NCT01631214|369783|P1|STARTED|Overall Study||2047
152450|NCT01631149|369847|P2|NOT COMPLETED|Overall Study||0
152451|NCT01631149|369848|P1|NOT COMPLETED|Overall Study||0
152452|NCT01631149|369847|P2|COMPLETED|Overall Study||12
152453|NCT01631149|369848|P1|COMPLETED|Overall Study||12
152454|NCT01631149|369847|P2|STARTED|Overall Study||12
152455|NCT01631149|369848|P1|STARTED|Overall Study||12
152456|NCT01631110|369864|P2|NOT COMPLETED|Overall Study||0
152457|NCT01631110|369865|P1|NOT COMPLETED|Overall Study||0
152458|NCT01631110|369864|P2|COMPLETED|Overall Study||55
152459|NCT01631110|369865|P1|COMPLETED|Overall Study||55
152460|NCT01631110|369864|P2|STARTED|Overall Study||55
152461|NCT01631110|369865|P1|STARTED|Overall Study||55
152462|NCT01631071|369879|P2|NOT COMPLETED|Overall Study||0
152463|NCT01631071|369880|P1|NOT COMPLETED|Overall Study||0
152464|NCT01631071|369879|P2|COMPLETED|Overall Study||55
152465|NCT01631071|369880|P1|COMPLETED|Overall Study||55
152466|NCT01631071|369879|P2|STARTED|Overall Study||55
152467|NCT01631071|369880|P1|STARTED|Overall Study||55
152468|NCT01630811|369892|P2|NOT COMPLETED|Second Washout (4 Weeks)||0
152469|NCT01630811|369893|P1|NOT COMPLETED|Second Washout (4 Weeks)||0
152470|NCT01630811|369892|P2|COMPLETED|Second Washout (4 Weeks)||6
152471|NCT01630811|369893|P1|COMPLETED|Second Washout (4 Weeks)||6
152472|NCT01630811|369892|P2|STARTED|Second Washout (4 Weeks)||6
152473|NCT01630811|369893|P1|STARTED|Second Washout (4 Weeks)||6
152474|NCT01630811|369892|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
152475|NCT01630811|369893|P1|NOT COMPLETED|Second Intervention (8 Weeks)||1
152476|NCT01630811|369892|P2|COMPLETED|Second Intervention (8 Weeks)||6
152477|NCT01630811|369893|P1|COMPLETED|Second Intervention (8 Weeks)||6
152478|NCT01630811|369892|P2|STARTED|Second Intervention (8 Weeks)||6
152479|NCT01630811|369893|P1|STARTED|Second Intervention (8 Weeks)||7
152480|NCT01630811|369892|P2|NOT COMPLETED|Washout (4 Weeks)||0
152481|NCT01630811|369893|P1|NOT COMPLETED|Washout (4 Weeks)||0
152482|NCT01630811|369892|P2|COMPLETED|Washout (4 Weeks)||6
152483|NCT01630811|369893|P1|COMPLETED|Washout (4 Weeks)||7
152484|NCT01630811|369892|P2|STARTED|Washout (4 Weeks)||6
152485|NCT01630811|369893|P1|STARTED|Washout (4 Weeks)||7
152486|NCT01630811|369892|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
152487|NCT01630811|369893|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
152488|NCT01630811|369892|P2|COMPLETED|First Intervention (8 Weeks)||6
152489|NCT01630811|369893|P1|COMPLETED|First Intervention (8 Weeks)||7
152490|NCT01630811|369892|P2|STARTED|First Intervention (8 Weeks)||6
152491|NCT01630811|369893|P1|STARTED|First Intervention (8 Weeks)||7
152492|NCT01630694|369905|P2|NOT COMPLETED|Overall Study||0
152493|NCT01630694|369906|P1|NOT COMPLETED|Overall Study||0
152494|NCT01630694|369905|P2|COMPLETED|Overall Study||16
152495|NCT01630694|369906|P1|COMPLETED|Overall Study||12
152496|NCT01630694|369905|P2|STARTED|Overall Study||16
152497|NCT01630694|369906|P1|STARTED|Overall Study||12
152498|NCT01630616|369920|P6|NOT COMPLETED|Overall Study||0
152499|NCT01630616|369921|P5|NOT COMPLETED|Overall Study||0
152500|NCT01630616|369922|P4|NOT COMPLETED|Overall Study||3
152501|NCT01630616|369923|P3|NOT COMPLETED|Overall Study||0
152502|NCT01630616|369924|P2|NOT COMPLETED|Overall Study||0
152503|NCT01630616|369925|P1|NOT COMPLETED|Overall Study||0
152504|NCT01630616|369920|P6|COMPLETED|Overall Study||2
152505|NCT01630616|369921|P5|COMPLETED|Overall Study||6
152506|NCT01630616|369922|P4|COMPLETED|Overall Study||9
152507|NCT01630616|369923|P3|COMPLETED|Overall Study||3
152508|NCT01630616|369924|P2|COMPLETED|Overall Study||3
152509|NCT01630616|369925|P1|COMPLETED|Overall Study||5
152510|NCT01630616|369920|P6|STARTED|Overall Study||2
152511|NCT01630616|369921|P5|STARTED|Overall Study||6
152512|NCT01630616|369922|P4|STARTED|Overall Study||12
152513|NCT01630616|369923|P3|STARTED|Overall Study||3
152514|NCT01630616|369924|P2|STARTED|Overall Study||3
152515|NCT01630616|369925|P1|STARTED|Overall Study||5
152516|NCT01630200|370000|P2|NOT COMPLETED|Overall Study||6
152517|NCT01630200|370001|P1|NOT COMPLETED|Overall Study||7
152518|NCT01630200|370000|P2|COMPLETED|Overall Study||34
152519|NCT01630200|370001|P1|COMPLETED|Overall Study||33
152520|NCT01630200|370000|P2|STARTED|Overall Study||40
152521|NCT01630200|370001|P1|STARTED|Overall Study||40
152522|NCT01630135|370025|P2|NOT COMPLETED|Overall Study||2
152523|NCT01630135|370026|P1|NOT COMPLETED|Overall Study||0
152524|NCT01630135|370025|P2|COMPLETED|Overall Study||128
152525|NCT01630135|370026|P1|COMPLETED|Overall Study||131
152526|NCT01630135|370025|P2|STARTED|Overall Study||130
152527|NCT01630135|370026|P1|STARTED|Overall Study||131
152528|NCT01630109|370065|P3|NOT COMPLETED|Overall Study||0
152529|NCT01630109|370066|P2|NOT COMPLETED|Overall Study||0
152530|NCT01630109|370067|P1|NOT COMPLETED|Overall Study||0
152531|NCT01630109|370065|P3|COMPLETED|Overall Study||3
152532|NCT01630109|370066|P2|COMPLETED|Overall Study||1
152533|NCT01630109|370067|P1|COMPLETED|Overall Study||1
152534|NCT01630109|370065|P3|STARTED|Overall Study||3
152535|NCT01630109|370066|P2|STARTED|Overall Study||1
152536|NCT01630109|370067|P1|STARTED|Overall Study||1
152537|NCT01629953|370089|P2|NOT COMPLETED|Overall Study||15
152538|NCT01629953|370090|P1|NOT COMPLETED|Overall Study||13
152539|NCT01629953|370089|P2|COMPLETED|Overall Study||60
152540|NCT01629953|370090|P1|COMPLETED|Overall Study||52
152541|NCT01629953|370089|P2|STARTED|Overall Study||75
152542|NCT01629953|370090|P1|STARTED|Overall Study||65
152543|NCT01629862|370100|P2|NOT COMPLETED|Overall Study||2
152544|NCT01629862|370101|P1|NOT COMPLETED|Overall Study||2
152545|NCT01629862|370100|P2|COMPLETED|Overall Study||23
152546|NCT01629862|370101|P1|COMPLETED|Overall Study||26
152547|NCT01629862|370100|P2|STARTED|Overall Study||25
152548|NCT01629862|370101|P1|STARTED|Overall Study||28
152549|NCT01629823|370110|P3|NOT COMPLETED|Washout Period||0
152550|NCT01629823|370111|P2|NOT COMPLETED|Washout Period||6
152551|NCT01629823|370112|P1|NOT COMPLETED|Washout Period||3
152552|NCT01629823|370110|P3|COMPLETED|Washout Period||50
152553|NCT01629823|370111|P2|COMPLETED|Washout Period||51
152554|NCT01629823|370112|P1|COMPLETED|Washout Period||51
152555|NCT01629823|370110|P3|STARTED|Washout Period||50
152556|NCT01629823|370111|P2|STARTED|Washout Period||57
152557|NCT01629823|370112|P1|STARTED|Washout Period||54
152558|NCT01629823|370110|P3|NOT COMPLETED|Trial Period||10
152559|NCT01629823|370111|P2|NOT COMPLETED|Trial Period||13
152560|NCT01629823|370112|P1|NOT COMPLETED|Trial Period||13
152561|NCT01629823|370110|P3|COMPLETED|Trial Period||49
152562|NCT01629823|370111|P2|COMPLETED|Trial Period||56
152563|NCT01629823|370112|P1|COMPLETED|Trial Period||53
152564|NCT01629823|370110|P3|STARTED|Trial Period||59
152565|NCT01629823|370111|P2|STARTED|Trial Period||69
152566|NCT01629823|370112|P1|STARTED|Trial Period||66
152567|NCT01629797|370120|P1|NOT COMPLETED|Overall Study||18
152568|NCT01629797|370120|P1|COMPLETED|Overall Study||82
152569|NCT01629797|370120|P1|STARTED|Overall Study||100
152570|NCT01629784|370127|P1|NOT COMPLETED|Overall Study||6
152571|NCT01629784|370127|P1|COMPLETED|Overall Study||25
152572|NCT01629784|370127|P1|STARTED|Overall Study||31
152573|NCT01629771|370136|P2|NOT COMPLETED|Overall Study||0
152574|NCT01629771|370137|P1|NOT COMPLETED|Overall Study||0
152575|NCT01629771|370136|P2|COMPLETED|Overall Study||36
152576|NCT01629771|370137|P1|COMPLETED|Overall Study||36
152577|NCT01629771|370136|P2|STARTED|Overall Study||36
152578|NCT01629771|370137|P1|STARTED|Overall Study||36
152579|NCT01629706|370147|P1|NOT COMPLETED|Phase 2 Habitual||10
152580|NCT01629706|370147|P1|COMPLETED|Phase 2 Habitual||48
152581|NCT01629706|370147|P1|STARTED|Phase 2 Habitual|Phase 2 enrolled 48 new participants, plus 10 participants from Phase 1|58
152582|NCT01629706|370147|P1|NOT COMPLETED|Phase 1 PureVision||9
152583|NCT01629706|370147|P1|COMPLETED|Phase 1 PureVision||35
152584|NCT01629706|370147|P1|STARTED|Phase 1 PureVision||44
152585|NCT01629693|370175|P2|NOT COMPLETED|Overall Study||10
152586|NCT01629693|370176|P1|NOT COMPLETED|Overall Study||5
152587|NCT01629693|370175|P2|COMPLETED|Overall Study||178
152588|NCT01629693|370176|P1|COMPLETED|Overall Study||188
152589|NCT01629693|370175|P2|STARTED|Overall Study||188
152590|NCT01629693|370176|P1|STARTED|Overall Study||193
152591|NCT01629667|370185|P3|NOT COMPLETED|Overall Study||45
152592|NCT01629667|370186|P2|NOT COMPLETED|Overall Study||41
152593|NCT01629667|370187|P1|NOT COMPLETED|Overall Study||47
152594|NCT01629667|370185|P3|COMPLETED|Overall Study||14
152595|NCT01629667|370186|P2|COMPLETED|Overall Study||17
152596|NCT01629667|370187|P1|COMPLETED|Overall Study||12
152597|NCT01629667|370185|P3|Randomized and Treated|Overall Study||59
152598|NCT01629667|370186|P2|Randomized and Treated|Overall Study||57
152599|NCT01629667|370187|P1|Randomized and Treated|Overall Study||57
152600|NCT01629667|370185|P3|STARTED|Overall Study||59
152601|NCT01629667|370186|P2|STARTED|Overall Study||58
152602|NCT01629667|370187|P1|STARTED|Overall Study||59
152603|NCT01629589|370271|P2|NOT COMPLETED|Overall Study||7
152604|NCT01629589|370272|P1|NOT COMPLETED|Overall Study||8
152605|NCT01629589|370271|P2|COMPLETED|Overall Study||204
152606|NCT01629589|370272|P1|COMPLETED|Overall Study|A participant received the Boostrix vaccine. Study data reported for the Boostrix vaccine group.|204
152607|NCT01629589|370271|P2|STARTED|Overall Study||211
152608|NCT01629589|370272|P1|STARTED|Overall Study||212
152609|NCT01629563|370290|P2|NOT COMPLETED|Overall Study||53
152610|NCT01629563|370291|P1|NOT COMPLETED|Overall Study||61
152611|NCT01629563|370290|P2|COMPLETED|Overall Study||170
152612|NCT01629563|370291|P1|COMPLETED|Overall Study||167
152613|NCT01629563|370290|P2|Started Treatment Course 4|Overall Study||176
152614|NCT01629563|370291|P1|Started Treatment Course 4|Overall Study||178
152615|NCT01629563|370290|P2|Started Treatment Course 3|Overall Study||190
152616|NCT01629563|370291|P1|Started Treatment Course 3|Overall Study||191
152617|NCT01629563|370290|P2|Started Treatment Course 2|Overall Study||207
152618|NCT01629563|370291|P1|Started Treatment Course 2|Overall Study||213
152619|NCT01629563|370290|P2|Safety Population|Overall Study||221
152620|NCT01629563|370291|P1|Safety Population|Overall Study||230
152621|NCT01629563|370290|P2|STARTED|Overall Study|2 subjects randomised to 10mg received 5mg treatment in error (FAS 1: 10mg, Safety Set: 5mg)|223
152622|NCT01629563|370291|P1|STARTED|Overall Study||228
152623|NCT01629290|370309|P1|NOT COMPLETED|Overall Study||0
152624|NCT01629290|370309|P1|COMPLETED|Overall Study||15
152625|NCT01629290|370309|P1|STARTED|Overall Study||15
152626|NCT01629134|370319|P1|NOT COMPLETED|Overall Study||0
152627|NCT01629134|370319|P1|COMPLETED|Overall Study||62
152628|NCT01629134|370319|P1|STARTED|Overall Study||62
152629|NCT01628965|370332|P1|NOT COMPLETED|Overall Study||49
152630|NCT01628965|370332|P1|COMPLETED|Overall Study||94
152631|NCT01628965|370332|P1|STARTED|Overall Study||143
152632|NCT01628926|370341|P3|NOT COMPLETED|Overall Study||17
152633|NCT01628926|370342|P2|NOT COMPLETED|Overall Study||23
152634|NCT01628926|370343|P1|NOT COMPLETED|Overall Study||26
152635|NCT01628926|370341|P3|COMPLETED|Overall Study||68
152636|NCT01628926|370342|P2|COMPLETED|Overall Study||144
152637|NCT01628926|370343|P1|COMPLETED|Overall Study||142
152638|NCT01628926|370341|P3|STARTED|Overall Study||85
152639|NCT01628926|370342|P2|STARTED|Overall Study||167
152640|NCT01628926|370343|P1|STARTED|Overall Study||168
152641|NCT01628913|370392|P2|NOT COMPLETED|Overall Study||31
152642|NCT01628913|370393|P1|NOT COMPLETED|Overall Study||31
152643|NCT01628913|370392|P2|COMPLETED|Overall Study||0
152644|NCT01628913|370393|P1|COMPLETED|Overall Study||0
152645|NCT01628913|370392|P2|STARTED|Overall Study||31
152646|NCT01628913|370393|P1|STARTED|Overall Study||31
152647|NCT01628874|370407|P2|NOT COMPLETED|Overall Study||3
152648|NCT01628874|370408|P1|NOT COMPLETED|Overall Study||5
152649|NCT01628874|370407|P2|COMPLETED|Overall Study||29
152650|NCT01628874|370408|P1|COMPLETED|Overall Study||29
152651|NCT01628874|370407|P2|STARTED|Overall Study||32
152652|NCT01628874|370408|P1|STARTED|Overall Study||34
152653|NCT01628848|370424|P2|NOT COMPLETED|Overall Study||14
152654|NCT01628848|370425|P1|NOT COMPLETED|Overall Study||12
152655|NCT01628848|370424|P2|COMPLETED|Overall Study||73
152656|NCT01628848|370425|P1|COMPLETED|Overall Study||75
152657|NCT01628848|370424|P2|STARTED|Overall Study||87
152658|NCT01628848|370425|P1|STARTED|Overall Study||87
152659|NCT01628692|370459|P6|NOT COMPLETED|Overall Study||9
152660|NCT01628692|370460|P5|NOT COMPLETED|Overall Study||4
152661|NCT01628692|370461|P4|NOT COMPLETED|Overall Study||1
152662|NCT01628692|370462|P3|NOT COMPLETED|Overall Study||8
152663|NCT01628692|370463|P2|NOT COMPLETED|Overall Study||6
152664|NCT01628692|370464|P1|NOT COMPLETED|Overall Study||7
152665|NCT01628692|370459|P6|COMPLETED|Overall Study||0
152666|NCT01628692|370460|P5|COMPLETED|Overall Study||8
152667|NCT01628692|370461|P4|COMPLETED|Overall Study||19
152668|NCT01628692|370462|P3|COMPLETED|Overall Study||43
152669|NCT01628692|370463|P2|COMPLETED|Overall Study||17
152670|NCT01628692|370464|P1|COMPLETED|Overall Study||46
152671|NCT01628692|370459|P6|STARTED|Overall Study||9
152672|NCT01628692|370460|P5|STARTED|Overall Study||12
152673|NCT01628692|370461|P4|STARTED|Overall Study||20
152674|NCT01628692|370462|P3|STARTED|Overall Study||51
152675|NCT01628692|370463|P2|STARTED|Overall Study||23
152676|NCT01628692|370464|P1|STARTED|Overall Study||53
152677|NCT01628614|370508|P1|NOT COMPLETED|Overall Study||1775
152678|NCT01628614|370508|P1|COMPLETED|Overall Study||3037
152679|NCT01628614|370508|P1|STARTED|Overall Study||4812
152680|NCT01628601|370514|P1|NOT COMPLETED|Overall Study||41
152681|NCT01628601|370514|P1|COMPLETED|Overall Study||351
152682|NCT01628601|370514|P1|STARTED|Overall Study||392
152683|NCT01628588|370522|P1|NOT COMPLETED|Overall Study||16
152684|NCT01628588|370522|P1|COMPLETED|Overall Study||838
152685|NCT01628588|370522|P1|STARTED|Overall Study||854
152686|NCT01628549|370534|P4|NOT COMPLETED|Overall Study||9
152687|NCT01628549|370535|P3|NOT COMPLETED|Overall Study||10
152688|NCT01628549|370536|P2|NOT COMPLETED|Overall Study||12
152689|NCT01628549|370537|P1|NOT COMPLETED|Overall Study||9
152690|NCT01628549|370534|P4|COMPLETED|Overall Study||57
152691|NCT01628549|370535|P3|COMPLETED|Overall Study||60
152692|NCT01628549|370536|P2|COMPLETED|Overall Study||64
152693|NCT01628549|370537|P1|COMPLETED|Overall Study||64
152694|NCT01628549|370534|P4|STARTED|Overall Study||66
152695|NCT01628549|370535|P3|STARTED|Overall Study||70
152696|NCT01628549|370536|P2|STARTED|Overall Study||76
152697|NCT01628549|370537|P1|STARTED|Overall Study||73
152698|NCT01628510|370573|P2|NOT COMPLETED|Overall Study||5
152699|NCT01628510|370574|P1|NOT COMPLETED|Overall Study||3
152700|NCT01628510|370573|P2|COMPLETED|Overall Study||44
152701|NCT01628510|370574|P1|COMPLETED|Overall Study||48
152702|NCT01628510|370573|P2|STARTED|Overall Study||49
152703|NCT01628510|370574|P1|STARTED|Overall Study||51
152704|NCT01628367|370584|P2|NOT COMPLETED|Overall Study||0
152705|NCT01628367|370585|P1|NOT COMPLETED|Overall Study||1
152706|NCT01628367|370584|P2|COMPLETED|Overall Study||16
152707|NCT01628367|370585|P1|COMPLETED|Overall Study||15
152708|NCT01628367|370584|P2|STARTED|Overall Study||16
152709|NCT01628367|370585|P1|STARTED|Overall Study||16
152710|NCT01628250|370597|P2|NOT COMPLETED|Overall Study||0
152711|NCT01628250|370598|P1|NOT COMPLETED|Overall Study||0
152712|NCT01628250|370597|P2|COMPLETED|Overall Study||50
152713|NCT01628250|370598|P1|COMPLETED|Overall Study||49
152714|NCT01628250|370597|P2|STARTED|Overall Study||50
152715|NCT01628250|370598|P1|STARTED|Overall Study||49
152716|NCT01628198|370604|P1|NOT COMPLETED|Overall Study||18
152717|NCT01628198|370604|P1|COMPLETED|Overall Study||20
152718|NCT01628198|370604|P1|STARTED|Overall Study||38
152719|NCT01628120|370617|P1|NOT COMPLETED|Overall Study||44
152720|NCT01628120|370617|P1|COMPLETED|Overall Study||129
152721|NCT01628120|370617|P1|Treated|Overall Study||170
152722|NCT01628120|370617|P1|STARTED|Overall Study||173
152723|NCT01628107|370642|P1|NOT COMPLETED|Overall Study||119
152724|NCT01628107|370642|P1|COMPLETED|Overall Study||295
152725|NCT01628107|370642|P1|Treated|Overall Study||406
152726|NCT01628107|370642|P1|STARTED|Overall Study||414
152727|NCT01628042|370671|P4|NOT COMPLETED|Overall Study||0
152728|NCT01628042|370672|P3|NOT COMPLETED|Overall Study||0
152729|NCT01628042|370673|P2|NOT COMPLETED|Overall Study||0
152730|NCT01628042|370674|P1|NOT COMPLETED|Overall Study||0
152731|NCT01628042|370671|P4|COMPLETED|Overall Study||8
152732|NCT01628042|370672|P3|COMPLETED|Overall Study||8
152733|NCT01628042|370673|P2|COMPLETED|Overall Study||8
152734|NCT01628042|370674|P1|COMPLETED|Overall Study||8
152735|NCT01628042|370671|P4|STARTED|Overall Study||8
152736|NCT01628042|370672|P3|STARTED|Overall Study||8
152737|NCT01628042|370673|P2|STARTED|Overall Study||8
152738|NCT01628042|370674|P1|STARTED|Overall Study||8
152739|NCT01628016|370695|P3|NOT COMPLETED|Posttraining to 5 Follow-ups||5
152740|NCT01628016|370696|P2|NOT COMPLETED|Posttraining to 5 Follow-ups||7
152741|NCT01628016|370697|P1|NOT COMPLETED|Posttraining to 5 Follow-ups||4
152742|NCT01628016|370695|P3|COMPLETED|Posttraining to 5 Follow-ups||18
152743|NCT01628016|370696|P2|COMPLETED|Posttraining to 5 Follow-ups||20
152744|NCT01628016|370697|P1|COMPLETED|Posttraining to 5 Follow-ups||23
152745|NCT01628016|370695|P3|STARTED|Posttraining to 5 Follow-ups||23
152746|NCT01628016|370696|P2|STARTED|Posttraining to 5 Follow-ups||27
152747|NCT01628016|370697|P1|STARTED|Posttraining to 5 Follow-ups||27
152748|NCT01628016|370695|P3|NOT COMPLETED|Pretraining to Posttraining||0
152749|NCT01628016|370696|P2|NOT COMPLETED|Pretraining to Posttraining||0
152750|NCT01628016|370697|P1|NOT COMPLETED|Pretraining to Posttraining||0
152751|NCT01628016|370695|P3|COMPLETED|Pretraining to Posttraining||23
152752|NCT01628016|370696|P2|COMPLETED|Pretraining to Posttraining||27
152753|NCT01628016|370697|P1|COMPLETED|Pretraining to Posttraining||27
152754|NCT01628016|370695|P3|STARTED|Pretraining to Posttraining||23
152755|NCT01628016|370696|P2|STARTED|Pretraining to Posttraining||27
152756|NCT01628016|370697|P1|STARTED|Pretraining to Posttraining||27
152757|NCT01627899|370708|P1|NOT COMPLETED|Overall Study||5
152758|NCT01627899|370708|P1|COMPLETED|Overall Study||0
152759|NCT01627899|370708|P1|STARTED|Overall Study||5
152760|NCT01627860|370718|P2|NOT COMPLETED|Overall Study||6
152761|NCT01627860|370719|P1|NOT COMPLETED|Overall Study||12
152762|NCT01627860|370718|P2|COMPLETED|Overall Study||14
152763|NCT01627860|370719|P1|COMPLETED|Overall Study||23
152764|NCT01627860|370718|P2|STARTED|Overall Study||20
152765|NCT01627860|370719|P1|STARTED|Overall Study||35
152766|NCT01627782|370733|P4|NOT COMPLETED|Overall Study||6
152767|NCT01627782|370734|P3|NOT COMPLETED|Overall Study||15
152768|NCT01627782|370735|P2|NOT COMPLETED|Overall Study||6
152769|NCT01627782|370736|P1|NOT COMPLETED|Overall Study||16
152770|NCT01627782|370733|P4|COMPLETED|Overall Study||11
152771|NCT01627782|370734|P3|COMPLETED|Overall Study||1
152772|NCT01627782|370735|P2|COMPLETED|Overall Study||12
152773|NCT01627782|370736|P1|COMPLETED|Overall Study||1
152774|NCT01627782|370733|P4|Treated|Overall Study||17
152775|NCT01627782|370734|P3|Treated|Overall Study||16
152776|NCT01627782|370735|P2|Treated|Overall Study||18
152777|NCT01627782|370736|P1|Treated|Overall Study||16
152778|NCT01627782|370733|P4|STARTED|Overall Study||17
152779|NCT01627782|370734|P3|STARTED|Overall Study||16
152780|NCT01627782|370735|P2|STARTED|Overall Study||18
152781|NCT01627782|370736|P1|STARTED|Overall Study||17
152782|NCT01627691|370792|P1|NOT COMPLETED|Overall Study||18
152783|NCT01627691|370792|P1|COMPLETED|Overall Study||232
152784|NCT01627691|370792|P1|Primary Endpoint (30days)|Overall Study||239
152785|NCT01627691|370792|P1|STARTED|Overall Study||250
152786|NCT01627561|370799|P2|NOT COMPLETED|Overall Study||3
152787|NCT01627561|370800|P1|NOT COMPLETED|Overall Study||0
152788|NCT01627561|370799|P2|COMPLETED|Overall Study||71
152789|NCT01627561|370800|P1|COMPLETED|Overall Study||74
152790|NCT01627561|370799|P2|STARTED|Overall Study||74
152791|NCT01627561|370800|P1|STARTED|Overall Study||74
152792|NCT01627340|370848|P2|NOT COMPLETED|Overall Study||4
152793|NCT01627340|370849|P1|NOT COMPLETED|Overall Study||12
152794|NCT01627340|370848|P2|COMPLETED|Overall Study||254
152795|NCT01627340|370849|P1|COMPLETED|Overall Study||404
152796|NCT01627340|370848|P2|STARTED|Overall Study||258
152797|NCT01627340|370849|P1|STARTED|Overall Study||416
152798|NCT01627327|370867|P2|NOT COMPLETED|Overall Study||39
152799|NCT01627327|370868|P1|NOT COMPLETED|Overall Study||19
152800|NCT01627327|370867|P2|COMPLETED|Overall Study||274
152801|NCT01627327|370868|P1|COMPLETED|Overall Study||291
152802|NCT01627327|370867|P2|STARTED|Overall Study||313
152803|NCT01627327|370868|P1|STARTED|Overall Study||310
152804|NCT01627249|370881|P3|NOT COMPLETED|Overall Study||12
152805|NCT01627249|370882|P2|NOT COMPLETED|Overall Study||12
152806|NCT01627249|370883|P1|NOT COMPLETED|Overall Study||16
152807|NCT01627249|370881|P3|COMPLETED|Overall Study||206
152808|NCT01627249|370882|P2|COMPLETED|Overall Study||206
152809|NCT01627249|370883|P1|COMPLETED|Overall Study||208
152810|NCT01627249|370881|P3|STARTED|Overall Study||218
152811|NCT01627249|370882|P2|STARTED|Overall Study||218
152812|NCT01627249|370883|P1|STARTED|Overall Study||224
152813|NCT01627002|370920|P9|NOT COMPLETED|Overall Study||0
152814|NCT01627002|370921|P8|NOT COMPLETED|Overall Study||0
152815|NCT01627002|370922|P7|NOT COMPLETED|Overall Study||0
152816|NCT01627002|370923|P6|NOT COMPLETED|Overall Study||0
152817|NCT01627002|370924|P5|NOT COMPLETED|Overall Study||0
152818|NCT01627002|370925|P4|NOT COMPLETED|Overall Study||0
152819|NCT01627002|370926|P3|NOT COMPLETED|Overall Study||0
152820|NCT01627002|370927|P2|NOT COMPLETED|Overall Study||0
152821|NCT01627002|370928|P1|NOT COMPLETED|Overall Study||0
152822|NCT01627002|370920|P9|COMPLETED|Overall Study||7
152823|NCT01627002|370921|P8|COMPLETED|Overall Study||5
152824|NCT01627002|370922|P7|COMPLETED|Overall Study||10
152825|NCT01627002|370923|P6|COMPLETED|Overall Study||9
152826|NCT01627002|370924|P5|COMPLETED|Overall Study||2
152827|NCT01627002|370925|P4|COMPLETED|Overall Study||4
152828|NCT01627002|370926|P3|COMPLETED|Overall Study||4
152829|NCT01627002|370927|P2|COMPLETED|Overall Study||4
152830|NCT01627002|370928|P1|COMPLETED|Overall Study||4
152831|NCT01627002|370920|P9|STARTED|Overall Study||7
152832|NCT01627002|370921|P8|STARTED|Overall Study||5
152833|NCT01627002|370922|P7|STARTED|Overall Study||10
152834|NCT01627002|370923|P6|STARTED|Overall Study||9
152835|NCT01627002|370924|P5|STARTED|Overall Study||2
152836|NCT01627002|370925|P4|STARTED|Overall Study||4
152837|NCT01627002|370926|P3|STARTED|Overall Study||4
152838|NCT01627002|370927|P2|STARTED|Overall Study||4
152839|NCT01627002|370928|P1|STARTED|Overall Study||4
152840|NCT01626989|370979|P3|NOT COMPLETED|Second Intervention (Night 2)||0
152841|NCT01626989|370980|P2|NOT COMPLETED|Second Intervention (Night 2)||0
152842|NCT01626989|370981|P1|NOT COMPLETED|Second Intervention (Night 2)||0
152843|NCT01626989|370979|P3|COMPLETED|Second Intervention (Night 2)||12
152844|NCT01626989|370980|P2|COMPLETED|Second Intervention (Night 2)||15
152845|NCT01626989|370981|P1|COMPLETED|Second Intervention (Night 2)||0
152846|NCT01626989|370979|P3|STARTED|Second Intervention (Night 2)||12
152847|NCT01626989|370980|P2|STARTED|Second Intervention (Night 2)||15
152848|NCT01626989|370981|P1|STARTED|Second Intervention (Night 2)||0
152849|NCT01626989|370979|P3|NOT COMPLETED|Fist Intervention (Night 1)||0
152850|NCT01626989|370980|P2|NOT COMPLETED|Fist Intervention (Night 1)||0
152851|NCT01626989|370981|P1|NOT COMPLETED|Fist Intervention (Night 1)||0
152852|NCT01626989|370979|P3|COMPLETED|Fist Intervention (Night 1)||12
152853|NCT01626989|370980|P2|COMPLETED|Fist Intervention (Night 1)||15
152854|NCT01626989|370981|P1|COMPLETED|Fist Intervention (Night 1)||0
152855|NCT01626989|370979|P3|STARTED|Fist Intervention (Night 1)||12
152856|NCT01626989|370980|P2|STARTED|Fist Intervention (Night 1)||15
152857|NCT01626989|370981|P1|STARTED|Fist Intervention (Night 1)||0
152858|NCT01626989|370979|P3|NOT COMPLETED|Screening Period||0
152859|NCT01626989|370980|P2|NOT COMPLETED|Screening Period||0
152860|NCT01626989|370981|P1|NOT COMPLETED|Screening Period||17
152861|NCT01626989|370979|P3|COMPLETED|Screening Period||0
152862|NCT01626989|370980|P2|COMPLETED|Screening Period||0
152863|NCT01626989|370981|P1|COMPLETED|Screening Period||27
152864|NCT01626989|370979|P3|STARTED|Screening Period||0
152865|NCT01626989|370980|P2|STARTED|Screening Period||0
152866|NCT01626989|370981|P1|STARTED|Screening Period||44
152867|NCT01626820|371030|P2|NOT COMPLETED|Overall Study||0
152868|NCT01626820|371031|P1|NOT COMPLETED|Overall Study||0
152869|NCT01626820|371030|P2|COMPLETED|Overall Study||57
152870|NCT01626820|371031|P1|COMPLETED|Overall Study||56
152871|NCT01626820|371030|P2|STARTED|Overall Study||57
152872|NCT01626820|371031|P1|STARTED|Overall Study||56
152873|NCT01626690|371053|P2|NOT COMPLETED|Overall Study||0
152874|NCT01626690|371054|P1|NOT COMPLETED|Overall Study||2
152875|NCT01626690|371053|P2|COMPLETED|Overall Study||51
152876|NCT01626690|371054|P1|COMPLETED|Overall Study||47
152877|NCT01626690|371053|P2|STARTED|Overall Study||51
152878|NCT01626690|371054|P1|STARTED|Overall Study||49
152879|NCT01626664|371076|P3|NOT COMPLETED|Crossover Period||0
152880|NCT01626664|371077|P2|NOT COMPLETED|Crossover Period||0
152881|NCT01626664|371078|P1|NOT COMPLETED|Crossover Period||0
152882|NCT01626664|371076|P3|COMPLETED|Crossover Period||18
152883|NCT01626664|371077|P2|COMPLETED|Crossover Period||0
152884|NCT01626664|371078|P1|COMPLETED|Crossover Period||0
152885|NCT01626664|371076|P3|STARTED|Crossover Period||18
152886|NCT01626664|371077|P2|STARTED|Crossover Period||0
152887|NCT01626664|371078|P1|STARTED|Crossover Period||0
152888|NCT01626664|371076|P3|NOT COMPLETED|Randomization Period||0
152889|NCT01626664|371077|P2|NOT COMPLETED|Randomization Period||0
152890|NCT01626664|371078|P1|NOT COMPLETED|Randomization Period||0
152891|NCT01626664|371076|P3|COMPLETED|Randomization Period||0
152892|NCT01626664|371077|P2|COMPLETED|Randomization Period||24
152893|NCT01626664|371078|P1|COMPLETED|Randomization Period||47
152894|NCT01626664|371076|P3|STARTED|Randomization Period||0
152895|NCT01626664|371077|P2|STARTED|Randomization Period||24
152896|NCT01626664|371078|P1|STARTED|Randomization Period||47
152897|NCT01626456|371093|P2|NOT COMPLETED|Overall Study||117
152898|NCT01626456|371094|P1|NOT COMPLETED|Overall Study||35
152899|NCT01626456|371093|P2|COMPLETED|Overall Study||251
152900|NCT01626456|371094|P1|COMPLETED|Overall Study||75
152901|NCT01626456|371093|P2|STARTED|Overall Study||368
152902|NCT01626456|371094|P1|STARTED|Overall Study||110
152903|NCT01626391|371124|P2|NOT COMPLETED|Overall Study||0
152904|NCT01626391|371125|P1|NOT COMPLETED|Overall Study||2
152905|NCT01626391|371124|P2|COMPLETED|Overall Study||4
152906|NCT01626391|371125|P1|COMPLETED|Overall Study||3
152907|NCT01626391|371124|P2|STARTED|Overall Study||4
152908|NCT01626391|371125|P1|STARTED|Overall Study||5
152909|NCT01626352|371131|P1|NOT COMPLETED|Overall Study||10
152910|NCT01626352|371131|P1|COMPLETED|Overall Study||12
152911|NCT01626352|371131|P1|STARTED|Overall Study||22
152912|NCT01626118|371145|P4|NOT COMPLETED|Overall Study||3
152913|NCT01626118|371146|P3|NOT COMPLETED|Overall Study||2
152914|NCT01626118|371147|P2|NOT COMPLETED|Overall Study||2
152915|NCT01626118|371148|P1|NOT COMPLETED|Overall Study||2
152916|NCT01626118|371145|P4|COMPLETED|Overall Study||91
152917|NCT01626118|371146|P3|COMPLETED|Overall Study||90
152918|NCT01626118|371147|P2|COMPLETED|Overall Study||91
152919|NCT01626118|371148|P1|COMPLETED|Overall Study||92
152920|NCT01626118|371145|P4|STARTED|Overall Study||94
152921|NCT01626118|371146|P3|STARTED|Overall Study||92
152922|NCT01626118|371147|P2|STARTED|Overall Study||93
152923|NCT01626118|371148|P1|STARTED|Overall Study||94
152924|NCT01626092|371186|P1|NOT COMPLETED|Overall Study||0
152925|NCT01626092|371186|P1|COMPLETED|Overall Study||3
152926|NCT01626092|371186|P1|STARTED|Overall Study||3
152927|NCT01625923|371192|P1|NOT COMPLETED|Overall Study||0
152928|NCT01625923|371192|P1|COMPLETED|Overall Study||3
152929|NCT01625923|371192|P1|STARTED|Overall Study||3
152930|NCT01625910|371202|P2|NOT COMPLETED|Overall Study||4
152931|NCT01625910|371203|P1|NOT COMPLETED|Overall Study||3
152932|NCT01625910|371202|P2|COMPLETED|Overall Study||33
152933|NCT01625910|371203|P1|COMPLETED|Overall Study||32
152934|NCT01625910|371202|P2|STARTED|Overall Study||37
152935|NCT01625910|371203|P1|STARTED|Overall Study||35
152936|NCT01625845|371213|P2|NOT COMPLETED|Overall Study||3
152937|NCT01625845|371214|P1|NOT COMPLETED|Overall Study||5
152938|NCT01625845|371213|P2|COMPLETED|Overall Study||3
152939|NCT01625845|371214|P1|COMPLETED|Overall Study||5
152940|NCT01625845|371213|P2|STARTED|Overall Study||6
152941|NCT01625845|371214|P1|STARTED|Overall Study||10
152942|NCT01625689|371234|P2|NOT COMPLETED|Overall Study||1
152943|NCT01625689|371235|P1|NOT COMPLETED|Overall Study||2
152944|NCT01625689|371234|P2|COMPLETED|Overall Study||149
152945|NCT01625689|371235|P1|COMPLETED|Overall Study||148
152946|NCT01625689|371234|P2|STARTED|Overall Study||150
152947|NCT01625689|371235|P1|STARTED|Overall Study||150
152948|NCT01625507|371245|P1|NOT COMPLETED|Overall Study||10
152949|NCT01625507|371245|P1|COMPLETED|Overall Study||63
152950|NCT01625507|371245|P1|STARTED|Overall Study||73
152951|NCT01625455|371260|P2|NOT COMPLETED|Overall Study||0
152952|NCT01625455|371261|P1|NOT COMPLETED|Overall Study||0
152953|NCT01625455|371260|P2|COMPLETED|Overall Study||3
152954|NCT01625455|371261|P1|COMPLETED|Overall Study||2
152955|NCT01625455|371260|P2|STARTED|Overall Study||3
152956|NCT01625455|371261|P1|STARTED|Overall Study||2
152957|NCT01625416|371271|P2|NOT COMPLETED|Overall Study||7
152958|NCT01625416|371272|P1|NOT COMPLETED|Overall Study||9
152959|NCT01625416|371271|P2|COMPLETED|Overall Study||54
152960|NCT01625416|371272|P1|COMPLETED|Overall Study||51
152961|NCT01625416|371271|P2|STARTED|Overall Study||61
152962|NCT01625416|371272|P1|STARTED|Overall Study||60
152963|NCT01625377|371290|P2|NOT COMPLETED|Overall Study||22
152964|NCT01625377|371291|P1|NOT COMPLETED|Overall Study||7
152965|NCT01625377|371290|P2|COMPLETED|Overall Study||71
152966|NCT01625377|371291|P1|COMPLETED|Overall Study||88
152967|NCT01625377|371290|P2|Intent to Treat Population|Overall Study||90
152968|NCT01625377|371291|P1|Intent to Treat Population|Overall Study||93
152969|NCT01625377|371290|P2|Safety Set of Population|Overall Study||90
152970|NCT01625377|371291|P1|Safety Set of Population|Overall Study||94
152971|NCT01625377|371290|P2|STARTED|Overall Study||93
152972|NCT01625377|371291|P1|STARTED|Overall Study|"Started indicates randomized patients."|95
152973|NCT01625338|371324|P3|NOT COMPLETED|Overall Study||39
152974|NCT01625338|371325|P2|NOT COMPLETED|Overall Study||44
152975|NCT01625338|371326|P1|NOT COMPLETED|Overall Study||32
152976|NCT01625338|371324|P3|COMPLETED|Overall Study||181
152977|NCT01625338|371325|P2|COMPLETED|Overall Study||156
152978|NCT01625338|371326|P1|COMPLETED|Overall Study||82
152979|NCT01625338|371324|P3|STARTED|Overall Study||220
152980|NCT01625338|371325|P2|STARTED|Overall Study||200
152981|NCT01625338|371326|P1|STARTED|Overall Study||114
152982|NCT01625286|371353|P7|NOT COMPLETED|Overall Study||56
152983|NCT01625286|371354|P6|NOT COMPLETED|Overall Study||54
152984|NCT01625286|371355|P5|NOT COMPLETED|Overall Study||6
152985|NCT01625286|371356|P4|NOT COMPLETED|Overall Study||7
152986|NCT01625286|371357|P3|NOT COMPLETED|Overall Study||5
152987|NCT01625286|371358|P2|NOT COMPLETED|Overall Study||8
152988|NCT01625286|371359|P1|NOT COMPLETED|Overall Study||12
152989|NCT01625286|371353|P7|COMPLETED|Overall Study||0
152990|NCT01625286|371354|P6|COMPLETED|Overall Study||0
152991|NCT01625286|371355|P5|COMPLETED|Overall Study||0
152992|NCT01625286|371356|P4|COMPLETED|Overall Study||0
152993|NCT01625286|371357|P3|COMPLETED|Overall Study||0
152994|NCT01625286|371358|P2|COMPLETED|Overall Study||0
152995|NCT01625286|371359|P1|COMPLETED|Overall Study||0
152996|NCT01625286|371353|P7|Did Not Receive AZD5363/Placebo Trt|Overall Study||1
152997|NCT01625286|371354|P6|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
152998|NCT01625286|371355|P5|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
152999|NCT01625286|371356|P4|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
153000|NCT01625286|371357|P3|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
153001|NCT01625286|371358|P2|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
153002|NCT01625286|371359|P1|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
153003|NCT01625286|371353|P7|Received AZD5363/Placebo Treatment|Overall Study||55
153004|NCT01625286|371354|P6|Received AZD5363/Placebo Treatment|Overall Study||54
153005|NCT01625286|371355|P5|Received AZD5363/Placebo Treatment|Overall Study||6
153006|NCT01625286|371356|P4|Received AZD5363/Placebo Treatment|Overall Study||7
153007|NCT01625286|371357|P3|Received AZD5363/Placebo Treatment|Overall Study||5
153008|NCT01625286|371358|P2|Received AZD5363/Placebo Treatment|Overall Study||8
153009|NCT01625286|371359|P1|Received AZD5363/Placebo Treatment|Overall Study||12
153010|NCT01625286|371353|P7|STARTED|Overall Study||56
153011|NCT01625286|371354|P6|STARTED|Overall Study||54
153012|NCT01625286|371355|P5|STARTED|Overall Study||6
153013|NCT01625286|371356|P4|STARTED|Overall Study||7
153014|NCT01625286|371357|P3|STARTED|Overall Study||5
153015|NCT01625286|371358|P2|STARTED|Overall Study||8
153016|NCT01625286|371359|P1|STARTED|Overall Study||12
153017|NCT01625221|371438|P1|NOT COMPLETED|Overall Study||7
153018|NCT01625221|371438|P1|COMPLETED|Overall Study||28
153019|NCT01625221|371438|P1|STARTED|Overall Study||35
153020|NCT01625182|371445|P2|NOT COMPLETED|Overall Study||11
153021|NCT01625182|371446|P1|NOT COMPLETED|Overall Study||20
153022|NCT01625182|371445|P2|COMPLETED|Overall Study||41
153023|NCT01625182|371446|P1|COMPLETED|Overall Study||34
153024|NCT01625182|371445|P2|STARTED|Overall Study||52
153025|NCT01625182|371446|P1|STARTED|Overall Study||54
153026|NCT01625169|371459|P1|NOT COMPLETED|Overall Study||0
153027|NCT01625169|371459|P1|COMPLETED|Overall Study||9
153028|NCT01625169|371459|P1|STARTED|Overall Study||9
153029|NCT01625104|371474|P2|NOT COMPLETED|Overall Study||0
153030|NCT01625104|371475|P1|NOT COMPLETED|Overall Study||0
153031|NCT01625104|371474|P2|COMPLETED|Overall Study||434
153032|NCT01625104|371475|P1|COMPLETED|Overall Study||448
153033|NCT01625104|371474|P2|STARTED|Overall Study||434
153034|NCT01625104|371475|P1|STARTED|Overall Study||448
153035|NCT01625091|371483|P2|NOT COMPLETED|Post-intervention||2
153036|NCT01625091|371484|P1|NOT COMPLETED|Post-intervention||4
153037|NCT01625091|371483|P2|COMPLETED|Post-intervention||85
153038|NCT01625091|371484|P1|COMPLETED|Post-intervention||81
153039|NCT01625091|371483|P2|7 Months|Post-intervention||85
153040|NCT01625091|371484|P1|7 Months|Post-intervention||81
153041|NCT01625091|371483|P2|STARTED|Post-intervention||87
153042|NCT01625091|371484|P1|STARTED|Post-intervention||85
153043|NCT01625091|371483|P2|NOT COMPLETED|Intervention||11
153044|NCT01625091|371484|P1|NOT COMPLETED|Intervention||11
153045|NCT01625091|371483|P2|COMPLETED|Intervention||87
153046|NCT01625091|371484|P1|COMPLETED|Intervention||85
153047|NCT01625091|371483|P2|4 Months|Intervention||87
153048|NCT01625091|371484|P1|4 Months|Intervention||85
153049|NCT01625091|371483|P2|2 Months|Intervention||93
153050|NCT01625091|371484|P1|2 Months|Intervention||90
153051|NCT01625091|371483|P2|STARTED|Intervention||98
153052|NCT01625091|371484|P1|STARTED|Intervention||96
153053|NCT01624974|371498|P2|NOT COMPLETED|Period V of Treatment (4 Weeks)||0
153054|NCT01624974|371499|P1|NOT COMPLETED|Period V of Treatment (4 Weeks)||5
153055|NCT01624974|371498|P2|COMPLETED|Period V of Treatment (4 Weeks)||42
153056|NCT01624974|371499|P1|COMPLETED|Period V of Treatment (4 Weeks)||39
153057|NCT01624974|371498|P2|STARTED|Period V of Treatment (4 Weeks)||42
153058|NCT01624974|371499|P1|STARTED|Period V of Treatment (4 Weeks)||44
153059|NCT01624974|371498|P2|NOT COMPLETED|Period IV Washout (4 Weeks)||3
153060|NCT01624974|371499|P1|NOT COMPLETED|Period IV Washout (4 Weeks)||3
153061|NCT01624974|371498|P2|COMPLETED|Period IV Washout (4 Weeks)||42
153062|NCT01624974|371499|P1|COMPLETED|Period IV Washout (4 Weeks)||44
153063|NCT01624974|371498|P2|STARTED|Period IV Washout (4 Weeks)||45
153064|NCT01624974|371499|P1|STARTED|Period IV Washout (4 Weeks)||47
153065|NCT01624974|371498|P2|NOT COMPLETED|Period III of Treatment (4 Weeks)||8
153066|NCT01624974|371499|P1|NOT COMPLETED|Period III of Treatment (4 Weeks)||7
153067|NCT01624974|371498|P2|COMPLETED|Period III of Treatment (4 Weeks)||45
153068|NCT01624974|371499|P1|COMPLETED|Period III of Treatment (4 Weeks)||47
153069|NCT01624974|371498|P2|STARTED|Period III of Treatment (4 Weeks)||53
153070|NCT01624974|371499|P1|STARTED|Period III of Treatment (4 Weeks)||54
153071|NCT01624948|371523|P2|NOT COMPLETED|Overall Study||0
153072|NCT01624948|371524|P1|NOT COMPLETED|Overall Study||0
153073|NCT01624948|371523|P2|COMPLETED|Overall Study||20
153074|NCT01624948|371524|P1|COMPLETED|Overall Study||20
153075|NCT01624948|371523|P2|STARTED|Overall Study||20
153076|NCT01624948|371524|P1|STARTED|Overall Study||20
153077|NCT01624870|371540|P1|NOT COMPLETED|Overall Study||27
153078|NCT01624870|371540|P1|COMPLETED|Overall Study|Completed 6 month follow up|173
153079|NCT01624870|371540|P1|STARTED|Overall Study|provided informed consent|200
153080|NCT01624740|371548|P2|NOT COMPLETED|Second Intervention (3-4 Days)||0
153081|NCT01624740|371549|P1|NOT COMPLETED|Second Intervention (3-4 Days)||1
153082|NCT01624740|371548|P2|COMPLETED|Second Intervention (3-4 Days)||9
153083|NCT01624740|371549|P1|COMPLETED|Second Intervention (3-4 Days)||8
153084|NCT01624740|371548|P2|STARTED|Second Intervention (3-4 Days)||9
153085|NCT01624740|371549|P1|STARTED|Second Intervention (3-4 Days)||9
153086|NCT01624740|371548|P2|NOT COMPLETED|Washout (1 Hour)||0
153087|NCT01624740|371549|P1|NOT COMPLETED|Washout (1 Hour)||0
153088|NCT01624740|371548|P2|COMPLETED|Washout (1 Hour)||9
153089|NCT01624740|371549|P1|COMPLETED|Washout (1 Hour)||9
153090|NCT01624740|371548|P2|STARTED|Washout (1 Hour)||9
153091|NCT01624740|371549|P1|STARTED|Washout (1 Hour)||9
153092|NCT01624740|371548|P2|NOT COMPLETED|First Intervention (3-4 Days)||0
153093|NCT01624740|371549|P1|NOT COMPLETED|First Intervention (3-4 Days)||0
153094|NCT01624740|371548|P2|COMPLETED|First Intervention (3-4 Days)||9
153095|NCT01624740|371549|P1|COMPLETED|First Intervention (3-4 Days)||9
153096|NCT01624740|371548|P2|STARTED|First Intervention (3-4 Days)||9
153097|NCT01624740|371549|P1|STARTED|First Intervention (3-4 Days)||9
153098|NCT01624662|371560|P4|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
153099|NCT01624662|371561|P3|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
153100|NCT01624662|371562|P2|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
153101|NCT01624662|371563|P1|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
153102|NCT01624662|371560|P4|COMPLETED|Open-Label Extension Phase (Wks 17-24)||78
153103|NCT01624662|371561|P3|COMPLETED|Open-Label Extension Phase (Wks 17-24)||71
153104|NCT01624662|371562|P2|COMPLETED|Open-Label Extension Phase (Wks 17-24)||76
153105|NCT01624662|371563|P1|COMPLETED|Open-Label Extension Phase (Wks 17-24)||69
153106|NCT01624662|371560|P4|STARTED|Open-Label Extension Phase (Wks 17-24)||79
153107|NCT01624662|371561|P3|STARTED|Open-Label Extension Phase (Wks 17-24)||72
153108|NCT01624662|371562|P2|STARTED|Open-Label Extension Phase (Wks 17-24)||78
153109|NCT01624662|371563|P1|STARTED|Open-Label Extension Phase (Wks 17-24)||70
153110|NCT01624662|371560|P4|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||0
153111|NCT01624662|371561|P3|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4
153112|NCT01624662|371562|P2|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||3
153113|NCT01624662|371563|P1|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||10
153114|NCT01624662|371560|P4|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||82
153115|NCT01624662|371561|P3|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76
153116|NCT01624662|371562|P2|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||78
153117|NCT01624662|371563|P1|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70
153118|NCT01624662|371560|P4|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82
153119|NCT01624662|371561|P3|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
153120|NCT01624662|371562|P2|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81
153121|NCT01624662|371563|P1|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
153122|NCT01624467|371634|P1|NOT COMPLETED|Overall Study||31
153123|NCT01624467|371634|P1|COMPLETED|Overall Study||44
153124|NCT01624467|371634|P1|Received at Least One Dose of Study Drug|Overall Study||75
153125|NCT01624467|371634|P1|STARTED|Overall Study||75
153126|NCT01624363|371647|P1|NOT COMPLETED|Overall Study||0
153127|NCT01624363|371647|P1|COMPLETED|Overall Study||341
153128|NCT01624363|371647|P1|STARTED|Overall Study||341
153129|NCT01624350|371651|P1|NOT COMPLETED|Overall Study||25
153130|NCT01624350|371651|P1|COMPLETED|Overall Study||75
153131|NCT01624350|371651|P1|STARTED|Overall Study||100
153132|NCT01624259|371673|P2|NOT COMPLETED|Overall Study||31
153133|NCT01624259|371674|P1|NOT COMPLETED|Overall Study||30
153134|NCT01624259|371673|P2|COMPLETED|Overall Study|Completed the study on study treatment|269
153135|NCT01624259|371674|P1|COMPLETED|Overall Study|Completed the study on study treatment|269
153136|NCT01624259|371673|P2|Received at Least One Dose of Study Drug|Overall Study||300
153137|NCT01624259|371674|P1|Received at Least One Dose of Study Drug|Overall Study||299
153138|NCT01624259|371673|P2|STARTED|Overall Study||300
153139|NCT01624259|371674|P1|STARTED|Overall Study||299
153140|NCT01624233|371723|P1|NOT COMPLETED|Period 6: Follow-up||9
153141|NCT01624233|371723|P1|COMPLETED|Period 6: Follow-up||79
153142|NCT01624233|371723|P1|STARTED|Period 6: Follow-up|Period 6 included participants received a dose of drug and exhibited the required neutrophil count.|88
153143|NCT01624233|371723|P1|NOT COMPLETED|Period 5 - Retreatment Period||10
153144|NCT01624233|371723|P1|COMPLETED|Period 5 - Retreatment Period||70
153145|NCT01624233|371723|P1|STARTED|Period 5 - Retreatment Period|Period 5 included (participants with erythrodermic Ps or pustular Ps) or Period 4 completers.|80
153146|NCT01624233|371723|P1|NOT COMPLETED|Period 4 - Drug Free Period||61
153147|NCT01624233|371723|P1|COMPLETED|Period 4 - Drug Free Period||9
153148|NCT01624233|371723|P1|Physician Decision|Period 4 - Drug Free Period|1 participant who discontinued due to physician decision is included in the participants relapsed.|1
153149|NCT01624233|371723|P1|Adverse Event|Period 4 - Drug Free Period|1 participant who discontinued due to adverse event is included in the participants who relapsed.|1
153150|NCT01624233|371723|P1|STARTED|Period 4 - Drug Free Period|Only responders in participants with plaque Ps moved to the Drug Free Period 4.|70
153151|NCT01624233|371723|P1|NOT COMPLETED|Period 3 - Maintenance||7
153152|NCT01624233|371723|P1|COMPLETED|Period 3 - Maintenance||83
153153|NCT01624233|371723|P1|Received at Least 1 Dose of Study Drug|Period 3 - Maintenance||90
153154|NCT01624233|371723|P1|STARTED|Period 3 - Maintenance||90
153155|NCT01624233|371723|P1|NOT COMPLETED|Period 2 - Induction||1
153156|NCT01624233|371723|P1|COMPLETED|Period 2 - Induction||90
153157|NCT01624233|371723|P1|Plaque Ps|Period 2 - Induction||78
153158|NCT01624233|371723|P1|Pustular Ps|Period 2 - Induction||5
153159|NCT01624233|371723|P1|Erythrodermic Psoriasis (Ps)|Period 2 - Induction||8
153160|NCT01624233|371723|P1|Received at Least 1 Dose of Study Drug|Period 2 - Induction||91
153161|NCT01624233|371723|P1|STARTED|Period 2 - Induction||91
153162|NCT01624194|371755|P2|NOT COMPLETED|Overall Study||0
153163|NCT01624194|371756|P1|NOT COMPLETED|Overall Study||2
153164|NCT01624194|371755|P2|COMPLETED|Overall Study||18
153165|NCT01624194|371756|P1|COMPLETED|Overall Study||14
153166|NCT01624194|371755|P2|STARTED|Overall Study||18
153167|NCT01624194|371756|P1|STARTED|Overall Study||16
153168|NCT01624168|371797|P3|NOT COMPLETED|Overall Study||6
153169|NCT01624168|371798|P2|NOT COMPLETED|Overall Study||12
153170|NCT01624168|371799|P1|NOT COMPLETED|Overall Study||4
153171|NCT01624168|371797|P3|COMPLETED|Overall Study||22
153172|NCT01624168|371798|P2|COMPLETED|Overall Study||16
153173|NCT01624168|371799|P1|COMPLETED|Overall Study||15
153174|NCT01624168|371797|P3|STARTED|Overall Study||28
153175|NCT01624168|371798|P2|STARTED|Overall Study||28
153176|NCT01624168|371799|P1|STARTED|Overall Study||19
153177|NCT01624142|371824|P2|NOT COMPLETED|Overall Study||16
153178|NCT01624142|371825|P1|NOT COMPLETED|Overall Study||32
153179|NCT01624142|371824|P2|COMPLETED|Overall Study||178
153180|NCT01624142|371825|P1|COMPLETED|Overall Study||74
153181|NCT01624142|371824|P2|STARTED|Overall Study||194
153182|NCT01624142|371825|P1|STARTED|Overall Study||106
153183|NCT01623869|371846|P1|NOT COMPLETED|Overall Study||0
153184|NCT01623869|371846|P1|COMPLETED|Overall Study||16
153185|NCT01623869|371846|P1|STARTED|Overall Study||16
153186|NCT01623830|371854|P2|NOT COMPLETED|Overall Study||9
153187|NCT01623830|371855|P1|NOT COMPLETED|Overall Study||7
153188|NCT01623830|371854|P2|COMPLETED|Overall Study||35
153189|NCT01623830|371855|P1|COMPLETED|Overall Study||38
153190|NCT01623830|371854|P2|STARTED|Overall Study||44
153191|NCT01623830|371855|P1|STARTED|Overall Study||45
153192|NCT01623752|371872|P3|NOT COMPLETED|Phase 2 (78 Weeks)||0
153193|NCT01623752|371873|P2|NOT COMPLETED|Phase 2 (78 Weeks)||18
153194|NCT01623752|371874|P1|NOT COMPLETED|Phase 2 (78 Weeks)||66
153195|NCT01623752|371872|P3|COMPLETED|Phase 2 (78 Weeks)||0
153196|NCT01623752|371873|P2|COMPLETED|Phase 2 (78 Weeks)||98
153197|NCT01623752|371874|P1|COMPLETED|Phase 2 (78 Weeks)||225
153198|NCT01623752|371872|P3|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|0
153199|NCT01623752|371873|P2|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|116
153200|NCT01623752|371874|P1|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|291
153201|NCT01623752|371872|P3|NOT COMPLETED|Phase 1 (78 Weeks)||2
153202|NCT01623752|371873|P2|NOT COMPLETED|Phase 1 (78 Weeks)||207
153203|NCT01623752|371874|P1|NOT COMPLETED|Phase 1 (78 Weeks)||631
153204|NCT01623752|371872|P3|COMPLETED|Phase 1 (78 Weeks)||1
153205|NCT01623752|371873|P2|COMPLETED|Phase 1 (78 Weeks)||233
153206|NCT01623752|371874|P1|COMPLETED|Phase 1 (78 Weeks)||747
153207|NCT01623752|371872|P3|STARTED|Phase 1 (78 Weeks)||3
153208|NCT01623752|371873|P2|STARTED|Phase 1 (78 Weeks)||440
153209|NCT01623752|371874|P1|STARTED|Phase 1 (78 Weeks)||1378
153210|NCT01623739|371959|P2|NOT COMPLETED|Overall Study||4
153211|NCT01623739|371960|P1|NOT COMPLETED|Overall Study||2
153212|NCT01623739|371959|P2|COMPLETED|Overall Study||15
153213|NCT01623739|371960|P1|COMPLETED|Overall Study||17
153214|NCT01623739|371959|P2|STARTED|Overall Study||19
153215|NCT01623739|371960|P1|STARTED|Overall Study||19
153216|NCT01623596|371977|P2|NOT COMPLETED|Overall Study||100
153217|NCT01623596|371978|P1|NOT COMPLETED|Overall Study||62
153218|NCT01623596|371977|P2|COMPLETED|Overall Study||339
153219|NCT01623596|371978|P1|COMPLETED|Overall Study||374
153220|NCT01623596|371977|P2|On Switched Treatment|Overall Study||214
153221|NCT01623596|371978|P1|On Switched Treatment|Overall Study||22
153222|NCT01623596|371977|P2|On Randomized Treatment|Overall Study||125
153223|NCT01623596|371978|P1|On Randomized Treatment|Overall Study||352
153224|NCT01623596|371977|P2|STARTED|Overall Study||439
153225|NCT01623596|371978|P1|STARTED|Overall Study||436
153226|NCT01623479|371994|P1|NOT COMPLETED|Overall Study||0
153227|NCT01623479|371994|P1|COMPLETED|Overall Study||585
153228|NCT01623479|371994|P1|STARTED|Overall Study||585
153229|NCT01623466|372002|P2|NOT COMPLETED|Overall Study||0
153230|NCT01623466|372003|P1|NOT COMPLETED|Overall Study||1
153231|NCT01623466|372002|P2|COMPLETED|Overall Study||18
153232|NCT01623466|372003|P1|COMPLETED|Overall Study||17
153233|NCT01623466|372002|P2|STARTED|Overall Study||18
153234|NCT01623466|372003|P1|STARTED|Overall Study||18
153235|NCT01623323|372017|P1|NOT COMPLETED|Overall Study||104
153236|NCT01623323|372017|P1|COMPLETED|Overall Study||601
153237|NCT01623323|372017|P1|STARTED|Overall Study||705
153238|NCT01623310|372021|P1|NOT COMPLETED|Overall Study||79
153239|NCT01623310|372021|P1|COMPLETED|Overall Study||144
153240|NCT01623310|372021|P1|STARTED|Overall Study||223
153241|NCT01623271|372030|P1|NOT COMPLETED|Overall Study||2
153242|NCT01623271|372030|P1|COMPLETED|Overall Study||3
153243|NCT01623271|372030|P1|STARTED|Overall Study||5
153244|NCT01623154|372034|P1|NOT COMPLETED|Overall Study||4
153245|NCT01623154|372034|P1|COMPLETED|Overall Study||95
153246|NCT01623154|372034|P1|Available for Analysis|Overall Study||95
153247|NCT01623154|372034|P1|STARTED|Overall Study||99
153248|NCT01623115|372042|P2|NOT COMPLETED|Overall Study||77
153249|NCT01623115|372043|P1|NOT COMPLETED|Overall Study||33
153250|NCT01623115|372042|P2|COMPLETED|Overall Study||246
153251|NCT01623115|372043|P1|COMPLETED|Overall Study||130
153252|NCT01623115|372042|P2|Treated|Overall Study||322
153253|NCT01623115|372043|P1|Treated|Overall Study||163
153254|NCT01623115|372042|P2|STARTED|Overall Study|Randomized|323
153255|NCT01623115|372043|P1|STARTED|Overall Study|Randomized|163
153256|NCT01623050|372103|P1|NOT COMPLETED|Overall Study||9
153257|NCT01623050|372103|P1|COMPLETED|Overall Study||27
153258|NCT01623050|372103|P1|Treated|Overall Study||34
153259|NCT01623050|372103|P1|STARTED|Overall Study||36
153260|NCT01622673|372117|P6|NOT COMPLETED|Treatment Period 5||0
153261|NCT01622673|372118|P5|NOT COMPLETED|Treatment Period 5||0
153262|NCT01622673|372119|P4|NOT COMPLETED|Treatment Period 5||0
153263|NCT01622673|372120|P3|NOT COMPLETED|Treatment Period 5||0
153264|NCT01622673|372121|P2|NOT COMPLETED|Treatment Period 5||0
153265|NCT01622673|372122|P1|NOT COMPLETED|Treatment Period 5||0
153266|NCT01622673|372117|P6|COMPLETED|Treatment Period 5||4
153267|NCT01622673|372118|P5|COMPLETED|Treatment Period 5||4
153268|NCT01622673|372119|P4|COMPLETED|Treatment Period 5||4
153269|NCT01622673|372120|P3|COMPLETED|Treatment Period 5||4
153270|NCT01622673|372121|P2|COMPLETED|Treatment Period 5||3
153271|NCT01622673|372122|P1|COMPLETED|Treatment Period 5||4
153272|NCT01622673|372117|P6|STARTED|Treatment Period 5||4
153273|NCT01622673|372118|P5|STARTED|Treatment Period 5||4
153274|NCT01622673|372119|P4|STARTED|Treatment Period 5||4
153275|NCT01622673|372120|P3|STARTED|Treatment Period 5||4
153276|NCT01622673|372121|P2|STARTED|Treatment Period 5||3
153277|NCT01622673|372122|P1|STARTED|Treatment Period 5||4
153278|NCT01622673|372117|P6|NOT COMPLETED|Treatment Period 4||0
153279|NCT01622673|372118|P5|NOT COMPLETED|Treatment Period 4||0
153280|NCT01622673|372119|P4|NOT COMPLETED|Treatment Period 4||0
153281|NCT01622673|372120|P3|NOT COMPLETED|Treatment Period 4||0
153282|NCT01622673|372121|P2|NOT COMPLETED|Treatment Period 4||0
153283|NCT01622673|372122|P1|NOT COMPLETED|Treatment Period 4||0
153284|NCT01622673|372117|P6|COMPLETED|Treatment Period 4||4
153285|NCT01622673|372118|P5|COMPLETED|Treatment Period 4||4
153286|NCT01622673|372119|P4|COMPLETED|Treatment Period 4||4
153287|NCT01622673|372120|P3|COMPLETED|Treatment Period 4||4
153288|NCT01622673|372121|P2|COMPLETED|Treatment Period 4||3
153289|NCT01622673|372122|P1|COMPLETED|Treatment Period 4||4
153290|NCT01622673|372117|P6|STARTED|Treatment Period 4||4
153291|NCT01622673|372118|P5|STARTED|Treatment Period 4||4
153292|NCT01622673|372119|P4|STARTED|Treatment Period 4||4
153293|NCT01622673|372120|P3|STARTED|Treatment Period 4||4
153294|NCT01622673|372121|P2|STARTED|Treatment Period 4||3
153295|NCT01622673|372122|P1|STARTED|Treatment Period 4||4
153296|NCT01622673|372117|P6|NOT COMPLETED|Treatment Period 3||0
153297|NCT01622673|372118|P5|NOT COMPLETED|Treatment Period 3||0
153298|NCT01622673|372119|P4|NOT COMPLETED|Treatment Period 3||0
153299|NCT01622673|372120|P3|NOT COMPLETED|Treatment Period 3||0
153300|NCT01622673|372121|P2|NOT COMPLETED|Treatment Period 3||1
153301|NCT01622673|372122|P1|NOT COMPLETED|Treatment Period 3||0
153302|NCT01622673|372117|P6|COMPLETED|Treatment Period 3||4
153303|NCT01622673|372118|P5|COMPLETED|Treatment Period 3||4
153304|NCT01622673|372119|P4|COMPLETED|Treatment Period 3||4
153305|NCT01622673|372120|P3|COMPLETED|Treatment Period 3||4
153306|NCT01622673|372121|P2|COMPLETED|Treatment Period 3||3
153307|NCT01622673|372122|P1|COMPLETED|Treatment Period 3||4
153308|NCT01622673|372117|P6|STARTED|Treatment Period 3||4
153309|NCT01622673|372118|P5|STARTED|Treatment Period 3||4
153310|NCT01622673|372119|P4|STARTED|Treatment Period 3||4
153311|NCT01622673|372120|P3|STARTED|Treatment Period 3||4
153312|NCT01622673|372121|P2|STARTED|Treatment Period 3||4
153313|NCT01622673|372122|P1|STARTED|Treatment Period 3||4
153314|NCT01622673|372117|P6|NOT COMPLETED|Treatment Period 2||0
153315|NCT01622673|372118|P5|NOT COMPLETED|Treatment Period 2||0
153316|NCT01622673|372119|P4|NOT COMPLETED|Treatment Period 2||1
153317|NCT01622673|372120|P3|NOT COMPLETED|Treatment Period 2||0
153318|NCT01622673|372121|P2|NOT COMPLETED|Treatment Period 2||0
153319|NCT01622673|372122|P1|NOT COMPLETED|Treatment Period 2||0
153320|NCT01622673|372117|P6|COMPLETED|Treatment Period 2||4
153321|NCT01622673|372118|P5|COMPLETED|Treatment Period 2||4
153322|NCT01622673|372119|P4|COMPLETED|Treatment Period 2||4
153323|NCT01622673|372120|P3|COMPLETED|Treatment Period 2||4
153324|NCT01622673|372121|P2|COMPLETED|Treatment Period 2||4
153325|NCT01622673|372122|P1|COMPLETED|Treatment Period 2||4
153326|NCT01622673|372117|P6|STARTED|Treatment Period 2||4
153327|NCT01622673|372118|P5|STARTED|Treatment Period 2||4
153328|NCT01622673|372119|P4|STARTED|Treatment Period 2||5
153329|NCT01622673|372120|P3|STARTED|Treatment Period 2||4
153330|NCT01622673|372121|P2|STARTED|Treatment Period 2||4
153331|NCT01622673|372122|P1|STARTED|Treatment Period 2||4
153332|NCT01622673|372117|P6|NOT COMPLETED|Treatment Period 1||0
153333|NCT01622673|372118|P5|NOT COMPLETED|Treatment Period 1||0
153334|NCT01622673|372119|P4|NOT COMPLETED|Treatment Period 1||1
153335|NCT01622673|372120|P3|NOT COMPLETED|Treatment Period 1||0
153336|NCT01622673|372121|P2|NOT COMPLETED|Treatment Period 1||1
153337|NCT01622673|372122|P1|NOT COMPLETED|Treatment Period 1||0
153338|NCT01622673|372117|P6|COMPLETED|Treatment Period 1||4
153339|NCT01622673|372118|P5|COMPLETED|Treatment Period 1||4
153340|NCT01622673|372119|P4|COMPLETED|Treatment Period 1||5
153341|NCT01622673|372120|P3|COMPLETED|Treatment Period 1||4
153342|NCT01622673|372121|P2|COMPLETED|Treatment Period 1||4
153343|NCT01622673|372122|P1|COMPLETED|Treatment Period 1||4
153344|NCT01622673|372117|P6|STARTED|Treatment Period 1||4
153345|NCT01622673|372118|P5|STARTED|Treatment Period 1||4
153346|NCT01622673|372119|P4|STARTED|Treatment Period 1||6
153347|NCT01622673|372120|P3|STARTED|Treatment Period 1||4
153348|NCT01622673|372121|P2|STARTED|Treatment Period 1||5
153349|NCT01622673|372122|P1|STARTED|Treatment Period 1||4
153350|NCT01622660|372157|P1|NOT COMPLETED|Overall Study||1
153351|NCT01622660|372157|P1|COMPLETED|Overall Study||1
153352|NCT01622660|372157|P1|STARTED|Overall Study||2
153353|NCT01622569|372165|P4|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
153354|NCT01622569|372166|P3|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||3
153355|NCT01622569|372167|P2|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
153356|NCT01622569|372168|P1|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
153357|NCT01622569|372165|P4|COMPLETED|Open-Label Extension Phase (Wks 17-24)||73
153358|NCT01622569|372166|P3|COMPLETED|Open-Label Extension Phase (Wks 17-24)||64
153359|NCT01622569|372167|P2|COMPLETED|Open-Label Extension Phase (Wks 17-24)||70
153360|NCT01622569|372168|P1|COMPLETED|Open-Label Extension Phase (Wks 17-24)||67
153361|NCT01622569|372165|P4|STARTED|Open-Label Extension Phase (Wks 17-24)||75
153362|NCT01622569|372166|P3|STARTED|Open-Label Extension Phase (Wks 17-24)||67
153363|NCT01622569|372167|P2|STARTED|Open-Label Extension Phase (Wks 17-24)||72
153364|NCT01622569|372168|P1|STARTED|Open-Label Extension Phase (Wks 17-24)||68
153365|NCT01622569|372165|P4|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4
153366|NCT01622569|372166|P3|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||9
153367|NCT01622569|372167|P2|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||6
153368|NCT01622569|372168|P1|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||12
153369|NCT01622569|372165|P4|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76
153370|NCT01622569|372166|P3|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||71
153371|NCT01622569|372167|P2|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||75
153372|NCT01622569|372168|P1|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70
153373|NCT01622569|372165|P4|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
153374|NCT01622569|372166|P3|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
153375|NCT01622569|372167|P2|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81
153376|NCT01622569|372168|P1|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82
153377|NCT01622348|372238|P3|NOT COMPLETED|Overall Study||1
153378|NCT01622348|372239|P2|NOT COMPLETED|Overall Study||0
153379|NCT01622348|372240|P1|NOT COMPLETED|Overall Study||1
153380|NCT01622348|372238|P3|COMPLETED|Overall Study||14
153381|NCT01622348|372239|P2|COMPLETED|Overall Study||14
153382|NCT01622348|372240|P1|COMPLETED|Overall Study||14
153383|NCT01622348|372238|P3|STARTED|Overall Study||15
153384|NCT01622348|372239|P2|STARTED|Overall Study||14
153385|NCT01622348|372240|P1|STARTED|Overall Study||15
153386|NCT01622296|372248|P2|NOT COMPLETED|Second Intervention||0
153387|NCT01622296|372249|P1|NOT COMPLETED|Second Intervention||0
153388|NCT01622296|372248|P2|COMPLETED|Second Intervention||10
153389|NCT01622296|372249|P1|COMPLETED|Second Intervention||10
153390|NCT01622296|372248|P2|STARTED|Second Intervention||10
153391|NCT01622296|372249|P1|STARTED|Second Intervention||10
153392|NCT01622296|372248|P2|NOT COMPLETED|Washout Period of at Least 1 Week||0
153393|NCT01622296|372249|P1|NOT COMPLETED|Washout Period of at Least 1 Week||0
153394|NCT01622296|372248|P2|COMPLETED|Washout Period of at Least 1 Week||10
153395|NCT01622296|372249|P1|COMPLETED|Washout Period of at Least 1 Week||10
153396|NCT01622296|372248|P2|STARTED|Washout Period of at Least 1 Week||10
153397|NCT01622296|372249|P1|STARTED|Washout Period of at Least 1 Week||10
153398|NCT01622296|372248|P2|NOT COMPLETED|First Intervention||0
153399|NCT01622296|372249|P1|NOT COMPLETED|First Intervention||0
153400|NCT01622296|372248|P2|COMPLETED|First Intervention||10
153401|NCT01622296|372249|P1|COMPLETED|First Intervention||10
153402|NCT01622296|372248|P2|STARTED|First Intervention||10
153403|NCT01622296|372249|P1|STARTED|First Intervention||10
153404|NCT01622257|372257|P3|NOT COMPLETED|Overall Study||0
153405|NCT01622257|372258|P2|NOT COMPLETED|Overall Study||0
153406|NCT01622257|372259|P1|NOT COMPLETED|Overall Study||0
153407|NCT01622257|372257|P3|COMPLETED|Overall Study||66
153408|NCT01622257|372258|P2|COMPLETED|Overall Study||66
153409|NCT01622257|372259|P1|COMPLETED|Overall Study||66
153410|NCT01622257|372257|P3|STARTED|Overall Study||66
153411|NCT01622257|372258|P2|STARTED|Overall Study||66
153412|NCT01622257|372259|P1|STARTED|Overall Study||66
153413|NCT01622231|372279|P1|NOT COMPLETED|Overall Study||2
153414|NCT01622231|372279|P1|COMPLETED|Overall Study||59
153415|NCT01622231|372279|P1|STARTED|Overall Study||61
153416|NCT01621880|372309|P2|NOT COMPLETED|Overall Study||5
153417|NCT01621880|372310|P1|NOT COMPLETED|Overall Study||10
153418|NCT01621880|372309|P2|COMPLETED|Overall Study||49
153419|NCT01621880|372310|P1|COMPLETED|Overall Study||48
153420|NCT01621880|372309|P2|STARTED|Overall Study||54
153421|NCT01621880|372310|P1|STARTED|Overall Study||58
153422|NCT01621802|372324|P6|NOT COMPLETED|Overall Study||12
153423|NCT01621802|372325|P5|NOT COMPLETED|Overall Study||35
153424|NCT01621802|372326|P4|NOT COMPLETED|Overall Study||11
153425|NCT01621802|372327|P3|NOT COMPLETED|Overall Study||33
153426|NCT01621802|372328|P2|NOT COMPLETED|Overall Study||23
153427|NCT01621802|372329|P1|NOT COMPLETED|Overall Study||47
153428|NCT01621802|372324|P6|COMPLETED|Overall Study||477
153429|NCT01621802|372325|P5|COMPLETED|Overall Study||1284
153430|NCT01621802|372326|P4|COMPLETED|Overall Study||292
153431|NCT01621802|372327|P3|COMPLETED|Overall Study||763
153432|NCT01621802|372328|P2|COMPLETED|Overall Study||275
153433|NCT01621802|372329|P1|COMPLETED|Overall Study||755
153434|NCT01621802|372324|P6|STARTED|Overall Study||489
153435|NCT01621802|372325|P5|STARTED|Overall Study||1319
153436|NCT01621802|372326|P4|STARTED|Overall Study||303
153437|NCT01621802|372327|P3|STARTED|Overall Study||796
153438|NCT01621802|372328|P2|STARTED|Overall Study||298
153439|NCT01621802|372329|P1|STARTED|Overall Study||802
153440|NCT01621776|372436|P3|NOT COMPLETED|Overall Study||0
153441|NCT01621776|372437|P2|NOT COMPLETED|Overall Study||0
153442|NCT01621776|372438|P1|NOT COMPLETED|Overall Study||0
153443|NCT01621776|372436|P3|COMPLETED|Overall Study||18
153444|NCT01621776|372437|P2|COMPLETED|Overall Study||40
153445|NCT01621776|372438|P1|COMPLETED|Overall Study||41
153446|NCT01621776|372436|P3|STARTED|Overall Study||18
153447|NCT01621776|372437|P2|STARTED|Overall Study||40
153448|NCT01621776|372438|P1|STARTED|Overall Study||41
153449|NCT01621737|372452|P1|NOT COMPLETED|Overall Study||0
153450|NCT01621737|372452|P1|COMPLETED|Overall Study||0
153451|NCT01621737|372452|P1|STARTED|Overall Study||0
153452|NCT01621672|372472|P2|NOT COMPLETED|Overall Study||0
153453|NCT01621672|372473|P1|NOT COMPLETED|Overall Study||0
153454|NCT01621672|372472|P2|COMPLETED|Overall Study||17
153455|NCT01621672|372473|P1|COMPLETED|Overall Study||25
153456|NCT01621672|372472|P2|STARTED|Overall Study||17
153457|NCT01621672|372473|P1|STARTED|Overall Study||25
153458|NCT01621633|372483|P4|NOT COMPLETED|Overall Study||0
153459|NCT01621633|372484|P3|NOT COMPLETED|Overall Study||0
153460|NCT01621633|372485|P2|NOT COMPLETED|Overall Study||0
153461|NCT01621633|372486|P1|NOT COMPLETED|Overall Study||0
153462|NCT01621633|372483|P4|COMPLETED|Overall Study||8
153463|NCT01621633|372484|P3|COMPLETED|Overall Study||8
153464|NCT01621633|372485|P2|COMPLETED|Overall Study||8
153465|NCT01621633|372486|P1|COMPLETED|Overall Study||8
153466|NCT01621633|372483|P4|STARTED|Overall Study||8
153467|NCT01621633|372484|P3|STARTED|Overall Study||8
153468|NCT01621633|372485|P2|STARTED|Overall Study||8
153469|NCT01621633|372486|P1|STARTED|Overall Study||8
153470|NCT01621542|372514|P6|NOT COMPLETED|Overall Study||9
153471|NCT01621542|372515|P5|NOT COMPLETED|Overall Study||9
153472|NCT01621542|372516|P4|NOT COMPLETED|Overall Study||28
153473|NCT01621542|372517|P3|NOT COMPLETED|Overall Study||6
153474|NCT01621542|372518|P2|NOT COMPLETED|Overall Study||5
153475|NCT01621542|372519|P1|NOT COMPLETED|Overall Study||5
153476|NCT01621542|372514|P6|COMPLETED|Overall Study||0
153477|NCT01621542|372515|P5|COMPLETED|Overall Study||0
153478|NCT01621542|372516|P4|COMPLETED|Overall Study||0
153479|NCT01621542|372517|P3|COMPLETED|Overall Study||0
153480|NCT01621542|372518|P2|COMPLETED|Overall Study||0
153481|NCT01621542|372519|P1|COMPLETED|Overall Study||0
153482|NCT01621542|372514|P6|STARTED|Overall Study||9
153483|NCT01621542|372515|P5|STARTED|Overall Study||9
153484|NCT01621542|372516|P4|STARTED|Overall Study||28
153485|NCT01621542|372517|P3|STARTED|Overall Study||6
153486|NCT01621542|372518|P2|STARTED|Overall Study||5
153487|NCT01621542|372519|P1|STARTED|Overall Study||5
153488|NCT01621477|372551|P1|NOT COMPLETED|Overall Study||0
153489|NCT01621477|372551|P1|COMPLETED|Overall Study||17
153490|NCT01621477|372551|P1|STARTED|Overall Study||17
153491|NCT01621191|372561|P1|NOT COMPLETED|Overall Study||25
153492|NCT01621191|372561|P1|COMPLETED|Overall Study||124
153493|NCT01621191|372561|P1|Had at Least 1 Post-Baseline Observation|Overall Study||148
153494|NCT01621191|372561|P1|Received at Least 1 Dose of Study Drug|Overall Study||149
153495|NCT01621191|372561|P1|STARTED|Overall Study||149
153496|NCT01621178|372575|P3|NOT COMPLETED|Overall Study||36
153497|NCT01621178|372576|P2|NOT COMPLETED|Overall Study||30
153498|NCT01621178|372577|P1|NOT COMPLETED|Overall Study||31
153499|NCT01621178|372575|P3|COMPLETED|Overall Study||157
153500|NCT01621178|372576|P2|COMPLETED|Overall Study||160
153501|NCT01621178|372577|P1|COMPLETED|Overall Study||163
153502|NCT01621178|372575|P3|Modified Intent to Treat Population|Overall Study||183
153503|NCT01621178|372576|P2|Modified Intent to Treat Population|Overall Study||180
153504|NCT01621178|372577|P1|Modified Intent to Treat Population|Overall Study||186
153505|NCT01621178|372575|P3|Received at Least One Dose of Study Drug|Overall Study||192
153506|NCT01621178|372576|P2|Received at Least One Dose of Study Drug|Overall Study||190
153507|NCT01621178|372577|P1|Received at Least One Dose of Study Drug|Overall Study||194
153508|NCT01621178|372575|P3|STARTED|Overall Study||193
153509|NCT01621178|372576|P2|STARTED|Overall Study||190
153510|NCT01621178|372577|P1|STARTED|Overall Study||194
153511|NCT01621126|372669|P1|NOT COMPLETED|Overall Study||6
153512|NCT01621126|372669|P1|COMPLETED|Overall Study||34
153513|NCT01621126|372669|P1|STARTED|Overall Study||40
153514|NCT01621009|372677|P4|NOT COMPLETED|Overall Study||53
153515|NCT01621009|372678|P3|NOT COMPLETED|Overall Study||63
153516|NCT01621009|372679|P2|NOT COMPLETED|Overall Study||51
153517|NCT01621009|372680|P1|NOT COMPLETED|Overall Study||43
153518|NCT01621009|372677|P4|COMPLETED|Overall Study||60
153519|NCT01621009|372678|P3|COMPLETED|Overall Study||58
153520|NCT01621009|372679|P2|COMPLETED|Overall Study||65
153521|NCT01621009|372680|P1|COMPLETED|Overall Study||70
153522|NCT01621009|372677|P4|STARTED|Overall Study||113
153523|NCT01621009|372678|P3|STARTED|Overall Study||121
153524|NCT01621009|372679|P2|STARTED|Overall Study||116
153525|NCT01621009|372680|P1|STARTED|Overall Study||113
153526|NCT01620983|372691|P3|NOT COMPLETED|Overall Study||15
153527|NCT01620983|372692|P2|NOT COMPLETED|Overall Study||22
153528|NCT01620983|372693|P1|NOT COMPLETED|Overall Study||19
153529|NCT01620983|372691|P3|COMPLETED|Overall Study||122
153530|NCT01620983|372692|P2|COMPLETED|Overall Study||113
153531|NCT01620983|372693|P1|COMPLETED|Overall Study||111
153532|NCT01620983|372691|P3|STARTED|Overall Study||137
153533|NCT01620983|372692|P2|STARTED|Overall Study||135
153534|NCT01620983|372693|P1|STARTED|Overall Study||130
153535|NCT01620762|372722|P3|NOT COMPLETED|Overall Study||53
153536|NCT01620762|372723|P2|NOT COMPLETED|Overall Study||58
153537|NCT01620762|372724|P1|NOT COMPLETED|Overall Study||48
153538|NCT01620762|372722|P3|COMPLETED|Overall Study||417
153539|NCT01620762|372723|P2|COMPLETED|Overall Study||412
153540|NCT01620762|372724|P1|COMPLETED|Overall Study||420
153541|NCT01620762|372722|P3|STARTED|Overall Study||470
153542|NCT01620762|372723|P2|STARTED|Overall Study||470
153543|NCT01620762|372724|P1|STARTED|Overall Study||468
153544|NCT01620593|372752|P2|NOT COMPLETED|Overall Study||1
153545|NCT01620593|372753|P1|NOT COMPLETED|Overall Study||4
153546|NCT01620593|372752|P2|COMPLETED|Overall Study||19
153547|NCT01620593|372753|P1|COMPLETED|Overall Study||17
153548|NCT01620593|372752|P2|STARTED|Overall Study||20
153549|NCT01620593|372753|P1|STARTED|Overall Study||21
153550|NCT01620567|372769|P2|NOT COMPLETED|Overall Study||5
153551|NCT01620567|372770|P1|NOT COMPLETED|Overall Study||3
153552|NCT01620567|372769|P2|COMPLETED|Overall Study||20
153553|NCT01620567|372770|P1|COMPLETED|Overall Study||20
153554|NCT01620567|372769|P2|STARTED|Overall Study||25
153555|NCT01620567|372770|P1|STARTED|Overall Study||23
153556|NCT01620528|372785|P3|NOT COMPLETED|Post-Treatment Follow-Up Period||14
153557|NCT01620528|372786|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||17
153558|NCT01620528|372787|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||20
153559|NCT01620528|372785|P3|COMPLETED|Post-Treatment Follow-Up Period||37
153560|NCT01620528|372786|P2|COMPLETED|Post-Treatment Follow-Up Period||31
153561|NCT01620528|372787|P1|COMPLETED|Post-Treatment Follow-Up Period||48
153562|NCT01620528|372785|P3|Completed PTFU Month 12|Post-Treatment Follow-Up Period||19
153563|NCT01620528|372786|P2|Completed PTFU Month 12|Post-Treatment Follow-Up Period||5
153564|NCT01620528|372787|P1|Completed PTFU Month 12|Post-Treatment Follow-Up Period||2
153565|NCT01620528|372785|P3|Completed PTFU Month 6|Post-Treatment Follow-Up Period|Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|18
153566|NCT01620528|372786|P2|Completed PTFU Month 6|Post-Treatment Follow-Up Period|Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|26
153567|NCT01620528|372787|P1|Completed PTFU Month 6|Post-Treatment Follow-Up Period||46
153568|NCT01620528|372785|P3|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|51
153569|NCT01620528|372786|P2|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|48
153570|NCT01620528|372787|P1|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|68
153571|NCT01620528|372785|P3|NOT COMPLETED|Treatment Period||66
153572|NCT01620528|372786|P2|NOT COMPLETED|Treatment Period||53
153573|NCT01620528|372787|P1|NOT COMPLETED|Treatment Period||100
153574|NCT01620528|372785|P3|COMPLETED|Treatment Period||183
153575|NCT01620528|372786|P2|COMPLETED|Treatment Period||196
153576|NCT01620528|372787|P1|COMPLETED|Treatment Period||274
153577|NCT01620528|372785|P3|STARTED|Treatment Period|1 subject did not receive study drug|249
153578|NCT01620528|372786|P2|STARTED|Treatment Period||249
153579|NCT01620528|372787|P1|STARTED|Treatment Period||374
153580|NCT01620489|373127|P2|NOT COMPLETED|Overall Study||34
153581|NCT01620489|373128|P1|NOT COMPLETED|Overall Study||35
153582|NCT01620489|373127|P2|COMPLETED|Overall Study|2 subjects did not take trial product|105
153583|NCT01620489|373128|P1|COMPLETED|Overall Study||105
153584|NCT01620489|373127|P2|Exposed|Overall Study|2 subjects did not take trial product|137
153585|NCT01620489|373128|P1|Exposed|Overall Study||140
153586|NCT01620489|373127|P2|STARTED|Overall Study||139
153587|NCT01620489|373128|P1|STARTED|Overall Study||140
153588|NCT01620255|373149|P5|NOT COMPLETED|Overall Study||6
153589|NCT01620255|373150|P4|NOT COMPLETED|Overall Study||3
153590|NCT01620255|373151|P3|NOT COMPLETED|Overall Study||2
153591|NCT01620255|373152|P2|NOT COMPLETED|Overall Study||6
153592|NCT01620255|373153|P1|NOT COMPLETED|Overall Study||4
153593|NCT01620255|373149|P5|COMPLETED|Overall Study||64
153594|NCT01620255|373150|P4|COMPLETED|Overall Study||70
153595|NCT01620255|373151|P3|COMPLETED|Overall Study||68
153596|NCT01620255|373152|P2|COMPLETED|Overall Study||65
153597|NCT01620255|373153|P1|COMPLETED|Overall Study||69
153598|NCT01620255|373149|P5|Treated|Overall Study||70
153599|NCT01620255|373150|P4|Treated|Overall Study||73
153600|NCT01620255|373151|P3|Treated|Overall Study||70
153601|NCT01620255|373152|P2|Treated|Overall Study||71
153602|NCT01620255|373153|P1|Treated|Overall Study||73
153603|NCT01620255|373149|P5|STARTED|Overall Study||70
153604|NCT01620255|373150|P4|STARTED|Overall Study||73
153605|NCT01620255|373151|P3|STARTED|Overall Study||70
153606|NCT01620255|373152|P2|STARTED|Overall Study||71
153607|NCT01620255|373153|P1|STARTED|Overall Study||73
153608|NCT01620177|373230|P1|NOT COMPLETED|Overall Study||79
153609|NCT01620177|373230|P1|COMPLETED|Overall Study||19
153610|NCT01620177|373230|P1|STARTED|Overall Study||98
153611|NCT01620138|373255|P2|NOT COMPLETED|Overall Study||0
153612|NCT01620138|373256|P1|NOT COMPLETED|Overall Study||6
153613|NCT01620138|373255|P2|COMPLETED|Overall Study||9
153614|NCT01620138|373256|P1|COMPLETED|Overall Study||6
153615|NCT01620138|373255|P2|STARTED|Overall Study||9
153616|NCT01620138|373256|P1|STARTED|Overall Study||12
153617|NCT01620086|373264|P3|NOT COMPLETED|Overall Study||0
153618|NCT01620086|373265|P2|NOT COMPLETED|Overall Study||7
153619|NCT01620086|373266|P1|NOT COMPLETED|Overall Study||5
153620|NCT01620086|373264|P3|COMPLETED|Overall Study||2
153621|NCT01620086|373265|P2|COMPLETED|Overall Study||4
153622|NCT01620086|373266|P1|COMPLETED|Overall Study||8
153623|NCT01620086|373264|P3|STARTED|Overall Study||2
153624|NCT01620086|373265|P2|STARTED|Overall Study||11
153625|NCT01620086|373266|P1|STARTED|Overall Study||13
153626|NCT01620060|373285|P1|NOT COMPLETED|Overall Study||15
153627|NCT01620060|373285|P1|COMPLETED|Overall Study||90
153628|NCT01620060|373285|P1|STARTED|Overall Study||105
153629|NCT01620047|373294|P3|NOT COMPLETED|Overall Study||0
153630|NCT01620047|373295|P2|NOT COMPLETED|Overall Study||0
153631|NCT01620047|373296|P1|NOT COMPLETED|Overall Study||0
153632|NCT01620047|373294|P3|COMPLETED|Overall Study||20
153633|NCT01620047|373295|P2|COMPLETED|Overall Study||20
153634|NCT01620047|373296|P1|COMPLETED|Overall Study||20
153635|NCT01620047|373294|P3|STARTED|Overall Study||20
153636|NCT01620047|373295|P2|STARTED|Overall Study||20
153637|NCT01620047|373296|P1|STARTED|Overall Study||20
153638|NCT01619982|373306|P2|NOT COMPLETED|Overall Study||0
153639|NCT01619982|373307|P1|NOT COMPLETED|Overall Study||0
153640|NCT01619982|373306|P2|COMPLETED|Overall Study||12
153641|NCT01619982|373307|P1|COMPLETED|Overall Study||20
153642|NCT01619982|373306|P2|STARTED|Overall Study||12
153643|NCT01619982|373307|P1|STARTED|Overall Study||20
153644|NCT01619878|373323|P1|NOT COMPLETED|Follow-up at 12 Months of Age||3
153645|NCT01619878|373323|P1|COMPLETED|Follow-up at 12 Months of Age||17
153646|NCT01619878|373323|P1|STARTED|Follow-up at 12 Months of Age||20
153647|NCT01619878|373323|P1|NOT COMPLETED|6 Week Follow-up Phase||1
153648|NCT01619878|373323|P1|COMPLETED|6 Week Follow-up Phase||19
153649|NCT01619878|373323|P1|STARTED|6 Week Follow-up Phase||20
153650|NCT01619852|373337|P2|NOT COMPLETED|3 Month Follow up||34
153651|NCT01619852|373338|P1|NOT COMPLETED|3 Month Follow up||31
153652|NCT01619852|373337|P2|COMPLETED|3 Month Follow up||40
153653|NCT01619852|373338|P1|COMPLETED|3 Month Follow up||43
153654|NCT01619852|373337|P2|STARTED|3 Month Follow up||74
153655|NCT01619852|373338|P1|STARTED|3 Month Follow up||74
153656|NCT01619852|373337|P2|NOT COMPLETED|24 Hour Assessment||1
153657|NCT01619852|373338|P1|NOT COMPLETED|24 Hour Assessment||1
153658|NCT01619852|373337|P2|COMPLETED|24 Hour Assessment||74
153659|NCT01619852|373338|P1|COMPLETED|24 Hour Assessment||74
153660|NCT01619852|373337|P2|STARTED|24 Hour Assessment||75
153661|NCT01619852|373338|P1|STARTED|24 Hour Assessment||75
153662|NCT01619800|373354|P2|NOT COMPLETED|Overall Study||0
153663|NCT01619800|373355|P1|NOT COMPLETED|Overall Study||2
153664|NCT01619800|373354|P2|COMPLETED|Overall Study||0
153665|NCT01619800|373355|P1|COMPLETED|Overall Study||0
153666|NCT01619800|373354|P2|STARTED|Overall Study||0
153667|NCT01619800|373355|P1|STARTED|Overall Study||2
153668|NCT01619787|373363|P1|NOT COMPLETED|Overall Study||5
153669|NCT01619787|373363|P1|COMPLETED|Overall Study||212
153670|NCT01619787|373363|P1|STARTED|Overall Study||217
153671|NCT01619774|373372|P1|NOT COMPLETED|Overall Study||0
153672|NCT01619774|373372|P1|COMPLETED|Overall Study||23
153673|NCT01619774|373372|P1|STARTED|Overall Study||23
153674|NCT01619579|373380|P2|NOT COMPLETED|Overall Study||3
153675|NCT01619579|373381|P1|NOT COMPLETED|Overall Study||0
153676|NCT01619579|373380|P2|COMPLETED|Overall Study||14
153677|NCT01619579|373381|P1|COMPLETED|Overall Study||5
153678|NCT01619579|373380|P2|STARTED|Overall Study||17
153679|NCT01619579|373381|P1|STARTED|Overall Study||5
153680|NCT01619423|373395|P4|NOT COMPLETED|Part 2b||0
153681|NCT01619423|373396|P3|NOT COMPLETED|Part 2b||0
153682|NCT01619423|373397|P2|NOT COMPLETED|Part 2b||0
153683|NCT01619423|373398|P1|NOT COMPLETED|Part 2b||0
153684|NCT01619423|373395|P4|COMPLETED|Part 2b||0
153685|NCT01619423|373396|P3|COMPLETED|Part 2b||45
153686|NCT01619423|373397|P2|COMPLETED|Part 2b||44
153687|NCT01619423|373398|P1|COMPLETED|Part 2b||45
153688|NCT01619423|373395|P4|STARTED|Part 2b||0
153689|NCT01619423|373396|P3|STARTED|Part 2b||45
153690|NCT01619423|373397|P2|STARTED|Part 2b||44
153691|NCT01619423|373398|P1|STARTED|Part 2b||45
153692|NCT01619423|373395|P4|NOT COMPLETED|Part 2a||0
153693|NCT01619423|373396|P3|NOT COMPLETED|Part 2a||0
153694|NCT01619423|373397|P2|NOT COMPLETED|Part 2a||0
153695|NCT01619423|373398|P1|NOT COMPLETED|Part 2a||0
153696|NCT01619423|373395|P4|COMPLETED|Part 2a||11
153697|NCT01619423|373396|P3|COMPLETED|Part 2a||0
153698|NCT01619423|373397|P2|COMPLETED|Part 2a||13
153699|NCT01619423|373398|P1|COMPLETED|Part 2a||15
153700|NCT01619423|373395|P4|STARTED|Part 2a||11
153701|NCT01619423|373396|P3|STARTED|Part 2a||0
153702|NCT01619423|373397|P2|STARTED|Part 2a||13
153703|NCT01619423|373398|P1|STARTED|Part 2a||15
153704|NCT01619423|373395|P4|NOT COMPLETED|Part 1 (Dose Escalation)||0
153705|NCT01619423|373396|P3|NOT COMPLETED|Part 1 (Dose Escalation)||0
153706|NCT01619423|373397|P2|NOT COMPLETED|Part 1 (Dose Escalation)||2
153707|NCT01619423|373398|P1|NOT COMPLETED|Part 1 (Dose Escalation)||0
153708|NCT01619423|373395|P4|COMPLETED|Part 1 (Dose Escalation)||5
153709|NCT01619423|373396|P3|COMPLETED|Part 1 (Dose Escalation)||3
153710|NCT01619423|373397|P2|COMPLETED|Part 1 (Dose Escalation)||3
153711|NCT01619423|373398|P1|COMPLETED|Part 1 (Dose Escalation)||0
153712|NCT01619423|373395|P4|STARTED|Part 1 (Dose Escalation)||5
153713|NCT01619423|373396|P3|STARTED|Part 1 (Dose Escalation)||3
153714|NCT01619423|373397|P2|STARTED|Part 1 (Dose Escalation)||5
153715|NCT01619423|373398|P1|STARTED|Part 1 (Dose Escalation)||0
153716|NCT01619410|373411|P2|NOT COMPLETED|Overall Study||4
153717|NCT01619410|373412|P1|NOT COMPLETED|Overall Study||7
153718|NCT01619410|373411|P2|COMPLETED|Overall Study||7
153719|NCT01619410|373412|P1|COMPLETED|Overall Study||7
153720|NCT01619410|373411|P2|STARTED|Overall Study||11
153721|NCT01619410|373412|P1|STARTED|Overall Study||14
153722|NCT01619085|373424|P1|NOT COMPLETED|Overall Study||369
153723|NCT01619085|373424|P1|COMPLETED|Overall Study|Total 341 patients did not complete the trial.|366
153724|NCT01619085|373424|P1|STARTED|Overall Study|27 patients were ongoing on trial at database lock. 1 patient was not treated with trial drugs.|735
153725|NCT01619059|373430|P2|NOT COMPLETED|Long-Term (LT) Treatment Period||9
153726|NCT01619059|373431|P1|NOT COMPLETED|Long-Term (LT) Treatment Period||8
153727|NCT01619059|373430|P2|COMPLETED|Long-Term (LT) Treatment Period||133
153728|NCT01619059|373431|P1|COMPLETED|Long-Term (LT) Treatment Period||147
153729|NCT01619059|373430|P2|STARTED|Long-Term (LT) Treatment Period||142
153730|NCT01619059|373431|P1|STARTED|Long-Term (LT) Treatment Period||155
153731|NCT01619059|373430|P2|NOT COMPLETED|Short-Term (ST) Treatment Period||11
153732|NCT01619059|373431|P1|NOT COMPLETED|Short-Term (ST) Treatment Period||6
153733|NCT01619059|373430|P2|COMPLETED|Short-Term (ST) Treatment Period||142
153734|NCT01619059|373431|P1|COMPLETED|Short-Term (ST) Treatment Period||156
153735|NCT01619059|373430|P2|STARTED|Short-Term (ST) Treatment Period||153
153736|NCT01619059|373431|P1|STARTED|Short-Term (ST) Treatment Period||162
153737|NCT01618968|373447|P4|NOT COMPLETED|Overall Study||1
153738|NCT01618968|373448|P3|NOT COMPLETED|Overall Study||0
153739|NCT01618968|373449|P2|NOT COMPLETED|Overall Study||0
153740|NCT01618968|373450|P1|NOT COMPLETED|Overall Study||1
153741|NCT01618968|373447|P4|COMPLETED|Overall Study||11
153742|NCT01618968|373448|P3|COMPLETED|Overall Study||12
153743|NCT01618968|373449|P2|COMPLETED|Overall Study||12
153744|NCT01618968|373450|P1|COMPLETED|Overall Study||12
153745|NCT01618968|373447|P4|Received Treatment C|Overall Study||11
153746|NCT01618968|373448|P3|Received Treatment C|Overall Study||12
153747|NCT01618968|373449|P2|Received Treatment C|Overall Study||12
153748|NCT01618968|373450|P1|Received Treatment C|Overall Study||12
153749|NCT01618968|373447|P4|Received Treatment B|Overall Study||12
153750|NCT01618968|373448|P3|Received Treatment B|Overall Study||12
153751|NCT01618968|373449|P2|Received Treatment B|Overall Study||12
153752|NCT01618968|373450|P1|Received Treatment B|Overall Study||13
153753|NCT01618968|373447|P4|Received Treatment A|Overall Study||11
153754|NCT01618968|373448|P3|Received Treatment A|Overall Study||12
153755|NCT01618968|373449|P2|Received Treatment A|Overall Study||12
153756|NCT01618968|373450|P1|Received Treatment A|Overall Study||12
153757|NCT01618968|373447|P4|STARTED|Overall Study||12
153758|NCT01618968|373448|P3|STARTED|Overall Study||12
153759|NCT01618968|373449|P2|STARTED|Overall Study||12
153760|NCT01618968|373450|P1|STARTED|Overall Study||13
153761|NCT01618955|373469|P4|NOT COMPLETED|Overall Study||0
153762|NCT01618955|373470|P3|NOT COMPLETED|Overall Study||0
153763|NCT01618955|373471|P2|NOT COMPLETED|Overall Study||0
153764|NCT01618955|373472|P1|NOT COMPLETED|Overall Study||0
153765|NCT01618955|373469|P4|COMPLETED|Overall Study||20
153766|NCT01618955|373470|P3|COMPLETED|Overall Study||31
153767|NCT01618955|373471|P2|COMPLETED|Overall Study||30
153768|NCT01618955|373472|P1|COMPLETED|Overall Study||20
153769|NCT01618955|373469|P4|STARTED|Overall Study||20
153770|NCT01618955|373470|P3|STARTED|Overall Study||31
153771|NCT01618955|373471|P2|STARTED|Overall Study||30
153772|NCT01618955|373472|P1|STARTED|Overall Study||20
153773|NCT01618942|373496|P2|NOT COMPLETED|Overall Study||0
153774|NCT01618942|373497|P1|NOT COMPLETED|Overall Study||0
153775|NCT01618942|373496|P2|COMPLETED|Overall Study||50
153776|NCT01618942|373497|P1|COMPLETED|Overall Study||50
153777|NCT01618942|373496|P2|STARTED|Overall Study||50
153778|NCT01618942|373497|P1|STARTED|Overall Study||50
153779|NCT01618916|373523|P6|NOT COMPLETED|Overall Study||0
153780|NCT01618916|373524|P5|NOT COMPLETED|Overall Study||1
153781|NCT01618916|373525|P4|NOT COMPLETED|Overall Study||2
153782|NCT01618916|373526|P3|NOT COMPLETED|Overall Study||1
153783|NCT01618916|373527|P2|NOT COMPLETED|Overall Study||1
153784|NCT01618916|373528|P1|NOT COMPLETED|Overall Study||2
153785|NCT01618916|373523|P6|COMPLETED|Overall Study||4
153786|NCT01618916|373524|P5|COMPLETED|Overall Study||4
153787|NCT01618916|373525|P4|COMPLETED|Overall Study||7
153788|NCT01618916|373526|P3|COMPLETED|Overall Study||10
153789|NCT01618916|373527|P2|COMPLETED|Overall Study||9
153790|NCT01618916|373528|P1|COMPLETED|Overall Study||10
153791|NCT01618916|373523|P6|Received At Least 1 Dose of Study Drug|Overall Study||4
153792|NCT01618916|373524|P5|Received At Least 1 Dose of Study Drug|Overall Study||5
153793|NCT01618916|373525|P4|Received At Least 1 Dose of Study Drug|Overall Study||9
153794|NCT01618916|373526|P3|Received At Least 1 Dose of Study Drug|Overall Study||11
153795|NCT01618916|373527|P2|Received At Least 1 Dose of Study Drug|Overall Study||10
153796|NCT01618916|373528|P1|Received At Least 1 Dose of Study Drug|Overall Study||12
153797|NCT01618916|373523|P6|STARTED|Overall Study||4
153798|NCT01618916|373524|P5|STARTED|Overall Study||5
153799|NCT01618916|373525|P4|STARTED|Overall Study||9
153800|NCT01618916|373526|P3|STARTED|Overall Study||11
153801|NCT01618916|373527|P2|STARTED|Overall Study||10
153802|NCT01618916|373528|P1|STARTED|Overall Study||12
153803|NCT01618864|373558|P1|NOT COMPLETED|Overall Study||4
153804|NCT01618864|373558|P1|COMPLETED|Overall Study|Completed 4 weeks and 8 weeks of treatment|19
153805|NCT01618864|373558|P1|Completed 2 Weeks|Overall Study||19
153806|NCT01618864|373558|P1|STARTED|Overall Study||23
153807|NCT01618838|373567|P1|NOT COMPLETED|Overall Study||4
153808|NCT01618838|373567|P1|COMPLETED|Overall Study||0
153809|NCT01618838|373567|P1|STARTED|Overall Study||4
153810|NCT01618708|373575|P2|NOT COMPLETED|Overall Study||46
153811|NCT01618708|373576|P1|NOT COMPLETED|Overall Study||44
153812|NCT01618708|373575|P2|COMPLETED|Overall Study||136
153813|NCT01618708|373576|P1|COMPLETED|Overall Study||131
153814|NCT01618708|373575|P2|Treated|Overall Study||180
153815|NCT01618708|373576|P1|Treated|Overall Study||172
153816|NCT01618708|373575|P2|STARTED|Overall Study||182
153817|NCT01618708|373576|P1|STARTED|Overall Study||175
153818|NCT01618669|373590|P2|NOT COMPLETED|Overall Study||23
153819|NCT01618669|373591|P1|NOT COMPLETED|Overall Study||34
153820|NCT01618669|373590|P2|COMPLETED|Overall Study||546
153821|NCT01618669|373591|P1|COMPLETED|Overall Study||544
153822|NCT01618669|373590|P2|Received Treatment|Overall Study||567
153823|NCT01618669|373591|P1|Received Treatment|Overall Study||575
153824|NCT01618669|373590|P2|STARTED|Overall Study||569
153825|NCT01618669|373591|P1|STARTED|Overall Study||578
153826|NCT01618422|373637|P2|NOT COMPLETED|Overall Study||0
153827|NCT01618422|373638|P1|NOT COMPLETED|Overall Study||0
153828|NCT01618422|373637|P2|COMPLETED|Overall Study||111
153829|NCT01618422|373638|P1|COMPLETED|Overall Study||114
153830|NCT01618422|373637|P2|STARTED|Overall Study||111
153831|NCT01618422|373638|P1|STARTED|Overall Study||114
153832|NCT01618344|373644|P1|NOT COMPLETED|Overall Study||9
153833|NCT01618344|373644|P1|COMPLETED|Overall Study||23
153834|NCT01618344|373644|P1|STARTED|Overall Study||32
153835|NCT01618266|373648|P1|NOT COMPLETED|Overall Study||96
153836|NCT01618266|373648|P1|COMPLETED|Overall Study||279
153837|NCT01618266|373648|P1|STARTED|Overall Study||375
153838|NCT01618240|373663|P1|NOT COMPLETED|Overall Study||0
153839|NCT01618240|373663|P1|COMPLETED|Overall Study||30
153840|NCT01618240|373663|P1|STARTED|Overall Study||30
153841|NCT01618227|373670|P2|NOT COMPLETED|Overall Study||2
153842|NCT01618227|373671|P1|NOT COMPLETED|Overall Study||0
153843|NCT01618227|373670|P2|COMPLETED|Overall Study||0
153844|NCT01618227|373671|P1|COMPLETED|Overall Study||2
153845|NCT01618227|373670|P2|STARTED|Overall Study||2
153846|NCT01618227|373671|P1|STARTED|Overall Study||2
153847|NCT01618214|373685|P2|NOT COMPLETED|Overall Study||13
153848|NCT01618214|373686|P1|NOT COMPLETED|Overall Study||10
153849|NCT01618214|373685|P2|COMPLETED|Overall Study||159
153850|NCT01618214|373686|P1|COMPLETED|Overall Study||162
153851|NCT01618214|373685|P2|Exposed|Overall Study||172
153852|NCT01618214|373686|P1|Exposed|Overall Study||172
153853|NCT01618214|373685|P2|STARTED|Overall Study||172
153854|NCT01618214|373686|P1|STARTED|Overall Study||172
153855|NCT01618162|373702|P2|NOT COMPLETED|Overall Study||35
153856|NCT01618162|373703|P1|NOT COMPLETED|Overall Study||38
153857|NCT01618162|373702|P2|COMPLETED|Overall Study||111
153858|NCT01618162|373703|P1|COMPLETED|Overall Study||251
153859|NCT01618162|373702|P2|Exposed|Overall Study||146
153860|NCT01618162|373703|P1|Exposed|Overall Study||288
153861|NCT01618162|373702|P2|STARTED|Overall Study||146
153862|NCT01618162|373703|P1|STARTED|Overall Study||289
153863|NCT01618019|373723|P2|NOT COMPLETED|Overall Study||14
153864|NCT01618019|373724|P1|NOT COMPLETED|Overall Study||14
153865|NCT01618019|373723|P2|COMPLETED|Overall Study||40
153866|NCT01618019|373724|P1|COMPLETED|Overall Study||41
153867|NCT01618019|373723|P2|STARTED|Overall Study||54
153868|NCT01618019|373724|P1|STARTED|Overall Study||55
153869|NCT01617967|373750|P6|NOT COMPLETED|Overall Study||1
153870|NCT01617967|373751|P5|NOT COMPLETED|Overall Study||0
153871|NCT01617967|373752|P4|NOT COMPLETED|Overall Study||1
153872|NCT01617967|373753|P3|NOT COMPLETED|Overall Study||0
153873|NCT01617967|373754|P2|NOT COMPLETED|Overall Study||0
153874|NCT01617967|373755|P1|NOT COMPLETED|Overall Study||1
153875|NCT01617967|373750|P6|COMPLETED|Overall Study||8
153876|NCT01617967|373751|P5|COMPLETED|Overall Study||3
153877|NCT01617967|373752|P4|COMPLETED|Overall Study||6
153878|NCT01617967|373753|P3|COMPLETED|Overall Study||3
153879|NCT01617967|373754|P2|COMPLETED|Overall Study||3
153880|NCT01617967|373755|P1|COMPLETED|Overall Study||3
153881|NCT01617967|373750|P6|STARTED|Overall Study||9
153882|NCT01617967|373751|P5|STARTED|Overall Study||3
153883|NCT01617967|373752|P4|STARTED|Overall Study||7
153884|NCT01617967|373753|P3|STARTED|Overall Study||3
153885|NCT01617967|373754|P2|STARTED|Overall Study||3
153886|NCT01617967|373755|P1|STARTED|Overall Study||4
153887|NCT01617681|373809|P5|NOT COMPLETED|Period 2 Open Label||6
153888|NCT01617681|373810|P4|NOT COMPLETED|Period 2 Open Label||0
153889|NCT01617681|373811|P3|NOT COMPLETED|Period 2 Open Label||0
153890|NCT01617681|373812|P2|NOT COMPLETED|Period 2 Open Label||0
153891|NCT01617681|373813|P1|NOT COMPLETED|Period 2 Open Label||0
153892|NCT01617681|373809|P5|COMPLETED|Period 2 Open Label||114
153893|NCT01617681|373810|P4|COMPLETED|Period 2 Open Label||0
153894|NCT01617681|373811|P3|COMPLETED|Period 2 Open Label||0
153895|NCT01617681|373812|P2|COMPLETED|Period 2 Open Label||0
153896|NCT01617681|373813|P1|COMPLETED|Period 2 Open Label||0
153897|NCT01617681|373809|P5|STARTED|Period 2 Open Label||120
153898|NCT01617681|373810|P4|STARTED|Period 2 Open Label||0
153899|NCT01617681|373811|P3|STARTED|Period 2 Open Label||0
153900|NCT01617681|373812|P2|STARTED|Period 2 Open Label||0
153901|NCT01617681|373813|P1|STARTED|Period 2 Open Label||0
153902|NCT01617681|373809|P5|NOT COMPLETED|Period 1 Double Blind||0
153903|NCT01617681|373810|P4|NOT COMPLETED|Period 1 Double Blind||2
153904|NCT01617681|373811|P3|NOT COMPLETED|Period 1 Double Blind||1
153905|NCT01617681|373812|P2|NOT COMPLETED|Period 1 Double Blind||1
153906|NCT01617681|373813|P1|NOT COMPLETED|Period 1 Double Blind||3
153907|NCT01617681|373809|P5|COMPLETED|Period 1 Double Blind||0
153908|NCT01617681|373810|P4|COMPLETED|Period 1 Double Blind||29
153909|NCT01617681|373811|P3|COMPLETED|Period 1 Double Blind||32
153910|NCT01617681|373812|P2|COMPLETED|Period 1 Double Blind||30
153911|NCT01617681|373813|P1|COMPLETED|Period 1 Double Blind||29
153912|NCT01617681|373809|P5|Full Analysis Set (FAS)|Period 1 Double Blind||0
153913|NCT01617681|373810|P4|Full Analysis Set (FAS)|Period 1 Double Blind||31
153914|NCT01617681|373811|P3|Full Analysis Set (FAS)|Period 1 Double Blind||33
153915|NCT01617681|373812|P2|Full Analysis Set (FAS)|Period 1 Double Blind||31
153916|NCT01617681|373813|P1|Full Analysis Set (FAS)|Period 1 Double Blind||31
153917|NCT01617681|373809|P5|STARTED|Period 1 Double Blind||0
153918|NCT01617681|373810|P4|STARTED|Period 1 Double Blind||31
153919|NCT01617681|373811|P3|STARTED|Period 1 Double Blind||33
153920|NCT01617681|373812|P2|STARTED|Period 1 Double Blind||31
153921|NCT01617681|373813|P1|STARTED|Period 1 Double Blind||32
153922|NCT01617668|373834|P4|NOT COMPLETED|Overall Study||15
153923|NCT01617668|373835|P3|NOT COMPLETED|Overall Study||23
153924|NCT01617668|373836|P2|NOT COMPLETED|Overall Study||9
153925|NCT01617668|373837|P1|NOT COMPLETED|Overall Study||13
153926|NCT01617668|373834|P4|COMPLETED|Overall Study||38
153927|NCT01617668|373835|P3|COMPLETED|Overall Study||32
153928|NCT01617668|373836|P2|COMPLETED|Overall Study||41
153929|NCT01617668|373837|P1|COMPLETED|Overall Study||38
153930|NCT01617668|373834|P4|Randomized Patients|Overall Study||55
153931|NCT01617668|373835|P3|Randomized Patients|Overall Study||55
153932|NCT01617668|373836|P2|Randomized Patients|Overall Study||54
153933|NCT01617668|373837|P1|Randomized Patients|Overall Study||51
153934|NCT01617668|373834|P4|STARTED|Overall Study|55 patients were randomized and only 53 received study treatment.|53
153935|NCT01617668|373835|P3|STARTED|Overall Study||55
153936|NCT01617668|373836|P2|STARTED|Overall Study|54 patients were randomized and only 50 received study treatment.|50
153937|NCT01617668|373837|P1|STARTED|Overall Study||51
153938|NCT01617655|373878|P2|NOT COMPLETED|Overall Study||29
153939|NCT01617655|373879|P1|NOT COMPLETED|Overall Study||9
153940|NCT01617655|373878|P2|COMPLETED|Overall Study||43
153941|NCT01617655|373879|P1|COMPLETED|Overall Study||26
153942|NCT01617655|373878|P2|Treated|Overall Study||72
153943|NCT01617655|373879|P1|Treated|Overall Study||35
153944|NCT01617655|373878|P2|STARTED|Overall Study|Randomized|72
153945|NCT01617655|373879|P1|STARTED|Overall Study|Randomized|35
153946|NCT01617629|373939|P1|NOT COMPLETED|Overall Study||6
153947|NCT01617629|373939|P1|COMPLETED|Overall Study||3
153948|NCT01617629|373939|P1|STARTED|Overall Study||9
153949|NCT01617603|373947|P3|NOT COMPLETED|Overall Study||1
153950|NCT01617603|373948|P2|NOT COMPLETED|Overall Study||2
153951|NCT01617603|373949|P1|NOT COMPLETED|Overall Study||3
153952|NCT01617603|373947|P3|COMPLETED|Overall Study||20
153953|NCT01617603|373948|P2|COMPLETED|Overall Study||19
153954|NCT01617603|373949|P1|COMPLETED|Overall Study||17
153955|NCT01617603|373947|P3|STARTED|Overall Study||21
153956|NCT01617603|373948|P2|STARTED|Overall Study||21
153957|NCT01617603|373949|P1|STARTED|Overall Study||20
153958|NCT01617577|373959|P2|NOT COMPLETED|Overall Study||0
153959|NCT01617577|373960|P1|NOT COMPLETED|Overall Study||0
153960|NCT01617577|373959|P2|COMPLETED|Overall Study||3
153961|NCT01617577|373960|P1|COMPLETED|Overall Study||5
153962|NCT01617577|373959|P2|STARTED|Overall Study||3
153963|NCT01617577|373960|P1|STARTED|Overall Study||5
153964|NCT01617460|373967|P1|NOT COMPLETED|Overall Study||40
153965|NCT01617460|373967|P1|COMPLETED|Overall Study||46
153966|NCT01617460|373967|P1|STARTED|Overall Study||86
153967|NCT01617447|373973|P2|NOT COMPLETED|Overall Study||3
153968|NCT01617447|373974|P1|NOT COMPLETED|Overall Study||0
153969|NCT01617447|373973|P2|COMPLETED|Overall Study||42
153970|NCT01617447|373974|P1|COMPLETED|Overall Study||47
153971|NCT01617447|373973|P2|STARTED|Overall Study||45
153972|NCT01617447|373974|P1|STARTED|Overall Study||47
153973|NCT01617434|373982|P2|NOT COMPLETED|Overall Study||51
153974|NCT01617434|373983|P1|NOT COMPLETED|Overall Study||35
153975|NCT01617434|373982|P2|COMPLETED|Overall Study||174
153976|NCT01617434|373983|P1|COMPLETED|Overall Study||191
153977|NCT01617434|373982|P2|Exposed|Overall Study||225
153978|NCT01617434|373983|P1|Exposed|Overall Study||225
153979|NCT01617434|373982|P2|STARTED|Overall Study||225
153980|NCT01617434|373983|P1|STARTED|Overall Study||226
153981|NCT01617421|374005|P1|NOT COMPLETED|Overall Study||6
153982|NCT01617421|374005|P1|COMPLETED|Overall Study||12
153983|NCT01617421|374005|P1|STARTED|Overall Study||18
153984|NCT01617369|374012|P1|NOT COMPLETED|Overall Study||0
153985|NCT01617369|374012|P1|COMPLETED|Overall Study||12
153986|NCT01617369|374012|P1|STARTED|Overall Study||12
153987|NCT01617187|374022|P4|NOT COMPLETED|Treatment Through Study Completion||10
153988|NCT01617187|374023|P3|NOT COMPLETED|Treatment Through Study Completion||5
153989|NCT01617187|374024|P2|NOT COMPLETED|Treatment Through Study Completion||11
153990|NCT01617187|374025|P1|NOT COMPLETED|Treatment Through Study Completion||11
153991|NCT01617187|374022|P4|COMPLETED|Treatment Through Study Completion||91
153992|NCT01617187|374023|P3|COMPLETED|Treatment Through Study Completion||41
153993|NCT01617187|374024|P2|COMPLETED|Treatment Through Study Completion||102
153994|NCT01617187|374025|P1|COMPLETED|Treatment Through Study Completion|Excludes the participant who did not receive study drug but completed study in database|86
153995|NCT01617187|374022|P4|STARTED|Treatment Through Study Completion|Treated|101
153996|NCT01617187|374023|P3|STARTED|Treatment Through Study Completion|Treated|46
153997|NCT01617187|374024|P2|STARTED|Treatment Through Study Completion|Treated|113
153998|NCT01617187|374025|P1|STARTED|Treatment Through Study Completion|Treated|97
153999|NCT01617187|374022|P4|NOT COMPLETED|Randomization Through Start Treatment||2
154000|NCT01617187|374023|P3|NOT COMPLETED|Randomization Through Start Treatment||0
154001|NCT01617187|374024|P2|NOT COMPLETED|Randomization Through Start Treatment||0
154002|NCT01617187|374025|P1|NOT COMPLETED|Randomization Through Start Treatment||1
154003|NCT01617187|374022|P4|COMPLETED|Randomization Through Start Treatment||101
154004|NCT01617187|374023|P3|COMPLETED|Randomization Through Start Treatment||46
154005|NCT01617187|374024|P2|COMPLETED|Randomization Through Start Treatment||113
154006|NCT01617187|374025|P1|COMPLETED|Randomization Through Start Treatment||97
154007|NCT01617187|374022|P4|STARTED|Randomization Through Start Treatment|Randomized|103
154008|NCT01617187|374023|P3|STARTED|Randomization Through Start Treatment|Randomized|46
154009|NCT01617187|374024|P2|STARTED|Randomization Through Start Treatment|Randomized|113
154010|NCT01617187|374025|P1|STARTED|Randomization Through Start Treatment|Randomized|98
154011|NCT01617148|374095|P1|NOT COMPLETED|Overall Study||0
154012|NCT01617148|374095|P1|COMPLETED|Overall Study||26
154013|NCT01617148|374095|P1|STARTED|Overall Study||26
154014|NCT01617083|374109|P3|NOT COMPLETED|Overall Study||0
154015|NCT01617083|374110|P2|NOT COMPLETED|Overall Study||0
154016|NCT01617083|374111|P1|NOT COMPLETED|Overall Study||0
154017|NCT01617083|374109|P3|COMPLETED|Overall Study||15
154018|NCT01617083|374110|P2|COMPLETED|Overall Study||14
154019|NCT01617083|374111|P1|COMPLETED|Overall Study||18
154020|NCT01617083|374109|P3|STARTED|Overall Study||15
154021|NCT01617083|374110|P2|STARTED|Overall Study||14
154022|NCT01617083|374111|P1|STARTED|Overall Study||18
154023|NCT01617070|374122|P1|NOT COMPLETED|BH4 and LNAA (4 Weeks)||1
154024|NCT01617070|374122|P1|COMPLETED|BH4 and LNAA (4 Weeks)||9
154025|NCT01617070|374122|P1|STARTED|BH4 and LNAA (4 Weeks)||10
154026|NCT01617070|374122|P1|NOT COMPLETED|BH4 Therapy (4 Weeks)||0
154027|NCT01617070|374122|P1|COMPLETED|BH4 Therapy (4 Weeks)||10
154028|NCT01617070|374122|P1|STARTED|BH4 Therapy (4 Weeks)||10
154029|NCT01617070|374122|P1|NOT COMPLETED|Washout (4 Weeks)||0
154030|NCT01617070|374122|P1|COMPLETED|Washout (4 Weeks)||10
154031|NCT01617070|374122|P1|STARTED|Washout (4 Weeks)||10
154032|NCT01617070|374122|P1|NOT COMPLETED|LNAA (4 Weeks)||0
154033|NCT01617070|374122|P1|COMPLETED|LNAA (4 Weeks)||10
154034|NCT01617070|374122|P1|STARTED|LNAA (4 Weeks)||10
154035|NCT01617005|374140|P1|NOT COMPLETED|Overall Study||2
154036|NCT01617005|374140|P1|COMPLETED|Overall Study||48
154037|NCT01617005|374140|P1|STARTED|Overall Study||50
154038|NCT01616953|374149|P2|NOT COMPLETED|Overall Study||0
154039|NCT01616953|374150|P1|NOT COMPLETED|Overall Study||2
154040|NCT01616953|374149|P2|COMPLETED|Overall Study||8
154041|NCT01616953|374150|P1|COMPLETED|Overall Study||8
154042|NCT01616953|374149|P2|6 Months Post-loading|Overall Study||8
154043|NCT01616953|374150|P1|6 Months Post-loading|Overall Study||8
154044|NCT01616953|374149|P2|Implant Uncovery|Overall Study||8
154045|NCT01616953|374150|P1|Implant Uncovery|Overall Study||8
154046|NCT01616953|374149|P2|Implant Placement Surgery|Overall Study||8
154047|NCT01616953|374150|P1|Implant Placement Surgery|Overall Study||9
154048|NCT01616953|374149|P2|STARTED|Overall Study||8
154049|NCT01616953|374150|P1|STARTED|Overall Study||10
154050|NCT01616771|374158|P1|NOT COMPLETED|Smaller Sized GVL for 5 Sec||4
154051|NCT01616771|374158|P1|COMPLETED|Smaller Sized GVL for 5 Sec||19
154052|NCT01616771|374158|P1|STARTED|Smaller Sized GVL for 5 Sec|Four of 23 patients could not be evaluated by smaller sized GVL, because there was no smaller one.|23
154053|NCT01616771|374158|P1|NOT COMPLETED|GVL Selected by Weight for 5 Sec||0
154054|NCT01616771|374158|P1|COMPLETED|GVL Selected by Weight for 5 Sec||23
154055|NCT01616771|374158|P1|STARTED|GVL Selected by Weight for 5 Sec||23
154056|NCT01616771|374158|P1|NOT COMPLETED|Macintosh Laryngoscopy for 5 Sec||0
154057|NCT01616771|374158|P1|COMPLETED|Macintosh Laryngoscopy for 5 Sec||23
154058|NCT01616771|374158|P1|STARTED|Macintosh Laryngoscopy for 5 Sec||23
154059|NCT01616693|374171|P4|NOT COMPLETED|Blood Analyzed for Immunogenicity||1
154060|NCT01616693|374172|P3|NOT COMPLETED|Blood Analyzed for Immunogenicity||6
154061|NCT01616693|374173|P2|NOT COMPLETED|Blood Analyzed for Immunogenicity||2
154062|NCT01616693|374174|P1|NOT COMPLETED|Blood Analyzed for Immunogenicity||4
154063|NCT01616693|374171|P4|COMPLETED|Blood Analyzed for Immunogenicity||135
154064|NCT01616693|374172|P3|COMPLETED|Blood Analyzed for Immunogenicity||136
154065|NCT01616693|374173|P2|COMPLETED|Blood Analyzed for Immunogenicity||143
154066|NCT01616693|374174|P1|COMPLETED|Blood Analyzed for Immunogenicity||137
154067|NCT01616693|374171|P4|STARTED|Blood Analyzed for Immunogenicity||136
154068|NCT01616693|374172|P3|STARTED|Blood Analyzed for Immunogenicity||142
154069|NCT01616693|374173|P2|STARTED|Blood Analyzed for Immunogenicity||145
154070|NCT01616693|374174|P1|STARTED|Blood Analyzed for Immunogenicity||141
154071|NCT01616693|374171|P4|NOT COMPLETED|Received Both Vaccines||19
154072|NCT01616693|374172|P3|NOT COMPLETED|Received Both Vaccines||12
154073|NCT01616693|374173|P2|NOT COMPLETED|Received Both Vaccines||10
154074|NCT01616693|374174|P1|NOT COMPLETED|Received Both Vaccines||13
154075|NCT01616693|374171|P4|COMPLETED|Received Both Vaccines||136
154076|NCT01616693|374172|P3|COMPLETED|Received Both Vaccines||142
154077|NCT01616693|374173|P2|COMPLETED|Received Both Vaccines||145
154078|NCT01616693|374174|P1|COMPLETED|Received Both Vaccines||141
154079|NCT01616693|374171|P4|STARTED|Received Both Vaccines||155
154080|NCT01616693|374172|P3|STARTED|Received Both Vaccines||154
154081|NCT01616693|374173|P2|STARTED|Received Both Vaccines||155
154082|NCT01616693|374174|P1|STARTED|Received Both Vaccines||154
154083|NCT01616693|374171|P4|NOT COMPLETED|Evaluated for Safety||0
154084|NCT01616693|374172|P3|NOT COMPLETED|Evaluated for Safety||1
154085|NCT01616693|374173|P2|NOT COMPLETED|Evaluated for Safety||0
154086|NCT01616693|374174|P1|NOT COMPLETED|Evaluated for Safety||1
154087|NCT01616693|374171|P4|COMPLETED|Evaluated for Safety||155
154088|NCT01616693|374172|P3|COMPLETED|Evaluated for Safety||154
154089|NCT01616693|374173|P2|COMPLETED|Evaluated for Safety||155
154090|NCT01616693|374174|P1|COMPLETED|Evaluated for Safety||154
154091|NCT01616693|374171|P4|STARTED|Evaluated for Safety||155
154092|NCT01616693|374172|P3|STARTED|Evaluated for Safety||155
154093|NCT01616693|374173|P2|STARTED|Evaluated for Safety||155
154094|NCT01616693|374174|P1|STARTED|Evaluated for Safety||155
154095|NCT01616576|374226|P2|NOT COMPLETED|Overall Study||0
154096|NCT01616576|374227|P1|NOT COMPLETED|Overall Study||0
154097|NCT01616576|374226|P2|COMPLETED|Overall Study||18
154098|NCT01616576|374227|P1|COMPLETED|Overall Study||18
154099|NCT01616576|374226|P2|STARTED|Overall Study||18
154100|NCT01616576|374227|P1|STARTED|Overall Study||18
154101|NCT01616459|374240|P4|NOT COMPLETED|Overall Study||8
154102|NCT01616459|374241|P3|NOT COMPLETED|Overall Study||10
154103|NCT01616459|374242|P2|NOT COMPLETED|Overall Study||17
154104|NCT01616459|374243|P1|NOT COMPLETED|Overall Study||4
154105|NCT01616459|374240|P4|COMPLETED|Overall Study||233
154106|NCT01616459|374241|P3|COMPLETED|Overall Study||220
154107|NCT01616459|374242|P2|COMPLETED|Overall Study||223
154108|NCT01616459|374243|P1|COMPLETED|Overall Study||236
154109|NCT01616459|374240|P4|STARTED|Overall Study||241
154110|NCT01616459|374241|P3|STARTED|Overall Study||230
154111|NCT01616459|374242|P2|STARTED|Overall Study||240
154112|NCT01616459|374243|P1|STARTED|Overall Study||240
154113|NCT01616173|374344|P3|NOT COMPLETED|Overall Study||0
154114|NCT01616173|374345|P2|NOT COMPLETED|Overall Study||2
154115|NCT01616173|374346|P1|NOT COMPLETED|Overall Study||0
154116|NCT01616173|374344|P3|COMPLETED|Overall Study||27
154117|NCT01616173|374345|P2|COMPLETED|Overall Study||24
154118|NCT01616173|374346|P1|COMPLETED|Overall Study||27
154119|NCT01616173|374344|P3|STARTED|Overall Study||27
154120|NCT01616173|374345|P2|STARTED|Overall Study||26
154121|NCT01616173|374346|P1|STARTED|Overall Study||27
154122|NCT01616160|374360|P1|NOT COMPLETED|Overall Study||2
154123|NCT01616160|374360|P1|COMPLETED|Overall Study||9
154124|NCT01616160|374360|P1|STARTED|Overall Study||11
154125|NCT01616056|374365|P1|NOT COMPLETED|Overall Study||1
154126|NCT01616056|374365|P1|COMPLETED|Overall Study||19
154127|NCT01616056|374365|P1|STARTED|Overall Study||20
154128|NCT01615939|374379|P2|NOT COMPLETED|Overall Study||0
154129|NCT01615939|374380|P1|NOT COMPLETED|Overall Study||5
154130|NCT01615939|374379|P2|COMPLETED|Overall Study||4
154131|NCT01615939|374380|P1|COMPLETED|Overall Study||8
154132|NCT01615939|374379|P2|STARTED|Overall Study||4
154133|NCT01615939|374380|P1|STARTED|Overall Study||13
154134|NCT01615822|374393|P3|NOT COMPLETED|Period 2||2
154135|NCT01615822|374394|P2|NOT COMPLETED|Period 2||1
154136|NCT01615822|374395|P1|NOT COMPLETED|Period 2||0
154137|NCT01615822|374393|P3|COMPLETED|Period 2||4
154138|NCT01615822|374394|P2|COMPLETED|Period 2||8
154139|NCT01615822|374395|P1|COMPLETED|Period 2||7
154140|NCT01615822|374393|P3|STARTED|Period 2||6
154141|NCT01615822|374394|P2|STARTED|Period 2||9
154142|NCT01615822|374395|P1|STARTED|Period 2||7
154143|NCT01615822|374393|P3|NOT COMPLETED|Period 1||0
154144|NCT01615822|374394|P2|NOT COMPLETED|Period 1||2
154145|NCT01615822|374395|P1|NOT COMPLETED|Period 1||1
154146|NCT01615822|374393|P3|COMPLETED|Period 1||6
154147|NCT01615822|374394|P2|COMPLETED|Period 1||9
154148|NCT01615822|374395|P1|COMPLETED|Period 1||7
154149|NCT01615822|374393|P3|STARTED|Period 1||6
154150|NCT01615822|374394|P2|STARTED|Period 1||11
154151|NCT01615822|374395|P1|STARTED|Period 1||8
154152|NCT01615809|374412|P1|NOT COMPLETED|Overall Study||10
154153|NCT01615809|374412|P1|COMPLETED|Overall Study||22
154154|NCT01615809|374412|P1|STARTED|Overall Study|basal visit|32
154155|NCT01615731|374420|P2|NOT COMPLETED|Overall Study||2
154156|NCT01615731|374421|P1|NOT COMPLETED|Overall Study||3
154157|NCT01615731|374420|P2|COMPLETED|Overall Study||24
154158|NCT01615731|374421|P1|COMPLETED|Overall Study||21
154159|NCT01615731|374420|P2|STARTED|Overall Study||26
154160|NCT01615731|374421|P1|STARTED|Overall Study||24
154161|NCT01615484|374443|P2|NOT COMPLETED|Overall Study||0
154162|NCT01615484|374444|P1|NOT COMPLETED|Overall Study||0
154163|NCT01615484|374443|P2|COMPLETED|Overall Study||24
154164|NCT01615484|374444|P1|COMPLETED|Overall Study||0
154165|NCT01615484|374443|P2|STARTED|Overall Study||24
154166|NCT01615484|374444|P1|STARTED|Overall Study||0
154167|NCT01615367|374462|P2|NOT COMPLETED|Overall Study||6
154168|NCT01615367|374463|P1|NOT COMPLETED|Overall Study||5
154169|NCT01615367|374462|P2|COMPLETED|Overall Study|11 TAU participants chose to participate in NEW Tx after the completion of the waitlist period.|13
154170|NCT01615367|374463|P1|COMPLETED|Overall Study||14
154171|NCT01615367|374462|P2|STARTED|Overall Study||19
154172|NCT01615367|374463|P1|STARTED|Overall Study||19
154173|NCT01615328|374483|P2|NOT COMPLETED|Overall Study||5
154174|NCT01615328|374484|P1|NOT COMPLETED|Overall Study||3
154175|NCT01615328|374483|P2|COMPLETED|Overall Study||38
154176|NCT01615328|374484|P1|COMPLETED|Overall Study||39
154177|NCT01615328|374483|P2|STARTED|Overall Study||43
154178|NCT01615328|374484|P1|STARTED|Overall Study||42
154179|NCT01615263|374496|P2|NOT COMPLETED|Overall Study||2
154180|NCT01615263|374497|P1|NOT COMPLETED|Overall Study||0
154181|NCT01615263|374496|P2|COMPLETED|Overall Study||18
154182|NCT01615263|374497|P1|COMPLETED|Overall Study||20
154183|NCT01615263|374496|P2|STARTED|Overall Study||20
154184|NCT01615263|374497|P1|STARTED|Overall Study||20
154185|NCT01615198|374511|P2|NOT COMPLETED|Overall Study||19
154186|NCT01615198|374512|P1|NOT COMPLETED|Overall Study||24
154187|NCT01615198|374511|P2|COMPLETED|Overall Study||273
154188|NCT01615198|374512|P1|COMPLETED|Overall Study||272
154189|NCT01615198|374511|P2|ABPM Dipper Status Subset|Overall Study||84
154190|NCT01615198|374512|P1|ABPM Dipper Status Subset|Overall Study||82
154191|NCT01615198|374511|P2|Safety Set|Overall Study||292
154192|NCT01615198|374512|P1|Safety Set|Overall Study||296
154193|NCT01615198|374511|P2|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||157
154194|NCT01615198|374512|P1|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||154
154195|NCT01615198|374511|P2|Full Analysis Set|Overall Study||292
154196|NCT01615198|374512|P1|Full Analysis Set|Overall Study||296
154197|NCT01615198|374511|P2|STARTED|Overall Study||292
154198|NCT01615198|374512|P1|STARTED|Overall Study||296
154199|NCT01615029|374545|P5|NOT COMPLETED|Overall Study||32
154200|NCT01615029|374546|P4|NOT COMPLETED|Overall Study||3
154201|NCT01615029|374547|P3|NOT COMPLETED|Overall Study||4
154202|NCT01615029|374548|P2|NOT COMPLETED|Overall Study||3
154203|NCT01615029|374549|P1|NOT COMPLETED|Overall Study||3
154204|NCT01615029|374545|P5|COMPLETED|Overall Study||0
154205|NCT01615029|374546|P4|COMPLETED|Overall Study||0
154206|NCT01615029|374547|P3|COMPLETED|Overall Study||0
154207|NCT01615029|374548|P2|COMPLETED|Overall Study||0
154208|NCT01615029|374549|P1|COMPLETED|Overall Study||0
154209|NCT01615029|374545|P5|STARTED|Overall Study||32
154210|NCT01615029|374546|P4|STARTED|Overall Study||3
154211|NCT01615029|374547|P3|STARTED|Overall Study||4
154212|NCT01615029|374548|P2|STARTED|Overall Study||3
154213|NCT01615029|374549|P1|STARTED|Overall Study||3
154214|NCT01614912|374570|P1|NOT COMPLETED|Overall Study||125
154215|NCT01614912|374570|P1|COMPLETED|Overall Study||159
154216|NCT01614912|374570|P1|STARTED|Overall Study||284
154217|NCT01614899|374584|P3|NOT COMPLETED|Overall Study||42
154218|NCT01614899|374585|P2|NOT COMPLETED|Overall Study||39
154219|NCT01614899|374586|P1|NOT COMPLETED|Overall Study||44
154220|NCT01614899|374584|P3|COMPLETED|Overall Study||110
154221|NCT01614899|374585|P2|COMPLETED|Overall Study||116
154222|NCT01614899|374586|P1|COMPLETED|Overall Study||106
154223|NCT01614899|374584|P3|STARTED|Overall Study||152
154224|NCT01614899|374585|P2|STARTED|Overall Study||155
154225|NCT01614899|374586|P1|STARTED|Overall Study||150
154226|NCT01614886|374617|P2|NOT COMPLETED|Overall Study||26
154227|NCT01614886|374618|P1|NOT COMPLETED|Overall Study||20
154228|NCT01614886|374617|P2|COMPLETED|Overall Study||83
154229|NCT01614886|374618|P1|COMPLETED|Overall Study||87
154230|NCT01614886|374617|P2|Full Analysis Set (FAS)|Overall Study||105
154231|NCT01614886|374618|P1|Full Analysis Set (FAS)|Overall Study||104
154232|NCT01614886|374617|P2|Safety Population (SAF)|Overall Study||108
154233|NCT01614886|374618|P1|Safety Population (SAF)|Overall Study||107
154234|NCT01614886|374617|P2|STARTED|Overall Study||109
154235|NCT01614886|374618|P1|STARTED|Overall Study||107
154236|NCT01614795|374636|P4|NOT COMPLETED|Overall Study||12
154237|NCT01614795|374637|P3|NOT COMPLETED|Overall Study||11
154238|NCT01614795|374638|P2|NOT COMPLETED|Overall Study||12
154239|NCT01614795|374639|P1|NOT COMPLETED|Overall Study||11
154240|NCT01614795|374636|P4|COMPLETED|Overall Study||0
154241|NCT01614795|374637|P3|COMPLETED|Overall Study||0
154242|NCT01614795|374638|P2|COMPLETED|Overall Study||0
154243|NCT01614795|374639|P1|COMPLETED|Overall Study||0
154244|NCT01614795|374636|P4|STARTED|Overall Study||12
154245|NCT01614795|374637|P3|STARTED|Overall Study||11
154246|NCT01614795|374638|P2|STARTED|Overall Study||12
154247|NCT01614795|374639|P1|STARTED|Overall Study||11
154248|NCT01614769|374659|P6|NOT COMPLETED|Period 3||0
154249|NCT01614769|374660|P5|NOT COMPLETED|Period 3||0
154250|NCT01614769|374661|P4|NOT COMPLETED|Period 3||0
154251|NCT01614769|374662|P3|NOT COMPLETED|Period 3||1
154252|NCT01614769|374663|P2|NOT COMPLETED|Period 3||0
154253|NCT01614769|374664|P1|NOT COMPLETED|Period 3||0
154254|NCT01614769|374659|P6|COMPLETED|Period 3||1
154255|NCT01614769|374660|P5|COMPLETED|Period 3||1
154256|NCT01614769|374661|P4|COMPLETED|Period 3||0
154257|NCT01614769|374662|P3|COMPLETED|Period 3||1
154258|NCT01614769|374663|P2|COMPLETED|Period 3||1
154259|NCT01614769|374664|P1|COMPLETED|Period 3||1
154260|NCT01614769|374659|P6|STARTED|Period 3||1
154261|NCT01614769|374660|P5|STARTED|Period 3||1
154262|NCT01614769|374661|P4|STARTED|Period 3||0
154263|NCT01614769|374662|P3|STARTED|Period 3||2
154264|NCT01614769|374663|P2|STARTED|Period 3||1
154265|NCT01614769|374664|P1|STARTED|Period 3||1
154266|NCT01614769|374659|P6|NOT COMPLETED|7-Day Washout||0
154267|NCT01614769|374660|P5|NOT COMPLETED|7-Day Washout||0
154268|NCT01614769|374661|P4|NOT COMPLETED|7-Day Washout||0
154269|NCT01614769|374662|P3|NOT COMPLETED|7-Day Washout||0
154270|NCT01614769|374663|P2|NOT COMPLETED|7-Day Washout||0
154271|NCT01614769|374664|P1|NOT COMPLETED|7-Day Washout||0
154272|NCT01614769|374659|P6|COMPLETED|7-Day Washout||1
154273|NCT01614769|374660|P5|COMPLETED|7-Day Washout||1
154274|NCT01614769|374661|P4|COMPLETED|7-Day Washout||0
154275|NCT01614769|374662|P3|COMPLETED|7-Day Washout||2
154276|NCT01614769|374663|P2|COMPLETED|7-Day Washout||1
154277|NCT01614769|374664|P1|COMPLETED|7-Day Washout||1
154278|NCT01614769|374659|P6|STARTED|7-Day Washout||1
154279|NCT01614769|374660|P5|STARTED|7-Day Washout||1
154280|NCT01614769|374661|P4|STARTED|7-Day Washout||0
154281|NCT01614769|374662|P3|STARTED|7-Day Washout||2
154282|NCT01614769|374663|P2|STARTED|7-Day Washout||1
154283|NCT01614769|374664|P1|STARTED|7-Day Washout||1
154284|NCT01614769|374659|P6|NOT COMPLETED|Period 2||0
154285|NCT01614769|374660|P5|NOT COMPLETED|Period 2||0
154286|NCT01614769|374661|P4|NOT COMPLETED|Period 2||0
154287|NCT01614769|374662|P3|NOT COMPLETED|Period 2||0
154288|NCT01614769|374663|P2|NOT COMPLETED|Period 2||0
154289|NCT01614769|374664|P1|NOT COMPLETED|Period 2||0
154290|NCT01614769|374659|P6|COMPLETED|Period 2||1
154291|NCT01614769|374660|P5|COMPLETED|Period 2||1
154292|NCT01614769|374661|P4|COMPLETED|Period 2||0
154293|NCT01614769|374662|P3|COMPLETED|Period 2||2
154294|NCT01614769|374663|P2|COMPLETED|Period 2||1
154295|NCT01614769|374664|P1|COMPLETED|Period 2||1
154296|NCT01614769|374659|P6|STARTED|Period 2||1
154297|NCT01614769|374660|P5|STARTED|Period 2||1
154298|NCT01614769|374661|P4|STARTED|Period 2||0
154299|NCT01614769|374662|P3|STARTED|Period 2||2
154300|NCT01614769|374663|P2|STARTED|Period 2||1
154301|NCT01614769|374664|P1|STARTED|Period 2||1
154302|NCT01614769|374659|P6|NOT COMPLETED|7-Day Washout||0
154303|NCT01614769|374660|P5|NOT COMPLETED|7-Day Washout||0
154304|NCT01614769|374661|P4|NOT COMPLETED|7-Day Washout||0
154305|NCT01614769|374662|P3|NOT COMPLETED|7-Day Washout||0
154306|NCT01614769|374663|P2|NOT COMPLETED|7-Day Washout||0
154307|NCT01614769|374664|P1|NOT COMPLETED|7-Day Washout||0
154308|NCT01614769|374659|P6|COMPLETED|7-Day Washout||1
154309|NCT01614769|374660|P5|COMPLETED|7-Day Washout||1
154310|NCT01614769|374661|P4|COMPLETED|7-Day Washout||0
154311|NCT01614769|374662|P3|COMPLETED|7-Day Washout||2
154312|NCT01614769|374663|P2|COMPLETED|7-Day Washout||1
154313|NCT01614769|374664|P1|COMPLETED|7-Day Washout||1
154314|NCT01614769|374659|P6|STARTED|7-Day Washout||1
154315|NCT01614769|374660|P5|STARTED|7-Day Washout||1
154316|NCT01614769|374661|P4|STARTED|7-Day Washout||0
154317|NCT01614769|374662|P3|STARTED|7-Day Washout||2
154318|NCT01614769|374663|P2|STARTED|7-Day Washout||1
154319|NCT01614769|374664|P1|STARTED|7-Day Washout||1
154320|NCT01614769|374659|P6|NOT COMPLETED|Period 1||1
154321|NCT01614769|374660|P5|NOT COMPLETED|Period 1||0
154322|NCT01614769|374661|P4|NOT COMPLETED|Period 1||2
154323|NCT01614769|374662|P3|NOT COMPLETED|Period 1||0
154324|NCT01614769|374663|P2|NOT COMPLETED|Period 1||0
154325|NCT01614769|374664|P1|NOT COMPLETED|Period 1||1
154326|NCT01614769|374659|P6|COMPLETED|Period 1||1
154327|NCT01614769|374660|P5|COMPLETED|Period 1||1
154328|NCT01614769|374661|P4|COMPLETED|Period 1||0
154329|NCT01614769|374662|P3|COMPLETED|Period 1||2
154330|NCT01614769|374663|P2|COMPLETED|Period 1||1
154331|NCT01614769|374664|P1|COMPLETED|Period 1||1
154332|NCT01614769|374659|P6|STARTED|Period 1||2
154333|NCT01614769|374660|P5|STARTED|Period 1||1
154334|NCT01614769|374661|P4|STARTED|Period 1||2
154335|NCT01614769|374662|P3|STARTED|Period 1||2
154336|NCT01614769|374663|P2|STARTED|Period 1||1
154337|NCT01614769|374664|P1|STARTED|Period 1||2
154338|NCT01614613|374678|P1|NOT COMPLETED|Overall Study||0
154339|NCT01614613|374678|P1|COMPLETED|Overall Study||146
154340|NCT01614613|374678|P1|STARTED|Overall Study||146
154341|NCT01614600|374686|P1|NOT COMPLETED|Overall Study||4
154342|NCT01614600|374686|P1|COMPLETED|Overall Study||84
154343|NCT01614600|374686|P1|STARTED|Overall Study||88
154344|NCT01614574|374690|P1|NOT COMPLETED|Overall Study||0
154345|NCT01614574|374690|P1|COMPLETED|Overall Study||6
154346|NCT01614574|374690|P1|STARTED|Overall Study||6
154347|NCT01614509|374706|P2|NOT COMPLETED|Overall Study||3
154348|NCT01614509|374707|P1|NOT COMPLETED|Overall Study||1
154349|NCT01614509|374706|P2|COMPLETED|Overall Study||18
154350|NCT01614509|374707|P1|COMPLETED|Overall Study||23
154351|NCT01614509|374706|P2|STARTED|Overall Study||21
154352|NCT01614509|374707|P1|STARTED|Overall Study||24
154353|NCT01614470|374717|P3|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
154354|NCT01614470|374718|P2|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
154355|NCT01614470|374719|P1|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
154356|NCT01614470|374717|P3|COMPLETED|Part 2: Open-label Period (16 Weeks)||36
154357|NCT01614470|374718|P2|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
154358|NCT01614470|374719|P1|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
154359|NCT01614470|374717|P3|STARTED|Part 2: Open-label Period (16 Weeks)||36
154360|NCT01614470|374718|P2|STARTED|Part 2: Open-label Period (16 Weeks)||0
154361|NCT01614470|374719|P1|STARTED|Part 2: Open-label Period (16 Weeks)||0
154362|NCT01614470|374717|P3|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
154363|NCT01614470|374718|P2|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
154364|NCT01614470|374719|P1|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
154365|NCT01614470|374717|P3|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
154366|NCT01614470|374718|P2|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
154367|NCT01614470|374719|P1|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
154368|NCT01614470|374717|P3|STARTED|Part 1: Treatment Period 2 (8 Weeks)||0
154369|NCT01614470|374718|P2|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
154370|NCT01614470|374719|P1|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
154371|NCT01614470|374717|P3|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
154372|NCT01614470|374718|P2|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
154373|NCT01614470|374719|P1|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
154374|NCT01614470|374717|P3|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
154375|NCT01614470|374718|P2|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
154376|NCT01614470|374719|P1|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
154377|NCT01614470|374717|P3|STARTED|Part 1: Washout Period (4 to 8 Weeks)||0
154378|NCT01614470|374718|P2|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
154379|NCT01614470|374719|P1|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
154380|NCT01614470|374717|P3|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
154381|NCT01614470|374718|P2|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||1
154382|NCT01614470|374719|P1|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||2
154383|NCT01614470|374717|P3|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
154384|NCT01614470|374718|P2|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
154385|NCT01614470|374719|P1|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
154386|NCT01614470|374717|P3|STARTED|Part 1: Treatment Period 1 (8 Weeks)||0
154387|NCT01614470|374718|P2|STARTED|Part 1: Treatment Period 1 (8 Weeks)||19
154388|NCT01614470|374719|P1|STARTED|Part 1: Treatment Period 1 (8 Weeks)||20
154389|NCT01614457|374741|P2|NOT COMPLETED|Overall Study||0
154390|NCT01614457|374742|P1|NOT COMPLETED|Overall Study||2
154391|NCT01614457|374741|P2|COMPLETED|Overall Study||35
154392|NCT01614457|374742|P1|COMPLETED|Overall Study||32
154393|NCT01614457|374741|P2|STARTED|Overall Study||35
154394|NCT01614457|374742|P1|STARTED|Overall Study||34
154395|NCT01614392|374760|P2|NOT COMPLETED|Overall Study||3
154396|NCT01614392|374761|P1|NOT COMPLETED|Overall Study||1
154397|NCT01614392|374760|P2|COMPLETED|Overall Study||24
154398|NCT01614392|374761|P1|COMPLETED|Overall Study||24
154399|NCT01614392|374760|P2|STARTED|Overall Study||27
154400|NCT01614392|374761|P1|STARTED|Overall Study||25
154401|NCT01614249|374769|P2|NOT COMPLETED|Overall Study||23
154402|NCT01614249|374770|P1|NOT COMPLETED|Overall Study||11
154403|NCT01614249|374769|P2|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|86
154404|NCT01614249|374770|P1|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|96
154405|NCT01614249|374769|P2|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|86
154406|NCT01614249|374770|P1|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|96
154407|NCT01614249|374769|P2|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|92
154408|NCT01614249|374770|P1|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|98
154409|NCT01614249|374769|P2|STARTED|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|109
154410|NCT01614249|374770|P1|STARTED|Overall Study|Participants received every two-weeks supply and monitored regularly on cell-phone and face-to-face.|107
154411|NCT01614210|374776|P1|NOT COMPLETED|Overall Study||0
154412|NCT01614210|374776|P1|COMPLETED|Overall Study||52
154413|NCT01614210|374776|P1|STARTED|Overall Study||52
154414|NCT01614093|374784|P1|NOT COMPLETED|Overall Study||1
154415|NCT01614093|374784|P1|COMPLETED|Overall Study||16
154416|NCT01614093|374784|P1|STARTED|Overall Study||17
154417|NCT01613768|374789|P1|NOT COMPLETED|Overall Study||0
154418|NCT01613768|374789|P1|COMPLETED|Overall Study||29
154419|NCT01613768|374789|P1|STARTED|Overall Study||29
154420|NCT01613716|374797|P1|NOT COMPLETED|Overall Study||7
154421|NCT01613716|374797|P1|COMPLETED|Overall Study||23
154422|NCT01613716|374797|P1|STARTED|Overall Study||30
154423|NCT01613599|374802|P1|NOT COMPLETED|Overall Study||25
154424|NCT01613599|374802|P1|COMPLETED|Overall Study||72
154425|NCT01613599|374802|P1|STARTED|Overall Study||97
154426|NCT01613417|374817|P2|NOT COMPLETED|Second Injection||0
154427|NCT01613417|374818|P1|NOT COMPLETED|Second Injection||0
154428|NCT01613417|374817|P2|COMPLETED|Second Injection||109
154429|NCT01613417|374818|P1|COMPLETED|Second Injection||100
154430|NCT01613417|374817|P2|STARTED|Second Injection||109
154431|NCT01613417|374818|P1|STARTED|Second Injection||100
154432|NCT01613417|374817|P2|NOT COMPLETED|Washout (no Second Injection/MRI)||7
154433|NCT01613417|374818|P1|NOT COMPLETED|Washout (no Second Injection/MRI)||13
154434|NCT01613417|374817|P2|COMPLETED|Washout (no Second Injection/MRI)||109
154435|NCT01613417|374818|P1|COMPLETED|Washout (no Second Injection/MRI)||100
154436|NCT01613417|374817|P2|STARTED|Washout (no Second Injection/MRI)||116
154437|NCT01613417|374818|P1|STARTED|Washout (no Second Injection/MRI)||113
154438|NCT01613417|374817|P2|NOT COMPLETED|First Injection||0
154439|NCT01613417|374818|P1|NOT COMPLETED|First Injection||0
154440|NCT01613417|374817|P2|COMPLETED|First Injection||116
154441|NCT01613417|374818|P1|COMPLETED|First Injection||113
154442|NCT01613417|374817|P2|STARTED|First Injection||116
154443|NCT01613417|374818|P1|STARTED|First Injection||113
154444|NCT01613378|374855|P1|NOT COMPLETED|Overall Study||39
154445|NCT01613378|374855|P1|COMPLETED|Overall Study||161
154446|NCT01613378|374855|P1|STARTED|Overall Study||200
154447|NCT01613339|374873|P2|NOT COMPLETED|Overall Study||1
154448|NCT01613339|374874|P1|NOT COMPLETED|Overall Study||3
154449|NCT01613339|374873|P2|COMPLETED|Overall Study||21
154450|NCT01613339|374874|P1|COMPLETED|Overall Study||21
154451|NCT01613339|374873|P2|STARTED|Overall Study||22
154452|NCT01613339|374874|P1|STARTED|Overall Study||24
154453|NCT01613326|374885|P2|NOT COMPLETED|Overall Study||14
154454|NCT01613326|374886|P1|NOT COMPLETED|Overall Study||13
154455|NCT01613326|374885|P2|COMPLETED|Overall Study||316
154456|NCT01613326|374886|P1|COMPLETED|Overall Study||314
154457|NCT01613326|374885|P2|STARTED|Overall Study||330
154458|NCT01613326|374886|P1|STARTED|Overall Study||327
154459|NCT01613313|374920|P4|NOT COMPLETED|Overall Study||0
154460|NCT01613313|374921|P3|NOT COMPLETED|Overall Study||0
154461|NCT01613313|374922|P2|NOT COMPLETED|Overall Study||0
154462|NCT01613313|374923|P1|NOT COMPLETED|Overall Study||0
154463|NCT01613313|374920|P4|COMPLETED|Overall Study||4
154464|NCT01613313|374921|P3|COMPLETED|Overall Study||4
154465|NCT01613313|374922|P2|COMPLETED|Overall Study||4
154466|NCT01613313|374923|P1|COMPLETED|Overall Study||2
154467|NCT01613313|374920|P4|STARTED|Overall Study||4
154468|NCT01613313|374921|P3|STARTED|Overall Study||4
154469|NCT01613313|374922|P2|STARTED|Overall Study||4
154470|NCT01613313|374923|P1|STARTED|Overall Study||2
154471|NCT01613248|374943|P6|NOT COMPLETED|Overall Study||38
154472|NCT01613248|374944|P5|NOT COMPLETED|Overall Study||35
154473|NCT01613248|374945|P4|NOT COMPLETED|Overall Study||38
154474|NCT01613248|374946|P3|NOT COMPLETED|Overall Study||33
154475|NCT01613248|374947|P2|NOT COMPLETED|Overall Study||34
154476|NCT01613248|374948|P1|NOT COMPLETED|Overall Study||29
154477|NCT01613248|374943|P6|COMPLETED|Overall Study||102
154478|NCT01613248|374944|P5|COMPLETED|Overall Study||104
154479|NCT01613248|374945|P4|COMPLETED|Overall Study||101
154480|NCT01613248|374946|P3|COMPLETED|Overall Study||106
154481|NCT01613248|374947|P2|COMPLETED|Overall Study||104
154482|NCT01613248|374948|P1|COMPLETED|Overall Study||110
154483|NCT01613248|374943|P6|STARTED|Overall Study||140
154484|NCT01613248|374944|P5|STARTED|Overall Study||139
154485|NCT01613248|374945|P4|STARTED|Overall Study||139
154486|NCT01613248|374946|P3|STARTED|Overall Study||139
154487|NCT01613248|374947|P2|STARTED|Overall Study||138
154488|NCT01613248|374948|P1|STARTED|Overall Study||139
154489|NCT01613222|375046|P1|NOT COMPLETED|Overall Study||12
154490|NCT01613222|375046|P1|COMPLETED|Overall Study||51
154491|NCT01613222|375046|P1|STARTED|Overall Study||63
154492|NCT01613131|375061|P2|NOT COMPLETED|Overall Study||5
154493|NCT01613131|375062|P1|NOT COMPLETED|Overall Study||3
154494|NCT01613131|375061|P2|COMPLETED|Overall Study||13
154495|NCT01613131|375062|P1|COMPLETED|Overall Study||17
154496|NCT01613131|375061|P2|STARTED|Overall Study||18
154497|NCT01613131|375062|P1|STARTED|Overall Study||20
154498|NCT01613027|375090|P1|NOT COMPLETED|Overall Study||8
154499|NCT01613027|375090|P1|COMPLETED|Overall Study||127
154500|NCT01613027|375090|P1|STARTED|Overall Study||135
154501|NCT01613014|375111|P2|NOT COMPLETED|Overall Study||12
154502|NCT01613014|375112|P1|NOT COMPLETED|Overall Study||18
154503|NCT01613014|375111|P2|COMPLETED|Overall Study||63
154504|NCT01613014|375112|P1|COMPLETED|Overall Study||57
154505|NCT01613014|375111|P2|STARTED|Overall Study||75
154506|NCT01613014|375112|P1|STARTED|Overall Study||75
154507|NCT01612884|375120|P2|NOT COMPLETED|Overall Study||0
154508|NCT01612884|375121|P1|NOT COMPLETED|Overall Study||0
154509|NCT01612884|375120|P2|COMPLETED|Overall Study||18
154510|NCT01612884|375121|P1|COMPLETED|Overall Study||19
154511|NCT01612884|375120|P2|STARTED|Overall Study||18
154512|NCT01612884|375121|P1|STARTED|Overall Study||19
154513|NCT01612858|375133|P2|NOT COMPLETED|Overall Study||1
154514|NCT01612858|375134|P1|NOT COMPLETED|Overall Study||5
154515|NCT01612858|375133|P2|COMPLETED|Overall Study||3
154516|NCT01612858|375134|P1|COMPLETED|Overall Study||11
154517|NCT01612858|375133|P2|STARTED|Overall Study||4
154518|NCT01612858|375134|P1|STARTED|Overall Study||16
154519|NCT01612793|375144|P2|NOT COMPLETED|Overall Study||0
154520|NCT01612793|375145|P1|NOT COMPLETED|Overall Study||0
154521|NCT01612793|375144|P2|COMPLETED|Overall Study||2
154522|NCT01612793|375145|P1|COMPLETED|Overall Study||2
154523|NCT01612793|375144|P2|STARTED|Overall Study||2
154524|NCT01612793|375145|P1|STARTED|Overall Study||2
154525|NCT01612767|375151|P1|NOT COMPLETED|Overall Study||42
154526|NCT01612767|375151|P1|COMPLETED|Overall Study||287
154527|NCT01612767|375151|P1|STARTED|Overall Study||329
154528|NCT01612702|375207|P2|NOT COMPLETED|Overall Study||11
154529|NCT01612702|375208|P1|NOT COMPLETED|Overall Study||11
154530|NCT01612702|375207|P2|COMPLETED|Overall Study||134
154531|NCT01612702|375208|P1|COMPLETED|Overall Study||135
154532|NCT01612702|375207|P2|STARTED|Overall Study||145
154533|NCT01612702|375208|P1|STARTED|Overall Study||146
154534|NCT01612676|375222|P4|NOT COMPLETED|Overall Study||3
154535|NCT01612676|375223|P3|NOT COMPLETED|Overall Study||1
154536|NCT01612676|375224|P2|NOT COMPLETED|Overall Study||4
154537|NCT01612676|375225|P1|NOT COMPLETED|Overall Study||2
154538|NCT01612676|375222|P4|COMPLETED|Overall Study||10
154539|NCT01612676|375223|P3|COMPLETED|Overall Study||4
154540|NCT01612676|375224|P2|COMPLETED|Overall Study||3
154541|NCT01612676|375225|P1|COMPLETED|Overall Study||4
154542|NCT01612676|375222|P4|Dosed|Overall Study||13
154543|NCT01612676|375223|P3|Dosed|Overall Study||5
154544|NCT01612676|375224|P2|Dosed|Overall Study||7
154545|NCT01612676|375225|P1|Dosed|Overall Study||5
154546|NCT01612676|375222|P4|STARTED|Overall Study||13
154547|NCT01612676|375223|P3|STARTED|Overall Study||5
154548|NCT01612676|375224|P2|STARTED|Overall Study||7
154549|NCT01612676|375225|P1|STARTED|Overall Study||6
154550|NCT01612546|375281|P1|NOT COMPLETED|Overall Study||0
154551|NCT01612546|375281|P1|COMPLETED|Overall Study||10
154552|NCT01612546|375281|P1|STARTED|Overall Study||10
154553|NCT01612494|375291|P2|NOT COMPLETED|Overall Study||0
154554|NCT01612494|375292|P1|NOT COMPLETED|Overall Study||0
154555|NCT01612494|375291|P2|COMPLETED|Overall Study||23
154556|NCT01612494|375292|P1|COMPLETED|Overall Study||21
154557|NCT01612494|375291|P2|STARTED|Overall Study||23
154558|NCT01612494|375292|P1|STARTED|Overall Study||21
154559|NCT01612351|375298|P1|NOT COMPLETED|Post-Operative Treatment||0
154560|NCT01612351|375298|P1|COMPLETED|Post-Operative Treatment|One patient completed chemotherapy then withdrew before surgery.|39
154561|NCT01612351|375298|P1|STARTED|Post-Operative Treatment||39
154562|NCT01612351|375298|P1|NOT COMPLETED|Transoral Surgery||0
154563|NCT01612351|375298|P1|COMPLETED|Transoral Surgery||39
154564|NCT01612351|375298|P1|STARTED|Transoral Surgery|One patient completed chemotherapy then withdrew before surgery.|39
154565|NCT01612351|375298|P1|NOT COMPLETED|Chemotherapy||0
154566|NCT01612351|375298|P1|COMPLETED|Chemotherapy||40
154567|NCT01612351|375298|P1|STARTED|Chemotherapy||40
154568|NCT01612221|375312|P2|NOT COMPLETED|Overall Study||0
154569|NCT01612221|375313|P1|NOT COMPLETED|Overall Study||0
154570|NCT01612221|375312|P2|COMPLETED|Overall Study||50
154571|NCT01612221|375313|P1|COMPLETED|Overall Study||50
154572|NCT01612221|375312|P2|STARTED|Overall Study||50
154573|NCT01612221|375313|P1|STARTED|Overall Study||50
154574|NCT01612156|375323|P2|NOT COMPLETED|Overall Study||0
154575|NCT01612156|375324|P1|NOT COMPLETED|Overall Study||2
154576|NCT01612156|375323|P2|COMPLETED|Overall Study||48
154577|NCT01612156|375324|P1|COMPLETED|Overall Study|Contraindication to urodynamics (urinary tract infection) diagnosed after randomization|40
154578|NCT01612156|375323|P2|STARTED|Overall Study||48
154579|NCT01612156|375324|P1|STARTED|Overall Study||42
154580|NCT01612000|375336|P4|NOT COMPLETED|Overall Study||10
154581|NCT01612000|375337|P3|NOT COMPLETED|Overall Study||7
154582|NCT01612000|375338|P2|NOT COMPLETED|Overall Study||5
154583|NCT01612000|375339|P1|NOT COMPLETED|Overall Study||9
154584|NCT01612000|375336|P4|COMPLETED|Overall Study||76
154585|NCT01612000|375337|P3|COMPLETED|Overall Study||78
154586|NCT01612000|375338|P2|COMPLETED|Overall Study||81
154587|NCT01612000|375339|P1|COMPLETED|Overall Study||75
154588|NCT01612000|375336|P4|STARTED|Overall Study||86
154589|NCT01612000|375337|P3|STARTED|Overall Study||85
154590|NCT01612000|375338|P2|STARTED|Overall Study||86
154591|NCT01612000|375339|P1|STARTED|Overall Study||84
154592|NCT01611974|375364|P3|NOT COMPLETED|Overall Study||16
154593|NCT01611974|375365|P2|NOT COMPLETED|Overall Study||15
154594|NCT01611974|375366|P1|NOT COMPLETED|Overall Study||15
154595|NCT01611974|375364|P3|COMPLETED|Overall Study||24
154596|NCT01611974|375365|P2|COMPLETED|Overall Study||25
154597|NCT01611974|375366|P1|COMPLETED|Overall Study||25
154598|NCT01611974|375364|P3|STARTED|Overall Study||40
154599|NCT01611974|375365|P2|STARTED|Overall Study||40
154600|NCT01611974|375366|P1|STARTED|Overall Study||40
154601|NCT01611948|375403|P2|NOT COMPLETED|Overall Study||12
154602|NCT01611948|375404|P1|NOT COMPLETED|Overall Study||14
154603|NCT01611948|375403|P2|COMPLETED|Overall Study||26
154604|NCT01611948|375404|P1|COMPLETED|Overall Study||18
154605|NCT01611948|375403|P2|STARTED|Overall Study||38
154606|NCT01611948|375404|P1|STARTED|Overall Study||32
154607|NCT01611935|375412|P2|NOT COMPLETED|Overall Study||0
154608|NCT01611935|375413|P1|NOT COMPLETED|Overall Study||1
154609|NCT01611935|375412|P2|COMPLETED|Overall Study||51
154610|NCT01611935|375413|P1|COMPLETED|Overall Study||49
154611|NCT01611935|375412|P2|STARTED|Overall Study||51
154612|NCT01611935|375413|P1|STARTED|Overall Study||50
154613|NCT01611883|375425|P2|NOT COMPLETED|Overall Study||1
154614|NCT01611883|375426|P1|NOT COMPLETED|Overall Study||1
154615|NCT01611883|375425|P2|COMPLETED|Overall Study||76
154616|NCT01611883|375426|P1|COMPLETED|Overall Study||74
154617|NCT01611883|375425|P2|STARTED|Overall Study||77
154618|NCT01611883|375426|P1|STARTED|Overall Study||75
154619|NCT01611857|375452|P2|NOT COMPLETED|Overall Study||2
154620|NCT01611857|375453|P1|NOT COMPLETED|Overall Study||0
154621|NCT01611857|375452|P2|COMPLETED|Overall Study||32
154622|NCT01611857|375453|P1|COMPLETED|Overall Study||15
154623|NCT01611857|375452|P2|Tivantinib 360 mg|Overall Study|Two participants withdrew prior to receiving drug.|32
154624|NCT01611857|375453|P1|Tivantinib 360 mg|Overall Study||7
154625|NCT01611857|375452|P2|Tivantinib 240 mg|Overall Study||0
154626|NCT01611857|375453|P1|Tivantinib 240 mg|Overall Study||3
154627|NCT01611857|375452|P2|Tivantinib 120 mg|Overall Study||0
154628|NCT01611857|375453|P1|Tivantinib 120 mg|Overall Study||5
154629|NCT01611857|375452|P2|STARTED|Overall Study||34
154630|NCT01611857|375453|P1|STARTED|Overall Study|Three dose levels of tivantinib (120 mg, 240 mg, and 360 mg) were evaluated to determine the MTD.|15
154631|NCT01611792|375465|P2|NOT COMPLETED|Followup: at 6 Months||13
154632|NCT01611792|375466|P1|NOT COMPLETED|Followup: at 6 Months||6
154633|NCT01611792|375465|P2|COMPLETED|Followup: at 6 Months||7
154634|NCT01611792|375466|P1|COMPLETED|Followup: at 6 Months||11
154635|NCT01611792|375465|P2|STARTED|Followup: at 6 Months||20
154636|NCT01611792|375466|P1|STARTED|Followup: at 6 Months||17
154637|NCT01611792|375465|P2|NOT COMPLETED|Follow-up: at 11 Weeks||0
154638|NCT01611792|375466|P1|NOT COMPLETED|Follow-up: at 11 Weeks||0
154639|NCT01611792|375465|P2|COMPLETED|Follow-up: at 11 Weeks||20
154640|NCT01611792|375466|P1|COMPLETED|Follow-up: at 11 Weeks||17
154641|NCT01611792|375465|P2|STARTED|Follow-up: at 11 Weeks||20
154642|NCT01611792|375466|P1|STARTED|Follow-up: at 11 Weeks||17
154643|NCT01611792|375465|P2|NOT COMPLETED|Initial Period: Time 0||9
154644|NCT01611792|375466|P1|NOT COMPLETED|Initial Period: Time 0||12
154645|NCT01611792|375465|P2|COMPLETED|Initial Period: Time 0||20
154646|NCT01611792|375466|P1|COMPLETED|Initial Period: Time 0||17
154647|NCT01611792|375465|P2|STARTED|Initial Period: Time 0||29
154648|NCT01611792|375466|P1|STARTED|Initial Period: Time 0||29
154649|NCT01611779|375482|P1|NOT COMPLETED|Overall Study||0
154650|NCT01611779|375482|P1|COMPLETED|Overall Study||5
154651|NCT01611779|375482|P1|STARTED|Overall Study||5
154652|NCT01611662|375491|P1|NOT COMPLETED|Overall Study||1
154653|NCT01611662|375491|P1|COMPLETED|Overall Study||31
154654|NCT01611662|375491|P1|STARTED|Overall Study||32
154655|NCT01611571|375498|P3|NOT COMPLETED|Overall Study||1
154656|NCT01611571|375499|P2|NOT COMPLETED|Overall Study||0
154657|NCT01611571|375500|P1|NOT COMPLETED|Overall Study||1
154658|NCT01611571|375498|P3|COMPLETED|Overall Study||9
154659|NCT01611571|375499|P2|COMPLETED|Overall Study||10
154660|NCT01611571|375500|P1|COMPLETED|Overall Study||10
154661|NCT01611571|375498|P3|STARTED|Overall Study||10
154662|NCT01611571|375499|P2|STARTED|Overall Study||10
154663|NCT01611571|375500|P1|STARTED|Overall Study||11
154664|NCT01611558|375520|P1|NOT COMPLETED|Maintenance Phase||2
154665|NCT01611558|375520|P1|COMPLETED|Maintenance Phase||0
154666|NCT01611558|375520|P1|STARTED|Maintenance Phase||2
154667|NCT01611558|375520|P1|NOT COMPLETED|Induction Phase||38
154668|NCT01611558|375520|P1|COMPLETED|Induction Phase||2
154669|NCT01611558|375520|P1|STARTED|Induction Phase||40
154670|NCT01611259|375526|P1|NOT COMPLETED|Overall Study||14
154671|NCT01611259|375526|P1|COMPLETED|Overall Study||34
154672|NCT01611259|375526|P1|STARTED|Overall Study||48
154673|NCT01611194|375532|P2|NOT COMPLETED|Overall Study||3
154674|NCT01611194|375533|P1|NOT COMPLETED|Overall Study||0
154675|NCT01611194|375532|P2|COMPLETED|Overall Study||32
154676|NCT01611194|375533|P1|COMPLETED|Overall Study||36
154677|NCT01611194|375532|P2|STARTED|Overall Study||35
154678|NCT01611194|375533|P1|STARTED|Overall Study||36
154679|NCT01611155|375571|P2|NOT COMPLETED|Overall Study||7
154680|NCT01611155|375572|P1|NOT COMPLETED|Overall Study||9
154681|NCT01611155|375571|P2|COMPLETED|Overall Study||18
154682|NCT01611155|375572|P1|COMPLETED|Overall Study||16
154683|NCT01611155|375571|P2|Received Treatment|Overall Study||25
154684|NCT01611155|375572|P1|Received Treatment|Overall Study||25
154685|NCT01611155|375571|P2|STARTED|Overall Study||25
154686|NCT01611155|375572|P1|STARTED|Overall Study||25
154687|NCT01610791|375580|P1|NOT COMPLETED|Overall Study||21
154688|NCT01610791|375580|P1|COMPLETED|Overall Study||100
154689|NCT01610791|375580|P1|STARTED|Overall Study||121
154690|NCT01610752|375604|P3|NOT COMPLETED|Overall Study||4
154691|NCT01610752|375605|P2|NOT COMPLETED|Overall Study||0
154692|NCT01610752|375606|P1|NOT COMPLETED|Overall Study||0
154693|NCT01610752|375604|P3|COMPLETED|Overall Study||13
154694|NCT01610752|375605|P2|COMPLETED|Overall Study||19
154695|NCT01610752|375606|P1|COMPLETED|Overall Study||18
154696|NCT01610752|375604|P3|STARTED|Overall Study||17
154697|NCT01610752|375605|P2|STARTED|Overall Study||19
154698|NCT01610752|375606|P1|STARTED|Overall Study||18
154699|NCT01610713|375628|P2|NOT COMPLETED|Overall Study||1
154700|NCT01610713|375629|P1|NOT COMPLETED|Overall Study||6
154701|NCT01610713|375628|P2|COMPLETED|Overall Study||76
154702|NCT01610713|375629|P1|COMPLETED|Overall Study||71
154703|NCT01610713|375628|P2|STARTED|Overall Study||77
154704|NCT01610713|375629|P1|STARTED|Overall Study||77
154705|NCT01610700|375687|P2|NOT COMPLETED|Overall Study||3
154706|NCT01610700|375688|P1|NOT COMPLETED|Overall Study||3
154707|NCT01610700|375687|P2|COMPLETED|Overall Study||77
154708|NCT01610700|375688|P1|COMPLETED|Overall Study||77
154709|NCT01610700|375687|P2|STARTED|Overall Study||80
154710|NCT01610700|375688|P1|STARTED|Overall Study||80
154711|NCT01610687|375742|P1|NOT COMPLETED|Overall Study||67
154712|NCT01610687|375742|P1|COMPLETED|Overall Study||70
154713|NCT01610687|375742|P1|STARTED|Overall Study||137
154714|NCT01610596|375755|P2|NOT COMPLETED|Overall Study||1
154715|NCT01610596|375756|P1|NOT COMPLETED|Overall Study||0
154716|NCT01610596|375755|P2|COMPLETED|Overall Study||35
154717|NCT01610596|375756|P1|COMPLETED|Overall Study||36
154718|NCT01610596|375755|P2|STARTED|Overall Study||36
154719|NCT01610596|375756|P1|STARTED|Overall Study||36
154720|NCT01610570|375772|P4|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
154721|NCT01610570|375773|P3|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
154722|NCT01610570|375774|P2|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
154723|NCT01610570|375775|P1|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
154724|NCT01610570|375772|P4|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
154725|NCT01610570|375773|P3|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
154726|NCT01610570|375774|P2|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
154727|NCT01610570|375775|P1|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
154728|NCT01610570|375772|P4|STARTED|Ph II >/= 12 mo. & </=17yrs||0
154729|NCT01610570|375773|P3|STARTED|Ph II >/= 12 mo. & </=17yrs||0
154730|NCT01610570|375774|P2|STARTED|Ph II >/= 12 mo. & </=17yrs||0
154731|NCT01610570|375775|P1|STARTED|Ph II >/= 12 mo. & </=17yrs||0
154732|NCT01610570|375772|P4|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
154733|NCT01610570|375773|P3|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
154734|NCT01610570|375774|P2|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
154735|NCT01610570|375775|P1|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
154736|NCT01610570|375772|P4|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||6
154737|NCT01610570|375773|P3|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
154738|NCT01610570|375774|P2|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
154739|NCT01610570|375775|P1|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
154740|NCT01610570|375772|P4|STARTED|Ph II >/= 18yrs of Age at Enrollment||6
154741|NCT01610570|375773|P3|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
154742|NCT01610570|375774|P2|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
154743|NCT01610570|375775|P1|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
154744|NCT01610570|375772|P4|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
154745|NCT01610570|375773|P3|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
154746|NCT01610570|375774|P2|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
154747|NCT01610570|375775|P1|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
154748|NCT01610570|375772|P4|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
154749|NCT01610570|375773|P3|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
154750|NCT01610570|375774|P2|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||2
154751|NCT01610570|375775|P1|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
154752|NCT01610570|375772|P4|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
154753|NCT01610570|375773|P3|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
154754|NCT01610570|375774|P2|STARTED|Ph I >/= 12 mo. Children & Adolescents||2
154755|NCT01610570|375775|P1|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
154756|NCT01610557|375814|P5|NOT COMPLETED|Post-36-Week Extension Phase||3
154757|NCT01610557|375815|P4|NOT COMPLETED|Post-36-Week Extension Phase||0
154758|NCT01610557|375816|P3|NOT COMPLETED|Post-36-Week Extension Phase||0
154759|NCT01610557|375817|P2|NOT COMPLETED|Post-36-Week Extension Phase||0
154760|NCT01610557|375818|P1|NOT COMPLETED|Post-36-Week Extension Phase||0
154761|NCT01610557|375814|P5|COMPLETED|Post-36-Week Extension Phase|2 bilateral participants withdrew before their first post-36-week extension visit|52
154762|NCT01610557|375815|P4|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
154763|NCT01610557|375816|P3|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
154764|NCT01610557|375817|P2|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
154765|NCT01610557|375818|P1|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
154766|NCT01610557|375814|P5|STARTED|Post-36-Week Extension Phase||55
154767|NCT01610557|375815|P4|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
154768|NCT01610557|375816|P3|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
154769|NCT01610557|375817|P2|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
154770|NCT01610557|375818|P1|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
154771|NCT01610557|375814|P5|NOT COMPLETED|36-Week Randomized Crossover Phase||0
154772|NCT01610557|375815|P4|NOT COMPLETED|36-Week Randomized Crossover Phase||0
154773|NCT01610557|375816|P3|NOT COMPLETED|36-Week Randomized Crossover Phase||0
154774|NCT01610557|375817|P2|NOT COMPLETED|36-Week Randomized Crossover Phase||1
154775|NCT01610557|375818|P1|NOT COMPLETED|36-Week Randomized Crossover Phase||0
154776|NCT01610557|375814|P5|COMPLETED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
154777|NCT01610557|375815|P4|COMPLETED|36-Week Randomized Crossover Phase||13
154778|NCT01610557|375816|P3|COMPLETED|36-Week Randomized Crossover Phase||14
154779|NCT01610557|375817|P2|COMPLETED|36-Week Randomized Crossover Phase|Unilateral participant unable to return for visits after Wk 4 due to recovery from an adverse event|12
154780|NCT01610557|375818|P1|COMPLETED|36-Week Randomized Crossover Phase||16
154781|NCT01610557|375814|P5|STARTED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
154782|NCT01610557|375815|P4|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 4: 11 unilateral and 2 bilateral (left eye assigned to Grp 2)|13
154783|NCT01610557|375816|P3|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 3: 13 unilateral and 1 bilateral (left eye assigned to Grp 1)|14
154784|NCT01610557|375817|P2|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 2: 12 unilateral and 1 bilateral (left eye assigned to Grp 4)|13
154785|NCT01610557|375818|P1|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 1: 14 unilateral and 2 bilateral (left eye assigned to Grp 3)|16
154786|NCT01610492|375831|P1|NOT COMPLETED|Overall Study||6
154787|NCT01610492|375831|P1|COMPLETED|Overall Study||8
154788|NCT01610492|375831|P1|STARTED|Overall Study||14
154789|NCT01610453|375875|P1|NOT COMPLETED|Overall Study||0
154790|NCT01610453|375875|P1|COMPLETED|Overall Study||150
154791|NCT01610453|375875|P1|STARTED|Overall Study||150
154792|NCT01610414|375882|P2|NOT COMPLETED|After Month 25||53
154793|NCT01610414|375883|P1|NOT COMPLETED|After Month 25||48
154794|NCT01610414|375882|P2|COMPLETED|After Month 25||871
154795|NCT01610414|375883|P1|COMPLETED|After Month 25||874
154796|NCT01610414|375882|P2|STARTED|After Month 25||924
154797|NCT01610414|375883|P1|STARTED|After Month 25||922
154798|NCT01610414|375882|P2|NOT COMPLETED|Month 13 - Month 25||70
154799|NCT01610414|375883|P1|NOT COMPLETED|Month 13 - Month 25||65
154800|NCT01610414|375882|P2|COMPLETED|Month 13 - Month 25||854
154801|NCT01610414|375883|P1|COMPLETED|Month 13 - Month 25||857
154802|NCT01610414|375882|P2|STARTED|Month 13 - Month 25||924
154803|NCT01610414|375883|P1|STARTED|Month 13 - Month 25||922
154804|NCT01610414|375882|P2|NOT COMPLETED|Study Start - Month 13||129
154805|NCT01610414|375883|P1|NOT COMPLETED|Study Start - Month 13||115
154806|NCT01610414|375882|P2|COMPLETED|Study Start - Month 13||795
154807|NCT01610414|375883|P1|COMPLETED|Study Start - Month 13||807
154808|NCT01610414|375882|P2|STARTED|Study Start - Month 13||924
154809|NCT01610414|375883|P1|STARTED|Study Start - Month 13||922
154810|NCT01610297|375912|P1|NOT COMPLETED|Overall Study||1
154811|NCT01610297|375912|P1|COMPLETED|Overall Study||26
154812|NCT01610297|375912|P1|STARTED|Overall Study||27
154813|NCT01610271|375922|P2|NOT COMPLETED|Overall Study||4
154814|NCT01610271|375923|P1|NOT COMPLETED|Overall Study||2
154815|NCT01610271|375922|P2|COMPLETED|Overall Study||146
154816|NCT01610271|375923|P1|COMPLETED|Overall Study||148
154817|NCT01610271|375922|P2|STARTED|Overall Study||150
154818|NCT01610271|375923|P1|STARTED|Overall Study||150
154819|NCT01610167|375938|P3|NOT COMPLETED|Overall Study||2
154820|NCT01610167|375939|P2|NOT COMPLETED|Overall Study||0
154821|NCT01610167|375940|P1|NOT COMPLETED|Overall Study||0
154822|NCT01610167|375938|P3|COMPLETED|Overall Study||48
154823|NCT01610167|375939|P2|COMPLETED|Overall Study||49
154824|NCT01610167|375940|P1|COMPLETED|Overall Study||52
154825|NCT01610167|375938|P3|STARTED|Overall Study||50
154826|NCT01610167|375939|P2|STARTED|Overall Study||49
154827|NCT01610167|375940|P1|STARTED|Overall Study||52
154828|NCT01610154|375960|P1|NOT COMPLETED|Overall Study||1
154829|NCT01610154|375960|P1|COMPLETED|Overall Study||84
154830|NCT01610154|375960|P1|STARTED|Overall Study||85
154831|NCT01610076|375977|P2|NOT COMPLETED|Overall Study||5
154832|NCT01610076|375978|P1|NOT COMPLETED|Overall Study||3
154833|NCT01610076|375977|P2|COMPLETED|Overall Study||100
154834|NCT01610076|375978|P1|COMPLETED|Overall Study||100
154835|NCT01610076|375977|P2|STARTED|Overall Study||105
154836|NCT01610076|375978|P1|STARTED|Overall Study||103
154837|NCT01610063|375989|P2|NOT COMPLETED|Overall Study||20
154838|NCT01610063|375990|P1|NOT COMPLETED|Overall Study||42
154839|NCT01610063|375989|P2|COMPLETED|Overall Study||93
154840|NCT01610063|375990|P1|COMPLETED|Overall Study||72
154841|NCT01610063|375989|P2|Completed 8-week|Overall Study||93
154842|NCT01610063|375990|P1|Completed 8-week|Overall Study||72
154843|NCT01610063|375989|P2|Completed 4-week|Overall Study||98
154844|NCT01610063|375990|P1|Completed 4-week|Overall Study||86
154845|NCT01610063|375989|P2|Completed 2-week|Overall Study||105
154846|NCT01610063|375990|P1|Completed 2-week|Overall Study||97
154847|NCT01610063|375989|P2|Baseline|Overall Study||113
154848|NCT01610063|375990|P1|Baseline|Overall Study||114
154849|NCT01610063|375989|P2|STARTED|Overall Study||113
154850|NCT01610063|375990|P1|STARTED|Overall Study||114
154851|NCT01610037|376013|P3|NOT COMPLETED|Treatment and Follow up Period||26
154852|NCT01610037|376014|P2|NOT COMPLETED|Treatment and Follow up Period||28
154853|NCT01610037|376015|P1|NOT COMPLETED|Treatment and Follow up Period||25
154854|NCT01610037|376013|P3|COMPLETED|Treatment and Follow up Period||378
154855|NCT01610037|376014|P2|COMPLETED|Treatment and Follow up Period||377
154856|NCT01610037|376015|P1|COMPLETED|Treatment and Follow up Period||382
154857|NCT01610037|376013|P3|STARTED|Treatment and Follow up Period||404
154858|NCT01610037|376014|P2|STARTED|Treatment and Follow up Period||405
154859|NCT01610037|376015|P1|STARTED|Treatment and Follow up Period||407
154860|NCT01610037|376013|P3|NOT COMPLETED|All Patients||84
154861|NCT01610037|376014|P2|NOT COMPLETED|All Patients||51
154862|NCT01610037|376015|P1|NOT COMPLETED|All Patients||59
154863|NCT01610037|376013|P3|COMPLETED|All Patients||320
154864|NCT01610037|376014|P2|COMPLETED|All Patients||354
154865|NCT01610037|376015|P1|COMPLETED|All Patients||348
154866|NCT01610037|376013|P3|Full Analysis Set (FAS)|All Patients||403
154867|NCT01610037|376014|P2|Full Analysis Set (FAS)|All Patients||405
154868|NCT01610037|376015|P1|Full Analysis Set (FAS)|All Patients||407
154869|NCT01610037|376013|P3|Randomized Set (RAN)|All Patients||404
154870|NCT01610037|376014|P2|Randomized Set (RAN)|All Patients||405
154871|NCT01610037|376015|P1|Randomized Set (RAN)|All Patients||407
154872|NCT01610037|376013|P3|STARTED|All Patients||404
154873|NCT01610037|376014|P2|STARTED|All Patients||405
154874|NCT01610037|376015|P1|STARTED|All Patients||407
154875|NCT01610011|376058|P2|NOT COMPLETED|Overall Study||0
154876|NCT01610011|376059|P1|NOT COMPLETED|Overall Study||10
154877|NCT01610011|376058|P2|COMPLETED|Overall Study||2
154878|NCT01610011|376059|P1|COMPLETED|Overall Study||9
154879|NCT01610011|376058|P2|STARTED|Overall Study||2
154880|NCT01610011|376059|P1|STARTED|Overall Study||19
154881|NCT01609933|376065|P1|NOT COMPLETED|Overall Study||4
154882|NCT01609933|376065|P1|COMPLETED|Overall Study||28
154883|NCT01609933|376065|P1|STARTED|Overall Study||32
154884|NCT01609790|376075|P3|NOT COMPLETED|Overall Study||8
154885|NCT01609790|376076|P2|NOT COMPLETED|Overall Study||7
154886|NCT01609790|376077|P1|NOT COMPLETED|Overall Study||1
154887|NCT01609790|376075|P3|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|57
154888|NCT01609790|376076|P2|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
154889|NCT01609790|376077|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|6
154890|NCT01609790|376075|P3|STARTED|Overall Study||65
154891|NCT01609790|376076|P2|STARTED|Overall Study||65
154892|NCT01609790|376077|P1|STARTED|Overall Study||7
154893|NCT01609582|376096|P2|NOT COMPLETED|Overall Study||1604
154894|NCT01609582|376097|P1|NOT COMPLETED|Overall Study||1603
154895|NCT01609582|376096|P2|COMPLETED|Overall Study||0
154896|NCT01609582|376097|P1|COMPLETED|Overall Study||0
154897|NCT01609582|376096|P2|Treated|Overall Study||1601
154898|NCT01609582|376097|P1|Treated|Overall Study||1603
154899|NCT01609582|376096|P2|STARTED|Overall Study||1604
154900|NCT01609582|376097|P1|STARTED|Overall Study||1603
154901|NCT01609543|376105|P1|NOT COMPLETED|Overall Study||42
154902|NCT01609543|376105|P1|COMPLETED|Overall Study||20
154903|NCT01609543|376105|P1|STARTED|Overall Study||62
154904|NCT01609478|376114|P3|NOT COMPLETED|Overall Study||9
154905|NCT01609478|376115|P2|NOT COMPLETED|Overall Study||2
154906|NCT01609478|376116|P1|NOT COMPLETED|Overall Study||7
154907|NCT01609478|376114|P3|COMPLETED|Overall Study||107
154908|NCT01609478|376115|P2|COMPLETED|Overall Study||106
154909|NCT01609478|376116|P1|COMPLETED|Overall Study||104
154910|NCT01609478|376114|P3|Full Analysis Set (FAS)|Overall Study||115
154911|NCT01609478|376115|P2|Full Analysis Set (FAS)|Overall Study||108
154912|NCT01609478|376116|P1|Full Analysis Set (FAS)|Overall Study||110
154913|NCT01609478|376114|P3|STARTED|Overall Study||116
154914|NCT01609478|376115|P2|STARTED|Overall Study||108
154915|NCT01609478|376116|P1|STARTED|Overall Study||111
154916|NCT01609348|376182|P2|NOT COMPLETED|Overall Study||0
154917|NCT01609348|376183|P1|NOT COMPLETED|Overall Study||0
154918|NCT01609348|376182|P2|COMPLETED|Overall Study||2
154919|NCT01609348|376183|P1|COMPLETED|Overall Study||3
154920|NCT01609348|376182|P2|STARTED|Overall Study||2
154921|NCT01609348|376183|P1|STARTED|Overall Study||3
154922|NCT01609296|376189|P1|NOT COMPLETED|Overall Study||120
154923|NCT01609296|376189|P1|COMPLETED|Overall Study||1286
154924|NCT01609296|376189|P1|STARTED|Overall Study||1406
154925|NCT01609257|376202|P2|NOT COMPLETED|Overall Study||8
154926|NCT01609257|376203|P1|NOT COMPLETED|Overall Study||6
154927|NCT01609257|376202|P2|COMPLETED|Overall Study||57
154928|NCT01609257|376203|P1|COMPLETED|Overall Study||61
154929|NCT01609257|376202|P2|Received Challenge Product|Overall Study||53
154930|NCT01609257|376203|P1|Received Challenge Product|Overall Study||56
154931|NCT01609257|376202|P2|Received 2 Doses|Overall Study||64
154932|NCT01609257|376203|P1|Received 2 Doses|Overall Study||63
154933|NCT01609257|376202|P2|STARTED|Overall Study||65
154934|NCT01609257|376203|P1|STARTED|Overall Study||67
154935|NCT01609062|376275|P2|NOT COMPLETED|Extension Phase||10
154936|NCT01609062|376276|P1|NOT COMPLETED|Extension Phase||15
154937|NCT01609062|376275|P2|COMPLETED|Extension Phase|EAP = Expanded Access Program|0
154938|NCT01609062|376276|P1|COMPLETED|Extension Phase||0
154939|NCT01609062|376275|P2|STARTED|Extension Phase||10
154940|NCT01609062|376276|P1|STARTED|Extension Phase||15
154941|NCT01609062|376275|P2|NOT COMPLETED|Primary Phase||0
154942|NCT01609062|376276|P1|NOT COMPLETED|Primary Phase||0
154943|NCT01609062|376275|P2|COMPLETED|Primary Phase||10
154944|NCT01609062|376276|P1|COMPLETED|Primary Phase||15
154945|NCT01609062|376275|P2|STARTED|Primary Phase||10
154946|NCT01609062|376276|P1|STARTED|Primary Phase||15
154947|NCT01609023|376319|P1|NOT COMPLETED|Overall Study||33
154948|NCT01609023|376319|P1|COMPLETED|Overall Study||34
154949|NCT01609023|376319|P1|STARTED|Overall Study||67
154950|NCT01609010|376331|P2|NOT COMPLETED|Overall Study||37
154951|NCT01609010|376332|P1|NOT COMPLETED|Overall Study||43
154952|NCT01609010|376331|P2|COMPLETED|Overall Study||120
154953|NCT01609010|376332|P1|COMPLETED|Overall Study||113
154954|NCT01609010|376331|P2|Entering Cycle 2|Overall Study||124
154955|NCT01609010|376332|P1|Entering Cycle 2|Overall Study||120
154956|NCT01609010|376331|P2|STARTED|Overall Study||157
154957|NCT01609010|376332|P1|STARTED|Overall Study||156
154958|NCT01608971|376358|P2|NOT COMPLETED|Overall Study||0
154959|NCT01608971|376359|P1|NOT COMPLETED|Overall Study||0
154960|NCT01608971|376358|P2|COMPLETED|Overall Study||15
154961|NCT01608971|376359|P1|COMPLETED|Overall Study||15
154962|NCT01608971|376358|P2|STARTED|Overall Study||15
154963|NCT01608971|376359|P1|STARTED|Overall Study||15
154964|NCT01608815|376374|P3|NOT COMPLETED|Overall Study||0
154965|NCT01608815|376375|P2|NOT COMPLETED|Overall Study||0
154966|NCT01608815|376376|P1|NOT COMPLETED|Overall Study||0
154967|NCT01608815|376374|P3|COMPLETED|Overall Study||5
154968|NCT01608815|376375|P2|COMPLETED|Overall Study||7
154969|NCT01608815|376376|P1|COMPLETED|Overall Study||188
154970|NCT01608815|376374|P3|STARTED|Overall Study||5
154971|NCT01608815|376375|P2|STARTED|Overall Study||7
154972|NCT01608815|376376|P1|STARTED|Overall Study||188
154973|NCT01608724|376393|P1|NOT COMPLETED|Overall Study||243
154974|NCT01608724|376393|P1|COMPLETED|Overall Study||1180
154975|NCT01608724|376393|P1|Treated|Overall Study||1361
154976|NCT01608724|376393|P1|STARTED|Overall Study|One patient was excluded because the Informed Consent Form was destroyed by site staff by mistake.|1423
154977|NCT01608672|376400|P1|NOT COMPLETED|Overall Study||0
154978|NCT01608672|376400|P1|COMPLETED|Overall Study||207
154979|NCT01608672|376400|P1|STARTED|Overall Study||207
154980|NCT01608659|376406|P1|NOT COMPLETED|Overall Study||16
154981|NCT01608659|376406|P1|COMPLETED|Overall Study||94
154982|NCT01608659|376406|P1|STARTED|Overall Study||110
154983|NCT01608490|376414|P2|NOT COMPLETED|Overall Study||0
154984|NCT01608490|376415|P1|NOT COMPLETED|Overall Study||0
154985|NCT01608490|376414|P2|COMPLETED|Overall Study||157
154986|NCT01608490|376415|P1|COMPLETED|Overall Study||158
154987|NCT01608490|376414|P2|STARTED|Overall Study||157
154988|NCT01608490|376415|P1|STARTED|Overall Study||158
154989|NCT01608321|376425|P2|NOT COMPLETED|Overall Study||0
154990|NCT01608321|376426|P1|NOT COMPLETED|Overall Study||1
154991|NCT01608321|376425|P2|COMPLETED|Overall Study||4
154992|NCT01608321|376426|P1|COMPLETED|Overall Study||12
154993|NCT01608321|376425|P2|STARTED|Overall Study||4
154994|NCT01608321|376426|P1|STARTED|Overall Study||13
154995|NCT01608308|376434|P2|NOT COMPLETED|Overall Study||2
154996|NCT01608308|376435|P1|NOT COMPLETED|Overall Study||0
154997|NCT01608308|376434|P2|COMPLETED|Overall Study||29
154998|NCT01608308|376435|P1|COMPLETED|Overall Study||31
154999|NCT01608308|376434|P2|STARTED|Overall Study||31
155000|NCT01608308|376435|P1|STARTED|Overall Study||31
155001|NCT01608295|376459|P2|NOT COMPLETED|Overall Study||5
155002|NCT01608295|376460|P1|NOT COMPLETED|Overall Study||6
155003|NCT01608295|376459|P2|COMPLETED|Overall Study||25
155004|NCT01608295|376460|P1|COMPLETED|Overall Study||20
155005|NCT01608295|376459|P2|STARTED|Overall Study||30
155006|NCT01608295|376460|P1|STARTED|Overall Study||26
155007|NCT01608100|376471|P1|NOT COMPLETED|Overall Study||0
155008|NCT01608100|376471|P1|COMPLETED|Overall Study||1101
155009|NCT01608100|376471|P1|STARTED|Overall Study||1101
155010|NCT01608087|376498|P3|NOT COMPLETED|Overall Study||0
155011|NCT01608087|376499|P2|NOT COMPLETED|Overall Study||2
155012|NCT01608087|376500|P1|NOT COMPLETED|Overall Study||0
155013|NCT01608087|376498|P3|COMPLETED|Overall Study||31
155014|NCT01608087|376499|P2|COMPLETED|Overall Study||28
155015|NCT01608087|376500|P1|COMPLETED|Overall Study||30
155016|NCT01608087|376498|P3|STARTED|Overall Study||31
155017|NCT01608087|376499|P2|STARTED|Overall Study||30
155018|NCT01608087|376500|P1|STARTED|Overall Study||30
155019|NCT01607957|376516|P2|NOT COMPLETED|Overall Study||215
155020|NCT01607957|376517|P1|NOT COMPLETED|Overall Study||372
155021|NCT01607957|376516|P2|COMPLETED|Overall Study||51
155022|NCT01607957|376517|P1|COMPLETED|Overall Study||162
155023|NCT01607957|376516|P2|Treated|Overall Study||265
155024|NCT01607957|376517|P1|Treated|Overall Study||533
155025|NCT01607957|376516|P2|STARTED|Overall Study||266
155026|NCT01607957|376517|P1|STARTED|Overall Study||534
155027|NCT01607853|376527|P1|NOT COMPLETED|Overall Study||0
155028|NCT01607853|376527|P1|COMPLETED|Overall Study||24
155029|NCT01607853|376527|P1|STARTED|Overall Study||24
155030|NCT01607658|376638|P4|NOT COMPLETED|Overall Study||11
155031|NCT01607658|376639|P3|NOT COMPLETED|Overall Study||11
155032|NCT01607658|376640|P2|NOT COMPLETED|Overall Study||11
155033|NCT01607658|376641|P1|NOT COMPLETED|Overall Study||9
155034|NCT01607658|376638|P4|COMPLETED|Overall Study||52
155035|NCT01607658|376639|P3|COMPLETED|Overall Study||47
155036|NCT01607658|376640|P2|COMPLETED|Overall Study||56
155037|NCT01607658|376641|P1|COMPLETED|Overall Study||56
155038|NCT01607658|376638|P4|STARTED|Overall Study||63
155039|NCT01607658|376639|P3|STARTED|Overall Study||58
155040|NCT01607658|376640|P2|STARTED|Overall Study||67
155041|NCT01607658|376641|P1|STARTED|Overall Study||65
155042|NCT01607645|376665|P2|NOT COMPLETED|Overall Study||0
155043|NCT01607645|376666|P1|NOT COMPLETED|Overall Study||0
155044|NCT01607645|376665|P2|COMPLETED|Overall Study||3
155045|NCT01607645|376666|P1|COMPLETED|Overall Study||4
155046|NCT01607645|376665|P2|STARTED|Overall Study||3
155047|NCT01607645|376666|P1|STARTED|Overall Study||4
155048|NCT01607593|376696|P1|NOT COMPLETED|Overall Study||93
155049|NCT01607593|376696|P1|COMPLETED|Overall Study||29
155050|NCT01607593|376696|P1|STARTED|Overall Study||122
155051|NCT01607554|376702|P1|NOT COMPLETED|Overall Study||2
155052|NCT01607554|376702|P1|COMPLETED|Overall Study||0
155053|NCT01607554|376702|P1|STARTED|Overall Study||2
155054|NCT01607476|376715|P3|NOT COMPLETED|Overall Study||3
155055|NCT01607476|376716|P2|NOT COMPLETED|Overall Study||0
155056|NCT01607476|376717|P1|NOT COMPLETED|Overall Study||1
155057|NCT01607476|376715|P3|COMPLETED|Overall Study||30
155058|NCT01607476|376716|P2|COMPLETED|Overall Study||30
155059|NCT01607476|376717|P1|COMPLETED|Overall Study||24
155060|NCT01607476|376715|P3|STARTED|Overall Study||33
155061|NCT01607476|376716|P2|STARTED|Overall Study||30
155062|NCT01607476|376717|P1|STARTED|Overall Study||25
155063|NCT01607450|376735|P7|NOT COMPLETED|Overall Study||0
155064|NCT01607450|376736|P6|NOT COMPLETED|Overall Study||0
155065|NCT01607450|376737|P5|NOT COMPLETED|Overall Study||0
155066|NCT01607450|376738|P4|NOT COMPLETED|Overall Study||0
155067|NCT01607450|376739|P3|NOT COMPLETED|Overall Study||0
155068|NCT01607450|376740|P2|NOT COMPLETED|Overall Study||0
155069|NCT01607450|376741|P1|NOT COMPLETED|Overall Study||0
155070|NCT01607450|376735|P7|COMPLETED|Overall Study||0
155071|NCT01607450|376736|P6|COMPLETED|Overall Study||0
155072|NCT01607450|376737|P5|COMPLETED|Overall Study||1
155073|NCT01607450|376738|P4|COMPLETED|Overall Study||11
155074|NCT01607450|376739|P3|COMPLETED|Overall Study||7
155075|NCT01607450|376740|P2|COMPLETED|Overall Study||8
155076|NCT01607450|376741|P1|COMPLETED|Overall Study||6
155077|NCT01607450|376735|P7|STARTED|Overall Study||0
155078|NCT01607450|376736|P6|STARTED|Overall Study||0
155079|NCT01607450|376737|P5|STARTED|Overall Study||1
155080|NCT01607450|376738|P4|STARTED|Overall Study||11
155081|NCT01607450|376739|P3|STARTED|Overall Study||7
155082|NCT01607450|376740|P2|STARTED|Overall Study||8
155083|NCT01607450|376741|P1|STARTED|Overall Study||6
155084|NCT01607411|376785|P4|NOT COMPLETED|Period IV||0
155085|NCT01607411|376786|P3|NOT COMPLETED|Period IV||0
155086|NCT01607411|376787|P2|NOT COMPLETED|Period IV||0
155087|NCT01607411|376788|P1|NOT COMPLETED|Period IV||0
155088|NCT01607411|376785|P4|COMPLETED|Period IV||14
155089|NCT01607411|376786|P3|COMPLETED|Period IV||14
155090|NCT01607411|376787|P2|COMPLETED|Period IV||14
155091|NCT01607411|376788|P1|COMPLETED|Period IV||13
155092|NCT01607411|376785|P4|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
155093|NCT01607411|376786|P3|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
155094|NCT01607411|376787|P2|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
155095|NCT01607411|376788|P1|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|13
155096|NCT01607411|376785|P4|NOT COMPLETED|Period III||0
155097|NCT01607411|376786|P3|NOT COMPLETED|Period III||0
155098|NCT01607411|376787|P2|NOT COMPLETED|Period III||0
155099|NCT01607411|376788|P1|NOT COMPLETED|Period III||0
155100|NCT01607411|376785|P4|COMPLETED|Period III||13
155101|NCT01607411|376786|P3|COMPLETED|Period III||14
155102|NCT01607411|376787|P2|COMPLETED|Period III||14
155103|NCT01607411|376788|P1|COMPLETED|Period III||14
155104|NCT01607411|376785|P4|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|13
155105|NCT01607411|376786|P3|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
155106|NCT01607411|376787|P2|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
155107|NCT01607411|376788|P1|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
155108|NCT01607411|376785|P4|NOT COMPLETED|Period II||0
155109|NCT01607411|376786|P3|NOT COMPLETED|Period II||0
155110|NCT01607411|376787|P2|NOT COMPLETED|Period II||0
155111|NCT01607411|376788|P1|NOT COMPLETED|Period II||0
155112|NCT01607411|376785|P4|COMPLETED|Period II||14
155113|NCT01607411|376786|P3|COMPLETED|Period II||13
155114|NCT01607411|376787|P2|COMPLETED|Period II||14
155115|NCT01607411|376788|P1|COMPLETED|Period II||14
155116|NCT01607411|376785|P4|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
155117|NCT01607411|376786|P3|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|13
155118|NCT01607411|376787|P2|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
155119|NCT01607411|376788|P1|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
155120|NCT01607411|376785|P4|NOT COMPLETED|Period I||0
155121|NCT01607411|376786|P3|NOT COMPLETED|Period I||0
155122|NCT01607411|376787|P2|NOT COMPLETED|Period I||0
155123|NCT01607411|376788|P1|NOT COMPLETED|Period I||0
155124|NCT01607411|376785|P4|COMPLETED|Period I||14
155125|NCT01607411|376786|P3|COMPLETED|Period I||14
155126|NCT01607411|376787|P2|COMPLETED|Period I||13
155127|NCT01607411|376788|P1|COMPLETED|Period I||14
155128|NCT01607411|376785|P4|STARTED|Period I||14
155129|NCT01607411|376786|P3|STARTED|Period I||14
155130|NCT01607411|376787|P2|STARTED|Period I||13
155131|NCT01607411|376788|P1|STARTED|Period I||14
155132|NCT01607398|376811|P2|NOT COMPLETED|Overall Study||2
155133|NCT01607398|376812|P1|NOT COMPLETED|Overall Study||2
155134|NCT01607398|376811|P2|COMPLETED|Overall Study||26
155135|NCT01607398|376812|P1|COMPLETED|Overall Study||26
155136|NCT01607398|376811|P2|STARTED|Overall Study||28
155137|NCT01607398|376812|P1|STARTED|Overall Study||28
155138|NCT01607346|376856|P1|NOT COMPLETED|Overall Study||3
155139|NCT01607346|376856|P1|COMPLETED|Overall Study||7
155140|NCT01607346|376856|P1|STARTED|Overall Study||10
155141|NCT01607320|376872|P2|NOT COMPLETED|Overall Study||0
155142|NCT01607320|376873|P1|NOT COMPLETED|Overall Study||0
155143|NCT01607320|376872|P2|COMPLETED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
155144|NCT01607320|376873|P1|COMPLETED|Overall Study|The study was randomized between the 2 treatments and was never unblinded,so unknown.|0
155145|NCT01607320|376872|P2|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
155146|NCT01607320|376873|P1|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
155147|NCT01607255|376881|P3|NOT COMPLETED|Overall Study||0
155148|NCT01607255|376882|P2|NOT COMPLETED|Overall Study||0
155149|NCT01607255|376883|P1|NOT COMPLETED|Overall Study||0
155150|NCT01607255|376881|P3|COMPLETED|Overall Study||159
155151|NCT01607255|376882|P2|COMPLETED|Overall Study||160
155152|NCT01607255|376883|P1|COMPLETED|Overall Study||161
155153|NCT01607255|376881|P3|STARTED|Overall Study||159
155154|NCT01607255|376882|P2|STARTED|Overall Study||160
155155|NCT01607255|376883|P1|STARTED|Overall Study||161
155156|NCT01607203|376893|P2|NOT COMPLETED|Overall Study||0
155157|NCT01607203|376894|P1|NOT COMPLETED|Overall Study||0
155158|NCT01607203|376893|P2|COMPLETED|Overall Study||61
155159|NCT01607203|376894|P1|COMPLETED|Overall Study||59
155160|NCT01607203|376893|P2|STARTED|Overall Study||61
155161|NCT01607203|376894|P1|STARTED|Overall Study||59
155162|NCT01607112|376906|P2|NOT COMPLETED|Overall Study||0
155163|NCT01607112|376907|P1|NOT COMPLETED|Overall Study||0
155164|NCT01607112|376906|P2|COMPLETED|Overall Study||59
155165|NCT01607112|376907|P1|COMPLETED|Overall Study||60
155166|NCT01607112|376906|P2|STARTED|Overall Study||59
155167|NCT01607112|376907|P1|STARTED|Overall Study||60
155168|NCT01606852|376943|P2|NOT COMPLETED|Overall Study||0
155169|NCT01606852|376944|P1|NOT COMPLETED|Overall Study||0
155170|NCT01606852|376943|P2|COMPLETED|Overall Study||8
155171|NCT01606852|376944|P1|COMPLETED|Overall Study||7
155172|NCT01606852|376943|P2|STARTED|Overall Study||8
155173|NCT01606852|376944|P1|STARTED|Overall Study||7
155174|NCT01606800|376954|P2|NOT COMPLETED|Overall Study||2
155175|NCT01606800|376955|P1|NOT COMPLETED|Overall Study||5
155176|NCT01606800|376954|P2|COMPLETED|Overall Study||21
155177|NCT01606800|376955|P1|COMPLETED|Overall Study||17
155178|NCT01606800|376954|P2|Treated|Overall Study||23
155179|NCT01606800|376955|P1|Treated|Overall Study||22
155180|NCT01606800|376954|P2|STARTED|Overall Study||23
155181|NCT01606800|376955|P1|STARTED|Overall Study||22
155182|NCT01606787|376963|P2|NOT COMPLETED|Overall Study||7
155183|NCT01606787|376964|P1|NOT COMPLETED|Overall Study||4
155184|NCT01606787|376963|P2|COMPLETED|Overall Study||98
155185|NCT01606787|376964|P1|COMPLETED|Overall Study||101
155186|NCT01606787|376963|P2|STARTED|Overall Study||105
155187|NCT01606787|376964|P1|STARTED|Overall Study||105
155188|NCT01606761|376975|P5|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||8
155189|NCT01606761|376976|P4|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||2
155190|NCT01606761|376977|P3|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||17
155191|NCT01606761|376978|P2|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||10
155192|NCT01606761|376979|P1|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||4
155193|NCT01606761|376975|P5|COMPLETED|Safety Follow-up Period (Week 52-68)||11
155194|NCT01606761|376976|P4|COMPLETED|Safety Follow-up Period (Week 52-68)||7
155195|NCT01606761|376977|P3|COMPLETED|Safety Follow-up Period (Week 52-68)||45
155196|NCT01606761|376978|P2|COMPLETED|Safety Follow-up Period (Week 52-68)||55
155197|NCT01606761|376979|P1|COMPLETED|Safety Follow-up Period (Week 52-68)||24
155198|NCT01606761|376975|P5|Safety Population|Safety Follow-up Period (Week 52-68)||19
155199|NCT01606761|376976|P4|Safety Population|Safety Follow-up Period (Week 52-68)||7
155200|NCT01606761|376977|P3|Safety Population|Safety Follow-up Period (Week 52-68)||62
155201|NCT01606761|376978|P2|Safety Population|Safety Follow-up Period (Week 52-68)||65
155202|NCT01606761|376979|P1|Safety Population|Safety Follow-up Period (Week 52-68)||28
155203|NCT01606761|376975|P5|STARTED|Safety Follow-up Period (Week 52-68)||19
155204|NCT01606761|376976|P4|STARTED|Safety Follow-up Period (Week 52-68)||9
155205|NCT01606761|376977|P3|STARTED|Safety Follow-up Period (Week 52-68)||62
155206|NCT01606761|376978|P2|STARTED|Safety Follow-up Period (Week 52-68)||65
155207|NCT01606761|376979|P1|STARTED|Safety Follow-up Period (Week 52-68)||28
155208|NCT01606761|376975|P5|NOT COMPLETED|Week 24 to Week 52||20
155209|NCT01606761|376976|P4|NOT COMPLETED|Week 24 to Week 52||17
155210|NCT01606761|376977|P3|NOT COMPLETED|Week 24 to Week 52||33
155211|NCT01606761|376978|P2|NOT COMPLETED|Week 24 to Week 52||33
155212|NCT01606761|376979|P1|NOT COMPLETED|Week 24 to Week 52||0
155213|NCT01606761|376975|P5|COMPLETED|Week 24 to Week 52||106
155214|NCT01606761|376976|P4|COMPLETED|Week 24 to Week 52||109
155215|NCT01606761|376977|P3|COMPLETED|Week 24 to Week 52||212
155216|NCT01606761|376978|P2|COMPLETED|Week 24 to Week 52||204
155217|NCT01606761|376979|P1|COMPLETED|Week 24 to Week 52||0
155218|NCT01606761|376975|P5|Treated|Week 24 to Week 52||126
155219|NCT01606761|376976|P4|Treated|Week 24 to Week 52||124
155220|NCT01606761|376977|P3|Treated|Week 24 to Week 52||245
155221|NCT01606761|376978|P2|Treated|Week 24 to Week 52||237
155222|NCT01606761|376979|P1|Treated|Week 24 to Week 52||0
155223|NCT01606761|376975|P5|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (48) and Week 24 (78) were included.|126
155224|NCT01606761|376976|P4|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (46) and Week 24 (80) were included.|126
155225|NCT01606761|376977|P3|STARTED|Week 24 to Week 52||245
155226|NCT01606761|376978|P2|STARTED|Week 24 to Week 52||237
155227|NCT01606761|376979|P1|STARTED|Week 24 to Week 52||0
155228|NCT01606761|376975|P5|NOT COMPLETED|Prior to Week 24||0
155229|NCT01606761|376976|P4|NOT COMPLETED|Prior to Week 24||0
155230|NCT01606761|376977|P3|NOT COMPLETED|Prior to Week 24||47
155231|NCT01606761|376978|P2|NOT COMPLETED|Prior to Week 24||55
155232|NCT01606761|376979|P1|NOT COMPLETED|Prior to Week 24||42
155233|NCT01606761|376975|P5|COMPLETED|Prior to Week 24||0
155234|NCT01606761|376976|P4|COMPLETED|Prior to Week 24||0
155235|NCT01606761|376977|P3|COMPLETED|Prior to Week 24||245
155236|NCT01606761|376978|P2|COMPLETED|Prior to Week 24||237
155237|NCT01606761|376979|P1|COMPLETED|Prior to Week 24||252
155238|NCT01606761|376975|P5|Participants Re-randomized at Week 18|Prior to Week 24||0
155239|NCT01606761|376976|P4|Participants Re-randomized at Week 18|Prior to Week 24||0
155240|NCT01606761|376977|P3|Participants Re-randomized at Week 18|Prior to Week 24||0
155241|NCT01606761|376978|P2|Participants Re-randomized at Week 18|Prior to Week 24||0
155242|NCT01606761|376979|P1|Participants Re-randomized at Week 18|Prior to Week 24|Out of 94, 46 were re-randomized to sirukumab 50 mg and 48 were re-randomized to 100 mg group.|94
155243|NCT01606761|376975|P5|STARTED|Prior to Week 24||0
155244|NCT01606761|376976|P4|STARTED|Prior to Week 24||0
155245|NCT01606761|376977|P3|STARTED|Prior to Week 24||292
155246|NCT01606761|376978|P2|STARTED|Prior to Week 24||292
155247|NCT01606761|376979|P1|STARTED|Prior to Week 24||294
155248|NCT01606748|377005|P2|NOT COMPLETED|Overall Study||0
155249|NCT01606748|377006|P1|NOT COMPLETED|Overall Study||3
155250|NCT01606748|377005|P2|COMPLETED|Overall Study||17
155251|NCT01606748|377006|P1|COMPLETED|Overall Study||15
155252|NCT01606748|377005|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
155253|NCT01606748|377006|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
155254|NCT01606748|377005|P2|STARTED|Overall Study||17
155255|NCT01606748|377006|P1|STARTED|Overall Study||18
155256|NCT01606735|377037|P3|NOT COMPLETED|Overall Study||0
155257|NCT01606735|377038|P2|NOT COMPLETED|Overall Study||0
155258|NCT01606735|377039|P1|NOT COMPLETED|Overall Study||0
155259|NCT01606735|377037|P3|COMPLETED|Overall Study||58
155260|NCT01606735|377038|P2|COMPLETED|Overall Study||56
155261|NCT01606735|377039|P1|COMPLETED|Overall Study||58
155262|NCT01606735|377037|P3|STARTED|Overall Study||58
155263|NCT01606735|377038|P2|STARTED|Overall Study||56
155264|NCT01606735|377039|P1|STARTED|Overall Study||58
155265|NCT01606709|377049|P2|NOT COMPLETED|Overall Study||0
155266|NCT01606709|377050|P1|NOT COMPLETED|Overall Study||0
155267|NCT01606709|377049|P2|COMPLETED|Overall Study||3
155268|NCT01606709|377050|P1|COMPLETED|Overall Study||4
155269|NCT01606709|377049|P2|STARTED|Overall Study||3
155270|NCT01606709|377050|P1|STARTED|Overall Study||4
155271|NCT01606670|377058|P1|NOT COMPLETED|Overall Study||16
155272|NCT01606670|377058|P1|COMPLETED|Overall Study||77
155273|NCT01606670|377058|P1|Full Analysis Set|Overall Study||70
155274|NCT01606670|377058|P1|Safety Set|Overall Study||93
155275|NCT01606670|377058|P1|STARTED|Overall Study||93
155276|NCT01606319|377068|P2|NOT COMPLETED|Overall Study||40
155277|NCT01606319|377069|P1|NOT COMPLETED|Overall Study||34
155278|NCT01606319|377068|P2|COMPLETED|Overall Study||110
155279|NCT01606319|377069|P1|COMPLETED|Overall Study||116
155280|NCT01606319|377068|P2|STARTED|Overall Study||150
155281|NCT01606319|377069|P1|STARTED|Overall Study||150
155282|NCT01606306|377087|P6|NOT COMPLETED|Overall Study||11
155283|NCT01606306|377088|P5|NOT COMPLETED|Overall Study||11
155284|NCT01606306|377089|P4|NOT COMPLETED|Overall Study||13
155285|NCT01606306|377090|P3|NOT COMPLETED|Overall Study||14
155286|NCT01606306|377091|P2|NOT COMPLETED|Overall Study||10
155287|NCT01606306|377092|P1|NOT COMPLETED|Overall Study||15
155288|NCT01606306|377087|P6|COMPLETED|Overall Study||36
155289|NCT01606306|377088|P5|COMPLETED|Overall Study||41
155290|NCT01606306|377089|P4|COMPLETED|Overall Study||38
155291|NCT01606306|377090|P3|COMPLETED|Overall Study||37
155292|NCT01606306|377091|P2|COMPLETED|Overall Study||39
155293|NCT01606306|377092|P1|COMPLETED|Overall Study||35
155294|NCT01606306|377087|P6|Completed Third Treatment Period|Overall Study||36
155295|NCT01606306|377088|P5|Completed Third Treatment Period|Overall Study||41
155296|NCT01606306|377089|P4|Completed Third Treatment Period|Overall Study||38
155297|NCT01606306|377090|P3|Completed Third Treatment Period|Overall Study||37
155298|NCT01606306|377091|P2|Completed Third Treatment Period|Overall Study||39
155299|NCT01606306|377092|P1|Completed Third Treatment Period|Overall Study||35
155300|NCT01606306|377087|P6|Completed Second Treatment Period|Overall Study||41
155301|NCT01606306|377088|P5|Completed Second Treatment Period|Overall Study||46
155302|NCT01606306|377089|P4|Completed Second Treatment Period|Overall Study||44
155303|NCT01606306|377090|P3|Completed Second Treatment Period|Overall Study||43
155304|NCT01606306|377091|P2|Completed Second Treatment Period|Overall Study||38
155305|NCT01606306|377092|P1|Completed Second Treatment Period|Overall Study||41
155306|NCT01606306|377087|P6|Completed First Treatment Period|Overall Study||44
155307|NCT01606306|377088|P5|Completed First Treatment Period|Overall Study||47
155308|NCT01606306|377089|P4|Completed First Treatment Period|Overall Study||45
155309|NCT01606306|377090|P3|Completed First Treatment Period|Overall Study||47
155310|NCT01606306|377091|P2|Completed First Treatment Period|Overall Study||47
155311|NCT01606306|377092|P1|Completed First Treatment Period|Overall Study||43
155312|NCT01606306|377087|P6|STARTED|Overall Study||47
155313|NCT01606306|377088|P5|STARTED|Overall Study||52
155314|NCT01606306|377089|P4|STARTED|Overall Study||51
155315|NCT01606306|377090|P3|STARTED|Overall Study||51
155316|NCT01606306|377091|P2|STARTED|Overall Study||49
155317|NCT01606306|377092|P1|STARTED|Overall Study||50
155318|NCT01606254|377102|P4|NOT COMPLETED|Overall Study||3
155319|NCT01606254|377103|P3|NOT COMPLETED|Overall Study||0
155320|NCT01606254|377104|P2|NOT COMPLETED|Overall Study||4
155321|NCT01606254|377105|P1|NOT COMPLETED|Overall Study||2
155322|NCT01606254|377102|P4|COMPLETED|Overall Study||11
155323|NCT01606254|377103|P3|COMPLETED|Overall Study||14
155324|NCT01606254|377104|P2|COMPLETED|Overall Study||10
155325|NCT01606254|377105|P1|COMPLETED|Overall Study||12
155326|NCT01606254|377102|P4|STARTED|Overall Study||14
155327|NCT01606254|377103|P3|STARTED|Overall Study||14
155328|NCT01606254|377104|P2|STARTED|Overall Study||14
155329|NCT01606254|377105|P1|STARTED|Overall Study||14
155330|NCT01606228|377187|P1|NOT COMPLETED|Overall Study||29
155331|NCT01606228|377187|P1|COMPLETED|Overall Study||159
155332|NCT01606228|377187|P1|STARTED|Overall Study||188
155333|NCT01606202|377204|P2|NOT COMPLETED|Overall Study||3
155334|NCT01606202|377205|P1|NOT COMPLETED|Overall Study||7
155335|NCT01606202|377204|P2|COMPLETED|Overall Study||57
155336|NCT01606202|377205|P1|COMPLETED|Overall Study||49
155337|NCT01606202|377204|P2|STARTED|Overall Study||60
155338|NCT01606202|377205|P1|STARTED|Overall Study||56
155339|NCT01606189|377237|P6|NOT COMPLETED|Third Intenvention (14-20 Days)||1
155340|NCT01606189|377238|P5|NOT COMPLETED|Third Intenvention (14-20 Days)||0
155341|NCT01606189|377239|P4|NOT COMPLETED|Third Intenvention (14-20 Days)||0
155342|NCT01606189|377240|P3|NOT COMPLETED|Third Intenvention (14-20 Days)||0
155343|NCT01606189|377241|P2|NOT COMPLETED|Third Intenvention (14-20 Days)||0
155344|NCT01606189|377242|P1|NOT COMPLETED|Third Intenvention (14-20 Days)||0
155345|NCT01606189|377237|P6|COMPLETED|Third Intenvention (14-20 Days)||6
155346|NCT01606189|377238|P5|COMPLETED|Third Intenvention (14-20 Days)||8
155347|NCT01606189|377239|P4|COMPLETED|Third Intenvention (14-20 Days)||8
155348|NCT01606189|377240|P3|COMPLETED|Third Intenvention (14-20 Days)||8
155349|NCT01606189|377241|P2|COMPLETED|Third Intenvention (14-20 Days)||8
155350|NCT01606189|377242|P1|COMPLETED|Third Intenvention (14-20 Days)||8
155351|NCT01606189|377237|P6|STARTED|Third Intenvention (14-20 Days)||7
155352|NCT01606189|377238|P5|STARTED|Third Intenvention (14-20 Days)||8
155353|NCT01606189|377239|P4|STARTED|Third Intenvention (14-20 Days)||8
155354|NCT01606189|377240|P3|STARTED|Third Intenvention (14-20 Days)||8
155355|NCT01606189|377241|P2|STARTED|Third Intenvention (14-20 Days)||8
155356|NCT01606189|377242|P1|STARTED|Third Intenvention (14-20 Days)||8
155357|NCT01606189|377237|P6|NOT COMPLETED|Second Intenvention (14-20 Days)||1
155358|NCT01606189|377238|P5|NOT COMPLETED|Second Intenvention (14-20 Days)||0
155359|NCT01606189|377239|P4|NOT COMPLETED|Second Intenvention (14-20 Days)||0
155360|NCT01606189|377240|P3|NOT COMPLETED|Second Intenvention (14-20 Days)||0
155361|NCT01606189|377241|P2|NOT COMPLETED|Second Intenvention (14-20 Days)||0
155362|NCT01606189|377242|P1|NOT COMPLETED|Second Intenvention (14-20 Days)||0
155363|NCT01606189|377237|P6|COMPLETED|Second Intenvention (14-20 Days)||7
155364|NCT01606189|377238|P5|COMPLETED|Second Intenvention (14-20 Days)||8
155365|NCT01606189|377239|P4|COMPLETED|Second Intenvention (14-20 Days)||8
155366|NCT01606189|377240|P3|COMPLETED|Second Intenvention (14-20 Days)||8
155367|NCT01606189|377241|P2|COMPLETED|Second Intenvention (14-20 Days)||8
155368|NCT01606189|377242|P1|COMPLETED|Second Intenvention (14-20 Days)||8
155369|NCT01606189|377237|P6|STARTED|Second Intenvention (14-20 Days)||8
155370|NCT01606189|377238|P5|STARTED|Second Intenvention (14-20 Days)||8
155371|NCT01606189|377239|P4|STARTED|Second Intenvention (14-20 Days)||8
155372|NCT01606189|377240|P3|STARTED|Second Intenvention (14-20 Days)||8
155373|NCT01606189|377241|P2|STARTED|Second Intenvention (14-20 Days)||8
155374|NCT01606189|377242|P1|STARTED|Second Intenvention (14-20 Days)||8
155375|NCT01606189|377237|P6|NOT COMPLETED|First Intenvention (14-20 Days)||0
155376|NCT01606189|377238|P5|NOT COMPLETED|First Intenvention (14-20 Days)||0
155377|NCT01606189|377239|P4|NOT COMPLETED|First Intenvention (14-20 Days)||0
155378|NCT01606189|377240|P3|NOT COMPLETED|First Intenvention (14-20 Days)||0
155379|NCT01606189|377241|P2|NOT COMPLETED|First Intenvention (14-20 Days)||0
155380|NCT01606189|377242|P1|NOT COMPLETED|First Intenvention (14-20 Days)||0
155381|NCT01606189|377237|P6|COMPLETED|First Intenvention (14-20 Days)||8
155382|NCT01606189|377238|P5|COMPLETED|First Intenvention (14-20 Days)||8
155383|NCT01606189|377239|P4|COMPLETED|First Intenvention (14-20 Days)||8
155384|NCT01606189|377240|P3|COMPLETED|First Intenvention (14-20 Days)||8
155385|NCT01606189|377241|P2|COMPLETED|First Intenvention (14-20 Days)||8
155386|NCT01606189|377242|P1|COMPLETED|First Intenvention (14-20 Days)||8
155387|NCT01606189|377237|P6|STARTED|First Intenvention (14-20 Days)||8
155388|NCT01606189|377238|P5|STARTED|First Intenvention (14-20 Days)||8
155389|NCT01606189|377239|P4|STARTED|First Intenvention (14-20 Days)||8
155390|NCT01606189|377240|P3|STARTED|First Intenvention (14-20 Days)||8
155391|NCT01606189|377241|P2|STARTED|First Intenvention (14-20 Days)||8
155392|NCT01606189|377242|P1|STARTED|First Intenvention (14-20 Days)||8
155393|NCT01606176|377276|P2|NOT COMPLETED|Overall Study||3
155394|NCT01606176|377277|P1|NOT COMPLETED|Overall Study||4
155395|NCT01606176|377276|P2|COMPLETED|Overall Study||31
155396|NCT01606176|377277|P1|COMPLETED|Overall Study||32
155397|NCT01606176|377276|P2|STARTED|Overall Study||34
155398|NCT01606176|377277|P1|STARTED|Overall Study||36
155399|NCT01606150|377313|P2|NOT COMPLETED|Overall Study||0
155400|NCT01606150|377314|P1|NOT COMPLETED|Overall Study||0
155401|NCT01606150|377313|P2|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
155402|NCT01606150|377314|P1|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
155403|NCT01606150|377313|P2|STARTED|Overall Study||0
155404|NCT01606150|377314|P1|STARTED|Overall Study||0
155405|NCT01606137|377322|P1|NOT COMPLETED|Overall Study||262
155406|NCT01606137|377322|P1|COMPLETED|Overall Study||245
155407|NCT01606137|377322|P1|STARTED|Overall Study||507
155408|NCT01606124|377344|P2|NOT COMPLETED|Overall Study||0
155409|NCT01606124|377345|P1|NOT COMPLETED|Overall Study||0
155410|NCT01606124|377344|P2|COMPLETED|Overall Study||20
155411|NCT01606124|377345|P1|COMPLETED|Overall Study||19
155412|NCT01606124|377344|P2|STARTED|Overall Study||20
155413|NCT01606124|377345|P1|STARTED|Overall Study||19
155414|NCT01606007|377356|P3|NOT COMPLETED|Overall Study||10
155415|NCT01606007|377357|P2|NOT COMPLETED|Overall Study||19
155416|NCT01606007|377358|P1|NOT COMPLETED|Overall Study||15
155417|NCT01606007|377356|P3|COMPLETED|Overall Study||169
155418|NCT01606007|377357|P2|COMPLETED|Overall Study||160
155419|NCT01606007|377358|P1|COMPLETED|Overall Study||161
155420|NCT01606007|377356|P3|STARTED|Overall Study||179
155421|NCT01606007|377357|P2|STARTED|Overall Study||179
155422|NCT01606007|377358|P1|STARTED|Overall Study||176
155423|NCT01605942|377380|P2|NOT COMPLETED|Overall Study||0
155424|NCT01605942|377381|P1|NOT COMPLETED|Overall Study||0
155425|NCT01605942|377380|P2|COMPLETED|Overall Study||2
155426|NCT01605942|377381|P1|COMPLETED|Overall Study||6
155427|NCT01605942|377380|P2|STARTED|Overall Study||2
155428|NCT01605942|377381|P1|STARTED|Overall Study||6
155429|NCT01605916|377393|P5|NOT COMPLETED|Overall Study||6
155430|NCT01605916|377394|P4|NOT COMPLETED|Overall Study||6
155431|NCT01605916|377395|P3|NOT COMPLETED|Overall Study||3
155432|NCT01605916|377396|P2|NOT COMPLETED|Overall Study||4
155433|NCT01605916|377397|P1|NOT COMPLETED|Overall Study||4
155434|NCT01605916|377393|P5|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
155435|NCT01605916|377394|P4|COMPLETED|Overall Study||0
155436|NCT01605916|377395|P3|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
155437|NCT01605916|377396|P2|COMPLETED|Overall Study||0
155438|NCT01605916|377397|P1|COMPLETED|Overall Study||0
155439|NCT01605916|377393|P5|STARTED|Overall Study||7
155440|NCT01605916|377394|P4|STARTED|Overall Study||6
155441|NCT01605916|377395|P3|STARTED|Overall Study||4
155442|NCT01605916|377396|P2|STARTED|Overall Study||4
155443|NCT01605916|377397|P1|STARTED|Overall Study||4
155444|NCT01605903|377472|P2|NOT COMPLETED|Overall Study||0
155445|NCT01605903|377473|P1|NOT COMPLETED|Overall Study||0
155446|NCT01605903|377472|P2|COMPLETED|Overall Study||343
155447|NCT01605903|377473|P1|COMPLETED|Overall Study||345
155448|NCT01605903|377472|P2|STARTED|Overall Study||343
155449|NCT01605903|377473|P1|STARTED|Overall Study||345
155450|NCT01605890|377479|P1|NOT COMPLETED|Overall Study||2
155451|NCT01605890|377479|P1|COMPLETED|Overall Study||28
155452|NCT01605890|377479|P1|STARTED|Overall Study||30
155453|NCT01605877|377494|P1|NOT COMPLETED|Overall Study||1
155454|NCT01605877|377494|P1|COMPLETED|Overall Study||63
155455|NCT01605877|377494|P1|STARTED|Overall Study||64
155456|NCT01605825|377558|P2|NOT COMPLETED|Overall Study||3
155457|NCT01605825|377559|P1|NOT COMPLETED|Overall Study||10
155458|NCT01605825|377558|P2|COMPLETED|Overall Study||25
155459|NCT01605825|377559|P1|COMPLETED|Overall Study||45
155460|NCT01605825|377558|P2|STARTED|Overall Study||28
155461|NCT01605825|377559|P1|STARTED|Overall Study||55
155462|NCT01605799|377567|P2|NOT COMPLETED|Overall Study||1
155463|NCT01605799|377568|P1|NOT COMPLETED|Overall Study||2
155464|NCT01605799|377567|P2|COMPLETED|Overall Study||15
155465|NCT01605799|377568|P1|COMPLETED|Overall Study||15
155466|NCT01605799|377567|P2|STARTED|Overall Study||16
155467|NCT01605799|377568|P1|STARTED|Overall Study||17
155468|NCT01605669|377576|P1|NOT COMPLETED|Overall Study||0
155469|NCT01605669|377576|P1|COMPLETED|Overall Study||50
155470|NCT01605669|377576|P1|STARTED|Overall Study||50
155471|NCT01605617|377583|P2|NOT COMPLETED|Second Intervention||0
155472|NCT01605617|377584|P1|NOT COMPLETED|Second Intervention||0
155473|NCT01605617|377583|P2|COMPLETED|Second Intervention||0
155474|NCT01605617|377584|P1|COMPLETED|Second Intervention||0
155475|NCT01605617|377583|P2|STARTED|Second Intervention||0
155476|NCT01605617|377584|P1|STARTED|Second Intervention||0
155477|NCT01605617|377583|P2|NOT COMPLETED|Washout Period of 4 Weeks||1
155478|NCT01605617|377584|P1|NOT COMPLETED|Washout Period of 4 Weeks||2
155479|NCT01605617|377583|P2|COMPLETED|Washout Period of 4 Weeks||0
155480|NCT01605617|377584|P1|COMPLETED|Washout Period of 4 Weeks||0
155481|NCT01605617|377583|P2|STARTED|Washout Period of 4 Weeks||1
155482|NCT01605617|377584|P1|STARTED|Washout Period of 4 Weeks||2
155483|NCT01605617|377583|P2|NOT COMPLETED|First Intervention||1
155484|NCT01605617|377584|P1|NOT COMPLETED|First Intervention||0
155485|NCT01605617|377583|P2|COMPLETED|First Intervention||1
155486|NCT01605617|377584|P1|COMPLETED|First Intervention||2
155487|NCT01605617|377583|P2|STARTED|First Intervention||2
155488|NCT01605617|377584|P1|STARTED|First Intervention||2
155489|NCT01605552|377604|P2|NOT COMPLETED|Overall Study||2
155490|NCT01605552|377605|P1|NOT COMPLETED|Overall Study||6
155491|NCT01605552|377604|P2|COMPLETED|Overall Study||14
155492|NCT01605552|377605|P1|COMPLETED|Overall Study|4 dropped out before the first BtB visit; it is unlikely that the treatment was the cause of dropout|7
155493|NCT01605552|377604|P2|STARTED|Overall Study||16
155494|NCT01605552|377605|P1|STARTED|Overall Study||13
155495|NCT01605539|377619|P3|NOT COMPLETED|Overall Study||0
155496|NCT01605539|377620|P2|NOT COMPLETED|Overall Study||1
155497|NCT01605539|377621|P1|NOT COMPLETED|Overall Study||0
155498|NCT01605539|377619|P3|COMPLETED|Overall Study||4
155499|NCT01605539|377620|P2|COMPLETED|Overall Study||2
155500|NCT01605539|377621|P1|COMPLETED|Overall Study||3
155501|NCT01605539|377619|P3|STARTED|Overall Study||4
155502|NCT01605539|377620|P2|STARTED|Overall Study||3
155503|NCT01605539|377621|P1|STARTED|Overall Study||3
155504|NCT01605461|377643|P1|NOT COMPLETED|Overall Study||4
155505|NCT01605461|377643|P1|COMPLETED|Overall Study||8
155506|NCT01605461|377643|P1|STARTED|Overall Study||12
155507|NCT01605435|377652|P2|NOT COMPLETED|Overall Study||0
155508|NCT01605435|377653|P1|NOT COMPLETED|Overall Study||0
155509|NCT01605435|377652|P2|COMPLETED|Overall Study||3
155510|NCT01605435|377653|P1|COMPLETED|Overall Study||2
155511|NCT01605435|377652|P2|STARTED|Overall Study||3
155512|NCT01605435|377653|P1|STARTED|Overall Study||2
155513|NCT01605396|377702|P2|NOT COMPLETED|Overall Study||40
155514|NCT01605396|377703|P1|NOT COMPLETED|Overall Study||40
155515|NCT01605396|377702|P2|COMPLETED|Overall Study||0
155516|NCT01605396|377703|P1|COMPLETED|Overall Study||0
155517|NCT01605396|377702|P2|Treated|Overall Study||40
155518|NCT01605396|377703|P1|Treated|Overall Study||39
155519|NCT01605396|377702|P2|STARTED|Overall Study||40
155520|NCT01605396|377703|P1|STARTED|Overall Study||40
155521|NCT01605370|377717|P2|NOT COMPLETED|Overall Study||0
155522|NCT01605370|377718|P1|NOT COMPLETED|Overall Study||1
155523|NCT01605370|377717|P2|COMPLETED|Overall Study||0
155524|NCT01605370|377718|P1|COMPLETED|Overall Study||0
155525|NCT01605370|377717|P2|STARTED|Overall Study||0
155526|NCT01605370|377718|P1|STARTED|Overall Study||1
155527|NCT01605292|377726|P2|NOT COMPLETED|Overall Study||0
155528|NCT01605292|377727|P1|NOT COMPLETED|Overall Study||0
155529|NCT01605292|377726|P2|COMPLETED|Overall Study||347
155530|NCT01605292|377727|P1|COMPLETED|Overall Study||351
155531|NCT01605292|377726|P2|STARTED|Overall Study||347
155532|NCT01605292|377727|P1|STARTED|Overall Study||351
155533|NCT01605227|377753|P2|NOT COMPLETED|Overall Study||329
155534|NCT01605227|377754|P1|NOT COMPLETED|Overall Study||621
155535|NCT01605227|377753|P2|COMPLETED|Overall Study||17
155536|NCT01605227|377754|P1|COMPLETED|Overall Study||61
155537|NCT01605227|377753|P2|STARTED|Overall Study||346
155538|NCT01605227|377754|P1|STARTED|Overall Study||682
155539|NCT01605136|377766|P2|NOT COMPLETED|Safety Follow-Up Period||2
155540|NCT01605136|377767|P1|NOT COMPLETED|Safety Follow-Up Period||1
155541|NCT01605136|377766|P2|COMPLETED|Safety Follow-Up Period||40
155542|NCT01605136|377767|P1|COMPLETED|Safety Follow-Up Period||44
155543|NCT01605136|377766|P2|STARTED|Safety Follow-Up Period||42
155544|NCT01605136|377767|P1|STARTED|Safety Follow-Up Period||45
155545|NCT01605136|377766|P2|NOT COMPLETED|Study Period||3
155546|NCT01605136|377767|P1|NOT COMPLETED|Study Period||3
155547|NCT01605136|377766|P2|COMPLETED|Study Period||42
155548|NCT01605136|377767|P1|COMPLETED|Study Period||45
155549|NCT01605136|377766|P2|STARTED|Study Period||45
155550|NCT01605136|377767|P1|STARTED|Study Period||48
155551|NCT01605019|377787|P2|NOT COMPLETED|Overall Study||0
155552|NCT01605019|377788|P1|NOT COMPLETED|Overall Study||3
155553|NCT01605019|377787|P2|COMPLETED|Overall Study||0
155554|NCT01605019|377788|P1|COMPLETED|Overall Study||1
155555|NCT01605019|377787|P2|STARTED|Overall Study||0
155556|NCT01605019|377788|P1|STARTED|Overall Study||4
155557|NCT01604941|377798|P6|NOT COMPLETED|Overall Study||7
155558|NCT01604941|377799|P5|NOT COMPLETED|Overall Study||1
155559|NCT01604941|377800|P4|NOT COMPLETED|Overall Study||3
155560|NCT01604941|377801|P3|NOT COMPLETED|Overall Study||3
155561|NCT01604941|377802|P2|NOT COMPLETED|Overall Study||4
155562|NCT01604941|377803|P1|NOT COMPLETED|Overall Study||11
155563|NCT01604941|377798|P6|COMPLETED|Overall Study||0
155564|NCT01604941|377799|P5|COMPLETED|Overall Study||3
155565|NCT01604941|377800|P4|COMPLETED|Overall Study||0
155566|NCT01604941|377801|P3|COMPLETED|Overall Study||0
155567|NCT01604941|377802|P2|COMPLETED|Overall Study||0
155568|NCT01604941|377803|P1|COMPLETED|Overall Study||0
155569|NCT01604941|377798|P6|STARTED|Overall Study||7
155570|NCT01604941|377799|P5|STARTED|Overall Study||4
155571|NCT01604941|377800|P4|STARTED|Overall Study||3
155572|NCT01604941|377801|P3|STARTED|Overall Study||3
155573|NCT01604941|377802|P2|STARTED|Overall Study||4
155574|NCT01604941|377803|P1|STARTED|Overall Study||11
155575|NCT01604850|377831|P2|NOT COMPLETED|Overall Study||30
155576|NCT01604850|377832|P1|NOT COMPLETED|Overall Study||52
155577|NCT01604850|377831|P2|COMPLETED|Overall Study||69
155578|NCT01604850|377832|P1|COMPLETED|Overall Study||51
155579|NCT01604850|377831|P2|Enrolled and Treated|Overall Study||98
155580|NCT01604850|377832|P1|Enrolled and Treated|Overall Study||103
155581|NCT01604850|377831|P2|STARTED|Overall Study||99
155582|NCT01604850|377832|P1|STARTED|Overall Study||103
155583|NCT01604785|377850|P2|NOT COMPLETED|Overall Study||1
155584|NCT01604785|377851|P1|NOT COMPLETED|Overall Study||7
155585|NCT01604785|377850|P2|COMPLETED|Overall Study||36
155586|NCT01604785|377851|P1|COMPLETED|Overall Study||30
155587|NCT01604785|377850|P2|STARTED|Overall Study||37
155588|NCT01604785|377851|P1|STARTED|Overall Study||37
155589|NCT01604772|377861|P1|NOT COMPLETED|Overall Study||0
155590|NCT01604772|377861|P1|COMPLETED|Overall Study||16
155591|NCT01604772|377861|P1|STARTED|Overall Study||16
155592|NCT01604408|377870|P2|NOT COMPLETED|Observation Period||3
155593|NCT01604408|377871|P1|NOT COMPLETED|Observation Period||1
155594|NCT01604408|377870|P2|COMPLETED|Observation Period||84
155595|NCT01604408|377871|P1|COMPLETED|Observation Period||85
155596|NCT01604408|377870|P2|STARTED|Observation Period||87
155597|NCT01604408|377871|P1|STARTED|Observation Period||86
155598|NCT01604408|377870|P2|NOT COMPLETED|Treatment Period 6||2
155599|NCT01604408|377871|P1|NOT COMPLETED|Treatment Period 6||2
155600|NCT01604408|377870|P2|COMPLETED|Treatment Period 6||87
155601|NCT01604408|377871|P1|COMPLETED|Treatment Period 6||86
155602|NCT01604408|377870|P2|STARTED|Treatment Period 6||89
155603|NCT01604408|377871|P1|STARTED|Treatment Period 6||88
155604|NCT01604408|377870|P2|NOT COMPLETED|Treatment Period 5||0
155605|NCT01604408|377871|P1|NOT COMPLETED|Treatment Period 5||4
155606|NCT01604408|377870|P2|COMPLETED|Treatment Period 5||89
155607|NCT01604408|377871|P1|COMPLETED|Treatment Period 5||88
155608|NCT01604408|377870|P2|STARTED|Treatment Period 5||89
155609|NCT01604408|377871|P1|STARTED|Treatment Period 5||92
155610|NCT01604408|377870|P2|NOT COMPLETED|Treatment Period 4||2
155611|NCT01604408|377871|P1|NOT COMPLETED|Treatment Period 4||3
155612|NCT01604408|377870|P2|COMPLETED|Treatment Period 4||89
155613|NCT01604408|377871|P1|COMPLETED|Treatment Period 4||92
155614|NCT01604408|377870|P2|STARTED|Treatment Period 4||91
155615|NCT01604408|377871|P1|STARTED|Treatment Period 4||95
155616|NCT01604408|377870|P2|NOT COMPLETED|Treatment Period 3||5
155617|NCT01604408|377871|P1|NOT COMPLETED|Treatment Period 3||5
155618|NCT01604408|377870|P2|COMPLETED|Treatment Period 3||91
155619|NCT01604408|377871|P1|COMPLETED|Treatment Period 3||95
155620|NCT01604408|377870|P2|STARTED|Treatment Period 3||96
155621|NCT01604408|377871|P1|STARTED|Treatment Period 3||100
155622|NCT01604408|377870|P2|NOT COMPLETED|Treatment Period 2||2
155623|NCT01604408|377871|P1|NOT COMPLETED|Treatment Period 2||2
155624|NCT01604408|377870|P2|COMPLETED|Treatment Period 2||96
155625|NCT01604408|377871|P1|COMPLETED|Treatment Period 2||100
155626|NCT01604408|377870|P2|STARTED|Treatment Period 2||98
155627|NCT01604408|377871|P1|STARTED|Treatment Period 2||102
155628|NCT01604408|377870|P2|NOT COMPLETED|Treatment Period 1||1
155629|NCT01604408|377871|P1|NOT COMPLETED|Treatment Period 1||0
155630|NCT01604408|377870|P2|COMPLETED|Treatment Period 1||98
155631|NCT01604408|377871|P1|COMPLETED|Treatment Period 1||102
155632|NCT01604408|377870|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||99
155633|NCT01604408|377871|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||102
155634|NCT01604408|377870|P2|STARTED|Treatment Period 1||99
155635|NCT01604408|377871|P1|STARTED|Treatment Period 1||102
155636|NCT01604343|377886|P5|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||29
155637|NCT01604343|377887|P4|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||10
155638|NCT01604343|377888|P3|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||33
155639|NCT01604343|377889|P2|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||7
155640|NCT01604343|377890|P1|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||30
155641|NCT01604343|377886|P5|COMPLETED|Safety Follow-up Period (Week 104-120)||85
155642|NCT01604343|377887|P4|COMPLETED|Safety Follow-up Period (Week 104-120)||26
155643|NCT01604343|377888|P3|COMPLETED|Safety Follow-up Period (Week 104-120)||72
155644|NCT01604343|377889|P2|COMPLETED|Safety Follow-up Period (Week 104-120)||20
155645|NCT01604343|377890|P1|COMPLETED|Safety Follow-up Period (Week 104-120)||79
155646|NCT01604343|377886|P5|Safety Population|Safety Follow-up Period (Week 104-120)||114
155647|NCT01604343|377887|P4|Safety Population|Safety Follow-up Period (Week 104-120)||36
155648|NCT01604343|377888|P3|Safety Population|Safety Follow-up Period (Week 104-120)||105
155649|NCT01604343|377889|P2|Safety Population|Safety Follow-up Period (Week 104-120)||26
155650|NCT01604343|377890|P1|Safety Population|Safety Follow-up Period (Week 104-120)||109
155651|NCT01604343|377886|P5|STARTED|Safety Follow-up Period (Week 104-120)||114
155652|NCT01604343|377887|P4|STARTED|Safety Follow-up Period (Week 104-120)||36
155653|NCT01604343|377888|P3|STARTED|Safety Follow-up Period (Week 104-120)||105
155654|NCT01604343|377889|P2|STARTED|Safety Follow-up Period (Week 104-120)||27
155655|NCT01604343|377890|P1|STARTED|Safety Follow-up Period (Week 104-120)||109
155656|NCT01604343|377886|P5|NOT COMPLETED|Week 52 to Week 104||41
155657|NCT01604343|377887|P4|NOT COMPLETED|Week 52 to Week 104||46
155658|NCT01604343|377888|P3|NOT COMPLETED|Week 52 to Week 104||67
155659|NCT01604343|377889|P2|NOT COMPLETED|Week 52 to Week 104||43
155660|NCT01604343|377890|P1|NOT COMPLETED|Week 52 to Week 104||0
155661|NCT01604343|377886|P5|COMPLETED|Week 52 to Week 104||429
155662|NCT01604343|377887|P4|COMPLETED|Week 52 to Week 104||195
155663|NCT01604343|377888|P3|COMPLETED|Week 52 to Week 104||414
155664|NCT01604343|377889|P2|COMPLETED|Week 52 to Week 104||200
155665|NCT01604343|377890|P1|COMPLETED|Week 52 to Week 104||0
155666|NCT01604343|377886|P5|Treated|Week 52 to Week 104||470
155667|NCT01604343|377887|P4|Treated|Week 52 to Week 104||241
155668|NCT01604343|377888|P3|Treated|Week 52 to Week 104||481
155669|NCT01604343|377889|P2|Treated|Week 52 to Week 104||242
155670|NCT01604343|377890|P1|Treated|Week 52 to Week 104||0
155671|NCT01604343|377886|P5|STARTED|Week 52 to Week 104||470
155672|NCT01604343|377887|P4|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (92), 40 (12) and 52 were included|241
155673|NCT01604343|377888|P3|STARTED|Week 52 to Week 104||481
155674|NCT01604343|377889|P2|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (95), 40 (12) and 52 were included|243
155675|NCT01604343|377890|P1|STARTED|Week 52 to Week 104||0
155676|NCT01604343|377886|P5|NOT COMPLETED|Prior to W52 Administration(Through W52)||87
155677|NCT01604343|377887|P4|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
155678|NCT01604343|377888|P3|NOT COMPLETED|Prior to W52 Administration(Through W52)||76
155679|NCT01604343|377889|P2|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
155680|NCT01604343|377890|P1|NOT COMPLETED|Prior to W52 Administration(Through W52)||98
155681|NCT01604343|377886|P5|COMPLETED|Prior to W52 Administration(Through W52)||470
155682|NCT01604343|377887|P4|COMPLETED|Prior to W52 Administration(Through W52)||0
155683|NCT01604343|377888|P3|COMPLETED|Prior to W52 Administration(Through W52)||481
155684|NCT01604343|377889|P2|COMPLETED|Prior to W52 Administration(Through W52)||0
155685|NCT01604343|377890|P1|COMPLETED|Prior to W52 Administration(Through W52)||458
155686|NCT01604343|377886|P5|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
155687|NCT01604343|377887|P4|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
155688|NCT01604343|377888|P3|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
155689|NCT01604343|377889|P2|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
155690|NCT01604343|377890|P1|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)|Out of 24, 12 were re-randomized to sirukumab 50 mg and 12 were re-randomized to 100 mg group.|24
155691|NCT01604343|377886|P5|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
155692|NCT01604343|377887|P4|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
155693|NCT01604343|377888|P3|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
155694|NCT01604343|377889|P2|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
155695|NCT01604343|377890|P1|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)|Out of 187, 95 were re-randomized to sirukumab 50 mg and 92 were re-randomized to 100 mg group.|187
155696|NCT01604343|377886|P5|STARTED|Prior to W52 Administration(Through W52)||557
155697|NCT01604343|377887|P4|STARTED|Prior to W52 Administration(Through W52)||0
155698|NCT01604343|377888|P3|STARTED|Prior to W52 Administration(Through W52)||557
155699|NCT01604343|377889|P2|STARTED|Prior to W52 Administration(Through W52)||0
155700|NCT01604343|377890|P1|STARTED|Prior to W52 Administration(Through W52)||556
155701|NCT01604291|378003|P4|NOT COMPLETED|Overall Study||0
155702|NCT01604291|378004|P3|NOT COMPLETED|Overall Study||0
155703|NCT01604291|378005|P2|NOT COMPLETED|Overall Study||0
155704|NCT01604291|378006|P1|NOT COMPLETED|Overall Study||0
155705|NCT01604291|378003|P4|COMPLETED|Overall Study||44
155706|NCT01604291|378004|P3|COMPLETED|Overall Study||193
155707|NCT01604291|378005|P2|COMPLETED|Overall Study||443
155708|NCT01604291|378006|P1|COMPLETED|Overall Study||311
155709|NCT01604291|378003|P4|STARTED|Overall Study||44
155710|NCT01604291|378004|P3|STARTED|Overall Study||193
155711|NCT01604291|378005|P2|STARTED|Overall Study||443
155712|NCT01604291|378006|P1|STARTED|Overall Study||311
155713|NCT01604278|378055|P2|NOT COMPLETED|Overall Study||13
155714|NCT01604278|378056|P1|NOT COMPLETED|Overall Study||14
155715|NCT01604278|378055|P2|COMPLETED|Overall Study||210
155716|NCT01604278|378056|P1|COMPLETED|Overall Study||212
155717|NCT01604278|378055|P2|Full Analysis Set|Overall Study|Three randomized participants excluded: 2 who did not receive study drug; 1 with a major deviation.|220
155718|NCT01604278|378056|P1|Full Analysis Set|Overall Study||226
155719|NCT01604278|378055|P2|Safety Set|Overall Study|Two randomized participants who did not receive study drug were excluded from this set.|221
155720|NCT01604278|378056|P1|Safety Set|Overall Study||226
155721|NCT01604278|378055|P2|STARTED|Overall Study||223
155722|NCT01604278|378056|P1|STARTED|Overall Study||226
155723|NCT01604265|378082|P2|NOT COMPLETED|Overall Study||0
155724|NCT01604265|378083|P1|NOT COMPLETED|Overall Study||2
155725|NCT01604265|378082|P2|COMPLETED|Overall Study||32
155726|NCT01604265|378083|P1|COMPLETED|Overall Study||32
155727|NCT01604265|378082|P2|STARTED|Overall Study||32
155728|NCT01604265|378083|P1|STARTED|Overall Study||34
155729|NCT01604122|378119|P2|NOT COMPLETED|Overall Study||0
155730|NCT01604122|378120|P1|NOT COMPLETED|Overall Study||0
155731|NCT01604122|378119|P2|COMPLETED|Overall Study||32
155732|NCT01604122|378120|P1|COMPLETED|Overall Study||60
155733|NCT01604122|378119|P2|STARTED|Overall Study||32
155734|NCT01604122|378120|P1|STARTED|Overall Study||60
155735|NCT01604109|378167|P2|NOT COMPLETED|Overall Study||34
155736|NCT01604109|378168|P1|NOT COMPLETED|Overall Study||33
155737|NCT01604109|378167|P2|COMPLETED|Overall Study||112
155738|NCT01604109|378168|P1|COMPLETED|Overall Study||117
155739|NCT01604109|378167|P2|STARTED|Overall Study||146
155740|NCT01604109|378168|P1|STARTED|Overall Study||150
155741|NCT01603940|378176|P2|NOT COMPLETED|Overall Study||0
155742|NCT01603940|378177|P1|NOT COMPLETED|Overall Study||0
155743|NCT01603940|378176|P2|COMPLETED|Overall Study||14
155744|NCT01603940|378177|P1|COMPLETED|Overall Study||16
155745|NCT01603940|378176|P2|STARTED|Overall Study||14
155746|NCT01603940|378177|P1|STARTED|Overall Study||16
155747|NCT01603875|378194|P3|NOT COMPLETED|Overall Study||9
155748|NCT01603875|378195|P2|NOT COMPLETED|Overall Study||8
155749|NCT01603875|378196|P1|NOT COMPLETED|Overall Study||7
155750|NCT01603875|378194|P3|COMPLETED|Overall Study||26
155751|NCT01603875|378195|P2|COMPLETED|Overall Study||27
155752|NCT01603875|378196|P1|COMPLETED|Overall Study||28
155753|NCT01603875|378194|P3|STARTED|Overall Study||35
155754|NCT01603875|378195|P2|STARTED|Overall Study||35
155755|NCT01603875|378196|P1|STARTED|Overall Study||35
155756|NCT01603641|378216|P1|NOT COMPLETED|Overall Study||35
155757|NCT01603641|378216|P1|COMPLETED|Overall Study||335
155758|NCT01603641|378216|P1|Modified Intent-to-treat Population|Overall Study||366
155759|NCT01603641|378216|P1|Safety Population (Treated)|Overall Study||367
155760|NCT01603641|378216|P1|STARTED|Overall Study||370
155761|NCT01603628|378223|P3|NOT COMPLETED|Overall Study||2
155762|NCT01603628|378224|P2|NOT COMPLETED|Overall Study||3
155763|NCT01603628|378225|P1|NOT COMPLETED|Overall Study||3
155764|NCT01603628|378223|P3|COMPLETED|Overall Study||128
155765|NCT01603628|378224|P2|COMPLETED|Overall Study||123
155766|NCT01603628|378225|P1|COMPLETED|Overall Study||125
155767|NCT01603628|378223|P3|Safety Population: Received Treatment|Overall Study||128
155768|NCT01603628|378224|P2|Safety Population: Received Treatment|Overall Study||126
155769|NCT01603628|378225|P1|Safety Population: Received Treatment|Overall Study||128
155770|NCT01603628|378223|P3|STARTED|Overall Study||130
155771|NCT01603628|378224|P2|STARTED|Overall Study||126
155772|NCT01603628|378225|P1|STARTED|Overall Study||128
155773|NCT01603615|378242|P1|NOT COMPLETED|Overall Study||34
155774|NCT01603615|378242|P1|COMPLETED|Overall Study||186
155775|NCT01603615|378242|P1|Safety Population (Treated)|Overall Study||213
155776|NCT01603615|378242|P1|STARTED|Overall Study||220
155777|NCT01603602|378249|P3|NOT COMPLETED|Overall Study||1
155778|NCT01603602|378250|P2|NOT COMPLETED|Overall Study||0
155779|NCT01603602|378251|P1|NOT COMPLETED|Overall Study||2
155780|NCT01603602|378249|P3|COMPLETED|Overall Study||79
155781|NCT01603602|378250|P2|COMPLETED|Overall Study||78
155782|NCT01603602|378251|P1|COMPLETED|Overall Study||75
155783|NCT01603602|378249|P3|STARTED|Overall Study||80
155784|NCT01603602|378250|P2|STARTED|Overall Study||78
155785|NCT01603602|378251|P1|STARTED|Overall Study||77
155786|NCT01603459|378271|P1|NOT COMPLETED|Overall Study||18
155787|NCT01603459|378271|P1|COMPLETED|Overall Study||137
155788|NCT01603459|378271|P1|STARTED|Overall Study||155
155789|NCT01603420|378393|P2|NOT COMPLETED|Overall Study||0
155790|NCT01603420|378394|P1|NOT COMPLETED|Overall Study||0
155791|NCT01603420|378393|P2|COMPLETED|Overall Study||1
155792|NCT01603420|378394|P1|COMPLETED|Overall Study||1
155793|NCT01603420|378393|P2|STARTED|Overall Study||1
155794|NCT01603420|378394|P1|STARTED|Overall Study||1
155795|NCT01603394|378422|P1|NOT COMPLETED|Overall Study||1
155796|NCT01603394|378422|P1|COMPLETED|Overall Study||8
155797|NCT01603394|378422|P1|STARTED|Overall Study||9
155798|NCT01603355|378437|P1|NOT COMPLETED|Overall Study||2
155799|NCT01603355|378437|P1|COMPLETED|Overall Study||1
155800|NCT01603355|378437|P1|STARTED|Overall Study||3
155801|NCT01603277|378443|P2|NOT COMPLETED|Overall Study||18
155802|NCT01603277|378444|P1|NOT COMPLETED|Overall Study||14
155803|NCT01603277|378443|P2|COMPLETED|Overall Study||64
155804|NCT01603277|378444|P1|COMPLETED|Overall Study||64
155805|NCT01603277|378443|P2|STARTED|Overall Study||82
155806|NCT01603277|378444|P1|STARTED|Overall Study||78
155807|NCT01603121|378450|P2|NOT COMPLETED|Second Intervention, 10 Hours||0
155808|NCT01603121|378451|P1|NOT COMPLETED|Second Intervention, 10 Hours||1
155809|NCT01603121|378450|P2|COMPLETED|Second Intervention, 10 Hours||0
155810|NCT01603121|378451|P1|COMPLETED|Second Intervention, 10 Hours||0
155811|NCT01603121|378450|P2|STARTED|Second Intervention, 10 Hours||0
155812|NCT01603121|378451|P1|STARTED|Second Intervention, 10 Hours||1
155813|NCT01603121|378450|P2|NOT COMPLETED|First Intervention, 10 Hours||0
155814|NCT01603121|378451|P1|NOT COMPLETED|First Intervention, 10 Hours||0
155815|NCT01603121|378450|P2|COMPLETED|First Intervention, 10 Hours||0
155816|NCT01603121|378451|P1|COMPLETED|First Intervention, 10 Hours||1
155817|NCT01603121|378450|P2|STARTED|First Intervention, 10 Hours||0
155818|NCT01603121|378451|P1|STARTED|First Intervention, 10 Hours||1
155819|NCT01603082|378463|P2|NOT COMPLETED|Overall Study||1
155820|NCT01603082|378464|P1|NOT COMPLETED|Overall Study||2
155821|NCT01603082|378463|P2|COMPLETED|Overall Study|Completed the study|48
155822|NCT01603082|378464|P1|COMPLETED|Overall Study|Completed the study.|49
155823|NCT01603082|378463|P2|STARTED|Overall Study|Randomized|49
155824|NCT01603082|378464|P1|STARTED|Overall Study|Randomized|51
155825|NCT01603056|378474|P2|NOT COMPLETED|Overall Study||14
155826|NCT01603056|378475|P1|NOT COMPLETED|Overall Study||34
155827|NCT01603056|378474|P2|COMPLETED|Overall Study||190
155828|NCT01603056|378475|P1|COMPLETED|Overall Study||379
155829|NCT01603056|378474|P2|STARTED|Overall Study||204
155830|NCT01603056|378475|P1|STARTED|Overall Study||413
155831|NCT01603043|378505|P2|NOT COMPLETED|Overall Study||3
155832|NCT01603043|378506|P1|NOT COMPLETED|Overall Study||7
155833|NCT01603043|378505|P2|COMPLETED|Overall Study||0
155834|NCT01603043|378506|P1|COMPLETED|Overall Study||0
155835|NCT01603043|378505|P2|STARTED|Overall Study||3
155836|NCT01603043|378506|P1|STARTED|Overall Study||7
155837|NCT01602965|378518|P2|NOT COMPLETED|Overall Study||2
155838|NCT01602965|378519|P1|NOT COMPLETED|Overall Study||4
155839|NCT01602965|378518|P2|COMPLETED|Overall Study||18
155840|NCT01602965|378519|P1|COMPLETED|Overall Study||16
155841|NCT01602965|378518|P2|STARTED|Overall Study||20
155842|NCT01602965|378519|P1|STARTED|Overall Study||20
155843|NCT01602744|378527|P2|NOT COMPLETED|Overall Study||23
155844|NCT01602744|378528|P1|NOT COMPLETED|Overall Study||30
155845|NCT01602744|378527|P2|COMPLETED|Overall Study||160
155846|NCT01602744|378528|P1|COMPLETED|Overall Study||146
155847|NCT01602744|378527|P2|STARTED|Overall Study||183
155848|NCT01602744|378528|P1|STARTED|Overall Study||176
155849|NCT01602731|378544|P1|NOT COMPLETED|Overall Study||30
155850|NCT01602731|378544|P1|COMPLETED|Overall Study||15
155851|NCT01602731|378544|P1|Poor Medication Adherence|Overall Study|24 out of 35 patients who completed 1-month pill counts had medication adherence <88%.|24
155852|NCT01602731|378544|P1|Cognitive Impairment|Overall Study|After repeat cognitive testing, additional 1 patient had no cognitive impairment and did not proceed|44
155853|NCT01602731|378544|P1|STARTED|Overall Study||45
155854|NCT01602679|378552|P2|NOT COMPLETED|Overall Study||0
155855|NCT01602679|378553|P1|NOT COMPLETED|Overall Study||0
155856|NCT01602679|378552|P2|COMPLETED|Overall Study||3
155857|NCT01602679|378553|P1|COMPLETED|Overall Study||4
155858|NCT01602679|378552|P2|STARTED|Overall Study||3
155859|NCT01602679|378553|P1|STARTED|Overall Study||4
155860|NCT01602562|378565|P2|NOT COMPLETED|Overall Study||3
155861|NCT01602562|378566|P1|NOT COMPLETED|Overall Study||5
155862|NCT01602562|378565|P2|COMPLETED|Overall Study||16
155863|NCT01602562|378566|P1|COMPLETED|Overall Study||16
155864|NCT01602562|378565|P2|STARTED|Overall Study||19
155865|NCT01602562|378566|P1|STARTED|Overall Study||21
155866|NCT01602549|378602|P2|NOT COMPLETED|Overall Study||1
155867|NCT01602549|378603|P1|NOT COMPLETED|Overall Study||1
155868|NCT01602549|378602|P2|COMPLETED|Overall Study||37
155869|NCT01602549|378603|P1|COMPLETED|Overall Study||18
155870|NCT01602549|378602|P2|STARTED|Overall Study||38
155871|NCT01602549|378603|P1|STARTED|Overall Study||19
155872|NCT01602510|378682|P3|NOT COMPLETED|Randomized Phase||73
155873|NCT01602510|378683|P2|NOT COMPLETED|Randomized Phase||74
155874|NCT01602510|378684|P1|NOT COMPLETED|Randomized Phase||0
155875|NCT01602510|378682|P3|COMPLETED|Randomized Phase||58
155876|NCT01602510|378683|P2|COMPLETED|Randomized Phase||59
155877|NCT01602510|378684|P1|COMPLETED|Randomized Phase||0
155878|NCT01602510|378682|P3|STARTED|Randomized Phase||131
155879|NCT01602510|378683|P2|STARTED|Randomized Phase||133
155880|NCT01602510|378684|P1|STARTED|Randomized Phase||0
155881|NCT01602510|378682|P3|NOT COMPLETED|Open Label Phase||0
155882|NCT01602510|378683|P2|NOT COMPLETED|Open Label Phase||0
155883|NCT01602510|378684|P1|NOT COMPLETED|Open Label Phase||303
155884|NCT01602510|378682|P3|COMPLETED|Open Label Phase||0
155885|NCT01602510|378683|P2|COMPLETED|Open Label Phase||0
155886|NCT01602510|378684|P1|COMPLETED|Open Label Phase||117
155887|NCT01602510|378682|P3|STARTED|Open Label Phase||0
155888|NCT01602510|378683|P2|STARTED|Open Label Phase||0
155889|NCT01602510|378684|P1|STARTED|Open Label Phase||420
155890|NCT01602484|378710|P2|NOT COMPLETED|Overall Study||1
155891|NCT01602484|378711|P1|NOT COMPLETED|Overall Study||0
155892|NCT01602484|378710|P2|COMPLETED|Overall Study||24
155893|NCT01602484|378711|P1|COMPLETED|Overall Study||25
155894|NCT01602484|378710|P2|STARTED|Overall Study||25
155895|NCT01602484|378711|P1|STARTED|Overall Study||25
155896|NCT01602471|378723|P1|NOT COMPLETED|Overall Study||0
155897|NCT01602471|378723|P1|COMPLETED|Overall Study||4
155898|NCT01602471|378723|P1|STARTED|Overall Study||4
155899|NCT01602380|378729|P2|NOT COMPLETED|Overall Study||101
155900|NCT01602380|378730|P1|NOT COMPLETED|Overall Study||93
155901|NCT01602380|378729|P2|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|131
155902|NCT01602380|378730|P1|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|137
155903|NCT01602380|378729|P2|STARTED|Overall Study||232
155904|NCT01602380|378730|P1|STARTED|Overall Study||230
155905|NCT01602341|378754|P2|NOT COMPLETED|Overall Study||1
155906|NCT01602341|378755|P1|NOT COMPLETED|Overall Study||0
155907|NCT01602341|378754|P2|COMPLETED|Overall Study||41
155908|NCT01602341|378755|P1|COMPLETED|Overall Study||44
155909|NCT01602341|378754|P2|STARTED|Overall Study||42
155910|NCT01602341|378755|P1|STARTED|Overall Study||44
155911|NCT01602315|378796|P7|NOT COMPLETED|Overall Study||29
155912|NCT01602315|378797|P6|NOT COMPLETED|Overall Study||35
155913|NCT01602315|378798|P5|NOT COMPLETED|Overall Study||71
155914|NCT01602315|378799|P4|NOT COMPLETED|Overall Study||6
155915|NCT01602315|378800|P3|NOT COMPLETED|Overall Study||18
155916|NCT01602315|378801|P2|NOT COMPLETED|Overall Study||5
155917|NCT01602315|378802|P1|NOT COMPLETED|Overall Study||16
155918|NCT01602315|378796|P7|COMPLETED|Overall Study||0
155919|NCT01602315|378797|P6|COMPLETED|Overall Study||0
155920|NCT01602315|378798|P5|COMPLETED|Overall Study||0
155921|NCT01602315|378799|P4|COMPLETED|Overall Study||0
155922|NCT01602315|378800|P3|COMPLETED|Overall Study||0
155923|NCT01602315|378801|P2|COMPLETED|Overall Study||0
155924|NCT01602315|378802|P1|COMPLETED|Overall Study||0
155925|NCT01602315|378796|P7|STARTED|Overall Study||29
155926|NCT01602315|378797|P6|STARTED|Overall Study||35
155927|NCT01602315|378798|P5|STARTED|Overall Study||71
155928|NCT01602315|378799|P4|STARTED|Overall Study||6
155929|NCT01602315|378800|P3|STARTED|Overall Study||18
155930|NCT01602315|378801|P2|STARTED|Overall Study||5
155931|NCT01602315|378802|P1|STARTED|Overall Study||16
155932|NCT01602224|378891|P3|NOT COMPLETED|Overall Study||6
155933|NCT01602224|378892|P2|NOT COMPLETED|Overall Study||8
155934|NCT01602224|378893|P1|NOT COMPLETED|Overall Study||8
155935|NCT01602224|378891|P3|COMPLETED|Overall Study||66
155936|NCT01602224|378892|P2|COMPLETED|Overall Study||66
155937|NCT01602224|378893|P1|COMPLETED|Overall Study||66
155938|NCT01602224|378891|P3|Received at Least 1 Dose of Study Drug|Overall Study||72
155939|NCT01602224|378892|P2|Received at Least 1 Dose of Study Drug|Overall Study||74
155940|NCT01602224|378893|P1|Received at Least 1 Dose of Study Drug|Overall Study||73
155941|NCT01602224|378891|P3|STARTED|Overall Study||72
155942|NCT01602224|378892|P2|STARTED|Overall Study||74
155943|NCT01602224|378893|P1|STARTED|Overall Study||74
155944|NCT01602198|378939|P2|NOT COMPLETED|Overall Study||0
155945|NCT01602198|378940|P1|NOT COMPLETED|Overall Study||0
155946|NCT01602198|378939|P2|COMPLETED|Overall Study||1
155947|NCT01602198|378940|P1|COMPLETED|Overall Study||0
155948|NCT01602198|378939|P2|STARTED|Overall Study||1
155949|NCT01602198|378940|P1|STARTED|Overall Study||0
155950|NCT01602172|378949|P3|NOT COMPLETED|Overall Study||0
155951|NCT01602172|378950|P2|NOT COMPLETED|Overall Study||6
155952|NCT01602172|378951|P1|NOT COMPLETED|Overall Study||5
155953|NCT01602172|378949|P3|COMPLETED|Overall Study||22
155954|NCT01602172|378950|P2|COMPLETED|Overall Study||17
155955|NCT01602172|378951|P1|COMPLETED|Overall Study||32
155956|NCT01602172|378949|P3|STARTED|Overall Study||22
155957|NCT01602172|378950|P2|STARTED|Overall Study||23
155958|NCT01602172|378951|P1|STARTED|Overall Study||37
155959|NCT01602120|378978|P4|NOT COMPLETED|Overall Study||53
155960|NCT01602120|378979|P3|NOT COMPLETED|Overall Study||17
155961|NCT01602120|378980|P2|NOT COMPLETED|Overall Study||60
155962|NCT01602120|378981|P1|NOT COMPLETED|Overall Study||29
155963|NCT01602120|378978|P4|COMPLETED|Overall Study||0
155964|NCT01602120|378979|P3|COMPLETED|Overall Study||0
155965|NCT01602120|378980|P2|COMPLETED|Overall Study||0
155966|NCT01602120|378981|P1|COMPLETED|Overall Study||0
155967|NCT01602120|378978|P4|STARTED|Overall Study||53
155968|NCT01602120|378979|P3|STARTED|Overall Study||17
155969|NCT01602120|378980|P2|STARTED|Overall Study||60
155970|NCT01602120|378981|P1|STARTED|Overall Study||29
155971|NCT01602068|378995|P2|NOT COMPLETED|Overall Study||0
155972|NCT01602068|378996|P1|NOT COMPLETED|Overall Study||0
155973|NCT01602068|378995|P2|COMPLETED|Overall Study||22
155974|NCT01602068|378996|P1|COMPLETED|Overall Study||23
155975|NCT01602068|378995|P2|STARTED|Overall Study|Day before surgery|22
155976|NCT01602068|378996|P1|STARTED|Overall Study|Day before surgery|23
155977|NCT01602016|379002|P1|NOT COMPLETED|Overall Study||0
155978|NCT01602016|379002|P1|COMPLETED|Overall Study||0
155979|NCT01602016|379002|P1|STARTED|Overall Study||0
155980|NCT01601977|379009|P1|NOT COMPLETED|Overall Study||0
155981|NCT01601977|379009|P1|COMPLETED|Overall Study||10
155982|NCT01601977|379009|P1|STARTED|Overall Study|5 patients consented for study participation but did not attend for study assessments.|10
155983|NCT01601873|379029|P2|NOT COMPLETED|Overall Study||3
155984|NCT01601873|379030|P1|NOT COMPLETED|Overall Study||2
155985|NCT01601873|379029|P2|COMPLETED|Overall Study||44
155986|NCT01601873|379030|P1|COMPLETED|Overall Study||48
155987|NCT01601873|379029|P2|STARTED|Overall Study||47
155988|NCT01601873|379030|P1|STARTED|Overall Study||50
155989|NCT01601847|379056|P2|NOT COMPLETED|Overall Study||10
155990|NCT01601847|379057|P1|NOT COMPLETED|Overall Study||13
155991|NCT01601847|379056|P2|COMPLETED|Overall Study||137
155992|NCT01601847|379057|P1|COMPLETED|Overall Study||140
155993|NCT01601847|379056|P2|STARTED|Overall Study||147
155994|NCT01601847|379057|P1|STARTED|Overall Study||153
155995|NCT01601821|379069|P2|NOT COMPLETED|Overall Study||29
155996|NCT01601821|379070|P1|NOT COMPLETED|Overall Study||29
155997|NCT01601821|379069|P2|COMPLETED|Overall Study||91
155998|NCT01601821|379070|P1|COMPLETED|Overall Study||96
155999|NCT01601821|379069|P2|STARTED|Overall Study||120
156000|NCT01601821|379070|P1|STARTED|Overall Study||125
156001|NCT01601782|379100|P1|NOT COMPLETED|Overall Study||0
156002|NCT01601782|379100|P1|COMPLETED|Overall Study||16
156003|NCT01601782|379100|P1|STARTED|Overall Study||16
156004|NCT01601704|379106|P2|NOT COMPLETED|Overall Study||4
156005|NCT01601704|379107|P1|NOT COMPLETED|Overall Study||1
156006|NCT01601704|379106|P2|COMPLETED|Overall Study||4450
156007|NCT01601704|379107|P1|COMPLETED|Overall Study||4455
156008|NCT01601704|379106|P2|Treated|Overall Study||4450
156009|NCT01601704|379107|P1|Treated|Overall Study||4455
156010|NCT01601704|379106|P2|STARTED|Overall Study||4454
156011|NCT01601704|379107|P1|STARTED|Overall Study||4456
156012|NCT01601691|379121|P1|NOT COMPLETED|Overall Study||0
156013|NCT01601691|379121|P1|COMPLETED|Overall Study||10
156014|NCT01601691|379121|P1|STARTED|Overall Study||10
156015|NCT01601626|379128|P3|NOT COMPLETED|Overall Study||2
156016|NCT01601626|379129|P2|NOT COMPLETED|Overall Study||5
156017|NCT01601626|379130|P1|NOT COMPLETED|Overall Study||3
156018|NCT01601626|379128|P3|COMPLETED|Overall Study||21
156019|NCT01601626|379129|P2|COMPLETED|Overall Study||19
156020|NCT01601626|379130|P1|COMPLETED|Overall Study||21
156021|NCT01601626|379128|P3|STARTED|Overall Study||23
156022|NCT01601626|379129|P2|STARTED|Overall Study||24
156023|NCT01601626|379130|P1|STARTED|Overall Study||24
156024|NCT01601535|379219|P6|NOT COMPLETED|Phase 2||12
156025|NCT01601535|379220|P5|NOT COMPLETED|Phase 2||19
156026|NCT01601535|379221|P4|NOT COMPLETED|Phase 2||0
156027|NCT01601535|379222|P3|NOT COMPLETED|Phase 2||0
156028|NCT01601535|379223|P2|NOT COMPLETED|Phase 2||0
156029|NCT01601535|379224|P1|NOT COMPLETED|Phase 2||0
156030|NCT01601535|379219|P6|COMPLETED|Phase 2||0
156031|NCT01601535|379220|P5|COMPLETED|Phase 2||1
156032|NCT01601535|379221|P4|COMPLETED|Phase 2||0
156033|NCT01601535|379222|P3|COMPLETED|Phase 2||0
156034|NCT01601535|379223|P2|COMPLETED|Phase 2||0
156035|NCT01601535|379224|P1|COMPLETED|Phase 2||0
156036|NCT01601535|379219|P6|STARTED|Phase 2||12
156037|NCT01601535|379220|P5|STARTED|Phase 2||20
156038|NCT01601535|379221|P4|STARTED|Phase 2||0
156039|NCT01601535|379222|P3|STARTED|Phase 2||0
156040|NCT01601535|379223|P2|STARTED|Phase 2||0
156041|NCT01601535|379224|P1|STARTED|Phase 2||0
156042|NCT01601535|379219|P6|NOT COMPLETED|Phase 1||0
156043|NCT01601535|379220|P5|NOT COMPLETED|Phase 1||0
156044|NCT01601535|379221|P4|NOT COMPLETED|Phase 1||4
156045|NCT01601535|379222|P3|NOT COMPLETED|Phase 1||5
156046|NCT01601535|379223|P2|NOT COMPLETED|Phase 1||6
156047|NCT01601535|379224|P1|NOT COMPLETED|Phase 1||6
156048|NCT01601535|379219|P6|COMPLETED|Phase 1||0
156049|NCT01601535|379220|P5|COMPLETED|Phase 1||0
156050|NCT01601535|379221|P4|COMPLETED|Phase 1||0
156051|NCT01601535|379222|P3|COMPLETED|Phase 1||1
156052|NCT01601535|379223|P2|COMPLETED|Phase 1||0
156053|NCT01601535|379224|P1|COMPLETED|Phase 1||0
156054|NCT01601535|379219|P6|STARTED|Phase 1||0
156055|NCT01601535|379220|P5|STARTED|Phase 1||0
156056|NCT01601535|379221|P4|STARTED|Phase 1||4
156057|NCT01601535|379222|P3|STARTED|Phase 1||6
156058|NCT01601535|379223|P2|STARTED|Phase 1||6
156059|NCT01601535|379224|P1|STARTED|Phase 1||6
156060|NCT01601470|379280|P1|NOT COMPLETED|Period 3 - LCZ696+Sildenafil||0
156061|NCT01601470|379280|P1|COMPLETED|Period 3 - LCZ696+Sildenafil||27
156062|NCT01601470|379280|P1|Safety Set|Period 3 - LCZ696+Sildenafil||27
156063|NCT01601470|379280|P1|PK Analysis Set|Period 3 - LCZ696+Sildenafil||27
156064|NCT01601470|379280|P1|STARTED|Period 3 - LCZ696+Sildenafil||27
156065|NCT01601470|379280|P1|NOT COMPLETED|Period 2 - LCZ696||1
156066|NCT01601470|379280|P1|COMPLETED|Period 2 - LCZ696||27
156067|NCT01601470|379280|P1|Safety Set|Period 2 - LCZ696||27
156068|NCT01601470|379280|P1|PK Analysis Set|Period 2 - LCZ696||27
156069|NCT01601470|379280|P1|STARTED|Period 2 - LCZ696||28
156070|NCT01601470|379280|P1|NOT COMPLETED|Period 1 - Sildenafil||0
156071|NCT01601470|379280|P1|COMPLETED|Period 1 - Sildenafil||28
156072|NCT01601470|379280|P1|Safety Set|Period 1 - Sildenafil||28
156073|NCT01601470|379280|P1|PK Analysis Set|Period 1 - Sildenafil||28
156074|NCT01601470|379280|P1|STARTED|Period 1 - Sildenafil||28
156075|NCT01601431|379297|P2|NOT COMPLETED|Overall Study||3
156076|NCT01601431|379298|P1|NOT COMPLETED|Overall Study||12
156077|NCT01601431|379297|P2|COMPLETED|Overall Study||214
156078|NCT01601431|379298|P1|COMPLETED|Overall Study||211
156079|NCT01601431|379297|P2|STARTED|Overall Study||217
156080|NCT01601431|379298|P1|STARTED|Overall Study||223
156081|NCT01601236|379310|P6|NOT COMPLETED|Overall Study||1
156082|NCT01601236|379311|P5|NOT COMPLETED|Overall Study||3
156083|NCT01601236|379312|P4|NOT COMPLETED|Overall Study||2
156084|NCT01601236|379313|P3|NOT COMPLETED|Overall Study||6
156085|NCT01601236|379314|P2|NOT COMPLETED|Overall Study||1
156086|NCT01601236|379315|P1|NOT COMPLETED|Overall Study||5
156087|NCT01601236|379310|P6|COMPLETED|Overall Study||0
156088|NCT01601236|379311|P5|COMPLETED|Overall Study||0
156089|NCT01601236|379312|P4|COMPLETED|Overall Study||4
156090|NCT01601236|379313|P3|COMPLETED|Overall Study||8
156091|NCT01601236|379314|P2|COMPLETED|Overall Study||2
156092|NCT01601236|379315|P1|COMPLETED|Overall Study||2
156093|NCT01601236|379310|P6|STARTED|Overall Study||1
156094|NCT01601236|379311|P5|STARTED|Overall Study||3
156095|NCT01601236|379312|P4|STARTED|Overall Study||6
156096|NCT01601236|379313|P3|STARTED|Overall Study||14
156097|NCT01601236|379314|P2|STARTED|Overall Study||3
156098|NCT01601236|379315|P1|STARTED|Overall Study||7
156099|NCT01601132|379351|P1|NOT COMPLETED|Overall Study||2
156100|NCT01601132|379351|P1|COMPLETED|Overall Study||28
156101|NCT01601132|379351|P1|STARTED|Overall Study||30
156102|NCT01601067|379370|P2|NOT COMPLETED|Overall Study||22
156103|NCT01601067|379371|P1|NOT COMPLETED|Overall Study||33
156104|NCT01601067|379370|P2|COMPLETED|Overall Study||34
156105|NCT01601067|379371|P1|COMPLETED|Overall Study||30
156106|NCT01601067|379370|P2|STARTED|Overall Study||56
156107|NCT01601067|379371|P1|STARTED|Overall Study||63
156108|NCT01600950|379379|P2|NOT COMPLETED|Period 2||0
156109|NCT01600950|379380|P1|NOT COMPLETED|Period 2||0
156110|NCT01600950|379379|P2|COMPLETED|Period 2||10
156111|NCT01600950|379380|P1|COMPLETED|Period 2||10
156112|NCT01600950|379379|P2|STARTED|Period 2||10
156113|NCT01600950|379380|P1|STARTED|Period 2||10
156114|NCT01600950|379379|P2|NOT COMPLETED|Period 1||0
156115|NCT01600950|379380|P1|NOT COMPLETED|Period 1||0
156116|NCT01600950|379379|P2|COMPLETED|Period 1||10
156117|NCT01600950|379380|P1|COMPLETED|Period 1||10
156118|NCT01600950|379379|P2|STARTED|Period 1||10
156119|NCT01600950|379380|P1|STARTED|Period 1||10
156120|NCT01600885|379396|P2|NOT COMPLETED|Second Period||0
156121|NCT01600885|379397|P1|NOT COMPLETED|Second Period||0
156122|NCT01600885|379396|P2|COMPLETED|Second Period||8
156123|NCT01600885|379397|P1|COMPLETED|Second Period||8
156124|NCT01600885|379396|P2|STARTED|Second Period||8
156125|NCT01600885|379397|P1|STARTED|Second Period||8
156126|NCT01600885|379396|P2|NOT COMPLETED|Wash Out Period||0
156127|NCT01600885|379397|P1|NOT COMPLETED|Wash Out Period||0
156128|NCT01600885|379396|P2|COMPLETED|Wash Out Period||8
156129|NCT01600885|379397|P1|COMPLETED|Wash Out Period||8
156130|NCT01600885|379396|P2|STARTED|Wash Out Period||8
156131|NCT01600885|379397|P1|STARTED|Wash Out Period||8
156132|NCT01600885|379396|P2|NOT COMPLETED|First Period||1
156133|NCT01600885|379397|P1|NOT COMPLETED|First Period||2
156134|NCT01600885|379396|P2|COMPLETED|First Period||8
156135|NCT01600885|379397|P1|COMPLETED|First Period||8
156136|NCT01600885|379396|P2|STARTED|First Period||9
156137|NCT01600885|379397|P1|STARTED|First Period||10
156138|NCT01600729|379407|P1|NOT COMPLETED|Overall Study||1
156139|NCT01600729|379407|P1|COMPLETED|Overall Study||65
156140|NCT01600729|379407|P1|STARTED|Overall Study||66
156141|NCT01600716|379414|P2|NOT COMPLETED|Overall Study||7
156142|NCT01600716|379415|P1|NOT COMPLETED|Overall Study||7
156143|NCT01600716|379414|P2|COMPLETED|Overall Study||71
156144|NCT01600716|379415|P1|COMPLETED|Overall Study||59
156145|NCT01600716|379414|P2|STARTED|Overall Study||78
156146|NCT01600716|379415|P1|STARTED|Overall Study||66
156147|NCT01600703|379431|P2|NOT COMPLETED|Second Intervention||0
156148|NCT01600703|379432|P1|NOT COMPLETED|Second Intervention||0
156149|NCT01600703|379431|P2|COMPLETED|Second Intervention||8
156150|NCT01600703|379432|P1|COMPLETED|Second Intervention||7
156151|NCT01600703|379431|P2|STARTED|Second Intervention||8
156152|NCT01600703|379432|P1|STARTED|Second Intervention||7
156153|NCT01600703|379431|P2|NOT COMPLETED|First Intervention||0
156154|NCT01600703|379432|P1|NOT COMPLETED|First Intervention||0
156155|NCT01600703|379431|P2|COMPLETED|First Intervention||8
156156|NCT01600703|379432|P1|COMPLETED|First Intervention||7
156157|NCT01600703|379431|P2|STARTED|First Intervention||8
156158|NCT01600703|379432|P1|STARTED|First Intervention||7
156159|NCT01600677|379442|P2|NOT COMPLETED|Overall Study||0
156160|NCT01600677|379443|P1|NOT COMPLETED|Overall Study||0
156161|NCT01600677|379442|P2|COMPLETED|Overall Study||4
156162|NCT01600677|379443|P1|COMPLETED|Overall Study||7
156163|NCT01600677|379442|P2|STARTED|Overall Study||4
156164|NCT01600677|379443|P1|STARTED|Overall Study||7
156165|NCT01600586|379455|P2|NOT COMPLETED|Overall Study||3
156166|NCT01600586|379456|P1|NOT COMPLETED|Overall Study||3
156167|NCT01600586|379455|P2|COMPLETED|Overall Study||48
156168|NCT01600586|379456|P1|COMPLETED|Overall Study||46
156169|NCT01600586|379455|P2|STARTED|Overall Study||51
156170|NCT01600586|379456|P1|STARTED|Overall Study||49
156171|NCT01600495|379472|P2|NOT COMPLETED|Overall Study||0
156172|NCT01600495|379473|P1|NOT COMPLETED|Overall Study||0
156173|NCT01600495|379472|P2|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
156174|NCT01600495|379473|P1|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
156175|NCT01600495|379472|P2|STARTED|Overall Study|We start with the prediction of collecting 20 control patients|23
156176|NCT01600495|379473|P1|STARTED|Overall Study|We start with the prediction of collecting 20 patients in the treated group|23
156177|NCT01600482|379487|P2|NOT COMPLETED|Overall Study||0
156178|NCT01600482|379488|P1|NOT COMPLETED|Overall Study||0
156179|NCT01600482|379487|P2|COMPLETED|Overall Study||59
156180|NCT01600482|379488|P1|COMPLETED|Overall Study|Last 26 patients allocated to CELT ACD|148
156181|NCT01600482|379487|P2|STARTED|Overall Study|Last 26 patients allocated to CELT ACD|59
156182|NCT01600482|379488|P1|STARTED|Overall Study||148
156183|NCT01600326|379508|P2|NOT COMPLETED|Overall Study||1
156184|NCT01600326|379509|P1|NOT COMPLETED|Overall Study||1
156185|NCT01600326|379508|P2|COMPLETED|Overall Study||14
156186|NCT01600326|379509|P1|COMPLETED|Overall Study||14
156187|NCT01600326|379508|P2|Primary Outcome Measure Data Collection|Overall Study||15
156188|NCT01600326|379509|P1|Primary Outcome Measure Data Collection|Overall Study||15
156189|NCT01600326|379508|P2|STARTED|Overall Study||15
156190|NCT01600326|379509|P1|STARTED|Overall Study||15
156191|NCT01600287|379519|P2|NOT COMPLETED|Overall Study||0
156192|NCT01600287|379520|P1|NOT COMPLETED|Overall Study||0
156193|NCT01600287|379519|P2|COMPLETED|Overall Study||20
156194|NCT01600287|379520|P1|COMPLETED|Overall Study||20
156195|NCT01600287|379519|P2|STARTED|Overall Study||20
156196|NCT01600287|379520|P1|STARTED|Overall Study||20
156197|NCT01600222|379560|P1|NOT COMPLETED|Overall Study||2
156198|NCT01600222|379560|P1|COMPLETED|Overall Study||35
156199|NCT01600222|379560|P1|STARTED|Overall Study||37
156200|NCT01600105|379585|P2|NOT COMPLETED|Sub Study III||0
156201|NCT01600105|379586|P1|NOT COMPLETED|Sub Study III||5
156202|NCT01600105|379585|P2|COMPLETED|Sub Study III||0
156203|NCT01600105|379586|P1|COMPLETED|Sub Study III||34
156204|NCT01600105|379585|P2|STARTED|Sub Study III||0
156205|NCT01600105|379586|P1|STARTED|Sub Study III||39
156206|NCT01600105|379585|P2|NOT COMPLETED|Sub Study II||0
156207|NCT01600105|379586|P1|NOT COMPLETED|Sub Study II||5
156208|NCT01600105|379585|P2|COMPLETED|Sub Study II||0
156209|NCT01600105|379586|P1|COMPLETED|Sub Study II||60
156210|NCT01600105|379585|P2|STARTED|Sub Study II||0
156211|NCT01600105|379586|P1|STARTED|Sub Study II||65
156212|NCT01600105|379585|P2|NOT COMPLETED|Sub Study I||10
156213|NCT01600105|379586|P1|NOT COMPLETED|Sub Study I||0
156214|NCT01600105|379585|P2|COMPLETED|Sub Study I||11
156215|NCT01600105|379586|P1|COMPLETED|Sub Study I||19
156216|NCT01600105|379585|P2|STARTED|Sub Study I||21
156217|NCT01600105|379586|P1|STARTED|Sub Study I||19
156218|NCT01600105|379585|P2|NOT COMPLETED|Total Participants||10
156219|NCT01600105|379586|P1|NOT COMPLETED|Total Participants||41
156220|NCT01600105|379585|P2|COMPLETED|Total Participants||11
156221|NCT01600105|379586|P1|COMPLETED|Total Participants||214
156222|NCT01600105|379585|P2|STARTED|Total Participants||21
156223|NCT01600105|379586|P1|STARTED|Total Participants||255
156224|NCT01600092|379614|P2|NOT COMPLETED|Overall Study||16
156225|NCT01600092|379615|P1|NOT COMPLETED|Overall Study||18
156226|NCT01600092|379614|P2|COMPLETED|Overall Study||491
156227|NCT01600092|379615|P1|COMPLETED|Overall Study||495
156228|NCT01600092|379614|P2|Received All 3 Vaccinations|Overall Study||494
156229|NCT01600092|379615|P1|Received All 3 Vaccinations|Overall Study||500
156230|NCT01600092|379614|P2|Received at Least 1 Vaccination|Overall Study||504
156231|NCT01600092|379615|P1|Received at Least 1 Vaccination|Overall Study|1 participant received RotaTeq™ existing formulation as their first vaccination|510
156232|NCT01600092|379614|P2|STARTED|Overall Study||507
156233|NCT01600092|379615|P1|STARTED|Overall Study||513
156234|NCT01600053|379629|P1|NOT COMPLETED|Overall Study||11
156235|NCT01600053|379629|P1|COMPLETED|Overall Study||0
156236|NCT01600053|379629|P1|STARTED|Overall Study||11
156237|NCT01600014|379634|P2|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||0
156238|NCT01600014|379635|P1|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||3
156239|NCT01600014|379634|P2|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||20
156240|NCT01600014|379635|P1|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||39
156241|NCT01600014|379634|P2|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||20
156242|NCT01600014|379635|P1|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||42
156243|NCT01600014|379634|P2|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||10
156244|NCT01600014|379635|P1|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||12
156245|NCT01600014|379634|P2|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||39
156246|NCT01600014|379635|P1|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||80
156247|NCT01600014|379634|P2|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||49
156248|NCT01600014|379635|P1|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||92
156249|NCT01600014|379634|P2|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||0
156250|NCT01600014|379635|P1|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||288
156251|NCT01600014|379634|P2|COMPLETED|1. Cycle & Observation Period D1 to W52||0
156252|NCT01600014|379635|P1|COMPLETED|1. Cycle & Observation Period D1 to W52||162
156253|NCT01600014|379634|P2|STARTED|1. Cycle & Observation Period D1 to W52||0
156254|NCT01600014|379635|P1|STARTED|1. Cycle & Observation Period D1 to W52|Subjects completing W52 without having been administered a 2nd cycle are counted as completers.|450
156255|NCT01599832|379653|P1|NOT COMPLETED|Overall Study||0
156256|NCT01599832|379653|P1|COMPLETED|Overall Study||20
156257|NCT01599832|379653|P1|STARTED|Overall Study||20
156258|NCT01599806|379663|P2|NOT COMPLETED|Overall Study||41
156259|NCT01599806|379664|P1|NOT COMPLETED|Overall Study||43
156260|NCT01599806|379663|P2|COMPLETED|Overall Study||476
156261|NCT01599806|379664|P1|COMPLETED|Overall Study||473
156262|NCT01599806|379663|P2|STARTED|Overall Study||517
156263|NCT01599806|379664|P1|STARTED|Overall Study||516
156264|NCT01599754|379790|P2|NOT COMPLETED|Overall Study||360
156265|NCT01599754|379791|P1|NOT COMPLETED|Overall Study||363
156266|NCT01599754|379790|P2|COMPLETED|Overall Study||1
156267|NCT01599754|379791|P1|COMPLETED|Overall Study||0
156268|NCT01599754|379790|P2|Treated|Overall Study||360
156269|NCT01599754|379791|P1|Treated|Overall Study||360
156270|NCT01599754|379790|P2|STARTED|Overall Study||361
156271|NCT01599754|379791|P1|STARTED|Overall Study||363
156272|NCT01599741|379813|P1|NOT COMPLETED|Overall Study||3
156273|NCT01599741|379813|P1|COMPLETED|Overall Study||48
156274|NCT01599741|379813|P1|Collected Dose and Image Information|Overall Study||48
156275|NCT01599741|379813|P1|STARTED|Overall Study||51
156276|NCT01599650|379822|P3|NOT COMPLETED|Overall Study||27
156277|NCT01599650|379823|P2|NOT COMPLETED|Overall Study||26
156278|NCT01599650|379824|P1|NOT COMPLETED|Overall Study||22
156279|NCT01599650|379822|P3|COMPLETED|Overall Study||65
156280|NCT01599650|379823|P2|COMPLETED|Overall Study||154
156281|NCT01599650|379824|P1|COMPLETED|Overall Study||161
156282|NCT01599650|379822|P3|Completed 6 Mos|Overall Study||80
156283|NCT01599650|379823|P2|Completed 6 Mos|Overall Study||170
156284|NCT01599650|379824|P1|Completed 6 Mos|Overall Study||174
156285|NCT01599650|379822|P3|STARTED|Overall Study||92
156286|NCT01599650|379823|P2|STARTED|Overall Study||180
156287|NCT01599650|379824|P1|STARTED|Overall Study||183
156288|NCT01599637|379863|P3|NOT COMPLETED|Overall Study||0
156289|NCT01599637|379864|P2|NOT COMPLETED|Overall Study||2
156290|NCT01599637|379865|P1|NOT COMPLETED|Overall Study||1
156291|NCT01599637|379863|P3|COMPLETED|Overall Study||10
156292|NCT01599637|379864|P2|COMPLETED|Overall Study||8
156293|NCT01599637|379865|P1|COMPLETED|Overall Study||19
156294|NCT01599637|379863|P3|STARTED|Overall Study||10
156295|NCT01599637|379864|P2|STARTED|Overall Study||10
156296|NCT01599637|379865|P1|STARTED|Overall Study|" started indicates randomized safety, pharmacodynamics and pharmocokinetics set"|20
156297|NCT01599585|379912|P2|NOT COMPLETED|Overall Study||17
156298|NCT01599585|379913|P1|NOT COMPLETED|Overall Study||22
156299|NCT01599585|379912|P2|COMPLETED|Overall Study||42
156300|NCT01599585|379913|P1|COMPLETED|Overall Study||40
156301|NCT01599585|379912|P2|STARTED|Overall Study||59
156302|NCT01599585|379913|P1|STARTED|Overall Study||62
156303|NCT01599325|379951|P1|NOT COMPLETED|Extension Phase||15
156304|NCT01599325|379951|P1|COMPLETED|Extension Phase||0
156305|NCT01599325|379951|P1|STARTED|Extension Phase||15
156306|NCT01599325|379951|P1|NOT COMPLETED|Primary Parent Phase||57
156307|NCT01599325|379951|P1|COMPLETED|Primary Parent Phase|Participants still on study treatment at time of study closure|15
156308|NCT01599325|379951|P1|Pharmacokinetic (PK) Population|Primary Parent Phase|Includes all participants with evaluable azacitidine plasma PK profiles.|12
156309|NCT01599325|379951|P1|Intent to Treat (ITT) Population|Primary Parent Phase|Includes all participants who were enrolled into the study|72
156310|NCT01599325|379951|P1|STARTED|Primary Parent Phase||72
156311|NCT01599234|379975|P2|NOT COMPLETED|Overall Study||15
156312|NCT01599234|379976|P1|NOT COMPLETED|Overall Study||17
156313|NCT01599234|379975|P2|COMPLETED|Overall Study||155
156314|NCT01599234|379976|P1|COMPLETED|Overall Study||150
156315|NCT01599234|379975|P2|STARTED|Overall Study||170
156316|NCT01599234|379976|P1|STARTED|Overall Study||167
156317|NCT01599104|380001|P3|NOT COMPLETED|Overall Study||26
156318|NCT01599104|380002|P2|NOT COMPLETED|Overall Study||14
156319|NCT01599104|380003|P1|NOT COMPLETED|Overall Study||16
156320|NCT01599104|380001|P3|COMPLETED|Overall Study||363
156321|NCT01599104|380002|P2|COMPLETED|Overall Study||371
156322|NCT01599104|380003|P1|COMPLETED|Overall Study||371
156323|NCT01599104|380001|P3|STARTED|Overall Study||389
156324|NCT01599104|380002|P2|STARTED|Overall Study||385
156325|NCT01599104|380003|P1|STARTED|Overall Study||387
156326|NCT01598987|380041|P1|NOT COMPLETED|Baseline to 24 Month||8
156327|NCT01598987|380041|P1|COMPLETED|Baseline to 24 Month||48
156328|NCT01598987|380041|P1|STARTED|Baseline to 24 Month||56
156329|NCT01598987|380041|P1|NOT COMPLETED|Baseline to Month 12||6
156330|NCT01598987|380041|P1|COMPLETED|Baseline to Month 12||50
156331|NCT01598987|380041|P1|STARTED|Baseline to Month 12||56
156332|NCT01598896|380077|P2|NOT COMPLETED|Overall Study||2
156333|NCT01598896|380078|P1|NOT COMPLETED|Overall Study||0
156334|NCT01598896|380077|P2|COMPLETED|Overall Study||2
156335|NCT01598896|380078|P1|COMPLETED|Overall Study||3
156336|NCT01598896|380077|P2|STARTED|Overall Study||4
156337|NCT01598896|380078|P1|STARTED|Overall Study||3
156338|NCT01598779|380090|P1|NOT COMPLETED|Overall Study||0
156339|NCT01598779|380090|P1|COMPLETED|Overall Study||150
156340|NCT01598779|380090|P1|STARTED|Overall Study||150
156341|NCT01598753|380098|P4|NOT COMPLETED|Overall Study||15
156342|NCT01598753|380099|P3|NOT COMPLETED|Overall Study||8
156343|NCT01598753|380100|P2|NOT COMPLETED|Overall Study||15
156344|NCT01598753|380101|P1|NOT COMPLETED|Overall Study||12
156345|NCT01598753|380098|P4|COMPLETED|Overall Study||19
156346|NCT01598753|380099|P3|COMPLETED|Overall Study||24
156347|NCT01598753|380100|P2|COMPLETED|Overall Study||16
156348|NCT01598753|380101|P1|COMPLETED|Overall Study||25
156349|NCT01598753|380098|P4|STARTED|Overall Study||34
156350|NCT01598753|380099|P3|STARTED|Overall Study||32
156351|NCT01598753|380100|P2|STARTED|Overall Study||31
156352|NCT01598753|380101|P1|STARTED|Overall Study||37
156353|NCT01598740|380113|P2|NOT COMPLETED|Period 2||0
156354|NCT01598740|380114|P1|NOT COMPLETED|Period 2||1
156355|NCT01598740|380113|P2|COMPLETED|Period 2||9
156356|NCT01598740|380114|P1|COMPLETED|Period 2||7
156357|NCT01598740|380113|P2|STARTED|Period 2||9
156358|NCT01598740|380114|P1|STARTED|Period 2|1 subject discontinued during the washout period prior to starting treatment period 2.|8
156359|NCT01598740|380113|P2|NOT COMPLETED|Period 1||0
156360|NCT01598740|380114|P1|NOT COMPLETED|Period 1||0
156361|NCT01598740|380113|P2|COMPLETED|Period 1||9
156362|NCT01598740|380114|P1|COMPLETED|Period 1||9
156363|NCT01598740|380113|P2|STARTED|Period 1||9
156364|NCT01598740|380114|P1|STARTED|Period 1||9
156365|NCT01598701|380124|P2|NOT COMPLETED|Overall Study||9
156366|NCT01598701|380125|P1|NOT COMPLETED|Overall Study||5
156367|NCT01598701|380124|P2|COMPLETED|Overall Study||41
156368|NCT01598701|380125|P1|COMPLETED|Overall Study||45
156369|NCT01598701|380124|P2|STARTED|Overall Study||50
156370|NCT01598701|380125|P1|STARTED|Overall Study||50
156371|NCT01598662|380141|P2|NOT COMPLETED|Overall Study||21
156372|NCT01598662|380142|P1|NOT COMPLETED|Overall Study||11
156373|NCT01598662|380141|P2|COMPLETED|Overall Study||0
156374|NCT01598662|380142|P1|COMPLETED|Overall Study||0
156375|NCT01598662|380141|P2|Patients Returned for 6 wk Postpartum|Overall Study||2
156376|NCT01598662|380142|P1|Patients Returned for 6 wk Postpartum|Overall Study||0
156377|NCT01598662|380141|P2|Patients Who Received IUD|Overall Study||18
156378|NCT01598662|380142|P1|Patients Who Received IUD|Overall Study|Subjects did not return at 6 weeks for IUD insertion.|0
156379|NCT01598662|380141|P2|STARTED|Overall Study||21
156380|NCT01598662|380142|P1|STARTED|Overall Study||11
156381|NCT01598610|380148|P1|NOT COMPLETED|Overall Study||1
156382|NCT01598610|380148|P1|COMPLETED|Overall Study||219
156383|NCT01598610|380148|P1|STARTED|Overall Study||220
156384|NCT01598545|380157|P1|NOT COMPLETED|Overall Study||0
156385|NCT01598545|380157|P1|COMPLETED|Overall Study||20
156386|NCT01598545|380157|P1|STARTED|Overall Study||20
156387|NCT01598532|380165|P1|NOT COMPLETED|Overall Study||11
156388|NCT01598532|380165|P1|COMPLETED|Overall Study||11
156389|NCT01598532|380165|P1|STARTED|Overall Study||22
156390|NCT01598506|380174|P1|NOT COMPLETED|Overall Study||2
156391|NCT01598506|380174|P1|COMPLETED|Overall Study||20
156392|NCT01598506|380174|P1|STARTED|Overall Study||22
156393|NCT01598428|380179|P1|NOT COMPLETED|Overall Study||0
156394|NCT01598428|380179|P1|COMPLETED|Overall Study||20
156395|NCT01598428|380179|P1|STARTED|Overall Study||20
156396|NCT01598350|380188|P1|NOT COMPLETED|Overall Study||0
156397|NCT01598350|380188|P1|COMPLETED|Overall Study||6
156398|NCT01598350|380188|P1|STARTED|Overall Study||6
156399|NCT01598311|380194|P2|NOT COMPLETED|Overall Study||61
156400|NCT01598311|380195|P1|NOT COMPLETED|Overall Study||47
156401|NCT01598311|380194|P2|COMPLETED|Overall Study||244
156402|NCT01598311|380195|P1|COMPLETED|Overall Study||256
156403|NCT01598311|380194|P2|Treated and Confirmed CDAD|Overall Study||292
156404|NCT01598311|380195|P1|Treated and Confirmed CDAD|Overall Study||285
156405|NCT01598311|380194|P2|Treated|Overall Study||301
156406|NCT01598311|380195|P1|Treated|Overall Study||294
156407|NCT01598311|380194|P2|STARTED|Overall Study||305
156408|NCT01598311|380195|P1|STARTED|Overall Study||303
156409|NCT01598298|380211|P2|NOT COMPLETED|Overall Study||41
156410|NCT01598298|380212|P1|NOT COMPLETED|Overall Study||40
156411|NCT01598298|380211|P2|COMPLETED|Overall Study||108
156412|NCT01598298|380212|P1|COMPLETED|Overall Study||110
156413|NCT01598298|380211|P2|Patients Evaluable for Adverse Events|Overall Study||141
156414|NCT01598298|380212|P1|Patients Evaluable for Adverse Events|Overall Study||138
156415|NCT01598298|380211|P2|Patients Evaluable for Primary Endpoint|Overall Study||128
156416|NCT01598298|380212|P1|Patients Evaluable for Primary Endpoint|Overall Study||127
156417|NCT01598298|380211|P2|STARTED|Overall Study||149
156418|NCT01598298|380212|P1|STARTED|Overall Study||150
156419|NCT01598207|380224|P2|NOT COMPLETED|Overall Study||0
156420|NCT01598207|380225|P1|NOT COMPLETED|Overall Study||1
156421|NCT01598207|380224|P2|COMPLETED|Overall Study||6
156422|NCT01598207|380225|P1|COMPLETED|Overall Study||6
156423|NCT01598207|380224|P2|STARTED|Overall Study||6
156424|NCT01598207|380225|P1|STARTED|Overall Study||7
156425|NCT01598194|380245|P2|NOT COMPLETED|Overall Study||0
156426|NCT01598194|380246|P1|NOT COMPLETED|Overall Study||0
156427|NCT01598194|380245|P2|COMPLETED|Overall Study||30
156428|NCT01598194|380246|P1|COMPLETED|Overall Study||30
156429|NCT01598194|380245|P2|1 Pass With 22Gpc for Histology|Overall Study|1 participant's pass could not be performed|29
156430|NCT01598194|380246|P1|1 Pass With 22Gpc for Histology|Overall Study|3 participants passes could not be performed|27
156431|NCT01598194|380245|P2|1 Pass With 22Gpc for Cytology|Overall Study||30
156432|NCT01598194|380246|P1|1 Pass With 22Gpc for Cytology|Overall Study|1 participant's pass could not be performed|29
156433|NCT01598194|380245|P2|2 Passes With 25G for Cytology|Overall Study||30
156434|NCT01598194|380246|P1|2 Passes With 25G for Cytology|Overall Study||30
156435|NCT01598194|380245|P2|STARTED|Overall Study||30
156436|NCT01598194|380246|P1|STARTED|Overall Study||30
156437|NCT01598129|380256|P1|NOT COMPLETED|Overall Study||9
156438|NCT01598129|380256|P1|COMPLETED|Overall Study||3
156439|NCT01598129|380256|P1|STARTED|Overall Study||12
156440|NCT01598090|380268|P3|NOT COMPLETED|Follow-up Period||28
156441|NCT01598090|380269|P2|NOT COMPLETED|Follow-up Period||35
156442|NCT01598090|380270|P1|NOT COMPLETED|Follow-up Period||5
156443|NCT01598090|380268|P3|COMPLETED|Follow-up Period||171
156444|NCT01598090|380269|P2|COMPLETED|Follow-up Period||364
156445|NCT01598090|380270|P1|COMPLETED|Follow-up Period||21
156446|NCT01598090|380268|P3|STARTED|Follow-up Period|Includes 28 participants who re-joined from treatment period to follow-up period.|199
156447|NCT01598090|380269|P2|STARTED|Follow-up Period|Includes 60 participants who re-joined from treatment period to follow-up period.|399
156448|NCT01598090|380270|P1|STARTED|Follow-up Period|Includes 10 participants who re-joined from treatment period to follow-up period.|26
156449|NCT01598090|380268|P3|NOT COMPLETED|Treatment Period||35
156450|NCT01598090|380269|P2|NOT COMPLETED|Treatment Period||72
156451|NCT01598090|380270|P1|NOT COMPLETED|Treatment Period||11
156452|NCT01598090|380268|P3|COMPLETED|Treatment Period||171
156453|NCT01598090|380269|P2|COMPLETED|Treatment Period||339
156454|NCT01598090|380270|P1|COMPLETED|Treatment Period||16
156455|NCT01598090|380268|P3|STARTED|Treatment Period||206
156456|NCT01598090|380269|P2|STARTED|Treatment Period||411
156457|NCT01598090|380270|P1|STARTED|Treatment Period||27
156458|NCT01598064|380296|P2|NOT COMPLETED|Overall Study||0
156459|NCT01598064|380297|P1|NOT COMPLETED|Overall Study||0
156460|NCT01598064|380296|P2|COMPLETED|Overall Study||24
156461|NCT01598064|380297|P1|COMPLETED|Overall Study||25
156462|NCT01598064|380296|P2|STARTED|Overall Study||24
156463|NCT01598064|380297|P1|STARTED|Overall Study||25
156464|NCT01598025|380307|P2|NOT COMPLETED|Overall Study||3
156465|NCT01598025|380308|P1|NOT COMPLETED|Overall Study||0
156466|NCT01598025|380307|P2|COMPLETED|Overall Study||0
156467|NCT01598025|380308|P1|COMPLETED|Overall Study||0
156468|NCT01598025|380307|P2|STARTED|Overall Study||3
156469|NCT01598025|380308|P1|STARTED|Overall Study||0
156470|NCT01597908|380317|P2|NOT COMPLETED|Overall Study||352
156471|NCT01597908|380318|P1|NOT COMPLETED|Overall Study||352
156472|NCT01597908|380317|P2|COMPLETED|Overall Study||0
156473|NCT01597908|380318|P1|COMPLETED|Overall Study||0
156474|NCT01597908|380317|P2|Ongoing|Overall Study||202
156475|NCT01597908|380318|P1|Ongoing|Overall Study||236
156476|NCT01597908|380317|P2|STARTED|Overall Study||352
156477|NCT01597908|380318|P1|STARTED|Overall Study||352
156478|NCT01597843|380333|P3|NOT COMPLETED|Overall Study||0
156479|NCT01597843|380334|P2|NOT COMPLETED|Overall Study||0
156480|NCT01597843|380335|P1|NOT COMPLETED|Overall Study||0
156481|NCT01597843|380333|P3|COMPLETED|Overall Study||81
156482|NCT01597843|380334|P2|COMPLETED|Overall Study||122
156483|NCT01597843|380335|P1|COMPLETED|Overall Study||79
156484|NCT01597843|380333|P3|Survey 3 Responses|Overall Study||76
156485|NCT01597843|380334|P2|Survey 3 Responses|Overall Study||56
156486|NCT01597843|380335|P1|Survey 3 Responses|Overall Study||65
156487|NCT01597843|380333|P3|Survey 2 Responses|Overall Study||58
156488|NCT01597843|380334|P2|Survey 2 Responses|Overall Study||42
156489|NCT01597843|380335|P1|Survey 2 Responses|Overall Study||52
156490|NCT01597843|380333|P3|Survey 1 Responses|Overall Study||59
156491|NCT01597843|380334|P2|Survey 1 Responses|Overall Study||71
156492|NCT01597843|380335|P1|Survey 1 Responses|Overall Study||45
156493|NCT01597843|380333|P3|STARTED|Overall Study||81
156494|NCT01597843|380334|P2|STARTED|Overall Study||122
156495|NCT01597843|380335|P1|STARTED|Overall Study||79
156496|NCT01597791|380345|P2|NOT COMPLETED|Overall Study||10
156497|NCT01597791|380346|P1|NOT COMPLETED|Overall Study||8
156498|NCT01597791|380345|P2|COMPLETED|Overall Study||18
156499|NCT01597791|380346|P1|COMPLETED|Overall Study||20
156500|NCT01597791|380345|P2|STARTED|Overall Study||28
156501|NCT01597791|380346|P1|STARTED|Overall Study||28
156502|NCT01597687|380355|P3|NOT COMPLETED|Overall Study||0
156503|NCT01597687|380356|P2|NOT COMPLETED|Overall Study||0
156504|NCT01597687|380357|P1|NOT COMPLETED|Overall Study||0
156505|NCT01597687|380355|P3|COMPLETED|Overall Study||147
156506|NCT01597687|380356|P2|COMPLETED|Overall Study||89
156507|NCT01597687|380357|P1|COMPLETED|Overall Study||76
156508|NCT01597687|380355|P3|STARTED|Overall Study||147
156509|NCT01597687|380356|P2|STARTED|Overall Study||89
156510|NCT01597687|380357|P1|STARTED|Overall Study||76
156511|NCT01597635|380433|P3|NOT COMPLETED|Part B||4
156512|NCT01597635|380434|P2|NOT COMPLETED|Part B||6
156513|NCT01597635|380435|P1|NOT COMPLETED|Part B||0
156514|NCT01597635|380433|P3|COMPLETED|Part B||15
156515|NCT01597635|380434|P2|COMPLETED|Part B||14
156516|NCT01597635|380435|P1|COMPLETED|Part B||0
156517|NCT01597635|380433|P3|STARTED|Part B||19
156518|NCT01597635|380434|P2|STARTED|Part B||20
156519|NCT01597635|380435|P1|STARTED|Part B||0
156520|NCT01597635|380433|P3|NOT COMPLETED|Part A||0
156521|NCT01597635|380434|P2|NOT COMPLETED|Part A||0
156522|NCT01597635|380435|P1|NOT COMPLETED|Part A||3
156523|NCT01597635|380433|P3|COMPLETED|Part A||0
156524|NCT01597635|380434|P2|COMPLETED|Part A||0
156525|NCT01597635|380435|P1|COMPLETED|Part A||2
156526|NCT01597635|380433|P3|STARTED|Part A||0
156527|NCT01597635|380434|P2|STARTED|Part A||0
156528|NCT01597635|380435|P1|STARTED|Part A||5
156529|NCT01597596|380500|P2|NOT COMPLETED|Overall Study||1
156530|NCT01597596|380501|P1|NOT COMPLETED|Overall Study||1
156531|NCT01597596|380500|P2|COMPLETED|Overall Study||2
156532|NCT01597596|380501|P1|COMPLETED|Overall Study||0
156533|NCT01597596|380500|P2|STARTED|Overall Study||3
156534|NCT01597596|380501|P1|STARTED|Overall Study||1
156535|NCT01597505|380515|P2|NOT COMPLETED|Overall Study||33
156536|NCT01597505|380516|P1|NOT COMPLETED|Overall Study||44
156537|NCT01597505|380515|P2|COMPLETED|Overall Study||265
156538|NCT01597505|380516|P1|COMPLETED|Overall Study||264
156539|NCT01597505|380515|P2|Treated|Overall Study||286
156540|NCT01597505|380516|P1|Treated|Overall Study|One participant was instead randomized to vancomycin|305
156541|NCT01597505|380515|P2|STARTED|Overall Study|Randomized participants|298
156542|NCT01597505|380516|P1|STARTED|Overall Study|Randomized participants|308
156543|NCT01597492|380550|P2|NOT COMPLETED|Overall Study||4
156544|NCT01597492|380551|P1|NOT COMPLETED|Overall Study||6
156545|NCT01597492|380550|P2|COMPLETED|Overall Study||41
156546|NCT01597492|380551|P1|COMPLETED|Overall Study||28
156547|NCT01597492|380550|P2|STARTED|Overall Study||45
156548|NCT01597492|380551|P1|STARTED|Overall Study||34
156549|NCT01597479|380559|P2|NOT COMPLETED|Overall Study||0
156550|NCT01597479|380560|P1|NOT COMPLETED|Overall Study||2
156551|NCT01597479|380559|P2|COMPLETED|Overall Study||26
156552|NCT01597479|380560|P1|COMPLETED|Overall Study||24
156553|NCT01597479|380559|P2|STARTED|Overall Study||26
156554|NCT01597479|380560|P1|STARTED|Overall Study||26
156555|NCT01597440|380569|P2|NOT COMPLETED|Overall Study||0
156556|NCT01597440|380570|P1|NOT COMPLETED|Overall Study||0
156557|NCT01597440|380569|P2|COMPLETED|Overall Study||0
156558|NCT01597440|380570|P1|COMPLETED|Overall Study||1
156559|NCT01597440|380569|P2|STARTED|Overall Study||0
156560|NCT01597440|380570|P1|STARTED|Overall Study||1
156561|NCT01597388|380587|P9|NOT COMPLETED|Overall Study||0
156562|NCT01597388|380588|P8|NOT COMPLETED|Overall Study||0
156563|NCT01597388|380589|P7|NOT COMPLETED|Overall Study||0
156564|NCT01597388|380590|P6|NOT COMPLETED|Overall Study||0
156565|NCT01597388|380591|P5|NOT COMPLETED|Overall Study||0
156566|NCT01597388|380592|P4|NOT COMPLETED|Overall Study||0
156567|NCT01597388|380593|P3|NOT COMPLETED|Overall Study||0
156568|NCT01597388|380594|P2|NOT COMPLETED|Overall Study||0
156569|NCT01597388|380595|P1|NOT COMPLETED|Overall Study||0
156570|NCT01597388|380587|P9|COMPLETED|Overall Study||2
156571|NCT01597388|380588|P8|COMPLETED|Overall Study||5
156572|NCT01597388|380589|P7|COMPLETED|Overall Study||8
156573|NCT01597388|380590|P6|COMPLETED|Overall Study||4
156574|NCT01597388|380591|P5|COMPLETED|Overall Study||37
156575|NCT01597388|380592|P4|COMPLETED|Overall Study||10
156576|NCT01597388|380593|P3|COMPLETED|Overall Study||14
156577|NCT01597388|380594|P2|COMPLETED|Overall Study||13
156578|NCT01597388|380595|P1|COMPLETED|Overall Study||6
156579|NCT01597388|380587|P9|STARTED|Overall Study||2
156580|NCT01597388|380588|P8|STARTED|Overall Study||5
156581|NCT01597388|380589|P7|STARTED|Overall Study||8
156582|NCT01597388|380590|P6|STARTED|Overall Study||4
156583|NCT01597388|380591|P5|STARTED|Overall Study||37
156584|NCT01597388|380592|P4|STARTED|Overall Study||10
156585|NCT01597388|380593|P3|STARTED|Overall Study||14
156586|NCT01597388|380594|P2|STARTED|Overall Study||13
156587|NCT01597388|380595|P1|STARTED|Overall Study||6
156588|NCT01597375|380846|P2|NOT COMPLETED|Second Intervention||1
156589|NCT01597375|380847|P1|NOT COMPLETED|Second Intervention||1
156590|NCT01597375|380846|P2|COMPLETED|Second Intervention||21
156591|NCT01597375|380847|P1|COMPLETED|Second Intervention||19
156592|NCT01597375|380846|P2|STARTED|Second Intervention||22
156593|NCT01597375|380847|P1|STARTED|Second Intervention||20
156594|NCT01597375|380846|P2|NOT COMPLETED|Washout (2 Weeks)||0
156595|NCT01597375|380847|P1|NOT COMPLETED|Washout (2 Weeks)||1
156596|NCT01597375|380846|P2|COMPLETED|Washout (2 Weeks)||22
156597|NCT01597375|380847|P1|COMPLETED|Washout (2 Weeks)||20
156598|NCT01597375|380846|P2|STARTED|Washout (2 Weeks)||22
156599|NCT01597375|380847|P1|STARTED|Washout (2 Weeks)||21
156600|NCT01597375|380846|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
156601|NCT01597375|380847|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
156602|NCT01597375|380846|P2|COMPLETED|First Intervention (4 Weeks)||22
156603|NCT01597375|380847|P1|COMPLETED|First Intervention (4 Weeks)||21
156604|NCT01597375|380846|P2|STARTED|First Intervention (4 Weeks)||23
156605|NCT01597375|380847|P1|STARTED|First Intervention (4 Weeks)||23
156606|NCT01597258|380864|P1|NOT COMPLETED|Overall Study||1
156607|NCT01597258|380864|P1|COMPLETED|Overall Study||2028
156608|NCT01597258|380864|P1|STARTED|Overall Study||2029
156609|NCT01597245|380873|P13|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||12
156610|NCT01597245|380874|P12|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||19
156611|NCT01597245|380875|P11|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||22
156612|NCT01597245|380876|P10|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||118
156613|NCT01597245|380877|P9|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||20
156614|NCT01597245|380878|P8|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||3
156615|NCT01597245|380879|P7|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||37
156616|NCT01597245|380880|P6|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||89
156617|NCT01597245|380881|P5|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||159
156618|NCT01597245|380882|P4|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
156619|NCT01597245|380883|P3|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
156620|NCT01597245|380884|P2|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
156621|NCT01597245|380885|P1|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
156622|NCT01597245|380873|P13|COMPLETED|Maintenance Period (Week 12 to Week 60)||37
156623|NCT01597245|380874|P12|COMPLETED|Maintenance Period (Week 12 to Week 60)||56
156624|NCT01597245|380875|P11|COMPLETED|Maintenance Period (Week 12 to Week 60)||178
156625|NCT01597245|380876|P10|COMPLETED|Maintenance Period (Week 12 to Week 60)||14
156626|NCT01597245|380877|P9|COMPLETED|Maintenance Period (Week 12 to Week 60)||135
156627|NCT01597245|380878|P8|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
156628|NCT01597245|380879|P7|COMPLETED|Maintenance Period (Week 12 to Week 60)||150
156629|NCT01597245|380880|P6|COMPLETED|Maintenance Period (Week 12 to Week 60)||92
156630|NCT01597245|380881|P5|COMPLETED|Maintenance Period (Week 12 to Week 60)||17
156631|NCT01597245|380882|P4|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
156632|NCT01597245|380883|P3|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
156633|NCT01597245|380884|P2|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
156634|NCT01597245|380885|P1|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
156635|NCT01597245|380873|P13|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||49
156636|NCT01597245|380874|P12|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||75
156637|NCT01597245|380875|P11|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||200
156638|NCT01597245|380876|P10|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||132
156639|NCT01597245|380877|P9|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||155
156640|NCT01597245|380878|P8|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||3
156641|NCT01597245|380879|P7|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||187
156642|NCT01597245|380880|P6|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||181
156643|NCT01597245|380881|P5|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||176
156644|NCT01597245|380882|P4|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
156645|NCT01597245|380883|P3|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
156646|NCT01597245|380884|P2|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
156647|NCT01597245|380885|P1|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
156648|NCT01597245|380873|P13|STARTED|Maintenance Period (Week 12 to Week 60)||49
156649|NCT01597245|380874|P12|STARTED|Maintenance Period (Week 12 to Week 60)||75
156650|NCT01597245|380875|P11|STARTED|Maintenance Period (Week 12 to Week 60)||200
156651|NCT01597245|380876|P10|STARTED|Maintenance Period (Week 12 to Week 60)||132
156652|NCT01597245|380877|P9|STARTED|Maintenance Period (Week 12 to Week 60)||155
156653|NCT01597245|380878|P8|STARTED|Maintenance Period (Week 12 to Week 60)||3
156654|NCT01597245|380879|P7|STARTED|Maintenance Period (Week 12 to Week 60)||187
156655|NCT01597245|380880|P6|STARTED|Maintenance Period (Week 12 to Week 60)||181
156656|NCT01597245|380881|P5|STARTED|Maintenance Period (Week 12 to Week 60)||176
156657|NCT01597245|380882|P4|STARTED|Maintenance Period (Week 12 to Week 60)||0
156658|NCT01597245|380883|P3|STARTED|Maintenance Period (Week 12 to Week 60)||0
156659|NCT01597245|380884|P2|STARTED|Maintenance Period (Week 12 to Week 60)||0
156660|NCT01597245|380885|P1|STARTED|Maintenance Period (Week 12 to Week 60)||0
156661|NCT01597245|380873|P13|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
156662|NCT01597245|380874|P12|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
156663|NCT01597245|380875|P11|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
156664|NCT01597245|380876|P10|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
156665|NCT01597245|380877|P9|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
156666|NCT01597245|380878|P8|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
156667|NCT01597245|380879|P7|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
156668|NCT01597245|380880|P6|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
156669|NCT01597245|380881|P5|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
156670|NCT01597245|380882|P4|NOT COMPLETED|Induction Period (Week 0 - Week 12)||9
156671|NCT01597245|380883|P3|NOT COMPLETED|Induction Period (Week 0 - Week 12)||19
156672|NCT01597245|380884|P2|NOT COMPLETED|Induction Period (Week 0 - Week 12)||25
156673|NCT01597245|380885|P1|NOT COMPLETED|Induction Period (Week 0 - Week 12)||10
156674|NCT01597245|380873|P13|COMPLETED|Induction Period (Week 0 - Week 12)||0
156675|NCT01597245|380874|P12|COMPLETED|Induction Period (Week 0 - Week 12)||0
156676|NCT01597245|380875|P11|COMPLETED|Induction Period (Week 0 - Week 12)||0
156677|NCT01597245|380876|P10|COMPLETED|Induction Period (Week 0 - Week 12)||0
156678|NCT01597245|380877|P9|COMPLETED|Induction Period (Week 0 - Week 12)||0
156679|NCT01597245|380878|P8|COMPLETED|Induction Period (Week 0 - Week 12)||0
156680|NCT01597245|380879|P7|COMPLETED|Induction Period (Week 0 - Week 12)||0
156681|NCT01597245|380880|P6|COMPLETED|Induction Period (Week 0 - Week 12)||0
156682|NCT01597245|380881|P5|COMPLETED|Induction Period (Week 0 - Week 12)||0
156683|NCT01597245|380882|P4|COMPLETED|Induction Period (Week 0 - Week 12)|2 participants discontinued after IND completion and prior to randomizing into maintenance period.|342
156684|NCT01597245|380883|P3|COMPLETED|Induction Period (Week 0 - Week 12)||328
156685|NCT01597245|380884|P2|COMPLETED|Induction Period (Week 0 - Week 12)|1 participant randomized to maintenance period but did not receive a dose in the maintenance period.|333
156686|NCT01597245|380885|P1|COMPLETED|Induction Period (Week 0 - Week 12)||158
156687|NCT01597245|380873|P13|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
156688|NCT01597245|380874|P12|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
156689|NCT01597245|380875|P11|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
156690|NCT01597245|380876|P10|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
156691|NCT01597245|380877|P9|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
156692|NCT01597245|380878|P8|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
156693|NCT01597245|380879|P7|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
156694|NCT01597245|380880|P6|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
156695|NCT01597245|380881|P5|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
156696|NCT01597245|380882|P4|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||350
156697|NCT01597245|380883|P3|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||347
156698|NCT01597245|380884|P2|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||357
156699|NCT01597245|380885|P1|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||167
156700|NCT01597245|380873|P13|STARTED|Induction Period (Week 0 - Week 12)||0
156701|NCT01597245|380874|P12|STARTED|Induction Period (Week 0 - Week 12)||0
156702|NCT01597245|380875|P11|STARTED|Induction Period (Week 0 - Week 12)||0
156703|NCT01597245|380876|P10|STARTED|Induction Period (Week 0 - Week 12)||0
156704|NCT01597245|380877|P9|STARTED|Induction Period (Week 0 - Week 12)||0
156705|NCT01597245|380878|P8|STARTED|Induction Period (Week 0 - Week 12)||0
156706|NCT01597245|380879|P7|STARTED|Induction Period (Week 0 - Week 12)||0
156707|NCT01597245|380880|P6|STARTED|Induction Period (Week 0 - Week 12)||0
156708|NCT01597245|380881|P5|STARTED|Induction Period (Week 0 - Week 12)||0
156709|NCT01597245|380882|P4|STARTED|Induction Period (Week 0 - Week 12)||351
156710|NCT01597245|380883|P3|STARTED|Induction Period (Week 0 - Week 12)||347
156711|NCT01597245|380884|P2|STARTED|Induction Period (Week 0 - Week 12)||358
156712|NCT01597245|380885|P1|STARTED|Induction Period (Week 0 - Week 12)||168
156713|NCT01597193|380975|P7|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||11
156714|NCT01597193|380976|P6|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||23
156715|NCT01597193|380977|P5|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||16
156716|NCT01597193|380978|P4|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||20
156717|NCT01597193|380979|P3|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||14
156718|NCT01597193|380980|P2|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
156719|NCT01597193|380981|P1|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
156720|NCT01597193|380975|P7|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
156721|NCT01597193|380976|P6|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
156722|NCT01597193|380977|P5|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
156723|NCT01597193|380978|P4|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
156724|NCT01597193|380979|P3|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
156725|NCT01597193|380980|P2|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
156726|NCT01597193|380981|P1|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
156727|NCT01597193|380975|P7|STARTED|Stage 2: Dose Expansion (1067 Days)||11
156728|NCT01597193|380976|P6|STARTED|Stage 2: Dose Expansion (1067 Days)||23
156729|NCT01597193|380977|P5|STARTED|Stage 2: Dose Expansion (1067 Days)||16
156730|NCT01597193|380978|P4|STARTED|Stage 2: Dose Expansion (1067 Days)||20
156731|NCT01597193|380979|P3|STARTED|Stage 2: Dose Expansion (1067 Days)||14
156732|NCT01597193|380980|P2|STARTED|Stage 2: Dose Expansion (1067 Days)||0
156733|NCT01597193|380981|P1|STARTED|Stage 2: Dose Expansion (1067 Days)||0
156734|NCT01597193|380975|P7|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
156735|NCT01597193|380976|P6|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
156736|NCT01597193|380977|P5|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
156737|NCT01597193|380978|P4|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
156738|NCT01597193|380979|P3|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
156739|NCT01597193|380980|P2|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||8
156740|NCT01597193|380981|P1|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||7
156741|NCT01597193|380975|P7|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
156742|NCT01597193|380976|P6|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
156743|NCT01597193|380977|P5|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
156744|NCT01597193|380978|P4|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
156745|NCT01597193|380979|P3|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
156746|NCT01597193|380980|P2|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
156747|NCT01597193|380981|P1|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
156748|NCT01597193|380975|P7|STARTED|Stage 1: Dose Escalation (141 Days)||0
156749|NCT01597193|380976|P6|STARTED|Stage 1: Dose Escalation (141 Days)||0
156750|NCT01597193|380977|P5|STARTED|Stage 1: Dose Escalation (141 Days)||0
156751|NCT01597193|380978|P4|STARTED|Stage 1: Dose Escalation (141 Days)||0
156752|NCT01597193|380979|P3|STARTED|Stage 1: Dose Escalation (141 Days)||0
156753|NCT01597193|380980|P2|STARTED|Stage 1: Dose Escalation (141 Days)||8
156754|NCT01597193|380981|P1|STARTED|Stage 1: Dose Escalation (141 Days)||7
156755|NCT01597141|381062|P2|NOT COMPLETED|Overall Study||0
156756|NCT01597141|381063|P1|NOT COMPLETED|Overall Study||0
156757|NCT01597141|381062|P2|COMPLETED|Overall Study||50
156758|NCT01597141|381063|P1|COMPLETED|Overall Study||50
156759|NCT01597141|381062|P2|STARTED|Overall Study||50
156760|NCT01597141|381063|P1|STARTED|Overall Study||50
156761|NCT01597128|381073|P2|NOT COMPLETED|Overall Study||0
156762|NCT01597128|381074|P1|NOT COMPLETED|Overall Study||0
156763|NCT01597128|381073|P2|COMPLETED|Overall Study||17
156764|NCT01597128|381074|P1|COMPLETED|Overall Study||18
156765|NCT01597128|381073|P2|STARTED|Overall Study||17
156766|NCT01597128|381074|P1|STARTED|Overall Study||18
156767|NCT01597050|381100|P2|NOT COMPLETED|Overall Study||0
156768|NCT01597050|381101|P1|NOT COMPLETED|Overall Study||1
156769|NCT01597050|381100|P2|COMPLETED|Overall Study||18
156770|NCT01597050|381101|P1|COMPLETED|Overall Study||35
156771|NCT01597050|381100|P2|STARTED|Overall Study||18
156772|NCT01597050|381101|P1|STARTED|Overall Study||36
156773|NCT01596972|381109|P2|NOT COMPLETED|Overall Study||14
156774|NCT01596972|381110|P1|NOT COMPLETED|Overall Study||1
156775|NCT01596972|381109|P2|COMPLETED|Overall Study||12
156776|NCT01596972|381110|P1|COMPLETED|Overall Study||24
156777|NCT01596972|381109|P2|STARTED|Overall Study||26
156778|NCT01596972|381110|P1|STARTED|Overall Study||25
156779|NCT01596842|381122|P2|NOT COMPLETED|Overall Study||0
156780|NCT01596842|381123|P1|NOT COMPLETED|Overall Study||2
156781|NCT01596842|381122|P2|COMPLETED|Overall Study||7
156782|NCT01596842|381123|P1|COMPLETED|Overall Study||8
156783|NCT01596842|381122|P2|STARTED|Overall Study||7
156784|NCT01596842|381123|P1|STARTED|Overall Study||10
156785|NCT01596582|381133|P2|NOT COMPLETED|Overall Study||7
156786|NCT01596582|381134|P1|NOT COMPLETED|Overall Study||4
156787|NCT01596582|381133|P2|COMPLETED|Overall Study||173
156788|NCT01596582|381134|P1|COMPLETED|Overall Study||168
156789|NCT01596582|381133|P2|STARTED|Overall Study||180
156790|NCT01596582|381134|P1|STARTED|Overall Study||172
156791|NCT01596504|381161|P3|NOT COMPLETED|Overall Study||1
156792|NCT01596504|381162|P2|NOT COMPLETED|Overall Study||3
156793|NCT01596504|381163|P1|NOT COMPLETED|Overall Study||2
156794|NCT01596504|381161|P3|COMPLETED|Overall Study||46
156795|NCT01596504|381162|P2|COMPLETED|Overall Study||44
156796|NCT01596504|381163|P1|COMPLETED|Overall Study||46
156797|NCT01596504|381161|P3|STARTED|Overall Study||47
156798|NCT01596504|381162|P2|STARTED|Overall Study||47
156799|NCT01596504|381163|P1|STARTED|Overall Study||48
156800|NCT01596335|381221|P2|NOT COMPLETED|Overall Study||9
156801|NCT01596335|381222|P1|NOT COMPLETED|Overall Study||5
156802|NCT01596335|381221|P2|COMPLETED|Overall Study||6
156803|NCT01596335|381222|P1|COMPLETED|Overall Study||11
156804|NCT01596335|381221|P2|STARTED|Overall Study||15
156805|NCT01596335|381222|P1|STARTED|Overall Study||16
156806|NCT01596283|381234|P2|NOT COMPLETED|Overall Study||0
156807|NCT01596283|381235|P1|NOT COMPLETED|Overall Study||0
156808|NCT01596283|381234|P2|COMPLETED|Overall Study||66
156809|NCT01596283|381235|P1|COMPLETED|Overall Study||69
156810|NCT01596283|381234|P2|STARTED|Overall Study||66
156811|NCT01596283|381235|P1|STARTED|Overall Study||69
156812|NCT01596231|381251|P2|NOT COMPLETED|Overall Study||0
156813|NCT01596231|381252|P1|NOT COMPLETED|Overall Study||0
156814|NCT01596231|381251|P2|COMPLETED|Overall Study||10
156815|NCT01596231|381252|P1|COMPLETED|Overall Study||10
156816|NCT01596231|381251|P2|STARTED|Overall Study||10
156817|NCT01596231|381252|P1|STARTED|Overall Study||10
156818|NCT01596127|381258|P1|NOT COMPLETED|Overall Study||1
156819|NCT01596127|381258|P1|COMPLETED|Overall Study||3
156820|NCT01596127|381258|P1|STARTED|Overall Study||4
156821|NCT01596088|381263|P1|NOT COMPLETED|Overall Study||0
156822|NCT01596088|381263|P1|COMPLETED|Overall Study||2
156823|NCT01596088|381263|P1|STARTED|Overall Study||2
156824|NCT01596062|381270|P3|NOT COMPLETED|Overall Study||3
156825|NCT01596062|381271|P2|NOT COMPLETED|Overall Study||0
156826|NCT01596062|381272|P1|NOT COMPLETED|Overall Study||1
156827|NCT01596062|381270|P3|COMPLETED|Overall Study||4
156828|NCT01596062|381271|P2|COMPLETED|Overall Study||6
156829|NCT01596062|381272|P1|COMPLETED|Overall Study||2
156830|NCT01596062|381270|P3|STARTED|Overall Study||7
156831|NCT01596062|381271|P2|STARTED|Overall Study||6
156832|NCT01596062|381272|P1|STARTED|Overall Study||3
156833|NCT01595854|381309|P5|NOT COMPLETED|Overall Study||0
156834|NCT01595854|381310|P4|NOT COMPLETED|Overall Study||0
156835|NCT01595854|381311|P3|NOT COMPLETED|Overall Study||0
156836|NCT01595854|381312|P2|NOT COMPLETED|Overall Study||0
156837|NCT01595854|381313|P1|NOT COMPLETED|Overall Study||0
156838|NCT01595854|381309|P5|COMPLETED|Overall Study||12
156839|NCT01595854|381310|P4|COMPLETED|Overall Study||4
156840|NCT01595854|381311|P3|COMPLETED|Overall Study||8
156841|NCT01595854|381312|P2|COMPLETED|Overall Study||4
156842|NCT01595854|381313|P1|COMPLETED|Overall Study||8
156843|NCT01595854|381309|P5|STARTED|Overall Study||12
156844|NCT01595854|381310|P4|STARTED|Overall Study||4
156845|NCT01595854|381311|P3|STARTED|Overall Study||8
156846|NCT01595854|381312|P2|STARTED|Overall Study||4
156847|NCT01595854|381313|P1|STARTED|Overall Study||8
156848|NCT01595646|381336|P3|NOT COMPLETED|Overall Study||0
156849|NCT01595646|381337|P2|NOT COMPLETED|Overall Study||0
156850|NCT01595646|381338|P1|NOT COMPLETED|Overall Study||1
156851|NCT01595646|381336|P3|COMPLETED|Overall Study||12
156852|NCT01595646|381337|P2|COMPLETED|Overall Study||12
156853|NCT01595646|381338|P1|COMPLETED|Overall Study||12
156854|NCT01595646|381336|P3|STARTED|Overall Study||12
156855|NCT01595646|381337|P2|STARTED|Overall Study||12
156856|NCT01595646|381338|P1|STARTED|Overall Study||13
156857|NCT01595516|381361|P3|NOT COMPLETED|Overall Study||0
156858|NCT01595516|381362|P2|NOT COMPLETED|Overall Study||0
156859|NCT01595516|381363|P1|NOT COMPLETED|Overall Study||0
156860|NCT01595516|381361|P3|COMPLETED|Overall Study||12
156861|NCT01595516|381362|P2|COMPLETED|Overall Study||16
156862|NCT01595516|381363|P1|COMPLETED|Overall Study||16
156863|NCT01595516|381361|P3|STARTED|Overall Study||12
156864|NCT01595516|381362|P2|STARTED|Overall Study||16
156865|NCT01595516|381363|P1|STARTED|Overall Study||16
156866|NCT01595438|381393|P2|NOT COMPLETED|Overall Study||41
156867|NCT01595438|381394|P1|NOT COMPLETED|Overall Study||43
156868|NCT01595438|381393|P2|COMPLETED|Overall Study||476
156869|NCT01595438|381394|P1|COMPLETED|Overall Study||473
156870|NCT01595438|381393|P2|STARTED|Overall Study||517
156871|NCT01595438|381394|P1|STARTED|Overall Study||516
156872|NCT01595386|381520|P2|NOT COMPLETED|Overall Study||0
156873|NCT01595386|381521|P1|NOT COMPLETED|Overall Study||0
156874|NCT01595386|381520|P2|COMPLETED|Overall Study||19
156875|NCT01595386|381521|P1|COMPLETED|Overall Study||21
156876|NCT01595386|381520|P2|STARTED|Overall Study||19
156877|NCT01595386|381521|P1|STARTED|Overall Study||21
156878|NCT01595282|381549|P2|NOT COMPLETED|Overall Study||0
156879|NCT01595282|381550|P1|NOT COMPLETED|Overall Study||0
156880|NCT01595282|381549|P2|COMPLETED|Overall Study||47
156881|NCT01595282|381550|P1|COMPLETED|Overall Study||47
156882|NCT01595282|381549|P2|STARTED|Overall Study||47
156883|NCT01595282|381550|P1|STARTED|Overall Study||47
156884|NCT01595009|381562|P4|NOT COMPLETED|Extension||11
156885|NCT01595009|381563|P3|NOT COMPLETED|Extension||4
156886|NCT01595009|381564|P2|NOT COMPLETED|Extension||0
156887|NCT01595009|381565|P1|NOT COMPLETED|Extension||0
156888|NCT01595009|381562|P4|COMPLETED|Extension||0
156889|NCT01595009|381563|P3|COMPLETED|Extension||0
156890|NCT01595009|381564|P2|COMPLETED|Extension||0
156891|NCT01595009|381565|P1|COMPLETED|Extension||0
156892|NCT01595009|381562|P4|STARTED|Extension||11
156893|NCT01595009|381563|P3|STARTED|Extension||4
156894|NCT01595009|381564|P2|STARTED|Extension||0
156895|NCT01595009|381565|P1|STARTED|Extension||0
156896|NCT01595009|381562|P4|NOT COMPLETED|Core||0
156897|NCT01595009|381563|P3|NOT COMPLETED|Core||0
156898|NCT01595009|381564|P2|NOT COMPLETED|Core||120
156899|NCT01595009|381565|P1|NOT COMPLETED|Core||126
156900|NCT01595009|381562|P4|COMPLETED|Core||0
156901|NCT01595009|381563|P3|COMPLETED|Core||0
156902|NCT01595009|381564|P2|COMPLETED|Core||0
156903|NCT01595009|381565|P1|COMPLETED|Core||0
156904|NCT01595009|381562|P4|STARTED|Core||0
156905|NCT01595009|381563|P3|STARTED|Core||0
156906|NCT01595009|381564|P2|STARTED|Core||120
156907|NCT01595009|381565|P1|STARTED|Core||126
156908|NCT01594970|381600|P3|NOT COMPLETED|Overall Study||66
156909|NCT01594970|381601|P2|NOT COMPLETED|Overall Study||82
156910|NCT01594970|381602|P1|NOT COMPLETED|Overall Study||75
156911|NCT01594970|381600|P3|COMPLETED|Overall Study||191
156912|NCT01594970|381601|P2|COMPLETED|Overall Study||166
156913|NCT01594970|381602|P1|COMPLETED|Overall Study||220
156914|NCT01594970|381600|P3|STARTED|Overall Study||257
156915|NCT01594970|381601|P2|STARTED|Overall Study||248
156916|NCT01594970|381602|P1|STARTED|Overall Study||295
156917|NCT01594853|381621|P2|NOT COMPLETED|Overall Study||3
156918|NCT01594853|381622|P1|NOT COMPLETED|Overall Study||2
156919|NCT01594853|381621|P2|COMPLETED|Overall Study||12
156920|NCT01594853|381622|P1|COMPLETED|Overall Study||14
156921|NCT01594853|381621|P2|STARTED|Overall Study||15
156922|NCT01594853|381622|P1|STARTED|Overall Study||16
156923|NCT01594827|381630|P2|NOT COMPLETED|Overall Study||0
156924|NCT01594827|381631|P1|NOT COMPLETED|Overall Study||4
156925|NCT01594827|381630|P2|COMPLETED|Overall Study||15
156926|NCT01594827|381631|P1|COMPLETED|Overall Study||10
156927|NCT01594827|381630|P2|STARTED|Overall Study||15
156928|NCT01594827|381631|P1|STARTED|Overall Study||14
156929|NCT01594762|381655|P2|NOT COMPLETED|Overall Study||10
156930|NCT01594762|381656|P1|NOT COMPLETED|Overall Study||11
156931|NCT01594762|381655|P2|COMPLETED|Overall Study||93
156932|NCT01594762|381656|P1|COMPLETED|Overall Study||86
156933|NCT01594762|381655|P2|STARTED|Overall Study||103
156934|NCT01594762|381656|P1|STARTED|Overall Study||97
156935|NCT01594749|381668|P2|NOT COMPLETED|Overall Study||18
156936|NCT01594749|381669|P1|NOT COMPLETED|Overall Study||22
156937|NCT01594749|381668|P2|COMPLETED|Overall Study||490
156938|NCT01594749|381669|P1|COMPLETED|Overall Study||485
156939|NCT01594749|381668|P2|Treated|Overall Study||498
156940|NCT01594749|381669|P1|Treated|Overall Study||503
156941|NCT01594749|381668|P2|STARTED|Overall Study||508
156942|NCT01594749|381669|P1|STARTED|Overall Study||507
156943|NCT01594528|381688|P3|NOT COMPLETED|Overall Study||0
156944|NCT01594528|381689|P2|NOT COMPLETED|Overall Study||0
156945|NCT01594528|381690|P1|NOT COMPLETED|Overall Study||0
156946|NCT01594528|381688|P3|COMPLETED|Overall Study||16
156947|NCT01594528|381689|P2|COMPLETED|Overall Study||17
156948|NCT01594528|381690|P1|COMPLETED|Overall Study||16
156949|NCT01594528|381688|P3|STARTED|Overall Study||16
156950|NCT01594528|381689|P2|STARTED|Overall Study||17
156951|NCT01594528|381690|P1|STARTED|Overall Study||16
156952|NCT01594515|381706|P10|NOT COMPLETED|Overall Study||0
156953|NCT01594515|381707|P9|NOT COMPLETED|Overall Study||0
156954|NCT01594515|381708|P8|NOT COMPLETED|Overall Study||0
156955|NCT01594515|381709|P7|NOT COMPLETED|Overall Study||0
156956|NCT01594515|381710|P6|NOT COMPLETED|Overall Study||0
156957|NCT01594515|381711|P5|NOT COMPLETED|Overall Study||0
156958|NCT01594515|381712|P4|NOT COMPLETED|Overall Study||0
156959|NCT01594515|381713|P3|NOT COMPLETED|Overall Study||0
156960|NCT01594515|381714|P2|NOT COMPLETED|Overall Study||0
156961|NCT01594515|381715|P1|NOT COMPLETED|Overall Study||0
156962|NCT01594515|381706|P10|COMPLETED|Overall Study||16
156963|NCT01594515|381707|P9|COMPLETED|Overall Study||6
156964|NCT01594515|381708|P8|COMPLETED|Overall Study||6
156965|NCT01594515|381709|P7|COMPLETED|Overall Study||6
156966|NCT01594515|381710|P6|COMPLETED|Overall Study||6
156967|NCT01594515|381711|P5|COMPLETED|Overall Study||6
156968|NCT01594515|381712|P4|COMPLETED|Overall Study||6
156969|NCT01594515|381713|P3|COMPLETED|Overall Study||6
156970|NCT01594515|381714|P2|COMPLETED|Overall Study||6
156971|NCT01594515|381715|P1|COMPLETED|Overall Study||6
156972|NCT01594515|381706|P10|STARTED|Overall Study||16
156973|NCT01594515|381707|P9|STARTED|Overall Study||6
156974|NCT01594515|381708|P8|STARTED|Overall Study||6
156975|NCT01594515|381709|P7|STARTED|Overall Study||6
156976|NCT01594515|381710|P6|STARTED|Overall Study||6
156977|NCT01594515|381711|P5|STARTED|Overall Study||6
156978|NCT01594515|381712|P4|STARTED|Overall Study||6
156979|NCT01594515|381713|P3|STARTED|Overall Study||6
156980|NCT01594515|381714|P2|STARTED|Overall Study||6
156981|NCT01594515|381715|P1|STARTED|Overall Study||6
156982|NCT01594476|381807|P2|NOT COMPLETED|Overall Study||3
156983|NCT01594476|381808|P1|NOT COMPLETED|Overall Study||1
156984|NCT01594476|381807|P2|COMPLETED|Overall Study||97
156985|NCT01594476|381808|P1|COMPLETED|Overall Study||100
156986|NCT01594476|381807|P2|Pregnant|Overall Study||5
156987|NCT01594476|381808|P1|Pregnant|Overall Study||2
156988|NCT01594476|381807|P2|IUD Expulsion|Overall Study||0
156989|NCT01594476|381808|P1|IUD Expulsion|Overall Study||2
156990|NCT01594476|381807|P2|IUD Removal|Overall Study||5
156991|NCT01594476|381808|P1|IUD Removal|Overall Study||3
156992|NCT01594476|381807|P2|Excluded After Allocation|Overall Study||3
156993|NCT01594476|381808|P1|Excluded After Allocation|Overall Study||1
156994|NCT01594476|381807|P2|Received Intervention|Overall Study||73
156995|NCT01594476|381808|P1|Received Intervention|Overall Study||66
156996|NCT01594476|381807|P2|STARTED|Overall Study||100
156997|NCT01594476|381808|P1|STARTED|Overall Study||101
156998|NCT01594424|381826|P1|NOT COMPLETED|Overall Study||2
156999|NCT01594424|381826|P1|COMPLETED|Overall Study||8
157000|NCT01594424|381826|P1|STARTED|Overall Study||10
157001|NCT01594411|381830|P1|NOT COMPLETED|Overall Study||2
157002|NCT01594411|381830|P1|COMPLETED|Overall Study||249
157003|NCT01594411|381830|P1|STARTED|Overall Study||251
157004|NCT01594385|381839|P2|NOT COMPLETED|Overall Study||0
157005|NCT01594385|381840|P1|NOT COMPLETED|Overall Study||0
157006|NCT01594385|381839|P2|COMPLETED|Overall Study||13
157007|NCT01594385|381840|P1|COMPLETED|Overall Study||17
157008|NCT01594385|381839|P2|STARTED|Overall Study||13
157009|NCT01594385|381840|P1|STARTED|Overall Study||17
157010|NCT01594294|381864|P2|NOT COMPLETED|Overall Study||4
157011|NCT01594294|381865|P1|NOT COMPLETED|Overall Study||3
157012|NCT01594294|381864|P2|COMPLETED|Overall Study||36
157013|NCT01594294|381865|P1|COMPLETED|Overall Study||36
157014|NCT01594294|381864|P2|STARTED|Overall Study||40
157015|NCT01594294|381865|P1|STARTED|Overall Study||39
157016|NCT01594281|381882|P3|NOT COMPLETED|Non-Interventional Follow Up Phase||2
157017|NCT01594281|381883|P2|NOT COMPLETED|Non-Interventional Follow Up Phase||2
157018|NCT01594281|381884|P1|NOT COMPLETED|Non-Interventional Follow Up Phase||3
157019|NCT01594281|381882|P3|COMPLETED|Non-Interventional Follow Up Phase||23
157020|NCT01594281|381883|P2|COMPLETED|Non-Interventional Follow Up Phase||19
157021|NCT01594281|381884|P1|COMPLETED|Non-Interventional Follow Up Phase||25
157022|NCT01594281|381882|P3|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||25
157023|NCT01594281|381883|P2|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||20
157024|NCT01594281|381884|P1|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||28
157115|NCT01592851|382102|P2|STARTED|Overall Study||57
157025|NCT01594281|381882|P3|STARTED|Non-Interventional Follow Up Phase|3 patients exited after completing Core Phase and did not start the Follow-Up Phase|25
157026|NCT01594281|381883|P2|STARTED|Non-Interventional Follow Up Phase|5 patients exited after completing Core Phase and did not start the Follow-Up Phase|21
157027|NCT01594281|381884|P1|STARTED|Non-Interventional Follow Up Phase|1 patient exited after completing Core Phase and did not start the Follow-Up Phase|28
157028|NCT01594281|381882|P3|NOT COMPLETED|Interventional Core Phase||8
157029|NCT01594281|381883|P2|NOT COMPLETED|Interventional Core Phase||10
157030|NCT01594281|381884|P1|NOT COMPLETED|Interventional Core Phase||7
157031|NCT01594281|381882|P3|COMPLETED|Interventional Core Phase||28
157032|NCT01594281|381883|P2|COMPLETED|Interventional Core Phase||26
157033|NCT01594281|381884|P1|COMPLETED|Interventional Core Phase||29
157034|NCT01594281|381882|P3|Full Analysis Set (FAS)|Interventional Core Phase||36
157035|NCT01594281|381883|P2|Full Analysis Set (FAS)|Interventional Core Phase||35
157036|NCT01594281|381884|P1|Full Analysis Set (FAS)|Interventional Core Phase||35
157037|NCT01594281|381882|P3|STARTED|Interventional Core Phase||36
157038|NCT01594281|381883|P2|STARTED|Interventional Core Phase||36
157039|NCT01594281|381884|P1|STARTED|Interventional Core Phase||36
157040|NCT01594125|381924|P5|NOT COMPLETED|Overall Study||7
157041|NCT01594125|381925|P4|NOT COMPLETED|Overall Study||4
157042|NCT01594125|381926|P3|NOT COMPLETED|Overall Study||3
157043|NCT01594125|381927|P2|NOT COMPLETED|Overall Study||12
157044|NCT01594125|381928|P1|NOT COMPLETED|Overall Study||4
157045|NCT01594125|381924|P5|COMPLETED|Overall Study||0
157046|NCT01594125|381925|P4|COMPLETED|Overall Study||0
157047|NCT01594125|381926|P3|COMPLETED|Overall Study||0
157048|NCT01594125|381927|P2|COMPLETED|Overall Study||0
157049|NCT01594125|381928|P1|COMPLETED|Overall Study||0
157050|NCT01594125|381924|P5|STARTED|Overall Study||7
157051|NCT01594125|381925|P4|STARTED|Overall Study||4
157052|NCT01594125|381926|P3|STARTED|Overall Study||3
157053|NCT01594125|381927|P2|STARTED|Overall Study||12
157054|NCT01594125|381928|P1|STARTED|Overall Study||4
157055|NCT01593852|381962|P2|NOT COMPLETED|Overall Study||0
157056|NCT01593852|381963|P1|NOT COMPLETED|Overall Study||0
157057|NCT01593852|381962|P2|COMPLETED|Overall Study||68
157058|NCT01593852|381963|P1|COMPLETED|Overall Study||68
157059|NCT01593852|381962|P2|STARTED|Overall Study||68
157060|NCT01593852|381963|P1|STARTED|Overall Study||68
157061|NCT01593787|381988|P3|NOT COMPLETED|Overall Study||0
157062|NCT01593787|381989|P2|NOT COMPLETED|Overall Study||0
157063|NCT01593787|381990|P1|NOT COMPLETED|Overall Study||1
157064|NCT01593787|381988|P3|COMPLETED|Overall Study||18
157065|NCT01593787|381989|P2|COMPLETED|Overall Study||8
157066|NCT01593787|381990|P1|COMPLETED|Overall Study||5
157067|NCT01593787|381988|P3|STARTED|Overall Study||18
157068|NCT01593787|381989|P2|STARTED|Overall Study||8
157069|NCT01593787|381990|P1|STARTED|Overall Study||6
157070|NCT01593722|382030|P2|NOT COMPLETED|Overall Study||0
157071|NCT01593722|382031|P1|NOT COMPLETED|Overall Study||0
157072|NCT01593722|382030|P2|COMPLETED|Overall Study||6
157073|NCT01593722|382031|P1|COMPLETED|Overall Study||6
157074|NCT01593722|382030|P2|STARTED|Overall Study||6
157075|NCT01593722|382031|P1|STARTED|Overall Study||6
157076|NCT01593670|382045|P1|NOT COMPLETED|Overall Study||0
157077|NCT01593670|382045|P1|COMPLETED|Overall Study||9
157078|NCT01593670|382045|P1|STARTED|Overall Study||9
157079|NCT01593592|382055|P2|NOT COMPLETED|Overall Study||0
157080|NCT01593592|382056|P1|NOT COMPLETED|Overall Study||0
157081|NCT01593592|382055|P2|COMPLETED|Overall Study||35
157082|NCT01593592|382056|P1|COMPLETED|Overall Study||35
157083|NCT01593592|382055|P2|STARTED|Overall Study||35
157084|NCT01593592|382056|P1|STARTED|Overall Study||35
157085|NCT01593254|382068|P2|NOT COMPLETED|Follow-Up Period||11
157086|NCT01593254|382069|P1|NOT COMPLETED|Follow-Up Period||3
157087|NCT01593254|382068|P2|COMPLETED|Follow-Up Period||17
157088|NCT01593254|382069|P1|COMPLETED|Follow-Up Period||11
157089|NCT01593254|382068|P2|STARTED|Follow-Up Period||28
157090|NCT01593254|382069|P1|STARTED|Follow-Up Period||14
157091|NCT01593254|382068|P2|NOT COMPLETED|Treatment Period||31
157092|NCT01593254|382069|P1|NOT COMPLETED|Treatment Period||14
157093|NCT01593254|382068|P2|COMPLETED|Treatment Period||143
157094|NCT01593254|382069|P1|COMPLETED|Treatment Period||72
157095|NCT01593254|382068|P2|Crossed Over to Dasatinib|Treatment Period||0
157096|NCT01593254|382069|P1|Crossed Over to Dasatinib|Treatment Period||42
157097|NCT01593254|382068|P2|STARTED|Treatment Period||174
157098|NCT01593254|382069|P1|STARTED|Treatment Period||86
157099|NCT01593215|382078|P2|NOT COMPLETED|Overall Study||0
157100|NCT01593215|382079|P1|NOT COMPLETED|Overall Study||1
157101|NCT01593215|382078|P2|COMPLETED|Overall Study||25
157102|NCT01593215|382079|P1|COMPLETED|Overall Study||24
157103|NCT01593215|382078|P2|STARTED|Overall Study||25
157104|NCT01593215|382079|P1|STARTED|Overall Study||25
157105|NCT01592864|382087|P2|NOT COMPLETED|Overall Study||1
157106|NCT01592864|382088|P1|NOT COMPLETED|Overall Study||0
157107|NCT01592864|382087|P2|COMPLETED|Overall Study||57
157108|NCT01592864|382088|P1|COMPLETED|Overall Study||60
157109|NCT01592864|382087|P2|STARTED|Overall Study||58
157110|NCT01592864|382088|P1|STARTED|Overall Study||60
157111|NCT01592851|382102|P2|NOT COMPLETED|Overall Study||0
157112|NCT01592851|382103|P1|NOT COMPLETED|Overall Study||0
157113|NCT01592851|382102|P2|COMPLETED|Overall Study||57
157114|NCT01592851|382103|P1|COMPLETED|Overall Study||56
157116|NCT01592851|382103|P1|STARTED|Overall Study||56
157117|NCT01592799|382119|P1|NOT COMPLETED|Overall Study||0
157118|NCT01592799|382119|P1|COMPLETED|Overall Study||501
157119|NCT01592799|382119|P1|STARTED|Overall Study||501
157120|NCT01592786|382149|P1|NOT COMPLETED|Overall Study||138
157121|NCT01592786|382149|P1|COMPLETED|Overall Study||765
157122|NCT01592786|382149|P1|STARTED|Overall Study|Participants in the Safety Population are being presented.|903
157123|NCT01592773|382153|P1|NOT COMPLETED|Overall Study||666
157124|NCT01592773|382153|P1|COMPLETED|Overall Study||81
157125|NCT01592773|382153|P1|STARTED|Overall Study|All enrolled patients received at least 1 dose of investigational product (Safety Population).|747
157126|NCT01592760|382160|P3|NOT COMPLETED|24-hour Follow-Up||2
157127|NCT01592760|382161|P2|NOT COMPLETED|24-hour Follow-Up||3
157128|NCT01592760|382162|P1|NOT COMPLETED|24-hour Follow-Up||4
157129|NCT01592760|382160|P3|COMPLETED|24-hour Follow-Up||43
157130|NCT01592760|382161|P2|COMPLETED|24-hour Follow-Up||87
157131|NCT01592760|382162|P1|COMPLETED|24-hour Follow-Up||86
157132|NCT01592760|382160|P3|STARTED|24-hour Follow-Up||45
157133|NCT01592760|382161|P2|STARTED|24-hour Follow-Up||90
157134|NCT01592760|382162|P1|STARTED|24-hour Follow-Up||90
157135|NCT01592760|382160|P3|NOT COMPLETED|Perioperative to Discharge||0
157136|NCT01592760|382161|P2|NOT COMPLETED|Perioperative to Discharge||0
157137|NCT01592760|382162|P1|NOT COMPLETED|Perioperative to Discharge||0
157138|NCT01592760|382160|P3|COMPLETED|Perioperative to Discharge||45
157139|NCT01592760|382161|P2|COMPLETED|Perioperative to Discharge||90
157140|NCT01592760|382162|P1|COMPLETED|Perioperative to Discharge||90
157141|NCT01592760|382160|P3|STARTED|Perioperative to Discharge||45
157142|NCT01592760|382161|P2|STARTED|Perioperative to Discharge||90
157143|NCT01592760|382162|P1|STARTED|Perioperative to Discharge||90
157144|NCT01592747|382206|P3|NOT COMPLETED|Overall Study||108
157145|NCT01592747|382207|P2|NOT COMPLETED|Overall Study||111
157146|NCT01592747|382208|P1|NOT COMPLETED|Overall Study||116
157147|NCT01592747|382206|P3|COMPLETED|Overall Study||50
157148|NCT01592747|382207|P2|COMPLETED|Overall Study||50
157149|NCT01592747|382208|P1|COMPLETED|Overall Study||44
157150|NCT01592747|382206|P3|STARTED|Overall Study|Based on Randomized Population|158
157151|NCT01592747|382207|P2|STARTED|Overall Study|Based on Randomized Population|161
157152|NCT01592747|382208|P1|STARTED|Overall Study|Based on Randomized Population|160
157153|NCT01592708|382251|P2|NOT COMPLETED|Overall Study||0
157154|NCT01592708|382252|P1|NOT COMPLETED|Overall Study||3
157155|NCT01592708|382251|P2|COMPLETED|Overall Study||137
157156|NCT01592708|382252|P1|COMPLETED|Overall Study||93
157157|NCT01592708|382251|P2|STARTED|Overall Study||137
157158|NCT01592708|382252|P1|STARTED|Overall Study||96
157159|NCT01592695|382268|P2|NOT COMPLETED|Overall Study||4
157160|NCT01592695|382269|P1|NOT COMPLETED|Overall Study||8
157161|NCT01592695|382268|P2|COMPLETED|Overall Study||28
157162|NCT01592695|382269|P1|COMPLETED|Overall Study||23
157163|NCT01592695|382268|P2|STARTED|Overall Study||32
157164|NCT01592695|382269|P1|STARTED|Overall Study||31
157165|NCT01592435|382287|P1|NOT COMPLETED|Overall Study||0
157166|NCT01592435|382287|P1|COMPLETED|Overall Study||76
157167|NCT01592435|382287|P1|STARTED|Overall Study||76
157168|NCT01592409|382295|P2|NOT COMPLETED|Overall Study||1
157169|NCT01592409|382296|P1|NOT COMPLETED|Overall Study||0
157170|NCT01592409|382295|P2|COMPLETED|Overall Study||31
157171|NCT01592409|382296|P1|COMPLETED|Overall Study||67
157172|NCT01592409|382295|P2|STARTED|Overall Study||32
157173|NCT01592409|382296|P1|STARTED|Overall Study||67
157174|NCT01592396|382304|P2|NOT COMPLETED|Overall Study||0
157175|NCT01592396|382305|P1|NOT COMPLETED|Overall Study||0
157176|NCT01592396|382304|P2|COMPLETED|Overall Study||10
157177|NCT01592396|382305|P1|COMPLETED|Overall Study||10
157178|NCT01592396|382304|P2|STARTED|Overall Study||10
157179|NCT01592396|382305|P1|STARTED|Overall Study||10
157180|NCT01592383|382320|P1|NOT COMPLETED|Overall Study||1
157181|NCT01592383|382320|P1|COMPLETED|Overall Study||1
157182|NCT01592383|382320|P1|STARTED|Overall Study||2
157183|NCT01592344|382331|P2|NOT COMPLETED|Overall Study||5
157184|NCT01592344|382332|P1|NOT COMPLETED|Overall Study||4
157185|NCT01592344|382331|P2|COMPLETED|Overall Study||44
157186|NCT01592344|382332|P1|COMPLETED|Overall Study||41
157187|NCT01592344|382331|P2|STARTED|Overall Study||49
157188|NCT01592344|382332|P1|STARTED|Overall Study||45
157189|NCT01592292|382346|P4|NOT COMPLETED|Overall Study||1
157190|NCT01592292|382347|P3|NOT COMPLETED|Overall Study||3
157191|NCT01592292|382348|P2|NOT COMPLETED|Overall Study||5
157192|NCT01592292|382349|P1|NOT COMPLETED|Overall Study||6
157193|NCT01592292|382346|P4|COMPLETED|Overall Study||10
157194|NCT01592292|382347|P3|COMPLETED|Overall Study||10
157195|NCT01592292|382348|P2|COMPLETED|Overall Study||15
157196|NCT01592292|382349|P1|COMPLETED|Overall Study|Participants who completed 12 months visit.|40
157197|NCT01592292|382346|P4|Standard Population Set (SPS)|Overall Study||7
157198|NCT01592292|382347|P3|Standard Population Set (SPS)|Overall Study||7
157199|NCT01592292|382348|P2|Standard Population Set (SPS)|Overall Study||10
157200|NCT01592292|382349|P1|Standard Population Set (SPS)|Overall Study|Excluding participants with change of administration drug or suspension of drug administration.|31
157201|NCT01592292|382346|P4|Intention to Treat (ITT) Set|Overall Study||8
157202|NCT01592292|382347|P3|Intention to Treat (ITT) Set|Overall Study||10
157203|NCT01592292|382348|P2|Intention to Treat (ITT) Set|Overall Study||13
157204|NCT01592292|382349|P1|Intention to Treat (ITT) Set|Overall Study|Excluding primary effect evaluation omission.|34
157205|NCT01592292|382346|P4|STARTED|Overall Study||11
157206|NCT01592292|382347|P3|STARTED|Overall Study||13
157207|NCT01592292|382348|P2|STARTED|Overall Study||20
157208|NCT01592292|382349|P1|STARTED|Overall Study||46
157209|NCT01592240|382388|P7|NOT COMPLETED|Overall Study||3
157210|NCT01592240|382389|P6|NOT COMPLETED|Overall Study||3
157211|NCT01592240|382390|P5|NOT COMPLETED|Overall Study||7
157212|NCT01592240|382391|P4|NOT COMPLETED|Overall Study||3
157213|NCT01592240|382392|P3|NOT COMPLETED|Overall Study||7
157214|NCT01592240|382393|P2|NOT COMPLETED|Overall Study||11
157215|NCT01592240|382394|P1|NOT COMPLETED|Overall Study||3
157216|NCT01592240|382388|P7|COMPLETED|Overall Study||48
157217|NCT01592240|382389|P6|COMPLETED|Overall Study||47
157218|NCT01592240|382390|P5|COMPLETED|Overall Study||44
157219|NCT01592240|382391|P4|COMPLETED|Overall Study||47
157220|NCT01592240|382392|P3|COMPLETED|Overall Study||45
157221|NCT01592240|382393|P2|COMPLETED|Overall Study||39
157222|NCT01592240|382394|P1|COMPLETED|Overall Study||47
157223|NCT01592240|382388|P7|STARTED|Overall Study||51
157224|NCT01592240|382389|P6|STARTED|Overall Study||50
157225|NCT01592240|382390|P5|STARTED|Overall Study||51
157226|NCT01592240|382391|P4|STARTED|Overall Study||50
157227|NCT01592240|382392|P3|STARTED|Overall Study||52
157228|NCT01592240|382393|P2|STARTED|Overall Study||50
157229|NCT01592240|382394|P1|STARTED|Overall Study||50
157230|NCT01592071|382574|P1|NOT COMPLETED|Overall Study||0
157231|NCT01592071|382574|P1|COMPLETED|Overall Study||120
157232|NCT01592071|382574|P1|STARTED|Overall Study||120
157233|NCT01592045|382587|P2|NOT COMPLETED|Overall Study||2
157234|NCT01592045|382588|P1|NOT COMPLETED|Overall Study||5
157235|NCT01592045|382587|P2|COMPLETED|Overall Study||12
157236|NCT01592045|382588|P1|COMPLETED|Overall Study||9
157237|NCT01592045|382587|P2|Completed Course 5|Overall Study||12
157238|NCT01592045|382588|P1|Completed Course 5|Overall Study||9
157239|NCT01592045|382587|P2|Completed Course 4|Overall Study||12
157240|NCT01592045|382588|P1|Completed Course 4|Overall Study||11
157241|NCT01592045|382587|P2|Completed Course 3|Overall Study||13
157242|NCT01592045|382588|P1|Completed Course 3|Overall Study||11
157243|NCT01592045|382587|P2|Completed Course 2|Overall Study||13
157244|NCT01592045|382588|P1|Completed Course 2|Overall Study||13
157245|NCT01592045|382587|P2|Completed Course 1|Overall Study||14
157246|NCT01592045|382588|P1|Completed Course 1|Overall Study||13
157247|NCT01592045|382587|P2|STARTED|Overall Study||14
157248|NCT01592045|382588|P1|STARTED|Overall Study||14
157249|NCT01592006|382596|P1|NOT COMPLETED|Overall Study||0
157250|NCT01592006|382596|P1|COMPLETED|Overall Study||3
157251|NCT01592006|382596|P1|STARTED|Overall Study||3
157252|NCT01591954|382601|P1|NOT COMPLETED|Overall Study||0
157253|NCT01591954|382601|P1|COMPLETED|Overall Study||1
157254|NCT01591954|382601|P1|STARTED|Overall Study||1
157255|NCT01591863|382606|P1|NOT COMPLETED|Overall Study||14
157256|NCT01591863|382606|P1|COMPLETED|Overall Study||24
157257|NCT01591863|382606|P1|STARTED|Overall Study||38
157258|NCT01591837|382618|P2|NOT COMPLETED|Overall Study||0
157259|NCT01591837|382619|P1|NOT COMPLETED|Overall Study||0
157260|NCT01591837|382618|P2|COMPLETED|Overall Study||60
157261|NCT01591837|382619|P1|COMPLETED|Overall Study||60
157262|NCT01591837|382618|P2|STARTED|Overall Study||60
157263|NCT01591837|382619|P1|STARTED|Overall Study||60
157264|NCT01591746|382635|P2|NOT COMPLETED|Overall Study||0
157265|NCT01591746|382636|P1|NOT COMPLETED|Overall Study||0
157266|NCT01591746|382635|P2|COMPLETED|Overall Study||63
157267|NCT01591746|382636|P1|COMPLETED|Overall Study||68
157268|NCT01591746|382635|P2|STARTED|Overall Study||63
157269|NCT01591746|382636|P1|STARTED|Overall Study||68
157270|NCT01591733|382652|P1|NOT COMPLETED|Overall Study||0
157271|NCT01591733|382652|P1|COMPLETED|Overall Study||48
157272|NCT01591733|382652|P1|STARTED|Overall Study||48
157273|NCT01591681|382663|P1|NOT COMPLETED|Overall Study||4
157274|NCT01591681|382663|P1|COMPLETED|Overall Study||45
157275|NCT01591681|382663|P1|STARTED|Overall Study||49
157276|NCT01591616|382689|P1|NOT COMPLETED|Overall Study||1
157277|NCT01591616|382689|P1|COMPLETED|Overall Study||15
157278|NCT01591616|382689|P1|STARTED|Overall Study||16
157279|NCT01591499|382830|P4|NOT COMPLETED|Second Intervention (up to 24 Days)||3
157280|NCT01591499|382831|P3|NOT COMPLETED|Second Intervention (up to 24 Days)||3
157281|NCT01591499|382832|P2|NOT COMPLETED|Second Intervention (up to 24 Days)||3
157282|NCT01591499|382833|P1|NOT COMPLETED|Second Intervention (up to 24 Days)||6
157283|NCT01591499|382830|P4|COMPLETED|Second Intervention (up to 24 Days)||34
157284|NCT01591499|382831|P3|COMPLETED|Second Intervention (up to 24 Days)||28
157285|NCT01591499|382832|P2|COMPLETED|Second Intervention (up to 24 Days)||34
157286|NCT01591499|382833|P1|COMPLETED|Second Intervention (up to 24 Days)||27
157287|NCT01591499|382830|P4|STARTED|Second Intervention (up to 24 Days)||37
157288|NCT01591499|382831|P3|STARTED|Second Intervention (up to 24 Days)||31
157289|NCT01591499|382832|P2|STARTED|Second Intervention (up to 24 Days)||37
157290|NCT01591499|382833|P1|STARTED|Second Intervention (up to 24 Days)||33
157291|NCT01591499|382830|P4|NOT COMPLETED|First Intervention (up to 24 Days)||0
157292|NCT01591499|382831|P3|NOT COMPLETED|First Intervention (up to 24 Days)||0
157293|NCT01591499|382832|P2|NOT COMPLETED|First Intervention (up to 24 Days)||0
157294|NCT01591499|382833|P1|NOT COMPLETED|First Intervention (up to 24 Days)||0
157295|NCT01591499|382830|P4|COMPLETED|First Intervention (up to 24 Days)||37
157296|NCT01591499|382831|P3|COMPLETED|First Intervention (up to 24 Days)||31
157297|NCT01591499|382832|P2|COMPLETED|First Intervention (up to 24 Days)||37
157298|NCT01591499|382833|P1|COMPLETED|First Intervention (up to 24 Days)||33
157299|NCT01591499|382830|P4|STARTED|First Intervention (up to 24 Days)||37
157300|NCT01591499|382831|P3|STARTED|First Intervention (up to 24 Days)||31
157301|NCT01591499|382832|P2|STARTED|First Intervention (up to 24 Days)||37
157302|NCT01591499|382833|P1|STARTED|First Intervention (up to 24 Days)||33
157303|NCT01591499|382830|P4|NOT COMPLETED|Baseline Visit||2
157304|NCT01591499|382831|P3|NOT COMPLETED|Baseline Visit||0
157305|NCT01591499|382832|P2|NOT COMPLETED|Baseline Visit||2
157306|NCT01591499|382833|P1|NOT COMPLETED|Baseline Visit||0
157307|NCT01591499|382830|P4|COMPLETED|Baseline Visit||37
157308|NCT01591499|382831|P3|COMPLETED|Baseline Visit||31
157309|NCT01591499|382832|P2|COMPLETED|Baseline Visit||37
157310|NCT01591499|382833|P1|COMPLETED|Baseline Visit||33
157311|NCT01591499|382830|P4|STARTED|Baseline Visit||39
157312|NCT01591499|382831|P3|STARTED|Baseline Visit||31
157313|NCT01591499|382832|P2|STARTED|Baseline Visit||39
157314|NCT01591499|382833|P1|STARTED|Baseline Visit||33
157315|NCT01591460|382899|P1|NOT COMPLETED|Overall Study||26
157316|NCT01591460|382899|P1|COMPLETED|Overall Study|The number who completed PEG-IFN, as scheduled according to response-guided treatment, is presented.|139
157317|NCT01591460|382899|P1|STARTED|Overall Study|Those with elevated (Week 12) or detectable (Week 24) virus discontinued due to the Futility Rule.|165
157318|NCT01591408|382981|P2|NOT COMPLETED|Overall Study||8
157319|NCT01591408|382982|P1|NOT COMPLETED|Overall Study||12
157320|NCT01591408|382981|P2|COMPLETED|Overall Study||24
157321|NCT01591408|382982|P1|COMPLETED|Overall Study||24
157322|NCT01591408|382981|P2|STARTED|Overall Study||32
157323|NCT01591408|382982|P1|STARTED|Overall Study||36
157324|NCT01591382|382990|P2|NOT COMPLETED|Overall Study||2
157325|NCT01591382|382991|P1|NOT COMPLETED|Overall Study||3
157326|NCT01591382|382990|P2|COMPLETED|Overall Study||30
157327|NCT01591382|382991|P1|COMPLETED|Overall Study||29
157328|NCT01591382|382990|P2|STARTED|Overall Study||32
157329|NCT01591382|382991|P1|STARTED|Overall Study||32
157330|NCT01591317|383008|P3|NOT COMPLETED|Overall Study||0
157331|NCT01591317|383009|P2|NOT COMPLETED|Overall Study||0
157332|NCT01591317|383010|P1|NOT COMPLETED|Overall Study||0
157333|NCT01591317|383008|P3|COMPLETED|Overall Study||10
157334|NCT01591317|383009|P2|COMPLETED|Overall Study||10
157335|NCT01591317|383010|P1|COMPLETED|Overall Study||10
157336|NCT01591317|383008|P3|STARTED|Overall Study||10
157337|NCT01591317|383009|P2|STARTED|Overall Study||10
157338|NCT01591317|383010|P1|STARTED|Overall Study||10
157339|NCT01591096|383036|P1|NOT COMPLETED|Overall Study||1
157340|NCT01591096|383036|P1|COMPLETED|Overall Study||0
157341|NCT01591096|383036|P1|STARTED|Overall Study||1
157342|NCT01591044|383045|P3|NOT COMPLETED|Overall Study||4
157343|NCT01591044|383046|P2|NOT COMPLETED|Overall Study||9
157344|NCT01591044|383047|P1|NOT COMPLETED|Overall Study||7
157345|NCT01591044|383045|P3|COMPLETED|Overall Study||96
157346|NCT01591044|383046|P2|COMPLETED|Overall Study||91
157347|NCT01591044|383047|P1|COMPLETED|Overall Study||94
157348|NCT01591044|383045|P3|STARTED|Overall Study||100
157349|NCT01591044|383046|P2|STARTED|Overall Study||100
157350|NCT01591044|383047|P1|STARTED|Overall Study||101
157351|NCT01591018|383057|P2|NOT COMPLETED|Overall Study||0
157352|NCT01591018|383058|P1|NOT COMPLETED|Overall Study||0
157353|NCT01591018|383057|P2|COMPLETED|Overall Study||60
157354|NCT01591018|383058|P1|COMPLETED|Overall Study||60
157355|NCT01591018|383057|P2|STARTED|Overall Study||60
157356|NCT01591018|383058|P1|STARTED|Overall Study||60
157357|NCT01591005|383072|P4|NOT COMPLETED|Overall Study||0
157358|NCT01591005|383073|P3|NOT COMPLETED|Overall Study||0
157359|NCT01591005|383074|P2|NOT COMPLETED|Overall Study||0
157360|NCT01591005|383075|P1|NOT COMPLETED|Overall Study||0
157361|NCT01591005|383072|P4|COMPLETED|Overall Study||68
157362|NCT01591005|383073|P3|COMPLETED|Overall Study||68
157363|NCT01591005|383074|P2|COMPLETED|Overall Study||53
157364|NCT01591005|383075|P1|COMPLETED|Overall Study||53
157365|NCT01591005|383072|P4|STARTED|Overall Study||68
157366|NCT01591005|383073|P3|STARTED|Overall Study||68
157367|NCT01591005|383074|P2|STARTED|Overall Study||53
157368|NCT01591005|383075|P1|STARTED|Overall Study||53
157369|NCT01590979|383111|P2|NOT COMPLETED|Overall Study||0
157370|NCT01590979|383112|P1|NOT COMPLETED|Overall Study||0
157371|NCT01590979|383111|P2|COMPLETED|Overall Study||27
157372|NCT01590979|383112|P1|COMPLETED|Overall Study||27
157373|NCT01590979|383111|P2|STARTED|Overall Study||27
157374|NCT01590979|383112|P1|STARTED|Overall Study||27
157375|NCT01590888|383121|P3|NOT COMPLETED|Overall Study||1
157376|NCT01590888|383122|P2|NOT COMPLETED|Overall Study||0
157377|NCT01590888|383123|P1|NOT COMPLETED|Overall Study||4
157378|NCT01590888|383121|P3|COMPLETED|Overall Study||34
157379|NCT01590888|383122|P2|COMPLETED|Overall Study||38
157380|NCT01590888|383123|P1|COMPLETED|Overall Study||32
157381|NCT01590888|383121|P3|STARTED|Overall Study||35
157382|NCT01590888|383122|P2|STARTED|Overall Study||38
157383|NCT01590888|383123|P1|STARTED|Overall Study||36
157384|NCT01590875|383169|P2|NOT COMPLETED|Overall Study||0
157385|NCT01590875|383170|P1|NOT COMPLETED|Overall Study||0
157386|NCT01590875|383169|P2|COMPLETED|Overall Study||10
157387|NCT01590875|383170|P1|COMPLETED|Overall Study||10
157388|NCT01590875|383169|P2|STARTED|Overall Study||10
157389|NCT01590875|383170|P1|STARTED|Overall Study||10
157390|NCT01590810|383183|P5|NOT COMPLETED|Overall Study||0
157391|NCT01590810|383184|P4|NOT COMPLETED|Overall Study||0
157392|NCT01590810|383185|P3|NOT COMPLETED|Overall Study||1
157393|NCT01590810|383186|P2|NOT COMPLETED|Overall Study||1
157394|NCT01590810|383187|P1|NOT COMPLETED|Overall Study||0
157395|NCT01590810|383183|P5|COMPLETED|Overall Study||2
157396|NCT01590810|383184|P4|COMPLETED|Overall Study||8
157397|NCT01590810|383185|P3|COMPLETED|Overall Study||7
157398|NCT01590810|383186|P2|COMPLETED|Overall Study||7
157399|NCT01590810|383187|P1|COMPLETED|Overall Study||8
157400|NCT01590810|383183|P5|STARTED|Overall Study||2
157401|NCT01590810|383184|P4|STARTED|Overall Study||8
157402|NCT01590810|383185|P3|STARTED|Overall Study||8
157403|NCT01590810|383186|P2|STARTED|Overall Study||8
157404|NCT01590810|383187|P1|STARTED|Overall Study||8
157405|NCT01590797|383332|P2|NOT COMPLETED|Overall Study||16
157406|NCT01590797|383333|P1|NOT COMPLETED|Overall Study||17
157407|NCT01590797|383332|P2|COMPLETED|Overall Study||217
157408|NCT01590797|383333|P1|COMPLETED|Overall Study||217
157409|NCT01590797|383332|P2|STARTED|Overall Study||233
157410|NCT01590797|383333|P1|STARTED|Overall Study||234
157411|NCT01590771|383349|P2|NOT COMPLETED|Overall Study||39
157412|NCT01590771|383350|P1|NOT COMPLETED|Overall Study||19
157413|NCT01590771|383349|P2|COMPLETED|Overall Study||210
157414|NCT01590771|383350|P1|COMPLETED|Overall Study||230
157415|NCT01590771|383349|P2|STARTED|Overall Study||249
157416|NCT01590771|383350|P1|STARTED|Overall Study||249
157417|NCT01590758|383378|P2|NOT COMPLETED|Overall Study||7
157418|NCT01590758|383379|P1|NOT COMPLETED|Overall Study||5
157419|NCT01590758|383378|P2|COMPLETED|Overall Study||97
157420|NCT01590758|383379|P1|COMPLETED|Overall Study||80
157421|NCT01590758|383378|P2|STARTED|Overall Study||104
157422|NCT01590758|383379|P1|STARTED|Overall Study||85
157423|NCT01590563|383389|P1|NOT COMPLETED|Overall Study||1
157424|NCT01590563|383389|P1|COMPLETED|Overall Study||14
157425|NCT01590563|383389|P1|STARTED|Overall Study||15
157426|NCT01590550|383395|P1|NOT COMPLETED|Overall Study||0
157427|NCT01590550|383395|P1|COMPLETED|Overall Study||18
157428|NCT01590550|383395|P1|STARTED|Overall Study||18
157429|NCT01590394|383401|P1|NOT COMPLETED|Overall Study||0
157430|NCT01590394|383401|P1|COMPLETED|Overall Study||3
157431|NCT01590394|383401|P1|STARTED|Overall Study||3
157432|NCT01590264|383405|P1|NOT COMPLETED|Overall Study||0
157433|NCT01590264|383405|P1|COMPLETED|Overall Study||5
157434|NCT01590264|383405|P1|STARTED|Overall Study||5
157435|NCT01590238|383410|P1|NOT COMPLETED|Overall Study||2
157436|NCT01590238|383410|P1|COMPLETED|Overall Study||13
157437|NCT01590238|383410|P1|STARTED|Overall Study||15
157438|NCT01590212|383417|P3|NOT COMPLETED|Overall Study||5
157439|NCT01590212|383418|P2|NOT COMPLETED|Overall Study||4
157440|NCT01590212|383419|P1|NOT COMPLETED|Overall Study||3
157441|NCT01590212|383417|P3|COMPLETED|Overall Study||9
157442|NCT01590212|383418|P2|COMPLETED|Overall Study||5
157443|NCT01590212|383419|P1|COMPLETED|Overall Study|Includes 2 contacted who failed contact at post-intervention data collection point|9
157444|NCT01590212|383417|P3|Post-intervention|Overall Study|failed contact=1|10
157445|NCT01590212|383418|P2|Post-intervention|Overall Study|failed contact=2; withdrew=1|6
157446|NCT01590212|383419|P1|Post-intervention|Overall Study|failed contact=3|7
157447|NCT01590212|383417|P3|Baseline (Pre-intervention)|Overall Study|failed contact=2|12
157448|NCT01590212|383418|P2|Baseline (Pre-intervention)|Overall Study||9
157449|NCT01590212|383419|P1|Baseline (Pre-intervention)|Overall Study|withdrew=2|10
157450|NCT01590212|383417|P3|STARTED|Overall Study||14
157451|NCT01590212|383418|P2|STARTED|Overall Study||9
157452|NCT01590212|383419|P1|STARTED|Overall Study||12
157453|NCT01590017|383436|P1|NOT COMPLETED|Overall Study||4
157454|NCT01590017|383436|P1|COMPLETED|Overall Study||37
157455|NCT01590017|383436|P1|STARTED|Overall Study||41
157456|NCT01589978|383441|P1|NOT COMPLETED|Overall Study||0
157457|NCT01589978|383441|P1|COMPLETED|Overall Study||2681
157458|NCT01589978|383441|P1|STARTED|Overall Study||2681
157459|NCT01589926|383467|P2|NOT COMPLETED|Overall Study||0
157460|NCT01589926|383468|P1|NOT COMPLETED|Overall Study||0
157461|NCT01589926|383467|P2|COMPLETED|Overall Study||0
157462|NCT01589926|383468|P1|COMPLETED|Overall Study||0
157463|NCT01589926|383467|P2|STARTED|Overall Study||0
157464|NCT01589926|383468|P1|STARTED|Overall Study||0
157465|NCT01589822|383489|P3|NOT COMPLETED|Overall Study||1
157466|NCT01589822|383490|P2|NOT COMPLETED|Overall Study||3
157467|NCT01589822|383491|P1|NOT COMPLETED|Overall Study||4
157468|NCT01589822|383489|P3|COMPLETED|Overall Study||40
157469|NCT01589822|383490|P2|COMPLETED|Overall Study||86
157470|NCT01589822|383491|P1|COMPLETED|Overall Study||80
157471|NCT01589822|383489|P3|STARTED|Overall Study||41
157472|NCT01589822|383490|P2|STARTED|Overall Study||89
157473|NCT01589822|383491|P1|STARTED|Overall Study||84
157474|NCT01589770|383510|P2|NOT COMPLETED|Overall Study||5
157475|NCT01589770|383511|P1|NOT COMPLETED|Overall Study||8
157476|NCT01589770|383510|P2|COMPLETED|Overall Study||56
157477|NCT01589770|383511|P1|COMPLETED|Overall Study||59
157478|NCT01589770|383510|P2|STARTED|Overall Study||61
157479|NCT01589770|383511|P1|STARTED|Overall Study||67
157480|NCT01589653|383521|P2|NOT COMPLETED|Overall Study||11
157481|NCT01589653|383522|P1|NOT COMPLETED|Overall Study||7
157482|NCT01589653|383521|P2|COMPLETED|Overall Study||68
157483|NCT01589653|383522|P1|COMPLETED|Overall Study||69
157484|NCT01589653|383521|P2|Exposed|Overall Study||78
157485|NCT01589653|383522|P1|Exposed|Overall Study||76
157486|NCT01589653|383521|P2|STARTED|Overall Study||79
157487|NCT01589653|383522|P1|STARTED|Overall Study||76
157488|NCT01589601|383538|P2|NOT COMPLETED|Overall Study||49
157489|NCT01589601|383539|P1|NOT COMPLETED|Overall Study||47
157490|NCT01589601|383538|P2|COMPLETED|Overall Study||26
157491|NCT01589601|383539|P1|COMPLETED|Overall Study||28
157492|NCT01589601|383538|P2|STARTED|Overall Study||75
157493|NCT01589601|383539|P1|STARTED|Overall Study||75
157494|NCT01589510|383557|P1|NOT COMPLETED|Overall Study||33
157495|NCT01589510|383557|P1|COMPLETED|Overall Study||386
157496|NCT01589510|383557|P1|STARTED|Overall Study||419
157497|NCT01589497|383572|P4|NOT COMPLETED|Overall Study||1
157498|NCT01589497|383573|P3|NOT COMPLETED|Overall Study||1
157499|NCT01589497|383574|P2|NOT COMPLETED|Overall Study||1
157500|NCT01589497|383575|P1|NOT COMPLETED|Overall Study||1
157501|NCT01589497|383572|P4|COMPLETED|Overall Study||17
157502|NCT01589497|383573|P3|COMPLETED|Overall Study||15
157503|NCT01589497|383574|P2|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|16
157504|NCT01589497|383575|P1|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|17
157505|NCT01589497|383572|P4|STARTED|Overall Study||18
157506|NCT01589497|383573|P3|STARTED|Overall Study||16
157507|NCT01589497|383574|P2|STARTED|Overall Study||17
157508|NCT01589497|383575|P1|STARTED|Overall Study||18
157509|NCT01589484|383676|P1|NOT COMPLETED|Overall Study||4
157510|NCT01589484|383676|P1|COMPLETED|Overall Study||100
157511|NCT01589484|383676|P1|STARTED|Overall Study||104
157512|NCT01589445|383681|P1|NOT COMPLETED|002 (Metformin)-3 Months||9
157513|NCT01589445|383681|P1|COMPLETED|002 (Metformin)-3 Months|61 patients completed the drug 002.9 patients dropped out.|61
157514|NCT01589445|383681|P1|STARTED|002 (Metformin)-3 Months|70 patients participated for trial of drug 002.|70
157515|NCT01589445|383681|P1|NOT COMPLETED|001 (Pioglitazone) -3 Months||7
157516|NCT01589445|383681|P1|COMPLETED|001 (Pioglitazone) -3 Months|dropped out 7 patients|70
157517|NCT01589445|383681|P1|STARTED|001 (Pioglitazone) -3 Months||77
157518|NCT01589315|383697|P1|NOT COMPLETED|Overall Study||1
157519|NCT01589315|383697|P1|COMPLETED|Overall Study||16
157520|NCT01589315|383697|P1|STARTED|Overall Study||17
157521|NCT01589302|383701|P1|NOT COMPLETED|Overall Study||2
157522|NCT01589302|383701|P1|COMPLETED|Overall Study||152
157523|NCT01589302|383701|P1|Non-Del17p Patients|Overall Study||76
157524|NCT01589302|383701|P1|Del17p Patients|Overall Study||76
157525|NCT01589302|383701|P1|STARTED|Overall Study||154
157526|NCT01589237|383724|P4|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
157527|NCT01589237|383725|P3|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
157528|NCT01589237|383726|P2|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||6
157529|NCT01589237|383727|P1|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||5
157530|NCT01589237|383724|P4|COMPLETED|Part B (Planned for 78 Week-terminated)||0
157531|NCT01589237|383725|P3|COMPLETED|Part B (Planned for 78 Week-terminated)||0
157532|NCT01589237|383726|P2|COMPLETED|Part B (Planned for 78 Week-terminated)||0
157533|NCT01589237|383727|P1|COMPLETED|Part B (Planned for 78 Week-terminated)||0
157534|NCT01589237|383724|P4|STARTED|Part B (Planned for 78 Week-terminated)||4
157535|NCT01589237|383725|P3|STARTED|Part B (Planned for 78 Week-terminated)||4
157536|NCT01589237|383726|P2|STARTED|Part B (Planned for 78 Week-terminated)||6
157537|NCT01589237|383727|P1|STARTED|Part B (Planned for 78 Week-terminated)||5
157538|NCT01589237|383724|P4|NOT COMPLETED|Part A (52 Weeks)||0
157539|NCT01589237|383725|P3|NOT COMPLETED|Part A (52 Weeks)||2
157540|NCT01589237|383726|P2|NOT COMPLETED|Part A (52 Weeks)||3
157541|NCT01589237|383727|P1|NOT COMPLETED|Part A (52 Weeks)||2
157542|NCT01589237|383724|P4|COMPLETED|Part A (52 Weeks)||5
157543|NCT01589237|383725|P3|COMPLETED|Part A (52 Weeks)||8
157544|NCT01589237|383726|P2|COMPLETED|Part A (52 Weeks)||9
157545|NCT01589237|383727|P1|COMPLETED|Part A (52 Weeks)||9
157546|NCT01589237|383724|P4|STARTED|Part A (52 Weeks)||5
157547|NCT01589237|383725|P3|STARTED|Part A (52 Weeks)||10
157548|NCT01589237|383726|P2|STARTED|Part A (52 Weeks)||12
157549|NCT01589237|383727|P1|STARTED|Part A (52 Weeks)|"Started = Full analysis set/safety set"|11
157550|NCT01589094|383773|P1|NOT COMPLETED|Overall Study||2
157551|NCT01589094|383773|P1|COMPLETED|Overall Study||49
157552|NCT01589094|383773|P1|STARTED|Overall Study||51
157553|NCT01588990|383780|P1|NOT COMPLETED|Phase B||16
157554|NCT01588990|383780|P1|COMPLETED|Phase B|A total of 37 participants had disease progression in Phase B and ended Phase B.|37
157555|NCT01588990|383780|P1|STARTED|Phase B|Of 58 participants who had documented disease progression in Phase A, 53 entered in Phase B.|53
157556|NCT01588990|383780|P1|NOT COMPLETED|Phase A||70
157557|NCT01588990|383780|P1|COMPLETED|Phase A|A total of 58 participants had disease progression in Phase A and ended Phase A.|58
157558|NCT01588990|383780|P1|STARTED|Phase A||128
157559|NCT01588951|383808|P3|NOT COMPLETED|Overall Study||1
157560|NCT01588951|383809|P2|NOT COMPLETED|Overall Study||0
157561|NCT01588951|383810|P1|NOT COMPLETED|Overall Study||0
157562|NCT01588951|383808|P3|COMPLETED|Overall Study||5
157563|NCT01588951|383809|P2|COMPLETED|Overall Study||2
157564|NCT01588951|383810|P1|COMPLETED|Overall Study||2
157565|NCT01588951|383808|P3|STARTED|Overall Study||6
157566|NCT01588951|383809|P2|STARTED|Overall Study||2
157567|NCT01588951|383810|P1|STARTED|Overall Study||2
157568|NCT01588821|383818|P1|NOT COMPLETED|Overall Study||0
157569|NCT01588821|383818|P1|COMPLETED|Overall Study||37
157570|NCT01588821|383818|P1|STARTED|Overall Study||37
157571|NCT01588561|383823|P2|NOT COMPLETED|Overall Study||0
157572|NCT01588561|383824|P1|NOT COMPLETED|Overall Study||0
157573|NCT01588561|383823|P2|COMPLETED|Overall Study||1
157574|NCT01588561|383824|P1|COMPLETED|Overall Study||14
157575|NCT01588561|383823|P2|Second Injection (Visit 2)|Overall Study||1
157576|NCT01588561|383824|P1|Second Injection (Visit 2)|Overall Study||14
157577|NCT01588561|383823|P2|Rest Period|Overall Study||1
157578|NCT01588561|383824|P1|Rest Period|Overall Study||14
157579|NCT01588561|383823|P2|First Injection (Visit 1)|Overall Study||1
157580|NCT01588561|383824|P1|First Injection (Visit 1)|Overall Study||14
157581|NCT01588561|383823|P2|STARTED|Overall Study||1
157582|NCT01588561|383824|P1|STARTED|Overall Study||14
157583|NCT01588548|383841|P6|NOT COMPLETED|Overall Study||6
157584|NCT01588548|383842|P5|NOT COMPLETED|Overall Study||6
157585|NCT01588548|383843|P4|NOT COMPLETED|Overall Study||7
157586|NCT01588548|383844|P3|NOT COMPLETED|Overall Study||6
157587|NCT01588548|383845|P2|NOT COMPLETED|Overall Study||7
157588|NCT01588548|383846|P1|NOT COMPLETED|Overall Study||3
157589|NCT01588548|383841|P6|COMPLETED|Overall Study||0
157590|NCT01588548|383842|P5|COMPLETED|Overall Study||0
157591|NCT01588548|383843|P4|COMPLETED|Overall Study||0
157592|NCT01588548|383844|P3|COMPLETED|Overall Study||0
157593|NCT01588548|383845|P2|COMPLETED|Overall Study||0
157594|NCT01588548|383846|P1|COMPLETED|Overall Study||0
157595|NCT01588548|383841|P6|Cycle 1 Day 21|Overall Study||3
157596|NCT01588548|383842|P5|Cycle 1 Day 21|Overall Study||3
157597|NCT01588548|383843|P4|Cycle 1 Day 21|Overall Study||5
157598|NCT01588548|383844|P3|Cycle 1 Day 21|Overall Study||2
157599|NCT01588548|383845|P2|Cycle 1 Day 21|Overall Study||5
157600|NCT01588548|383846|P1|Cycle 1 Day 21|Overall Study||3
157601|NCT01588548|383841|P6|STARTED|Overall Study||6
157602|NCT01588548|383842|P5|STARTED|Overall Study||6
157603|NCT01588548|383843|P4|STARTED|Overall Study||7
157604|NCT01588548|383844|P3|STARTED|Overall Study||6
157605|NCT01588548|383845|P2|STARTED|Overall Study||7
157606|NCT01588548|383846|P1|STARTED|Overall Study||3
157607|NCT01588509|383862|P2|NOT COMPLETED|Overall Study||0
157608|NCT01588509|383863|P1|NOT COMPLETED|Overall Study||1
157609|NCT01588509|383862|P2|COMPLETED|Overall Study||30
157610|NCT01588509|383863|P1|COMPLETED|Overall Study||29
157611|NCT01588509|383862|P2|Received Treatment|Overall Study||30
157612|NCT01588509|383863|P1|Received Treatment|Overall Study||30
157613|NCT01588509|383862|P2|STARTED|Overall Study||30
157614|NCT01588509|383863|P1|STARTED|Overall Study||30
157615|NCT01588496|383886|P3|NOT COMPLETED|Overall Study||0
157616|NCT01588496|383887|P2|NOT COMPLETED|Overall Study||1
157617|NCT01588496|383888|P1|NOT COMPLETED|Overall Study||0
157618|NCT01588496|383886|P3|COMPLETED|Overall Study||33
157619|NCT01588496|383887|P2|COMPLETED|Overall Study||16
157620|NCT01588496|383888|P1|COMPLETED|Overall Study||8
157621|NCT01588496|383886|P3|Received Treatment|Overall Study||33
157622|NCT01588496|383887|P2|Received Treatment|Overall Study||16
157623|NCT01588496|383888|P1|Received Treatment|Overall Study||8
157624|NCT01588496|383886|P3|STARTED|Overall Study||33
157625|NCT01588496|383887|P2|STARTED|Overall Study||17
157626|NCT01588496|383888|P1|STARTED|Overall Study||8
157627|NCT01588470|383913|P1|NOT COMPLETED|Overall Study||80
157628|NCT01588470|383913|P1|COMPLETED|Overall Study|Completed Dec. 2011|50
157629|NCT01588470|383913|P1|STARTED|Overall Study|First enrolled April 2007|130
157630|NCT01588444|383924|P2|NOT COMPLETED|Overall Study||0
157631|NCT01588444|383925|P1|NOT COMPLETED|Overall Study||0
157632|NCT01588444|383924|P2|COMPLETED|Overall Study||20
157633|NCT01588444|383925|P1|COMPLETED|Overall Study||20
157634|NCT01588444|383924|P2|STARTED|Overall Study||20
157635|NCT01588444|383925|P1|STARTED|Overall Study||20
157636|NCT01588418|383931|P2|NOT COMPLETED|Overall Study||0
157637|NCT01588418|383932|P1|NOT COMPLETED|Overall Study||0
157638|NCT01588418|383931|P2|COMPLETED|Overall Study||4
157639|NCT01588418|383932|P1|COMPLETED|Overall Study||11
157640|NCT01588418|383931|P2|STARTED|Overall Study||4
157641|NCT01588418|383932|P1|STARTED|Overall Study||11
157642|NCT01588405|383938|P1|NOT COMPLETED|Overall Study||2
157643|NCT01588405|383938|P1|COMPLETED|Overall Study||31
157644|NCT01588405|383938|P1|STARTED|Overall Study||33
157645|NCT01588366|383967|P6|NOT COMPLETED|Overall Study||2
157646|NCT01588366|383968|P5|NOT COMPLETED|Overall Study||0
157647|NCT01588366|383969|P4|NOT COMPLETED|Overall Study||1
157648|NCT01588366|383970|P3|NOT COMPLETED|Overall Study||0
157649|NCT01588366|383971|P2|NOT COMPLETED|Overall Study||1
157650|NCT01588366|383972|P1|NOT COMPLETED|Overall Study||0
157651|NCT01588366|383967|P6|COMPLETED|Overall Study||7
157652|NCT01588366|383968|P5|COMPLETED|Overall Study||3
157653|NCT01588366|383969|P4|COMPLETED|Overall Study||6
157654|NCT01588366|383970|P3|COMPLETED|Overall Study||2
157655|NCT01588366|383971|P2|COMPLETED|Overall Study||6
157656|NCT01588366|383972|P1|COMPLETED|Overall Study||2
157657|NCT01588366|383967|P6|Received at Least One Dose of Study Drug|Overall Study||9
157658|NCT01588366|383968|P5|Received at Least One Dose of Study Drug|Overall Study||3
157843|NCT01587118|384507|P1|NOT COMPLETED|Overall Study||7
157659|NCT01588366|383969|P4|Received at Least One Dose of Study Drug|Overall Study||7
157660|NCT01588366|383970|P3|Received at Least One Dose of Study Drug|Overall Study||2
157661|NCT01588366|383971|P2|Received at Least One Dose of Study Drug|Overall Study||7
157662|NCT01588366|383972|P1|Received at Least One Dose of Study Drug|Overall Study||2
157663|NCT01588366|383967|P6|STARTED|Overall Study||9
157664|NCT01588366|383968|P5|STARTED|Overall Study||3
157665|NCT01588366|383969|P4|STARTED|Overall Study||7
157666|NCT01588366|383970|P3|STARTED|Overall Study||2
157667|NCT01588366|383971|P2|STARTED|Overall Study||7
157668|NCT01588366|383972|P1|STARTED|Overall Study||2
157669|NCT01588353|384000|P3|NOT COMPLETED|Step3||2
157670|NCT01588353|384001|P2|NOT COMPLETED|Step3||0
157671|NCT01588353|384002|P1|NOT COMPLETED|Step3||0
157672|NCT01588353|384000|P3|COMPLETED|Step3||23
157673|NCT01588353|384001|P2|COMPLETED|Step3||0
157674|NCT01588353|384002|P1|COMPLETED|Step3||0
157675|NCT01588353|384000|P3|STARTED|Step3||25
157676|NCT01588353|384001|P2|STARTED|Step3||0
157677|NCT01588353|384002|P1|STARTED|Step3||0
157678|NCT01588353|384000|P3|NOT COMPLETED|Step2||0
157679|NCT01588353|384001|P2|NOT COMPLETED|Step2||1
157680|NCT01588353|384002|P1|NOT COMPLETED|Step2||0
157681|NCT01588353|384000|P3|COMPLETED|Step2||0
157682|NCT01588353|384001|P2|COMPLETED|Step2||70
157683|NCT01588353|384002|P1|COMPLETED|Step2||0
157684|NCT01588353|384000|P3|STARTED|Step2||0
157685|NCT01588353|384001|P2|STARTED|Step2||71
157686|NCT01588353|384002|P1|STARTED|Step2||0
157687|NCT01588353|384000|P3|NOT COMPLETED|Step1||0
157688|NCT01588353|384001|P2|NOT COMPLETED|Step1||0
157689|NCT01588353|384002|P1|NOT COMPLETED|Step1||0
157690|NCT01588353|384000|P3|COMPLETED|Step1||0
157691|NCT01588353|384001|P2|COMPLETED|Step1||0
157692|NCT01588353|384002|P1|COMPLETED|Step1||6
157693|NCT01588353|384000|P3|STARTED|Step1||0
157694|NCT01588353|384001|P2|STARTED|Step1||0
157695|NCT01588353|384002|P1|STARTED|Step1||6
157696|NCT01588236|384021|P3|NOT COMPLETED|Overall Study||25
157697|NCT01588236|384022|P2|NOT COMPLETED|Overall Study||28
157698|NCT01588236|384023|P1|NOT COMPLETED|Overall Study||16
157699|NCT01588236|384021|P3|COMPLETED|Overall Study||69
157700|NCT01588236|384022|P2|COMPLETED|Overall Study||66
157701|NCT01588236|384023|P1|COMPLETED|Overall Study||76
157702|NCT01588236|384021|P3|STARTED|Overall Study||94
157703|NCT01588236|384022|P2|STARTED|Overall Study||94
157704|NCT01588236|384023|P1|STARTED|Overall Study||92
157705|NCT01588197|384051|P2|NOT COMPLETED|Overall Study||1
157706|NCT01588197|384052|P1|NOT COMPLETED|Overall Study||1
157707|NCT01588197|384051|P2|COMPLETED|Overall Study||9
157708|NCT01588197|384052|P1|COMPLETED|Overall Study||9
157709|NCT01588197|384051|P2|STARTED|Overall Study||10
157710|NCT01588197|384052|P1|STARTED|Overall Study||10
157711|NCT01588158|384064|P2|NOT COMPLETED|Overall Study||0
157712|NCT01588158|384065|P1|NOT COMPLETED|Overall Study||0
157713|NCT01588158|384064|P2|COMPLETED|Overall Study||3
157714|NCT01588158|384065|P1|COMPLETED|Overall Study||4
157715|NCT01588158|384064|P2|STARTED|Overall Study||3
157716|NCT01588158|384065|P1|STARTED|Overall Study||4
157717|NCT01588106|384089|P2|NOT COMPLETED|Overall Study||4
157718|NCT01588106|384090|P1|NOT COMPLETED|Overall Study||5
157719|NCT01588106|384089|P2|COMPLETED|Overall Study||72
157720|NCT01588106|384090|P1|COMPLETED|Overall Study||73
157721|NCT01588106|384089|P2|STARTED|Overall Study||76
157722|NCT01588106|384090|P1|STARTED|Overall Study||78
157723|NCT01587989|384098|P3|NOT COMPLETED|Randomized Study Treatment||1
157724|NCT01587989|384099|P2|NOT COMPLETED|Randomized Study Treatment||2
157725|NCT01587989|384100|P1|NOT COMPLETED|Randomized Study Treatment||0
157726|NCT01587989|384098|P3|COMPLETED|Randomized Study Treatment||32
157727|NCT01587989|384099|P2|COMPLETED|Randomized Study Treatment||30
157728|NCT01587989|384100|P1|COMPLETED|Randomized Study Treatment||0
157729|NCT01587989|384098|P3|STARTED|Randomized Study Treatment||33
157730|NCT01587989|384099|P2|STARTED|Randomized Study Treatment||32
157731|NCT01587989|384100|P1|STARTED|Randomized Study Treatment||0
157732|NCT01587989|384098|P3|NOT COMPLETED|12-Week Open-Label Run-In Period||0
157733|NCT01587989|384099|P2|NOT COMPLETED|12-Week Open-Label Run-In Period||0
157734|NCT01587989|384100|P1|NOT COMPLETED|12-Week Open-Label Run-In Period||12
157735|NCT01587989|384098|P3|COMPLETED|12-Week Open-Label Run-In Period||0
157736|NCT01587989|384099|P2|COMPLETED|12-Week Open-Label Run-In Period||0
157737|NCT01587989|384100|P1|COMPLETED|12-Week Open-Label Run-In Period||65
157738|NCT01587989|384098|P3|STARTED|12-Week Open-Label Run-In Period||0
157739|NCT01587989|384099|P2|STARTED|12-Week Open-Label Run-In Period||0
157740|NCT01587989|384100|P1|STARTED|12-Week Open-Label Run-In Period||77
157741|NCT01587963|384124|P2|NOT COMPLETED|Overall Study||0
157742|NCT01587963|384125|P1|NOT COMPLETED|Overall Study||1
157743|NCT01587963|384124|P2|COMPLETED|Overall Study||4
157744|NCT01587963|384125|P1|COMPLETED|Overall Study||6
157745|NCT01587963|384124|P2|STARTED|Overall Study||4
157746|NCT01587963|384125|P1|STARTED|Overall Study||7
157747|NCT01587950|384131|P1|NOT COMPLETED|Period 3||0
157748|NCT01587950|384131|P1|COMPLETED|Period 3||12
157749|NCT01587950|384131|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 3||5
157750|NCT01587950|384131|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 3||3
157751|NCT01587950|384131|P1|Received 5% KNO3 Solution (2 Minutes)|Period 3||3
157752|NCT01587950|384131|P1|Received 5% KNO3 Solution (5 Minutes)|Period 3||5
157753|NCT01587950|384131|P1|Received Sterile Water (5 Minutes)|Period 3||5
157754|NCT01587950|384131|P1|Received 5% KNO3 Solution (10 Minutes)|Period 3||4
157755|NCT01587950|384131|P1|Received Sterile Water (2 Minutes)|Period 3||2
157756|NCT01587950|384131|P1|Received Sterile Water (10 Minutes)|Period 3||5
157757|NCT01587950|384131|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 3||4
157758|NCT01587950|384131|P1|STARTED|Period 3||12
157759|NCT01587950|384131|P1|NOT COMPLETED|Washout 2||0
157760|NCT01587950|384131|P1|COMPLETED|Washout 2||12
157761|NCT01587950|384131|P1|STARTED|Washout 2||12
157762|NCT01587950|384131|P1|NOT COMPLETED|Period 2||0
157763|NCT01587950|384131|P1|COMPLETED|Period 2||12
157764|NCT01587950|384131|P1|Received 5% KNO3 Solution (5 Minutes)|Period 2||2
157765|NCT01587950|384131|P1|Received Sterile Water (10 Minutes)|Period 2||2
157766|NCT01587950|384131|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 2||4
157767|NCT01587950|384131|P1|Received Sterile Water (5 Minutes)|Period 2||2
157768|NCT01587950|384131|P1|Received 5% KNO3 Solution (2 Minutes)|Period 2||6
157769|NCT01587950|384131|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 2||6
157770|NCT01587950|384131|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 2||2
157771|NCT01587950|384131|P1|Received 5% KNO3 Solution (10 Minutes)|Period 2||4
157772|NCT01587950|384131|P1|Received Sterile Water (2 Minutes)|Period 2||8
157773|NCT01587950|384131|P1|STARTED|Period 2||12
157774|NCT01587950|384131|P1|NOT COMPLETED|Washout 1||0
157775|NCT01587950|384131|P1|COMPLETED|Washout 1||12
157776|NCT01587950|384131|P1|STARTED|Washout 1||12
157777|NCT01587950|384131|P1|NOT COMPLETED|Period 1||0
157778|NCT01587950|384131|P1|COMPLETED|Period 1||12
157779|NCT01587950|384131|P1|Received Sterile Water (5 Minutes)|Period 1||5
157780|NCT01587950|384131|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 1||5
157781|NCT01587950|384131|P1|Received Sterile Water (10 Minutes)|Period 1||5
157782|NCT01587950|384131|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 1||3
157783|NCT01587950|384131|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 1||4
157784|NCT01587950|384131|P1|Received 5% KNO3 Solution (10 Minutes)|Period 1||4
157785|NCT01587950|384131|P1|Received Sterile Water (2 Minutes)|Period 1||2
157786|NCT01587950|384131|P1|Received 5% KNO3 Solution (2 Minutes)|Period 1||3
157787|NCT01587950|384131|P1|Received 5% KNO3 Solution (5 Minutes)|Period 1||5
157788|NCT01587950|384131|P1|STARTED|Period 1||12
157789|NCT01587924|384165|P4|NOT COMPLETED|Overall Study||1
157790|NCT01587924|384166|P3|NOT COMPLETED|Overall Study||4
157791|NCT01587924|384167|P2|NOT COMPLETED|Overall Study||4
157792|NCT01587924|384168|P1|NOT COMPLETED|Overall Study||4
157793|NCT01587924|384165|P4|COMPLETED|Overall Study||19
157794|NCT01587924|384166|P3|COMPLETED|Overall Study||17
157795|NCT01587924|384167|P2|COMPLETED|Overall Study||17
157796|NCT01587924|384168|P1|COMPLETED|Overall Study||17
157797|NCT01587924|384165|P4|STARTED|Overall Study||20
157798|NCT01587924|384166|P3|STARTED|Overall Study||21
157799|NCT01587924|384167|P2|STARTED|Overall Study||21
157800|NCT01587924|384168|P1|STARTED|Overall Study||21
157801|NCT01587898|384269|P4|NOT COMPLETED|Overall Study||2
157802|NCT01587898|384270|P3|NOT COMPLETED|Overall Study||2
157803|NCT01587898|384271|P2|NOT COMPLETED|Overall Study||5
157804|NCT01587898|384272|P1|NOT COMPLETED|Overall Study||4
157805|NCT01587898|384269|P4|COMPLETED|Overall Study||17
157806|NCT01587898|384270|P3|COMPLETED|Overall Study||16
157807|NCT01587898|384271|P2|COMPLETED|Overall Study||12
157808|NCT01587898|384272|P1|COMPLETED|Overall Study||14
157809|NCT01587898|384269|P4|STARTED|Overall Study||19
157810|NCT01587898|384270|P3|STARTED|Overall Study||18
157811|NCT01587898|384271|P2|STARTED|Overall Study||17
157812|NCT01587898|384272|P1|STARTED|Overall Study||18
157813|NCT01587885|384448|P2|NOT COMPLETED|Treatment Period 2||0
157814|NCT01587885|384449|P1|NOT COMPLETED|Treatment Period 2||0
157815|NCT01587885|384448|P2|COMPLETED|Treatment Period 2||19
157816|NCT01587885|384449|P1|COMPLETED|Treatment Period 2||26
157817|NCT01587885|384448|P2|STARTED|Treatment Period 2||19
157818|NCT01587885|384449|P1|STARTED|Treatment Period 2||26
157819|NCT01587885|384448|P2|NOT COMPLETED|Treatment Period 1||3
157820|NCT01587885|384449|P1|NOT COMPLETED|Treatment Period 1||0
157821|NCT01587885|384448|P2|COMPLETED|Treatment Period 1||19
157822|NCT01587885|384449|P1|COMPLETED|Treatment Period 1||26
157823|NCT01587885|384448|P2|STARTED|Treatment Period 1||22
157824|NCT01587885|384449|P1|STARTED|Treatment Period 1||26
157825|NCT01587651|384465|P3|NOT COMPLETED|Overall Study||1
157826|NCT01587651|384466|P2|NOT COMPLETED|Overall Study||3
157827|NCT01587651|384467|P1|NOT COMPLETED|Overall Study||0
157828|NCT01587651|384465|P3|COMPLETED|Overall Study||34
157829|NCT01587651|384466|P2|COMPLETED|Overall Study||38
157830|NCT01587651|384467|P1|COMPLETED|Overall Study||34
157831|NCT01587651|384465|P3|STARTED|Overall Study||35
157832|NCT01587651|384466|P2|STARTED|Overall Study||41
157833|NCT01587651|384467|P1|STARTED|Overall Study||34
157834|NCT01587274|384497|P3|NOT COMPLETED|Overall Study||3
157835|NCT01587274|384498|P2|NOT COMPLETED|Overall Study||5
157836|NCT01587274|384499|P1|NOT COMPLETED|Overall Study||4
157837|NCT01587274|384497|P3|COMPLETED|Overall Study||104
157838|NCT01587274|384498|P2|COMPLETED|Overall Study||103
157839|NCT01587274|384499|P1|COMPLETED|Overall Study||104
157840|NCT01587274|384497|P3|STARTED|Overall Study||107
157841|NCT01587274|384498|P2|STARTED|Overall Study||108
157842|NCT01587274|384499|P1|STARTED|Overall Study||108
157844|NCT01587118|384507|P1|COMPLETED|Overall Study||11
157845|NCT01587118|384507|P1|STARTED|Overall Study|31 signed consent and 18 were deemed eligible and initiated treatment with adjunctive asenapine.|18
157846|NCT01587105|384514|P2|NOT COMPLETED|Overall Study||43
157847|NCT01587105|384515|P1|NOT COMPLETED|Overall Study||6
157848|NCT01587105|384514|P2|COMPLETED|Overall Study||138
157849|NCT01587105|384515|P1|COMPLETED|Overall Study||144
157850|NCT01587105|384514|P2|STARTED|Overall Study||181
157851|NCT01587105|384515|P1|STARTED|Overall Study||150
157852|NCT01587079|384531|P1|NOT COMPLETED|Overall Study||39
157853|NCT01587079|384531|P1|COMPLETED|Overall Study||120
157854|NCT01587079|384531|P1|STARTED|Overall Study||159
157855|NCT01587040|384657|P4|NOT COMPLETED|Overall Study||4
157856|NCT01587040|384658|P3|NOT COMPLETED|Overall Study||37
157857|NCT01587040|384659|P2|NOT COMPLETED|Overall Study||3
157858|NCT01587040|384660|P1|NOT COMPLETED|Overall Study||17
157859|NCT01587040|384657|P4|COMPLETED|Overall Study||0
157860|NCT01587040|384658|P3|COMPLETED|Overall Study||0
157861|NCT01587040|384659|P2|COMPLETED|Overall Study||0
157862|NCT01587040|384660|P1|COMPLETED|Overall Study||0
157863|NCT01587040|384657|P4|STARTED|Overall Study||4
157864|NCT01587040|384658|P3|STARTED|Overall Study||37
157865|NCT01587040|384659|P2|STARTED|Overall Study||3
157866|NCT01587040|384660|P1|STARTED|Overall Study||17
157867|NCT01587027|384680|P2|NOT COMPLETED|Discharge (1 Day)||0
157868|NCT01587027|384681|P1|NOT COMPLETED|Discharge (1 Day)||0
157869|NCT01587027|384680|P2|COMPLETED|Discharge (1 Day)||8
157870|NCT01587027|384681|P1|COMPLETED|Discharge (1 Day)||8
157871|NCT01587027|384680|P2|STARTED|Discharge (1 Day)||8
157872|NCT01587027|384681|P1|STARTED|Discharge (1 Day)||8
157873|NCT01587027|384680|P2|NOT COMPLETED|Third Intervention (1 Day)||0
157874|NCT01587027|384681|P1|NOT COMPLETED|Third Intervention (1 Day)||0
157875|NCT01587027|384680|P2|COMPLETED|Third Intervention (1 Day)||8
157876|NCT01587027|384681|P1|COMPLETED|Third Intervention (1 Day)||8
157877|NCT01587027|384680|P2|STARTED|Third Intervention (1 Day)||8
157878|NCT01587027|384681|P1|STARTED|Third Intervention (1 Day)||8
157879|NCT01587027|384680|P2|NOT COMPLETED|Washout (1 Day)||0
157880|NCT01587027|384681|P1|NOT COMPLETED|Washout (1 Day)||0
157881|NCT01587027|384680|P2|COMPLETED|Washout (1 Day)||8
157882|NCT01587027|384681|P1|COMPLETED|Washout (1 Day)||8
157883|NCT01587027|384680|P2|STARTED|Washout (1 Day)||8
157884|NCT01587027|384681|P1|STARTED|Washout (1 Day)||8
157885|NCT01587027|384680|P2|NOT COMPLETED|Second Intervention (1 Day)||0
157886|NCT01587027|384681|P1|NOT COMPLETED|Second Intervention (1 Day)||0
157887|NCT01587027|384680|P2|COMPLETED|Second Intervention (1 Day)||8
157888|NCT01587027|384681|P1|COMPLETED|Second Intervention (1 Day)||8
157889|NCT01587027|384680|P2|STARTED|Second Intervention (1 Day)||8
157890|NCT01587027|384681|P1|STARTED|Second Intervention (1 Day)||8
157891|NCT01587027|384680|P2|NOT COMPLETED|Washout (1 Day)||0
157892|NCT01587027|384681|P1|NOT COMPLETED|Washout (1 Day)||0
157893|NCT01587027|384680|P2|COMPLETED|Washout (1 Day)||8
157894|NCT01587027|384681|P1|COMPLETED|Washout (1 Day)||8
157895|NCT01587027|384680|P2|STARTED|Washout (1 Day)||8
157896|NCT01587027|384681|P1|STARTED|Washout (1 Day)||8
157897|NCT01587027|384680|P2|NOT COMPLETED|First Intervention (1 Day)||0
157898|NCT01587027|384681|P1|NOT COMPLETED|First Intervention (1 Day)||0
157899|NCT01587027|384680|P2|COMPLETED|First Intervention (1 Day)||8
157900|NCT01587027|384681|P1|COMPLETED|First Intervention (1 Day)||8
157901|NCT01587027|384680|P2|STARTED|First Intervention (1 Day)||8
157902|NCT01587027|384681|P1|STARTED|First Intervention (1 Day)||8
157903|NCT01587014|384687|P1|NOT COMPLETED|Overall Study||2
157904|NCT01587014|384687|P1|COMPLETED|Overall Study||24
157905|NCT01587014|384687|P1|STARTED|Overall Study||26
157906|NCT01587001|384694|P2|NOT COMPLETED|Overall Study||1
157907|NCT01587001|384695|P1|NOT COMPLETED|Overall Study||6
157908|NCT01587001|384694|P2|COMPLETED|Overall Study||2
157909|NCT01587001|384695|P1|COMPLETED|Overall Study||8
157910|NCT01587001|384694|P2|STARTED|Overall Study||3
157911|NCT01587001|384695|P1|STARTED|Overall Study||14
157912|NCT01586975|384706|P3|NOT COMPLETED|Overall Study||0
157913|NCT01586975|384707|P2|NOT COMPLETED|Overall Study||0
157914|NCT01586975|384708|P1|NOT COMPLETED|Overall Study||0
157915|NCT01586975|384706|P3|COMPLETED|Overall Study||46
157916|NCT01586975|384707|P2|COMPLETED|Overall Study||32
157917|NCT01586975|384708|P1|COMPLETED|Overall Study||15
157918|NCT01586975|384706|P3|STARTED|Overall Study||46
157919|NCT01586975|384707|P2|STARTED|Overall Study||32
157920|NCT01586975|384708|P1|STARTED|Overall Study||15
157921|NCT01586962|384716|P1|NOT COMPLETED|Overall Study||0
157922|NCT01586962|384716|P1|COMPLETED|Overall Study||56
157923|NCT01586962|384716|P1|STARTED|Overall Study||56
157924|NCT01586910|384724|P2|NOT COMPLETED|Overall Study||71
157925|NCT01586910|384725|P1|NOT COMPLETED|Overall Study||15
157926|NCT01586910|384724|P2|COMPLETED|Overall Study||796
157927|NCT01586910|384725|P1|COMPLETED|Overall Study||864
157928|NCT01586910|384724|P2|STARTED|Overall Study||867
157929|NCT01586910|384725|P1|STARTED|Overall Study||879
157930|NCT01586897|384780|P2|NOT COMPLETED|Overall Study||0
157931|NCT01586897|384781|P1|NOT COMPLETED|Overall Study||0
157932|NCT01586897|384780|P2|COMPLETED|Overall Study||26
157933|NCT01586897|384781|P1|COMPLETED|Overall Study||26
157934|NCT01586897|384780|P2|STARTED|Overall Study||26
157935|NCT01586897|384781|P1|STARTED|Overall Study||26
157936|NCT01586819|384799|P2|NOT COMPLETED|Overall Study||0
157937|NCT01586819|384800|P1|NOT COMPLETED|Overall Study||1
157938|NCT01586819|384799|P2|COMPLETED|Overall Study||14
157939|NCT01586819|384800|P1|COMPLETED|Overall Study||11
157940|NCT01586819|384799|P2|STARTED|Overall Study||14
157941|NCT01586819|384800|P1|STARTED|Overall Study||12
157942|NCT01586806|384811|P3|NOT COMPLETED|Overall Study||2
157943|NCT01586806|384812|P2|NOT COMPLETED|Overall Study||4
157944|NCT01586806|384813|P1|NOT COMPLETED|Overall Study||3
157945|NCT01586806|384811|P3|COMPLETED|Overall Study||63
157946|NCT01586806|384812|P2|COMPLETED|Overall Study||61
157947|NCT01586806|384813|P1|COMPLETED|Overall Study||62
157948|NCT01586806|384811|P3|STARTED|Overall Study||65
157949|NCT01586806|384812|P2|STARTED|Overall Study||65
157950|NCT01586806|384813|P1|STARTED|Overall Study||65
157951|NCT01586364|384833|P1|NOT COMPLETED|Overall Study||117
157952|NCT01586364|384833|P1|COMPLETED|Overall Study||184
157953|NCT01586364|384833|P1|STARTED|Overall Study||301
157954|NCT01586338|384886|P1|NOT COMPLETED|Overall Study||8
157955|NCT01586338|384886|P1|COMPLETED|Overall Study||229
157956|NCT01586338|384886|P1|STARTED|Overall Study||237
157957|NCT01586312|384898|P2|NOT COMPLETED|Overall Study||0
157958|NCT01586312|384899|P1|NOT COMPLETED|Overall Study||0
157959|NCT01586312|384898|P2|COMPLETED|Overall Study||15
157960|NCT01586312|384899|P1|COMPLETED|Overall Study||15
157961|NCT01586312|384898|P2|STARTED|Overall Study||15
157962|NCT01586312|384899|P1|STARTED|Overall Study||15
157963|NCT01586195|384909|P1|NOT COMPLETED|Overall Study||26
157964|NCT01586195|384909|P1|COMPLETED|Overall Study||5
157965|NCT01586195|384909|P1|STARTED|Overall Study||31
157966|NCT01586156|384923|P3|NOT COMPLETED|Overall Study||0
157967|NCT01586156|384924|P2|NOT COMPLETED|Overall Study||1
157968|NCT01586156|384925|P1|NOT COMPLETED|Overall Study||0
157969|NCT01586156|384923|P3|COMPLETED|Overall Study||10
157970|NCT01586156|384924|P2|COMPLETED|Overall Study||9
157971|NCT01586156|384925|P1|COMPLETED|Overall Study||10
157972|NCT01586156|384923|P3|STARTED|Overall Study||10
157973|NCT01586156|384924|P2|STARTED|Overall Study||10
157974|NCT01586156|384925|P1|STARTED|Overall Study||10
157975|NCT01586091|384954|P3|NOT COMPLETED|Overall Study||0
157976|NCT01586091|384955|P2|NOT COMPLETED|Overall Study||0
157977|NCT01586091|384956|P1|NOT COMPLETED|Overall Study||0
157978|NCT01586091|384954|P3|COMPLETED|Overall Study||6
157979|NCT01586091|384955|P2|COMPLETED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
157980|NCT01586091|384956|P1|COMPLETED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
157981|NCT01586091|384954|P3|STARTED|Overall Study||6
157982|NCT01586091|384955|P2|STARTED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
157983|NCT01586091|384956|P1|STARTED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
157984|NCT01586026|384970|P3|NOT COMPLETED|Overall Study||0
157985|NCT01586026|384971|P2|NOT COMPLETED|Overall Study||0
157986|NCT01586026|384972|P1|NOT COMPLETED|Overall Study||0
157987|NCT01586026|384970|P3|COMPLETED|Overall Study||271
157988|NCT01586026|384971|P2|COMPLETED|Overall Study||414
157989|NCT01586026|384972|P1|COMPLETED|Overall Study||350
157990|NCT01586026|384970|P3|STARTED|Overall Study||271
157991|NCT01586026|384971|P2|STARTED|Overall Study||414
157992|NCT01586026|384972|P1|STARTED|Overall Study||350
157993|NCT01585987|384982|P2|NOT COMPLETED|Treated||49
157994|NCT01585987|384983|P1|NOT COMPLETED|Treated||54
157995|NCT01585987|384982|P2|COMPLETED|Treated||2
157996|NCT01585987|384983|P1|COMPLETED|Treated||3
157997|NCT01585987|384982|P2|STARTED|Treated||51
157998|NCT01585987|384983|P1|STARTED|Treated||57
157999|NCT01585987|384982|P2|NOT COMPLETED|Randomized||6
158000|NCT01585987|384983|P1|NOT COMPLETED|Randomized||0
158001|NCT01585987|384982|P2|COMPLETED|Randomized||51
158002|NCT01585987|384983|P1|COMPLETED|Randomized||57
158003|NCT01585987|384982|P2|STARTED|Randomized||57
158004|NCT01585987|384983|P1|STARTED|Randomized||57
158005|NCT01585961|384998|P1|NOT COMPLETED|Overall Study||33
158006|NCT01585961|384998|P1|COMPLETED|Overall Study||478
158007|NCT01585961|384998|P1|Safety|Overall Study|Patients ablated with study catheter|508
158008|NCT01585961|384998|P1|STARTED|Overall Study||511
158009|NCT01585779|385015|P2|NOT COMPLETED|Overall Study||7
158010|NCT01585779|385016|P1|NOT COMPLETED|Overall Study||10
158011|NCT01585779|385015|P2|COMPLETED|Overall Study||21
158012|NCT01585779|385016|P1|COMPLETED|Overall Study||26
158013|NCT01585779|385015|P2|STARTED|Overall Study||28
158014|NCT01585779|385016|P1|STARTED|Overall Study||36
158015|NCT01585766|385076|P6|NOT COMPLETED|Overall Study||0
158016|NCT01585766|385077|P5|NOT COMPLETED|Overall Study||0
158017|NCT01585766|385078|P4|NOT COMPLETED|Overall Study||0
158018|NCT01585766|385079|P3|NOT COMPLETED|Overall Study||2
158019|NCT01585766|385080|P2|NOT COMPLETED|Overall Study||2
158020|NCT01585766|385081|P1|NOT COMPLETED|Overall Study||0
158021|NCT01585766|385076|P6|COMPLETED|Overall Study||6
158022|NCT01585766|385077|P5|COMPLETED|Overall Study||3
158023|NCT01585766|385078|P4|COMPLETED|Overall Study||4
158024|NCT01585766|385079|P3|COMPLETED|Overall Study||1
158025|NCT01585766|385080|P2|COMPLETED|Overall Study||3
158026|NCT01585766|385081|P1|COMPLETED|Overall Study||7
158027|NCT01585766|385076|P6|STARTED|Overall Study||6
158028|NCT01585766|385077|P5|STARTED|Overall Study||3
158029|NCT01585766|385078|P4|STARTED|Overall Study||4
158030|NCT01585766|385079|P3|STARTED|Overall Study||3
158031|NCT01585766|385080|P2|STARTED|Overall Study||5
158032|NCT01585766|385081|P1|STARTED|Overall Study||7
158033|NCT01585597|385180|P1|NOT COMPLETED|Overall Study||0
158034|NCT01585597|385180|P1|COMPLETED|Overall Study||20
158035|NCT01585597|385180|P1|STARTED|Overall Study||20
158036|NCT01585584|385185|P1|NOT COMPLETED|Overall Study||4
158037|NCT01585584|385185|P1|COMPLETED|Overall Study||6
158038|NCT01585584|385185|P1|STARTED|Overall Study||10
158039|NCT01585558|385192|P3|NOT COMPLETED|Overall Study||15
158040|NCT01585558|385193|P2|NOT COMPLETED|Overall Study||12
158041|NCT01585558|385194|P1|NOT COMPLETED|Overall Study||13
158042|NCT01585558|385192|P3|COMPLETED|Overall Study||34
158043|NCT01585558|385193|P2|COMPLETED|Overall Study||57
158044|NCT01585558|385194|P1|COMPLETED|Overall Study||49
158045|NCT01585558|385192|P3|STARTED|Overall Study||49
158046|NCT01585558|385193|P2|STARTED|Overall Study||69
158047|NCT01585558|385194|P1|STARTED|Overall Study||62
158048|NCT01585441|385375|P2|NOT COMPLETED|Overall Study||0
158049|NCT01585441|385376|P1|NOT COMPLETED|Overall Study||0
158050|NCT01585441|385375|P2|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
158051|NCT01585441|385376|P1|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
158052|NCT01585441|385375|P2|Final Study Safety Visit|Overall Study|A final study visit was not required for the placebo participant who completed the study at Month 3.|2
158053|NCT01585441|385376|P1|Final Study Safety Visit|Overall Study||3
158054|NCT01585441|385375|P2|Received Finasteride at Month 3|Overall Study||2
158055|NCT01585441|385376|P1|Received Finasteride at Month 3|Overall Study||2
158056|NCT01585441|385375|P2|Month 3|Overall Study||3
158057|NCT01585441|385376|P1|Month 3|Overall Study|One participant was not evaluated at Month 3 but at the final visit due to study terminating early.|2
158058|NCT01585441|385375|P2|STARTED|Overall Study||3
158059|NCT01585441|385376|P1|STARTED|Overall Study||3
158060|NCT01585428|385428|P2|NOT COMPLETED|Overall Study||0
158061|NCT01585428|385429|P1|NOT COMPLETED|Overall Study||1
158062|NCT01585428|385428|P2|COMPLETED|Overall Study||11
158063|NCT01585428|385429|P1|COMPLETED|Overall Study||17
158064|NCT01585428|385428|P2|STARTED|Overall Study||11
158065|NCT01585428|385429|P1|STARTED|Overall Study||18
158066|NCT01585324|385437|P1|NOT COMPLETED|Overall Study||0
158067|NCT01585324|385437|P1|COMPLETED|Overall Study||30
158068|NCT01585324|385437|P1|STARTED|Overall Study||30
158069|NCT01585298|385453|P1|NOT COMPLETED|Overall Study||37
158070|NCT01585298|385453|P1|COMPLETED|Overall Study||6961
158071|NCT01585298|385453|P1|STARTED|Overall Study||6998
158072|NCT01585272|385461|P1|NOT COMPLETED|Overall Study||39
158073|NCT01585272|385461|P1|COMPLETED|Overall Study||82
158074|NCT01585272|385461|P1|Exelon Patch 10 cm2|Overall Study||96
158075|NCT01585272|385461|P1|Exelon Patch 5 cm2|Overall Study||114
158076|NCT01585272|385461|P1|Safety Set|Overall Study|Subjects received 3 mg bid Exelon caps for more than 4 weeks & used at least 1 dose of Exelon patch.|102
158077|NCT01585272|385461|P1|STARTED|Overall Study||121
158078|NCT01585246|385474|P5|NOT COMPLETED|Overall Study||2
158079|NCT01585246|385475|P4|NOT COMPLETED|Overall Study||4
158080|NCT01585246|385476|P3|NOT COMPLETED|Overall Study||4
158081|NCT01585246|385477|P2|NOT COMPLETED|Overall Study||1
158082|NCT01585246|385478|P1|NOT COMPLETED|Overall Study||0
158083|NCT01585246|385474|P5|COMPLETED|Overall Study||9
158084|NCT01585246|385475|P4|COMPLETED|Overall Study||6
158085|NCT01585246|385476|P3|COMPLETED|Overall Study||16
158086|NCT01585246|385477|P2|COMPLETED|Overall Study||3
158087|NCT01585246|385478|P1|COMPLETED|Overall Study||3
158088|NCT01585246|385474|P5|STARTED|Overall Study||11
158089|NCT01585246|385475|P4|STARTED|Overall Study||10
158090|NCT01585246|385476|P3|STARTED|Overall Study||20
158091|NCT01585246|385477|P2|STARTED|Overall Study||4
158092|NCT01585246|385478|P1|STARTED|Overall Study||3
158093|NCT01585207|385493|P1|NOT COMPLETED|Overall Study||0
158094|NCT01585207|385493|P1|COMPLETED|Overall Study||4
158095|NCT01585207|385493|P1|STARTED|Overall Study||4
158096|NCT01585168|385499|P4|NOT COMPLETED|Overall Study||1
158097|NCT01585168|385500|P3|NOT COMPLETED|Overall Study||1
158098|NCT01585168|385501|P2|NOT COMPLETED|Overall Study||1
158099|NCT01585168|385502|P1|NOT COMPLETED|Overall Study||3
158100|NCT01585168|385499|P4|COMPLETED|Overall Study||18
158101|NCT01585168|385500|P3|COMPLETED|Overall Study||15
158102|NCT01585168|385501|P2|COMPLETED|Overall Study||17
158103|NCT01585168|385502|P1|COMPLETED|Overall Study||15
158104|NCT01585168|385499|P4|STARTED|Overall Study||19
158105|NCT01585168|385500|P3|STARTED|Overall Study||16
158106|NCT01585168|385501|P2|STARTED|Overall Study||18
158107|NCT01585168|385502|P1|STARTED|Overall Study||18
158108|NCT01585155|385522|P1|NOT COMPLETED|Overall Study||5
158109|NCT01585155|385522|P1|COMPLETED|Overall Study||16
158110|NCT01585155|385522|P1|STARTED|Overall Study||21
158111|NCT01585129|385531|P2|NOT COMPLETED|Overall Study||0
158112|NCT01585129|385532|P1|NOT COMPLETED|Overall Study||0
158113|NCT01585129|385531|P2|COMPLETED|Overall Study||39
158114|NCT01585129|385532|P1|COMPLETED|Overall Study||41
158115|NCT01585129|385531|P2|STARTED|Overall Study||39
158116|NCT01585129|385532|P1|STARTED|Overall Study||41
158117|NCT01585038|385544|P2|NOT COMPLETED|Overall Study||2
158118|NCT01585038|385545|P1|NOT COMPLETED|Overall Study||2
158119|NCT01585038|385544|P2|COMPLETED|Overall Study||18
158120|NCT01585038|385545|P1|COMPLETED|Overall Study||18
158121|NCT01585038|385544|P2|STARTED|Overall Study||20
158122|NCT01585038|385545|P1|STARTED|Overall Study||20
158123|NCT01585025|385560|P3|NOT COMPLETED|Overall Study||4
158124|NCT01585025|385561|P2|NOT COMPLETED|Overall Study||3
158125|NCT01585025|385562|P1|NOT COMPLETED|Overall Study||0
158126|NCT01585025|385560|P3|COMPLETED|Overall Study||8
158127|NCT01585025|385561|P2|COMPLETED|Overall Study||10
158128|NCT01585025|385562|P1|COMPLETED|Overall Study||10
158129|NCT01585025|385560|P3|STARTED|Overall Study||12
158130|NCT01585025|385561|P2|STARTED|Overall Study||13
158131|NCT01585025|385562|P1|STARTED|Overall Study||10
158132|NCT01584843|385592|P6|NOT COMPLETED|Second Treatment Period||1
158133|NCT01584843|385593|P5|NOT COMPLETED|Second Treatment Period||0
158134|NCT01584843|385594|P4|NOT COMPLETED|Second Treatment Period||0
158135|NCT01584843|385595|P3|NOT COMPLETED|Second Treatment Period||0
158136|NCT01584843|385596|P2|NOT COMPLETED|Second Treatment Period||0
158137|NCT01584843|385597|P1|NOT COMPLETED|Second Treatment Period||0
158138|NCT01584843|385592|P6|COMPLETED|Second Treatment Period||0
158139|NCT01584843|385593|P5|COMPLETED|Second Treatment Period||3
158140|NCT01584843|385594|P4|COMPLETED|Second Treatment Period||6
158141|NCT01584843|385595|P3|COMPLETED|Second Treatment Period||2
158142|NCT01584843|385596|P2|COMPLETED|Second Treatment Period||1
158143|NCT01584843|385597|P1|COMPLETED|Second Treatment Period||2
158144|NCT01584843|385592|P6|STARTED|Second Treatment Period||1
158145|NCT01584843|385593|P5|STARTED|Second Treatment Period||3
158146|NCT01584843|385594|P4|STARTED|Second Treatment Period||6
158147|NCT01584843|385595|P3|STARTED|Second Treatment Period||2
158148|NCT01584843|385596|P2|STARTED|Second Treatment Period||1
158149|NCT01584843|385597|P1|STARTED|Second Treatment Period||2
158150|NCT01584843|385592|P6|NOT COMPLETED|First Treatment Period||2
158151|NCT01584843|385593|P5|NOT COMPLETED|First Treatment Period||0
158152|NCT01584843|385594|P4|NOT COMPLETED|First Treatment Period||0
158153|NCT01584843|385595|P3|NOT COMPLETED|First Treatment Period||1
158154|NCT01584843|385596|P2|NOT COMPLETED|First Treatment Period||0
158155|NCT01584843|385597|P1|NOT COMPLETED|First Treatment Period||0
158156|NCT01584843|385592|P6|COMPLETED|First Treatment Period||9
158157|NCT01584843|385593|P5|COMPLETED|First Treatment Period||10
158158|NCT01584843|385594|P4|COMPLETED|First Treatment Period||10
158159|NCT01584843|385595|P3|COMPLETED|First Treatment Period||2
158160|NCT01584843|385596|P2|COMPLETED|First Treatment Period||4
158161|NCT01584843|385597|P1|COMPLETED|First Treatment Period||3
158162|NCT01584843|385592|P6|STARTED|First Treatment Period||11
158163|NCT01584843|385593|P5|STARTED|First Treatment Period||10
158164|NCT01584843|385594|P4|STARTED|First Treatment Period||10
158165|NCT01584843|385595|P3|STARTED|First Treatment Period||3
158166|NCT01584843|385596|P2|STARTED|First Treatment Period||4
158167|NCT01584843|385597|P1|STARTED|First Treatment Period||3
158168|NCT01584648|385708|P2|NOT COMPLETED|Overall Study||212
158169|NCT01584648|385709|P1|NOT COMPLETED|Overall Study||211
158170|NCT01584648|385708|P2|COMPLETED|Overall Study||0
158171|NCT01584648|385709|P1|COMPLETED|Overall Study||0
158172|NCT01584648|385708|P2|Ongoing|Overall Study||147
158173|NCT01584648|385709|P1|Ongoing|Overall Study||154
158174|NCT01584648|385708|P2|STARTED|Overall Study||212
158175|NCT01584648|385709|P1|STARTED|Overall Study||211
158176|NCT01584609|385749|P2|NOT COMPLETED|Overall Study||4
158177|NCT01584609|385750|P1|NOT COMPLETED|Overall Study||12
158178|NCT01584609|385749|P2|COMPLETED|Overall Study||96
158179|NCT01584609|385750|P1|COMPLETED|Overall Study||86
158180|NCT01584609|385749|P2|STARTED|Overall Study||100
158181|NCT01584609|385750|P1|STARTED|Overall Study||98
158182|NCT01584544|385775|P5|NOT COMPLETED|Overall Study||0
158183|NCT01584544|385776|P4|NOT COMPLETED|Overall Study||0
158184|NCT01584544|385777|P3|NOT COMPLETED|Overall Study||0
158185|NCT01584544|385778|P2|NOT COMPLETED|Overall Study||0
158186|NCT01584544|385779|P1|NOT COMPLETED|Overall Study||0
158187|NCT01584544|385775|P5|COMPLETED|Overall Study||6
158188|NCT01584544|385776|P4|COMPLETED|Overall Study||3
158189|NCT01584544|385777|P3|COMPLETED|Overall Study||6
158190|NCT01584544|385778|P2|COMPLETED|Overall Study||6
158191|NCT01584544|385779|P1|COMPLETED|Overall Study||3
158192|NCT01584544|385775|P5|STARTED|Overall Study||6
158193|NCT01584544|385776|P4|STARTED|Overall Study||3
158194|NCT01584544|385777|P3|STARTED|Overall Study||6
158195|NCT01584544|385778|P2|STARTED|Overall Study||6
158196|NCT01584544|385779|P1|STARTED|Overall Study||3
158197|NCT01584518|385793|P2|NOT COMPLETED|Overall Study||0
158198|NCT01584518|385794|P1|NOT COMPLETED|Overall Study||0
158199|NCT01584518|385793|P2|COMPLETED|Overall Study||25
158200|NCT01584518|385794|P1|COMPLETED|Overall Study||25
158201|NCT01584518|385793|P2|STARTED|Overall Study||25
158202|NCT01584518|385794|P1|STARTED|Overall Study||25
158203|NCT01584479|385804|P4|NOT COMPLETED|Overall Study||0
158204|NCT01584479|385805|P3|NOT COMPLETED|Overall Study||0
158205|NCT01584479|385806|P2|NOT COMPLETED|Overall Study||0
158206|NCT01584479|385807|P1|NOT COMPLETED|Overall Study||0
158207|NCT01584479|385804|P4|COMPLETED|Overall Study||1847
158208|NCT01584479|385805|P3|COMPLETED|Overall Study||852
158209|NCT01584479|385806|P2|COMPLETED|Overall Study||1686
158210|NCT01584479|385807|P1|COMPLETED|Overall Study||732
158211|NCT01584479|385804|P4|STARTED|Overall Study||1847
158212|NCT01584479|385805|P3|STARTED|Overall Study||852
158213|NCT01584479|385806|P2|STARTED|Overall Study||1686
158214|NCT01584479|385807|P1|STARTED|Overall Study||732
158215|NCT01584388|385817|P1|NOT COMPLETED|Overall Study||0
158216|NCT01584388|385817|P1|COMPLETED|Overall Study||30
158217|NCT01584388|385817|P1|STARTED|Overall Study||30
158218|NCT01584232|385837|P2|NOT COMPLETED|Overall Study||3
158219|NCT01584232|385838|P1|NOT COMPLETED|Overall Study||8
158220|NCT01584232|385837|P2|COMPLETED|Overall Study||177
158221|NCT01584232|385838|P1|COMPLETED|Overall Study||173
158222|NCT01584232|385837|P2|Received at Least 1 Dose of Study Drug|Overall Study||180
158223|NCT01584232|385838|P1|Received at Least 1 Dose of Study Drug|Overall Study||181
158224|NCT01584232|385837|P2|STARTED|Overall Study||180
158225|NCT01584232|385838|P1|STARTED|Overall Study||181
158226|NCT01584024|385854|P1|NOT COMPLETED|Overall Study||13
158227|NCT01584024|385854|P1|COMPLETED|Overall Study||29
158228|NCT01584024|385854|P1|STARTED|Overall Study||42
158229|NCT01583985|385863|P2|NOT COMPLETED|Overall Study||3
158230|NCT01583985|385864|P1|NOT COMPLETED|Overall Study||3
158231|NCT01583985|385863|P2|COMPLETED|Overall Study||117
158232|NCT01583985|385864|P1|COMPLETED|Overall Study||117
158233|NCT01583985|385863|P2|Included in Primary Analysis|Overall Study||119
158234|NCT01583985|385864|P1|Included in Primary Analysis|Overall Study||119
158235|NCT01583985|385863|P2|STARTED|Overall Study||120
158236|NCT01583985|385864|P1|STARTED|Overall Study||120
158237|NCT01583894|385878|P1|NOT COMPLETED|Overall Study||15
158238|NCT01583894|385878|P1|COMPLETED|Overall Study||813
158239|NCT01583894|385878|P1|STARTED|Overall Study||828
158240|NCT01583686|385887|P5|NOT COMPLETED|Overall Study||0
158241|NCT01583686|385888|P4|NOT COMPLETED|Overall Study||0
158242|NCT01583686|385889|P3|NOT COMPLETED|Overall Study||0
158243|NCT01583686|385890|P2|NOT COMPLETED|Overall Study||0
158244|NCT01583686|385891|P1|NOT COMPLETED|Overall Study||0
158245|NCT01583686|385887|P5|COMPLETED|Overall Study||3
158246|NCT01583686|385888|P4|COMPLETED|Overall Study||3
158247|NCT01583686|385889|P3|COMPLETED|Overall Study||3
158248|NCT01583686|385890|P2|COMPLETED|Overall Study||3
158249|NCT01583686|385891|P1|COMPLETED|Overall Study||3
158250|NCT01583686|385887|P5|STARTED|Overall Study||3
158251|NCT01583686|385888|P4|STARTED|Overall Study||3
158252|NCT01583686|385889|P3|STARTED|Overall Study||3
158253|NCT01583686|385890|P2|STARTED|Overall Study||3
158254|NCT01583686|385891|P1|STARTED|Overall Study||3
158255|NCT01583647|385908|P2|NOT COMPLETED|Overall Study||0
158256|NCT01583647|385909|P1|NOT COMPLETED|Overall Study||0
158257|NCT01583647|385908|P2|COMPLETED|Overall Study||0
158258|NCT01583647|385909|P1|COMPLETED|Overall Study||10
158259|NCT01583647|385908|P2|STARTED|Overall Study|Study terminated prior to Panel B being conducted.|0
158260|NCT01583647|385909|P1|STARTED|Overall Study||10
158261|NCT01583543|385921|P1|NOT COMPLETED|Overall Study||0
158262|NCT01583543|385921|P1|COMPLETED|Overall Study||12
158263|NCT01583543|385921|P1|STARTED|Overall Study||12
158264|NCT01583530|385934|P6|NOT COMPLETED|Overall Study||3
158265|NCT01583530|385935|P5|NOT COMPLETED|Overall Study||5
158266|NCT01583530|385936|P4|NOT COMPLETED|Overall Study||1
158267|NCT01583530|385937|P3|NOT COMPLETED|Overall Study||0
158268|NCT01583530|385938|P2|NOT COMPLETED|Overall Study||3
158269|NCT01583530|385939|P1|NOT COMPLETED|Overall Study||0
158270|NCT01583530|385934|P6|COMPLETED|Overall Study||17
158271|NCT01583530|385935|P5|COMPLETED|Overall Study||15
158272|NCT01583530|385936|P4|COMPLETED|Overall Study||18
158273|NCT01583530|385937|P3|COMPLETED|Overall Study||20
158274|NCT01583530|385938|P2|COMPLETED|Overall Study||17
158275|NCT01583530|385939|P1|COMPLETED|Overall Study||19
158276|NCT01583530|385934|P6|STARTED|Overall Study||20
158277|NCT01583530|385935|P5|STARTED|Overall Study||20
158278|NCT01583530|385936|P4|STARTED|Overall Study||19
158279|NCT01583530|385937|P3|STARTED|Overall Study||20
158280|NCT01583530|385938|P2|STARTED|Overall Study||20
158281|NCT01583530|385939|P1|STARTED|Overall Study||19
158282|NCT01583452|385985|P2|NOT COMPLETED|Overall Study||0
158283|NCT01583452|385986|P1|NOT COMPLETED|Overall Study||0
158284|NCT01583452|385985|P2|COMPLETED|Overall Study||20
158285|NCT01583452|385986|P1|COMPLETED|Overall Study||21
158286|NCT01583452|385985|P2|STARTED|Overall Study||20
158287|NCT01583452|385986|P1|STARTED|Overall Study||21
158288|NCT01583374|386001|P9|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||10
158289|NCT01583374|386002|P8|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||9
158290|NCT01583374|386003|P7|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||18
158291|NCT01583374|386004|P6|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||17
158292|NCT01583374|386005|P5|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||31
158293|NCT01583374|386006|P4|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||13
158294|NCT01583374|386007|P3|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||20
158295|NCT01583374|386008|P2|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||26
158296|NCT01583374|386009|P1|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||0
158297|NCT01583374|386001|P9|COMPLETED|Long-Term Extension Phase Weeks 52-260||10
158298|NCT01583374|386002|P8|COMPLETED|Long-Term Extension Phase Weeks 52-260||12
158299|NCT01583374|386003|P7|COMPLETED|Long-Term Extension Phase Weeks 52-260||20
158300|NCT01583374|386004|P6|COMPLETED|Long-Term Extension Phase Weeks 52-260||22
158301|NCT01583374|386005|P5|COMPLETED|Long-Term Extension Phase Weeks 52-260||50
158302|NCT01583374|386006|P4|COMPLETED|Long-Term Extension Phase Weeks 52-260||22
158303|NCT01583374|386007|P3|COMPLETED|Long-Term Extension Phase Weeks 52-260||41
158304|NCT01583374|386008|P2|COMPLETED|Long-Term Extension Phase Weeks 52-260||40
158305|NCT01583374|386009|P1|COMPLETED|Long-Term Extension Phase Weeks 52-260||0
158306|NCT01583374|386001|P9|STARTED|Long-Term Extension Phase Weeks 52-260||20
158307|NCT01583374|386002|P8|STARTED|Long-Term Extension Phase Weeks 52-260||21
158308|NCT01583374|386003|P7|STARTED|Long-Term Extension Phase Weeks 52-260||38
158309|NCT01583374|386004|P6|STARTED|Long-Term Extension Phase Weeks 52-260||39
158310|NCT01583374|386005|P5|STARTED|Long-Term Extension Phase Weeks 52-260||81
158311|NCT01583374|386006|P4|STARTED|Long-Term Extension Phase Weeks 52-260||35
158312|NCT01583374|386007|P3|STARTED|Long-Term Extension Phase Weeks 52-260||61
158313|NCT01583374|386008|P2|STARTED|Long-Term Extension Phase Weeks 52-260||66
158314|NCT01583374|386009|P1|STARTED|Long-Term Extension Phase Weeks 52-260||0
158315|NCT01583374|386001|P9|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||2
158316|NCT01583374|386002|P8|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||3
158317|NCT01583374|386003|P7|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
158318|NCT01583374|386004|P6|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
158319|NCT01583374|386005|P5|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||6
158320|NCT01583374|386006|P4|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||6
158321|NCT01583374|386007|P3|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||4
158322|NCT01583374|386008|P2|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
158323|NCT01583374|386009|P1|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||0
158324|NCT01583374|386001|P9|COMPLETED|Extension Phase (Weeks 24 to 52)||21
158325|NCT01583374|386002|P8|COMPLETED|Extension Phase (Weeks 24 to 52)||22
158326|NCT01583374|386003|P7|COMPLETED|Extension Phase (Weeks 24 to 52)||43
158327|NCT01583374|386004|P6|COMPLETED|Extension Phase (Weeks 24 to 52)||43
158328|NCT01583374|386005|P5|COMPLETED|Extension Phase (Weeks 24 to 52)||85
158329|NCT01583374|386006|P4|COMPLETED|Extension Phase (Weeks 24 to 52)||41
158330|NCT01583374|386007|P3|COMPLETED|Extension Phase (Weeks 24 to 52)||61
158331|NCT01583374|386008|P2|COMPLETED|Extension Phase (Weeks 24 to 52)||69
158332|NCT01583374|386009|P1|COMPLETED|Extension Phase (Weeks 24 to 52)||0
158333|NCT01583374|386001|P9|STARTED|Extension Phase (Weeks 24 to 52)||23
158334|NCT01583374|386002|P8|STARTED|Extension Phase (Weeks 24 to 52)||25
158335|NCT01583374|386003|P7|STARTED|Extension Phase (Weeks 24 to 52)||48
158336|NCT01583374|386004|P6|STARTED|Extension Phase (Weeks 24 to 52)||48
158337|NCT01583374|386005|P5|STARTED|Extension Phase (Weeks 24 to 52)||91
158338|NCT01583374|386006|P4|STARTED|Extension Phase (Weeks 24 to 52)||47
158339|NCT01583374|386007|P3|STARTED|Extension Phase (Weeks 24 to 52)||65
158340|NCT01583374|386008|P2|STARTED|Extension Phase (Weeks 24 to 52)||74
158341|NCT01583374|386009|P1|STARTED|Extension Phase (Weeks 24 to 52)||0
158342|NCT01583374|386001|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
158343|NCT01583374|386002|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
158344|NCT01583374|386003|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
158345|NCT01583374|386004|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
158346|NCT01583374|386005|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
158347|NCT01583374|386006|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
158348|NCT01583374|386007|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||25
158349|NCT01583374|386008|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||16
158350|NCT01583374|386009|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||19
158351|NCT01583374|386001|P9|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
158352|NCT01583374|386002|P8|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
158353|NCT01583374|386003|P7|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
158354|NCT01583374|386004|P6|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
158355|NCT01583374|386005|P5|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
158356|NCT01583374|386006|P4|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
158357|NCT01583374|386007|P3|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|138
158358|NCT01583374|386008|P2|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|147
158359|NCT01583374|386009|P1|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|145
158360|NCT01583374|386001|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
158361|NCT01583374|386002|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
158362|NCT01583374|386003|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
158363|NCT01583374|386004|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
158364|NCT01583374|386005|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
158365|NCT01583374|386006|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
158366|NCT01583374|386007|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|One participant who escaped early did not complete Week 24|49
158367|NCT01583374|386008|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||49
158368|NCT01583374|386009|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|One participant who escaped early did not complete Week 24|51
158369|NCT01583374|386001|P9|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
158370|NCT01583374|386002|P8|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
158371|NCT01583374|386003|P7|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
158372|NCT01583374|386004|P6|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
158373|NCT01583374|386005|P5|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
158374|NCT01583374|386006|P4|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
158375|NCT01583374|386007|P3|Completed Week 16|Placebo-controlled Phase (Week 0-24)||144
158376|NCT01583374|386008|P2|Completed Week 16|Placebo-controlled Phase (Week 0-24)||151
158377|NCT01583374|386009|P1|Completed Week 16|Placebo-controlled Phase (Week 0-24)||150
158378|NCT01583374|386001|P9|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
158379|NCT01583374|386002|P8|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
158380|NCT01583374|386003|P7|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
158381|NCT01583374|386004|P6|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
158382|NCT01583374|386005|P5|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
158383|NCT01583374|386006|P4|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
158384|NCT01583374|386007|P3|Received Treatment|Placebo-controlled Phase (Week 0-24)||163
158385|NCT01583374|386008|P2|Received Treatment|Placebo-controlled Phase (Week 0-24)||163
158386|NCT01583374|386009|P1|Received Treatment|Placebo-controlled Phase (Week 0-24)||164
158387|NCT01583374|386001|P9|STARTED|Placebo-controlled Phase (Week 0-24)||0
158388|NCT01583374|386002|P8|STARTED|Placebo-controlled Phase (Week 0-24)||0
158389|NCT01583374|386003|P7|STARTED|Placebo-controlled Phase (Week 0-24)||0
158390|NCT01583374|386004|P6|STARTED|Placebo-controlled Phase (Week 0-24)||0
158391|NCT01583374|386005|P5|STARTED|Placebo-controlled Phase (Week 0-24)||0
158392|NCT01583374|386006|P4|STARTED|Placebo-controlled Phase (Week 0-24)||0
158393|NCT01583374|386007|P3|STARTED|Placebo-controlled Phase (Week 0-24)||163
158394|NCT01583374|386008|P2|STARTED|Placebo-controlled Phase (Week 0-24)||163
158395|NCT01583374|386009|P1|STARTED|Placebo-controlled Phase (Week 0-24)||164
158396|NCT01583218|386051|P2|NOT COMPLETED|Overall Study||283
158397|NCT01583218|386052|P1|NOT COMPLETED|Overall Study||289
158398|NCT01583218|386051|P2|COMPLETED|Overall Study||3471
158399|NCT01583218|386052|P1|COMPLETED|Overall Study||3470
158400|NCT01583218|386051|P2|STARTED|Overall Study||3754
158401|NCT01583218|386052|P1|STARTED|Overall Study||3759
158402|NCT01583179|386072|P2|NOT COMPLETED|Overall Study||2
158403|NCT01583179|386073|P1|NOT COMPLETED|Overall Study||1
158404|NCT01583179|386072|P2|COMPLETED|Overall Study||10
158405|NCT01583179|386073|P1|COMPLETED|Overall Study||13
158406|NCT01583179|386072|P2|STARTED|Overall Study||12
158407|NCT01583179|386073|P1|STARTED|Overall Study||14
158408|NCT01583166|386083|P2|NOT COMPLETED|Overall Study||6
158409|NCT01583166|386084|P1|NOT COMPLETED|Overall Study||4
158410|NCT01583166|386083|P2|COMPLETED|Overall Study||39
158411|NCT01583166|386084|P1|COMPLETED|Overall Study||41
158412|NCT01583166|386083|P2|STARTED|Overall Study||45
158413|NCT01583166|386084|P1|STARTED|Overall Study||45
158414|NCT01583101|386098|P2|NOT COMPLETED|Overall Study||0
158415|NCT01583101|386099|P1|NOT COMPLETED|Overall Study||0
158416|NCT01583101|386098|P2|COMPLETED|Overall Study||1161
158417|NCT01583101|386099|P1|COMPLETED|Overall Study||1076
158418|NCT01583101|386098|P2|STARTED|Overall Study||1161
158419|NCT01583101|386099|P1|STARTED|Overall Study||1076
158420|NCT01582971|386107|P2|NOT COMPLETED|Overall Study||37
158421|NCT01582971|386108|P1|NOT COMPLETED|Overall Study||39
158422|NCT01582971|386107|P2|COMPLETED|Overall Study||91
158423|NCT01582971|386108|P1|COMPLETED|Overall Study||89
158424|NCT01582971|386107|P2|STARTED|Overall Study||128
158425|NCT01582971|386108|P1|STARTED|Overall Study||128
158426|NCT01582945|386126|P1|NOT COMPLETED|Overall Study||2
158427|NCT01582945|386126|P1|COMPLETED|Overall Study||12
158428|NCT01582945|386126|P1|STARTED|Overall Study||14
158429|NCT01582880|386130|P1|NOT COMPLETED|Overall Study||0
158430|NCT01582880|386130|P1|COMPLETED|Overall Study||1
158431|NCT01582880|386130|P1|STARTED|Overall Study||1
158432|NCT01582854|386140|P2|NOT COMPLETED|Overall Study||34
158433|NCT01582854|386141|P1|NOT COMPLETED|Overall Study||36
158434|NCT01582854|386140|P2|COMPLETED|Overall Study||221
158435|NCT01582854|386141|P1|COMPLETED|Overall Study||212
158436|NCT01582854|386140|P2|STARTED|Overall Study||255
158437|NCT01582854|386141|P1|STARTED|Overall Study||248
158438|NCT01582789|386169|P2|NOT COMPLETED|Second Intervention (14 Days)||0
158439|NCT01582789|386170|P1|NOT COMPLETED|Second Intervention (14 Days)||1
158440|NCT01582789|386169|P2|COMPLETED|Second Intervention (14 Days)||27
158441|NCT01582789|386170|P1|COMPLETED|Second Intervention (14 Days)||33
158442|NCT01582789|386169|P2|STARTED|Second Intervention (14 Days)||27
158443|NCT01582789|386170|P1|STARTED|Second Intervention (14 Days)||34
158444|NCT01582789|386169|P2|NOT COMPLETED|First Intervention (14 Days)||0
158445|NCT01582789|386170|P1|NOT COMPLETED|First Intervention (14 Days)||0
158446|NCT01582789|386169|P2|COMPLETED|First Intervention (14 Days)||27
158447|NCT01582789|386170|P1|COMPLETED|First Intervention (14 Days)||34
158448|NCT01582789|386169|P2|STARTED|First Intervention (14 Days)||27
158449|NCT01582789|386170|P1|STARTED|First Intervention (14 Days)||34
158450|NCT01582490|386188|P2|NOT COMPLETED|Overall Study||1
158451|NCT01582490|386189|P1|NOT COMPLETED|Overall Study||1
158452|NCT01582490|386188|P2|COMPLETED|Overall Study||9
158453|NCT01582490|386189|P1|COMPLETED|Overall Study||8
158454|NCT01582490|386188|P2|STARTED|Overall Study||10
158455|NCT01582490|386189|P1|STARTED|Overall Study||9
158456|NCT01582477|386211|P2|NOT COMPLETED|Overall Study||0
158457|NCT01582477|386212|P1|NOT COMPLETED|Overall Study||0
158458|NCT01582477|386211|P2|COMPLETED|Overall Study||12
158459|NCT01582477|386212|P1|COMPLETED|Overall Study||12
158460|NCT01582477|386211|P2|STARTED|Overall Study||12
158461|NCT01582477|386212|P1|STARTED|Overall Study||12
158462|NCT01582451|386230|P2|NOT COMPLETED|Overall Study||20
158463|NCT01582451|386231|P1|NOT COMPLETED|Overall Study||32
158464|NCT01582451|386230|P2|COMPLETED|Overall Study||139
158465|NCT01582451|386231|P1|COMPLETED|Overall Study||275
158466|NCT01582451|386230|P2|Received at Least 1 Dose of Study Drug|Overall Study||159
158467|NCT01582451|386231|P1|Received at Least 1 Dose of Study Drug|Overall Study||305
158468|NCT01582451|386230|P2|STARTED|Overall Study||159
158469|NCT01582451|386231|P1|STARTED|Overall Study||307
158470|NCT01582308|386273|P10|NOT COMPLETED|Period 5||0
158471|NCT01582308|386274|P9|NOT COMPLETED|Period 5||0
158472|NCT01582308|386275|P8|NOT COMPLETED|Period 5||0
158473|NCT01582308|386276|P7|NOT COMPLETED|Period 5||0
158474|NCT01582308|386277|P6|NOT COMPLETED|Period 5||0
158475|NCT01582308|386278|P5|NOT COMPLETED|Period 5||0
158476|NCT01582308|386279|P4|NOT COMPLETED|Period 5||0
158477|NCT01582308|386280|P3|NOT COMPLETED|Period 5||0
158478|NCT01582308|386281|P2|NOT COMPLETED|Period 5||0
158479|NCT01582308|386282|P1|NOT COMPLETED|Period 5||0
158480|NCT01582308|386273|P10|COMPLETED|Period 5||1
158481|NCT01582308|386274|P9|COMPLETED|Period 5||2
158482|NCT01582308|386275|P8|COMPLETED|Period 5||2
158483|NCT01582308|386276|P7|COMPLETED|Period 5||2
158484|NCT01582308|386277|P6|COMPLETED|Period 5||1
158485|NCT01582308|386278|P5|COMPLETED|Period 5||2
158486|NCT01582308|386279|P4|COMPLETED|Period 5||2
158487|NCT01582308|386280|P3|COMPLETED|Period 5||2
158488|NCT01582308|386281|P2|COMPLETED|Period 5||2
158489|NCT01582308|386282|P1|COMPLETED|Period 5||1
158490|NCT01582308|386273|P10|STARTED|Period 5||1
158491|NCT01582308|386274|P9|STARTED|Period 5||2
158492|NCT01582308|386275|P8|STARTED|Period 5||2
158493|NCT01582308|386276|P7|STARTED|Period 5||2
158494|NCT01582308|386277|P6|STARTED|Period 5||1
158495|NCT01582308|386278|P5|STARTED|Period 5||2
158496|NCT01582308|386279|P4|STARTED|Period 5||2
158497|NCT01582308|386280|P3|STARTED|Period 5||2
158498|NCT01582308|386281|P2|STARTED|Period 5||2
158499|NCT01582308|386282|P1|STARTED|Period 5||1
158500|NCT01582308|386273|P10|NOT COMPLETED|10-day Washout Following Period 4||0
158501|NCT01582308|386274|P9|NOT COMPLETED|10-day Washout Following Period 4||0
158502|NCT01582308|386275|P8|NOT COMPLETED|10-day Washout Following Period 4||0
158503|NCT01582308|386276|P7|NOT COMPLETED|10-day Washout Following Period 4||0
158504|NCT01582308|386277|P6|NOT COMPLETED|10-day Washout Following Period 4||0
158505|NCT01582308|386278|P5|NOT COMPLETED|10-day Washout Following Period 4||0
158506|NCT01582308|386279|P4|NOT COMPLETED|10-day Washout Following Period 4||0
158507|NCT01582308|386280|P3|NOT COMPLETED|10-day Washout Following Period 4||0
158508|NCT01582308|386281|P2|NOT COMPLETED|10-day Washout Following Period 4||0
158509|NCT01582308|386282|P1|NOT COMPLETED|10-day Washout Following Period 4||0
158510|NCT01582308|386273|P10|COMPLETED|10-day Washout Following Period 4||1
158511|NCT01582308|386274|P9|COMPLETED|10-day Washout Following Period 4||2
158512|NCT01582308|386275|P8|COMPLETED|10-day Washout Following Period 4||2
158513|NCT01582308|386276|P7|COMPLETED|10-day Washout Following Period 4||2
158514|NCT01582308|386277|P6|COMPLETED|10-day Washout Following Period 4||1
158515|NCT01582308|386278|P5|COMPLETED|10-day Washout Following Period 4||2
158516|NCT01582308|386279|P4|COMPLETED|10-day Washout Following Period 4||2
158517|NCT01582308|386280|P3|COMPLETED|10-day Washout Following Period 4||2
158518|NCT01582308|386281|P2|COMPLETED|10-day Washout Following Period 4||2
158519|NCT01582308|386282|P1|COMPLETED|10-day Washout Following Period 4||1
158520|NCT01582308|386273|P10|STARTED|10-day Washout Following Period 4||1
158521|NCT01582308|386274|P9|STARTED|10-day Washout Following Period 4||2
158522|NCT01582308|386275|P8|STARTED|10-day Washout Following Period 4||2
158523|NCT01582308|386276|P7|STARTED|10-day Washout Following Period 4||2
158524|NCT01582308|386277|P6|STARTED|10-day Washout Following Period 4||1
158525|NCT01582308|386278|P5|STARTED|10-day Washout Following Period 4||2
158526|NCT01582308|386279|P4|STARTED|10-day Washout Following Period 4||2
158527|NCT01582308|386280|P3|STARTED|10-day Washout Following Period 4||2
158528|NCT01582308|386281|P2|STARTED|10-day Washout Following Period 4||2
158529|NCT01582308|386282|P1|STARTED|10-day Washout Following Period 4||1
158530|NCT01582308|386273|P10|NOT COMPLETED|Period 4||1
158531|NCT01582308|386274|P9|NOT COMPLETED|Period 4||0
158532|NCT01582308|386275|P8|NOT COMPLETED|Period 4||0
158533|NCT01582308|386276|P7|NOT COMPLETED|Period 4||0
158534|NCT01582308|386277|P6|NOT COMPLETED|Period 4||1
158535|NCT01582308|386278|P5|NOT COMPLETED|Period 4||0
158536|NCT01582308|386279|P4|NOT COMPLETED|Period 4||0
158537|NCT01582308|386280|P3|NOT COMPLETED|Period 4||0
158538|NCT01582308|386281|P2|NOT COMPLETED|Period 4||0
158539|NCT01582308|386282|P1|NOT COMPLETED|Period 4||1
158540|NCT01582308|386273|P10|COMPLETED|Period 4||1
158541|NCT01582308|386274|P9|COMPLETED|Period 4||2
158542|NCT01582308|386275|P8|COMPLETED|Period 4||2
158543|NCT01582308|386276|P7|COMPLETED|Period 4||2
158544|NCT01582308|386277|P6|COMPLETED|Period 4||1
158545|NCT01582308|386278|P5|COMPLETED|Period 4||2
158546|NCT01582308|386279|P4|COMPLETED|Period 4||2
158547|NCT01582308|386280|P3|COMPLETED|Period 4||2
158548|NCT01582308|386281|P2|COMPLETED|Period 4||2
158549|NCT01582308|386282|P1|COMPLETED|Period 4||1
158550|NCT01582308|386273|P10|STARTED|Period 4||2
158551|NCT01582308|386274|P9|STARTED|Period 4||2
158552|NCT01582308|386275|P8|STARTED|Period 4||2
158553|NCT01582308|386276|P7|STARTED|Period 4||2
158554|NCT01582308|386277|P6|STARTED|Period 4||2
158555|NCT01582308|386278|P5|STARTED|Period 4||2
158556|NCT01582308|386279|P4|STARTED|Period 4||2
158557|NCT01582308|386280|P3|STARTED|Period 4||2
158558|NCT01582308|386281|P2|STARTED|Period 4||2
158559|NCT01582308|386282|P1|STARTED|Period 4||2
158560|NCT01582308|386273|P10|NOT COMPLETED|10-day Washout Following Period 3||0
158561|NCT01582308|386274|P9|NOT COMPLETED|10-day Washout Following Period 3||0
158562|NCT01582308|386275|P8|NOT COMPLETED|10-day Washout Following Period 3||0
158563|NCT01582308|386276|P7|NOT COMPLETED|10-day Washout Following Period 3||0
158564|NCT01582308|386277|P6|NOT COMPLETED|10-day Washout Following Period 3||0
158565|NCT01582308|386278|P5|NOT COMPLETED|10-day Washout Following Period 3||0
158566|NCT01582308|386279|P4|NOT COMPLETED|10-day Washout Following Period 3||0
158567|NCT01582308|386280|P3|NOT COMPLETED|10-day Washout Following Period 3||0
158568|NCT01582308|386281|P2|NOT COMPLETED|10-day Washout Following Period 3||0
158569|NCT01582308|386282|P1|NOT COMPLETED|10-day Washout Following Period 3||0
158570|NCT01582308|386273|P10|COMPLETED|10-day Washout Following Period 3||2
158571|NCT01582308|386274|P9|COMPLETED|10-day Washout Following Period 3||2
158572|NCT01582308|386275|P8|COMPLETED|10-day Washout Following Period 3||2
158573|NCT01582308|386276|P7|COMPLETED|10-day Washout Following Period 3||2
158574|NCT01582308|386277|P6|COMPLETED|10-day Washout Following Period 3||2
158575|NCT01582308|386278|P5|COMPLETED|10-day Washout Following Period 3||2
158576|NCT01582308|386279|P4|COMPLETED|10-day Washout Following Period 3||2
158577|NCT01582308|386280|P3|COMPLETED|10-day Washout Following Period 3||2
158578|NCT01582308|386281|P2|COMPLETED|10-day Washout Following Period 3||2
158579|NCT01582308|386282|P1|COMPLETED|10-day Washout Following Period 3||2
158580|NCT01582308|386273|P10|STARTED|10-day Washout Following Period 3||2
158581|NCT01582308|386274|P9|STARTED|10-day Washout Following Period 3||2
158582|NCT01582308|386275|P8|STARTED|10-day Washout Following Period 3||2
158583|NCT01582308|386276|P7|STARTED|10-day Washout Following Period 3||2
158584|NCT01582308|386277|P6|STARTED|10-day Washout Following Period 3||2
158585|NCT01582308|386278|P5|STARTED|10-day Washout Following Period 3||2
158586|NCT01582308|386279|P4|STARTED|10-day Washout Following Period 3||2
158587|NCT01582308|386280|P3|STARTED|10-day Washout Following Period 3||2
158588|NCT01582308|386281|P2|STARTED|10-day Washout Following Period 3||2
158589|NCT01582308|386282|P1|STARTED|10-day Washout Following Period 3||2
158590|NCT01582308|386273|P10|NOT COMPLETED|Period 3||0
158591|NCT01582308|386274|P9|NOT COMPLETED|Period 3||0
158592|NCT01582308|386275|P8|NOT COMPLETED|Period 3||0
158593|NCT01582308|386276|P7|NOT COMPLETED|Period 3||0
158594|NCT01582308|386277|P6|NOT COMPLETED|Period 3||0
158595|NCT01582308|386278|P5|NOT COMPLETED|Period 3||0
158596|NCT01582308|386279|P4|NOT COMPLETED|Period 3||0
158597|NCT01582308|386280|P3|NOT COMPLETED|Period 3||0
158598|NCT01582308|386281|P2|NOT COMPLETED|Period 3||0
158599|NCT01582308|386282|P1|NOT COMPLETED|Period 3||0
158600|NCT01582308|386273|P10|COMPLETED|Period 3||2
158601|NCT01582308|386274|P9|COMPLETED|Period 3||2
158602|NCT01582308|386275|P8|COMPLETED|Period 3||2
158603|NCT01582308|386276|P7|COMPLETED|Period 3||2
158604|NCT01582308|386277|P6|COMPLETED|Period 3||2
158605|NCT01582308|386278|P5|COMPLETED|Period 3||2
158606|NCT01582308|386279|P4|COMPLETED|Period 3||2
158607|NCT01582308|386280|P3|COMPLETED|Period 3||2
158608|NCT01582308|386281|P2|COMPLETED|Period 3||2
158609|NCT01582308|386282|P1|COMPLETED|Period 3||2
158610|NCT01582308|386273|P10|STARTED|Period 3||2
158611|NCT01582308|386274|P9|STARTED|Period 3||2
158612|NCT01582308|386275|P8|STARTED|Period 3||2
158613|NCT01582308|386276|P7|STARTED|Period 3||2
158614|NCT01582308|386277|P6|STARTED|Period 3||2
158615|NCT01582308|386278|P5|STARTED|Period 3||2
158616|NCT01582308|386279|P4|STARTED|Period 3||2
158617|NCT01582308|386280|P3|STARTED|Period 3||2
158618|NCT01582308|386281|P2|STARTED|Period 3||2
158619|NCT01582308|386282|P1|STARTED|Period 3||2
158620|NCT01582308|386273|P10|NOT COMPLETED|10-day Washout Following Period 2||0
158621|NCT01582308|386274|P9|NOT COMPLETED|10-day Washout Following Period 2||0
158622|NCT01582308|386275|P8|NOT COMPLETED|10-day Washout Following Period 2||0
158623|NCT01582308|386276|P7|NOT COMPLETED|10-day Washout Following Period 2||0
158624|NCT01582308|386277|P6|NOT COMPLETED|10-day Washout Following Period 2||0
158625|NCT01582308|386278|P5|NOT COMPLETED|10-day Washout Following Period 2||0
158626|NCT01582308|386279|P4|NOT COMPLETED|10-day Washout Following Period 2||0
158627|NCT01582308|386280|P3|NOT COMPLETED|10-day Washout Following Period 2||0
158628|NCT01582308|386281|P2|NOT COMPLETED|10-day Washout Following Period 2||0
158629|NCT01582308|386282|P1|NOT COMPLETED|10-day Washout Following Period 2||0
158630|NCT01582308|386273|P10|COMPLETED|10-day Washout Following Period 2||2
158631|NCT01582308|386274|P9|COMPLETED|10-day Washout Following Period 2||2
158632|NCT01582308|386275|P8|COMPLETED|10-day Washout Following Period 2||2
158633|NCT01582308|386276|P7|COMPLETED|10-day Washout Following Period 2||2
158634|NCT01582308|386277|P6|COMPLETED|10-day Washout Following Period 2||2
158635|NCT01582308|386278|P5|COMPLETED|10-day Washout Following Period 2||2
158636|NCT01582308|386279|P4|COMPLETED|10-day Washout Following Period 2||2
158637|NCT01582308|386280|P3|COMPLETED|10-day Washout Following Period 2||2
158638|NCT01582308|386281|P2|COMPLETED|10-day Washout Following Period 2||2
158639|NCT01582308|386282|P1|COMPLETED|10-day Washout Following Period 2||2
158640|NCT01582308|386273|P10|STARTED|10-day Washout Following Period 2||2
158641|NCT01582308|386274|P9|STARTED|10-day Washout Following Period 2||2
158642|NCT01582308|386275|P8|STARTED|10-day Washout Following Period 2||2
158643|NCT01582308|386276|P7|STARTED|10-day Washout Following Period 2||2
158644|NCT01582308|386277|P6|STARTED|10-day Washout Following Period 2||2
158645|NCT01582308|386278|P5|STARTED|10-day Washout Following Period 2||2
158646|NCT01582308|386279|P4|STARTED|10-day Washout Following Period 2||2
158647|NCT01582308|386280|P3|STARTED|10-day Washout Following Period 2||2
158648|NCT01582308|386281|P2|STARTED|10-day Washout Following Period 2||2
158649|NCT01582308|386282|P1|STARTED|10-day Washout Following Period 2||2
158650|NCT01582308|386273|P10|NOT COMPLETED|Period 2||0
158651|NCT01582308|386274|P9|NOT COMPLETED|Period 2||0
158652|NCT01582308|386275|P8|NOT COMPLETED|Period 2||0
158653|NCT01582308|386276|P7|NOT COMPLETED|Period 2||0
158654|NCT01582308|386277|P6|NOT COMPLETED|Period 2||0
158655|NCT01582308|386278|P5|NOT COMPLETED|Period 2||0
158656|NCT01582308|386279|P4|NOT COMPLETED|Period 2||0
158657|NCT01582308|386280|P3|NOT COMPLETED|Period 2||0
158658|NCT01582308|386281|P2|NOT COMPLETED|Period 2||0
158659|NCT01582308|386282|P1|NOT COMPLETED|Period 2||0
158660|NCT01582308|386273|P10|COMPLETED|Period 2||2
158661|NCT01582308|386274|P9|COMPLETED|Period 2||2
158662|NCT01582308|386275|P8|COMPLETED|Period 2||2
158663|NCT01582308|386276|P7|COMPLETED|Period 2||2
158664|NCT01582308|386277|P6|COMPLETED|Period 2||2
158665|NCT01582308|386278|P5|COMPLETED|Period 2||2
158666|NCT01582308|386279|P4|COMPLETED|Period 2||2
158667|NCT01582308|386280|P3|COMPLETED|Period 2||2
158668|NCT01582308|386281|P2|COMPLETED|Period 2||2
158669|NCT01582308|386282|P1|COMPLETED|Period 2||2
158670|NCT01582308|386273|P10|STARTED|Period 2||2
158671|NCT01582308|386274|P9|STARTED|Period 2||2
158672|NCT01582308|386275|P8|STARTED|Period 2||2
158673|NCT01582308|386276|P7|STARTED|Period 2||2
158674|NCT01582308|386277|P6|STARTED|Period 2||2
158675|NCT01582308|386278|P5|STARTED|Period 2||2
158676|NCT01582308|386279|P4|STARTED|Period 2||2
158677|NCT01582308|386280|P3|STARTED|Period 2||2
158678|NCT01582308|386281|P2|STARTED|Period 2||2
158679|NCT01582308|386282|P1|STARTED|Period 2||2
158680|NCT01582308|386273|P10|NOT COMPLETED|10-day Washout Following Period 1||0
158681|NCT01582308|386274|P9|NOT COMPLETED|10-day Washout Following Period 1||0
158682|NCT01582308|386275|P8|NOT COMPLETED|10-day Washout Following Period 1||0
158683|NCT01582308|386276|P7|NOT COMPLETED|10-day Washout Following Period 1||0
158684|NCT01582308|386277|P6|NOT COMPLETED|10-day Washout Following Period 1||0
158685|NCT01582308|386278|P5|NOT COMPLETED|10-day Washout Following Period 1||1
158686|NCT01582308|386279|P4|NOT COMPLETED|10-day Washout Following Period 1||0
158687|NCT01582308|386280|P3|NOT COMPLETED|10-day Washout Following Period 1||0
158688|NCT01582308|386281|P2|NOT COMPLETED|10-day Washout Following Period 1||0
158689|NCT01582308|386282|P1|NOT COMPLETED|10-day Washout Following Period 1||0
158690|NCT01582308|386273|P10|COMPLETED|10-day Washout Following Period 1||2
158691|NCT01582308|386274|P9|COMPLETED|10-day Washout Following Period 1||2
158692|NCT01582308|386275|P8|COMPLETED|10-day Washout Following Period 1||2
158693|NCT01582308|386276|P7|COMPLETED|10-day Washout Following Period 1||2
158694|NCT01582308|386277|P6|COMPLETED|10-day Washout Following Period 1||2
158695|NCT01582308|386278|P5|COMPLETED|10-day Washout Following Period 1||2
158696|NCT01582308|386279|P4|COMPLETED|10-day Washout Following Period 1||2
158697|NCT01582308|386280|P3|COMPLETED|10-day Washout Following Period 1||2
158698|NCT01582308|386281|P2|COMPLETED|10-day Washout Following Period 1||2
158699|NCT01582308|386282|P1|COMPLETED|10-day Washout Following Period 1||2
158700|NCT01582308|386273|P10|STARTED|10-day Washout Following Period 1||2
158701|NCT01582308|386274|P9|STARTED|10-day Washout Following Period 1||2
158702|NCT01582308|386275|P8|STARTED|10-day Washout Following Period 1||2
158703|NCT01582308|386276|P7|STARTED|10-day Washout Following Period 1||2
158704|NCT01582308|386277|P6|STARTED|10-day Washout Following Period 1||2
158705|NCT01582308|386278|P5|STARTED|10-day Washout Following Period 1||3
158706|NCT01582308|386279|P4|STARTED|10-day Washout Following Period 1||2
158707|NCT01582308|386280|P3|STARTED|10-day Washout Following Period 1||2
158708|NCT01582308|386281|P2|STARTED|10-day Washout Following Period 1||2
158709|NCT01582308|386282|P1|STARTED|10-day Washout Following Period 1||2
158710|NCT01582308|386273|P10|NOT COMPLETED|Period 1||0
158711|NCT01582308|386274|P9|NOT COMPLETED|Period 1||0
158712|NCT01582308|386275|P8|NOT COMPLETED|Period 1||0
158713|NCT01582308|386276|P7|NOT COMPLETED|Period 1||1
158714|NCT01582308|386277|P6|NOT COMPLETED|Period 1||0
158715|NCT01582308|386278|P5|NOT COMPLETED|Period 1||0
158716|NCT01582308|386279|P4|NOT COMPLETED|Period 1||0
158717|NCT01582308|386280|P3|NOT COMPLETED|Period 1||0
158718|NCT01582308|386281|P2|NOT COMPLETED|Period 1||0
158719|NCT01582308|386282|P1|NOT COMPLETED|Period 1||0
158720|NCT01582308|386273|P10|COMPLETED|Period 1||2
158721|NCT01582308|386274|P9|COMPLETED|Period 1||2
158722|NCT01582308|386275|P8|COMPLETED|Period 1||2
158723|NCT01582308|386276|P7|COMPLETED|Period 1||2
158724|NCT01582308|386277|P6|COMPLETED|Period 1||2
158725|NCT01582308|386278|P5|COMPLETED|Period 1||3
158726|NCT01582308|386279|P4|COMPLETED|Period 1||2
158727|NCT01582308|386280|P3|COMPLETED|Period 1||2
158728|NCT01582308|386281|P2|COMPLETED|Period 1||2
158729|NCT01582308|386282|P1|COMPLETED|Period 1||2
158730|NCT01582308|386273|P10|STARTED|Period 1||2
158731|NCT01582308|386274|P9|STARTED|Period 1||2
158732|NCT01582308|386275|P8|STARTED|Period 1||2
158733|NCT01582308|386276|P7|STARTED|Period 1|Includes replacement for a participant who discontinued during period 1|3
158734|NCT01582308|386277|P6|STARTED|Period 1||2
158735|NCT01582308|386278|P5|STARTED|Period 1|Includes replacement for a participant who discontinued after period 1|3
158736|NCT01582308|386279|P4|STARTED|Period 1||2
158737|NCT01582308|386280|P3|STARTED|Period 1||2
158738|NCT01582308|386281|P2|STARTED|Period 1||2
158739|NCT01582308|386282|P1|STARTED|Period 1||2
158740|NCT01582282|386310|P3|NOT COMPLETED|Overall Study||0
158741|NCT01582282|386311|P2|NOT COMPLETED|Overall Study||2
158742|NCT01582282|386312|P1|NOT COMPLETED|Overall Study||2
158743|NCT01582282|386310|P3|COMPLETED|Overall Study||8
158744|NCT01582282|386311|P2|COMPLETED|Overall Study||12
158745|NCT01582282|386312|P1|COMPLETED|Overall Study||13
158746|NCT01582282|386310|P3|STARTED|Overall Study||8
158747|NCT01582282|386311|P2|STARTED|Overall Study||14
158748|NCT01582282|386312|P1|STARTED|Overall Study||15
158749|NCT01582243|386335|P1|NOT COMPLETED|Overall Study||3
158750|NCT01582243|386335|P1|COMPLETED|Overall Study||37
158751|NCT01582243|386335|P1|STARTED|Overall Study||40
158752|NCT01582178|386346|P2|NOT COMPLETED|Overall Study||5
158753|NCT01582178|386347|P1|NOT COMPLETED|Overall Study||6
158754|NCT01582178|386346|P2|COMPLETED|Overall Study||101
158755|NCT01582178|386347|P1|COMPLETED|Overall Study||100
158756|NCT01582178|386346|P2|STARTED|Overall Study||106
158757|NCT01582178|386347|P1|STARTED|Overall Study||106
158758|NCT01582152|386355|P2|NOT COMPLETED|Overall Study||6
158759|NCT01582152|386356|P1|NOT COMPLETED|Overall Study||6
158760|NCT01582152|386355|P2|COMPLETED|Overall Study||0
158761|NCT01582152|386356|P1|COMPLETED|Overall Study||0
158762|NCT01582152|386355|P2|STARTED|Overall Study||6
158763|NCT01582152|386356|P1|STARTED|Overall Study||6
158764|NCT01582139|386366|P2|NOT COMPLETED|Overall Study||0
158765|NCT01582139|386367|P1|NOT COMPLETED|Overall Study||0
158766|NCT01582139|386366|P2|COMPLETED|Overall Study||6
158767|NCT01582139|386367|P1|COMPLETED|Overall Study||6
158768|NCT01582139|386366|P2|STARTED|Overall Study||6
158769|NCT01582139|386367|P1|STARTED|Overall Study||6
158770|NCT01582100|386379|P1|NOT COMPLETED|Overall Study||2
158771|NCT01582100|386379|P1|COMPLETED|Overall Study||0
158772|NCT01582100|386379|P1|STARTED|Overall Study||2
158773|NCT01582061|386385|P2|NOT COMPLETED|Overall Study||36
158774|NCT01582061|386386|P1|NOT COMPLETED|Overall Study||28
158775|NCT01582061|386385|P2|COMPLETED|Overall Study||19
158776|NCT01582061|386386|P1|COMPLETED|Overall Study||21
158777|NCT01582061|386385|P2|STARTED|Overall Study||55
158778|NCT01582061|386386|P1|STARTED|Overall Study||49
158779|NCT01582009|386436|P1|NOT COMPLETED|Overall Study||2
158780|NCT01582009|386436|P1|COMPLETED|Overall Study||24
158781|NCT01582009|386436|P1|STARTED|Overall Study||26
158782|NCT01581970|386444|P1|NOT COMPLETED|Overall Study||0
158783|NCT01581970|386444|P1|COMPLETED|Overall Study||7
158784|NCT01581970|386444|P1|STARTED|Overall Study||7
158785|NCT01581931|386453|P2|NOT COMPLETED|Second Period||0
158786|NCT01581931|386454|P1|NOT COMPLETED|Second Period||0
158787|NCT01581931|386453|P2|COMPLETED|Second Period||15
158788|NCT01581931|386454|P1|COMPLETED|Second Period||16
158789|NCT01581931|386453|P2|STARTED|Second Period||15
158790|NCT01581931|386454|P1|STARTED|Second Period||16
158791|NCT01581931|386453|P2|NOT COMPLETED|Washout||1
158792|NCT01581931|386454|P1|NOT COMPLETED|Washout||0
158793|NCT01581931|386453|P2|COMPLETED|Washout||15
158794|NCT01581931|386454|P1|COMPLETED|Washout||16
158795|NCT01581931|386453|P2|STARTED|Washout||16
158796|NCT01581931|386454|P1|STARTED|Washout||16
158797|NCT01581931|386453|P2|NOT COMPLETED|First Period||0
158798|NCT01581931|386454|P1|NOT COMPLETED|First Period||0
158799|NCT01581931|386453|P2|COMPLETED|First Period||16
158800|NCT01581931|386454|P1|COMPLETED|First Period||16
158801|NCT01581931|386453|P2|STARTED|First Period||16
158802|NCT01581931|386454|P1|STARTED|First Period||16
158803|NCT01581710|386468|P2|NOT COMPLETED|Second Intervention (14days)||2
158804|NCT01581710|386469|P1|NOT COMPLETED|Second Intervention (14days)||0
158805|NCT01581710|386468|P2|COMPLETED|Second Intervention (14days)||12
158806|NCT01581710|386469|P1|COMPLETED|Second Intervention (14days)||18
158807|NCT01581710|386468|P2|STARTED|Second Intervention (14days)||14
158808|NCT01581710|386469|P1|STARTED|Second Intervention (14days)||18
158809|NCT01581710|386468|P2|NOT COMPLETED|Washout Period (14days)||0
158810|NCT01581710|386469|P1|NOT COMPLETED|Washout Period (14days)||0
158811|NCT01581710|386468|P2|COMPLETED|Washout Period (14days)||14
158812|NCT01581710|386469|P1|COMPLETED|Washout Period (14days)||18
158813|NCT01581710|386468|P2|STARTED|Washout Period (14days)||14
158814|NCT01581710|386469|P1|STARTED|Washout Period (14days)||18
158815|NCT01581710|386468|P2|NOT COMPLETED|First Intervention (14days)||0
158816|NCT01581710|386469|P1|NOT COMPLETED|First Intervention (14days)||0
158817|NCT01581710|386468|P2|COMPLETED|First Intervention (14days)||14
158818|NCT01581710|386469|P1|COMPLETED|First Intervention (14days)||18
158819|NCT01581710|386468|P2|STARTED|First Intervention (14days)||14
158820|NCT01581710|386469|P1|STARTED|First Intervention (14days)||18
158821|NCT01581684|386507|P10|NOT COMPLETED|Overall Study||0
158822|NCT01581684|386508|P9|NOT COMPLETED|Overall Study||1
158823|NCT01581684|386509|P8|NOT COMPLETED|Overall Study||0
158824|NCT01581684|386510|P7|NOT COMPLETED|Overall Study||0
158825|NCT01581684|386511|P6|NOT COMPLETED|Overall Study||0
158826|NCT01581684|386512|P5|NOT COMPLETED|Overall Study||0
158827|NCT01581684|386513|P4|NOT COMPLETED|Overall Study||0
158828|NCT01581684|386514|P3|NOT COMPLETED|Overall Study||0
158829|NCT01581684|386515|P2|NOT COMPLETED|Overall Study||0
158830|NCT01581684|386516|P1|NOT COMPLETED|Overall Study||0
158831|NCT01581684|386507|P10|COMPLETED|Overall Study||5
158832|NCT01581684|386508|P9|COMPLETED|Overall Study||0
158833|NCT01581684|386509|P8|COMPLETED|Overall Study||6
158834|NCT01581684|386510|P7|COMPLETED|Overall Study||6
158835|NCT01581684|386511|P6|COMPLETED|Overall Study||6
158836|NCT01581684|386512|P5|COMPLETED|Overall Study||6
158837|NCT01581684|386513|P4|COMPLETED|Overall Study||6
158838|NCT01581684|386514|P3|COMPLETED|Overall Study||6
158839|NCT01581684|386515|P2|COMPLETED|Overall Study||6
158840|NCT01581684|386516|P1|COMPLETED|Overall Study||14
158841|NCT01581684|386507|P10|STARTED|Overall Study||5
158842|NCT01581684|386508|P9|STARTED|Overall Study||1
158843|NCT01581684|386509|P8|STARTED|Overall Study||6
158844|NCT01581684|386510|P7|STARTED|Overall Study||6
158845|NCT01581684|386511|P6|STARTED|Overall Study||6
158846|NCT01581684|386512|P5|STARTED|Overall Study||6
158847|NCT01581684|386513|P4|STARTED|Overall Study||6
158848|NCT01581684|386514|P3|STARTED|Overall Study||6
158849|NCT01581684|386515|P2|STARTED|Overall Study||6
158850|NCT01581684|386516|P1|STARTED|Overall Study||14
158851|NCT01581658|386591|P4|NOT COMPLETED|Overall Study||0
158852|NCT01581658|386592|P3|NOT COMPLETED|Overall Study||0
158853|NCT01581658|386593|P2|NOT COMPLETED|Overall Study||0
158854|NCT01581658|386594|P1|NOT COMPLETED|Overall Study||0
158855|NCT01581658|386591|P4|COMPLETED|Overall Study||8
158856|NCT01581658|386592|P3|COMPLETED|Overall Study||8
158857|NCT01581658|386593|P2|COMPLETED|Overall Study||8
158858|NCT01581658|386594|P1|COMPLETED|Overall Study||8
158859|NCT01581658|386591|P4|STARTED|Overall Study||8
158860|NCT01581658|386592|P3|STARTED|Overall Study||8
158861|NCT01581658|386593|P2|STARTED|Overall Study||8
158862|NCT01581658|386594|P1|STARTED|Overall Study||8
158863|NCT01581619|386612|P1|NOT COMPLETED|Overall Study||2
158864|NCT01581619|386612|P1|COMPLETED|Overall Study||52
158865|NCT01581619|386612|P1|STARTED|Overall Study||54
158866|NCT01581541|386620|P11|NOT COMPLETED|Overall Study||0
158867|NCT01581541|386621|P10|NOT COMPLETED|Overall Study||0
158868|NCT01581541|386622|P9|NOT COMPLETED|Overall Study||0
158869|NCT01581541|386623|P8|NOT COMPLETED|Overall Study||0
158870|NCT01581541|386624|P7|NOT COMPLETED|Overall Study||0
158871|NCT01581541|386625|P6|NOT COMPLETED|Overall Study||0
158872|NCT01581541|386626|P5|NOT COMPLETED|Overall Study||0
158873|NCT01581541|386627|P4|NOT COMPLETED|Overall Study||0
158874|NCT01581541|386628|P3|NOT COMPLETED|Overall Study||0
158875|NCT01581541|386629|P2|NOT COMPLETED|Overall Study||0
158876|NCT01581541|386630|P1|NOT COMPLETED|Overall Study||0
158877|NCT01581541|386620|P11|COMPLETED|Overall Study||1
158878|NCT01581541|386621|P10|COMPLETED|Overall Study||3
158879|NCT01581541|386622|P9|COMPLETED|Overall Study||1
158880|NCT01581541|386623|P8|COMPLETED|Overall Study||2
158881|NCT01581541|386624|P7|COMPLETED|Overall Study||1
158882|NCT01581541|386625|P6|COMPLETED|Overall Study||3
158883|NCT01581541|386626|P5|COMPLETED|Overall Study||2
158884|NCT01581541|386627|P4|COMPLETED|Overall Study||1
158885|NCT01581541|386628|P3|COMPLETED|Overall Study||1
158886|NCT01581541|386629|P2|COMPLETED|Overall Study||1
158887|NCT01581541|386630|P1|COMPLETED|Overall Study||1
158888|NCT01581541|386620|P11|STARTED|Overall Study||1
158889|NCT01581541|386621|P10|STARTED|Overall Study||3
158890|NCT01581541|386622|P9|STARTED|Overall Study||1
158891|NCT01581541|386623|P8|STARTED|Overall Study||2
158892|NCT01581541|386624|P7|STARTED|Overall Study||1
158893|NCT01581541|386625|P6|STARTED|Overall Study||3
158894|NCT01581541|386626|P5|STARTED|Overall Study||2
158895|NCT01581541|386627|P4|STARTED|Overall Study||1
158896|NCT01581541|386628|P3|STARTED|Overall Study||1
158897|NCT01581541|386629|P2|STARTED|Overall Study||1
158898|NCT01581541|386630|P1|STARTED|Overall Study||1
158899|NCT01581437|386754|P1|NOT COMPLETED|Overall Study||0
158900|NCT01581437|386754|P1|COMPLETED|Overall Study||78
158901|NCT01581437|386754|P1|STARTED|Overall Study||78
158902|NCT01581307|386765|P1|NOT COMPLETED|Overall Study||1
158903|NCT01581307|386765|P1|COMPLETED|Overall Study||8
158904|NCT01581307|386765|P1|STARTED|Overall Study||9
158905|NCT01581281|386774|P3|NOT COMPLETED|Overall Study||12
158906|NCT01581281|386775|P2|NOT COMPLETED|Overall Study||6
158907|NCT01581281|386776|P1|NOT COMPLETED|Overall Study||15
158908|NCT01581281|386774|P3|COMPLETED|Overall Study||132
158909|NCT01581281|386775|P2|COMPLETED|Overall Study||66
158910|NCT01581281|386776|P1|COMPLETED|Overall Study||130
158911|NCT01581281|386774|P3|STARTED|Overall Study||144
158912|NCT01581281|386775|P2|STARTED|Overall Study||72
158913|NCT01581281|386776|P1|STARTED|Overall Study||145
158914|NCT01581021|386798|P2|NOT COMPLETED|Overall Study||11
158915|NCT01581021|386799|P1|NOT COMPLETED|Overall Study||10
158916|NCT01581021|386798|P2|COMPLETED|Overall Study||18
158917|NCT01581021|386799|P1|COMPLETED|Overall Study||19
158918|NCT01581021|386798|P2|STARTED|Overall Study||29
158919|NCT01581021|386799|P1|STARTED|Overall Study||29
158920|NCT01581008|386813|P2|NOT COMPLETED|Overall Study||6
158921|NCT01581008|386814|P1|NOT COMPLETED|Overall Study||1
158922|NCT01581008|386813|P2|COMPLETED|Overall Study||7
158923|NCT01581008|386814|P1|COMPLETED|Overall Study||16
158924|NCT01581008|386813|P2|STARTED|Overall Study||13
158925|NCT01581008|386814|P1|STARTED|Overall Study||17
158926|NCT01580995|386826|P2|NOT COMPLETED|Overall Study||2
158927|NCT01580995|386827|P1|NOT COMPLETED|Overall Study||2
158928|NCT01580995|386826|P2|COMPLETED|Overall Study||7
158929|NCT01580995|386827|P1|COMPLETED|Overall Study||8
158930|NCT01580995|386826|P2|STARTED|Overall Study||9
158931|NCT01580995|386827|P1|STARTED|Overall Study||10
158932|NCT01580969|386836|P3|NOT COMPLETED|Overall Study||0
158933|NCT01580969|386837|P2|NOT COMPLETED|Overall Study||0
158934|NCT01580969|386838|P1|NOT COMPLETED|Overall Study||3
158935|NCT01580969|386836|P3|COMPLETED|Overall Study||13
158936|NCT01580969|386837|P2|COMPLETED|Overall Study||3
158937|NCT01580969|386838|P1|COMPLETED|Overall Study||3
158938|NCT01580969|386836|P3|STARTED|Overall Study||13
158939|NCT01580969|386837|P2|STARTED|Overall Study||3
158940|NCT01580969|386838|P1|STARTED|Overall Study||6
158941|NCT01580904|386872|P2|NOT COMPLETED|Overall Study||7
158942|NCT01580904|386873|P1|NOT COMPLETED|Overall Study||4
158943|NCT01580904|386872|P2|COMPLETED|Overall Study||42
158944|NCT01580904|386873|P1|COMPLETED|Overall Study||47
158945|NCT01580904|386872|P2|STARTED|Overall Study||49
158946|NCT01580904|386873|P1|STARTED|Overall Study||51
158947|NCT01580670|386885|P1|NOT COMPLETED|Maintenance Period (Week 14 to 54)||2
158948|NCT01580670|386885|P1|COMPLETED|Maintenance Period (Week 14 to 54)||12
158949|NCT01580670|386885|P1|STARTED|Maintenance Period (Week 14 to 54)||14
158950|NCT01580670|386885|P1|NOT COMPLETED|Induction Period (Week 0 to 14)||0
158951|NCT01580670|386885|P1|COMPLETED|Induction Period (Week 0 to 14)||14
158952|NCT01580670|386885|P1|STARTED|Induction Period (Week 0 to 14)||14
158953|NCT01580618|386896|P2|NOT COMPLETED|Overall Study||0
158954|NCT01580618|386897|P1|NOT COMPLETED|Overall Study||1
158955|NCT01580618|386896|P2|COMPLETED|Overall Study||12
158956|NCT01580618|386897|P1|COMPLETED|Overall Study|One patient was switched from the normal saline to TNKase arm at attending physician request.|7
158957|NCT01580618|386896|P2|STARTED|Overall Study||12
158958|NCT01580618|386897|P1|STARTED|Overall Study||8
158959|NCT01580592|386913|P3|NOT COMPLETED|Overall Study||0
158960|NCT01580592|386914|P2|NOT COMPLETED|Overall Study||0
158961|NCT01580592|386915|P1|NOT COMPLETED|Overall Study||0
158962|NCT01580592|386913|P3|COMPLETED|Overall Study||12
158963|NCT01580592|386914|P2|COMPLETED|Overall Study||9
158964|NCT01580592|386915|P1|COMPLETED|Overall Study||10
158965|NCT01580592|386913|P3|STARTED|Overall Study||12
158966|NCT01580592|386914|P2|STARTED|Overall Study||9
158967|NCT01580592|386915|P1|STARTED|Overall Study||10
158968|NCT01580488|386926|P1|NOT COMPLETED|Overall Study||1
158969|NCT01580488|386926|P1|COMPLETED|Overall Study||23
158970|NCT01580488|386926|P1|STARTED|Overall Study||24
158971|NCT01580423|386970|P2|NOT COMPLETED|Second Intervention||0
158972|NCT01580423|386971|P1|NOT COMPLETED|Second Intervention||0
158973|NCT01580423|386970|P2|COMPLETED|Second Intervention||8
158974|NCT01580423|386971|P1|COMPLETED|Second Intervention||8
158975|NCT01580423|386970|P2|STARTED|Second Intervention||8
158976|NCT01580423|386971|P1|STARTED|Second Intervention||8
158977|NCT01580423|386970|P2|NOT COMPLETED|First Intervention||0
158978|NCT01580423|386971|P1|NOT COMPLETED|First Intervention||0
158979|NCT01580423|386970|P2|COMPLETED|First Intervention||8
158980|NCT01580423|386971|P1|COMPLETED|First Intervention||8
158981|NCT01580423|386970|P2|STARTED|First Intervention||8
158982|NCT01580423|386971|P1|STARTED|First Intervention||8
158983|NCT01580410|386983|P2|NOT COMPLETED|Overall Study||8
158984|NCT01580410|386984|P1|NOT COMPLETED|Overall Study||11
158985|NCT01580410|386983|P2|COMPLETED|Overall Study||60
158986|NCT01580410|386984|P1|COMPLETED|Overall Study||57
158987|NCT01580410|386983|P2|STARTED|Overall Study||68
158988|NCT01580410|386984|P1|STARTED|Overall Study||68
158989|NCT01580306|387000|P4|NOT COMPLETED|Overall Study||0
158990|NCT01580306|387001|P3|NOT COMPLETED|Overall Study||0
158991|NCT01580306|387002|P2|NOT COMPLETED|Overall Study||0
158992|NCT01580306|387003|P1|NOT COMPLETED|Overall Study||0
158993|NCT01580306|387000|P4|COMPLETED|Overall Study||8
158994|NCT01580306|387001|P3|COMPLETED|Overall Study||8
158995|NCT01580306|387002|P2|COMPLETED|Overall Study||8
158996|NCT01580306|387003|P1|COMPLETED|Overall Study||8
158997|NCT01580306|387000|P4|STARTED|Overall Study||8
158998|NCT01580306|387001|P3|STARTED|Overall Study||8
158999|NCT01580306|387002|P2|STARTED|Overall Study||8
159000|NCT01580306|387003|P1|STARTED|Overall Study||8
159001|NCT01580293|387032|P3|NOT COMPLETED|Part B||3
159002|NCT01580293|387033|P2|NOT COMPLETED|Part B||0
159003|NCT01580293|387034|P1|NOT COMPLETED|Part B||0
159004|NCT01580293|387032|P3|COMPLETED|Part B||16
159005|NCT01580293|387033|P2|COMPLETED|Part B||0
159006|NCT01580293|387034|P1|COMPLETED|Part B||0
159007|NCT01580293|387032|P3|Part B Ongoing|Part B||1
159008|NCT01580293|387033|P2|Part B Ongoing|Part B||0
159009|NCT01580293|387034|P1|Part B Ongoing|Part B||0
159010|NCT01580293|387032|P3|STARTED|Part B|11 participants were enrolled in Part B only, 8 participants switched from Part A to Part B.|19
159011|NCT01580293|387033|P2|STARTED|Part B|Time in Part A for 8 participants coming from Part A was not counted in part B.|0
159104|NCT01579565|387296|P1|STARTED|Randomized||207
159012|NCT01580293|387034|P1|STARTED|Part B|Time in Part A for 8 participants coming from Part A was not counted in part B.|0
159013|NCT01580293|387032|P3|NOT COMPLETED|Part A_Extension||0
159014|NCT01580293|387033|P2|NOT COMPLETED|Part A_Extension||75
159015|NCT01580293|387034|P1|NOT COMPLETED|Part A_Extension||9
159016|NCT01580293|387032|P3|COMPLETED|Part A_Extension||0
159017|NCT01580293|387033|P2|COMPLETED|Part A_Extension||32
159018|NCT01580293|387034|P1|COMPLETED|Part A_Extension||5
159019|NCT01580293|387032|P3|Extension Ongoing|Part A_Extension||0
159020|NCT01580293|387033|P2|Extension Ongoing|Part A_Extension||69
159021|NCT01580293|387034|P1|Extension Ongoing|Part A_Extension||9
159022|NCT01580293|387032|P3|STARTED|Part A_Extension|Participants in Part B were not counted for part A|0
159023|NCT01580293|387033|P2|STARTED|Part A_Extension|Not all participants from main trial entered extension or remained in the same arm.|107
159024|NCT01580293|387034|P1|STARTED|Part A_Extension|Not all participants from main trial entered extension or remained in the same arm.|14
159025|NCT01580293|387032|P3|NOT COMPLETED|Part A_Main Trial||0
159026|NCT01580293|387033|P2|NOT COMPLETED|Part A_Main Trial||6
159027|NCT01580293|387034|P1|NOT COMPLETED|Part A_Main Trial||2
159028|NCT01580293|387032|P3|COMPLETED|Part A_Main Trial||0
159029|NCT01580293|387033|P2|COMPLETED|Part A_Main Trial||108
159030|NCT01580293|387034|P1|COMPLETED|Part A_Main Trial||18
159031|NCT01580293|387032|P3|STARTED|Part A_Main Trial|Participants in Part B were not counted for Part A|0
159032|NCT01580293|387033|P2|STARTED|Part A_Main Trial||114
159033|NCT01580293|387034|P1|STARTED|Part A_Main Trial||20
159034|NCT01580098|387119|P3|NOT COMPLETED|Overall Study||3
159035|NCT01580098|387120|P2|NOT COMPLETED|Overall Study||13
159036|NCT01580098|387121|P1|NOT COMPLETED|Overall Study||15
159037|NCT01580098|387119|P3|COMPLETED|Overall Study|Due to high age and bad health conditions no patients finished (nursing)|0
159038|NCT01580098|387120|P2|COMPLETED|Overall Study||101
159039|NCT01580098|387121|P1|COMPLETED|Overall Study||61
159040|NCT01580098|387119|P3|STARTED|Overall Study||3
159041|NCT01580098|387120|P2|STARTED|Overall Study||114
159042|NCT01580098|387121|P1|STARTED|Overall Study||76
159043|NCT01580072|387144|P3|NOT COMPLETED|Overall Study||0
159044|NCT01580072|387145|P2|NOT COMPLETED|Overall Study||9
159045|NCT01580072|387146|P1|NOT COMPLETED|Overall Study||12
159046|NCT01580072|387144|P3|COMPLETED|Overall Study||0
159047|NCT01580072|387145|P2|COMPLETED|Overall Study||28
159048|NCT01580072|387146|P1|COMPLETED|Overall Study||16
159049|NCT01580072|387144|P3|STARTED|Overall Study||0
159050|NCT01580072|387145|P2|STARTED|Overall Study||37
159051|NCT01580072|387146|P1|STARTED|Overall Study||28
159052|NCT01580020|387174|P4|NOT COMPLETED|Overall Study||2
159053|NCT01580020|387175|P3|NOT COMPLETED|Overall Study||4
159054|NCT01580020|387176|P2|NOT COMPLETED|Overall Study||7
159055|NCT01580020|387177|P1|NOT COMPLETED|Overall Study||1
159056|NCT01580020|387174|P4|COMPLETED|Overall Study||20
159057|NCT01580020|387175|P3|COMPLETED|Overall Study||57
159058|NCT01580020|387176|P2|COMPLETED|Overall Study||33
159059|NCT01580020|387177|P1|COMPLETED|Overall Study||51
159060|NCT01580020|387174|P4|STARTED|Overall Study||22
159061|NCT01580020|387175|P3|STARTED|Overall Study||61
159062|NCT01580020|387176|P2|STARTED|Overall Study||40
159063|NCT01580020|387177|P1|STARTED|Overall Study||52
159064|NCT01579916|387221|P2|NOT COMPLETED|Overall Study||2
159065|NCT01579916|387222|P1|NOT COMPLETED|Overall Study||8
159066|NCT01579916|387221|P2|COMPLETED|Overall Study||59
159067|NCT01579916|387222|P1|COMPLETED|Overall Study||234
159068|NCT01579916|387221|P2|STARTED|Overall Study||61
159069|NCT01579916|387222|P1|STARTED|Overall Study||242
159070|NCT01579812|387248|P1|NOT COMPLETED|Overall Study||52
159071|NCT01579812|387248|P1|COMPLETED|Overall Study||38
159072|NCT01579812|387248|P1|STARTED|Overall Study||90
159073|NCT01579747|387258|P2|NOT COMPLETED|Overall Study||0
159074|NCT01579747|387259|P1|NOT COMPLETED|Overall Study||0
159075|NCT01579747|387258|P2|COMPLETED|Overall Study||12
159076|NCT01579747|387259|P1|COMPLETED|Overall Study||12
159077|NCT01579747|387258|P2|STARTED|Overall Study||12
159078|NCT01579747|387259|P1|STARTED|Overall Study||12
159079|NCT01579669|387269|P2|NOT COMPLETED|Overall Study||0
159080|NCT01579669|387270|P1|NOT COMPLETED|Overall Study||36
159081|NCT01579669|387269|P2|COMPLETED|Overall Study||41
159082|NCT01579669|387270|P1|COMPLETED|Overall Study||134
159083|NCT01579669|387269|P2|STARTED|Overall Study||41
159084|NCT01579669|387270|P1|STARTED|Overall Study||170
159085|NCT01579578|387282|P2|NOT COMPLETED|Overall Study||12
159086|NCT01579578|387283|P1|NOT COMPLETED|Overall Study||13
159087|NCT01579578|387282|P2|COMPLETED|Overall Study||0
159088|NCT01579578|387283|P1|COMPLETED|Overall Study||0
159089|NCT01579578|387282|P2|Ongoing|Overall Study||0
159090|NCT01579578|387283|P1|Ongoing|Overall Study||3
159091|NCT01579578|387282|P2|STARTED|Overall Study||12
159092|NCT01579578|387283|P1|STARTED|Overall Study||13
159093|NCT01579565|387295|P2|NOT COMPLETED|Treated||3
159094|NCT01579565|387296|P1|NOT COMPLETED|Treated||2
159095|NCT01579565|387295|P2|COMPLETED|Treated||201
159096|NCT01579565|387296|P1|COMPLETED|Treated||200
159097|NCT01579565|387295|P2|STARTED|Treated||204
159098|NCT01579565|387296|P1|STARTED|Treated||202
159099|NCT01579565|387295|P2|NOT COMPLETED|Randomized||5
159100|NCT01579565|387296|P1|NOT COMPLETED|Randomized||5
159101|NCT01579565|387295|P2|COMPLETED|Randomized||204
159102|NCT01579565|387296|P1|COMPLETED|Randomized||202
159103|NCT01579565|387295|P2|STARTED|Randomized||209
159105|NCT01579513|387326|P2|NOT COMPLETED|1 Year Neurodevelopmental Follow up||27
159106|NCT01579513|387327|P1|NOT COMPLETED|1 Year Neurodevelopmental Follow up||20
159107|NCT01579513|387326|P2|COMPLETED|1 Year Neurodevelopmental Follow up||68
159108|NCT01579513|387327|P1|COMPLETED|1 Year Neurodevelopmental Follow up||61
159109|NCT01579513|387326|P2|STARTED|1 Year Neurodevelopmental Follow up||95
159110|NCT01579513|387327|P1|STARTED|1 Year Neurodevelopmental Follow up||81
159111|NCT01579513|387326|P2|NOT COMPLETED|Primary Hospitalization||4
159112|NCT01579513|387327|P1|NOT COMPLETED|Primary Hospitalization||10
159113|NCT01579513|387326|P2|COMPLETED|Primary Hospitalization||95
159114|NCT01579513|387327|P1|COMPLETED|Primary Hospitalization||81
159115|NCT01579513|387326|P2|STARTED|Primary Hospitalization||99
159116|NCT01579513|387327|P1|STARTED|Primary Hospitalization||91
159117|NCT01579474|387345|P6|NOT COMPLETED|Overall Study||1
159118|NCT01579474|387346|P5|NOT COMPLETED|Overall Study||1
159119|NCT01579474|387347|P4|NOT COMPLETED|Overall Study||0
159120|NCT01579474|387348|P3|NOT COMPLETED|Overall Study||2
159121|NCT01579474|387349|P2|NOT COMPLETED|Overall Study||13
159122|NCT01579474|387350|P1|NOT COMPLETED|Overall Study||3
159123|NCT01579474|387345|P6|COMPLETED|Overall Study||1
159124|NCT01579474|387346|P5|COMPLETED|Overall Study||9
159125|NCT01579474|387347|P4|COMPLETED|Overall Study||3
159126|NCT01579474|387348|P3|COMPLETED|Overall Study||27
159127|NCT01579474|387349|P2|COMPLETED|Overall Study||30
159128|NCT01579474|387350|P1|COMPLETED|Overall Study||41
159129|NCT01579474|387345|P6|STARTED|Overall Study||2
159130|NCT01579474|387346|P5|STARTED|Overall Study||10
159131|NCT01579474|387347|P4|STARTED|Overall Study||3
159132|NCT01579474|387348|P3|STARTED|Overall Study||29
159133|NCT01579474|387349|P2|STARTED|Overall Study||43
159134|NCT01579474|387350|P1|STARTED|Overall Study||44
159135|NCT01579318|387424|P1|NOT COMPLETED|Overall Study||1
159136|NCT01579318|387424|P1|COMPLETED|Overall Study||1
159137|NCT01579318|387424|P1|STARTED|Overall Study||2
159138|NCT01579305|387437|P2|NOT COMPLETED|Overall Study||27
159139|NCT01579305|387438|P1|NOT COMPLETED|Overall Study||21
159140|NCT01579305|387437|P2|COMPLETED|Overall Study||115
159141|NCT01579305|387438|P1|COMPLETED|Overall Study||118
159142|NCT01579305|387437|P2|Continued After Treatment|Overall Study||141
159143|NCT01579305|387438|P1|Continued After Treatment|Overall Study||139
159144|NCT01579305|387437|P2|Discontinued Before Treatment|Overall Study||1
159145|NCT01579305|387438|P1|Discontinued Before Treatment|Overall Study||0
159146|NCT01579305|387437|P2|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|142
159147|NCT01579305|387438|P1|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|139
159148|NCT01579214|387446|P2|NOT COMPLETED|Overall Study||0
159149|NCT01579214|387447|P1|NOT COMPLETED|Overall Study||0
159150|NCT01579214|387446|P2|COMPLETED|Overall Study||138
159151|NCT01579214|387447|P1|COMPLETED|Overall Study||45
159152|NCT01579214|387446|P2|STARTED|Overall Study||138
159153|NCT01579214|387447|P1|STARTED|Overall Study||45
159154|NCT01579084|387465|P10|NOT COMPLETED|Overall Study||0
159155|NCT01579084|387466|P9|NOT COMPLETED|Overall Study||0
159156|NCT01579084|387467|P8|NOT COMPLETED|Overall Study||0
159157|NCT01579084|387468|P7|NOT COMPLETED|Overall Study||0
159158|NCT01579084|387469|P6|NOT COMPLETED|Overall Study||0
159159|NCT01579084|387470|P5|NOT COMPLETED|Overall Study||0
159160|NCT01579084|387471|P4|NOT COMPLETED|Overall Study||0
159161|NCT01579084|387472|P3|NOT COMPLETED|Overall Study||0
159162|NCT01579084|387473|P2|NOT COMPLETED|Overall Study||0
159163|NCT01579084|387474|P1|NOT COMPLETED|Overall Study||0
159164|NCT01579084|387465|P10|COMPLETED|Overall Study||4
159165|NCT01579084|387466|P9|COMPLETED|Overall Study||4
159166|NCT01579084|387467|P8|COMPLETED|Overall Study||4
159167|NCT01579084|387468|P7|COMPLETED|Overall Study||4
159168|NCT01579084|387469|P6|COMPLETED|Overall Study||8
159169|NCT01579084|387470|P5|COMPLETED|Overall Study||8
159170|NCT01579084|387471|P4|COMPLETED|Overall Study||8
159171|NCT01579084|387472|P3|COMPLETED|Overall Study||8
159172|NCT01579084|387473|P2|COMPLETED|Overall Study||8
159173|NCT01579084|387474|P1|COMPLETED|Overall Study||8
159174|NCT01579084|387465|P10|STARTED|Overall Study||4
159175|NCT01579084|387466|P9|STARTED|Overall Study||4
159176|NCT01579084|387467|P8|STARTED|Overall Study||4
159177|NCT01579084|387468|P7|STARTED|Overall Study||4
159178|NCT01579084|387469|P6|STARTED|Overall Study||8
159179|NCT01579084|387470|P5|STARTED|Overall Study||8
159180|NCT01579084|387471|P4|STARTED|Overall Study||8
159181|NCT01579084|387472|P3|STARTED|Overall Study||8
159182|NCT01579084|387473|P2|STARTED|Overall Study||8
159183|NCT01579084|387474|P1|STARTED|Overall Study||8
159184|NCT01579045|387502|P1|NOT COMPLETED|Overall Study||0
159185|NCT01579045|387502|P1|COMPLETED|Overall Study||24
159186|NCT01579045|387502|P1|STARTED|Overall Study||24
159187|NCT01579006|387519|P1|NOT COMPLETED|Overall Study||33
159188|NCT01579006|387519|P1|COMPLETED|Overall Study||151
159189|NCT01579006|387519|P1|STARTED|Overall Study||184
159190|NCT01578993|387558|P1|NOT COMPLETED|Overall Study||0
159191|NCT01578993|387558|P1|COMPLETED|Overall Study||101
159192|NCT01578993|387558|P1|STARTED|Overall Study||101
159193|NCT01578980|387562|P1|NOT COMPLETED|Overall Study||0
159194|NCT01578980|387562|P1|COMPLETED|Overall Study||20
159195|NCT01578980|387562|P1|STARTED|Overall Study||20
159196|NCT01578967|387567|P1|NOT COMPLETED|Overall Study||0
159197|NCT01578967|387567|P1|COMPLETED|Overall Study||41
159198|NCT01578967|387567|P1|STARTED|Overall Study||41
159199|NCT01578850|387578|P3|NOT COMPLETED|Period 2||14
159200|NCT01578850|387579|P2|NOT COMPLETED|Period 2||13
159201|NCT01578850|387580|P1|NOT COMPLETED|Period 2||0
159202|NCT01578850|387578|P3|COMPLETED|Period 2||162
159203|NCT01578850|387579|P2|COMPLETED|Period 2||154
159204|NCT01578850|387580|P1|COMPLETED|Period 2||0
159205|NCT01578850|387578|P3|STARTED|Period 2|One participants in PBO did not receive treatment.|176
159206|NCT01578850|387579|P2|STARTED|Period 2|Two participants in ETN did not receive treatment.|167
159207|NCT01578850|387580|P1|STARTED|Period 2||0
159208|NCT01578850|387578|P3|NOT COMPLETED|Period 1||0
159209|NCT01578850|387579|P2|NOT COMPLETED|Period 1||0
159210|NCT01578850|387580|P1|NOT COMPLETED|Period 1||37
159211|NCT01578850|387578|P3|COMPLETED|Period 1||0
159212|NCT01578850|387579|P2|COMPLETED|Period 1||0
159213|NCT01578850|387580|P1|COMPLETED|Period 1||452
159214|NCT01578850|387578|P3|STARTED|Period 1||0
159215|NCT01578850|387579|P2|STARTED|Period 1||0
159216|NCT01578850|387580|P1|STARTED|Period 1|491 participants were enrolled in open-label treatment but 2 did not receive study medication.|489
159217|NCT01578785|387632|P2|NOT COMPLETED|Overall Study||119
159218|NCT01578785|387633|P1|NOT COMPLETED|Overall Study||59
159219|NCT01578785|387632|P2|COMPLETED|Overall Study||0
159220|NCT01578785|387633|P1|COMPLETED|Overall Study||0
159221|NCT01578785|387632|P2|STARTED|Overall Study||119
159222|NCT01578785|387633|P1|STARTED|Overall Study||59
159223|NCT01578772|387645|P1|NOT COMPLETED|Overall Study||0
159224|NCT01578772|387645|P1|COMPLETED|Overall Study||17
159225|NCT01578772|387645|P1|STARTED|Overall Study||17
159226|NCT01578707|387654|P2|NOT COMPLETED|Overall Study||0
159227|NCT01578707|387655|P1|NOT COMPLETED|Overall Study||0
159228|NCT01578707|387654|P2|COMPLETED|Overall Study||195
159229|NCT01578707|387655|P1|COMPLETED|Overall Study||196
159230|NCT01578707|387654|P2|STARTED|Overall Study||195
159231|NCT01578707|387655|P1|STARTED|Overall Study||196
159232|NCT01578577|387666|P3|NOT COMPLETED|Overall Study||35
159233|NCT01578577|387667|P2|NOT COMPLETED|Overall Study||40
159234|NCT01578577|387668|P1|NOT COMPLETED|Overall Study||51
159235|NCT01578577|387666|P3|COMPLETED|Overall Study||278
159236|NCT01578577|387667|P2|COMPLETED|Overall Study||262
159237|NCT01578577|387668|P1|COMPLETED|Overall Study||254
159238|NCT01578577|387666|P3|STARTED|Overall Study||313
159239|NCT01578577|387667|P2|STARTED|Overall Study||302
159240|NCT01578577|387668|P1|STARTED|Overall Study||305
159241|NCT01578551|387690|P2|NOT COMPLETED|Overall Study||0
159242|NCT01578551|387691|P1|NOT COMPLETED|Overall Study||1
159243|NCT01578551|387690|P2|COMPLETED|Overall Study||6
159244|NCT01578551|387691|P1|COMPLETED|Overall Study||18
159245|NCT01578551|387690|P2|STARTED|Overall Study||6
159246|NCT01578551|387691|P1|STARTED|Overall Study||19
159247|NCT01578499|387703|P2|NOT COMPLETED|Overall Study||43
159248|NCT01578499|387704|P1|NOT COMPLETED|Overall Study||34
159249|NCT01578499|387703|P2|COMPLETED|Overall Study||22
159250|NCT01578499|387704|P1|COMPLETED|Overall Study||32
159251|NCT01578499|387703|P2|Intent to Treat Population: CD30+|Overall Study||64
159252|NCT01578499|387704|P1|Intent to Treat Population: CD30+|Overall Study||64
159253|NCT01578499|387703|P2|Safety Population: Treated|Overall Study||62
159254|NCT01578499|387704|P1|Safety Population: Treated|Overall Study||66
159255|NCT01578499|387703|P2|STARTED|Overall Study||65
159256|NCT01578499|387704|P1|STARTED|Overall Study||66
159257|NCT01578486|387738|P1|NOT COMPLETED|Overall Study||5
159258|NCT01578486|387738|P1|COMPLETED|Overall Study||8
159259|NCT01578486|387738|P1|STARTED|Overall Study||13
159260|NCT01578330|387749|P1|NOT COMPLETED|Overall Study||7
159261|NCT01578330|387749|P1|COMPLETED|Overall Study||35
159262|NCT01578330|387749|P1|Per Protocol Population|Overall Study||35
159263|NCT01578330|387749|P1|STARTED|Overall Study||42
159264|NCT01578317|387758|P2|NOT COMPLETED|Overall Study||1
159265|NCT01578317|387759|P1|NOT COMPLETED|Overall Study||0
159266|NCT01578317|387758|P2|COMPLETED|Overall Study||20
159267|NCT01578317|387759|P1|COMPLETED|Overall Study||22
159268|NCT01578317|387758|P2|Analysis Population|Overall Study||20
159269|NCT01578317|387759|P1|Analysis Population|Overall Study||22
159270|NCT01578317|387758|P2|STARTED|Overall Study||21
159271|NCT01578317|387759|P1|STARTED|Overall Study||22
159272|NCT01578239|387767|P2|NOT COMPLETED|Overall Study||25
159273|NCT01578239|387768|P1|NOT COMPLETED|Overall Study||22
159274|NCT01578239|387767|P2|COMPLETED|Overall Study||88
159275|NCT01578239|387768|P1|COMPLETED|Overall Study||94
159276|NCT01578239|387767|P2|STARTED|Overall Study||113
159277|NCT01578239|387768|P1|STARTED|Overall Study||116
159278|NCT01578187|387774|P1|NOT COMPLETED|Usability Phase||1
159279|NCT01578187|387774|P1|COMPLETED|Usability Phase||47
159280|NCT01578187|387774|P1|STARTED|Usability Phase||48
159281|NCT01578187|387774|P1|NOT COMPLETED|Label Comprehension Phase||0
159282|NCT01578187|387774|P1|COMPLETED|Label Comprehension Phase||63
159283|NCT01578187|387774|P1|STARTED|Label Comprehension Phase||63
159284|NCT01578044|387782|P2|NOT COMPLETED|Overall Study||0
159285|NCT01578044|387783|P1|NOT COMPLETED|Overall Study||0
159286|NCT01578044|387782|P2|COMPLETED|Overall Study||6
159287|NCT01578044|387783|P1|COMPLETED|Overall Study||6
159288|NCT01578044|387782|P2|STARTED|Overall Study||6
159289|NCT01578044|387783|P1|STARTED|Overall Study||6
159290|NCT01578031|387793|P4|NOT COMPLETED|Overall Study||0
159291|NCT01578031|387794|P3|NOT COMPLETED|Overall Study||0
159292|NCT01578031|387795|P2|NOT COMPLETED|Overall Study||34
159293|NCT01578031|387796|P1|NOT COMPLETED|Overall Study||62
159294|NCT01578031|387793|P4|COMPLETED|Overall Study|Only baseline data collected|30
159295|NCT01578031|387794|P3|COMPLETED|Overall Study|Only baseline data collected|12
159296|NCT01578031|387795|P2|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|35
159297|NCT01578031|387796|P1|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|67
159298|NCT01578031|387793|P4|STARTED|Overall Study||30
159299|NCT01578031|387794|P3|STARTED|Overall Study||12
159300|NCT01578031|387795|P2|STARTED|Overall Study||69
159301|NCT01578031|387796|P1|STARTED|Overall Study||129
159302|NCT01577966|387812|P1|NOT COMPLETED|Overall Study||0
159303|NCT01577966|387812|P1|COMPLETED|Overall Study||9
159304|NCT01577966|387812|P1|STARTED|Overall Study||9
159305|NCT01577758|387816|P8|NOT COMPLETED|mCRC Expansion Phase||25
159306|NCT01577758|387817|P7|NOT COMPLETED|mCRC Expansion Phase||0
159307|NCT01577758|387818|P6|NOT COMPLETED|mCRC Expansion Phase||0
159308|NCT01577758|387819|P5|NOT COMPLETED|mCRC Expansion Phase||0
159309|NCT01577758|387820|P4|NOT COMPLETED|mCRC Expansion Phase||0
159310|NCT01577758|387821|P3|NOT COMPLETED|mCRC Expansion Phase||0
159311|NCT01577758|387822|P2|NOT COMPLETED|mCRC Expansion Phase||0
159312|NCT01577758|387823|P1|NOT COMPLETED|mCRC Expansion Phase||0
159313|NCT01577758|387816|P8|COMPLETED|mCRC Expansion Phase||0
159314|NCT01577758|387817|P7|COMPLETED|mCRC Expansion Phase||0
159315|NCT01577758|387818|P6|COMPLETED|mCRC Expansion Phase||0
159316|NCT01577758|387819|P5|COMPLETED|mCRC Expansion Phase||0
159317|NCT01577758|387820|P4|COMPLETED|mCRC Expansion Phase||0
159318|NCT01577758|387821|P3|COMPLETED|mCRC Expansion Phase||0
159319|NCT01577758|387822|P2|COMPLETED|mCRC Expansion Phase||0
159320|NCT01577758|387823|P1|COMPLETED|mCRC Expansion Phase||0
159321|NCT01577758|387816|P8|STARTED|mCRC Expansion Phase||25
159322|NCT01577758|387817|P7|STARTED|mCRC Expansion Phase||0
159323|NCT01577758|387818|P6|STARTED|mCRC Expansion Phase||0
159324|NCT01577758|387819|P5|STARTED|mCRC Expansion Phase||0
159325|NCT01577758|387820|P4|STARTED|mCRC Expansion Phase||0
159326|NCT01577758|387821|P3|STARTED|mCRC Expansion Phase||0
159327|NCT01577758|387822|P2|STARTED|mCRC Expansion Phase||0
159328|NCT01577758|387823|P1|STARTED|mCRC Expansion Phase||0
159329|NCT01577758|387816|P8|NOT COMPLETED|Dose Escalation Phase||0
159330|NCT01577758|387817|P7|NOT COMPLETED|Dose Escalation Phase||1
159331|NCT01577758|387818|P6|NOT COMPLETED|Dose Escalation Phase||4
159332|NCT01577758|387819|P5|NOT COMPLETED|Dose Escalation Phase||6
159333|NCT01577758|387820|P4|NOT COMPLETED|Dose Escalation Phase||2
159334|NCT01577758|387821|P3|NOT COMPLETED|Dose Escalation Phase||2
159335|NCT01577758|387822|P2|NOT COMPLETED|Dose Escalation Phase||2
159336|NCT01577758|387823|P1|NOT COMPLETED|Dose Escalation Phase||2
159337|NCT01577758|387816|P8|COMPLETED|Dose Escalation Phase||0
159338|NCT01577758|387817|P7|COMPLETED|Dose Escalation Phase||0
159339|NCT01577758|387818|P6|COMPLETED|Dose Escalation Phase||0
159340|NCT01577758|387819|P5|COMPLETED|Dose Escalation Phase||0
159341|NCT01577758|387820|P4|COMPLETED|Dose Escalation Phase||0
159342|NCT01577758|387821|P3|COMPLETED|Dose Escalation Phase||0
159343|NCT01577758|387822|P2|COMPLETED|Dose Escalation Phase||0
159344|NCT01577758|387823|P1|COMPLETED|Dose Escalation Phase||0
159345|NCT01577758|387816|P8|STARTED|Dose Escalation Phase||0
159346|NCT01577758|387817|P7|STARTED|Dose Escalation Phase||1
159347|NCT01577758|387818|P6|STARTED|Dose Escalation Phase||4
159348|NCT01577758|387819|P5|STARTED|Dose Escalation Phase||6
159349|NCT01577758|387820|P4|STARTED|Dose Escalation Phase||2
159350|NCT01577758|387821|P3|STARTED|Dose Escalation Phase||2
159351|NCT01577758|387822|P2|STARTED|Dose Escalation Phase||2
159352|NCT01577758|387823|P1|STARTED|Dose Escalation Phase||2
159353|NCT01577745|387862|P6|NOT COMPLETED|Overall Study||4
159354|NCT01577745|387863|P5|NOT COMPLETED|Overall Study||5
159355|NCT01577745|387864|P4|NOT COMPLETED|Overall Study||6
159356|NCT01577745|387865|P3|NOT COMPLETED|Overall Study||2
159357|NCT01577745|387866|P2|NOT COMPLETED|Overall Study||3
159358|NCT01577745|387867|P1|NOT COMPLETED|Overall Study||3
159359|NCT01577745|387862|P6|COMPLETED|Overall Study||1
159360|NCT01577745|387863|P5|COMPLETED|Overall Study||0
159361|NCT01577745|387864|P4|COMPLETED|Overall Study||0
159362|NCT01577745|387865|P3|COMPLETED|Overall Study||1
159363|NCT01577745|387866|P2|COMPLETED|Overall Study||0
159364|NCT01577745|387867|P1|COMPLETED|Overall Study||0
159365|NCT01577745|387862|P6|STARTED|Overall Study||5
159366|NCT01577745|387863|P5|STARTED|Overall Study||5
159367|NCT01577745|387864|P4|STARTED|Overall Study||6
159368|NCT01577745|387865|P3|STARTED|Overall Study||3
159369|NCT01577745|387866|P2|STARTED|Overall Study||3
159370|NCT01577745|387867|P1|STARTED|Overall Study||3
159371|NCT01577732|387984|P1|NOT COMPLETED|Overall Study||0
159372|NCT01577732|387984|P1|COMPLETED|Overall Study||300
159373|NCT01577732|387984|P1|STARTED|Overall Study||300
159374|NCT01577706|387991|P3|NOT COMPLETED|Third Intervention (1 Day)||0
159375|NCT01577706|387992|P2|NOT COMPLETED|Third Intervention (1 Day)||0
159376|NCT01577706|387993|P1|NOT COMPLETED|Third Intervention (1 Day)||0
159377|NCT01577706|387991|P3|COMPLETED|Third Intervention (1 Day)||3
159378|NCT01577706|387992|P2|COMPLETED|Third Intervention (1 Day)||1
159379|NCT01577706|387993|P1|COMPLETED|Third Intervention (1 Day)||3
159380|NCT01577706|387991|P3|STARTED|Third Intervention (1 Day)||3
159381|NCT01577706|387992|P2|STARTED|Third Intervention (1 Day)||1
159382|NCT01577706|387993|P1|STARTED|Third Intervention (1 Day)||3
159383|NCT01577706|387991|P3|NOT COMPLETED|Washout (at Least 1 Week)||0
159384|NCT01577706|387992|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
159385|NCT01577706|387993|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
159386|NCT01577706|387991|P3|COMPLETED|Washout (at Least 1 Week)||3
159387|NCT01577706|387992|P2|COMPLETED|Washout (at Least 1 Week)||1
159388|NCT01577706|387993|P1|COMPLETED|Washout (at Least 1 Week)||3
159389|NCT01577706|387991|P3|STARTED|Washout (at Least 1 Week)||3
159390|NCT01577706|387992|P2|STARTED|Washout (at Least 1 Week)||1
159391|NCT01577706|387993|P1|STARTED|Washout (at Least 1 Week)||3
159392|NCT01577706|387991|P3|NOT COMPLETED|Second Intervention (1 Day)||0
159393|NCT01577706|387992|P2|NOT COMPLETED|Second Intervention (1 Day)||0
159394|NCT01577706|387993|P1|NOT COMPLETED|Second Intervention (1 Day)||0
159395|NCT01577706|387991|P3|COMPLETED|Second Intervention (1 Day)||3
159396|NCT01577706|387992|P2|COMPLETED|Second Intervention (1 Day)||1
159397|NCT01577706|387993|P1|COMPLETED|Second Intervention (1 Day)||3
159398|NCT01577706|387991|P3|STARTED|Second Intervention (1 Day)||3
159399|NCT01577706|387992|P2|STARTED|Second Intervention (1 Day)||1
159400|NCT01577706|387993|P1|STARTED|Second Intervention (1 Day)||3
159401|NCT01577706|387991|P3|NOT COMPLETED|Washout (at Least 1 Week)||0
159402|NCT01577706|387992|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
159403|NCT01577706|387993|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
159404|NCT01577706|387991|P3|COMPLETED|Washout (at Least 1 Week)||3
159405|NCT01577706|387992|P2|COMPLETED|Washout (at Least 1 Week)||1
159406|NCT01577706|387993|P1|COMPLETED|Washout (at Least 1 Week)||3
159407|NCT01577706|387991|P3|STARTED|Washout (at Least 1 Week)||3
159408|NCT01577706|387992|P2|STARTED|Washout (at Least 1 Week)||1
159409|NCT01577706|387993|P1|STARTED|Washout (at Least 1 Week)||3
159410|NCT01577706|387991|P3|NOT COMPLETED|First Intervention (1 Day)||0
159411|NCT01577706|387992|P2|NOT COMPLETED|First Intervention (1 Day)||0
159412|NCT01577706|387993|P1|NOT COMPLETED|First Intervention (1 Day)||0
159413|NCT01577706|387991|P3|COMPLETED|First Intervention (1 Day)||3
159414|NCT01577706|387992|P2|COMPLETED|First Intervention (1 Day)||1
159415|NCT01577706|387993|P1|COMPLETED|First Intervention (1 Day)||3
159416|NCT01577706|387991|P3|STARTED|First Intervention (1 Day)||3
159417|NCT01577706|387992|P2|STARTED|First Intervention (1 Day)||1
159418|NCT01577706|387993|P1|STARTED|First Intervention (1 Day)||3
159419|NCT01577628|388021|P3|NOT COMPLETED|Overall Study||2
159420|NCT01577628|388022|P2|NOT COMPLETED|Overall Study||0
159421|NCT01577628|388023|P1|NOT COMPLETED|Overall Study||0
159422|NCT01577628|388021|P3|COMPLETED|Overall Study||0
159423|NCT01577628|388022|P2|COMPLETED|Overall Study||0
159424|NCT01577628|388023|P1|COMPLETED|Overall Study||0
159425|NCT01577628|388021|P3|STARTED|Overall Study||2
159426|NCT01577628|388022|P2|STARTED|Overall Study||0
159427|NCT01577628|388023|P1|STARTED|Overall Study||0
159428|NCT01577537|388049|P2|NOT COMPLETED|Overall Study||7
159429|NCT01577537|388050|P1|NOT COMPLETED|Overall Study||8
159430|NCT01577537|388049|P2|COMPLETED|Overall Study||116
159431|NCT01577537|388050|P1|COMPLETED|Overall Study||120
159432|NCT01577537|388049|P2|STARTED|Overall Study||123
159433|NCT01577537|388050|P1|STARTED|Overall Study||128
159434|NCT01577381|388068|P4|NOT COMPLETED|Overall Study||2
159435|NCT01577381|388069|P3|NOT COMPLETED|Overall Study||3
159436|NCT01577381|388070|P2|NOT COMPLETED|Overall Study||3
159437|NCT01577381|388071|P1|NOT COMPLETED|Overall Study||2
159438|NCT01577381|388068|P4|COMPLETED|Overall Study||0
159439|NCT01577381|388069|P3|COMPLETED|Overall Study||0
159440|NCT01577381|388070|P2|COMPLETED|Overall Study||0
159441|NCT01577381|388071|P1|COMPLETED|Overall Study||0
159442|NCT01577381|388068|P4|STARTED|Overall Study||2
159443|NCT01577381|388069|P3|STARTED|Overall Study||3
159444|NCT01577381|388070|P2|STARTED|Overall Study||3
159445|NCT01577381|388071|P1|STARTED|Overall Study||2
159446|NCT01577329|388202|P2|NOT COMPLETED|Overall Study||0
159447|NCT01577329|388203|P1|NOT COMPLETED|Overall Study||3
159448|NCT01577329|388202|P2|COMPLETED|Overall Study||22
159449|NCT01577329|388203|P1|COMPLETED|Overall Study||16
159450|NCT01577329|388202|P2|STARTED|Overall Study||22
159451|NCT01577329|388203|P1|STARTED|Overall Study||19
159452|NCT01577238|388211|P2|NOT COMPLETED|Overall Study||12
159453|NCT01577238|388212|P1|NOT COMPLETED|Overall Study||10
159454|NCT01577238|388211|P2|COMPLETED|Overall Study||111
159455|NCT01577238|388212|P1|COMPLETED|Overall Study||117
159456|NCT01577238|388211|P2|STARTED|Overall Study||123
159457|NCT01577238|388212|P1|STARTED|Overall Study||127
159458|NCT01577186|388226|P1|NOT COMPLETED|Overall Study||130
159459|NCT01577186|388226|P1|COMPLETED|Overall Study||350
159460|NCT01577186|388226|P1|STARTED|Overall Study||480
159461|NCT01577160|388234|P1|NOT COMPLETED|Overall Study||98
159462|NCT01577160|388234|P1|COMPLETED|Overall Study||255
159463|NCT01577160|388234|P1|STARTED|Overall Study||353
159464|NCT01577108|388244|P2|NOT COMPLETED|Overall Study||6
159465|NCT01577108|388245|P1|NOT COMPLETED|Overall Study||5
159466|NCT01577108|388244|P2|COMPLETED|Overall Study||50
159467|NCT01577108|388245|P1|COMPLETED|Overall Study||49
159468|NCT01577108|388244|P2|STARTED|Overall Study||56
159469|NCT01577108|388245|P1|STARTED|Overall Study||54
159470|NCT01576952|388253|P2|NOT COMPLETED|Overall Study||55
159471|NCT01576952|388254|P1|NOT COMPLETED|Overall Study||41
159472|NCT01576952|388253|P2|COMPLETED|Overall Study||33
159473|NCT01576952|388254|P1|COMPLETED|Overall Study||139
159474|NCT01576952|388253|P2|mITT Population|Overall Study||85
159475|NCT01576952|388254|P1|mITT Population|Overall Study||168
159476|NCT01576952|388253|P2|Safety Population|Overall Study||85
159477|NCT01576952|388254|P1|Safety Population|Overall Study||169
159478|NCT01576952|388253|P2|STARTED|Overall Study||88
159479|NCT01576952|388254|P1|STARTED|Overall Study||180
159480|NCT01576939|388260|P1|NOT COMPLETED|Overall Study||0
159481|NCT01576939|388260|P1|COMPLETED|Overall Study||30
159482|NCT01576939|388260|P1|STARTED|Overall Study||30
159483|NCT01576874|388270|P2|NOT COMPLETED|Overall Study||0
159484|NCT01576874|388271|P1|NOT COMPLETED|Overall Study||0
159485|NCT01576874|388270|P2|COMPLETED|Overall Study||72
159486|NCT01576874|388271|P1|COMPLETED|Overall Study||72
159487|NCT01576874|388270|P2|STARTED|Overall Study||72
159488|NCT01576874|388271|P1|STARTED|Overall Study||72
159489|NCT01576809|388281|P1|NOT COMPLETED|Overall Study||0
159490|NCT01576809|388281|P1|COMPLETED|Overall Study||51
159491|NCT01576809|388281|P1|STARTED|Overall Study||51
159492|NCT01576783|388289|P2|NOT COMPLETED|Overall Study||17
159493|NCT01576783|388290|P1|NOT COMPLETED|Overall Study||20
159494|NCT01576783|388289|P2|COMPLETED|Overall Study||171
159495|NCT01576783|388290|P1|COMPLETED|Overall Study||169
159496|NCT01576783|388289|P2|STARTED|Overall Study||188
159497|NCT01576783|388290|P1|STARTED|Overall Study||189
159498|NCT01576718|388312|P7|NOT COMPLETED|Treatment Period||30
159499|NCT01576718|388313|P6|NOT COMPLETED|Treatment Period||48
159500|NCT01576718|388314|P5|NOT COMPLETED|Treatment Period||27
159501|NCT01576718|388315|P4|NOT COMPLETED|Treatment Period||31
159502|NCT01576718|388316|P3|NOT COMPLETED|Treatment Period||20
159503|NCT01576718|388317|P2|NOT COMPLETED|Treatment Period||25
159504|NCT01576718|388318|P1|NOT COMPLETED|Treatment Period||0
159505|NCT01576718|388312|P7|COMPLETED|Treatment Period||77
159506|NCT01576718|388313|P6|COMPLETED|Treatment Period||58
159507|NCT01576718|388314|P5|COMPLETED|Treatment Period||80
159508|NCT01576718|388315|P4|COMPLETED|Treatment Period||75
159509|NCT01576718|388316|P3|COMPLETED|Treatment Period||87
159510|NCT01576718|388317|P2|COMPLETED|Treatment Period||82
159511|NCT01576718|388318|P1|COMPLETED|Treatment Period||0
159512|NCT01576718|388312|P7|Efficacy Population (Full Analysis Set)|Treatment Period||103
159513|NCT01576718|388313|P6|Efficacy Population (Full Analysis Set)|Treatment Period||105
159514|NCT01576718|388314|P5|Efficacy Population (Full Analysis Set)|Treatment Period||107
159515|NCT01576718|388315|P4|Efficacy Population (Full Analysis Set)|Treatment Period||102
159516|NCT01576718|388316|P3|Efficacy Population (Full Analysis Set)|Treatment Period||106
159517|NCT01576718|388317|P2|Efficacy Population (Full Analysis Set)|Treatment Period||107
159518|NCT01576718|388318|P1|Efficacy Population (Full Analysis Set)|Treatment Period||0
159519|NCT01576718|388312|P7|Safety Population|Treatment Period||106
159520|NCT01576718|388313|P6|Safety Population|Treatment Period||106
159521|NCT01576718|388314|P5|Safety Population|Treatment Period||107
159522|NCT01576718|388315|P4|Safety Population|Treatment Period||106
159523|NCT01576718|388316|P3|Safety Population|Treatment Period||107
159524|NCT01576718|388317|P2|Safety Population|Treatment Period||107
159525|NCT01576718|388318|P1|Safety Population|Treatment Period||0
159526|NCT01576718|388312|P7|STARTED|Treatment Period||107
159527|NCT01576718|388313|P6|STARTED|Treatment Period||106
159528|NCT01576718|388314|P5|STARTED|Treatment Period||107
159529|NCT01576718|388315|P4|STARTED|Treatment Period||106
159530|NCT01576718|388316|P3|STARTED|Treatment Period||107
159531|NCT01576718|388317|P2|STARTED|Treatment Period||107
159532|NCT01576718|388318|P1|STARTED|Treatment Period||0
159533|NCT01576718|388312|P7|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
159534|NCT01576718|388313|P6|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
159535|NCT01576718|388314|P5|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
159536|NCT01576718|388315|P4|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
159537|NCT01576718|388316|P3|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
159538|NCT01576718|388317|P2|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
159539|NCT01576718|388318|P1|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||249
159540|NCT01576718|388312|P7|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
159541|NCT01576718|388313|P6|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
159542|NCT01576718|388314|P5|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
159543|NCT01576718|388315|P4|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
159544|NCT01576718|388316|P3|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
159545|NCT01576718|388317|P2|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
159546|NCT01576718|388318|P1|COMPLETED|Pre-Assignment Period (Run-In Placebo)|Participants randomized into the Treatment Period|640
159547|NCT01576718|388312|P7|STARTED|Pre-Assignment Period (Run-In Placebo)||0
159548|NCT01576718|388313|P6|STARTED|Pre-Assignment Period (Run-In Placebo)||0
159549|NCT01576718|388314|P5|STARTED|Pre-Assignment Period (Run-In Placebo)||0
159550|NCT01576718|388315|P4|STARTED|Pre-Assignment Period (Run-In Placebo)||0
159551|NCT01576718|388316|P3|STARTED|Pre-Assignment Period (Run-In Placebo)||0
159552|NCT01576718|388317|P2|STARTED|Pre-Assignment Period (Run-In Placebo)||0
159553|NCT01576718|388318|P1|STARTED|Pre-Assignment Period (Run-In Placebo)||889
159554|NCT01576549|388410|P1|NOT COMPLETED|Overall Study||2
159555|NCT01576549|388410|P1|COMPLETED|Overall Study||0
159556|NCT01576549|388410|P1|Completed Post-Treatment Follow-Up|Overall Study|Each participant discontinued dosing and completed the Post-Treatment Follow-Up Period.|2
159557|NCT01576549|388410|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
159558|NCT01576549|388410|P1|STARTED|Overall Study||2
159559|NCT01576536|388418|P1|NOT COMPLETED|Overall Study||0
159560|NCT01576536|388418|P1|COMPLETED|Overall Study||117
159561|NCT01576536|388418|P1|STARTED|Overall Study||117
159562|NCT01576471|388426|P2|NOT COMPLETED|Overall Study||9
159563|NCT01576471|388427|P1|NOT COMPLETED|Overall Study||8
159564|NCT01576471|388426|P2|COMPLETED|Overall Study||116
159565|NCT01576471|388427|P1|COMPLETED|Overall Study||117
159566|NCT01576471|388426|P2|STARTED|Overall Study||125
159567|NCT01576471|388427|P1|STARTED|Overall Study||125
159568|NCT01576406|388439|P6|NOT COMPLETED|Overall Study||12
159569|NCT01576406|388440|P5|NOT COMPLETED|Overall Study||8
159570|NCT01576406|388441|P4|NOT COMPLETED|Overall Study||9
159571|NCT01576406|388442|P3|NOT COMPLETED|Overall Study||16
159572|NCT01576406|388443|P2|NOT COMPLETED|Overall Study||8
159573|NCT01576406|388444|P1|NOT COMPLETED|Overall Study||6
159574|NCT01576406|388439|P6|COMPLETED|Overall Study||4
159575|NCT01576406|388440|P5|COMPLETED|Overall Study||8
159576|NCT01576406|388441|P4|COMPLETED|Overall Study||1
159577|NCT01576406|388442|P3|COMPLETED|Overall Study||4
159578|NCT01576406|388443|P2|COMPLETED|Overall Study||7
159579|NCT01576406|388444|P1|COMPLETED|Overall Study||5
159580|NCT01576406|388439|P6|STARTED|Overall Study||16
159581|NCT01576406|388440|P5|STARTED|Overall Study||16
159582|NCT01576406|388441|P4|STARTED|Overall Study||10
159583|NCT01576406|388442|P3|STARTED|Overall Study||20
159584|NCT01576406|388443|P2|STARTED|Overall Study||15
159585|NCT01576406|388444|P1|STARTED|Overall Study||11
159586|NCT01576367|388692|P1|NOT COMPLETED|Overall Study||3
159587|NCT01576367|388692|P1|COMPLETED|Overall Study||14
159588|NCT01576367|388692|P1|STARTED|Overall Study||17
159589|NCT01576341|388700|P1|NOT COMPLETED|Overall Study||93
159590|NCT01576341|388700|P1|COMPLETED|Overall Study||324
159591|NCT01576341|388700|P1|STARTED|Overall Study||417
159592|NCT01576276|388709|P2|NOT COMPLETED|Overall Study||11
159593|NCT01576276|388710|P1|NOT COMPLETED|Overall Study||8
159594|NCT01576276|388709|P2|COMPLETED|Overall Study||18
159595|NCT01576276|388710|P1|COMPLETED|Overall Study||14
159596|NCT01576276|388709|P2|STARTED|Overall Study||29
159597|NCT01576276|388710|P1|STARTED|Overall Study||22
159598|NCT01576159|388721|P4|NOT COMPLETED|Overall Study||1
159599|NCT01576159|388722|P3|NOT COMPLETED|Overall Study||1
159600|NCT01576159|388723|P2|NOT COMPLETED|Overall Study||1
159601|NCT01576159|388724|P1|NOT COMPLETED|Overall Study||1
159602|NCT01576159|388721|P4|COMPLETED|Overall Study||11
159603|NCT01576159|388722|P3|COMPLETED|Overall Study||11
159604|NCT01576159|388723|P2|COMPLETED|Overall Study||11
159605|NCT01576159|388724|P1|COMPLETED|Overall Study||11
159606|NCT01576159|388721|P4|STARTED|Overall Study||12
159607|NCT01576159|388722|P3|STARTED|Overall Study||12
159608|NCT01576159|388723|P2|STARTED|Overall Study||12
159609|NCT01576159|388724|P1|STARTED|Overall Study||12
159610|NCT01576146|388742|P1|NOT COMPLETED|Extension Period 2||17
159611|NCT01576146|388742|P1|COMPLETED|Extension Period 2||0
159612|NCT01576146|388742|P1|STARTED|Extension Period 2|Three participants who completed Extension Period 1 did not enroll in Period 2|17
159613|NCT01576146|388742|P1|NOT COMPLETED|Extension Period 1||10
159614|NCT01576146|388742|P1|COMPLETED|Extension Period 1||20
159615|NCT01576146|388742|P1|STARTED|Extension Period 1||30
159616|NCT01576120|388751|P2|NOT COMPLETED|Overall Study||0
159617|NCT01576120|388752|P1|NOT COMPLETED|Overall Study||0
159618|NCT01576120|388751|P2|COMPLETED|Overall Study||19
159619|NCT01576120|388752|P1|COMPLETED|Overall Study||21
159620|NCT01576120|388751|P2|STARTED|Overall Study||19
159621|NCT01576120|388752|P1|STARTED|Overall Study||21
159622|NCT01576055|388760|P2|NOT COMPLETED|Overall Study||6
159623|NCT01576055|388761|P1|NOT COMPLETED|Overall Study||19
159624|NCT01576055|388760|P2|COMPLETED|Overall Study||64
159625|NCT01576055|388761|P1|COMPLETED|Overall Study||178
159626|NCT01576055|388760|P2|STARTED|Overall Study||70
159627|NCT01576055|388761|P1|STARTED|Overall Study||197
159628|NCT01576042|388775|P2|NOT COMPLETED|Overall Study||0
159629|NCT01576042|388776|P1|NOT COMPLETED|Overall Study||2
159630|NCT01576042|388775|P2|COMPLETED|Overall Study||14
159631|NCT01576042|388776|P1|COMPLETED|Overall Study||11
159632|NCT01576042|388775|P2|Switched to the Other Arm|Overall Study||1
159633|NCT01576042|388776|P1|Switched to the Other Arm|Overall Study||5
159634|NCT01576042|388775|P2|STARTED|Overall Study||14
159635|NCT01576042|388776|P1|STARTED|Overall Study||13
159636|NCT01575912|388799|P3|NOT COMPLETED|Overall Study||0
159637|NCT01575912|388800|P2|NOT COMPLETED|Overall Study||0
159638|NCT01575912|388801|P1|NOT COMPLETED|Overall Study||0
159639|NCT01575912|388799|P3|COMPLETED|Overall Study||30
159640|NCT01575912|388800|P2|COMPLETED|Overall Study||32
159641|NCT01575912|388801|P1|COMPLETED|Overall Study||30
159642|NCT01575912|388799|P3|STARTED|Overall Study||30
159643|NCT01575912|388800|P2|STARTED|Overall Study||32
159644|NCT01575912|388801|P1|STARTED|Overall Study||30
159645|NCT01575899|388812|P3|NOT COMPLETED|Overall Study||2
159646|NCT01575899|388813|P2|NOT COMPLETED|Overall Study||5
159647|NCT01575899|388814|P1|NOT COMPLETED|Overall Study||5
159648|NCT01575899|388812|P3|COMPLETED|Overall Study||60
159649|NCT01575899|388813|P2|COMPLETED|Overall Study||68
159650|NCT01575899|388814|P1|COMPLETED|Overall Study||68
159651|NCT01575899|388812|P3|STARTED|Overall Study|Included patients still with Hp infection after previous therapy without levofloxacin and Augmentin.|62
159652|NCT01575899|388813|P2|STARTED|Overall Study||73
159653|NCT01575899|388814|P1|STARTED|Overall Study||73
159654|NCT01575873|388828|P4|NOT COMPLETED|Overall Study||67
159655|NCT01575873|388829|P3|NOT COMPLETED|Overall Study||74
159656|NCT01575873|388830|P2|NOT COMPLETED|Overall Study||36
159657|NCT01575873|388831|P1|NOT COMPLETED|Overall Study||28
159658|NCT01575873|388828|P4|COMPLETED|Overall Study||186
159659|NCT01575873|388829|P3|COMPLETED|Overall Study||178
159660|NCT01575873|388830|P2|COMPLETED|Overall Study||109
159661|NCT01575873|388831|P1|COMPLETED|Overall Study||117
159662|NCT01575873|388828|P4|Received Study Drug|Overall Study|Participants who received subcutaneous denosumab|251
159663|NCT01575873|388829|P3|Received Study Drug|Overall Study|Participants who received oral risedronate|246
159664|NCT01575873|388830|P2|Received Study Drug|Overall Study|Participants who received subcutaneous denosumab|142
159665|NCT01575873|388831|P1|Received Study Drug|Overall Study|Participants who received oral risedronate|140
159666|NCT01575873|388828|P4|STARTED|Overall Study||253
159667|NCT01575873|388829|P3|STARTED|Overall Study||252
159668|NCT01575873|388830|P2|STARTED|Overall Study||145
159669|NCT01575873|388831|P1|STARTED|Overall Study||145
159670|NCT01575834|388857|P2|NOT COMPLETED|Overall Study||738
159671|NCT01575834|388858|P1|NOT COMPLETED|Overall Study||699
159672|NCT01575834|388857|P2|COMPLETED|Overall Study|Completed 36-month study period|2851
159673|NCT01575834|388858|P1|COMPLETED|Overall Study|Completed 36-month study period|2892
159674|NCT01575834|388857|P2|Completed 24-month Study Period|Overall Study||2994
159675|NCT01575834|388858|P1|Completed 24-month Study Period|Overall Study||3032
159676|NCT01575834|388857|P2|Completed Double-blind Period|Overall Study||3185
159677|NCT01575834|388858|P1|Completed Double-blind Period|Overall Study||3205
159678|NCT01575834|388857|P2|Received Double-blind Treatment|Overall Study||3575
159679|NCT01575834|388858|P1|Received Double-blind Treatment|Overall Study|Six participants received a dose of romosozumab in error during the double-blind period.|3582
159680|NCT01575834|388857|P2|STARTED|Overall Study||3589
159681|NCT01575834|388858|P1|STARTED|Overall Study||3591
159682|NCT01575808|388910|P2|NOT COMPLETED|Overall Study||0
159683|NCT01575808|388911|P1|NOT COMPLETED|Overall Study||3
159684|NCT01575808|388910|P2|COMPLETED|Overall Study||68
159685|NCT01575808|388911|P1|COMPLETED|Overall Study|Study ongoing. All 103 assessed for primary invasiveness endpoints,100 for primary efficacy endpoint|100
159686|NCT01575808|388910|P2|STARTED|Overall Study||68
159687|NCT01575808|388911|P1|STARTED|Overall Study||103
159688|NCT01575769|388958|P1|NOT COMPLETED|Overall Study||41
159689|NCT01575769|388958|P1|COMPLETED|Overall Study||0
159690|NCT01575769|388958|P1|STARTED|Overall Study||41
159691|NCT01575756|388984|P2|NOT COMPLETED|Treatment Period 2||0
159692|NCT01575756|388985|P1|NOT COMPLETED|Treatment Period 2||0
159693|NCT01575756|388984|P2|COMPLETED|Treatment Period 2||11
159694|NCT01575756|388985|P1|COMPLETED|Treatment Period 2||11
159695|NCT01575756|388984|P2|STARTED|Treatment Period 2||11
159696|NCT01575756|388985|P1|STARTED|Treatment Period 2||11
159697|NCT01575756|388984|P2|NOT COMPLETED|Treatment Period 1||0
159698|NCT01575756|388985|P1|NOT COMPLETED|Treatment Period 1||0
159699|NCT01575756|388984|P2|COMPLETED|Treatment Period 1||11
159700|NCT01575756|388985|P1|COMPLETED|Treatment Period 1||11
159701|NCT01575756|388984|P2|STARTED|Treatment Period 1||11
159702|NCT01575756|388985|P1|STARTED|Treatment Period 1||11
159703|NCT01575561|389016|P1|NOT COMPLETED|Overall Study||39
159704|NCT01575561|389016|P1|COMPLETED|Overall Study||338
159705|NCT01575561|389016|P1|STARTED|Overall Study||377
159706|NCT01575522|389028|P1|NOT COMPLETED|Overall Study||0
159707|NCT01575522|389028|P1|COMPLETED|Overall Study||22
159708|NCT01575522|389028|P1|STARTED|Overall Study||22
159709|NCT01575275|389036|P1|NOT COMPLETED|Overall Study||0
159710|NCT01575275|389036|P1|COMPLETED|Overall Study||8
159711|NCT01575275|389036|P1|STARTED|Overall Study||8
159712|NCT01575197|389046|P3|NOT COMPLETED|Overall Study||6
159713|NCT01575197|389047|P2|NOT COMPLETED|Overall Study||9
159714|NCT01575197|389048|P1|NOT COMPLETED|Overall Study||3
159715|NCT01575197|389046|P3|COMPLETED|Overall Study||146
159716|NCT01575197|389047|P2|COMPLETED|Overall Study||143
159717|NCT01575197|389048|P1|COMPLETED|Overall Study||149
159718|NCT01575197|389046|P3|STARTED|Overall Study||152
159719|NCT01575197|389047|P2|STARTED|Overall Study||152
159720|NCT01575197|389048|P1|STARTED|Overall Study||152
159721|NCT01575106|389061|P1|NOT COMPLETED|Overall Study||14
159722|NCT01575106|389061|P1|COMPLETED|Overall Study||24
159723|NCT01575106|389061|P1|STARTED|Overall Study||38
159724|NCT01575080|389067|P1|NOT COMPLETED|Overall Study||0
159725|NCT01575080|389067|P1|COMPLETED|Overall Study||102
159726|NCT01575080|389067|P1|STARTED|Overall Study||102
159727|NCT01575054|389076|P2|NOT COMPLETED|Overall Study||26
159728|NCT01575054|389077|P1|NOT COMPLETED|Overall Study||29
159729|NCT01575054|389076|P2|COMPLETED|Overall Study||209
159730|NCT01575054|389077|P1|COMPLETED|Overall Study||204
159731|NCT01575054|389076|P2|STARTED|Overall Study||235
159732|NCT01575054|389077|P1|STARTED|Overall Study||233
159733|NCT01575028|389093|P2|NOT COMPLETED|Overall Study||1
159734|NCT01575028|389094|P1|NOT COMPLETED|Overall Study||0
159735|NCT01575028|389093|P2|COMPLETED|Overall Study||0
159736|NCT01575028|389094|P1|COMPLETED|Overall Study||2
159737|NCT01575028|389093|P2|STARTED|Overall Study||1
159738|NCT01575028|389094|P1|STARTED|Overall Study||2
159739|NCT01574716|389105|P5|NOT COMPLETED|Part 2||70
159740|NCT01574716|389106|P4|NOT COMPLETED|Part 2||137
159741|NCT01574716|389107|P3|NOT COMPLETED|Part 2||0
159742|NCT01574716|389108|P2|NOT COMPLETED|Part 2||0
159743|NCT01574716|389109|P1|NOT COMPLETED|Part 2||0
159744|NCT01574716|389105|P5|COMPLETED|Part 2||0
159745|NCT01574716|389106|P4|COMPLETED|Part 2||2
159746|NCT01574716|389107|P3|COMPLETED|Part 2||0
159747|NCT01574716|389108|P2|COMPLETED|Part 2||0
159748|NCT01574716|389109|P1|COMPLETED|Part 2||0
159749|NCT01574716|389105|P5|Treated Participants|Part 2||67
159750|NCT01574716|389106|P4|Treated Participants|Part 2||140
159751|NCT01574716|389107|P3|Treated Participants|Part 2||0
159752|NCT01574716|389108|P2|Treated Participants|Part 2||0
159753|NCT01574716|389109|P1|Treated Participants|Part 2||0
159754|NCT01574716|389105|P5|STARTED|Part 2||70
159755|NCT01574716|389106|P4|STARTED|Part 2||139
159756|NCT01574716|389107|P3|STARTED|Part 2||0
159757|NCT01574716|389108|P2|STARTED|Part 2||0
159758|NCT01574716|389109|P1|STARTED|Part 2||0
159759|NCT01574716|389105|P5|NOT COMPLETED|Part 1||0
159760|NCT01574716|389106|P4|NOT COMPLETED|Part 1||0
159761|NCT01574716|389107|P3|NOT COMPLETED|Part 1||9
159762|NCT01574716|389108|P2|NOT COMPLETED|Part 1||4
159763|NCT01574716|389109|P1|NOT COMPLETED|Part 1||3
159764|NCT01574716|389105|P5|COMPLETED|Part 1||0
159765|NCT01574716|389106|P4|COMPLETED|Part 1||0
159766|NCT01574716|389107|P3|COMPLETED|Part 1||0
159767|NCT01574716|389108|P2|COMPLETED|Part 1||0
159768|NCT01574716|389109|P1|COMPLETED|Part 1||0
159769|NCT01574716|389105|P5|STARTED|Part 1||0
159770|NCT01574716|389106|P4|STARTED|Part 1||0
159771|NCT01574716|389107|P3|STARTED|Part 1||9
159772|NCT01574716|389108|P2|STARTED|Part 1||4
159773|NCT01574716|389109|P1|STARTED|Part 1||3
159774|NCT01574703|389132|P4|NOT COMPLETED|Overall Study||114
159775|NCT01574703|389133|P3|NOT COMPLETED|Overall Study||105
159776|NCT01574703|389134|P2|NOT COMPLETED|Overall Study||112
159777|NCT01574703|389135|P1|NOT COMPLETED|Overall Study||125
159778|NCT01574703|389132|P4|COMPLETED|Overall Study||1007
159779|NCT01574703|389133|P3|COMPLETED|Overall Study||1011
159780|NCT01574703|389134|P2|COMPLETED|Overall Study||1054
159781|NCT01574703|389135|P1|COMPLETED|Overall Study||1067
159782|NCT01574703|389132|P4|STARTED|Overall Study||1121
159783|NCT01574703|389133|P3|STARTED|Overall Study||1116
159784|NCT01574703|389134|P2|STARTED|Overall Study||1166
159785|NCT01574703|389135|P1|STARTED|Overall Study||1192
159786|NCT01574651|389179|P2|NOT COMPLETED|Overall Study||52
159787|NCT01574651|389180|P1|NOT COMPLETED|Overall Study||61
159788|NCT01574651|389179|P2|COMPLETED|Overall Study||406
159789|NCT01574651|389180|P1|COMPLETED|Overall Study||415
159790|NCT01574651|389179|P2|Per Protocol Set (PPS)|Overall Study||374
159791|NCT01574651|389180|P1|Per Protocol Set (PPS)|Overall Study||373
159792|NCT01574651|389179|P2|Full Analysis Set (FAS)|Overall Study||458
159793|NCT01574651|389180|P1|Full Analysis Set (FAS)|Overall Study||476
159794|NCT01574651|389179|P2|STARTED|Overall Study||458
159795|NCT01574651|389180|P1|STARTED|Overall Study||476
159796|NCT01574612|389202|P1|NOT COMPLETED|Overall Study||8
159797|NCT01574612|389202|P1|COMPLETED|Overall Study||46
159798|NCT01574612|389202|P1|STARTED|Overall Study|patients who were identified as having the appropriate medical history of herpes labialis|54
159799|NCT01574326|389208|P2|NOT COMPLETED|Overall Study||19
159800|NCT01574326|389209|P1|NOT COMPLETED|Overall Study||16
159801|NCT01574326|389208|P2|COMPLETED|Overall Study||31
159802|NCT01574326|389209|P1|COMPLETED|Overall Study||35
159803|NCT01574326|389208|P2|Treated|Overall Study||49
159804|NCT01574326|389209|P1|Treated|Overall Study||51
159805|NCT01574326|389208|P2|STARTED|Overall Study||50
159806|NCT01574326|389209|P1|STARTED|Overall Study||51
159807|NCT01574287|389220|P1|NOT COMPLETED|Overall Study||0
159808|NCT01574287|389220|P1|COMPLETED|Overall Study||4
159809|NCT01574287|389220|P1|STARTED|Overall Study||4
159810|NCT01574248|389227|P2|NOT COMPLETED|Overall Study||0
159811|NCT01574248|389228|P1|NOT COMPLETED|Overall Study||3
159812|NCT01574248|389227|P2|COMPLETED|Overall Study||18
159813|NCT01574248|389228|P1|COMPLETED|Overall Study||12
159814|NCT01574248|389227|P2|STARTED|Overall Study||18
159815|NCT01574248|389228|P1|STARTED|Overall Study||15
159816|NCT01574183|389248|P2|NOT COMPLETED|Overall Study||18
159817|NCT01574183|389249|P1|NOT COMPLETED|Overall Study||27
159818|NCT01574183|389248|P2|COMPLETED|Overall Study||17
159819|NCT01574183|389249|P1|COMPLETED|Overall Study||14
159820|NCT01574183|389248|P2|STARTED|Overall Study||35
159821|NCT01574183|389249|P1|STARTED|Overall Study||41
159822|NCT01574157|389261|P2|NOT COMPLETED|Overall Study||8
159823|NCT01574157|389262|P1|NOT COMPLETED|Overall Study||4
159824|NCT01574157|389261|P2|COMPLETED|Overall Study||31
159825|NCT01574157|389262|P1|COMPLETED|Overall Study||31
159826|NCT01574157|389261|P2|Month 3|Overall Study||33
159827|NCT01574157|389262|P1|Month 3|Overall Study||31
159828|NCT01574157|389261|P2|STARTED|Overall Study||39
159829|NCT01574157|389262|P1|STARTED|Overall Study||35
159830|NCT01574144|389278|P1|NOT COMPLETED|Overall Study||0
159831|NCT01574144|389278|P1|COMPLETED|Overall Study||70
159832|NCT01574144|389278|P1|STARTED|Overall Study||70
159833|NCT01574105|389285|P2|NOT COMPLETED|Overall Study||0
159834|NCT01574105|389286|P1|NOT COMPLETED|Overall Study||0
159835|NCT01574105|389285|P2|COMPLETED|Overall Study||37
159836|NCT01574105|389286|P1|COMPLETED|Overall Study||29
159837|NCT01574105|389285|P2|STARTED|Overall Study||37
159838|NCT01574105|389286|P1|STARTED|Overall Study||29
159839|NCT01574079|389296|P2|NOT COMPLETED|Overall Study||2
159840|NCT01574079|389297|P1|NOT COMPLETED|Overall Study||1
159841|NCT01574079|389296|P2|COMPLETED|Overall Study||13
159842|NCT01574079|389297|P1|COMPLETED|Overall Study||17
159843|NCT01574079|389296|P2|STARTED|Overall Study||15
159844|NCT01574079|389297|P1|STARTED|Overall Study||18
159845|NCT01573910|389309|P2|NOT COMPLETED|Overall Study||17
159846|NCT01573910|389310|P1|NOT COMPLETED|Overall Study||20
159847|NCT01573910|389309|P2|COMPLETED|Overall Study||476
159848|NCT01573910|389310|P1|COMPLETED|Overall Study||469
159849|NCT01573910|389309|P2|STARTED|Overall Study||493
159850|NCT01573910|389310|P1|STARTED|Overall Study||489
159851|NCT01573767|389322|P4|NOT COMPLETED|Overall Study||24
159852|NCT01573767|389323|P3|NOT COMPLETED|Overall Study||14
159853|NCT01573767|389324|P2|NOT COMPLETED|Overall Study||21
159854|NCT01573767|389325|P1|NOT COMPLETED|Overall Study||22
159855|NCT01573767|389322|P4|COMPLETED|Overall Study||90
159856|NCT01573767|389323|P3|COMPLETED|Overall Study||99
159857|NCT01573767|389324|P2|COMPLETED|Overall Study||93
159858|NCT01573767|389325|P1|COMPLETED|Overall Study||93
159859|NCT01573767|389322|P4|STARTED|Overall Study||114
159860|NCT01573767|389323|P3|STARTED|Overall Study||113
159861|NCT01573767|389324|P2|STARTED|Overall Study||114
159862|NCT01573767|389325|P1|STARTED|Overall Study||115
159863|NCT01573624|389359|P7|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
159864|NCT01573624|389360|P6|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
159865|NCT01573624|389361|P5|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||2
159866|NCT01573624|389362|P4|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
159867|NCT01573624|389363|P3|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
159868|NCT01573624|389364|P2|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
159869|NCT01573624|389365|P1|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
159870|NCT01573624|389359|P7|COMPLETED|Period 6 : Follow-up Period (7 Days)||48
159871|NCT01573624|389360|P6|COMPLETED|Period 6 : Follow-up Period (7 Days)||38
159872|NCT01573624|389361|P5|COMPLETED|Period 6 : Follow-up Period (7 Days)||49
159873|NCT01573624|389362|P4|COMPLETED|Period 6 : Follow-up Period (7 Days)||53
159874|NCT01573624|389363|P3|COMPLETED|Period 6 : Follow-up Period (7 Days)||43
159875|NCT01573624|389364|P2|COMPLETED|Period 6 : Follow-up Period (7 Days)||47
159876|NCT01573624|389365|P1|COMPLETED|Period 6 : Follow-up Period (7 Days)||45
159877|NCT01573624|389359|P7|STARTED|Period 6 : Follow-up Period (7 Days)||48
159878|NCT01573624|389360|P6|STARTED|Period 6 : Follow-up Period (7 Days)||39
159879|NCT01573624|389361|P5|STARTED|Period 6 : Follow-up Period (7 Days)||51
159880|NCT01573624|389362|P4|STARTED|Period 6 : Follow-up Period (7 Days)||53
159881|NCT01573624|389363|P3|STARTED|Period 6 : Follow-up Period (7 Days)||43
159882|NCT01573624|389364|P2|STARTED|Period 6 : Follow-up Period (7 Days)||47
159883|NCT01573624|389365|P1|STARTED|Period 6 : Follow-up Period (7 Days)||46
159884|NCT01573624|389359|P7|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||4
159885|NCT01573624|389360|P6|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||2
159886|NCT01573624|389361|P5|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
159887|NCT01573624|389362|P4|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
159888|NCT01573624|389363|P3|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
159889|NCT01573624|389364|P2|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
159890|NCT01573624|389365|P1|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||3
159891|NCT01573624|389359|P7|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||48
159892|NCT01573624|389360|P6|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||39
159893|NCT01573624|389361|P5|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||51
159894|NCT01573624|389362|P4|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||53
159895|NCT01573624|389363|P3|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||43
159896|NCT01573624|389364|P2|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||47
159897|NCT01573624|389365|P1|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||46
159898|NCT01573624|389359|P7|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
159899|NCT01573624|389360|P6|STARTED|Period 5 : Treatment Period 3 (14 Days)||41
159900|NCT01573624|389361|P5|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
159901|NCT01573624|389362|P4|STARTED|Period 5 : Treatment Period 3 (14 Days)||53
159902|NCT01573624|389363|P3|STARTED|Period 5 : Treatment Period 3 (14 Days)||43
159903|NCT01573624|389364|P2|STARTED|Period 5 : Treatment Period 3 (14 Days)||48
159904|NCT01573624|389365|P1|STARTED|Period 5 : Treatment Period 3 (14 Days)||49
159905|NCT01573624|389359|P7|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||3
159906|NCT01573624|389360|P6|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
159907|NCT01573624|389361|P5|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
159908|NCT01573624|389362|P4|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
159909|NCT01573624|389363|P3|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
159910|NCT01573624|389364|P2|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||4
159911|NCT01573624|389365|P1|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
159912|NCT01573624|389359|P7|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
159913|NCT01573624|389360|P6|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||41
159914|NCT01573624|389361|P5|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
159915|NCT01573624|389362|P4|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||53
159916|NCT01573624|389363|P3|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||43
159917|NCT01573624|389364|P2|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||48
159918|NCT01573624|389365|P1|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||49
159919|NCT01573624|389359|P7|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
159920|NCT01573624|389360|P6|STARTED|Period 4 : Washout Period 2 (12-14 Days)||43
159921|NCT01573624|389361|P5|STARTED|Period 4 : Washout Period 2 (12-14 Days)||53
159922|NCT01573624|389362|P4|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
159923|NCT01573624|389363|P3|STARTED|Period 4 : Washout Period 2 (12-14 Days)||45
159924|NCT01573624|389364|P2|STARTED|Period 4 : Washout Period 2 (12-14 Days)||52
159925|NCT01573624|389365|P1|STARTED|Period 4 : Washout Period 2 (12-14 Days)||50
159926|NCT01573624|389359|P7|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||0
159927|NCT01573624|389360|P6|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||5
159928|NCT01573624|389361|P5|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
159929|NCT01573624|389362|P4|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||1
159930|NCT01573624|389363|P3|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
159931|NCT01573624|389364|P2|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||6
159932|NCT01573624|389365|P1|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||7
159933|NCT01573624|389359|P7|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
159934|NCT01573624|389360|P6|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||43
159935|NCT01573624|389361|P5|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||53
159936|NCT01573624|389362|P4|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
159937|NCT01573624|389363|P3|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||45
159938|NCT01573624|389364|P2|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||52
159939|NCT01573624|389365|P1|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||50
159940|NCT01573624|389359|P7|STARTED|Period 3 : Treatment Period 2 (14 Days)||55
159941|NCT01573624|389360|P6|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
159942|NCT01573624|389361|P5|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
159943|NCT01573624|389362|P4|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
159944|NCT01573624|389363|P3|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
159945|NCT01573624|389364|P2|STARTED|Period 3 : Treatment Period 2 (14 Days)||58
159946|NCT01573624|389365|P1|STARTED|Period 3 : Treatment Period 2 (14 Days)||57
159947|NCT01573624|389359|P7|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||2
159948|NCT01573624|389360|P6|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
159949|NCT01573624|389361|P5|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||0
159950|NCT01573624|389362|P4|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||5
159951|NCT01573624|389363|P3|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
159952|NCT01573624|389364|P2|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
159953|NCT01573624|389365|P1|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
159954|NCT01573624|389359|P7|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||55
159955|NCT01573624|389360|P6|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
159956|NCT01573624|389361|P5|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
159957|NCT01573624|389362|P4|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
159958|NCT01573624|389363|P3|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
159959|NCT01573624|389364|P2|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||58
159960|NCT01573624|389365|P1|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||57
159961|NCT01573624|389359|P7|STARTED|Period 2 : Washout Period 1 (12-14 Days)||57
159962|NCT01573624|389360|P6|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
159963|NCT01573624|389361|P5|STARTED|Period 2 : Washout Period 1 (12-14 Days)||56
159964|NCT01573624|389362|P4|STARTED|Period 2 : Washout Period 1 (12-14 Days)||61
159965|NCT01573624|389363|P3|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
159966|NCT01573624|389364|P2|STARTED|Period 2 : Washout Period 1 (12-14 Days)||59
159967|NCT01573624|389365|P1|STARTED|Period 2 : Washout Period 1 (12-14 Days)||58
159968|NCT01573624|389359|P7|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
159969|NCT01573624|389360|P6|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||4
159970|NCT01573624|389361|P5|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
159971|NCT01573624|389362|P4|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
159972|NCT01573624|389363|P3|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||9
159973|NCT01573624|389364|P2|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||3
159974|NCT01573624|389365|P1|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||6
159975|NCT01573624|389359|P7|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||57
159976|NCT01573624|389360|P6|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
159977|NCT01573624|389361|P5|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||56
159978|NCT01573624|389362|P4|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||61
159979|NCT01573624|389363|P3|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
159980|NCT01573624|389364|P2|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||59
159981|NCT01573624|389365|P1|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||58
159982|NCT01573624|389359|P7|STARTED|Period 1 : Treatment Period 1 (14 Days)||59
159983|NCT01573624|389360|P6|STARTED|Period 1 : Treatment Period 1 (14 Days)||55
159984|NCT01573624|389361|P5|STARTED|Period 1 : Treatment Period 1 (14 Days)||58
159985|NCT01573624|389362|P4|STARTED|Period 1 : Treatment Period 1 (14 Days)||63
159986|NCT01573624|389363|P3|STARTED|Period 1 : Treatment Period 1 (14 Days)||60
159987|NCT01573624|389364|P2|STARTED|Period 1 : Treatment Period 1 (14 Days)||62
159988|NCT01573624|389365|P1|STARTED|Period 1 : Treatment Period 1 (14 Days)||64
159989|NCT01573442|389414|P2|NOT COMPLETED|Overall Study||10
159990|NCT01573442|389415|P1|NOT COMPLETED|Overall Study||9
159991|NCT01573442|389414|P2|COMPLETED|Overall Study||104
159992|NCT01573442|389415|P1|COMPLETED|Overall Study||104
159993|NCT01573442|389414|P2|STARTED|Overall Study||114
159994|NCT01573442|389415|P1|STARTED|Overall Study||113
159995|NCT01573325|389451|P1|NOT COMPLETED|Overall Study||0
159996|NCT01573325|389451|P1|COMPLETED|Overall Study||50
159997|NCT01573325|389451|P1|STARTED|Overall Study||50
159998|NCT01573273|389460|P12|NOT COMPLETED|MRI 2||0
159999|NCT01573273|389461|P11|NOT COMPLETED|MRI 2||0
160000|NCT01573273|389462|P10|NOT COMPLETED|MRI 2||0
160001|NCT01573273|389463|P9|NOT COMPLETED|MRI 2||0
160002|NCT01573273|389464|P8|NOT COMPLETED|MRI 2||0
160003|NCT01573273|389465|P7|NOT COMPLETED|MRI 2||0
160004|NCT01573273|389466|P6|NOT COMPLETED|MRI 2||0
160005|NCT01573273|389467|P5|NOT COMPLETED|MRI 2||0
160006|NCT01573273|389468|P4|NOT COMPLETED|MRI 2||0
160007|NCT01573273|389469|P3|NOT COMPLETED|MRI 2||0
160008|NCT01573273|389470|P2|NOT COMPLETED|MRI 2||0
160009|NCT01573273|389471|P1|NOT COMPLETED|MRI 2||0
160010|NCT01573273|389460|P12|COMPLETED|MRI 2||28
160011|NCT01573273|389461|P11|COMPLETED|MRI 2||27
160012|NCT01573273|389462|P10|COMPLETED|MRI 2||0
160013|NCT01573273|389463|P9|COMPLETED|MRI 2||0
160014|NCT01573273|389464|P8|COMPLETED|MRI 2||0
160015|NCT01573273|389465|P7|COMPLETED|MRI 2||0
160016|NCT01573273|389466|P6|COMPLETED|MRI 2||18
160017|NCT01573273|389467|P5|COMPLETED|MRI 2||23
160018|NCT01573273|389468|P4|COMPLETED|MRI 2||0
160019|NCT01573273|389469|P3|COMPLETED|MRI 2||0
160020|NCT01573273|389470|P2|COMPLETED|MRI 2||0
160021|NCT01573273|389471|P1|COMPLETED|MRI 2||0
160022|NCT01573273|389460|P12|STARTED|MRI 2||28
160023|NCT01573273|389461|P11|STARTED|MRI 2||27
160024|NCT01573273|389462|P10|STARTED|MRI 2||0
160025|NCT01573273|389463|P9|STARTED|MRI 2||0
160026|NCT01573273|389464|P8|STARTED|MRI 2||0
160027|NCT01573273|389465|P7|STARTED|MRI 2||0
160028|NCT01573273|389466|P6|STARTED|MRI 2||18
160029|NCT01573273|389467|P5|STARTED|MRI 2||23
160030|NCT01573273|389468|P4|STARTED|MRI 2||0
160031|NCT01573273|389469|P3|STARTED|MRI 2||0
160032|NCT01573273|389470|P2|STARTED|MRI 2||0
160033|NCT01573273|389471|P1|STARTED|MRI 2||0
160034|NCT01573273|389460|P12|NOT COMPLETED|MRI 1||0
160035|NCT01573273|389461|P11|NOT COMPLETED|MRI 1||0
160036|NCT01573273|389462|P10|NOT COMPLETED|MRI 1||0
160037|NCT01573273|389463|P9|NOT COMPLETED|MRI 1||0
160038|NCT01573273|389464|P8|NOT COMPLETED|MRI 1||0
160039|NCT01573273|389465|P7|NOT COMPLETED|MRI 1||0
160040|NCT01573273|389466|P6|NOT COMPLETED|MRI 1||0
160041|NCT01573273|389467|P5|NOT COMPLETED|MRI 1||0
160042|NCT01573273|389468|P4|NOT COMPLETED|MRI 1||0
160043|NCT01573273|389469|P3|NOT COMPLETED|MRI 1||0
160044|NCT01573273|389470|P2|NOT COMPLETED|MRI 1||0
160045|NCT01573273|389471|P1|NOT COMPLETED|MRI 1||0
160046|NCT01573273|389460|P12|COMPLETED|MRI 1||0
160047|NCT01573273|389461|P11|COMPLETED|MRI 1||0
160048|NCT01573273|389462|P10|COMPLETED|MRI 1||29
160049|NCT01573273|389463|P9|COMPLETED|MRI 1||28
160050|NCT01573273|389464|P8|COMPLETED|MRI 1||0
160051|NCT01573273|389465|P7|COMPLETED|MRI 1||0
160052|NCT01573273|389466|P6|COMPLETED|MRI 1||0
160053|NCT01573273|389467|P5|COMPLETED|MRI 1||0
160054|NCT01573273|389468|P4|COMPLETED|MRI 1||23
160055|NCT01573273|389469|P3|COMPLETED|MRI 1||19
160056|NCT01573273|389470|P2|COMPLETED|MRI 1||0
160057|NCT01573273|389471|P1|COMPLETED|MRI 1||0
160058|NCT01573273|389460|P12|STARTED|MRI 1||0
160059|NCT01573273|389461|P11|STARTED|MRI 1||0
160060|NCT01573273|389462|P10|STARTED|MRI 1||29
160061|NCT01573273|389463|P9|STARTED|MRI 1||28
160062|NCT01573273|389464|P8|STARTED|MRI 1||0
160063|NCT01573273|389465|P7|STARTED|MRI 1||0
160064|NCT01573273|389466|P6|STARTED|MRI 1||0
160065|NCT01573273|389467|P5|STARTED|MRI 1||0
160066|NCT01573273|389468|P4|STARTED|MRI 1||23
160067|NCT01573273|389469|P3|STARTED|MRI 1||19
160068|NCT01573273|389470|P2|STARTED|MRI 1||0
160069|NCT01573273|389471|P1|STARTED|MRI 1||0
160070|NCT01573273|389460|P12|NOT COMPLETED|TSST : Trier Social Stress Task||0
160071|NCT01573273|389461|P11|NOT COMPLETED|TSST : Trier Social Stress Task||0
160072|NCT01573273|389462|P10|NOT COMPLETED|TSST : Trier Social Stress Task||0
160073|NCT01573273|389463|P9|NOT COMPLETED|TSST : Trier Social Stress Task||0
160074|NCT01573273|389464|P8|NOT COMPLETED|TSST : Trier Social Stress Task||0
160075|NCT01573273|389465|P7|NOT COMPLETED|TSST : Trier Social Stress Task||0
160076|NCT01573273|389466|P6|NOT COMPLETED|TSST : Trier Social Stress Task||0
160077|NCT01573273|389467|P5|NOT COMPLETED|TSST : Trier Social Stress Task||0
160078|NCT01573273|389468|P4|NOT COMPLETED|TSST : Trier Social Stress Task||0
160079|NCT01573273|389469|P3|NOT COMPLETED|TSST : Trier Social Stress Task||0
160080|NCT01573273|389470|P2|NOT COMPLETED|TSST : Trier Social Stress Task||0
160081|NCT01573273|389471|P1|NOT COMPLETED|TSST : Trier Social Stress Task||0
160082|NCT01573273|389460|P12|COMPLETED|TSST : Trier Social Stress Task||0
160083|NCT01573273|389461|P11|COMPLETED|TSST : Trier Social Stress Task||0
160084|NCT01573273|389462|P10|COMPLETED|TSST : Trier Social Stress Task||0
160085|NCT01573273|389463|P9|COMPLETED|TSST : Trier Social Stress Task||0
160086|NCT01573273|389464|P8|COMPLETED|TSST : Trier Social Stress Task||31
160087|NCT01573273|389465|P7|COMPLETED|TSST : Trier Social Stress Task||32
160088|NCT01573273|389466|P6|COMPLETED|TSST : Trier Social Stress Task||0
160089|NCT01573273|389467|P5|COMPLETED|TSST : Trier Social Stress Task||0
160090|NCT01573273|389468|P4|COMPLETED|TSST : Trier Social Stress Task||0
160091|NCT01573273|389469|P3|COMPLETED|TSST : Trier Social Stress Task||0
160092|NCT01573273|389470|P2|COMPLETED|TSST : Trier Social Stress Task||25
160093|NCT01573273|389471|P1|COMPLETED|TSST : Trier Social Stress Task||24
160094|NCT01573273|389460|P12|STARTED|TSST : Trier Social Stress Task||0
160095|NCT01573273|389461|P11|STARTED|TSST : Trier Social Stress Task||0
160096|NCT01573273|389462|P10|STARTED|TSST : Trier Social Stress Task||0
160097|NCT01573273|389463|P9|STARTED|TSST : Trier Social Stress Task||0
160098|NCT01573273|389464|P8|STARTED|TSST : Trier Social Stress Task||31
160099|NCT01573273|389465|P7|STARTED|TSST : Trier Social Stress Task||32
160100|NCT01573273|389466|P6|STARTED|TSST : Trier Social Stress Task||0
160101|NCT01573273|389467|P5|STARTED|TSST : Trier Social Stress Task||0
160102|NCT01573273|389468|P4|STARTED|TSST : Trier Social Stress Task||0
160103|NCT01573273|389469|P3|STARTED|TSST : Trier Social Stress Task||0
160104|NCT01573273|389470|P2|STARTED|TSST : Trier Social Stress Task||25
160105|NCT01573273|389471|P1|STARTED|TSST : Trier Social Stress Task||24
160106|NCT01573260|389511|P2|NOT COMPLETED|Overall Study||0
160107|NCT01573260|389512|P1|NOT COMPLETED|Overall Study||0
160108|NCT01573260|389511|P2|COMPLETED|Overall Study||15
160109|NCT01573260|389512|P1|COMPLETED|Overall Study||18
160110|NCT01573260|389511|P2|STARTED|Overall Study||15
160111|NCT01573260|389512|P1|STARTED|Overall Study||18
160112|NCT01573000|389546|P2|NOT COMPLETED|Long-Term Follow-Up||1
160113|NCT01573000|389547|P1|NOT COMPLETED|Long-Term Follow-Up||3
160114|NCT01573000|389546|P2|COMPLETED|Long-Term Follow-Up|One participant who received crossover treatment was lost to follow up.|4
160115|NCT01573000|389547|P1|COMPLETED|Long-Term Follow-Up||11
160116|NCT01573000|389546|P2|STARTED|Long-Term Follow-Up|5 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|5
160117|NCT01573000|389547|P1|STARTED|Long-Term Follow-Up|14 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|14
160118|NCT01573000|389546|P2|NOT COMPLETED|Crossover Phase||18
160119|NCT01573000|389547|P1|NOT COMPLETED|Crossover Phase||0
160120|NCT01573000|389546|P2|COMPLETED|Crossover Phase|This participant completed 2 years of follow up and enrolled in BEX104526.|1
160121|NCT01573000|389547|P1|COMPLETED|Crossover Phase||0
160122|NCT01573000|389546|P2|STARTED|Crossover Phase|19 of 36 par. randomized to receive Unlabeled TST crossed over to receive TST and Iodine I 131 TST.|19
160123|NCT01573000|389547|P1|STARTED|Crossover Phase||0
160124|NCT01573000|389546|P2|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
160125|NCT01573000|389547|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
160126|NCT01573000|389546|P2|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|1
160127|NCT01573000|389547|P1|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|7
160128|NCT01573000|389546|P2|STARTED|Dosimetric and Therapeutic Treatment||36
160129|NCT01573000|389547|P1|STARTED|Dosimetric and Therapeutic Treatment||42
160130|NCT01572948|389643|P2|NOT COMPLETED|Overall Study||1
160131|NCT01572948|389644|P1|NOT COMPLETED|Overall Study||1
160132|NCT01572948|389643|P2|COMPLETED|Overall Study||15
160133|NCT01572948|389644|P1|COMPLETED|Overall Study||10
160134|NCT01572948|389643|P2|STARTED|Overall Study||16
160135|NCT01572948|389644|P1|STARTED|Overall Study||11
160136|NCT01572922|389660|P1|NOT COMPLETED|Overall Study||3
160137|NCT01572922|389660|P1|COMPLETED|Overall Study||139
160138|NCT01572922|389660|P1|STARTED|Overall Study||142
160139|NCT01572844|389670|P2|NOT COMPLETED|Overall Study||1
160140|NCT01572844|389671|P1|NOT COMPLETED|Overall Study||1
160141|NCT01572844|389670|P2|COMPLETED|Overall Study||2
160142|NCT01572844|389671|P1|COMPLETED|Overall Study||2
160143|NCT01572844|389670|P2|STARTED|Overall Study||3
160144|NCT01572844|389671|P1|STARTED|Overall Study||3
160145|NCT01572792|389689|P5|NOT COMPLETED|Extension Study||32
160146|NCT01572792|389690|P4|NOT COMPLETED|Extension Study||29
160147|NCT01572792|389691|P3|NOT COMPLETED|Extension Study||26
160148|NCT01572792|389692|P2|NOT COMPLETED|Extension Study||29
160149|NCT01572792|389693|P1|NOT COMPLETED|Extension Study||25
160150|NCT01572792|389689|P5|COMPLETED|Extension Study||160
160151|NCT01572792|389690|P4|COMPLETED|Extension Study||165
160152|NCT01572792|389691|P3|COMPLETED|Extension Study||179
160153|NCT01572792|389692|P2|COMPLETED|Extension Study||155
160154|NCT01572792|389693|P1|COMPLETED|Extension Study||121
160155|NCT01572792|389689|P5|STARTED|Extension Study||192
160156|NCT01572792|389690|P4|STARTED|Extension Study||194
160157|NCT01572792|389691|P3|STARTED|Extension Study||205
160158|NCT01572792|389692|P2|STARTED|Extension Study||184
160159|NCT01572792|389693|P1|STARTED|Extension Study||146
160160|NCT01572792|389689|P5|NOT COMPLETED|Lead-in Study||69
160161|NCT01572792|389690|P4|NOT COMPLETED|Lead-in Study||72
160162|NCT01572792|389691|P3|NOT COMPLETED|Lead-in Study||62
160163|NCT01572792|389692|P2|NOT COMPLETED|Lead-in Study||66
160164|NCT01572792|389693|P1|NOT COMPLETED|Lead-in Study||101
160165|NCT01572792|389689|P5|COMPLETED|Lead-in Study||270
160166|NCT01572792|389690|P4|COMPLETED|Lead-in Study||268
160167|NCT01572792|389691|P3|COMPLETED|Lead-in Study||276
160168|NCT01572792|389692|P2|COMPLETED|Lead-in Study||272
160169|NCT01572792|389693|P1|COMPLETED|Lead-in Study||236
160170|NCT01572792|389689|P5|STARTED|Lead-in Study||339
160171|NCT01572792|389690|P4|STARTED|Lead-in Study||340
160172|NCT01572792|389691|P3|STARTED|Lead-in Study||338
160173|NCT01572792|389692|P2|STARTED|Lead-in Study||338
160174|NCT01572792|389693|P1|STARTED|Lead-in Study||337
160175|NCT01572740|389742|P2|NOT COMPLETED|Overall Study||5
160176|NCT01572740|389743|P1|NOT COMPLETED|Overall Study||6
160177|NCT01572740|389742|P2|COMPLETED|Overall Study||125
160178|NCT01572740|389743|P1|COMPLETED|Overall Study||121
160179|NCT01572740|389742|P2|STARTED|Overall Study||130
160180|NCT01572740|389743|P1|STARTED|Overall Study||127
160181|NCT01572727|389773|P2|NOT COMPLETED|Overall Study||209
160182|NCT01572727|389774|P1|NOT COMPLETED|Overall Study||207
160183|NCT01572727|389773|P2|COMPLETED|Overall Study||0
160184|NCT01572727|389774|P1|COMPLETED|Overall Study||0
160185|NCT01572727|389773|P2|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|201
160186|NCT01572727|389774|P1|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|202
160187|NCT01572727|389773|P2|STARTED|Overall Study||209
160188|NCT01572727|389774|P1|STARTED|Overall Study||207
160189|NCT01572675|389796|P2|NOT COMPLETED|Overall Study||223
160190|NCT01572675|389797|P1|NOT COMPLETED|Overall Study||237
160191|NCT01572675|389796|P2|COMPLETED|Overall Study||56
160192|NCT01572675|389797|P1|COMPLETED|Overall Study||31
160193|NCT01572675|389796|P2|STARTED|Overall Study||279
160194|NCT01572675|389797|P1|STARTED|Overall Study||268
160195|NCT01572428|389896|P2|NOT COMPLETED|Overall Study||1
160196|NCT01572428|389897|P1|NOT COMPLETED|Overall Study||3
160197|NCT01572428|389896|P2|COMPLETED|Overall Study||401
160198|NCT01572428|389897|P1|COMPLETED|Overall Study||399
160199|NCT01572428|389896|P2|STARTED|Overall Study||402
160200|NCT01572428|389897|P1|STARTED|Overall Study||402
160201|NCT01572389|389915|P2|NOT COMPLETED|Overall Study||21
160202|NCT01572389|389916|P1|NOT COMPLETED|Overall Study||46
160203|NCT01572389|389915|P2|COMPLETED|Overall Study||68
160204|NCT01572389|389916|P1|COMPLETED|Overall Study||90
160205|NCT01572389|389915|P2|STARTED|Overall Study||89
160206|NCT01572389|389916|P1|STARTED|Overall Study||136
160207|NCT01572298|389926|P2|NOT COMPLETED|Overall Study||1
160208|NCT01572298|389927|P1|NOT COMPLETED|Overall Study||2
160209|NCT01572298|389926|P2|COMPLETED|Overall Study||12
160210|NCT01572298|389927|P1|COMPLETED|Overall Study||12
160211|NCT01572298|389926|P2|STARTED|Overall Study||13
160212|NCT01572298|389927|P1|STARTED|Overall Study||14
160213|NCT01572207|389937|P2|NOT COMPLETED|Overall Study||3
160214|NCT01572207|389938|P1|NOT COMPLETED|Overall Study||2
160215|NCT01572207|389937|P2|COMPLETED|Overall Study||13
160216|NCT01572207|389938|P1|COMPLETED|Overall Study||12
160217|NCT01572207|389937|P2|STARTED|Overall Study||16
160218|NCT01572207|389938|P1|STARTED|Overall Study||14
160219|NCT01571557|389948|P1|NOT COMPLETED|Overall Study||0
160220|NCT01571557|389948|P1|COMPLETED|Overall Study||573
160221|NCT01571557|389948|P1|STARTED|Overall Study||573
160222|NCT01571453|389957|P2|NOT COMPLETED|Overall Study||62
160223|NCT01571453|389958|P1|NOT COMPLETED|Overall Study||38
160224|NCT01571453|389957|P2|COMPLETED|Overall Study||164
160225|NCT01571453|389958|P1|COMPLETED|Overall Study||173
160226|NCT01571453|389957|P2|STARTED|Overall Study||226
160227|NCT01571453|389958|P1|STARTED|Overall Study||211
160228|NCT01571427|389976|P2|NOT COMPLETED|Overall Study||0
160229|NCT01571427|389977|P1|NOT COMPLETED|Overall Study||0
160230|NCT01571427|389976|P2|COMPLETED|Overall Study||42
160231|NCT01571427|389977|P1|COMPLETED|Overall Study||41
160232|NCT01571427|389976|P2|STARTED|Overall Study||42
160233|NCT01571427|389977|P1|STARTED|Overall Study||41
160234|NCT01571362|390005|P3|NOT COMPLETED|Double-Blind Treatment Period||39
160235|NCT01571362|390006|P2|NOT COMPLETED|Double-Blind Treatment Period||53
160236|NCT01571362|390007|P1|NOT COMPLETED|Double-Blind Treatment Period||0
160237|NCT01571362|390005|P3|COMPLETED|Double-Blind Treatment Period||107
160238|NCT01571362|390006|P2|COMPLETED|Double-Blind Treatment Period||81
160239|NCT01571362|390007|P1|COMPLETED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
160240|NCT01571362|390005|P3|STARTED|Double-Blind Treatment Period||146
160241|NCT01571362|390006|P2|STARTED|Double-Blind Treatment Period||134
160242|NCT01571362|390007|P1|STARTED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
160243|NCT01571362|390005|P3|NOT COMPLETED|Open-Label Conversion + Titration Period||0
160244|NCT01571362|390006|P2|NOT COMPLETED|Open-Label Conversion + Titration Period||0
160245|NCT01571362|390007|P1|NOT COMPLETED|Open-Label Conversion + Titration Period||129
160246|NCT01571362|390005|P3|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
160247|NCT01571362|390006|P2|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
160248|NCT01571362|390007|P1|COMPLETED|Open-Label Conversion + Titration Period||281
160249|NCT01571362|390005|P3|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
160250|NCT01571362|390006|P2|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
160251|NCT01571362|390007|P1|STARTED|Open-Label Conversion + Titration Period||410
160252|NCT01571284|390177|P1|NOT COMPLETED|Overall Study||169
160253|NCT01571284|390177|P1|COMPLETED|Overall Study|403 participants with DP and 209 with adverse events were considered as completed.|612
160254|NCT01571284|390177|P1|Safety Population|Overall Study||779
160255|NCT01571284|390177|P1|STARTED|Overall Study||781
160256|NCT01571232|390200|P2|NOT COMPLETED|Overall Study||1
160257|NCT01571232|390201|P1|NOT COMPLETED|Overall Study||1
160258|NCT01571232|390200|P2|COMPLETED|Overall Study||9
160259|NCT01571232|390201|P1|COMPLETED|Overall Study||9
160260|NCT01571232|390200|P2|STARTED|Overall Study||10
160261|NCT01571232|390201|P1|STARTED|Overall Study||10
160262|NCT01570868|390213|P2|NOT COMPLETED|Overall Study||8
160263|NCT01570868|390214|P1|NOT COMPLETED|Overall Study||43
160264|NCT01570868|390213|P2|COMPLETED|Overall Study||0
160265|NCT01570868|390214|P1|COMPLETED|Overall Study||0
160266|NCT01570868|390213|P2|STARTED|Overall Study||8
160267|NCT01570868|390214|P1|STARTED|Overall Study||43
160268|NCT01570751|390226|P2|NOT COMPLETED|Period B (16 Weeks)||1
160269|NCT01570751|390227|P1|NOT COMPLETED|Period B (16 Weeks)||1
160270|NCT01570751|390226|P2|COMPLETED|Period B (16 Weeks)||66
160271|NCT01570751|390227|P1|COMPLETED|Period B (16 Weeks)||69
160272|NCT01570751|390226|P2|Exposed|Period B (16 Weeks)||67
160273|NCT01570751|390227|P1|Exposed|Period B (16 Weeks)||70
160274|NCT01570751|390226|P2|STARTED|Period B (16 Weeks)||67
160275|NCT01570751|390227|P1|STARTED|Period B (16 Weeks)||70
160276|NCT01570751|390226|P2|NOT COMPLETED|Period A (16 Weeks)||5
160277|NCT01570751|390227|P1|NOT COMPLETED|Period A (16 Weeks)||3
160278|NCT01570751|390226|P2|COMPLETED|Period A (16 Weeks)||67
160279|NCT01570751|390227|P1|COMPLETED|Period A (16 Weeks)||70
160280|NCT01570751|390226|P2|Exposed|Period A (16 Weeks)||72
160281|NCT01570751|390227|P1|Exposed|Period A (16 Weeks)||73
160282|NCT01570751|390226|P2|STARTED|Period A (16 Weeks)||72
160283|NCT01570751|390227|P1|STARTED|Period A (16 Weeks)||73
160284|NCT01570686|390245|P2|NOT COMPLETED|Overall Study||16
160285|NCT01570686|390246|P1|NOT COMPLETED|Overall Study||22
160286|NCT01570686|390245|P2|COMPLETED|Overall Study||278
160287|NCT01570686|390246|P1|COMPLETED|Overall Study||274
160288|NCT01570686|390245|P2|Safety and Full Analysis Set (FAS)|Overall Study||294
160289|NCT01570686|390246|P1|Safety and Full Analysis Set (FAS)|Overall Study|One patient was mis-randomized and never received study drug. Hence not included in Safety or FAS.|295
160290|NCT01570686|390245|P2|STARTED|Overall Study||294
160291|NCT01570686|390246|P1|STARTED|Overall Study||296
160292|NCT01570634|390272|P1|NOT COMPLETED|Overall Study||0
160293|NCT01570634|390272|P1|COMPLETED|Overall Study||2
160294|NCT01570634|390272|P1|STARTED|Overall Study||2
160295|NCT01570491|390282|P2|NOT COMPLETED|Overall Study||1
160296|NCT01570491|390283|P1|NOT COMPLETED|Overall Study||5
160297|NCT01570491|390282|P2|COMPLETED|Overall Study||18
160298|NCT01570491|390283|P1|COMPLETED|Overall Study||14
160299|NCT01570491|390282|P2|STARTED|Overall Study||19
160300|NCT01570491|390283|P1|STARTED|Overall Study||19
160301|NCT01570309|390297|P2|NOT COMPLETED|Overall Study||3
160302|NCT01570309|390298|P1|NOT COMPLETED|Overall Study||3
160303|NCT01570309|390297|P2|COMPLETED|Overall Study||45
160304|NCT01570309|390298|P1|COMPLETED|Overall Study||45
160305|NCT01570309|390297|P2|STARTED|Overall Study||48
160306|NCT01570309|390298|P1|STARTED|Overall Study||48
160307|NCT01570283|390315|P6|NOT COMPLETED|Cohort 3: Dose Level 3||2
160308|NCT01570283|390316|P5|NOT COMPLETED|Cohort 3: Dose Level 3||0
160309|NCT01570283|390317|P4|NOT COMPLETED|Cohort 3: Dose Level 3||0
160310|NCT01570283|390318|P3|NOT COMPLETED|Cohort 3: Dose Level 3||0
160311|NCT01570283|390319|P2|NOT COMPLETED|Cohort 3: Dose Level 3||0
160312|NCT01570283|390320|P1|NOT COMPLETED|Cohort 3: Dose Level 3||0
160313|NCT01570283|390315|P6|COMPLETED|Cohort 3: Dose Level 3||10
160314|NCT01570283|390316|P5|COMPLETED|Cohort 3: Dose Level 3||1
160315|NCT01570283|390317|P4|COMPLETED|Cohort 3: Dose Level 3||0
160316|NCT01570283|390318|P3|COMPLETED|Cohort 3: Dose Level 3||0
160317|NCT01570283|390319|P2|COMPLETED|Cohort 3: Dose Level 3||0
160318|NCT01570283|390320|P1|COMPLETED|Cohort 3: Dose Level 3||0
160319|NCT01570283|390315|P6|STARTED|Cohort 3: Dose Level 3||12
160320|NCT01570283|390316|P5|STARTED|Cohort 3: Dose Level 3||1
160321|NCT01570283|390317|P4|STARTED|Cohort 3: Dose Level 3||0
160322|NCT01570283|390318|P3|STARTED|Cohort 3: Dose Level 3||0
160323|NCT01570283|390319|P2|STARTED|Cohort 3: Dose Level 3||0
160324|NCT01570283|390320|P1|STARTED|Cohort 3: Dose Level 3||0
160325|NCT01570283|390315|P6|NOT COMPLETED|Cohort 2: Dose Level 2||0
160326|NCT01570283|390316|P5|NOT COMPLETED|Cohort 2: Dose Level 2||0
160327|NCT01570283|390317|P4|NOT COMPLETED|Cohort 2: Dose Level 2||1
160328|NCT01570283|390318|P3|NOT COMPLETED|Cohort 2: Dose Level 2||1
160329|NCT01570283|390319|P2|NOT COMPLETED|Cohort 2: Dose Level 2||0
160330|NCT01570283|390320|P1|NOT COMPLETED|Cohort 2: Dose Level 2||0
160331|NCT01570283|390315|P6|COMPLETED|Cohort 2: Dose Level 2||0
160332|NCT01570283|390316|P5|COMPLETED|Cohort 2: Dose Level 2||0
160333|NCT01570283|390317|P4|COMPLETED|Cohort 2: Dose Level 2||1
160334|NCT01570283|390318|P3|COMPLETED|Cohort 2: Dose Level 2||1
160335|NCT01570283|390319|P2|COMPLETED|Cohort 2: Dose Level 2||0
160336|NCT01570283|390320|P1|COMPLETED|Cohort 2: Dose Level 2||0
160337|NCT01570283|390315|P6|STARTED|Cohort 2: Dose Level 2||0
160338|NCT01570283|390316|P5|STARTED|Cohort 2: Dose Level 2||0
160339|NCT01570283|390317|P4|STARTED|Cohort 2: Dose Level 2||2
160340|NCT01570283|390318|P3|STARTED|Cohort 2: Dose Level 2||2
160341|NCT01570283|390319|P2|STARTED|Cohort 2: Dose Level 2||0
160342|NCT01570283|390320|P1|STARTED|Cohort 2: Dose Level 2||0
160343|NCT01570283|390315|P6|NOT COMPLETED|Cohort 1: Dose Level 1||0
160344|NCT01570283|390316|P5|NOT COMPLETED|Cohort 1: Dose Level 1||0
160345|NCT01570283|390317|P4|NOT COMPLETED|Cohort 1: Dose Level 1||0
160346|NCT01570283|390318|P3|NOT COMPLETED|Cohort 1: Dose Level 1||0
160347|NCT01570283|390319|P2|NOT COMPLETED|Cohort 1: Dose Level 1||2
160348|NCT01570283|390320|P1|NOT COMPLETED|Cohort 1: Dose Level 1||0
160349|NCT01570283|390315|P6|COMPLETED|Cohort 1: Dose Level 1||0
160350|NCT01570283|390316|P5|COMPLETED|Cohort 1: Dose Level 1||0
160351|NCT01570283|390317|P4|COMPLETED|Cohort 1: Dose Level 1||0
160352|NCT01570283|390318|P3|COMPLETED|Cohort 1: Dose Level 1||0
160353|NCT01570283|390319|P2|COMPLETED|Cohort 1: Dose Level 1||1
160354|NCT01570283|390320|P1|COMPLETED|Cohort 1: Dose Level 1||1
160355|NCT01570283|390315|P6|STARTED|Cohort 1: Dose Level 1||0
160356|NCT01570283|390316|P5|STARTED|Cohort 1: Dose Level 1||0
160357|NCT01570283|390317|P4|STARTED|Cohort 1: Dose Level 1||0
160358|NCT01570283|390318|P3|STARTED|Cohort 1: Dose Level 1||0
160359|NCT01570283|390319|P2|STARTED|Cohort 1: Dose Level 1||3
160360|NCT01570283|390320|P1|STARTED|Cohort 1: Dose Level 1||1
160361|NCT01570244|390337|P1|NOT COMPLETED|Microgynon+Faldaprevir||1
160362|NCT01570244|390337|P1|COMPLETED|Microgynon+Faldaprevir||15
160363|NCT01570244|390337|P1|STARTED|Microgynon+Faldaprevir||16
160364|NCT01570244|390337|P1|NOT COMPLETED|Microgynon||0
160365|NCT01570244|390337|P1|COMPLETED|Microgynon||16
160366|NCT01570244|390337|P1|STARTED|Microgynon||16
160367|NCT01570192|390359|P2|NOT COMPLETED|Overall Study||13
160368|NCT01570192|390360|P1|NOT COMPLETED|Overall Study||7
160369|NCT01570192|390359|P2|COMPLETED|Overall Study||17
160370|NCT01570192|390360|P1|COMPLETED|Overall Study||6
160371|NCT01570192|390359|P2|STARTED|Overall Study||30
160372|NCT01570192|390360|P1|STARTED|Overall Study||13
160373|NCT01569841|390398|P2|NOT COMPLETED|Period B (6 Weeks)||0
160374|NCT01569841|390399|P1|NOT COMPLETED|Period B (6 Weeks)||0
160375|NCT01569841|390398|P2|COMPLETED|Period B (6 Weeks)||11
160376|NCT01569841|390399|P1|COMPLETED|Period B (6 Weeks)||12
160377|NCT01569841|390398|P2|Exposed|Period B (6 Weeks)||11
160378|NCT01569841|390399|P1|Exposed|Period B (6 Weeks)||12
160379|NCT01569841|390398|P2|STARTED|Period B (6 Weeks)||11
160380|NCT01569841|390399|P1|STARTED|Period B (6 Weeks)||12
160381|NCT01569841|390398|P2|NOT COMPLETED|Period A (6 Weeks)||1
160382|NCT01569841|390399|P1|NOT COMPLETED|Period A (6 Weeks)||0
160383|NCT01569841|390398|P2|COMPLETED|Period A (6 Weeks)||11
160384|NCT01569841|390399|P1|COMPLETED|Period A (6 Weeks)||12
160385|NCT01569841|390398|P2|Exposed|Period A (6 Weeks)||12
160386|NCT01569841|390399|P1|Exposed|Period A (6 Weeks)||12
160387|NCT01569841|390398|P2|STARTED|Period A (6 Weeks)||12
160388|NCT01569841|390399|P1|STARTED|Period A (6 Weeks)||12
160389|NCT01569828|390417|P2|NOT COMPLETED|Overall Study||0
160390|NCT01569828|390418|P1|NOT COMPLETED|Overall Study||0
160391|NCT01569828|390417|P2|COMPLETED|Overall Study||6
160392|NCT01569828|390418|P1|COMPLETED|Overall Study||6
160393|NCT01569828|390417|P2|STARTED|Overall Study||6
160394|NCT01569828|390418|P1|STARTED|Overall Study||6
160395|NCT01569815|390440|P4|NOT COMPLETED|Overall Study||0
160396|NCT01569815|390441|P3|NOT COMPLETED|Overall Study||0
160397|NCT01569815|390442|P2|NOT COMPLETED|Overall Study||0
160398|NCT01569815|390443|P1|NOT COMPLETED|Overall Study||0
160399|NCT01569815|390440|P4|COMPLETED|Overall Study||8
160400|NCT01569815|390441|P3|COMPLETED|Overall Study||8
160401|NCT01569815|390442|P2|COMPLETED|Overall Study||8
160402|NCT01569815|390443|P1|COMPLETED|Overall Study||8
160403|NCT01569815|390440|P4|STARTED|Overall Study||8
160404|NCT01569815|390441|P3|STARTED|Overall Study||8
160405|NCT01569815|390442|P2|STARTED|Overall Study||8
160406|NCT01569815|390443|P1|STARTED|Overall Study||8
160407|NCT01569763|390488|P2|NOT COMPLETED|Overall Study||7
160408|NCT01569763|390489|P1|NOT COMPLETED|Overall Study||3
160409|NCT01569763|390488|P2|COMPLETED|Overall Study|Completed 12 Months of Follow-up|44
160410|NCT01569763|390489|P1|COMPLETED|Overall Study|Completed 12 Months of Follow-up|99
160411|NCT01569763|390488|P2|Treated|Overall Study||51
160412|NCT01569763|390489|P1|Treated|Overall Study||102
160413|NCT01569763|390488|P2|STARTED|Overall Study||51
160414|NCT01569763|390489|P1|STARTED|Overall Study||102
160415|NCT01569737|390499|P1|NOT COMPLETED|Overall Study||3
160416|NCT01569737|390499|P1|COMPLETED|Overall Study||95
160417|NCT01569737|390499|P1|STARTED|Overall Study||98
160418|NCT01569607|390505|P2|NOT COMPLETED|Overall Study||1
160419|NCT01569607|390506|P1|NOT COMPLETED|Overall Study||1
160420|NCT01569607|390505|P2|COMPLETED|Overall Study||10
160421|NCT01569607|390506|P1|COMPLETED|Overall Study||10
160422|NCT01569607|390505|P2|STARTED|Overall Study||11
160423|NCT01569607|390506|P1|STARTED|Overall Study||11
160424|NCT01569568|390530|P2|NOT COMPLETED|Overall Study||2
160425|NCT01569568|390531|P1|NOT COMPLETED|Overall Study||0
160426|NCT01569568|390530|P2|COMPLETED|Overall Study||27
160427|NCT01569568|390531|P1|COMPLETED|Overall Study||20
160428|NCT01569568|390530|P2|STARTED|Overall Study||29
160429|NCT01569568|390531|P1|STARTED|Overall Study||20
160430|NCT01569529|390545|P2|NOT COMPLETED|Overall Study||0
160431|NCT01569529|390546|P1|NOT COMPLETED|Overall Study||0
160432|NCT01569529|390545|P2|COMPLETED|Overall Study||394
160433|NCT01569529|390546|P1|COMPLETED|Overall Study||2676
160434|NCT01569529|390545|P2|STARTED|Overall Study||394
160435|NCT01569529|390546|P1|STARTED|Overall Study||2676
160436|NCT01569464|390554|P2|NOT COMPLETED|Overall Study||5
160437|NCT01569464|390555|P1|NOT COMPLETED|Overall Study||10
160438|NCT01569464|390554|P2|COMPLETED|Overall Study||44
160439|NCT01569464|390555|P1|COMPLETED|Overall Study||91
160440|NCT01569464|390554|P2|STARTED|Overall Study||49
160441|NCT01569464|390555|P1|STARTED|Overall Study||101
160442|NCT01569451|390593|P2|NOT COMPLETED|Overall Study||13
160443|NCT01569451|390594|P1|NOT COMPLETED|Overall Study||14
160444|NCT01569451|390593|P2|COMPLETED|Overall Study||14
160445|NCT01569451|390594|P1|COMPLETED|Overall Study||12
160446|NCT01569451|390593|P2|STARTED|Overall Study||27
160447|NCT01569451|390594|P1|STARTED|Overall Study||26
160448|NCT01569438|390622|P2|NOT COMPLETED|Overall Study||9
160449|NCT01569438|390623|P1|NOT COMPLETED|Overall Study||2
160450|NCT01569438|390622|P2|COMPLETED|Overall Study||27
160451|NCT01569438|390623|P1|COMPLETED|Overall Study||36
160452|NCT01569438|390622|P2|STARTED|Overall Study||36
160453|NCT01569438|390623|P1|STARTED|Overall Study||38
160454|NCT01569295|390637|P2|NOT COMPLETED|Overall Study||67
160455|NCT01569295|390638|P1|NOT COMPLETED|Overall Study||134
160456|NCT01569295|390637|P2|COMPLETED|Overall Study||142
160457|NCT01569295|390638|P1|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint (progressive disease or death)|73
160458|NCT01569295|390637|P2|STARTED|Overall Study||209
160459|NCT01569295|390638|P1|STARTED|Overall Study||207
160460|NCT01569191|390654|P2|NOT COMPLETED|Overall Study||0
160461|NCT01569191|390655|P1|NOT COMPLETED|Overall Study||0
160462|NCT01569191|390654|P2|COMPLETED|Overall Study||7
160463|NCT01569191|390655|P1|COMPLETED|Overall Study||11
160464|NCT01569191|390654|P2|STARTED|Overall Study||7
160465|NCT01569191|390655|P1|STARTED|Overall Study||11
160466|NCT01569152|390675|P3|NOT COMPLETED|Safety Extension, Period 3||55
160467|NCT01569152|390676|P2|NOT COMPLETED|Safety Extension, Period 3||0
160468|NCT01569152|390677|P1|NOT COMPLETED|Safety Extension, Period 3||0
160469|NCT01569152|390675|P3|COMPLETED|Safety Extension, Period 3||0
160470|NCT01569152|390676|P2|COMPLETED|Safety Extension, Period 3||0
160471|NCT01569152|390677|P1|COMPLETED|Safety Extension, Period 3||0
160472|NCT01569152|390675|P3|STARTED|Safety Extension, Period 3|Includes 29 completers and 26 early escapees from Base Study Phase IIa|55
160473|NCT01569152|390676|P2|STARTED|Safety Extension, Period 3||0
160474|NCT01569152|390677|P1|STARTED|Safety Extension, Period 3||0
160475|NCT01569152|390675|P3|NOT COMPLETED|Phase IIa, Period 1||0
160476|NCT01569152|390676|P2|NOT COMPLETED|Phase IIa, Period 1||32
160477|NCT01569152|390677|P1|NOT COMPLETED|Phase IIa, Period 1||21
160478|NCT01569152|390675|P3|COMPLETED|Phase IIa, Period 1||0
160479|NCT01569152|390676|P2|COMPLETED|Phase IIa, Period 1||9
160480|NCT01569152|390677|P1|COMPLETED|Phase IIa, Period 1||20
160481|NCT01569152|390675|P3|STARTED|Phase IIa, Period 1||0
160482|NCT01569152|390676|P2|STARTED|Phase IIa, Period 1||41
160483|NCT01569152|390677|P1|STARTED|Phase IIa, Period 1||41
160484|NCT01569126|390740|P6|NOT COMPLETED|Overall Study||0
160485|NCT01569126|390741|P5|NOT COMPLETED|Overall Study||0
160486|NCT01569126|390742|P4|NOT COMPLETED|Overall Study||0
160487|NCT01569126|390743|P3|NOT COMPLETED|Overall Study||0
160488|NCT01569126|390744|P2|NOT COMPLETED|Overall Study||0
160489|NCT01569126|390745|P1|NOT COMPLETED|Overall Study||0
160490|NCT01569126|390740|P6|COMPLETED|Overall Study||12
160491|NCT01569126|390741|P5|COMPLETED|Overall Study||12
160492|NCT01569126|390742|P4|COMPLETED|Overall Study||8
160493|NCT01569126|390743|P3|COMPLETED|Overall Study||8
160494|NCT01569126|390744|P2|COMPLETED|Overall Study||8
160495|NCT01569126|390745|P1|COMPLETED|Overall Study||8
160496|NCT01569126|390740|P6|Received at Least 1 Dose of Study Drug|Overall Study||12
160497|NCT01569126|390741|P5|Received at Least 1 Dose of Study Drug|Overall Study||12
160498|NCT01569126|390742|P4|Received at Least 1 Dose of Study Drug|Overall Study||8
160499|NCT01569126|390743|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
160500|NCT01569126|390744|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
160501|NCT01569126|390745|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
160502|NCT01569126|390740|P6|STARTED|Overall Study||12
160503|NCT01569126|390741|P5|STARTED|Overall Study||12
160504|NCT01569126|390742|P4|STARTED|Overall Study||8
160505|NCT01569126|390743|P3|STARTED|Overall Study||8
160506|NCT01569126|390744|P2|STARTED|Overall Study||8
160507|NCT01569126|390745|P1|STARTED|Overall Study||8
160508|NCT01569087|390783|P3|NOT COMPLETED|Overall Study||1
160509|NCT01569087|390784|P2|NOT COMPLETED|Overall Study||0
160510|NCT01569087|390785|P1|NOT COMPLETED|Overall Study||1
160511|NCT01569087|390783|P3|COMPLETED|Overall Study||18
160512|NCT01569087|390784|P2|COMPLETED|Overall Study||20
160513|NCT01569087|390785|P1|COMPLETED|Overall Study||20
160514|NCT01569087|390783|P3|STARTED|Overall Study||19
160515|NCT01569087|390784|P2|STARTED|Overall Study||20
160516|NCT01569087|390785|P1|STARTED|Overall Study||21
160517|NCT01569074|390813|P5|NOT COMPLETED|Overall Study||8
160518|NCT01569074|390814|P4|NOT COMPLETED|Overall Study||8
160519|NCT01569074|390815|P3|NOT COMPLETED|Overall Study||12
160520|NCT01569074|390816|P2|NOT COMPLETED|Overall Study||9
160521|NCT01569074|390817|P1|NOT COMPLETED|Overall Study||7
160522|NCT01569074|390813|P5|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
160523|NCT01569074|390814|P4|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
160524|NCT01569074|390815|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|21
160525|NCT01569074|390816|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
160526|NCT01569074|390817|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
160527|NCT01569074|390813|P5|Randomised But Did Not Receive Treatment|Overall Study||0
160528|NCT01569074|390814|P4|Randomised But Did Not Receive Treatment|Overall Study||0
160529|NCT01569074|390815|P3|Randomised But Did Not Receive Treatment|Overall Study||0
160530|NCT01569074|390816|P2|Randomised But Did Not Receive Treatment|Overall Study||0
160531|NCT01569074|390817|P1|Randomised But Did Not Receive Treatment|Overall Study||0
160532|NCT01569074|390813|P5|STARTED|Overall Study|Patients who received treatment|33
160533|NCT01569074|390814|P4|STARTED|Overall Study|Patients who received treatment|33
160534|NCT01569074|390815|P3|STARTED|Overall Study|Patients who received treatment|33
160535|NCT01569074|390816|P2|STARTED|Overall Study|Patients who received treatment|33
160536|NCT01569074|390817|P1|STARTED|Overall Study|Patients who received treatment|31
160537|NCT01569022|390873|P2|NOT COMPLETED|Second Intervention||2
160538|NCT01569022|390874|P1|NOT COMPLETED|Second Intervention||2
160539|NCT01569022|390873|P2|COMPLETED|Second Intervention||18
160540|NCT01569022|390874|P1|COMPLETED|Second Intervention||17
160541|NCT01569022|390873|P2|STARTED|Second Intervention||20
160542|NCT01569022|390874|P1|STARTED|Second Intervention||19
160543|NCT01569022|390873|P2|NOT COMPLETED|First Intervention||1
160544|NCT01569022|390874|P1|NOT COMPLETED|First Intervention||2
160545|NCT01569022|390873|P2|COMPLETED|First Intervention||20
160546|NCT01569022|390874|P1|COMPLETED|First Intervention||19
160547|NCT01569022|390873|P2|STARTED|First Intervention||21
160548|NCT01569022|390874|P1|STARTED|First Intervention||21
160549|NCT01568905|390889|P3|NOT COMPLETED|Overall Study||0
160550|NCT01568905|390890|P2|NOT COMPLETED|Overall Study||0
160551|NCT01568905|390891|P1|NOT COMPLETED|Overall Study||1
160552|NCT01568905|390889|P3|COMPLETED|Overall Study||12
160553|NCT01568905|390890|P2|COMPLETED|Overall Study||11
160554|NCT01568905|390891|P1|COMPLETED|Overall Study||12
160555|NCT01568905|390889|P3|STARTED|Overall Study||12
160556|NCT01568905|390890|P2|STARTED|Overall Study||11
160557|NCT01568905|390891|P1|STARTED|Overall Study||13
160558|NCT01568892|390910|P2|NOT COMPLETED|Open-label Phase||3
160559|NCT01568892|390911|P1|NOT COMPLETED|Open-label Phase||6
160560|NCT01568892|390910|P2|COMPLETED|Open-label Phase||13
160561|NCT01568892|390911|P1|COMPLETED|Open-label Phase||7
160562|NCT01568892|390910|P2|STARTED|Open-label Phase||16
160563|NCT01568892|390911|P1|STARTED|Open-label Phase|One participant completing the DB Phase withdrew on Day 8 and did not enter the Open-label Phase.|13
160564|NCT01568892|390910|P2|NOT COMPLETED|Double-blind Phase||0
160565|NCT01568892|390911|P1|NOT COMPLETED|Double-blind Phase||0
160566|NCT01568892|390910|P2|COMPLETED|Double-blind Phase||16
160567|NCT01568892|390911|P1|COMPLETED|Double-blind Phase||14
160568|NCT01568892|390910|P2|STARTED|Double-blind Phase||16
160569|NCT01568892|390911|P1|STARTED|Double-blind Phase||14
160570|NCT01568866|390981|P2|NOT COMPLETED|Overall Study||416
160571|NCT01568866|390982|P1|NOT COMPLETED|Overall Study||438
160572|NCT01568866|390981|P2|COMPLETED|Overall Study|Indicates participants still receiving treatment|48
160573|NCT01568866|390982|P1|COMPLETED|Overall Study|Indicates participants still receiving treatment|27
160574|NCT01568866|390981|P2|Received Treatment|Overall Study||463
160575|NCT01568866|390982|P1|Received Treatment|Overall Study||456
160576|NCT01568866|390981|P2|STARTED|Overall Study||464
160577|NCT01568866|390982|P1|STARTED|Overall Study||465
160578|NCT01568827|391004|P2|NOT COMPLETED|Intervention 2 (5 Days)||0
160579|NCT01568827|391005|P1|NOT COMPLETED|Intervention 2 (5 Days)||0
160580|NCT01568827|391004|P2|COMPLETED|Intervention 2 (5 Days)||5
160581|NCT01568827|391005|P1|COMPLETED|Intervention 2 (5 Days)||5
160582|NCT01568827|391004|P2|STARTED|Intervention 2 (5 Days)||5
160583|NCT01568827|391005|P1|STARTED|Intervention 2 (5 Days)||5
160584|NCT01568827|391004|P2|NOT COMPLETED|Washout (2 Days)||0
160585|NCT01568827|391005|P1|NOT COMPLETED|Washout (2 Days)||0
160586|NCT01568827|391004|P2|COMPLETED|Washout (2 Days)||5
160587|NCT01568827|391005|P1|COMPLETED|Washout (2 Days)||5
160588|NCT01568827|391004|P2|STARTED|Washout (2 Days)||5
160589|NCT01568827|391005|P1|STARTED|Washout (2 Days)||5
160590|NCT01568827|391004|P2|NOT COMPLETED|First Intervention (6 Days)||0
160591|NCT01568827|391005|P1|NOT COMPLETED|First Intervention (6 Days)||0
160592|NCT01568827|391004|P2|COMPLETED|First Intervention (6 Days)||5
160593|NCT01568827|391005|P1|COMPLETED|First Intervention (6 Days)||5
160594|NCT01568827|391004|P2|STARTED|First Intervention (6 Days)||5
160595|NCT01568827|391005|P1|STARTED|First Intervention (6 Days)||5
160596|NCT01568593|391013|P2|NOT COMPLETED|Overall Study||3
160597|NCT01568593|391014|P1|NOT COMPLETED|Overall Study||7
160598|NCT01568593|391013|P2|COMPLETED|Overall Study||42
160599|NCT01568593|391014|P1|COMPLETED|Overall Study||41
160600|NCT01568593|391013|P2|STARTED|Overall Study||45
160601|NCT01568593|391014|P1|STARTED|Overall Study||48
160602|NCT01568528|391023|P3|NOT COMPLETED|Overall Study||0
160603|NCT01568528|391024|P2|NOT COMPLETED|Overall Study||0
160604|NCT01568528|391025|P1|NOT COMPLETED|Overall Study||0
160605|NCT01568528|391023|P3|COMPLETED|Overall Study||9
160606|NCT01568528|391024|P2|COMPLETED|Overall Study||11
160607|NCT01568528|391025|P1|COMPLETED|Overall Study||19
160608|NCT01568528|391023|P3|STARTED|Overall Study||9
160609|NCT01568528|391024|P2|STARTED|Overall Study||11
160610|NCT01568528|391025|P1|STARTED|Overall Study||19
160611|NCT01568424|391045|P1|NOT COMPLETED|Overall Study||0
160612|NCT01568424|391045|P1|COMPLETED|Overall Study||25
160613|NCT01568424|391045|P1|STARTED|Overall Study||25
160614|NCT01568112|391059|P4|NOT COMPLETED|Overall Study||12
160615|NCT01568112|391060|P3|NOT COMPLETED|Overall Study||7
160616|NCT01568112|391061|P2|NOT COMPLETED|Overall Study||8
160617|NCT01568112|391062|P1|NOT COMPLETED|Overall Study||5
160618|NCT01568112|391059|P4|COMPLETED|Overall Study||30
160619|NCT01568112|391060|P3|COMPLETED|Overall Study||36
160620|NCT01568112|391061|P2|COMPLETED|Overall Study||36
160621|NCT01568112|391062|P1|COMPLETED|Overall Study||39
160622|NCT01568112|391059|P4|STARTED|Overall Study||42
160623|NCT01568112|391060|P3|STARTED|Overall Study||43
160624|NCT01568112|391061|P2|STARTED|Overall Study||44
160625|NCT01568112|391062|P1|STARTED|Overall Study||44
160626|NCT01568073|391185|P5|NOT COMPLETED|Overall Study||9
160627|NCT01568073|391186|P4|NOT COMPLETED|Overall Study||11
160628|NCT01568073|391187|P3|NOT COMPLETED|Overall Study||12
160629|NCT01568073|391188|P2|NOT COMPLETED|Overall Study||15
160630|NCT01568073|391189|P1|NOT COMPLETED|Overall Study||11
160631|NCT01568073|391185|P5|COMPLETED|Overall Study||107
160632|NCT01568073|391186|P4|COMPLETED|Overall Study||108
160633|NCT01568073|391187|P3|COMPLETED|Overall Study||110
160634|NCT01568073|391188|P2|COMPLETED|Overall Study||107
160635|NCT01568073|391189|P1|COMPLETED|Overall Study||110
160636|NCT01568073|391185|P5|STARTED|Overall Study||116
160637|NCT01568073|391186|P4|STARTED|Overall Study||119
160638|NCT01568073|391187|P3|STARTED|Overall Study||122
160639|NCT01568073|391188|P2|STARTED|Overall Study||122
160640|NCT01568073|391189|P1|STARTED|Overall Study||121
160641|NCT01568047|391220|P4|NOT COMPLETED|Overall Study||1
160642|NCT01568047|391221|P3|NOT COMPLETED|Overall Study||1
160643|NCT01568047|391222|P2|NOT COMPLETED|Overall Study||1
160644|NCT01568047|391223|P1|NOT COMPLETED|Overall Study||1
160645|NCT01568047|391220|P4|COMPLETED|Overall Study||9
160646|NCT01568047|391221|P3|COMPLETED|Overall Study||9
160647|NCT01568047|391222|P2|COMPLETED|Overall Study||9
160648|NCT01568047|391223|P1|COMPLETED|Overall Study||9
160649|NCT01568047|391220|P4|STARTED|Overall Study||10
160650|NCT01568047|391221|P3|STARTED|Overall Study||10
160651|NCT01568047|391222|P2|STARTED|Overall Study||10
160652|NCT01568047|391223|P1|STARTED|Overall Study||10
160653|NCT01568034|391241|P4|NOT COMPLETED|Overall Study||0
160654|NCT01568034|391242|P3|NOT COMPLETED|Overall Study||0
160655|NCT01568034|391243|P2|NOT COMPLETED|Overall Study||0
160656|NCT01568034|391244|P1|NOT COMPLETED|Overall Study||1
160657|NCT01568034|391241|P4|COMPLETED|Overall Study||3
160658|NCT01568034|391242|P3|COMPLETED|Overall Study||3
160659|NCT01568034|391243|P2|COMPLETED|Overall Study||2
160660|NCT01568034|391244|P1|COMPLETED|Overall Study||1
160661|NCT01568034|391241|P4|Placebo|Overall Study||3
160662|NCT01568034|391242|P3|Placebo|Overall Study||3
160663|NCT01568034|391243|P2|Placebo|Overall Study||2
160664|NCT01568034|391244|P1|Placebo|Overall Study||1
160665|NCT01568034|391241|P4|100 mg BIA 9-1067|Overall Study||3
160666|NCT01568034|391242|P3|100 mg BIA 9-1067|Overall Study||3
160667|NCT01568034|391243|P2|100 mg BIA 9-1067|Overall Study||2
160668|NCT01568034|391244|P1|100 mg BIA 9-1067|Overall Study||2
160669|NCT01568034|391241|P4|50 mg BIA 9-1067|Overall Study||3
160670|NCT01568034|391242|P3|50 mg BIA 9-1067|Overall Study||3
160671|NCT01568034|391243|P2|50 mg BIA 9-1067|Overall Study||2
160672|NCT01568034|391244|P1|50 mg BIA 9-1067|Overall Study||2
160673|NCT01568034|391241|P4|25 mg BIA 9-1067|Overall Study||3
160674|NCT01568034|391242|P3|25 mg BIA 9-1067|Overall Study||3
160675|NCT01568034|391243|P2|25 mg BIA 9-1067|Overall Study||2
160676|NCT01568034|391244|P1|25 mg BIA 9-1067|Overall Study||2
160677|NCT01568034|391241|P4|STARTED|Overall Study||3
160678|NCT01568034|391242|P3|STARTED|Overall Study||3
160679|NCT01568034|391243|P2|STARTED|Overall Study||2
160680|NCT01568034|391244|P1|STARTED|Overall Study||2
160681|NCT01568021|391262|P1|NOT COMPLETED|Overall Study||16
160682|NCT01568021|391262|P1|COMPLETED|Overall Study||83
160683|NCT01568021|391262|P1|STARTED|Overall Study||99
160684|NCT01568008|391268|P1|NOT COMPLETED|Overall Study||234
160685|NCT01568008|391268|P1|COMPLETED|Overall Study||699
160686|NCT01568008|391268|P1|STARTED|Overall Study||933
160687|NCT01567943|391279|P3|NOT COMPLETED|Overall Study||0
160688|NCT01567943|391280|P2|NOT COMPLETED|Overall Study||10
160689|NCT01567943|391281|P1|NOT COMPLETED|Overall Study||14
160690|NCT01567943|391279|P3|COMPLETED|Overall Study||44
160691|NCT01567943|391280|P2|COMPLETED|Overall Study||29
160692|NCT01567943|391281|P1|COMPLETED|Overall Study||26
160693|NCT01567943|391279|P3|STARTED|Overall Study||44
160694|NCT01567943|391280|P2|STARTED|Overall Study||39
160695|NCT01567943|391281|P1|STARTED|Overall Study||40
160696|NCT01567891|391289|P1|NOT COMPLETED|Overall Study||3
160697|NCT01567891|391289|P1|COMPLETED|Overall Study||6
160698|NCT01567891|391289|P1|Received T-cell|Overall Study||6
160699|NCT01567891|391289|P1|STARTED|Overall Study||9
160700|NCT01567865|391307|P4|NOT COMPLETED|Evaluated for Immunogenicity||30
160701|NCT01567865|391308|P3|NOT COMPLETED|Evaluated for Immunogenicity||19
160702|NCT01567865|391309|P2|NOT COMPLETED|Evaluated for Immunogenicity||25
160703|NCT01567865|391310|P1|NOT COMPLETED|Evaluated for Immunogenicity||17
160704|NCT01567865|391307|P4|COMPLETED|Evaluated for Immunogenicity||194
160705|NCT01567865|391308|P3|COMPLETED|Evaluated for Immunogenicity||192
160706|NCT01567865|391309|P2|COMPLETED|Evaluated for Immunogenicity||195
160707|NCT01567865|391310|P1|COMPLETED|Evaluated for Immunogenicity||146
160708|NCT01567865|391307|P4|STARTED|Evaluated for Immunogenicity||224
160709|NCT01567865|391308|P3|STARTED|Evaluated for Immunogenicity||211
160710|NCT01567865|391309|P2|STARTED|Evaluated for Immunogenicity||220
160711|NCT01567865|391310|P1|STARTED|Evaluated for Immunogenicity||163
160712|NCT01567865|391307|P4|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
160713|NCT01567865|391308|P3|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
160714|NCT01567865|391309|P2|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
160715|NCT01567865|391310|P1|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
160716|NCT01567865|391307|P4|COMPLETED|Enrolled and Vaccinated (Day 0)||224
160717|NCT01567865|391308|P3|COMPLETED|Enrolled and Vaccinated (Day 0)||211
160718|NCT01567865|391309|P2|COMPLETED|Enrolled and Vaccinated (Day 0)||220
160719|NCT01567865|391310|P1|COMPLETED|Enrolled and Vaccinated (Day 0)||163
160720|NCT01567865|391307|P4|STARTED|Enrolled and Vaccinated (Day 0)||224
160721|NCT01567865|391308|P3|STARTED|Enrolled and Vaccinated (Day 0)||211
160722|NCT01567865|391309|P2|STARTED|Enrolled and Vaccinated (Day 0)||220
160723|NCT01567865|391310|P1|STARTED|Enrolled and Vaccinated (Day 0)||163
160724|NCT01567852|391340|P2|NOT COMPLETED|Overall Study||7
160725|NCT01567852|391341|P1|NOT COMPLETED|Overall Study||4
160726|NCT01567852|391340|P2|COMPLETED|Overall Study||5
160727|NCT01567852|391341|P1|COMPLETED|Overall Study||4
160728|NCT01567852|391340|P2|STARTED|Overall Study||12
160729|NCT01567852|391341|P1|STARTED|Overall Study||8
160730|NCT01567839|391349|P1|NOT COMPLETED|Overall Study||0
160731|NCT01567839|391349|P1|COMPLETED|Overall Study||60
160732|NCT01567839|391349|P1|STARTED|Overall Study||60
160733|NCT01567826|391359|P2|NOT COMPLETED|Overall Study||2
160734|NCT01567826|391360|P1|NOT COMPLETED|Overall Study||3
160735|NCT01567826|391359|P2|COMPLETED|Overall Study||42
160736|NCT01567826|391360|P1|COMPLETED|Overall Study||40
160737|NCT01567826|391359|P2|STARTED|Overall Study||44
160738|NCT01567826|391360|P1|STARTED|Overall Study||43
160739|NCT01567527|391386|P5|NOT COMPLETED|Double-blind, Placebo-controlled Phase||95
160740|NCT01567527|391387|P4|NOT COMPLETED|Double-blind, Placebo-controlled Phase||69
160741|NCT01567527|391388|P3|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
160742|NCT01567527|391389|P2|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
160743|NCT01567527|391390|P1|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
160744|NCT01567527|391386|P5|COMPLETED|Double-blind, Placebo-controlled Phase||38
160745|NCT01567527|391387|P4|COMPLETED|Double-blind, Placebo-controlled Phase||64
160746|NCT01567527|391388|P3|COMPLETED|Double-blind, Placebo-controlled Phase||0
160747|NCT01567527|391389|P2|COMPLETED|Double-blind, Placebo-controlled Phase||0
160748|NCT01567527|391390|P1|COMPLETED|Double-blind, Placebo-controlled Phase||0
160749|NCT01567527|391386|P5|STARTED|Double-blind, Placebo-controlled Phase||133
160750|NCT01567527|391387|P4|STARTED|Double-blind, Placebo-controlled Phase||133
160751|NCT01567527|391388|P3|STARTED|Double-blind, Placebo-controlled Phase|Subjects were randomized to Aripiprazole IM Depot and placebo groups in this phase of the study|0
160752|NCT01567527|391389|P2|STARTED|Double-blind, Placebo-controlled Phase||0
160753|NCT01567527|391390|P1|STARTED|Double-blind, Placebo-controlled Phase||0
160754|NCT01567527|391386|P5|NOT COMPLETED|IM Depot Stabilization.||0
160755|NCT01567527|391387|P4|NOT COMPLETED|IM Depot Stabilization.||0
160756|NCT01567527|391388|P3|NOT COMPLETED|IM Depot Stabilization.||159
160757|NCT01567527|391389|P2|NOT COMPLETED|IM Depot Stabilization.||0
160758|NCT01567527|391390|P1|NOT COMPLETED|IM Depot Stabilization.||0
160759|NCT01567527|391386|P5|COMPLETED|IM Depot Stabilization.||0
160760|NCT01567527|391387|P4|COMPLETED|IM Depot Stabilization.||0
160761|NCT01567527|391388|P3|COMPLETED|IM Depot Stabilization.||266
160762|NCT01567527|391389|P2|COMPLETED|IM Depot Stabilization.||0
160763|NCT01567527|391390|P1|COMPLETED|IM Depot Stabilization.||0
160764|NCT01567527|391386|P5|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
160765|NCT01567527|391387|P4|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
160766|NCT01567527|391388|P3|STARTED|IM Depot Stabilization.||425
160767|NCT01567527|391389|P2|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
160768|NCT01567527|391390|P1|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
160769|NCT01567527|391386|P5|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
160770|NCT01567527|391387|P4|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
160771|NCT01567527|391388|P3|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
160772|NCT01567527|391389|P2|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||207
160773|NCT01567527|391390|P1|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
160774|NCT01567527|391386|P5|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
160775|NCT01567527|391387|P4|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
160776|NCT01567527|391388|P3|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
160777|NCT01567527|391389|P2|COMPLETED|Oral Aripiprazole Stabilization Phase.||425
160778|NCT01567527|391390|P1|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
160779|NCT01567527|391386|P5|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
160780|NCT01567527|391387|P4|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
160781|NCT01567527|391388|P3|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
160782|NCT01567527|391389|P2|STARTED|Oral Aripiprazole Stabilization Phase.|265 of the 632 subjects who started this phase entered the Oral Stabilization Phase directly.|632
160783|NCT01567527|391390|P1|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
160784|NCT01567527|391386|P5|NOT COMPLETED|Conversion Phase.||0
160785|NCT01567527|391387|P4|NOT COMPLETED|Conversion Phase.||0
160786|NCT01567527|391388|P3|NOT COMPLETED|Conversion Phase.||0
160787|NCT01567527|391389|P2|NOT COMPLETED|Conversion Phase.||0
160788|NCT01567527|391390|P1|NOT COMPLETED|Conversion Phase.||99
160789|NCT01567527|391386|P5|COMPLETED|Conversion Phase.||0
160790|NCT01567527|391387|P4|COMPLETED|Conversion Phase.||0
160791|NCT01567527|391388|P3|COMPLETED|Conversion Phase.||0
160792|NCT01567527|391389|P2|COMPLETED|Conversion Phase.||0
160793|NCT01567527|391390|P1|COMPLETED|Conversion Phase.||367
160794|NCT01567527|391386|P5|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
160795|NCT01567527|391387|P4|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
160796|NCT01567527|391388|P3|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
160797|NCT01567527|391389|P2|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
160798|NCT01567527|391390|P1|STARTED|Conversion Phase.||466
160799|NCT01567462|391407|P2|NOT COMPLETED|Overall Study||7
160800|NCT01567462|391408|P1|NOT COMPLETED|Overall Study||4
160801|NCT01567462|391407|P2|COMPLETED|Overall Study||38
160802|NCT01567462|391408|P1|COMPLETED|Overall Study||41
160803|NCT01567462|391407|P2|STARTED|Overall Study||45
160804|NCT01567462|391408|P1|STARTED|Overall Study||45
160805|NCT01567371|391420|P1|NOT COMPLETED|Overall Study||0
160806|NCT01567371|391420|P1|COMPLETED|Overall Study||30
160807|NCT01567371|391420|P1|STARTED|Overall Study||30
160808|NCT01567306|391431|P6|NOT COMPLETED|Overall Study||3
160809|NCT01567306|391432|P5|NOT COMPLETED|Overall Study||7
160810|NCT01567306|391433|P4|NOT COMPLETED|Overall Study||5
160811|NCT01567306|391434|P3|NOT COMPLETED|Overall Study||0
160812|NCT01567306|391435|P2|NOT COMPLETED|Overall Study||2
160813|NCT01567306|391436|P1|NOT COMPLETED|Overall Study||3
160814|NCT01567306|391431|P6|COMPLETED|Overall Study||23
160815|NCT01567306|391432|P5|COMPLETED|Overall Study||18
160816|NCT01567306|391433|P4|COMPLETED|Overall Study||19
160817|NCT01567306|391434|P3|COMPLETED|Overall Study||24
160818|NCT01567306|391435|P2|COMPLETED|Overall Study||23
160819|NCT01567306|391436|P1|COMPLETED|Overall Study||24
160820|NCT01567306|391431|P6|STARTED|Overall Study||26
160821|NCT01567306|391432|P5|STARTED|Overall Study||25
160822|NCT01567306|391433|P4|STARTED|Overall Study||24
160823|NCT01567306|391434|P3|STARTED|Overall Study||24
160824|NCT01567306|391435|P2|STARTED|Overall Study||25
160825|NCT01567306|391436|P1|STARTED|Overall Study||27
160826|NCT01567163|391450|P1|NOT COMPLETED|Overall Study||4
160827|NCT01567163|391450|P1|COMPLETED|Overall Study||18
160828|NCT01567163|391450|P1|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1, Day 1 and Cycle 2, Day 1 treatment with required assessments.|18
160829|NCT01567163|391450|P1|Received at Least 1 Dose of Study Drug|Overall Study||22
160830|NCT01567163|391450|P1|STARTED|Overall Study||22
160831|NCT01567150|391462|P2|NOT COMPLETED|Overall Study||2
160832|NCT01567150|391463|P1|NOT COMPLETED|Overall Study||2
160833|NCT01567150|391462|P2|COMPLETED|Overall Study||16
160834|NCT01567150|391463|P1|COMPLETED|Overall Study||19
160835|NCT01567150|391462|P2|STARTED|Overall Study||18
160836|NCT01567150|391463|P1|STARTED|Overall Study||21
160837|NCT01567085|391471|P1|NOT COMPLETED|Overall Study||20
160838|NCT01567085|391471|P1|COMPLETED|Overall Study||60
160839|NCT01567085|391471|P1|Received at Least 1 Dose of Study Drug|Overall Study||80
160840|NCT01567085|391471|P1|STARTED|Overall Study||80
160841|NCT01567020|391481|P4|NOT COMPLETED|Overall Study||1
160842|NCT01567020|391482|P3|NOT COMPLETED|Overall Study||2
160843|NCT01567020|391483|P2|NOT COMPLETED|Overall Study||5
160844|NCT01567020|391484|P1|NOT COMPLETED|Overall Study||7
160845|NCT01567020|391481|P4|COMPLETED|Overall Study||10
160846|NCT01567020|391482|P3|COMPLETED|Overall Study||18
160847|NCT01567020|391483|P2|COMPLETED|Overall Study||41
160848|NCT01567020|391484|P1|COMPLETED|Overall Study||21
160849|NCT01567020|391481|P4|STARTED|Overall Study||11
160850|NCT01567020|391482|P3|STARTED|Overall Study||20
160851|NCT01567020|391483|P2|STARTED|Overall Study||46
160852|NCT01567020|391484|P1|STARTED|Overall Study||28
160853|NCT01566981|391508|P2|NOT COMPLETED|Overall Study||8
160854|NCT01566981|391509|P1|NOT COMPLETED|Overall Study||5
160855|NCT01566981|391508|P2|COMPLETED|Overall Study||54
160856|NCT01566981|391509|P1|COMPLETED|Overall Study||53
160857|NCT01566981|391508|P2|STARTED|Overall Study||62
160858|NCT01566981|391509|P1|STARTED|Overall Study||58
160859|NCT01566838|391521|P2|NOT COMPLETED|Overall Study||0
160860|NCT01566838|391522|P1|NOT COMPLETED|Overall Study||3
160861|NCT01566838|391521|P2|COMPLETED|Overall Study||42
160862|NCT01566838|391522|P1|COMPLETED|Overall Study||38
160863|NCT01566838|391521|P2|STARTED|Overall Study||42
160864|NCT01566838|391522|P1|STARTED|Overall Study||41
160865|NCT01566773|391538|P1|NOT COMPLETED|Overall Study||30
160866|NCT01566773|391538|P1|COMPLETED|Overall Study||110
160867|NCT01566773|391538|P1|Spiriva® Handihaler®|Overall Study||62
160868|NCT01566773|391538|P1|Placebo MDI|Overall Study||62
160869|NCT01566773|391538|P1|GP MDI 0.6 µg BID|Overall Study||59
160870|NCT01566773|391538|P1|GP MDI 1.2 µg BID|Overall Study||57
160871|NCT01566773|391538|P1|GP MDI 2.4 µg BID|Overall Study||64
160872|NCT01566773|391538|P1|GP MDI 4.6 µg BID|Overall Study||62
160873|NCT01566773|391538|P1|GP MDI 9 µg BID|Overall Study||64
160874|NCT01566773|391538|P1|GP MDI 18 µg BID|Overall Study||64
160875|NCT01566773|391538|P1|STARTED|Overall Study||140
160876|NCT01566721|391747|P2|NOT COMPLETED|Overall Study||710
160877|NCT01566721|391748|P1|NOT COMPLETED|Overall Study||1867
160878|NCT01566721|391747|P2|COMPLETED|Overall Study||0
160879|NCT01566721|391748|P1|COMPLETED|Overall Study||0
160880|NCT01566721|391747|P2|Received Treatment|Overall Study||709
160881|NCT01566721|391748|P1|Received Treatment|Overall Study||1864
160882|NCT01566721|391747|P2|STARTED|Overall Study||710
160883|NCT01566721|391748|P1|STARTED|Overall Study||1867
160884|NCT01566682|391771|P1|NOT COMPLETED|Overall Study||46
160885|NCT01566682|391771|P1|COMPLETED|Overall Study||374
160886|NCT01566682|391771|P1|STARTED|Overall Study||420
160887|NCT01566630|391777|P2|NOT COMPLETED|Overall Study||0
160888|NCT01566630|391778|P1|NOT COMPLETED|Overall Study||0
160889|NCT01566630|391777|P2|COMPLETED|Overall Study||1
160890|NCT01566630|391778|P1|COMPLETED|Overall Study||2
160891|NCT01566630|391777|P2|STARTED|Overall Study||1
160892|NCT01566630|391778|P1|STARTED|Overall Study||2
160893|NCT01566604|391834|P2|NOT COMPLETED|Overall Study||11
160894|NCT01566604|391835|P1|NOT COMPLETED|Overall Study||24
160895|NCT01566604|391834|P2|COMPLETED|Overall Study||143
160896|NCT01566604|391835|P1|COMPLETED|Overall Study||282
160897|NCT01566604|391834|P2|FAS, Serial Spirometry Subgroup|Overall Study||58
160898|NCT01566604|391835|P1|FAS, Serial Spirometry Subgroup|Overall Study||134
160899|NCT01566604|391834|P2|Full Analysis Set (FAS)|Overall Study||154
160900|NCT01566604|391835|P1|Full Analysis Set (FAS)|Overall Study||305
160901|NCT01566604|391834|P2|Safety Set|Overall Study||154
160902|NCT01566604|391835|P1|Safety Set|Overall Study||305
160903|NCT01566604|391834|P2|STARTED|Overall Study||154
160904|NCT01566604|391835|P1|STARTED|Overall Study||306
160905|NCT01566539|391869|P9|NOT COMPLETED|Within Subject Group||0
160906|NCT01566539|391870|P8|NOT COMPLETED|Within Subject Group||0
160907|NCT01566539|391871|P7|NOT COMPLETED|Within Subject Group||0
160908|NCT01566539|391872|P6|NOT COMPLETED|Within Subject Group||0
160909|NCT01566539|391873|P5|NOT COMPLETED|Within Subject Group||0
160910|NCT01566539|391874|P4|NOT COMPLETED|Within Subject Group||3
160911|NCT01566539|391875|P3|NOT COMPLETED|Within Subject Group||0
160912|NCT01566539|391876|P2|NOT COMPLETED|Within Subject Group||0
160913|NCT01566539|391877|P1|NOT COMPLETED|Within Subject Group||0
160914|NCT01566539|391869|P9|COMPLETED|Within Subject Group||0
160915|NCT01566539|391870|P8|COMPLETED|Within Subject Group||0
160916|NCT01566539|391871|P7|COMPLETED|Within Subject Group||0
160917|NCT01566539|391872|P6|COMPLETED|Within Subject Group||0
160918|NCT01566539|391873|P5|COMPLETED|Within Subject Group||0
160919|NCT01566539|391874|P4|COMPLETED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|153
160920|NCT01566539|391875|P3|COMPLETED|Within Subject Group||0
160921|NCT01566539|391876|P2|COMPLETED|Within Subject Group||0
160922|NCT01566539|391877|P1|COMPLETED|Within Subject Group||0
160923|NCT01566539|391869|P9|STARTED|Within Subject Group||0
160924|NCT01566539|391870|P8|STARTED|Within Subject Group||0
160925|NCT01566539|391871|P7|STARTED|Within Subject Group||0
160926|NCT01566539|391872|P6|STARTED|Within Subject Group||0
160927|NCT01566539|391873|P5|STARTED|Within Subject Group||0
160928|NCT01566539|391874|P4|STARTED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|156
160929|NCT01566539|391875|P3|STARTED|Within Subject Group||0
160930|NCT01566539|391876|P2|STARTED|Within Subject Group||0
160931|NCT01566539|391877|P1|STARTED|Within Subject Group||0
160932|NCT01566539|391869|P9|NOT COMPLETED|Main Study Period||0
160933|NCT01566539|391870|P8|NOT COMPLETED|Main Study Period||0
160934|NCT01566539|391871|P7|NOT COMPLETED|Main Study Period||0
160935|NCT01566539|391872|P6|NOT COMPLETED|Main Study Period||3
160936|NCT01566539|391873|P5|NOT COMPLETED|Main Study Period||0
160937|NCT01566539|391874|P4|NOT COMPLETED|Main Study Period||0
160938|NCT01566539|391875|P3|NOT COMPLETED|Main Study Period||0
160939|NCT01566539|391876|P2|NOT COMPLETED|Main Study Period||0
160940|NCT01566539|391877|P1|NOT COMPLETED|Main Study Period||1
160941|NCT01566539|391869|P9|COMPLETED|Main Study Period||1
160942|NCT01566539|391870|P8|COMPLETED|Main Study Period||30
160943|NCT01566539|391871|P7|COMPLETED|Main Study Period||30
160944|NCT01566539|391872|P6|COMPLETED|Main Study Period||40
160945|NCT01566539|391873|P5|COMPLETED|Main Study Period||40
160946|NCT01566539|391874|P4|COMPLETED|Main Study Period||0
160947|NCT01566539|391875|P3|COMPLETED|Main Study Period||104
160948|NCT01566539|391876|P2|COMPLETED|Main Study Period||100
160949|NCT01566539|391877|P1|COMPLETED|Main Study Period||100
160950|NCT01566539|391869|P9|STARTED|Main Study Period||1
160951|NCT01566539|391870|P8|STARTED|Main Study Period||30
160952|NCT01566539|391871|P7|STARTED|Main Study Period||30
160953|NCT01566539|391872|P6|STARTED|Main Study Period||43
160954|NCT01566539|391873|P5|STARTED|Main Study Period||40
160955|NCT01566539|391874|P4|STARTED|Main Study Period||0
160956|NCT01566539|391875|P3|STARTED|Main Study Period||104
160957|NCT01566539|391876|P2|STARTED|Main Study Period||100
160958|NCT01566539|391877|P1|STARTED|Main Study Period||101
160959|NCT01566526|391930|P1|NOT COMPLETED|Overall Study||0
160960|NCT01566526|391930|P1|COMPLETED|Overall Study||26
160961|NCT01566526|391930|P1|STARTED|Overall Study||26
160962|NCT01566500|391940|P1|NOT COMPLETED|Overall Study||0
160963|NCT01566500|391940|P1|COMPLETED|Overall Study||140
160964|NCT01566500|391940|P1|STARTED|Overall Study||140
160965|NCT01566461|391946|P2|NOT COMPLETED|IN.PACT SFA II Phase||5
160966|NCT01566461|391947|P1|NOT COMPLETED|IN.PACT SFA II Phase||12
160967|NCT01566461|391946|P2|COMPLETED|IN.PACT SFA II Phase||55
160968|NCT01566461|391947|P1|COMPLETED|IN.PACT SFA II Phase||109
160969|NCT01566461|391946|P2|STARTED|IN.PACT SFA II Phase||60
160970|NCT01566461|391947|P1|STARTED|IN.PACT SFA II Phase||121
160971|NCT01566461|391946|P2|NOT COMPLETED|IN.PACT SFA I Phase||2
160972|NCT01566461|391947|P1|NOT COMPLETED|IN.PACT SFA I Phase||11
160973|NCT01566461|391946|P2|COMPLETED|IN.PACT SFA I Phase||49
160974|NCT01566461|391947|P1|COMPLETED|IN.PACT SFA I Phase||88
160975|NCT01566461|391946|P2|STARTED|IN.PACT SFA I Phase||51
160976|NCT01566461|391947|P1|STARTED|IN.PACT SFA I Phase||99
160977|NCT01566435|391991|P1|NOT COMPLETED|ACF Definitive Chemoradiation-cetuximab||0
160978|NCT01566435|391991|P1|COMPLETED|ACF Definitive Chemoradiation-cetuximab||2
160979|NCT01566435|391991|P1|STARTED|ACF Definitive Chemoradiation-cetuximab||2
160980|NCT01566435|391991|P1|NOT COMPLETED|ACF Definitive Chemoradiation-cisplatin||1
160981|NCT01566435|391991|P1|COMPLETED|ACF Definitive Chemoradiation-cisplatin||27
160982|NCT01566435|391991|P1|STARTED|ACF Definitive Chemoradiation-cisplatin||28
160983|NCT01566435|391991|P1|NOT COMPLETED|ACF Induction Therapy||0
160984|NCT01566435|391991|P1|COMPLETED|ACF Induction Therapy||30
160985|NCT01566435|391991|P1|STARTED|ACF Induction Therapy||30
160986|NCT01566409|392007|P2|NOT COMPLETED|Overall Study||5
160987|NCT01566409|392008|P1|NOT COMPLETED|Overall Study||2
160988|NCT01566409|392007|P2|COMPLETED|Overall Study||48
160989|NCT01566409|392008|P1|COMPLETED|Overall Study||47
160990|NCT01566409|392007|P2|STARTED|Overall Study||53
160991|NCT01566409|392008|P1|STARTED|Overall Study||49
160992|NCT01566370|392016|P2|NOT COMPLETED|Overall Study||1
160993|NCT01566370|392017|P1|NOT COMPLETED|Overall Study||2
160994|NCT01566370|392016|P2|COMPLETED|Overall Study||0
160995|NCT01566370|392017|P1|COMPLETED|Overall Study||0
160996|NCT01566370|392016|P2|STARTED|Overall Study||1
160997|NCT01566370|392017|P1|STARTED|Overall Study||2
160998|NCT01566331|392043|P2|NOT COMPLETED|Overall Study||0
160999|NCT01566331|392044|P1|NOT COMPLETED|Overall Study||0
161000|NCT01566331|392043|P2|COMPLETED|Overall Study||40
161001|NCT01566331|392044|P1|COMPLETED|Overall Study||40
161002|NCT01566331|392043|P2|STARTED|Overall Study||40
161003|NCT01566331|392044|P1|STARTED|Overall Study||40
161004|NCT01566214|392052|P2|NOT COMPLETED|Overall Study||0
161005|NCT01566214|392053|P1|NOT COMPLETED|Overall Study||3
161006|NCT01566214|392052|P2|COMPLETED|Overall Study||6
161007|NCT01566214|392053|P1|COMPLETED|Overall Study||3
161008|NCT01566214|392052|P2|STARTED|Overall Study||6
161009|NCT01566214|392053|P1|STARTED|Overall Study||6
161010|NCT01566162|392083|P1|NOT COMPLETED|Overall Study||36
161011|NCT01566162|392083|P1|COMPLETED|Overall Study||155
161012|NCT01566162|392083|P1|STARTED|Overall Study||191
161013|NCT01566149|392097|P2|NOT COMPLETED|Overall Study||2
161014|NCT01566149|392098|P1|NOT COMPLETED|Overall Study||3
161015|NCT01566149|392097|P2|COMPLETED|Overall Study||23
161016|NCT01566149|392098|P1|COMPLETED|Overall Study||21
161017|NCT01566149|392097|P2|STARTED|Overall Study||25
161018|NCT01566149|392098|P1|STARTED|Overall Study||24
161019|NCT01566084|392114|P2|NOT COMPLETED|Overall Study||0
161020|NCT01566084|392115|P1|NOT COMPLETED|Overall Study||0
161021|NCT01566084|392114|P2|COMPLETED|Overall Study||10
161022|NCT01566084|392115|P1|COMPLETED|Overall Study||7
161023|NCT01566084|392114|P2|STARTED|Overall Study||10
161024|NCT01566084|392115|P1|STARTED|Overall Study||7
161025|NCT01565993|392131|P2|NOT COMPLETED|Overall Study||3
161026|NCT01565993|392132|P1|NOT COMPLETED|Overall Study||0
161027|NCT01565993|392131|P2|COMPLETED|Overall Study||39
161028|NCT01565993|392132|P1|COMPLETED|Overall Study|A total of 105 polypectomies were performed on 98 patients|66
161029|NCT01565993|392131|P2|STARTED|Overall Study|3 patients were excluded for failing to meet the inclusion criteria|42
161030|NCT01565993|392132|P1|STARTED|Overall Study||66
161031|NCT01565980|392140|P2|NOT COMPLETED|Overall Study||4
161032|NCT01565980|392141|P1|NOT COMPLETED|Overall Study||4
161033|NCT01565980|392140|P2|COMPLETED|Overall Study||16
161034|NCT01565980|392141|P1|COMPLETED|Overall Study||16
161035|NCT01565980|392140|P2|STARTED|Overall Study|Three patients had started the intervention protocol at the time of study withdrawal.|20
161036|NCT01565980|392141|P1|STARTED|Overall Study||20
161037|NCT01565941|392161|P2|NOT COMPLETED|Overall Study||4
161038|NCT01565941|392162|P1|NOT COMPLETED|Overall Study||11
161039|NCT01565941|392161|P2|COMPLETED|Overall Study||349
161040|NCT01565941|392162|P1|COMPLETED|Overall Study||349
161041|NCT01565941|392161|P2|STARTED|Overall Study||353
161042|NCT01565941|392162|P1|STARTED|Overall Study||360
161043|NCT01565928|392204|P1|NOT COMPLETED|Overall Study||22
161044|NCT01565928|392204|P1|COMPLETED|Overall Study||0
161045|NCT01565928|392204|P1|STARTED|Overall Study||22
161046|NCT01565902|392221|P4|NOT COMPLETED|Overall Study||0
161047|NCT01565902|392222|P3|NOT COMPLETED|Overall Study||0
161048|NCT01565902|392223|P2|NOT COMPLETED|Overall Study||0
161049|NCT01565902|392224|P1|NOT COMPLETED|Overall Study||0
161050|NCT01565902|392221|P4|COMPLETED|Overall Study||16
161051|NCT01565902|392222|P3|COMPLETED|Overall Study||8
161052|NCT01565902|392223|P2|COMPLETED|Overall Study||8
161053|NCT01565902|392224|P1|COMPLETED|Overall Study||8
161054|NCT01565902|392221|P4|STARTED|Overall Study||16
161055|NCT01565902|392222|P3|STARTED|Overall Study||8
161056|NCT01565902|392223|P2|STARTED|Overall Study||8
161057|NCT01565902|392224|P1|STARTED|Overall Study||8
161058|NCT01565889|392258|P6|NOT COMPLETED|Part B||4
161059|NCT01565889|392259|P5|NOT COMPLETED|Part B||0
161060|NCT01565889|392260|P4|NOT COMPLETED|Part B||0
161061|NCT01565889|392261|P3|NOT COMPLETED|Part B||0
161062|NCT01565889|392262|P2|NOT COMPLETED|Part B||0
161063|NCT01565889|392263|P1|NOT COMPLETED|Part B||0
161064|NCT01565889|392258|P6|COMPLETED|Part B||19
161065|NCT01565889|392259|P5|COMPLETED|Part B||0
161066|NCT01565889|392260|P4|COMPLETED|Part B||0
161067|NCT01565889|392261|P3|COMPLETED|Part B||0
161068|NCT01565889|392262|P2|COMPLETED|Part B||0
161069|NCT01565889|392263|P1|COMPLETED|Part B||0
161070|NCT01565889|392258|P6|STARTED|Part B|9 participants in this group transferred from a Part A cohort, and 14 participants joined the study.|23
161071|NCT01565889|392259|P5|STARTED|Part B||0
161072|NCT01565889|392260|P4|STARTED|Part B||0
161073|NCT01565889|392261|P3|STARTED|Part B||0
161074|NCT01565889|392262|P2|STARTED|Part B||0
161075|NCT01565889|392263|P1|STARTED|Part B||0
161076|NCT01565889|392258|P6|NOT COMPLETED|Part A||0
161077|NCT01565889|392259|P5|NOT COMPLETED|Part A||0
161078|NCT01565889|392260|P4|NOT COMPLETED|Part A||0
161079|NCT01565889|392261|P3|NOT COMPLETED|Part A||0
161080|NCT01565889|392262|P2|NOT COMPLETED|Part A||0
161081|NCT01565889|392263|P1|NOT COMPLETED|Part A||1
161082|NCT01565889|392258|P6|COMPLETED|Part A||0
161083|NCT01565889|392259|P5|COMPLETED|Part A|1 participant from this group continued in the Part B: SOF+PEG+RBV group.|7
161084|NCT01565889|392260|P4|COMPLETED|Part A|2 participants from this group continued in the Part B: SOF+PEG+RBV group.|7
161085|NCT01565889|392261|P3|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|8
161086|NCT01565889|392262|P2|COMPLETED|Part A|No participants from this group continued in the Part B: SOF+PEG+RBV group.|4
161087|NCT01565889|392263|P1|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|11
161088|NCT01565889|392258|P6|STARTED|Part A||0
161089|NCT01565889|392259|P5|STARTED|Part A||7
161090|NCT01565889|392260|P4|STARTED|Part A||7
161091|NCT01565889|392261|P3|STARTED|Part A||8
161092|NCT01565889|392262|P2|STARTED|Part A||4
161093|NCT01565889|392263|P1|STARTED|Part A||12
161094|NCT01565850|392294|P2|NOT COMPLETED|Overall Study||8
161095|NCT01565850|392295|P1|NOT COMPLETED|Overall Study||20
161096|NCT01565850|392294|P2|COMPLETED|Overall Study||42
161097|NCT01565850|392295|P1|COMPLETED|Overall Study||83
161098|NCT01565850|392294|P2|STARTED|Overall Study||50
161099|NCT01565850|392295|P1|STARTED|Overall Study||103
161100|NCT01565707|392315|P4|NOT COMPLETED|Overall Study||5
161101|NCT01565707|392316|P3|NOT COMPLETED|Overall Study||3
161102|NCT01565707|392317|P2|NOT COMPLETED|Overall Study||8
161103|NCT01565707|392318|P1|NOT COMPLETED|Overall Study||9
161104|NCT01565707|392315|P4|COMPLETED|Overall Study||17
161105|NCT01565707|392316|P3|COMPLETED|Overall Study||16
161106|NCT01565707|392317|P2|COMPLETED|Overall Study||65
161107|NCT01565707|392318|P1|COMPLETED|Overall Study||66
161108|NCT01565707|392315|P4|Treated|Overall Study||22
161109|NCT01565707|392316|P3|Treated|Overall Study||19
161110|NCT01565707|392317|P2|Treated|Overall Study||73
161111|NCT01565707|392318|P1|Treated|Overall Study||73
161112|NCT01565707|392315|P4|STARTED|Overall Study||22
161113|NCT01565707|392316|P3|STARTED|Overall Study||19
161114|NCT01565707|392317|P2|STARTED|Overall Study||73
161115|NCT01565707|392318|P1|STARTED|Overall Study||75
161116|NCT01565694|392409|P1|NOT COMPLETED|Fixed-Dose Assessment Period||4
161117|NCT01565694|392409|P1|COMPLETED|Fixed-Dose Assessment Period||58
161118|NCT01565694|392409|P1|STARTED|Fixed-Dose Assessment Period||62
161119|NCT01565694|392409|P1|NOT COMPLETED|Dose-Titration Period||14
161120|NCT01565694|392409|P1|COMPLETED|Dose-Titration Period||62
161121|NCT01565694|392409|P1|STARTED|Dose-Titration Period||76
161122|NCT01565642|392430|P2|NOT COMPLETED|Overall Study||1
161123|NCT01565642|392431|P1|NOT COMPLETED|Overall Study||2
161124|NCT01565642|392430|P2|COMPLETED|Overall Study||150
161125|NCT01565642|392431|P1|COMPLETED|Overall Study||149
161126|NCT01565642|392430|P2|STARTED|Overall Study||151
161127|NCT01565642|392431|P1|STARTED|Overall Study||151
161128|NCT01565616|392453|P1|NOT COMPLETED|Overall Study||0
161129|NCT01565616|392453|P1|COMPLETED|Overall Study||22
161130|NCT01565616|392453|P1|Second Component: Related or Unrelated|Overall Study||17
161131|NCT01565616|392453|P1|First Component: 5 Related Donors|Overall Study||5
161132|NCT01565616|392453|P1|STARTED|Overall Study||22
161133|NCT01565564|392466|P2|NOT COMPLETED|Overall Study||1
161134|NCT01565564|392467|P1|NOT COMPLETED|Overall Study||5
161135|NCT01565564|392466|P2|COMPLETED|Overall Study||361
161136|NCT01565564|392467|P1|COMPLETED|Overall Study||339
161137|NCT01565564|392466|P2|STARTED|Overall Study||362
161138|NCT01565564|392467|P1|STARTED|Overall Study||344
161139|NCT01565551|392477|P2|NOT COMPLETED|Overall Study||0
161140|NCT01565551|392478|P1|NOT COMPLETED|Overall Study||0
161141|NCT01565551|392477|P2|COMPLETED|Overall Study||51
161142|NCT01565551|392478|P1|COMPLETED|Overall Study||586
161143|NCT01565551|392477|P2|6-Month Outcomes|Overall Study||30
161144|NCT01565551|392478|P1|6-Month Outcomes|Overall Study||412
161145|NCT01565551|392477|P2|Neuroimaging|Overall Study||25
161146|NCT01565551|392478|P1|Neuroimaging|Overall Study||233
161147|NCT01565551|392477|P2|Biospecimens/Biomarkers|Overall Study||22
161148|NCT01565551|392478|P1|Biospecimens/Biomarkers|Overall Study||479
161149|NCT01565551|392477|P2|Clinical/Demographics|Overall Study||51
161150|NCT01565551|392478|P1|Clinical/Demographics|Overall Study||586
161151|NCT01565551|392477|P2|STARTED|Overall Study||51
161152|NCT01565551|392478|P1|STARTED|Overall Study||586
161153|NCT01565538|392486|P2|NOT COMPLETED|Overall Study||0
161154|NCT01565538|392487|P1|NOT COMPLETED|Overall Study||0
161155|NCT01565538|392486|P2|COMPLETED|Overall Study||62
161156|NCT01565538|392487|P1|COMPLETED|Overall Study||61
161157|NCT01565538|392486|P2|STARTED|Overall Study||62
161158|NCT01565538|392487|P1|STARTED|Overall Study||61
161159|NCT01565382|392497|P2|NOT COMPLETED|Overall Study||0
161160|NCT01565382|392498|P1|NOT COMPLETED|Overall Study||0
161161|NCT01565382|392497|P2|COMPLETED|Overall Study||7
161162|NCT01565382|392498|P1|COMPLETED|Overall Study||40
161163|NCT01565382|392497|P2|STARTED|Overall Study||7
161164|NCT01565382|392498|P1|STARTED|Overall Study||40
161165|NCT01565369|392503|P1|NOT COMPLETED|Overall Study||0
161166|NCT01565369|392503|P1|COMPLETED|Overall Study||35
161167|NCT01565369|392503|P1|STARTED|Overall Study||35
161168|NCT01565356|392509|P1|NOT COMPLETED|Overall Study||0
161169|NCT01565356|392509|P1|COMPLETED|Overall Study||41
161170|NCT01565356|392509|P1|STARTED|Overall Study||41
161171|NCT01565343|392517|P3|NOT COMPLETED|Overall Study||0
161172|NCT01565343|392518|P2|NOT COMPLETED|Overall Study||0
161173|NCT01565343|392519|P1|NOT COMPLETED|Overall Study||1
161174|NCT01565343|392517|P3|COMPLETED|Overall Study||10
161175|NCT01565343|392518|P2|COMPLETED|Overall Study||4
161176|NCT01565343|392519|P1|COMPLETED|Overall Study||10
161177|NCT01565343|392517|P3|STARTED|Overall Study||10
161178|NCT01565343|392518|P2|STARTED|Overall Study||4
161179|NCT01565343|392519|P1|STARTED|Overall Study||11
161180|NCT01565330|392530|P4|NOT COMPLETED|Overall Study||0
161181|NCT01565330|392531|P3|NOT COMPLETED|Overall Study||0
161182|NCT01565330|392532|P2|NOT COMPLETED|Overall Study||0
161183|NCT01565330|392533|P1|NOT COMPLETED|Overall Study||0
161184|NCT01565330|392530|P4|COMPLETED|Overall Study||7
161185|NCT01565330|392531|P3|COMPLETED|Overall Study||4
161186|NCT01565330|392532|P2|COMPLETED|Overall Study||4
161187|NCT01565330|392533|P1|COMPLETED|Overall Study||5
161188|NCT01565330|392530|P4|STARTED|Overall Study||7
161189|NCT01565330|392531|P3|STARTED|Overall Study||4
161190|NCT01565330|392532|P2|STARTED|Overall Study||4
161191|NCT01565330|392533|P1|STARTED|Overall Study||5
161192|NCT01565291|392549|P2|NOT COMPLETED|Overall Study||0
161193|NCT01565291|392550|P1|NOT COMPLETED|Overall Study||1
161194|NCT01565291|392549|P2|COMPLETED|Overall Study||16
161195|NCT01565291|392550|P1|COMPLETED|Overall Study||15
161196|NCT01565291|392549|P2|STARTED|Overall Study||16
161197|NCT01565291|392550|P1|STARTED|Overall Study||16
161198|NCT01565148|392562|P4|NOT COMPLETED|Overall Study||13
161199|NCT01565148|392563|P3|NOT COMPLETED|Overall Study||7
161200|NCT01565148|392564|P2|NOT COMPLETED|Overall Study||15
161201|NCT01565148|392565|P1|NOT COMPLETED|Overall Study||15
161202|NCT01565148|392562|P4|COMPLETED|Overall Study||32
161203|NCT01565148|392563|P3|COMPLETED|Overall Study||40
161204|NCT01565148|392564|P2|COMPLETED|Overall Study||31
161205|NCT01565148|392565|P1|COMPLETED|Overall Study||32
161206|NCT01565148|392562|P4|STARTED|Overall Study||45
161207|NCT01565148|392563|P3|STARTED|Overall Study||47
161208|NCT01565148|392564|P2|STARTED|Overall Study||46
161209|NCT01565148|392565|P1|STARTED|Overall Study||47
161210|NCT01565083|392601|P2|NOT COMPLETED|Overall Study||39
161211|NCT01565083|392602|P1|NOT COMPLETED|Overall Study||33
161212|NCT01565083|392601|P2|COMPLETED|Overall Study||68
161213|NCT01565083|392602|P1|COMPLETED|Overall Study||73
161214|NCT01565083|392601|P2|STARTED|Overall Study||107
161215|NCT01565083|392602|P1|STARTED|Overall Study||106
161216|NCT01564953|392628|P1|NOT COMPLETED|Overall Study||0
161217|NCT01564953|392628|P1|COMPLETED|Overall Study||143
161218|NCT01564953|392628|P1|STARTED|Overall Study||143
161219|NCT01564914|392638|P2|NOT COMPLETED|Overall Study||0
161220|NCT01564914|392639|P1|NOT COMPLETED|Overall Study||0
161221|NCT01564914|392638|P2|COMPLETED|Overall Study||6
161222|NCT01564914|392639|P1|COMPLETED|Overall Study||16
161223|NCT01564914|392638|P2|STARTED|Overall Study||6
161224|NCT01564914|392639|P1|STARTED|Overall Study||16
161225|NCT01564862|392653|P3|NOT COMPLETED|Overall Study||30
161226|NCT01564862|392654|P2|NOT COMPLETED|Overall Study||34
161227|NCT01564862|392655|P1|NOT COMPLETED|Overall Study||30
161228|NCT01564862|392653|P3|COMPLETED|Overall Study||164
161229|NCT01564862|392654|P2|COMPLETED|Overall Study||176
161230|NCT01564862|392655|P1|COMPLETED|Overall Study||168
161231|NCT01564862|392653|P3|Received Treatment|Overall Study||191
161232|NCT01564862|392654|P2|Received Treatment|Overall Study||207
161233|NCT01564862|392655|P1|Received Treatment|Overall Study||196
161234|NCT01564862|392653|P3|STARTED|Overall Study||194
161235|NCT01564862|392654|P2|STARTED|Overall Study||210
161236|NCT01564862|392655|P1|STARTED|Overall Study||198
161237|NCT01564784|392706|P2|NOT COMPLETED|Overall Study||133
161238|NCT01564784|392707|P1|NOT COMPLETED|Overall Study||134
161239|NCT01564784|392706|P2|COMPLETED|Overall Study||10
161240|NCT01564784|392707|P1|COMPLETED|Overall Study||30
161241|NCT01564784|392706|P2|STARTED|Overall Study|Treated (162 randomized)|143
161242|NCT01564784|392707|P1|STARTED|Overall Study|Treated (164 randomized)|164
161243|NCT01564758|392734|P1|NOT COMPLETED|Overall Study||14
161244|NCT01564758|392734|P1|COMPLETED|Overall Study||85
161245|NCT01564758|392734|P1|STARTED|Overall Study||99
161246|NCT01564732|392741|P2|NOT COMPLETED|Overall Study||5
161247|NCT01564732|392742|P1|NOT COMPLETED|Overall Study||6
161248|NCT01564732|392741|P2|COMPLETED|Overall Study||0
161249|NCT01564732|392742|P1|COMPLETED|Overall Study||0
161250|NCT01564732|392741|P2|STARTED|Overall Study||5
161251|NCT01564732|392742|P1|STARTED|Overall Study||6
161252|NCT01564706|392758|P1|NOT COMPLETED|Overall Study||0
161253|NCT01564706|392758|P1|COMPLETED|Overall Study||9
161254|NCT01564706|392758|P1|STARTED|Overall Study||9
161255|NCT01564693|392765|P3|NOT COMPLETED|Overall Study||0
161256|NCT01564693|392766|P2|NOT COMPLETED|Overall Study||0
161257|NCT01564693|392767|P1|NOT COMPLETED|Overall Study||0
161258|NCT01564693|392765|P3|COMPLETED|Overall Study||2
161259|NCT01564693|392766|P2|COMPLETED|Overall Study||4
161260|NCT01564693|392767|P1|COMPLETED|Overall Study||9
161261|NCT01564693|392765|P3|STARTED|Overall Study|Only 2 patients were found necessary to give statistical relevance to the patients' results.|2
161262|NCT01564693|392766|P2|STARTED|Overall Study||4
161263|NCT01564693|392767|P1|STARTED|Overall Study|Originally we planned to study 4 patients. We expanded to 9 to improve consistency of the results.|9
161264|NCT01564628|392775|P3|NOT COMPLETED|Overall Study||2
161265|NCT01564628|392776|P2|NOT COMPLETED|Overall Study||2
161266|NCT01564628|392777|P1|NOT COMPLETED|Overall Study||4
161267|NCT01564628|392775|P3|COMPLETED|Overall Study||61
161268|NCT01564628|392776|P2|COMPLETED|Overall Study||56
161269|NCT01564628|392777|P1|COMPLETED|Overall Study||181
161270|NCT01564628|392775|P3|STARTED|Overall Study||63
161271|NCT01564628|392776|P2|STARTED|Overall Study||58
161272|NCT01564628|392777|P1|STARTED|Overall Study||185
161273|NCT01564537|392783|P2|NOT COMPLETED|Overall Study||6
161274|NCT01564537|392784|P1|NOT COMPLETED|Overall Study||6
161275|NCT01564537|392783|P2|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|356
161276|NCT01564537|392784|P1|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|354
161277|NCT01564537|392783|P2|Safety Population: Received Study Drug|Overall Study||360
161278|NCT01564537|392784|P1|Safety Population: Received Study Drug|Overall Study||360
161279|NCT01564537|392783|P2|STARTED|Overall Study||362
161280|NCT01564537|392784|P1|STARTED|Overall Study||360
161281|NCT01564459|392807|P3|NOT COMPLETED|Double-blind Treatment||1
161282|NCT01564459|392808|P2|NOT COMPLETED|Double-blind Treatment||0
161283|NCT01564459|392809|P1|NOT COMPLETED|Double-blind Treatment||0
161284|NCT01564459|392807|P3|COMPLETED|Double-blind Treatment||82
161285|NCT01564459|392808|P2|COMPLETED|Double-blind Treatment||87
161286|NCT01564459|392809|P1|COMPLETED|Double-blind Treatment||0
161287|NCT01564459|392807|P3|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|83
161288|NCT01564459|392808|P2|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|87
161289|NCT01564459|392809|P1|STARTED|Double-blind Treatment||0
161290|NCT01564459|392807|P3|NOT COMPLETED|Run-In||0
161291|NCT01564459|392808|P2|NOT COMPLETED|Run-In||0
161292|NCT01564459|392809|P1|NOT COMPLETED|Run-In||12
161293|NCT01564459|392807|P3|COMPLETED|Run-In||83
161294|NCT01564459|392808|P2|COMPLETED|Run-In||87
161295|NCT01564459|392809|P1|COMPLETED|Run-In||0
161296|NCT01564459|392807|P3|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|83
161297|NCT01564459|392808|P2|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|87
161298|NCT01564459|392809|P1|STARTED|Run-In||12
161299|NCT01564407|392833|P5|NOT COMPLETED|Overall Study||0
161300|NCT01564407|392834|P4|NOT COMPLETED|Overall Study||1
161301|NCT01564407|392835|P3|NOT COMPLETED|Overall Study||0
161302|NCT01564407|392836|P2|NOT COMPLETED|Overall Study||2
161303|NCT01564407|392837|P1|NOT COMPLETED|Overall Study||0
161304|NCT01564407|392833|P5|COMPLETED|Overall Study||0
161305|NCT01564407|392834|P4|COMPLETED|Overall Study||1
161306|NCT01564407|392835|P3|COMPLETED|Overall Study||4
161307|NCT01564407|392836|P2|COMPLETED|Overall Study||3
161308|NCT01564407|392837|P1|COMPLETED|Overall Study||4
161309|NCT01564407|392833|P5|STARTED|Overall Study||0
161310|NCT01564407|392834|P4|STARTED|Overall Study||2
161311|NCT01564407|392835|P3|STARTED|Overall Study||4
161312|NCT01564407|392836|P2|STARTED|Overall Study||5
161313|NCT01564407|392837|P1|STARTED|Overall Study||4
161314|NCT01564394|392878|P2|NOT COMPLETED|Overall Study||10
161315|NCT01564394|392879|P1|NOT COMPLETED|Overall Study||6
161316|NCT01564394|392878|P2|COMPLETED|Overall Study|Prostate cancer survivors n=13, family n=7.|20
161317|NCT01564394|392879|P1|COMPLETED|Overall Study|Prostate cancer survivors n=16, family n=8.|24
161318|NCT01564394|392878|P2|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
161319|NCT01564394|392879|P1|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
161320|NCT01564277|392893|P2|NOT COMPLETED|Overall Study||1
161321|NCT01564277|392894|P1|NOT COMPLETED|Overall Study||1
161322|NCT01564277|392893|P2|COMPLETED|Overall Study||11
161323|NCT01564277|392894|P1|COMPLETED|Overall Study||11
161324|NCT01564277|392893|P2|STARTED|Overall Study||12
161325|NCT01564277|392894|P1|STARTED|Overall Study||12
161326|NCT01563978|392912|P2|NOT COMPLETED|Overall Study||2
161327|NCT01563978|392913|P1|NOT COMPLETED|Overall Study||4
161328|NCT01563978|392912|P2|COMPLETED|Overall Study||65
161329|NCT01563978|392913|P1|COMPLETED|Overall Study||64
161330|NCT01563978|392912|P2|Randomised But Did Not Receive Treatment|Overall Study||0
161331|NCT01563978|392913|P1|Randomised But Did Not Receive Treatment|Overall Study||0
161332|NCT01563978|392912|P2|STARTED|Overall Study|Patients who received treatment.|67
161333|NCT01563978|392913|P1|STARTED|Overall Study|Patients who received treatment.|68
161334|NCT01563913|392939|P2|NOT COMPLETED|Overall Study||0
161335|NCT01563913|392940|P1|NOT COMPLETED|Overall Study||2
161336|NCT01563913|392939|P2|COMPLETED|Overall Study||15
161337|NCT01563913|392940|P1|COMPLETED|Overall Study||13
161338|NCT01563913|392939|P2|STARTED|Overall Study||15
161339|NCT01563913|392940|P1|STARTED|Overall Study||15
161340|NCT01563536|392952|P2|NOT COMPLETED|Overall Study||2
161341|NCT01563536|392953|P1|NOT COMPLETED|Overall Study||1
161342|NCT01563536|392952|P2|COMPLETED|Overall Study||4
161343|NCT01563536|392953|P1|COMPLETED|Overall Study||5
161344|NCT01563536|392952|P2|STARTED|Overall Study||6
161345|NCT01563536|392953|P1|STARTED|Overall Study||6
161346|NCT01563406|392985|P4|NOT COMPLETED|Overall Study||0
161347|NCT01563406|392986|P3|NOT COMPLETED|Overall Study||0
161348|NCT01563406|392987|P2|NOT COMPLETED|Overall Study||0
161349|NCT01563406|392988|P1|NOT COMPLETED|Overall Study||0
161350|NCT01563406|392985|P4|COMPLETED|Overall Study|112 hubs|29
161351|NCT01563406|392986|P3|COMPLETED|Overall Study|101 hubs|30
161352|NCT01563406|392987|P2|COMPLETED|Overall Study|102 hubs|30
161353|NCT01563406|392988|P1|COMPLETED|Overall Study|194 hubs|60
161354|NCT01563406|392985|P4|STARTED|Overall Study|112 hubs|29
161355|NCT01563406|392986|P3|STARTED|Overall Study|101 hubs|30
161356|NCT01563406|392987|P2|STARTED|Overall Study|102 hubs|30
161357|NCT01563406|392988|P1|STARTED|Overall Study|194 hubs|60
161358|NCT01563198|393006|P1|NOT COMPLETED|After Training||0
161359|NCT01563198|393006|P1|COMPLETED|After Training||47979
161360|NCT01563198|393006|P1|STARTED|After Training||47979
161361|NCT01563198|393006|P1|NOT COMPLETED|Baseline||0
161362|NCT01563198|393006|P1|COMPLETED|Baseline||49733
161363|NCT01563198|393006|P1|STARTED|Baseline||49733
161364|NCT01563185|393012|P1|NOT COMPLETED|Overall Study||2
161365|NCT01563185|393012|P1|COMPLETED|Overall Study||10
161366|NCT01563185|393012|P1|STARTED|Overall Study||12
161367|NCT01563172|393026|P1|NOT COMPLETED|Overall Study||13
161368|NCT01563172|393026|P1|COMPLETED|Overall Study||52
161369|NCT01563172|393026|P1|Control Dentifrice|Overall Study||60
161370|NCT01563172|393026|P1|Experimental Dentifrice 1.5g/ 45 Sec|Overall Study||58
161371|NCT01563172|393026|P1|Experimental Dentifrice 1.5g/ 2min|Overall Study||58
161372|NCT01563172|393026|P1|Experimental Dentifrice 0.5g/45 Sec|Overall Study||59
161373|NCT01563172|393026|P1|Experimental Dentifrice 0.5g/2 Min|Overall Study||59
161374|NCT01563172|393026|P1|STARTED|Overall Study||65
161375|NCT01563081|393055|P2|NOT COMPLETED|Overall Study||0
161376|NCT01563081|393056|P1|NOT COMPLETED|Overall Study||0
161377|NCT01563081|393055|P2|COMPLETED|Overall Study||30
161378|NCT01563081|393056|P1|COMPLETED|Overall Study||30
161379|NCT01563081|393055|P2|STARTED|Overall Study||30
161380|NCT01563081|393056|P1|STARTED|Overall Study||30
161381|NCT01563055|393069|P1|NOT COMPLETED|Overall Study||0
161382|NCT01563055|393069|P1|COMPLETED|Overall Study||10
161383|NCT01563055|393069|P1|STARTED|Overall Study||10
161384|NCT01563029|393132|P5|NOT COMPLETED|Overall Study||29
161385|NCT01563029|393133|P4|NOT COMPLETED|Overall Study||33
161386|NCT01563029|393134|P3|NOT COMPLETED|Overall Study||33
161387|NCT01563029|393135|P2|NOT COMPLETED|Overall Study||24
161388|NCT01563029|393136|P1|NOT COMPLETED|Overall Study||53
161389|NCT01563029|393132|P5|COMPLETED|Overall Study||89
161390|NCT01563029|393133|P4|COMPLETED|Overall Study||85
161391|NCT01563029|393134|P3|COMPLETED|Overall Study||87
161392|NCT01563029|393135|P2|COMPLETED|Overall Study||94
161393|NCT01563029|393136|P1|COMPLETED|Overall Study||66
161394|NCT01563029|393132|P5|STARTED|Overall Study||118
161395|NCT01563029|393133|P4|STARTED|Overall Study||118
161396|NCT01563029|393134|P3|STARTED|Overall Study||120
161397|NCT01563029|393135|P2|STARTED|Overall Study||118
161398|NCT01563029|393136|P1|STARTED|Overall Study||119
161399|NCT01563003|393186|P2|NOT COMPLETED|Overall Study||0
161400|NCT01563003|393187|P1|NOT COMPLETED|Overall Study||0
161401|NCT01563003|393186|P2|COMPLETED|Overall Study||15
161402|NCT01563003|393187|P1|COMPLETED|Overall Study||16
161403|NCT01563003|393186|P2|STARTED|Overall Study||15
161404|NCT01563003|393187|P1|STARTED|Overall Study||16
161405|NCT01562886|393197|P1|NOT COMPLETED|Overall Study||1
161406|NCT01562886|393197|P1|COMPLETED|Overall Study||13
161407|NCT01562886|393197|P1|STARTED|Overall Study||14
161408|NCT01562873|393202|P2|NOT COMPLETED|Overall Study||0
161409|NCT01562873|393203|P1|NOT COMPLETED|Overall Study||21
161410|NCT01562873|393202|P2|COMPLETED|Overall Study||0
161411|NCT01562873|393203|P1|COMPLETED|Overall Study||0
161412|NCT01562873|393202|P2|STARTED|Overall Study|The observed number of objective responses in Cohort A was not sufficient for Cohort B to open.|0
161413|NCT01562873|393203|P1|STARTED|Overall Study||21
161414|NCT01562782|393212|P2|NOT COMPLETED|Overall Study||5
161415|NCT01562782|393213|P1|NOT COMPLETED|Overall Study||4
161416|NCT01562782|393212|P2|COMPLETED|Overall Study||15
161417|NCT01562782|393213|P1|COMPLETED|Overall Study||15
161418|NCT01562782|393212|P2|STARTED|Overall Study||20
161419|NCT01562782|393213|P1|STARTED|Overall Study||19
161420|NCT01562756|393237|P1|NOT COMPLETED|Overall Study||0
161421|NCT01562756|393237|P1|COMPLETED|Overall Study||6
161422|NCT01562756|393237|P1|STARTED|Overall Study||6
161423|NCT01562743|393242|P1|NOT COMPLETED|Overall Study||52
161424|NCT01562743|393242|P1|COMPLETED|Overall Study||133
161425|NCT01562743|393242|P1|STARTED|Overall Study||185
161426|NCT01562678|393254|P2|NOT COMPLETED|Overall Study||2
161427|NCT01562678|393255|P1|NOT COMPLETED|Overall Study||6
161428|NCT01562678|393254|P2|COMPLETED|Overall Study||12
161429|NCT01562678|393255|P1|COMPLETED|Overall Study||8
161430|NCT01562678|393254|P2|STARTED|Overall Study||14
161431|NCT01562678|393255|P1|STARTED|Overall Study||14
161432|NCT01562613|393261|P1|NOT COMPLETED|Overall Study||4
161433|NCT01562613|393261|P1|COMPLETED|Overall Study||529
161434|NCT01562613|393261|P1|STARTED|Overall Study||533
161435|NCT01562548|393271|P4|NOT COMPLETED|Overall Study||0
161436|NCT01562548|393272|P3|NOT COMPLETED|Overall Study||1
161437|NCT01562548|393273|P2|NOT COMPLETED|Overall Study||0
161438|NCT01562548|393274|P1|NOT COMPLETED|Overall Study||0
161439|NCT01562548|393271|P4|COMPLETED|Overall Study||14
161440|NCT01562548|393272|P3|COMPLETED|Overall Study||24
161441|NCT01562548|393273|P2|COMPLETED|Overall Study||15
161442|NCT01562548|393274|P1|COMPLETED|Overall Study||25
161443|NCT01562548|393271|P4|STARTED|Overall Study||14
161444|NCT01562548|393272|P3|STARTED|Overall Study||25
161445|NCT01562548|393273|P2|STARTED|Overall Study||15
161446|NCT01562548|393274|P1|STARTED|Overall Study||25
161447|NCT01562444|393327|P3|NOT COMPLETED|Overall Study||7
161448|NCT01562444|393328|P2|NOT COMPLETED|Overall Study||2
161449|NCT01562444|393329|P1|NOT COMPLETED|Overall Study||5
161450|NCT01562444|393327|P3|COMPLETED|Overall Study||99
161451|NCT01562444|393328|P2|COMPLETED|Overall Study||49
161452|NCT01562444|393329|P1|COMPLETED|Overall Study||43
161453|NCT01562444|393327|P3|STARTED|Overall Study||106
161454|NCT01562444|393328|P2|STARTED|Overall Study||51
161455|NCT01562444|393329|P1|STARTED|Overall Study||48
161456|NCT01562379|393579|P5|NOT COMPLETED|Overall Study||40
161457|NCT01562379|393580|P4|NOT COMPLETED|Overall Study||57
161458|NCT01562379|393581|P3|NOT COMPLETED|Overall Study||62
161459|NCT01562379|393582|P2|NOT COMPLETED|Overall Study||97
161460|NCT01562379|393583|P1|NOT COMPLETED|Overall Study||126
161461|NCT01562379|393579|P5|COMPLETED|Overall Study||785
161462|NCT01562379|393580|P4|COMPLETED|Overall Study||786
161463|NCT01562379|393581|P3|COMPLETED|Overall Study||789
161464|NCT01562379|393582|P2|COMPLETED|Overall Study||1395
161465|NCT01562379|393583|P1|COMPLETED|Overall Study||1312
161466|NCT01562379|393579|P5|STARTED|Overall Study||825
161467|NCT01562379|393580|P4|STARTED|Overall Study||843
161468|NCT01562379|393581|P3|STARTED|Overall Study||851
161469|NCT01562379|393582|P2|STARTED|Overall Study||1492
161470|NCT01562379|393583|P1|STARTED|Overall Study||1438
161471|NCT01562327|393595|P1|NOT COMPLETED|Overall Study||8
161472|NCT01562327|393595|P1|COMPLETED|Overall Study||42
161473|NCT01562327|393595|P1|STARTED|Overall Study||50
161474|NCT01562314|393625|P2|NOT COMPLETED|Overall Study||8
161475|NCT01562314|393626|P1|NOT COMPLETED|Overall Study||13
161476|NCT01562314|393625|P2|COMPLETED|Overall Study||23
161477|NCT01562314|393626|P1|COMPLETED|Overall Study||16
161478|NCT01562314|393625|P2|Per Protocol (PP) Analysis Set|Overall Study||27
161479|NCT01562314|393626|P1|Per Protocol (PP) Analysis Set|Overall Study||17
161480|NCT01562314|393625|P2|Intent-to-Treat (ITT) Analysis Set|Overall Study||31
161481|NCT01562314|393626|P1|Intent-to-Treat (ITT) Analysis Set|Overall Study||29
161482|NCT01562314|393625|P2|Received at Least 1 Dose of Study Drug|Overall Study||31
161483|NCT01562314|393626|P1|Received at Least 1 Dose of Study Drug|Overall Study||29
161484|NCT01562314|393625|P2|STARTED|Overall Study||31
161485|NCT01562314|393626|P1|STARTED|Overall Study||29
161486|NCT01562275|393683|P13|NOT COMPLETED|Stage 2||5
161487|NCT01562275|393684|P12|NOT COMPLETED|Stage 2||14
161488|NCT01562275|393685|P11|NOT COMPLETED|Stage 2||0
161489|NCT01562275|393686|P10|NOT COMPLETED|Stage 2||0
161490|NCT01562275|393687|P9|NOT COMPLETED|Stage 2||0
161491|NCT01562275|393688|P8|NOT COMPLETED|Stage 2||0
161492|NCT01562275|393689|P7|NOT COMPLETED|Stage 2||0
161493|NCT01562275|393690|P6|NOT COMPLETED|Stage 2||0
161494|NCT01562275|393691|P5|NOT COMPLETED|Stage 2||0
161495|NCT01562275|393692|P4|NOT COMPLETED|Stage 2||0
161496|NCT01562275|393693|P3|NOT COMPLETED|Stage 2||0
161497|NCT01562275|393694|P2|NOT COMPLETED|Stage 2||0
161498|NCT01562275|393695|P1|NOT COMPLETED|Stage 2||0
161499|NCT01562275|393683|P13|COMPLETED|Stage 2||0
161500|NCT01562275|393684|P12|COMPLETED|Stage 2||0
161501|NCT01562275|393685|P11|COMPLETED|Stage 2||0
161502|NCT01562275|393686|P10|COMPLETED|Stage 2||0
161503|NCT01562275|393687|P9|COMPLETED|Stage 2||0
161504|NCT01562275|393688|P8|COMPLETED|Stage 2||0
161505|NCT01562275|393689|P7|COMPLETED|Stage 2||0
161506|NCT01562275|393690|P6|COMPLETED|Stage 2||0
161507|NCT01562275|393691|P5|COMPLETED|Stage 2||0
161508|NCT01562275|393692|P4|COMPLETED|Stage 2||0
161509|NCT01562275|393693|P3|COMPLETED|Stage 2||0
161510|NCT01562275|393694|P2|COMPLETED|Stage 2||0
161511|NCT01562275|393695|P1|COMPLETED|Stage 2||0
161512|NCT01562275|393683|P13|STARTED|Stage 2||5
161513|NCT01562275|393684|P12|STARTED|Stage 2||14
161514|NCT01562275|393685|P11|STARTED|Stage 2||0
161515|NCT01562275|393686|P10|STARTED|Stage 2||0
161516|NCT01562275|393687|P9|STARTED|Stage 2||0
161517|NCT01562275|393688|P8|STARTED|Stage 2||0
161518|NCT01562275|393689|P7|STARTED|Stage 2||0
161519|NCT01562275|393690|P6|STARTED|Stage 2||0
161520|NCT01562275|393691|P5|STARTED|Stage 2||0
161521|NCT01562275|393692|P4|STARTED|Stage 2||0
161522|NCT01562275|393693|P3|STARTED|Stage 2||0
161523|NCT01562275|393694|P2|STARTED|Stage 2||0
161524|NCT01562275|393695|P1|STARTED|Stage 2||0
161525|NCT01562275|393683|P13|NOT COMPLETED|Stage 1||0
161526|NCT01562275|393684|P12|NOT COMPLETED|Stage 1||0
161527|NCT01562275|393685|P11|NOT COMPLETED|Stage 1||3
161528|NCT01562275|393686|P10|NOT COMPLETED|Stage 1||7
161529|NCT01562275|393687|P9|NOT COMPLETED|Stage 1||3
161530|NCT01562275|393688|P8|NOT COMPLETED|Stage 1||7
161531|NCT01562275|393689|P7|NOT COMPLETED|Stage 1||3
161532|NCT01562275|393690|P6|NOT COMPLETED|Stage 1||4
161533|NCT01562275|393691|P5|NOT COMPLETED|Stage 1||4
161534|NCT01562275|393692|P4|NOT COMPLETED|Stage 1||4
161535|NCT01562275|393693|P3|NOT COMPLETED|Stage 1||3
161536|NCT01562275|393694|P2|NOT COMPLETED|Stage 1||7
161537|NCT01562275|393695|P1|NOT COMPLETED|Stage 1||3
161538|NCT01562275|393683|P13|COMPLETED|Stage 1||0
161539|NCT01562275|393684|P12|COMPLETED|Stage 1||0
161540|NCT01562275|393685|P11|COMPLETED|Stage 1||0
161541|NCT01562275|393686|P10|COMPLETED|Stage 1||0
161542|NCT01562275|393687|P9|COMPLETED|Stage 1||0
161543|NCT01562275|393688|P8|COMPLETED|Stage 1||0
161544|NCT01562275|393689|P7|COMPLETED|Stage 1||0
161545|NCT01562275|393690|P6|COMPLETED|Stage 1||0
161546|NCT01562275|393691|P5|COMPLETED|Stage 1||0
161547|NCT01562275|393692|P4|COMPLETED|Stage 1||0
161548|NCT01562275|393693|P3|COMPLETED|Stage 1||0
161549|NCT01562275|393694|P2|COMPLETED|Stage 1||0
161550|NCT01562275|393695|P1|COMPLETED|Stage 1||0
161551|NCT01562275|393683|P13|STARTED|Stage 1||0
161552|NCT01562275|393684|P12|STARTED|Stage 1||0
161553|NCT01562275|393685|P11|STARTED|Stage 1||3
161554|NCT01562275|393686|P10|STARTED|Stage 1||7
161555|NCT01562275|393687|P9|STARTED|Stage 1||3
161556|NCT01562275|393688|P8|STARTED|Stage 1||7
161557|NCT01562275|393689|P7|STARTED|Stage 1||3
161558|NCT01562275|393690|P6|STARTED|Stage 1||4
161559|NCT01562275|393691|P5|STARTED|Stage 1||4
161560|NCT01562275|393692|P4|STARTED|Stage 1||4
161561|NCT01562275|393693|P3|STARTED|Stage 1||3
161562|NCT01562275|393694|P2|STARTED|Stage 1||7
161563|NCT01562275|393695|P1|STARTED|Stage 1||3
161564|NCT01562132|393827|P2|NOT COMPLETED|Overall Study||0
161565|NCT01562132|393828|P1|NOT COMPLETED|Overall Study||0
161566|NCT01562132|393827|P2|COMPLETED|Overall Study||3
161567|NCT01562132|393828|P1|COMPLETED|Overall Study||3
161568|NCT01562132|393827|P2|STARTED|Overall Study||3
161569|NCT01562132|393828|P1|STARTED|Overall Study||3
161570|NCT01562028|393836|P2|NOT COMPLETED|Overall Study||2
161571|NCT01562028|393837|P1|NOT COMPLETED|Overall Study||3
161572|NCT01562028|393836|P2|COMPLETED|Overall Study||70
161573|NCT01562028|393837|P1|COMPLETED|Overall Study||34
161574|NCT01562028|393836|P2|STARTED|Overall Study||72
161575|NCT01562028|393837|P1|STARTED|Overall Study||37
161576|NCT01561976|393861|P6|NOT COMPLETED|Period 3||0
161577|NCT01561976|393862|P5|NOT COMPLETED|Period 3||0
161578|NCT01561976|393863|P4|NOT COMPLETED|Period 3||0
161579|NCT01561976|393864|P3|NOT COMPLETED|Period 3||0
161580|NCT01561976|393865|P2|NOT COMPLETED|Period 3||0
161581|NCT01561976|393866|P1|NOT COMPLETED|Period 3||0
161582|NCT01561976|393861|P6|COMPLETED|Period 3||4
161583|NCT01561976|393862|P5|COMPLETED|Period 3||5
161584|NCT01561976|393863|P4|COMPLETED|Period 3||4
161585|NCT01561976|393864|P3|COMPLETED|Period 3||3
161586|NCT01561976|393865|P2|COMPLETED|Period 3||5
161587|NCT01561976|393866|P1|COMPLETED|Period 3||4
161588|NCT01561976|393861|P6|STARTED|Period 3||4
161589|NCT01561976|393862|P5|STARTED|Period 3||5
161590|NCT01561976|393863|P4|STARTED|Period 3||4
161591|NCT01561976|393864|P3|STARTED|Period 3||3
161592|NCT01561976|393865|P2|STARTED|Period 3||5
161593|NCT01561976|393866|P1|STARTED|Period 3||4
161594|NCT01561976|393861|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
161595|NCT01561976|393862|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
161596|NCT01561976|393863|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
161597|NCT01561976|393864|P3|NOT COMPLETED|Washout Period 2 (7 Days)||1
161598|NCT01561976|393865|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
161599|NCT01561976|393866|P1|NOT COMPLETED|Washout Period 2 (7 Days)||1
161600|NCT01561976|393861|P6|COMPLETED|Washout Period 2 (7 Days)||4
161601|NCT01561976|393862|P5|COMPLETED|Washout Period 2 (7 Days)||5
161602|NCT01561976|393863|P4|COMPLETED|Washout Period 2 (7 Days)||4
161603|NCT01561976|393864|P3|COMPLETED|Washout Period 2 (7 Days)||3
161604|NCT01561976|393865|P2|COMPLETED|Washout Period 2 (7 Days)||5
161605|NCT01561976|393866|P1|COMPLETED|Washout Period 2 (7 Days)||4
161606|NCT01561976|393861|P6|STARTED|Washout Period 2 (7 Days)||4
161607|NCT01561976|393862|P5|STARTED|Washout Period 2 (7 Days)||5
161608|NCT01561976|393863|P4|STARTED|Washout Period 2 (7 Days)||4
161609|NCT01561976|393864|P3|STARTED|Washout Period 2 (7 Days)||4
161610|NCT01561976|393865|P2|STARTED|Washout Period 2 (7 Days)||5
161611|NCT01561976|393866|P1|STARTED|Washout Period 2 (7 Days)||5
161612|NCT01561976|393861|P6|NOT COMPLETED|Period 2||0
161613|NCT01561976|393862|P5|NOT COMPLETED|Period 2||0
161614|NCT01561976|393863|P4|NOT COMPLETED|Period 2||0
161615|NCT01561976|393864|P3|NOT COMPLETED|Period 2||0
161616|NCT01561976|393865|P2|NOT COMPLETED|Period 2||0
161617|NCT01561976|393866|P1|NOT COMPLETED|Period 2||0
161618|NCT01561976|393861|P6|COMPLETED|Period 2||4
161619|NCT01561976|393862|P5|COMPLETED|Period 2||5
161620|NCT01561976|393863|P4|COMPLETED|Period 2||4
161621|NCT01561976|393864|P3|COMPLETED|Period 2||4
161622|NCT01561976|393865|P2|COMPLETED|Period 2||5
161623|NCT01561976|393866|P1|COMPLETED|Period 2||5
161624|NCT01561976|393861|P6|STARTED|Period 2||4
161625|NCT01561976|393862|P5|STARTED|Period 2||5
161626|NCT01561976|393863|P4|STARTED|Period 2||4
161627|NCT01561976|393864|P3|STARTED|Period 2||4
161628|NCT01561976|393865|P2|STARTED|Period 2||5
161629|NCT01561976|393866|P1|STARTED|Period 2||5
161630|NCT01561976|393861|P6|NOT COMPLETED|Washout Period 1 (7 Days)||1
161631|NCT01561976|393862|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
161632|NCT01561976|393863|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
161633|NCT01561976|393864|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
161634|NCT01561976|393865|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
161635|NCT01561976|393866|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
161636|NCT01561976|393861|P6|COMPLETED|Washout Period 1 (7 Days)||4
161637|NCT01561976|393862|P5|COMPLETED|Washout Period 1 (7 Days)||5
161638|NCT01561976|393863|P4|COMPLETED|Washout Period 1 (7 Days)||4
161639|NCT01561976|393864|P3|COMPLETED|Washout Period 1 (7 Days)||4
161640|NCT01561976|393865|P2|COMPLETED|Washout Period 1 (7 Days)||5
161641|NCT01561976|393866|P1|COMPLETED|Washout Period 1 (7 Days)||5
161642|NCT01561976|393861|P6|STARTED|Washout Period 1 (7 Days)||5
161643|NCT01561976|393862|P5|STARTED|Washout Period 1 (7 Days)||5
161644|NCT01561976|393863|P4|STARTED|Washout Period 1 (7 Days)||5
161645|NCT01561976|393864|P3|STARTED|Washout Period 1 (7 Days)||4
161646|NCT01561976|393865|P2|STARTED|Washout Period 1 (7 Days)||5
161647|NCT01561976|393866|P1|STARTED|Washout Period 1 (7 Days)||5
161648|NCT01561976|393861|P6|NOT COMPLETED|Period 1||0
161649|NCT01561976|393862|P5|NOT COMPLETED|Period 1||0
161650|NCT01561976|393863|P4|NOT COMPLETED|Period 1||0
161651|NCT01561976|393864|P3|NOT COMPLETED|Period 1||1
161652|NCT01561976|393865|P2|NOT COMPLETED|Period 1||0
161653|NCT01561976|393866|P1|NOT COMPLETED|Period 1||0
161654|NCT01561976|393861|P6|COMPLETED|Period 1||5
161655|NCT01561976|393862|P5|COMPLETED|Period 1||5
161656|NCT01561976|393863|P4|COMPLETED|Period 1||5
161657|NCT01561976|393864|P3|COMPLETED|Period 1||4
161658|NCT01561976|393865|P2|COMPLETED|Period 1||5
161659|NCT01561976|393866|P1|COMPLETED|Period 1||5
161660|NCT01561976|393861|P6|STARTED|Period 1||5
161661|NCT01561976|393862|P5|STARTED|Period 1||5
161662|NCT01561976|393863|P4|STARTED|Period 1||5
161663|NCT01561976|393864|P3|STARTED|Period 1||5
161664|NCT01561976|393865|P2|STARTED|Period 1||5
161665|NCT01561976|393866|P1|STARTED|Period 1||5
161666|NCT01561898|393899|P4|NOT COMPLETED|Overall Study||20
161667|NCT01561898|393900|P3|NOT COMPLETED|Overall Study||44
161668|NCT01561898|393901|P2|NOT COMPLETED|Overall Study||41
161669|NCT01561898|393902|P1|NOT COMPLETED|Overall Study||2
161670|NCT01561898|393899|P4|COMPLETED|Overall Study||12
161671|NCT01561898|393900|P3|COMPLETED|Overall Study||53
161672|NCT01561898|393901|P2|COMPLETED|Overall Study||51
161673|NCT01561898|393902|P1|COMPLETED|Overall Study||5
161674|NCT01561898|393899|P4|STARTED|Overall Study||32
161675|NCT01561898|393900|P3|STARTED|Overall Study||97
161676|NCT01561898|393901|P2|STARTED|Overall Study||92
161677|NCT01561898|393902|P1|STARTED|Overall Study||7
161678|NCT01561755|393916|P2|NOT COMPLETED|Overall Study||1
161679|NCT01561755|393917|P1|NOT COMPLETED|Overall Study||0
161680|NCT01561755|393916|P2|COMPLETED|Overall Study||5
161681|NCT01561755|393917|P1|COMPLETED|Overall Study||6
161682|NCT01561755|393916|P2|STARTED|Overall Study||6
161683|NCT01561755|393917|P1|STARTED|Overall Study||6
161684|NCT01561716|393941|P6|NOT COMPLETED|Overall Study||0
161685|NCT01561716|393942|P5|NOT COMPLETED|Overall Study||0
161686|NCT01561716|393943|P4|NOT COMPLETED|Overall Study||0
161687|NCT01561716|393944|P3|NOT COMPLETED|Overall Study||0
161688|NCT01561716|393945|P2|NOT COMPLETED|Overall Study||0
161689|NCT01561716|393946|P1|NOT COMPLETED|Overall Study||0
161690|NCT01561716|393941|P6|COMPLETED|Overall Study||5
161691|NCT01561716|393942|P5|COMPLETED|Overall Study||5
161692|NCT01561716|393943|P4|COMPLETED|Overall Study||5
161693|NCT01561716|393944|P3|COMPLETED|Overall Study||5
161694|NCT01561716|393945|P2|COMPLETED|Overall Study||5
161695|NCT01561716|393946|P1|COMPLETED|Overall Study||5
161696|NCT01561716|393941|P6|STARTED|Overall Study||5
161697|NCT01561716|393942|P5|STARTED|Overall Study||5
161698|NCT01561716|393943|P4|STARTED|Overall Study||5
161699|NCT01561716|393944|P3|STARTED|Overall Study||5
161700|NCT01561716|393945|P2|STARTED|Overall Study||5
161701|NCT01561716|393946|P1|STARTED|Overall Study||5
161702|NCT01561703|393962|P2|NOT COMPLETED|Overall Study||6
161703|NCT01561703|393963|P1|NOT COMPLETED|Overall Study||8
161704|NCT01561703|393962|P2|COMPLETED|Overall Study||24
161705|NCT01561703|393963|P1|COMPLETED|Overall Study||20
161706|NCT01561703|393962|P2|STARTED|Overall Study||30
161707|NCT01561703|393963|P1|STARTED|Overall Study||28
161708|NCT01561560|393969|P2|NOT COMPLETED|Second Two Weeks of Wear||1
161709|NCT01561560|393970|P1|NOT COMPLETED|Second Two Weeks of Wear||0
161710|NCT01561560|393969|P2|COMPLETED|Second Two Weeks of Wear||58
161711|NCT01561560|393970|P1|COMPLETED|Second Two Weeks of Wear||60
161712|NCT01561560|393969|P2|STARTED|Second Two Weeks of Wear||59
161713|NCT01561560|393970|P1|STARTED|Second Two Weeks of Wear||60
161714|NCT01561560|393969|P2|NOT COMPLETED|First Two Weeks of Wear||2
161715|NCT01561560|393970|P1|NOT COMPLETED|First Two Weeks of Wear||0
161716|NCT01561560|393969|P2|COMPLETED|First Two Weeks of Wear||59
161717|NCT01561560|393970|P1|COMPLETED|First Two Weeks of Wear||60
161718|NCT01561560|393969|P2|STARTED|First Two Weeks of Wear||61
161719|NCT01561560|393970|P1|STARTED|First Two Weeks of Wear||60
161720|NCT01561469|393978|P2|NOT COMPLETED|Overall Study||0
161721|NCT01561469|393979|P1|NOT COMPLETED|Overall Study||0
161722|NCT01561469|393978|P2|COMPLETED|Overall Study||87
161723|NCT01561469|393979|P1|COMPLETED|Overall Study||101
161724|NCT01561469|393978|P2|STARTED|Overall Study||87
161725|NCT01561469|393979|P1|STARTED|Overall Study||101
161726|NCT01561430|394001|P4|NOT COMPLETED|Overall Study||13
161727|NCT01561430|394002|P3|NOT COMPLETED|Overall Study||17
161728|NCT01561430|394003|P2|NOT COMPLETED|Overall Study||15
161729|NCT01561430|394004|P1|NOT COMPLETED|Overall Study||1
161730|NCT01561430|394001|P4|COMPLETED|Overall Study||7
161731|NCT01561430|394002|P3|COMPLETED|Overall Study||1
161732|NCT01561430|394003|P2|COMPLETED|Overall Study||8
161733|NCT01561430|394004|P1|COMPLETED|Overall Study||8
161734|NCT01561430|394001|P4|Received at Least One Dose of Study Drug|Overall Study||20
161735|NCT01561430|394002|P3|Received at Least One Dose of Study Drug|Overall Study||18
161736|NCT01561430|394003|P2|Received at Least One Dose of Study Drug|Overall Study||23
161737|NCT01561430|394004|P1|Received at Least One Dose of Study Drug|Overall Study||9
161738|NCT01561430|394001|P4|STARTED|Overall Study||20
161739|NCT01561430|394002|P3|STARTED|Overall Study||18
161740|NCT01561430|394003|P2|STARTED|Overall Study||23
161741|NCT01561430|394004|P1|STARTED|Overall Study||9
161742|NCT01561313|394044|P2|NOT COMPLETED|Overall Study||0
161743|NCT01561313|394045|P1|NOT COMPLETED|Overall Study||2
161744|NCT01561313|394044|P2|COMPLETED|Overall Study||31
161745|NCT01561313|394045|P1|COMPLETED|Overall Study||31
161746|NCT01561313|394044|P2|STARTED|Overall Study||31
161747|NCT01561313|394045|P1|STARTED|Overall Study||33
161748|NCT01561300|394063|P2|NOT COMPLETED|Second Intervention||0
161749|NCT01561300|394064|P1|NOT COMPLETED|Second Intervention||0
161750|NCT01561300|394063|P2|COMPLETED|Second Intervention||15
161751|NCT01561300|394064|P1|COMPLETED|Second Intervention||14
161752|NCT01561300|394063|P2|STARTED|Second Intervention||15
161753|NCT01561300|394064|P1|STARTED|Second Intervention||14
161754|NCT01561300|394063|P2|NOT COMPLETED|Washout on Placebo||0
161755|NCT01561300|394064|P1|NOT COMPLETED|Washout on Placebo||0
161756|NCT01561300|394063|P2|COMPLETED|Washout on Placebo||15
161757|NCT01561300|394064|P1|COMPLETED|Washout on Placebo||14
161758|NCT01561300|394063|P2|STARTED|Washout on Placebo||15
161759|NCT01561300|394064|P1|STARTED|Washout on Placebo||14
161760|NCT01561300|394063|P2|NOT COMPLETED|First Intervention||0
161761|NCT01561300|394064|P1|NOT COMPLETED|First Intervention||0
161762|NCT01561300|394063|P2|COMPLETED|First Intervention||15
161763|NCT01561300|394064|P1|COMPLETED|First Intervention||14
161764|NCT01561300|394063|P2|STARTED|First Intervention||15
161765|NCT01561300|394064|P1|STARTED|First Intervention||14
161766|NCT01561300|394063|P2|NOT COMPLETED|Run in on Placebo||0
161767|NCT01561300|394064|P1|NOT COMPLETED|Run in on Placebo||1
161768|NCT01561300|394063|P2|COMPLETED|Run in on Placebo||15
161769|NCT01561300|394064|P1|COMPLETED|Run in on Placebo||14
161770|NCT01561300|394063|P2|STARTED|Run in on Placebo||15
161771|NCT01561300|394064|P1|STARTED|Run in on Placebo||15
161772|NCT01561079|394075|P1|NOT COMPLETED|Overall Study||78
161773|NCT01561079|394075|P1|COMPLETED|Overall Study||49
161774|NCT01561079|394075|P1|STARTED|Overall Study||127
161775|NCT01561053|394122|P4|NOT COMPLETED|Overall Study||23
161776|NCT01561053|394123|P3|NOT COMPLETED|Overall Study||21
161777|NCT01561053|394124|P2|NOT COMPLETED|Overall Study||36
161778|NCT01561053|394125|P1|NOT COMPLETED|Overall Study||35
161779|NCT01561053|394122|P4|COMPLETED|Overall Study||64
161780|NCT01561053|394123|P3|COMPLETED|Overall Study||61
161781|NCT01561053|394124|P2|COMPLETED|Overall Study||56
161782|NCT01561053|394125|P1|COMPLETED|Overall Study||51
161783|NCT01561053|394122|P4|Evaluable Subjects|Overall Study||80
161784|NCT01561053|394123|P3|Evaluable Subjects|Overall Study||78
161785|NCT01561053|394124|P2|Evaluable Subjects|Overall Study||86
161786|NCT01561053|394125|P1|Evaluable Subjects|Overall Study||78
161787|NCT01561053|394122|P4|Randomized Not Treated|Overall Study||7
161788|NCT01561053|394123|P3|Randomized Not Treated|Overall Study||4
161789|NCT01561053|394124|P2|Randomized Not Treated|Overall Study||6
161790|NCT01561053|394125|P1|Randomized Not Treated|Overall Study||8
161791|NCT01561053|394122|P4|Patients With Baseline MMSE:22-26|Overall Study||45
161792|NCT01561053|394123|P3|Patients With Baseline MMSE:22-26|Overall Study||35
161793|NCT01561053|394124|P2|Patients With Baseline MMSE:22-26|Overall Study||52
161794|NCT01561053|394125|P1|Patients With Baseline MMSE:22-26|Overall Study||39
161795|NCT01561053|394122|P4|Patients With Baseline MMSE:18-21|Overall Study||42
161796|NCT01561053|394123|P3|Patients With Baseline MMSE:18-21|Overall Study||47
161797|NCT01561053|394124|P2|Patients With Baseline MMSE:18-21|Overall Study||40
161798|NCT01561053|394125|P1|Patients With Baseline MMSE:18-21|Overall Study||47
161799|NCT01561053|394122|P4|STARTED|Overall Study||87
161800|NCT01561053|394123|P3|STARTED|Overall Study||82
161801|NCT01561053|394124|P2|STARTED|Overall Study||92
161802|NCT01561053|394125|P1|STARTED|Overall Study||86
161803|NCT01560988|394161|P2|NOT COMPLETED|Second Intervention (Six Weeks)||2
161804|NCT01560988|394162|P1|NOT COMPLETED|Second Intervention (Six Weeks)||2
161805|NCT01560988|394161|P2|COMPLETED|Second Intervention (Six Weeks)||22
161806|NCT01560988|394162|P1|COMPLETED|Second Intervention (Six Weeks)||18
161807|NCT01560988|394161|P2|STARTED|Second Intervention (Six Weeks)||24
161808|NCT01560988|394162|P1|STARTED|Second Intervention (Six Weeks)||20
161809|NCT01560988|394161|P2|NOT COMPLETED|Washout (Six Weeks)||2
161810|NCT01560988|394162|P1|NOT COMPLETED|Washout (Six Weeks)||2
161811|NCT01560988|394161|P2|COMPLETED|Washout (Six Weeks)||24
161812|NCT01560988|394162|P1|COMPLETED|Washout (Six Weeks)||20
161813|NCT01560988|394161|P2|STARTED|Washout (Six Weeks)||26
161814|NCT01560988|394162|P1|STARTED|Washout (Six Weeks)||22
161815|NCT01560988|394161|P2|NOT COMPLETED|First Intervention (Six Weeks)||4
161816|NCT01560988|394162|P1|NOT COMPLETED|First Intervention (Six Weeks)||10
161817|NCT01560988|394161|P2|COMPLETED|First Intervention (Six Weeks)||26
161818|NCT01560988|394162|P1|COMPLETED|First Intervention (Six Weeks)||22
161819|NCT01560988|394161|P2|STARTED|First Intervention (Six Weeks)||30
161820|NCT01560988|394162|P1|STARTED|First Intervention (Six Weeks)||32
161821|NCT01560975|394185|P1|NOT COMPLETED|Overall Study||0
161822|NCT01560975|394185|P1|COMPLETED|Overall Study||10
161823|NCT01560975|394185|P1|STARTED|Overall Study||10
161824|NCT01560819|394200|P2|NOT COMPLETED|Overall Study||0
161825|NCT01560819|394201|P1|NOT COMPLETED|Overall Study||1
161826|NCT01560819|394200|P2|COMPLETED|Overall Study||10
161827|NCT01560819|394201|P1|COMPLETED|Overall Study||9
161828|NCT01560819|394200|P2|STARTED|Overall Study||10
161829|NCT01560819|394201|P1|STARTED|Overall Study||10
161830|NCT01560780|394207|P2|NOT COMPLETED|Overall Study||12
161831|NCT01560780|394208|P1|NOT COMPLETED|Overall Study||13
161832|NCT01560780|394207|P2|COMPLETED|Overall Study||30
161833|NCT01560780|394208|P1|COMPLETED|Overall Study||29
161834|NCT01560780|394207|P2|Completed Study Drug for 12 Months|Overall Study||27
161835|NCT01560780|394208|P1|Completed Study Drug for 12 Months|Overall Study||27
161836|NCT01560780|394207|P2|Clinical Follow-Up at 12 Months|Overall Study||42
161837|NCT01560780|394208|P1|Clinical Follow-Up at 12 Months|Overall Study||42
161838|NCT01560780|394207|P2|STARTED|Overall Study||42
161839|NCT01560780|394208|P1|STARTED|Overall Study||42
161840|NCT01560507|394229|P3|NOT COMPLETED|Overall Study||2
161841|NCT01560507|394230|P2|NOT COMPLETED|Overall Study||2
161842|NCT01560507|394231|P1|NOT COMPLETED|Overall Study||4
161843|NCT01560507|394229|P3|COMPLETED|Overall Study||0
161844|NCT01560507|394230|P2|COMPLETED|Overall Study||0
161845|NCT01560507|394231|P1|COMPLETED|Overall Study||1
161846|NCT01560507|394229|P3|STARTED|Overall Study||2
161847|NCT01560507|394230|P2|STARTED|Overall Study||2
161848|NCT01560507|394231|P1|STARTED|Overall Study||5
161849|NCT01560429|394244|P2|NOT COMPLETED|Overall Study||6
161850|NCT01560429|394245|P1|NOT COMPLETED|Overall Study||3
161851|NCT01560429|394244|P2|COMPLETED|Overall Study||20
161852|NCT01560429|394245|P1|COMPLETED|Overall Study||23
161853|NCT01560429|394244|P2|STARTED|Overall Study||26
161854|NCT01560429|394245|P1|STARTED|Overall Study||26
161855|NCT01560416|394255|P2|NOT COMPLETED|Crossover Phase||0
161856|NCT01560416|394256|P1|NOT COMPLETED|Crossover Phase||0
161857|NCT01560416|394255|P2|COMPLETED|Crossover Phase||0
161858|NCT01560416|394256|P1|COMPLETED|Crossover Phase||7
161859|NCT01560416|394255|P2|STARTED|Crossover Phase||0
161860|NCT01560416|394256|P1|STARTED|Crossover Phase||7
161861|NCT01560416|394255|P2|NOT COMPLETED|Randomized Phase||0
161862|NCT01560416|394256|P1|NOT COMPLETED|Randomized Phase||7
161863|NCT01560416|394255|P2|COMPLETED|Randomized Phase||35
161864|NCT01560416|394256|P1|COMPLETED|Randomized Phase||8
161865|NCT01560416|394255|P2|STARTED|Randomized Phase||35
161866|NCT01560416|394256|P1|STARTED|Randomized Phase||15
161867|NCT01560403|394274|P2|NOT COMPLETED|Overall Study||1
161868|NCT01560403|394275|P1|NOT COMPLETED|Overall Study||0
161869|NCT01560403|394274|P2|COMPLETED|Overall Study||8
161870|NCT01560403|394275|P1|COMPLETED|Overall Study||5
161871|NCT01560403|394274|P2|STARTED|Overall Study||9
161872|NCT01560403|394275|P1|STARTED|Overall Study||5
161873|NCT01560377|394281|P1|NOT COMPLETED|Overall Study||0
161874|NCT01560377|394281|P1|COMPLETED|Overall Study||147
161875|NCT01560377|394281|P1|Eligible for Analysis|Overall Study||139
161876|NCT01560377|394281|P1|STARTED|Overall Study||147
161877|NCT01560286|394286|P1|NOT COMPLETED|Overall Study||0
161878|NCT01560286|394286|P1|COMPLETED|Overall Study||24
161879|NCT01560286|394286|P1|STARTED|Overall Study||24
161880|NCT01560260|394299|P1|NOT COMPLETED|Overall Study||0
161881|NCT01560260|394299|P1|COMPLETED|Overall Study||20
161882|NCT01560260|394299|P1|STARTED|Overall Study||20
161883|NCT01560234|394323|P8|NOT COMPLETED|Overall Study||2
161884|NCT01560234|394324|P7|NOT COMPLETED|Overall Study||0
161885|NCT01560234|394325|P6|NOT COMPLETED|Overall Study||2
161886|NCT01560234|394326|P5|NOT COMPLETED|Overall Study||0
161887|NCT01560234|394327|P4|NOT COMPLETED|Overall Study||0
161888|NCT01560234|394328|P3|NOT COMPLETED|Overall Study||1
161889|NCT01560234|394329|P2|NOT COMPLETED|Overall Study||0
161890|NCT01560234|394330|P1|NOT COMPLETED|Overall Study||3
161891|NCT01560234|394323|P8|COMPLETED|Overall Study||6
161892|NCT01560234|394324|P7|COMPLETED|Overall Study||4
161893|NCT01560234|394325|P6|COMPLETED|Overall Study||2
161894|NCT01560234|394326|P5|COMPLETED|Overall Study||4
161895|NCT01560234|394327|P4|COMPLETED|Overall Study||3
161896|NCT01560234|394328|P3|COMPLETED|Overall Study||3
161897|NCT01560234|394329|P2|COMPLETED|Overall Study||4
161898|NCT01560234|394330|P1|COMPLETED|Overall Study||13
161899|NCT01560234|394323|P8|STARTED|Overall Study||8
161900|NCT01560234|394324|P7|STARTED|Overall Study||4
161901|NCT01560234|394325|P6|STARTED|Overall Study||4
161902|NCT01560234|394326|P5|STARTED|Overall Study||4
161903|NCT01560234|394327|P4|STARTED|Overall Study||3
161904|NCT01560234|394328|P3|STARTED|Overall Study||4
161905|NCT01560234|394329|P2|STARTED|Overall Study||4
161906|NCT01560234|394330|P1|STARTED|Overall Study||16
161907|NCT01560143|394404|P1|NOT COMPLETED|Overall Study||0
161908|NCT01560143|394404|P1|COMPLETED|Overall Study||12
161909|NCT01560143|394404|P1|STARTED|Overall Study||12
161910|NCT01559948|394410|P2|NOT COMPLETED|Overall Study||0
161911|NCT01559948|394411|P1|NOT COMPLETED|Overall Study||0
161912|NCT01559948|394410|P2|COMPLETED|Overall Study||15
161913|NCT01559948|394411|P1|COMPLETED|Overall Study||15
161914|NCT01559948|394410|P2|STARTED|Overall Study||15
161915|NCT01559948|394411|P1|STARTED|Overall Study||15
161916|NCT01559935|394425|P1|NOT COMPLETED|Maintenance Phase||54
161917|NCT01559935|394425|P1|COMPLETED|Maintenance Phase||0
161918|NCT01559935|394425|P1|STARTED|Maintenance Phase||54
161919|NCT01559935|394425|P1|NOT COMPLETED|BiRD Phase||4
161920|NCT01559935|394425|P1|COMPLETED|BiRD Phase||54
161921|NCT01559935|394425|P1|STARTED|BiRD Phase||58
161922|NCT01559935|394425|P1|NOT COMPLETED|Car Phase||14
161923|NCT01559935|394425|P1|COMPLETED|Car Phase||58
161924|NCT01559935|394425|P1|STARTED|Car Phase||72
161925|NCT01559922|394435|P2|NOT COMPLETED|Overall Study||10
161926|NCT01559922|394436|P1|NOT COMPLETED|Overall Study||4
161927|NCT01559922|394435|P2|COMPLETED|Overall Study||87
161928|NCT01559922|394436|P1|COMPLETED|Overall Study||46
161929|NCT01559922|394435|P2|STARTED|Overall Study||97
161930|NCT01559922|394436|P1|STARTED|Overall Study||50
161931|NCT01559857|394444|P2|NOT COMPLETED|Overall Study||0
161932|NCT01559857|394445|P1|NOT COMPLETED|Overall Study||0
161933|NCT01559857|394444|P2|COMPLETED|Overall Study||18
161934|NCT01559857|394445|P1|COMPLETED|Overall Study||19
161935|NCT01559857|394444|P2|STARTED|Overall Study||18
161936|NCT01559857|394445|P1|STARTED|Overall Study||19
161937|NCT01559844|394461|P1|NOT COMPLETED|Overall Study||25
161938|NCT01559844|394461|P1|COMPLETED|Overall Study||36
161939|NCT01559844|394461|P1|STARTED|Overall Study||61
161940|NCT01559675|394474|P2|NOT COMPLETED|Overall Study||14
161941|NCT01559675|394475|P1|NOT COMPLETED|Overall Study||15
161942|NCT01559675|394474|P2|COMPLETED|Overall Study||49
161943|NCT01559675|394475|P1|COMPLETED|Overall Study||43
161944|NCT01559675|394474|P2|STARTED|Overall Study||63
161945|NCT01559675|394475|P1|STARTED|Overall Study||58
161946|NCT01559649|394483|P2|NOT COMPLETED|Overall Study||6
161947|NCT01559649|394484|P1|NOT COMPLETED|Overall Study||19
161948|NCT01559649|394483|P2|COMPLETED|Overall Study||9
161949|NCT01559649|394484|P1|COMPLETED|Overall Study|Screening not completed in 11, VFSS not completed in 2, 6 excluded from analysis. N=250 analyzed|250
161950|NCT01559649|394483|P2|STARTED|Overall Study|Started with 10 nurses. As an RN dropped out due to scheduling, etc, RN replaced with another RN|15
161951|NCT01559649|394484|P1|STARTED|Overall Study||269
161952|NCT01559506|394497|P2|NOT COMPLETED|Overall Study||3
161953|NCT01559506|394498|P1|NOT COMPLETED|Overall Study||0
161954|NCT01559506|394497|P2|COMPLETED|Overall Study||18
161955|NCT01559506|394498|P1|COMPLETED|Overall Study||20
161956|NCT01559506|394497|P2|STARTED|Overall Study||21
161957|NCT01559506|394498|P1|STARTED|Overall Study||20
161958|NCT01559454|394506|P2|NOT COMPLETED|Overall Study||6
161959|NCT01559454|394507|P1|NOT COMPLETED|Overall Study||3
161960|NCT01559454|394506|P2|COMPLETED|Overall Study||4
161961|NCT01559454|394507|P1|COMPLETED|Overall Study||6
161962|NCT01559454|394506|P2|STARTED|Overall Study||10
161963|NCT01559454|394507|P1|STARTED|Overall Study||9
161964|NCT01559311|394526|P3|NOT COMPLETED|Overall Study||8
161965|NCT01559311|394527|P2|NOT COMPLETED|Overall Study||6
161966|NCT01559311|394528|P1|NOT COMPLETED|Overall Study||3
161967|NCT01559311|394526|P3|COMPLETED|Overall Study|12-Month|26
161968|NCT01559311|394527|P2|COMPLETED|Overall Study|12-Month|28
161969|NCT01559311|394528|P1|COMPLETED|Overall Study|12-Month|27
161970|NCT01559311|394526|P3|6-Month|Overall Study||28
161971|NCT01559311|394527|P2|6-Month|Overall Study||33
161972|NCT01559311|394528|P1|6-Month|Overall Study||27
161973|NCT01559311|394526|P3|3-Month|Overall Study||29
161974|NCT01559311|394527|P2|3-Month|Overall Study||34
161975|NCT01559311|394528|P1|3-Month|Overall Study||27
161976|NCT01559311|394526|P3|1-Month|Overall Study||29
161977|NCT01559311|394527|P2|1-Month|Overall Study||34
161978|NCT01559311|394528|P1|1-Month|Overall Study||27
161979|NCT01559311|394526|P3|Implant|Overall Study||32
161980|NCT01559311|394527|P2|Implant|Overall Study||34
161981|NCT01559311|394528|P1|Implant|Overall Study||28
161982|NCT01559311|394526|P3|STARTED|Overall Study|Enrollment & Baseline|34
161983|NCT01559311|394527|P2|STARTED|Overall Study|Enrollment & Baseline|34
161984|NCT01559311|394528|P1|STARTED|Overall Study|Enrollment & Baseline|30
161985|NCT01559129|394541|P2|NOT COMPLETED|Open-label Extension Period||2
161986|NCT01559129|394542|P1|NOT COMPLETED|Open-label Extension Period||6
161987|NCT01559129|394541|P2|COMPLETED|Open-label Extension Period||0
161988|NCT01559129|394542|P1|COMPLETED|Open-label Extension Period||0
161989|NCT01559129|394541|P2|STARTED|Open-label Extension Period|Two participants elected not to enter the Extension Phase.|2
161990|NCT01559129|394542|P1|STARTED|Open-label Extension Period|One participant elected not to enter the Extension Phase.|6
161991|NCT01559129|394541|P2|NOT COMPLETED|Treatment Phase||7
161992|NCT01559129|394542|P1|NOT COMPLETED|Treatment Phase||5
161993|NCT01559129|394541|P2|COMPLETED|Treatment Phase||4
161994|NCT01559129|394542|P1|COMPLETED|Treatment Phase||7
161995|NCT01559129|394541|P2|Received Treatment|Treatment Phase||10
161996|NCT01559129|394542|P1|Received Treatment|Treatment Phase||12
161997|NCT01559129|394541|P2|STARTED|Treatment Phase||11
161998|NCT01559129|394542|P1|STARTED|Treatment Phase||12
161999|NCT01559116|394618|P1|NOT COMPLETED|Overall Study||26
162000|NCT01559116|394618|P1|COMPLETED|Overall Study|Completed all 4 treatment periods|193
162001|NCT01559116|394618|P1|STARTED|Overall Study|Randomised|219
162002|NCT01559090|394689|P3|NOT COMPLETED|Stage II||0
162003|NCT01559090|394690|P2|NOT COMPLETED|Stage II||0
162004|NCT01559090|394691|P1|NOT COMPLETED|Stage II||1
162005|NCT01559090|394689|P3|COMPLETED|Stage II||2
162006|NCT01559090|394690|P2|COMPLETED|Stage II||3
162007|NCT01559090|394691|P1|COMPLETED|Stage II||3
162008|NCT01559090|394689|P3|STARTED|Stage II|One subject who completed Stage I did not agree to participate in Stage II|2
162009|NCT01559090|394690|P2|STARTED|Stage II||3
162010|NCT01559090|394691|P1|STARTED|Stage II||4
162011|NCT01559090|394689|P3|NOT COMPLETED|Stage I||3
162012|NCT01559090|394690|P2|NOT COMPLETED|Stage I||2
162013|NCT01559090|394691|P1|NOT COMPLETED|Stage I||2
162014|NCT01559090|394689|P3|COMPLETED|Stage I||3
162015|NCT01559090|394690|P2|COMPLETED|Stage I||3
162016|NCT01559090|394691|P1|COMPLETED|Stage I||4
162017|NCT01559090|394689|P3|STARTED|Stage I||6
162018|NCT01559090|394690|P2|STARTED|Stage I||5
162019|NCT01559090|394691|P1|STARTED|Stage I||6
162020|NCT01559064|394711|P3|NOT COMPLETED|Overall Study||2
162021|NCT01559064|394712|P2|NOT COMPLETED|Overall Study||1
162022|NCT01559064|394713|P1|NOT COMPLETED|Overall Study||1
162023|NCT01559064|394711|P3|COMPLETED|Overall Study||57
162024|NCT01559064|394712|P2|COMPLETED|Overall Study||39
162025|NCT01559064|394713|P1|COMPLETED|Overall Study||15
162026|NCT01559064|394711|P3|STARTED|Overall Study||59
162027|NCT01559064|394712|P2|STARTED|Overall Study||40
162028|NCT01559064|394713|P1|STARTED|Overall Study||16
162029|NCT01559012|394723|P2|NOT COMPLETED|Overall Study||1
162030|NCT01559012|394724|P1|NOT COMPLETED|Overall Study||0
162031|NCT01559012|394723|P2|COMPLETED|Overall Study|Patient N. 2 withdrew from study for alleged side effects at day 1 of placebo cycle.|6
162032|NCT01559012|394724|P1|COMPLETED|Overall Study||6
162033|NCT01559012|394723|P2|STARTED|Overall Study|1 more patient added to randomization list to reach the pre-assignment number of treated patients|7
162034|NCT01559012|394724|P1|STARTED|Overall Study||6
162035|NCT01558791|394749|P2|NOT COMPLETED|Overall Study||0
162036|NCT01558791|394750|P1|NOT COMPLETED|Overall Study||0
162037|NCT01558791|394749|P2|COMPLETED|Overall Study||629
162038|NCT01558791|394750|P1|COMPLETED|Overall Study||607
162039|NCT01558791|394749|P2|STARTED|Overall Study||629
162040|NCT01558791|394750|P1|STARTED|Overall Study||607
162041|NCT01558739|394762|P1|NOT COMPLETED|Overall Study||17
162042|NCT01558739|394762|P1|COMPLETED|Overall Study||31
162043|NCT01558739|394762|P1|STARTED|Overall Study||48
162044|NCT01558700|394776|P2|NOT COMPLETED|Overall Study||0
162045|NCT01558700|394777|P1|NOT COMPLETED|Overall Study||0
162046|NCT01558700|394776|P2|COMPLETED|Overall Study||21
162047|NCT01558700|394777|P1|COMPLETED|Overall Study||19
162048|NCT01558700|394776|P2|STARTED|Overall Study||21
162049|NCT01558700|394777|P1|STARTED|Overall Study||19
162050|NCT01558674|394787|P2|NOT COMPLETED|Part 2||0
162051|NCT01558674|394788|P1|NOT COMPLETED|Part 2||0
162052|NCT01558674|394787|P2|COMPLETED|Part 2||0
162053|NCT01558674|394788|P1|COMPLETED|Part 2||0
162054|NCT01558674|394787|P2|STARTED|Part 2||0
162055|NCT01558674|394788|P1|STARTED|Part 2||0
162056|NCT01558674|394787|P2|NOT COMPLETED|Part 1||0
162057|NCT01558674|394788|P1|NOT COMPLETED|Part 1||11
162058|NCT01558674|394787|P2|COMPLETED|Part 1||0
162059|NCT01558674|394788|P1|COMPLETED|Part 1||0
162060|NCT01558674|394787|P2|STARTED|Part 1||0
162061|NCT01558674|394788|P1|STARTED|Part 1||11
162062|NCT01558661|394832|P1|NOT COMPLETED|Overall Study||0
162063|NCT01558661|394832|P1|COMPLETED|Overall Study||33
162064|NCT01558661|394832|P1|Second Stage|Overall Study||15
162065|NCT01558661|394832|P1|First Stage|Overall Study||18
162066|NCT01558661|394832|P1|STARTED|Overall Study||33
162067|NCT01558635|394839|P1|NOT COMPLETED|Overall Study||6
162068|NCT01558635|394839|P1|COMPLETED|Overall Study||11
162069|NCT01558635|394839|P1|6 Months Post-procedure|Overall Study||14
162070|NCT01558635|394839|P1|3 Months Post-procedure|Overall Study||14
162071|NCT01558635|394839|P1|Discharge /1 Month Post-procedure|Overall Study||15
162072|NCT01558635|394839|P1|Treated|Overall Study||17
162073|NCT01558635|394839|P1|STARTED|Overall Study||17
162074|NCT01558596|394856|P2|NOT COMPLETED|Overall Study||1
162075|NCT01558596|394857|P1|NOT COMPLETED|Overall Study||3
162076|NCT01558596|394856|P2|COMPLETED|Overall Study||100
162077|NCT01558596|394857|P1|COMPLETED|Overall Study||101
162078|NCT01558596|394856|P2|STARTED|Overall Study||101
162079|NCT01558596|394857|P1|STARTED|Overall Study||104
162080|NCT01558492|394863|P1|NOT COMPLETED|Overall Study||0
162081|NCT01558492|394863|P1|COMPLETED|Overall Study||3
162082|NCT01558492|394863|P1|STARTED|Overall Study||3
162083|NCT01558297|394872|P3|NOT COMPLETED|Overall Study||1
162084|NCT01558297|394873|P2|NOT COMPLETED|Overall Study||2
162085|NCT01558297|394874|P1|NOT COMPLETED|Overall Study||2
162086|NCT01558297|394872|P3|COMPLETED|Overall Study||29
162087|NCT01558297|394873|P2|COMPLETED|Overall Study||27
162088|NCT01558297|394874|P1|COMPLETED|Overall Study||28
162089|NCT01558297|394872|P3|STARTED|Overall Study||30
162090|NCT01558297|394873|P2|STARTED|Overall Study||29
162091|NCT01558297|394874|P1|STARTED|Overall Study||30
162092|NCT01558271|394891|P3|NOT COMPLETED|Overall Study||17
162093|NCT01558271|394892|P2|NOT COMPLETED|Overall Study||11
162094|NCT01558271|394893|P1|NOT COMPLETED|Overall Study||18
162095|NCT01558271|394891|P3|COMPLETED|Overall Study||124
162096|NCT01558271|394892|P2|COMPLETED|Overall Study||59
162097|NCT01558271|394893|P1|COMPLETED|Overall Study||263
162098|NCT01558271|394891|P3|Completed 26 Weeks|Overall Study||128
162099|NCT01558271|394892|P2|Completed 26 Weeks|Overall Study||63
162100|NCT01558271|394893|P1|Completed 26 Weeks|Overall Study||271
162101|NCT01558271|394891|P3|Received at Least 1 Dose of Study Drug|Overall Study||137
162102|NCT01558271|394892|P2|Received at Least 1 Dose of Study Drug|Overall Study||70
162103|NCT01558271|394893|P1|Received at Least 1 Dose of Study Drug|Overall Study||280
162104|NCT01558271|394891|P3|STARTED|Overall Study||141
162105|NCT01558271|394892|P2|STARTED|Overall Study||70
162106|NCT01558271|394893|P1|STARTED|Overall Study||281
162107|NCT01558128|394955|P1|NOT COMPLETED|Overall Study||0
162108|NCT01558128|394955|P1|COMPLETED|Overall Study||1
162109|NCT01558128|394955|P1|STARTED|Overall Study||1
162110|NCT01558089|394959|P1|NOT COMPLETED|Overall Study||13
162111|NCT01558089|394959|P1|COMPLETED|Overall Study||63
162112|NCT01558089|394959|P1|STARTED|Overall Study||76
162113|NCT01558063|394976|P6|NOT COMPLETED|Overall Study||0
162114|NCT01558063|394977|P5|NOT COMPLETED|Overall Study||0
162115|NCT01558063|394978|P4|NOT COMPLETED|Overall Study||0
162116|NCT01558063|394979|P3|NOT COMPLETED|Overall Study||0
162117|NCT01558063|394980|P2|NOT COMPLETED|Overall Study||0
162118|NCT01558063|394981|P1|NOT COMPLETED|Overall Study||0
162119|NCT01558063|394976|P6|COMPLETED|Overall Study||5
162120|NCT01558063|394977|P5|COMPLETED|Overall Study||9
162121|NCT01558063|394978|P4|COMPLETED|Overall Study||5
162122|NCT01558063|394979|P3|COMPLETED|Overall Study||8
162123|NCT01558063|394980|P2|COMPLETED|Overall Study||6
162124|NCT01558063|394981|P1|COMPLETED|Overall Study||5
162125|NCT01558063|394976|P6|STARTED|Overall Study||5
162126|NCT01558063|394977|P5|STARTED|Overall Study||9
162127|NCT01558063|394978|P4|STARTED|Overall Study||5
162128|NCT01558063|394979|P3|STARTED|Overall Study||8
162129|NCT01558063|394980|P2|STARTED|Overall Study||6
162130|NCT01558063|394981|P1|STARTED|Overall Study||5
162131|NCT01557959|395002|P1|NOT COMPLETED|Overall Study||0
162132|NCT01557959|395002|P1|COMPLETED|Overall Study||45
162133|NCT01557959|395002|P1|STARTED|Overall Study||45
162134|NCT01557946|395012|P2|NOT COMPLETED|Overall Study||0
162135|NCT01557946|395013|P1|NOT COMPLETED|Overall Study||3
162136|NCT01557946|395012|P2|COMPLETED|Overall Study|2 subjects with unusable imaging data.|12
162137|NCT01557946|395013|P1|COMPLETED|Overall Study|20 consented and scanned - 1 subject's data not used due to ongoing neurological condition.|17
162138|NCT01557946|395012|P2|STARTED|Overall Study||12
162139|NCT01557946|395013|P1|STARTED|Overall Study||20
162140|NCT01557920|395019|P2|NOT COMPLETED|Overall Study||3
162141|NCT01557920|395020|P1|NOT COMPLETED|Overall Study||3
162142|NCT01557920|395019|P2|COMPLETED|Overall Study||6
162143|NCT01557920|395020|P1|COMPLETED|Overall Study||6
162144|NCT01557920|395019|P2|STARTED|Overall Study||9
162145|NCT01557920|395020|P1|STARTED|Overall Study||9
162146|NCT01557894|395055|P2|NOT COMPLETED|Overall Study||5
162147|NCT01557894|395056|P1|NOT COMPLETED|Overall Study||3
162148|NCT01557894|395055|P2|COMPLETED|Overall Study||33
162149|NCT01557894|395056|P1|COMPLETED|Overall Study||35
162150|NCT01557894|395055|P2|STARTED|Overall Study||38
162151|NCT01557894|395056|P1|STARTED|Overall Study||38
162152|NCT01557868|395072|P2|NOT COMPLETED|Overall Study||30
162153|NCT01557868|395073|P1|NOT COMPLETED|Overall Study||27
162154|NCT01557868|395072|P2|COMPLETED|Overall Study||65
162155|NCT01557868|395073|P1|COMPLETED|Overall Study||76
162156|NCT01557868|395072|P2|STARTED|Overall Study||95
162157|NCT01557868|395073|P1|STARTED|Overall Study||103
162158|NCT01557842|395083|P2|NOT COMPLETED|Overall Study||6
162159|NCT01557842|395084|P1|NOT COMPLETED|Overall Study||9
162160|NCT01557842|395083|P2|COMPLETED|Overall Study||0
162161|NCT01557842|395084|P1|COMPLETED|Overall Study||0
162162|NCT01557842|395083|P2|STARTED|Overall Study||6
162163|NCT01557842|395084|P1|STARTED|Overall Study||9
162164|NCT01557790|395092|P1|NOT COMPLETED|Overall Study||1
162165|NCT01557790|395092|P1|COMPLETED|Overall Study||4
162166|NCT01557790|395092|P1|STARTED|Overall Study||5
162167|NCT01557751|395096|P1|NOT COMPLETED|Overall Study||3
162168|NCT01557751|395096|P1|COMPLETED|Overall Study||153
162169|NCT01557751|395096|P1|STARTED|Overall Study||156
162170|NCT01557699|395103|P3|NOT COMPLETED|Overall Study||0
162171|NCT01557699|395104|P2|NOT COMPLETED|Overall Study||0
162172|NCT01557699|395105|P1|NOT COMPLETED|Overall Study||0
162173|NCT01557699|395103|P3|COMPLETED|Overall Study||20
162174|NCT01557699|395104|P2|COMPLETED|Overall Study||20
162175|NCT01557699|395105|P1|COMPLETED|Overall Study||20
162176|NCT01557699|395103|P3|STARTED|Overall Study||20
162177|NCT01557699|395104|P2|STARTED|Overall Study||20
162178|NCT01557699|395105|P1|STARTED|Overall Study||20
162179|NCT01557595|395137|P1|NOT COMPLETED|Overall Study||8
162180|NCT01557595|395137|P1|COMPLETED|Overall Study||14
162181|NCT01557595|395137|P1|STARTED|Overall Study||22
162182|NCT01557582|395141|P1|NOT COMPLETED|Overall Study||6
162183|NCT01557582|395141|P1|COMPLETED|Overall Study||97
162184|NCT01557582|395141|P1|STARTED|Overall Study||103
162185|NCT01557569|395149|P2|NOT COMPLETED|Overall Study||7
162186|NCT01557569|395150|P1|NOT COMPLETED|Overall Study||5
162187|NCT01557569|395149|P2|COMPLETED|Overall Study||0
162188|NCT01557569|395150|P1|COMPLETED|Overall Study||1
162189|NCT01557569|395149|P2|Completed 2-wk Residential Stay|Overall Study||1
162190|NCT01557569|395150|P1|Completed 2-wk Residential Stay|Overall Study||3
162191|NCT01557569|395149|P2|STARTED|Overall Study|Those who received at least one dose of medication|7
162192|NCT01557569|395150|P1|STARTED|Overall Study|Those who received at least one dose of medication|6
162193|NCT01557517|395158|P2|NOT COMPLETED|Overall Study||4
162194|NCT01557517|395159|P1|NOT COMPLETED|Overall Study||2
162195|NCT01557517|395158|P2|COMPLETED|Overall Study||17
162196|NCT01557517|395159|P1|COMPLETED|Overall Study||17
162197|NCT01557517|395158|P2|STARTED|Overall Study||21
162198|NCT01557517|395159|P1|STARTED|Overall Study||19
162199|NCT01557504|395185|P2|NOT COMPLETED|Overall Study||0
162200|NCT01557504|395186|P1|NOT COMPLETED|Overall Study||1
162201|NCT01557504|395185|P2|COMPLETED|Overall Study||12
162202|NCT01557504|395186|P1|COMPLETED|Overall Study||12
162203|NCT01557504|395185|P2|STARTED|Overall Study||12
162204|NCT01557504|395186|P1|STARTED|Overall Study||13
162205|NCT01557348|395211|P2|NOT COMPLETED|Overall Study||90
162206|NCT01557348|395212|P1|NOT COMPLETED|Overall Study||80
162207|NCT01557348|395211|P2|COMPLETED|Overall Study||417
162208|NCT01557348|395212|P1|COMPLETED|Overall Study||524
162209|NCT01557348|395211|P2|Safety Population|Overall Study||507
162210|NCT01557348|395212|P1|Safety Population|Overall Study||604
162211|NCT01557348|395211|P2|STARTED|Overall Study||507
162212|NCT01557348|395212|P1|STARTED|Overall Study||604
162213|NCT01557322|395254|P2|NOT COMPLETED|Overall Study||0
162214|NCT01557322|395255|P1|NOT COMPLETED|Overall Study||0
162215|NCT01557322|395254|P2|COMPLETED|Overall Study||1543
162216|NCT01557322|395255|P1|COMPLETED|Overall Study||211
162217|NCT01557322|395254|P2|STARTED|Overall Study||1543
162218|NCT01557322|395255|P1|STARTED|Overall Study||211
162219|NCT01557283|395329|P1|NOT COMPLETED|Overall Study||44
162220|NCT01557283|395329|P1|COMPLETED|Overall Study||96
162221|NCT01557283|395329|P1|STARTED|Overall Study||140
162222|NCT01557166|395341|P2|NOT COMPLETED|Overall Study||37
162223|NCT01557166|395342|P1|NOT COMPLETED|Overall Study||46
162224|NCT01557166|395341|P2|COMPLETED|Overall Study||142
162225|NCT01557166|395342|P1|COMPLETED|Overall Study||134
162226|NCT01557166|395341|P2|Exposed|Overall Study||179
162227|NCT01557166|395342|P1|Exposed|Overall Study||176
162228|NCT01557166|395341|P2|STARTED|Overall Study||179
162229|NCT01557166|395342|P1|STARTED|Overall Study||180
162230|NCT01556997|395357|P3|NOT COMPLETED|Overall Study||32
162231|NCT01556997|395358|P2|NOT COMPLETED|Overall Study||28
162232|NCT01556997|395359|P1|NOT COMPLETED|Overall Study||26
162233|NCT01556997|395357|P3|COMPLETED|Overall Study||246
162234|NCT01556997|395358|P2|COMPLETED|Overall Study||252
162235|NCT01556997|395359|P1|COMPLETED|Overall Study||253
162236|NCT01556997|395357|P3|STARTED|Overall Study||278
162237|NCT01556997|395358|P2|STARTED|Overall Study||280
162238|NCT01556997|395359|P1|STARTED|Overall Study||279
162239|NCT01556932|395370|P2|NOT COMPLETED|Second Treament||0
162240|NCT01556932|395371|P1|NOT COMPLETED|Second Treament||0
162241|NCT01556932|395370|P2|COMPLETED|Second Treament||8
162242|NCT01556932|395371|P1|COMPLETED|Second Treament||12
162243|NCT01556932|395370|P2|Recieved|Second Treament||8
162244|NCT01556932|395371|P1|Recieved|Second Treament||12
162245|NCT01556932|395370|P2|STARTED|Second Treament||8
162246|NCT01556932|395371|P1|STARTED|Second Treament||12
162247|NCT01556932|395370|P2|NOT COMPLETED|Time Point 60 Minutes||1
162248|NCT01556932|395371|P1|NOT COMPLETED|Time Point 60 Minutes||1
162249|NCT01556932|395370|P2|COMPLETED|Time Point 60 Minutes||8
162250|NCT01556932|395371|P1|COMPLETED|Time Point 60 Minutes||12
162251|NCT01556932|395370|P2|Recieved|Time Point 60 Minutes||8
162252|NCT01556932|395371|P1|Recieved|Time Point 60 Minutes||12
162253|NCT01556932|395370|P2|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|9
162254|NCT01556932|395371|P1|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|13
162255|NCT01556932|395370|P2|NOT COMPLETED|Baseline First Treatment||0
162256|NCT01556932|395371|P1|NOT COMPLETED|Baseline First Treatment||0
162257|NCT01556932|395370|P2|COMPLETED|Baseline First Treatment||9
162258|NCT01556932|395371|P1|COMPLETED|Baseline First Treatment||13
162259|NCT01556932|395370|P2|Recieved|Baseline First Treatment||9
162260|NCT01556932|395371|P1|Recieved|Baseline First Treatment||13
162261|NCT01556932|395370|P2|STARTED|Baseline First Treatment||9
162262|NCT01556932|395371|P1|STARTED|Baseline First Treatment||13
162263|NCT01556906|395376|P1|NOT COMPLETED|Overall Study||0
162264|NCT01556906|395376|P1|COMPLETED|Overall Study||6
162265|NCT01556906|395376|P1|STARTED|Overall Study||6
162266|NCT01556763|395397|P3|NOT COMPLETED|Overall Study||0
162267|NCT01556763|395398|P2|NOT COMPLETED|Overall Study||1
162268|NCT01556763|395399|P1|NOT COMPLETED|Overall Study||0
162269|NCT01556763|395397|P3|COMPLETED|Overall Study||8
162270|NCT01556763|395398|P2|COMPLETED|Overall Study||8
162271|NCT01556763|395399|P1|COMPLETED|Overall Study||4
162272|NCT01556763|395397|P3|STARTED|Overall Study||8
162273|NCT01556763|395398|P2|STARTED|Overall Study||9
162274|NCT01556763|395399|P1|STARTED|Overall Study||4
162275|NCT01556724|395437|P2|NOT COMPLETED|Overall Study||0
162276|NCT01556724|395438|P1|NOT COMPLETED|Overall Study||0
162277|NCT01556724|395437|P2|COMPLETED|Overall Study||14
162278|NCT01556724|395438|P1|COMPLETED|Overall Study||16
162279|NCT01556724|395437|P2|STARTED|Overall Study||14
162280|NCT01556724|395438|P1|STARTED|Overall Study||16
162281|NCT01556633|395454|P2|NOT COMPLETED|Overall Study||0
162282|NCT01556633|395455|P1|NOT COMPLETED|Overall Study||0
162283|NCT01556633|395454|P2|COMPLETED|Overall Study||6
162284|NCT01556633|395455|P1|COMPLETED|Overall Study||10
162285|NCT01556633|395454|P2|STARTED|Overall Study||6
162286|NCT01556633|395455|P1|STARTED|Overall Study||10
162287|NCT01556594|395480|P3|NOT COMPLETED|Overall Study||0
162288|NCT01556594|395481|P2|NOT COMPLETED|Overall Study||0
162289|NCT01556594|395482|P1|NOT COMPLETED|Overall Study||0
162290|NCT01556594|395480|P3|COMPLETED|Overall Study||6
162291|NCT01556594|395481|P2|COMPLETED|Overall Study||2
162292|NCT01556594|395482|P1|COMPLETED|Overall Study||10
162293|NCT01556594|395480|P3|STARTED|Overall Study||6
162294|NCT01556594|395481|P2|STARTED|Overall Study||2
162295|NCT01556594|395482|P1|STARTED|Overall Study||10
162296|NCT01556451|395516|P1|NOT COMPLETED|Overall Study||0
162297|NCT01556451|395516|P1|COMPLETED|Overall Study||180
162298|NCT01556451|395516|P1|STARTED|Overall Study||180
162299|NCT01556438|395525|P2|NOT COMPLETED|Overall Study||11
162300|NCT01556438|395526|P1|NOT COMPLETED|Overall Study||4
162301|NCT01556438|395525|P2|COMPLETED|Overall Study||1
162302|NCT01556438|395526|P1|COMPLETED|Overall Study||0
162303|NCT01556438|395525|P2|Received BTZ SC|Overall Study||8
162304|NCT01556438|395526|P1|Received BTZ SC|Overall Study||0
162305|NCT01556438|395525|P2|Received BTZ IV|Overall Study||4
162306|NCT01556438|395526|P1|Received BTZ IV|Overall Study||4
162307|NCT01556438|395525|P2|Received at Least 1 Dose of Study Drug|Overall Study|300 mg tabalumab IV|12
162308|NCT01556438|395526|P1|Received at Least 1 Dose of Study Drug|Overall Study|100 mg tabalumab IV|4
162309|NCT01556438|395525|P2|STARTED|Overall Study||12
162310|NCT01556438|395526|P1|STARTED|Overall Study||4
162311|NCT01556425|395555|P4|NOT COMPLETED|Overall Study||0
162312|NCT01556425|395556|P3|NOT COMPLETED|Overall Study||0
162313|NCT01556425|395557|P2|NOT COMPLETED|Overall Study||0
162314|NCT01556425|395558|P1|NOT COMPLETED|Overall Study||0
162315|NCT01556425|395555|P4|COMPLETED|Overall Study||18
162316|NCT01556425|395556|P3|COMPLETED|Overall Study||18
162317|NCT01556425|395557|P2|COMPLETED|Overall Study||23
162318|NCT01556425|395558|P1|COMPLETED|Overall Study||25
162319|NCT01556425|395555|P4|STARTED|Overall Study||18
162320|NCT01556425|395556|P3|STARTED|Overall Study||18
162321|NCT01556425|395557|P2|STARTED|Overall Study||23
162322|NCT01556425|395558|P1|STARTED|Overall Study||25
162323|NCT01556347|395572|P1|NOT COMPLETED|Recovery Phase||0
162324|NCT01556347|395572|P1|COMPLETED|Recovery Phase||2
162325|NCT01556347|395572|P1|STARTED|Recovery Phase||2
162326|NCT01556347|395572|P1|NOT COMPLETED|Bortezomib Treatment Phase||0
162327|NCT01556347|395572|P1|COMPLETED|Bortezomib Treatment Phase||2
162328|NCT01556347|395572|P1|STARTED|Bortezomib Treatment Phase||2
162329|NCT01556347|395572|P1|NOT COMPLETED|Induction Immunotherapy||0
162330|NCT01556347|395572|P1|COMPLETED|Induction Immunotherapy||2
162331|NCT01556347|395572|P1|STARTED|Induction Immunotherapy||2
162332|NCT01556204|395602|P2|NOT COMPLETED|Overall Study||0
162333|NCT01556204|395603|P1|NOT COMPLETED|Overall Study||0
162334|NCT01556204|395602|P2|COMPLETED|Overall Study||38
162335|NCT01556204|395603|P1|COMPLETED|Overall Study||35
162336|NCT01556204|395602|P2|STARTED|Overall Study||38
162337|NCT01556204|395603|P1|STARTED|Overall Study||35
162338|NCT01556165|395613|P2|NOT COMPLETED|Overall Study||7
162339|NCT01556165|395614|P1|NOT COMPLETED|Overall Study||12
162340|NCT01556165|395613|P2|COMPLETED|Overall Study||58
162341|NCT01556165|395614|P1|COMPLETED|Overall Study||53
162342|NCT01556165|395613|P2|STARTED|Overall Study||65
162343|NCT01556165|395614|P1|STARTED|Overall Study||65
162344|NCT01556100|395626|P1|NOT COMPLETED|Overall Study||6
162345|NCT01556100|395626|P1|COMPLETED|Overall Study||34
162346|NCT01556100|395626|P1|STARTED|Overall Study||40
162347|NCT01556061|395633|P2|NOT COMPLETED|Overall Study||0
162348|NCT01556061|395634|P1|NOT COMPLETED|Overall Study||0
162349|NCT01556061|395633|P2|COMPLETED|Overall Study||25
162350|NCT01556061|395634|P1|COMPLETED|Overall Study||25
162351|NCT01556061|395633|P2|STARTED|Overall Study||25
162352|NCT01556061|395634|P1|STARTED|Overall Study||25
162353|NCT01555983|395644|P6|NOT COMPLETED|Overall Study||1
162354|NCT01555983|395645|P5|NOT COMPLETED|Overall Study||1
162355|NCT01555983|395646|P4|NOT COMPLETED|Overall Study||0
162356|NCT01555983|395647|P3|NOT COMPLETED|Overall Study||0
162357|NCT01555983|395648|P2|NOT COMPLETED|Overall Study||0
162358|NCT01555983|395649|P1|NOT COMPLETED|Overall Study||1
162359|NCT01555983|395644|P6|COMPLETED|Overall Study|One subject completed the 6.7%THC session, then dropped out.|6
162360|NCT01555983|395645|P5|COMPLETED|Overall Study|One subject complete 6.7%THC and placebo sessions, then dropped out|4
162361|NCT01555983|395646|P4|COMPLETED|Overall Study||7
162362|NCT01555983|395647|P3|COMPLETED|Overall Study||7
162363|NCT01555983|395648|P2|COMPLETED|Overall Study||7
162364|NCT01555983|395649|P1|COMPLETED|Overall Study|One subject only finished the placebo session, then dropped out of study|8
162365|NCT01555983|395644|P6|STARTED|Overall Study||7
162366|NCT01555983|395645|P5|STARTED|Overall Study||5
162367|NCT01555983|395646|P4|STARTED|Overall Study||7
162368|NCT01555983|395647|P3|STARTED|Overall Study||7
162369|NCT01555983|395648|P2|STARTED|Overall Study||7
162370|NCT01555983|395649|P1|STARTED|Overall Study||9
162371|NCT01555931|395659|P2|NOT COMPLETED|Overall Study||5
162372|NCT01555931|395660|P1|NOT COMPLETED|Overall Study||2
162373|NCT01555931|395659|P2|COMPLETED|Overall Study||13
162374|NCT01555931|395660|P1|COMPLETED|Overall Study||15
162375|NCT01555931|395659|P2|STARTED|Overall Study||18
162376|NCT01555931|395660|P1|STARTED|Overall Study||17
162377|NCT01555762|395668|P1|NOT COMPLETED|Overall Study||274
162378|NCT01555762|395668|P1|COMPLETED|Overall Study||128
162379|NCT01555762|395668|P1|Efficacy Population|Overall Study||358
162380|NCT01555762|395668|P1|Safety Population|Overall Study||383
162381|NCT01555762|395668|P1|STARTED|Overall Study||402
162382|NCT01555567|395682|P4|NOT COMPLETED|Return to Activity||1
162383|NCT01555567|395683|P3|NOT COMPLETED|Return to Activity||0
162384|NCT01555567|395684|P2|NOT COMPLETED|Return to Activity||2
162385|NCT01555567|395685|P1|NOT COMPLETED|Return to Activity||1
162386|NCT01555567|395682|P4|COMPLETED|Return to Activity||8
162387|NCT01555567|395683|P3|COMPLETED|Return to Activity||8
162388|NCT01555567|395684|P2|COMPLETED|Return to Activity||10
162389|NCT01555567|395685|P1|COMPLETED|Return to Activity||10
162390|NCT01555567|395682|P4|STARTED|Return to Activity||9
162391|NCT01555567|395683|P3|STARTED|Return to Activity||8
162392|NCT01555567|395684|P2|STARTED|Return to Activity||12
162393|NCT01555567|395685|P1|STARTED|Return to Activity||11
162394|NCT01555567|395682|P4|NOT COMPLETED|12 Week||0
162395|NCT01555567|395683|P3|NOT COMPLETED|12 Week||1
162396|NCT01555567|395684|P2|NOT COMPLETED|12 Week||1
162397|NCT01555567|395685|P1|NOT COMPLETED|12 Week||1
162398|NCT01555567|395682|P4|COMPLETED|12 Week||9
162399|NCT01555567|395683|P3|COMPLETED|12 Week||8
162400|NCT01555567|395684|P2|COMPLETED|12 Week||12
162401|NCT01555567|395685|P1|COMPLETED|12 Week||11
162402|NCT01555567|395682|P4|STARTED|12 Week||9
162403|NCT01555567|395683|P3|STARTED|12 Week||9
162404|NCT01555567|395684|P2|STARTED|12 Week||13
162405|NCT01555567|395685|P1|STARTED|12 Week||12
162406|NCT01555541|395699|P1|NOT COMPLETED|Autologous Transplantation||0
162407|NCT01555541|395699|P1|COMPLETED|Autologous Transplantation||12
162408|NCT01555541|395699|P1|STARTED|Autologous Transplantation||12
162409|NCT01555541|395699|P1|NOT COMPLETED|OVA Treatment||0
162410|NCT01555541|395699|P1|COMPLETED|OVA Treatment||19
162411|NCT01555541|395699|P1|STARTED|OVA Treatment||19
162412|NCT01555541|395699|P1|NOT COMPLETED|Salvage Response Assessment||0
162413|NCT01555541|395699|P1|COMPLETED|Salvage Response Assessment||19
162414|NCT01555541|395699|P1|STARTED|Salvage Response Assessment||19
162415|NCT01555489|395706|P1|NOT COMPLETED|Overall Study||0
162416|NCT01555489|395706|P1|COMPLETED|Overall Study||11
162417|NCT01555489|395706|P1|STARTED|Overall Study||11
162418|NCT01555463|395713|P2|NOT COMPLETED|Follow up||45
162419|NCT01555463|395714|P1|NOT COMPLETED|Follow up||38
162420|NCT01555463|395713|P2|COMPLETED|Follow up||394
162421|NCT01555463|395714|P1|COMPLETED|Follow up||409
162422|NCT01555463|395713|P2|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|439
162423|NCT01555463|395714|P1|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|447
162424|NCT01555463|395713|P2|NOT COMPLETED|Treatment||79
162425|NCT01555463|395714|P1|NOT COMPLETED|Treatment||64
162426|NCT01555463|395713|P2|COMPLETED|Treatment||399
162427|NCT01555463|395714|P1|COMPLETED|Treatment||419
162428|NCT01555463|395713|P2|STARTED|Treatment||478
162429|NCT01555463|395714|P1|STARTED|Treatment||483
162430|NCT01555164|395756|P2|NOT COMPLETED|Overall Study||35
162431|NCT01555164|395757|P1|NOT COMPLETED|Overall Study||40
162432|NCT01555164|395756|P2|COMPLETED|Overall Study||185
162433|NCT01555164|395757|P1|COMPLETED|Overall Study||182
162434|NCT01555164|395756|P2|STARTED|Overall Study||220
162435|NCT01555164|395757|P1|STARTED|Overall Study||222
162436|NCT01555151|395771|P4|NOT COMPLETED|Overall Study||10
162437|NCT01555151|395772|P3|NOT COMPLETED|Overall Study||6
162438|NCT01555151|395773|P2|NOT COMPLETED|Overall Study||8
162439|NCT01555151|395774|P1|NOT COMPLETED|Overall Study||13
162440|NCT01555151|395771|P4|COMPLETED|Overall Study||176
162441|NCT01555151|395772|P3|COMPLETED|Overall Study||178
162442|NCT01555151|395773|P2|COMPLETED|Overall Study||173
162443|NCT01555151|395774|P1|COMPLETED|Overall Study||175
162444|NCT01555151|395771|P4|Safety Set (SAF)|Overall Study||186
162445|NCT01555151|395772|P3|Safety Set (SAF)|Overall Study||183
162446|NCT01555151|395773|P2|Safety Set (SAF)|Overall Study||180
162447|NCT01555151|395774|P1|Safety Set (SAF)|Overall Study||186
162448|NCT01555151|395771|P4|STARTED|Overall Study||186
162449|NCT01555151|395772|P3|STARTED|Overall Study||184
162450|NCT01555151|395773|P2|STARTED|Overall Study||181
162451|NCT01555151|395774|P1|STARTED|Overall Study||188
162452|NCT01555138|395827|P2|NOT COMPLETED|Overall Study||38
162453|NCT01555138|395828|P1|NOT COMPLETED|Overall Study||47
162454|NCT01555138|395827|P2|COMPLETED|Overall Study||250
162455|NCT01555138|395828|P1|COMPLETED|Overall Study||246
162456|NCT01555138|395827|P2|STARTED|Overall Study||288
162457|NCT01555138|395828|P1|STARTED|Overall Study||293
162458|NCT01555125|395857|P5|NOT COMPLETED|Follow-Up Period||0
162459|NCT01555125|395858|P4|NOT COMPLETED|Follow-Up Period||1
162460|NCT01555125|395859|P3|NOT COMPLETED|Follow-Up Period||1
162461|NCT01555125|395860|P2|NOT COMPLETED|Follow-Up Period||1
162462|NCT01555125|395861|P1|NOT COMPLETED|Follow-Up Period||4
162463|NCT01555125|395857|P5|COMPLETED|Follow-Up Period||0
162464|NCT01555125|395858|P4|COMPLETED|Follow-Up Period||17
162465|NCT01555125|395859|P3|COMPLETED|Follow-Up Period||18
162466|NCT01555125|395860|P2|COMPLETED|Follow-Up Period||30
162467|NCT01555125|395861|P1|COMPLETED|Follow-Up Period||32
162468|NCT01555125|395857|P5|STARTED|Follow-Up Period||0
162469|NCT01555125|395858|P4|STARTED|Follow-Up Period||18
162470|NCT01555125|395859|P3|STARTED|Follow-Up Period||19
162471|NCT01555125|395860|P2|STARTED|Follow-Up Period||31
162472|NCT01555125|395861|P1|STARTED|Follow-Up Period||36
162473|NCT01555125|395857|P5|NOT COMPLETED|Extension||0
162474|NCT01555125|395858|P4|NOT COMPLETED|Extension||22
162475|NCT01555125|395859|P3|NOT COMPLETED|Extension||23
162476|NCT01555125|395860|P2|NOT COMPLETED|Extension||51
162477|NCT01555125|395861|P1|NOT COMPLETED|Extension||45
162478|NCT01555125|395857|P5|COMPLETED|Extension||0
162479|NCT01555125|395858|P4|COMPLETED|Extension||1
162480|NCT01555125|395859|P3|COMPLETED|Extension||0
162481|NCT01555125|395860|P2|COMPLETED|Extension||0
162482|NCT01555125|395861|P1|COMPLETED|Extension||1
162483|NCT01555125|395857|P5|STARTED|Extension||0
162484|NCT01555125|395858|P4|STARTED|Extension||23
162485|NCT01555125|395859|P3|STARTED|Extension||23
162486|NCT01555125|395860|P2|STARTED|Extension||51
162487|NCT01555125|395861|P1|STARTED|Extension||46
162488|NCT01555125|395857|P5|NOT COMPLETED|Maintenance Period||0
162489|NCT01555125|395858|P4|NOT COMPLETED|Maintenance Period||2
162490|NCT01555125|395859|P3|NOT COMPLETED|Maintenance Period||4
162491|NCT01555125|395860|P2|NOT COMPLETED|Maintenance Period||4
162492|NCT01555125|395861|P1|NOT COMPLETED|Maintenance Period||10
162493|NCT01555125|395857|P5|COMPLETED|Maintenance Period||0
162494|NCT01555125|395858|P4|COMPLETED|Maintenance Period||25
162495|NCT01555125|395859|P3|COMPLETED|Maintenance Period||25
162496|NCT01555125|395860|P2|COMPLETED|Maintenance Period||52
162497|NCT01555125|395861|P1|COMPLETED|Maintenance Period||48
162498|NCT01555125|395857|P5|STARTED|Maintenance Period||0
162499|NCT01555125|395858|P4|STARTED|Maintenance Period||27
162500|NCT01555125|395859|P3|STARTED|Maintenance Period||29
162501|NCT01555125|395860|P2|STARTED|Maintenance Period||56
162502|NCT01555125|395861|P1|STARTED|Maintenance Period||58
162503|NCT01555125|395857|P5|NOT COMPLETED|Induction Period||3
162504|NCT01555125|395858|P4|NOT COMPLETED|Induction Period||0
162505|NCT01555125|395859|P3|NOT COMPLETED|Induction Period||0
162506|NCT01555125|395860|P2|NOT COMPLETED|Induction Period||3
162507|NCT01555125|395861|P1|NOT COMPLETED|Induction Period||1
162508|NCT01555125|395857|P5|COMPLETED|Induction Period||56
162509|NCT01555125|395858|P4|COMPLETED|Induction Period||0
162510|NCT01555125|395859|P3|COMPLETED|Induction Period||0
162511|NCT01555125|395860|P2|COMPLETED|Induction Period||56
162512|NCT01555125|395861|P1|COMPLETED|Induction Period||58
162513|NCT01555125|395857|P5|STARTED|Induction Period||59
162514|NCT01555125|395858|P4|STARTED|Induction Period||0
162515|NCT01555125|395859|P3|STARTED|Induction Period||0
162516|NCT01555125|395860|P2|STARTED|Induction Period||59
162517|NCT01555125|395861|P1|STARTED|Induction Period||59
162518|NCT01555073|395954|P4|NOT COMPLETED|Overall Study||5
162519|NCT01555073|395955|P3|NOT COMPLETED|Overall Study||0
162520|NCT01555073|395956|P2|NOT COMPLETED|Overall Study||2
162521|NCT01555073|395957|P1|NOT COMPLETED|Overall Study||1
162522|NCT01555073|395954|P4|COMPLETED|Overall Study||1
162523|NCT01555073|395955|P3|COMPLETED|Overall Study||7
162524|NCT01555073|395956|P2|COMPLETED|Overall Study||1
162525|NCT01555073|395957|P1|COMPLETED|Overall Study||6
162526|NCT01555073|395954|P4|STARTED|Overall Study||6
162527|NCT01555073|395955|P3|STARTED|Overall Study||7
162528|NCT01555073|395956|P2|STARTED|Overall Study||3
162529|NCT01555073|395957|P1|STARTED|Overall Study||7
162530|NCT01555021|395973|P2|NOT COMPLETED|Overall Study||2
162531|NCT01555021|395974|P1|NOT COMPLETED|Overall Study||1
162532|NCT01555021|395973|P2|COMPLETED|Overall Study|None of the AGT subjects competed month 1, month 3, or month 6 follow up visits.|0
162533|NCT01555021|395974|P1|COMPLETED|Overall Study|One treatment as usual subject completed 1 month, 3 month, and 6 month follow up visits|1
162534|NCT01555021|395973|P2|STARTED|Overall Study||2
162535|NCT01555021|395974|P1|STARTED|Overall Study||2
162536|NCT01554982|395986|P1|NOT COMPLETED|Overall Study||43
162537|NCT01554982|395986|P1|COMPLETED|Overall Study||125
162538|NCT01554982|395986|P1|Received Drug|Overall Study||166
162539|NCT01554982|395986|P1|STARTED|Overall Study||168
162540|NCT01554904|395999|P1|NOT COMPLETED|Overall Study||4
162541|NCT01554904|395999|P1|COMPLETED|Overall Study||14
162542|NCT01554904|395999|P1|Home Sleep Study 2|Overall Study||14
162543|NCT01554904|395999|P1|Complete 6 Weeks of Facial Training|Overall Study|3 subjects withdrew during training|14
162544|NCT01554904|395999|P1|Start 6 Weeks of Facial Training|Overall Study|1 participant was found to have obstructive sleep apnea on the home sleep study #1|17
162545|NCT01554904|395999|P1|Home Sleep Study 1|Overall Study|After informed consent signed.|18
162546|NCT01554904|395999|P1|STARTED|Overall Study||18
162547|NCT01554891|396007|P3|NOT COMPLETED|Overall Study||2
162548|NCT01554891|396008|P2|NOT COMPLETED|Overall Study||5
162549|NCT01554891|396009|P1|NOT COMPLETED|Overall Study||7
162550|NCT01554891|396007|P3|COMPLETED|Overall Study||55
162551|NCT01554891|396008|P2|COMPLETED|Overall Study||115
162552|NCT01554891|396009|P1|COMPLETED|Overall Study||98
162553|NCT01554891|396007|P3|STARTED|Overall Study||57
162554|NCT01554891|396008|P2|STARTED|Overall Study||120
162555|NCT01554891|396009|P1|STARTED|Overall Study||105
162556|NCT01554579|396019|P2|NOT COMPLETED|Overall Study||27
162557|NCT01554579|396020|P1|NOT COMPLETED|Overall Study||10
162558|NCT01554579|396019|P2|COMPLETED|Overall Study||58
162559|NCT01554579|396020|P1|COMPLETED|Overall Study||76
162560|NCT01554579|396019|P2|STARTED|Overall Study||85
162561|NCT01554579|396020|P1|STARTED|Overall Study||86
162562|NCT01554527|396033|P3|NOT COMPLETED|Overall Study||8
162563|NCT01554527|396034|P2|NOT COMPLETED|Overall Study||0
162564|NCT01554527|396035|P1|NOT COMPLETED|Overall Study||1
162565|NCT01554527|396033|P3|COMPLETED|Overall Study||25
162566|NCT01554527|396034|P2|COMPLETED|Overall Study||38
162567|NCT01554527|396035|P1|COMPLETED|Overall Study||33
162568|NCT01554527|396033|P3|Completed as a Control|Overall Study||1
162569|NCT01554527|396034|P2|Completed as a Control|Overall Study||0
162570|NCT01554527|396035|P1|Completed as a Control|Overall Study||33
162571|NCT01554527|396033|P3|Initiated CPAP Treatment at Home|Overall Study||28
162572|NCT01554527|396034|P2|Initiated CPAP Treatment at Home|Overall Study||38
162573|NCT01554527|396035|P1|Initiated CPAP Treatment at Home|Overall Study||0
162574|NCT01554527|396033|P3|Had CPAP Titration|Overall Study||30
162575|NCT01554527|396034|P2|Had CPAP Titration|Overall Study||38
162576|NCT01554527|396035|P1|Had CPAP Titration|Overall Study|No control group members received CPAP (definitionally)|0
162577|NCT01554527|396033|P3|Crossed Over to Control|Overall Study||2
162578|NCT01554527|396034|P2|Crossed Over to Control|Overall Study||0
162579|NCT01554527|396035|P1|Crossed Over to Control|Overall Study||0
162580|NCT01554527|396033|P3|STARTED|Overall Study||33
162581|NCT01554527|396034|P2|STARTED|Overall Study||38
162582|NCT01554527|396035|P1|STARTED|Overall Study||34
162583|NCT01554241|396066|P4|NOT COMPLETED|Overall Study||1
162584|NCT01554241|396067|P3|NOT COMPLETED|Overall Study||4
162585|NCT01554241|396068|P2|NOT COMPLETED|Overall Study||1
162586|NCT01554241|396069|P1|NOT COMPLETED|Overall Study||3
162587|NCT01554241|396066|P4|COMPLETED|Overall Study||13
162588|NCT01554241|396067|P3|COMPLETED|Overall Study||20
162589|NCT01554241|396068|P2|COMPLETED|Overall Study||19
162590|NCT01554241|396069|P1|COMPLETED|Overall Study||20
162591|NCT01554241|396066|P4|STARTED|Overall Study||14
162592|NCT01554241|396067|P3|STARTED|Overall Study||24
162593|NCT01554241|396068|P2|STARTED|Overall Study||20
162594|NCT01554241|396069|P1|STARTED|Overall Study||23
162595|NCT01554176|396085|P5|NOT COMPLETED|Run-out Phase||0
162596|NCT01554176|396086|P4|NOT COMPLETED|Run-out Phase||1
162597|NCT01554176|396087|P3|NOT COMPLETED|Run-out Phase||0
162598|NCT01554176|396088|P2|NOT COMPLETED|Run-out Phase||0
162599|NCT01554176|396089|P1|NOT COMPLETED|Run-out Phase||0
162600|NCT01554176|396085|P5|COMPLETED|Run-out Phase||59
162601|NCT01554176|396086|P4|COMPLETED|Run-out Phase||27
162602|NCT01554176|396087|P3|COMPLETED|Run-out Phase||29
162603|NCT01554176|396088|P2|COMPLETED|Run-out Phase||0
162604|NCT01554176|396089|P1|COMPLETED|Run-out Phase||0
162605|NCT01554176|396085|P5|Treated|Run-out Phase||59
162606|NCT01554176|396086|P4|Treated|Run-out Phase||28
162607|NCT01554176|396087|P3|Treated|Run-out Phase||29
162608|NCT01554176|396088|P2|Treated|Run-out Phase||0
162609|NCT01554176|396089|P1|Treated|Run-out Phase||0
162610|NCT01554176|396085|P5|STARTED|Run-out Phase||59
162611|NCT01554176|396086|P4|STARTED|Run-out Phase||28
162612|NCT01554176|396087|P3|STARTED|Run-out Phase||29
162613|NCT01554176|396088|P2|STARTED|Run-out Phase||0
162614|NCT01554176|396089|P1|STARTED|Run-out Phase||0
162615|NCT01554176|396085|P5|NOT COMPLETED|Treatment Phase||0
162616|NCT01554176|396086|P4|NOT COMPLETED|Treatment Phase||0
162617|NCT01554176|396087|P3|NOT COMPLETED|Treatment Phase||0
162618|NCT01554176|396088|P2|NOT COMPLETED|Treatment Phase||5
162619|NCT01554176|396089|P1|NOT COMPLETED|Treatment Phase||8
162620|NCT01554176|396085|P5|COMPLETED|Treatment Phase||0
162621|NCT01554176|396086|P4|COMPLETED|Treatment Phase||0
162622|NCT01554176|396087|P3|COMPLETED|Treatment Phase||0
162623|NCT01554176|396088|P2|COMPLETED|Treatment Phase||59
162624|NCT01554176|396089|P1|COMPLETED|Treatment Phase||57
162625|NCT01554176|396085|P5|Treated|Treatment Phase||0
162626|NCT01554176|396086|P4|Treated|Treatment Phase||0
162627|NCT01554176|396087|P3|Treated|Treatment Phase||0
162628|NCT01554176|396088|P2|Treated|Treatment Phase||64
162629|NCT01554176|396089|P1|Treated|Treatment Phase||64
162630|NCT01554176|396085|P5|STARTED|Treatment Phase||0
162631|NCT01554176|396086|P4|STARTED|Treatment Phase||0
162632|NCT01554176|396087|P3|STARTED|Treatment Phase||0
162633|NCT01554176|396088|P2|STARTED|Treatment Phase||64
162634|NCT01554176|396089|P1|STARTED|Treatment Phase||65
162635|NCT01554163|396116|P2|NOT COMPLETED|Overall Study||10
162636|NCT01554163|396117|P1|NOT COMPLETED|Overall Study||8
162637|NCT01554163|396116|P2|COMPLETED|Overall Study||109
162638|NCT01554163|396117|P1|COMPLETED|Overall Study||112
162639|NCT01554163|396116|P2|Number Treated|Overall Study||119
162640|NCT01554163|396117|P1|Number Treated|Overall Study||119
162641|NCT01554163|396116|P2|STARTED|Overall Study||119
162642|NCT01554163|396117|P1|STARTED|Overall Study||120
162643|NCT01553916|396135|P1|NOT COMPLETED|Overall Study||3
162644|NCT01553916|396135|P1|COMPLETED|Overall Study||16
162645|NCT01553916|396135|P1|STARTED|Overall Study||19
162646|NCT01553851|396152|P1|NOT COMPLETED|Overall Study||3
162647|NCT01553851|396152|P1|COMPLETED|Overall Study||17
162648|NCT01553851|396152|P1|STARTED|Overall Study||20
162649|NCT01553747|396167|P3|NOT COMPLETED|Overall Study||109
162650|NCT01553747|396168|P2|NOT COMPLETED|Overall Study||119
162651|NCT01553747|396169|P1|NOT COMPLETED|Overall Study||131
162652|NCT01553747|396167|P3|COMPLETED|Overall Study||273
162653|NCT01553747|396168|P2|COMPLETED|Overall Study||264
162654|NCT01553747|396169|P1|COMPLETED|Overall Study||250
162655|NCT01553747|396167|P3|Participated in Blinded-Placebo Period|Overall Study||272
162656|NCT01553747|396168|P2|Participated in Blinded-Placebo Period|Overall Study||253
162657|NCT01553747|396169|P1|Participated in Blinded-Placebo Period|Overall Study||246
162658|NCT01553747|396167|P3|Attended Week 26 Visit|Overall Study||278
162659|NCT01553747|396168|P2|Attended Week 26 Visit|Overall Study||271
162660|NCT01553747|396169|P1|Attended Week 26 Visit|Overall Study||259
162661|NCT01553747|396167|P3|Attended Week 12 Visit|Overall Study||312
162662|NCT01553747|396168|P2|Attended Week 12 Visit|Overall Study||301
162663|NCT01553747|396169|P1|Attended Week 12 Visit|Overall Study||296
162664|NCT01553747|396167|P3|STARTED|Overall Study||382
162665|NCT01553747|396168|P2|STARTED|Overall Study||383
162666|NCT01553747|396169|P1|STARTED|Overall Study||381
162667|NCT01553708|396221|P2|NOT COMPLETED|Overall Study||0
162668|NCT01553708|396222|P1|NOT COMPLETED|Overall Study||0
162669|NCT01553708|396221|P2|COMPLETED|Overall Study||17
162670|NCT01553708|396222|P1|COMPLETED|Overall Study||17
162671|NCT01553708|396221|P2|STARTED|Overall Study||17
162672|NCT01553708|396222|P1|STARTED|Overall Study||17
162673|NCT01553591|396231|P3|NOT COMPLETED|Overall Study||158
162674|NCT01553591|396232|P2|NOT COMPLETED|Overall Study||169
162675|NCT01553591|396233|P1|NOT COMPLETED|Overall Study||172
162676|NCT01553591|396231|P3|COMPLETED|Overall Study||269
162677|NCT01553591|396232|P2|COMPLETED|Overall Study||257
162678|NCT01553591|396233|P1|COMPLETED|Overall Study||257
162679|NCT01553591|396231|P3|Attended Week 26 Visit|Overall Study||290
162680|NCT01553591|396232|P2|Attended Week 26 Visit|Overall Study||291
162681|NCT01553591|396233|P1|Attended Week 26 Visit|Overall Study||289
162682|NCT01553591|396231|P3|Attended Week 12 Visit|Overall Study||342
162683|NCT01553591|396232|P2|Attended Week 12 Visit|Overall Study||330
162684|NCT01553591|396233|P1|Attended Week 12 Visit|Overall Study||341
162685|NCT01553591|396231|P3|STARTED|Overall Study||427
162686|NCT01553591|396232|P2|STARTED|Overall Study||426
162687|NCT01553591|396233|P1|STARTED|Overall Study||429
162688|NCT01553539|396283|P1|NOT COMPLETED|Overall Study||0
162689|NCT01553539|396283|P1|COMPLETED|Overall Study||20
162690|NCT01553539|396283|P1|STARTED|Overall Study||20
162691|NCT01553318|396293|P2|NOT COMPLETED|Overall Study||2
162692|NCT01553318|396294|P1|NOT COMPLETED|Overall Study||3
162693|NCT01553318|396293|P2|COMPLETED|Overall Study||25
162694|NCT01553318|396294|P1|COMPLETED|Overall Study||21
162695|NCT01553318|396293|P2|STARTED|Overall Study||27
162696|NCT01553318|396294|P1|STARTED|Overall Study||24
162697|NCT01553292|396306|P1|NOT COMPLETED|Overall Study||0
162698|NCT01553292|396306|P1|COMPLETED|Overall Study||21
162699|NCT01553292|396306|P1|STARTED|Overall Study||21
162700|NCT01553279|396324|P2|NOT COMPLETED|Period 2: Toddler Vaccinations||7
162701|NCT01553279|396325|P1|NOT COMPLETED|Period 2: Toddler Vaccinations||3
162702|NCT01553279|396324|P2|COMPLETED|Period 2: Toddler Vaccinations||132
162703|NCT01553279|396325|P1|COMPLETED|Period 2: Toddler Vaccinations||134
162704|NCT01553279|396324|P2|STARTED|Period 2: Toddler Vaccinations||139
162705|NCT01553279|396325|P1|STARTED|Period 2: Toddler Vaccinations||137
162706|NCT01553279|396324|P2|NOT COMPLETED|Interim Period||2
162707|NCT01553279|396325|P1|NOT COMPLETED|Interim Period||3
162708|NCT01553279|396324|P2|COMPLETED|Interim Period||139
162709|NCT01553279|396325|P1|COMPLETED|Interim Period||137
162710|NCT01553279|396324|P2|STARTED|Interim Period||141
162711|NCT01553279|396325|P1|STARTED|Interim Period||140
162712|NCT01553279|396324|P2|NOT COMPLETED|Part 1 (Infant Vaccinations)||1
162713|NCT01553279|396325|P1|NOT COMPLETED|Part 1 (Infant Vaccinations)||2
162714|NCT01553279|396324|P2|COMPLETED|Part 1 (Infant Vaccinations)||141
162715|NCT01553279|396325|P1|COMPLETED|Part 1 (Infant Vaccinations)||140
162716|NCT01553279|396324|P2|STARTED|Part 1 (Infant Vaccinations)||142
162717|NCT01553279|396325|P1|STARTED|Part 1 (Infant Vaccinations)||142
162718|NCT01553240|396382|P1|NOT COMPLETED|Overall Study||0
162719|NCT01553240|396382|P1|COMPLETED|Overall Study||0
162720|NCT01553240|396382|P1|STARTED|Overall Study||0
162721|NCT01553188|396391|P4|NOT COMPLETED|Overall Study||0
162722|NCT01553188|396392|P3|NOT COMPLETED|Overall Study||2
162723|NCT01553188|396393|P2|NOT COMPLETED|Overall Study||1
162724|NCT01553188|396394|P1|NOT COMPLETED|Overall Study||1
162725|NCT01553188|396391|P4|COMPLETED|Overall Study||11
162726|NCT01553188|396392|P3|COMPLETED|Overall Study||14
162727|NCT01553188|396393|P2|COMPLETED|Overall Study||5
162728|NCT01553188|396394|P1|COMPLETED|Overall Study||2
162729|NCT01553188|396391|P4|STARTED|Overall Study||11
162730|NCT01553188|396392|P3|STARTED|Overall Study||16
162731|NCT01553188|396393|P2|STARTED|Overall Study||6
162732|NCT01553188|396394|P1|STARTED|Overall Study||3
162733|NCT01553136|396421|P2|NOT COMPLETED|Overall Study||22
162734|NCT01553136|396422|P1|NOT COMPLETED|Overall Study||16
162735|NCT01553136|396421|P2|COMPLETED|Overall Study||45
162736|NCT01553136|396422|P1|COMPLETED|Overall Study||48
162737|NCT01553136|396421|P2|Completed Treatment|Overall Study||52
162738|NCT01553136|396422|P1|Completed Treatment|Overall Study||55
162739|NCT01553136|396421|P2|STARTED|Overall Study||67
162740|NCT01553136|396422|P1|STARTED|Overall Study||64
162741|NCT01553084|396439|P3|NOT COMPLETED|Overall Study||35
162742|NCT01553084|396440|P2|NOT COMPLETED|Overall Study||13
162743|NCT01553084|396441|P1|NOT COMPLETED|Overall Study||15
162744|NCT01553084|396439|P3|COMPLETED|Overall Study||389
162745|NCT01553084|396440|P2|COMPLETED|Overall Study||408
162746|NCT01553084|396441|P1|COMPLETED|Overall Study||226
162747|NCT01553084|396439|P3|STARTED|Overall Study||424
162748|NCT01553084|396440|P2|STARTED|Overall Study||421
162749|NCT01553084|396441|P1|STARTED|Overall Study||241
162750|NCT01553058|396460|P3|NOT COMPLETED|Overall Study||3
162751|NCT01553058|396461|P2|NOT COMPLETED|Overall Study||1
162752|NCT01553058|396462|P1|NOT COMPLETED|Overall Study||1
162753|NCT01553058|396460|P3|COMPLETED|Overall Study||30
162754|NCT01553058|396461|P2|COMPLETED|Overall Study||30
162755|NCT01553058|396462|P1|COMPLETED|Overall Study||32
162756|NCT01553058|396460|P3|STARTED|Overall Study||33
162757|NCT01553058|396461|P2|STARTED|Overall Study||31
162758|NCT01553058|396462|P1|STARTED|Overall Study||33
162759|NCT01552954|396523|P2|NOT COMPLETED|Overall Study||6
162760|NCT01552954|396524|P1|NOT COMPLETED|Overall Study||5
162761|NCT01552954|396523|P2|COMPLETED|Overall Study||119
162762|NCT01552954|396524|P1|COMPLETED|Overall Study||126
162763|NCT01552954|396523|P2|STARTED|Overall Study||125
162764|NCT01552954|396524|P1|STARTED|Overall Study|A total of 13 patients were withdrawn from 269 patients. The remained 256 patients were randomized.|131
162765|NCT01552928|396540|P4|NOT COMPLETED|Period 4||0
162766|NCT01552928|396541|P3|NOT COMPLETED|Period 4||0
162767|NCT01552928|396542|P2|NOT COMPLETED|Period 4||0
162768|NCT01552928|396543|P1|NOT COMPLETED|Period 4||0
162769|NCT01552928|396540|P4|COMPLETED|Period 4||16
162770|NCT01552928|396541|P3|COMPLETED|Period 4||14
162771|NCT01552928|396542|P2|COMPLETED|Period 4||15
162772|NCT01552928|396543|P1|COMPLETED|Period 4||14
162773|NCT01552928|396540|P4|STARTED|Period 4||16
162774|NCT01552928|396541|P3|STARTED|Period 4||14
162775|NCT01552928|396542|P2|STARTED|Period 4||15
162776|NCT01552928|396543|P1|STARTED|Period 4||14
162777|NCT01552928|396540|P4|NOT COMPLETED|Period 3||0
162778|NCT01552928|396541|P3|NOT COMPLETED|Period 3||1
162779|NCT01552928|396542|P2|NOT COMPLETED|Period 3||0
162780|NCT01552928|396543|P1|NOT COMPLETED|Period 3||0
162781|NCT01552928|396540|P4|COMPLETED|Period 3||16
162782|NCT01552928|396541|P3|COMPLETED|Period 3||14
162783|NCT01552928|396542|P2|COMPLETED|Period 3||15
162784|NCT01552928|396543|P1|COMPLETED|Period 3||14
162785|NCT01552928|396540|P4|STARTED|Period 3||16
162786|NCT01552928|396541|P3|STARTED|Period 3||15
162787|NCT01552928|396542|P2|STARTED|Period 3||15
162788|NCT01552928|396543|P1|STARTED|Period 3||14
162789|NCT01552928|396540|P4|NOT COMPLETED|Period 2||0
162790|NCT01552928|396541|P3|NOT COMPLETED|Period 2||0
162791|NCT01552928|396542|P2|NOT COMPLETED|Period 2||0
162792|NCT01552928|396543|P1|NOT COMPLETED|Period 2||0
162793|NCT01552928|396540|P4|COMPLETED|Period 2||16
162794|NCT01552928|396541|P3|COMPLETED|Period 2||15
162795|NCT01552928|396542|P2|COMPLETED|Period 2||15
162796|NCT01552928|396543|P1|COMPLETED|Period 2||14
162797|NCT01552928|396540|P4|STARTED|Period 2||16
162798|NCT01552928|396541|P3|STARTED|Period 2||15
162799|NCT01552928|396542|P2|STARTED|Period 2||15
162800|NCT01552928|396543|P1|STARTED|Period 2||14
162801|NCT01552928|396540|P4|NOT COMPLETED|Period 1||0
162802|NCT01552928|396541|P3|NOT COMPLETED|Period 1||0
162803|NCT01552928|396542|P2|NOT COMPLETED|Period 1||0
162804|NCT01552928|396543|P1|NOT COMPLETED|Period 1||0
162805|NCT01552928|396540|P4|COMPLETED|Period 1||16
162806|NCT01552928|396541|P3|COMPLETED|Period 1||15
162807|NCT01552928|396542|P2|COMPLETED|Period 1||15
162808|NCT01552928|396543|P1|COMPLETED|Period 1||14
162809|NCT01552928|396540|P4|STARTED|Period 1||16
162810|NCT01552928|396541|P3|STARTED|Period 1||15
162811|NCT01552928|396542|P2|STARTED|Period 1||15
162812|NCT01552928|396543|P1|STARTED|Period 1||14
162813|NCT01552915|396590|P3|NOT COMPLETED|Overall Study||27
162814|NCT01552915|396591|P2|NOT COMPLETED|Overall Study||29
162815|NCT01552915|396592|P1|NOT COMPLETED|Overall Study||23
162816|NCT01552915|396590|P3|COMPLETED|Overall Study||157
162817|NCT01552915|396591|P2|COMPLETED|Overall Study||155
162818|NCT01552915|396592|P1|COMPLETED|Overall Study||68
162819|NCT01552915|396590|P3|STARTED|Overall Study|This population is from the Safety Set. One randomized subject was not dosed and was excluded.|184
162820|NCT01552915|396591|P2|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|184
162821|NCT01552915|396592|P1|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|91
162822|NCT01552902|396615|P3|NOT COMPLETED|Overall Study||33
162823|NCT01552902|396616|P2|NOT COMPLETED|Overall Study||37
162824|NCT01552902|396617|P1|NOT COMPLETED|Overall Study||13
162825|NCT01552902|396615|P3|COMPLETED|Overall Study||186
162826|NCT01552902|396616|P2|COMPLETED|Overall Study||181
162827|NCT01552902|396617|P1|COMPLETED|Overall Study||97
162828|NCT01552902|396615|P3|STARTED|Overall Study||219
162829|NCT01552902|396616|P2|STARTED|Overall Study||218
162830|NCT01552902|396617|P1|STARTED|Overall Study||110
162831|NCT01552889|396639|P2|NOT COMPLETED|Overall Study||5
162832|NCT01552889|396640|P1|NOT COMPLETED|Overall Study||11
162833|NCT01552889|396639|P2|COMPLETED|Overall Study||95
162834|NCT01552889|396640|P1|COMPLETED|Overall Study||90
162835|NCT01552889|396639|P2|STARTED|Overall Study||100
162836|NCT01552889|396640|P1|STARTED|Overall Study||101
162837|NCT01552876|396650|P2|NOT COMPLETED|Overall Study||0
162838|NCT01552876|396651|P1|NOT COMPLETED|Overall Study||0
162839|NCT01552876|396650|P2|COMPLETED|Overall Study||20
162840|NCT01552876|396651|P1|COMPLETED|Overall Study||20
162841|NCT01552876|396650|P2|STARTED|Overall Study||20
162842|NCT01552876|396651|P1|STARTED|Overall Study||20
162843|NCT01552772|396667|P1|NOT COMPLETED|Overall Study||4
162844|NCT01552772|396667|P1|COMPLETED|Overall Study|Participants who completed the Day 28 visit were defined as completers for the trial.|56
162845|NCT01552772|396667|P1|STARTED|Overall Study||60
162846|NCT01552694|396683|P2|NOT COMPLETED|Overall Study||2
162847|NCT01552694|396684|P1|NOT COMPLETED|Overall Study||0
162848|NCT01552694|396683|P2|COMPLETED|Overall Study||18
162849|NCT01552694|396684|P1|COMPLETED|Overall Study||18
162850|NCT01552694|396683|P2|STARTED|Overall Study||20
162851|NCT01552694|396684|P1|STARTED|Overall Study||18
162852|NCT01552681|396700|P2|NOT COMPLETED|Overall Study||1
162853|NCT01552681|396701|P1|NOT COMPLETED|Overall Study||5
162854|NCT01552681|396700|P2|COMPLETED|Overall Study||18
162855|NCT01552681|396701|P1|COMPLETED|Overall Study||28
162856|NCT01552681|396700|P2|STARTED|Overall Study||19
162857|NCT01552681|396701|P1|STARTED|Overall Study||33
162858|NCT01552603|396749|P1|NOT COMPLETED|Overall Study||1
162859|NCT01552603|396749|P1|COMPLETED|Overall Study||13
162860|NCT01552603|396749|P1|STARTED|Overall Study||14
162861|NCT01552408|396756|P2|NOT COMPLETED|Overall Study||2
162862|NCT01552408|396757|P1|NOT COMPLETED|Overall Study||4
162863|NCT01552408|396756|P2|COMPLETED|Overall Study||18
162864|NCT01552408|396757|P1|COMPLETED|Overall Study||16
162865|NCT01552408|396756|P2|STARTED|Overall Study||20
162866|NCT01552408|396757|P1|STARTED|Overall Study||20
162867|NCT01552369|396779|P2|NOT COMPLETED|Overall Study||9
162868|NCT01552369|396780|P1|NOT COMPLETED|Overall Study||8
162869|NCT01552369|396779|P2|COMPLETED|Overall Study||96
162870|NCT01552369|396780|P1|COMPLETED|Overall Study||92
162871|NCT01552369|396779|P2|Final Follow up|Overall Study||96
162872|NCT01552369|396780|P1|Final Follow up|Overall Study||92
162873|NCT01552369|396779|P2|One Year|Overall Study||105
162874|NCT01552369|396780|P1|One Year|Overall Study||100
162875|NCT01552369|396779|P2|STARTED|Overall Study||105
162876|NCT01552369|396780|P1|STARTED|Overall Study||100
162877|NCT01552343|396808|P2|NOT COMPLETED|Overall Study||0
162878|NCT01552343|396809|P1|NOT COMPLETED|Overall Study||0
162879|NCT01552343|396808|P2|COMPLETED|Overall Study||27
162880|NCT01552343|396809|P1|COMPLETED|Overall Study||29
162881|NCT01552343|396808|P2|STARTED|Overall Study||27
162882|NCT01552343|396809|P1|STARTED|Overall Study||29
162883|NCT01552213|396832|P2|NOT COMPLETED|Overall Study||8
162884|NCT01552213|396833|P1|NOT COMPLETED|Overall Study||13
162885|NCT01552213|396832|P2|COMPLETED|Overall Study||37
162886|NCT01552213|396833|P1|COMPLETED|Overall Study||37
162887|NCT01552213|396832|P2|Analyzed|Overall Study||41
162888|NCT01552213|396833|P1|Analyzed|Overall Study||42
162889|NCT01552213|396832|P2|STARTED|Overall Study||45
162890|NCT01552213|396833|P1|STARTED|Overall Study||50
162891|NCT01552057|396869|P2|NOT COMPLETED|Overall Study||48
162892|NCT01552057|396870|P1|NOT COMPLETED|Overall Study||30
162893|NCT01552057|396869|P2|COMPLETED|Overall Study||149
162894|NCT01552057|396870|P1|COMPLETED|Overall Study||166
162895|NCT01552057|396869|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
162896|NCT01552057|396870|P1|Received at Least 1 Dose of Study Drug|Overall Study||194
162897|NCT01552057|396869|P2|STARTED|Overall Study||197
162898|NCT01552057|396870|P1|STARTED|Overall Study||196
162899|NCT01551979|396904|P2|NOT COMPLETED|Overall Study||2
162900|NCT01551979|396905|P1|NOT COMPLETED|Overall Study||2
162901|NCT01551979|396904|P2|COMPLETED|Overall Study||5
162902|NCT01551979|396905|P1|COMPLETED|Overall Study||8
162903|NCT01551979|396904|P2|1 Week Post Treatment|Overall Study||6
162904|NCT01551979|396905|P1|1 Week Post Treatment|Overall Study||10
162905|NCT01551979|396904|P2|Last Day of Treatment (After 5 Days)|Overall Study||7
162906|NCT01551979|396905|P1|Last Day of Treatment (After 5 Days)|Overall Study||10
162907|NCT01551979|396904|P2|STARTED|Overall Study||7
162908|NCT01551979|396905|P1|STARTED|Overall Study||10
162909|NCT01551888|396921|P2|NOT COMPLETED|Period 2||0
162910|NCT01551888|396922|P1|NOT COMPLETED|Period 2||0
162911|NCT01551888|396921|P2|COMPLETED|Period 2||12
162912|NCT01551888|396922|P1|COMPLETED|Period 2||12
162913|NCT01551888|396921|P2|STARTED|Period 2||12
162914|NCT01551888|396922|P1|STARTED|Period 2||12
162915|NCT01551888|396921|P2|NOT COMPLETED|Period 1||0
162916|NCT01551888|396922|P1|NOT COMPLETED|Period 1||0
162917|NCT01551888|396921|P2|COMPLETED|Period 1||12
162918|NCT01551888|396922|P1|COMPLETED|Period 1||12
162919|NCT01551888|396921|P2|STARTED|Period 1||12
162920|NCT01551888|396922|P1|STARTED|Period 1||12
162921|NCT01551758|396936|P2|NOT COMPLETED|Overall Study||105
162922|NCT01551758|396937|P1|NOT COMPLETED|Overall Study||94
162923|NCT01551758|396936|P2|COMPLETED|Overall Study||1291
162924|NCT01551758|396937|P1|COMPLETED|Overall Study||1309
162925|NCT01551758|396936|P2|STARTED|Overall Study||1396
162926|NCT01551758|396937|P1|STARTED|Overall Study||1403
162927|NCT01551745|396975|P1|NOT COMPLETED|Overall Study||3
162928|NCT01551745|396975|P1|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses"|2
162929|NCT01551745|396975|P1|STARTED|Overall Study||5
162930|NCT01551693|396984|P2|NOT COMPLETED|Overall Study||2
162931|NCT01551693|396985|P1|NOT COMPLETED|Overall Study||1
162932|NCT01551693|396984|P2|COMPLETED|Overall Study||0
162933|NCT01551693|396985|P1|COMPLETED|Overall Study||0
162934|NCT01551693|396984|P2|STARTED|Overall Study||2
162935|NCT01551693|396985|P1|STARTED|Overall Study||1
162936|NCT01551550|396997|P2|NOT COMPLETED|Overall Study||1
162937|NCT01551550|396998|P1|NOT COMPLETED|Overall Study||0
162938|NCT01551550|396997|P2|COMPLETED|Overall Study||40
162939|NCT01551550|396998|P1|COMPLETED|Overall Study||41
162940|NCT01551550|396997|P2|STARTED|Overall Study||41
162941|NCT01551550|396998|P1|STARTED|Overall Study||41
162942|NCT01551420|397006|P2|NOT COMPLETED|Home Use (Part B)||1
162943|NCT01551420|397007|P1|NOT COMPLETED|Home Use (Part B)||6
162944|NCT01551420|397006|P2|COMPLETED|Home Use (Part B)||7
162945|NCT01551420|397007|P1|COMPLETED|Home Use (Part B)||18
162946|NCT01551420|397006|P2|STARTED|Home Use (Part B)||8
162947|NCT01551420|397007|P1|STARTED|Home Use (Part B)||24
162948|NCT01551420|397006|P2|NOT COMPLETED|Screened for Part B Eligibility||3
162949|NCT01551420|397007|P1|NOT COMPLETED|Screened for Part B Eligibility||9
162950|NCT01551420|397006|P2|COMPLETED|Screened for Part B Eligibility||8
162951|NCT01551420|397007|P1|COMPLETED|Screened for Part B Eligibility||24
162952|NCT01551420|397006|P2|STARTED|Screened for Part B Eligibility||11
162953|NCT01551420|397007|P1|STARTED|Screened for Part B Eligibility||33
162954|NCT01551420|397006|P2|NOT COMPLETED|In-laboratory (Part A)||2
162955|NCT01551420|397007|P1|NOT COMPLETED|In-laboratory (Part A)||6
162956|NCT01551420|397006|P2|COMPLETED|In-laboratory (Part A)||11
162957|NCT01551420|397007|P1|COMPLETED|In-laboratory (Part A)||33
162958|NCT01551420|397006|P2|STARTED|In-laboratory (Part A)||13
162959|NCT01551420|397007|P1|STARTED|In-laboratory (Part A)||39
162960|NCT01551355|397037|P6|NOT COMPLETED|Overall Study||6
162961|NCT01551355|397038|P5|NOT COMPLETED|Overall Study||9
162962|NCT01551355|397039|P4|NOT COMPLETED|Overall Study||24
162963|NCT01551355|397040|P3|NOT COMPLETED|Overall Study||34
162964|NCT01551355|397041|P2|NOT COMPLETED|Overall Study||49
162965|NCT01551355|397042|P1|NOT COMPLETED|Overall Study||51
162966|NCT01551355|397037|P6|COMPLETED|Overall Study||65
162967|NCT01551355|397038|P5|COMPLETED|Overall Study||55
162968|NCT01551355|397039|P4|COMPLETED|Overall Study||411
162969|NCT01551355|397040|P3|COMPLETED|Overall Study||459
162970|NCT01551355|397041|P2|COMPLETED|Overall Study||545
162971|NCT01551355|397042|P1|COMPLETED|Overall Study||571
162972|NCT01551355|397037|P6|STARTED|Overall Study||71
162973|NCT01551355|397038|P5|STARTED|Overall Study||64
162974|NCT01551355|397039|P4|STARTED|Overall Study||435
162975|NCT01551355|397040|P3|STARTED|Overall Study||493
162976|NCT01551355|397041|P2|STARTED|Overall Study||594
162977|NCT01551355|397042|P1|STARTED|Overall Study||622
162978|NCT01551303|397056|P2|NOT COMPLETED|Overall Study||7
162979|NCT01551303|397057|P1|NOT COMPLETED|Overall Study||4
162980|NCT01551303|397056|P2|COMPLETED|Overall Study||15
162981|NCT01551303|397057|P1|COMPLETED|Overall Study||21
162982|NCT01551303|397056|P2|STARTED|Overall Study||22
162983|NCT01551303|397057|P1|STARTED|Overall Study||25
162984|NCT01551212|397065|P2|NOT COMPLETED|Overall Study||20
162985|NCT01551212|397066|P1|NOT COMPLETED|Overall Study||5
162986|NCT01551212|397065|P2|COMPLETED|Overall Study||148
162987|NCT01551212|397066|P1|COMPLETED|Overall Study||166
162988|NCT01551212|397065|P2|Per Protocol Set (PP)|Overall Study||101
162989|NCT01551212|397066|P1|Per Protocol Set (PP)|Overall Study||110
162990|NCT01551212|397065|P2|Safety Set|Overall Study||164
162991|NCT01551212|397066|P1|Safety Set|Overall Study||169
162992|NCT01551212|397065|P2|Full Anylsis Set (FAS)|Overall Study||164
162993|NCT01551212|397066|P1|Full Anylsis Set (FAS)|Overall Study||169
162994|NCT01551212|397065|P2|STARTED|Overall Study||168
162995|NCT01551212|397066|P1|STARTED|Overall Study||171
162996|NCT01551199|397084|P1|NOT COMPLETED|Overall Study||5
162997|NCT01551199|397084|P1|COMPLETED|Overall Study||2
162998|NCT01551199|397084|P1|STARTED|Overall Study||7
162999|NCT01551186|397092|P2|NOT COMPLETED|Overall Study||13
163000|NCT01551186|397093|P1|NOT COMPLETED|Overall Study||20
163001|NCT01551186|397092|P2|COMPLETED|Overall Study||40
163002|NCT01551186|397093|P1|COMPLETED|Overall Study||30
163003|NCT01551186|397092|P2|STARTED|Overall Study||53
163004|NCT01551186|397093|P1|STARTED|Overall Study||50
163005|NCT01551173|397101|P2|NOT COMPLETED|Overall Study||32
163006|NCT01551173|397102|P1|NOT COMPLETED|Overall Study||28
163007|NCT01551173|397101|P2|COMPLETED|Overall Study||186
163008|NCT01551173|397102|P1|COMPLETED|Overall Study||190
163009|NCT01551173|397101|P2|Full Analysis Set (FAS)|Overall Study||214
163010|NCT01551173|397102|P1|Full Analysis Set (FAS)|Overall Study|Patients took at least 1 dose of study drug & had at least 1 post-randomization efficacy parameter|210
163011|NCT01551173|397101|P2|STARTED|Overall Study||218
163012|NCT01551173|397102|P1|STARTED|Overall Study|"Started indicates randomized"|218
163013|NCT01551095|397113|P1|NOT COMPLETED|Overall Study||0
163014|NCT01551095|397113|P1|COMPLETED|Overall Study||7
163015|NCT01551095|397113|P1|STARTED|Overall Study||7
163016|NCT01551082|397118|P1|NOT COMPLETED|Overall Study||0
163017|NCT01551082|397118|P1|COMPLETED|Overall Study||12
163018|NCT01551082|397118|P1|STARTED|Overall Study||12
163019|NCT01551056|397124|P2|NOT COMPLETED|Overall Study||0
163020|NCT01551056|397125|P1|NOT COMPLETED|Overall Study||2
163021|NCT01551056|397124|P2|COMPLETED|Overall Study||45
163022|NCT01551056|397125|P1|COMPLETED|Overall Study||44
163023|NCT01551056|397124|P2|STARTED|Overall Study||45
163024|NCT01551056|397125|P1|STARTED|Overall Study||46
163025|NCT01550965|397179|P1|NOT COMPLETED|Overall Study||110
163026|NCT01550965|397179|P1|COMPLETED|Overall Study||353
163027|NCT01550965|397179|P1|STARTED|Overall Study||463
163028|NCT01550952|397198|P1|NOT COMPLETED|Overall Study||0
163029|NCT01550952|397198|P1|COMPLETED|Overall Study||10
163030|NCT01550952|397198|P1|STARTED|Overall Study||10
163031|NCT01550809|397208|P2|NOT COMPLETED|Overall Study||0
163032|NCT01550809|397209|P1|NOT COMPLETED|Overall Study||0
163033|NCT01550809|397208|P2|COMPLETED|Overall Study||6
163034|NCT01550809|397209|P1|COMPLETED|Overall Study||6
163035|NCT01550809|397208|P2|STARTED|Overall Study|Six patients started with the iBolus, the others with the tBolus, according to a crossover design.|6
163036|NCT01550809|397209|P1|STARTED|Overall Study|Six patients started with the tBolus, the others with the iBolus, according to a crossover design.|6
163037|NCT01550757|397223|P4|NOT COMPLETED|Overall Study||54
163038|NCT01550757|397224|P3|NOT COMPLETED|Overall Study||45
163039|NCT01550757|397225|P2|NOT COMPLETED|Overall Study||14
163040|NCT01550757|397226|P1|NOT COMPLETED|Overall Study||23
163041|NCT01550757|397223|P4|COMPLETED|Overall Study||90
163042|NCT01550757|397224|P3|COMPLETED|Overall Study||85
163043|NCT01550757|397225|P2|COMPLETED|Overall Study||38
163044|NCT01550757|397226|P1|COMPLETED|Overall Study||33
163045|NCT01550757|397223|P4|STARTED|Overall Study||144
163046|NCT01550757|397224|P3|STARTED|Overall Study||130
163047|NCT01550757|397225|P2|STARTED|Overall Study||52
163048|NCT01550757|397226|P1|STARTED|Overall Study||56
163049|NCT01550744|397236|P3|NOT COMPLETED|Double-Blind||67
163050|NCT01550744|397237|P2|NOT COMPLETED|Double-Blind||17
163051|NCT01550744|397238|P1|NOT COMPLETED|Double-Blind||0
163052|NCT01550744|397236|P3|COMPLETED|Double-Blind||235
163053|NCT01550744|397237|P2|COMPLETED|Double-Blind||59
163054|NCT01550744|397238|P1|COMPLETED|Double-Blind||0
163055|NCT01550744|397236|P3|STARTED|Double-Blind||302
163056|NCT01550744|397237|P2|STARTED|Double-Blind||76
163057|NCT01550744|397238|P1|STARTED|Double-Blind||0
163058|NCT01550744|397236|P3|NOT COMPLETED|Open-Label||0
163059|NCT01550744|397237|P2|NOT COMPLETED|Open-Label||0
163060|NCT01550744|397238|P1|NOT COMPLETED|Open-Label||100
163061|NCT01550744|397236|P3|COMPLETED|Open-Label||0
163062|NCT01550744|397237|P2|COMPLETED|Open-Label||0
163063|NCT01550744|397238|P1|COMPLETED|Open-Label||378
163064|NCT01550744|397236|P3|STARTED|Open-Label||0
163065|NCT01550744|397237|P2|STARTED|Open-Label||0
163066|NCT01550744|397238|P1|STARTED|Open-Label||478
163067|NCT01550731|397253|P2|NOT COMPLETED|Overall Study||0
163068|NCT01550731|397254|P1|NOT COMPLETED|Overall Study||0
163069|NCT01550731|397253|P2|COMPLETED|Overall Study||209
163070|NCT01550731|397254|P1|COMPLETED|Overall Study||205
163071|NCT01550731|397253|P2|STARTED|Overall Study||209
163072|NCT01550731|397254|P1|STARTED|Overall Study||205
163073|NCT01550705|397262|P1|NOT COMPLETED|Overall Study||1
163074|NCT01550705|397262|P1|COMPLETED|Overall Study||10
163075|NCT01550705|397262|P1|STARTED|Overall Study||11
163076|NCT01550549|397267|P1|NOT COMPLETED|Overall Study||0
163077|NCT01550549|397267|P1|COMPLETED|Overall Study||151
163078|NCT01550549|397267|P1|STARTED|Overall Study||151
163079|NCT01550510|397281|P2|NOT COMPLETED|Overall Study||0
163080|NCT01550510|397282|P1|NOT COMPLETED|Overall Study||0
163081|NCT01550510|397281|P2|COMPLETED|Overall Study||0
163082|NCT01550510|397282|P1|COMPLETED|Overall Study||4
163083|NCT01550510|397281|P2|STARTED|Overall Study||0
163084|NCT01550510|397282|P1|STARTED|Overall Study||4
163085|NCT01550367|397290|P1|NOT COMPLETED|Overall Study||0
163086|NCT01550367|397290|P1|COMPLETED|Overall Study||30
163087|NCT01550367|397290|P1|600 mg/d HCQ|Overall Study||17
163088|NCT01550367|397290|P1|1200 mg/d HCQ|Overall Study||13
163089|NCT01550367|397290|P1|STARTED|Overall Study||30
163090|NCT01550302|397317|P2|NOT COMPLETED|Overall Study||0
163091|NCT01550302|397318|P1|NOT COMPLETED|Overall Study||0
163092|NCT01550302|397317|P2|COMPLETED|Overall Study||5
163093|NCT01550302|397318|P1|COMPLETED|Overall Study||5
163094|NCT01550302|397317|P2|STARTED|Overall Study||5
163095|NCT01550302|397318|P1|STARTED|Overall Study||5
163096|NCT01550289|397338|P2|NOT COMPLETED|Overall Study||4
163097|NCT01550289|397339|P1|NOT COMPLETED|Overall Study||13
163098|NCT01550289|397338|P2|COMPLETED|Overall Study||57
163099|NCT01550289|397339|P1|COMPLETED|Overall Study||115
163100|NCT01550289|397338|P2|STARTED|Overall Study||61
163101|NCT01550289|397339|P1|STARTED|Overall Study||128
163102|NCT01550224|397371|P2|NOT COMPLETED|Overall Study||0
163103|NCT01550224|397372|P1|NOT COMPLETED|Overall Study||0
163104|NCT01550224|397371|P2|COMPLETED|Overall Study||20
163105|NCT01550224|397372|P1|COMPLETED|Overall Study||3
163106|NCT01550224|397371|P2|STARTED|Overall Study||20
163107|NCT01550224|397372|P1|STARTED|Overall Study||3
163108|NCT01549977|397396|P2|NOT COMPLETED|Overall Study||0
163109|NCT01549977|397397|P1|NOT COMPLETED|Overall Study||0
163110|NCT01549977|397396|P2|COMPLETED|Overall Study||0
163111|NCT01549977|397397|P1|COMPLETED|Overall Study||1
163112|NCT01549977|397396|P2|STARTED|Overall Study||0
163113|NCT01549977|397397|P1|STARTED|Overall Study||1
163114|NCT01549964|397415|P4|NOT COMPLETED|80-Week Extension Period||137
163115|NCT01549964|397416|P3|NOT COMPLETED|80-Week Extension Period||140
163116|NCT01549964|397417|P2|NOT COMPLETED|80-Week Extension Period||138
163117|NCT01549964|397418|P1|NOT COMPLETED|80-Week Extension Period||66
163118|NCT01549964|397415|P4|COMPLETED|80-Week Extension Period||0
163119|NCT01549964|397416|P3|COMPLETED|80-Week Extension Period||0
163120|NCT01549964|397417|P2|COMPLETED|80-Week Extension Period||0
163121|NCT01549964|397418|P1|COMPLETED|80-Week Extension Period||0
163122|NCT01549964|397415|P4|STARTED|80-Week Extension Period||137
163123|NCT01549964|397416|P3|STARTED|80-Week Extension Period||140
163124|NCT01549964|397417|P2|STARTED|80-Week Extension Period||138
163125|NCT01549964|397418|P1|STARTED|80-Week Extension Period||66
163126|NCT01549964|397415|P4|NOT COMPLETED|24-Week Treatment Period||121
163127|NCT01549964|397416|P3|NOT COMPLETED|24-Week Treatment Period||116
163128|NCT01549964|397417|P2|NOT COMPLETED|24-Week Treatment Period||111
163129|NCT01549964|397418|P1|NOT COMPLETED|24-Week Treatment Period||61
163130|NCT01549964|397415|P4|COMPLETED|24-Week Treatment Period||140
163131|NCT01549964|397416|P3|COMPLETED|24-Week Treatment Period||147
163132|NCT01549964|397417|P2|COMPLETED|24-Week Treatment Period||149
163133|NCT01549964|397418|P1|COMPLETED|24-Week Treatment Period||71
163134|NCT01549964|397415|P4|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
163135|NCT01549964|397416|P3|Safety Analysis Set=Received Treatment|24-Week Treatment Period||263
163136|NCT01549964|397417|P2|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
163137|NCT01549964|397418|P1|Safety Analysis Set=Received Treatment|24-Week Treatment Period||132
163138|NCT01549964|397415|P4|STARTED|24-Week Treatment Period||261
163139|NCT01549964|397416|P3|STARTED|24-Week Treatment Period||263
163140|NCT01549964|397417|P2|STARTED|24-Week Treatment Period||260
163141|NCT01549964|397418|P1|STARTED|24-Week Treatment Period||132
163142|NCT01549951|397436|P1|NOT COMPLETED|Overall Study||50
163143|NCT01549951|397436|P1|COMPLETED|Overall Study||0
163144|NCT01549951|397436|P1|Primary Reason Off Study Treatment|Overall Study||50
163145|NCT01549951|397436|P1|STARTED|Overall Study||50
163146|NCT01549925|397454|P2|NOT COMPLETED|Overall Study||0
163147|NCT01549925|397455|P1|NOT COMPLETED|Overall Study||0
163148|NCT01549925|397454|P2|COMPLETED|Overall Study||25
163149|NCT01549925|397455|P1|COMPLETED|Overall Study||25
163150|NCT01549925|397454|P2|STARTED|Overall Study||25
163151|NCT01549925|397455|P1|STARTED|Overall Study||25
163152|NCT01549873|397463|P2|NOT COMPLETED|Overall Study||1
163153|NCT01549873|397464|P1|NOT COMPLETED|Overall Study||0
163154|NCT01549873|397463|P2|COMPLETED|Overall Study||14
163155|NCT01549873|397464|P1|COMPLETED|Overall Study||15
163156|NCT01549873|397463|P2|STARTED|Overall Study||15
163157|NCT01549873|397464|P1|STARTED|Overall Study||15
163158|NCT01549860|397476|P2|NOT COMPLETED|Overall Study||1
163159|NCT01549860|397477|P1|NOT COMPLETED|Overall Study||2
163160|NCT01549860|397476|P2|COMPLETED|Overall Study||40
163161|NCT01549860|397477|P1|COMPLETED|Overall Study||38
163162|NCT01549860|397476|P2|STARTED|Overall Study||41
163163|NCT01549860|397477|P1|STARTED|Overall Study||40
163164|NCT01549652|397490|P4|NOT COMPLETED|Overall Study||11
163165|NCT01549652|397491|P3|NOT COMPLETED|Overall Study||17
163166|NCT01549652|397492|P2|NOT COMPLETED|Overall Study||12
163167|NCT01549652|397493|P1|NOT COMPLETED|Overall Study||12
163168|NCT01549652|397490|P4|COMPLETED|Overall Study||25
163169|NCT01549652|397491|P3|COMPLETED|Overall Study||23
163170|NCT01549652|397492|P2|COMPLETED|Overall Study||18
163171|NCT01549652|397493|P1|COMPLETED|Overall Study||15
163172|NCT01549652|397490|P4|STARTED|Overall Study||36
163173|NCT01549652|397491|P3|STARTED|Overall Study||40
163174|NCT01549652|397492|P2|STARTED|Overall Study||30
163175|NCT01549652|397493|P1|STARTED|Overall Study||27
163176|NCT01549613|397511|P2|NOT COMPLETED|Overall Study||11
163177|NCT01549613|397512|P1|NOT COMPLETED|Overall Study||11
163178|NCT01549613|397511|P2|COMPLETED|Overall Study||39
163179|NCT01549613|397512|P1|COMPLETED|Overall Study||39
163180|NCT01549613|397511|P2|STARTED|Overall Study||50
163181|NCT01549613|397512|P1|STARTED|Overall Study||50
163182|NCT01549405|397520|P2|NOT COMPLETED|Overall Study||0
163183|NCT01549405|397521|P1|NOT COMPLETED|Overall Study||0
163184|NCT01549405|397520|P2|COMPLETED|Overall Study||20
163185|NCT01549405|397521|P1|COMPLETED|Overall Study||20
163186|NCT01549405|397520|P2|STARTED|Overall Study||20
163187|NCT01549405|397521|P1|STARTED|Overall Study||20
163188|NCT01549392|397531|P2|NOT COMPLETED|Overall Study||0
163189|NCT01549392|397532|P1|NOT COMPLETED|Overall Study||1
163190|NCT01549392|397531|P2|COMPLETED|Overall Study||0
163191|NCT01549392|397532|P1|COMPLETED|Overall Study||2
163192|NCT01549392|397531|P2|STARTED|Overall Study||0
163193|NCT01549392|397532|P1|STARTED|Overall Study||3
163194|NCT01549340|397538|P1|NOT COMPLETED|Overall Study||8405
163195|NCT01549340|397538|P1|COMPLETED|Overall Study|Completed 5 years of AIT|385
163196|NCT01549340|397538|P1|Started AIT|Overall Study||3182
163197|NCT01549340|397538|P1|STARTED|Overall Study|Advised to receive AIT|8790
163198|NCT01549275|397551|P2|NOT COMPLETED|Overall Study||0
163199|NCT01549275|397552|P1|NOT COMPLETED|Overall Study||1
163200|NCT01549275|397551|P2|COMPLETED|Overall Study||29
163201|NCT01549275|397552|P1|COMPLETED|Overall Study||75
163202|NCT01549275|397551|P2|STARTED|Overall Study||29
163203|NCT01549275|397552|P1|STARTED|Overall Study||76
163204|NCT01549223|397564|P2|NOT COMPLETED|Overall Study||0
163205|NCT01549223|397565|P1|NOT COMPLETED|Overall Study||0
163206|NCT01549223|397564|P2|COMPLETED|Overall Study||30
163207|NCT01549223|397565|P1|COMPLETED|Overall Study||30
163208|NCT01549223|397564|P2|STARTED|Overall Study||30
163209|NCT01549223|397565|P1|STARTED|Overall Study||30
163210|NCT01549041|397575|P2|NOT COMPLETED|Overall Study||8
163211|NCT01549041|397576|P1|NOT COMPLETED|Overall Study||2
163212|NCT01549041|397575|P2|COMPLETED|Overall Study||10
163213|NCT01549041|397576|P1|COMPLETED|Overall Study||10
163214|NCT01549041|397575|P2|STARTED|Overall Study||18
163215|NCT01549041|397576|P1|STARTED|Overall Study||12
163216|NCT01549002|397586|P2|NOT COMPLETED|Overall Study||4
163217|NCT01549002|397587|P1|NOT COMPLETED|Overall Study||0
163218|NCT01549002|397586|P2|COMPLETED|Overall Study||6
163219|NCT01549002|397587|P1|COMPLETED|Overall Study||10
163220|NCT01549002|397586|P2|STARTED|Overall Study||10
163221|NCT01549002|397587|P1|STARTED|Overall Study||10
163222|NCT01548885|397597|P1|NOT COMPLETED|Overall Study||0
163223|NCT01548885|397597|P1|COMPLETED|Overall Study||146
163224|NCT01548885|397597|P1|STARTED|Overall Study||146
163225|NCT01548833|397602|P1|NOT COMPLETED|Overall Study||0
163226|NCT01548833|397602|P1|COMPLETED|Overall Study||39
163227|NCT01548833|397602|P1|STARTED|Overall Study||39
163228|NCT01548742|397612|P2|NOT COMPLETED|Overall Study||4
163229|NCT01548742|397613|P1|NOT COMPLETED|Overall Study||13
163230|NCT01548742|397612|P2|COMPLETED|Overall Study||54
163231|NCT01548742|397613|P1|COMPLETED|Overall Study||45
163232|NCT01548742|397612|P2|STARTED|Overall Study||58
163233|NCT01548742|397613|P1|STARTED|Overall Study||58
163234|NCT01548690|397631|P4|NOT COMPLETED|Overall Study||5
163235|NCT01548690|397632|P3|NOT COMPLETED|Overall Study||5
163236|NCT01548690|397633|P2|NOT COMPLETED|Overall Study||3
163237|NCT01548690|397634|P1|NOT COMPLETED|Overall Study||0
163238|NCT01548690|397631|P4|COMPLETED|Overall Study||10
163239|NCT01548690|397632|P3|COMPLETED|Overall Study||8
163240|NCT01548690|397633|P2|COMPLETED|Overall Study||7
163241|NCT01548690|397634|P1|COMPLETED|Overall Study||9
163242|NCT01548690|397631|P4|Evaluable (72 Hours on Infusion)|Overall Study||12
163243|NCT01548690|397632|P3|Evaluable (72 Hours on Infusion)|Overall Study||12
163244|NCT01548690|397633|P2|Evaluable (72 Hours on Infusion)|Overall Study||6
163245|NCT01548690|397634|P1|Evaluable (72 Hours on Infusion)|Overall Study||6
163246|NCT01548690|397631|P4|STARTED|Overall Study||15
163247|NCT01548690|397632|P3|STARTED|Overall Study||13
163248|NCT01548690|397633|P2|STARTED|Overall Study||10
163249|NCT01548690|397634|P1|STARTED|Overall Study||9
163250|NCT01548638|397660|P1|NOT COMPLETED|Overall Study||4
163251|NCT01548638|397660|P1|COMPLETED|Overall Study||9
163252|NCT01548638|397660|P1|STARTED|Overall Study||13
163253|NCT01548573|397670|P1|NOT COMPLETED|Overall Study||5
163254|NCT01548573|397670|P1|COMPLETED|Overall Study||14
163255|NCT01548573|397670|P1|STARTED|Overall Study||19
163256|NCT01548417|397679|P2|NOT COMPLETED|Overall Study||2
163257|NCT01548417|397680|P1|NOT COMPLETED|Overall Study||0
163258|NCT01548417|397679|P2|COMPLETED|Overall Study||26
163259|NCT01548417|397680|P1|COMPLETED|Overall Study||28
163260|NCT01548417|397679|P2|STARTED|Overall Study||28
163261|NCT01548417|397680|P1|STARTED|Overall Study||28
163262|NCT01548404|397690|P2|NOT COMPLETED|Overall Study||14
163263|NCT01548404|397691|P1|NOT COMPLETED|Overall Study||30
163264|NCT01548404|397690|P2|COMPLETED|Overall Study||41
163265|NCT01548404|397691|P1|COMPLETED|Overall Study||24
163266|NCT01548404|397690|P2|STARTED|Overall Study||55
163267|NCT01548404|397691|P1|STARTED|Overall Study||54
163268|NCT01548339|397715|P2|NOT COMPLETED|Overall Study||1
163269|NCT01548339|397716|P1|NOT COMPLETED|Overall Study||6
163270|NCT01548339|397715|P2|COMPLETED|Overall Study||41
163271|NCT01548339|397716|P1|COMPLETED|Overall Study||38
163272|NCT01548339|397715|P2|STARTED|Overall Study||42
163273|NCT01548339|397716|P1|STARTED|Overall Study||44
163274|NCT01548287|397730|P5|NOT COMPLETED|Randomized Period||0
163275|NCT01548287|397731|P4|NOT COMPLETED|Randomized Period||0
163276|NCT01548287|397732|P3|NOT COMPLETED|Randomized Period||7
163277|NCT01548287|397733|P2|NOT COMPLETED|Randomized Period||2
163278|NCT01548287|397734|P1|NOT COMPLETED|Randomized Period||0
163279|NCT01548287|397730|P5|COMPLETED|Randomized Period||0
163280|NCT01548287|397731|P4|COMPLETED|Randomized Period||20
163281|NCT01548287|397732|P3|COMPLETED|Randomized Period||13
163282|NCT01548287|397733|P2|COMPLETED|Randomized Period||20
163283|NCT01548287|397734|P1|COMPLETED|Randomized Period||19
163284|NCT01548287|397730|P5|STARTED|Randomized Period||0
163285|NCT01548287|397731|P4|STARTED|Randomized Period||20
163286|NCT01548287|397732|P3|STARTED|Randomized Period||20
163287|NCT01548287|397733|P2|STARTED|Randomized Period||22
163288|NCT01548287|397734|P1|STARTED|Randomized Period||19
163289|NCT01548287|397730|P5|NOT COMPLETED|Screening||83
163290|NCT01548287|397731|P4|NOT COMPLETED|Screening||0
163291|NCT01548287|397732|P3|NOT COMPLETED|Screening||0
163292|NCT01548287|397733|P2|NOT COMPLETED|Screening||0
163293|NCT01548287|397734|P1|NOT COMPLETED|Screening||0
163294|NCT01548287|397730|P5|COMPLETED|Screening||0
163295|NCT01548287|397731|P4|COMPLETED|Screening||20
163296|NCT01548287|397732|P3|COMPLETED|Screening||20
163297|NCT01548287|397733|P2|COMPLETED|Screening||22
163298|NCT01548287|397734|P1|COMPLETED|Screening||19
163299|NCT01548287|397730|P5|STARTED|Screening||83
163300|NCT01548287|397731|P4|STARTED|Screening||20
163301|NCT01548287|397732|P3|STARTED|Screening||20
163302|NCT01548287|397733|P2|STARTED|Screening||22
163303|NCT01548287|397734|P1|STARTED|Screening||19
163304|NCT01548040|397766|P2|NOT COMPLETED|Overall Study||10
163305|NCT01548040|397767|P1|NOT COMPLETED|Overall Study||13
163306|NCT01548040|397766|P2|COMPLETED|Overall Study||45
163307|NCT01548040|397767|P1|COMPLETED|Overall Study||43
163308|NCT01548040|397766|P2|STARTED|Overall Study||55
163309|NCT01548040|397767|P1|STARTED|Overall Study||56
163310|NCT01547806|397775|P1|NOT COMPLETED|Overall Study||0
163311|NCT01547806|397775|P1|COMPLETED|Overall Study||49
163312|NCT01547806|397775|P1|STARTED|Overall Study||49
163313|NCT01547728|397791|P1|NOT COMPLETED|Overall Study||41
163314|NCT01547728|397791|P1|COMPLETED|Overall Study||1
163315|NCT01547728|397791|P1|STARTED|Overall Study||42
163316|NCT01547715|397798|P3|NOT COMPLETED|Overall Study||0
163317|NCT01547715|397799|P2|NOT COMPLETED|Overall Study||0
163318|NCT01547715|397800|P1|NOT COMPLETED|Overall Study||0
163319|NCT01547715|397798|P3|COMPLETED|Overall Study||60
163320|NCT01547715|397799|P2|COMPLETED|Overall Study||60
163321|NCT01547715|397800|P1|COMPLETED|Overall Study||60
163322|NCT01547715|397798|P3|STARTED|Overall Study||60
163323|NCT01547715|397799|P2|STARTED|Overall Study||60
163324|NCT01547715|397800|P1|STARTED|Overall Study||60
163325|NCT01547598|397900|P2|NOT COMPLETED|Overall Study||5
163326|NCT01547598|397901|P1|NOT COMPLETED|Overall Study||6
163327|NCT01547598|397900|P2|COMPLETED|Overall Study||63
163328|NCT01547598|397901|P1|COMPLETED|Overall Study||61
163329|NCT01547598|397900|P2|STARTED|Overall Study||68
163330|NCT01547598|397901|P1|STARTED|Overall Study||67
163331|NCT01547390|397918|P2|NOT COMPLETED|Overall Study||10
163332|NCT01547390|397919|P1|NOT COMPLETED|Overall Study||13
163333|NCT01547390|397918|P2|COMPLETED|Overall Study||16
163334|NCT01547390|397919|P1|COMPLETED|Overall Study||14
163335|NCT01547390|397918|P2|STARTED|Overall Study||26
163336|NCT01547390|397919|P1|STARTED|Overall Study||27
163337|NCT01547299|397929|P2|NOT COMPLETED|Overall Study||2
163338|NCT01547299|397930|P1|NOT COMPLETED|Overall Study||2
163339|NCT01547299|397929|P2|COMPLETED|Overall Study||25
163340|NCT01547299|397930|P1|COMPLETED|Overall Study||23
163341|NCT01547299|397929|P2|STARTED|Overall Study||27
163342|NCT01547299|397930|P1|STARTED|Overall Study||25
163343|NCT01547286|397996|P1|NOT COMPLETED|Overall Study||2
163344|NCT01547286|397996|P1|COMPLETED|Overall Study||5
163345|NCT01547286|397996|P1|STARTED|Overall Study||7
163346|NCT01547247|398005|P2|NOT COMPLETED|Overall Study||6
163347|NCT01547247|398006|P1|NOT COMPLETED|Overall Study||6
163348|NCT01547247|398005|P2|COMPLETED|Overall Study||98
163349|NCT01547247|398006|P1|COMPLETED|Overall Study||98
163350|NCT01547247|398005|P2|STARTED|Overall Study||104
163351|NCT01547247|398006|P1|STARTED|Overall Study||104
163352|NCT01547130|398016|P2|NOT COMPLETED|Overall Study||5
163353|NCT01547130|398017|P1|NOT COMPLETED|Overall Study||9
163354|NCT01547130|398016|P2|COMPLETED|Overall Study||68
163355|NCT01547130|398017|P1|COMPLETED|Overall Study||65
163356|NCT01547130|398016|P2|STARTED|Overall Study||73
163357|NCT01547130|398017|P1|STARTED|Overall Study||74
163358|NCT01547000|398033|P2|NOT COMPLETED|Overall Study||0
163359|NCT01547000|398034|P1|NOT COMPLETED|Overall Study||0
163360|NCT01547000|398033|P2|COMPLETED|Overall Study||16
163361|NCT01547000|398034|P1|COMPLETED|Overall Study||18
163362|NCT01547000|398033|P2|STARTED|Overall Study||16
163363|NCT01547000|398034|P1|STARTED|Overall Study||18
163364|NCT01546922|398040|P2|NOT COMPLETED|Second Period of 10 Weeks||3
163365|NCT01546922|398041|P1|NOT COMPLETED|Second Period of 10 Weeks||3
163366|NCT01546922|398040|P2|COMPLETED|Second Period of 10 Weeks||25
163367|NCT01546922|398041|P1|COMPLETED|Second Period of 10 Weeks||22
163368|NCT01546922|398040|P2|STARTED|Second Period of 10 Weeks||28
163369|NCT01546922|398041|P1|STARTED|Second Period of 10 Weeks||25
163370|NCT01546922|398040|P2|NOT COMPLETED|First Period of 10 Weeks||2
163371|NCT01546922|398041|P1|NOT COMPLETED|First Period of 10 Weeks||5
163372|NCT01546922|398040|P2|COMPLETED|First Period of 10 Weeks||28
163373|NCT01546922|398041|P1|COMPLETED|First Period of 10 Weeks||25
163374|NCT01546922|398040|P2|STARTED|First Period of 10 Weeks||30
163375|NCT01546922|398041|P1|STARTED|First Period of 10 Weeks||30
163376|NCT01546883|398047|P1|NOT COMPLETED|Overall Study||12
163377|NCT01546883|398047|P1|COMPLETED|Overall Study||2
163378|NCT01546883|398047|P1|STARTED|Overall Study||14
163379|NCT01546688|398053|P2|NOT COMPLETED|Overall Study||5
163380|NCT01546688|398054|P1|NOT COMPLETED|Overall Study||3
163381|NCT01546688|398053|P2|COMPLETED|Overall Study||28
163382|NCT01546688|398054|P1|COMPLETED|Overall Study||15
163383|NCT01546688|398053|P2|STARTED|Overall Study||33
163384|NCT01546688|398054|P1|STARTED|Overall Study||18
163385|NCT01546675|398068|P2|NOT COMPLETED|Overall Study||0
163386|NCT01546675|398069|P1|NOT COMPLETED|Overall Study||0
163387|NCT01546675|398068|P2|COMPLETED|Overall Study||1
163388|NCT01546675|398069|P1|COMPLETED|Overall Study||1
163389|NCT01546675|398068|P2|STARTED|Overall Study||1
163390|NCT01546675|398069|P1|STARTED|Overall Study||1
163391|NCT01546649|398086|P2|NOT COMPLETED|Overall Study||9
163392|NCT01546649|398087|P1|NOT COMPLETED|Overall Study||8
163393|NCT01546649|398086|P2|COMPLETED|Overall Study||75
163394|NCT01546649|398087|P1|COMPLETED|Overall Study||75
163395|NCT01546649|398086|P2|STARTED|Overall Study||84
163396|NCT01546649|398087|P1|STARTED|Overall Study||83
163397|NCT01546636|398109|P2|NOT COMPLETED|Overall Study||0
163398|NCT01546636|398110|P1|NOT COMPLETED|Overall Study||0
163399|NCT01546636|398109|P2|COMPLETED|Overall Study||34
163400|NCT01546636|398110|P1|COMPLETED|Overall Study||36
163401|NCT01546636|398109|P2|STARTED|Overall Study||34
163402|NCT01546636|398110|P1|STARTED|Overall Study||36
163403|NCT01546623|398122|P2|NOT COMPLETED|Overall Study||6
163404|NCT01546623|398123|P1|NOT COMPLETED|Overall Study||6
163405|NCT01546623|398122|P2|COMPLETED|Overall Study||74
163406|NCT01546623|398123|P1|COMPLETED|Overall Study||76
163407|NCT01546623|398122|P2|Received Study Drug|Overall Study||79
163408|NCT01546623|398123|P1|Received Study Drug|Overall Study||81
163409|NCT01546623|398122|P2|STARTED|Overall Study||80
163410|NCT01546623|398123|P1|STARTED|Overall Study||82
163411|NCT01546519|398153|P4|NOT COMPLETED|Overall Study||6
163412|NCT01546519|398154|P3|NOT COMPLETED|Overall Study||8
163413|NCT01546519|398155|P2|NOT COMPLETED|Overall Study||8
163414|NCT01546519|398156|P1|NOT COMPLETED|Overall Study||9
163415|NCT01546519|398153|P4|COMPLETED|Overall Study||0
163416|NCT01546519|398154|P3|COMPLETED|Overall Study||0
163417|NCT01546519|398155|P2|COMPLETED|Overall Study||0
163418|NCT01546519|398156|P1|COMPLETED|Overall Study||0
163419|NCT01546519|398153|P4|Safety-Evaluable Participants|Overall Study||6
163420|NCT01546519|398154|P3|Safety-Evaluable Participants|Overall Study||8
163421|NCT01546519|398155|P2|Safety-Evaluable Participants|Overall Study||8
163422|NCT01546519|398156|P1|Safety-Evaluable Participants|Overall Study||9
163423|NCT01546519|398153|P4|STARTED|Overall Study||6
163424|NCT01546519|398154|P3|STARTED|Overall Study||8
163425|NCT01546519|398155|P2|STARTED|Overall Study||8
163426|NCT01546519|398156|P1|STARTED|Overall Study||9
163427|NCT01546454|398198|P1|NOT COMPLETED|Estrogen/Progesterone Replacement Cycle||0
163428|NCT01546454|398198|P1|COMPLETED|Estrogen/Progesterone Replacement Cycle||4
163429|NCT01546454|398198|P1|STARTED|Estrogen/Progesterone Replacement Cycle||4
163430|NCT01546454|398198|P1|NOT COMPLETED|Eligard Treatment||0
163431|NCT01546454|398198|P1|COMPLETED|Eligard Treatment||4
163432|NCT01546454|398198|P1|STARTED|Eligard Treatment||4
163433|NCT01546454|398198|P1|NOT COMPLETED|Oral Contraceptive Cycle||0
163434|NCT01546454|398198|P1|COMPLETED|Oral Contraceptive Cycle||4
163435|NCT01546454|398198|P1|STARTED|Oral Contraceptive Cycle||4
163436|NCT01546454|398198|P1|NOT COMPLETED|Natural Menstrual Cycle||0
163437|NCT01546454|398198|P1|COMPLETED|Natural Menstrual Cycle||4
163438|NCT01546454|398198|P1|STARTED|Natural Menstrual Cycle||4
163439|NCT01546402|398206|P2|NOT COMPLETED|Overall Study||0
163440|NCT01546402|398207|P1|NOT COMPLETED|Overall Study||0
163441|NCT01546402|398206|P2|COMPLETED|Overall Study||10
163442|NCT01546402|398207|P1|COMPLETED|Overall Study||10
163443|NCT01546402|398206|P2|STARTED|Overall Study||10
163444|NCT01546402|398207|P1|STARTED|Overall Study||10
163445|NCT01546285|398215|P1|NOT COMPLETED|Overall Study||0
163446|NCT01546285|398215|P1|COMPLETED|Overall Study||66
163447|NCT01546285|398215|P1|STARTED|Overall Study||66
163448|NCT01546207|398221|P1|NOT COMPLETED|Overall Study||1
163449|NCT01546207|398221|P1|COMPLETED|Overall Study||3
163450|NCT01546207|398221|P1|STARTED|Overall Study||4
163451|NCT01546194|398227|P2|NOT COMPLETED|Overall Study||35
163452|NCT01546194|398228|P1|NOT COMPLETED|Overall Study||36
163453|NCT01546194|398227|P2|COMPLETED|Overall Study||65
163454|NCT01546194|398228|P1|COMPLETED|Overall Study||64
163455|NCT01546194|398227|P2|STARTED|Overall Study||100
163456|NCT01546194|398228|P1|STARTED|Overall Study||100
163457|NCT01546168|398236|P2|NOT COMPLETED|Overall Study||0
163458|NCT01546168|398237|P1|NOT COMPLETED|Overall Study||4
163459|NCT01546168|398236|P2|COMPLETED|Overall Study||33
163460|NCT01546168|398237|P1|COMPLETED|Overall Study||51
163461|NCT01546168|398236|P2|STARTED|Overall Study||33
163462|NCT01546168|398237|P1|STARTED|Overall Study||55
163463|NCT01546155|398249|P1|NOT COMPLETED|Overall Study||3
163464|NCT01546155|398249|P1|COMPLETED|Overall Study||8
163465|NCT01546155|398249|P1|STARTED|Overall Study||11
163466|NCT01546142|398255|P2|NOT COMPLETED|Overall Study||34
163467|NCT01546142|398256|P1|NOT COMPLETED|Overall Study||44
163468|NCT01546142|398255|P2|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|224
163469|NCT01546142|398256|P1|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|214
163470|NCT01546142|398255|P2|Received Treatment|Overall Study||257
163471|NCT01546142|398256|P1|Received Treatment|Overall Study||257
163472|NCT01546142|398255|P2|STARTED|Overall Study||258
163473|NCT01546142|398256|P1|STARTED|Overall Study||258
163474|NCT01546038|398274|P9|NOT COMPLETED|Overall Study||44
163475|NCT01546038|398275|P8|NOT COMPLETED|Overall Study||88
163476|NCT01546038|398276|P7|NOT COMPLETED|Overall Study||71
163477|NCT01546038|398277|P6|NOT COMPLETED|Overall Study||6
163478|NCT01546038|398278|P5|NOT COMPLETED|Overall Study||16
163479|NCT01546038|398279|P4|NOT COMPLETED|Overall Study||3
163480|NCT01546038|398280|P3|NOT COMPLETED|Overall Study||4
163481|NCT01546038|398281|P2|NOT COMPLETED|Overall Study||6
163482|NCT01546038|398282|P1|NOT COMPLETED|Overall Study||17
163483|NCT01546038|398274|P9|COMPLETED|Overall Study||0
163484|NCT01546038|398275|P8|COMPLETED|Overall Study||0
163485|NCT01546038|398276|P7|COMPLETED|Overall Study||0
163486|NCT01546038|398277|P6|COMPLETED|Overall Study||0
163487|NCT01546038|398278|P5|COMPLETED|Overall Study||0
163488|NCT01546038|398279|P4|COMPLETED|Overall Study||0
163489|NCT01546038|398280|P3|COMPLETED|Overall Study||0
163490|NCT01546038|398281|P2|COMPLETED|Overall Study||0
163491|NCT01546038|398282|P1|COMPLETED|Overall Study||0
163492|NCT01546038|398274|P9|Received Treatment|Overall Study||41
163493|NCT01546038|398275|P8|Received Treatment|Overall Study||84
163494|NCT01546038|398276|P7|Received Treatment|Overall Study||69
163495|NCT01546038|398277|P6|Received Treatment|Overall Study||6
163496|NCT01546038|398278|P5|Received Treatment|Overall Study||16
163497|NCT01546038|398279|P4|Received Treatment|Overall Study||3
163498|NCT01546038|398280|P3|Received Treatment|Overall Study||4
163499|NCT01546038|398281|P2|Received Treatment|Overall Study||6
163500|NCT01546038|398282|P1|Received Treatment|Overall Study||17
163501|NCT01546038|398274|P9|STARTED|Overall Study||44
163502|NCT01546038|398275|P8|STARTED|Overall Study||88
163503|NCT01546038|398276|P7|STARTED|Overall Study||71
163504|NCT01546038|398277|P6|STARTED|Overall Study||6
163505|NCT01546038|398278|P5|STARTED|Overall Study||16
163506|NCT01546038|398279|P4|STARTED|Overall Study||3
163507|NCT01546038|398280|P3|STARTED|Overall Study||4
163508|NCT01546038|398281|P2|STARTED|Overall Study||6
163509|NCT01546038|398282|P1|STARTED|Overall Study||17
163510|NCT01545843|398445|P3|NOT COMPLETED|Overall Study||4
163511|NCT01545843|398446|P2|NOT COMPLETED|Overall Study||7
163512|NCT01545843|398447|P1|NOT COMPLETED|Overall Study||3
163513|NCT01545843|398445|P3|COMPLETED|Overall Study||21
163514|NCT01545843|398446|P2|COMPLETED|Overall Study||17
163515|NCT01545843|398447|P1|COMPLETED|Overall Study||16
163516|NCT01545843|398445|P3|STARTED|Overall Study||25
163517|NCT01545843|398446|P2|STARTED|Overall Study||24
163518|NCT01545843|398447|P1|STARTED|Overall Study||19
163519|NCT01545817|398476|P2|NOT COMPLETED|Everolimus||38
163520|NCT01545817|398477|P1|NOT COMPLETED|Everolimus||0
163521|NCT01545817|398476|P2|COMPLETED|Everolimus||0
163522|NCT01545817|398477|P1|COMPLETED|Everolimus||0
163523|NCT01545817|398476|P2|STARTED|Everolimus||38
163524|NCT01545817|398477|P1|STARTED|Everolimus||0
163525|NCT01545817|398476|P2|NOT COMPLETED|Pazopanib||0
163526|NCT01545817|398477|P1|NOT COMPLETED|Pazopanib||74
163527|NCT01545817|398476|P2|COMPLETED|Pazopanib||0
163528|NCT01545817|398477|P1|COMPLETED|Pazopanib||0
163529|NCT01545817|398476|P2|STARTED|Pazopanib||0
163530|NCT01545817|398477|P1|STARTED|Pazopanib||74
163531|NCT01545765|398488|P1|NOT COMPLETED|Overall Study||0
163532|NCT01545765|398488|P1|COMPLETED|Overall Study||31
163533|NCT01545765|398488|P1|STARTED|Overall Study||31
163534|NCT01545700|398505|P6|NOT COMPLETED|Overall Study||0
163535|NCT01545700|398506|P5|NOT COMPLETED|Overall Study||1
163536|NCT01545700|398507|P4|NOT COMPLETED|Overall Study||0
163537|NCT01545700|398508|P3|NOT COMPLETED|Overall Study||2
163538|NCT01545700|398509|P2|NOT COMPLETED|Overall Study||1
163539|NCT01545700|398510|P1|NOT COMPLETED|Overall Study||1
163540|NCT01545700|398505|P6|COMPLETED|Overall Study||33
163541|NCT01545700|398506|P5|COMPLETED|Overall Study||32
163542|NCT01545700|398507|P4|COMPLETED|Overall Study||34
163543|NCT01545700|398508|P3|COMPLETED|Overall Study||31
163544|NCT01545700|398509|P2|COMPLETED|Overall Study||32
163545|NCT01545700|398510|P1|COMPLETED|Overall Study||33
163546|NCT01545700|398505|P6|STARTED|Overall Study||33
163547|NCT01545700|398506|P5|STARTED|Overall Study||33
163548|NCT01545700|398507|P4|STARTED|Overall Study||34
163549|NCT01545700|398508|P3|STARTED|Overall Study||33
163550|NCT01545700|398509|P2|STARTED|Overall Study||33
163551|NCT01545700|398510|P1|STARTED|Overall Study||34
163552|NCT01545583|398553|P9|NOT COMPLETED|Overall Study||0
163553|NCT01545583|398554|P8|NOT COMPLETED|Overall Study||0
163554|NCT01545583|398555|P7|NOT COMPLETED|Overall Study||0
163555|NCT01545583|398556|P6|NOT COMPLETED|Overall Study||0
163556|NCT01545583|398557|P5|NOT COMPLETED|Overall Study||0
163557|NCT01545583|398558|P4|NOT COMPLETED|Overall Study||0
163558|NCT01545583|398559|P3|NOT COMPLETED|Overall Study||0
163559|NCT01545583|398560|P2|NOT COMPLETED|Overall Study||0
163560|NCT01545583|398561|P1|NOT COMPLETED|Overall Study||0
163561|NCT01545583|398553|P9|COMPLETED|Overall Study||6
163562|NCT01545583|398554|P8|COMPLETED|Overall Study||6
163563|NCT01545583|398555|P7|COMPLETED|Overall Study||6
163564|NCT01545583|398556|P6|COMPLETED|Overall Study||6
163565|NCT01545583|398557|P5|COMPLETED|Overall Study||6
163566|NCT01545583|398558|P4|COMPLETED|Overall Study||6
163567|NCT01545583|398559|P3|COMPLETED|Overall Study||6
163568|NCT01545583|398560|P2|COMPLETED|Overall Study||2
163569|NCT01545583|398561|P1|COMPLETED|Overall Study||12
163570|NCT01545583|398553|P9|Received at Least 1 Dose of Study Drug|Overall Study||6
163571|NCT01545583|398554|P8|Received at Least 1 Dose of Study Drug|Overall Study||6
163572|NCT01545583|398555|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
163573|NCT01545583|398556|P6|Received at Least 1 Dose of Study Drug|Overall Study||6
163574|NCT01545583|398557|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
163575|NCT01545583|398558|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
163576|NCT01545583|398559|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
163577|NCT01545583|398560|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
163578|NCT01545583|398561|P1|Received at Least 1 Dose of Study Drug|Overall Study||12
163579|NCT01545583|398553|P9|STARTED|Overall Study||6
163580|NCT01545583|398554|P8|STARTED|Overall Study||6
163581|NCT01545583|398555|P7|STARTED|Overall Study||6
163582|NCT01545583|398556|P6|STARTED|Overall Study||6
163583|NCT01545583|398557|P5|STARTED|Overall Study||6
163584|NCT01545583|398558|P4|STARTED|Overall Study||6
163585|NCT01545583|398559|P3|STARTED|Overall Study||6
163586|NCT01545583|398560|P2|STARTED|Overall Study||2
163587|NCT01545583|398561|P1|STARTED|Overall Study||12
163588|NCT01545518|398613|P1|NOT COMPLETED|Overall Study||0
163589|NCT01545518|398613|P1|COMPLETED|Overall Study||20
163590|NCT01545518|398613|P1|STARTED|Overall Study||20
163591|NCT01545388|398620|P3|NOT COMPLETED|Overall Study||8
163592|NCT01545388|398621|P2|NOT COMPLETED|Overall Study||11
163593|NCT01545388|398622|P1|NOT COMPLETED|Overall Study||8
163594|NCT01545388|398620|P3|COMPLETED|Overall Study||58
163595|NCT01545388|398621|P2|COMPLETED|Overall Study||122
163596|NCT01545388|398622|P1|COMPLETED|Overall Study||130
163597|NCT01545388|398620|P3|STARTED|Overall Study||66
163598|NCT01545388|398621|P2|STARTED|Overall Study||133
163599|NCT01545388|398622|P1|STARTED|Overall Study||138
163600|NCT01545375|398641|P2|NOT COMPLETED|Overall Study||90
163601|NCT01545375|398642|P1|NOT COMPLETED|Overall Study||97
163602|NCT01545375|398641|P2|COMPLETED|Overall Study||813
163603|NCT01545375|398642|P1|COMPLETED|Overall Study||803
163604|NCT01545375|398641|P2|STARTED|Overall Study||903
163605|NCT01545375|398642|P1|STARTED|Overall Study||900
163606|NCT01545336|398698|P2|NOT COMPLETED|Overall Study||0
163607|NCT01545336|398699|P1|NOT COMPLETED|Overall Study||0
163608|NCT01545336|398698|P2|COMPLETED|Overall Study||6
163609|NCT01545336|398699|P1|COMPLETED|Overall Study||12
163610|NCT01545336|398698|P2|STARTED|Overall Study||6
163611|NCT01545336|398699|P1|STARTED|Overall Study||12
163612|NCT01545232|398711|P2|NOT COMPLETED|Overall Study||0
163613|NCT01545232|398712|P1|NOT COMPLETED|Overall Study||0
163614|NCT01545232|398711|P2|COMPLETED|Overall Study||342
163615|NCT01545232|398712|P1|COMPLETED|Overall Study||338
163616|NCT01545232|398711|P2|STARTED|Overall Study||342
163617|NCT01545232|398712|P1|STARTED|Overall Study||338
163618|NCT01545193|398744|P2|NOT COMPLETED|Overall Study||1
163619|NCT01545193|398745|P1|NOT COMPLETED|Overall Study||0
163620|NCT01545193|398744|P2|COMPLETED|Overall Study||149
163621|NCT01545193|398745|P1|COMPLETED|Overall Study||150
163622|NCT01545193|398744|P2|STARTED|Overall Study||150
163623|NCT01545193|398745|P1|STARTED|Overall Study||150
163624|NCT01545076|398757|P5|NOT COMPLETED|IgPro10 Rescue Period||0
163625|NCT01545076|398758|P4|NOT COMPLETED|IgPro10 Rescue Period||0
163626|NCT01545076|398759|P3|NOT COMPLETED|IgPro10 Rescue Period||0
163627|NCT01545076|398760|P2|NOT COMPLETED|IgPro10 Rescue Period||0
163628|NCT01545076|398761|P1|NOT COMPLETED|IgPro10 Rescue Period||0
163629|NCT01545076|398757|P5|COMPLETED|IgPro10 Rescue Period||60
163630|NCT01545076|398758|P4|COMPLETED|IgPro10 Rescue Period||0
163631|NCT01545076|398759|P3|COMPLETED|IgPro10 Rescue Period||0
163632|NCT01545076|398760|P2|COMPLETED|IgPro10 Rescue Period||0
163633|NCT01545076|398761|P1|COMPLETED|IgPro10 Rescue Period||0
163634|NCT01545076|398757|P5|STARTED|IgPro10 Rescue Period||60
163635|NCT01545076|398758|P4|STARTED|IgPro10 Rescue Period||0
163636|NCT01545076|398759|P3|STARTED|IgPro10 Rescue Period||0
163637|NCT01545076|398760|P2|STARTED|IgPro10 Rescue Period||0
163638|NCT01545076|398761|P1|STARTED|IgPro10 Rescue Period||0
163639|NCT01545076|398757|P5|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0
163640|NCT01545076|398758|P4|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||36
163641|NCT01545076|398759|P3|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||21
163642|NCT01545076|398760|P2|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||19
163643|NCT01545076|398761|P1|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0
163644|NCT01545076|398757|P5|COMPLETED|IgPro20 Subcutaneous Treatment Period||0
163645|NCT01545076|398758|P4|COMPLETED|IgPro20 Subcutaneous Treatment Period||21
163646|NCT01545076|398759|P3|COMPLETED|IgPro20 Subcutaneous Treatment Period||36
163647|NCT01545076|398760|P2|COMPLETED|IgPro20 Subcutaneous Treatment Period||39
163648|NCT01545076|398761|P1|COMPLETED|IgPro20 Subcutaneous Treatment Period||0
163649|NCT01545076|398757|P5|STARTED|IgPro20 Subcutaneous Treatment Period||0
163650|NCT01545076|398758|P4|STARTED|IgPro20 Subcutaneous Treatment Period||57
163651|NCT01545076|398759|P3|STARTED|IgPro20 Subcutaneous Treatment Period||57
163652|NCT01545076|398760|P2|STARTED|IgPro20 Subcutaneous Treatment Period||58
163653|NCT01545076|398761|P1|STARTED|IgPro20 Subcutaneous Treatment Period||0
163654|NCT01545076|398757|P5|NOT COMPLETED|IgPro10 Restabilization Period||0
163655|NCT01545076|398758|P4|NOT COMPLETED|IgPro10 Restabilization Period||0
163656|NCT01545076|398759|P3|NOT COMPLETED|IgPro10 Restabilization Period||0
163657|NCT01545076|398760|P2|NOT COMPLETED|IgPro10 Restabilization Period||0
163658|NCT01545076|398761|P1|NOT COMPLETED|IgPro10 Restabilization Period||36
163659|NCT01545076|398757|P5|COMPLETED|IgPro10 Restabilization Period||0
163660|NCT01545076|398758|P4|COMPLETED|IgPro10 Restabilization Period||0
163661|NCT01545076|398759|P3|COMPLETED|IgPro10 Restabilization Period||0
163662|NCT01545076|398760|P2|COMPLETED|IgPro10 Restabilization Period||0
163663|NCT01545076|398761|P1|COMPLETED|IgPro10 Restabilization Period||172
163664|NCT01545076|398757|P5|STARTED|IgPro10 Restabilization Period||0
163665|NCT01545076|398758|P4|STARTED|IgPro10 Restabilization Period||0
163666|NCT01545076|398759|P3|STARTED|IgPro10 Restabilization Period||0
163667|NCT01545076|398760|P2|STARTED|IgPro10 Restabilization Period||0
163668|NCT01545076|398761|P1|STARTED|IgPro10 Restabilization Period||208
163669|NCT01544998|398811|P2|NOT COMPLETED|Second Intervention (3 Hours)||0
163670|NCT01544998|398812|P1|NOT COMPLETED|Second Intervention (3 Hours)||0
163671|NCT01544998|398811|P2|COMPLETED|Second Intervention (3 Hours)||15
163672|NCT01544998|398812|P1|COMPLETED|Second Intervention (3 Hours)||26
163673|NCT01544998|398811|P2|STARTED|Second Intervention (3 Hours)||15
163674|NCT01544998|398812|P1|STARTED|Second Intervention (3 Hours)||26
163675|NCT01544998|398811|P2|NOT COMPLETED|Washout (1 Week)||0
163676|NCT01544998|398812|P1|NOT COMPLETED|Washout (1 Week)||0
163677|NCT01544998|398811|P2|COMPLETED|Washout (1 Week)||15
163678|NCT01544998|398812|P1|COMPLETED|Washout (1 Week)||26
163679|NCT01544998|398811|P2|STARTED|Washout (1 Week)||15
163680|NCT01544998|398812|P1|STARTED|Washout (1 Week)||26
163681|NCT01544998|398811|P2|NOT COMPLETED|First Intervention (3 Hours)||0
163682|NCT01544998|398812|P1|NOT COMPLETED|First Intervention (3 Hours)||0
163683|NCT01544998|398811|P2|COMPLETED|First Intervention (3 Hours)||15
163684|NCT01544998|398812|P1|COMPLETED|First Intervention (3 Hours)||26
163685|NCT01544998|398811|P2|STARTED|First Intervention (3 Hours)||15
163686|NCT01544998|398812|P1|STARTED|First Intervention (3 Hours)||26
163687|NCT01544920|398832|P2|NOT COMPLETED|Overall Study||23
163688|NCT01544920|398833|P1|NOT COMPLETED|Overall Study||19
163689|NCT01544920|398832|P2|COMPLETED|Overall Study||346
163690|NCT01544920|398833|P1|COMPLETED|Overall Study||349
163691|NCT01544920|398832|P2|STARTED|Overall Study||369
163692|NCT01544920|398833|P1|STARTED|Overall Study||368
163693|NCT01544595|398847|P6|NOT COMPLETED|Status at Week 156||15
163694|NCT01544595|398848|P5|NOT COMPLETED|Status at Week 156||38
163695|NCT01544595|398849|P4|NOT COMPLETED|Status at Week 156||166
163696|NCT01544595|398850|P3|NOT COMPLETED|Status at Week 156||140
163697|NCT01544595|398851|P2|NOT COMPLETED|Status at Week 156||78
163698|NCT01544595|398852|P1|NOT COMPLETED|Status at Week 156||117
163699|NCT01544595|398847|P6|COMPLETED|Status at Week 156||38
163700|NCT01544595|398848|P5|COMPLETED|Status at Week 156||60
163701|NCT01544595|398849|P4|COMPLETED|Status at Week 156||15
163702|NCT01544595|398850|P3|COMPLETED|Status at Week 156||10
163703|NCT01544595|398851|P2|COMPLETED|Status at Week 156||285
163704|NCT01544595|398852|P1|COMPLETED|Status at Week 156||184
163705|NCT01544595|398847|P6|STARTED|Status at Week 156||53
163706|NCT01544595|398848|P5|STARTED|Status at Week 156||98
163707|NCT01544595|398849|P4|STARTED|Status at Week 156||181
163708|NCT01544595|398850|P3|STARTED|Status at Week 156||150
163709|NCT01544595|398851|P2|STARTED|Status at Week 156||363
163710|NCT01544595|398852|P1|STARTED|Status at Week 156||301
163711|NCT01544595|398847|P6|NOT COMPLETED|Status at Week 68||0
163712|NCT01544595|398848|P5|NOT COMPLETED|Status at Week 68||0
163713|NCT01544595|398849|P4|NOT COMPLETED|Status at Week 68||51
163714|NCT01544595|398850|P3|NOT COMPLETED|Status at Week 68||63
163715|NCT01544595|398851|P2|NOT COMPLETED|Status at Week 68||17
163716|NCT01544595|398852|P1|NOT COMPLETED|Status at Week 68||39
163717|NCT01544595|398847|P6|COMPLETED|Status at Week 68|These patients were not in the study arms at this time point.|0
163718|NCT01544595|398848|P5|COMPLETED|Status at Week 68|These patients were not in the study arms at this time point.|0
163719|NCT01544595|398849|P4|COMPLETED|Status at Week 68||130
163720|NCT01544595|398850|P3|COMPLETED|Status at Week 68||87
163721|NCT01544595|398851|P2|COMPLETED|Status at Week 68||346
163722|NCT01544595|398852|P1|COMPLETED|Status at Week 68||262
163723|NCT01544595|398847|P6|STARTED|Status at Week 68|These patients were not in the study arms at this time point.|0
163724|NCT01544595|398848|P5|STARTED|Status at Week 68|These patients were not in the study arms at this time point.|0
163725|NCT01544595|398849|P4|STARTED|Status at Week 68||181
163726|NCT01544595|398850|P3|STARTED|Status at Week 68||150
163727|NCT01544595|398851|P2|STARTED|Status at Week 68||363
163728|NCT01544595|398852|P1|STARTED|Status at Week 68||301
163729|NCT01544582|398928|P4|NOT COMPLETED|Analysis Population||39
163730|NCT01544582|398929|P3|NOT COMPLETED|Analysis Population||102
163731|NCT01544582|398930|P2|NOT COMPLETED|Analysis Population||118
163732|NCT01544582|398931|P1|NOT COMPLETED|Analysis Population||0
163733|NCT01544582|398928|P4|COMPLETED|Analysis Population||35
163734|NCT01544582|398929|P3|COMPLETED|Analysis Population||205
163735|NCT01544582|398930|P2|COMPLETED|Analysis Population||180
163736|NCT01544582|398931|P1|COMPLETED|Analysis Population||0
163737|NCT01544582|398928|P4|STARTED|Analysis Population||74
163738|NCT01544582|398929|P3|STARTED|Analysis Population||307
163739|NCT01544582|398930|P2|STARTED|Analysis Population||298
163740|NCT01544582|398931|P1|STARTED|Analysis Population|Analysis Population was grouped into Boceprevir+PR, Telaprevir+PR, or PR Alone|0
163741|NCT01544582|398928|P4|NOT COMPLETED|Screening/Eligibility||0
163742|NCT01544582|398929|P3|NOT COMPLETED|Screening/Eligibility||0
163743|NCT01544582|398930|P2|NOT COMPLETED|Screening/Eligibility||0
163744|NCT01544582|398931|P1|NOT COMPLETED|Screening/Eligibility||34
163745|NCT01544582|398928|P4|COMPLETED|Screening/Eligibility||0
163746|NCT01544582|398929|P3|COMPLETED|Screening/Eligibility||0
163747|NCT01544582|398930|P2|COMPLETED|Screening/Eligibility||0
163748|NCT01544582|398931|P1|COMPLETED|Screening/Eligibility|Completed means met criteria for Analysis Population|679
163749|NCT01544582|398928|P4|Analysis Population|Screening/Eligibility||0
163750|NCT01544582|398929|P3|Analysis Population|Screening/Eligibility||0
163751|NCT01544582|398930|P2|Analysis Population|Screening/Eligibility||0
163752|NCT01544582|398931|P1|Analysis Population|Screening/Eligibility||679
163753|NCT01544582|398928|P4|STARTED|Screening/Eligibility||0
163754|NCT01544582|398929|P3|STARTED|Screening/Eligibility||0
163755|NCT01544582|398930|P2|STARTED|Screening/Eligibility||0
163756|NCT01544582|398931|P1|STARTED|Screening/Eligibility||713
163757|NCT01544491|398991|P2|NOT COMPLETED|Overall Study||3
163758|NCT01544491|398992|P1|NOT COMPLETED|Overall Study||5
163759|NCT01544491|398991|P2|COMPLETED|Overall Study||51
163760|NCT01544491|398992|P1|COMPLETED|Overall Study||47
163761|NCT01544491|398991|P2|STARTED|Overall Study||54
163762|NCT01544491|398992|P1|STARTED|Overall Study||52
163763|NCT01544478|399018|P1|NOT COMPLETED|Overall Study||118
163764|NCT01544478|399018|P1|COMPLETED|Overall Study||912
163765|NCT01544478|399018|P1|Vaccination 3|Overall Study||1019
163766|NCT01544478|399018|P1|Vaccination 2|Overall Study||1026
163767|NCT01544478|399018|P1|Vaccination 1|Overall Study||1030
163768|NCT01544478|399018|P1|STARTED|Overall Study||1030
163769|NCT01544361|399027|P5|NOT COMPLETED|Overall Study||0
163770|NCT01544361|399028|P4|NOT COMPLETED|Overall Study||0
163771|NCT01544361|399029|P3|NOT COMPLETED|Overall Study||0
163772|NCT01544361|399030|P2|NOT COMPLETED|Overall Study||0
163773|NCT01544361|399031|P1|NOT COMPLETED|Overall Study||0
163774|NCT01544361|399027|P5|COMPLETED|Overall Study||6
163775|NCT01544361|399028|P4|COMPLETED|Overall Study||6
163776|NCT01544361|399029|P3|COMPLETED|Overall Study||6
163777|NCT01544361|399030|P2|COMPLETED|Overall Study||6
163778|NCT01544361|399031|P1|COMPLETED|Overall Study||8
163779|NCT01544361|399027|P5|STARTED|Overall Study||6
163780|NCT01544361|399028|P4|STARTED|Overall Study||6
163781|NCT01544361|399029|P3|STARTED|Overall Study||6
163782|NCT01544361|399030|P2|STARTED|Overall Study||6
163783|NCT01544361|399031|P1|STARTED|Overall Study||8
163784|NCT01544348|399061|P8|NOT COMPLETED|Overall Study||0
163785|NCT01544348|399062|P7|NOT COMPLETED|Overall Study||2
163786|NCT01544348|399063|P6|NOT COMPLETED|Overall Study||3
163787|NCT01544348|399064|P5|NOT COMPLETED|Overall Study||1
163788|NCT01544348|399065|P4|NOT COMPLETED|Overall Study||0
163789|NCT01544348|399066|P3|NOT COMPLETED|Overall Study||0
163790|NCT01544348|399067|P2|NOT COMPLETED|Overall Study||0
163791|NCT01544348|399068|P1|NOT COMPLETED|Overall Study||2
163792|NCT01544348|399061|P8|COMPLETED|Overall Study||8
163793|NCT01544348|399062|P7|COMPLETED|Overall Study||12
163794|NCT01544348|399063|P6|COMPLETED|Overall Study||16
163795|NCT01544348|399064|P5|COMPLETED|Overall Study||15
163796|NCT01544348|399065|P4|COMPLETED|Overall Study||3
163797|NCT01544348|399066|P3|COMPLETED|Overall Study||3
163798|NCT01544348|399067|P2|COMPLETED|Overall Study||6
163799|NCT01544348|399068|P1|COMPLETED|Overall Study||15
163800|NCT01544348|399061|P8|Treated|Overall Study||8
163801|NCT01544348|399062|P7|Treated|Overall Study||14
163802|NCT01544348|399063|P6|Treated|Overall Study||18
163803|NCT01544348|399064|P5|Treated|Overall Study||15
163804|NCT01544348|399065|P4|Treated|Overall Study||3
163805|NCT01544348|399066|P3|Treated|Overall Study||3
163806|NCT01544348|399067|P2|Treated|Overall Study||6
163807|NCT01544348|399068|P1|Treated|Overall Study||17
163808|NCT01544348|399061|P8|STARTED|Overall Study||8
163809|NCT01544348|399062|P7|STARTED|Overall Study||14
163810|NCT01544348|399063|P6|STARTED|Overall Study||19
163811|NCT01544348|399064|P5|STARTED|Overall Study||16
163812|NCT01544348|399065|P4|STARTED|Overall Study||3
163813|NCT01544348|399066|P3|STARTED|Overall Study||3
163814|NCT01544348|399067|P2|STARTED|Overall Study||6
163815|NCT01544348|399068|P1|STARTED|Overall Study||17
163816|NCT01544309|399110|P2|NOT COMPLETED|Overall Study||11
163817|NCT01544309|399111|P1|NOT COMPLETED|Overall Study||20
163818|NCT01544309|399110|P2|COMPLETED|Overall Study||514
163819|NCT01544309|399111|P1|COMPLETED|Overall Study||504
163820|NCT01544309|399110|P2|STARTED|Overall Study||525
163821|NCT01544309|399111|P1|STARTED|Overall Study||524
163822|NCT01544179|399149|P2|NOT COMPLETED|Overall Study||46
163823|NCT01544179|399150|P1|NOT COMPLETED|Overall Study||63
163824|NCT01544179|399149|P2|COMPLETED|Overall Study|Patients are ongoing in the study|86
163825|NCT01544179|399150|P1|COMPLETED|Overall Study|Patients are ongoing in the study|70
163826|NCT01544179|399149|P2|Did Not Receive Treatment|Overall Study||0
163827|NCT01544179|399150|P1|Did Not Receive Treatment|Overall Study||1
163828|NCT01544179|399149|P2|Received Treatment|Overall Study||132
163829|NCT01544179|399150|P1|Received Treatment|Overall Study||132
163830|NCT01544179|399149|P2|STARTED|Overall Study||132
163831|NCT01544179|399150|P1|STARTED|Overall Study||133
163832|NCT01544166|399178|P1|NOT COMPLETED|Overall Study||0
163833|NCT01544166|399178|P1|COMPLETED|Overall Study||44
163834|NCT01544166|399178|P1|STARTED|Overall Study||44
163835|NCT01544153|399243|P4|NOT COMPLETED|Overall Study||0
163836|NCT01544153|399244|P3|NOT COMPLETED|Overall Study||1
163837|NCT01544153|399245|P2|NOT COMPLETED|Overall Study||1
163838|NCT01544153|399246|P1|NOT COMPLETED|Overall Study||0
163839|NCT01544153|399243|P4|COMPLETED|Overall Study||1317
163840|NCT01544153|399244|P3|COMPLETED|Overall Study||1313
163841|NCT01544153|399245|P2|COMPLETED|Overall Study||1323
163842|NCT01544153|399246|P1|COMPLETED|Overall Study||1337
163843|NCT01544153|399243|P4|STARTED|Overall Study||1317
163844|NCT01544153|399244|P3|STARTED|Overall Study||1314
163845|NCT01544153|399245|P2|STARTED|Overall Study||1324
163846|NCT01544153|399246|P1|STARTED|Overall Study||1337
163847|NCT01544127|399263|P3|NOT COMPLETED|Overall Study||14
163848|NCT01544127|399264|P2|NOT COMPLETED|Overall Study||6
163849|NCT01544127|399265|P1|NOT COMPLETED|Overall Study||11
163850|NCT01544127|399263|P3|COMPLETED|Overall Study||52
163851|NCT01544127|399264|P2|COMPLETED|Overall Study||27
163852|NCT01544127|399265|P1|COMPLETED|Overall Study||22
163853|NCT01544127|399263|P3|STARTED|Overall Study||66
163854|NCT01544127|399264|P2|STARTED|Overall Study||33
163855|NCT01544127|399265|P1|STARTED|Overall Study||33
163856|NCT01544114|399285|P3|NOT COMPLETED|Overall Study||5
163857|NCT01544114|399286|P2|NOT COMPLETED|Overall Study||4
163858|NCT01544114|399287|P1|NOT COMPLETED|Overall Study||1
163859|NCT01544114|399285|P3|COMPLETED|Overall Study|completed study and received 6 months of study drug|17
163860|NCT01544114|399286|P2|COMPLETED|Overall Study|completed study and received 6 months of study drug|16
163861|NCT01544114|399287|P1|COMPLETED|Overall Study|completed study and received 6 months of study drug|3
163862|NCT01544114|399285|P3|STARTED|Overall Study||22
163863|NCT01544114|399286|P2|STARTED|Overall Study||20
163864|NCT01544114|399287|P1|STARTED|Overall Study||4
163865|NCT01544088|399318|P2|NOT COMPLETED|Overall Study||21
163866|NCT01544088|399319|P1|NOT COMPLETED|Overall Study||37
163867|NCT01544088|399318|P2|COMPLETED|Overall Study||79
163868|NCT01544088|399319|P1|COMPLETED|Overall Study||61
163869|NCT01544088|399318|P2|STARTED|Overall Study||100
163870|NCT01544088|399319|P1|STARTED|Overall Study||98
163871|NCT01544062|399333|P2|NOT COMPLETED|Overall Study||0
163872|NCT01544062|399334|P1|NOT COMPLETED|Overall Study||0
163873|NCT01544062|399333|P2|COMPLETED|Overall Study||35
163874|NCT01544062|399334|P1|COMPLETED|Overall Study||33
163875|NCT01544062|399333|P2|STARTED|Overall Study||35
163876|NCT01544062|399334|P1|STARTED|Overall Study||33
163877|NCT01544023|399380|P1|NOT COMPLETED|Overall Study||0
163878|NCT01544023|399380|P1|COMPLETED|Overall Study||207
163879|NCT01544023|399380|P1|STARTED|Overall Study|retrospective|207
163880|NCT01543958|399385|P1|NOT COMPLETED|Overall Study||4
163881|NCT01543958|399385|P1|COMPLETED|Overall Study||36
163882|NCT01543958|399385|P1|STARTED|Overall Study||40
163883|NCT01543828|399440|P2|NOT COMPLETED|Treatment 2||0
163884|NCT01543828|399441|P1|NOT COMPLETED|Treatment 2||1
163885|NCT01543828|399440|P2|COMPLETED|Treatment 2||19
163886|NCT01543828|399441|P1|COMPLETED|Treatment 2||19
163887|NCT01543828|399440|P2|STARTED|Treatment 2|1 participant completed treatment 1, had an adverse event, and did not receive treatment 2.|19
163888|NCT01543828|399441|P1|STARTED|Treatment 2||20
163889|NCT01543828|399440|P2|NOT COMPLETED|Treatment 1||0
163890|NCT01543828|399441|P1|NOT COMPLETED|Treatment 1||0
163891|NCT01543828|399440|P2|COMPLETED|Treatment 1||20
163892|NCT01543828|399441|P1|COMPLETED|Treatment 1||20
163893|NCT01543828|399440|P2|STARTED|Treatment 1||20
163894|NCT01543828|399441|P1|STARTED|Treatment 1||20
163895|NCT01543776|399451|P2|NOT COMPLETED|Overall Study||2
163896|NCT01543776|399452|P1|NOT COMPLETED|Overall Study||2
163897|NCT01543776|399451|P2|COMPLETED|Overall Study||34
163898|NCT01543776|399452|P1|COMPLETED|Overall Study||34
163899|NCT01543776|399451|P2|STARTED|Overall Study||36
163900|NCT01543776|399452|P1|STARTED|Overall Study||36
163901|NCT01543685|399471|P5|NOT COMPLETED|Overall Study||4
163902|NCT01543685|399472|P4|NOT COMPLETED|Overall Study||0
163903|NCT01543685|399473|P3|NOT COMPLETED|Overall Study||2
163904|NCT01543685|399474|P2|NOT COMPLETED|Overall Study||3
163905|NCT01543685|399475|P1|NOT COMPLETED|Overall Study||3
163906|NCT01543685|399471|P5|COMPLETED|Overall Study||90
163907|NCT01543685|399472|P4|COMPLETED|Overall Study||93
163908|NCT01543685|399473|P3|COMPLETED|Overall Study||89
163909|NCT01543685|399474|P2|COMPLETED|Overall Study||88
163910|NCT01543685|399475|P1|COMPLETED|Overall Study||90
163911|NCT01543685|399471|P5|STARTED|Overall Study||94
163912|NCT01543685|399472|P4|STARTED|Overall Study||93
163913|NCT01543685|399473|P3|STARTED|Overall Study||91
163914|NCT01543685|399474|P2|STARTED|Overall Study||91
163915|NCT01543685|399475|P1|STARTED|Overall Study||93
163916|NCT01543607|399522|P1|NOT COMPLETED|Overall Study||0
163917|NCT01543607|399522|P1|COMPLETED|Overall Study||1
163918|NCT01543607|399522|P1|STARTED|Overall Study||1
163919|NCT01543581|399528|P2|NOT COMPLETED|Overall Study||0
163920|NCT01543581|399529|P1|NOT COMPLETED|Overall Study||0
163921|NCT01543581|399528|P2|COMPLETED|Overall Study||0
163922|NCT01543581|399529|P1|COMPLETED|Overall Study||1
163923|NCT01543581|399528|P2|STARTED|Overall Study||0
163924|NCT01543581|399529|P1|STARTED|Overall Study||1
163925|NCT01543568|399535|P1|NOT COMPLETED|Overall Study||1
163926|NCT01543568|399535|P1|COMPLETED|Overall Study||45
163927|NCT01543568|399535|P1|STARTED|Overall Study||46
163928|NCT01543503|399547|P2|NOT COMPLETED|Overall Study||87
163929|NCT01543503|399548|P1|NOT COMPLETED|Overall Study||76
163930|NCT01543503|399547|P2|COMPLETED|Overall Study||711
163931|NCT01543503|399548|P1|COMPLETED|Overall Study||350
163932|NCT01543503|399547|P2|STARTED|Overall Study||798
163933|NCT01543503|399548|P1|STARTED|Overall Study||426
163934|NCT01543204|399592|P1|NOT COMPLETED|Overall Study||8
163935|NCT01543204|399592|P1|COMPLETED|Overall Study||56
163936|NCT01543204|399592|P1|STARTED|Overall Study||64
163937|NCT01543178|399639|P3|NOT COMPLETED|Double-blind Period||37
163938|NCT01543178|399640|P2|NOT COMPLETED|Double-blind Period||44
163939|NCT01543178|399641|P1|NOT COMPLETED|Double-blind Period||0
163940|NCT01543178|399639|P3|COMPLETED|Double-blind Period|283 completed 1st double-blind retreatment and 271 completed 2nd double-blind retreatment.|271
163941|NCT01543178|399640|P2|COMPLETED|Double-blind Period|295 completed 1st double-blind retreatment and 284 completed 2nd double-blind retreatment.|284
163942|NCT01543178|399641|P1|COMPLETED|Double-blind Period||0
163943|NCT01543178|399639|P3|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 308 randomized to placebo.|308
163944|NCT01543178|399640|P2|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 328 randomized to rifaximin.|328
163945|NCT01543178|399641|P1|STARTED|Double-blind Period|The open-label rifaximin arm/group is not applicable to the double-blind period.|0
163946|NCT01543178|399639|P3|NOT COMPLETED|Open-label Period||0
163947|NCT01543178|399640|P2|NOT COMPLETED|Open-label Period||0
163948|NCT01543178|399641|P1|NOT COMPLETED|Open-label Period||1947
163949|NCT01543178|399639|P3|COMPLETED|Open-label Period||0
163950|NCT01543178|399640|P2|COMPLETED|Open-label Period||0
163951|NCT01543178|399641|P1|COMPLETED|Open-label Period||636
163952|NCT01543178|399639|P3|STARTED|Open-label Period|The double-blind placebo arm/group is not applicable to the open-label period.|0
163953|NCT01543178|399640|P2|STARTED|Open-label Period|The double-blind rifaximin arm/group is not applicable to the open-label period.|0
163954|NCT01543178|399641|P1|STARTED|Open-label Period|2583 subjects entered the open-label period, but 4 received no rifaximin; 2579 received rifaximin.|2583
163955|NCT01543074|399652|P4|NOT COMPLETED|Overall Study||0
163956|NCT01543074|399653|P3|NOT COMPLETED|Overall Study||0
163957|NCT01543074|399654|P2|NOT COMPLETED|Overall Study||0
163958|NCT01543074|399655|P1|NOT COMPLETED|Overall Study||0
163959|NCT01543074|399652|P4|COMPLETED|Overall Study||6
163960|NCT01543074|399653|P3|COMPLETED|Overall Study||5
163961|NCT01543074|399654|P2|COMPLETED|Overall Study||7
163962|NCT01543074|399655|P1|COMPLETED|Overall Study||5
163963|NCT01543074|399652|P4|STARTED|Overall Study||6
163964|NCT01543074|399653|P3|STARTED|Overall Study||5
163965|NCT01543074|399654|P2|STARTED|Overall Study||7
163966|NCT01543074|399655|P1|STARTED|Overall Study||5
163967|NCT01542957|399675|P2|NOT COMPLETED|12-month Follow-up||13
163968|NCT01542957|399676|P1|NOT COMPLETED|12-month Follow-up||16
163969|NCT01542957|399675|P2|COMPLETED|12-month Follow-up||40
163970|NCT01542957|399676|P1|COMPLETED|12-month Follow-up||37
163971|NCT01542957|399675|P2|STARTED|12-month Follow-up||53
163972|NCT01542957|399676|P1|STARTED|12-month Follow-up||53
163973|NCT01542957|399675|P2|NOT COMPLETED|3-month Follow-up||8
163974|NCT01542957|399676|P1|NOT COMPLETED|3-month Follow-up||3
163975|NCT01542957|399675|P2|COMPLETED|3-month Follow-up||45
163976|NCT01542957|399676|P1|COMPLETED|3-month Follow-up||50
163977|NCT01542957|399675|P2|STARTED|3-month Follow-up||53
163978|NCT01542957|399676|P1|STARTED|3-month Follow-up||53
163979|NCT01542957|399675|P2|NOT COMPLETED|End of Therapy||10
163980|NCT01542957|399676|P1|NOT COMPLETED|End of Therapy||12
163981|NCT01542957|399675|P2|COMPLETED|End of Therapy||53
163982|NCT01542957|399676|P1|COMPLETED|End of Therapy||53
163983|NCT01542957|399675|P2|STARTED|End of Therapy||63
163984|NCT01542957|399676|P1|STARTED|End of Therapy||65
163985|NCT01542788|399688|P2|NOT COMPLETED|Overall Study||71
163986|NCT01542788|399689|P1|NOT COMPLETED|Overall Study||55
163987|NCT01542788|399688|P2|COMPLETED|Overall Study||0
163988|NCT01542788|399689|P1|COMPLETED|Overall Study||154
163989|NCT01542788|399688|P2|Randomized and Treated|Overall Study||71
163990|NCT01542788|399689|P1|Randomized and Treated|Overall Study||207
163991|NCT01542788|399688|P2|STARTED|Overall Study||71
163992|NCT01542788|399689|P1|STARTED|Overall Study||209
163993|NCT01542684|399705|P1|NOT COMPLETED|Overall Study||0
163994|NCT01542684|399705|P1|COMPLETED|Overall Study||8
163995|NCT01542684|399705|P1|STARTED|Overall Study||8
163996|NCT01542645|399711|P2|NOT COMPLETED|Overall Study||3
163997|NCT01542645|399712|P1|NOT COMPLETED|Overall Study||5
163998|NCT01542645|399711|P2|COMPLETED|Overall Study||79
163999|NCT01542645|399712|P1|COMPLETED|Overall Study||77
164000|NCT01542645|399711|P2|STARTED|Overall Study||82
164001|NCT01542645|399712|P1|STARTED|Overall Study||82
164002|NCT01542632|399736|P6|NOT COMPLETED|Overall Study||0
164003|NCT01542632|399737|P5|NOT COMPLETED|Overall Study||4
164004|NCT01542632|399738|P4|NOT COMPLETED|Overall Study||2
164005|NCT01542632|399739|P3|NOT COMPLETED|Overall Study||1
164006|NCT01542632|399740|P2|NOT COMPLETED|Overall Study||1
164007|NCT01542632|399741|P1|NOT COMPLETED|Overall Study||0
164008|NCT01542632|399736|P6|COMPLETED|Overall Study||24
164009|NCT01542632|399737|P5|COMPLETED|Overall Study||17
164010|NCT01542632|399738|P4|COMPLETED|Overall Study||19
164011|NCT01542632|399739|P3|COMPLETED|Overall Study||23
164012|NCT01542632|399740|P2|COMPLETED|Overall Study||24
164013|NCT01542632|399741|P1|COMPLETED|Overall Study||25
164014|NCT01542632|399736|P6|STARTED|Overall Study||24
164015|NCT01542632|399737|P5|STARTED|Overall Study||21
164016|NCT01542632|399738|P4|STARTED|Overall Study||21
164017|NCT01542632|399739|P3|STARTED|Overall Study||24
164018|NCT01542632|399740|P2|STARTED|Overall Study||25
164019|NCT01542632|399741|P1|STARTED|Overall Study||25
164020|NCT01542541|399787|P2|NOT COMPLETED|Overall Study||0
164021|NCT01542541|399788|P1|NOT COMPLETED|Overall Study||8
164022|NCT01542541|399787|P2|COMPLETED|Overall Study||30
164023|NCT01542541|399788|P1|COMPLETED|Overall Study||30
164024|NCT01542541|399787|P2|STARTED|Overall Study||30
164025|NCT01542541|399788|P1|STARTED|Overall Study||38
164026|NCT01542528|399798|P2|NOT COMPLETED|Overall Study||7
164027|NCT01542528|399799|P1|NOT COMPLETED|Overall Study||12
164028|NCT01542528|399798|P2|COMPLETED|Overall Study||49
164029|NCT01542528|399799|P1|COMPLETED|Overall Study||49
164030|NCT01542528|399798|P2|STARTED|Overall Study||56
164031|NCT01542528|399799|P1|STARTED|Overall Study||61
164032|NCT01542502|399807|P2|NOT COMPLETED|Overall Study||0
164033|NCT01542502|399808|P1|NOT COMPLETED|Overall Study||0
164034|NCT01542502|399807|P2|COMPLETED|Overall Study||6
164035|NCT01542502|399808|P1|COMPLETED|Overall Study||6
164036|NCT01542502|399807|P2|STARTED|Overall Study||6
164037|NCT01542502|399808|P1|STARTED|Overall Study||6
164038|NCT01542398|399818|P2|NOT COMPLETED|Overall Study||13
164039|NCT01542398|399819|P1|NOT COMPLETED|Overall Study||8
164040|NCT01542398|399818|P2|COMPLETED|Overall Study||67
164041|NCT01542398|399819|P1|COMPLETED|Overall Study||71
164042|NCT01542398|399818|P2|Post-Intervention Assessment|Overall Study||80
164043|NCT01542398|399819|P1|Post-Intervention Assessment|Overall Study||78
164044|NCT01542398|399818|P2|STARTED|Overall Study||80
164045|NCT01542398|399819|P1|STARTED|Overall Study||79
164046|NCT01542372|399827|P2|NOT COMPLETED|Overall Study||0
164047|NCT01542372|399828|P1|NOT COMPLETED|Overall Study||0
164048|NCT01542372|399827|P2|COMPLETED|Overall Study||11
164049|NCT01542372|399828|P1|COMPLETED|Overall Study||11
164050|NCT01542372|399827|P2|STARTED|Overall Study||11
164051|NCT01542372|399828|P1|STARTED|Overall Study||11
164052|NCT01542307|399843|P2|NOT COMPLETED|Overall Study||0
164053|NCT01542307|399844|P1|NOT COMPLETED|Overall Study||0
164054|NCT01542307|399843|P2|COMPLETED|Overall Study||22
164055|NCT01542307|399844|P1|COMPLETED|Overall Study||22
164056|NCT01542307|399843|P2|STARTED|Overall Study|Each subject inhaled Medical Air for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
164057|NCT01542307|399844|P1|STARTED|Overall Study|Each subject inhaled Oxygen for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
164058|NCT01542255|399864|P1|NOT COMPLETED|Overall Study||0
164059|NCT01542255|399864|P1|COMPLETED|Overall Study||7
164060|NCT01542255|399864|P1|Analyzed for Time to Progression|Overall Study||7
164061|NCT01542255|399864|P1|STARTED|Overall Study||7
164062|NCT01542229|399871|P2|NOT COMPLETED|Overall Study||36
164063|NCT01542229|399872|P1|NOT COMPLETED|Overall Study||23
164064|NCT01542229|399871|P2|COMPLETED|Overall Study||30
164065|NCT01542229|399872|P1|COMPLETED|Overall Study||45
164066|NCT01542229|399871|P2|STARTED|Overall Study||66
164067|NCT01542229|399872|P1|STARTED|Overall Study||68
164068|NCT01542125|399898|P2|NOT COMPLETED|Overall Study||0
164069|NCT01542125|399899|P1|NOT COMPLETED|Overall Study||0
164070|NCT01542125|399898|P2|COMPLETED|Overall Study||141
164071|NCT01542125|399899|P1|COMPLETED|Overall Study||140
164072|NCT01542125|399898|P2|STARTED|Overall Study||141
164073|NCT01542125|399899|P1|STARTED|Overall Study||140
164074|NCT01542034|399907|P2|NOT COMPLETED|Overall Study||23
164075|NCT01542034|399908|P1|NOT COMPLETED|Overall Study||30
164076|NCT01542034|399907|P2|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|227
164077|NCT01542034|399908|P1|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|226
164078|NCT01542034|399907|P2|Received Treatment|Overall Study||249
164079|NCT01542034|399908|P1|Received Treatment|Overall Study||256
164080|NCT01542034|399907|P2|STARTED|Overall Study||250
164081|NCT01542034|399908|P1|STARTED|Overall Study||256
164082|NCT01541969|399922|P2|NOT COMPLETED|Open Label Extension (12-36 Weeks)||13
164083|NCT01541969|399923|P1|NOT COMPLETED|Open Label Extension (12-36 Weeks)||11
164084|NCT01541969|399922|P2|COMPLETED|Open Label Extension (12-36 Weeks)||35
164085|NCT01541969|399923|P1|COMPLETED|Open Label Extension (12-36 Weeks)||33
164086|NCT01541969|399922|P2|STARTED|Open Label Extension (12-36 Weeks)||48
164087|NCT01541969|399923|P1|STARTED|Open Label Extension (12-36 Weeks)||44
164088|NCT01541969|399922|P2|NOT COMPLETED|Double-blind (0-12 Weeks)||2
164089|NCT01541969|399923|P1|NOT COMPLETED|Double-blind (0-12 Weeks)||6
164090|NCT01541969|399922|P2|COMPLETED|Double-blind (0-12 Weeks)||48
164091|NCT01541969|399923|P1|COMPLETED|Double-blind (0-12 Weeks)||44
164092|NCT01541969|399922|P2|STARTED|Double-blind (0-12 Weeks)||50
164093|NCT01541969|399923|P1|STARTED|Double-blind (0-12 Weeks)||50
164094|NCT01541930|399939|P1|NOT COMPLETED|Overall Study||1
164095|NCT01541930|399939|P1|COMPLETED|Overall Study||20
164096|NCT01541930|399939|P1|STARTED|Overall Study||21
164097|NCT01541917|399961|P2|NOT COMPLETED|Overall Study||9
164098|NCT01541917|399962|P1|NOT COMPLETED|Overall Study||15
164099|NCT01541917|399961|P2|COMPLETED|Overall Study||136
164100|NCT01541917|399962|P1|COMPLETED|Overall Study||129
164101|NCT01541917|399961|P2|STARTED|Overall Study||145
164102|NCT01541917|399962|P1|STARTED|Overall Study||144
164103|NCT01541891|399980|P2|NOT COMPLETED|Overall Study||1
164104|NCT01541891|399981|P1|NOT COMPLETED|Overall Study||1
164105|NCT01541891|399980|P2|COMPLETED|Overall Study||14
164106|NCT01541891|399981|P1|COMPLETED|Overall Study||14
164107|NCT01541891|399980|P2|STARTED|Overall Study||15
164108|NCT01541891|399981|P1|STARTED|Overall Study||15
164109|NCT01541865|399991|P1|NOT COMPLETED|Overall Study||22
164110|NCT01541865|399991|P1|COMPLETED|Overall Study||124
164111|NCT01541865|399991|P1|STARTED|Overall Study||146
164112|NCT01541826|400009|P3|NOT COMPLETED|Overall Study||0
164113|NCT01541826|400010|P2|NOT COMPLETED|Overall Study||3
164114|NCT01541826|400011|P1|NOT COMPLETED|Overall Study||4
164115|NCT01541826|400009|P3|COMPLETED|Overall Study||6
164116|NCT01541826|400010|P2|COMPLETED|Overall Study||25
164117|NCT01541826|400011|P1|COMPLETED|Overall Study||24
164118|NCT01541826|400009|P3|STARTED|Overall Study||6
164119|NCT01541826|400010|P2|STARTED|Overall Study||28
164120|NCT01541826|400011|P1|STARTED|Overall Study||28
164121|NCT01541735|400080|P2|NOT COMPLETED|Overall Study||0
164122|NCT01541735|400081|P1|NOT COMPLETED|Overall Study||0
164123|NCT01541735|400080|P2|COMPLETED|Overall Study||7
164124|NCT01541735|400081|P1|COMPLETED|Overall Study||7
164125|NCT01541735|400080|P2|STARTED|Overall Study||7
164126|NCT01541735|400081|P1|STARTED|Overall Study||7
164127|NCT01541644|400093|P1|NOT COMPLETED|Overall Study||3
164128|NCT01541644|400093|P1|COMPLETED|Overall Study||24
164129|NCT01541644|400093|P1|STARTED|Overall Study||27
164130|NCT01541553|400099|P2|NOT COMPLETED|Overall Study||14
164131|NCT01541553|400100|P1|NOT COMPLETED|Overall Study||12
164132|NCT01541553|400099|P2|COMPLETED|Overall Study||148
164133|NCT01541553|400100|P1|COMPLETED|Overall Study||155
164134|NCT01541553|400099|P2|STARTED|Overall Study||162
164135|NCT01541553|400100|P1|STARTED|Overall Study||167
164136|NCT01541397|400112|P2|NOT COMPLETED|Overall Study||2
164137|NCT01541397|400113|P1|NOT COMPLETED|Overall Study||4
164138|NCT01541397|400112|P2|COMPLETED|Overall Study||0
164139|NCT01541397|400113|P1|COMPLETED|Overall Study||0
164140|NCT01541397|400112|P2|STARTED|Overall Study||2
164141|NCT01541397|400113|P1|STARTED|Overall Study||4
164142|NCT01541384|400128|P3|NOT COMPLETED|Overall Study||2
164143|NCT01541384|400129|P2|NOT COMPLETED|Overall Study||1
164144|NCT01541384|400130|P1|NOT COMPLETED|Overall Study||0
164145|NCT01541384|400128|P3|COMPLETED|Overall Study||38
164146|NCT01541384|400129|P2|COMPLETED|Overall Study||39
164147|NCT01541384|400130|P1|COMPLETED|Overall Study||40
164148|NCT01541384|400128|P3|STARTED|Overall Study||40
164149|NCT01541384|400129|P2|STARTED|Overall Study||40
164150|NCT01541384|400130|P1|STARTED|Overall Study||40
164151|NCT01541371|400138|P1|NOT COMPLETED|Overall Study||77
164152|NCT01541371|400138|P1|COMPLETED|Overall Study||326
164153|NCT01541371|400138|P1|Full Analysis Set|Overall Study||394
164154|NCT01541371|400138|P1|STARTED|Overall Study||403
164155|NCT01541358|400161|P1|NOT COMPLETED|Overall Study||0
164156|NCT01541358|400161|P1|COMPLETED|Overall Study||2
164157|NCT01541358|400161|P1|STARTED|Overall Study||2
164158|NCT01541254|400167|P1|NOT COMPLETED|Overall Study||6
164159|NCT01541254|400167|P1|COMPLETED|Overall Study||30
164160|NCT01541254|400167|P1|STARTED|Overall Study||36
164161|NCT01541215|400174|P2|NOT COMPLETED|Overall Study||16
164162|NCT01541215|400175|P1|NOT COMPLETED|Overall Study||10
164163|NCT01541215|400174|P2|COMPLETED|Overall Study||53
164164|NCT01541215|400175|P1|COMPLETED|Overall Study||56
164165|NCT01541215|400174|P2|Exposed|Overall Study||68
164166|NCT01541215|400175|P1|Exposed|Overall Study||66
164167|NCT01541215|400174|P2|STARTED|Overall Study||69
164168|NCT01541215|400175|P1|STARTED|Overall Study||66
164169|NCT01540981|400313|P2|NOT COMPLETED|Overall Study||0
164170|NCT01540981|400314|P1|NOT COMPLETED|Overall Study||1
164171|NCT01540981|400313|P2|COMPLETED|Overall Study||6
164172|NCT01540981|400314|P1|COMPLETED|Overall Study||5
164173|NCT01540981|400313|P2|STARTED|Overall Study||6
164174|NCT01540981|400314|P1|STARTED|Overall Study||6
164175|NCT01540851|400324|P2|NOT COMPLETED|Overall Study||18
164176|NCT01540851|400325|P1|NOT COMPLETED|Overall Study||21
164177|NCT01540851|400324|P2|COMPLETED|Overall Study||136
164178|NCT01540851|400325|P1|COMPLETED|Overall Study||133
164179|NCT01540851|400324|P2|STARTED|Overall Study||154
164180|NCT01540851|400325|P1|STARTED|Overall Study||154
164181|NCT01540838|400337|P2|NOT COMPLETED|Overall Study||23
164182|NCT01540838|400338|P1|NOT COMPLETED|Overall Study||22
164183|NCT01540838|400337|P2|COMPLETED|Overall Study||164
164184|NCT01540838|400338|P1|COMPLETED|Overall Study||166
164185|NCT01540838|400337|P2|STARTED|Overall Study||187
164186|NCT01540838|400338|P1|STARTED|Overall Study||188
164187|NCT01540825|400371|P11|NOT COMPLETED|Overall Study||0
164188|NCT01540825|400372|P10|NOT COMPLETED|Overall Study||0
164189|NCT01540825|400373|P9|NOT COMPLETED|Overall Study||0
164190|NCT01540825|400374|P8|NOT COMPLETED|Overall Study||0
164191|NCT01540825|400375|P7|NOT COMPLETED|Overall Study||0
164192|NCT01540825|400376|P6|NOT COMPLETED|Overall Study||0
164193|NCT01540825|400377|P5|NOT COMPLETED|Overall Study||0
164194|NCT01540825|400378|P4|NOT COMPLETED|Overall Study||0
164195|NCT01540825|400379|P3|NOT COMPLETED|Overall Study||0
164196|NCT01540825|400380|P2|NOT COMPLETED|Overall Study||0
164197|NCT01540825|400381|P1|NOT COMPLETED|Overall Study||0
164198|NCT01540825|400371|P11|COMPLETED|Overall Study||6
164199|NCT01540825|400372|P10|COMPLETED|Overall Study||6
164200|NCT01540825|400373|P9|COMPLETED|Overall Study||6
164201|NCT01540825|400374|P8|COMPLETED|Overall Study||6
164202|NCT01540825|400375|P7|COMPLETED|Overall Study||6
164203|NCT01540825|400376|P6|COMPLETED|Overall Study||6
164204|NCT01540825|400377|P5|COMPLETED|Overall Study||6
164205|NCT01540825|400378|P4|COMPLETED|Overall Study||6
164206|NCT01540825|400379|P3|COMPLETED|Overall Study||6
164207|NCT01540825|400380|P2|COMPLETED|Overall Study||6
164208|NCT01540825|400381|P1|COMPLETED|Overall Study||20
164209|NCT01540825|400371|P11|STARTED|Overall Study||6
164210|NCT01540825|400372|P10|STARTED|Overall Study||6
164211|NCT01540825|400373|P9|STARTED|Overall Study||6
164212|NCT01540825|400374|P8|STARTED|Overall Study||6
164213|NCT01540825|400375|P7|STARTED|Overall Study||6
164214|NCT01540825|400376|P6|STARTED|Overall Study||6
164215|NCT01540825|400377|P5|STARTED|Overall Study||6
164216|NCT01540825|400378|P4|STARTED|Overall Study||6
164217|NCT01540825|400379|P3|STARTED|Overall Study||6
164218|NCT01540825|400380|P2|STARTED|Overall Study||6
164219|NCT01540825|400381|P1|STARTED|Overall Study||20
164220|NCT01540773|400477|P2|NOT COMPLETED|Second Intervention||0
164221|NCT01540773|400478|P1|NOT COMPLETED|Second Intervention||0
164222|NCT01540773|400477|P2|COMPLETED|Second Intervention||8
164223|NCT01540773|400478|P1|COMPLETED|Second Intervention||8
164224|NCT01540773|400477|P2|STARTED|Second Intervention||8
164225|NCT01540773|400478|P1|STARTED|Second Intervention||8
164226|NCT01540773|400477|P2|NOT COMPLETED|Wash Out Period of 1 Week||0
164227|NCT01540773|400478|P1|NOT COMPLETED|Wash Out Period of 1 Week||0
164228|NCT01540773|400477|P2|COMPLETED|Wash Out Period of 1 Week||8
164229|NCT01540773|400478|P1|COMPLETED|Wash Out Period of 1 Week||8
164230|NCT01540773|400477|P2|STARTED|Wash Out Period of 1 Week||8
164231|NCT01540773|400478|P1|STARTED|Wash Out Period of 1 Week||8
164232|NCT01540773|400477|P2|NOT COMPLETED|First Intervention||0
164233|NCT01540773|400478|P1|NOT COMPLETED|First Intervention||0
164234|NCT01540773|400477|P2|COMPLETED|First Intervention||8
164235|NCT01540773|400478|P1|COMPLETED|First Intervention||8
164236|NCT01540773|400477|P2|STARTED|First Intervention||8
164237|NCT01540773|400478|P1|STARTED|First Intervention||8
164238|NCT01540565|400488|P1|NOT COMPLETED|Overall Study||2
164239|NCT01540565|400488|P1|COMPLETED|Overall Study||50
164240|NCT01540565|400488|P1|STARTED|Overall Study||52
164241|NCT01540513|400498|P1|NOT COMPLETED|Overall Study||0
164242|NCT01540513|400498|P1|COMPLETED|Overall Study||12
164243|NCT01540513|400498|P1|STARTED|Overall Study||12
164244|NCT01540487|400507|P2|NOT COMPLETED|Overall Study||0
164245|NCT01540487|400508|P1|NOT COMPLETED|Overall Study||1
164246|NCT01540487|400507|P2|COMPLETED|Overall Study||24
164247|NCT01540487|400508|P1|COMPLETED|Overall Study||23
164248|NCT01540487|400507|P2|STARTED|Overall Study||24
164249|NCT01540487|400508|P1|STARTED|Overall Study||24
164250|NCT01540409|400544|P2|NOT COMPLETED|Overall Study||0
164251|NCT01540409|400545|P1|NOT COMPLETED|Overall Study||0
164252|NCT01540409|400544|P2|COMPLETED|Overall Study||6
164253|NCT01540409|400545|P1|COMPLETED|Overall Study||6
164254|NCT01540409|400544|P2|STARTED|Overall Study||6
164255|NCT01540409|400545|P1|STARTED|Overall Study||6
164256|NCT01540370|400554|P1|NOT COMPLETED|Overall Study||2
164257|NCT01540370|400554|P1|COMPLETED|Overall Study||100
164258|NCT01540370|400554|P1|STARTED|Overall Study||102
164259|NCT01540266|400565|P6|NOT COMPLETED|Overall Study||0
164260|NCT01540266|400566|P5|NOT COMPLETED|Overall Study||0
164261|NCT01540266|400567|P4|NOT COMPLETED|Overall Study||0
164262|NCT01540266|400568|P3|NOT COMPLETED|Overall Study||1
164263|NCT01540266|400569|P2|NOT COMPLETED|Overall Study||1
164264|NCT01540266|400570|P1|NOT COMPLETED|Overall Study||6
164265|NCT01540266|400565|P6|COMPLETED|Overall Study||19
164266|NCT01540266|400566|P5|COMPLETED|Overall Study||20
164267|NCT01540266|400567|P4|COMPLETED|Overall Study||38
164268|NCT01540266|400568|P3|COMPLETED|Overall Study||59
164269|NCT01540266|400569|P2|COMPLETED|Overall Study||41
164270|NCT01540266|400570|P1|COMPLETED|Overall Study||57
164271|NCT01540266|400565|P6|STARTED|Overall Study||19
164272|NCT01540266|400566|P5|STARTED|Overall Study||20
164273|NCT01540266|400567|P4|STARTED|Overall Study||38
164274|NCT01540266|400568|P3|STARTED|Overall Study||60
164275|NCT01540266|400569|P2|STARTED|Overall Study||42
164276|NCT01540266|400570|P1|STARTED|Overall Study||63
164277|NCT01540162|400586|P2|NOT COMPLETED|Overall Study||0
164278|NCT01540162|400587|P1|NOT COMPLETED|Overall Study||0
164279|NCT01540162|400586|P2|COMPLETED|Overall Study||32
164280|NCT01540162|400587|P1|COMPLETED|Overall Study||30
164281|NCT01540162|400586|P2|STARTED|Overall Study||32
164282|NCT01540162|400587|P1|STARTED|Overall Study||30
164283|NCT01540045|400597|P1|NOT COMPLETED|Overall Study||0
164284|NCT01540045|400597|P1|COMPLETED|Overall Study||40
164285|NCT01540045|400597|P1|STARTED|Overall Study||40
164286|NCT01539980|400636|P1|NOT COMPLETED|Overall Study||0
164287|NCT01539980|400636|P1|COMPLETED|Overall Study||30
164288|NCT01539980|400636|P1|STARTED|Overall Study||30
164289|NCT01539811|400646|P2|NOT COMPLETED|Overall Study||0
164290|NCT01539811|400647|P1|NOT COMPLETED|Overall Study||0
164291|NCT01539811|400646|P2|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
164292|NCT01539811|400647|P1|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
164293|NCT01539811|400646|P2|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
164294|NCT01539811|400647|P1|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
164295|NCT01539759|400655|P2|NOT COMPLETED|Overall Study||8
164296|NCT01539759|400656|P1|NOT COMPLETED|Overall Study||6
164297|NCT01539759|400655|P2|COMPLETED|Overall Study||48
164298|NCT01539759|400656|P1|COMPLETED|Overall Study||50
164299|NCT01539759|400655|P2|IUD in Place at 6 Months Posptartum|Overall Study||40
164300|NCT01539759|400656|P1|IUD in Place at 6 Months Posptartum|Overall Study||32
164301|NCT01539759|400655|P2|IUD Removal|Overall Study||7
164302|NCT01539759|400656|P1|IUD Removal|Overall Study||2
164303|NCT01539759|400655|P2|IUD Expulsion|Overall Study||4
164304|NCT01539759|400656|P1|IUD Expulsion|Overall Study||1
164305|NCT01539759|400655|P2|Had Successful IUD Placement|Overall Study||53
164306|NCT01539759|400656|P1|Had Successful IUD Placement|Overall Study||34
164307|NCT01539759|400655|P2|STARTED|Overall Study||56
164308|NCT01539759|400656|P1|STARTED|Overall Study||56
164309|NCT01539642|400668|P2|NOT COMPLETED|Overall Study||31
164310|NCT01539642|400669|P1|NOT COMPLETED|Overall Study||36
164311|NCT01539642|400668|P2|COMPLETED|Overall Study||27
164312|NCT01539642|400669|P1|COMPLETED|Overall Study||78
164313|NCT01539642|400668|P2|STARTED|Overall Study||58
164314|NCT01539642|400669|P1|STARTED|Overall Study||114
164315|NCT01539590|400677|P2|NOT COMPLETED|Overall Study||0
164316|NCT01539590|400678|P1|NOT COMPLETED|Overall Study||3
164317|NCT01539590|400677|P2|COMPLETED|Overall Study||2
164318|NCT01539590|400678|P1|COMPLETED|Overall Study||0
164319|NCT01539590|400677|P2|Complete Study Treatment|Overall Study||2
164320|NCT01539590|400678|P1|Complete Study Treatment|Overall Study||1
164321|NCT01539590|400677|P2|STARTED|Overall Study||2
164322|NCT01539590|400678|P1|STARTED|Overall Study||3
164323|NCT01539538|400686|P2|NOT COMPLETED|Overall Study||44
164324|NCT01539538|400687|P1|NOT COMPLETED|Overall Study||31
164325|NCT01539538|400686|P2|COMPLETED|Overall Study||136
164326|NCT01539538|400687|P1|COMPLETED|Overall Study||146
164327|NCT01539538|400686|P2|STARTED|Overall Study||180
164328|NCT01539538|400687|P1|STARTED|Overall Study||177
164329|NCT01539525|400696|P3|NOT COMPLETED|Overall Study||17
164330|NCT01539525|400697|P2|NOT COMPLETED|Overall Study||16
164331|NCT01539525|400698|P1|NOT COMPLETED|Overall Study||20
164332|NCT01539525|400696|P3|COMPLETED|Overall Study||134
164333|NCT01539525|400697|P2|COMPLETED|Overall Study||127
164334|NCT01539525|400698|P1|COMPLETED|Overall Study||125
164335|NCT01539525|400696|P3|STARTED|Overall Study||151
164336|NCT01539525|400697|P2|STARTED|Overall Study||143
164337|NCT01539525|400698|P1|STARTED|Overall Study||145
164338|NCT01539512|400717|P2|NOT COMPLETED|Overall Study||13
164339|NCT01539512|400718|P1|NOT COMPLETED|Overall Study||23
164340|NCT01539512|400717|P2|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|97
164341|NCT01539512|400718|P1|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|87
164342|NCT01539512|400717|P2|STARTED|Overall Study||110
164343|NCT01539512|400718|P1|STARTED|Overall Study||110
164344|NCT01539317|400734|P2|NOT COMPLETED|Overall Study||0
164345|NCT01539317|400735|P1|NOT COMPLETED|Overall Study||1
164346|NCT01539317|400734|P2|COMPLETED|Overall Study||25
164347|NCT01539317|400735|P1|COMPLETED|Overall Study||24
164348|NCT01539317|400734|P2|STARTED|Overall Study||25
164349|NCT01539317|400735|P1|STARTED|Overall Study||25
164350|NCT01539291|400753|P4|NOT COMPLETED|Study GS-US-312-0117||26
164351|NCT01539291|400754|P3|NOT COMPLETED|Study GS-US-312-0117||22
164352|NCT01539291|400755|P2|NOT COMPLETED|Study GS-US-312-0117||2
164353|NCT01539291|400756|P1|NOT COMPLETED|Study GS-US-312-0117||41
164354|NCT01539291|400753|P4|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|18
164355|NCT01539291|400754|P3|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|20
164356|NCT01539291|400755|P2|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|2
164357|NCT01539291|400756|P1|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|30
164358|NCT01539291|400753|P4|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|44
164359|NCT01539291|400754|P3|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|42
164360|NCT01539291|400755|P2|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|4
164361|NCT01539291|400756|P1|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|71
164362|NCT01539291|400753|P4|NOT COMPLETED|Study GS-US-312-0116||0
164363|NCT01539291|400754|P3|NOT COMPLETED|Study GS-US-312-0116||0
164364|NCT01539291|400755|P2|NOT COMPLETED|Study GS-US-312-0116||0
164365|NCT01539291|400756|P1|NOT COMPLETED|Study GS-US-312-0116||25
164366|NCT01539291|400753|P4|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|44
164367|NCT01539291|400754|P3|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|42
164446|NCT01537900|400959|P1|NOT COMPLETED|Overall Study||0
164368|NCT01539291|400755|P2|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|4
164369|NCT01539291|400756|P1|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|81
164370|NCT01539291|400753|P4|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|44
164371|NCT01539291|400754|P3|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|42
164372|NCT01539291|400755|P2|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|4
164373|NCT01539291|400756|P1|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|106
164374|NCT01539239|400828|P2|NOT COMPLETED|Overall Study||17
164375|NCT01539239|400829|P1|NOT COMPLETED|Overall Study||12
164376|NCT01539239|400828|P2|COMPLETED|Overall Study||170
164377|NCT01539239|400829|P1|COMPLETED|Overall Study||357
164378|NCT01539239|400828|P2|STARTED|Overall Study||187
164379|NCT01539239|400829|P1|STARTED|Overall Study||369
164380|NCT01539135|400839|P2|NOT COMPLETED|Overall Study||0
164381|NCT01539135|400840|P1|NOT COMPLETED|Overall Study||0
164382|NCT01539135|400839|P2|COMPLETED|Overall Study||37
164383|NCT01539135|400840|P1|COMPLETED|Overall Study||43
164384|NCT01539135|400839|P2|STARTED|Overall Study||37
164385|NCT01539135|400840|P1|STARTED|Overall Study||43
164386|NCT01539083|400852|P3|NOT COMPLETED|After Randomization (TP and VTP)||23
164387|NCT01539083|400853|P2|NOT COMPLETED|After Randomization (TP and VTP)||21
164388|NCT01539083|400854|P1|NOT COMPLETED|After Randomization (TP and VTP)||0
164389|NCT01539083|400852|P3|COMPLETED|After Randomization (TP and VTP)||80
164390|NCT01539083|400853|P2|COMPLETED|After Randomization (TP and VTP)||79
164391|NCT01539083|400854|P1|COMPLETED|After Randomization (TP and VTP)||0
164392|NCT01539083|400852|P3|Safety Population|After Randomization (TP and VTP)||103
164393|NCT01539083|400853|P2|Safety Population|After Randomization (TP and VTP)|One participant was randomized but not treated. Hence, was not included in safety population.|99
164394|NCT01539083|400854|P1|Safety Population|After Randomization (TP and VTP)||0
164395|NCT01539083|400852|P3|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidation treatment phase.|103
164396|NCT01539083|400853|P2|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidated treatment.|100
164397|NCT01539083|400854|P1|STARTED|After Randomization (TP and VTP)||0
164398|NCT01539083|400852|P3|NOT COMPLETED|Before Randomization (VCD Induction)||0
164399|NCT01539083|400853|P2|NOT COMPLETED|Before Randomization (VCD Induction)||0
164400|NCT01539083|400854|P1|NOT COMPLETED|Before Randomization (VCD Induction)||53
164401|NCT01539083|400852|P3|COMPLETED|Before Randomization (VCD Induction)||0
164402|NCT01539083|400853|P2|COMPLETED|Before Randomization (VCD Induction)||0
164403|NCT01539083|400854|P1|COMPLETED|Before Randomization (VCD Induction)||203
164404|NCT01539083|400852|P3|Treated|Before Randomization (VCD Induction)||0
164405|NCT01539083|400853|P2|Treated|Before Randomization (VCD Induction)||0
164406|NCT01539083|400854|P1|Treated|Before Randomization (VCD Induction)||254
164407|NCT01539083|400852|P3|STARTED|Before Randomization (VCD Induction)||0
164408|NCT01539083|400853|P2|STARTED|Before Randomization (VCD Induction)||0
164409|NCT01539083|400854|P1|STARTED|Before Randomization (VCD Induction)||256
164410|NCT01539070|400877|P2|NOT COMPLETED|Overall Study||39
164411|NCT01539070|400878|P1|NOT COMPLETED|Overall Study||59
164412|NCT01539070|400877|P2|COMPLETED|Overall Study||99
164413|NCT01539070|400878|P1|COMPLETED|Overall Study||109
164414|NCT01539070|400877|P2|STARTED|Overall Study||138
164415|NCT01539070|400878|P1|STARTED|Overall Study||168
164416|NCT01538862|400890|P1|NOT COMPLETED|Overall Study||0
164417|NCT01538862|400890|P1|COMPLETED|Overall Study||7
164418|NCT01538862|400890|P1|STARTED|Overall Study||7
164419|NCT01538719|400898|P2|NOT COMPLETED|Overall Study||0
164420|NCT01538719|400899|P1|NOT COMPLETED|Overall Study||2
164421|NCT01538719|400898|P2|COMPLETED|Overall Study||12
164422|NCT01538719|400899|P1|COMPLETED|Overall Study||5
164423|NCT01538719|400898|P2|STARTED|Overall Study||12
164424|NCT01538719|400899|P1|STARTED|Overall Study||7
164425|NCT01538615|400909|P2|NOT COMPLETED|Overall Study||12
164426|NCT01538615|400910|P1|NOT COMPLETED|Overall Study||22
164427|NCT01538615|400909|P2|COMPLETED|Overall Study||146
164428|NCT01538615|400910|P1|COMPLETED|Overall Study||140
164429|NCT01538615|400909|P2|STARTED|Overall Study||158
164430|NCT01538615|400910|P1|STARTED|Overall Study||162
164431|NCT01538472|400922|P1|NOT COMPLETED|Overall Study||4
164432|NCT01538472|400922|P1|COMPLETED|Overall Study||36
164433|NCT01538472|400922|P1|STARTED|Overall Study||40
164434|NCT01538199|400933|P4|NOT COMPLETED|Overall Study||2
164435|NCT01538199|400934|P3|NOT COMPLETED|Overall Study||1
164436|NCT01538199|400935|P2|NOT COMPLETED|Overall Study||3
164437|NCT01538199|400936|P1|NOT COMPLETED|Overall Study||2
164438|NCT01538199|400933|P4|COMPLETED|Overall Study|Completer excluded from analyses because determined to be not eligible at end of study.|1
164439|NCT01538199|400934|P3|COMPLETED|Overall Study|1 non-completer included in analyses because only missed follow up, completed all treatment visits.|3
164440|NCT01538199|400935|P2|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
164441|NCT01538199|400936|P1|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
164442|NCT01538199|400933|P4|STARTED|Overall Study||3
164443|NCT01538199|400934|P3|STARTED|Overall Study||4
164444|NCT01538199|400935|P2|STARTED|Overall Study||11
164445|NCT01538199|400936|P1|STARTED|Overall Study||10
164447|NCT01537900|400959|P1|COMPLETED|Overall Study||4
164448|NCT01537900|400959|P1|STARTED|Overall Study||4
164449|NCT01537887|400970|P6|NOT COMPLETED|Period 3||0
164450|NCT01537887|400971|P5|NOT COMPLETED|Period 3||0
164451|NCT01537887|400972|P4|NOT COMPLETED|Period 3||0
164452|NCT01537887|400973|P3|NOT COMPLETED|Period 3||1
164453|NCT01537887|400974|P2|NOT COMPLETED|Period 3||1
164454|NCT01537887|400975|P1|NOT COMPLETED|Period 3||0
164455|NCT01537887|400970|P6|COMPLETED|Period 3||11
164456|NCT01537887|400971|P5|COMPLETED|Period 3||11
164457|NCT01537887|400972|P4|COMPLETED|Period 3||12
164458|NCT01537887|400973|P3|COMPLETED|Period 3||10
164459|NCT01537887|400974|P2|COMPLETED|Period 3||10
164460|NCT01537887|400975|P1|COMPLETED|Period 3||12
164461|NCT01537887|400970|P6|STARTED|Period 3||11
164462|NCT01537887|400971|P5|STARTED|Period 3||11
164463|NCT01537887|400972|P4|STARTED|Period 3||12
164464|NCT01537887|400973|P3|STARTED|Period 3||11
164465|NCT01537887|400974|P2|STARTED|Period 3||11
164466|NCT01537887|400975|P1|STARTED|Period 3||12
164467|NCT01537887|400970|P6|NOT COMPLETED|Period 2||0
164468|NCT01537887|400971|P5|NOT COMPLETED|Period 2||0
164469|NCT01537887|400972|P4|NOT COMPLETED|Period 2||0
164470|NCT01537887|400973|P3|NOT COMPLETED|Period 2||0
164471|NCT01537887|400974|P2|NOT COMPLETED|Period 2||1
164472|NCT01537887|400975|P1|NOT COMPLETED|Period 2||0
164473|NCT01537887|400970|P6|COMPLETED|Period 2||11
164474|NCT01537887|400971|P5|COMPLETED|Period 2||11
164475|NCT01537887|400972|P4|COMPLETED|Period 2||12
164476|NCT01537887|400973|P3|COMPLETED|Period 2||11
164477|NCT01537887|400974|P2|COMPLETED|Period 2||11
164478|NCT01537887|400975|P1|COMPLETED|Period 2||12
164479|NCT01537887|400970|P6|STARTED|Period 2||11
164480|NCT01537887|400971|P5|STARTED|Period 2||11
164481|NCT01537887|400972|P4|STARTED|Period 2||12
164482|NCT01537887|400973|P3|STARTED|Period 2||11
164483|NCT01537887|400974|P2|STARTED|Period 2||12
164484|NCT01537887|400975|P1|STARTED|Period 2||12
164485|NCT01537887|400970|P6|NOT COMPLETED|Period 1||1
164486|NCT01537887|400971|P5|NOT COMPLETED|Period 1||1
164487|NCT01537887|400972|P4|NOT COMPLETED|Period 1||0
164488|NCT01537887|400973|P3|NOT COMPLETED|Period 1||1
164489|NCT01537887|400974|P2|NOT COMPLETED|Period 1||0
164490|NCT01537887|400975|P1|NOT COMPLETED|Period 1||0
164491|NCT01537887|400970|P6|COMPLETED|Period 1||11
164492|NCT01537887|400971|P5|COMPLETED|Period 1||11
164493|NCT01537887|400972|P4|COMPLETED|Period 1||12
164494|NCT01537887|400973|P3|COMPLETED|Period 1||11
164495|NCT01537887|400974|P2|COMPLETED|Period 1||12
164496|NCT01537887|400975|P1|COMPLETED|Period 1||12
164497|NCT01537887|400970|P6|Received at Least 1 Dose of Study Drug|Period 1||12
164498|NCT01537887|400971|P5|Received at Least 1 Dose of Study Drug|Period 1||12
164499|NCT01537887|400972|P4|Received at Least 1 Dose of Study Drug|Period 1||12
164500|NCT01537887|400973|P3|Received at Least 1 Dose of Study Drug|Period 1||11
164501|NCT01537887|400974|P2|Received at Least 1 Dose of Study Drug|Period 1||12
164502|NCT01537887|400975|P1|Received at Least 1 Dose of Study Drug|Period 1||12
164503|NCT01537887|400970|P6|STARTED|Period 1||12
164504|NCT01537887|400971|P5|STARTED|Period 1||12
164505|NCT01537887|400972|P4|STARTED|Period 1||12
164506|NCT01537887|400973|P3|STARTED|Period 1||12
164507|NCT01537887|400974|P2|STARTED|Period 1||12
164508|NCT01537887|400975|P1|STARTED|Period 1||12
164509|NCT01537835|400989|P3|NOT COMPLETED|Overall Study||0
164510|NCT01537835|400990|P2|NOT COMPLETED|Overall Study||0
164511|NCT01537835|400991|P1|NOT COMPLETED|Overall Study||0
164512|NCT01537835|400989|P3|COMPLETED|Overall Study||35
164513|NCT01537835|400990|P2|COMPLETED|Overall Study||37
164514|NCT01537835|400991|P1|COMPLETED|Overall Study||37
164515|NCT01537835|400989|P3|STARTED|Overall Study||35
164516|NCT01537835|400990|P2|STARTED|Overall Study||37
164517|NCT01537835|400991|P1|STARTED|Overall Study||37
164518|NCT01537783|401004|P2|NOT COMPLETED|Overall Study||2
164519|NCT01537783|401005|P1|NOT COMPLETED|Overall Study||11
164520|NCT01537783|401004|P2|COMPLETED|Overall Study||23
164521|NCT01537783|401005|P1|COMPLETED|Overall Study||14
164522|NCT01537783|401004|P2|STARTED|Overall Study||25
164523|NCT01537783|401005|P1|STARTED|Overall Study||25
164524|NCT01537666|401015|P4|NOT COMPLETED|Overall Study||0
164525|NCT01537666|401016|P3|NOT COMPLETED|Overall Study||0
164526|NCT01537666|401017|P2|NOT COMPLETED|Overall Study||0
164527|NCT01537666|401018|P1|NOT COMPLETED|Overall Study||0
164528|NCT01537666|401015|P4|COMPLETED|Overall Study|1 patient withdrew after a 32 mg dose and was replaced by a patient who only received an 80 mg dose.|7
164529|NCT01537666|401016|P3|COMPLETED|Overall Study||6
164530|NCT01537666|401017|P2|COMPLETED|Overall Study||6
164531|NCT01537666|401018|P1|COMPLETED|Overall Study||6
164532|NCT01537666|401015|P4|STARTED|Overall Study|5 of 7 patients received a 32 mg dose of AeroVanc followed by a dose of 80 mg at least 1 week later.|7
164533|NCT01537666|401016|P3|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
164534|NCT01537666|401017|P2|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
164535|NCT01537666|401018|P1|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
164536|NCT01537549|401056|P1|NOT COMPLETED|Overall Study||3
164537|NCT01537549|401056|P1|COMPLETED|Overall Study||8
164538|NCT01537549|401056|P1|STARTED|Overall Study||11
164539|NCT01537432|401064|P2|NOT COMPLETED|Overall Study||2
164540|NCT01537432|401065|P1|NOT COMPLETED|Overall Study||6
164541|NCT01537432|401064|P2|COMPLETED|Overall Study||10
164542|NCT01537432|401065|P1|COMPLETED|Overall Study||18
164543|NCT01537432|401064|P2|STARTED|Overall Study||12
164544|NCT01537432|401065|P1|STARTED|Overall Study||24
164545|NCT01537419|401075|P2|NOT COMPLETED|Overall Study||12
164546|NCT01537419|401076|P1|NOT COMPLETED|Overall Study||11
164547|NCT01537419|401075|P2|COMPLETED|Overall Study||54
164548|NCT01537419|401076|P1|COMPLETED|Overall Study||52
164549|NCT01537419|401075|P2|STARTED|Overall Study||66
164550|NCT01537419|401076|P1|STARTED|Overall Study||63
164551|NCT01537393|401088|P2|NOT COMPLETED|Overall Study||191
164552|NCT01537393|401089|P1|NOT COMPLETED|Overall Study||154
164553|NCT01537393|401088|P2|COMPLETED|Overall Study||507
164554|NCT01537393|401089|P1|COMPLETED|Overall Study||553
164555|NCT01537393|401088|P2|STARTED|Overall Study||698
164556|NCT01537393|401089|P1|STARTED|Overall Study||707
164557|NCT01537367|401100|P3|NOT COMPLETED|Overall Study||0
164558|NCT01537367|401101|P2|NOT COMPLETED|Overall Study||0
164559|NCT01537367|401102|P1|NOT COMPLETED|Overall Study||0
164560|NCT01537367|401100|P3|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|613
164561|NCT01537367|401101|P2|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|610
164562|NCT01537367|401102|P1|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|615
164563|NCT01537367|401100|P3|STARTED|Overall Study||613
164564|NCT01537367|401101|P2|STARTED|Overall Study||610
164565|NCT01537367|401102|P1|STARTED|Overall Study||615
164566|NCT01537315|401118|P2|NOT COMPLETED|Overall Study||0
164567|NCT01537315|401119|P1|NOT COMPLETED|Overall Study||0
164568|NCT01537315|401118|P2|COMPLETED|Overall Study||7
164569|NCT01537315|401119|P1|COMPLETED|Overall Study||1
164570|NCT01537315|401118|P2|STARTED|Overall Study||7
164571|NCT01537315|401119|P1|STARTED|Overall Study||1
164572|NCT01537302|401125|P1|NOT COMPLETED|Overall Study||2
164573|NCT01537302|401125|P1|COMPLETED|Overall Study||199
164574|NCT01537302|401125|P1|STARTED|Overall Study||201
164575|NCT01537211|401134|P2|NOT COMPLETED|Overall Study||1
164576|NCT01537211|401135|P1|NOT COMPLETED|Overall Study||0
164577|NCT01537211|401134|P2|COMPLETED|Overall Study||5
164578|NCT01537211|401135|P1|COMPLETED|Overall Study||4
164579|NCT01537211|401134|P2|STARTED|Overall Study||6
164580|NCT01537211|401135|P1|STARTED|Overall Study||4
164581|NCT01537198|401169|P1|NOT COMPLETED|Overall Study||154
164582|NCT01537198|401169|P1|COMPLETED|Overall Study||463
164583|NCT01537198|401169|P1|STARTED|Overall Study||617
164584|NCT01537185|401177|P4|NOT COMPLETED|Overall Study||2
164585|NCT01537185|401178|P3|NOT COMPLETED|Overall Study||6
164586|NCT01537185|401179|P2|NOT COMPLETED|Overall Study||6
164587|NCT01537185|401180|P1|NOT COMPLETED|Overall Study||3
164588|NCT01537185|401177|P4|COMPLETED|Overall Study||8
164589|NCT01537185|401178|P3|COMPLETED|Overall Study||4
164590|NCT01537185|401179|P2|COMPLETED|Overall Study||6
164591|NCT01537185|401180|P1|COMPLETED|Overall Study||7
164592|NCT01537185|401177|P4|STARTED|Overall Study||10
164593|NCT01537185|401178|P3|STARTED|Overall Study||10
164594|NCT01537185|401179|P2|STARTED|Overall Study||12
164595|NCT01537185|401180|P1|STARTED|Overall Study||10
164596|NCT01537133|401198|P4|NOT COMPLETED|Overall Study||0
164597|NCT01537133|401199|P3|NOT COMPLETED|Overall Study||0
164598|NCT01537133|401200|P2|NOT COMPLETED|Overall Study||0
164599|NCT01537133|401201|P1|NOT COMPLETED|Overall Study||3
164600|NCT01537133|401198|P4|COMPLETED|Overall Study||21
164601|NCT01537133|401199|P3|COMPLETED|Overall Study||21
164602|NCT01537133|401200|P2|COMPLETED|Overall Study||14
164603|NCT01537133|401201|P1|COMPLETED|Overall Study||25
164604|NCT01537133|401198|P4|STARTED|Overall Study||21
164605|NCT01537133|401199|P3|STARTED|Overall Study||21
164606|NCT01537133|401200|P2|STARTED|Overall Study||14
164607|NCT01537133|401201|P1|STARTED|Overall Study||28
164608|NCT01537120|401217|P1|NOT COMPLETED|12 Weeks Vildagliptin||0
164609|NCT01537120|401217|P1|COMPLETED|12 Weeks Vildagliptin||23
164610|NCT01537120|401217|P1|STARTED|12 Weeks Vildagliptin||23
164611|NCT01537120|401217|P1|NOT COMPLETED|3 Weeks Placebo||1
164612|NCT01537120|401217|P1|COMPLETED|3 Weeks Placebo||23
164613|NCT01537120|401217|P1|STARTED|3 Weeks Placebo||24
164614|NCT01537120|401217|P1|NOT COMPLETED|8 Weeks Washout||1
164615|NCT01537120|401217|P1|COMPLETED|8 Weeks Washout||24
164616|NCT01537120|401217|P1|STARTED|8 Weeks Washout||25
164617|NCT01537120|401217|P1|NOT COMPLETED|Enrolled||0
164618|NCT01537120|401217|P1|COMPLETED|Enrolled||25
164619|NCT01537120|401217|P1|STARTED|Enrolled||25
164620|NCT01537081|401230|P3|NOT COMPLETED|Overall Study||16
164621|NCT01537081|401231|P2|NOT COMPLETED|Overall Study||38
164622|NCT01537081|401232|P1|NOT COMPLETED|Overall Study||39
164623|NCT01537081|401230|P3|COMPLETED|Overall Study||547
164624|NCT01537081|401231|P2|COMPLETED|Overall Study||1086
164625|NCT01537081|401232|P1|COMPLETED|Overall Study||1084
164626|NCT01537081|401230|P3|Modified Intent to Treat Population|Overall Study||556
164627|NCT01537081|401231|P2|Modified Intent to Treat Population|Overall Study||1109
164628|NCT01537081|401232|P1|Modified Intent to Treat Population|Overall Study||1106
164629|NCT01537081|401230|P3|Safety Population|Overall Study||561
164630|NCT01537081|401231|P2|Safety Population|Overall Study||1122
164631|NCT01537081|401232|P1|Safety Population|Overall Study||1122
164632|NCT01537081|401230|P3|STARTED|Overall Study||563
164633|NCT01537081|401231|P2|STARTED|Overall Study||1124
164634|NCT01537081|401232|P1|STARTED|Overall Study||1123
164635|NCT01537068|401245|P2|NOT COMPLETED|Overall Study||3
164636|NCT01537068|401246|P1|NOT COMPLETED|Overall Study||4
164637|NCT01537068|401245|P2|COMPLETED|Overall Study||26
164638|NCT01537068|401246|P1|COMPLETED|Overall Study||26
164639|NCT01537068|401245|P2|STARTED|Overall Study||29
164640|NCT01537068|401246|P1|STARTED|Overall Study||30
164641|NCT01537042|401258|P2|NOT COMPLETED|Overall Study||5
164642|NCT01537042|401259|P1|NOT COMPLETED|Overall Study||0
164643|NCT01537042|401258|P2|COMPLETED|Overall Study||15
164644|NCT01537042|401259|P1|COMPLETED|Overall Study||10
164645|NCT01537042|401258|P2|STARTED|Overall Study||20
164646|NCT01537042|401259|P1|STARTED|Overall Study||10
164647|NCT01537029|401295|P1|NOT COMPLETED|Overall Study||0
164648|NCT01537029|401295|P1|COMPLETED|Overall Study||15
164649|NCT01537029|401295|P1|STARTED|Overall Study||15
164650|NCT01536951|401301|P9|NOT COMPLETED|Third Intervention||0
164651|NCT01536951|401302|P8|NOT COMPLETED|Third Intervention||0
164652|NCT01536951|401303|P7|NOT COMPLETED|Third Intervention||0
164653|NCT01536951|401304|P6|NOT COMPLETED|Third Intervention||0
164654|NCT01536951|401305|P5|NOT COMPLETED|Third Intervention||0
164655|NCT01536951|401306|P4|NOT COMPLETED|Third Intervention||0
164656|NCT01536951|401307|P3|NOT COMPLETED|Third Intervention||0
164657|NCT01536951|401308|P2|NOT COMPLETED|Third Intervention||0
164658|NCT01536951|401309|P1|NOT COMPLETED|Third Intervention||0
164659|NCT01536951|401301|P9|COMPLETED|Third Intervention||9
164660|NCT01536951|401302|P8|COMPLETED|Third Intervention||8
164661|NCT01536951|401303|P7|COMPLETED|Third Intervention||9
164662|NCT01536951|401304|P6|COMPLETED|Third Intervention||9
164663|NCT01536951|401305|P5|COMPLETED|Third Intervention||9
164664|NCT01536951|401306|P4|COMPLETED|Third Intervention||8
164665|NCT01536951|401307|P3|COMPLETED|Third Intervention||2
164666|NCT01536951|401308|P2|COMPLETED|Third Intervention||3
164667|NCT01536951|401309|P1|COMPLETED|Third Intervention||3
164668|NCT01536951|401301|P9|STARTED|Third Intervention||9
164669|NCT01536951|401302|P8|STARTED|Third Intervention||8
164670|NCT01536951|401303|P7|STARTED|Third Intervention||9
164671|NCT01536951|401304|P6|STARTED|Third Intervention||9
164672|NCT01536951|401305|P5|STARTED|Third Intervention||9
164673|NCT01536951|401306|P4|STARTED|Third Intervention||8
164674|NCT01536951|401307|P3|STARTED|Third Intervention||2
164675|NCT01536951|401308|P2|STARTED|Third Intervention||3
164676|NCT01536951|401309|P1|STARTED|Third Intervention||3
164677|NCT01536951|401301|P9|NOT COMPLETED|Second Intervention and Washout Period 2||0
164678|NCT01536951|401302|P8|NOT COMPLETED|Second Intervention and Washout Period 2||1
164679|NCT01536951|401303|P7|NOT COMPLETED|Second Intervention and Washout Period 2||0
164680|NCT01536951|401304|P6|NOT COMPLETED|Second Intervention and Washout Period 2||0
164681|NCT01536951|401305|P5|NOT COMPLETED|Second Intervention and Washout Period 2||0
164682|NCT01536951|401306|P4|NOT COMPLETED|Second Intervention and Washout Period 2||0
164683|NCT01536951|401307|P3|NOT COMPLETED|Second Intervention and Washout Period 2||0
164684|NCT01536951|401308|P2|NOT COMPLETED|Second Intervention and Washout Period 2||0
164685|NCT01536951|401309|P1|NOT COMPLETED|Second Intervention and Washout Period 2||0
164686|NCT01536951|401301|P9|COMPLETED|Second Intervention and Washout Period 2||9
164687|NCT01536951|401302|P8|COMPLETED|Second Intervention and Washout Period 2||8
164688|NCT01536951|401303|P7|COMPLETED|Second Intervention and Washout Period 2||9
164689|NCT01536951|401304|P6|COMPLETED|Second Intervention and Washout Period 2||9
164690|NCT01536951|401305|P5|COMPLETED|Second Intervention and Washout Period 2||9
164691|NCT01536951|401306|P4|COMPLETED|Second Intervention and Washout Period 2||8
164692|NCT01536951|401307|P3|COMPLETED|Second Intervention and Washout Period 2||2
164693|NCT01536951|401308|P2|COMPLETED|Second Intervention and Washout Period 2||3
164694|NCT01536951|401309|P1|COMPLETED|Second Intervention and Washout Period 2||3
164695|NCT01536951|401301|P9|STARTED|Second Intervention and Washout Period 2||9
164696|NCT01536951|401302|P8|STARTED|Second Intervention and Washout Period 2||9
164697|NCT01536951|401303|P7|STARTED|Second Intervention and Washout Period 2||9
164698|NCT01536951|401304|P6|STARTED|Second Intervention and Washout Period 2||9
164699|NCT01536951|401305|P5|STARTED|Second Intervention and Washout Period 2||9
164700|NCT01536951|401306|P4|STARTED|Second Intervention and Washout Period 2||8
164701|NCT01536951|401307|P3|STARTED|Second Intervention and Washout Period 2||2
164702|NCT01536951|401308|P2|STARTED|Second Intervention and Washout Period 2||3
164703|NCT01536951|401309|P1|STARTED|Second Intervention and Washout Period 2||3
164704|NCT01536951|401301|P9|NOT COMPLETED|First Intervention and Washout Period 1||0
164705|NCT01536951|401302|P8|NOT COMPLETED|First Intervention and Washout Period 1||0
164706|NCT01536951|401303|P7|NOT COMPLETED|First Intervention and Washout Period 1||0
164707|NCT01536951|401304|P6|NOT COMPLETED|First Intervention and Washout Period 1||0
164708|NCT01536951|401305|P5|NOT COMPLETED|First Intervention and Washout Period 1||0
164709|NCT01536951|401306|P4|NOT COMPLETED|First Intervention and Washout Period 1||0
164710|NCT01536951|401307|P3|NOT COMPLETED|First Intervention and Washout Period 1||1
164711|NCT01536951|401308|P2|NOT COMPLETED|First Intervention and Washout Period 1||0
164712|NCT01536951|401309|P1|NOT COMPLETED|First Intervention and Washout Period 1||0
164713|NCT01536951|401301|P9|COMPLETED|First Intervention and Washout Period 1||9
164794|NCT01536860|401366|P3|STARTED|Washout Period (3 Days)||4
164714|NCT01536951|401302|P8|COMPLETED|First Intervention and Washout Period 1||9
164715|NCT01536951|401303|P7|COMPLETED|First Intervention and Washout Period 1||9
164716|NCT01536951|401304|P6|COMPLETED|First Intervention and Washout Period 1||9
164717|NCT01536951|401305|P5|COMPLETED|First Intervention and Washout Period 1||9
164718|NCT01536951|401306|P4|COMPLETED|First Intervention and Washout Period 1||8
164719|NCT01536951|401307|P3|COMPLETED|First Intervention and Washout Period 1||2
164720|NCT01536951|401308|P2|COMPLETED|First Intervention and Washout Period 1||3
164721|NCT01536951|401309|P1|COMPLETED|First Intervention and Washout Period 1||3
164722|NCT01536951|401301|P9|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
164723|NCT01536951|401302|P8|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
164724|NCT01536951|401303|P7|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
164725|NCT01536951|401304|P6|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
164726|NCT01536951|401305|P5|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
164727|NCT01536951|401306|P4|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||8
164728|NCT01536951|401307|P3|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
164729|NCT01536951|401308|P2|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
164730|NCT01536951|401309|P1|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1|Across all reporting groups, study drug is LY3009104, moxifloxacin, or placebo.|3
164731|NCT01536951|401301|P9|STARTED|First Intervention and Washout Period 1||9
164732|NCT01536951|401302|P8|STARTED|First Intervention and Washout Period 1||9
164733|NCT01536951|401303|P7|STARTED|First Intervention and Washout Period 1||9
164734|NCT01536951|401304|P6|STARTED|First Intervention and Washout Period 1||9
164735|NCT01536951|401305|P5|STARTED|First Intervention and Washout Period 1||9
164736|NCT01536951|401306|P4|STARTED|First Intervention and Washout Period 1||8
164737|NCT01536951|401307|P3|STARTED|First Intervention and Washout Period 1||3
164738|NCT01536951|401308|P2|STARTED|First Intervention and Washout Period 1||3
164739|NCT01536951|401309|P1|STARTED|First Intervention and Washout Period 1||3
164740|NCT01536938|401339|P3|NOT COMPLETED|Overall Study||8
164741|NCT01536938|401340|P2|NOT COMPLETED|Overall Study||7
164742|NCT01536938|401341|P1|NOT COMPLETED|Overall Study||6
164743|NCT01536938|401339|P3|COMPLETED|Overall Study||93
164744|NCT01536938|401340|P2|COMPLETED|Overall Study||94
164745|NCT01536938|401341|P1|COMPLETED|Overall Study||94
164746|NCT01536938|401339|P3|STARTED|Overall Study||101
164747|NCT01536938|401340|P2|STARTED|Overall Study||101
164748|NCT01536938|401341|P1|STARTED|Overall Study||100
164749|NCT01536886|401353|P4|NOT COMPLETED|Overall Study||3
164750|NCT01536886|401354|P3|NOT COMPLETED|Overall Study||2
164751|NCT01536886|401355|P2|NOT COMPLETED|Overall Study||8
164752|NCT01536886|401356|P1|NOT COMPLETED|Overall Study||5
164753|NCT01536886|401353|P4|COMPLETED|Overall Study||48
164754|NCT01536886|401354|P3|COMPLETED|Overall Study||47
164755|NCT01536886|401355|P2|COMPLETED|Overall Study||127
164756|NCT01536886|401356|P1|COMPLETED|Overall Study||136
164757|NCT01536886|401353|P4|STARTED|Overall Study||51
164758|NCT01536886|401354|P3|STARTED|Overall Study||49
164759|NCT01536886|401355|P2|STARTED|Overall Study||135
164760|NCT01536886|401356|P1|STARTED|Overall Study||141
164761|NCT01536860|401366|P3|NOT COMPLETED|Third Intervention (1 Day)||0
164762|NCT01536860|401367|P2|NOT COMPLETED|Third Intervention (1 Day)||0
164763|NCT01536860|401368|P1|NOT COMPLETED|Third Intervention (1 Day)||0
164764|NCT01536860|401366|P3|COMPLETED|Third Intervention (1 Day)||4
164765|NCT01536860|401367|P2|COMPLETED|Third Intervention (1 Day)||4
164766|NCT01536860|401368|P1|COMPLETED|Third Intervention (1 Day)||3
164767|NCT01536860|401366|P3|STARTED|Third Intervention (1 Day)||4
164768|NCT01536860|401367|P2|STARTED|Third Intervention (1 Day)||4
164769|NCT01536860|401368|P1|STARTED|Third Intervention (1 Day)||3
164770|NCT01536860|401366|P3|NOT COMPLETED|Washout Period (3 Days)||0
164771|NCT01536860|401367|P2|NOT COMPLETED|Washout Period (3 Days)||0
164772|NCT01536860|401368|P1|NOT COMPLETED|Washout Period (3 Days)||1
164773|NCT01536860|401366|P3|COMPLETED|Washout Period (3 Days)||4
164774|NCT01536860|401367|P2|COMPLETED|Washout Period (3 Days)||4
164775|NCT01536860|401368|P1|COMPLETED|Washout Period (3 Days)||3
164776|NCT01536860|401366|P3|STARTED|Washout Period (3 Days)||4
164777|NCT01536860|401367|P2|STARTED|Washout Period (3 Days)||4
164778|NCT01536860|401368|P1|STARTED|Washout Period (3 Days)||4
164779|NCT01536860|401366|P3|NOT COMPLETED|Second Intervention (1 Day)||0
164780|NCT01536860|401367|P2|NOT COMPLETED|Second Intervention (1 Day)||0
164781|NCT01536860|401368|P1|NOT COMPLETED|Second Intervention (1 Day)||0
164782|NCT01536860|401366|P3|COMPLETED|Second Intervention (1 Day)||4
164783|NCT01536860|401367|P2|COMPLETED|Second Intervention (1 Day)||4
164784|NCT01536860|401368|P1|COMPLETED|Second Intervention (1 Day)||4
164785|NCT01536860|401366|P3|STARTED|Second Intervention (1 Day)||4
164786|NCT01536860|401367|P2|STARTED|Second Intervention (1 Day)||4
164787|NCT01536860|401368|P1|STARTED|Second Intervention (1 Day)||4
164788|NCT01536860|401366|P3|NOT COMPLETED|Washout Period (3 Days)||0
164789|NCT01536860|401367|P2|NOT COMPLETED|Washout Period (3 Days)||0
164790|NCT01536860|401368|P1|NOT COMPLETED|Washout Period (3 Days)||0
164791|NCT01536860|401366|P3|COMPLETED|Washout Period (3 Days)||4
164792|NCT01536860|401367|P2|COMPLETED|Washout Period (3 Days)||4
164793|NCT01536860|401368|P1|COMPLETED|Washout Period (3 Days)||4
164795|NCT01536860|401367|P2|STARTED|Washout Period (3 Days)||4
164796|NCT01536860|401368|P1|STARTED|Washout Period (3 Days)||4
164797|NCT01536860|401366|P3|NOT COMPLETED|First Intervention (1 Day)||0
164798|NCT01536860|401367|P2|NOT COMPLETED|First Intervention (1 Day)||0
164799|NCT01536860|401368|P1|NOT COMPLETED|First Intervention (1 Day)||0
164800|NCT01536860|401366|P3|COMPLETED|First Intervention (1 Day)||4
164801|NCT01536860|401367|P2|COMPLETED|First Intervention (1 Day)||4
164802|NCT01536860|401368|P1|COMPLETED|First Intervention (1 Day)||4
164803|NCT01536860|401366|P3|STARTED|First Intervention (1 Day)||4
164804|NCT01536860|401367|P2|STARTED|First Intervention (1 Day)||4
164805|NCT01536860|401368|P1|STARTED|First Intervention (1 Day)||4
164806|NCT01536704|401376|P4|NOT COMPLETED|Period 4||0
164807|NCT01536704|401377|P3|NOT COMPLETED|Period 4||0
164808|NCT01536704|401378|P2|NOT COMPLETED|Period 4||0
164809|NCT01536704|401379|P1|NOT COMPLETED|Period 4||0
164810|NCT01536704|401376|P4|COMPLETED|Period 4||10
164811|NCT01536704|401377|P3|COMPLETED|Period 4||10
164812|NCT01536704|401378|P2|COMPLETED|Period 4||11
164813|NCT01536704|401379|P1|COMPLETED|Period 4||12
164814|NCT01536704|401376|P4|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
164815|NCT01536704|401377|P3|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
164816|NCT01536704|401378|P2|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
164817|NCT01536704|401379|P1|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|12
164818|NCT01536704|401376|P4|NOT COMPLETED|Washout Period 3||0
164819|NCT01536704|401377|P3|NOT COMPLETED|Washout Period 3||1
164820|NCT01536704|401378|P2|NOT COMPLETED|Washout Period 3||0
164821|NCT01536704|401379|P1|NOT COMPLETED|Washout Period 3||0
164822|NCT01536704|401376|P4|COMPLETED|Washout Period 3||10
164823|NCT01536704|401377|P3|COMPLETED|Washout Period 3||11
164824|NCT01536704|401378|P2|COMPLETED|Washout Period 3||12
164825|NCT01536704|401379|P1|COMPLETED|Washout Period 3||10
164826|NCT01536704|401376|P4|STARTED|Washout Period 3||10
164827|NCT01536704|401377|P3|STARTED|Washout Period 3||12
164828|NCT01536704|401378|P2|STARTED|Washout Period 3||12
164829|NCT01536704|401379|P1|STARTED|Washout Period 3||10
164830|NCT01536704|401376|P4|NOT COMPLETED|Period 3||1
164831|NCT01536704|401377|P3|NOT COMPLETED|Period 3||0
164832|NCT01536704|401378|P2|NOT COMPLETED|Period 3||0
164833|NCT01536704|401379|P1|NOT COMPLETED|Period 3||0
164834|NCT01536704|401376|P4|COMPLETED|Period 3||10
164835|NCT01536704|401377|P3|COMPLETED|Period 3||12
164836|NCT01536704|401378|P2|COMPLETED|Period 3||12
164837|NCT01536704|401379|P1|COMPLETED|Period 3||10
164838|NCT01536704|401376|P4|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|11
164839|NCT01536704|401377|P3|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
164840|NCT01536704|401378|P2|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
164841|NCT01536704|401379|P1|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|10
164842|NCT01536704|401376|P4|NOT COMPLETED|Washout Period 2||1
164843|NCT01536704|401377|P3|NOT COMPLETED|Washout Period 2||0
164844|NCT01536704|401378|P2|NOT COMPLETED|Washout Period 2||0
164845|NCT01536704|401379|P1|NOT COMPLETED|Washout Period 2||1
164846|NCT01536704|401376|P4|COMPLETED|Washout Period 2||12
164847|NCT01536704|401377|P3|COMPLETED|Washout Period 2||10
164848|NCT01536704|401378|P2|COMPLETED|Washout Period 2||11
164849|NCT01536704|401379|P1|COMPLETED|Washout Period 2||12
164850|NCT01536704|401376|P4|STARTED|Washout Period 2||13
164851|NCT01536704|401377|P3|STARTED|Washout Period 2||10
164852|NCT01536704|401378|P2|STARTED|Washout Period 2||11
164853|NCT01536704|401379|P1|STARTED|Washout Period 2||13
164854|NCT01536704|401376|P4|NOT COMPLETED|Period 2||0
164855|NCT01536704|401377|P3|NOT COMPLETED|Period 2||0
164856|NCT01536704|401378|P2|NOT COMPLETED|Period 2||0
164857|NCT01536704|401379|P1|NOT COMPLETED|Period 2||0
164858|NCT01536704|401376|P4|COMPLETED|Period 2||13
164859|NCT01536704|401377|P3|COMPLETED|Period 2||10
164860|NCT01536704|401378|P2|COMPLETED|Period 2||11
164861|NCT01536704|401379|P1|COMPLETED|Period 2||13
164862|NCT01536704|401376|P4|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
164863|NCT01536704|401377|P3|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|10
164864|NCT01536704|401378|P2|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
164865|NCT01536704|401379|P1|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
164866|NCT01536704|401376|P4|NOT COMPLETED|Washout Period 1||0
164867|NCT01536704|401377|P3|NOT COMPLETED|Washout Period 1||0
164868|NCT01536704|401378|P2|NOT COMPLETED|Washout Period 1||2
164869|NCT01536704|401379|P1|NOT COMPLETED|Washout Period 1||1
164870|NCT01536704|401376|P4|COMPLETED|Washout Period 1||13
164871|NCT01536704|401377|P3|COMPLETED|Washout Period 1||13
164872|NCT01536704|401378|P2|COMPLETED|Washout Period 1||10
164873|NCT01536704|401379|P1|COMPLETED|Washout Period 1||11
164874|NCT01536704|401376|P4|STARTED|Washout Period 1||13
164875|NCT01536704|401377|P3|STARTED|Washout Period 1||13
164876|NCT01536704|401378|P2|STARTED|Washout Period 1||12
164877|NCT01536704|401379|P1|STARTED|Washout Period 1||12
164878|NCT01536704|401376|P4|NOT COMPLETED|Period 1||0
164879|NCT01536704|401377|P3|NOT COMPLETED|Period 1||0
164880|NCT01536704|401378|P2|NOT COMPLETED|Period 1||0
164881|NCT01536704|401379|P1|NOT COMPLETED|Period 1||0
164882|NCT01536704|401376|P4|COMPLETED|Period 1||13
164883|NCT01536704|401377|P3|COMPLETED|Period 1||13
164884|NCT01536704|401378|P2|COMPLETED|Period 1||12
164885|NCT01536704|401379|P1|COMPLETED|Period 1||12
164886|NCT01536704|401376|P4|STARTED|Period 1||13
164887|NCT01536704|401377|P3|STARTED|Period 1||13
164888|NCT01536704|401378|P2|STARTED|Period 1||12
164889|NCT01536704|401379|P1|STARTED|Period 1||12
164890|NCT01536587|401409|P1|NOT COMPLETED|Overall Study||2
164891|NCT01536587|401409|P1|COMPLETED|Overall Study||30
164892|NCT01536587|401409|P1|STARTED|Overall Study||32
164893|NCT01536574|401448|P2|NOT COMPLETED|Overall Study||7
164894|NCT01536574|401449|P1|NOT COMPLETED|Overall Study||6
164895|NCT01536574|401448|P2|COMPLETED|Overall Study||126
164896|NCT01536574|401449|P1|COMPLETED|Overall Study||156
164897|NCT01536574|401448|P2|STARTED|Overall Study||133
164898|NCT01536574|401449|P1|STARTED|Overall Study||162
164899|NCT01536561|401467|P1|NOT COMPLETED|Long-Term Follow-Up||0
164900|NCT01536561|401467|P1|COMPLETED|Long-Term Follow-Up||13
164901|NCT01536561|401467|P1|STARTED|Long-Term Follow-Up||13
164902|NCT01536561|401467|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||59
164903|NCT01536561|401467|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
164904|NCT01536561|401467|P1|STARTED|Dosimetric and Therapeutic Treatment||59
164905|NCT01536535|401507|P2|NOT COMPLETED|Overall Study||13
164906|NCT01536535|401508|P1|NOT COMPLETED|Overall Study||15
164907|NCT01536535|401507|P2|COMPLETED|Overall Study|Patients either completed week 52 visit or had early colectomy or had additional therapy.|237
164908|NCT01536535|401508|P1|COMPLETED|Overall Study|Patients either completed week 52 visit or had early colectomy or had additional therapy.|163
164909|NCT01536535|401507|P2|STARTED|Overall Study||250
164910|NCT01536535|401508|P1|STARTED|Overall Study||178
164911|NCT01536496|401520|P2|NOT COMPLETED|Overall Study||1
164912|NCT01536496|401521|P1|NOT COMPLETED|Overall Study||2
164913|NCT01536496|401520|P2|COMPLETED|Overall Study||56
164914|NCT01536496|401521|P1|COMPLETED|Overall Study||55
164915|NCT01536496|401520|P2|STARTED|Overall Study||57
164916|NCT01536496|401521|P1|STARTED|Overall Study||57
164917|NCT01536418|401557|P2|NOT COMPLETED|Overall Study||66
164918|NCT01536418|401558|P1|NOT COMPLETED|Overall Study||69
164919|NCT01536418|401557|P2|COMPLETED|Overall Study||60
164920|NCT01536418|401558|P1|COMPLETED|Overall Study||58
164921|NCT01536418|401557|P2|STARTED|Overall Study||126
164922|NCT01536418|401558|P1|STARTED|Overall Study||127
164923|NCT01536405|401578|P2|NOT COMPLETED|Visit 4 to Extended Study Follow-up||23
164924|NCT01536405|401579|P1|NOT COMPLETED|Visit 4 to Extended Study Follow-up||20
164925|NCT01536405|401578|P2|COMPLETED|Visit 4 to Extended Study Follow-up||595
164926|NCT01536405|401579|P1|COMPLETED|Visit 4 to Extended Study Follow-up||595
164927|NCT01536405|401578|P2|STARTED|Visit 4 to Extended Study Follow-up||618
164928|NCT01536405|401579|P1|STARTED|Visit 4 to Extended Study Follow-up||615
164929|NCT01536405|401578|P2|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||16
164930|NCT01536405|401579|P1|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||20
164931|NCT01536405|401578|P2|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||618
164932|NCT01536405|401579|P1|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||615
164933|NCT01536405|401578|P2|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||632
164934|NCT01536405|401579|P1|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||634
164935|NCT01536405|401578|P2|STARTED|Visit 3 (Vaccination 2) to Visit 4||634
164936|NCT01536405|401579|P1|STARTED|Visit 3 (Vaccination 2) to Visit 4||635
164937|NCT01536405|401578|P2|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||28
164938|NCT01536405|401579|P1|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||31
164939|NCT01536405|401578|P2|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||634
164940|NCT01536405|401579|P1|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||635
164941|NCT01536405|401578|P2|STARTED|Visit 2 to Visit 3 (Vaccination 2)||662
164942|NCT01536405|401579|P1|STARTED|Visit 2 to Visit 3 (Vaccination 2)||666
164943|NCT01536405|401578|P2|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||40
164944|NCT01536405|401579|P1|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||32
164945|NCT01536405|401578|P2|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||662
164946|NCT01536405|401579|P1|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||666
164947|NCT01536405|401578|P2|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||702
164948|NCT01536405|401579|P1|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||698
164949|NCT01536405|401578|P2|STARTED|Visit 1 (Vaccination 1) to Visit 2||702
164950|NCT01536405|401579|P1|STARTED|Visit 1 (Vaccination 1) to Visit 2||698
164951|NCT01536405|401578|P2|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||4
164952|NCT01536405|401579|P1|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||8
164953|NCT01536405|401578|P2|COMPLETED|Randomization to Visit 1 (Vaccination 1)||702
164954|NCT01536405|401579|P1|COMPLETED|Randomization to Visit 1 (Vaccination 1)||698
164955|NCT01536405|401578|P2|STARTED|Randomization to Visit 1 (Vaccination 1)||706
164956|NCT01536405|401579|P1|STARTED|Randomization to Visit 1 (Vaccination 1)||706
164957|NCT01536379|401617|P2|NOT COMPLETED|Overall Study||3
164958|NCT01536379|401618|P1|NOT COMPLETED|Overall Study||2
164959|NCT01536379|401617|P2|COMPLETED|Overall Study||9
164960|NCT01536379|401618|P1|COMPLETED|Overall Study||11
164961|NCT01536379|401617|P2|STARTED|Overall Study||12
164962|NCT01536379|401618|P1|STARTED|Overall Study||13
164963|NCT01536366|401694|P2|NOT COMPLETED|Overall Study||4
164964|NCT01536366|401695|P1|NOT COMPLETED|Overall Study||13
164965|NCT01536366|401694|P2|COMPLETED|Overall Study||9
164966|NCT01536366|401695|P1|COMPLETED|Overall Study||1
164967|NCT01536366|401694|P2|Follow-up|Overall Study||9
164968|NCT01536366|401695|P1|Follow-up|Overall Study||13
164969|NCT01536366|401694|P2|Repaglinide|Overall Study||13
164970|NCT01536366|401695|P1|Repaglinide|Overall Study||14
164971|NCT01536366|401694|P2|BIA 9-1067 + Repaglinide|Overall Study||10
164972|NCT01536366|401695|P1|BIA 9-1067 + Repaglinide|Overall Study||14
164973|NCT01536366|401694|P2|STARTED|Overall Study||13
164974|NCT01536366|401695|P1|STARTED|Overall Study||14
164975|NCT01536262|401710|P3|NOT COMPLETED|Overall Study||2
164976|NCT01536262|401711|P2|NOT COMPLETED|Overall Study||2
164977|NCT01536262|401712|P1|NOT COMPLETED|Overall Study||8
164978|NCT01536262|401710|P3|COMPLETED|Overall Study||39
164979|NCT01536262|401711|P2|COMPLETED|Overall Study||38
164980|NCT01536262|401712|P1|COMPLETED|Overall Study||33
164981|NCT01536262|401710|P3|STARTED|Overall Study||41
164982|NCT01536262|401711|P2|STARTED|Overall Study||40
164983|NCT01536262|401712|P1|STARTED|Overall Study||41
164984|NCT01536197|401728|P2|NOT COMPLETED|Overall Study||0
164985|NCT01536197|401729|P1|NOT COMPLETED|Overall Study||0
164986|NCT01536197|401728|P2|COMPLETED|Overall Study||10
164987|NCT01536197|401729|P1|COMPLETED|Overall Study||23
164988|NCT01536197|401728|P2|STARTED|Overall Study||10
164989|NCT01536197|401729|P1|STARTED|Overall Study||23
164990|NCT01536184|401739|P2|NOT COMPLETED|Overall Study||0
164991|NCT01536184|401740|P1|NOT COMPLETED|Overall Study||0
164992|NCT01536184|401739|P2|COMPLETED|Overall Study||4
164993|NCT01536184|401740|P1|COMPLETED|Overall Study||8
164994|NCT01536184|401739|P2|STARTED|Overall Study||4
164995|NCT01536184|401740|P1|STARTED|Overall Study||8
164996|NCT01536171|401754|P1|NOT COMPLETED|Overall Study||1
164997|NCT01536171|401754|P1|COMPLETED|Overall Study||21
164998|NCT01536171|401754|P1|STARTED|Overall Study||22
164999|NCT01536145|401759|P11|NOT COMPLETED|Overall Study||10
165000|NCT01536145|401760|P10|NOT COMPLETED|Overall Study||6
165001|NCT01536145|401761|P9|NOT COMPLETED|Overall Study||3
165002|NCT01536145|401762|P8|NOT COMPLETED|Overall Study||4
165003|NCT01536145|401763|P7|NOT COMPLETED|Overall Study||2
165004|NCT01536145|401764|P6|NOT COMPLETED|Overall Study||3
165005|NCT01536145|401765|P5|NOT COMPLETED|Overall Study||2
165006|NCT01536145|401766|P4|NOT COMPLETED|Overall Study||2
165007|NCT01536145|401767|P3|NOT COMPLETED|Overall Study||2
165008|NCT01536145|401768|P2|NOT COMPLETED|Overall Study||4
165009|NCT01536145|401769|P1|NOT COMPLETED|Overall Study||3
165010|NCT01536145|401759|P11|COMPLETED|Overall Study||0
165011|NCT01536145|401760|P10|COMPLETED|Overall Study||1
165012|NCT01536145|401761|P9|COMPLETED|Overall Study||0
165013|NCT01536145|401762|P8|COMPLETED|Overall Study||0
165014|NCT01536145|401763|P7|COMPLETED|Overall Study||1
165015|NCT01536145|401764|P6|COMPLETED|Overall Study||0
165016|NCT01536145|401765|P5|COMPLETED|Overall Study||2
165017|NCT01536145|401766|P4|COMPLETED|Overall Study||1
165018|NCT01536145|401767|P3|COMPLETED|Overall Study||1
165019|NCT01536145|401768|P2|COMPLETED|Overall Study||0
165020|NCT01536145|401769|P1|COMPLETED|Overall Study||0
165021|NCT01536145|401759|P11|STARTED|Overall Study||10
165022|NCT01536145|401760|P10|STARTED|Overall Study||7
165023|NCT01536145|401761|P9|STARTED|Overall Study||3
165024|NCT01536145|401762|P8|STARTED|Overall Study||4
165025|NCT01536145|401763|P7|STARTED|Overall Study||3
165026|NCT01536145|401764|P6|STARTED|Overall Study||3
165027|NCT01536145|401765|P5|STARTED|Overall Study||4
165028|NCT01536145|401766|P4|STARTED|Overall Study||3
165029|NCT01536145|401767|P3|STARTED|Overall Study||3
165030|NCT01536145|401768|P2|STARTED|Overall Study||4
165031|NCT01536145|401769|P1|STARTED|Overall Study||3
165032|NCT01536119|401876|P2|NOT COMPLETED|Overall Study||14
165033|NCT01536119|401877|P1|NOT COMPLETED|Overall Study||17
165034|NCT01536119|401876|P2|COMPLETED|Overall Study|105 mothers + 95 fathers = 200 participants 2 mothers + 12 fathers = 14 did not complete the study|200
165035|NCT01536119|401877|P1|COMPLETED|Overall Study|104 Mothers + 93 fathers = 197 participants 3 mothers + 14 fathers = 17 did not complete the study|197
165036|NCT01536119|401876|P2|STARTED|Overall Study|(107*2=214) (107 mothers and 107 fathers)|214
165037|NCT01536119|401877|P1|STARTED|Overall Study|(107*2= 214) (107 mothers and 107 fathers)|214
165038|NCT01536093|401903|P2|NOT COMPLETED|Overall Study||3
165039|NCT01536093|401904|P1|NOT COMPLETED|Overall Study||3
165040|NCT01536093|401903|P2|COMPLETED|Overall Study||21
165041|NCT01536093|401904|P1|COMPLETED|Overall Study||21
165042|NCT01536093|401903|P2|STARTED|Overall Study||24
165043|NCT01536093|401904|P1|STARTED|Overall Study||24
165044|NCT01536067|401920|P1|NOT COMPLETED|Overall Study||1
165045|NCT01536067|401920|P1|COMPLETED|Overall Study||2
165046|NCT01536067|401920|P1|STARTED|Overall Study||3
165047|NCT01536015|401933|P2|NOT COMPLETED|Overall Study||10
165048|NCT01536015|401934|P1|NOT COMPLETED|Overall Study||8
165049|NCT01536015|401933|P2|COMPLETED|Overall Study||3
165050|NCT01536015|401934|P1|COMPLETED|Overall Study||4
165051|NCT01536015|401933|P2|STARTED|Overall Study||13
165052|NCT01536015|401934|P1|STARTED|Overall Study||12
165053|NCT01535976|401952|P2|NOT COMPLETED|Overall Study||1
165054|NCT01535976|401953|P1|NOT COMPLETED|Overall Study||1
165055|NCT01535976|401952|P2|COMPLETED|Overall Study||26
165056|NCT01535976|401953|P1|COMPLETED|Overall Study||26
165057|NCT01535976|401952|P2|STARTED|Overall Study||27
165058|NCT01535976|401953|P1|STARTED|Overall Study||27
165059|NCT01535937|401961|P2|NOT COMPLETED|Overall Study||0
165060|NCT01535937|401962|P1|NOT COMPLETED|Overall Study||0
165061|NCT01535937|401961|P2|COMPLETED|Overall Study||28
165062|NCT01535937|401962|P1|COMPLETED|Overall Study||27
165063|NCT01535937|401961|P2|STARTED|Overall Study||28
165064|NCT01535937|401962|P1|STARTED|Overall Study||27
165065|NCT01535807|401972|P2|NOT COMPLETED|Overall Study||2
165066|NCT01535807|401973|P1|NOT COMPLETED|Overall Study||2
165067|NCT01535807|401972|P2|COMPLETED|Overall Study||20
165068|NCT01535807|401973|P1|COMPLETED|Overall Study||20
165069|NCT01535807|401972|P2|STARTED|Overall Study||22
165070|NCT01535807|401973|P1|STARTED|Overall Study||22
165071|NCT01535729|401979|P1|NOT COMPLETED|Overall Study||416
165072|NCT01535729|401979|P1|COMPLETED|Overall Study||49
165073|NCT01535729|401979|P1|Treated|Overall Study||385
165074|NCT01535729|401979|P1|STARTED|Overall Study||465
165075|NCT01535664|402006|P1|NOT COMPLETED|Overall Study||0
165076|NCT01535664|402006|P1|COMPLETED|Overall Study||20
165077|NCT01535664|402006|P1|STARTED|Overall Study||20
165078|NCT01535638|402020|P6|NOT COMPLETED|Treatment 3 (Single Dose)||0
165079|NCT01535638|402021|P5|NOT COMPLETED|Treatment 3 (Single Dose)||0
165080|NCT01535638|402022|P4|NOT COMPLETED|Treatment 3 (Single Dose)||1
165081|NCT01535638|402023|P3|NOT COMPLETED|Treatment 3 (Single Dose)||0
165082|NCT01535638|402024|P2|NOT COMPLETED|Treatment 3 (Single Dose)||0
165083|NCT01535638|402025|P1|NOT COMPLETED|Treatment 3 (Single Dose)||0
165084|NCT01535638|402020|P6|COMPLETED|Treatment 3 (Single Dose)||2
165085|NCT01535638|402021|P5|COMPLETED|Treatment 3 (Single Dose)||3
165086|NCT01535638|402022|P4|COMPLETED|Treatment 3 (Single Dose)||2
165087|NCT01535638|402023|P3|COMPLETED|Treatment 3 (Single Dose)||3
165088|NCT01535638|402024|P2|COMPLETED|Treatment 3 (Single Dose)||3
165089|NCT01535638|402025|P1|COMPLETED|Treatment 3 (Single Dose)||3
165090|NCT01535638|402020|P6|STARTED|Treatment 3 (Single Dose)||2
165091|NCT01535638|402021|P5|STARTED|Treatment 3 (Single Dose)||3
165092|NCT01535638|402022|P4|STARTED|Treatment 3 (Single Dose)||3
165093|NCT01535638|402023|P3|STARTED|Treatment 3 (Single Dose)||3
165094|NCT01535638|402024|P2|STARTED|Treatment 3 (Single Dose)||3
165095|NCT01535638|402025|P1|STARTED|Treatment 3 (Single Dose)||3
165096|NCT01535638|402020|P6|NOT COMPLETED|Treatment 2 (Single Dose)||0
165097|NCT01535638|402021|P5|NOT COMPLETED|Treatment 2 (Single Dose)||0
165098|NCT01535638|402022|P4|NOT COMPLETED|Treatment 2 (Single Dose)||0
165099|NCT01535638|402023|P3|NOT COMPLETED|Treatment 2 (Single Dose)||0
165100|NCT01535638|402024|P2|NOT COMPLETED|Treatment 2 (Single Dose)||0
165101|NCT01535638|402025|P1|NOT COMPLETED|Treatment 2 (Single Dose)||0
165102|NCT01535638|402020|P6|COMPLETED|Treatment 2 (Single Dose)||2
165103|NCT01535638|402021|P5|COMPLETED|Treatment 2 (Single Dose)||3
165104|NCT01535638|402022|P4|COMPLETED|Treatment 2 (Single Dose)||3
165105|NCT01535638|402023|P3|COMPLETED|Treatment 2 (Single Dose)||3
165106|NCT01535638|402024|P2|COMPLETED|Treatment 2 (Single Dose)||3
165107|NCT01535638|402025|P1|COMPLETED|Treatment 2 (Single Dose)||3
165108|NCT01535638|402020|P6|STARTED|Treatment 2 (Single Dose)||2
165109|NCT01535638|402021|P5|STARTED|Treatment 2 (Single Dose)||3
165110|NCT01535638|402022|P4|STARTED|Treatment 2 (Single Dose)||3
165111|NCT01535638|402023|P3|STARTED|Treatment 2 (Single Dose)||3
165112|NCT01535638|402024|P2|STARTED|Treatment 2 (Single Dose)||3
165113|NCT01535638|402025|P1|STARTED|Treatment 2 (Single Dose)||3
165114|NCT01535638|402020|P6|NOT COMPLETED|Treatment 1 (Single Dose)||1
165115|NCT01535638|402021|P5|NOT COMPLETED|Treatment 1 (Single Dose)||0
165116|NCT01535638|402022|P4|NOT COMPLETED|Treatment 1 (Single Dose)||0
165117|NCT01535638|402023|P3|NOT COMPLETED|Treatment 1 (Single Dose)||0
165118|NCT01535638|402024|P2|NOT COMPLETED|Treatment 1 (Single Dose)||0
165119|NCT01535638|402025|P1|NOT COMPLETED|Treatment 1 (Single Dose)||0
165120|NCT01535638|402020|P6|COMPLETED|Treatment 1 (Single Dose)||2
165121|NCT01535638|402021|P5|COMPLETED|Treatment 1 (Single Dose)||3
165122|NCT01535638|402022|P4|COMPLETED|Treatment 1 (Single Dose)||3
165123|NCT01535638|402023|P3|COMPLETED|Treatment 1 (Single Dose)||3
165124|NCT01535638|402024|P2|COMPLETED|Treatment 1 (Single Dose)||3
165125|NCT01535638|402025|P1|COMPLETED|Treatment 1 (Single Dose)||3
165126|NCT01535638|402020|P6|STARTED|Treatment 1 (Single Dose)||3
165127|NCT01535638|402021|P5|STARTED|Treatment 1 (Single Dose)||3
165128|NCT01535638|402022|P4|STARTED|Treatment 1 (Single Dose)||3
165129|NCT01535638|402023|P3|STARTED|Treatment 1 (Single Dose)||3
165130|NCT01535638|402024|P2|STARTED|Treatment 1 (Single Dose)||3
165131|NCT01535638|402025|P1|STARTED|Treatment 1 (Single Dose)||3
165132|NCT01535599|402039|P2|NOT COMPLETED|Overall Study||96
165133|NCT01535599|402040|P1|NOT COMPLETED|Overall Study||50
165134|NCT01535599|402039|P2|COMPLETED|Overall Study||250
165135|NCT01535599|402040|P1|COMPLETED|Overall Study||297
165136|NCT01535599|402039|P2|STARTED|Overall Study||346
165137|NCT01535599|402040|P1|STARTED|Overall Study||347
165138|NCT01535560|402052|P2|NOT COMPLETED|Overall Study||96
165139|NCT01535560|402053|P1|NOT COMPLETED|Overall Study||37
165140|NCT01535560|402052|P2|COMPLETED|Overall Study||179
165141|NCT01535560|402053|P1|COMPLETED|Overall Study||237
165142|NCT01535560|402052|P2|STARTED|Overall Study||275
165143|NCT01535560|402053|P1|STARTED|Overall Study||274
165144|NCT01535443|402063|P1|NOT COMPLETED|Overall Study||3
165145|NCT01535443|402063|P1|COMPLETED|Overall Study||32
165146|NCT01535443|402063|P1|STARTED|Overall Study||35
165147|NCT01535365|402080|P2|NOT COMPLETED|Overall Study||0
165148|NCT01535365|402081|P1|NOT COMPLETED|Overall Study||0
165149|NCT01535365|402080|P2|COMPLETED|Overall Study||29
165150|NCT01535365|402081|P1|COMPLETED|Overall Study||31
165151|NCT01535365|402080|P2|STARTED|Overall Study||29
165152|NCT01535365|402081|P1|STARTED|Overall Study||31
165153|NCT01535326|402092|P3|NOT COMPLETED|Overall Study||0
165154|NCT01535326|402093|P2|NOT COMPLETED|Overall Study||0
165155|NCT01535326|402094|P1|NOT COMPLETED|Overall Study||0
165156|NCT01535326|402092|P3|COMPLETED|Overall Study||90
165157|NCT01535326|402093|P2|COMPLETED|Overall Study||90
165158|NCT01535326|402094|P1|COMPLETED|Overall Study||90
165159|NCT01535326|402092|P3|STARTED|Overall Study||90
165160|NCT01535326|402093|P2|STARTED|Overall Study||90
165161|NCT01535326|402094|P1|STARTED|Overall Study||90
165162|NCT01535287|402113|P2|NOT COMPLETED|Overall Study||6
165163|NCT01535287|402114|P1|NOT COMPLETED|Overall Study||5
165164|NCT01535287|402113|P2|COMPLETED|Overall Study||64
165165|NCT01535287|402114|P1|COMPLETED|Overall Study||65
165166|NCT01535287|402113|P2|STARTED|Overall Study||70
165167|NCT01535287|402114|P1|STARTED|Overall Study||70
165168|NCT01535261|402130|P1|NOT COMPLETED|Overall Study||50
165169|NCT01535261|402130|P1|COMPLETED|Overall Study||307
165170|NCT01535261|402130|P1|STARTED|Overall Study||357
165171|NCT01535235|402143|P2|NOT COMPLETED|Overall Study||0
165172|NCT01535235|402144|P1|NOT COMPLETED|Overall Study||1
165173|NCT01535235|402143|P2|COMPLETED|Overall Study||15
165174|NCT01535235|402144|P1|COMPLETED|Overall Study||15
165175|NCT01535235|402143|P2|STARTED|Overall Study||15
165176|NCT01535235|402144|P1|STARTED|Overall Study||16
165177|NCT01535222|402158|P6|NOT COMPLETED|Overall Study||0
165178|NCT01535222|402159|P5|NOT COMPLETED|Overall Study||0
165179|NCT01535222|402160|P4|NOT COMPLETED|Overall Study||0
165180|NCT01535222|402161|P3|NOT COMPLETED|Overall Study||1
165181|NCT01535222|402162|P2|NOT COMPLETED|Overall Study||0
165182|NCT01535222|402163|P1|NOT COMPLETED|Overall Study||0
165183|NCT01535222|402158|P6|COMPLETED|Overall Study||8
165184|NCT01535222|402159|P5|COMPLETED|Overall Study||6
165185|NCT01535222|402160|P4|COMPLETED|Overall Study||6
165186|NCT01535222|402161|P3|COMPLETED|Overall Study||6
165187|NCT01535222|402162|P2|COMPLETED|Overall Study||3
165188|NCT01535222|402163|P1|COMPLETED|Overall Study||3
165189|NCT01535222|402158|P6|STARTED|Overall Study||8
165190|NCT01535222|402159|P5|STARTED|Overall Study||6
165191|NCT01535222|402160|P4|STARTED|Overall Study||6
165192|NCT01535222|402161|P3|STARTED|Overall Study|Patient randomized but did not meet inclusion/exclusion criteria and did not receive study drug|7
165193|NCT01535222|402162|P2|STARTED|Overall Study||3
165194|NCT01535222|402163|P1|STARTED|Overall Study||3
165195|NCT01535118|402183|P1|NOT COMPLETED|Overall Study||0
165196|NCT01535118|402183|P1|COMPLETED|Overall Study||2765
165197|NCT01535118|402183|P1|STARTED|Overall Study||2765
165198|NCT01535053|402194|P2|NOT COMPLETED|Overall Study||2
165199|NCT01535053|402195|P1|NOT COMPLETED|Overall Study||1
165200|NCT01535053|402194|P2|COMPLETED|Overall Study|treated for 3 cycles after hCG <5mIU/ml or until biologic,disease progression, unacceptable toxicity|26
165201|NCT01535053|402195|P1|COMPLETED|Overall Study|treated for 3 cycles after hCG <5mIU/ml or until biologic,disease progression, unacceptable toxicity|28
165202|NCT01535053|402194|P2|STARTED|Overall Study||28
165203|NCT01535053|402195|P1|STARTED|Overall Study||29
165204|NCT01535040|402213|P2|NOT COMPLETED|Overall Study||21
165205|NCT01535040|402214|P1|NOT COMPLETED|Overall Study||30
165206|NCT01535040|402213|P2|COMPLETED|Overall Study||44
165207|NCT01535040|402214|P1|COMPLETED|Overall Study||35
165208|NCT01535040|402213|P2|STARTED|Overall Study||65
165209|NCT01535040|402214|P1|STARTED|Overall Study||65
165210|NCT01535014|402230|P4|NOT COMPLETED|Overall Study||0
165211|NCT01535014|402231|P3|NOT COMPLETED|Overall Study||1
165212|NCT01535014|402232|P2|NOT COMPLETED|Overall Study||6
165213|NCT01535014|402233|P1|NOT COMPLETED|Overall Study||2
165214|NCT01535014|402230|P4|COMPLETED|Overall Study||33
165215|NCT01535014|402231|P3|COMPLETED|Overall Study||49
165216|NCT01535014|402232|P2|COMPLETED|Overall Study||194
165217|NCT01535014|402233|P1|COMPLETED|Overall Study||208
165218|NCT01535014|402230|P4|STARTED|Overall Study||33
165219|NCT01535014|402231|P3|STARTED|Overall Study||50
165220|NCT01535014|402232|P2|STARTED|Overall Study||200
165221|NCT01535014|402233|P1|STARTED|Overall Study||210
165222|NCT01535001|402267|P2|NOT COMPLETED|Overall Study||6
165223|NCT01535001|402268|P1|NOT COMPLETED|Overall Study||3
165224|NCT01535001|402267|P2|COMPLETED|Overall Study||44
165225|NCT01535001|402268|P1|COMPLETED|Overall Study||47
165226|NCT01535001|402267|P2|STARTED|Overall Study||50
165227|NCT01535001|402268|P1|STARTED|Overall Study||50
165228|NCT01534975|402294|P4|NOT COMPLETED|Overall Study||0
165229|NCT01534975|402295|P3|NOT COMPLETED|Overall Study||0
165230|NCT01534975|402296|P2|NOT COMPLETED|Overall Study||0
165231|NCT01534975|402297|P1|NOT COMPLETED|Overall Study||0
165232|NCT01534975|402294|P4|COMPLETED|Overall Study||84
165233|NCT01534975|402295|P3|COMPLETED|Overall Study||160
165234|NCT01534975|402296|P2|COMPLETED|Overall Study||133
165235|NCT01534975|402297|P1|COMPLETED|Overall Study||136
165236|NCT01534975|402294|P4|STARTED|Overall Study||84
165237|NCT01534975|402295|P3|STARTED|Overall Study||160
165238|NCT01534975|402296|P2|STARTED|Overall Study||133
165239|NCT01534975|402297|P1|STARTED|Overall Study||136
165240|NCT01534962|402311|P4|NOT COMPLETED|Overall Study||32
165241|NCT01534962|402312|P3|NOT COMPLETED|Overall Study||24
165242|NCT01534962|402313|P2|NOT COMPLETED|Overall Study||26
165243|NCT01534962|402314|P1|NOT COMPLETED|Overall Study||37
165244|NCT01534962|402311|P4|COMPLETED|Overall Study||24
165245|NCT01534962|402312|P3|COMPLETED|Overall Study||34
165246|NCT01534962|402313|P2|COMPLETED|Overall Study||34
165247|NCT01534962|402314|P1|COMPLETED|Overall Study||30
165248|NCT01534962|402311|P4|STARTED|Overall Study||56
165249|NCT01534962|402312|P3|STARTED|Overall Study||58
165250|NCT01534962|402313|P2|STARTED|Overall Study||60
165251|NCT01534962|402314|P1|STARTED|Overall Study||67
165252|NCT01534910|402346|P2|NOT COMPLETED|Overall Study||4
165253|NCT01534910|402347|P1|NOT COMPLETED|Overall Study||4
165254|NCT01534910|402346|P2|COMPLETED|Overall Study||28
165255|NCT01534910|402347|P1|COMPLETED|Overall Study||29
165256|NCT01534910|402346|P2|STARTED|Overall Study||32
165257|NCT01534910|402347|P1|STARTED|Overall Study||33
165258|NCT01534897|402355|P1|NOT COMPLETED|Overall Study||0
165259|NCT01534897|402355|P1|COMPLETED|Overall Study||10
165260|NCT01534897|402355|P1|Day 37 Iodine-131 Treatment|Overall Study||6
165261|NCT01534897|402355|P1|Day 25 Iodine-131 Scan|Overall Study||10
165262|NCT01534897|402355|P1|STARTED|Overall Study||10
165263|NCT01534689|402363|P1|NOT COMPLETED|Overall Study||0
165264|NCT01534689|402363|P1|COMPLETED|Overall Study||105
165265|NCT01534689|402363|P1|STARTED|Overall Study||105
165266|NCT01534676|402371|P2|NOT COMPLETED|Overall Study||1
165267|NCT01534676|402372|P1|NOT COMPLETED|Overall Study||2
165268|NCT01534676|402371|P2|COMPLETED|Overall Study||0
165269|NCT01534676|402372|P1|COMPLETED|Overall Study||0
165270|NCT01534676|402371|P2|STARTED|Overall Study||1
165271|NCT01534676|402372|P1|STARTED|Overall Study||2
165272|NCT01534637|402378|P1|NOT COMPLETED|Overall Study||9
165273|NCT01534637|402378|P1|COMPLETED|Overall Study||13
165274|NCT01534637|402378|P1|STARTED|Overall Study||22
165275|NCT01534533|402388|P4|NOT COMPLETED|Overall Study||4
165276|NCT01534533|402389|P3|NOT COMPLETED|Overall Study||8
165277|NCT01534533|402390|P2|NOT COMPLETED|Overall Study||3
165278|NCT01534533|402391|P1|NOT COMPLETED|Overall Study||8
165279|NCT01534533|402388|P4|COMPLETED|Overall Study||44
165280|NCT01534533|402389|P3|COMPLETED|Overall Study||40
165281|NCT01534533|402390|P2|COMPLETED|Overall Study||45
165282|NCT01534533|402391|P1|COMPLETED|Overall Study||40
165283|NCT01534533|402388|P4|STARTED|Overall Study||48
165284|NCT01534533|402389|P3|STARTED|Overall Study||48
165285|NCT01534533|402390|P2|STARTED|Overall Study||48
165286|NCT01534533|402391|P1|STARTED|Overall Study||48
165287|NCT01534520|402419|P2|NOT COMPLETED|Overall Study||1
165288|NCT01534520|402420|P1|NOT COMPLETED|Overall Study||0
165289|NCT01534520|402419|P2|COMPLETED|Overall Study|1 subject withdrew consent at time of uterine sound attempt due to intolerable pain|28
165290|NCT01534520|402420|P1|COMPLETED|Overall Study||30
165291|NCT01534520|402419|P2|STARTED|Overall Study||29
165292|NCT01534520|402420|P1|STARTED|Overall Study||30
165293|NCT01534416|402434|P2|NOT COMPLETED|Overall Study||0
165294|NCT01534416|402435|P1|NOT COMPLETED|Overall Study||0
165295|NCT01534416|402434|P2|COMPLETED|Overall Study||64
165296|NCT01534416|402435|P1|COMPLETED|Overall Study||68
165297|NCT01534416|402434|P2|STARTED|Overall Study||64
165298|NCT01534416|402435|P1|STARTED|Overall Study||68
165299|NCT01534351|402454|P3|NOT COMPLETED|Overall Study||0
165300|NCT01534351|402455|P2|NOT COMPLETED|Overall Study||0
165301|NCT01534351|402456|P1|NOT COMPLETED|Overall Study||1
165302|NCT01534351|402454|P3|COMPLETED|Overall Study||0
165303|NCT01534351|402455|P2|COMPLETED|Overall Study||0
165304|NCT01534351|402456|P1|COMPLETED|Overall Study||0
165305|NCT01534351|402454|P3|STARTED|Overall Study||0
165306|NCT01534351|402455|P2|STARTED|Overall Study||0
165307|NCT01534351|402456|P1|STARTED|Overall Study||1
165308|NCT01534273|402477|P7|NOT COMPLETED|Period 2||0
165309|NCT01534273|402478|P6|NOT COMPLETED|Period 2||0
165310|NCT01534273|402479|P5|NOT COMPLETED|Period 2||0
165311|NCT01534273|402480|P4|NOT COMPLETED|Period 2||0
165312|NCT01534273|402481|P3|NOT COMPLETED|Period 2||0
165313|NCT01534273|402482|P2|NOT COMPLETED|Period 2||0
165314|NCT01534273|402483|P1|NOT COMPLETED|Period 2||0
165315|NCT01534273|402477|P7|COMPLETED|Period 2||0
165316|NCT01534273|402478|P6|COMPLETED|Period 2||0
165317|NCT01534273|402479|P5|COMPLETED|Period 2||0
165318|NCT01534273|402480|P4|COMPLETED|Period 2||6
165319|NCT01534273|402481|P3|COMPLETED|Period 2||2
165320|NCT01534273|402482|P2|COMPLETED|Period 2||0
165321|NCT01534273|402483|P1|COMPLETED|Period 2||0
165322|NCT01534273|402477|P7|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
165323|NCT01534273|402478|P6|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
165324|NCT01534273|402479|P5|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
165325|NCT01534273|402480|P4|STARTED|Period 2||6
165326|NCT01534273|402481|P3|STARTED|Period 2||2
165327|NCT01534273|402482|P2|STARTED|Period 2|Participants in Cohort A participated in only 1 treatment period.|0
165328|NCT01534273|402483|P1|STARTED|Period 2|Participants in Cohort A participated in only 1 treatment period.|0
165329|NCT01534273|402477|P7|NOT COMPLETED|Period 1||0
165330|NCT01534273|402478|P6|NOT COMPLETED|Period 1||0
165331|NCT01534273|402479|P5|NOT COMPLETED|Period 1||0
165332|NCT01534273|402480|P4|NOT COMPLETED|Period 1||1
165333|NCT01534273|402481|P3|NOT COMPLETED|Period 1||0
165334|NCT01534273|402482|P2|NOT COMPLETED|Period 1||0
165335|NCT01534273|402483|P1|NOT COMPLETED|Period 1||0
165336|NCT01534273|402477|P7|COMPLETED|Period 1||6
165337|NCT01534273|402478|P6|COMPLETED|Period 1||3
165338|NCT01534273|402479|P5|COMPLETED|Period 1||3
165339|NCT01534273|402480|P4|COMPLETED|Period 1||6
165340|NCT01534273|402481|P3|COMPLETED|Period 1||2
165341|NCT01534273|402482|P2|COMPLETED|Period 1||6
165342|NCT01534273|402483|P1|COMPLETED|Period 1||3
165343|NCT01534273|402477|P7|Received at Least 1 Dose of Study Drug|Period 1||6
165344|NCT01534273|402478|P6|Received at Least 1 Dose of Study Drug|Period 1||3
165345|NCT01534273|402479|P5|Received at Least 1 Dose of Study Drug|Period 1||3
165346|NCT01534273|402480|P4|Received at Least 1 Dose of Study Drug|Period 1||7
165347|NCT01534273|402481|P3|Received at Least 1 Dose of Study Drug|Period 1||2
165348|NCT01534273|402482|P2|Received at Least 1 Dose of Study Drug|Period 1||6
165349|NCT01534273|402483|P1|Received at Least 1 Dose of Study Drug|Period 1||3
165350|NCT01534273|402477|P7|STARTED|Period 1||6
165351|NCT01534273|402478|P6|STARTED|Period 1||3
165352|NCT01534273|402479|P5|STARTED|Period 1||3
165353|NCT01534273|402480|P4|STARTED|Period 1||7
165354|NCT01534273|402481|P3|STARTED|Period 1||2
165355|NCT01534273|402482|P2|STARTED|Period 1||6
165356|NCT01534273|402483|P1|STARTED|Period 1||3
165357|NCT01534260|402510|P2|NOT COMPLETED|Overall Study||20
165358|NCT01534260|402511|P1|NOT COMPLETED|Overall Study||16
165359|NCT01534260|402510|P2|COMPLETED|Overall Study||0
165360|NCT01534260|402511|P1|COMPLETED|Overall Study||1
165361|NCT01534260|402510|P2|STARTED|Overall Study||20
165362|NCT01534260|402511|P1|STARTED|Overall Study||17
165363|NCT01534208|402521|P2|NOT COMPLETED|Overall Study||49
165364|NCT01534208|402522|P1|NOT COMPLETED|Overall Study||57
165365|NCT01534208|402521|P2|COMPLETED|Overall Study||234
165366|NCT01534208|402522|P1|COMPLETED|Overall Study||159
165367|NCT01534208|402521|P2|STARTED|Overall Study||283
165368|NCT01534208|402522|P1|STARTED|Overall Study||216
165369|NCT01534195|402540|P2|NOT COMPLETED|Overall Study||1
165370|NCT01534195|402541|P1|NOT COMPLETED|Overall Study||1
165371|NCT01534195|402540|P2|COMPLETED|Overall Study||5
165372|NCT01534195|402541|P1|COMPLETED|Overall Study||4
165373|NCT01534195|402540|P2|STARTED|Overall Study||6
165374|NCT01534195|402541|P1|STARTED|Overall Study||5
165375|NCT01534182|402555|P2|NOT COMPLETED|Overall Study||10
165376|NCT01534182|402556|P1|NOT COMPLETED|Overall Study||12
165377|NCT01534182|402555|P2|COMPLETED|Overall Study||58
165378|NCT01534182|402556|P1|COMPLETED|Overall Study||218
165379|NCT01534182|402555|P2|Full Analysis Set|Overall Study||62
165380|NCT01534182|402556|P1|Full Analysis Set|Overall Study||229
165381|NCT01534182|402555|P2|Safety Set|Overall Study||64
165382|NCT01534182|402556|P1|Safety Set|Overall Study||230
165383|NCT01534182|402555|P2|STARTED|Overall Study||68
165384|NCT01534182|402556|P1|STARTED|Overall Study||230
165385|NCT01534143|402571|P1|NOT COMPLETED|Overall Study||0
165386|NCT01534143|402571|P1|COMPLETED|Overall Study||1
165387|NCT01534143|402571|P1|STARTED|Overall Study||1
165388|NCT01534078|402587|P1|NOT COMPLETED|Overall Study||2
165389|NCT01534078|402587|P1|COMPLETED|Overall Study||32
165390|NCT01534078|402587|P1|STARTED|Overall Study||34
165391|NCT01534052|402594|P1|NOT COMPLETED|Overall Study||0
165392|NCT01534052|402594|P1|COMPLETED|Overall Study||52
165393|NCT01534052|402594|P1|Treatment Received|Overall Study||52
165394|NCT01534052|402594|P1|STARTED|Overall Study||52
165395|NCT01534013|402600|P2|NOT COMPLETED|Overall Study||0
165396|NCT01534013|402601|P1|NOT COMPLETED|Overall Study||2
165397|NCT01534013|402600|P2|COMPLETED|Overall Study||6
165398|NCT01534013|402601|P1|COMPLETED|Overall Study||6
165399|NCT01534013|402600|P2|STARTED|Overall Study||6
165400|NCT01534013|402601|P1|STARTED|Overall Study||8
165401|NCT01533974|402609|P2|NOT COMPLETED|Overall Study||50
165402|NCT01533974|402610|P1|NOT COMPLETED|Overall Study||51
165403|NCT01533974|402609|P2|COMPLETED|Overall Study||176
165404|NCT01533974|402610|P1|COMPLETED|Overall Study||173
165405|NCT01533974|402609|P2|STARTED|Overall Study||226
165406|NCT01533974|402610|P1|STARTED|Overall Study||224
165407|NCT01533948|402616|P1|NOT COMPLETED|Overall Study||0
165408|NCT01533948|402616|P1|COMPLETED|Overall Study||25
165409|NCT01533948|402616|P1|STARTED|Overall Study||25
165410|NCT01533935|402624|P5|NOT COMPLETED|Overall Study||8
165411|NCT01533935|402625|P4|NOT COMPLETED|Overall Study||7
165412|NCT01533935|402626|P3|NOT COMPLETED|Overall Study||8
165413|NCT01533935|402627|P2|NOT COMPLETED|Overall Study||13
165414|NCT01533935|402628|P1|NOT COMPLETED|Overall Study||6
165415|NCT01533935|402624|P5|COMPLETED|Overall Study|All treatment periods|50
165416|NCT01533935|402625|P4|COMPLETED|Overall Study|All treatment periods|52
165417|NCT01533935|402626|P3|COMPLETED|Overall Study|All treatment periods|50
165418|NCT01533935|402627|P2|COMPLETED|Overall Study|All treatment periods|45
165419|NCT01533935|402628|P1|COMPLETED|Overall Study|All treatment periods|52
165420|NCT01533935|402624|P5|Received Tio+Olo 5/5|Overall Study||55
165421|NCT01533935|402625|P4|Received Tio+Olo 5/5|Overall Study||54
165422|NCT01533935|402626|P3|Received Tio+Olo 5/5|Overall Study|One patient received Tio+Olo 5/5 instead of Tio+Olo 2.5/5 by mistake.|1
165423|NCT01533935|402627|P2|Received Tio+Olo 5/5|Overall Study||58
165424|NCT01533935|402628|P1|Received Tio+Olo 5/5|Overall Study||56
165425|NCT01533935|402624|P5|Received Tio+Olo 2.5/5|Overall Study||56
165426|NCT01533935|402625|P4|Received Tio+Olo 2.5/5|Overall Study||56
165427|NCT01533935|402626|P3|Received Tio+Olo 2.5/5|Overall Study||49
165428|NCT01533935|402627|P2|Received Tio+Olo 2.5/5|Overall Study||0
165429|NCT01533935|402628|P1|Received Tio+Olo 2.5/5|Overall Study||58
165430|NCT01533935|402624|P5|Received Tio 5|Overall Study||52
165431|NCT01533935|402625|P4|Received Tio 5|Overall Study||0
165432|NCT01533935|402626|P3|Received Tio 5|Overall Study||58
165433|NCT01533935|402627|P2|Received Tio 5|Overall Study||54
165434|NCT01533935|402628|P1|Received Tio 5|Overall Study||54
165435|NCT01533935|402624|P5|Received Olo 5|Overall Study||0
165436|NCT01533935|402625|P4|Received Olo 5|Overall Study||59
165437|NCT01533935|402626|P3|Received Olo 5|Overall Study||55
165438|NCT01533935|402627|P2|Received Olo 5|Overall Study||52
165439|NCT01533935|402628|P1|Received Olo 5|Overall Study||52
165440|NCT01533935|402624|P5|Received Placebo|Overall Study||58
165441|NCT01533935|402625|P4|Received Placebo|Overall Study||57
165442|NCT01533935|402626|P3|Received Placebo|Overall Study||52
165443|NCT01533935|402627|P2|Received Placebo|Overall Study||47
165444|NCT01533935|402628|P1|Received Placebo|Overall Study||0
165445|NCT01533935|402624|P5|STARTED|Overall Study||58
165446|NCT01533935|402625|P4|STARTED|Overall Study||59
165447|NCT01533935|402626|P3|STARTED|Overall Study||58
165448|NCT01533935|402627|P2|STARTED|Overall Study||58
165449|NCT01533935|402628|P1|STARTED|Overall Study||58
165450|NCT01533922|402655|P5|NOT COMPLETED|Overall Study||6
165451|NCT01533922|402656|P4|NOT COMPLETED|Overall Study||5
165452|NCT01533922|402657|P3|NOT COMPLETED|Overall Study||10
165453|NCT01533922|402658|P2|NOT COMPLETED|Overall Study||12
165454|NCT01533922|402659|P1|NOT COMPLETED|Overall Study||10
165455|NCT01533922|402655|P5|COMPLETED|Overall Study|Completed all treatment arms|53
165456|NCT01533922|402656|P4|COMPLETED|Overall Study|Completed all treatment arms|53
165457|NCT01533922|402657|P3|COMPLETED|Overall Study|Completed all treatment arms|50
165458|NCT01533922|402658|P2|COMPLETED|Overall Study|Completed all treatment arms|47
165459|NCT01533922|402659|P1|COMPLETED|Overall Study|Completed all treatment arms|49
165460|NCT01533922|402655|P5|Received Tio+Olo 5/5|Overall Study||56
165461|NCT01533922|402656|P4|Received Tio+Olo 5/5|Overall Study||53
165462|NCT01533922|402657|P3|Received Tio+Olo 5/5|Overall Study||0
165463|NCT01533922|402658|P2|Received Tio+Olo 5/5|Overall Study||59
165464|NCT01533922|402659|P1|Received Tio+Olo 5/5|Overall Study||58
165465|NCT01533922|402655|P5|Received Tio+Olo 2.5/5|Overall Study||56
165466|NCT01533922|402656|P4|Received Tio+Olo 2.5/5|Overall Study||55
165467|NCT01533922|402657|P3|Received Tio+Olo 2.5/5|Overall Study||52
165468|NCT01533922|402658|P2|Received Tio+Olo 2.5/5|Overall Study||0
165469|NCT01533922|402659|P1|Received Tio+Olo 2.5/5|Overall Study||59
165470|NCT01533922|402655|P5|Received Tio 5|Overall Study||54
165471|NCT01533922|402656|P4|Received Tio 5|Overall Study|One patient received Tio 5 instead of Olo 5 by mistake.|1
165472|NCT01533922|402657|P3|Received Tio 5|Overall Study||59
165473|NCT01533922|402658|P2|Received Tio 5|Overall Study||58
165474|NCT01533922|402659|P1|Received Tio 5|Overall Study||54
165475|NCT01533922|402655|P5|Received Olo 5|Overall Study||0
165476|NCT01533922|402656|P4|Received Olo 5|Overall Study||57
165477|NCT01533922|402657|P3|Received Olo 5|Overall Study||57
165478|NCT01533922|402658|P2|Received Olo 5|Overall Study||52
165479|NCT01533922|402659|P1|Received Olo 5|Overall Study||51
165480|NCT01533922|402655|P5|Received Placebo|Overall Study||59
165481|NCT01533922|402656|P4|Received Placebo|Overall Study||57
165482|NCT01533922|402657|P3|Received Placebo|Overall Study||57
165483|NCT01533922|402658|P2|Received Placebo|Overall Study||49
165484|NCT01533922|402659|P1|Received Placebo|Overall Study||0
165485|NCT01533922|402655|P5|STARTED|Overall Study||59
165486|NCT01533922|402656|P4|STARTED|Overall Study||58
165487|NCT01533922|402657|P3|STARTED|Overall Study||60
165488|NCT01533922|402658|P2|STARTED|Overall Study||59
165489|NCT01533922|402659|P1|STARTED|Overall Study||59
165490|NCT01533753|402688|P2|NOT COMPLETED|Overall Study||0
165491|NCT01533753|402689|P1|NOT COMPLETED|Overall Study||0
165492|NCT01533753|402688|P2|COMPLETED|Overall Study||3
165493|NCT01533753|402689|P1|COMPLETED|Overall Study||2
165494|NCT01533753|402688|P2|STARTED|Overall Study||3
165495|NCT01533753|402689|P1|STARTED|Overall Study||2
165496|NCT01533688|402704|P3|NOT COMPLETED|Overall Study||8
165497|NCT01533688|402705|P2|NOT COMPLETED|Overall Study||10
165498|NCT01533688|402706|P1|NOT COMPLETED|Overall Study||8
165499|NCT01533688|402704|P3|COMPLETED|Overall Study||63
165500|NCT01533688|402705|P2|COMPLETED|Overall Study||60
165501|NCT01533688|402706|P1|COMPLETED|Overall Study||63
165502|NCT01533688|402704|P3|STARTED|Overall Study||71
165503|NCT01533688|402705|P2|STARTED|Overall Study||70
165504|NCT01533688|402706|P1|STARTED|Overall Study||71
165505|NCT01533597|402719|P2|NOT COMPLETED|Overall Study||10
165506|NCT01533597|402720|P1|NOT COMPLETED|Overall Study||6
165507|NCT01533597|402719|P2|COMPLETED|Overall Study||25
165508|NCT01533597|402720|P1|COMPLETED|Overall Study||29
165509|NCT01533597|402719|P2|STARTED|Overall Study||35
165510|NCT01533597|402720|P1|STARTED|Overall Study||35
165511|NCT01533493|402738|P2|NOT COMPLETED|Overall Study||3
165512|NCT01533493|402739|P1|NOT COMPLETED|Overall Study||5
165513|NCT01533493|402738|P2|COMPLETED|Overall Study||11
165514|NCT01533493|402739|P1|COMPLETED|Overall Study||7
165515|NCT01533493|402738|P2|STARTED|Overall Study||14
165516|NCT01533493|402739|P1|STARTED|Overall Study||12
165517|NCT01533428|402747|P2|NOT COMPLETED|Overall Study||8
165518|NCT01533428|402748|P1|NOT COMPLETED|Overall Study||9
165519|NCT01533428|402747|P2|COMPLETED|Overall Study||175
165520|NCT01533428|402748|P1|COMPLETED|Overall Study||177
165521|NCT01533428|402747|P2|STARTED|Overall Study||183
165522|NCT01533428|402748|P1|STARTED|Overall Study||186
165523|NCT01533259|402788|P1|NOT COMPLETED|Overall Study||0
165524|NCT01533259|402788|P1|COMPLETED|Overall Study||48
165525|NCT01533259|402788|P1|STARTED|Overall Study||48
165526|NCT01533246|402794|P1|NOT COMPLETED|Overall Study||2
165527|NCT01533246|402794|P1|COMPLETED|Overall Study||15
165528|NCT01533246|402794|P1|STARTED|Overall Study||17
165529|NCT01533181|402805|P2|NOT COMPLETED|Overall Study||1
165530|NCT01533181|402806|P1|NOT COMPLETED|Overall Study||1
165531|NCT01533181|402805|P2|COMPLETED|Overall Study||28
165532|NCT01533181|402806|P1|COMPLETED|Overall Study||14
165533|NCT01533181|402805|P2|STARTED|Overall Study||29
165534|NCT01533181|402806|P1|STARTED|Overall Study||15
165535|NCT01533116|402822|P4|NOT COMPLETED|Overall Study||0
165536|NCT01533116|402823|P3|NOT COMPLETED|Overall Study||1
165537|NCT01533116|402824|P2|NOT COMPLETED|Overall Study||1
165538|NCT01533116|402825|P1|NOT COMPLETED|Overall Study||2
165539|NCT01533116|402822|P4|COMPLETED|Overall Study||12
165540|NCT01533116|402823|P3|COMPLETED|Overall Study||12
165541|NCT01533116|402824|P2|COMPLETED|Overall Study||12
165542|NCT01533116|402825|P1|COMPLETED|Overall Study||12
165543|NCT01533116|402822|P4|STARTED|Overall Study||12
165544|NCT01533116|402823|P3|STARTED|Overall Study||13
165545|NCT01533116|402824|P2|STARTED|Overall Study||13
165546|NCT01533116|402825|P1|STARTED|Overall Study||14
165547|NCT01533077|402855|P4|NOT COMPLETED|Overall Study||0
165548|NCT01533077|402856|P3|NOT COMPLETED|Overall Study||0
165549|NCT01533077|402857|P2|NOT COMPLETED|Overall Study||1
165550|NCT01533077|402858|P1|NOT COMPLETED|Overall Study||1
165551|NCT01533077|402855|P4|COMPLETED|Overall Study||4
165552|NCT01533077|402856|P3|COMPLETED|Overall Study||4
165553|NCT01533077|402857|P2|COMPLETED|Overall Study||4
165554|NCT01533077|402858|P1|COMPLETED|Overall Study||4
165555|NCT01533077|402855|P4|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
165556|NCT01533077|402856|P3|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
165557|NCT01533077|402857|P2|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
165558|NCT01533077|402858|P1|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
165559|NCT01533077|402855|P4|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
165560|NCT01533077|402856|P3|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
165561|NCT01533077|402857|P2|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
165562|NCT01533077|402858|P1|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
165563|NCT01533077|402855|P4|Sinemet® 100/25|Overall Study||4
165564|NCT01533077|402856|P3|Sinemet® 100/25|Overall Study||4
165565|NCT01533077|402857|P2|Sinemet® 100/25|Overall Study||5
165566|NCT01533077|402858|P1|Sinemet® 100/25|Overall Study||4
165567|NCT01533077|402855|P4|BIA 9-1067 50 mg|Overall Study||4
165568|NCT01533077|402856|P3|BIA 9-1067 50 mg|Overall Study||4
165569|NCT01533077|402857|P2|BIA 9-1067 50 mg|Overall Study||5
165570|NCT01533077|402858|P1|BIA 9-1067 50 mg|Overall Study||5
165571|NCT01533077|402855|P4|STARTED|Overall Study||4
165572|NCT01533077|402856|P3|STARTED|Overall Study||4
165573|NCT01533077|402857|P2|STARTED|Overall Study||5
165574|NCT01533077|402858|P1|STARTED|Overall Study||5
165575|NCT01533038|402914|P2|NOT COMPLETED|Overall Study||1
165576|NCT01533038|402915|P1|NOT COMPLETED|Overall Study||0
165577|NCT01533038|402914|P2|COMPLETED|Overall Study||34
165578|NCT01533038|402915|P1|COMPLETED|Overall Study||45
165579|NCT01533038|402914|P2|STARTED|Overall Study||35
165580|NCT01533038|402915|P1|STARTED|Overall Study||45
165581|NCT01532999|402923|P2|NOT COMPLETED|Overall Study||18
165582|NCT01532999|402924|P1|NOT COMPLETED|Overall Study||31
165583|NCT01532999|402923|P2|COMPLETED|Overall Study||77
165584|NCT01532999|402924|P1|COMPLETED|Overall Study||65
165585|NCT01532999|402923|P2|STARTED|Overall Study||95
165586|NCT01532999|402924|P1|STARTED|Overall Study||96
165587|NCT01532986|402948|P2|NOT COMPLETED|Overall Study||24
165588|NCT01532986|402949|P1|NOT COMPLETED|Overall Study||23
165589|NCT01532986|402948|P2|COMPLETED|Overall Study||138
165590|NCT01532986|402949|P1|COMPLETED|Overall Study||143
165591|NCT01532986|402948|P2|STARTED|Overall Study||162
165592|NCT01532986|402949|P1|STARTED|Overall Study||166
165593|NCT01532973|402982|P10|NOT COMPLETED|Part 3||0
165594|NCT01532973|402983|P9|NOT COMPLETED|Part 3||0
165595|NCT01532973|402984|P8|NOT COMPLETED|Part 3||0
165596|NCT01532973|402985|P7|NOT COMPLETED|Part 3||0
165597|NCT01532973|402986|P6|NOT COMPLETED|Part 3||0
165598|NCT01532973|402987|P5|NOT COMPLETED|Part 3||0
165599|NCT01532973|402988|P4|NOT COMPLETED|Part 3||0
165600|NCT01532973|402989|P3|NOT COMPLETED|Part 3||0
165601|NCT01532973|402990|P2|NOT COMPLETED|Part 3||0
165602|NCT01532973|402991|P1|NOT COMPLETED|Part 3||0
165603|NCT01532973|402982|P10|COMPLETED|Part 3||6
165604|NCT01532973|402983|P9|COMPLETED|Part 3||6
165605|NCT01532973|402984|P8|COMPLETED|Part 3||0
165606|NCT01532973|402985|P7|COMPLETED|Part 3||0
165607|NCT01532973|402986|P6|COMPLETED|Part 3||0
165608|NCT01532973|402987|P5|COMPLETED|Part 3||0
165609|NCT01532973|402988|P4|COMPLETED|Part 3||0
165610|NCT01532973|402989|P3|COMPLETED|Part 3||0
165611|NCT01532973|402990|P2|COMPLETED|Part 3||0
165612|NCT01532973|402991|P1|COMPLETED|Part 3||0
165613|NCT01532973|402982|P10|STARTED|Part 3||6
165614|NCT01532973|402983|P9|STARTED|Part 3||6
165615|NCT01532973|402984|P8|STARTED|Part 3||0
165616|NCT01532973|402985|P7|STARTED|Part 3||0
165617|NCT01532973|402986|P6|STARTED|Part 3||0
165618|NCT01532973|402987|P5|STARTED|Part 3||0
165619|NCT01532973|402988|P4|STARTED|Part 3||0
165620|NCT01532973|402989|P3|STARTED|Part 3||0
165621|NCT01532973|402990|P2|STARTED|Part 3||0
165622|NCT01532973|402991|P1|STARTED|Part 3||0
165623|NCT01532973|402982|P10|NOT COMPLETED|Part 2||0
165624|NCT01532973|402983|P9|NOT COMPLETED|Part 2||0
165625|NCT01532973|402984|P8|NOT COMPLETED|Part 2||0
165626|NCT01532973|402985|P7|NOT COMPLETED|Part 2||0
165627|NCT01532973|402986|P6|NOT COMPLETED|Part 2||0
165628|NCT01532973|402987|P5|NOT COMPLETED|Part 2||0
165629|NCT01532973|402988|P4|NOT COMPLETED|Part 2||0
165630|NCT01532973|402989|P3|NOT COMPLETED|Part 2||0
165631|NCT01532973|402990|P2|NOT COMPLETED|Part 2||0
165632|NCT01532973|402991|P1|NOT COMPLETED|Part 2||0
165633|NCT01532973|402982|P10|COMPLETED|Part 2||0
165634|NCT01532973|402983|P9|COMPLETED|Part 2||0
165635|NCT01532973|402984|P8|COMPLETED|Part 2||0
165636|NCT01532973|402985|P7|COMPLETED|Part 2||6
165637|NCT01532973|402986|P6|COMPLETED|Part 2||6
165638|NCT01532973|402987|P5|COMPLETED|Part 2||6
165639|NCT01532973|402988|P4|COMPLETED|Part 2||0
165640|NCT01532973|402989|P3|COMPLETED|Part 2||0
165641|NCT01532973|402990|P2|COMPLETED|Part 2||0
165642|NCT01532973|402991|P1|COMPLETED|Part 2||0
165643|NCT01532973|402982|P10|STARTED|Part 2||0
165644|NCT01532973|402983|P9|STARTED|Part 2||0
165645|NCT01532973|402984|P8|STARTED|Part 2|Planned panel not performed. No participants were enrolled.|0
165646|NCT01532973|402985|P7|STARTED|Part 2||6
165647|NCT01532973|402986|P6|STARTED|Part 2||6
165648|NCT01532973|402987|P5|STARTED|Part 2||6
165649|NCT01532973|402988|P4|STARTED|Part 2||0
165650|NCT01532973|402989|P3|STARTED|Part 2||0
165651|NCT01532973|402990|P2|STARTED|Part 2||0
165652|NCT01532973|402991|P1|STARTED|Part 2||0
165653|NCT01532973|402982|P10|NOT COMPLETED|Part 1||0
165654|NCT01532973|402983|P9|NOT COMPLETED|Part 1||0
165655|NCT01532973|402984|P8|NOT COMPLETED|Part 1||0
165656|NCT01532973|402985|P7|NOT COMPLETED|Part 1||0
165657|NCT01532973|402986|P6|NOT COMPLETED|Part 1||0
165658|NCT01532973|402987|P5|NOT COMPLETED|Part 1||0
165659|NCT01532973|402988|P4|NOT COMPLETED|Part 1||0
165660|NCT01532973|402989|P3|NOT COMPLETED|Part 1||0
165661|NCT01532973|402990|P2|NOT COMPLETED|Part 1||0
165662|NCT01532973|402991|P1|NOT COMPLETED|Part 1||0
165663|NCT01532973|402982|P10|COMPLETED|Part 1||0
165664|NCT01532973|402983|P9|COMPLETED|Part 1||0
165665|NCT01532973|402984|P8|COMPLETED|Part 1||0
165666|NCT01532973|402985|P7|COMPLETED|Part 1||0
165667|NCT01532973|402986|P6|COMPLETED|Part 1||0
165668|NCT01532973|402987|P5|COMPLETED|Part 1||0
165669|NCT01532973|402988|P4|COMPLETED|Part 1||0
165670|NCT01532973|402989|P3|COMPLETED|Part 1||6
165671|NCT01532973|402990|P2|COMPLETED|Part 1||6
165672|NCT01532973|402991|P1|COMPLETED|Part 1||6
165673|NCT01532973|402982|P10|STARTED|Part 1||0
165674|NCT01532973|402983|P9|STARTED|Part 1||0
165675|NCT01532973|402984|P8|STARTED|Part 1||0
165676|NCT01532973|402985|P7|STARTED|Part 1||0
165677|NCT01532973|402986|P6|STARTED|Part 1||0
165678|NCT01532973|402987|P5|STARTED|Part 1||0
165679|NCT01532973|402988|P4|STARTED|Part 1|Planned panel not performed. No participants were enrolled.|0
165680|NCT01532973|402989|P3|STARTED|Part 1||6
165681|NCT01532973|402990|P2|STARTED|Part 1||6
165682|NCT01532973|402991|P1|STARTED|Part 1||6
165683|NCT01532934|403033|P2|NOT COMPLETED|Overall Study||13
165684|NCT01532934|403034|P1|NOT COMPLETED|Overall Study||14
165685|NCT01532934|403033|P2|COMPLETED|Overall Study||39
165686|NCT01532934|403034|P1|COMPLETED|Overall Study||39
165687|NCT01532934|403033|P2|STARTED|Overall Study||52
165688|NCT01532934|403034|P1|STARTED|Overall Study||53
165689|NCT01532921|403044|P1|NOT COMPLETED|Overall Study||16
165690|NCT01532921|403044|P1|COMPLETED|Overall Study||69
165691|NCT01532921|403044|P1|6 Months Follow Up|Overall Study||68
165692|NCT01532921|403044|P1|Discharge|Overall Study||75
165693|NCT01532921|403044|P1|Implantation Procedure|Overall Study||76
165694|NCT01532921|403044|P1|STARTED|Overall Study||85
165695|NCT01532869|403066|P2|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||3
165696|NCT01532869|403067|P1|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||7
165697|NCT01532869|403066|P2|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|27
165698|NCT01532869|403067|P1|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|24
165699|NCT01532869|403066|P2|STARTED|Open-label Period (Week 48 to Week 96)||30
165700|NCT01532869|403067|P1|STARTED|Open-label Period (Week 48 to Week 96)|Two participants did not start the open label extension period.|31
165701|NCT01532869|403066|P2|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||13
165702|NCT01532869|403067|P1|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||11
165791|NCT01532141|403242|P1|STARTED|Overall Study||9
165792|NCT01532128|403260|P3|NOT COMPLETED|Overall Study||0
165703|NCT01532869|403066|P2|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|30
165704|NCT01532869|403067|P1|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|33
165705|NCT01532869|403066|P2|STARTED|Blinded-Treatment Period (Up to Week 48)||43
165706|NCT01532869|403067|P1|STARTED|Blinded-Treatment Period (Up to Week 48)||44
165707|NCT01532869|403066|P2|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
165708|NCT01532869|403067|P1|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
165709|NCT01532869|403066|P2|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|35
165710|NCT01532869|403067|P1|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|36
165711|NCT01532869|403066|P2|STARTED|Blinded-Treatment Period (Up to Week 24)||43
165712|NCT01532869|403067|P1|STARTED|Blinded-Treatment Period (Up to Week 24)||44
165713|NCT01532830|403104|P1|NOT COMPLETED|Overall Study||4
165714|NCT01532830|403104|P1|COMPLETED|Overall Study||26
165715|NCT01532830|403104|P1|STARTED|Overall Study||30
165716|NCT01532817|403113|P1|NOT COMPLETED|Overall Study||0
165717|NCT01532817|403113|P1|COMPLETED|Overall Study||30
165718|NCT01532817|403113|P1|STARTED|Overall Study||30
165719|NCT01532700|403117|P1|NOT COMPLETED|Overall Study||0
165720|NCT01532700|403117|P1|COMPLETED|Overall Study||28
165721|NCT01532700|403117|P1|STARTED|Overall Study||28
165722|NCT01532648|403126|P2|NOT COMPLETED|Overall Study||17
165723|NCT01532648|403127|P1|NOT COMPLETED|Overall Study||36
165724|NCT01532648|403126|P2|COMPLETED|Overall Study||238
165725|NCT01532648|403127|P1|COMPLETED|Overall Study||219
165726|NCT01532648|403126|P2|Intent-To-Treat Population|Overall Study||228
165727|NCT01532648|403127|P1|Intent-To-Treat Population|Overall Study||230
165728|NCT01532648|403126|P2|Safety Population|Overall Study||255
165729|NCT01532648|403127|P1|Safety Population|Overall Study||255
165730|NCT01532648|403126|P2|STARTED|Overall Study||255
165731|NCT01532648|403127|P1|STARTED|Overall Study||255
165732|NCT01532635|403145|P1|NOT COMPLETED|Overall Study||0
165733|NCT01532635|403145|P1|COMPLETED|Overall Study||4
165734|NCT01532635|403145|P1|STARTED|Overall Study||4
165735|NCT01532570|403161|P4|NOT COMPLETED|Overall Study||0
165736|NCT01532570|403162|P3|NOT COMPLETED|Overall Study||0
165737|NCT01532570|403163|P2|NOT COMPLETED|Overall Study||1
165738|NCT01532570|403164|P1|NOT COMPLETED|Overall Study||1
165739|NCT01532570|403161|P4|COMPLETED|Overall Study||4
165740|NCT01532570|403162|P3|COMPLETED|Overall Study||1
165741|NCT01532570|403163|P2|COMPLETED|Overall Study||1
165742|NCT01532570|403164|P1|COMPLETED|Overall Study||10
165743|NCT01532570|403161|P4|STARTED|Overall Study||4
165744|NCT01532570|403162|P3|STARTED|Overall Study||1
165745|NCT01532570|403163|P2|STARTED|Overall Study||2
165746|NCT01532570|403164|P1|STARTED|Overall Study||11
165747|NCT01532453|403197|P2|NOT COMPLETED|Overall Study||70
165748|NCT01532453|403198|P1|NOT COMPLETED|Overall Study||27
165749|NCT01532453|403197|P2|COMPLETED|Overall Study||90
165750|NCT01532453|403198|P1|COMPLETED|Overall Study||54
165751|NCT01532453|403197|P2|STARTED|Overall Study||160
165752|NCT01532453|403198|P1|STARTED|Overall Study||81
165753|NCT01532414|403209|P3|NOT COMPLETED|Overall Study||3
165754|NCT01532414|403210|P2|NOT COMPLETED|Overall Study||2
165755|NCT01532414|403211|P1|NOT COMPLETED|Overall Study||7
165756|NCT01532414|403209|P3|COMPLETED|Overall Study||35
165757|NCT01532414|403210|P2|COMPLETED|Overall Study||19
165758|NCT01532414|403211|P1|COMPLETED|Overall Study||85
165759|NCT01532414|403209|P3|STARTED|Overall Study||38
165760|NCT01532414|403210|P2|STARTED|Overall Study|Up-titrated at 6 weeks from a starting dose of 12.5 mg due to morning testosterone <300 ng/dL|21
165761|NCT01532414|403211|P1|STARTED|Overall Study||92
165762|NCT01532362|403221|P2|NOT COMPLETED|Overall Study||0
165763|NCT01532362|403222|P1|NOT COMPLETED|Overall Study||0
165764|NCT01532362|403221|P2|COMPLETED|Overall Study||0
165765|NCT01532362|403222|P1|COMPLETED|Overall Study||1
165766|NCT01532362|403221|P2|STARTED|Overall Study||0
165767|NCT01532362|403222|P1|STARTED|Overall Study||1
165768|NCT01532349|403230|P2|NOT COMPLETED|Overall Study||5
165769|NCT01532349|403231|P1|NOT COMPLETED|Overall Study||2
165770|NCT01532349|403230|P2|COMPLETED|Overall Study||12
165771|NCT01532349|403231|P1|COMPLETED|Overall Study||15
165772|NCT01532349|403230|P2|STARTED|Overall Study||17
165773|NCT01532349|403231|P1|STARTED|Overall Study||17
165774|NCT01532141|403240|P3|NOT COMPLETED|Overall Study||0
165775|NCT01532141|403241|P2|NOT COMPLETED|Overall Study||0
165776|NCT01532141|403242|P1|NOT COMPLETED|Overall Study||1
165777|NCT01532141|403240|P3|COMPLETED|Overall Study||8
165778|NCT01532141|403241|P2|COMPLETED|Overall Study||8
165779|NCT01532141|403242|P1|COMPLETED|Overall Study||8
165780|NCT01532141|403240|P3|Period 3|Overall Study||8
165781|NCT01532141|403241|P2|Period 3|Overall Study||8
165782|NCT01532141|403242|P1|Period 3|Overall Study||8
165783|NCT01532141|403240|P3|Period 2|Overall Study||8
165784|NCT01532141|403241|P2|Period 2|Overall Study||8
165785|NCT01532141|403242|P1|Period 2|Overall Study||8
165786|NCT01532141|403240|P3|Period 1|Overall Study||8
165787|NCT01532141|403241|P2|Period 1|Overall Study||8
165788|NCT01532141|403242|P1|Period 1|Overall Study||9
165789|NCT01532141|403240|P3|STARTED|Overall Study||8
165790|NCT01532141|403241|P2|STARTED|Overall Study||8
165793|NCT01532128|403261|P2|NOT COMPLETED|Overall Study||0
165794|NCT01532128|403262|P1|NOT COMPLETED|Overall Study||0
165795|NCT01532128|403260|P3|COMPLETED|Overall Study||8
165796|NCT01532128|403261|P2|COMPLETED|Overall Study||8
165797|NCT01532128|403262|P1|COMPLETED|Overall Study||8
165798|NCT01532128|403260|P3|STARTED|Overall Study||8
165799|NCT01532128|403261|P2|STARTED|Overall Study||8
165800|NCT01532128|403262|P1|STARTED|Overall Study||8
165801|NCT01531998|403277|P1|NOT COMPLETED|Overall Study||3
165802|NCT01531998|403277|P1|COMPLETED|Overall Study||8
165803|NCT01531998|403277|P1|STARTED|Overall Study||11
165804|NCT01531894|403282|P1|NOT COMPLETED|Overall Study||9
165805|NCT01531894|403282|P1|COMPLETED|Overall Study||2
165806|NCT01531894|403282|P1|STARTED|Overall Study||11
165807|NCT01531725|403286|P1|NOT COMPLETED|Overall Study||5
165808|NCT01531725|403286|P1|COMPLETED|Overall Study||197
165809|NCT01531725|403286|P1|STARTED|Overall Study|5 patients with protocol violation were excluded.|202
165810|NCT01531673|403304|P13|NOT COMPLETED|Overall Study||0
165811|NCT01531673|403305|P12|NOT COMPLETED|Overall Study||0
165812|NCT01531673|403306|P11|NOT COMPLETED|Overall Study||0
165813|NCT01531673|403307|P10|NOT COMPLETED|Overall Study||1
165814|NCT01531673|403308|P9|NOT COMPLETED|Overall Study||0
165815|NCT01531673|403309|P8|NOT COMPLETED|Overall Study||0
165816|NCT01531673|403310|P7|NOT COMPLETED|Overall Study||0
165817|NCT01531673|403311|P6|NOT COMPLETED|Overall Study||1
165818|NCT01531673|403312|P5|NOT COMPLETED|Overall Study||1
165819|NCT01531673|403313|P4|NOT COMPLETED|Overall Study||1
165820|NCT01531673|403314|P3|NOT COMPLETED|Overall Study||0
165821|NCT01531673|403315|P2|NOT COMPLETED|Overall Study||1
165822|NCT01531673|403316|P1|NOT COMPLETED|Overall Study||0
165823|NCT01531673|403304|P13|COMPLETED|Overall Study||14
165824|NCT01531673|403305|P12|COMPLETED|Overall Study||4
165825|NCT01531673|403306|P11|COMPLETED|Overall Study||16
165826|NCT01531673|403307|P10|COMPLETED|Overall Study||18
165827|NCT01531673|403308|P9|COMPLETED|Overall Study||17
165828|NCT01531673|403309|P8|COMPLETED|Overall Study||9
165829|NCT01531673|403310|P7|COMPLETED|Overall Study||17
165830|NCT01531673|403311|P6|COMPLETED|Overall Study||18
165831|NCT01531673|403312|P5|COMPLETED|Overall Study||7
165832|NCT01531673|403313|P4|COMPLETED|Overall Study||17
165833|NCT01531673|403314|P3|COMPLETED|Overall Study||8
165834|NCT01531673|403315|P2|COMPLETED|Overall Study||7
165835|NCT01531673|403316|P1|COMPLETED|Overall Study||33
165836|NCT01531673|403304|P13|STARTED|Overall Study||14
165837|NCT01531673|403305|P12|STARTED|Overall Study||4
165838|NCT01531673|403306|P11|STARTED|Overall Study||16
165839|NCT01531673|403307|P10|STARTED|Overall Study||19
165840|NCT01531673|403308|P9|STARTED|Overall Study||17
165841|NCT01531673|403309|P8|STARTED|Overall Study||9
165842|NCT01531673|403310|P7|STARTED|Overall Study||17
165843|NCT01531673|403311|P6|STARTED|Overall Study||19
165844|NCT01531673|403312|P5|STARTED|Overall Study||8
165845|NCT01531673|403313|P4|STARTED|Overall Study||18
165846|NCT01531673|403314|P3|STARTED|Overall Study||8
165847|NCT01531673|403315|P2|STARTED|Overall Study||8
165848|NCT01531673|403316|P1|STARTED|Overall Study||33
165849|NCT01531387|403427|P2|NOT COMPLETED|Overall Study||11
165850|NCT01531387|403428|P1|NOT COMPLETED|Overall Study||11
165851|NCT01531387|403427|P2|COMPLETED|Overall Study||0
165852|NCT01531387|403428|P1|COMPLETED|Overall Study||0
165853|NCT01531387|403427|P2|STARTED|Overall Study||11
165854|NCT01531387|403428|P1|STARTED|Overall Study||11
165855|NCT01531374|403445|P3|NOT COMPLETED|Overall Study||283
165856|NCT01531374|403446|P2|NOT COMPLETED|Overall Study||142
165857|NCT01531374|403447|P1|NOT COMPLETED|Overall Study||364
165858|NCT01531374|403445|P3|COMPLETED|Overall Study||836
165859|NCT01531374|403446|P2|COMPLETED|Overall Study||231
165860|NCT01531374|403447|P1|COMPLETED|Overall Study||921
165861|NCT01531374|403445|P3|STARTED|Overall Study||1119
165862|NCT01531374|403446|P2|STARTED|Overall Study||373
165863|NCT01531374|403447|P1|STARTED|Overall Study||1285
165864|NCT01531335|403511|P2|NOT COMPLETED|Overall Study||0
165865|NCT01531335|403512|P1|NOT COMPLETED|Overall Study||0
165866|NCT01531335|403511|P2|COMPLETED|Overall Study||40
165867|NCT01531335|403512|P1|COMPLETED|Overall Study||40
165868|NCT01531335|403511|P2|STARTED|Overall Study||40
165869|NCT01531335|403512|P1|STARTED|Overall Study||40
165870|NCT01531205|403520|P1|NOT COMPLETED|Overall Study||1
165871|NCT01531205|403520|P1|COMPLETED|Overall Study||1
165872|NCT01531205|403520|P1|STARTED|Overall Study||2
165873|NCT01531153|403532|P3|NOT COMPLETED|Overall Study||15
165874|NCT01531153|403533|P2|NOT COMPLETED|Overall Study||9
165875|NCT01531153|403534|P1|NOT COMPLETED|Overall Study||10
165876|NCT01531153|403532|P3|COMPLETED|Overall Study||15
165877|NCT01531153|403533|P2|COMPLETED|Overall Study||22
165878|NCT01531153|403534|P1|COMPLETED|Overall Study||22
165879|NCT01531153|403532|P3|STARTED|Overall Study||30
165880|NCT01531153|403533|P2|STARTED|Overall Study||31
165881|NCT01531153|403534|P1|STARTED|Overall Study||32
165882|NCT01530997|403590|P1|NOT COMPLETED|Overall Study||2
165883|NCT01530997|403590|P1|COMPLETED|Overall Study||43
165884|NCT01530997|403590|P1|STARTED|Overall Study||45
165885|NCT01530880|403610|P1|NOT COMPLETED|Overall Study||0
165886|NCT01530880|403610|P1|COMPLETED|Overall Study||35
165887|NCT01530880|403610|P1|STARTED|Overall Study||35
165888|NCT01530477|403624|P3|NOT COMPLETED|Overall Study||0
165889|NCT01530477|403625|P2|NOT COMPLETED|Overall Study||0
165890|NCT01530477|403626|P1|NOT COMPLETED|Overall Study||0
165891|NCT01530477|403624|P3|COMPLETED|Overall Study|53 subjects completed the imaging in both the Skeletal and Body Composition cohorts.|53
165892|NCT01530477|403625|P2|COMPLETED|Overall Study|12 subjects completed imaging in the Body Composition cohort only.|12
165893|NCT01530477|403626|P1|COMPLETED|Overall Study|17 subjects completed imaging in the Skeletal cohort only.|17
165894|NCT01530477|403624|P3|STARTED|Overall Study|53 subjects consented to both the Skeletal and body Composition cohorts.|53
165895|NCT01530477|403625|P2|STARTED|Overall Study|12 subjects consented to the Body Composition cohort only.|12
165896|NCT01530477|403626|P1|STARTED|Overall Study|17 subjects consented to the Skeletal cohort only.|17
165897|NCT01530464|403634|P2|NOT COMPLETED|Washout (24h)||1
165898|NCT01530464|403635|P1|NOT COMPLETED|Washout (24h)||0
165899|NCT01530464|403634|P2|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|7
165900|NCT01530464|403635|P1|COMPLETED|Washout (24h)||9
165901|NCT01530464|403634|P2|STARTED|Washout (24h)||8
165902|NCT01530464|403635|P1|STARTED|Washout (24h)||9
165903|NCT01530464|403634|P2|NOT COMPLETED|Third Intervention (24h)||0
165904|NCT01530464|403635|P1|NOT COMPLETED|Third Intervention (24h)||0
165905|NCT01530464|403634|P2|COMPLETED|Third Intervention (24h)||8
165906|NCT01530464|403635|P1|COMPLETED|Third Intervention (24h)||9
165907|NCT01530464|403634|P2|STARTED|Third Intervention (24h)||8
165908|NCT01530464|403635|P1|STARTED|Third Intervention (24h)||9
165909|NCT01530464|403634|P2|NOT COMPLETED|Washout (24h)||0
165910|NCT01530464|403635|P1|NOT COMPLETED|Washout (24h)||1
165911|NCT01530464|403634|P2|COMPLETED|Washout (24h)||8
165912|NCT01530464|403635|P1|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|9
165913|NCT01530464|403634|P2|STARTED|Washout (24h)||8
165914|NCT01530464|403635|P1|STARTED|Washout (24h)||10
165915|NCT01530464|403634|P2|NOT COMPLETED|Second Intervention (24h)||0
165916|NCT01530464|403635|P1|NOT COMPLETED|Second Intervention (24h)||0
165917|NCT01530464|403634|P2|COMPLETED|Second Intervention (24h)||8
165918|NCT01530464|403635|P1|COMPLETED|Second Intervention (24h)||10
165919|NCT01530464|403634|P2|STARTED|Second Intervention (24h)||8
165920|NCT01530464|403635|P1|STARTED|Second Intervention (24h)||10
165921|NCT01530464|403634|P2|NOT COMPLETED|Washout (24h)||0
165922|NCT01530464|403635|P1|NOT COMPLETED|Washout (24h)||0
165923|NCT01530464|403634|P2|COMPLETED|Washout (24h)||8
165924|NCT01530464|403635|P1|COMPLETED|Washout (24h)||10
165925|NCT01530464|403634|P2|STARTED|Washout (24h)||8
165926|NCT01530464|403635|P1|STARTED|Washout (24h)||10
165927|NCT01530464|403634|P2|NOT COMPLETED|First Intervention (24h)||0
165928|NCT01530464|403635|P1|NOT COMPLETED|First Intervention (24h)||0
165929|NCT01530464|403634|P2|COMPLETED|First Intervention (24h)||8
165930|NCT01530464|403635|P1|COMPLETED|First Intervention (24h)||10
165931|NCT01530464|403634|P2|STARTED|First Intervention (24h)||8
165932|NCT01530464|403635|P1|STARTED|First Intervention (24h)||10
165933|NCT01530399|403668|P6|NOT COMPLETED|Overall Study||1
165934|NCT01530399|403669|P5|NOT COMPLETED|Overall Study||0
165935|NCT01530399|403670|P4|NOT COMPLETED|Overall Study||0
165936|NCT01530399|403671|P3|NOT COMPLETED|Overall Study||1
165937|NCT01530399|403672|P2|NOT COMPLETED|Overall Study||2
165938|NCT01530399|403673|P1|NOT COMPLETED|Overall Study||1
165939|NCT01530399|403668|P6|COMPLETED|Overall Study||6
165940|NCT01530399|403669|P5|COMPLETED|Overall Study||6
165941|NCT01530399|403670|P4|COMPLETED|Overall Study||10
165942|NCT01530399|403671|P3|COMPLETED|Overall Study||7
165943|NCT01530399|403672|P2|COMPLETED|Overall Study||8
165944|NCT01530399|403673|P1|COMPLETED|Overall Study||7
165945|NCT01530399|403668|P6|STARTED|Overall Study||7
165946|NCT01530399|403669|P5|STARTED|Overall Study||6
165947|NCT01530399|403670|P4|STARTED|Overall Study||10
165948|NCT01530399|403671|P3|STARTED|Overall Study||8
165949|NCT01530399|403672|P2|STARTED|Overall Study||10
165950|NCT01530399|403673|P1|STARTED|Overall Study||8
165951|NCT01530334|403687|P1|NOT COMPLETED|Overall Study||51
165952|NCT01530334|403687|P1|COMPLETED|Overall Study||10
165953|NCT01530334|403687|P1|STARTED|Overall Study||61
165954|NCT01530243|403700|P4|NOT COMPLETED|Overall Study||2
165955|NCT01530243|403701|P3|NOT COMPLETED|Overall Study||3
165956|NCT01530243|403702|P2|NOT COMPLETED|Overall Study||3
165957|NCT01530243|403703|P1|NOT COMPLETED|Overall Study||2
165958|NCT01530243|403700|P4|COMPLETED|Overall Study||24
165959|NCT01530243|403701|P3|COMPLETED|Overall Study||23
165960|NCT01530243|403702|P2|COMPLETED|Overall Study||23
165961|NCT01530243|403703|P1|COMPLETED|Overall Study||24
165962|NCT01530243|403700|P4|STARTED|Overall Study||26
165963|NCT01530243|403701|P3|STARTED|Overall Study||26
165964|NCT01530243|403702|P2|STARTED|Overall Study||26
165965|NCT01530243|403703|P1|STARTED|Overall Study||26
165966|NCT01530178|403723|P2|NOT COMPLETED|Overall Study||0
165967|NCT01530178|403724|P1|NOT COMPLETED|Overall Study||0
165968|NCT01530178|403723|P2|COMPLETED|Overall Study||6
165969|NCT01530178|403724|P1|COMPLETED|Overall Study||2
165970|NCT01530178|403723|P2|STARTED|Overall Study||6
165971|NCT01530178|403724|P1|STARTED|Overall Study||2
165972|NCT01530087|403734|P1|NOT COMPLETED|Overall Study||2
165973|NCT01530087|403734|P1|COMPLETED|Overall Study||1
165974|NCT01530087|403734|P1|STARTED|Overall Study||3
165975|NCT01529827|403739|P1|NOT COMPLETED|Overall Study||0
165976|NCT01529827|403739|P1|COMPLETED|Overall Study||94
165977|NCT01529827|403739|P1|STARTED|Overall Study||94
165978|NCT01529749|403750|P4|NOT COMPLETED|Overall Study||2
165979|NCT01529749|403751|P3|NOT COMPLETED|Overall Study||2
165980|NCT01529749|403752|P2|NOT COMPLETED|Overall Study||2
165981|NCT01529749|403753|P1|NOT COMPLETED|Overall Study||0
165982|NCT01529749|403750|P4|COMPLETED|Overall Study||10
165983|NCT01529749|403751|P3|COMPLETED|Overall Study||10
165984|NCT01529749|403752|P2|COMPLETED|Overall Study||10
165985|NCT01529749|403753|P1|COMPLETED|Overall Study||12
165986|NCT01529749|403750|P4|STARTED|Overall Study||12
165987|NCT01529749|403751|P3|STARTED|Overall Study||12
165988|NCT01529749|403752|P2|STARTED|Overall Study||12
165989|NCT01529749|403753|P1|STARTED|Overall Study||12
165990|NCT01529645|403837|P10|NOT COMPLETED|Overall Study||0
165991|NCT01529645|403838|P9|NOT COMPLETED|Overall Study||1
165992|NCT01529645|403839|P8|NOT COMPLETED|Overall Study||0
165993|NCT01529645|403840|P7|NOT COMPLETED|Overall Study||2
165994|NCT01529645|403841|P6|NOT COMPLETED|Overall Study||1
165995|NCT01529645|403842|P5|NOT COMPLETED|Overall Study||2
165996|NCT01529645|403843|P4|NOT COMPLETED|Overall Study||2
165997|NCT01529645|403844|P3|NOT COMPLETED|Overall Study||2
165998|NCT01529645|403845|P2|NOT COMPLETED|Overall Study||1
165999|NCT01529645|403846|P1|NOT COMPLETED|Overall Study||2
166000|NCT01529645|403837|P10|COMPLETED|Overall Study||42
166001|NCT01529645|403838|P9|COMPLETED|Overall Study||41
166002|NCT01529645|403839|P8|COMPLETED|Overall Study||42
166003|NCT01529645|403840|P7|COMPLETED|Overall Study||40
166004|NCT01529645|403841|P6|COMPLETED|Overall Study||41
166005|NCT01529645|403842|P5|COMPLETED|Overall Study||40
166006|NCT01529645|403843|P4|COMPLETED|Overall Study||40
166007|NCT01529645|403844|P3|COMPLETED|Overall Study||40
166008|NCT01529645|403845|P2|COMPLETED|Overall Study||41
166009|NCT01529645|403846|P1|COMPLETED|Overall Study||40
166010|NCT01529645|403837|P10|STARTED|Overall Study||42
166011|NCT01529645|403838|P9|STARTED|Overall Study||42
166012|NCT01529645|403839|P8|STARTED|Overall Study||42
166013|NCT01529645|403840|P7|STARTED|Overall Study||42
166014|NCT01529645|403841|P6|STARTED|Overall Study||42
166015|NCT01529645|403842|P5|STARTED|Overall Study||42
166016|NCT01529645|403843|P4|STARTED|Overall Study||42
166017|NCT01529645|403844|P3|STARTED|Overall Study||42
166018|NCT01529645|403845|P2|STARTED|Overall Study||42
166019|NCT01529645|403846|P1|STARTED|Overall Study||42
166020|NCT01529632|403944|P2|NOT COMPLETED|Overall Study||3
166021|NCT01529632|403945|P1|NOT COMPLETED|Overall Study||3
166022|NCT01529632|403944|P2|COMPLETED|Overall Study||100
166023|NCT01529632|403945|P1|COMPLETED|Overall Study||87
166024|NCT01529632|403944|P2|STARTED|Overall Study||103
166025|NCT01529632|403945|P1|STARTED|Overall Study||90
166026|NCT01529515|403965|P4|NOT COMPLETED|DOUBLE BLIND PHASE||12
166027|NCT01529515|403966|P3|NOT COMPLETED|DOUBLE BLIND PHASE||23
166028|NCT01529515|403967|P2|NOT COMPLETED|DOUBLE BLIND PHASE||0
166029|NCT01529515|403968|P1|NOT COMPLETED|DOUBLE BLIND PHASE||0
166030|NCT01529515|403965|P4|COMPLETED|DOUBLE BLIND PHASE||148
166031|NCT01529515|403966|P3|COMPLETED|DOUBLE BLIND PHASE||122
166032|NCT01529515|403967|P2|COMPLETED|DOUBLE BLIND PHASE||0
166033|NCT01529515|403968|P1|COMPLETED|DOUBLE BLIND PHASE||0
166034|NCT01529515|403965|P4|STARTED|DOUBLE BLIND PHASE||160
166035|NCT01529515|403966|P3|STARTED|DOUBLE BLIND PHASE||145
166036|NCT01529515|403967|P2|STARTED|DOUBLE BLIND PHASE||0
166037|NCT01529515|403968|P1|STARTED|DOUBLE BLIND PHASE||0
166038|NCT01529515|403965|P4|NOT COMPLETED|MAINTENANCE PHASE||0
166039|NCT01529515|403966|P3|NOT COMPLETED|MAINTENANCE PHASE||0
166040|NCT01529515|403967|P2|NOT COMPLETED|MAINTENANCE PHASE||74
166041|NCT01529515|403968|P1|NOT COMPLETED|MAINTENANCE PHASE||0
166042|NCT01529515|403965|P4|COMPLETED|MAINTENANCE PHASE||0
166043|NCT01529515|403966|P3|COMPLETED|MAINTENANCE PHASE||0
166044|NCT01529515|403967|P2|COMPLETED|MAINTENANCE PHASE||305
166045|NCT01529515|403968|P1|COMPLETED|MAINTENANCE PHASE||0
166046|NCT01529515|403965|P4|STARTED|MAINTENANCE PHASE||0
166047|NCT01529515|403966|P3|STARTED|MAINTENANCE PHASE||0
166048|NCT01529515|403967|P2|STARTED|MAINTENANCE PHASE||379
166049|NCT01529515|403968|P1|STARTED|MAINTENANCE PHASE||0
166050|NCT01529515|403965|P4|NOT COMPLETED|TRANSITION PHASE||0
166051|NCT01529515|403966|P3|NOT COMPLETED|TRANSITION PHASE||0
166052|NCT01529515|403967|P2|NOT COMPLETED|TRANSITION PHASE||0
166053|NCT01529515|403968|P1|NOT COMPLETED|TRANSITION PHASE||127
166054|NCT01529515|403965|P4|COMPLETED|TRANSITION PHASE||0
166055|NCT01529515|403966|P3|COMPLETED|TRANSITION PHASE||0
166056|NCT01529515|403967|P2|COMPLETED|TRANSITION PHASE||0
166057|NCT01529515|403968|P1|COMPLETED|TRANSITION PHASE||379
166058|NCT01529515|403965|P4|STARTED|TRANSITION PHASE||0
166059|NCT01529515|403966|P3|STARTED|TRANSITION PHASE||0
166060|NCT01529515|403967|P2|STARTED|TRANSITION PHASE||0
166061|NCT01529515|403968|P1|STARTED|TRANSITION PHASE||506
166062|NCT01529502|403987|P6|NOT COMPLETED|Overall Study||0
166063|NCT01529502|403988|P5|NOT COMPLETED|Overall Study||0
166064|NCT01529502|403989|P4|NOT COMPLETED|Overall Study||2
166065|NCT01529502|403990|P3|NOT COMPLETED|Overall Study||0
166066|NCT01529502|403991|P2|NOT COMPLETED|Overall Study||0
166067|NCT01529502|403992|P1|NOT COMPLETED|Overall Study||0
166068|NCT01529502|403987|P6|COMPLETED|Overall Study||2
166069|NCT01529502|403988|P5|COMPLETED|Overall Study||2
166070|NCT01529502|403989|P4|COMPLETED|Overall Study||1
166071|NCT01529502|403990|P3|COMPLETED|Overall Study||2
166072|NCT01529502|403991|P2|COMPLETED|Overall Study||3
166073|NCT01529502|403992|P1|COMPLETED|Overall Study||2
166074|NCT01529502|403987|P6|STARTED|Overall Study||2
166075|NCT01529502|403988|P5|STARTED|Overall Study||2
166076|NCT01529502|403989|P4|STARTED|Overall Study||3
166077|NCT01529502|403990|P3|STARTED|Overall Study||2
166078|NCT01529502|403991|P2|STARTED|Overall Study||3
166079|NCT01529502|403992|P1|STARTED|Overall Study||2
166080|NCT01529450|404005|P2|NOT COMPLETED|Overall Study||2
166081|NCT01529450|404006|P1|NOT COMPLETED|Overall Study||0
166082|NCT01529450|404005|P2|COMPLETED|Overall Study||6
166083|NCT01529450|404006|P1|COMPLETED|Overall Study||3
166084|NCT01529450|404005|P2|STARTED|Overall Study||8
166085|NCT01529450|404006|P1|STARTED|Overall Study||3
166086|NCT01529385|404015|P2|NOT COMPLETED|Overall Study||1
166087|NCT01529385|404016|P1|NOT COMPLETED|Overall Study||2
166088|NCT01529385|404015|P2|COMPLETED|Overall Study||39
166089|NCT01529385|404016|P1|COMPLETED|Overall Study||38
166090|NCT01529385|404015|P2|Received Intervention|Overall Study||40
166091|NCT01529385|404016|P1|Received Intervention|Overall Study|1 participant failed to show up to treatment allocation visit and was subsequently lost to follow up|39
166092|NCT01529385|404015|P2|STARTED|Overall Study||40
166093|NCT01529385|404016|P1|STARTED|Overall Study||40
166094|NCT01529346|404045|P5|NOT COMPLETED|Overall Study||0
166095|NCT01529346|404046|P4|NOT COMPLETED|Overall Study||0
166096|NCT01529346|404047|P3|NOT COMPLETED|Overall Study||2
166097|NCT01529346|404048|P2|NOT COMPLETED|Overall Study||1
166098|NCT01529346|404049|P1|NOT COMPLETED|Overall Study||2
166099|NCT01529346|404045|P5|COMPLETED|Overall Study||36
166100|NCT01529346|404046|P4|COMPLETED|Overall Study||36
166101|NCT01529346|404047|P3|COMPLETED|Overall Study||52
166102|NCT01529346|404048|P2|COMPLETED|Overall Study||53
166103|NCT01529346|404049|P1|COMPLETED|Overall Study||53
166104|NCT01529346|404045|P5|STARTED|Overall Study||36
166105|NCT01529346|404046|P4|STARTED|Overall Study||36
166106|NCT01529346|404047|P3|STARTED|Overall Study||54
166107|NCT01529346|404048|P2|STARTED|Overall Study||54
166108|NCT01529346|404049|P1|STARTED|Overall Study||55
166109|NCT01529268|404137|P2|NOT COMPLETED|Overall Study||3
166110|NCT01529268|404138|P1|NOT COMPLETED|Overall Study||12
166111|NCT01529268|404137|P2|COMPLETED|Overall Study||78
166112|NCT01529268|404138|P1|COMPLETED|Overall Study||76
166113|NCT01529268|404137|P2|Completed 52-week Biopsy|Overall Study||75
166114|NCT01529268|404138|P1|Completed 52-week Biopsy|Overall Study||71
166115|NCT01529268|404137|P2|STARTED|Overall Study||81
166116|NCT01529268|404138|P1|STARTED|Overall Study||88
166117|NCT01529203|404192|P1|NOT COMPLETED|Overall Study||3
166118|NCT01529203|404192|P1|COMPLETED|Overall Study||57
166119|NCT01529203|404192|P1|STARTED|Overall Study||60
166120|NCT01529112|404200|P2|NOT COMPLETED|Overall Study||41
166121|NCT01529112|404201|P1|NOT COMPLETED|Overall Study||69
166122|NCT01529112|404200|P2|COMPLETED|Overall Study|Discontinued treatment-continued follow-up=5 (data cut-off date 21 January 2014)|5
166123|NCT01529112|404201|P1|COMPLETED|Overall Study|On treatment=2, Discontinued treatment-continued follow-up=18 (data cut-off date 21 January 2014)|20
166124|NCT01529112|404200|P2|STARTED|Overall Study||46
166125|NCT01529112|404201|P1|STARTED|Overall Study||89
166126|NCT01529060|404228|P2|NOT COMPLETED|Overall Study||0
166127|NCT01529060|404229|P1|NOT COMPLETED|Overall Study||0
166128|NCT01529060|404228|P2|COMPLETED|Overall Study||10
166129|NCT01529060|404229|P1|COMPLETED|Overall Study||10
166130|NCT01529060|404228|P2|STARTED|Overall Study||10
166131|NCT01529060|404229|P1|STARTED|Overall Study||10
166132|NCT01529034|404237|P1|NOT COMPLETED|Overall Study||174
166133|NCT01529034|404237|P1|COMPLETED|Overall Study|Completed under initial protocol duration of 2 years; amended protocol open-ended duration|1
166134|NCT01529034|404237|P1|Exposed|Overall Study|Treated at least 1 seizure cluster with USL261|161
166135|NCT01529034|404237|P1|STARTED|Overall Study|Completed Study P261-401 and rolled over to Study P261-402|175
166136|NCT01528969|404252|P2|NOT COMPLETED|Overall Study||0
166137|NCT01528969|404253|P1|NOT COMPLETED|Overall Study||2
166138|NCT01528969|404252|P2|COMPLETED|Overall Study||38
166139|NCT01528969|404253|P1|COMPLETED|Overall Study||35
166140|NCT01528969|404252|P2|STARTED|Overall Study||38
166141|NCT01528969|404253|P1|STARTED|Overall Study||37
166142|NCT01528891|404261|P2|NOT COMPLETED|Overall Study||0
166143|NCT01528891|404262|P1|NOT COMPLETED|Overall Study||0
166144|NCT01528891|404261|P2|COMPLETED|Overall Study||200
166145|NCT01528891|404262|P1|COMPLETED|Overall Study||200
166146|NCT01528891|404261|P2|STARTED|Overall Study||200
166147|NCT01528891|404262|P1|STARTED|Overall Study||200
166148|NCT01528878|404274|P1|NOT COMPLETED|Overall Study||0
166149|NCT01528878|404274|P1|COMPLETED|Overall Study||30
166150|NCT01528878|404274|P1|STARTED|Overall Study||30
166151|NCT01528787|404286|P4|NOT COMPLETED|Overall Study||1
166152|NCT01528787|404287|P3|NOT COMPLETED|Overall Study||1
166153|NCT01528787|404288|P2|NOT COMPLETED|Overall Study||0
166154|NCT01528787|404289|P1|NOT COMPLETED|Overall Study||0
166155|NCT01528787|404286|P4|COMPLETED|Overall Study||22
166156|NCT01528787|404287|P3|COMPLETED|Overall Study||18
166157|NCT01528787|404288|P2|COMPLETED|Overall Study||21
166158|NCT01528787|404289|P1|COMPLETED|Overall Study||22
166159|NCT01528787|404286|P4|STARTED|Overall Study||23
166160|NCT01528787|404287|P3|STARTED|Overall Study||19
166161|NCT01528787|404288|P2|STARTED|Overall Study||21
166162|NCT01528787|404289|P1|STARTED|Overall Study||22
166163|NCT01528735|404301|P2|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||0
166164|NCT01528735|404302|P1|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||1
166165|NCT01528735|404301|P2|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||12
166166|NCT01528735|404302|P1|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||10
166167|NCT01528735|404301|P2|STARTED|Treatment Period 2: Faldap/PegIFN/RBV|One patient was treated with only PegIFN/RBV, as faldaprevir was discontinued due to adverse events|12
166168|NCT01528735|404302|P1|STARTED|Treatment Period 2: Faldap/PegIFN/RBV||11
166169|NCT01528735|404301|P2|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
166170|NCT01528735|404302|P1|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
166171|NCT01528735|404301|P2|COMPLETED|Treatment Period 1: Faldap/Del/RBV||12
166172|NCT01528735|404302|P1|COMPLETED|Treatment Period 1: Faldap/Del/RBV||11
166173|NCT01528735|404301|P2|STARTED|Treatment Period 1: Faldap/Del/RBV||13
166174|NCT01528735|404302|P1|STARTED|Treatment Period 1: Faldap/Del/RBV||12
166175|NCT01528709|404404|P2|NOT COMPLETED|Overall Study||15
166176|NCT01528709|404405|P1|NOT COMPLETED|Overall Study||13
166177|NCT01528709|404404|P2|COMPLETED|Overall Study||72
166178|NCT01528709|404405|P1|COMPLETED|Overall Study||73
166179|NCT01528709|404404|P2|STARTED|Overall Study||87
166180|NCT01528709|404405|P1|STARTED|Overall Study||86
166181|NCT01528696|404415|P2|NOT COMPLETED|Overall Study||19
166182|NCT01528696|404416|P1|NOT COMPLETED|Overall Study||18
166183|NCT01528696|404415|P2|COMPLETED|Overall Study||0
166184|NCT01528696|404416|P1|COMPLETED|Overall Study||0
166185|NCT01528696|404415|P2|Hospital Stay (2-5 Days)|Overall Study||19
166186|NCT01528696|404416|P1|Hospital Stay (2-5 Days)|Overall Study||18
166187|NCT01528696|404415|P2|STARTED|Overall Study||19
166188|NCT01528696|404416|P1|STARTED|Overall Study||18
166189|NCT01528605|404432|P6|NOT COMPLETED|Overall Study||0
166190|NCT01528605|404433|P5|NOT COMPLETED|Overall Study||0
166191|NCT01528605|404434|P4|NOT COMPLETED|Overall Study||1
166192|NCT01528605|404435|P3|NOT COMPLETED|Overall Study||1
166193|NCT01528605|404436|P2|NOT COMPLETED|Overall Study||0
166194|NCT01528605|404437|P1|NOT COMPLETED|Overall Study||2
166195|NCT01528605|404432|P6|COMPLETED|Overall Study||28
166196|NCT01528605|404433|P5|COMPLETED|Overall Study||28
166197|NCT01528605|404434|P4|COMPLETED|Overall Study||27
166198|NCT01528605|404435|P3|COMPLETED|Overall Study||27
166199|NCT01528605|404436|P2|COMPLETED|Overall Study||28
166200|NCT01528605|404437|P1|COMPLETED|Overall Study||26
166201|NCT01528605|404432|P6|STARTED|Overall Study||28
166202|NCT01528605|404433|P5|STARTED|Overall Study||28
166203|NCT01528605|404434|P4|STARTED|Overall Study||28
166204|NCT01528605|404435|P3|STARTED|Overall Study||28
166205|NCT01528605|404436|P2|STARTED|Overall Study||28
166206|NCT01528605|404437|P1|STARTED|Overall Study||28
166207|NCT01528592|404461|P1|NOT COMPLETED|Overall Study||0
166208|NCT01528592|404461|P1|COMPLETED|Overall Study||18
166209|NCT01528592|404461|P1|STARTED|Overall Study||18
166210|NCT01528345|404467|P2|NOT COMPLETED|Overall Study||50
166211|NCT01528345|404468|P1|NOT COMPLETED|Overall Study||47
166212|NCT01528345|404467|P2|COMPLETED|Overall Study||0
166213|NCT01528345|404468|P1|COMPLETED|Overall Study||0
166214|NCT01528345|404467|P2|STARTED|Overall Study||50
166215|NCT01528345|404468|P1|STARTED|Overall Study||47
166216|NCT01528332|404486|P2|NOT COMPLETED|Overall Study||2
166217|NCT01528332|404487|P1|NOT COMPLETED|Overall Study||4
166218|NCT01528332|404486|P2|COMPLETED|Overall Study||84
166219|NCT01528332|404487|P1|COMPLETED|Overall Study||81
166220|NCT01528332|404486|P2|STARTED|Overall Study||86
166221|NCT01528332|404487|P1|STARTED|Overall Study||85
166222|NCT01528319|404493|P1|NOT COMPLETED|Overall Study||1
166223|NCT01528319|404493|P1|COMPLETED|Overall Study||23
166224|NCT01528319|404493|P1|12 Weeks After Surgery|Overall Study||24
166225|NCT01528319|404493|P1|STARTED|Overall Study||24
166226|NCT01528293|404504|P2|NOT COMPLETED|Overall Study||0
166227|NCT01528293|404505|P1|NOT COMPLETED|Overall Study||1
166228|NCT01528293|404504|P2|COMPLETED|Overall Study||1
166229|NCT01528293|404505|P1|COMPLETED|Overall Study||0
166230|NCT01528293|404504|P2|STARTED|Overall Study||1
166231|NCT01528293|404505|P1|STARTED|Overall Study||1
166232|NCT01528228|404519|P2|NOT COMPLETED|Overall Study||1
166233|NCT01528228|404520|P1|NOT COMPLETED|Overall Study||1
166234|NCT01528228|404519|P2|COMPLETED|Overall Study||9
166235|NCT01528228|404520|P1|COMPLETED|Overall Study||9
166236|NCT01528228|404519|P2|STARTED|Overall Study||10
166237|NCT01528228|404520|P1|STARTED|Overall Study||10
166238|NCT01528215|404528|P2|NOT COMPLETED|Overall Study||1
166239|NCT01528215|404529|P1|NOT COMPLETED|Overall Study||4
166240|NCT01528215|404528|P2|COMPLETED|Overall Study||60
166241|NCT01528215|404529|P1|COMPLETED|Overall Study||55
166242|NCT01528215|404528|P2|STARTED|Overall Study||61
166243|NCT01528215|404529|P1|STARTED|Overall Study||59
166244|NCT01528150|404535|P1|NOT COMPLETED|Overall Study||44
166245|NCT01528150|404535|P1|COMPLETED|Overall Study||422
166246|NCT01528150|404535|P1|STARTED|Overall Study||466
166247|NCT01528124|404546|P7|NOT COMPLETED|Overall Study||0
166248|NCT01528124|404547|P6|NOT COMPLETED|Overall Study||0
166249|NCT01528124|404548|P5|NOT COMPLETED|Overall Study||0
166250|NCT01528124|404549|P4|NOT COMPLETED|Overall Study||0
166251|NCT01528124|404550|P3|NOT COMPLETED|Overall Study||0
166252|NCT01528124|404551|P2|NOT COMPLETED|Overall Study||0
166253|NCT01528124|404552|P1|NOT COMPLETED|Overall Study||0
166254|NCT01528124|404546|P7|COMPLETED|Overall Study||6
166255|NCT01528124|404547|P6|COMPLETED|Overall Study||6
166256|NCT01528124|404548|P5|COMPLETED|Overall Study||5
166257|NCT01528124|404549|P4|COMPLETED|Overall Study||6
166258|NCT01528124|404550|P3|COMPLETED|Overall Study||6
166259|NCT01528124|404551|P2|COMPLETED|Overall Study||6
166260|NCT01528124|404552|P1|COMPLETED|Overall Study||6
166261|NCT01528124|404546|P7|Received Study Drug|Overall Study||6
166262|NCT01528124|404547|P6|Received Study Drug|Overall Study||6
166263|NCT01528124|404548|P5|Received Study Drug|Overall Study||5
166264|NCT01528124|404549|P4|Received Study Drug|Overall Study||6
166265|NCT01528124|404550|P3|Received Study Drug|Overall Study||6
166266|NCT01528124|404551|P2|Received Study Drug|Overall Study||6
166267|NCT01528124|404552|P1|Received Study Drug|Overall Study||6
166268|NCT01528124|404546|P7|STARTED|Overall Study||6
166269|NCT01528124|404547|P6|STARTED|Overall Study||6
166270|NCT01528124|404548|P5|STARTED|Overall Study||5
166271|NCT01528124|404549|P4|STARTED|Overall Study||6
166272|NCT01528124|404550|P3|STARTED|Overall Study||6
166273|NCT01528124|404551|P2|STARTED|Overall Study||6
166274|NCT01528124|404552|P1|STARTED|Overall Study||6
166275|NCT01527942|404588|P2|NOT COMPLETED|Overall Study||0
166276|NCT01527942|404589|P1|NOT COMPLETED|Overall Study||0
166277|NCT01527942|404588|P2|COMPLETED|Overall Study||18
166278|NCT01527942|404589|P1|COMPLETED|Overall Study||16
166279|NCT01527942|404588|P2|STARTED|Overall Study||18
166280|NCT01527942|404589|P1|STARTED|Overall Study||16
166281|NCT01527682|404599|P1|NOT COMPLETED|Overall Study||8
166282|NCT01527682|404599|P1|COMPLETED|Overall Study||29
166283|NCT01527682|404599|P1|STARTED|Overall Study||37
166284|NCT01527513|404607|P2|NOT COMPLETED|Eligible for 1-Year Open Label Period||17
166285|NCT01527513|404608|P1|NOT COMPLETED|Eligible for 1-Year Open Label Period||0
166286|NCT01527513|404607|P2|COMPLETED|Eligible for 1-Year Open Label Period||95
166287|NCT01527513|404608|P1|COMPLETED|Eligible for 1-Year Open Label Period||0
166288|NCT01527513|404607|P2|STARTED|Eligible for 1-Year Open Label Period|Participants that were eligible to participate in for 1-Year Open Label Period - Part II|112
166289|NCT01527513|404608|P1|STARTED|Eligible for 1-Year Open Label Period||0
166290|NCT01527513|404607|P2|NOT COMPLETED|Double Blind Period (DB) - Part I||8
166291|NCT01527513|404608|P1|NOT COMPLETED|Double Blind Period (DB) - Part I||3
166292|NCT01527513|404607|P2|COMPLETED|Double Blind Period (DB) - Part I||75
166293|NCT01527513|404608|P1|COMPLETED|Double Blind Period (DB) - Part I||37
166294|NCT01527513|404607|P2|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||66
166295|NCT01527513|404608|P1|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||36
166296|NCT01527513|404607|P2|Efficacy PP Population|Double Blind Period (DB) - Part I||67
166297|NCT01527513|404608|P1|Efficacy PP Population|Double Blind Period (DB) - Part I||37
166298|NCT01527513|404607|P2|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||75
166299|NCT01527513|404608|P1|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||37
166300|NCT01527513|404607|P2|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||75
166301|NCT01527513|404608|P1|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||37
166302|NCT01527513|404607|P2|Entered Maintenance Period|Double Blind Period (DB) - Part I||76
166303|NCT01527513|404608|P1|Entered Maintenance Period|Double Blind Period (DB) - Part I||40
166304|NCT01527513|404607|P2|Safety Population|Double Blind Period (DB) - Part I||83
166305|NCT01527513|404608|P1|Safety Population|Double Blind Period (DB) - Part I||40
166306|NCT01527513|404607|P2|Randomized|Double Blind Period (DB) - Part I||83
166307|NCT01527513|404608|P1|Randomized|Double Blind Period (DB) - Part I||40
166308|NCT01527513|404607|P2|STARTED|Double Blind Period (DB) - Part I||83
166309|NCT01527513|404608|P1|STARTED|Double Blind Period (DB) - Part I||40
166310|NCT01527500|404622|P2|NOT COMPLETED|Part B||0
166311|NCT01527500|404623|P1|NOT COMPLETED|Part B||1
166312|NCT01527500|404622|P2|COMPLETED|Part B||1
166313|NCT01527500|404623|P1|COMPLETED|Part B||6
166314|NCT01527500|404622|P2|STARTED|Part B||1
166315|NCT01527500|404623|P1|STARTED|Part B||7
166316|NCT01527500|404622|P2|NOT COMPLETED|Part A||13
166317|NCT01527500|404623|P1|NOT COMPLETED|Part A||30
166318|NCT01527500|404622|P2|COMPLETED|Part A||38
166319|NCT01527500|404623|P1|COMPLETED|Part A||69
166320|NCT01527500|404622|P2|STARTED|Part A||51
166321|NCT01527500|404623|P1|STARTED|Part A||99
166322|NCT01527487|404653|P2|NOT COMPLETED|Overall Study||7
166323|NCT01527487|404654|P1|NOT COMPLETED|Overall Study||8
166324|NCT01527487|404653|P2|COMPLETED|Overall Study||15
166325|NCT01527487|404654|P1|COMPLETED|Overall Study|Patients who completed 6 cycles plus surgery.|46
166326|NCT01527487|404653|P2|STARTED|Overall Study||22
166327|NCT01527487|404654|P1|STARTED|Overall Study|Includes 10 patients from safety lead-in.|54
166328|NCT01527383|404668|P2|NOT COMPLETED|Overall Study||4
166329|NCT01527383|404669|P1|NOT COMPLETED|Overall Study||15
166330|NCT01527383|404668|P2|COMPLETED|Overall Study||58
166331|NCT01527383|404669|P1|COMPLETED|Overall Study||277
166332|NCT01527383|404668|P2|Vaccination 4 (~Day 90)|Overall Study||58
166333|NCT01527383|404669|P1|Vaccination 4 (~Day 90)|Overall Study||277
166334|NCT01527383|404668|P2|Vaccination 3 (~Day 60)|Overall Study||58
166335|NCT01527383|404669|P1|Vaccination 3 (~Day 60)|Overall Study||278
166336|NCT01527383|404668|P2|Vaccination 2 (~Day 30)|Overall Study||61
166337|NCT01527383|404669|P1|Vaccination 2 (~Day 30)|Overall Study||283
166338|NCT01527383|404668|P2|Vaccination 1 (Day 1)|Overall Study||62
166339|NCT01527383|404669|P1|Vaccination 1 (Day 1)|Overall Study||291
166340|NCT01527383|404668|P2|STARTED|Overall Study||62
166341|NCT01527383|404669|P1|STARTED|Overall Study||292
166342|NCT01527370|404683|P1|NOT COMPLETED|Overall Study||6
166343|NCT01527370|404683|P1|COMPLETED|Overall Study||244
166344|NCT01527370|404683|P1|STARTED|Overall Study||250
166345|NCT01527292|404691|P2|NOT COMPLETED|Overall Study||3
166346|NCT01527292|404692|P1|NOT COMPLETED|Overall Study||0
166347|NCT01527292|404691|P2|COMPLETED|Overall Study||0
166348|NCT01527292|404692|P1|COMPLETED|Overall Study||0
166349|NCT01527292|404691|P2|STARTED|Overall Study||3
166350|NCT01527292|404692|P1|STARTED|Overall Study||0
166351|NCT01527162|404708|P2|NOT COMPLETED|Overall Study||0
166352|NCT01527162|404709|P1|NOT COMPLETED|Overall Study||0
166353|NCT01527162|404708|P2|COMPLETED|Overall Study||5
166354|NCT01527162|404709|P1|COMPLETED|Overall Study||6
166355|NCT01527162|404708|P2|STARTED|Overall Study||5
166356|NCT01527162|404709|P1|STARTED|Overall Study||6
166357|NCT01527110|404719|P1|NOT COMPLETED|Overall Study||1
166358|NCT01527110|404719|P1|COMPLETED|Overall Study||20
166359|NCT01527110|404719|P1|STARTED|Overall Study||21
166360|NCT01527045|404767|P3|NOT COMPLETED|Overall Study||0
166361|NCT01527045|404768|P2|NOT COMPLETED|Overall Study||0
166362|NCT01527045|404769|P1|NOT COMPLETED|Overall Study||1
166363|NCT01527045|404767|P3|COMPLETED|Overall Study||12
166364|NCT01527045|404768|P2|COMPLETED|Overall Study||5
166365|NCT01527045|404769|P1|COMPLETED|Overall Study||29
166366|NCT01527045|404767|P3|STARTED|Overall Study||12
166367|NCT01527045|404768|P2|STARTED|Overall Study||5
166368|NCT01527045|404769|P1|STARTED|Overall Study||30
166369|NCT01527006|404800|P2|NOT COMPLETED|Extension Phase||8
166370|NCT01527006|404801|P1|NOT COMPLETED|Extension Phase||6
166371|NCT01527006|404800|P2|COMPLETED|Extension Phase||14
166372|NCT01527006|404801|P1|COMPLETED|Extension Phase||13
166373|NCT01527006|404800|P2|STARTED|Extension Phase||22
166374|NCT01527006|404801|P1|STARTED|Extension Phase|Of the 20 subjects who completed the Core Study, 19 subjects continued into the Extension Phase.|19
166375|NCT01527006|404800|P2|NOT COMPLETED|Core Study||6
166376|NCT01527006|404801|P1|NOT COMPLETED|Core Study||2
166377|NCT01527006|404800|P2|COMPLETED|Core Study||22
166378|NCT01527006|404801|P1|COMPLETED|Core Study||20
166379|NCT01527006|404800|P2|STARTED|Core Study||28
166380|NCT01527006|404801|P1|STARTED|Core Study||22
166381|NCT01526902|404851|P2|NOT COMPLETED|Overall Study||0
166382|NCT01526902|404852|P1|NOT COMPLETED|Overall Study||0
166383|NCT01526902|404851|P2|COMPLETED|Overall Study||24
166384|NCT01526902|404852|P1|COMPLETED|Overall Study||25
166385|NCT01526902|404851|P2|STARTED|Overall Study||24
166386|NCT01526902|404852|P1|STARTED|Overall Study||25
166387|NCT01526889|404870|P2|NOT COMPLETED|Treatment Extension Period||0
166388|NCT01526889|404871|P1|NOT COMPLETED|Treatment Extension Period||1
166389|NCT01526889|404870|P2|COMPLETED|Treatment Extension Period||0
166390|NCT01526889|404871|P1|COMPLETED|Treatment Extension Period||4
166391|NCT01526889|404870|P2|STARTED|Treatment Extension Period||0
166392|NCT01526889|404871|P1|STARTED|Treatment Extension Period||5
166393|NCT01526889|404870|P2|NOT COMPLETED|Treatment Period||0
166394|NCT01526889|404871|P1|NOT COMPLETED|Treatment Period||2
166395|NCT01526889|404870|P2|COMPLETED|Treatment Period||7
166396|NCT01526889|404871|P1|COMPLETED|Treatment Period||16
166397|NCT01526889|404870|P2|STARTED|Treatment Period||7
166398|NCT01526889|404871|P1|STARTED|Treatment Period||18
166399|NCT01526785|404892|P1|NOT COMPLETED|Overall Study||13
166400|NCT01526785|404892|P1|COMPLETED|Overall Study||100
166401|NCT01526785|404892|P1|STARTED|Overall Study||113
166402|NCT01526733|404902|P2|NOT COMPLETED|Phase 2||0
166403|NCT01526733|404903|P1|NOT COMPLETED|Phase 2||0
166404|NCT01526733|404902|P2|COMPLETED|Phase 2||12
166405|NCT01526733|404903|P1|COMPLETED|Phase 2||10
166406|NCT01526733|404902|P2|STARTED|Phase 2||12
166407|NCT01526733|404903|P1|STARTED|Phase 2||10
166408|NCT01526733|404902|P2|NOT COMPLETED|Washout Period of 5 to 21 Days||0
166409|NCT01526733|404903|P1|NOT COMPLETED|Washout Period of 5 to 21 Days||0
166410|NCT01526733|404902|P2|COMPLETED|Washout Period of 5 to 21 Days||12
166411|NCT01526733|404903|P1|COMPLETED|Washout Period of 5 to 21 Days||10
166412|NCT01526733|404902|P2|STARTED|Washout Period of 5 to 21 Days||12
166413|NCT01526733|404903|P1|STARTED|Washout Period of 5 to 21 Days||10
166414|NCT01526733|404902|P2|NOT COMPLETED|Phase 1||1
166415|NCT01526733|404903|P1|NOT COMPLETED|Phase 1||2
166416|NCT01526733|404902|P2|COMPLETED|Phase 1||12
166417|NCT01526733|404903|P1|COMPLETED|Phase 1||10
166418|NCT01526733|404902|P2|Received at Least 1 Dose of Study Drug|Phase 1||13
166419|NCT01526733|404903|P1|Received at Least 1 Dose of Study Drug|Phase 1||12
166420|NCT01526733|404902|P2|STARTED|Phase 1|One participant discontinued after receiving insulin-sham and before receiving insulin-rHuPH20.|13
166421|NCT01526733|404903|P1|STARTED|Phase 1||12
166422|NCT01526629|404921|P1|NOT COMPLETED|Overall Study||46
166423|NCT01526629|404921|P1|COMPLETED|Overall Study||308
166424|NCT01526629|404921|P1|STARTED|Overall Study||354
166425|NCT01526577|404930|P5|NOT COMPLETED|Overall Study||2
166426|NCT01526577|404931|P4|NOT COMPLETED|Overall Study||1
166427|NCT01526577|404932|P3|NOT COMPLETED|Overall Study||1
166428|NCT01526577|404933|P2|NOT COMPLETED|Overall Study||0
166429|NCT01526577|404934|P1|NOT COMPLETED|Overall Study||1
166430|NCT01526577|404930|P5|COMPLETED|Overall Study||8
166431|NCT01526577|404931|P4|COMPLETED|Overall Study||8
166432|NCT01526577|404932|P3|COMPLETED|Overall Study||32
166433|NCT01526577|404933|P2|COMPLETED|Overall Study||12
166434|NCT01526577|404934|P1|COMPLETED|Overall Study||48
166435|NCT01526577|404930|P5|STARTED|Overall Study|2 more subjects were enrolled as the substitutes for 2 withdrawn subjects before the administration.|10
166436|NCT01526577|404931|P4|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|9
166437|NCT01526577|404932|P3|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|33
166438|NCT01526577|404933|P2|STARTED|Overall Study||12
166439|NCT01526577|404934|P1|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|49
166440|NCT01526551|404942|P1|NOT COMPLETED|Overall Study||424
166441|NCT01526551|404942|P1|COMPLETED|Overall Study||511
166442|NCT01526551|404942|P1|STARTED|Overall Study||935
166443|NCT01526538|404949|P2|NOT COMPLETED|Overall Study||4
166444|NCT01526538|404950|P1|NOT COMPLETED|Overall Study||9
166445|NCT01526538|404949|P2|COMPLETED|Overall Study||18
166446|NCT01526538|404950|P1|COMPLETED|Overall Study||21
166447|NCT01526538|404949|P2|STARTED|Overall Study||22
166448|NCT01526538|404950|P1|STARTED|Overall Study||30
166449|NCT01526343|404960|P1|NOT COMPLETED|Overall Study||0
166450|NCT01526343|404960|P1|COMPLETED|Overall Study||47
166451|NCT01526343|404960|P1|STARTED|Overall Study||47
166452|NCT01526213|404971|P6|NOT COMPLETED|Period 3 (5 Days)||0
166453|NCT01526213|404972|P5|NOT COMPLETED|Period 3 (5 Days)||0
166454|NCT01526213|404973|P4|NOT COMPLETED|Period 3 (5 Days)||0
166455|NCT01526213|404974|P3|NOT COMPLETED|Period 3 (5 Days)||0
166456|NCT01526213|404975|P2|NOT COMPLETED|Period 3 (5 Days)||0
166457|NCT01526213|404976|P1|NOT COMPLETED|Period 3 (5 Days)||0
166458|NCT01526213|404971|P6|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
166459|NCT01526213|404972|P5|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
166460|NCT01526213|404973|P4|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
166461|NCT01526213|404974|P3|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
166462|NCT01526213|404975|P2|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
166463|NCT01526213|404976|P1|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
166464|NCT01526213|404971|P6|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
166465|NCT01526213|404972|P5|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
166466|NCT01526213|404973|P4|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
166467|NCT01526213|404974|P3|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
166468|NCT01526213|404975|P2|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
166469|NCT01526213|404976|P1|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
166470|NCT01526213|404971|P6|NOT COMPLETED|Washout 2 (10 Days)||0
166471|NCT01526213|404972|P5|NOT COMPLETED|Washout 2 (10 Days)||0
166472|NCT01526213|404973|P4|NOT COMPLETED|Washout 2 (10 Days)||0
166473|NCT01526213|404974|P3|NOT COMPLETED|Washout 2 (10 Days)||0
166474|NCT01526213|404975|P2|NOT COMPLETED|Washout 2 (10 Days)||0
166475|NCT01526213|404976|P1|NOT COMPLETED|Washout 2 (10 Days)||0
166476|NCT01526213|404971|P6|COMPLETED|Washout 2 (10 Days)||3
166477|NCT01526213|404972|P5|COMPLETED|Washout 2 (10 Days)||3
166478|NCT01526213|404973|P4|COMPLETED|Washout 2 (10 Days)||3
166479|NCT01526213|404974|P3|COMPLETED|Washout 2 (10 Days)||3
166480|NCT01526213|404975|P2|COMPLETED|Washout 2 (10 Days)||3
166481|NCT01526213|404976|P1|COMPLETED|Washout 2 (10 Days)||3
166482|NCT01526213|404971|P6|STARTED|Washout 2 (10 Days)||3
166483|NCT01526213|404972|P5|STARTED|Washout 2 (10 Days)||3
166484|NCT01526213|404973|P4|STARTED|Washout 2 (10 Days)||3
166485|NCT01526213|404974|P3|STARTED|Washout 2 (10 Days)||3
166486|NCT01526213|404975|P2|STARTED|Washout 2 (10 Days)||3
166487|NCT01526213|404976|P1|STARTED|Washout 2 (10 Days)||3
166488|NCT01526213|404971|P6|NOT COMPLETED|Period 2 (5 Days)||0
166489|NCT01526213|404972|P5|NOT COMPLETED|Period 2 (5 Days)||0
166490|NCT01526213|404973|P4|NOT COMPLETED|Period 2 (5 Days)||0
166491|NCT01526213|404974|P3|NOT COMPLETED|Period 2 (5 Days)||0
166492|NCT01526213|404975|P2|NOT COMPLETED|Period 2 (5 Days)||0
166493|NCT01526213|404976|P1|NOT COMPLETED|Period 2 (5 Days)||0
166494|NCT01526213|404971|P6|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
166495|NCT01526213|404972|P5|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
166496|NCT01526213|404973|P4|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
166497|NCT01526213|404974|P3|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
166498|NCT01526213|404975|P2|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
166499|NCT01526213|404976|P1|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
166500|NCT01526213|404971|P6|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
166501|NCT01526213|404972|P5|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
166502|NCT01526213|404973|P4|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
166503|NCT01526213|404974|P3|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
166504|NCT01526213|404975|P2|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
166505|NCT01526213|404976|P1|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
166506|NCT01526213|404971|P6|NOT COMPLETED|Washout 1 (10 Days)||0
166507|NCT01526213|404972|P5|NOT COMPLETED|Washout 1 (10 Days)||0
166508|NCT01526213|404973|P4|NOT COMPLETED|Washout 1 (10 Days)||0
166509|NCT01526213|404974|P3|NOT COMPLETED|Washout 1 (10 Days)||0
166510|NCT01526213|404975|P2|NOT COMPLETED|Washout 1 (10 Days)||0
166511|NCT01526213|404976|P1|NOT COMPLETED|Washout 1 (10 Days)||0
166512|NCT01526213|404971|P6|COMPLETED|Washout 1 (10 Days)||3
166513|NCT01526213|404972|P5|COMPLETED|Washout 1 (10 Days)||3
166514|NCT01526213|404973|P4|COMPLETED|Washout 1 (10 Days)||3
166515|NCT01526213|404974|P3|COMPLETED|Washout 1 (10 Days)||3
166516|NCT01526213|404975|P2|COMPLETED|Washout 1 (10 Days)||3
166517|NCT01526213|404976|P1|COMPLETED|Washout 1 (10 Days)||3
166518|NCT01526213|404971|P6|STARTED|Washout 1 (10 Days)||3
166519|NCT01526213|404972|P5|STARTED|Washout 1 (10 Days)||3
166520|NCT01526213|404973|P4|STARTED|Washout 1 (10 Days)||3
166521|NCT01526213|404974|P3|STARTED|Washout 1 (10 Days)||3
166522|NCT01526213|404975|P2|STARTED|Washout 1 (10 Days)||3
166523|NCT01526213|404976|P1|STARTED|Washout 1 (10 Days)||3
166524|NCT01526213|404971|P6|NOT COMPLETED|Period 1 (5 Days)||0
166525|NCT01526213|404972|P5|NOT COMPLETED|Period 1 (5 Days)||0
166526|NCT01526213|404973|P4|NOT COMPLETED|Period 1 (5 Days)||0
166527|NCT01526213|404974|P3|NOT COMPLETED|Period 1 (5 Days)||0
166528|NCT01526213|404975|P2|NOT COMPLETED|Period 1 (5 Days)||0
166529|NCT01526213|404976|P1|NOT COMPLETED|Period 1 (5 Days)||0
166530|NCT01526213|404971|P6|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
166531|NCT01526213|404972|P5|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
166532|NCT01526213|404973|P4|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
166533|NCT01526213|404974|P3|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
166534|NCT01526213|404975|P2|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
166535|NCT01526213|404976|P1|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
166536|NCT01526213|404971|P6|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to (and completed) one of six sequences.|3
166537|NCT01526213|404972|P5|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
166538|NCT01526213|404973|P4|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
166539|NCT01526213|404974|P3|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
166540|NCT01526213|404975|P2|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
166541|NCT01526213|404976|P1|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
166542|NCT01526148|404989|P2|NOT COMPLETED|Overall Study||13
166543|NCT01526148|404990|P1|NOT COMPLETED|Overall Study||14
166544|NCT01526148|404989|P2|COMPLETED|Overall Study||11
166545|NCT01526148|404990|P1|COMPLETED|Overall Study||4
166546|NCT01526148|404989|P2|STARTED|Overall Study||24
166547|NCT01526148|404990|P1|STARTED|Overall Study||18
166548|NCT01526057|405001|P3|NOT COMPLETED|Overall Study||6
166549|NCT01526057|405002|P2|NOT COMPLETED|Overall Study||3
166550|NCT01526057|405003|P1|NOT COMPLETED|Overall Study||9
166551|NCT01526057|405001|P3|COMPLETED|Overall Study||67
166552|NCT01526057|405002|P2|COMPLETED|Overall Study||71
166553|NCT01526057|405003|P1|COMPLETED|Overall Study||64
166554|NCT01526057|405001|P3|STARTED|Overall Study||73
166555|NCT01526057|405002|P2|STARTED|Overall Study||74
166556|NCT01526057|405003|P1|STARTED|Overall Study||73
166557|NCT01525927|405088|P1|NOT COMPLETED|Overall Study||0
166558|NCT01525927|405088|P1|COMPLETED|Overall Study||0
166559|NCT01525927|405088|P1|STARTED|Overall Study||0
166560|NCT01525875|405102|P2|NOT COMPLETED|Open-label Period||2
166561|NCT01525875|405103|P1|NOT COMPLETED|Open-label Period||0
166562|NCT01525875|405102|P2|COMPLETED|Open-label Period||18
166563|NCT01525875|405103|P1|COMPLETED|Open-label Period||21
166564|NCT01525875|405102|P2|STARTED|Open-label Period||20
166565|NCT01525875|405103|P1|STARTED|Open-label Period||21
166566|NCT01525875|405102|P2|NOT COMPLETED|Placebo-controlled Period||2
166567|NCT01525875|405103|P1|NOT COMPLETED|Placebo-controlled Period||1
166568|NCT01525875|405102|P2|COMPLETED|Placebo-controlled Period||20
166569|NCT01525875|405103|P1|COMPLETED|Placebo-controlled Period||21
166570|NCT01525875|405102|P2|STARTED|Placebo-controlled Period||22
166571|NCT01525875|405103|P1|STARTED|Placebo-controlled Period||22
166572|NCT01525849|405119|P2|NOT COMPLETED|Overall Study||16
166573|NCT01525849|405120|P1|NOT COMPLETED|Overall Study||5
166574|NCT01525849|405119|P2|COMPLETED|Overall Study||59
166575|NCT01525849|405120|P1|COMPLETED|Overall Study||71
166576|NCT01525849|405119|P2|6-Months|Overall Study||60
166577|NCT01525849|405120|P1|6-Months|Overall Study||73
166578|NCT01525849|405119|P2|Treated|Overall Study|14 withdrew before treatment: 8 didn't want FESS, 1 too busy, 2 medical issues, 3 excl. criteria.|61
166673|NCT01525173|405499|P1|STARTED|Overall Study||70
166579|NCT01525849|405120|P1|Treated|Overall Study|2 withdrew before treatment: 1 didn't want balloon dilation, 1 unrelated medical issue.|74
166580|NCT01525849|405119|P2|STARTED|Overall Study||75
166581|NCT01525849|405120|P1|STARTED|Overall Study||76
166582|NCT01525745|405136|P2|NOT COMPLETED|Overall Study||1
166583|NCT01525745|405137|P1|NOT COMPLETED|Overall Study||1
166584|NCT01525745|405136|P2|COMPLETED|Overall Study||1
166585|NCT01525745|405137|P1|COMPLETED|Overall Study||3
166586|NCT01525745|405136|P2|STARTED|Overall Study||2
166587|NCT01525745|405137|P1|STARTED|Overall Study||4
166588|NCT01525667|405154|P3|NOT COMPLETED|Overall Study||0
166589|NCT01525667|405155|P2|NOT COMPLETED|Overall Study||0
166590|NCT01525667|405156|P1|NOT COMPLETED|Overall Study||0
166591|NCT01525667|405154|P3|COMPLETED|Overall Study||7
166592|NCT01525667|405155|P2|COMPLETED|Overall Study||6
166593|NCT01525667|405156|P1|COMPLETED|Overall Study||7
166594|NCT01525667|405154|P3|STARTED|Overall Study||7
166595|NCT01525667|405155|P2|STARTED|Overall Study||6
166596|NCT01525667|405156|P1|STARTED|Overall Study||7
166597|NCT01525641|405176|P1|NOT COMPLETED|Overall Study||180
166598|NCT01525641|405176|P1|COMPLETED|Overall Study||435
166599|NCT01525641|405176|P1|STARTED|Overall Study||615
166600|NCT01525628|405190|P5|NOT COMPLETED|Overall Study||3
166601|NCT01525628|405191|P4|NOT COMPLETED|Overall Study||4
166602|NCT01525628|405192|P3|NOT COMPLETED|Overall Study||5
166603|NCT01525628|405193|P2|NOT COMPLETED|Overall Study||5
166604|NCT01525628|405194|P1|NOT COMPLETED|Overall Study||2
166605|NCT01525628|405190|P5|COMPLETED|Overall Study||4
166606|NCT01525628|405191|P4|COMPLETED|Overall Study||10
166607|NCT01525628|405192|P3|COMPLETED|Overall Study||11
166608|NCT01525628|405193|P2|COMPLETED|Overall Study||14
166609|NCT01525628|405194|P1|COMPLETED|Overall Study||14
166610|NCT01525628|405190|P5|STARTED|Overall Study||7
166611|NCT01525628|405191|P4|STARTED|Overall Study||14
166612|NCT01525628|405192|P3|STARTED|Overall Study||16
166613|NCT01525628|405193|P2|STARTED|Overall Study||19
166614|NCT01525628|405194|P1|STARTED|Overall Study||16
166615|NCT01525615|405261|P3|NOT COMPLETED|Overall Study||6
166616|NCT01525615|405262|P2|NOT COMPLETED|Overall Study||7
166617|NCT01525615|405263|P1|NOT COMPLETED|Overall Study||14
166618|NCT01525615|405261|P3|COMPLETED|Overall Study||133
166619|NCT01525615|405262|P2|COMPLETED|Overall Study||126
166620|NCT01525615|405263|P1|COMPLETED|Overall Study||118
166621|NCT01525615|405261|P3|STARTED|Overall Study||139
166622|NCT01525615|405262|P2|STARTED|Overall Study||133
166623|NCT01525615|405263|P1|STARTED|Overall Study||132
166624|NCT01525563|405307|P1|NOT COMPLETED|Overall Study||212
166625|NCT01525563|405307|P1|COMPLETED|Overall Study|6 Months Follow-up|788
166626|NCT01525563|405307|P1|3 Months Follow-up|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|838
166627|NCT01525563|405307|P1|End of Treatment|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|910
166628|NCT01525563|405307|P1|STARTED|Overall Study||1000
166629|NCT01525550|405319|P2|NOT COMPLETED|Overall Study||45
166630|NCT01525550|405320|P1|NOT COMPLETED|Overall Study||61
166631|NCT01525550|405319|P2|COMPLETED|Overall Study||0
166632|NCT01525550|405320|P1|COMPLETED|Overall Study||0
166633|NCT01525550|405319|P2|STARTED|Overall Study||45
166634|NCT01525550|405320|P1|STARTED|Overall Study||61
166635|NCT01525420|405382|P2|NOT COMPLETED|Overall Study||24
166636|NCT01525420|405383|P1|NOT COMPLETED|Overall Study||16
166637|NCT01525420|405382|P2|COMPLETED|Overall Study||38
166638|NCT01525420|405383|P1|COMPLETED|Overall Study||43
166639|NCT01525420|405382|P2|STARTED|Overall Study||62
166640|NCT01525420|405383|P1|STARTED|Overall Study||59
166641|NCT01525407|405391|P2|NOT COMPLETED|Overall Study||4
166642|NCT01525407|405392|P1|NOT COMPLETED|Overall Study||3
166643|NCT01525407|405391|P2|COMPLETED|Overall Study||38
166644|NCT01525407|405392|P1|COMPLETED|Overall Study||38
166645|NCT01525407|405391|P2|STARTED|Overall Study||42
166646|NCT01525407|405392|P1|STARTED|Overall Study||41
166647|NCT01525329|405408|P2|NOT COMPLETED|Overall Study||0
166648|NCT01525329|405409|P1|NOT COMPLETED|Overall Study||0
166649|NCT01525329|405408|P2|COMPLETED|Overall Study||14
166650|NCT01525329|405409|P1|COMPLETED|Overall Study||4
166651|NCT01525329|405408|P2|STARTED|Overall Study||14
166652|NCT01525329|405409|P1|STARTED|Overall Study||4
166653|NCT01525238|405424|P3|NOT COMPLETED|Overall Study||0
166654|NCT01525238|405425|P2|NOT COMPLETED|Overall Study||0
166655|NCT01525238|405426|P1|NOT COMPLETED|Overall Study||1
166656|NCT01525238|405424|P3|COMPLETED|Overall Study||8
166657|NCT01525238|405425|P2|COMPLETED|Overall Study||8
166658|NCT01525238|405426|P1|COMPLETED|Overall Study||7
166659|NCT01525238|405424|P3|STARTED|Overall Study||8
166660|NCT01525238|405425|P2|STARTED|Overall Study||8
166661|NCT01525238|405426|P1|STARTED|Overall Study||8
166662|NCT01525225|405491|P1|NOT COMPLETED|Treated||0
166663|NCT01525225|405491|P1|COMPLETED|Treated||2
166664|NCT01525225|405491|P1|STARTED|Treated||2
166665|NCT01525225|405491|P1|NOT COMPLETED|Enrollment||2
166666|NCT01525225|405491|P1|COMPLETED|Enrollment||2
166667|NCT01525225|405491|P1|STARTED|Enrollment||4
166668|NCT01525173|405498|P2|NOT COMPLETED|Overall Study||5
166669|NCT01525173|405499|P1|NOT COMPLETED|Overall Study||7
166670|NCT01525173|405498|P2|COMPLETED|Overall Study||62
166671|NCT01525173|405499|P1|COMPLETED|Overall Study||63
166672|NCT01525173|405498|P2|STARTED|Overall Study||67
166674|NCT01524991|405505|P1|NOT COMPLETED|Overall Study||34
166675|NCT01524991|405505|P1|COMPLETED|Overall Study||2
166676|NCT01524991|405505|P1|STARTED|Overall Study||36
166677|NCT01524978|405523|P11|NOT COMPLETED|Overall Study||28
166678|NCT01524978|405524|P10|NOT COMPLETED|Overall Study||9
166679|NCT01524978|405525|P9|NOT COMPLETED|Overall Study||12
166680|NCT01524978|405526|P8|NOT COMPLETED|Overall Study||12
166681|NCT01524978|405527|P7|NOT COMPLETED|Overall Study||26
166682|NCT01524978|405528|P6|NOT COMPLETED|Overall Study||9
166683|NCT01524978|405529|P5|NOT COMPLETED|Overall Study||9
166684|NCT01524978|405530|P4|NOT COMPLETED|Overall Study||27
166685|NCT01524978|405531|P3|NOT COMPLETED|Overall Study||10
166686|NCT01524978|405532|P2|NOT COMPLETED|Overall Study||4
166687|NCT01524978|405533|P1|NOT COMPLETED|Overall Study||62
166688|NCT01524978|405523|P11|COMPLETED|Overall Study||0
166689|NCT01524978|405524|P10|COMPLETED|Overall Study||0
166690|NCT01524978|405525|P9|COMPLETED|Overall Study||0
166691|NCT01524978|405526|P8|COMPLETED|Overall Study||0
166692|NCT01524978|405527|P7|COMPLETED|Overall Study||0
166693|NCT01524978|405528|P6|COMPLETED|Overall Study||0
166694|NCT01524978|405529|P5|COMPLETED|Overall Study||0
166695|NCT01524978|405530|P4|COMPLETED|Overall Study||0
166696|NCT01524978|405531|P3|COMPLETED|Overall Study||0
166697|NCT01524978|405532|P2|COMPLETED|Overall Study||0
166698|NCT01524978|405533|P1|COMPLETED|Overall Study||0
166699|NCT01524978|405523|P11|STARTED|Overall Study||28
166700|NCT01524978|405524|P10|STARTED|Overall Study||9
166701|NCT01524978|405525|P9|STARTED|Overall Study||12
166702|NCT01524978|405526|P8|STARTED|Overall Study||12
166703|NCT01524978|405527|P7|STARTED|Overall Study||26
166704|NCT01524978|405528|P6|STARTED|Overall Study||9
166705|NCT01524978|405529|P5|STARTED|Overall Study||9
166706|NCT01524978|405530|P4|STARTED|Overall Study||27
166707|NCT01524978|405531|P3|STARTED|Overall Study||10
166708|NCT01524978|405532|P2|STARTED|Overall Study||4
166709|NCT01524978|405533|P1|STARTED|Overall Study||62
166710|NCT01524913|405661|P3|NOT COMPLETED|Overall Study||0
166711|NCT01524913|405662|P2|NOT COMPLETED|Overall Study||0
166712|NCT01524913|405663|P1|NOT COMPLETED|Overall Study||4
166713|NCT01524913|405661|P3|COMPLETED|Overall Study||31
166714|NCT01524913|405662|P2|COMPLETED|Overall Study||36
166715|NCT01524913|405663|P1|COMPLETED|Overall Study||31
166716|NCT01524913|405661|P3|STARTED|Overall Study||31
166717|NCT01524913|405662|P2|STARTED|Overall Study||36
166718|NCT01524913|405663|P1|STARTED|Overall Study||35
166719|NCT01524900|405685|P5|NOT COMPLETED|Overall Study||0
166720|NCT01524900|405686|P4|NOT COMPLETED|Overall Study||1
166721|NCT01524900|405687|P3|NOT COMPLETED|Overall Study||1
166722|NCT01524900|405688|P2|NOT COMPLETED|Overall Study||14
166723|NCT01524900|405689|P1|NOT COMPLETED|Overall Study||6
166724|NCT01524900|405685|P5|COMPLETED|Overall Study||40
166725|NCT01524900|405686|P4|COMPLETED|Overall Study||21
166726|NCT01524900|405687|P3|COMPLETED|Overall Study||29
166727|NCT01524900|405688|P2|COMPLETED|Overall Study||232
166728|NCT01524900|405689|P1|COMPLETED|Overall Study||43
166729|NCT01524900|405685|P5|STARTED|Overall Study||40
166730|NCT01524900|405686|P4|STARTED|Overall Study||22
166731|NCT01524900|405687|P3|STARTED|Overall Study||30
166732|NCT01524900|405688|P2|STARTED|Overall Study||246
166733|NCT01524900|405689|P1|STARTED|Overall Study||49
166734|NCT01524887|405734|P3|NOT COMPLETED|Overall Study||86
166735|NCT01524887|405735|P2|NOT COMPLETED|Overall Study||90
166736|NCT01524887|405736|P1|NOT COMPLETED|Overall Study||85
166737|NCT01524887|405734|P3|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
166738|NCT01524887|405735|P2|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
166739|NCT01524887|405736|P1|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
166740|NCT01524887|405734|P3|Received Treatment|Overall Study||83
166741|NCT01524887|405735|P2|Received Treatment|Overall Study||85
166742|NCT01524887|405736|P1|Received Treatment|Overall Study||83
166743|NCT01524887|405734|P3|STARTED|Overall Study||86
166744|NCT01524887|405735|P2|STARTED|Overall Study||90
166745|NCT01524887|405736|P1|STARTED|Overall Study||85
166746|NCT01524796|405780|P1|NOT COMPLETED|Overall Study||28
166747|NCT01524796|405780|P1|COMPLETED|Overall Study||100
166748|NCT01524796|405780|P1|STARTED|Overall Study||128
166749|NCT01524783|405795|P2|NOT COMPLETED|Randomized and Treated||84
166750|NCT01524783|405796|P1|NOT COMPLETED|Randomized and Treated||155
166751|NCT01524783|405795|P2|COMPLETED|Randomized and Treated|Completed = Patients with ongoing treatment at the time of data cut-off of 28-Nov-2014.|13
166752|NCT01524783|405796|P1|COMPLETED|Randomized and Treated|Completed = Patients with ongoing treatment at the time of data cut-off of 28-Nov-2014.|48
166753|NCT01524783|405795|P2|STARTED|Randomized and Treated||97
166754|NCT01524783|405796|P1|STARTED|Randomized and Treated||203
166755|NCT01524783|405795|P2|NOT COMPLETED|Randomized But Not Treated||0
166756|NCT01524783|405796|P1|NOT COMPLETED|Randomized But Not Treated||2
166757|NCT01524783|405795|P2|COMPLETED|Randomized But Not Treated|Completed = Participants randomized and treated with study drug|97
166758|NCT01524783|405796|P1|COMPLETED|Randomized But Not Treated|Completed = Participants randomized and treated with study drug|203
166759|NCT01524783|405795|P2|STARTED|Randomized But Not Treated||97
166760|NCT01524783|405796|P1|STARTED|Randomized But Not Treated||205
166761|NCT01524770|405804|P2|NOT COMPLETED|Second Intervention||0
166762|NCT01524770|405805|P1|NOT COMPLETED|Second Intervention||0
166763|NCT01524770|405804|P2|COMPLETED|Second Intervention||23
166764|NCT01524770|405805|P1|COMPLETED|Second Intervention||23
166765|NCT01524770|405804|P2|STARTED|Second Intervention||23
166766|NCT01524770|405805|P1|STARTED|Second Intervention||23
166767|NCT01524770|405804|P2|NOT COMPLETED|Washout Period of at Least 28 Days||0
166768|NCT01524770|405805|P1|NOT COMPLETED|Washout Period of at Least 28 Days||0
166769|NCT01524770|405804|P2|COMPLETED|Washout Period of at Least 28 Days||23
166770|NCT01524770|405805|P1|COMPLETED|Washout Period of at Least 28 Days||23
166771|NCT01524770|405804|P2|STARTED|Washout Period of at Least 28 Days||23
166772|NCT01524770|405805|P1|STARTED|Washout Period of at Least 28 Days||23
166773|NCT01524770|405804|P2|NOT COMPLETED|First Intervention||1
166774|NCT01524770|405805|P1|NOT COMPLETED|First Intervention||3
166775|NCT01524770|405804|P2|COMPLETED|First Intervention||23
166776|NCT01524770|405805|P1|COMPLETED|First Intervention||23
166777|NCT01524770|405804|P2|Received at Least 1 Dose of Study Drug|First Intervention||24
166778|NCT01524770|405805|P1|Received at Least 1 Dose of Study Drug|First Intervention||26
166779|NCT01524770|405804|P2|STARTED|First Intervention||24
166780|NCT01524770|405805|P1|STARTED|First Intervention||26
166781|NCT01524692|405815|P1|NOT COMPLETED|Overall Study||3
166782|NCT01524692|405815|P1|COMPLETED|Overall Study||32
166783|NCT01524692|405815|P1|STARTED|Overall Study||35
166784|NCT01524627|405825|P2|NOT COMPLETED|Overall Study||2
166785|NCT01524627|405826|P1|NOT COMPLETED|Overall Study||1
166786|NCT01524627|405825|P2|COMPLETED|Overall Study||19
166787|NCT01524627|405826|P1|COMPLETED|Overall Study||21
166788|NCT01524627|405825|P2|STARTED|Overall Study||21
166789|NCT01524627|405826|P1|STARTED|Overall Study||22
166790|NCT01524302|405834|P2|NOT COMPLETED|Overall Study||0
166791|NCT01524302|405835|P1|NOT COMPLETED|Overall Study||0
166792|NCT01524302|405834|P2|COMPLETED|Overall Study||6
166793|NCT01524302|405835|P1|COMPLETED|Overall Study||6
166794|NCT01524302|405834|P2|STARTED|Overall Study||6
166795|NCT01524302|405835|P1|STARTED|Overall Study||6
166796|NCT01524289|405853|P2|NOT COMPLETED|Overall Study||14
166797|NCT01524289|405854|P1|NOT COMPLETED|Overall Study||30
166798|NCT01524289|405853|P2|COMPLETED|Overall Study||88
166799|NCT01524289|405854|P1|COMPLETED|Overall Study||174
166800|NCT01524289|405853|P2|Treated|Overall Study||102
166801|NCT01524289|405854|P1|Treated|Overall Study||203
166802|NCT01524289|405853|P2|STARTED|Overall Study||102
166803|NCT01524289|405854|P1|STARTED|Overall Study||204
166804|NCT01524224|405912|P8|NOT COMPLETED|Overall Study||6
166805|NCT01524224|405913|P7|NOT COMPLETED|Overall Study||3
166806|NCT01524224|405914|P6|NOT COMPLETED|Overall Study||2
166807|NCT01524224|405915|P5|NOT COMPLETED|Overall Study||4
166808|NCT01524224|405916|P4|NOT COMPLETED|Overall Study||2
166809|NCT01524224|405917|P3|NOT COMPLETED|Overall Study||2
166810|NCT01524224|405918|P2|NOT COMPLETED|Overall Study||1
166811|NCT01524224|405919|P1|NOT COMPLETED|Overall Study||3
166812|NCT01524224|405912|P8|COMPLETED|Overall Study||0
166813|NCT01524224|405913|P7|COMPLETED|Overall Study||0
166814|NCT01524224|405914|P6|COMPLETED|Overall Study||1
166815|NCT01524224|405915|P5|COMPLETED|Overall Study||0
166816|NCT01524224|405916|P4|COMPLETED|Overall Study||1
166817|NCT01524224|405917|P3|COMPLETED|Overall Study||1
166818|NCT01524224|405918|P2|COMPLETED|Overall Study||2
166819|NCT01524224|405919|P1|COMPLETED|Overall Study||1
166820|NCT01524224|405912|P8|Received at Least One Dose of Study Drug|Overall Study||6
166821|NCT01524224|405913|P7|Received at Least One Dose of Study Drug|Overall Study||3
166822|NCT01524224|405914|P6|Received at Least One Dose of Study Drug|Overall Study||3
166823|NCT01524224|405915|P5|Received at Least One Dose of Study Drug|Overall Study||4
166824|NCT01524224|405916|P4|Received at Least One Dose of Study Drug|Overall Study||3
166825|NCT01524224|405917|P3|Received at Least One Dose of Study Drug|Overall Study||3
166826|NCT01524224|405918|P2|Received at Least One Dose of Study Drug|Overall Study||3
166827|NCT01524224|405919|P1|Received at Least One Dose of Study Drug|Overall Study||4
166828|NCT01524224|405912|P8|STARTED|Overall Study||6
166829|NCT01524224|405913|P7|STARTED|Overall Study||3
166830|NCT01524224|405914|P6|STARTED|Overall Study||3
166831|NCT01524224|405915|P5|STARTED|Overall Study||4
166832|NCT01524224|405916|P4|STARTED|Overall Study||3
166833|NCT01524224|405917|P3|STARTED|Overall Study||3
166834|NCT01524224|405918|P2|STARTED|Overall Study||3
166835|NCT01524224|405919|P1|STARTED|Overall Study||4
166836|NCT01524198|405955|P2|NOT COMPLETED|Overall Study||16
166837|NCT01524198|405956|P1|NOT COMPLETED|Overall Study||23
166838|NCT01524198|405955|P2|COMPLETED|Overall Study||458
166839|NCT01524198|405956|P1|COMPLETED|Overall Study||448
166840|NCT01524198|405955|P2|STARTED|Overall Study||474
166841|NCT01524198|405956|P1|STARTED|Overall Study||471
166842|NCT01524133|405967|P3|NOT COMPLETED|Overall Study 52 Weeks||27
166843|NCT01524133|405968|P2|NOT COMPLETED|Overall Study 52 Weeks||20
166844|NCT01524133|405969|P1|NOT COMPLETED|Overall Study 52 Weeks||21
166845|NCT01524133|405967|P3|COMPLETED|Overall Study 52 Weeks||40
166846|NCT01524133|405968|P2|COMPLETED|Overall Study 52 Weeks||49
166847|NCT01524133|405969|P1|COMPLETED|Overall Study 52 Weeks||50
166848|NCT01524133|405967|P3|STARTED|Overall Study 52 Weeks||67
166849|NCT01524133|405968|P2|STARTED|Overall Study 52 Weeks||69
166850|NCT01524133|405969|P1|STARTED|Overall Study 52 Weeks||71
166851|NCT01524133|405967|P3|NOT COMPLETED|Treatment Phase||36
166852|NCT01524133|405968|P2|NOT COMPLETED|Treatment Phase||32
166853|NCT01524133|405969|P1|NOT COMPLETED|Treatment Phase||19
166854|NCT01524133|405967|P3|COMPLETED|Treatment Phase|Completed both assigned treatments|31
166855|NCT01524133|405968|P2|COMPLETED|Treatment Phase|Completed Both Assigned Treatments|37
166856|NCT01524133|405969|P1|COMPLETED|Treatment Phase|Completed Both Assigned treatment|52
166857|NCT01524133|405967|P3|STARTED|Treatment Phase||67
166858|NCT01524133|405968|P2|STARTED|Treatment Phase||69
166859|NCT01524133|405969|P1|STARTED|Treatment Phase||71
166860|NCT01523964|405984|P4|NOT COMPLETED|Overall Study||0
166861|NCT01523964|405985|P3|NOT COMPLETED|Overall Study||0
166862|NCT01523964|405986|P2|NOT COMPLETED|Overall Study||0
166863|NCT01523964|405987|P1|NOT COMPLETED|Overall Study||0
166864|NCT01523964|405984|P4|COMPLETED|Overall Study||15
166865|NCT01523964|405985|P3|COMPLETED|Overall Study||16
166866|NCT01523964|405986|P2|COMPLETED|Overall Study||30
166867|NCT01523964|405987|P1|COMPLETED|Overall Study||31
166868|NCT01523964|405984|P4|STARTED|Overall Study||15
166869|NCT01523964|405985|P3|STARTED|Overall Study||16
166870|NCT01523964|405986|P2|STARTED|Overall Study||30
166871|NCT01523964|405987|P1|STARTED|Overall Study||31
166872|NCT01523899|405999|P2|NOT COMPLETED|Overall Study||0
166873|NCT01523899|406000|P1|NOT COMPLETED|Overall Study||0
166874|NCT01523899|405999|P2|COMPLETED|Overall Study||126
166875|NCT01523899|406000|P1|COMPLETED|Overall Study||126
166876|NCT01523899|405999|P2|STARTED|Overall Study||126
166877|NCT01523899|406000|P1|STARTED|Overall Study||126
166878|NCT01523886|406012|P2|NOT COMPLETED|Overall Study||1
166879|NCT01523886|406013|P1|NOT COMPLETED|Overall Study||0
166880|NCT01523886|406012|P2|COMPLETED|Overall Study||23
166881|NCT01523886|406013|P1|COMPLETED|Overall Study||25
166882|NCT01523886|406012|P2|STARTED|Overall Study||24
166883|NCT01523886|406013|P1|STARTED|Overall Study||25
166884|NCT01523873|406019|P1|NOT COMPLETED|Overall Study||422
166885|NCT01523873|406019|P1|COMPLETED|Overall Study||35499
166886|NCT01523873|406019|P1|Administered With Dotarem|Overall Study||35474
166887|NCT01523873|406019|P1|STARTED|Overall Study||35921
166888|NCT01523834|406026|P1|NOT COMPLETED|Overall Study||31
166889|NCT01523834|406026|P1|COMPLETED|Overall Study||4
166890|NCT01523834|406026|P1|Maintenance Phase|Overall Study|Started Maintenance Phase|6
166891|NCT01523834|406026|P1|Consolidation Phase|Overall Study|Started Consolidation Phase|7
166892|NCT01523834|406026|P1|STARTED|Overall Study|Started Induction Phase|35
166893|NCT01523821|406037|P3|NOT COMPLETED|Overall Study||0
166894|NCT01523821|406038|P2|NOT COMPLETED|Overall Study||0
166895|NCT01523821|406039|P1|NOT COMPLETED|Overall Study||0
166896|NCT01523821|406037|P3|COMPLETED|Overall Study||6
166897|NCT01523821|406038|P2|COMPLETED|Overall Study||6
166898|NCT01523821|406039|P1|COMPLETED|Overall Study||8
166899|NCT01523821|406037|P3|STARTED|Overall Study||6
166900|NCT01523821|406038|P2|STARTED|Overall Study||6
166901|NCT01523821|406039|P1|STARTED|Overall Study||8
166902|NCT01523782|406065|P3|NOT COMPLETED|Overall Study||5
166903|NCT01523782|406066|P2|NOT COMPLETED|Overall Study||0
166904|NCT01523782|406067|P1|NOT COMPLETED|Overall Study||1
166905|NCT01523782|406065|P3|COMPLETED|Overall Study||9
166906|NCT01523782|406066|P2|COMPLETED|Overall Study||13
166907|NCT01523782|406067|P1|COMPLETED|Overall Study||2
166908|NCT01523782|406065|P3|STARTED|Overall Study||14
166909|NCT01523782|406066|P2|STARTED|Overall Study||13
166910|NCT01523782|406067|P1|STARTED|Overall Study||3
166911|NCT01523756|406114|P2|NOT COMPLETED|Test Period 2||1
166912|NCT01523756|406115|P1|NOT COMPLETED|Test Period 2||0
166913|NCT01523756|406114|P2|COMPLETED|Test Period 2||7
166914|NCT01523756|406115|P1|COMPLETED|Test Period 2||10
166915|NCT01523756|406114|P2|STARTED|Test Period 2||8
166916|NCT01523756|406115|P1|STARTED|Test Period 2||10
166917|NCT01523756|406114|P2|NOT COMPLETED|Test Period 1||0
166918|NCT01523756|406115|P1|NOT COMPLETED|Test Period 1||1
166919|NCT01523756|406114|P2|COMPLETED|Test Period 1||8
166920|NCT01523756|406115|P1|COMPLETED|Test Period 1||10
166921|NCT01523756|406114|P2|STARTED|Test Period 1||8
166922|NCT01523756|406115|P1|STARTED|Test Period 1||11
166923|NCT01523756|406114|P2|NOT COMPLETED|Baseline Period||1
166924|NCT01523756|406115|P1|NOT COMPLETED|Baseline Period||0
166925|NCT01523756|406114|P2|COMPLETED|Baseline Period||8
166926|NCT01523756|406115|P1|COMPLETED|Baseline Period||11
166927|NCT01523756|406114|P2|STARTED|Baseline Period||9
166928|NCT01523756|406115|P1|STARTED|Baseline Period||11
166929|NCT01523743|406123|P2|NOT COMPLETED|Period 2||2
166930|NCT01523743|406124|P1|NOT COMPLETED|Period 2||1
166931|NCT01523743|406123|P2|COMPLETED|Period 2||58
166932|NCT01523743|406124|P1|COMPLETED|Period 2||52
166933|NCT01523743|406123|P2|STARTED|Period 2||60
166934|NCT01523743|406124|P1|STARTED|Period 2||53
166935|NCT01523743|406123|P2|NOT COMPLETED|Period 1||2
166936|NCT01523743|406124|P1|NOT COMPLETED|Period 1||10
166937|NCT01523743|406123|P2|COMPLETED|Period 1||60
166938|NCT01523743|406124|P1|COMPLETED|Period 1||53
166939|NCT01523743|406123|P2|STARTED|Period 1||62
166940|NCT01523743|406124|P1|STARTED|Period 1||63
166941|NCT01523613|406133|P3|NOT COMPLETED|Overall Study||12
166942|NCT01523613|406134|P2|NOT COMPLETED|Overall Study||5
166943|NCT01523613|406135|P1|NOT COMPLETED|Overall Study||7
166944|NCT01523613|406133|P3|COMPLETED|Overall Study|- 42 paired restorations (21R and 21F)|21
166945|NCT01523613|406134|P2|COMPLETED|Overall Study|- 25 single restorations (25F)|25
166946|NCT01523613|406135|P1|COMPLETED|Overall Study|- 23 single restorations (23R)|23
166947|NCT01523613|406133|P3|STARTED|Overall Study|- 66 paired restorations (33R + 33F)|33
166948|NCT01523613|406134|P2|STARTED|Overall Study|- 30 single restorations (30 F)|30
166949|NCT01523613|406135|P1|STARTED|Overall Study|- 30 single restorations (30 R)|30
166950|NCT01523587|406147|P2|NOT COMPLETED|Overall Study||397
166951|NCT01523587|406148|P1|NOT COMPLETED|Overall Study||398
166952|NCT01523587|406147|P2|COMPLETED|Overall Study||0
166953|NCT01523587|406148|P1|COMPLETED|Overall Study||0
166954|NCT01523587|406147|P2|Treated|Overall Study||395
166955|NCT01523587|406148|P1|Treated|Overall Study||392
166956|NCT01523587|406147|P2|STARTED|Overall Study||397
166957|NCT01523587|406148|P1|STARTED|Overall Study||398
166958|NCT01523496|406172|P4|NOT COMPLETED|Overall Study||3
166959|NCT01523496|406173|P3|NOT COMPLETED|Overall Study||12
166960|NCT01523496|406174|P2|NOT COMPLETED|Overall Study||4
166961|NCT01523496|406175|P1|NOT COMPLETED|Overall Study||10
166962|NCT01523496|406172|P4|COMPLETED|Overall Study||27
166963|NCT01523496|406173|P3|COMPLETED|Overall Study||46
166964|NCT01523496|406174|P2|COMPLETED|Overall Study||32
166965|NCT01523496|406175|P1|COMPLETED|Overall Study||56
166966|NCT01523496|406172|P4|STARTED|Overall Study||30
166967|NCT01523496|406173|P3|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|58
166968|NCT01523496|406174|P2|STARTED|Overall Study||36
166969|NCT01523496|406175|P1|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|66
166970|NCT01523457|406191|P2|NOT COMPLETED|Overall Study||2
166971|NCT01523457|406192|P1|NOT COMPLETED|Overall Study||7
166972|NCT01523457|406191|P2|COMPLETED|Overall Study||29
166973|NCT01523457|406192|P1|COMPLETED|Overall Study||37
166974|NCT01523457|406191|P2|STARTED|Overall Study||31
166975|NCT01523457|406192|P1|STARTED|Overall Study||44
166976|NCT01523392|406210|P2|NOT COMPLETED|Treatment Period 2||0
166977|NCT01523392|406211|P1|NOT COMPLETED|Treatment Period 2||0
166978|NCT01523392|406210|P2|COMPLETED|Treatment Period 2||14
166979|NCT01523392|406211|P1|COMPLETED|Treatment Period 2||17
166980|NCT01523392|406210|P2|STARTED|Treatment Period 2||14
166981|NCT01523392|406211|P1|STARTED|Treatment Period 2||17
166982|NCT01523392|406210|P2|NOT COMPLETED|Washout Period - 10 to 14 Days||0
166983|NCT01523392|406211|P1|NOT COMPLETED|Washout Period - 10 to 14 Days||1
166984|NCT01523392|406210|P2|COMPLETED|Washout Period - 10 to 14 Days||14
166985|NCT01523392|406211|P1|COMPLETED|Washout Period - 10 to 14 Days||17
166986|NCT01523392|406210|P2|STARTED|Washout Period - 10 to 14 Days||14
166987|NCT01523392|406211|P1|STARTED|Washout Period - 10 to 14 Days|1 patient did not complete 7-9 days of Period 1 treatment but continued in the Washout and Period 2|18
166988|NCT01523392|406210|P2|NOT COMPLETED|Treatment Period 1||0
166989|NCT01523392|406211|P1|NOT COMPLETED|Treatment Period 1||3
166990|NCT01523392|406210|P2|COMPLETED|Treatment Period 1||14
166991|NCT01523392|406211|P1|COMPLETED|Treatment Period 1||17
166992|NCT01523392|406210|P2|STARTED|Treatment Period 1||14
166993|NCT01523392|406211|P1|STARTED|Treatment Period 1||20
166994|NCT01523366|406227|P2|NOT COMPLETED|Treatment Period 2||0
166995|NCT01523366|406228|P1|NOT COMPLETED|Treatment Period 2||1
166996|NCT01523366|406227|P2|COMPLETED|Treatment Period 2||20
166997|NCT01523366|406228|P1|COMPLETED|Treatment Period 2||18
166998|NCT01523366|406227|P2|STARTED|Treatment Period 2||20
166999|NCT01523366|406228|P1|STARTED|Treatment Period 2||19
167000|NCT01523366|406227|P2|NOT COMPLETED|Washout Period - 10-14 Days||0
167001|NCT01523366|406228|P1|NOT COMPLETED|Washout Period - 10-14 Days||0
167002|NCT01523366|406227|P2|COMPLETED|Washout Period - 10-14 Days||20
167003|NCT01523366|406228|P1|COMPLETED|Washout Period - 10-14 Days||19
167004|NCT01523366|406227|P2|STARTED|Washout Period - 10-14 Days||20
167005|NCT01523366|406228|P1|STARTED|Washout Period - 10-14 Days||19
167006|NCT01523366|406227|P2|NOT COMPLETED|Treatment Period 1||0
167007|NCT01523366|406228|P1|NOT COMPLETED|Treatment Period 1||1
167008|NCT01523366|406227|P2|COMPLETED|Treatment Period 1||20
167009|NCT01523366|406228|P1|COMPLETED|Treatment Period 1||19
167010|NCT01523366|406227|P2|STARTED|Treatment Period 1||20
167011|NCT01523366|406228|P1|STARTED|Treatment Period 1||20
167012|NCT01523301|406244|P2|NOT COMPLETED|Overall Study||32
167013|NCT01523301|406245|P1|NOT COMPLETED|Overall Study||35
167014|NCT01523301|406244|P2|COMPLETED|Overall Study||164
167015|NCT01523301|406245|P1|COMPLETED|Overall Study||149
167016|NCT01523301|406244|P2|STARTED|Overall Study||196
167017|NCT01523301|406245|P1|STARTED|Overall Study||184
167018|NCT01523275|406265|P2|NOT COMPLETED|Overall Study||2
167019|NCT01523275|406266|P1|NOT COMPLETED|Overall Study||2
167020|NCT01523275|406265|P2|COMPLETED|Overall Study||7
167021|NCT01523275|406266|P1|COMPLETED|Overall Study||4
167022|NCT01523275|406265|P2|STARTED|Overall Study||9
167023|NCT01523275|406266|P1|STARTED|Overall Study||6
167024|NCT01522976|406279|P3|NOT COMPLETED|Overall Study||93
167025|NCT01522976|406280|P2|NOT COMPLETED|Overall Study||92
167026|NCT01522976|406281|P1|NOT COMPLETED|Overall Study||97
167027|NCT01522976|406279|P3|COMPLETED|Overall Study||0
167028|NCT01522976|406280|P2|COMPLETED|Overall Study||0
167029|NCT01522976|406281|P1|COMPLETED|Overall Study||0
167030|NCT01522976|406279|P3|STARTED|Overall Study||93
167031|NCT01522976|406280|P2|STARTED|Overall Study||92
167032|NCT01522976|406281|P1|STARTED|Overall Study||97
167033|NCT01522963|406308|P4|NOT COMPLETED|Overall Study||6
167034|NCT01522963|406309|P3|NOT COMPLETED|Overall Study||3
167035|NCT01522963|406310|P2|NOT COMPLETED|Overall Study||3
167036|NCT01522963|406311|P1|NOT COMPLETED|Overall Study||2
167037|NCT01522963|406308|P4|COMPLETED|Overall Study||18
167038|NCT01522963|406309|P3|COMPLETED|Overall Study||22
167039|NCT01522963|406310|P2|COMPLETED|Overall Study||22
167040|NCT01522963|406311|P1|COMPLETED|Overall Study||22
167041|NCT01522963|406308|P4|STARTED|Overall Study||24
167042|NCT01522963|406309|P3|STARTED|Overall Study||25
167043|NCT01522963|406310|P2|STARTED|Overall Study||25
167044|NCT01522963|406311|P1|STARTED|Overall Study||24
167045|NCT01522937|406323|P1|NOT COMPLETED|Overall Study||0
167046|NCT01522937|406323|P1|COMPLETED|Overall Study||146
167047|NCT01522937|406323|P1|STARTED|Overall Study||146
167048|NCT01522924|406333|P2|NOT COMPLETED|Overall Study||0
167049|NCT01522924|406334|P1|NOT COMPLETED|Overall Study||0
167050|NCT01522924|406333|P2|COMPLETED|Overall Study|There were 52 dental students who completed the second survey after the lecture.|52
167051|NCT01522924|406334|P1|COMPLETED|Overall Study|There were 42 dental students who completed the second survey after the intervention.|42
167052|NCT01522924|406333|P2|STARTED|Overall Study|There were 52 dental students in the control group.|52
167053|NCT01522924|406334|P1|STARTED|Overall Study|There were 42 dental students in the intervention group.|42
167054|NCT01522703|406354|P2|NOT COMPLETED|Overall Study||6
167055|NCT01522703|406355|P1|NOT COMPLETED|Overall Study||5
167056|NCT01522703|406354|P2|COMPLETED|Overall Study||20
167057|NCT01522703|406355|P1|COMPLETED|Overall Study||20
167058|NCT01522703|406354|P2|STARTED|Overall Study||26
167059|NCT01522703|406355|P1|STARTED|Overall Study||25
167060|NCT01522456|406361|P1|NOT COMPLETED|Overall Study||8
167061|NCT01522456|406361|P1|COMPLETED|Overall Study||65
167062|NCT01522456|406361|P1|STARTED|Overall Study||73
167063|NCT01522443|406424|P2|NOT COMPLETED|Overall Study||55
167064|NCT01522443|406425|P1|NOT COMPLETED|Overall Study||53
167065|NCT01522443|406424|P2|COMPLETED|Overall Study||3
167066|NCT01522443|406425|P1|COMPLETED|Overall Study||8
167067|NCT01522443|406424|P2|STARTED|Overall Study||58
167068|NCT01522443|406425|P1|STARTED|Overall Study||61
167069|NCT01522404|406437|P2|NOT COMPLETED|Second Intervention (up to Week 58)||0
167070|NCT01522404|406438|P1|NOT COMPLETED|Second Intervention (up to Week 58)||1
167071|NCT01522404|406437|P2|COMPLETED|Second Intervention (up to Week 58)||19
167072|NCT01522404|406438|P1|COMPLETED|Second Intervention (up to Week 58)||17
167073|NCT01522404|406437|P2|STARTED|Second Intervention (up to Week 58)||19
167074|NCT01522404|406438|P1|STARTED|Second Intervention (up to Week 58)||18
167075|NCT01522404|406437|P2|NOT COMPLETED|First Intervention (up to Week 29)||0
167076|NCT01522404|406438|P1|NOT COMPLETED|First Intervention (up to Week 29)||2
167077|NCT01522404|406437|P2|COMPLETED|First Intervention (up to Week 29)||19
167078|NCT01522404|406438|P1|COMPLETED|First Intervention (up to Week 29)||18
167079|NCT01522404|406437|P2|STARTED|First Intervention (up to Week 29)||19
167080|NCT01522404|406438|P1|STARTED|First Intervention (up to Week 29)||20
167081|NCT01522391|406456|P2|NOT COMPLETED|Overall Study||1
167082|NCT01522391|406457|P1|NOT COMPLETED|Overall Study||1
167083|NCT01522391|406456|P2|COMPLETED|Overall Study||20
167084|NCT01522391|406457|P1|COMPLETED|Overall Study||19
167085|NCT01522391|406456|P2|STARTED|Overall Study||21
167086|NCT01522391|406457|P1|STARTED|Overall Study||20
167087|NCT01522339|406517|P1|NOT COMPLETED|Overall Study||0
167088|NCT01522339|406517|P1|COMPLETED|Overall Study||15
167089|NCT01522339|406517|P1|STARTED|Overall Study||15
167090|NCT01522248|406524|P2|NOT COMPLETED|Overall Study||0
167091|NCT01522248|406525|P1|NOT COMPLETED|Overall Study||1
167092|NCT01522248|406524|P2|COMPLETED|Overall Study||10
167093|NCT01522248|406525|P1|COMPLETED|Overall Study||9
167094|NCT01522248|406524|P2|STARTED|Overall Study||10
167095|NCT01522248|406525|P1|STARTED|Overall Study||10
167096|NCT01522235|406540|P2|NOT COMPLETED|Overall Study||1
167097|NCT01522235|406541|P1|NOT COMPLETED|Overall Study||1
167098|NCT01522235|406540|P2|COMPLETED|Overall Study||2
167099|NCT01522235|406541|P1|COMPLETED|Overall Study||2
167100|NCT01522235|406540|P2|Randomized|Overall Study||3
167101|NCT01522235|406541|P1|Randomized|Overall Study||2
167102|NCT01522235|406540|P2|STARTED|Overall Study||3
167103|NCT01522235|406541|P1|STARTED|Overall Study||3
167104|NCT01522131|406559|P2|NOT COMPLETED|Overall Study||0
167105|NCT01522131|406560|P1|NOT COMPLETED|Overall Study||2
167106|NCT01522131|406559|P2|COMPLETED|Overall Study||17
167107|NCT01522131|406560|P1|COMPLETED|Overall Study||14
167108|NCT01522131|406559|P2|STARTED|Overall Study||17
167109|NCT01522131|406560|P1|STARTED|Overall Study||16
167110|NCT01521949|406568|P1|NOT COMPLETED|Overall Study||0
167111|NCT01521949|406568|P1|COMPLETED|Overall Study||21
167112|NCT01521949|406568|P1|STARTED|Overall Study||21
167113|NCT01521923|406577|P4|NOT COMPLETED|Overall Study||13
167114|NCT01521923|406578|P3|NOT COMPLETED|Overall Study||15
167115|NCT01521923|406579|P2|NOT COMPLETED|Overall Study||9
167116|NCT01521923|406580|P1|NOT COMPLETED|Overall Study||7
167117|NCT01521923|406577|P4|COMPLETED|Overall Study||70
167118|NCT01521923|406578|P3|COMPLETED|Overall Study||112
167119|NCT01521923|406579|P2|COMPLETED|Overall Study||72
167120|NCT01521923|406580|P1|COMPLETED|Overall Study||59
167121|NCT01521923|406577|P4|STARTED|Overall Study||83
167122|NCT01521923|406578|P3|STARTED|Overall Study||127
167123|NCT01521923|406579|P2|STARTED|Overall Study||81
167124|NCT01521923|406580|P1|STARTED|Overall Study||66
167125|NCT01521897|406700|P1|NOT COMPLETED|Overall Study||23
167126|NCT01521897|406700|P1|COMPLETED|Overall Study||1120
167127|NCT01521897|406700|P1|STARTED|Overall Study||1143
167128|NCT01521884|406712|P1|NOT COMPLETED|Overall Study||27
167129|NCT01521884|406712|P1|COMPLETED|Overall Study||35
167130|NCT01521884|406712|P1|STARTED|Overall Study||62
167131|NCT01521871|406731|P2|NOT COMPLETED|Overall Study||0
167132|NCT01521871|406732|P1|NOT COMPLETED|Overall Study||0
167133|NCT01521871|406731|P2|COMPLETED|Overall Study||32
167134|NCT01521871|406732|P1|COMPLETED|Overall Study||32
167135|NCT01521871|406731|P2|STARTED|Overall Study||32
167136|NCT01521871|406732|P1|STARTED|Overall Study||32
167137|NCT01521845|406772|P2|NOT COMPLETED|Overall Study||5
167138|NCT01521845|406773|P1|NOT COMPLETED|Overall Study||9
167139|NCT01521845|406772|P2|COMPLETED|Overall Study||47
167140|NCT01521845|406773|P1|COMPLETED|Overall Study||43
167141|NCT01521845|406772|P2|STARTED|Overall Study||52
167142|NCT01521845|406773|P1|STARTED|Overall Study||52
167143|NCT01521780|406783|P3|NOT COMPLETED|Overall Study||0
167144|NCT01521780|406784|P2|NOT COMPLETED|Overall Study||0
167145|NCT01521780|406785|P1|NOT COMPLETED|Overall Study||0
167146|NCT01521780|406783|P3|COMPLETED|Overall Study||2
167147|NCT01521780|406784|P2|COMPLETED|Overall Study||1
167148|NCT01521780|406785|P1|COMPLETED|Overall Study||9
167149|NCT01521780|406783|P3|STARTED|Overall Study||2
167150|NCT01521780|406784|P2|STARTED|Overall Study||1
167151|NCT01521780|406785|P1|STARTED|Overall Study||9
167152|NCT01521559|406809|P2|NOT COMPLETED|Overall Study||18
167153|NCT01521559|406810|P1|NOT COMPLETED|Overall Study||15
167154|NCT01521559|406809|P2|COMPLETED|Overall Study||73
167155|NCT01521559|406810|P1|COMPLETED|Overall Study||77
167156|NCT01521559|406809|P2|Completed Week 52|Overall Study||73
167157|NCT01521559|406810|P1|Completed Week 52|Overall Study||77
167158|NCT01521559|406809|P2|Completed Week 24|Overall Study||85
167159|NCT01521559|406810|P1|Completed Week 24|Overall Study||83
167160|NCT01521559|406809|P2|STARTED|Overall Study||91
167161|NCT01521559|406810|P1|STARTED|Overall Study||92
167162|NCT01521546|406824|P2|NOT COMPLETED|Overall Study||0
167163|NCT01521546|406825|P1|NOT COMPLETED|Overall Study||2
167164|NCT01521546|406824|P2|COMPLETED|Overall Study||20
167165|NCT01521546|406825|P1|COMPLETED|Overall Study||20
167166|NCT01521546|406824|P2|STARTED|Overall Study||20
167167|NCT01521546|406825|P1|STARTED|Overall Study||22
167168|NCT01521507|406833|P2|NOT COMPLETED|Stage 2: Observational Design||2
167169|NCT01521507|406834|P1|NOT COMPLETED|Stage 2: Observational Design||4
167170|NCT01521507|406833|P2|COMPLETED|Stage 2: Observational Design||92
167171|NCT01521507|406834|P1|COMPLETED|Stage 2: Observational Design||94
167172|NCT01521507|406833|P2|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||1
167173|NCT01521507|406834|P1|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||2
167174|NCT01521507|406833|P2|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||9
167175|NCT01521507|406834|P1|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||11
167176|NCT01521507|406833|P2|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||82
167177|NCT01521507|406834|P1|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||81
167178|NCT01521507|406833|P2|Received Crossover LipiFlow Tx|Stage 2: Observational Design||93
167179|NCT01521507|406834|P1|Received Crossover LipiFlow Tx|Stage 2: Observational Design||0
167180|NCT01521507|406833|P2|STARTED|Stage 2: Observational Design||94
167181|NCT01521507|406834|P1|STARTED|Stage 2: Observational Design||98
167182|NCT01521507|406833|P2|NOT COMPLETED|Stage 1: Randomized Design||5
167183|NCT01521507|406834|P1|NOT COMPLETED|Stage 1: Randomized Design||3
167184|NCT01521507|406833|P2|COMPLETED|Stage 1: Randomized Design||94
167185|NCT01521507|406834|P1|COMPLETED|Stage 1: Randomized Design||98
167186|NCT01521507|406833|P2|Received Initial Treatment (Tx)|Stage 1: Randomized Design||98
167187|NCT01521507|406834|P1|Received Initial Treatment (Tx)|Stage 1: Randomized Design||99
167188|NCT01521507|406833|P2|STARTED|Stage 1: Randomized Design||99
167189|NCT01521507|406834|P1|STARTED|Stage 1: Randomized Design||101
167190|NCT01521494|406856|P5|NOT COMPLETED|Overall Study||7
167191|NCT01521494|406857|P4|NOT COMPLETED|Overall Study||21
167192|NCT01521494|406858|P3|NOT COMPLETED|Overall Study||12
167193|NCT01521494|406859|P2|NOT COMPLETED|Overall Study||5
167194|NCT01521494|406860|P1|NOT COMPLETED|Overall Study||2
167195|NCT01521494|406856|P5|COMPLETED|Overall Study||30
167196|NCT01521494|406857|P4|COMPLETED|Overall Study||15
167197|NCT01521494|406858|P3|COMPLETED|Overall Study||23
167198|NCT01521494|406859|P2|COMPLETED|Overall Study||31
167199|NCT01521494|406860|P1|COMPLETED|Overall Study||37
167200|NCT01521494|406856|P5|STARTED|Overall Study||37
167201|NCT01521494|406857|P4|STARTED|Overall Study||36
167202|NCT01521494|406858|P3|STARTED|Overall Study||35
167203|NCT01521494|406859|P2|STARTED|Overall Study||36
167204|NCT01521494|406860|P1|STARTED|Overall Study||39
167205|NCT01521364|406882|P1|NOT COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||1
167206|NCT01521364|406882|P1|COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||5
167207|NCT01521364|406882|P1|STARTED|Linezolid + 500mg Claritromycin (wk 4&5)||6
167208|NCT01521364|406882|P1|NOT COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||1
167209|NCT01521364|406882|P1|COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||6
167210|NCT01521364|406882|P1|STARTED|Linezolid + 250mg Claritromycin (wk 2&3)||7
167211|NCT01521364|406882|P1|NOT COMPLETED|Linezolid Without Clarithromycin (1 wk)||0
167212|NCT01521364|406882|P1|COMPLETED|Linezolid Without Clarithromycin (1 wk)||7
167213|NCT01521364|406882|P1|STARTED|Linezolid Without Clarithromycin (1 wk)||7
167214|NCT01521260|406895|P2|NOT COMPLETED|Overall Study||0
167215|NCT01521260|406896|P1|NOT COMPLETED|Overall Study||0
167216|NCT01521260|406895|P2|COMPLETED|Overall Study||15
167217|NCT01521260|406896|P1|COMPLETED|Overall Study||15
167218|NCT01521260|406895|P2|STARTED|Overall Study||15
167219|NCT01521260|406896|P1|STARTED|Overall Study||15
167220|NCT01521143|406906|P4|NOT COMPLETED|Overall Study||7
167221|NCT01521143|406907|P3|NOT COMPLETED|Overall Study||8
167222|NCT01521143|406908|P2|NOT COMPLETED|Overall Study||26
167223|NCT01521143|406909|P1|NOT COMPLETED|Overall Study||29
167224|NCT01521143|406906|P4|COMPLETED|Overall Study||0
167225|NCT01521143|406907|P3|COMPLETED|Overall Study||0
167226|NCT01521143|406908|P2|COMPLETED|Overall Study||10
167227|NCT01521143|406909|P1|COMPLETED|Overall Study||11
167228|NCT01521143|406906|P4|Received Treatment|Overall Study||4
167229|NCT01521143|406907|P3|Received Treatment|Overall Study||3
167230|NCT01521143|406908|P2|Received Treatment|Overall Study||20
167231|NCT01521143|406909|P1|Received Treatment|Overall Study||20
167232|NCT01521143|406906|P4|STARTED|Overall Study||7
167233|NCT01521143|406907|P3|STARTED|Overall Study||8
167234|NCT01521143|406908|P2|STARTED|Overall Study||36
167235|NCT01521143|406909|P1|STARTED|Overall Study||40
167236|NCT01521026|406941|P2|NOT COMPLETED|Overall Study||3
167237|NCT01521026|406942|P1|NOT COMPLETED|Overall Study||15
167238|NCT01521026|406941|P2|COMPLETED|Overall Study||28
167239|NCT01521026|406942|P1|COMPLETED|Overall Study||23
167240|NCT01521026|406941|P2|STARTED|Overall Study||31
167241|NCT01521026|406942|P1|STARTED|Overall Study||38
167242|NCT01520987|406958|P8|NOT COMPLETED|Overall Study||0
167243|NCT01520987|406959|P7|NOT COMPLETED|Overall Study||0
167244|NCT01520987|406960|P6|NOT COMPLETED|Overall Study||1
167245|NCT01520987|406961|P5|NOT COMPLETED|Overall Study||0
167246|NCT01520987|406962|P4|NOT COMPLETED|Overall Study||0
167247|NCT01520987|406963|P3|NOT COMPLETED|Overall Study||0
167248|NCT01520987|406964|P2|NOT COMPLETED|Overall Study||0
167249|NCT01520987|406965|P1|NOT COMPLETED|Overall Study||1
167250|NCT01520987|406958|P8|COMPLETED|Overall Study||14
167251|NCT01520987|406959|P7|COMPLETED|Overall Study||12
167252|NCT01520987|406960|P6|COMPLETED|Overall Study||13
167253|NCT01520987|406961|P5|COMPLETED|Overall Study||14
167254|NCT01520987|406962|P4|COMPLETED|Overall Study||15
167255|NCT01520987|406963|P3|COMPLETED|Overall Study||11
167256|NCT01520987|406964|P2|COMPLETED|Overall Study||12
167257|NCT01520987|406965|P1|COMPLETED|Overall Study||12
167258|NCT01520987|406958|P8|Dosed|Overall Study||14
167259|NCT01520987|406959|P7|Dosed|Overall Study||12
167260|NCT01520987|406960|P6|Dosed|Overall Study||14
167261|NCT01520987|406961|P5|Dosed|Overall Study||14
167262|NCT01520987|406962|P4|Dosed|Overall Study||15
167263|NCT01520987|406963|P3|Dosed|Overall Study||11
167264|NCT01520987|406964|P2|Dosed|Overall Study||12
167265|NCT01520987|406965|P1|Dosed|Overall Study||13
167266|NCT01520987|406958|P8|STARTED|Overall Study||14
167267|NCT01520987|406959|P7|STARTED|Overall Study||12
167268|NCT01520987|406960|P6|STARTED|Overall Study||14
167269|NCT01520987|406961|P5|STARTED|Overall Study||14
167270|NCT01520987|406962|P4|STARTED|Overall Study||15
167271|NCT01520987|406963|P3|STARTED|Overall Study||11
167272|NCT01520987|406964|P2|STARTED|Overall Study||12
167273|NCT01520987|406965|P1|STARTED|Overall Study||13
167274|NCT01520922|407025|P2|NOT COMPLETED|Survival Follow-up||0
167275|NCT01520922|407026|P1|NOT COMPLETED|Survival Follow-up||1
167276|NCT01520922|407025|P2|COMPLETED|Survival Follow-up||40
167277|NCT01520922|407026|P1|COMPLETED|Survival Follow-up||20
167278|NCT01520922|407025|P2|STARTED|Survival Follow-up||40
167279|NCT01520922|407026|P1|STARTED|Survival Follow-up||21
167280|NCT01520922|407025|P2|NOT COMPLETED|Follow up||1
167281|NCT01520922|407026|P1|NOT COMPLETED|Follow up||0
167282|NCT01520922|407025|P2|COMPLETED|Follow up||44
167283|NCT01520922|407026|P1|COMPLETED|Follow up||44
167284|NCT01520922|407025|P2|STARTED|Follow up||45
167285|NCT01520922|407026|P1|STARTED|Follow up||44
167286|NCT01520922|407025|P2|NOT COMPLETED|Treatment Phase||8
167287|NCT01520922|407026|P1|NOT COMPLETED|Treatment Phase||5
167288|NCT01520922|407025|P2|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|45
167289|NCT01520922|407026|P1|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|39
167290|NCT01520922|407025|P2|STARTED|Treatment Phase||53
167291|NCT01520922|407026|P1|STARTED|Treatment Phase||44
167292|NCT01520909|407088|P3|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||7
167293|NCT01520909|407089|P2|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
167294|NCT01520909|407090|P1|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
167295|NCT01520909|407088|P3|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||80
167296|NCT01520909|407089|P2|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
167297|NCT01520909|407090|P1|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
167298|NCT01520909|407088|P3|STARTED|Part 2 (Open-Label Period)-Eltrombopag|Two participants that completed Part 1 did not start Part 2 because of lack of efficacy.|87
167299|NCT01520909|407089|P2|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
167300|NCT01520909|407090|P1|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
167301|NCT01520909|407088|P3|NOT COMPLETED|Part 1 (Randomized Period)||0
167302|NCT01520909|407089|P2|NOT COMPLETED|Part 1 (Randomized Period)||2
167303|NCT01520909|407090|P1|NOT COMPLETED|Part 1 (Randomized Period)||1
167304|NCT01520909|407088|P3|COMPLETED|Part 1 (Randomized Period)||0
167305|NCT01520909|407089|P2|COMPLETED|Part 1 (Randomized Period)||61
167306|NCT01520909|407090|P1|COMPLETED|Part 1 (Randomized Period)||28
167307|NCT01520909|407088|P3|STARTED|Part 1 (Randomized Period)||0
167308|NCT01520909|407089|P2|STARTED|Part 1 (Randomized Period)||63
167309|NCT01520909|407090|P1|STARTED|Part 1 (Randomized Period)||29
167310|NCT01520727|407161|P9|NOT COMPLETED|Overall Study||0
167311|NCT01520727|407162|P8|NOT COMPLETED|Overall Study||0
167312|NCT01520727|407163|P7|NOT COMPLETED|Overall Study||0
167313|NCT01520727|407164|P6|NOT COMPLETED|Overall Study||0
167314|NCT01520727|407165|P5|NOT COMPLETED|Overall Study||0
167315|NCT01520727|407166|P4|NOT COMPLETED|Overall Study||0
167316|NCT01520727|407167|P3|NOT COMPLETED|Overall Study||0
167317|NCT01520727|407168|P2|NOT COMPLETED|Overall Study||0
167318|NCT01520727|407169|P1|NOT COMPLETED|Overall Study||0
167319|NCT01520727|407161|P9|COMPLETED|Overall Study||16
167320|NCT01520727|407162|P8|COMPLETED|Overall Study||6
167321|NCT01520727|407163|P7|COMPLETED|Overall Study||6
167322|NCT01520727|407164|P6|COMPLETED|Overall Study||6
167323|NCT01520727|407165|P5|COMPLETED|Overall Study||6
167324|NCT01520727|407166|P4|COMPLETED|Overall Study||6
167325|NCT01520727|407167|P3|COMPLETED|Overall Study||6
167326|NCT01520727|407168|P2|COMPLETED|Overall Study||6
167327|NCT01520727|407169|P1|COMPLETED|Overall Study||6
167328|NCT01520727|407161|P9|STARTED|Overall Study||16
167329|NCT01520727|407162|P8|STARTED|Overall Study||6
167330|NCT01520727|407163|P7|STARTED|Overall Study||6
167331|NCT01520727|407164|P6|STARTED|Overall Study||6
167332|NCT01520727|407165|P5|STARTED|Overall Study||6
167333|NCT01520727|407166|P4|STARTED|Overall Study||6
167334|NCT01520727|407167|P3|STARTED|Overall Study||6
167335|NCT01520727|407168|P2|STARTED|Overall Study||6
167336|NCT01520727|407169|P1|STARTED|Overall Study||6
167337|NCT01520714|407207|P2|NOT COMPLETED|Overall Study||6
167338|NCT01520714|407208|P1|NOT COMPLETED|Overall Study||0
167339|NCT01520714|407207|P2|COMPLETED|Overall Study||5
167340|NCT01520714|407208|P1|COMPLETED|Overall Study||0
167341|NCT01520714|407207|P2|STARTED|Overall Study||11
167342|NCT01520714|407208|P1|STARTED|Overall Study||0
167343|NCT01520558|407217|P3|NOT COMPLETED|Overall Study||3
167344|NCT01520558|407218|P2|NOT COMPLETED|Overall Study||2
167345|NCT01520558|407219|P1|NOT COMPLETED|Overall Study||2
167346|NCT01520558|407217|P3|COMPLETED|Overall Study||3
167347|NCT01520558|407218|P2|COMPLETED|Overall Study||1
167348|NCT01520558|407219|P1|COMPLETED|Overall Study||1
167349|NCT01520558|407217|P3|STARTED|Overall Study||6
167350|NCT01520558|407218|P2|STARTED|Overall Study||3
167351|NCT01520558|407219|P1|STARTED|Overall Study||3
167352|NCT01520532|407227|P1|NOT COMPLETED|Overall Study||0
167353|NCT01520532|407227|P1|COMPLETED|Overall Study||60
167354|NCT01520532|407227|P1|STARTED|Overall Study|Subjects who underwent an ablation and had post-procedure MRI|60
167355|NCT01520519|407233|P1|NOT COMPLETED|Overall Study||0
167356|NCT01520519|407233|P1|COMPLETED|Overall Study||40
167357|NCT01520519|407233|P1|STARTED|Overall Study||40
167358|NCT01520506|407238|P1|NOT COMPLETED|Overall Study||6
167359|NCT01520506|407238|P1|COMPLETED|Overall Study||44
167360|NCT01520506|407238|P1|STARTED|Overall Study||50
167361|NCT01520454|407248|P4|NOT COMPLETED|Overall Study||0
167362|NCT01520454|407249|P3|NOT COMPLETED|Overall Study||0
167363|NCT01520454|407250|P2|NOT COMPLETED|Overall Study||0
167364|NCT01520454|407251|P1|NOT COMPLETED|Overall Study||0
167365|NCT01520454|407248|P4|COMPLETED|Overall Study||6
167366|NCT01520454|407249|P3|COMPLETED|Overall Study||5
167367|NCT01520454|407250|P2|COMPLETED|Overall Study||6
167368|NCT01520454|407251|P1|COMPLETED|Overall Study||9
167369|NCT01520454|407248|P4|STARTED|Overall Study||6
167370|NCT01520454|407249|P3|STARTED|Overall Study||5
167371|NCT01520454|407250|P2|STARTED|Overall Study||6
167372|NCT01520454|407251|P1|STARTED|Overall Study||9
167373|NCT01520402|407293|P1|NOT COMPLETED|Overall Study||5
167374|NCT01520402|407293|P1|COMPLETED|Overall Study||30
167375|NCT01520402|407293|P1|STARTED|Overall Study||35
167376|NCT01520363|407306|P2|NOT COMPLETED|Overall Study||0
167377|NCT01520363|407307|P1|NOT COMPLETED|Overall Study||2
167378|NCT01520363|407306|P2|COMPLETED|Overall Study||26
167379|NCT01520363|407307|P1|COMPLETED|Overall Study||24
167380|NCT01520363|407306|P2|STARTED|Overall Study||26
167381|NCT01520363|407307|P1|STARTED|Overall Study||26
167382|NCT01520324|407381|P1|NOT COMPLETED|Overall Study||1
167383|NCT01520324|407381|P1|COMPLETED|Overall Study||52
167384|NCT01520324|407381|P1|STARTED|Overall Study||53
167385|NCT01520207|407394|P2|NOT COMPLETED|Overall Study||0
167386|NCT01520207|407395|P1|NOT COMPLETED|Overall Study||2
167387|NCT01520207|407394|P2|COMPLETED|Overall Study||25
167388|NCT01520207|407395|P1|COMPLETED|Overall Study||25
167389|NCT01520207|407394|P2|STARTED|Overall Study||25
167390|NCT01520207|407395|P1|STARTED|Overall Study||27
167391|NCT01520038|407401|P1|NOT COMPLETED|Overall Study||1
167392|NCT01520038|407401|P1|COMPLETED|Overall Study||1
167393|NCT01520038|407401|P1|STARTED|Overall Study||2
167394|NCT01519960|407410|P3|NOT COMPLETED|Overall Study||10
167395|NCT01519960|407411|P2|NOT COMPLETED|Overall Study||50
167396|NCT01519960|407412|P1|NOT COMPLETED|Overall Study||101
167397|NCT01519960|407410|P3|COMPLETED|Overall Study||0
167398|NCT01519960|407411|P2|COMPLETED|Overall Study||0
167399|NCT01519960|407412|P1|COMPLETED|Overall Study||0
167400|NCT01519960|407410|P3|Completed FU Week 24|Overall Study||10
167401|NCT01519960|407411|P2|Completed FU Week 24|Overall Study||15
167402|NCT01519960|407412|P1|Completed FU Week 24|Overall Study||101
167403|NCT01519960|407410|P3|Completed Follow-Up (FU) Week 12|Overall Study||10
167404|NCT01519960|407411|P2|Completed Follow-Up (FU) Week 12|Overall Study||26
167405|NCT01519960|407412|P1|Completed Follow-Up (FU) Week 12|Overall Study||101
167406|NCT01519960|407410|P3|Completed Week 48|Overall Study||10
167407|NCT01519960|407411|P2|Completed Week 48|Overall Study||47
167408|NCT01519960|407412|P1|Completed Week 48|Overall Study||99
167409|NCT01519960|407410|P3|STARTED|Overall Study||10
167410|NCT01519960|407411|P2|STARTED|Overall Study||50
167411|NCT01519960|407412|P1|STARTED|Overall Study||101
167412|NCT01519947|407522|P4|NOT COMPLETED|Overall Study||8
167413|NCT01519947|407523|P3|NOT COMPLETED|Overall Study||7
167414|NCT01519947|407524|P2|NOT COMPLETED|Overall Study||4
167415|NCT01519947|407525|P1|NOT COMPLETED|Overall Study||2
167416|NCT01519947|407522|P4|COMPLETED|Overall Study||34
167417|NCT01519947|407523|P3|COMPLETED|Overall Study||8
167418|NCT01519947|407524|P2|COMPLETED|Overall Study||7
167419|NCT01519947|407525|P1|COMPLETED|Overall Study||17
167420|NCT01519947|407522|P4|STARTED|Overall Study||42
167421|NCT01519947|407523|P3|STARTED|Overall Study||15
167422|NCT01519947|407524|P2|STARTED|Overall Study||11
167423|NCT01519947|407525|P1|STARTED|Overall Study||19
167424|NCT01519934|407555|P1|NOT COMPLETED|Overall Study||3
167425|NCT01519934|407555|P1|COMPLETED|Overall Study||45
167426|NCT01519934|407555|P1|STARTED|Overall Study||48
167427|NCT01519921|407564|P2|NOT COMPLETED|Overall Study||15
167428|NCT01519921|407565|P1|NOT COMPLETED|Overall Study||21
167429|NCT01519921|407564|P2|COMPLETED|Overall Study||49
167430|NCT01519921|407565|P1|COMPLETED|Overall Study||65
167431|NCT01519921|407564|P2|STARTED|Overall Study||64
167432|NCT01519921|407565|P1|STARTED|Overall Study||86
167433|NCT01519882|407589|P2|NOT COMPLETED|Overall Study||0
167434|NCT01519882|407590|P1|NOT COMPLETED|Overall Study||0
167435|NCT01519882|407589|P2|COMPLETED|Overall Study||0
167436|NCT01519882|407590|P1|COMPLETED|Overall Study||1
167437|NCT01519882|407589|P2|STARTED|Overall Study||0
167438|NCT01519882|407590|P1|STARTED|Overall Study||1
167439|NCT01519817|407614|P4|NOT COMPLETED|Overall Study||1
167440|NCT01519817|407615|P3|NOT COMPLETED|Overall Study||0
167441|NCT01519817|407616|P2|NOT COMPLETED|Overall Study||0
167442|NCT01519817|407617|P1|NOT COMPLETED|Overall Study||1
167443|NCT01519817|407614|P4|COMPLETED|Overall Study||10
167444|NCT01519817|407615|P3|COMPLETED|Overall Study||16
167445|NCT01519817|407616|P2|COMPLETED|Overall Study||3
167446|NCT01519817|407617|P1|COMPLETED|Overall Study||3
167447|NCT01519817|407614|P4|STARTED|Overall Study||11
167448|NCT01519817|407615|P3|STARTED|Overall Study||16
167449|NCT01519817|407616|P2|STARTED|Overall Study||3
167450|NCT01519817|407617|P1|STARTED|Overall Study||4
167451|NCT01519791|407657|P2|NOT COMPLETED|Overall Study||368
167452|NCT01519791|407658|P1|NOT COMPLETED|Overall Study||152
167453|NCT01519791|407657|P2|COMPLETED|Overall Study||292
167454|NCT01519791|407658|P1|COMPLETED|Overall Study||67
167455|NCT01519791|407657|P2|Completed Week 52|Overall Study||500
167456|NCT01519791|407658|P1|Completed Week 52|Overall Study||143
167457|NCT01519791|407657|P2|STARTED|Overall Study||660
167458|NCT01519791|407658|P1|STARTED|Overall Study||219
167459|NCT01519778|407722|P1|NOT COMPLETED|Overall Study||14
167460|NCT01519778|407722|P1|COMPLETED|Overall Study||186
167461|NCT01519778|407722|P1|STARTED|Overall Study||200
167462|NCT01519765|407728|P2|NOT COMPLETED|Overall Study||2
167463|NCT01519765|407729|P1|NOT COMPLETED|Overall Study||3
167464|NCT01519765|407728|P2|COMPLETED|Overall Study||34
167465|NCT01519765|407729|P1|COMPLETED|Overall Study||34
167466|NCT01519765|407728|P2|STARTED|Overall Study||36
167467|NCT01519765|407729|P1|STARTED|Overall Study||37
167468|NCT01519713|407778|P3|NOT COMPLETED|Overall Study||0
167469|NCT01519713|407779|P2|NOT COMPLETED|Overall Study||0
167470|NCT01519713|407780|P1|NOT COMPLETED|Overall Study||0
167471|NCT01519713|407778|P3|COMPLETED|Overall Study||4
167472|NCT01519713|407779|P2|COMPLETED|Overall Study||2
167473|NCT01519713|407780|P1|COMPLETED|Overall Study||194
167474|NCT01519713|407778|P3|STARTED|Overall Study||4
167475|NCT01519713|407779|P2|STARTED|Overall Study||2
167476|NCT01519713|407780|P1|STARTED|Overall Study||194
167477|NCT01519700|407807|P4|NOT COMPLETED|Overall Study||7
167478|NCT01519700|407808|P3|NOT COMPLETED|Overall Study||7
167479|NCT01519700|407809|P2|NOT COMPLETED|Overall Study||6
167480|NCT01519700|407810|P1|NOT COMPLETED|Overall Study||9
167481|NCT01519700|407807|P4|COMPLETED|Overall Study||47
167482|NCT01519700|407808|P3|COMPLETED|Overall Study||48
167483|NCT01519700|407809|P2|COMPLETED|Overall Study||49
167484|NCT01519700|407810|P1|COMPLETED|Overall Study||45
167485|NCT01519700|407807|P4|Treated Cycle 6 Neupogen|Overall Study||49
167486|NCT01519700|407808|P3|Treated Cycle 6 Neupogen|Overall Study||0
167487|NCT01519700|407809|P2|Treated Cycle 6 Neupogen|Overall Study||49
167488|NCT01519700|407810|P1|Treated Cycle 6 Neupogen|Overall Study||0
167489|NCT01519700|407807|P4|Treated Cycle 6 EP2006|Overall Study||0
167490|NCT01519700|407808|P3|Treated Cycle 6 EP2006|Overall Study||48
167491|NCT01519700|407809|P2|Treated Cycle 6 EP2006|Overall Study||0
167492|NCT01519700|407810|P1|Treated Cycle 6 EP2006|Overall Study||45
167493|NCT01519700|407807|P4|Treated Cycle 5 Neupogen|Overall Study||50
167494|NCT01519700|407808|P3|Treated Cycle 5 Neupogen|Overall Study||48
167495|NCT01519700|407809|P2|Treated Cycle 5 Neupogen|Overall Study||0
167496|NCT01519700|407810|P1|Treated Cycle 5 Neupogen|Overall Study||0
167497|NCT01519700|407807|P4|Treated Cycle 5 EP2006|Overall Study||0
167498|NCT01519700|407808|P3|Treated Cycle 5 EP2006|Overall Study||0
167499|NCT01519700|407809|P2|Treated Cycle 5 EP2006|Overall Study||49
167500|NCT01519700|407810|P1|Treated Cycle 5 EP2006|Overall Study||46
167501|NCT01519700|407807|P4|Treated Cycle 4 Neupogen|Overall Study||50
167502|NCT01519700|407808|P3|Treated Cycle 4 Neupogen|Overall Study||0
167503|NCT01519700|407809|P2|Treated Cycle 4 Neupogen|Overall Study||51
167504|NCT01519700|407810|P1|Treated Cycle 4 Neupogen|Overall Study||0
167505|NCT01519700|407807|P4|Treated Cycle 4 EP2006|Overall Study||0
167506|NCT01519700|407808|P3|Treated Cycle 4 EP2006|Overall Study||50
167507|NCT01519700|407809|P2|Treated Cycle 4 EP2006|Overall Study||0
167508|NCT01519700|407810|P1|Treated Cycle 4 EP2006|Overall Study||51
167509|NCT01519700|407807|P4|Treated Cycle 3 Neupogen|Overall Study||51
167510|NCT01519700|407808|P3|Treated Cycle 3 Neupogen|Overall Study||54
167511|NCT01519700|407809|P2|Treated Cycle 3 Neupogen|Overall Study||0
167512|NCT01519700|407810|P1|Treated Cycle 3 Neupogen|Overall Study||0
167513|NCT01519700|407807|P4|Treated Cycle 3 EP2006|Overall Study||0
167514|NCT01519700|407808|P3|Treated Cycle 3 EP2006|Overall Study||0
167515|NCT01519700|407809|P2|Treated Cycle 3 EP2006|Overall Study||51
167516|NCT01519700|407810|P1|Treated Cycle 3 EP2006|Overall Study||51
167517|NCT01519700|407807|P4|Treated Cycle 2 Neupogen|Overall Study||51
167518|NCT01519700|407808|P3|Treated Cycle 2 Neupogen|Overall Study||0
167519|NCT01519700|407809|P2|Treated Cycle 2 Neupogen|Overall Study||52
167520|NCT01519700|407810|P1|Treated Cycle 2 Neupogen|Overall Study||0
167521|NCT01519700|407807|P4|Treated Cycle 2 EP2006|Overall Study||0
167522|NCT01519700|407808|P3|Treated Cycle 2 EP2006|Overall Study||55
167523|NCT01519700|407809|P2|Treated Cycle 2 EP2006|Overall Study||0
167524|NCT01519700|407810|P1|Treated Cycle 2 EP2006|Overall Study||52
167525|NCT01519700|407807|P4|Treated Cycle 1 Neupogen|Overall Study||52
167526|NCT01519700|407808|P3|Treated Cycle 1 Neupogen|Overall Study||55
167527|NCT01519700|407809|P2|Treated Cycle 1 Neupogen|Overall Study||0
167528|NCT01519700|407810|P1|Treated Cycle 1 Neupogen|Overall Study||0
167529|NCT01519700|407807|P4|Treated Cycle 1 EP2006|Overall Study||0
167530|NCT01519700|407808|P3|Treated Cycle 1 EP2006|Overall Study||0
167531|NCT01519700|407809|P2|Treated Cycle 1 EP2006|Overall Study||54
167532|NCT01519700|407810|P1|Treated Cycle 1 EP2006|Overall Study||53
167533|NCT01519700|407807|P4|STARTED|Overall Study||54
167534|NCT01519700|407808|P3|STARTED|Overall Study||55
167535|NCT01519700|407809|P2|STARTED|Overall Study||55
167536|NCT01519700|407810|P1|STARTED|Overall Study||54
167537|NCT01519674|407845|P3|NOT COMPLETED|Overall Study||12
167538|NCT01519674|407846|P2|NOT COMPLETED|Overall Study||13
167539|NCT01519674|407847|P1|NOT COMPLETED|Overall Study||21
167540|NCT01519674|407845|P3|COMPLETED|Overall Study||181
167541|NCT01519674|407846|P2|COMPLETED|Overall Study||182
167542|NCT01519674|407847|P1|COMPLETED|Overall Study||173
167543|NCT01519674|407845|P3|Exposed|Overall Study||190
167544|NCT01519674|407846|P2|Exposed|Overall Study||193
167545|NCT01519674|407847|P1|Exposed|Overall Study||192
167546|NCT01519674|407845|P3|STARTED|Overall Study||193
167547|NCT01519674|407846|P2|STARTED|Overall Study||195
167548|NCT01519674|407847|P1|STARTED|Overall Study||194
167549|NCT01519661|407885|P1|NOT COMPLETED|Overall Study||61
167550|NCT01519661|407885|P1|COMPLETED|Overall Study||96
167551|NCT01519661|407885|P1|STARTED|Overall Study||157
167552|NCT01519648|407902|P2|NOT COMPLETED|Overall Study||0
167553|NCT01519648|407903|P1|NOT COMPLETED|Overall Study||0
167554|NCT01519648|407902|P2|COMPLETED|Overall Study||306
167555|NCT01519648|407903|P1|COMPLETED|Overall Study||502
167556|NCT01519648|407902|P2|STARTED|Overall Study||306
167557|NCT01519648|407903|P1|STARTED|Overall Study||502
167558|NCT01519635|407911|P2|NOT COMPLETED|Overall Study||3
167559|NCT01519635|407912|P1|NOT COMPLETED|Overall Study||1
167560|NCT01519635|407911|P2|COMPLETED|Overall Study||9
167561|NCT01519635|407912|P1|COMPLETED|Overall Study||11
167562|NCT01519635|407911|P2|STARTED|Overall Study||12
167563|NCT01519635|407912|P1|STARTED|Overall Study||12
167564|NCT01519570|407920|P2|NOT COMPLETED|Overall Study||0
167565|NCT01519570|407921|P1|NOT COMPLETED|Overall Study||0
167566|NCT01519570|407920|P2|COMPLETED|Overall Study||2089
167567|NCT01519570|407921|P1|COMPLETED|Overall Study||500
167568|NCT01519570|407920|P2|STARTED|Overall Study||2089
167569|NCT01519570|407921|P1|STARTED|Overall Study||500
167570|NCT01519518|407929|P2|NOT COMPLETED|Overall Study||10
167571|NCT01519518|407930|P1|NOT COMPLETED|Overall Study||7
167572|NCT01519518|407929|P2|COMPLETED|Overall Study||905
167573|NCT01519518|407930|P1|COMPLETED|Overall Study||907
167574|NCT01519518|407929|P2|STARTED|Overall Study||915
167575|NCT01519518|407930|P1|STARTED|Overall Study||914
167576|NCT01519466|407944|P2|NOT COMPLETED|Overall Study||0
167577|NCT01519466|407945|P1|NOT COMPLETED|Overall Study||0
167578|NCT01519466|407944|P2|COMPLETED|Overall Study||16
167579|NCT01519466|407945|P1|COMPLETED|Overall Study||33
167580|NCT01519466|407944|P2|STARTED|Overall Study||16
167581|NCT01519466|407945|P1|STARTED|Overall Study||33
167582|NCT01519427|407955|P1|NOT COMPLETED|Overall Study||2
167583|NCT01519427|407955|P1|COMPLETED|Overall Study||0
167584|NCT01519427|407955|P1|STARTED|Overall Study||2
167585|NCT01519414|407964|P3|NOT COMPLETED|Post Cross-over||0
167586|NCT01519414|407965|P2|NOT COMPLETED|Post Cross-over||0
167587|NCT01519414|407966|P1|NOT COMPLETED|Post Cross-over||0
167588|NCT01519414|407964|P3|COMPLETED|Post Cross-over||12
167589|NCT01519414|407965|P2|COMPLETED|Post Cross-over||14
167590|NCT01519414|407966|P1|COMPLETED|Post Cross-over||52
167591|NCT01519414|407964|P3|STARTED|Post Cross-over||12
167592|NCT01519414|407965|P2|STARTED|Post Cross-over||14
167593|NCT01519414|407966|P1|STARTED|Post Cross-over||52
167594|NCT01519414|407964|P3|NOT COMPLETED|Pre Cross-over||0
167595|NCT01519414|407965|P2|NOT COMPLETED|Pre Cross-over||0
167596|NCT01519414|407966|P1|NOT COMPLETED|Pre Cross-over||0
167597|NCT01519414|407964|P3|COMPLETED|Pre Cross-over||0
167598|NCT01519414|407965|P2|COMPLETED|Pre Cross-over||26
167599|NCT01519414|407966|P1|COMPLETED|Pre Cross-over||52
167600|NCT01519414|407964|P3|STARTED|Pre Cross-over||0
167601|NCT01519414|407965|P2|STARTED|Pre Cross-over||26
167602|NCT01519414|407966|P1|STARTED|Pre Cross-over||52
167603|NCT01519323|407987|P2|NOT COMPLETED|Overall Study||3
167604|NCT01519323|407988|P1|NOT COMPLETED|Overall Study||3
167605|NCT01519323|407987|P2|COMPLETED|Overall Study||0
167606|NCT01519323|407988|P1|COMPLETED|Overall Study||0
167607|NCT01519323|407987|P2|STARTED|Overall Study||3
167608|NCT01519323|407988|P1|STARTED|Overall Study||3
167609|NCT01519284|408004|P5|NOT COMPLETED|Overall Study||0
167610|NCT01519284|408005|P4|NOT COMPLETED|Overall Study||0
167611|NCT01519284|408006|P3|NOT COMPLETED|Overall Study||2
167612|NCT01519284|408007|P2|NOT COMPLETED|Overall Study||0
167613|NCT01519284|408008|P1|NOT COMPLETED|Overall Study||0
167614|NCT01519284|408004|P5|COMPLETED|Overall Study||16
167615|NCT01519284|408005|P4|COMPLETED|Overall Study||16
167616|NCT01519284|408006|P3|COMPLETED|Overall Study||16
167617|NCT01519284|408007|P2|COMPLETED|Overall Study||16
167618|NCT01519284|408008|P1|COMPLETED|Overall Study||16
167619|NCT01519284|408004|P5|STARTED|Overall Study||16
167620|NCT01519284|408005|P4|STARTED|Overall Study||16
167621|NCT01519284|408006|P3|STARTED|Overall Study||18
167622|NCT01519284|408007|P2|STARTED|Overall Study||16
167623|NCT01519284|408008|P1|STARTED|Overall Study||16
167624|NCT01519271|408037|P2|NOT COMPLETED|Phase 2||0
167625|NCT01519271|408038|P1|NOT COMPLETED|Phase 2||0
167626|NCT01519271|408037|P2|COMPLETED|Phase 2||14
167627|NCT01519271|408038|P1|COMPLETED|Phase 2||12
167628|NCT01519271|408037|P2|STARTED|Phase 2||14
167629|NCT01519271|408038|P1|STARTED|Phase 2|2 participants discontinued after Phase 1|12
167630|NCT01519271|408037|P2|NOT COMPLETED|Phase 1||1
167631|NCT01519271|408038|P1|NOT COMPLETED|Phase 1||0
167632|NCT01519271|408037|P2|COMPLETED|Phase 1|1 participant discontinued participation in the middle of phase 1.|13
167633|NCT01519271|408038|P1|COMPLETED|Phase 1||14
167634|NCT01519271|408037|P2|STARTED|Phase 1||14
167635|NCT01519271|408038|P1|STARTED|Phase 1||14
167636|NCT01519245|408048|P2|NOT COMPLETED|Overall Study||2
167637|NCT01519245|408049|P1|NOT COMPLETED|Overall Study||1
167638|NCT01519245|408048|P2|COMPLETED|Overall Study||18
167639|NCT01519245|408049|P1|COMPLETED|Overall Study||23
167640|NCT01519245|408048|P2|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|2
167641|NCT01519245|408049|P1|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|6
167642|NCT01519245|408048|P2|Received Pre-pump IV TXA|Overall Study|All patients meeting inclusion criteria received appropriate dosing, as per protocol.|18
167643|NCT01519245|408049|P1|Received Pre-pump IV TXA|Overall Study|Two patients included in in the final analysis did not receive pre-pump IV TXA.|21
167644|NCT01519245|408048|P2|STARTED|Overall Study||20
167645|NCT01519245|408049|P1|STARTED|Overall Study||24
167646|NCT01519206|408061|P1|NOT COMPLETED|Overall Study||5
167647|NCT01519206|408061|P1|COMPLETED|Overall Study||27
167648|NCT01519206|408061|P1|STARTED|Overall Study||32
167649|NCT01519167|408075|P2|NOT COMPLETED|Overall Study||8
167650|NCT01519167|408076|P1|NOT COMPLETED|Overall Study||0
167651|NCT01519167|408075|P2|COMPLETED|Overall Study||81
167652|NCT01519167|408076|P1|COMPLETED|Overall Study||1
167653|NCT01519167|408075|P2|STARTED|Overall Study||89
167654|NCT01519167|408076|P1|STARTED|Overall Study||1
167655|NCT01519089|408102|P2|NOT COMPLETED|Overall Study||15
167656|NCT01519089|408103|P1|NOT COMPLETED|Overall Study||7
167657|NCT01519089|408102|P2|COMPLETED|Overall Study||33
167658|NCT01519089|408103|P1|COMPLETED|Overall Study||40
167659|NCT01519089|408102|P2|Received Treatment|Overall Study||47
167660|NCT01519089|408103|P1|Received Treatment|Overall Study||47
167661|NCT01519089|408102|P2|STARTED|Overall Study||48
167662|NCT01519089|408103|P1|STARTED|Overall Study||47
167663|NCT01519063|408224|P2|NOT COMPLETED|Overall Study||5
167664|NCT01519063|408225|P1|NOT COMPLETED|Overall Study||7
167665|NCT01519063|408224|P2|COMPLETED|Overall Study||25
167666|NCT01519063|408225|P1|COMPLETED|Overall Study||19
167667|NCT01519063|408224|P2|STARTED|Overall Study||30
167668|NCT01519063|408225|P1|STARTED|Overall Study||26
167669|NCT01518946|408245|P3|NOT COMPLETED|Randomized Phase (Second Intervention)||0
167670|NCT01518946|408246|P2|NOT COMPLETED|Randomized Phase (Second Intervention)||0
167671|NCT01518946|408247|P1|NOT COMPLETED|Randomized Phase (Second Intervention)||0
167672|NCT01518946|408245|P3|COMPLETED|Randomized Phase (Second Intervention)||10
167673|NCT01518946|408246|P2|COMPLETED|Randomized Phase (Second Intervention)||9
167674|NCT01518946|408247|P1|COMPLETED|Randomized Phase (Second Intervention)||0
167675|NCT01518946|408245|P3|STARTED|Randomized Phase (Second Intervention)||10
167676|NCT01518946|408246|P2|STARTED|Randomized Phase (Second Intervention)||9
167677|NCT01518946|408247|P1|STARTED|Randomized Phase (Second Intervention)||0
167678|NCT01518946|408245|P3|NOT COMPLETED|Randomized Phase (First Intervention)||0
167679|NCT01518946|408246|P2|NOT COMPLETED|Randomized Phase (First Intervention)||1
167680|NCT01518946|408247|P1|NOT COMPLETED|Randomized Phase (First Intervention)||0
167681|NCT01518946|408245|P3|COMPLETED|Randomized Phase (First Intervention)||10
167682|NCT01518946|408246|P2|COMPLETED|Randomized Phase (First Intervention)||9
167683|NCT01518946|408247|P1|COMPLETED|Randomized Phase (First Intervention)||0
167684|NCT01518946|408245|P3|STARTED|Randomized Phase (First Intervention)||10
167685|NCT01518946|408246|P2|STARTED|Randomized Phase (First Intervention)||10
167686|NCT01518946|408247|P1|STARTED|Randomized Phase (First Intervention)||0
167687|NCT01518946|408245|P3|NOT COMPLETED|Open-label Phase||0
167688|NCT01518946|408246|P2|NOT COMPLETED|Open-label Phase||0
167689|NCT01518946|408247|P1|NOT COMPLETED|Open-label Phase||4
167690|NCT01518946|408245|P3|COMPLETED|Open-label Phase||0
167691|NCT01518946|408246|P2|COMPLETED|Open-label Phase||0
167692|NCT01518946|408247|P1|COMPLETED|Open-label Phase||20
167693|NCT01518946|408245|P3|STARTED|Open-label Phase||0
167694|NCT01518946|408246|P2|STARTED|Open-label Phase||0
167695|NCT01518946|408247|P1|STARTED|Open-label Phase||24
167696|NCT01518530|408254|P1|NOT COMPLETED|Post-Treatment Follow-up||0
167697|NCT01518530|408254|P1|COMPLETED|Post-Treatment Follow-up||9
167698|NCT01518530|408254|P1|STARTED|Post-Treatment Follow-up||9
167699|NCT01518530|408254|P1|NOT COMPLETED|Active Treatment Period||1
167700|NCT01518530|408254|P1|COMPLETED|Active Treatment Period||9
167701|NCT01518530|408254|P1|STARTED|Active Treatment Period||10
167702|NCT01518374|408258|P1|NOT COMPLETED|Overall Study||7
167703|NCT01518374|408258|P1|COMPLETED|Overall Study||1761
167704|NCT01518374|408258|P1|STARTED|Overall Study||1768
167705|NCT01518322|408262|P1|NOT COMPLETED|Overall Study||13
167706|NCT01518322|408262|P1|COMPLETED|Overall Study||222
167707|NCT01518322|408262|P1|STARTED|Overall Study||235
167708|NCT01518270|408275|P1|NOT COMPLETED|Overall Study||0
167709|NCT01518270|408275|P1|COMPLETED|Overall Study||179
167710|NCT01518270|408275|P1|STARTED|Overall Study||179
167711|NCT01518257|408283|P2|NOT COMPLETED|Overall Study||0
167712|NCT01518257|408284|P1|NOT COMPLETED|Overall Study||2
167713|NCT01518257|408283|P2|COMPLETED|Overall Study||60
167714|NCT01518257|408284|P1|COMPLETED|Overall Study||59
167715|NCT01518257|408283|P2|STARTED|Overall Study||60
167716|NCT01518257|408284|P1|STARTED|Overall Study||61
167717|NCT01518244|408306|P1|NOT COMPLETED|Overall Study||3
167718|NCT01518244|408306|P1|COMPLETED|Overall Study||47
167719|NCT01518244|408306|P1|STARTED|Overall Study||50
167720|NCT01518192|408314|P3|NOT COMPLETED|Overall Study||35
167721|NCT01518192|408315|P2|NOT COMPLETED|Overall Study||26
167722|NCT01518192|408316|P1|NOT COMPLETED|Overall Study||29
167723|NCT01518192|408314|P3|COMPLETED|Overall Study||224
167724|NCT01518192|408315|P2|COMPLETED|Overall Study||114
167725|NCT01518192|408316|P1|COMPLETED|Overall Study||116
167726|NCT01518192|408314|P3|STARTED|Overall Study||259
167727|NCT01518192|408315|P2|STARTED|Overall Study||140
167728|NCT01518192|408316|P1|STARTED|Overall Study||145
167729|NCT01518153|408337|P3|NOT COMPLETED|Donor Lymphocyte Infusion||1
167730|NCT01518153|408338|P2|NOT COMPLETED|Donor Lymphocyte Infusion||2
167731|NCT01518153|408339|P1|NOT COMPLETED|Donor Lymphocyte Infusion||0
167732|NCT01518153|408337|P3|COMPLETED|Donor Lymphocyte Infusion||3
167733|NCT01518153|408338|P2|COMPLETED|Donor Lymphocyte Infusion||1
167734|NCT01518153|408339|P1|COMPLETED|Donor Lymphocyte Infusion||0
167735|NCT01518153|408337|P3|STARTED|Donor Lymphocyte Infusion||4
167736|NCT01518153|408338|P2|STARTED|Donor Lymphocyte Infusion||3
167737|NCT01518153|408339|P1|STARTED|Donor Lymphocyte Infusion||0
167738|NCT01518153|408337|P3|NOT COMPLETED|Stem Cell Transplant||0
167739|NCT01518153|408338|P2|NOT COMPLETED|Stem Cell Transplant||0
167740|NCT01518153|408339|P1|NOT COMPLETED|Stem Cell Transplant||9
167741|NCT01518153|408337|P3|COMPLETED|Stem Cell Transplant||0
167742|NCT01518153|408338|P2|COMPLETED|Stem Cell Transplant||0
167743|NCT01518153|408339|P1|COMPLETED|Stem Cell Transplant||7
167744|NCT01518153|408337|P3|STARTED|Stem Cell Transplant||0
167745|NCT01518153|408338|P2|STARTED|Stem Cell Transplant||0
167746|NCT01518153|408339|P1|STARTED|Stem Cell Transplant||16
167747|NCT01517984|408350|P4|NOT COMPLETED|Overall Study||1
167748|NCT01517984|408351|P3|NOT COMPLETED|Overall Study||4
167749|NCT01517984|408352|P2|NOT COMPLETED|Overall Study||23
167750|NCT01517984|408353|P1|NOT COMPLETED|Overall Study||5
167751|NCT01517984|408350|P4|COMPLETED|Overall Study||6
167752|NCT01517984|408351|P3|COMPLETED|Overall Study||10
167753|NCT01517984|408352|P2|COMPLETED|Overall Study||3
167754|NCT01517984|408353|P1|COMPLETED|Overall Study||0
167755|NCT01517984|408350|P4|STARTED|Overall Study||7
167756|NCT01517984|408351|P3|STARTED|Overall Study||14
167757|NCT01517984|408352|P2|STARTED|Overall Study||26
167758|NCT01517984|408353|P1|STARTED|Overall Study||5
167759|NCT01517893|408379|P2|NOT COMPLETED|Overall Study||0
167760|NCT01517893|408380|P1|NOT COMPLETED|Overall Study||3
167761|NCT01517893|408379|P2|COMPLETED|Overall Study||7
167762|NCT01517893|408380|P1|COMPLETED|Overall Study||5
167763|NCT01517893|408379|P2|STARTED|Overall Study||7
167764|NCT01517893|408380|P1|STARTED|Overall Study||8
167765|NCT01517867|408402|P2|NOT COMPLETED|Overall Study||65
167766|NCT01517867|408403|P1|NOT COMPLETED|Overall Study||63
167767|NCT01517867|408402|P2|COMPLETED|Overall Study||15
167768|NCT01517867|408403|P1|COMPLETED|Overall Study||18
167769|NCT01517867|408402|P2|STARTED|Overall Study||80
167770|NCT01517867|408403|P1|STARTED|Overall Study||81
167771|NCT01517763|408414|P3|NOT COMPLETED|Overall Study||0
167772|NCT01517763|408415|P2|NOT COMPLETED|Overall Study||0
167773|NCT01517763|408416|P1|NOT COMPLETED|Overall Study||0
167774|NCT01517763|408414|P3|COMPLETED|Overall Study||0
167775|NCT01517763|408415|P2|COMPLETED|Overall Study||0
167776|NCT01517763|408416|P1|COMPLETED|Overall Study||0
167777|NCT01517763|408414|P3|STARTED|Overall Study||0
167778|NCT01517763|408415|P2|STARTED|Overall Study||0
167779|NCT01517763|408416|P1|STARTED|Overall Study||0
167780|NCT01517750|408431|P4|NOT COMPLETED|Overall Study||1
167781|NCT01517750|408432|P3|NOT COMPLETED|Overall Study||4
167782|NCT01517750|408433|P2|NOT COMPLETED|Overall Study||2
167783|NCT01517750|408434|P1|NOT COMPLETED|Overall Study||1
167784|NCT01517750|408431|P4|COMPLETED|Overall Study||18
167785|NCT01517750|408432|P3|COMPLETED|Overall Study||17
167786|NCT01517750|408433|P2|COMPLETED|Overall Study||17
167787|NCT01517750|408434|P1|COMPLETED|Overall Study||20
167788|NCT01517750|408431|P4|STARTED|Overall Study||19
167789|NCT01517750|408432|P3|STARTED|Overall Study||21
167790|NCT01517750|408433|P2|STARTED|Overall Study||19
167791|NCT01517750|408434|P1|STARTED|Overall Study||21
167792|NCT01517529|408464|P1|NOT COMPLETED|Overall Study||0
167793|NCT01517529|408464|P1|COMPLETED|Overall Study||10
167794|NCT01517529|408464|P1|STARTED|Overall Study||10
167795|NCT01517412|408471|P2|NOT COMPLETED|Overall Study||24
167796|NCT01517412|408472|P1|NOT COMPLETED|Overall Study||36
167797|NCT01517412|408471|P2|COMPLETED|Overall Study||202
167798|NCT01517412|408472|P1|COMPLETED|Overall Study||189
167799|NCT01517412|408471|P2|STARTED|Overall Study||226
167800|NCT01517412|408472|P1|STARTED|Overall Study||225
167801|NCT01517373|408501|P6|NOT COMPLETED|Treatment Period||7
167802|NCT01517373|408502|P5|NOT COMPLETED|Treatment Period||6
167803|NCT01517373|408503|P4|NOT COMPLETED|Treatment Period||7
167804|NCT01517373|408504|P3|NOT COMPLETED|Treatment Period||6
167805|NCT01517373|408505|P2|NOT COMPLETED|Treatment Period||4
167806|NCT01517373|408506|P1|NOT COMPLETED|Treatment Period||0
167807|NCT01517373|408501|P6|COMPLETED|Treatment Period||54
167808|NCT01517373|408502|P5|COMPLETED|Treatment Period||55
167809|NCT01517373|408503|P4|COMPLETED|Treatment Period||54
167810|NCT01517373|408504|P3|COMPLETED|Treatment Period||54
167811|NCT01517373|408505|P2|COMPLETED|Treatment Period||57
167812|NCT01517373|408506|P1|COMPLETED|Treatment Period||0
167813|NCT01517373|408501|P6|STARTED|Treatment Period||61
167814|NCT01517373|408502|P5|STARTED|Treatment Period||61
167815|NCT01517373|408503|P4|STARTED|Treatment Period||61
167816|NCT01517373|408504|P3|STARTED|Treatment Period||60
167817|NCT01517373|408505|P2|STARTED|Treatment Period||61
167818|NCT01517373|408506|P1|STARTED|Treatment Period||0
167819|NCT01517373|408501|P6|NOT COMPLETED|Run-in Period||0
167820|NCT01517373|408502|P5|NOT COMPLETED|Run-in Period||0
167821|NCT01517373|408503|P4|NOT COMPLETED|Run-in Period||0
167822|NCT01517373|408504|P3|NOT COMPLETED|Run-in Period||0
167823|NCT01517373|408505|P2|NOT COMPLETED|Run-in Period||0
167824|NCT01517373|408506|P1|NOT COMPLETED|Run-in Period||57
167825|NCT01517373|408501|P6|COMPLETED|Run-in Period||0
167826|NCT01517373|408502|P5|COMPLETED|Run-in Period||0
167827|NCT01517373|408503|P4|COMPLETED|Run-in Period||0
167828|NCT01517373|408504|P3|COMPLETED|Run-in Period||0
167829|NCT01517373|408505|P2|COMPLETED|Run-in Period||0
167830|NCT01517373|408506|P1|COMPLETED|Run-in Period||304
167831|NCT01517373|408501|P6|STARTED|Run-in Period||0
167832|NCT01517373|408502|P5|STARTED|Run-in Period||0
167833|NCT01517373|408503|P4|STARTED|Run-in Period||0
167834|NCT01517373|408504|P3|STARTED|Run-in Period||0
167835|NCT01517373|408505|P2|STARTED|Run-in Period||0
167836|NCT01517373|408506|P1|STARTED|Run-in Period||361
167837|NCT01517295|408576|P2|NOT COMPLETED|Overall Study||0
167838|NCT01517295|408577|P1|NOT COMPLETED|Overall Study||1
167839|NCT01517295|408576|P2|COMPLETED|Overall Study||14
167840|NCT01517295|408577|P1|COMPLETED|Overall Study||15
167841|NCT01517295|408576|P2|STARTED|Overall Study||14
167842|NCT01517295|408577|P1|STARTED|Overall Study||16
167843|NCT01517282|408591|P4|NOT COMPLETED|Overall Study||1
167844|NCT01517282|408592|P3|NOT COMPLETED|Overall Study||1
167845|NCT01517282|408593|P2|NOT COMPLETED|Overall Study||1
167846|NCT01517282|408594|P1|NOT COMPLETED|Overall Study||1
167847|NCT01517282|408591|P4|COMPLETED|Overall Study||5
167848|NCT01517282|408592|P3|COMPLETED|Overall Study||8
167849|NCT01517282|408593|P2|COMPLETED|Overall Study||7
167850|NCT01517282|408594|P1|COMPLETED|Overall Study||8
167851|NCT01517282|408591|P4|STARTED|Overall Study||6
167852|NCT01517282|408592|P3|STARTED|Overall Study|1 patient completed the trial, but received only 4 doses of medication and 2 MRIs due to pregnancy|9
167853|NCT01517282|408593|P2|STARTED|Overall Study||8
167854|NCT01517282|408594|P1|STARTED|Overall Study|One patient was randomized but did not receive study medication based on the investigator's decision|9
167855|NCT01517178|408628|P2|NOT COMPLETED|Period 2||2
167856|NCT01517178|408629|P1|NOT COMPLETED|Period 2||6
167857|NCT01517178|408628|P2|COMPLETED|Period 2||4
167858|NCT01517178|408629|P1|COMPLETED|Period 2||5
167859|NCT01517178|408628|P2|STARTED|Period 2||6
167860|NCT01517178|408629|P1|STARTED|Period 2|One subject discontinued during run-in and did not start period 2.|11
167861|NCT01517178|408628|P2|NOT COMPLETED|Period 1||5
167862|NCT01517178|408629|P1|NOT COMPLETED|Period 1||4
167863|NCT01517178|408628|P2|COMPLETED|Period 1||6
167864|NCT01517178|408629|P1|COMPLETED|Period 1||12
167865|NCT01517178|408628|P2|STARTED|Period 1||11
167866|NCT01517178|408629|P1|STARTED|Period 1|One subject (who discontinued due to an adverse event) actually used New ostomy base plate.|16
167867|NCT01517074|408635|P1|NOT COMPLETED|Overall Study||0
167868|NCT01517074|408635|P1|COMPLETED|Overall Study||5
167869|NCT01517074|408635|P1|STARTED|Overall Study||5
167870|NCT01516970|408648|P2|NOT COMPLETED|Overall Study||21
167871|NCT01516970|408649|P1|NOT COMPLETED|Overall Study||18
167872|NCT01516970|408648|P2|COMPLETED|Overall Study||132
167873|NCT01516970|408649|P1|COMPLETED|Overall Study||141
167874|NCT01516970|408648|P2|STARTED|Overall Study||153
167875|NCT01516970|408649|P1|STARTED|Overall Study||159
167876|NCT01516892|408661|P1|NOT COMPLETED|Overall Study||343
167877|NCT01516892|408661|P1|COMPLETED|Overall Study||373
167878|NCT01516892|408661|P1|STARTED|Overall Study||716
167879|NCT01516879|408669|P2|NOT COMPLETED|Overall Study||34
167880|NCT01516879|408670|P1|NOT COMPLETED|Overall Study||16
167881|NCT01516879|408669|P2|COMPLETED|Overall Study||568
167882|NCT01516879|408670|P1|COMPLETED|Overall Study||287
167883|NCT01516879|408669|P2|Received Treatment|Overall Study||599
167884|NCT01516879|408670|P1|Received Treatment|Overall Study||302
167885|NCT01516879|408669|P2|STARTED|Overall Study||602
167886|NCT01516879|408670|P1|STARTED|Overall Study||303
167887|NCT01516749|408704|P1|NOT COMPLETED|Follow-up Off Therapy||1
167888|NCT01516749|408704|P1|COMPLETED|Follow-up Off Therapy||4
167889|NCT01516749|408704|P1|STARTED|Follow-up Off Therapy||5
167890|NCT01516749|408704|P1|NOT COMPLETED|Active Therapy||1
167891|NCT01516749|408704|P1|COMPLETED|Active Therapy||5
167892|NCT01516749|408704|P1|STARTED|Active Therapy||6
167893|NCT01516736|408713|P2|NOT COMPLETED|Overall Study||13
167894|NCT01516736|408714|P1|NOT COMPLETED|Overall Study||20
167895|NCT01516736|408713|P2|COMPLETED|Overall Study||140
167896|NCT01516736|408714|P1|COMPLETED|Overall Study||135
167897|NCT01516736|408713|P2|STARTED|Overall Study||153
167898|NCT01516736|408714|P1|STARTED|Overall Study||155
167899|NCT01516684|408736|P2|NOT COMPLETED|Overall Study||0
167900|NCT01516684|408737|P1|NOT COMPLETED|Overall Study||0
167901|NCT01516684|408736|P2|COMPLETED|Overall Study|"Overall number of units (trials) completed was 152~Trials were randomized for each arm, not participants"|0
167902|NCT01516684|408737|P1|COMPLETED|Overall Study|Trials were randomized for each arm, not participants|0
167903|NCT01516684|408736|P2|STARTED|Overall Study|"Overall number of units (trials) was used for measuring results with 170 trials.~Trials were randomized for each arm, not participants"|0
167904|NCT01516684|408737|P1|STARTED|Overall Study|"Overall number of units (trials) was used for measuring results with 170 trials.~Trials were randomized for each arm, not participants"|0
167905|NCT01516632|408753|P2|NOT COMPLETED|Overall Study||15
167906|NCT01516632|408754|P1|NOT COMPLETED|Overall Study||24
167907|NCT01516632|408753|P2|COMPLETED|Overall Study||48
167908|NCT01516632|408754|P1|COMPLETED|Overall Study||77
167909|NCT01516632|408753|P2|STARTED|Overall Study||63
167910|NCT01516632|408754|P1|STARTED|Overall Study||101
167911|NCT01516437|408768|P4|NOT COMPLETED|Overall Study||1
167912|NCT01516437|408769|P3|NOT COMPLETED|Overall Study||1
167913|NCT01516437|408770|P2|NOT COMPLETED|Overall Study||0
167914|NCT01516437|408771|P1|NOT COMPLETED|Overall Study||0
167915|NCT01516437|408768|P4|COMPLETED|Overall Study||6
167916|NCT01516437|408769|P3|COMPLETED|Overall Study||14
167917|NCT01516437|408770|P2|COMPLETED|Overall Study||24
167918|NCT01516437|408771|P1|COMPLETED|Overall Study||24
167919|NCT01516437|408768|P4|STARTED|Overall Study||7
167920|NCT01516437|408769|P3|STARTED|Overall Study||15
167921|NCT01516437|408770|P2|STARTED|Overall Study||24
167922|NCT01516437|408771|P1|STARTED|Overall Study||24
167923|NCT01516424|408827|P2|NOT COMPLETED|Overall Study||22
167924|NCT01516424|408828|P1|NOT COMPLETED|Overall Study||35
167925|NCT01516424|408827|P2|COMPLETED|Overall Study||114
167926|NCT01516424|408828|P1|COMPLETED|Overall Study||96
167927|NCT01516424|408827|P2|STARTED|Overall Study|the patient number of randomization for Risperidone Group|136
167928|NCT01516424|408828|P1|STARTED|Overall Study|the patient number of randomization for Blonanserin Group|131
167929|NCT01516268|408836|P2|NOT COMPLETED|Overall Study||0
167930|NCT01516268|408837|P1|NOT COMPLETED|Overall Study||0
167931|NCT01516268|408836|P2|COMPLETED|Overall Study||25
167932|NCT01516268|408837|P1|COMPLETED|Overall Study||25
167933|NCT01516268|408836|P2|STARTED|Overall Study||25
167934|NCT01516268|408837|P1|STARTED|Overall Study||25
167935|NCT01516034|408843|P1|NOT COMPLETED|Overall Study||8
167936|NCT01516034|408843|P1|COMPLETED|Overall Study||0
167937|NCT01516034|408843|P1|STARTED|Overall Study||8
167938|NCT01516008|408850|P3|NOT COMPLETED|Overall Study||18
167939|NCT01516008|408851|P2|NOT COMPLETED|Overall Study||16
167940|NCT01516008|408852|P1|NOT COMPLETED|Overall Study||45
167941|NCT01516008|408850|P3|COMPLETED|Overall Study||99
167942|NCT01516008|408851|P2|COMPLETED|Overall Study||105
167943|NCT01516008|408852|P1|COMPLETED|Overall Study||69
167944|NCT01516008|408850|P3|STARTED|Overall Study||117
167945|NCT01516008|408851|P2|STARTED|Overall Study||121
167946|NCT01516008|408852|P1|STARTED|Overall Study||114
167947|NCT01515995|408886|P2|NOT COMPLETED|Overall Study||4
167948|NCT01515995|408887|P1|NOT COMPLETED|Overall Study||3
167949|NCT01515995|408886|P2|COMPLETED|Overall Study||21
167950|NCT01515995|408887|P1|COMPLETED|Overall Study||22
167951|NCT01515995|408886|P2|STARTED|Overall Study||25
167952|NCT01515995|408887|P1|STARTED|Overall Study||25
167953|NCT01515956|408893|P1|NOT COMPLETED|Overall Study||0
167954|NCT01515956|408893|P1|COMPLETED|Overall Study||15
167955|NCT01515956|408893|P1|STARTED|Overall Study||15
167956|NCT01515943|408902|P3|NOT COMPLETED|Overall Study||13
167957|NCT01515943|408903|P2|NOT COMPLETED|Overall Study||16
167958|NCT01515943|408904|P1|NOT COMPLETED|Overall Study||6
167959|NCT01515943|408902|P3|COMPLETED|Overall Study||31
167960|NCT01515943|408903|P2|COMPLETED|Overall Study||69
167961|NCT01515943|408904|P1|COMPLETED|Overall Study||69
167962|NCT01515943|408902|P3|STARTED|Overall Study||44
167963|NCT01515943|408903|P2|STARTED|Overall Study||85
167964|NCT01515943|408904|P1|STARTED|Overall Study||75
167965|NCT01515891|408950|P1|NOT COMPLETED|Overall Study||0
167966|NCT01515891|408950|P1|COMPLETED|Overall Study||4
167967|NCT01515891|408950|P1|STARTED|Overall Study||4
167968|NCT01515865|408957|P3|NOT COMPLETED|Part C (Randomized)||0
167969|NCT01515865|408958|P2|NOT COMPLETED|Part C (Randomized)||0
167970|NCT01515865|408959|P1|NOT COMPLETED|Part C (Randomized)||0
167971|NCT01515865|408957|P3|COMPLETED|Part C (Randomized)||34
167972|NCT01515865|408958|P2|COMPLETED|Part C (Randomized)||33
167973|NCT01515865|408959|P1|COMPLETED|Part C (Randomized)||0
167974|NCT01515865|408957|P3|STARTED|Part C (Randomized)||34
167975|NCT01515865|408958|P2|STARTED|Part C (Randomized)|A total of two subjects from Part B did not meet the criteria required to be enrolled into Part C.|33
167976|NCT01515865|408959|P1|STARTED|Part C (Randomized)||0
167977|NCT01515865|408957|P3|NOT COMPLETED|Part B (Open-label)||0
167978|NCT01515865|408958|P2|NOT COMPLETED|Part B (Open-label)||0
167979|NCT01515865|408959|P1|NOT COMPLETED|Part B (Open-label)||2
167980|NCT01515865|408957|P3|COMPLETED|Part B (Open-label)||0
167981|NCT01515865|408958|P2|COMPLETED|Part B (Open-label)||0
167982|NCT01515865|408959|P1|COMPLETED|Part B (Open-label)||69
167983|NCT01515865|408957|P3|STARTED|Part B (Open-label)||0
167984|NCT01515865|408958|P2|STARTED|Part B (Open-label)||0
167985|NCT01515865|408959|P1|STARTED|Part B (Open-label)|Twenty-four subjects from Part A did not meet the criteria required to be enrolled into Part B.|71
167986|NCT01515865|408957|P3|NOT COMPLETED|Part A (Open-label)||0
167987|NCT01515865|408958|P2|NOT COMPLETED|Part A (Open-label)||0
167988|NCT01515865|408959|P1|NOT COMPLETED|Part A (Open-label)||3
167989|NCT01515865|408957|P3|COMPLETED|Part A (Open-label)||0
167990|NCT01515865|408958|P2|COMPLETED|Part A (Open-label)||0
167991|NCT01515865|408959|P1|COMPLETED|Part A (Open-label)||95
167992|NCT01515865|408957|P3|STARTED|Part A (Open-label)||0
167993|NCT01515865|408958|P2|STARTED|Part A (Open-label)||0
167994|NCT01515865|408959|P1|STARTED|Part A (Open-label)||98
167995|NCT01515696|408969|P2|NOT COMPLETED|Overall Study||10
167996|NCT01515696|408970|P1|NOT COMPLETED|Overall Study||8
167997|NCT01515696|408969|P2|COMPLETED|Overall Study||39
167998|NCT01515696|408970|P1|COMPLETED|Overall Study||39
167999|NCT01515696|408969|P2|STARTED|Overall Study||49
168000|NCT01515696|408970|P1|STARTED|Overall Study||47
168001|NCT01515657|408980|P3|NOT COMPLETED|Third Intervention||0
168002|NCT01515657|408981|P2|NOT COMPLETED|Third Intervention||0
168003|NCT01515657|408982|P1|NOT COMPLETED|Third Intervention||1
168004|NCT01515657|408980|P3|COMPLETED|Third Intervention||13
168005|NCT01515657|408981|P2|COMPLETED|Third Intervention||11
168006|NCT01515657|408982|P1|COMPLETED|Third Intervention||13
168007|NCT01515657|408980|P3|STARTED|Third Intervention||13
168008|NCT01515657|408981|P2|STARTED|Third Intervention||11
168009|NCT01515657|408982|P1|STARTED|Third Intervention||14
168010|NCT01515657|408980|P3|NOT COMPLETED|Second Intervention||0
168011|NCT01515657|408981|P2|NOT COMPLETED|Second Intervention||1
168012|NCT01515657|408982|P1|NOT COMPLETED|Second Intervention||0
168013|NCT01515657|408980|P3|COMPLETED|Second Intervention||13
168014|NCT01515657|408981|P2|COMPLETED|Second Intervention||11
168015|NCT01515657|408982|P1|COMPLETED|Second Intervention||14
168016|NCT01515657|408980|P3|STARTED|Second Intervention||13
168017|NCT01515657|408981|P2|STARTED|Second Intervention||12
168018|NCT01515657|408982|P1|STARTED|Second Intervention||14
168019|NCT01515657|408980|P3|NOT COMPLETED|First Intervention||0
168020|NCT01515657|408981|P2|NOT COMPLETED|First Intervention||1
168021|NCT01515657|408982|P1|NOT COMPLETED|First Intervention||0
168022|NCT01515657|408980|P3|COMPLETED|First Intervention||13
168023|NCT01515657|408981|P2|COMPLETED|First Intervention||12
168024|NCT01515657|408982|P1|COMPLETED|First Intervention||14
168025|NCT01515657|408980|P3|STARTED|First Intervention||13
168026|NCT01515657|408981|P2|STARTED|First Intervention||13
168027|NCT01515657|408982|P1|STARTED|First Intervention||14
168028|NCT01515566|408992|P2|NOT COMPLETED|Overall Study||0
168029|NCT01515566|408993|P1|NOT COMPLETED|Overall Study||0
168030|NCT01515566|408992|P2|COMPLETED|Overall Study||10
168031|NCT01515566|408993|P1|COMPLETED|Overall Study||10
168032|NCT01515566|408992|P2|STARTED|Overall Study||10
168033|NCT01515566|408993|P1|STARTED|Overall Study||10
168034|NCT01515540|409005|P2|NOT COMPLETED|Overall Study||3
168035|NCT01515540|409006|P1|NOT COMPLETED|Overall Study||5
168036|NCT01515540|409005|P2|COMPLETED|Overall Study||15
168037|NCT01515540|409006|P1|COMPLETED|Overall Study||15
168038|NCT01515540|409005|P2|STARTED|Overall Study||18
168039|NCT01515540|409006|P1|STARTED|Overall Study||20
168040|NCT01515488|409014|P2|NOT COMPLETED|Overall Study||0
168041|NCT01515488|409015|P1|NOT COMPLETED|Overall Study||0
168042|NCT01515488|409014|P2|COMPLETED|Overall Study||200
168043|NCT01515488|409015|P1|COMPLETED|Overall Study||200
168044|NCT01515488|409014|P2|STARTED|Overall Study||200
168045|NCT01515488|409015|P1|STARTED|Overall Study||200
168046|NCT01515475|409029|P4|NOT COMPLETED|Overall Study||12
168047|NCT01515475|409030|P3|NOT COMPLETED|Overall Study||12
168048|NCT01515475|409031|P2|NOT COMPLETED|Overall Study||15
168049|NCT01515475|409032|P1|NOT COMPLETED|Overall Study||20
168050|NCT01515475|409029|P4|COMPLETED|Overall Study||53
168051|NCT01515475|409030|P3|COMPLETED|Overall Study||53
168052|NCT01515475|409031|P2|COMPLETED|Overall Study||43
168053|NCT01515475|409032|P1|COMPLETED|Overall Study||41
168054|NCT01515475|409029|P4|STARTED|Overall Study||65
168055|NCT01515475|409030|P3|STARTED|Overall Study||65
168056|NCT01515475|409031|P2|STARTED|Overall Study||58
168057|NCT01515475|409032|P1|STARTED|Overall Study||61
168058|NCT01515423|409106|P3|NOT COMPLETED|DOUBLE BLIND||92
168059|NCT01515423|409107|P2|NOT COMPLETED|DOUBLE BLIND||82
168060|NCT01515423|409108|P1|NOT COMPLETED|DOUBLE BLIND||0
168061|NCT01515423|409106|P3|COMPLETED|DOUBLE BLIND||420
168062|NCT01515423|409107|P2|COMPLETED|DOUBLE BLIND||422
168063|NCT01515423|409108|P1|COMPLETED|DOUBLE BLIND||0
168064|NCT01515423|409106|P3|STARTED|DOUBLE BLIND||512
168065|NCT01515423|409107|P2|STARTED|DOUBLE BLIND||504
168066|NCT01515423|409108|P1|STARTED|DOUBLE BLIND||0
168067|NCT01515423|409106|P3|NOT COMPLETED|Open Label Phase||0
168068|NCT01515423|409107|P2|NOT COMPLETED|Open Label Phase||0
168069|NCT01515423|409108|P1|NOT COMPLETED|Open Label Phase||413
168070|NCT01515423|409106|P3|COMPLETED|Open Label Phase||0
168071|NCT01515423|409107|P2|COMPLETED|Open Label Phase||0
168072|NCT01515423|409108|P1|COMPLETED|Open Label Phase||1016
168073|NCT01515423|409106|P3|STARTED|Open Label Phase||0
168074|NCT01515423|409107|P2|STARTED|Open Label Phase||0
168075|NCT01515423|409108|P1|STARTED|Open Label Phase||1429
168076|NCT01515410|409127|P2|NOT COMPLETED|Overall Study||0
168077|NCT01515410|409128|P1|NOT COMPLETED|Overall Study||0
168078|NCT01515410|409127|P2|COMPLETED|Overall Study||15
168079|NCT01515410|409128|P1|COMPLETED|Overall Study||19
168080|NCT01515410|409127|P2|STARTED|Overall Study||15
168081|NCT01515410|409128|P1|STARTED|Overall Study||19
168082|NCT01515345|409136|P2|NOT COMPLETED|Overall Study||0
168083|NCT01515345|409137|P1|NOT COMPLETED|Overall Study||1
168084|NCT01515345|409136|P2|COMPLETED|Overall Study||343
168085|NCT01515345|409137|P1|COMPLETED|Overall Study||664
168086|NCT01515345|409136|P2|STARTED|Overall Study||343
168087|NCT01515345|409137|P1|STARTED|Overall Study||665
168088|NCT01515306|409149|P2|NOT COMPLETED|Overall Study||14
168089|NCT01515306|409150|P1|NOT COMPLETED|Overall Study||12
168090|NCT01515306|409149|P2|COMPLETED|Overall Study||2
168091|NCT01515306|409150|P1|COMPLETED|Overall Study|Completed the required treatment in Cycle 1 Day 1 and Cycle 2 Day 1 and assessment.|12
168092|NCT01515306|409149|P2|Drug-Drug Interaction Population|Overall Study|Drug-drug interaction was only assessed in Part A.|0
168093|NCT01515306|409150|P1|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1 Day 1 and Cycle 2 Day 1 treatment.|21
168094|NCT01515306|409149|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
168095|NCT01515306|409150|P1|Received at Least 1 Dose of Study Drug|Overall Study||24
168096|NCT01515306|409149|P2|STARTED|Overall Study||16
168097|NCT01515306|409150|P1|STARTED|Overall Study||24
168098|NCT01515189|409163|P2|NOT COMPLETED|First Re-Induction Phase||15
168099|NCT01515189|409164|P1|NOT COMPLETED|First Re-Induction Phase||14
168100|NCT01515189|409163|P2|COMPLETED|First Re-Induction Phase||17
168101|NCT01515189|409164|P1|COMPLETED|First Re-Induction Phase||9
168102|NCT01515189|409163|P2|STARTED|First Re-Induction Phase||32
168103|NCT01515189|409164|P1|STARTED|First Re-Induction Phase||23
168104|NCT01515189|409163|P2|NOT COMPLETED|Induction||232
168105|NCT01515189|409164|P1|NOT COMPLETED|Induction||237
168106|NCT01515189|409163|P2|COMPLETED|Induction||130
168107|NCT01515189|409164|P1|COMPLETED|Induction||128
168108|NCT01515189|409163|P2|STARTED|Induction||362
168109|NCT01515189|409164|P1|STARTED|Induction|Includes 1 subject who was randomized but not treated due to an Adverse Event before treatment|365
168110|NCT01515176|409186|P2|NOT COMPLETED|Overall Study||0
168111|NCT01515176|409187|P1|NOT COMPLETED|Overall Study||0
168112|NCT01515176|409186|P2|COMPLETED|Overall Study||32
168113|NCT01515176|409187|P1|COMPLETED|Overall Study||4
168114|NCT01515176|409186|P2|STARTED|Overall Study||32
168115|NCT01515176|409187|P1|STARTED|Overall Study||4
168116|NCT01515072|409201|P2|NOT COMPLETED|Overall Study||0
168117|NCT01515072|409202|P1|NOT COMPLETED|Overall Study||0
168118|NCT01515072|409201|P2|COMPLETED|Overall Study|There were 513 total organs transplanted and 235 kidneys transplanted in the RIPC group|155
168119|NCT01515072|409202|P1|COMPLETED|Overall Study|There were 566 total organs transplanted and 248 kidneys transplanted in the No RIPC group.|166
168120|NCT01515072|409201|P2|STARTED|Overall Study||155
168121|NCT01515072|409202|P1|STARTED|Overall Study||166
168122|NCT01515046|409242|P1|NOT COMPLETED|Overall Study||0
168123|NCT01515046|409242|P1|COMPLETED|Overall Study||1
168124|NCT01515046|409242|P1|STARTED|Overall Study||1
168125|NCT01514864|409252|P2|NOT COMPLETED|Overall Study||5
168126|NCT01514864|409253|P1|NOT COMPLETED|Overall Study||9
168127|NCT01514864|409252|P2|COMPLETED|Overall Study||0
168128|NCT01514864|409253|P1|COMPLETED|Overall Study|Study was terminated; no patients completed study treatment|0
168129|NCT01514864|409252|P2|STARTED|Overall Study||5
168130|NCT01514864|409253|P1|STARTED|Overall Study||9
168131|NCT01514786|409271|P2|NOT COMPLETED|Overall Study||0
168132|NCT01514786|409272|P1|NOT COMPLETED|Overall Study||0
168133|NCT01514786|409271|P2|COMPLETED|Overall Study||284
168134|NCT01514786|409272|P1|COMPLETED|Overall Study||286
168135|NCT01514786|409271|P2|STARTED|Overall Study||284
168136|NCT01514786|409272|P1|STARTED|Overall Study||286
168137|NCT01514760|409278|P1|NOT COMPLETED|Overall Study||2
168138|NCT01514760|409278|P1|COMPLETED|Overall Study||20
168139|NCT01514760|409278|P1|STARTED|Overall Study||22
168140|NCT01514734|409285|P1|NOT COMPLETED|Overall Study||0
168141|NCT01514734|409285|P1|COMPLETED|Overall Study||9
168142|NCT01514734|409285|P1|STARTED|Overall Study||9
168143|NCT01514682|409291|P2|NOT COMPLETED|Overall Study||6
168144|NCT01514682|409292|P1|NOT COMPLETED|Overall Study||6
168145|NCT01514682|409291|P2|COMPLETED|Overall Study||14
168146|NCT01514682|409292|P1|COMPLETED|Overall Study||13
168147|NCT01514682|409291|P2|STARTED|Overall Study||20
168148|NCT01514682|409292|P1|STARTED|Overall Study||19
168149|NCT01514630|409308|P1|NOT COMPLETED|Overall Study||3
168150|NCT01514630|409308|P1|COMPLETED|Overall Study||11
168151|NCT01514630|409308|P1|STARTED|Overall Study||14
168152|NCT01514513|409314|P2|NOT COMPLETED|Overall Study||1
168153|NCT01514513|409315|P1|NOT COMPLETED|Overall Study||1
168154|NCT01514513|409314|P2|COMPLETED|Overall Study||20
168155|NCT01514513|409315|P1|COMPLETED|Overall Study||20
168156|NCT01514513|409314|P2|STARTED|Overall Study||21
168157|NCT01514513|409315|P1|STARTED|Overall Study||21
168158|NCT01514461|409326|P3|NOT COMPLETED|Overall Study||4
168159|NCT01514461|409327|P2|NOT COMPLETED|Overall Study||3
168160|NCT01514461|409328|P1|NOT COMPLETED|Overall Study||5
168161|NCT01514461|409326|P3|COMPLETED|Overall Study||11
168162|NCT01514461|409327|P2|COMPLETED|Overall Study||12
168163|NCT01514461|409328|P1|COMPLETED|Overall Study||10
168164|NCT01514461|409326|P3|STARTED|Overall Study||15
168165|NCT01514461|409327|P2|STARTED|Overall Study||15
168166|NCT01514461|409328|P1|STARTED|Overall Study||15
168167|NCT01514448|409367|P2|NOT COMPLETED|Overall Study||8
168168|NCT01514448|409368|P1|NOT COMPLETED|Overall Study||12
168169|NCT01514448|409367|P2|COMPLETED|Overall Study||5
168170|NCT01514448|409368|P1|COMPLETED|Overall Study||4
168171|NCT01514448|409367|P2|Full Analysis Set (FAS)|Overall Study||13
168172|NCT01514448|409368|P1|Full Analysis Set (FAS)|Overall Study||12
168173|NCT01514448|409367|P2|STARTED|Overall Study||13
168174|NCT01514448|409368|P1|STARTED|Overall Study||16
168175|NCT01514422|409383|P1|NOT COMPLETED|Overall Study||1
168176|NCT01514422|409383|P1|COMPLETED|Overall Study||19
168177|NCT01514422|409383|P1|STARTED|Overall Study||20
168178|NCT01514396|409389|P1|NOT COMPLETED|Overall Study||0
168179|NCT01514396|409389|P1|COMPLETED|Overall Study||8
168180|NCT01514396|409389|P1|STARTED|Overall Study||8
168181|NCT01514383|409394|P1|NOT COMPLETED|Overall Study||0
168182|NCT01514383|409394|P1|COMPLETED|Overall Study||34
168183|NCT01514383|409394|P1|STARTED|Overall Study||34
168184|NCT01514370|409401|P2|NOT COMPLETED|Overall Study||16
168185|NCT01514370|409402|P1|NOT COMPLETED|Overall Study||11
168186|NCT01514370|409401|P2|COMPLETED|Overall Study||24
168187|NCT01514370|409402|P1|COMPLETED|Overall Study||29
168188|NCT01514370|409401|P2|Safety Population|Overall Study|The Safety population consisted all randomized subjects who received at least 1 dose of study drug.|40
168189|NCT01514370|409402|P1|Safety Population|Overall Study|The Safety population consisted all randomized subjects who received at least 1 dose of study drug.|38
168190|NCT01514370|409401|P2|STARTED|Overall Study||40
168191|NCT01514370|409402|P1|STARTED|Overall Study||40
168192|NCT01514357|409448|P2|NOT COMPLETED|Overall Study||0
168193|NCT01514357|409449|P1|NOT COMPLETED|Overall Study||4
168194|NCT01514357|409448|P2|COMPLETED|Overall Study||0
168195|NCT01514357|409449|P1|COMPLETED|Overall Study||8
168196|NCT01514357|409448|P2|STARTED|Overall Study||0
168197|NCT01514357|409449|P1|STARTED|Overall Study||12
168198|NCT01514318|409455|P1|NOT COMPLETED|Overall Study||0
168199|NCT01514318|409455|P1|COMPLETED|Overall Study||8
168200|NCT01514318|409455|P1|STARTED|Overall Study||8
168201|NCT01514292|409461|P1|NOT COMPLETED|Overall Study||0
168202|NCT01514292|409461|P1|COMPLETED|Overall Study||72
168203|NCT01514292|409461|P1|STARTED|Overall Study||72
168204|NCT01514240|409467|P2|NOT COMPLETED|Overall Study||11
168205|NCT01514240|409468|P1|NOT COMPLETED|Overall Study||6
168206|NCT01514240|409467|P2|COMPLETED|Overall Study||45
168207|NCT01514240|409468|P1|COMPLETED|Overall Study||50
168208|NCT01514240|409467|P2|STARTED|Overall Study||56
168209|NCT01514240|409468|P1|STARTED|Overall Study||56
168210|NCT01514201|409546|P4|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||33
168211|NCT01514201|409547|P3|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
168212|NCT01514201|409548|P2|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
168213|NCT01514201|409549|P1|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
168214|NCT01514201|409546|P4|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||2
168215|NCT01514201|409547|P3|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
168216|NCT01514201|409548|P2|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
168217|NCT01514201|409549|P1|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
168218|NCT01514201|409546|P4|STARTED|PHASE II: Maintenance With Veliparib/TMZ||35
168219|NCT01514201|409547|P3|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
168220|NCT01514201|409548|P2|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
168221|NCT01514201|409549|P1|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
168222|NCT01514201|409546|P4|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||12
168223|NCT01514201|409547|P3|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
168224|NCT01514201|409548|P2|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
168225|NCT01514201|409549|P1|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
168226|NCT01514201|409546|P4|COMPLETED|PHASE II: Veliparib + Radiation Therapy||35
168227|NCT01514201|409547|P3|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
168228|NCT01514201|409548|P2|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
168229|NCT01514201|409549|P1|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
168230|NCT01514201|409546|P4|STARTED|PHASE II: Veliparib + Radiation Therapy||47
168231|NCT01514201|409547|P3|STARTED|PHASE II: Veliparib + Radiation Therapy||0
168232|NCT01514201|409548|P2|STARTED|PHASE II: Veliparib + Radiation Therapy||0
168233|NCT01514201|409549|P1|STARTED|PHASE II: Veliparib + Radiation Therapy||0
168234|NCT01514201|409546|P4|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
168235|NCT01514201|409547|P3|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||6
168236|NCT01514201|409548|P2|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||6
168237|NCT01514201|409549|P1|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||5
168238|NCT01514201|409546|P4|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
168239|NCT01514201|409547|P3|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
168240|NCT01514201|409548|P2|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
168241|NCT01514201|409549|P1|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
168242|NCT01514201|409546|P4|STARTED|PHASE I: Maintenance With Veliparib/TMZ||0
168243|NCT01514201|409547|P3|STARTED|PHASE I: Maintenance With Veliparib/TMZ||6
168244|NCT01514201|409548|P2|STARTED|PHASE I: Maintenance With Veliparib/TMZ||6
168245|NCT01514201|409549|P1|STARTED|PHASE I: Maintenance With Veliparib/TMZ||5
168246|NCT01514201|409546|P4|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
168247|NCT01514201|409547|P3|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
168248|NCT01514201|409548|P2|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
168249|NCT01514201|409549|P1|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||1
168250|NCT01514201|409546|P4|COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
168251|NCT01514201|409547|P3|COMPLETED|PHASE I: Veliparib + Radiation Therapy||6
168252|NCT01514201|409548|P2|COMPLETED|PHASE I: Veliparib + Radiation Therapy||6
168253|NCT01514201|409549|P1|COMPLETED|PHASE I: Veliparib + Radiation Therapy||5
168254|NCT01514201|409546|P4|STARTED|PHASE I: Veliparib + Radiation Therapy||0
168255|NCT01514201|409547|P3|STARTED|PHASE I: Veliparib + Radiation Therapy||6
168256|NCT01514201|409548|P2|STARTED|PHASE I: Veliparib + Radiation Therapy||6
168257|NCT01514201|409549|P1|STARTED|PHASE I: Veliparib + Radiation Therapy||6
168258|NCT01514162|409608|P1|NOT COMPLETED|Overall Study||85
168259|NCT01514162|409608|P1|COMPLETED|Overall Study||160
168260|NCT01514162|409608|P1|STARTED|Overall Study||245
168261|NCT01514149|409619|P5|NOT COMPLETED|Overall Study||1
168262|NCT01514149|409620|P4|NOT COMPLETED|Overall Study||1
168263|NCT01514149|409621|P3|NOT COMPLETED|Overall Study||3
168264|NCT01514149|409622|P2|NOT COMPLETED|Overall Study||1
168265|NCT01514149|409623|P1|NOT COMPLETED|Overall Study||3
168266|NCT01514149|409619|P5|COMPLETED|Overall Study||14
168267|NCT01514149|409620|P4|COMPLETED|Overall Study||13
168268|NCT01514149|409621|P3|COMPLETED|Overall Study||11
168269|NCT01514149|409622|P2|COMPLETED|Overall Study||14
168270|NCT01514149|409623|P1|COMPLETED|Overall Study||12
168271|NCT01514149|409619|P5|STARTED|Overall Study||15
168272|NCT01514149|409620|P4|STARTED|Overall Study||14
168273|NCT01514149|409621|P3|STARTED|Overall Study||14
168274|NCT01514149|409622|P2|STARTED|Overall Study||15
168275|NCT01514149|409623|P1|STARTED|Overall Study||15
168276|NCT01514136|409647|P8|NOT COMPLETED|Test Period; Test D*||0
168277|NCT01514136|409648|P7|NOT COMPLETED|Test Period; Test D*||0
168278|NCT01514136|409649|P6|NOT COMPLETED|Test Period; Test D*||0
168279|NCT01514136|409650|P5|NOT COMPLETED|Test Period; Test D*||0
168280|NCT01514136|409651|P4|NOT COMPLETED|Test Period; Test D*||0
168281|NCT01514136|409652|P3|NOT COMPLETED|Test Period; Test D*||0
168282|NCT01514136|409653|P2|NOT COMPLETED|Test Period; Test D*||0
168283|NCT01514136|409654|P1|NOT COMPLETED|Test Period; Test D*||0
168284|NCT01514136|409647|P8|COMPLETED|Test Period; Test D*||23
168285|NCT01514136|409648|P7|COMPLETED|Test Period; Test D*||0
168286|NCT01514136|409649|P6|COMPLETED|Test Period; Test D*||0
168287|NCT01514136|409650|P5|COMPLETED|Test Period; Test D*||0
168288|NCT01514136|409651|P4|COMPLETED|Test Period; Test D*||0
168289|NCT01514136|409652|P3|COMPLETED|Test Period; Test D*||0
168290|NCT01514136|409653|P2|COMPLETED|Test Period; Test D*||0
168291|NCT01514136|409654|P1|COMPLETED|Test Period; Test D*||0
168292|NCT01514136|409647|P8|STARTED|Test Period; Test D*||23
168293|NCT01514136|409648|P7|STARTED|Test Period; Test D*||0
168294|NCT01514136|409649|P6|STARTED|Test Period; Test D*||0
168295|NCT01514136|409650|P5|STARTED|Test Period; Test D*||0
168296|NCT01514136|409651|P4|STARTED|Test Period; Test D*||0
168297|NCT01514136|409652|P3|STARTED|Test Period; Test D*||0
168298|NCT01514136|409653|P2|STARTED|Test Period; Test D*||0
168299|NCT01514136|409654|P1|STARTED|Test Period; Test D*||0
168300|NCT01514136|409647|P8|NOT COMPLETED|Test Period 2; Test C*||0
168301|NCT01514136|409648|P7|NOT COMPLETED|Test Period 2; Test C*||3
168302|NCT01514136|409649|P6|NOT COMPLETED|Test Period 2; Test C*||0
168303|NCT01514136|409650|P5|NOT COMPLETED|Test Period 2; Test C*||0
168304|NCT01514136|409651|P4|NOT COMPLETED|Test Period 2; Test C*||0
168305|NCT01514136|409652|P3|NOT COMPLETED|Test Period 2; Test C*||0
168306|NCT01514136|409653|P2|NOT COMPLETED|Test Period 2; Test C*||0
168307|NCT01514136|409654|P1|NOT COMPLETED|Test Period 2; Test C*||0
168308|NCT01514136|409647|P8|COMPLETED|Test Period 2; Test C*||0
168309|NCT01514136|409648|P7|COMPLETED|Test Period 2; Test C*||23
168310|NCT01514136|409649|P6|COMPLETED|Test Period 2; Test C*||0
168311|NCT01514136|409650|P5|COMPLETED|Test Period 2; Test C*||0
168312|NCT01514136|409651|P4|COMPLETED|Test Period 2; Test C*||0
168313|NCT01514136|409652|P3|COMPLETED|Test Period 2; Test C*||0
168314|NCT01514136|409653|P2|COMPLETED|Test Period 2; Test C*||0
168315|NCT01514136|409654|P1|COMPLETED|Test Period 2; Test C*||0
168316|NCT01514136|409647|P8|STARTED|Test Period 2; Test C*||0
168317|NCT01514136|409648|P7|STARTED|Test Period 2; Test C*||26
168318|NCT01514136|409649|P6|STARTED|Test Period 2; Test C*||0
168319|NCT01514136|409650|P5|STARTED|Test Period 2; Test C*||0
168320|NCT01514136|409651|P4|STARTED|Test Period 2; Test C*||0
168321|NCT01514136|409652|P3|STARTED|Test Period 2; Test C*||0
168322|NCT01514136|409653|P2|STARTED|Test Period 2; Test C*||0
168323|NCT01514136|409654|P1|STARTED|Test Period 2; Test C*||0
168324|NCT01514136|409647|P8|NOT COMPLETED|Test Period 2; Test B*||0
168325|NCT01514136|409648|P7|NOT COMPLETED|Test Period 2; Test B*||0
168326|NCT01514136|409649|P6|NOT COMPLETED|Test Period 2; Test B*||2
168327|NCT01514136|409650|P5|NOT COMPLETED|Test Period 2; Test B*||0
168328|NCT01514136|409651|P4|NOT COMPLETED|Test Period 2; Test B*||0
168329|NCT01514136|409652|P3|NOT COMPLETED|Test Period 2; Test B*||0
168330|NCT01514136|409653|P2|NOT COMPLETED|Test Period 2; Test B*||0
168331|NCT01514136|409654|P1|NOT COMPLETED|Test Period 2; Test B*||0
168332|NCT01514136|409647|P8|COMPLETED|Test Period 2; Test B*||0
168333|NCT01514136|409648|P7|COMPLETED|Test Period 2; Test B*||0
168334|NCT01514136|409649|P6|COMPLETED|Test Period 2; Test B*||26
168335|NCT01514136|409650|P5|COMPLETED|Test Period 2; Test B*||0
168336|NCT01514136|409651|P4|COMPLETED|Test Period 2; Test B*||0
168337|NCT01514136|409652|P3|COMPLETED|Test Period 2; Test B*||0
168338|NCT01514136|409653|P2|COMPLETED|Test Period 2; Test B*||0
168339|NCT01514136|409654|P1|COMPLETED|Test Period 2; Test B*||0
168340|NCT01514136|409647|P8|STARTED|Test Period 2; Test B*||0
168341|NCT01514136|409648|P7|STARTED|Test Period 2; Test B*||0
168342|NCT01514136|409649|P6|STARTED|Test Period 2; Test B*|Two subjects did not test test A*, but had a break and continued again on Test B*|28
168343|NCT01514136|409650|P5|STARTED|Test Period 2; Test B*||0
168344|NCT01514136|409651|P4|STARTED|Test Period 2; Test B*||0
168345|NCT01514136|409652|P3|STARTED|Test Period 2; Test B*||0
168346|NCT01514136|409653|P2|STARTED|Test Period 2; Test B*||0
168347|NCT01514136|409654|P1|STARTED|Test Period 2; Test B*||0
168348|NCT01514136|409647|P8|NOT COMPLETED|Test Period 2; Test A*||0
168349|NCT01514136|409648|P7|NOT COMPLETED|Test Period 2; Test A*||0
168350|NCT01514136|409649|P6|NOT COMPLETED|Test Period 2; Test A*||0
168351|NCT01514136|409650|P5|NOT COMPLETED|Test Period 2; Test A*||2
168352|NCT01514136|409651|P4|NOT COMPLETED|Test Period 2; Test A*||0
168353|NCT01514136|409652|P3|NOT COMPLETED|Test Period 2; Test A*||0
168354|NCT01514136|409653|P2|NOT COMPLETED|Test Period 2; Test A*||0
168355|NCT01514136|409654|P1|NOT COMPLETED|Test Period 2; Test A*||0
168356|NCT01514136|409647|P8|COMPLETED|Test Period 2; Test A*||0
168357|NCT01514136|409648|P7|COMPLETED|Test Period 2; Test A*||0
168358|NCT01514136|409649|P6|COMPLETED|Test Period 2; Test A*||0
168359|NCT01514136|409650|P5|COMPLETED|Test Period 2; Test A*||26
168360|NCT01514136|409651|P4|COMPLETED|Test Period 2; Test A*||0
168361|NCT01514136|409652|P3|COMPLETED|Test Period 2; Test A*||0
168362|NCT01514136|409653|P2|COMPLETED|Test Period 2; Test A*||0
168363|NCT01514136|409654|P1|COMPLETED|Test Period 2; Test A*||0
168364|NCT01514136|409647|P8|STARTED|Test Period 2; Test A*||0
168365|NCT01514136|409648|P7|STARTED|Test Period 2; Test A*||0
168366|NCT01514136|409649|P6|STARTED|Test Period 2; Test A*||0
168367|NCT01514136|409650|P5|STARTED|Test Period 2; Test A*|4 new subjects were included in the investigation|28
168368|NCT01514136|409651|P4|STARTED|Test Period 2; Test A*||0
168369|NCT01514136|409652|P3|STARTED|Test Period 2; Test A*||0
168370|NCT01514136|409653|P2|STARTED|Test Period 2; Test A*||0
168371|NCT01514136|409654|P1|STARTED|Test Period 2; Test A*||0
168372|NCT01514136|409647|P8|NOT COMPLETED|Test Period 1; Test D||0
168373|NCT01514136|409648|P7|NOT COMPLETED|Test Period 1; Test D||0
168374|NCT01514136|409649|P6|NOT COMPLETED|Test Period 1; Test D||0
168375|NCT01514136|409650|P5|NOT COMPLETED|Test Period 1; Test D||0
168376|NCT01514136|409651|P4|NOT COMPLETED|Test Period 1; Test D||2
168377|NCT01514136|409652|P3|NOT COMPLETED|Test Period 1; Test D||0
168378|NCT01514136|409653|P2|NOT COMPLETED|Test Period 1; Test D||0
168379|NCT01514136|409654|P1|NOT COMPLETED|Test Period 1; Test D||0
168380|NCT01514136|409647|P8|COMPLETED|Test Period 1; Test D||0
168381|NCT01514136|409648|P7|COMPLETED|Test Period 1; Test D||0
168382|NCT01514136|409649|P6|COMPLETED|Test Period 1; Test D||0
168383|NCT01514136|409650|P5|COMPLETED|Test Period 1; Test D||0
168384|NCT01514136|409651|P4|COMPLETED|Test Period 1; Test D||24
168385|NCT01514136|409652|P3|COMPLETED|Test Period 1; Test D||0
168386|NCT01514136|409653|P2|COMPLETED|Test Period 1; Test D||0
168387|NCT01514136|409654|P1|COMPLETED|Test Period 1; Test D||0
168388|NCT01514136|409647|P8|STARTED|Test Period 1; Test D||0
168389|NCT01514136|409648|P7|STARTED|Test Period 1; Test D||0
168390|NCT01514136|409649|P6|STARTED|Test Period 1; Test D||0
168391|NCT01514136|409650|P5|STARTED|Test Period 1; Test D||0
168392|NCT01514136|409651|P4|STARTED|Test Period 1; Test D|The two subject that were on holiday after test A re-entered the investigation|26
168393|NCT01514136|409652|P3|STARTED|Test Period 1; Test D||0
168394|NCT01514136|409653|P2|STARTED|Test Period 1; Test D||0
168395|NCT01514136|409654|P1|STARTED|Test Period 1; Test D||0
168396|NCT01514136|409647|P8|NOT COMPLETED|Test Period 1; Test C||0
168397|NCT01514136|409648|P7|NOT COMPLETED|Test Period 1; Test C||0
168398|NCT01514136|409649|P6|NOT COMPLETED|Test Period 1; Test C||0
168399|NCT01514136|409650|P5|NOT COMPLETED|Test Period 1; Test C||0
168400|NCT01514136|409651|P4|NOT COMPLETED|Test Period 1; Test C||0
168401|NCT01514136|409652|P3|NOT COMPLETED|Test Period 1; Test C||0
168402|NCT01514136|409653|P2|NOT COMPLETED|Test Period 1; Test C||0
168403|NCT01514136|409654|P1|NOT COMPLETED|Test Period 1; Test C||0
168404|NCT01514136|409647|P8|COMPLETED|Test Period 1; Test C||0
168405|NCT01514136|409648|P7|COMPLETED|Test Period 1; Test C||0
168406|NCT01514136|409649|P6|COMPLETED|Test Period 1; Test C||0
168407|NCT01514136|409650|P5|COMPLETED|Test Period 1; Test C||0
168408|NCT01514136|409651|P4|COMPLETED|Test Period 1; Test C||0
168409|NCT01514136|409652|P3|COMPLETED|Test Period 1; Test C||24
168410|NCT01514136|409653|P2|COMPLETED|Test Period 1; Test C||0
168411|NCT01514136|409654|P1|COMPLETED|Test Period 1; Test C||0
168412|NCT01514136|409647|P8|STARTED|Test Period 1; Test C||0
168413|NCT01514136|409648|P7|STARTED|Test Period 1; Test C||0
168414|NCT01514136|409649|P6|STARTED|Test Period 1; Test C||0
168415|NCT01514136|409650|P5|STARTED|Test Period 1; Test C||0
168416|NCT01514136|409651|P4|STARTED|Test Period 1; Test C||0
168417|NCT01514136|409652|P3|STARTED|Test Period 1; Test C|1 new subject was included in the investigation|24
168418|NCT01514136|409653|P2|STARTED|Test Period 1; Test C||0
168419|NCT01514136|409654|P1|STARTED|Test Period 1; Test C||0
168420|NCT01514136|409647|P8|NOT COMPLETED|Test Period 1; Test B||0
168421|NCT01514136|409648|P7|NOT COMPLETED|Test Period 1; Test B||0
168422|NCT01514136|409649|P6|NOT COMPLETED|Test Period 1; Test B||0
168423|NCT01514136|409650|P5|NOT COMPLETED|Test Period 1; Test B||0
168424|NCT01514136|409651|P4|NOT COMPLETED|Test Period 1; Test B||0
168425|NCT01514136|409652|P3|NOT COMPLETED|Test Period 1; Test B||0
168426|NCT01514136|409653|P2|NOT COMPLETED|Test Period 1; Test B||1
168427|NCT01514136|409654|P1|NOT COMPLETED|Test Period 1; Test B||0
168428|NCT01514136|409647|P8|COMPLETED|Test Period 1; Test B||0
168429|NCT01514136|409648|P7|COMPLETED|Test Period 1; Test B||0
168430|NCT01514136|409649|P6|COMPLETED|Test Period 1; Test B||0
168431|NCT01514136|409650|P5|COMPLETED|Test Period 1; Test B||0
168432|NCT01514136|409651|P4|COMPLETED|Test Period 1; Test B||0
168433|NCT01514136|409652|P3|COMPLETED|Test Period 1; Test B||0
168434|NCT01514136|409653|P2|COMPLETED|Test Period 1; Test B||23
168435|NCT01514136|409654|P1|COMPLETED|Test Period 1; Test B||0
168436|NCT01514136|409647|P8|STARTED|Test Period 1; Test B||0
168437|NCT01514136|409648|P7|STARTED|Test Period 1; Test B||0
168438|NCT01514136|409649|P6|STARTED|Test Period 1; Test B||0
168439|NCT01514136|409650|P5|STARTED|Test Period 1; Test B||0
168440|NCT01514136|409651|P4|STARTED|Test Period 1; Test B||0
168441|NCT01514136|409652|P3|STARTED|Test Period 1; Test B||0
168442|NCT01514136|409653|P2|STARTED|Test Period 1; Test B|2 new subjects were entered the investigation|24
168443|NCT01514136|409654|P1|STARTED|Test Period 1; Test B||0
168444|NCT01514136|409647|P8|NOT COMPLETED|Test Period 1; Test A||0
168445|NCT01514136|409648|P7|NOT COMPLETED|Test Period 1; Test A||0
168446|NCT01514136|409649|P6|NOT COMPLETED|Test Period 1; Test A||0
168447|NCT01514136|409650|P5|NOT COMPLETED|Test Period 1; Test A||0
168448|NCT01514136|409651|P4|NOT COMPLETED|Test Period 1; Test A||0
168449|NCT01514136|409652|P3|NOT COMPLETED|Test Period 1; Test A||0
168450|NCT01514136|409653|P2|NOT COMPLETED|Test Period 1; Test A||0
168451|NCT01514136|409654|P1|NOT COMPLETED|Test Period 1; Test A||3
168452|NCT01514136|409647|P8|COMPLETED|Test Period 1; Test A||0
168453|NCT01514136|409648|P7|COMPLETED|Test Period 1; Test A||0
168454|NCT01514136|409649|P6|COMPLETED|Test Period 1; Test A||0
168455|NCT01514136|409650|P5|COMPLETED|Test Period 1; Test A||0
168456|NCT01514136|409651|P4|COMPLETED|Test Period 1; Test A||0
168457|NCT01514136|409652|P3|COMPLETED|Test Period 1; Test A||0
168458|NCT01514136|409653|P2|COMPLETED|Test Period 1; Test A||0
168459|NCT01514136|409654|P1|COMPLETED|Test Period 1; Test A||22
168460|NCT01514136|409647|P8|STARTED|Test Period 1; Test A||0
168461|NCT01514136|409648|P7|STARTED|Test Period 1; Test A||0
168462|NCT01514136|409649|P6|STARTED|Test Period 1; Test A||0
168463|NCT01514136|409650|P5|STARTED|Test Period 1; Test A||0
168464|NCT01514136|409651|P4|STARTED|Test Period 1; Test A||0
168465|NCT01514136|409652|P3|STARTED|Test Period 1; Test A||0
168466|NCT01514136|409653|P2|STARTED|Test Period 1; Test A||0
168467|NCT01514136|409654|P1|STARTED|Test Period 1; Test A|26 subjects tested Test A|25
168468|NCT01513902|409683|P3|NOT COMPLETED|Overall Study||0
168469|NCT01513902|409684|P2|NOT COMPLETED|Overall Study||0
168470|NCT01513902|409685|P1|NOT COMPLETED|Overall Study||0
168471|NCT01513902|409683|P3|COMPLETED|Overall Study||9
168472|NCT01513902|409684|P2|COMPLETED|Overall Study||9
168473|NCT01513902|409685|P1|COMPLETED|Overall Study||8
168474|NCT01513902|409683|P3|STARTED|Overall Study||9
168475|NCT01513902|409684|P2|STARTED|Overall Study||9
168476|NCT01513902|409685|P1|STARTED|Overall Study||8
168477|NCT01513759|409720|P1|NOT COMPLETED|Overall Study||5
168478|NCT01513759|409720|P1|COMPLETED|Overall Study||145
168479|NCT01513759|409720|P1|At Least One Device Successfully Placed|Overall Study||149
168480|NCT01513759|409720|P1|STARTED|Overall Study||150
168481|NCT01513590|409731|P2|NOT COMPLETED|Overall Study||13
168482|NCT01513590|409732|P1|NOT COMPLETED|Overall Study||10
168483|NCT01513590|409731|P2|COMPLETED|Overall Study||184
168484|NCT01513590|409732|P1|COMPLETED|Overall Study||187
168485|NCT01513590|409731|P2|Exposed|Overall Study|"Two (2) subjects were withdrawn prior to exposure due to withdrawal of consent"|195
168486|NCT01513590|409732|P1|Exposed|Overall Study|One (1) subject was withdrawn prior to exposure due to “non fulfilment of inclusion criteria”|196
168487|NCT01513590|409731|P2|STARTED|Overall Study||197
168488|NCT01513590|409732|P1|STARTED|Overall Study||197
168489|NCT01513551|409753|P3|NOT COMPLETED|Overall Study||5
168490|NCT01513551|409754|P2|NOT COMPLETED|Overall Study||6
168491|NCT01513551|409755|P1|NOT COMPLETED|Overall Study||4
168492|NCT01513551|409753|P3|COMPLETED|Overall Study||226
168493|NCT01513551|409754|P2|COMPLETED|Overall Study||225
168494|NCT01513551|409755|P1|COMPLETED|Overall Study||226
168495|NCT01513551|409753|P3|Vaccinated|Overall Study||230
168496|NCT01513551|409754|P2|Vaccinated|Overall Study||231
168497|NCT01513551|409755|P1|Vaccinated|Overall Study||230
168498|NCT01513551|409753|P3|STARTED|Overall Study||231
168499|NCT01513551|409754|P2|STARTED|Overall Study||231
168500|NCT01513551|409755|P1|STARTED|Overall Study||230
168501|NCT01513538|409781|P1|NOT COMPLETED|Overall Study||5
168502|NCT01513538|409781|P1|COMPLETED|Overall Study||573
168503|NCT01513538|409781|P1|STARTED|Overall Study||578
168504|NCT01513473|409787|P2|NOT COMPLETED|Extension Trial (26 Weeks)||6
168505|NCT01513473|409788|P1|NOT COMPLETED|Extension Trial (26 Weeks)||1
168506|NCT01513473|409787|P2|COMPLETED|Extension Trial (26 Weeks)||122
168507|NCT01513473|409788|P1|COMPLETED|Extension Trial (26 Weeks)||151
168508|NCT01513473|409787|P2|STARTED|Extension Trial (26 Weeks)|37 subjects did not consent to participate in the extension trial.|128
168509|NCT01513473|409788|P1|STARTED|Extension Trial (26 Weeks)|18 subjects did not consent to participate in the extension trial.|152
168510|NCT01513473|409787|P2|NOT COMPLETED|Main Trial (26 Weeks)||11
168511|NCT01513473|409788|P1|NOT COMPLETED|Main Trial (26 Weeks)||4
168512|NCT01513473|409787|P2|COMPLETED|Main Trial (26 Weeks)||165
168513|NCT01513473|409788|P1|COMPLETED|Main Trial (26 Weeks)||170
168514|NCT01513473|409787|P2|Exposed|Main Trial (26 Weeks)||175
168515|NCT01513473|409788|P1|Exposed|Main Trial (26 Weeks)||174
168516|NCT01513473|409787|P2|STARTED|Main Trial (26 Weeks)|1 subject was randomised but withdrew before the drug exposure.|176
168517|NCT01513473|409788|P1|STARTED|Main Trial (26 Weeks)||174
168518|NCT01513460|409815|P3|NOT COMPLETED|Overall Study||56
168519|NCT01513460|409816|P2|NOT COMPLETED|Overall Study||32
168520|NCT01513460|409817|P1|NOT COMPLETED|Overall Study||29
168521|NCT01513460|409815|P3|COMPLETED|Overall Study||201
168522|NCT01513460|409816|P2|COMPLETED|Overall Study||226
168523|NCT01513460|409817|P1|COMPLETED|Overall Study||229
168524|NCT01513460|409815|P3|Per-protocol Set|Overall Study||166
168525|NCT01513460|409816|P2|Per-protocol Set|Overall Study||186
168526|NCT01513460|409817|P1|Per-protocol Set|Overall Study||196
168527|NCT01513460|409815|P3|Full Analysis Set|Overall Study||257
168528|NCT01513460|409816|P2|Full Analysis Set|Overall Study||258
168529|NCT01513460|409817|P1|Full Analysis Set|Overall Study||257
168530|NCT01513460|409815|P3|STARTED|Overall Study||257
168531|NCT01513460|409816|P2|STARTED|Overall Study||258
168532|NCT01513460|409817|P1|STARTED|Overall Study||258
168533|NCT01513447|409843|P2|NOT COMPLETED|Overall Study||0
168534|NCT01513447|409844|P1|NOT COMPLETED|Overall Study||0
168535|NCT01513447|409843|P2|COMPLETED|Overall Study||5
168536|NCT01513447|409844|P1|COMPLETED|Overall Study||3
168537|NCT01513447|409843|P2|STARTED|Overall Study||5
168538|NCT01513447|409844|P1|STARTED|Overall Study||3
168539|NCT01513330|409852|P2|NOT COMPLETED|Standard Care First,||4
168540|NCT01513330|409853|P1|NOT COMPLETED|Standard Care First,||4
168541|NCT01513330|409852|P2|COMPLETED|Standard Care First,||52
168542|NCT01513330|409853|P1|COMPLETED|Standard Care First,||56
168543|NCT01513330|409852|P2|STARTED|Standard Care First,||56
168544|NCT01513330|409853|P1|STARTED|Standard Care First,||60
168545|NCT01513330|409852|P2|NOT COMPLETED|SenSura Mio First,||2
168546|NCT01513330|409853|P1|NOT COMPLETED|SenSura Mio First,||4
168547|NCT01513330|409852|P2|COMPLETED|SenSura Mio First,||56
168548|NCT01513330|409853|P1|COMPLETED|SenSura Mio First,||60
168549|NCT01513330|409852|P2|STARTED|SenSura Mio First,||58
168550|NCT01513330|409853|P1|STARTED|SenSura Mio First,||64
168551|NCT01513317|409861|P2|NOT COMPLETED|Overall Study||24
168552|NCT01513317|409862|P1|NOT COMPLETED|Overall Study||34
168553|NCT01513317|409861|P2|COMPLETED|Overall Study||2
168554|NCT01513317|409862|P1|COMPLETED|Overall Study||16
168555|NCT01513317|409861|P2|STARTED|Overall Study||26
168556|NCT01513317|409862|P1|STARTED|Overall Study||50
168557|NCT01513291|409880|P5|NOT COMPLETED|Run-out Period||0
168558|NCT01513291|409881|P4|NOT COMPLETED|Run-out Period||2
168559|NCT01513291|409882|P3|NOT COMPLETED|Run-out Period||0
168560|NCT01513291|409883|P2|NOT COMPLETED|Run-out Period||0
168561|NCT01513291|409884|P1|NOT COMPLETED|Run-out Period||0
168562|NCT01513291|409880|P5|COMPLETED|Run-out Period||101
168563|NCT01513291|409881|P4|COMPLETED|Run-out Period||45
168564|NCT01513291|409882|P3|COMPLETED|Run-out Period||50
168565|NCT01513291|409883|P2|COMPLETED|Run-out Period||0
168566|NCT01513291|409884|P1|COMPLETED|Run-out Period||0
168567|NCT01513291|409880|P5|STARTED|Run-out Period|These participants were completers from the Treatment Period: Placebo group|101
168568|NCT01513291|409881|P4|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|47
168569|NCT01513291|409882|P3|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|50
168570|NCT01513291|409883|P2|STARTED|Run-out Period||0
168571|NCT01513291|409884|P1|STARTED|Run-out Period||0
168572|NCT01513291|409880|P5|NOT COMPLETED|Treatment Period||0
168573|NCT01513291|409881|P4|NOT COMPLETED|Treatment Period||0
168574|NCT01513291|409882|P3|NOT COMPLETED|Treatment Period||0
168575|NCT01513291|409883|P2|NOT COMPLETED|Treatment Period||16
168576|NCT01513291|409884|P1|NOT COMPLETED|Treatment Period||23
168577|NCT01513291|409880|P5|COMPLETED|Treatment Period||0
168578|NCT01513291|409881|P4|COMPLETED|Treatment Period||0
168579|NCT01513291|409882|P3|COMPLETED|Treatment Period||0
168580|NCT01513291|409883|P2|COMPLETED|Treatment Period||101
168581|NCT01513291|409884|P1|COMPLETED|Treatment Period||97
168582|NCT01513291|409880|P5|Treated|Treatment Period||0
168583|NCT01513291|409881|P4|Treated|Treatment Period||0
168584|NCT01513291|409882|P3|Treated|Treatment Period||0
168585|NCT01513291|409883|P2|Treated|Treatment Period||115
168586|NCT01513291|409884|P1|Treated|Treatment Period||120
168587|NCT01513291|409880|P5|STARTED|Treatment Period||0
168588|NCT01513291|409881|P4|STARTED|Treatment Period||0
168589|NCT01513291|409882|P3|STARTED|Treatment Period||0
168590|NCT01513291|409883|P2|STARTED|Treatment Period||117
168591|NCT01513291|409884|P1|STARTED|Treatment Period||120
168592|NCT01513239|409912|P6|NOT COMPLETED|Period 2: 9 Month Extension Phase||5
168593|NCT01513239|409913|P5|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
168594|NCT01513239|409914|P4|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
168595|NCT01513239|409915|P3|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
168596|NCT01513239|409916|P2|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
168597|NCT01513239|409917|P1|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
168598|NCT01513239|409912|P6|COMPLETED|Period 2: 9 Month Extension Phase||78
168599|NCT01513239|409913|P5|COMPLETED|Period 2: 9 Month Extension Phase||90
168600|NCT01513239|409914|P4|COMPLETED|Period 2: 9 Month Extension Phase||102
168601|NCT01513239|409915|P3|COMPLETED|Period 2: 9 Month Extension Phase||0
168602|NCT01513239|409916|P2|COMPLETED|Period 2: 9 Month Extension Phase||0
168603|NCT01513239|409917|P1|COMPLETED|Period 2: 9 Month Extension Phase||0
168604|NCT01513239|409912|P6|STARTED|Period 2: 9 Month Extension Phase||83
168605|NCT01513239|409913|P5|STARTED|Period 2: 9 Month Extension Phase||100
168606|NCT01513239|409914|P4|STARTED|Period 2: 9 Month Extension Phase||112
168607|NCT01513239|409915|P3|STARTED|Period 2: 9 Month Extension Phase||0
168608|NCT01513239|409916|P2|STARTED|Period 2: 9 Month Extension Phase||0
168609|NCT01513239|409917|P1|STARTED|Period 2: 9 Month Extension Phase||0
168610|NCT01513239|409912|P6|NOT COMPLETED|Period 1: Main Phase||0
168611|NCT01513239|409913|P5|NOT COMPLETED|Period 1: Main Phase||0
168612|NCT01513239|409914|P4|NOT COMPLETED|Period 1: Main Phase||0
168613|NCT01513239|409915|P3|NOT COMPLETED|Period 1: Main Phase||88
168614|NCT01513239|409916|P2|NOT COMPLETED|Period 1: Main Phase||70
168615|NCT01513239|409917|P1|NOT COMPLETED|Period 1: Main Phase||75
168616|NCT01513239|409912|P6|COMPLETED|Period 1: Main Phase||0
168617|NCT01513239|409913|P5|COMPLETED|Period 1: Main Phase||0
168618|NCT01513239|409914|P4|COMPLETED|Period 1: Main Phase||0
168619|NCT01513239|409915|P3|COMPLETED|Period 1: Main Phase||311
168620|NCT01513239|409916|P2|COMPLETED|Period 1: Main Phase||337
168621|NCT01513239|409917|P1|COMPLETED|Period 1: Main Phase||322
168622|NCT01513239|409912|P6|All Participants as Treated|Period 1: Main Phase||0
168623|NCT01513239|409913|P5|All Participants as Treated|Period 1: Main Phase||0
168624|NCT01513239|409914|P4|All Participants as Treated|Period 1: Main Phase||0
168625|NCT01513239|409915|P3|All Participants as Treated|Period 1: Main Phase|Treatment actually received|381
168626|NCT01513239|409916|P2|All Participants as Treated|Period 1: Main Phase|Treatment actually received|396
168627|NCT01513239|409917|P1|All Participants as Treated|Period 1: Main Phase|One participant randomized to receive MK-3415A (MK-3415 plus MK-6072) received only MK-3415|390
168628|NCT01513239|409912|P6|Treated|Period 1: Main Phase||0
168629|NCT01513239|409913|P5|Treated|Period 1: Main Phase||0
168630|NCT01513239|409914|P4|Treated|Period 1: Main Phase||0
168631|NCT01513239|409915|P3|Treated|Period 1: Main Phase|Treated participants|381
168632|NCT01513239|409916|P2|Treated|Period 1: Main Phase|Treated participants|396
168633|NCT01513239|409917|P1|Treated|Period 1: Main Phase|Treated participants|391
168634|NCT01513239|409912|P6|STARTED|Period 1: Main Phase||0
168635|NCT01513239|409913|P5|STARTED|Period 1: Main Phase||0
168636|NCT01513239|409914|P4|STARTED|Period 1: Main Phase||0
168729|NCT01512264|410212|P2|NOT COMPLETED|Overall Study||0
168637|NCT01513239|409915|P3|STARTED|Period 1: Main Phase|Randomized participants|399
168638|NCT01513239|409916|P2|STARTED|Period 1: Main Phase|Randomized participants|407
168639|NCT01513239|409917|P1|STARTED|Period 1: Main Phase|Randomized participants|397
168640|NCT01513148|409970|P2|NOT COMPLETED|Overall Study||2
168641|NCT01513148|409971|P1|NOT COMPLETED|Overall Study||2
168642|NCT01513148|409970|P2|COMPLETED|Overall Study||14
168643|NCT01513148|409971|P1|COMPLETED|Overall Study||14
168644|NCT01513148|409970|P2|STARTED|Overall Study||16
168645|NCT01513148|409971|P1|STARTED|Overall Study||16
168646|NCT01513122|410019|P2|NOT COMPLETED|Overall Study||3
168647|NCT01513122|410020|P1|NOT COMPLETED|Overall Study||11
168648|NCT01513122|410019|P2|COMPLETED|Overall Study||105
168649|NCT01513122|410020|P1|COMPLETED|Overall Study||91
168650|NCT01513122|410019|P2|STARTED|Overall Study||108
168651|NCT01513122|410020|P1|STARTED|Overall Study||102
168652|NCT01512979|410038|P2|NOT COMPLETED|Overall Study||22
168653|NCT01512979|410039|P1|NOT COMPLETED|Overall Study||19
168654|NCT01512979|410038|P2|COMPLETED|Overall Study||135
168655|NCT01512979|410039|P1|COMPLETED|Overall Study||140
168656|NCT01512979|410038|P2|STARTED|Overall Study|Randomised and treated|157
168657|NCT01512979|410039|P1|STARTED|Overall Study|Randomised and treated|159
168658|NCT01512849|410059|P4|NOT COMPLETED|Crossover Period 2||0
168659|NCT01512849|410060|P3|NOT COMPLETED|Crossover Period 2||0
168660|NCT01512849|410061|P2|NOT COMPLETED|Crossover Period 2||0
168661|NCT01512849|410062|P1|NOT COMPLETED|Crossover Period 2||0
168662|NCT01512849|410059|P4|COMPLETED|Crossover Period 2||6
168663|NCT01512849|410060|P3|COMPLETED|Crossover Period 2||6
168664|NCT01512849|410061|P2|COMPLETED|Crossover Period 2||6
168665|NCT01512849|410062|P1|COMPLETED|Crossover Period 2||6
168666|NCT01512849|410059|P4|STARTED|Crossover Period 2||6
168667|NCT01512849|410060|P3|STARTED|Crossover Period 2||6
168668|NCT01512849|410061|P2|STARTED|Crossover Period 2||6
168669|NCT01512849|410062|P1|STARTED|Crossover Period 2||6
168670|NCT01512849|410059|P4|NOT COMPLETED|Crossover Period 1||0
168671|NCT01512849|410060|P3|NOT COMPLETED|Crossover Period 1||0
168672|NCT01512849|410061|P2|NOT COMPLETED|Crossover Period 1||0
168673|NCT01512849|410062|P1|NOT COMPLETED|Crossover Period 1||0
168674|NCT01512849|410059|P4|COMPLETED|Crossover Period 1||6
168675|NCT01512849|410060|P3|COMPLETED|Crossover Period 1||6
168676|NCT01512849|410061|P2|COMPLETED|Crossover Period 1||6
168677|NCT01512849|410062|P1|COMPLETED|Crossover Period 1||6
168678|NCT01512849|410059|P4|STARTED|Crossover Period 1||6
168679|NCT01512849|410060|P3|STARTED|Crossover Period 1||6
168680|NCT01512849|410061|P2|STARTED|Crossover Period 1||6
168681|NCT01512849|410062|P1|STARTED|Crossover Period 1||6
168682|NCT01512797|410086|P2|NOT COMPLETED|Overall Study||0
168683|NCT01512797|410087|P1|NOT COMPLETED|Overall Study||0
168684|NCT01512797|410086|P2|COMPLETED|Overall Study||16
168685|NCT01512797|410087|P1|COMPLETED|Overall Study||16
168686|NCT01512797|410086|P2|STARTED|Overall Study||16
168687|NCT01512797|410087|P1|STARTED|Overall Study||16
168688|NCT01512758|410103|P2|NOT COMPLETED|Overall Study||0
168689|NCT01512758|410104|P1|NOT COMPLETED|Overall Study||0
168690|NCT01512758|410103|P2|COMPLETED|Overall Study||6
168691|NCT01512758|410104|P1|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK assessment.|30
168692|NCT01512758|410103|P2|STARTED|Overall Study||6
168693|NCT01512758|410104|P1|STARTED|Overall Study||30
168694|NCT01512745|410139|P2|NOT COMPLETED|Overall Study||20
168695|NCT01512745|410140|P1|NOT COMPLETED|Overall Study||40
168696|NCT01512745|410139|P2|COMPLETED|Overall Study||71
168697|NCT01512745|410140|P1|COMPLETED|Overall Study||136
168698|NCT01512745|410139|P2|STARTED|Overall Study||91
168699|NCT01512745|410140|P1|STARTED|Overall Study||176
168700|NCT01512693|410156|P2|NOT COMPLETED|Overall Study||1
168701|NCT01512693|410157|P1|NOT COMPLETED|Overall Study||0
168702|NCT01512693|410156|P2|COMPLETED|Overall Study||8
168703|NCT01512693|410157|P1|COMPLETED|Overall Study||8
168704|NCT01512693|410156|P2|STARTED|Overall Study||9
168705|NCT01512693|410157|P1|STARTED|Overall Study||8
168706|NCT01512667|410171|P2|NOT COMPLETED|Overall Study||0
168707|NCT01512667|410172|P1|NOT COMPLETED|Overall Study||0
168708|NCT01512667|410171|P2|COMPLETED|Overall Study||12
168709|NCT01512667|410172|P1|COMPLETED|Overall Study||13
168710|NCT01512667|410171|P2|Unmatched Participants|Overall Study||0
168711|NCT01512667|410172|P1|Unmatched Participants|Overall Study|Participant was not matched to a healthy control participant.|1
168712|NCT01512667|410171|P2|Matched Participants|Overall Study||12
168713|NCT01512667|410172|P1|Matched Participants|Overall Study||12
168714|NCT01512667|410171|P2|STARTED|Overall Study||12
168715|NCT01512667|410172|P1|STARTED|Overall Study||13
168716|NCT01512446|410186|P2|NOT COMPLETED|Overall Study||215
168717|NCT01512446|410187|P1|NOT COMPLETED|Overall Study||221
168718|NCT01512446|410186|P2|COMPLETED|Overall Study||0
168719|NCT01512446|410187|P1|COMPLETED|Overall Study||0
168720|NCT01512446|410186|P2|Safety Analysis Set|Overall Study||188
168721|NCT01512446|410187|P1|Safety Analysis Set|Overall Study||197
168722|NCT01512446|410186|P2|STARTED|Overall Study||215
168723|NCT01512446|410187|P1|STARTED|Overall Study||221
168724|NCT01512368|410197|P1|NOT COMPLETED|Overall Study||3
168725|NCT01512368|410197|P1|COMPLETED|Overall Study||60
168726|NCT01512368|410197|P1|STARTED|Overall Study||63
168727|NCT01512264|410210|P4|NOT COMPLETED|Overall Study||1
168728|NCT01512264|410211|P3|NOT COMPLETED|Overall Study||0
168730|NCT01512264|410213|P1|NOT COMPLETED|Overall Study||0
168731|NCT01512264|410210|P4|COMPLETED|Overall Study||6
168732|NCT01512264|410211|P3|COMPLETED|Overall Study||7
168733|NCT01512264|410212|P2|COMPLETED|Overall Study||7
168734|NCT01512264|410213|P1|COMPLETED|Overall Study||7
168735|NCT01512264|410210|P4|STARTED|Overall Study||7
168736|NCT01512264|410211|P3|STARTED|Overall Study||7
168737|NCT01512264|410212|P2|STARTED|Overall Study||7
168738|NCT01512264|410213|P1|STARTED|Overall Study||7
168739|NCT01512251|410305|P2|NOT COMPLETED|Phase II||0
168740|NCT01512251|410306|P1|NOT COMPLETED|Phase II||0
168741|NCT01512251|410305|P2|COMPLETED|Phase II||0
168742|NCT01512251|410306|P1|COMPLETED|Phase II||0
168743|NCT01512251|410305|P2|STARTED|Phase II||0
168744|NCT01512251|410306|P1|STARTED|Phase II||0
168745|NCT01512251|410305|P2|NOT COMPLETED|Phase I, Dose 4||0
168746|NCT01512251|410306|P1|NOT COMPLETED|Phase I, Dose 4||0
168747|NCT01512251|410305|P2|COMPLETED|Phase I, Dose 4||0
168748|NCT01512251|410306|P1|COMPLETED|Phase I, Dose 4||0
168749|NCT01512251|410305|P2|STARTED|Phase I, Dose 4||0
168750|NCT01512251|410306|P1|STARTED|Phase I, Dose 4||0
168751|NCT01512251|410305|P2|NOT COMPLETED|Phase I, Dose 3||0
168752|NCT01512251|410306|P1|NOT COMPLETED|Phase I, Dose 3||0
168753|NCT01512251|410305|P2|COMPLETED|Phase I, Dose 3||0
168754|NCT01512251|410306|P1|COMPLETED|Phase I, Dose 3||0
168755|NCT01512251|410305|P2|STARTED|Phase I, Dose 3||0
168756|NCT01512251|410306|P1|STARTED|Phase I, Dose 3||0
168757|NCT01512251|410305|P2|NOT COMPLETED|Phase I, Dose 2||0
168758|NCT01512251|410306|P1|NOT COMPLETED|Phase I, Dose 2||0
168759|NCT01512251|410305|P2|COMPLETED|Phase I, Dose 2||0
168760|NCT01512251|410306|P1|COMPLETED|Phase I, Dose 2||0
168761|NCT01512251|410305|P2|STARTED|Phase I, Dose 2||0
168762|NCT01512251|410306|P1|STARTED|Phase I, Dose 2||0
168763|NCT01512251|410305|P2|NOT COMPLETED|Phase I, Dose 1||5
168764|NCT01512251|410306|P1|NOT COMPLETED|Phase I, Dose 1||3
168765|NCT01512251|410305|P2|COMPLETED|Phase I, Dose 1||0
168766|NCT01512251|410306|P1|COMPLETED|Phase I, Dose 1||0
168767|NCT01512251|410305|P2|STARTED|Phase I, Dose 1||5
168768|NCT01512251|410306|P1|STARTED|Phase I, Dose 1||3
168769|NCT01512251|410305|P2|NOT COMPLETED|Dose Level -1||0
168770|NCT01512251|410306|P1|NOT COMPLETED|Dose Level -1||0
168771|NCT01512251|410305|P2|COMPLETED|Dose Level -1||5
168772|NCT01512251|410306|P1|COMPLETED|Dose Level -1||3
168773|NCT01512251|410305|P2|STARTED|Dose Level -1||5
168774|NCT01512251|410306|P1|STARTED|Dose Level -1||3
168775|NCT01512225|410327|P2|NOT COMPLETED|Overall Study||0
168776|NCT01512225|410328|P1|NOT COMPLETED|Overall Study||0
168777|NCT01512225|410327|P2|COMPLETED|Overall Study||45
168778|NCT01512225|410328|P1|COMPLETED|Overall Study||45
168779|NCT01512225|410327|P2|Provided Day 14 Volume|Overall Study||40
168780|NCT01512225|410328|P1|Provided Day 14 Volume|Overall Study||45
168781|NCT01512225|410327|P2|STARTED|Overall Study||45
168782|NCT01512225|410328|P1|STARTED|Overall Study||45
168783|NCT01512160|410352|P4|NOT COMPLETED|Overall Study||1
168784|NCT01512160|410353|P3|NOT COMPLETED|Overall Study||0
168785|NCT01512160|410354|P2|NOT COMPLETED|Overall Study||0
168786|NCT01512160|410355|P1|NOT COMPLETED|Overall Study||2
168787|NCT01512160|410352|P4|COMPLETED|Overall Study||22
168788|NCT01512160|410353|P3|COMPLETED|Overall Study||22
168789|NCT01512160|410354|P2|COMPLETED|Overall Study||23
168790|NCT01512160|410355|P1|COMPLETED|Overall Study||20
168791|NCT01512160|410352|P4|STARTED|Overall Study||23
168792|NCT01512160|410353|P3|STARTED|Overall Study||22
168793|NCT01512160|410354|P2|STARTED|Overall Study||23
168794|NCT01512160|410355|P1|STARTED|Overall Study||22
168795|NCT01512108|410447|P2|NOT COMPLETED|Overall Study||9
168796|NCT01512108|410448|P1|NOT COMPLETED|Overall Study||22
168797|NCT01512108|410447|P2|COMPLETED|Overall Study||111
168798|NCT01512108|410448|P1|COMPLETED|Overall Study||221
168799|NCT01512108|410447|P2|Exposed|Overall Study||120
168800|NCT01512108|410448|P1|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|240
168801|NCT01512108|410447|P2|STARTED|Overall Study||120
168802|NCT01512108|410448|P1|STARTED|Overall Study||243
168803|NCT01511978|410462|P2|NOT COMPLETED|Overall Study||0
168804|NCT01511978|410463|P1|NOT COMPLETED|Overall Study||0
168805|NCT01511978|410462|P2|COMPLETED|Overall Study||18
168806|NCT01511978|410463|P1|COMPLETED|Overall Study||14
168807|NCT01511978|410462|P2|STARTED|Overall Study||18
168808|NCT01511978|410463|P1|STARTED|Overall Study||14
168809|NCT01511939|410474|P3|NOT COMPLETED|Overall Study||0
168810|NCT01511939|410475|P2|NOT COMPLETED|Overall Study||1
168811|NCT01511939|410476|P1|NOT COMPLETED|Overall Study||2
168812|NCT01511939|410474|P3|COMPLETED|Overall Study||8
168813|NCT01511939|410475|P2|COMPLETED|Overall Study||4
168814|NCT01511939|410476|P1|COMPLETED|Overall Study||7
168815|NCT01511939|410474|P3|STARTED|Overall Study||8
168816|NCT01511939|410475|P2|STARTED|Overall Study|Includes one patient who was also taking aspirin.|5
168817|NCT01511939|410476|P1|STARTED|Overall Study|Includes 1 subject who was also taking aspirin.|9
168818|NCT01511809|410495|P2|NOT COMPLETED|Overall Study||7
168819|NCT01511809|410496|P1|NOT COMPLETED|Overall Study||7
168820|NCT01511809|410495|P2|COMPLETED|Overall Study||52
168821|NCT01511809|410496|P1|COMPLETED|Overall Study||51
168822|NCT01511809|410495|P2|STARTED|Overall Study||59
168823|NCT01511809|410496|P1|STARTED|Overall Study||58
168824|NCT01511536|410505|P3|NOT COMPLETED|Phase 2||9
168825|NCT01511536|410506|P2|NOT COMPLETED|Phase 2||0
168826|NCT01511536|410507|P1|NOT COMPLETED|Phase 2||0
168827|NCT01511536|410505|P3|COMPLETED|Phase 2|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|18
168828|NCT01511536|410506|P2|COMPLETED|Phase 2||0
168829|NCT01511536|410507|P1|COMPLETED|Phase 2||0
168830|NCT01511536|410505|P3|STARTED|Phase 2||27
168831|NCT01511536|410506|P2|STARTED|Phase 2||0
168832|NCT01511536|410507|P1|STARTED|Phase 2||0
168833|NCT01511536|410505|P3|NOT COMPLETED|Phase 1||0
168834|NCT01511536|410506|P2|NOT COMPLETED|Phase 1||1
168835|NCT01511536|410507|P1|NOT COMPLETED|Phase 1||0
168836|NCT01511536|410505|P3|COMPLETED|Phase 1||0
168837|NCT01511536|410506|P2|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|6
168838|NCT01511536|410507|P1|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|3
168839|NCT01511536|410505|P3|STARTED|Phase 1|Phase 1 and phase 2 are separate populations.|0
168840|NCT01511536|410506|P2|STARTED|Phase 1||7
168841|NCT01511536|410507|P1|STARTED|Phase 1||3
168842|NCT01511445|410529|P2|NOT COMPLETED|Overall Study||4
168843|NCT01511445|410530|P1|NOT COMPLETED|Overall Study||5
168844|NCT01511445|410529|P2|COMPLETED|Overall Study|Data analysis was completed in February, 2016|47
168845|NCT01511445|410530|P1|COMPLETED|Overall Study|Data analysis was completed in February, 2016|48
168846|NCT01511445|410529|P2|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|47
168847|NCT01511445|410530|P1|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|48
168848|NCT01511445|410529|P2|Primary Completion October, 2014|Overall Study|3 protocol violations. 1 lost to follow-up.|47
168849|NCT01511445|410530|P1|Primary Completion October, 2014|Overall Study|1 was excluded Bechterew's disease. 1 protocol violation. 3 were lost to follow-up.|48
168850|NCT01511445|410529|P2|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|51
168851|NCT01511445|410530|P1|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|53
168852|NCT01511445|410529|P2|STARTED|Overall Study|Patient enrollment started in December, 2011.|51
168853|NCT01511445|410530|P1|STARTED|Overall Study|Patient enrollment started in December, 2011.|53
168854|NCT01511419|410540|P2|NOT COMPLETED|Dose 2||0
168855|NCT01511419|410541|P1|NOT COMPLETED|Dose 2||1
168856|NCT01511419|410540|P2|COMPLETED|Dose 2||10
168857|NCT01511419|410541|P1|COMPLETED|Dose 2||29
168858|NCT01511419|410540|P2|STARTED|Dose 2||10
168859|NCT01511419|410541|P1|STARTED|Dose 2||30
168860|NCT01511419|410540|P2|NOT COMPLETED|Dose 1||0
168861|NCT01511419|410541|P1|NOT COMPLETED|Dose 1||0
168862|NCT01511419|410540|P2|COMPLETED|Dose 1||10
168863|NCT01511419|410541|P1|COMPLETED|Dose 1||30
168864|NCT01511419|410540|P2|STARTED|Dose 1||10
168865|NCT01511419|410541|P1|STARTED|Dose 1||30
168866|NCT01511315|410633|P1|NOT COMPLETED|Overall Study||4
168867|NCT01511315|410633|P1|COMPLETED|Overall Study||32
168868|NCT01511315|410633|P1|STARTED|Overall Study||36
168869|NCT01511250|410653|P10|NOT COMPLETED|Overall Study||5
168870|NCT01511250|410654|P9|NOT COMPLETED|Overall Study||14
168871|NCT01511250|410655|P8|NOT COMPLETED|Overall Study||4
168872|NCT01511250|410656|P7|NOT COMPLETED|Overall Study||2
168873|NCT01511250|410657|P6|NOT COMPLETED|Overall Study||0
168874|NCT01511250|410658|P5|NOT COMPLETED|Overall Study||0
168875|NCT01511250|410659|P4|NOT COMPLETED|Overall Study||3
168876|NCT01511250|410660|P3|NOT COMPLETED|Overall Study||4
168877|NCT01511250|410661|P2|NOT COMPLETED|Overall Study||5
168878|NCT01511250|410662|P1|NOT COMPLETED|Overall Study||9
168879|NCT01511250|410653|P10|COMPLETED|Overall Study||48
168880|NCT01511250|410654|P9|COMPLETED|Overall Study||145
168881|NCT01511250|410655|P8|COMPLETED|Overall Study||9
168882|NCT01511250|410656|P7|COMPLETED|Overall Study||21
168883|NCT01511250|410657|P6|COMPLETED|Overall Study||17
168884|NCT01511250|410658|P5|COMPLETED|Overall Study||21
168885|NCT01511250|410659|P4|COMPLETED|Overall Study||11
168886|NCT01511250|410660|P3|COMPLETED|Overall Study||18
168887|NCT01511250|410661|P2|COMPLETED|Overall Study||9
168888|NCT01511250|410662|P1|COMPLETED|Overall Study||15
168889|NCT01511250|410653|P10|STARTED|Overall Study||53
168890|NCT01511250|410654|P9|STARTED|Overall Study||159
168891|NCT01511250|410655|P8|STARTED|Overall Study||13
168892|NCT01511250|410656|P7|STARTED|Overall Study||23
168893|NCT01511250|410657|P6|STARTED|Overall Study||17
168894|NCT01511250|410658|P5|STARTED|Overall Study||21
168895|NCT01511250|410659|P4|STARTED|Overall Study||14
168896|NCT01511250|410660|P3|STARTED|Overall Study||22
168897|NCT01511250|410661|P2|STARTED|Overall Study||14
168898|NCT01511250|410662|P1|STARTED|Overall Study||24
168899|NCT01511107|410810|P2|NOT COMPLETED|Overall Study||41
168900|NCT01511107|410811|P1|NOT COMPLETED|Overall Study||22
168901|NCT01511107|410810|P2|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|219
168902|NCT01511107|410811|P1|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|238
168903|NCT01511107|410810|P2|STARTED|Overall Study|Randomized to the treatment group.|260
168904|NCT01511107|410811|P1|STARTED|Overall Study|Randomized to the treatment group.|260
168905|NCT01511081|410861|P2|NOT COMPLETED|Overall Study||0
168906|NCT01511081|410862|P1|NOT COMPLETED|Overall Study||0
168907|NCT01511081|410861|P2|COMPLETED|Overall Study||9
168908|NCT01511081|410862|P1|COMPLETED|Overall Study||8
168909|NCT01511081|410861|P2|STARTED|Overall Study||9
168910|NCT01511081|410862|P1|STARTED|Overall Study||8
168911|NCT01511016|410872|P2|NOT COMPLETED|Overall Study||2
168912|NCT01511016|410873|P1|NOT COMPLETED|Overall Study||2
168913|NCT01511016|410872|P2|COMPLETED|Overall Study||7
168914|NCT01511016|410873|P1|COMPLETED|Overall Study||6
168915|NCT01511016|410872|P2|STARTED|Overall Study||9
168916|NCT01511016|410873|P1|STARTED|Overall Study||8
168917|NCT01510912|410889|P1|NOT COMPLETED|Overall Study||242
168918|NCT01510912|410889|P1|COMPLETED|Overall Study||360
168919|NCT01510912|410889|P1|STARTED|Overall Study||602
168920|NCT01510834|410895|P1|NOT COMPLETED|Overall Study||33
168921|NCT01510834|410895|P1|COMPLETED|Overall Study||57
168922|NCT01510834|410895|P1|STARTED|Overall Study||90
168923|NCT01510769|410905|P3|NOT COMPLETED|Overall Study||22
168924|NCT01510769|410906|P2|NOT COMPLETED|Overall Study||25
168925|NCT01510769|410907|P1|NOT COMPLETED|Overall Study||27
168926|NCT01510769|410905|P3|COMPLETED|Overall Study||87
168927|NCT01510769|410906|P2|COMPLETED|Overall Study||84
168928|NCT01510769|410907|P1|COMPLETED|Overall Study||79
168929|NCT01510769|410905|P3|STARTED|Overall Study||109
168930|NCT01510769|410906|P2|STARTED|Overall Study||109
168931|NCT01510769|410907|P1|STARTED|Overall Study||106
168932|NCT01510756|410924|P1|NOT COMPLETED|Overall Study||4
168933|NCT01510756|410924|P1|COMPLETED|Overall Study||0
168934|NCT01510756|410924|P1|STARTED|Overall Study||4
168935|NCT01510717|410932|P2|NOT COMPLETED|Overall Study||5
168936|NCT01510717|410933|P1|NOT COMPLETED|Overall Study||2
168937|NCT01510717|410932|P2|COMPLETED|Overall Study||160
168938|NCT01510717|410933|P1|COMPLETED|Overall Study||153
168939|NCT01510717|410932|P2|STARTED|Overall Study||165
168940|NCT01510717|410933|P1|STARTED|Overall Study||155
168941|NCT01510704|410961|P4|NOT COMPLETED|Overall Study||0
168942|NCT01510704|410962|P3|NOT COMPLETED|Overall Study||0
168943|NCT01510704|410963|P2|NOT COMPLETED|Overall Study||0
168944|NCT01510704|410964|P1|NOT COMPLETED|Overall Study||0
168945|NCT01510704|410961|P4|COMPLETED|Overall Study||53
168946|NCT01510704|410962|P3|COMPLETED|Overall Study||50
168947|NCT01510704|410963|P2|COMPLETED|Overall Study||58
168948|NCT01510704|410964|P1|COMPLETED|Overall Study||54
168949|NCT01510704|410961|P4|STARTED|Overall Study||53
168950|NCT01510704|410962|P3|STARTED|Overall Study||50
168951|NCT01510704|410963|P2|STARTED|Overall Study||58
168952|NCT01510704|410964|P1|STARTED|Overall Study||54
168953|NCT01510652|410976|P2|NOT COMPLETED|Overall Study||67
168954|NCT01510652|410977|P1|NOT COMPLETED|Overall Study||92
168955|NCT01510652|410976|P2|COMPLETED|Overall Study||288
168956|NCT01510652|410977|P1|COMPLETED|Overall Study||627
168957|NCT01510652|410976|P2|Baseline|Overall Study||348
168958|NCT01510652|410977|P1|Baseline|Overall Study||718
168959|NCT01510652|410976|P2|STARTED|Overall Study||355
168960|NCT01510652|410977|P1|STARTED|Overall Study||719
168961|NCT01510457|410989|P2|NOT COMPLETED|Overall Study||3
168962|NCT01510457|410990|P1|NOT COMPLETED|Overall Study||5
168963|NCT01510457|410989|P2|COMPLETED|Overall Study||26
168964|NCT01510457|410990|P1|COMPLETED|Overall Study||12
168965|NCT01510457|410989|P2|STARTED|Overall Study||29
168966|NCT01510457|410990|P1|STARTED|Overall Study||17
168967|NCT01510379|411010|P2|NOT COMPLETED|Overall Study||0
168968|NCT01510379|411011|P1|NOT COMPLETED|Overall Study||0
168969|NCT01510379|411010|P2|COMPLETED|Overall Study||51
168970|NCT01510379|411011|P1|COMPLETED|Overall Study||49
168971|NCT01510379|411010|P2|STARTED|Overall Study||51
168972|NCT01510379|411011|P1|STARTED|Overall Study||49
168973|NCT01510327|411019|P1|NOT COMPLETED|Overall Study||0
168974|NCT01510327|411019|P1|COMPLETED|Overall Study||22
168975|NCT01510327|411019|P1|STARTED|Overall Study||22
168976|NCT01510158|411053|P3|NOT COMPLETED|Overall Study||50
168977|NCT01510158|411054|P2|NOT COMPLETED|Overall Study||53
168978|NCT01510158|411055|P1|NOT COMPLETED|Overall Study||51
168979|NCT01510158|411053|P3|COMPLETED|Overall Study||152
168980|NCT01510158|411054|P2|COMPLETED|Overall Study||150
168981|NCT01510158|411055|P1|COMPLETED|Overall Study||151
168982|NCT01510158|411053|P3|STARTED|Overall Study||202
168983|NCT01510158|411054|P2|STARTED|Overall Study||203
168984|NCT01510158|411055|P1|STARTED|Overall Study||202
168985|NCT01510145|411069|P1|NOT COMPLETED|Overall Study||18
168986|NCT01510145|411069|P1|COMPLETED|Overall Study||173
168987|NCT01510145|411069|P1|STARTED|Overall Study||191
168988|NCT01510028|411078|P4|NOT COMPLETED|Overall Study||0
168989|NCT01510028|411079|P3|NOT COMPLETED|Overall Study||0
168990|NCT01510028|411080|P2|NOT COMPLETED|Overall Study||0
168991|NCT01510028|411081|P1|NOT COMPLETED|Overall Study||1
168992|NCT01510028|411078|P4|COMPLETED|Overall Study||6
168993|NCT01510028|411079|P3|COMPLETED|Overall Study||6
168994|NCT01510028|411080|P2|COMPLETED|Overall Study||6
168995|NCT01510028|411081|P1|COMPLETED|Overall Study||5
168996|NCT01510028|411078|P4|STARTED|Overall Study||6
168997|NCT01510028|411079|P3|STARTED|Overall Study||6
168998|NCT01510028|411080|P2|STARTED|Overall Study||6
168999|NCT01510028|411081|P1|STARTED|Overall Study||6
169000|NCT01509950|411197|P3|NOT COMPLETED|Overall Study||0
169001|NCT01509950|411198|P2|NOT COMPLETED|Overall Study||0
169002|NCT01509950|411199|P1|NOT COMPLETED|Overall Study||0
169003|NCT01509950|411197|P3|COMPLETED|Overall Study||0
169004|NCT01509950|411198|P2|COMPLETED|Overall Study||8
169005|NCT01509950|411199|P1|COMPLETED|Overall Study||7
169006|NCT01509950|411197|P3|STARTED|Overall Study||0
169007|NCT01509950|411198|P2|STARTED|Overall Study||8
169008|NCT01509950|411199|P1|STARTED|Overall Study||7
169009|NCT01509872|411227|P2|NOT COMPLETED|Overall Study||0
169010|NCT01509872|411228|P1|NOT COMPLETED|Overall Study||1
169011|NCT01509872|411227|P2|COMPLETED|Overall Study||24
169012|NCT01509872|411228|P1|COMPLETED|Overall Study||25
169013|NCT01509872|411227|P2|Post-Intervention Assessment|Overall Study||24
169014|NCT01509872|411228|P1|Post-Intervention Assessment|Overall Study||26
169015|NCT01509872|411227|P2|STARTED|Overall Study||24
169016|NCT01509872|411228|P1|STARTED|Overall Study||26
169017|NCT01509807|411242|P2|NOT COMPLETED|Overall Study||1
169018|NCT01509807|411243|P1|NOT COMPLETED|Overall Study||1
169019|NCT01509807|411242|P2|COMPLETED|Overall Study||16
169020|NCT01509807|411243|P1|COMPLETED|Overall Study||15
169021|NCT01509807|411242|P2|STARTED|Overall Study||17
169022|NCT01509807|411243|P1|STARTED|Overall Study||16
169023|NCT01509677|411269|P2|NOT COMPLETED|Overall Study||6
169024|NCT01509677|411270|P1|NOT COMPLETED|Overall Study||3
169025|NCT01509677|411269|P2|COMPLETED|Overall Study||73
169026|NCT01509677|411270|P1|COMPLETED|Overall Study||76
169027|NCT01509677|411269|P2|STARTED|Overall Study||79
169028|NCT01509677|411270|P1|STARTED|Overall Study||79
169029|NCT01509664|411342|P2|NOT COMPLETED|Overall Study||21
169030|NCT01509664|411343|P1|NOT COMPLETED|Overall Study||15
169031|NCT01509664|411342|P2|COMPLETED|Overall Study||28
169032|NCT01509664|411343|P1|COMPLETED|Overall Study||34
169033|NCT01509664|411342|P2|T3 Follow-up|Overall Study||33
169034|NCT01509664|411343|P1|T3 Follow-up|Overall Study||40
169035|NCT01509664|411342|P2|T2 Follow-up|Overall Study||38
169036|NCT01509664|411343|P1|T2 Follow-up|Overall Study||45
169037|NCT01509664|411342|P2|STARTED|Overall Study||49
169038|NCT01509664|411343|P1|STARTED|Overall Study||49
169039|NCT01509638|411351|P2|NOT COMPLETED|Overall Study||2
169040|NCT01509638|411352|P1|NOT COMPLETED|Overall Study||3
169041|NCT01509638|411351|P2|COMPLETED|Overall Study||24
169042|NCT01509638|411352|P1|COMPLETED|Overall Study||20
169043|NCT01509638|411351|P2|STARTED|Overall Study||26
169044|NCT01509638|411352|P1|STARTED|Overall Study||23
169045|NCT01509625|411376|P1|NOT COMPLETED|Overall Study||9
169046|NCT01509625|411376|P1|COMPLETED|Overall Study||263
169047|NCT01509625|411376|P1|STARTED|Overall Study||272
169048|NCT01509586|411394|P2|NOT COMPLETED|Overall Study||0
169049|NCT01509586|411395|P1|NOT COMPLETED|Overall Study||0
169050|NCT01509586|411394|P2|COMPLETED|Overall Study|final intent to treat sample|610
169051|NCT01509586|411395|P1|COMPLETED|Overall Study|final intent to treat sample|626
169052|NCT01509586|411394|P2|Week 58 (Month 12)|Overall Study||499
169053|NCT01509586|411395|P1|Week 58 (Month 12)|Overall Study||492
169054|NCT01509586|411394|P2|Week 46|Overall Study||494
169055|NCT01509586|411395|P1|Week 46|Overall Study||483
169056|NCT01509586|411394|P2|Week 32 (Month 6)|Overall Study||523
169057|NCT01509586|411395|P1|Week 32 (Month 6)|Overall Study||504
169058|NCT01509586|411394|P2|Week18|Overall Study||555
169059|NCT01509586|411395|P1|Week18|Overall Study||529
169060|NCT01509586|411394|P2|Week 14|Overall Study||566
169061|NCT01509586|411395|P1|Week 14|Overall Study||528
169062|NCT01509586|411394|P2|Week 10|Overall Study||574
169063|NCT01509586|411395|P1|Week 10|Overall Study||537
169064|NCT01509586|411394|P2|Week 6|Overall Study||585
169065|NCT01509586|411395|P1|Week 6|Overall Study||551
169066|NCT01509586|411394|P2|Week 3|Overall Study||585
169067|NCT01509586|411395|P1|Week 3|Overall Study||574
169068|NCT01509586|411394|P2|STARTED|Overall Study|Week 0|610
169069|NCT01509586|411395|P1|STARTED|Overall Study|Week 0|626
169070|NCT01509547|411403|P2|NOT COMPLETED|Overall Study||39
169071|NCT01509547|411404|P1|NOT COMPLETED|Overall Study||35
169072|NCT01509547|411403|P2|COMPLETED|Overall Study||41
169073|NCT01509547|411404|P1|COMPLETED|Overall Study||42
169074|NCT01509547|411403|P2|STARTED|Overall Study||80
169075|NCT01509547|411404|P1|STARTED|Overall Study||77
169076|NCT01509404|411422|P2|NOT COMPLETED|Overall Study||0
169077|NCT01509404|411423|P1|NOT COMPLETED|Overall Study||0
169078|NCT01509404|411422|P2|COMPLETED|Overall Study||20
169079|NCT01509404|411423|P1|COMPLETED|Overall Study||20
169080|NCT01509404|411422|P2|STARTED|Overall Study||20
169081|NCT01509404|411423|P1|STARTED|Overall Study||20
169082|NCT01509183|411445|P2|NOT COMPLETED|Overall Study||111
169083|NCT01509183|411446|P1|NOT COMPLETED|Overall Study||109
169084|NCT01509183|411445|P2|COMPLETED|Overall Study||134
169085|NCT01509183|411446|P1|COMPLETED|Overall Study||141
169086|NCT01509183|411445|P2|STARTED|Overall Study||245
169087|NCT01509183|411446|P1|STARTED|Overall Study||250
169088|NCT01509105|411454|P1|NOT COMPLETED|Overall Study||0
169089|NCT01509105|411454|P1|COMPLETED|Overall Study||649
169090|NCT01509105|411454|P1|STARTED|Overall Study||649
169091|NCT01509079|411471|P2|NOT COMPLETED|Overall Study||3
169092|NCT01509079|411472|P1|NOT COMPLETED|Overall Study||0
169093|NCT01509079|411471|P2|COMPLETED|Overall Study||56
169094|NCT01509079|411472|P1|COMPLETED|Overall Study||57
169095|NCT01509079|411471|P2|STARTED|Overall Study||59
169096|NCT01509079|411472|P1|STARTED|Overall Study||57
169097|NCT01509053|411492|P1|NOT COMPLETED|Aripiprazole IM Depot Extension Phase(C)||3
169098|NCT01509053|411492|P1|COMPLETED|Aripiprazole IM Depot Extension Phase(C)||0
169187|NCT01508650|411652|P2|NOT COMPLETED|Overall Study||3
169099|NCT01509053|411492|P1|STARTED|Aripiprazole IM Depot Extension Phase(C)||3
169100|NCT01509053|411492|P1|NOT COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||16
169101|NCT01509053|411492|P1|COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||3
169102|NCT01509053|411492|P1|STARTED|Aripiprazole IM Depot Treatment Phase(B)|Includes 8 patients from Phase A + 11 patients who entered directly into Phase B.|19
169103|NCT01509053|411492|P1|NOT COMPLETED|Oral Aripirazole (Phase A)||11
169104|NCT01509053|411492|P1|COMPLETED|Oral Aripirazole (Phase A)||8
169105|NCT01509053|411492|P1|STARTED|Oral Aripirazole (Phase A)||19
169106|NCT01509040|411506|P3|NOT COMPLETED|Overall Study||0
169107|NCT01509040|411507|P2|NOT COMPLETED|Overall Study||1
169108|NCT01509040|411508|P1|NOT COMPLETED|Overall Study||0
169109|NCT01509040|411506|P3|COMPLETED|Overall Study||0
169110|NCT01509040|411507|P2|COMPLETED|Overall Study||1
169111|NCT01509040|411508|P1|COMPLETED|Overall Study||0
169112|NCT01509040|411506|P3|STARTED|Overall Study||0
169113|NCT01509040|411507|P2|STARTED|Overall Study||2
169114|NCT01509040|411508|P1|STARTED|Overall Study||0
169115|NCT01508936|411554|P2|NOT COMPLETED|Overall Study||79
169116|NCT01508936|411555|P1|NOT COMPLETED|Overall Study||23
169117|NCT01508936|411554|P2|COMPLETED|Overall Study||330
169118|NCT01508936|411555|P1|COMPLETED|Overall Study||79
169119|NCT01508936|411554|P2|FEV1 Subpopulation Analysis Set|Overall Study||346
169120|NCT01508936|411555|P1|FEV1 Subpopulation Analysis Set|Overall Study||91
169121|NCT01508936|411554|P2|Full Analysis Set|Overall Study||395
169122|NCT01508936|411555|P1|Full Analysis Set|Overall Study||97
169123|NCT01508936|411554|P2|Safety Analysis Set|Overall Study||395
169124|NCT01508936|411555|P1|Safety Analysis Set|Overall Study||97
169125|NCT01508936|411554|P2|Randomized, Not Treated|Overall Study||3
169126|NCT01508936|411555|P1|Randomized, Not Treated|Overall Study||1
169127|NCT01508936|411554|P2|Randomized|Overall Study||398
169128|NCT01508936|411555|P1|Randomized|Overall Study||98
169129|NCT01508936|411554|P2|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|11
169130|NCT01508936|411555|P1|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|4
169131|NCT01508936|411554|P2|STARTED|Overall Study||409
169132|NCT01508936|411555|P1|STARTED|Overall Study||102
169133|NCT01508910|411594|P4|NOT COMPLETED|Treatment||3
169134|NCT01508910|411595|P3|NOT COMPLETED|Treatment||10
169135|NCT01508910|411596|P2|NOT COMPLETED|Treatment||4
169136|NCT01508910|411597|P1|NOT COMPLETED|Treatment||2
169137|NCT01508910|411594|P4|COMPLETED|Treatment||3
169138|NCT01508910|411595|P3|COMPLETED|Treatment||18
169139|NCT01508910|411596|P2|COMPLETED|Treatment||24
169140|NCT01508910|411597|P1|COMPLETED|Treatment||48
169141|NCT01508910|411594|P4|STARTED|Treatment|3 moved from Treatment (Tx) to Active Control (AC) Arm; 6 in Not injected Arm(4 from Tx ; 2 from AC)|6
169142|NCT01508910|411595|P3|STARTED|Treatment||28
169143|NCT01508910|411596|P2|STARTED|Treatment||28
169144|NCT01508910|411597|P1|STARTED|Treatment||50
169145|NCT01508910|411594|P4|NOT COMPLETED|Randomization||0
169146|NCT01508910|411595|P3|NOT COMPLETED|Randomization||0
169147|NCT01508910|411596|P2|NOT COMPLETED|Randomization||0
169148|NCT01508910|411597|P1|NOT COMPLETED|Randomization||0
169149|NCT01508910|411594|P4|COMPLETED|Randomization||0
169150|NCT01508910|411595|P3|COMPLETED|Randomization||28
169151|NCT01508910|411596|P2|COMPLETED|Randomization||27
169152|NCT01508910|411597|P1|COMPLETED|Randomization||57
169153|NCT01508910|411594|P4|STARTED|Randomization|Participants not randomized into Not Injected arm, but some were re-assigned here during treatment.|0
169154|NCT01508910|411595|P3|STARTED|Randomization||28
169155|NCT01508910|411596|P2|STARTED|Randomization||27
169156|NCT01508910|411597|P1|STARTED|Randomization||57
169157|NCT01508832|411621|P2|NOT COMPLETED|Overall Study||0
169158|NCT01508832|411622|P1|NOT COMPLETED|Overall Study||0
169159|NCT01508832|411621|P2|COMPLETED|Overall Study||6
169160|NCT01508832|411622|P1|COMPLETED|Overall Study||6
169161|NCT01508832|411621|P2|STARTED|Overall Study||6
169162|NCT01508832|411622|P1|STARTED|Overall Study||6
169163|NCT01508702|411630|P2|NOT COMPLETED|Overall Study||13
169164|NCT01508702|411631|P1|NOT COMPLETED|Overall Study||23
169165|NCT01508702|411630|P2|COMPLETED|Overall Study||94
169166|NCT01508702|411631|P1|COMPLETED|Overall Study||84
169167|NCT01508702|411630|P2|STARTED|Overall Study||107
169168|NCT01508702|411631|P1|STARTED|Overall Study||107
169169|NCT01508676|411639|P2|NOT COMPLETED|Phase II (2 Weeks)||1
169170|NCT01508676|411640|P1|NOT COMPLETED|Phase II (2 Weeks)||1
169171|NCT01508676|411639|P2|COMPLETED|Phase II (2 Weeks)||13
169172|NCT01508676|411640|P1|COMPLETED|Phase II (2 Weeks)||15
169173|NCT01508676|411639|P2|STARTED|Phase II (2 Weeks)||14
169174|NCT01508676|411640|P1|STARTED|Phase II (2 Weeks)||16
169175|NCT01508676|411639|P2|NOT COMPLETED|Washout Period (1 Week)||0
169176|NCT01508676|411640|P1|NOT COMPLETED|Washout Period (1 Week)||0
169177|NCT01508676|411639|P2|COMPLETED|Washout Period (1 Week)||14
169178|NCT01508676|411640|P1|COMPLETED|Washout Period (1 Week)||16
169179|NCT01508676|411639|P2|STARTED|Washout Period (1 Week)||14
169180|NCT01508676|411640|P1|STARTED|Washout Period (1 Week)||16
169181|NCT01508676|411639|P2|NOT COMPLETED|Phase I (2 Weeks)||3
169182|NCT01508676|411640|P1|NOT COMPLETED|Phase I (2 Weeks)||2
169183|NCT01508676|411639|P2|COMPLETED|Phase I (2 Weeks)||14
169184|NCT01508676|411640|P1|COMPLETED|Phase I (2 Weeks)||16
169185|NCT01508676|411639|P2|STARTED|Phase I (2 Weeks)||17
169186|NCT01508676|411640|P1|STARTED|Phase I (2 Weeks)||18
169188|NCT01508650|411653|P1|NOT COMPLETED|Overall Study||0
169189|NCT01508650|411652|P2|COMPLETED|Overall Study||12
169190|NCT01508650|411653|P1|COMPLETED|Overall Study||12
169191|NCT01508650|411652|P2|STARTED|Overall Study||15
169192|NCT01508650|411653|P1|STARTED|Overall Study||12
169193|NCT01508455|411661|P1|NOT COMPLETED|Overall Study||0
169194|NCT01508455|411661|P1|COMPLETED|Overall Study||6
169195|NCT01508455|411661|P1|STARTED|Overall Study||6
169196|NCT01508325|411672|P2|NOT COMPLETED|Overall Study||21
169197|NCT01508325|411673|P1|NOT COMPLETED|Overall Study||18
169198|NCT01508325|411672|P2|COMPLETED|Overall Study||72
169199|NCT01508325|411673|P1|COMPLETED|Overall Study||75
169200|NCT01508325|411672|P2|STARTED|Overall Study||93
169201|NCT01508325|411673|P1|STARTED|Overall Study||93
169202|NCT01508169|411703|P2|NOT COMPLETED|Overall Study||2
169203|NCT01508169|411704|P1|NOT COMPLETED|Overall Study||3
169204|NCT01508169|411703|P2|COMPLETED|Overall Study||45
169205|NCT01508169|411704|P1|COMPLETED|Overall Study||44
169206|NCT01508169|411703|P2|STARTED|Overall Study||47
169207|NCT01508169|411704|P1|STARTED|Overall Study||47
169208|NCT01508130|411718|P2|NOT COMPLETED|Overall Study||69
169209|NCT01508130|411719|P1|NOT COMPLETED|Overall Study||227
169210|NCT01508130|411718|P2|COMPLETED|Overall Study||73
169211|NCT01508130|411719|P1|COMPLETED|Overall Study||266
169212|NCT01508130|411718|P2|mTRT|Overall Study||142
169213|NCT01508130|411719|P1|mTRT|Overall Study||493
169214|NCT01508130|411718|P2|STARTED|Overall Study||142
169215|NCT01508130|411719|P1|STARTED|Overall Study||493
169216|NCT01508117|411761|P1|NOT COMPLETED|Overall Study||0
169217|NCT01508117|411761|P1|COMPLETED|Overall Study||1
169218|NCT01508117|411761|P1|STARTED|Overall Study||1
169219|NCT01508052|411767|P2|NOT COMPLETED|Overall Study||0
169220|NCT01508052|411768|P1|NOT COMPLETED|Overall Study||0
169221|NCT01508052|411767|P2|COMPLETED|Overall Study||20
169222|NCT01508052|411768|P1|COMPLETED|Overall Study||20
169223|NCT01508052|411767|P2|STARTED|Overall Study||20
169224|NCT01508052|411768|P1|STARTED|Overall Study||20
169225|NCT01508013|411776|P2|NOT COMPLETED|Overall Study||23
169226|NCT01508013|411777|P1|NOT COMPLETED|Overall Study||32
169227|NCT01508013|411776|P2|COMPLETED|Overall Study||206
169228|NCT01508013|411777|P1|COMPLETED|Overall Study||182
169229|NCT01508013|411776|P2|STARTED|Overall Study||229
169230|NCT01508013|411777|P1|STARTED|Overall Study||214
169231|NCT01507896|411787|P1|NOT COMPLETED|Overall Study||2
169232|NCT01507896|411787|P1|COMPLETED|Overall Study|28 unique participants had 38 surgeries (participants could have multiple surgeries).|28
169233|NCT01507896|411787|P1|STARTED|Overall Study|30 unique participants had 40 surgeries planned (participants could have multiple surgeries).|30
169234|NCT01507831|411830|P2|NOT COMPLETED|Overall Study||440
169235|NCT01507831|411831|P1|NOT COMPLETED|Overall Study||193
169236|NCT01507831|411830|P2|COMPLETED|Overall Study||1113
169237|NCT01507831|411831|P1|COMPLETED|Overall Study||595
169238|NCT01507831|411830|P2|Treated|Overall Study||1550
169239|NCT01507831|411831|P1|Treated|Overall Study||788
169240|NCT01507831|411830|P2|STARTED|Overall Study|Randomized|1553
169241|NCT01507831|411831|P1|STARTED|Overall Study|Randomized|788
169242|NCT01507779|411901|P2|NOT COMPLETED|Overall Study||0
169243|NCT01507779|411902|P1|NOT COMPLETED|Overall Study||0
169244|NCT01507779|411901|P2|COMPLETED|Overall Study||25
169245|NCT01507779|411902|P1|COMPLETED|Overall Study||23
169246|NCT01507779|411901|P2|STARTED|Overall Study||25
169247|NCT01507779|411902|P1|STARTED|Overall Study||23
169248|NCT01507688|411942|P2|NOT COMPLETED|6 Month to 12 Month Assessment||3
169249|NCT01507688|411943|P1|NOT COMPLETED|6 Month to 12 Month Assessment||5
169250|NCT01507688|411942|P2|COMPLETED|6 Month to 12 Month Assessment||116
169251|NCT01507688|411943|P1|COMPLETED|6 Month to 12 Month Assessment||108
169252|NCT01507688|411942|P2|STARTED|6 Month to 12 Month Assessment||119
169253|NCT01507688|411943|P1|STARTED|6 Month to 12 Month Assessment||113
169254|NCT01507688|411942|P2|NOT COMPLETED|Baseline to 6 Month Assessment||10
169255|NCT01507688|411943|P1|NOT COMPLETED|Baseline to 6 Month Assessment||16
169256|NCT01507688|411942|P2|COMPLETED|Baseline to 6 Month Assessment||119
169257|NCT01507688|411943|P1|COMPLETED|Baseline to 6 Month Assessment||113
169258|NCT01507688|411942|P2|STARTED|Baseline to 6 Month Assessment||129
169259|NCT01507688|411943|P1|STARTED|Baseline to 6 Month Assessment||129
169260|NCT01507662|411951|P2|NOT COMPLETED|Overall Study||831
169261|NCT01507662|411952|P1|NOT COMPLETED|Overall Study||816
169262|NCT01507662|411951|P2|COMPLETED|Overall Study||3020
169263|NCT01507662|411952|P1|COMPLETED|Overall Study||3082
169264|NCT01507662|411951|P2|STARTED|Overall Study||3851
169265|NCT01507662|411952|P1|STARTED|Overall Study||3898
169266|NCT01507584|411958|P1|NOT COMPLETED|Overall Study||0
169267|NCT01507584|411958|P1|COMPLETED|Overall Study||0
169268|NCT01507584|411958|P1|STARTED|Overall Study||0
169269|NCT01507493|411966|P2|NOT COMPLETED|Overall Study||0
169270|NCT01507493|411967|P1|NOT COMPLETED|Overall Study||0
169271|NCT01507493|411966|P2|COMPLETED|Overall Study||178
169272|NCT01507493|411967|P1|COMPLETED|Overall Study||22
169273|NCT01507493|411966|P2|STARTED|Overall Study||178
169274|NCT01507493|411967|P1|STARTED|Overall Study||22
169275|NCT01507298|411983|P2|NOT COMPLETED|Overall Study||6
169276|NCT01507298|411984|P1|NOT COMPLETED|Overall Study||0
169277|NCT01507298|411983|P2|COMPLETED|Overall Study||14
169278|NCT01507298|411984|P1|COMPLETED|Overall Study||1
169279|NCT01507298|411983|P2|STARTED|Overall Study||20
169280|NCT01507298|411984|P1|STARTED|Overall Study||1
169281|NCT01507246|411994|P2|NOT COMPLETED|Overall Study||1
169282|NCT01507246|411995|P1|NOT COMPLETED|Overall Study||2
169283|NCT01507246|411994|P2|COMPLETED|Overall Study||21
169284|NCT01507246|411995|P1|COMPLETED|Overall Study||18
169285|NCT01507246|411994|P2|STARTED|Overall Study||22
169286|NCT01507246|411995|P1|STARTED|Overall Study||20
169287|NCT01507233|412009|P2|NOT COMPLETED|Overall Study||0
169288|NCT01507233|412010|P1|NOT COMPLETED|Overall Study||0
169289|NCT01507233|412009|P2|COMPLETED|Overall Study||0
169290|NCT01507233|412010|P1|COMPLETED|Overall Study||5
169291|NCT01507233|412009|P2|STARTED|Overall Study||0
169292|NCT01507233|412010|P1|STARTED|Overall Study||5
169293|NCT01507220|412022|P2|NOT COMPLETED|Overall Study||0
169294|NCT01507220|412023|P1|NOT COMPLETED|Overall Study||0
169295|NCT01507220|412022|P2|COMPLETED|Overall Study||0
169296|NCT01507220|412023|P1|COMPLETED|Overall Study||2
169297|NCT01507220|412022|P2|STARTED|Overall Study||0
169298|NCT01507220|412023|P1|STARTED|Overall Study||2
169299|NCT01507181|412037|P2|NOT COMPLETED|Overall Study||0
169300|NCT01507181|412038|P1|NOT COMPLETED|Overall Study||0
169301|NCT01507181|412037|P2|COMPLETED|Overall Study||12
169302|NCT01507181|412038|P1|COMPLETED|Overall Study||12
169303|NCT01507181|412037|P2|STARTED|Overall Study||12
169304|NCT01507181|412038|P1|STARTED|Overall Study||12
169305|NCT01507155|412058|P2|NOT COMPLETED|Overall Study||0
169306|NCT01507155|412059|P1|NOT COMPLETED|Overall Study||0
169307|NCT01507155|412058|P2|COMPLETED|Overall Study||60
169308|NCT01507155|412059|P1|COMPLETED|Overall Study||625
169309|NCT01507155|412058|P2|STARTED|Overall Study||60
169310|NCT01507155|412059|P1|STARTED|Overall Study||625
169311|NCT01507103|412068|P3|NOT COMPLETED|Overall Study||0
169312|NCT01507103|412069|P2|NOT COMPLETED|Overall Study||0
169313|NCT01507103|412070|P1|NOT COMPLETED|Overall Study||0
169314|NCT01507103|412068|P3|COMPLETED|Overall Study||42
169315|NCT01507103|412069|P2|COMPLETED|Overall Study||41
169316|NCT01507103|412070|P1|COMPLETED|Overall Study||41
169317|NCT01507103|412068|P3|STARTED|Overall Study||42
169318|NCT01507103|412069|P2|STARTED|Overall Study||41
169319|NCT01507103|412070|P1|STARTED|Overall Study||41
169320|NCT01507090|412093|P1|NOT COMPLETED|Overall Study||18
169321|NCT01507090|412093|P1|COMPLETED|Overall Study||624
169322|NCT01507090|412093|P1|STARTED|Overall Study||642
169323|NCT01507051|412132|P4|NOT COMPLETED|Overall Study||7
169324|NCT01507051|412133|P3|NOT COMPLETED|Overall Study||1
169325|NCT01507051|412134|P2|NOT COMPLETED|Overall Study||3
169326|NCT01507051|412135|P1|NOT COMPLETED|Overall Study||2
169327|NCT01507051|412132|P4|COMPLETED|Overall Study||0
169328|NCT01507051|412133|P3|COMPLETED|Overall Study||28
169329|NCT01507051|412134|P2|COMPLETED|Overall Study||28
169330|NCT01507051|412135|P1|COMPLETED|Overall Study||27
169331|NCT01507051|412132|P4|Received Placebo or Rivaroxaban|Overall Study||0
169332|NCT01507051|412133|P3|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG3|28
169333|NCT01507051|412134|P2|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG2 and in RG4|28
169334|NCT01507051|412135|P1|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG1 and in RG4 (RG = Reporting Group for Safety Data)|28
169335|NCT01507051|412132|P4|Warfarin run-in Phase|Overall Study|Safety Population: in RG4|7
169336|NCT01507051|412133|P3|Warfarin run-in Phase|Overall Study||0
169337|NCT01507051|412134|P2|Warfarin run-in Phase|Overall Study||28
169338|NCT01507051|412135|P1|Warfarin run-in Phase|Overall Study||28
169339|NCT01507051|412132|P4|STARTED|Overall Study||7
169340|NCT01507051|412133|P3|STARTED|Overall Study||29
169341|NCT01507051|412134|P2|STARTED|Overall Study||31
169342|NCT01507051|412135|P1|STARTED|Overall Study||29
169343|NCT01506960|412253|P1|NOT COMPLETED|Overall Study||47
169344|NCT01506960|412253|P1|COMPLETED|Overall Study||17
169345|NCT01506960|412253|P1|STARTED|Overall Study||64
169346|NCT01506947|412259|P1|NOT COMPLETED|Overall Study||16
169347|NCT01506947|412259|P1|COMPLETED|Overall Study||49
169348|NCT01506947|412259|P1|STARTED|Overall Study||65
169349|NCT01506908|412277|P2|NOT COMPLETED|Overall Study||0
169350|NCT01506908|412278|P1|NOT COMPLETED|Overall Study||1
169351|NCT01506908|412277|P2|COMPLETED|Overall Study||161
169352|NCT01506908|412278|P1|COMPLETED|Overall Study||161
169353|NCT01506908|412277|P2|STARTED|Overall Study||161
169354|NCT01506908|412278|P1|STARTED|Overall Study||162
169355|NCT01506882|412296|P2|NOT COMPLETED|Overall Study||7
169356|NCT01506882|412297|P1|NOT COMPLETED|Overall Study||22
169357|NCT01506882|412296|P2|COMPLETED|Overall Study||3
169358|NCT01506882|412297|P1|COMPLETED|Overall Study||39
169359|NCT01506882|412296|P2|STARTED|Overall Study||10
169360|NCT01506882|412297|P1|STARTED|Overall Study||61
169361|NCT01506726|412311|P2|NOT COMPLETED|Overall Study||2
169362|NCT01506726|412312|P1|NOT COMPLETED|Overall Study||1
169363|NCT01506726|412311|P2|COMPLETED|Overall Study||3
169364|NCT01506726|412312|P1|COMPLETED|Overall Study||5
169365|NCT01506726|412311|P2|STARTED|Overall Study||5
169366|NCT01506726|412312|P1|STARTED|Overall Study||6
169367|NCT01506596|412352|P1|NOT COMPLETED|Overall Study||1
169368|NCT01506596|412352|P1|COMPLETED|Overall Study|One enrolled patient had ineligible pathology after starting treatment; was removed from treatment.|41
169369|NCT01506596|412352|P1|STARTED|Overall Study||42
169370|NCT01506479|412363|P3|NOT COMPLETED|Overall Study||3
169371|NCT01506479|412364|P2|NOT COMPLETED|Overall Study||5
169372|NCT01506479|412365|P1|NOT COMPLETED|Overall Study||3
169373|NCT01506479|412363|P3|COMPLETED|Overall Study||42
169374|NCT01506479|412364|P2|COMPLETED|Overall Study||38
169375|NCT01506479|412365|P1|COMPLETED|Overall Study||37
169376|NCT01506479|412363|P3|STARTED|Overall Study||45
169377|NCT01506479|412364|P2|STARTED|Overall Study||43
169378|NCT01506479|412365|P1|STARTED|Overall Study||40
169379|NCT01506453|412379|P2|NOT COMPLETED|Overall Study||2
169380|NCT01506453|412380|P1|NOT COMPLETED|Overall Study||0
169381|NCT01506453|412379|P2|COMPLETED|Overall Study||24
169382|NCT01506453|412380|P1|COMPLETED|Overall Study||25
169383|NCT01506453|412379|P2|STARTED|Overall Study||26
169384|NCT01506453|412380|P1|STARTED|Overall Study||25
169385|NCT01506362|412390|P1|NOT COMPLETED|Overall Study||6
169386|NCT01506362|412390|P1|COMPLETED|Overall Study||16
169387|NCT01506362|412390|P1|STARTED|Overall Study||22
169388|NCT01506323|412396|P2|NOT COMPLETED|Overall Study||13
169389|NCT01506323|412397|P1|NOT COMPLETED|Overall Study||24
169390|NCT01506323|412396|P2|COMPLETED|Overall Study||71
169391|NCT01506323|412397|P1|COMPLETED|Overall Study||65
169392|NCT01506323|412396|P2|Post-treatment Completed CAPS|Overall Study||72
169393|NCT01506323|412397|P1|Post-treatment Completed CAPS|Overall Study||68
169394|NCT01506323|412396|P2|Post-treatment Completers|Overall Study||72
169395|NCT01506323|412397|P1|Post-treatment Completers|Overall Study||69
169396|NCT01506323|412396|P2|STARTED|Overall Study||84
169397|NCT01506323|412397|P1|STARTED|Overall Study||89
169398|NCT01506271|412426|P3|NOT COMPLETED|Overall Study||3
169399|NCT01506271|412427|P2|NOT COMPLETED|Overall Study||7
169400|NCT01506271|412428|P1|NOT COMPLETED|Overall Study||4
169401|NCT01506271|412426|P3|COMPLETED|Overall Study||114
169402|NCT01506271|412427|P2|COMPLETED|Overall Study||109
169403|NCT01506271|412428|P1|COMPLETED|Overall Study||114
169404|NCT01506271|412426|P3|Treated|Overall Study||114
169405|NCT01506271|412427|P2|Treated|Overall Study||116
169406|NCT01506271|412428|P1|Treated|Overall Study||117
169407|NCT01506271|412426|P3|STARTED|Overall Study||117
169408|NCT01506271|412427|P2|STARTED|Overall Study||116
169409|NCT01506271|412428|P1|STARTED|Overall Study||118
169410|NCT01506193|412490|P3|NOT COMPLETED|Overall Study||14
169411|NCT01506193|412491|P2|NOT COMPLETED|Overall Study||4
169412|NCT01506193|412492|P1|NOT COMPLETED|Overall Study||14
169413|NCT01506193|412490|P3|COMPLETED|Overall Study||168
169414|NCT01506193|412491|P2|COMPLETED|Overall Study||179
169415|NCT01506193|412492|P1|COMPLETED|Overall Study||337
169416|NCT01506193|412490|P3|STARTED|Overall Study||182
169417|NCT01506193|412491|P2|STARTED|Overall Study||183
169418|NCT01506193|412492|P1|STARTED|Overall Study||351
169419|NCT01505933|412525|P2|NOT COMPLETED|Overall Study||0
169420|NCT01505933|412526|P1|NOT COMPLETED|Overall Study||0
169421|NCT01505933|412525|P2|COMPLETED|Overall Study||14
169422|NCT01505933|412526|P1|COMPLETED|Overall Study||10
169423|NCT01505933|412525|P2|STARTED|Overall Study||14
169424|NCT01505933|412526|P1|STARTED|Overall Study||10
169425|NCT01505881|412538|P2|NOT COMPLETED|Overall Study||1
169426|NCT01505881|412539|P1|NOT COMPLETED|Overall Study||4
169427|NCT01505881|412538|P2|COMPLETED|Overall Study||58
169428|NCT01505881|412539|P1|COMPLETED|Overall Study||95
169429|NCT01505881|412538|P2|STARTED|Overall Study||59
169430|NCT01505881|412539|P1|STARTED|Overall Study||99
169431|NCT01505764|412553|P2|NOT COMPLETED|Overall Study||1
169432|NCT01505764|412554|P1|NOT COMPLETED|Overall Study||3
169433|NCT01505764|412553|P2|COMPLETED|Overall Study||2
169434|NCT01505764|412554|P1|COMPLETED|Overall Study||3
169435|NCT01505764|412553|P2|STARTED|Overall Study||3
169436|NCT01505764|412554|P1|STARTED|Overall Study||6
169437|NCT01505673|412584|P2|NOT COMPLETED|Overall Study||2
169438|NCT01505673|412585|P1|NOT COMPLETED|Overall Study||3
169439|NCT01505673|412584|P2|COMPLETED|Overall Study||34
169440|NCT01505673|412585|P1|COMPLETED|Overall Study||32
169441|NCT01505673|412584|P2|STARTED|Overall Study||36
169442|NCT01505673|412585|P1|STARTED|Overall Study||35
169443|NCT01505647|412645|P2|NOT COMPLETED|Day 43 Through Day 182 Follow-up||3
169444|NCT01505647|412646|P1|NOT COMPLETED|Day 43 Through Day 182 Follow-up||1
169445|NCT01505647|412645|P2|COMPLETED|Day 43 Through Day 182 Follow-up||163
169446|NCT01505647|412646|P1|COMPLETED|Day 43 Through Day 182 Follow-up||328
169447|NCT01505647|412645|P2|STARTED|Day 43 Through Day 182 Follow-up||166
169448|NCT01505647|412646|P1|STARTED|Day 43 Through Day 182 Follow-up||329
169449|NCT01505647|412645|P2|NOT COMPLETED|Day 1 Through Day 42 Follow-up||0
169450|NCT01505647|412646|P1|NOT COMPLETED|Day 1 Through Day 42 Follow-up||3
169451|NCT01505647|412645|P2|COMPLETED|Day 1 Through Day 42 Follow-up||166
169452|NCT01505647|412646|P1|COMPLETED|Day 1 Through Day 42 Follow-up||329
169453|NCT01505647|412645|P2|Vaccinated|Day 1 Through Day 42 Follow-up||166
169454|NCT01505647|412646|P1|Vaccinated|Day 1 Through Day 42 Follow-up||331
169455|NCT01505647|412645|P2|STARTED|Day 1 Through Day 42 Follow-up||166
169456|NCT01505647|412646|P1|STARTED|Day 1 Through Day 42 Follow-up||332
169457|NCT01505634|412663|P3|NOT COMPLETED|Overall Study||6
169458|NCT01505634|412664|P2|NOT COMPLETED|Overall Study||10
169459|NCT01505634|412665|P1|NOT COMPLETED|Overall Study||9
169460|NCT01505634|412663|P3|COMPLETED|Overall Study||94
169461|NCT01505634|412664|P2|COMPLETED|Overall Study||91
169462|NCT01505634|412665|P1|COMPLETED|Overall Study||92
169463|NCT01505634|412663|P3|Treated|Overall Study||100
169464|NCT01505634|412664|P2|Treated|Overall Study||99
169465|NCT01505634|412665|P1|Treated|Overall Study||99
169466|NCT01505634|412663|P3|STARTED|Overall Study||100
169467|NCT01505634|412664|P2|STARTED|Overall Study||101
169468|NCT01505634|412665|P1|STARTED|Overall Study||101
169469|NCT01505608|412720|P2|NOT COMPLETED|Phase II||2
169470|NCT01505608|412721|P1|NOT COMPLETED|Phase II||2
169471|NCT01505608|412720|P2|COMPLETED|Phase II||2
169472|NCT01505608|412721|P1|COMPLETED|Phase II||0
169473|NCT01505608|412720|P2|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|4
169474|NCT01505608|412721|P1|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|2
169475|NCT01505608|412720|P2|NOT COMPLETED|Phase I||6
169476|NCT01505608|412721|P1|NOT COMPLETED|Phase I||0
169477|NCT01505608|412720|P2|COMPLETED|Phase I||2
169478|NCT01505608|412721|P1|COMPLETED|Phase I||0
169479|NCT01505608|412720|P2|STARTED|Phase I||8
169480|NCT01505608|412721|P1|STARTED|Phase I|Randomization to Arm A began in Phase 2. All patients in Phase I were enrolled to receive TPI 287.|0
169481|NCT01505530|412740|P3|NOT COMPLETED|Overall Study||41
169482|NCT01505530|412741|P2|NOT COMPLETED|Overall Study||43
169483|NCT01505530|412742|P1|NOT COMPLETED|Overall Study||41
169484|NCT01505530|412740|P3|COMPLETED|Overall Study||0
169485|NCT01505530|412741|P2|COMPLETED|Overall Study||0
169486|NCT01505530|412742|P1|COMPLETED|Overall Study||0
169487|NCT01505530|412740|P3|Completed One Cycle of Study Drug|Overall Study||31
169488|NCT01505530|412741|P2|Completed One Cycle of Study Drug|Overall Study||27
169489|NCT01505530|412742|P1|Completed One Cycle of Study Drug|Overall Study||29
169490|NCT01505530|412740|P3|Received At Least One Dose of Study Drug|Overall Study||41
169491|NCT01505530|412741|P2|Received At Least One Dose of Study Drug|Overall Study||42
169492|NCT01505530|412742|P1|Received At Least One Dose of Study Drug|Overall Study||41
169493|NCT01505530|412740|P3|STARTED|Overall Study||41
169494|NCT01505530|412741|P2|STARTED|Overall Study||43
169495|NCT01505530|412742|P1|STARTED|Overall Study||41
169496|NCT01505491|412786|P3|NOT COMPLETED|Overall Study||5
169497|NCT01505491|412787|P2|NOT COMPLETED|Overall Study||1
169498|NCT01505491|412788|P1|NOT COMPLETED|Overall Study||2
169499|NCT01505491|412786|P3|COMPLETED|Overall Study||59
169500|NCT01505491|412787|P2|COMPLETED|Overall Study||61
169501|NCT01505491|412788|P1|COMPLETED|Overall Study||65
169502|NCT01505491|412786|P3|STARTED|Overall Study||64
169503|NCT01505491|412787|P2|STARTED|Overall Study||62
169504|NCT01505491|412788|P1|STARTED|Overall Study||67
169505|NCT01505465|412810|P2|NOT COMPLETED|Overall Study||7
169506|NCT01505465|412811|P1|NOT COMPLETED|Overall Study||6
169507|NCT01505465|412810|P2|COMPLETED|Overall Study||18
169508|NCT01505465|412811|P1|COMPLETED|Overall Study||19
169509|NCT01505465|412810|P2|STARTED|Overall Study||25
169510|NCT01505465|412811|P1|STARTED|Overall Study||25
169511|NCT01505387|412827|P2|NOT COMPLETED|Overall Study||1
169512|NCT01505387|412828|P1|NOT COMPLETED|Overall Study||2
169513|NCT01505387|412827|P2|COMPLETED|Overall Study||24
169514|NCT01505387|412828|P1|COMPLETED|Overall Study|1 subject not included in intention to treat population as violated inclusion criteria|23
169515|NCT01505387|412827|P2|Treated|Overall Study||24
169516|NCT01505387|412828|P1|Treated|Overall Study||24
169517|NCT01505387|412827|P2|STARTED|Overall Study||25
169518|NCT01505387|412828|P1|STARTED|Overall Study||25
169519|NCT01505374|412834|P2|NOT COMPLETED|Overall Study||0
169520|NCT01505374|412835|P1|NOT COMPLETED|Overall Study||1
169521|NCT01505374|412834|P2|COMPLETED|Overall Study||30
169522|NCT01505374|412835|P1|COMPLETED|Overall Study||29
169523|NCT01505374|412834|P2|STARTED|Overall Study||30
169524|NCT01505374|412835|P1|STARTED|Overall Study||30
169525|NCT01505166|412852|P3|NOT COMPLETED|Overall Study||0
169526|NCT01505166|412853|P2|NOT COMPLETED|Overall Study||0
169527|NCT01505166|412854|P1|NOT COMPLETED|Overall Study||0
169528|NCT01505166|412852|P3|COMPLETED|Overall Study||0
169529|NCT01505166|412853|P2|COMPLETED|Overall Study||0
169530|NCT01505166|412854|P1|COMPLETED|Overall Study|"Completed means subject had successful Vigil manufacturing and had been given all the doses."|3
169531|NCT01505166|412852|P3|STARTED|Overall Study||0
169532|NCT01505166|412853|P2|STARTED|Overall Study||0
169533|NCT01505166|412854|P1|STARTED|Overall Study||3
169534|NCT01505114|412870|P4|NOT COMPLETED|Overall Study||23
169535|NCT01505114|412871|P3|NOT COMPLETED|Overall Study||18
169536|NCT01505114|412872|P2|NOT COMPLETED|Overall Study||13
169537|NCT01505114|412873|P1|NOT COMPLETED|Overall Study||25
169538|NCT01505114|412870|P4|COMPLETED|Overall Study||128
169539|NCT01505114|412871|P3|COMPLETED|Overall Study||129
169540|NCT01505114|412872|P2|COMPLETED|Overall Study||135
169541|NCT01505114|412873|P1|COMPLETED|Overall Study||123
169542|NCT01505114|412870|P4|STARTED|Overall Study||151
169543|NCT01505114|412871|P3|STARTED|Overall Study||147
169544|NCT01505114|412872|P2|STARTED|Overall Study||148
169545|NCT01505114|412873|P1|STARTED|Overall Study||148
169546|NCT01504997|412883|P1|NOT COMPLETED|Overall Study||0
169547|NCT01504997|412883|P1|COMPLETED|Overall Study||18
169548|NCT01504997|412883|P1|STARTED|Overall Study||18
169549|NCT01504971|412887|P1|NOT COMPLETED|Overall Study||13
169550|NCT01504971|412887|P1|COMPLETED|Overall Study||82
169551|NCT01504971|412887|P1|STARTED|Overall Study||95
169552|NCT01504958|412898|P3|NOT COMPLETED|Overall Study||0
169553|NCT01504958|412899|P2|NOT COMPLETED|Overall Study||0
169554|NCT01504958|412900|P1|NOT COMPLETED|Overall Study||0
169555|NCT01504958|412898|P3|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
169556|NCT01504958|412899|P2|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
169557|NCT01504958|412900|P1|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|10
169558|NCT01504958|412898|P3|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
169559|NCT01504958|412899|P2|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
169560|NCT01504958|412900|P1|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|10
169561|NCT01504867|412916|P2|NOT COMPLETED|Overall Study||3
169562|NCT01504867|412917|P1|NOT COMPLETED|Overall Study||7
169563|NCT01504867|412916|P2|COMPLETED|Overall Study||195
169564|NCT01504867|412917|P1|COMPLETED|Overall Study||195
169565|NCT01504867|412916|P2|STARTED|Overall Study||198
169566|NCT01504867|412917|P1|STARTED|Overall Study||202
169567|NCT01504854|412937|P2|NOT COMPLETED|Overall Study||7
169568|NCT01504854|412938|P1|NOT COMPLETED|Overall Study||8
169569|NCT01504854|412937|P2|COMPLETED|Overall Study||48
169570|NCT01504854|412938|P1|COMPLETED|Overall Study||56
169571|NCT01504854|412937|P2|STARTED|Overall Study||55
169572|NCT01504854|412938|P1|STARTED|Overall Study||64
169573|NCT01504841|412955|P3|NOT COMPLETED|Overall Study||0
169574|NCT01504841|412956|P2|NOT COMPLETED|Overall Study||4
169575|NCT01504841|412957|P1|NOT COMPLETED|Overall Study||16
169576|NCT01504841|412955|P3|COMPLETED|Overall Study||0
169577|NCT01504841|412956|P2|COMPLETED|Overall Study||2
169578|NCT01504841|412957|P1|COMPLETED|Overall Study||4
169579|NCT01504841|412955|P3|STARTED|Overall Study|No enrollments occurred into Cohort 3 during the study.|0
169580|NCT01504841|412956|P2|STARTED|Overall Study||6
169581|NCT01504841|412957|P1|STARTED|Overall Study||20
169582|NCT01504204|412992|P2|NOT COMPLETED|Overall Study||1
169583|NCT01504204|412993|P1|NOT COMPLETED|Overall Study||1
169584|NCT01504204|412992|P2|COMPLETED|Overall Study||9
169585|NCT01504204|412993|P1|COMPLETED|Overall Study||9
169586|NCT01504204|412992|P2|STARTED|Overall Study||10
169587|NCT01504204|412993|P1|STARTED|Overall Study||10
169588|NCT01503749|413006|P3|NOT COMPLETED|Overall Study||0
169589|NCT01503749|413007|P2|NOT COMPLETED|Overall Study||0
169590|NCT01503749|413008|P1|NOT COMPLETED|Overall Study||0
169591|NCT01503749|413006|P3|COMPLETED|Overall Study||3
169592|NCT01503749|413007|P2|COMPLETED|Overall Study||3
169593|NCT01503749|413008|P1|COMPLETED|Overall Study||3
169594|NCT01503749|413006|P3|STARTED|Overall Study||3
169595|NCT01503749|413007|P2|STARTED|Overall Study||3
169596|NCT01503749|413008|P1|STARTED|Overall Study||3
169597|NCT01503333|413021|P2|NOT COMPLETED|Overall Study||305
169598|NCT01503333|413022|P1|NOT COMPLETED|Overall Study||340
169599|NCT01503333|413021|P2|COMPLETED|Overall Study||461
169600|NCT01503333|413022|P1|COMPLETED|Overall Study||437
169601|NCT01503333|413021|P2|Completed Post-intervention|Overall Study||706
169602|NCT01503333|413022|P1|Completed Post-intervention|Overall Study||680
169603|NCT01503333|413021|P2|Completed Baseline|Overall Study||753
169604|NCT01503333|413022|P1|Completed Baseline|Overall Study||766
169605|NCT01503333|413021|P2|STARTED|Overall Study||766
169606|NCT01503333|413022|P1|STARTED|Overall Study||777
169607|NCT01503164|413050|P2|NOT COMPLETED|Overall Study||1
169608|NCT01503164|413051|P1|NOT COMPLETED|Overall Study||2
169609|NCT01503164|413050|P2|COMPLETED|Overall Study||55
169610|NCT01503164|413051|P1|COMPLETED|Overall Study||53
169611|NCT01503164|413050|P2|STARTED|Overall Study||56
169612|NCT01503164|413051|P1|STARTED|Overall Study||55
169613|NCT01503021|413081|P2|NOT COMPLETED|Overall Study||26
169614|NCT01503021|413082|P1|NOT COMPLETED|Overall Study||27
169615|NCT01503021|413081|P2|COMPLETED|Overall Study||332
169616|NCT01503021|413082|P1|COMPLETED|Overall Study||333
169617|NCT01503021|413081|P2|Completed Treatment|Overall Study|One patient completed the treatment period but discontinued prior to completing the follow-up visit.|333
169618|NCT01503021|413082|P1|Completed Treatment|Overall Study||333
169619|NCT01503021|413081|P2|Dosed|Overall Study||352
169620|NCT01503021|413082|P1|Dosed|Overall Study||351
169621|NCT01503021|413081|P2|STARTED|Overall Study||358
169622|NCT01503021|413082|P1|STARTED|Overall Study||360
169623|NCT01502956|413131|P2|NOT COMPLETED|Overall Study||26
169624|NCT01502956|413132|P1|NOT COMPLETED|Overall Study||24
169625|NCT01502956|413131|P2|COMPLETED|Overall Study||168
169626|NCT01502956|413132|P1|COMPLETED|Overall Study||168
169627|NCT01502956|413131|P2|STARTED|Overall Study||194
169628|NCT01502956|413132|P1|STARTED|Overall Study||192
169629|NCT01502787|413156|P2|NOT COMPLETED|Overall Study||0
169630|NCT01502787|413157|P1|NOT COMPLETED|Overall Study||0
169631|NCT01502787|413156|P2|COMPLETED|Overall Study||10
169632|NCT01502787|413157|P1|COMPLETED|Overall Study||11
169633|NCT01502787|413156|P2|STARTED|Overall Study||10
169634|NCT01502787|413157|P1|STARTED|Overall Study||11
169635|NCT01502761|413171|P4|NOT COMPLETED|Overall Study||0
169636|NCT01502761|413172|P3|NOT COMPLETED|Overall Study||0
169637|NCT01502761|413173|P2|NOT COMPLETED|Overall Study||0
169638|NCT01502761|413174|P1|NOT COMPLETED|Overall Study||0
169639|NCT01502761|413171|P4|COMPLETED|Overall Study||0
169640|NCT01502761|413172|P3|COMPLETED|Overall Study||0
169641|NCT01502761|413173|P2|COMPLETED|Overall Study||0
169642|NCT01502761|413174|P1|COMPLETED|Overall Study||4
169643|NCT01502761|413171|P4|STARTED|Overall Study||0
169644|NCT01502761|413172|P3|STARTED|Overall Study||0
169645|NCT01502761|413173|P2|STARTED|Overall Study||0
169646|NCT01502761|413174|P1|STARTED|Overall Study||4
169647|NCT01502709|413190|P2|NOT COMPLETED|Overall Study||0
169648|NCT01502709|413191|P1|NOT COMPLETED|Overall Study||4
169649|NCT01502709|413190|P2|COMPLETED|Overall Study||0
169650|NCT01502709|413191|P1|COMPLETED|Overall Study||1
169651|NCT01502709|413190|P2|STARTED|Overall Study||0
169652|NCT01502709|413191|P1|STARTED|Overall Study||5
169653|NCT01502644|413204|P4|NOT COMPLETED|Assigned to NA Groups||8
169654|NCT01502644|413205|P3|NOT COMPLETED|Assigned to NA Groups||3
169655|NCT01502644|413206|P2|NOT COMPLETED|Assigned to NA Groups||6
169656|NCT01502644|413207|P1|NOT COMPLETED|Assigned to NA Groups||0
169657|NCT01502644|413204|P4|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
169658|NCT01502644|413205|P3|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|7
169659|NCT01502644|413206|P2|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
169660|NCT01502644|413207|P1|COMPLETED|Assigned to NA Groups||0
169661|NCT01502644|413204|P4|STARTED|Assigned to NA Groups||32
169662|NCT01502644|413205|P3|STARTED|Assigned to NA Groups||10
169663|NCT01502644|413206|P2|STARTED|Assigned to NA Groups||30
169664|NCT01502644|413207|P1|STARTED|Assigned to NA Groups||0
169665|NCT01502644|413204|P4|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
169666|NCT01502644|413205|P3|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
169667|NCT01502644|413206|P2|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
169668|NCT01502644|413207|P1|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||9
169669|NCT01502644|413204|P4|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
169670|NCT01502644|413205|P3|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
169671|NCT01502644|413206|P2|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
169672|NCT01502644|413207|P1|COMPLETED|Enrolled at Visit 1 After Pre-screening|Participants who completed Visit 1 were assigned to 1 of the 3 NA groups for remainder of the trial|72
169673|NCT01502644|413204|P4|STARTED|Enrolled at Visit 1 After Pre-screening||0
169674|NCT01502644|413205|P3|STARTED|Enrolled at Visit 1 After Pre-screening||0
169675|NCT01502644|413206|P2|STARTED|Enrolled at Visit 1 After Pre-screening||0
169676|NCT01502644|413207|P1|STARTED|Enrolled at Visit 1 After Pre-screening||81
169677|NCT01502423|413217|P2|NOT COMPLETED|Overall Study||1
169678|NCT01502423|413218|P1|NOT COMPLETED|Overall Study||0
169679|NCT01502423|413217|P2|COMPLETED|Overall Study||29
169680|NCT01502423|413218|P1|COMPLETED|Overall Study||31
169681|NCT01502423|413217|P2|STARTED|Overall Study||30
169682|NCT01502423|413218|P1|STARTED|Overall Study||31
169683|NCT01502410|413240|P4|NOT COMPLETED|Overall Study||0
169684|NCT01502410|413241|P3|NOT COMPLETED|Overall Study||0
169685|NCT01502410|413242|P2|NOT COMPLETED|Overall Study||10
169686|NCT01502410|413243|P1|NOT COMPLETED|Overall Study||10
169687|NCT01502410|413240|P4|COMPLETED|Overall Study||0
169688|NCT01502410|413241|P3|COMPLETED|Overall Study||0
169689|NCT01502410|413242|P2|COMPLETED|Overall Study||0
169690|NCT01502410|413243|P1|COMPLETED|Overall Study||0
169691|NCT01502410|413240|P4|STARTED|Overall Study||0
169692|NCT01502410|413241|P3|STARTED|Overall Study||0
169693|NCT01502410|413242|P2|STARTED|Overall Study||10
169694|NCT01502410|413243|P1|STARTED|Overall Study||10
169695|NCT01502371|413261|P5|NOT COMPLETED|Overall Study||52
169696|NCT01502371|413262|P4|NOT COMPLETED|Overall Study||37
169697|NCT01502371|413263|P3|NOT COMPLETED|Overall Study||25
169698|NCT01502371|413264|P2|NOT COMPLETED|Overall Study||32
169699|NCT01502371|413265|P1|NOT COMPLETED|Overall Study||41
169700|NCT01502371|413261|P5|COMPLETED|Overall Study||60
169701|NCT01502371|413262|P4|COMPLETED|Overall Study||88
169702|NCT01502371|413263|P3|COMPLETED|Overall Study||83
169703|NCT01502371|413264|P2|COMPLETED|Overall Study||81
169704|NCT01502371|413265|P1|COMPLETED|Overall Study||79
169705|NCT01502371|413261|P5|STARTED|Overall Study||112
169706|NCT01502371|413262|P4|STARTED|Overall Study||125
169707|NCT01502371|413263|P3|STARTED|Overall Study||108
169708|NCT01502371|413264|P2|STARTED|Overall Study||113
169709|NCT01502371|413265|P1|STARTED|Overall Study||120
169710|NCT01502332|413290|P2|NOT COMPLETED|Overall Study||0
169711|NCT01502332|413291|P1|NOT COMPLETED|Overall Study||0
169712|NCT01502332|413290|P2|COMPLETED|Overall Study||163
169713|NCT01502332|413291|P1|COMPLETED|Overall Study||157
169714|NCT01502332|413290|P2|STARTED|Overall Study||163
169715|NCT01502332|413291|P1|STARTED|Overall Study||157
169716|NCT01502306|413308|P3|NOT COMPLETED|Overall Study||0
169717|NCT01502306|413309|P2|NOT COMPLETED|Overall Study||0
169718|NCT01502306|413310|P1|NOT COMPLETED|Overall Study||0
169719|NCT01502306|413308|P3|COMPLETED|Overall Study||1407
169720|NCT01502306|413309|P2|COMPLETED|Overall Study||1405
169721|NCT01502306|413310|P1|COMPLETED|Overall Study||1004
169722|NCT01502306|413308|P3|STARTED|Overall Study||1407
169723|NCT01502306|413309|P2|STARTED|Overall Study||1405
169724|NCT01502306|413310|P1|STARTED|Overall Study||1004
169725|NCT01502293|413330|P3|NOT COMPLETED|Overall Study||4
169726|NCT01502293|413331|P2|NOT COMPLETED|Overall Study||17
169727|NCT01502293|413332|P1|NOT COMPLETED|Overall Study||25
169728|NCT01502293|413330|P3|COMPLETED|Overall Study||0
169729|NCT01502293|413331|P2|COMPLETED|Overall Study||0
169730|NCT01502293|413332|P1|COMPLETED|Overall Study||5
169731|NCT01502293|413330|P3|STARTED|Overall Study||4
169732|NCT01502293|413331|P2|STARTED|Overall Study||17
169733|NCT01502293|413332|P1|STARTED|Overall Study||30
169734|NCT01502228|413361|P1|NOT COMPLETED|Overall Study||1
169735|NCT01502228|413361|P1|COMPLETED|Overall Study||13
169736|NCT01502228|413361|P1|STARTED|Overall Study||14
169737|NCT01502033|413366|P1|NOT COMPLETED|Overall Study||3
169738|NCT01502033|413366|P1|COMPLETED|Overall Study|Milestone (10 participants) met|7
169739|NCT01502033|413366|P1|STARTED|Overall Study|Milestone (10 participants) met.|10
169740|NCT01501955|413374|P2|NOT COMPLETED|Overall Study||3
169741|NCT01501955|413375|P1|NOT COMPLETED|Overall Study||2
169742|NCT01501955|413374|P2|COMPLETED|Overall Study||6
169743|NCT01501955|413375|P1|COMPLETED|Overall Study||9
169744|NCT01501955|413374|P2|2 Years Postop|Overall Study|1 patient terminated due to stem revision|6
169745|NCT01501955|413375|P1|2 Years Postop|Overall Study||9
169746|NCT01501955|413374|P2|1 Year Postop|Overall Study|2 patients terminated due to stem revision|7
169747|NCT01501955|413375|P1|1 Year Postop|Overall Study|1 patient terminated due to stem revision|9
169748|NCT01501955|413374|P2|6 Weeks Postop|Overall Study||9
169749|NCT01501955|413375|P1|6 Weeks Postop|Overall Study|1 patient withdrew on own request|10
169750|NCT01501955|413374|P2|Surgery|Overall Study||9
169751|NCT01501955|413375|P1|Surgery|Overall Study||11
169752|NCT01501955|413374|P2|STARTED|Overall Study||9
169753|NCT01501955|413375|P1|STARTED|Overall Study||11
169754|NCT01501929|413417|P2|NOT COMPLETED|Second Intervention||0
169755|NCT01501929|413418|P1|NOT COMPLETED|Second Intervention||0
169756|NCT01501929|413417|P2|COMPLETED|Second Intervention||17
169757|NCT01501929|413418|P1|COMPLETED|Second Intervention||8
169758|NCT01501929|413417|P2|STARTED|Second Intervention||17
169759|NCT01501929|413418|P1|STARTED|Second Intervention||8
169760|NCT01501929|413417|P2|NOT COMPLETED|First Intervention||0
169761|NCT01501929|413418|P1|NOT COMPLETED|First Intervention||0
169762|NCT01501929|413417|P2|COMPLETED|First Intervention||17
169763|NCT01501929|413418|P1|COMPLETED|First Intervention||8
169764|NCT01501929|413417|P2|STARTED|First Intervention||17
169765|NCT01501929|413418|P1|STARTED|First Intervention||8
169766|NCT01501162|413428|P2|NOT COMPLETED|Overall Study||5
169767|NCT01501162|413429|P1|NOT COMPLETED|Overall Study||8
169768|NCT01501162|413428|P2|COMPLETED|Overall Study||60
169769|NCT01501162|413429|P1|COMPLETED|Overall Study||57
169770|NCT01501162|413428|P2|STARTED|Overall Study||65
169771|NCT01501162|413429|P1|STARTED|Overall Study||65
169772|NCT01501110|413439|P2|NOT COMPLETED|Overall Study||1
169773|NCT01501110|413440|P1|NOT COMPLETED|Overall Study||0
169774|NCT01501110|413439|P2|COMPLETED|Overall Study||33
169775|NCT01501110|413440|P1|COMPLETED|Overall Study||34
169776|NCT01501110|413439|P2|STARTED|Overall Study||34
169777|NCT01501110|413440|P1|STARTED|Overall Study||34
169778|NCT01500772|413446|P1|NOT COMPLETED|Overall Study||6
169779|NCT01500772|413446|P1|COMPLETED|Overall Study||0
169780|NCT01500772|413446|P1|STARTED|Overall Study||6
169781|NCT01500746|413455|P2|NOT COMPLETED|Overall Study||0
169782|NCT01500746|413456|P1|NOT COMPLETED|Overall Study||0
169783|NCT01500746|413455|P2|COMPLETED|Overall Study||4
169784|NCT01500746|413456|P1|COMPLETED|Overall Study||4
169785|NCT01500746|413455|P2|STARTED|Overall Study||4
169786|NCT01500746|413456|P1|STARTED|Overall Study||4
169787|NCT01500733|413464|P2|NOT COMPLETED|Overall Study||3
169788|NCT01500733|413465|P1|NOT COMPLETED|Overall Study||2
169789|NCT01500733|413464|P2|COMPLETED|Overall Study||48
169790|NCT01500733|413465|P1|COMPLETED|Overall Study||33
169791|NCT01500733|413464|P2|STARTED|Overall Study||51
169792|NCT01500733|413465|P1|STARTED|Overall Study||35
169793|NCT01500720|413473|P2|NOT COMPLETED|Overall Study||9
169794|NCT01500720|413474|P1|NOT COMPLETED|Overall Study||5
169795|NCT01500720|413473|P2|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|80
169796|NCT01500720|413474|P1|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|85
169797|NCT01500720|413473|P2|Treated|Overall Study||88
169798|NCT01500720|413474|P1|Treated|Overall Study||89
169799|NCT01500720|413473|P2|STARTED|Overall Study|Randomized|89
169800|NCT01500720|413474|P1|STARTED|Overall Study|Randomized|90
169801|NCT01500694|413488|P2|NOT COMPLETED|Overall Study||29
169802|NCT01500694|413489|P1|NOT COMPLETED|Overall Study||52
169803|NCT01500694|413488|P2|COMPLETED|Overall Study||54
169804|NCT01500694|413489|P1|COMPLETED|Overall Study||79
169805|NCT01500694|413488|P2|STARTED|Overall Study|Participants who received treatment were reported as Started.|83
169806|NCT01500694|413489|P1|STARTED|Overall Study||131
169807|NCT01500629|413515|P2|NOT COMPLETED|Period 2 (Single Dose)||0
169808|NCT01500629|413516|P1|NOT COMPLETED|Period 2 (Single Dose)||0
169809|NCT01500629|413515|P2|COMPLETED|Period 2 (Single Dose)||10
169810|NCT01500629|413516|P1|COMPLETED|Period 2 (Single Dose)||10
169811|NCT01500629|413515|P2|STARTED|Period 2 (Single Dose)||10
169812|NCT01500629|413516|P1|STARTED|Period 2 (Single Dose)||10
169813|NCT01500629|413515|P2|NOT COMPLETED|Washout Period of 14 to 30 Days||0
169814|NCT01500629|413516|P1|NOT COMPLETED|Washout Period of 14 to 30 Days||1
169815|NCT01500629|413515|P2|COMPLETED|Washout Period of 14 to 30 Days||10
169816|NCT01500629|413516|P1|COMPLETED|Washout Period of 14 to 30 Days||10
169817|NCT01500629|413515|P2|STARTED|Washout Period of 14 to 30 Days||10
169818|NCT01500629|413516|P1|STARTED|Washout Period of 14 to 30 Days||11
169819|NCT01500629|413515|P2|NOT COMPLETED|Period 1 (Single Dose)||0
169820|NCT01500629|413516|P1|NOT COMPLETED|Period 1 (Single Dose)||0
169821|NCT01500629|413515|P2|COMPLETED|Period 1 (Single Dose)||10
169822|NCT01500629|413516|P1|COMPLETED|Period 1 (Single Dose)||11
169823|NCT01500629|413515|P2|STARTED|Period 1 (Single Dose)||10
169824|NCT01500629|413516|P1|STARTED|Period 1 (Single Dose)||11
169825|NCT01500434|413600|P1|NOT COMPLETED|Overall Study||7
169826|NCT01500434|413600|P1|COMPLETED|Overall Study||95
169827|NCT01500434|413600|P1|STARTED|Overall Study||102
169828|NCT01500382|413633|P4|NOT COMPLETED|Treatment Period 2||0
169829|NCT01500382|413634|P3|NOT COMPLETED|Treatment Period 2||0
169830|NCT01500382|413635|P2|NOT COMPLETED|Treatment Period 2||0
169831|NCT01500382|413636|P1|NOT COMPLETED|Treatment Period 2||0
169832|NCT01500382|413633|P4|COMPLETED|Treatment Period 2||1
169833|NCT01500382|413634|P3|COMPLETED|Treatment Period 2||0
169834|NCT01500382|413635|P2|COMPLETED|Treatment Period 2||1
169835|NCT01500382|413636|P1|COMPLETED|Treatment Period 2||1
169836|NCT01500382|413633|P4|STARTED|Treatment Period 2||1
169837|NCT01500382|413634|P3|STARTED|Treatment Period 2||0
169838|NCT01500382|413635|P2|STARTED|Treatment Period 2||1
169839|NCT01500382|413636|P1|STARTED|Treatment Period 2||1
169840|NCT01500382|413633|P4|NOT COMPLETED|Washout Period||0
169841|NCT01500382|413634|P3|NOT COMPLETED|Washout Period||1
169842|NCT01500382|413635|P2|NOT COMPLETED|Washout Period||0
169843|NCT01500382|413636|P1|NOT COMPLETED|Washout Period||0
169844|NCT01500382|413633|P4|COMPLETED|Washout Period||1
169845|NCT01500382|413634|P3|COMPLETED|Washout Period||0
169846|NCT01500382|413635|P2|COMPLETED|Washout Period||1
169847|NCT01500382|413636|P1|COMPLETED|Washout Period||1
169848|NCT01500382|413633|P4|STARTED|Washout Period||1
169849|NCT01500382|413634|P3|STARTED|Washout Period||1
169850|NCT01500382|413635|P2|STARTED|Washout Period||1
169851|NCT01500382|413636|P1|STARTED|Washout Period||1
169852|NCT01500382|413633|P4|NOT COMPLETED|Treatment Period 1||0
169853|NCT01500382|413634|P3|NOT COMPLETED|Treatment Period 1||0
169854|NCT01500382|413635|P2|NOT COMPLETED|Treatment Period 1||0
169855|NCT01500382|413636|P1|NOT COMPLETED|Treatment Period 1||0
169856|NCT01500382|413633|P4|COMPLETED|Treatment Period 1||1
169857|NCT01500382|413634|P3|COMPLETED|Treatment Period 1||1
169858|NCT01500382|413635|P2|COMPLETED|Treatment Period 1||1
169859|NCT01500382|413636|P1|COMPLETED|Treatment Period 1||1
169860|NCT01500382|413633|P4|STARTED|Treatment Period 1||1
169861|NCT01500382|413634|P3|STARTED|Treatment Period 1||1
169862|NCT01500382|413635|P2|STARTED|Treatment Period 1||1
169863|NCT01500382|413636|P1|STARTED|Treatment Period 1||1
169864|NCT01500317|413661|P3|NOT COMPLETED|Overall Study||0
169865|NCT01500317|413662|P2|NOT COMPLETED|Overall Study||2
169866|NCT01500317|413663|P1|NOT COMPLETED|Overall Study||3
169867|NCT01500317|413661|P3|COMPLETED|Overall Study||13
169868|NCT01500317|413662|P2|COMPLETED|Overall Study||10
169869|NCT01500317|413663|P1|COMPLETED|Overall Study||10
169870|NCT01500317|413661|P3|STARTED|Overall Study||13
169871|NCT01500317|413662|P2|STARTED|Overall Study||12
169872|NCT01500317|413663|P1|STARTED|Overall Study||13
169873|NCT01500278|413685|P2|NOT COMPLETED|Week 13 - Week 104||126
169874|NCT01500278|413686|P1|NOT COMPLETED|Week 13 - Week 104||139
169875|NCT01500278|413685|P2|COMPLETED|Week 13 - Week 104||302
169876|NCT01500278|413686|P1|COMPLETED|Week 13 - Week 104||287
169877|NCT01500278|413685|P2|STARTED|Week 13 - Week 104||428
169878|NCT01500278|413686|P1|STARTED|Week 13 - Week 104||426
169879|NCT01500278|413685|P2|NOT COMPLETED|Week 0 - Week 12||30
169880|NCT01500278|413686|P1|NOT COMPLETED|Week 0 - Week 12||31
169881|NCT01500278|413685|P2|COMPLETED|Week 0 - Week 12||428
169882|NCT01500278|413686|P1|COMPLETED|Week 0 - Week 12||426
169883|NCT01500278|413685|P2|STARTED|Week 0 - Week 12||458
169884|NCT01500278|413686|P1|STARTED|Week 0 - Week 12||457
169885|NCT01500252|413710|P2|NOT COMPLETED|Overall Study||6
169886|NCT01500252|413711|P1|NOT COMPLETED|Overall Study||9
169887|NCT01500252|413710|P2|COMPLETED|Overall Study|2 participant deceased by 5 years; no further deaths between 5 & 10 years for a total of 2 deaths|11
169888|NCT01500252|413711|P1|COMPLETED|Overall Study|2 participants died within 5 years; 2 participants died between 5 & 10 years for a total of 4 deaths|12
169889|NCT01500252|413710|P2|Ten Years|Overall Study||11
169890|NCT01500252|413711|P1|Ten Years|Overall Study||12
169891|NCT01500252|413710|P2|Five Years|Overall Study||13
169892|NCT01500252|413711|P1|Five Years|Overall Study||17
169893|NCT01500252|413710|P2|One Years|Overall Study||16
169894|NCT01500252|413711|P1|One Years|Overall Study||20
169895|NCT01500252|413710|P2|STARTED|Overall Study||17
169896|NCT01500252|413711|P1|STARTED|Overall Study||21
169897|NCT01500226|413737|P2|NOT COMPLETED|Overall Study||494
169898|NCT01500226|413738|P1|NOT COMPLETED|Overall Study||499
169899|NCT01500226|413737|P2|COMPLETED|Overall Study||191
169900|NCT01500226|413738|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|185
169901|NCT01500226|413737|P2|STARTED|Overall Study||685
169902|NCT01500226|413738|P1|STARTED|Overall Study|Number of randomized patients|684
169903|NCT01500213|413750|P2|NOT COMPLETED|Overall Study||224
169904|NCT01500213|413751|P1|NOT COMPLETED|Overall Study||217
169905|NCT01500213|413750|P2|COMPLETED|Overall Study||53
169906|NCT01500213|413751|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|61
169907|NCT01500213|413750|P2|STARTED|Overall Study||277
169908|NCT01500213|413751|P1|STARTED|Overall Study|Number of randomized patients|278
169909|NCT01500200|413764|P6|NOT COMPLETED|Stage 2||4
169910|NCT01500200|413765|P5|NOT COMPLETED|Stage 2||5
169911|NCT01500200|413766|P4|NOT COMPLETED|Stage 2||0
169912|NCT01500200|413767|P3|NOT COMPLETED|Stage 2||0
169913|NCT01500200|413768|P2|NOT COMPLETED|Stage 2||0
169914|NCT01500200|413769|P1|NOT COMPLETED|Stage 2||0
169915|NCT01500200|413764|P6|COMPLETED|Stage 2||18
169916|NCT01500200|413765|P5|COMPLETED|Stage 2||18
169917|NCT01500200|413766|P4|COMPLETED|Stage 2||20
169918|NCT01500200|413767|P3|COMPLETED|Stage 2||0
169919|NCT01500200|413768|P2|COMPLETED|Stage 2||0
169920|NCT01500200|413769|P1|COMPLETED|Stage 2||0
169921|NCT01500200|413764|P6|STARTED|Stage 2||22
169922|NCT01500200|413765|P5|STARTED|Stage 2||23
169923|NCT01500200|413766|P4|STARTED|Stage 2||20
169924|NCT01500200|413767|P3|STARTED|Stage 2||0
169925|NCT01500200|413768|P2|STARTED|Stage 2||0
169926|NCT01500200|413769|P1|STARTED|Stage 2||0
169927|NCT01500200|413764|P6|NOT COMPLETED|Stage 1||0
169928|NCT01500200|413765|P5|NOT COMPLETED|Stage 1||0
169929|NCT01500200|413766|P4|NOT COMPLETED|Stage 1||0
169930|NCT01500200|413767|P3|NOT COMPLETED|Stage 1||6
169931|NCT01500200|413768|P2|NOT COMPLETED|Stage 1||6
169932|NCT01500200|413769|P1|NOT COMPLETED|Stage 1||8
169933|NCT01500200|413764|P6|COMPLETED|Stage 1||0
169934|NCT01500200|413765|P5|COMPLETED|Stage 1||0
169935|NCT01500200|413766|P4|COMPLETED|Stage 1||0
169936|NCT01500200|413767|P3|COMPLETED|Stage 1||13
169937|NCT01500200|413768|P2|COMPLETED|Stage 1||18
169938|NCT01500200|413769|P1|COMPLETED|Stage 1||90
169939|NCT01500200|413764|P6|STARTED|Stage 1||0
169940|NCT01500200|413765|P5|STARTED|Stage 1||0
169941|NCT01500200|413766|P4|STARTED|Stage 1||0
169942|NCT01500200|413767|P3|STARTED|Stage 1||19
169943|NCT01500200|413768|P2|STARTED|Stage 1||24
169944|NCT01500200|413769|P1|STARTED|Stage 1||98
169945|NCT01500187|413803|P2|NOT COMPLETED|Overall Study||0
169946|NCT01500187|413804|P1|NOT COMPLETED|Overall Study||6
169947|NCT01500187|413803|P2|COMPLETED|Overall Study||15
169948|NCT01500187|413804|P1|COMPLETED|Overall Study||17
169949|NCT01500187|413803|P2|STARTED|Overall Study||15
169950|NCT01500187|413804|P1|STARTED|Overall Study||23
169951|NCT01500135|413812|P2|NOT COMPLETED|Overall Study||11
169952|NCT01500135|413813|P1|NOT COMPLETED|Overall Study||17
169953|NCT01500135|413812|P2|COMPLETED|Overall Study||39
169954|NCT01500135|413813|P1|COMPLETED|Overall Study||83
169955|NCT01500135|413812|P2|STARTED|Overall Study||50
169956|NCT01500135|413813|P1|STARTED|Overall Study||100
169957|NCT01500109|413826|P3|NOT COMPLETED|Overall Study||0
169958|NCT01500109|413827|P2|NOT COMPLETED|Overall Study||0
169959|NCT01500109|413828|P1|NOT COMPLETED|Overall Study||0
169960|NCT01500109|413826|P3|COMPLETED|Overall Study||16
169961|NCT01500109|413827|P2|COMPLETED|Overall Study||14
169962|NCT01500109|413828|P1|COMPLETED|Overall Study||15
169963|NCT01500109|413826|P3|STARTED|Overall Study||16
169964|NCT01500109|413827|P2|STARTED|Overall Study||14
169965|NCT01500109|413828|P1|STARTED|Overall Study||15
169966|NCT01500096|413840|P4|NOT COMPLETED|Overall Study||2
169967|NCT01500096|413841|P3|NOT COMPLETED|Overall Study||0
169968|NCT01500096|413842|P2|NOT COMPLETED|Overall Study||0
169969|NCT01500096|413843|P1|NOT COMPLETED|Overall Study||1
169970|NCT01500096|413840|P4|COMPLETED|Overall Study||14
169971|NCT01500096|413841|P3|COMPLETED|Overall Study||31
169972|NCT01500096|413842|P2|COMPLETED|Overall Study||17
169973|NCT01500096|413843|P1|COMPLETED|Overall Study||31
169974|NCT01500096|413840|P4|STARTED|Overall Study||16
169975|NCT01500096|413841|P3|STARTED|Overall Study||31
169976|NCT01500096|413842|P2|STARTED|Overall Study||17
169977|NCT01500096|413843|P1|STARTED|Overall Study||32
169978|NCT01500083|413899|P2|NOT COMPLETED|Overall Study||43
169979|NCT01500083|413900|P1|NOT COMPLETED|Overall Study||12
169980|NCT01500083|413899|P2|COMPLETED|Overall Study||31
169981|NCT01500083|413900|P1|COMPLETED|Overall Study||4
169982|NCT01500083|413899|P2|STARTED|Overall Study||74
169983|NCT01500083|413900|P1|STARTED|Overall Study||16
169984|NCT01500057|413908|P2|NOT COMPLETED|Overall Study||4
169985|NCT01500057|413909|P1|NOT COMPLETED|Overall Study||6
169986|NCT01500057|413908|P2|COMPLETED|Overall Study||31
169987|NCT01500057|413909|P1|COMPLETED|Overall Study||25
169988|NCT01500057|413908|P2|STARTED|Overall Study||35
169989|NCT01500057|413909|P1|STARTED|Overall Study||31
169990|NCT01500031|413919|P1|NOT COMPLETED|Overall Study||5
169991|NCT01500031|413919|P1|COMPLETED|Overall Study||87
169992|NCT01500031|413919|P1|STARTED|Overall Study||92
169993|NCT01499862|413934|P1|NOT COMPLETED|Overall Study||0
169994|NCT01499862|413934|P1|COMPLETED|Overall Study||3
169995|NCT01499862|413934|P1|STARTED|Overall Study||3
169996|NCT01499849|413954|P2|NOT COMPLETED|Overall Study||226
169997|NCT01499849|413955|P1|NOT COMPLETED|Overall Study||224
169998|NCT01499849|413954|P2|COMPLETED|Overall Study||40
169999|NCT01499849|413955|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|42
170000|NCT01499849|413954|P2|STARTED|Overall Study||266
170001|NCT01499849|413955|P1|STARTED|Overall Study|Number of randomized patients|266
170002|NCT01499810|413965|P1|NOT COMPLETED|Overall Study||12
170003|NCT01499810|413965|P1|COMPLETED|Overall Study||41
170004|NCT01499810|413965|P1|STARTED|Overall Study||53
170005|NCT01499667|414015|P3|NOT COMPLETED|Overall Study||10
170006|NCT01499667|414016|P2|NOT COMPLETED|Overall Study||11
170007|NCT01499667|414017|P1|NOT COMPLETED|Overall Study||9
170008|NCT01499667|414015|P3|COMPLETED|Overall Study||40
170009|NCT01499667|414016|P2|COMPLETED|Overall Study||31
170010|NCT01499667|414017|P1|COMPLETED|Overall Study||41
170011|NCT01499667|414015|P3|Modified Full Analysis Set|Overall Study||39
170012|NCT01499667|414016|P2|Modified Full Analysis Set|Overall Study||29
170013|NCT01499667|414017|P1|Modified Full Analysis Set|Overall Study|mFAS included all FAS patients who completed 8 wks of fingolimod treatment with MRI scan|41
170014|NCT01499667|414015|P3|Full Analysis Set (FAS)|Overall Study||50
170015|NCT01499667|414016|P2|Full Analysis Set (FAS)|Overall Study||42
170016|NCT01499667|414017|P1|Full Analysis Set (FAS)|Overall Study|One randomized patient did not receive natalizumub at screening, which was a requirement for FAS.|49
170017|NCT01499667|414015|P3|STARTED|Overall Study||50
170018|NCT01499667|414016|P2|STARTED|Overall Study||42
170019|NCT01499667|414017|P1|STARTED|Overall Study|Started” indicates randomized as well as safety population.|50
170020|NCT01499654|414046|P1|NOT COMPLETED|Overall Study||0
170021|NCT01499654|414046|P1|COMPLETED|Overall Study||64
170022|NCT01499654|414046|P1|STARTED|Overall Study||64
170023|NCT01499576|414065|P1|NOT COMPLETED|Overall Study||21
170024|NCT01499576|414065|P1|COMPLETED|Overall Study||105
170025|NCT01499576|414065|P1|STARTED|Overall Study||126
170026|NCT01499498|414071|P1|NOT COMPLETED|Overall Study||0
170027|NCT01499498|414071|P1|COMPLETED|Overall Study||13
170028|NCT01499498|414071|P1|STARTED|Overall Study||13
170029|NCT01499355|414079|P4|NOT COMPLETED|Double-Blind Period||23
170030|NCT01499355|414080|P3|NOT COMPLETED|Double-Blind Period||25
170031|NCT01499355|414081|P2|NOT COMPLETED|Double-Blind Period||23
170032|NCT01499355|414082|P1|NOT COMPLETED|Double-Blind Period||0
170033|NCT01499355|414079|P4|COMPLETED|Double-Blind Period||39
170034|NCT01499355|414080|P3|COMPLETED|Double-Blind Period||38
170035|NCT01499355|414081|P2|COMPLETED|Double-Blind Period||40
170036|NCT01499355|414082|P1|COMPLETED|Double-Blind Period||0
170037|NCT01499355|414079|P4|STARTED|Double-Blind Period||62
170038|NCT01499355|414080|P3|STARTED|Double-Blind Period||63
170039|NCT01499355|414081|P2|STARTED|Double-Blind Period||63
170040|NCT01499355|414082|P1|STARTED|Double-Blind Period||0
170041|NCT01499355|414079|P4|NOT COMPLETED|Run-In Period||0
170042|NCT01499355|414080|P3|NOT COMPLETED|Run-In Period||0
170043|NCT01499355|414081|P2|NOT COMPLETED|Run-In Period||0
170044|NCT01499355|414082|P1|NOT COMPLETED|Run-In Period||31
170045|NCT01499355|414079|P4|COMPLETED|Run-In Period||0
170046|NCT01499355|414080|P3|COMPLETED|Run-In Period||0
170047|NCT01499355|414081|P2|COMPLETED|Run-In Period||0
170048|NCT01499355|414082|P1|COMPLETED|Run-In Period||245
170049|NCT01499355|414079|P4|STARTED|Run-In Period||0
170050|NCT01499355|414080|P3|STARTED|Run-In Period||0
170051|NCT01499355|414081|P2|STARTED|Run-In Period||0
170052|NCT01499355|414082|P1|STARTED|Run-In Period||276
170053|NCT01499303|414115|P2|NOT COMPLETED|Overall Study||7
170054|NCT01499303|414116|P1|NOT COMPLETED|Overall Study||3
170055|NCT01499303|414115|P2|COMPLETED|Overall Study||40
170056|NCT01499303|414116|P1|COMPLETED|Overall Study||18
170057|NCT01499303|414115|P2|STARTED|Overall Study||47
170058|NCT01499303|414116|P1|STARTED|Overall Study||21
170059|NCT01499290|414124|P2|NOT COMPLETED|Overall Study||35
170060|NCT01499290|414125|P1|NOT COMPLETED|Overall Study||55
170061|NCT01499290|414124|P2|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|494
170062|NCT01499290|414125|P1|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|474
170063|NCT01499290|414124|P2|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
170064|NCT01499290|414125|P1|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
170065|NCT01499277|414175|P2|NOT COMPLETED|Overall Study||32
170066|NCT01499277|414176|P1|NOT COMPLETED|Overall Study||47
170067|NCT01499277|414175|P2|COMPLETED|Overall Study||223
170068|NCT01499277|414176|P1|COMPLETED|Overall Study||459
170069|NCT01499277|414175|P2|STARTED|Overall Study||255
170070|NCT01499277|414176|P1|STARTED|Overall Study||506
170071|NCT01499199|414198|P1|NOT COMPLETED|Overall Study||2
170072|NCT01499199|414198|P1|COMPLETED|Overall Study||11
170073|NCT01499199|414198|P1|STARTED|Overall Study||13
170074|NCT01499173|414217|P1|NOT COMPLETED|Overall Study||37
170075|NCT01499173|414217|P1|COMPLETED|Overall Study||64
170076|NCT01499173|414217|P1|STARTED|Overall Study||101
170077|NCT01499160|414227|P1|NOT COMPLETED|Overall Study||2
170078|NCT01499160|414227|P1|COMPLETED|Overall Study|"1 pt-withdrew consent~1pt-had cardiac toxicity"|5
170079|NCT01499160|414227|P1|STARTED|Overall Study||7
170080|NCT01499147|414234|P2|NOT COMPLETED|Overall Study||5
170081|NCT01499147|414235|P1|NOT COMPLETED|Overall Study||15
170082|NCT01499147|414234|P2|COMPLETED|Overall Study||12
170083|NCT01499147|414235|P1|COMPLETED|Overall Study||18
170084|NCT01499147|414234|P2|STARTED|Overall Study||17
170085|NCT01499147|414235|P1|STARTED|Overall Study||33
170086|NCT01499134|414250|P2|NOT COMPLETED|Overall Study||1
170087|NCT01499134|414251|P1|NOT COMPLETED|Overall Study||0
170088|NCT01499134|414250|P2|COMPLETED|Overall Study||7
170089|NCT01499134|414251|P1|COMPLETED|Overall Study||9
170090|NCT01499134|414250|P2|STARTED|Overall Study||8
170091|NCT01499134|414251|P1|STARTED|Overall Study||9
170092|NCT01499095|414273|P2|NOT COMPLETED|Overall Study||93
170093|NCT01499095|414274|P1|NOT COMPLETED|Overall Study||89
170094|NCT01499095|414273|P2|COMPLETED|Overall Study||314
170095|NCT01499095|414274|P1|COMPLETED|Overall Study||315
170096|NCT01499095|414273|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|405
170097|NCT01499095|414274|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|403
170098|NCT01499095|414273|P2|Participated in Substudy|Overall Study||0
170099|NCT01499095|414274|P1|Participated in Substudy|Overall Study|45 participants received adaptable dosing regimen and 44 participants received fixed dosing regimen|89
170100|NCT01499095|414273|P2|Treated|Overall Study||406
170101|NCT01499095|414274|P1|Treated|Overall Study||403
170102|NCT01499095|414273|P2|STARTED|Overall Study||407
170103|NCT01499095|414274|P1|STARTED|Overall Study||404
170104|NCT01499082|414304|P2|NOT COMPLETED|Overall Study||48
170105|NCT01499082|414305|P1|NOT COMPLETED|Overall Study||45
170106|NCT01499082|414304|P2|COMPLETED|Overall Study||355
170107|NCT01499082|414305|P1|COMPLETED|Overall Study||359
170108|NCT01499082|414304|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|400
170109|NCT01499082|414305|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|404
170110|NCT01499082|414304|P2|Participated in Substudy|Overall Study||0
170111|NCT01499082|414305|P1|Participated in Substudy|Overall Study|56 participants received adaptable dosing regimen and 53 participants received fixed dosing regimen|109
170112|NCT01499082|414304|P2|Treated|Overall Study||402
170113|NCT01499082|414305|P1|Treated|Overall Study||404
170114|NCT01499082|414304|P2|STARTED|Overall Study||403
170115|NCT01499082|414305|P1|STARTED|Overall Study||404
170116|NCT01499043|414333|P1|NOT COMPLETED|Overall Study||6
170117|NCT01499043|414333|P1|COMPLETED|Overall Study||0
170118|NCT01499043|414333|P1|STARTED|Overall Study||6
170119|NCT01498991|414343|P1|NOT COMPLETED|Overall Study||0
170120|NCT01498991|414343|P1|COMPLETED|Overall Study||2
170121|NCT01498991|414343|P1|STARTED|Overall Study||2
170122|NCT01498978|414354|P1|NOT COMPLETED|Overall Study||2
170123|NCT01498978|414354|P1|COMPLETED|Overall Study||8
170124|NCT01498978|414354|P1|STARTED|Overall Study||10
170125|NCT01498952|414376|P5|NOT COMPLETED|Overall Study||0
170126|NCT01498952|414377|P4|NOT COMPLETED|Overall Study||0
170127|NCT01498952|414378|P3|NOT COMPLETED|Overall Study||0
170128|NCT01498952|414379|P2|NOT COMPLETED|Overall Study||2
170129|NCT01498952|414380|P1|NOT COMPLETED|Overall Study||2
170130|NCT01498952|414376|P5|COMPLETED|Overall Study||0
170131|NCT01498952|414377|P4|COMPLETED|Overall Study||0
170132|NCT01498952|414378|P3|COMPLETED|Overall Study||0
170133|NCT01498952|414379|P2|COMPLETED|Overall Study||1
170134|NCT01498952|414380|P1|COMPLETED|Overall Study||1
170135|NCT01498952|414376|P5|STARTED|Overall Study||0
170136|NCT01498952|414377|P4|STARTED|Overall Study||0
170137|NCT01498952|414378|P3|STARTED|Overall Study||0
170138|NCT01498952|414379|P2|STARTED|Overall Study||3
170139|NCT01498952|414380|P1|STARTED|Overall Study||3
170140|NCT01498887|414422|P2|NOT COMPLETED|Overall Study||11
170141|NCT01498887|414423|P1|NOT COMPLETED|Overall Study||16
170142|NCT01498887|414422|P2|COMPLETED|Overall Study||136
170143|NCT01498887|414423|P1|COMPLETED|Overall Study||184
170144|NCT01498887|414422|P2|Intent-to-treat|Overall Study||135
170145|NCT01498887|414423|P1|Intent-to-treat|Overall Study||185
170146|NCT01498887|414422|P2|Safety Set|Overall Study||147
170147|NCT01498887|414423|P1|Safety Set|Overall Study||200
170148|NCT01498887|414422|P2|STARTED|Overall Study||147
170149|NCT01498887|414423|P1|STARTED|Overall Study||200
170150|NCT01498822|414444|P2|NOT COMPLETED|Overall Study||56
170151|NCT01498822|414445|P1|NOT COMPLETED|Overall Study||54
170152|NCT01498822|414444|P2|COMPLETED|Overall Study||122
170153|NCT01498822|414445|P1|COMPLETED|Overall Study||121
170154|NCT01498822|414444|P2|STARTED|Overall Study||178
170155|NCT01498822|414445|P1|STARTED|Overall Study||175
170156|NCT01498744|414459|P2|NOT COMPLETED|Overall Study||0
170157|NCT01498744|414460|P1|NOT COMPLETED|Overall Study||0
170158|NCT01498744|414459|P2|COMPLETED|Overall Study||31
170159|NCT01498744|414460|P1|COMPLETED|Overall Study||22
170160|NCT01498744|414459|P2|STARTED|Overall Study||31
170161|NCT01498744|414460|P1|STARTED|Overall Study||22
170162|NCT01498692|414472|P1|NOT COMPLETED|Overall Study||8
170163|NCT01498692|414472|P1|COMPLETED|Overall Study||86
170164|NCT01498692|414472|P1|STARTED|Overall Study||94
170165|NCT01498679|414503|P2|NOT COMPLETED|Overall Study||22
170166|NCT01498679|414504|P1|NOT COMPLETED|Overall Study||89
170167|NCT01498679|414503|P2|COMPLETED|Overall Study||131
170168|NCT01498679|414504|P1|COMPLETED|Overall Study||65
170169|NCT01498679|414503|P2|STARTED|Overall Study||153
170170|NCT01498679|414504|P1|STARTED|Overall Study||154
170171|NCT01498653|414520|P2|NOT COMPLETED|Overall Study||35
170172|NCT01498653|414521|P1|NOT COMPLETED|Overall Study||19
170173|NCT01498653|414520|P2|COMPLETED|Overall Study||119
170174|NCT01498653|414521|P1|COMPLETED|Overall Study||136
170175|NCT01498653|414520|P2|STARTED|Overall Study||154
170176|NCT01498653|414521|P1|STARTED|Overall Study||155
170177|NCT01498640|414535|P1|NOT COMPLETED|Overall Study||5
170178|NCT01498640|414535|P1|COMPLETED|Overall Study||47
170179|NCT01498640|414535|P1|STARTED|Overall Study||52
170180|NCT01498601|414551|P2|NOT COMPLETED|Overall Study||0
170181|NCT01498601|414552|P1|NOT COMPLETED|Overall Study||0
170182|NCT01498601|414551|P2|COMPLETED|Overall Study||32
170183|NCT01498601|414552|P1|COMPLETED|Overall Study||51
170184|NCT01498601|414551|P2|STARTED|Overall Study||32
170185|NCT01498601|414552|P1|STARTED|Overall Study||51
170186|NCT01498588|414558|P1|NOT COMPLETED|Overall Study||0
170187|NCT01498588|414558|P1|COMPLETED|Overall Study||7
170188|NCT01498588|414558|P1|STARTED|Overall Study||7
170189|NCT01498575|414565|P2|NOT COMPLETED|On the Road Driving Assessment (ODA)||24
170190|NCT01498575|414566|P1|NOT COMPLETED|On the Road Driving Assessment (ODA)||42
170191|NCT01498575|414565|P2|COMPLETED|On the Road Driving Assessment (ODA)||65
170192|NCT01498575|414566|P1|COMPLETED|On the Road Driving Assessment (ODA)||86
170193|NCT01498575|414565|P2|STARTED|On the Road Driving Assessment (ODA)||89
170194|NCT01498575|414566|P1|STARTED|On the Road Driving Assessment (ODA)||128
170195|NCT01498575|414565|P2|NOT COMPLETED|Overall Sample||14
170196|NCT01498575|414566|P1|NOT COMPLETED|Overall Sample||60
170197|NCT01498575|414565|P2|COMPLETED|Overall Sample||400
170198|NCT01498575|414566|P1|COMPLETED|Overall Sample||550
170199|NCT01498575|414565|P2|STARTED|Overall Sample||414
170200|NCT01498575|414566|P1|STARTED|Overall Sample||610
170201|NCT01498549|414572|P1|NOT COMPLETED|Overall Study||4
170202|NCT01498549|414572|P1|COMPLETED|Overall Study||35
170203|NCT01498549|414572|P1|Sugar Pill 0 mg|Overall Study||36
170204|NCT01498549|414572|P1|Atomoxetine 80 mg|Overall Study||37
170205|NCT01498549|414572|P1|Atomoxetine 40 mg|Overall Study||39
170206|NCT01498549|414572|P1|STARTED|Overall Study||39
170207|NCT01498458|414583|P1|NOT COMPLETED|Overall Study||7
170208|NCT01498458|414583|P1|COMPLETED|Overall Study|only 1 patient was in the study at the end. 7 left due to Adverse Events or Investigators Decision.|1
170209|NCT01498458|414583|P1|STARTED|Overall Study|9 patients took part in the study of which 8 received pazopanib.|8
170210|NCT01498419|414596|P4|NOT COMPLETED|Overall Study||19
170211|NCT01498419|414597|P3|NOT COMPLETED|Overall Study||18
170212|NCT01498419|414598|P2|NOT COMPLETED|Overall Study||23
170213|NCT01498419|414599|P1|NOT COMPLETED|Overall Study||18
170214|NCT01498419|414596|P4|COMPLETED|Overall Study||7
170215|NCT01498419|414597|P3|COMPLETED|Overall Study||41
170216|NCT01498419|414598|P2|COMPLETED|Overall Study||39
170217|NCT01498419|414599|P1|COMPLETED|Overall Study||42
170218|NCT01498419|414596|P4|STARTED|Overall Study||26
170219|NCT01498419|414597|P3|STARTED|Overall Study||59
170220|NCT01498419|414598|P2|STARTED|Overall Study||62
170221|NCT01498419|414599|P1|STARTED|Overall Study||60
170222|NCT01498289|414635|P2|NOT COMPLETED|Overall Study||104
170223|NCT01498289|414636|P1|NOT COMPLETED|Overall Study||98
170224|NCT01498289|414635|P2|COMPLETED|Overall Study||0
170225|NCT01498289|414636|P1|COMPLETED|Overall Study||0
170226|NCT01498289|414635|P2|Participants Assessed for AEs|Overall Study||98
170227|NCT01498289|414636|P1|Participants Assessed for AEs|Overall Study||91
170228|NCT01498289|414635|P2|STARTED|Overall Study||104
170229|NCT01498289|414636|P1|STARTED|Overall Study||98
170230|NCT01498185|414657|P5|NOT COMPLETED|Overall Study||3
170231|NCT01498185|414658|P4|NOT COMPLETED|Overall Study||3
170232|NCT01498185|414659|P3|NOT COMPLETED|Overall Study||0
170233|NCT01498185|414660|P2|NOT COMPLETED|Overall Study||1
170234|NCT01498185|414661|P1|NOT COMPLETED|Overall Study||1
170235|NCT01498185|414657|P5|COMPLETED|Overall Study||12
170236|NCT01498185|414658|P4|COMPLETED|Overall Study||11
170237|NCT01498185|414659|P3|COMPLETED|Overall Study||15
170238|NCT01498185|414660|P2|COMPLETED|Overall Study||12
170239|NCT01498185|414661|P1|COMPLETED|Overall Study||12
170240|NCT01498185|414657|P5|STARTED|Overall Study||15
170241|NCT01498185|414658|P4|STARTED|Overall Study||14
170242|NCT01498185|414659|P3|STARTED|Overall Study||15
170243|NCT01498185|414660|P2|STARTED|Overall Study||13
170244|NCT01498185|414661|P1|STARTED|Overall Study||13
170245|NCT01498120|414701|P1|NOT COMPLETED|Overall Study||13
170246|NCT01498120|414701|P1|COMPLETED|Overall Study||1
170247|NCT01498120|414701|P1|STARTED|Overall Study||14
170248|NCT01498068|414708|P2|NOT COMPLETED|Overall Study||1
170249|NCT01498068|414709|P1|NOT COMPLETED|Overall Study||1
170250|NCT01498068|414708|P2|COMPLETED|Overall Study||19
170251|NCT01498068|414709|P1|COMPLETED|Overall Study||15
170252|NCT01498068|414708|P2|STARTED|Overall Study||20
170253|NCT01498068|414709|P1|STARTED|Overall Study||16
170254|NCT01497938|414727|P2|NOT COMPLETED|Overall Study||2
170255|NCT01497938|414728|P1|NOT COMPLETED|Overall Study||5
170256|NCT01497938|414727|P2|COMPLETED|Overall Study||124
170257|NCT01497938|414728|P1|COMPLETED|Overall Study||116
170258|NCT01497938|414727|P2|STARTED|Overall Study||126
170259|NCT01497938|414728|P1|STARTED|Overall Study||121
170260|NCT01497899|414740|P4|NOT COMPLETED|Open-Label Extension Phase||5
170261|NCT01497899|414741|P3|NOT COMPLETED|Open-Label Extension Phase||9
170262|NCT01497899|414742|P2|NOT COMPLETED|Open-Label Extension Phase||7
170263|NCT01497899|414743|P1|NOT COMPLETED|Open-Label Extension Phase||19
170264|NCT01497899|414740|P4|COMPLETED|Open-Label Extension Phase||33
170265|NCT01497899|414741|P3|COMPLETED|Open-Label Extension Phase||61
170266|NCT01497899|414742|P2|COMPLETED|Open-Label Extension Phase||46
170267|NCT01497899|414743|P1|COMPLETED|Open-Label Extension Phase||86
170268|NCT01497899|414740|P4|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|38
170269|NCT01497899|414741|P3|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|70
170270|NCT01497899|414742|P2|STARTED|Open-Label Extension Phase||53
170271|NCT01497899|414743|P1|STARTED|Open-Label Extension Phase|2 participants completed the Double-Blind Phase, but did not continue in the Open-Label Extension.|105
170272|NCT01497899|414740|P4|NOT COMPLETED|Double-Blind Phase||0
170273|NCT01497899|414741|P3|NOT COMPLETED|Double-Blind Phase||0
170274|NCT01497899|414742|P2|NOT COMPLETED|Double-Blind Phase||5
170275|NCT01497899|414743|P1|NOT COMPLETED|Double-Blind Phase||6
170276|NCT01497899|414740|P4|COMPLETED|Double-Blind Phase||0
170277|NCT01497899|414741|P3|COMPLETED|Double-Blind Phase||0
170278|NCT01497899|414742|P2|COMPLETED|Double-Blind Phase||53
170279|NCT01497899|414743|P1|COMPLETED|Double-Blind Phase||107
170280|NCT01497899|414740|P4|STARTED|Double-Blind Phase||0
170281|NCT01497899|414741|P3|STARTED|Double-Blind Phase||0
170282|NCT01497899|414742|P2|STARTED|Double-Blind Phase||58
170283|NCT01497899|414743|P1|STARTED|Double-Blind Phase||113
170284|NCT01497860|414756|P1|NOT COMPLETED|Overall Study||0
170285|NCT01497860|414756|P1|COMPLETED|Overall Study||12
170286|NCT01497860|414756|P1|STARTED|Overall Study||12
170287|NCT01497756|414760|P1|NOT COMPLETED|Overall Study||0
170288|NCT01497756|414760|P1|COMPLETED|Overall Study||10
170289|NCT01497756|414760|P1|STARTED|Overall Study||10
170290|NCT01497665|414765|P1|NOT COMPLETED|Overall Study||0
170291|NCT01497665|414765|P1|COMPLETED|Overall Study||16
170292|NCT01497665|414765|P1|Completed Effifcacy Assessment|Overall Study|Number of patients who completed efficacy assessment with CNS lesions per Overall RECIST 1.1.|10
170293|NCT01497665|414765|P1|STARTED|Overall Study||16
170294|NCT01497613|414775|P2|NOT COMPLETED|Overall Study||19
170295|NCT01497613|414776|P1|NOT COMPLETED|Overall Study||37
170296|NCT01497613|414775|P2|COMPLETED|Overall Study||131
170297|NCT01497613|414776|P1|COMPLETED|Overall Study||113
170298|NCT01497613|414775|P2|STARTED|Overall Study||150
170299|NCT01497613|414776|P1|STARTED|Overall Study||150
170300|NCT01497366|414814|P2|NOT COMPLETED|Overall Study||88
170301|NCT01497366|414815|P1|NOT COMPLETED|Overall Study||39
170302|NCT01497366|414814|P2|COMPLETED|Overall Study||176
170303|NCT01497366|414815|P1|COMPLETED|Overall Study||224
170304|NCT01497366|414814|P2|Randomized But Not Treated|Overall Study||21
170305|NCT01497366|414815|P1|Randomized But Not Treated|Overall Study||7
170306|NCT01497366|414814|P2|STARTED|Overall Study||264
170307|NCT01497366|414815|P1|STARTED|Overall Study||263
170308|NCT01497275|414833|P1|NOT COMPLETED|Overall Study||2
170309|NCT01497275|414833|P1|COMPLETED|Overall Study||3
170310|NCT01497275|414833|P1|STARTED|Overall Study||5
170311|NCT01497262|414840|P1|NOT COMPLETED|Overall Study||11
170312|NCT01497262|414840|P1|COMPLETED|Overall Study||151
170313|NCT01497262|414840|P1|STARTED|Overall Study||162
170314|NCT01497197|414847|P2|NOT COMPLETED|Overall Study||15
170315|NCT01497197|414848|P1|NOT COMPLETED|Overall Study||17
170316|NCT01497197|414847|P2|COMPLETED|Overall Study||70
170317|NCT01497197|414848|P1|COMPLETED|Overall Study||72
170318|NCT01497197|414847|P2|STARTED|Overall Study||85
170319|NCT01497197|414848|P1|STARTED|Overall Study||89
170320|NCT01497171|414876|P2|NOT COMPLETED|Overall Study||0
170321|NCT01497171|414877|P1|NOT COMPLETED|Overall Study||0
170322|NCT01497171|414876|P2|COMPLETED|Overall Study||3
170323|NCT01497171|414877|P1|COMPLETED|Overall Study||2
170324|NCT01497171|414876|P2|STARTED|Overall Study||3
170325|NCT01497171|414877|P1|STARTED|Overall Study||2
170326|NCT01497067|414883|P1|NOT COMPLETED|Overall Study||82
170327|NCT01497067|414883|P1|COMPLETED|Overall Study||575
170328|NCT01497067|414883|P1|STARTED|Overall Study||657
170329|NCT01496846|414894|P6|NOT COMPLETED|Supplemental Buccal Infiltration||0
170330|NCT01496846|414895|P5|NOT COMPLETED|Supplemental Buccal Infiltration||0
170331|NCT01496846|414896|P4|NOT COMPLETED|Supplemental Buccal Infiltration||0
170332|NCT01496846|414897|P3|NOT COMPLETED|Supplemental Buccal Infiltration||0
170333|NCT01496846|414898|P2|NOT COMPLETED|Supplemental Buccal Infiltration||0
170334|NCT01496846|414899|P1|NOT COMPLETED|Supplemental Buccal Infiltration||0
170335|NCT01496846|414894|P6|COMPLETED|Supplemental Buccal Infiltration||38
170336|NCT01496846|414895|P5|COMPLETED|Supplemental Buccal Infiltration||35
170337|NCT01496846|414896|P4|COMPLETED|Supplemental Buccal Infiltration||40
170338|NCT01496846|414897|P3|COMPLETED|Supplemental Buccal Infiltration||36
170339|NCT01496846|414898|P2|COMPLETED|Supplemental Buccal Infiltration||0
170340|NCT01496846|414899|P1|COMPLETED|Supplemental Buccal Infiltration||0
170341|NCT01496846|414894|P6|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|38
170342|NCT01496846|414895|P5|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|35
170343|NCT01496846|414896|P4|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|40
170344|NCT01496846|414897|P3|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|36
170345|NCT01496846|414898|P2|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
170346|NCT01496846|414899|P1|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
170347|NCT01496846|414894|P6|NOT COMPLETED|IANB Articaine (All Participants)||0
170348|NCT01496846|414895|P5|NOT COMPLETED|IANB Articaine (All Participants)||0
170349|NCT01496846|414896|P4|NOT COMPLETED|IANB Articaine (All Participants)||0
170350|NCT01496846|414897|P3|NOT COMPLETED|IANB Articaine (All Participants)||0
170351|NCT01496846|414898|P2|NOT COMPLETED|IANB Articaine (All Participants)||1
170352|NCT01496846|414899|P1|NOT COMPLETED|IANB Articaine (All Participants)||1
170353|NCT01496846|414894|P6|COMPLETED|IANB Articaine (All Participants)||38
170354|NCT01496846|414895|P5|COMPLETED|IANB Articaine (All Participants)||35
170355|NCT01496846|414896|P4|COMPLETED|IANB Articaine (All Participants)||40
170356|NCT01496846|414897|P3|COMPLETED|IANB Articaine (All Participants)||36
170357|NCT01496846|414898|P2|COMPLETED|IANB Articaine (All Participants)||23
170358|NCT01496846|414899|P1|COMPLETED|IANB Articaine (All Participants)||27
170359|NCT01496846|414894|P6|STARTED|IANB Articaine (All Participants)||38
170360|NCT01496846|414895|P5|STARTED|IANB Articaine (All Participants)||35
170361|NCT01496846|414896|P4|STARTED|IANB Articaine (All Participants)||40
170362|NCT01496846|414897|P3|STARTED|IANB Articaine (All Participants)||36
170363|NCT01496846|414898|P2|STARTED|IANB Articaine (All Participants)||24
170364|NCT01496846|414899|P1|STARTED|IANB Articaine (All Participants)||28
170365|NCT01496807|414910|P1|NOT COMPLETED|Overall Study||30
170366|NCT01496807|414910|P1|COMPLETED|Overall Study||1
170367|NCT01496807|414910|P1|STARTED|Overall Study||31
170368|NCT01496469|414922|P2|NOT COMPLETED|Overall Study||8
170369|NCT01496469|414923|P1|NOT COMPLETED|Overall Study||10
170370|NCT01496469|414922|P2|COMPLETED|Overall Study||53
170371|NCT01496469|414923|P1|COMPLETED|Overall Study||50
170372|NCT01496469|414922|P2|STARTED|Overall Study||61
170373|NCT01496469|414923|P1|STARTED|Overall Study||60
170374|NCT01496456|414933|P1|NOT COMPLETED|Overall Study||8
170375|NCT01496456|414933|P1|COMPLETED|Overall Study||9
170376|NCT01496456|414933|P1|3-yr Final Recall|Overall Study||9
170377|NCT01496456|414933|P1|2-yr Recall|Overall Study||10
170378|NCT01496456|414933|P1|1-yr Recall|Overall Study||12
170379|NCT01496456|414933|P1|Baseline|Overall Study|Baseline group started with 16 patients.|16
170380|NCT01496456|414933|P1|STARTED|Overall Study||17
170381|NCT01496430|414946|P3|NOT COMPLETED|Overall Study||10
170382|NCT01496430|414947|P2|NOT COMPLETED|Overall Study||5
170383|NCT01496430|414948|P1|NOT COMPLETED|Overall Study||6
170384|NCT01496430|414946|P3|COMPLETED|Overall Study||25
170385|NCT01496430|414947|P2|COMPLETED|Overall Study||30
170386|NCT01496430|414948|P1|COMPLETED|Overall Study||29
170387|NCT01496430|414946|P3|STARTED|Overall Study||35
170388|NCT01496430|414947|P2|STARTED|Overall Study||35
170389|NCT01496430|414948|P1|STARTED|Overall Study||35
170390|NCT01496352|415024|P2|NOT COMPLETED|Overall Study||0
170391|NCT01496352|415025|P1|NOT COMPLETED|Overall Study||0
170392|NCT01496352|415024|P2|COMPLETED|Overall Study||6
170393|NCT01496352|415025|P1|COMPLETED|Overall Study||24
170394|NCT01496352|415024|P2|STARTED|Overall Study||6
170395|NCT01496352|415025|P1|STARTED|Overall Study||24
170396|NCT01496313|415043|P2|NOT COMPLETED|Overall Study||15
170397|NCT01496313|415044|P1|NOT COMPLETED|Overall Study||5
170398|NCT01496313|415043|P2|COMPLETED|Overall Study||26
170399|NCT01496313|415044|P1|COMPLETED|Overall Study||35
170400|NCT01496313|415043|P2|STARTED|Overall Study||41
170401|NCT01496313|415044|P1|STARTED|Overall Study||40
170402|NCT01496287|415060|P1|NOT COMPLETED|Overall Study||6
170403|NCT01496287|415060|P1|COMPLETED|Overall Study||64
170404|NCT01496287|415060|P1|STARTED|Overall Study||70
170405|NCT01496274|415070|P2|NOT COMPLETED|Overall Study||5
170406|NCT01496274|415071|P1|NOT COMPLETED|Overall Study||3
170407|NCT01496274|415070|P2|COMPLETED|Overall Study||18
170408|NCT01496274|415071|P1|COMPLETED|Overall Study||37
170409|NCT01496274|415070|P2|STARTED|Overall Study||23
170410|NCT01496274|415071|P1|STARTED|Overall Study||40
170411|NCT01496248|415103|P1|NOT COMPLETED|Overall Study||10
170412|NCT01496248|415103|P1|COMPLETED|Overall Study||25
170413|NCT01496248|415103|P1|STARTED|Overall Study||35
170414|NCT01496183|415116|P2|NOT COMPLETED|Overall Study||2
170415|NCT01496183|415117|P1|NOT COMPLETED|Overall Study||3
170416|NCT01496183|415116|P2|COMPLETED|Overall Study||13
170417|NCT01496183|415117|P1|COMPLETED|Overall Study||6
170418|NCT01496183|415116|P2|STARTED|Overall Study||15
170419|NCT01496183|415117|P1|STARTED|Overall Study||9
170420|NCT01496157|415147|P1|NOT COMPLETED|Overall Study||0
170421|NCT01496157|415147|P1|COMPLETED|Overall Study||13
170422|NCT01496157|415147|P1|STARTED|Overall Study||13
170423|NCT01496131|415154|P2|NOT COMPLETED|Overall Study||0
170424|NCT01496131|415155|P1|NOT COMPLETED|Overall Study||0
170425|NCT01496131|415154|P2|COMPLETED|Overall Study||14
170426|NCT01496131|415155|P1|COMPLETED|Overall Study||14
170427|NCT01496131|415154|P2|STARTED|Overall Study||14
170428|NCT01496131|415155|P1|STARTED|Overall Study||14
170429|NCT01496066|415169|P2|NOT COMPLETED|Overall Study||9
170430|NCT01496066|415170|P1|NOT COMPLETED|Overall Study||12
170431|NCT01496066|415169|P2|COMPLETED|Overall Study||188
170432|NCT01496066|415170|P1|COMPLETED|Overall Study||391
170433|NCT01496066|415169|P2|STARTED|Overall Study||197
170434|NCT01496066|415170|P1|STARTED|Overall Study||403
170435|NCT01495988|415193|P4|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
170436|NCT01495988|415194|P3|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
170437|NCT01495988|415195|P2|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
170438|NCT01495988|415196|P1|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
170439|NCT01495988|415193|P4|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
170440|NCT01495988|415194|P3|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
170441|NCT01495988|415195|P2|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||2
170442|NCT01495988|415196|P1|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
170443|NCT01495988|415193|P4|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
170444|NCT01495988|415194|P3|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
170445|NCT01495988|415195|P2|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||2
170446|NCT01495988|415196|P1|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
170447|NCT01495988|415193|P4|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
170448|NCT01495988|415194|P3|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
170449|NCT01495988|415195|P2|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
170450|NCT01495988|415196|P1|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
170451|NCT01495988|415193|P4|COMPLETED|Vem +/- Bev (Protocol v2.0)||3
170452|NCT01495988|415194|P3|COMPLETED|Vem +/- Bev (Protocol v2.0)||5
170453|NCT01495988|415195|P2|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
170454|NCT01495988|415196|P1|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
170455|NCT01495988|415193|P4|STARTED|Vem +/- Bev (Protocol v2.0)||3
170456|NCT01495988|415194|P3|STARTED|Vem +/- Bev (Protocol v2.0)||5
170457|NCT01495988|415195|P2|STARTED|Vem +/- Bev (Protocol v2.0)||0
170458|NCT01495988|415196|P1|STARTED|Vem +/- Bev (Protocol v2.0)||0
170459|NCT01495975|415232|P2|NOT COMPLETED|Overall Study||0
170460|NCT01495975|415233|P1|NOT COMPLETED|Overall Study||1
170461|NCT01495975|415232|P2|COMPLETED|Overall Study||14
170462|NCT01495975|415233|P1|COMPLETED|Overall Study||14
170463|NCT01495975|415232|P2|STARTED|Overall Study||14
170464|NCT01495975|415233|P1|STARTED|Overall Study||15
170465|NCT01495923|415241|P2|NOT COMPLETED|Overall Study||0
170466|NCT01495923|415242|P1|NOT COMPLETED|Overall Study||0
170467|NCT01495923|415241|P2|COMPLETED|Overall Study||72
170468|NCT01495923|415242|P1|COMPLETED|Overall Study||73
170469|NCT01495923|415241|P2|STARTED|Overall Study||72
170470|NCT01495923|415242|P1|STARTED|Overall Study||73
170471|NCT01495858|415275|P3|NOT COMPLETED|Overall Study||0
170472|NCT01495858|415276|P2|NOT COMPLETED|Overall Study||0
170473|NCT01495858|415277|P1|NOT COMPLETED|Overall Study||0
170474|NCT01495858|415275|P3|COMPLETED|Overall Study||54
170475|NCT01495858|415276|P2|COMPLETED|Overall Study||106
170476|NCT01495858|415277|P1|COMPLETED|Overall Study||107
170477|NCT01495858|415275|P3|STARTED|Overall Study||54
170478|NCT01495858|415276|P2|STARTED|Overall Study||106
170479|NCT01495858|415277|P1|STARTED|Overall Study||107
170480|NCT01495793|415357|P1|NOT COMPLETED|Overall Study||2
170481|NCT01495793|415357|P1|COMPLETED|Overall Study||22
170482|NCT01495793|415357|P1|STARTED|Overall Study||24
170483|NCT01495702|415370|P2|NOT COMPLETED|Extension Phase||0
170484|NCT01495702|415371|P1|NOT COMPLETED|Extension Phase||0
170485|NCT01495702|415370|P2|COMPLETED|Extension Phase||2
170486|NCT01495702|415371|P1|COMPLETED|Extension Phase||26
170487|NCT01495702|415370|P2|STARTED|Extension Phase||2
170488|NCT01495702|415371|P1|STARTED|Extension Phase||26
170489|NCT01495702|415370|P2|NOT COMPLETED|Randomized Phase||28
170490|NCT01495702|415371|P1|NOT COMPLETED|Randomized Phase||26
170491|NCT01495702|415370|P2|COMPLETED|Randomized Phase||119
170492|NCT01495702|415371|P1|COMPLETED|Randomized Phase||266
170493|NCT01495702|415370|P2|STARTED|Randomized Phase||147
170494|NCT01495702|415371|P1|STARTED|Randomized Phase||292
170495|NCT01495689|415386|P2|NOT COMPLETED|Overall Study||7
170496|NCT01495689|415387|P1|NOT COMPLETED|Overall Study||10
170497|NCT01495689|415386|P2|COMPLETED|Overall Study||16
170498|NCT01495689|415387|P1|COMPLETED|Overall Study||16
170499|NCT01495689|415386|P2|STARTED|Overall Study||23
170500|NCT01495689|415387|P1|STARTED|Overall Study||26
170501|NCT01495585|415396|P3|NOT COMPLETED|Overall Study||0
170502|NCT01495585|415397|P2|NOT COMPLETED|Overall Study||0
170503|NCT01495585|415398|P1|NOT COMPLETED|Overall Study||0
170504|NCT01495585|415396|P3|COMPLETED|Overall Study||4
170505|NCT01495585|415397|P2|COMPLETED|Overall Study||6
170506|NCT01495585|415398|P1|COMPLETED|Overall Study||4
170507|NCT01495585|415396|P3|Open Label Lonafarnib 200 mg|Overall Study||0
170508|NCT01495585|415397|P2|Open Label Lonafarnib 200 mg|Overall Study||0
170509|NCT01495585|415398|P1|Open Label Lonafarnib 200 mg|Overall Study||2
170510|NCT01495585|415396|P3|STARTED|Overall Study||4
170511|NCT01495585|415397|P2|STARTED|Overall Study||6
170512|NCT01495585|415398|P1|STARTED|Overall Study||4
170513|NCT01495572|415411|P2|NOT COMPLETED|Overall Study||0
170514|NCT01495572|415412|P1|NOT COMPLETED|Overall Study||0
170515|NCT01495572|415411|P2|COMPLETED|Overall Study||5
170516|NCT01495572|415412|P1|COMPLETED|Overall Study||0
170517|NCT01495572|415411|P2|STARTED|Overall Study||5
170518|NCT01495572|415412|P1|STARTED|Overall Study||0
170519|NCT01495481|415420|P1|NOT COMPLETED|Dexmedetomidine||0
170520|NCT01495481|415420|P1|COMPLETED|Dexmedetomidine||22
170521|NCT01495481|415420|P1|STARTED|Dexmedetomidine||22
170522|NCT01495481|415420|P1|NOT COMPLETED|Washout||0
170523|NCT01495481|415420|P1|COMPLETED|Washout||22
170524|NCT01495481|415420|P1|STARTED|Washout||22
170525|NCT01495481|415420|P1|NOT COMPLETED|Adenosine||0
170526|NCT01495481|415420|P1|COMPLETED|Adenosine||22
170527|NCT01495481|415420|P1|STARTED|Adenosine|Patients first received adenosine and then dexmedetomidine.|22
170528|NCT01495286|415432|P1|NOT COMPLETED|Overall Study||0
170529|NCT01495286|415432|P1|COMPLETED|Overall Study||30
170530|NCT01495286|415432|P1|STARTED|Overall Study||30
170531|NCT01495221|415440|P1|NOT COMPLETED|Overall Study||0
170532|NCT01495221|415440|P1|COMPLETED|Overall Study|Last patient enrolled May 2012.|9
170533|NCT01495221|415440|P1|STARTED|Overall Study|First Patient enrolled December 2011.|9
170534|NCT01495000|415449|P2|NOT COMPLETED|Overall Study||12
170535|NCT01495000|415450|P1|NOT COMPLETED|Overall Study||13
170536|NCT01495000|415449|P2|COMPLETED|Overall Study||114
170537|NCT01495000|415450|P1|COMPLETED|Overall Study||111
170538|NCT01495000|415449|P2|STARTED|Overall Study||126
170539|NCT01495000|415450|P1|STARTED|Overall Study||124
170540|NCT01494987|415492|P2|NOT COMPLETED|Overall Study||28
170541|NCT01494987|415493|P1|NOT COMPLETED|Overall Study||28
170542|NCT01494987|415492|P2|COMPLETED|Overall Study||187
170543|NCT01494987|415493|P1|COMPLETED|Overall Study||188
170544|NCT01494987|415492|P2|STARTED|Overall Study||215
170545|NCT01494987|415493|P1|STARTED|Overall Study||216
170546|NCT01494818|415507|P2|NOT COMPLETED|Overall Study||2
170547|NCT01494818|415508|P1|NOT COMPLETED|Overall Study||2
170548|NCT01494818|415507|P2|COMPLETED|Overall Study||37
170549|NCT01494818|415508|P1|COMPLETED|Overall Study||37
170550|NCT01494818|415507|P2|STARTED|Overall Study||39
170551|NCT01494818|415508|P1|STARTED|Overall Study||39
170552|NCT01494753|415530|P2|NOT COMPLETED|Day42-Day84||0
170553|NCT01494753|415531|P1|NOT COMPLETED|Day42-Day84||0
170554|NCT01494753|415530|P2|COMPLETED|Day42-Day84||15
170555|NCT01494753|415531|P1|COMPLETED|Day42-Day84||15
170556|NCT01494753|415530|P2|STARTED|Day42-Day84||15
170557|NCT01494753|415531|P1|STARTED|Day42-Day84||15
170558|NCT01494753|415530|P2|NOT COMPLETED|Day0-Day42||0
170559|NCT01494753|415531|P1|NOT COMPLETED|Day0-Day42||0
170560|NCT01494753|415530|P2|COMPLETED|Day0-Day42||15
170561|NCT01494753|415531|P1|COMPLETED|Day0-Day42||15
170562|NCT01494753|415530|P2|STARTED|Day0-Day42||15
170563|NCT01494753|415531|P1|STARTED|Day0-Day42||15
170564|NCT01494649|415539|P2|NOT COMPLETED|Overall Study||1
170565|NCT01494649|415540|P1|NOT COMPLETED|Overall Study||0
170566|NCT01494649|415539|P2|COMPLETED|Overall Study||58
170567|NCT01494649|415540|P1|COMPLETED|Overall Study||59
170568|NCT01494649|415539|P2|STARTED|Overall Study||59
170569|NCT01494649|415540|P1|STARTED|Overall Study||59
170570|NCT01494610|415556|P2|NOT COMPLETED|Period 4||0
170571|NCT01494610|415557|P1|NOT COMPLETED|Period 4||1
170572|NCT01494610|415556|P2|COMPLETED|Period 4||28
170573|NCT01494610|415557|P1|COMPLETED|Period 4||27
170574|NCT01494610|415556|P2|STARTED|Period 4||28
170575|NCT01494610|415557|P1|STARTED|Period 4||28
170576|NCT01494610|415556|P2|NOT COMPLETED|Period 3||0
170577|NCT01494610|415557|P1|NOT COMPLETED|Period 3||2
170578|NCT01494610|415556|P2|COMPLETED|Period 3||28
170579|NCT01494610|415557|P1|COMPLETED|Period 3||28
170580|NCT01494610|415556|P2|STARTED|Period 3||28
170581|NCT01494610|415557|P1|STARTED|Period 3||30
170582|NCT01494610|415556|P2|NOT COMPLETED|Period 2||0
170583|NCT01494610|415557|P1|NOT COMPLETED|Period 2||0
170584|NCT01494610|415556|P2|COMPLETED|Period 2||28
170585|NCT01494610|415557|P1|COMPLETED|Period 2||30
170586|NCT01494610|415556|P2|STARTED|Period 2||28
170587|NCT01494610|415557|P1|STARTED|Period 2||30
170588|NCT01494610|415556|P2|NOT COMPLETED|Period 1||1
170589|NCT01494610|415557|P1|NOT COMPLETED|Period 1||1
170590|NCT01494610|415556|P2|COMPLETED|Period 1||28
170591|NCT01494610|415557|P1|COMPLETED|Period 1||30
170592|NCT01494610|415556|P2|STARTED|Period 1||29
170593|NCT01494610|415557|P1|STARTED|Period 1||31
170594|NCT01494584|415625|P1|NOT COMPLETED|Overall Study||1
170595|NCT01494584|415625|P1|COMPLETED|Overall Study||4
170596|NCT01494584|415625|P1|STARTED|Overall Study||5
170597|NCT01494545|415714|P1|NOT COMPLETED|Overall Study||10
170598|NCT01494545|415714|P1|COMPLETED|Overall Study||92
170599|NCT01494545|415714|P1|STARTED|Overall Study||102
170600|NCT01494532|415757|P6|NOT COMPLETED|Overall Study||0
170601|NCT01494532|415758|P5|NOT COMPLETED|Overall Study||12
170602|NCT01494532|415759|P4|NOT COMPLETED|Overall Study||15
170603|NCT01494532|415760|P3|NOT COMPLETED|Overall Study||17
170604|NCT01494532|415761|P2|NOT COMPLETED|Overall Study||4
170605|NCT01494532|415762|P1|NOT COMPLETED|Overall Study||10
170606|NCT01494532|415757|P6|COMPLETED|Overall Study||25
170607|NCT01494532|415758|P5|COMPLETED|Overall Study||64
170608|NCT01494532|415759|P4|COMPLETED|Overall Study||60
170609|NCT01494532|415760|P3|COMPLETED|Overall Study||59
170610|NCT01494532|415761|P2|COMPLETED|Overall Study||21
170611|NCT01494532|415762|P1|COMPLETED|Overall Study||65
170612|NCT01494532|415757|P6|STARTED|Overall Study||25
170613|NCT01494532|415758|P5|STARTED|Overall Study||76
170614|NCT01494532|415759|P4|STARTED|Overall Study||75
170615|NCT01494532|415760|P3|STARTED|Overall Study||76
170616|NCT01494532|415761|P2|STARTED|Overall Study||25
170617|NCT01494532|415762|P1|STARTED|Overall Study||75
170618|NCT01494506|415917|P3|NOT COMPLETED|Overall Study||103
170619|NCT01494506|415918|P2|NOT COMPLETED|Overall Study||143
170620|NCT01494506|415919|P1|NOT COMPLETED|Overall Study||148
170621|NCT01494506|415917|P3|COMPLETED|Overall Study||14
170622|NCT01494506|415918|P2|COMPLETED|Overall Study||6
170623|NCT01494506|415919|P1|COMPLETED|Overall Study|Completed = Subjects remaining on treatment at the time of the primary analysis data cut off.|3
170624|NCT01494506|415917|P3|Treated Population|Overall Study|2 randomized Arm C patients did not receive study drug. 1 patient each in A and B received Arm C.|117
170625|NCT01494506|415918|P2|Treated Population|Overall Study||134
170626|NCT01494506|415919|P1|Treated Population|Overall Study|Treated population: Patients who received at least 1 dose of study drug.|147
170627|NCT01494506|415917|P3|STARTED|Overall Study||117
170628|NCT01494506|415918|P2|STARTED|Overall Study||149
170629|NCT01494506|415919|P1|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|151
170630|NCT01494467|415956|P2|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
170631|NCT01494467|415957|P1|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
170632|NCT01494467|415956|P2|COMPLETED|Part C Safety Follow up (4 Weeks)||159
170633|NCT01494467|415957|P1|COMPLETED|Part C Safety Follow up (4 Weeks)||353
170634|NCT01494467|415956|P2|STARTED|Part C Safety Follow up (4 Weeks)||159
170635|NCT01494467|415957|P1|STARTED|Part C Safety Follow up (4 Weeks)||353
170636|NCT01494467|415956|P2|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||49
170637|NCT01494467|415957|P1|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||75
170638|NCT01494467|415956|P2|COMPLETED|Part B Long Term Active Control 40 Weeks||159
170639|NCT01494467|415957|P1|COMPLETED|Part B Long Term Active Control 40 Weeks||353
170640|NCT01494467|415956|P2|STARTED|Part B Long Term Active Control 40 Weeks||208
170641|NCT01494467|415957|P1|STARTED|Part B Long Term Active Control 40 Weeks|429 completed Part A. Subsequently, one subject discontinued so only 428 entered Part B|428
170642|NCT01494467|415956|P2|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||21
170643|NCT01494467|415957|P1|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||30
170644|NCT01494467|415956|P2|COMPLETED|Part A Vehicle Control (12 Weeks)||208
170645|NCT01494467|415957|P1|COMPLETED|Part A Vehicle Control (12 Weeks)||429
170646|NCT01494467|415956|P2|STARTED|Part A Vehicle Control (12 Weeks)||229
170647|NCT01494467|415957|P1|STARTED|Part A Vehicle Control (12 Weeks)||459
170648|NCT01494350|415973|P1|NOT COMPLETED|Overall Study||1
170649|NCT01494350|415973|P1|COMPLETED|Overall Study||49
170650|NCT01494350|415973|P1|STARTED|Overall Study||50
170651|NCT01494298|415983|P2|NOT COMPLETED|Overall Study||8
170652|NCT01494298|415984|P1|NOT COMPLETED|Overall Study||2
170653|NCT01494298|415983|P2|COMPLETED|Overall Study||47
170654|NCT01494298|415984|P1|COMPLETED|Overall Study||54
170655|NCT01494298|415983|P2|STARTED|Overall Study||55
170656|NCT01494298|415984|P1|STARTED|Overall Study||56
170657|NCT01494038|415996|P2|NOT COMPLETED|Overall Study||83
170658|NCT01494038|415997|P1|NOT COMPLETED|Overall Study||88
170659|NCT01494038|415996|P2|COMPLETED|Overall Study||396
170660|NCT01494038|415997|P1|COMPLETED|Overall Study||389
170661|NCT01494038|415996|P2|STARTED|Overall Study||479
170662|NCT01494038|415997|P1|STARTED|Overall Study||477
170663|NCT01493960|416085|P2|NOT COMPLETED|Overall Study||18
170664|NCT01493960|416086|P1|NOT COMPLETED|Overall Study||32
170665|NCT01493960|416085|P2|COMPLETED|Overall Study||26
170666|NCT01493960|416086|P1|COMPLETED|Overall Study||55
170667|NCT01493960|416085|P2|Received Study Drug|Overall Study||43
170668|NCT01493960|416086|P1|Received Study Drug|Overall Study||87
170669|NCT01493960|416085|P2|STARTED|Overall Study||44
170670|NCT01493960|416086|P1|STARTED|Overall Study||87
170671|NCT01493947|416106|P2|NOT COMPLETED|Period B Extension Period||32
170672|NCT01493947|416107|P1|NOT COMPLETED|Period B Extension Period||33
170673|NCT01493947|416106|P2|COMPLETED|Period B Extension Period||326
170674|NCT01493947|416107|P1|COMPLETED|Period B Extension Period||366
170675|NCT01493947|416106|P2|STARTED|Period B Extension Period|358 / 456 subjects were eligible to enter in Period B (i.e IGA =0 or 1 at end of Period A).|358
170676|NCT01493947|416107|P1|STARTED|Period B Extension Period|Only 399 /446 subjects were eligible to enter in Period B (i.e IGA=0 or1 at end of Period A).|399
170677|NCT01493947|416106|P2|NOT COMPLETED|Period A Efficacy and Safety Data||28
170678|NCT01493947|416107|P1|NOT COMPLETED|Period A Efficacy and Safety Data||32
170679|NCT01493947|416106|P2|COMPLETED|Period A Efficacy and Safety Data||456
170680|NCT01493947|416107|P1|COMPLETED|Period A Efficacy and Safety Data||446
170681|NCT01493947|416106|P2|STARTED|Period A Efficacy and Safety Data||484
170682|NCT01493947|416107|P1|STARTED|Period A Efficacy and Safety Data||478
170683|NCT01493778|416117|P1|NOT COMPLETED|Overall Study||3
170684|NCT01493778|416117|P1|COMPLETED|Overall Study||56
170685|NCT01493778|416117|P1|STARTED|Overall Study||59
170686|NCT01493687|416145|P2|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||1
170687|NCT01493687|416146|P1|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
170688|NCT01493687|416145|P2|COMPLETED|Part C Safety Follow up (4 Weeks)||174
170689|NCT01493687|416146|P1|COMPLETED|Part C Safety Follow up (4 Weeks)||350
170690|NCT01493687|416145|P2|STARTED|Part C Safety Follow up (4 Weeks)||175
170691|NCT01493687|416146|P1|STARTED|Part C Safety Follow up (4 Weeks)|351 completed Part B. Then 1 discontinued (subject request) prior to Part C.|350
170692|NCT01493687|416145|P2|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||35
170693|NCT01493687|416146|P1|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||61
170694|NCT01493687|416145|P2|COMPLETED|Part B Long Term Active Control 40 Weeks||175
170695|NCT01493687|416146|P1|COMPLETED|Part B Long Term Active Control 40 Weeks||351
170696|NCT01493687|416145|P2|STARTED|Part B Long Term Active Control 40 Weeks||210
170697|NCT01493687|416146|P1|STARTED|Part B Long Term Active Control 40 Weeks|414 completed Part A. Then 2 discontinued (lack of efficacy, subject request) prior to Part B.|412
170698|NCT01493687|416145|P2|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||22
170699|NCT01493687|416146|P1|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||37
170700|NCT01493687|416145|P2|COMPLETED|Part A Vehicle Control (12 Weeks)||210
170701|NCT01493687|416146|P1|COMPLETED|Part A Vehicle Control (12 Weeks)||414
170702|NCT01493687|416145|P2|STARTED|Part A Vehicle Control (12 Weeks)||232
170703|NCT01493687|416146|P1|STARTED|Part A Vehicle Control (12 Weeks)||451
170704|NCT01493557|416165|P3|NOT COMPLETED|Adding the Second Strategy||0
170705|NCT01493557|416166|P2|NOT COMPLETED|Adding the Second Strategy||4
170706|NCT01493557|416167|P1|NOT COMPLETED|Adding the Second Strategy||2
170707|NCT01493557|416165|P3|COMPLETED|Adding the Second Strategy||0
170708|NCT01493557|416166|P2|COMPLETED|Adding the Second Strategy||11
170709|NCT01493557|416167|P1|COMPLETED|Adding the Second Strategy||12
170710|NCT01493557|416165|P3|STARTED|Adding the Second Strategy||0
170711|NCT01493557|416166|P2|STARTED|Adding the Second Strategy||15
170712|NCT01493557|416167|P1|STARTED|Adding the Second Strategy||14
170713|NCT01493557|416165|P3|NOT COMPLETED|Randomized to Management Strategies||0
170714|NCT01493557|416166|P2|NOT COMPLETED|Randomized to Management Strategies||11
170715|NCT01493557|416167|P1|NOT COMPLETED|Randomized to Management Strategies||15
170716|NCT01493557|416165|P3|COMPLETED|Randomized to Management Strategies||0
170717|NCT01493557|416166|P2|COMPLETED|Randomized to Management Strategies||47
170718|NCT01493557|416167|P1|COMPLETED|Randomized to Management Strategies||44
170719|NCT01493557|416165|P3|STARTED|Randomized to Management Strategies||0
170720|NCT01493557|416166|P2|STARTED|Randomized to Management Strategies||58
170721|NCT01493557|416167|P1|STARTED|Randomized to Management Strategies||59
170722|NCT01493557|416165|P3|NOT COMPLETED|Not Randomized to Management Strategies||134
170723|NCT01493557|416166|P2|NOT COMPLETED|Not Randomized to Management Strategies||0
170724|NCT01493557|416167|P1|NOT COMPLETED|Not Randomized to Management Strategies||0
170725|NCT01493557|416165|P3|COMPLETED|Not Randomized to Management Strategies||816
170726|NCT01493557|416166|P2|COMPLETED|Not Randomized to Management Strategies||0
170727|NCT01493557|416167|P1|COMPLETED|Not Randomized to Management Strategies||0
170728|NCT01493557|416165|P3|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies|26 patients completed (GIS resolved ) and 4 patients completed (GIS not resolved ) the trial.|48
170729|NCT01493557|416166|P2|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
170730|NCT01493557|416167|P1|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
170731|NCT01493557|416165|P3|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies|32 patients completed the trial.|48
170732|NCT01493557|416166|P2|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
170733|NCT01493557|416167|P1|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
170734|NCT01493557|416165|P3|Without Experiencing GIS|Not Randomized to Management Strategies|754 patients completed the trial.|854
170735|NCT01493557|416166|P2|Without Experiencing GIS|Not Randomized to Management Strategies||0
170736|NCT01493557|416167|P1|Without Experiencing GIS|Not Randomized to Management Strategies||0
170737|NCT01493557|416165|P3|STARTED|Not Randomized to Management Strategies||950
170738|NCT01493557|416166|P2|STARTED|Not Randomized to Management Strategies||0
170739|NCT01493557|416167|P1|STARTED|Not Randomized to Management Strategies||0
170740|NCT01493531|416195|P3|NOT COMPLETED|Overall Study||48
170741|NCT01493531|416196|P2|NOT COMPLETED|Overall Study||50
170742|NCT01493531|416197|P1|NOT COMPLETED|Overall Study||41
170743|NCT01493531|416195|P3|COMPLETED|Overall Study||158
170744|NCT01493531|416196|P2|COMPLETED|Overall Study||150
170745|NCT01493531|416197|P1|COMPLETED|Overall Study||163
170746|NCT01493531|416195|P3|STARTED|Overall Study||206
170747|NCT01493531|416196|P2|STARTED|Overall Study||200
170748|NCT01493531|416197|P1|STARTED|Overall Study||204
170749|NCT01493427|416211|P1|NOT COMPLETED|Overall Study||20
170750|NCT01493427|416211|P1|COMPLETED|Overall Study||179
170751|NCT01493427|416211|P1|STARTED|Overall Study||199
170752|NCT01493414|416216|P1|NOT COMPLETED|Overall Study||950
170753|NCT01493414|416216|P1|COMPLETED|Overall Study||1283
170754|NCT01493414|416216|P1|STARTED|Overall Study||2233
170755|NCT01493284|416229|P1|NOT COMPLETED|Overall Study||61
170756|NCT01493284|416229|P1|COMPLETED|Overall Study||161
170757|NCT01493284|416229|P1|STARTED|Overall Study||222
170758|NCT01493180|416238|P2|NOT COMPLETED|Overall Study||2
170759|NCT01493180|416239|P1|NOT COMPLETED|Overall Study||3
170760|NCT01493180|416238|P2|COMPLETED|Overall Study||49
170761|NCT01493180|416239|P1|COMPLETED|Overall Study||48
170762|NCT01493180|416238|P2|STARTED|Overall Study||51
170763|NCT01493180|416239|P1|STARTED|Overall Study||51
170764|NCT01493167|416245|P1|NOT COMPLETED|Overall Study||0
170765|NCT01493167|416245|P1|COMPLETED|Overall Study||97
170766|NCT01493167|416245|P1|STARTED|Overall Study||97
170767|NCT01493089|416251|P2|NOT COMPLETED|Overall Study||3
170768|NCT01493089|416252|P1|NOT COMPLETED|Overall Study||3
170769|NCT01493089|416251|P2|COMPLETED|Overall Study||114
170770|NCT01493089|416252|P1|COMPLETED|Overall Study||119
170771|NCT01493089|416251|P2|STARTED|Overall Study||117
170772|NCT01493089|416252|P1|STARTED|Overall Study||122
170773|NCT01493024|416272|P4|NOT COMPLETED|Overall Study||0
170774|NCT01493024|416273|P3|NOT COMPLETED|Overall Study||0
170775|NCT01493024|416274|P2|NOT COMPLETED|Overall Study||0
170776|NCT01493024|416275|P1|NOT COMPLETED|Overall Study||0
170777|NCT01493024|416272|P4|COMPLETED|Overall Study||24
170778|NCT01493024|416273|P3|COMPLETED|Overall Study||24
170779|NCT01493024|416274|P2|COMPLETED|Overall Study||12
170780|NCT01493024|416275|P1|COMPLETED|Overall Study||30
170781|NCT01493024|416272|P4|STARTED|Overall Study||24
170782|NCT01493024|416273|P3|STARTED|Overall Study||24
170783|NCT01493024|416274|P2|STARTED|Overall Study||12
170784|NCT01493024|416275|P1|STARTED|Overall Study||30
170785|NCT01492686|416351|P2|NOT COMPLETED|Open-label Phase||18
170786|NCT01492686|416352|P1|NOT COMPLETED|Open-label Phase||12
170787|NCT01492686|416351|P2|COMPLETED|Open-label Phase||40
170788|NCT01492686|416352|P1|COMPLETED|Open-label Phase||53
170789|NCT01492686|416351|P2|STARTED|Open-label Phase||58
170790|NCT01492686|416352|P1|STARTED|Open-label Phase||65
170791|NCT01492686|416351|P2|NOT COMPLETED|Double-blind Phase||8
170792|NCT01492686|416352|P1|NOT COMPLETED|Double-blind Phase||2
170793|NCT01492686|416351|P2|COMPLETED|Double-blind Phase||60
170794|NCT01492686|416352|P1|COMPLETED|Double-blind Phase||67
170795|NCT01492686|416351|P2|STARTED|Double-blind Phase||68
170796|NCT01492686|416352|P1|STARTED|Double-blind Phase||69
170797|NCT01492673|416376|P1|NOT COMPLETED|Overall Study||0
170798|NCT01492673|416376|P1|COMPLETED|Overall Study||9
170799|NCT01492673|416376|P1|STARTED|Overall Study||9
170800|NCT01492439|416383|P2|NOT COMPLETED|Overall Study||9
170801|NCT01492439|416384|P1|NOT COMPLETED|Overall Study||4
170802|NCT01492439|416383|P2|COMPLETED|Overall Study||9
170803|NCT01492439|416384|P1|COMPLETED|Overall Study||15
170804|NCT01492439|416383|P2|Post-intervention|Overall Study||13
170805|NCT01492439|416384|P1|Post-intervention|Overall Study||18
170806|NCT01492439|416383|P2|STARTED|Overall Study||18
170807|NCT01492439|416384|P1|STARTED|Overall Study||19
170808|NCT01492426|416432|P2|NOT COMPLETED|Follow-Up||10
170809|NCT01492426|416433|P1|NOT COMPLETED|Follow-Up||25
170810|NCT01492426|416432|P2|COMPLETED|Follow-Up||181
170811|NCT01492426|416433|P1|COMPLETED|Follow-Up||359
170812|NCT01492426|416432|P2|STARTED|Follow-Up|This total number includes 160 who completed treatment plus 31 who rejoined for follow-up.|191
170813|NCT01492426|416433|P1|STARTED|Follow-Up|This total number includes 319 who completed treatment plus 65 who rejoined for follow-up.|384
170814|NCT01492426|416432|P2|NOT COMPLETED|Treatment||40
170815|NCT01492426|416433|P1|NOT COMPLETED|Treatment||83
170816|NCT01492426|416432|P2|COMPLETED|Treatment||160
170817|NCT01492426|416433|P1|COMPLETED|Treatment||319
170818|NCT01492426|416432|P2|STARTED|Treatment||200
170819|NCT01492426|416433|P1|STARTED|Treatment||402
170820|NCT01492400|416451|P2|NOT COMPLETED|Overall Study||16
170821|NCT01492400|416452|P1|NOT COMPLETED|Overall Study||16
170822|NCT01492400|416451|P2|COMPLETED|Overall Study||166
170823|NCT01492400|416452|P1|COMPLETED|Overall Study||165
170824|NCT01492400|416451|P2|STARTED|Overall Study||182
170825|NCT01492400|416452|P1|STARTED|Overall Study||181
170826|NCT01492309|416464|P2|NOT COMPLETED|Overall Study||0
170827|NCT01492309|416465|P1|NOT COMPLETED|Overall Study||0
170828|NCT01492309|416464|P2|COMPLETED|Overall Study||11
170829|NCT01492309|416465|P1|COMPLETED|Overall Study||11
170830|NCT01492309|416464|P2|STARTED|Overall Study||11
170831|NCT01492309|416465|P1|STARTED|Overall Study||11
170832|NCT01492088|416476|P3|NOT COMPLETED|Overall Study||14
170833|NCT01492088|416477|P2|NOT COMPLETED|Overall Study||14
170834|NCT01492088|416478|P1|NOT COMPLETED|Overall Study||3
170835|NCT01492088|416476|P3|COMPLETED|Overall Study||3
170836|NCT01492088|416477|P2|COMPLETED|Overall Study||2
170837|NCT01492088|416478|P1|COMPLETED|Overall Study||0
170838|NCT01492088|416476|P3|STARTED|Overall Study||17
170839|NCT01492088|416477|P2|STARTED|Overall Study||16
170840|NCT01492088|416478|P1|STARTED|Overall Study||3
170841|NCT01491984|416538|P2|NOT COMPLETED|Overall Study||1
170842|NCT01491984|416539|P1|NOT COMPLETED|Overall Study||2
170843|NCT01491984|416538|P2|COMPLETED|Overall Study||44
170844|NCT01491984|416539|P1|COMPLETED|Overall Study||47
170845|NCT01491984|416538|P2|STARTED|Overall Study||45
170846|NCT01491984|416539|P1|STARTED|Overall Study||49
170847|NCT01491958|416547|P2|NOT COMPLETED|Overall Study||0
170848|NCT01491958|416548|P1|NOT COMPLETED|Overall Study||0
170849|NCT01491958|416547|P2|COMPLETED|Overall Study||40
170850|NCT01491958|416548|P1|COMPLETED|Overall Study||40
170851|NCT01491958|416547|P2|STARTED|Overall Study||40
170852|NCT01491958|416548|P1|STARTED|Overall Study||40
170853|NCT01491919|416559|P3|NOT COMPLETED|Overall Study||1
170854|NCT01491919|416560|P2|NOT COMPLETED|Overall Study||2
170855|NCT01491919|416561|P1|NOT COMPLETED|Overall Study||1
170856|NCT01491919|416559|P3|COMPLETED|Overall Study||2
170857|NCT01491919|416560|P2|COMPLETED|Overall Study||8
170858|NCT01491919|416561|P1|COMPLETED|Overall Study||12
170859|NCT01491919|416559|P3|STARTED|Overall Study||3
170860|NCT01491919|416560|P2|STARTED|Overall Study||10
170861|NCT01491919|416561|P1|STARTED|Overall Study||13
170862|NCT01491893|416607|P10|NOT COMPLETED|Overall Study||0
170863|NCT01491893|416608|P9|NOT COMPLETED|Overall Study||0
170864|NCT01491893|416609|P8|NOT COMPLETED|Overall Study||0
170865|NCT01491893|416610|P7|NOT COMPLETED|Overall Study||0
170866|NCT01491893|416611|P6|NOT COMPLETED|Overall Study||0
170867|NCT01491893|416612|P5|NOT COMPLETED|Overall Study||0
170868|NCT01491893|416613|P4|NOT COMPLETED|Overall Study||0
170869|NCT01491893|416614|P3|NOT COMPLETED|Overall Study||0
170870|NCT01491893|416615|P2|NOT COMPLETED|Overall Study||0
170871|NCT01491893|416616|P1|NOT COMPLETED|Overall Study||0
170872|NCT01491893|416607|P10|COMPLETED|Overall Study||7
170873|NCT01491893|416608|P9|COMPLETED|Overall Study||15
170874|NCT01491893|416609|P8|COMPLETED|Overall Study||24
170875|NCT01491893|416610|P7|COMPLETED|Overall Study||6
170876|NCT01491893|416611|P6|COMPLETED|Overall Study||1
170877|NCT01491893|416612|P5|COMPLETED|Overall Study||4
170878|NCT01491893|416613|P4|COMPLETED|Overall Study||1
170879|NCT01491893|416614|P3|COMPLETED|Overall Study||1
170880|NCT01491893|416615|P2|COMPLETED|Overall Study||1
170881|NCT01491893|416616|P1|COMPLETED|Overall Study||1
170882|NCT01491893|416607|P10|STARTED|Overall Study||7
170883|NCT01491893|416608|P9|STARTED|Overall Study||15
170884|NCT01491893|416609|P8|STARTED|Overall Study||24
170885|NCT01491893|416610|P7|STARTED|Overall Study||6
170886|NCT01491893|416611|P6|STARTED|Overall Study||1
170887|NCT01491893|416612|P5|STARTED|Overall Study||4
170888|NCT01491893|416613|P4|STARTED|Overall Study||1
170889|NCT01491893|416614|P3|STARTED|Overall Study||1
170890|NCT01491893|416615|P2|STARTED|Overall Study||1
170891|NCT01491893|416616|P1|STARTED|Overall Study||1
170892|NCT01491854|416632|P1|NOT COMPLETED|Overall Study||130
170893|NCT01491854|416632|P1|COMPLETED|Overall Study||0
170894|NCT01491854|416632|P1|STARTED|Overall Study||130
170895|NCT01491841|416643|P1|NOT COMPLETED|Overall Study||11
170896|NCT01491841|416643|P1|COMPLETED|Overall Study||22
170897|NCT01491841|416643|P1|STARTED|Overall Study||33
170898|NCT01491802|416657|P2|NOT COMPLETED|Overall Study||2
170899|NCT01491802|416658|P1|NOT COMPLETED|Overall Study||1
170900|NCT01491802|416657|P2|COMPLETED|Overall Study||6
170901|NCT01491802|416658|P1|COMPLETED|Overall Study||8
170902|NCT01491802|416657|P2|STARTED|Overall Study||8
170903|NCT01491802|416658|P1|STARTED|Overall Study||9
170904|NCT01491737|416685|P2|NOT COMPLETED|Overall Study||50
170905|NCT01491737|416686|P1|NOT COMPLETED|Overall Study||49
170906|NCT01491737|416685|P2|COMPLETED|Overall Study||79
170907|NCT01491737|416686|P1|COMPLETED|Overall Study||80
170908|NCT01491737|416685|P2|STARTED|Overall Study||129
170909|NCT01491737|416686|P1|STARTED|Overall Study||129
170910|NCT01491672|416709|P3|NOT COMPLETED|Overall Study||11
170911|NCT01491672|416710|P2|NOT COMPLETED|Overall Study||60
170912|NCT01491672|416711|P1|NOT COMPLETED|Overall Study||56
170913|NCT01491672|416709|P3|COMPLETED|Overall Study||3
170914|NCT01491672|416710|P2|COMPLETED|Overall Study||2
170915|NCT01491672|416711|P1|COMPLETED|Overall Study||2
170916|NCT01491672|416709|P3|Safety Set|Overall Study||14
170917|NCT01491672|416710|P2|Safety Set|Overall Study||61
170918|NCT01491672|416711|P1|Safety Set|Overall Study||58
170919|NCT01491672|416709|P3|STARTED|Overall Study||14
170920|NCT01491672|416710|P2|STARTED|Overall Study|1 participant died prior to treatment initiation.|62
170921|NCT01491672|416711|P1|STARTED|Overall Study||58
170922|NCT01491633|416736|P1|NOT COMPLETED|Overall Study||5
170923|NCT01491633|416736|P1|COMPLETED|Overall Study||0
170924|NCT01491633|416736|P1|STARTED|Overall Study||5
170925|NCT01491607|416748|P1|NOT COMPLETED|Overall Study||10
170926|NCT01491607|416748|P1|COMPLETED|Overall Study||190
170927|NCT01491607|416748|P1|STARTED|Overall Study||200
170928|NCT01491490|416846|P2|NOT COMPLETED|Overall Study||0
170929|NCT01491490|416847|P1|NOT COMPLETED|Overall Study||0
170930|NCT01491490|416846|P2|COMPLETED|Overall Study||1
170931|NCT01491490|416847|P1|COMPLETED|Overall Study||1
170932|NCT01491490|416846|P2|STARTED|Overall Study||1
170933|NCT01491490|416847|P1|STARTED|Overall Study||1
170934|NCT01491178|416853|P1|NOT COMPLETED|Overall Study||2794
170935|NCT01491178|416853|P1|COMPLETED|Overall Study|Completed is defined as 104 weeks follow-up after enrollment.|3649
170936|NCT01491178|416853|P1|STARTED|Overall Study|Started are the enrolled subjects who followed registration rule and for who eCRF was collected.|6443
170937|NCT01491113|416863|P5|NOT COMPLETED|Overall Study||0
170938|NCT01491113|416864|P4|NOT COMPLETED|Overall Study||0
170939|NCT01491113|416865|P3|NOT COMPLETED|Overall Study||0
170940|NCT01491113|416866|P2|NOT COMPLETED|Overall Study||0
170941|NCT01491113|416867|P1|NOT COMPLETED|Overall Study||0
170942|NCT01491113|416863|P5|COMPLETED|Overall Study||6
170943|NCT01491113|416864|P4|COMPLETED|Overall Study||6
170944|NCT01491113|416865|P3|COMPLETED|Overall Study||6
170945|NCT01491113|416866|P2|COMPLETED|Overall Study||6
170946|NCT01491113|416867|P1|COMPLETED|Overall Study||6
170947|NCT01491113|416863|P5|STARTED|Overall Study||6
170948|NCT01491113|416864|P4|STARTED|Overall Study||6
170949|NCT01491113|416865|P3|STARTED|Overall Study||6
170950|NCT01491113|416866|P2|STARTED|Overall Study||6
170951|NCT01491113|416867|P1|STARTED|Overall Study||6
170952|NCT01491035|416962|P8|NOT COMPLETED|Overall Study||0
170953|NCT01491035|416963|P7|NOT COMPLETED|Overall Study||0
170954|NCT01491035|416964|P6|NOT COMPLETED|Overall Study||0
170955|NCT01491035|416965|P5|NOT COMPLETED|Overall Study||1
170956|NCT01491035|416966|P4|NOT COMPLETED|Overall Study||0
170957|NCT01491035|416967|P3|NOT COMPLETED|Overall Study||0
170958|NCT01491035|416968|P2|NOT COMPLETED|Overall Study||0
170959|NCT01491035|416969|P1|NOT COMPLETED|Overall Study||0
170960|NCT01491035|416962|P8|COMPLETED|Overall Study||6
170961|NCT01491035|416963|P7|COMPLETED|Overall Study||6
170962|NCT01491035|416964|P6|COMPLETED|Overall Study||6
170963|NCT01491035|416965|P5|COMPLETED|Overall Study||5
170964|NCT01491035|416966|P4|COMPLETED|Overall Study||6
170965|NCT01491035|416967|P3|COMPLETED|Overall Study||6
170966|NCT01491035|416968|P2|COMPLETED|Overall Study||6
170967|NCT01491035|416969|P1|COMPLETED|Overall Study||6
170968|NCT01491035|416962|P8|STARTED|Overall Study||6
170969|NCT01491035|416963|P7|STARTED|Overall Study||6
170970|NCT01491035|416964|P6|STARTED|Overall Study||6
170971|NCT01491035|416965|P5|STARTED|Overall Study||6
170972|NCT01491035|416966|P4|STARTED|Overall Study||6
170973|NCT01491035|416967|P3|STARTED|Overall Study||6
170974|NCT01491035|416968|P2|STARTED|Overall Study||6
170975|NCT01491035|416969|P1|STARTED|Overall Study||6
170976|NCT01491022|417037|P2|NOT COMPLETED|Intervention 2||0
170977|NCT01491022|417038|P1|NOT COMPLETED|Intervention 2||1
170978|NCT01491022|417037|P2|COMPLETED|Intervention 2||11
170979|NCT01491022|417038|P1|COMPLETED|Intervention 2||8
170980|NCT01491022|417037|P2|STARTED|Intervention 2||11
170981|NCT01491022|417038|P1|STARTED|Intervention 2||9
170982|NCT01491022|417037|P2|NOT COMPLETED|2 Week Washout||0
170983|NCT01491022|417038|P1|NOT COMPLETED|2 Week Washout||0
170984|NCT01491022|417037|P2|COMPLETED|2 Week Washout||11
170985|NCT01491022|417038|P1|COMPLETED|2 Week Washout||9
170986|NCT01491022|417037|P2|STARTED|2 Week Washout||11
170987|NCT01491022|417038|P1|STARTED|2 Week Washout||9
170988|NCT01491022|417037|P2|NOT COMPLETED|Intervention 1||1
170989|NCT01491022|417038|P1|NOT COMPLETED|Intervention 1||1
170990|NCT01491022|417037|P2|COMPLETED|Intervention 1||11
170991|NCT01491022|417038|P1|COMPLETED|Intervention 1||9
170992|NCT01491022|417037|P2|STARTED|Intervention 1||12
170993|NCT01491022|417038|P1|STARTED|Intervention 1||10
170994|NCT01490931|417054|P1|NOT COMPLETED|Overall Study||0
170995|NCT01490931|417054|P1|COMPLETED|Overall Study||25
170996|NCT01490931|417054|P1|STARTED|Overall Study||25
170997|NCT01490866|417070|P1|NOT COMPLETED|Axitinib Maintenance Therapy||49
170998|NCT01490866|417070|P1|COMPLETED|Axitinib Maintenance Therapy|No protocol defined endpoint to Axitinib maintenance treatment.|0
170999|NCT01490866|417070|P1|STARTED|Axitinib Maintenance Therapy||49
171000|NCT01490866|417070|P1|NOT COMPLETED|FOLFOX/Bevacizumab Treatment||21
171001|NCT01490866|417070|P1|COMPLETED|FOLFOX/Bevacizumab Treatment||49
171002|NCT01490866|417070|P1|STARTED|FOLFOX/Bevacizumab Treatment||70
171003|NCT01490840|417081|P2|NOT COMPLETED|Phase 2||6
171004|NCT01490840|417082|P1|NOT COMPLETED|Phase 2||6
171005|NCT01490840|417081|P2|COMPLETED|Phase 2||68
171006|NCT01490840|417082|P1|COMPLETED|Phase 2||75
171007|NCT01490840|417081|P2|STARTED|Phase 2|4 participants discontinued between phase 1 and phase 2|74
171008|NCT01490840|417082|P1|STARTED|Phase 2|3 participants discontinued between phase 1 and phase 2|81
171009|NCT01490840|417081|P2|NOT COMPLETED|Phase 1||6
171010|NCT01490840|417082|P1|NOT COMPLETED|Phase 1||10
171011|NCT01490840|417081|P2|COMPLETED|Phase 1||78
171012|NCT01490840|417082|P1|COMPLETED|Phase 1||84
171013|NCT01490840|417081|P2|Modified Full Analysis Set|Phase 1||83
171014|NCT01490840|417082|P1|Modified Full Analysis Set|Phase 1||56
171015|NCT01490840|417081|P2|STARTED|Phase 1||84
171016|NCT01490840|417082|P1|STARTED|Phase 1||94
171017|NCT01490814|417106|P2|NOT COMPLETED|Overall Study||8
171018|NCT01490814|417107|P1|NOT COMPLETED|Overall Study||4
171019|NCT01490814|417106|P2|COMPLETED|Overall Study|376 received ablation|376
171020|NCT01490814|417107|P1|COMPLETED|Overall Study|374 received ablation|374
171021|NCT01490814|417106|P2|STARTED|Overall Study|384 subjects randomized to radiofrequency arm|384
171022|NCT01490814|417107|P1|STARTED|Overall Study|378 subjects randomized to Cryoballoon arm|378
171023|NCT01490788|417127|P6|NOT COMPLETED|Overall Study||0
171024|NCT01490788|417128|P5|NOT COMPLETED|Overall Study||0
171025|NCT01490788|417129|P4|NOT COMPLETED|Overall Study||0
171026|NCT01490788|417130|P3|NOT COMPLETED|Overall Study||0
171027|NCT01490788|417131|P2|NOT COMPLETED|Overall Study||0
171028|NCT01490788|417132|P1|NOT COMPLETED|Overall Study||1
171029|NCT01490788|417127|P6|COMPLETED|Overall Study||5
171030|NCT01490788|417128|P5|COMPLETED|Overall Study||5
171031|NCT01490788|417129|P4|COMPLETED|Overall Study||5
171032|NCT01490788|417130|P3|COMPLETED|Overall Study||5
171033|NCT01490788|417131|P2|COMPLETED|Overall Study||5
171034|NCT01490788|417132|P1|COMPLETED|Overall Study||4
171035|NCT01490788|417127|P6|STARTED|Overall Study||5
171036|NCT01490788|417128|P5|STARTED|Overall Study||5
171037|NCT01490788|417129|P4|STARTED|Overall Study||5
171038|NCT01490788|417130|P3|STARTED|Overall Study||5
171039|NCT01490788|417131|P2|STARTED|Overall Study||5
171040|NCT01490788|417132|P1|STARTED|Overall Study||5
171041|NCT01490697|417145|P2|NOT COMPLETED|Overall Study||2
171042|NCT01490697|417146|P1|NOT COMPLETED|Overall Study||1
171043|NCT01490697|417145|P2|COMPLETED|Overall Study||16
171044|NCT01490697|417146|P1|COMPLETED|Overall Study||15
171045|NCT01490697|417145|P2|STARTED|Overall Study||18
171046|NCT01490697|417146|P1|STARTED|Overall Study||16
171047|NCT01490684|417154|P1|NOT COMPLETED|Overall Study||0
171048|NCT01490684|417154|P1|COMPLETED|Overall Study||162
171049|NCT01490684|417154|P1|STARTED|Overall Study||162
171050|NCT01490632|417166|P20|NOT COMPLETED|Part D: Re-Treatment Period||7
171051|NCT01490632|417167|P19|NOT COMPLETED|Part D: Re-Treatment Period||7
171052|NCT01490632|417168|P18|NOT COMPLETED|Part D: Re-Treatment Period||5
171053|NCT01490632|417169|P17|NOT COMPLETED|Part D: Re-Treatment Period||0
171054|NCT01490632|417170|P16|NOT COMPLETED|Part D: Re-Treatment Period||0
171055|NCT01490632|417171|P15|NOT COMPLETED|Part D: Re-Treatment Period||0
171056|NCT01490632|417172|P14|NOT COMPLETED|Part D: Re-Treatment Period||0
171057|NCT01490632|417173|P13|NOT COMPLETED|Part D: Re-Treatment Period||0
171058|NCT01490632|417174|P12|NOT COMPLETED|Part D: Re-Treatment Period||0
171059|NCT01490632|417175|P11|NOT COMPLETED|Part D: Re-Treatment Period||0
171060|NCT01490632|417176|P10|NOT COMPLETED|Part D: Re-Treatment Period||0
171061|NCT01490632|417177|P9|NOT COMPLETED|Part D: Re-Treatment Period||0
171062|NCT01490632|417178|P8|NOT COMPLETED|Part D: Re-Treatment Period||0
171063|NCT01490632|417179|P7|NOT COMPLETED|Part D: Re-Treatment Period||0
171064|NCT01490632|417180|P6|NOT COMPLETED|Part D: Re-Treatment Period||0
171065|NCT01490632|417181|P5|NOT COMPLETED|Part D: Re-Treatment Period||0
171066|NCT01490632|417182|P4|NOT COMPLETED|Part D: Re-Treatment Period||0
171067|NCT01490632|417183|P3|NOT COMPLETED|Part D: Re-Treatment Period||0
171068|NCT01490632|417184|P2|NOT COMPLETED|Part D: Re-Treatment Period||0
171069|NCT01490632|417185|P1|NOT COMPLETED|Part D: Re-Treatment Period||0
171070|NCT01490632|417166|P20|COMPLETED|Part D: Re-Treatment Period||30
171071|NCT01490632|417167|P19|COMPLETED|Part D: Re-Treatment Period||12
171072|NCT01490632|417168|P18|COMPLETED|Part D: Re-Treatment Period||8
171073|NCT01490632|417169|P17|COMPLETED|Part D: Re-Treatment Period||3
171074|NCT01490632|417170|P16|COMPLETED|Part D: Re-Treatment Period||0
171075|NCT01490632|417171|P15|COMPLETED|Part D: Re-Treatment Period||0
171076|NCT01490632|417172|P14|COMPLETED|Part D: Re-Treatment Period||0
171077|NCT01490632|417173|P13|COMPLETED|Part D: Re-Treatment Period||0
171078|NCT01490632|417174|P12|COMPLETED|Part D: Re-Treatment Period||0
171079|NCT01490632|417175|P11|COMPLETED|Part D: Re-Treatment Period||0
171080|NCT01490632|417176|P10|COMPLETED|Part D: Re-Treatment Period||0
171081|NCT01490632|417177|P9|COMPLETED|Part D: Re-Treatment Period||0
171082|NCT01490632|417178|P8|COMPLETED|Part D: Re-Treatment Period||0
171083|NCT01490632|417179|P7|COMPLETED|Part D: Re-Treatment Period||0
171084|NCT01490632|417180|P6|COMPLETED|Part D: Re-Treatment Period||0
171085|NCT01490632|417181|P5|COMPLETED|Part D: Re-Treatment Period||0
171086|NCT01490632|417182|P4|COMPLETED|Part D: Re-Treatment Period||0
171087|NCT01490632|417183|P3|COMPLETED|Part D: Re-Treatment Period||0
171088|NCT01490632|417184|P2|COMPLETED|Part D: Re-Treatment Period||0
171089|NCT01490632|417185|P1|COMPLETED|Part D: Re-Treatment Period||0
171090|NCT01490632|417166|P20|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 10 mg.|37
171091|NCT01490632|417167|P19|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 8 mg.|19
171092|NCT01490632|417168|P18|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 4 mg.|13
171093|NCT01490632|417169|P17|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 2 mg.|3
171094|NCT01490632|417170|P16|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|0
171095|NCT01490632|417171|P15|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|0
171096|NCT01490632|417172|P14|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|0
171097|NCT01490632|417173|P13|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|0
171098|NCT01490632|417174|P12|STARTED|Part D: Re-Treatment Period||0
171099|NCT01490632|417175|P11|STARTED|Part D: Re-Treatment Period||0
171100|NCT01490632|417176|P10|STARTED|Part D: Re-Treatment Period||0
171101|NCT01490632|417177|P9|STARTED|Part D: Re-Treatment Period||0
171102|NCT01490632|417178|P8|STARTED|Part D: Re-Treatment Period||0
171103|NCT01490632|417179|P7|STARTED|Part D: Re-Treatment Period||0
171104|NCT01490632|417180|P6|STARTED|Part D: Re-Treatment Period||0
171105|NCT01490632|417181|P5|STARTED|Part D: Re-Treatment Period||0
171106|NCT01490632|417182|P4|STARTED|Part D: Re-Treatment Period||0
171107|NCT01490632|417183|P3|STARTED|Part D: Re-Treatment Period||0
171108|NCT01490632|417184|P2|STARTED|Part D: Re-Treatment Period||0
171109|NCT01490632|417185|P1|STARTED|Part D: Re-Treatment Period||0
171110|NCT01490632|417166|P20|NOT COMPLETED|Part C: Washout or Step-Down Period||0
171111|NCT01490632|417167|P19|NOT COMPLETED|Part C: Washout or Step-Down Period||0
171112|NCT01490632|417168|P18|NOT COMPLETED|Part C: Washout or Step-Down Period||0
171113|NCT01490632|417169|P17|NOT COMPLETED|Part C: Washout or Step-Down Period||0
171114|NCT01490632|417170|P16|NOT COMPLETED|Part C: Washout or Step-Down Period||37
171115|NCT01490632|417171|P15|NOT COMPLETED|Part C: Washout or Step-Down Period||18
171116|NCT01490632|417172|P14|NOT COMPLETED|Part C: Washout or Step-Down Period||10
171117|NCT01490632|417173|P13|NOT COMPLETED|Part C: Washout or Step-Down Period||5
171118|NCT01490632|417174|P12|NOT COMPLETED|Part C: Washout or Step-Down Period||0
171119|NCT01490632|417175|P11|NOT COMPLETED|Part C: Washout or Step-Down Period||0
171120|NCT01490632|417176|P10|NOT COMPLETED|Part C: Washout or Step-Down Period||0
171121|NCT01490632|417177|P9|NOT COMPLETED|Part C: Washout or Step-Down Period||0
171122|NCT01490632|417178|P8|NOT COMPLETED|Part C: Washout or Step-Down Period||0
171123|NCT01490632|417179|P7|NOT COMPLETED|Part C: Washout or Step-Down Period||0
171124|NCT01490632|417180|P6|NOT COMPLETED|Part C: Washout or Step-Down Period||0
171125|NCT01490632|417181|P5|NOT COMPLETED|Part C: Washout or Step-Down Period||0
171126|NCT01490632|417182|P4|NOT COMPLETED|Part C: Washout or Step-Down Period||0
171127|NCT01490632|417183|P3|NOT COMPLETED|Part C: Washout or Step-Down Period||0
171128|NCT01490632|417184|P2|NOT COMPLETED|Part C: Washout or Step-Down Period||0
171129|NCT01490632|417185|P1|NOT COMPLETED|Part C: Washout or Step-Down Period||0
171130|NCT01490632|417166|P20|COMPLETED|Part C: Washout or Step-Down Period||0
171131|NCT01490632|417167|P19|COMPLETED|Part C: Washout or Step-Down Period||0
171132|NCT01490632|417168|P18|COMPLETED|Part C: Washout or Step-Down Period||0
171133|NCT01490632|417169|P17|COMPLETED|Part C: Washout or Step-Down Period||0
171134|NCT01490632|417170|P16|COMPLETED|Part C: Washout or Step-Down Period||18
171135|NCT01490632|417171|P15|COMPLETED|Part C: Washout or Step-Down Period||37
171136|NCT01490632|417172|P14|COMPLETED|Part C: Washout or Step-Down Period||6
171137|NCT01490632|417173|P13|COMPLETED|Part C: Washout or Step-Down Period||10
171138|NCT01490632|417174|P12|COMPLETED|Part C: Washout or Step-Down Period||0
171139|NCT01490632|417175|P11|COMPLETED|Part C: Washout or Step-Down Period||0
171140|NCT01490632|417176|P10|COMPLETED|Part C: Washout or Step-Down Period||0
171141|NCT01490632|417177|P9|COMPLETED|Part C: Washout or Step-Down Period||0
171142|NCT01490632|417178|P8|COMPLETED|Part C: Washout or Step-Down Period||0
171143|NCT01490632|417179|P7|COMPLETED|Part C: Washout or Step-Down Period||0
171144|NCT01490632|417180|P6|COMPLETED|Part C: Washout or Step-Down Period||0
171145|NCT01490632|417181|P5|COMPLETED|Part C: Washout or Step-Down Period||0
171146|NCT01490632|417182|P4|COMPLETED|Part C: Washout or Step-Down Period||0
171147|NCT01490632|417183|P3|COMPLETED|Part C: Washout or Step-Down Period||0
171148|NCT01490632|417184|P2|COMPLETED|Part C: Washout or Step-Down Period||0
171149|NCT01490632|417185|P1|COMPLETED|Part C: Washout or Step-Down Period||0
171150|NCT01490632|417166|P20|STARTED|Part C: Washout or Step-Down Period||0
171151|NCT01490632|417167|P19|STARTED|Part C: Washout or Step-Down Period||0
171152|NCT01490632|417168|P18|STARTED|Part C: Washout or Step-Down Period||0
171153|NCT01490632|417169|P17|STARTED|Part C: Washout or Step-Down Period||0
171154|NCT01490632|417170|P16|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|55
171155|NCT01490632|417171|P15|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|55
171156|NCT01490632|417172|P14|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|16
171157|NCT01490632|417173|P13|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|15
171158|NCT01490632|417174|P12|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to Placebo remained on Placebo.|0
171159|NCT01490632|417175|P11|STARTED|Part C: Washout or Step-Down Period|Part A 10 mg non-responders were discontinued from the study.|0
171160|NCT01490632|417176|P10|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|0
171161|NCT01490632|417177|P9|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|0
171162|NCT01490632|417178|P8|STARTED|Part C: Washout or Step-Down Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|0
171163|NCT01490632|417179|P7|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|0
171164|NCT01490632|417180|P6|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|0
171165|NCT01490632|417181|P5|STARTED|Part C: Washout or Step-Down Period|One participant completed Part B but discontinued without receiving a Part C treatment assignment.|0
171166|NCT01490632|417182|P4|STARTED|Part C: Washout or Step-Down Period||0
171167|NCT01490632|417183|P3|STARTED|Part C: Washout or Step-Down Period||0
171168|NCT01490632|417184|P2|STARTED|Part C: Washout or Step-Down Period||0
171169|NCT01490632|417185|P1|STARTED|Part C: Washout or Step-Down Period||0
171170|NCT01490632|417166|P20|NOT COMPLETED|Part B: Extension or Step-Up Period||0
171171|NCT01490632|417167|P19|NOT COMPLETED|Part B: Extension or Step-Up Period||0
171172|NCT01490632|417168|P18|NOT COMPLETED|Part B: Extension or Step-Up Period||0
171173|NCT01490632|417169|P17|NOT COMPLETED|Part B: Extension or Step-Up Period||0
171174|NCT01490632|417170|P16|NOT COMPLETED|Part B: Extension or Step-Up Period||0
171175|NCT01490632|417171|P15|NOT COMPLETED|Part B: Extension or Step-Up Period||0
171176|NCT01490632|417172|P14|NOT COMPLETED|Part B: Extension or Step-Up Period||0
171177|NCT01490632|417173|P13|NOT COMPLETED|Part B: Extension or Step-Up Period||0
171178|NCT01490632|417174|P12|NOT COMPLETED|Part B: Extension or Step-Up Period||8
171179|NCT01490632|417175|P11|NOT COMPLETED|Part B: Extension or Step-Up Period||21
171180|NCT01490632|417176|P10|NOT COMPLETED|Part B: Extension or Step-Up Period||25
171181|NCT01490632|417177|P9|NOT COMPLETED|Part B: Extension or Step-Up Period||10
171182|NCT01490632|417178|P8|NOT COMPLETED|Part B: Extension or Step-Up Period||6
171183|NCT01490632|417179|P7|NOT COMPLETED|Part B: Extension or Step-Up Period||13
171184|NCT01490632|417180|P6|NOT COMPLETED|Part B: Extension or Step-Up Period||4
171185|NCT01490632|417181|P5|NOT COMPLETED|Part B: Extension or Step-Up Period||0
171186|NCT01490632|417182|P4|NOT COMPLETED|Part B: Extension or Step-Up Period||0
171187|NCT01490632|417183|P3|NOT COMPLETED|Part B: Extension or Step-Up Period||0
171188|NCT01490632|417184|P2|NOT COMPLETED|Part B: Extension or Step-Up Period||0
171189|NCT01490632|417185|P1|NOT COMPLETED|Part B: Extension or Step-Up Period||0
171190|NCT01490632|417166|P20|COMPLETED|Part B: Extension or Step-Up Period||0
171191|NCT01490632|417167|P19|COMPLETED|Part B: Extension or Step-Up Period||0
171192|NCT01490632|417168|P18|COMPLETED|Part B: Extension or Step-Up Period||0
171193|NCT01490632|417169|P17|COMPLETED|Part B: Extension or Step-Up Period||0
171194|NCT01490632|417170|P16|COMPLETED|Part B: Extension or Step-Up Period||0
171195|NCT01490632|417171|P15|COMPLETED|Part B: Extension or Step-Up Period||0
171196|NCT01490632|417172|P14|COMPLETED|Part B: Extension or Step-Up Period||0
171197|NCT01490632|417173|P13|COMPLETED|Part B: Extension or Step-Up Period||0
171198|NCT01490632|417174|P12|COMPLETED|Part B: Extension or Step-Up Period||0
171199|NCT01490632|417175|P11|COMPLETED|Part B: Extension or Step-Up Period||22
171200|NCT01490632|417176|P10|COMPLETED|Part B: Extension or Step-Up Period||25
171201|NCT01490632|417177|P9|COMPLETED|Part B: Extension or Step-Up Period||6
171202|NCT01490632|417178|P8|COMPLETED|Part B: Extension or Step-Up Period||13
171203|NCT01490632|417179|P7|COMPLETED|Part B: Extension or Step-Up Period||51
171204|NCT01490632|417180|P6|COMPLETED|Part B: Extension or Step-Up Period||25
171205|NCT01490632|417181|P5|COMPLETED|Part B: Extension or Step-Up Period||0
171206|NCT01490632|417182|P4|COMPLETED|Part B: Extension or Step-Up Period||0
171207|NCT01490632|417183|P3|COMPLETED|Part B: Extension or Step-Up Period||0
171208|NCT01490632|417184|P2|COMPLETED|Part B: Extension or Step-Up Period||0
171209|NCT01490632|417185|P1|COMPLETED|Part B: Extension or Step-Up Period||0
171210|NCT01490632|417166|P20|STARTED|Part B: Extension or Step-Up Period||0
171211|NCT01490632|417167|P19|STARTED|Part B: Extension or Step-Up Period||0
171212|NCT01490632|417168|P18|STARTED|Part B: Extension or Step-Up Period||0
171213|NCT01490632|417169|P17|STARTED|Part B: Extension or Step-Up Period||0
171214|NCT01490632|417170|P16|STARTED|Part B: Extension or Step-Up Period||0
171215|NCT01490632|417171|P15|STARTED|Part B: Extension or Step-Up Period||0
171216|NCT01490632|417172|P14|STARTED|Part B: Extension or Step-Up Period||0
171217|NCT01490632|417173|P13|STARTED|Part B: Extension or Step-Up Period||0
171218|NCT01490632|417174|P12|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to Placebo remained on Placebo.|8
171219|NCT01490632|417175|P11|STARTED|Part B: Extension or Step-Up Period|Part A 10 mg non-responders were discontinued from the study.|43
171220|NCT01490632|417176|P10|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|50
171221|NCT01490632|417177|P9|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|16
171222|NCT01490632|417178|P8|STARTED|Part B: Extension or Step-Up Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|19
171223|NCT01490632|417179|P7|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|64
171224|NCT01490632|417180|P6|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|29
171225|NCT01490632|417181|P5|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
171226|NCT01490632|417182|P4|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
171227|NCT01490632|417183|P3|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
171228|NCT01490632|417184|P2|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
171229|NCT01490632|417185|P1|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
171230|NCT01490632|417166|P20|NOT COMPLETED|Part A: Initial Treatment Period||0
171231|NCT01490632|417167|P19|NOT COMPLETED|Part A: Initial Treatment Period||0
171232|NCT01490632|417168|P18|NOT COMPLETED|Part A: Initial Treatment Period||0
171233|NCT01490632|417169|P17|NOT COMPLETED|Part A: Initial Treatment Period||0
171234|NCT01490632|417170|P16|NOT COMPLETED|Part A: Initial Treatment Period||0
171235|NCT01490632|417171|P15|NOT COMPLETED|Part A: Initial Treatment Period||0
171236|NCT01490632|417172|P14|NOT COMPLETED|Part A: Initial Treatment Period||0
171237|NCT01490632|417173|P13|NOT COMPLETED|Part A: Initial Treatment Period||0
171238|NCT01490632|417174|P12|NOT COMPLETED|Part A: Initial Treatment Period||0
171239|NCT01490632|417175|P11|NOT COMPLETED|Part A: Initial Treatment Period||0
171240|NCT01490632|417176|P10|NOT COMPLETED|Part A: Initial Treatment Period||0
171241|NCT01490632|417177|P9|NOT COMPLETED|Part A: Initial Treatment Period||0
171242|NCT01490632|417178|P8|NOT COMPLETED|Part A: Initial Treatment Period||0
171243|NCT01490632|417179|P7|NOT COMPLETED|Part A: Initial Treatment Period||0
171244|NCT01490632|417180|P6|NOT COMPLETED|Part A: Initial Treatment Period||0
171245|NCT01490632|417181|P5|NOT COMPLETED|Part A: Initial Treatment Period||17
171246|NCT01490632|417182|P4|NOT COMPLETED|Part A: Initial Treatment Period||9
171247|NCT01490632|417183|P3|NOT COMPLETED|Part A: Initial Treatment Period||5
171248|NCT01490632|417184|P2|NOT COMPLETED|Part A: Initial Treatment Period||4
171249|NCT01490632|417185|P1|NOT COMPLETED|Part A: Initial Treatment Period||7
171250|NCT01490632|417166|P20|COMPLETED|Part A: Initial Treatment Period||0
171251|NCT01490632|417167|P19|COMPLETED|Part A: Initial Treatment Period||0
171252|NCT01490632|417168|P18|COMPLETED|Part A: Initial Treatment Period||0
171253|NCT01490632|417169|P17|COMPLETED|Part A: Initial Treatment Period||0
171254|NCT01490632|417170|P16|COMPLETED|Part A: Initial Treatment Period||0
171255|NCT01490632|417171|P15|COMPLETED|Part A: Initial Treatment Period||0
171256|NCT01490632|417172|P14|COMPLETED|Part A: Initial Treatment Period||0
171257|NCT01490632|417173|P13|COMPLETED|Part A: Initial Treatment Period||0
171258|NCT01490632|417174|P12|COMPLETED|Part A: Initial Treatment Period||0
171259|NCT01490632|417175|P11|COMPLETED|Part A: Initial Treatment Period||0
171260|NCT01490632|417176|P10|COMPLETED|Part A: Initial Treatment Period||0
171261|NCT01490632|417177|P9|COMPLETED|Part A: Initial Treatment Period||0
171262|NCT01490632|417178|P8|COMPLETED|Part A: Initial Treatment Period||0
171263|NCT01490632|417179|P7|COMPLETED|Part A: Initial Treatment Period||0
171264|NCT01490632|417180|P6|COMPLETED|Part A: Initial Treatment Period||0
171265|NCT01490632|417181|P5|COMPLETED|Part A: Initial Treatment Period|Includes participants who completed Part A, but discontinued per protocol using Part A PASI score.|52
171266|NCT01490632|417182|P4|COMPLETED|Part A: Initial Treatment Period||55
171267|NCT01490632|417183|P3|COMPLETED|Part A: Initial Treatment Period||67
171268|NCT01490632|417184|P2|COMPLETED|Part A: Initial Treatment Period||28
171269|NCT01490632|417185|P1|COMPLETED|Part A: Initial Treatment Period||27
171270|NCT01490632|417166|P20|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
171271|NCT01490632|417167|P19|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
171272|NCT01490632|417168|P18|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
171273|NCT01490632|417169|P17|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
171274|NCT01490632|417170|P16|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
171275|NCT01490632|417171|P15|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
171276|NCT01490632|417172|P14|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
171361|NCT01490125|417628|P5|STARTED|Period III||32
171277|NCT01490632|417173|P13|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
171278|NCT01490632|417174|P12|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
171279|NCT01490632|417175|P11|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
171280|NCT01490632|417176|P10|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
171281|NCT01490632|417177|P9|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
171282|NCT01490632|417178|P8|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
171283|NCT01490632|417179|P7|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
171284|NCT01490632|417180|P6|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
171285|NCT01490632|417181|P5|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||69
171286|NCT01490632|417182|P4|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||64
171287|NCT01490632|417183|P3|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||72
171288|NCT01490632|417184|P2|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||32
171289|NCT01490632|417185|P1|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||34
171290|NCT01490632|417166|P20|STARTED|Part A: Initial Treatment Period||0
171291|NCT01490632|417167|P19|STARTED|Part A: Initial Treatment Period||0
171292|NCT01490632|417168|P18|STARTED|Part A: Initial Treatment Period||0
171293|NCT01490632|417169|P17|STARTED|Part A: Initial Treatment Period||0
171294|NCT01490632|417170|P16|STARTED|Part A: Initial Treatment Period||0
171295|NCT01490632|417171|P15|STARTED|Part A: Initial Treatment Period||0
171296|NCT01490632|417172|P14|STARTED|Part A: Initial Treatment Period||0
171297|NCT01490632|417173|P13|STARTED|Part A: Initial Treatment Period||0
171298|NCT01490632|417174|P12|STARTED|Part A: Initial Treatment Period||0
171299|NCT01490632|417175|P11|STARTED|Part A: Initial Treatment Period||0
171300|NCT01490632|417176|P10|STARTED|Part A: Initial Treatment Period||0
171301|NCT01490632|417177|P9|STARTED|Part A: Initial Treatment Period||0
171302|NCT01490632|417178|P8|STARTED|Part A: Initial Treatment Period||0
171303|NCT01490632|417179|P7|STARTED|Part A: Initial Treatment Period||0
171304|NCT01490632|417180|P6|STARTED|Part A: Initial Treatment Period||0
171305|NCT01490632|417181|P5|STARTED|Part A: Initial Treatment Period||69
171306|NCT01490632|417182|P4|STARTED|Part A: Initial Treatment Period||64
171307|NCT01490632|417183|P3|STARTED|Part A: Initial Treatment Period||72
171308|NCT01490632|417184|P2|STARTED|Part A: Initial Treatment Period||32
171309|NCT01490632|417185|P1|STARTED|Part A: Initial Treatment Period||34
171310|NCT01490580|417315|P2|NOT COMPLETED|Overall Study||2
171311|NCT01490580|417316|P1|NOT COMPLETED|Overall Study||0
171312|NCT01490580|417315|P2|COMPLETED|Overall Study||89
171313|NCT01490580|417316|P1|COMPLETED|Overall Study||82
171314|NCT01490580|417315|P2|STARTED|Overall Study||91
171315|NCT01490580|417316|P1|STARTED|Overall Study||82
171316|NCT01490359|417338|P2|NOT COMPLETED|Overall Study||17
171317|NCT01490359|417339|P1|NOT COMPLETED|Overall Study||24
171318|NCT01490359|417338|P2|COMPLETED|Overall Study||555
171319|NCT01490359|417339|P1|COMPLETED|Overall Study||585
171320|NCT01490359|417338|P2|Followed-up at 12 mo|Overall Study||537
171321|NCT01490359|417339|P1|Followed-up at 12 mo|Overall Study||569
171322|NCT01490359|417338|P2|Followed-up at 6 mo|Overall Study||535
171323|NCT01490359|417339|P1|Followed-up at 6 mo|Overall Study||558
171324|NCT01490359|417338|P2|STARTED|Overall Study||572
171325|NCT01490359|417339|P1|STARTED|Overall Study||609
171326|NCT01490294|417363|P4|NOT COMPLETED|Overall Study||1
171327|NCT01490294|417364|P3|NOT COMPLETED|Overall Study||1
171328|NCT01490294|417365|P2|NOT COMPLETED|Overall Study||0
171329|NCT01490294|417366|P1|NOT COMPLETED|Overall Study||5
171330|NCT01490294|417363|P4|COMPLETED|Overall Study||54
171331|NCT01490294|417364|P3|COMPLETED|Overall Study||58
171332|NCT01490294|417365|P2|COMPLETED|Overall Study||60
171333|NCT01490294|417366|P1|COMPLETED|Overall Study||53
171334|NCT01490294|417363|P4|Participant Received Treatment|Overall Study||54
171335|NCT01490294|417364|P3|Participant Received Treatment|Overall Study||58
171336|NCT01490294|417365|P2|Participant Received Treatment|Overall Study||60
171337|NCT01490294|417366|P1|Participant Received Treatment|Overall Study||54
171338|NCT01490294|417363|P4|STARTED|Overall Study||55
171339|NCT01490294|417364|P3|STARTED|Overall Study||59
171340|NCT01490294|417365|P2|STARTED|Overall Study||60
171341|NCT01490294|417366|P1|STARTED|Overall Study||58
171342|NCT01490190|417600|P1|NOT COMPLETED|Overall Study||48
171343|NCT01490190|417600|P1|COMPLETED|Overall Study||204
171344|NCT01490190|417600|P1|STARTED|Overall Study||252
171345|NCT01490151|417621|P1|NOT COMPLETED|Overall Study||0
171346|NCT01490151|417621|P1|COMPLETED|Overall Study||22
171347|NCT01490151|417621|P1|STARTED|Overall Study||22
171348|NCT01490125|417627|P6|NOT COMPLETED|Period III||0
171349|NCT01490125|417628|P5|NOT COMPLETED|Period III||1
171350|NCT01490125|417629|P4|NOT COMPLETED|Period III||2
171351|NCT01490125|417630|P3|NOT COMPLETED|Period III||0
171352|NCT01490125|417631|P2|NOT COMPLETED|Period III||1
171353|NCT01490125|417632|P1|NOT COMPLETED|Period III||3
171354|NCT01490125|417627|P6|COMPLETED|Period III||35
171355|NCT01490125|417628|P5|COMPLETED|Period III||31
171356|NCT01490125|417629|P4|COMPLETED|Period III||28
171357|NCT01490125|417630|P3|COMPLETED|Period III||34
171358|NCT01490125|417631|P2|COMPLETED|Period III||32
171359|NCT01490125|417632|P1|COMPLETED|Period III||31
171360|NCT01490125|417627|P6|STARTED|Period III||35
171362|NCT01490125|417629|P4|STARTED|Period III||30
171363|NCT01490125|417630|P3|STARTED|Period III||34
171364|NCT01490125|417631|P2|STARTED|Period III||33
171365|NCT01490125|417632|P1|STARTED|Period III||34
171366|NCT01490125|417627|P6|NOT COMPLETED|Period II||2
171367|NCT01490125|417628|P5|NOT COMPLETED|Period II||4
171368|NCT01490125|417629|P4|NOT COMPLETED|Period II||3
171369|NCT01490125|417630|P3|NOT COMPLETED|Period II||3
171370|NCT01490125|417631|P2|NOT COMPLETED|Period II||4
171371|NCT01490125|417632|P1|NOT COMPLETED|Period II||3
171372|NCT01490125|417627|P6|COMPLETED|Period II||35
171373|NCT01490125|417628|P5|COMPLETED|Period II||32
171374|NCT01490125|417629|P4|COMPLETED|Period II||30
171375|NCT01490125|417630|P3|COMPLETED|Period II||34
171376|NCT01490125|417631|P2|COMPLETED|Period II||33
171377|NCT01490125|417632|P1|COMPLETED|Period II||34
171378|NCT01490125|417627|P6|STARTED|Period II||37
171379|NCT01490125|417628|P5|STARTED|Period II||36
171380|NCT01490125|417629|P4|STARTED|Period II||33
171381|NCT01490125|417630|P3|STARTED|Period II||37
171382|NCT01490125|417631|P2|STARTED|Period II||37
171383|NCT01490125|417632|P1|STARTED|Period II||37
171384|NCT01490125|417627|P6|NOT COMPLETED|Period I||5
171385|NCT01490125|417628|P5|NOT COMPLETED|Period I||4
171386|NCT01490125|417629|P4|NOT COMPLETED|Period I||5
171387|NCT01490125|417630|P3|NOT COMPLETED|Period I||4
171388|NCT01490125|417631|P2|NOT COMPLETED|Period I||5
171389|NCT01490125|417632|P1|NOT COMPLETED|Period I||6
171390|NCT01490125|417627|P6|COMPLETED|Period I||37
171391|NCT01490125|417628|P5|COMPLETED|Period I||36
171392|NCT01490125|417629|P4|COMPLETED|Period I||33
171393|NCT01490125|417630|P3|COMPLETED|Period I||37
171394|NCT01490125|417631|P2|COMPLETED|Period I||37
171395|NCT01490125|417632|P1|COMPLETED|Period I||37
171396|NCT01490125|417627|P6|STARTED|Period I||42
171397|NCT01490125|417628|P5|STARTED|Period I||40
171398|NCT01490125|417629|P4|STARTED|Period I||38
171399|NCT01490125|417630|P3|STARTED|Period I||41
171400|NCT01490125|417631|P2|STARTED|Period I||42
171401|NCT01490125|417632|P1|STARTED|Period I||43
171402|NCT01490086|417660|P5|NOT COMPLETED|Overall Study||11
171403|NCT01490086|417661|P4|NOT COMPLETED|Overall Study||7
171404|NCT01490086|417662|P3|NOT COMPLETED|Overall Study||7
171405|NCT01490086|417663|P2|NOT COMPLETED|Overall Study||15
171406|NCT01490086|417664|P1|NOT COMPLETED|Overall Study||8
171407|NCT01490086|417660|P5|COMPLETED|Overall Study||28
171408|NCT01490086|417661|P4|COMPLETED|Overall Study||13
171409|NCT01490086|417662|P3|COMPLETED|Overall Study||51
171410|NCT01490086|417663|P2|COMPLETED|Overall Study||44
171411|NCT01490086|417664|P1|COMPLETED|Overall Study||50
171412|NCT01490086|417660|P5|STARTED|Overall Study||39
171413|NCT01490086|417661|P4|STARTED|Overall Study||20
171414|NCT01490086|417662|P3|STARTED|Overall Study||58
171415|NCT01490086|417663|P2|STARTED|Overall Study||59
171416|NCT01490086|417664|P1|STARTED|Overall Study||58
171417|NCT01490073|417698|P2|NOT COMPLETED|Overall Study||0
171418|NCT01490073|417699|P1|NOT COMPLETED|Overall Study||0
171419|NCT01490073|417698|P2|COMPLETED|Overall Study||12
171420|NCT01490073|417699|P1|COMPLETED|Overall Study||12
171421|NCT01490073|417698|P2|STARTED|Overall Study||12
171422|NCT01490073|417699|P1|STARTED|Overall Study||12
171423|NCT01490060|417709|P4|NOT COMPLETED|Cycle 2||0
171424|NCT01490060|417710|P3|NOT COMPLETED|Cycle 2||1
171425|NCT01490060|417711|P2|NOT COMPLETED|Cycle 2||1
171426|NCT01490060|417712|P1|NOT COMPLETED|Cycle 2||2
171427|NCT01490060|417709|P4|COMPLETED|Cycle 2||8
171428|NCT01490060|417710|P3|COMPLETED|Cycle 2||8
171429|NCT01490060|417711|P2|COMPLETED|Cycle 2||11
171430|NCT01490060|417712|P1|COMPLETED|Cycle 2||9
171431|NCT01490060|417709|P4|STARTED|Cycle 2||8
171432|NCT01490060|417710|P3|STARTED|Cycle 2||9
171433|NCT01490060|417711|P2|STARTED|Cycle 2||12
171434|NCT01490060|417712|P1|STARTED|Cycle 2||11
171435|NCT01490060|417709|P4|NOT COMPLETED|Cycle 1||3
171436|NCT01490060|417710|P3|NOT COMPLETED|Cycle 1||3
171437|NCT01490060|417711|P2|NOT COMPLETED|Cycle 1||1
171438|NCT01490060|417712|P1|NOT COMPLETED|Cycle 1||0
171439|NCT01490060|417709|P4|COMPLETED|Cycle 1||8
171440|NCT01490060|417710|P3|COMPLETED|Cycle 1||9
171441|NCT01490060|417711|P2|COMPLETED|Cycle 1||12
171442|NCT01490060|417712|P1|COMPLETED|Cycle 1||11
171443|NCT01490060|417709|P4|STARTED|Cycle 1||11
171444|NCT01490060|417710|P3|STARTED|Cycle 1||12
171445|NCT01490060|417711|P2|STARTED|Cycle 1||13
171446|NCT01490060|417712|P1|STARTED|Cycle 1||11
171447|NCT01489969|417723|P3|NOT COMPLETED|Overall Study||1
171448|NCT01489969|417724|P2|NOT COMPLETED|Overall Study||4
171449|NCT01489969|417725|P1|NOT COMPLETED|Overall Study||5
171450|NCT01489969|417723|P3|COMPLETED|Overall Study||44
171451|NCT01489969|417724|P2|COMPLETED|Overall Study||43
171452|NCT01489969|417725|P1|COMPLETED|Overall Study||40
171453|NCT01489969|417723|P3|STARTED|Overall Study||45
171454|NCT01489969|417724|P2|STARTED|Overall Study||47
171455|NCT01489969|417725|P1|STARTED|Overall Study||45
171456|NCT01489956|417741|P3|NOT COMPLETED|Overall Study||1
171457|NCT01489956|417742|P2|NOT COMPLETED|Overall Study||0
171458|NCT01489956|417743|P1|NOT COMPLETED|Overall Study||1
171459|NCT01489956|417741|P3|COMPLETED|Overall Study||5
171460|NCT01489956|417742|P2|COMPLETED|Overall Study||0
171461|NCT01489956|417743|P1|COMPLETED|Overall Study||12
171552|NCT01489020|418052|P6|NOT COMPLETED|Overall Study||0
171462|NCT01489956|417741|P3|STARTED|Overall Study|These 6 subjects had Immucothel alone since Montanide was not needed for the 10 participants dosed.|6
171463|NCT01489956|417742|P2|STARTED|Overall Study|Nine of the 10 participants receiving Immucothel alone had a response, so Montanide was not used.|0
171464|NCT01489956|417743|P1|STARTED|Overall Study|Ten of the 13 participants were considered evaluable.|13
171465|NCT01489891|417780|P2|NOT COMPLETED|Overall Study||0
171466|NCT01489891|417781|P1|NOT COMPLETED|Overall Study||1
171467|NCT01489891|417780|P2|COMPLETED|Overall Study||60
171468|NCT01489891|417781|P1|COMPLETED|Overall Study||59
171469|NCT01489891|417780|P2|STARTED|Overall Study||60
171470|NCT01489891|417781|P1|STARTED|Overall Study||60
171471|NCT01489826|417802|P9|NOT COMPLETED|Overall Study||0
171472|NCT01489826|417803|P8|NOT COMPLETED|Overall Study||0
171473|NCT01489826|417804|P7|NOT COMPLETED|Overall Study||0
171474|NCT01489826|417805|P6|NOT COMPLETED|Overall Study||0
171475|NCT01489826|417806|P5|NOT COMPLETED|Overall Study||0
171476|NCT01489826|417807|P4|NOT COMPLETED|Overall Study||0
171477|NCT01489826|417808|P3|NOT COMPLETED|Overall Study||0
171478|NCT01489826|417809|P2|NOT COMPLETED|Overall Study||0
171479|NCT01489826|417810|P1|NOT COMPLETED|Overall Study||0
171480|NCT01489826|417802|P9|COMPLETED|Overall Study||6
171481|NCT01489826|417803|P8|COMPLETED|Overall Study||3
171482|NCT01489826|417804|P7|COMPLETED|Overall Study||9
171483|NCT01489826|417805|P6|COMPLETED|Overall Study||3
171484|NCT01489826|417806|P5|COMPLETED|Overall Study||3
171485|NCT01489826|417807|P4|COMPLETED|Overall Study||7
171486|NCT01489826|417808|P3|COMPLETED|Overall Study||3
171487|NCT01489826|417809|P2|COMPLETED|Overall Study||3
171488|NCT01489826|417810|P1|COMPLETED|Overall Study||3
171489|NCT01489826|417802|P9|STARTED|Overall Study||6
171490|NCT01489826|417803|P8|STARTED|Overall Study||3
171491|NCT01489826|417804|P7|STARTED|Overall Study||9
171492|NCT01489826|417805|P6|STARTED|Overall Study||3
171493|NCT01489826|417806|P5|STARTED|Overall Study||3
171494|NCT01489826|417807|P4|STARTED|Overall Study||7
171495|NCT01489826|417808|P3|STARTED|Overall Study||3
171496|NCT01489826|417809|P2|STARTED|Overall Study||3
171497|NCT01489826|417810|P1|STARTED|Overall Study||3
171498|NCT01489670|417907|P1|NOT COMPLETED|Overall Study||53
171499|NCT01489670|417907|P1|COMPLETED|Overall Study||334
171500|NCT01489670|417907|P1|STARTED|Overall Study||387
171501|NCT01489579|417919|P2|NOT COMPLETED|Overall Study||7
171502|NCT01489579|417920|P1|NOT COMPLETED|Overall Study||9
171503|NCT01489579|417919|P2|COMPLETED|Overall Study||57
171504|NCT01489579|417920|P1|COMPLETED|Overall Study||47
171505|NCT01489579|417919|P2|STARTED|Overall Study||64
171506|NCT01489579|417920|P1|STARTED|Overall Study||56
171507|NCT01489527|417936|P2|NOT COMPLETED|Overall Study||26
171508|NCT01489527|417937|P1|NOT COMPLETED|Overall Study||22
171509|NCT01489527|417936|P2|COMPLETED|Overall Study||175
171510|NCT01489527|417937|P1|COMPLETED|Overall Study||183
171511|NCT01489527|417936|P2|STARTED|Overall Study||201
171512|NCT01489527|417937|P1|STARTED|Overall Study||205
171513|NCT01489358|417954|P3|NOT COMPLETED|Overall Study||2
171514|NCT01489358|417955|P2|NOT COMPLETED|Overall Study||0
171515|NCT01489358|417956|P1|NOT COMPLETED|Overall Study||0
171516|NCT01489358|417954|P3|COMPLETED|Overall Study||8
171517|NCT01489358|417955|P2|COMPLETED|Overall Study||10
171518|NCT01489358|417956|P1|COMPLETED|Overall Study||5
171519|NCT01489358|417954|P3|STARTED|Overall Study||10
171520|NCT01489358|417955|P2|STARTED|Overall Study||10
171521|NCT01489358|417956|P1|STARTED|Overall Study||5
171522|NCT01489254|418006|P4|NOT COMPLETED|Open-label Extension Part||58
171523|NCT01489254|418007|P3|NOT COMPLETED|Open-label Extension Part||0
171524|NCT01489254|418008|P2|NOT COMPLETED|Open-label Extension Part||0
171525|NCT01489254|418009|P1|NOT COMPLETED|Open-label Extension Part||0
171526|NCT01489254|418006|P4|COMPLETED|Open-label Extension Part||670
171527|NCT01489254|418007|P3|COMPLETED|Open-label Extension Part||0
171528|NCT01489254|418008|P2|COMPLETED|Open-label Extension Part||0
171529|NCT01489254|418009|P1|COMPLETED|Open-label Extension Part||0
171530|NCT01489254|418006|P4|STARTED|Open-label Extension Part|735 completed the DB part, 729 were eligible to continue in the OL part, 1 opted not to continue|728
171531|NCT01489254|418007|P3|STARTED|Open-label Extension Part||0
171532|NCT01489254|418008|P2|STARTED|Open-label Extension Part||0
171533|NCT01489254|418009|P1|STARTED|Open-label Extension Part||0
171534|NCT01489254|418006|P4|NOT COMPLETED|Double-blind Part||0
171535|NCT01489254|418007|P3|NOT COMPLETED|Double-blind Part||3
171536|NCT01489254|418008|P2|NOT COMPLETED|Double-blind Part||33
171537|NCT01489254|418009|P1|NOT COMPLETED|Double-blind Part||25
171538|NCT01489254|418006|P4|COMPLETED|Double-blind Part||0
171539|NCT01489254|418007|P3|COMPLETED|Double-blind Part||81
171540|NCT01489254|418008|P2|COMPLETED|Double-blind Part||324
171541|NCT01489254|418009|P1|COMPLETED|Double-blind Part||330
171542|NCT01489254|418006|P4|STARTED|Double-blind Part||0
171543|NCT01489254|418007|P3|STARTED|Double-blind Part||84
171544|NCT01489254|418008|P2|STARTED|Double-blind Part||357
171545|NCT01489254|418009|P1|STARTED|Double-blind Part||355
171546|NCT01489189|418020|P2|NOT COMPLETED|Overall Study||35
171547|NCT01489189|418021|P1|NOT COMPLETED|Overall Study||31
171548|NCT01489189|418020|P2|COMPLETED|Overall Study|Number of Eyes|168
171549|NCT01489189|418021|P1|COMPLETED|Overall Study|Number of Eyes|160
171550|NCT01489189|418020|P2|STARTED|Overall Study|Number of Eyes|203
171551|NCT01489189|418021|P1|STARTED|Overall Study|Number of Eyes|191
171553|NCT01489020|418053|P5|NOT COMPLETED|Overall Study||6
171554|NCT01489020|418054|P4|NOT COMPLETED|Overall Study||0
171555|NCT01489020|418055|P3|NOT COMPLETED|Overall Study||3
171556|NCT01489020|418056|P2|NOT COMPLETED|Overall Study||0
171557|NCT01489020|418057|P1|NOT COMPLETED|Overall Study||1
171558|NCT01489020|418052|P6|COMPLETED|Overall Study||4
171559|NCT01489020|418053|P5|COMPLETED|Overall Study||6
171560|NCT01489020|418054|P4|COMPLETED|Overall Study||4
171561|NCT01489020|418055|P3|COMPLETED|Overall Study||9
171562|NCT01489020|418056|P2|COMPLETED|Overall Study||4
171563|NCT01489020|418057|P1|COMPLETED|Overall Study||11
171564|NCT01489020|418052|P6|STARTED|Overall Study||4
171565|NCT01489020|418053|P5|STARTED|Overall Study||12
171566|NCT01489020|418054|P4|STARTED|Overall Study||4
171567|NCT01489020|418055|P3|STARTED|Overall Study||12
171568|NCT01489020|418056|P2|STARTED|Overall Study||4
171569|NCT01489020|418057|P1|STARTED|Overall Study||12
171570|NCT01488994|418091|P2|NOT COMPLETED|Overall Study||1
171571|NCT01488994|418092|P1|NOT COMPLETED|Overall Study||0
171572|NCT01488994|418091|P2|COMPLETED|Overall Study||11
171573|NCT01488994|418092|P1|COMPLETED|Overall Study||11
171574|NCT01488994|418091|P2|STARTED|Overall Study||12
171575|NCT01488994|418092|P1|STARTED|Overall Study||11
171576|NCT01488890|418183|P4|NOT COMPLETED|Overall Study||5
171577|NCT01488890|418184|P3|NOT COMPLETED|Overall Study||35
171578|NCT01488890|418185|P2|NOT COMPLETED|Overall Study||20
171579|NCT01488890|418186|P1|NOT COMPLETED|Overall Study||32
171580|NCT01488890|418183|P4|COMPLETED|Overall Study||25
171581|NCT01488890|418184|P3|COMPLETED|Overall Study||85
171582|NCT01488890|418185|P2|COMPLETED|Overall Study||100
171583|NCT01488890|418186|P1|COMPLETED|Overall Study||88
171584|NCT01488890|418183|P4|Treated|Overall Study||30
171585|NCT01488890|418184|P3|Treated|Overall Study||119
171586|NCT01488890|418185|P2|Treated|Overall Study||120
171587|NCT01488890|418186|P1|Treated|Overall Study||120
171588|NCT01488890|418183|P4|STARTED|Overall Study||30
171589|NCT01488890|418184|P3|STARTED|Overall Study||120
171590|NCT01488890|418185|P2|STARTED|Overall Study||120
171591|NCT01488890|418186|P1|STARTED|Overall Study||120
171592|NCT01488877|418224|P3|NOT COMPLETED|Re-randomization||0
171593|NCT01488877|418225|P2|NOT COMPLETED|Re-randomization||0
171594|NCT01488877|418226|P1|NOT COMPLETED|Re-randomization||0
171595|NCT01488877|418224|P3|COMPLETED|Re-randomization||3
171596|NCT01488877|418225|P2|COMPLETED|Re-randomization||0
171597|NCT01488877|418226|P1|COMPLETED|Re-randomization||0
171598|NCT01488877|418224|P3|STARTED|Re-randomization|Three participants were re-randomized from PF-03882845 3 mg arm.|3
171599|NCT01488877|418225|P2|STARTED|Re-randomization||0
171600|NCT01488877|418226|P1|STARTED|Re-randomization||0
171601|NCT01488877|418224|P3|NOT COMPLETED|Initial Randomization||0
171602|NCT01488877|418225|P2|NOT COMPLETED|Initial Randomization||0
171603|NCT01488877|418226|P1|NOT COMPLETED|Initial Randomization||0
171604|NCT01488877|418224|P3|COMPLETED|Initial Randomization||0
171605|NCT01488877|418225|P2|COMPLETED|Initial Randomization||5
171606|NCT01488877|418226|P1|COMPLETED|Initial Randomization||1
171607|NCT01488877|418224|P3|STARTED|Initial Randomization||0
171608|NCT01488877|418225|P2|STARTED|Initial Randomization||5
171609|NCT01488877|418226|P1|STARTED|Initial Randomization||1
171610|NCT01488708|418243|P2|NOT COMPLETED|Overall Study||578
171611|NCT01488708|418244|P1|NOT COMPLETED|Overall Study||940
171612|NCT01488708|418243|P2|COMPLETED|Overall Study||0
171613|NCT01488708|418244|P1|COMPLETED|Overall Study||0
171614|NCT01488708|418243|P2|Participated in Follow Up|Overall Study||526
171615|NCT01488708|418244|P1|Participated in Follow Up|Overall Study||810
171616|NCT01488708|418243|P2|Received at Least 1 Dose of Study Drug|Overall Study||578
171617|NCT01488708|418244|P1|Received at Least 1 Dose of Study Drug|Overall Study||937
171618|NCT01488708|418243|P2|STARTED|Overall Study||578
171619|NCT01488708|418244|P1|STARTED|Overall Study||940
171620|NCT01488578|418264|P1|NOT COMPLETED|Overall Study||1836
171621|NCT01488578|418264|P1|COMPLETED|Overall Study||9321
171622|NCT01488578|418264|P1|STARTED|Overall Study||11157
171623|NCT01488487|418298|P1|NOT COMPLETED|Overall Study||9
171624|NCT01488487|418298|P1|COMPLETED|Overall Study||15
171625|NCT01488487|418298|P1|Received Treatment|Overall Study||24
171626|NCT01488487|418298|P1|STARTED|Overall Study||24
171627|NCT01488448|418307|P2|NOT COMPLETED|Overall Study||17
171628|NCT01488448|418308|P1|NOT COMPLETED|Overall Study||20
171629|NCT01488448|418307|P2|COMPLETED|Overall Study||97
171630|NCT01488448|418308|P1|COMPLETED|Overall Study||93
171631|NCT01488448|418307|P2|STARTED|Overall Study||114
171632|NCT01488448|418308|P1|STARTED|Overall Study||113
171633|NCT01488409|418332|P2|NOT COMPLETED|Overall Study||4
171634|NCT01488409|418333|P1|NOT COMPLETED|Overall Study||4
171635|NCT01488409|418332|P2|COMPLETED|Overall Study||15
171636|NCT01488409|418333|P1|COMPLETED|Overall Study||16
171637|NCT01488409|418332|P2|STARTED|Overall Study||19
171638|NCT01488409|418333|P1|STARTED|Overall Study||20
171639|NCT01488370|418350|P3|NOT COMPLETED|Overall Study||1
171640|NCT01488370|418351|P2|NOT COMPLETED|Overall Study||1
171641|NCT01488370|418352|P1|NOT COMPLETED|Overall Study||0
171642|NCT01488370|418350|P3|COMPLETED|Overall Study||19
171643|NCT01488370|418351|P2|COMPLETED|Overall Study||22
171644|NCT01488370|418352|P1|COMPLETED|Overall Study||22
171645|NCT01488370|418350|P3|STARTED|Overall Study||20
171646|NCT01488370|418351|P2|STARTED|Overall Study||23
171647|NCT01488370|418352|P1|STARTED|Overall Study||22
171648|NCT01488318|418372|P1|NOT COMPLETED|Overall Study||0
171649|NCT01488318|418372|P1|COMPLETED|Overall Study||14
171650|NCT01488318|418372|P1|STARTED|Overall Study||14
171651|NCT01488279|418381|P2|NOT COMPLETED|Overall Study||0
171652|NCT01488279|418382|P1|NOT COMPLETED|Overall Study||0
171653|NCT01488279|418381|P2|COMPLETED|Overall Study||5
171654|NCT01488279|418382|P1|COMPLETED|Overall Study||5
171655|NCT01488279|418381|P2|STARTED|Overall Study||5
171656|NCT01488279|418382|P1|STARTED|Overall Study||5
171657|NCT01488188|418398|P2|NOT COMPLETED|Overall Study||0
171658|NCT01488188|418399|P1|NOT COMPLETED|Overall Study||0
171659|NCT01488188|418398|P2|COMPLETED|Overall Study||20
171660|NCT01488188|418399|P1|COMPLETED|Overall Study||20
171661|NCT01488188|418398|P2|STARTED|Overall Study||20
171662|NCT01488188|418399|P1|STARTED|Overall Study||20
171663|NCT01488097|418411|P1|NOT COMPLETED|Overall Study||1
171664|NCT01488097|418411|P1|COMPLETED|Overall Study||7
171665|NCT01488097|418411|P1|Received Study Drug in Extension Study|Overall Study||8
171666|NCT01488097|418411|P1|STARTED|Overall Study||8
171667|NCT01488071|418424|P2|NOT COMPLETED|Overall Study||63
171668|NCT01488071|418425|P1|NOT COMPLETED|Overall Study||53
171669|NCT01488071|418424|P2|COMPLETED|Overall Study||179
171670|NCT01488071|418425|P1|COMPLETED|Overall Study||200
171671|NCT01488071|418424|P2|STARTED|Overall Study|APTS|242
171672|NCT01488071|418425|P1|STARTED|Overall Study|all-patients-treated set (APTS)|253
171673|NCT01488019|418459|P2|NOT COMPLETED|Overall Study||304
171674|NCT01488019|418460|P1|NOT COMPLETED|Overall Study||247
171675|NCT01488019|418459|P2|COMPLETED|Overall Study||226
171676|NCT01488019|418460|P1|COMPLETED|Overall Study||294
171677|NCT01488019|418459|P2|STARTED|Overall Study||530
171678|NCT01488019|418460|P1|STARTED|Overall Study||541
171679|NCT01487954|418494|P2|NOT COMPLETED|Overall Study||0
171680|NCT01487954|418495|P1|NOT COMPLETED|Overall Study||0
171681|NCT01487954|418494|P2|COMPLETED|Overall Study||16
171682|NCT01487954|418495|P1|COMPLETED|Overall Study||29
171683|NCT01487954|418494|P2|Safety lead-in|Overall Study|Only the first 10 patients in the alkaline group were analyzed, as that was the experimental group.|0
171684|NCT01487954|418495|P1|Safety lead-in|Overall Study||10
171685|NCT01487954|418494|P2|STARTED|Overall Study||16
171686|NCT01487954|418495|P1|STARTED|Overall Study||29
171687|NCT01487863|418505|P2|NOT COMPLETED|Overall Study||19
171688|NCT01487863|418506|P1|NOT COMPLETED|Overall Study||19
171689|NCT01487863|418505|P2|COMPLETED|Overall Study||15
171690|NCT01487863|418506|P1|COMPLETED|Overall Study||16
171691|NCT01487863|418505|P2|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||34
171692|NCT01487863|418506|P1|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||35
171693|NCT01487863|418505|P2|Subjects Randomized (Efficacy Analysis)|Overall Study||34
171694|NCT01487863|418506|P1|Subjects Randomized (Efficacy Analysis)|Overall Study||35
171695|NCT01487863|418505|P2|STARTED|Overall Study||34
171696|NCT01487863|418506|P1|STARTED|Overall Study||35
171697|NCT01487668|418514|P2|NOT COMPLETED|Overall Study||17
171698|NCT01487668|418515|P1|NOT COMPLETED|Overall Study||25
171699|NCT01487668|418514|P2|COMPLETED|Overall Study||124
171700|NCT01487668|418515|P1|COMPLETED|Overall Study||121
171701|NCT01487668|418514|P2|STARTED|Overall Study||141
171702|NCT01487668|418515|P1|STARTED|Overall Study||146
171703|NCT01487577|418523|P1|NOT COMPLETED|Overall Study||1
171704|NCT01487577|418523|P1|COMPLETED|Overall Study|One participant became ineligible after signing consent, but before receiving protocol therapy.|18
171705|NCT01487577|418523|P1|STARTED|Overall Study||19
171706|NCT01487525|418537|P2|NOT COMPLETED|Overall Study||1
171707|NCT01487525|418538|P1|NOT COMPLETED|Overall Study||0
171708|NCT01487525|418537|P2|COMPLETED|Overall Study||19
171709|NCT01487525|418538|P1|COMPLETED|Overall Study||22
171710|NCT01487525|418537|P2|STARTED|Overall Study||20
171711|NCT01487525|418538|P1|STARTED|Overall Study||22
171712|NCT01487499|418548|P1|NOT COMPLETED|Overall Study||0
171713|NCT01487499|418548|P1|COMPLETED|Overall Study||4
171714|NCT01487499|418548|P1|STARTED|Overall Study||4
171715|NCT01487265|418554|P1|NOT COMPLETED|Overall Study||37
171716|NCT01487265|418554|P1|COMPLETED|Overall Study||0
171717|NCT01487265|418554|P1|STARTED|Overall Study||37
171718|NCT01487161|418566|P4|NOT COMPLETED|Overall Study||2
171719|NCT01487161|418567|P3|NOT COMPLETED|Overall Study||1
171720|NCT01487161|418568|P2|NOT COMPLETED|Overall Study||2
171721|NCT01487161|418569|P1|NOT COMPLETED|Overall Study||2
171722|NCT01487161|418566|P4|COMPLETED|Overall Study||50
171723|NCT01487161|418567|P3|COMPLETED|Overall Study||59
171724|NCT01487161|418568|P2|COMPLETED|Overall Study||57
171725|NCT01487161|418569|P1|COMPLETED|Overall Study||56
171726|NCT01487161|418566|P4|STARTED|Overall Study||52
171727|NCT01487161|418567|P3|STARTED|Overall Study||60
171728|NCT01487161|418568|P2|STARTED|Overall Study||59
171729|NCT01487161|418569|P1|STARTED|Overall Study||58
171730|NCT01486966|418634|P2|NOT COMPLETED|Overall Study||2
171731|NCT01486966|418635|P1|NOT COMPLETED|Overall Study||0
171732|NCT01486966|418634|P2|COMPLETED|Overall Study||27
171733|NCT01486966|418635|P1|COMPLETED|Overall Study||29
171734|NCT01486966|418634|P2|STARTED|Overall Study||29
171735|NCT01486966|418635|P1|STARTED|Overall Study||29
171736|NCT01486927|418659|P1|NOT COMPLETED|Overall Study||13
171737|NCT01486927|418659|P1|COMPLETED|Overall Study||161
171738|NCT01486927|418659|P1|STARTED|Overall Study||174
171739|NCT01486810|418690|P1|NOT COMPLETED|Overall Study||8
171740|NCT01486810|418690|P1|COMPLETED|Overall Study||9
171741|NCT01486810|418690|P1|STARTED|Overall Study||17
171742|NCT01486758|418697|P2|NOT COMPLETED|Overall Study||1
171743|NCT01486758|418698|P1|NOT COMPLETED|Overall Study||0
171744|NCT01486758|418697|P2|COMPLETED|Overall Study||19
171745|NCT01486758|418698|P1|COMPLETED|Overall Study||20
171746|NCT01486758|418697|P2|STARTED|Overall Study||20
171747|NCT01486758|418698|P1|STARTED|Overall Study||20
171748|NCT01486615|418722|P4|NOT COMPLETED|Overall Study||2
171749|NCT01486615|418723|P3|NOT COMPLETED|Overall Study||2
171750|NCT01486615|418724|P2|NOT COMPLETED|Overall Study||1
171751|NCT01486615|418725|P1|NOT COMPLETED|Overall Study||0
171752|NCT01486615|418722|P4|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
171753|NCT01486615|418723|P3|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
171754|NCT01486615|418724|P2|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|19
171755|NCT01486615|418725|P1|COMPLETED|Overall Study||20
171756|NCT01486615|418722|P4|STARTED|Overall Study||20
171757|NCT01486615|418723|P3|STARTED|Overall Study||20
171758|NCT01486615|418724|P2|STARTED|Overall Study||20
171759|NCT01486615|418725|P1|STARTED|Overall Study||20
171760|NCT01486446|418765|P2|NOT COMPLETED|Overall Study||0
171761|NCT01486446|418766|P1|NOT COMPLETED|Overall Study||1
171762|NCT01486446|418765|P2|COMPLETED|Overall Study||1
171763|NCT01486446|418766|P1|COMPLETED|Overall Study||6
171764|NCT01486446|418765|P2|STARTED|Overall Study||1
171765|NCT01486446|418766|P1|STARTED|Overall Study||7
171766|NCT01486316|418789|P4|NOT COMPLETED|Overall Study||2
171767|NCT01486316|418790|P3|NOT COMPLETED|Overall Study||5
171768|NCT01486316|418791|P2|NOT COMPLETED|Overall Study||3
171769|NCT01486316|418792|P1|NOT COMPLETED|Overall Study||4
171770|NCT01486316|418789|P4|COMPLETED|Overall Study||0
171771|NCT01486316|418790|P3|COMPLETED|Overall Study||0
171772|NCT01486316|418791|P2|COMPLETED|Overall Study||7
171773|NCT01486316|418792|P1|COMPLETED|Overall Study||3
171774|NCT01486316|418789|P4|STARTED|Overall Study|Exited prior to 6 month visit|2
171775|NCT01486316|418790|P3|STARTED|Overall Study|Exited prior to implant|5
171776|NCT01486316|418791|P2|STARTED|Overall Study|prior to study closure, 24 subjects were enrolled with 10 being randomized to HFRS Guided Arm|10
171777|NCT01486316|418792|P1|STARTED|Overall Study|prior to study closure, 24 subjects were enrolled 7 subjects randomized to Control Arm|7
171778|NCT01486264|418804|P2|NOT COMPLETED|Overall Study||47
171779|NCT01486264|418805|P1|NOT COMPLETED|Overall Study||29
171780|NCT01486264|418804|P2|COMPLETED|Overall Study||94
171781|NCT01486264|418805|P1|COMPLETED|Overall Study||113
171782|NCT01486264|418804|P2|Treated|Overall Study||140
171783|NCT01486264|418805|P1|Treated|Overall Study||142
171784|NCT01486264|418804|P2|STARTED|Overall Study||141
171785|NCT01486264|418805|P1|STARTED|Overall Study||142
171786|NCT01486238|418837|P2|NOT COMPLETED|Overall Study||6
171787|NCT01486238|418838|P1|NOT COMPLETED|Overall Study||2
171788|NCT01486238|418837|P2|COMPLETED|Overall Study||43
171789|NCT01486238|418838|P1|COMPLETED|Overall Study||21
171790|NCT01486238|418837|P2|STARTED|Overall Study||49
171791|NCT01486238|418838|P1|STARTED|Overall Study||23
171792|NCT01486199|418846|P2|NOT COMPLETED|Study Day at t= 2 Years||0
171793|NCT01486199|418847|P1|NOT COMPLETED|Study Day at t= 2 Years||0
171794|NCT01486199|418846|P2|COMPLETED|Study Day at t= 2 Years||0
171795|NCT01486199|418847|P1|COMPLETED|Study Day at t= 2 Years||9
171796|NCT01486199|418846|P2|STARTED|Study Day at t= 2 Years||0
171797|NCT01486199|418847|P1|STARTED|Study Day at t= 2 Years||9
171798|NCT01486199|418846|P2|NOT COMPLETED|Two Year Period Between Study Days||0
171799|NCT01486199|418847|P1|NOT COMPLETED|Two Year Period Between Study Days||1
171800|NCT01486199|418846|P2|COMPLETED|Two Year Period Between Study Days||0
171801|NCT01486199|418847|P1|COMPLETED|Two Year Period Between Study Days||9
171802|NCT01486199|418846|P2|STARTED|Two Year Period Between Study Days||0
171803|NCT01486199|418847|P1|STARTED|Two Year Period Between Study Days||10
171804|NCT01486199|418846|P2|NOT COMPLETED|Baseline Study Day||1
171805|NCT01486199|418847|P1|NOT COMPLETED|Baseline Study Day||0
171806|NCT01486199|418846|P2|COMPLETED|Baseline Study Day||9
171807|NCT01486199|418847|P1|COMPLETED|Baseline Study Day||10
171808|NCT01486199|418846|P2|STARTED|Baseline Study Day||10
171809|NCT01486199|418847|P1|STARTED|Baseline Study Day||10
171810|NCT01486043|418859|P1|NOT COMPLETED|Overall Study||2
171811|NCT01486043|418859|P1|COMPLETED|Overall Study|Study terminated due to insufficient recruitment|2
171812|NCT01486043|418859|P1|STARTED|Overall Study||4
171813|NCT01485991|418867|P2|NOT COMPLETED|Overall Study||36
171814|NCT01485991|418868|P1|NOT COMPLETED|Overall Study||32
171815|NCT01485991|418867|P2|COMPLETED|Overall Study||350
171816|NCT01485991|418868|P1|COMPLETED|Overall Study||353
171817|NCT01485991|418867|P2|Treated|Overall Study||384
171818|NCT01485991|418868|P1|Treated|Overall Study||379
171819|NCT01485991|418867|P2|STARTED|Overall Study||386
171820|NCT01485991|418868|P1|STARTED|Overall Study||385
171821|NCT01485887|418878|P1|NOT COMPLETED|Overall Study||12
171822|NCT01485887|418878|P1|COMPLETED|Overall Study||38
171823|NCT01485887|418878|P1|STARTED|Overall Study||50
171824|NCT01485796|418890|P1|NOT COMPLETED|Overall Trial (Incl. Safety Follow-up)||12
171912|NCT01484951|419108|P1|NOT COMPLETED|Overall Study||5
171825|NCT01485796|418890|P1|COMPLETED|Overall Trial (Incl. Safety Follow-up)|1 subject who completed Epoch 2 + 24 subjects who completed the safety follow-up|25
171826|NCT01485796|418890|P1|Completed Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||24
171827|NCT01485796|418890|P1|Switch to Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||26
171828|NCT01485796|418890|P1|Completed Epoch 2|Overall Trial (Incl. Safety Follow-up)||1
171829|NCT01485796|418890|P1|Treated in Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
171830|NCT01485796|418890|P1|Started Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
171831|NCT01485796|418890|P1|Completed Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||36
171832|NCT01485796|418890|P1|Treated in Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||37
171833|NCT01485796|418890|P1|STARTED|Overall Trial (Incl. Safety Follow-up)||37
171834|NCT01485796|418890|P1|NOT COMPLETED|Period 2: Epoch 2||35
171835|NCT01485796|418890|P1|COMPLETED|Period 2: Epoch 2||1
171836|NCT01485796|418890|P1|Treated in Epoch 2|Period 2: Epoch 2||36
171837|NCT01485796|418890|P1|STARTED|Period 2: Epoch 2||36
171838|NCT01485796|418890|P1|NOT COMPLETED|Period 1: Epoch 1 (Ramp-up)||1
171839|NCT01485796|418890|P1|COMPLETED|Period 1: Epoch 1 (Ramp-up)||36
171840|NCT01485796|418890|P1|Treated in Epoch 1|Period 1: Epoch 1 (Ramp-up)||37
171841|NCT01485796|418890|P1|STARTED|Period 1: Epoch 1 (Ramp-up)||37
171842|NCT01485640|418912|P1|NOT COMPLETED|Overall Study||122
171843|NCT01485640|418912|P1|COMPLETED|Overall Study||40
171844|NCT01485640|418912|P1|STARTED|Overall Study||162
171845|NCT01485627|418919|P2|NOT COMPLETED|Overall Study||57
171846|NCT01485627|418920|P1|NOT COMPLETED|Overall Study||66
171847|NCT01485627|418919|P2|COMPLETED|Overall Study|135 patients and 49 caregivers|184
171848|NCT01485627|418920|P1|COMPLETED|Overall Study|130 patients and 48 caregivers|178
171849|NCT01485627|418919|P2|Bereaved Caregivers: 7 Month Completed|Overall Study||49
171850|NCT01485627|418920|P1|Bereaved Caregivers: 7 Month Completed|Overall Study||48
171851|NCT01485627|418919|P2|Bereaved Caregivers: 2 Month Completed|Overall Study||52
171852|NCT01485627|418920|P1|Bereaved Caregivers: 2 Month Completed|Overall Study||49
171853|NCT01485627|418919|P2|Bereaved Caregivers: 1 Month|Overall Study||51
171854|NCT01485627|418920|P1|Bereaved Caregivers: 1 Month|Overall Study||51
171855|NCT01485627|418919|P2|Bereaved Caregivers: Total|Overall Study||64
171856|NCT01485627|418920|P1|Bereaved Caregivers: Total|Overall Study||63
171857|NCT01485627|418919|P2|Allocated Caregivers: Total|Overall Study||99
171858|NCT01485627|418920|P1|Allocated Caregivers: Total|Overall Study||105
171859|NCT01485627|418919|P2|STARTED|Overall Study|142 patients and 99 caregivers|241
171860|NCT01485627|418920|P1|STARTED|Overall Study|139 patients and 105 caregivers|244
171861|NCT01485536|418938|P1|NOT COMPLETED|Overall Study||4
171862|NCT01485536|418938|P1|COMPLETED|Overall Study||17
171863|NCT01485536|418938|P1|STARTED|Overall Study||21
171864|NCT01485393|418943|P2|NOT COMPLETED|Overall Study||0
171865|NCT01485393|418944|P1|NOT COMPLETED|Overall Study||0
171866|NCT01485393|418943|P2|COMPLETED|Overall Study||5
171867|NCT01485393|418944|P1|COMPLETED|Overall Study||5
171868|NCT01485393|418943|P2|STARTED|Overall Study||5
171869|NCT01485393|418944|P1|STARTED|Overall Study||5
171870|NCT01485380|418952|P1|NOT COMPLETED|Overall Study||3
171871|NCT01485380|418952|P1|COMPLETED|Overall Study||17
171872|NCT01485380|418952|P1|STARTED|Overall Study||20
171873|NCT01485354|418956|P1|NOT COMPLETED|Overall Study||5
171874|NCT01485354|418956|P1|COMPLETED|Overall Study||12
171875|NCT01485354|418956|P1|STARTED|Overall Study||17
171876|NCT01485172|418970|P6|NOT COMPLETED|Overall Study||4
171877|NCT01485172|418971|P5|NOT COMPLETED|Overall Study||5
171878|NCT01485172|418972|P4|NOT COMPLETED|Overall Study||8
171879|NCT01485172|418973|P3|NOT COMPLETED|Overall Study||7
171880|NCT01485172|418974|P2|NOT COMPLETED|Overall Study||1
171881|NCT01485172|418975|P1|NOT COMPLETED|Overall Study||7
171882|NCT01485172|418970|P6|COMPLETED|Overall Study||9
171883|NCT01485172|418971|P5|COMPLETED|Overall Study||34
171884|NCT01485172|418972|P4|COMPLETED|Overall Study||32
171885|NCT01485172|418973|P3|COMPLETED|Overall Study||34
171886|NCT01485172|418974|P2|COMPLETED|Overall Study||12
171887|NCT01485172|418975|P1|COMPLETED|Overall Study||33
171888|NCT01485172|418970|P6|STARTED|Overall Study||13
171889|NCT01485172|418971|P5|STARTED|Overall Study||39
171890|NCT01485172|418972|P4|STARTED|Overall Study||40
171891|NCT01485172|418973|P3|STARTED|Overall Study||41
171892|NCT01485172|418974|P2|STARTED|Overall Study||13
171893|NCT01485172|418975|P1|STARTED|Overall Study||40
171894|NCT01485120|419049|P1|NOT COMPLETED|Overall Study||2
171895|NCT01485120|419049|P1|COMPLETED|Overall Study||32
171896|NCT01485120|419049|P1|STARTED|Overall Study||34
171897|NCT01485094|419057|P3|NOT COMPLETED|Overall Study||1
171898|NCT01485094|419058|P2|NOT COMPLETED|Overall Study||2
171899|NCT01485094|419059|P1|NOT COMPLETED|Overall Study||3
171900|NCT01485094|419057|P3|COMPLETED|Overall Study||18
171901|NCT01485094|419058|P2|COMPLETED|Overall Study||18
171902|NCT01485094|419059|P1|COMPLETED|Overall Study||17
171903|NCT01485094|419057|P3|STARTED|Overall Study||19
171904|NCT01485094|419058|P2|STARTED|Overall Study||20
171905|NCT01485094|419059|P1|STARTED|Overall Study||20
171906|NCT01485055|419100|P1|NOT COMPLETED|Overall Study||0
171907|NCT01485055|419100|P1|COMPLETED|Overall Study||11
171908|NCT01485055|419100|P1|STARTED|Overall Study||11
171909|NCT01484977|419104|P1|NOT COMPLETED|Overall Study||27
171910|NCT01484977|419104|P1|COMPLETED|Overall Study||93
171911|NCT01484977|419104|P1|STARTED|Overall Study||120
171913|NCT01484951|419108|P1|COMPLETED|Overall Study||69
171914|NCT01484951|419108|P1|STARTED|Overall Study||74
171915|NCT01484938|419113|P1|NOT COMPLETED|Overall Study||4
171916|NCT01484938|419113|P1|COMPLETED|Overall Study||171
171917|NCT01484938|419113|P1|STARTED|Overall Study||175
171918|NCT01484912|419120|P2|NOT COMPLETED|Overall Study||1
171919|NCT01484912|419121|P1|NOT COMPLETED|Overall Study||1
171920|NCT01484912|419120|P2|COMPLETED|Overall Study||39
171921|NCT01484912|419121|P1|COMPLETED|Overall Study||38
171922|NCT01484912|419120|P2|STARTED|Overall Study||40
171923|NCT01484912|419121|P1|STARTED|Overall Study||39
171924|NCT01484873|419131|P1|NOT COMPLETED|Overall Study||2
171925|NCT01484873|419131|P1|COMPLETED|Overall Study||8
171926|NCT01484873|419131|P1|STARTED|Overall Study||10
171927|NCT01484834|419143|P4|NOT COMPLETED|Overall Study||4
171928|NCT01484834|419144|P3|NOT COMPLETED|Overall Study||1
171929|NCT01484834|419145|P2|NOT COMPLETED|Overall Study||8
171930|NCT01484834|419146|P1|NOT COMPLETED|Overall Study||5
171931|NCT01484834|419143|P4|COMPLETED|Overall Study||20
171932|NCT01484834|419144|P3|COMPLETED|Overall Study||38
171933|NCT01484834|419145|P2|COMPLETED|Overall Study||54
171934|NCT01484834|419146|P1|COMPLETED|Overall Study||60
171935|NCT01484834|419143|P4|STARTED|Overall Study||24
171936|NCT01484834|419144|P3|STARTED|Overall Study||39
171937|NCT01484834|419145|P2|STARTED|Overall Study||62
171938|NCT01484834|419146|P1|STARTED|Overall Study||65
171939|NCT01484652|419174|P2|NOT COMPLETED|Overall Study||21
171940|NCT01484652|419175|P1|NOT COMPLETED|Overall Study||15
171941|NCT01484652|419174|P2|COMPLETED|Overall Study||142
171942|NCT01484652|419175|P1|COMPLETED|Overall Study||151
171943|NCT01484652|419174|P2|STARTED|Overall Study||163
171944|NCT01484652|419175|P1|STARTED|Overall Study||166
171945|NCT01484626|419181|P1|NOT COMPLETED|Overall Study||0
171946|NCT01484626|419181|P1|COMPLETED|Overall Study||3
171947|NCT01484626|419181|P1|STARTED|Overall Study||3
171948|NCT01484561|419187|P2|NOT COMPLETED|Overall Study||6
171949|NCT01484561|419188|P1|NOT COMPLETED|Overall Study||9
171950|NCT01484561|419187|P2|COMPLETED|Overall Study||45
171951|NCT01484561|419188|P1|COMPLETED|Overall Study||88
171952|NCT01484561|419187|P2|STARTED|Overall Study||51
171953|NCT01484561|419188|P1|STARTED|Overall Study||97
171954|NCT01484496|419278|P4|NOT COMPLETED|Period 2||22
171955|NCT01484496|419279|P3|NOT COMPLETED|Period 2||15
171956|NCT01484496|419280|P2|NOT COMPLETED|Period 2||0
171957|NCT01484496|419281|P1|NOT COMPLETED|Period 2||0
171958|NCT01484496|419278|P4|COMPLETED|Period 2||434
171959|NCT01484496|419279|P3|COMPLETED|Period 2||191
171960|NCT01484496|419280|P2|COMPLETED|Period 2||0
171961|NCT01484496|419281|P1|COMPLETED|Period 2||0
171962|NCT01484496|419278|P4|STARTED|Period 2||456
171963|NCT01484496|419279|P3|STARTED|Period 2||206
171964|NCT01484496|419280|P2|STARTED|Period 2||0
171965|NCT01484496|419281|P1|STARTED|Period 2||0
171966|NCT01484496|419278|P4|NOT COMPLETED|Period 1||0
171967|NCT01484496|419279|P3|NOT COMPLETED|Period 1||0
171968|NCT01484496|419280|P2|NOT COMPLETED|Period 1||93
171969|NCT01484496|419281|P1|NOT COMPLETED|Period 1||66
171970|NCT01484496|419278|P4|COMPLETED|Period 1||0
171971|NCT01484496|419279|P3|COMPLETED|Period 1||0
171972|NCT01484496|419280|P2|COMPLETED|Period 1||463
171973|NCT01484496|419281|P1|COMPLETED|Period 1||214
171974|NCT01484496|419278|P4|STARTED|Period 1||0
171975|NCT01484496|419279|P3|STARTED|Period 1||0
171976|NCT01484496|419280|P2|STARTED|Period 1||556
171977|NCT01484496|419281|P1|STARTED|Period 1||280
171978|NCT01484431|419296|P3|NOT COMPLETED|Period 2||2
171979|NCT01484431|419297|P2|NOT COMPLETED|Period 2||1
171980|NCT01484431|419298|P1|NOT COMPLETED|Period 2||1
171981|NCT01484431|419296|P3|COMPLETED|Period 2||4
171982|NCT01484431|419297|P2|COMPLETED|Period 2||5
171983|NCT01484431|419298|P1|COMPLETED|Period 2||5
171984|NCT01484431|419296|P3|Received 40 mg|Period 2||1
171985|NCT01484431|419297|P2|Received 40 mg|Period 2||0
171986|NCT01484431|419298|P1|Received 40 mg|Period 2||0
171987|NCT01484431|419296|P3|Received 20 mg|Period 2||4
171988|NCT01484431|419297|P2|Received 20 mg|Period 2||1
171989|NCT01484431|419298|P1|Received 20 mg|Period 2||3
171990|NCT01484431|419296|P3|Received 15 mg|Period 2||1
171991|NCT01484431|419297|P2|Received 15 mg|Period 2||2
171992|NCT01484431|419298|P1|Received 15 mg|Period 2||1
171993|NCT01484431|419296|P3|Received 10 mg|Period 2||0
171994|NCT01484431|419297|P2|Received 10 mg|Period 2||1
171995|NCT01484431|419298|P1|Received 10 mg|Period 2||0
171996|NCT01484431|419296|P3|Received 8 mg|Period 2||0
171997|NCT01484431|419297|P2|Received 8 mg|Period 2||0
171998|NCT01484431|419298|P1|Received 8 mg|Period 2||1
171999|NCT01484431|419296|P3|Received 7.5 mg|Period 2||0
172000|NCT01484431|419297|P2|Received 7.5 mg|Period 2||2
172001|NCT01484431|419298|P1|Received 7.5 mg|Period 2||0
172002|NCT01484431|419296|P3|Received 7 mg|Period 2||0
172003|NCT01484431|419297|P2|Received 7 mg|Period 2||0
172004|NCT01484431|419298|P1|Received 7 mg|Period 2||1
172005|NCT01484431|419296|P3|STARTED|Period 2||6
172006|NCT01484431|419297|P2|STARTED|Period 2||6
172007|NCT01484431|419298|P1|STARTED|Period 2||6
172008|NCT01484431|419296|P3|NOT COMPLETED|Period 1: High Dose||0
172009|NCT01484431|419297|P2|NOT COMPLETED|Period 1: High Dose||1
172010|NCT01484431|419298|P1|NOT COMPLETED|Period 1: High Dose||0
172011|NCT01484431|419296|P3|COMPLETED|Period 1: High Dose||6
172012|NCT01484431|419297|P2|COMPLETED|Period 1: High Dose||6
172013|NCT01484431|419298|P1|COMPLETED|Period 1: High Dose||6
172014|NCT01484431|419296|P3|Received 40 mg|Period 1: High Dose||5
172015|NCT01484431|419297|P2|Received 40 mg|Period 1: High Dose||0
172016|NCT01484431|419298|P1|Received 40 mg|Period 1: High Dose||0
172017|NCT01484431|419296|P3|Received 20 mg|Period 1: High Dose||1
172018|NCT01484431|419297|P2|Received 20 mg|Period 1: High Dose||5
172019|NCT01484431|419298|P1|Received 20 mg|Period 1: High Dose||3
172020|NCT01484431|419296|P3|Received 15 mg|Period 1: High Dose||0
172021|NCT01484431|419297|P2|Received 15 mg|Period 1: High Dose||1
172022|NCT01484431|419298|P1|Received 15 mg|Period 1: High Dose||1
172023|NCT01484431|419296|P3|Received 10 mg|Period 1: High Dose||0
172024|NCT01484431|419297|P2|Received 10 mg|Period 1: High Dose||1
172025|NCT01484431|419298|P1|Received 10 mg|Period 1: High Dose||1
172026|NCT01484431|419296|P3|Received 8 mg|Period 1: High Dose||0
172027|NCT01484431|419297|P2|Received 8 mg|Period 1: High Dose||0
172028|NCT01484431|419298|P1|Received 8 mg|Period 1: High Dose||1
172029|NCT01484431|419296|P3|STARTED|Period 1: High Dose||6
172030|NCT01484431|419297|P2|STARTED|Period 1: High Dose||7
172031|NCT01484431|419298|P1|STARTED|Period 1: High Dose||6
172032|NCT01484431|419296|P3|NOT COMPLETED|Period 1: Low Dose||0
172033|NCT01484431|419297|P2|NOT COMPLETED|Period 1: Low Dose||0
172034|NCT01484431|419298|P1|NOT COMPLETED|Period 1: Low Dose||0
172035|NCT01484431|419296|P3|COMPLETED|Period 1: Low Dose||6
172036|NCT01484431|419297|P2|COMPLETED|Period 1: Low Dose||7
172037|NCT01484431|419298|P1|COMPLETED|Period 1: Low Dose||6
172038|NCT01484431|419296|P3|Received 10 mg|Period 1: Low Dose||6
172039|NCT01484431|419297|P2|Received 10 mg|Period 1: Low Dose||0
172040|NCT01484431|419298|P1|Received 10 mg|Period 1: Low Dose||0
172041|NCT01484431|419296|P3|Received 5 mg|Period 1: Low Dose||0
172042|NCT01484431|419297|P2|Received 5 mg|Period 1: Low Dose||7
172043|NCT01484431|419298|P1|Received 5 mg|Period 1: Low Dose||0
172044|NCT01484431|419296|P3|Received 4 mg|Period 1: Low Dose||0
172045|NCT01484431|419297|P2|Received 4 mg|Period 1: Low Dose||0
172046|NCT01484431|419298|P1|Received 4 mg|Period 1: Low Dose||5
172047|NCT01484431|419296|P3|Received 2 mg|Period 1: Low Dose||0
172048|NCT01484431|419297|P2|Received 2 mg|Period 1: Low Dose||0
172049|NCT01484431|419298|P1|Received 2 mg|Period 1: Low Dose||1
172050|NCT01484431|419296|P3|STARTED|Period 1: Low Dose||6
172051|NCT01484431|419297|P2|STARTED|Period 1: Low Dose||7
172052|NCT01484431|419298|P1|STARTED|Period 1: Low Dose||6
172053|NCT01484340|419315|P2|NOT COMPLETED|Overall Study||0
172054|NCT01484340|419316|P1|NOT COMPLETED|Overall Study||0
172055|NCT01484340|419315|P2|COMPLETED|Overall Study||279
172056|NCT01484340|419316|P1|COMPLETED|Overall Study||281
172057|NCT01484340|419315|P2|STARTED|Overall Study||279
172058|NCT01484340|419316|P1|STARTED|Overall Study||281
172059|NCT01484314|419328|P1|NOT COMPLETED|Overall Study||0
172060|NCT01484314|419328|P1|COMPLETED|Overall Study||1
172061|NCT01484314|419328|P1|STARTED|Overall Study||1
172062|NCT01484197|419334|P4|NOT COMPLETED|Treatment Period 4||0
172063|NCT01484197|419335|P3|NOT COMPLETED|Treatment Period 4||0
172064|NCT01484197|419336|P2|NOT COMPLETED|Treatment Period 4||0
172065|NCT01484197|419337|P1|NOT COMPLETED|Treatment Period 4||0
172066|NCT01484197|419334|P4|COMPLETED|Treatment Period 4||6
172067|NCT01484197|419335|P3|COMPLETED|Treatment Period 4||9
172068|NCT01484197|419336|P2|COMPLETED|Treatment Period 4||8
172069|NCT01484197|419337|P1|COMPLETED|Treatment Period 4||7
172070|NCT01484197|419334|P4|STARTED|Treatment Period 4|2 patients completed Period 3 but did not enter Period 4 due to a Protocol deviation and an AE.|6
172071|NCT01484197|419335|P3|STARTED|Treatment Period 4||9
172072|NCT01484197|419336|P2|STARTED|Treatment Period 4||8
172073|NCT01484197|419337|P1|STARTED|Treatment Period 4||7
172074|NCT01484197|419334|P4|NOT COMPLETED|Treatment Period 3||0
172075|NCT01484197|419335|P3|NOT COMPLETED|Treatment Period 3||0
172076|NCT01484197|419336|P2|NOT COMPLETED|Treatment Period 3||0
172077|NCT01484197|419337|P1|NOT COMPLETED|Treatment Period 3||0
172078|NCT01484197|419334|P4|COMPLETED|Treatment Period 3||8
172079|NCT01484197|419335|P3|COMPLETED|Treatment Period 3||9
172080|NCT01484197|419336|P2|COMPLETED|Treatment Period 3||8
172081|NCT01484197|419337|P1|COMPLETED|Treatment Period 3||7
172082|NCT01484197|419334|P4|STARTED|Treatment Period 3||8
172083|NCT01484197|419335|P3|STARTED|Treatment Period 3||9
172084|NCT01484197|419336|P2|STARTED|Treatment Period 3||8
172085|NCT01484197|419337|P1|STARTED|Treatment Period 3||7
172086|NCT01484197|419334|P4|NOT COMPLETED|Treatment Period 2||1
172087|NCT01484197|419335|P3|NOT COMPLETED|Treatment Period 2||0
172088|NCT01484197|419336|P2|NOT COMPLETED|Treatment Period 2||0
172089|NCT01484197|419337|P1|NOT COMPLETED|Treatment Period 2||0
172090|NCT01484197|419334|P4|COMPLETED|Treatment Period 2||8
172091|NCT01484197|419335|P3|COMPLETED|Treatment Period 2||9
172092|NCT01484197|419336|P2|COMPLETED|Treatment Period 2||8
172093|NCT01484197|419337|P1|COMPLETED|Treatment Period 2||7
172094|NCT01484197|419334|P4|STARTED|Treatment Period 2||9
172095|NCT01484197|419335|P3|STARTED|Treatment Period 2||9
172096|NCT01484197|419336|P2|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to an Adverse event (AE).|8
172097|NCT01484197|419337|P1|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to a Protocol deviation.|7
172098|NCT01484197|419334|P4|NOT COMPLETED|Treatment Period 1||0
172099|NCT01484197|419335|P3|NOT COMPLETED|Treatment Period 1||0
172100|NCT01484197|419336|P2|NOT COMPLETED|Treatment Period 1||0
172101|NCT01484197|419337|P1|NOT COMPLETED|Treatment Period 1||1
172102|NCT01484197|419334|P4|COMPLETED|Treatment Period 1||9
172103|NCT01484197|419335|P3|COMPLETED|Treatment Period 1||9
172104|NCT01484197|419336|P2|COMPLETED|Treatment Period 1||9
172105|NCT01484197|419337|P1|COMPLETED|Treatment Period 1||8
172106|NCT01484197|419334|P4|STARTED|Treatment Period 1||9
172107|NCT01484197|419335|P3|STARTED|Treatment Period 1||9
172108|NCT01484197|419336|P2|STARTED|Treatment Period 1||9
172109|NCT01484197|419337|P1|STARTED|Treatment Period 1||9
172110|NCT01484132|419420|P1|NOT COMPLETED|Overall Study||22
172111|NCT01484132|419420|P1|COMPLETED|Overall Study|91 subjects had at least one pre-treatment and at least one post-treatment urine sample.|91
172112|NCT01484132|419420|P1|Pre-treatment Urine Sample|Overall Study|Urine samples were collected twice pre-treatment. 101 subjects completed at least one urine sample.|101
172113|NCT01484132|419420|P1|STARTED|Overall Study||113
172114|NCT01484054|419428|P2|NOT COMPLETED|Period 2||0
172115|NCT01484054|419429|P1|NOT COMPLETED|Period 2||0
172116|NCT01484054|419428|P2|COMPLETED|Period 2||49
172117|NCT01484054|419429|P1|COMPLETED|Period 2||50
172118|NCT01484054|419428|P2|STARTED|Period 2||49
172119|NCT01484054|419429|P1|STARTED|Period 2||50
172120|NCT01484054|419428|P2|NOT COMPLETED|Period 1||1
172121|NCT01484054|419429|P1|NOT COMPLETED|Period 1||0
172122|NCT01484054|419428|P2|COMPLETED|Period 1||49
172123|NCT01484054|419429|P1|COMPLETED|Period 1||50
172124|NCT01484054|419428|P2|STARTED|Period 1||50
172125|NCT01484054|419429|P1|STARTED|Period 1||50
172126|NCT01484041|419439|P1|NOT COMPLETED|Overall Study||0
172127|NCT01484041|419439|P1|COMPLETED|Overall Study||12
172128|NCT01484041|419439|P1|STARTED|Overall Study||12
172129|NCT01484028|419447|P4|NOT COMPLETED|Period 2||0
172130|NCT01484028|419448|P3|NOT COMPLETED|Period 2||0
172131|NCT01484028|419449|P2|NOT COMPLETED|Period 2||0
172132|NCT01484028|419450|P1|NOT COMPLETED|Period 2||0
172133|NCT01484028|419447|P4|COMPLETED|Period 2||66
172134|NCT01484028|419448|P3|COMPLETED|Period 2||64
172135|NCT01484028|419449|P2|COMPLETED|Period 2||67
172136|NCT01484028|419450|P1|COMPLETED|Period 2||66
172137|NCT01484028|419447|P4|STARTED|Period 2||66
172138|NCT01484028|419448|P3|STARTED|Period 2||64
172139|NCT01484028|419449|P2|STARTED|Period 2||67
172140|NCT01484028|419450|P1|STARTED|Period 2||66
172141|NCT01484028|419447|P4|NOT COMPLETED|Period 1||1
172142|NCT01484028|419448|P3|NOT COMPLETED|Period 1||0
172143|NCT01484028|419449|P2|NOT COMPLETED|Period 1||3
172144|NCT01484028|419450|P1|NOT COMPLETED|Period 1||0
172145|NCT01484028|419447|P4|COMPLETED|Period 1||66
172146|NCT01484028|419448|P3|COMPLETED|Period 1||64
172147|NCT01484028|419449|P2|COMPLETED|Period 1||67
172148|NCT01484028|419450|P1|COMPLETED|Period 1||66
172149|NCT01484028|419447|P4|STARTED|Period 1||67
172150|NCT01484028|419448|P3|STARTED|Period 1||64
172151|NCT01484028|419449|P2|STARTED|Period 1||70
172152|NCT01484028|419450|P1|STARTED|Period 1||66
172153|NCT01483963|419465|P5|NOT COMPLETED|Overall Study||0
172154|NCT01483963|419466|P4|NOT COMPLETED|Overall Study||0
172155|NCT01483963|419467|P3|NOT COMPLETED|Overall Study||0
172156|NCT01483963|419468|P2|NOT COMPLETED|Overall Study||0
172157|NCT01483963|419469|P1|NOT COMPLETED|Overall Study||0
172158|NCT01483963|419465|P5|COMPLETED|Overall Study||10
172159|NCT01483963|419466|P4|COMPLETED|Overall Study||10
172160|NCT01483963|419467|P3|COMPLETED|Overall Study||10
172161|NCT01483963|419468|P2|COMPLETED|Overall Study||10
172162|NCT01483963|419469|P1|COMPLETED|Overall Study||10
172163|NCT01483963|419465|P5|STARTED|Overall Study||10
172164|NCT01483963|419466|P4|STARTED|Overall Study||10
172165|NCT01483963|419467|P3|STARTED|Overall Study||10
172166|NCT01483963|419468|P2|STARTED|Overall Study||10
172167|NCT01483963|419469|P1|STARTED|Overall Study||10
172168|NCT01483937|419543|P2|NOT COMPLETED|Overall Study||3
172169|NCT01483937|419544|P1|NOT COMPLETED|Overall Study||4
172170|NCT01483937|419543|P2|COMPLETED|Overall Study||14
172171|NCT01483937|419544|P1|COMPLETED|Overall Study||11
172172|NCT01483937|419543|P2|STARTED|Overall Study||17
172173|NCT01483937|419544|P1|STARTED|Overall Study||15
172174|NCT01483924|419571|P5|NOT COMPLETED|Overall Study||2
172175|NCT01483924|419572|P4|NOT COMPLETED|Overall Study||4
172176|NCT01483924|419573|P3|NOT COMPLETED|Overall Study||1
172177|NCT01483924|419574|P2|NOT COMPLETED|Overall Study||0
172178|NCT01483924|419575|P1|NOT COMPLETED|Overall Study||2
172179|NCT01483924|419571|P5|COMPLETED|Overall Study||10
172180|NCT01483924|419572|P4|COMPLETED|Overall Study||8
172181|NCT01483924|419573|P3|COMPLETED|Overall Study||11
172182|NCT01483924|419574|P2|COMPLETED|Overall Study||12
172183|NCT01483924|419575|P1|COMPLETED|Overall Study||10
172184|NCT01483924|419571|P5|STARTED|Overall Study||12
172185|NCT01483924|419572|P4|STARTED|Overall Study||12
172186|NCT01483924|419573|P3|STARTED|Overall Study||12
172187|NCT01483924|419574|P2|STARTED|Overall Study||12
172188|NCT01483924|419575|P1|STARTED|Overall Study||12
172189|NCT01483872|419623|P2|NOT COMPLETED|Overall Study||0
172190|NCT01483872|419624|P1|NOT COMPLETED|Overall Study||0
172191|NCT01483872|419623|P2|COMPLETED|Overall Study||1
172192|NCT01483872|419624|P1|COMPLETED|Overall Study||0
172193|NCT01483872|419623|P2|STARTED|Overall Study||1
172194|NCT01483872|419624|P1|STARTED|Overall Study||0
172195|NCT01483820|419628|P1|NOT COMPLETED|Overall Study||8
172196|NCT01483820|419628|P1|COMPLETED|Overall Study||0
172197|NCT01483820|419628|P1|STARTED|Overall Study||8
172198|NCT01483807|419637|P2|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
172199|NCT01483807|419638|P1|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
172200|NCT01483807|419637|P2|COMPLETED|Second Treatment Phase (7 Weeks)||10
172201|NCT01483807|419638|P1|COMPLETED|Second Treatment Phase (7 Weeks)||10
172202|NCT01483807|419637|P2|STARTED|Second Treatment Phase (7 Weeks)||10
172203|NCT01483807|419638|P1|STARTED|Second Treatment Phase (7 Weeks)||10
172204|NCT01483807|419637|P2|NOT COMPLETED|Washout (2 Weeks)||0
172205|NCT01483807|419638|P1|NOT COMPLETED|Washout (2 Weeks)||0
172206|NCT01483807|419637|P2|COMPLETED|Washout (2 Weeks)||10
172207|NCT01483807|419638|P1|COMPLETED|Washout (2 Weeks)||10
172208|NCT01483807|419637|P2|STARTED|Washout (2 Weeks)||10
172209|NCT01483807|419638|P1|STARTED|Washout (2 Weeks)||10
172210|NCT01483807|419637|P2|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
172211|NCT01483807|419638|P1|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
172212|NCT01483807|419637|P2|COMPLETED|First Treatment Phase (7 Weeks)||10
172213|NCT01483807|419638|P1|COMPLETED|First Treatment Phase (7 Weeks)||10
172214|NCT01483807|419637|P2|STARTED|First Treatment Phase (7 Weeks)||10
172215|NCT01483807|419638|P1|STARTED|First Treatment Phase (7 Weeks)||10
172216|NCT01483651|419649|P6|NOT COMPLETED|Overall Study||1
172217|NCT01483651|419650|P5|NOT COMPLETED|Overall Study||0
172218|NCT01483651|419651|P4|NOT COMPLETED|Overall Study||0
172219|NCT01483651|419652|P3|NOT COMPLETED|Overall Study||1
172220|NCT01483651|419653|P2|NOT COMPLETED|Overall Study||1
172221|NCT01483651|419654|P1|NOT COMPLETED|Overall Study||0
172222|NCT01483651|419649|P6|COMPLETED|Overall Study||1
172223|NCT01483651|419650|P5|COMPLETED|Overall Study||2
172224|NCT01483651|419651|P4|COMPLETED|Overall Study||1
172225|NCT01483651|419652|P3|COMPLETED|Overall Study||1
172226|NCT01483651|419653|P2|COMPLETED|Overall Study||2
172227|NCT01483651|419654|P1|COMPLETED|Overall Study||1
172228|NCT01483651|419649|P6|STARTED|Overall Study||2
172229|NCT01483651|419650|P5|STARTED|Overall Study||2
172230|NCT01483651|419651|P4|STARTED|Overall Study||1
172231|NCT01483651|419652|P3|STARTED|Overall Study||2
172232|NCT01483651|419653|P2|STARTED|Overall Study||3
172233|NCT01483651|419654|P1|STARTED|Overall Study||1
172234|NCT01483625|419664|P2|NOT COMPLETED|Overall Study||2
172235|NCT01483625|419665|P1|NOT COMPLETED|Overall Study||4
172236|NCT01483625|419664|P2|COMPLETED|Overall Study||66
172237|NCT01483625|419665|P1|COMPLETED|Overall Study||68
172238|NCT01483625|419664|P2|STARTED|Overall Study||68
172239|NCT01483625|419665|P1|STARTED|Overall Study||72
172240|NCT01483599|419688|P14|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||7
172241|NCT01483599|419689|P13|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||3
172242|NCT01483599|419690|P12|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||1
172243|NCT01483599|419691|P11|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
172244|NCT01483599|419692|P10|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||4
172245|NCT01483599|419693|P9|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||9
172246|NCT01483599|419694|P8|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
172247|NCT01483599|419695|P7|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
172248|NCT01483599|419696|P6|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
172249|NCT01483599|419697|P5|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
172250|NCT01483599|419698|P4|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
172251|NCT01483599|419699|P3|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
172252|NCT01483599|419700|P2|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
172253|NCT01483599|419701|P1|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
172254|NCT01483599|419688|P14|COMPLETED|After Controlled Period(Week 16-Week 40)||32
172255|NCT01483599|419689|P13|COMPLETED|After Controlled Period(Week 16-Week 40)||35
172256|NCT01483599|419690|P12|COMPLETED|After Controlled Period(Week 16-Week 40)||39
172257|NCT01483599|419691|P11|COMPLETED|After Controlled Period(Week 16-Week 40)||37
172258|NCT01483599|419692|P10|COMPLETED|After Controlled Period(Week 16-Week 40)||37
172259|NCT01483599|419693|P9|COMPLETED|After Controlled Period(Week 16-Week 40)||29
172260|NCT01483599|419694|P8|COMPLETED|After Controlled Period(Week 16-Week 40)||37
172261|NCT01483599|419695|P7|COMPLETED|After Controlled Period(Week 16-Week 40)||0
172262|NCT01483599|419696|P6|COMPLETED|After Controlled Period(Week 16-Week 40)||0
172263|NCT01483599|419697|P5|COMPLETED|After Controlled Period(Week 16-Week 40)||0
172264|NCT01483599|419698|P4|COMPLETED|After Controlled Period(Week 16-Week 40)||0
172265|NCT01483599|419699|P3|COMPLETED|After Controlled Period(Week 16-Week 40)||0
172266|NCT01483599|419700|P2|COMPLETED|After Controlled Period(Week 16-Week 40)||0
172267|NCT01483599|419701|P1|COMPLETED|After Controlled Period(Week 16-Week 40)||0
172268|NCT01483599|419688|P14|STARTED|After Controlled Period(Week 16-Week 40)||39
172269|NCT01483599|419689|P13|STARTED|After Controlled Period(Week 16-Week 40)||38
172270|NCT01483599|419690|P12|STARTED|After Controlled Period(Week 16-Week 40)||40
172271|NCT01483599|419691|P11|STARTED|After Controlled Period(Week 16-Week 40)||39
172272|NCT01483599|419692|P10|STARTED|After Controlled Period(Week 16-Week 40)||41
172273|NCT01483599|419693|P9|STARTED|After Controlled Period(Week 16-Week 40)||38
172274|NCT01483599|419694|P8|STARTED|After Controlled Period(Week 16-Week 40)||39
172275|NCT01483599|419695|P7|STARTED|After Controlled Period(Week 16-Week 40)||0
172276|NCT01483599|419696|P6|STARTED|After Controlled Period(Week 16-Week 40)||0
172277|NCT01483599|419697|P5|STARTED|After Controlled Period(Week 16-Week 40)||0
172278|NCT01483599|419698|P4|STARTED|After Controlled Period(Week 16-Week 40)||0
172279|NCT01483599|419699|P3|STARTED|After Controlled Period(Week 16-Week 40)||0
172280|NCT01483599|419700|P2|STARTED|After Controlled Period(Week 16-Week 40)||0
172281|NCT01483599|419701|P1|STARTED|After Controlled Period(Week 16-Week 40)||0
172282|NCT01483599|419688|P14|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
172283|NCT01483599|419689|P13|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
172284|NCT01483599|419690|P12|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
172285|NCT01483599|419691|P11|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
172286|NCT01483599|419692|P10|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
172287|NCT01483599|419693|P9|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
172288|NCT01483599|419694|P8|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
172289|NCT01483599|419695|P7|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
172290|NCT01483599|419696|P6|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
172291|NCT01483599|419697|P5|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||2
172292|NCT01483599|419698|P4|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
172293|NCT01483599|419699|P3|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
172294|NCT01483599|419700|P2|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
172295|NCT01483599|419701|P1|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
172296|NCT01483599|419688|P14|COMPLETED|Controlled Period (CP) (up to Week 16)||0
172297|NCT01483599|419689|P13|COMPLETED|Controlled Period (CP) (up to Week 16)||0
172298|NCT01483599|419690|P12|COMPLETED|Controlled Period (CP) (up to Week 16)||0
172299|NCT01483599|419691|P11|COMPLETED|Controlled Period (CP) (up to Week 16)||0
172300|NCT01483599|419692|P10|COMPLETED|Controlled Period (CP) (up to Week 16)||0
172301|NCT01483599|419693|P9|COMPLETED|Controlled Period (CP) (up to Week 16)||0
172302|NCT01483599|419694|P8|COMPLETED|Controlled Period (CP) (up to Week 16)||0
172303|NCT01483599|419695|P7|COMPLETED|Controlled Period (CP) (up to Week 16)||39
172304|NCT01483599|419696|P6|COMPLETED|Controlled Period (CP) (up to Week 16)||38
172305|NCT01483599|419697|P5|COMPLETED|Controlled Period (CP) (up to Week 16)||40
172306|NCT01483599|419698|P4|COMPLETED|Controlled Period (CP) (up to Week 16)||39
172307|NCT01483599|419699|P3|COMPLETED|Controlled Period (CP) (up to Week 16)||41
172308|NCT01483599|419700|P2|COMPLETED|Controlled Period (CP) (up to Week 16)||38
172309|NCT01483599|419701|P1|COMPLETED|Controlled Period (CP) (up to Week 16)||39
172310|NCT01483599|419688|P14|Treated|Controlled Period (CP) (up to Week 16)||0
172311|NCT01483599|419689|P13|Treated|Controlled Period (CP) (up to Week 16)||0
172312|NCT01483599|419690|P12|Treated|Controlled Period (CP) (up to Week 16)||0
172313|NCT01483599|419691|P11|Treated|Controlled Period (CP) (up to Week 16)||0
172314|NCT01483599|419692|P10|Treated|Controlled Period (CP) (up to Week 16)||0
172315|NCT01483599|419693|P9|Treated|Controlled Period (CP) (up to Week 16)||0
172316|NCT01483599|419694|P8|Treated|Controlled Period (CP) (up to Week 16)||0
172317|NCT01483599|419695|P7|Treated|Controlled Period (CP) (up to Week 16)||43
172318|NCT01483599|419696|P6|Treated|Controlled Period (CP) (up to Week 16)||41
172319|NCT01483599|419697|P5|Treated|Controlled Period (CP) (up to Week 16)||42
172320|NCT01483599|419698|P4|Treated|Controlled Period (CP) (up to Week 16)||42
172321|NCT01483599|419699|P3|Treated|Controlled Period (CP) (up to Week 16)||41
172322|NCT01483599|419700|P2|Treated|Controlled Period (CP) (up to Week 16)||41
172323|NCT01483599|419701|P1|Treated|Controlled Period (CP) (up to Week 16)||42
172324|NCT01483599|419688|P14|STARTED|Controlled Period (CP) (up to Week 16)||0
172325|NCT01483599|419689|P13|STARTED|Controlled Period (CP) (up to Week 16)||0
172326|NCT01483599|419690|P12|STARTED|Controlled Period (CP) (up to Week 16)||0
172327|NCT01483599|419691|P11|STARTED|Controlled Period (CP) (up to Week 16)||0
172328|NCT01483599|419692|P10|STARTED|Controlled Period (CP) (up to Week 16)||0
172329|NCT01483599|419693|P9|STARTED|Controlled Period (CP) (up to Week 16)||0
172330|NCT01483599|419694|P8|STARTED|Controlled Period (CP) (up to Week 16)||0
172331|NCT01483599|419695|P7|STARTED|Controlled Period (CP) (up to Week 16)||43
172332|NCT01483599|419696|P6|STARTED|Controlled Period (CP) (up to Week 16)||42
172333|NCT01483599|419697|P5|STARTED|Controlled Period (CP) (up to Week 16)||42
172334|NCT01483599|419698|P4|STARTED|Controlled Period (CP) (up to Week 16)||42
172335|NCT01483599|419699|P3|STARTED|Controlled Period (CP) (up to Week 16)||41
172336|NCT01483599|419700|P2|STARTED|Controlled Period (CP) (up to Week 16)||41
172337|NCT01483599|419701|P1|STARTED|Controlled Period (CP) (up to Week 16)||42
172338|NCT01483560|419752|P2|NOT COMPLETED|Overall Study||15
172339|NCT01483560|419753|P1|NOT COMPLETED|Overall Study||26
172340|NCT01483560|419752|P2|COMPLETED|Overall Study||194
172341|NCT01483560|419753|P1|COMPLETED|Overall Study||193
172342|NCT01483560|419752|P2|STARTED|Overall Study||209
172343|NCT01483560|419753|P1|STARTED|Overall Study||219
172344|NCT01483378|419773|P2|NOT COMPLETED|Overall Study||0
172345|NCT01483378|419774|P1|NOT COMPLETED|Overall Study||0
172346|NCT01483378|419773|P2|COMPLETED|Overall Study||66
172347|NCT01483378|419774|P1|COMPLETED|Overall Study||100
172348|NCT01483378|419773|P2|STARTED|Overall Study||66
172349|NCT01483378|419774|P1|STARTED|Overall Study||100
172350|NCT01483352|419780|P1|NOT COMPLETED|Overall Study||0
172351|NCT01483352|419780|P1|COMPLETED|Overall Study||12
172352|NCT01483352|419780|P1|STARTED|Overall Study||12
172353|NCT01483209|419799|P1|NOT COMPLETED|Overall Study||1
172354|NCT01483209|419799|P1|COMPLETED|Overall Study||1
172355|NCT01483209|419799|P1|STARTED|Overall Study||2
172356|NCT01483183|419814|P10|NOT COMPLETED|Overall Study||1
172357|NCT01483183|419815|P9|NOT COMPLETED|Overall Study||0
172358|NCT01483183|419816|P8|NOT COMPLETED|Overall Study||0
172359|NCT01483183|419817|P7|NOT COMPLETED|Overall Study||2
172360|NCT01483183|419818|P6|NOT COMPLETED|Overall Study||0
172361|NCT01483183|419819|P5|NOT COMPLETED|Overall Study||0
172362|NCT01483183|419820|P4|NOT COMPLETED|Overall Study||0
172363|NCT01483183|419821|P3|NOT COMPLETED|Overall Study||0
172364|NCT01483183|419822|P2|NOT COMPLETED|Overall Study||0
172365|NCT01483183|419823|P1|NOT COMPLETED|Overall Study||0
172366|NCT01483183|419814|P10|COMPLETED|Overall Study||4
172367|NCT01483183|419815|P9|COMPLETED|Overall Study||4
172368|NCT01483183|419816|P8|COMPLETED|Overall Study||4
172369|NCT01483183|419817|P7|COMPLETED|Overall Study||4
172370|NCT01483183|419818|P6|COMPLETED|Overall Study||4
172371|NCT01483183|419819|P5|COMPLETED|Overall Study||4
172372|NCT01483183|419820|P4|COMPLETED|Overall Study||3
172373|NCT01483183|419821|P3|COMPLETED|Overall Study||5
172374|NCT01483183|419822|P2|COMPLETED|Overall Study||1
172375|NCT01483183|419823|P1|COMPLETED|Overall Study||4
172376|NCT01483183|419814|P10|STARTED|Overall Study||5
172377|NCT01483183|419815|P9|STARTED|Overall Study||4
172378|NCT01483183|419816|P8|STARTED|Overall Study||4
172379|NCT01483183|419817|P7|STARTED|Overall Study||6
172380|NCT01483183|419818|P6|STARTED|Overall Study||4
172381|NCT01483183|419819|P5|STARTED|Overall Study||4
172382|NCT01483183|419820|P4|STARTED|Overall Study||3
172383|NCT01483183|419821|P3|STARTED|Overall Study||5
172384|NCT01483183|419822|P2|STARTED|Overall Study||1
172385|NCT01483183|419823|P1|STARTED|Overall Study||4
172386|NCT01483118|419893|P2|NOT COMPLETED|Overall Study||16
172387|NCT01483118|419894|P1|NOT COMPLETED|Overall Study||12
172388|NCT01483118|419893|P2|COMPLETED|Overall Study||6
172389|NCT01483118|419894|P1|COMPLETED|Overall Study||11
172390|NCT01483118|419893|P2|Completed 3 Months|Overall Study||11
172391|NCT01483118|419894|P1|Completed 3 Months|Overall Study||15
172392|NCT01483118|419893|P2|STARTED|Overall Study||22
172393|NCT01483118|419894|P1|STARTED|Overall Study||23
172394|NCT01482962|419906|P2|NOT COMPLETED|Overall Study||133
172395|NCT01482962|419907|P1|NOT COMPLETED|Overall Study||138
172396|NCT01482962|419906|P2|COMPLETED|Overall Study||0
172397|NCT01482962|419907|P1|COMPLETED|Overall Study||0
172398|NCT01482962|419906|P2|Safety Population: Received Study Drug|Overall Study||127
172399|NCT01482962|419907|P1|Safety Population: Received Study Drug|Overall Study||137
172400|NCT01482962|419906|P2|STARTED|Overall Study||133
172401|NCT01482962|419907|P1|STARTED|Overall Study||138
172402|NCT01482910|419940|P2|NOT COMPLETED|Overall Study||9
172403|NCT01482910|419941|P1|NOT COMPLETED|Overall Study||15
172404|NCT01482910|419940|P2|COMPLETED|Overall Study||67
172405|NCT01482910|419941|P1|COMPLETED|Overall Study||213
172406|NCT01482910|419940|P2|Completed Week 28|Overall Study||71
172407|NCT01482910|419941|P1|Completed Week 28|Overall Study||216
172408|NCT01482910|419940|P2|STARTED|Overall Study||76
172409|NCT01482910|419941|P1|STARTED|Overall Study||228
172410|NCT01482884|419953|P2|NOT COMPLETED|Overall Study||18
172411|NCT01482884|419954|P1|NOT COMPLETED|Overall Study||13
172412|NCT01482884|419953|P2|COMPLETED|Overall Study||37
172413|NCT01482884|419954|P1|COMPLETED|Overall Study||43
172414|NCT01482884|419953|P2|STARTED|Overall Study||55
172415|NCT01482884|419954|P1|STARTED|Overall Study|One participant did not receive study treatment|56
172416|NCT01482819|419980|P1|NOT COMPLETED|Overall Study||2
172417|NCT01482819|419980|P1|COMPLETED|Overall Study||19
172418|NCT01482819|419980|P1|STARTED|Overall Study||21
172419|NCT01482767|420000|P2|NOT COMPLETED|Overall Study||49
172420|NCT01482767|420001|P1|NOT COMPLETED|Overall Study||54
172421|NCT01482767|420000|P2|COMPLETED|Overall Study||78
172422|NCT01482767|420001|P1|COMPLETED|Overall Study||81
172423|NCT01482767|420000|P2|STARTED|Overall Study||127
172424|NCT01482767|420001|P1|STARTED|Overall Study||135
172425|NCT01482429|420023|P2|NOT COMPLETED|Protocol||0
172426|NCT01482429|420024|P1|NOT COMPLETED|Protocol||275
172427|NCT01482429|420023|P2|COMPLETED|Protocol||0
172428|NCT01482429|420024|P1|COMPLETED|Protocol||139
172429|NCT01482429|420023|P2|STARTED|Protocol||0
172430|NCT01482429|420024|P1|STARTED|Protocol||414
172431|NCT01482429|420023|P2|NOT COMPLETED|Care Usual||173
172432|NCT01482429|420024|P1|NOT COMPLETED|Care Usual||0
172433|NCT01482429|420023|P2|COMPLETED|Care Usual||96
172434|NCT01482429|420024|P1|COMPLETED|Care Usual||0
172435|NCT01482429|420023|P2|STARTED|Care Usual||269
172436|NCT01482429|420024|P1|STARTED|Care Usual||0
172437|NCT01482351|420034|P1|NOT COMPLETED|Overall Study||14
172438|NCT01482351|420034|P1|COMPLETED|Overall Study||54
172439|NCT01482351|420034|P1|12 Months|Overall Study||54
172440|NCT01482351|420034|P1|6 Months|Overall Study|14 dropped out|54
172441|NCT01482351|420034|P1|STARTED|Overall Study||68
172442|NCT01482325|420056|P1|NOT COMPLETED|Overall Study||0
172443|NCT01482325|420056|P1|COMPLETED|Overall Study||31
172444|NCT01482325|420056|P1|STARTED|Overall Study||31
172445|NCT01482312|420060|P3|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
172446|NCT01482312|420061|P2|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
172447|NCT01482312|420062|P1|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
172448|NCT01482312|420060|P3|COMPLETED|Period 3, 90 Minutes of Wear||9
172449|NCT01482312|420061|P2|COMPLETED|Period 3, 90 Minutes of Wear||9
172450|NCT01482312|420062|P1|COMPLETED|Period 3, 90 Minutes of Wear||8
172451|NCT01482312|420060|P3|STARTED|Period 3, 90 Minutes of Wear||9
172452|NCT01482312|420061|P2|STARTED|Period 3, 90 Minutes of Wear||9
172453|NCT01482312|420062|P1|STARTED|Period 3, 90 Minutes of Wear||8
172454|NCT01482312|420060|P3|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
172455|NCT01482312|420061|P2|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
172456|NCT01482312|420062|P1|NOT COMPLETED|Period 2, 90 Minutes of Wear||1
172457|NCT01482312|420060|P3|COMPLETED|Period 2, 90 Minutes of Wear||9
172458|NCT01482312|420061|P2|COMPLETED|Period 2, 90 Minutes of Wear||9
172459|NCT01482312|420062|P1|COMPLETED|Period 2, 90 Minutes of Wear||8
172460|NCT01482312|420060|P3|STARTED|Period 2, 90 Minutes of Wear|One participant discontinued between Period 1 and Period 2|9
172461|NCT01482312|420061|P2|STARTED|Period 2, 90 Minutes of Wear||9
172462|NCT01482312|420062|P1|STARTED|Period 2, 90 Minutes of Wear||9
172463|NCT01482312|420060|P3|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
172464|NCT01482312|420061|P2|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
172465|NCT01482312|420062|P1|NOT COMPLETED|Period 1, 90 Minutes of Wear||1
172466|NCT01482312|420060|P3|COMPLETED|Period 1, 90 Minutes of Wear||10
172467|NCT01482312|420061|P2|COMPLETED|Period 1, 90 Minutes of Wear||9
172468|NCT01482312|420062|P1|COMPLETED|Period 1, 90 Minutes of Wear||9
172469|NCT01482312|420060|P3|STARTED|Period 1, 90 Minutes of Wear||10
172470|NCT01482312|420061|P2|STARTED|Period 1, 90 Minutes of Wear||9
172471|NCT01482312|420062|P1|STARTED|Period 1, 90 Minutes of Wear||10
172472|NCT01482221|420076|P3|NOT COMPLETED|Overall Study||23
172473|NCT01482221|420077|P2|NOT COMPLETED|Overall Study||20
172474|NCT01482221|420078|P1|NOT COMPLETED|Overall Study||21
172475|NCT01482221|420076|P3|COMPLETED|Overall Study||77
172476|NCT01482221|420077|P2|COMPLETED|Overall Study||81
172477|NCT01482221|420078|P1|COMPLETED|Overall Study||80
172478|NCT01482221|420076|P3|STARTED|Overall Study||100
172479|NCT01482221|420077|P2|STARTED|Overall Study||101
172480|NCT01482221|420078|P1|STARTED|Overall Study||101
172481|NCT01482169|420119|P1|NOT COMPLETED|Overall Study||2
172482|NCT01482169|420119|P1|COMPLETED|Overall Study||46
172483|NCT01482169|420119|P1|STARTED|Overall Study||48
172484|NCT01482091|420128|P2|NOT COMPLETED|Overall Study||0
172485|NCT01482091|420129|P1|NOT COMPLETED|Overall Study||0
172486|NCT01482091|420128|P2|COMPLETED|Overall Study||24
172487|NCT01482091|420129|P1|COMPLETED|Overall Study||25
172488|NCT01482091|420128|P2|STARTED|Overall Study||24
172489|NCT01482091|420129|P1|STARTED|Overall Study||25
172490|NCT01482065|420161|P2|NOT COMPLETED|Overall Study||1
172491|NCT01482065|420162|P1|NOT COMPLETED|Overall Study||0
172492|NCT01482065|420161|P2|COMPLETED|Overall Study||4
172493|NCT01482065|420162|P1|COMPLETED|Overall Study||4
172494|NCT01482065|420161|P2|STARTED|Overall Study||5
172495|NCT01482065|420162|P1|STARTED|Overall Study||4
172496|NCT01481935|420176|P2|NOT COMPLETED|Overall Study||0
172497|NCT01481935|420177|P1|NOT COMPLETED|Overall Study||0
172498|NCT01481935|420176|P2|COMPLETED|Overall Study||93
172499|NCT01481935|420177|P1|COMPLETED|Overall Study||97
172500|NCT01481935|420176|P2|STARTED|Overall Study||93
172501|NCT01481935|420177|P1|STARTED|Overall Study||97
172502|NCT01481896|420183|P1|NOT COMPLETED|Overall Study||12
172503|NCT01481896|420183|P1|COMPLETED|Overall Study|The 114 participants includes 5 participants with bilateral hip replacements for a total of 119 THAs|114
172504|NCT01481896|420183|P1|Min 4.75 yr Follow-up, Revised or Dead|Overall Study|114 participants with 119 THAs had at least 4.75 year follow-up or were known revised or deceased|114
172505|NCT01481896|420183|P1|STARTED|Overall Study|The 126 participants includes 5 participants with bilateral hip replacements for a total of 131 THAs|126
172506|NCT01481779|420199|P2|NOT COMPLETED|Overall Study||28
172507|NCT01481779|420200|P1|NOT COMPLETED|Overall Study||70
172508|NCT01481779|420199|P2|COMPLETED|Overall Study||132
172509|NCT01481779|420200|P1|COMPLETED|Overall Study||225
172510|NCT01481779|420199|P2|Received at Least 1 Dose of Study Drug|Overall Study||159
172511|NCT01481779|420200|P1|Received at Least 1 Dose of Study Drug|Overall Study||294
172512|NCT01481779|420199|P2|STARTED|Overall Study||160
172513|NCT01481779|420200|P1|STARTED|Overall Study||295
172514|NCT01481740|420248|P2|NOT COMPLETED|Overall Study||7
172515|NCT01481740|420249|P1|NOT COMPLETED|Overall Study||11
172516|NCT01481740|420248|P2|COMPLETED|Overall Study||81
172517|NCT01481740|420249|P1|COMPLETED|Overall Study||79
172518|NCT01481740|420248|P2|STARTED|Overall Study||88
172519|NCT01481740|420249|P1|STARTED|Overall Study||90
172520|NCT01481558|420267|P2|NOT COMPLETED|Overall Study||0
172521|NCT01481558|420268|P1|NOT COMPLETED|Overall Study||0
172522|NCT01481558|420267|P2|COMPLETED|Overall Study||20
172523|NCT01481558|420268|P1|COMPLETED|Overall Study||20
172524|NCT01481558|420267|P2|STARTED|Overall Study||20
172525|NCT01481558|420268|P1|STARTED|Overall Study||20
172526|NCT01481376|420274|P1|NOT COMPLETED|Overall Study||31
172527|NCT01481376|420274|P1|COMPLETED|Overall Study||169
172528|NCT01481376|420274|P1|STARTED|Overall Study||200
172529|NCT01481324|420285|P3|NOT COMPLETED|Overall Study||2
172530|NCT01481324|420286|P2|NOT COMPLETED|Overall Study||2
172531|NCT01481324|420287|P1|NOT COMPLETED|Overall Study||0
172532|NCT01481324|420285|P3|COMPLETED|Overall Study||20
172533|NCT01481324|420286|P2|COMPLETED|Overall Study||22
172534|NCT01481324|420287|P1|COMPLETED|Overall Study||21
172535|NCT01481324|420285|P3|Month 3-Wear Rate Data|Overall Study||6
172536|NCT01481324|420286|P2|Month 3-Wear Rate Data|Overall Study||11
172537|NCT01481324|420287|P1|Month 3-Wear Rate Data|Overall Study||7
172538|NCT01481324|420285|P3|Month 2-Wear Rate Data|Overall Study||7
172539|NCT01481324|420286|P2|Month 2-Wear Rate Data|Overall Study||13
172540|NCT01481324|420287|P1|Month 2-Wear Rate Data|Overall Study||9
172541|NCT01481324|420285|P3|Month 1-Wear Rate Data|Overall Study||8
172542|NCT01481324|420286|P2|Month 1-Wear Rate Data|Overall Study||16
172543|NCT01481324|420287|P1|Month 1-Wear Rate Data|Overall Study||15
172544|NCT01481324|420285|P3|STARTED|Overall Study||22
172545|NCT01481324|420286|P2|STARTED|Overall Study||24
172546|NCT01481324|420287|P1|STARTED|Overall Study||21
172547|NCT01481129|420295|P1|NOT COMPLETED|Overall Study||0
172548|NCT01481129|420295|P1|COMPLETED|Overall Study||22
172549|NCT01481129|420295|P1|STARTED|Overall Study||22
172550|NCT01481116|420306|P3|NOT COMPLETED|Overall Study||813
172551|NCT01481116|420307|P2|NOT COMPLETED|Overall Study||817
172552|NCT01481116|420308|P1|NOT COMPLETED|Overall Study||824
172553|NCT01481116|420306|P3|COMPLETED|Overall Study||0
172554|NCT01481116|420307|P2|COMPLETED|Overall Study||0
172555|NCT01481116|420308|P1|COMPLETED|Overall Study||0
172556|NCT01481116|420306|P3|Treated|Overall Study||813
172557|NCT01481116|420307|P2|Treated|Overall Study||816
172558|NCT01481116|420308|P1|Treated|Overall Study||822
172559|NCT01481116|420306|P3|STARTED|Overall Study||813
172560|NCT01481116|420307|P2|STARTED|Overall Study||817
172561|NCT01481116|420308|P1|STARTED|Overall Study||824
172562|NCT01480843|420334|P1|NOT COMPLETED|Overall Study||5
172563|NCT01480843|420334|P1|COMPLETED|Overall Study||60
172564|NCT01480843|420334|P1|STARTED|Overall Study||65
172565|NCT01480674|420339|P1|NOT COMPLETED|Overall Study||35
172566|NCT01480674|420339|P1|COMPLETED|Overall Study||125
172567|NCT01480674|420339|P1|Analysed Set|Overall Study||128
172568|NCT01480674|420339|P1|Safety Set|Overall Study||154
172569|NCT01480674|420339|P1|STARTED|Overall Study||160
172570|NCT01480596|420353|P2|NOT COMPLETED|Overall Study||2
172571|NCT01480596|420354|P1|NOT COMPLETED|Overall Study||5
172572|NCT01480596|420353|P2|COMPLETED|Overall Study||16
172573|NCT01480596|420354|P1|COMPLETED|Overall Study||17
172574|NCT01480596|420353|P2|STARTED|Overall Study||18
172575|NCT01480596|420354|P1|STARTED|Overall Study||22
172576|NCT01480297|420396|P1|NOT COMPLETED|Overall Study||0
172577|NCT01480297|420396|P1|COMPLETED|Overall Study||8
172578|NCT01480297|420396|P1|STARTED|Overall Study||8
172579|NCT01480284|420402|P2|NOT COMPLETED|Overall Study||0
172580|NCT01480284|420403|P1|NOT COMPLETED|Overall Study||8
172581|NCT01480284|420402|P2|COMPLETED|Overall Study||56
172582|NCT01480284|420403|P1|COMPLETED|Overall Study||102
172583|NCT01480284|420402|P2|STARTED|Overall Study||56
172584|NCT01480284|420403|P1|STARTED|Overall Study||110
172585|NCT01480258|420433|P2|NOT COMPLETED|Toddler Dose||0
172586|NCT01480258|420434|P1|NOT COMPLETED|Toddler Dose||0
172587|NCT01480258|420433|P2|COMPLETED|Toddler Dose||642
172588|NCT01480258|420434|P1|COMPLETED|Toddler Dose||639
172589|NCT01480258|420433|P2|STARTED|Toddler Dose||642
172590|NCT01480258|420434|P1|STARTED|Toddler Dose||639
172591|NCT01480258|420433|P2|NOT COMPLETED|Interim Period||9
172592|NCT01480258|420434|P1|NOT COMPLETED|Interim Period||10
172593|NCT01480258|420433|P2|COMPLETED|Interim Period||642
172594|NCT01480258|420434|P1|COMPLETED|Interim Period||639
172595|NCT01480258|420433|P2|STARTED|Interim Period||651
172596|NCT01480258|420434|P1|STARTED|Interim Period||649
172597|NCT01480258|420433|P2|NOT COMPLETED|Infant Series||8
172598|NCT01480258|420434|P1|NOT COMPLETED|Infant Series||7
172599|NCT01480258|420433|P2|COMPLETED|Infant Series||651
172600|NCT01480258|420434|P1|COMPLETED|Infant Series||649
172601|NCT01480258|420433|P2|Vaccinated|Infant Series||659
172602|NCT01480258|420434|P1|Vaccinated|Infant Series||653
172603|NCT01480258|420433|P2|STARTED|Infant Series||659
172604|NCT01480258|420434|P1|STARTED|Infant Series||656
172605|NCT01480232|420460|P4|NOT COMPLETED|Overall Study||19
172606|NCT01480232|420461|P3|NOT COMPLETED|Overall Study||17
172607|NCT01480232|420462|P2|NOT COMPLETED|Overall Study||22
172608|NCT01480232|420463|P1|NOT COMPLETED|Overall Study||18
172609|NCT01480232|420460|P4|COMPLETED|Overall Study||22
172610|NCT01480232|420461|P3|COMPLETED|Overall Study||21
172611|NCT01480232|420462|P2|COMPLETED|Overall Study||19
172612|NCT01480232|420463|P1|COMPLETED|Overall Study||22
172613|NCT01480232|420460|P4|STARTED|Overall Study||41
172614|NCT01480232|420461|P3|STARTED|Overall Study||38
172615|NCT01480232|420462|P2|STARTED|Overall Study||41
172616|NCT01480232|420463|P1|STARTED|Overall Study||40
172617|NCT01480219|420491|P2|NOT COMPLETED|Overall Study||0
172618|NCT01480219|420492|P1|NOT COMPLETED|Overall Study||0
172619|NCT01480219|420491|P2|COMPLETED|Overall Study||142
172620|NCT01480219|420492|P1|COMPLETED|Overall Study||325
172621|NCT01480219|420491|P2|STARTED|Overall Study||142
172622|NCT01480219|420492|P1|STARTED|Overall Study||325
172623|NCT01480089|420500|P2|NOT COMPLETED|Overall Study||0
172624|NCT01480089|420501|P1|NOT COMPLETED|Overall Study||0
172625|NCT01480089|420500|P2|COMPLETED|Overall Study||30
172626|NCT01480089|420501|P1|COMPLETED|Overall Study||25
172627|NCT01480089|420500|P2|STARTED|Overall Study||30
172628|NCT01480089|420501|P1|STARTED|Overall Study||25
172629|NCT01480076|420511|P1|NOT COMPLETED|Overall Study||290
172630|NCT01480076|420511|P1|COMPLETED|Overall Study||611
172631|NCT01480076|420511|P1|Intent to Treat Population|Overall Study|Received ≥1 dose of study drug & provided ≥1 efficacy assessment at Baseline & the 3-month visit.|835
172632|NCT01480076|420511|P1|STARTED|Overall Study|enrolled and started run-in treatment|901
172633|NCT01479985|420632|P2|NOT COMPLETED|Overall Study||0
172634|NCT01479985|420633|P1|NOT COMPLETED|Overall Study||0
172635|NCT01479985|420632|P2|COMPLETED|Overall Study||80
172636|NCT01479985|420633|P1|COMPLETED|Overall Study||161
172637|NCT01479985|420632|P2|STARTED|Overall Study||80
172638|NCT01479985|420633|P1|STARTED|Overall Study||161
172639|NCT01479868|420641|P1|NOT COMPLETED|Overall Study||9
172640|NCT01479868|420641|P1|COMPLETED|Overall Study||97
172641|NCT01479868|420641|P1|STARTED|Overall Study|Restricted to subject who received at least one dose of treatment (TMC435/RBV/PegIFN).|106
172642|NCT01479777|420656|P1|NOT COMPLETED|Overall Study||2
172643|NCT01479777|420656|P1|COMPLETED|Overall Study||10
172644|NCT01479777|420656|P1|STARTED|Overall Study||12
172645|NCT01479764|420668|P2|NOT COMPLETED|Treated||2
172646|NCT01479764|420669|P1|NOT COMPLETED|Treated||0
172647|NCT01479764|420668|P2|COMPLETED|Treated||75
172648|NCT01479764|420669|P1|COMPLETED|Treated||74
172649|NCT01479764|420668|P2|STARTED|Treated||77
172650|NCT01479764|420669|P1|STARTED|Treated||74
172651|NCT01479764|420668|P2|NOT COMPLETED|Randomized||1
172652|NCT01479764|420669|P1|NOT COMPLETED|Randomized||2
172653|NCT01479764|420668|P2|COMPLETED|Randomized|1 randomized participant did not receive study drug|77
172654|NCT01479764|420669|P1|COMPLETED|Randomized|2 randomized participants did not receive study drug|74
172655|NCT01479764|420668|P2|STARTED|Randomized||78
172656|NCT01479764|420669|P1|STARTED|Randomized||76
172657|NCT01479725|420679|P2|NOT COMPLETED|Overall Study||1
172658|NCT01479725|420680|P1|NOT COMPLETED|Overall Study||2
172659|NCT01479725|420679|P2|COMPLETED|Overall Study||1
172660|NCT01479725|420680|P1|COMPLETED|Overall Study||4
172661|NCT01479725|420679|P2|STARTED|Overall Study||2
172662|NCT01479725|420680|P1|STARTED|Overall Study||6
172663|NCT01479621|420692|P7|NOT COMPLETED|Treatment Period||20
172664|NCT01479621|420693|P6|NOT COMPLETED|Treatment Period||41
172665|NCT01479621|420694|P5|NOT COMPLETED|Treatment Period||21
172666|NCT01479621|420695|P4|NOT COMPLETED|Treatment Period||12
172667|NCT01479621|420696|P3|NOT COMPLETED|Treatment Period||21
172668|NCT01479621|420697|P2|NOT COMPLETED|Treatment Period||24
172669|NCT01479621|420698|P1|NOT COMPLETED|Treatment Period||0
172670|NCT01479621|420692|P7|COMPLETED|Treatment Period||84
172671|NCT01479621|420693|P6|COMPLETED|Treatment Period||63
172672|NCT01479621|420694|P5|COMPLETED|Treatment Period||82
172673|NCT01479621|420695|P4|COMPLETED|Treatment Period||92
172674|NCT01479621|420696|P3|COMPLETED|Treatment Period||83
172675|NCT01479621|420697|P2|COMPLETED|Treatment Period||79
172676|NCT01479621|420698|P1|COMPLETED|Treatment Period||0
172677|NCT01479621|420692|P7|Full Analysis Set|Treatment Period||102
172678|NCT01479621|420693|P6|Full Analysis Set|Treatment Period||102
172679|NCT01479621|420694|P5|Full Analysis Set|Treatment Period||102
172680|NCT01479621|420695|P4|Full Analysis Set|Treatment Period||102
172681|NCT01479621|420696|P3|Full Analysis Set|Treatment Period||101
172682|NCT01479621|420697|P2|Full Analysis Set|Treatment Period||102
172683|NCT01479621|420698|P1|Full Analysis Set|Treatment Period||0
172684|NCT01479621|420692|P7|Safety Population|Treatment Period||104
172685|NCT01479621|420693|P6|Safety Population|Treatment Period||104
172686|NCT01479621|420694|P5|Safety Population|Treatment Period||103
172687|NCT01479621|420695|P4|Safety Population|Treatment Period||104
172688|NCT01479621|420696|P3|Safety Population|Treatment Period||104
172689|NCT01479621|420697|P2|Safety Population|Treatment Period||103
172690|NCT01479621|420698|P1|Safety Population|Treatment Period||0
172691|NCT01479621|420692|P7|STARTED|Treatment Period||104
172692|NCT01479621|420693|P6|STARTED|Treatment Period||104
172693|NCT01479621|420694|P5|STARTED|Treatment Period||103
172694|NCT01479621|420695|P4|STARTED|Treatment Period||104
172695|NCT01479621|420696|P3|STARTED|Treatment Period||104
172696|NCT01479621|420697|P2|STARTED|Treatment Period||103
172697|NCT01479621|420698|P1|STARTED|Treatment Period||0
172698|NCT01479621|420692|P7|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
172699|NCT01479621|420693|P6|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
172700|NCT01479621|420694|P5|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
172701|NCT01479621|420695|P4|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
172702|NCT01479621|420696|P3|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
172703|NCT01479621|420697|P2|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
172704|NCT01479621|420698|P1|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||287
172705|NCT01479621|420692|P7|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
172706|NCT01479621|420693|P6|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
172707|NCT01479621|420694|P5|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
172708|NCT01479621|420695|P4|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
172709|NCT01479621|420696|P3|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
172710|NCT01479621|420697|P2|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
172711|NCT01479621|420698|P1|COMPLETED|Pre-Assignment Period (Run-In Placebo)||622
172712|NCT01479621|420692|P7|STARTED|Pre-Assignment Period (Run-In Placebo)||0
172713|NCT01479621|420693|P6|STARTED|Pre-Assignment Period (Run-In Placebo)||0
172714|NCT01479621|420694|P5|STARTED|Pre-Assignment Period (Run-In Placebo)||0
172715|NCT01479621|420695|P4|STARTED|Pre-Assignment Period (Run-In Placebo)||0
172716|NCT01479621|420696|P3|STARTED|Pre-Assignment Period (Run-In Placebo)||0
172717|NCT01479621|420697|P2|STARTED|Pre-Assignment Period (Run-In Placebo)||0
172718|NCT01479621|420698|P1|STARTED|Pre-Assignment Period (Run-In Placebo)||909
172719|NCT01479595|420786|P2|NOT COMPLETED|Overall Study||2
172720|NCT01479595|420787|P1|NOT COMPLETED|Overall Study||2
172721|NCT01479595|420786|P2|COMPLETED|Overall Study||19
172722|NCT01479595|420787|P1|COMPLETED|Overall Study||42
172723|NCT01479595|420786|P2|Per Protocol Analysis Set|Overall Study||20
172724|NCT01479595|420787|P1|Per Protocol Analysis Set|Overall Study||41
172725|NCT01479595|420786|P2|PK Analysis Set|Overall Study||0
172726|NCT01479595|420787|P1|PK Analysis Set|Overall Study||42
172727|NCT01479595|420786|P2|STARTED|Overall Study||21
172728|NCT01479595|420787|P1|STARTED|Overall Study||44
172729|NCT01479543|420814|P5|NOT COMPLETED|Overall Study||1
172730|NCT01479543|420815|P4|NOT COMPLETED|Overall Study||0
172731|NCT01479543|420816|P3|NOT COMPLETED|Overall Study||1
172732|NCT01479543|420817|P2|NOT COMPLETED|Overall Study||0
172733|NCT01479543|420818|P1|NOT COMPLETED|Overall Study||1
172734|NCT01479543|420814|P5|COMPLETED|Overall Study||20
172735|NCT01479543|420815|P4|COMPLETED|Overall Study||20
172736|NCT01479543|420816|P3|COMPLETED|Overall Study||20
172737|NCT01479543|420817|P2|COMPLETED|Overall Study||20
172738|NCT01479543|420818|P1|COMPLETED|Overall Study||20
172739|NCT01479543|420814|P5|STARTED|Overall Study||21
172740|NCT01479543|420815|P4|STARTED|Overall Study||20
172741|NCT01479543|420816|P3|STARTED|Overall Study||21
172742|NCT01479543|420817|P2|STARTED|Overall Study||20
172743|NCT01479543|420818|P1|STARTED|Overall Study||21
172744|NCT01479530|420832|P2|NOT COMPLETED|Overall Study||12
172745|NCT01479530|420833|P1|NOT COMPLETED|Overall Study||10
172746|NCT01479530|420832|P2|COMPLETED|Overall Study||151
172747|NCT01479530|420833|P1|COMPLETED|Overall Study||148
172748|NCT01479530|420832|P2|STARTED|Overall Study||163
172749|NCT01479530|420833|P1|STARTED|Overall Study||158
172750|NCT01479517|420848|P3|NOT COMPLETED|Overall Study||0
172751|NCT01479517|420849|P2|NOT COMPLETED|Overall Study||0
172752|NCT01479517|420850|P1|NOT COMPLETED|Overall Study||0
172753|NCT01479517|420848|P3|COMPLETED|Overall Study||10
172754|NCT01479517|420849|P2|COMPLETED|Overall Study||10
172755|NCT01479517|420850|P1|COMPLETED|Overall Study||10
172756|NCT01479517|420848|P3|STARTED|Overall Study||10
172757|NCT01479517|420849|P2|STARTED|Overall Study||10
172758|NCT01479517|420850|P1|STARTED|Overall Study||10
172759|NCT01479478|420869|P2|NOT COMPLETED|Overall Study||0
172760|NCT01479478|420870|P1|NOT COMPLETED|Overall Study||0
172761|NCT01479478|420869|P2|COMPLETED|Overall Study||126
172762|NCT01479478|420870|P1|COMPLETED|Overall Study||125
172763|NCT01479478|420869|P2|STARTED|Overall Study||126
172764|NCT01479478|420870|P1|STARTED|Overall Study||125
172765|NCT01479465|420914|P4|NOT COMPLETED|Overall Study||85
172766|NCT01479465|420915|P3|NOT COMPLETED|Overall Study||86
172767|NCT01479465|420916|P2|NOT COMPLETED|Overall Study||84
172768|NCT01479465|420917|P1|NOT COMPLETED|Overall Study||11
172769|NCT01479465|420914|P4|COMPLETED|Overall Study||0
172770|NCT01479465|420915|P3|COMPLETED|Overall Study||0
172771|NCT01479465|420916|P2|COMPLETED|Overall Study||0
172772|NCT01479465|420917|P1|COMPLETED|Overall Study||0
172773|NCT01479465|420914|P4|STARTED|Overall Study||85
172774|NCT01479465|420915|P3|STARTED|Overall Study||86
172775|NCT01479465|420916|P2|STARTED|Overall Study||84
172776|NCT01479465|420917|P1|STARTED|Overall Study||11
172777|NCT01479426|420937|P2|NOT COMPLETED|Overall Study||3
172778|NCT01479426|420938|P1|NOT COMPLETED|Overall Study||4
172779|NCT01479426|420937|P2|COMPLETED|Overall Study||37
172780|NCT01479426|420938|P1|COMPLETED|Overall Study||36
172781|NCT01479426|420937|P2|STARTED|Overall Study||40
172782|NCT01479426|420938|P1|STARTED|Overall Study||40
172783|NCT01479374|420953|P3|NOT COMPLETED|Overall Study||5
172784|NCT01479374|420954|P2|NOT COMPLETED|Overall Study||8
172785|NCT01479374|420955|P1|NOT COMPLETED|Overall Study||3
172786|NCT01479374|420953|P3|COMPLETED|Overall Study||63
172787|NCT01479374|420954|P2|COMPLETED|Overall Study||60
172788|NCT01479374|420955|P1|COMPLETED|Overall Study||63
172789|NCT01479374|420953|P3|STARTED|Overall Study||68
172790|NCT01479374|420954|P2|STARTED|Overall Study||68
172791|NCT01479374|420955|P1|STARTED|Overall Study||66
172792|NCT01479270|420983|P2|NOT COMPLETED|Overall Study||0
172793|NCT01479270|420984|P1|NOT COMPLETED|Overall Study||0
172794|NCT01479270|420983|P2|COMPLETED|Overall Study||28
172795|NCT01479270|420984|P1|COMPLETED|Overall Study||28
172796|NCT01479270|420983|P2|STARTED|Overall Study||28
172797|NCT01479270|420984|P1|STARTED|Overall Study||28
172798|NCT01479127|420996|P1|NOT COMPLETED|Overall Study||3
172799|NCT01479127|420996|P1|COMPLETED|Overall Study||5
172800|NCT01479127|420996|P1|Started LCIG|Overall Study||6
172801|NCT01479127|420996|P1|STARTED|Overall Study|started oral study drug (full safety sample)|8
172802|NCT01479010|421030|P1|NOT COMPLETED|Overall Study||1
172803|NCT01479010|421030|P1|COMPLETED|Overall Study||1
172804|NCT01479010|421030|P1|STARTED|Overall Study||2
172805|NCT01478971|421041|P1|NOT COMPLETED|Peginesatide Treatment Period||14
172806|NCT01478971|421041|P1|COMPLETED|Peginesatide Treatment Period||143
172807|NCT01478971|421041|P1|STARTED|Peginesatide Treatment Period|2 participants terminated the study before transitioning to peginesatide for unknown reasons|157
172808|NCT01478971|421041|P1|NOT COMPLETED|Standard of Care Period||25
172809|NCT01478971|421041|P1|COMPLETED|Standard of Care Period||159
172810|NCT01478971|421041|P1|Received Treatment|Standard of Care Period||178
172811|NCT01478971|421041|P1|STARTED|Standard of Care Period||184
172812|NCT01478958|421058|P3|NOT COMPLETED|Overall Study||3
172813|NCT01478958|421059|P2|NOT COMPLETED|Overall Study||2
172814|NCT01478958|421060|P1|NOT COMPLETED|Overall Study||2
172815|NCT01478958|421058|P3|COMPLETED|Overall Study||66
172816|NCT01478958|421059|P2|COMPLETED|Overall Study||64
172817|NCT01478958|421060|P1|COMPLETED|Overall Study||65
172818|NCT01478958|421058|P3|STARTED|Overall Study||69
172819|NCT01478958|421059|P2|STARTED|Overall Study||66
172820|NCT01478958|421060|P1|STARTED|Overall Study||67
172821|NCT01478854|421068|P1|NOT COMPLETED|Overall Study||0
172822|NCT01478854|421068|P1|COMPLETED|Overall Study||30
172823|NCT01478854|421068|P1|STARTED|Overall Study||30
172824|NCT01478828|421080|P1|NOT COMPLETED|Overall Study||1
172825|NCT01478828|421080|P1|COMPLETED|Overall Study||1
172826|NCT01478828|421080|P1|STARTED|Overall Study||2
172827|NCT01478620|421091|P1|NOT COMPLETED|Overall Study||6
172828|NCT01478620|421091|P1|COMPLETED|Overall Study||119
172829|NCT01478620|421091|P1|STARTED|Overall Study||125
172830|NCT01478594|421097|P2|NOT COMPLETED|Overall Study||28
172831|NCT01478594|421098|P1|NOT COMPLETED|Overall Study||65
172832|NCT01478594|421097|P2|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|60
172833|NCT01478594|421098|P1|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|112
172834|NCT01478594|421097|P2|Treated|Overall Study||87
172835|NCT01478594|421098|P1|Treated|Overall Study||177
172836|NCT01478594|421097|P2|STARTED|Overall Study||88
172837|NCT01478594|421098|P1|STARTED|Overall Study||177
172838|NCT01478581|421174|P4|NOT COMPLETED|Overall Study||0
172839|NCT01478581|421175|P3|NOT COMPLETED|Overall Study||0
172840|NCT01478581|421176|P2|NOT COMPLETED|Overall Study||0
172841|NCT01478581|421177|P1|NOT COMPLETED|Overall Study||0
172842|NCT01478581|421174|P4|COMPLETED|Overall Study||43
172843|NCT01478581|421175|P3|COMPLETED|Overall Study||18
172844|NCT01478581|421176|P2|COMPLETED|Overall Study||18
172845|NCT01478581|421177|P1|COMPLETED|Overall Study||13
172846|NCT01478581|421174|P4|STARTED|Overall Study|Simon 2-stage design - cohort 4 expansion per stage 1 data (≥3 Clinical Benefit Responders observed|43
172847|NCT01478581|421175|P3|STARTED|Overall Study||18
172848|NCT01478581|421176|P2|STARTED|Overall Study||18
172849|NCT01478581|421177|P1|STARTED|Overall Study||13
172850|NCT01478373|421227|P1|NOT COMPLETED|Survival Phase||38
172851|NCT01478373|421227|P1|COMPLETED|Survival Phase||0
172852|NCT01478373|421227|P1|STARTED|Survival Phase||38
172853|NCT01478373|421227|P1|NOT COMPLETED|Treatment Phase||1
172854|NCT01478373|421227|P1|COMPLETED|Treatment Phase||38
172855|NCT01478373|421227|P1|STARTED|Treatment Phase||39
172856|NCT01478360|421240|P2|NOT COMPLETED|Overall Study||3
172857|NCT01478360|421241|P1|NOT COMPLETED|Overall Study||2
172858|NCT01478360|421240|P2|COMPLETED|Overall Study||12
172859|NCT01478360|421241|P1|COMPLETED|Overall Study||29
172860|NCT01478360|421240|P2|PK (Pharmacokinetics) Analysis Set|Overall Study||0
172861|NCT01478360|421241|P1|PK (Pharmacokinetics) Analysis Set|Overall Study|Serum samples were collected during the study and analyzed only for the AIN457 group|31
172862|NCT01478360|421240|P2|PD (Pharmacodynamic) Analysis Set|Overall Study||15
172863|NCT01478360|421241|P1|PD (Pharmacodynamic) Analysis Set|Overall Study||31
172864|NCT01478360|421240|P2|STARTED|Overall Study||15
172865|NCT01478360|421241|P1|STARTED|Overall Study||31
172866|NCT01478347|421247|P1|NOT COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||8
172867|NCT01478347|421247|P1|COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||4
172868|NCT01478347|421247|P1|STARTED|Visit 4-Visit 7 (Day 151-331) - Part II||12
172869|NCT01478347|421247|P1|NOT COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||1
172870|NCT01478347|421247|P1|COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||17
172871|NCT01478347|421247|P1|STARTED|Visit 1-Visit 3 (Day 0-91) - Part I||18
172872|NCT01478256|421254|P2|NOT COMPLETED|Overall Study||0
172873|NCT01478256|421255|P1|NOT COMPLETED|Overall Study||0
172874|NCT01478256|421254|P2|COMPLETED|Overall Study||15
172875|NCT01478256|421255|P1|COMPLETED|Overall Study||15
172876|NCT01478256|421254|P2|STARTED|Overall Study||15
172877|NCT01478256|421255|P1|STARTED|Overall Study||15
172878|NCT01478113|421265|P2|NOT COMPLETED|Overall Study||1
172879|NCT01478113|421266|P1|NOT COMPLETED|Overall Study||1
172880|NCT01478113|421265|P2|COMPLETED|Overall Study||1
172881|NCT01478113|421266|P1|COMPLETED|Overall Study||1
172882|NCT01478113|421265|P2|STARTED|Overall Study||2
172883|NCT01478113|421266|P1|STARTED|Overall Study||2
172884|NCT01478087|421284|P1|NOT COMPLETED|Overall Study||1
172885|NCT01478087|421284|P1|COMPLETED|Overall Study||2
172886|NCT01478087|421284|P1|STARTED|Overall Study||3
172887|NCT01478048|421291|P2|NOT COMPLETED|Overall Study||75
172888|NCT01478048|421292|P1|NOT COMPLETED|Overall Study||77
172889|NCT01478048|421291|P2|COMPLETED|Overall Study||0
172890|NCT01478048|421292|P1|COMPLETED|Overall Study||0
172891|NCT01478048|421291|P2|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|74
172892|NCT01478048|421292|P1|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|76
172893|NCT01478048|421291|P2|STARTED|Overall Study||75
172894|NCT01478048|421292|P1|STARTED|Overall Study||77
172895|NCT01478009|421310|P2|NOT COMPLETED|Overall Study||1
172896|NCT01478009|421311|P1|NOT COMPLETED|Overall Study||1
172897|NCT01478009|421310|P2|COMPLETED|Overall Study||49
172898|NCT01478009|421311|P1|COMPLETED|Overall Study||49
172899|NCT01478009|421310|P2|STARTED|Overall Study||50
172900|NCT01478009|421311|P1|STARTED|Overall Study||50
172901|NCT01477892|421321|P2|NOT COMPLETED|Overall Study||2
172902|NCT01477892|421322|P1|NOT COMPLETED|Overall Study||0
172903|NCT01477892|421321|P2|COMPLETED|Overall Study||5
172904|NCT01477892|421322|P1|COMPLETED|Overall Study||7
172905|NCT01477892|421321|P2|STARTED|Overall Study||7
172906|NCT01477892|421322|P1|STARTED|Overall Study||7
172907|NCT01477853|421333|P3|NOT COMPLETED|Phase B||11
172908|NCT01477853|421334|P2|NOT COMPLETED|Phase B||11
172909|NCT01477853|421335|P1|NOT COMPLETED|Phase B||12
172910|NCT01477853|421333|P3|COMPLETED|Phase B||0
172911|NCT01477853|421334|P2|COMPLETED|Phase B||0
172912|NCT01477853|421335|P1|COMPLETED|Phase B||0
172913|NCT01477853|421333|P3|STARTED|Phase B||11
172914|NCT01477853|421334|P2|STARTED|Phase B||11
172915|NCT01477853|421335|P1|STARTED|Phase B||12
172916|NCT01477853|421333|P3|NOT COMPLETED|Phase A||44
172917|NCT01477853|421334|P2|NOT COMPLETED|Phase A||45
172918|NCT01477853|421335|P1|NOT COMPLETED|Phase A||43
172919|NCT01477853|421333|P3|COMPLETED|Phase A||11
172920|NCT01477853|421334|P2|COMPLETED|Phase A||11
172921|NCT01477853|421335|P1|COMPLETED|Phase A||12
172922|NCT01477853|421333|P3|STARTED|Phase A||55
172923|NCT01477853|421334|P2|STARTED|Phase A||56
172924|NCT01477853|421335|P1|STARTED|Phase A||55
172925|NCT01477762|421377|P4|NOT COMPLETED|Overall Study||2
172926|NCT01477762|421378|P3|NOT COMPLETED|Overall Study||4
172927|NCT01477762|421379|P2|NOT COMPLETED|Overall Study||13
172928|NCT01477762|421380|P1|NOT COMPLETED|Overall Study||9
172929|NCT01477762|421377|P4|COMPLETED|Overall Study||11
172930|NCT01477762|421378|P3|COMPLETED|Overall Study||16
172931|NCT01477762|421379|P2|COMPLETED|Overall Study||20
172932|NCT01477762|421380|P1|COMPLETED|Overall Study||16
172933|NCT01477762|421377|P4|STARTED|Overall Study||13
172934|NCT01477762|421378|P3|STARTED|Overall Study||20
172935|NCT01477762|421379|P2|STARTED|Overall Study||33
172936|NCT01477762|421380|P1|STARTED|Overall Study||25
172937|NCT01477749|421402|P1|NOT COMPLETED|Overall Study||4
172938|NCT01477749|421402|P1|COMPLETED|Overall Study||43
172939|NCT01477749|421402|P1|STARTED|Overall Study||47
172940|NCT01477710|421409|P1|NOT COMPLETED|Overall Study||0
172941|NCT01477710|421409|P1|COMPLETED|Overall Study||30
172942|NCT01477710|421409|P1|STARTED|Overall Study||30
172943|NCT01477567|421424|P7|NOT COMPLETED|Overall Study||0
172944|NCT01477567|421425|P6|NOT COMPLETED|Overall Study||0
172945|NCT01477567|421426|P5|NOT COMPLETED|Overall Study||0
172946|NCT01477567|421427|P4|NOT COMPLETED|Overall Study||0
172947|NCT01477567|421428|P3|NOT COMPLETED|Overall Study||0
172948|NCT01477567|421429|P2|NOT COMPLETED|Overall Study||0
172949|NCT01477567|421430|P1|NOT COMPLETED|Overall Study||0
172950|NCT01477567|421424|P7|COMPLETED|Overall Study||6
172951|NCT01477567|421425|P6|COMPLETED|Overall Study||5
172952|NCT01477567|421426|P5|COMPLETED|Overall Study||6
172953|NCT01477567|421427|P4|COMPLETED|Overall Study||6
172954|NCT01477567|421428|P3|COMPLETED|Overall Study||6
172955|NCT01477567|421429|P2|COMPLETED|Overall Study||6
172956|NCT01477567|421430|P1|COMPLETED|Overall Study||5
172957|NCT01477567|421424|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
172958|NCT01477567|421425|P6|Received at Least 1 Dose of Study Drug|Overall Study||5
172959|NCT01477567|421426|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
172960|NCT01477567|421427|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
172961|NCT01477567|421428|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
172962|NCT01477567|421429|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
172963|NCT01477567|421430|P1|Received at Least 1 Dose of Study Drug|Overall Study||5
172964|NCT01477567|421424|P7|STARTED|Overall Study||6
172965|NCT01477567|421425|P6|STARTED|Overall Study||5
172966|NCT01477567|421426|P5|STARTED|Overall Study||6
172967|NCT01477567|421427|P4|STARTED|Overall Study||6
172968|NCT01477567|421428|P3|STARTED|Overall Study||6
172969|NCT01477567|421429|P2|STARTED|Overall Study||6
172970|NCT01477567|421430|P1|STARTED|Overall Study||5
172971|NCT01477463|421486|P2|NOT COMPLETED|Overall Study||0
172972|NCT01477463|421487|P1|NOT COMPLETED|Overall Study||0
172973|NCT01477463|421486|P2|COMPLETED|Overall Study||6
172974|NCT01477463|421487|P1|COMPLETED|Overall Study||18
172975|NCT01477463|421486|P2|STARTED|Overall Study||6
172976|NCT01477463|421487|P1|STARTED|Overall Study||18
172977|NCT01477450|421500|P3|NOT COMPLETED|Overall Study||0
172978|NCT01477450|421501|P2|NOT COMPLETED|Overall Study||0
172979|NCT01477450|421502|P1|NOT COMPLETED|Overall Study||0
172980|NCT01477450|421500|P3|COMPLETED|Overall Study||10
172981|NCT01477450|421501|P2|COMPLETED|Overall Study||10
172982|NCT01477450|421502|P1|COMPLETED|Overall Study||10
172983|NCT01477450|421500|P3|STARTED|Overall Study||10
172984|NCT01477450|421501|P2|STARTED|Overall Study||10
172985|NCT01477450|421502|P1|STARTED|Overall Study||10
172986|NCT01477333|421510|P1|NOT COMPLETED|Overall Study||3
172987|NCT01477333|421510|P1|COMPLETED|Overall Study||15
172988|NCT01477333|421510|P1|STARTED|Overall Study||18
172989|NCT01477320|421528|P2|NOT COMPLETED|Overall Study||15
172990|NCT01477320|421529|P1|NOT COMPLETED|Overall Study||7
172991|NCT01477320|421528|P2|COMPLETED|Overall Study||47
172992|NCT01477320|421529|P1|COMPLETED|Overall Study||55
172993|NCT01477320|421528|P2|STARTED|Overall Study||62
172994|NCT01477320|421529|P1|STARTED|Overall Study||62
172995|NCT01477177|421537|P1|NOT COMPLETED|Overall Study||0
172996|NCT01477177|421537|P1|COMPLETED|Overall Study||4
172997|NCT01477177|421537|P1|STARTED|Overall Study||4
172998|NCT01476748|421548|P3|NOT COMPLETED|Overall Study||0
172999|NCT01476748|421549|P2|NOT COMPLETED|Overall Study||0
173000|NCT01476748|421550|P1|NOT COMPLETED|Overall Study||0
173001|NCT01476748|421548|P3|COMPLETED|Overall Study||5
173002|NCT01476748|421549|P2|COMPLETED|Overall Study||5
173003|NCT01476748|421550|P1|COMPLETED|Overall Study||5
173004|NCT01476748|421548|P3|STARTED|Overall Study||5
173005|NCT01476748|421549|P2|STARTED|Overall Study||5
173006|NCT01476748|421550|P1|STARTED|Overall Study||5
173007|NCT01476722|421561|P1|NOT COMPLETED|Overall Study||1
173008|NCT01476722|421561|P1|COMPLETED|Overall Study||124
173009|NCT01476722|421561|P1|STARTED|Overall Study||125
173010|NCT01476696|421568|P3|NOT COMPLETED|Overall Study||0
173011|NCT01476696|421569|P2|NOT COMPLETED|Overall Study||1
173012|NCT01476696|421570|P1|NOT COMPLETED|Overall Study||3
173013|NCT01476696|421568|P3|COMPLETED|Overall Study||9
173014|NCT01476696|421569|P2|COMPLETED|Overall Study||8
173015|NCT01476696|421570|P1|COMPLETED|Overall Study||12
173016|NCT01476696|421568|P3|Received at Least 1 Dose of Study Drug|Overall Study||9
173017|NCT01476696|421569|P2|Received at Least 1 Dose of Study Drug|Overall Study||9
173018|NCT01476696|421570|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
173019|NCT01476696|421568|P3|STARTED|Overall Study||9
173020|NCT01476696|421569|P2|STARTED|Overall Study||9
173021|NCT01476696|421570|P1|STARTED|Overall Study||15
173022|NCT01476644|421584|P1|NOT COMPLETED|Overall Study||39
173023|NCT01476644|421584|P1|COMPLETED|Overall Study||122
173024|NCT01476644|421584|P1|STARTED|Overall Study||161
173025|NCT01476475|421591|P2|NOT COMPLETED|Overall Study||3
173026|NCT01476475|421592|P1|NOT COMPLETED|Overall Study||11
173027|NCT01476475|421591|P2|COMPLETED|Overall Study||159
173028|NCT01476475|421592|P1|COMPLETED|Overall Study||150
173029|NCT01476475|421591|P2|STARTED|Overall Study||162
173030|NCT01476475|421592|P1|STARTED|Overall Study||161
173031|NCT01476449|421626|P2|NOT COMPLETED|Overall Study||2
173032|NCT01476449|421627|P1|NOT COMPLETED|Overall Study||2
173033|NCT01476449|421626|P2|COMPLETED|Overall Study||8
173034|NCT01476449|421627|P1|COMPLETED|Overall Study||8
173035|NCT01476449|421626|P2|STARTED|Overall Study||10
173036|NCT01476449|421627|P1|STARTED|Overall Study||10
173037|NCT01476345|421641|P2|NOT COMPLETED|Period 4||0
173038|NCT01476345|421642|P1|NOT COMPLETED|Period 4||0
173039|NCT01476345|421641|P2|COMPLETED|Period 4||39
173040|NCT01476345|421642|P1|COMPLETED|Period 4||39
173041|NCT01476345|421641|P2|STARTED|Period 4||39
173042|NCT01476345|421642|P1|STARTED|Period 4||39
173043|NCT01476345|421641|P2|NOT COMPLETED|Period 3||0
173044|NCT01476345|421642|P1|NOT COMPLETED|Period 3||0
173045|NCT01476345|421641|P2|COMPLETED|Period 3||39
173046|NCT01476345|421642|P1|COMPLETED|Period 3||39
173047|NCT01476345|421641|P2|STARTED|Period 3||39
173048|NCT01476345|421642|P1|STARTED|Period 3||39
173049|NCT01476345|421641|P2|NOT COMPLETED|Period 2||0
173050|NCT01476345|421642|P1|NOT COMPLETED|Period 2||0
173051|NCT01476345|421641|P2|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
173052|NCT01476345|421642|P1|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
173053|NCT01476345|421641|P2|STARTED|Period 2||40
173054|NCT01476345|421642|P1|STARTED|Period 2||40
173055|NCT01476345|421641|P2|NOT COMPLETED|Period 1||0
173056|NCT01476345|421642|P1|NOT COMPLETED|Period 1||0
173057|NCT01476345|421641|P2|COMPLETED|Period 1||40
173058|NCT01476345|421642|P1|COMPLETED|Period 1||40
173059|NCT01476345|421641|P2|Received at Least 1 Dose of Study Drug|Period 1||40
173060|NCT01476345|421642|P1|Received at Least 1 Dose of Study Drug|Period 1||40
173061|NCT01476345|421641|P2|STARTED|Period 1||40
173062|NCT01476345|421642|P1|STARTED|Period 1||40
173063|NCT01476202|421657|P3|NOT COMPLETED|Overall Study||0
173064|NCT01476202|421658|P2|NOT COMPLETED|Overall Study||0
173065|NCT01476202|421659|P1|NOT COMPLETED|Overall Study||0
173066|NCT01476202|421657|P3|COMPLETED|Overall Study||40
173067|NCT01476202|421658|P2|COMPLETED|Overall Study||40
173068|NCT01476202|421659|P1|COMPLETED|Overall Study||40
173069|NCT01476202|421657|P3|STARTED|Overall Study||40
173070|NCT01476202|421658|P2|STARTED|Overall Study||40
173071|NCT01476202|421659|P1|STARTED|Overall Study||40
173072|NCT01475955|421675|P5|NOT COMPLETED|Overall Study||0
173073|NCT01475955|421676|P4|NOT COMPLETED|Overall Study||0
173074|NCT01475955|421677|P3|NOT COMPLETED|Overall Study||3
173075|NCT01475955|421678|P2|NOT COMPLETED|Overall Study||0
173076|NCT01475955|421679|P1|NOT COMPLETED|Overall Study||1
173077|NCT01475955|421675|P5|COMPLETED|Overall Study||46
173078|NCT01475955|421676|P4|COMPLETED|Overall Study||46
173079|NCT01475955|421677|P3|COMPLETED|Overall Study||44
173080|NCT01475955|421678|P2|COMPLETED|Overall Study||48
173081|NCT01475955|421679|P1|COMPLETED|Overall Study||47
173082|NCT01475955|421675|P5|STARTED|Overall Study||46
173083|NCT01475955|421676|P4|STARTED|Overall Study||46
173084|NCT01475955|421677|P3|STARTED|Overall Study||47
173085|NCT01475955|421678|P2|STARTED|Overall Study||48
173086|NCT01475955|421679|P1|STARTED|Overall Study||48
173087|NCT01475851|422038|P2|NOT COMPLETED|Overall Study||0
173088|NCT01475851|422039|P1|NOT COMPLETED|Overall Study||1
173089|NCT01475851|422038|P2|COMPLETED|Overall Study||21
173090|NCT01475851|422039|P1|COMPLETED|Overall Study||12
173091|NCT01475851|422038|P2|STARTED|Overall Study||21
173092|NCT01475851|422039|P1|STARTED|Overall Study||13
173093|NCT01475838|422067|P2|NOT COMPLETED|Extension Phase||0
173094|NCT01475838|422068|P1|NOT COMPLETED|Extension Phase||1
173095|NCT01475838|422067|P2|COMPLETED|Extension Phase||20
173096|NCT01475838|422068|P1|COMPLETED|Extension Phase||41
173097|NCT01475838|422067|P2|STARTED|Extension Phase||20
173098|NCT01475838|422068|P1|STARTED|Extension Phase||42
173099|NCT01475838|422067|P2|NOT COMPLETED|Randomized Phase||36
173100|NCT01475838|422068|P1|NOT COMPLETED|Randomized Phase||30
173101|NCT01475838|422067|P2|COMPLETED|Randomized Phase||109
173102|NCT01475838|422068|P1|COMPLETED|Randomized Phase||263
173103|NCT01475838|422067|P2|STARTED|Randomized Phase||145
173104|NCT01475838|422068|P1|STARTED|Randomized Phase||293
173105|NCT01475825|422085|P4|NOT COMPLETED|Overall Study||30
173106|NCT01475825|422086|P3|NOT COMPLETED|Overall Study||64
173107|NCT01475825|422087|P2|NOT COMPLETED|Overall Study||32
173108|NCT01475825|422088|P1|NOT COMPLETED|Overall Study||67
173109|NCT01475825|422085|P4|COMPLETED|Overall Study||22
173110|NCT01475825|422086|P3|COMPLETED|Overall Study||38
173111|NCT01475825|422087|P2|COMPLETED|Overall Study||19
173112|NCT01475825|422088|P1|COMPLETED|Overall Study||37
173113|NCT01475825|422085|P4|Completed Open-Label Continuation|Overall Study||22
173114|NCT01475825|422086|P3|Completed Open-Label Continuation|Overall Study||38
173115|NCT01475825|422087|P2|Completed Open-Label Continuation|Overall Study||19
173116|NCT01475825|422088|P1|Completed Open-Label Continuation|Overall Study||37
173117|NCT01475825|422085|P4|Entered Open-Label Continuation|Overall Study||29
173118|NCT01475825|422086|P3|Entered Open-Label Continuation|Overall Study||44
173119|NCT01475825|422087|P2|Entered Open-Label Continuation|Overall Study||31
173120|NCT01475825|422088|P1|Entered Open-Label Continuation|Overall Study||45
173121|NCT01475825|422085|P4|Completed Blinded Treatment Period|Overall Study||40
173122|NCT01475825|422086|P3|Completed Blinded Treatment Period|Overall Study||59
173123|NCT01475825|422087|P2|Completed Blinded Treatment Period|Overall Study||42
173124|NCT01475825|422088|P1|Completed Blinded Treatment Period|Overall Study||60
173125|NCT01475825|422085|P4|Randomized and Treated|Overall Study||52
173126|NCT01475825|422086|P3|Randomized and Treated|Overall Study||102
173127|NCT01475825|422087|P2|Randomized and Treated|Overall Study||51
173128|NCT01475825|422088|P1|Randomized and Treated|Overall Study||104
173129|NCT01475825|422085|P4|STARTED|Overall Study||52
173130|NCT01475825|422086|P3|STARTED|Overall Study||102
173131|NCT01475825|422087|P2|STARTED|Overall Study||51
173132|NCT01475825|422088|P1|STARTED|Overall Study||104
173133|NCT01475734|422120|P2|NOT COMPLETED|Overall Study||1
173134|NCT01475734|422121|P1|NOT COMPLETED|Overall Study||2
173135|NCT01475734|422120|P2|COMPLETED|Overall Study||21
173136|NCT01475734|422121|P1|COMPLETED|Overall Study||20
173137|NCT01475734|422120|P2|STARTED|Overall Study||22
173138|NCT01475734|422121|P1|STARTED|Overall Study||22
173139|NCT01475721|422149|P2|NOT COMPLETED|Overall Study||14
173140|NCT01475721|422150|P1|NOT COMPLETED|Overall Study||11
173141|NCT01475721|422149|P2|COMPLETED|Overall Study||5831
173142|NCT01475721|422150|P1|COMPLETED|Overall Study||5823
173143|NCT01475721|422149|P2|STARTED|Overall Study||5845
173144|NCT01475721|422150|P1|STARTED|Overall Study||5834
173145|NCT01475643|422166|P2|NOT COMPLETED|Overall Study||10
173146|NCT01475643|422167|P1|NOT COMPLETED|Overall Study||14
173147|NCT01475643|422166|P2|COMPLETED|Overall Study||43
173148|NCT01475643|422167|P1|COMPLETED|Overall Study||40
173149|NCT01475643|422166|P2|STARTED|Overall Study|52 included in Intent-to-treat (ITT) population, due to no post-treatment assessment.|53
173150|NCT01475643|422167|P1|STARTED|Overall Study|53 included in Intent-to-treat (ITT) population, due to no post-treatment assessment.|54
173151|NCT01475513|422177|P2|NOT COMPLETED|Overall Study||10
173152|NCT01475513|422178|P1|NOT COMPLETED|Overall Study||3
173153|NCT01475513|422177|P2|COMPLETED|Overall Study||16
173154|NCT01475513|422178|P1|COMPLETED|Overall Study||17
173155|NCT01475513|422177|P2|STARTED|Overall Study||26
173156|NCT01475513|422178|P1|STARTED|Overall Study||20
173157|NCT01475487|422216|P2|NOT COMPLETED|Overall Study||1
173158|NCT01475487|422217|P1|NOT COMPLETED|Overall Study||2
173159|NCT01475487|422216|P2|COMPLETED|Overall Study||24
173160|NCT01475487|422217|P1|COMPLETED|Overall Study||23
173161|NCT01475487|422216|P2|STARTED|Overall Study||25
173162|NCT01475487|422217|P1|STARTED|Overall Study||25
173163|NCT01475474|422229|P1|NOT COMPLETED|Return to Baseline Period - 4 Weeks||2
173164|NCT01475474|422229|P1|COMPLETED|Return to Baseline Period - 4 Weeks||71
173165|NCT01475474|422229|P1|STARTED|Return to Baseline Period - 4 Weeks||73
173166|NCT01475474|422229|P1|NOT COMPLETED|Treatment Period - 12 Weeks||18
173167|NCT01475474|422229|P1|COMPLETED|Treatment Period - 12 Weeks||73
173168|NCT01475474|422229|P1|STARTED|Treatment Period - 12 Weeks||91
173169|NCT01475474|422229|P1|NOT COMPLETED|Baseline Period - 4 Weeks||6
173170|NCT01475474|422229|P1|COMPLETED|Baseline Period - 4 Weeks||91
173171|NCT01475474|422229|P1|STARTED|Baseline Period - 4 Weeks||97
173172|NCT01475461|422240|P7|NOT COMPLETED|Treatment Period||2
173173|NCT01475461|422241|P6|NOT COMPLETED|Treatment Period||5
173174|NCT01475461|422242|P5|NOT COMPLETED|Treatment Period||4
173175|NCT01475461|422243|P4|NOT COMPLETED|Treatment Period||8
173176|NCT01475461|422244|P3|NOT COMPLETED|Treatment Period||4
173177|NCT01475461|422245|P2|NOT COMPLETED|Treatment Period||9
173178|NCT01475461|422246|P1|NOT COMPLETED|Treatment Period||0
173179|NCT01475461|422240|P7|COMPLETED|Treatment Period||53
173180|NCT01475461|422241|P6|COMPLETED|Treatment Period||51
173181|NCT01475461|422242|P5|COMPLETED|Treatment Period||52
173182|NCT01475461|422243|P4|COMPLETED|Treatment Period||46
173183|NCT01475461|422244|P3|COMPLETED|Treatment Period||53
173184|NCT01475461|422245|P2|COMPLETED|Treatment Period||48
173185|NCT01475461|422246|P1|COMPLETED|Treatment Period||0
173186|NCT01475461|422240|P7|STARTED|Treatment Period||55
173187|NCT01475461|422241|P6|STARTED|Treatment Period||56
173188|NCT01475461|422242|P5|STARTED|Treatment Period||56
173189|NCT01475461|422243|P4|STARTED|Treatment Period||54
173190|NCT01475461|422244|P3|STARTED|Treatment Period||57
173191|NCT01475461|422245|P2|STARTED|Treatment Period||57
173192|NCT01475461|422246|P1|STARTED|Treatment Period||0
173193|NCT01475461|422240|P7|NOT COMPLETED|Run-in Period||0
173194|NCT01475461|422241|P6|NOT COMPLETED|Run-in Period||0
173195|NCT01475461|422242|P5|NOT COMPLETED|Run-in Period||0
173196|NCT01475461|422243|P4|NOT COMPLETED|Run-in Period||0
173197|NCT01475461|422244|P3|NOT COMPLETED|Run-in Period||0
173198|NCT01475461|422245|P2|NOT COMPLETED|Run-in Period||0
173199|NCT01475461|422246|P1|NOT COMPLETED|Run-in Period||41
173200|NCT01475461|422240|P7|COMPLETED|Run-in Period||0
173201|NCT01475461|422241|P6|COMPLETED|Run-in Period||0
173202|NCT01475461|422242|P5|COMPLETED|Run-in Period||0
173203|NCT01475461|422243|P4|COMPLETED|Run-in Period||0
173204|NCT01475461|422244|P3|COMPLETED|Run-in Period||0
173205|NCT01475461|422245|P2|COMPLETED|Run-in Period||0
173206|NCT01475461|422246|P1|COMPLETED|Run-in Period||335
173207|NCT01475461|422240|P7|STARTED|Run-in Period||0
173208|NCT01475461|422241|P6|STARTED|Run-in Period||0
173209|NCT01475461|422242|P5|STARTED|Run-in Period||0
173210|NCT01475461|422243|P4|STARTED|Run-in Period||0
173211|NCT01475461|422244|P3|STARTED|Run-in Period||0
173212|NCT01475461|422245|P2|STARTED|Run-in Period||0
173213|NCT01475461|422246|P1|STARTED|Run-in Period||376
173214|NCT01475331|422326|P2|NOT COMPLETED|Overall Study||2
173215|NCT01475331|422327|P1|NOT COMPLETED|Overall Study||5
173216|NCT01475331|422326|P2|COMPLETED|Overall Study||21
173217|NCT01475331|422327|P1|COMPLETED|Overall Study||18
173218|NCT01475331|422326|P2|STARTED|Overall Study||23
173219|NCT01475331|422327|P1|STARTED|Overall Study||23
173220|NCT01475305|422335|P2|NOT COMPLETED|Overall Study||0
173221|NCT01475305|422336|P1|NOT COMPLETED|Overall Study||0
173222|NCT01475305|422335|P2|COMPLETED|Overall Study||3
173223|NCT01475305|422336|P1|COMPLETED|Overall Study||4
173224|NCT01475305|422335|P2|End of Quarantine, Day 15|Overall Study||3
173225|NCT01475305|422336|P1|End of Quarantine, Day 15|Overall Study||4
173226|NCT01475305|422335|P2|STARTED|Overall Study||3
173227|NCT01475305|422336|P1|STARTED|Overall Study||4
173228|NCT01475253|422379|P4|NOT COMPLETED|Open Label Extension||0
173229|NCT01475253|422380|P3|NOT COMPLETED|Open Label Extension||0
173230|NCT01475253|422381|P2|NOT COMPLETED|Open Label Extension||0
173231|NCT01475253|422382|P1|NOT COMPLETED|Open Label Extension||0
173232|NCT01475253|422379|P4|COMPLETED|Open Label Extension||56
173233|NCT01475253|422380|P3|COMPLETED|Open Label Extension||0
173234|NCT01475253|422381|P2|COMPLETED|Open Label Extension||0
173235|NCT01475253|422382|P1|COMPLETED|Open Label Extension||0
173236|NCT01475253|422379|P4|STARTED|Open Label Extension||56
173237|NCT01475253|422380|P3|STARTED|Open Label Extension||0
173238|NCT01475253|422381|P2|STARTED|Open Label Extension||0
173239|NCT01475253|422382|P1|STARTED|Open Label Extension||0
173240|NCT01475253|422379|P4|NOT COMPLETED|Randomized, Blinded Study||0
173241|NCT01475253|422380|P3|NOT COMPLETED|Randomized, Blinded Study||0
173242|NCT01475253|422381|P2|NOT COMPLETED|Randomized, Blinded Study||1
173243|NCT01475253|422382|P1|NOT COMPLETED|Randomized, Blinded Study||2
173244|NCT01475253|422379|P4|COMPLETED|Randomized, Blinded Study||0
173245|NCT01475253|422380|P3|COMPLETED|Randomized, Blinded Study||11
173246|NCT01475253|422381|P2|COMPLETED|Randomized, Blinded Study||45
173247|NCT01475253|422382|P1|COMPLETED|Randomized, Blinded Study||45
173248|NCT01475253|422379|P4|STARTED|Randomized, Blinded Study||0
173249|NCT01475253|422380|P3|STARTED|Randomized, Blinded Study||11
173250|NCT01475253|422381|P2|STARTED|Randomized, Blinded Study||46
173251|NCT01475253|422382|P1|STARTED|Randomized, Blinded Study||47
173252|NCT01475214|422411|P3|NOT COMPLETED|Overall Study||2
173253|NCT01475214|422412|P2|NOT COMPLETED|Overall Study||4
173254|NCT01475214|422413|P1|NOT COMPLETED|Overall Study||5
173255|NCT01475214|422411|P3|COMPLETED|Overall Study||79
173256|NCT01475214|422412|P2|COMPLETED|Overall Study||75
173257|NCT01475214|422413|P1|COMPLETED|Overall Study||79
173258|NCT01475214|422411|P3|STARTED|Overall Study||81
173259|NCT01475214|422412|P2|STARTED|Overall Study||79
173260|NCT01475214|422413|P1|STARTED|Overall Study||84
173261|NCT01475175|422424|P1|NOT COMPLETED|Overall Study||0
173262|NCT01475175|422424|P1|COMPLETED|Overall Study||12
173263|NCT01475175|422424|P1|STARTED|Overall Study||12
173264|NCT01475097|422438|P2|NOT COMPLETED|Overall Study||1
173265|NCT01475097|422439|P1|NOT COMPLETED|Overall Study||1
173266|NCT01475097|422438|P2|COMPLETED|Overall Study||126
173267|NCT01475097|422439|P1|COMPLETED|Overall Study||127
173268|NCT01475097|422438|P2|STARTED|Overall Study||127
173269|NCT01475097|422439|P1|STARTED|Overall Study||128
173270|NCT01475071|422447|P1|NOT COMPLETED|Overall Study||8
173271|NCT01475071|422447|P1|COMPLETED|Overall Study||92
173272|NCT01475071|422447|P1|STARTED|Overall Study||100
173273|NCT01474993|422457|P2|NOT COMPLETED|Overall Study||3
173274|NCT01474993|422458|P1|NOT COMPLETED|Overall Study||1
173275|NCT01474993|422457|P2|COMPLETED|Overall Study||26
173276|NCT01474993|422458|P1|COMPLETED|Overall Study||14
173277|NCT01474993|422457|P2|STARTED|Overall Study||29
173278|NCT01474993|422458|P1|STARTED|Overall Study||15
173279|NCT01474915|422488|P2|NOT COMPLETED|Overall Study||10
173280|NCT01474915|422489|P1|NOT COMPLETED|Overall Study||10
173281|NCT01474915|422488|P2|COMPLETED|Overall Study||51
173282|NCT01474915|422489|P1|COMPLETED|Overall Study||50
173283|NCT01474915|422488|P2|STARTED|Overall Study||61
173284|NCT01474915|422489|P1|STARTED|Overall Study||60
173285|NCT01474876|422500|P3|NOT COMPLETED|Overall Study||0
173286|NCT01474876|422501|P2|NOT COMPLETED|Overall Study||23
173287|NCT01474876|422502|P1|NOT COMPLETED|Overall Study||66
173288|NCT01474876|422500|P3|COMPLETED|Overall Study||1
173289|NCT01474876|422501|P2|COMPLETED|Overall Study||128
173290|NCT01474876|422502|P1|COMPLETED|Overall Study||337
173291|NCT01474876|422500|P3|STARTED|Overall Study||1
173292|NCT01474876|422501|P2|STARTED|Overall Study||151
173293|NCT01474876|422502|P1|STARTED|Overall Study||403
173294|NCT01474863|422536|P3|NOT COMPLETED|Overall Study||0
173295|NCT01474863|422537|P2|NOT COMPLETED|Overall Study||0
173296|NCT01474863|422538|P1|NOT COMPLETED|Overall Study||0
173297|NCT01474863|422536|P3|COMPLETED|Overall Study||24
173298|NCT01474863|422537|P2|COMPLETED|Overall Study||22
173299|NCT01474863|422538|P1|COMPLETED|Overall Study||26
173300|NCT01474863|422536|P3|STARTED|Overall Study||24
173301|NCT01474863|422537|P2|STARTED|Overall Study||22
173302|NCT01474863|422538|P1|STARTED|Overall Study||26
173303|NCT01474772|422548|P2|NOT COMPLETED|Follow-up||1
173304|NCT01474772|422549|P1|NOT COMPLETED|Follow-up||0
173305|NCT01474772|422548|P2|COMPLETED|Follow-up||86
173306|NCT01474772|422549|P1|COMPLETED|Follow-up||77
173307|NCT01474772|422548|P2|STARTED|Follow-up||87
173308|NCT01474772|422549|P1|STARTED|Follow-up||77
173309|NCT01474772|422548|P2|NOT COMPLETED|Period 2||10
173310|NCT01474772|422549|P1|NOT COMPLETED|Period 2||9
173311|NCT01474772|422548|P2|COMPLETED|Period 2||87
173312|NCT01474772|422549|P1|COMPLETED|Period 2||77
173313|NCT01474772|422548|P2|STARTED|Period 2||97
173314|NCT01474772|422549|P1|STARTED|Period 2||86
173315|NCT01474772|422548|P2|NOT COMPLETED|Washout||2
173316|NCT01474772|422549|P1|NOT COMPLETED|Washout||3
173317|NCT01474772|422548|P2|COMPLETED|Washout||97
173318|NCT01474772|422549|P1|COMPLETED|Washout||86
173319|NCT01474772|422548|P2|STARTED|Washout||99
173320|NCT01474772|422549|P1|STARTED|Washout||89
173321|NCT01474772|422548|P2|NOT COMPLETED|Period 1||3
173322|NCT01474772|422549|P1|NOT COMPLETED|Period 1||12
173323|NCT01474772|422548|P2|COMPLETED|Period 1||99
173324|NCT01474772|422549|P1|COMPLETED|Period 1||89
173325|NCT01474772|422548|P2|STARTED|Period 1|STARTED=treated|102
173326|NCT01474772|422549|P1|STARTED|Period 1|STARTED=treated. In Period 1 a participant discontinued due to an AE and later died due to the AE.|101
173327|NCT01474746|422599|P2|NOT COMPLETED|Overall Study||2
173328|NCT01474746|422600|P1|NOT COMPLETED|Overall Study||3
173329|NCT01474746|422599|P2|COMPLETED|Overall Study||25
173330|NCT01474746|422600|P1|COMPLETED|Overall Study||27
173331|NCT01474746|422599|P2|STARTED|Overall Study||27
173332|NCT01474746|422600|P1|STARTED|Overall Study||30
173333|NCT01474681|422664|P4|NOT COMPLETED|Overall Study||6
173334|NCT01474681|422665|P3|NOT COMPLETED|Overall Study||2
173335|NCT01474681|422666|P2|NOT COMPLETED|Overall Study||3
173336|NCT01474681|422667|P1|NOT COMPLETED|Overall Study||0
173337|NCT01474681|422664|P4|COMPLETED|Overall Study||9
173338|NCT01474681|422665|P3|COMPLETED|Overall Study||1
173339|NCT01474681|422666|P2|COMPLETED|Overall Study||5
173340|NCT01474681|422667|P1|COMPLETED|Overall Study||1
173341|NCT01474681|422664|P4|STARTED|Overall Study||15
173342|NCT01474681|422665|P3|STARTED|Overall Study||3
173343|NCT01474681|422666|P2|STARTED|Overall Study||8
173344|NCT01474681|422667|P1|STARTED|Overall Study||1
173345|NCT01474590|422711|P2|NOT COMPLETED|Overall Study||17
173346|NCT01474590|422712|P1|NOT COMPLETED|Overall Study||28
173347|NCT01474590|422711|P2|COMPLETED|Overall Study||116
173348|NCT01474590|422712|P1|COMPLETED|Overall Study||105
173349|NCT01474590|422711|P2|STARTED|Overall Study||133
173350|NCT01474590|422712|P1|STARTED|Overall Study||133
173351|NCT01474551|422718|P1|NOT COMPLETED|Overall Study||1
173352|NCT01474551|422718|P1|COMPLETED|Overall Study||1
173353|NCT01474551|422718|P1|STARTED|Overall Study||2
173354|NCT01474538|422724|P2|NOT COMPLETED|Treatment Period 2||2
173355|NCT01474538|422725|P1|NOT COMPLETED|Treatment Period 2||6
173356|NCT01474538|422724|P2|COMPLETED|Treatment Period 2||56
173357|NCT01474538|422725|P1|COMPLETED|Treatment Period 2||51
173358|NCT01474538|422724|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||58
173359|NCT01474538|422725|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||57
173360|NCT01474538|422724|P2|STARTED|Treatment Period 2||58
173361|NCT01474538|422725|P1|STARTED|Treatment Period 2||57
173362|NCT01474538|422724|P2|NOT COMPLETED|Treatment Period 1||4
173363|NCT01474538|422725|P1|NOT COMPLETED|Treatment Period 1||3
173364|NCT01474538|422724|P2|COMPLETED|Treatment Period 1||58
173365|NCT01474538|422725|P1|COMPLETED|Treatment Period 1||57
173366|NCT01474538|422724|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||62
173367|NCT01474538|422725|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||60
173368|NCT01474538|422724|P2|STARTED|Treatment Period 1||62
173369|NCT01474538|422725|P1|STARTED|Treatment Period 1||60
173370|NCT01474512|422742|P18|NOT COMPLETED|Post-Treatment Follow-Up||46
173371|NCT01474512|422743|P17|NOT COMPLETED|Post-Treatment Follow-Up||156
173372|NCT01474512|422744|P16|NOT COMPLETED|Post-Treatment Follow-Up||8
173373|NCT01474512|422745|P15|NOT COMPLETED|Post-Treatment Follow-Up||18
173374|NCT01474512|422746|P14|NOT COMPLETED|Post-Treatment Follow-Up||0
173375|NCT01474512|422747|P13|NOT COMPLETED|Post-Treatment Follow-Up||0
173376|NCT01474512|422748|P12|NOT COMPLETED|Post-Treatment Follow-Up||0
173377|NCT01474512|422749|P11|NOT COMPLETED|Post-Treatment Follow-Up||0
173378|NCT01474512|422750|P10|NOT COMPLETED|Post-Treatment Follow-Up||0
173379|NCT01474512|422751|P9|NOT COMPLETED|Post-Treatment Follow-Up||0
173380|NCT01474512|422752|P8|NOT COMPLETED|Post-Treatment Follow-Up||0
173381|NCT01474512|422753|P7|NOT COMPLETED|Post-Treatment Follow-Up||0
173382|NCT01474512|422754|P6|NOT COMPLETED|Post-Treatment Follow-Up||0
173383|NCT01474512|422755|P5|NOT COMPLETED|Post-Treatment Follow-Up||0
173384|NCT01474512|422756|P4|NOT COMPLETED|Post-Treatment Follow-Up||0
173385|NCT01474512|422757|P3|NOT COMPLETED|Post-Treatment Follow-Up||0
173386|NCT01474512|422758|P2|NOT COMPLETED|Post-Treatment Follow-Up||0
173387|NCT01474512|422759|P1|NOT COMPLETED|Post-Treatment Follow-Up||0
173388|NCT01474512|422742|P18|COMPLETED|Post-Treatment Follow-Up||239
173389|NCT01474512|422743|P17|COMPLETED|Post-Treatment Follow-Up||544
173390|NCT01474512|422744|P16|COMPLETED|Post-Treatment Follow-Up||17
173391|NCT01474512|422745|P15|COMPLETED|Post-Treatment Follow-Up||0
173392|NCT01474512|422746|P14|COMPLETED|Post-Treatment Follow-Up||0
173393|NCT01474512|422747|P13|COMPLETED|Post-Treatment Follow-Up||0
173394|NCT01474512|422748|P12|COMPLETED|Post-Treatment Follow-Up||0
173395|NCT01474512|422749|P11|COMPLETED|Post-Treatment Follow-Up||0
173396|NCT01474512|422750|P10|COMPLETED|Post-Treatment Follow-Up||0
173397|NCT01474512|422751|P9|COMPLETED|Post-Treatment Follow-Up||0
173398|NCT01474512|422752|P8|COMPLETED|Post-Treatment Follow-Up||0
173399|NCT01474512|422753|P7|COMPLETED|Post-Treatment Follow-Up||0
173400|NCT01474512|422754|P6|COMPLETED|Post-Treatment Follow-Up||0
173401|NCT01474512|422755|P5|COMPLETED|Post-Treatment Follow-Up||0
173402|NCT01474512|422756|P4|COMPLETED|Post-Treatment Follow-Up||0
173403|NCT01474512|422757|P3|COMPLETED|Post-Treatment Follow-Up||0
173404|NCT01474512|422758|P2|COMPLETED|Post-Treatment Follow-Up||0
173405|NCT01474512|422759|P1|COMPLETED|Post-Treatment Follow-Up||0
173406|NCT01474512|422742|P18|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|285
173407|NCT01474512|422743|P17|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|700
173408|NCT01474512|422744|P16|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|25
173409|NCT01474512|422745|P15|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|18
173410|NCT01474512|422746|P14|STARTED|Post-Treatment Follow-Up||0
173411|NCT01474512|422747|P13|STARTED|Post-Treatment Follow-Up||0
173412|NCT01474512|422748|P12|STARTED|Post-Treatment Follow-Up||0
173413|NCT01474512|422749|P11|STARTED|Post-Treatment Follow-Up||0
173414|NCT01474512|422750|P10|STARTED|Post-Treatment Follow-Up||0
173415|NCT01474512|422751|P9|STARTED|Post-Treatment Follow-Up||0
173416|NCT01474512|422752|P8|STARTED|Post-Treatment Follow-Up||0
173417|NCT01474512|422753|P7|STARTED|Post-Treatment Follow-Up||0
173418|NCT01474512|422754|P6|STARTED|Post-Treatment Follow-Up||0
173419|NCT01474512|422755|P5|STARTED|Post-Treatment Follow-Up||0
173420|NCT01474512|422756|P4|STARTED|Post-Treatment Follow-Up||0
173421|NCT01474512|422757|P3|STARTED|Post-Treatment Follow-Up||0
173422|NCT01474512|422758|P2|STARTED|Post-Treatment Follow-Up||0
173423|NCT01474512|422759|P1|STARTED|Post-Treatment Follow-Up||0
173424|NCT01474512|422742|P18|NOT COMPLETED|Long-Term Extension Period||0
173425|NCT01474512|422743|P17|NOT COMPLETED|Long-Term Extension Period||0
173426|NCT01474512|422744|P16|NOT COMPLETED|Long-Term Extension Period||0
173427|NCT01474512|422745|P15|NOT COMPLETED|Long-Term Extension Period||0
173428|NCT01474512|422746|P14|NOT COMPLETED|Long-Term Extension Period||220
173429|NCT01474512|422747|P13|NOT COMPLETED|Long-Term Extension Period||218
173430|NCT01474512|422748|P12|NOT COMPLETED|Long-Term Extension Period||26
173431|NCT01474512|422749|P11|NOT COMPLETED|Long-Term Extension Period||0
173432|NCT01474512|422750|P10|NOT COMPLETED|Long-Term Extension Period||0
173433|NCT01474512|422751|P9|NOT COMPLETED|Long-Term Extension Period||0
173434|NCT01474512|422752|P8|NOT COMPLETED|Long-Term Extension Period||0
173435|NCT01474512|422753|P7|NOT COMPLETED|Long-Term Extension Period||0
173436|NCT01474512|422754|P6|NOT COMPLETED|Long-Term Extension Period||0
173437|NCT01474512|422755|P5|NOT COMPLETED|Long-Term Extension Period||0
173438|NCT01474512|422756|P4|NOT COMPLETED|Long-Term Extension Period||0
173439|NCT01474512|422757|P3|NOT COMPLETED|Long-Term Extension Period||0
173440|NCT01474512|422758|P2|NOT COMPLETED|Long-Term Extension Period||0
173441|NCT01474512|422759|P1|NOT COMPLETED|Long-Term Extension Period||0
173442|NCT01474512|422742|P18|COMPLETED|Long-Term Extension Period||0
173443|NCT01474512|422743|P17|COMPLETED|Long-Term Extension Period||0
173444|NCT01474512|422744|P16|COMPLETED|Long-Term Extension Period||0
173445|NCT01474512|422745|P15|COMPLETED|Long-Term Extension Period||0
173446|NCT01474512|422746|P14|COMPLETED|Long-Term Extension Period||855
173447|NCT01474512|422747|P13|COMPLETED|Long-Term Extension Period||836
173448|NCT01474512|422748|P12|COMPLETED|Long-Term Extension Period||0
173449|NCT01474512|422749|P11|COMPLETED|Long-Term Extension Period||0
173450|NCT01474512|422750|P10|COMPLETED|Long-Term Extension Period||0
173451|NCT01474512|422751|P9|COMPLETED|Long-Term Extension Period||0
173452|NCT01474512|422752|P8|COMPLETED|Long-Term Extension Period||0
173453|NCT01474512|422753|P7|COMPLETED|Long-Term Extension Period||0
173454|NCT01474512|422754|P6|COMPLETED|Long-Term Extension Period||0
173455|NCT01474512|422755|P5|COMPLETED|Long-Term Extension Period||0
173456|NCT01474512|422756|P4|COMPLETED|Long-Term Extension Period||0
173457|NCT01474512|422757|P3|COMPLETED|Long-Term Extension Period||0
173458|NCT01474512|422758|P2|COMPLETED|Long-Term Extension Period||0
173459|NCT01474512|422759|P1|COMPLETED|Long-Term Extension Period||0
173460|NCT01474512|422742|P18|STARTED|Long-Term Extension Period||0
173461|NCT01474512|422743|P17|STARTED|Long-Term Extension Period||0
173462|NCT01474512|422744|P16|STARTED|Long-Term Extension Period||0
173463|NCT01474512|422745|P15|STARTED|Long-Term Extension Period||0
173464|NCT01474512|422746|P14|STARTED|Long-Term Extension Period|Participants received Ixe in all dosing regimens, including participants who switched PBO to Ixe.|1075
173465|NCT01474512|422747|P13|STARTED|Long-Term Extension Period|Participants received Ixe alone at the start of long-term extension.|1054
173466|NCT01474512|422748|P12|STARTED|Long-Term Extension Period|9 participants did not start the long-term extension period.|26
173467|NCT01474512|422749|P11|STARTED|Long-Term Extension Period||0
173468|NCT01474512|422750|P10|STARTED|Long-Term Extension Period||0
173469|NCT01474512|422751|P9|STARTED|Long-Term Extension Period||0
173470|NCT01474512|422752|P8|STARTED|Long-Term Extension Period||0
173471|NCT01474512|422753|P7|STARTED|Long-Term Extension Period||0
173472|NCT01474512|422754|P6|STARTED|Long-Term Extension Period||0
173473|NCT01474512|422755|P5|STARTED|Long-Term Extension Period||0
173474|NCT01474512|422756|P4|STARTED|Long-Term Extension Period||0
173475|NCT01474512|422757|P3|STARTED|Long-Term Extension Period||0
173476|NCT01474512|422758|P2|STARTED|Long-Term Extension Period||0
173477|NCT01474512|422759|P1|STARTED|Long-Term Extension Period||0
173478|NCT01474512|422742|P18|NOT COMPLETED|Maintenance Period||0
173479|NCT01474512|422743|P17|NOT COMPLETED|Maintenance Period||0
173480|NCT01474512|422744|P16|NOT COMPLETED|Maintenance Period||0
173481|NCT01474512|422745|P15|NOT COMPLETED|Maintenance Period||0
173482|NCT01474512|422746|P14|NOT COMPLETED|Maintenance Period||0
173483|NCT01474512|422747|P13|NOT COMPLETED|Maintenance Period||0
173484|NCT01474512|422748|P12|NOT COMPLETED|Maintenance Period||0
173485|NCT01474512|422749|P11|NOT COMPLETED|Maintenance Period||0
173486|NCT01474512|422750|P10|NOT COMPLETED|Maintenance Period||18
173487|NCT01474512|422751|P9|NOT COMPLETED|Maintenance Period||16
173488|NCT01474512|422752|P8|NOT COMPLETED|Maintenance Period||41
173489|NCT01474512|422753|P7|NOT COMPLETED|Maintenance Period||10
173490|NCT01474512|422754|P6|NOT COMPLETED|Maintenance Period||52
173491|NCT01474512|422755|P5|NOT COMPLETED|Maintenance Period||119
173492|NCT01474512|422756|P4|NOT COMPLETED|Maintenance Period||202
173493|NCT01474512|422757|P3|NOT COMPLETED|Maintenance Period||0
173494|NCT01474512|422758|P2|NOT COMPLETED|Maintenance Period||0
173495|NCT01474512|422759|P1|NOT COMPLETED|Maintenance Period||0
173496|NCT01474512|422742|P18|COMPLETED|Maintenance Period||0
173497|NCT01474512|422743|P17|COMPLETED|Maintenance Period||0
173498|NCT01474512|422744|P16|COMPLETED|Maintenance Period||0
173499|NCT01474512|422745|P15|COMPLETED|Maintenance Period||0
173500|NCT01474512|422746|P14|COMPLETED|Maintenance Period||0
173501|NCT01474512|422747|P13|COMPLETED|Maintenance Period||0
173502|NCT01474512|422748|P12|COMPLETED|Maintenance Period||0
173503|NCT01474512|422749|P11|COMPLETED|Maintenance Period||0
173504|NCT01474512|422750|P10|COMPLETED|Maintenance Period||44
173505|NCT01474512|422751|P9|COMPLETED|Maintenance Period||62
173506|NCT01474512|422752|P8|COMPLETED|Maintenance Period||350
173507|NCT01474512|422753|P7|COMPLETED|Maintenance Period||6
173508|NCT01474512|422754|P6|COMPLETED|Maintenance Period||177
173509|NCT01474512|422755|P5|COMPLETED|Maintenance Period||108
173510|NCT01474512|422756|P4|COMPLETED|Maintenance Period||24
173511|NCT01474512|422757|P3|COMPLETED|Maintenance Period||0
173512|NCT01474512|422758|P2|COMPLETED|Maintenance Period||0
173513|NCT01474512|422759|P1|COMPLETED|Maintenance Period||0
173514|NCT01474512|422742|P18|Relapsed Population Completers|Maintenance Period||0
173515|NCT01474512|422743|P17|Relapsed Population Completers|Maintenance Period||0
173516|NCT01474512|422744|P16|Relapsed Population Completers|Maintenance Period||0
173517|NCT01474512|422745|P15|Relapsed Population Completers|Maintenance Period||0
173518|NCT01474512|422746|P14|Relapsed Population Completers|Maintenance Period||0
173519|NCT01474512|422747|P13|Relapsed Population Completers|Maintenance Period||0
173520|NCT01474512|422748|P12|Relapsed Population Completers|Maintenance Period||0
173521|NCT01474512|422749|P11|Relapsed Population Completers|Maintenance Period||321
173522|NCT01474512|422750|P10|Relapsed Population Completers|Maintenance Period||0
173523|NCT01474512|422751|P9|Relapsed Population Completers|Maintenance Period||0
173524|NCT01474512|422752|P8|Relapsed Population Completers|Maintenance Period||0
173525|NCT01474512|422753|P7|Relapsed Population Completers|Maintenance Period||0
173526|NCT01474512|422754|P6|Relapsed Population Completers|Maintenance Period||0
173527|NCT01474512|422755|P5|Relapsed Population Completers|Maintenance Period||0
173528|NCT01474512|422756|P4|Relapsed Population Completers|Maintenance Period||0
173529|NCT01474512|422757|P3|Relapsed Population Completers|Maintenance Period||0
173530|NCT01474512|422758|P2|Relapsed Population Completers|Maintenance Period||0
173531|NCT01474512|422759|P1|Relapsed Population Completers|Maintenance Period||0
173532|NCT01474512|422742|P18|Relapsed Population Received Drug|Maintenance Period||0
173533|NCT01474512|422743|P17|Relapsed Population Received Drug|Maintenance Period||0
173534|NCT01474512|422744|P16|Relapsed Population Received Drug|Maintenance Period||0
173535|NCT01474512|422745|P15|Relapsed Population Received Drug|Maintenance Period||0
173536|NCT01474512|422746|P14|Relapsed Population Received Drug|Maintenance Period||0
173537|NCT01474512|422747|P13|Relapsed Population Received Drug|Maintenance Period||0
173538|NCT01474512|422748|P12|Relapsed Population Received Drug|Maintenance Period||0
173539|NCT01474512|422749|P11|Relapsed Population Received Drug|Maintenance Period||348
173540|NCT01474512|422750|P10|Relapsed Population Received Drug|Maintenance Period||0
173541|NCT01474512|422751|P9|Relapsed Population Received Drug|Maintenance Period||0
173542|NCT01474512|422752|P8|Relapsed Population Received Drug|Maintenance Period||0
173543|NCT01474512|422753|P7|Relapsed Population Received Drug|Maintenance Period||0
173544|NCT01474512|422754|P6|Relapsed Population Received Drug|Maintenance Period||0
173545|NCT01474512|422755|P5|Relapsed Population Received Drug|Maintenance Period||0
173546|NCT01474512|422756|P4|Relapsed Population Received Drug|Maintenance Period||0
173547|NCT01474512|422757|P3|Relapsed Population Received Drug|Maintenance Period||0
173548|NCT01474512|422758|P2|Relapsed Population Received Drug|Maintenance Period||0
173549|NCT01474512|422759|P1|Relapsed Population Received Drug|Maintenance Period||0
173550|NCT01474512|422742|P18|Received Study Drug|Maintenance Period||0
173551|NCT01474512|422743|P17|Received Study Drug|Maintenance Period||0
173552|NCT01474512|422744|P16|Received Study Drug|Maintenance Period||0
173553|NCT01474512|422745|P15|Received Study Drug|Maintenance Period||0
173554|NCT01474512|422746|P14|Received Study Drug|Maintenance Period||0
173555|NCT01474512|422747|P13|Received Study Drug|Maintenance Period||0
173556|NCT01474512|422748|P12|Received Study Drug|Maintenance Period||0
173557|NCT01474512|422749|P11|Received Study Drug|Maintenance Period||0
173558|NCT01474512|422750|P10|Received Study Drug|Maintenance Period||62
173559|NCT01474512|422751|P9|Received Study Drug|Maintenance Period||78
173560|NCT01474512|422752|P8|Received Study Drug|Maintenance Period||391
173561|NCT01474512|422753|P7|Received Study Drug|Maintenance Period||16
173562|NCT01474512|422754|P6|Received Study Drug|Maintenance Period||229
173563|NCT01474512|422755|P5|Received Study Drug|Maintenance Period||227
173564|NCT01474512|422756|P4|Received Study Drug|Maintenance Period||226
173565|NCT01474512|422757|P3|Received Study Drug|Maintenance Period||0
173566|NCT01474512|422758|P2|Received Study Drug|Maintenance Period||0
173567|NCT01474512|422759|P1|Received Study Drug|Maintenance Period||0
173568|NCT01474512|422742|P18|STARTED|Maintenance Period||0
173569|NCT01474512|422743|P17|STARTED|Maintenance Period||0
173570|NCT01474512|422744|P16|STARTED|Maintenance Period||0
173571|NCT01474512|422745|P15|STARTED|Maintenance Period||0
173572|NCT01474512|422746|P14|STARTED|Maintenance Period||0
173573|NCT01474512|422747|P13|STARTED|Maintenance Period||0
173574|NCT01474512|422748|P12|STARTED|Maintenance Period||0
173575|NCT01474512|422749|P11|STARTED|Maintenance Period||0
173576|NCT01474512|422750|P10|STARTED|Maintenance Period||62
173577|NCT01474512|422751|P9|STARTED|Maintenance Period||78
173578|NCT01474512|422752|P8|STARTED|Maintenance Period||391
173579|NCT01474512|422753|P7|STARTED|Maintenance Period||16
173580|NCT01474512|422754|P6|STARTED|Maintenance Period||229
173581|NCT01474512|422755|P5|STARTED|Maintenance Period|One participant withdrew end of Induction but re-randomized and treated with maintenance dose ixe.|227
173582|NCT01474512|422756|P4|STARTED|Maintenance Period||226
173583|NCT01474512|422757|P3|STARTED|Maintenance Period||0
173584|NCT01474512|422758|P2|STARTED|Maintenance Period||0
173585|NCT01474512|422759|P1|STARTED|Maintenance Period||0
173586|NCT01474512|422742|P18|NOT COMPLETED|Induction Period||0
173587|NCT01474512|422743|P17|NOT COMPLETED|Induction Period||0
173588|NCT01474512|422744|P16|NOT COMPLETED|Induction Period||0
173589|NCT01474512|422745|P15|NOT COMPLETED|Induction Period||0
173590|NCT01474512|422746|P14|NOT COMPLETED|Induction Period||0
173591|NCT01474512|422747|P13|NOT COMPLETED|Induction Period||0
173592|NCT01474512|422748|P12|NOT COMPLETED|Induction Period||0
173593|NCT01474512|422749|P11|NOT COMPLETED|Induction Period||0
173594|NCT01474512|422750|P10|NOT COMPLETED|Induction Period||0
173595|NCT01474512|422751|P9|NOT COMPLETED|Induction Period||0
173596|NCT01474512|422752|P8|NOT COMPLETED|Induction Period||0
173597|NCT01474512|422753|P7|NOT COMPLETED|Induction Period||0
173598|NCT01474512|422754|P6|NOT COMPLETED|Induction Period||0
173599|NCT01474512|422755|P5|NOT COMPLETED|Induction Period||0
173600|NCT01474512|422756|P4|NOT COMPLETED|Induction Period||0
173601|NCT01474512|422757|P3|NOT COMPLETED|Induction Period||18
173602|NCT01474512|422758|P2|NOT COMPLETED|Induction Period||24
173603|NCT01474512|422759|P1|NOT COMPLETED|Induction Period||24
173604|NCT01474512|422742|P18|COMPLETED|Induction Period||0
173605|NCT01474512|422743|P17|COMPLETED|Induction Period||0
173606|NCT01474512|422744|P16|COMPLETED|Induction Period||0
173607|NCT01474512|422745|P15|COMPLETED|Induction Period||0
173608|NCT01474512|422746|P14|COMPLETED|Induction Period||0
173609|NCT01474512|422747|P13|COMPLETED|Induction Period||0
173610|NCT01474512|422748|P12|COMPLETED|Induction Period||0
173611|NCT01474512|422749|P11|COMPLETED|Induction Period||0
173612|NCT01474512|422750|P10|COMPLETED|Induction Period||0
173613|NCT01474512|422751|P9|COMPLETED|Induction Period||0
173614|NCT01474512|422752|P8|COMPLETED|Induction Period||0
173615|NCT01474512|422753|P7|COMPLETED|Induction Period||0
173616|NCT01474512|422754|P6|COMPLETED|Induction Period||0
173617|NCT01474512|422755|P5|COMPLETED|Induction Period||0
173618|NCT01474512|422756|P4|COMPLETED|Induction Period||0
173619|NCT01474512|422757|P3|COMPLETED|Induction Period||415
173620|NCT01474512|422758|P2|COMPLETED|Induction Period||408
173621|NCT01474512|422759|P1|COMPLETED|Induction Period||407
173622|NCT01474512|422742|P18|Received Study Drug|Induction Period||0
173623|NCT01474512|422743|P17|Received Study Drug|Induction Period||0
173624|NCT01474512|422744|P16|Received Study Drug|Induction Period||0
173625|NCT01474512|422745|P15|Received Study Drug|Induction Period||0
173626|NCT01474512|422746|P14|Received Study Drug|Induction Period||0
173627|NCT01474512|422747|P13|Received Study Drug|Induction Period||0
173628|NCT01474512|422748|P12|Received Study Drug|Induction Period||0
173629|NCT01474512|422749|P11|Received Study Drug|Induction Period||0
173630|NCT01474512|422750|P10|Received Study Drug|Induction Period||0
173631|NCT01474512|422751|P9|Received Study Drug|Induction Period||0
173632|NCT01474512|422752|P8|Received Study Drug|Induction Period||0
173633|NCT01474512|422753|P7|Received Study Drug|Induction Period||0
173634|NCT01474512|422754|P6|Received Study Drug|Induction Period||0
173635|NCT01474512|422755|P5|Received Study Drug|Induction Period||0
173636|NCT01474512|422756|P4|Received Study Drug|Induction Period||0
173637|NCT01474512|422757|P3|Received Study Drug|Induction Period||433
173638|NCT01474512|422758|P2|Received Study Drug|Induction Period||432
173639|NCT01474512|422759|P1|Received Study Drug|Induction Period||431
173640|NCT01474512|422742|P18|STARTED|Induction Period||0
173641|NCT01474512|422743|P17|STARTED|Induction Period||0
173642|NCT01474512|422744|P16|STARTED|Induction Period||0
173643|NCT01474512|422745|P15|STARTED|Induction Period||0
173644|NCT01474512|422746|P14|STARTED|Induction Period||0
173645|NCT01474512|422747|P13|STARTED|Induction Period||0
173646|NCT01474512|422748|P12|STARTED|Induction Period||0
173647|NCT01474512|422749|P11|STARTED|Induction Period||0
173648|NCT01474512|422750|P10|STARTED|Induction Period||0
173649|NCT01474512|422751|P9|STARTED|Induction Period||0
173650|NCT01474512|422752|P8|STARTED|Induction Period||0
173651|NCT01474512|422753|P7|STARTED|Induction Period||0
173652|NCT01474512|422754|P6|STARTED|Induction Period||0
173653|NCT01474512|422755|P5|STARTED|Induction Period||0
173654|NCT01474512|422756|P4|STARTED|Induction Period||0
173655|NCT01474512|422757|P3|STARTED|Induction Period||433
173656|NCT01474512|422758|P2|STARTED|Induction Period||432
173657|NCT01474512|422759|P1|STARTED|Induction Period||431
173658|NCT01474434|422835|P4|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
173659|NCT01474434|422836|P3|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
173660|NCT01474434|422837|P2|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
173661|NCT01474434|422838|P1|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
173662|NCT01474434|422835|P4|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||11
173663|NCT01474434|422836|P3|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||10
173664|NCT01474434|422837|P2|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||9
173665|NCT01474434|422838|P1|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||7
173666|NCT01474434|422835|P4|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||11
173667|NCT01474434|422836|P3|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||10
173668|NCT01474434|422837|P2|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||9
173669|NCT01474434|422838|P1|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||7
173670|NCT01474434|422835|P4|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||2
173671|NCT01474434|422836|P3|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
173672|NCT01474434|422837|P2|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||0
173673|NCT01474434|422838|P1|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
173674|NCT01474434|422835|P4|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||11
173675|NCT01474434|422836|P3|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||10
173676|NCT01474434|422837|P2|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||9
173677|NCT01474434|422838|P1|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||7
173678|NCT01474434|422835|P4|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||13
173679|NCT01474434|422836|P3|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||11
173680|NCT01474434|422837|P2|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||9
173681|NCT01474434|422838|P1|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||8
173682|NCT01474317|422880|P1|NOT COMPLETED|Overall Study||2
173683|NCT01474317|422880|P1|COMPLETED|Overall Study||224
173684|NCT01474317|422880|P1|STARTED|Overall Study||226
173685|NCT01474291|422889|P1|NOT COMPLETED|Overall Study||220
173686|NCT01474291|422889|P1|COMPLETED|Overall Study||383
173687|NCT01474291|422889|P1|Evaluable for Efficacy|Overall Study|Received tocilizumab infusion and met all inclusion/exclusion criteria|577
173688|NCT01474291|422889|P1|STARTED|Overall Study||603
173689|NCT01474239|422933|P2|NOT COMPLETED|Overall Study||32
173690|NCT01474239|422934|P1|NOT COMPLETED|Overall Study||59
173691|NCT01474239|422933|P2|COMPLETED|Overall Study||0
173692|NCT01474239|422934|P1|COMPLETED|Overall Study||0
173693|NCT01474239|422933|P2|STARTED|Overall Study||32
173694|NCT01474239|422934|P1|STARTED|Overall Study||59
173695|NCT01474213|422972|P2|NOT COMPLETED|Overall Study||0
173696|NCT01474213|422973|P1|NOT COMPLETED|Overall Study||0
173697|NCT01474213|422972|P2|COMPLETED|Overall Study||20
173698|NCT01474213|422973|P1|COMPLETED|Overall Study||20
173699|NCT01474213|422972|P2|STARTED|Overall Study||20
173700|NCT01474213|422973|P1|STARTED|Overall Study||20
173701|NCT01474200|422997|P2|NOT COMPLETED|Overall Study||30
173702|NCT01474200|422998|P1|NOT COMPLETED|Overall Study||29
173703|NCT01474200|422997|P2|COMPLETED|Overall Study||84
173704|NCT01474200|422998|P1|COMPLETED|Overall Study||81
173705|NCT01474200|422997|P2|STARTED|Overall Study||114
173706|NCT01474200|422998|P1|STARTED|Overall Study||110
173707|NCT01474122|423051|P3|NOT COMPLETED|Period 2: Week 16 to End of Study||15
173708|NCT01474122|423052|P2|NOT COMPLETED|Period 2: Week 16 to End of Study||13
173709|NCT01474122|423053|P1|NOT COMPLETED|Period 2: Week 16 to End of Study||17
173710|NCT01474122|423051|P3|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
173711|NCT01474122|423052|P2|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
173712|NCT01474122|423053|P1|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|70
173713|NCT01474122|423051|P3|STARTED|Period 2: Week 16 to End of Study||88
173714|NCT01474122|423052|P2|STARTED|Period 2: Week 16 to End of Study||86
173715|NCT01474122|423053|P1|STARTED|Period 2: Week 16 to End of Study||87
173716|NCT01474122|423051|P3|NOT COMPLETED|Period 1: Baseline to Week 16||1
173717|NCT01474122|423052|P2|NOT COMPLETED|Period 1: Baseline to Week 16||2
173718|NCT01474122|423053|P1|NOT COMPLETED|Period 1: Baseline to Week 16||1
173719|NCT01474122|423051|P3|COMPLETED|Period 1: Baseline to Week 16||88
173720|NCT01474122|423052|P2|COMPLETED|Period 1: Baseline to Week 16||86
173721|NCT01474122|423053|P1|COMPLETED|Period 1: Baseline to Week 16||87
173722|NCT01474122|423051|P3|STARTED|Period 1: Baseline to Week 16||89
173723|NCT01474122|423052|P2|STARTED|Period 1: Baseline to Week 16|One patient was randomised but did not receive study treatment|88
173724|NCT01474122|423053|P1|STARTED|Period 1: Baseline to Week 16||88
173725|NCT01474109|423079|P3|NOT COMPLETED|Period 2: Week 16 to End of Study||12
173726|NCT01474109|423080|P2|NOT COMPLETED|Period 2: Week 16 to End of Study||18
173727|NCT01474109|423081|P1|NOT COMPLETED|Period 2: Week 16 to End of Study||18
173728|NCT01474109|423079|P3|COMPLETED|Period 2: Week 16 to End of Study||83
173729|NCT01474109|423080|P2|COMPLETED|Period 2: Week 16 to End of Study||73
173730|NCT01474109|423081|P1|COMPLETED|Period 2: Week 16 to End of Study||70
173731|NCT01474109|423079|P3|STARTED|Period 2: Week 16 to End of Study||95
173732|NCT01474109|423080|P2|STARTED|Period 2: Week 16 to End of Study||91
173733|NCT01474109|423081|P1|STARTED|Period 2: Week 16 to End of Study||88
173734|NCT01474109|423079|P3|NOT COMPLETED|Period 1: Baseline to Week 16||2
173735|NCT01474109|423080|P2|NOT COMPLETED|Period 1: Baseline to Week 16||6
173736|NCT01474109|423081|P1|NOT COMPLETED|Period 1: Baseline to Week 16||7
173737|NCT01474109|423079|P3|COMPLETED|Period 1: Baseline to Week 16||95
173738|NCT01474109|423080|P2|COMPLETED|Period 1: Baseline to Week 16||91
173739|NCT01474109|423081|P1|COMPLETED|Period 1: Baseline to Week 16||88
173740|NCT01474109|423079|P3|STARTED|Period 1: Baseline to Week 16||97
173741|NCT01474109|423080|P2|STARTED|Period 1: Baseline to Week 16||97
173742|NCT01474109|423081|P1|STARTED|Period 1: Baseline to Week 16||95
173743|NCT01474018|423106|P2|NOT COMPLETED|Overall Study||3
173744|NCT01474018|423107|P1|NOT COMPLETED|Overall Study||0
173745|NCT01474018|423106|P2|COMPLETED|Overall Study||7
173746|NCT01474018|423107|P1|COMPLETED|Overall Study|Writing paper|5
173747|NCT01474018|423106|P2|STARTED|Overall Study||10
173748|NCT01474018|423107|P1|STARTED|Overall Study||5
173749|NCT01473992|423117|P3|NOT COMPLETED|Overall Study||0
173750|NCT01473992|423118|P2|NOT COMPLETED|Overall Study||0
173751|NCT01473992|423119|P1|NOT COMPLETED|Overall Study||0
173752|NCT01473992|423117|P3|COMPLETED|Overall Study||5
173753|NCT01473992|423118|P2|COMPLETED|Overall Study||10
173754|NCT01473992|423119|P1|COMPLETED|Overall Study||10
173755|NCT01473992|423117|P3|STARTED|Overall Study||5
173756|NCT01473992|423118|P2|STARTED|Overall Study||10
173757|NCT01473992|423119|P1|STARTED|Overall Study||10
173758|NCT01473953|423139|P5|NOT COMPLETED|Overall Study||0
173759|NCT01473953|423140|P4|NOT COMPLETED|Overall Study||0
173760|NCT01473953|423141|P3|NOT COMPLETED|Overall Study||0
173761|NCT01473953|423142|P2|NOT COMPLETED|Overall Study||0
173762|NCT01473953|423143|P1|NOT COMPLETED|Overall Study||1
173763|NCT01473953|423139|P5|COMPLETED|Overall Study||8
173764|NCT01473953|423140|P4|COMPLETED|Overall Study||5
173765|NCT01473953|423141|P3|COMPLETED|Overall Study||6
173766|NCT01473953|423142|P2|COMPLETED|Overall Study||6
173767|NCT01473953|423143|P1|COMPLETED|Overall Study||5
173768|NCT01473953|423139|P5|STARTED|Overall Study||8
173769|NCT01473953|423140|P4|STARTED|Overall Study||5
173770|NCT01473953|423141|P3|STARTED|Overall Study||6
173771|NCT01473953|423142|P2|STARTED|Overall Study||6
173772|NCT01473953|423143|P1|STARTED|Overall Study||6
173773|NCT01473836|423185|P1|NOT COMPLETED|Overall Study||6
173774|NCT01473836|423185|P1|COMPLETED|Overall Study||32
173775|NCT01473836|423185|P1|STARTED|Overall Study||38
173776|NCT01473758|423196|P4|NOT COMPLETED|Cycle 2||0
173777|NCT01473758|423197|P3|NOT COMPLETED|Cycle 2||5
173778|NCT01473758|423198|P2|NOT COMPLETED|Cycle 2||0
173779|NCT01473758|423199|P1|NOT COMPLETED|Cycle 2||0
173780|NCT01473758|423196|P4|COMPLETED|Cycle 2||4
173781|NCT01473758|423197|P3|COMPLETED|Cycle 2||5
173782|NCT01473758|423198|P2|COMPLETED|Cycle 2||0
173783|NCT01473758|423199|P1|COMPLETED|Cycle 2||0
173784|NCT01473758|423196|P4|STARTED|Cycle 2||4
173785|NCT01473758|423197|P3|STARTED|Cycle 2||10
173786|NCT01473758|423198|P2|STARTED|Cycle 2||0
173787|NCT01473758|423199|P1|STARTED|Cycle 2||0
173788|NCT01473758|423196|P4|NOT COMPLETED|Cycle 1||0
173789|NCT01473758|423197|P3|NOT COMPLETED|Cycle 1||0
173790|NCT01473758|423198|P2|NOT COMPLETED|Cycle 1||3
173791|NCT01473758|423199|P1|NOT COMPLETED|Cycle 1||11
173792|NCT01473758|423196|P4|COMPLETED|Cycle 1||0
173793|NCT01473758|423197|P3|COMPLETED|Cycle 1||0
173794|NCT01473758|423198|P2|COMPLETED|Cycle 1||40
173795|NCT01473758|423199|P1|COMPLETED|Cycle 1||27
173796|NCT01473758|423196|P4|STARTED|Cycle 1||0
173797|NCT01473758|423197|P3|STARTED|Cycle 1||0
173798|NCT01473758|423198|P2|STARTED|Cycle 1||43
173799|NCT01473758|423199|P1|STARTED|Cycle 1||38
173800|NCT01473745|423323|P2|NOT COMPLETED|Overall Study||0
173801|NCT01473745|423324|P1|NOT COMPLETED|Overall Study||0
173802|NCT01473745|423323|P2|COMPLETED|Overall Study||24
173803|NCT01473745|423324|P1|COMPLETED|Overall Study||24
173804|NCT01473745|423323|P2|STARTED|Overall Study||24
173805|NCT01473745|423324|P1|STARTED|Overall Study||24
173806|NCT01473732|423336|P2|NOT COMPLETED|Overall Study||0
173807|NCT01473732|423337|P1|NOT COMPLETED|Overall Study||2
173808|NCT01473732|423336|P2|COMPLETED|Overall Study||0
173809|NCT01473732|423337|P1|COMPLETED|Overall Study||0
173810|NCT01473732|423336|P2|STARTED|Overall Study||0
173811|NCT01473732|423337|P1|STARTED|Overall Study||2
173812|NCT01473602|423345|P2|NOT COMPLETED|Overall Study||8
173813|NCT01473602|423346|P1|NOT COMPLETED|Overall Study||8
173814|NCT01473602|423345|P2|COMPLETED|Overall Study||13
173815|NCT01473602|423346|P1|COMPLETED|Overall Study||10
173816|NCT01473602|423345|P2|Completed 12 Months|Overall Study||13
173817|NCT01473602|423346|P1|Completed 12 Months|Overall Study||10
173818|NCT01473602|423345|P2|Completed 6 Months|Overall Study||15
173819|NCT01473602|423346|P1|Completed 6 Months|Overall Study||12
173820|NCT01473602|423345|P2|Received at Least 1 Dose of Study Drug|Overall Study||20
173821|NCT01473602|423346|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
173822|NCT01473602|423345|P2|STARTED|Overall Study||21
173823|NCT01473602|423346|P1|STARTED|Overall Study||18
173824|NCT01473589|423382|P2|NOT COMPLETED|Overall Study||16
173825|NCT01473589|423383|P1|NOT COMPLETED|Overall Study||11
173826|NCT01473589|423382|P2|COMPLETED|Overall Study||46
173827|NCT01473589|423383|P1|COMPLETED|Overall Study||49
173828|NCT01473589|423382|P2|Completed 12 Months|Overall Study||48
173829|NCT01473589|423383|P1|Completed 12 Months|Overall Study||49
173830|NCT01473589|423382|P2|Completed 6 Months|Overall Study||54
173831|NCT01473589|423383|P1|Completed 6 Months|Overall Study||51
173832|NCT01473589|423382|P2|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|61
173833|NCT01473589|423383|P1|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|60
173834|NCT01473589|423382|P2|STARTED|Overall Study||62
173835|NCT01473589|423383|P1|STARTED|Overall Study||60
173836|NCT01473563|423417|P1|NOT COMPLETED|Overall Study||1
173837|NCT01473563|423417|P1|COMPLETED|Overall Study||51
173838|NCT01473563|423417|P1|Received at Least 1 Dose of Study Drug|Overall Study||52
173839|NCT01473563|423417|P1|STARTED|Overall Study||52
173840|NCT01473524|423439|P3|NOT COMPLETED|Overall Study||3
173841|NCT01473524|423440|P2|NOT COMPLETED|Overall Study||9
173842|NCT01473524|423441|P1|NOT COMPLETED|Overall Study||7
173843|NCT01473524|423439|P3|COMPLETED|Overall Study||70
173844|NCT01473524|423440|P2|COMPLETED|Overall Study||64
173845|NCT01473524|423441|P1|COMPLETED|Overall Study||64
173846|NCT01473524|423439|P3|STARTED|Overall Study||73
173847|NCT01473524|423440|P2|STARTED|Overall Study||73
173848|NCT01473524|423441|P1|STARTED|Overall Study||71
173849|NCT01473420|423474|P2|NOT COMPLETED|Maintenance Period (16 Weeks)||17
173850|NCT01473420|423475|P1|NOT COMPLETED|Maintenance Period (16 Weeks)||18
173851|NCT01473420|423474|P2|COMPLETED|Maintenance Period (16 Weeks)||105
173852|NCT01473420|423475|P1|COMPLETED|Maintenance Period (16 Weeks)||106
173853|NCT01473420|423474|P2|STARTED|Maintenance Period (16 Weeks)||122
173854|NCT01473420|423475|P1|STARTED|Maintenance Period (16 Weeks)||124
173855|NCT01473420|423474|P2|NOT COMPLETED|Titration Period (18 Weeks)||38
173856|NCT01473420|423475|P1|NOT COMPLETED|Titration Period (18 Weeks)||36
173857|NCT01473420|423474|P2|COMPLETED|Titration Period (18 Weeks)||122
173858|NCT01473420|423475|P1|COMPLETED|Titration Period (18 Weeks)||124
173859|NCT01473420|423474|P2|Treated|Titration Period (18 Weeks)||86
173860|NCT01473420|423475|P1|Treated|Titration Period (18 Weeks)||80
173861|NCT01473420|423474|P2|STARTED|Titration Period (18 Weeks)||160
173862|NCT01473420|423475|P1|STARTED|Titration Period (18 Weeks)||160
173863|NCT01473407|423559|P2|NOT COMPLETED|Overall Study||47
173864|NCT01473407|423560|P1|NOT COMPLETED|Overall Study||54
173865|NCT01473407|423559|P2|COMPLETED|Overall Study||259
173866|NCT01473407|423560|P1|COMPLETED|Overall Study||252
173867|NCT01473407|423559|P2|STARTED|Overall Study||306
173868|NCT01473407|423560|P1|STARTED|Overall Study||306
173869|NCT01473394|423614|P2|NOT COMPLETED|Overall Study||43
173870|NCT01473394|423615|P1|NOT COMPLETED|Overall Study||45
173871|NCT01473394|423614|P2|COMPLETED|Overall Study||212
173872|NCT01473394|423615|P1|COMPLETED|Overall Study||208
173873|NCT01473394|423614|P2|STARTED|Overall Study||255
173874|NCT01473394|423615|P1|STARTED|Overall Study||253
173875|NCT01473381|423629|P4|NOT COMPLETED|Overall Study||89
173876|NCT01473381|423630|P3|NOT COMPLETED|Overall Study||102
173877|NCT01473381|423631|P2|NOT COMPLETED|Overall Study||93
173878|NCT01473381|423632|P1|NOT COMPLETED|Overall Study||80
173879|NCT01473381|423629|P4|COMPLETED|Overall Study||200
173880|NCT01473381|423630|P3|COMPLETED|Overall Study||189
173881|NCT01473381|423631|P2|COMPLETED|Overall Study||199
173882|NCT01473381|423632|P1|COMPLETED|Overall Study||210
173883|NCT01473381|423629|P4|Safety Population|Overall Study||282
173884|NCT01473381|423630|P3|Safety Population|Overall Study||287
173885|NCT01473381|423631|P2|Safety Population|Overall Study||288
173886|NCT01473381|423632|P1|Safety Population|Overall Study||281
173887|NCT01473381|423629|P4|STARTED|Overall Study||289
173888|NCT01473381|423630|P3|STARTED|Overall Study||291
173889|NCT01473381|423631|P2|STARTED|Overall Study||292
173890|NCT01473381|423632|P1|STARTED|Overall Study||290
173891|NCT01473368|423654|P4|NOT COMPLETED|Overall Study||0
173892|NCT01473368|423655|P3|NOT COMPLETED|Overall Study||3
173893|NCT01473368|423656|P2|NOT COMPLETED|Overall Study||0
173894|NCT01473368|423657|P1|NOT COMPLETED|Overall Study||1
173895|NCT01473368|423654|P4|COMPLETED|Overall Study||12
173896|NCT01473368|423655|P3|COMPLETED|Overall Study||12
173897|NCT01473368|423656|P2|COMPLETED|Overall Study||12
173898|NCT01473368|423657|P1|COMPLETED|Overall Study||13
173899|NCT01473368|423654|P4|STARTED|Overall Study||12
173900|NCT01473368|423655|P3|STARTED|Overall Study||15
173901|NCT01473368|423656|P2|STARTED|Overall Study||12
173902|NCT01473368|423657|P1|STARTED|Overall Study||14
173903|NCT01473355|423694|P1|NOT COMPLETED|Overall Study||6
173904|NCT01473355|423694|P1|COMPLETED|Overall Study||39
173905|NCT01473355|423694|P1|STARTED|Overall Study||45
173906|NCT01473160|423703|P1|NOT COMPLETED|Overall Study||0
173907|NCT01473160|423703|P1|COMPLETED|Overall Study||9
173908|NCT01473160|423703|P1|STARTED|Overall Study||9
173909|NCT01472965|423723|P2|NOT COMPLETED|Overall Study||0
173910|NCT01472965|423724|P1|NOT COMPLETED|Overall Study||1
173911|NCT01472965|423723|P2|COMPLETED|Overall Study||46
173912|NCT01472965|423724|P1|COMPLETED|Overall Study||48
173913|NCT01472965|423723|P2|STARTED|Overall Study||46
173914|NCT01472965|423724|P1|STARTED|Overall Study||49
173915|NCT01472939|423744|P4|NOT COMPLETED|Overall Study||20
173916|NCT01472939|423745|P3|NOT COMPLETED|Overall Study||11
173917|NCT01472939|423746|P2|NOT COMPLETED|Overall Study||14
173918|NCT01472939|423747|P1|NOT COMPLETED|Overall Study||20
173919|NCT01472939|423744|P4|COMPLETED|Overall Study||99
173920|NCT01472939|423745|P3|COMPLETED|Overall Study||108
173921|NCT01472939|423746|P2|COMPLETED|Overall Study||105
173922|NCT01472939|423747|P1|COMPLETED|Overall Study||103
173923|NCT01472939|423744|P4|STARTED|Overall Study||119
173924|NCT01472939|423745|P3|STARTED|Overall Study||119
173925|NCT01472939|423746|P2|STARTED|Overall Study||119
173926|NCT01472939|423747|P1|STARTED|Overall Study||123
173927|NCT01472874|423774|P1|NOT COMPLETED|Overall Study||0
173928|NCT01472874|423774|P1|COMPLETED|Overall Study||8
173929|NCT01472874|423774|P1|STARTED|Overall Study||8
173930|NCT01472835|423791|P2|NOT COMPLETED|Overall Study||0
173931|NCT01472835|423792|P1|NOT COMPLETED|Overall Study||2
173932|NCT01472835|423791|P2|COMPLETED|Overall Study||36
173933|NCT01472835|423792|P1|COMPLETED|Overall Study||35
173934|NCT01472835|423791|P2|STARTED|Overall Study||36
173935|NCT01472835|423792|P1|STARTED|Overall Study||37
173936|NCT01472822|423808|P2|NOT COMPLETED|Overall Study||2
173937|NCT01472822|423809|P1|NOT COMPLETED|Overall Study||2
173938|NCT01472822|423808|P2|COMPLETED|Overall Study||28
173939|NCT01472822|423809|P1|COMPLETED|Overall Study||28
173940|NCT01472822|423808|P2|STARTED|Overall Study||30
173941|NCT01472822|423809|P1|STARTED|Overall Study||30
173942|NCT01472718|423825|P2|NOT COMPLETED|Overall Study||7
173943|NCT01472718|423826|P1|NOT COMPLETED|Overall Study||6
173944|NCT01472718|423825|P2|COMPLETED|Overall Study||97
173945|NCT01472718|423826|P1|COMPLETED|Overall Study||98
173946|NCT01472718|423825|P2|STARTED|Overall Study||104
173947|NCT01472718|423826|P1|STARTED|Overall Study||104
173948|NCT01472562|423834|P1|NOT COMPLETED|Maintenance Phase (Week 49 to PD)||23
173949|NCT01472562|423834|P1|COMPLETED|Maintenance Phase (Week 49 to PD)||4
173950|NCT01472562|423834|P1|STARTED|Maintenance Phase (Week 49 to PD)||27
173951|NCT01472562|423834|P1|NOT COMPLETED|Induction Phase (Week 1- 48)||11
173952|NCT01472562|423834|P1|COMPLETED|Induction Phase (Week 1- 48)||27
173953|NCT01472562|423834|P1|STARTED|Induction Phase (Week 1- 48)||38
173954|NCT01472549|423841|P2|NOT COMPLETED|Overall Study||0
173955|NCT01472549|423842|P1|NOT COMPLETED|Overall Study||0
173956|NCT01472549|423841|P2|COMPLETED|Overall Study||575
173957|NCT01472549|423842|P1|COMPLETED|Overall Study||572
173958|NCT01472549|423841|P2|STARTED|Overall Study||575
173959|NCT01472549|423842|P1|STARTED|Overall Study||572
173960|NCT01472445|423864|P2|NOT COMPLETED|Overall Study||0
173961|NCT01472445|423865|P1|NOT COMPLETED|Overall Study||0
173962|NCT01472445|423864|P2|COMPLETED|Overall Study||16
173963|NCT01472445|423865|P1|COMPLETED|Overall Study||25
173964|NCT01472445|423864|P2|STARTED|Overall Study||16
173965|NCT01472445|423865|P1|STARTED|Overall Study||25
173966|NCT01472432|423889|P2|NOT COMPLETED|Overall Study||0
173967|NCT01472432|423890|P1|NOT COMPLETED|Overall Study||0
173968|NCT01472432|423889|P2|COMPLETED|Overall Study||53
173969|NCT01472432|423890|P1|COMPLETED|Overall Study||53
173970|NCT01472432|423889|P2|Ulcer Reduction|Overall Study||33
173971|NCT01472432|423890|P1|Ulcer Reduction|Overall Study||13
173972|NCT01472432|423889|P2|STARTED|Overall Study||53
173973|NCT01472432|423890|P1|STARTED|Overall Study||53
173974|NCT01472380|423906|P1|NOT COMPLETED|Efavirenz and FFA||0
173975|NCT01472380|423906|P1|COMPLETED|Efavirenz and FFA||28
173976|NCT01472380|423906|P1|STARTED|Efavirenz and FFA||28
173977|NCT01472380|423906|P1|NOT COMPLETED|1 Day Period Between Dosing||1
173978|NCT01472380|423906|P1|COMPLETED|1 Day Period Between Dosing||28
173979|NCT01472380|423906|P1|STARTED|1 Day Period Between Dosing||29
173980|NCT01472380|423906|P1|NOT COMPLETED|Fenofibric Acid (FFA) Alone||0
173981|NCT01472380|423906|P1|COMPLETED|Fenofibric Acid (FFA) Alone||29
173982|NCT01472380|423906|P1|STARTED|Fenofibric Acid (FFA) Alone||29
173983|NCT01472380|423906|P1|NOT COMPLETED|Efavirenz Alone||1
173984|NCT01472380|423906|P1|COMPLETED|Efavirenz Alone||29
173985|NCT01472380|423906|P1|STARTED|Efavirenz Alone||30
173986|NCT01472341|423917|P1|NOT COMPLETED|Overall Study||272
173987|NCT01472341|423917|P1|COMPLETED|Overall Study||235
173988|NCT01472341|423917|P1|STARTED|Overall Study||507
173989|NCT01472289|423923|P1|NOT COMPLETED|Overall Study||2
173990|NCT01472289|423923|P1|COMPLETED|Overall Study||15
173991|NCT01472289|423923|P1|STARTED|Overall Study||17
173992|NCT01472185|423935|P2|NOT COMPLETED|Overall Study||34
173993|NCT01472185|423936|P1|NOT COMPLETED|Overall Study||34
173994|NCT01472185|423935|P2|COMPLETED|Overall Study||199
173995|NCT01472185|423936|P1|COMPLETED|Overall Study||198
173996|NCT01472185|423935|P2|STARTED|Overall Study||233
173997|NCT01472185|423936|P1|STARTED|Overall Study||232
173998|NCT01472081|423956|P6|NOT COMPLETED|Overall Study||6
173999|NCT01472081|423957|P5|NOT COMPLETED|Overall Study||47
174000|NCT01472081|423958|P4|NOT COMPLETED|Overall Study||46
174001|NCT01472081|423959|P3|NOT COMPLETED|Overall Study||20
174002|NCT01472081|423960|P2|NOT COMPLETED|Overall Study||26
174003|NCT01472081|423961|P1|NOT COMPLETED|Overall Study||7
174004|NCT01472081|423956|P6|COMPLETED|Overall Study||0
174005|NCT01472081|423957|P5|COMPLETED|Overall Study||0
174006|NCT01472081|423958|P4|COMPLETED|Overall Study||1
174007|NCT01472081|423959|P3|COMPLETED|Overall Study||0
174008|NCT01472081|423960|P2|COMPLETED|Overall Study||0
174009|NCT01472081|423961|P1|COMPLETED|Overall Study||0
174010|NCT01472081|423956|P6|STARTED|Overall Study||6
174011|NCT01472081|423957|P5|STARTED|Overall Study||47
174012|NCT01472081|423958|P4|STARTED|Overall Study||47
174013|NCT01472081|423959|P3|STARTED|Overall Study||20
174014|NCT01472081|423960|P2|STARTED|Overall Study||26
174015|NCT01472081|423961|P1|STARTED|Overall Study||7
174016|NCT01471782|424010|P6|NOT COMPLETED|Overall Study||41
174017|NCT01471782|424011|P5|NOT COMPLETED|Overall Study||26
174018|NCT01471782|424012|P4|NOT COMPLETED|Overall Study||5
174019|NCT01471782|424013|P3|NOT COMPLETED|Overall Study||5
174020|NCT01471782|424014|P2|NOT COMPLETED|Overall Study||6
174021|NCT01471782|424015|P1|NOT COMPLETED|Overall Study||5
174022|NCT01471782|424010|P6|COMPLETED|Overall Study|Completed 5 cycles|3
174023|NCT01471782|424011|P5|COMPLETED|Overall Study|Completed 5 cycles|0
174024|NCT01471782|424012|P4|COMPLETED|Overall Study|Completed 5 cycles|1
174025|NCT01471782|424013|P3|COMPLETED|Overall Study|Completed 5 cycles|0
174026|NCT01471782|424014|P2|COMPLETED|Overall Study|Completed 5 cycles|1
174027|NCT01471782|424015|P1|COMPLETED|Overall Study|Completed 5 cycles|0
174028|NCT01471782|424010|P6|STARTED|Overall Study||44
174029|NCT01471782|424011|P5|STARTED|Overall Study||26
174030|NCT01471782|424012|P4|STARTED|Overall Study||6
174031|NCT01471782|424013|P3|STARTED|Overall Study||5
174032|NCT01471782|424014|P2|STARTED|Overall Study||7
174033|NCT01471782|424015|P1|STARTED|Overall Study||5
174034|NCT01471691|424069|P2|NOT COMPLETED|Overall Study||1
174035|NCT01471691|424070|P1|NOT COMPLETED|Overall Study||0
174036|NCT01471691|424069|P2|COMPLETED|Overall Study||5
174037|NCT01471691|424070|P1|COMPLETED|Overall Study||8
174038|NCT01471691|424069|P2|STARTED|Overall Study||6
174039|NCT01471691|424070|P1|STARTED|Overall Study||8
174040|NCT01471379|424079|P3|NOT COMPLETED|Overall Study||0
174041|NCT01471379|424080|P2|NOT COMPLETED|Overall Study||1
174042|NCT01471379|424081|P1|NOT COMPLETED|Overall Study||1
174043|NCT01471379|424079|P3|COMPLETED|Overall Study||0
174044|NCT01471379|424080|P2|COMPLETED|Overall Study||0
174045|NCT01471379|424081|P1|COMPLETED|Overall Study||0
174046|NCT01471379|424079|P3|STARTED|Overall Study||0
174047|NCT01471379|424080|P2|STARTED|Overall Study||1
174048|NCT01471379|424081|P1|STARTED|Overall Study||1
174049|NCT01471353|424101|P1|NOT COMPLETED|Overall Study||3
174050|NCT01471353|424101|P1|COMPLETED|Overall Study||39
174051|NCT01471353|424101|P1|STARTED|Overall Study||42
174052|NCT01471340|424112|P2|NOT COMPLETED|Overall Study||6
174053|NCT01471340|424113|P1|NOT COMPLETED|Overall Study||6
174054|NCT01471340|424112|P2|COMPLETED|Overall Study||5855
174055|NCT01471340|424113|P1|COMPLETED|Overall Study||5862
174056|NCT01471340|424112|P2|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5861
174057|NCT01471340|424113|P1|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5868
174058|NCT01471639|424123|P1|NOT COMPLETED|Overall Study||0
174059|NCT01471639|424123|P1|COMPLETED|Overall Study||37
174060|NCT01471639|424123|P1|STARTED|Overall Study||37
174061|NCT01471626|424128|P1|NOT COMPLETED|Overall Study||0
174062|NCT01471626|424128|P1|COMPLETED|Overall Study||21
174063|NCT01471626|424128|P1|STARTED|Overall Study||21
174064|NCT01471574|424136|P4|NOT COMPLETED|Follow-up Period||3
174065|NCT01471574|424137|P3|NOT COMPLETED|Follow-up Period||7
174066|NCT01471574|424138|P2|NOT COMPLETED|Follow-up Period||2
174067|NCT01471574|424139|P1|NOT COMPLETED|Follow-up Period||7
174068|NCT01471574|424136|P4|COMPLETED|Follow-up Period||21
174069|NCT01471574|424137|P3|COMPLETED|Follow-up Period||95
174070|NCT01471574|424138|P2|COMPLETED|Follow-up Period||32
174071|NCT01471574|424139|P1|COMPLETED|Follow-up Period||114
174072|NCT01471574|424136|P4|STARTED|Follow-up Period||24
174073|NCT01471574|424137|P3|STARTED|Follow-up Period||102
174074|NCT01471574|424138|P2|STARTED|Follow-up Period||34
174075|NCT01471574|424139|P1|STARTED|Follow-up Period||121
174076|NCT01471574|424136|P4|NOT COMPLETED|Treatment Period||3
174077|NCT01471574|424137|P3|NOT COMPLETED|Treatment Period||24
174078|NCT01471574|424138|P2|NOT COMPLETED|Treatment Period||10
174079|NCT01471574|424139|P1|NOT COMPLETED|Treatment Period||31
174080|NCT01471574|424136|P4|COMPLETED|Treatment Period||21
174081|NCT01471574|424137|P3|COMPLETED|Treatment Period||82
174082|NCT01471574|424138|P2|COMPLETED|Treatment Period||29
174083|NCT01471574|424139|P1|COMPLETED|Treatment Period||101
174084|NCT01471574|424136|P4|STARTED|Treatment Period||24
174085|NCT01471574|424137|P3|STARTED|Treatment Period||106
174086|NCT01471574|424138|P2|STARTED|Treatment Period||39
174087|NCT01471574|424139|P1|STARTED|Treatment Period||132
174088|NCT01471197|424170|P2|NOT COMPLETED|Overall Study||2
174089|NCT01471197|424171|P1|NOT COMPLETED|Overall Study||6
174090|NCT01471197|424170|P2|COMPLETED|Overall Study||0
174091|NCT01471197|424171|P1|COMPLETED|Overall Study||0
174092|NCT01471197|424170|P2|STARTED|Overall Study||2
174093|NCT01471197|424171|P1|STARTED|Overall Study||6
174094|NCT01471171|424181|P2|NOT COMPLETED|Treatment Period 2||0
174095|NCT01471171|424182|P1|NOT COMPLETED|Treatment Period 2||1
174096|NCT01471171|424181|P2|COMPLETED|Treatment Period 2||54
174097|NCT01471171|424182|P1|COMPLETED|Treatment Period 2||52
174098|NCT01471171|424181|P2|STARTED|Treatment Period 2||54
174099|NCT01471171|424182|P1|STARTED|Treatment Period 2||53
174100|NCT01471171|424181|P2|NOT COMPLETED|Treatment Period 1||1
174101|NCT01471171|424182|P1|NOT COMPLETED|Treatment Period 1||4
174102|NCT01471171|424181|P2|COMPLETED|Treatment Period 1||54
174103|NCT01471171|424182|P1|COMPLETED|Treatment Period 1||53
174104|NCT01471171|424181|P2|STARTED|Treatment Period 1||55
174105|NCT01471171|424182|P1|STARTED|Treatment Period 1||57
174106|NCT01471054|424194|P2|NOT COMPLETED|Overall Study||0
174107|NCT01471054|424195|P1|NOT COMPLETED|Overall Study||4
174108|NCT01471054|424194|P2|COMPLETED|Overall Study||1
174109|NCT01471054|424195|P1|COMPLETED|Overall Study||1
174110|NCT01471054|424194|P2|STARTED|Overall Study||1
174111|NCT01471054|424195|P1|STARTED|Overall Study||5
174112|NCT01471041|424211|P1|NOT COMPLETED|Overall Study||7
174113|NCT01471041|424211|P1|COMPLETED|Overall Study||47
174114|NCT01471041|424211|P1|STARTED|Overall Study||54
174115|NCT01471028|424218|P2|NOT COMPLETED|VTI-208E||12
174116|NCT01471028|424219|P1|NOT COMPLETED|VTI-208E||8
174117|NCT01471028|424218|P2|COMPLETED|VTI-208E||51
174118|NCT01471028|424219|P1|COMPLETED|VTI-208E||48
174119|NCT01471028|424218|P2|Database Lock, 31 July 2015|VTI-208E||63
174120|NCT01471028|424219|P1|Database Lock, 31 July 2015|VTI-208E||56
174121|NCT01471028|424218|P2|STARTED|VTI-208E||63
174122|NCT01471028|424219|P1|STARTED|VTI-208E||56
174123|NCT01471028|424218|P2|NOT COMPLETED|VTI-208||44
174124|NCT01471028|424219|P1|NOT COMPLETED|VTI-208||40
174125|NCT01471028|424218|P2|COMPLETED|VTI-208||63
174126|NCT01471028|424219|P1|COMPLETED|VTI-208||56
174127|NCT01471028|424218|P2|STARTED|VTI-208||107
174128|NCT01471028|424219|P1|STARTED|VTI-208||96
174129|NCT01471015|424234|P3|NOT COMPLETED|Overall Study||1
174130|NCT01471015|424235|P2|NOT COMPLETED|Overall Study||1
174131|NCT01471015|424236|P1|NOT COMPLETED|Overall Study||0
174132|NCT01471015|424234|P3|COMPLETED|Overall Study||9
174133|NCT01471015|424235|P2|COMPLETED|Overall Study||9
174134|NCT01471015|424236|P1|COMPLETED|Overall Study||10
174135|NCT01471015|424234|P3|STARTED|Overall Study||10
174136|NCT01471015|424235|P2|STARTED|Overall Study||10
174137|NCT01471015|424236|P1|STARTED|Overall Study||10
174138|NCT01470859|424250|P2|NOT COMPLETED|Overall Study||0
174139|NCT01470859|424251|P1|NOT COMPLETED|Overall Study||1
174140|NCT01470859|424250|P2|COMPLETED|Overall Study||15
174141|NCT01470859|424251|P1|COMPLETED|Overall Study||14
174142|NCT01470859|424250|P2|STARTED|Overall Study||15
174143|NCT01470859|424251|P1|STARTED|Overall Study||15
174144|NCT01470651|424267|P2|NOT COMPLETED|Overall Study||3
174145|NCT01470651|424268|P1|NOT COMPLETED|Overall Study||7
174146|NCT01470651|424267|P2|COMPLETED|Overall Study||10
174147|NCT01470651|424268|P1|COMPLETED|Overall Study||6
174148|NCT01470651|424267|P2|STARTED|Overall Study||13
174149|NCT01470651|424268|P1|STARTED|Overall Study||13
174150|NCT01470599|424278|P2|NOT COMPLETED|Overall Study||43
174151|NCT01470599|424279|P1|NOT COMPLETED|Overall Study||19
174152|NCT01470599|424278|P2|COMPLETED|Overall Study||45
174153|NCT01470599|424279|P1|COMPLETED|Overall Study||43
174154|NCT01470599|424278|P2|STARTED|Overall Study||88
174155|NCT01470599|424279|P1|STARTED|Overall Study||62
174156|NCT01470469|424343|P2|NOT COMPLETED|Overall Study||24
174157|NCT01470469|424344|P1|NOT COMPLETED|Overall Study||10
174158|NCT01470469|424343|P2|COMPLETED|Overall Study||38
174159|NCT01470469|424344|P1|COMPLETED|Overall Study||11
174160|NCT01470469|424343|P2|STARTED|Overall Study||62
174161|NCT01470469|424344|P1|STARTED|Overall Study||21
174162|NCT01470417|424364|P2|NOT COMPLETED|Overall Study||2
174163|NCT01470417|424365|P1|NOT COMPLETED|Overall Study||0
174164|NCT01470417|424364|P2|COMPLETED|Overall Study||5
174165|NCT01470417|424365|P1|COMPLETED|Overall Study||3
174166|NCT01470417|424364|P2|STARTED|Overall Study||7
174167|NCT01470417|424365|P1|STARTED|Overall Study||3
174168|NCT01470326|424377|P1|NOT COMPLETED|Overall Study||153
174169|NCT01470326|424377|P1|COMPLETED|Overall Study||3034
174170|NCT01470326|424377|P1|STARTED|Overall Study||3187
174171|NCT01470248|424388|P1|NOT COMPLETED|Overall Study||1
174172|NCT01470248|424388|P1|COMPLETED|Overall Study||19
174173|NCT01470248|424388|P1|STARTED|Overall Study||20
174174|NCT01470196|424395|P1|NOT COMPLETED|Overall Study||0
174175|NCT01470196|424395|P1|COMPLETED|Overall Study||31
174176|NCT01470196|424395|P1|STARTED|Overall Study||31
174177|NCT01470170|424408|P5|NOT COMPLETED|Overall Study||0
174178|NCT01470170|424409|P4|NOT COMPLETED|Overall Study||0
174179|NCT01470170|424410|P3|NOT COMPLETED|Overall Study||0
174180|NCT01470170|424411|P2|NOT COMPLETED|Overall Study||0
174181|NCT01470170|424412|P1|NOT COMPLETED|Overall Study||0
174182|NCT01470170|424408|P5|COMPLETED|Overall Study||34
174183|NCT01470170|424409|P4|COMPLETED|Overall Study||36
174184|NCT01470170|424410|P3|COMPLETED|Overall Study||34
174185|NCT01470170|424411|P2|COMPLETED|Overall Study||35
174186|NCT01470170|424412|P1|COMPLETED|Overall Study||34
174187|NCT01470170|424408|P5|STARTED|Overall Study||34
174188|NCT01470170|424409|P4|STARTED|Overall Study||36
174189|NCT01470170|424410|P3|STARTED|Overall Study||34
174190|NCT01470170|424411|P2|STARTED|Overall Study||35
174191|NCT01470170|424412|P1|STARTED|Overall Study||34
174192|NCT01470144|424444|P1|NOT COMPLETED|Overall Study||10
174193|NCT01470144|424444|P1|COMPLETED|Overall Study|"Completed corresponds to subjects switching to commercial EFI upon market approval/reimbursement"|31
174194|NCT01470144|424444|P1|STARTED|Overall Study||41
174195|NCT01470118|424452|P3|NOT COMPLETED|Overall Study||2
174196|NCT01470118|424453|P2|NOT COMPLETED|Overall Study||5
174197|NCT01470118|424454|P1|NOT COMPLETED|Overall Study||5
174198|NCT01470118|424452|P3|COMPLETED|Overall Study||39
174199|NCT01470118|424453|P2|COMPLETED|Overall Study||38
174200|NCT01470118|424454|P1|COMPLETED|Overall Study||38
174201|NCT01470118|424452|P3|STARTED|Overall Study||41
174202|NCT01470118|424453|P2|STARTED|Overall Study||43
174203|NCT01470118|424454|P1|STARTED|Overall Study||43
174204|NCT01470027|424489|P3|NOT COMPLETED|Overall Study||1
174205|NCT01470027|424490|P2|NOT COMPLETED|Overall Study||1
174206|NCT01470027|424491|P1|NOT COMPLETED|Overall Study||1
174207|NCT01470027|424489|P3|COMPLETED|Overall Study||15
174208|NCT01470027|424490|P2|COMPLETED|Overall Study||14
174209|NCT01470027|424491|P1|COMPLETED|Overall Study||15
174210|NCT01470027|424489|P3|STARTED|Overall Study||16
174211|NCT01470027|424490|P2|STARTED|Overall Study||15
174212|NCT01470027|424491|P1|STARTED|Overall Study||16
174213|NCT01470001|424549|P2|NOT COMPLETED|Overall Study||2
174214|NCT01470001|424550|P1|NOT COMPLETED|Overall Study||5
174215|NCT01470001|424549|P2|COMPLETED|Overall Study||58
174216|NCT01470001|424550|P1|COMPLETED|Overall Study||53
174217|NCT01470001|424549|P2|STARTED|Overall Study||60
174218|NCT01470001|424550|P1|STARTED|Overall Study||58
174219|NCT01469819|424560|P1|NOT COMPLETED|Overall Study||8
174220|NCT01469819|424560|P1|COMPLETED|Overall Study||29
174221|NCT01469819|424560|P1|STARTED|Overall Study||37
174222|NCT01469767|424570|P1|NOT COMPLETED|Overall Study||0
174223|NCT01469767|424570|P1|COMPLETED|Overall Study||10
174224|NCT01469767|424570|P1|STARTED|Overall Study||10
174225|NCT01469715|424578|P1|NOT COMPLETED|Overall Study||0
174226|NCT01469715|424578|P1|COMPLETED|Overall Study||16
174227|NCT01469715|424578|P1|STARTED|Overall Study||16
174228|NCT01469637|424584|P2|NOT COMPLETED|Second Intervention||0
174229|NCT01469637|424585|P1|NOT COMPLETED|Second Intervention||1
174230|NCT01469637|424584|P2|COMPLETED|Second Intervention||21
174231|NCT01469637|424585|P1|COMPLETED|Second Intervention||21
174232|NCT01469637|424584|P2|STARTED|Second Intervention||21
174233|NCT01469637|424585|P1|STARTED|Second Intervention||22
174234|NCT01469637|424584|P2|NOT COMPLETED|First Intervention||1
174235|NCT01469637|424585|P1|NOT COMPLETED|First Intervention||0
174236|NCT01469637|424584|P2|COMPLETED|First Intervention||21
174237|NCT01469637|424585|P1|COMPLETED|First Intervention||22
174238|NCT01469637|424584|P2|STARTED|First Intervention||22
174239|NCT01469637|424585|P1|STARTED|First Intervention||22
174240|NCT01469546|424593|P1|NOT COMPLETED|Dose Escalation to 10 mg||0
174241|NCT01469546|424593|P1|COMPLETED|Dose Escalation to 10 mg||19
174242|NCT01469546|424593|P1|STARTED|Dose Escalation to 10 mg||19
174243|NCT01469546|424593|P1|NOT COMPLETED|Received 5 mg Dose||23
174244|NCT01469546|424593|P1|COMPLETED|Received 5 mg Dose||19
174245|NCT01469546|424593|P1|Completed First Cycle|Received 5 mg Dose||30
174246|NCT01469546|424593|P1|STARTED|Received 5 mg Dose||42
174247|NCT01469377|424603|P3|NOT COMPLETED|Overall Study||66
174248|NCT01469377|424604|P2|NOT COMPLETED|Overall Study||48
174249|NCT01469377|424605|P1|NOT COMPLETED|Overall Study||35
174250|NCT01469377|424603|P3|COMPLETED|Overall Study||210
174251|NCT01469377|424604|P2|COMPLETED|Overall Study||226
174252|NCT01469377|424605|P1|COMPLETED|Overall Study||234
174253|NCT01469377|424603|P3|STARTED|Overall Study||276
174254|NCT01469377|424604|P2|STARTED|Overall Study||274
174255|NCT01469377|424605|P1|STARTED|Overall Study||269
174256|NCT01469364|424616|P1|NOT COMPLETED|Overall Study||2
174257|NCT01469364|424616|P1|COMPLETED|Overall Study||28
174258|NCT01469364|424616|P1|STARTED|Overall Study||30
174259|NCT01469234|424634|P3|NOT COMPLETED|Overall Study||0
174260|NCT01469234|424635|P2|NOT COMPLETED|Overall Study||0
174261|NCT01469234|424636|P1|NOT COMPLETED|Overall Study||0
174262|NCT01469234|424634|P3|COMPLETED|Overall Study||85
174263|NCT01469234|424635|P2|COMPLETED|Overall Study||85
174264|NCT01469234|424636|P1|COMPLETED|Overall Study||85
174265|NCT01469234|424634|P3|STARTED|Overall Study||85
174266|NCT01469234|424635|P2|STARTED|Overall Study||85
174267|NCT01469234|424636|P1|STARTED|Overall Study||85
174268|NCT01469221|424667|P3|NOT COMPLETED|Double Blind Phase||0
174269|NCT01469221|424668|P2|NOT COMPLETED|Double Blind Phase||17
174270|NCT01469221|424669|P1|NOT COMPLETED|Double Blind Phase||14
174271|NCT01469221|424667|P3|COMPLETED|Double Blind Phase||0
174272|NCT01469221|424668|P2|COMPLETED|Double Blind Phase||0
174273|NCT01469221|424669|P1|COMPLETED|Double Blind Phase||0
174274|NCT01469221|424667|P3|STARTED|Double Blind Phase||0
174275|NCT01469221|424668|P2|STARTED|Double Blind Phase||17
174276|NCT01469221|424669|P1|STARTED|Double Blind Phase||14
174277|NCT01469221|424667|P3|NOT COMPLETED|Open Label Phase||3
174278|NCT01469221|424668|P2|NOT COMPLETED|Open Label Phase||0
174279|NCT01469221|424669|P1|NOT COMPLETED|Open Label Phase||0
174280|NCT01469221|424667|P3|COMPLETED|Open Label Phase||44
174281|NCT01469221|424668|P2|COMPLETED|Open Label Phase||0
174282|NCT01469221|424669|P1|COMPLETED|Open Label Phase||0
174283|NCT01469221|424667|P3|STARTED|Open Label Phase||47
174284|NCT01469221|424668|P2|STARTED|Open Label Phase||0
174285|NCT01469221|424669|P1|STARTED|Open Label Phase||0
174286|NCT01469182|424680|P2|NOT COMPLETED|Overall Study||6
174287|NCT01469182|424681|P1|NOT COMPLETED|Overall Study||35
174288|NCT01469182|424680|P2|COMPLETED|Overall Study||298
174289|NCT01469182|424681|P1|COMPLETED|Overall Study||575
174290|NCT01469182|424680|P2|Treated|Overall Study||304
174291|NCT01469182|424681|P1|Treated|Overall Study||609
174292|NCT01469182|424680|P2|STARTED|Overall Study||304
174293|NCT01469182|424681|P1|STARTED|Overall Study||610
174294|NCT01469065|424708|P5|NOT COMPLETED|Overall Study||1
174295|NCT01469065|424709|P4|NOT COMPLETED|Overall Study||0
174296|NCT01469065|424710|P3|NOT COMPLETED|Overall Study||0
174297|NCT01469065|424711|P2|NOT COMPLETED|Overall Study||1
174298|NCT01469065|424712|P1|NOT COMPLETED|Overall Study||0
174299|NCT01469065|424708|P5|COMPLETED|Overall Study||16
174300|NCT01469065|424709|P4|COMPLETED|Overall Study||16
174301|NCT01469065|424710|P3|COMPLETED|Overall Study||16
174302|NCT01469065|424711|P2|COMPLETED|Overall Study||16
174303|NCT01469065|424712|P1|COMPLETED|Overall Study||16
174304|NCT01469065|424708|P5|STARTED|Overall Study||17
174305|NCT01469065|424709|P4|STARTED|Overall Study||16
174306|NCT01469065|424710|P3|STARTED|Overall Study||16
174307|NCT01469065|424711|P2|STARTED|Overall Study||17
174308|NCT01469065|424712|P1|STARTED|Overall Study||16
174309|NCT01469052|424808|P6|NOT COMPLETED|Overall Study||6
174310|NCT01469052|424809|P5|NOT COMPLETED|Overall Study||8
174311|NCT01469052|424810|P4|NOT COMPLETED|Overall Study||5
174312|NCT01469052|424811|P3|NOT COMPLETED|Overall Study||6
174313|NCT01469052|424812|P2|NOT COMPLETED|Overall Study||4
174314|NCT01469052|424813|P1|NOT COMPLETED|Overall Study||6
174315|NCT01469052|424808|P6|COMPLETED|Overall Study||0
174316|NCT01469052|424809|P5|COMPLETED|Overall Study||0
174317|NCT01469052|424810|P4|COMPLETED|Overall Study||1
174318|NCT01469052|424811|P3|COMPLETED|Overall Study||0
174319|NCT01469052|424812|P2|COMPLETED|Overall Study||0
174320|NCT01469052|424813|P1|COMPLETED|Overall Study||0
174321|NCT01469052|424808|P6|STARTED|Overall Study||6
174322|NCT01469052|424809|P5|STARTED|Overall Study||8
174323|NCT01469052|424810|P4|STARTED|Overall Study||6
174324|NCT01469052|424811|P3|STARTED|Overall Study||6
174325|NCT01469052|424812|P2|STARTED|Overall Study||4
174326|NCT01469052|424813|P1|STARTED|Overall Study||6
174327|NCT01469039|424860|P3|NOT COMPLETED|Overall Study||113
174328|NCT01469039|424861|P2|NOT COMPLETED|Overall Study||73
174329|NCT01469039|424862|P1|NOT COMPLETED|Overall Study||77
174330|NCT01469039|424860|P3|COMPLETED|Overall Study||95
174331|NCT01469039|424861|P2|COMPLETED|Overall Study||135
174332|NCT01469039|424862|P1|COMPLETED|Overall Study||130
174333|NCT01469039|424860|P3|STARTED|Overall Study||208
174334|NCT01469039|424861|P2|STARTED|Overall Study||208
174335|NCT01469039|424862|P1|STARTED|Overall Study||207
174336|NCT01469013|424878|P13|NOT COMPLETED|Part B (Extension Period)||6
174337|NCT01469013|424879|P12|NOT COMPLETED|Part B (Extension Period)||6
174338|NCT01469013|424880|P11|NOT COMPLETED|Part B (Extension Period)||2
174339|NCT01469013|424881|P10|NOT COMPLETED|Part B (Extension Period)||3
174340|NCT01469013|424882|P9|NOT COMPLETED|Part B (Extension Period)||4
174341|NCT01469013|424883|P8|NOT COMPLETED|Part B (Extension Period)||5
174342|NCT01469013|424884|P7|NOT COMPLETED|Part B (Extension Period)||5
174343|NCT01469013|424885|P6|NOT COMPLETED|Part B (Extension Period)||2
174344|NCT01469013|424886|P5|NOT COMPLETED|Part B (Extension Period)||0
174345|NCT01469013|424887|P4|NOT COMPLETED|Part B (Extension Period)||0
174346|NCT01469013|424888|P3|NOT COMPLETED|Part B (Extension Period)||0
174347|NCT01469013|424889|P2|NOT COMPLETED|Part B (Extension Period)||0
174348|NCT01469013|424890|P1|NOT COMPLETED|Part B (Extension Period)||0
174349|NCT01469013|424878|P13|COMPLETED|Part B (Extension Period)||18
174350|NCT01469013|424879|P12|COMPLETED|Part B (Extension Period)||18
174351|NCT01469013|424880|P11|COMPLETED|Part B (Extension Period)||10
174352|NCT01469013|424881|P10|COMPLETED|Part B (Extension Period)||8
174353|NCT01469013|424882|P9|COMPLETED|Part B (Extension Period)||20
174354|NCT01469013|424883|P8|COMPLETED|Part B (Extension Period)||18
174355|NCT01469013|424884|P7|COMPLETED|Part B (Extension Period)||7
174356|NCT01469013|424885|P6|COMPLETED|Part B (Extension Period)||10
174357|NCT01469013|424886|P5|COMPLETED|Part B (Extension Period)||0
174358|NCT01469013|424887|P4|COMPLETED|Part B (Extension Period)||0
174359|NCT01469013|424888|P3|COMPLETED|Part B (Extension Period)||0
174360|NCT01469013|424889|P2|COMPLETED|Part B (Extension Period)||0
174361|NCT01469013|424890|P1|COMPLETED|Part B (Extension Period)||0
174362|NCT01469013|424878|P13|Received at Least 1 Dose of Study Drug|Part B (Extension Period)|1 participant discontinued prior to receiving study drug|23
174363|NCT01469013|424879|P12|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24
174364|NCT01469013|424880|P11|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
174365|NCT01469013|424881|P10|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||11
174366|NCT01469013|424882|P9|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24
174367|NCT01469013|424883|P8|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||23
174368|NCT01469013|424884|P7|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
174369|NCT01469013|424885|P6|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
174370|NCT01469013|424886|P5|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
174371|NCT01469013|424887|P4|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
174372|NCT01469013|424888|P3|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
174373|NCT01469013|424889|P2|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
174374|NCT01469013|424890|P1|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
174375|NCT01469013|424878|P13|STARTED|Part B (Extension Period)||24
174376|NCT01469013|424879|P12|STARTED|Part B (Extension Period)||24
174377|NCT01469013|424880|P11|STARTED|Part B (Extension Period)||12
174378|NCT01469013|424881|P10|STARTED|Part B (Extension Period)||11
174379|NCT01469013|424882|P9|STARTED|Part B (Extension Period)||24
174380|NCT01469013|424883|P8|STARTED|Part B (Extension Period)||23
174381|NCT01469013|424884|P7|STARTED|Part B (Extension Period)||12
174382|NCT01469013|424885|P6|STARTED|Part B (Extension Period)||12
174383|NCT01469013|424886|P5|STARTED|Part B (Extension Period)||0
174384|NCT01469013|424887|P4|STARTED|Part B (Extension Period)||0
174385|NCT01469013|424888|P3|STARTED|Part B (Extension Period)||0
174386|NCT01469013|424889|P2|STARTED|Part B (Extension Period)||0
174387|NCT01469013|424890|P1|STARTED|Part B (Extension Period)||0
174388|NCT01469013|424878|P13|NOT COMPLETED|Part A (Treatment Period)||0
174389|NCT01469013|424879|P12|NOT COMPLETED|Part A (Treatment Period)||0
174390|NCT01469013|424880|P11|NOT COMPLETED|Part A (Treatment Period)||0
174391|NCT01469013|424881|P10|NOT COMPLETED|Part A (Treatment Period)||0
174392|NCT01469013|424882|P9|NOT COMPLETED|Part A (Treatment Period)||0
174393|NCT01469013|424883|P8|NOT COMPLETED|Part A (Treatment Period)||0
174394|NCT01469013|424884|P7|NOT COMPLETED|Part A (Treatment Period)||0
174395|NCT01469013|424885|P6|NOT COMPLETED|Part A (Treatment Period)||0
174396|NCT01469013|424886|P5|NOT COMPLETED|Part A (Treatment Period)||1
174397|NCT01469013|424887|P4|NOT COMPLETED|Part A (Treatment Period)||0
174398|NCT01469013|424888|P3|NOT COMPLETED|Part A (Treatment Period)||1
174399|NCT01469013|424889|P2|NOT COMPLETED|Part A (Treatment Period)||0
174400|NCT01469013|424890|P1|NOT COMPLETED|Part A (Treatment Period)||1
174401|NCT01469013|424878|P13|COMPLETED|Part A (Treatment Period)||0
174402|NCT01469013|424879|P12|COMPLETED|Part A (Treatment Period)||0
174403|NCT01469013|424880|P11|COMPLETED|Part A (Treatment Period)||0
174404|NCT01469013|424881|P10|COMPLETED|Part A (Treatment Period)||0
174405|NCT01469013|424882|P9|COMPLETED|Part A (Treatment Period)||0
174406|NCT01469013|424883|P8|COMPLETED|Part A (Treatment Period)||0
174407|NCT01469013|424884|P7|COMPLETED|Part A (Treatment Period)||0
174408|NCT01469013|424885|P6|COMPLETED|Part A (Treatment Period)||0
174409|NCT01469013|424886|P5|COMPLETED|Part A (Treatment Period)||48
174410|NCT01469013|424887|P4|COMPLETED|Part A (Treatment Period)||24
174411|NCT01469013|424888|P3|COMPLETED|Part A (Treatment Period)||23
174412|NCT01469013|424889|P2|COMPLETED|Part A (Treatment Period)||24
174413|NCT01469013|424890|P1|COMPLETED|Part A (Treatment Period)||23
174414|NCT01469013|424878|P13|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
174415|NCT01469013|424879|P12|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
174416|NCT01469013|424880|P11|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
174417|NCT01469013|424881|P10|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
174418|NCT01469013|424882|P9|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
174419|NCT01469013|424883|P8|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
174420|NCT01469013|424884|P7|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
174421|NCT01469013|424885|P6|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
174422|NCT01469013|424886|P5|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||49
174423|NCT01469013|424887|P4|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
174424|NCT01469013|424888|P3|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
174425|NCT01469013|424889|P2|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
174426|NCT01469013|424890|P1|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
174427|NCT01469013|424878|P13|STARTED|Part A (Treatment Period)||0
174428|NCT01469013|424879|P12|STARTED|Part A (Treatment Period)||0
174429|NCT01469013|424880|P11|STARTED|Part A (Treatment Period)||0
174430|NCT01469013|424881|P10|STARTED|Part A (Treatment Period)||0
174431|NCT01469013|424882|P9|STARTED|Part A (Treatment Period)||0
174432|NCT01469013|424883|P8|STARTED|Part A (Treatment Period)||0
174433|NCT01469013|424884|P7|STARTED|Part A (Treatment Period)||0
174434|NCT01469013|424885|P6|STARTED|Part A (Treatment Period)||0
174435|NCT01469013|424886|P5|STARTED|Part A (Treatment Period)||49
174436|NCT01469013|424887|P4|STARTED|Part A (Treatment Period)||24
174437|NCT01469013|424888|P3|STARTED|Part A (Treatment Period)||24
174438|NCT01469013|424889|P2|STARTED|Part A (Treatment Period)||24
174439|NCT01469013|424890|P1|STARTED|Part A (Treatment Period)||24
174440|NCT01469000|424975|P2|NOT COMPLETED|Overall Study||4
174441|NCT01469000|424976|P1|NOT COMPLETED|Overall Study||20
174442|NCT01469000|424975|P2|COMPLETED|Overall Study||62
174443|NCT01469000|424976|P1|COMPLETED|Overall Study||109
174444|NCT01469000|424975|P2|Received at Least 1 Dose of Study Drug|Overall Study||65
174445|NCT01469000|424976|P1|Received at Least 1 Dose of Study Drug|Overall Study||126
174446|NCT01469000|424975|P2|STARTED|Overall Study||66
174447|NCT01469000|424976|P1|STARTED|Overall Study||129
174448|NCT01468987|424996|P2|NOT COMPLETED|Overall Study||60
174449|NCT01468987|424997|P1|NOT COMPLETED|Overall Study||71
174450|NCT01468987|424996|P2|COMPLETED|Overall Study||618
174451|NCT01468987|424997|P1|COMPLETED|Overall Study||620
174452|NCT01468987|424996|P2|Received at Least 1 Dose of Study Drug|Overall Study||677
174453|NCT01468987|424997|P1|Received at Least 1 Dose of Study Drug|Overall Study||691
174454|NCT01468987|424996|P2|STARTED|Overall Study||678
174455|NCT01468987|424997|P1|STARTED|Overall Study||691
174456|NCT01468974|425041|P1|NOT COMPLETED|3 Years Follow-up||6
174457|NCT01468974|425041|P1|COMPLETED|3 Years Follow-up||26
174458|NCT01468974|425041|P1|STARTED|3 Years Follow-up||32
174459|NCT01468974|425041|P1|NOT COMPLETED|2 Years Follow-up||2
174460|NCT01468974|425041|P1|COMPLETED|2 Years Follow-up||32
174461|NCT01468974|425041|P1|STARTED|2 Years Follow-up||34
174462|NCT01468974|425041|P1|NOT COMPLETED|1 Year Follow-up||0
174463|NCT01468974|425041|P1|COMPLETED|1 Year Follow-up||34
174464|NCT01468974|425041|P1|STARTED|1 Year Follow-up||34
174465|NCT01468974|425041|P1|NOT COMPLETED|6 Months Follow-up||0
174466|NCT01468974|425041|P1|COMPLETED|6 Months Follow-up||34
174467|NCT01468974|425041|P1|STARTED|6 Months Follow-up||34
174468|NCT01468974|425041|P1|NOT COMPLETED|1 Month Follow-up||1
174469|NCT01468974|425041|P1|COMPLETED|1 Month Follow-up||34
174470|NCT01468974|425041|P1|STARTED|1 Month Follow-up|Intent-to-treat (ITT) population|35
174471|NCT01468909|425174|P2|NOT COMPLETED|Overall Study||2
174472|NCT01468909|425175|P1|NOT COMPLETED|Overall Study||2
174473|NCT01468909|425174|P2|COMPLETED|Overall Study||52
174474|NCT01468909|425175|P1|COMPLETED|Overall Study||50
174475|NCT01468909|425174|P2|STARTED|Overall Study||54
174476|NCT01468909|425175|P1|STARTED|Overall Study||52
174477|NCT01468896|425191|P2|NOT COMPLETED|Overall Study||0
174478|NCT01468896|425192|P1|NOT COMPLETED|Overall Study||0
174479|NCT01468896|425191|P2|COMPLETED|Overall Study||17
174480|NCT01468896|425192|P1|COMPLETED|Overall Study||6
174481|NCT01468896|425191|P2|STARTED|Overall Study||17
174482|NCT01468896|425192|P1|STARTED|Overall Study||6
174483|NCT01468818|425208|P1|NOT COMPLETED|Overall Study||2
174484|NCT01468818|425208|P1|COMPLETED|Overall Study||16
174485|NCT01468818|425208|P1|STARTED|Overall Study||18
174486|NCT01468675|425215|P2|NOT COMPLETED|Overall Study||1372
174487|NCT01468675|425216|P1|NOT COMPLETED|Overall Study||1000
174488|NCT01468675|425215|P2|COMPLETED|Overall Study||2004
174489|NCT01468675|425216|P1|COMPLETED|Overall Study||1699
174490|NCT01468675|425215|P2|STARTED|Overall Study||3376
174491|NCT01468675|425216|P1|STARTED|Overall Study||2699
174492|NCT01468584|425222|P1|NOT COMPLETED|Overall Study||0
174493|NCT01468584|425222|P1|COMPLETED|Overall Study||10
174494|NCT01468584|425222|P1|STARTED|Overall Study||10
174495|NCT01468558|425226|P1|NOT COMPLETED|Overall Study||2
174496|NCT01468558|425226|P1|COMPLETED|Overall Study||22
174497|NCT01468558|425226|P1|STARTED|Overall Study||24
174498|NCT01468350|425241|P4|NOT COMPLETED|(PART B) Day 1, Day 15||0
174499|NCT01468350|425242|P3|NOT COMPLETED|(PART B) Day 1, Day 15||0
174500|NCT01468350|425243|P2|NOT COMPLETED|(PART B) Day 1, Day 15||0
174501|NCT01468350|425244|P1|NOT COMPLETED|(PART B) Day 1, Day 15||0
174502|NCT01468350|425241|P4|COMPLETED|(PART B) Day 1, Day 15||12
174503|NCT01468350|425242|P3|COMPLETED|(PART B) Day 1, Day 15||12
174504|NCT01468350|425243|P2|COMPLETED|(PART B) Day 1, Day 15||0
174505|NCT01468350|425244|P1|COMPLETED|(PART B) Day 1, Day 15||0
174506|NCT01468350|425241|P4|STARTED|(PART B) Day 1, Day 15||12
174507|NCT01468350|425242|P3|STARTED|(PART B) Day 1, Day 15||12
174508|NCT01468350|425243|P2|STARTED|(PART B) Day 1, Day 15||0
174509|NCT01468350|425244|P1|STARTED|(PART B) Day 1, Day 15||0
174510|NCT01468350|425241|P4|NOT COMPLETED|(PART A) Day 1, Day 3||0
174511|NCT01468350|425242|P3|NOT COMPLETED|(PART A) Day 1, Day 3||0
174512|NCT01468350|425243|P2|NOT COMPLETED|(PART A) Day 1, Day 3||0
174513|NCT01468350|425244|P1|NOT COMPLETED|(PART A) Day 1, Day 3||0
174514|NCT01468350|425241|P4|COMPLETED|(PART A) Day 1, Day 3||0
174515|NCT01468350|425242|P3|COMPLETED|(PART A) Day 1, Day 3||0
174516|NCT01468350|425243|P2|COMPLETED|(PART A) Day 1, Day 3||5
174517|NCT01468350|425244|P1|COMPLETED|(PART A) Day 1, Day 3||6
174518|NCT01468350|425241|P4|STARTED|(PART A) Day 1, Day 3||0
174519|NCT01468350|425242|P3|STARTED|(PART A) Day 1, Day 3||0
174520|NCT01468350|425243|P2|STARTED|(PART A) Day 1, Day 3||5
174521|NCT01468350|425244|P1|STARTED|(PART A) Day 1, Day 3||6
174522|NCT01468337|425254|P1|NOT COMPLETED|Overall Study||0
174523|NCT01468337|425254|P1|COMPLETED|Overall Study||5
174524|NCT01468337|425254|P1|Week 48|Overall Study|Two participants did not have a Week 48 visit but completed the study.|3
174525|NCT01468337|425254|P1|Received Interferon Gamma-1b After Wk 8|Overall Study|Two participants had 2 Interferon gamma-1b dosing cycles after Wk 8|4
174526|NCT01468337|425254|P1|Received Interferon Gamma-1b at Week 4|Overall Study|One participant received additional Interferon gamma-1b dosing at Week 4 and after Week 8|2
174527|NCT01468337|425254|P1|Week 2|Overall Study||5
174528|NCT01468337|425254|P1|STARTED|Overall Study||5
174529|NCT01468311|425266|P1|NOT COMPLETED|Overall Study||2
174530|NCT01468311|425266|P1|COMPLETED|Overall Study||4
174531|NCT01468311|425266|P1|STARTED|Overall Study||6
174532|NCT01468233|425278|P6|NOT COMPLETED|Treatment Period 2||23
174533|NCT01468233|425279|P5|NOT COMPLETED|Treatment Period 2||28
174534|NCT01468233|425280|P4|NOT COMPLETED|Treatment Period 2||28
174535|NCT01468233|425281|P3|NOT COMPLETED|Treatment Period 2||111
174536|NCT01468233|425282|P2|NOT COMPLETED|Treatment Period 2||0
174537|NCT01468233|425283|P1|NOT COMPLETED|Treatment Period 2||0
174538|NCT01468233|425278|P6|COMPLETED|Treatment Period 2||28
174539|NCT01468233|425279|P5|COMPLETED|Treatment Period 2||25
174540|NCT01468233|425280|P4|COMPLETED|Treatment Period 2||23
174541|NCT01468233|425281|P3|COMPLETED|Treatment Period 2||40
174542|NCT01468233|425282|P2|COMPLETED|Treatment Period 2||0
174543|NCT01468233|425283|P1|COMPLETED|Treatment Period 2||0
174544|NCT01468233|425278|P6|STARTED|Treatment Period 2||51
174545|NCT01468233|425279|P5|STARTED|Treatment Period 2||53
174546|NCT01468233|425280|P4|STARTED|Treatment Period 2||51
174547|NCT01468233|425281|P3|STARTED|Treatment Period 2||151
174548|NCT01468233|425282|P2|STARTED|Treatment Period 2||0
174549|NCT01468233|425283|P1|STARTED|Treatment Period 2||0
174550|NCT01468233|425278|P6|NOT COMPLETED|Treatment Period 1||0
174551|NCT01468233|425279|P5|NOT COMPLETED|Treatment Period 1||0
174552|NCT01468233|425280|P4|NOT COMPLETED|Treatment Period 1||0
174553|NCT01468233|425281|P3|NOT COMPLETED|Treatment Period 1||0
174554|NCT01468233|425282|P2|NOT COMPLETED|Treatment Period 1||8
174555|NCT01468233|425283|P1|NOT COMPLETED|Treatment Period 1||12
174556|NCT01468233|425278|P6|COMPLETED|Treatment Period 1||0
174557|NCT01468233|425279|P5|COMPLETED|Treatment Period 1||0
174558|NCT01468233|425280|P4|COMPLETED|Treatment Period 1||0
174559|NCT01468233|425281|P3|COMPLETED|Treatment Period 1||0
174560|NCT01468233|425282|P2|COMPLETED|Treatment Period 1||155
174561|NCT01468233|425283|P1|COMPLETED|Treatment Period 1||151
174562|NCT01468233|425278|P6|STARTED|Treatment Period 1||0
174563|NCT01468233|425279|P5|STARTED|Treatment Period 1||0
174564|NCT01468233|425280|P4|STARTED|Treatment Period 1||0
174565|NCT01468233|425281|P3|STARTED|Treatment Period 1||0
174566|NCT01468233|425282|P2|STARTED|Treatment Period 1||163
174567|NCT01468233|425283|P1|STARTED|Treatment Period 1||163
174568|NCT01468207|425305|P6|NOT COMPLETED|Treatment Period 2||20
174569|NCT01468207|425306|P5|NOT COMPLETED|Treatment Period 2||21
174570|NCT01468207|425307|P4|NOT COMPLETED|Treatment Period 2||27
174571|NCT01468207|425308|P3|NOT COMPLETED|Treatment Period 2||52
174572|NCT01468207|425309|P2|NOT COMPLETED|Treatment Period 2||0
174573|NCT01468207|425310|P1|NOT COMPLETED|Treatment Period 2||0
174574|NCT01468207|425305|P6|COMPLETED|Treatment Period 2||28
174575|NCT01468207|425306|P5|COMPLETED|Treatment Period 2||27
174576|NCT01468207|425307|P4|COMPLETED|Treatment Period 2||22
174577|NCT01468207|425308|P3|COMPLETED|Treatment Period 2||93
174578|NCT01468207|425309|P2|COMPLETED|Treatment Period 2||0
174579|NCT01468207|425310|P1|COMPLETED|Treatment Period 2||0
174580|NCT01468207|425305|P6|STARTED|Treatment Period 2||48
174581|NCT01468207|425306|P5|STARTED|Treatment Period 2||48
174582|NCT01468207|425307|P4|STARTED|Treatment Period 2||49
174583|NCT01468207|425308|P3|STARTED|Treatment Period 2||145
174584|NCT01468207|425309|P2|STARTED|Treatment Period 2||0
174585|NCT01468207|425310|P1|STARTED|Treatment Period 2||0
174586|NCT01468207|425305|P6|NOT COMPLETED|Treatment Period 1||0
174587|NCT01468207|425306|P5|NOT COMPLETED|Treatment Period 1||0
174588|NCT01468207|425307|P4|NOT COMPLETED|Treatment Period 1||0
174589|NCT01468207|425308|P3|NOT COMPLETED|Treatment Period 1||0
174590|NCT01468207|425309|P2|NOT COMPLETED|Treatment Period 1||8
174591|NCT01468207|425310|P1|NOT COMPLETED|Treatment Period 1||9
174592|NCT01468207|425305|P6|COMPLETED|Treatment Period 1||0
174593|NCT01468207|425306|P5|COMPLETED|Treatment Period 1||0
174594|NCT01468207|425307|P4|COMPLETED|Treatment Period 1||0
174595|NCT01468207|425308|P3|COMPLETED|Treatment Period 1||0
174596|NCT01468207|425309|P2|COMPLETED|Treatment Period 1||145
174597|NCT01468207|425310|P1|COMPLETED|Treatment Period 1||145
174598|NCT01468207|425305|P6|Received Study Drug|Treatment Period 1||0
174599|NCT01468207|425306|P5|Received Study Drug|Treatment Period 1||0
174600|NCT01468207|425307|P4|Received Study Drug|Treatment Period 1||0
174601|NCT01468207|425308|P3|Received Study Drug|Treatment Period 1||0
174602|NCT01468207|425309|P2|Received Study Drug|Treatment Period 1||153
174603|NCT01468207|425310|P1|Received Study Drug|Treatment Period 1||152
174604|NCT01468207|425305|P6|STARTED|Treatment Period 1||0
174605|NCT01468207|425306|P5|STARTED|Treatment Period 1||0
174606|NCT01468207|425307|P4|STARTED|Treatment Period 1||0
174607|NCT01468207|425308|P3|STARTED|Treatment Period 1||0
174608|NCT01468207|425309|P2|STARTED|Treatment Period 1||153
174609|NCT01468207|425310|P1|STARTED|Treatment Period 1||154
174610|NCT01468181|425335|P5|NOT COMPLETED|Overall Study||5
174611|NCT01468181|425336|P4|NOT COMPLETED|Overall Study||3
174612|NCT01468181|425337|P3|NOT COMPLETED|Overall Study||8
174613|NCT01468181|425338|P2|NOT COMPLETED|Overall Study||2
174614|NCT01468181|425339|P1|NOT COMPLETED|Overall Study||10
174615|NCT01468181|425335|P5|COMPLETED|Overall Study||66
174616|NCT01468181|425336|P4|COMPLETED|Overall Study||63
174617|NCT01468181|425337|P3|COMPLETED|Overall Study||57
174618|NCT01468181|425338|P2|COMPLETED|Overall Study||59
174619|NCT01468181|425339|P1|COMPLETED|Overall Study||121
174620|NCT01468181|425335|P5|Received at Least 1 Dose of Study Drug|Overall Study||71
174621|NCT01468181|425336|P4|Received at Least 1 Dose of Study Drug|Overall Study||66
174622|NCT01468181|425337|P3|Received at Least 1 Dose of Study Drug|Overall Study||65
174623|NCT01468181|425338|P2|Received at Least 1 Dose of Study Drug|Overall Study||61
174624|NCT01468181|425339|P1|Received at Least 1 Dose of Study Drug|Overall Study||131
174625|NCT01468181|425335|P5|STARTED|Overall Study||71
174626|NCT01468181|425336|P4|STARTED|Overall Study||66
174627|NCT01468181|425337|P3|STARTED|Overall Study||65
174628|NCT01468181|425338|P2|STARTED|Overall Study||61
174629|NCT01468181|425339|P1|STARTED|Overall Study||131
174630|NCT01468077|425388|P2|NOT COMPLETED|Overall Study||3
174631|NCT01468077|425389|P1|NOT COMPLETED|Overall Study||4
174632|NCT01468077|425388|P2|COMPLETED|Overall Study||22
174633|NCT01468077|425389|P1|COMPLETED|Overall Study||18
174634|NCT01468077|425388|P2|STARTED|Overall Study||25
174635|NCT01468077|425389|P1|STARTED|Overall Study||22
174636|NCT01468012|425428|P3|NOT COMPLETED|Overall Study||4
174637|NCT01468012|425429|P2|NOT COMPLETED|Overall Study||1
174638|NCT01468012|425430|P1|NOT COMPLETED|Overall Study||2
174639|NCT01468012|425428|P3|COMPLETED|Overall Study||0
174640|NCT01468012|425429|P2|COMPLETED|Overall Study||9
174641|NCT01468012|425430|P1|COMPLETED|Overall Study||7
174642|NCT01468012|425428|P3|STARTED|Overall Study||4
174643|NCT01468012|425429|P2|STARTED|Overall Study||10
174644|NCT01468012|425430|P1|STARTED|Overall Study||9
174645|NCT01467999|425441|P1|NOT COMPLETED|Overall Study||13
174646|NCT01467999|425441|P1|COMPLETED|Overall Study||9
174647|NCT01467999|425441|P1|STARTED|Overall Study||22
174648|NCT01467960|425451|P6|NOT COMPLETED|Overall Study||30
174649|NCT01467960|425452|P5|NOT COMPLETED|Overall Study||30
174650|NCT01467960|425453|P4|NOT COMPLETED|Overall Study||30
174651|NCT01467960|425454|P3|NOT COMPLETED|Overall Study||0
174652|NCT01467960|425455|P2|NOT COMPLETED|Overall Study||0
174653|NCT01467960|425456|P1|NOT COMPLETED|Overall Study||0
174654|NCT01467960|425451|P6|COMPLETED|Overall Study||0
174655|NCT01467960|425452|P5|COMPLETED|Overall Study||0
174656|NCT01467960|425453|P4|COMPLETED|Overall Study||0
174657|NCT01467960|425454|P3|COMPLETED|Overall Study||30
174658|NCT01467960|425455|P2|COMPLETED|Overall Study||30
174659|NCT01467960|425456|P1|COMPLETED|Overall Study||30
174660|NCT01467960|425451|P6|STARTED|Overall Study||30
174661|NCT01467960|425452|P5|STARTED|Overall Study||30
174662|NCT01467960|425453|P4|STARTED|Overall Study||30
174663|NCT01467960|425454|P3|STARTED|Overall Study||30
174664|NCT01467960|425455|P2|STARTED|Overall Study||30
174665|NCT01467960|425456|P1|STARTED|Overall Study||30
174666|NCT01467947|425470|P1|NOT COMPLETED|Overall Study||0
174667|NCT01467947|425470|P1|COMPLETED|Overall Study||46
174668|NCT01467947|425470|P1|STARTED|Overall Study||46
174669|NCT01467934|425478|P3|NOT COMPLETED|Overall Study||0
174670|NCT01467934|425479|P2|NOT COMPLETED|Overall Study||0
174671|NCT01467934|425480|P1|NOT COMPLETED|Overall Study||0
174672|NCT01467934|425478|P3|COMPLETED|Overall Study||110
174673|NCT01467934|425479|P2|COMPLETED|Overall Study||212
174674|NCT01467934|425480|P1|COMPLETED|Overall Study||208
174675|NCT01467934|425478|P3|STARTED|Overall Study||110
174676|NCT01467934|425479|P2|STARTED|Overall Study||212
174677|NCT01467934|425480|P1|STARTED|Overall Study||208
174678|NCT01467882|425488|P1|NOT COMPLETED|Overall Study||0
174679|NCT01467882|425488|P1|COMPLETED|Overall Study||44
174680|NCT01467882|425488|P1|STARTED|Overall Study||44
174681|NCT01467713|425515|P4|NOT COMPLETED|Overall Study||109
174682|NCT01467713|425516|P3|NOT COMPLETED|Overall Study||102
174683|NCT01467713|425517|P2|NOT COMPLETED|Overall Study||104
174684|NCT01467713|425518|P1|NOT COMPLETED|Overall Study||102
174685|NCT01467713|425515|P4|COMPLETED|Overall Study||45
174686|NCT01467713|425516|P3|COMPLETED|Overall Study||58
174687|NCT01467713|425517|P2|COMPLETED|Overall Study||60
174688|NCT01467713|425518|P1|COMPLETED|Overall Study||62
174689|NCT01467713|425515|P4|Safety Analysis Set: Received Treatment|Overall Study||154
174690|NCT01467713|425516|P3|Safety Analysis Set: Received Treatment|Overall Study||159
174691|NCT01467713|425517|P2|Safety Analysis Set: Received Treatment|Overall Study||164
174692|NCT01467713|425518|P1|Safety Analysis Set: Received Treatment|Overall Study||163
174693|NCT01467713|425515|P4|STARTED|Overall Study||154
174694|NCT01467713|425516|P3|STARTED|Overall Study||160
174695|NCT01467713|425517|P2|STARTED|Overall Study||164
174696|NCT01467713|425518|P1|STARTED|Overall Study||164
174697|NCT01467700|425572|P4|NOT COMPLETED|Overall Study||27
174698|NCT01467700|425573|P3|NOT COMPLETED|Overall Study||27
174699|NCT01467700|425574|P2|NOT COMPLETED|Overall Study||28
174700|NCT01467700|425575|P1|NOT COMPLETED|Overall Study||29
174701|NCT01467700|425572|P4|COMPLETED|Overall Study||96
174702|NCT01467700|425573|P3|COMPLETED|Overall Study||97
174703|NCT01467700|425574|P2|COMPLETED|Overall Study||100
174704|NCT01467700|425575|P1|COMPLETED|Overall Study||86
174705|NCT01467700|425572|P4|Safety Set - Received Treatment|Overall Study||123
174706|NCT01467700|425573|P3|Safety Set - Received Treatment|Overall Study||124
174707|NCT01467700|425574|P2|Safety Set - Received Treatment|Overall Study||127
174708|NCT01467700|425575|P1|Safety Set - Received Treatment|Overall Study||115
174709|NCT01467700|425572|P4|STARTED|Overall Study||123
174710|NCT01467700|425573|P3|STARTED|Overall Study||124
174711|NCT01467700|425574|P2|STARTED|Overall Study||128
174712|NCT01467700|425575|P1|STARTED|Overall Study||115
174713|NCT01467661|425617|P1|NOT COMPLETED|Overall Study||21
174714|NCT01467661|425617|P1|COMPLETED|Overall Study||32
174715|NCT01467661|425617|P1|Started Post Marketing Trial|Overall Study||33
174716|NCT01467661|425617|P1|Started SPD422-309 (NCT01467661)|Overall Study||41
174717|NCT01467661|425617|P1|Completed SPD422-308 (NCT01214915)|Overall Study||42
174718|NCT01467661|425617|P1|STARTED|Overall Study||53
174719|NCT01467583|425637|P3|NOT COMPLETED|Overall Study||2
174720|NCT01467583|425638|P2|NOT COMPLETED|Overall Study||1
174721|NCT01467583|425639|P1|NOT COMPLETED|Overall Study||2
174722|NCT01467583|425637|P3|COMPLETED|Overall Study||10
174723|NCT01467583|425638|P2|COMPLETED|Overall Study|Death unrelated to study drug on day #3. Data to that point is included in the results|3
174724|NCT01467583|425639|P1|COMPLETED|Overall Study|Both patients completed > 1 dose and so their data was included in the results.|14
174725|NCT01467583|425637|P3|STARTED|Overall Study||12
174726|NCT01467583|425638|P2|STARTED|Overall Study||4
174727|NCT01467583|425639|P1|STARTED|Overall Study||16
174728|NCT01467570|425652|P2|NOT COMPLETED|Overall Study||9
174729|NCT01467570|425653|P1|NOT COMPLETED|Overall Study||8
174730|NCT01467570|425652|P2|COMPLETED|Overall Study||63
174731|NCT01467570|425653|P1|COMPLETED|Overall Study||67
174732|NCT01467570|425652|P2|STARTED|Overall Study||72
174733|NCT01467570|425653|P1|STARTED|Overall Study||75
174734|NCT01467557|425679|P2|NOT COMPLETED|Overall Study||107
174735|NCT01467557|425680|P1|NOT COMPLETED|Overall Study||99
174736|NCT01467557|425679|P2|COMPLETED|Overall Study||463
174737|NCT01467557|425680|P1|COMPLETED|Overall Study||502
174738|NCT01467557|425679|P2|12 Month Survey Completed|Overall Study||463
174739|NCT01467557|425680|P1|12 Month Survey Completed|Overall Study||502
174740|NCT01467557|425679|P2|4 Month Survey Completed|Overall Study||493
174741|NCT01467557|425680|P1|4 Month Survey Completed|Overall Study||533
174742|NCT01467557|425679|P2|2 Week Survey Completed|Overall Study||522
174743|NCT01467557|425680|P1|2 Week Survey Completed|Overall Study||551
174744|NCT01467557|425679|P2|STARTED|Overall Study||570
174745|NCT01467557|425680|P1|STARTED|Overall Study||601
174746|NCT01467505|425690|P2|NOT COMPLETED|Overall Study||3
174747|NCT01467505|425691|P1|NOT COMPLETED|Overall Study||33
174748|NCT01467505|425690|P2|COMPLETED|Overall Study||7
174749|NCT01467505|425691|P1|COMPLETED|Overall Study||18
174750|NCT01467505|425690|P2|STARTED|Overall Study||10
174751|NCT01467505|425691|P1|STARTED|Overall Study||51
174752|NCT01467492|425723|P2|NOT COMPLETED|Overall Study||13
174753|NCT01467492|425724|P1|NOT COMPLETED|Overall Study||22
174754|NCT01467492|425723|P2|COMPLETED|Overall Study||25
174755|NCT01467492|425724|P1|COMPLETED|Overall Study||61
174756|NCT01467492|425723|P2|STARTED|Overall Study||38
174757|NCT01467492|425724|P1|STARTED|Overall Study||83
174758|NCT01467479|425748|P3|NOT COMPLETED|Overall Study||16
174759|NCT01467479|425749|P2|NOT COMPLETED|Overall Study||17
174760|NCT01467479|425750|P1|NOT COMPLETED|Overall Study||9
174761|NCT01467479|425748|P3|COMPLETED|Overall Study||45
174762|NCT01467479|425749|P2|COMPLETED|Overall Study||52
174763|NCT01467479|425750|P1|COMPLETED|Overall Study||46
174764|NCT01467479|425748|P3|Treated|Overall Study||59
174765|NCT01467479|425749|P2|Treated|Overall Study||69
174766|NCT01467479|425750|P1|Treated|Overall Study||54
174767|NCT01467479|425748|P3|STARTED|Overall Study||61
174768|NCT01467479|425749|P2|STARTED|Overall Study||69
174769|NCT01467479|425750|P1|STARTED|Overall Study||55
174770|NCT01467466|425781|P4|NOT COMPLETED|Overall Study||88
174771|NCT01467466|425782|P3|NOT COMPLETED|Overall Study||104
174772|NCT01467466|425783|P2|NOT COMPLETED|Overall Study||104
174773|NCT01467466|425784|P1|NOT COMPLETED|Overall Study||109
174774|NCT01467466|425781|P4|COMPLETED|Overall Study||1203
174775|NCT01467466|425782|P3|COMPLETED|Overall Study||1190
174776|NCT01467466|425783|P2|COMPLETED|Overall Study||1188
174777|NCT01467466|425784|P1|COMPLETED|Overall Study||1191
174778|NCT01467466|425781|P4|STARTED|Overall Study||1291
174779|NCT01467466|425782|P3|STARTED|Overall Study||1294
174780|NCT01467466|425783|P2|STARTED|Overall Study||1292
174781|NCT01467466|425784|P1|STARTED|Overall Study||1300
174782|NCT01467427|425796|P2|NOT COMPLETED|Overall Study||13
174783|NCT01467427|425797|P1|NOT COMPLETED|Overall Study||12
174784|NCT01467427|425796|P2|COMPLETED|Overall Study||0
174785|NCT01467427|425797|P1|COMPLETED|Overall Study||0
174786|NCT01467427|425796|P2|Completed Main Phase|Overall Study||13
174787|NCT01467427|425797|P1|Completed Main Phase|Overall Study||11
174788|NCT01467427|425796|P2|STARTED|Overall Study||13
174789|NCT01467427|425797|P1|STARTED|Overall Study||12
174790|NCT01467271|425815|P1|NOT COMPLETED|Overall Study||202
174791|NCT01467271|425815|P1|COMPLETED|Overall Study||338
174792|NCT01467271|425815|P1|STARTED|Overall Study||540
174793|NCT01467076|425822|P3|NOT COMPLETED|Overall Study||0
174794|NCT01467076|425823|P2|NOT COMPLETED|Overall Study||0
174795|NCT01467076|425824|P1|NOT COMPLETED|Overall Study||1
174796|NCT01467076|425822|P3|COMPLETED|Overall Study||2
174797|NCT01467076|425823|P2|COMPLETED|Overall Study||2
174798|NCT01467076|425824|P1|COMPLETED|Overall Study||2
174799|NCT01467076|425822|P3|STARTED|Overall Study||2
174800|NCT01467076|425823|P2|STARTED|Overall Study||2
174801|NCT01467076|425824|P1|STARTED|Overall Study||3
174802|NCT01467037|425861|P1|NOT COMPLETED|Overall Study||0
174803|NCT01467037|425861|P1|COMPLETED|Overall Study||374
174804|NCT01467037|425861|P1|STARTED|Overall Study||374
174805|NCT01466985|425871|P3|NOT COMPLETED|Overall Study||0
174806|NCT01466985|425872|P2|NOT COMPLETED|Overall Study||0
174807|NCT01466985|425873|P1|NOT COMPLETED|Overall Study||0
174808|NCT01466985|425871|P3|COMPLETED|Overall Study||6
174809|NCT01466985|425872|P2|COMPLETED|Overall Study||6
174810|NCT01466985|425873|P1|COMPLETED|Overall Study||6
174811|NCT01466985|425871|P3|STARTED|Overall Study||6
174812|NCT01466985|425872|P2|STARTED|Overall Study||6
174813|NCT01466985|425873|P1|STARTED|Overall Study||6
174814|NCT01466881|425890|P1|NOT COMPLETED|Overall Study||40
174815|NCT01466881|425890|P1|COMPLETED|Overall Study||2
174816|NCT01466881|425890|P1|Eligible and Treated|Overall Study||37
174817|NCT01466881|425890|P1|STARTED|Overall Study||42
174818|NCT01466790|425907|P8|NOT COMPLETED|Overall Study||1
174819|NCT01466790|425908|P7|NOT COMPLETED|Overall Study||1
174820|NCT01466790|425909|P6|NOT COMPLETED|Overall Study||0
174821|NCT01466790|425910|P5|NOT COMPLETED|Overall Study||3
174822|NCT01466790|425911|P4|NOT COMPLETED|Overall Study||0
174823|NCT01466790|425912|P3|NOT COMPLETED|Overall Study||0
174824|NCT01466790|425913|P2|NOT COMPLETED|Overall Study||1
174825|NCT01466790|425914|P1|NOT COMPLETED|Overall Study||4
174826|NCT01466790|425907|P8|COMPLETED|Overall Study||13
174827|NCT01466790|425908|P7|COMPLETED|Overall Study||26
174828|NCT01466790|425909|P6|COMPLETED|Overall Study||16
174829|NCT01466790|425910|P5|COMPLETED|Overall Study||27
174830|NCT01466790|425911|P4|COMPLETED|Overall Study||14
174831|NCT01466790|425912|P3|COMPLETED|Overall Study||27
174832|NCT01466790|425913|P2|COMPLETED|Overall Study||14
174833|NCT01466790|425914|P1|COMPLETED|Overall Study||20
174834|NCT01466790|425907|P8|STARTED|Overall Study||14
174835|NCT01466790|425908|P7|STARTED|Overall Study||27
174836|NCT01466790|425909|P6|STARTED|Overall Study||16
174837|NCT01466790|425910|P5|STARTED|Overall Study||30
174838|NCT01466790|425911|P4|STARTED|Overall Study||14
174839|NCT01466790|425912|P3|STARTED|Overall Study||27
174840|NCT01466790|425913|P2|STARTED|Overall Study||15
174841|NCT01466790|425914|P1|STARTED|Overall Study|Not including 1 participant who was randomized to this group, but never received treatment.|24
174842|NCT01466764|425978|P2|NOT COMPLETED|Overall Study||0
174843|NCT01466764|425979|P1|NOT COMPLETED|Overall Study||0
174844|NCT01466764|425978|P2|COMPLETED|Overall Study||5
174845|NCT01466764|425979|P1|COMPLETED|Overall Study||5
174846|NCT01466764|425978|P2|STARTED|Overall Study||5
174847|NCT01466764|425979|P1|STARTED|Overall Study||5
174848|NCT01466751|425999|P2|NOT COMPLETED|Overall Study||0
174849|NCT01466751|426000|P1|NOT COMPLETED|Overall Study||1
174850|NCT01466751|425999|P2|COMPLETED|Overall Study||14
174851|NCT01466751|426000|P1|COMPLETED|Overall Study||13
174852|NCT01466751|425999|P2|STARTED|Overall Study||14
174853|NCT01466751|426000|P1|STARTED|Overall Study||14
174854|NCT01466673|426010|P2|NOT COMPLETED|Overall Study||6
174855|NCT01466673|426011|P1|NOT COMPLETED|Overall Study||7
174856|NCT01466673|426010|P2|COMPLETED|Overall Study||95
174857|NCT01466673|426011|P1|COMPLETED|Overall Study||93
174858|NCT01466673|426010|P2|STARTED|Overall Study||101
174859|NCT01466673|426011|P1|STARTED|Overall Study||100
174860|NCT01466660|426037|P2|NOT COMPLETED|Overall Study||151
174861|NCT01466660|426038|P1|NOT COMPLETED|Overall Study||146
174862|NCT01466660|426037|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date, 08 April 2016|8
174863|NCT01466660|426038|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date, 08 April 2016|14
174864|NCT01466660|426037|P2|STARTED|Overall Study||159
174865|NCT01466660|426038|P1|STARTED|Overall Study||160
174866|NCT01466595|426064|P2|NOT COMPLETED|Overall Study||1
174867|NCT01466595|426065|P1|NOT COMPLETED|Overall Study||0
174868|NCT01466595|426064|P2|COMPLETED|Overall Study||23
174869|NCT01466595|426065|P1|COMPLETED|Overall Study||49
174870|NCT01466595|426064|P2|STARTED|Overall Study||24
174871|NCT01466595|426065|P1|STARTED|Overall Study||49
174872|NCT01466491|426159|P4|NOT COMPLETED|Overall Study||0
174873|NCT01466491|426160|P3|NOT COMPLETED|Overall Study||3
174874|NCT01466491|426161|P2|NOT COMPLETED|Overall Study||3
174875|NCT01466491|426162|P1|NOT COMPLETED|Overall Study||0
174876|NCT01466491|426159|P4|COMPLETED|Overall Study||83
174877|NCT01466491|426160|P3|COMPLETED|Overall Study||80
174878|NCT01466491|426161|P2|COMPLETED|Overall Study||80
174879|NCT01466491|426162|P1|COMPLETED|Overall Study||83
174880|NCT01466491|426159|P4|STARTED|Overall Study||83
174881|NCT01466491|426160|P3|STARTED|Overall Study||83
174882|NCT01466491|426161|P2|STARTED|Overall Study||83
174883|NCT01466491|426162|P1|STARTED|Overall Study||83
174884|NCT01466387|426182|P6|NOT COMPLETED|Overall Study||1
174885|NCT01466387|426183|P5|NOT COMPLETED|Overall Study||0
174886|NCT01466387|426184|P4|NOT COMPLETED|Overall Study||2
174887|NCT01466387|426185|P3|NOT COMPLETED|Overall Study||1
174888|NCT01466387|426186|P2|NOT COMPLETED|Overall Study||0
174889|NCT01466387|426187|P1|NOT COMPLETED|Overall Study||1
174890|NCT01466387|426182|P6|COMPLETED|Overall Study||99
174891|NCT01466387|426183|P5|COMPLETED|Overall Study||51
174892|NCT01466387|426184|P4|COMPLETED|Overall Study||99
174893|NCT01466387|426185|P3|COMPLETED|Overall Study||98
174894|NCT01466387|426186|P2|COMPLETED|Overall Study||100
174895|NCT01466387|426187|P1|COMPLETED|Overall Study||100
174896|NCT01466387|426182|P6|STARTED|Overall Study||100
174897|NCT01466387|426183|P5|STARTED|Overall Study||51
174898|NCT01466387|426184|P4|STARTED|Overall Study||101
174899|NCT01466387|426185|P3|STARTED|Overall Study||99
174900|NCT01466387|426186|P2|STARTED|Overall Study||100
174901|NCT01466387|426187|P1|STARTED|Overall Study||101
174902|NCT01466361|426229|P4|NOT COMPLETED|Overall Study||0
174903|NCT01466361|426230|P3|NOT COMPLETED|Overall Study||0
174904|NCT01466361|426231|P2|NOT COMPLETED|Overall Study||0
174905|NCT01466361|426232|P1|NOT COMPLETED|Overall Study||0
174906|NCT01466361|426229|P4|COMPLETED|Overall Study||41
174907|NCT01466361|426230|P3|COMPLETED|Overall Study||60
174908|NCT01466361|426231|P2|COMPLETED|Overall Study||34
174909|NCT01466361|426232|P1|COMPLETED|Overall Study||52
174910|NCT01466361|426229|P4|STARTED|Overall Study||41
174911|NCT01466361|426230|P3|STARTED|Overall Study||60
174912|NCT01466361|426231|P2|STARTED|Overall Study||34
174913|NCT01466361|426232|P1|STARTED|Overall Study||52
174914|NCT01466348|426248|P2|NOT COMPLETED|Period II - Second Intervention||0
174915|NCT01466348|426249|P1|NOT COMPLETED|Period II - Second Intervention||0
174916|NCT01466348|426248|P2|COMPLETED|Period II - Second Intervention||36
174917|NCT01466348|426249|P1|COMPLETED|Period II - Second Intervention||35
174918|NCT01466348|426248|P2|STARTED|Period II - Second Intervention||36
174919|NCT01466348|426249|P1|STARTED|Period II - Second Intervention||35
174920|NCT01466348|426248|P2|NOT COMPLETED|Period I - First Intervention||1
174921|NCT01466348|426249|P1|NOT COMPLETED|Period I - First Intervention||0
174922|NCT01466348|426248|P2|COMPLETED|Period I - First Intervention||35
174923|NCT01466348|426249|P1|COMPLETED|Period I - First Intervention||36
174924|NCT01466348|426248|P2|Intent To Treat (ITT) Population|Period I - First Intervention|1 participant withdrew prior receiving the treatment|35
174925|NCT01466348|426249|P1|Intent To Treat (ITT) Population|Period I - First Intervention||36
174926|NCT01466348|426248|P2|STARTED|Period I - First Intervention||36
174927|NCT01466348|426249|P1|STARTED|Period I - First Intervention||36
174928|NCT01466270|426277|P2|NOT COMPLETED|Overall Study||6
174929|NCT01466270|426278|P1|NOT COMPLETED|Overall Study||12
174930|NCT01466270|426277|P2|COMPLETED|Overall Study||25
174931|NCT01466270|426278|P1|COMPLETED|Overall Study||19
174932|NCT01466270|426277|P2|STARTED|Overall Study||31
174933|NCT01466270|426278|P1|STARTED|Overall Study||31
174934|NCT01466192|426290|P1|NOT COMPLETED|Overall Study||4
174935|NCT01466192|426290|P1|COMPLETED|Overall Study||104
174936|NCT01466192|426290|P1|STARTED|Overall Study||108
174937|NCT01466179|426294|P1|NOT COMPLETED|Overall Study||179
174938|NCT01466179|426294|P1|COMPLETED|Overall Study|Completed 5 cycles of treatment; Data as of the time of the data cut-off date (10 October 2013).|10
174939|NCT01466179|426294|P1|STARTED|Overall Study|Participants enrolled during the first 3 stages of the study|189
174940|NCT01466166|426314|P1|NOT COMPLETED|Overall Study||163
174941|NCT01466166|426314|P1|COMPLETED|Overall Study||25
174942|NCT01466166|426314|P1|Completed 24 Weeks of Treatment|Overall Study||55
174943|NCT01466166|426314|P1|Received Treatment|Overall Study||188
174944|NCT01466166|426314|P1|STARTED|Overall Study||188
174945|NCT01466153|426328|P3|NOT COMPLETED|Overall Study||25
174946|NCT01466153|426329|P2|NOT COMPLETED|Overall Study||24
174947|NCT01466153|426330|P1|NOT COMPLETED|Overall Study||29
174948|NCT01466153|426328|P3|COMPLETED|Overall Study||36
174949|NCT01466153|426329|P2|COMPLETED|Overall Study||12
174950|NCT01466153|426330|P1|COMPLETED|Overall Study||33
174951|NCT01466153|426328|P3|STARTED|Overall Study||61
174952|NCT01466153|426329|P2|STARTED|Overall Study||36
174953|NCT01466153|426330|P1|STARTED|Overall Study||62
174954|NCT01466127|426371|P2|NOT COMPLETED|Overall Study||16
174955|NCT01466127|426372|P1|NOT COMPLETED|Overall Study||14
174956|NCT01466127|426371|P2|COMPLETED|Overall Study||14
174957|NCT01466127|426372|P1|COMPLETED|Overall Study||16
174958|NCT01466127|426371|P2|STARTED|Overall Study||30
174959|NCT01466127|426372|P1|STARTED|Overall Study||30
174960|NCT01466075|426378|P1|NOT COMPLETED|Overall Study||0
174961|NCT01466075|426378|P1|COMPLETED|Overall Study||207
174962|NCT01466075|426378|P1|STARTED|Overall Study||207
174963|NCT01466062|426385|P1|NOT COMPLETED|Overall Study||2
174964|NCT01466062|426385|P1|COMPLETED|Overall Study||26
174965|NCT01466062|426385|P1|STARTED|Overall Study||28
174966|NCT01465997|426408|P2|NOT COMPLETED|Overall Study||89
174967|NCT01465997|426409|P1|NOT COMPLETED|Overall Study||68
174968|NCT01465997|426408|P2|COMPLETED|Overall Study||180
174969|NCT01465997|426409|P1|COMPLETED|Overall Study||211
174970|NCT01465997|426408|P2|STARTED|Overall Study||269
174971|NCT01465997|426409|P1|STARTED|Overall Study||279
174972|NCT01465958|426419|P2|NOT COMPLETED|Subcutaneous (SC) Phase||1
174973|NCT01465958|426420|P1|NOT COMPLETED|Subcutaneous (SC) Phase||0
174974|NCT01465958|426419|P2|COMPLETED|Subcutaneous (SC) Phase||10
174975|NCT01465958|426420|P1|COMPLETED|Subcutaneous (SC) Phase||0
174976|NCT01465958|426419|P2|STARTED|Subcutaneous (SC) Phase|Eleven subjects completed the IV phase and entered the SC phase.|11
174977|NCT01465958|426420|P1|STARTED|Subcutaneous (SC) Phase|After completing the intravenous (IV) phase, subjects entered the subcutaneous (SC) phase.|0
174978|NCT01465958|426419|P2|NOT COMPLETED|Intravenous (IV) Phase||0
174979|NCT01465958|426420|P1|NOT COMPLETED|Intravenous (IV) Phase||0
174980|NCT01465958|426419|P2|COMPLETED|Intravenous (IV) Phase||0
174981|NCT01465958|426420|P1|COMPLETED|Intravenous (IV) Phase||11
174982|NCT01465958|426419|P2|STARTED|Intravenous (IV) Phase||0
174983|NCT01465958|426420|P1|STARTED|Intravenous (IV) Phase|One subject entered the IV phase directly.|11
174984|NCT01465958|426419|P2|NOT COMPLETED|Run-in Phase||0
174985|NCT01465958|426420|P1|NOT COMPLETED|Run-in Phase||1
174986|NCT01465958|426419|P2|COMPLETED|Run-in Phase||0
174987|NCT01465958|426420|P1|COMPLETED|Run-in Phase||10
174988|NCT01465958|426419|P2|STARTED|Run-in Phase||0
174989|NCT01465958|426420|P1|STARTED|Run-in Phase||11
174990|NCT01465802|426433|P5|NOT COMPLETED|Overall Study||12
174991|NCT01465802|426434|P4|NOT COMPLETED|Overall Study||29
174992|NCT01465802|426435|P3|NOT COMPLETED|Overall Study||0
174993|NCT01465802|426436|P2|NOT COMPLETED|Overall Study||24
174994|NCT01465802|426437|P1|NOT COMPLETED|Overall Study||33
174995|NCT01465802|426433|P5|COMPLETED|Overall Study||13
174996|NCT01465802|426434|P4|COMPLETED|Overall Study||38
174997|NCT01465802|426435|P3|COMPLETED|Overall Study||7
174998|NCT01465802|426436|P2|COMPLETED|Overall Study||42
174999|NCT01465802|426437|P1|COMPLETED|Overall Study||33
175000|NCT01465802|426433|P5|STARTED|Overall Study||25
175001|NCT01465802|426434|P4|STARTED|Overall Study|An additional 5 participants were enrolled in Cohort II but not treated.|67
175002|NCT01465802|426435|P3|STARTED|Overall Study||7
175003|NCT01465802|426436|P2|STARTED|Overall Study||66
175004|NCT01465802|426437|P1|STARTED|Overall Study||66
175005|NCT01465763|426489|P3|NOT COMPLETED|Overall Study||4
175006|NCT01465763|426490|P2|NOT COMPLETED|Overall Study||1
175007|NCT01465763|426491|P1|NOT COMPLETED|Overall Study||31
175008|NCT01465763|426489|P3|COMPLETED|Overall Study||118
175009|NCT01465763|426490|P2|COMPLETED|Overall Study||15
175010|NCT01465763|426491|P1|COMPLETED|Overall Study||445
175011|NCT01465763|426489|P3|STARTED|Overall Study||122
175012|NCT01465763|426490|P2|STARTED|Overall Study||16
175013|NCT01465763|426491|P1|STARTED|Overall Study||476
175014|NCT01465464|426518|P2|NOT COMPLETED|Overall Study||444
175015|NCT01465464|426519|P1|NOT COMPLETED|Overall Study||444
175016|NCT01465464|426518|P2|COMPLETED|Overall Study||0
175017|NCT01465464|426519|P1|COMPLETED|Overall Study||0
175018|NCT01465464|426518|P2|STARTED|Overall Study||444
175019|NCT01465464|426519|P1|STARTED|Overall Study||444
175020|NCT01465412|426531|P4|NOT COMPLETED|Overall Study||0
175021|NCT01465412|426532|P3|NOT COMPLETED|Overall Study||0
175022|NCT01465412|426533|P2|NOT COMPLETED|Overall Study||0
175023|NCT01465412|426534|P1|NOT COMPLETED|Overall Study||0
175024|NCT01465412|426531|P4|COMPLETED|Overall Study||9
175025|NCT01465412|426532|P3|COMPLETED|Overall Study||9
175026|NCT01465412|426533|P2|COMPLETED|Overall Study||12
175027|NCT01465412|426534|P1|COMPLETED|Overall Study||12
175028|NCT01465412|426531|P4|STARTED|Overall Study||9
175029|NCT01465412|426532|P3|STARTED|Overall Study||9
175030|NCT01465412|426533|P2|STARTED|Overall Study||12
175031|NCT01465412|426534|P1|STARTED|Overall Study||12
175032|NCT01465386|426572|P1|NOT COMPLETED|Overall Study||4
175033|NCT01465386|426572|P1|COMPLETED|Overall Study||2
175034|NCT01465386|426572|P1|STARTED|Overall Study||6
175035|NCT01465347|426576|P2|NOT COMPLETED|Overall Study||3
175036|NCT01465347|426577|P1|NOT COMPLETED|Overall Study||1
175037|NCT01465347|426576|P2|COMPLETED|Overall Study||53
175038|NCT01465347|426577|P1|COMPLETED|Overall Study||2
175039|NCT01465347|426576|P2|STARTED|Overall Study||56
175040|NCT01465347|426577|P1|STARTED|Overall Study||3
175041|NCT01465334|426589|P2|NOT COMPLETED|Overall Study||6
175042|NCT01465334|426590|P1|NOT COMPLETED|Overall Study||2
175043|NCT01465334|426589|P2|COMPLETED|Overall Study||9
175044|NCT01465334|426590|P1|COMPLETED|Overall Study||13
175045|NCT01465334|426589|P2|Eligible for Allogeneic Transplant|Overall Study||9
175046|NCT01465334|426590|P1|Eligible for Allogeneic Transplant|Overall Study||9
175047|NCT01465334|426589|P2|Complete Part B Induction|Overall Study||15
175048|NCT01465334|426590|P1|Complete Part B Induction|Overall Study||7
175049|NCT01465334|426589|P2|Complete Part A Induction|Overall Study||15
175050|NCT01465334|426590|P1|Complete Part A Induction|Overall Study||12
175051|NCT01465334|426589|P2|STARTED|Overall Study||15
175052|NCT01465334|426590|P1|STARTED|Overall Study||15
175053|NCT01465230|426616|P1|NOT COMPLETED|Overall Study||2
175054|NCT01465230|426616|P1|COMPLETED|Overall Study||0
175055|NCT01465230|426616|P1|STARTED|Overall Study||2
175056|NCT01465178|426622|P2|NOT COMPLETED|Overall Study||0
175057|NCT01465178|426623|P1|NOT COMPLETED|Overall Study||1
175058|NCT01465178|426622|P2|COMPLETED|Overall Study||31
175059|NCT01465178|426623|P1|COMPLETED|Overall Study||30
175060|NCT01465178|426622|P2|STARTED|Overall Study||31
175061|NCT01465178|426623|P1|STARTED|Overall Study||31
175062|NCT01465048|426634|P3|NOT COMPLETED|Overall Study||0
175063|NCT01465048|426635|P2|NOT COMPLETED|Overall Study||0
175064|NCT01465048|426636|P1|NOT COMPLETED|Overall Study||0
175065|NCT01465048|426634|P3|COMPLETED|Overall Study||6
175066|NCT01465048|426635|P2|COMPLETED|Overall Study||6
175067|NCT01465048|426636|P1|COMPLETED|Overall Study||6
175068|NCT01465048|426634|P3|STARTED|Overall Study||6
175069|NCT01465048|426635|P2|STARTED|Overall Study||6
175070|NCT01465048|426636|P1|STARTED|Overall Study||6
175071|NCT01465022|426647|P3|NOT COMPLETED|Overall Study||70
175072|NCT01465022|426648|P2|NOT COMPLETED|Overall Study||23
175073|NCT01465022|426649|P1|NOT COMPLETED|Overall Study||23
175074|NCT01465022|426647|P3|COMPLETED|Overall Study||0
175075|NCT01465022|426648|P2|COMPLETED|Overall Study||40
175076|NCT01465022|426649|P1|COMPLETED|Overall Study||41
175077|NCT01465022|426647|P3|STARTED|Overall Study||70
175078|NCT01465022|426648|P2|STARTED|Overall Study||63
175079|NCT01465022|426649|P1|STARTED|Overall Study||64
175080|NCT01464996|426663|P1|NOT COMPLETED|Overall Study||0
175081|NCT01464996|426663|P1|COMPLETED|Overall Study||24
175082|NCT01464996|426663|P1|OptiBond FL|Overall Study||24
175083|NCT01464996|426663|P1|OptiBond XTR|Overall Study||23
175084|NCT01464996|426663|P1|STARTED|Overall Study||24
175085|NCT01464931|426683|P2|NOT COMPLETED|Overall Study||0
175086|NCT01464931|426684|P1|NOT COMPLETED|Overall Study||1
175087|NCT01464931|426683|P2|COMPLETED|Overall Study||16
175088|NCT01464931|426684|P1|COMPLETED|Overall Study||15
175089|NCT01464931|426683|P2|STARTED|Overall Study||16
175090|NCT01464931|426684|P1|STARTED|Overall Study||16
175091|NCT01464879|426721|P1|NOT COMPLETED|Overall Study||2
175092|NCT01464879|426721|P1|COMPLETED|Overall Study||18
175093|NCT01464879|426721|P1|Applicator Application (3.75 mL)|Overall Study||18
175094|NCT01464879|426721|P1|Applicator Application (2.50 mL)|Overall Study|One subject discontinued due to physician's decision.|18
175095|NCT01464879|426721|P1|Applicator Application (1.25 mL)|Overall Study|One subject discontinued due to non-compliance.|19
175096|NCT01464879|426721|P1|Washout Period|Overall Study||20
175097|NCT01464879|426721|P1|Hand Application (2.50 mL)|Overall Study||20
175098|NCT01464879|426721|P1|STARTED|Overall Study||20
175099|NCT01464840|426758|P3|NOT COMPLETED|Overall Study||0
175100|NCT01464840|426759|P2|NOT COMPLETED|Overall Study||0
175101|NCT01464840|426760|P1|NOT COMPLETED|Overall Study||0
175102|NCT01464840|426758|P3|COMPLETED|Overall Study||10
175103|NCT01464840|426759|P2|COMPLETED|Overall Study||10
175104|NCT01464840|426760|P1|COMPLETED|Overall Study||10
175105|NCT01464840|426758|P3|STARTED|Overall Study||10
175106|NCT01464840|426759|P2|STARTED|Overall Study||10
175107|NCT01464840|426760|P1|STARTED|Overall Study||10
175108|NCT01464827|426782|P14|NOT COMPLETED|Overall Study||3
175109|NCT01464827|426783|P13|NOT COMPLETED|Overall Study||2
175110|NCT01464827|426784|P12|NOT COMPLETED|Overall Study||2
175111|NCT01464827|426785|P11|NOT COMPLETED|Overall Study||2
175112|NCT01464827|426786|P10|NOT COMPLETED|Overall Study||3
175113|NCT01464827|426787|P9|NOT COMPLETED|Overall Study||3
175114|NCT01464827|426788|P8|NOT COMPLETED|Overall Study||3
175115|NCT01464827|426789|P7|NOT COMPLETED|Overall Study||4
175116|NCT01464827|426790|P6|NOT COMPLETED|Overall Study||1
175117|NCT01464827|426791|P5|NOT COMPLETED|Overall Study||8
175118|NCT01464827|426792|P4|NOT COMPLETED|Overall Study||4
175119|NCT01464827|426793|P3|NOT COMPLETED|Overall Study||0
175120|NCT01464827|426794|P2|NOT COMPLETED|Overall Study||7
175121|NCT01464827|426795|P1|NOT COMPLETED|Overall Study||3
175122|NCT01464827|426782|P14|COMPLETED|Overall Study||19
175123|NCT01464827|426783|P13|COMPLETED|Overall Study||21
175124|NCT01464827|426784|P12|COMPLETED|Overall Study||21
175125|NCT01464827|426785|P11|COMPLETED|Overall Study||21
175126|NCT01464827|426786|P10|COMPLETED|Overall Study||44
175127|NCT01464827|426787|P9|COMPLETED|Overall Study||37
175128|NCT01464827|426788|P8|COMPLETED|Overall Study||37
175129|NCT01464827|426789|P7|COMPLETED|Overall Study||37
175130|NCT01464827|426790|P6|COMPLETED|Overall Study||38
175131|NCT01464827|426791|P5|COMPLETED|Overall Study||72
175132|NCT01464827|426792|P4|COMPLETED|Overall Study||36
175133|NCT01464827|426793|P3|COMPLETED|Overall Study||39
175134|NCT01464827|426794|P2|COMPLETED|Overall Study||36
175135|NCT01464827|426795|P1|COMPLETED|Overall Study||77
175136|NCT01464827|426782|P14|Treated|Overall Study||20
175137|NCT01464827|426783|P13|Treated|Overall Study||23
175138|NCT01464827|426784|P12|Treated|Overall Study||22
175139|NCT01464827|426785|P11|Treated|Overall Study||23
175140|NCT01464827|426786|P10|Treated|Overall Study||45
175141|NCT01464827|426787|P9|Treated|Overall Study||40
175142|NCT01464827|426788|P8|Treated|Overall Study||40
175143|NCT01464827|426789|P7|Treated|Overall Study||40
175144|NCT01464827|426790|P6|Treated|Overall Study||39
175145|NCT01464827|426791|P5|Treated|Overall Study||79
175146|NCT01464827|426792|P4|Treated|Overall Study||40
175147|NCT01464827|426793|P3|Treated|Overall Study||39
175148|NCT01464827|426794|P2|Treated|Overall Study||41
175149|NCT01464827|426795|P1|Treated|Overall Study||80
175150|NCT01464827|426782|P14|STARTED|Overall Study||22
175151|NCT01464827|426783|P13|STARTED|Overall Study||23
175152|NCT01464827|426784|P12|STARTED|Overall Study||23
175153|NCT01464827|426785|P11|STARTED|Overall Study||23
175154|NCT01464827|426786|P10|STARTED|Overall Study||47
175155|NCT01464827|426787|P9|STARTED|Overall Study||40
175156|NCT01464827|426788|P8|STARTED|Overall Study||40
175157|NCT01464827|426789|P7|STARTED|Overall Study||41
175158|NCT01464827|426790|P6|STARTED|Overall Study||39
175159|NCT01464827|426791|P5|STARTED|Overall Study||80
175160|NCT01464827|426792|P4|STARTED|Overall Study||40
175161|NCT01464827|426793|P3|STARTED|Overall Study||39
175162|NCT01464827|426794|P2|STARTED|Overall Study||43
175163|NCT01464827|426795|P1|STARTED|Overall Study||80
175164|NCT01464788|426842|P3|NOT COMPLETED|Overall Study||0
175165|NCT01464788|426843|P2|NOT COMPLETED|Overall Study||2
175166|NCT01464788|426844|P1|NOT COMPLETED|Overall Study||0
175167|NCT01464788|426842|P3|COMPLETED|Overall Study||29
175168|NCT01464788|426843|P2|COMPLETED|Overall Study||29
175169|NCT01464788|426844|P1|COMPLETED|Overall Study||30
175170|NCT01464788|426842|P3|STARTED|Overall Study||29
175171|NCT01464788|426843|P2|STARTED|Overall Study||31
175172|NCT01464788|426844|P1|STARTED|Overall Study||30
175173|NCT01464723|426855|P1|NOT COMPLETED|Overall Study||0
175174|NCT01464723|426855|P1|COMPLETED|Overall Study||0
175175|NCT01464723|426855|P1|STARTED|Overall Study||0
175176|NCT01464619|426864|P2|NOT COMPLETED|Overall Study||4
175177|NCT01464619|426865|P1|NOT COMPLETED|Overall Study||3
175178|NCT01464619|426864|P2|COMPLETED|Overall Study||25
175179|NCT01464619|426865|P1|COMPLETED|Overall Study||29
175180|NCT01464619|426864|P2|STARTED|Overall Study||29
175181|NCT01464619|426865|P1|STARTED|Overall Study||32
175182|NCT01464424|426885|P2|NOT COMPLETED|Period 2, Second 6 Weeks||0
175183|NCT01464424|426886|P1|NOT COMPLETED|Period 2, Second 6 Weeks||0
175184|NCT01464424|426885|P2|COMPLETED|Period 2, Second 6 Weeks||41
175185|NCT01464424|426886|P1|COMPLETED|Period 2, Second 6 Weeks||42
175186|NCT01464424|426885|P2|STARTED|Period 2, Second 6 Weeks||41
175187|NCT01464424|426886|P1|STARTED|Period 2, Second 6 Weeks||42
175188|NCT01464424|426885|P2|NOT COMPLETED|Period 1, First 6 Weeks||1
175189|NCT01464424|426886|P1|NOT COMPLETED|Period 1, First 6 Weeks||0
175190|NCT01464424|426885|P2|COMPLETED|Period 1, First 6 Weeks||41
175191|NCT01464424|426886|P1|COMPLETED|Period 1, First 6 Weeks||42
175192|NCT01464424|426885|P2|STARTED|Period 1, First 6 Weeks||42
175193|NCT01464424|426886|P1|STARTED|Period 1, First 6 Weeks||42
175194|NCT01464359|426894|P1|NOT COMPLETED|Overall Study||0
175195|NCT01464359|426894|P1|COMPLETED|Overall Study||3
175196|NCT01464359|426894|P1|STARTED|Overall Study||3
175197|NCT01464346|426906|P3|NOT COMPLETED|Overall Study||1
175198|NCT01464346|426907|P2|NOT COMPLETED|Overall Study||0
175199|NCT01464346|426908|P1|NOT COMPLETED|Overall Study||0
175200|NCT01464346|426906|P3|COMPLETED|Overall Study||28
175201|NCT01464346|426907|P2|COMPLETED|Overall Study||32
175202|NCT01464346|426908|P1|COMPLETED|Overall Study||29
175203|NCT01464346|426906|P3|STARTED|Overall Study||29
175204|NCT01464346|426907|P2|STARTED|Overall Study||32
175205|NCT01464346|426908|P1|STARTED|Overall Study||29
175206|NCT01464333|426917|P1|NOT COMPLETED|Overall Study||163
175207|NCT01464333|426917|P1|COMPLETED|Overall Study||226
175208|NCT01464333|426917|P1|STARTED|Overall Study||389
175209|NCT01464307|426930|P2|NOT COMPLETED|Open-Label Extension Period||0
175210|NCT01464307|426931|P1|NOT COMPLETED|Open-Label Extension Period||51
175211|NCT01464307|426930|P2|COMPLETED|Open-Label Extension Period||0
175212|NCT01464307|426931|P1|COMPLETED|Open-Label Extension Period||218
175213|NCT01464307|426930|P2|Treated|Open-Label Extension Period||0
175214|NCT01464307|426931|P1|Treated|Open-Label Extension Period||269
175215|NCT01464307|426930|P2|STARTED|Open-Label Extension Period||0
175216|NCT01464307|426931|P1|STARTED|Open-Label Extension Period||269
175217|NCT01464307|426930|P2|NOT COMPLETED|Main Period||5
175218|NCT01464307|426931|P1|NOT COMPLETED|Main Period||15
175219|NCT01464307|426930|P2|COMPLETED|Main Period||140
175220|NCT01464307|426931|P1|COMPLETED|Main Period||129
175221|NCT01464307|426930|P2|Treated|Main Period||145
175222|NCT01464307|426931|P1|Treated|Main Period||144
175223|NCT01464307|426930|P2|STARTED|Main Period||145
175224|NCT01464307|426931|P1|STARTED|Main Period||144
175225|NCT01464255|426946|P2|NOT COMPLETED|Overall Study||1
175226|NCT01464255|426947|P1|NOT COMPLETED|Overall Study||0
175227|NCT01464255|426946|P2|COMPLETED|Overall Study||24
175228|NCT01464255|426947|P1|COMPLETED|Overall Study||25
175229|NCT01464255|426946|P2|STARTED|Overall Study||25
175230|NCT01464255|426947|P1|STARTED|Overall Study||25
175231|NCT01464229|426972|P2|NOT COMPLETED|Overall Study||2
175232|NCT01464229|426973|P1|NOT COMPLETED|Overall Study||5
175233|NCT01464229|426972|P2|COMPLETED|Overall Study||8
175234|NCT01464229|426973|P1|COMPLETED|Overall Study||5
175235|NCT01464229|426972|P2|STARTED|Overall Study||10
175236|NCT01464229|426973|P1|STARTED|Overall Study||10
175237|NCT01464190|426981|P2|NOT COMPLETED|Overall Study||41
175238|NCT01464190|426982|P1|NOT COMPLETED|Overall Study||69
175239|NCT01464190|426981|P2|COMPLETED|Overall Study||227
175240|NCT01464190|426982|P1|COMPLETED|Overall Study||322
175241|NCT01464190|426981|P2|STARTED|Overall Study||268
175242|NCT01464190|426982|P1|STARTED|Overall Study||391
175243|NCT01464021|426992|P1|NOT COMPLETED|Overall Study||26
175244|NCT01464021|426992|P1|COMPLETED|Overall Study||0
175245|NCT01464021|426992|P1|STARTED|Overall Study||26
175246|NCT01463982|427008|P4|NOT COMPLETED|Overall Study||0
175247|NCT01463982|427009|P3|NOT COMPLETED|Overall Study||2
175248|NCT01463982|427010|P2|NOT COMPLETED|Overall Study||1
175249|NCT01463982|427011|P1|NOT COMPLETED|Overall Study||0
175250|NCT01463982|427008|P4|COMPLETED|Overall Study||6
175251|NCT01463982|427009|P3|COMPLETED|Overall Study||2
175252|NCT01463982|427010|P2|COMPLETED|Overall Study||7
175253|NCT01463982|427011|P1|COMPLETED|Overall Study||3
175254|NCT01463982|427008|P4|STARTED|Overall Study||6
175255|NCT01463982|427009|P3|STARTED|Overall Study||4
175256|NCT01463982|427010|P2|STARTED|Overall Study||8
175257|NCT01463982|427011|P1|STARTED|Overall Study||3
175258|NCT01463878|427027|P2|NOT COMPLETED|Overall Study||2
175259|NCT01463878|427028|P1|NOT COMPLETED|Overall Study||2
175260|NCT01463878|427027|P2|COMPLETED|Overall Study||7
175261|NCT01463878|427028|P1|COMPLETED|Overall Study||7
175262|NCT01463878|427027|P2|STARTED|Overall Study||9
175263|NCT01463878|427028|P1|STARTED|Overall Study||9
175264|NCT01463696|427042|P8|NOT COMPLETED|Overall Study||4
175265|NCT01463696|427043|P7|NOT COMPLETED|Overall Study||10
175266|NCT01463696|427044|P6|NOT COMPLETED|Overall Study||3
175267|NCT01463696|427045|P5|NOT COMPLETED|Overall Study||1
175268|NCT01463696|427046|P4|NOT COMPLETED|Overall Study||4
175269|NCT01463696|427047|P3|NOT COMPLETED|Overall Study||1
175270|NCT01463696|427048|P2|NOT COMPLETED|Overall Study||2
175271|NCT01463696|427049|P1|NOT COMPLETED|Overall Study||0
175272|NCT01463696|427042|P8|COMPLETED|Overall Study||2
175273|NCT01463696|427043|P7|COMPLETED|Overall Study||6
175274|NCT01463696|427044|P6|COMPLETED|Overall Study||3
175275|NCT01463696|427045|P5|COMPLETED|Overall Study||2
175276|NCT01463696|427046|P4|COMPLETED|Overall Study||3
175277|NCT01463696|427047|P3|COMPLETED|Overall Study||2
175278|NCT01463696|427048|P2|COMPLETED|Overall Study||4
175279|NCT01463696|427049|P1|COMPLETED|Overall Study||1
175280|NCT01463696|427042|P8|Treated|Overall Study||6
175281|NCT01463696|427043|P7|Treated|Overall Study||15
175282|NCT01463696|427044|P6|Treated|Overall Study||6
175283|NCT01463696|427045|P5|Treated|Overall Study||3
175284|NCT01463696|427046|P4|Treated|Overall Study||7
175285|NCT01463696|427047|P3|Treated|Overall Study||3
175286|NCT01463696|427048|P2|Treated|Overall Study||6
175287|NCT01463696|427049|P1|Treated|Overall Study||1
175288|NCT01463696|427042|P8|STARTED|Overall Study||6
175289|NCT01463696|427043|P7|STARTED|Overall Study||16
175290|NCT01463696|427044|P6|STARTED|Overall Study||6
175291|NCT01463696|427045|P5|STARTED|Overall Study||3
175292|NCT01463696|427046|P4|STARTED|Overall Study||7
175293|NCT01463696|427047|P3|STARTED|Overall Study||3
175294|NCT01463696|427048|P2|STARTED|Overall Study||6
175295|NCT01463696|427049|P1|STARTED|Overall Study||1
175296|NCT01463683|427102|P3|NOT COMPLETED|Overall Study||11
175297|NCT01463683|427103|P2|NOT COMPLETED|Overall Study||31
175298|NCT01463683|427104|P1|NOT COMPLETED|Overall Study||19
175299|NCT01463683|427102|P3|COMPLETED|Overall Study||93
175300|NCT01463683|427103|P2|COMPLETED|Overall Study||278
175301|NCT01463683|427104|P1|COMPLETED|Overall Study||290
175302|NCT01463683|427102|P3|Received Vaccination 3 (Month 6)|Overall Study||93
175303|NCT01463683|427103|P2|Received Vaccination 3 (Month 6)|Overall Study||281
175304|NCT01463683|427104|P1|Received Vaccination 3 (Month 6)|Overall Study||290
175305|NCT01463683|427102|P3|Received Vaccination 2 (Month 1)|Overall Study||103
175306|NCT01463683|427103|P2|Received Vaccination 2 (Month 1)|Overall Study||300
175307|NCT01463683|427104|P1|Received Vaccination 2 (Month 1)|Overall Study||302
175308|NCT01463683|427102|P3|Received Vaccination 1 (Day 1)|Overall Study||104
175309|NCT01463683|427103|P2|Received Vaccination 1 (Day 1)|Overall Study||308
175310|NCT01463683|427104|P1|Received Vaccination 1 (Day 1)|Overall Study||309
175311|NCT01463683|427102|P3|STARTED|Overall Study||104
175312|NCT01463683|427103|P2|STARTED|Overall Study||309
175313|NCT01463683|427104|P1|STARTED|Overall Study||309
175314|NCT01463631|427121|P4|NOT COMPLETED|Overall Study||6
175315|NCT01463631|427122|P3|NOT COMPLETED|Overall Study||1
175316|NCT01463631|427123|P2|NOT COMPLETED|Overall Study||0
175317|NCT01463631|427124|P1|NOT COMPLETED|Overall Study||0
175318|NCT01463631|427121|P4|COMPLETED|Overall Study||9
175319|NCT01463631|427122|P3|COMPLETED|Overall Study||4
175320|NCT01463631|427123|P2|COMPLETED|Overall Study||4
175321|NCT01463631|427124|P1|COMPLETED|Overall Study||3
175322|NCT01463631|427121|P4|Received at Least One Dose of Study Drug|Overall Study||15
175323|NCT01463631|427122|P3|Received at Least One Dose of Study Drug|Overall Study||5
175324|NCT01463631|427123|P2|Received at Least One Dose of Study Drug|Overall Study||4
175325|NCT01463631|427124|P1|Received at Least One Dose of Study Drug|Overall Study||3
175326|NCT01463631|427121|P4|STARTED|Overall Study||15
175327|NCT01463631|427122|P3|STARTED|Overall Study||5
175328|NCT01463631|427123|P2|STARTED|Overall Study||4
175329|NCT01463631|427124|P1|STARTED|Overall Study||3
175330|NCT01463527|427146|P2|NOT COMPLETED|Overall Study||7
175331|NCT01463527|427147|P1|NOT COMPLETED|Overall Study||6
175332|NCT01463527|427146|P2|COMPLETED|Overall Study||77
175333|NCT01463527|427147|P1|COMPLETED|Overall Study||77
175334|NCT01463527|427146|P2|STARTED|Overall Study||84
175335|NCT01463527|427147|P1|STARTED|Overall Study||83
175336|NCT01463384|427155|P1|NOT COMPLETED|Overall Study||0
175337|NCT01463384|427155|P1|COMPLETED|Overall Study||13
175338|NCT01463384|427155|P1|STARTED|Overall Study||13
175339|NCT01463293|427170|P3|NOT COMPLETED|Overall Study||12
175340|NCT01463293|427171|P2|NOT COMPLETED|Overall Study||16
175341|NCT01463293|427172|P1|NOT COMPLETED|Overall Study||6
175342|NCT01463293|427170|P3|COMPLETED|Overall Study||59
175343|NCT01463293|427171|P2|COMPLETED|Overall Study||63
175344|NCT01463293|427172|P1|COMPLETED|Overall Study||68
175345|NCT01463293|427170|P3|STARTED|Overall Study||71
175346|NCT01463293|427171|P2|STARTED|Overall Study||79
175347|NCT01463293|427172|P1|STARTED|Overall Study||74
175348|NCT01463202|427182|P2|NOT COMPLETED|Overall Study||0
175349|NCT01463202|427183|P1|NOT COMPLETED|Overall Study||0
175350|NCT01463202|427182|P2|COMPLETED|Overall Study||78
175351|NCT01463202|427183|P1|COMPLETED|Overall Study||79
175352|NCT01463202|427182|P2|STARTED|Overall Study||78
175353|NCT01463202|427183|P1|STARTED|Overall Study||79
175354|NCT01463111|427195|P1|NOT COMPLETED|Overall Study||9
175355|NCT01463111|427195|P1|COMPLETED|Overall Study||17
175356|NCT01463111|427195|P1|STARTED|Overall Study||26
175357|NCT01463033|427205|P2|NOT COMPLETED|Overall Study||6
175358|NCT01463033|427206|P1|NOT COMPLETED|Overall Study||7
175359|NCT01463033|427205|P2|COMPLETED|Overall Study|2 deaths, 4 lost to follow up|54
175360|NCT01463033|427206|P1|COMPLETED|Overall Study|3 deaths, 4 lost to follow up|59
175361|NCT01463033|427205|P2|STARTED|Overall Study||60
175362|NCT01463033|427206|P1|STARTED|Overall Study||66
175363|NCT01463007|427213|P1|NOT COMPLETED|Overall Study||1
175364|NCT01463007|427213|P1|COMPLETED|Overall Study||40
175365|NCT01463007|427213|P1|STARTED|Overall Study||41
175366|NCT01462942|427224|P5|NOT COMPLETED|Overall Study||45
175367|NCT01462942|427225|P4|NOT COMPLETED|Overall Study||50
175368|NCT01462942|427226|P3|NOT COMPLETED|Overall Study||40
175369|NCT01462942|427227|P2|NOT COMPLETED|Overall Study||34
175370|NCT01462942|427228|P1|NOT COMPLETED|Overall Study||34
175371|NCT01462942|427224|P5|COMPLETED|Overall Study||339
175372|NCT01462942|427225|P4|COMPLETED|Overall Study||335
175373|NCT01462942|427226|P3|COMPLETED|Overall Study||341
175374|NCT01462942|427227|P2|COMPLETED|Overall Study||351
175375|NCT01462942|427228|P1|COMPLETED|Overall Study||160
175376|NCT01462942|427224|P5|STARTED|Overall Study||384
175377|NCT01462942|427225|P4|STARTED|Overall Study||385
175378|NCT01462942|427226|P3|STARTED|Overall Study||381
175379|NCT01462942|427227|P2|STARTED|Overall Study||385
175380|NCT01462942|427228|P1|STARTED|Overall Study||194
175381|NCT01462929|427258|P3|NOT COMPLETED|Overall Study||5
175382|NCT01462929|427259|P2|NOT COMPLETED|Overall Study||4
175383|NCT01462929|427260|P1|NOT COMPLETED|Overall Study||5
175384|NCT01462929|427258|P3|COMPLETED|Overall Study||80
175385|NCT01462929|427259|P2|COMPLETED|Overall Study||154
175386|NCT01462929|427260|P1|COMPLETED|Overall Study||166
175387|NCT01462929|427258|P3|STARTED|Overall Study||85
175388|NCT01462929|427259|P2|STARTED|Overall Study||158
175389|NCT01462929|427260|P1|STARTED|Overall Study||171
175390|NCT01462877|427271|P1|NOT COMPLETED|Overall Study||71
175391|NCT01462877|427271|P1|COMPLETED|Overall Study||435
175392|NCT01462877|427271|P1|Per-protocol Set|Overall Study||364
175393|NCT01462877|427271|P1|Full Analysis Set|Overall Study||468
175394|NCT01462877|427271|P1|Safety Set|Overall Study||492
175395|NCT01462877|427271|P1|STARTED|Overall Study||506
175396|NCT01462812|427287|P2|NOT COMPLETED|Overall Study||1
175397|NCT01462812|427288|P1|NOT COMPLETED|Overall Study||0
175398|NCT01462812|427287|P2|COMPLETED|Overall Study||111
175399|NCT01462812|427288|P1|COMPLETED|Overall Study||111
175400|NCT01462812|427287|P2|STARTED|Overall Study||112
175401|NCT01462812|427288|P1|STARTED|Overall Study||111
175402|NCT01462773|427294|P1|NOT COMPLETED|Overall Study||0
175403|NCT01462773|427294|P1|COMPLETED|Overall Study||16
175404|NCT01462773|427294|P1|STARTED|Overall Study||16
175405|NCT01462695|427301|P2|NOT COMPLETED|Overall Study||13
175406|NCT01462695|427302|P1|NOT COMPLETED|Overall Study||17
175407|NCT01462695|427301|P2|COMPLETED|Overall Study||0
175408|NCT01462695|427302|P1|COMPLETED|Overall Study||0
175409|NCT01462695|427301|P2|STARTED|Overall Study||13
175410|NCT01462695|427302|P1|STARTED|Overall Study||17
175411|NCT01462565|427308|P1|NOT COMPLETED|Overall Study||0
175412|NCT01462565|427308|P1|COMPLETED|Overall Study||16
175413|NCT01462565|427308|P1|STARTED|Overall Study||16
175414|NCT01462435|427330|P4|NOT COMPLETED|Overall Study||5
175415|NCT01462435|427331|P3|NOT COMPLETED|Overall Study||1
175416|NCT01462435|427332|P2|NOT COMPLETED|Overall Study||0
175417|NCT01462435|427333|P1|NOT COMPLETED|Overall Study||1
175418|NCT01462435|427330|P4|COMPLETED|Overall Study||101
175419|NCT01462435|427331|P3|COMPLETED|Overall Study||106
175420|NCT01462435|427332|P2|COMPLETED|Overall Study||109
175421|NCT01462435|427333|P1|COMPLETED|Overall Study||105
175422|NCT01462435|427330|P4|STARTED|Overall Study||106
175423|NCT01462435|427331|P3|STARTED|Overall Study||107
175424|NCT01462435|427332|P2|STARTED|Overall Study||109
175425|NCT01462435|427333|P1|STARTED|Overall Study||106
175426|NCT01462370|427371|P2|NOT COMPLETED|Overall Study||5
175427|NCT01462370|427372|P1|NOT COMPLETED|Overall Study||1
175428|NCT01462370|427371|P2|COMPLETED|Overall Study||65
175429|NCT01462370|427372|P1|COMPLETED|Overall Study||68
175430|NCT01462370|427371|P2|STARTED|Overall Study||70
175431|NCT01462370|427372|P1|STARTED|Overall Study||69
175432|NCT01462357|427407|P3|NOT COMPLETED|Overall Study||12
175433|NCT01462357|427408|P2|NOT COMPLETED|Overall Study||19
175434|NCT01462357|427409|P1|NOT COMPLETED|Overall Study||8
175435|NCT01462357|427407|P3|COMPLETED|Overall Study||346
175436|NCT01462357|427408|P2|COMPLETED|Overall Study||339
175437|NCT01462357|427409|P1|COMPLETED|Overall Study||351
175438|NCT01462357|427407|P3|STARTED|Overall Study||358
175439|NCT01462357|427408|P2|STARTED|Overall Study||358
175440|NCT01462357|427409|P1|STARTED|Overall Study||359
175441|NCT01462344|427482|P2|NOT COMPLETED|Overall Study||350
175442|NCT01462344|427483|P1|NOT COMPLETED|Overall Study||383
175443|NCT01462344|427482|P2|COMPLETED|Overall Study||2751
175444|NCT01462344|427483|P1|COMPLETED|Overall Study||2724
175445|NCT01462344|427482|P2|STARTED|Overall Study||3101
175446|NCT01462344|427483|P1|STARTED|Overall Study||3107
175447|NCT01462318|427505|P3|NOT COMPLETED|Extension Phase||45
175448|NCT01462318|427506|P2|NOT COMPLETED|Extension Phase||0
175449|NCT01462318|427507|P1|NOT COMPLETED|Extension Phase||0
175450|NCT01462318|427505|P3|COMPLETED|Extension Phase||70
175451|NCT01462318|427506|P2|COMPLETED|Extension Phase||0
175452|NCT01462318|427507|P1|COMPLETED|Extension Phase||0
175453|NCT01462318|427505|P3|STARTED|Extension Phase|10 participants from the Main Study did not enter the Extension Phase.|115
175454|NCT01462318|427506|P2|STARTED|Extension Phase|20 participants from the TP-DI Study entered the Extension Phase|0
175455|NCT01462318|427507|P1|STARTED|Extension Phase|95 participants from the Main Study entered the Extension Phase|0
175456|NCT01462318|427505|P3|NOT COMPLETED|Main Study / TP-DI Study||0
175457|NCT01462318|427506|P2|NOT COMPLETED|Main Study / TP-DI Study||0
175458|NCT01462318|427507|P1|NOT COMPLETED|Main Study / TP-DI Study||8
175459|NCT01462318|427505|P3|COMPLETED|Main Study / TP-DI Study||0
175460|NCT01462318|427506|P2|COMPLETED|Main Study / TP-DI Study||20
175461|NCT01462318|427507|P1|COMPLETED|Main Study / TP-DI Study||105
175462|NCT01462318|427505|P3|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
175463|NCT01462318|427506|P2|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
175464|NCT01462318|427507|P1|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||26
175465|NCT01462318|427505|P3|STARTED|Main Study / TP-DI Study||0
175466|NCT01462318|427506|P2|STARTED|Main Study / TP-DI Study||20
175467|NCT01462318|427507|P1|STARTED|Main Study / TP-DI Study||113
175468|NCT01462305|427526|P2|NOT COMPLETED|Overall Study||4
175469|NCT01462305|427527|P1|NOT COMPLETED|Overall Study||2
175470|NCT01462305|427526|P2|COMPLETED|Overall Study||13
175471|NCT01462305|427527|P1|COMPLETED|Overall Study||16
175472|NCT01462305|427526|P2|STARTED|Overall Study||17
175473|NCT01462305|427527|P1|STARTED|Overall Study||18
175474|NCT01462292|427540|P3|NOT COMPLETED|Overall Study||0
175475|NCT01462292|427541|P2|NOT COMPLETED|Overall Study||0
175476|NCT01462292|427542|P1|NOT COMPLETED|Overall Study||0
175477|NCT01462292|427540|P3|COMPLETED|Overall Study||18
175478|NCT01462292|427541|P2|COMPLETED|Overall Study||17
175479|NCT01462292|427542|P1|COMPLETED|Overall Study||16
175480|NCT01462292|427540|P3|STARTED|Overall Study||18
175481|NCT01462292|427541|P2|STARTED|Overall Study||17
175482|NCT01462292|427542|P1|STARTED|Overall Study||16
175483|NCT01462279|427601|P1|NOT COMPLETED|Overall Study||3
175484|NCT01462279|427601|P1|COMPLETED|Overall Study||17
175485|NCT01462279|427601|P1|STARTED|Overall Study||20
175486|NCT01462266|427608|P2|NOT COMPLETED|Overall Study||27
175487|NCT01462266|427609|P1|NOT COMPLETED|Overall Study||35
175488|NCT01462266|427608|P2|COMPLETED|Overall Study||303
175489|NCT01462266|427609|P1|COMPLETED|Overall Study||295
175490|NCT01462266|427608|P2|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
175491|NCT01462266|427609|P1|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
175492|NCT01462266|427608|P2|STARTED|Overall Study||330
175493|NCT01462266|427609|P1|STARTED|Overall Study||330
175494|NCT01462253|427623|P1|NOT COMPLETED|Overall Study||8
175495|NCT01462253|427623|P1|COMPLETED|Overall Study||27
175496|NCT01462253|427623|P1|STARTED|Overall Study||35
175497|NCT01462227|427634|P4|NOT COMPLETED|Second Assignment||0
175498|NCT01462227|427635|P3|NOT COMPLETED|Second Assignment||1
175499|NCT01462227|427636|P2|NOT COMPLETED|Second Assignment||1
175500|NCT01462227|427637|P1|NOT COMPLETED|Second Assignment||1
175501|NCT01462227|427634|P4|COMPLETED|Second Assignment||5
175502|NCT01462227|427635|P3|COMPLETED|Second Assignment||5
175503|NCT01462227|427636|P2|COMPLETED|Second Assignment||1
175504|NCT01462227|427637|P1|COMPLETED|Second Assignment||3
175505|NCT01462227|427634|P4|STARTED|Second Assignment||5
175506|NCT01462227|427635|P3|STARTED|Second Assignment||6
175507|NCT01462227|427636|P2|STARTED|Second Assignment||2
175508|NCT01462227|427637|P1|STARTED|Second Assignment||4
175509|NCT01462227|427634|P4|NOT COMPLETED|First Assignment||0
175510|NCT01462227|427635|P3|NOT COMPLETED|First Assignment||0
175511|NCT01462227|427636|P2|NOT COMPLETED|First Assignment||0
175512|NCT01462227|427637|P1|NOT COMPLETED|First Assignment||0
175513|NCT01462227|427634|P4|COMPLETED|First Assignment||5
175514|NCT01462227|427635|P3|COMPLETED|First Assignment||6
175515|NCT01462227|427636|P2|COMPLETED|First Assignment||2
175516|NCT01462227|427637|P1|COMPLETED|First Assignment||4
175517|NCT01462227|427634|P4|STARTED|First Assignment||5
175518|NCT01462227|427635|P3|STARTED|First Assignment||6
175519|NCT01462227|427636|P2|STARTED|First Assignment||2
175520|NCT01462227|427637|P1|STARTED|First Assignment||4
175521|NCT01462162|427655|P1|NOT COMPLETED|Overall Study||12
175522|NCT01462162|427655|P1|COMPLETED|Overall Study||108
175523|NCT01462162|427655|P1|STARTED|Overall Study||120
175524|NCT01462084|427680|P2|NOT COMPLETED|Overall Study||1
175525|NCT01462084|427681|P1|NOT COMPLETED|Overall Study||2
175526|NCT01462084|427680|P2|COMPLETED|Overall Study||9
175527|NCT01462084|427681|P1|COMPLETED|Overall Study||9
175528|NCT01462084|427680|P2|Included for Analysis|Overall Study||9
175529|NCT01462084|427681|P1|Included for Analysis|Overall Study||9
175530|NCT01462084|427680|P2|STARTED|Overall Study||10
175531|NCT01462084|427681|P1|STARTED|Overall Study||11
175532|NCT01462045|427692|P3|NOT COMPLETED|Overall Study||0
175533|NCT01462045|427693|P2|NOT COMPLETED|Overall Study||1
175534|NCT01462045|427694|P1|NOT COMPLETED|Overall Study||0
175535|NCT01462045|427692|P3|COMPLETED|Overall Study||7
175536|NCT01462045|427693|P2|COMPLETED|Overall Study||10
175537|NCT01462045|427694|P1|COMPLETED|Overall Study||11
175538|NCT01462045|427692|P3|STARTED|Overall Study||7
175539|NCT01462045|427693|P2|STARTED|Overall Study||11
175540|NCT01462045|427694|P1|STARTED|Overall Study||11
175541|NCT01461993|427708|P3|NOT COMPLETED|Overall Study||64
175542|NCT01461993|427709|P2|NOT COMPLETED|Overall Study||157
175543|NCT01461993|427710|P1|NOT COMPLETED|Overall Study||151
175544|NCT01461993|427708|P3|COMPLETED|Overall Study||438
175545|NCT01461993|427709|P2|COMPLETED|Overall Study||841
175546|NCT01461993|427710|P1|COMPLETED|Overall Study||848
175547|NCT01461993|427708|P3|STARTED|Overall Study||502
175548|NCT01461993|427709|P2|STARTED|Overall Study||998
175549|NCT01461993|427710|P1|STARTED|Overall Study||999
175550|NCT01461980|427735|P3|NOT COMPLETED|Overall Study||165
175551|NCT01461980|427736|P2|NOT COMPLETED|Overall Study||145
175552|NCT01461980|427737|P1|NOT COMPLETED|Overall Study||166
175553|NCT01461980|427735|P3|COMPLETED|Overall Study||717
175554|NCT01461980|427736|P2|COMPLETED|Overall Study||733
175555|NCT01461980|427737|P1|COMPLETED|Overall Study||722
175556|NCT01461980|427735|P3|Vaccination 3|Overall Study||748
175557|NCT01461980|427736|P2|Vaccination 3|Overall Study||777
175558|NCT01461980|427737|P1|Vaccination 3|Overall Study||757
175559|NCT01461980|427735|P3|Vaccination 2|Overall Study||799
175560|NCT01461980|427736|P2|Vaccination 2|Overall Study||819
175561|NCT01461980|427737|P1|Vaccination 2|Overall Study||802
175562|NCT01461980|427735|P3|Vaccination 1|Overall Study||875
175563|NCT01461980|427736|P2|Vaccination 1|Overall Study||870
175564|NCT01461980|427737|P1|Vaccination 1|Overall Study||884
175565|NCT01461980|427735|P3|STARTED|Overall Study||882
175566|NCT01461980|427736|P2|STARTED|Overall Study||878
175567|NCT01461980|427737|P1|STARTED|Overall Study||888
175568|NCT01461928|427767|P3|NOT COMPLETED|Maintenance II (15 Months)||27
175569|NCT01461928|427768|P2|NOT COMPLETED|Maintenance II (15 Months)||23
175570|NCT01461928|427769|P1|NOT COMPLETED|Maintenance II (15 Months)||0
175571|NCT01461928|427767|P3|COMPLETED|Maintenance II (15 Months)||111
175572|NCT01461928|427768|P2|COMPLETED|Maintenance II (15 Months)|6 participants did not receive treatment|115
175573|NCT01461928|427769|P1|COMPLETED|Maintenance II (15 Months)||0
175574|NCT01461928|427767|P3|STARTED|Maintenance II (15 Months)||138
175575|NCT01461928|427768|P2|STARTED|Maintenance II (15 Months)||138
175576|NCT01461928|427769|P1|STARTED|Maintenance II (15 Months)||0
175577|NCT01461928|427767|P3|NOT COMPLETED|Maintenance I (24 Months)||0
175578|NCT01461928|427768|P2|NOT COMPLETED|Maintenance I (24 Months)||0
175579|NCT01461928|427769|P1|NOT COMPLETED|Maintenance I (24 Months)||218
175580|NCT01461928|427767|P3|COMPLETED|Maintenance I (24 Months)||0
175581|NCT01461928|427768|P2|COMPLETED|Maintenance I (24 Months)||0
175582|NCT01461928|427769|P1|COMPLETED|Maintenance I (24 Months)|Responders during 2 yrs Maint I treatment|276
175583|NCT01461928|427767|P3|STARTED|Maintenance I (24 Months)||0
175584|NCT01461928|427768|P2|STARTED|Maintenance I (24 Months)||0
175585|NCT01461928|427769|P1|STARTED|Maintenance I (24 Months)||494
175586|NCT01461928|427767|P3|NOT COMPLETED|Induction (up to 8 Months)||0
175587|NCT01461928|427768|P2|NOT COMPLETED|Induction (up to 8 Months)||0
175588|NCT01461928|427769|P1|NOT COMPLETED|Induction (up to 8 Months)||198
175589|NCT01461928|427767|P3|COMPLETED|Induction (up to 8 Months)||0
175590|NCT01461928|427768|P2|COMPLETED|Induction (up to 8 Months)||0
175591|NCT01461928|427769|P1|COMPLETED|Induction (up to 8 Months)||494
175592|NCT01461928|427767|P3|STARTED|Induction (up to 8 Months)||0
175593|NCT01461928|427768|P2|STARTED|Induction (up to 8 Months)||0
175594|NCT01461928|427769|P1|STARTED|Induction (up to 8 Months)||692
175595|NCT01461863|427790|P2|NOT COMPLETED|Overall Study||0
175596|NCT01461863|427791|P1|NOT COMPLETED|Overall Study||0
175597|NCT01461863|427790|P2|COMPLETED|Overall Study||48
175598|NCT01461863|427791|P1|COMPLETED|Overall Study||48
175599|NCT01461863|427790|P2|STARTED|Overall Study||48
175600|NCT01461863|427791|P1|STARTED|Overall Study||48
175601|NCT01461824|427802|P3|NOT COMPLETED|Overall Study||3
175602|NCT01461824|427803|P2|NOT COMPLETED|Overall Study||4
175603|NCT01461824|427804|P1|NOT COMPLETED|Overall Study||2
175604|NCT01461824|427802|P3|COMPLETED|Overall Study||8
175605|NCT01461824|427803|P2|COMPLETED|Overall Study||7
175606|NCT01461824|427804|P1|COMPLETED|Overall Study||10
175607|NCT01461824|427802|P3|STARTED|Overall Study||11
175608|NCT01461824|427803|P2|STARTED|Overall Study||11
175609|NCT01461824|427804|P1|STARTED|Overall Study||12
175610|NCT01461811|427820|P2|NOT COMPLETED|Overall Study||3
175611|NCT01461811|427821|P1|NOT COMPLETED|Overall Study||4
175612|NCT01461811|427820|P2|COMPLETED|Overall Study||46
175613|NCT01461811|427821|P1|COMPLETED|Overall Study||91
175614|NCT01461811|427820|P2|STARTED|Overall Study||49
175615|NCT01461811|427821|P1|STARTED|Overall Study||95
175616|NCT01461733|427851|P2|NOT COMPLETED|Overall Study||4
175617|NCT01461733|427852|P1|NOT COMPLETED|Overall Study||4
175618|NCT01461733|427851|P2|COMPLETED|Overall Study||8
175619|NCT01461733|427852|P1|COMPLETED|Overall Study||8
175620|NCT01461733|427851|P2|STARTED|Overall Study||12
175621|NCT01461733|427852|P1|STARTED|Overall Study||12
175622|NCT01461707|427860|P2|NOT COMPLETED|Overall Study||0
175623|NCT01461707|427861|P1|NOT COMPLETED|Overall Study||1
175624|NCT01461707|427860|P2|COMPLETED|Overall Study||15
175625|NCT01461707|427861|P1|COMPLETED|Overall Study||14
175626|NCT01461707|427860|P2|STARTED|Overall Study||15
175627|NCT01461707|427861|P1|STARTED|Overall Study||15
175628|NCT01461668|427871|P2|NOT COMPLETED|Overall Study||1
175629|NCT01461668|427872|P1|NOT COMPLETED|Overall Study||2
175630|NCT01461668|427871|P2|COMPLETED|Overall Study||25
175631|NCT01461668|427872|P1|COMPLETED|Overall Study||25
175632|NCT01461668|427871|P2|STARTED|Overall Study||26
175633|NCT01461668|427872|P1|STARTED|Overall Study||27
175634|NCT01461655|427878|P1|NOT COMPLETED|Overall Study||0
175635|NCT01461655|427878|P1|COMPLETED|Overall Study||40
175636|NCT01461655|427878|P1|STARTED|Overall Study||40
175637|NCT01461551|427898|P3|NOT COMPLETED|Overall Study||2
175638|NCT01461551|427899|P2|NOT COMPLETED|Overall Study||1
175639|NCT01461551|427900|P1|NOT COMPLETED|Overall Study||2
175640|NCT01461551|427898|P3|COMPLETED|Overall Study||33
175641|NCT01461551|427899|P2|COMPLETED|Overall Study||34
175642|NCT01461551|427900|P1|COMPLETED|Overall Study||33
175643|NCT01461551|427898|P3|STARTED|Overall Study||35
175644|NCT01461551|427899|P2|STARTED|Overall Study||35
175645|NCT01461551|427900|P1|STARTED|Overall Study||35
175646|NCT01461538|427911|P3|NOT COMPLETED|Overall Study||2
175647|NCT01461538|427912|P2|NOT COMPLETED|Overall Study||8
175648|NCT01461538|427913|P1|NOT COMPLETED|Overall Study||18
175649|NCT01461538|427911|P3|COMPLETED|Overall Study||7
175650|NCT01461538|427912|P2|COMPLETED|Overall Study||20
175651|NCT01461538|427913|P1|COMPLETED|Overall Study||28
175652|NCT01461538|427911|P3|STARTED|Overall Study||9
175653|NCT01461538|427912|P2|STARTED|Overall Study||28
175654|NCT01461538|427913|P1|STARTED|Overall Study||46
175655|NCT01461499|427951|P2|NOT COMPLETED|Overall Study||4
175656|NCT01461499|427952|P1|NOT COMPLETED|Overall Study||8
175657|NCT01461499|427951|P2|COMPLETED|Overall Study||114
175658|NCT01461499|427952|P1|COMPLETED|Overall Study||111
175659|NCT01461499|427951|P2|STARTED|Overall Study||118
175660|NCT01461499|427952|P1|STARTED|Overall Study||119
175661|NCT01461473|427962|P2|NOT COMPLETED|Overall Study||4
175662|NCT01461473|427963|P1|NOT COMPLETED|Overall Study||5
175663|NCT01461473|427962|P2|COMPLETED|Overall Study||55
175664|NCT01461473|427963|P1|COMPLETED|Overall Study||67
175665|NCT01461473|427962|P2|STARTED|Overall Study||59
175666|NCT01461473|427963|P1|STARTED|Overall Study||72
175667|NCT01461369|427982|P3|NOT COMPLETED|Overall Study||17
175668|NCT01461369|427983|P2|NOT COMPLETED|Overall Study||17
175669|NCT01461369|427984|P1|NOT COMPLETED|Overall Study||13
175670|NCT01461369|427982|P3|COMPLETED|Overall Study||86
175671|NCT01461369|427983|P2|COMPLETED|Overall Study||81
175672|NCT01461369|427984|P1|COMPLETED|Overall Study||91
175673|NCT01461369|427982|P3|STARTED|Overall Study||103
175674|NCT01461369|427983|P2|STARTED|Overall Study||98
175675|NCT01461369|427984|P1|STARTED|Overall Study||104
175676|NCT01461096|428009|P2|NOT COMPLETED|Overall Study||61
175677|NCT01461096|428010|P1|NOT COMPLETED|Overall Study||62
175678|NCT01461096|428009|P2|COMPLETED|Overall Study||226
175679|NCT01461096|428010|P1|COMPLETED|Overall Study||226
175680|NCT01461096|428009|P2|Did Not Start Treatment|Overall Study|Randomized but never started treatment and was discontinued from the study|1
175681|NCT01461096|428010|P1|Did Not Start Treatment|Overall Study||0
175682|NCT01461096|428009|P2|STARTED|Overall Study||287
175683|NCT01461096|428010|P1|STARTED|Overall Study||288
175684|NCT01461057|428026|P2|NOT COMPLETED|Overall Study||15
175685|NCT01461057|428027|P1|NOT COMPLETED|Overall Study||15
175686|NCT01461057|428026|P2|COMPLETED|Overall Study||0
175687|NCT01461057|428027|P1|COMPLETED|Overall Study||0
175688|NCT01461057|428026|P2|STARTED|Overall Study||15
175689|NCT01461057|428027|P1|STARTED|Overall Study||15
175690|NCT01461044|428037|P2|NOT COMPLETED|Overall Study||40
175691|NCT01461044|428038|P1|NOT COMPLETED|Overall Study||70
175692|NCT01461044|428037|P2|COMPLETED|Overall Study||37
175693|NCT01461044|428038|P1|COMPLETED|Overall Study||80
175694|NCT01461044|428037|P2|Participants Alive at Inclusion|Overall Study||58
175695|NCT01461044|428038|P1|Participants Alive at Inclusion|Overall Study||127
175696|NCT01461044|428037|P2|STARTED|Overall Study||77
175697|NCT01461044|428038|P1|STARTED|Overall Study||150
175698|NCT01461005|428111|P1|NOT COMPLETED|Overall Study||1
175699|NCT01461005|428111|P1|COMPLETED|Overall Study||0
175700|NCT01461005|428111|P1|STARTED|Overall Study||1
175701|NCT01460940|428120|P1|NOT COMPLETED|Overall Study||0
175702|NCT01460940|428120|P1|COMPLETED|Overall Study||24
175703|NCT01460940|428120|P1|STARTED|Overall Study||24
175704|NCT01460927|428126|P1|NOT COMPLETED|Overall Study||0
175705|NCT01460927|428126|P1|COMPLETED|Overall Study||25
175706|NCT01460927|428126|P1|STARTED|Overall Study||25
175707|NCT01460901|428134|P1|NOT COMPLETED|Overall Study||2
175708|NCT01460901|428134|P1|COMPLETED|Overall Study|Follow-up completed|3
175709|NCT01460901|428134|P1|tV-CTL Infusion|Overall Study||3
175710|NCT01460901|428134|P1|STARTED|Overall Study|First enrollment|5
175711|NCT01460875|428142|P1|NOT COMPLETED|Overall Study||0
175712|NCT01460875|428142|P1|COMPLETED|Overall Study||34
175713|NCT01460875|428142|P1|STARTED|Overall Study||34
175714|NCT01460732|428153|P1|NOT COMPLETED|Overall Study||0
175715|NCT01460732|428153|P1|COMPLETED|Overall Study||81
175716|NCT01460732|428153|P1|STARTED|Overall Study||81
175717|NCT01460719|428166|P1|NOT COMPLETED|Overall Study||2
175718|NCT01460719|428166|P1|COMPLETED|Overall Study||78
175719|NCT01460719|428166|P1|Vaccination 4 (~Day 90)|Overall Study||78
175720|NCT01460719|428166|P1|Vaccination 3 (~Day 60)|Overall Study||78
175721|NCT01460719|428166|P1|Vaccination 2 (~Day 30)|Overall Study||78
175722|NCT01460719|428166|P1|Vaccination 1 (Day 1)|Overall Study||80
175723|NCT01460719|428166|P1|STARTED|Overall Study||80
175724|NCT01460628|428176|P1|NOT COMPLETED|Overall Study||5
175725|NCT01460628|428176|P1|COMPLETED|Overall Study||20
175726|NCT01460628|428176|P1|STARTED|Overall Study||25
175727|NCT01460446|428188|P2|NOT COMPLETED|Overall Study||20
175728|NCT01460446|428189|P1|NOT COMPLETED|Overall Study||5
175729|NCT01460446|428188|P2|COMPLETED|Overall Study||93
175730|NCT01460446|428189|P1|COMPLETED|Overall Study||100
175731|NCT01460446|428188|P2|STARTED|Overall Study||113
175732|NCT01460446|428189|P1|STARTED|Overall Study||105
175733|NCT01460407|428216|P2|NOT COMPLETED|Period 2: Day 6 to Day 14||1
175734|NCT01460407|428217|P1|NOT COMPLETED|Period 2: Day 6 to Day 14||0
175735|NCT01460407|428216|P2|COMPLETED|Period 2: Day 6 to Day 14||13
175736|NCT01460407|428217|P1|COMPLETED|Period 2: Day 6 to Day 14||0
175737|NCT01460407|428216|P2|STARTED|Period 2: Day 6 to Day 14||14
175738|NCT01460407|428217|P1|STARTED|Period 2: Day 6 to Day 14||0
175739|NCT01460407|428216|P2|NOT COMPLETED|Period 1: Day 1 to Day 5||0
175740|NCT01460407|428217|P1|NOT COMPLETED|Period 1: Day 1 to Day 5||0
175741|NCT01460407|428216|P2|COMPLETED|Period 1: Day 1 to Day 5||0
175742|NCT01460407|428217|P1|COMPLETED|Period 1: Day 1 to Day 5||14
175743|NCT01460407|428216|P2|STARTED|Period 1: Day 1 to Day 5||0
175744|NCT01460407|428217|P1|STARTED|Period 1: Day 1 to Day 5||14
175745|NCT01460381|428230|P2|NOT COMPLETED|Period 2 (Days 8-15)||0
175746|NCT01460381|428231|P1|NOT COMPLETED|Period 2 (Days 8-15)||1
175747|NCT01460381|428230|P2|COMPLETED|Period 2 (Days 8-15)|CYP2C19 extensive metabolizers did not participate in Period 2|0
175748|NCT01460381|428231|P1|COMPLETED|Period 2 (Days 8-15)|One participant was lost to follow-up after completing Period 2 and did not complete the study.|6
175749|NCT01460381|428230|P2|STARTED|Period 2 (Days 8-15)|CYP2C19 extensive metabolizers did not participate in Period 2.|0
175750|NCT01460381|428231|P1|STARTED|Period 2 (Days 8-15)||7
175751|NCT01460381|428230|P2|NOT COMPLETED|Period 1 (Days 1-7)||0
175752|NCT01460381|428231|P1|NOT COMPLETED|Period 1 (Days 1-7)||0
175753|NCT01460381|428230|P2|COMPLETED|Period 1 (Days 1-7)||11
175754|NCT01460381|428231|P1|COMPLETED|Period 1 (Days 1-7)||7
175755|NCT01460381|428230|P2|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||11
175756|NCT01460381|428231|P1|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||7
175757|NCT01460381|428230|P2|STARTED|Period 1 (Days 1-7)||11
175758|NCT01460381|428231|P1|STARTED|Period 1 (Days 1-7)||7
175759|NCT01460368|428247|P7|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
175760|NCT01460368|428248|P6|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
175761|NCT01460368|428249|P5|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
175762|NCT01460368|428250|P4|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
175763|NCT01460368|428251|P3|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
175764|NCT01460368|428252|P2|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
175765|NCT01460368|428253|P1|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
175766|NCT01460368|428247|P7|COMPLETED|Part B: Third Interventions (Period 3)||9
175767|NCT01460368|428248|P6|COMPLETED|Part B: Third Interventions (Period 3)||9
175768|NCT01460368|428249|P5|COMPLETED|Part B: Third Interventions (Period 3)||9
175769|NCT01460368|428250|P4|COMPLETED|Part B: Third Interventions (Period 3)||9
175770|NCT01460368|428251|P3|COMPLETED|Part B: Third Interventions (Period 3)||8
175771|NCT01460368|428252|P2|COMPLETED|Part B: Third Interventions (Period 3)||8
175772|NCT01460368|428253|P1|COMPLETED|Part B: Third Interventions (Period 3)||0
175773|NCT01460368|428247|P7|STARTED|Part B: Third Interventions (Period 3)||9
175774|NCT01460368|428248|P6|STARTED|Part B: Third Interventions (Period 3)||10
175775|NCT01460368|428249|P5|STARTED|Part B: Third Interventions (Period 3)||9
175776|NCT01460368|428250|P4|STARTED|Part B: Third Interventions (Period 3)||10
175777|NCT01460368|428251|P3|STARTED|Part B: Third Interventions (Period 3)||9
175778|NCT01460368|428252|P2|STARTED|Part B: Third Interventions (Period 3)||8
175779|NCT01460368|428253|P1|STARTED|Part B: Third Interventions (Period 3)||0
175780|NCT01460368|428247|P7|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
175781|NCT01460368|428248|P6|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
175782|NCT01460368|428249|P5|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
175783|NCT01460368|428250|P4|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
175784|NCT01460368|428251|P3|NOT COMPLETED|Part B: Washout (up to 15 Days)||1
175785|NCT01460368|428252|P2|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
175786|NCT01460368|428253|P1|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
175787|NCT01460368|428247|P7|COMPLETED|Part B: Washout (up to 15 Days)||9
175788|NCT01460368|428248|P6|COMPLETED|Part B: Washout (up to 15 Days)||10
175789|NCT01460368|428249|P5|COMPLETED|Part B: Washout (up to 15 Days)||9
175790|NCT01460368|428250|P4|COMPLETED|Part B: Washout (up to 15 Days)||10
175791|NCT01460368|428251|P3|COMPLETED|Part B: Washout (up to 15 Days)||9
175792|NCT01460368|428252|P2|COMPLETED|Part B: Washout (up to 15 Days)||8
175793|NCT01460368|428253|P1|COMPLETED|Part B: Washout (up to 15 Days)||0
175794|NCT01460368|428247|P7|STARTED|Part B: Washout (up to 15 Days)||9
175795|NCT01460368|428248|P6|STARTED|Part B: Washout (up to 15 Days)||10
175796|NCT01460368|428249|P5|STARTED|Part B: Washout (up to 15 Days)||9
175797|NCT01460368|428250|P4|STARTED|Part B: Washout (up to 15 Days)||10
175798|NCT01460368|428251|P3|STARTED|Part B: Washout (up to 15 Days)||10
175799|NCT01460368|428252|P2|STARTED|Part B: Washout (up to 15 Days)||8
175800|NCT01460368|428253|P1|STARTED|Part B: Washout (up to 15 Days)||0
175801|NCT01460368|428247|P7|NOT COMPLETED|Part B: Second Intervention (Period 2)||1
175802|NCT01460368|428248|P6|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
175803|NCT01460368|428249|P5|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
175804|NCT01460368|428250|P4|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
175805|NCT01460368|428251|P3|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
175806|NCT01460368|428252|P2|NOT COMPLETED|Part B: Second Intervention (Period 2)||2
175807|NCT01460368|428253|P1|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
175808|NCT01460368|428247|P7|COMPLETED|Part B: Second Intervention (Period 2)||9
175809|NCT01460368|428248|P6|COMPLETED|Part B: Second Intervention (Period 2)||10
175810|NCT01460368|428249|P5|COMPLETED|Part B: Second Intervention (Period 2)||9
175811|NCT01460368|428250|P4|COMPLETED|Part B: Second Intervention (Period 2)||10
175812|NCT01460368|428251|P3|COMPLETED|Part B: Second Intervention (Period 2)||10
175813|NCT01460368|428252|P2|COMPLETED|Part B: Second Intervention (Period 2)||8
175814|NCT01460368|428253|P1|COMPLETED|Part B: Second Intervention (Period 2)||0
175815|NCT01460368|428247|P7|STARTED|Part B: Second Intervention (Period 2)||10
175816|NCT01460368|428248|P6|STARTED|Part B: Second Intervention (Period 2)||10
175817|NCT01460368|428249|P5|STARTED|Part B: Second Intervention (Period 2)||9
175818|NCT01460368|428250|P4|STARTED|Part B: Second Intervention (Period 2)||10
175819|NCT01460368|428251|P3|STARTED|Part B: Second Intervention (Period 2)||10
175820|NCT01460368|428252|P2|STARTED|Part B: Second Intervention (Period 2)||10
175821|NCT01460368|428253|P1|STARTED|Part B: Second Intervention (Period 2)||0
175822|NCT01460368|428247|P7|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
175823|NCT01460368|428248|P6|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
175824|NCT01460368|428249|P5|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
175825|NCT01460368|428250|P4|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
175826|NCT01460368|428251|P3|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
175827|NCT01460368|428252|P2|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
175828|NCT01460368|428253|P1|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
175829|NCT01460368|428247|P7|COMPLETED|Part B: Washout (up to 15 Days)||10
175830|NCT01460368|428248|P6|COMPLETED|Part B: Washout (up to 15 Days)||10
175831|NCT01460368|428249|P5|COMPLETED|Part B: Washout (up to 15 Days)||9
175832|NCT01460368|428250|P4|COMPLETED|Part B: Washout (up to 15 Days)||10
175833|NCT01460368|428251|P3|COMPLETED|Part B: Washout (up to 15 Days)||10
175834|NCT01460368|428252|P2|COMPLETED|Part B: Washout (up to 15 Days)||10
175835|NCT01460368|428253|P1|COMPLETED|Part B: Washout (up to 15 Days)||0
175836|NCT01460368|428247|P7|STARTED|Part B: Washout (up to 15 Days)||10
175837|NCT01460368|428248|P6|STARTED|Part B: Washout (up to 15 Days)||10
175838|NCT01460368|428249|P5|STARTED|Part B: Washout (up to 15 Days)||9
175839|NCT01460368|428250|P4|STARTED|Part B: Washout (up to 15 Days)||10
175840|NCT01460368|428251|P3|STARTED|Part B: Washout (up to 15 Days)||10
175841|NCT01460368|428252|P2|STARTED|Part B: Washout (up to 15 Days)||10
175842|NCT01460368|428253|P1|STARTED|Part B: Washout (up to 15 Days)||0
175843|NCT01460368|428247|P7|NOT COMPLETED|Part B: First Intervention (Period 1)||0
175844|NCT01460368|428248|P6|NOT COMPLETED|Part B: First Intervention (Period 1)||0
175845|NCT01460368|428249|P5|NOT COMPLETED|Part B: First Intervention (Period 1)||1
175846|NCT01460368|428250|P4|NOT COMPLETED|Part B: First Intervention (Period 1)||0
175847|NCT01460368|428251|P3|NOT COMPLETED|Part B: First Intervention (Period 1)||0
175848|NCT01460368|428252|P2|NOT COMPLETED|Part B: First Intervention (Period 1)||0
175849|NCT01460368|428253|P1|NOT COMPLETED|Part B: First Intervention (Period 1)||0
175850|NCT01460368|428247|P7|COMPLETED|Part B: First Intervention (Period 1)||10
175851|NCT01460368|428248|P6|COMPLETED|Part B: First Intervention (Period 1)||10
175852|NCT01460368|428249|P5|COMPLETED|Part B: First Intervention (Period 1)||9
175853|NCT01460368|428250|P4|COMPLETED|Part B: First Intervention (Period 1)||10
175854|NCT01460368|428251|P3|COMPLETED|Part B: First Intervention (Period 1)||10
175855|NCT01460368|428252|P2|COMPLETED|Part B: First Intervention (Period 1)||10
175856|NCT01460368|428253|P1|COMPLETED|Part B: First Intervention (Period 1)||0
175857|NCT01460368|428247|P7|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
175858|NCT01460368|428248|P6|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
175859|NCT01460368|428249|P5|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
175860|NCT01460368|428250|P4|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
175861|NCT01460368|428251|P3|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
175862|NCT01460368|428252|P2|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
175863|NCT01460368|428253|P1|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||0
175864|NCT01460368|428247|P7|STARTED|Part B: First Intervention (Period 1)||10
175865|NCT01460368|428248|P6|STARTED|Part B: First Intervention (Period 1)||10
175866|NCT01460368|428249|P5|STARTED|Part B: First Intervention (Period 1)||10
175867|NCT01460368|428250|P4|STARTED|Part B: First Intervention (Period 1)||10
175868|NCT01460368|428251|P3|STARTED|Part B: First Intervention (Period 1)||10
175869|NCT01460368|428252|P2|STARTED|Part B: First Intervention (Period 1)||10
175870|NCT01460368|428253|P1|STARTED|Part B: First Intervention (Period 1)||0
175871|NCT01460368|428247|P7|NOT COMPLETED|Part A||0
175872|NCT01460368|428248|P6|NOT COMPLETED|Part A||0
175873|NCT01460368|428249|P5|NOT COMPLETED|Part A||0
175874|NCT01460368|428250|P4|NOT COMPLETED|Part A||0
175875|NCT01460368|428251|P3|NOT COMPLETED|Part A||0
175876|NCT01460368|428252|P2|NOT COMPLETED|Part A||0
175877|NCT01460368|428253|P1|NOT COMPLETED|Part A||0
175878|NCT01460368|428247|P7|COMPLETED|Part A||0
175879|NCT01460368|428248|P6|COMPLETED|Part A||0
175880|NCT01460368|428249|P5|COMPLETED|Part A||0
175881|NCT01460368|428250|P4|COMPLETED|Part A||0
175882|NCT01460368|428251|P3|COMPLETED|Part A||0
175883|NCT01460368|428252|P2|COMPLETED|Part A||0
175884|NCT01460368|428253|P1|COMPLETED|Part A||7
175885|NCT01460368|428247|P7|Received at Least One Dose of Study Drug|Part A||0
175886|NCT01460368|428248|P6|Received at Least One Dose of Study Drug|Part A||0
175887|NCT01460368|428249|P5|Received at Least One Dose of Study Drug|Part A||0
175888|NCT01460368|428250|P4|Received at Least One Dose of Study Drug|Part A||0
175889|NCT01460368|428251|P3|Received at Least One Dose of Study Drug|Part A||0
175890|NCT01460368|428252|P2|Received at Least One Dose of Study Drug|Part A||0
175891|NCT01460368|428253|P1|Received at Least One Dose of Study Drug|Part A||7
175892|NCT01460368|428247|P7|STARTED|Part A||0
175893|NCT01460368|428248|P6|STARTED|Part A||0
175894|NCT01460368|428249|P5|STARTED|Part A||0
175895|NCT01460368|428250|P4|STARTED|Part A||0
175896|NCT01460368|428251|P3|STARTED|Part A||0
175897|NCT01460368|428252|P2|STARTED|Part A||0
175898|NCT01460368|428253|P1|STARTED|Part A||7
175899|NCT01460342|428265|P2|NOT COMPLETED|Overall Study||14
175900|NCT01460342|428266|P1|NOT COMPLETED|Overall Study||11
175901|NCT01460342|428265|P2|COMPLETED|Overall Study||292
175902|NCT01460342|428266|P1|COMPLETED|Overall Study||293
175903|NCT01460342|428265|P2|Received at Least 1 Dose of Study Drug|Overall Study||306
175904|NCT01460342|428266|P1|Received at Least 1 Dose of Study Drug|Overall Study||304
175905|NCT01460342|428265|P2|STARTED|Overall Study||306
175906|NCT01460342|428266|P1|STARTED|Overall Study||304
175907|NCT01460303|428288|P2|NOT COMPLETED|Overall Study||0
175908|NCT01460303|428289|P1|NOT COMPLETED|Overall Study||0
175909|NCT01460303|428288|P2|COMPLETED|Overall Study||24
175910|NCT01460303|428289|P1|COMPLETED|Overall Study||25
175911|NCT01460303|428288|P2|STARTED|Overall Study||24
175912|NCT01460303|428289|P1|STARTED|Overall Study||25
175913|NCT01460290|428297|P1|NOT COMPLETED|Overall Study||4
175914|NCT01460290|428297|P1|COMPLETED|Overall Study||11
175915|NCT01460290|428297|P1|STARTED|Overall Study||15
175916|NCT01460225|428317|P1|NOT COMPLETED|Overall Study||0
175917|NCT01460225|428317|P1|COMPLETED|Overall Study|November 2010|19
175918|NCT01460225|428317|P1|STARTED|Overall Study|January 2009.|19
175919|NCT01460160|428324|P2|NOT COMPLETED|Follow-up||2
175920|NCT01460160|428325|P1|NOT COMPLETED|Follow-up||11
175921|NCT01460160|428324|P2|COMPLETED|Follow-up||20
175922|NCT01460160|428325|P1|COMPLETED|Follow-up||67
175923|NCT01460160|428324|P2|STARTED|Follow-up||22
175924|NCT01460160|428325|P1|STARTED|Follow-up||78
175925|NCT01460160|428324|P2|NOT COMPLETED|Treatment||5
175926|NCT01460160|428325|P1|NOT COMPLETED|Treatment||23
175927|NCT01460160|428324|P2|COMPLETED|Treatment||19
175928|NCT01460160|428325|P1|COMPLETED|Treatment||59
175929|NCT01460160|428324|P2|STARTED|Treatment||24
175930|NCT01460160|428325|P1|STARTED|Treatment||82
175931|NCT01459913|428366|P4|NOT COMPLETED|Overall Study||33
175932|NCT01459913|428367|P3|NOT COMPLETED|Overall Study||13
175933|NCT01459913|428368|P2|NOT COMPLETED|Overall Study||20
175934|NCT01459913|428369|P1|NOT COMPLETED|Overall Study||41
175935|NCT01459913|428366|P4|COMPLETED|Overall Study||29
175936|NCT01459913|428367|P3|COMPLETED|Overall Study||6
175937|NCT01459913|428368|P2|COMPLETED|Overall Study||32
175938|NCT01459913|428369|P1|COMPLETED|Overall Study||65
175939|NCT01459913|428366|P4|STARTED|Overall Study||62
175940|NCT01459913|428367|P3|STARTED|Overall Study||19
175941|NCT01459913|428368|P2|STARTED|Overall Study||52
175942|NCT01459913|428369|P1|STARTED|Overall Study||106
175943|NCT01459796|428400|P2|NOT COMPLETED|Overall Study||126
175944|NCT01459796|428401|P1|NOT COMPLETED|Overall Study||94
175945|NCT01459796|428400|P2|COMPLETED|Overall Study||0
175946|NCT01459796|428401|P1|COMPLETED|Overall Study||0
175947|NCT01459796|428400|P2|STARTED|Overall Study||126
175948|NCT01459796|428401|P1|STARTED|Overall Study||94
175949|NCT01459783|428419|P2|NOT COMPLETED|6 Months to 12 Months||30
175950|NCT01459783|428420|P1|NOT COMPLETED|6 Months to 12 Months||19
175951|NCT01459783|428419|P2|COMPLETED|6 Months to 12 Months||23
175952|NCT01459783|428420|P1|COMPLETED|6 Months to 12 Months||20
175953|NCT01459783|428419|P2|STARTED|6 Months to 12 Months||53
175954|NCT01459783|428420|P1|STARTED|6 Months to 12 Months||39
175955|NCT01459783|428419|P2|NOT COMPLETED|Baseline to 6 Months||20
175956|NCT01459783|428420|P1|NOT COMPLETED|Baseline to 6 Months||32
175957|NCT01459783|428419|P2|COMPLETED|Baseline to 6 Months||53
175958|NCT01459783|428420|P1|COMPLETED|Baseline to 6 Months||39
175959|NCT01459783|428419|P2|STARTED|Baseline to 6 Months||73
175960|NCT01459783|428420|P1|STARTED|Baseline to 6 Months||71
175961|NCT01459718|428428|P1|NOT COMPLETED|Overall Study||3
175962|NCT01459718|428428|P1|COMPLETED|Overall Study||10
175963|NCT01459718|428428|P1|Safety Analysis Set|Overall Study||13
175964|NCT01459718|428428|P1|STARTED|Overall Study||13
175965|NCT01459705|428442|P3|NOT COMPLETED|Overall Study||7
175966|NCT01459705|428443|P2|NOT COMPLETED|Overall Study||24
175967|NCT01459705|428444|P1|NOT COMPLETED|Overall Study||22
175968|NCT01459705|428442|P3|COMPLETED|Overall Study||47
175969|NCT01459705|428443|P2|COMPLETED|Overall Study||30
175970|NCT01459705|428444|P1|COMPLETED|Overall Study||32
175971|NCT01459705|428442|P3|STARTED|Overall Study||54
175972|NCT01459705|428443|P2|STARTED|Overall Study||54
175973|NCT01459705|428444|P1|STARTED|Overall Study||54
175974|NCT01459653|428462|P1|NOT COMPLETED|Overall Study||668
175975|NCT01459653|428462|P1|COMPLETED|Overall Study||828
175976|NCT01459653|428462|P1|STARTED|Overall Study||1496
175977|NCT01459614|428610|P2|NOT COMPLETED|Overall Study||0
175978|NCT01459614|428611|P1|NOT COMPLETED|Overall Study||1
175979|NCT01459614|428610|P2|COMPLETED|Overall Study||10
175980|NCT01459614|428611|P1|COMPLETED|Overall Study||28
175981|NCT01459614|428610|P2|STARTED|Overall Study||10
175982|NCT01459614|428611|P1|STARTED|Overall Study||29
175983|NCT01459588|428621|P4|NOT COMPLETED|Overall Study||1
175984|NCT01459588|428622|P3|NOT COMPLETED|Overall Study||1
175985|NCT01459588|428623|P2|NOT COMPLETED|Overall Study||2
175986|NCT01459588|428624|P1|NOT COMPLETED|Overall Study||1
175987|NCT01459588|428621|P4|COMPLETED|Overall Study||55
175988|NCT01459588|428622|P3|COMPLETED|Overall Study||102
175989|NCT01459588|428623|P2|COMPLETED|Overall Study||49
175990|NCT01459588|428624|P1|COMPLETED|Overall Study||104
175991|NCT01459588|428621|P4|STARTED|Overall Study||56
175992|NCT01459588|428622|P3|STARTED|Overall Study||103
175993|NCT01459588|428623|P2|STARTED|Overall Study||51
175994|NCT01459588|428624|P1|STARTED|Overall Study||105
175995|NCT01459068|428652|P2|NOT COMPLETED|Overall Study||34
175996|NCT01459068|428653|P1|NOT COMPLETED|Overall Study||39
175997|NCT01459068|428652|P2|COMPLETED|Overall Study||148
175998|NCT01459068|428653|P1|COMPLETED|Overall Study||126
175999|NCT01459068|428652|P2|STARTED|Overall Study||182
176000|NCT01459068|428653|P1|STARTED|Overall Study||165
176001|NCT01459016|428669|P1|NOT COMPLETED|Overall Study||15
176002|NCT01459016|428669|P1|COMPLETED|Overall Study||41
176003|NCT01459016|428669|P1|STARTED|Overall Study||56
176004|NCT01458990|428685|P2|NOT COMPLETED|Overall Study||0
176005|NCT01458990|428686|P1|NOT COMPLETED|Overall Study||0
176006|NCT01458990|428685|P2|COMPLETED|Overall Study||15
176007|NCT01458990|428686|P1|COMPLETED|Overall Study||45
176008|NCT01458990|428685|P2|STARTED|Overall Study||15
176009|NCT01458990|428686|P1|STARTED|Overall Study||45
176010|NCT01458951|428697|P3|NOT COMPLETED|Overall Study||15
176011|NCT01458951|428698|P2|NOT COMPLETED|Overall Study||1
176012|NCT01458951|428699|P1|NOT COMPLETED|Overall Study||32
176013|NCT01458951|428697|P3|COMPLETED|Overall Study||97
176014|NCT01458951|428698|P2|COMPLETED|Overall Study||5
176015|NCT01458951|428699|P1|COMPLETED|Overall Study||397
176016|NCT01458951|428697|P3|STARTED|Overall Study||112
176017|NCT01458951|428698|P2|STARTED|Overall Study||6
176018|NCT01458951|428699|P1|STARTED|Overall Study||429
176019|NCT01458639|428724|P1|NOT COMPLETED|Overall Study||6
176020|NCT01458639|428724|P1|COMPLETED|Overall Study||12
176021|NCT01458639|428724|P1|STARTED|Overall Study||18
176022|NCT01458587|428736|P2|NOT COMPLETED|Overall Study||0
176023|NCT01458587|428737|P1|NOT COMPLETED|Overall Study||1
176024|NCT01458587|428736|P2|COMPLETED|Overall Study||35
176025|NCT01458587|428737|P1|COMPLETED|Overall Study||34
176026|NCT01458587|428736|P2|STARTED|Overall Study||35
176027|NCT01458587|428737|P1|STARTED|Overall Study||35
176028|NCT01458574|428900|P3|NOT COMPLETED|Overall Study||145
176029|NCT01458574|428901|P2|NOT COMPLETED|Overall Study||71
176030|NCT01458574|428902|P1|NOT COMPLETED|Overall Study||87
176031|NCT01458574|428900|P3|COMPLETED|Overall Study||53
176032|NCT01458574|428901|P2|COMPLETED|Overall Study||126
176033|NCT01458574|428902|P1|COMPLETED|Overall Study||111
176034|NCT01458574|428900|P3|Treated|Overall Study||198
176035|NCT01458574|428901|P2|Treated|Overall Study||196
176036|NCT01458574|428902|P1|Treated|Overall Study||198
176037|NCT01458574|428900|P3|STARTED|Overall Study||198
176038|NCT01458574|428901|P2|STARTED|Overall Study||197
176039|NCT01458574|428902|P1|STARTED|Overall Study||198
176040|NCT01458561|428987|P2|NOT COMPLETED|Overall Study||0
176041|NCT01458561|428988|P1|NOT COMPLETED|Overall Study||0
176042|NCT01458561|428987|P2|COMPLETED|Overall Study||1
176043|NCT01458561|428988|P1|COMPLETED|Overall Study||0
176044|NCT01458561|428987|P2|STARTED|Overall Study||1
176045|NCT01458561|428988|P1|STARTED|Overall Study||0
176046|NCT01458535|429032|P6|NOT COMPLETED|Overall Study||4
176047|NCT01458535|429033|P5|NOT COMPLETED|Overall Study||4
176048|NCT01458535|429034|P4|NOT COMPLETED|Overall Study||4
176049|NCT01458535|429035|P3|NOT COMPLETED|Overall Study||2
176050|NCT01458535|429036|P2|NOT COMPLETED|Overall Study||2
176051|NCT01458535|429037|P1|NOT COMPLETED|Overall Study||0
176052|NCT01458535|429032|P6|COMPLETED|Overall Study||7
176053|NCT01458535|429033|P5|COMPLETED|Overall Study||6
176054|NCT01458535|429034|P4|COMPLETED|Overall Study||6
176055|NCT01458535|429035|P3|COMPLETED|Overall Study||8
176056|NCT01458535|429036|P2|COMPLETED|Overall Study||8
176057|NCT01458535|429037|P1|COMPLETED|Overall Study||10
176058|NCT01458535|429032|P6|STARTED|Overall Study||11
176059|NCT01458535|429033|P5|STARTED|Overall Study||10
176060|NCT01458535|429034|P4|STARTED|Overall Study||10
176061|NCT01458535|429035|P3|STARTED|Overall Study||10
176062|NCT01458535|429036|P2|STARTED|Overall Study||10
176063|NCT01458535|429037|P1|STARTED|Overall Study||10
176064|NCT01458522|429089|P2|NOT COMPLETED|Overall Study||11
176065|NCT01458522|429090|P1|NOT COMPLETED|Overall Study||3
176066|NCT01458522|429089|P2|COMPLETED|Overall Study||26
176067|NCT01458522|429090|P1|COMPLETED|Overall Study||34
176068|NCT01458522|429089|P2|Crossover to Second Drug|Overall Study||10
176069|NCT01458522|429090|P1|Crossover to Second Drug|Overall Study||15
176070|NCT01458522|429089|P2|Received First Drug|Overall Study||35
176071|NCT01458522|429090|P1|Received First Drug|Overall Study||35
176072|NCT01458522|429089|P2|STARTED|Overall Study||37
176073|NCT01458522|429090|P1|STARTED|Overall Study||37
176074|NCT01458392|429119|P3|NOT COMPLETED|Overall Study||31
176075|NCT01458392|429120|P2|NOT COMPLETED|Overall Study||13
176076|NCT01458392|429121|P1|NOT COMPLETED|Overall Study||2
176077|NCT01458392|429119|P3|COMPLETED|Overall Study||0
176078|NCT01458392|429120|P2|COMPLETED|Overall Study||0
176079|NCT01458392|429121|P1|COMPLETED|Overall Study||0
176080|NCT01458392|429119|P3|STARTED|Overall Study||31
176081|NCT01458392|429120|P2|STARTED|Overall Study||13
176082|NCT01458392|429121|P1|STARTED|Overall Study||2
176083|NCT01458288|429141|P1|NOT COMPLETED|Overall Study||0
176084|NCT01458288|429141|P1|COMPLETED|Overall Study||12
176085|NCT01458288|429141|P1|STARTED|Overall Study||12
176086|NCT01458275|429153|P3|NOT COMPLETED|Overall Study||9
176087|NCT01458275|429154|P2|NOT COMPLETED|Overall Study||13
176088|NCT01458275|429155|P1|NOT COMPLETED|Overall Study||14
176089|NCT01458275|429153|P3|COMPLETED|Overall Study||273
176090|NCT01458275|429154|P2|COMPLETED|Overall Study||269
176091|NCT01458275|429155|P1|COMPLETED|Overall Study||269
176092|NCT01458275|429153|P3|STARTED|Overall Study||282
176093|NCT01458275|429154|P2|STARTED|Overall Study||282
176094|NCT01458275|429155|P1|STARTED|Overall Study||283
176095|NCT01458249|429197|P1|NOT COMPLETED|Overall Study||8
176096|NCT01458249|429197|P1|COMPLETED|Overall Study||44
176097|NCT01458249|429197|P1|Participants Treated|Overall Study||51
176098|NCT01458249|429197|P1|STARTED|Overall Study||52
176099|NCT01458210|429216|P1|NOT COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||3
176100|NCT01458210|429216|P1|COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||15
176101|NCT01458210|429216|P1|STARTED|Ortho-Cyclen + Dulaglutide (Period 2)|1 participant received Ortho-Cyclen, discontinued due to Adverse Event before receiving Dulaglutide.|18
176102|NCT01458210|429216|P1|NOT COMPLETED|Ortho-Cyclen Alone (Period 1)||4
176103|NCT01458210|429216|P1|COMPLETED|Ortho-Cyclen Alone (Period 1)||18
176104|NCT01458210|429216|P1|STARTED|Ortho-Cyclen Alone (Period 1)||22
176105|NCT01458210|429216|P1|NOT COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||0
176106|NCT01458210|429216|P1|COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||22
176107|NCT01458210|429216|P1|Received at Least One Dose of Study Drug|Lead-in (1st Course of Ortho-Cyclen)||22
176108|NCT01458210|429216|P1|STARTED|Lead-in (1st Course of Ortho-Cyclen)||22
176109|NCT01458171|429233|P1|NOT COMPLETED|Overall Study||1
176110|NCT01458171|429233|P1|COMPLETED|Overall Study||22
176111|NCT01458171|429233|P1|STARTED|Overall Study||23
176112|NCT01458132|429256|P2|NOT COMPLETED|Overall Study||3
176113|NCT01458132|429257|P1|NOT COMPLETED|Overall Study||15
176114|NCT01458132|429256|P2|COMPLETED|Overall Study||1
176115|NCT01458132|429257|P1|COMPLETED|Overall Study||0
176116|NCT01458132|429256|P2|STARTED|Overall Study||4
176117|NCT01458132|429257|P1|STARTED|Overall Study||15
176118|NCT01458119|429265|P1|NOT COMPLETED|Overall Study||20
176119|NCT01458119|429265|P1|COMPLETED|Overall Study||65
176120|NCT01458119|429265|P1|ITT-Amenable Population|Overall Study||68
176121|NCT01458119|429265|P1|Intent to Treat (ITT) Population|Overall Study||85
176122|NCT01458119|429265|P1|Safety Population|Overall Study||85
176123|NCT01458119|429265|P1|Received at Least 1 Dose of Study Drug|Overall Study||85
176124|NCT01458119|429265|P1|STARTED|Overall Study||85
176125|NCT01458106|429272|P2|NOT COMPLETED|Overall Study||1
176126|NCT01458106|429273|P1|NOT COMPLETED|Overall Study||3
176127|NCT01458106|429272|P2|COMPLETED|Overall Study||34
176128|NCT01458106|429273|P1|COMPLETED|Overall Study||33
176129|NCT01458106|429272|P2|Non-PK Subgroup|Overall Study||0
176130|NCT01458106|429273|P1|Non-PK Subgroup|Overall Study||11
176131|NCT01458106|429272|P2|PK Subgroup|Overall Study||35
176132|NCT01458106|429273|P1|PK Subgroup|Overall Study||25
176133|NCT01458106|429272|P2|STARTED|Overall Study||35
176134|NCT01458106|429273|P1|STARTED|Overall Study||36
176135|NCT01457950|429350|P4|NOT COMPLETED|Open-Label Phase||2
176136|NCT01457950|429351|P3|NOT COMPLETED|Open-Label Phase||2
176137|NCT01457950|429352|P2|NOT COMPLETED|Open-Label Phase||0
176138|NCT01457950|429353|P1|NOT COMPLETED|Open-Label Phase||0
176139|NCT01457950|429350|P4|COMPLETED|Open-Label Phase||61
176140|NCT01457950|429351|P3|COMPLETED|Open-Label Phase||58
176141|NCT01457950|429352|P2|COMPLETED|Open-Label Phase||0
176142|NCT01457950|429353|P1|COMPLETED|Open-Label Phase||0
176143|NCT01457950|429350|P4|STARTED|Open-Label Phase||63
176144|NCT01457950|429351|P3|STARTED|Open-Label Phase||60
176145|NCT01457950|429352|P2|STARTED|Open-Label Phase||0
176146|NCT01457950|429353|P1|STARTED|Open-Label Phase||0
176147|NCT01457950|429350|P4|NOT COMPLETED|Double-Blind Phase||0
176148|NCT01457950|429351|P3|NOT COMPLETED|Double-Blind Phase||0
176149|NCT01457950|429352|P2|NOT COMPLETED|Double-Blind Phase||3
176150|NCT01457950|429353|P1|NOT COMPLETED|Double-Blind Phase||9
176151|NCT01457950|429350|P4|COMPLETED|Double-Blind Phase||0
176152|NCT01457950|429351|P3|COMPLETED|Double-Blind Phase||0
176153|NCT01457950|429352|P2|COMPLETED|Double-Blind Phase|“Completed” refers to par. that did not have a withdraw reason at the 6 month visit.|63
176154|NCT01457950|429353|P1|COMPLETED|Double-Blind Phase|“Completed” refers to par. that did not have a withdraw reason at the 6 month visit.|60
176155|NCT01457950|429350|P4|Completed the 6 Month Assessment|Double-Blind Phase||0
176156|NCT01457950|429351|P3|Completed the 6 Month Assessment|Double-Blind Phase||0
176157|NCT01457950|429352|P2|Completed the 6 Month Assessment|Double-Blind Phase|“Completed 6 month assessment” refers to par. that completed at least one 6 month assessment.|64
176158|NCT01457950|429353|P1|Completed the 6 Month Assessment|Double-Blind Phase|“Completed 6 month assessment” refers to par. that completed at least one 6 month assessment.|62
176159|NCT01457950|429350|P4|STARTED|Double-Blind Phase||0
176160|NCT01457950|429351|P3|STARTED|Double-Blind Phase||0
176161|NCT01457950|429352|P2|STARTED|Double-Blind Phase||66
176162|NCT01457950|429353|P1|STARTED|Double-Blind Phase||69
176163|NCT01457924|429432|P5|NOT COMPLETED|Individualized FUP (Weeks 48+)||6
176164|NCT01457924|429433|P4|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
176165|NCT01457924|429434|P3|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
176166|NCT01457924|429435|P2|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
176167|NCT01457924|429436|P1|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
176168|NCT01457924|429432|P5|COMPLETED|Individualized FUP (Weeks 48+)||36
176169|NCT01457924|429433|P4|COMPLETED|Individualized FUP (Weeks 48+)||15
176170|NCT01457924|429434|P3|COMPLETED|Individualized FUP (Weeks 48+)||12
176171|NCT01457924|429435|P2|COMPLETED|Individualized FUP (Weeks 48+)||14
176172|NCT01457924|429436|P1|COMPLETED|Individualized FUP (Weeks 48+)||11
176173|NCT01457924|429432|P5|STARTED|Individualized FUP (Weeks 48+)||42
176174|NCT01457924|429433|P4|STARTED|Individualized FUP (Weeks 48+)||20
176175|NCT01457924|429434|P3|STARTED|Individualized FUP (Weeks 48+)||16
176176|NCT01457924|429435|P2|STARTED|Individualized FUP (Weeks 48+)||18
176177|NCT01457924|429436|P1|STARTED|Individualized FUP (Weeks 48+)||16
176178|NCT01457924|429432|P5|NOT COMPLETED|FUP (Weeks 24-48)||2
176179|NCT01457924|429433|P4|NOT COMPLETED|FUP (Weeks 24-48)||1
176180|NCT01457924|429434|P3|NOT COMPLETED|FUP (Weeks 24-48)||2
176181|NCT01457924|429435|P2|NOT COMPLETED|FUP (Weeks 24-48)||1
176182|NCT01457924|429436|P1|NOT COMPLETED|FUP (Weeks 24-48)||3
176183|NCT01457924|429432|P5|COMPLETED|FUP (Weeks 24-48)||57
176184|NCT01457924|429433|P4|COMPLETED|FUP (Weeks 24-48)||32
176185|NCT01457924|429434|P3|COMPLETED|FUP (Weeks 24-48)||30
176186|NCT01457924|429435|P2|COMPLETED|FUP (Weeks 24-48)||30
176187|NCT01457924|429436|P1|COMPLETED|FUP (Weeks 24-48)||63
176188|NCT01457924|429432|P5|STARTED|FUP (Weeks 24-48)||59
176189|NCT01457924|429433|P4|STARTED|FUP (Weeks 24-48)||33
176190|NCT01457924|429434|P3|STARTED|FUP (Weeks 24-48)||32
176191|NCT01457924|429435|P2|STARTED|FUP (Weeks 24-48)||31
176192|NCT01457924|429436|P1|STARTED|FUP (Weeks 24-48)||66
176193|NCT01457924|429432|P5|NOT COMPLETED|Treatment Phase (Weeks 0-24)||6
176194|NCT01457924|429433|P4|NOT COMPLETED|Treatment Phase (Weeks 0-24)||1
176195|NCT01457924|429434|P3|NOT COMPLETED|Treatment Phase (Weeks 0-24)||2
176196|NCT01457924|429435|P2|NOT COMPLETED|Treatment Phase (Weeks 0-24)||5
176197|NCT01457924|429436|P1|NOT COMPLETED|Treatment Phase (Weeks 0-24)||3
176198|NCT01457924|429432|P5|COMPLETED|Treatment Phase (Weeks 0-24)||58
176199|NCT01457924|429433|P4|COMPLETED|Treatment Phase (Weeks 0-24)||33
176200|NCT01457924|429434|P3|COMPLETED|Treatment Phase (Weeks 0-24)||30
176201|NCT01457924|429435|P2|COMPLETED|Treatment Phase (Weeks 0-24)||29
176202|NCT01457924|429436|P1|COMPLETED|Treatment Phase (Weeks 0-24)||64
176203|NCT01457924|429432|P5|Completed to Week 12|Treatment Phase (Weeks 0-24)||60
176204|NCT01457924|429433|P4|Completed to Week 12|Treatment Phase (Weeks 0-24)||33
176205|NCT01457924|429434|P3|Completed to Week 12|Treatment Phase (Weeks 0-24)||30
176206|NCT01457924|429435|P2|Completed to Week 12|Treatment Phase (Weeks 0-24)||31
176207|NCT01457924|429436|P1|Completed to Week 12|Treatment Phase (Weeks 0-24)||65
176208|NCT01457924|429432|P5|STARTED|Treatment Phase (Weeks 0-24)||64
176209|NCT01457924|429433|P4|STARTED|Treatment Phase (Weeks 0-24)||34
176210|NCT01457924|429434|P3|STARTED|Treatment Phase (Weeks 0-24)||32
176211|NCT01457924|429435|P2|STARTED|Treatment Phase (Weeks 0-24)||34
176212|NCT01457924|429436|P1|STARTED|Treatment Phase (Weeks 0-24)||67
176213|NCT01457885|429498|P1|NOT COMPLETED|Overall Study||0
176214|NCT01457885|429498|P1|COMPLETED|Overall Study||74
176215|NCT01457885|429498|P1|STARTED|Overall Study||74
176216|NCT01457846|429506|P2|NOT COMPLETED|Overall Study||30
176217|NCT01457846|429507|P1|NOT COMPLETED|Overall Study||41
176218|NCT01457846|429506|P2|COMPLETED|Overall Study||0
176219|NCT01457846|429507|P1|COMPLETED|Overall Study||0
176220|NCT01457846|429506|P2|Ongoing Treatment at Data Cut-off|Overall Study||1
176221|NCT01457846|429507|P1|Ongoing Treatment at Data Cut-off|Overall Study||1
176222|NCT01457846|429506|P2|Did Not Receive Treatment|Overall Study||3
176223|NCT01457846|429507|P1|Did Not Receive Treatment|Overall Study||1
176224|NCT01457846|429506|P2|Received Treatment|Overall Study||27
176225|NCT01457846|429507|P1|Received Treatment|Overall Study||40
176226|NCT01457846|429506|P2|STARTED|Overall Study||30
176227|NCT01457846|429507|P1|STARTED|Overall Study||41
176228|NCT01457703|429523|P2|NOT COMPLETED|Overall Study||11
176229|NCT01457703|429524|P1|NOT COMPLETED|Overall Study||6
176230|NCT01457703|429523|P2|COMPLETED|Overall Study||22
176231|NCT01457703|429524|P1|COMPLETED|Overall Study||23
176232|NCT01457703|429523|P2|STARTED|Overall Study||33
176233|NCT01457703|429524|P1|STARTED|Overall Study||29
176234|NCT01457573|429538|P1|NOT COMPLETED|Overall Study||0
176235|NCT01457573|429538|P1|COMPLETED|Overall Study||10
176236|NCT01457573|429538|P1|STARTED|Overall Study||10
176237|NCT01457521|429554|P2|NOT COMPLETED|Overall Study||10
176238|NCT01457521|429555|P1|NOT COMPLETED|Overall Study||12
176239|NCT01457521|429554|P2|COMPLETED|Overall Study||117
176240|NCT01457521|429555|P1|COMPLETED|Overall Study||111
176241|NCT01457521|429554|P2|STARTED|Overall Study||127
176242|NCT01457521|429555|P1|STARTED|Overall Study||123
176243|NCT01457430|429561|P1|NOT COMPLETED|Overall Study||0
176244|NCT01457430|429561|P1|COMPLETED|Overall Study||19
176245|NCT01457430|429561|P1|STARTED|Overall Study||19
176246|NCT01457417|429573|P5|NOT COMPLETED|Overall Study||0
176247|NCT01457417|429574|P4|NOT COMPLETED|Overall Study||0
176248|NCT01457417|429575|P3|NOT COMPLETED|Overall Study||0
176249|NCT01457417|429576|P2|NOT COMPLETED|Overall Study||0
176250|NCT01457417|429577|P1|NOT COMPLETED|Overall Study||0
176251|NCT01457417|429573|P5|COMPLETED|Overall Study||19
176252|NCT01457417|429574|P4|COMPLETED|Overall Study||3
176253|NCT01457417|429575|P3|COMPLETED|Overall Study||4
176254|NCT01457417|429576|P2|COMPLETED|Overall Study||3
176255|NCT01457417|429577|P1|COMPLETED|Overall Study||3
176256|NCT01457417|429573|P5|STARTED|Overall Study||19
176257|NCT01457417|429574|P4|STARTED|Overall Study||3
176258|NCT01457417|429575|P3|STARTED|Overall Study||4
176259|NCT01457417|429576|P2|STARTED|Overall Study||3
176260|NCT01457417|429577|P1|STARTED|Overall Study||3
176261|NCT01457352|429635|P2|NOT COMPLETED|Period 3||5
176262|NCT01457352|429636|P1|NOT COMPLETED|Period 3||1
176263|NCT01457352|429635|P2|COMPLETED|Period 3||144
176264|NCT01457352|429636|P1|COMPLETED|Period 3||146
176265|NCT01457352|429635|P2|Randomization|Period 3||149
176266|NCT01457352|429636|P1|Randomization|Period 3||147
176267|NCT01457352|429635|P2|STARTED|Period 3||149
176268|NCT01457352|429636|P1|STARTED|Period 3||147
176269|NCT01457352|429635|P2|NOT COMPLETED|Period 2||0
176270|NCT01457352|429636|P1|NOT COMPLETED|Period 2||80
176271|NCT01457352|429635|P2|COMPLETED|Period 2||0
176272|NCT01457352|429636|P1|COMPLETED|Period 2||296
176273|NCT01457352|429635|P2|STARTED|Period 2||0
176274|NCT01457352|429636|P1|STARTED|Period 2||376
176275|NCT01457352|429635|P2|NOT COMPLETED|Period 1||0
176276|NCT01457352|429636|P1|NOT COMPLETED|Period 1||16
176277|NCT01457352|429635|P2|COMPLETED|Period 1||0
176278|NCT01457352|429636|P1|COMPLETED|Period 1||376
176279|NCT01457352|429635|P2|STARTED|Period 1||0
176280|NCT01457352|429636|P1|STARTED|Period 1||392
176281|NCT01457339|429648|P2|NOT COMPLETED|Period 6 (250 mg)||1
176282|NCT01457339|429649|P1|NOT COMPLETED|Period 6 (250 mg)||1
176283|NCT01457339|429648|P2|COMPLETED|Period 6 (250 mg)||21
176284|NCT01457339|429649|P1|COMPLETED|Period 6 (250 mg)||6
176285|NCT01457339|429648|P2|STARTED|Period 6 (250 mg)||22
176286|NCT01457339|429649|P1|STARTED|Period 6 (250 mg)||7
176287|NCT01457339|429648|P2|NOT COMPLETED|Period 5 (200 mg)||1
176288|NCT01457339|429649|P1|NOT COMPLETED|Period 5 (200 mg)||0
176289|NCT01457339|429648|P2|COMPLETED|Period 5 (200 mg)||22
176290|NCT01457339|429649|P1|COMPLETED|Period 5 (200 mg)||7
176291|NCT01457339|429648|P2|STARTED|Period 5 (200 mg)||23
176292|NCT01457339|429649|P1|STARTED|Period 5 (200 mg)||7
176293|NCT01457339|429648|P2|NOT COMPLETED|Period 4 (150 mg)||0
176294|NCT01457339|429649|P1|NOT COMPLETED|Period 4 (150 mg)||0
176295|NCT01457339|429648|P2|COMPLETED|Period 4 (150 mg)||23
176296|NCT01457339|429649|P1|COMPLETED|Period 4 (150 mg)||7
176297|NCT01457339|429648|P2|STARTED|Period 4 (150 mg)||23
176298|NCT01457339|429649|P1|STARTED|Period 4 (150 mg)||7
176299|NCT01457339|429648|P2|NOT COMPLETED|Period 3 (100 mg)||1
176300|NCT01457339|429649|P1|NOT COMPLETED|Period 3 (100 mg)||0
176301|NCT01457339|429648|P2|COMPLETED|Period 3 (100 mg)||23
176302|NCT01457339|429649|P1|COMPLETED|Period 3 (100 mg)||7
176303|NCT01457339|429648|P2|STARTED|Period 3 (100 mg)||24
176304|NCT01457339|429649|P1|STARTED|Period 3 (100 mg)||7
176305|NCT01457339|429648|P2|NOT COMPLETED|Period 2 (70 mg)||0
176306|NCT01457339|429649|P1|NOT COMPLETED|Period 2 (70 mg)||0
176307|NCT01457339|429648|P2|COMPLETED|Period 2 (70 mg)||24
176308|NCT01457339|429649|P1|COMPLETED|Period 2 (70 mg)||7
176309|NCT01457339|429648|P2|STARTED|Period 2 (70 mg)||24
176310|NCT01457339|429649|P1|STARTED|Period 2 (70 mg)||7
176311|NCT01457339|429648|P2|NOT COMPLETED|Period 1 (50 mg)||0
176312|NCT01457339|429649|P1|NOT COMPLETED|Period 1 (50 mg)||0
176313|NCT01457339|429648|P2|COMPLETED|Period 1 (50 mg)||24
176314|NCT01457339|429649|P1|COMPLETED|Period 1 (50 mg)||7
176315|NCT01457339|429648|P2|STARTED|Period 1 (50 mg)||24
176316|NCT01457339|429649|P1|STARTED|Period 1 (50 mg)||7
176317|NCT01457053|429815|P2|NOT COMPLETED|Overall Study||1
176318|NCT01457053|429816|P1|NOT COMPLETED|Overall Study||1
176319|NCT01457053|429815|P2|COMPLETED|Overall Study||1
176320|NCT01457053|429816|P1|COMPLETED|Overall Study||1
176321|NCT01457053|429815|P2|STARTED|Overall Study||2
176322|NCT01457053|429816|P1|STARTED|Overall Study||2
176323|NCT01457014|429822|P4|NOT COMPLETED|Fourth Night||0
176324|NCT01457014|429823|P3|NOT COMPLETED|Fourth Night||0
176325|NCT01457014|429824|P2|NOT COMPLETED|Fourth Night||0
176326|NCT01457014|429825|P1|NOT COMPLETED|Fourth Night||0
176327|NCT01457014|429822|P4|COMPLETED|Fourth Night||11
176328|NCT01457014|429823|P3|COMPLETED|Fourth Night||12
176329|NCT01457014|429824|P2|COMPLETED|Fourth Night||11
176330|NCT01457014|429825|P1|COMPLETED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
176331|NCT01457014|429822|P4|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
176332|NCT01457014|429823|P3|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
176333|NCT01457014|429824|P2|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
176334|NCT01457014|429825|P1|STARTED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
176335|NCT01457014|429822|P4|NOT COMPLETED|Third Night||0
176336|NCT01457014|429823|P3|NOT COMPLETED|Third Night||0
176337|NCT01457014|429824|P2|NOT COMPLETED|Third Night||0
176338|NCT01457014|429825|P1|NOT COMPLETED|Third Night||0
176339|NCT01457014|429822|P4|COMPLETED|Third Night||12
176340|NCT01457014|429823|P3|COMPLETED|Third Night||11
176341|NCT01457014|429824|P2|COMPLETED|Third Night||11
176342|NCT01457014|429825|P1|COMPLETED|Third Night|The Diagnostic PSG was only completed on the First night|0
176343|NCT01457014|429822|P4|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
176344|NCT01457014|429823|P3|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
176345|NCT01457014|429824|P2|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
176346|NCT01457014|429825|P1|STARTED|Third Night|The Diagnostic PSG was only completed on the First night|0
176347|NCT01457014|429822|P4|NOT COMPLETED|Second Night||0
176348|NCT01457014|429823|P3|NOT COMPLETED|Second Night||0
176349|NCT01457014|429824|P2|NOT COMPLETED|Second Night||0
176350|NCT01457014|429825|P1|NOT COMPLETED|Second Night||0
176351|NCT01457014|429822|P4|COMPLETED|Second Night||11
176352|NCT01457014|429823|P3|COMPLETED|Second Night||11
176353|NCT01457014|429824|P2|COMPLETED|Second Night||12
176354|NCT01457014|429825|P1|COMPLETED|Second Night|The Diagnostic PSG was only completed on the First night|0
176355|NCT01457014|429822|P4|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
176356|NCT01457014|429823|P3|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
176357|NCT01457014|429824|P2|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
176358|NCT01457014|429825|P1|STARTED|Second Night|The Diagnostic PSG was only completed on the First night|0
176359|NCT01457014|429822|P4|NOT COMPLETED|First Night||0
176360|NCT01457014|429823|P3|NOT COMPLETED|First Night||0
176361|NCT01457014|429824|P2|NOT COMPLETED|First Night||0
176362|NCT01457014|429825|P1|NOT COMPLETED|First Night||40
176363|NCT01457014|429822|P4|COMPLETED|First Night||0
176364|NCT01457014|429823|P3|COMPLETED|First Night||0
176365|NCT01457014|429824|P2|COMPLETED|First Night||0
176366|NCT01457014|429825|P1|COMPLETED|First Night||34
176367|NCT01457014|429822|P4|STARTED|First Night||0
176368|NCT01457014|429823|P3|STARTED|First Night||0
176369|NCT01457014|429824|P2|STARTED|First Night||0
176370|NCT01457014|429825|P1|STARTED|First Night||74
176371|NCT01456962|429842|P2|NOT COMPLETED|Overall Study||1
176372|NCT01456962|429843|P1|NOT COMPLETED|Overall Study||2
176373|NCT01456962|429842|P2|COMPLETED|Overall Study||19
176374|NCT01456962|429843|P1|COMPLETED|Overall Study||14
176375|NCT01456962|429842|P2|STARTED|Overall Study||20
176376|NCT01456962|429843|P1|STARTED|Overall Study||16
176377|NCT01456949|429849|P1|NOT COMPLETED|Study Cryoablation Procedure & Follow-up||62
176378|NCT01456949|429849|P1|COMPLETED|Study Cryoablation Procedure & Follow-up|5 subjects completed at least 36 months of follow-up but did not complete a 36 month follow-up visit|303
176379|NCT01456949|429849|P1|36-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|298
176380|NCT01456949|429849|P1|24-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|309
176381|NCT01456949|429849|P1|12-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|325
176382|NCT01456949|429849|P1|6-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|342
176383|NCT01456949|429849|P1|3-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of 354 subjects who were treated and met all I/E criteria (mITT group).|344
176384|NCT01456949|429849|P1|STARTED|Study Cryoablation Procedure & Follow-up||365
176385|NCT01456949|429849|P1|NOT COMPLETED|Enrollment||37
176386|NCT01456949|429849|P1|COMPLETED|Enrollment|6 rollover subjects not included in final analysis. 359 treated; 354 treated & met all I/E criteria.|365
176387|NCT01456949|429849|P1|Modified Intent to Treat Group (mITT)|Enrollment||354
176388|NCT01456949|429849|P1|Treated|Enrollment||359
176389|NCT01456949|429849|P1|STARTED|Enrollment||402
176390|NCT01456936|429860|P4|NOT COMPLETED|Overall Study||483
176391|NCT01456936|429861|P3|NOT COMPLETED|Overall Study||481
176392|NCT01456936|429862|P2|NOT COMPLETED|Overall Study||448
176393|NCT01456936|429863|P1|NOT COMPLETED|Overall Study||439
176394|NCT01456936|429860|P4|COMPLETED|Overall Study||1552
176395|NCT01456936|429861|P3|COMPLETED|Overall Study||1557
176396|NCT01456936|429862|P2|COMPLETED|Overall Study||1586
176397|NCT01456936|429863|P1|COMPLETED|Overall Study||1598
176398|NCT01456936|429860|P4|Randomized and Treated|Overall Study||2014
176399|NCT01456936|429861|P3|Randomized and Treated|Overall Study||2022
176400|NCT01456936|429862|P2|Randomized and Treated|Overall Study||2006
176401|NCT01456936|429863|P1|Randomized and Treated|Overall Study||2016
176402|NCT01456936|429860|P4|STARTED|Overall Study||2035
176403|NCT01456936|429861|P3|STARTED|Overall Study||2038
176404|NCT01456936|429862|P2|STARTED|Overall Study||2034
176405|NCT01456936|429863|P1|STARTED|Overall Study||2037
176406|NCT01456780|429972|P3|NOT COMPLETED|Overall Study||0
176407|NCT01456780|429973|P2|NOT COMPLETED|Overall Study||3
176408|NCT01456780|429974|P1|NOT COMPLETED|Overall Study||3
176409|NCT01456780|429972|P3|COMPLETED|Overall Study||20
176410|NCT01456780|429973|P2|COMPLETED|Overall Study||17
176411|NCT01456780|429974|P1|COMPLETED|Overall Study||17
176412|NCT01456780|429972|P3|STARTED|Overall Study||20
176413|NCT01456780|429973|P2|STARTED|Overall Study||20
176414|NCT01456780|429974|P1|STARTED|Overall Study||20
176415|NCT01456494|429993|P2|NOT COMPLETED|Follow-Up Visit (Post 30-day Discharge)||6
176416|NCT01456494|429994|P1|NOT COMPLETED|Follow-Up Visit (Post 30-day Discharge)||5
176417|NCT01456494|429993|P2|COMPLETED|Follow-Up Visit (Post 30-day Discharge)||20
176418|NCT01456494|429994|P1|COMPLETED|Follow-Up Visit (Post 30-day Discharge)||19
176419|NCT01456494|429993|P2|STARTED|Follow-Up Visit (Post 30-day Discharge)||26
176420|NCT01456494|429994|P1|STARTED|Follow-Up Visit (Post 30-day Discharge)||24
176421|NCT01456494|429993|P2|NOT COMPLETED|Initial Inpatient Visit||0
176422|NCT01456494|429994|P1|NOT COMPLETED|Initial Inpatient Visit||0
176423|NCT01456494|429993|P2|COMPLETED|Initial Inpatient Visit||26
176424|NCT01456494|429994|P1|COMPLETED|Initial Inpatient Visit||24
176425|NCT01456494|429993|P2|STARTED|Initial Inpatient Visit||26
176426|NCT01456494|429994|P1|STARTED|Initial Inpatient Visit||24
176427|NCT01456299|430011|P3|NOT COMPLETED|Overall Study||1
176428|NCT01456299|430012|P2|NOT COMPLETED|Overall Study||1
176429|NCT01456299|430013|P1|NOT COMPLETED|Overall Study||0
176430|NCT01456299|430011|P3|COMPLETED|Overall Study||33
176431|NCT01456299|430012|P2|COMPLETED|Overall Study||33
176432|NCT01456299|430013|P1|COMPLETED|Overall Study||34
176433|NCT01456299|430011|P3|STARTED|Overall Study||34
176434|NCT01456299|430012|P2|STARTED|Overall Study||34
176435|NCT01456299|430013|P1|STARTED|Overall Study||34
176436|NCT01456195|430024|P3|NOT COMPLETED|Overall Study||14
176437|NCT01456195|430025|P2|NOT COMPLETED|Overall Study||10
176438|NCT01456195|430026|P1|NOT COMPLETED|Overall Study||11
176439|NCT01456195|430024|P3|COMPLETED|Overall Study||127
176440|NCT01456195|430025|P2|COMPLETED|Overall Study||127
176441|NCT01456195|430026|P1|COMPLETED|Overall Study||132
176442|NCT01456195|430024|P3|STARTED|Overall Study||141
176443|NCT01456195|430025|P2|STARTED|Overall Study||137
176444|NCT01456195|430026|P1|STARTED|Overall Study||143
176445|NCT01456169|430046|P3|NOT COMPLETED|Overall Study||12
176446|NCT01456169|430047|P2|NOT COMPLETED|Overall Study||5
176447|NCT01456169|430048|P1|NOT COMPLETED|Overall Study||10
176448|NCT01456169|430046|P3|COMPLETED|Overall Study||123
176449|NCT01456169|430047|P2|COMPLETED|Overall Study||122
176450|NCT01456169|430048|P1|COMPLETED|Overall Study||123
176451|NCT01456169|430046|P3|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|135
176452|NCT01456169|430047|P2|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|127
176453|NCT01456169|430048|P1|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|133
176454|NCT01456143|430099|P1|NOT COMPLETED|Overall Study||0
176455|NCT01456143|430099|P1|COMPLETED|Overall Study||33
176456|NCT01456143|430099|P1|STARTED|Overall Study||33
176457|NCT01456130|430108|P1|NOT COMPLETED|Overall Study||10
176458|NCT01456130|430108|P1|COMPLETED|Overall Study||57
176459|NCT01456130|430108|P1|STARTED|Overall Study||67
176460|NCT01456052|430118|P3|NOT COMPLETED|Overall Study||5
176461|NCT01456052|430119|P2|NOT COMPLETED|Overall Study||5
176462|NCT01456052|430120|P1|NOT COMPLETED|Overall Study||2
176463|NCT01456052|430118|P3|COMPLETED|Overall Study||19
176464|NCT01456052|430119|P2|COMPLETED|Overall Study||20
176465|NCT01456052|430120|P1|COMPLETED|Overall Study||8
176466|NCT01456052|430118|P3|STARTED|Overall Study||24
176467|NCT01456052|430119|P2|STARTED|Overall Study|One subject did not receive any study drug. That subject is not included in the safety population.|25
176468|NCT01456052|430120|P1|STARTED|Overall Study||10
176469|NCT01456039|430140|P3|NOT COMPLETED|Phase 2 (Second Step)||33
176470|NCT01456039|430141|P2|NOT COMPLETED|Phase 2 (Second Step)||0
176471|NCT01456039|430142|P1|NOT COMPLETED|Phase 2 (Second Step)||0
176472|NCT01456039|430140|P3|COMPLETED|Phase 2 (Second Step)||7
176473|NCT01456039|430141|P2|COMPLETED|Phase 2 (Second Step)||0
176474|NCT01456039|430142|P1|COMPLETED|Phase 2 (Second Step)||0
176475|NCT01456039|430140|P3|STARTED|Phase 2 (Second Step)||40
176476|NCT01456039|430141|P2|STARTED|Phase 2 (Second Step)||0
176477|NCT01456039|430142|P1|STARTED|Phase 2 (Second Step)||0
176478|NCT01456039|430140|P3|NOT COMPLETED|Phase 1 (First Step)||0
176479|NCT01456039|430141|P2|NOT COMPLETED|Phase 1 (First Step)||7
176480|NCT01456039|430142|P1|NOT COMPLETED|Phase 1 (First Step)||2
176481|NCT01456039|430140|P3|COMPLETED|Phase 1 (First Step)||0
176482|NCT01456039|430141|P2|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
176483|NCT01456039|430142|P1|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
176484|NCT01456039|430140|P3|STARTED|Phase 1 (First Step)||0
176485|NCT01456039|430141|P2|STARTED|Phase 1 (First Step)||8
176486|NCT01456039|430142|P1|STARTED|Phase 1 (First Step)||3
176487|NCT01456000|430214|P2|NOT COMPLETED|Overall Study||3
176488|NCT01456000|430215|P1|NOT COMPLETED|Overall Study||8
176489|NCT01456000|430214|P2|COMPLETED|Overall Study||172
176490|NCT01456000|430215|P1|COMPLETED|Overall Study||170
176491|NCT01456000|430214|P2|STARTED|Overall Study||175
176492|NCT01456000|430215|P1|STARTED|Overall Study||178
176493|NCT01455545|430221|P2|NOT COMPLETED|Overall Study||0
176494|NCT01455545|430222|P1|NOT COMPLETED|Overall Study||0
176495|NCT01455545|430221|P2|COMPLETED|Overall Study||45
176496|NCT01455545|430222|P1|COMPLETED|Overall Study||55
176497|NCT01455545|430221|P2|STARTED|Overall Study||45
176498|NCT01455545|430222|P1|STARTED|Overall Study||55
176499|NCT01455519|430252|P2|NOT COMPLETED|Overall Study||5
176500|NCT01455519|430253|P1|NOT COMPLETED|Overall Study||4
176501|NCT01455519|430252|P2|COMPLETED|Overall Study||18
176502|NCT01455519|430253|P1|COMPLETED|Overall Study||8
176503|NCT01455519|430252|P2|STARTED|Overall Study||23
176504|NCT01455519|430253|P1|STARTED|Overall Study||12
176505|NCT01455428|430285|P2|NOT COMPLETED|Overall Study||18
176506|NCT01455428|430286|P1|NOT COMPLETED|Overall Study||14
176507|NCT01455428|430285|P2|COMPLETED|Overall Study||92
176508|NCT01455428|430286|P1|COMPLETED|Overall Study||98
176509|NCT01455428|430285|P2|Treated|Overall Study||109
176510|NCT01455428|430286|P1|Treated|Overall Study||111
176511|NCT01455428|430285|P2|STARTED|Overall Study||110
176512|NCT01455428|430286|P1|STARTED|Overall Study||112
176513|NCT01455415|430342|P2|NOT COMPLETED|Follow-up||2
176514|NCT01455415|430343|P1|NOT COMPLETED|Follow-up||3
176515|NCT01455415|430342|P2|COMPLETED|Follow-up||104
176516|NCT01455415|430343|P1|COMPLETED|Follow-up||111
176517|NCT01455415|430342|P2|STARTED|Follow-up||106
176518|NCT01455415|430343|P1|STARTED|Follow-up||114
176519|NCT01455415|430342|P2|NOT COMPLETED|Period 2||10
176520|NCT01455415|430343|P1|NOT COMPLETED|Period 2||13
176521|NCT01455415|430342|P2|COMPLETED|Period 2||106
176522|NCT01455415|430343|P1|COMPLETED|Period 2||114
176523|NCT01455415|430342|P2|STARTED|Period 2||116
176524|NCT01455415|430343|P1|STARTED|Period 2||127
176525|NCT01455415|430342|P2|NOT COMPLETED|Washout||7
176526|NCT01455415|430343|P1|NOT COMPLETED|Washout||8
176527|NCT01455415|430342|P2|COMPLETED|Washout||116
176528|NCT01455415|430343|P1|COMPLETED|Washout||127
176529|NCT01455415|430342|P2|STARTED|Washout||123
176530|NCT01455415|430343|P1|STARTED|Washout||135
176531|NCT01455415|430342|P2|NOT COMPLETED|Period 1||24
176532|NCT01455415|430343|P1|NOT COMPLETED|Period 1||19
176533|NCT01455415|430342|P2|COMPLETED|Period 1||123
176534|NCT01455415|430343|P1|COMPLETED|Period 1||135
176535|NCT01455415|430342|P2|STARTED|Period 1|Started=Treated|147
176536|NCT01455415|430343|P1|STARTED|Period 1|Started=Treated|154
176537|NCT01455220|430393|P1|NOT COMPLETED|Overall Study||30
176538|NCT01455220|430393|P1|COMPLETED|Overall Study||15
176539|NCT01455220|430393|P1|STARTED|Overall Study||45
176540|NCT01455194|430403|P4|NOT COMPLETED|Overall Study||28
176541|NCT01455194|430404|P3|NOT COMPLETED|Overall Study||30
176542|NCT01455194|430405|P2|NOT COMPLETED|Overall Study||31
176543|NCT01455194|430406|P1|NOT COMPLETED|Overall Study||153
176544|NCT01455194|430403|P4|COMPLETED|Overall Study||97
176545|NCT01455194|430404|P3|COMPLETED|Overall Study||92
176546|NCT01455194|430405|P2|COMPLETED|Overall Study||89
176547|NCT01455194|430406|P1|COMPLETED|Overall Study||0
176548|NCT01455194|430403|P4|STARTED|Overall Study||125
176549|NCT01455194|430404|P3|STARTED|Overall Study||122
176550|NCT01455194|430405|P2|STARTED|Overall Study||120
176551|NCT01455194|430406|P1|STARTED|Overall Study||153
176552|NCT01455181|430455|P1|NOT COMPLETED|Overall Study||0
176553|NCT01455181|430455|P1|COMPLETED|Overall Study||24
176554|NCT01455181|430455|P1|STARTED|Overall Study||24
176555|NCT01455064|430463|P1|NOT COMPLETED|Overall Study||1
176556|NCT01455064|430463|P1|COMPLETED|Overall Study||30
176557|NCT01455064|430463|P1|STARTED|Overall Study||31
176558|NCT01455012|430469|P2|NOT COMPLETED|Overall Study||4
176559|NCT01455012|430470|P1|NOT COMPLETED|Overall Study||11
176560|NCT01455012|430469|P2|COMPLETED|Overall Study||36
176561|NCT01455012|430470|P1|COMPLETED|Overall Study||30
176562|NCT01455012|430469|P2|STARTED|Overall Study||40
176563|NCT01455012|430470|P1|STARTED|Overall Study||41
176564|NCT01454947|430510|P8|NOT COMPLETED|Overall Study||5
176565|NCT01454947|430511|P7|NOT COMPLETED|Overall Study||1
176566|NCT01454947|430512|P6|NOT COMPLETED|Overall Study||3
176567|NCT01454947|430513|P5|NOT COMPLETED|Overall Study||1
176568|NCT01454947|430514|P4|NOT COMPLETED|Overall Study||1
176569|NCT01454947|430515|P3|NOT COMPLETED|Overall Study||3
176570|NCT01454947|430516|P2|NOT COMPLETED|Overall Study||4
176571|NCT01454947|430517|P1|NOT COMPLETED|Overall Study||3
176572|NCT01454947|430510|P8|COMPLETED|Overall Study||23
176573|NCT01454947|430511|P7|COMPLETED|Overall Study||26
176574|NCT01454947|430512|P6|COMPLETED|Overall Study||32
176575|NCT01454947|430513|P5|COMPLETED|Overall Study||33
176576|NCT01454947|430514|P4|COMPLETED|Overall Study||19
176577|NCT01454947|430515|P3|COMPLETED|Overall Study||32
176578|NCT01454947|430516|P2|COMPLETED|Overall Study||38
176579|NCT01454947|430517|P1|COMPLETED|Overall Study||24
176580|NCT01454947|430510|P8|STARTED|Overall Study||28
176581|NCT01454947|430511|P7|STARTED|Overall Study||27
176582|NCT01454947|430512|P6|STARTED|Overall Study||35
176583|NCT01454947|430513|P5|STARTED|Overall Study||34
176584|NCT01454947|430514|P4|STARTED|Overall Study||20
176585|NCT01454947|430515|P3|STARTED|Overall Study||35
176586|NCT01454947|430516|P2|STARTED|Overall Study||42
176587|NCT01454947|430517|P1|STARTED|Overall Study||27
176588|NCT01454934|430537|P2|NOT COMPLETED|Overall Study||270
176589|NCT01454934|430538|P1|NOT COMPLETED|Overall Study||270
176590|NCT01454934|430537|P2|COMPLETED|Overall Study||0
176591|NCT01454934|430538|P1|COMPLETED|Overall Study||0
176592|NCT01454934|430537|P2|STARTED|Overall Study||270
176593|NCT01454934|430538|P1|STARTED|Overall Study||270
176594|NCT01454830|430550|P2|NOT COMPLETED|Overall Study||27
176595|NCT01454830|430551|P1|NOT COMPLETED|Overall Study||31
176596|NCT01454830|430550|P2|COMPLETED|Overall Study||30
176597|NCT01454830|430551|P1|COMPLETED|Overall Study||30
176598|NCT01454830|430550|P2|STARTED|Overall Study||57
176599|NCT01454830|430551|P1|STARTED|Overall Study||61
176600|NCT01454791|430571|P2|NOT COMPLETED|Overall Study||0
176601|NCT01454791|430572|P1|NOT COMPLETED|Overall Study||0
176602|NCT01454791|430571|P2|COMPLETED|Overall Study|20 subjects started with placebo, then switched to Diclofenac|20
176603|NCT01454791|430572|P1|COMPLETED|Overall Study|20 subjects started with Diclofenac, then switched to placebo|20
176604|NCT01454791|430571|P2|STARTED|Overall Study||20
176605|NCT01454791|430572|P1|STARTED|Overall Study||20
176606|NCT01454778|430582|P1|NOT COMPLETED|Overall Study||3
176607|NCT01454778|430582|P1|COMPLETED|Overall Study||47
176608|NCT01454778|430582|P1|STARTED|Overall Study||50
176609|NCT01454739|430593|P2|NOT COMPLETED|Overall Study||21
176610|NCT01454739|430594|P1|NOT COMPLETED|Overall Study||7
176611|NCT01454739|430593|P2|COMPLETED|Overall Study||158
176612|NCT01454739|430594|P1|COMPLETED|Overall Study||54
176613|NCT01454739|430593|P2|Surgery Subgroup|Overall Study||26
176614|NCT01454739|430594|P1|Surgery Subgroup|Overall Study||2
176615|NCT01454739|430593|P2|Episodic|Overall Study||13
176616|NCT01454739|430594|P1|Episodic|Overall Study||0
176617|NCT01454739|430593|P2|Personalized Prophylaxis|Overall Study||23
176618|NCT01454739|430594|P1|Personalized Prophylaxis|Overall Study||3
176619|NCT01454739|430593|P2|Weekly Prophylaxis|Overall Study||34
176620|NCT01454739|430594|P1|Weekly Prophylaxis|Overall Study||0
176621|NCT01454739|430593|P2|Tailored Prophylaxis|Overall Study||131
176622|NCT01454739|430594|P1|Tailored Prophylaxis|Overall Study||59
176623|NCT01454739|430593|P2|STARTED|Overall Study||179
176624|NCT01454739|430594|P1|STARTED|Overall Study|30 participants in <6 Years Old Age Cohort and 31 participants in 6 to <12 Years Old Age Cohort.|61
176625|NCT01454726|430623|P2|NOT COMPLETED|Overall Study||1
176626|NCT01454726|430624|P1|NOT COMPLETED|Overall Study||0
176627|NCT01454726|430623|P2|COMPLETED|Overall Study||10
176628|NCT01454726|430624|P1|COMPLETED|Overall Study||16
176629|NCT01454726|430623|P2|STARTED|Overall Study||11
176630|NCT01454726|430624|P1|STARTED|Overall Study||16
176631|NCT01454596|430642|P12|NOT COMPLETED|Overall Study||0
176632|NCT01454596|430643|P11|NOT COMPLETED|Overall Study||1
176633|NCT01454596|430644|P10|NOT COMPLETED|Overall Study||1
176634|NCT01454596|430645|P9|NOT COMPLETED|Overall Study||0
176635|NCT01454596|430646|P8|NOT COMPLETED|Overall Study||0
176636|NCT01454596|430647|P7|NOT COMPLETED|Overall Study||0
176637|NCT01454596|430648|P6|NOT COMPLETED|Overall Study||0
176638|NCT01454596|430649|P5|NOT COMPLETED|Overall Study||0
176639|NCT01454596|430650|P4|NOT COMPLETED|Overall Study||0
176640|NCT01454596|430651|P3|NOT COMPLETED|Overall Study||0
176641|NCT01454596|430652|P2|NOT COMPLETED|Overall Study||0
176642|NCT01454596|430653|P1|NOT COMPLETED|Overall Study||0
176643|NCT01454596|430642|P12|COMPLETED|Overall Study||1
176644|NCT01454596|430643|P11|COMPLETED|Overall Study||0
176645|NCT01454596|430644|P10|COMPLETED|Overall Study||2
176646|NCT01454596|430645|P9|COMPLETED|Overall Study||3
176647|NCT01454596|430646|P8|COMPLETED|Overall Study||3
176648|NCT01454596|430647|P7|COMPLETED|Overall Study||1
176649|NCT01454596|430648|P6|COMPLETED|Overall Study||1
176650|NCT01454596|430649|P5|COMPLETED|Overall Study||1
176651|NCT01454596|430650|P4|COMPLETED|Overall Study||1
176652|NCT01454596|430651|P3|COMPLETED|Overall Study||1
176653|NCT01454596|430652|P2|COMPLETED|Overall Study||1
176654|NCT01454596|430653|P1|COMPLETED|Overall Study||1
176655|NCT01454596|430642|P12|STARTED|Overall Study||1
176656|NCT01454596|430643|P11|STARTED|Overall Study||1
176657|NCT01454596|430644|P10|STARTED|Overall Study||3
176658|NCT01454596|430645|P9|STARTED|Overall Study||3
176659|NCT01454596|430646|P8|STARTED|Overall Study||3
176660|NCT01454596|430647|P7|STARTED|Overall Study||1
176661|NCT01454596|430648|P6|STARTED|Overall Study||1
176662|NCT01454596|430649|P5|STARTED|Overall Study||1
176663|NCT01454596|430650|P4|STARTED|Overall Study||1
176664|NCT01454596|430651|P3|STARTED|Overall Study||1
176665|NCT01454596|430652|P2|STARTED|Overall Study||1
176666|NCT01454596|430653|P1|STARTED|Overall Study||1
176667|NCT01454583|430730|P3|NOT COMPLETED|3rd Year||297
176668|NCT01454583|430731|P2|NOT COMPLETED|3rd Year||512
176669|NCT01454583|430732|P1|NOT COMPLETED|3rd Year||1959
176670|NCT01454583|430730|P3|COMPLETED|3rd Year||285
176671|NCT01454583|430731|P2|COMPLETED|3rd Year||470
176672|NCT01454583|430732|P1|COMPLETED|3rd Year||1832
176673|NCT01454583|430730|P3|STARTED|3rd Year||582
176674|NCT01454583|430731|P2|STARTED|3rd Year||982
176675|NCT01454583|430732|P1|STARTED|3rd Year||3791
176676|NCT01454583|430730|P3|NOT COMPLETED|2nd Year||737
176677|NCT01454583|430731|P2|NOT COMPLETED|2nd Year||1049
176678|NCT01454583|430732|P1|NOT COMPLETED|2nd Year||3965
176679|NCT01454583|430730|P3|COMPLETED|2nd Year||1376
176680|NCT01454583|430731|P2|COMPLETED|2nd Year||1647
176681|NCT01454583|430732|P1|COMPLETED|2nd Year||6212
176682|NCT01454583|430730|P3|STARTED|2nd Year||2113
176683|NCT01454583|430731|P2|STARTED|2nd Year||2696
176684|NCT01454583|430732|P1|STARTED|2nd Year||10177
176685|NCT01454583|430730|P3|NOT COMPLETED|1st Year||180
176686|NCT01454583|430731|P2|NOT COMPLETED|1st Year||318
176687|NCT01454583|430732|P1|NOT COMPLETED|1st Year||1057
176688|NCT01454583|430730|P3|COMPLETED|1st Year||1933
176689|NCT01454583|430731|P2|COMPLETED|1st Year||2378
176690|NCT01454583|430732|P1|COMPLETED|1st Year||9120
176691|NCT01454583|430730|P3|STARTED|1st Year||2113
176692|NCT01454583|430731|P2|STARTED|1st Year||2696
176693|NCT01454583|430732|P1|STARTED|1st Year|From initially 15337 pat. 351 withdrawed from the registry, 14986 pat. were assigned to the groups.|10177
176694|NCT01454531|430800|P1|NOT COMPLETED|Overall Study||23
176695|NCT01454531|430800|P1|COMPLETED|Overall Study||173
176696|NCT01454531|430800|P1|Subjects Treated|Overall Study||192
176697|NCT01454531|430800|P1|STARTED|Overall Study||196
176698|NCT01454505|430812|P4|NOT COMPLETED|Overall Study||0
176699|NCT01454505|430813|P3|NOT COMPLETED|Overall Study||0
176700|NCT01454505|430814|P2|NOT COMPLETED|Overall Study||0
176701|NCT01454505|430815|P1|NOT COMPLETED|Overall Study||0
176702|NCT01454505|430812|P4|COMPLETED|Overall Study||20
176703|NCT01454505|430813|P3|COMPLETED|Overall Study||40
176704|NCT01454505|430814|P2|COMPLETED|Overall Study||15
176705|NCT01454505|430815|P1|COMPLETED|Overall Study||35
176706|NCT01454505|430812|P4|STARTED|Overall Study||20
176707|NCT01454505|430813|P3|STARTED|Overall Study||40
176708|NCT01454505|430814|P2|STARTED|Overall Study||15
176709|NCT01454505|430815|P1|STARTED|Overall Study||35
176710|NCT01454414|430829|P2|NOT COMPLETED|Overall Study||16
176711|NCT01454414|430830|P1|NOT COMPLETED|Overall Study||13
176712|NCT01454414|430829|P2|COMPLETED|Overall Study||64
176713|NCT01454414|430830|P1|COMPLETED|Overall Study||66
176714|NCT01454414|430829|P2|Baseline: Subjects That Sent Uniforms|Overall Study||66
176715|NCT01454414|430830|P1|Baseline: Subjects That Sent Uniforms|Overall Study||67
176716|NCT01454414|430829|P2|STARTED|Overall Study||80
176717|NCT01454414|430830|P1|STARTED|Overall Study||79
176718|NCT01454401|430836|P1|NOT COMPLETED|Overall Study||5
176719|NCT01454401|430836|P1|COMPLETED|Overall Study|Per Protocol (PP)|39
176720|NCT01454401|430836|P1|STARTED|Overall Study|ITT|44
176721|NCT01454362|430843|P2|NOT COMPLETED|Overall Study||0
176722|NCT01454362|430844|P1|NOT COMPLETED|Overall Study||0
176723|NCT01454362|430843|P2|COMPLETED|Overall Study||23
176724|NCT01454362|430844|P1|COMPLETED|Overall Study||28
176725|NCT01454362|430843|P2|STARTED|Overall Study||23
176726|NCT01454362|430844|P1|STARTED|Overall Study||28
176727|NCT01454284|430860|P2|NOT COMPLETED|Overall Study||73
176728|NCT01454284|430861|P1|NOT COMPLETED|Overall Study||116
176729|NCT01454284|430860|P2|COMPLETED|Overall Study||377
176730|NCT01454284|430861|P1|COMPLETED|Overall Study||548
176731|NCT01454284|430860|P2|Received at Least 1 Dose of Study Drug|Overall Study||449
176732|NCT01454284|430861|P1|Received at Least 1 Dose of Study Drug|Overall Study||663
176733|NCT01454284|430860|P2|STARTED|Overall Study||450
176734|NCT01454284|430861|P1|STARTED|Overall Study||664
176735|NCT01454258|430909|P1|NOT COMPLETED|Overall Study||997
176736|NCT01454258|430909|P1|COMPLETED|Overall Study||9103
176737|NCT01454258|430909|P1|STARTED|Overall Study||10100
176738|NCT01454102|430931|P16|NOT COMPLETED|Overall Study||1
176739|NCT01454102|430932|P15|NOT COMPLETED|Overall Study||3
176740|NCT01454102|430933|P14|NOT COMPLETED|Overall Study||4
176741|NCT01454102|430934|P13|NOT COMPLETED|Overall Study||7
176742|NCT01454102|430935|P12|NOT COMPLETED|Overall Study||4
176743|NCT01454102|430936|P11|NOT COMPLETED|Overall Study||0
176744|NCT01454102|430937|P10|NOT COMPLETED|Overall Study||0
176745|NCT01454102|430938|P9|NOT COMPLETED|Overall Study||1
176746|NCT01454102|430939|P8|NOT COMPLETED|Overall Study||0
176747|NCT01454102|430940|P7|NOT COMPLETED|Overall Study||2
176748|NCT01454102|430941|P6|NOT COMPLETED|Overall Study||3
176749|NCT01454102|430942|P5|NOT COMPLETED|Overall Study||3
176750|NCT01454102|430943|P4|NOT COMPLETED|Overall Study||0
176751|NCT01454102|430944|P3|NOT COMPLETED|Overall Study||0
176752|NCT01454102|430945|P2|NOT COMPLETED|Overall Study||0
176753|NCT01454102|430946|P1|NOT COMPLETED|Overall Study||0
176754|NCT01454102|430931|P16|COMPLETED|Overall Study||13
176755|NCT01454102|430932|P15|COMPLETED|Overall Study||36
176756|NCT01454102|430933|P14|COMPLETED|Overall Study||34
176757|NCT01454102|430934|P13|COMPLETED|Overall Study||33
176758|NCT01454102|430935|P12|COMPLETED|Overall Study||27
176759|NCT01454102|430936|P11|COMPLETED|Overall Study||12
176760|NCT01454102|430937|P10|COMPLETED|Overall Study||13
176761|NCT01454102|430938|P9|COMPLETED|Overall Study||12
176762|NCT01454102|430939|P8|COMPLETED|Overall Study||25
176763|NCT01454102|430940|P7|COMPLETED|Overall Study||22
176764|NCT01454102|430941|P6|COMPLETED|Overall Study||49
176765|NCT01454102|430942|P5|COMPLETED|Overall Study||18
176766|NCT01454102|430943|P4|COMPLETED|Overall Study||12
176767|NCT01454102|430944|P3|COMPLETED|Overall Study||15
176768|NCT01454102|430945|P2|COMPLETED|Overall Study||15
176769|NCT01454102|430946|P1|COMPLETED|Overall Study||12
176770|NCT01454102|430931|P16|STARTED|Overall Study||14
176771|NCT01454102|430932|P15|STARTED|Overall Study||39
176772|NCT01454102|430933|P14|STARTED|Overall Study||38
176773|NCT01454102|430934|P13|STARTED|Overall Study||40
176774|NCT01454102|430935|P12|STARTED|Overall Study||31
176775|NCT01454102|430936|P11|STARTED|Overall Study||12
176776|NCT01454102|430937|P10|STARTED|Overall Study||13
176777|NCT01454102|430938|P9|STARTED|Overall Study||13
176778|NCT01454102|430939|P8|STARTED|Overall Study||25
176779|NCT01454102|430940|P7|STARTED|Overall Study||24
176780|NCT01454102|430941|P6|STARTED|Overall Study||52
176781|NCT01454102|430942|P5|STARTED|Overall Study||21
176782|NCT01454102|430943|P4|STARTED|Overall Study||12
176783|NCT01454102|430944|P3|STARTED|Overall Study||15
176784|NCT01454102|430945|P2|STARTED|Overall Study||15
176785|NCT01454102|430946|P1|STARTED|Overall Study||12
176786|NCT01454076|431066|P5|NOT COMPLETED|Overall Study||6
176787|NCT01454076|431067|P4|NOT COMPLETED|Overall Study||2
176788|NCT01454076|431068|P3|NOT COMPLETED|Overall Study||9
176789|NCT01454076|431069|P2|NOT COMPLETED|Overall Study||6
176790|NCT01454076|431070|P1|NOT COMPLETED|Overall Study||13
176791|NCT01454076|431066|P5|COMPLETED|Overall Study||15
176792|NCT01454076|431067|P4|COMPLETED|Overall Study||16
176793|NCT01454076|431068|P3|COMPLETED|Overall Study||15
176794|NCT01454076|431069|P2|COMPLETED|Overall Study||14
176795|NCT01454076|431070|P1|COMPLETED|Overall Study||16
176796|NCT01454076|431066|P5|STARTED|Overall Study||21
176797|NCT01454076|431067|P4|STARTED|Overall Study||18
176798|NCT01454076|431068|P3|STARTED|Overall Study||24
176799|NCT01454076|431069|P2|STARTED|Overall Study||20
176800|NCT01454076|431070|P1|STARTED|Overall Study||29
176801|NCT01454063|431123|P2|NOT COMPLETED|Treated||0
176802|NCT01454063|431124|P1|NOT COMPLETED|Treated||2
176803|NCT01454063|431123|P2|COMPLETED|Treated||201
176804|NCT01454063|431124|P1|COMPLETED|Treated||199
176805|NCT01454063|431123|P2|STARTED|Treated||201
176806|NCT01454063|431124|P1|STARTED|Treated||201
176807|NCT01454063|431123|P2|NOT COMPLETED|Randomized||2
176808|NCT01454063|431124|P1|NOT COMPLETED|Randomized||1
176809|NCT01454063|431123|P2|COMPLETED|Randomized||201
176810|NCT01454063|431124|P1|COMPLETED|Randomized||201
176811|NCT01454063|431123|P2|STARTED|Randomized||203
176812|NCT01454063|431124|P1|STARTED|Randomized||202
176813|NCT01453998|431145|P3|NOT COMPLETED|After Protocol Amendment 2.||0
176814|NCT01453998|431146|P2|NOT COMPLETED|After Protocol Amendment 2.||0
176815|NCT01453998|431147|P1|NOT COMPLETED|After Protocol Amendment 2.||1
176816|NCT01453998|431145|P3|COMPLETED|After Protocol Amendment 2.||183
176817|NCT01453998|431146|P2|COMPLETED|After Protocol Amendment 2.||99
176818|NCT01453998|431147|P1|COMPLETED|After Protocol Amendment 2.||102
176819|NCT01453998|431145|P3|STARTED|After Protocol Amendment 2.||183
176820|NCT01453998|431146|P2|STARTED|After Protocol Amendment 2.||99
176821|NCT01453998|431147|P1|STARTED|After Protocol Amendment 2.||103
176822|NCT01453998|431145|P3|NOT COMPLETED|Before Protocol Amendment 2||0
176823|NCT01453998|431146|P2|NOT COMPLETED|Before Protocol Amendment 2||0
176824|NCT01453998|431147|P1|NOT COMPLETED|Before Protocol Amendment 2||0
176825|NCT01453998|431145|P3|COMPLETED|Before Protocol Amendment 2||99
176826|NCT01453998|431146|P2|COMPLETED|Before Protocol Amendment 2||88
176827|NCT01453998|431147|P1|COMPLETED|Before Protocol Amendment 2||85
176828|NCT01453998|431145|P3|STARTED|Before Protocol Amendment 2||99
176829|NCT01453998|431146|P2|STARTED|Before Protocol Amendment 2||88
176830|NCT01453998|431147|P1|STARTED|Before Protocol Amendment 2||85
176831|NCT01453946|431212|P1|NOT COMPLETED|Overall Study||9
176832|NCT01453946|431212|P1|COMPLETED|Overall Study||41
176833|NCT01453946|431212|P1|STARTED|Overall Study||50
176834|NCT01453894|431220|P2|NOT COMPLETED|Overall Study||0
176835|NCT01453894|431221|P1|NOT COMPLETED|Overall Study||0
176836|NCT01453894|431220|P2|COMPLETED|Overall Study||225
176837|NCT01453894|431221|P1|COMPLETED|Overall Study||225
176838|NCT01453894|431220|P2|STARTED|Overall Study||225
176839|NCT01453894|431221|P1|STARTED|Overall Study||225
176840|NCT01453855|431229|P2|NOT COMPLETED|Overall Study||14
176841|NCT01453855|431230|P1|NOT COMPLETED|Overall Study||10
176842|NCT01453855|431229|P2|COMPLETED|Overall Study||408
176843|NCT01453855|431230|P1|COMPLETED|Overall Study||432
176844|NCT01453855|431229|P2|STARTED|Overall Study||422
176845|NCT01453855|431230|P1|STARTED|Overall Study||442
176846|NCT01453725|431238|P2|NOT COMPLETED|Overall Study||11
176847|NCT01453725|431239|P1|NOT COMPLETED|Overall Study||13
176848|NCT01453725|431238|P2|COMPLETED|Overall Study||89
176849|NCT01453725|431239|P1|COMPLETED|Overall Study||85
176850|NCT01453725|431238|P2|STARTED|Overall Study||100
176851|NCT01453725|431239|P1|STARTED|Overall Study||98
176852|NCT01453595|431262|P3|NOT COMPLETED|Overall Study||2
176853|NCT01453595|431263|P2|NOT COMPLETED|Overall Study||1
176854|NCT01453595|431264|P1|NOT COMPLETED|Overall Study||2
176855|NCT01453595|431262|P3|COMPLETED|Overall Study||0
176856|NCT01453595|431263|P2|COMPLETED|Overall Study||5
176857|NCT01453595|431264|P1|COMPLETED|Overall Study||0
176858|NCT01453595|431262|P3|STARTED|Overall Study||2
176859|NCT01453595|431263|P2|STARTED|Overall Study||6
176860|NCT01453595|431264|P1|STARTED|Overall Study||2
176861|NCT01453569|431273|P3|NOT COMPLETED|Overall Study||7
176862|NCT01453569|431274|P2|NOT COMPLETED|Overall Study||14
176863|NCT01453569|431275|P1|NOT COMPLETED|Overall Study||11
176864|NCT01453569|431273|P3|COMPLETED|Overall Study||78
176865|NCT01453569|431274|P2|COMPLETED|Overall Study||70
176866|NCT01453569|431275|P1|COMPLETED|Overall Study||75
176867|NCT01453569|431273|P3|STARTED|Overall Study||85
176868|NCT01453569|431274|P2|STARTED|Overall Study||84
176869|NCT01453569|431275|P1|STARTED|Overall Study||86
176870|NCT01453413|431292|P1|NOT COMPLETED|Overall Study||0
176871|NCT01453413|431292|P1|COMPLETED|Overall Study||297
176872|NCT01453413|431292|P1|STARTED|Overall Study||297
176873|NCT01453387|431299|P2|NOT COMPLETED|Overall Study||0
176874|NCT01453387|431300|P1|NOT COMPLETED|Overall Study||0
176875|NCT01453387|431299|P2|COMPLETED|Overall Study||7
176876|NCT01453387|431300|P1|COMPLETED|Overall Study||21
176877|NCT01453387|431299|P2|STARTED|Overall Study||7
176878|NCT01453387|431300|P1|STARTED|Overall Study||21
176879|NCT01453374|431383|P1|NOT COMPLETED|Overall Study||18
176880|NCT01453374|431383|P1|COMPLETED|Overall Study|Defined as receiving 7 injections and 2 follow-up visits.|9
176881|NCT01453374|431383|P1|STARTED|Overall Study||27
176882|NCT01453361|431399|P1|NOT COMPLETED|Overall Study||16
176883|NCT01453361|431399|P1|COMPLETED|Overall Study||2
176884|NCT01453361|431399|P1|STARTED|Overall Study||18
176885|NCT01453348|431407|P3|NOT COMPLETED|Overall Study||1
176886|NCT01453348|431408|P2|NOT COMPLETED|Overall Study||1
176887|NCT01453348|431409|P1|NOT COMPLETED|Overall Study||1
176888|NCT01453348|431407|P3|COMPLETED|Overall Study||83
176889|NCT01453348|431408|P2|COMPLETED|Overall Study||83
176890|NCT01453348|431409|P1|COMPLETED|Overall Study||83
176891|NCT01453348|431407|P3|STARTED|Overall Study||84
176892|NCT01453348|431408|P2|STARTED|Overall Study||84
176893|NCT01453348|431409|P1|STARTED|Overall Study||84
176894|NCT01453296|431425|P2|NOT COMPLETED|Treatment Period 2||0
176895|NCT01453296|431426|P1|NOT COMPLETED|Treatment Period 2||2
176896|NCT01453296|431425|P2|COMPLETED|Treatment Period 2||13
176897|NCT01453296|431426|P1|COMPLETED|Treatment Period 2||11
176898|NCT01453296|431425|P2|STARTED|Treatment Period 2||13
176899|NCT01453296|431426|P1|STARTED|Treatment Period 2||13
176900|NCT01453296|431425|P2|NOT COMPLETED|Washout Period||0
176901|NCT01453296|431426|P1|NOT COMPLETED|Washout Period||0
176902|NCT01453296|431425|P2|COMPLETED|Washout Period||13
176903|NCT01453296|431426|P1|COMPLETED|Washout Period||13
176904|NCT01453296|431425|P2|STARTED|Washout Period||13
176905|NCT01453296|431426|P1|STARTED|Washout Period||13
176906|NCT01453296|431425|P2|NOT COMPLETED|Treatment Period 1||1
176907|NCT01453296|431426|P1|NOT COMPLETED|Treatment Period 1||1
176908|NCT01453296|431425|P2|COMPLETED|Treatment Period 1||13
176909|NCT01453296|431426|P1|COMPLETED|Treatment Period 1||13
176910|NCT01453296|431425|P2|STARTED|Treatment Period 1||14
176911|NCT01453296|431426|P1|STARTED|Treatment Period 1||14
176912|NCT01453205|431493|P3|NOT COMPLETED|Overall Study||54
176913|NCT01453205|431494|P2|NOT COMPLETED|Overall Study||52
176914|NCT01453205|431495|P1|NOT COMPLETED|Overall Study||80
176915|NCT01453205|431493|P3|COMPLETED|Overall Study||1
176916|NCT01453205|431494|P2|COMPLETED|Overall Study||0
176917|NCT01453205|431495|P1|COMPLETED|Overall Study||0
176918|NCT01453205|431493|P3|STARTED|Overall Study||55
176919|NCT01453205|431494|P2|STARTED|Overall Study||52
176920|NCT01453205|431495|P1|STARTED|Overall Study||80
176921|NCT01453166|431546|P3|NOT COMPLETED|Overall Study||1
176922|NCT01453166|431547|P2|NOT COMPLETED|Overall Study||2
176923|NCT01453166|431548|P1|NOT COMPLETED|Overall Study||2
176924|NCT01453166|431546|P3|COMPLETED|Overall Study||38
176925|NCT01453166|431547|P2|COMPLETED|Overall Study||39
176926|NCT01453166|431548|P1|COMPLETED|Overall Study||40
176927|NCT01453166|431546|P3|STARTED|Overall Study||39
176928|NCT01453166|431547|P2|STARTED|Overall Study||41
176929|NCT01453166|431548|P1|STARTED|Overall Study||42
176930|NCT01453153|431571|P3|NOT COMPLETED|Overall Study||20
176931|NCT01453153|431572|P2|NOT COMPLETED|Overall Study||4
176932|NCT01453153|431573|P1|NOT COMPLETED|Overall Study||4
176933|NCT01453153|431571|P3|COMPLETED|Overall Study||0
176934|NCT01453153|431572|P2|COMPLETED|Overall Study||0
176935|NCT01453153|431573|P1|COMPLETED|Overall Study||0
176936|NCT01453153|431571|P3|STARTED|Overall Study||20
176937|NCT01453153|431572|P2|STARTED|Overall Study||4
176938|NCT01453153|431573|P1|STARTED|Overall Study||4
176939|NCT01453075|431646|P2|NOT COMPLETED|Overall Study||1
176940|NCT01453075|431647|P1|NOT COMPLETED|Overall Study||5
176941|NCT01453075|431646|P2|COMPLETED|Overall Study||14
176942|NCT01453075|431647|P1|COMPLETED|Overall Study||11
176943|NCT01453075|431646|P2|STARTED|Overall Study||15
176944|NCT01453075|431647|P1|STARTED|Overall Study||16
176945|NCT01453049|431655|P2|NOT COMPLETED|Overall Study||42
176946|NCT01453049|431656|P1|NOT COMPLETED|Overall Study||41
176947|NCT01453049|431655|P2|COMPLETED|Overall Study||2
176948|NCT01453049|431656|P1|COMPLETED|Overall Study||1
176949|NCT01453049|431655|P2|STARTED|Overall Study||44
176950|NCT01453049|431656|P1|STARTED|Overall Study||42
176951|NCT01453036|431729|P3|NOT COMPLETED|Overall Study||31
176952|NCT01453036|431730|P2|NOT COMPLETED|Overall Study||115
176953|NCT01453036|431731|P1|NOT COMPLETED|Overall Study||26
176954|NCT01453036|431729|P3|COMPLETED|Overall Study||277
176955|NCT01453036|431730|P2|COMPLETED|Overall Study||193
176956|NCT01453036|431731|P1|COMPLETED|Overall Study||282
176957|NCT01453036|431729|P3|STARTED|Overall Study||308
176958|NCT01453036|431730|P2|STARTED|Overall Study||308
176959|NCT01453036|431731|P1|STARTED|Overall Study||308
176960|NCT01453023|431739|P2|NOT COMPLETED|Treatment Period 2||1
176961|NCT01453023|431740|P1|NOT COMPLETED|Treatment Period 2||0
176962|NCT01453023|431739|P2|COMPLETED|Treatment Period 2||11
176963|NCT01453023|431740|P1|COMPLETED|Treatment Period 2||12
176964|NCT01453023|431739|P2|STARTED|Treatment Period 2||12
176965|NCT01453023|431740|P1|STARTED|Treatment Period 2||12
176966|NCT01453023|431739|P2|NOT COMPLETED|Washout Period||0
176967|NCT01453023|431740|P1|NOT COMPLETED|Washout Period||0
176968|NCT01453023|431739|P2|COMPLETED|Washout Period||12
176969|NCT01453023|431740|P1|COMPLETED|Washout Period||12
176970|NCT01453023|431739|P2|STARTED|Washout Period||12
176971|NCT01453023|431740|P1|STARTED|Washout Period||12
176972|NCT01453023|431739|P2|NOT COMPLETED|Treatment Period (TP) 1||1
176973|NCT01453023|431740|P1|NOT COMPLETED|Treatment Period (TP) 1||1
176974|NCT01453023|431739|P2|COMPLETED|Treatment Period (TP) 1||12
176975|NCT01453023|431740|P1|COMPLETED|Treatment Period (TP) 1||12
176976|NCT01453023|431739|P2|STARTED|Treatment Period (TP) 1||13
176977|NCT01453023|431740|P1|STARTED|Treatment Period (TP) 1||13
176978|NCT01452854|431808|P1|NOT COMPLETED|Overall Study||0
176979|NCT01452854|431808|P1|COMPLETED|Overall Study||2
176980|NCT01452854|431808|P1|STARTED|Overall Study||2
176981|NCT01452529|431814|P3|NOT COMPLETED|Double-blind (DB) Period||82
176982|NCT01452529|431815|P2|NOT COMPLETED|Double-blind (DB) Period||67
176983|NCT01452529|431816|P1|NOT COMPLETED|Double-blind (DB) Period||0
176984|NCT01452529|431814|P3|COMPLETED|Double-blind (DB) Period||210
176985|NCT01452529|431815|P2|COMPLETED|Double-blind (DB) Period|4 subjects who did not receive DB medication were still counted as discontinued in the DB period|229
176986|NCT01452529|431816|P1|COMPLETED|Double-blind (DB) Period||0
176987|NCT01452529|431814|P3|STARTED|Double-blind (DB) Period||292
176988|NCT01452529|431815|P2|STARTED|Double-blind (DB) Period|Four subjects were randomized but did not receive DB medication|296
176989|NCT01452529|431816|P1|STARTED|Double-blind (DB) Period||0
176990|NCT01452529|431814|P3|NOT COMPLETED|Run-in Period||0
176991|NCT01452529|431815|P2|NOT COMPLETED|Run-in Period||0
176992|NCT01452529|431816|P1|NOT COMPLETED|Run-in Period||313
176993|NCT01452529|431814|P3|COMPLETED|Run-in Period||0
176994|NCT01452529|431815|P2|COMPLETED|Run-in Period||0
176995|NCT01452529|431816|P1|COMPLETED|Run-in Period||592
176996|NCT01452529|431814|P3|STARTED|Run-in Period||0
176997|NCT01452529|431815|P2|STARTED|Run-in Period||0
176998|NCT01452529|431816|P1|STARTED|Run-in Period||905
176999|NCT01452425|431831|P1|NOT COMPLETED|Overall Study||0
177000|NCT01452425|431831|P1|COMPLETED|Overall Study||10
177001|NCT01452425|431831|P1|STARTED|Overall Study||10
177002|NCT01452347|431838|P2|NOT COMPLETED|Overall Study||7
177003|NCT01452347|431839|P1|NOT COMPLETED|Overall Study||17
177004|NCT01452347|431838|P2|COMPLETED|Overall Study||77
177005|NCT01452347|431839|P1|COMPLETED|Overall Study||151
177006|NCT01452347|431838|P2|STARTED|Overall Study||84
177007|NCT01452347|431839|P1|STARTED|Overall Study||168
177008|NCT01452269|431857|P2|NOT COMPLETED|Overall Study||5
177009|NCT01452269|431858|P1|NOT COMPLETED|Overall Study||1
177010|NCT01452269|431857|P2|COMPLETED|Overall Study||51
177011|NCT01452269|431858|P1|COMPLETED|Overall Study||47
177012|NCT01452269|431857|P2|STARTED|Overall Study||56
177013|NCT01452269|431858|P1|STARTED|Overall Study||48
177014|NCT01452191|431871|P3|NOT COMPLETED|Overall Study||112
177015|NCT01452191|431872|P2|NOT COMPLETED|Overall Study||117
177016|NCT01452191|431873|P1|NOT COMPLETED|Overall Study||132
177017|NCT01452191|431871|P3|COMPLETED|Overall Study||258
177018|NCT01452191|431872|P2|COMPLETED|Overall Study||252
177019|NCT01452191|431873|P1|COMPLETED|Overall Study||241
177020|NCT01452191|431871|P3|STARTED|Overall Study||370
177021|NCT01452191|431872|P2|STARTED|Overall Study||369
177022|NCT01452191|431873|P1|STARTED|Overall Study||373
177023|NCT01452152|431899|P3|NOT COMPLETED|Overall Study||4
177024|NCT01452152|431900|P2|NOT COMPLETED|Overall Study||0
177025|NCT01452152|431901|P1|NOT COMPLETED|Overall Study||5
177026|NCT01452152|431899|P3|COMPLETED|Overall Study||0
177027|NCT01452152|431900|P2|COMPLETED|Overall Study||0
177028|NCT01452152|431901|P1|COMPLETED|Overall Study||0
177029|NCT01452152|431899|P3|STARTED|Overall Study||4
177030|NCT01452152|431900|P2|STARTED|Overall Study||0
177031|NCT01452152|431901|P1|STARTED|Overall Study||5
177032|NCT01452126|431924|P1|NOT COMPLETED|Overall Study||0
177033|NCT01452126|431924|P1|COMPLETED|Overall Study||49
177034|NCT01452126|431924|P1|STARTED|Overall Study||49
177035|NCT01451996|431936|P4|NOT COMPLETED|Overall Study||0
177036|NCT01451996|431937|P3|NOT COMPLETED|Overall Study||0
177037|NCT01451996|431938|P2|NOT COMPLETED|Overall Study||0
177038|NCT01451996|431939|P1|NOT COMPLETED|Overall Study||0
177039|NCT01451996|431936|P4|COMPLETED|Overall Study||85
177040|NCT01451996|431937|P3|COMPLETED|Overall Study||85
177041|NCT01451996|431938|P2|COMPLETED|Overall Study||87
177042|NCT01451996|431939|P1|COMPLETED|Overall Study||83
177043|NCT01451996|431936|P4|STARTED|Overall Study||85
177044|NCT01451996|431937|P3|STARTED|Overall Study||85
177045|NCT01451996|431938|P2|STARTED|Overall Study||87
177046|NCT01451996|431939|P1|STARTED|Overall Study||83
177047|NCT01451983|431957|P4|NOT COMPLETED|Overall Study||0
177048|NCT01451983|431958|P3|NOT COMPLETED|Overall Study||0
177049|NCT01451983|431959|P2|NOT COMPLETED|Overall Study||0
177050|NCT01451983|431960|P1|NOT COMPLETED|Overall Study||0
177051|NCT01451983|431957|P4|COMPLETED|Overall Study||24
177052|NCT01451983|431958|P3|COMPLETED|Overall Study||61
177053|NCT01451983|431959|P2|COMPLETED|Overall Study||27
177054|NCT01451983|431960|P1|COMPLETED|Overall Study||26
177055|NCT01451983|431957|P4|STARTED|Overall Study||24
177056|NCT01451983|431958|P3|STARTED|Overall Study||61
177057|NCT01451983|431959|P2|STARTED|Overall Study||27
177058|NCT01451983|431960|P1|STARTED|Overall Study||26
177059|NCT01451931|431973|P3|NOT COMPLETED|Overall Study||43
177060|NCT01451931|431974|P2|NOT COMPLETED|Overall Study||58
177061|NCT01451931|431975|P1|NOT COMPLETED|Overall Study||33
177062|NCT01451931|431973|P3|COMPLETED|Overall Study||923
177063|NCT01451931|431974|P2|COMPLETED|Overall Study||843
177064|NCT01451931|431975|P1|COMPLETED|Overall Study||876
177065|NCT01451931|431973|P3|6-month Follow up|Overall Study||923
177066|NCT01451931|431974|P2|6-month Follow up|Overall Study||843
177067|NCT01451931|431975|P1|6-month Follow up|Overall Study||876
177068|NCT01451931|431973|P3|Baseline Data Collection|Overall Study||958
177069|NCT01451931|431974|P2|Baseline Data Collection|Overall Study||893
177070|NCT01451931|431975|P1|Baseline Data Collection|Overall Study||908
177071|NCT01451931|431973|P3|STARTED|Overall Study||966
177072|NCT01451931|431974|P2|STARTED|Overall Study||901
177073|NCT01451931|431975|P1|STARTED|Overall Study||909
177074|NCT01451827|431999|P4|NOT COMPLETED|Overall Study||4
177075|NCT01451827|432000|P3|NOT COMPLETED|Overall Study||2
177076|NCT01451827|432001|P2|NOT COMPLETED|Overall Study||5
177077|NCT01451827|432002|P1|NOT COMPLETED|Overall Study||3
177078|NCT01451827|431999|P4|COMPLETED|Overall Study||39
177079|NCT01451827|432000|P3|COMPLETED|Overall Study||42
177080|NCT01451827|432001|P2|COMPLETED|Overall Study||40
177081|NCT01451827|432002|P1|COMPLETED|Overall Study||42
177082|NCT01451827|431999|P4|STARTED|Overall Study||43
177083|NCT01451827|432000|P3|STARTED|Overall Study||44
177084|NCT01451827|432001|P2|STARTED|Overall Study||45
177085|NCT01451827|432002|P1|STARTED|Overall Study||45
177086|NCT01451814|432022|P2|NOT COMPLETED|Overall Study||5
177087|NCT01451814|432023|P1|NOT COMPLETED|Overall Study||6
177088|NCT01451814|432022|P2|COMPLETED|Overall Study||26
177089|NCT01451814|432023|P1|COMPLETED|Overall Study||29
177090|NCT01451814|432022|P2|Attended a Session|Overall Study||31
177091|NCT01451814|432023|P1|Attended a Session|Overall Study||35
177092|NCT01451814|432022|P2|STARTED|Overall Study||31
177093|NCT01451814|432023|P1|STARTED|Overall Study||35
177094|NCT01451775|432033|P6|NOT COMPLETED|Overall Study||0
177095|NCT01451775|432034|P5|NOT COMPLETED|Overall Study||0
177096|NCT01451775|432035|P4|NOT COMPLETED|Overall Study||0
177097|NCT01451775|432036|P3|NOT COMPLETED|Overall Study||0
177098|NCT01451775|432037|P2|NOT COMPLETED|Overall Study||0
177099|NCT01451775|432038|P1|NOT COMPLETED|Overall Study||0
177100|NCT01451775|432033|P6|COMPLETED|Overall Study||3
177101|NCT01451775|432034|P5|COMPLETED|Overall Study||3
177102|NCT01451775|432035|P4|COMPLETED|Overall Study||3
177103|NCT01451775|432036|P3|COMPLETED|Overall Study||3
177104|NCT01451775|432037|P2|COMPLETED|Overall Study||3
177105|NCT01451775|432038|P1|COMPLETED|Overall Study||3
177106|NCT01451775|432033|P6|STARTED|Overall Study||3
177107|NCT01451775|432034|P5|STARTED|Overall Study||3
177108|NCT01451775|432035|P4|STARTED|Overall Study||3
177109|NCT01451775|432036|P3|STARTED|Overall Study||3
177110|NCT01451775|432037|P2|STARTED|Overall Study||3
177111|NCT01451775|432038|P1|STARTED|Overall Study||3
177112|NCT01451762|432055|P3|NOT COMPLETED|Overall Study||6
177113|NCT01451762|432056|P2|NOT COMPLETED|Overall Study||6
177114|NCT01451762|432057|P1|NOT COMPLETED|Overall Study||3
177115|NCT01451762|432055|P3|COMPLETED|Overall Study||24
177116|NCT01451762|432056|P2|COMPLETED|Overall Study||24
177117|NCT01451762|432057|P1|COMPLETED|Overall Study||27
177118|NCT01451762|432055|P3|STARTED|Overall Study||30
177119|NCT01451762|432056|P2|STARTED|Overall Study||30
177120|NCT01451762|432057|P1|STARTED|Overall Study||30
177121|NCT01451749|432067|P2|NOT COMPLETED|Overall Study||14
177122|NCT01451749|432068|P1|NOT COMPLETED|Overall Study||32
177123|NCT01451749|432067|P2|COMPLETED|Overall Study||94
177124|NCT01451749|432068|P1|COMPLETED|Overall Study||184
177125|NCT01451749|432067|P2|STARTED|Overall Study||108
177126|NCT01451749|432068|P1|STARTED|Overall Study||216
177127|NCT01451723|432080|P2|NOT COMPLETED|Overall Study||5
177128|NCT01451723|432081|P1|NOT COMPLETED|Overall Study||6
177129|NCT01451723|432080|P2|COMPLETED|Overall Study||0
177130|NCT01451723|432081|P1|COMPLETED|Overall Study||0
177131|NCT01451723|432080|P2|STARTED|Overall Study||5
177132|NCT01451723|432081|P1|STARTED|Overall Study||6
177133|NCT01451645|432091|P2|NOT COMPLETED|Overall Study||8
177134|NCT01451645|432092|P1|NOT COMPLETED|Overall Study||9
177135|NCT01451645|432091|P2|COMPLETED|Overall Study||33
177136|NCT01451645|432092|P1|COMPLETED|Overall Study||32
177137|NCT01451645|432091|P2|STARTED|Overall Study||41
177138|NCT01451645|432092|P1|STARTED|Overall Study||41
177139|NCT01451632|432106|P10|NOT COMPLETED|Overall Study||0
177140|NCT01451632|432107|P9|NOT COMPLETED|Overall Study||0
177141|NCT01451632|432108|P8|NOT COMPLETED|Overall Study||0
177142|NCT01451632|432109|P7|NOT COMPLETED|Overall Study||0
177143|NCT01451632|432110|P6|NOT COMPLETED|Overall Study||0
177144|NCT01451632|432111|P5|NOT COMPLETED|Overall Study||0
177145|NCT01451632|432112|P4|NOT COMPLETED|Overall Study||0
177146|NCT01451632|432113|P3|NOT COMPLETED|Overall Study||0
177147|NCT01451632|432114|P2|NOT COMPLETED|Overall Study||0
177148|NCT01451632|432115|P1|NOT COMPLETED|Overall Study||0
177149|NCT01451632|432106|P10|COMPLETED|Overall Study||4
177150|NCT01451632|432107|P9|COMPLETED|Overall Study||4
177151|NCT01451632|432108|P8|COMPLETED|Overall Study||6
177152|NCT01451632|432109|P7|COMPLETED|Overall Study||8
177153|NCT01451632|432110|P6|COMPLETED|Overall Study||4
177154|NCT01451632|432111|P5|COMPLETED|Overall Study||4
177155|NCT01451632|432112|P4|COMPLETED|Overall Study||3
177156|NCT01451632|432113|P3|COMPLETED|Overall Study||3
177157|NCT01451632|432114|P2|COMPLETED|Overall Study||4
177158|NCT01451632|432115|P1|COMPLETED|Overall Study||8
177159|NCT01451632|432106|P10|STARTED|Overall Study||4
177160|NCT01451632|432107|P9|STARTED|Overall Study||4
177161|NCT01451632|432108|P8|STARTED|Overall Study||6
177162|NCT01451632|432109|P7|STARTED|Overall Study||8
177163|NCT01451632|432110|P6|STARTED|Overall Study||4
177164|NCT01451632|432111|P5|STARTED|Overall Study||4
177165|NCT01451632|432112|P4|STARTED|Overall Study||3
177166|NCT01451632|432113|P3|STARTED|Overall Study||3
177167|NCT01451632|432114|P2|STARTED|Overall Study||4
177168|NCT01451632|432115|P1|STARTED|Overall Study||8
177169|NCT01451606|432163|P2|NOT COMPLETED|Overall Study||3
177170|NCT01451606|432164|P1|NOT COMPLETED|Overall Study||4
177171|NCT01451606|432163|P2|COMPLETED|Overall Study||15
177172|NCT01451606|432164|P1|COMPLETED|Overall Study||12
177173|NCT01451606|432163|P2|STARTED|Overall Study||18
177174|NCT01451606|432164|P1|STARTED|Overall Study||16
177175|NCT01451554|432174|P2|NOT COMPLETED|Overall Study||9
177176|NCT01451554|432175|P1|NOT COMPLETED|Overall Study||14
177177|NCT01451554|432174|P2|COMPLETED|Overall Study||23
177178|NCT01451554|432175|P1|COMPLETED|Overall Study||19
177179|NCT01451554|432174|P2|STARTED|Overall Study||32
177180|NCT01451554|432175|P1|STARTED|Overall Study||33
177181|NCT01451541|432186|P3|NOT COMPLETED|Overall Study||27
177182|NCT01451541|432187|P2|NOT COMPLETED|Overall Study||25
177183|NCT01451541|432188|P1|NOT COMPLETED|Overall Study||36
177184|NCT01451541|432186|P3|COMPLETED|Overall Study||254
177185|NCT01451541|432187|P2|COMPLETED|Overall Study||257
177186|NCT01451541|432188|P1|COMPLETED|Overall Study||247
177187|NCT01451541|432186|P3|STARTED|Overall Study|283 randomized. ITT = 281 (2 subjects discontinued prior to study medication).|281
177188|NCT01451541|432187|P2|STARTED|Overall Study||282
177189|NCT01451541|432188|P1|STARTED|Overall Study||283
177190|NCT01451463|432228|P1|NOT COMPLETED|Overall Study||0
177191|NCT01451463|432228|P1|COMPLETED|Overall Study||11
177192|NCT01451463|432228|P1|STARTED|Overall Study||11
177193|NCT01451437|432246|P9|NOT COMPLETED|Overall Study||4
177194|NCT01451437|432247|P8|NOT COMPLETED|Overall Study||3
177195|NCT01451437|432248|P7|NOT COMPLETED|Overall Study||6
177196|NCT01451437|432249|P6|NOT COMPLETED|Overall Study||3
177197|NCT01451437|432250|P5|NOT COMPLETED|Overall Study||4
177198|NCT01451437|432251|P4|NOT COMPLETED|Overall Study||1
177199|NCT01451437|432252|P3|NOT COMPLETED|Overall Study||3
177200|NCT01451437|432253|P2|NOT COMPLETED|Overall Study||1
177201|NCT01451437|432254|P1|NOT COMPLETED|Overall Study||1
177202|NCT01451437|432246|P9|COMPLETED|Overall Study||0
177203|NCT01451437|432247|P8|COMPLETED|Overall Study||0
177204|NCT01451437|432248|P7|COMPLETED|Overall Study||0
177205|NCT01451437|432249|P6|COMPLETED|Overall Study||0
177206|NCT01451437|432250|P5|COMPLETED|Overall Study||0
177207|NCT01451437|432251|P4|COMPLETED|Overall Study||0
177208|NCT01451437|432252|P3|COMPLETED|Overall Study||0
177209|NCT01451437|432253|P2|COMPLETED|Overall Study||0
177210|NCT01451437|432254|P1|COMPLETED|Overall Study||0
177211|NCT01451437|432246|P9|STARTED|Overall Study||4
177212|NCT01451437|432247|P8|STARTED|Overall Study||3
177213|NCT01451437|432248|P7|STARTED|Overall Study||6
177214|NCT01451437|432249|P6|STARTED|Overall Study||3
177215|NCT01451437|432250|P5|STARTED|Overall Study||4
177216|NCT01451437|432251|P4|STARTED|Overall Study||1
177217|NCT01451437|432252|P3|STARTED|Overall Study||3
177218|NCT01451437|432253|P2|STARTED|Overall Study||1
177219|NCT01451437|432254|P1|STARTED|Overall Study||1
177220|NCT01451424|432386|P4|NOT COMPLETED|Overall Study||5
177221|NCT01451424|432387|P3|NOT COMPLETED|Overall Study||1
177222|NCT01451424|432388|P2|NOT COMPLETED|Overall Study||2
177223|NCT01451424|432389|P1|NOT COMPLETED|Overall Study||1
177224|NCT01451424|432386|P4|COMPLETED|Overall Study||5
177225|NCT01451424|432387|P3|COMPLETED|Overall Study||11
177226|NCT01451424|432388|P2|COMPLETED|Overall Study||7
177227|NCT01451424|432389|P1|COMPLETED|Overall Study||8
177228|NCT01451424|432386|P4|STARTED|Overall Study||10
177229|NCT01451424|432387|P3|STARTED|Overall Study||12
177230|NCT01451424|432388|P2|STARTED|Overall Study||9
177231|NCT01451424|432389|P1|STARTED|Overall Study||9
177232|NCT01451411|432422|P2|NOT COMPLETED|Overall Study||0
177233|NCT01451411|432423|P1|NOT COMPLETED|Overall Study||0
177234|NCT01451411|432422|P2|COMPLETED|Overall Study||1
177235|NCT01451411|432423|P1|COMPLETED|Overall Study||3
177236|NCT01451411|432422|P2|STARTED|Overall Study||1
177237|NCT01451411|432423|P1|STARTED|Overall Study||3
177238|NCT01451398|432447|P2|NOT COMPLETED|Overall Study||37
177239|NCT01451398|432448|P1|NOT COMPLETED|Overall Study||27
177240|NCT01451398|432447|P2|COMPLETED|Overall Study||139
177241|NCT01451398|432448|P1|COMPLETED|Overall Study||150
177242|NCT01451398|432447|P2|STARTED|Overall Study||176
177243|NCT01451398|432448|P1|STARTED|Overall Study||177
177244|NCT01451372|432480|P1|NOT COMPLETED|Overall Study||0
177245|NCT01451372|432480|P1|COMPLETED|Overall Study||69
177246|NCT01451372|432480|P1|STARTED|Overall Study||69
177247|NCT01451203|432487|P2|NOT COMPLETED|Post-treatment Period||34
177248|NCT01451203|432488|P1|NOT COMPLETED|Post-treatment Period||14
177249|NCT01451203|432487|P2|COMPLETED|Post-treatment Period||74
177250|NCT01451203|432488|P1|COMPLETED|Post-treatment Period||57
177251|NCT01451203|432487|P2|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|28
177252|NCT01451203|432488|P1|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|12
177253|NCT01451203|432487|P2|STARTED|Post-treatment Period|Three participants received rescue treatment and did not enter this period.|108
177254|NCT01451203|432488|P1|STARTED|Post-treatment Period|Two participants received rescue treatment and did not enter this period.|71
177255|NCT01451203|432487|P2|NOT COMPLETED|Double-blind Treatment Period||50
177256|NCT01451203|432488|P1|NOT COMPLETED|Double-blind Treatment Period||85
177257|NCT01451203|432487|P2|COMPLETED|Double-blind Treatment Period||111
177258|NCT01451203|432488|P1|COMPLETED|Double-blind Treatment Period||73
177259|NCT01451203|432487|P2|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|36
177260|NCT01451203|432488|P1|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|70
177261|NCT01451203|432487|P2|Received Treatment|Double-blind Treatment Period||159
177262|NCT01451203|432488|P1|Received Treatment|Double-blind Treatment Period||157
177263|NCT01451203|432487|P2|STARTED|Double-blind Treatment Period||161
177264|NCT01451203|432488|P1|STARTED|Double-blind Treatment Period||158
177265|NCT01451164|432506|P4|NOT COMPLETED|Overall Study||46
177266|NCT01451164|432507|P3|NOT COMPLETED|Overall Study||45
177267|NCT01451164|432508|P2|NOT COMPLETED|Overall Study||34
177268|NCT01451164|432509|P1|NOT COMPLETED|Overall Study||43
177269|NCT01451164|432506|P4|COMPLETED|Overall Study||70
177270|NCT01451164|432507|P3|COMPLETED|Overall Study||68
177271|NCT01451164|432508|P2|COMPLETED|Overall Study||81
177272|NCT01451164|432509|P1|COMPLETED|Overall Study||72
177273|NCT01451164|432506|P4|STARTED|Overall Study||116
177274|NCT01451164|432507|P3|STARTED|Overall Study||113
177275|NCT01451164|432508|P2|STARTED|Overall Study||115
177276|NCT01451164|432509|P1|STARTED|Overall Study||115
177277|NCT01450943|432538|P3|NOT COMPLETED|Overall Study||6
177278|NCT01450943|432539|P2|NOT COMPLETED|Overall Study||7
177279|NCT01450943|432540|P1|NOT COMPLETED|Overall Study||2
177280|NCT01450943|432538|P3|COMPLETED|Overall Study||42
177281|NCT01450943|432539|P2|COMPLETED|Overall Study||35
177282|NCT01450943|432540|P1|COMPLETED|Overall Study||26
177283|NCT01450943|432538|P3|STARTED|Overall Study||48
177284|NCT01450943|432539|P2|STARTED|Overall Study||42
177285|NCT01450943|432540|P1|STARTED|Overall Study||28
177286|NCT01450826|432556|P2|NOT COMPLETED|Overall Study||0
177287|NCT01450826|432557|P1|NOT COMPLETED|Overall Study||0
177288|NCT01450826|432556|P2|COMPLETED|Overall Study||66
177289|NCT01450826|432557|P1|COMPLETED|Overall Study||70
177290|NCT01450826|432556|P2|STARTED|Overall Study||66
177291|NCT01450826|432557|P1|STARTED|Overall Study||70
177292|NCT01450813|432573|P4|NOT COMPLETED|Overall Study||3
177293|NCT01450813|432574|P3|NOT COMPLETED|Overall Study||0
177294|NCT01450813|432575|P2|NOT COMPLETED|Overall Study||1
177295|NCT01450813|432576|P1|NOT COMPLETED|Overall Study||1
177296|NCT01450813|432573|P4|COMPLETED|Overall Study||17
177297|NCT01450813|432574|P3|COMPLETED|Overall Study||20
177298|NCT01450813|432575|P2|COMPLETED|Overall Study||19
177299|NCT01450813|432576|P1|COMPLETED|Overall Study||19
177300|NCT01450813|432573|P4|STARTED|Overall Study||20
177301|NCT01450813|432574|P3|STARTED|Overall Study||20
177302|NCT01450813|432575|P2|STARTED|Overall Study||20
177303|NCT01450813|432576|P1|STARTED|Overall Study||20
177304|NCT01450800|432590|P2|NOT COMPLETED|Overall Study||3
177305|NCT01450800|432591|P1|NOT COMPLETED|Overall Study||1
177306|NCT01450800|432590|P2|COMPLETED|Overall Study||78
177307|NCT01450800|432591|P1|COMPLETED|Overall Study||81
177308|NCT01450800|432590|P2|STARTED|Overall Study|81 participants were randomized to placebo|81
177309|NCT01450800|432591|P1|STARTED|Overall Study|82 participants were randomized to nitrofurantoin|82
177310|NCT01450787|432607|P2|NOT COMPLETED|Overall Study||0
177311|NCT01450787|432608|P1|NOT COMPLETED|Overall Study||0
177312|NCT01450787|432607|P2|COMPLETED|Overall Study||25
177313|NCT01450787|432608|P1|COMPLETED|Overall Study||38
177314|NCT01450787|432607|P2|STARTED|Overall Study||25
177315|NCT01450787|432608|P1|STARTED|Overall Study||38
177316|NCT01450761|432626|P2|NOT COMPLETED|Treatment With Blinded Study Therapy||476
177317|NCT01450761|432627|P1|NOT COMPLETED|Treatment With Blinded Study Therapy||478
177318|NCT01450761|432626|P2|COMPLETED|Treatment With Blinded Study Therapy||0
177319|NCT01450761|432627|P1|COMPLETED|Treatment With Blinded Study Therapy||0
177320|NCT01450761|432626|P2|STARTED|Treatment With Blinded Study Therapy||476
177321|NCT01450761|432627|P1|STARTED|Treatment With Blinded Study Therapy||478
177322|NCT01450761|432626|P2|NOT COMPLETED|Lead-in Chemotherapy||85
177323|NCT01450761|432627|P1|NOT COMPLETED|Lead-in Chemotherapy||84
177324|NCT01450761|432626|P2|COMPLETED|Lead-in Chemotherapy||476
177325|NCT01450761|432627|P1|COMPLETED|Lead-in Chemotherapy||478
177326|NCT01450761|432626|P2|STARTED|Lead-in Chemotherapy||561
177327|NCT01450761|432627|P1|STARTED|Lead-in Chemotherapy||562
177328|NCT01450761|432626|P2|NOT COMPLETED|Randomization||5
177329|NCT01450761|432627|P1|NOT COMPLETED|Randomization||4
177330|NCT01450761|432626|P2|COMPLETED|Randomization||561
177331|NCT01450761|432627|P1|COMPLETED|Randomization||562
177332|NCT01450761|432626|P2|STARTED|Randomization||566
177333|NCT01450761|432627|P1|STARTED|Randomization||566
177334|NCT01450696|432639|P2|NOT COMPLETED|Overall Study||148
177335|NCT01450696|432640|P1|NOT COMPLETED|Overall Study||148
177336|NCT01450696|432639|P2|COMPLETED|Overall Study||0
177337|NCT01450696|432640|P1|COMPLETED|Overall Study||0
177338|NCT01450696|432639|P2|Treated (Safety Population)|Overall Study||147
177339|NCT01450696|432640|P1|Treated (Safety Population)|Overall Study||147
177340|NCT01450696|432639|P2|STARTED|Overall Study||148
177341|NCT01450696|432640|P1|STARTED|Overall Study||148
177342|NCT01450683|432662|P1|NOT COMPLETED|Overall Study||2
177343|NCT01450683|432662|P1|COMPLETED|Overall Study||2
177344|NCT01450683|432662|P1|STARTED|Overall Study||4
177345|NCT01450631|432668|P2|NOT COMPLETED|Overall Study||4
177346|NCT01450631|432669|P1|NOT COMPLETED|Overall Study||3
177347|NCT01450631|432668|P2|COMPLETED|Overall Study||42
177348|NCT01450631|432669|P1|COMPLETED|Overall Study||43
177349|NCT01450631|432668|P2|STARTED|Overall Study||46
177350|NCT01450631|432669|P1|STARTED|Overall Study||46
177351|NCT01450397|432677|P1|NOT COMPLETED|Overall Study||0
177352|NCT01450397|432677|P1|COMPLETED|Overall Study||5
177353|NCT01450397|432677|P1|STARTED|Overall Study||5
177354|NCT01450319|432681|P1|NOT COMPLETED|Overall Study||0
177355|NCT01450319|432681|P1|COMPLETED|Overall Study||70
177356|NCT01450319|432681|P1|STARTED|Overall Study||70
177357|NCT01450306|432694|P2|NOT COMPLETED|Overall Study||0
177358|NCT01450306|432695|P1|NOT COMPLETED|Overall Study||0
177359|NCT01450306|432694|P2|COMPLETED|Overall Study||10
177360|NCT01450306|432695|P1|COMPLETED|Overall Study||10
177361|NCT01450306|432694|P2|STARTED|Overall Study||10
177362|NCT01450306|432695|P1|STARTED|Overall Study||10
177363|NCT01450189|432708|P3|NOT COMPLETED|Overall Study||0
177364|NCT01450189|432709|P2|NOT COMPLETED|Overall Study||0
177365|NCT01450189|432710|P1|NOT COMPLETED|Overall Study||0
177366|NCT01450189|432708|P3|COMPLETED|Overall Study||19
177367|NCT01450189|432709|P2|COMPLETED|Overall Study||18
177368|NCT01450189|432710|P1|COMPLETED|Overall Study||9
177369|NCT01450189|432708|P3|STARTED|Overall Study||19
177370|NCT01450189|432709|P2|STARTED|Overall Study||18
177371|NCT01450189|432710|P1|STARTED|Overall Study||9
177372|NCT01450137|432799|P2|NOT COMPLETED|Week 12 to Study End||2
177373|NCT01450137|432800|P1|NOT COMPLETED|Week 12 to Study End||0
177374|NCT01450137|432799|P2|COMPLETED|Week 12 to Study End||5
177375|NCT01450137|432800|P1|COMPLETED|Week 12 to Study End||18
177376|NCT01450137|432799|P2|STARTED|Week 12 to Study End||7
177377|NCT01450137|432800|P1|STARTED|Week 12 to Study End||18
177378|NCT01450137|432799|P2|NOT COMPLETED|Up to Week 12||3
177379|NCT01450137|432800|P1|NOT COMPLETED|Up to Week 12||2
177380|NCT01450137|432799|P2|COMPLETED|Up to Week 12||7
177381|NCT01450137|432800|P1|COMPLETED|Up to Week 12||18
177382|NCT01450137|432799|P2|STARTED|Up to Week 12||10
177383|NCT01450137|432800|P1|STARTED|Up to Week 12||20
177384|NCT01450098|432814|P2|NOT COMPLETED|Period 3||3
177385|NCT01450098|432815|P1|NOT COMPLETED|Period 3||0
177386|NCT01450098|432814|P2|COMPLETED|Period 3||28
177387|NCT01450098|432815|P1|COMPLETED|Period 3||8
177388|NCT01450098|432814|P2|Received at Least 1 Dose of Study Drug|Period 3||30
177389|NCT01450098|432815|P1|Received at Least 1 Dose of Study Drug|Period 3||8
177390|NCT01450098|432814|P2|STARTED|Period 3||31
177391|NCT01450098|432815|P1|STARTED|Period 3||8
177392|NCT01450098|432814|P2|NOT COMPLETED|Washout of at Least 14 Days||0
177393|NCT01450098|432815|P1|NOT COMPLETED|Washout of at Least 14 Days||0
177394|NCT01450098|432814|P2|COMPLETED|Washout of at Least 14 Days||31
177395|NCT01450098|432815|P1|COMPLETED|Washout of at Least 14 Days||8
177396|NCT01450098|432814|P2|STARTED|Washout of at Least 14 Days||31
177397|NCT01450098|432815|P1|STARTED|Washout of at Least 14 Days||8
177398|NCT01450098|432814|P2|NOT COMPLETED|Period 2||0
177399|NCT01450098|432815|P1|NOT COMPLETED|Period 2||0
177400|NCT01450098|432814|P2|COMPLETED|Period 2||31
177401|NCT01450098|432815|P1|COMPLETED|Period 2||8
177402|NCT01450098|432814|P2|Received at Least 1 Dose of Study Drug|Period 2||31
177403|NCT01450098|432815|P1|Received at Least 1 Dose of Study Drug|Period 2||8
177404|NCT01450098|432814|P2|STARTED|Period 2||31
177405|NCT01450098|432815|P1|STARTED|Period 2||8
177406|NCT01450098|432814|P2|NOT COMPLETED|Washout Period of at Least 14 Days||0
177407|NCT01450098|432815|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
177408|NCT01450098|432814|P2|COMPLETED|Washout Period of at Least 14 Days||31
177409|NCT01450098|432815|P1|COMPLETED|Washout Period of at Least 14 Days||8
177410|NCT01450098|432814|P2|STARTED|Washout Period of at Least 14 Days||31
177411|NCT01450098|432815|P1|STARTED|Washout Period of at Least 14 Days||8
177412|NCT01450098|432814|P2|NOT COMPLETED|Period 1||0
177413|NCT01450098|432815|P1|NOT COMPLETED|Period 1||0
177414|NCT01450098|432814|P2|COMPLETED|Period 1||31
177415|NCT01450098|432815|P1|COMPLETED|Period 1||8
177416|NCT01450098|432814|P2|Received at Least 1 Dose of Study Drug|Period 1||31
177417|NCT01450098|432815|P1|Received at Least 1 Dose of Study Drug|Period 1||8
177418|NCT01450098|432814|P2|STARTED|Period 1||31
177419|NCT01450098|432815|P1|STARTED|Period 1||8
177420|NCT01450007|432834|P3|NOT COMPLETED|Overall Study||3
177421|NCT01450007|432835|P2|NOT COMPLETED|Overall Study||5
177422|NCT01450007|432836|P1|NOT COMPLETED|Overall Study||2
177423|NCT01450007|432834|P3|COMPLETED|Overall Study||41
177424|NCT01450007|432835|P2|COMPLETED|Overall Study||37
177425|NCT01450007|432836|P1|COMPLETED|Overall Study||42
177426|NCT01450007|432834|P3|STARTED|Overall Study||44
177427|NCT01450007|432835|P2|STARTED|Overall Study||42
177428|NCT01450007|432836|P1|STARTED|Overall Study||44
177429|NCT01449955|432855|P2|NOT COMPLETED|Overall Study||2
177430|NCT01449955|432856|P1|NOT COMPLETED|Overall Study||1
177431|NCT01449955|432855|P2|COMPLETED|Overall Study||24
177432|NCT01449955|432856|P1|COMPLETED|Overall Study||27
177433|NCT01449955|432855|P2|STARTED|Overall Study||26
177434|NCT01449955|432856|P1|STARTED|Overall Study||28
177435|NCT01449929|432884|P3|NOT COMPLETED|Extension Phase Approximately 3 Years||8
177436|NCT01449929|432885|P2|NOT COMPLETED|Extension Phase Approximately 3 Years||0
177437|NCT01449929|432886|P1|NOT COMPLETED|Extension Phase Approximately 3 Years||0
177438|NCT01449929|432884|P3|COMPLETED|Extension Phase Approximately 3 Years||115
177439|NCT01449929|432885|P2|COMPLETED|Extension Phase Approximately 3 Years||0
177440|NCT01449929|432886|P1|COMPLETED|Extension Phase Approximately 3 Years||0
177441|NCT01449929|432884|P3|STARTED|Extension Phase Approximately 3 Years||123
177442|NCT01449929|432885|P2|STARTED|Extension Phase Approximately 3 Years||0
177443|NCT01449929|432886|P1|STARTED|Extension Phase Approximately 3 Years||0
177444|NCT01449929|432884|P3|NOT COMPLETED|Randomization Phase 96 Week||0
177445|NCT01449929|432885|P2|NOT COMPLETED|Randomization Phase 96 Week||53
177446|NCT01449929|432886|P1|NOT COMPLETED|Randomization Phase 96 Week||33
177447|NCT01449929|432884|P3|COMPLETED|Randomization Phase 96 Week||0
177448|NCT01449929|432885|P2|COMPLETED|Randomization Phase 96 Week||189
177449|NCT01449929|432886|P1|COMPLETED|Randomization Phase 96 Week||209
177450|NCT01449929|432884|P3|STARTED|Randomization Phase 96 Week||0
177451|NCT01449929|432885|P2|STARTED|Randomization Phase 96 Week||242
177452|NCT01449929|432886|P1|STARTED|Randomization Phase 96 Week||242
177453|NCT01449864|432923|P1|NOT COMPLETED|Overall Study||5
177454|NCT01449864|432923|P1|COMPLETED|Overall Study||17
177455|NCT01449864|432923|P1|STARTED|Overall Study||22
177456|NCT01449812|432931|P3|NOT COMPLETED|Overall Study||1
177457|NCT01449812|432932|P2|NOT COMPLETED|Overall Study||0
177458|NCT01449812|432933|P1|NOT COMPLETED|Overall Study||2
177459|NCT01449812|432931|P3|COMPLETED|Overall Study||279
177460|NCT01449812|432932|P2|COMPLETED|Overall Study||273
177461|NCT01449812|432933|P1|COMPLETED|Overall Study||270
177462|NCT01449812|432931|P3|STARTED|Overall Study||280
177463|NCT01449812|432932|P2|STARTED|Overall Study||273
177464|NCT01449812|432933|P1|STARTED|Overall Study||272
177465|NCT01449747|433027|P2|NOT COMPLETED|Overall Study||0
177466|NCT01449747|433028|P1|NOT COMPLETED|Overall Study||0
177467|NCT01449747|433027|P2|COMPLETED|Overall Study||12
177468|NCT01449747|433028|P1|COMPLETED|Overall Study||12
177469|NCT01449747|433027|P2|STARTED|Overall Study||12
177470|NCT01449747|433028|P1|STARTED|Overall Study||12
177471|NCT01449734|433042|P1|NOT COMPLETED|Overall Study||0
177472|NCT01449734|433042|P1|COMPLETED|Overall Study||215
177473|NCT01449734|433042|P1|STARTED|Overall Study||215
177474|NCT01449721|433048|P2|NOT COMPLETED|Overall Study||2
177475|NCT01449721|433049|P1|NOT COMPLETED|Overall Study||0
177476|NCT01449721|433048|P2|COMPLETED|Overall Study||28
177477|NCT01449721|433049|P1|COMPLETED|Overall Study||112
177478|NCT01449721|433048|P2|STARTED|Overall Study||30
177479|NCT01449721|433049|P1|STARTED|Overall Study||112
177480|NCT01449708|433061|P2|NOT COMPLETED|Overall Study||3
177481|NCT01449708|433062|P1|NOT COMPLETED|Overall Study||2
177482|NCT01449708|433061|P2|COMPLETED|Overall Study||60
177483|NCT01449708|433062|P1|COMPLETED|Overall Study||59
177484|NCT01449708|433061|P2|STARTED|Overall Study||63
177485|NCT01449708|433062|P1|STARTED|Overall Study||61
177486|NCT01449682|433073|P2|NOT COMPLETED|Overall Study||1
177487|NCT01449682|433074|P1|NOT COMPLETED|Overall Study||1
177488|NCT01449682|433073|P2|COMPLETED|Overall Study||4
177489|NCT01449682|433074|P1|COMPLETED|Overall Study||4
177490|NCT01449682|433073|P2|STARTED|Overall Study||5
177491|NCT01449682|433074|P1|STARTED|Overall Study||5
177492|NCT01449630|433095|P9|NOT COMPLETED|Period 3||0
177493|NCT01449630|433096|P8|NOT COMPLETED|Period 3||0
177494|NCT01449630|433097|P7|NOT COMPLETED|Period 3||0
177495|NCT01449630|433098|P6|NOT COMPLETED|Period 3||0
177496|NCT01449630|433099|P5|NOT COMPLETED|Period 3||0
177497|NCT01449630|433100|P4|NOT COMPLETED|Period 3||0
177498|NCT01449630|433101|P3|NOT COMPLETED|Period 3||0
177499|NCT01449630|433102|P2|NOT COMPLETED|Period 3||0
177500|NCT01449630|433103|P1|NOT COMPLETED|Period 3||0
177501|NCT01449630|433095|P9|COMPLETED|Period 3||2
177502|NCT01449630|433096|P8|COMPLETED|Period 3||6
177503|NCT01449630|433097|P7|COMPLETED|Period 3||1
177504|NCT01449630|433098|P6|COMPLETED|Period 3||1
177505|NCT01449630|433099|P5|COMPLETED|Period 3||5
177506|NCT01449630|433100|P4|COMPLETED|Period 3||1
177507|NCT01449630|433101|P3|COMPLETED|Period 3||2
177508|NCT01449630|433102|P2|COMPLETED|Period 3||6
177509|NCT01449630|433103|P1|COMPLETED|Period 3||1
177510|NCT01449630|433095|P9|STARTED|Period 3||2
177511|NCT01449630|433096|P8|STARTED|Period 3||6
177512|NCT01449630|433097|P7|STARTED|Period 3||1
177513|NCT01449630|433098|P6|STARTED|Period 3||1
177514|NCT01449630|433099|P5|STARTED|Period 3||5
177515|NCT01449630|433100|P4|STARTED|Period 3||1
177516|NCT01449630|433101|P3|STARTED|Period 3||2
177517|NCT01449630|433102|P2|STARTED|Period 3||6
177518|NCT01449630|433103|P1|STARTED|Period 3||1
177519|NCT01449630|433095|P9|NOT COMPLETED|Period 2||0
177520|NCT01449630|433096|P8|NOT COMPLETED|Period 2||0
177521|NCT01449630|433097|P7|NOT COMPLETED|Period 2||1
177522|NCT01449630|433098|P6|NOT COMPLETED|Period 2||0
177523|NCT01449630|433099|P5|NOT COMPLETED|Period 2||0
177524|NCT01449630|433100|P4|NOT COMPLETED|Period 2||0
177525|NCT01449630|433101|P3|NOT COMPLETED|Period 2||0
177526|NCT01449630|433102|P2|NOT COMPLETED|Period 2||0
177527|NCT01449630|433103|P1|NOT COMPLETED|Period 2||0
177528|NCT01449630|433095|P9|COMPLETED|Period 2||2
177529|NCT01449630|433096|P8|COMPLETED|Period 2||6
177530|NCT01449630|433097|P7|COMPLETED|Period 2||1
177531|NCT01449630|433098|P6|COMPLETED|Period 2||1
177532|NCT01449630|433099|P5|COMPLETED|Period 2||5
177533|NCT01449630|433100|P4|COMPLETED|Period 2||1
177534|NCT01449630|433101|P3|COMPLETED|Period 2||2
177535|NCT01449630|433102|P2|COMPLETED|Period 2||6
177536|NCT01449630|433103|P1|COMPLETED|Period 2||1
177537|NCT01449630|433095|P9|STARTED|Period 2||2
177538|NCT01449630|433096|P8|STARTED|Period 2||6
177539|NCT01449630|433097|P7|STARTED|Period 2||2
177540|NCT01449630|433098|P6|STARTED|Period 2||1
177541|NCT01449630|433099|P5|STARTED|Period 2||5
177542|NCT01449630|433100|P4|STARTED|Period 2||1
177543|NCT01449630|433101|P3|STARTED|Period 2||2
177544|NCT01449630|433102|P2|STARTED|Period 2||6
177545|NCT01449630|433103|P1|STARTED|Period 2||1
177546|NCT01449630|433095|P9|NOT COMPLETED|Period 1||0
177547|NCT01449630|433096|P8|NOT COMPLETED|Period 1||0
177548|NCT01449630|433097|P7|NOT COMPLETED|Period 1||0
177549|NCT01449630|433098|P6|NOT COMPLETED|Period 1||1
177550|NCT01449630|433099|P5|NOT COMPLETED|Period 1||0
177551|NCT01449630|433100|P4|NOT COMPLETED|Period 1||1
177552|NCT01449630|433101|P3|NOT COMPLETED|Period 1||0
177553|NCT01449630|433102|P2|NOT COMPLETED|Period 1||0
177554|NCT01449630|433103|P1|NOT COMPLETED|Period 1||1
177555|NCT01449630|433095|P9|COMPLETED|Period 1||2
177556|NCT01449630|433096|P8|COMPLETED|Period 1||6
177557|NCT01449630|433097|P7|COMPLETED|Period 1||2
177558|NCT01449630|433098|P6|COMPLETED|Period 1||1
177559|NCT01449630|433099|P5|COMPLETED|Period 1||5
177560|NCT01449630|433100|P4|COMPLETED|Period 1||1
177561|NCT01449630|433101|P3|COMPLETED|Period 1||2
177562|NCT01449630|433102|P2|COMPLETED|Period 1||6
177563|NCT01449630|433103|P1|COMPLETED|Period 1||1
177564|NCT01449630|433095|P9|Received at Least 1 Dose|Period 1||2
177565|NCT01449630|433096|P8|Received at Least 1 Dose|Period 1||6
177566|NCT01449630|433097|P7|Received at Least 1 Dose|Period 1||2
177567|NCT01449630|433098|P6|Received at Least 1 Dose|Period 1||1
177568|NCT01449630|433099|P5|Received at Least 1 Dose|Period 1||5
177569|NCT01449630|433100|P4|Received at Least 1 Dose|Period 1||2
177570|NCT01449630|433101|P3|Received at Least 1 Dose|Period 1||2
177571|NCT01449630|433102|P2|Received at Least 1 Dose|Period 1||6
177572|NCT01449630|433103|P1|Received at Least 1 Dose|Period 1||2
177573|NCT01449630|433095|P9|STARTED|Period 1||2
177574|NCT01449630|433096|P8|STARTED|Period 1||6
177575|NCT01449630|433097|P7|STARTED|Period 1||2
177576|NCT01449630|433098|P6|STARTED|Period 1||2
177577|NCT01449630|433099|P5|STARTED|Period 1||5
177578|NCT01449630|433100|P4|STARTED|Period 1||2
177579|NCT01449630|433101|P3|STARTED|Period 1||2
177580|NCT01449630|433102|P2|STARTED|Period 1||6
177581|NCT01449630|433103|P1|STARTED|Period 1||2
177582|NCT01449539|433173|P1|NOT COMPLETED|Overall Study||4
177583|NCT01449539|433173|P1|COMPLETED|Overall Study||4
177584|NCT01449539|433173|P1|STARTED|Overall Study||8
177585|NCT01449526|433179|P2|NOT COMPLETED|Overall Study||6
177586|NCT01449526|433180|P1|NOT COMPLETED|Overall Study||2
177587|NCT01449526|433179|P2|COMPLETED|Overall Study||77
177588|NCT01449526|433180|P1|COMPLETED|Overall Study||81
177589|NCT01449526|433179|P2|STARTED|Overall Study||83
177590|NCT01449526|433180|P1|STARTED|Overall Study||83
177591|NCT01449513|433190|P2|NOT COMPLETED|Overall Study||0
177592|NCT01449513|433191|P1|NOT COMPLETED|Overall Study||0
177593|NCT01449513|433190|P2|COMPLETED|Overall Study||8
177594|NCT01449513|433191|P1|COMPLETED|Overall Study||16
177595|NCT01449513|433190|P2|STARTED|Overall Study||8
177596|NCT01449513|433191|P1|STARTED|Overall Study||16
177597|NCT01449461|433249|P6|NOT COMPLETED|Overall Study||15
177598|NCT01449461|433250|P5|NOT COMPLETED|Overall Study||48
177599|NCT01449461|433251|P4|NOT COMPLETED|Overall Study||32
177600|NCT01449461|433252|P3|NOT COMPLETED|Overall Study||18
177601|NCT01449461|433253|P2|NOT COMPLETED|Overall Study||18
177602|NCT01449461|433254|P1|NOT COMPLETED|Overall Study||6
177603|NCT01449461|433249|P6|COMPLETED|Overall Study||0
177604|NCT01449461|433250|P5|COMPLETED|Overall Study||0
177605|NCT01449461|433251|P4|COMPLETED|Overall Study||0
177606|NCT01449461|433252|P3|COMPLETED|Overall Study||0
177607|NCT01449461|433253|P2|COMPLETED|Overall Study||0
177608|NCT01449461|433254|P1|COMPLETED|Overall Study||0
177609|NCT01449461|433249|P6|STARTED|Overall Study||15
177610|NCT01449461|433250|P5|STARTED|Overall Study||48
177611|NCT01449461|433251|P4|STARTED|Overall Study||32
177612|NCT01449461|433252|P3|STARTED|Overall Study||18
177613|NCT01449461|433253|P2|STARTED|Overall Study||18
177614|NCT01449461|433254|P1|STARTED|Overall Study||6
177615|NCT01449370|433391|P25|NOT COMPLETED|Overall Study||8
177616|NCT01449370|433392|P24|NOT COMPLETED|Overall Study||10
177617|NCT01449370|433393|P23|NOT COMPLETED|Overall Study||4
177618|NCT01449370|433394|P22|NOT COMPLETED|Overall Study||4
177619|NCT01449370|433395|P21|NOT COMPLETED|Overall Study||6
177620|NCT01449370|433396|P20|NOT COMPLETED|Overall Study||3
177621|NCT01449370|433397|P19|NOT COMPLETED|Overall Study||3
177622|NCT01449370|433398|P18|NOT COMPLETED|Overall Study||3
177623|NCT01449370|433399|P17|NOT COMPLETED|Overall Study||7
177624|NCT01449370|433400|P16|NOT COMPLETED|Overall Study||3
177625|NCT01449370|433401|P15|NOT COMPLETED|Overall Study||3
177626|NCT01449370|433402|P14|NOT COMPLETED|Overall Study||11
177627|NCT01449370|433403|P13|NOT COMPLETED|Overall Study||3
177628|NCT01449370|433404|P12|NOT COMPLETED|Overall Study||3
177629|NCT01449370|433405|P11|NOT COMPLETED|Overall Study||3
177630|NCT01449370|433406|P10|NOT COMPLETED|Overall Study||3
177631|NCT01449370|433407|P9|NOT COMPLETED|Overall Study||12
177632|NCT01449370|433408|P8|NOT COMPLETED|Overall Study||3
177633|NCT01449370|433409|P7|NOT COMPLETED|Overall Study||3
177634|NCT01449370|433410|P6|NOT COMPLETED|Overall Study||3
177635|NCT01449370|433411|P5|NOT COMPLETED|Overall Study||3
177636|NCT01449370|433412|P4|NOT COMPLETED|Overall Study||4
177637|NCT01449370|433413|P3|NOT COMPLETED|Overall Study||8
177638|NCT01449370|433414|P2|NOT COMPLETED|Overall Study||6
177639|NCT01449370|433415|P1|NOT COMPLETED|Overall Study||6
177640|NCT01449370|433391|P25|COMPLETED|Overall Study||0
177641|NCT01449370|433392|P24|COMPLETED|Overall Study||0
177642|NCT01449370|433393|P23|COMPLETED|Overall Study||0
177643|NCT01449370|433394|P22|COMPLETED|Overall Study||0
177644|NCT01449370|433395|P21|COMPLETED|Overall Study||0
177645|NCT01449370|433396|P20|COMPLETED|Overall Study||0
177646|NCT01449370|433397|P19|COMPLETED|Overall Study||0
177647|NCT01449370|433398|P18|COMPLETED|Overall Study||0
177648|NCT01449370|433399|P17|COMPLETED|Overall Study||0
177649|NCT01449370|433400|P16|COMPLETED|Overall Study||0
177650|NCT01449370|433401|P15|COMPLETED|Overall Study||0
177651|NCT01449370|433402|P14|COMPLETED|Overall Study||0
177652|NCT01449370|433403|P13|COMPLETED|Overall Study||0
177653|NCT01449370|433404|P12|COMPLETED|Overall Study||0
177654|NCT01449370|433405|P11|COMPLETED|Overall Study||0
177655|NCT01449370|433406|P10|COMPLETED|Overall Study||0
177656|NCT01449370|433407|P9|COMPLETED|Overall Study||0
177657|NCT01449370|433408|P8|COMPLETED|Overall Study||0
177658|NCT01449370|433409|P7|COMPLETED|Overall Study||0
177659|NCT01449370|433410|P6|COMPLETED|Overall Study||0
177660|NCT01449370|433411|P5|COMPLETED|Overall Study||0
177661|NCT01449370|433412|P4|COMPLETED|Overall Study||0
177662|NCT01449370|433413|P3|COMPLETED|Overall Study||0
177663|NCT01449370|433414|P2|COMPLETED|Overall Study||0
177664|NCT01449370|433415|P1|COMPLETED|Overall Study||0
177665|NCT01449370|433391|P25|STARTED|Overall Study||8
177666|NCT01449370|433392|P24|STARTED|Overall Study||10
177667|NCT01449370|433393|P23|STARTED|Overall Study||4
177668|NCT01449370|433394|P22|STARTED|Overall Study||4
177669|NCT01449370|433395|P21|STARTED|Overall Study||6
177670|NCT01449370|433396|P20|STARTED|Overall Study||3
177671|NCT01449370|433397|P19|STARTED|Overall Study||3
177672|NCT01449370|433398|P18|STARTED|Overall Study||3
177673|NCT01449370|433399|P17|STARTED|Overall Study||7
177674|NCT01449370|433400|P16|STARTED|Overall Study||3
177675|NCT01449370|433401|P15|STARTED|Overall Study||3
177676|NCT01449370|433402|P14|STARTED|Overall Study||11
177677|NCT01449370|433403|P13|STARTED|Overall Study||3
177678|NCT01449370|433404|P12|STARTED|Overall Study||3
177679|NCT01449370|433405|P11|STARTED|Overall Study||3
177680|NCT01449370|433406|P10|STARTED|Overall Study||3
177681|NCT01449370|433407|P9|STARTED|Overall Study||12
177682|NCT01449370|433408|P8|STARTED|Overall Study||3
177683|NCT01449370|433409|P7|STARTED|Overall Study||3
177684|NCT01449370|433410|P6|STARTED|Overall Study||3
177685|NCT01449370|433411|P5|STARTED|Overall Study||3
177686|NCT01449370|433412|P4|STARTED|Overall Study||4
177687|NCT01449370|433413|P3|STARTED|Overall Study||8
177688|NCT01449370|433414|P2|STARTED|Overall Study||6
177689|NCT01449370|433415|P1|STARTED|Overall Study||6
177690|NCT01449305|433788|P1|NOT COMPLETED|Overall Study||2
177691|NCT01449305|433788|P1|COMPLETED|Overall Study||42
177692|NCT01449305|433788|P1|STARTED|Overall Study||44
177693|NCT01449279|433793|P1|NOT COMPLETED|Overall Study||7
177694|NCT01449279|433793|P1|COMPLETED|Overall Study||15
177695|NCT01449279|433793|P1|STARTED|Overall Study||22
177696|NCT01449266|433804|P1|NOT COMPLETED|Overall Study||0
177697|NCT01449266|433804|P1|COMPLETED|Overall Study||10
177698|NCT01449266|433804|P1|STARTED|Overall Study||10
177699|NCT01449240|433811|P1|NOT COMPLETED|Overall Study||0
177700|NCT01449240|433811|P1|COMPLETED|Overall Study||10
177701|NCT01449240|433811|P1|STARTED|Overall Study||10
177702|NCT01449006|433818|P2|NOT COMPLETED|Overall Study||0
177703|NCT01449006|433819|P1|NOT COMPLETED|Overall Study||3
177704|NCT01449006|433818|P2|COMPLETED|Overall Study||9
177705|NCT01449006|433819|P1|COMPLETED|Overall Study||5
177706|NCT01449006|433818|P2|STARTED|Overall Study||9
177707|NCT01449006|433819|P1|STARTED|Overall Study||8
177708|NCT01448850|433833|P2|NOT COMPLETED|Overall Study||40
177709|NCT01448850|433834|P1|NOT COMPLETED|Overall Study||34
177710|NCT01448850|433833|P2|COMPLETED|Overall Study||120
177711|NCT01448850|433834|P1|COMPLETED|Overall Study||130
177712|NCT01448850|433833|P2|STARTED|Overall Study||160
177713|NCT01448850|433834|P1|STARTED|Overall Study||164
177714|NCT01448824|433865|P8|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||3
177715|NCT01448824|433866|P7|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
177716|NCT01448824|433867|P6|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
177717|NCT01448824|433868|P5|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
177718|NCT01448824|433869|P4|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
177719|NCT01448824|433870|P3|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
177720|NCT01448824|433871|P2|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
177721|NCT01448824|433872|P1|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
177722|NCT01448824|433865|P8|COMPLETED|Part 2 Period 2: Drug-drug Interaction||8
177723|NCT01448824|433866|P7|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
177724|NCT01448824|433867|P6|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
177725|NCT01448824|433868|P5|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
177726|NCT01448824|433869|P4|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
177727|NCT01448824|433870|P3|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
177728|NCT01448824|433871|P2|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
177729|NCT01448824|433872|P1|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
177730|NCT01448824|433865|P8|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||10
177731|NCT01448824|433866|P7|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
177732|NCT01448824|433867|P6|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
177733|NCT01448824|433868|P5|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
177734|NCT01448824|433869|P4|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
177735|NCT01448824|433870|P3|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
177736|NCT01448824|433871|P2|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
177737|NCT01448824|433872|P1|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
177738|NCT01448824|433865|P8|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||11
177739|NCT01448824|433866|P7|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
177740|NCT01448824|433867|P6|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
177741|NCT01448824|433868|P5|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
177742|NCT01448824|433869|P4|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
177743|NCT01448824|433870|P3|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
177744|NCT01448824|433871|P2|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
177745|NCT01448824|433872|P1|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
177746|NCT01448824|433865|P8|STARTED|Part 2 Period 2: Drug-drug Interaction||11
177747|NCT01448824|433866|P7|STARTED|Part 2 Period 2: Drug-drug Interaction||0
177748|NCT01448824|433867|P6|STARTED|Part 2 Period 2: Drug-drug Interaction||0
177749|NCT01448824|433868|P5|STARTED|Part 2 Period 2: Drug-drug Interaction||0
177750|NCT01448824|433869|P4|STARTED|Part 2 Period 2: Drug-drug Interaction||0
177751|NCT01448824|433870|P3|STARTED|Part 2 Period 2: Drug-drug Interaction||0
177752|NCT01448824|433871|P2|STARTED|Part 2 Period 2: Drug-drug Interaction||0
177753|NCT01448824|433872|P1|STARTED|Part 2 Period 2: Drug-drug Interaction||0
177754|NCT01448824|433865|P8|NOT COMPLETED|Part 2: Washout Period||0
177755|NCT01448824|433866|P7|NOT COMPLETED|Part 2: Washout Period||0
177756|NCT01448824|433867|P6|NOT COMPLETED|Part 2: Washout Period||0
177757|NCT01448824|433868|P5|NOT COMPLETED|Part 2: Washout Period||0
177758|NCT01448824|433869|P4|NOT COMPLETED|Part 2: Washout Period||0
177759|NCT01448824|433870|P3|NOT COMPLETED|Part 2: Washout Period||0
177760|NCT01448824|433871|P2|NOT COMPLETED|Part 2: Washout Period||0
177761|NCT01448824|433872|P1|NOT COMPLETED|Part 2: Washout Period||0
177762|NCT01448824|433865|P8|COMPLETED|Part 2: Washout Period||11
177763|NCT01448824|433866|P7|COMPLETED|Part 2: Washout Period||0
177764|NCT01448824|433867|P6|COMPLETED|Part 2: Washout Period||0
177765|NCT01448824|433868|P5|COMPLETED|Part 2: Washout Period||0
177766|NCT01448824|433869|P4|COMPLETED|Part 2: Washout Period||0
177767|NCT01448824|433870|P3|COMPLETED|Part 2: Washout Period||0
177768|NCT01448824|433871|P2|COMPLETED|Part 2: Washout Period||0
177769|NCT01448824|433872|P1|COMPLETED|Part 2: Washout Period||0
177770|NCT01448824|433865|P8|STARTED|Part 2: Washout Period||11
177771|NCT01448824|433866|P7|STARTED|Part 2: Washout Period||0
177772|NCT01448824|433867|P6|STARTED|Part 2: Washout Period||0
177773|NCT01448824|433868|P5|STARTED|Part 2: Washout Period||0
177774|NCT01448824|433869|P4|STARTED|Part 2: Washout Period||0
177775|NCT01448824|433870|P3|STARTED|Part 2: Washout Period||0
177776|NCT01448824|433871|P2|STARTED|Part 2: Washout Period||0
177777|NCT01448824|433872|P1|STARTED|Part 2: Washout Period||0
177778|NCT01448824|433865|P8|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||1
177779|NCT01448824|433866|P7|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
177780|NCT01448824|433867|P6|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
177781|NCT01448824|433868|P5|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
177782|NCT01448824|433869|P4|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
177783|NCT01448824|433870|P3|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
177784|NCT01448824|433871|P2|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
177785|NCT01448824|433872|P1|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
177786|NCT01448824|433865|P8|COMPLETED|Part 2 Period 1: Drug-drug Interaction||11
177787|NCT01448824|433866|P7|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
177788|NCT01448824|433867|P6|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
177789|NCT01448824|433868|P5|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
177790|NCT01448824|433869|P4|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
177791|NCT01448824|433870|P3|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
177792|NCT01448824|433871|P2|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
177793|NCT01448824|433872|P1|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
177794|NCT01448824|433865|P8|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||12
177795|NCT01448824|433866|P7|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
177796|NCT01448824|433867|P6|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
177797|NCT01448824|433868|P5|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
177798|NCT01448824|433869|P4|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
177799|NCT01448824|433870|P3|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
177800|NCT01448824|433871|P2|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
177801|NCT01448824|433872|P1|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
177802|NCT01448824|433865|P8|STARTED|Part 2 Period 1: Drug-drug Interaction||12
177803|NCT01448824|433866|P7|STARTED|Part 2 Period 1: Drug-drug Interaction||0
177804|NCT01448824|433867|P6|STARTED|Part 2 Period 1: Drug-drug Interaction||0
177805|NCT01448824|433868|P5|STARTED|Part 2 Period 1: Drug-drug Interaction||0
177806|NCT01448824|433869|P4|STARTED|Part 2 Period 1: Drug-drug Interaction||0
177807|NCT01448824|433870|P3|STARTED|Part 2 Period 1: Drug-drug Interaction||0
177808|NCT01448824|433871|P2|STARTED|Part 2 Period 1: Drug-drug Interaction||0
177809|NCT01448824|433872|P1|STARTED|Part 2 Period 1: Drug-drug Interaction||0
177810|NCT01448824|433865|P8|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
177811|NCT01448824|433866|P7|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
177812|NCT01448824|433867|P6|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
177813|NCT01448824|433868|P5|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
177814|NCT01448824|433869|P4|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
177815|NCT01448824|433870|P3|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
177816|NCT01448824|433871|P2|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
177817|NCT01448824|433872|P1|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
177818|NCT01448824|433865|P8|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
177819|NCT01448824|433866|P7|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
177820|NCT01448824|433867|P6|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
177821|NCT01448824|433868|P5|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
177822|NCT01448824|433869|P4|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
177823|NCT01448824|433870|P3|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||4
177824|NCT01448824|433871|P2|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||4
177825|NCT01448824|433872|P1|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||11
177826|NCT01448824|433865|P8|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
177827|NCT01448824|433866|P7|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
177828|NCT01448824|433867|P6|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
177829|NCT01448824|433868|P5|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
177830|NCT01448824|433869|P4|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
177831|NCT01448824|433870|P3|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||4
177832|NCT01448824|433871|P2|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||4
177833|NCT01448824|433872|P1|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||11
177834|NCT01448824|433865|P8|STARTED|Part 1 Period 2: Multiple Ascending Dose||0
177835|NCT01448824|433866|P7|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort D participated in Period 1 only.|0
177836|NCT01448824|433867|P6|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort C participated in Period 1 only.|0
177837|NCT01448824|433868|P5|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort B participated in Period 1 only.|0
177838|NCT01448824|433869|P4|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohorts B through D participated in Period 1 only.|0
177839|NCT01448824|433870|P3|STARTED|Part 1 Period 2: Multiple Ascending Dose||4
177840|NCT01448824|433871|P2|STARTED|Part 1 Period 2: Multiple Ascending Dose||4
177841|NCT01448824|433872|P1|STARTED|Part 1 Period 2: Multiple Ascending Dose||11
177842|NCT01448824|433865|P8|NOT COMPLETED|Part 1: Washout Period||0
177843|NCT01448824|433866|P7|NOT COMPLETED|Part 1: Washout Period||0
177844|NCT01448824|433867|P6|NOT COMPLETED|Part 1: Washout Period||0
177845|NCT01448824|433868|P5|NOT COMPLETED|Part 1: Washout Period||0
177846|NCT01448824|433869|P4|NOT COMPLETED|Part 1: Washout Period||0
177847|NCT01448824|433870|P3|NOT COMPLETED|Part 1: Washout Period||0
177848|NCT01448824|433871|P2|NOT COMPLETED|Part 1: Washout Period||0
177849|NCT01448824|433872|P1|NOT COMPLETED|Part 1: Washout Period||1
177850|NCT01448824|433865|P8|COMPLETED|Part 1: Washout Period||0
177851|NCT01448824|433866|P7|COMPLETED|Part 1: Washout Period||0
177852|NCT01448824|433867|P6|COMPLETED|Part 1: Washout Period||0
177853|NCT01448824|433868|P5|COMPLETED|Part 1: Washout Period||0
177854|NCT01448824|433869|P4|COMPLETED|Part 1: Washout Period||0
177855|NCT01448824|433870|P3|COMPLETED|Part 1: Washout Period||4
177856|NCT01448824|433871|P2|COMPLETED|Part 1: Washout Period||4
177857|NCT01448824|433872|P1|COMPLETED|Part 1: Washout Period||11
177858|NCT01448824|433865|P8|STARTED|Part 1: Washout Period||0
177859|NCT01448824|433866|P7|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort D participated in Period 1 only.|0
177860|NCT01448824|433867|P6|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort C participated in Period 1 only.|0
177861|NCT01448824|433868|P5|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort B participated in Period 1 only.|0
177862|NCT01448824|433869|P4|STARTED|Part 1: Washout Period|Participants in Part 1 Cohorts B through D participated in Period 1 only.|0
177863|NCT01448824|433870|P3|STARTED|Part 1: Washout Period||4
177864|NCT01448824|433871|P2|STARTED|Part 1: Washout Period||4
177865|NCT01448824|433872|P1|STARTED|Part 1: Washout Period||12
177866|NCT01448824|433865|P8|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
177867|NCT01448824|433866|P7|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||1
177868|NCT01448824|433867|P6|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||2
177869|NCT01448824|433868|P5|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||2
177870|NCT01448824|433869|P4|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||1
177871|NCT01448824|433870|P3|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
177872|NCT01448824|433871|P2|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
177873|NCT01448824|433872|P1|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
177874|NCT01448824|433865|P8|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
177875|NCT01448824|433866|P7|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||11
177876|NCT01448824|433867|P6|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||10
177877|NCT01448824|433868|P5|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||14
177878|NCT01448824|433869|P4|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||9
177879|NCT01448824|433870|P3|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||4
177880|NCT01448824|433871|P2|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||4
177881|NCT01448824|433872|P1|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||12
177882|NCT01448824|433865|P8|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||0
177883|NCT01448824|433866|P7|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
177884|NCT01448824|433867|P6|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
177885|NCT01448824|433868|P5|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||16
177886|NCT01448824|433869|P4|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||10
177887|NCT01448824|433870|P3|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||4
177888|NCT01448824|433871|P2|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||4
177889|NCT01448824|433872|P1|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
177890|NCT01448824|433865|P8|STARTED|Part 1 Period 1: Multiple Ascending Dose||0
177891|NCT01448824|433866|P7|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
177892|NCT01448824|433867|P6|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
177893|NCT01448824|433868|P5|STARTED|Part 1 Period 1: Multiple Ascending Dose||16
177894|NCT01448824|433869|P4|STARTED|Part 1 Period 1: Multiple Ascending Dose||10
177895|NCT01448824|433870|P3|STARTED|Part 1 Period 1: Multiple Ascending Dose||4
177896|NCT01448824|433871|P2|STARTED|Part 1 Period 1: Multiple Ascending Dose||4
177897|NCT01448824|433872|P1|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
177898|NCT01448707|433923|P2|NOT COMPLETED|Overall Study||18
177899|NCT01448707|433924|P1|NOT COMPLETED|Overall Study||18
177900|NCT01448707|433923|P2|COMPLETED|Overall Study||118
177901|NCT01448707|433924|P1|COMPLETED|Overall Study||119
177902|NCT01448707|433923|P2|STARTED|Overall Study||136
177903|NCT01448707|433924|P1|STARTED|Overall Study||137
177904|NCT01448616|433945|P4|NOT COMPLETED|Study Drug (Treatment Phase)||4
177905|NCT01448616|433946|P3|NOT COMPLETED|Study Drug (Treatment Phase)||4
177906|NCT01448616|433947|P2|NOT COMPLETED|Study Drug (Treatment Phase)||2
177907|NCT01448616|433948|P1|NOT COMPLETED|Study Drug (Treatment Phase)||0
177908|NCT01448616|433945|P4|COMPLETED|Study Drug (Treatment Phase)||9
177909|NCT01448616|433946|P3|COMPLETED|Study Drug (Treatment Phase)||23
177910|NCT01448616|433947|P2|COMPLETED|Study Drug (Treatment Phase)||22
177911|NCT01448616|433948|P1|COMPLETED|Study Drug (Treatment Phase)||0
177912|NCT01448616|433945|P4|STARTED|Study Drug (Treatment Phase)||13
177913|NCT01448616|433946|P3|STARTED|Study Drug (Treatment Phase)||27
177914|NCT01448616|433947|P2|STARTED|Study Drug (Treatment Phase)||24
177915|NCT01448616|433948|P1|STARTED|Study Drug (Treatment Phase)|All qualifying participants from this group moved to treatment group.|0
177916|NCT01448616|433945|P4|NOT COMPLETED|Lead-In (Observational Phase)||0
177917|NCT01448616|433946|P3|NOT COMPLETED|Lead-In (Observational Phase)||0
177918|NCT01448616|433947|P2|NOT COMPLETED|Lead-In (Observational Phase)||0
177919|NCT01448616|433948|P1|NOT COMPLETED|Lead-In (Observational Phase)||9
177920|NCT01448616|433945|P4|COMPLETED|Lead-In (Observational Phase)||0
177921|NCT01448616|433946|P3|COMPLETED|Lead-In (Observational Phase)||0
177922|NCT01448616|433947|P2|COMPLETED|Lead-In (Observational Phase)|completed >90% of sample collection to qualify for randomization for next phase|0
177923|NCT01448616|433948|P1|COMPLETED|Lead-In (Observational Phase)|Participants who swabbed >90% completed this phase and were randomized to treatment 2:2:1.|64
177924|NCT01448616|433945|P4|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
178105|NCT01447225|434274|P9|NOT COMPLETED|Overall Study||0
177925|NCT01448616|433946|P3|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
177926|NCT01448616|433947|P2|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
177927|NCT01448616|433948|P1|STARTED|Lead-In (Observational Phase)||73
177928|NCT01448525|433968|P2|NOT COMPLETED|Overall Study||2
177929|NCT01448525|433969|P1|NOT COMPLETED|Overall Study||1
177930|NCT01448525|433968|P2|COMPLETED|Overall Study||42
177931|NCT01448525|433969|P1|COMPLETED|Overall Study||43
177932|NCT01448525|433968|P2|STARTED|Overall Study||44
177933|NCT01448525|433969|P1|STARTED|Overall Study||44
177934|NCT01448486|433979|P2|NOT COMPLETED|Overall Study||0
177935|NCT01448486|433980|P1|NOT COMPLETED|Overall Study||0
177936|NCT01448486|433979|P2|COMPLETED|Overall Study||3
177937|NCT01448486|433980|P1|COMPLETED|Overall Study||3
177938|NCT01448486|433979|P2|STARTED|Overall Study||3
177939|NCT01448486|433980|P1|STARTED|Overall Study||3
177940|NCT01448356|433988|P1|NOT COMPLETED|Overall Study||0
177941|NCT01448356|433988|P1|COMPLETED|Overall Study|cross-over|10
177942|NCT01448356|433988|P1|STARTED|Overall Study||10
177943|NCT01448213|433995|P2|NOT COMPLETED|Overall Study||22
177944|NCT01448213|433996|P1|NOT COMPLETED|Overall Study||17
177945|NCT01448213|433995|P2|COMPLETED|Overall Study||112
177946|NCT01448213|433996|P1|COMPLETED|Overall Study||113
177947|NCT01448213|433995|P2|STARTED|Overall Study||134
177948|NCT01448213|433996|P1|STARTED|Overall Study||130
177949|NCT01448057|434006|P2|NOT COMPLETED|Overall Study||4
177950|NCT01448057|434007|P1|NOT COMPLETED|Overall Study||8
177951|NCT01448057|434006|P2|COMPLETED|Overall Study||167
177952|NCT01448057|434007|P1|COMPLETED|Overall Study||162
177953|NCT01448057|434006|P2|STARTED|Overall Study||171
177954|NCT01448057|434007|P1|STARTED|Overall Study||170
177955|NCT01448044|434017|P2|NOT COMPLETED|Follow Up Period||14
177956|NCT01448044|434018|P1|NOT COMPLETED|Follow Up Period||12
177957|NCT01448044|434017|P2|COMPLETED|Follow Up Period||26
177958|NCT01448044|434018|P1|COMPLETED|Follow Up Period||65
177959|NCT01448044|434017|P2|STARTED|Follow Up Period|Out of 42 participants who entered the treatment period, 40 continued in the follow-up period.|40
177960|NCT01448044|434018|P1|STARTED|Follow Up Period|Out of 82 participants who entered the treatment period, 77 continued in the follow-up period.|77
177961|NCT01448044|434017|P2|NOT COMPLETED|Treatment Period||16
177962|NCT01448044|434018|P1|NOT COMPLETED|Treatment Period||23
177963|NCT01448044|434017|P2|COMPLETED|Treatment Period||26
177964|NCT01448044|434018|P1|COMPLETED|Treatment Period||59
177965|NCT01448044|434017|P2|STARTED|Treatment Period||42
177966|NCT01448044|434018|P1|STARTED|Treatment Period||82
177967|NCT01447927|434034|P2|NOT COMPLETED|Overall Study||3
177968|NCT01447927|434035|P1|NOT COMPLETED|Overall Study||5
177969|NCT01447927|434034|P2|COMPLETED|Overall Study||33
177970|NCT01447927|434035|P1|COMPLETED|Overall Study||33
177971|NCT01447927|434034|P2|STARTED|Overall Study||36
177972|NCT01447927|434035|P1|STARTED|Overall Study||38
177973|NCT01447914|434043|P1|NOT COMPLETED|Overall Study||0
177974|NCT01447914|434043|P1|COMPLETED|Overall Study||16
177975|NCT01447914|434043|P1|STARTED|Overall Study||16
177976|NCT01447849|434056|P4|NOT COMPLETED|Second Intervention||0
177977|NCT01447849|434057|P3|NOT COMPLETED|Second Intervention||0
177978|NCT01447849|434058|P2|NOT COMPLETED|Second Intervention||0
177979|NCT01447849|434059|P1|NOT COMPLETED|Second Intervention||0
177980|NCT01447849|434056|P4|COMPLETED|Second Intervention||10
177981|NCT01447849|434057|P3|COMPLETED|Second Intervention||10
177982|NCT01447849|434058|P2|COMPLETED|Second Intervention||10
177983|NCT01447849|434059|P1|COMPLETED|Second Intervention||10
177984|NCT01447849|434056|P4|STARTED|Second Intervention||10
177985|NCT01447849|434057|P3|STARTED|Second Intervention||10
177986|NCT01447849|434058|P2|STARTED|Second Intervention||10
177987|NCT01447849|434059|P1|STARTED|Second Intervention||10
177988|NCT01447849|434056|P4|NOT COMPLETED|Washout Period for 1 Week||0
177989|NCT01447849|434057|P3|NOT COMPLETED|Washout Period for 1 Week||0
177990|NCT01447849|434058|P2|NOT COMPLETED|Washout Period for 1 Week||0
177991|NCT01447849|434059|P1|NOT COMPLETED|Washout Period for 1 Week||0
177992|NCT01447849|434056|P4|COMPLETED|Washout Period for 1 Week||10
177993|NCT01447849|434057|P3|COMPLETED|Washout Period for 1 Week||10
177994|NCT01447849|434058|P2|COMPLETED|Washout Period for 1 Week||10
177995|NCT01447849|434059|P1|COMPLETED|Washout Period for 1 Week||10
177996|NCT01447849|434056|P4|STARTED|Washout Period for 1 Week||10
177997|NCT01447849|434057|P3|STARTED|Washout Period for 1 Week||10
177998|NCT01447849|434058|P2|STARTED|Washout Period for 1 Week||10
177999|NCT01447849|434059|P1|STARTED|Washout Period for 1 Week||10
178000|NCT01447849|434056|P4|NOT COMPLETED|First Intervention||0
178001|NCT01447849|434057|P3|NOT COMPLETED|First Intervention||0
178002|NCT01447849|434058|P2|NOT COMPLETED|First Intervention||0
178003|NCT01447849|434059|P1|NOT COMPLETED|First Intervention||0
178004|NCT01447849|434056|P4|COMPLETED|First Intervention||10
178005|NCT01447849|434057|P3|COMPLETED|First Intervention||10
178006|NCT01447849|434058|P2|COMPLETED|First Intervention||10
178007|NCT01447849|434059|P1|COMPLETED|First Intervention||10
178008|NCT01447849|434056|P4|STARTED|First Intervention||10
178009|NCT01447849|434057|P3|STARTED|First Intervention||10
178010|NCT01447849|434058|P2|STARTED|First Intervention||10
178011|NCT01447849|434059|P1|STARTED|First Intervention||10
178012|NCT01447719|434069|P1|NOT COMPLETED|Overall Study||93
178013|NCT01447719|434069|P1|COMPLETED|Overall Study||59
178014|NCT01447719|434069|P1|Deceased <2 Years After AV-45 Scan|Overall Study||66
178015|NCT01447719|434069|P1|Valid AV-45 Scan Acquired|Overall Study||147
178016|NCT01447719|434069|P1|STARTED|Overall Study||152
178017|NCT01447706|434082|P2|NOT COMPLETED|Overall Study||3
178018|NCT01447706|434083|P1|NOT COMPLETED|Overall Study||0
178019|NCT01447706|434082|P2|COMPLETED|Overall Study||80
178020|NCT01447706|434083|P1|COMPLETED|Overall Study||140
178021|NCT01447706|434082|P2|STARTED|Overall Study|3 patients enrolled but not dosed|83
178022|NCT01447706|434083|P1|STARTED|Overall Study||140
178023|NCT01447576|434095|P1|NOT COMPLETED|Overall Study||476
178024|NCT01447576|434095|P1|COMPLETED|Overall Study||560
178025|NCT01447576|434095|P1|STARTED|Overall Study||1036
178026|NCT01447511|434106|P5|NOT COMPLETED|Rifampin Period||0
178027|NCT01447511|434107|P4|NOT COMPLETED|Rifampin Period||1
178028|NCT01447511|434108|P3|NOT COMPLETED|Rifampin Period||0
178029|NCT01447511|434109|P2|NOT COMPLETED|Rifampin Period||0
178030|NCT01447511|434110|P1|NOT COMPLETED|Rifampin Period||0
178031|NCT01447511|434106|P5|COMPLETED|Rifampin Period||4
178032|NCT01447511|434107|P4|COMPLETED|Rifampin Period||2
178033|NCT01447511|434108|P3|COMPLETED|Rifampin Period||8
178034|NCT01447511|434109|P2|COMPLETED|Rifampin Period||5
178035|NCT01447511|434110|P1|COMPLETED|Rifampin Period||8
178036|NCT01447511|434106|P5|STARTED|Rifampin Period||4
178037|NCT01447511|434107|P4|STARTED|Rifampin Period||3
178038|NCT01447511|434108|P3|STARTED|Rifampin Period||8
178039|NCT01447511|434109|P2|STARTED|Rifampin Period||5
178040|NCT01447511|434110|P1|STARTED|Rifampin Period||8
178041|NCT01447511|434106|P5|NOT COMPLETED|Fluconazole Period||0
178042|NCT01447511|434107|P4|NOT COMPLETED|Fluconazole Period||0
178043|NCT01447511|434108|P3|NOT COMPLETED|Fluconazole Period||1
178044|NCT01447511|434109|P2|NOT COMPLETED|Fluconazole Period||0
178045|NCT01447511|434110|P1|NOT COMPLETED|Fluconazole Period||0
178046|NCT01447511|434106|P5|COMPLETED|Fluconazole Period||4
178047|NCT01447511|434107|P4|COMPLETED|Fluconazole Period||3
178048|NCT01447511|434108|P3|COMPLETED|Fluconazole Period||8
178049|NCT01447511|434109|P2|COMPLETED|Fluconazole Period||0
178050|NCT01447511|434110|P1|COMPLETED|Fluconazole Period||8
178051|NCT01447511|434106|P5|STARTED|Fluconazole Period||4
178052|NCT01447511|434107|P4|STARTED|Fluconazole Period||3
178053|NCT01447511|434108|P3|STARTED|Fluconazole Period||9
178054|NCT01447511|434109|P2|STARTED|Fluconazole Period||0
178055|NCT01447511|434110|P1|STARTED|Fluconazole Period||8
178056|NCT01447511|434106|P5|NOT COMPLETED|Control Period||0
178057|NCT01447511|434107|P4|NOT COMPLETED|Control Period||0
178058|NCT01447511|434108|P3|NOT COMPLETED|Control Period||0
178059|NCT01447511|434109|P2|NOT COMPLETED|Control Period||0
178060|NCT01447511|434110|P1|NOT COMPLETED|Control Period||0
178061|NCT01447511|434106|P5|COMPLETED|Control Period||4
178062|NCT01447511|434107|P4|COMPLETED|Control Period||3
178063|NCT01447511|434108|P3|COMPLETED|Control Period||9
178064|NCT01447511|434109|P2|COMPLETED|Control Period||5
178065|NCT01447511|434110|P1|COMPLETED|Control Period||8
178066|NCT01447511|434106|P5|STARTED|Control Period||4
178067|NCT01447511|434107|P4|STARTED|Control Period||3
178068|NCT01447511|434108|P3|STARTED|Control Period||9
178069|NCT01447511|434109|P2|STARTED|Control Period||5
178070|NCT01447511|434110|P1|STARTED|Control Period||8
178071|NCT01447446|434128|P6|NOT COMPLETED|Overall Study||32
178072|NCT01447446|434129|P5|NOT COMPLETED|Overall Study||211
178073|NCT01447446|434130|P4|NOT COMPLETED|Overall Study||33
178074|NCT01447446|434131|P3|NOT COMPLETED|Overall Study||100
178075|NCT01447446|434132|P2|NOT COMPLETED|Overall Study||165
178076|NCT01447446|434133|P1|NOT COMPLETED|Overall Study||722
178077|NCT01447446|434128|P6|COMPLETED|Overall Study||54
178078|NCT01447446|434129|P5|COMPLETED|Overall Study||610
178079|NCT01447446|434130|P4|COMPLETED|Overall Study||60
178080|NCT01447446|434131|P3|COMPLETED|Overall Study||192
178081|NCT01447446|434132|P2|COMPLETED|Overall Study|Insuff.=Insufficient VR= Virological response TRT.=Treatment SVR= Sustained Virological Response|331
178082|NCT01447446|434133|P1|COMPLETED|Overall Study|Completed means the participants who completed the 24- weeks of follow-up period.|1590
178083|NCT01447446|434128|P6|STARTED|Overall Study||86
178084|NCT01447446|434129|P5|STARTED|Overall Study||821
178085|NCT01447446|434130|P4|STARTED|Overall Study||93
178086|NCT01447446|434131|P3|STARTED|Overall Study||292
178087|NCT01447446|434132|P2|STARTED|Overall Study||496
178088|NCT01447446|434133|P1|STARTED|Overall Study|Started means participants who started treatment and included in core population.|2312
178089|NCT01447433|434223|P2|NOT COMPLETED|Overall Study||6
178090|NCT01447433|434224|P1|NOT COMPLETED|Overall Study||4
178091|NCT01447433|434223|P2|COMPLETED|Overall Study||21
178092|NCT01447433|434224|P1|COMPLETED|Overall Study||22
178093|NCT01447433|434223|P2|STARTED|Overall Study||27
178094|NCT01447433|434224|P1|STARTED|Overall Study||26
178095|NCT01447420|434251|P3|NOT COMPLETED|Overall Study||10
178096|NCT01447420|434252|P2|NOT COMPLETED|Overall Study||27
178097|NCT01447420|434253|P1|NOT COMPLETED|Overall Study||10
178098|NCT01447420|434251|P3|COMPLETED|Overall Study||8
178099|NCT01447420|434252|P2|COMPLETED|Overall Study||45
178100|NCT01447420|434253|P1|COMPLETED|Overall Study||29
178101|NCT01447420|434251|P3|STARTED|Overall Study||18
178102|NCT01447420|434252|P2|STARTED|Overall Study||72
178103|NCT01447420|434253|P1|STARTED|Overall Study||39
178104|NCT01447225|434273|P10|NOT COMPLETED|Overall Study||0
178106|NCT01447225|434275|P8|NOT COMPLETED|Overall Study||0
178107|NCT01447225|434276|P7|NOT COMPLETED|Overall Study||0
178108|NCT01447225|434277|P6|NOT COMPLETED|Overall Study||0
178109|NCT01447225|434278|P5|NOT COMPLETED|Overall Study||0
178110|NCT01447225|434279|P4|NOT COMPLETED|Overall Study||0
178111|NCT01447225|434280|P3|NOT COMPLETED|Overall Study||0
178112|NCT01447225|434281|P2|NOT COMPLETED|Overall Study||0
178113|NCT01447225|434282|P1|NOT COMPLETED|Overall Study||0
178114|NCT01447225|434273|P10|COMPLETED|Overall Study||4
178115|NCT01447225|434274|P9|COMPLETED|Overall Study||3
178116|NCT01447225|434275|P8|COMPLETED|Overall Study||4
178117|NCT01447225|434276|P7|COMPLETED|Overall Study||7
178118|NCT01447225|434277|P6|COMPLETED|Overall Study||3
178119|NCT01447225|434278|P5|COMPLETED|Overall Study||3
178120|NCT01447225|434279|P4|COMPLETED|Overall Study||3
178121|NCT01447225|434280|P3|COMPLETED|Overall Study||5
178122|NCT01447225|434281|P2|COMPLETED|Overall Study||8
178123|NCT01447225|434282|P1|COMPLETED|Overall Study||3
178124|NCT01447225|434273|P10|STARTED|Overall Study||4
178125|NCT01447225|434274|P9|STARTED|Overall Study||3
178126|NCT01447225|434275|P8|STARTED|Overall Study||4
178127|NCT01447225|434276|P7|STARTED|Overall Study||7
178128|NCT01447225|434277|P6|STARTED|Overall Study||3
178129|NCT01447225|434278|P5|STARTED|Overall Study||3
178130|NCT01447225|434279|P4|STARTED|Overall Study||3
178131|NCT01447225|434280|P3|STARTED|Overall Study||5
178132|NCT01447225|434281|P2|STARTED|Overall Study||8
178133|NCT01447225|434282|P1|STARTED|Overall Study||3
178134|NCT01447121|434352|P1|NOT COMPLETED|Overall Study||0
178135|NCT01447121|434352|P1|COMPLETED|Overall Study||118
178136|NCT01447121|434352|P1|STARTED|Overall Study||118
178137|NCT01447017|434359|P2|NOT COMPLETED|Overall Study||10
178138|NCT01447017|434360|P1|NOT COMPLETED|Overall Study||10
178139|NCT01447017|434359|P2|COMPLETED|Overall Study|In safety analysis: 24. In efficacy analyses: 24 in full analysis set, and 22 in per-protocol set.|14
178140|NCT01447017|434360|P1|COMPLETED|Overall Study|In safety analysis: 42. In efficacy analyses: 40 in full analysis set, and 39 in per-protocol set.|35
178141|NCT01447017|434359|P2|Performed Visit 2|Overall Study||24
178142|NCT01447017|434360|P1|Performed Visit 2|Overall Study||43
178143|NCT01447017|434359|P2|STARTED|Overall Study||24
178144|NCT01447017|434360|P1|STARTED|Overall Study||45
178145|NCT01446874|434369|P3|NOT COMPLETED|Overall Study||18
178146|NCT01446874|434370|P2|NOT COMPLETED|Overall Study||4
178147|NCT01446874|434371|P1|NOT COMPLETED|Overall Study||2
178148|NCT01446874|434369|P3|COMPLETED|Overall Study||62
178149|NCT01446874|434370|P2|COMPLETED|Overall Study||46
178150|NCT01446874|434371|P1|COMPLETED|Overall Study||18
178151|NCT01446874|434369|P3|STARTED|Overall Study||80
178152|NCT01446874|434370|P2|STARTED|Overall Study||50
178153|NCT01446874|434371|P1|STARTED|Overall Study||20
178154|NCT01446809|434399|P3|NOT COMPLETED|Overall Study||2
178155|NCT01446809|434400|P2|NOT COMPLETED|Overall Study||0
178156|NCT01446809|434401|P1|NOT COMPLETED|Overall Study||0
178157|NCT01446809|434399|P3|COMPLETED|Overall Study||0
178158|NCT01446809|434400|P2|COMPLETED|Overall Study||7
178159|NCT01446809|434401|P1|COMPLETED|Overall Study||14
178160|NCT01446809|434399|P3|STARTED|Overall Study||2
178161|NCT01446809|434400|P2|STARTED|Overall Study||7
178162|NCT01446809|434401|P1|STARTED|Overall Study||14
178163|NCT01446796|434414|P2|NOT COMPLETED|Overall Study||0
178164|NCT01446796|434415|P1|NOT COMPLETED|Overall Study||1
178165|NCT01446796|434414|P2|COMPLETED|Overall Study|Study terminated early|0
178166|NCT01446796|434415|P1|COMPLETED|Overall Study|"Study terminated early~One subject of three withdrew prior to randomization and did not start"|2
178167|NCT01446796|434414|P2|STARTED|Overall Study||0
178168|NCT01446796|434415|P1|STARTED|Overall Study||3
178169|NCT01446705|434429|P2|NOT COMPLETED|Overall Study||0
178170|NCT01446705|434430|P1|NOT COMPLETED|Overall Study||0
178171|NCT01446705|434429|P2|COMPLETED|Overall Study||6627
178172|NCT01446705|434430|P1|COMPLETED|Overall Study||50446
178173|NCT01446705|434429|P2|STARTED|Overall Study||6627
178174|NCT01446705|434430|P1|STARTED|Overall Study||50446
178175|NCT01446666|434446|P1|NOT COMPLETED|Overall Study||81
178176|NCT01446666|434446|P1|COMPLETED|Overall Study||326
178177|NCT01446666|434446|P1|STARTED|Overall Study|Among the 423 participants who consented, 15 withdrew the consent and one died.|407
178178|NCT01446419|434461|P2|NOT COMPLETED|Overall Study||1
178179|NCT01446419|434462|P1|NOT COMPLETED|Overall Study||5
178180|NCT01446419|434461|P2|COMPLETED|Overall Study||77
178181|NCT01446419|434462|P1|COMPLETED|Overall Study||142
178182|NCT01446419|434461|P2|12 Month Follow-up|Overall Study||77
178183|NCT01446419|434462|P1|12 Month Follow-up|Overall Study||142
178184|NCT01446419|434461|P2|6 Month Follow-up|Overall Study||77
178185|NCT01446419|434462|P1|6 Month Follow-up|Overall Study||144
178186|NCT01446419|434461|P2|3 Month Follow-up|Overall Study||77
178187|NCT01446419|434462|P1|3 Month Follow-up|Overall Study||146
178188|NCT01446419|434461|P2|STARTED|Overall Study||78
178189|NCT01446419|434462|P1|STARTED|Overall Study||147
178190|NCT01446289|434476|P4|NOT COMPLETED|Overall Study||0
178191|NCT01446289|434477|P3|NOT COMPLETED|Overall Study||1
178192|NCT01446289|434478|P2|NOT COMPLETED|Overall Study||0
178193|NCT01446289|434479|P1|NOT COMPLETED|Overall Study||1
178194|NCT01446289|434476|P4|COMPLETED|Overall Study||35
178195|NCT01446289|434477|P3|COMPLETED|Overall Study||50
178196|NCT01446289|434478|P2|COMPLETED|Overall Study||35
178197|NCT01446289|434479|P1|COMPLETED|Overall Study||50
178198|NCT01446289|434476|P4|STARTED|Overall Study||35
178199|NCT01446289|434477|P3|STARTED|Overall Study||51
178200|NCT01446289|434478|P2|STARTED|Overall Study||35
178201|NCT01446289|434479|P1|STARTED|Overall Study||51
178202|NCT01446250|434507|P4|NOT COMPLETED|Follow-up||6
178203|NCT01446250|434508|P3|NOT COMPLETED|Follow-up||0
178204|NCT01446250|434509|P2|NOT COMPLETED|Follow-up||0
178205|NCT01446250|434510|P1|NOT COMPLETED|Follow-up||0
178206|NCT01446250|434507|P4|COMPLETED|Follow-up||0
178207|NCT01446250|434508|P3|COMPLETED|Follow-up||0
178208|NCT01446250|434509|P2|COMPLETED|Follow-up||0
178209|NCT01446250|434510|P1|COMPLETED|Follow-up||0
178210|NCT01446250|434507|P4|STARTED|Follow-up||6
178211|NCT01446250|434508|P3|STARTED|Follow-up||0
178212|NCT01446250|434509|P2|STARTED|Follow-up||0
178213|NCT01446250|434510|P1|STARTED|Follow-up||0
178214|NCT01446250|434507|P4|NOT COMPLETED|Treatment Period 2||0
178215|NCT01446250|434508|P3|NOT COMPLETED|Treatment Period 2||0
178216|NCT01446250|434509|P2|NOT COMPLETED|Treatment Period 2||1
178217|NCT01446250|434510|P1|NOT COMPLETED|Treatment Period 2||0
178218|NCT01446250|434507|P4|COMPLETED|Treatment Period 2||0
178219|NCT01446250|434508|P3|COMPLETED|Treatment Period 2||0
178220|NCT01446250|434509|P2|COMPLETED|Treatment Period 2||6
178221|NCT01446250|434510|P1|COMPLETED|Treatment Period 2||0
178222|NCT01446250|434507|P4|STARTED|Treatment Period 2||0
178223|NCT01446250|434508|P3|STARTED|Treatment Period 2||0
178224|NCT01446250|434509|P2|STARTED|Treatment Period 2||7
178225|NCT01446250|434510|P1|STARTED|Treatment Period 2||0
178226|NCT01446250|434507|P4|NOT COMPLETED|Clinical Hold||0
178227|NCT01446250|434508|P3|NOT COMPLETED|Clinical Hold||0
178228|NCT01446250|434509|P2|NOT COMPLETED|Clinical Hold||0
178229|NCT01446250|434510|P1|NOT COMPLETED|Clinical Hold||0
178230|NCT01446250|434507|P4|COMPLETED|Clinical Hold||0
178231|NCT01446250|434508|P3|COMPLETED|Clinical Hold||5
178232|NCT01446250|434509|P2|COMPLETED|Clinical Hold||2
178233|NCT01446250|434510|P1|COMPLETED|Clinical Hold||0
178234|NCT01446250|434507|P4|STARTED|Clinical Hold||0
178235|NCT01446250|434508|P3|STARTED|Clinical Hold||5
178236|NCT01446250|434509|P2|STARTED|Clinical Hold||2
178237|NCT01446250|434510|P1|STARTED|Clinical Hold||0
178238|NCT01446250|434507|P4|NOT COMPLETED|Treatment Period 1||0
178239|NCT01446250|434508|P3|NOT COMPLETED|Treatment Period 1||0
178240|NCT01446250|434509|P2|NOT COMPLETED|Treatment Period 1||1
178241|NCT01446250|434510|P1|NOT COMPLETED|Treatment Period 1||0
178242|NCT01446250|434507|P4|COMPLETED|Treatment Period 1||0
178243|NCT01446250|434508|P3|COMPLETED|Treatment Period 1||0
178244|NCT01446250|434509|P2|COMPLETED|Treatment Period 1||2
178245|NCT01446250|434510|P1|COMPLETED|Treatment Period 1||5
178246|NCT01446250|434507|P4|STARTED|Treatment Period 1||0
178247|NCT01446250|434508|P3|STARTED|Treatment Period 1||0
178248|NCT01446250|434509|P2|STARTED|Treatment Period 1||3
178249|NCT01446250|434510|P1|STARTED|Treatment Period 1||5
178250|NCT01446237|434522|P1|NOT COMPLETED|Overall Study||10
178251|NCT01446237|434522|P1|COMPLETED|Overall Study||115
178252|NCT01446237|434522|P1|STARTED|Overall Study||125
178253|NCT01446159|434534|P4|NOT COMPLETED|Overall Study||62
178254|NCT01446159|434535|P3|NOT COMPLETED|Overall Study||72
178255|NCT01446159|434536|P2|NOT COMPLETED|Overall Study||3
178256|NCT01446159|434537|P1|NOT COMPLETED|Overall Study||3
178257|NCT01446159|434534|P4|COMPLETED|Overall Study||23
178258|NCT01446159|434535|P3|COMPLETED|Overall Study||20
178259|NCT01446159|434536|P2|COMPLETED|Overall Study||0
178260|NCT01446159|434537|P1|COMPLETED|Overall Study||0
178261|NCT01446159|434534|P4|STARTED|Overall Study||85
178262|NCT01446159|434535|P3|STARTED|Overall Study||92
178263|NCT01446159|434536|P2|STARTED|Overall Study||3
178264|NCT01446159|434537|P1|STARTED|Overall Study||3
178265|NCT01446042|434612|P3|NOT COMPLETED|Overall Study||9
178266|NCT01446042|434613|P2|NOT COMPLETED|Overall Study||3
178267|NCT01446042|434614|P1|NOT COMPLETED|Overall Study||20
178268|NCT01446042|434612|P3|COMPLETED|Overall Study||69
178269|NCT01446042|434613|P2|COMPLETED|Overall Study||83
178270|NCT01446042|434614|P1|COMPLETED|Overall Study||122
178271|NCT01446042|434612|P3|STARTED|Overall Study||78
178272|NCT01446042|434613|P2|STARTED|Overall Study||86
178273|NCT01446042|434614|P1|STARTED|Overall Study||142
178274|NCT01446003|434625|P2|NOT COMPLETED|Period 2||0
178275|NCT01446003|434626|P1|NOT COMPLETED|Period 2||1
178276|NCT01446003|434625|P2|COMPLETED|Period 2||15
178277|NCT01446003|434626|P1|COMPLETED|Period 2||13
178278|NCT01446003|434625|P2|STARTED|Period 2||15
178279|NCT01446003|434626|P1|STARTED|Period 2||14
178280|NCT01446003|434625|P2|NOT COMPLETED|Period 1||0
178281|NCT01446003|434626|P1|NOT COMPLETED|Period 1||2
178282|NCT01446003|434625|P2|COMPLETED|Period 1||15
178283|NCT01446003|434626|P1|COMPLETED|Period 1||14
178284|NCT01446003|434625|P2|STARTED|Period 1||15
178285|NCT01446003|434626|P1|STARTED|Period 1||16
178286|NCT01445951|434647|P3|NOT COMPLETED|Overall Study||19
178287|NCT01445951|434648|P2|NOT COMPLETED|Overall Study||36
178288|NCT01445951|434649|P1|NOT COMPLETED|Overall Study||44
178289|NCT01445951|434647|P3|COMPLETED|Overall Study||151
178290|NCT01445951|434648|P2|COMPLETED|Overall Study||138
178291|NCT01445951|434649|P1|COMPLETED|Overall Study||130
178292|NCT01445951|434647|P3|STARTED|Overall Study||170
178293|NCT01445951|434648|P2|STARTED|Overall Study||174
178294|NCT01445951|434649|P1|STARTED|Overall Study||174
178295|NCT01445886|434687|P1|NOT COMPLETED|Overall Study||5
178296|NCT01445886|434687|P1|COMPLETED|Overall Study||28
178297|NCT01445886|434687|P1|STARTED|Overall Study||33
178298|NCT01445873|434697|P1|NOT COMPLETED|Overall Study||0
178299|NCT01445873|434697|P1|COMPLETED|Overall Study||36
178300|NCT01445873|434697|P1|STARTED|Overall Study||36
178301|NCT01445847|434727|P2|NOT COMPLETED|Overall Study||14
178302|NCT01445847|434728|P1|NOT COMPLETED|Overall Study||14
178303|NCT01445847|434727|P2|COMPLETED|Overall Study||36
178304|NCT01445847|434728|P1|COMPLETED|Overall Study||36
178305|NCT01445847|434727|P2|STARTED|Overall Study||50
178306|NCT01445847|434728|P1|STARTED|Overall Study||50
178307|NCT01445769|434734|P1|NOT COMPLETED|Overall Study||8
178308|NCT01445769|434734|P1|COMPLETED|Overall Study||37
178309|NCT01445769|434734|P1|STARTED|Overall Study||45
178310|NCT01445678|434754|P2|NOT COMPLETED|Overall Study||21
178311|NCT01445678|434755|P1|NOT COMPLETED|Overall Study||30
178312|NCT01445678|434754|P2|COMPLETED|Overall Study||476
178313|NCT01445678|434755|P1|COMPLETED|Overall Study||452
178314|NCT01445678|434754|P2|STARTED|Overall Study||497
178315|NCT01445678|434755|P1|STARTED|Overall Study||482
178316|NCT01445652|434773|P2|NOT COMPLETED|Overall Study||3
178317|NCT01445652|434774|P1|NOT COMPLETED|Overall Study||10
178318|NCT01445652|434773|P2|COMPLETED|Overall Study||50
178319|NCT01445652|434774|P1|COMPLETED|Overall Study||47
178320|NCT01445652|434773|P2|STARTED|Overall Study||53
178321|NCT01445652|434774|P1|STARTED|Overall Study||57
178322|NCT01445626|434782|P1|NOT COMPLETED|Overall Study||0
178323|NCT01445626|434782|P1|COMPLETED|Overall Study||87
178324|NCT01445626|434782|P1|STARTED|Overall Study||87
178325|NCT01445613|434792|P1|NOT COMPLETED|1-year Follow-up||77
178326|NCT01445613|434792|P1|COMPLETED|1-year Follow-up||1088
178327|NCT01445613|434792|P1|STARTED|1-year Follow-up||1165
178328|NCT01445613|434792|P1|NOT COMPLETED|30-day Follow-up||35
178329|NCT01445613|434792|P1|COMPLETED|30-day Follow-up||1165
178330|NCT01445613|434792|P1|STARTED|30-day Follow-up||1200
178331|NCT01445548|434810|P1|NOT COMPLETED|Overall Study||1
178332|NCT01445548|434810|P1|COMPLETED|Overall Study||5
178333|NCT01445548|434810|P1|STARTED|Overall Study||6
178334|NCT01445301|434835|P3|NOT COMPLETED|Overall Study||9
178335|NCT01445301|434836|P2|NOT COMPLETED|Overall Study||35
178336|NCT01445301|434837|P1|NOT COMPLETED|Overall Study||21
178337|NCT01445301|434835|P3|COMPLETED|Overall Study||290
178338|NCT01445301|434836|P2|COMPLETED|Overall Study||262
178339|NCT01445301|434837|P1|COMPLETED|Overall Study||183
178340|NCT01445301|434835|P3|STARTED|Overall Study||299
178341|NCT01445301|434836|P2|STARTED|Overall Study||297
178342|NCT01445301|434837|P1|STARTED|Overall Study||204
178343|NCT01445028|434874|P2|NOT COMPLETED|Overall Study||3
178344|NCT01445028|434875|P1|NOT COMPLETED|Overall Study||0
178345|NCT01445028|434874|P2|COMPLETED|Overall Study||51
178346|NCT01445028|434875|P1|COMPLETED|Overall Study||58
178347|NCT01445028|434874|P2|STARTED|Overall Study||54
178348|NCT01445028|434875|P1|STARTED|Overall Study||58
178349|NCT01444924|434883|P2|NOT COMPLETED|Overall Study||0
178350|NCT01444924|434884|P1|NOT COMPLETED|Overall Study||0
178351|NCT01444924|434883|P2|COMPLETED|Overall Study||33
178352|NCT01444924|434884|P1|COMPLETED|Overall Study||31
178353|NCT01444924|434883|P2|STARTED|Overall Study||33
178354|NCT01444924|434884|P1|STARTED|Overall Study||31
178355|NCT01444911|434894|P2|NOT COMPLETED|Overall Study||0
178356|NCT01444911|434895|P1|NOT COMPLETED|Overall Study||8
178357|NCT01444911|434894|P2|COMPLETED|Overall Study||13
178358|NCT01444911|434895|P1|COMPLETED|Overall Study||8
178359|NCT01444911|434894|P2|STARTED|Overall Study||13
178360|NCT01444911|434895|P1|STARTED|Overall Study||16
178361|NCT01444898|434907|P1|NOT COMPLETED|Overall Study||1
178362|NCT01444898|434907|P1|COMPLETED|Overall Study||9
178363|NCT01444898|434907|P1|STARTED|Overall Study||10
178364|NCT01444781|434922|P3|NOT COMPLETED|Overall Study||3
178365|NCT01444781|434923|P2|NOT COMPLETED|Overall Study||4
178366|NCT01444781|434924|P1|NOT COMPLETED|Overall Study||3
178367|NCT01444781|434922|P3|COMPLETED|Overall Study||272
178368|NCT01444781|434923|P2|COMPLETED|Overall Study||411
178369|NCT01444781|434924|P1|COMPLETED|Overall Study||413
178370|NCT01444781|434922|P3|STARTED|Overall Study||275
178371|NCT01444781|434923|P2|STARTED|Overall Study||415
178372|NCT01444781|434924|P1|STARTED|Overall Study||416
178373|NCT01444742|434962|P1|NOT COMPLETED|Overall Study||1
178374|NCT01444742|434962|P1|COMPLETED|Overall Study||80
178375|NCT01444742|434962|P1|STARTED|Overall Study||81
178376|NCT01444651|434969|P2|NOT COMPLETED|Overall Study||9
178377|NCT01444651|434970|P1|NOT COMPLETED|Overall Study||11
178378|NCT01444651|434969|P2|COMPLETED|Overall Study||28
178379|NCT01444651|434970|P1|COMPLETED|Overall Study||25
178380|NCT01444651|434969|P2|STARTED|Overall Study||37
178381|NCT01444651|434970|P1|STARTED|Overall Study||36
178382|NCT01444456|434986|P1|NOT COMPLETED|Overall Study||285
178383|NCT01444456|434986|P1|COMPLETED|Overall Study|Defined as 4 weeks after last dose of ESA or chemotherapy or 13 weeks after enrolment|977
178384|NCT01444456|434986|P1|Received Darbepoetin Alfa|Overall Study||1134
178385|NCT01444456|434986|P1|Received Darbepoetin Alfa or Other ESA|Overall Study||1158
178386|NCT01444456|434986|P1|STARTED|Overall Study||1262
178387|NCT01444430|434997|P2|NOT COMPLETED|Overall Study||81
178388|NCT01444430|434998|P1|NOT COMPLETED|Overall Study||61
178389|NCT01444430|434997|P2|COMPLETED|Overall Study||5766
178390|NCT01444430|434998|P1|COMPLETED|Overall Study||5785
178391|NCT01444430|434997|P2|STARTED|Overall Study||5847
178392|NCT01444430|434998|P1|STARTED|Overall Study||5846
178393|NCT01444417|435020|P2|NOT COMPLETED|Overall Study||1
178394|NCT01444417|435021|P1|NOT COMPLETED|Overall Study||2
178395|NCT01444417|435020|P2|COMPLETED|Overall Study||41
178396|NCT01444417|435021|P1|COMPLETED|Overall Study||18
178397|NCT01444417|435020|P2|Received Treatment|Overall Study||42
178398|NCT01444417|435021|P1|Received Treatment|Overall Study||19
178399|NCT01444417|435020|P2|STARTED|Overall Study||42
178400|NCT01444417|435021|P1|STARTED|Overall Study||20
178401|NCT01444391|435037|P1|NOT COMPLETED|Overall Study||1
178402|NCT01444391|435037|P1|COMPLETED|Overall Study||41
178403|NCT01444391|435037|P1|STARTED|Overall Study||42
178404|NCT01444378|435045|P1|NOT COMPLETED|Overall Study||17
178405|NCT01444378|435045|P1|COMPLETED|Overall Study||124
178406|NCT01444378|435045|P1|STARTED|Overall Study|A total of 141 patients were enrolled into MOMENTUM|141
178407|NCT01444300|435157|P2|NOT COMPLETED|Overall Study||0
178408|NCT01444300|435158|P1|NOT COMPLETED|Overall Study||4
178409|NCT01444300|435157|P2|COMPLETED|Overall Study||12
178410|NCT01444300|435158|P1|COMPLETED|Overall Study||8
178411|NCT01444300|435157|P2|STARTED|Overall Study||12
178412|NCT01444300|435158|P1|STARTED|Overall Study||12
178413|NCT01444287|435168|P1|NOT COMPLETED|Period 4||0
178414|NCT01444287|435168|P1|COMPLETED|Period 4||22
178415|NCT01444287|435168|P1|STARTED|Period 4||22
178416|NCT01444287|435168|P1|NOT COMPLETED|Period 3||0
178417|NCT01444287|435168|P1|COMPLETED|Period 3||22
178418|NCT01444287|435168|P1|STARTED|Period 3||22
178419|NCT01444287|435168|P1|NOT COMPLETED|Period 2||0
178420|NCT01444287|435168|P1|COMPLETED|Period 2||22
178421|NCT01444287|435168|P1|STARTED|Period 2||22
178422|NCT01444287|435168|P1|NOT COMPLETED|Period 1||0
178423|NCT01444287|435168|P1|COMPLETED|Period 1||22
178424|NCT01444287|435168|P1|STARTED|Period 1||22
178425|NCT01444092|435190|P1|NOT COMPLETED|Overall Study||17
178426|NCT01444092|435190|P1|COMPLETED|Overall Study||91
178427|NCT01444092|435190|P1|INFORMED CONSENT OBTAINED|Overall Study||108
178428|NCT01444092|435190|P1|STARTED|Overall Study||108
178429|NCT01444027|435199|P3|NOT COMPLETED|Overall Study||38
178430|NCT01444027|435200|P2|NOT COMPLETED|Overall Study||30
178431|NCT01444027|435201|P1|NOT COMPLETED|Overall Study||30
178432|NCT01444027|435199|P3|COMPLETED|Overall Study||133
178433|NCT01444027|435200|P2|COMPLETED|Overall Study||141
178434|NCT01444027|435201|P1|COMPLETED|Overall Study||142
178435|NCT01444027|435199|P3|3 Month Follow-up|Overall Study||133
178436|NCT01444027|435200|P2|3 Month Follow-up|Overall Study||141
178437|NCT01444027|435201|P1|3 Month Follow-up|Overall Study||142
178438|NCT01444027|435199|P3|1 Month Follow-up|Overall Study||141
178439|NCT01444027|435200|P2|1 Month Follow-up|Overall Study||159
178440|NCT01444027|435201|P1|1 Month Follow-up|Overall Study||160
178441|NCT01444027|435199|P3|Received Intervention as Assigned|Overall Study||147
178442|NCT01444027|435200|P2|Received Intervention as Assigned|Overall Study||161
178443|NCT01444027|435201|P1|Received Intervention as Assigned|Overall Study||168
178444|NCT01444027|435199|P3|STARTED|Overall Study||171
178445|NCT01444027|435200|P2|STARTED|Overall Study||171
178446|NCT01444027|435201|P1|STARTED|Overall Study||172
178447|NCT01443923|435223|P2|NOT COMPLETED|Overall Study||0
178448|NCT01443923|435224|P1|NOT COMPLETED|Overall Study||1
178449|NCT01443923|435223|P2|COMPLETED|Overall Study||1
178450|NCT01443923|435224|P1|COMPLETED|Overall Study||2
178451|NCT01443923|435223|P2|STARTED|Overall Study||1
178452|NCT01443923|435224|P1|STARTED|Overall Study||3
178453|NCT01443858|435241|P3|NOT COMPLETED|Overall Study||7
178454|NCT01443858|435242|P2|NOT COMPLETED|Overall Study||13
178455|NCT01443858|435243|P1|NOT COMPLETED|Overall Study||15
178456|NCT01443858|435241|P3|COMPLETED|Overall Study||18
178457|NCT01443858|435242|P2|COMPLETED|Overall Study||12
178458|NCT01443858|435243|P1|COMPLETED|Overall Study||10
178459|NCT01443858|435241|P3|STARTED|Overall Study||25
178460|NCT01443858|435242|P2|STARTED|Overall Study||25
178461|NCT01443858|435243|P1|STARTED|Overall Study||25
178462|NCT01443845|435265|P2|NOT COMPLETED|Overall Study||337
178463|NCT01443845|435266|P1|NOT COMPLETED|Overall Study||254
178464|NCT01443845|435265|P2|COMPLETED|Overall Study||841
178465|NCT01443845|435266|P1|COMPLETED|Overall Study||922
178466|NCT01443845|435265|P2|STARTED|Overall Study||1178
178467|NCT01443845|435266|P1|STARTED|Overall Study||1176
178468|NCT01443546|435281|P3|NOT COMPLETED|Overall Study||0
178469|NCT01443546|435282|P2|NOT COMPLETED|Overall Study||0
178470|NCT01443546|435283|P1|NOT COMPLETED|Overall Study||0
178471|NCT01443546|435281|P3|COMPLETED|Overall Study||8
178472|NCT01443546|435282|P2|COMPLETED|Overall Study||9
178473|NCT01443546|435283|P1|COMPLETED|Overall Study||9
178474|NCT01443546|435281|P3|STARTED|Overall Study||8
178475|NCT01443546|435282|P2|STARTED|Overall Study||9
178476|NCT01443546|435283|P1|STARTED|Overall Study||9
178477|NCT01443494|435303|P1|NOT COMPLETED|Overall Study||0
178478|NCT01443494|435303|P1|COMPLETED|Overall Study||19
178479|NCT01443494|435303|P1|STARTED|Overall Study||19
178480|NCT01443442|435310|P2|NOT COMPLETED|Overall Study||0
178481|NCT01443442|435311|P1|NOT COMPLETED|Overall Study||0
178482|NCT01443442|435310|P2|COMPLETED|Overall Study||11
178483|NCT01443442|435311|P1|COMPLETED|Overall Study||12
178484|NCT01443442|435310|P2|STARTED|Overall Study||11
178485|NCT01443442|435311|P1|STARTED|Overall Study||12
178486|NCT01443403|435321|P4|NOT COMPLETED|Overall Study||9
178487|NCT01443403|435322|P3|NOT COMPLETED|Overall Study||7
178488|NCT01443403|435323|P2|NOT COMPLETED|Overall Study||6
178489|NCT01443403|435324|P1|NOT COMPLETED|Overall Study||6
178490|NCT01443403|435321|P4|COMPLETED|Overall Study||52
178491|NCT01443403|435322|P3|COMPLETED|Overall Study||54
178492|NCT01443403|435323|P2|COMPLETED|Overall Study||55
178493|NCT01443403|435324|P1|COMPLETED|Overall Study||55
178494|NCT01443403|435321|P4|Received Treatment|Overall Study||61
178495|NCT01443403|435322|P3|Received Treatment|Overall Study||60
178496|NCT01443403|435323|P2|Received Treatment|Overall Study||61
178497|NCT01443403|435324|P1|Received Treatment|Overall Study||61
178498|NCT01443403|435321|P4|STARTED|Overall Study||61
178499|NCT01443403|435322|P3|STARTED|Overall Study||61
178500|NCT01443403|435323|P2|STARTED|Overall Study||61
178501|NCT01443403|435324|P1|STARTED|Overall Study||61
178502|NCT01443364|435471|P1|NOT COMPLETED|Overall Study||41
178503|NCT01443364|435471|P1|COMPLETED|Overall Study||91
178504|NCT01443364|435471|P1|STARTED|Overall Study||132
178505|NCT01443130|435600|P6|NOT COMPLETED|Overall Study||34
178506|NCT01443130|435601|P5|NOT COMPLETED|Overall Study||44
178507|NCT01443130|435602|P4|NOT COMPLETED|Overall Study||39
178508|NCT01443130|435603|P3|NOT COMPLETED|Overall Study||77
178509|NCT01443130|435604|P2|NOT COMPLETED|Overall Study||69
178510|NCT01443130|435605|P1|NOT COMPLETED|Overall Study||68
178511|NCT01443130|435600|P6|COMPLETED|Overall Study||225
178512|NCT01443130|435601|P5|COMPLETED|Overall Study||230
178513|NCT01443130|435602|P4|COMPLETED|Overall Study||231
178514|NCT01443130|435603|P3|COMPLETED|Overall Study||223
178515|NCT01443130|435604|P2|COMPLETED|Overall Study||231
178516|NCT01443130|435605|P1|COMPLETED|Overall Study||232
178517|NCT01443130|435600|P6|STARTED|Overall Study||259
178518|NCT01443130|435601|P5|STARTED|Overall Study||274
178519|NCT01443130|435602|P4|STARTED|Overall Study||270
178520|NCT01443130|435603|P3|STARTED|Overall Study||300
178521|NCT01443130|435604|P2|STARTED|Overall Study||300
178522|NCT01443130|435605|P1|STARTED|Overall Study||300
178523|NCT01443078|435655|P1|NOT COMPLETED|Overall Study||29
178524|NCT01443078|435655|P1|COMPLETED|Overall Study||13
178525|NCT01443078|435655|P1|STARTED|Overall Study||42
178526|NCT01443026|435662|P2|NOT COMPLETED|Overall Study||5
178527|NCT01443026|435663|P1|NOT COMPLETED|Overall Study||3
178528|NCT01443026|435662|P2|COMPLETED|Overall Study||32
178529|NCT01443026|435663|P1|COMPLETED|Overall Study||26
178530|NCT01443026|435662|P2|STARTED|Overall Study||37
178531|NCT01443026|435663|P1|STARTED|Overall Study||29
178532|NCT01442844|435671|P2|NOT COMPLETED|Overall Study||0
178533|NCT01442844|435672|P1|NOT COMPLETED|Overall Study||0
178534|NCT01442844|435671|P2|COMPLETED|Overall Study||2
178535|NCT01442844|435672|P1|COMPLETED|Overall Study||1
178536|NCT01442844|435671|P2|STARTED|Overall Study||2
178537|NCT01442844|435672|P1|STARTED|Overall Study||1
178538|NCT01442779|435678|P1|NOT COMPLETED|Overall Study||7
178539|NCT01442779|435678|P1|COMPLETED|Overall Study||11
178540|NCT01442779|435678|P1|STARTED|Overall Study||18
178541|NCT01442714|435684|P1|NOT COMPLETED|Overall Study||12
178542|NCT01442714|435684|P1|COMPLETED|Overall Study||21
178543|NCT01442714|435684|P1|STARTED|Overall Study||33
178544|NCT01442688|435692|P2|NOT COMPLETED|Second Intervention||0
178545|NCT01442688|435693|P1|NOT COMPLETED|Second Intervention||1
178546|NCT01442688|435692|P2|COMPLETED|Second Intervention||31
178547|NCT01442688|435693|P1|COMPLETED|Second Intervention||28
178548|NCT01442688|435692|P2|STARTED|Second Intervention||31
178549|NCT01442688|435693|P1|STARTED|Second Intervention||29
178550|NCT01442688|435692|P2|NOT COMPLETED|First Intervention||0
178551|NCT01442688|435693|P1|NOT COMPLETED|First Intervention||2
178552|NCT01442688|435692|P2|COMPLETED|First Intervention||31
178553|NCT01442688|435693|P1|COMPLETED|First Intervention||29
178554|NCT01442688|435692|P2|STARTED|First Intervention||31
178555|NCT01442688|435693|P1|STARTED|First Intervention||31
178556|NCT01442675|435701|P1|NOT COMPLETED|Overall Study||12
178557|NCT01442675|435701|P1|COMPLETED|Overall Study||822
178558|NCT01442675|435701|P1|Per-Protocol Analysis Set|Overall Study|The Per-Protocol Analysis Set are subjects with no pre-defined protocol deviations.|781
178559|NCT01442675|435701|P1|Safety Analysis Set|Overall Study|Safety Analysis Set are subjects who received study vaccine and for whom safety data were available.|831
178560|NCT01442675|435701|P1|STARTED|Overall Study||834
178561|NCT01442493|435713|P2|NOT COMPLETED|Overall Study||2
178562|NCT01442493|435714|P1|NOT COMPLETED|Overall Study||3
178563|NCT01442493|435713|P2|COMPLETED|Overall Study||149
178564|NCT01442493|435714|P1|COMPLETED|Overall Study||146
178565|NCT01442493|435713|P2|STARTED|Overall Study||151
178566|NCT01442493|435714|P1|STARTED|Overall Study||149
178567|NCT01442376|435735|P3|NOT COMPLETED|Overall Study||5
178568|NCT01442376|435736|P2|NOT COMPLETED|Overall Study||9
178569|NCT01442376|435737|P1|NOT COMPLETED|Overall Study||3
178570|NCT01442376|435735|P3|COMPLETED|Overall Study||159
178571|NCT01442376|435736|P2|COMPLETED|Overall Study||160
178572|NCT01442376|435737|P1|COMPLETED|Overall Study||166
178573|NCT01442376|435735|P3|STARTED|Overall Study|Randomized patients|164
178574|NCT01442376|435736|P2|STARTED|Overall Study|Randomized patients|169
178575|NCT01442376|435737|P1|STARTED|Overall Study|Randomized patients|169
178576|NCT01442181|435750|P2|NOT COMPLETED|Overall Study||3
178577|NCT01442181|435751|P1|NOT COMPLETED|Overall Study||4
178578|NCT01442181|435750|P2|COMPLETED|Overall Study||8
178579|NCT01442181|435751|P1|COMPLETED|Overall Study||10
178580|NCT01442181|435750|P2|STARTED|Overall Study||11
178581|NCT01442181|435751|P1|STARTED|Overall Study||14
178582|NCT01442155|435775|P1|NOT COMPLETED|Overall Study||65
178583|NCT01442155|435775|P1|COMPLETED|Overall Study||9
178584|NCT01442155|435775|P1|STARTED|Overall Study||74
178585|NCT01442129|435782|P2|NOT COMPLETED|Overall Study||0
178586|NCT01442129|435783|P1|NOT COMPLETED|Overall Study||0
178587|NCT01442129|435782|P2|COMPLETED|Overall Study||10
178588|NCT01442129|435783|P1|COMPLETED|Overall Study|Treatment withheld from 1 patient randomized before results of screening PRA known|20
178589|NCT01442129|435782|P2|STARTED|Overall Study||10
178590|NCT01442129|435783|P1|STARTED|Overall Study||20
178591|NCT01442103|435791|P1|NOT COMPLETED|Overall Study||2
178592|NCT01442103|435791|P1|COMPLETED|Overall Study||8
178593|NCT01442103|435791|P1|STARTED|Overall Study||10
178594|NCT01442064|435801|P6|NOT COMPLETED|Overall Study||99
178595|NCT01442064|435802|P5|NOT COMPLETED|Overall Study||106
178596|NCT01442064|435803|P4|NOT COMPLETED|Overall Study||98
178597|NCT01442064|435804|P3|NOT COMPLETED|Overall Study||104
178598|NCT01442064|435805|P2|NOT COMPLETED|Overall Study||101
178599|NCT01442064|435806|P1|NOT COMPLETED|Overall Study||97
178600|NCT01442064|435801|P6|COMPLETED|Overall Study||0
178601|NCT01442064|435802|P5|COMPLETED|Overall Study||1
178602|NCT01442064|435803|P4|COMPLETED|Overall Study||0
178603|NCT01442064|435804|P3|COMPLETED|Overall Study||0
178604|NCT01442064|435805|P2|COMPLETED|Overall Study||2
178605|NCT01442064|435806|P1|COMPLETED|Overall Study||0
178606|NCT01442064|435801|P6|Received Study Drug in Extension Study|Overall Study||81
178607|NCT01442064|435802|P5|Received Study Drug in Extension Study|Overall Study||89
178608|NCT01442064|435803|P4|Received Study Drug in Extension Study|Overall Study||70
178609|NCT01442064|435804|P3|Received Study Drug in Extension Study|Overall Study||60
178610|NCT01442064|435805|P2|Received Study Drug in Extension Study|Overall Study||70
178611|NCT01442064|435806|P1|Received Study Drug in Extension Study|Overall Study||61
178612|NCT01442064|435801|P6|Ranibizumab-Treated Subjects|Overall Study||99
178613|NCT01442064|435802|P5|Ranibizumab-Treated Subjects|Overall Study||107
178614|NCT01442064|435803|P4|Ranibizumab-Treated Subjects|Overall Study||96
178615|NCT01442064|435804|P3|Ranibizumab-Treated Subjects|Overall Study||104
178616|NCT01442064|435805|P2|Ranibizumab-Treated Subjects|Overall Study||103
178617|NCT01442064|435806|P1|Ranibizumab-Treated Subjects|Overall Study|Includes participants who received Ranibizumab in either the initial studies or the extension study.|93
178618|NCT01442064|435801|P6|STARTED|Overall Study||99
178619|NCT01442064|435802|P5|STARTED|Overall Study||107
178620|NCT01442064|435803|P4|STARTED|Overall Study||98
178621|NCT01442064|435804|P3|STARTED|Overall Study||104
178622|NCT01442064|435805|P2|STARTED|Overall Study||103
178623|NCT01442064|435806|P1|STARTED|Overall Study||97
178624|NCT01442038|435843|P2|NOT COMPLETED|Overall Study||279
178625|NCT01442038|435844|P1|NOT COMPLETED|Overall Study||303
178626|NCT01442038|435843|P2|COMPLETED|Overall Study||1040
178627|NCT01442038|435844|P1|COMPLETED|Overall Study||1029
178628|NCT01442038|435843|P2|STARTED|Overall Study||1319
178629|NCT01442038|435844|P1|STARTED|Overall Study||1332
178630|NCT01441973|435858|P2|NOT COMPLETED|Overall Study||16
178631|NCT01441973|435859|P1|NOT COMPLETED|Overall Study||15
178632|NCT01441973|435858|P2|COMPLETED|Overall Study|Still receiving treatment|0
178633|NCT01441973|435859|P1|COMPLETED|Overall Study|Still receiving treatment|0
178634|NCT01441973|435858|P2|STARTED|Overall Study||16
178635|NCT01441973|435859|P1|STARTED|Overall Study||15
178636|NCT01441960|435881|P2|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
178637|NCT01441960|435882|P1|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
178638|NCT01441960|435881|P2|COMPLETED|Second Neuromuscular Blocking Agent||13
178639|NCT01441960|435882|P1|COMPLETED|Second Neuromuscular Blocking Agent||18
178640|NCT01441960|435881|P2|STARTED|Second Neuromuscular Blocking Agent||13
178641|NCT01441960|435882|P1|STARTED|Second Neuromuscular Blocking Agent||18
178642|NCT01441960|435881|P2|NOT COMPLETED|First Neuromuscular Blocking Agent:||6
178643|NCT01441960|435882|P1|NOT COMPLETED|First Neuromuscular Blocking Agent:||8
178644|NCT01441960|435881|P2|COMPLETED|First Neuromuscular Blocking Agent:||13
178645|NCT01441960|435882|P1|COMPLETED|First Neuromuscular Blocking Agent:||18
178646|NCT01441960|435881|P2|STARTED|First Neuromuscular Blocking Agent:||19
178647|NCT01441960|435882|P1|STARTED|First Neuromuscular Blocking Agent:||26
178648|NCT01441882|435892|P1|NOT COMPLETED|Overall Study||6
178649|NCT01441882|435892|P1|COMPLETED|Overall Study||13
178650|NCT01441882|435892|P1|STARTED|Overall Study||19
178651|NCT01441843|435898|P2|NOT COMPLETED|Overall Study||5
178652|NCT01441843|435899|P1|NOT COMPLETED|Overall Study||12
178653|NCT01441843|435898|P2|COMPLETED|Overall Study||195
178654|NCT01441843|435899|P1|COMPLETED|Overall Study||188
178655|NCT01441843|435898|P2|STARTED|Overall Study||200
178656|NCT01441843|435899|P1|STARTED|Overall Study||200
178657|NCT01441765|435907|P2|NOT COMPLETED|Overall Study||0
178658|NCT01441765|435908|P1|NOT COMPLETED|Overall Study||1
178659|NCT01441765|435907|P2|COMPLETED|Overall Study|not opened|0
178660|NCT01441765|435908|P1|COMPLETED|Overall Study||10
178661|NCT01441765|435907|P2|STARTED|Overall Study|not opened|0
178662|NCT01441765|435908|P1|STARTED|Overall Study||11
178663|NCT01441596|435925|P3|NOT COMPLETED|Overall Study||4
178664|NCT01441596|435926|P2|NOT COMPLETED|Overall Study||3
178665|NCT01441596|435927|P1|NOT COMPLETED|Overall Study||4
178666|NCT01441596|435925|P3|COMPLETED|Overall Study||39
178667|NCT01441596|435926|P2|COMPLETED|Overall Study||35
178668|NCT01441596|435927|P1|COMPLETED|Overall Study||36
178669|NCT01441596|435925|P3|STARTED|Overall Study||43
178670|NCT01441596|435926|P2|STARTED|Overall Study||38
178671|NCT01441596|435927|P1|STARTED|Overall Study||40
178672|NCT01441570|435943|P2|NOT COMPLETED|Overall Study||0
178673|NCT01441570|435944|P1|NOT COMPLETED|Overall Study||0
178674|NCT01441570|435943|P2|COMPLETED|Overall Study||5
178675|NCT01441570|435944|P1|COMPLETED|Overall Study||6
178676|NCT01441570|435943|P2|STARTED|Overall Study||5
178677|NCT01441570|435944|P1|STARTED|Overall Study||6
178678|NCT01441466|435954|P2|NOT COMPLETED|Overall Study||0
178679|NCT01441466|435955|P1|NOT COMPLETED|Overall Study||0
178680|NCT01441466|435954|P2|COMPLETED|Overall Study||11
178681|NCT01441466|435955|P1|COMPLETED|Overall Study||37
178682|NCT01441466|435954|P2|STARTED|Overall Study||11
178683|NCT01441466|435955|P1|STARTED|Overall Study||37
178684|NCT01441440|435974|P3|NOT COMPLETED|Overall Study||22
178685|NCT01441440|435975|P2|NOT COMPLETED|Overall Study||23
178686|NCT01441440|435976|P1|NOT COMPLETED|Overall Study||17
178687|NCT01441440|435974|P3|COMPLETED|Overall Study||158
178688|NCT01441440|435975|P2|COMPLETED|Overall Study||151
178689|NCT01441440|435976|P1|COMPLETED|Overall Study||166
178690|NCT01441440|435974|P3|STARTED|Overall Study|Safety analysis set|180
178691|NCT01441440|435975|P2|STARTED|Overall Study|Safety analysis set|174
178692|NCT01441440|435976|P1|STARTED|Overall Study|Safety analysis set|183
178693|NCT01441414|435999|P1|NOT COMPLETED|Overall Study||15
178694|NCT01441414|435999|P1|COMPLETED|Overall Study||3
178695|NCT01441414|435999|P1|STARTED|Overall Study||18
178696|NCT01441401|436024|P1|NOT COMPLETED|Overall Study||0
178697|NCT01441401|436024|P1|COMPLETED|Overall Study|Number of participants whose survey form was collected was presented.|82
178698|NCT01441401|436024|P1|STARTED|Overall Study||82
178699|NCT01441245|436052|P2|NOT COMPLETED|Overall Study||0
178700|NCT01441245|436053|P1|NOT COMPLETED|Overall Study||0
178701|NCT01441245|436052|P2|COMPLETED|Overall Study||27
178702|NCT01441245|436053|P1|COMPLETED|Overall Study||30
178703|NCT01441245|436052|P2|STARTED|Overall Study||27
178704|NCT01441245|436053|P1|STARTED|Overall Study||30
178705|NCT01441180|436078|P3|NOT COMPLETED|Overall Study||3
178706|NCT01441180|436079|P2|NOT COMPLETED|Overall Study||1
178707|NCT01441180|436080|P1|NOT COMPLETED|Overall Study||1
178708|NCT01441180|436078|P3|COMPLETED|Overall Study||22
178709|NCT01441180|436079|P2|COMPLETED|Overall Study||24
178710|NCT01441180|436080|P1|COMPLETED|Overall Study||9
178711|NCT01441180|436078|P3|STARTED|Overall Study||25
178712|NCT01441180|436079|P2|STARTED|Overall Study||25
178713|NCT01441180|436080|P1|STARTED|Overall Study||10
178714|NCT01441102|436091|P1|NOT COMPLETED|Overall Study||3
178715|NCT01441102|436091|P1|COMPLETED|Overall Study||4
178716|NCT01441102|436091|P1|STARTED|Overall Study|Two participants withdrew prior to Month 6; therefore, two additional participants were enrolled.|7
178717|NCT01441076|436111|P1|NOT COMPLETED|Overall Study||2
178718|NCT01441076|436111|P1|COMPLETED|Overall Study||4
178719|NCT01441076|436111|P1|STARTED|Overall Study||6
178720|NCT01441037|436129|P1|NOT COMPLETED|Overall Study||0
178721|NCT01441037|436129|P1|COMPLETED|Overall Study||27
178722|NCT01441037|436129|P1|STARTED|Overall Study||27
178723|NCT01440972|436135|P2|NOT COMPLETED|Overall Study||2
178724|NCT01440972|436136|P1|NOT COMPLETED|Overall Study||3
178725|NCT01440972|436135|P2|COMPLETED|Overall Study||19
178726|NCT01440972|436136|P1|COMPLETED|Overall Study||21
178727|NCT01440972|436135|P2|STARTED|Overall Study||21
178728|NCT01440972|436136|P1|STARTED|Overall Study||24
178729|NCT01440959|436150|P1|NOT COMPLETED|Overall Study||0
178730|NCT01440959|436150|P1|COMPLETED|Overall Study||30
178731|NCT01440959|436150|P1|STARTED|Overall Study||30
178732|NCT01440946|436160|P2|NOT COMPLETED|Overall Study||1
178733|NCT01440946|436161|P1|NOT COMPLETED|Overall Study||2
178734|NCT01440946|436160|P2|COMPLETED|Overall Study||14
178735|NCT01440946|436161|P1|COMPLETED|Overall Study||13
178736|NCT01440946|436160|P2|STARTED|Overall Study||15
178737|NCT01440946|436161|P1|STARTED|Overall Study||15
178738|NCT01440881|436200|P2|NOT COMPLETED|Overall Study||1
178739|NCT01440881|436201|P1|NOT COMPLETED|Overall Study||0
178740|NCT01440881|436200|P2|COMPLETED|Overall Study||14
178741|NCT01440881|436201|P1|COMPLETED|Overall Study||14
178742|NCT01440881|436200|P2|STARTED|Overall Study||15
178743|NCT01440881|436201|P1|STARTED|Overall Study||14
178744|NCT01440816|436215|P2|NOT COMPLETED|Overall Study||11
178745|NCT01440816|436216|P1|NOT COMPLETED|Overall Study||1
178746|NCT01440816|436215|P2|COMPLETED|Overall Study||1
178747|NCT01440816|436216|P1|COMPLETED|Overall Study||2
178748|NCT01440816|436215|P2|STARTED|Overall Study||12
178749|NCT01440816|436216|P1|STARTED|Overall Study||3
178750|NCT01440803|436232|P2|NOT COMPLETED|Overall Study||4
178751|NCT01440803|436233|P1|NOT COMPLETED|Overall Study||2
178752|NCT01440803|436232|P2|COMPLETED|Overall Study||24
178753|NCT01440803|436233|P1|COMPLETED|Overall Study||11
178754|NCT01440803|436232|P2|Period 3 - Forteo Open Label|Overall Study||27
178755|NCT01440803|436233|P1|Period 3 - Forteo Open Label|Overall Study||13
178756|NCT01440803|436232|P2|Period 2 - Forteo/Forteo|Overall Study||28
178757|NCT01440803|436233|P1|Period 2 - Forteo/Forteo|Overall Study||13
178758|NCT01440803|436232|P2|Period 1 - Forteo/Placebo|Overall Study||28
178759|NCT01440803|436233|P1|Period 1 - Forteo/Placebo|Overall Study||13
178760|NCT01440803|436232|P2|STARTED|Overall Study||28
178761|NCT01440803|436233|P1|STARTED|Overall Study||13
178762|NCT01440764|436242|P7|NOT COMPLETED|Test Day 3||0
178763|NCT01440764|436243|P6|NOT COMPLETED|Test Day 3||0
178764|NCT01440764|436244|P5|NOT COMPLETED|Test Day 3||0
178765|NCT01440764|436245|P4|NOT COMPLETED|Test Day 3||0
178766|NCT01440764|436246|P3|NOT COMPLETED|Test Day 3||0
178767|NCT01440764|436247|P2|NOT COMPLETED|Test Day 3||0
178768|NCT01440764|436248|P1|NOT COMPLETED|Test Day 3||0
178769|NCT01440764|436242|P7|COMPLETED|Test Day 3||3
178770|NCT01440764|436243|P6|COMPLETED|Test Day 3||5
178771|NCT01440764|436244|P5|COMPLETED|Test Day 3||3
178772|NCT01440764|436245|P4|COMPLETED|Test Day 3||1
178773|NCT01440764|436246|P3|COMPLETED|Test Day 3||6
178774|NCT01440764|436247|P2|COMPLETED|Test Day 3||2
178775|NCT01440764|436248|P1|COMPLETED|Test Day 3||3
178776|NCT01440764|436242|P7|STARTED|Test Day 3||3
178777|NCT01440764|436243|P6|STARTED|Test Day 3||5
178778|NCT01440764|436244|P5|STARTED|Test Day 3||3
178779|NCT01440764|436245|P4|STARTED|Test Day 3||1
178780|NCT01440764|436246|P3|STARTED|Test Day 3||6
178781|NCT01440764|436247|P2|STARTED|Test Day 3||2
178782|NCT01440764|436248|P1|STARTED|Test Day 3||3
178783|NCT01440764|436242|P7|NOT COMPLETED|Test Day 2||0
178784|NCT01440764|436243|P6|NOT COMPLETED|Test Day 2||0
178785|NCT01440764|436244|P5|NOT COMPLETED|Test Day 2||0
178786|NCT01440764|436245|P4|NOT COMPLETED|Test Day 2||0
178787|NCT01440764|436246|P3|NOT COMPLETED|Test Day 2||0
178788|NCT01440764|436247|P2|NOT COMPLETED|Test Day 2||0
178789|NCT01440764|436248|P1|NOT COMPLETED|Test Day 2||0
178790|NCT01440764|436242|P7|COMPLETED|Test Day 2||3
178791|NCT01440764|436243|P6|COMPLETED|Test Day 2||5
178792|NCT01440764|436244|P5|COMPLETED|Test Day 2||3
178793|NCT01440764|436245|P4|COMPLETED|Test Day 2||1
178794|NCT01440764|436246|P3|COMPLETED|Test Day 2||6
178795|NCT01440764|436247|P2|COMPLETED|Test Day 2||2
178796|NCT01440764|436248|P1|COMPLETED|Test Day 2||3
178797|NCT01440764|436242|P7|STARTED|Test Day 2||3
178798|NCT01440764|436243|P6|STARTED|Test Day 2||5
178799|NCT01440764|436244|P5|STARTED|Test Day 2||3
178800|NCT01440764|436245|P4|STARTED|Test Day 2||1
178801|NCT01440764|436246|P3|STARTED|Test Day 2||6
178802|NCT01440764|436247|P2|STARTED|Test Day 2||2
178803|NCT01440764|436248|P1|STARTED|Test Day 2|Following Test Day 1, 1 subject withdrew from the study before beginning Test Day 2.|3
178804|NCT01440764|436242|P7|NOT COMPLETED|Test Day 1||0
178805|NCT01440764|436243|P6|NOT COMPLETED|Test Day 1||0
178806|NCT01440764|436244|P5|NOT COMPLETED|Test Day 1||0
178807|NCT01440764|436245|P4|NOT COMPLETED|Test Day 1||0
178808|NCT01440764|436246|P3|NOT COMPLETED|Test Day 1||0
178809|NCT01440764|436247|P2|NOT COMPLETED|Test Day 1||0
178810|NCT01440764|436248|P1|NOT COMPLETED|Test Day 1||0
178811|NCT01440764|436242|P7|COMPLETED|Test Day 1||3
178812|NCT01440764|436243|P6|COMPLETED|Test Day 1||5
178813|NCT01440764|436244|P5|COMPLETED|Test Day 1||3
178814|NCT01440764|436245|P4|COMPLETED|Test Day 1||1
178815|NCT01440764|436246|P3|COMPLETED|Test Day 1||6
178816|NCT01440764|436247|P2|COMPLETED|Test Day 1||2
178817|NCT01440764|436248|P1|COMPLETED|Test Day 1||4
178818|NCT01440764|436242|P7|STARTED|Test Day 1||3
178819|NCT01440764|436243|P6|STARTED|Test Day 1||5
178820|NCT01440764|436244|P5|STARTED|Test Day 1||3
178821|NCT01440764|436245|P4|STARTED|Test Day 1||1
178822|NCT01440764|436246|P3|STARTED|Test Day 1||6
178823|NCT01440764|436247|P2|STARTED|Test Day 1||2
178824|NCT01440764|436248|P1|STARTED|Test Day 1||4
178825|NCT01440647|436269|P2|NOT COMPLETED|Overall Study||3
178826|NCT01440647|436270|P1|NOT COMPLETED|Overall Study||2
178827|NCT01440647|436269|P2|COMPLETED|Overall Study||15
178828|NCT01440647|436270|P1|COMPLETED|Overall Study||14
178829|NCT01440647|436269|P2|STARTED|Overall Study||18
178830|NCT01440647|436270|P1|STARTED|Overall Study||16
178831|NCT01440634|436280|P2|NOT COMPLETED|Randomization Phase||10
178832|NCT01440634|436281|P1|NOT COMPLETED|Randomization Phase||6
178833|NCT01440634|436280|P2|COMPLETED|Randomization Phase||14
178834|NCT01440634|436281|P1|COMPLETED|Randomization Phase||24
178835|NCT01440634|436280|P2|STARTED|Randomization Phase||24
178836|NCT01440634|436281|P1|STARTED|Randomization Phase||30
178837|NCT01440634|436280|P2|NOT COMPLETED|Cross Sectional Phase||0
178838|NCT01440634|436281|P1|NOT COMPLETED|Cross Sectional Phase||0
178839|NCT01440634|436280|P2|COMPLETED|Cross Sectional Phase||347
178840|NCT01440634|436281|P1|COMPLETED|Cross Sectional Phase||0
178841|NCT01440634|436280|P2|STARTED|Cross Sectional Phase||347
178842|NCT01440634|436281|P1|STARTED|Cross Sectional Phase||0
178843|NCT01440595|436289|P3|NOT COMPLETED|Overall Study||1
178844|NCT01440595|436290|P2|NOT COMPLETED|Overall Study||3
178845|NCT01440595|436291|P1|NOT COMPLETED|Overall Study||1
178846|NCT01440595|436289|P3|COMPLETED|Overall Study||0
178847|NCT01440595|436290|P2|COMPLETED|Overall Study||0
178848|NCT01440595|436291|P1|COMPLETED|Overall Study||0
178849|NCT01440595|436289|P3|STARTED|Overall Study||1
178850|NCT01440595|436290|P2|STARTED|Overall Study||3
178851|NCT01440595|436291|P1|STARTED|Overall Study||1
178852|NCT01440569|436311|P2|NOT COMPLETED|Open-Label Rollover Phase||6
178853|NCT01440569|436312|P1|NOT COMPLETED|Open-Label Rollover Phase||47
178854|NCT01440569|436311|P2|COMPLETED|Open-Label Rollover Phase||7
178855|NCT01440569|436312|P1|COMPLETED|Open-Label Rollover Phase||204
178856|NCT01440569|436311|P2|STARTED|Open-Label Rollover Phase|1 participant who completed the Main Study did not enroll into the Rollover Phase.|13
178857|NCT01440569|436312|P1|STARTED|Open-Label Rollover Phase|9 participants who completed the Main Study did not enroll into the Rollover Phase.|251
178858|NCT01440569|436311|P2|NOT COMPLETED|Main Study||4
178859|NCT01440569|436312|P1|NOT COMPLETED|Main Study||36
178860|NCT01440569|436311|P2|COMPLETED|Main Study||14
178861|NCT01440569|436312|P1|COMPLETED|Main Study||260
178862|NCT01440569|436311|P2|Enrolled and Treated|Main Study||18
178863|NCT01440569|436312|P1|Enrolled and Treated|Main Study||295
178864|NCT01440569|436311|P2|STARTED|Main Study||18
178865|NCT01440569|436312|P1|STARTED|Main Study||296
178866|NCT01440543|436334|P4|NOT COMPLETED|Overall Study||6
178867|NCT01440543|436335|P3|NOT COMPLETED|Overall Study||2
178868|NCT01440543|436336|P2|NOT COMPLETED|Overall Study||4
178869|NCT01440543|436337|P1|NOT COMPLETED|Overall Study||4
178870|NCT01440543|436334|P4|COMPLETED|Overall Study||101
178871|NCT01440543|436335|P3|COMPLETED|Overall Study||100
178872|NCT01440543|436336|P2|COMPLETED|Overall Study||101
178873|NCT01440543|436337|P1|COMPLETED|Overall Study||102
178874|NCT01440543|436334|P4|STARTED|Overall Study||107
178875|NCT01440543|436335|P3|STARTED|Overall Study||102
178876|NCT01440543|436336|P2|STARTED|Overall Study||105
178877|NCT01440543|436337|P1|STARTED|Overall Study||106
178878|NCT01440517|436347|P1|NOT COMPLETED|Overall Study||1
178879|NCT01440517|436347|P1|COMPLETED|Overall Study||4
178880|NCT01440517|436347|P1|STARTED|Overall Study||5
178881|NCT01440387|436354|P2|NOT COMPLETED|Overall Study||0
178882|NCT01440387|436355|P1|NOT COMPLETED|Overall Study||0
178883|NCT01440387|436354|P2|COMPLETED|Overall Study||56
178884|NCT01440387|436355|P1|COMPLETED|Overall Study||56
178885|NCT01440387|436354|P2|STARTED|Overall Study||56
178886|NCT01440387|436355|P1|STARTED|Overall Study||56
178887|NCT01440374|436378|P4|NOT COMPLETED|Part 3: Extension||32
178888|NCT01440374|436379|P3|NOT COMPLETED|Part 3: Extension||0
178889|NCT01440374|436380|P2|NOT COMPLETED|Part 3: Extension||0
178890|NCT01440374|436381|P1|NOT COMPLETED|Part 3: Extension||0
178891|NCT01440374|436378|P4|COMPLETED|Part 3: Extension||27
178892|NCT01440374|436379|P3|COMPLETED|Part 3: Extension||0
178893|NCT01440374|436380|P2|COMPLETED|Part 3: Extension||0
178894|NCT01440374|436381|P1|COMPLETED|Part 3: Extension||0
178895|NCT01440374|436378|P4|STARTED|Part 3: Extension||59
178896|NCT01440374|436379|P3|STARTED|Part 3: Extension||0
178897|NCT01440374|436380|P2|STARTED|Part 3: Extension||0
178898|NCT01440374|436381|P1|STARTED|Part 3: Extension||0
178899|NCT01440374|436378|P4|NOT COMPLETED|Part 2; Double-blind Phase||0
178900|NCT01440374|436379|P3|NOT COMPLETED|Part 2; Double-blind Phase||55
178901|NCT01440374|436380|P2|NOT COMPLETED|Part 2; Double-blind Phase||20
178902|NCT01440374|436381|P1|NOT COMPLETED|Part 2; Double-blind Phase||0
178903|NCT01440374|436378|P4|COMPLETED|Part 2; Double-blind Phase||0
178904|NCT01440374|436379|P3|COMPLETED|Part 2; Double-blind Phase||43
178905|NCT01440374|436380|P2|COMPLETED|Part 2; Double-blind Phase||27
178906|NCT01440374|436381|P1|COMPLETED|Part 2; Double-blind Phase||0
178907|NCT01440374|436378|P4|STARTED|Part 2; Double-blind Phase||0
178908|NCT01440374|436379|P3|STARTED|Part 2; Double-blind Phase||98
178909|NCT01440374|436380|P2|STARTED|Part 2; Double-blind Phase||47
178910|NCT01440374|436381|P1|STARTED|Part 2; Double-blind Phase||0
178911|NCT01440374|436378|P4|NOT COMPLETED|Part 1: Open-label Phase||0
178912|NCT01440374|436379|P3|NOT COMPLETED|Part 1: Open-label Phase||0
178913|NCT01440374|436380|P2|NOT COMPLETED|Part 1: Open-label Phase||0
178914|NCT01440374|436381|P1|NOT COMPLETED|Part 1: Open-label Phase||6
178915|NCT01440374|436378|P4|COMPLETED|Part 1: Open-label Phase||0
178916|NCT01440374|436379|P3|COMPLETED|Part 1: Open-label Phase||0
178917|NCT01440374|436380|P2|COMPLETED|Part 1: Open-label Phase||0
178918|NCT01440374|436381|P1|COMPLETED|Part 1: Open-label Phase||11
178919|NCT01440374|436378|P4|STARTED|Part 1: Open-label Phase||0
178920|NCT01440374|436379|P3|STARTED|Part 1: Open-label Phase||0
178921|NCT01440374|436380|P2|STARTED|Part 1: Open-label Phase||0
178922|NCT01440374|436381|P1|STARTED|Part 1: Open-label Phase||17
178923|NCT01440322|436416|P2|NOT COMPLETED|Overall Study||1
178924|NCT01440322|436417|P1|NOT COMPLETED|Overall Study||7
178925|NCT01440322|436416|P2|COMPLETED|Overall Study||49
178926|NCT01440322|436417|P1|COMPLETED|Overall Study||90
178927|NCT01440322|436416|P2|STARTED|Overall Study||50
178928|NCT01440322|436417|P1|STARTED|Overall Study||97
178929|NCT01440283|436439|P1|NOT COMPLETED|Overall Study||10
178930|NCT01440283|436439|P1|COMPLETED|Overall Study||4
178931|NCT01440283|436439|P1|STARTED|Overall Study||14
178932|NCT01440101|436454|P3|NOT COMPLETED|Overall Study||1
178933|NCT01440101|436455|P2|NOT COMPLETED|Overall Study||4
178934|NCT01440101|436456|P1|NOT COMPLETED|Overall Study||2
178935|NCT01440101|436454|P3|COMPLETED|Overall Study||46
178936|NCT01440101|436455|P2|COMPLETED|Overall Study||43
178937|NCT01440101|436456|P1|COMPLETED|Overall Study||10
178938|NCT01440101|436454|P3|STARTED|Overall Study||47
178939|NCT01440101|436455|P2|STARTED|Overall Study||47
178940|NCT01440101|436456|P1|STARTED|Overall Study||12
178941|NCT01440049|436489|P1|NOT COMPLETED|Overall Study||5
178942|NCT01440049|436489|P1|COMPLETED|Overall Study||155
178943|NCT01440049|436489|P1|STARTED|Overall Study||160
178944|NCT01439971|436521|P5|NOT COMPLETED|Overall Study||1
178945|NCT01439971|436522|P4|NOT COMPLETED|Overall Study||0
178946|NCT01439971|436523|P3|NOT COMPLETED|Overall Study||2
178947|NCT01439971|436524|P2|NOT COMPLETED|Overall Study||1
178948|NCT01439971|436525|P1|NOT COMPLETED|Overall Study||0
178949|NCT01439971|436521|P5|COMPLETED|Overall Study||6
178950|NCT01439971|436522|P4|COMPLETED|Overall Study||6
178951|NCT01439971|436523|P3|COMPLETED|Overall Study||6
178952|NCT01439971|436524|P2|COMPLETED|Overall Study||6
178953|NCT01439971|436525|P1|COMPLETED|Overall Study||1
178954|NCT01439971|436521|P5|Received Treatment|Overall Study||6
178955|NCT01439971|436522|P4|Received Treatment|Overall Study||6
178956|NCT01439971|436523|P3|Received Treatment|Overall Study||6
178957|NCT01439971|436524|P2|Received Treatment|Overall Study||6
178958|NCT01439971|436525|P1|Received Treatment|Overall Study||1
178959|NCT01439971|436521|P5|STARTED|Overall Study||7
178960|NCT01439971|436522|P4|STARTED|Overall Study||6
178961|NCT01439971|436523|P3|STARTED|Overall Study||8
178962|NCT01439971|436524|P2|STARTED|Overall Study||7
178963|NCT01439971|436525|P1|STARTED|Overall Study||1
178964|NCT01439945|436705|P4|NOT COMPLETED|Optional Continuation Phase||0
178965|NCT01439945|436706|P3|NOT COMPLETED|Optional Continuation Phase||0
178966|NCT01439945|436707|P2|NOT COMPLETED|Optional Continuation Phase||0
178967|NCT01439945|436708|P1|NOT COMPLETED|Optional Continuation Phase||0
178968|NCT01439945|436705|P4|COMPLETED|Optional Continuation Phase||0
178969|NCT01439945|436706|P3|COMPLETED|Optional Continuation Phase||0
178970|NCT01439945|436707|P2|COMPLETED|Optional Continuation Phase||44
178971|NCT01439945|436708|P1|COMPLETED|Optional Continuation Phase||72
178972|NCT01439945|436705|P4|STARTED|Optional Continuation Phase||0
178973|NCT01439945|436706|P3|STARTED|Optional Continuation Phase||0
178974|NCT01439945|436707|P2|STARTED|Optional Continuation Phase||44
178975|NCT01439945|436708|P1|STARTED|Optional Continuation Phase||72
178976|NCT01439945|436705|P4|NOT COMPLETED|Double-Blind Treatment Phase||2
178977|NCT01439945|436706|P3|NOT COMPLETED|Double-Blind Treatment Phase||3
178978|NCT01439945|436707|P2|NOT COMPLETED|Double-Blind Treatment Phase||5
178979|NCT01439945|436708|P1|NOT COMPLETED|Double-Blind Treatment Phase||4
178980|NCT01439945|436705|P4|COMPLETED|Double-Blind Treatment Phase||46
178981|NCT01439945|436706|P3|COMPLETED|Double-Blind Treatment Phase||45
178982|NCT01439945|436707|P2|COMPLETED|Double-Blind Treatment Phase||91
178983|NCT01439945|436708|P1|COMPLETED|Double-Blind Treatment Phase||93
178984|NCT01439945|436705|P4|STARTED|Double-Blind Treatment Phase||48
178985|NCT01439945|436706|P3|STARTED|Double-Blind Treatment Phase||48
178986|NCT01439945|436707|P2|STARTED|Double-Blind Treatment Phase||96
178987|NCT01439945|436708|P1|STARTED|Double-Blind Treatment Phase||97
178988|NCT01439880|436733|P2|NOT COMPLETED|All-IP Period (Years 2 to 5)||140
178989|NCT01439880|436734|P1|NOT COMPLETED|All-IP Period (Years 2 to 5)||70
178990|NCT01439880|436733|P2|COMPLETED|All-IP Period (Years 2 to 5)||682
178991|NCT01439880|436734|P1|COMPLETED|All-IP Period (Years 2 to 5)||328
178992|NCT01439880|436733|P2|Received Evolocumab|All-IP Period (Years 2 to 5)||777
178993|NCT01439880|436734|P1|Received Evolocumab|All-IP Period (Years 2 to 5)||374
178994|NCT01439880|436733|P2|STARTED|All-IP Period (Years 2 to 5)||822
178995|NCT01439880|436734|P1|STARTED|All-IP Period (Years 2 to 5)||398
178996|NCT01439880|436733|P2|NOT COMPLETED|SOC-controlled Period (Year 1)||60
178997|NCT01439880|436734|P1|NOT COMPLETED|SOC-controlled Period (Year 1)||44
178998|NCT01439880|436733|P2|COMPLETED|SOC-controlled Period (Year 1)||822
178999|NCT01439880|436734|P1|COMPLETED|SOC-controlled Period (Year 1)||398
179000|NCT01439880|436733|P2|Received Evolocumab|SOC-controlled Period (Year 1)||881
179001|NCT01439880|436734|P1|Received Evolocumab|SOC-controlled Period (Year 1)||0
179002|NCT01439880|436733|P2|STARTED|SOC-controlled Period (Year 1)||882
179003|NCT01439880|436734|P1|STARTED|SOC-controlled Period (Year 1)||442
179004|NCT01439867|436777|P2|NOT COMPLETED|Overall Study||8
179005|NCT01439867|436778|P1|NOT COMPLETED|Overall Study||6
179006|NCT01439867|436777|P2|COMPLETED|Overall Study||2
179007|NCT01439867|436778|P1|COMPLETED|Overall Study||2
179008|NCT01439867|436777|P2|Received Treatment|Overall Study||10
179009|NCT01439867|436778|P1|Received Treatment|Overall Study||7
179010|NCT01439867|436777|P2|STARTED|Overall Study||10
179011|NCT01439867|436778|P1|STARTED|Overall Study||8
179012|NCT01439854|436819|P2|NOT COMPLETED|Overall Study||0
179013|NCT01439854|436820|P1|NOT COMPLETED|Overall Study||0
179014|NCT01439854|436819|P2|COMPLETED|Overall Study||10
179015|NCT01439854|436820|P1|COMPLETED|Overall Study||8
179016|NCT01439854|436819|P2|STARTED|Overall Study||10
179017|NCT01439854|436820|P1|STARTED|Overall Study||8
179018|NCT01439724|436830|P2|NOT COMPLETED|Overall Study||8
179019|NCT01439724|436831|P1|NOT COMPLETED|Overall Study||9
179020|NCT01439724|436830|P2|COMPLETED|Overall Study||39
179021|NCT01439724|436831|P1|COMPLETED|Overall Study||38
179022|NCT01439724|436830|P2|STARTED|Overall Study||47
179023|NCT01439724|436831|P1|STARTED|Overall Study||47
179024|NCT01439711|436837|P1|NOT COMPLETED|Overall Study||40
179025|NCT01439711|436837|P1|COMPLETED|Overall Study||68
179026|NCT01439711|436837|P1|STARTED|Overall Study||108
179027|NCT01439672|436848|P1|NOT COMPLETED|Overall Study||24
179028|NCT01439672|436848|P1|COMPLETED|Overall Study||11
179029|NCT01439672|436848|P1|STARTED|Overall Study||35
179030|NCT01439633|436852|P1|NOT COMPLETED|Overall Study||0
179031|NCT01439633|436852|P1|COMPLETED|Overall Study||22
179032|NCT01439633|436852|P1|STARTED|Overall Study||22
179033|NCT01439620|436856|P1|NOT COMPLETED|Overall Study||0
179034|NCT01439620|436856|P1|COMPLETED|Overall Study||7
179035|NCT01439620|436856|P1|STARTED|Overall Study||7
179036|NCT01439594|436860|P1|NOT COMPLETED|Overall Study||0
179037|NCT01439594|436860|P1|COMPLETED|Overall Study||17
179038|NCT01439594|436860|P1|STARTED|Overall Study||17
179039|NCT01439581|436866|P2|NOT COMPLETED|Overall Study||0
179040|NCT01439581|436867|P1|NOT COMPLETED|Overall Study||0
179041|NCT01439581|436866|P2|COMPLETED|Overall Study||212
179042|NCT01439581|436867|P1|COMPLETED|Overall Study||216
179043|NCT01439581|436866|P2|STARTED|Overall Study||212
179044|NCT01439581|436867|P1|STARTED|Overall Study||216
179045|NCT01439568|436875|P2|NOT COMPLETED|Overall Study||2
179046|NCT01439568|436876|P1|NOT COMPLETED|Overall Study||3
179047|NCT01439568|436875|P2|COMPLETED|Overall Study||41
179048|NCT01439568|436876|P1|COMPLETED|Overall Study||44
179049|NCT01439568|436875|P2|Received at Least One Dose of Study Drug|Overall Study||43
179050|NCT01439568|436876|P1|Received at Least One Dose of Study Drug|Overall Study||47
179051|NCT01439568|436875|P2|STARTED|Overall Study||43
179052|NCT01439568|436876|P1|STARTED|Overall Study||47
179053|NCT01439555|436888|P1|NOT COMPLETED|Overall Study||1
179054|NCT01439555|436888|P1|COMPLETED|Overall Study||10
179055|NCT01439555|436888|P1|STARTED|Overall Study||11
179056|NCT01439373|436900|P2|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||0
179057|NCT01439373|436901|P1|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||2
179058|NCT01439373|436900|P2|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||4
179059|NCT01439373|436901|P1|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||9
179060|NCT01439373|436900|P2|STARTED|Combined With PEG and RIBA (Day 2 to 28)||4
179061|NCT01439373|436901|P1|STARTED|Combined With PEG and RIBA (Day 2 to 28)||11
179062|NCT01439373|436900|P2|NOT COMPLETED|Monotherapy (Day 1)||1
179063|NCT01439373|436901|P1|NOT COMPLETED|Monotherapy (Day 1)||0
179064|NCT01439373|436900|P2|COMPLETED|Monotherapy (Day 1)||4
179065|NCT01439373|436901|P1|COMPLETED|Monotherapy (Day 1)||11
179066|NCT01439373|436900|P2|STARTED|Monotherapy (Day 1)||5
179067|NCT01439373|436901|P1|STARTED|Monotherapy (Day 1)||11
179068|NCT01439360|436944|P2|NOT COMPLETED|Overall Study||208
179069|NCT01439360|436945|P1|NOT COMPLETED|Overall Study||198
179070|NCT01439360|436944|P2|COMPLETED|Overall Study||5804
179071|NCT01439360|436945|P1|COMPLETED|Overall Study||5808
179072|NCT01439360|436944|P2|STARTED|Overall Study||6012
179073|NCT01439360|436945|P1|STARTED|Overall Study||6006
179074|NCT01439282|436995|P2|NOT COMPLETED|Overall Study||1
179075|NCT01439282|436996|P1|NOT COMPLETED|Overall Study||8
179076|NCT01439282|436995|P2|COMPLETED|Overall Study||9
179077|NCT01439282|436996|P1|COMPLETED|Overall Study||59
179078|NCT01439282|436995|P2|STARTED|Overall Study||10
179079|NCT01439282|436996|P1|STARTED|Overall Study||67
179080|NCT01439204|437006|P2|NOT COMPLETED|Overall Study||3
179081|NCT01439204|437007|P1|NOT COMPLETED|Overall Study||4
179082|NCT01439204|437006|P2|COMPLETED|Overall Study||33
179083|NCT01439204|437007|P1|COMPLETED|Overall Study||32
179084|NCT01439204|437006|P2|STARTED|Overall Study||36
179085|NCT01439204|437007|P1|STARTED|Overall Study||36
179086|NCT01439165|437041|P2|NOT COMPLETED|Overall Study||2
179087|NCT01439165|437042|P1|NOT COMPLETED|Overall Study||21
179088|NCT01439165|437041|P2|COMPLETED|Overall Study||326
179089|NCT01439165|437042|P1|COMPLETED|Overall Study||981
179090|NCT01439165|437041|P2|STARTED|Overall Study||328
179091|NCT01439165|437042|P1|STARTED|Overall Study||1002
179092|NCT01439126|437056|P2|NOT COMPLETED|Overall Study||42
179093|NCT01439126|437057|P1|NOT COMPLETED|Overall Study||31
179094|NCT01439126|437056|P2|COMPLETED|Overall Study||25
179095|NCT01439126|437057|P1|COMPLETED|Overall Study||37
179096|NCT01439126|437056|P2|STARTED|Overall Study||67
179097|NCT01439126|437057|P1|STARTED|Overall Study||68
179098|NCT01439074|437079|P2|NOT COMPLETED|Overall Study||13
179099|NCT01439074|437080|P1|NOT COMPLETED|Overall Study||9
179100|NCT01439074|437079|P2|COMPLETED|Overall Study||74
179101|NCT01439074|437080|P1|COMPLETED|Overall Study||66
179102|NCT01439074|437079|P2|STARTED|Overall Study||87
179103|NCT01439074|437080|P1|STARTED|Overall Study||75
179104|NCT01439035|437092|P1|NOT COMPLETED|Overall Study||0
179105|NCT01439035|437092|P1|COMPLETED|Overall Study||6
179106|NCT01439035|437092|P1|STARTED|Overall Study||6
179107|NCT01439009|437098|P2|NOT COMPLETED|Overall Study||3
179108|NCT01439009|437099|P1|NOT COMPLETED|Overall Study||8
179109|NCT01439009|437098|P2|COMPLETED|Overall Study||47
179110|NCT01439009|437099|P1|COMPLETED|Overall Study||42
179111|NCT01439009|437098|P2|STARTED|Overall Study||50
179112|NCT01439009|437099|P1|STARTED|Overall Study||50
179113|NCT01438996|437132|P3|NOT COMPLETED|Overall Study||0
179114|NCT01438996|437133|P2|NOT COMPLETED|Overall Study||1
179115|NCT01438996|437134|P1|NOT COMPLETED|Overall Study||4
179116|NCT01438996|437132|P3|COMPLETED|Overall Study||20
179117|NCT01438996|437133|P2|COMPLETED|Overall Study||12
179118|NCT01438996|437134|P1|COMPLETED|Overall Study||14
179119|NCT01438996|437132|P3|STARTED|Overall Study||20
179120|NCT01438996|437133|P2|STARTED|Overall Study||13
179121|NCT01438996|437134|P1|STARTED|Overall Study||18
179122|NCT01438840|437168|P3|NOT COMPLETED|Extension Phase||10
179123|NCT01438840|437169|P2|NOT COMPLETED|Extension Phase||0
179124|NCT01438840|437170|P1|NOT COMPLETED|Extension Phase||0
179125|NCT01438840|437168|P3|COMPLETED|Extension Phase||29
179126|NCT01438840|437169|P2|COMPLETED|Extension Phase||0
179127|NCT01438840|437170|P1|COMPLETED|Extension Phase||0
179128|NCT01438840|437168|P3|STARTED|Extension Phase|39 participants met eligibility criteria for the Extension Phase.|39
179129|NCT01438840|437169|P2|STARTED|Extension Phase||0
179130|NCT01438840|437170|P1|STARTED|Extension Phase||0
179131|NCT01438840|437168|P3|NOT COMPLETED|Core Study||0
179132|NCT01438840|437169|P2|NOT COMPLETED|Core Study||10
179133|NCT01438840|437170|P1|NOT COMPLETED|Core Study||16
179134|NCT01438840|437168|P3|COMPLETED|Core Study||0
179135|NCT01438840|437169|P2|COMPLETED|Core Study||22
179136|NCT01438840|437170|P1|COMPLETED|Core Study||1
179137|NCT01438840|437168|P3|STARTED|Core Study||0
179138|NCT01438840|437169|P2|STARTED|Core Study||32
179139|NCT01438840|437170|P1|STARTED|Core Study||17
179140|NCT01438814|437183|P2|NOT COMPLETED|Overall Study||14
179141|NCT01438814|437184|P1|NOT COMPLETED|Overall Study||14
179142|NCT01438814|437183|P2|COMPLETED|Overall Study||331
179143|NCT01438814|437184|P1|COMPLETED|Overall Study||330
179144|NCT01438814|437183|P2|STARTED|Overall Study||345
179145|NCT01438814|437184|P1|STARTED|Overall Study||344
179146|NCT01438710|437214|P2|NOT COMPLETED|Second Week of Treatment||0
179147|NCT01438710|437215|P1|NOT COMPLETED|Second Week of Treatment||1
179148|NCT01438710|437214|P2|COMPLETED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
179149|NCT01438710|437215|P1|COMPLETED|Second Week of Treatment||40
179150|NCT01438710|437214|P2|STARTED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
179151|NCT01438710|437215|P1|STARTED|Second Week of Treatment|Patients completing the first week will continue on LCP-Tacro treatment during the second week.|41
179152|NCT01438710|437214|P2|NOT COMPLETED|First Week of Treatment||3
179153|NCT01438710|437215|P1|NOT COMPLETED|First Week of Treatment||0
179154|NCT01438710|437214|P2|COMPLETED|First Week of Treatment||41
179155|NCT01438710|437215|P1|COMPLETED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
179156|NCT01438710|437214|P2|STARTED|First Week of Treatment||44
179157|NCT01438710|437215|P1|STARTED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
179158|NCT01438541|437220|P1|NOT COMPLETED|Overall Study||7
179159|NCT01438541|437220|P1|COMPLETED|Overall Study||22
179160|NCT01438541|437220|P1|STARTED|Overall Study||29
179161|NCT01438489|437229|P3|NOT COMPLETED|Overall Study||19
179162|NCT01438489|437230|P2|NOT COMPLETED|Overall Study||16
179163|NCT01438489|437231|P1|NOT COMPLETED|Overall Study||26
179164|NCT01438489|437229|P3|COMPLETED|Overall Study||85
179165|NCT01438489|437230|P2|COMPLETED|Overall Study||84
179166|NCT01438489|437231|P1|COMPLETED|Overall Study||77
179167|NCT01438489|437229|P3|STARTED|Overall Study||104
179168|NCT01438489|437230|P2|STARTED|Overall Study||100
179169|NCT01438489|437231|P1|STARTED|Overall Study||103
179170|NCT01438424|437274|P1|NOT COMPLETED|Overall Study||417
179171|NCT01438424|437274|P1|COMPLETED|Overall Study|Completed treatment|634
179172|NCT01438424|437274|P1|STARTED|Overall Study|Received treatment|1051
179173|NCT01438307|437312|P2|NOT COMPLETED|Overall Study||1
179174|NCT01438307|437313|P1|NOT COMPLETED|Overall Study||1
179175|NCT01438307|437312|P2|COMPLETED|Overall Study||13
179176|NCT01438307|437313|P1|COMPLETED|Overall Study||13
179177|NCT01438307|437312|P2|STARTED|Overall Study||14
179178|NCT01438307|437313|P1|STARTED|Overall Study||14
179179|NCT01438294|437327|P2|NOT COMPLETED|Overall Study||7
179180|NCT01438294|437328|P1|NOT COMPLETED|Overall Study||3
179181|NCT01438294|437327|P2|COMPLETED|Overall Study||13
179182|NCT01438294|437328|P1|COMPLETED|Overall Study||13
179183|NCT01438294|437327|P2|STARTED|Overall Study||20
179184|NCT01438294|437328|P1|STARTED|Overall Study||16
179185|NCT01438229|437338|P1|NOT COMPLETED|Overall Study||3
179186|NCT01438229|437338|P1|COMPLETED|Overall Study||44
179187|NCT01438229|437338|P1|Underwent Procedure|Overall Study||46
179188|NCT01438229|437338|P1|Excluded Due to Renal Artery Anatomy|Overall Study||1
179189|NCT01438229|437338|P1|STARTED|Overall Study||47
179190|NCT01438177|437371|P1|NOT COMPLETED|Overall Study||2
179191|NCT01438177|437371|P1|COMPLETED|Overall Study|Patients who were off due to disease progression|9
179192|NCT01438177|437371|P1|STARTED|Overall Study||11
179193|NCT01438151|437377|P1|NOT COMPLETED|Overall Study||8
179194|NCT01438151|437377|P1|COMPLETED|Overall Study||3
179195|NCT01438151|437377|P1|STARTED|Overall Study||11
179196|NCT01438060|437383|P2|NOT COMPLETED|On Study Beyond Week 140||8
179197|NCT01438060|437384|P1|NOT COMPLETED|On Study Beyond Week 140||0
179198|NCT01438060|437383|P2|COMPLETED|On Study Beyond Week 140||1
179199|NCT01438060|437384|P1|COMPLETED|On Study Beyond Week 140||0
179200|NCT01438060|437383|P2|STARTED|On Study Beyond Week 140|9 participants in France who showed improvement at Week 140 continued treatment beyond 140 weeks|9
179201|NCT01438060|437384|P1|STARTED|On Study Beyond Week 140||0
179202|NCT01438060|437383|P2|NOT COMPLETED|Extension Phase: Week 10 to Week 130||56
179203|NCT01438060|437384|P1|NOT COMPLETED|Extension Phase: Week 10 to Week 130||58
179204|NCT01438060|437383|P2|COMPLETED|Extension Phase: Week 10 to Week 130||25
179205|NCT01438060|437384|P1|COMPLETED|Extension Phase: Week 10 to Week 130||22
179206|NCT01438060|437383|P2|STARTED|Extension Phase: Week 10 to Week 130|Of the 88 participants, who completed Acute Phase, 81 opted to enter 130-week extension phase|81
179300|NCT01437267|437638|P6|COMPLETED|Overall Study||20
179207|NCT01438060|437384|P1|STARTED|Extension Phase: Week 10 to Week 130|80 out of the 84 participants entered extension phase. All were treated with open-label aripiprazole|80
179208|NCT01438060|437383|P2|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
179209|NCT01438060|437384|P1|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
179210|NCT01438060|437383|P2|COMPLETED|Acute Phase: Double-blind, 10 Weeks||88
179211|NCT01438060|437384|P1|COMPLETED|Acute Phase: Double-blind, 10 Weeks||84
179212|NCT01438060|437383|P2|STARTED|Acute Phase: Double-blind, 10 Weeks||106
179213|NCT01438060|437384|P1|STARTED|Acute Phase: Double-blind, 10 Weeks||102
179214|NCT01437995|437465|P3|NOT COMPLETED|Overall Study||20
179215|NCT01437995|437466|P2|NOT COMPLETED|Overall Study||18
179216|NCT01437995|437467|P1|NOT COMPLETED|Overall Study||11
179217|NCT01437995|437465|P3|COMPLETED|Overall Study||135
179218|NCT01437995|437466|P2|COMPLETED|Overall Study||131
179219|NCT01437995|437467|P1|COMPLETED|Overall Study||140
179220|NCT01437995|437465|P3|Included in Treatment Failure Analysis|Overall Study||151
179221|NCT01437995|437466|P2|Included in Treatment Failure Analysis|Overall Study||146
179222|NCT01437995|437467|P1|Included in Treatment Failure Analysis|Overall Study||150
179223|NCT01437995|437465|P3|STARTED|Overall Study||155
179224|NCT01437995|437466|P2|STARTED|Overall Study||149
179225|NCT01437995|437467|P1|STARTED|Overall Study||151
179226|NCT01437943|437489|P2|NOT COMPLETED|Overall Study||2
179227|NCT01437943|437490|P1|NOT COMPLETED|Overall Study||7
179228|NCT01437943|437489|P2|COMPLETED|Overall Study||1
179229|NCT01437943|437490|P1|COMPLETED|Overall Study||0
179230|NCT01437943|437489|P2|STARTED|Overall Study||3
179231|NCT01437943|437490|P1|STARTED|Overall Study||7
179232|NCT01437878|437498|P2|NOT COMPLETED|Overall Study||0
179233|NCT01437878|437499|P1|NOT COMPLETED|Overall Study||1
179234|NCT01437878|437498|P2|COMPLETED|Overall Study||1
179235|NCT01437878|437499|P1|COMPLETED|Overall Study||0
179236|NCT01437878|437498|P2|STARTED|Overall Study||1
179237|NCT01437878|437499|P1|STARTED|Overall Study|Patient discontinued the study prior to initiation of study treatment|1
179238|NCT01437852|437539|P1|NOT COMPLETED|Overall Study||0
179239|NCT01437852|437539|P1|COMPLETED|Overall Study||30
179240|NCT01437852|437539|P1|Received Autograft|Overall Study||30
179241|NCT01437852|437539|P1|Received StrataGraft Skin Tissue|Overall Study||30
179242|NCT01437852|437539|P1|STARTED|Overall Study||30
179243|NCT01437540|437547|P2|NOT COMPLETED|Overall Study||65
179244|NCT01437540|437548|P1|NOT COMPLETED|Overall Study||127
179245|NCT01437540|437547|P2|COMPLETED|Overall Study||133
179246|NCT01437540|437548|P1|COMPLETED|Overall Study||265
179247|NCT01437540|437547|P2|STARTED|Overall Study||198
179248|NCT01437540|437548|P1|STARTED|Overall Study||392
179249|NCT01437501|437562|P2|NOT COMPLETED|Overall Study||11
179250|NCT01437501|437563|P1|NOT COMPLETED|Overall Study||13
179251|NCT01437501|437562|P2|COMPLETED|Overall Study||132
179252|NCT01437501|437563|P1|COMPLETED|Overall Study||135
179253|NCT01437501|437562|P2|STARTED|Overall Study||143
179254|NCT01437501|437563|P1|STARTED|Overall Study||148
179255|NCT01437488|437571|P1|NOT COMPLETED|Overall Study||0
179256|NCT01437488|437571|P1|COMPLETED|Overall Study||14
179257|NCT01437488|437571|P1|STARTED|Overall Study||14
179258|NCT01437423|437578|P1|NOT COMPLETED|Overall Study||15
179259|NCT01437423|437578|P1|COMPLETED|Overall Study||647
179260|NCT01437423|437578|P1|STARTED|Overall Study||662
179261|NCT01437397|437590|P5|NOT COMPLETED|Overall Study||101
179262|NCT01437397|437591|P4|NOT COMPLETED|Overall Study||69
179263|NCT01437397|437592|P3|NOT COMPLETED|Overall Study||72
179264|NCT01437397|437593|P2|NOT COMPLETED|Overall Study||62
179265|NCT01437397|437594|P1|NOT COMPLETED|Overall Study||66
179266|NCT01437397|437590|P5|COMPLETED|Overall Study||236
179267|NCT01437397|437591|P4|COMPLETED|Overall Study||270
179268|NCT01437397|437592|P3|COMPLETED|Overall Study||268
179269|NCT01437397|437593|P2|COMPLETED|Overall Study||276
179270|NCT01437397|437594|P1|COMPLETED|Overall Study||272
179271|NCT01437397|437590|P5|STARTED|Overall Study||337
179272|NCT01437397|437591|P4|STARTED|Overall Study||339
179273|NCT01437397|437592|P3|STARTED|Overall Study||340
179274|NCT01437397|437593|P2|STARTED|Overall Study||338
179275|NCT01437397|437594|P1|STARTED|Overall Study||338
179276|NCT01437319|437621|P3|NOT COMPLETED|Phase II||37
179277|NCT01437319|437622|P2|NOT COMPLETED|Phase II||44
179278|NCT01437319|437623|P1|NOT COMPLETED|Phase II||0
179279|NCT01437319|437621|P3|COMPLETED|Phase II||75
179280|NCT01437319|437622|P2|COMPLETED|Phase II||71
179281|NCT01437319|437623|P1|COMPLETED|Phase II||0
179282|NCT01437319|437621|P3|STARTED|Phase II||112
179283|NCT01437319|437622|P2|STARTED|Phase II||115
179284|NCT01437319|437623|P1|STARTED|Phase II||0
179285|NCT01437319|437621|P3|NOT COMPLETED|Phase I||0
179286|NCT01437319|437622|P2|NOT COMPLETED|Phase I||0
179287|NCT01437319|437623|P1|NOT COMPLETED|Phase I||55
179288|NCT01437319|437621|P3|COMPLETED|Phase I||0
179289|NCT01437319|437622|P2|COMPLETED|Phase I||0
179290|NCT01437319|437623|P1|COMPLETED|Phase I||227
179291|NCT01437319|437621|P3|STARTED|Phase I||0
179292|NCT01437319|437622|P2|STARTED|Phase I||0
179293|NCT01437319|437623|P1|STARTED|Phase I||282
179294|NCT01437267|437638|P6|NOT COMPLETED|Overall Study||0
179295|NCT01437267|437639|P5|NOT COMPLETED|Overall Study||0
179296|NCT01437267|437640|P4|NOT COMPLETED|Overall Study||1
179297|NCT01437267|437641|P3|NOT COMPLETED|Overall Study||0
179298|NCT01437267|437642|P2|NOT COMPLETED|Overall Study||1
179299|NCT01437267|437643|P1|NOT COMPLETED|Overall Study||0
179301|NCT01437267|437639|P5|COMPLETED|Overall Study||20
179302|NCT01437267|437640|P4|COMPLETED|Overall Study||19
179303|NCT01437267|437641|P3|COMPLETED|Overall Study||20
179304|NCT01437267|437642|P2|COMPLETED|Overall Study||19
179305|NCT01437267|437643|P1|COMPLETED|Overall Study||20
179306|NCT01437267|437638|P6|STARTED|Overall Study||20
179307|NCT01437267|437639|P5|STARTED|Overall Study||20
179308|NCT01437267|437640|P4|STARTED|Overall Study||20
179309|NCT01437267|437641|P3|STARTED|Overall Study||20
179310|NCT01437267|437642|P2|STARTED|Overall Study||20
179311|NCT01437267|437643|P1|STARTED|Overall Study||20
179312|NCT01437124|437681|P1|NOT COMPLETED|Overall Study||0
179313|NCT01437124|437681|P1|COMPLETED|Overall Study||83
179314|NCT01437124|437681|P1|STARTED|Overall Study||83
179315|NCT01437111|437686|P1|NOT COMPLETED|Overall Study||18
179316|NCT01437111|437686|P1|COMPLETED|Overall Study||182
179317|NCT01437111|437686|P1|Treated Participants|Overall Study||198
179318|NCT01437111|437686|P1|STARTED|Overall Study||200
179319|NCT01437098|437697|P1|NOT COMPLETED|Overall Study||13
179320|NCT01437098|437697|P1|COMPLETED|Overall Study||42
179321|NCT01437098|437697|P1|36 Months|Overall Study||36
179322|NCT01437098|437697|P1|24 Months|Overall Study||42
179323|NCT01437098|437697|P1|12 Months|Overall Study||45
179324|NCT01437098|437697|P1|6 Months|Overall Study||47
179325|NCT01437098|437697|P1|30 Days|Overall Study||51
179326|NCT01437098|437697|P1|STARTED|Overall Study||55
179327|NCT01436799|437754|P2|NOT COMPLETED|Overall Study||0
179328|NCT01436799|437755|P1|NOT COMPLETED|Overall Study||0
179329|NCT01436799|437754|P2|COMPLETED|Overall Study||20
179330|NCT01436799|437755|P1|COMPLETED|Overall Study||20
179331|NCT01436799|437754|P2|STARTED|Overall Study||20
179332|NCT01436799|437755|P1|STARTED|Overall Study||20
179333|NCT01436643|437764|P4|NOT COMPLETED|Core Phase (16 Weeks)||0
179334|NCT01436643|437765|P3|NOT COMPLETED|Core Phase (16 Weeks)||3
179335|NCT01436643|437766|P2|NOT COMPLETED|Core Phase (16 Weeks)||4
179336|NCT01436643|437767|P1|NOT COMPLETED|Core Phase (16 Weeks)||1
179337|NCT01436643|437764|P4|COMPLETED|Core Phase (16 Weeks)||0
179338|NCT01436643|437765|P3|COMPLETED|Core Phase (16 Weeks)||17
179339|NCT01436643|437766|P2|COMPLETED|Core Phase (16 Weeks)||11
179340|NCT01436643|437767|P1|COMPLETED|Core Phase (16 Weeks)||16
179341|NCT01436643|437764|P4|STARTED|Core Phase (16 Weeks)||0
179342|NCT01436643|437765|P3|STARTED|Core Phase (16 Weeks)||20
179343|NCT01436643|437766|P2|STARTED|Core Phase (16 Weeks)||15
179344|NCT01436643|437767|P1|STARTED|Core Phase (16 Weeks)||17
179345|NCT01436643|437764|P4|NOT COMPLETED|2-week Pre-treatment||10
179346|NCT01436643|437765|P3|NOT COMPLETED|2-week Pre-treatment||0
179347|NCT01436643|437766|P2|NOT COMPLETED|2-week Pre-treatment||0
179348|NCT01436643|437767|P1|NOT COMPLETED|2-week Pre-treatment||0
179349|NCT01436643|437764|P4|COMPLETED|2-week Pre-treatment||44
179350|NCT01436643|437765|P3|COMPLETED|2-week Pre-treatment||0
179351|NCT01436643|437766|P2|COMPLETED|2-week Pre-treatment||0
179352|NCT01436643|437767|P1|COMPLETED|2-week Pre-treatment||0
179353|NCT01436643|437764|P4|STARTED|2-week Pre-treatment||54
179354|NCT01436643|437765|P3|STARTED|2-week Pre-treatment||0
179355|NCT01436643|437766|P2|STARTED|2-week Pre-treatment||0
179356|NCT01436643|437767|P1|STARTED|2-week Pre-treatment||0
179357|NCT01436526|437779|P2|NOT COMPLETED|Period 2||0
179358|NCT01436526|437780|P1|NOT COMPLETED|Period 2||0
179359|NCT01436526|437779|P2|COMPLETED|Period 2||13
179360|NCT01436526|437780|P1|COMPLETED|Period 2||13
179361|NCT01436526|437779|P2|Participants Received Treatment|Period 2||13
179362|NCT01436526|437780|P1|Participants Received Treatment|Period 2||13
179363|NCT01436526|437779|P2|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
179364|NCT01436526|437780|P1|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
179365|NCT01436526|437779|P2|NOT COMPLETED|Period 1||0
179366|NCT01436526|437780|P1|NOT COMPLETED|Period 1||0
179367|NCT01436526|437779|P2|COMPLETED|Period 1||14
179368|NCT01436526|437780|P1|COMPLETED|Period 1||14
179369|NCT01436526|437779|P2|Participants Received Treatment|Period 1||14
179370|NCT01436526|437780|P1|Participants Received Treatment|Period 1||14
179371|NCT01436526|437779|P2|STARTED|Period 1||14
179372|NCT01436526|437780|P1|STARTED|Period 1||14
179373|NCT01436500|437802|P5|NOT COMPLETED|Overall Study||4
179374|NCT01436500|437803|P4|NOT COMPLETED|Overall Study||1
179375|NCT01436500|437804|P3|NOT COMPLETED|Overall Study||5
179376|NCT01436500|437805|P2|NOT COMPLETED|Overall Study||3
179377|NCT01436500|437806|P1|NOT COMPLETED|Overall Study||3
179378|NCT01436500|437802|P5|COMPLETED|Overall Study||9
179379|NCT01436500|437803|P4|COMPLETED|Overall Study||5
179380|NCT01436500|437804|P3|COMPLETED|Overall Study||7
179381|NCT01436500|437805|P2|COMPLETED|Overall Study||9
179382|NCT01436500|437806|P1|COMPLETED|Overall Study||9
179383|NCT01436500|437802|P5|STARTED|Overall Study||13
179384|NCT01436500|437803|P4|STARTED|Overall Study||6
179385|NCT01436500|437804|P3|STARTED|Overall Study||12
179386|NCT01436500|437805|P2|STARTED|Overall Study||12
179387|NCT01436500|437806|P1|STARTED|Overall Study||12
179388|NCT01436435|437839|P1|NOT COMPLETED|Overall Study||64
179389|NCT01436435|437839|P1|COMPLETED|Overall Study||177
179390|NCT01436435|437839|P1|STARTED|Overall Study||241
179391|NCT01436396|437850|P2|NOT COMPLETED|Overall Study||42
179392|NCT01436396|437851|P1|NOT COMPLETED|Overall Study||32
179393|NCT01436396|437850|P2|COMPLETED|Overall Study||354
179394|NCT01436396|437851|P1|COMPLETED|Overall Study||364
179395|NCT01436396|437850|P2|Vaccinated|Overall Study||393
179396|NCT01436396|437851|P1|Vaccinated|Overall Study||394
179397|NCT01436396|437850|P2|STARTED|Overall Study||396
179398|NCT01436396|437851|P1|STARTED|Overall Study||396
179399|NCT01436370|437891|P8|NOT COMPLETED|Overall Study||0
179400|NCT01436370|437892|P7|NOT COMPLETED|Overall Study||0
179401|NCT01436370|437893|P6|NOT COMPLETED|Overall Study||0
179402|NCT01436370|437894|P5|NOT COMPLETED|Overall Study||1
179403|NCT01436370|437895|P4|NOT COMPLETED|Overall Study||0
179404|NCT01436370|437896|P3|NOT COMPLETED|Overall Study||0
179405|NCT01436370|437897|P2|NOT COMPLETED|Overall Study||0
179406|NCT01436370|437898|P1|NOT COMPLETED|Overall Study||0
179407|NCT01436370|437891|P8|COMPLETED|Overall Study||16
179408|NCT01436370|437892|P7|COMPLETED|Overall Study||16
179409|NCT01436370|437893|P6|COMPLETED|Overall Study||19
179410|NCT01436370|437894|P5|COMPLETED|Overall Study||18
179411|NCT01436370|437895|P4|COMPLETED|Overall Study||10
179412|NCT01436370|437896|P3|COMPLETED|Overall Study||10
179413|NCT01436370|437897|P2|COMPLETED|Overall Study||6
179414|NCT01436370|437898|P1|COMPLETED|Overall Study||6
179415|NCT01436370|437891|P8|STARTED|Overall Study||16
179416|NCT01436370|437892|P7|STARTED|Overall Study||16
179417|NCT01436370|437893|P6|STARTED|Overall Study||19
179418|NCT01436370|437894|P5|STARTED|Overall Study||19
179419|NCT01436370|437895|P4|STARTED|Overall Study||10
179420|NCT01436370|437896|P3|STARTED|Overall Study||10
179421|NCT01436370|437897|P2|STARTED|Overall Study||6
179422|NCT01436370|437898|P1|STARTED|Overall Study||6
179423|NCT01436357|437978|P2|NOT COMPLETED|Overall Study||128
179424|NCT01436357|437979|P1|NOT COMPLETED|Overall Study||122
179425|NCT01436357|437978|P2|COMPLETED|Overall Study||146
179426|NCT01436357|437979|P1|COMPLETED|Overall Study||152
179427|NCT01436357|437978|P2|Stage 2|Overall Study||226
179428|NCT01436357|437979|P1|Stage 2|Overall Study||225
179429|NCT01436357|437978|P2|Stage 1|Overall Study||48
179430|NCT01436357|437979|P1|Stage 1|Overall Study||49
179431|NCT01436357|437978|P2|STARTED|Overall Study||274
179432|NCT01436357|437979|P1|STARTED|Overall Study||274
179433|NCT01436305|438000|P3|NOT COMPLETED|Overall Study||0
179434|NCT01436305|438001|P2|NOT COMPLETED|Overall Study||4
179435|NCT01436305|438002|P1|NOT COMPLETED|Overall Study||2
179436|NCT01436305|438000|P3|COMPLETED|Overall Study||7
179437|NCT01436305|438001|P2|COMPLETED|Overall Study||2
179438|NCT01436305|438002|P1|COMPLETED|Overall Study||4
179439|NCT01436305|438000|P3|STARTED|Overall Study||7
179440|NCT01436305|438001|P2|STARTED|Overall Study||6
179441|NCT01436305|438002|P1|STARTED|Overall Study||6
179442|NCT01436279|438099|P2|NOT COMPLETED|Overall Study||0
179443|NCT01436279|438100|P1|NOT COMPLETED|Overall Study||0
179444|NCT01436279|438099|P2|COMPLETED|Overall Study||20
179445|NCT01436279|438100|P1|COMPLETED|Overall Study||30
179446|NCT01436279|438099|P2|STARTED|Overall Study||20
179447|NCT01436279|438100|P1|STARTED|Overall Study||30
179448|NCT01436266|438122|P2|NOT COMPLETED|Overall Study||0
179449|NCT01436266|438123|P1|NOT COMPLETED|Overall Study||0
179450|NCT01436266|438122|P2|COMPLETED|Overall Study||1
179451|NCT01436266|438123|P1|COMPLETED|Overall Study||1
179452|NCT01436266|438122|P2|STARTED|Overall Study||1
179453|NCT01436266|438123|P1|STARTED|Overall Study||1
179454|NCT01436253|438129|P1|NOT COMPLETED|Overall Study||299
179455|NCT01436253|438129|P1|COMPLETED|Overall Study||1897
179456|NCT01436253|438129|P1|STARTED|Overall Study||2196
179457|NCT01436201|438134|P1|NOT COMPLETED|Overall Study||4
179458|NCT01436201|438134|P1|COMPLETED|Overall Study||20
179459|NCT01436201|438134|P1|Received at Least 1 Dose of Study Drug|Overall Study||24
179460|NCT01436201|438134|P1|STARTED|Overall Study||24
179461|NCT01436175|438144|P1|NOT COMPLETED|Overall Study||1270
179462|NCT01436175|438144|P1|COMPLETED|Overall Study||300
179463|NCT01436175|438144|P1|STARTED|Overall Study||1570
179464|NCT01436162|438171|P3|NOT COMPLETED|Randomized Phase||25
179465|NCT01436162|438172|P2|NOT COMPLETED|Randomized Phase||31
179466|NCT01436162|438173|P1|NOT COMPLETED|Randomized Phase||44
179467|NCT01436162|438171|P3|COMPLETED|Randomized Phase||189
179468|NCT01436162|438172|P2|COMPLETED|Randomized Phase||181
179469|NCT01436162|438173|P1|COMPLETED|Randomized Phase||353
179470|NCT01436162|438171|P3|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|214
179471|NCT01436162|438172|P2|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|212
179472|NCT01436162|438173|P1|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|397
179473|NCT01436162|438171|P3|NOT COMPLETED|Single-blind Lead-in Phase||0
179474|NCT01436162|438172|P2|NOT COMPLETED|Single-blind Lead-in Phase||0
179475|NCT01436162|438173|P1|NOT COMPLETED|Single-blind Lead-in Phase||282
179476|NCT01436162|438171|P3|COMPLETED|Single-blind Lead-in Phase||0
179477|NCT01436162|438172|P2|COMPLETED|Single-blind Lead-in Phase||0
179478|NCT01436162|438173|P1|COMPLETED|Single-blind Lead-in Phase||823
179479|NCT01436162|438171|P3|STARTED|Single-blind Lead-in Phase||0
179480|NCT01436162|438172|P2|STARTED|Single-blind Lead-in Phase||0
179481|NCT01436162|438173|P1|STARTED|Single-blind Lead-in Phase|Ten subjects were enrolled but not dosed.|1105
179482|NCT01436149|438207|P3|NOT COMPLETED|Randomized Phase||42
179483|NCT01436149|438208|P2|NOT COMPLETED|Randomized Phase||38
179484|NCT01436149|438209|P1|NOT COMPLETED|Randomized Phase||77
179485|NCT01436149|438207|P3|COMPLETED|Randomized Phase|1 subject completed the study without a Visit 14 MADRS and was not included in the completers set.|160
179486|NCT01436149|438208|P2|COMPLETED|Randomized Phase||164
179487|NCT01436149|438209|P1|COMPLETED|Randomized Phase||415
179488|NCT01436149|438207|P3|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
179489|NCT01436149|438208|P2|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
179490|NCT01436149|438209|P1|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|492
179491|NCT01436149|438207|P3|NOT COMPLETED|Antidepressant Lead-in Phase||0
179492|NCT01436149|438208|P2|NOT COMPLETED|Antidepressant Lead-in Phase||0
179493|NCT01436149|438209|P1|NOT COMPLETED|Antidepressant Lead-in Phase||366
179494|NCT01436149|438207|P3|COMPLETED|Antidepressant Lead-in Phase||0
179495|NCT01436149|438208|P2|COMPLETED|Antidepressant Lead-in Phase||0
179496|NCT01436149|438209|P1|COMPLETED|Antidepressant Lead-in Phase||896
179497|NCT01436149|438207|P3|STARTED|Antidepressant Lead-in Phase||0
179498|NCT01436149|438208|P2|STARTED|Antidepressant Lead-in Phase||0
179499|NCT01436149|438209|P1|STARTED|Antidepressant Lead-in Phase|Twenty-three subjects were enrolled but not dosed.|1262
179500|NCT01436110|438240|P3|NOT COMPLETED|Overall Study||23
179501|NCT01436110|438241|P2|NOT COMPLETED|Overall Study||26
179502|NCT01436110|438242|P1|NOT COMPLETED|Overall Study||39
179503|NCT01436110|438240|P3|COMPLETED|Overall Study||95
179504|NCT01436110|438241|P2|COMPLETED|Overall Study||91
179505|NCT01436110|438242|P1|COMPLETED|Overall Study||77
179506|NCT01436110|438240|P3|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
179507|NCT01436110|438241|P2|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|117
179508|NCT01436110|438242|P1|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
179509|NCT01436110|438240|P3|STARTED|Overall Study|These participants were randomized to trial medication.|118
179510|NCT01436110|438241|P2|STARTED|Overall Study|These participants were randomized to trial medication.|117
179511|NCT01436110|438242|P1|STARTED|Overall Study|These participants were randomized to trial medication.|116
179512|NCT01436084|438265|P1|NOT COMPLETED|Overall Study||4
179513|NCT01436084|438265|P1|COMPLETED|Overall Study||0
179514|NCT01436084|438265|P1|STARTED|Overall Study||4
179515|NCT01436071|438271|P2|NOT COMPLETED|Overall Study||14
179516|NCT01436071|438272|P1|NOT COMPLETED|Overall Study||26
179517|NCT01436071|438271|P2|COMPLETED|Overall Study||110
179518|NCT01436071|438272|P1|COMPLETED|Overall Study||98
179519|NCT01436071|438271|P2|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
179520|NCT01436071|438272|P1|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
179521|NCT01436071|438271|P2|STARTED|Overall Study|These participants were randomized to trial medication.|124
179522|NCT01436071|438272|P1|STARTED|Overall Study|These participants were randomized to trial medication.|124
179523|NCT01436045|438288|P2|NOT COMPLETED|Overall Study||0
179524|NCT01436045|438289|P1|NOT COMPLETED|Overall Study||0
179525|NCT01436045|438288|P2|COMPLETED|Overall Study||6
179526|NCT01436045|438289|P1|COMPLETED|Overall Study||6
179527|NCT01436045|438288|P2|STARTED|Overall Study||6
179528|NCT01436045|438289|P1|STARTED|Overall Study||6
179529|NCT01436006|438300|P1|NOT COMPLETED|Overall Study||37
179530|NCT01436006|438300|P1|COMPLETED|Overall Study||6663
179531|NCT01436006|438300|P1|STARTED|Overall Study||6700
179532|NCT01435928|438314|P3|NOT COMPLETED|Double Blind Phase - 28 Weeks||121
179533|NCT01435928|438315|P2|NOT COMPLETED|Double Blind Phase - 28 Weeks||116
179534|NCT01435928|438316|P1|NOT COMPLETED|Double Blind Phase - 28 Weeks||0
179535|NCT01435928|438314|P3|COMPLETED|Double Blind Phase - 28 Weeks||20
179536|NCT01435928|438315|P2|COMPLETED|Double Blind Phase - 28 Weeks||28
179537|NCT01435928|438316|P1|COMPLETED|Double Blind Phase - 28 Weeks||0
179538|NCT01435928|438314|P3|STARTED|Double Blind Phase - 28 Weeks||141
179539|NCT01435928|438315|P2|STARTED|Double Blind Phase - 28 Weeks||144
179540|NCT01435928|438316|P1|STARTED|Double Blind Phase - 28 Weeks||0
179541|NCT01435928|438314|P3|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
179542|NCT01435928|438315|P2|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
179543|NCT01435928|438316|P1|NOT COMPLETED|Open Label Phase - up to 24 Weeks||389
179544|NCT01435928|438314|P3|COMPLETED|Open Label Phase - up to 24 Weeks||0
179545|NCT01435928|438315|P2|COMPLETED|Open Label Phase - up to 24 Weeks||0
179546|NCT01435928|438316|P1|COMPLETED|Open Label Phase - up to 24 Weeks||287
179547|NCT01435928|438314|P3|STARTED|Open Label Phase - up to 24 Weeks||0
179548|NCT01435928|438315|P2|STARTED|Open Label Phase - up to 24 Weeks||0
179549|NCT01435928|438316|P1|STARTED|Open Label Phase - up to 24 Weeks||676
179550|NCT01435798|438343|P1|NOT COMPLETED|Overall Study||1
179551|NCT01435798|438343|P1|COMPLETED|Overall Study|Crossover design|25
179552|NCT01435798|438343|P1|100% MTD|Overall Study||25
179553|NCT01435798|438343|P1|50% MTD|Overall Study||25
179554|NCT01435798|438343|P1|25% MTD|Overall Study||26
179555|NCT01435798|438343|P1|0% MTD|Overall Study||25
179556|NCT01435798|438343|P1|STARTED|Overall Study|Crossover design|26
179557|NCT01435772|438360|P3|NOT COMPLETED|Overall Study||15
179558|NCT01435772|438361|P2|NOT COMPLETED|Overall Study||3
179559|NCT01435772|438362|P1|NOT COMPLETED|Overall Study||3
179560|NCT01435772|438360|P3|COMPLETED|Overall Study||0
179561|NCT01435772|438361|P2|COMPLETED|Overall Study||0
179562|NCT01435772|438362|P1|COMPLETED|Overall Study||0
179563|NCT01435772|438360|P3|STARTED|Overall Study||15
179564|NCT01435772|438361|P2|STARTED|Overall Study||3
179565|NCT01435772|438362|P1|STARTED|Overall Study||3
179566|NCT01435759|438412|P6|NOT COMPLETED|Double-blind Phase||9
179567|NCT01435759|438413|P5|NOT COMPLETED|Double-blind Phase||9
179568|NCT01435759|438414|P4|NOT COMPLETED|Double-blind Phase||9
179569|NCT01435759|438415|P3|NOT COMPLETED|Double-blind Phase||7
179570|NCT01435759|438416|P2|NOT COMPLETED|Double-blind Phase||7
179571|NCT01435759|438417|P1|NOT COMPLETED|Double-blind Phase||66
179572|NCT01435759|438412|P6|COMPLETED|Double-blind Phase||71
179573|NCT01435759|438413|P5|COMPLETED|Double-blind Phase||69
179574|NCT01435759|438414|P4|COMPLETED|Double-blind Phase||69
179575|NCT01435759|438415|P3|COMPLETED|Double-blind Phase||71
179576|NCT01435759|438416|P2|COMPLETED|Double-blind Phase||71
179577|NCT01435759|438417|P1|COMPLETED|Double-blind Phase||397
179578|NCT01435759|438412|P6|STARTED|Double-blind Phase||80
179579|NCT01435759|438413|P5|STARTED|Double-blind Phase||78
179580|NCT01435759|438414|P4|STARTED|Double-blind Phase|Two subjects were not dosed.|78
179581|NCT01435759|438415|P3|STARTED|Double-blind Phase|One subject was not dosed.|78
179582|NCT01435759|438416|P2|STARTED|Double-blind Phase||78
179583|NCT01435759|438417|P1|STARTED|Double-blind Phase|These subjects were not included in the Safety Dose Response Evaluable Set or Safety Analysis Set.|463
179584|NCT01435759|438412|P6|NOT COMPLETED|Antidepressant Lead-in Phase||0
179585|NCT01435759|438413|P5|NOT COMPLETED|Antidepressant Lead-in Phase||0
179586|NCT01435759|438414|P4|NOT COMPLETED|Antidepressant Lead-in Phase||0
179587|NCT01435759|438415|P3|NOT COMPLETED|Antidepressant Lead-in Phase||0
179588|NCT01435759|438416|P2|NOT COMPLETED|Antidepressant Lead-in Phase||0
179589|NCT01435759|438417|P1|NOT COMPLETED|Antidepressant Lead-in Phase||342
179590|NCT01435759|438412|P6|COMPLETED|Antidepressant Lead-in Phase||0
179591|NCT01435759|438413|P5|COMPLETED|Antidepressant Lead-in Phase||0
179592|NCT01435759|438414|P4|COMPLETED|Antidepressant Lead-in Phase||0
179593|NCT01435759|438415|P3|COMPLETED|Antidepressant Lead-in Phase||0
179594|NCT01435759|438416|P2|COMPLETED|Antidepressant Lead-in Phase||0
179595|NCT01435759|438417|P1|COMPLETED|Antidepressant Lead-in Phase||855
179596|NCT01435759|438412|P6|STARTED|Antidepressant Lead-in Phase||0
179597|NCT01435759|438413|P5|STARTED|Antidepressant Lead-in Phase||0
179598|NCT01435759|438414|P4|STARTED|Antidepressant Lead-in Phase||0
179599|NCT01435759|438415|P3|STARTED|Antidepressant Lead-in Phase||0
179600|NCT01435759|438416|P2|STARTED|Antidepressant Lead-in Phase||0
179601|NCT01435759|438417|P1|STARTED|Antidepressant Lead-in Phase|Of these 1197 subjects, 19 subjects were not dosed.|1197
179602|NCT01435655|438444|P1|NOT COMPLETED|Overall Study||3
179603|NCT01435655|438444|P1|COMPLETED|Overall Study||7
179604|NCT01435655|438444|P1|STARTED|Overall Study||10
179605|NCT01435616|438458|P2|NOT COMPLETED|Overall Study||80
179606|NCT01435616|438459|P1|NOT COMPLETED|Overall Study||171
179607|NCT01435616|438458|P2|COMPLETED|Overall Study||455
179608|NCT01435616|438459|P1|COMPLETED|Overall Study||832
179609|NCT01435616|438458|P2|Received at Least 1 Dose of Study Drug|Overall Study||535
179610|NCT01435616|438459|P1|Received at Least 1 Dose of Study Drug|Overall Study||1003
179611|NCT01435616|438458|P2|STARTED|Overall Study||535
179612|NCT01435616|438459|P1|STARTED|Overall Study||1003
179613|NCT01435603|438505|P2|NOT COMPLETED|Overall Study||35
179614|NCT01435603|438506|P1|NOT COMPLETED|Overall Study||39
179615|NCT01435603|438505|P2|COMPLETED|Overall Study||129
179616|NCT01435603|438506|P1|COMPLETED|Overall Study||128
179617|NCT01435603|438505|P2|STARTED|Overall Study||164
179618|NCT01435603|438506|P1|STARTED|Overall Study||167
179619|NCT01435577|438514|P2|NOT COMPLETED|Overall Study||52
179620|NCT01435577|438515|P1|NOT COMPLETED|Overall Study||17
179621|NCT01435577|438514|P2|COMPLETED|Overall Study||13
179622|NCT01435577|438515|P1|COMPLETED|Overall Study||47
179623|NCT01435577|438514|P2|STARTED|Overall Study||65
179624|NCT01435577|438515|P1|STARTED|Overall Study||64
179625|NCT01435460|438565|P2|NOT COMPLETED|Overall Study||6
179626|NCT01435460|438566|P1|NOT COMPLETED|Overall Study||11
179627|NCT01435460|438565|P2|COMPLETED|Overall Study||143
179628|NCT01435460|438566|P1|COMPLETED|Overall Study||140
179629|NCT01435460|438565|P2|STARTED|Overall Study||149
179630|NCT01435460|438566|P1|STARTED|Overall Study||151
179631|NCT01435382|438582|P4|NOT COMPLETED|Overall Study||1
179632|NCT01435382|438583|P3|NOT COMPLETED|Overall Study||1
179633|NCT01435382|438584|P2|NOT COMPLETED|Overall Study||2
179634|NCT01435382|438585|P1|NOT COMPLETED|Overall Study||1
179635|NCT01435382|438582|P4|COMPLETED|Overall Study||10
179636|NCT01435382|438583|P3|COMPLETED|Overall Study||12
179637|NCT01435382|438584|P2|COMPLETED|Overall Study||11
179638|NCT01435382|438585|P1|COMPLETED|Overall Study||11
179639|NCT01435382|438582|P4|STARTED|Overall Study||11
179640|NCT01435382|438583|P3|STARTED|Overall Study||13
179641|NCT01435382|438584|P2|STARTED|Overall Study||13
179642|NCT01435382|438585|P1|STARTED|Overall Study||12
179643|NCT01435356|438674|P2|NOT COMPLETED|Overall Study||24
179644|NCT01435356|438675|P1|NOT COMPLETED|Overall Study||32
179645|NCT01435356|438674|P2|COMPLETED|Overall Study||5
179646|NCT01435356|438675|P1|COMPLETED|Overall Study||16
179647|NCT01435356|438674|P2|STARTED|Overall Study||29
179648|NCT01435356|438675|P1|STARTED|Overall Study||48
179649|NCT01435304|438689|P2|NOT COMPLETED|Overall Study||0
179650|NCT01435304|438690|P1|NOT COMPLETED|Overall Study||0
179651|NCT01435304|438689|P2|COMPLETED|Overall Study||50
179652|NCT01435304|438690|P1|COMPLETED|Overall Study||50
179653|NCT01435304|438689|P2|STARTED|Overall Study||50
179654|NCT01435304|438690|P1|STARTED|Overall Study||50
179655|NCT01435265|438708|P2|NOT COMPLETED|Overall Study||1
179656|NCT01435265|438709|P1|NOT COMPLETED|Overall Study||0
179657|NCT01435265|438708|P2|COMPLETED|Overall Study||3
179658|NCT01435265|438709|P1|COMPLETED|Overall Study||3
179659|NCT01435265|438708|P2|STARTED|Overall Study||4
179660|NCT01435265|438709|P1|STARTED|Overall Study||3
179661|NCT01435174|438719|P1|NOT COMPLETED|Overall Study||9
179662|NCT01435174|438719|P1|COMPLETED|Overall Study||8
179663|NCT01435174|438719|P1|STARTED|Overall Study||17
179664|NCT01435122|438723|P1|NOT COMPLETED|Overall Study||8
179665|NCT01435122|438723|P1|COMPLETED|Overall Study||22
179666|NCT01435122|438723|P1|STARTED|Overall Study||30
179667|NCT01435031|438732|P1|NOT COMPLETED|ITT at 4 Years||7
179668|NCT01435031|438732|P1|COMPLETED|ITT at 4 Years||171
179669|NCT01435031|438732|P1|STARTED|ITT at 4 Years||178
179670|NCT01435031|438732|P1|NOT COMPLETED|ITT at 3 Years||11
179671|NCT01435031|438732|P1|COMPLETED|ITT at 3 Years||178
179672|NCT01435031|438732|P1|STARTED|ITT at 3 Years||189
179673|NCT01435031|438732|P1|NOT COMPLETED|ITT at 2 Years||13
179674|NCT01435031|438732|P1|COMPLETED|ITT at 2 Years||189
179675|NCT01435031|438732|P1|STARTED|ITT at 2 Years||202
179676|NCT01435031|438732|P1|NOT COMPLETED|ITT at 1 Year||9
179677|NCT01435031|438732|P1|COMPLETED|ITT at 1 Year||202
179678|NCT01435031|438732|P1|STARTED|ITT at 1 Year||211
179679|NCT01435031|438732|P1|NOT COMPLETED|ITT at 6 Months||5
179680|NCT01435031|438732|P1|COMPLETED|ITT at 6 Months||211
179681|NCT01435031|438732|P1|STARTED|ITT at 6 Months||216
179682|NCT01435031|438732|P1|NOT COMPLETED|ITT at 1 Month||6
179683|NCT01435031|438732|P1|COMPLETED|ITT at 1 Month||216
179684|NCT01435031|438732|P1|STARTED|ITT at 1 Month|ITT population|222
179685|NCT01435018|438833|P3|NOT COMPLETED|Overall Study||108
179686|NCT01435018|438834|P2|NOT COMPLETED|Overall Study||50
179687|NCT01435018|438835|P1|NOT COMPLETED|Overall Study||110
179688|NCT01435018|438833|P3|COMPLETED|Overall Study||31
179689|NCT01435018|438834|P2|COMPLETED|Overall Study||10
179690|NCT01435018|438835|P1|COMPLETED|Overall Study||25
179691|NCT01435018|438833|P3|STARTED|Overall Study||139
179692|NCT01435018|438834|P2|STARTED|Overall Study||60
179693|NCT01435018|438835|P1|STARTED|Overall Study||135
179694|NCT01434823|438920|P2|NOT COMPLETED|Overall Study||7
179695|NCT01434823|438921|P1|NOT COMPLETED|Overall Study||4
179696|NCT01434823|438920|P2|COMPLETED|Overall Study||778
179697|NCT01434823|438921|P1|COMPLETED|Overall Study||820
179698|NCT01434823|438920|P2|STARTED|Overall Study||785
179699|NCT01434823|438921|P1|STARTED|Overall Study||824
179700|NCT01434810|438939|P2|NOT COMPLETED|Overall Study||10
179701|NCT01434810|438940|P1|NOT COMPLETED|Overall Study||23
179702|NCT01434810|438939|P2|COMPLETED|Overall Study||213
179703|NCT01434810|438940|P1|COMPLETED|Overall Study||201
179704|NCT01434810|438939|P2|STARTED|Overall Study||223
179705|NCT01434810|438940|P1|STARTED|Overall Study||224
179706|NCT01434745|438952|P2|NOT COMPLETED|Overall Study||0
179707|NCT01434745|438953|P1|NOT COMPLETED|Overall Study||0
179708|NCT01434745|438952|P2|COMPLETED|Overall Study||0
179709|NCT01434745|438953|P1|COMPLETED|Overall Study||0
179710|NCT01434745|438952|P2|STARTED|Overall Study||0
179711|NCT01434745|438953|P1|STARTED|Overall Study||0
179712|NCT01434693|438975|P4|NOT COMPLETED|Overall Study||1
179713|NCT01434693|438976|P3|NOT COMPLETED|Overall Study||1
179714|NCT01434693|438977|P2|NOT COMPLETED|Overall Study||0
179715|NCT01434693|438978|P1|NOT COMPLETED|Overall Study||3
179716|NCT01434693|438975|P4|COMPLETED|Overall Study||8
179717|NCT01434693|438976|P3|COMPLETED|Overall Study||8
179718|NCT01434693|438977|P2|COMPLETED|Overall Study||9
179719|NCT01434693|438978|P1|COMPLETED|Overall Study||6
179720|NCT01434693|438975|P4|STARTED|Overall Study||9
179721|NCT01434693|438976|P3|STARTED|Overall Study||9
179722|NCT01434693|438977|P2|STARTED|Overall Study||9
179723|NCT01434693|438978|P1|STARTED|Overall Study||9
179724|NCT01434680|438992|P4|NOT COMPLETED|Overall Study||0
179725|NCT01434680|438993|P3|NOT COMPLETED|Overall Study||2
179726|NCT01434680|438994|P2|NOT COMPLETED|Overall Study||2
179727|NCT01434680|438995|P1|NOT COMPLETED|Overall Study||3
179728|NCT01434680|438992|P4|COMPLETED|Overall Study||119
179729|NCT01434680|438993|P3|COMPLETED|Overall Study||304
179730|NCT01434680|438994|P2|COMPLETED|Overall Study||266
179731|NCT01434680|438995|P1|COMPLETED|Overall Study||296
179732|NCT01434680|438992|P4|STARTED|Overall Study||119
179733|NCT01434680|438993|P3|STARTED|Overall Study||306
179734|NCT01434680|438994|P2|STARTED|Overall Study||268
179735|NCT01434680|438995|P1|STARTED|Overall Study||299
179736|NCT01434667|439012|P2|NOT COMPLETED|Overall Study||10
179737|NCT01434667|439013|P1|NOT COMPLETED|Overall Study||5
179738|NCT01434667|439012|P2|COMPLETED|Overall Study||65
179739|NCT01434667|439013|P1|COMPLETED|Overall Study||34
179740|NCT01434667|439012|P2|STARTED|Overall Study||75
179741|NCT01434667|439013|P1|STARTED|Overall Study||39
179742|NCT01434654|439039|P2|NOT COMPLETED|Overall Study||0
179743|NCT01434654|439040|P1|NOT COMPLETED|Overall Study||2
179744|NCT01434654|439039|P2|COMPLETED|Overall Study||12
179745|NCT01434654|439040|P1|COMPLETED|Overall Study||5
179746|NCT01434654|439039|P2|STARTED|Overall Study||12
179747|NCT01434654|439040|P1|STARTED|Overall Study||7
179748|NCT01434641|439052|P1|NOT COMPLETED|Overall Study||0
179749|NCT01434641|439052|P1|COMPLETED|Overall Study||102
179750|NCT01434641|439052|P1|STARTED|Overall Study||102
179751|NCT01434511|439057|P1|NOT COMPLETED|Overall Study||0
179752|NCT01434511|439057|P1|COMPLETED|Overall Study||1
179753|NCT01434511|439057|P1|STARTED|Overall Study||1
179754|NCT01434342|439076|P2|NOT COMPLETED|Overall Study||17
179755|NCT01434342|439077|P1|NOT COMPLETED|Overall Study||48
179756|NCT01434342|439076|P2|COMPLETED|Overall Study||31
179757|NCT01434342|439077|P1|COMPLETED|Overall Study||50
179758|NCT01434342|439076|P2|STARTED|Overall Study||48
179759|NCT01434342|439077|P1|STARTED|Overall Study||98
179760|NCT01434290|439087|P2|NOT COMPLETED|Overall Study||7
179761|NCT01434290|439088|P1|NOT COMPLETED|Overall Study||8
179762|NCT01434290|439087|P2|COMPLETED|Overall Study|Eligible subjects included in analysis|121
179763|NCT01434290|439088|P1|COMPLETED|Overall Study|Eligible subjects included in analysis|119
179764|NCT01434290|439087|P2|STARTED|Overall Study||128
179765|NCT01434290|439088|P1|STARTED|Overall Study||127
179766|NCT01434186|439116|P2|NOT COMPLETED|Overall Study||0
179767|NCT01434186|439117|P1|NOT COMPLETED|Overall Study||0
179768|NCT01434186|439116|P2|COMPLETED|Overall Study||4
179769|NCT01434186|439117|P1|COMPLETED|Overall Study||2
179770|NCT01434186|439116|P2|STARTED|Overall Study||4
179771|NCT01434186|439117|P1|STARTED|Overall Study||2
179772|NCT01434121|439126|P3|NOT COMPLETED|Overall Study||0
179773|NCT01434121|439127|P2|NOT COMPLETED|Overall Study||0
179774|NCT01434121|439128|P1|NOT COMPLETED|Overall Study||0
179775|NCT01434121|439126|P3|COMPLETED|Overall Study||8
179776|NCT01434121|439127|P2|COMPLETED|Overall Study||8
179777|NCT01434121|439128|P1|COMPLETED|Overall Study||8
179778|NCT01434121|439126|P3|STARTED|Overall Study||8
179779|NCT01434121|439127|P2|STARTED|Overall Study||8
179780|NCT01434121|439128|P1|STARTED|Overall Study||8
179781|NCT01434030|439154|P1|NOT COMPLETED|Overall Study||1
179782|NCT01434030|439154|P1|COMPLETED|Overall Study||56
179783|NCT01434030|439154|P1|STARTED|Overall Study||57
179784|NCT01433978|439161|P3|NOT COMPLETED|Extension Phase||6
179785|NCT01433978|439162|P2|NOT COMPLETED|Extension Phase||0
179786|NCT01433978|439163|P1|NOT COMPLETED|Extension Phase||0
179787|NCT01433978|439161|P3|COMPLETED|Extension Phase||0
179788|NCT01433978|439162|P2|COMPLETED|Extension Phase||0
179789|NCT01433978|439163|P1|COMPLETED|Extension Phase||0
179790|NCT01433978|439161|P3|STARTED|Extension Phase||6
179791|NCT01433978|439162|P2|STARTED|Extension Phase||0
179792|NCT01433978|439163|P1|STARTED|Extension Phase||0
179793|NCT01433978|439161|P3|NOT COMPLETED|Core Study||0
179794|NCT01433978|439162|P2|NOT COMPLETED|Core Study||11
179795|NCT01433978|439163|P1|NOT COMPLETED|Core Study||11
179796|NCT01433978|439161|P3|COMPLETED|Core Study||0
179797|NCT01433978|439162|P2|COMPLETED|Core Study||1
179798|NCT01433978|439163|P1|COMPLETED|Core Study||0
179799|NCT01433978|439161|P3|STARTED|Core Study||0
179800|NCT01433978|439162|P2|STARTED|Core Study||12
179801|NCT01433978|439163|P1|STARTED|Core Study||11
179802|NCT01433913|439172|P2|NOT COMPLETED|Overall Study||0
179803|NCT01433913|439173|P1|NOT COMPLETED|Overall Study||1
179804|NCT01433913|439172|P2|COMPLETED|Overall Study||10
179805|NCT01433913|439173|P1|COMPLETED|Overall Study||9
179806|NCT01433913|439172|P2|STARTED|Overall Study||10
179807|NCT01433913|439173|P1|STARTED|Overall Study||10
179808|NCT01433731|439209|P4|NOT COMPLETED|Overall Study||0
179809|NCT01433731|439210|P3|NOT COMPLETED|Overall Study||0
179810|NCT01433731|439211|P2|NOT COMPLETED|Overall Study||0
179811|NCT01433731|439212|P1|NOT COMPLETED|Overall Study||0
179812|NCT01433731|439209|P4|COMPLETED|Overall Study||5
179813|NCT01433731|439210|P3|COMPLETED|Overall Study||5
179814|NCT01433731|439211|P2|COMPLETED|Overall Study||5
179815|NCT01433731|439212|P1|COMPLETED|Overall Study||3
179816|NCT01433731|439209|P4|STARTED|Overall Study||5
179817|NCT01433731|439210|P3|STARTED|Overall Study||5
179818|NCT01433731|439211|P2|STARTED|Overall Study||5
179819|NCT01433731|439212|P1|STARTED|Overall Study||3
179820|NCT01433549|439220|P2|NOT COMPLETED|Phase 2: Second Study Product||1
179821|NCT01433549|439221|P1|NOT COMPLETED|Phase 2: Second Study Product||0
179822|NCT01433549|439220|P2|COMPLETED|Phase 2: Second Study Product||12
179823|NCT01433549|439221|P1|COMPLETED|Phase 2: Second Study Product||12
179824|NCT01433549|439220|P2|STARTED|Phase 2: Second Study Product||13
179825|NCT01433549|439221|P1|STARTED|Phase 2: Second Study Product||12
179826|NCT01433549|439220|P2|NOT COMPLETED|Phase 1: First Study Product||0
179827|NCT01433549|439221|P1|NOT COMPLETED|Phase 1: First Study Product||0
179828|NCT01433549|439220|P2|COMPLETED|Phase 1: First Study Product||13
179829|NCT01433549|439221|P1|COMPLETED|Phase 1: First Study Product||12
179830|NCT01433549|439220|P2|STARTED|Phase 1: First Study Product||13
179831|NCT01433549|439221|P1|STARTED|Phase 1: First Study Product||12
179832|NCT01433471|439231|P2|NOT COMPLETED|Overall Study||1
179833|NCT01433471|439232|P1|NOT COMPLETED|Overall Study||0
179834|NCT01433471|439231|P2|COMPLETED|Overall Study||1
179835|NCT01433471|439232|P1|COMPLETED|Overall Study||2
179836|NCT01433471|439231|P2|STARTED|Overall Study||2
179837|NCT01433471|439232|P1|STARTED|Overall Study||2
179838|NCT01433354|439248|P1|NOT COMPLETED|Overall Study||119
179839|NCT01433354|439248|P1|COMPLETED|Overall Study||0
179840|NCT01433354|439248|P1|STARTED|Overall Study|120 enrolled of which 119 were administered drug|119
179841|NCT01433263|439264|P2|NOT COMPLETED|Overall Study||12
179842|NCT01433263|439265|P1|NOT COMPLETED|Overall Study||19
179843|NCT01433263|439264|P2|COMPLETED|Overall Study||16
179844|NCT01433263|439265|P1|COMPLETED|Overall Study||10
179845|NCT01433263|439264|P2|STARTED|Overall Study||28
179846|NCT01433263|439265|P1|STARTED|Overall Study||29
179847|NCT01433250|439294|P2|NOT COMPLETED|Overall Study||3
179848|NCT01433250|439295|P1|NOT COMPLETED|Overall Study||3
179849|NCT01433250|439294|P2|COMPLETED|Overall Study||14
179850|NCT01433250|439295|P1|COMPLETED|Overall Study||19
179851|NCT01433250|439294|P2|STARTED|Overall Study||17
179852|NCT01433250|439295|P1|STARTED|Overall Study||22
179853|NCT01433172|439314|P3|NOT COMPLETED|Overall Study||1
179854|NCT01433172|439315|P2|NOT COMPLETED|Overall Study||3
179855|NCT01433172|439316|P1|NOT COMPLETED|Overall Study||0
179856|NCT01433172|439314|P3|COMPLETED|Overall Study||32
179857|NCT01433172|439315|P2|COMPLETED|Overall Study||34
179858|NCT01433172|439316|P1|COMPLETED|Overall Study||3
179859|NCT01433172|439314|P3|STARTED|Overall Study||33
179860|NCT01433172|439315|P2|STARTED|Overall Study||37
179861|NCT01433172|439316|P1|STARTED|Overall Study||3
179862|NCT01433159|439328|P2|NOT COMPLETED|Overall Study||1
179863|NCT01433159|439329|P1|NOT COMPLETED|Overall Study||2
179864|NCT01433159|439328|P2|COMPLETED|Overall Study||9
179865|NCT01433159|439329|P1|COMPLETED|Overall Study||7
179866|NCT01433159|439328|P2|STARTED|Overall Study||10
179867|NCT01433159|439329|P1|STARTED|Overall Study||9
179868|NCT01433107|439337|P2|NOT COMPLETED|Overall Study||17
179869|NCT01433107|439338|P1|NOT COMPLETED|Overall Study||27
179870|NCT01433107|439337|P2|COMPLETED|Overall Study||128
179871|NCT01433107|439338|P1|COMPLETED|Overall Study||118
179872|NCT01433107|439337|P2|STARTED|Overall Study||145
179873|NCT01433107|439338|P1|STARTED|Overall Study||145
179874|NCT01433081|439350|P2|NOT COMPLETED|Overall Study||2
179875|NCT01433081|439351|P1|NOT COMPLETED|Overall Study||2
179876|NCT01433081|439350|P2|COMPLETED|Overall Study||23
179877|NCT01433081|439351|P1|COMPLETED|Overall Study||23
179878|NCT01433081|439350|P2|STARTED|Overall Study||25
179879|NCT01433081|439351|P1|STARTED|Overall Study||25
179880|NCT01433055|439361|P2|NOT COMPLETED|Overall Study||0
179881|NCT01433055|439362|P1|NOT COMPLETED|Overall Study||2
179882|NCT01433055|439361|P2|COMPLETED|Overall Study||23
179883|NCT01433055|439362|P1|COMPLETED|Overall Study||27
179884|NCT01433055|439361|P2|STARTED|Overall Study||23
179885|NCT01433055|439362|P1|STARTED|Overall Study||29
179886|NCT01433042|439376|P1|NOT COMPLETED|Overall Study||1
179887|NCT01433042|439376|P1|COMPLETED|Overall Study||224
179888|NCT01433042|439376|P1|STARTED|Overall Study||225
179889|NCT01433016|439380|P1|NOT COMPLETED|Overall Study||0
179890|NCT01433016|439380|P1|COMPLETED|Overall Study||20
179891|NCT01433016|439380|P1|STARTED|Overall Study||20
179892|NCT01432938|439384|P2|NOT COMPLETED|Second Intervention||0
179893|NCT01432938|439385|P1|NOT COMPLETED|Second Intervention||1
179894|NCT01432938|439384|P2|COMPLETED|Second Intervention||14
179895|NCT01432938|439385|P1|COMPLETED|Second Intervention||11
179896|NCT01432938|439384|P2|STARTED|Second Intervention||14
179897|NCT01432938|439385|P1|STARTED|Second Intervention||12
179898|NCT01432938|439384|P2|NOT COMPLETED|Washout Period of at Least 24 Days||0
179899|NCT01432938|439385|P1|NOT COMPLETED|Washout Period of at Least 24 Days||0
179900|NCT01432938|439384|P2|COMPLETED|Washout Period of at Least 24 Days||14
179901|NCT01432938|439385|P1|COMPLETED|Washout Period of at Least 24 Days||12
179902|NCT01432938|439384|P2|STARTED|Washout Period of at Least 24 Days||14
179903|NCT01432938|439385|P1|STARTED|Washout Period of at Least 24 Days||12
179904|NCT01432938|439384|P2|NOT COMPLETED|First Intervention||0
179905|NCT01432938|439385|P1|NOT COMPLETED|First Intervention||2
179906|NCT01432938|439384|P2|COMPLETED|First Intervention||14
179907|NCT01432938|439385|P1|COMPLETED|First Intervention||12
179908|NCT01432938|439384|P2|Received at Least 1 Dose of Study Drug|First Intervention||14
179909|NCT01432938|439385|P1|Received at Least 1 Dose of Study Drug|First Intervention||14
179910|NCT01432938|439384|P2|STARTED|First Intervention||14
179911|NCT01432938|439385|P1|STARTED|First Intervention||14
179912|NCT01432886|439402|P2|NOT COMPLETED|Overall Study||0
179913|NCT01432886|439403|P1|NOT COMPLETED|Overall Study||0
179914|NCT01432886|439402|P2|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
179915|NCT01432886|439403|P1|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
179916|NCT01432886|439402|P2|STARTED|Overall Study||6
179917|NCT01432886|439403|P1|STARTED|Overall Study||6
179918|NCT01432756|439415|P4|NOT COMPLETED|Overall Study||1
179919|NCT01432756|439416|P3|NOT COMPLETED|Overall Study||2
179920|NCT01432756|439417|P2|NOT COMPLETED|Overall Study||0
179921|NCT01432756|439418|P1|NOT COMPLETED|Overall Study||1
179922|NCT01432756|439415|P4|COMPLETED|Overall Study||33
179923|NCT01432756|439416|P3|COMPLETED|Overall Study||30
179924|NCT01432756|439417|P2|COMPLETED|Overall Study||34
179925|NCT01432756|439418|P1|COMPLETED|Overall Study||31
179926|NCT01432756|439415|P4|STARTED|Overall Study||34
179927|NCT01432756|439416|P3|STARTED|Overall Study||32
179928|NCT01432756|439417|P2|STARTED|Overall Study||34
179929|NCT01432756|439418|P1|STARTED|Overall Study||32
179930|NCT01432626|439426|P1|NOT COMPLETED|Overall Study||7
179931|NCT01432626|439426|P1|COMPLETED|Overall Study|Completed both images|3
179932|NCT01432626|439426|P1|STARTED|Overall Study||10
179933|NCT01432600|439433|P3|NOT COMPLETED|Overall Study||1
179934|NCT01432600|439434|P2|NOT COMPLETED|Overall Study||1
179935|NCT01432600|439435|P1|NOT COMPLETED|Overall Study||0
179936|NCT01432600|439433|P3|COMPLETED|Overall Study||33
179937|NCT01432600|439434|P2|COMPLETED|Overall Study||35
179938|NCT01432600|439435|P1|COMPLETED|Overall Study||10
179939|NCT01432600|439433|P3|STARTED|Overall Study||34
179940|NCT01432600|439434|P2|STARTED|Overall Study||36
179941|NCT01432600|439435|P1|STARTED|Overall Study||10
179942|NCT01432574|439451|P1|NOT COMPLETED|Overall Study||3
179943|NCT01432574|439451|P1|COMPLETED|Overall Study||147
179944|NCT01432574|439451|P1|STARTED|Overall Study||150
179945|NCT01432561|439457|P1|NOT COMPLETED|Overall Study||0
179946|NCT01432561|439457|P1|COMPLETED|Overall Study||8
179947|NCT01432561|439457|P1|STARTED|Overall Study||8
179948|NCT01432535|439466|P3|NOT COMPLETED|Overall Study||0
179949|NCT01432535|439467|P2|NOT COMPLETED|Overall Study||0
179950|NCT01432535|439468|P1|NOT COMPLETED|Overall Study||0
179951|NCT01432535|439466|P3|COMPLETED|Overall Study||6
179952|NCT01432535|439467|P2|COMPLETED|Overall Study||7
179953|NCT01432535|439468|P1|COMPLETED|Overall Study||12
179954|NCT01432535|439466|P3|STARTED|Overall Study||6
179955|NCT01432535|439467|P2|STARTED|Overall Study|One participant later determined ineligible is not included in baseline/efficacy analyses.|7
179956|NCT01432535|439468|P1|STARTED|Overall Study||12
179957|NCT01432457|439497|P3|NOT COMPLETED|Overall Study||59
179958|NCT01432457|439498|P2|NOT COMPLETED|Overall Study||48
179959|NCT01432457|439499|P1|NOT COMPLETED|Overall Study||37
179960|NCT01432457|439497|P3|COMPLETED|Overall Study||253
179961|NCT01432457|439498|P2|COMPLETED|Overall Study||258
179962|NCT01432457|439499|P1|COMPLETED|Overall Study||269
179963|NCT01432457|439497|P3|STARTED|Overall Study||312
179964|NCT01432457|439498|P2|STARTED|Overall Study||306
179965|NCT01432457|439499|P1|STARTED|Overall Study||306
179966|NCT01432444|439528|P3|NOT COMPLETED|Extension Phase||192
179967|NCT01432444|439529|P2|NOT COMPLETED|Extension Phase||0
179968|NCT01432444|439530|P1|NOT COMPLETED|Extension Phase||0
179969|NCT01432444|439528|P3|COMPLETED|Extension Phase||0
179970|NCT01432444|439529|P2|COMPLETED|Extension Phase||0
179971|NCT01432444|439530|P1|COMPLETED|Extension Phase||0
179972|NCT01432444|439528|P3|STARTED|Extension Phase||192
179973|NCT01432444|439529|P2|STARTED|Extension Phase||0
179974|NCT01432444|439530|P1|STARTED|Extension Phase||0
179975|NCT01432444|439528|P3|NOT COMPLETED|Treatment Phase||0
179976|NCT01432444|439529|P2|NOT COMPLETED|Treatment Phase||140
179977|NCT01432444|439530|P1|NOT COMPLETED|Treatment Phase||0
179978|NCT01432444|439528|P3|COMPLETED|Treatment Phase||0
179979|NCT01432444|439529|P2|COMPLETED|Treatment Phase||293
179980|NCT01432444|439530|P1|COMPLETED|Treatment Phase||0
179981|NCT01432444|439528|P3|STARTED|Treatment Phase||0
179982|NCT01432444|439529|P2|STARTED|Treatment Phase||433
179983|NCT01432444|439530|P1|STARTED|Treatment Phase||0
179984|NCT01432444|439528|P3|NOT COMPLETED|Tolerability/Cross-titration Phase||0
179985|NCT01432444|439529|P2|NOT COMPLETED|Tolerability/Cross-titration Phase||0
179986|NCT01432444|439530|P1|NOT COMPLETED|Tolerability/Cross-titration Phase||60
179987|NCT01432444|439528|P3|COMPLETED|Tolerability/Cross-titration Phase||0
179988|NCT01432444|439529|P2|COMPLETED|Tolerability/Cross-titration Phase||0
179989|NCT01432444|439530|P1|COMPLETED|Tolerability/Cross-titration Phase||265
179990|NCT01432444|439528|P3|STARTED|Tolerability/Cross-titration Phase||0
179991|NCT01432444|439529|P2|STARTED|Tolerability/Cross-titration Phase||0
179992|NCT01432444|439530|P1|STARTED|Tolerability/Cross-titration Phase||325
179993|NCT01432405|439542|P2|NOT COMPLETED|Overall Study||2
179994|NCT01432405|439543|P1|NOT COMPLETED|Overall Study||1
179995|NCT01432405|439542|P2|COMPLETED|Overall Study||10
179996|NCT01432405|439543|P1|COMPLETED|Overall Study||11
179997|NCT01432405|439542|P2|STARTED|Overall Study||12
179998|NCT01432405|439543|P1|STARTED|Overall Study||12
179999|NCT01432379|439551|P1|NOT COMPLETED|Overall Study||385
180000|NCT01432379|439551|P1|COMPLETED|Overall Study||783
180001|NCT01432379|439551|P1|STARTED|Overall Study||1168
180002|NCT01432366|439556|P1|NOT COMPLETED|Overall Study||68
180003|NCT01432366|439556|P1|COMPLETED|Overall Study||392
180004|NCT01432366|439556|P1|STARTED|Overall Study||460
180005|NCT01432327|439578|P4|NOT COMPLETED|Posttest 1 Year||23
180006|NCT01432327|439579|P3|NOT COMPLETED|Posttest 1 Year||20
180007|NCT01432327|439580|P2|NOT COMPLETED|Posttest 1 Year||28
180008|NCT01432327|439581|P1|NOT COMPLETED|Posttest 1 Year||24
180009|NCT01432327|439578|P4|COMPLETED|Posttest 1 Year||31
180010|NCT01432327|439579|P3|COMPLETED|Posttest 1 Year||30
180011|NCT01432327|439580|P2|COMPLETED|Posttest 1 Year||27
180012|NCT01432327|439581|P1|COMPLETED|Posttest 1 Year||28
180013|NCT01432327|439578|P4|STARTED|Posttest 1 Year||54
180014|NCT01432327|439579|P3|STARTED|Posttest 1 Year||50
180015|NCT01432327|439580|P2|STARTED|Posttest 1 Year||55
180016|NCT01432327|439581|P1|STARTED|Posttest 1 Year||52
180017|NCT01432327|439578|P4|NOT COMPLETED|Posttest 6 Months||2
180018|NCT01432327|439579|P3|NOT COMPLETED|Posttest 6 Months||5
180019|NCT01432327|439580|P2|NOT COMPLETED|Posttest 6 Months||0
180020|NCT01432327|439581|P1|NOT COMPLETED|Posttest 6 Months||0
180021|NCT01432327|439578|P4|COMPLETED|Posttest 6 Months||54
180022|NCT01432327|439579|P3|COMPLETED|Posttest 6 Months||50
180023|NCT01432327|439580|P2|COMPLETED|Posttest 6 Months||55
180024|NCT01432327|439581|P1|COMPLETED|Posttest 6 Months||52
180025|NCT01432327|439578|P4|STARTED|Posttest 6 Months||56
180026|NCT01432327|439579|P3|STARTED|Posttest 6 Months||55
180027|NCT01432327|439580|P2|STARTED|Posttest 6 Months||55
180028|NCT01432327|439581|P1|STARTED|Posttest 6 Months||52
180029|NCT01432327|439578|P4|NOT COMPLETED|Posttest 3 Months||1
180030|NCT01432327|439579|P3|NOT COMPLETED|Posttest 3 Months||2
180031|NCT01432327|439580|P2|NOT COMPLETED|Posttest 3 Months||2
180032|NCT01432327|439581|P1|NOT COMPLETED|Posttest 3 Months||4
180033|NCT01432327|439578|P4|COMPLETED|Posttest 3 Months||56
180034|NCT01432327|439579|P3|COMPLETED|Posttest 3 Months||55
180035|NCT01432327|439580|P2|COMPLETED|Posttest 3 Months||55
180036|NCT01432327|439581|P1|COMPLETED|Posttest 3 Months||52
180037|NCT01432327|439578|P4|STARTED|Posttest 3 Months||57
180038|NCT01432327|439579|P3|STARTED|Posttest 3 Months||57
180039|NCT01432327|439580|P2|STARTED|Posttest 3 Months||57
180040|NCT01432327|439581|P1|STARTED|Posttest 3 Months||56
180041|NCT01432327|439578|P4|NOT COMPLETED|Baseline||0
180042|NCT01432327|439579|P3|NOT COMPLETED|Baseline||0
180043|NCT01432327|439580|P2|NOT COMPLETED|Baseline||0
180044|NCT01432327|439581|P1|NOT COMPLETED|Baseline||0
180045|NCT01432327|439578|P4|COMPLETED|Baseline||57
180046|NCT01432327|439579|P3|COMPLETED|Baseline||57
180047|NCT01432327|439580|P2|COMPLETED|Baseline||57
180048|NCT01432327|439581|P1|COMPLETED|Baseline||56
180049|NCT01432327|439578|P4|STARTED|Baseline||57
180050|NCT01432327|439579|P3|STARTED|Baseline||57
180051|NCT01432327|439580|P2|STARTED|Baseline||57
180052|NCT01432327|439581|P1|STARTED|Baseline||56
180053|NCT01432275|439591|P2|NOT COMPLETED|ADC With Calculator (10 Days)||2
180054|NCT01432275|439592|P1|NOT COMPLETED|ADC With Calculator (10 Days)||3
180055|NCT01432275|439591|P2|COMPLETED|ADC With Calculator (10 Days)||79
180056|NCT01432275|439592|P1|COMPLETED|ADC With Calculator (10 Days)||85
180057|NCT01432275|439591|P2|STARTED|ADC With Calculator (10 Days)||81
180058|NCT01432275|439592|P1|STARTED|ADC With Calculator (10 Days)||88
180059|NCT01432275|439591|P2|NOT COMPLETED|Second BG Meter System (7 Days)||3
180060|NCT01432275|439592|P1|NOT COMPLETED|Second BG Meter System (7 Days)||2
180061|NCT01432275|439591|P2|COMPLETED|Second BG Meter System (7 Days)||81
180062|NCT01432275|439592|P1|COMPLETED|Second BG Meter System (7 Days)||88
180063|NCT01432275|439591|P2|STARTED|Second BG Meter System (7 Days)||84
180064|NCT01432275|439592|P1|STARTED|Second BG Meter System (7 Days)||90
180065|NCT01432275|439591|P2|NOT COMPLETED|First BG Meter System (7 Days)||3
180066|NCT01432275|439592|P1|NOT COMPLETED|First BG Meter System (7 Days)||0
180067|NCT01432275|439591|P2|COMPLETED|First BG Meter System (7 Days)||84
180068|NCT01432275|439592|P1|COMPLETED|First BG Meter System (7 Days)||90
180069|NCT01432275|439591|P2|STARTED|First BG Meter System (7 Days)||87
180070|NCT01432275|439592|P1|STARTED|First BG Meter System (7 Days)||90
180071|NCT01432262|439601|P2|NOT COMPLETED|Overall Study||1
180072|NCT01432262|439602|P1|NOT COMPLETED|Overall Study||2
180073|NCT01432262|439601|P2|COMPLETED|Overall Study||161
180074|NCT01432262|439602|P1|COMPLETED|Overall Study||160
180075|NCT01432262|439601|P2|Vaccinated|Overall Study||161
180076|NCT01432262|439602|P1|Vaccinated|Overall Study||162
180077|NCT01432262|439601|P2|STARTED|Overall Study||162
180078|NCT01432262|439602|P1|STARTED|Overall Study||162
180079|NCT01432236|439620|P2|NOT COMPLETED|Overall Study||18
180080|NCT01432236|439621|P1|NOT COMPLETED|Overall Study||26
180081|NCT01432236|439620|P2|COMPLETED|Overall Study||79
180082|NCT01432236|439621|P1|COMPLETED|Overall Study||70
180083|NCT01432236|439620|P2|STARTED|Overall Study||97
180084|NCT01432236|439621|P1|STARTED|Overall Study||96
180085|NCT01432171|439668|P2|NOT COMPLETED|Overall Study||11
180086|NCT01432171|439669|P1|NOT COMPLETED|Overall Study||14
180087|NCT01432171|439668|P2|COMPLETED|Overall Study||8
180088|NCT01432171|439669|P1|COMPLETED|Overall Study||4
180089|NCT01432171|439668|P2|STARTED|Overall Study||19
180090|NCT01432171|439669|P1|STARTED|Overall Study||18
180091|NCT01432145|439675|P1|NOT COMPLETED|Overall Study||7
180092|NCT01432145|439675|P1|COMPLETED|Overall Study||67
180093|NCT01432145|439675|P1|STARTED|Overall Study|Corrected from 75. 75 was entered in error|74
180094|NCT01432015|439682|P2|NOT COMPLETED|Overall Study||0
180095|NCT01432015|439683|P1|NOT COMPLETED|Overall Study||0
180096|NCT01432015|439682|P2|COMPLETED|Overall Study||10
180097|NCT01432015|439683|P1|COMPLETED|Overall Study||10
180098|NCT01432015|439682|P2|STARTED|Overall Study||10
180099|NCT01432015|439683|P1|STARTED|Overall Study||10
180100|NCT01431989|439691|P2|NOT COMPLETED|Period 2||0
180101|NCT01431989|439692|P1|NOT COMPLETED|Period 2||0
180102|NCT01431989|439691|P2|COMPLETED|Period 2||14
180103|NCT01431989|439692|P1|COMPLETED|Period 2||14
180104|NCT01431989|439691|P2|STARTED|Period 2||14
180105|NCT01431989|439692|P1|STARTED|Period 2||14
180106|NCT01431989|439691|P2|NOT COMPLETED|14-Day Washout Period||0
180107|NCT01431989|439692|P1|NOT COMPLETED|14-Day Washout Period||0
180108|NCT01431989|439691|P2|COMPLETED|14-Day Washout Period||14
180109|NCT01431989|439692|P1|COMPLETED|14-Day Washout Period||14
180110|NCT01431989|439691|P2|STARTED|14-Day Washout Period||14
180111|NCT01431989|439692|P1|STARTED|14-Day Washout Period||14
180112|NCT01431989|439691|P2|NOT COMPLETED|Period 1||0
180113|NCT01431989|439692|P1|NOT COMPLETED|Period 1||0
180114|NCT01431989|439691|P2|COMPLETED|Period 1||14
180115|NCT01431989|439692|P1|COMPLETED|Period 1||14
180116|NCT01431989|439691|P2|STARTED|Period 1||14
180117|NCT01431989|439692|P1|STARTED|Period 1||14
180118|NCT01431976|439710|P1|NOT COMPLETED|Overall Study||14
180119|NCT01431976|439710|P1|COMPLETED|Overall Study||6
180120|NCT01431976|439710|P1|STARTED|Overall Study||20
180121|NCT01431963|439721|P1|NOT COMPLETED|Overall Study||35
180122|NCT01431963|439721|P1|COMPLETED|Overall Study||32
180123|NCT01431963|439721|P1|Complete ExP (gt= 24 Weeks)|Overall Study|(>=24 weeks); gt= abbreviation for greater than or equal to|19
180124|NCT01431963|439721|P1|Begin Extension Phase (ExP; gt= 24weeks)|Overall Study|Only Japanese participants in ExP,lamotrigine monotherapy was available in Korea. (>=24weeks)|19
180125|NCT01431963|439721|P1|Complete MP (24 Weeks)|Overall Study||42
180126|NCT01431963|439721|P1|Begin Maintenance Phase (MP; 24 Weeks)|Overall Study||52
180127|NCT01431963|439721|P1|Complete EP (6 Weeks)|Overall Study||52
180128|NCT01431963|439721|P1|Received Treatment|Overall Study||65
180129|NCT01431963|439721|P1|Begin Escalation Phase (EP; 6 Weeks)|Overall Study||67
180130|NCT01431963|439721|P1|STARTED|Overall Study||67
180131|NCT01431950|439729|P2|NOT COMPLETED|Overall Study||15
180132|NCT01431950|439730|P1|NOT COMPLETED|Overall Study||19
180133|NCT01431950|439729|P2|COMPLETED|Overall Study||104
180134|NCT01431950|439730|P1|COMPLETED|Overall Study||100
180135|NCT01431950|439729|P2|STARTED|Overall Study||119
180136|NCT01431950|439730|P1|STARTED|Overall Study||119
180137|NCT01431846|439747|P3|NOT COMPLETED|Overall Study||0
180138|NCT01431846|439748|P2|NOT COMPLETED|Overall Study||0
180139|NCT01431846|439749|P1|NOT COMPLETED|Overall Study||0
180140|NCT01431846|439747|P3|COMPLETED|Overall Study||8
180141|NCT01431846|439748|P2|COMPLETED|Overall Study||3
180142|NCT01431846|439749|P1|COMPLETED|Overall Study||8
180143|NCT01431846|439747|P3|STARTED|Overall Study||8
180144|NCT01431846|439748|P2|STARTED|Overall Study||3
180145|NCT01431846|439749|P1|STARTED|Overall Study||8
180146|NCT01431794|439762|P5|NOT COMPLETED|Overall Study||0
180147|NCT01431794|439763|P4|NOT COMPLETED|Overall Study||0
180148|NCT01431794|439764|P3|NOT COMPLETED|Overall Study||0
180149|NCT01431794|439765|P2|NOT COMPLETED|Overall Study||0
180150|NCT01431794|439766|P1|NOT COMPLETED|Overall Study||0
180151|NCT01431794|439762|P5|COMPLETED|Overall Study|not started due to early study's termination|0
180152|NCT01431794|439763|P4|COMPLETED|Overall Study|not started due to early study's termination|0
180153|NCT01431794|439764|P3|COMPLETED|Overall Study|not started due to early study's termination|0
180154|NCT01431794|439765|P2|COMPLETED|Overall Study|not started due to early study's termination|0
180155|NCT01431794|439766|P1|COMPLETED|Overall Study||13
180156|NCT01431794|439762|P5|STARTED|Overall Study|not started due to early study's termination|0
180157|NCT01431794|439763|P4|STARTED|Overall Study|not started due to early study's termination|0
180158|NCT01431794|439764|P3|STARTED|Overall Study|not started due to early study's termination|0
180159|NCT01431794|439765|P2|STARTED|Overall Study|not started due to early study's termination|0
180160|NCT01431794|439766|P1|STARTED|Overall Study||13
180161|NCT01431755|439778|P1|NOT COMPLETED|Overall Study||5
180162|NCT01431755|439778|P1|COMPLETED|Overall Study||49
180163|NCT01431755|439778|P1|STARTED|Overall Study||54
180164|NCT01431716|439789|P1|NOT COMPLETED|Overall Study||1
180165|NCT01431716|439789|P1|COMPLETED|Overall Study||41
180166|NCT01431716|439789|P1|STARTED|Overall Study||42
180167|NCT01431703|439806|P1|NOT COMPLETED|Overall Study||0
180168|NCT01431703|439806|P1|COMPLETED|Overall Study||326
180169|NCT01431703|439806|P1|STARTED|Overall Study||326
180170|NCT01431534|439813|P3|NOT COMPLETED|Extension Phase||0
180171|NCT01431534|439814|P2|NOT COMPLETED|Extension Phase||0
180172|NCT01431534|439815|P1|NOT COMPLETED|Extension Phase||0
180173|NCT01431534|439813|P3|COMPLETED|Extension Phase||2
180174|NCT01431534|439814|P2|COMPLETED|Extension Phase||0
180175|NCT01431534|439815|P1|COMPLETED|Extension Phase||0
180176|NCT01431534|439813|P3|STARTED|Extension Phase|Participants from Treatment Phase who continued in Extension Phase.|2
180177|NCT01431534|439814|P2|STARTED|Extension Phase|No participants continued in Extension Phase.|0
180178|NCT01431534|439815|P1|STARTED|Extension Phase|No participants continued in Extension Phase.|0
180179|NCT01431534|439813|P3|NOT COMPLETED|Treatment Phase||11
180180|NCT01431534|439814|P2|NOT COMPLETED|Treatment Phase||3
180181|NCT01431534|439815|P1|NOT COMPLETED|Treatment Phase||4
180182|NCT01431534|439813|P3|COMPLETED|Treatment Phase|Participants completing Treatment Phase could continue in Extension Phase.|2
180183|NCT01431534|439814|P2|COMPLETED|Treatment Phase||0
180184|NCT01431534|439815|P1|COMPLETED|Treatment Phase||0
180185|NCT01431534|439813|P3|STARTED|Treatment Phase||13
180186|NCT01431534|439814|P2|STARTED|Treatment Phase||3
180187|NCT01431534|439815|P1|STARTED|Treatment Phase||4
180188|NCT01431521|439830|P4|NOT COMPLETED|Overall Study||0
180189|NCT01431521|439831|P3|NOT COMPLETED|Overall Study||1
180190|NCT01431521|439832|P2|NOT COMPLETED|Overall Study||0
180191|NCT01431521|439833|P1|NOT COMPLETED|Overall Study||0
180192|NCT01431521|439830|P4|COMPLETED|Overall Study||5
180193|NCT01431521|439831|P3|COMPLETED|Overall Study||10
180194|NCT01431521|439832|P2|COMPLETED|Overall Study||5
180195|NCT01431521|439833|P1|COMPLETED|Overall Study||10
180196|NCT01431521|439830|P4|Treated|Overall Study||5
180197|NCT01431521|439831|P3|Treated|Overall Study||10
180198|NCT01431521|439832|P2|Treated|Overall Study||5
180199|NCT01431521|439833|P1|Treated|Overall Study||10
180200|NCT01431521|439830|P4|STARTED|Overall Study||5
180201|NCT01431521|439831|P3|STARTED|Overall Study||11
180202|NCT01431521|439832|P2|STARTED|Overall Study||5
180203|NCT01431521|439833|P1|STARTED|Overall Study||10
180204|NCT01431508|439854|P1|NOT COMPLETED|Overall Study||2
180205|NCT01431508|439854|P1|COMPLETED|Overall Study||13
180206|NCT01431508|439854|P1|STARTED|Overall Study||15
180207|NCT01431391|439860|P2|NOT COMPLETED|Overall Study||4
180208|NCT01431391|439861|P1|NOT COMPLETED|Overall Study||8
180209|NCT01431391|439860|P2|COMPLETED|Overall Study||30
180210|NCT01431391|439861|P1|COMPLETED|Overall Study||26
180211|NCT01431391|439860|P2|Received ≥1 Leaukapheresis|Overall Study||34
180212|NCT01431391|439861|P1|Received ≥1 Leaukapheresis|Overall Study||34
180213|NCT01431391|439860|P2|STARTED|Overall Study||34
180214|NCT01431391|439861|P1|STARTED|Overall Study||34
180215|NCT01431339|439871|P2|NOT COMPLETED|Overall Study||35
180216|NCT01431339|439872|P1|NOT COMPLETED|Overall Study||39
180217|NCT01431339|439871|P2|COMPLETED|Overall Study||333
180218|NCT01431339|439872|P1|COMPLETED|Overall Study||332
180219|NCT01431339|439871|P2|Safety Population|Overall Study||367
180220|NCT01431339|439872|P1|Safety Population|Overall Study||368
180221|NCT01431339|439871|P2|STARTED|Overall Study||368
180222|NCT01431339|439872|P1|STARTED|Overall Study||371
180223|NCT01431313|439887|P3|NOT COMPLETED|Overall Study||0
180224|NCT01431313|439888|P2|NOT COMPLETED|Overall Study||0
180225|NCT01431313|439889|P1|NOT COMPLETED|Overall Study||0
180226|NCT01431313|439887|P3|COMPLETED|Overall Study||8
180227|NCT01431313|439888|P2|COMPLETED|Overall Study||20
180228|NCT01431313|439889|P1|COMPLETED|Overall Study||20
180229|NCT01431313|439887|P3|STARTED|Overall Study||8
180230|NCT01431313|439888|P2|STARTED|Overall Study||20
180231|NCT01431313|439889|P1|STARTED|Overall Study||20
180232|NCT01431300|439921|P3|NOT COMPLETED|Overall Study||0
180233|NCT01431300|439922|P2|NOT COMPLETED|Overall Study||0
180234|NCT01431300|439923|P1|NOT COMPLETED|Overall Study||1
180235|NCT01431300|439921|P3|COMPLETED|Overall Study||10
180236|NCT01431300|439922|P2|COMPLETED|Overall Study||10
180237|NCT01431300|439923|P1|COMPLETED|Overall Study||10
180238|NCT01431300|439921|P3|STARTED|Overall Study||10
180239|NCT01431300|439922|P2|STARTED|Overall Study||10
180240|NCT01431300|439923|P1|STARTED|Overall Study|One subject with indeterminate pregnancy test, subject declined to proceed|11
180241|NCT01431287|439939|P5|NOT COMPLETED|Overall Study||77
180242|NCT01431287|439940|P4|NOT COMPLETED|Overall Study||63
180243|NCT01431287|439941|P3|NOT COMPLETED|Overall Study||97
180244|NCT01431287|439942|P2|NOT COMPLETED|Overall Study||98
180245|NCT01431287|439943|P1|NOT COMPLETED|Overall Study||98
180246|NCT01431287|439939|P5|COMPLETED|Overall Study||430
180247|NCT01431287|439940|P4|COMPLETED|Overall Study||445
180248|NCT01431287|439941|P3|COMPLETED|Overall Study||410
180249|NCT01431287|439942|P2|COMPLETED|Overall Study||409
180250|NCT01431287|439943|P1|COMPLETED|Overall Study||412
180251|NCT01431287|439939|P5|STARTED|Overall Study||507
180252|NCT01431287|439940|P4|STARTED|Overall Study||508
180253|NCT01431287|439941|P3|STARTED|Overall Study||507
180254|NCT01431287|439942|P2|STARTED|Overall Study||507
180255|NCT01431287|439943|P1|STARTED|Overall Study|started are actually the randomized|510
180256|NCT01431274|440105|P5|NOT COMPLETED|Overall Study||56
180257|NCT01431274|440106|P4|NOT COMPLETED|Overall Study||60
180258|NCT01431274|440107|P3|NOT COMPLETED|Overall Study||72
180259|NCT01431274|440108|P2|NOT COMPLETED|Overall Study||77
180260|NCT01431274|440109|P1|NOT COMPLETED|Overall Study||97
180261|NCT01431274|440105|P5|COMPLETED|Overall Study||466
180262|NCT01431274|440106|P4|COMPLETED|Overall Study||462
180263|NCT01431274|440107|P3|COMPLETED|Overall Study||455
180264|NCT01431274|440108|P2|COMPLETED|Overall Study||448
180265|NCT01431274|440109|P1|COMPLETED|Overall Study||431
180266|NCT01431274|440105|P5|STARTED|Overall Study||522
180267|NCT01431274|440106|P4|STARTED|Overall Study||522
180268|NCT01431274|440107|P3|STARTED|Overall Study||527
180269|NCT01431274|440108|P2|STARTED|Overall Study||525
180270|NCT01431274|440109|P1|STARTED|Overall Study||528
180271|NCT01431170|440268|P2|NOT COMPLETED|Overall Study||1
180272|NCT01431170|440269|P1|NOT COMPLETED|Overall Study||3
180273|NCT01431170|440268|P2|COMPLETED|Overall Study||11
180274|NCT01431170|440269|P1|COMPLETED|Overall Study||9
180275|NCT01431170|440268|P2|STARTED|Overall Study||12
180276|NCT01431170|440269|P1|STARTED|Overall Study||12
180277|NCT01431144|440287|P2|NOT COMPLETED|Overall Study||0
180278|NCT01431144|440288|P1|NOT COMPLETED|Overall Study||2
180279|NCT01431144|440287|P2|COMPLETED|Overall Study||14
180280|NCT01431144|440288|P1|COMPLETED|Overall Study||11
180281|NCT01431144|440287|P2|STARTED|Overall Study||14
180282|NCT01431144|440288|P1|STARTED|Overall Study||13
180283|NCT01431131|440296|P2|NOT COMPLETED|Overall Study||0
180284|NCT01431131|440297|P1|NOT COMPLETED|Overall Study||0
180285|NCT01431131|440296|P2|COMPLETED|Overall Study||12
180286|NCT01431131|440297|P1|COMPLETED|Overall Study||12
180287|NCT01431131|440296|P2|STARTED|Overall Study||12
180288|NCT01431131|440297|P1|STARTED|Overall Study||12
180289|NCT01431105|440305|P1|NOT COMPLETED|Overall Study||0
180290|NCT01431105|440305|P1|COMPLETED|Overall Study||34
180291|NCT01431105|440305|P1|STARTED|Overall Study||34
180292|NCT01431079|440311|P2|NOT COMPLETED|Overall Study||39
180293|NCT01431079|440312|P1|NOT COMPLETED|Overall Study||35
180294|NCT01431079|440311|P2|COMPLETED|Overall Study||6
180295|NCT01431079|440312|P1|COMPLETED|Overall Study||10
180296|NCT01431079|440311|P2|Post-test|Overall Study||45
180297|NCT01431079|440312|P1|Post-test|Overall Study||45
180298|NCT01431079|440311|P2|STARTED|Overall Study||45
180299|NCT01431079|440312|P1|STARTED|Overall Study||45
180300|NCT01431014|440366|P2|NOT COMPLETED|Overall Study||9
180301|NCT01431014|440367|P1|NOT COMPLETED|Overall Study||3
180302|NCT01431014|440366|P2|COMPLETED|Overall Study||25
180303|NCT01431014|440367|P1|COMPLETED|Overall Study||31
180304|NCT01431014|440366|P2|STARTED|Overall Study||34
180305|NCT01431014|440367|P1|STARTED|Overall Study||34
180306|NCT01430819|440375|P2|NOT COMPLETED|Overall Study||0
180307|NCT01430819|440376|P1|NOT COMPLETED|Overall Study||0
180308|NCT01430819|440375|P2|COMPLETED|Overall Study||150
180309|NCT01430819|440376|P1|COMPLETED|Overall Study||150
180310|NCT01430819|440375|P2|STARTED|Overall Study||150
180311|NCT01430819|440376|P1|STARTED|Overall Study||150
180312|NCT01430754|440391|P2|NOT COMPLETED|Randomized Phase||0
180313|NCT01430754|440392|P1|NOT COMPLETED|Randomized Phase||0
180314|NCT01430754|440391|P2|COMPLETED|Randomized Phase||10
180315|NCT01430754|440392|P1|COMPLETED|Randomized Phase||10
180316|NCT01430754|440391|P2|STARTED|Randomized Phase||10
180317|NCT01430754|440392|P1|STARTED|Randomized Phase||10
180318|NCT01430754|440391|P2|NOT COMPLETED|Run-In Phase||0
180319|NCT01430754|440392|P1|NOT COMPLETED|Run-In Phase||37
180320|NCT01430754|440391|P2|COMPLETED|Run-In Phase||0
180321|NCT01430754|440392|P1|COMPLETED|Run-In Phase|Defined as the number of patients who entered the randomized-withdrawal phase|20
180322|NCT01430754|440391|P2|Entrained - After Run-In Phase|Run-In Phase||0
180323|NCT01430754|440392|P1|Entrained - After Run-In Phase|Run-In Phase||24
180324|NCT01430754|440391|P2|STARTED|Run-In Phase|During the run-in phase, participants were treated with tasimelteon only.|0
180325|NCT01430754|440392|P1|STARTED|Run-In Phase||57
180326|NCT01430741|440414|P4|NOT COMPLETED|Overall Study||0
180327|NCT01430741|440415|P3|NOT COMPLETED|Overall Study||10
180328|NCT01430741|440416|P2|NOT COMPLETED|Overall Study||0
180329|NCT01430741|440417|P1|NOT COMPLETED|Overall Study||0
180330|NCT01430741|440414|P4|COMPLETED|Overall Study||81
180331|NCT01430741|440415|P3|COMPLETED|Overall Study||37
180332|NCT01430741|440416|P2|COMPLETED|Overall Study||87
180333|NCT01430741|440417|P1|COMPLETED|Overall Study||22
180334|NCT01430741|440414|P4|STARTED|Overall Study||81
180335|NCT01430741|440415|P3|STARTED|Overall Study||47
180336|NCT01430741|440416|P2|STARTED|Overall Study||87
180337|NCT01430741|440417|P1|STARTED|Overall Study||22
180338|NCT01430624|440450|P3|NOT COMPLETED|Overall Study||29
180339|NCT01430624|440451|P2|NOT COMPLETED|Overall Study||34
180340|NCT01430624|440452|P1|NOT COMPLETED|Overall Study||28
180341|NCT01430624|440450|P3|COMPLETED|Overall Study|Completed one or more follow-ups|52
180342|NCT01430624|440451|P2|COMPLETED|Overall Study|Completed one or more follow-ups|48
180343|NCT01430624|440452|P1|COMPLETED|Overall Study|Completed one or more follow-ups|54
180344|NCT01430624|440450|P3|Eligible Baseline Completes|Overall Study||79
180345|NCT01430624|440451|P2|Eligible Baseline Completes|Overall Study||77
180346|NCT01430624|440452|P1|Eligible Baseline Completes|Overall Study||77
180347|NCT01430624|440450|P3|STARTED|Overall Study||81
180348|NCT01430624|440451|P2|STARTED|Overall Study||82
180349|NCT01430624|440452|P1|STARTED|Overall Study|Initial potential eligible screened enrolled|82
180350|NCT01430611|440483|P2|NOT COMPLETED|Overall Study||15
180351|NCT01430611|440484|P1|NOT COMPLETED|Overall Study||17
180352|NCT01430611|440483|P2|COMPLETED|Overall Study||318
180353|NCT01430611|440484|P1|COMPLETED|Overall Study||315
180354|NCT01430611|440483|P2|STARTED|Overall Study||333
180355|NCT01430611|440484|P1|STARTED|Overall Study||332
180356|NCT01430585|440502|P1|NOT COMPLETED|Overall Study||14
180357|NCT01430585|440502|P1|COMPLETED|Overall Study||0
180358|NCT01430585|440502|P1|STARTED|Overall Study||14
180359|NCT01430468|440537|P2|NOT COMPLETED|Overall Study||2
180360|NCT01430468|440538|P1|NOT COMPLETED|Overall Study||3
180361|NCT01430468|440537|P2|COMPLETED|Overall Study||16
180362|NCT01430468|440538|P1|COMPLETED|Overall Study||15
180363|NCT01430468|440537|P2|STARTED|Overall Study||18
180364|NCT01430468|440538|P1|STARTED|Overall Study||18
180365|NCT01430455|440544|P1|NOT COMPLETED|Overall Study||2
180366|NCT01430455|440544|P1|COMPLETED|Overall Study||5
180367|NCT01430455|440544|P1|STARTED|Overall Study||7
180368|NCT01430403|440551|P3|NOT COMPLETED|Overall Study||8
180369|NCT01430403|440552|P2|NOT COMPLETED|Overall Study||9
180370|NCT01430403|440553|P1|NOT COMPLETED|Overall Study||17
180371|NCT01430403|440551|P3|COMPLETED|Overall Study||81
180372|NCT01430403|440552|P2|COMPLETED|Overall Study||121
180373|NCT01430403|440553|P1|COMPLETED|Overall Study||242
180374|NCT01430403|440551|P3|STARTED|Overall Study|Intent-to-treat|89
180375|NCT01430403|440552|P2|STARTED|Overall Study|Intent-to-treat|130
180376|NCT01430403|440553|P1|STARTED|Overall Study|Intent-to-treat|259
180377|NCT01430325|440606|P4|NOT COMPLETED|Overall Study||0
180378|NCT01430325|440607|P3|NOT COMPLETED|Overall Study||0
180379|NCT01430325|440608|P2|NOT COMPLETED|Overall Study||0
180380|NCT01430325|440609|P1|NOT COMPLETED|Overall Study||0
180381|NCT01430325|440606|P4|COMPLETED|Overall Study||12
180382|NCT01430325|440607|P3|COMPLETED|Overall Study||8
180383|NCT01430325|440608|P2|COMPLETED|Overall Study||12
180384|NCT01430325|440609|P1|COMPLETED|Overall Study||10
180385|NCT01430325|440606|P4|STARTED|Overall Study||12
180386|NCT01430325|440607|P3|STARTED|Overall Study||8
180387|NCT01430325|440608|P2|STARTED|Overall Study||12
180388|NCT01430325|440609|P1|STARTED|Overall Study||10
180389|NCT01430299|440629|P2|NOT COMPLETED|Overall Study||2
180390|NCT01430299|440630|P1|NOT COMPLETED|Overall Study||4
180391|NCT01430299|440629|P2|COMPLETED|Overall Study||21
180392|NCT01430299|440630|P1|COMPLETED|Overall Study||16
180393|NCT01430299|440629|P2|STARTED|Overall Study||23
180394|NCT01430299|440630|P1|STARTED|Overall Study||20
180395|NCT01430182|440638|P2|NOT COMPLETED|Overall Study||0
180396|NCT01430182|440639|P1|NOT COMPLETED|Overall Study||0
180397|NCT01430182|440638|P2|COMPLETED|Overall Study||8
180398|NCT01430182|440639|P1|COMPLETED|Overall Study||9
180399|NCT01430182|440638|P2|STARTED|Overall Study||8
180400|NCT01430182|440639|P1|STARTED|Overall Study||9
180401|NCT01430169|440645|P1|NOT COMPLETED|Overall Study||0
180402|NCT01430169|440645|P1|COMPLETED|Overall Study||20
180403|NCT01430169|440645|P1|STARTED|Overall Study||20
180404|NCT01430130|440660|P1|NOT COMPLETED|Overall Study||2
180405|NCT01430130|440660|P1|COMPLETED|Overall Study||10
180406|NCT01430130|440660|P1|STARTED|Overall Study||12
180407|NCT01430104|440666|P1|NOT COMPLETED|28-Day Teriparatide Treatment Period||1
180408|NCT01430104|440666|P1|COMPLETED|28-Day Teriparatide Treatment Period||28
180409|NCT01430104|440666|P1|Received at Least 1 Dose of Teriparatide|28-Day Teriparatide Treatment Period||29
180410|NCT01430104|440666|P1|STARTED|28-Day Teriparatide Treatment Period|1 participant withdrew from the study after completing the 14-day Lead-in Period.|29
180411|NCT01430104|440666|P1|NOT COMPLETED|14-Day Lead-In Period||0
180412|NCT01430104|440666|P1|COMPLETED|14-Day Lead-In Period||30
180413|NCT01430104|440666|P1|STARTED|14-Day Lead-In Period||30
180414|NCT01430091|440678|P1|NOT COMPLETED|Overall Study||0
180415|NCT01430091|440678|P1|COMPLETED|Overall Study||18
180416|NCT01430091|440678|P1|STARTED|Overall Study||18
180417|NCT01429987|440704|P4|NOT COMPLETED|Overall Study||66
180418|NCT01429987|440705|P3|NOT COMPLETED|Overall Study||36
180419|NCT01429987|440706|P2|NOT COMPLETED|Overall Study||62
180420|NCT01429987|440707|P1|NOT COMPLETED|Overall Study||49
180421|NCT01429987|440704|P4|COMPLETED|Overall Study||171
180422|NCT01429987|440705|P3|COMPLETED|Overall Study||202
180423|NCT01429987|440706|P2|COMPLETED|Overall Study||176
180424|NCT01429987|440707|P1|COMPLETED|Overall Study||189
180425|NCT01429987|440704|P4|STARTED|Overall Study||237
180426|NCT01429987|440705|P3|STARTED|Overall Study||238
180427|NCT01429987|440706|P2|STARTED|Overall Study||238
180428|NCT01429987|440707|P1|STARTED|Overall Study||238
180429|NCT01429792|440733|P1|NOT COMPLETED|Overall Study||406
180430|NCT01429792|440733|P1|COMPLETED|Overall Study||607
180431|NCT01429792|440733|P1|Genotype 4|Overall Study||5
180432|NCT01429792|440733|P1|Genotype 2 & 3|Overall Study||305
180433|NCT01429792|440733|P1|Genotype 1|Overall Study||687
180434|NCT01429792|440733|P1|STARTED|Overall Study||1013
180435|NCT01429623|440747|P2|NOT COMPLETED|Overall Study||59
180436|NCT01429623|440748|P1|NOT COMPLETED|Overall Study||51
180437|NCT01429623|440747|P2|COMPLETED|Overall Study||48
180438|NCT01429623|440748|P1|COMPLETED|Overall Study||51
180439|NCT01429623|440747|P2|Converted to Alzheimer's|Overall Study|21 of 103|21
180440|NCT01429623|440748|P1|Converted to Alzheimer's|Overall Study|14 of 99|14
180441|NCT01429623|440747|P2|STARTED|Overall Study|107 allocated, 4 lacked post baseline data|107
180442|NCT01429623|440748|P1|STARTED|Overall Study|103 allocated, 1 withdrew consent prior to first dose, 4 lacked post baseline data|102
180443|NCT01429584|440762|P2|NOT COMPLETED|Overall Study||1
180444|NCT01429584|440763|P1|NOT COMPLETED|Overall Study||1
180445|NCT01429584|440762|P2|COMPLETED|Overall Study||14
180446|NCT01429584|440763|P1|COMPLETED|Overall Study||14
180447|NCT01429584|440762|P2|STARTED|Overall Study||15
180448|NCT01429584|440763|P1|STARTED|Overall Study||15
180449|NCT01429532|440776|P3|NOT COMPLETED|Overall Study||0
180450|NCT01429532|440777|P2|NOT COMPLETED|Overall Study||0
180451|NCT01429532|440778|P1|NOT COMPLETED|Overall Study||0
180452|NCT01429532|440776|P3|COMPLETED|Overall Study||40
180453|NCT01429532|440777|P2|COMPLETED|Overall Study||40
180454|NCT01429532|440778|P1|COMPLETED|Overall Study||40
180455|NCT01429532|440776|P3|STARTED|Overall Study||40
180456|NCT01429532|440777|P2|STARTED|Overall Study||40
180457|NCT01429532|440778|P1|STARTED|Overall Study||40
180458|NCT01429441|440794|P2|NOT COMPLETED|Overall Study||23
180459|NCT01429441|440795|P1|NOT COMPLETED|Overall Study||38
180460|NCT01429441|440794|P2|COMPLETED|Overall Study||51
180461|NCT01429441|440795|P1|COMPLETED|Overall Study||108
180462|NCT01429441|440794|P2|STARTED|Overall Study||74
180463|NCT01429441|440795|P1|STARTED|Overall Study||146
180464|NCT01429298|440805|P2|NOT COMPLETED|Overall Study||6
180465|NCT01429298|440806|P1|NOT COMPLETED|Overall Study||4
180466|NCT01429298|440805|P2|COMPLETED|Overall Study||169
180467|NCT01429298|440806|P1|COMPLETED|Overall Study||171
180468|NCT01429298|440805|P2|Given IV Opioids|Overall Study|6 never given IV opioids|169
180469|NCT01429298|440806|P1|Given IV Opioids|Overall Study|4 never given IV opioids|171
180470|NCT01429298|440805|P2|STARTED|Overall Study||175
180471|NCT01429298|440806|P1|STARTED|Overall Study||175
180472|NCT01429285|440822|P2|NOT COMPLETED|Overall Study||9
180473|NCT01429285|440823|P1|NOT COMPLETED|Overall Study||22
180474|NCT01429285|440822|P2|COMPLETED|Overall Study||166
180475|NCT01429285|440823|P1|COMPLETED|Overall Study||153
180476|NCT01429285|440822|P2|Confirmation of no Duplicate Enrollment|Overall Study|2 patients were enrolled twice, at two separate ED visits, which was only noted at study conclusion|166
180477|NCT01429285|440823|P1|Confirmation of no Duplicate Enrollment|Overall Study|8 patients were enrolled twice at two separate ED visits, which was only noted at study conclusion.|153
180478|NCT01429285|440822|P2|Completed Primary Outcome Data|Overall Study|3 patients had missing data|168
180479|NCT01429285|440823|P1|Completed Primary Outcome Data|Overall Study|5 patients had missing data|161
180480|NCT01429285|440822|P2|Given IV Opioids|Overall Study|4 patients never given IV opioids|171
180481|NCT01429285|440823|P1|Given IV Opioids|Overall Study|9 patients never given IV opioids|166
180482|NCT01429285|440822|P2|STARTED|Overall Study||175
180483|NCT01429285|440823|P1|STARTED|Overall Study||175
180484|NCT01429272|440845|P4|NOT COMPLETED|Overall Study||5
180485|NCT01429272|440846|P3|NOT COMPLETED|Overall Study||4
180486|NCT01429272|440847|P2|NOT COMPLETED|Overall Study||9
180487|NCT01429272|440848|P1|NOT COMPLETED|Overall Study||6
180488|NCT01429272|440845|P4|COMPLETED|Overall Study||14
180489|NCT01429272|440846|P3|COMPLETED|Overall Study||15
180490|NCT01429272|440847|P2|COMPLETED|Overall Study||22
180491|NCT01429272|440848|P1|COMPLETED|Overall Study||24
180492|NCT01429272|440845|P4|STARTED|Overall Study||19
180493|NCT01429272|440846|P3|STARTED|Overall Study||19
180494|NCT01429272|440847|P2|STARTED|Overall Study||31
180495|NCT01429272|440848|P1|STARTED|Overall Study||30
180496|NCT01429259|440862|P1|NOT COMPLETED|Overall Study||0
180497|NCT01429259|440862|P1|COMPLETED|Overall Study||30
180498|NCT01429259|440862|P1|STARTED|Overall Study||30
180499|NCT01429077|440869|P2|NOT COMPLETED|Overall Study||3
180500|NCT01429077|440870|P1|NOT COMPLETED|Overall Study||0
180501|NCT01429077|440869|P2|COMPLETED|Overall Study||14
180502|NCT01429077|440870|P1|COMPLETED|Overall Study||19
180503|NCT01429077|440869|P2|Completed 6-week Intervention|Overall Study||17
180504|NCT01429077|440870|P1|Completed 6-week Intervention|Overall Study||19
180505|NCT01429077|440869|P2|STARTED|Overall Study||17
180506|NCT01429077|440870|P1|STARTED|Overall Study||19
180507|NCT01429064|440880|P4|NOT COMPLETED|Overall Study||0
180508|NCT01429064|440881|P3|NOT COMPLETED|Overall Study||0
180509|NCT01429064|440882|P2|NOT COMPLETED|Overall Study||0
180510|NCT01429064|440883|P1|NOT COMPLETED|Overall Study||0
180511|NCT01429064|440880|P4|COMPLETED|Overall Study||16
180512|NCT01429064|440881|P3|COMPLETED|Overall Study||19
180513|NCT01429064|440882|P2|COMPLETED|Overall Study||22
180514|NCT01429064|440883|P1|COMPLETED|Overall Study||19
180515|NCT01429064|440880|P4|STARTED|Overall Study||16
180516|NCT01429064|440881|P3|STARTED|Overall Study||19
180517|NCT01429064|440882|P2|STARTED|Overall Study||22
180518|NCT01429064|440883|P1|STARTED|Overall Study||19
180519|NCT01429051|440893|P1|NOT COMPLETED|Tolerability Phase||15
180520|NCT01429051|440893|P1|COMPLETED|Tolerability Phase||16
180521|NCT01429051|440893|P1|STARTED|Tolerability Phase|Participants entered directly from the Titration or Efficacy Phase|31
180522|NCT01429051|440893|P1|NOT COMPLETED|Efficacy Phase||2
180523|NCT01429051|440893|P1|COMPLETED|Efficacy Phase||13
180524|NCT01429051|440893|P1|STARTED|Efficacy Phase|Participants titrated to 200 or 400 μg INFS in Titration Phase|15
180525|NCT01429051|440893|P1|NOT COMPLETED|Titration Phase||12
180526|NCT01429051|440893|P1|COMPLETED|Titration Phase||33
180527|NCT01429051|440893|P1|STARTED|Titration Phase||45
180528|NCT01428882|440916|P2|NOT COMPLETED|Overall Study||10
180529|NCT01428882|440917|P1|NOT COMPLETED|Overall Study||6
180530|NCT01428882|440916|P2|COMPLETED|Overall Study||58
180531|NCT01428882|440917|P1|COMPLETED|Overall Study||61
180532|NCT01428882|440916|P2|STARTED|Overall Study||68
180533|NCT01428882|440917|P1|STARTED|Overall Study||67
180534|NCT01428765|440929|P1|NOT COMPLETED|Overall Study||0
180535|NCT01428765|440929|P1|COMPLETED|Overall Study||1063
180536|NCT01428765|440929|P1|STARTED|Overall Study||1063
180537|NCT01428713|440940|P2|NOT COMPLETED|Overall Study||5
180538|NCT01428713|440941|P1|NOT COMPLETED|Overall Study||3
180539|NCT01428713|440940|P2|COMPLETED|Overall Study||3
180540|NCT01428713|440941|P1|COMPLETED|Overall Study||6
180541|NCT01428713|440940|P2|STARTED|Overall Study||8
180542|NCT01428713|440941|P1|STARTED|Overall Study||9
180543|NCT01428661|440950|P3|NOT COMPLETED|Open Label Extension||320
180544|NCT01428661|440951|P2|NOT COMPLETED|Open Label Extension||0
180545|NCT01428661|440952|P1|NOT COMPLETED|Open Label Extension||0
180546|NCT01428661|440950|P3|COMPLETED|Open Label Extension||19
180547|NCT01428661|440951|P2|COMPLETED|Open Label Extension|Does not apply.|0
180548|NCT01428661|440952|P1|COMPLETED|Open Label Extension|Does not apply.|0
180549|NCT01428661|440950|P3|STARTED|Open Label Extension||339
180550|NCT01428661|440951|P2|STARTED|Open Label Extension|Does not apply.|0
180551|NCT01428661|440952|P1|STARTED|Open Label Extension|Does not apply.|0
180552|NCT01428661|440950|P3|NOT COMPLETED|Double-Masked Phase||0
180553|NCT01428661|440951|P2|NOT COMPLETED|Double-Masked Phase||49
180554|NCT01428661|440952|P1|NOT COMPLETED|Double-Masked Phase||57
180555|NCT01428661|440950|P3|COMPLETED|Double-Masked Phase|Does not apply.|0
180556|NCT01428661|440951|P2|COMPLETED|Double-Masked Phase||204
180557|NCT01428661|440952|P1|COMPLETED|Double-Masked Phase||197
180558|NCT01428661|440950|P3|STARTED|Double-Masked Phase|Does not apply.|0
180559|NCT01428661|440951|P2|STARTED|Double-Masked Phase||253
180560|NCT01428661|440952|P1|STARTED|Double-Masked Phase||254
180561|NCT01428583|440960|P1|NOT COMPLETED|Overall Study||237
180562|NCT01428583|440960|P1|COMPLETED|Overall Study||158
180563|NCT01428583|440960|P1|STARTED|Overall Study||395
180564|NCT01428453|440984|P2|NOT COMPLETED|Overall Study||9
180565|NCT01428453|440985|P1|NOT COMPLETED|Overall Study||6
180566|NCT01428453|440984|P2|COMPLETED|Overall Study||52
180567|NCT01428453|440985|P1|COMPLETED|Overall Study||56
180568|NCT01428453|440984|P2|STARTED|Overall Study||61
180569|NCT01428453|440985|P1|STARTED|Overall Study||62
180570|NCT01428336|441011|P2|NOT COMPLETED|Overall Study||0
180571|NCT01428336|441012|P1|NOT COMPLETED|Overall Study||0
180572|NCT01428336|441011|P2|COMPLETED|Overall Study||12
180573|NCT01428336|441012|P1|COMPLETED|Overall Study||10
180574|NCT01428336|441011|P2|STARTED|Overall Study||12
180575|NCT01428336|441012|P1|STARTED|Overall Study||10
180576|NCT01428258|441024|P2|NOT COMPLETED|Intervention 2||0
180577|NCT01428258|441025|P1|NOT COMPLETED|Intervention 2||0
180578|NCT01428258|441024|P2|COMPLETED|Intervention 2||15
180579|NCT01428258|441025|P1|COMPLETED|Intervention 2||15
180580|NCT01428258|441024|P2|STARTED|Intervention 2||15
180581|NCT01428258|441025|P1|STARTED|Intervention 2||15
180582|NCT01428258|441024|P2|NOT COMPLETED|Intervention 1||0
180583|NCT01428258|441025|P1|NOT COMPLETED|Intervention 1||2
180584|NCT01428258|441024|P2|COMPLETED|Intervention 1||15
180585|NCT01428258|441025|P1|COMPLETED|Intervention 1||15
180586|NCT01428258|441024|P2|STARTED|Intervention 1||15
180587|NCT01428258|441025|P1|STARTED|Intervention 1||17
180588|NCT01428219|441043|P1|NOT COMPLETED|Overall Study||3
180589|NCT01428219|441043|P1|COMPLETED|Overall Study||22
180590|NCT01428219|441043|P1|STARTED|Overall Study||25
180591|NCT01428193|441054|P1|NOT COMPLETED|Overall Study||2
180592|NCT01428193|441054|P1|COMPLETED|Overall Study||2
180593|NCT01428193|441054|P1|STARTED|Overall Study||4
180594|NCT01428128|441058|P1|NOT COMPLETED|Overall Study||17
180595|NCT01428128|441058|P1|COMPLETED|Overall Study||33
180596|NCT01428128|441058|P1|STARTED|Overall Study||50
180597|NCT01428115|441063|P1|NOT COMPLETED|Overall Study||21
180598|NCT01428115|441063|P1|COMPLETED|Overall Study||62
180599|NCT01428115|441063|P1|STARTED|Overall Study||83
180600|NCT01428076|441078|P2|NOT COMPLETED|Overall Study||1
180601|NCT01428076|441079|P1|NOT COMPLETED|Overall Study||0
180602|NCT01428076|441078|P2|COMPLETED|Overall Study||11
180603|NCT01428076|441079|P1|COMPLETED|Overall Study||9
180604|NCT01428076|441078|P2|STARTED|Overall Study||12
180605|NCT01428076|441079|P1|STARTED|Overall Study||9
180606|NCT01428063|441090|P3|NOT COMPLETED|Overall Study||1
180607|NCT01428063|441091|P2|NOT COMPLETED|Overall Study||10
180608|NCT01428063|441092|P1|NOT COMPLETED|Overall Study||10
180609|NCT01428063|441090|P3|COMPLETED|Overall Study||5
180610|NCT01428063|441091|P2|COMPLETED|Overall Study||112
180611|NCT01428063|441092|P1|COMPLETED|Overall Study||89
180612|NCT01428063|441090|P3|STARTED|Overall Study||6
180613|NCT01428063|441091|P2|STARTED|Overall Study||122
180614|NCT01428063|441092|P1|STARTED|Overall Study||99
180615|NCT01428024|441163|P2|NOT COMPLETED|Overall Study||1
180616|NCT01428024|441164|P1|NOT COMPLETED|Overall Study||1
180617|NCT01428024|441163|P2|COMPLETED|Overall Study||29
180618|NCT01428024|441164|P1|COMPLETED|Overall Study||29
180619|NCT01428024|441163|P2|STARTED|Overall Study||30
180620|NCT01428024|441164|P1|STARTED|Overall Study||30
180621|NCT01427972|441193|P12|NOT COMPLETED|Treatment Period 2 (21 Days)||0
180622|NCT01427972|441194|P11|NOT COMPLETED|Treatment Period 2 (21 Days)||0
180623|NCT01427972|441195|P10|NOT COMPLETED|Treatment Period 2 (21 Days)||0
180624|NCT01427972|441196|P9|NOT COMPLETED|Treatment Period 2 (21 Days)||0
180625|NCT01427972|441197|P8|NOT COMPLETED|Treatment Period 2 (21 Days)||0
180626|NCT01427972|441198|P7|NOT COMPLETED|Treatment Period 2 (21 Days)||0
180627|NCT01427972|441199|P6|NOT COMPLETED|Treatment Period 2 (21 Days)||0
180628|NCT01427972|441200|P5|NOT COMPLETED|Treatment Period 2 (21 Days)||0
180629|NCT01427972|441201|P4|NOT COMPLETED|Treatment Period 2 (21 Days)||0
180630|NCT01427972|441202|P3|NOT COMPLETED|Treatment Period 2 (21 Days)||0
180631|NCT01427972|441203|P2|NOT COMPLETED|Treatment Period 2 (21 Days)||1
180632|NCT01427972|441204|P1|NOT COMPLETED|Treatment Period 2 (21 Days)||0
180633|NCT01427972|441193|P12|COMPLETED|Treatment Period 2 (21 Days)||4
180634|NCT01427972|441194|P11|COMPLETED|Treatment Period 2 (21 Days)||3
180635|NCT01427972|441195|P10|COMPLETED|Treatment Period 2 (21 Days)||3
180636|NCT01427972|441196|P9|COMPLETED|Treatment Period 2 (21 Days)||3
180637|NCT01427972|441197|P8|COMPLETED|Treatment Period 2 (21 Days)||4
180638|NCT01427972|441198|P7|COMPLETED|Treatment Period 2 (21 Days)||3
180639|NCT01427972|441199|P6|COMPLETED|Treatment Period 2 (21 Days)||1
180640|NCT01427972|441200|P5|COMPLETED|Treatment Period 2 (21 Days)||4
180641|NCT01427972|441201|P4|COMPLETED|Treatment Period 2 (21 Days)||3
180642|NCT01427972|441202|P3|COMPLETED|Treatment Period 2 (21 Days)||4
180643|NCT01427972|441203|P2|COMPLETED|Treatment Period 2 (21 Days)||3
180644|NCT01427972|441204|P1|COMPLETED|Treatment Period 2 (21 Days)||3
180645|NCT01427972|441193|P12|STARTED|Treatment Period 2 (21 Days)||4
180646|NCT01427972|441194|P11|STARTED|Treatment Period 2 (21 Days)||3
180647|NCT01427972|441195|P10|STARTED|Treatment Period 2 (21 Days)||3
180648|NCT01427972|441196|P9|STARTED|Treatment Period 2 (21 Days)||3
180649|NCT01427972|441197|P8|STARTED|Treatment Period 2 (21 Days)||4
180650|NCT01427972|441198|P7|STARTED|Treatment Period 2 (21 Days)||3
180651|NCT01427972|441199|P6|STARTED|Treatment Period 2 (21 Days)||1
180652|NCT01427972|441200|P5|STARTED|Treatment Period 2 (21 Days)||4
180653|NCT01427972|441201|P4|STARTED|Treatment Period 2 (21 Days)||3
180654|NCT01427972|441202|P3|STARTED|Treatment Period 2 (21 Days)||4
180655|NCT01427972|441203|P2|STARTED|Treatment Period 2 (21 Days)||4
180656|NCT01427972|441204|P1|STARTED|Treatment Period 2 (21 Days)||3
180657|NCT01427972|441193|P12|NOT COMPLETED|Washout (at Least 28 Days)||0
180658|NCT01427972|441194|P11|NOT COMPLETED|Washout (at Least 28 Days)||0
180659|NCT01427972|441195|P10|NOT COMPLETED|Washout (at Least 28 Days)||0
180660|NCT01427972|441196|P9|NOT COMPLETED|Washout (at Least 28 Days)||0
180661|NCT01427972|441197|P8|NOT COMPLETED|Washout (at Least 28 Days)||0
180662|NCT01427972|441198|P7|NOT COMPLETED|Washout (at Least 28 Days)||0
180663|NCT01427972|441199|P6|NOT COMPLETED|Washout (at Least 28 Days)||2
180664|NCT01427972|441200|P5|NOT COMPLETED|Washout (at Least 28 Days)||0
180665|NCT01427972|441201|P4|NOT COMPLETED|Washout (at Least 28 Days)||0
180666|NCT01427972|441202|P3|NOT COMPLETED|Washout (at Least 28 Days)||0
180667|NCT01427972|441203|P2|NOT COMPLETED|Washout (at Least 28 Days)||0
180668|NCT01427972|441204|P1|NOT COMPLETED|Washout (at Least 28 Days)||0
180669|NCT01427972|441193|P12|COMPLETED|Washout (at Least 28 Days)||4
180670|NCT01427972|441194|P11|COMPLETED|Washout (at Least 28 Days)||3
180671|NCT01427972|441195|P10|COMPLETED|Washout (at Least 28 Days)||3
180672|NCT01427972|441196|P9|COMPLETED|Washout (at Least 28 Days)||3
180673|NCT01427972|441197|P8|COMPLETED|Washout (at Least 28 Days)||4
180674|NCT01427972|441198|P7|COMPLETED|Washout (at Least 28 Days)||3
180675|NCT01427972|441199|P6|COMPLETED|Washout (at Least 28 Days)||1
180676|NCT01427972|441200|P5|COMPLETED|Washout (at Least 28 Days)||4
180677|NCT01427972|441201|P4|COMPLETED|Washout (at Least 28 Days)||3
180678|NCT01427972|441202|P3|COMPLETED|Washout (at Least 28 Days)||4
180679|NCT01427972|441203|P2|COMPLETED|Washout (at Least 28 Days)||4
180680|NCT01427972|441204|P1|COMPLETED|Washout (at Least 28 Days)||3
180681|NCT01427972|441193|P12|STARTED|Washout (at Least 28 Days)||4
180682|NCT01427972|441194|P11|STARTED|Washout (at Least 28 Days)||3
180683|NCT01427972|441195|P10|STARTED|Washout (at Least 28 Days)||3
180684|NCT01427972|441196|P9|STARTED|Washout (at Least 28 Days)||3
180685|NCT01427972|441197|P8|STARTED|Washout (at Least 28 Days)||4
180686|NCT01427972|441198|P7|STARTED|Washout (at Least 28 Days)||3
180687|NCT01427972|441199|P6|STARTED|Washout (at Least 28 Days)||3
180688|NCT01427972|441200|P5|STARTED|Washout (at Least 28 Days)||4
180689|NCT01427972|441201|P4|STARTED|Washout (at Least 28 Days)||3
180690|NCT01427972|441202|P3|STARTED|Washout (at Least 28 Days)||4
180691|NCT01427972|441203|P2|STARTED|Washout (at Least 28 Days)||4
180692|NCT01427972|441204|P1|STARTED|Washout (at Least 28 Days)||3
180693|NCT01427972|441193|P12|NOT COMPLETED|Treatment Period 1 (21 Days)||0
180694|NCT01427972|441194|P11|NOT COMPLETED|Treatment Period 1 (21 Days)||0
180695|NCT01427972|441195|P10|NOT COMPLETED|Treatment Period 1 (21 Days)||0
180696|NCT01427972|441196|P9|NOT COMPLETED|Treatment Period 1 (21 Days)||0
180697|NCT01427972|441197|P8|NOT COMPLETED|Treatment Period 1 (21 Days)||1
180698|NCT01427972|441198|P7|NOT COMPLETED|Treatment Period 1 (21 Days)||0
180699|NCT01427972|441199|P6|NOT COMPLETED|Treatment Period 1 (21 Days)||0
180700|NCT01427972|441200|P5|NOT COMPLETED|Treatment Period 1 (21 Days)||0
180701|NCT01427972|441201|P4|NOT COMPLETED|Treatment Period 1 (21 Days)||0
180702|NCT01427972|441202|P3|NOT COMPLETED|Treatment Period 1 (21 Days)||0
180703|NCT01427972|441203|P2|NOT COMPLETED|Treatment Period 1 (21 Days)||0
180704|NCT01427972|441204|P1|NOT COMPLETED|Treatment Period 1 (21 Days)||0
180705|NCT01427972|441193|P12|COMPLETED|Treatment Period 1 (21 Days)||4
180706|NCT01427972|441194|P11|COMPLETED|Treatment Period 1 (21 Days)||3
180707|NCT01427972|441195|P10|COMPLETED|Treatment Period 1 (21 Days)||3
180708|NCT01427972|441196|P9|COMPLETED|Treatment Period 1 (21 Days)||3
180709|NCT01427972|441197|P8|COMPLETED|Treatment Period 1 (21 Days)||4
180710|NCT01427972|441198|P7|COMPLETED|Treatment Period 1 (21 Days)||3
180711|NCT01427972|441199|P6|COMPLETED|Treatment Period 1 (21 Days)||3
180712|NCT01427972|441200|P5|COMPLETED|Treatment Period 1 (21 Days)||4
180713|NCT01427972|441201|P4|COMPLETED|Treatment Period 1 (21 Days)||3
180714|NCT01427972|441202|P3|COMPLETED|Treatment Period 1 (21 Days)||4
180715|NCT01427972|441203|P2|COMPLETED|Treatment Period 1 (21 Days)||4
180716|NCT01427972|441204|P1|COMPLETED|Treatment Period 1 (21 Days)||3
180717|NCT01427972|441193|P12|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
180718|NCT01427972|441194|P11|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
180719|NCT01427972|441195|P10|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
180720|NCT01427972|441196|P9|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
180721|NCT01427972|441197|P8|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||5
180722|NCT01427972|441198|P7|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
180723|NCT01427972|441199|P6|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
180724|NCT01427972|441200|P5|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
180725|NCT01427972|441201|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
180726|NCT01427972|441202|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
180727|NCT01427972|441203|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
180728|NCT01427972|441204|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
180729|NCT01427972|441193|P12|STARTED|Treatment Period 1 (21 Days)||4
180730|NCT01427972|441194|P11|STARTED|Treatment Period 1 (21 Days)||3
180731|NCT01427972|441195|P10|STARTED|Treatment Period 1 (21 Days)||3
180732|NCT01427972|441196|P9|STARTED|Treatment Period 1 (21 Days)||3
180733|NCT01427972|441197|P8|STARTED|Treatment Period 1 (21 Days)||5
180734|NCT01427972|441198|P7|STARTED|Treatment Period 1 (21 Days)||3
180735|NCT01427972|441199|P6|STARTED|Treatment Period 1 (21 Days)||3
180736|NCT01427972|441200|P5|STARTED|Treatment Period 1 (21 Days)||4
180737|NCT01427972|441201|P4|STARTED|Treatment Period 1 (21 Days)||3
180738|NCT01427972|441202|P3|STARTED|Treatment Period 1 (21 Days)||4
180739|NCT01427972|441203|P2|STARTED|Treatment Period 1 (21 Days)||4
180740|NCT01427972|441204|P1|STARTED|Treatment Period 1 (21 Days)||3
180741|NCT01427933|441230|P2|NOT COMPLETED|Overall Study||13
180742|NCT01427933|441231|P1|NOT COMPLETED|Overall Study||8
180743|NCT01427933|441230|P2|COMPLETED|Overall Study||57
180744|NCT01427933|441231|P1|COMPLETED|Overall Study||63
180745|NCT01427933|441230|P2|Received at Least 1 Dose of Study Drug|Overall Study||65
180746|NCT01427933|441231|P1|Received at Least 1 Dose of Study Drug|Overall Study||69
180747|NCT01427933|441230|P2|STARTED|Overall Study||70
180748|NCT01427933|441231|P1|STARTED|Overall Study||71
180749|NCT01427920|441251|P2|NOT COMPLETED|Overall Study||17
180750|NCT01427920|441252|P1|NOT COMPLETED|Overall Study||9
180751|NCT01427920|441251|P2|COMPLETED|Overall Study||157
180752|NCT01427920|441252|P1|COMPLETED|Overall Study||165
180753|NCT01427920|441251|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|173
180754|NCT01427920|441252|P1|Exposed|Overall Study||174
180755|NCT01427920|441251|P2|STARTED|Overall Study||174
180756|NCT01427920|441252|P1|STARTED|Overall Study||174
180757|NCT01427907|441272|P2|NOT COMPLETED|Overall Study||4
180758|NCT01427907|441273|P1|NOT COMPLETED|Overall Study||3
180759|NCT01427907|441272|P2|COMPLETED|Overall Study|Completed study|14
180760|NCT01427907|441273|P1|COMPLETED|Overall Study|Completed study|17
180761|NCT01427907|441272|P2|STARTED|Overall Study|Randomized|18
180762|NCT01427907|441273|P1|STARTED|Overall Study|Randomized|20
180763|NCT01427881|441279|P1|NOT COMPLETED|Overall Study||0
180764|NCT01427881|441279|P1|COMPLETED|Overall Study||43
180765|NCT01427881|441279|P1|STARTED|Overall Study||43
180766|NCT01427803|441294|P2|NOT COMPLETED|Overall Study||26
180767|NCT01427803|441295|P1|NOT COMPLETED|Overall Study||63
180768|NCT01427803|441294|P2|COMPLETED|Overall Study|130 participants interviewed. Remaining subjects continued in trial to collect safety information.|226
180769|NCT01427803|441295|P1|COMPLETED|Overall Study||463
180770|NCT01427803|441294|P2|Took Product|Overall Study|Those who took at least one dose of investigational product as logged in e diary & 1 on Health Log.|237
180771|NCT01427803|441295|P1|Took Product|Overall Study|Those who took at least one dose of investigational product. Only 502 qualified for data analysis.|508
180772|NCT01427803|441294|P2|Baseline Assessment|Overall Study|only interviewed participants were assessed|130
180773|NCT01427803|441295|P1|Baseline Assessment|Overall Study||516
180774|NCT01427803|441294|P2|Purchased Product|Overall Study||252
180775|NCT01427803|441295|P1|Purchased Product|Overall Study|Only 516 participants used e-diary|525
180776|NCT01427803|441294|P2|STARTED|Overall Study||252
180777|NCT01427803|441295|P1|STARTED|Overall Study||526
180778|NCT01427751|441309|P2|NOT COMPLETED|Overall Study||14
180779|NCT01427751|441310|P1|NOT COMPLETED|Overall Study||42
180780|NCT01427751|441309|P2|COMPLETED|Overall Study||139
180781|NCT01427751|441310|P1|COMPLETED|Overall Study||112
180782|NCT01427751|441309|P2|STARTED|Overall Study||153
180783|NCT01427751|441310|P1|STARTED|Overall Study||154
180784|NCT01427738|441330|P2|NOT COMPLETED|Overall Study||21
180785|NCT01427738|441331|P1|NOT COMPLETED|Overall Study||19
180786|NCT01427738|441330|P2|COMPLETED|Overall Study||90
180787|NCT01427738|441331|P1|COMPLETED|Overall Study||91
180788|NCT01427738|441330|P2|STARTED|Overall Study||111
180789|NCT01427738|441331|P1|STARTED|Overall Study||110
180790|NCT01427608|441351|P2|NOT COMPLETED|Overall Study||38
180791|NCT01427608|441352|P1|NOT COMPLETED|Overall Study||21
180792|NCT01427608|441351|P2|COMPLETED|Overall Study||24
180793|NCT01427608|441352|P1|COMPLETED|Overall Study||43
180794|NCT01427608|441351|P2|STARTED|Overall Study||62
180795|NCT01427608|441352|P1|STARTED|Overall Study||64
180796|NCT01427517|441367|P3|NOT COMPLETED|Overall Study||0
180797|NCT01427517|441368|P2|NOT COMPLETED|Overall Study||0
180798|NCT01427517|441369|P1|NOT COMPLETED|Overall Study||0
180799|NCT01427517|441367|P3|COMPLETED|Overall Study||3
180800|NCT01427517|441368|P2|COMPLETED|Overall Study||3
180801|NCT01427517|441369|P1|COMPLETED|Overall Study||3
180802|NCT01427517|441367|P3|STARTED|Overall Study||3
180803|NCT01427517|441368|P2|STARTED|Overall Study||3
180804|NCT01427517|441369|P1|STARTED|Overall Study||3
180805|NCT01427504|441383|P6|NOT COMPLETED|Overall Study||2
180806|NCT01427504|441384|P5|NOT COMPLETED|Overall Study||1
180807|NCT01427504|441385|P4|NOT COMPLETED|Overall Study||1
180808|NCT01427504|441386|P3|NOT COMPLETED|Overall Study||1
180809|NCT01427504|441387|P2|NOT COMPLETED|Overall Study||1
180810|NCT01427504|441388|P1|NOT COMPLETED|Overall Study||0
180811|NCT01427504|441383|P6|COMPLETED|Overall Study||4
180812|NCT01427504|441384|P5|COMPLETED|Overall Study||2
180813|NCT01427504|441385|P4|COMPLETED|Overall Study||5
180814|NCT01427504|441386|P3|COMPLETED|Overall Study||3
180815|NCT01427504|441387|P2|COMPLETED|Overall Study||2
180816|NCT01427504|441388|P1|COMPLETED|Overall Study||4
180817|NCT01427504|441383|P6|Received Combination|Overall Study||6
180818|NCT01427504|441384|P5|Received Combination|Overall Study||3
180819|NCT01427504|441385|P4|Received Combination|Overall Study||6
180820|NCT01427504|441386|P3|Received Combination|Overall Study||3
180821|NCT01427504|441387|P2|Received Combination|Overall Study||3
180822|NCT01427504|441388|P1|Received Combination|Overall Study||4
180823|NCT01427504|441383|P6|Received Etravirine|Overall Study||4
180824|NCT01427504|441384|P5|Received Etravirine|Overall Study||2
180825|NCT01427504|441385|P4|Received Etravirine|Overall Study||6
180826|NCT01427504|441386|P3|Received Etravirine|Overall Study||4
180827|NCT01427504|441387|P2|Received Etravirine|Overall Study||2
180828|NCT01427504|441388|P1|Received Etravirine|Overall Study||4
180829|NCT01427504|441383|P6|Received Boceprevir|Overall Study||4
180830|NCT01427504|441384|P5|Received Boceprevir|Overall Study||2
180831|NCT01427504|441385|P4|Received Boceprevir|Overall Study||5
180832|NCT01427504|441386|P3|Received Boceprevir|Overall Study||3
180833|NCT01427504|441387|P2|Received Boceprevir|Overall Study||3
180834|NCT01427504|441388|P1|Received Boceprevir|Overall Study||4
180835|NCT01427504|441383|P6|STARTED|Overall Study||6
180836|NCT01427504|441384|P5|STARTED|Overall Study||3
180837|NCT01427504|441385|P4|STARTED|Overall Study||6
180838|NCT01427504|441386|P3|STARTED|Overall Study||4
180839|NCT01427504|441387|P2|STARTED|Overall Study||3
180840|NCT01427504|441388|P1|STARTED|Overall Study||4
180841|NCT01427309|441409|P4|NOT COMPLETED|Overall Study||376
180842|NCT01427309|441410|P3|NOT COMPLETED|Overall Study||361
180843|NCT01427309|441411|P2|NOT COMPLETED|Overall Study||407
180844|NCT01427309|441412|P1|NOT COMPLETED|Overall Study||372
180845|NCT01427309|441409|P4|COMPLETED|Overall Study||8373
180846|NCT01427309|441410|P3|COMPLETED|Overall Study||8376
180847|NCT01427309|441411|P2|COMPLETED|Overall Study||6837
180848|NCT01427309|441412|P1|COMPLETED|Overall Study||6881
180849|NCT01427309|441409|P4|STARTED|Overall Study||8749
180850|NCT01427309|441410|P3|STARTED|Overall Study||8737
180851|NCT01427309|441411|P2|STARTED|Overall Study||7244
180852|NCT01427309|441412|P1|STARTED|Overall Study||7253
180853|NCT01427296|441452|P2|NOT COMPLETED|Overall Study||0
180854|NCT01427296|441453|P1|NOT COMPLETED|Overall Study||0
180855|NCT01427296|441452|P2|COMPLETED|Overall Study||1051
180856|NCT01427296|441453|P1|COMPLETED|Overall Study||1041
180857|NCT01427296|441452|P2|STARTED|Overall Study||1051
180858|NCT01427296|441453|P1|STARTED|Overall Study||1041
180859|NCT01426958|441459|P1|NOT COMPLETED|Overall Study||2
180860|NCT01426958|441459|P1|COMPLETED|Overall Study||22
180861|NCT01426958|441459|P1|STARTED|Overall Study||24
180862|NCT01426867|441476|P3|NOT COMPLETED|Overall Study||0
180863|NCT01426867|441477|P2|NOT COMPLETED|Overall Study||0
180864|NCT01426867|441478|P1|NOT COMPLETED|Overall Study||0
180865|NCT01426867|441476|P3|COMPLETED|Overall Study||34
180866|NCT01426867|441477|P2|COMPLETED|Overall Study||34
180867|NCT01426867|441478|P1|COMPLETED|Overall Study||33
180868|NCT01426867|441476|P3|STARTED|Overall Study||34
180869|NCT01426867|441477|P2|STARTED|Overall Study||34
180870|NCT01426867|441478|P1|STARTED|Overall Study||33
180871|NCT01426854|441488|P2|NOT COMPLETED|Overall Study||31
180872|NCT01426854|441489|P1|NOT COMPLETED|Overall Study||12
180873|NCT01426854|441488|P2|COMPLETED|Overall Study||98
180874|NCT01426854|441489|P1|COMPLETED|Overall Study||119
180875|NCT01426854|441488|P2|STARTED|Overall Study||129
180876|NCT01426854|441489|P1|STARTED|Overall Study||131
180877|NCT01426789|441499|P6|NOT COMPLETED|Part 2||0
180878|NCT01426789|441500|P5|NOT COMPLETED|Part 2||8
180879|NCT01426789|441501|P4|NOT COMPLETED|Part 2||1
180880|NCT01426789|441502|P3|NOT COMPLETED|Part 2||15
180881|NCT01426789|441503|P2|NOT COMPLETED|Part 2||0
180882|NCT01426789|441504|P1|NOT COMPLETED|Part 2||0
180883|NCT01426789|441499|P6|COMPLETED|Part 2||1
180884|NCT01426789|441500|P5|COMPLETED|Part 2||19
180885|NCT01426789|441501|P4|COMPLETED|Part 2||12
180886|NCT01426789|441502|P3|COMPLETED|Part 2||34
180887|NCT01426789|441503|P2|COMPLETED|Part 2||0
180888|NCT01426789|441504|P1|COMPLETED|Part 2||0
180889|NCT01426789|441499|P6|STARTED|Part 2||1
180890|NCT01426789|441500|P5|STARTED|Part 2||27
180891|NCT01426789|441501|P4|STARTED|Part 2||13
180892|NCT01426789|441502|P3|STARTED|Part 2||49
180893|NCT01426789|441503|P2|STARTED|Part 2||0
180894|NCT01426789|441504|P1|STARTED|Part 2||0
180895|NCT01426789|441499|P6|NOT COMPLETED|Part 1||0
180896|NCT01426789|441500|P5|NOT COMPLETED|Part 1||0
180897|NCT01426789|441501|P4|NOT COMPLETED|Part 1||0
180898|NCT01426789|441502|P3|NOT COMPLETED|Part 1||0
180899|NCT01426789|441503|P2|NOT COMPLETED|Part 1||4
180900|NCT01426789|441504|P1|NOT COMPLETED|Part 1||6
180901|NCT01426789|441499|P6|COMPLETED|Part 1||0
180902|NCT01426789|441500|P5|COMPLETED|Part 1||0
180903|NCT01426789|441501|P4|COMPLETED|Part 1||0
180904|NCT01426789|441502|P3|COMPLETED|Part 1||0
180905|NCT01426789|441503|P2|COMPLETED|Part 1||28
180906|NCT01426789|441504|P1|COMPLETED|Part 1||62
180907|NCT01426789|441499|P6|STARTED|Part 1||0
180908|NCT01426789|441500|P5|STARTED|Part 1||0
180909|NCT01426789|441501|P4|STARTED|Part 1||0
180910|NCT01426789|441502|P3|STARTED|Part 1||0
180911|NCT01426789|441503|P2|STARTED|Part 1||32
180912|NCT01426789|441504|P1|STARTED|Part 1||68
180913|NCT01426763|441520|P2|NOT COMPLETED|Overall Study||0
180914|NCT01426763|441521|P1|NOT COMPLETED|Overall Study||0
180915|NCT01426763|441520|P2|COMPLETED|Overall Study||6
180916|NCT01426763|441521|P1|COMPLETED|Overall Study||6
180917|NCT01426763|441520|P2|STARTED|Overall Study||6
180918|NCT01426763|441521|P1|STARTED|Overall Study||6
180919|NCT01426581|441529|P2|NOT COMPLETED|Overall Study||0
180920|NCT01426581|441530|P1|NOT COMPLETED|Overall Study||0
180921|NCT01426581|441529|P2|COMPLETED|Overall Study||58
180922|NCT01426581|441530|P1|COMPLETED|Overall Study||62
180923|NCT01426581|441529|P2|STARTED|Overall Study||58
180924|NCT01426581|441530|P1|STARTED|Overall Study||62
180925|NCT01426555|441546|P2|NOT COMPLETED|Overall Study||15
180926|NCT01426555|441547|P1|NOT COMPLETED|Overall Study||18
180927|NCT01426555|441546|P2|COMPLETED|Overall Study||20
180928|NCT01426555|441547|P1|COMPLETED|Overall Study||17
180929|NCT01426555|441546|P2|STARTED|Overall Study||35
180930|NCT01426555|441547|P1|STARTED|Overall Study||35
180931|NCT01426516|441557|P2|NOT COMPLETED|Overall Study||0
180932|NCT01426516|441558|P1|NOT COMPLETED|Overall Study||0
180933|NCT01426516|441557|P2|COMPLETED|Overall Study||17
180934|NCT01426516|441558|P1|COMPLETED|Overall Study||12
180935|NCT01426516|441557|P2|STARTED|Overall Study||17
180936|NCT01426516|441558|P1|STARTED|Overall Study||12
180937|NCT01426438|441566|P2|NOT COMPLETED|Overall Study||10
180938|NCT01426438|441567|P1|NOT COMPLETED|Overall Study||15
180939|NCT01426438|441566|P2|COMPLETED|Overall Study||39
180940|NCT01426438|441567|P1|COMPLETED|Overall Study||35
180941|NCT01426438|441566|P2|STARTED|Overall Study||49
180942|NCT01426438|441567|P1|STARTED|Overall Study||50
180943|NCT01426425|441599|P1|NOT COMPLETED|Overall Study||175
180944|NCT01426425|441599|P1|COMPLETED|Overall Study|The pre-specified modified intent-to-treat analysis set was used for the primary objectives.|397
180945|NCT01426425|441599|P1|Intent to Treat|Overall Study|Met all inclusion and no exclusion criteria.|399
180946|NCT01426425|441599|P1|EP Study|Overall Study|EP study used to assess inclusion and exclusion criteria.|550
180947|NCT01426425|441599|P1|STARTED|Overall Study||572
180948|NCT01426412|441614|P9|NOT COMPLETED|Overall Study||1
180949|NCT01426412|441615|P8|NOT COMPLETED|Overall Study||3
180950|NCT01426412|441616|P7|NOT COMPLETED|Overall Study||0
180951|NCT01426412|441617|P6|NOT COMPLETED|Overall Study||0
180952|NCT01426412|441618|P5|NOT COMPLETED|Overall Study||1
180953|NCT01426412|441619|P4|NOT COMPLETED|Overall Study||0
180954|NCT01426412|441620|P3|NOT COMPLETED|Overall Study||0
180955|NCT01426412|441621|P2|NOT COMPLETED|Overall Study||0
180956|NCT01426412|441622|P1|NOT COMPLETED|Overall Study||1
180957|NCT01426412|441614|P9|COMPLETED|Overall Study||16
180958|NCT01426412|441615|P8|COMPLETED|Overall Study||7
180959|NCT01426412|441616|P7|COMPLETED|Overall Study||6
180960|NCT01426412|441617|P6|COMPLETED|Overall Study||6
180961|NCT01426412|441618|P5|COMPLETED|Overall Study||5
180962|NCT01426412|441619|P4|COMPLETED|Overall Study||6
180963|NCT01426412|441620|P3|COMPLETED|Overall Study||6
180964|NCT01426412|441621|P2|COMPLETED|Overall Study||6
180965|NCT01426412|441622|P1|COMPLETED|Overall Study||5
180966|NCT01426412|441614|P9|Received at Least 1 Dose of Study Drug|Overall Study||17
180967|NCT01426412|441615|P8|Received at Least 1 Dose of Study Drug|Overall Study||10
180968|NCT01426412|441616|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
180969|NCT01426412|441617|P6|Received at Least 1 Dose of Study Drug|Overall Study||6
180970|NCT01426412|441618|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
180971|NCT01426412|441619|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
180972|NCT01426412|441620|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
180973|NCT01426412|441621|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
180974|NCT01426412|441622|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
180975|NCT01426412|441614|P9|STARTED|Overall Study||17
180976|NCT01426412|441615|P8|STARTED|Overall Study||10
180977|NCT01426412|441616|P7|STARTED|Overall Study||6
180978|NCT01426412|441617|P6|STARTED|Overall Study||6
180979|NCT01426412|441618|P5|STARTED|Overall Study||6
180980|NCT01426412|441619|P4|STARTED|Overall Study||6
180981|NCT01426412|441620|P3|STARTED|Overall Study||6
180982|NCT01426412|441621|P2|STARTED|Overall Study||6
180983|NCT01426412|441622|P1|STARTED|Overall Study||6
180984|NCT01426386|441685|P6|NOT COMPLETED|Overall Study||1
180985|NCT01426386|441686|P5|NOT COMPLETED|Overall Study||4
180986|NCT01426386|441687|P4|NOT COMPLETED|Overall Study||0
180987|NCT01426386|441688|P3|NOT COMPLETED|Overall Study||2
180988|NCT01426386|441689|P2|NOT COMPLETED|Overall Study||6
180989|NCT01426386|441690|P1|NOT COMPLETED|Overall Study||3
180990|NCT01426386|441685|P6|COMPLETED|Overall Study||42
180991|NCT01426386|441686|P5|COMPLETED|Overall Study||43
180992|NCT01426386|441687|P4|COMPLETED|Overall Study||44
180993|NCT01426386|441688|P3|COMPLETED|Overall Study||42
180994|NCT01426386|441689|P2|COMPLETED|Overall Study||39
180995|NCT01426386|441690|P1|COMPLETED|Overall Study||39
180996|NCT01426386|441685|P6|STARTED|Overall Study||43
180997|NCT01426386|441686|P5|STARTED|Overall Study||47
180998|NCT01426386|441687|P4|STARTED|Overall Study||44
180999|NCT01426386|441688|P3|STARTED|Overall Study||44
181000|NCT01426386|441689|P2|STARTED|Overall Study||45
181001|NCT01426386|441690|P1|STARTED|Overall Study||42
181002|NCT01426373|441746|P1|NOT COMPLETED|Overall Study||34
181003|NCT01426373|441746|P1|COMPLETED|Overall Study|Completed the last follow-up visit 12 months after last treatment|131
181004|NCT01426373|441746|P1|STARTED|Overall Study||165
181005|NCT01426360|441764|P2|NOT COMPLETED|Overall Study||0
181006|NCT01426360|441765|P1|NOT COMPLETED|Overall Study||0
181007|NCT01426360|441764|P2|COMPLETED|Overall Study||41
181008|NCT01426360|441765|P1|COMPLETED|Overall Study||38
181009|NCT01426360|441764|P2|STARTED|Overall Study||41
181010|NCT01426360|441765|P1|STARTED|Overall Study||38
181011|NCT01426347|441779|P2|NOT COMPLETED|Overall Study||3
181012|NCT01426347|441780|P1|NOT COMPLETED|Overall Study||7
181013|NCT01426347|441779|P2|COMPLETED|Overall Study||39
181014|NCT01426347|441780|P1|COMPLETED|Overall Study||34
181015|NCT01426347|441779|P2|STARTED|Overall Study||42
181016|NCT01426347|441780|P1|STARTED|Overall Study||41
181017|NCT01426269|441788|P3|NOT COMPLETED|Period 2: 40 Weeks||47
181018|NCT01426269|441789|P2|NOT COMPLETED|Period 2: 40 Weeks||38
181019|NCT01426269|441790|P1|NOT COMPLETED|Period 2: 40 Weeks||0
181020|NCT01426269|441788|P3|COMPLETED|Period 2: 40 Weeks||18
181021|NCT01426269|441789|P2|COMPLETED|Period 2: 40 Weeks||27
181022|NCT01426269|441790|P1|COMPLETED|Period 2: 40 Weeks||0
181023|NCT01426269|441788|P3|STARTED|Period 2: 40 Weeks||65
181024|NCT01426269|441789|P2|STARTED|Period 2: 40 Weeks||65
181025|NCT01426269|441790|P1|STARTED|Period 2: 40 Weeks||0
181026|NCT01426269|441788|P3|NOT COMPLETED|Eligibility for Period 2, Randomization||0
181027|NCT01426269|441789|P2|NOT COMPLETED|Eligibility for Period 2, Randomization||0
181028|NCT01426269|441790|P1|NOT COMPLETED|Eligibility for Period 2, Randomization||50
181029|NCT01426269|441788|P3|COMPLETED|Eligibility for Period 2, Randomization||0
181030|NCT01426269|441789|P2|COMPLETED|Eligibility for Period 2, Randomization||0
181031|NCT01426269|441790|P1|COMPLETED|Eligibility for Period 2, Randomization||130
181032|NCT01426269|441788|P3|STARTED|Eligibility for Period 2, Randomization||0
181033|NCT01426269|441789|P2|STARTED|Eligibility for Period 2, Randomization||0
181034|NCT01426269|441790|P1|STARTED|Eligibility for Period 2, Randomization||180
181035|NCT01426269|441788|P3|NOT COMPLETED|Period 1: 12 Weeks||0
181036|NCT01426269|441789|P2|NOT COMPLETED|Period 1: 12 Weeks||0
181037|NCT01426269|441790|P1|NOT COMPLETED|Period 1: 12 Weeks||55
181038|NCT01426269|441788|P3|COMPLETED|Period 1: 12 Weeks||0
181039|NCT01426269|441789|P2|COMPLETED|Period 1: 12 Weeks||0
181040|NCT01426269|441790|P1|COMPLETED|Period 1: 12 Weeks||180
181041|NCT01426269|441788|P3|STARTED|Period 1: 12 Weeks||0
181042|NCT01426269|441789|P2|STARTED|Period 1: 12 Weeks||0
181043|NCT01426269|441790|P1|STARTED|Period 1: 12 Weeks||235
181044|NCT01426230|441817|P2|NOT COMPLETED|Overall Study||27
181045|NCT01426230|441818|P1|NOT COMPLETED|Overall Study||31
181046|NCT01426230|441817|P2|COMPLETED|Overall Study||84
181047|NCT01426230|441818|P1|COMPLETED|Overall Study||55
181048|NCT01426230|441817|P2|STARTED|Overall Study||111
181049|NCT01426230|441818|P1|STARTED|Overall Study|90 patients were enrolled, but only 86 received study treatment.|86
181050|NCT01426217|441825|P2|NOT COMPLETED|Overall Study||14
181051|NCT01426217|441826|P1|NOT COMPLETED|Overall Study||8
181052|NCT01426217|441825|P2|COMPLETED|Overall Study||266
181053|NCT01426217|441826|P1|COMPLETED|Overall Study||306
181054|NCT01426217|441825|P2|STARTED|Overall Study||280
181055|NCT01426217|441826|P1|STARTED|Overall Study||314
181056|NCT01426191|441832|P1|NOT COMPLETED|Overall Study||0
181057|NCT01426191|441832|P1|COMPLETED|Overall Study||2032
181058|NCT01426191|441832|P1|STARTED|Overall Study||2032
181059|NCT01426113|441839|P2|NOT COMPLETED|Overall Study||2
181060|NCT01426113|441840|P1|NOT COMPLETED|Overall Study||1
181061|NCT01426113|441839|P2|COMPLETED|Overall Study||1
181062|NCT01426113|441840|P1|COMPLETED|Overall Study||2
181063|NCT01426113|441839|P2|STARTED|Overall Study||3
181064|NCT01426113|441840|P1|STARTED|Overall Study||3
181065|NCT01426009|441846|P1|NOT COMPLETED|Washout 4||1
181066|NCT01426009|441846|P1|COMPLETED|Washout 4||126
181067|NCT01426009|441846|P1|STARTED|Washout 4||127
181068|NCT01426009|441846|P1|NOT COMPLETED|Period 4-Fourth Intervention (7 Days)||1
181069|NCT01426009|441846|P1|COMPLETED|Period 4-Fourth Intervention (7 Days)||127
181070|NCT01426009|441846|P1|Placebo|Period 4-Fourth Intervention (7 Days)||10
181071|NCT01426009|441846|P1|Tiotropium Bromide|Period 4-Fourth Intervention (7 Days)||76
181072|NCT01426009|441846|P1|Ipratropium Bromide|Period 4-Fourth Intervention (7 Days)||8
181073|NCT01426009|441846|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||9
181074|NCT01426009|441846|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||8
181075|NCT01426009|441846|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||7
181076|NCT01426009|441846|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||10
181077|NCT01426009|441846|P1|STARTED|Period 4-Fourth Intervention (7 Days)||128
181078|NCT01426009|441846|P1|NOT COMPLETED|Washout 3||1
181079|NCT01426009|441846|P1|COMPLETED|Washout 3||128
181080|NCT01426009|441846|P1|STARTED|Washout 3||129
181081|NCT01426009|441846|P1|NOT COMPLETED|Period 3-Third Intervention (7 Days)||0
181082|NCT01426009|441846|P1|COMPLETED|Period 3-Third Intervention (7 Days)||129
181083|NCT01426009|441846|P1|Placebo|Period 3-Third Intervention (7 Days)||22
181084|NCT01426009|441846|P1|Ipratropium Bromide|Period 3-Third Intervention (7 Days)||23
181085|NCT01426009|441846|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||20
181086|NCT01426009|441846|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||22
181087|NCT01426009|441846|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||23
181088|NCT01426009|441846|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||19
181089|NCT01426009|441846|P1|STARTED|Period 3-Third Intervention (7 Days)||129
181090|NCT01426009|441846|P1|NOT COMPLETED|Washout 2||1
181091|NCT01426009|441846|P1|COMPLETED|Washout 2||129
181092|NCT01426009|441846|P1|STARTED|Washout 2||130
181093|NCT01426009|441846|P1|NOT COMPLETED|Period 2-Second Intervention (7 Days)||5
181094|NCT01426009|441846|P1|COMPLETED|Period 2-Second Intervention (7 Days)||130
181095|NCT01426009|441846|P1|Placebo|Period 2-Second Intervention (7 Days)||21
181096|NCT01426009|441846|P1|Ipratropium Bromide|Period 2-Second Intervention (7 Days)||21
181097|NCT01426009|441846|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||23
181098|NCT01426009|441846|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
181099|NCT01426009|441846|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
181100|NCT01426009|441846|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||22
181101|NCT01426009|441846|P1|STARTED|Period 2-Second Intervention (7 Days)||135
181102|NCT01426009|441846|P1|NOT COMPLETED|Washout 1||2
181103|NCT01426009|441846|P1|COMPLETED|Washout 1||135
181104|NCT01426009|441846|P1|STARTED|Washout 1||137
181105|NCT01426009|441846|P1|NOT COMPLETED|Period 1-First Intervention (7 Days)||2
181106|NCT01426009|441846|P1|COMPLETED|Period 1-First Intervention (7 Days)||137
181107|NCT01426009|441846|P1|Placebo|Period 1-First Intervention (7 Days)||24
181108|NCT01426009|441846|P1|Ipratropium Bromide|Period 1-First Intervention (7 Days)||23
181109|NCT01426009|441846|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
181110|NCT01426009|441846|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||22
181111|NCT01426009|441846|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||24
181112|NCT01426009|441846|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
181113|NCT01426009|441846|P1|STARTED|Period 1-First Intervention (7 Days)||139
181114|NCT01425879|441902|P1|NOT COMPLETED|Overall Study||0
181115|NCT01425879|441902|P1|COMPLETED|Overall Study||8
181116|NCT01425879|441902|P1|STARTED|Overall Study||8
181117|NCT01425853|441911|P2|NOT COMPLETED|Overall Study||77
181118|NCT01425853|441912|P1|NOT COMPLETED|Overall Study||64
181119|NCT01425853|441911|P2|COMPLETED|Overall Study||225
181120|NCT01425853|441912|P1|COMPLETED|Overall Study||240
181121|NCT01425853|441911|P2|Per Protocol (PP)|Overall Study||258
181122|NCT01425853|441912|P1|Per Protocol (PP)|Overall Study||264
181123|NCT01425853|441911|P2|Safety Population|Overall Study||299
181124|NCT01425853|441912|P1|Safety Population|Overall Study||304
181125|NCT01425853|441911|P2|STARTED|Overall Study||302
181126|NCT01425853|441912|P1|STARTED|Overall Study||304
181127|NCT01425814|441942|P6|NOT COMPLETED|Period 5||1
181128|NCT01425814|441943|P5|NOT COMPLETED|Period 5||0
181129|NCT01425814|441944|P4|NOT COMPLETED|Period 5||0
181130|NCT01425814|441945|P3|NOT COMPLETED|Period 5||1
181131|NCT01425814|441946|P2|NOT COMPLETED|Period 5||0
181132|NCT01425814|441947|P1|NOT COMPLETED|Period 5||0
181133|NCT01425814|441942|P6|COMPLETED|Period 5||11
181134|NCT01425814|441943|P5|COMPLETED|Period 5||12
181135|NCT01425814|441944|P4|COMPLETED|Period 5||10
181136|NCT01425814|441945|P3|COMPLETED|Period 5||10
181137|NCT01425814|441946|P2|COMPLETED|Period 5||9
181138|NCT01425814|441947|P1|COMPLETED|Period 5||11
181139|NCT01425814|441942|P6|STARTED|Period 5||12
181140|NCT01425814|441943|P5|STARTED|Period 5||12
181141|NCT01425814|441944|P4|STARTED|Period 5||10
181142|NCT01425814|441945|P3|STARTED|Period 5||11
181143|NCT01425814|441946|P2|STARTED|Period 5||9
181144|NCT01425814|441947|P1|STARTED|Period 5||11
181145|NCT01425814|441942|P6|NOT COMPLETED|Period 4||0
181146|NCT01425814|441943|P5|NOT COMPLETED|Period 4||0
181147|NCT01425814|441944|P4|NOT COMPLETED|Period 4||0
181148|NCT01425814|441945|P3|NOT COMPLETED|Period 4||1
181149|NCT01425814|441946|P2|NOT COMPLETED|Period 4||0
181150|NCT01425814|441947|P1|NOT COMPLETED|Period 4||1
181151|NCT01425814|441942|P6|COMPLETED|Period 4||12
181152|NCT01425814|441943|P5|COMPLETED|Period 4||12
181153|NCT01425814|441944|P4|COMPLETED|Period 4||10
181154|NCT01425814|441945|P3|COMPLETED|Period 4||11
181155|NCT01425814|441946|P2|COMPLETED|Period 4||9
181156|NCT01425814|441947|P1|COMPLETED|Period 4||11
181157|NCT01425814|441942|P6|STARTED|Period 4||12
181158|NCT01425814|441943|P5|STARTED|Period 4||12
181159|NCT01425814|441944|P4|STARTED|Period 4||10
181160|NCT01425814|441945|P3|STARTED|Period 4||12
181161|NCT01425814|441946|P2|STARTED|Period 4||9
181162|NCT01425814|441947|P1|STARTED|Period 4||12
181163|NCT01425814|441942|P6|NOT COMPLETED|Period 3||1
181164|NCT01425814|441943|P5|NOT COMPLETED|Period 3||0
181165|NCT01425814|441944|P4|NOT COMPLETED|Period 3||0
181166|NCT01425814|441945|P3|NOT COMPLETED|Period 3||0
181167|NCT01425814|441946|P2|NOT COMPLETED|Period 3||0
181168|NCT01425814|441947|P1|NOT COMPLETED|Period 3||0
181169|NCT01425814|441942|P6|COMPLETED|Period 3||12
181170|NCT01425814|441943|P5|COMPLETED|Period 3||12
181171|NCT01425814|441944|P4|COMPLETED|Period 3||10
181172|NCT01425814|441945|P3|COMPLETED|Period 3||12
181173|NCT01425814|441946|P2|COMPLETED|Period 3||9
181174|NCT01425814|441947|P1|COMPLETED|Period 3||12
181175|NCT01425814|441942|P6|STARTED|Period 3||13
181176|NCT01425814|441943|P5|STARTED|Period 3||12
181177|NCT01425814|441944|P4|STARTED|Period 3||10
181178|NCT01425814|441945|P3|STARTED|Period 3||12
181179|NCT01425814|441946|P2|STARTED|Period 3||9
181180|NCT01425814|441947|P1|STARTED|Period 3||12
181181|NCT01425814|441942|P6|NOT COMPLETED|Period 2||0
181182|NCT01425814|441943|P5|NOT COMPLETED|Period 2||0
181183|NCT01425814|441944|P4|NOT COMPLETED|Period 2||0
181184|NCT01425814|441945|P3|NOT COMPLETED|Period 2||0
181185|NCT01425814|441946|P2|NOT COMPLETED|Period 2||1
181186|NCT01425814|441947|P1|NOT COMPLETED|Period 2||0
181187|NCT01425814|441942|P6|COMPLETED|Period 2||13
181188|NCT01425814|441943|P5|COMPLETED|Period 2||12
181189|NCT01425814|441944|P4|COMPLETED|Period 2||10
181190|NCT01425814|441945|P3|COMPLETED|Period 2||12
181191|NCT01425814|441946|P2|COMPLETED|Period 2||9
181192|NCT01425814|441947|P1|COMPLETED|Period 2||12
181193|NCT01425814|441942|P6|STARTED|Period 2||13
181194|NCT01425814|441943|P5|STARTED|Period 2||12
181195|NCT01425814|441944|P4|STARTED|Period 2||10
181196|NCT01425814|441945|P3|STARTED|Period 2||12
181197|NCT01425814|441946|P2|STARTED|Period 2||10
181198|NCT01425814|441947|P1|STARTED|Period 2||12
181199|NCT01425814|441942|P6|NOT COMPLETED|Period 1||0
181200|NCT01425814|441943|P5|NOT COMPLETED|Period 1||0
181201|NCT01425814|441944|P4|NOT COMPLETED|Period 1||0
181202|NCT01425814|441945|P3|NOT COMPLETED|Period 1||0
181203|NCT01425814|441946|P2|NOT COMPLETED|Period 1||1
181204|NCT01425814|441947|P1|NOT COMPLETED|Period 1||0
181205|NCT01425814|441942|P6|COMPLETED|Period 1||13
181206|NCT01425814|441943|P5|COMPLETED|Period 1||12
181207|NCT01425814|441944|P4|COMPLETED|Period 1||10
181208|NCT01425814|441945|P3|COMPLETED|Period 1||12
181209|NCT01425814|441946|P2|COMPLETED|Period 1||10
181210|NCT01425814|441947|P1|COMPLETED|Period 1||12
181211|NCT01425814|441942|P6|STARTED|Period 1||13
181212|NCT01425814|441943|P5|STARTED|Period 1||12
181213|NCT01425814|441944|P4|STARTED|Period 1||10
181214|NCT01425814|441945|P3|STARTED|Period 1||12
181215|NCT01425814|441946|P2|STARTED|Period 1||11
181216|NCT01425814|441947|P1|STARTED|Period 1||12
181217|NCT01425801|442039|P6|NOT COMPLETED|Period 6||0
181218|NCT01425801|442040|P5|NOT COMPLETED|Period 6||0
181219|NCT01425801|442041|P4|NOT COMPLETED|Period 6||0
181220|NCT01425801|442042|P3|NOT COMPLETED|Period 6||0
181221|NCT01425801|442043|P2|NOT COMPLETED|Period 6||0
181222|NCT01425801|442044|P1|NOT COMPLETED|Period 6||0
181223|NCT01425801|442039|P6|COMPLETED|Period 6||10
181224|NCT01425801|442040|P5|COMPLETED|Period 6||11
181225|NCT01425801|442041|P4|COMPLETED|Period 6||12
181226|NCT01425801|442042|P3|COMPLETED|Period 6||7
181227|NCT01425801|442043|P2|COMPLETED|Period 6||9
181228|NCT01425801|442044|P1|COMPLETED|Period 6||9
181229|NCT01425801|442039|P6|STARTED|Period 6||10
181230|NCT01425801|442040|P5|STARTED|Period 6||11
181231|NCT01425801|442041|P4|STARTED|Period 6||12
181232|NCT01425801|442042|P3|STARTED|Period 6||7
181233|NCT01425801|442043|P2|STARTED|Period 6||9
181234|NCT01425801|442044|P1|STARTED|Period 6||9
181235|NCT01425801|442039|P6|NOT COMPLETED|Period 5||0
181236|NCT01425801|442040|P5|NOT COMPLETED|Period 5||0
181237|NCT01425801|442041|P4|NOT COMPLETED|Period 5||0
181238|NCT01425801|442042|P3|NOT COMPLETED|Period 5||0
181239|NCT01425801|442043|P2|NOT COMPLETED|Period 5||0
181240|NCT01425801|442044|P1|NOT COMPLETED|Period 5||0
181241|NCT01425801|442039|P6|COMPLETED|Period 5||10
181242|NCT01425801|442040|P5|COMPLETED|Period 5||11
181243|NCT01425801|442041|P4|COMPLETED|Period 5||12
181244|NCT01425801|442042|P3|COMPLETED|Period 5||7
181245|NCT01425801|442043|P2|COMPLETED|Period 5||9
181246|NCT01425801|442044|P1|COMPLETED|Period 5||9
181247|NCT01425801|442039|P6|STARTED|Period 5||10
181248|NCT01425801|442040|P5|STARTED|Period 5||11
181249|NCT01425801|442041|P4|STARTED|Period 5||12
181250|NCT01425801|442042|P3|STARTED|Period 5||7
181251|NCT01425801|442043|P2|STARTED|Period 5||9
181252|NCT01425801|442044|P1|STARTED|Period 5||9
181253|NCT01425801|442039|P6|NOT COMPLETED|Period 4||0
181254|NCT01425801|442040|P5|NOT COMPLETED|Period 4||0
181255|NCT01425801|442041|P4|NOT COMPLETED|Period 4||0
181256|NCT01425801|442042|P3|NOT COMPLETED|Period 4||1
181257|NCT01425801|442043|P2|NOT COMPLETED|Period 4||0
181258|NCT01425801|442044|P1|NOT COMPLETED|Period 4||0
181259|NCT01425801|442039|P6|COMPLETED|Period 4||10
181260|NCT01425801|442040|P5|COMPLETED|Period 4||11
181261|NCT01425801|442041|P4|COMPLETED|Period 4||12
181262|NCT01425801|442042|P3|COMPLETED|Period 4||7
181263|NCT01425801|442043|P2|COMPLETED|Period 4||9
181264|NCT01425801|442044|P1|COMPLETED|Period 4||9
181265|NCT01425801|442039|P6|STARTED|Period 4||10
181266|NCT01425801|442040|P5|STARTED|Period 4||11
181267|NCT01425801|442041|P4|STARTED|Period 4||12
181268|NCT01425801|442042|P3|STARTED|Period 4||8
181269|NCT01425801|442043|P2|STARTED|Period 4||9
181270|NCT01425801|442044|P1|STARTED|Period 4||9
181271|NCT01425801|442039|P6|NOT COMPLETED|Period 3||0
181272|NCT01425801|442040|P5|NOT COMPLETED|Period 3||0
181273|NCT01425801|442041|P4|NOT COMPLETED|Period 3||0
181274|NCT01425801|442042|P3|NOT COMPLETED|Period 3||1
181275|NCT01425801|442043|P2|NOT COMPLETED|Period 3||0
181276|NCT01425801|442044|P1|NOT COMPLETED|Period 3||0
181277|NCT01425801|442039|P6|COMPLETED|Period 3||10
181278|NCT01425801|442040|P5|COMPLETED|Period 3||11
181279|NCT01425801|442041|P4|COMPLETED|Period 3||12
181280|NCT01425801|442042|P3|COMPLETED|Period 3||8
181281|NCT01425801|442043|P2|COMPLETED|Period 3||9
181282|NCT01425801|442044|P1|COMPLETED|Period 3||9
181283|NCT01425801|442039|P6|STARTED|Period 3||10
181284|NCT01425801|442040|P5|STARTED|Period 3||11
181285|NCT01425801|442041|P4|STARTED|Period 3||12
181286|NCT01425801|442042|P3|STARTED|Period 3||9
181287|NCT01425801|442043|P2|STARTED|Period 3||9
181288|NCT01425801|442044|P1|STARTED|Period 3||9
181289|NCT01425801|442039|P6|NOT COMPLETED|Period 2||0
181290|NCT01425801|442040|P5|NOT COMPLETED|Period 2||1
181291|NCT01425801|442041|P4|NOT COMPLETED|Period 2||0
181292|NCT01425801|442042|P3|NOT COMPLETED|Period 2||0
181293|NCT01425801|442043|P2|NOT COMPLETED|Period 2||0
181294|NCT01425801|442044|P1|NOT COMPLETED|Period 2||0
181295|NCT01425801|442039|P6|COMPLETED|Period 2||10
181296|NCT01425801|442040|P5|COMPLETED|Period 2||11
181297|NCT01425801|442041|P4|COMPLETED|Period 2||12
181298|NCT01425801|442042|P3|COMPLETED|Period 2||9
181299|NCT01425801|442043|P2|COMPLETED|Period 2||9
181300|NCT01425801|442044|P1|COMPLETED|Period 2||9
181301|NCT01425801|442039|P6|STARTED|Period 2||10
181302|NCT01425801|442040|P5|STARTED|Period 2||12
181303|NCT01425801|442041|P4|STARTED|Period 2||12
181304|NCT01425801|442042|P3|STARTED|Period 2||9
181305|NCT01425801|442043|P2|STARTED|Period 2||9
181306|NCT01425801|442044|P1|STARTED|Period 2||9
181307|NCT01425801|442039|P6|NOT COMPLETED|Period 1||0
181308|NCT01425801|442040|P5|NOT COMPLETED|Period 1||1
181309|NCT01425801|442041|P4|NOT COMPLETED|Period 1||0
181310|NCT01425801|442042|P3|NOT COMPLETED|Period 1||0
181311|NCT01425801|442043|P2|NOT COMPLETED|Period 1||0
181312|NCT01425801|442044|P1|NOT COMPLETED|Period 1||0
181313|NCT01425801|442039|P6|COMPLETED|Period 1||10
181314|NCT01425801|442040|P5|COMPLETED|Period 1||12
181315|NCT01425801|442041|P4|COMPLETED|Period 1||12
181316|NCT01425801|442042|P3|COMPLETED|Period 1||9
181317|NCT01425801|442043|P2|COMPLETED|Period 1||9
181318|NCT01425801|442044|P1|COMPLETED|Period 1||9
181319|NCT01425801|442039|P6|STARTED|Period 1||10
181320|NCT01425801|442040|P5|STARTED|Period 1||13
181321|NCT01425801|442041|P4|STARTED|Period 1||12
181322|NCT01425801|442042|P3|STARTED|Period 1||9
181323|NCT01425801|442043|P2|STARTED|Period 1||9
181324|NCT01425801|442044|P1|STARTED|Period 1||9
181325|NCT01425749|442150|P2|NOT COMPLETED|Overall Study||1
181326|NCT01425749|442151|P1|NOT COMPLETED|Overall Study||0
181327|NCT01425749|442150|P2|COMPLETED|Overall Study||11
181328|NCT01425749|442151|P1|COMPLETED|Overall Study||13
181329|NCT01425749|442150|P2|STARTED|Overall Study||12
181330|NCT01425749|442151|P1|STARTED|Overall Study||13
181331|NCT01425723|442168|P2|NOT COMPLETED|Overall Study||18
181332|NCT01425723|442169|P1|NOT COMPLETED|Overall Study||4
181333|NCT01425723|442168|P2|COMPLETED|Overall Study||75
181334|NCT01425723|442169|P1|COMPLETED|Overall Study||23
181335|NCT01425723|442168|P2|Surgery Subgroup|Overall Study||15
181336|NCT01425723|442169|P1|Surgery Subgroup|Overall Study||1
181337|NCT01425723|442168|P2|Episodic|Overall Study||15
181338|NCT01425723|442169|P1|Episodic|Overall Study||0
181339|NCT01425723|442168|P2|Personalized Prophylaxis|Overall Study||17
181340|NCT01425723|442169|P1|Personalized Prophylaxis|Overall Study||2
181341|NCT01425723|442168|P2|Individualized Prophylaxis|Overall Study||31
181342|NCT01425723|442169|P1|Individualized Prophylaxis|Overall Study||5
181343|NCT01425723|442168|P2|Weekly Prophylaxis|Overall Study||51
181344|NCT01425723|442169|P1|Weekly Prophylaxis|Overall Study||23
181345|NCT01425723|442168|P2|STARTED|Overall Study||93
181346|NCT01425723|442169|P1|STARTED|Overall Study|13 participants in <6 Years Old Age Cohort and 14 participants in 6 to <12 Years Old Age Cohort.|27
181347|NCT01425632|442199|P3|NOT COMPLETED|Overall Study||4
181348|NCT01425632|442200|P2|NOT COMPLETED|Overall Study||1
181349|NCT01425632|442201|P1|NOT COMPLETED|Overall Study||1
181350|NCT01425632|442199|P3|COMPLETED|Overall Study||159
181351|NCT01425632|442200|P2|COMPLETED|Overall Study||165
181352|NCT01425632|442201|P1|COMPLETED|Overall Study||160
181353|NCT01425632|442199|P3|STARTED|Overall Study||163
181354|NCT01425632|442200|P2|STARTED|Overall Study||166
181355|NCT01425632|442201|P1|STARTED|Overall Study||161
181356|NCT01425528|442211|P2|NOT COMPLETED|Overall Study||1
181357|NCT01425528|442212|P1|NOT COMPLETED|Overall Study||1
181358|NCT01425528|442211|P2|COMPLETED|Overall Study||5
181359|NCT01425528|442212|P1|COMPLETED|Overall Study||5
181360|NCT01425528|442211|P2|STARTED|Overall Study||6
181361|NCT01425528|442212|P1|STARTED|Overall Study||6
181362|NCT01425463|442220|P2|NOT COMPLETED|Overall Study||24
181363|NCT01425463|442221|P1|NOT COMPLETED|Overall Study||24
181364|NCT01425463|442220|P2|COMPLETED|Overall Study||102
181365|NCT01425463|442221|P1|COMPLETED|Overall Study||106
181366|NCT01425463|442220|P2|Full Analysis Set|Overall Study||116
181367|NCT01425463|442221|P1|Full Analysis Set|Overall Study||122
181368|NCT01425463|442220|P2|Safety Set|Overall Study||122
181369|NCT01425463|442221|P1|Safety Set|Overall Study||126
181370|NCT01425463|442220|P2|STARTED|Overall Study||126
181371|NCT01425463|442221|P1|STARTED|Overall Study||130
181372|NCT01425359|442237|P2|NOT COMPLETED|Overall Study||22
181373|NCT01425359|442238|P1|NOT COMPLETED|Overall Study||19
181374|NCT01425359|442237|P2|COMPLETED|Overall Study||451
181375|NCT01425359|442238|P1|COMPLETED|Overall Study||457
181376|NCT01425359|442237|P2|STARTED|Overall Study||473
181377|NCT01425359|442238|P1|STARTED|Overall Study||476
181378|NCT01425307|442256|P2|NOT COMPLETED|Overall Study||19
181379|NCT01425307|442257|P1|NOT COMPLETED|Overall Study||19
181380|NCT01425307|442256|P2|COMPLETED|Overall Study|Treatment Phase: 41; 6-Month Follow-up:59|41
181381|NCT01425307|442257|P1|COMPLETED|Overall Study|Treatment Phase: 42; 6-Month Follow up: 58|42
181382|NCT01425307|442256|P2|STARTED|Overall Study|Randomized Sample: 60; Intention-to Treat Sample:60|60
181383|NCT01425307|442257|P1|STARTED|Overall Study|Randomized Sample: 61; Intention-to Treat Sample:61|61
181384|NCT01425281|442269|P2|NOT COMPLETED|At 5-year Clinical Follow-up||11
181385|NCT01425281|442270|P1|NOT COMPLETED|At 5-year Clinical Follow-up||32
181386|NCT01425281|442269|P2|COMPLETED|At 5-year Clinical Follow-up||125
181387|NCT01425281|442270|P1|COMPLETED|At 5-year Clinical Follow-up||256
181388|NCT01425281|442269|P2|STARTED|At 5-year Clinical Follow-up||136
181389|NCT01425281|442270|P1|STARTED|At 5-year Clinical Follow-up||288
181390|NCT01425281|442269|P2|NOT COMPLETED|At 4-year Clinical Follow-up||21
181391|NCT01425281|442270|P1|NOT COMPLETED|At 4-year Clinical Follow-up||30
181392|NCT01425281|442269|P2|COMPLETED|At 4-year Clinical Follow-up||136
181393|NCT01425281|442270|P1|COMPLETED|At 4-year Clinical Follow-up||288
181394|NCT01425281|442269|P2|STARTED|At 4-year Clinical Follow-up||157
181395|NCT01425281|442270|P1|STARTED|At 4-year Clinical Follow-up||318
181396|NCT01425281|442269|P2|NOT COMPLETED|At 3-year Clinical Follow-up||6
181397|NCT01425281|442270|P1|NOT COMPLETED|At 3-year Clinical Follow-up||5
181398|NCT01425281|442269|P2|COMPLETED|At 3-year Clinical Follow-up||157
181399|NCT01425281|442270|P1|COMPLETED|At 3-year Clinical Follow-up||318
181400|NCT01425281|442269|P2|STARTED|At 3-year Clinical Follow-up||163
181401|NCT01425281|442270|P1|STARTED|At 3-year Clinical Follow-up||323
181402|NCT01425281|442269|P2|NOT COMPLETED|At 2-year Clinical Follow-up||1
181403|NCT01425281|442270|P1|NOT COMPLETED|At 2-year Clinical Follow-up||6
181404|NCT01425281|442269|P2|COMPLETED|At 2-year Clinical Follow-up||163
181405|NCT01425281|442270|P1|COMPLETED|At 2-year Clinical Follow-up||323
181406|NCT01425281|442269|P2|STARTED|At 2-year Clinical Follow-up||164
181407|NCT01425281|442270|P1|STARTED|At 2-year Clinical Follow-up||329
181408|NCT01425281|442269|P2|NOT COMPLETED|At 1-year Clinical Follow-up||1
181409|NCT01425281|442270|P1|NOT COMPLETED|At 1-year Clinical Follow-up||2
181410|NCT01425281|442269|P2|COMPLETED|At 1-year Clinical Follow-up||164
181411|NCT01425281|442270|P1|COMPLETED|At 1-year Clinical Follow-up||329
181412|NCT01425281|442269|P2|STARTED|At 1-year Clinical Follow-up||165
181413|NCT01425281|442270|P1|STARTED|At 1-year Clinical Follow-up||331
181414|NCT01425281|442269|P2|NOT COMPLETED|At 180-day Clinical Follow-up||1
181415|NCT01425281|442270|P1|NOT COMPLETED|At 180-day Clinical Follow-up||3
181416|NCT01425281|442269|P2|COMPLETED|At 180-day Clinical Follow-up||165
181417|NCT01425281|442270|P1|COMPLETED|At 180-day Clinical Follow-up||331
181418|NCT01425281|442269|P2|STARTED|At 180-day Clinical Follow-up||166
181419|NCT01425281|442270|P1|STARTED|At 180-day Clinical Follow-up||334
181420|NCT01425281|442269|P2|NOT COMPLETED|At 30-day Clinical Follow-up||0
181421|NCT01425281|442270|P1|NOT COMPLETED|At 30-day Clinical Follow-up||1
181422|NCT01425281|442269|P2|COMPLETED|At 30-day Clinical Follow-up||166
181423|NCT01425281|442270|P1|COMPLETED|At 30-day Clinical Follow-up||334
181424|NCT01425281|442269|P2|STARTED|At 30-day Clinical Follow-up|Intent-to-Treat (ITT) Population|166
181425|NCT01425281|442270|P1|STARTED|At 30-day Clinical Follow-up|Intent-to-Treat (ITT) Population|335
181426|NCT01425268|442488|P2|NOT COMPLETED|Overall Study||0
181427|NCT01425268|442489|P1|NOT COMPLETED|Overall Study||8
181428|NCT01425268|442488|P2|COMPLETED|Overall Study||52
181429|NCT01425268|442489|P1|COMPLETED|Overall Study||98
181430|NCT01425268|442488|P2|STARTED|Overall Study|52 Subjects Randomized to Saline Arm / 52 Subjects Treated (Implanted)|52
181431|NCT01425268|442489|P1|STARTED|Overall Study|106 Subjects Randomized to AeroForm Arm / 98 Subjects Treated (Implanted)|106
181432|NCT01425229|442497|P1|NOT COMPLETED|Bosentan During Clarithromycin||0
181433|NCT01425229|442497|P1|COMPLETED|Bosentan During Clarithromycin||16
181434|NCT01425229|442497|P1|STARTED|Bosentan During Clarithromycin||16
181435|NCT01425229|442497|P1|NOT COMPLETED|Bosentan Steady-state||0
181436|NCT01425229|442497|P1|COMPLETED|Bosentan Steady-state||16
181437|NCT01425229|442497|P1|STARTED|Bosentan Steady-state||16
181438|NCT01425229|442497|P1|NOT COMPLETED|Bosentan Single Dose||0
181439|NCT01425229|442497|P1|COMPLETED|Bosentan Single Dose||16
181440|NCT01425229|442497|P1|STARTED|Bosentan Single Dose||16
181441|NCT01425203|442510|P3|NOT COMPLETED|Follow-up Phase||0
181442|NCT01425203|442511|P2|NOT COMPLETED|Follow-up Phase||0
181443|NCT01425203|442512|P1|NOT COMPLETED|Follow-up Phase||0
181444|NCT01425203|442510|P3|COMPLETED|Follow-up Phase||27
181445|NCT01425203|442511|P2|COMPLETED|Follow-up Phase||49
181446|NCT01425203|442512|P1|COMPLETED|Follow-up Phase||153
181447|NCT01425203|442510|P3|STARTED|Follow-up Phase|All participants treated in crossover arm entered follow-up.|27
181448|NCT01425203|442511|P2|STARTED|Follow-up Phase|27 starting treatment in PBO+PR Control arm switched to Crossover arm and 2 did not enter follow-up|49
181449|NCT01425203|442512|P1|STARTED|Follow-up Phase|6 participants who started treatment in RGT BOC + PR arm did not enter follow-up.|153
181450|NCT01425203|442510|P3|NOT COMPLETED|Crossover Phase||6
181451|NCT01425203|442511|P2|NOT COMPLETED|Crossover Phase||0
181452|NCT01425203|442512|P1|NOT COMPLETED|Crossover Phase||0
181453|NCT01425203|442510|P3|COMPLETED|Crossover Phase||21
181454|NCT01425203|442511|P2|COMPLETED|Crossover Phase||0
181455|NCT01425203|442512|P1|COMPLETED|Crossover Phase||0
181456|NCT01425203|442510|P3|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|27
181457|NCT01425203|442511|P2|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
181458|NCT01425203|442512|P1|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
181459|NCT01425203|442510|P3|NOT COMPLETED|Treatment Phase||0
181460|NCT01425203|442511|P2|NOT COMPLETED|Treatment Phase||37
181461|NCT01425203|442512|P1|NOT COMPLETED|Treatment Phase||27
181462|NCT01425203|442510|P3|COMPLETED|Treatment Phase||0
181463|NCT01425203|442511|P2|COMPLETED|Treatment Phase||42
181464|NCT01425203|442512|P1|COMPLETED|Treatment Phase||132
181465|NCT01425203|442510|P3|Treated (FAS)|Treatment Phase||0
181466|NCT01425203|442511|P2|Treated (FAS)|Treatment Phase||78
181467|NCT01425203|442512|P1|Treated (FAS)|Treatment Phase||159
181468|NCT01425203|442510|P3|STARTED|Treatment Phase||0
181469|NCT01425203|442511|P2|STARTED|Treatment Phase||79
181470|NCT01425203|442512|P1|STARTED|Treatment Phase||159
181471|NCT01425190|442529|P3|NOT COMPLETED|Overall Study||0
181472|NCT01425190|442530|P2|NOT COMPLETED|Overall Study||0
181473|NCT01425190|442531|P1|NOT COMPLETED|Overall Study||1
181474|NCT01425190|442529|P3|COMPLETED|Overall Study||0
181475|NCT01425190|442530|P2|COMPLETED|Overall Study||0
181476|NCT01425190|442531|P1|COMPLETED|Overall Study||15
181477|NCT01425190|442529|P3|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 3.|0
181478|NCT01425190|442530|P2|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 2.|0
181479|NCT01425190|442531|P1|STARTED|Overall Study||16
181480|NCT01424943|442550|P2|NOT COMPLETED|Overall Study||1
181481|NCT01424943|442551|P1|NOT COMPLETED|Overall Study||13
181482|NCT01424943|442550|P2|COMPLETED|Overall Study||23
181483|NCT01424943|442551|P1|COMPLETED|Overall Study||12
181484|NCT01424943|442550|P2|STARTED|Overall Study||24
181485|NCT01424943|442551|P1|STARTED|Overall Study||25
181486|NCT01424930|442567|P2|NOT COMPLETED|Overall Study||14
181487|NCT01424930|442568|P1|NOT COMPLETED|Overall Study||4
181488|NCT01424930|442567|P2|COMPLETED|Overall Study||4
181489|NCT01424930|442568|P1|COMPLETED|Overall Study||3
181490|NCT01424930|442567|P2|Completed Food Safety Evaluation|Overall Study||18
181491|NCT01424930|442568|P1|Completed Food Safety Evaluation|Overall Study||6
181492|NCT01424930|442567|P2|STARTED|Overall Study||18
181493|NCT01424930|442568|P1|STARTED|Overall Study||7
181494|NCT01424813|442582|P2|NOT COMPLETED|Overall Study||2
181495|NCT01424813|442583|P1|NOT COMPLETED|Overall Study||5
181496|NCT01424813|442582|P2|COMPLETED|Overall Study||77
181497|NCT01424813|442583|P1|COMPLETED|Overall Study||74
181498|NCT01424813|442582|P2|Treated|Overall Study|Safety set and full analysis set|78
181499|NCT01424813|442583|P1|Treated|Overall Study|Safety set and full analysis set|79
181500|NCT01424813|442582|P2|STARTED|Overall Study||79
181501|NCT01424813|442583|P1|STARTED|Overall Study||79
181502|NCT01424670|442603|P2|NOT COMPLETED|Continuation Period||14
181503|NCT01424670|442604|P1|NOT COMPLETED|Continuation Period||34
181504|NCT01424670|442603|P2|COMPLETED|Continuation Period||142
181505|NCT01424670|442604|P1|COMPLETED|Continuation Period||288
181506|NCT01424670|442603|P2|STARTED|Continuation Period||156
181507|NCT01424670|442604|P1|STARTED|Continuation Period||322
181508|NCT01424670|442603|P2|NOT COMPLETED|6-Month Intensive Period (182 Days)||14
181509|NCT01424670|442604|P1|NOT COMPLETED|6-Month Intensive Period (182 Days)||19
181510|NCT01424670|442603|P2|COMPLETED|6-Month Intensive Period (182 Days)||156
181511|NCT01424670|442604|P1|COMPLETED|6-Month Intensive Period (182 Days)||322
181512|NCT01424670|442603|P2|Received at Least 1 Dose of Study Drug|6-Month Intensive Period (182 Days)||170
181513|NCT01424670|442604|P1|Received at Least 1 Dose of Study Drug|6-Month Intensive Period (182 Days)||341
181514|NCT01424670|442603|P2|STARTED|6-Month Intensive Period (182 Days)||170
181515|NCT01424670|442604|P1|STARTED|6-Month Intensive Period (182 Days)||341
181516|NCT01424644|442626|P2|NOT COMPLETED|Overall Study||27
181517|NCT01424644|442627|P1|NOT COMPLETED|Overall Study||33
181518|NCT01424644|442626|P2|COMPLETED|Overall Study||372
181519|NCT01424644|442627|P1|COMPLETED|Overall Study||369
181520|NCT01424644|442626|P2|STARTED|Overall Study||399
181521|NCT01424644|442627|P1|STARTED|Overall Study||402
181522|NCT01424566|442641|P3|NOT COMPLETED|Double-blind Treatment||15
181523|NCT01424566|442642|P2|NOT COMPLETED|Double-blind Treatment||25
181524|NCT01424566|442643|P1|NOT COMPLETED|Double-blind Treatment||0
181525|NCT01424566|442641|P3|COMPLETED|Double-blind Treatment||88
181526|NCT01424566|442642|P2|COMPLETED|Double-blind Treatment||78
181527|NCT01424566|442643|P1|COMPLETED|Double-blind Treatment||0
181528|NCT01424566|442641|P3|ITT Population|Double-blind Treatment||103
181529|NCT01424566|442642|P2|ITT Population|Double-blind Treatment||103
181530|NCT01424566|442643|P1|ITT Population|Double-blind Treatment||0
181531|NCT01424566|442641|P3|Randomized Safety Population|Double-blind Treatment||103
181532|NCT01424566|442642|P2|Randomized Safety Population|Double-blind Treatment||103
181533|NCT01424566|442643|P1|Randomized Safety Population|Double-blind Treatment||0
181534|NCT01424566|442641|P3|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
181535|NCT01424566|442642|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
181536|NCT01424566|442643|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment||0
181537|NCT01424566|442641|P3|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
181538|NCT01424566|442642|P2|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
181539|NCT01424566|442643|P1|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the double-blind period.|0
181540|NCT01424566|442641|P3|NOT COMPLETED|Single-blind Treatment||0
181541|NCT01424566|442642|P2|NOT COMPLETED|Single-blind Treatment||0
181542|NCT01424566|442643|P1|NOT COMPLETED|Single-blind Treatment||200
181543|NCT01424566|442641|P3|COMPLETED|Single-blind Treatment||0
181544|NCT01424566|442642|P2|COMPLETED|Single-blind Treatment||0
181545|NCT01424566|442643|P1|COMPLETED|Single-blind Treatment||206
181546|NCT01424566|442641|P3|Met Randomization Criteria|Single-blind Treatment||0
181547|NCT01424566|442642|P2|Met Randomization Criteria|Single-blind Treatment||0
181548|NCT01424566|442643|P1|Met Randomization Criteria|Single-blind Treatment||206
181549|NCT01424566|442641|P3|Single-blind Safety Population|Single-blind Treatment||0
181550|NCT01424566|442642|P2|Single-blind Safety Population|Single-blind Treatment||0
181551|NCT01424566|442643|P1|Single-blind Safety Population|Single-blind Treatment||404
181552|NCT01424566|442641|P3|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
181553|NCT01424566|442642|P2|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
181554|NCT01424566|442643|P1|Received at Least 1 Dose of Study Drug|Single-blind Treatment|Two participants did not administer any study drug.|404
181555|NCT01424566|442641|P3|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
181556|NCT01424566|442642|P2|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
181557|NCT01424566|442643|P1|STARTED|Single-blind Treatment||406
181558|NCT01424514|442670|P2|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||0
181559|NCT01424514|442671|P1|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||1
181560|NCT01424514|442670|P2|COMPLETED|Period 3:Intervention Period 2 (14 Days)||19
181561|NCT01424514|442671|P1|COMPLETED|Period 3:Intervention Period 2 (14 Days)||18
181562|NCT01424514|442670|P2|STARTED|Period 3:Intervention Period 2 (14 Days)||19
181563|NCT01424514|442671|P1|STARTED|Period 3:Intervention Period 2 (14 Days)||19
181564|NCT01424514|442670|P2|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
181565|NCT01424514|442671|P1|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
181566|NCT01424514|442670|P2|COMPLETED|Period 2:Washout Period (4 Weeks)||19
181567|NCT01424514|442671|P1|COMPLETED|Period 2:Washout Period (4 Weeks)||19
181568|NCT01424514|442670|P2|STARTED|Period 2:Washout Period (4 Weeks)||19
181569|NCT01424514|442671|P1|STARTED|Period 2:Washout Period (4 Weeks)||19
181570|NCT01424514|442670|P2|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
181571|NCT01424514|442671|P1|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
181572|NCT01424514|442670|P2|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
181573|NCT01424514|442671|P1|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
181574|NCT01424514|442670|P2|STARTED|Period 1:Intervention Period 1 (14 Days)||20
181575|NCT01424514|442671|P1|STARTED|Period 1:Intervention Period 1 (14 Days)||20
181576|NCT01424501|442716|P6|NOT COMPLETED|Overall Study||0
181577|NCT01424501|442717|P5|NOT COMPLETED|Overall Study||0
181578|NCT01424501|442718|P4|NOT COMPLETED|Overall Study||0
181579|NCT01424501|442719|P3|NOT COMPLETED|Overall Study||2
181580|NCT01424501|442720|P2|NOT COMPLETED|Overall Study||1
181581|NCT01424501|442721|P1|NOT COMPLETED|Overall Study||1
181582|NCT01424501|442716|P6|COMPLETED|Overall Study||40
181583|NCT01424501|442717|P5|COMPLETED|Overall Study||40
181584|NCT01424501|442718|P4|COMPLETED|Overall Study||25
181585|NCT01424501|442719|P3|COMPLETED|Overall Study||22
181586|NCT01424501|442720|P2|COMPLETED|Overall Study||5
181587|NCT01424501|442721|P1|COMPLETED|Overall Study||6
181588|NCT01424501|442716|P6|STARTED|Overall Study||40
181589|NCT01424501|442717|P5|STARTED|Overall Study||40
181590|NCT01424501|442718|P4|STARTED|Overall Study||25
181591|NCT01424501|442719|P3|STARTED|Overall Study||24
181592|NCT01424501|442720|P2|STARTED|Overall Study||6
181593|NCT01424501|442721|P1|STARTED|Overall Study||7
181594|NCT01424397|442897|P12|NOT COMPLETED|Period-3 (8 Days)||0
181595|NCT01424397|442898|P11|NOT COMPLETED|Period-3 (8 Days)||0
181596|NCT01424397|442899|P10|NOT COMPLETED|Period-3 (8 Days)||0
181597|NCT01424397|442900|P9|NOT COMPLETED|Period-3 (8 Days)||0
181598|NCT01424397|442901|P8|NOT COMPLETED|Period-3 (8 Days)||0
181599|NCT01424397|442902|P7|NOT COMPLETED|Period-3 (8 Days)||0
181600|NCT01424397|442903|P6|NOT COMPLETED|Period-3 (8 Days)||0
181601|NCT01424397|442904|P5|NOT COMPLETED|Period-3 (8 Days)||0
181602|NCT01424397|442905|P4|NOT COMPLETED|Period-3 (8 Days)||0
181603|NCT01424397|442906|P3|NOT COMPLETED|Period-3 (8 Days)||0
181604|NCT01424397|442907|P2|NOT COMPLETED|Period-3 (8 Days)||0
181605|NCT01424397|442908|P1|NOT COMPLETED|Period-3 (8 Days)||0
181606|NCT01424397|442897|P12|COMPLETED|Period-3 (8 Days)||4
181607|NCT01424397|442898|P11|COMPLETED|Period-3 (8 Days)||4
181608|NCT01424397|442899|P10|COMPLETED|Period-3 (8 Days)||3
181609|NCT01424397|442900|P9|COMPLETED|Period-3 (8 Days)||4
181610|NCT01424397|442901|P8|COMPLETED|Period-3 (8 Days)||4
181611|NCT01424397|442902|P7|COMPLETED|Period-3 (8 Days)||4
181612|NCT01424397|442903|P6|COMPLETED|Period-3 (8 Days)||8
181613|NCT01424397|442904|P5|COMPLETED|Period-3 (8 Days)||8
181614|NCT01424397|442905|P4|COMPLETED|Period-3 (8 Days)||8
181615|NCT01424397|442906|P3|COMPLETED|Period-3 (8 Days)||7
181616|NCT01424397|442907|P2|COMPLETED|Period-3 (8 Days)||8
181617|NCT01424397|442908|P1|COMPLETED|Period-3 (8 Days)||7
181618|NCT01424397|442897|P12|STARTED|Period-3 (8 Days)||4
181619|NCT01424397|442898|P11|STARTED|Period-3 (8 Days)||4
181620|NCT01424397|442899|P10|STARTED|Period-3 (8 Days)||3
181621|NCT01424397|442900|P9|STARTED|Period-3 (8 Days)||4
181622|NCT01424397|442901|P8|STARTED|Period-3 (8 Days)||4
181623|NCT01424397|442902|P7|STARTED|Period-3 (8 Days)||4
181624|NCT01424397|442903|P6|STARTED|Period-3 (8 Days)||8
181625|NCT01424397|442904|P5|STARTED|Period-3 (8 Days)||8
181626|NCT01424397|442905|P4|STARTED|Period-3 (8 Days)||8
181627|NCT01424397|442906|P3|STARTED|Period-3 (8 Days)||7
181628|NCT01424397|442907|P2|STARTED|Period-3 (8 Days)||8
181629|NCT01424397|442908|P1|STARTED|Period-3 (8 Days)||7
181630|NCT01424397|442897|P12|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
181631|NCT01424397|442898|P11|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
181632|NCT01424397|442899|P10|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
181633|NCT01424397|442900|P9|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
181634|NCT01424397|442901|P8|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
181635|NCT01424397|442902|P7|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
181636|NCT01424397|442903|P6|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
181637|NCT01424397|442904|P5|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
181638|NCT01424397|442905|P4|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
181639|NCT01424397|442906|P3|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
181640|NCT01424397|442907|P2|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
181641|NCT01424397|442908|P1|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
181642|NCT01424397|442897|P12|COMPLETED|Washout Period-2 (14-20 Days)||4
181643|NCT01424397|442898|P11|COMPLETED|Washout Period-2 (14-20 Days)||4
181644|NCT01424397|442899|P10|COMPLETED|Washout Period-2 (14-20 Days)||3
181645|NCT01424397|442900|P9|COMPLETED|Washout Period-2 (14-20 Days)||4
181646|NCT01424397|442901|P8|COMPLETED|Washout Period-2 (14-20 Days)||4
181647|NCT01424397|442902|P7|COMPLETED|Washout Period-2 (14-20 Days)||4
181648|NCT01424397|442903|P6|COMPLETED|Washout Period-2 (14-20 Days)||8
181649|NCT01424397|442904|P5|COMPLETED|Washout Period-2 (14-20 Days)||8
181650|NCT01424397|442905|P4|COMPLETED|Washout Period-2 (14-20 Days)||8
181651|NCT01424397|442906|P3|COMPLETED|Washout Period-2 (14-20 Days)||7
181652|NCT01424397|442907|P2|COMPLETED|Washout Period-2 (14-20 Days)||8
181653|NCT01424397|442908|P1|COMPLETED|Washout Period-2 (14-20 Days)||7
181654|NCT01424397|442897|P12|STARTED|Washout Period-2 (14-20 Days)||4
181655|NCT01424397|442898|P11|STARTED|Washout Period-2 (14-20 Days)||4
181656|NCT01424397|442899|P10|STARTED|Washout Period-2 (14-20 Days)||3
181657|NCT01424397|442900|P9|STARTED|Washout Period-2 (14-20 Days)||4
181658|NCT01424397|442901|P8|STARTED|Washout Period-2 (14-20 Days)||4
181659|NCT01424397|442902|P7|STARTED|Washout Period-2 (14-20 Days)||4
181660|NCT01424397|442903|P6|STARTED|Washout Period-2 (14-20 Days)||8
181661|NCT01424397|442904|P5|STARTED|Washout Period-2 (14-20 Days)||8
181662|NCT01424397|442905|P4|STARTED|Washout Period-2 (14-20 Days)||8
181663|NCT01424397|442906|P3|STARTED|Washout Period-2 (14-20 Days)||7
181664|NCT01424397|442907|P2|STARTED|Washout Period-2 (14-20 Days)||8
181665|NCT01424397|442908|P1|STARTED|Washout Period-2 (14-20 Days)||7
181666|NCT01424397|442897|P12|NOT COMPLETED|Period-2 (8 Days)||0
181667|NCT01424397|442898|P11|NOT COMPLETED|Period-2 (8 Days)||0
181668|NCT01424397|442899|P10|NOT COMPLETED|Period-2 (8 Days)||0
181669|NCT01424397|442900|P9|NOT COMPLETED|Period-2 (8 Days)||0
181670|NCT01424397|442901|P8|NOT COMPLETED|Period-2 (8 Days)||0
181671|NCT01424397|442902|P7|NOT COMPLETED|Period-2 (8 Days)||0
181672|NCT01424397|442903|P6|NOT COMPLETED|Period-2 (8 Days)||0
181673|NCT01424397|442904|P5|NOT COMPLETED|Period-2 (8 Days)||0
181674|NCT01424397|442905|P4|NOT COMPLETED|Period-2 (8 Days)||0
181675|NCT01424397|442906|P3|NOT COMPLETED|Period-2 (8 Days)||1
181676|NCT01424397|442907|P2|NOT COMPLETED|Period-2 (8 Days)||0
181677|NCT01424397|442908|P1|NOT COMPLETED|Period-2 (8 Days)||0
181678|NCT01424397|442897|P12|COMPLETED|Period-2 (8 Days)||4
181679|NCT01424397|442898|P11|COMPLETED|Period-2 (8 Days)||4
181680|NCT01424397|442899|P10|COMPLETED|Period-2 (8 Days)||3
181681|NCT01424397|442900|P9|COMPLETED|Period-2 (8 Days)||4
181682|NCT01424397|442901|P8|COMPLETED|Period-2 (8 Days)||4
181683|NCT01424397|442902|P7|COMPLETED|Period-2 (8 Days)||4
181684|NCT01424397|442903|P6|COMPLETED|Period-2 (8 Days)||8
181685|NCT01424397|442904|P5|COMPLETED|Period-2 (8 Days)||8
181686|NCT01424397|442905|P4|COMPLETED|Period-2 (8 Days)||8
181687|NCT01424397|442906|P3|COMPLETED|Period-2 (8 Days)||7
181688|NCT01424397|442907|P2|COMPLETED|Period-2 (8 Days)||8
181689|NCT01424397|442908|P1|COMPLETED|Period-2 (8 Days)||7
181690|NCT01424397|442897|P12|STARTED|Period-2 (8 Days)||4
181691|NCT01424397|442898|P11|STARTED|Period-2 (8 Days)||4
181692|NCT01424397|442899|P10|STARTED|Period-2 (8 Days)||3
181693|NCT01424397|442900|P9|STARTED|Period-2 (8 Days)||4
181694|NCT01424397|442901|P8|STARTED|Period-2 (8 Days)||4
181695|NCT01424397|442902|P7|STARTED|Period-2 (8 Days)||4
181696|NCT01424397|442903|P6|STARTED|Period-2 (8 Days)||8
181697|NCT01424397|442904|P5|STARTED|Period-2 (8 Days)||8
181698|NCT01424397|442905|P4|STARTED|Period-2 (8 Days)||8
181699|NCT01424397|442906|P3|STARTED|Period-2 (8 Days)||8
181700|NCT01424397|442907|P2|STARTED|Period-2 (8 Days)||8
181701|NCT01424397|442908|P1|STARTED|Period-2 (8 Days)||7
181702|NCT01424397|442897|P12|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
181703|NCT01424397|442898|P11|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
181704|NCT01424397|442899|P10|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
181705|NCT01424397|442900|P9|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
181706|NCT01424397|442901|P8|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
181707|NCT01424397|442902|P7|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
181708|NCT01424397|442903|P6|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
181709|NCT01424397|442904|P5|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
181710|NCT01424397|442905|P4|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
181711|NCT01424397|442906|P3|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
181712|NCT01424397|442907|P2|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
181713|NCT01424397|442908|P1|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
181714|NCT01424397|442897|P12|COMPLETED|Washout Period-1 (14-20 Days)||4
181715|NCT01424397|442898|P11|COMPLETED|Washout Period-1 (14-20 Days)||4
181716|NCT01424397|442899|P10|COMPLETED|Washout Period-1 (14-20 Days)||3
181717|NCT01424397|442900|P9|COMPLETED|Washout Period-1 (14-20 Days)||4
181718|NCT01424397|442901|P8|COMPLETED|Washout Period-1 (14-20 Days)||4
181719|NCT01424397|442902|P7|COMPLETED|Washout Period-1 (14-20 Days)||4
181720|NCT01424397|442903|P6|COMPLETED|Washout Period-1 (14-20 Days)||8
181721|NCT01424397|442904|P5|COMPLETED|Washout Period-1 (14-20 Days)||8
181722|NCT01424397|442905|P4|COMPLETED|Washout Period-1 (14-20 Days)||8
181723|NCT01424397|442906|P3|COMPLETED|Washout Period-1 (14-20 Days)||8
181724|NCT01424397|442907|P2|COMPLETED|Washout Period-1 (14-20 Days)||8
181725|NCT01424397|442908|P1|COMPLETED|Washout Period-1 (14-20 Days)||7
181726|NCT01424397|442897|P12|STARTED|Washout Period-1 (14-20 Days)||4
181727|NCT01424397|442898|P11|STARTED|Washout Period-1 (14-20 Days)||4
181728|NCT01424397|442899|P10|STARTED|Washout Period-1 (14-20 Days)||3
181729|NCT01424397|442900|P9|STARTED|Washout Period-1 (14-20 Days)||4
181730|NCT01424397|442901|P8|STARTED|Washout Period-1 (14-20 Days)||4
181731|NCT01424397|442902|P7|STARTED|Washout Period-1 (14-20 Days)||4
181732|NCT01424397|442903|P6|STARTED|Washout Period-1 (14-20 Days)||8
181733|NCT01424397|442904|P5|STARTED|Washout Period-1 (14-20 Days)||8
181734|NCT01424397|442905|P4|STARTED|Washout Period-1 (14-20 Days)||8
181735|NCT01424397|442906|P3|STARTED|Washout Period-1 (14-20 Days)||8
181736|NCT01424397|442907|P2|STARTED|Washout Period-1 (14-20 Days)||8
181737|NCT01424397|442908|P1|STARTED|Washout Period-1 (14-20 Days)||7
181738|NCT01424397|442897|P12|NOT COMPLETED|Period-1 (8 Days)||0
181739|NCT01424397|442898|P11|NOT COMPLETED|Period-1 (8 Days)||0
181740|NCT01424397|442899|P10|NOT COMPLETED|Period-1 (8 Days)||0
181741|NCT01424397|442900|P9|NOT COMPLETED|Period-1 (8 Days)||0
181742|NCT01424397|442901|P8|NOT COMPLETED|Period-1 (8 Days)||0
181743|NCT01424397|442902|P7|NOT COMPLETED|Period-1 (8 Days)||0
181744|NCT01424397|442903|P6|NOT COMPLETED|Period-1 (8 Days)||0
181745|NCT01424397|442904|P5|NOT COMPLETED|Period-1 (8 Days)||0
181746|NCT01424397|442905|P4|NOT COMPLETED|Period-1 (8 Days)||0
181747|NCT01424397|442906|P3|NOT COMPLETED|Period-1 (8 Days)||0
181748|NCT01424397|442907|P2|NOT COMPLETED|Period-1 (8 Days)||0
181749|NCT01424397|442908|P1|NOT COMPLETED|Period-1 (8 Days)||0
181750|NCT01424397|442897|P12|COMPLETED|Period-1 (8 Days)||4
181751|NCT01424397|442898|P11|COMPLETED|Period-1 (8 Days)||4
181752|NCT01424397|442899|P10|COMPLETED|Period-1 (8 Days)||3
181753|NCT01424397|442900|P9|COMPLETED|Period-1 (8 Days)||4
181754|NCT01424397|442901|P8|COMPLETED|Period-1 (8 Days)||4
181755|NCT01424397|442902|P7|COMPLETED|Period-1 (8 Days)||4
181756|NCT01424397|442903|P6|COMPLETED|Period-1 (8 Days)||8
181757|NCT01424397|442904|P5|COMPLETED|Period-1 (8 Days)||8
181758|NCT01424397|442905|P4|COMPLETED|Period-1 (8 Days)||8
181759|NCT01424397|442906|P3|COMPLETED|Period-1 (8 Days)||8
181760|NCT01424397|442907|P2|COMPLETED|Period-1 (8 Days)||8
181761|NCT01424397|442908|P1|COMPLETED|Period-1 (8 Days)||7
181762|NCT01424397|442897|P12|STARTED|Period-1 (8 Days)||4
181763|NCT01424397|442898|P11|STARTED|Period-1 (8 Days)||4
181764|NCT01424397|442899|P10|STARTED|Period-1 (8 Days)||3
181765|NCT01424397|442900|P9|STARTED|Period-1 (8 Days)||4
181766|NCT01424397|442901|P8|STARTED|Period-1 (8 Days)||4
181767|NCT01424397|442902|P7|STARTED|Period-1 (8 Days)||4
181768|NCT01424397|442903|P6|STARTED|Period-1 (8 Days)||8
181769|NCT01424397|442904|P5|STARTED|Period-1 (8 Days)||8
181770|NCT01424397|442905|P4|STARTED|Period-1 (8 Days)||8
181771|NCT01424397|442906|P3|STARTED|Period-1 (8 Days)||8
181772|NCT01424397|442907|P2|STARTED|Period-1 (8 Days)||8
181773|NCT01424397|442908|P1|STARTED|Period-1 (8 Days)||7
181774|NCT01424306|442954|P6|NOT COMPLETED|Overall Study||0
181775|NCT01424306|442955|P5|NOT COMPLETED|Overall Study||1
181776|NCT01424306|442956|P4|NOT COMPLETED|Overall Study||0
181777|NCT01424306|442957|P3|NOT COMPLETED|Overall Study||0
181778|NCT01424306|442958|P2|NOT COMPLETED|Overall Study||0
181779|NCT01424306|442959|P1|NOT COMPLETED|Overall Study||0
181780|NCT01424306|442954|P6|COMPLETED|Overall Study||6
181781|NCT01424306|442955|P5|COMPLETED|Overall Study||4
181782|NCT01424306|442956|P4|COMPLETED|Overall Study||3
181783|NCT01424306|442957|P3|COMPLETED|Overall Study||3
181784|NCT01424306|442958|P2|COMPLETED|Overall Study||4
181785|NCT01424306|442959|P1|COMPLETED|Overall Study||4
181786|NCT01424306|442954|P6|STARTED|Overall Study||6
181787|NCT01424306|442955|P5|STARTED|Overall Study||5
181788|NCT01424306|442956|P4|STARTED|Overall Study||3
181789|NCT01424306|442957|P3|STARTED|Overall Study||3
181790|NCT01424306|442958|P2|STARTED|Overall Study||4
181791|NCT01424306|442959|P1|STARTED|Overall Study||4
181792|NCT01424228|443008|P2|NOT COMPLETED|Overall Study||47
181793|NCT01424228|443009|P1|NOT COMPLETED|Overall Study||56
181794|NCT01424228|443008|P2|COMPLETED|Overall Study||135
181795|NCT01424228|443009|P1|COMPLETED|Overall Study||126
181796|NCT01424228|443008|P2|STARTED|Overall Study||182
181797|NCT01424228|443009|P1|STARTED|Overall Study||182
181798|NCT01424189|443049|P2|NOT COMPLETED|Overall Study||6
181799|NCT01424189|443050|P1|NOT COMPLETED|Overall Study||13
181800|NCT01424189|443049|P2|COMPLETED|Overall Study||182
181801|NCT01424189|443050|P1|COMPLETED|Overall Study||373
181802|NCT01424189|443049|P2|STARTED|Overall Study||188
181803|NCT01424189|443050|P1|STARTED|Overall Study||386
181804|NCT01424072|443065|P3|NOT COMPLETED|Overall Study||0
181805|NCT01424072|443066|P2|NOT COMPLETED|Overall Study||0
181806|NCT01424072|443067|P1|NOT COMPLETED|Overall Study||0
181807|NCT01424072|443065|P3|COMPLETED|Overall Study||22
181808|NCT01424072|443066|P2|COMPLETED|Overall Study||26
181809|NCT01424072|443067|P1|COMPLETED|Overall Study||27
181810|NCT01424072|443065|P3|STARTED|Overall Study||22
181811|NCT01424072|443066|P2|STARTED|Overall Study||26
181812|NCT01424072|443067|P1|STARTED|Overall Study||27
181813|NCT01424033|443084|P1|NOT COMPLETED|Overall Study||5
181814|NCT01424033|443084|P1|COMPLETED|Overall Study||0
181815|NCT01424033|443084|P1|STARTED|Overall Study||5
181816|NCT01423916|443091|P3|NOT COMPLETED|Overall Study||7
181817|NCT01423916|443092|P2|NOT COMPLETED|Overall Study||20
181818|NCT01423916|443093|P1|NOT COMPLETED|Overall Study||11
181819|NCT01423916|443091|P3|COMPLETED|Overall Study||64
181820|NCT01423916|443092|P2|COMPLETED|Overall Study||53
181821|NCT01423916|443093|P1|COMPLETED|Overall Study||63
181822|NCT01423916|443091|P3|STARTED|Overall Study||71
181823|NCT01423916|443092|P2|STARTED|Overall Study||73
181824|NCT01423916|443093|P1|STARTED|Overall Study||74
181825|NCT01423812|443149|P2|NOT COMPLETED|Overall Study||4
181826|NCT01423812|443150|P1|NOT COMPLETED|Overall Study||3
181827|NCT01423812|443149|P2|COMPLETED|Overall Study||26
181828|NCT01423812|443150|P1|COMPLETED|Overall Study||27
181829|NCT01423812|443149|P2|STARTED|Overall Study||30
181830|NCT01423812|443150|P1|STARTED|Overall Study||30
181831|NCT01423773|443158|P2|NOT COMPLETED|Period 2, 2 Days||0
181832|NCT01423773|443159|P1|NOT COMPLETED|Period 2, 2 Days||0
181833|NCT01423773|443158|P2|COMPLETED|Period 2, 2 Days||10
181834|NCT01423773|443159|P1|COMPLETED|Period 2, 2 Days||10
181835|NCT01423773|443158|P2|STARTED|Period 2, 2 Days||10
181836|NCT01423773|443159|P1|STARTED|Period 2, 2 Days||10
181837|NCT01423773|443158|P2|NOT COMPLETED|Period One, 2 Days||0
181838|NCT01423773|443159|P1|NOT COMPLETED|Period One, 2 Days||0
181839|NCT01423773|443158|P2|COMPLETED|Period One, 2 Days||10
181840|NCT01423773|443159|P1|COMPLETED|Period One, 2 Days||10
181841|NCT01423773|443158|P2|STARTED|Period One, 2 Days||10
181842|NCT01423773|443159|P1|STARTED|Period One, 2 Days||10
181843|NCT01423760|443167|P2|NOT COMPLETED|Overall Study||0
181844|NCT01423760|443168|P1|NOT COMPLETED|Overall Study||0
181845|NCT01423760|443167|P2|COMPLETED|Overall Study||13
181846|NCT01423760|443168|P1|COMPLETED|Overall Study||14
181847|NCT01423760|443167|P2|Safety Analysis Set|Overall Study||8
181848|NCT01423760|443168|P1|Safety Analysis Set|Overall Study||12
181849|NCT01423760|443167|P2|Number of Non-treatment Subjects|Overall Study||5
181850|NCT01423760|443168|P1|Number of Non-treatment Subjects|Overall Study||2
181851|NCT01423760|443167|P2|Number of Tecemotide Subjects|Overall Study||8
181852|NCT01423760|443168|P1|Number of Tecemotide Subjects|Overall Study||12
181853|NCT01423760|443167|P2|STARTED|Overall Study||13
181854|NCT01423760|443168|P1|STARTED|Overall Study||14
181855|NCT01423617|443178|P2|NOT COMPLETED|Overall Study||1
181856|NCT01423617|443179|P1|NOT COMPLETED|Overall Study||0
181857|NCT01423617|443178|P2|COMPLETED|Overall Study||45
181858|NCT01423617|443179|P1|COMPLETED|Overall Study||46
181859|NCT01423617|443178|P2|STARTED|Overall Study||46
181860|NCT01423617|443179|P1|STARTED|Overall Study||46
181861|NCT01423604|443196|P2|NOT COMPLETED|Randomized||63
181862|NCT01423604|443197|P1|NOT COMPLETED|Randomized||63
181863|NCT01423604|443196|P2|COMPLETED|Randomized||0
181864|NCT01423604|443197|P1|COMPLETED|Randomized|As of 07August2015, 1 subject was receiving treatment in the randomized portion.|1
181865|NCT01423604|443196|P2|STARTED|Randomized||63
181866|NCT01423604|443197|P1|STARTED|Randomized||64
181867|NCT01423604|443196|P2|NOT COMPLETED|Safety Run-In||0
181868|NCT01423604|443197|P1|NOT COMPLETED|Safety Run-In||9
181869|NCT01423604|443196|P2|COMPLETED|Safety Run-In||0
181870|NCT01423604|443197|P1|COMPLETED|Safety Run-In||0
181871|NCT01423604|443196|P2|STARTED|Safety Run-In||0
181872|NCT01423604|443197|P1|STARTED|Safety Run-In||9
181873|NCT01423253|443212|P1|NOT COMPLETED|Overall Study||9
181874|NCT01423253|443212|P1|COMPLETED|Overall Study||39
181875|NCT01423253|443212|P1|STARTED|Overall Study||48
181876|NCT01423162|443225|P2|NOT COMPLETED|Overall Study||0
181877|NCT01423162|443226|P1|NOT COMPLETED|Overall Study||0
181878|NCT01423162|443225|P2|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|9
181879|NCT01423162|443226|P1|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|11
181880|NCT01423162|443225|P2|STARTED|Overall Study||9
181881|NCT01423162|443226|P1|STARTED|Overall Study||11
181882|NCT01423084|443234|P2|NOT COMPLETED|Overall Study||4
181883|NCT01423084|443235|P1|NOT COMPLETED|Overall Study||2
181884|NCT01423084|443234|P2|COMPLETED|Overall Study||170
181885|NCT01423084|443235|P1|COMPLETED|Overall Study||168
181886|NCT01423084|443234|P2|STARTED|Overall Study||174
181887|NCT01423084|443235|P1|STARTED|Overall Study||170
181888|NCT01422915|443265|P1|NOT COMPLETED|Overall Study||1
181889|NCT01422915|443265|P1|COMPLETED|Overall Study||3
181890|NCT01422915|443265|P1|STARTED|Overall Study|1 subject with abnormal liver chemistries removed during the first period.|4
181891|NCT01422889|443270|P1|NOT COMPLETED|Overall Study||9
181892|NCT01422889|443270|P1|COMPLETED|Overall Study|9 subjects did not receive a study stent therefore 1111 subjects were eligible for follow up.|1111
181893|NCT01422889|443270|P1|STARTED|Overall Study||1120
181894|NCT01422876|443285|P10|NOT COMPLETED|Week 52||17
181895|NCT01422876|443286|P9|NOT COMPLETED|Week 52||21
181896|NCT01422876|443287|P8|NOT COMPLETED|Week 52||23
181897|NCT01422876|443288|P7|NOT COMPLETED|Week 52||16
181898|NCT01422876|443289|P6|NOT COMPLETED|Week 52||17
181899|NCT01422876|443290|P5|NOT COMPLETED|Week 52||15
181900|NCT01422876|443291|P4|NOT COMPLETED|Week 52||18
181901|NCT01422876|443292|P3|NOT COMPLETED|Week 52||13
181902|NCT01422876|443293|P2|NOT COMPLETED|Week 52||10
181903|NCT01422876|443294|P1|NOT COMPLETED|Week 52||12
181904|NCT01422876|443285|P10|COMPLETED|Week 52||118
181905|NCT01422876|443286|P9|COMPLETED|Week 52||113
181906|NCT01422876|443287|P8|COMPLETED|Week 52||112
181907|NCT01422876|443288|P7|COMPLETED|Week 52||120
181908|NCT01422876|443289|P6|COMPLETED|Week 52||120
181909|NCT01422876|443290|P5|COMPLETED|Week 52||117
181910|NCT01422876|443291|P4|COMPLETED|Week 52||122
181911|NCT01422876|443292|P3|COMPLETED|Week 52||128
181912|NCT01422876|443293|P2|COMPLETED|Week 52||126
181913|NCT01422876|443294|P1|COMPLETED|Week 52||125
181914|NCT01422876|443285|P10|STARTED|Week 52||135
181915|NCT01422876|443286|P9|STARTED|Week 52||134
181916|NCT01422876|443287|P8|STARTED|Week 52||135
181917|NCT01422876|443288|P7|STARTED|Week 52||136
181918|NCT01422876|443289|P6|STARTED|Week 52||137
181919|NCT01422876|443290|P5|STARTED|Week 52||132
181920|NCT01422876|443291|P4|STARTED|Week 52||140
181921|NCT01422876|443292|P3|STARTED|Week 52||141
181922|NCT01422876|443293|P2|STARTED|Week 52||136
181923|NCT01422876|443294|P1|STARTED|Week 52||137
181924|NCT01422876|443285|P10|NOT COMPLETED|Week 24||10
181925|NCT01422876|443286|P9|NOT COMPLETED|Week 24||6
181926|NCT01422876|443287|P8|NOT COMPLETED|Week 24||7
181927|NCT01422876|443288|P7|NOT COMPLETED|Week 24||6
181928|NCT01422876|443289|P6|NOT COMPLETED|Week 24||6
181929|NCT01422876|443290|P5|NOT COMPLETED|Week 24||7
181930|NCT01422876|443291|P4|NOT COMPLETED|Week 24||8
181931|NCT01422876|443292|P3|NOT COMPLETED|Week 24||5
181932|NCT01422876|443293|P2|NOT COMPLETED|Week 24||3
181933|NCT01422876|443294|P1|NOT COMPLETED|Week 24||6
181934|NCT01422876|443285|P10|COMPLETED|Week 24||125
181935|NCT01422876|443286|P9|COMPLETED|Week 24||128
181936|NCT01422876|443287|P8|COMPLETED|Week 24||128
181937|NCT01422876|443288|P7|COMPLETED|Week 24||130
181938|NCT01422876|443289|P6|COMPLETED|Week 24||131
181939|NCT01422876|443290|P5|COMPLETED|Week 24||125
181940|NCT01422876|443291|P4|COMPLETED|Week 24||132
181941|NCT01422876|443292|P3|COMPLETED|Week 24||136
181942|NCT01422876|443293|P2|COMPLETED|Week 24||133
181943|NCT01422876|443294|P1|COMPLETED|Week 24||131
181944|NCT01422876|443285|P10|STARTED|Week 24||135
181945|NCT01422876|443286|P9|STARTED|Week 24||134
181946|NCT01422876|443287|P8|STARTED|Week 24||135
181947|NCT01422876|443288|P7|STARTED|Week 24||136
181948|NCT01422876|443289|P6|STARTED|Week 24||137
181949|NCT01422876|443290|P5|STARTED|Week 24||132
181950|NCT01422876|443291|P4|STARTED|Week 24||140
181951|NCT01422876|443292|P3|STARTED|Week 24||141
181952|NCT01422876|443293|P2|STARTED|Week 24||136
181953|NCT01422876|443294|P1|STARTED|Week 24||137
181954|NCT01422850|443341|P1|NOT COMPLETED|Overall Study||3
181955|NCT01422850|443341|P1|COMPLETED|Overall Study||18
181956|NCT01422850|443341|P1|Week 15|Overall Study|One patient withdrawn by PI due to increased PSA. Started bicalutamide treatment.|18
181957|NCT01422850|443341|P1|Week 14 - Third Treatment|Overall Study|One patient withdrawn by PI and referred to external radiotherapy due to progressive disease.|19
181958|NCT01422850|443341|P1|Week 9 - Second Treatment|Overall Study||20
181959|NCT01422850|443341|P1|Week 5|Overall Study|One patient withdrawn by PI due to progressive disease|20
181960|NCT01422850|443341|P1|Week 4 - First Treatment|Overall Study||21
181961|NCT01422850|443341|P1|STARTED|Overall Study||21
181962|NCT01422824|443347|P1|NOT COMPLETED|Overall Study||38
181963|NCT01422824|443347|P1|COMPLETED|Overall Study||147
181964|NCT01422824|443347|P1|Treated|Overall Study||184
181965|NCT01422824|443347|P1|STARTED|Overall Study||185
181966|NCT01422720|443352|P1|NOT COMPLETED|Overall Study||22
181967|NCT01422720|443352|P1|COMPLETED|Overall Study||50
181968|NCT01422720|443352|P1|Per-Protocol Set (PPS)|Overall Study||55
181969|NCT01422720|443352|P1|Full Analysis Set (FAS)|Overall Study||71
181970|NCT01422720|443352|P1|Safety Set|Overall Study||72
181971|NCT01422720|443352|P1|STARTED|Overall Study||72
181972|NCT01422538|443363|P3|NOT COMPLETED|Overall Study||2
181973|NCT01422538|443364|P2|NOT COMPLETED|Overall Study||2
181974|NCT01422538|443365|P1|NOT COMPLETED|Overall Study||0
181975|NCT01422538|443363|P3|COMPLETED|Overall Study||8
181976|NCT01422538|443364|P2|COMPLETED|Overall Study||8
181977|NCT01422538|443365|P1|COMPLETED|Overall Study||10
181978|NCT01422538|443363|P3|STARTED|Overall Study||10
181979|NCT01422538|443364|P2|STARTED|Overall Study||10
181980|NCT01422538|443365|P1|STARTED|Overall Study||10
181981|NCT01422434|443390|P3|NOT COMPLETED|Overall Study||6
181982|NCT01422434|443391|P2|NOT COMPLETED|Overall Study||5
181983|NCT01422434|443392|P1|NOT COMPLETED|Overall Study||11
181984|NCT01422434|443390|P3|COMPLETED|Overall Study||217
181985|NCT01422434|443391|P2|COMPLETED|Overall Study||221
181986|NCT01422434|443392|P1|COMPLETED|Overall Study||216
181987|NCT01422434|443390|P3|STARTED|Overall Study||223
181988|NCT01422434|443391|P2|STARTED|Overall Study||226
181989|NCT01422434|443392|P1|STARTED|Overall Study||227
181990|NCT01422408|443409|P1|NOT COMPLETED|Overall Study||4
181991|NCT01422408|443409|P1|COMPLETED|Overall Study||30
181992|NCT01422408|443409|P1|STARTED|Overall Study||34
181993|NCT01422382|443438|P1|NOT COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||1
181994|NCT01422382|443438|P1|COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||27
181995|NCT01422382|443438|P1|STARTED|NK-104 4mg QD and Diltiazem 240 mg QD||28
181996|NCT01422382|443438|P1|NOT COMPLETED|Diltiazem 240 mg QD||0
181997|NCT01422382|443438|P1|COMPLETED|Diltiazem 240 mg QD||28
181998|NCT01422382|443438|P1|STARTED|Diltiazem 240 mg QD||28
181999|NCT01422382|443438|P1|NOT COMPLETED|NK-104 4mg Once Daily (QD)||0
182000|NCT01422382|443438|P1|COMPLETED|NK-104 4mg Once Daily (QD)||28
182001|NCT01422382|443438|P1|STARTED|NK-104 4mg Once Daily (QD)||28
182002|NCT01422369|443443|P1|NOT COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||1
182003|NCT01422369|443443|P1|COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||27
182004|NCT01422369|443443|P1|STARTED|NK-104 4mg QD & Prezista 800mg/100mg QD||28
182005|NCT01422369|443443|P1|NOT COMPLETED|Prezista 800mg/100mg QD||0
182006|NCT01422369|443443|P1|COMPLETED|Prezista 800mg/100mg QD||28
182007|NCT01422369|443443|P1|STARTED|Prezista 800mg/100mg QD||28
182008|NCT01422369|443443|P1|NOT COMPLETED|NK-104 4mg QD||0
182009|NCT01422369|443443|P1|COMPLETED|NK-104 4mg QD||28
182010|NCT01422369|443443|P1|STARTED|NK-104 4mg QD||28
182011|NCT01422356|443448|P1|NOT COMPLETED|Overall Study||31
182012|NCT01422356|443448|P1|COMPLETED|Overall Study||169
182013|NCT01422356|443448|P1|STARTED|Overall Study||200
182014|NCT01422304|443454|P2|NOT COMPLETED|Overall Study||37
182015|NCT01422304|443455|P1|NOT COMPLETED|Overall Study||24
182016|NCT01422304|443454|P2|COMPLETED|Overall Study||563
182017|NCT01422304|443455|P1|COMPLETED|Overall Study||574
182018|NCT01422304|443454|P2|Treated|Overall Study|1 given sugammadex; thus All Participants as Treated (APaT) Ns are 596 Sugammadex, 588 Usual Care|589
182019|NCT01422304|443455|P1|Treated|Overall Study||595
182020|NCT01422304|443454|P2|STARTED|Overall Study|Randomized|600
182021|NCT01422304|443455|P1|STARTED|Overall Study|Randomized|598
182022|NCT01422239|443487|P2|NOT COMPLETED|Overall Study||3
182023|NCT01422239|443488|P1|NOT COMPLETED|Overall Study||4
182024|NCT01422239|443487|P2|COMPLETED|Overall Study||3
182025|NCT01422239|443488|P1|COMPLETED|Overall Study||10
182026|NCT01422239|443487|P2|STARTED|Overall Study||6
182027|NCT01422239|443488|P1|STARTED|Overall Study||14
182028|NCT01422226|443500|P2|NOT COMPLETED|Overall Study||0
182029|NCT01422226|443501|P1|NOT COMPLETED|Overall Study||0
182030|NCT01422226|443500|P2|COMPLETED|Overall Study||2
182031|NCT01422226|443501|P1|COMPLETED|Overall Study||1
182032|NCT01422226|443500|P2|STARTED|Overall Study||2
182033|NCT01422226|443501|P1|STARTED|Overall Study||1
182034|NCT01422213|443510|P3|NOT COMPLETED|Overall Study||29
182035|NCT01422213|443511|P2|NOT COMPLETED|Overall Study||22
182036|NCT01422213|443512|P1|NOT COMPLETED|Overall Study||33
182037|NCT01422213|443510|P3|COMPLETED|Overall Study||178
182038|NCT01422213|443511|P2|COMPLETED|Overall Study||173
182039|NCT01422213|443512|P1|COMPLETED|Overall Study||163
182040|NCT01422213|443510|P3|STARTED|Overall Study||207
182041|NCT01422213|443511|P2|STARTED|Overall Study||195
182042|NCT01422213|443512|P1|STARTED|Overall Study||196
182043|NCT01422187|443573|P3|NOT COMPLETED|Overall Study||0
182044|NCT01422187|443574|P2|NOT COMPLETED|Overall Study||1
182045|NCT01422187|443575|P1|NOT COMPLETED|Overall Study||1
182046|NCT01422187|443573|P3|COMPLETED|Overall Study||2
182047|NCT01422187|443574|P2|COMPLETED|Overall Study||8
182048|NCT01422187|443575|P1|COMPLETED|Overall Study||7
182049|NCT01422187|443573|P3|STARTED|Overall Study||2
182050|NCT01422187|443574|P2|STARTED|Overall Study||9
182051|NCT01422187|443575|P1|STARTED|Overall Study||8
182052|NCT01422161|443594|P2|NOT COMPLETED|Overall Study||0
182053|NCT01422161|443595|P1|NOT COMPLETED|Overall Study||0
182054|NCT01422161|443594|P2|COMPLETED|Overall Study||6
182055|NCT01422161|443595|P1|COMPLETED|Overall Study||10
182056|NCT01422161|443594|P2|STARTED|Overall Study||6
182057|NCT01422161|443595|P1|STARTED|Overall Study||10
182058|NCT01422135|443611|P6|NOT COMPLETED|Overall Study||1
182059|NCT01422135|443612|P5|NOT COMPLETED|Overall Study||0
182060|NCT01422135|443613|P4|NOT COMPLETED|Overall Study||0
182061|NCT01422135|443614|P3|NOT COMPLETED|Overall Study||1
182062|NCT01422135|443615|P2|NOT COMPLETED|Overall Study||0
182063|NCT01422135|443616|P1|NOT COMPLETED|Overall Study||0
182064|NCT01422135|443611|P6|COMPLETED|Overall Study||3
182065|NCT01422135|443612|P5|COMPLETED|Overall Study||4
182066|NCT01422135|443613|P4|COMPLETED|Overall Study||4
182067|NCT01422135|443614|P3|COMPLETED|Overall Study||3
182068|NCT01422135|443615|P2|COMPLETED|Overall Study||4
182069|NCT01422135|443616|P1|COMPLETED|Overall Study||4
182070|NCT01422135|443611|P6|STARTED|Overall Study||4
182071|NCT01422135|443612|P5|STARTED|Overall Study||4
182072|NCT01422135|443613|P4|STARTED|Overall Study||4
182073|NCT01422135|443614|P3|STARTED|Overall Study||4
182074|NCT01422135|443615|P2|STARTED|Overall Study||4
182075|NCT01422135|443616|P1|STARTED|Overall Study||4
182076|NCT01422070|443627|P2|NOT COMPLETED|Overall Study||0
182077|NCT01422070|443628|P1|NOT COMPLETED|Overall Study||0
182078|NCT01422070|443627|P2|COMPLETED|Overall Study||803
182079|NCT01422070|443628|P1|COMPLETED|Overall Study||5031
182080|NCT01422070|443627|P2|STARTED|Overall Study|Number of patients admitted to 27 intensive care units.|803
182081|NCT01422070|443628|P1|STARTED|Overall Study|Number of patients admitted to 140 intensive care units|5031
182082|NCT01421719|443639|P1|NOT COMPLETED|Overall Study||4
182083|NCT01421719|443639|P1|COMPLETED|Overall Study||16
182084|NCT01421719|443639|P1|STARTED|Overall Study||20
182085|NCT01421667|443648|P4|NOT COMPLETED|Overall Study||1
182086|NCT01421667|443649|P3|NOT COMPLETED|Overall Study||2
182087|NCT01421667|443650|P2|NOT COMPLETED|Overall Study||2
182088|NCT01421667|443651|P1|NOT COMPLETED|Overall Study||0
182089|NCT01421667|443648|P4|COMPLETED|Overall Study|Completed per protocol due to death [7] or study termination by sponsor [8]|15
182090|NCT01421667|443649|P3|COMPLETED|Overall Study|Completed per protocol due to death [33] or study termination by sponsor [18]|51
182091|NCT01421667|443650|P2|COMPLETED|Overall Study|Completed per protocol due to death [45] or study termination by sponsor [21]|66
182092|NCT01421667|443651|P1|COMPLETED|Overall Study|Completed per protocol due to death [24] or study termination by sponsor [11]|35
182093|NCT01421667|443648|P4|STARTED|Overall Study||16
182094|NCT01421667|443649|P3|STARTED|Overall Study||53
182095|NCT01421667|443650|P2|STARTED|Overall Study||68
182096|NCT01421667|443651|P1|STARTED|Overall Study||35
182097|NCT01421654|443703|P2|NOT COMPLETED|Overall Study||0
182098|NCT01421654|443704|P1|NOT COMPLETED|Overall Study||0
182099|NCT01421654|443703|P2|COMPLETED|Overall Study|10 subjects completed study, but 1 subject was found to not meet IEC at the end; data was not used.|9
182100|NCT01421654|443704|P1|COMPLETED|Overall Study||11
182101|NCT01421654|443703|P2|STARTED|Overall Study||9
182102|NCT01421654|443704|P1|STARTED|Overall Study||11
182103|NCT01421641|443712|P2|NOT COMPLETED|Overall Study||2
182104|NCT01421641|443713|P1|NOT COMPLETED|Overall Study||2
182105|NCT01421641|443712|P2|COMPLETED|Overall Study||35
182106|NCT01421641|443713|P1|COMPLETED|Overall Study||35
182107|NCT01421641|443712|P2|STARTED|Overall Study||37
182108|NCT01421641|443713|P1|STARTED|Overall Study||37
182109|NCT01421589|443723|P1|NOT COMPLETED|Overall Study||0
182110|NCT01421589|443723|P1|COMPLETED|Overall Study||15
182111|NCT01421589|443723|P1|STARTED|Overall Study||15
182112|NCT01421511|443735|P2|NOT COMPLETED|Overall Study||28
182113|NCT01421511|443736|P1|NOT COMPLETED|Overall Study||19
182114|NCT01421511|443735|P2|COMPLETED|Overall Study||306
182115|NCT01421511|443736|P1|COMPLETED|Overall Study||313
182116|NCT01421511|443735|P2|STARTED|Overall Study||334
182117|NCT01421511|443736|P1|STARTED|Overall Study||332
182118|NCT01421498|443758|P2|NOT COMPLETED|Overall Study||11
182119|NCT01421498|443759|P1|NOT COMPLETED|Overall Study||12
182120|NCT01421498|443758|P2|COMPLETED|Overall Study||284
182121|NCT01421498|443759|P1|COMPLETED|Overall Study||281
182122|NCT01421498|443758|P2|STARTED|Overall Study||295
182123|NCT01421498|443759|P1|STARTED|Overall Study||293
182124|NCT01421472|443771|P4|NOT COMPLETED|Overall Study||0
182125|NCT01421472|443772|P3|NOT COMPLETED|Overall Study||0
182126|NCT01421472|443773|P2|NOT COMPLETED|Overall Study||0
182127|NCT01421472|443774|P1|NOT COMPLETED|Overall Study||0
182128|NCT01421472|443771|P4|COMPLETED|Overall Study||32
182129|NCT01421472|443772|P3|COMPLETED|Overall Study||64
182130|NCT01421472|443773|P2|COMPLETED|Overall Study||33
182131|NCT01421472|443774|P1|COMPLETED|Overall Study||67
182132|NCT01421472|443771|P4|STARTED|Overall Study||32
182133|NCT01421472|443772|P3|STARTED|Overall Study||64
182134|NCT01421472|443773|P2|STARTED|Overall Study||33
182135|NCT01421472|443774|P1|STARTED|Overall Study||67
182136|NCT01421459|443786|P2|NOT COMPLETED|Overall Study||52
182137|NCT01421459|443787|P1|NOT COMPLETED|Overall Study||45
182138|NCT01421459|443786|P2|COMPLETED|Overall Study||328
182139|NCT01421459|443787|P1|COMPLETED|Overall Study||334
182140|NCT01421459|443786|P2|Received at Least 1 Dose of Study Drug|Overall Study||380
182141|NCT01421459|443787|P1|Received at Least 1 Dose of Study Drug|Overall Study||376
182142|NCT01421459|443786|P2|STARTED|Overall Study||380
182143|NCT01421459|443787|P1|STARTED|Overall Study||379
182144|NCT01421355|443821|P1|NOT COMPLETED|Overall Study||6
182145|NCT01421355|443821|P1|COMPLETED|Overall Study||15
182146|NCT01421355|443821|P1|STARTED|Overall Study||21
182147|NCT01421342|443828|P3|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||65
182148|NCT01421342|443829|P2|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||59
182149|NCT01421342|443830|P1|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||52
182150|NCT01421342|443828|P3|COMPLETED|Continuation of Treatment (Week 12 - 36)||203
182151|NCT01421342|443829|P2|COMPLETED|Continuation of Treatment (Week 12 - 36)||194
182152|NCT01421342|443830|P1|COMPLETED|Continuation of Treatment (Week 12 - 36)||152
182153|NCT01421342|443828|P3|STARTED|Continuation of Treatment (Week 12 - 36)||268
182154|NCT01421342|443829|P2|STARTED|Continuation of Treatment (Week 12 - 36)||253
182155|NCT01421342|443830|P1|STARTED|Continuation of Treatment (Week 12 - 36)||204
182156|NCT01421342|443828|P3|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||138
182157|NCT01421342|443829|P2|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||125
182158|NCT01421342|443830|P1|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||149
182159|NCT01421342|443828|P3|COMPLETED|Completed to Week 12 But Then Withdrawn||268
182160|NCT01421342|443829|P2|COMPLETED|Completed to Week 12 But Then Withdrawn||253
182161|NCT01421342|443830|P1|COMPLETED|Completed to Week 12 But Then Withdrawn||204
182162|NCT01421342|443828|P3|STARTED|Completed to Week 12 But Then Withdrawn||406
182163|NCT01421342|443829|P2|STARTED|Completed to Week 12 But Then Withdrawn||378
182164|NCT01421342|443830|P1|STARTED|Completed to Week 12 But Then Withdrawn||353
182165|NCT01421342|443828|P3|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||99
182166|NCT01421342|443829|P2|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||128
182167|NCT01421342|443830|P1|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||158
182168|NCT01421342|443828|P3|COMPLETED|Acute Treatment Phase (12 Weeks)||406
182169|NCT01421342|443829|P2|COMPLETED|Acute Treatment Phase (12 Weeks)||378
182170|NCT01421342|443830|P1|COMPLETED|Acute Treatment Phase (12 Weeks)||353
182171|NCT01421342|443828|P3|STARTED|Acute Treatment Phase (12 Weeks)||505
182172|NCT01421342|443829|P2|STARTED|Acute Treatment Phase (12 Weeks)||506
182173|NCT01421342|443830|P1|STARTED|Acute Treatment Phase (12 Weeks)||511
182174|NCT01421303|443847|P1|NOT COMPLETED|Overall Study||22
182175|NCT01421303|443847|P1|COMPLETED|Overall Study||58
182176|NCT01421303|443847|P1|STARTED|Overall Study||80
182177|NCT01421277|443874|P2|NOT COMPLETED|Overall Study||92
182178|NCT01421277|443875|P1|NOT COMPLETED|Overall Study||0
182179|NCT01421277|443874|P2|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|99
182180|NCT01421277|443875|P1|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|25
182181|NCT01421277|443874|P2|STARTED|Overall Study||191
182182|NCT01421277|443875|P1|STARTED|Overall Study||25
182183|NCT01421225|443887|P2|NOT COMPLETED|Overall Study||1
182184|NCT01421225|443888|P1|NOT COMPLETED|Overall Study||0
182185|NCT01421225|443887|P2|COMPLETED|Overall Study||5
182186|NCT01421225|443888|P1|COMPLETED|Overall Study||4
182187|NCT01421225|443887|P2|STARTED|Overall Study||6
182188|NCT01421225|443888|P1|STARTED|Overall Study||4
182189|NCT01421147|443902|P2|NOT COMPLETED|Extension Period||11
182190|NCT01421147|443903|P1|NOT COMPLETED|Extension Period||8
182191|NCT01421147|443902|P2|COMPLETED|Extension Period||245
182192|NCT01421147|443903|P1|COMPLETED|Extension Period||245
182193|NCT01421147|443902|P2|STARTED|Extension Period||256
182194|NCT01421147|443903|P1|STARTED|Extension Period||253
182195|NCT01421147|443902|P2|NOT COMPLETED|Treatment Period||11
182196|NCT01421147|443903|P1|NOT COMPLETED|Treatment Period||16
182197|NCT01421147|443902|P2|COMPLETED|Treatment Period||256
182198|NCT01421147|443903|P1|COMPLETED|Treatment Period||253
182199|NCT01421147|443902|P2|Received at Least 1 Dose of Study Drug|Treatment Period||267
182200|NCT01421147|443903|P1|Received at Least 1 Dose of Study Drug|Treatment Period||268
182201|NCT01421147|443902|P2|STARTED|Treatment Period||267
182202|NCT01421147|443903|P1|STARTED|Treatment Period||269
182203|NCT01421134|443935|P2|NOT COMPLETED|Overall Study||15
182204|NCT01421134|443936|P1|NOT COMPLETED|Overall Study||7
182205|NCT01421134|443935|P2|COMPLETED|Overall Study||87
182206|NCT01421134|443936|P1|COMPLETED|Overall Study||102
182207|NCT01421134|443935|P2|STARTED|Overall Study||102
182208|NCT01421134|443936|P1|STARTED|Overall Study||109
182209|NCT01420965|443957|P3|NOT COMPLETED|Overall Study||0
182210|NCT01420965|443958|P2|NOT COMPLETED|Overall Study||1
182211|NCT01420965|443959|P1|NOT COMPLETED|Overall Study||1
182212|NCT01420965|443957|P3|COMPLETED|Overall Study||3
182213|NCT01420965|443958|P2|COMPLETED|Overall Study||1
182214|NCT01420965|443959|P1|COMPLETED|Overall Study||1
182215|NCT01420965|443957|P3|STARTED|Overall Study||3
182216|NCT01420965|443958|P2|STARTED|Overall Study||2
182217|NCT01420965|443959|P1|STARTED|Overall Study||2
182218|NCT01420926|443972|P2|NOT COMPLETED|Overall Study||65
182219|NCT01420926|443973|P1|NOT COMPLETED|Overall Study||60
182220|NCT01420926|443972|P2|COMPLETED|Overall Study||16
182221|NCT01420926|443973|P1|COMPLETED|Overall Study||22
182222|NCT01420926|443972|P2|STARTED|Overall Study||81
182223|NCT01420926|443973|P1|STARTED|Overall Study||82
182224|NCT01420848|443990|P3|NOT COMPLETED|Overall Study||0
182225|NCT01420848|443991|P2|NOT COMPLETED|Overall Study||0
182226|NCT01420848|443992|P1|NOT COMPLETED|Overall Study||0
182227|NCT01420848|443990|P3|COMPLETED|Overall Study||22
182228|NCT01420848|443991|P2|COMPLETED|Overall Study||25
182229|NCT01420848|443992|P1|COMPLETED|Overall Study||24
182230|NCT01420848|443990|P3|STARTED|Overall Study||22
182231|NCT01420848|443991|P2|STARTED|Overall Study||25
182232|NCT01420848|443992|P1|STARTED|Overall Study||24
182233|NCT01420653|444007|P4|NOT COMPLETED|Overall Study||7
182234|NCT01420653|444008|P3|NOT COMPLETED|Overall Study||4
182235|NCT01420653|444009|P2|NOT COMPLETED|Overall Study||3
182236|NCT01420653|444010|P1|NOT COMPLETED|Overall Study||3
182237|NCT01420653|444007|P4|COMPLETED|Overall Study||68
182238|NCT01420653|444008|P3|COMPLETED|Overall Study||108
182239|NCT01420653|444009|P2|COMPLETED|Overall Study||108
182240|NCT01420653|444010|P1|COMPLETED|Overall Study||107
182241|NCT01420653|444007|P4|STARTED|Overall Study||75
182242|NCT01420653|444008|P3|STARTED|Overall Study||112
182243|NCT01420653|444009|P2|STARTED|Overall Study||111
182244|NCT01420653|444010|P1|STARTED|Overall Study||110
182245|NCT01420289|444022|P2|NOT COMPLETED|Overall Study||0
182246|NCT01420289|444023|P1|NOT COMPLETED|Overall Study||0
182247|NCT01420289|444022|P2|COMPLETED|Overall Study||16
182248|NCT01420289|444023|P1|COMPLETED|Overall Study||18
182249|NCT01420289|444022|P2|STARTED|Overall Study||16
182250|NCT01420289|444023|P1|STARTED|Overall Study||18
182251|NCT01420146|444035|P1|NOT COMPLETED|Overall Study||0
182252|NCT01420146|444035|P1|COMPLETED|Overall Study||20
182253|NCT01420146|444035|P1|STARTED|Overall Study||20
182254|NCT01420081|444048|P9|NOT COMPLETED|Overall Study||3
182255|NCT01420081|444049|P8|NOT COMPLETED|Overall Study||3
182256|NCT01420081|444050|P7|NOT COMPLETED|Overall Study||3
182257|NCT01420081|444051|P6|NOT COMPLETED|Overall Study||20
182258|NCT01420081|444052|P5|NOT COMPLETED|Overall Study||20
182259|NCT01420081|444053|P4|NOT COMPLETED|Overall Study||3
182260|NCT01420081|444054|P3|NOT COMPLETED|Overall Study||11
182261|NCT01420081|444055|P2|NOT COMPLETED|Overall Study||1
182262|NCT01420081|444056|P1|NOT COMPLETED|Overall Study||3
182263|NCT01420081|444048|P9|COMPLETED|Overall Study||0
182264|NCT01420081|444049|P8|COMPLETED|Overall Study||0
182265|NCT01420081|444050|P7|COMPLETED|Overall Study||0
182266|NCT01420081|444051|P6|COMPLETED|Overall Study||0
182267|NCT01420081|444052|P5|COMPLETED|Overall Study||0
182268|NCT01420081|444053|P4|COMPLETED|Overall Study||0
182269|NCT01420081|444054|P3|COMPLETED|Overall Study||0
182270|NCT01420081|444055|P2|COMPLETED|Overall Study||0
182271|NCT01420081|444056|P1|COMPLETED|Overall Study||0
182272|NCT01420081|444048|P9|STARTED|Overall Study||3
182273|NCT01420081|444049|P8|STARTED|Overall Study||3
182274|NCT01420081|444050|P7|STARTED|Overall Study||3
182275|NCT01420081|444051|P6|STARTED|Overall Study||20
182276|NCT01420081|444052|P5|STARTED|Overall Study||20
182277|NCT01420081|444053|P4|STARTED|Overall Study||3
182278|NCT01420081|444054|P3|STARTED|Overall Study||11
182279|NCT01420081|444055|P2|STARTED|Overall Study||1
182280|NCT01420081|444056|P1|STARTED|Overall Study||3
182281|NCT01420068|444137|P2|NOT COMPLETED|Overall Study||5
182282|NCT01420068|444138|P1|NOT COMPLETED|Overall Study||2
182283|NCT01420068|444137|P2|COMPLETED|Overall Study||50
182284|NCT01420068|444138|P1|COMPLETED|Overall Study||49
182285|NCT01420068|444137|P2|STARTED|Overall Study||55
182286|NCT01420068|444138|P1|STARTED|Overall Study||51
182287|NCT01420016|444160|P4|NOT COMPLETED|Safety Analysis||0
182288|NCT01420016|444161|P3|NOT COMPLETED|Safety Analysis||0
182289|NCT01420016|444162|P2|NOT COMPLETED|Safety Analysis||0
182290|NCT01420016|444163|P1|NOT COMPLETED|Safety Analysis||0
182291|NCT01420016|444160|P4|COMPLETED|Safety Analysis||5159
182292|NCT01420016|444161|P3|COMPLETED|Safety Analysis||6392
182293|NCT01420016|444162|P2|COMPLETED|Safety Analysis||0
182294|NCT01420016|444163|P1|COMPLETED|Safety Analysis||0
182295|NCT01420016|444160|P4|STARTED|Safety Analysis||5159
182296|NCT01420016|444161|P3|STARTED|Safety Analysis||6392
182297|NCT01420016|444162|P2|STARTED|Safety Analysis||0
182298|NCT01420016|444163|P1|STARTED|Safety Analysis||0
182299|NCT01420016|444160|P4|NOT COMPLETED|Primary Analysis||0
182300|NCT01420016|444161|P3|NOT COMPLETED|Primary Analysis||0
182301|NCT01420016|444162|P2|NOT COMPLETED|Primary Analysis||2540
182302|NCT01420016|444163|P1|NOT COMPLETED|Primary Analysis||2927
182303|NCT01420016|444160|P4|COMPLETED|Primary Analysis||0
182304|NCT01420016|444161|P3|COMPLETED|Primary Analysis||0
182305|NCT01420016|444162|P2|COMPLETED|Primary Analysis|Reflects patient participants included in final analysis.|3871
182306|NCT01420016|444163|P1|COMPLETED|Primary Analysis|Reflects patient participants included in final analysis.|4043
182307|NCT01420016|444160|P4|STARTED|Primary Analysis||0
182308|NCT01420016|444161|P3|STARTED|Primary Analysis||0
182309|NCT01420016|444162|P2|STARTED|Primary Analysis||6411
182310|NCT01420016|444163|P1|STARTED|Primary Analysis||6970
182311|NCT01419977|444171|P2|NOT COMPLETED|Overall Study||0
182312|NCT01419977|444172|P1|NOT COMPLETED|Overall Study||0
182313|NCT01419977|444171|P2|COMPLETED|Overall Study||13
182314|NCT01419977|444172|P1|COMPLETED|Overall Study||16
182315|NCT01419977|444171|P2|STARTED|Overall Study||13
182316|NCT01419977|444172|P1|STARTED|Overall Study||16
182317|NCT01419795|444186|P2|NOT COMPLETED|Overall Study||0
182318|NCT01419795|444187|P1|NOT COMPLETED|Overall Study||0
182319|NCT01419795|444186|P2|COMPLETED|Overall Study||0
182320|NCT01419795|444187|P1|COMPLETED|Overall Study||3
182321|NCT01419795|444186|P2|STARTED|Overall Study||0
182322|NCT01419795|444187|P1|STARTED|Overall Study||3
182323|NCT01419769|444209|P1|NOT COMPLETED|Overall Study||4
182324|NCT01419769|444209|P1|COMPLETED|Overall Study||29
182325|NCT01419769|444209|P1|STARTED|Overall Study||33
182326|NCT01419717|444222|P1|NOT COMPLETED|Overall Study||125
182327|NCT01419717|444222|P1|COMPLETED|Overall Study||4
182328|NCT01419717|444222|P1|Received Denosumab|Overall Study||128
182329|NCT01419717|444222|P1|STARTED|Overall Study||129
182330|NCT01419639|444227|P1|NOT COMPLETED|Overall Study||1
182331|NCT01419639|444227|P1|COMPLETED|Overall Study||9
182332|NCT01419639|444227|P1|STARTED|Overall Study||10
182333|NCT01419314|444235|P2|NOT COMPLETED|Follow-up at Week 6 of the Trial||2
182334|NCT01419314|444236|P1|NOT COMPLETED|Follow-up at Week 6 of the Trial||1
182335|NCT01419314|444235|P2|COMPLETED|Follow-up at Week 6 of the Trial||19
182336|NCT01419314|444236|P1|COMPLETED|Follow-up at Week 6 of the Trial|2 people who missed the first follow-up, returned for the final follow-up at week 6 (n=18).|16
182337|NCT01419314|444235|P2|STARTED|Follow-up at Week 6 of the Trial|2 participants did not return for their final follow-up|21
182338|NCT01419314|444236|P1|STARTED|Follow-up at Week 6 of the Trial||17
182339|NCT01419314|444235|P2|NOT COMPLETED|Follow-up at Week 3 of the Trial||1
182340|NCT01419314|444236|P1|NOT COMPLETED|Follow-up at Week 3 of the Trial||6
182341|NCT01419314|444235|P2|COMPLETED|Follow-up at Week 3 of the Trial||21
182342|NCT01419314|444236|P1|COMPLETED|Follow-up at Week 3 of the Trial||17
182343|NCT01419314|444235|P2|STARTED|Follow-up at Week 3 of the Trial|one participant failed to return for the 3 week follow-up|22
182344|NCT01419314|444236|P1|STARTED|Follow-up at Week 3 of the Trial|3 participants discontinued the trial, 3 failed to return for additional follow-ups.|23
182345|NCT01419314|444235|P2|NOT COMPLETED|Start of Study||0
182346|NCT01419314|444236|P1|NOT COMPLETED|Start of Study||0
182347|NCT01419314|444235|P2|COMPLETED|Start of Study||22
182348|NCT01419314|444236|P1|COMPLETED|Start of Study||23
182349|NCT01419314|444235|P2|STARTED|Start of Study|No comfort issues reported.|22
182350|NCT01419314|444236|P1|STARTED|Start of Study|minor comfort issues were reported within the first 2 weeks of the trial|23
182351|NCT01419275|444256|P1|NOT COMPLETED|Overall Study||0
182352|NCT01419275|444256|P1|COMPLETED|Overall Study||126
182353|NCT01419275|444256|P1|STARTED|Overall Study||126
182354|NCT01419249|444262|P2|NOT COMPLETED|Overall Study||0
182355|NCT01419249|444263|P1|NOT COMPLETED|Overall Study||0
182356|NCT01419249|444262|P2|COMPLETED|Overall Study||140
182357|NCT01419249|444263|P1|COMPLETED|Overall Study||318
182358|NCT01419249|444262|P2|STARTED|Overall Study||140
182359|NCT01419249|444263|P1|STARTED|Overall Study||318
182360|NCT01419236|444277|P2|NOT COMPLETED|Overall Study||5
182361|NCT01419236|444278|P1|NOT COMPLETED|Overall Study||5
182362|NCT01419236|444277|P2|COMPLETED|Overall Study||35
182363|NCT01419236|444278|P1|COMPLETED|Overall Study||31
182364|NCT01419236|444277|P2|Received at Least 1 Dose of Study Drug|Overall Study||39
182365|NCT01419236|444278|P1|Received at Least 1 Dose of Study Drug|Overall Study||35
182366|NCT01419236|444277|P2|STARTED|Overall Study||40
182367|NCT01419236|444278|P1|STARTED|Overall Study||36
182368|NCT01419197|444302|P2|NOT COMPLETED|Overall Study||198
182369|NCT01419197|444303|P1|NOT COMPLETED|Overall Study||404
182370|NCT01419197|444302|P2|COMPLETED|Overall Study||0
182371|NCT01419197|444303|P1|COMPLETED|Overall Study||0
182372|NCT01419197|444302|P2|Switched to Trastuzumab Emtansine|Overall Study||94
182373|NCT01419197|444303|P1|Switched to Trastuzumab Emtansine|Overall Study||0
182374|NCT01419197|444302|P2|STARTED|Overall Study||198
182375|NCT01419197|444303|P1|STARTED|Overall Study||404
182376|NCT01419184|444328|P2|NOT COMPLETED|Overall Study||15
182377|NCT01419184|444329|P1|NOT COMPLETED|Overall Study||10
182378|NCT01419184|444328|P2|COMPLETED|Overall Study|13 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|106
182379|NCT01419184|444329|P1|COMPLETED|Overall Study|6 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|118
182380|NCT01419184|444328|P2|Received at Least 1 Dose of Study Drug|Overall Study||106
182381|NCT01419184|444329|P1|Received at Least 1 Dose of Study Drug|Overall Study||118
182382|NCT01419184|444328|P2|STARTED|Overall Study||121
182383|NCT01419184|444329|P1|STARTED|Overall Study||128
182384|NCT01419171|444345|P1|NOT COMPLETED|Overall Study||0
182385|NCT01419171|444345|P1|COMPLETED|Overall Study||328
182386|NCT01419171|444345|P1|STARTED|Overall Study||328
182387|NCT01419080|444362|P1|NOT COMPLETED|Overall Study||131
182388|NCT01419080|444362|P1|COMPLETED|Overall Study||666
182389|NCT01419080|444362|P1|STARTED|Overall Study||797
182390|NCT01419028|444368|P1|NOT COMPLETED|Overall Study||0
182391|NCT01419028|444368|P1|COMPLETED|Overall Study||48
182392|NCT01419028|444368|P1|STARTED|Overall Study||48
182393|NCT01418937|444373|P1|NOT COMPLETED|Overall Study||8
182394|NCT01418937|444373|P1|COMPLETED|Overall Study||156
182395|NCT01418937|444373|P1|STARTED|Overall Study||164
182396|NCT01418703|444382|P4|NOT COMPLETED|Overall Study||0
182397|NCT01418703|444383|P3|NOT COMPLETED|Overall Study||0
182398|NCT01418703|444384|P2|NOT COMPLETED|Overall Study||0
182399|NCT01418703|444385|P1|NOT COMPLETED|Overall Study||0
182400|NCT01418703|444382|P4|COMPLETED|Overall Study||6
182401|NCT01418703|444383|P3|COMPLETED|Overall Study||6
182402|NCT01418703|444384|P2|COMPLETED|Overall Study||13
182403|NCT01418703|444385|P1|COMPLETED|Overall Study||13
182404|NCT01418703|444382|P4|STARTED|Overall Study||6
182405|NCT01418703|444383|P3|STARTED|Overall Study||6
182406|NCT01418703|444384|P2|STARTED|Overall Study||13
182407|NCT01418703|444385|P1|STARTED|Overall Study||13
182408|NCT01418482|444396|P1|NOT COMPLETED|Overall Study||0
182409|NCT01418482|444396|P1|COMPLETED|Overall Study||15
182410|NCT01418482|444396|P1|STARTED|Overall Study||15
182411|NCT01418378|444404|P2|NOT COMPLETED|Overall Study||5
182412|NCT01418378|444405|P1|NOT COMPLETED|Overall Study||1
182413|NCT01418378|444404|P2|COMPLETED|Overall Study||83
182414|NCT01418378|444405|P1|COMPLETED|Overall Study||89
182415|NCT01418378|444404|P2|Subjects Who Received Study Implant|Overall Study|the number of subjects implanted with study implant|88
182416|NCT01418378|444405|P1|Subjects Who Received Study Implant|Overall Study|the number of subjects implanted with study implant|90
182417|NCT01418378|444404|P2|STARTED|Overall Study|A total of 191 subjects were enrolled into the study. 13/191 did not receive a study implant|88
182418|NCT01418378|444405|P1|STARTED|Overall Study|A total of 191 subjects were enrolled into the study. 13/191 did not receive a study implant|90
182419|NCT01418365|444479|P2|NOT COMPLETED|Second Intervention||1
182420|NCT01418365|444480|P1|NOT COMPLETED|Second Intervention||0
182421|NCT01418365|444479|P2|COMPLETED|Second Intervention||13
182422|NCT01418365|444480|P1|COMPLETED|Second Intervention||14
182423|NCT01418365|444479|P2|STARTED|Second Intervention||14
182424|NCT01418365|444480|P1|STARTED|Second Intervention||14
182425|NCT01418365|444479|P2|NOT COMPLETED|First Intervention||1
182426|NCT01418365|444480|P1|NOT COMPLETED|First Intervention||1
182427|NCT01418365|444479|P2|COMPLETED|First Intervention||14
182428|NCT01418365|444480|P1|COMPLETED|First Intervention||14
182429|NCT01418365|444479|P2|STARTED|First Intervention||15
182430|NCT01418365|444480|P1|STARTED|First Intervention||15
182431|NCT01418209|444491|P3|NOT COMPLETED|Overall Study||4
182432|NCT01418209|444492|P2|NOT COMPLETED|Overall Study||3
182433|NCT01418209|444493|P1|NOT COMPLETED|Overall Study||2
182434|NCT01418209|444491|P3|COMPLETED|Overall Study||142
182435|NCT01418209|444492|P2|COMPLETED|Overall Study||93
182436|NCT01418209|444493|P1|COMPLETED|Overall Study||95
182437|NCT01418209|444491|P3|STARTED|Overall Study||146
182438|NCT01418209|444492|P2|STARTED|Overall Study||96
182439|NCT01418209|444493|P1|STARTED|Overall Study||97
182440|NCT01418001|444522|P1|NOT COMPLETED|Overall Study||0
182441|NCT01418001|444522|P1|COMPLETED|Overall Study||5
182442|NCT01418001|444522|P1|STARTED|Overall Study||5
182443|NCT01417936|444527|P1|NOT COMPLETED|Overall Study||0
182444|NCT01417936|444527|P1|COMPLETED|Overall Study||26
182445|NCT01417936|444527|P1|STARTED|Overall Study||26
182446|NCT01417741|444548|P2|NOT COMPLETED|Overall Study||0
182447|NCT01417741|444549|P1|NOT COMPLETED|Overall Study||0
182448|NCT01417741|444548|P2|COMPLETED|Overall Study|only 73 received the post op day phone phone call|86
182449|NCT01417741|444549|P1|COMPLETED|Overall Study||75
182450|NCT01417741|444548|P2|STARTED|Overall Study||86
182451|NCT01417741|444549|P1|STARTED|Overall Study||75
182452|NCT01417481|444557|P2|NOT COMPLETED|Second Period (8 Weeks)||0
182453|NCT01417481|444558|P1|NOT COMPLETED|Second Period (8 Weeks)||0
182454|NCT01417481|444557|P2|COMPLETED|Second Period (8 Weeks)||5
182455|NCT01417481|444558|P1|COMPLETED|Second Period (8 Weeks)||8
182456|NCT01417481|444557|P2|STARTED|Second Period (8 Weeks)||5
182457|NCT01417481|444558|P1|STARTED|Second Period (8 Weeks)||8
182458|NCT01417481|444557|P2|NOT COMPLETED|Washout (2 Weeks)||0
182459|NCT01417481|444558|P1|NOT COMPLETED|Washout (2 Weeks)||0
182460|NCT01417481|444557|P2|COMPLETED|Washout (2 Weeks)||5
182461|NCT01417481|444558|P1|COMPLETED|Washout (2 Weeks)||8
182462|NCT01417481|444557|P2|STARTED|Washout (2 Weeks)||5
182463|NCT01417481|444558|P1|STARTED|Washout (2 Weeks)||8
182464|NCT01417481|444557|P2|NOT COMPLETED|First Intervention (8 Weeks)||2
182465|NCT01417481|444558|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
182466|NCT01417481|444557|P2|COMPLETED|First Intervention (8 Weeks)||5
182467|NCT01417481|444558|P1|COMPLETED|First Intervention (8 Weeks)||8
182468|NCT01417481|444557|P2|STARTED|First Intervention (8 Weeks)||7
182469|NCT01417481|444558|P1|STARTED|First Intervention (8 Weeks)||8
182470|NCT01417455|444590|P8|NOT COMPLETED|Overall Study||0
182471|NCT01417455|444591|P7|NOT COMPLETED|Overall Study||0
182472|NCT01417455|444592|P6|NOT COMPLETED|Overall Study||0
182473|NCT01417455|444593|P5|NOT COMPLETED|Overall Study||0
182474|NCT01417455|444594|P4|NOT COMPLETED|Overall Study||0
182475|NCT01417455|444595|P3|NOT COMPLETED|Overall Study||0
182476|NCT01417455|444596|P2|NOT COMPLETED|Overall Study||0
182477|NCT01417455|444597|P1|NOT COMPLETED|Overall Study||0
182478|NCT01417455|444590|P8|COMPLETED|Overall Study||25
182479|NCT01417455|444591|P7|COMPLETED|Overall Study||13
182480|NCT01417455|444592|P6|COMPLETED|Overall Study||13
182481|NCT01417455|444593|P5|COMPLETED|Overall Study||30
182482|NCT01417455|444594|P4|COMPLETED|Overall Study||17
182483|NCT01417455|444595|P3|COMPLETED|Overall Study||17
182484|NCT01417455|444596|P2|COMPLETED|Overall Study||16
182485|NCT01417455|444597|P1|COMPLETED|Overall Study||16
182486|NCT01417455|444590|P8|STARTED|Overall Study||25
182487|NCT01417455|444591|P7|STARTED|Overall Study||13
182488|NCT01417455|444592|P6|STARTED|Overall Study||13
182489|NCT01417455|444593|P5|STARTED|Overall Study||30
182490|NCT01417455|444594|P4|STARTED|Overall Study||17
182491|NCT01417455|444595|P3|STARTED|Overall Study||17
182492|NCT01417455|444596|P2|STARTED|Overall Study||16
182493|NCT01417455|444597|P1|STARTED|Overall Study||16
182494|NCT01417377|444623|P1|NOT COMPLETED|Overall Study||13
182495|NCT01417377|444623|P1|COMPLETED|Overall Study||9
182496|NCT01417377|444623|P1|Treated|Overall Study||21
182497|NCT01417377|444623|P1|STARTED|Overall Study||22
182498|NCT01417195|444632|P2|NOT COMPLETED|Overall Study||1
182499|NCT01417195|444633|P1|NOT COMPLETED|Overall Study||3
182500|NCT01417195|444632|P2|COMPLETED|Overall Study||61
182501|NCT01417195|444633|P1|COMPLETED|Overall Study||57
182502|NCT01417195|444632|P2|STARTED|Overall Study||62
182503|NCT01417195|444633|P1|STARTED|Overall Study||60
182504|NCT01417156|444649|P1|NOT COMPLETED|Overall Study||14
182505|NCT01417156|444649|P1|COMPLETED|Overall Study||6
182506|NCT01417156|444649|P1|STARTED|Overall Study||20
182507|NCT01417104|444659|P2|NOT COMPLETED|Overall Study||2
182508|NCT01417104|444660|P1|NOT COMPLETED|Overall Study||6
182509|NCT01417104|444659|P2|COMPLETED|Overall Study||35
182510|NCT01417104|444660|P1|COMPLETED|Overall Study||28
182511|NCT01417104|444659|P2|STARTED|Overall Study||37
182512|NCT01417104|444660|P1|STARTED|Overall Study||34
182513|NCT01417078|444670|P1|NOT COMPLETED|Overall Study||1
182514|NCT01417078|444670|P1|COMPLETED|Overall Study||30
182515|NCT01417078|444670|P1|STARTED|Overall Study||31
182516|NCT01417026|444682|P2|NOT COMPLETED|Overall Study||0
182517|NCT01417026|444683|P1|NOT COMPLETED|Overall Study||2
182518|NCT01417026|444682|P2|COMPLETED|Overall Study||13
182519|NCT01417026|444683|P1|COMPLETED|Overall Study||14
182520|NCT01417026|444682|P2|STARTED|Overall Study||13
182521|NCT01417026|444683|P1|STARTED|Overall Study||16
182522|NCT01417000|444695|P2|NOT COMPLETED|Overall Study||29
182523|NCT01417000|444696|P1|NOT COMPLETED|Overall Study||61
182524|NCT01417000|444695|P2|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
182525|NCT01417000|444696|P1|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
182526|NCT01417000|444695|P2|STARTED|Overall Study|31 subjects randomized into Cy/GVAX arm; 29 subjects received ≥ 1 protocol-specified drug.|29
182527|NCT01417000|444696|P1|STARTED|Overall Study|62 subjects randomized into Cy/GVAX + CRS-207 arm; 61 subjects received ≥ 1 protocol-specified drug.|61
182528|NCT01416987|444704|P1|NOT COMPLETED|Overall Study||0
182529|NCT01416987|444704|P1|COMPLETED|Overall Study||600
182530|NCT01416987|444704|P1|STARTED|Overall Study||600
182531|NCT01416805|444713|P2|NOT COMPLETED|Overall Study||4
182532|NCT01416805|444714|P1|NOT COMPLETED|Overall Study||4
182533|NCT01416805|444713|P2|COMPLETED|Overall Study||47
182534|NCT01416805|444714|P1|COMPLETED|Overall Study||45
182535|NCT01416805|444713|P2|STARTED|Overall Study||51
182536|NCT01416805|444714|P1|STARTED|Overall Study||49
182537|NCT01416636|444724|P2|NOT COMPLETED|Overall Study||6
182538|NCT01416636|444725|P1|NOT COMPLETED|Overall Study||8
182539|NCT01416636|444724|P2|COMPLETED|Overall Study||46
182540|NCT01416636|444725|P1|COMPLETED|Overall Study||45
182541|NCT01416636|444724|P2|STARTED|Overall Study||52
182542|NCT01416636|444725|P1|STARTED|Overall Study||53
182543|NCT01416610|444753|P1|NOT COMPLETED|Overall Study||43
182544|NCT01416610|444753|P1|COMPLETED|Overall Study||45
182545|NCT01416610|444753|P1|Completed Follow-up|Overall Study||45
182546|NCT01416610|444753|P1|Completed Treatment|Overall Study||47
182547|NCT01416610|444753|P1|Per Protocol|Overall Study||83
182548|NCT01416610|444753|P1|Safety Population|Overall Study||86
182549|NCT01416610|444753|P1|Intention to Treat|Overall Study||88
182550|NCT01416610|444753|P1|STARTED|Overall Study||88
182551|NCT01416584|444770|P3|NOT COMPLETED|Overall Study||1
182552|NCT01416584|444771|P2|NOT COMPLETED|Overall Study||2
182553|NCT01416584|444772|P1|NOT COMPLETED|Overall Study||3
182554|NCT01416584|444770|P3|COMPLETED|Overall Study||32
182555|NCT01416584|444771|P2|COMPLETED|Overall Study||33
182556|NCT01416584|444772|P1|COMPLETED|Overall Study||27
182557|NCT01416584|444770|P3|STARTED|Overall Study||33
182558|NCT01416584|444771|P2|STARTED|Overall Study||35
182559|NCT01416584|444772|P1|STARTED|Overall Study||30
182560|NCT01416571|444807|P1|NOT COMPLETED|Overall Study||2
182561|NCT01416571|444807|P1|COMPLETED|Overall Study|Number of subjects completed at Day 385.|76
182562|NCT01416571|444807|P1|STARTED|Overall Study||78
182563|NCT01416389|444836|P2|NOT COMPLETED|Overall Study||0
182564|NCT01416389|444837|P1|NOT COMPLETED|Overall Study||3
182565|NCT01416389|444836|P2|COMPLETED|Overall Study||13
182566|NCT01416389|444837|P1|COMPLETED|Overall Study||23
182567|NCT01416389|444836|P2|Received at Least 1 Dose of Study Drug|Overall Study||13
182568|NCT01416389|444837|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
182569|NCT01416389|444836|P2|STARTED|Overall Study||13
182570|NCT01416389|444837|P1|STARTED|Overall Study||26
182571|NCT01416272|444854|P1|NOT COMPLETED|Overall Study||4
182572|NCT01416272|444854|P1|COMPLETED|Overall Study||8
182573|NCT01416272|444854|P1|STARTED|Overall Study||12
182574|NCT01416181|444862|P2|NOT COMPLETED|Part 2||286
182575|NCT01416181|444863|P1|NOT COMPLETED|Part 2||271
182576|NCT01416181|444862|P2|COMPLETED|Part 2||6
182577|NCT01416181|444863|P1|COMPLETED|Part 2||3
182578|NCT01416181|444862|P2|Completed Treatment for > 96 Weeks|Part 2||0
182579|NCT01416181|444863|P1|Completed Treatment for > 96 Weeks|Part 2||1
182580|NCT01416181|444862|P2|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|0
182581|NCT01416181|444863|P1|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|1
182582|NCT01416181|444862|P2|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|111
182583|NCT01416181|444863|P1|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|98
182584|NCT01416181|444862|P2|STARTED|Part 2||292
182585|NCT01416181|444863|P1|STARTED|Part 2||274
182586|NCT01416181|444862|P2|NOT COMPLETED|Part 1||114
182587|NCT01416181|444863|P1|NOT COMPLETED|Part 1||137
182588|NCT01416181|444862|P2|COMPLETED|Part 1|Completed Study through Week 108|326
182589|NCT01416181|444863|P1|COMPLETED|Part 1|Completed Study through Week 108|312
182590|NCT01416181|444862|P2|Withdrew Prior to Dosing|Part 1||1
182591|NCT01416181|444863|P1|Withdrew Prior to Dosing|Part 1||0
182592|NCT01416181|444862|P2|STARTED|Part 1||440
182593|NCT01416181|444863|P1|STARTED|Part 1||449
182594|NCT01416155|444925|P1|NOT COMPLETED|Overall Study||58
182595|NCT01416155|444925|P1|COMPLETED|Overall Study||39
182596|NCT01416155|444925|P1|STARTED|Overall Study||97
182597|NCT01416142|444932|P3|NOT COMPLETED|PureVision2 HD||1
182598|NCT01416142|444933|P2|NOT COMPLETED|PureVision2 HD||0
182599|NCT01416142|444934|P1|NOT COMPLETED|PureVision2 HD||0
182600|NCT01416142|444932|P3|COMPLETED|PureVision2 HD||62
182601|NCT01416142|444933|P2|COMPLETED|PureVision2 HD||0
182602|NCT01416142|444934|P1|COMPLETED|PureVision2 HD||0
182603|NCT01416142|444932|P3|STARTED|PureVision2 HD||63
182604|NCT01416142|444933|P2|STARTED|PureVision2 HD||0
182605|NCT01416142|444934|P1|STARTED|PureVision2 HD||0
182606|NCT01416142|444932|P3|NOT COMPLETED|Cross Over at Movie Intermission||0
182607|NCT01416142|444933|P2|NOT COMPLETED|Cross Over at Movie Intermission||0
182608|NCT01416142|444934|P1|NOT COMPLETED|Cross Over at Movie Intermission||0
182609|NCT01416142|444932|P3|COMPLETED|Cross Over at Movie Intermission||0
182610|NCT01416142|444933|P2|COMPLETED|Cross Over at Movie Intermission||31
182611|NCT01416142|444934|P1|COMPLETED|Cross Over at Movie Intermission||32
182612|NCT01416142|444932|P3|STARTED|Cross Over at Movie Intermission||0
182613|NCT01416142|444933|P2|STARTED|Cross Over at Movie Intermission||31
182614|NCT01416142|444934|P1|STARTED|Cross Over at Movie Intermission||32
182615|NCT01416129|444945|P2|NOT COMPLETED|Experimental Condition: Brimless||0
182616|NCT01416129|444946|P1|NOT COMPLETED|Experimental Condition: Brimless||0
182617|NCT01416129|444945|P2|COMPLETED|Experimental Condition: Brimless||5
182618|NCT01416129|444946|P1|COMPLETED|Experimental Condition: Brimless||5
182619|NCT01416129|444945|P2|STARTED|Experimental Condition: Brimless||5
182620|NCT01416129|444946|P1|STARTED|Experimental Condition: Brimless||5
182621|NCT01416129|444945|P2|NOT COMPLETED|Control Condition: Ischial Containment||0
182622|NCT01416129|444946|P1|NOT COMPLETED|Control Condition: Ischial Containment||0
182623|NCT01416129|444945|P2|COMPLETED|Control Condition: Ischial Containment||5
182624|NCT01416129|444946|P1|COMPLETED|Control Condition: Ischial Containment||5
182625|NCT01416129|444945|P2|STARTED|Control Condition: Ischial Containment||5
182626|NCT01416129|444946|P1|STARTED|Control Condition: Ischial Containment||5
182627|NCT01416025|444954|P2|NOT COMPLETED|Overall Study||0
182628|NCT01416025|444955|P1|NOT COMPLETED|Overall Study||0
182629|NCT01416025|444954|P2|COMPLETED|Overall Study||15
182630|NCT01416025|444955|P1|COMPLETED|Overall Study||14
182631|NCT01416025|444954|P2|STARTED|Overall Study||15
182632|NCT01416025|444955|P1|STARTED|Overall Study||14
182633|NCT01415986|444961|P1|NOT COMPLETED|Overall Study||1
182634|NCT01415986|444961|P1|COMPLETED|Overall Study|Study terminated|0
182635|NCT01415986|444961|P1|STARTED|Overall Study||1
182636|NCT01415960|444966|P1|NOT COMPLETED|Overall Study||12
182637|NCT01415960|444966|P1|COMPLETED|Overall Study|Patients completed Study (151) Per protocol Patients (146)|151
182638|NCT01415960|444966|P1|PK Subgroup|Overall Study||30
182639|NCT01415960|444966|P1|ITT|Overall Study||161
182640|NCT01415960|444966|P1|STARTED|Overall Study||163
182641|NCT01415934|444978|P2|NOT COMPLETED|Overall Study||7
182642|NCT01415934|444979|P1|NOT COMPLETED|Overall Study||3
182643|NCT01415934|444978|P2|COMPLETED|Overall Study||182
182644|NCT01415934|444979|P1|COMPLETED|Overall Study||189
182645|NCT01415934|444978|P2|STARTED|Overall Study||189
182646|NCT01415934|444979|P1|STARTED|Overall Study||192
182647|NCT01415921|444987|P2|NOT COMPLETED|Overall Study||3
182648|NCT01415921|444988|P1|NOT COMPLETED|Overall Study||3
182649|NCT01415921|444987|P2|COMPLETED|Overall Study||14
182650|NCT01415921|444988|P1|COMPLETED|Overall Study||13
182651|NCT01415921|444987|P2|STARTED|Overall Study||17
182652|NCT01415921|444988|P1|STARTED|Overall Study||16
182653|NCT01415908|444998|P2|NOT COMPLETED|Overall Study||0
182654|NCT01415908|444999|P1|NOT COMPLETED|Overall Study||1
182655|NCT01415908|444998|P2|COMPLETED|Overall Study||4
182656|NCT01415908|444999|P1|COMPLETED|Overall Study||10
182657|NCT01415908|444998|P2|STARTED|Overall Study||4
182658|NCT01415908|444999|P1|STARTED|Overall Study||11
182659|NCT01415583|445027|P2|NOT COMPLETED|Overall Study||0
182660|NCT01415583|445028|P1|NOT COMPLETED|Overall Study||0
182661|NCT01415583|445027|P2|COMPLETED|Overall Study||157
182662|NCT01415583|445028|P1|COMPLETED|Overall Study||157
182663|NCT01415583|445027|P2|STARTED|Overall Study||157
182664|NCT01415583|445028|P1|STARTED|Overall Study||157
182665|NCT01415531|445036|P2|NOT COMPLETED|Overall Study||37
182666|NCT01415531|445037|P1|NOT COMPLETED|Overall Study||25
182667|NCT01415531|445036|P2|COMPLETED|Overall Study||390
182668|NCT01415531|445037|P1|COMPLETED|Overall Study||189
182669|NCT01415531|445036|P2|STARTED|Overall Study||427
182670|NCT01415531|445037|P1|STARTED|Overall Study||214
182671|NCT01415518|445047|P2|NOT COMPLETED|Overall Study||31
182672|NCT01415518|445048|P1|NOT COMPLETED|Overall Study||16
182673|NCT01415518|445047|P2|COMPLETED|Overall Study||261
182674|NCT01415518|445048|P1|COMPLETED|Overall Study||276
182675|NCT01415518|445047|P2|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 292 patients. Safety analysis used 292-3=289 patients.|289
182676|NCT01415518|445048|P1|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 290 patients. Safety analysis used 290+3=293 patients.|290
182677|NCT01415518|445047|P2|Patients Who Received Study Treatment|Overall Study||292
182678|NCT01415518|445048|P1|Patients Who Received Study Treatment|Overall Study||290
182679|NCT01415518|445047|P2|STARTED|Overall Study||292
182680|NCT01415518|445048|P1|STARTED|Overall Study||292
182681|NCT01415453|445100|P1|NOT COMPLETED|Overall Study||0
182682|NCT01415453|445100|P1|COMPLETED|Overall Study||1
182683|NCT01415453|445100|P1|Imaging Study|Overall Study||1
182684|NCT01415453|445100|P1|STARTED|Overall Study||1
182685|NCT01415440|445107|P3|NOT COMPLETED|Overall Study||2
182686|NCT01415440|445108|P2|NOT COMPLETED|Overall Study||1
182687|NCT01415440|445109|P1|NOT COMPLETED|Overall Study||4
182688|NCT01415440|445107|P3|COMPLETED|Overall Study||27
182689|NCT01415440|445108|P2|COMPLETED|Overall Study||28
182690|NCT01415440|445109|P1|COMPLETED|Overall Study||37
182691|NCT01415440|445107|P3|STARTED|Overall Study||29
182692|NCT01415440|445108|P2|STARTED|Overall Study||29
182693|NCT01415440|445109|P1|STARTED|Overall Study||41
182694|NCT01415427|445120|P4|NOT COMPLETED|Overall Study||56
182695|NCT01415427|445121|P3|NOT COMPLETED|Overall Study||58
182696|NCT01415427|445122|P2|NOT COMPLETED|Overall Study||29
182697|NCT01415427|445123|P1|NOT COMPLETED|Overall Study||29
182698|NCT01415427|445120|P4|COMPLETED|Overall Study||0
182699|NCT01415427|445121|P3|COMPLETED|Overall Study||1
182700|NCT01415427|445122|P2|COMPLETED|Overall Study||0
182701|NCT01415427|445123|P1|COMPLETED|Overall Study||0
182702|NCT01415427|445120|P4|STARTED|Overall Study||56
182703|NCT01415427|445121|P3|STARTED|Overall Study||59
182704|NCT01415427|445122|P2|STARTED|Overall Study||29
182705|NCT01415427|445123|P1|STARTED|Overall Study||29
182706|NCT01415401|445160|P1|NOT COMPLETED|Overall Study||7
182707|NCT01415401|445160|P1|COMPLETED|Overall Study||47
182708|NCT01415401|445160|P1|STARTED|Overall Study||54
182709|NCT01415349|445165|P2|NOT COMPLETED|Treatment Period 2||0
182710|NCT01415349|445166|P1|NOT COMPLETED|Treatment Period 2||0
182711|NCT01415349|445165|P2|COMPLETED|Treatment Period 2||19
182712|NCT01415349|445166|P1|COMPLETED|Treatment Period 2||21
182713|NCT01415349|445165|P2|STARTED|Treatment Period 2||19
182714|NCT01415349|445166|P1|STARTED|Treatment Period 2||21
182715|NCT01415349|445165|P2|NOT COMPLETED|Treatment Period 1||2
182716|NCT01415349|445166|P1|NOT COMPLETED|Treatment Period 1||0
182717|NCT01415349|445165|P2|COMPLETED|Treatment Period 1||19
182718|NCT01415349|445166|P1|COMPLETED|Treatment Period 1||21
182719|NCT01415349|445165|P2|STARTED|Treatment Period 1||21
182720|NCT01415349|445166|P1|STARTED|Treatment Period 1||21
182721|NCT01415232|445174|P1|NOT COMPLETED|Overall Study||0
182722|NCT01415232|445174|P1|COMPLETED|Overall Study||160
182723|NCT01415232|445174|P1|STARTED|Overall Study||160
182724|NCT01414855|445178|P1|NOT COMPLETED|Overall Study||29
182725|NCT01414855|445178|P1|COMPLETED|Overall Study||71
182726|NCT01414855|445178|P1|STARTED|Overall Study||100
182727|NCT01414634|445194|P8|NOT COMPLETED|Overall Study||0
182728|NCT01414634|445195|P7|NOT COMPLETED|Overall Study||0
182729|NCT01414634|445196|P6|NOT COMPLETED|Overall Study||0
182730|NCT01414634|445197|P5|NOT COMPLETED|Overall Study||0
182731|NCT01414634|445198|P4|NOT COMPLETED|Overall Study||0
182732|NCT01414634|445199|P3|NOT COMPLETED|Overall Study||0
182733|NCT01414634|445200|P2|NOT COMPLETED|Overall Study||0
182734|NCT01414634|445201|P1|NOT COMPLETED|Overall Study||0
182735|NCT01414634|445194|P8|COMPLETED|Overall Study||1
182736|NCT01414634|445195|P7|COMPLETED|Overall Study||1
182737|NCT01414634|445196|P6|COMPLETED|Overall Study||2
182738|NCT01414634|445197|P5|COMPLETED|Overall Study||1
182739|NCT01414634|445198|P4|COMPLETED|Overall Study||1
182740|NCT01414634|445199|P3|COMPLETED|Overall Study||1
182741|NCT01414634|445200|P2|COMPLETED|Overall Study||1
182742|NCT01414634|445201|P1|COMPLETED|Overall Study||1
182743|NCT01414634|445194|P8|STARTED|Overall Study||1
182744|NCT01414634|445195|P7|STARTED|Overall Study||1
182745|NCT01414634|445196|P6|STARTED|Overall Study||2
182746|NCT01414634|445197|P5|STARTED|Overall Study||1
182747|NCT01414634|445198|P4|STARTED|Overall Study||1
182748|NCT01414634|445199|P3|STARTED|Overall Study||1
182749|NCT01414634|445200|P2|STARTED|Overall Study||1
182750|NCT01414634|445201|P1|STARTED|Overall Study||1
182751|NCT01414413|445214|P2|NOT COMPLETED|Overall Study||0
182752|NCT01414413|445215|P1|NOT COMPLETED|Overall Study||0
182753|NCT01414413|445214|P2|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8466
182754|NCT01414413|445215|P1|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8194
182755|NCT01414413|445214|P2|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8466
182756|NCT01414413|445215|P1|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8194
182757|NCT01414257|445227|P1|NOT COMPLETED|Overall Study||22
182758|NCT01414257|445227|P1|COMPLETED|Overall Study||2838
182759|NCT01414257|445227|P1|STARTED|Overall Study||2860
182760|NCT01414244|445240|P2|NOT COMPLETED|Overall Study||0
182761|NCT01414244|445241|P1|NOT COMPLETED|Overall Study||0
182762|NCT01414244|445240|P2|COMPLETED|Overall Study||52
182763|NCT01414244|445241|P1|COMPLETED|Overall Study||54
182764|NCT01414244|445240|P2|STARTED|Overall Study||52
182765|NCT01414244|445241|P1|STARTED|Overall Study||54
182766|NCT01414205|445255|P2|NOT COMPLETED|Overall Study||7
182767|NCT01414205|445256|P1|NOT COMPLETED|Overall Study||7
182768|NCT01414205|445255|P2|COMPLETED|Overall Study||32
182769|NCT01414205|445256|P1|COMPLETED|Overall Study||34
182770|NCT01414205|445255|P2|Received Study Drug|Overall Study||38
182771|NCT01414205|445256|P1|Received Study Drug|Overall Study||40
182772|NCT01414205|445255|P2|STARTED|Overall Study||39
182773|NCT01414205|445256|P1|STARTED|Overall Study||41
182774|NCT01414192|445292|P4|NOT COMPLETED|Overall Study||0
182775|NCT01414192|445293|P3|NOT COMPLETED|Overall Study||0
182776|NCT01414192|445294|P2|NOT COMPLETED|Overall Study||0
182777|NCT01414192|445295|P1|NOT COMPLETED|Overall Study||0
182778|NCT01414192|445292|P4|COMPLETED|Overall Study||1726
182779|NCT01414192|445293|P3|COMPLETED|Overall Study||424
182780|NCT01414192|445294|P2|COMPLETED|Overall Study||575
182781|NCT01414192|445295|P1|COMPLETED|Overall Study||490
182782|NCT01414192|445292|P4|STARTED|Overall Study||1726
182783|NCT01414192|445293|P3|STARTED|Overall Study||424
182784|NCT01414192|445294|P2|STARTED|Overall Study||575
182785|NCT01414192|445295|P1|STARTED|Overall Study||490
182786|NCT01414166|445325|P2|NOT COMPLETED|Overall Study||83
182787|NCT01414166|445326|P1|NOT COMPLETED|Overall Study||91
182788|NCT01414166|445325|P2|COMPLETED|Overall Study||39
182789|NCT01414166|445326|P1|COMPLETED|Overall Study||31
182790|NCT01414166|445325|P2|Treated|Overall Study||121
182791|NCT01414166|445326|P1|Treated|Overall Study||120
182792|NCT01414166|445325|P2|STARTED|Overall Study||122
182793|NCT01414166|445326|P1|STARTED|Overall Study||122
182794|NCT01414153|445352|P4|NOT COMPLETED|Overall Study||4
182795|NCT01414153|445353|P3|NOT COMPLETED|Overall Study||4
182796|NCT01414153|445354|P2|NOT COMPLETED|Overall Study||2
182797|NCT01414153|445355|P1|NOT COMPLETED|Overall Study||8
182798|NCT01414153|445352|P4|COMPLETED|Overall Study||37
182799|NCT01414153|445353|P3|COMPLETED|Overall Study||35
182800|NCT01414153|445354|P2|COMPLETED|Overall Study||38
182801|NCT01414153|445355|P1|COMPLETED|Overall Study||30
182802|NCT01414153|445352|P4|STARTED|Overall Study||41
182803|NCT01414153|445353|P3|STARTED|Overall Study||39
182804|NCT01414153|445354|P2|STARTED|Overall Study||40
182805|NCT01414153|445355|P1|STARTED|Overall Study||38
182806|NCT01414114|445389|P1|NOT COMPLETED|Overall Study||5
182807|NCT01414114|445389|P1|COMPLETED|Overall Study|Completed 12-week treatment period|32
182808|NCT01414114|445389|P1|STARTED|Overall Study||37
182809|NCT01414036|445409|P2|NOT COMPLETED|Completed 3 Month Survey||5
182810|NCT01414036|445410|P1|NOT COMPLETED|Completed 3 Month Survey||9
182811|NCT01414036|445409|P2|COMPLETED|Completed 3 Month Survey||19
182812|NCT01414036|445410|P1|COMPLETED|Completed 3 Month Survey||14
182813|NCT01414036|445409|P2|STARTED|Completed 3 Month Survey||24
182814|NCT01414036|445410|P1|STARTED|Completed 3 Month Survey||23
182815|NCT01414036|445409|P2|NOT COMPLETED|Received Allocated Intervention||13
182816|NCT01414036|445410|P1|NOT COMPLETED|Received Allocated Intervention||0
182817|NCT01414036|445409|P2|COMPLETED|Received Allocated Intervention||11
182818|NCT01414036|445410|P1|COMPLETED|Received Allocated Intervention||23
182819|NCT01414036|445409|P2|STARTED|Received Allocated Intervention||24
182820|NCT01414036|445410|P1|STARTED|Received Allocated Intervention||23
182821|NCT01414010|445424|P4|NOT COMPLETED|Overall Study||0
182822|NCT01414010|445425|P3|NOT COMPLETED|Overall Study||0
182823|NCT01414010|445426|P2|NOT COMPLETED|Overall Study||0
182824|NCT01414010|445427|P1|NOT COMPLETED|Overall Study||2
182825|NCT01414010|445424|P4|COMPLETED|Overall Study||8
182826|NCT01414010|445425|P3|COMPLETED|Overall Study||8
182827|NCT01414010|445426|P2|COMPLETED|Overall Study||8
182828|NCT01414010|445427|P1|COMPLETED|Overall Study||6
182829|NCT01414010|445424|P4|STARTED|Overall Study||8
182830|NCT01414010|445425|P3|STARTED|Overall Study||8
182831|NCT01414010|445426|P2|STARTED|Overall Study||8
182832|NCT01414010|445427|P1|STARTED|Overall Study||8
182833|NCT01413958|445445|P2|NOT COMPLETED|Overall Study||1
182834|NCT01413958|445446|P1|NOT COMPLETED|Overall Study||0
182835|NCT01413958|445445|P2|COMPLETED|Overall Study||286
182836|NCT01413958|445446|P1|COMPLETED|Overall Study||288
182837|NCT01413958|445445|P2|STARTED|Overall Study||287
182838|NCT01413958|445446|P1|STARTED|Overall Study||288
182839|NCT01413750|445481|P4|NOT COMPLETED|Overall Study||0
182840|NCT01413750|445482|P3|NOT COMPLETED|Overall Study||0
182841|NCT01413750|445483|P2|NOT COMPLETED|Overall Study||0
182842|NCT01413750|445484|P1|NOT COMPLETED|Overall Study||0
182843|NCT01413750|445481|P4|COMPLETED|Overall Study||7
182844|NCT01413750|445482|P3|COMPLETED|Overall Study||4
182845|NCT01413750|445483|P2|COMPLETED|Overall Study||6
182846|NCT01413750|445484|P1|COMPLETED|Overall Study||6
182847|NCT01413750|445481|P4|STARTED|Overall Study||7
182848|NCT01413750|445482|P3|STARTED|Overall Study||4
182849|NCT01413750|445483|P2|STARTED|Overall Study||6
182850|NCT01413750|445484|P1|STARTED|Overall Study||6
182851|NCT01413542|445497|P4|NOT COMPLETED|Overall Study||1
182852|NCT01413542|445498|P3|NOT COMPLETED|Overall Study||3
182853|NCT01413542|445499|P2|NOT COMPLETED|Overall Study||0
182854|NCT01413542|445500|P1|NOT COMPLETED|Overall Study||1
182855|NCT01413542|445497|P4|COMPLETED|Overall Study||7
182856|NCT01413542|445498|P3|COMPLETED|Overall Study||6
182857|NCT01413542|445499|P2|COMPLETED|Overall Study||6
182858|NCT01413542|445500|P1|COMPLETED|Overall Study||5
182859|NCT01413542|445497|P4|STARTED|Overall Study||8
182860|NCT01413542|445498|P3|STARTED|Overall Study||9
182861|NCT01413542|445499|P2|STARTED|Overall Study||6
182862|NCT01413542|445500|P1|STARTED|Overall Study||6
182863|NCT01413516|445515|P2|NOT COMPLETED|Overall Study||0
182864|NCT01413516|445516|P1|NOT COMPLETED|Overall Study||0
182865|NCT01413516|445515|P2|COMPLETED|Overall Study||9
182866|NCT01413516|445516|P1|COMPLETED|Overall Study||8
182867|NCT01413516|445515|P2|STARTED|Overall Study||9
182868|NCT01413516|445516|P1|STARTED|Overall Study||8
182869|NCT01413503|445522|P1|NOT COMPLETED|Overall Study||1
182870|NCT01413503|445522|P1|COMPLETED|Overall Study||49
182871|NCT01413503|445522|P1|STARTED|Overall Study||50
182872|NCT01413360|445526|P1|NOT COMPLETED|Overall Study||3
182873|NCT01413360|445526|P1|COMPLETED|Overall Study||7
182874|NCT01413360|445526|P1|STARTED|Overall Study||10
182875|NCT01413204|445534|P3|NOT COMPLETED|Overall Study||19
182876|NCT01413204|445535|P2|NOT COMPLETED|Overall Study||6
182877|NCT01413204|445536|P1|NOT COMPLETED|Overall Study||6
182878|NCT01413204|445534|P3|COMPLETED|Overall Study||74
182879|NCT01413204|445535|P2|COMPLETED|Overall Study||83
182880|NCT01413204|445536|P1|COMPLETED|Overall Study||84
182881|NCT01413204|445534|P3|STARTED|Overall Study||93
182882|NCT01413204|445535|P2|STARTED|Overall Study||89
182883|NCT01413204|445536|P1|STARTED|Overall Study||90
182884|NCT01413191|445544|P1|NOT COMPLETED|Overall Study||11
182885|NCT01413191|445544|P1|COMPLETED|Overall Study||7
182886|NCT01413191|445544|P1|STARTED|Overall Study||18
182887|NCT01413087|445550|P2|NOT COMPLETED|Overall Study||0
182888|NCT01413087|445551|P1|NOT COMPLETED|Overall Study||0
182889|NCT01413087|445550|P2|COMPLETED|Overall Study||6
182890|NCT01413087|445551|P1|COMPLETED|Overall Study||6
182891|NCT01413087|445550|P2|STARTED|Overall Study||6
182892|NCT01413087|445551|P1|STARTED|Overall Study||6
182893|NCT01412983|445577|P2|NOT COMPLETED|2nd Period||0
182894|NCT01412983|445578|P1|NOT COMPLETED|2nd Period||0
182895|NCT01412983|445577|P2|COMPLETED|2nd Period||46
182896|NCT01412983|445578|P1|COMPLETED|2nd Period||50
182897|NCT01412983|445577|P2|STARTED|2nd Period||46
182898|NCT01412983|445578|P1|STARTED|2nd Period||50
182899|NCT01412983|445577|P2|NOT COMPLETED|1st Period||4
182900|NCT01412983|445578|P1|NOT COMPLETED|1st Period||0
182901|NCT01412983|445577|P2|COMPLETED|1st Period||46
182902|NCT01412983|445578|P1|COMPLETED|1st Period||50
182903|NCT01412983|445577|P2|STARTED|1st Period||50
182904|NCT01412983|445578|P1|STARTED|1st Period||50
182905|NCT01412957|445588|P2|NOT COMPLETED|Overall Study||157
182906|NCT01412957|445589|P1|NOT COMPLETED|Overall Study||149
182907|NCT01412957|445588|P2|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|31
182908|NCT01412957|445589|P1|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|40
182909|NCT01412957|445588|P2|STARTED|Overall Study||188
182910|NCT01412957|445589|P1|STARTED|Overall Study||189
182911|NCT01412944|445611|P6|NOT COMPLETED|Follow-up||0
182912|NCT01412944|445612|P5|NOT COMPLETED|Follow-up||0
182913|NCT01412944|445613|P4|NOT COMPLETED|Follow-up||0
182914|NCT01412944|445614|P3|NOT COMPLETED|Follow-up||0
182915|NCT01412944|445615|P2|NOT COMPLETED|Follow-up||0
182916|NCT01412944|445616|P1|NOT COMPLETED|Follow-up||0
182917|NCT01412944|445611|P6|COMPLETED|Follow-up||0
182918|NCT01412944|445612|P5|COMPLETED|Follow-up||2
182919|NCT01412944|445613|P4|COMPLETED|Follow-up||1
182920|NCT01412944|445614|P3|COMPLETED|Follow-up||2
182921|NCT01412944|445615|P2|COMPLETED|Follow-up||0
182922|NCT01412944|445616|P1|COMPLETED|Follow-up||0
182923|NCT01412944|445611|P6|STARTED|Follow-up||0
182924|NCT01412944|445612|P5|STARTED|Follow-up||2
182925|NCT01412944|445613|P4|STARTED|Follow-up||1
182926|NCT01412944|445614|P3|STARTED|Follow-up||2
182927|NCT01412944|445615|P2|STARTED|Follow-up||0
182928|NCT01412944|445616|P1|STARTED|Follow-up||0
182929|NCT01412944|445611|P6|NOT COMPLETED|Entire: IV + Maintenance||0
182930|NCT01412944|445612|P5|NOT COMPLETED|Entire: IV + Maintenance||0
182931|NCT01412944|445613|P4|NOT COMPLETED|Entire: IV + Maintenance||0
182932|NCT01412944|445614|P3|NOT COMPLETED|Entire: IV + Maintenance||0
182933|NCT01412944|445615|P2|NOT COMPLETED|Entire: IV + Maintenance||5
182934|NCT01412944|445616|P1|NOT COMPLETED|Entire: IV + Maintenance||2
182935|NCT01412944|445611|P6|COMPLETED|Entire: IV + Maintenance||0
182936|NCT01412944|445612|P5|COMPLETED|Entire: IV + Maintenance||0
182937|NCT01412944|445613|P4|COMPLETED|Entire: IV + Maintenance||0
182938|NCT01412944|445614|P3|COMPLETED|Entire: IV + Maintenance||0
182939|NCT01412944|445615|P2|COMPLETED|Entire: IV + Maintenance||17
182940|NCT01412944|445616|P1|COMPLETED|Entire: IV + Maintenance||19
182941|NCT01412944|445611|P6|STARTED|Entire: IV + Maintenance||0
182942|NCT01412944|445612|P5|STARTED|Entire: IV + Maintenance||0
182943|NCT01412944|445613|P4|STARTED|Entire: IV + Maintenance||0
182944|NCT01412944|445614|P3|STARTED|Entire: IV + Maintenance||0
182945|NCT01412944|445615|P2|STARTED|Entire: IV + Maintenance||22
182946|NCT01412944|445616|P1|STARTED|Entire: IV + Maintenance||21
182947|NCT01412944|445611|P6|NOT COMPLETED|Entire: IV + Maintenance||2
182948|NCT01412944|445612|P5|NOT COMPLETED|Entire: IV + Maintenance||3
182949|NCT01412944|445613|P4|NOT COMPLETED|Entire: IV + Maintenance||1
182950|NCT01412944|445614|P3|NOT COMPLETED|Entire: IV + Maintenance||1
182951|NCT01412944|445615|P2|NOT COMPLETED|Entire: IV + Maintenance||0
182952|NCT01412944|445616|P1|NOT COMPLETED|Entire: IV + Maintenance||0
182953|NCT01412944|445611|P6|COMPLETED|Entire: IV + Maintenance||6
182954|NCT01412944|445612|P5|COMPLETED|Entire: IV + Maintenance||11
182955|NCT01412944|445613|P4|COMPLETED|Entire: IV + Maintenance||5
182956|NCT01412944|445614|P3|COMPLETED|Entire: IV + Maintenance||14
182957|NCT01412944|445615|P2|COMPLETED|Entire: IV + Maintenance||0
182958|NCT01412944|445616|P1|COMPLETED|Entire: IV + Maintenance||0
182959|NCT01412944|445611|P6|STARTED|Entire: IV + Maintenance||8
182960|NCT01412944|445612|P5|STARTED|Entire: IV + Maintenance||14
182961|NCT01412944|445613|P4|STARTED|Entire: IV + Maintenance||6
182962|NCT01412944|445614|P3|STARTED|Entire: IV + Maintenance||15
182963|NCT01412944|445615|P2|STARTED|Entire: IV + Maintenance||0
182964|NCT01412944|445616|P1|STARTED|Entire: IV + Maintenance||0
182965|NCT01412944|445611|P6|NOT COMPLETED|IV: Per CAIN457A2307||0
182966|NCT01412944|445612|P5|NOT COMPLETED|IV: Per CAIN457A2307||0
182967|NCT01412944|445613|P4|NOT COMPLETED|IV: Per CAIN457A2307||0
182968|NCT01412944|445614|P3|NOT COMPLETED|IV: Per CAIN457A2307||0
182969|NCT01412944|445615|P2|NOT COMPLETED|IV: Per CAIN457A2307||2
182970|NCT01412944|445616|P1|NOT COMPLETED|IV: Per CAIN457A2307||1
182971|NCT01412944|445611|P6|COMPLETED|IV: Per CAIN457A2307||0
182972|NCT01412944|445612|P5|COMPLETED|IV: Per CAIN457A2307||0
182973|NCT01412944|445613|P4|COMPLETED|IV: Per CAIN457A2307||0
182974|NCT01412944|445614|P3|COMPLETED|IV: Per CAIN457A2307||0
182975|NCT01412944|445615|P2|COMPLETED|IV: Per CAIN457A2307||20
182976|NCT01412944|445616|P1|COMPLETED|IV: Per CAIN457A2307||20
182977|NCT01412944|445611|P6|STARTED|IV: Per CAIN457A2307||0
182978|NCT01412944|445612|P5|STARTED|IV: Per CAIN457A2307||0
182979|NCT01412944|445613|P4|STARTED|IV: Per CAIN457A2307||0
182980|NCT01412944|445614|P3|STARTED|IV: Per CAIN457A2307||0
182981|NCT01412944|445615|P2|STARTED|IV: Per CAIN457A2307||22
182982|NCT01412944|445616|P1|STARTED|IV: Per CAIN457A2307||21
182983|NCT01412944|445611|P6|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||2
182984|NCT01412944|445612|P5|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
182985|NCT01412944|445613|P4|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
182986|NCT01412944|445614|P3|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||1
182987|NCT01412944|445615|P2|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
182988|NCT01412944|445616|P1|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
182989|NCT01412944|445611|P6|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
182990|NCT01412944|445612|P5|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
182991|NCT01412944|445613|P4|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
182992|NCT01412944|445614|P3|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
182993|NCT01412944|445615|P2|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
182994|NCT01412944|445616|P1|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
182995|NCT01412944|445611|P6|STARTED|IV: Per Previous CAIN457A2304 Treatment||8
182996|NCT01412944|445612|P5|STARTED|IV: Per Previous CAIN457A2304 Treatment||14
182997|NCT01412944|445613|P4|STARTED|IV: Per Previous CAIN457A2304 Treatment||6
182998|NCT01412944|445614|P3|STARTED|IV: Per Previous CAIN457A2304 Treatment||15
182999|NCT01412944|445615|P2|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
183000|NCT01412944|445616|P1|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
183001|NCT01412918|445652|P2|NOT COMPLETED|Overall Study||0
183002|NCT01412918|445653|P1|NOT COMPLETED|Overall Study||0
183003|NCT01412918|445652|P2|COMPLETED|Overall Study||1
183004|NCT01412918|445653|P1|COMPLETED|Overall Study||20
183005|NCT01412918|445652|P2|STARTED|Overall Study||1
183006|NCT01412918|445653|P1|STARTED|Overall Study||20
183007|NCT01412879|445662|P3|NOT COMPLETED|Consolidation Therapy||0
183008|NCT01412879|445663|P2|NOT COMPLETED|Consolidation Therapy||0
183009|NCT01412879|445664|P1|NOT COMPLETED|Consolidation Therapy||0
183010|NCT01412879|445662|P3|COMPLETED|Consolidation Therapy||26
183011|NCT01412879|445663|P2|COMPLETED|Consolidation Therapy||0
183012|NCT01412879|445664|P1|COMPLETED|Consolidation Therapy||0
183013|NCT01412879|445662|P3|STARTED|Consolidation Therapy|Only eligible patients who are able to have stem cell harvested receive consolidation therapy.|26
183014|NCT01412879|445663|P2|STARTED|Consolidation Therapy||0
183015|NCT01412879|445664|P1|STARTED|Consolidation Therapy||0
183016|NCT01412879|445662|P3|NOT COMPLETED|Initial Registration (Induction Therapy)||0
183017|NCT01412879|445663|P2|NOT COMPLETED|Initial Registration (Induction Therapy)||8
183018|NCT01412879|445664|P1|NOT COMPLETED|Initial Registration (Induction Therapy)||13
183019|NCT01412879|445662|P3|COMPLETED|Initial Registration (Induction Therapy)||0
183020|NCT01412879|445663|P2|COMPLETED|Initial Registration (Induction Therapy)||27
183021|NCT01412879|445664|P1|COMPLETED|Initial Registration (Induction Therapy)||5
183022|NCT01412879|445662|P3|Treatment Started|Initial Registration (Induction Therapy)||0
183023|NCT01412879|445663|P2|Treatment Started|Initial Registration (Induction Therapy)||35
183024|NCT01412879|445664|P1|Treatment Started|Initial Registration (Induction Therapy)||17
183025|NCT01412879|445662|P3|STARTED|Initial Registration (Induction Therapy)||0
183026|NCT01412879|445663|P2|STARTED|Initial Registration (Induction Therapy)||35
183027|NCT01412879|445664|P1|STARTED|Initial Registration (Induction Therapy)||18
183028|NCT01412866|445680|P2|NOT COMPLETED|Overall Study||2
183029|NCT01412866|445681|P1|NOT COMPLETED|Overall Study||1
183030|NCT01412866|445680|P2|COMPLETED|Overall Study||64
183031|NCT01412866|445681|P1|COMPLETED|Overall Study||57
183032|NCT01412866|445680|P2|STARTED|Overall Study||66
183033|NCT01412866|445681|P1|STARTED|Overall Study||58
183034|NCT01412801|445693|P6|NOT COMPLETED|Overall Study||3
183035|NCT01412801|445694|P5|NOT COMPLETED|Overall Study||3
183036|NCT01412801|445695|P4|NOT COMPLETED|Overall Study||4
183037|NCT01412801|445696|P3|NOT COMPLETED|Overall Study||7
183038|NCT01412801|445697|P2|NOT COMPLETED|Overall Study||5
183039|NCT01412801|445698|P1|NOT COMPLETED|Overall Study||4
183040|NCT01412801|445693|P6|COMPLETED|Overall Study||84
183041|NCT01412801|445694|P5|COMPLETED|Overall Study||85
183042|NCT01412801|445695|P4|COMPLETED|Overall Study||87
183043|NCT01412801|445696|P3|COMPLETED|Overall Study||83
183044|NCT01412801|445697|P2|COMPLETED|Overall Study||84
183045|NCT01412801|445698|P1|COMPLETED|Overall Study||87
183046|NCT01412801|445693|P6|STARTED|Overall Study||87
183047|NCT01412801|445694|P5|STARTED|Overall Study||88
183048|NCT01412801|445695|P4|STARTED|Overall Study||91
183049|NCT01412801|445696|P3|STARTED|Overall Study||90
183050|NCT01412801|445697|P2|STARTED|Overall Study||89
183051|NCT01412801|445698|P1|STARTED|Overall Study||91
183052|NCT01412710|445737|P2|NOT COMPLETED|Overall Study||5
183053|NCT01412710|445738|P1|NOT COMPLETED|Overall Study||4
183054|NCT01412710|445737|P2|COMPLETED|Overall Study||22
183055|NCT01412710|445738|P1|COMPLETED|Overall Study||46
183056|NCT01412710|445737|P2|STARTED|Overall Study||27
183057|NCT01412710|445738|P1|STARTED|Overall Study||50
183058|NCT01412554|445746|P1|NOT COMPLETED|Overall Study||0
183059|NCT01412554|445746|P1|COMPLETED|Overall Study||103
183060|NCT01412554|445746|P1|STARTED|Overall Study|103 persons re-examined in 2012-13 out of 158 persons originally examined in 1991-96.|103
183061|NCT01412541|445752|P2|NOT COMPLETED|Overall Study||20
183062|NCT01412541|445753|P1|NOT COMPLETED|Overall Study||36
183063|NCT01412541|445752|P2|COMPLETED|Overall Study||140
183064|NCT01412541|445753|P1|COMPLETED|Overall Study||280
183065|NCT01412541|445752|P2|STARTED|Overall Study||160
183066|NCT01412541|445753|P1|STARTED|Overall Study||316
183067|NCT01412424|445861|P1|NOT COMPLETED|Extension Treatment Period||6
183068|NCT01412424|445861|P1|COMPLETED|Extension Treatment Period||82
183069|NCT01412424|445861|P1|STARTED|Extension Treatment Period|86% of participants who completed the core period voluntarily entered the optional extension period.|88
183070|NCT01412424|445861|P1|NOT COMPLETED|Core Treatment Period||53
183071|NCT01412424|445861|P1|COMPLETED|Core Treatment Period||102
183072|NCT01412424|445861|P1|STARTED|Core Treatment Period||155
183073|NCT01412333|445879|P2|NOT COMPLETED|Overall Study||57
183074|NCT01412333|445880|P1|NOT COMPLETED|Overall Study||98
183075|NCT01412333|445879|P2|COMPLETED|Overall Study||360
183076|NCT01412333|445880|P1|COMPLETED|Overall Study||320
183077|NCT01412333|445879|P2|STARTED|Overall Study||417
183078|NCT01412333|445880|P1|STARTED|Overall Study||418
183079|NCT01412281|445915|P4|NOT COMPLETED|Overall Study||0
183080|NCT01412281|445916|P3|NOT COMPLETED|Overall Study||0
183081|NCT01412281|445917|P2|NOT COMPLETED|Overall Study||0
183082|NCT01412281|445918|P1|NOT COMPLETED|Overall Study||0
183083|NCT01412281|445915|P4|COMPLETED|Overall Study||110
183084|NCT01412281|445916|P3|COMPLETED|Overall Study||110
183085|NCT01412281|445917|P2|COMPLETED|Overall Study||110
183086|NCT01412281|445918|P1|COMPLETED|Overall Study||110
183087|NCT01412281|445915|P4|STARTED|Overall Study||110
183088|NCT01412281|445916|P3|STARTED|Overall Study||110
183089|NCT01412281|445917|P2|STARTED|Overall Study||110
183090|NCT01412281|445918|P1|STARTED|Overall Study||110
183091|NCT01412229|445940|P1|NOT COMPLETED|Overall Study||1
183092|NCT01412229|445940|P1|COMPLETED|Overall Study||38
183093|NCT01412229|445940|P1|STARTED|Overall Study||39
183094|NCT01412164|445952|P1|NOT COMPLETED|Overall Study||47
183095|NCT01412164|445952|P1|COMPLETED|Overall Study||683
183096|NCT01412164|445952|P1|STARTED|Overall Study||730
183097|NCT01412151|445963|P1|NOT COMPLETED|Week 306 - 310 - Washout Period||2
183098|NCT01412151|445963|P1|COMPLETED|Week 306 - 310 - Washout Period||3
183099|NCT01412151|445963|P1|STARTED|Week 306 - 310 - Washout Period||5
183100|NCT01412151|445963|P1|NOT COMPLETED|Week 0 - 306 - Treatment Period||5
183101|NCT01412151|445963|P1|COMPLETED|Week 0 - 306 - Treatment Period||5
183102|NCT01412151|445963|P1|STARTED|Week 0 - 306 - Treatment Period||10
183103|NCT01412086|445969|P1|NOT COMPLETED|Overall Study||0
183104|NCT01412086|445969|P1|COMPLETED|Overall Study||112
183105|NCT01412086|445969|P1|STARTED|Overall Study||112
183106|NCT01412060|445974|P3|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83
183107|NCT01412060|445975|P2|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83
183108|NCT01412060|445976|P1|NOT COMPLETED|Double-blind Treatment Phase (DBP)||0
183109|NCT01412060|445974|P3|COMPLETED|Double-blind Treatment Phase (DBP)||18
183110|NCT01412060|445975|P2|COMPLETED|Double-blind Treatment Phase (DBP)||16
183111|NCT01412060|445976|P1|COMPLETED|Double-blind Treatment Phase (DBP)||0
183112|NCT01412060|445974|P3|STARTED|Double-blind Treatment Phase (DBP)||101
183113|NCT01412060|445975|P2|STARTED|Double-blind Treatment Phase (DBP)||99
183114|NCT01412060|445976|P1|STARTED|Double-blind Treatment Phase (DBP)||0
183115|NCT01412060|445974|P3|NOT COMPLETED|Period Between SP and DBP||0
183116|NCT01412060|445975|P2|NOT COMPLETED|Period Between SP and DBP||0
183117|NCT01412060|445976|P1|NOT COMPLETED|Period Between SP and DBP||64
183118|NCT01412060|445974|P3|COMPLETED|Period Between SP and DBP||0
183119|NCT01412060|445975|P2|COMPLETED|Period Between SP and DBP||0
183120|NCT01412060|445976|P1|COMPLETED|Period Between SP and DBP||200
183121|NCT01412060|445974|P3|STARTED|Period Between SP and DBP||0
183122|NCT01412060|445975|P2|STARTED|Period Between SP and DBP||0
183123|NCT01412060|445976|P1|STARTED|Period Between SP and DBP||264
183124|NCT01412060|445974|P3|NOT COMPLETED|Open-label Stabilization Period (SP)||0
183125|NCT01412060|445975|P2|NOT COMPLETED|Open-label Stabilization Period (SP)||0
183126|NCT01412060|445976|P1|NOT COMPLETED|Open-label Stabilization Period (SP)||100
183127|NCT01412060|445974|P3|COMPLETED|Open-label Stabilization Period (SP)||0
183128|NCT01412060|445975|P2|COMPLETED|Open-label Stabilization Period (SP)||0
183129|NCT01412060|445976|P1|COMPLETED|Open-label Stabilization Period (SP)||264
183130|NCT01412060|445974|P3|STARTED|Open-label Stabilization Period (SP)||0
183131|NCT01412060|445975|P2|STARTED|Open-label Stabilization Period (SP)||0
183132|NCT01412060|445976|P1|STARTED|Open-label Stabilization Period (SP)||364
183133|NCT01412060|445974|P3|NOT COMPLETED|Period Between RIP and SP||0
183134|NCT01412060|445975|P2|NOT COMPLETED|Period Between RIP and SP||0
183135|NCT01412060|445976|P1|NOT COMPLETED|Period Between RIP and SP||54
183136|NCT01412060|445974|P3|COMPLETED|Period Between RIP and SP||0
183137|NCT01412060|445975|P2|COMPLETED|Period Between RIP and SP||0
183138|NCT01412060|445976|P1|COMPLETED|Period Between RIP and SP||364
183139|NCT01412060|445974|P3|STARTED|Period Between RIP and SP||0
183140|NCT01412060|445975|P2|STARTED|Period Between RIP and SP||0
183141|NCT01412060|445976|P1|STARTED|Period Between RIP and SP||418
183142|NCT01412060|445974|P3|NOT COMPLETED|Open-label Run-in Period (RIP)||0
183143|NCT01412060|445975|P2|NOT COMPLETED|Open-label Run-in Period (RIP)||0
183144|NCT01412060|445976|P1|NOT COMPLETED|Open-label Run-in Period (RIP)||347
183145|NCT01412060|445974|P3|COMPLETED|Open-label Run-in Period (RIP)||0
183146|NCT01412060|445975|P2|COMPLETED|Open-label Run-in Period (RIP)||0
183147|NCT01412060|445976|P1|COMPLETED|Open-label Run-in Period (RIP)||418
183148|NCT01412060|445974|P3|STARTED|Open-label Run-in Period (RIP)||0
183149|NCT01412060|445975|P2|STARTED|Open-label Run-in Period (RIP)||0
183150|NCT01412060|445976|P1|STARTED|Open-label Run-in Period (RIP)||765
183151|NCT01412021|445986|P1|NOT COMPLETED|Overall Study||19
183152|NCT01412021|445986|P1|COMPLETED|Overall Study||356
183153|NCT01412021|445986|P1|Case Report Forms Locked|Overall Study||368
183154|NCT01412021|445986|P1|STARTED|Overall Study||375
183155|NCT01411995|446023|P2|NOT COMPLETED|Overall Study||1
183156|NCT01411995|446024|P1|NOT COMPLETED|Overall Study||0
183157|NCT01411995|446023|P2|COMPLETED|Overall Study||99
183158|NCT01411995|446024|P1|COMPLETED|Overall Study||100
183159|NCT01411995|446023|P2|STARTED|Overall Study||100
183160|NCT01411995|446024|P1|STARTED|Overall Study||100
183161|NCT01411917|446032|P2|NOT COMPLETED|Overall Study||1
183162|NCT01411917|446033|P1|NOT COMPLETED|Overall Study||0
183163|NCT01411917|446032|P2|COMPLETED|Overall Study||36
183164|NCT01411917|446033|P1|COMPLETED|Overall Study||32
183165|NCT01411917|446032|P2|STARTED|Overall Study||37
183166|NCT01411917|446033|P1|STARTED|Overall Study||32
183167|NCT01411891|446055|P2|NOT COMPLETED|Overall Study||2
183168|NCT01411891|446056|P1|NOT COMPLETED|Overall Study||3
183169|NCT01411891|446055|P2|COMPLETED|Overall Study||48
183170|NCT01411891|446056|P1|COMPLETED|Overall Study||47
183171|NCT01411891|446055|P2|STARTED|Overall Study||50
183172|NCT01411891|446056|P1|STARTED|Overall Study||50
183173|NCT01411852|446066|P2|NOT COMPLETED|Hospital Intervention Phase||18
183174|NCT01411852|446067|P1|NOT COMPLETED|Hospital Intervention Phase||24
183175|NCT01411852|446066|P2|COMPLETED|Hospital Intervention Phase|18 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|71
183176|NCT01411852|446067|P1|COMPLETED|Hospital Intervention Phase|24 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|59
183177|NCT01411852|446066|P2|STARTED|Hospital Intervention Phase||89
183178|NCT01411852|446067|P1|STARTED|Hospital Intervention Phase||83
183179|NCT01411852|446066|P2|NOT COMPLETED|Prehospital Intervention Phase||7
183180|NCT01411852|446067|P1|NOT COMPLETED|Prehospital Intervention Phase||12
183181|NCT01411852|446066|P2|COMPLETED|Prehospital Intervention Phase|7 patients had intervention stopped prior to hospital arrival|89
183182|NCT01411852|446067|P1|COMPLETED|Prehospital Intervention Phase|12 patients had the intervention stopped prior to hospital arrival|83
183183|NCT01411852|446066|P2|STARTED|Prehospital Intervention Phase|One patient was in police custody at the time of enrollment. Patient's data omitted from analyses.|96
183184|NCT01411852|446067|P1|STARTED|Prehospital Intervention Phase|1 patient randomized to 2000 mL bolus arm but received 250 mL bolus. Analyzed in 2000 mL arm.|95
183185|NCT01411839|446112|P2|NOT COMPLETED|Overall Study||3
183186|NCT01411839|446113|P1|NOT COMPLETED|Overall Study||4
183187|NCT01411839|446112|P2|COMPLETED|Overall Study||17
183188|NCT01411839|446113|P1|COMPLETED|Overall Study||16
183189|NCT01411839|446112|P2|STARTED|Overall Study||20
183190|NCT01411839|446113|P1|STARTED|Overall Study||20
183191|NCT01411774|446125|P2|NOT COMPLETED|Overall Study||3
183192|NCT01411774|446126|P1|NOT COMPLETED|Overall Study||0
183193|NCT01411774|446125|P2|COMPLETED|Overall Study||67
183194|NCT01411774|446126|P1|COMPLETED|Overall Study||72
183195|NCT01411774|446125|P2|STARTED|Overall Study||70
183196|NCT01411774|446126|P1|STARTED|Overall Study||72
183197|NCT01411696|446134|P1|NOT COMPLETED|Overall Study||0
183198|NCT01411696|446134|P1|COMPLETED|Overall Study||289
183199|NCT01411696|446134|P1|STARTED|Overall Study||289
183200|NCT01411592|446143|P2|NOT COMPLETED|Overall Study||0
183201|NCT01411592|446144|P1|NOT COMPLETED|Overall Study||0
183202|NCT01411592|446143|P2|COMPLETED|Overall Study||16
183203|NCT01411592|446144|P1|COMPLETED|Overall Study||14
183204|NCT01411592|446143|P2|5-Year Time Frame|Overall Study||16
183205|NCT01411592|446144|P1|5-Year Time Frame|Overall Study||14
183206|NCT01411592|446143|P2|STARTED|Overall Study||16
183207|NCT01411592|446144|P1|STARTED|Overall Study||14
183208|NCT01411527|446154|P2|NOT COMPLETED|Overall Study||0
183209|NCT01411527|446155|P1|NOT COMPLETED|Overall Study||0
183210|NCT01411527|446154|P2|COMPLETED|Overall Study||93
183211|NCT01411527|446155|P1|COMPLETED|Overall Study||1864
183212|NCT01411527|446154|P2|STARTED|Overall Study||93
183213|NCT01411527|446155|P1|STARTED|Overall Study||1864
183214|NCT01411501|446164|P4|NOT COMPLETED|Overall Study||7
183215|NCT01411501|446165|P3|NOT COMPLETED|Overall Study||6
183216|NCT01411501|446166|P2|NOT COMPLETED|Overall Study||6
183217|NCT01411501|446167|P1|NOT COMPLETED|Overall Study||10
183218|NCT01411501|446164|P4|COMPLETED|Overall Study||163
183219|NCT01411501|446165|P3|COMPLETED|Overall Study||159
183220|NCT01411501|446166|P2|COMPLETED|Overall Study||166
183221|NCT01411501|446167|P1|COMPLETED|Overall Study||158
183222|NCT01411501|446164|P4|STARTED|Overall Study||170
183223|NCT01411501|446165|P3|STARTED|Overall Study||165
183224|NCT01411501|446166|P2|STARTED|Overall Study||172
183225|NCT01411501|446167|P1|STARTED|Overall Study||168
183226|NCT01411488|446199|P2|NOT COMPLETED|Overall Study||5
183227|NCT01411488|446200|P1|NOT COMPLETED|Overall Study||6
183228|NCT01411488|446199|P2|COMPLETED|Overall Study||38
183229|NCT01411488|446200|P1|COMPLETED|Overall Study||41
183230|NCT01411488|446199|P2|STARTED|Overall Study||43
183231|NCT01411488|446200|P1|STARTED|Overall Study||47
183232|NCT01411241|446208|P2|NOT COMPLETED|Overall Study||22
183233|NCT01411241|446209|P1|NOT COMPLETED|Overall Study||11
183234|NCT01411241|446208|P2|COMPLETED|Overall Study||293
183235|NCT01411241|446209|P1|COMPLETED|Overall Study||298
183236|NCT01411241|446208|P2|STARTED|Overall Study||315
183237|NCT01411241|446209|P1|STARTED|Overall Study||309
183238|NCT01411228|446234|P3|NOT COMPLETED|Overall Study||1
183239|NCT01411228|446235|P2|NOT COMPLETED|Overall Study||0
183240|NCT01411228|446236|P1|NOT COMPLETED|Overall Study||1
183241|NCT01411228|446234|P3|COMPLETED|Overall Study||4
183242|NCT01411228|446235|P2|COMPLETED|Overall Study||5
183243|NCT01411228|446236|P1|COMPLETED|Overall Study||4
183244|NCT01411228|446234|P3|STARTED|Overall Study||5
183245|NCT01411228|446235|P2|STARTED|Overall Study||5
183246|NCT01411228|446236|P1|STARTED|Overall Study||5
183247|NCT01411215|446258|P2|NOT COMPLETED|Overall Study||84
183248|NCT01411215|446259|P1|NOT COMPLETED|Overall Study||66
183249|NCT01411215|446258|P2|COMPLETED|Overall Study||7
183250|NCT01411215|446259|P1|COMPLETED|Overall Study||3
183251|NCT01411215|446258|P2|Treated|Overall Study|1 participant was considered as screen failure and therefore not treated.|90
183252|NCT01411215|446259|P1|Treated|Overall Study||69
183253|NCT01411215|446258|P2|STARTED|Overall Study||91
183254|NCT01411215|446259|P1|STARTED|Overall Study||69
183255|NCT01411137|446292|P1|NOT COMPLETED|Part 3: Open-Label Extension||0
183256|NCT01411137|446292|P1|COMPLETED|Part 3: Open-Label Extension||12
183257|NCT01411137|446292|P1|STARTED|Part 3: Open-Label Extension|Two sites with 11 completers of Part 2 did not participate in Part 3. Two subjects lost contact.|12
183258|NCT01411137|446292|P1|NOT COMPLETED|Part 2: Open-Label Extension||7
183259|NCT01411137|446292|P1|COMPLETED|Part 2: Open-Label Extension||25
183260|NCT01411137|446292|P1|STARTED|Part 2: Open-Label Extension|1 subject who completed Part 1 did not elect to continue into Part 2.|32
183261|NCT01411137|446292|P1|NOT COMPLETED|Part 1: Dose Conversion||10
183262|NCT01411137|446292|P1|COMPLETED|Part 1: Dose Conversion||33
183263|NCT01411137|446292|P1|STARTED|Part 1: Dose Conversion||43
183264|NCT01411085|446311|P1|NOT COMPLETED|Overall Study||3
183265|NCT01411085|446311|P1|COMPLETED|Overall Study||7
183266|NCT01411085|446311|P1|STARTED|Overall Study||10
183267|NCT01410812|446318|P3|NOT COMPLETED|Overall Study||0
183268|NCT01410812|446319|P2|NOT COMPLETED|Overall Study||0
183269|NCT01410812|446320|P1|NOT COMPLETED|Overall Study||0
183270|NCT01410812|446318|P3|COMPLETED|Overall Study||76
183271|NCT01410812|446319|P2|COMPLETED|Overall Study||75
183272|NCT01410812|446320|P1|COMPLETED|Overall Study||75
183273|NCT01410812|446318|P3|STARTED|Overall Study||76
183274|NCT01410812|446319|P2|STARTED|Overall Study||75
183275|NCT01410812|446320|P1|STARTED|Overall Study||75
183276|NCT01410799|446331|P1|NOT COMPLETED|Overall Study||13
183277|NCT01410799|446331|P1|COMPLETED|Overall Study||0
183278|NCT01410799|446331|P1|STARTED|Overall Study||13
183279|NCT01410773|446340|P1|NOT COMPLETED|Overall Study||0
183280|NCT01410773|446340|P1|COMPLETED|Overall Study||110
183281|NCT01410773|446340|P1|STARTED|Overall Study||110
183282|NCT01410604|446347|P2|NOT COMPLETED|Overall Study||2
183283|NCT01410604|446348|P1|NOT COMPLETED|Overall Study||3
183284|NCT01410604|446347|P2|COMPLETED|Overall Study||14
183285|NCT01410604|446348|P1|COMPLETED|Overall Study||12
183286|NCT01410604|446347|P2|STARTED|Overall Study||16
183287|NCT01410604|446348|P1|STARTED|Overall Study||15
183288|NCT01410565|446370|P3|NOT COMPLETED|Double Blind Phase||0
183289|NCT01410565|446371|P2|NOT COMPLETED|Double Blind Phase||15
183290|NCT01410565|446372|P1|NOT COMPLETED|Double Blind Phase||13
183291|NCT01410565|446370|P3|COMPLETED|Double Blind Phase||0
183292|NCT01410565|446371|P2|COMPLETED|Double Blind Phase||0
183293|NCT01410565|446372|P1|COMPLETED|Double Blind Phase||0
183294|NCT01410565|446370|P3|STARTED|Double Blind Phase||0
183295|NCT01410565|446371|P2|STARTED|Double Blind Phase||15
183296|NCT01410565|446372|P1|STARTED|Double Blind Phase|All 66 patients received one dose of Apaziquone in the open label phase.|13
183297|NCT01410565|446370|P3|NOT COMPLETED|Open Label Phase Apaziquone||8
183298|NCT01410565|446371|P2|NOT COMPLETED|Open Label Phase Apaziquone||0
183299|NCT01410565|446372|P1|NOT COMPLETED|Open Label Phase Apaziquone||0
183300|NCT01410565|446370|P3|COMPLETED|Open Label Phase Apaziquone||58
183301|NCT01410565|446371|P2|COMPLETED|Open Label Phase Apaziquone||0
183302|NCT01410565|446372|P1|COMPLETED|Open Label Phase Apaziquone||0
183303|NCT01410565|446370|P3|STARTED|Open Label Phase Apaziquone||66
183304|NCT01410565|446371|P2|STARTED|Open Label Phase Apaziquone||0
183305|NCT01410565|446372|P1|STARTED|Open Label Phase Apaziquone||0
183306|NCT01410552|446382|P1|NOT COMPLETED|Overall Study||136
183307|NCT01410552|446382|P1|COMPLETED|Overall Study||877
183308|NCT01410552|446382|P1|STARTED|Overall Study||1013
183309|NCT01410474|446389|P2|NOT COMPLETED|Overall Study||1
183310|NCT01410474|446390|P1|NOT COMPLETED|Overall Study||0
183311|NCT01410474|446389|P2|COMPLETED|Overall Study||167
183312|NCT01410474|446390|P1|COMPLETED|Overall Study||173
183313|NCT01410474|446389|P2|STARTED|Overall Study||168
183314|NCT01410474|446390|P1|STARTED|Overall Study||173
183315|NCT01410448|446413|P2|NOT COMPLETED|Overall Study||35
183316|NCT01410448|446414|P1|NOT COMPLETED|Overall Study||12
183317|NCT01410448|446413|P2|COMPLETED|Overall Study||155
183318|NCT01410448|446414|P1|COMPLETED|Overall Study||181
183319|NCT01410448|446413|P2|Modified ITT Analysis Set|Overall Study||149
183320|NCT01410448|446414|P1|Modified ITT Analysis Set|Overall Study||161
183321|NCT01410448|446413|P2|Intent-to Treat (ITT) Analysis Set|Overall Study||190
183322|NCT01410448|446414|P1|Intent-to Treat (ITT) Analysis Set|Overall Study||193
183323|NCT01410448|446413|P2|STARTED|Overall Study||190
183324|NCT01410448|446414|P1|STARTED|Overall Study||193
183325|NCT01410409|446454|P2|NOT COMPLETED|Overall Study||4
183326|NCT01410409|446455|P1|NOT COMPLETED|Overall Study||1
183327|NCT01410409|446454|P2|COMPLETED|Overall Study||46
183328|NCT01410409|446455|P1|COMPLETED|Overall Study||49
183329|NCT01410409|446454|P2|STARTED|Overall Study||50
183330|NCT01410409|446455|P1|STARTED|Overall Study||50
183331|NCT01410357|446479|P2|NOT COMPLETED|Overall Study||24
183332|NCT01410357|446480|P1|NOT COMPLETED|Overall Study||26
183333|NCT01410357|446479|P2|COMPLETED|Overall Study||76
183334|NCT01410357|446480|P1|COMPLETED|Overall Study||74
183335|NCT01410357|446479|P2|STARTED|Overall Study||100
183336|NCT01410357|446480|P1|STARTED|Overall Study||100
183337|NCT01410344|446534|P1|NOT COMPLETED|Overall Study||3
183338|NCT01410344|446534|P1|COMPLETED|Overall Study||17
183339|NCT01410344|446534|P1|STARTED|Overall Study||20
183340|NCT01410240|446551|P3|NOT COMPLETED|Overall Study||2
183341|NCT01410240|446552|P2|NOT COMPLETED|Overall Study||1
183342|NCT01410240|446553|P1|NOT COMPLETED|Overall Study||1
183343|NCT01410240|446551|P3|COMPLETED|Overall Study||10
183344|NCT01410240|446552|P2|COMPLETED|Overall Study||52
183345|NCT01410240|446553|P1|COMPLETED|Overall Study||52
183346|NCT01410240|446551|P3|STARTED|Overall Study||12
183347|NCT01410240|446552|P2|STARTED|Overall Study||53
183348|NCT01410240|446553|P1|STARTED|Overall Study||53
183349|NCT01410227|446624|P4|NOT COMPLETED|Overall Study||1
183350|NCT01410227|446625|P3|NOT COMPLETED|Overall Study||2
183351|NCT01410227|446626|P2|NOT COMPLETED|Overall Study||0
183352|NCT01410227|446627|P1|NOT COMPLETED|Overall Study||4
183353|NCT01410227|446624|P4|COMPLETED|Overall Study||5
183354|NCT01410227|446625|P3|COMPLETED|Overall Study||13
183355|NCT01410227|446626|P2|COMPLETED|Overall Study||8
183356|NCT01410227|446627|P1|COMPLETED|Overall Study||4
183357|NCT01410227|446624|P4|STARTED|Overall Study||6
183358|NCT01410227|446625|P3|STARTED|Overall Study||15
183359|NCT01410227|446626|P2|STARTED|Overall Study||8
183360|NCT01410227|446627|P1|STARTED|Overall Study||8
183361|NCT01410110|446699|P2|NOT COMPLETED|Overall Study||2
183362|NCT01410110|446700|P1|NOT COMPLETED|Overall Study||4
183363|NCT01410110|446699|P2|COMPLETED|Overall Study||22
183364|NCT01410110|446700|P1|COMPLETED|Overall Study||20
183365|NCT01410110|446699|P2|6 Month Follow-up|Overall Study||22
183366|NCT01410110|446700|P1|6 Month Follow-up|Overall Study||20
183367|NCT01410110|446699|P2|3 Months (End of Intervention)|Overall Study||22
183368|NCT01410110|446700|P1|3 Months (End of Intervention)|Overall Study||20
183369|NCT01410110|446699|P2|Randomization|Overall Study||24
183370|NCT01410110|446700|P1|Randomization|Overall Study||24
183371|NCT01410110|446699|P2|STARTED|Overall Study||24
183372|NCT01410110|446700|P1|STARTED|Overall Study||24
183373|NCT01410097|446724|P2|NOT COMPLETED|Overall Study||3
183374|NCT01410097|446725|P1|NOT COMPLETED|Overall Study||5
183375|NCT01410097|446724|P2|COMPLETED|Overall Study||530
183376|NCT01410097|446725|P1|COMPLETED|Overall Study||551
183377|NCT01410097|446724|P2|STARTED|Overall Study||533
183378|NCT01410097|446725|P1|STARTED|Overall Study||556
183379|NCT01410084|446749|P2|NOT COMPLETED|Overall Study||3
183380|NCT01410084|446750|P1|NOT COMPLETED|Overall Study||1
183381|NCT01410084|446749|P2|COMPLETED|Overall Study||27
183382|NCT01410084|446750|P1|COMPLETED|Overall Study||37
183383|NCT01410084|446749|P2|STARTED|Overall Study||30
183384|NCT01410084|446750|P1|STARTED|Overall Study||38
183385|NCT01410058|446762|P2|NOT COMPLETED|Day 35||0
183386|NCT01410058|446763|P1|NOT COMPLETED|Day 35||0
183387|NCT01410058|446762|P2|COMPLETED|Day 35||6
183388|NCT01410058|446763|P1|COMPLETED|Day 35||13
183389|NCT01410058|446762|P2|STARTED|Day 35||6
183390|NCT01410058|446763|P1|STARTED|Day 35||13
183391|NCT01410058|446762|P2|NOT COMPLETED|Baseline Day 22||0
183392|NCT01410058|446763|P1|NOT COMPLETED|Baseline Day 22||0
183393|NCT01410058|446762|P2|COMPLETED|Baseline Day 22||6
183394|NCT01410058|446763|P1|COMPLETED|Baseline Day 22||13
183395|NCT01410058|446762|P2|STARTED|Baseline Day 22||6
183396|NCT01410058|446763|P1|STARTED|Baseline Day 22||13
183397|NCT01410058|446762|P2|NOT COMPLETED|Washout Day 0||0
183398|NCT01410058|446763|P1|NOT COMPLETED|Washout Day 0||0
183399|NCT01410058|446762|P2|COMPLETED|Washout Day 0||6
183400|NCT01410058|446763|P1|COMPLETED|Washout Day 0||13
183401|NCT01410058|446762|P2|STARTED|Washout Day 0||6
183402|NCT01410058|446763|P1|STARTED|Washout Day 0||13
183403|NCT01409993|446775|P4|NOT COMPLETED|Overall Study||5
183404|NCT01409993|446776|P3|NOT COMPLETED|Overall Study||3
183405|NCT01409993|446777|P2|NOT COMPLETED|Overall Study||5
183406|NCT01409993|446778|P1|NOT COMPLETED|Overall Study||4
183407|NCT01409993|446775|P4|COMPLETED|Overall Study||8
183408|NCT01409993|446776|P3|COMPLETED|Overall Study||11
183409|NCT01409993|446777|P2|COMPLETED|Overall Study||21
183410|NCT01409993|446778|P1|COMPLETED|Overall Study||21
183411|NCT01409993|446775|P4|STARTED|Overall Study||13
183412|NCT01409993|446776|P3|STARTED|Overall Study||14
183413|NCT01409993|446777|P2|STARTED|Overall Study||26
183414|NCT01409993|446778|P1|STARTED|Overall Study||25
183415|NCT01409837|446798|P2|NOT COMPLETED|Overall Study||2
183416|NCT01409837|446799|P1|NOT COMPLETED|Overall Study||3
183417|NCT01409837|446798|P2|COMPLETED|Overall Study||14
183418|NCT01409837|446799|P1|COMPLETED|Overall Study||14
183419|NCT01409837|446798|P2|282nd Week|Overall Study||14
183420|NCT01409837|446799|P1|282nd Week|Overall Study||14
183421|NCT01409837|446798|P2|186th Week|Overall Study||14
183422|NCT01409837|446799|P1|186th Week|Overall Study|Moved away to another location|14
183423|NCT01409837|446798|P2|138th Week|Overall Study||14
183424|NCT01409837|446799|P1|138th Week|Overall Study||15
183425|NCT01409837|446798|P2|114th Week|Overall Study||14
183426|NCT01409837|446799|P1|114th Week|Overall Study||15
183427|NCT01409837|446798|P2|102nd Week|Overall Study|Married another wife|14
183428|NCT01409837|446799|P1|102nd Week|Overall Study||15
183429|NCT01409837|446798|P2|96th Week|Overall Study||15
183430|NCT01409837|446799|P1|96th Week|Overall Study||15
183431|NCT01409837|446798|P2|48th Week|Overall Study||15
183432|NCT01409837|446799|P1|48th Week|Overall Study|Lost to follow-up|15
183433|NCT01409837|446798|P2|24th Week|Overall Study|Diagnosed with Lymphocytic Lymphoma and withdrawn|15
183434|NCT01409837|446799|P1|24th Week|Overall Study||16
183435|NCT01409837|446798|P2|12th Week|Overall Study||16
183436|NCT01409837|446799|P1|12th Week|Overall Study|Moved away to another location|16
183437|NCT01409837|446798|P2|6th Week|Overall Study||16
183438|NCT01409837|446799|P1|6th Week|Overall Study||17
183439|NCT01409837|446798|P2|STARTED|Overall Study||16
183440|NCT01409837|446799|P1|STARTED|Overall Study||17
183441|NCT01409707|446824|P3|NOT COMPLETED|Overall Study||16
183442|NCT01409707|446825|P2|NOT COMPLETED|Overall Study||17
183443|NCT01409707|446826|P1|NOT COMPLETED|Overall Study||5
183444|NCT01409707|446824|P3|COMPLETED|Overall Study||24
183445|NCT01409707|446825|P2|COMPLETED|Overall Study||28
183446|NCT01409707|446826|P1|COMPLETED|Overall Study||36
183447|NCT01409707|446824|P3|STARTED|Overall Study||40
183448|NCT01409707|446825|P2|STARTED|Overall Study||45
183449|NCT01409707|446826|P1|STARTED|Overall Study||41
183450|NCT01409564|446838|P2|NOT COMPLETED|Overall Study||5
183451|NCT01409564|446839|P1|NOT COMPLETED|Overall Study||5
183452|NCT01409564|446838|P2|COMPLETED|Overall Study||18
183453|NCT01409564|446839|P1|COMPLETED|Overall Study||18
183454|NCT01409564|446838|P2|STARTED|Overall Study||23
183455|NCT01409564|446839|P1|STARTED|Overall Study||23
183456|NCT01409434|446857|P1|NOT COMPLETED|Overall Study||4
183457|NCT01409434|446857|P1|COMPLETED|Overall Study||40
183458|NCT01409434|446857|P1|STARTED|Overall Study||44
183459|NCT01409382|446867|P2|NOT COMPLETED|Overall Study||80
183460|NCT01409382|446868|P1|NOT COMPLETED|Overall Study||81
183461|NCT01409382|446867|P2|COMPLETED|Overall Study||160
183462|NCT01409382|446868|P1|COMPLETED|Overall Study||159
183463|NCT01409382|446867|P2|STARTED|Overall Study||240
183464|NCT01409382|446868|P1|STARTED|Overall Study||240
183465|NCT01409291|446882|P2|NOT COMPLETED|Overall Study||9
183466|NCT01409291|446883|P1|NOT COMPLETED|Overall Study||7
183467|NCT01409291|446882|P2|COMPLETED|Overall Study||19
183468|NCT01409291|446883|P1|COMPLETED|Overall Study||29
183469|NCT01409291|446882|P2|STARTED|Overall Study||28
183470|NCT01409291|446883|P1|STARTED|Overall Study||36
183471|NCT01409239|446893|P2|NOT COMPLETED|Overall Study||0
183472|NCT01409239|446894|P1|NOT COMPLETED|Overall Study||0
183473|NCT01409239|446893|P2|COMPLETED|Overall Study||17
183474|NCT01409239|446894|P1|COMPLETED|Overall Study||16
183475|NCT01409239|446893|P2|STARTED|Overall Study||17
183476|NCT01409239|446894|P1|STARTED|Overall Study||16
183477|NCT01409213|446900|P1|NOT COMPLETED|Overall Study||0
183478|NCT01409213|446900|P1|COMPLETED|Overall Study||1523
183479|NCT01409213|446900|P1|STARTED|Overall Study||1523
183480|NCT01409096|446907|P2|NOT COMPLETED|Overall Study||5
183481|NCT01409096|446908|P1|NOT COMPLETED|Overall Study||2
183482|NCT01409096|446907|P2|COMPLETED|Overall Study||35
183483|NCT01409096|446908|P1|COMPLETED|Overall Study||38
183484|NCT01409096|446907|P2|STARTED|Overall Study||40
183485|NCT01409096|446908|P1|STARTED|Overall Study||40
183486|NCT01409031|446922|P2|NOT COMPLETED|Overall Study||0
183487|NCT01409031|446923|P1|NOT COMPLETED|Overall Study||1
183488|NCT01409031|446922|P2|COMPLETED|Overall Study||2
183489|NCT01409031|446923|P1|COMPLETED|Overall Study||0
183490|NCT01409031|446922|P2|STARTED|Overall Study||2
183491|NCT01409031|446923|P1|STARTED|Overall Study||1
183492|NCT01408992|446939|P1|NOT COMPLETED|Overall Study||0
183493|NCT01408992|446939|P1|COMPLETED|Overall Study||558
183494|NCT01408992|446939|P1|STARTED|Overall Study||558
183495|NCT01408914|446954|P3|NOT COMPLETED|Overall Study||13
183496|NCT01408914|446955|P2|NOT COMPLETED|Overall Study||12
183497|NCT01408914|446956|P1|NOT COMPLETED|Overall Study||12
183498|NCT01408914|446954|P3|COMPLETED|Overall Study||47
183499|NCT01408914|446955|P2|COMPLETED|Overall Study||48
183500|NCT01408914|446956|P1|COMPLETED|Overall Study||48
183501|NCT01408914|446954|P3|STARTED|Overall Study||60
183502|NCT01408914|446955|P2|STARTED|Overall Study||60
183503|NCT01408914|446956|P1|STARTED|Overall Study||60
183504|NCT01408888|446970|P2|NOT COMPLETED|Second Intervention||0
183505|NCT01408888|446971|P1|NOT COMPLETED|Second Intervention||2
183506|NCT01408888|446970|P2|COMPLETED|Second Intervention||8
183507|NCT01408888|446971|P1|COMPLETED|Second Intervention||16
183508|NCT01408888|446970|P2|STARTED|Second Intervention||8
183509|NCT01408888|446971|P1|STARTED|Second Intervention||18
183510|NCT01408888|446970|P2|NOT COMPLETED|Washout of at Least 21 Days||0
183511|NCT01408888|446971|P1|NOT COMPLETED|Washout of at Least 21 Days||0
183512|NCT01408888|446970|P2|COMPLETED|Washout of at Least 21 Days||8
183513|NCT01408888|446971|P1|COMPLETED|Washout of at Least 21 Days||18
183514|NCT01408888|446970|P2|STARTED|Washout of at Least 21 Days||8
183515|NCT01408888|446971|P1|STARTED|Washout of at Least 21 Days||18
183516|NCT01408888|446970|P2|NOT COMPLETED|First Intervention||3
183517|NCT01408888|446971|P1|NOT COMPLETED|First Intervention||0
183518|NCT01408888|446970|P2|COMPLETED|First Intervention||8
183519|NCT01408888|446971|P1|COMPLETED|First Intervention||18
183520|NCT01408888|446970|P2|Received at Least 1 Dose of Drug|First Intervention||11
183521|NCT01408888|446971|P1|Received at Least 1 Dose of Drug|First Intervention||18
183522|NCT01408888|446970|P2|STARTED|First Intervention||11
183523|NCT01408888|446971|P1|STARTED|First Intervention||18
183524|NCT01408862|446994|P1|NOT COMPLETED|Overall Study||0
183525|NCT01408862|446994|P1|COMPLETED|Overall Study||20
183526|NCT01408862|446994|P1|STARTED|Overall Study||20
183527|NCT01408732|446999|P2|NOT COMPLETED|Overall Study||2
183528|NCT01408732|447000|P1|NOT COMPLETED|Overall Study||2
183529|NCT01408732|446999|P2|COMPLETED|Overall Study||7
183530|NCT01408732|447000|P1|COMPLETED|Overall Study||7
183531|NCT01408732|446999|P2|STARTED|Overall Study||9
183532|NCT01408732|447000|P1|STARTED|Overall Study||9
183533|NCT01408719|447026|P20|NOT COMPLETED|Fourth Intervention (35 Days)||0
183534|NCT01408719|447027|P19|NOT COMPLETED|Fourth Intervention (35 Days)||0
183535|NCT01408719|447028|P18|NOT COMPLETED|Fourth Intervention (35 Days)||0
183536|NCT01408719|447029|P17|NOT COMPLETED|Fourth Intervention (35 Days)||0
183537|NCT01408719|447030|P16|NOT COMPLETED|Fourth Intervention (35 Days)||0
183538|NCT01408719|447031|P15|NOT COMPLETED|Fourth Intervention (35 Days)||0
183539|NCT01408719|447032|P14|NOT COMPLETED|Fourth Intervention (35 Days)||0
183540|NCT01408719|447033|P13|NOT COMPLETED|Fourth Intervention (35 Days)||0
183541|NCT01408719|447034|P12|NOT COMPLETED|Fourth Intervention (35 Days)||0
183542|NCT01408719|447035|P11|NOT COMPLETED|Fourth Intervention (35 Days)||0
183543|NCT01408719|447036|P10|NOT COMPLETED|Fourth Intervention (35 Days)||0
183544|NCT01408719|447037|P9|NOT COMPLETED|Fourth Intervention (35 Days)||0
183545|NCT01408719|447038|P8|NOT COMPLETED|Fourth Intervention (35 Days)||0
183546|NCT01408719|447039|P7|NOT COMPLETED|Fourth Intervention (35 Days)||0
183547|NCT01408719|447040|P6|NOT COMPLETED|Fourth Intervention (35 Days)||0
183548|NCT01408719|447041|P5|NOT COMPLETED|Fourth Intervention (35 Days)||0
183549|NCT01408719|447042|P4|NOT COMPLETED|Fourth Intervention (35 Days)||0
183550|NCT01408719|447043|P3|NOT COMPLETED|Fourth Intervention (35 Days)||0
183551|NCT01408719|447044|P2|NOT COMPLETED|Fourth Intervention (35 Days)||0
183552|NCT01408719|447045|P1|NOT COMPLETED|Fourth Intervention (35 Days)||0
183553|NCT01408719|447026|P20|COMPLETED|Fourth Intervention (35 Days)||1
183554|NCT01408719|447027|P19|COMPLETED|Fourth Intervention (35 Days)||0
183555|NCT01408719|447028|P18|COMPLETED|Fourth Intervention (35 Days)||2
183556|NCT01408719|447029|P17|COMPLETED|Fourth Intervention (35 Days)||2
183557|NCT01408719|447030|P16|COMPLETED|Fourth Intervention (35 Days)||1
183558|NCT01408719|447031|P15|COMPLETED|Fourth Intervention (35 Days)||1
183559|NCT01408719|447032|P14|COMPLETED|Fourth Intervention (35 Days)||3
183560|NCT01408719|447033|P13|COMPLETED|Fourth Intervention (35 Days)||1
183561|NCT01408719|447034|P12|COMPLETED|Fourth Intervention (35 Days)||2
183562|NCT01408719|447035|P11|COMPLETED|Fourth Intervention (35 Days)||2
183563|NCT01408719|447036|P10|COMPLETED|Fourth Intervention (35 Days)||1
183564|NCT01408719|447037|P9|COMPLETED|Fourth Intervention (35 Days)||1
183565|NCT01408719|447038|P8|COMPLETED|Fourth Intervention (35 Days)||2
183566|NCT01408719|447039|P7|COMPLETED|Fourth Intervention (35 Days)||2
183567|NCT01408719|447040|P6|COMPLETED|Fourth Intervention (35 Days)||3
183568|NCT01408719|447041|P5|COMPLETED|Fourth Intervention (35 Days)||3
183569|NCT01408719|447042|P4|COMPLETED|Fourth Intervention (35 Days)||2
183570|NCT01408719|447043|P3|COMPLETED|Fourth Intervention (35 Days)||1
183571|NCT01408719|447044|P2|COMPLETED|Fourth Intervention (35 Days)||3
183572|NCT01408719|447045|P1|COMPLETED|Fourth Intervention (35 Days)||2
183573|NCT01408719|447026|P20|STARTED|Fourth Intervention (35 Days)||1
183574|NCT01408719|447027|P19|STARTED|Fourth Intervention (35 Days)||0
183575|NCT01408719|447028|P18|STARTED|Fourth Intervention (35 Days)||2
183576|NCT01408719|447029|P17|STARTED|Fourth Intervention (35 Days)||2
183577|NCT01408719|447030|P16|STARTED|Fourth Intervention (35 Days)||1
183578|NCT01408719|447031|P15|STARTED|Fourth Intervention (35 Days)||1
183579|NCT01408719|447032|P14|STARTED|Fourth Intervention (35 Days)||3
183580|NCT01408719|447033|P13|STARTED|Fourth Intervention (35 Days)||1
183581|NCT01408719|447034|P12|STARTED|Fourth Intervention (35 Days)||2
183582|NCT01408719|447035|P11|STARTED|Fourth Intervention (35 Days)||2
183583|NCT01408719|447036|P10|STARTED|Fourth Intervention (35 Days)||1
183584|NCT01408719|447037|P9|STARTED|Fourth Intervention (35 Days)||1
183585|NCT01408719|447038|P8|STARTED|Fourth Intervention (35 Days)||2
183586|NCT01408719|447039|P7|STARTED|Fourth Intervention (35 Days)||2
183587|NCT01408719|447040|P6|STARTED|Fourth Intervention (35 Days)||3
183588|NCT01408719|447041|P5|STARTED|Fourth Intervention (35 Days)||3
183589|NCT01408719|447042|P4|STARTED|Fourth Intervention (35 Days)||2
183590|NCT01408719|447043|P3|STARTED|Fourth Intervention (35 Days)||1
183591|NCT01408719|447044|P2|STARTED|Fourth Intervention (35 Days)||3
183592|NCT01408719|447045|P1|STARTED|Fourth Intervention (35 Days)||2
183593|NCT01408719|447026|P20|NOT COMPLETED|Washout Period (28 Days)||0
183594|NCT01408719|447027|P19|NOT COMPLETED|Washout Period (28 Days)||0
183595|NCT01408719|447028|P18|NOT COMPLETED|Washout Period (28 Days)||0
183596|NCT01408719|447029|P17|NOT COMPLETED|Washout Period (28 Days)||0
183597|NCT01408719|447030|P16|NOT COMPLETED|Washout Period (28 Days)||0
183598|NCT01408719|447031|P15|NOT COMPLETED|Washout Period (28 Days)||0
183599|NCT01408719|447032|P14|NOT COMPLETED|Washout Period (28 Days)||0
183600|NCT01408719|447033|P13|NOT COMPLETED|Washout Period (28 Days)||0
183601|NCT01408719|447034|P12|NOT COMPLETED|Washout Period (28 Days)||0
183602|NCT01408719|447035|P11|NOT COMPLETED|Washout Period (28 Days)||0
183603|NCT01408719|447036|P10|NOT COMPLETED|Washout Period (28 Days)||0
183604|NCT01408719|447037|P9|NOT COMPLETED|Washout Period (28 Days)||0
183605|NCT01408719|447038|P8|NOT COMPLETED|Washout Period (28 Days)||0
183606|NCT01408719|447039|P7|NOT COMPLETED|Washout Period (28 Days)||0
183607|NCT01408719|447040|P6|NOT COMPLETED|Washout Period (28 Days)||0
183608|NCT01408719|447041|P5|NOT COMPLETED|Washout Period (28 Days)||0
183609|NCT01408719|447042|P4|NOT COMPLETED|Washout Period (28 Days)||0
183610|NCT01408719|447043|P3|NOT COMPLETED|Washout Period (28 Days)||0
183611|NCT01408719|447044|P2|NOT COMPLETED|Washout Period (28 Days)||0
183612|NCT01408719|447045|P1|NOT COMPLETED|Washout Period (28 Days)||0
183613|NCT01408719|447026|P20|COMPLETED|Washout Period (28 Days)||1
183614|NCT01408719|447027|P19|COMPLETED|Washout Period (28 Days)||0
183615|NCT01408719|447028|P18|COMPLETED|Washout Period (28 Days)||2
183616|NCT01408719|447029|P17|COMPLETED|Washout Period (28 Days)||2
183617|NCT01408719|447030|P16|COMPLETED|Washout Period (28 Days)||1
183618|NCT01408719|447031|P15|COMPLETED|Washout Period (28 Days)||1
183619|NCT01408719|447032|P14|COMPLETED|Washout Period (28 Days)||3
183620|NCT01408719|447033|P13|COMPLETED|Washout Period (28 Days)||1
183621|NCT01408719|447034|P12|COMPLETED|Washout Period (28 Days)||2
183622|NCT01408719|447035|P11|COMPLETED|Washout Period (28 Days)||2
183623|NCT01408719|447036|P10|COMPLETED|Washout Period (28 Days)||1
183624|NCT01408719|447037|P9|COMPLETED|Washout Period (28 Days)||1
183625|NCT01408719|447038|P8|COMPLETED|Washout Period (28 Days)||2
183626|NCT01408719|447039|P7|COMPLETED|Washout Period (28 Days)||2
183627|NCT01408719|447040|P6|COMPLETED|Washout Period (28 Days)||3
183628|NCT01408719|447041|P5|COMPLETED|Washout Period (28 Days)||3
183629|NCT01408719|447042|P4|COMPLETED|Washout Period (28 Days)||2
183630|NCT01408719|447043|P3|COMPLETED|Washout Period (28 Days)||1
183631|NCT01408719|447044|P2|COMPLETED|Washout Period (28 Days)||3
183632|NCT01408719|447045|P1|COMPLETED|Washout Period (28 Days)||2
183633|NCT01408719|447026|P20|STARTED|Washout Period (28 Days)||1
183634|NCT01408719|447027|P19|STARTED|Washout Period (28 Days)||0
183635|NCT01408719|447028|P18|STARTED|Washout Period (28 Days)||2
183636|NCT01408719|447029|P17|STARTED|Washout Period (28 Days)||2
183637|NCT01408719|447030|P16|STARTED|Washout Period (28 Days)||1
183638|NCT01408719|447031|P15|STARTED|Washout Period (28 Days)||1
183639|NCT01408719|447032|P14|STARTED|Washout Period (28 Days)||3
183640|NCT01408719|447033|P13|STARTED|Washout Period (28 Days)||1
183641|NCT01408719|447034|P12|STARTED|Washout Period (28 Days)||2
183642|NCT01408719|447035|P11|STARTED|Washout Period (28 Days)||2
183643|NCT01408719|447036|P10|STARTED|Washout Period (28 Days)||1
183644|NCT01408719|447037|P9|STARTED|Washout Period (28 Days)||1
183645|NCT01408719|447038|P8|STARTED|Washout Period (28 Days)||2
183646|NCT01408719|447039|P7|STARTED|Washout Period (28 Days)||2
183647|NCT01408719|447040|P6|STARTED|Washout Period (28 Days)||3
183648|NCT01408719|447041|P5|STARTED|Washout Period (28 Days)||3
183649|NCT01408719|447042|P4|STARTED|Washout Period (28 Days)||2
183650|NCT01408719|447043|P3|STARTED|Washout Period (28 Days)||1
183651|NCT01408719|447044|P2|STARTED|Washout Period (28 Days)||3
183652|NCT01408719|447045|P1|STARTED|Washout Period (28 Days)||2
183653|NCT01408719|447026|P20|NOT COMPLETED|Third Intervention (35 Days)||0
183654|NCT01408719|447027|P19|NOT COMPLETED|Third Intervention (35 Days)||0
183655|NCT01408719|447028|P18|NOT COMPLETED|Third Intervention (35 Days)||0
183656|NCT01408719|447029|P17|NOT COMPLETED|Third Intervention (35 Days)||0
183657|NCT01408719|447030|P16|NOT COMPLETED|Third Intervention (35 Days)||0
183658|NCT01408719|447031|P15|NOT COMPLETED|Third Intervention (35 Days)||0
183659|NCT01408719|447032|P14|NOT COMPLETED|Third Intervention (35 Days)||0
183660|NCT01408719|447033|P13|NOT COMPLETED|Third Intervention (35 Days)||0
183661|NCT01408719|447034|P12|NOT COMPLETED|Third Intervention (35 Days)||0
183662|NCT01408719|447035|P11|NOT COMPLETED|Third Intervention (35 Days)||0
183663|NCT01408719|447036|P10|NOT COMPLETED|Third Intervention (35 Days)||0
183664|NCT01408719|447037|P9|NOT COMPLETED|Third Intervention (35 Days)||0
183665|NCT01408719|447038|P8|NOT COMPLETED|Third Intervention (35 Days)||1
183666|NCT01408719|447039|P7|NOT COMPLETED|Third Intervention (35 Days)||0
183667|NCT01408719|447040|P6|NOT COMPLETED|Third Intervention (35 Days)||0
183668|NCT01408719|447041|P5|NOT COMPLETED|Third Intervention (35 Days)||0
183669|NCT01408719|447042|P4|NOT COMPLETED|Third Intervention (35 Days)||0
183670|NCT01408719|447043|P3|NOT COMPLETED|Third Intervention (35 Days)||0
183671|NCT01408719|447044|P2|NOT COMPLETED|Third Intervention (35 Days)||0
183672|NCT01408719|447045|P1|NOT COMPLETED|Third Intervention (35 Days)||0
183673|NCT01408719|447026|P20|COMPLETED|Third Intervention (35 Days)||1
183674|NCT01408719|447027|P19|COMPLETED|Third Intervention (35 Days)||0
183675|NCT01408719|447028|P18|COMPLETED|Third Intervention (35 Days)||2
183676|NCT01408719|447029|P17|COMPLETED|Third Intervention (35 Days)||2
183677|NCT01408719|447030|P16|COMPLETED|Third Intervention (35 Days)||1
183678|NCT01408719|447031|P15|COMPLETED|Third Intervention (35 Days)||1
183679|NCT01408719|447032|P14|COMPLETED|Third Intervention (35 Days)||3
183680|NCT01408719|447033|P13|COMPLETED|Third Intervention (35 Days)||2
183681|NCT01408719|447034|P12|COMPLETED|Third Intervention (35 Days)||2
183682|NCT01408719|447035|P11|COMPLETED|Third Intervention (35 Days)||2
183683|NCT01408719|447036|P10|COMPLETED|Third Intervention (35 Days)||1
183684|NCT01408719|447037|P9|COMPLETED|Third Intervention (35 Days)||1
183685|NCT01408719|447038|P8|COMPLETED|Third Intervention (35 Days)||2
183686|NCT01408719|447039|P7|COMPLETED|Third Intervention (35 Days)||2
183687|NCT01408719|447040|P6|COMPLETED|Third Intervention (35 Days)||3
183688|NCT01408719|447041|P5|COMPLETED|Third Intervention (35 Days)||3
183689|NCT01408719|447042|P4|COMPLETED|Third Intervention (35 Days)||2
183690|NCT01408719|447043|P3|COMPLETED|Third Intervention (35 Days)||1
183691|NCT01408719|447044|P2|COMPLETED|Third Intervention (35 Days)||3
183692|NCT01408719|447045|P1|COMPLETED|Third Intervention (35 Days)||2
183693|NCT01408719|447026|P20|STARTED|Third Intervention (35 Days)||1
183694|NCT01408719|447027|P19|STARTED|Third Intervention (35 Days)||0
183695|NCT01408719|447028|P18|STARTED|Third Intervention (35 Days)||2
183696|NCT01408719|447029|P17|STARTED|Third Intervention (35 Days)||2
183697|NCT01408719|447030|P16|STARTED|Third Intervention (35 Days)||1
183698|NCT01408719|447031|P15|STARTED|Third Intervention (35 Days)||1
183699|NCT01408719|447032|P14|STARTED|Third Intervention (35 Days)||3
183700|NCT01408719|447033|P13|STARTED|Third Intervention (35 Days)||2
183701|NCT01408719|447034|P12|STARTED|Third Intervention (35 Days)||2
183702|NCT01408719|447035|P11|STARTED|Third Intervention (35 Days)||2
183703|NCT01408719|447036|P10|STARTED|Third Intervention (35 Days)||1
183704|NCT01408719|447037|P9|STARTED|Third Intervention (35 Days)||1
183705|NCT01408719|447038|P8|STARTED|Third Intervention (35 Days)||3
183706|NCT01408719|447039|P7|STARTED|Third Intervention (35 Days)||2
183707|NCT01408719|447040|P6|STARTED|Third Intervention (35 Days)||3
183708|NCT01408719|447041|P5|STARTED|Third Intervention (35 Days)||3
183709|NCT01408719|447042|P4|STARTED|Third Intervention (35 Days)||2
183710|NCT01408719|447043|P3|STARTED|Third Intervention (35 Days)||1
183711|NCT01408719|447044|P2|STARTED|Third Intervention (35 Days)||3
183712|NCT01408719|447045|P1|STARTED|Third Intervention (35 Days)||2
183713|NCT01408719|447026|P20|NOT COMPLETED|Washout Period (28 Days)||0
183714|NCT01408719|447027|P19|NOT COMPLETED|Washout Period (28 Days)||0
183715|NCT01408719|447028|P18|NOT COMPLETED|Washout Period (28 Days)||0
183716|NCT01408719|447029|P17|NOT COMPLETED|Washout Period (28 Days)||0
183717|NCT01408719|447030|P16|NOT COMPLETED|Washout Period (28 Days)||0
183718|NCT01408719|447031|P15|NOT COMPLETED|Washout Period (28 Days)||0
183719|NCT01408719|447032|P14|NOT COMPLETED|Washout Period (28 Days)||0
183720|NCT01408719|447033|P13|NOT COMPLETED|Washout Period (28 Days)||0
183721|NCT01408719|447034|P12|NOT COMPLETED|Washout Period (28 Days)||0
183722|NCT01408719|447035|P11|NOT COMPLETED|Washout Period (28 Days)||0
183723|NCT01408719|447036|P10|NOT COMPLETED|Washout Period (28 Days)||0
183724|NCT01408719|447037|P9|NOT COMPLETED|Washout Period (28 Days)||0
183725|NCT01408719|447038|P8|NOT COMPLETED|Washout Period (28 Days)||0
183726|NCT01408719|447039|P7|NOT COMPLETED|Washout Period (28 Days)||0
183727|NCT01408719|447040|P6|NOT COMPLETED|Washout Period (28 Days)||0
183728|NCT01408719|447041|P5|NOT COMPLETED|Washout Period (28 Days)||0
183729|NCT01408719|447042|P4|NOT COMPLETED|Washout Period (28 Days)||0
183730|NCT01408719|447043|P3|NOT COMPLETED|Washout Period (28 Days)||0
183731|NCT01408719|447044|P2|NOT COMPLETED|Washout Period (28 Days)||0
183732|NCT01408719|447045|P1|NOT COMPLETED|Washout Period (28 Days)||0
183733|NCT01408719|447026|P20|COMPLETED|Washout Period (28 Days)||1
183734|NCT01408719|447027|P19|COMPLETED|Washout Period (28 Days)||0
183735|NCT01408719|447028|P18|COMPLETED|Washout Period (28 Days)||2
183736|NCT01408719|447029|P17|COMPLETED|Washout Period (28 Days)||2
183737|NCT01408719|447030|P16|COMPLETED|Washout Period (28 Days)||1
183738|NCT01408719|447031|P15|COMPLETED|Washout Period (28 Days)||1
183739|NCT01408719|447032|P14|COMPLETED|Washout Period (28 Days)||3
183740|NCT01408719|447033|P13|COMPLETED|Washout Period (28 Days)||2
183741|NCT01408719|447034|P12|COMPLETED|Washout Period (28 Days)||2
183742|NCT01408719|447035|P11|COMPLETED|Washout Period (28 Days)||2
183743|NCT01408719|447036|P10|COMPLETED|Washout Period (28 Days)||1
183744|NCT01408719|447037|P9|COMPLETED|Washout Period (28 Days)||1
183745|NCT01408719|447038|P8|COMPLETED|Washout Period (28 Days)||3
183746|NCT01408719|447039|P7|COMPLETED|Washout Period (28 Days)||2
183747|NCT01408719|447040|P6|COMPLETED|Washout Period (28 Days)||3
183748|NCT01408719|447041|P5|COMPLETED|Washout Period (28 Days)||3
183749|NCT01408719|447042|P4|COMPLETED|Washout Period (28 Days)||2
183750|NCT01408719|447043|P3|COMPLETED|Washout Period (28 Days)||1
183751|NCT01408719|447044|P2|COMPLETED|Washout Period (28 Days)||3
183752|NCT01408719|447045|P1|COMPLETED|Washout Period (28 Days)||2
183753|NCT01408719|447026|P20|STARTED|Washout Period (28 Days)||1
183754|NCT01408719|447027|P19|STARTED|Washout Period (28 Days)||0
183755|NCT01408719|447028|P18|STARTED|Washout Period (28 Days)||2
183756|NCT01408719|447029|P17|STARTED|Washout Period (28 Days)||2
183757|NCT01408719|447030|P16|STARTED|Washout Period (28 Days)||1
183758|NCT01408719|447031|P15|STARTED|Washout Period (28 Days)||1
183759|NCT01408719|447032|P14|STARTED|Washout Period (28 Days)||3
183760|NCT01408719|447033|P13|STARTED|Washout Period (28 Days)||2
183761|NCT01408719|447034|P12|STARTED|Washout Period (28 Days)||2
183762|NCT01408719|447035|P11|STARTED|Washout Period (28 Days)||2
183763|NCT01408719|447036|P10|STARTED|Washout Period (28 Days)||1
183764|NCT01408719|447037|P9|STARTED|Washout Period (28 Days)||1
183765|NCT01408719|447038|P8|STARTED|Washout Period (28 Days)||3
183766|NCT01408719|447039|P7|STARTED|Washout Period (28 Days)||2
183767|NCT01408719|447040|P6|STARTED|Washout Period (28 Days)||3
183768|NCT01408719|447041|P5|STARTED|Washout Period (28 Days)||3
183769|NCT01408719|447042|P4|STARTED|Washout Period (28 Days)||2
183770|NCT01408719|447043|P3|STARTED|Washout Period (28 Days)||1
183771|NCT01408719|447044|P2|STARTED|Washout Period (28 Days)||3
183772|NCT01408719|447045|P1|STARTED|Washout Period (28 Days)||2
183773|NCT01408719|447026|P20|NOT COMPLETED|Second Intervention (35 Days)||0
183774|NCT01408719|447027|P19|NOT COMPLETED|Second Intervention (35 Days)||0
183775|NCT01408719|447028|P18|NOT COMPLETED|Second Intervention (35 Days)||0
183776|NCT01408719|447029|P17|NOT COMPLETED|Second Intervention (35 Days)||0
183777|NCT01408719|447030|P16|NOT COMPLETED|Second Intervention (35 Days)||0
183778|NCT01408719|447031|P15|NOT COMPLETED|Second Intervention (35 Days)||0
183779|NCT01408719|447032|P14|NOT COMPLETED|Second Intervention (35 Days)||1
183780|NCT01408719|447033|P13|NOT COMPLETED|Second Intervention (35 Days)||0
183781|NCT01408719|447034|P12|NOT COMPLETED|Second Intervention (35 Days)||0
183782|NCT01408719|447035|P11|NOT COMPLETED|Second Intervention (35 Days)||0
183783|NCT01408719|447036|P10|NOT COMPLETED|Second Intervention (35 Days)||0
183784|NCT01408719|447037|P9|NOT COMPLETED|Second Intervention (35 Days)||0
183785|NCT01408719|447038|P8|NOT COMPLETED|Second Intervention (35 Days)||0
183786|NCT01408719|447039|P7|NOT COMPLETED|Second Intervention (35 Days)||0
183787|NCT01408719|447040|P6|NOT COMPLETED|Second Intervention (35 Days)||0
183788|NCT01408719|447041|P5|NOT COMPLETED|Second Intervention (35 Days)||0
183789|NCT01408719|447042|P4|NOT COMPLETED|Second Intervention (35 Days)||0
183790|NCT01408719|447043|P3|NOT COMPLETED|Second Intervention (35 Days)||0
183791|NCT01408719|447044|P2|NOT COMPLETED|Second Intervention (35 Days)||0
183792|NCT01408719|447045|P1|NOT COMPLETED|Second Intervention (35 Days)||0
183793|NCT01408719|447026|P20|COMPLETED|Second Intervention (35 Days)||1
183794|NCT01408719|447027|P19|COMPLETED|Second Intervention (35 Days)||0
183795|NCT01408719|447028|P18|COMPLETED|Second Intervention (35 Days)||2
183796|NCT01408719|447029|P17|COMPLETED|Second Intervention (35 Days)||2
183797|NCT01408719|447030|P16|COMPLETED|Second Intervention (35 Days)||2
183798|NCT01408719|447031|P15|COMPLETED|Second Intervention (35 Days)||1
183799|NCT01408719|447032|P14|COMPLETED|Second Intervention (35 Days)||3
183800|NCT01408719|447033|P13|COMPLETED|Second Intervention (35 Days)||2
183801|NCT01408719|447034|P12|COMPLETED|Second Intervention (35 Days)||2
183802|NCT01408719|447035|P11|COMPLETED|Second Intervention (35 Days)||2
183803|NCT01408719|447036|P10|COMPLETED|Second Intervention (35 Days)||1
183804|NCT01408719|447037|P9|COMPLETED|Second Intervention (35 Days)||1
183805|NCT01408719|447038|P8|COMPLETED|Second Intervention (35 Days)||3
183806|NCT01408719|447039|P7|COMPLETED|Second Intervention (35 Days)||2
183807|NCT01408719|447040|P6|COMPLETED|Second Intervention (35 Days)||3
183808|NCT01408719|447041|P5|COMPLETED|Second Intervention (35 Days)||3
183809|NCT01408719|447042|P4|COMPLETED|Second Intervention (35 Days)||2
183810|NCT01408719|447043|P3|COMPLETED|Second Intervention (35 Days)||1
183811|NCT01408719|447044|P2|COMPLETED|Second Intervention (35 Days)||3
183812|NCT01408719|447045|P1|COMPLETED|Second Intervention (35 Days)||2
183813|NCT01408719|447026|P20|STARTED|Second Intervention (35 Days)||1
183814|NCT01408719|447027|P19|STARTED|Second Intervention (35 Days)||0
183815|NCT01408719|447028|P18|STARTED|Second Intervention (35 Days)||2
183816|NCT01408719|447029|P17|STARTED|Second Intervention (35 Days)||2
183817|NCT01408719|447030|P16|STARTED|Second Intervention (35 Days)||2
183818|NCT01408719|447031|P15|STARTED|Second Intervention (35 Days)||1
183819|NCT01408719|447032|P14|STARTED|Second Intervention (35 Days)||4
183820|NCT01408719|447033|P13|STARTED|Second Intervention (35 Days)||2
183821|NCT01408719|447034|P12|STARTED|Second Intervention (35 Days)||2
183822|NCT01408719|447035|P11|STARTED|Second Intervention (35 Days)||2
183823|NCT01408719|447036|P10|STARTED|Second Intervention (35 Days)||1
183824|NCT01408719|447037|P9|STARTED|Second Intervention (35 Days)||1
183825|NCT01408719|447038|P8|STARTED|Second Intervention (35 Days)||3
183826|NCT01408719|447039|P7|STARTED|Second Intervention (35 Days)||2
183827|NCT01408719|447040|P6|STARTED|Second Intervention (35 Days)||3
183828|NCT01408719|447041|P5|STARTED|Second Intervention (35 Days)||3
183829|NCT01408719|447042|P4|STARTED|Second Intervention (35 Days)||2
183830|NCT01408719|447043|P3|STARTED|Second Intervention (35 Days)||1
183831|NCT01408719|447044|P2|STARTED|Second Intervention (35 Days)||3
183832|NCT01408719|447045|P1|STARTED|Second Intervention (35 Days)||2
183833|NCT01408719|447026|P20|NOT COMPLETED|Washout Period (28 Days)||0
183834|NCT01408719|447027|P19|NOT COMPLETED|Washout Period (28 Days)||0
183835|NCT01408719|447028|P18|NOT COMPLETED|Washout Period (28 Days)||0
183836|NCT01408719|447029|P17|NOT COMPLETED|Washout Period (28 Days)||0
183837|NCT01408719|447030|P16|NOT COMPLETED|Washout Period (28 Days)||0
183838|NCT01408719|447031|P15|NOT COMPLETED|Washout Period (28 Days)||0
183839|NCT01408719|447032|P14|NOT COMPLETED|Washout Period (28 Days)||0
183840|NCT01408719|447033|P13|NOT COMPLETED|Washout Period (28 Days)||0
183841|NCT01408719|447034|P12|NOT COMPLETED|Washout Period (28 Days)||0
183842|NCT01408719|447035|P11|NOT COMPLETED|Washout Period (28 Days)||0
183843|NCT01408719|447036|P10|NOT COMPLETED|Washout Period (28 Days)||0
183844|NCT01408719|447037|P9|NOT COMPLETED|Washout Period (28 Days)||0
183845|NCT01408719|447038|P8|NOT COMPLETED|Washout Period (28 Days)||0
183846|NCT01408719|447039|P7|NOT COMPLETED|Washout Period (28 Days)||0
183847|NCT01408719|447040|P6|NOT COMPLETED|Washout Period (28 Days)||0
183848|NCT01408719|447041|P5|NOT COMPLETED|Washout Period (28 Days)||0
183849|NCT01408719|447042|P4|NOT COMPLETED|Washout Period (28 Days)||0
183850|NCT01408719|447043|P3|NOT COMPLETED|Washout Period (28 Days)||0
183851|NCT01408719|447044|P2|NOT COMPLETED|Washout Period (28 Days)||0
183852|NCT01408719|447045|P1|NOT COMPLETED|Washout Period (28 Days)||0
183853|NCT01408719|447026|P20|COMPLETED|Washout Period (28 Days)||1
183854|NCT01408719|447027|P19|COMPLETED|Washout Period (28 Days)||0
183855|NCT01408719|447028|P18|COMPLETED|Washout Period (28 Days)||2
183856|NCT01408719|447029|P17|COMPLETED|Washout Period (28 Days)||2
183857|NCT01408719|447030|P16|COMPLETED|Washout Period (28 Days)||2
183858|NCT01408719|447031|P15|COMPLETED|Washout Period (28 Days)||1
183859|NCT01408719|447032|P14|COMPLETED|Washout Period (28 Days)||4
183860|NCT01408719|447033|P13|COMPLETED|Washout Period (28 Days)||2
183861|NCT01408719|447034|P12|COMPLETED|Washout Period (28 Days)||2
183862|NCT01408719|447035|P11|COMPLETED|Washout Period (28 Days)||2
183863|NCT01408719|447036|P10|COMPLETED|Washout Period (28 Days)||1
183864|NCT01408719|447037|P9|COMPLETED|Washout Period (28 Days)||1
183865|NCT01408719|447038|P8|COMPLETED|Washout Period (28 Days)||3
183866|NCT01408719|447039|P7|COMPLETED|Washout Period (28 Days)||2
183867|NCT01408719|447040|P6|COMPLETED|Washout Period (28 Days)||3
183868|NCT01408719|447041|P5|COMPLETED|Washout Period (28 Days)||3
183869|NCT01408719|447042|P4|COMPLETED|Washout Period (28 Days)||2
183870|NCT01408719|447043|P3|COMPLETED|Washout Period (28 Days)||1
183871|NCT01408719|447044|P2|COMPLETED|Washout Period (28 Days)||3
183872|NCT01408719|447045|P1|COMPLETED|Washout Period (28 Days)||2
183873|NCT01408719|447026|P20|STARTED|Washout Period (28 Days)||1
183874|NCT01408719|447027|P19|STARTED|Washout Period (28 Days)||0
183875|NCT01408719|447028|P18|STARTED|Washout Period (28 Days)||2
183876|NCT01408719|447029|P17|STARTED|Washout Period (28 Days)||2
183877|NCT01408719|447030|P16|STARTED|Washout Period (28 Days)||2
183878|NCT01408719|447031|P15|STARTED|Washout Period (28 Days)||1
183879|NCT01408719|447032|P14|STARTED|Washout Period (28 Days)||4
183880|NCT01408719|447033|P13|STARTED|Washout Period (28 Days)||2
183881|NCT01408719|447034|P12|STARTED|Washout Period (28 Days)||2
183882|NCT01408719|447035|P11|STARTED|Washout Period (28 Days)||2
183883|NCT01408719|447036|P10|STARTED|Washout Period (28 Days)||1
183884|NCT01408719|447037|P9|STARTED|Washout Period (28 Days)||1
183885|NCT01408719|447038|P8|STARTED|Washout Period (28 Days)||3
183886|NCT01408719|447039|P7|STARTED|Washout Period (28 Days)||2
183887|NCT01408719|447040|P6|STARTED|Washout Period (28 Days)||3
183888|NCT01408719|447041|P5|STARTED|Washout Period (28 Days)||3
183889|NCT01408719|447042|P4|STARTED|Washout Period (28 Days)||2
183890|NCT01408719|447043|P3|STARTED|Washout Period (28 Days)||1
183891|NCT01408719|447044|P2|STARTED|Washout Period (28 Days)||3
183892|NCT01408719|447045|P1|STARTED|Washout Period (28 Days)||2
183893|NCT01408719|447026|P20|NOT COMPLETED|First Intervention (35 Days)||0
183894|NCT01408719|447027|P19|NOT COMPLETED|First Intervention (35 Days)||1
183895|NCT01408719|447028|P18|NOT COMPLETED|First Intervention (35 Days)||0
183896|NCT01408719|447029|P17|NOT COMPLETED|First Intervention (35 Days)||1
183897|NCT01408719|447030|P16|NOT COMPLETED|First Intervention (35 Days)||0
183898|NCT01408719|447031|P15|NOT COMPLETED|First Intervention (35 Days)||0
183899|NCT01408719|447032|P14|NOT COMPLETED|First Intervention (35 Days)||1
183900|NCT01408719|447033|P13|NOT COMPLETED|First Intervention (35 Days)||0
183901|NCT01408719|447034|P12|NOT COMPLETED|First Intervention (35 Days)||0
183902|NCT01408719|447035|P11|NOT COMPLETED|First Intervention (35 Days)||0
183903|NCT01408719|447036|P10|NOT COMPLETED|First Intervention (35 Days)||0
183904|NCT01408719|447037|P9|NOT COMPLETED|First Intervention (35 Days)||1
183905|NCT01408719|447038|P8|NOT COMPLETED|First Intervention (35 Days)||0
183906|NCT01408719|447039|P7|NOT COMPLETED|First Intervention (35 Days)||0
183907|NCT01408719|447040|P6|NOT COMPLETED|First Intervention (35 Days)||0
183908|NCT01408719|447041|P5|NOT COMPLETED|First Intervention (35 Days)||1
183909|NCT01408719|447042|P4|NOT COMPLETED|First Intervention (35 Days)||0
183910|NCT01408719|447043|P3|NOT COMPLETED|First Intervention (35 Days)||1
183911|NCT01408719|447044|P2|NOT COMPLETED|First Intervention (35 Days)||0
183912|NCT01408719|447045|P1|NOT COMPLETED|First Intervention (35 Days)||0
183913|NCT01408719|447026|P20|COMPLETED|First Intervention (35 Days)||1
183914|NCT01408719|447027|P19|COMPLETED|First Intervention (35 Days)||0
183915|NCT01408719|447028|P18|COMPLETED|First Intervention (35 Days)||2
183916|NCT01408719|447029|P17|COMPLETED|First Intervention (35 Days)||2
183917|NCT01408719|447030|P16|COMPLETED|First Intervention (35 Days)||2
183918|NCT01408719|447031|P15|COMPLETED|First Intervention (35 Days)||1
183919|NCT01408719|447032|P14|COMPLETED|First Intervention (35 Days)||4
183920|NCT01408719|447033|P13|COMPLETED|First Intervention (35 Days)||2
183921|NCT01408719|447034|P12|COMPLETED|First Intervention (35 Days)||2
183922|NCT01408719|447035|P11|COMPLETED|First Intervention (35 Days)||2
183923|NCT01408719|447036|P10|COMPLETED|First Intervention (35 Days)||1
183924|NCT01408719|447037|P9|COMPLETED|First Intervention (35 Days)||1
183925|NCT01408719|447038|P8|COMPLETED|First Intervention (35 Days)||3
183926|NCT01408719|447039|P7|COMPLETED|First Intervention (35 Days)||2
183927|NCT01408719|447040|P6|COMPLETED|First Intervention (35 Days)||3
183928|NCT01408719|447041|P5|COMPLETED|First Intervention (35 Days)||3
183929|NCT01408719|447042|P4|COMPLETED|First Intervention (35 Days)||2
183930|NCT01408719|447043|P3|COMPLETED|First Intervention (35 Days)||1
183931|NCT01408719|447044|P2|COMPLETED|First Intervention (35 Days)||3
183932|NCT01408719|447045|P1|COMPLETED|First Intervention (35 Days)||2
183933|NCT01408719|447026|P20|STARTED|First Intervention (35 Days)||1
183934|NCT01408719|447027|P19|STARTED|First Intervention (35 Days)||1
183935|NCT01408719|447028|P18|STARTED|First Intervention (35 Days)||2
183936|NCT01408719|447029|P17|STARTED|First Intervention (35 Days)||3
183937|NCT01408719|447030|P16|STARTED|First Intervention (35 Days)||2
183938|NCT01408719|447031|P15|STARTED|First Intervention (35 Days)||1
183939|NCT01408719|447032|P14|STARTED|First Intervention (35 Days)||5
183940|NCT01408719|447033|P13|STARTED|First Intervention (35 Days)||2
183941|NCT01408719|447034|P12|STARTED|First Intervention (35 Days)||2
183942|NCT01408719|447035|P11|STARTED|First Intervention (35 Days)||2
183943|NCT01408719|447036|P10|STARTED|First Intervention (35 Days)||1
183944|NCT01408719|447037|P9|STARTED|First Intervention (35 Days)||2
183945|NCT01408719|447038|P8|STARTED|First Intervention (35 Days)||3
183946|NCT01408719|447039|P7|STARTED|First Intervention (35 Days)||2
183947|NCT01408719|447040|P6|STARTED|First Intervention (35 Days)||3
183948|NCT01408719|447041|P5|STARTED|First Intervention (35 Days)||4
183949|NCT01408719|447042|P4|STARTED|First Intervention (35 Days)||2
183950|NCT01408719|447043|P3|STARTED|First Intervention (35 Days)||2
183951|NCT01408719|447044|P2|STARTED|First Intervention (35 Days)||3
183952|NCT01408719|447045|P1|STARTED|First Intervention (35 Days)||2
183953|NCT01408706|447057|P2|NOT COMPLETED|Overall Study||0
183954|NCT01408706|447058|P1|NOT COMPLETED|Overall Study||1
183955|NCT01408706|447057|P2|COMPLETED|Overall Study||30
183956|NCT01408706|447058|P1|COMPLETED|Overall Study||29
183957|NCT01408706|447057|P2|STARTED|Overall Study||30
183958|NCT01408706|447058|P1|STARTED|Overall Study||30
183959|NCT01408641|447070|P2|NOT COMPLETED|Overall Study||0
183960|NCT01408641|447071|P1|NOT COMPLETED|Overall Study||1
183961|NCT01408641|447070|P2|COMPLETED|Overall Study||0
183962|NCT01408641|447071|P1|COMPLETED|Overall Study||0
183963|NCT01408641|447070|P2|STARTED|Overall Study||0
183964|NCT01408641|447071|P1|STARTED|Overall Study||1
183965|NCT01408628|447079|P1|NOT COMPLETED|Completed 6 Month Follow-Up||14
183966|NCT01408628|447079|P1|COMPLETED|Completed 6 Month Follow-Up||25
183967|NCT01408628|447079|P1|STARTED|Completed 6 Month Follow-Up||39
183968|NCT01408628|447079|P1|NOT COMPLETED|Started Classes/Intervention||0
183969|NCT01408628|447079|P1|COMPLETED|Started Classes/Intervention||39
183970|NCT01408628|447079|P1|STARTED|Started Classes/Intervention||39
183971|NCT01408628|447079|P1|NOT COMPLETED|Consented||12
183972|NCT01408628|447079|P1|COMPLETED|Consented||39
183973|NCT01408628|447079|P1|STARTED|Consented||51
183974|NCT01408576|447088|P3|NOT COMPLETED|Overall Study||508
183975|NCT01408576|447089|P2|NOT COMPLETED|Overall Study||498
183976|NCT01408576|447090|P1|NOT COMPLETED|Overall Study||188
183977|NCT01408576|447088|P3|COMPLETED|Overall Study||0
183978|NCT01408576|447089|P2|COMPLETED|Overall Study||0
183979|NCT01408576|447090|P1|COMPLETED|Overall Study||56
183980|NCT01408576|447088|P3|STARTED|Overall Study||508
183981|NCT01408576|447089|P2|STARTED|Overall Study||498
183982|NCT01408576|447090|P1|STARTED|Overall Study||244
183983|NCT01408563|447137|P1|NOT COMPLETED|Overall Study||2
183984|NCT01408563|447137|P1|COMPLETED|Overall Study||31
183985|NCT01408563|447137|P1|Received Transplant|Overall Study||31
183986|NCT01408563|447137|P1|STARTED|Overall Study||33
183987|NCT01408537|447153|P1|NOT COMPLETED|Overall Study||8
183988|NCT01408537|447153|P1|COMPLETED|Overall Study||144
183989|NCT01408537|447153|P1|STARTED|Overall Study||152
183990|NCT01408485|447169|P1|NOT COMPLETED|Overall Study||21
183991|NCT01408485|447169|P1|COMPLETED|Overall Study||179
183992|NCT01408485|447169|P1|STARTED|Overall Study||200
183993|NCT01408329|447177|P2|NOT COMPLETED|Overall Study||4
183994|NCT01408329|447178|P1|NOT COMPLETED|Overall Study||3
183995|NCT01408329|447177|P2|COMPLETED|Overall Study||11
183996|NCT01408329|447178|P1|COMPLETED|Overall Study||10
183997|NCT01408329|447177|P2|STARTED|Overall Study||15
183998|NCT01408329|447178|P1|STARTED|Overall Study||13
183999|NCT01408303|447187|P3|NOT COMPLETED|Overall Study||6
184000|NCT01408303|447188|P2|NOT COMPLETED|Overall Study||12
184001|NCT01408303|447189|P1|NOT COMPLETED|Overall Study||6
184002|NCT01408303|447187|P3|COMPLETED|Overall Study||210
184003|NCT01408303|447188|P2|COMPLETED|Overall Study||204
184004|NCT01408303|447189|P1|COMPLETED|Overall Study||209
184005|NCT01408303|447187|P3|STARTED|Overall Study||216
184006|NCT01408303|447188|P2|STARTED|Overall Study||216
184007|NCT01408303|447189|P1|STARTED|Overall Study||215
184008|NCT01408277|447199|P2|NOT COMPLETED|Overall Study||4
184009|NCT01408277|447200|P1|NOT COMPLETED|Overall Study||8
184010|NCT01408277|447199|P2|COMPLETED|Overall Study||23
184011|NCT01408277|447200|P1|COMPLETED|Overall Study||20
184012|NCT01408277|447199|P2|STARTED|Overall Study||27
184013|NCT01408277|447200|P1|STARTED|Overall Study||28
184014|NCT01408043|447206|P1|NOT COMPLETED|Overall Study||1
184015|NCT01408043|447206|P1|COMPLETED|Overall Study||24
184016|NCT01408043|447206|P1|STARTED|Overall Study||25
184017|NCT01408030|447225|P4|NOT COMPLETED|Observation Phase (Off Drug)||4
184018|NCT01408030|447226|P3|NOT COMPLETED|Observation Phase (Off Drug)||6
184019|NCT01408030|447227|P2|NOT COMPLETED|Observation Phase (Off Drug)||6
184020|NCT01408030|447228|P1|NOT COMPLETED|Observation Phase (Off Drug)||4
184021|NCT01408030|447225|P4|COMPLETED|Observation Phase (Off Drug)||21
184022|NCT01408030|447226|P3|COMPLETED|Observation Phase (Off Drug)||26
184023|NCT01408030|447227|P2|COMPLETED|Observation Phase (Off Drug)||18
184024|NCT01408030|447228|P1|COMPLETED|Observation Phase (Off Drug)||22
184025|NCT01408030|447225|P4|STARTED|Observation Phase (Off Drug)||25
184026|NCT01408030|447226|P3|STARTED|Observation Phase (Off Drug)||32
184027|NCT01408030|447227|P2|STARTED|Observation Phase (Off Drug)||24
184028|NCT01408030|447228|P1|STARTED|Observation Phase (Off Drug)||26
184029|NCT01408030|447225|P4|NOT COMPLETED|Treatment Phase (on Drug)||3
184030|NCT01408030|447226|P3|NOT COMPLETED|Treatment Phase (on Drug)||1
184031|NCT01408030|447227|P2|NOT COMPLETED|Treatment Phase (on Drug)||7
184032|NCT01408030|447228|P1|NOT COMPLETED|Treatment Phase (on Drug)||3
184033|NCT01408030|447225|P4|COMPLETED|Treatment Phase (on Drug)||25
184034|NCT01408030|447226|P3|COMPLETED|Treatment Phase (on Drug)||32
184035|NCT01408030|447227|P2|COMPLETED|Treatment Phase (on Drug)||24
184036|NCT01408030|447228|P1|COMPLETED|Treatment Phase (on Drug)||26
184037|NCT01408030|447225|P4|STARTED|Treatment Phase (on Drug)||28
184038|NCT01408030|447226|P3|STARTED|Treatment Phase (on Drug)||33
184039|NCT01408030|447227|P2|STARTED|Treatment Phase (on Drug)||31
184040|NCT01408030|447228|P1|STARTED|Treatment Phase (on Drug)||29
184041|NCT01407952|447260|P2|NOT COMPLETED|Overall Study||37
184042|NCT01407952|447261|P1|NOT COMPLETED|Overall Study||46
184043|NCT01407952|447260|P2|COMPLETED|Overall Study||266
184044|NCT01407952|447261|P1|COMPLETED|Overall Study||251
184045|NCT01407952|447260|P2|STARTED|Overall Study||303
184046|NCT01407952|447261|P1|STARTED|Overall Study||297
184047|NCT01407926|447287|P1|NOT COMPLETED|Overall Study||55
184048|NCT01407926|447287|P1|COMPLETED|Overall Study||87
184049|NCT01407926|447287|P1|STARTED|Overall Study||142
184050|NCT01407575|447304|P2|NOT COMPLETED|Overall Study||1
184051|NCT01407575|447305|P1|NOT COMPLETED|Overall Study||2
184052|NCT01407575|447304|P2|COMPLETED|Overall Study||5
184053|NCT01407575|447305|P1|COMPLETED|Overall Study||5
184054|NCT01407575|447304|P2|STARTED|Overall Study||6
184055|NCT01407575|447305|P1|STARTED|Overall Study||7
184056|NCT01407523|447323|P1|NOT COMPLETED|Overall Study||0
184057|NCT01407523|447323|P1|COMPLETED|Overall Study||16
184058|NCT01407523|447323|P1|STARTED|Overall Study||16
184059|NCT01407367|447335|P2|NOT COMPLETED|Overall Study||78
184060|NCT01407367|447336|P1|NOT COMPLETED|Overall Study||40
184061|NCT01407367|447335|P2|COMPLETED|Overall Study||164
184062|NCT01407367|447336|P1|COMPLETED|Overall Study||68
184063|NCT01407367|447335|P2|STARTED|Overall Study||242
184064|NCT01407367|447336|P1|STARTED|Overall Study||108
184065|NCT01407354|447350|P2|NOT COMPLETED|Second Intervention||2
184066|NCT01407354|447351|P1|NOT COMPLETED|Second Intervention||0
184067|NCT01407354|447350|P2|COMPLETED|Second Intervention||13
184068|NCT01407354|447351|P1|COMPLETED|Second Intervention||18
184069|NCT01407354|447350|P2|STARTED|Second Intervention||15
184070|NCT01407354|447351|P1|STARTED|Second Intervention||18
184071|NCT01407354|447350|P2|NOT COMPLETED|First Intervention||2
184072|NCT01407354|447351|P1|NOT COMPLETED|First Intervention||2
184073|NCT01407354|447350|P2|COMPLETED|First Intervention||15
184074|NCT01407354|447351|P1|COMPLETED|First Intervention||18
184075|NCT01407354|447350|P2|STARTED|First Intervention||17
184076|NCT01407354|447351|P1|STARTED|First Intervention||20
184077|NCT01407276|447367|P8|NOT COMPLETED|Overall Study||1
184078|NCT01407276|447368|P7|NOT COMPLETED|Overall Study||0
184079|NCT01407276|447369|P6|NOT COMPLETED|Overall Study||0
184080|NCT01407276|447370|P5|NOT COMPLETED|Overall Study||0
184081|NCT01407276|447371|P4|NOT COMPLETED|Overall Study||0
184082|NCT01407276|447372|P3|NOT COMPLETED|Overall Study||0
184083|NCT01407276|447373|P2|NOT COMPLETED|Overall Study||0
184084|NCT01407276|447374|P1|NOT COMPLETED|Overall Study||0
184085|NCT01407276|447367|P8|COMPLETED|Overall Study||6
184086|NCT01407276|447368|P7|COMPLETED|Overall Study||6
184087|NCT01407276|447369|P6|COMPLETED|Overall Study||6
184088|NCT01407276|447370|P5|COMPLETED|Overall Study||6
184089|NCT01407276|447371|P4|COMPLETED|Overall Study||6
184090|NCT01407276|447372|P3|COMPLETED|Overall Study||6
184091|NCT01407276|447373|P2|COMPLETED|Overall Study||6
184092|NCT01407276|447374|P1|COMPLETED|Overall Study||6
184093|NCT01407276|447367|P8|STARTED|Overall Study||7
184094|NCT01407276|447368|P7|STARTED|Overall Study||6
184095|NCT01407276|447369|P6|STARTED|Overall Study||6
184096|NCT01407276|447370|P5|STARTED|Overall Study||6
184097|NCT01407276|447371|P4|STARTED|Overall Study||6
184098|NCT01407276|447372|P3|STARTED|Overall Study||6
184099|NCT01407276|447373|P2|STARTED|Overall Study||6
184100|NCT01407276|447374|P1|STARTED|Overall Study||6
184101|NCT01407094|447501|P3|NOT COMPLETED|Stage 2||15
184102|NCT01407094|447502|P2|NOT COMPLETED|Stage 2||11
184103|NCT01407094|447503|P1|NOT COMPLETED|Stage 2||21
184104|NCT01407094|447501|P3|COMPLETED|Stage 2||38
184105|NCT01407094|447502|P2|COMPLETED|Stage 2||35
184106|NCT01407094|447503|P1|COMPLETED|Stage 2||113
184107|NCT01407094|447501|P3|STARTED|Stage 2|Stage 2 BUP includes Stage 1 SERT non-responders (n=54); 1 early exit (n=53).|53
184108|NCT01407094|447502|P2|STARTED|Stage 2|Stage 2 PBO includes Stage 1 PBO responders (n=47); 1 early exit (n=46).|46
184109|NCT01407094|447503|P1|STARTED|Stage 2|Stage 2 SERT includes Stage 1 SERT responders (n=61) and Stage 1 PBO non-responders (n=73).|134
184110|NCT01407094|447501|P3|NOT COMPLETED|Stage 1||0
184111|NCT01407094|447502|P2|NOT COMPLETED|Stage 1||27
184112|NCT01407094|447503|P1|NOT COMPLETED|Stage 1||34
184113|NCT01407094|447501|P3|COMPLETED|Stage 1||0
184114|NCT01407094|447502|P2|COMPLETED|Stage 1|Four participants completed Stage 1 but did not continue to Stage 2.|123
184115|NCT01407094|447503|P1|COMPLETED|Stage 1|One participant completed Stage 1 but did not continue to Stage 2.|112
184116|NCT01407094|447501|P3|STARTED|Stage 1|Bupropion (BUP) was used only in Stage 2 for non-responders to SERT.|0
184117|NCT01407094|447502|P2|STARTED|Stage 1|Stage 1 Placebo (PBO): 27 exited.|150
184118|NCT01407094|447503|P1|STARTED|Stage 1|Stage 1 Sertraline (SERT): 34 exited|146
184119|NCT01407068|447511|P1|NOT COMPLETED|Overall Study||0
184120|NCT01407068|447511|P1|COMPLETED|Overall Study||60
184121|NCT01407068|447511|P1|STARTED|Overall Study||60
184122|NCT01406990|447520|P1|NOT COMPLETED|Overall Study||0
184123|NCT01406990|447520|P1|COMPLETED|Overall Study||15
184124|NCT01406990|447520|P1|STARTED|Overall Study||15
184125|NCT01406938|447526|P6|NOT COMPLETED|Follow up||3
184126|NCT01406938|447527|P5|NOT COMPLETED|Follow up||9
184127|NCT01406938|447528|P4|NOT COMPLETED|Follow up||3
184128|NCT01406938|447529|P3|NOT COMPLETED|Follow up||8
184129|NCT01406938|447530|P2|NOT COMPLETED|Follow up||5
184130|NCT01406938|447531|P1|NOT COMPLETED|Follow up||8
184131|NCT01406938|447526|P6|COMPLETED|Follow up||32
184132|NCT01406938|447527|P5|COMPLETED|Follow up||31
184133|NCT01406938|447528|P4|COMPLETED|Follow up||36
184134|NCT01406938|447529|P3|COMPLETED|Follow up||32
184135|NCT01406938|447530|P2|COMPLETED|Follow up||18
184136|NCT01406938|447531|P1|COMPLETED|Follow up||18
184137|NCT01406938|447526|P6|STARTED|Follow up||35
184138|NCT01406938|447527|P5|STARTED|Follow up||40
184139|NCT01406938|447528|P4|STARTED|Follow up||39
184140|NCT01406938|447529|P3|STARTED|Follow up||40
184141|NCT01406938|447530|P2|STARTED|Follow up||23
184142|NCT01406938|447531|P1|STARTED|Follow up||26
184143|NCT01406938|447526|P6|NOT COMPLETED|Maintenance Period||16
184144|NCT01406938|447527|P5|NOT COMPLETED|Maintenance Period||25
184145|NCT01406938|447528|P4|NOT COMPLETED|Maintenance Period||18
184146|NCT01406938|447529|P3|NOT COMPLETED|Maintenance Period||17
184147|NCT01406938|447530|P2|NOT COMPLETED|Maintenance Period||0
184148|NCT01406938|447531|P1|NOT COMPLETED|Maintenance Period||0
184149|NCT01406938|447526|P6|COMPLETED|Maintenance Period||201
184150|NCT01406938|447527|P5|COMPLETED|Maintenance Period||181
184151|NCT01406938|447528|P4|COMPLETED|Maintenance Period||199
184152|NCT01406938|447529|P3|COMPLETED|Maintenance Period||186
184153|NCT01406938|447530|P2|COMPLETED|Maintenance Period||0
184154|NCT01406938|447531|P1|COMPLETED|Maintenance Period||0
184155|NCT01406938|447526|P6|FAS: Patients Assigned Treatment Drug|Maintenance Period||217
184156|NCT01406938|447527|P5|FAS: Patients Assigned Treatment Drug|Maintenance Period||206
184157|NCT01406938|447528|P4|FAS: Patients Assigned Treatment Drug|Maintenance Period||216
184158|NCT01406938|447529|P3|FAS: Patients Assigned Treatment Drug|Maintenance Period||203
184159|NCT01406938|447530|P2|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
184160|NCT01406938|447531|P1|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
184161|NCT01406938|447526|P6|STARTED|Maintenance Period||217
184162|NCT01406938|447527|P5|STARTED|Maintenance Period||206
184163|NCT01406938|447528|P4|STARTED|Maintenance Period||217
184164|NCT01406938|447529|P3|STARTED|Maintenance Period||203
184165|NCT01406938|447530|P2|STARTED|Maintenance Period||0
184166|NCT01406938|447531|P1|STARTED|Maintenance Period||0
184167|NCT01406938|447526|P6|NOT COMPLETED|Induction Period||0
184168|NCT01406938|447527|P5|NOT COMPLETED|Induction Period||0
184169|NCT01406938|447528|P4|NOT COMPLETED|Induction Period||0
184170|NCT01406938|447529|P3|NOT COMPLETED|Induction Period||0
184171|NCT01406938|447530|P2|NOT COMPLETED|Induction Period||20
184172|NCT01406938|447531|P1|NOT COMPLETED|Induction Period||18
184173|NCT01406938|447526|P6|COMPLETED|Induction Period||0
184174|NCT01406938|447527|P5|COMPLETED|Induction Period||0
184175|NCT01406938|447528|P4|COMPLETED|Induction Period||0
184176|NCT01406938|447529|P3|COMPLETED|Induction Period||0
184177|NCT01406938|447530|P2|COMPLETED|Induction Period||464
184178|NCT01406938|447531|P1|COMPLETED|Induction Period||464
184179|NCT01406938|447526|P6|FAS:Patients Assigned Study Treatment|Induction Period||0
184180|NCT01406938|447527|P5|FAS:Patients Assigned Study Treatment|Induction Period||0
184181|NCT01406938|447528|P4|FAS:Patients Assigned Study Treatment|Induction Period||0
184182|NCT01406938|447529|P3|FAS:Patients Assigned Study Treatment|Induction Period||0
184183|NCT01406938|447530|P2|FAS:Patients Assigned Study Treatment|Induction Period||483
184184|NCT01406938|447531|P1|FAS:Patients Assigned Study Treatment|Induction Period||482
184185|NCT01406938|447526|P6|STARTED|Induction Period||0
184186|NCT01406938|447527|P5|STARTED|Induction Period||0
184187|NCT01406938|447528|P4|STARTED|Induction Period||0
184188|NCT01406938|447529|P3|STARTED|Induction Period||0
184189|NCT01406938|447530|P2|STARTED|Induction Period||484
184190|NCT01406938|447531|P1|STARTED|Induction Period||482
184191|NCT01406873|447649|P2|NOT COMPLETED|Overall Study||1
184192|NCT01406873|447650|P1|NOT COMPLETED|Overall Study||1
184193|NCT01406873|447649|P2|COMPLETED|Overall Study||20
184194|NCT01406873|447650|P1|COMPLETED|Overall Study||20
184195|NCT01406873|447649|P2|STARTED|Overall Study||21
184196|NCT01406873|447650|P1|STARTED|Overall Study||21
184197|NCT01406860|447668|P2|NOT COMPLETED|Overall Study||0
184198|NCT01406860|447669|P1|NOT COMPLETED|Overall Study||0
184199|NCT01406860|447668|P2|COMPLETED|Overall Study||8
184200|NCT01406860|447669|P1|COMPLETED|Overall Study||11
184201|NCT01406860|447668|P2|STARTED|Overall Study||8
184202|NCT01406860|447669|P1|STARTED|Overall Study||11
184203|NCT01406795|447681|P1|NOT COMPLETED|Overall Study||1
184204|NCT01406795|447681|P1|COMPLETED|Overall Study||0
184205|NCT01406795|447681|P1|STARTED|Overall Study||1
184206|NCT01406717|447697|P2|NOT COMPLETED|Overall Study||31
184207|NCT01406717|447698|P1|NOT COMPLETED|Overall Study||43
184208|NCT01406717|447697|P2|COMPLETED|Overall Study||149
184209|NCT01406717|447698|P1|COMPLETED|Overall Study||137
184210|NCT01406717|447697|P2|STARTED|Overall Study||180
184211|NCT01406717|447698|P1|STARTED|Overall Study||180
184212|NCT01406652|447728|P2|NOT COMPLETED|Overall Study||20
184213|NCT01406652|447729|P1|NOT COMPLETED|Overall Study||20
184214|NCT01406652|447728|P2|COMPLETED|Overall Study||95
184215|NCT01406652|447729|P1|COMPLETED|Overall Study||89
184216|NCT01406652|447728|P2|STARTED|Overall Study||115
184217|NCT01406652|447729|P1|STARTED|Overall Study||109
184218|NCT01406574|447737|P4|NOT COMPLETED|Overall Study||4
184219|NCT01406574|447738|P3|NOT COMPLETED|Overall Study||1
184220|NCT01406574|447739|P2|NOT COMPLETED|Overall Study||1
184221|NCT01406574|447740|P1|NOT COMPLETED|Overall Study||1
184222|NCT01406574|447737|P4|COMPLETED|Overall Study||1
184223|NCT01406574|447738|P3|COMPLETED|Overall Study||6
184224|NCT01406574|447739|P2|COMPLETED|Overall Study||3
184225|NCT01406574|447740|P1|COMPLETED|Overall Study||6
184226|NCT01406574|447737|P4|STARTED|Overall Study||5
184227|NCT01406574|447738|P3|STARTED|Overall Study||7
184228|NCT01406574|447739|P2|STARTED|Overall Study||4
184229|NCT01406574|447740|P1|STARTED|Overall Study||7
184230|NCT01406223|447756|P4|NOT COMPLETED|Overall Study||16
184231|NCT01406223|447757|P3|NOT COMPLETED|Overall Study||18
184232|NCT01406223|447758|P2|NOT COMPLETED|Overall Study||12
184233|NCT01406223|447759|P1|NOT COMPLETED|Overall Study||12
184234|NCT01406223|447756|P4|COMPLETED|Overall Study||3
184235|NCT01406223|447757|P3|COMPLETED|Overall Study||2
184236|NCT01406223|447758|P2|COMPLETED|Overall Study||7
184237|NCT01406223|447759|P1|COMPLETED|Overall Study||6
184238|NCT01406223|447756|P4|STARTED|Overall Study||19
184239|NCT01406223|447757|P3|STARTED|Overall Study||20
184240|NCT01406223|447758|P2|STARTED|Overall Study||19
184241|NCT01406223|447759|P1|STARTED|Overall Study||18
184242|NCT01406015|447775|P2|NOT COMPLETED|Overall Study||3
184243|NCT01406015|447776|P1|NOT COMPLETED|Overall Study||3
184244|NCT01406015|447775|P2|COMPLETED|Overall Study||16
184245|NCT01406015|447776|P1|COMPLETED|Overall Study||16
184246|NCT01406015|447775|P2|STARTED|Overall Study||19
184247|NCT01406015|447776|P1|STARTED|Overall Study||19
184248|NCT01405950|447792|P4|NOT COMPLETED|Overall Study||0
184249|NCT01405950|447793|P3|NOT COMPLETED|Overall Study||0
184250|NCT01405950|447794|P2|NOT COMPLETED|Overall Study||0
184251|NCT01405950|447795|P1|NOT COMPLETED|Overall Study||1
184252|NCT01405950|447792|P4|COMPLETED|Overall Study||0
184253|NCT01405950|447793|P3|COMPLETED|Overall Study||0
184254|NCT01405950|447794|P2|COMPLETED|Overall Study||2
184255|NCT01405950|447795|P1|COMPLETED|Overall Study||7
184256|NCT01405950|447792|P4|STARTED|Overall Study||0
184257|NCT01405950|447793|P3|STARTED|Overall Study||0
184258|NCT01405950|447794|P2|STARTED|Overall Study||2
184259|NCT01405950|447795|P1|STARTED|Overall Study||8
184260|NCT01405937|447809|P2|NOT COMPLETED|Overall Study||0
184261|NCT01405937|447810|P1|NOT COMPLETED|Overall Study||0
184262|NCT01405937|447809|P2|COMPLETED|Overall Study||26
184263|NCT01405937|447810|P1|COMPLETED|Overall Study||25
184264|NCT01405937|447809|P2|STARTED|Overall Study||26
184265|NCT01405937|447810|P1|STARTED|Overall Study||25
184266|NCT01405924|447830|P1|NOT COMPLETED|Overall Study||10
184267|NCT01405924|447830|P1|COMPLETED|Overall Study||101
184268|NCT01405924|447830|P1|STARTED|Overall Study||111
184269|NCT01405898|447842|P2|NOT COMPLETED|Overall Study||2
184270|NCT01405898|447843|P1|NOT COMPLETED|Overall Study||2
184271|NCT01405898|447842|P2|COMPLETED|Overall Study||32
184272|NCT01405898|447843|P1|COMPLETED|Overall Study||32
184273|NCT01405898|447842|P2|STARTED|Overall Study||34
184274|NCT01405898|447843|P1|STARTED|Overall Study||34
184275|NCT01405820|447867|P6|NOT COMPLETED|Open-Label Treatment Period||2
184276|NCT01405820|447868|P5|NOT COMPLETED|Open-Label Treatment Period||2
184277|NCT01405820|447869|P4|NOT COMPLETED|Open-Label Treatment Period||5
184278|NCT01405820|447870|P3|NOT COMPLETED|Open-Label Treatment Period||3
184279|NCT01405820|447871|P2|NOT COMPLETED|Open-Label Treatment Period||2
184280|NCT01405820|447872|P1|NOT COMPLETED|Open-Label Treatment Period||4
184281|NCT01405820|447867|P6|COMPLETED|Open-Label Treatment Period||30
184282|NCT01405820|447868|P5|COMPLETED|Open-Label Treatment Period||40
184283|NCT01405820|447869|P4|COMPLETED|Open-Label Treatment Period||37
184284|NCT01405820|447870|P3|COMPLETED|Open-Label Treatment Period||39
184285|NCT01405820|447871|P2|COMPLETED|Open-Label Treatment Period||33
184286|NCT01405820|447872|P1|COMPLETED|Open-Label Treatment Period||40
184287|NCT01405820|447867|P6|STARTED|Open-Label Treatment Period||32
184288|NCT01405820|447868|P5|STARTED|Open-Label Treatment Period||42
184289|NCT01405820|447869|P4|STARTED|Open-Label Treatment Period||42
184290|NCT01405820|447870|P3|STARTED|Open-Label Treatment Period||42
184291|NCT01405820|447871|P2|STARTED|Open-Label Treatment Period||35
184292|NCT01405820|447872|P1|STARTED|Open-Label Treatment Period|1 participant discontinued randomized period due to an adverse event but entered open-label period.|44
184293|NCT01405820|447867|P6|NOT COMPLETED|Randomized Treatment Period||37
184294|NCT01405820|447868|P5|NOT COMPLETED|Randomized Treatment Period||45
184295|NCT01405820|447869|P4|NOT COMPLETED|Randomized Treatment Period||51
184296|NCT01405820|447870|P3|NOT COMPLETED|Randomized Treatment Period||43
184297|NCT01405820|447871|P2|NOT COMPLETED|Randomized Treatment Period||10
184298|NCT01405820|447872|P1|NOT COMPLETED|Randomized Treatment Period||11
184299|NCT01405820|447867|P6|COMPLETED|Randomized Treatment Period||1
184300|NCT01405820|447868|P5|COMPLETED|Randomized Treatment Period||2
184301|NCT01405820|447869|P4|COMPLETED|Randomized Treatment Period||3
184302|NCT01405820|447870|P3|COMPLETED|Randomized Treatment Period||9
184303|NCT01405820|447871|P2|COMPLETED|Randomized Treatment Period||35
184304|NCT01405820|447872|P1|COMPLETED|Randomized Treatment Period||43
184305|NCT01405820|447867|P6|Safety Population|Randomized Treatment Period||38
184306|NCT01405820|447868|P5|Safety Population|Randomized Treatment Period||47
184307|NCT01405820|447869|P4|Safety Population|Randomized Treatment Period|1 participant did not receive any study medication.|53
184308|NCT01405820|447870|P3|Safety Population|Randomized Treatment Period||52
184309|NCT01405820|447871|P2|Safety Population|Randomized Treatment Period||45
184310|NCT01405820|447872|P1|Safety Population|Randomized Treatment Period||54
184311|NCT01405820|447867|P6|STARTED|Randomized Treatment Period||38
184312|NCT01405820|447868|P5|STARTED|Randomized Treatment Period||47
184313|NCT01405820|447869|P4|STARTED|Randomized Treatment Period||54
184314|NCT01405820|447870|P3|STARTED|Randomized Treatment Period||52
184315|NCT01405820|447871|P2|STARTED|Randomized Treatment Period||45
184316|NCT01405820|447872|P1|STARTED|Randomized Treatment Period||54
184317|NCT01405794|447892|P1|NOT COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||0
184318|NCT01405794|447892|P1|COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||12
184319|NCT01405794|447892|P1|STARTED|Second Dose 32ppm Oral Silver (14 Days)||12
184320|NCT01405794|447892|P1|NOT COMPLETED|72 hr Washout||0
184321|NCT01405794|447892|P1|COMPLETED|72 hr Washout||12
184322|NCT01405794|447892|P1|STARTED|72 hr Washout||12
184323|NCT01405794|447892|P1|NOT COMPLETED|First Dose Placebo (14 Days)||0
184324|NCT01405794|447892|P1|COMPLETED|First Dose Placebo (14 Days)||12
184325|NCT01405794|447892|P1|STARTED|First Dose Placebo (14 Days)||12
184326|NCT01405768|447968|P2|NOT COMPLETED|Overall Study||0
184327|NCT01405768|447969|P1|NOT COMPLETED|Overall Study||4
184328|NCT01405768|447968|P2|COMPLETED|Overall Study||28
184329|NCT01405768|447969|P1|COMPLETED|Overall Study||24
184330|NCT01405768|447968|P2|STARTED|Overall Study||28
184331|NCT01405768|447969|P1|STARTED|Overall Study||28
184332|NCT01405742|447981|P2|NOT COMPLETED|Overall Study||0
184333|NCT01405742|447982|P1|NOT COMPLETED|Overall Study||1
184334|NCT01405742|447981|P2|COMPLETED|Overall Study||2
184335|NCT01405742|447982|P1|COMPLETED|Overall Study||1
184336|NCT01405742|447981|P2|STARTED|Overall Study||2
184337|NCT01405742|447982|P1|STARTED|Overall Study||2
184338|NCT01405560|447992|P1|NOT COMPLETED|Overall Study||1
184339|NCT01405560|447992|P1|COMPLETED|Overall Study||41
184340|NCT01405560|447992|P1|STARTED|Overall Study||42
184341|NCT01405508|448007|P4|NOT COMPLETED|Overall Study||0
184342|NCT01405508|448008|P3|NOT COMPLETED|Overall Study||0
184343|NCT01405508|448009|P2|NOT COMPLETED|Overall Study||1
184344|NCT01405508|448010|P1|NOT COMPLETED|Overall Study||1
184345|NCT01405508|448007|P4|COMPLETED|Overall Study||26
184346|NCT01405508|448008|P3|COMPLETED|Overall Study||27
184347|NCT01405508|448009|P2|COMPLETED|Overall Study||25
184348|NCT01405508|448010|P1|COMPLETED|Overall Study||25
184349|NCT01405508|448007|P4|STARTED|Overall Study||26
184350|NCT01405508|448008|P3|STARTED|Overall Study||27
184351|NCT01405508|448009|P2|STARTED|Overall Study||26
184352|NCT01405508|448010|P1|STARTED|Overall Study||26
184353|NCT01405469|448028|P1|NOT COMPLETED|Overall Study||0
184354|NCT01405469|448028|P1|COMPLETED|Overall Study||16
184355|NCT01405469|448028|P1|STARTED|Overall Study||16
184356|NCT01405456|448042|P2|NOT COMPLETED|Overall Study||1
184357|NCT01405456|448043|P1|NOT COMPLETED|Overall Study||3
184358|NCT01405456|448042|P2|COMPLETED|Overall Study||20
184359|NCT01405456|448043|P1|COMPLETED|Overall Study||22
184360|NCT01405456|448042|P2|STARTED|Overall Study||21
184361|NCT01405456|448043|P1|STARTED|Overall Study||25
184362|NCT01405313|448071|P1|NOT COMPLETED|Overall Study||0
184363|NCT01405313|448071|P1|COMPLETED|Overall Study||21
184364|NCT01405313|448071|P1|STARTED|Overall Study||21
184365|NCT01405196|448083|P4|NOT COMPLETED|Overall Study||9
184366|NCT01405196|448084|P3|NOT COMPLETED|Overall Study||23
184367|NCT01405196|448085|P2|NOT COMPLETED|Overall Study||12
184368|NCT01405196|448086|P1|NOT COMPLETED|Overall Study||11
184369|NCT01405196|448083|P4|COMPLETED|Overall Study||36
184370|NCT01405196|448084|P3|COMPLETED|Overall Study||23
184371|NCT01405196|448085|P2|COMPLETED|Overall Study||35
184372|NCT01405196|448086|P1|COMPLETED|Overall Study||34
184373|NCT01405196|448083|P4|STARTED|Overall Study||45
184374|NCT01405196|448084|P3|STARTED|Overall Study||46
184375|NCT01405196|448085|P2|STARTED|Overall Study||47
184376|NCT01405196|448086|P1|STARTED|Overall Study||45
184377|NCT01405053|448173|P2|NOT COMPLETED|Overall Study||8
184378|NCT01405053|448174|P1|NOT COMPLETED|Overall Study||10
184379|NCT01405053|448173|P2|COMPLETED|Overall Study||4
184380|NCT01405053|448174|P1|COMPLETED|Overall Study||15
184381|NCT01405053|448173|P2|STARTED|Overall Study||12
184382|NCT01405053|448174|P1|STARTED|Overall Study||25
184383|NCT01405027|448200|P2|NOT COMPLETED|Overall Study||51
184384|NCT01405027|448201|P1|NOT COMPLETED|Overall Study||32
184385|NCT01405027|448200|P2|COMPLETED|Overall Study||62
184386|NCT01405027|448201|P1|COMPLETED|Overall Study||52
184387|NCT01405027|448200|P2|STARTED|Overall Study||113
184388|NCT01405027|448201|P1|STARTED|Overall Study||84
184389|NCT01404988|448218|P3|NOT COMPLETED|Overall Study||3
184390|NCT01404988|448219|P2|NOT COMPLETED|Overall Study||4
184391|NCT01404988|448220|P1|NOT COMPLETED|Overall Study||6
184392|NCT01404988|448218|P3|COMPLETED|Overall Study||30
184393|NCT01404988|448219|P2|COMPLETED|Overall Study||29
184394|NCT01404988|448220|P1|COMPLETED|Overall Study||27
184395|NCT01404988|448218|P3|STARTED|Overall Study||33
184396|NCT01404988|448219|P2|STARTED|Overall Study||33
184397|NCT01404988|448220|P1|STARTED|Overall Study||33
184398|NCT01404936|448237|P1|NOT COMPLETED|Overall Study||0
184399|NCT01404936|448237|P1|COMPLETED|Overall Study||30
184400|NCT01404936|448237|P1|STARTED|Overall Study||30
184401|NCT01404923|448243|P2|NOT COMPLETED|Overall Study||17
184402|NCT01404923|448244|P1|NOT COMPLETED|Overall Study||23
184403|NCT01404923|448243|P2|COMPLETED|Overall Study||197
184404|NCT01404923|448244|P1|COMPLETED|Overall Study||199
184405|NCT01404923|448243|P2|STARTED|Overall Study||214
184406|NCT01404923|448244|P1|STARTED|Overall Study||222
184407|NCT01404832|448252|P1|NOT COMPLETED|Overall Study||0
184408|NCT01404832|448252|P1|COMPLETED|Overall Study||21
184409|NCT01404832|448252|P1|STARTED|Overall Study||21
184410|NCT01404650|448257|P1|NOT COMPLETED|Overall Study||0
184411|NCT01404650|448257|P1|COMPLETED|Overall Study||25
184412|NCT01404650|448257|P1|STARTED|Overall Study|Twenty-five patients received a median of 2 cycles of AUY922.|25
184413|NCT01404611|448267|P3|NOT COMPLETED|Overall Study||5
184414|NCT01404611|448268|P2|NOT COMPLETED|Overall Study||19
184415|NCT01404611|448269|P1|NOT COMPLETED|Overall Study||8
184416|NCT01404611|448267|P3|COMPLETED|Overall Study||106
184417|NCT01404611|448268|P2|COMPLETED|Overall Study||89
184418|NCT01404611|448269|P1|COMPLETED|Overall Study||104
184419|NCT01404611|448267|P3|STARTED|Overall Study||111
184420|NCT01404611|448268|P2|STARTED|Overall Study||108
184421|NCT01404611|448269|P1|STARTED|Overall Study||112
184422|NCT01404572|448277|P3|NOT COMPLETED|Overall Study||0
184423|NCT01404572|448278|P2|NOT COMPLETED|Overall Study||0
184424|NCT01404572|448279|P1|NOT COMPLETED|Overall Study||0
184425|NCT01404572|448277|P3|COMPLETED|Overall Study||4
184426|NCT01404572|448278|P2|COMPLETED|Overall Study||4
184427|NCT01404572|448279|P1|COMPLETED|Overall Study||4
184428|NCT01404572|448277|P3|STARTED|Overall Study||4
184429|NCT01404572|448278|P2|STARTED|Overall Study||4
184430|NCT01404572|448279|P1|STARTED|Overall Study||4
184431|NCT01404559|448310|P4|NOT COMPLETED|Overall Study||0
184432|NCT01404559|448311|P3|NOT COMPLETED|Overall Study||0
184433|NCT01404559|448312|P2|NOT COMPLETED|Overall Study||0
184434|NCT01404559|448313|P1|NOT COMPLETED|Overall Study||0
184435|NCT01404559|448310|P4|COMPLETED|Overall Study||14
184436|NCT01404559|448311|P3|COMPLETED|Overall Study||4
184437|NCT01404559|448312|P2|COMPLETED|Overall Study||5
184438|NCT01404559|448313|P1|COMPLETED|Overall Study||5
184439|NCT01404559|448310|P4|STARTED|Overall Study||14
184440|NCT01404559|448311|P3|STARTED|Overall Study||4
184441|NCT01404559|448312|P2|STARTED|Overall Study||5
184442|NCT01404559|448313|P1|STARTED|Overall Study||5
184443|NCT01404429|448326|P2|NOT COMPLETED|Overall Study||7
184444|NCT01404429|448327|P1|NOT COMPLETED|Overall Study||9
184445|NCT01404429|448326|P2|COMPLETED|Overall Study||46
184446|NCT01404429|448327|P1|COMPLETED|Overall Study||38
184447|NCT01404429|448326|P2|STARTED|Overall Study||53
184448|NCT01404429|448327|P1|STARTED|Overall Study||47
184449|NCT01404325|448341|P2|NOT COMPLETED|Overall Study||2
184450|NCT01404325|448342|P1|NOT COMPLETED|Overall Study||4
184451|NCT01404325|448341|P2|COMPLETED|Overall Study||61
184452|NCT01404325|448342|P1|COMPLETED|Overall Study||63
184453|NCT01404325|448341|P2|STARTED|Overall Study||63
184454|NCT01404325|448342|P1|STARTED|Overall Study||67
184455|NCT01404312|448400|P2|NOT COMPLETED|Overall Study||311
184456|NCT01404312|448401|P1|NOT COMPLETED|Overall Study||298
184457|NCT01404312|448400|P2|COMPLETED|Overall Study||1193
184458|NCT01404312|448401|P1|COMPLETED|Overall Study||1198
184459|NCT01404312|448400|P2|STARTED|Overall Study||1504
184460|NCT01404312|448401|P1|STARTED|Overall Study||1496
184461|NCT01404260|448423|P2|NOT COMPLETED|Overall Study||9
184462|NCT01404260|448424|P1|NOT COMPLETED|Overall Study||3
184463|NCT01404260|448423|P2|COMPLETED|Overall Study||101
184464|NCT01404260|448424|P1|COMPLETED|Overall Study||106
184465|NCT01404260|448423|P2|STARTED|Overall Study||110
184466|NCT01404260|448424|P1|STARTED|Overall Study||109
184467|NCT01404234|448430|P1|NOT COMPLETED|Overall Study||2
184468|NCT01404234|448430|P1|COMPLETED|Overall Study||59
184469|NCT01404234|448430|P1|STARTED|Overall Study||61
184470|NCT01404208|448446|P2|NOT COMPLETED|Overall Study||0
184471|NCT01404208|448447|P1|NOT COMPLETED|Overall Study||3
184472|NCT01404208|448446|P2|COMPLETED|Overall Study||72
184473|NCT01404208|448447|P1|COMPLETED|Overall Study||67
184474|NCT01404208|448446|P2|STARTED|Overall Study||72
184475|NCT01404208|448447|P1|STARTED|Overall Study||70
184476|NCT01404078|448457|P2|NOT COMPLETED|Overall Study||20
184477|NCT01404078|448458|P1|NOT COMPLETED|Overall Study||18
184478|NCT01404078|448457|P2|COMPLETED|Overall Study||237
184479|NCT01404078|448458|P1|COMPLETED|Overall Study||243
184480|NCT01404078|448457|P2|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|257
184481|NCT01404078|448458|P1|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|261
184482|NCT01404039|448473|P13|NOT COMPLETED|Overall Study||0
184483|NCT01404039|448474|P12|NOT COMPLETED|Overall Study||0
184484|NCT01404039|448475|P11|NOT COMPLETED|Overall Study||1
184485|NCT01404039|448476|P10|NOT COMPLETED|Overall Study||1
184486|NCT01404039|448477|P9|NOT COMPLETED|Overall Study||0
184487|NCT01404039|448478|P8|NOT COMPLETED|Overall Study||0
184488|NCT01404039|448479|P7|NOT COMPLETED|Overall Study||0
184489|NCT01404039|448480|P6|NOT COMPLETED|Overall Study||0
184490|NCT01404039|448481|P5|NOT COMPLETED|Overall Study||0
184491|NCT01404039|448482|P4|NOT COMPLETED|Overall Study||0
184492|NCT01404039|448483|P3|NOT COMPLETED|Overall Study||0
184493|NCT01404039|448484|P2|NOT COMPLETED|Overall Study||0
184494|NCT01404039|448485|P1|NOT COMPLETED|Overall Study||1
184495|NCT01404039|448473|P13|COMPLETED|Overall Study||0
184496|NCT01404039|448474|P12|COMPLETED|Overall Study||0
184497|NCT01404039|448475|P11|COMPLETED|Overall Study||14
184498|NCT01404039|448476|P10|COMPLETED|Overall Study||14
184499|NCT01404039|448477|P9|COMPLETED|Overall Study||15
184500|NCT01404039|448478|P8|COMPLETED|Overall Study||15
184501|NCT01404039|448479|P7|COMPLETED|Overall Study||10
184502|NCT01404039|448480|P6|COMPLETED|Overall Study||10
184503|NCT01404039|448481|P5|COMPLETED|Overall Study||10
184504|NCT01404039|448482|P4|COMPLETED|Overall Study||10
184505|NCT01404039|448483|P3|COMPLETED|Overall Study||5
184506|NCT01404039|448484|P2|COMPLETED|Overall Study||5
184507|NCT01404039|448485|P1|COMPLETED|Overall Study||4
184508|NCT01404039|448473|P13|STARTED|Overall Study||0
184509|NCT01404039|448474|P12|STARTED|Overall Study||0
184510|NCT01404039|448475|P11|STARTED|Overall Study||15
184511|NCT01404039|448476|P10|STARTED|Overall Study||15
184512|NCT01404039|448477|P9|STARTED|Overall Study||15
184513|NCT01404039|448478|P8|STARTED|Overall Study||15
184514|NCT01404039|448479|P7|STARTED|Overall Study||10
184515|NCT01404039|448480|P6|STARTED|Overall Study||10
184516|NCT01404039|448481|P5|STARTED|Overall Study||10
184517|NCT01404039|448482|P4|STARTED|Overall Study||10
184518|NCT01404039|448483|P3|STARTED|Overall Study||5
184519|NCT01404039|448484|P2|STARTED|Overall Study||5
184520|NCT01404039|448485|P1|STARTED|Overall Study||5
184521|NCT01403987|448512|P3|NOT COMPLETED|Overall Study||18
184522|NCT01403987|448513|P2|NOT COMPLETED|Overall Study||17
184523|NCT01403987|448514|P1|NOT COMPLETED|Overall Study||18
184524|NCT01403987|448512|P3|COMPLETED|Overall Study||50
184525|NCT01403987|448513|P2|COMPLETED|Overall Study||17
184526|NCT01403987|448514|P1|COMPLETED|Overall Study||16
184527|NCT01403987|448512|P3|STARTED|Overall Study||68
184528|NCT01403987|448513|P2|STARTED|Overall Study||34
184529|NCT01403987|448514|P1|STARTED|Overall Study||34
184530|NCT01403805|448530|P2|NOT COMPLETED|Overall Study||7
184531|NCT01403805|448531|P1|NOT COMPLETED|Overall Study||0
184532|NCT01403805|448530|P2|COMPLETED|Overall Study||98
184533|NCT01403805|448531|P1|COMPLETED|Overall Study||94
184534|NCT01403805|448530|P2|Pneumonia Diagnosis|Overall Study||2
184535|NCT01403805|448531|P1|Pneumonia Diagnosis|Overall Study||21
184536|NCT01403805|448530|P2|STARTED|Overall Study||105
184537|NCT01403805|448531|P1|STARTED|Overall Study||94
184538|NCT01403610|448547|P4|NOT COMPLETED|Overall Study||0
184539|NCT01403610|448548|P3|NOT COMPLETED|Overall Study||0
184540|NCT01403610|448549|P2|NOT COMPLETED|Overall Study||3
184541|NCT01403610|448550|P1|NOT COMPLETED|Overall Study||2
184542|NCT01403610|448547|P4|COMPLETED|Overall Study||13
184543|NCT01403610|448548|P3|COMPLETED|Overall Study||4
184544|NCT01403610|448549|P2|COMPLETED|Overall Study||3
184545|NCT01403610|448550|P1|COMPLETED|Overall Study||3
184546|NCT01403610|448547|P4|STARTED|Overall Study||13
184547|NCT01403610|448548|P3|STARTED|Overall Study||4
184548|NCT01403610|448549|P2|STARTED|Overall Study||6
184549|NCT01403610|448550|P1|STARTED|Overall Study||5
184550|NCT01403441|448560|P1|NOT COMPLETED|Overall Study||0
184551|NCT01403441|448560|P1|COMPLETED|Overall Study||3
184552|NCT01403441|448560|P1|STARTED|Overall Study||3
184553|NCT01403376|448570|P3|NOT COMPLETED|Overall Study||0
184554|NCT01403376|448571|P2|NOT COMPLETED|Overall Study||0
184555|NCT01403376|448572|P1|NOT COMPLETED|Overall Study||0
184556|NCT01403376|448570|P3|COMPLETED|Overall Study||46
184557|NCT01403376|448571|P2|COMPLETED|Overall Study||41
184558|NCT01403376|448572|P1|COMPLETED|Overall Study||41
184559|NCT01403376|448570|P3|STARTED|Overall Study||46
184560|NCT01403376|448571|P2|STARTED|Overall Study||41
184561|NCT01403376|448572|P1|STARTED|Overall Study||41
184562|NCT01403246|448592|P1|NOT COMPLETED|Overall Study||0
184563|NCT01403246|448592|P1|COMPLETED|Overall Study||9
184564|NCT01403246|448592|P1|STARTED|Overall Study||9
184565|NCT01403194|448596|P1|NOT COMPLETED|Overall Study||10
184566|NCT01403194|448596|P1|COMPLETED|Overall Study||1
184567|NCT01403194|448596|P1|STARTED|Overall Study||11
184568|NCT01403116|448604|P2|NOT COMPLETED|Overall Study||27
184569|NCT01403116|448605|P1|NOT COMPLETED|Overall Study||32
184570|NCT01403116|448604|P2|COMPLETED|Overall Study||133
184571|NCT01403116|448605|P1|COMPLETED|Overall Study||129
184572|NCT01403116|448604|P2|Randomized in Error/ No Treatment Recvd|Overall Study||3
184573|NCT01403116|448605|P1|Randomized in Error/ No Treatment Recvd|Overall Study||1
184574|NCT01403116|448604|P2|Randomized|Overall Study||163
184575|NCT01403116|448605|P1|Randomized|Overall Study||162
184576|NCT01403116|448604|P2|STARTED|Overall Study||160
184577|NCT01403116|448605|P1|STARTED|Overall Study||161
184578|NCT01403090|448612|P1|NOT COMPLETED|Overall Study||0
184579|NCT01403090|448612|P1|COMPLETED|Overall Study||8
184580|NCT01403090|448612|P1|STARTED|Overall Study||8
184581|NCT01403051|448618|P2|NOT COMPLETED|Overall Study||6
184582|NCT01403051|448619|P1|NOT COMPLETED|Overall Study||10
184583|NCT01403051|448618|P2|COMPLETED|Overall Study||80
184584|NCT01403051|448619|P1|COMPLETED|Overall Study||71
184585|NCT01403051|448618|P2|Initiated Study Treatment|Overall Study||86
184586|NCT01403051|448619|P1|Initiated Study Treatment|Overall Study||81
184587|NCT01403051|448618|P2|STARTED|Overall Study||86
184588|NCT01403051|448619|P1|STARTED|Overall Study||81
184589|NCT01402986|448655|P4|NOT COMPLETED|Overall Study||22
184590|NCT01402986|448656|P3|NOT COMPLETED|Overall Study||8
184591|NCT01402986|448657|P2|NOT COMPLETED|Overall Study||15
184592|NCT01402986|448658|P1|NOT COMPLETED|Overall Study||9
184593|NCT01402986|448655|P4|COMPLETED|Overall Study||129
184594|NCT01402986|448656|P3|COMPLETED|Overall Study||67
184595|NCT01402986|448657|P2|COMPLETED|Overall Study||135
184596|NCT01402986|448658|P1|COMPLETED|Overall Study||67
184597|NCT01402986|448655|P4|STARTED|Overall Study||151
184598|NCT01402986|448656|P3|STARTED|Overall Study||75
184599|NCT01402986|448657|P2|STARTED|Overall Study||150
184600|NCT01402986|448658|P1|STARTED|Overall Study||76
184601|NCT01402947|448793|P2|NOT COMPLETED|Second Intervention||0
184602|NCT01402947|448794|P1|NOT COMPLETED|Second Intervention||0
184603|NCT01402947|448793|P2|COMPLETED|Second Intervention||14
184604|NCT01402947|448794|P1|COMPLETED|Second Intervention||15
184605|NCT01402947|448793|P2|STARTED|Second Intervention||14
184606|NCT01402947|448794|P1|STARTED|Second Intervention||15
184607|NCT01402947|448793|P2|NOT COMPLETED|First Intervention||1
184608|NCT01402947|448794|P1|NOT COMPLETED|First Intervention||0
184609|NCT01402947|448793|P2|COMPLETED|First Intervention||14
184610|NCT01402947|448794|P1|COMPLETED|First Intervention||15
184611|NCT01402947|448793|P2|STARTED|First Intervention||15
184612|NCT01402947|448794|P1|STARTED|First Intervention||15
184613|NCT01402869|448805|P3|NOT COMPLETED|Overall Study||1
184614|NCT01402869|448806|P2|NOT COMPLETED|Overall Study||0
184615|NCT01402869|448807|P1|NOT COMPLETED|Overall Study||0
184616|NCT01402869|448805|P3|COMPLETED|Overall Study||30
184617|NCT01402869|448806|P2|COMPLETED|Overall Study||30
184618|NCT01402869|448807|P1|COMPLETED|Overall Study||30
184619|NCT01402869|448805|P3|STARTED|Overall Study||31
184620|NCT01402869|448806|P2|STARTED|Overall Study||30
184621|NCT01402869|448807|P1|STARTED|Overall Study||30
184622|NCT01402817|448821|P1|NOT COMPLETED|Overall Study||11
184623|NCT01402817|448821|P1|COMPLETED|Overall Study||8
184624|NCT01402817|448821|P1|STARTED|Overall Study||19
184625|NCT01402700|448826|P1|NOT COMPLETED|Overall Study||7
184626|NCT01402700|448826|P1|COMPLETED|Overall Study||68
184627|NCT01402700|448826|P1|STARTED|Overall Study||75
184628|NCT01402570|448830|P1|NOT COMPLETED|Overall Study||1
184629|NCT01402570|448830|P1|COMPLETED|Overall Study||19
184630|NCT01402570|448830|P1|STARTED|Overall Study||20
184631|NCT01402544|448837|P1|NOT COMPLETED|Overall Study||6
184632|NCT01402544|448837|P1|COMPLETED|Overall Study||6
184633|NCT01402544|448837|P1|STARTED|Overall Study||12
184634|NCT01402427|448845|P2|NOT COMPLETED|Overall Study||0
184635|NCT01402427|448846|P1|NOT COMPLETED|Overall Study||0
184636|NCT01402427|448845|P2|COMPLETED|Overall Study||294
184637|NCT01402427|448846|P1|COMPLETED|Overall Study||297
184638|NCT01402427|448845|P2|STARTED|Overall Study||294
184639|NCT01402427|448846|P1|STARTED|Overall Study||297
184640|NCT01402375|448870|P6|NOT COMPLETED|Overall Study||0
184641|NCT01402375|448871|P5|NOT COMPLETED|Overall Study||0
184642|NCT01402375|448872|P4|NOT COMPLETED|Overall Study||0
184643|NCT01402375|448873|P3|NOT COMPLETED|Overall Study||0
184644|NCT01402375|448874|P2|NOT COMPLETED|Overall Study||0
184645|NCT01402375|448875|P1|NOT COMPLETED|Overall Study||0
184646|NCT01402375|448870|P6|COMPLETED|Overall Study||120
184647|NCT01402375|448871|P5|COMPLETED|Overall Study||120
184648|NCT01402375|448872|P4|COMPLETED|Overall Study||120
184649|NCT01402375|448873|P3|COMPLETED|Overall Study||120
184650|NCT01402375|448874|P2|COMPLETED|Overall Study||120
184651|NCT01402375|448875|P1|COMPLETED|Overall Study||120
184652|NCT01402375|448870|P6|STARTED|Overall Study||120
184653|NCT01402375|448871|P5|STARTED|Overall Study||120
184654|NCT01402375|448872|P4|STARTED|Overall Study||120
184655|NCT01402375|448873|P3|STARTED|Overall Study||120
184656|NCT01402375|448874|P2|STARTED|Overall Study||120
184657|NCT01402375|448875|P1|STARTED|Overall Study||120
184658|NCT01402284|448907|P1|NOT COMPLETED|Overall Study||14
184659|NCT01402284|448907|P1|COMPLETED|Overall Study||31
184660|NCT01402284|448907|P1|STARTED|Overall Study||45
184661|NCT01402141|448920|P2|NOT COMPLETED|Overall Study||2
184662|NCT01402141|448921|P1|NOT COMPLETED|Overall Study||1
184663|NCT01402141|448920|P2|COMPLETED|Overall Study||28
184664|NCT01402141|448921|P1|COMPLETED|Overall Study||29
184665|NCT01402141|448920|P2|STARTED|Overall Study||30
184666|NCT01402141|448921|P1|STARTED|Overall Study||30
184667|NCT01402128|448943|P2|NOT COMPLETED|Overall Study||0
184668|NCT01402128|448944|P1|NOT COMPLETED|Overall Study||1
184669|NCT01402128|448943|P2|COMPLETED|Overall Study||40
184670|NCT01402128|448944|P1|COMPLETED|Overall Study||39
184671|NCT01402128|448943|P2|STARTED|Overall Study||40
184672|NCT01402128|448944|P1|STARTED|Overall Study||40
184673|NCT01402115|448972|P2|NOT COMPLETED|Overall Study||1
184674|NCT01402115|448973|P1|NOT COMPLETED|Overall Study||1
184675|NCT01402115|448972|P2|COMPLETED|Overall Study||29
184676|NCT01402115|448973|P1|COMPLETED|Overall Study||29
184677|NCT01402115|448972|P2|STARTED|Overall Study||30
184678|NCT01402115|448973|P1|STARTED|Overall Study||30
184679|NCT01402102|448989|P2|NOT COMPLETED|Overall Study||3
184680|NCT01402102|448990|P1|NOT COMPLETED|Overall Study||2
184681|NCT01402102|448989|P2|COMPLETED|Overall Study||27
184682|NCT01402102|448990|P1|COMPLETED|Overall Study||28
184683|NCT01402102|448989|P2|STARTED|Overall Study||30
184684|NCT01402102|448990|P1|STARTED|Overall Study||30
184685|NCT01402063|449010|P2|NOT COMPLETED|Overall Study||3
184686|NCT01402063|449011|P1|NOT COMPLETED|Overall Study||3
184687|NCT01402063|449010|P2|COMPLETED|Overall Study||18
184688|NCT01402063|449011|P1|COMPLETED|Overall Study||39
184689|NCT01402063|449010|P2|STARTED|Overall Study||21
184690|NCT01402063|449011|P1|STARTED|Overall Study||42
184691|NCT01402011|449020|P3|NOT COMPLETED|Nine Month Follow-up||0
184692|NCT01402011|449021|P2|NOT COMPLETED|Nine Month Follow-up||1
184693|NCT01402011|449022|P1|NOT COMPLETED|Nine Month Follow-up||0
184694|NCT01402011|449020|P3|COMPLETED|Nine Month Follow-up||26
184695|NCT01402011|449021|P2|COMPLETED|Nine Month Follow-up||19
184696|NCT01402011|449022|P1|COMPLETED|Nine Month Follow-up||27
184697|NCT01402011|449020|P3|STARTED|Nine Month Follow-up||26
184698|NCT01402011|449021|P2|STARTED|Nine Month Follow-up||20
184699|NCT01402011|449022|P1|STARTED|Nine Month Follow-up||27
184700|NCT01402011|449020|P3|NOT COMPLETED|Active Treatment Period||0
184701|NCT01402011|449021|P2|NOT COMPLETED|Active Treatment Period||3
184702|NCT01402011|449022|P1|NOT COMPLETED|Active Treatment Period||1
184703|NCT01402011|449020|P3|COMPLETED|Active Treatment Period||26
184704|NCT01402011|449021|P2|COMPLETED|Active Treatment Period||20
184705|NCT01402011|449022|P1|COMPLETED|Active Treatment Period||27
184706|NCT01402011|449020|P3|STARTED|Active Treatment Period||26
184707|NCT01402011|449021|P2|STARTED|Active Treatment Period||23
184708|NCT01402011|449022|P1|STARTED|Active Treatment Period||28
184709|NCT01402011|449020|P3|NOT COMPLETED|Delayed Treatment Period||0
184710|NCT01402011|449021|P2|NOT COMPLETED|Delayed Treatment Period||0
184711|NCT01402011|449022|P1|NOT COMPLETED|Delayed Treatment Period||1
184712|NCT01402011|449020|P3|COMPLETED|Delayed Treatment Period||26
184713|NCT01402011|449021|P2|COMPLETED|Delayed Treatment Period||23
184714|NCT01402011|449022|P1|COMPLETED|Delayed Treatment Period|One patient with needle phobia declined to be treated before the 1st set of injections|28
184715|NCT01402011|449020|P3|STARTED|Delayed Treatment Period||26
184716|NCT01402011|449021|P2|STARTED|Delayed Treatment Period||23
184717|NCT01402011|449022|P1|STARTED|Delayed Treatment Period||29
184718|NCT01401959|449051|P3|NOT COMPLETED|Treated||5
184719|NCT01401959|449052|P2|NOT COMPLETED|Treated||8
184720|NCT01401959|449053|P1|NOT COMPLETED|Treated||7
184721|NCT01401959|449051|P3|COMPLETED|Treated||26
184722|NCT01401959|449052|P2|COMPLETED|Treated||34
184723|NCT01401959|449053|P1|COMPLETED|Treated||46
184724|NCT01401959|449051|P3|STARTED|Treated||31
184725|NCT01401959|449052|P2|STARTED|Treated||42
184726|NCT01401959|449053|P1|STARTED|Treated||53
184727|NCT01401959|449051|P3|NOT COMPLETED|Enrolled||0
184728|NCT01401959|449052|P2|NOT COMPLETED|Enrolled||0
184729|NCT01401959|449053|P1|NOT COMPLETED|Enrolled||1
184730|NCT01401959|449051|P3|COMPLETED|Enrolled||31
184731|NCT01401959|449052|P2|COMPLETED|Enrolled||42
184732|NCT01401959|449053|P1|COMPLETED|Enrolled||53
184733|NCT01401959|449051|P3|STARTED|Enrolled||31
184734|NCT01401959|449052|P2|STARTED|Enrolled||42
184735|NCT01401959|449053|P1|STARTED|Enrolled||54
184736|NCT01401907|449069|P2|NOT COMPLETED|Overall Study||51
184737|NCT01401907|449070|P1|NOT COMPLETED|Overall Study||57
184738|NCT01401907|449069|P2|COMPLETED|Overall Study||124
184739|NCT01401907|449070|P1|COMPLETED|Overall Study||118
184740|NCT01401907|449069|P2|12 Week Outcomes|Overall Study||153
184741|NCT01401907|449070|P1|12 Week Outcomes|Overall Study||148
184742|NCT01401907|449069|P2|STARTED|Overall Study||175
184743|NCT01401907|449070|P1|STARTED|Overall Study||175
184744|NCT01401842|449090|P2|NOT COMPLETED|Overall Study||67
184745|NCT01401842|449091|P1|NOT COMPLETED|Overall Study||68
184746|NCT01401842|449090|P2|COMPLETED|Overall Study||217
184747|NCT01401842|449091|P1|COMPLETED|Overall Study||230
184748|NCT01401842|449090|P2|STARTED|Overall Study||284
184749|NCT01401842|449091|P1|STARTED|Overall Study||298
184750|NCT01401699|449101|P1|NOT COMPLETED|Overall Study||0
184751|NCT01401699|449101|P1|COMPLETED|Overall Study||109
184752|NCT01401699|449101|P1|STARTED|Overall Study||109
184753|NCT01401647|449108|P3|NOT COMPLETED|Overall Study||3
184754|NCT01401647|449109|P2|NOT COMPLETED|Overall Study||8
184755|NCT01401647|449110|P1|NOT COMPLETED|Overall Study||4
184756|NCT01401647|449108|P3|COMPLETED|Overall Study||1056
184757|NCT01401647|449109|P2|COMPLETED|Overall Study||985
184758|NCT01401647|449110|P1|COMPLETED|Overall Study||968
184759|NCT01401647|449108|P3|STARTED|Overall Study||1059
184760|NCT01401647|449109|P2|STARTED|Overall Study||993
184761|NCT01401647|449110|P1|STARTED|Overall Study||972
184762|NCT01401595|449123|P2|NOT COMPLETED|Imaging and Treatment (for NE Arm)||0
184763|NCT01401595|449124|P1|NOT COMPLETED|Imaging and Treatment (for NE Arm)||14
184764|NCT01401595|449123|P2|COMPLETED|Imaging and Treatment (for NE Arm)||10
184765|NCT01401595|449124|P1|COMPLETED|Imaging and Treatment (for NE Arm)||18
184766|NCT01401595|449123|P2|STARTED|Imaging and Treatment (for NE Arm)||10
184767|NCT01401595|449124|P1|STARTED|Imaging and Treatment (for NE Arm)||32
184768|NCT01401595|449123|P2|NOT COMPLETED|Recruitment and Screening||2
184769|NCT01401595|449124|P1|NOT COMPLETED|Recruitment and Screening||43
184770|NCT01401595|449123|P2|COMPLETED|Recruitment and Screening|10 of the 12 remained eligible/interested after the initial screening visit.|10
184771|NCT01401595|449124|P1|COMPLETED|Recruitment and Screening|Of the 75, 32 remained interested/eligible after the initial screening period.|32
184772|NCT01401595|449123|P2|STARTED|Recruitment and Screening|Of 32 calls, 12 control subjects attended an initial screening visit.|12
184773|NCT01401595|449124|P1|STARTED|Recruitment and Screening|Of 345 calls, 75 potential NES subjects attended the screening visit and provided informed consent.|75
184774|NCT01401582|449135|P2|NOT COMPLETED|Overall Study||117
184775|NCT01401582|449136|P1|NOT COMPLETED|Overall Study||110
184776|NCT01401582|449135|P2|COMPLETED|Overall Study||291
184777|NCT01401582|449136|P1|COMPLETED|Overall Study||116
184778|NCT01401582|449135|P2|Baseline Completed|Overall Study||348
184779|NCT01401582|449136|P1|Baseline Completed|Overall Study||168
184780|NCT01401582|449135|P2|STARTED|Overall Study||408
184781|NCT01401582|449136|P1|STARTED|Overall Study||226
184782|NCT01401543|449152|P4|NOT COMPLETED|Fourth Intervention||0
184783|NCT01401543|449153|P3|NOT COMPLETED|Fourth Intervention||0
184784|NCT01401543|449154|P2|NOT COMPLETED|Fourth Intervention||0
184785|NCT01401543|449155|P1|NOT COMPLETED|Fourth Intervention||0
184786|NCT01401543|449152|P4|COMPLETED|Fourth Intervention||6
184787|NCT01401543|449153|P3|COMPLETED|Fourth Intervention||6
184788|NCT01401543|449154|P2|COMPLETED|Fourth Intervention||6
184789|NCT01401543|449155|P1|COMPLETED|Fourth Intervention||6
184790|NCT01401543|449152|P4|STARTED|Fourth Intervention||6
184791|NCT01401543|449153|P3|STARTED|Fourth Intervention||6
184792|NCT01401543|449154|P2|STARTED|Fourth Intervention||6
184793|NCT01401543|449155|P1|STARTED|Fourth Intervention||6
184794|NCT01401543|449152|P4|NOT COMPLETED|Third Washout Period of 1 Week||0
184795|NCT01401543|449153|P3|NOT COMPLETED|Third Washout Period of 1 Week||0
184796|NCT01401543|449154|P2|NOT COMPLETED|Third Washout Period of 1 Week||0
184797|NCT01401543|449155|P1|NOT COMPLETED|Third Washout Period of 1 Week||0
184798|NCT01401543|449152|P4|COMPLETED|Third Washout Period of 1 Week||6
184799|NCT01401543|449153|P3|COMPLETED|Third Washout Period of 1 Week||6
184800|NCT01401543|449154|P2|COMPLETED|Third Washout Period of 1 Week||6
184801|NCT01401543|449155|P1|COMPLETED|Third Washout Period of 1 Week||6
184802|NCT01401543|449152|P4|STARTED|Third Washout Period of 1 Week||6
184803|NCT01401543|449153|P3|STARTED|Third Washout Period of 1 Week||6
184804|NCT01401543|449154|P2|STARTED|Third Washout Period of 1 Week||6
184805|NCT01401543|449155|P1|STARTED|Third Washout Period of 1 Week||6
184806|NCT01401543|449152|P4|NOT COMPLETED|Third Intervention||0
184807|NCT01401543|449153|P3|NOT COMPLETED|Third Intervention||0
184808|NCT01401543|449154|P2|NOT COMPLETED|Third Intervention||0
184809|NCT01401543|449155|P1|NOT COMPLETED|Third Intervention||0
184810|NCT01401543|449152|P4|COMPLETED|Third Intervention||6
184811|NCT01401543|449153|P3|COMPLETED|Third Intervention||6
184812|NCT01401543|449154|P2|COMPLETED|Third Intervention||6
184813|NCT01401543|449155|P1|COMPLETED|Third Intervention||6
184814|NCT01401543|449152|P4|STARTED|Third Intervention||6
184815|NCT01401543|449153|P3|STARTED|Third Intervention||6
184816|NCT01401543|449154|P2|STARTED|Third Intervention||6
184817|NCT01401543|449155|P1|STARTED|Third Intervention||6
184818|NCT01401543|449152|P4|NOT COMPLETED|Second Washout Period of 1 Week||0
184819|NCT01401543|449153|P3|NOT COMPLETED|Second Washout Period of 1 Week||0
184820|NCT01401543|449154|P2|NOT COMPLETED|Second Washout Period of 1 Week||0
184821|NCT01401543|449155|P1|NOT COMPLETED|Second Washout Period of 1 Week||0
184822|NCT01401543|449152|P4|COMPLETED|Second Washout Period of 1 Week||6
184823|NCT01401543|449153|P3|COMPLETED|Second Washout Period of 1 Week||6
184824|NCT01401543|449154|P2|COMPLETED|Second Washout Period of 1 Week||6
184825|NCT01401543|449155|P1|COMPLETED|Second Washout Period of 1 Week||6
184826|NCT01401543|449152|P4|STARTED|Second Washout Period of 1 Week||6
184827|NCT01401543|449153|P3|STARTED|Second Washout Period of 1 Week||6
184828|NCT01401543|449154|P2|STARTED|Second Washout Period of 1 Week||6
184829|NCT01401543|449155|P1|STARTED|Second Washout Period of 1 Week||6
184830|NCT01401543|449152|P4|NOT COMPLETED|Second Intervention||0
184831|NCT01401543|449153|P3|NOT COMPLETED|Second Intervention||0
184832|NCT01401543|449154|P2|NOT COMPLETED|Second Intervention||0
184833|NCT01401543|449155|P1|NOT COMPLETED|Second Intervention||0
184834|NCT01401543|449152|P4|COMPLETED|Second Intervention||6
184835|NCT01401543|449153|P3|COMPLETED|Second Intervention||6
184836|NCT01401543|449154|P2|COMPLETED|Second Intervention||6
184837|NCT01401543|449155|P1|COMPLETED|Second Intervention||6
184838|NCT01401543|449152|P4|STARTED|Second Intervention||6
184839|NCT01401543|449153|P3|STARTED|Second Intervention||6
184840|NCT01401543|449154|P2|STARTED|Second Intervention||6
184841|NCT01401543|449155|P1|STARTED|Second Intervention||6
184842|NCT01401543|449152|P4|NOT COMPLETED|First Washout Period of 1 Week||0
184843|NCT01401543|449153|P3|NOT COMPLETED|First Washout Period of 1 Week||0
184844|NCT01401543|449154|P2|NOT COMPLETED|First Washout Period of 1 Week||0
184845|NCT01401543|449155|P1|NOT COMPLETED|First Washout Period of 1 Week||0
184846|NCT01401543|449152|P4|COMPLETED|First Washout Period of 1 Week||6
184847|NCT01401543|449153|P3|COMPLETED|First Washout Period of 1 Week||6
184848|NCT01401543|449154|P2|COMPLETED|First Washout Period of 1 Week||6
184849|NCT01401543|449155|P1|COMPLETED|First Washout Period of 1 Week||6
184850|NCT01401543|449152|P4|STARTED|First Washout Period of 1 Week||6
184851|NCT01401543|449153|P3|STARTED|First Washout Period of 1 Week||6
184852|NCT01401543|449154|P2|STARTED|First Washout Period of 1 Week||6
184853|NCT01401543|449155|P1|STARTED|First Washout Period of 1 Week||6
184854|NCT01401543|449152|P4|NOT COMPLETED|First Intervention||0
184855|NCT01401543|449153|P3|NOT COMPLETED|First Intervention||0
184856|NCT01401543|449154|P2|NOT COMPLETED|First Intervention||0
184857|NCT01401543|449155|P1|NOT COMPLETED|First Intervention||0
184858|NCT01401543|449152|P4|COMPLETED|First Intervention||6
184859|NCT01401543|449153|P3|COMPLETED|First Intervention||6
184860|NCT01401543|449154|P2|COMPLETED|First Intervention||6
184861|NCT01401543|449155|P1|COMPLETED|First Intervention||6
184862|NCT01401543|449152|P4|STARTED|First Intervention||6
184863|NCT01401543|449153|P3|STARTED|First Intervention||6
184864|NCT01401543|449154|P2|STARTED|First Intervention||6
184865|NCT01401543|449155|P1|STARTED|First Intervention||6
184866|NCT01401530|449180|P3|NOT COMPLETED|Overall Study||3
184867|NCT01401530|449181|P2|NOT COMPLETED|Overall Study||6
184868|NCT01401530|449182|P1|NOT COMPLETED|Overall Study||3
184869|NCT01401530|449180|P3|COMPLETED|Overall Study||0
184870|NCT01401530|449181|P2|COMPLETED|Overall Study||1
184871|NCT01401530|449182|P1|COMPLETED|Overall Study||0
184872|NCT01401530|449180|P3|STARTED|Overall Study||3
184873|NCT01401530|449181|P2|STARTED|Overall Study||7
184874|NCT01401530|449182|P1|STARTED|Overall Study||3
184875|NCT01401517|449222|P3|NOT COMPLETED|Overall Study||3
184876|NCT01401517|449223|P2|NOT COMPLETED|Overall Study||2
184877|NCT01401517|449224|P1|NOT COMPLETED|Overall Study||3
184878|NCT01401517|449222|P3|COMPLETED|Overall Study||15
184879|NCT01401517|449223|P2|COMPLETED|Overall Study||17
184880|NCT01401517|449224|P1|COMPLETED|Overall Study||15
184881|NCT01401517|449222|P3|STARTED|Overall Study||18
184882|NCT01401517|449223|P2|STARTED|Overall Study||19
184883|NCT01401517|449224|P1|STARTED|Overall Study||18
184884|NCT01401478|449232|P1|NOT COMPLETED|Overall Study||31
184885|NCT01401478|449232|P1|COMPLETED|Overall Study||55
184886|NCT01401478|449232|P1|STARTED|Overall Study||86
184887|NCT01401465|449245|P2|NOT COMPLETED|Treatment Period 2||2
184888|NCT01401465|449246|P1|NOT COMPLETED|Treatment Period 2||0
184889|NCT01401465|449245|P2|COMPLETED|Treatment Period 2||144
184890|NCT01401465|449246|P1|COMPLETED|Treatment Period 2||150
184891|NCT01401465|449245|P2|STARTED|Treatment Period 2||146
184892|NCT01401465|449246|P1|STARTED|Treatment Period 2||150
184893|NCT01401465|449245|P2|NOT COMPLETED|Washout||0
184894|NCT01401465|449246|P1|NOT COMPLETED|Washout||0
184895|NCT01401465|449245|P2|COMPLETED|Washout||146
184896|NCT01401465|449246|P1|COMPLETED|Washout||150
184897|NCT01401465|449245|P2|STARTED|Washout||146
184898|NCT01401465|449246|P1|STARTED|Washout||150
184899|NCT01401465|449245|P2|NOT COMPLETED|Treatment Period 1||16
184900|NCT01401465|449246|P1|NOT COMPLETED|Treatment Period 1||15
184901|NCT01401465|449245|P2|COMPLETED|Treatment Period 1||146
184902|NCT01401465|449246|P1|COMPLETED|Treatment Period 1||150
184903|NCT01401465|449245|P2|STARTED|Treatment Period 1||162
184904|NCT01401465|449246|P1|STARTED|Treatment Period 1||165
184905|NCT01401452|449309|P1|NOT COMPLETED|Overall Study||72
184906|NCT01401452|449309|P1|COMPLETED|Overall Study||174
184907|NCT01401452|449309|P1|Visit 5 (9 Months)|Overall Study||175
184908|NCT01401452|449309|P1|Visit 4 (6 Months)|Overall Study||172
184909|NCT01401452|449309|P1|Visit 3 (3 Months)|Overall Study||217
184910|NCT01401452|449309|P1|Visit 2 (1 Month)|Overall Study||225
184911|NCT01401452|449309|P1|Visit 1 (Baseline)|Overall Study||246
184912|NCT01401452|449309|P1|STARTED|Overall Study||246
184913|NCT01401361|449321|P1|NOT COMPLETED|Overall Study||28
184914|NCT01401361|449321|P1|COMPLETED|Overall Study|16 subjects were withdrawn prior to the use of the investigational device|122
184915|NCT01401361|449321|P1|STARTED|Overall Study||150
184916|NCT01401322|449327|P1|NOT COMPLETED|Overall Study||2
184917|NCT01401322|449327|P1|COMPLETED|Overall Study||3
184918|NCT01401322|449327|P1|STARTED|Overall Study||5
184919|NCT01401283|449333|P2|NOT COMPLETED|Overall Study||10
184920|NCT01401283|449334|P1|NOT COMPLETED|Overall Study||10
184921|NCT01401283|449333|P2|COMPLETED|Overall Study||81
184922|NCT01401283|449334|P1|COMPLETED|Overall Study||79
184923|NCT01401283|449333|P2|STARTED|Overall Study||91
184924|NCT01401283|449334|P1|STARTED|Overall Study||89
184925|NCT01401257|449346|P4|NOT COMPLETED|Overall Study||2
184926|NCT01401257|449347|P3|NOT COMPLETED|Overall Study||3
184927|NCT01401257|449348|P2|NOT COMPLETED|Overall Study||2
184928|NCT01401257|449349|P1|NOT COMPLETED|Overall Study||0
184929|NCT01401257|449346|P4|COMPLETED|Overall Study||17
184930|NCT01401257|449347|P3|COMPLETED|Overall Study||16
184931|NCT01401257|449348|P2|COMPLETED|Overall Study||19
184932|NCT01401257|449349|P1|COMPLETED|Overall Study||21
184933|NCT01401257|449346|P4|STARTED|Overall Study||19
184934|NCT01401257|449347|P3|STARTED|Overall Study||19
184935|NCT01401257|449348|P2|STARTED|Overall Study||21
184936|NCT01401257|449349|P1|STARTED|Overall Study||21
184937|NCT01401166|449361|P4|NOT COMPLETED|Safety Follow-Up Period||19
184938|NCT01401166|449362|P3|NOT COMPLETED|Safety Follow-Up Period||17
184939|NCT01401166|449363|P2|NOT COMPLETED|Safety Follow-Up Period||18
184940|NCT01401166|449364|P1|NOT COMPLETED|Safety Follow-Up Period||25
184941|NCT01401166|449361|P4|COMPLETED|Safety Follow-Up Period||100
184942|NCT01401166|449362|P3|COMPLETED|Safety Follow-Up Period||104
184943|NCT01401166|449363|P2|COMPLETED|Safety Follow-Up Period||106
184944|NCT01401166|449364|P1|COMPLETED|Safety Follow-Up Period||99
184945|NCT01401166|449361|P4|STARTED|Safety Follow-Up Period|All 119 randomized participants entered follow-up regardless of whether they received treatment.|119
184946|NCT01401166|449362|P3|STARTED|Safety Follow-Up Period|All 121 randomized participants entered follow-up regardless of whether they received treatment.|121
184947|NCT01401166|449363|P2|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
184948|NCT01401166|449364|P1|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
184949|NCT01401166|449361|P4|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||3
184950|NCT01401166|449362|P3|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||2
184951|NCT01401166|449363|P2|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||7
184952|NCT01401166|449364|P1|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||4
184953|NCT01401166|449361|P4|COMPLETED|Continuation Treatment (Cycles 9 to 18)||102
184954|NCT01401166|449362|P3|COMPLETED|Continuation Treatment (Cycles 9 to 18)||105
184955|NCT01401166|449363|P2|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
184956|NCT01401166|449364|P1|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
184957|NCT01401166|449361|P4|STARTED|Continuation Treatment (Cycles 9 to 18)||105
184958|NCT01401166|449362|P3|STARTED|Continuation Treatment (Cycles 9 to 18)||107
184959|NCT01401166|449363|P2|STARTED|Continuation Treatment (Cycles 9 to 18)||116
184960|NCT01401166|449364|P1|STARTED|Continuation Treatment (Cycles 9 to 18)||113
184961|NCT01401166|449361|P4|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||11
184962|NCT01401166|449362|P3|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||12
184963|NCT01401166|449363|P2|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||4
184964|NCT01401166|449364|P1|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||6
184965|NCT01401166|449361|P4|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||105
184966|NCT01401166|449362|P3|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||107
184967|NCT01401166|449363|P2|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||116
184968|NCT01401166|449364|P1|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||113
184969|NCT01401166|449361|P4|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||116
184970|NCT01401166|449362|P3|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
184971|NCT01401166|449363|P2|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||120
184972|NCT01401166|449364|P1|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
184973|NCT01401166|449361|P4|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
184974|NCT01401166|449362|P3|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
184975|NCT01401166|449363|P2|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
184976|NCT01401166|449364|P1|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||3
184977|NCT01401166|449361|P4|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||116
184978|NCT01401166|449362|P3|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
184979|NCT01401166|449363|P2|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||120
184980|NCT01401166|449364|P1|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
184981|NCT01401166|449361|P4|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 119 participants were randomized, but 1 did not receive any treatment.|118
184982|NCT01401166|449362|P3|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 121 participants were randomized who all received study treatment.|121
184983|NCT01401166|449363|P2|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
184984|NCT01401166|449364|P1|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
184985|NCT01401153|449400|P2|NOT COMPLETED|Second Test Day||5
184986|NCT01401153|449401|P1|NOT COMPLETED|Second Test Day||0
184987|NCT01401153|449400|P2|COMPLETED|Second Test Day||60
184988|NCT01401153|449401|P1|COMPLETED|Second Test Day||45
184989|NCT01401153|449400|P2|STARTED|Second Test Day||65
184990|NCT01401153|449401|P1|STARTED|Second Test Day||45
184991|NCT01401153|449400|P2|NOT COMPLETED|First Test Day||10
184992|NCT01401153|449401|P1|NOT COMPLETED|First Test Day||1
184993|NCT01401153|449400|P2|COMPLETED|First Test Day||45
184994|NCT01401153|449401|P1|COMPLETED|First Test Day||65
184995|NCT01401153|449400|P2|STARTED|First Test Day||55
184996|NCT01401153|449401|P1|STARTED|First Test Day||66
184997|NCT01401101|449435|P2|NOT COMPLETED|Overall Study||27
184998|NCT01401101|449436|P1|NOT COMPLETED|Overall Study||22
184999|NCT01401101|449435|P2|COMPLETED|Overall Study||171
185000|NCT01401101|449436|P1|COMPLETED|Overall Study||184
185001|NCT01401101|449435|P2|STARTED|Overall Study||198
185002|NCT01401101|449436|P1|STARTED|Overall Study||206
185003|NCT01401062|449448|P2|NOT COMPLETED|Overall Study||8
185004|NCT01401062|449449|P1|NOT COMPLETED|Overall Study||11
185005|NCT01401062|449448|P2|COMPLETED|Overall Study|At time of data entry, these 4 patients are still undergoing follow-up|4
185006|NCT01401062|449449|P1|COMPLETED|Overall Study||0
185007|NCT01401062|449448|P2|STARTED|Overall Study||12
185008|NCT01401062|449449|P1|STARTED|Overall Study||11
185009|NCT01401049|449457|P2|NOT COMPLETED|Overall Study||0
185010|NCT01401049|449458|P1|NOT COMPLETED|Overall Study||0
185011|NCT01401049|449457|P2|COMPLETED|Overall Study||0
185012|NCT01401049|449458|P1|COMPLETED|Overall Study||0
185013|NCT01401049|449457|P2|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
185014|NCT01401049|449458|P1|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
185015|NCT01401023|449466|P1|NOT COMPLETED|Overall Study||0
185016|NCT01401023|449466|P1|COMPLETED|Overall Study||10
185017|NCT01401023|449466|P1|STARTED|Overall Study||10
185018|NCT01401010|449476|P2|NOT COMPLETED|Overall Study||0
185019|NCT01401010|449477|P1|NOT COMPLETED|Overall Study||1
185020|NCT01401010|449476|P2|COMPLETED|Overall Study||6
185021|NCT01401010|449477|P1|COMPLETED|Overall Study||5
185022|NCT01401010|449476|P2|STARTED|Overall Study||6
185023|NCT01401010|449477|P1|STARTED|Overall Study||6
185024|NCT01400958|449502|P2|NOT COMPLETED|Overall Study||2
185025|NCT01400958|449503|P1|NOT COMPLETED|Overall Study||1
185026|NCT01400958|449502|P2|COMPLETED|Overall Study||1
185027|NCT01400958|449503|P1|COMPLETED|Overall Study||2
185028|NCT01400958|449502|P2|STARTED|Overall Study||3
185029|NCT01400958|449503|P1|STARTED|Overall Study||3
185030|NCT01400932|449513|P2|NOT COMPLETED|Overall Study||15
185031|NCT01400932|449514|P1|NOT COMPLETED|Overall Study||14
185032|NCT01400932|449513|P2|COMPLETED|Overall Study||167
185033|NCT01400932|449514|P1|COMPLETED|Overall Study||164
185034|NCT01400932|449513|P2|STARTED|Overall Study||182
185035|NCT01400932|449514|P1|STARTED|Overall Study||178
185036|NCT01400919|449536|P1|NOT COMPLETED|Overall Study||8
185037|NCT01400919|449536|P1|COMPLETED|Overall Study||67
185038|NCT01400919|449536|P1|STARTED|Overall Study||75
185039|NCT01400906|449540|P6|NOT COMPLETED|Treatment Period 3||0
185040|NCT01400906|449541|P5|NOT COMPLETED|Treatment Period 3||0
185041|NCT01400906|449542|P4|NOT COMPLETED|Treatment Period 3||0
185042|NCT01400906|449543|P3|NOT COMPLETED|Treatment Period 3||0
185043|NCT01400906|449544|P2|NOT COMPLETED|Treatment Period 3||0
185044|NCT01400906|449545|P1|NOT COMPLETED|Treatment Period 3||0
185045|NCT01400906|449540|P6|COMPLETED|Treatment Period 3||5
185046|NCT01400906|449541|P5|COMPLETED|Treatment Period 3||6
185047|NCT01400906|449542|P4|COMPLETED|Treatment Period 3||6
185048|NCT01400906|449543|P3|COMPLETED|Treatment Period 3||6
185049|NCT01400906|449544|P2|COMPLETED|Treatment Period 3||6
185050|NCT01400906|449545|P1|COMPLETED|Treatment Period 3||6
185051|NCT01400906|449540|P6|STARTED|Treatment Period 3||5
185052|NCT01400906|449541|P5|STARTED|Treatment Period 3||6
185053|NCT01400906|449542|P4|STARTED|Treatment Period 3||6
185054|NCT01400906|449543|P3|STARTED|Treatment Period 3||6
185055|NCT01400906|449544|P2|STARTED|Treatment Period 3||6
185056|NCT01400906|449545|P1|STARTED|Treatment Period 3||6
185057|NCT01400906|449540|P6|NOT COMPLETED|Washout Period 2||0
185058|NCT01400906|449541|P5|NOT COMPLETED|Washout Period 2||0
185059|NCT01400906|449542|P4|NOT COMPLETED|Washout Period 2||0
185060|NCT01400906|449543|P3|NOT COMPLETED|Washout Period 2||0
185061|NCT01400906|449544|P2|NOT COMPLETED|Washout Period 2||0
185062|NCT01400906|449545|P1|NOT COMPLETED|Washout Period 2||0
185063|NCT01400906|449540|P6|COMPLETED|Washout Period 2||5
185064|NCT01400906|449541|P5|COMPLETED|Washout Period 2||6
185065|NCT01400906|449542|P4|COMPLETED|Washout Period 2||6
185066|NCT01400906|449543|P3|COMPLETED|Washout Period 2||6
185067|NCT01400906|449544|P2|COMPLETED|Washout Period 2||6
185068|NCT01400906|449545|P1|COMPLETED|Washout Period 2||6
185069|NCT01400906|449540|P6|STARTED|Washout Period 2||5
185070|NCT01400906|449541|P5|STARTED|Washout Period 2||6
185071|NCT01400906|449542|P4|STARTED|Washout Period 2||6
185072|NCT01400906|449543|P3|STARTED|Washout Period 2||6
185073|NCT01400906|449544|P2|STARTED|Washout Period 2||6
185074|NCT01400906|449545|P1|STARTED|Washout Period 2||6
185075|NCT01400906|449540|P6|NOT COMPLETED|Treatment Period 2||0
185076|NCT01400906|449541|P5|NOT COMPLETED|Treatment Period 2||0
185077|NCT01400906|449542|P4|NOT COMPLETED|Treatment Period 2||0
185078|NCT01400906|449543|P3|NOT COMPLETED|Treatment Period 2||0
185079|NCT01400906|449544|P2|NOT COMPLETED|Treatment Period 2||0
185080|NCT01400906|449545|P1|NOT COMPLETED|Treatment Period 2||0
185081|NCT01400906|449540|P6|COMPLETED|Treatment Period 2||5
185082|NCT01400906|449541|P5|COMPLETED|Treatment Period 2||6
185083|NCT01400906|449542|P4|COMPLETED|Treatment Period 2||6
185084|NCT01400906|449543|P3|COMPLETED|Treatment Period 2||6
185085|NCT01400906|449544|P2|COMPLETED|Treatment Period 2||6
185086|NCT01400906|449545|P1|COMPLETED|Treatment Period 2||6
185087|NCT01400906|449540|P6|STARTED|Treatment Period 2||5
185088|NCT01400906|449541|P5|STARTED|Treatment Period 2||6
185089|NCT01400906|449542|P4|STARTED|Treatment Period 2||6
185090|NCT01400906|449543|P3|STARTED|Treatment Period 2||6
185091|NCT01400906|449544|P2|STARTED|Treatment Period 2||6
185092|NCT01400906|449545|P1|STARTED|Treatment Period 2||6
185093|NCT01400906|449540|P6|NOT COMPLETED|Washout Period 1||0
185094|NCT01400906|449541|P5|NOT COMPLETED|Washout Period 1||0
185095|NCT01400906|449542|P4|NOT COMPLETED|Washout Period 1||0
185096|NCT01400906|449543|P3|NOT COMPLETED|Washout Period 1||0
185097|NCT01400906|449544|P2|NOT COMPLETED|Washout Period 1||0
185098|NCT01400906|449545|P1|NOT COMPLETED|Washout Period 1||0
185099|NCT01400906|449540|P6|COMPLETED|Washout Period 1||5
185100|NCT01400906|449541|P5|COMPLETED|Washout Period 1||6
185101|NCT01400906|449542|P4|COMPLETED|Washout Period 1||6
185102|NCT01400906|449543|P3|COMPLETED|Washout Period 1||6
185103|NCT01400906|449544|P2|COMPLETED|Washout Period 1||6
185104|NCT01400906|449545|P1|COMPLETED|Washout Period 1||6
185105|NCT01400906|449540|P6|STARTED|Washout Period 1||5
185106|NCT01400906|449541|P5|STARTED|Washout Period 1||6
185107|NCT01400906|449542|P4|STARTED|Washout Period 1||6
185108|NCT01400906|449543|P3|STARTED|Washout Period 1||6
185109|NCT01400906|449544|P2|STARTED|Washout Period 1||6
185110|NCT01400906|449545|P1|STARTED|Washout Period 1||6
185111|NCT01400906|449540|P6|NOT COMPLETED|Treatment Period 1||0
185112|NCT01400906|449541|P5|NOT COMPLETED|Treatment Period 1||0
185113|NCT01400906|449542|P4|NOT COMPLETED|Treatment Period 1||0
185114|NCT01400906|449543|P3|NOT COMPLETED|Treatment Period 1||0
185115|NCT01400906|449544|P2|NOT COMPLETED|Treatment Period 1||0
185116|NCT01400906|449545|P1|NOT COMPLETED|Treatment Period 1||0
185117|NCT01400906|449540|P6|COMPLETED|Treatment Period 1||5
185118|NCT01400906|449541|P5|COMPLETED|Treatment Period 1||6
185119|NCT01400906|449542|P4|COMPLETED|Treatment Period 1||6
185120|NCT01400906|449543|P3|COMPLETED|Treatment Period 1||6
185121|NCT01400906|449544|P2|COMPLETED|Treatment Period 1||6
185122|NCT01400906|449545|P1|COMPLETED|Treatment Period 1||6
185123|NCT01400906|449540|P6|STARTED|Treatment Period 1||5
185124|NCT01400906|449541|P5|STARTED|Treatment Period 1||6
185125|NCT01400906|449542|P4|STARTED|Treatment Period 1||6
185126|NCT01400906|449543|P3|STARTED|Treatment Period 1||6
185127|NCT01400906|449544|P2|STARTED|Treatment Period 1||6
185128|NCT01400906|449545|P1|STARTED|Treatment Period 1||6
185129|NCT01400893|449579|P2|NOT COMPLETED|Overall Study||27
185130|NCT01400893|449580|P1|NOT COMPLETED|Overall Study||27
185131|NCT01400893|449579|P2|COMPLETED|Overall Study||38
185132|NCT01400893|449580|P1|COMPLETED|Overall Study||42
185133|NCT01400893|449579|P2|STARTED|Overall Study||65
185134|NCT01400893|449580|P1|STARTED|Overall Study||69
185135|NCT01400880|449588|P1|NOT COMPLETED|Overall Study||2
185136|NCT01400880|449588|P1|COMPLETED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|101
185137|NCT01400880|449588|P1|STARTED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|103
185138|NCT01400841|449592|P1|NOT COMPLETED|Extended Study Phase (2 Years)||2
185139|NCT01400841|449592|P1|COMPLETED|Extended Study Phase (2 Years)||11
185140|NCT01400841|449592|P1|STARTED|Extended Study Phase (2 Years)|"1 subject refused further participation~1 subject death prior to agreeing to extended follow-up"|13
185141|NCT01400841|449592|P1|NOT COMPLETED|Initial Study Phase (6 Months)||1
185142|NCT01400841|449592|P1|COMPLETED|Initial Study Phase (6 Months)||15
185143|NCT01400841|449592|P1|STARTED|Initial Study Phase (6 Months)|2 of the 18 consented subjects did not receive the device|16
185144|NCT01400698|449630|P6|NOT COMPLETED|Overall Study||6
185145|NCT01400698|449631|P5|NOT COMPLETED|Overall Study||7
185146|NCT01400698|449632|P4|NOT COMPLETED|Overall Study||8
185147|NCT01400698|449633|P3|NOT COMPLETED|Overall Study||2
185148|NCT01400698|449634|P2|NOT COMPLETED|Overall Study||11
185149|NCT01400698|449635|P1|NOT COMPLETED|Overall Study||15
185150|NCT01400698|449630|P6|COMPLETED|Overall Study||9
185151|NCT01400698|449631|P5|COMPLETED|Overall Study||7
185152|NCT01400698|449632|P4|COMPLETED|Overall Study||6
185153|NCT01400698|449633|P3|COMPLETED|Overall Study||0
185154|NCT01400698|449634|P2|COMPLETED|Overall Study||12
185155|NCT01400698|449635|P1|COMPLETED|Overall Study||8
185156|NCT01400698|449630|P6|STARTED|Overall Study||15
185157|NCT01400698|449631|P5|STARTED|Overall Study||14
185158|NCT01400698|449632|P4|STARTED|Overall Study||14
185159|NCT01400698|449633|P3|STARTED|Overall Study||2
185160|NCT01400698|449634|P2|STARTED|Overall Study||23
185161|NCT01400698|449635|P1|STARTED|Overall Study||23
185162|NCT01400516|449659|P2|NOT COMPLETED|Extension Trial||0
185163|NCT01400516|449660|P1|NOT COMPLETED|Extension Trial||0
185164|NCT01400516|449659|P2|COMPLETED|Extension Trial||7
185165|NCT01400516|449660|P1|COMPLETED|Extension Trial||6
185166|NCT01400516|449659|P2|STARTED|Extension Trial|Only 7 participants in the Teriparatide arm entered the Extension Trial.|7
185167|NCT01400516|449660|P1|STARTED|Extension Trial|Only 6 participants in the Control arm entered the Extension Trial.|6
185168|NCT01400516|449659|P2|NOT COMPLETED|Primary Trial||2
185169|NCT01400516|449660|P1|NOT COMPLETED|Primary Trial||0
185170|NCT01400516|449659|P2|COMPLETED|Primary Trial||12
185171|NCT01400516|449660|P1|COMPLETED|Primary Trial||12
185172|NCT01400516|449659|P2|STARTED|Primary Trial||14
185173|NCT01400516|449660|P1|STARTED|Primary Trial||12
185174|NCT01400503|449670|P1|NOT COMPLETED|Overall Study||60
185175|NCT01400503|449670|P1|COMPLETED|Overall Study||0
185176|NCT01400503|449670|P1|STARTED|Overall Study||60
185177|NCT01400477|449681|P2|NOT COMPLETED|Overall Study||0
185178|NCT01400477|449682|P1|NOT COMPLETED|Overall Study||2
185179|NCT01400477|449681|P2|COMPLETED|Overall Study||40
185180|NCT01400477|449682|P1|COMPLETED|Overall Study||38
185181|NCT01400477|449681|P2|STARTED|Overall Study||40
185182|NCT01400477|449682|P1|STARTED|Overall Study||40
185183|NCT01400451|449693|P3|NOT COMPLETED|Combination Treatment (or Intended)||2
185184|NCT01400451|449694|P2|NOT COMPLETED|Combination Treatment (or Intended)||4
185185|NCT01400451|449695|P1|NOT COMPLETED|Combination Treatment (or Intended)||6
185186|NCT01400451|449693|P3|COMPLETED|Combination Treatment (or Intended)||0
185187|NCT01400451|449694|P2|COMPLETED|Combination Treatment (or Intended)||0
185188|NCT01400451|449695|P1|COMPLETED|Combination Treatment (or Intended)||0
185189|NCT01400451|449693|P3|STARTED|Combination Treatment (or Intended)|Did not start Ipilimumab but remained on vemurafenib alone.|2
185190|NCT01400451|449694|P2|STARTED|Combination Treatment (or Intended)||4
185191|NCT01400451|449695|P1|STARTED|Combination Treatment (or Intended)||6
185192|NCT01400451|449693|P3|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
185193|NCT01400451|449694|P2|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
185194|NCT01400451|449695|P1|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
185195|NCT01400451|449693|P3|COMPLETED|28 Day Lead In With Vemurafenib Alone||2
185196|NCT01400451|449694|P2|COMPLETED|28 Day Lead In With Vemurafenib Alone||4
185197|NCT01400451|449695|P1|COMPLETED|28 Day Lead In With Vemurafenib Alone||6
185198|NCT01400451|449693|P3|STARTED|28 Day Lead In With Vemurafenib Alone||2
185199|NCT01400451|449694|P2|STARTED|28 Day Lead In With Vemurafenib Alone||4
185200|NCT01400451|449695|P1|STARTED|28 Day Lead In With Vemurafenib Alone||6
185201|NCT01400425|449709|P1|NOT COMPLETED|Overall Study||10
185202|NCT01400425|449709|P1|COMPLETED|Overall Study||229
185203|NCT01400425|449709|P1|STARTED|Overall Study||239
185204|NCT01400412|449722|P2|NOT COMPLETED|Overall Study||17
185205|NCT01400412|449723|P1|NOT COMPLETED|Overall Study||10
185206|NCT01400412|449722|P2|COMPLETED|Overall Study||115
185207|NCT01400412|449723|P1|COMPLETED|Overall Study||120
185208|NCT01400412|449722|P2|STARTED|Overall Study||132
185209|NCT01400412|449723|P1|STARTED|Overall Study||130
185210|NCT01400243|449769|P2|NOT COMPLETED|Overall Study||11
185211|NCT01400243|449770|P1|NOT COMPLETED|Overall Study||8
185212|NCT01400243|449769|P2|COMPLETED|Overall Study||52
185213|NCT01400243|449770|P1|COMPLETED|Overall Study||56
185214|NCT01400243|449769|P2|STARTED|Overall Study||63
185215|NCT01400243|449770|P1|STARTED|Overall Study||64
185216|NCT01400139|449792|P1|NOT COMPLETED|HYD Extension Period||23
185217|NCT01400139|449792|P1|COMPLETED|HYD Extension Period||83
185218|NCT01400139|449792|P1|STARTED|HYD Extension Period|Subjects completing the Core Study were offered an option to enter the 24-week open-label Extension|106
185219|NCT01400139|449792|P1|NOT COMPLETED|HYD Core Study||512
185220|NCT01400139|449792|P1|COMPLETED|HYD Core Study||410
185221|NCT01400139|449792|P1|STARTED|HYD Core Study||922
185222|NCT01400113|449802|P2|NOT COMPLETED|Overall Study||1
185223|NCT01400113|449803|P1|NOT COMPLETED|Overall Study||1
185224|NCT01400113|449802|P2|COMPLETED|Overall Study||59
185225|NCT01400113|449803|P1|COMPLETED|Overall Study||59
185226|NCT01400113|449802|P2|STARTED|Overall Study||60
185227|NCT01400113|449803|P1|STARTED|Overall Study||60
185228|NCT01399866|449811|P2|NOT COMPLETED|Overall Study||2
185229|NCT01399866|449812|P1|NOT COMPLETED|Overall Study||4
185230|NCT01399866|449811|P2|COMPLETED|Overall Study||28
185231|NCT01399866|449812|P1|COMPLETED|Overall Study||28
185232|NCT01399866|449811|P2|STARTED|Overall Study||30
185233|NCT01399866|449812|P1|STARTED|Overall Study||32
185234|NCT01399827|449830|P2|NOT COMPLETED|Overall Study||0
185235|NCT01399827|449831|P1|NOT COMPLETED|Overall Study||0
185236|NCT01399827|449830|P2|COMPLETED|Overall Study||1
185237|NCT01399827|449831|P1|COMPLETED|Overall Study||1
185238|NCT01399827|449830|P2|STARTED|Overall Study||1
185239|NCT01399827|449831|P1|STARTED|Overall Study||1
185240|NCT01399788|449845|P2|NOT COMPLETED|Second Intervention Period||0
185241|NCT01399788|449846|P1|NOT COMPLETED|Second Intervention Period||0
185242|NCT01399788|449845|P2|COMPLETED|Second Intervention Period||18
185243|NCT01399788|449846|P1|COMPLETED|Second Intervention Period||17
185244|NCT01399788|449845|P2|STARTED|Second Intervention Period||18
185245|NCT01399788|449846|P1|STARTED|Second Intervention Period||17
185246|NCT01399788|449845|P2|NOT COMPLETED|Washout Period (at Least 1 Week)||0
185247|NCT01399788|449846|P1|NOT COMPLETED|Washout Period (at Least 1 Week)||0
185248|NCT01399788|449845|P2|COMPLETED|Washout Period (at Least 1 Week)||18
185249|NCT01399788|449846|P1|COMPLETED|Washout Period (at Least 1 Week)||17
185250|NCT01399788|449845|P2|STARTED|Washout Period (at Least 1 Week)||18
185251|NCT01399788|449846|P1|STARTED|Washout Period (at Least 1 Week)||17
185252|NCT01399788|449845|P2|NOT COMPLETED|First Intervention Period||0
185253|NCT01399788|449846|P1|NOT COMPLETED|First Intervention Period||1
185254|NCT01399788|449845|P2|COMPLETED|First Intervention Period||18
185255|NCT01399788|449846|P1|COMPLETED|First Intervention Period||17
185256|NCT01399788|449845|P2|STARTED|First Intervention Period||18
185257|NCT01399788|449846|P1|STARTED|First Intervention Period||18
185258|NCT01399723|449868|P2|NOT COMPLETED|Overall Study||1
185259|NCT01399723|449869|P1|NOT COMPLETED|Overall Study||0
185260|NCT01399723|449868|P2|COMPLETED|Overall Study||263
185261|NCT01399723|449869|P1|COMPLETED|Overall Study||263
185262|NCT01399723|449868|P2|STARTED|Overall Study||264
185263|NCT01399723|449869|P1|STARTED|Overall Study||263
185264|NCT01399697|449882|P3|NOT COMPLETED|Overall Study||4
185265|NCT01399697|449883|P2|NOT COMPLETED|Overall Study||3
185266|NCT01399697|449884|P1|NOT COMPLETED|Overall Study||41
185267|NCT01399697|449882|P3|COMPLETED|Overall Study||78
185268|NCT01399697|449883|P2|COMPLETED|Overall Study||80
185269|NCT01399697|449884|P1|COMPLETED|Overall Study||55
185270|NCT01399697|449882|P3|STARTED|Overall Study||82
185271|NCT01399697|449883|P2|STARTED|Overall Study||83
185272|NCT01399697|449884|P1|STARTED|Overall Study||96
185273|NCT01399619|449911|P4|NOT COMPLETED|Overall Study||17
185274|NCT01399619|449912|P3|NOT COMPLETED|Overall Study||12
185275|NCT01399619|449913|P2|NOT COMPLETED|Overall Study||0
185276|NCT01399619|449914|P1|NOT COMPLETED|Overall Study||25
185277|NCT01399619|449911|P4|COMPLETED|Overall Study||0
185278|NCT01399619|449912|P3|COMPLETED|Overall Study||74
185279|NCT01399619|449913|P2|COMPLETED|Overall Study||84
185280|NCT01399619|449914|P1|COMPLETED|Overall Study||98
185281|NCT01399619|449911|P4|STARTED|Overall Study||17
185282|NCT01399619|449912|P3|STARTED|Overall Study||86
185283|NCT01399619|449913|P2|STARTED|Overall Study||84
185284|NCT01399619|449914|P1|STARTED|Overall Study||123
185285|NCT01399593|449977|P2|NOT COMPLETED|Overall Study||2
185286|NCT01399593|449978|P1|NOT COMPLETED|Overall Study||3
185287|NCT01399593|449977|P2|COMPLETED|Overall Study||49
185288|NCT01399593|449978|P1|COMPLETED|Overall Study||48
185289|NCT01399593|449977|P2|STARTED|Overall Study||51
185290|NCT01399593|449978|P1|STARTED|Overall Study||51
185291|NCT01399268|449986|P2|NOT COMPLETED|Overall Study||0
185292|NCT01399268|449987|P1|NOT COMPLETED|Overall Study||0
185293|NCT01399268|449986|P2|COMPLETED|Overall Study||15
185294|NCT01399268|449987|P1|COMPLETED|Overall Study||15
185295|NCT01399268|449986|P2|STARTED|Overall Study||15
185296|NCT01399268|449987|P1|STARTED|Overall Study||15
185297|NCT01399229|450005|P3|NOT COMPLETED|Overall Study||0
185298|NCT01399229|450006|P2|NOT COMPLETED|Overall Study||0
185299|NCT01399229|450007|P1|NOT COMPLETED|Overall Study||0
185300|NCT01399229|450005|P3|COMPLETED|Overall Study||5
185301|NCT01399229|450006|P2|COMPLETED|Overall Study||5
185302|NCT01399229|450007|P1|COMPLETED|Overall Study||20
185303|NCT01399229|450005|P3|STARTED|Overall Study||5
185304|NCT01399229|450006|P2|STARTED|Overall Study||5
185305|NCT01399229|450007|P1|STARTED|Overall Study||20
185306|NCT01399190|450011|P1|NOT COMPLETED|Overall Study||20
185307|NCT01399190|450011|P1|COMPLETED|Overall Study||48
185308|NCT01399190|450011|P1|Evaluable for Primary Endpoint Analysis|Overall Study||60
185309|NCT01399190|450011|P1|Included in Final Analysis|Overall Study||63
185310|NCT01399190|450011|P1|STARTED|Overall Study||68
185311|NCT01399125|450019|P2|NOT COMPLETED|Overall Study||60
185312|NCT01399125|450020|P1|NOT COMPLETED|Overall Study||51
185313|NCT01399125|450019|P2|COMPLETED|Overall Study||193
185314|NCT01399125|450020|P1|COMPLETED|Overall Study||197
185315|NCT01399125|450019|P2|Per Protocol (PP) Population|Overall Study||188
185316|NCT01399125|450020|P1|Per Protocol (PP) Population|Overall Study||192
185317|NCT01399125|450019|P2|STARTED|Overall Study||253
185318|NCT01399125|450020|P1|STARTED|Overall Study||248
185319|NCT01399099|450034|P1|NOT COMPLETED|Overall Study||31
185320|NCT01399099|450034|P1|COMPLETED|Overall Study||36
185321|NCT01399099|450034|P1|6 Months|Overall Study||47
185322|NCT01399099|450034|P1|STARTED|Overall Study||67
185323|NCT01399047|450041|P2|NOT COMPLETED|Overall Study||1
185324|NCT01399047|450042|P1|NOT COMPLETED|Overall Study||0
185325|NCT01399047|450041|P2|COMPLETED|Overall Study||8
185326|NCT01399047|450042|P1|COMPLETED|Overall Study||10
185327|NCT01399047|450041|P2|STARTED|Overall Study||9
185328|NCT01399047|450042|P1|STARTED|Overall Study||10
185329|NCT01399008|450059|P3|NOT COMPLETED|Overall Study||2
185330|NCT01399008|450060|P2|NOT COMPLETED|Overall Study||5
185331|NCT01399008|450061|P1|NOT COMPLETED|Overall Study||3
185332|NCT01399008|450059|P3|COMPLETED|Overall Study||31
185333|NCT01399008|450060|P2|COMPLETED|Overall Study||27
185334|NCT01399008|450061|P1|COMPLETED|Overall Study||32
185335|NCT01399008|450059|P3|STARTED|Overall Study||33
185336|NCT01399008|450060|P2|STARTED|Overall Study||32
185337|NCT01399008|450061|P1|STARTED|Overall Study||35
185338|NCT01398982|450071|P2|NOT COMPLETED|Overall Study||2
185339|NCT01398982|450072|P1|NOT COMPLETED|Overall Study||6
185340|NCT01398982|450071|P2|COMPLETED|Overall Study||47
185341|NCT01398982|450072|P1|COMPLETED|Overall Study||38
185342|NCT01398982|450071|P2|STARTED|Overall Study||49
185343|NCT01398982|450072|P1|STARTED|Overall Study||44
185344|NCT01398956|450078|P1|NOT COMPLETED|Overall Study||10
185345|NCT01398956|450078|P1|COMPLETED|Overall Study||34
185346|NCT01398956|450078|P1|STARTED|Overall Study||44
185347|NCT01398943|450086|P4|NOT COMPLETED|Second Intervention (1 Day)||0
185348|NCT01398943|450087|P3|NOT COMPLETED|Second Intervention (1 Day)||0
185349|NCT01398943|450088|P2|NOT COMPLETED|Second Intervention (1 Day)||0
185350|NCT01398943|450089|P1|NOT COMPLETED|Second Intervention (1 Day)||0
185351|NCT01398943|450086|P4|COMPLETED|Second Intervention (1 Day)||15
185352|NCT01398943|450087|P3|COMPLETED|Second Intervention (1 Day)||15
185353|NCT01398943|450088|P2|COMPLETED|Second Intervention (1 Day)||15
185354|NCT01398943|450089|P1|COMPLETED|Second Intervention (1 Day)||15
185355|NCT01398943|450086|P4|STARTED|Second Intervention (1 Day)||15
185356|NCT01398943|450087|P3|STARTED|Second Intervention (1 Day)||15
185357|NCT01398943|450088|P2|STARTED|Second Intervention (1 Day)||15
185358|NCT01398943|450089|P1|STARTED|Second Intervention (1 Day)||15
185359|NCT01398943|450086|P4|NOT COMPLETED|Washout (2-7 Days)||0
185360|NCT01398943|450087|P3|NOT COMPLETED|Washout (2-7 Days)||0
185361|NCT01398943|450088|P2|NOT COMPLETED|Washout (2-7 Days)||0
185362|NCT01398943|450089|P1|NOT COMPLETED|Washout (2-7 Days)||0
185363|NCT01398943|450086|P4|COMPLETED|Washout (2-7 Days)||15
185364|NCT01398943|450087|P3|COMPLETED|Washout (2-7 Days)||15
185365|NCT01398943|450088|P2|COMPLETED|Washout (2-7 Days)||15
185366|NCT01398943|450089|P1|COMPLETED|Washout (2-7 Days)||15
185367|NCT01398943|450086|P4|STARTED|Washout (2-7 Days)||15
185368|NCT01398943|450087|P3|STARTED|Washout (2-7 Days)||15
185369|NCT01398943|450088|P2|STARTED|Washout (2-7 Days)||15
185370|NCT01398943|450089|P1|STARTED|Washout (2-7 Days)||15
185371|NCT01398943|450086|P4|NOT COMPLETED|First Intervention (1 Day)||0
185372|NCT01398943|450087|P3|NOT COMPLETED|First Intervention (1 Day)||0
185373|NCT01398943|450088|P2|NOT COMPLETED|First Intervention (1 Day)||0
185374|NCT01398943|450089|P1|NOT COMPLETED|First Intervention (1 Day)||0
185375|NCT01398943|450086|P4|COMPLETED|First Intervention (1 Day)||15
185376|NCT01398943|450087|P3|COMPLETED|First Intervention (1 Day)||15
185377|NCT01398943|450088|P2|COMPLETED|First Intervention (1 Day)||15
185378|NCT01398943|450089|P1|COMPLETED|First Intervention (1 Day)||15
185379|NCT01398943|450086|P4|STARTED|First Intervention (1 Day)||15
185380|NCT01398943|450087|P3|STARTED|First Intervention (1 Day)||15
185381|NCT01398943|450088|P2|STARTED|First Intervention (1 Day)||15
185382|NCT01398943|450089|P1|STARTED|First Intervention (1 Day)||15
185383|NCT01398852|450097|P1|NOT COMPLETED|Overall Study||372
185384|NCT01398852|450097|P1|COMPLETED|Overall Study||0
185385|NCT01398852|450097|P1|STARTED|Overall Study|Due to termination of the study the exact number of participants enrolled is unknown at this time.|372
185386|NCT01398839|450103|P2|NOT COMPLETED|Overall Study||0
185387|NCT01398839|450104|P1|NOT COMPLETED|Overall Study||0
185388|NCT01398839|450103|P2|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|37
185389|NCT01398839|450104|P1|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|35
185390|NCT01398839|450103|P2|STARTED|Overall Study||37
185391|NCT01398839|450104|P1|STARTED|Overall Study||35
185392|NCT01398787|450110|P1|NOT COMPLETED|Overall Study||1
185393|NCT01398787|450110|P1|COMPLETED|Overall Study||197
185394|NCT01398787|450110|P1|STARTED|Overall Study||198
185395|NCT01398514|450128|P2|NOT COMPLETED|Overall Study||6
185396|NCT01398514|450129|P1|NOT COMPLETED|Overall Study||8
185397|NCT01398514|450128|P2|COMPLETED|Overall Study||20
185398|NCT01398514|450129|P1|COMPLETED|Overall Study||18
185399|NCT01398514|450128|P2|STARTED|Overall Study||26
185400|NCT01398514|450129|P1|STARTED|Overall Study||26
185401|NCT01398475|450141|P4|NOT COMPLETED|Overall Study||0
185402|NCT01398475|450142|P3|NOT COMPLETED|Overall Study||0
185403|NCT01398475|450143|P2|NOT COMPLETED|Overall Study||0
185404|NCT01398475|450144|P1|NOT COMPLETED|Overall Study||0
185405|NCT01398475|450141|P4|COMPLETED|Overall Study||4
185406|NCT01398475|450142|P3|COMPLETED|Overall Study||4
185407|NCT01398475|450143|P2|COMPLETED|Overall Study||3
185408|NCT01398475|450144|P1|COMPLETED|Overall Study||4
185409|NCT01398475|450141|P4|Received Fourth Intervention|Overall Study||4
185410|NCT01398475|450142|P3|Received Fourth Intervention|Overall Study||4
185411|NCT01398475|450143|P2|Received Fourth Intervention|Overall Study||3
185412|NCT01398475|450144|P1|Received Fourth Intervention|Overall Study||4
185413|NCT01398475|450141|P4|Received Third Intervention|Overall Study||4
185414|NCT01398475|450142|P3|Received Third Intervention|Overall Study||4
185415|NCT01398475|450143|P2|Received Third Intervention|Overall Study||3
185416|NCT01398475|450144|P1|Received Third Intervention|Overall Study||4
185417|NCT01398475|450141|P4|Received Second Intervention|Overall Study||4
185418|NCT01398475|450142|P3|Received Second Intervention|Overall Study||4
185419|NCT01398475|450143|P2|Received Second Intervention|Overall Study||3
185420|NCT01398475|450144|P1|Received Second Intervention|Overall Study||4
185421|NCT01398475|450141|P4|Received First Intervention|Overall Study||4
185422|NCT01398475|450142|P3|Received First Intervention|Overall Study||4
185423|NCT01398475|450143|P2|Received First Intervention|Overall Study||3
185424|NCT01398475|450144|P1|Received First Intervention|Overall Study||4
185425|NCT01398475|450141|P4|STARTED|Overall Study||4
185426|NCT01398475|450142|P3|STARTED|Overall Study||4
185427|NCT01398475|450143|P2|STARTED|Overall Study||3
185428|NCT01398475|450144|P1|STARTED|Overall Study||4
185429|NCT01398410|450164|P2|NOT COMPLETED|Overall Study||56
185430|NCT01398410|450165|P1|NOT COMPLETED|Overall Study||58
185431|NCT01398410|450164|P2|COMPLETED|Overall Study||148
185432|NCT01398410|450165|P1|COMPLETED|Overall Study||143
185433|NCT01398410|450164|P2|STARTED|Overall Study||204
185434|NCT01398410|450165|P1|STARTED|Overall Study|Treated participants (all participants who received at least one dose of rabeprazole).|201
185435|NCT01398358|450176|P3|NOT COMPLETED|Overall Study||21
185436|NCT01398358|450177|P2|NOT COMPLETED|Overall Study||23
185437|NCT01398358|450178|P1|NOT COMPLETED|Overall Study||15
185438|NCT01398358|450176|P3|COMPLETED|Overall Study||234
185439|NCT01398358|450177|P2|COMPLETED|Overall Study||201
185440|NCT01398358|450178|P1|COMPLETED|Overall Study||203
185441|NCT01398358|450176|P3|STARTED|Overall Study||255
185442|NCT01398358|450177|P2|STARTED|Overall Study||224
185443|NCT01398358|450178|P1|STARTED|Overall Study||218
185444|NCT01398280|450191|P2|NOT COMPLETED|Overall Study||0
185445|NCT01398280|450192|P1|NOT COMPLETED|Overall Study||4
185446|NCT01398280|450191|P2|COMPLETED|Overall Study||4
185447|NCT01398280|450192|P1|COMPLETED|Overall Study||7
185448|NCT01398280|450191|P2|STARTED|Overall Study||4
185449|NCT01398280|450192|P1|STARTED|Overall Study||11
185450|NCT01398176|450200|P2|NOT COMPLETED|Overall Study||6
185451|NCT01398176|450201|P1|NOT COMPLETED|Overall Study||3
185452|NCT01398176|450200|P2|COMPLETED|Overall Study||19
185453|NCT01398176|450201|P1|COMPLETED|Overall Study||23
185454|NCT01398176|450200|P2|STARTED|Overall Study||25
185455|NCT01398176|450201|P1|STARTED|Overall Study||26
185456|NCT01398059|450207|P6|NOT COMPLETED|Overall Study||0
185457|NCT01398059|450208|P5|NOT COMPLETED|Overall Study||0
185458|NCT01398059|450209|P4|NOT COMPLETED|Overall Study||0
185459|NCT01398059|450210|P3|NOT COMPLETED|Overall Study||0
185460|NCT01398059|450211|P2|NOT COMPLETED|Overall Study||0
185461|NCT01398059|450212|P1|NOT COMPLETED|Overall Study||0
185462|NCT01398059|450207|P6|COMPLETED|Overall Study||2
185463|NCT01398059|450208|P5|COMPLETED|Overall Study||4
185464|NCT01398059|450209|P4|COMPLETED|Overall Study||2
185465|NCT01398059|450210|P3|COMPLETED|Overall Study||4
185466|NCT01398059|450211|P2|COMPLETED|Overall Study||3
185467|NCT01398059|450212|P1|COMPLETED|Overall Study||4
185468|NCT01398059|450207|P6|STARTED|Overall Study||2
185469|NCT01398059|450208|P5|STARTED|Overall Study||4
185470|NCT01398059|450209|P4|STARTED|Overall Study||2
185471|NCT01398059|450210|P3|STARTED|Overall Study||4
185472|NCT01398059|450211|P2|STARTED|Overall Study||3
185473|NCT01398059|450212|P1|STARTED|Overall Study||4
185474|NCT01397890|450234|P2|NOT COMPLETED|Overall Study||31
185475|NCT01397890|450235|P1|NOT COMPLETED|Overall Study||23
185476|NCT01397890|450234|P2|COMPLETED|Overall Study||260
185477|NCT01397890|450235|P1|COMPLETED|Overall Study||264
185478|NCT01397890|450234|P2|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =291+1-3=289.|287
185479|NCT01397890|450235|P1|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =287+3-1=289. 3 and 1 pts in respective groups received opposite treatment.|286
185480|NCT01397890|450234|P2|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|290
185481|NCT01397890|450235|P1|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|287
185482|NCT01397890|450234|P2|STARTED|Overall Study||291
185483|NCT01397890|450235|P1|STARTED|Overall Study||287
185484|NCT01397851|450289|P2|NOT COMPLETED|Overall Study||46
185485|NCT01397851|450290|P1|NOT COMPLETED|Overall Study||79
185486|NCT01397851|450289|P2|COMPLETED|Overall Study||39917
185487|NCT01397851|450290|P1|COMPLETED|Overall Study||41555
185488|NCT01397851|450289|P2|STARTED|Overall Study||39963
185489|NCT01397851|450290|P1|STARTED|Overall Study||41634
185490|NCT01397825|450306|P5|NOT COMPLETED|Overall Study||0
185491|NCT01397825|450307|P4|NOT COMPLETED|Overall Study||3
185492|NCT01397825|450308|P3|NOT COMPLETED|Overall Study||25
185493|NCT01397825|450309|P2|NOT COMPLETED|Overall Study||4
185494|NCT01397825|450310|P1|NOT COMPLETED|Overall Study||13
185495|NCT01397825|450306|P5|COMPLETED|Overall Study||0
185496|NCT01397825|450307|P4|COMPLETED|Overall Study||0
185497|NCT01397825|450308|P3|COMPLETED|Overall Study||0
185498|NCT01397825|450309|P2|COMPLETED|Overall Study||0
185499|NCT01397825|450310|P1|COMPLETED|Overall Study||0
185500|NCT01397825|450306|P5|STARTED|Overall Study||0
185501|NCT01397825|450307|P4|STARTED|Overall Study||3
185502|NCT01397825|450308|P3|STARTED|Overall Study||25
185503|NCT01397825|450309|P2|STARTED|Overall Study||4
185504|NCT01397825|450310|P1|STARTED|Overall Study||13
185505|NCT01397786|450380|P3|NOT COMPLETED|Phase B||138
185506|NCT01397786|450381|P2|NOT COMPLETED|Phase B||95
185507|NCT01397786|450382|P1|NOT COMPLETED|Phase B||303
185508|NCT01397786|450380|P3|COMPLETED|Phase B||91
185509|NCT01397786|450381|P2|COMPLETED|Phase B||109
185510|NCT01397786|450382|P1|COMPLETED|Phase B||308
185511|NCT01397786|450380|P3|STARTED|Phase B||229
185512|NCT01397786|450381|P2|STARTED|Phase B||204
185513|NCT01397786|450382|P1|STARTED|Phase B||611
185514|NCT01397786|450380|P3|NOT COMPLETED|Phase A||28
185515|NCT01397786|450381|P2|NOT COMPLETED|Phase A||0
185516|NCT01397786|450382|P1|NOT COMPLETED|Phase A||0
185517|NCT01397786|450380|P3|COMPLETED|Phase A||199
185518|NCT01397786|450381|P2|COMPLETED|Phase A||0
185519|NCT01397786|450382|P1|COMPLETED|Phase A||12
185520|NCT01397786|450380|P3|STARTED|Phase A||227
185521|NCT01397786|450381|P2|STARTED|Phase A||0
185522|NCT01397786|450382|P1|STARTED|Phase A|Subjects in NCT01668797 Phase A at IA-related study termination rolled over to NCT01397786 Phase A.|12
185523|NCT01397747|450448|P1|NOT COMPLETED|Overall Study||1027
185524|NCT01397747|450448|P1|COMPLETED|Overall Study||9989
185525|NCT01397747|450448|P1|STARTED|Overall Study||11016
185526|NCT01397695|450453|P1|NOT COMPLETED|Overall Study||0
185527|NCT01397695|450453|P1|COMPLETED|Overall Study||0
185528|NCT01397695|450453|P1|STARTED|Overall Study||0
185529|NCT01397656|450459|P2|NOT COMPLETED|Overall Study||0
185530|NCT01397656|450460|P1|NOT COMPLETED|Overall Study||0
185531|NCT01397656|450459|P2|COMPLETED|Overall Study||30
185532|NCT01397656|450460|P1|COMPLETED|Overall Study||33
185533|NCT01397656|450459|P2|STARTED|Overall Study||30
185534|NCT01397656|450460|P1|STARTED|Overall Study||33
185535|NCT01397617|450475|P3|NOT COMPLETED|Overall Study||29
185536|NCT01397617|450476|P2|NOT COMPLETED|Overall Study||23
185537|NCT01397617|450477|P1|NOT COMPLETED|Overall Study||31
185538|NCT01397617|450475|P3|COMPLETED|Overall Study||31
185539|NCT01397617|450476|P2|COMPLETED|Overall Study||30
185540|NCT01397617|450477|P1|COMPLETED|Overall Study||33
185541|NCT01397617|450475|P3|STARTED|Overall Study||60
185542|NCT01397617|450476|P2|STARTED|Overall Study||53
185543|NCT01397617|450477|P1|STARTED|Overall Study||64
185544|NCT01397591|450488|P1|NOT COMPLETED|Overall Study||0
185545|NCT01397591|450488|P1|COMPLETED|Overall Study||2
185546|NCT01397591|450488|P1|STARTED|Overall Study||2
185547|NCT01397552|450498|P2|NOT COMPLETED|Overall Study||1
185548|NCT01397552|450499|P1|NOT COMPLETED|Overall Study||3
185549|NCT01397552|450498|P2|COMPLETED|Overall Study||3
185550|NCT01397552|450499|P1|COMPLETED|Overall Study||1
185551|NCT01397552|450498|P2|STARTED|Overall Study||4
185552|NCT01397552|450499|P1|STARTED|Overall Study||4
185553|NCT01397461|450508|P3|NOT COMPLETED|Overall Study||2
185554|NCT01397461|450509|P2|NOT COMPLETED|Overall Study||6
185555|NCT01397461|450510|P1|NOT COMPLETED|Overall Study||2
185556|NCT01397461|450508|P3|COMPLETED|Overall Study||152
185557|NCT01397461|450509|P2|COMPLETED|Overall Study||150
185558|NCT01397461|450510|P1|COMPLETED|Overall Study||153
185559|NCT01397461|450508|P3|STARTED|Overall Study||154
185560|NCT01397461|450509|P2|STARTED|Overall Study||156
185561|NCT01397461|450510|P1|STARTED|Overall Study||155
185562|NCT01397448|450521|P3|NOT COMPLETED|Overall Study||18
185563|NCT01397448|450522|P2|NOT COMPLETED|Overall Study||15
185564|NCT01397448|450523|P1|NOT COMPLETED|Overall Study||18
185565|NCT01397448|450521|P3|COMPLETED|Overall Study||140
185566|NCT01397448|450522|P2|COMPLETED|Overall Study||142
185567|NCT01397448|450523|P1|COMPLETED|Overall Study||138
185568|NCT01397448|450521|P3|STARTED|Overall Study||158
185569|NCT01397448|450522|P2|STARTED|Overall Study|158 participants were randomized but 1 participant was not treated with drug.|157
185570|NCT01397448|450523|P1|STARTED|Overall Study||156
185571|NCT01397422|450538|P4|NOT COMPLETED|Overall Study||8
185572|NCT01397422|450539|P3|NOT COMPLETED|Overall Study||3
185573|NCT01397422|450540|P2|NOT COMPLETED|Overall Study||3
185574|NCT01397422|450541|P1|NOT COMPLETED|Overall Study||2
185575|NCT01397422|450538|P4|COMPLETED|Overall Study||12
185576|NCT01397422|450539|P3|COMPLETED|Overall Study|AE = adverse event; eGFR = estimated glomerular filtration rate|18
185577|NCT01397422|450540|P2|COMPLETED|Overall Study||17
185578|NCT01397422|450541|P1|COMPLETED|Overall Study||20
185579|NCT01397422|450538|P4|STARTED|Overall Study||20
185580|NCT01397422|450539|P3|STARTED|Overall Study|Of the 3 participants who discontinued, 1 withdrew due to both an AE and an eGFR < 50 mL/min/1.73m^2|21
185581|NCT01397422|450540|P2|STARTED|Overall Study||20
185582|NCT01397422|450541|P1|STARTED|Overall Study||22
185583|NCT01397409|450581|P10|NOT COMPLETED|Stage 3||0
185584|NCT01397409|450582|P9|NOT COMPLETED|Stage 3||0
185585|NCT01397409|450583|P8|NOT COMPLETED|Stage 3||2
185586|NCT01397409|450584|P7|NOT COMPLETED|Stage 3||0
185587|NCT01397409|450585|P6|NOT COMPLETED|Stage 3||0
185588|NCT01397409|450586|P5|NOT COMPLETED|Stage 3||0
185589|NCT01397409|450587|P4|NOT COMPLETED|Stage 3||0
185590|NCT01397409|450588|P3|NOT COMPLETED|Stage 3||0
185591|NCT01397409|450589|P2|NOT COMPLETED|Stage 3||0
185592|NCT01397409|450590|P1|NOT COMPLETED|Stage 3||0
185593|NCT01397409|450581|P10|COMPLETED|Stage 3||16
185594|NCT01397409|450582|P9|COMPLETED|Stage 3||25
185595|NCT01397409|450583|P8|COMPLETED|Stage 3||21
185596|NCT01397409|450584|P7|COMPLETED|Stage 3||0
185597|NCT01397409|450585|P6|COMPLETED|Stage 3||0
185598|NCT01397409|450586|P5|COMPLETED|Stage 3||0
185599|NCT01397409|450587|P4|COMPLETED|Stage 3||0
185600|NCT01397409|450588|P3|COMPLETED|Stage 3||0
185601|NCT01397409|450589|P2|COMPLETED|Stage 3||0
185602|NCT01397409|450590|P1|COMPLETED|Stage 3||0
185603|NCT01397409|450581|P10|STARTED|Stage 3||16
185604|NCT01397409|450582|P9|STARTED|Stage 3||25
185605|NCT01397409|450583|P8|STARTED|Stage 3||23
185606|NCT01397409|450584|P7|STARTED|Stage 3||0
185607|NCT01397409|450585|P6|STARTED|Stage 3||0
185608|NCT01397409|450586|P5|STARTED|Stage 3||0
185609|NCT01397409|450587|P4|STARTED|Stage 3||0
185610|NCT01397409|450588|P3|STARTED|Stage 3||0
185611|NCT01397409|450589|P2|STARTED|Stage 3||0
185612|NCT01397409|450590|P1|STARTED|Stage 3||0
185613|NCT01397409|450581|P10|NOT COMPLETED|Stage 2||0
185614|NCT01397409|450582|P9|NOT COMPLETED|Stage 2||0
185615|NCT01397409|450583|P8|NOT COMPLETED|Stage 2||0
185616|NCT01397409|450584|P7|NOT COMPLETED|Stage 2||0
185617|NCT01397409|450585|P6|NOT COMPLETED|Stage 2||4
185618|NCT01397409|450586|P5|NOT COMPLETED|Stage 2||8
185619|NCT01397409|450587|P4|NOT COMPLETED|Stage 2||0
185620|NCT01397409|450588|P3|NOT COMPLETED|Stage 2||0
185621|NCT01397409|450589|P2|NOT COMPLETED|Stage 2||0
185622|NCT01397409|450590|P1|NOT COMPLETED|Stage 2||0
185623|NCT01397409|450581|P10|COMPLETED|Stage 2||0
185624|NCT01397409|450582|P9|COMPLETED|Stage 2||0
185625|NCT01397409|450583|P8|COMPLETED|Stage 2||0
185626|NCT01397409|450584|P7|COMPLETED|Stage 2||58
185627|NCT01397409|450585|P6|COMPLETED|Stage 2||54
185628|NCT01397409|450586|P5|COMPLETED|Stage 2||59
185629|NCT01397409|450587|P4|COMPLETED|Stage 2||0
185630|NCT01397409|450588|P3|COMPLETED|Stage 2||0
185631|NCT01397409|450589|P2|COMPLETED|Stage 2||0
185632|NCT01397409|450590|P1|COMPLETED|Stage 2||0
185633|NCT01397409|450581|P10|STARTED|Stage 2||0
185634|NCT01397409|450582|P9|STARTED|Stage 2||0
185635|NCT01397409|450583|P8|STARTED|Stage 2||0
185636|NCT01397409|450584|P7|STARTED|Stage 2||58
185637|NCT01397409|450585|P6|STARTED|Stage 2||58
185638|NCT01397409|450586|P5|STARTED|Stage 2||67
185639|NCT01397409|450587|P4|STARTED|Stage 2||0
185640|NCT01397409|450588|P3|STARTED|Stage 2||0
185641|NCT01397409|450589|P2|STARTED|Stage 2||0
185642|NCT01397409|450590|P1|STARTED|Stage 2||0
185643|NCT01397409|450581|P10|NOT COMPLETED|Stage 1||0
185644|NCT01397409|450582|P9|NOT COMPLETED|Stage 1||0
185645|NCT01397409|450583|P8|NOT COMPLETED|Stage 1||0
185646|NCT01397409|450584|P7|NOT COMPLETED|Stage 1||0
185647|NCT01397409|450585|P6|NOT COMPLETED|Stage 1||0
185648|NCT01397409|450586|P5|NOT COMPLETED|Stage 1||0
185649|NCT01397409|450587|P4|NOT COMPLETED|Stage 1||0
185650|NCT01397409|450588|P3|NOT COMPLETED|Stage 1||0
185651|NCT01397409|450589|P2|NOT COMPLETED|Stage 1||0
185652|NCT01397409|450590|P1|NOT COMPLETED|Stage 1||0
185653|NCT01397409|450581|P10|COMPLETED|Stage 1||0
185654|NCT01397409|450582|P9|COMPLETED|Stage 1||0
185655|NCT01397409|450583|P8|COMPLETED|Stage 1||0
185656|NCT01397409|450584|P7|COMPLETED|Stage 1||0
185657|NCT01397409|450585|P6|COMPLETED|Stage 1||0
185658|NCT01397409|450586|P5|COMPLETED|Stage 1||0
185659|NCT01397409|450587|P4|COMPLETED|Stage 1||3
185660|NCT01397409|450588|P3|COMPLETED|Stage 1||6
185661|NCT01397409|450589|P2|COMPLETED|Stage 1||6
185662|NCT01397409|450590|P1|COMPLETED|Stage 1||9
185663|NCT01397409|450581|P10|STARTED|Stage 1||0
185664|NCT01397409|450582|P9|STARTED|Stage 1||0
185665|NCT01397409|450583|P8|STARTED|Stage 1||0
185666|NCT01397409|450584|P7|STARTED|Stage 1||0
185667|NCT01397409|450585|P6|STARTED|Stage 1||0
185668|NCT01397409|450586|P5|STARTED|Stage 1||0
185669|NCT01397409|450587|P4|STARTED|Stage 1||3
185670|NCT01397409|450588|P3|STARTED|Stage 1||6
185671|NCT01397409|450589|P2|STARTED|Stage 1||6
185672|NCT01397409|450590|P1|STARTED|Stage 1||9
185673|NCT01397253|450630|P2|NOT COMPLETED|Overall Study||149
185674|NCT01397253|450631|P1|NOT COMPLETED|Overall Study||126
185675|NCT01397253|450630|P2|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|243
185676|NCT01397253|450631|P1|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|317
185677|NCT01397253|450630|P2|STARTED|Overall Study||392
185678|NCT01397253|450631|P1|STARTED|Overall Study||443
185679|NCT01397084|450637|P1|NOT COMPLETED|Overall Study||8
185680|NCT01397084|450637|P1|COMPLETED|Overall Study||100
185681|NCT01397084|450637|P1|STARTED|Overall Study||108
185682|NCT01397071|450644|P1|NOT COMPLETED|Consumption of Beef Patty With Avocado||0
185683|NCT01397071|450644|P1|COMPLETED|Consumption of Beef Patty With Avocado||11
185684|NCT01397071|450644|P1|STARTED|Consumption of Beef Patty With Avocado||11
185685|NCT01397071|450644|P1|NOT COMPLETED|Consumption of Beef Patty Alone||0
185686|NCT01397071|450644|P1|COMPLETED|Consumption of Beef Patty Alone||11
185687|NCT01397071|450644|P1|STARTED|Consumption of Beef Patty Alone||11
185688|NCT01396551|450652|P1|NOT COMPLETED|Overall Study||0
185689|NCT01396551|450652|P1|COMPLETED|Overall Study||69
185690|NCT01396551|450652|P1|STARTED|Overall Study||69
185691|NCT01396525|450656|P1|NOT COMPLETED|Overall Study||26
185692|NCT01396525|450656|P1|COMPLETED|Overall Study||127
185693|NCT01396525|450656|P1|STARTED|Overall Study||153
185694|NCT01396512|450756|P2|NOT COMPLETED|Overall Study||1
185695|NCT01396512|450757|P1|NOT COMPLETED|Overall Study||0
185696|NCT01396512|450756|P2|COMPLETED|Overall Study||136
185697|NCT01396512|450757|P1|COMPLETED|Overall Study||137
185698|NCT01396512|450756|P2|STARTED|Overall Study||137
185699|NCT01396512|450757|P1|STARTED|Overall Study||137
185700|NCT01396447|450773|P4|NOT COMPLETED|Overall Study||52
185701|NCT01396447|450774|P3|NOT COMPLETED|Overall Study||30
185702|NCT01396447|450775|P2|NOT COMPLETED|Overall Study||40
185703|NCT01396447|450776|P1|NOT COMPLETED|Overall Study||43
185704|NCT01396447|450773|P4|COMPLETED|Overall Study||94
185705|NCT01396447|450774|P3|COMPLETED|Overall Study||117
185706|NCT01396447|450775|P2|COMPLETED|Overall Study||103
185707|NCT01396447|450776|P1|COMPLETED|Overall Study||105
185708|NCT01396447|450773|P4|Received Treatment|Overall Study||146
185709|NCT01396447|450774|P3|Received Treatment|Overall Study||146
185710|NCT01396447|450775|P2|Received Treatment|Overall Study||141
185711|NCT01396447|450776|P1|Received Treatment|Overall Study||145
185712|NCT01396447|450773|P4|STARTED|Overall Study||146
185713|NCT01396447|450774|P3|STARTED|Overall Study||147
185714|NCT01396447|450775|P2|STARTED|Overall Study||143
185715|NCT01396447|450776|P1|STARTED|Overall Study||148
185716|NCT01396434|450793|P3|NOT COMPLETED|Overall Study||0
185717|NCT01396434|450794|P2|NOT COMPLETED|Overall Study||0
185718|NCT01396434|450795|P1|NOT COMPLETED|Overall Study||11
185719|NCT01396434|450793|P3|COMPLETED|Overall Study||14
185720|NCT01396434|450794|P2|COMPLETED|Overall Study||175
185721|NCT01396434|450795|P1|COMPLETED|Overall Study||2806
185722|NCT01396434|450793|P3|STARTED|Overall Study||14
185723|NCT01396434|450794|P2|STARTED|Overall Study||175
185724|NCT01396434|450795|P1|STARTED|Overall Study||2817
185725|NCT01396421|450807|P4|NOT COMPLETED|Overall Study||75
185726|NCT01396421|450808|P3|NOT COMPLETED|Overall Study||34
185727|NCT01396421|450809|P2|NOT COMPLETED|Overall Study||58
185728|NCT01396421|450810|P1|NOT COMPLETED|Overall Study||59
185729|NCT01396421|450807|P4|COMPLETED|Overall Study||109
185730|NCT01396421|450808|P3|COMPLETED|Overall Study||56
185731|NCT01396421|450809|P2|COMPLETED|Overall Study||124
185732|NCT01396421|450810|P1|COMPLETED|Overall Study||121
185733|NCT01396421|450807|P4|STARTED|Overall Study||184
185734|NCT01396421|450808|P3|STARTED|Overall Study||90
185735|NCT01396421|450809|P2|STARTED|Overall Study||182
185736|NCT01396421|450810|P1|STARTED|Overall Study||180
185737|NCT01396395|450882|P2|NOT COMPLETED|Overall Study||27
185738|NCT01396395|450883|P1|NOT COMPLETED|Overall Study||40
185739|NCT01396395|450882|P2|COMPLETED|Overall Study||175
185740|NCT01396395|450883|P1|COMPLETED|Overall Study||160
185741|NCT01396395|450882|P2|Safety Analysis Set|Overall Study|4 subjects randomized to standard+nicorandil were included in standard as no nicorandil was received|205
185742|NCT01396395|450883|P1|Safety Analysis Set|Overall Study|1 subject randomized to standard was included in standard+nicorandil as nicorandil was received.|197
185743|NCT01396395|450882|P2|STARTED|Overall Study||202
185744|NCT01396395|450883|P1|STARTED|Overall Study||200
185745|NCT01396382|450918|P1|NOT COMPLETED|Overall Study||0
185746|NCT01396382|450918|P1|COMPLETED|Overall Study||97
185747|NCT01396382|450918|P1|STARTED|Overall Study||97
185748|NCT01396317|450925|P2|NOT COMPLETED|Overall Study||0
185749|NCT01396317|450926|P1|NOT COMPLETED|Overall Study||1
185750|NCT01396317|450925|P2|COMPLETED|Overall Study||10
185751|NCT01396317|450926|P1|COMPLETED|Overall Study||9
185752|NCT01396317|450925|P2|STARTED|Overall Study||10
185753|NCT01396317|450926|P1|STARTED|Overall Study||10
185754|NCT01396265|450940|P1|NOT COMPLETED|Rifa+Afatinib||1
185755|NCT01396265|450940|P1|COMPLETED|Rifa+Afatinib||21
185756|NCT01396265|450940|P1|STARTED|Rifa+Afatinib||22
185757|NCT01396265|450940|P1|NOT COMPLETED|Washout||0
185758|NCT01396265|450940|P1|COMPLETED|Washout||22
185759|NCT01396265|450940|P1|STARTED|Washout||22
185760|NCT01396265|450940|P1|NOT COMPLETED|Afatinib||0
185761|NCT01396265|450940|P1|COMPLETED|Afatinib||22
185762|NCT01396265|450940|P1|STARTED|Afatinib||22
185763|NCT01396239|450967|P4|NOT COMPLETED|Overall Study||0
185764|NCT01396239|450968|P3|NOT COMPLETED|Overall Study||0
185765|NCT01396239|450969|P2|NOT COMPLETED|Overall Study||0
185766|NCT01396239|450970|P1|NOT COMPLETED|Overall Study||0
185767|NCT01396239|450967|P4|COMPLETED|Overall Study||2
185768|NCT01396239|450968|P3|COMPLETED|Overall Study||4
185769|NCT01396239|450969|P2|COMPLETED|Overall Study||2
185770|NCT01396239|450970|P1|COMPLETED|Overall Study||4
185771|NCT01396239|450967|P4|STARTED|Overall Study||2
185772|NCT01396239|450968|P3|STARTED|Overall Study||4
185773|NCT01396239|450969|P2|STARTED|Overall Study||2
185774|NCT01396239|450970|P1|STARTED|Overall Study||4
185775|NCT01396226|450993|P2|NOT COMPLETED|Overall Study||0
185776|NCT01396226|450994|P1|NOT COMPLETED|Overall Study||0
185777|NCT01396226|450993|P2|COMPLETED|Overall Study||6
185778|NCT01396226|450994|P1|COMPLETED|Overall Study||12
185779|NCT01396226|450993|P2|Patients Who Completed Treatment|Overall Study||6
185780|NCT01396226|450994|P1|Patients Who Completed Treatment|Overall Study||12
185781|NCT01396226|450993|P2|Patients Who Received Treatment|Overall Study||6
185782|NCT01396226|450994|P1|Patients Who Received Treatment|Overall Study||12
185783|NCT01396226|450993|P2|STARTED|Overall Study||6
185784|NCT01396226|450994|P1|STARTED|Overall Study||12
185785|NCT01396187|451029|P5|NOT COMPLETED|Overall Study||1
185786|NCT01396187|451030|P4|NOT COMPLETED|Overall Study||0
185787|NCT01396187|451031|P3|NOT COMPLETED|Overall Study||1
185788|NCT01396187|451032|P2|NOT COMPLETED|Overall Study||3
185789|NCT01396187|451033|P1|NOT COMPLETED|Overall Study||1
185790|NCT01396187|451029|P5|COMPLETED|Overall Study||9
185791|NCT01396187|451030|P4|COMPLETED|Overall Study||10
185792|NCT01396187|451031|P3|COMPLETED|Overall Study||9
185793|NCT01396187|451032|P2|COMPLETED|Overall Study||9
185794|NCT01396187|451033|P1|COMPLETED|Overall Study||7
185795|NCT01396187|451029|P5|STARTED|Overall Study||10
185796|NCT01396187|451030|P4|STARTED|Overall Study||10
185797|NCT01396187|451031|P3|STARTED|Overall Study||10
185798|NCT01396187|451032|P2|STARTED|Overall Study||12
185799|NCT01396187|451033|P1|STARTED|Overall Study||8
185800|NCT01396161|451133|P7|NOT COMPLETED|Overall Study||1
185801|NCT01396161|451134|P6|NOT COMPLETED|Overall Study||0
185802|NCT01396161|451135|P5|NOT COMPLETED|Overall Study||1
185803|NCT01396161|451136|P4|NOT COMPLETED|Overall Study||0
185804|NCT01396161|451137|P3|NOT COMPLETED|Overall Study||0
185805|NCT01396161|451138|P2|NOT COMPLETED|Overall Study||0
185806|NCT01396161|451139|P1|NOT COMPLETED|Overall Study||0
185807|NCT01396161|451133|P7|COMPLETED|Overall Study||10
185808|NCT01396161|451134|P6|COMPLETED|Overall Study||9
185809|NCT01396161|451135|P5|COMPLETED|Overall Study||8
185810|NCT01396161|451136|P4|COMPLETED|Overall Study||9
185811|NCT01396161|451137|P3|COMPLETED|Overall Study||9
185812|NCT01396161|451138|P2|COMPLETED|Overall Study||5
185813|NCT01396161|451139|P1|COMPLETED|Overall Study||12
185814|NCT01396161|451133|P7|STARTED|Overall Study||11
185815|NCT01396161|451134|P6|STARTED|Overall Study||9
185816|NCT01396161|451135|P5|STARTED|Overall Study||9
185817|NCT01396161|451136|P4|STARTED|Overall Study||9
185818|NCT01396161|451137|P3|STARTED|Overall Study||9
185819|NCT01396161|451138|P2|STARTED|Overall Study||5
185820|NCT01396161|451139|P1|STARTED|Overall Study||12
185821|NCT01396148|451192|P1|NOT COMPLETED|Overall Study||1
185822|NCT01396148|451192|P1|COMPLETED|Overall Study||5
185823|NCT01396148|451192|P1|STARTED|Overall Study||6
185824|NCT01396083|451222|P2|NOT COMPLETED|Overall Study||47
185825|NCT01396083|451223|P1|NOT COMPLETED|Overall Study||11
185826|NCT01396083|451222|P2|COMPLETED|Overall Study||72
185827|NCT01396083|451223|P1|COMPLETED|Overall Study||113
185828|NCT01396083|451222|P2|STARTED|Overall Study||119
185829|NCT01396083|451223|P1|STARTED|Overall Study||124
185830|NCT01396070|451247|P1|NOT COMPLETED|Overall Study||19
185831|NCT01396070|451247|P1|COMPLETED|Overall Study||17
185832|NCT01396070|451247|P1|STARTED|Overall Study||36
185833|NCT01396057|451256|P2|NOT COMPLETED|Overall Study||18
185834|NCT01396057|451257|P1|NOT COMPLETED|Overall Study||11
185835|NCT01396057|451256|P2|COMPLETED|Overall Study||100
185836|NCT01396057|451257|P1|COMPLETED|Overall Study||115
185837|NCT01396057|451256|P2|STARTED|Overall Study||118
185838|NCT01396057|451257|P1|STARTED|Overall Study||126
185839|NCT01396044|451283|P2|NOT COMPLETED|Overall Study||0
185840|NCT01396044|451284|P1|NOT COMPLETED|Overall Study||0
185841|NCT01396044|451283|P2|COMPLETED|Overall Study||171
185842|NCT01396044|451284|P1|COMPLETED|Overall Study||125
185843|NCT01396044|451283|P2|STARTED|Overall Study||171
185844|NCT01396044|451284|P1|STARTED|Overall Study||125
185845|NCT01396005|451306|P2|NOT COMPLETED|Overall Study||2
185846|NCT01396005|451307|P1|NOT COMPLETED|Overall Study||0
185847|NCT01396005|451306|P2|COMPLETED|Overall Study||9
185848|NCT01396005|451307|P1|COMPLETED|Overall Study||10
185849|NCT01396005|451306|P2|STARTED|Overall Study||11
185850|NCT01396005|451307|P1|STARTED|Overall Study||10
185851|NCT01395966|451326|P3|NOT COMPLETED|Overall Study||8
185852|NCT01395966|451327|P2|NOT COMPLETED|Overall Study||19
185853|NCT01395966|451328|P1|NOT COMPLETED|Overall Study||10
185854|NCT01395966|451326|P3|COMPLETED|Overall Study||104
185855|NCT01395966|451327|P2|COMPLETED|Overall Study||91
185856|NCT01395966|451328|P1|COMPLETED|Overall Study||99
185857|NCT01395966|451326|P3|STARTED|Overall Study||112
185858|NCT01395966|451327|P2|STARTED|Overall Study||110
185859|NCT01395966|451328|P1|STARTED|Overall Study||109
185860|NCT01395914|451338|P2|NOT COMPLETED|Overall Study||37
185861|NCT01395914|451339|P1|NOT COMPLETED|Overall Study||72
185862|NCT01395914|451338|P2|COMPLETED|Overall Study||131
185863|NCT01395914|451339|P1|COMPLETED|Overall Study||273
185864|NCT01395914|451338|P2|Safety Population|Overall Study||167
185865|NCT01395914|451339|P1|Safety Population|Overall Study||343
185866|NCT01395914|451338|P2|ITT Population|Overall Study||168
185867|NCT01395914|451339|P1|ITT Population|Overall Study||345
185868|NCT01395914|451338|P2|STARTED|Overall Study||168
185869|NCT01395914|451339|P1|STARTED|Overall Study||345
185870|NCT01395901|451353|P2|NOT COMPLETED|Overall Study||5
185871|NCT01395901|451354|P1|NOT COMPLETED|Overall Study||10
185872|NCT01395901|451353|P2|COMPLETED|Overall Study|Treated patients completing the study|329
185873|NCT01395901|451354|P1|COMPLETED|Overall Study|Treated patients completing the study|326
185874|NCT01395901|451353|P2|STARTED|Overall Study|Randomized Population|334
185875|NCT01395901|451354|P1|STARTED|Overall Study|Randomized Population|336
185876|NCT01395888|451370|P3|NOT COMPLETED|Treatment Period (TP)||17
185877|NCT01395888|451371|P2|NOT COMPLETED|Treatment Period (TP)||15
185878|NCT01395888|451372|P1|NOT COMPLETED|Treatment Period (TP)||0
185879|NCT01395888|451370|P3|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|113
185880|NCT01395888|451371|P2|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|112
185881|NCT01395888|451372|P1|COMPLETED|Treatment Period (TP)||0
185882|NCT01395888|451370|P3|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|113
185883|NCT01395888|451371|P2|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|112
185884|NCT01395888|451372|P1|Completed the Treatment Period|Treatment Period (TP)||0
185885|NCT01395888|451370|P3|STARTED|Treatment Period (TP)||130
185886|NCT01395888|451371|P2|STARTED|Treatment Period (TP)||127
185887|NCT01395888|451372|P1|STARTED|Treatment Period (TP)||0
185888|NCT01395888|451370|P3|NOT COMPLETED|2-week Run-in Period||0
185889|NCT01395888|451371|P2|NOT COMPLETED|2-week Run-in Period||0
185890|NCT01395888|451372|P1|NOT COMPLETED|2-week Run-in Period||22
185891|NCT01395888|451370|P3|COMPLETED|2-week Run-in Period||0
185892|NCT01395888|451371|P2|COMPLETED|2-week Run-in Period||0
185893|NCT01395888|451372|P1|COMPLETED|2-week Run-in Period||257
185894|NCT01395888|451370|P3|STARTED|2-week Run-in Period||0
185895|NCT01395888|451371|P2|STARTED|2-week Run-in Period||0
185896|NCT01395888|451372|P1|STARTED|2-week Run-in Period||279
185897|NCT01395823|451380|P2|NOT COMPLETED|Overall Study||9
185898|NCT01395823|451381|P1|NOT COMPLETED|Overall Study||15
185899|NCT01395823|451380|P2|COMPLETED|Overall Study||130
185900|NCT01395823|451381|P1|COMPLETED|Overall Study||122
185901|NCT01395823|451380|P2|STARTED|Overall Study||139
185902|NCT01395823|451381|P1|STARTED|Overall Study||137
185903|NCT01395810|451391|P4|NOT COMPLETED|Overall Study||0
185904|NCT01395810|451392|P3|NOT COMPLETED|Overall Study||0
185905|NCT01395810|451393|P2|NOT COMPLETED|Overall Study||4
185906|NCT01395810|451394|P1|NOT COMPLETED|Overall Study||2
185907|NCT01395810|451391|P4|COMPLETED|Overall Study||5
185908|NCT01395810|451392|P3|COMPLETED|Overall Study||0
185909|NCT01395810|451393|P2|COMPLETED|Overall Study||44
185910|NCT01395810|451394|P1|COMPLETED|Overall Study||16
185911|NCT01395810|451391|P4|After Switching the Arms|Overall Study||5
185912|NCT01395810|451392|P3|After Switching the Arms|Overall Study|No subjects started in this arm initially, 2 patients in 40 IU/kg arm switched to this arm.|2
185913|NCT01395810|451393|P2|After Switching the Arms|Overall Study|48 subjects started in this arm, 3 subjects in 10 IU/kg+1 subject in on-demand switched to this arm|52
185914|NCT01395810|451394|P1|After Switching the Arms|Overall Study|18 subjects started in this arm and additional 3 subjects from 40 IU/kg switched to this arm|21
185915|NCT01395810|451391|P4|STARTED|Overall Study||5
185916|NCT01395810|451392|P3|STARTED|Overall Study||0
185917|NCT01395810|451393|P2|STARTED|Overall Study||48
185918|NCT01395810|451394|P1|STARTED|Overall Study||18
185919|NCT01395797|451428|P6|NOT COMPLETED|Overall Study||3
185920|NCT01395797|451429|P5|NOT COMPLETED|Overall Study||2
185921|NCT01395797|451430|P4|NOT COMPLETED|Overall Study||2
185922|NCT01395797|451431|P3|NOT COMPLETED|Overall Study||4
185923|NCT01395797|451432|P2|NOT COMPLETED|Overall Study||1
185924|NCT01395797|451433|P1|NOT COMPLETED|Overall Study||3
185925|NCT01395797|451428|P6|COMPLETED|Overall Study||14
185926|NCT01395797|451429|P5|COMPLETED|Overall Study||7
185927|NCT01395797|451430|P4|COMPLETED|Overall Study||13
185928|NCT01395797|451431|P3|COMPLETED|Overall Study||14
185929|NCT01395797|451432|P2|COMPLETED|Overall Study||3
185930|NCT01395797|451433|P1|COMPLETED|Overall Study||16
185931|NCT01395797|451428|P6|STARTED|Overall Study||17
185932|NCT01395797|451429|P5|STARTED|Overall Study||9
185933|NCT01395797|451430|P4|STARTED|Overall Study||15
185934|NCT01395797|451431|P3|STARTED|Overall Study||18
185935|NCT01395797|451432|P2|STARTED|Overall Study||4
185936|NCT01395797|451433|P1|STARTED|Overall Study||19
185937|NCT01395784|451453|P1|NOT COMPLETED|Overall Study||15
185938|NCT01395784|451453|P1|COMPLETED|Overall Study||17
185939|NCT01395784|451453|P1|STARTED|Overall Study||32
185940|NCT01395758|451460|P3|NOT COMPLETED|Crossover Period||0
185941|NCT01395758|451461|P2|NOT COMPLETED|Crossover Period||0
185942|NCT01395758|451462|P1|NOT COMPLETED|Crossover Period||0
185943|NCT01395758|451460|P3|COMPLETED|Crossover Period||26
185944|NCT01395758|451461|P2|COMPLETED|Crossover Period||0
185945|NCT01395758|451462|P1|COMPLETED|Crossover Period||0
185946|NCT01395758|451460|P3|STARTED|Crossover Period||26
185947|NCT01395758|451461|P2|STARTED|Crossover Period||0
185948|NCT01395758|451462|P1|STARTED|Crossover Period||0
185949|NCT01395758|451460|P3|NOT COMPLETED|Open-label Treatment Period||0
185950|NCT01395758|451461|P2|NOT COMPLETED|Open-label Treatment Period||0
185951|NCT01395758|451462|P1|NOT COMPLETED|Open-label Treatment Period||4
185952|NCT01395758|451460|P3|COMPLETED|Open-label Treatment Period||0
185953|NCT01395758|451461|P2|COMPLETED|Open-label Treatment Period||45
185954|NCT01395758|451462|P1|COMPLETED|Open-label Treatment Period||47
185955|NCT01395758|451460|P3|STARTED|Open-label Treatment Period||0
185956|NCT01395758|451461|P2|STARTED|Open-label Treatment Period||45
185957|NCT01395758|451462|P1|STARTED|Open-label Treatment Period||51
185958|NCT01395537|451473|P1|NOT COMPLETED|Phase II||0
185959|NCT01395537|451473|P1|COMPLETED|Phase II||1
185960|NCT01395537|451473|P1|STARTED|Phase II||1
185961|NCT01395537|451473|P1|NOT COMPLETED|Phase I||0
185962|NCT01395537|451473|P1|COMPLETED|Phase I||13
185963|NCT01395537|451473|P1|STARTED|Phase I||13
185964|NCT01395524|451482|P3|NOT COMPLETED|Overall Study||17
185965|NCT01395524|451483|P2|NOT COMPLETED|Overall Study||16
185966|NCT01395524|451484|P1|NOT COMPLETED|Overall Study||18
185967|NCT01395524|451482|P3|COMPLETED|Overall Study||89
185968|NCT01395524|451483|P2|COMPLETED|Overall Study||83
185969|NCT01395524|451484|P1|COMPLETED|Overall Study||79
185970|NCT01395524|451482|P3|STARTED|Overall Study||106
185971|NCT01395524|451483|P2|STARTED|Overall Study||99
185972|NCT01395524|451484|P1|STARTED|Overall Study||97
185973|NCT01395394|451507|P3|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
185974|NCT01395394|451508|P2|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
185975|NCT01395394|451509|P1|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
185976|NCT01395394|451507|P3|COMPLETED|Study Visit 2 (Non-responders Only)||0
185977|NCT01395394|451508|P2|COMPLETED|Study Visit 2 (Non-responders Only)||0
185978|NCT01395394|451509|P1|COMPLETED|Study Visit 2 (Non-responders Only)||3
185979|NCT01395394|451507|P3|STARTED|Study Visit 2 (Non-responders Only)||0
185980|NCT01395394|451508|P2|STARTED|Study Visit 2 (Non-responders Only)||0
185981|NCT01395394|451509|P1|STARTED|Study Visit 2 (Non-responders Only)||3
185982|NCT01395394|451507|P3|NOT COMPLETED|Baseline Study Visit||0
185983|NCT01395394|451508|P2|NOT COMPLETED|Baseline Study Visit||0
185984|NCT01395394|451509|P1|NOT COMPLETED|Baseline Study Visit||1
185985|NCT01395394|451507|P3|COMPLETED|Baseline Study Visit||5
185986|NCT01395394|451508|P2|COMPLETED|Baseline Study Visit||3
185987|NCT01395394|451509|P1|COMPLETED|Baseline Study Visit||3
185988|NCT01395394|451507|P3|STARTED|Baseline Study Visit||5
185989|NCT01395394|451508|P2|STARTED|Baseline Study Visit||3
185990|NCT01395394|451509|P1|STARTED|Baseline Study Visit||4
185991|NCT01395368|451520|P1|NOT COMPLETED|Overall Study||16
185992|NCT01395368|451520|P1|COMPLETED|Overall Study||92
185993|NCT01395368|451520|P1|STARTED|Overall Study||108
185994|NCT01395329|451527|P3|NOT COMPLETED|Overall Study||0
185995|NCT01395329|451528|P2|NOT COMPLETED|Overall Study||0
185996|NCT01395329|451529|P1|NOT COMPLETED|Overall Study||0
185997|NCT01395329|451527|P3|COMPLETED|Overall Study||14
185998|NCT01395329|451528|P2|COMPLETED|Overall Study||14
185999|NCT01395329|451529|P1|COMPLETED|Overall Study||14
186000|NCT01395329|451527|P3|STARTED|Overall Study||14
186001|NCT01395329|451528|P2|STARTED|Overall Study||14
186002|NCT01395329|451529|P1|STARTED|Overall Study||14
186003|NCT01395316|451576|P1|NOT COMPLETED|Overall Study||3
186004|NCT01395316|451576|P1|COMPLETED|Overall Study||5
186005|NCT01395316|451576|P1|STARTED|Overall Study||8
186006|NCT01395277|451582|P2|NOT COMPLETED|Overall Study||0
186007|NCT01395277|451583|P1|NOT COMPLETED|Overall Study||0
186008|NCT01395277|451582|P2|COMPLETED|Overall Study||15
186009|NCT01395277|451583|P1|COMPLETED|Overall Study||15
186010|NCT01395277|451582|P2|STARTED|Overall Study||15
186011|NCT01395277|451583|P1|STARTED|Overall Study||15
186012|NCT01395043|451591|P1|NOT COMPLETED|Overall Study||0
186013|NCT01395043|451591|P1|COMPLETED|Overall Study||15
186014|NCT01395043|451591|P1|STARTED|Overall Study||15
186015|NCT01395030|451596|P1|NOT COMPLETED|Overall Study||7
186016|NCT01395030|451596|P1|COMPLETED|Overall Study||57
186017|NCT01395030|451596|P1|Adequate Tissue for Analysis|Overall Study||50
186018|NCT01395030|451596|P1|Complete FCH PET/CT|Overall Study||57
186019|NCT01395030|451596|P1|STARTED|Overall Study||64
186020|NCT01395017|451606|P2|NOT COMPLETED|Overall Study||102
186021|NCT01395017|451607|P1|NOT COMPLETED|Overall Study||100
186022|NCT01395017|451606|P2|COMPLETED|Overall Study||0
186023|NCT01395017|451607|P1|COMPLETED|Overall Study||0
186024|NCT01395017|451606|P2|Treated|Overall Study||101
186025|NCT01395017|451607|P1|Treated|Overall Study||98
186026|NCT01395017|451606|P2|STARTED|Overall Study||102
186027|NCT01395017|451607|P1|STARTED|Overall Study||100
186028|NCT01394991|451617|P2|NOT COMPLETED|Overall Study||72
186029|NCT01394991|451618|P1|NOT COMPLETED|Overall Study||59
186030|NCT01394991|451617|P2|COMPLETED|Overall Study||190
186031|NCT01394991|451618|P1|COMPLETED|Overall Study||183
186032|NCT01394991|451617|P2|STARTED|Overall Study||262
186033|NCT01394991|451618|P1|STARTED|Overall Study||242
186034|NCT01394978|451640|P2|NOT COMPLETED|Overall Study||31
186035|NCT01394978|451641|P1|NOT COMPLETED|Overall Study||21
186036|NCT01394978|451640|P2|COMPLETED|Overall Study||245
186037|NCT01394978|451641|P1|COMPLETED|Overall Study||147
186038|NCT01394978|451640|P2|STARTED|Overall Study||276
186039|NCT01394978|451641|P1|STARTED|Overall Study||168
186040|NCT01394952|451649|P2|NOT COMPLETED|Overall Study||17
186041|NCT01394952|451650|P1|NOT COMPLETED|Overall Study||17
186042|NCT01394952|451649|P2|COMPLETED|Overall Study||4932
186043|NCT01394952|451650|P1|COMPLETED|Overall Study||4935
186044|NCT01394952|451649|P2|Received at Least One Dose of Study Drug|Overall Study||4943
186045|NCT01394952|451650|P1|Received at Least One Dose of Study Drug|Overall Study||4949
186046|NCT01394952|451649|P2|STARTED|Overall Study||4949
186047|NCT01394952|451650|P1|STARTED|Overall Study||4952
186048|NCT01394926|451666|P1|NOT COMPLETED|Overall Study||0
186049|NCT01394926|451666|P1|COMPLETED|Overall Study||21
186050|NCT01394926|451666|P1|STARTED|Overall Study||21
186051|NCT01394718|451677|P2|NOT COMPLETED|Overall Study||1
186052|NCT01394718|451678|P1|NOT COMPLETED|Overall Study||2
186053|NCT01394718|451677|P2|COMPLETED|Overall Study||29
186054|NCT01394718|451678|P1|COMPLETED|Overall Study||28
186055|NCT01394718|451677|P2|STARTED|Overall Study||30
186056|NCT01394718|451678|P1|STARTED|Overall Study||30
186057|NCT01394705|451692|P2|NOT COMPLETED|Overall Study||2
186058|NCT01394705|451693|P1|NOT COMPLETED|Overall Study||2
186059|NCT01394705|451692|P2|COMPLETED|Overall Study||19
186060|NCT01394705|451693|P1|COMPLETED|Overall Study||19
186061|NCT01394705|451692|P2|STARTED|Overall Study||21
186062|NCT01394705|451693|P1|STARTED|Overall Study||21
186063|NCT01394692|451703|P2|NOT COMPLETED|Overall Study||0
186064|NCT01394692|451704|P1|NOT COMPLETED|Overall Study||0
186065|NCT01394692|451703|P2|COMPLETED|Overall Study||29
186066|NCT01394692|451704|P1|COMPLETED|Overall Study||29
186067|NCT01394692|451703|P2|STARTED|Overall Study||29
186068|NCT01394692|451704|P1|STARTED|Overall Study||29
186069|NCT01394627|451710|P2|NOT COMPLETED|Second Intervention (1 Day)||0
186070|NCT01394627|451711|P1|NOT COMPLETED|Second Intervention (1 Day)||0
186071|NCT01394627|451710|P2|COMPLETED|Second Intervention (1 Day)||12
186072|NCT01394627|451711|P1|COMPLETED|Second Intervention (1 Day)||7
186073|NCT01394627|451710|P2|STARTED|Second Intervention (1 Day)||12
186074|NCT01394627|451711|P1|STARTED|Second Intervention (1 Day)||7
186075|NCT01394627|451710|P2|NOT COMPLETED|Washout (1-3 Months)||0
186076|NCT01394627|451711|P1|NOT COMPLETED|Washout (1-3 Months)||1
186077|NCT01394627|451710|P2|COMPLETED|Washout (1-3 Months)||12
186078|NCT01394627|451711|P1|COMPLETED|Washout (1-3 Months)||7
186079|NCT01394627|451710|P2|STARTED|Washout (1-3 Months)||12
186080|NCT01394627|451711|P1|STARTED|Washout (1-3 Months)||8
186081|NCT01394627|451710|P2|NOT COMPLETED|First Intervention (1 Day)||1
186082|NCT01394627|451711|P1|NOT COMPLETED|First Intervention (1 Day)||0
186083|NCT01394627|451710|P2|COMPLETED|First Intervention (1 Day)||12
186084|NCT01394627|451711|P1|COMPLETED|First Intervention (1 Day)||8
186085|NCT01394627|451710|P2|STARTED|First Intervention (1 Day)||13
186086|NCT01394627|451711|P1|STARTED|First Intervention (1 Day)||8
186087|NCT01394614|451721|P2|NOT COMPLETED|Overall Study||0
186088|NCT01394614|451722|P1|NOT COMPLETED|Overall Study||0
186089|NCT01394614|451721|P2|COMPLETED|Overall Study||16
186090|NCT01394614|451722|P1|COMPLETED|Overall Study||8
186091|NCT01394614|451721|P2|STARTED|Overall Study||16
186092|NCT01394614|451722|P1|STARTED|Overall Study||8
186093|NCT01394523|451731|P3|NOT COMPLETED|Overall Study||0
186094|NCT01394523|451732|P2|NOT COMPLETED|Overall Study||0
186095|NCT01394523|451733|P1|NOT COMPLETED|Overall Study||1
186096|NCT01394523|451731|P3|COMPLETED|Overall Study||13
186097|NCT01394523|451732|P2|COMPLETED|Overall Study||13
186098|NCT01394523|451733|P1|COMPLETED|Overall Study||12
186099|NCT01394523|451731|P3|STARTED|Overall Study||13
186100|NCT01394523|451732|P2|STARTED|Overall Study||13
186101|NCT01394523|451733|P1|STARTED|Overall Study||13
186102|NCT01394510|451741|P1|NOT COMPLETED|Overall Study||0
186103|NCT01394510|451741|P1|COMPLETED|Overall Study||13
186104|NCT01394510|451741|P1|STARTED|Overall Study||13
186105|NCT01394276|451747|P1|NOT COMPLETED|Overall Study||62
186106|NCT01394276|451747|P1|COMPLETED|Overall Study||260
186107|NCT01394276|451747|P1|STARTED|Overall Study||322
186108|NCT01394250|451771|P2|NOT COMPLETED|Successful IV Placement & Follow-Up||11
186109|NCT01394250|451772|P1|NOT COMPLETED|Successful IV Placement & Follow-Up||6
186110|NCT01394250|451771|P2|COMPLETED|Successful IV Placement & Follow-Up||110
186111|NCT01394250|451772|P1|COMPLETED|Successful IV Placement & Follow-Up||114
186112|NCT01394250|451771|P2|STARTED|Successful IV Placement & Follow-Up||121
186113|NCT01394250|451772|P1|STARTED|Successful IV Placement & Follow-Up||120
186114|NCT01394250|451771|P2|NOT COMPLETED|Randomization and IV Placement Attempt||13
186115|NCT01394250|451772|P1|NOT COMPLETED|Randomization and IV Placement Attempt||14
186116|NCT01394250|451771|P2|COMPLETED|Randomization and IV Placement Attempt||121
186117|NCT01394250|451772|P1|COMPLETED|Randomization and IV Placement Attempt||120
186118|NCT01394250|451771|P2|STARTED|Randomization and IV Placement Attempt||134
186119|NCT01394250|451772|P1|STARTED|Randomization and IV Placement Attempt||134
186120|NCT01394211|451780|P1|NOT COMPLETED|Overall Study||2
186121|NCT01394211|451780|P1|COMPLETED|Overall Study||0
186122|NCT01394211|451780|P1|STARTED|Overall Study||2
186123|NCT01394185|451786|P6|NOT COMPLETED|Overall Study||1
186124|NCT01394185|451787|P5|NOT COMPLETED|Overall Study||4
186125|NCT01394185|451788|P4|NOT COMPLETED|Overall Study||1
186126|NCT01394185|451789|P3|NOT COMPLETED|Overall Study||0
186127|NCT01394185|451790|P2|NOT COMPLETED|Overall Study||0
186128|NCT01394185|451791|P1|NOT COMPLETED|Overall Study||6
186129|NCT01394185|451786|P6|COMPLETED|Overall Study||2
186130|NCT01394185|451787|P5|COMPLETED|Overall Study||2
186131|NCT01394185|451788|P4|COMPLETED|Overall Study||3
186132|NCT01394185|451789|P3|COMPLETED|Overall Study||2
186133|NCT01394185|451790|P2|COMPLETED|Overall Study||2
186134|NCT01394185|451791|P1|COMPLETED|Overall Study||2
186135|NCT01394185|451786|P6|STARTED|Overall Study||3
186136|NCT01394185|451787|P5|STARTED|Overall Study||6
186137|NCT01394185|451788|P4|STARTED|Overall Study||4
186138|NCT01394185|451789|P3|STARTED|Overall Study||2
186139|NCT01394185|451790|P2|STARTED|Overall Study||2
186140|NCT01394185|451791|P1|STARTED|Overall Study||8
186141|NCT01394159|451804|P2|NOT COMPLETED|Overall Study||0
186142|NCT01394159|451805|P1|NOT COMPLETED|Overall Study||0
186143|NCT01394159|451804|P2|COMPLETED|Overall Study||28
186144|NCT01394159|451805|P1|COMPLETED|Overall Study||28
186145|NCT01394159|451804|P2|STARTED|Overall Study||28
186146|NCT01394159|451805|P1|STARTED|Overall Study||28
186147|NCT01394081|451817|P2|NOT COMPLETED|Overall Study||0
186148|NCT01394081|451818|P1|NOT COMPLETED|Overall Study||0
186149|NCT01394081|451817|P2|COMPLETED|Overall Study||102
186150|NCT01394081|451818|P1|COMPLETED|Overall Study||101
186151|NCT01394081|451817|P2|STARTED|Overall Study||102
186152|NCT01394081|451818|P1|STARTED|Overall Study||101
186153|NCT01394003|451834|P8|NOT COMPLETED|Overall Study||0
186154|NCT01394003|451835|P7|NOT COMPLETED|Overall Study||0
186155|NCT01394003|451836|P6|NOT COMPLETED|Overall Study||0
186156|NCT01394003|451837|P5|NOT COMPLETED|Overall Study||0
186157|NCT01394003|451838|P4|NOT COMPLETED|Overall Study||0
186158|NCT01394003|451839|P3|NOT COMPLETED|Overall Study||0
186159|NCT01394003|451840|P2|NOT COMPLETED|Overall Study||0
186160|NCT01394003|451841|P1|NOT COMPLETED|Overall Study||0
186161|NCT01394003|451834|P8|COMPLETED|Overall Study||2
186162|NCT01394003|451835|P7|COMPLETED|Overall Study||6
186163|NCT01394003|451836|P6|COMPLETED|Overall Study||3
186164|NCT01394003|451837|P5|COMPLETED|Overall Study||3
186165|NCT01394003|451838|P4|COMPLETED|Overall Study||6
186166|NCT01394003|451839|P3|COMPLETED|Overall Study||3
186167|NCT01394003|451840|P2|COMPLETED|Overall Study||8
186168|NCT01394003|451841|P1|COMPLETED|Overall Study||3
186169|NCT01394003|451834|P8|Received at Least 1 Dose of Study Drug|Overall Study||2
186170|NCT01394003|451835|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
186171|NCT01394003|451836|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
186172|NCT01394003|451837|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
186173|NCT01394003|451838|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
186174|NCT01394003|451839|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
186175|NCT01394003|451840|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
186176|NCT01394003|451841|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
186177|NCT01394003|451834|P8|STARTED|Overall Study||2
186178|NCT01394003|451835|P7|STARTED|Overall Study||6
186179|NCT01394003|451836|P6|STARTED|Overall Study||3
186180|NCT01394003|451837|P5|STARTED|Overall Study||3
186181|NCT01394003|451838|P4|STARTED|Overall Study||6
186182|NCT01394003|451839|P3|STARTED|Overall Study||3
186183|NCT01394003|451840|P2|STARTED|Overall Study||8
186184|NCT01394003|451841|P1|STARTED|Overall Study||3
186185|NCT01393964|451880|P3|NOT COMPLETED|Overall Study||9
186186|NCT01393964|451881|P2|NOT COMPLETED|Overall Study||9
186187|NCT01393964|451882|P1|NOT COMPLETED|Overall Study||8
186188|NCT01393964|451880|P3|COMPLETED|Overall Study|Completed=treatment on-going|0
186189|NCT01393964|451881|P2|COMPLETED|Overall Study|Completed=treatment on-going|0
186190|NCT01393964|451882|P1|COMPLETED|Overall Study|Completed=treatment on-going|0
186191|NCT01393964|451880|P3|STARTED|Overall Study||9
186192|NCT01393964|451881|P2|STARTED|Overall Study||9
186193|NCT01393964|451882|P1|STARTED|Overall Study||8
186194|NCT01393899|451923|P3|NOT COMPLETED|Overall Study||23
186195|NCT01393899|451924|P2|NOT COMPLETED|Overall Study||28
186196|NCT01393899|451925|P1|NOT COMPLETED|Overall Study||32
186197|NCT01393899|451923|P3|COMPLETED|Overall Study||38
186198|NCT01393899|451924|P2|COMPLETED|Overall Study||32
186199|NCT01393899|451925|P1|COMPLETED|Overall Study||27
186200|NCT01393899|451923|P3|STARTED|Overall Study||61
186201|NCT01393899|451924|P2|STARTED|Overall Study||60
186202|NCT01393899|451925|P1|STARTED|Overall Study||59
186203|NCT01393821|451979|P2|NOT COMPLETED|Overall Study||3
186204|NCT01393821|451980|P1|NOT COMPLETED|Overall Study||5
186205|NCT01393821|451979|P2|COMPLETED|Overall Study||10
186206|NCT01393821|451980|P1|COMPLETED|Overall Study||9
186207|NCT01393821|451979|P2|STARTED|Overall Study||13
186208|NCT01393821|451980|P1|STARTED|Overall Study||14
186209|NCT01393743|451994|P3|NOT COMPLETED|Extension Phase||60
186210|NCT01393743|451995|P2|NOT COMPLETED|Extension Phase||0
186211|NCT01393743|451996|P1|NOT COMPLETED|Extension Phase||0
186212|NCT01393743|451994|P3|COMPLETED|Extension Phase||78
186213|NCT01393743|451995|P2|COMPLETED|Extension Phase||0
186214|NCT01393743|451996|P1|COMPLETED|Extension Phase||0
186215|NCT01393743|451994|P3|STARTED|Extension Phase|Continuation into the Extension Phase was optional.|138
186216|NCT01393743|451995|P2|STARTED|Extension Phase||0
186217|NCT01393743|451996|P1|STARTED|Extension Phase||0
186218|NCT01393743|451994|P3|NOT COMPLETED|Core Study||0
186219|NCT01393743|451995|P2|NOT COMPLETED|Core Study||13
186220|NCT01393743|451996|P1|NOT COMPLETED|Core Study||10
186221|NCT01393743|451994|P3|COMPLETED|Core Study||0
186222|NCT01393743|451995|P2|COMPLETED|Core Study||68
186223|NCT01393743|451996|P1|COMPLETED|Core Study||72
186224|NCT01393743|451994|P3|STARTED|Core Study||0
186225|NCT01393743|451995|P2|STARTED|Core Study|Treated|81
186226|NCT01393743|451996|P1|STARTED|Core Study|Treated|82
186227|NCT01393730|452019|P1|NOT COMPLETED|Overall Study||6
186228|NCT01393730|452019|P1|COMPLETED|Overall Study||34
186229|NCT01393730|452019|P1|Evaluable AR Mutation|Overall Study||14
186230|NCT01393730|452019|P1|Evaluable AR Amplification|Overall Study||21
186231|NCT01393730|452019|P1|Treated|Overall Study||38
186232|NCT01393730|452019|P1|STARTED|Overall Study||40
186233|NCT01393717|452031|P2|NOT COMPLETED|Overall Study||0
186234|NCT01393717|452032|P1|NOT COMPLETED|Overall Study||0
186235|NCT01393717|452031|P2|COMPLETED|Overall Study||20
186236|NCT01393717|452032|P1|COMPLETED|Overall Study||37
186237|NCT01393717|452031|P2|STARTED|Overall Study||20
186238|NCT01393717|452032|P1|STARTED|Overall Study||37
186239|NCT01393704|452046|P2|NOT COMPLETED|Overall Study||0
186240|NCT01393704|452047|P1|NOT COMPLETED|Overall Study||0
186241|NCT01393704|452046|P2|COMPLETED|Overall Study||76
186242|NCT01393704|452047|P1|COMPLETED|Overall Study||76
186243|NCT01393704|452046|P2|STARTED|Overall Study||76
186244|NCT01393704|452047|P1|STARTED|Overall Study||76
186245|NCT01393626|452065|P4|NOT COMPLETED|Overall Study||1
186246|NCT01393626|452066|P3|NOT COMPLETED|Overall Study||12
186247|NCT01393626|452067|P2|NOT COMPLETED|Overall Study||12
186248|NCT01393626|452068|P1|NOT COMPLETED|Overall Study||18
186249|NCT01393626|452065|P4|COMPLETED|Overall Study||15
186250|NCT01393626|452066|P3|COMPLETED|Overall Study||74
186251|NCT01393626|452067|P2|COMPLETED|Overall Study||74
186252|NCT01393626|452068|P1|COMPLETED|Overall Study||73
186253|NCT01393626|452065|P4|STARTED|Overall Study||16
186254|NCT01393626|452066|P3|STARTED|Overall Study||86
186255|NCT01393626|452067|P2|STARTED|Overall Study||86
186256|NCT01393626|452068|P1|STARTED|Overall Study||91
186257|NCT01393613|452148|P4|NOT COMPLETED|Overall Study||66
186258|NCT01393613|452149|P3|NOT COMPLETED|Overall Study||54
186259|NCT01393613|452150|P2|NOT COMPLETED|Overall Study||57
186260|NCT01393613|452151|P1|NOT COMPLETED|Overall Study||39
186261|NCT01393613|452148|P4|COMPLETED|Overall Study||118
186262|NCT01393613|452149|P3|COMPLETED|Overall Study||130
186263|NCT01393613|452150|P2|COMPLETED|Overall Study||129
186264|NCT01393613|452151|P1|COMPLETED|Overall Study||81
186265|NCT01393613|452148|P4|STARTED|Overall Study||184
186266|NCT01393613|452149|P3|STARTED|Overall Study||184
186267|NCT01393613|452150|P2|STARTED|Overall Study||186
186268|NCT01393613|452151|P1|STARTED|Overall Study||120
186269|NCT01393600|452213|P4|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
186270|NCT01393600|452214|P3|NOT COMPLETED|Follow-up Period (Day 29 to 35)||1
186271|NCT01393600|452215|P2|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
186272|NCT01393600|452216|P1|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
186273|NCT01393600|452213|P4|COMPLETED|Follow-up Period (Day 29 to 35)||8
186274|NCT01393600|452214|P3|COMPLETED|Follow-up Period (Day 29 to 35)||6
186275|NCT01393600|452215|P2|COMPLETED|Follow-up Period (Day 29 to 35)||7
186276|NCT01393600|452216|P1|COMPLETED|Follow-up Period (Day 29 to 35)||9
186277|NCT01393600|452213|P4|STARTED|Follow-up Period (Day 29 to 35)||8
186278|NCT01393600|452214|P3|STARTED|Follow-up Period (Day 29 to 35)||7
186279|NCT01393600|452215|P2|STARTED|Follow-up Period (Day 29 to 35)||7
186280|NCT01393600|452216|P1|STARTED|Follow-up Period (Day 29 to 35)||9
186281|NCT01393600|452213|P4|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||1
186282|NCT01393600|452214|P3|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||2
186283|NCT01393600|452215|P2|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
186284|NCT01393600|452216|P1|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
186285|NCT01393600|452213|P4|COMPLETED|Treatment Period 2 (Day 15 to 28)||8
186286|NCT01393600|452214|P3|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
186287|NCT01393600|452215|P2|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
186288|NCT01393600|452216|P1|COMPLETED|Treatment Period 2 (Day 15 to 28)||9
186289|NCT01393600|452213|P4|STARTED|Treatment Period 2 (Day 15 to 28)||9
186290|NCT01393600|452214|P3|STARTED|Treatment Period 2 (Day 15 to 28)||9
186291|NCT01393600|452215|P2|STARTED|Treatment Period 2 (Day 15 to 28)||7
186292|NCT01393600|452216|P1|STARTED|Treatment Period 2 (Day 15 to 28)||9
186293|NCT01393600|452213|P4|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
186294|NCT01393600|452214|P3|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
186295|NCT01393600|452215|P2|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
186296|NCT01393600|452216|P1|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||0
186297|NCT01393600|452213|P4|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
186298|NCT01393600|452214|P3|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
186299|NCT01393600|452215|P2|COMPLETED|Treatment Period 1 (Day 1 to 14)||7
186300|NCT01393600|452216|P1|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
186301|NCT01393600|452213|P4|STARTED|Treatment Period 1 (Day 1 to 14)||10
186302|NCT01393600|452214|P3|STARTED|Treatment Period 1 (Day 1 to 14)||10
186303|NCT01393600|452215|P2|STARTED|Treatment Period 1 (Day 1 to 14)||8
186304|NCT01393600|452216|P1|STARTED|Treatment Period 1 (Day 1 to 14)||9
186305|NCT01393457|452235|P4|NOT COMPLETED|Overall Study||12
186306|NCT01393457|452236|P3|NOT COMPLETED|Overall Study||15
186307|NCT01393457|452237|P2|NOT COMPLETED|Overall Study||12
186308|NCT01393457|452238|P1|NOT COMPLETED|Overall Study||12
186309|NCT01393457|452235|P4|COMPLETED|Overall Study||15
186310|NCT01393457|452236|P3|COMPLETED|Overall Study||16
186311|NCT01393457|452237|P2|COMPLETED|Overall Study||14
186312|NCT01393457|452238|P1|COMPLETED|Overall Study||14
186313|NCT01393457|452235|P4|STARTED|Overall Study||27
186314|NCT01393457|452236|P3|STARTED|Overall Study||31
186315|NCT01393457|452237|P2|STARTED|Overall Study||26
186316|NCT01393457|452238|P1|STARTED|Overall Study||26
186317|NCT01393444|452252|P1|NOT COMPLETED|Overall Study||3
186318|NCT01393444|452252|P1|COMPLETED|Overall Study|2015: Third implanted subject completed the study. This fulfilled the requirements of our grant.|3
186319|NCT01393444|452252|P1|Sixth (3rd Implanted) Subject|Overall Study|2014: Individual with brachial plexus injury enrolled and was eligible. Implanted in 2015.|1
186320|NCT01393444|452252|P1|Fifth (2nd Implanted) Subject Enrolled|Overall Study|2013: Individual with ALS enrolled and was eligible. Implanted in 2014.|1
186321|NCT01393444|452252|P1|Fourth Subject Enrolled|Overall Study|2013: Fourth participant enrolled. Ineligible.|1
186322|NCT01393444|452252|P1|Third Subject Enrolled|Overall Study|2013: Third participant enrolled. Withdrew due to family commitments.|1
186323|NCT01393444|452252|P1|Second Subject Enrolled|Overall Study|2012: Second participant enrolled. Ineligible.|1
186324|NCT01393444|452252|P1|First (1st Implanted) Subject Enrolled|Overall Study|2011: Individual with cervical spinal cord injury enrolled and was eligible. Implanted in 2011.|1
186325|NCT01393444|452252|P1|STARTED|Overall Study||6
186326|NCT01393405|452257|P3|NOT COMPLETED|Maintenance Period Week||24
186327|NCT01393405|452258|P2|NOT COMPLETED|Maintenance Period Week||29
186328|NCT01393405|452259|P1|NOT COMPLETED|Maintenance Period Week||0
186329|NCT01393405|452257|P3|COMPLETED|Maintenance Period Week||16
186330|NCT01393405|452258|P2|COMPLETED|Maintenance Period Week||15
186331|NCT01393405|452259|P1|COMPLETED|Maintenance Period Week||0
186332|NCT01393405|452257|P3|STARTED|Maintenance Period Week||40
186333|NCT01393405|452258|P2|STARTED|Maintenance Period Week||44
186334|NCT01393405|452259|P1|STARTED|Maintenance Period Week||0
186335|NCT01393405|452257|P3|NOT COMPLETED|Induction Period (week1-16)||0
186336|NCT01393405|452258|P2|NOT COMPLETED|Induction Period (week1-16)||0
186337|NCT01393405|452259|P1|NOT COMPLETED|Induction Period (week1-16)||95
186338|NCT01393405|452257|P3|COMPLETED|Induction Period (week1-16)||0
186339|NCT01393405|452258|P2|COMPLETED|Induction Period (week1-16)||0
186340|NCT01393405|452259|P1|COMPLETED|Induction Period (week1-16)||84
186341|NCT01393405|452257|P3|STARTED|Induction Period (week1-16)||0
186342|NCT01393405|452258|P2|STARTED|Induction Period (week1-16)||0
186343|NCT01393405|452259|P1|STARTED|Induction Period (week1-16)||179
186344|NCT01393392|452278|P2|NOT COMPLETED|Overall Study||19
186345|NCT01393392|452279|P1|NOT COMPLETED|Overall Study||11
186346|NCT01393392|452278|P2|COMPLETED|Overall Study||24
186347|NCT01393392|452279|P1|COMPLETED|Overall Study||33
186348|NCT01393392|452278|P2|STARTED|Overall Study||43
186349|NCT01393392|452279|P1|STARTED|Overall Study||44
186350|NCT01393301|452297|P2|NOT COMPLETED|Overall Study||3
186351|NCT01393301|452298|P1|NOT COMPLETED|Overall Study||9
186352|NCT01393301|452297|P2|COMPLETED|Overall Study||24
186353|NCT01393301|452298|P1|COMPLETED|Overall Study||17
186354|NCT01393301|452297|P2|STARTED|Overall Study||27
186355|NCT01393301|452298|P1|STARTED|Overall Study||26
186356|NCT01393132|452311|P2|NOT COMPLETED|Overall Study||0
186357|NCT01393132|452312|P1|NOT COMPLETED|Overall Study||0
186358|NCT01393132|452311|P2|COMPLETED|Overall Study||3
186359|NCT01393132|452312|P1|COMPLETED|Overall Study||6
186360|NCT01393132|452311|P2|STARTED|Overall Study||3
186361|NCT01393132|452312|P1|STARTED|Overall Study||6
186362|NCT01393106|452324|P1|NOT COMPLETED|Overall Study||5
186363|NCT01393106|452324|P1|COMPLETED|Overall Study|Completed: Disease Progression/Death|20
186364|NCT01393106|452324|P1|STARTED|Overall Study||25
186365|NCT01392989|452341|P1|NOT COMPLETED|CIK Cell Infusion||0
186366|NCT01392989|452341|P1|COMPLETED|CIK Cell Infusion||31
186367|NCT01392989|452341|P1|STARTED|CIK Cell Infusion||31
186368|NCT01392989|452341|P1|NOT COMPLETED|Total Lymphoid Irradiation (TLI)||0
186369|NCT01392989|452341|P1|COMPLETED|Total Lymphoid Irradiation (TLI)||44
186370|NCT01392989|452341|P1|STARTED|Total Lymphoid Irradiation (TLI)||44
186371|NCT01392963|452351|P2|NOT COMPLETED|Week 24 Follow-up||0
186372|NCT01392963|452352|P1|NOT COMPLETED|Week 24 Follow-up||2
186373|NCT01392963|452351|P2|COMPLETED|Week 24 Follow-up||17
186374|NCT01392963|452352|P1|COMPLETED|Week 24 Follow-up||9
186375|NCT01392963|452351|P2|STARTED|Week 24 Follow-up||17
186376|NCT01392963|452352|P1|STARTED|Week 24 Follow-up||11
186377|NCT01392963|452351|P2|NOT COMPLETED|Week 12 (Second Intervention)||0
186378|NCT01392963|452352|P1|NOT COMPLETED|Week 12 (Second Intervention)||0
186379|NCT01392963|452351|P2|COMPLETED|Week 12 (Second Intervention)||17
186380|NCT01392963|452352|P1|COMPLETED|Week 12 (Second Intervention)||11
186381|NCT01392963|452351|P2|STARTED|Week 12 (Second Intervention)||17
186382|NCT01392963|452352|P1|STARTED|Week 12 (Second Intervention)||11
186383|NCT01392963|452351|P2|NOT COMPLETED|Week 0 (First Intervention)||2
186384|NCT01392963|452352|P1|NOT COMPLETED|Week 0 (First Intervention)||0
186385|NCT01392963|452351|P2|COMPLETED|Week 0 (First Intervention)||17
186386|NCT01392963|452352|P1|COMPLETED|Week 0 (First Intervention)||11
186387|NCT01392963|452351|P2|STARTED|Week 0 (First Intervention)||19
186388|NCT01392963|452352|P1|STARTED|Week 0 (First Intervention)||11
186389|NCT01392742|452360|P1|NOT COMPLETED|Overall Study||201
186390|NCT01392742|452360|P1|COMPLETED|Overall Study||242
186391|NCT01392742|452360|P1|STARTED|Overall Study||443
186392|NCT01392703|452375|P3|NOT COMPLETED|Day 9||0
186393|NCT01392703|452376|P2|NOT COMPLETED|Day 9||0
186394|NCT01392703|452377|P1|NOT COMPLETED|Day 9||0
186395|NCT01392703|452375|P3|COMPLETED|Day 9||25
186396|NCT01392703|452376|P2|COMPLETED|Day 9||26
186397|NCT01392703|452377|P1|COMPLETED|Day 9||26
186398|NCT01392703|452375|P3|STARTED|Day 9||25
186399|NCT01392703|452376|P2|STARTED|Day 9||26
186400|NCT01392703|452377|P1|STARTED|Day 9||26
186401|NCT01392703|452375|P3|NOT COMPLETED|Day 5||0
186402|NCT01392703|452376|P2|NOT COMPLETED|Day 5||0
186403|NCT01392703|452377|P1|NOT COMPLETED|Day 5||0
186404|NCT01392703|452375|P3|COMPLETED|Day 5||26
186405|NCT01392703|452376|P2|COMPLETED|Day 5||25
186406|NCT01392703|452377|P1|COMPLETED|Day 5||26
186407|NCT01392703|452375|P3|STARTED|Day 5||26
186408|NCT01392703|452376|P2|STARTED|Day 5|1 participant no longer met dosing criteria and dropped out during washout period prior to Day 5.|25
186409|NCT01392703|452377|P1|STARTED|Day 5||26
186410|NCT01392703|452375|P3|NOT COMPLETED|Day 1||0
186411|NCT01392703|452376|P2|NOT COMPLETED|Day 1||0
186412|NCT01392703|452377|P1|NOT COMPLETED|Day 1||0
186413|NCT01392703|452375|P3|COMPLETED|Day 1||26
186414|NCT01392703|452376|P2|COMPLETED|Day 1||26
186415|NCT01392703|452377|P1|COMPLETED|Day 1||26
186416|NCT01392703|452375|P3|STARTED|Day 1||26
186417|NCT01392703|452376|P2|STARTED|Day 1||26
186418|NCT01392703|452377|P1|STARTED|Day 1||26
186419|NCT01392677|452406|P2|NOT COMPLETED|Overall Study||8
186420|NCT01392677|452407|P1|NOT COMPLETED|Overall Study||8
186421|NCT01392677|452406|P2|COMPLETED|Overall Study||101
186422|NCT01392677|452407|P1|COMPLETED|Overall Study||101
186423|NCT01392677|452406|P2|STARTED|Overall Study||109
186424|NCT01392677|452407|P1|STARTED|Overall Study||109
186425|NCT01392625|452423|P2|NOT COMPLETED|Overall Study||1
186426|NCT01392625|452424|P1|NOT COMPLETED|Overall Study||2
186427|NCT01392625|452423|P2|COMPLETED|Overall Study||18
186428|NCT01392625|452424|P1|COMPLETED|Overall Study||16
186429|NCT01392625|452423|P2|STARTED|Overall Study||19
186430|NCT01392625|452424|P1|STARTED|Overall Study||18
186431|NCT01392573|452442|P2|NOT COMPLETED|Overall Study||35
186432|NCT01392573|452443|P1|NOT COMPLETED|Overall Study||32
186433|NCT01392573|452442|P2|COMPLETED|Overall Study||171
186434|NCT01392573|452443|P1|COMPLETED|Overall Study||175
186435|NCT01392573|452442|P2|Exposed|Overall Study||206
186436|NCT01392573|452443|P1|Exposed|Overall Study||207
186437|NCT01392573|452442|P2|STARTED|Overall Study||206
186438|NCT01392573|452443|P1|STARTED|Overall Study||207
186439|NCT01392560|452451|P1|NOT COMPLETED|Overall Study||12
186440|NCT01392560|452451|P1|COMPLETED|Overall Study||40
186441|NCT01392560|452451|P1|STARTED|Overall Study||52
186442|NCT01392547|452457|P1|NOT COMPLETED|Overall Study||8
186443|NCT01392547|452457|P1|COMPLETED|Overall Study||64
186444|NCT01392547|452457|P1|STARTED|Overall Study|567 bleeds by 69 subjects, 340 were treated with vatreptacog alfa and 227 with rFVIIa|72
186445|NCT01392495|452471|P1|NOT COMPLETED|Overall Study||16
186446|NCT01392495|452471|P1|COMPLETED|Overall Study||1
186447|NCT01392495|452471|P1|Received 400 mg|Overall Study||13
186448|NCT01392495|452471|P1|Received 200 mg|Overall Study||4
186449|NCT01392495|452471|P1|STARTED|Overall Study||17
186450|NCT01392443|452483|P1|NOT COMPLETED|Overall Study||68
186451|NCT01392443|452483|P1|COMPLETED|Overall Study||52
186452|NCT01392443|452483|P1|STARTED|Overall Study||120
186453|NCT01392378|452496|P5|NOT COMPLETED|Toddler Dose||1
186454|NCT01392378|452497|P4|NOT COMPLETED|Toddler Dose||2
186455|NCT01392378|452498|P3|NOT COMPLETED|Toddler Dose||0
186456|NCT01392378|452499|P2|NOT COMPLETED|Toddler Dose||1
186457|NCT01392378|452500|P1|NOT COMPLETED|Toddler Dose||0
186458|NCT01392378|452496|P5|COMPLETED|Toddler Dose||208
186459|NCT01392378|452497|P4|COMPLETED|Toddler Dose||173
186460|NCT01392378|452498|P3|COMPLETED|Toddler Dose||170
186461|NCT01392378|452499|P2|COMPLETED|Toddler Dose||172
186462|NCT01392378|452500|P1|COMPLETED|Toddler Dose||169
186463|NCT01392378|452496|P5|STARTED|Toddler Dose||209
186464|NCT01392378|452497|P4|STARTED|Toddler Dose||175
186465|NCT01392378|452498|P3|STARTED|Toddler Dose||170
186466|NCT01392378|452499|P2|STARTED|Toddler Dose||173
186467|NCT01392378|452500|P1|STARTED|Toddler Dose||169
186468|NCT01392378|452496|P5|NOT COMPLETED|After Infant Series||1
186469|NCT01392378|452497|P4|NOT COMPLETED|After Infant Series||0
186470|NCT01392378|452498|P3|NOT COMPLETED|After Infant Series||2
186471|NCT01392378|452499|P2|NOT COMPLETED|After Infant Series||1
186472|NCT01392378|452500|P1|NOT COMPLETED|After Infant Series||0
186473|NCT01392378|452496|P5|COMPLETED|After Infant Series||209
186474|NCT01392378|452497|P4|COMPLETED|After Infant Series||175
186475|NCT01392378|452498|P3|COMPLETED|After Infant Series||170
186476|NCT01392378|452499|P2|COMPLETED|After Infant Series||173
186477|NCT01392378|452500|P1|COMPLETED|After Infant Series||169
186478|NCT01392378|452496|P5|STARTED|After Infant Series||210
186479|NCT01392378|452497|P4|STARTED|After Infant Series||175
186480|NCT01392378|452498|P3|STARTED|After Infant Series||172
186481|NCT01392378|452499|P2|STARTED|After Infant Series||174
186482|NCT01392378|452500|P1|STARTED|After Infant Series||169
186483|NCT01392378|452496|P5|NOT COMPLETED|Infant Series||0
186484|NCT01392378|452497|P4|NOT COMPLETED|Infant Series||2
186485|NCT01392378|452498|P3|NOT COMPLETED|Infant Series||0
186486|NCT01392378|452499|P2|NOT COMPLETED|Infant Series||2
186487|NCT01392378|452500|P1|NOT COMPLETED|Infant Series||4
186488|NCT01392378|452496|P5|COMPLETED|Infant Series||210
186489|NCT01392378|452497|P4|COMPLETED|Infant Series||175
186490|NCT01392378|452498|P3|COMPLETED|Infant Series||172
186491|NCT01392378|452499|P2|COMPLETED|Infant Series||174
186492|NCT01392378|452500|P1|COMPLETED|Infant Series||169
186493|NCT01392378|452496|P5|Vaccinated Dose 3|Infant Series||210
186494|NCT01392378|452497|P4|Vaccinated Dose 3|Infant Series||176
186495|NCT01392378|452498|P3|Vaccinated Dose 3|Infant Series||172
186496|NCT01392378|452499|P2|Vaccinated Dose 3|Infant Series||174
186497|NCT01392378|452500|P1|Vaccinated Dose 3|Infant Series||170
186498|NCT01392378|452496|P5|Vaccinated Dose 2|Infant Series||210
186499|NCT01392378|452497|P4|Vaccinated Dose 2|Infant Series||177
186500|NCT01392378|452498|P3|Vaccinated Dose 2|Infant Series||172
186501|NCT01392378|452499|P2|Vaccinated Dose 2|Infant Series||174
186502|NCT01392378|452500|P1|Vaccinated Dose 2|Infant Series||171
186503|NCT01392378|452496|P5|Vaccinated Dose 1|Infant Series||210
186504|NCT01392378|452497|P4|Vaccinated Dose 1|Infant Series||177
186505|NCT01392378|452498|P3|Vaccinated Dose 1|Infant Series||172
186506|NCT01392378|452499|P2|Vaccinated Dose 1|Infant Series||176
186507|NCT01392378|452500|P1|Vaccinated Dose 1|Infant Series||173
186508|NCT01392378|452496|P5|STARTED|Infant Series||210
186509|NCT01392378|452497|P4|STARTED|Infant Series||177
186510|NCT01392378|452498|P3|STARTED|Infant Series||172
186511|NCT01392378|452499|P2|STARTED|Infant Series||176
186512|NCT01392378|452500|P1|STARTED|Infant Series||173
186513|NCT01392326|452640|P3|NOT COMPLETED|Overall Study||48
186514|NCT01392326|452641|P2|NOT COMPLETED|Overall Study||35
186515|NCT01392326|452642|P1|NOT COMPLETED|Overall Study||47
186516|NCT01392326|452640|P3|COMPLETED|Overall Study||154
186517|NCT01392326|452641|P2|COMPLETED|Overall Study||167
186518|NCT01392326|452642|P1|COMPLETED|Overall Study||155
186519|NCT01392326|452640|P3|STARTED|Overall Study||202
186520|NCT01392326|452641|P2|STARTED|Overall Study||202
186521|NCT01392326|452642|P1|STARTED|Overall Study||202
186522|NCT01392300|452679|P3|NOT COMPLETED|Open Label Extension (OLEX) Period||51
186523|NCT01392300|452680|P2|NOT COMPLETED|Open Label Extension (OLEX) Period||0
186524|NCT01392300|452681|P1|NOT COMPLETED|Open Label Extension (OLEX) Period||0
186525|NCT01392300|452679|P3|COMPLETED|Open Label Extension (OLEX) Period||248
186526|NCT01392300|452680|P2|COMPLETED|Open Label Extension (OLEX) Period||0
186527|NCT01392300|452681|P1|COMPLETED|Open Label Extension (OLEX) Period||0
186528|NCT01392300|452679|P3|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|299
186529|NCT01392300|452680|P2|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
186530|NCT01392300|452681|P1|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
186531|NCT01392300|452679|P3|NOT COMPLETED|Main Period (MP)||0
186532|NCT01392300|452680|P2|NOT COMPLETED|Main Period (MP)||7
186533|NCT01392300|452681|P1|NOT COMPLETED|Main Period (MP)||11
186534|NCT01392300|452679|P3|COMPLETED|Main Period (MP)||0
186535|NCT01392300|452680|P2|COMPLETED|Main Period (MP)||100
186536|NCT01392300|452681|P1|COMPLETED|Main Period (MP)||199
186537|NCT01392300|452679|P3|STARTED|Main Period (MP)||0
186538|NCT01392300|452680|P2|STARTED|Main Period (MP)||107
186539|NCT01392300|452681|P1|STARTED|Main Period (MP)||210
186540|NCT01392170|452786|P1|NOT COMPLETED|Overall Study||2
186541|NCT01392170|452786|P1|COMPLETED|Overall Study||0
186542|NCT01392170|452786|P1|STARTED|Overall Study||2
186543|NCT01392053|452792|P2|NOT COMPLETED|Overall Study||0
186544|NCT01392053|452793|P1|NOT COMPLETED|Overall Study||0
186545|NCT01392053|452792|P2|COMPLETED|Overall Study||23
186546|NCT01392053|452793|P1|COMPLETED|Overall Study||23
186547|NCT01392053|452792|P2|STARTED|Overall Study||23
186548|NCT01392053|452793|P1|STARTED|Overall Study||23
186549|NCT01391858|452813|P2|NOT COMPLETED|Overall Study||0
186550|NCT01391858|452814|P1|NOT COMPLETED|Overall Study||2
186551|NCT01391858|452813|P2|COMPLETED|Overall Study||24
186552|NCT01391858|452814|P1|COMPLETED|Overall Study||23
186553|NCT01391858|452813|P2|STARTED|Overall Study||24
186554|NCT01391858|452814|P1|STARTED|Overall Study||25
186555|NCT01391819|452834|P1|NOT COMPLETED|Overall Study||402
186556|NCT01391819|452834|P1|COMPLETED|Overall Study||1714
186557|NCT01391819|452834|P1|STARTED|Overall Study||2116
186558|NCT01391793|452878|P2|NOT COMPLETED|Overall Study||144
186559|NCT01391793|452879|P1|NOT COMPLETED|Overall Study||147
186560|NCT01391793|452878|P2|COMPLETED|Overall Study||131
186561|NCT01391793|452879|P1|COMPLETED|Overall Study||124
186562|NCT01391793|452878|P2|Had a Positive Urine Culture|Overall Study||188
186563|NCT01391793|452879|P1|Had a Positive Urine Culture|Overall Study||197
186564|NCT01391793|452878|P2|STARTED|Overall Study||275
186565|NCT01391793|452879|P1|STARTED|Overall Study||271
186566|NCT01391663|452893|P4|NOT COMPLETED|Overall Study||0
186567|NCT01391663|452894|P3|NOT COMPLETED|Overall Study||1
186568|NCT01391663|452895|P2|NOT COMPLETED|Overall Study||0
186569|NCT01391663|452896|P1|NOT COMPLETED|Overall Study||0
186570|NCT01391663|452893|P4|COMPLETED|Overall Study||12
186571|NCT01391663|452894|P3|COMPLETED|Overall Study||11
186572|NCT01391663|452895|P2|COMPLETED|Overall Study||12
186573|NCT01391663|452896|P1|COMPLETED|Overall Study||12
186574|NCT01391663|452893|P4|STARTED|Overall Study||12
186575|NCT01391663|452894|P3|STARTED|Overall Study||12
186576|NCT01391663|452895|P2|STARTED|Overall Study||12
186577|NCT01391663|452896|P1|STARTED|Overall Study||12
186578|NCT01391611|452926|P1|NOT COMPLETED|Overall Study||22
186579|NCT01391611|452926|P1|COMPLETED|Overall Study||3
186580|NCT01391611|452926|P1|STARTED|Overall Study||25
186581|NCT01391559|452931|P2|NOT COMPLETED|Second Intervention||0
186582|NCT01391559|452932|P1|NOT COMPLETED|Second Intervention||0
186583|NCT01391559|452931|P2|COMPLETED|Second Intervention||10
186584|NCT01391559|452932|P1|COMPLETED|Second Intervention||10
186585|NCT01391559|452931|P2|STARTED|Second Intervention||10
186586|NCT01391559|452932|P1|STARTED|Second Intervention||10
186587|NCT01391559|452931|P2|NOT COMPLETED|First Intervention||0
186588|NCT01391559|452932|P1|NOT COMPLETED|First Intervention||0
186589|NCT01391559|452931|P2|COMPLETED|First Intervention||10
186590|NCT01391559|452932|P1|COMPLETED|First Intervention||10
186591|NCT01391559|452931|P2|STARTED|First Intervention||10
186592|NCT01391559|452932|P1|STARTED|First Intervention||10
186593|NCT01391546|452940|P2|NOT COMPLETED|Overall Study||0
186594|NCT01391546|452941|P1|NOT COMPLETED|Overall Study||1
186595|NCT01391546|452940|P2|COMPLETED|Overall Study||177
186596|NCT01391546|452941|P1|COMPLETED|Overall Study||176
186597|NCT01391546|452940|P2|Vaccinated|Overall Study||177
186598|NCT01391546|452941|P1|Vaccinated|Overall Study||176
186599|NCT01391546|452940|P2|STARTED|Overall Study||177
186600|NCT01391546|452941|P1|STARTED|Overall Study||177
186601|NCT01391507|452963|P4|NOT COMPLETED|Overall Study||7
186602|NCT01391507|452964|P3|NOT COMPLETED|Overall Study||4
186603|NCT01391507|452965|P2|NOT COMPLETED|Overall Study||4
186604|NCT01391507|452966|P1|NOT COMPLETED|Overall Study||4
186605|NCT01391507|452963|P4|COMPLETED|Overall Study||5
186606|NCT01391507|452964|P3|COMPLETED|Overall Study||2
186607|NCT01391507|452965|P2|COMPLETED|Overall Study||4
186608|NCT01391507|452966|P1|COMPLETED|Overall Study||6
186609|NCT01391507|452963|P4|STARTED|Overall Study||12
186610|NCT01391507|452964|P3|STARTED|Overall Study||6
186611|NCT01391507|452965|P2|STARTED|Overall Study||8
186612|NCT01391507|452966|P1|STARTED|Overall Study||10
186613|NCT01391468|453014|P2|NOT COMPLETED|Overall Study||2
186614|NCT01391468|453015|P1|NOT COMPLETED|Overall Study||6
186615|NCT01391468|453014|P2|COMPLETED|Overall Study||21
186616|NCT01391468|453015|P1|COMPLETED|Overall Study||18
186617|NCT01391468|453014|P2|STARTED|Overall Study||23
186618|NCT01391468|453015|P1|STARTED|Overall Study||24
186619|NCT01391325|453027|P1|NOT COMPLETED|Overall Study||494
186620|NCT01391325|453027|P1|COMPLETED|Overall Study||1238
186621|NCT01391325|453027|P1|STARTED|Overall Study||1732
186622|NCT01391312|453036|P2|NOT COMPLETED|Overall Study||1
186623|NCT01391312|453037|P1|NOT COMPLETED|Overall Study||2
186624|NCT01391312|453036|P2|COMPLETED|Overall Study||19
186625|NCT01391312|453037|P1|COMPLETED|Overall Study||18
186626|NCT01391312|453036|P2|STARTED|Overall Study||20
186627|NCT01391312|453037|P1|STARTED|Overall Study||20
186628|NCT01391299|453050|P3|NOT COMPLETED|Overall Study||2
186629|NCT01391299|453051|P2|NOT COMPLETED|Overall Study||1
186630|NCT01391299|453052|P1|NOT COMPLETED|Overall Study||0
186631|NCT01391299|453050|P3|COMPLETED|Overall Study||56
186632|NCT01391299|453051|P2|COMPLETED|Overall Study||59
186633|NCT01391299|453052|P1|COMPLETED|Overall Study||57
186634|NCT01391299|453050|P3|STARTED|Overall Study||58
186635|NCT01391299|453051|P2|STARTED|Overall Study||60
186636|NCT01391299|453052|P1|STARTED|Overall Study||57
186637|NCT01391286|453074|P2|NOT COMPLETED|Overall Study||0
186638|NCT01391286|453075|P1|NOT COMPLETED|Overall Study||0
186639|NCT01391286|453074|P2|COMPLETED|Overall Study||18
186640|NCT01391286|453075|P1|COMPLETED|Overall Study||18
186641|NCT01391286|453074|P2|STARTED|Overall Study||18
186642|NCT01391286|453075|P1|STARTED|Overall Study||18
186643|NCT01391273|453089|P2|NOT COMPLETED|Overall Study||2
186644|NCT01391273|453090|P1|NOT COMPLETED|Overall Study||4
186645|NCT01391273|453089|P2|COMPLETED|Overall Study||83
186646|NCT01391273|453090|P1|COMPLETED|Overall Study||84
186647|NCT01391273|453089|P2|STARTED|Overall Study||85
186648|NCT01391273|453090|P1|STARTED|Overall Study||88
186649|NCT01391130|453104|P2|NOT COMPLETED|Overall Study||6
186650|NCT01391130|453105|P1|NOT COMPLETED|Overall Study||6
186651|NCT01391130|453104|P2|COMPLETED|Overall Study||31
186652|NCT01391130|453105|P1|COMPLETED|Overall Study||67
186653|NCT01391130|453104|P2|Received At Least One Dose of Study Drug|Overall Study||36
186654|NCT01391130|453105|P1|Received At Least One Dose of Study Drug|Overall Study||72
186655|NCT01391130|453104|P2|STARTED|Overall Study||37
186656|NCT01391130|453105|P1|STARTED|Overall Study||73
186657|NCT01391013|453121|P2|NOT COMPLETED|Overall Study||0
186658|NCT01391013|453122|P1|NOT COMPLETED|Overall Study||0
186659|NCT01391013|453121|P2|COMPLETED|Overall Study||15
186660|NCT01391013|453122|P1|COMPLETED|Overall Study||15
186661|NCT01391013|453121|P2|STARTED|Overall Study||15
186662|NCT01391013|453122|P1|STARTED|Overall Study||15
186663|NCT01391000|453162|P2|NOT COMPLETED|Overall Study||0
186664|NCT01391000|453163|P1|NOT COMPLETED|Overall Study||2
186665|NCT01391000|453162|P2|COMPLETED|Overall Study||35
186666|NCT01391000|453163|P1|COMPLETED|Overall Study||33
186667|NCT01391000|453162|P2|STARTED|Overall Study||35
186668|NCT01391000|453163|P1|STARTED|Overall Study||35
186669|NCT01390948|453176|P3|NOT COMPLETED|Overall Study||3
186670|NCT01390948|453177|P2|NOT COMPLETED|Overall Study||62
186671|NCT01390948|453178|P1|NOT COMPLETED|Overall Study||59
186672|NCT01390948|453176|P3|COMPLETED|Overall Study||0
186673|NCT01390948|453177|P2|COMPLETED|Overall Study||0
186674|NCT01390948|453178|P1|COMPLETED|Overall Study||0
186675|NCT01390948|453176|P3|Treated|Overall Study||3
186676|NCT01390948|453177|P2|Treated|Overall Study||60
186677|NCT01390948|453178|P1|Treated|Overall Study||56
186678|NCT01390948|453176|P3|STARTED|Overall Study||3
186679|NCT01390948|453177|P2|STARTED|Overall Study||62
186680|NCT01390948|453178|P1|STARTED|Overall Study||59
186681|NCT01390909|453217|P6|NOT COMPLETED|Overall Study||0
186682|NCT01390909|453218|P5|NOT COMPLETED|Overall Study||0
186683|NCT01390909|453219|P4|NOT COMPLETED|Overall Study||0
186684|NCT01390909|453220|P3|NOT COMPLETED|Overall Study||0
186685|NCT01390909|453221|P2|NOT COMPLETED|Overall Study||0
186686|NCT01390909|453222|P1|NOT COMPLETED|Overall Study||0
186687|NCT01390909|453217|P6|COMPLETED|Overall Study||613
186688|NCT01390909|453218|P5|COMPLETED|Overall Study||613
186689|NCT01390909|453219|P4|COMPLETED|Overall Study||602
186690|NCT01390909|453220|P3|COMPLETED|Overall Study||3552
186691|NCT01390909|453221|P2|COMPLETED|Overall Study||3552
186692|NCT01390909|453222|P1|COMPLETED|Overall Study||3454
186693|NCT01390909|453217|P6|Participants in Subgroup|Overall Study||0
186694|NCT01390909|453218|P5|Participants in Subgroup|Overall Study||602
186695|NCT01390909|453219|P4|Participants in Subgroup|Overall Study||0
186696|NCT01390909|453220|P3|Participants in Subgroup|Overall Study||0
186697|NCT01390909|453221|P2|Participants in Subgroup|Overall Study||3454
186698|NCT01390909|453222|P1|Participants in Subgroup|Overall Study||0
186699|NCT01390909|453217|P6|STARTED|Overall Study||613
186700|NCT01390909|453218|P5|STARTED|Overall Study||613
186701|NCT01390909|453219|P4|STARTED|Overall Study||602
186702|NCT01390909|453220|P3|STARTED|Overall Study||3552
186703|NCT01390909|453221|P2|STARTED|Overall Study||3552
186704|NCT01390909|453222|P1|STARTED|Overall Study||3454
186705|NCT01390870|453240|P1|NOT COMPLETED|Overall Study||0
186706|NCT01390870|453240|P1|COMPLETED|Overall Study||400
186707|NCT01390870|453240|P1|STARTED|Overall Study||400
186708|NCT01390857|453244|P1|NOT COMPLETED|Overall Study||10
186709|NCT01390857|453244|P1|COMPLETED|Overall Study||369
186710|NCT01390857|453244|P1|STARTED|Overall Study||379
186711|NCT01390844|453255|P4|NOT COMPLETED|Follow-Up Phase||0
186712|NCT01390844|453256|P3|NOT COMPLETED|Follow-Up Phase||1
186713|NCT01390844|453257|P2|NOT COMPLETED|Follow-Up Phase||1
186714|NCT01390844|453258|P1|NOT COMPLETED|Follow-Up Phase||1
186715|NCT01390844|453255|P4|COMPLETED|Follow-Up Phase||8
186716|NCT01390844|453256|P3|COMPLETED|Follow-Up Phase||25
186717|NCT01390844|453257|P2|COMPLETED|Follow-Up Phase||36
186718|NCT01390844|453258|P1|COMPLETED|Follow-Up Phase||92
186719|NCT01390844|453255|P4|STARTED|Follow-Up Phase||8
186720|NCT01390844|453256|P3|STARTED|Follow-Up Phase||26
186721|NCT01390844|453257|P2|STARTED|Follow-Up Phase||37
186722|NCT01390844|453258|P1|STARTED|Follow-Up Phase||93
186723|NCT01390844|453255|P4|NOT COMPLETED|Treatment Phase||19
186724|NCT01390844|453256|P3|NOT COMPLETED|Treatment Phase||31
186725|NCT01390844|453257|P2|NOT COMPLETED|Treatment Phase||28
186726|NCT01390844|453258|P1|NOT COMPLETED|Treatment Phase||40
186727|NCT01390844|453255|P4|COMPLETED|Treatment Phase||8
186728|NCT01390844|453256|P3|COMPLETED|Treatment Phase||26
186729|NCT01390844|453257|P2|COMPLETED|Treatment Phase||37
186730|NCT01390844|453258|P1|COMPLETED|Treatment Phase||93
186731|NCT01390844|453255|P4|Followed Good Clinical Practice (GCP)|Treatment Phase||24
186732|NCT01390844|453256|P3|Followed Good Clinical Practice (GCP)|Treatment Phase||47
186733|NCT01390844|453257|P2|Followed Good Clinical Practice (GCP)|Treatment Phase||65
186734|NCT01390844|453258|P1|Followed Good Clinical Practice (GCP)|Treatment Phase||133
186735|NCT01390844|453255|P4|STARTED|Treatment Phase||27
186736|NCT01390844|453256|P3|STARTED|Treatment Phase||57
186737|NCT01390844|453257|P2|STARTED|Treatment Phase||65
186738|NCT01390844|453258|P1|STARTED|Treatment Phase||133
186739|NCT01390818|453299|P15|NOT COMPLETED|Overall Study||0
186740|NCT01390818|453300|P14|NOT COMPLETED|Overall Study||0
186741|NCT01390818|453301|P13|NOT COMPLETED|Overall Study||0
186742|NCT01390818|453302|P12|NOT COMPLETED|Overall Study||0
186743|NCT01390818|453303|P11|NOT COMPLETED|Overall Study||0
186744|NCT01390818|453304|P10|NOT COMPLETED|Overall Study||0
186745|NCT01390818|453305|P9|NOT COMPLETED|Overall Study||0
186746|NCT01390818|453306|P8|NOT COMPLETED|Overall Study||0
186747|NCT01390818|453307|P7|NOT COMPLETED|Overall Study||0
186748|NCT01390818|453308|P6|NOT COMPLETED|Overall Study||0
186749|NCT01390818|453309|P5|NOT COMPLETED|Overall Study||0
186750|NCT01390818|453310|P4|NOT COMPLETED|Overall Study||0
186751|NCT01390818|453311|P3|NOT COMPLETED|Overall Study||0
186752|NCT01390818|453312|P2|NOT COMPLETED|Overall Study||0
186753|NCT01390818|453313|P1|NOT COMPLETED|Overall Study||0
186754|NCT01390818|453299|P15|COMPLETED|Overall Study||15
186755|NCT01390818|453300|P14|COMPLETED|Overall Study||18
186756|NCT01390818|453301|P13|COMPLETED|Overall Study||24
186757|NCT01390818|453302|P12|COMPLETED|Overall Study||26
186758|NCT01390818|453303|P11|COMPLETED|Overall Study||4
186759|NCT01390818|453304|P10|COMPLETED|Overall Study||3
186760|NCT01390818|453305|P9|COMPLETED|Overall Study||3
186761|NCT01390818|453306|P8|COMPLETED|Overall Study||14
186762|NCT01390818|453307|P7|COMPLETED|Overall Study||19
186763|NCT01390818|453308|P6|COMPLETED|Overall Study||3
186764|NCT01390818|453309|P5|COMPLETED|Overall Study||4
186765|NCT01390818|453310|P4|COMPLETED|Overall Study||4
186766|NCT01390818|453311|P3|COMPLETED|Overall Study||3
186767|NCT01390818|453312|P2|COMPLETED|Overall Study||3
186768|NCT01390818|453313|P1|COMPLETED|Overall Study||3
186769|NCT01390818|453299|P15|STARTED|Overall Study||15
186770|NCT01390818|453300|P14|STARTED|Overall Study||18
186771|NCT01390818|453301|P13|STARTED|Overall Study||24
186772|NCT01390818|453302|P12|STARTED|Overall Study||26
186773|NCT01390818|453303|P11|STARTED|Overall Study||4
186774|NCT01390818|453304|P10|STARTED|Overall Study||3
186775|NCT01390818|453305|P9|STARTED|Overall Study||3
186776|NCT01390818|453306|P8|STARTED|Overall Study||14
186777|NCT01390818|453307|P7|STARTED|Overall Study||19
186778|NCT01390818|453308|P6|STARTED|Overall Study||3
186779|NCT01390818|453309|P5|STARTED|Overall Study||4
186780|NCT01390818|453310|P4|STARTED|Overall Study||4
186781|NCT01390818|453311|P3|STARTED|Overall Study||3
186782|NCT01390818|453312|P2|STARTED|Overall Study||3
186783|NCT01390818|453313|P1|STARTED|Overall Study||3
186784|NCT01390779|453585|P1|NOT COMPLETED|Overall Study||1
186785|NCT01390779|453585|P1|COMPLETED|Overall Study||32
186786|NCT01390779|453585|P1|STARTED|Overall Study||33
186787|NCT01390649|453590|P1|NOT COMPLETED|Overall Study||1
186788|NCT01390649|453590|P1|COMPLETED|Overall Study||56
186789|NCT01390649|453590|P1|STARTED|Overall Study|Subjects treated with Privigen|57
186790|NCT01390441|453600|P5|NOT COMPLETED|Extension Period||0
186791|NCT01390441|453601|P4|NOT COMPLETED|Extension Period||1
186792|NCT01390441|453602|P3|NOT COMPLETED|Extension Period||0
186793|NCT01390441|453603|P2|NOT COMPLETED|Extension Period||1
186794|NCT01390441|453604|P1|NOT COMPLETED|Extension Period||3
186795|NCT01390441|453600|P5|COMPLETED|Extension Period||3
186796|NCT01390441|453601|P4|COMPLETED|Extension Period||0
186797|NCT01390441|453602|P3|COMPLETED|Extension Period||1
186798|NCT01390441|453603|P2|COMPLETED|Extension Period||12
186799|NCT01390441|453604|P1|COMPLETED|Extension Period||12
186800|NCT01390441|453600|P5|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|3
186801|NCT01390441|453601|P4|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
186802|NCT01390441|453602|P3|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
186803|NCT01390441|453603|P2|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|13
186804|NCT01390441|453604|P1|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|15
186805|NCT01390441|453600|P5|NOT COMPLETED|Treatment Period||11
186806|NCT01390441|453601|P4|NOT COMPLETED|Treatment Period||13
186807|NCT01390441|453602|P3|NOT COMPLETED|Treatment Period||10
186808|NCT01390441|453603|P2|NOT COMPLETED|Treatment Period||1
186809|NCT01390441|453604|P1|NOT COMPLETED|Treatment Period||1
186810|NCT01390441|453600|P5|COMPLETED|Treatment Period||7
186811|NCT01390441|453601|P4|COMPLETED|Treatment Period||6
186812|NCT01390441|453602|P3|COMPLETED|Treatment Period||8
186813|NCT01390441|453603|P2|COMPLETED|Treatment Period||21
186814|NCT01390441|453604|P1|COMPLETED|Treatment Period||22
186815|NCT01390441|453600|P5|STARTED|Treatment Period||18
186816|NCT01390441|453601|P4|STARTED|Treatment Period||19
186817|NCT01390441|453602|P3|STARTED|Treatment Period||18
186818|NCT01390441|453603|P2|STARTED|Treatment Period||22
186819|NCT01390441|453604|P1|STARTED|Treatment Period||23
186820|NCT01390428|453669|P6|NOT COMPLETED|Overall Study||0
186821|NCT01390428|453670|P5|NOT COMPLETED|Overall Study||1
186822|NCT01390428|453671|P4|NOT COMPLETED|Overall Study||0
186823|NCT01390428|453672|P3|NOT COMPLETED|Overall Study||1
186824|NCT01390428|453673|P2|NOT COMPLETED|Overall Study||0
186825|NCT01390428|453674|P1|NOT COMPLETED|Overall Study||0
186826|NCT01390428|453669|P6|COMPLETED|Overall Study||8
186827|NCT01390428|453670|P5|COMPLETED|Overall Study||7
186828|NCT01390428|453671|P4|COMPLETED|Overall Study||9
186829|NCT01390428|453672|P3|COMPLETED|Overall Study||8
186830|NCT01390428|453673|P2|COMPLETED|Overall Study||8
186831|NCT01390428|453674|P1|COMPLETED|Overall Study||8
186832|NCT01390428|453669|P6|STARTED|Overall Study||8
186833|NCT01390428|453670|P5|STARTED|Overall Study||8
186834|NCT01390428|453671|P4|STARTED|Overall Study||9
186835|NCT01390428|453672|P3|STARTED|Overall Study||9
186836|NCT01390428|453673|P2|STARTED|Overall Study||8
186837|NCT01390428|453674|P1|STARTED|Overall Study||8
186838|NCT01390415|453726|P2|NOT COMPLETED|Overall Study||0
186839|NCT01390415|453727|P1|NOT COMPLETED|Overall Study||0
186840|NCT01390415|453726|P2|COMPLETED|Overall Study||37
186841|NCT01390415|453727|P1|COMPLETED|Overall Study||99
186842|NCT01390415|453726|P2|STARTED|Overall Study||37
186843|NCT01390415|453727|P1|STARTED|Overall Study||99
186844|NCT01390402|453737|P1|NOT COMPLETED|Overall Study||5
186845|NCT01390402|453737|P1|COMPLETED|Overall Study||1
186846|NCT01390402|453737|P1|STARTED|Overall Study||6
186847|NCT01390389|453743|P2|NOT COMPLETED|Overall Study||1
186848|NCT01390389|453744|P1|NOT COMPLETED|Overall Study||4
186849|NCT01390389|453743|P2|COMPLETED|Overall Study||8
186850|NCT01390389|453744|P1|COMPLETED|Overall Study||6
186851|NCT01390389|453743|P2|STARTED|Overall Study||9
186852|NCT01390389|453744|P1|STARTED|Overall Study||10
186853|NCT01390298|453754|P1|NOT COMPLETED|Overall Study||24
186854|NCT01390298|453754|P1|COMPLETED|Overall Study||31
186855|NCT01390298|453754|P1|STARTED|Overall Study||55
186856|NCT01390272|453760|P2|NOT COMPLETED|Overall Study||15
186857|NCT01390272|453761|P1|NOT COMPLETED|Overall Study||17
186858|NCT01390272|453760|P2|COMPLETED|Overall Study||178
186859|NCT01390272|453761|P1|COMPLETED|Overall Study||175
186860|NCT01390272|453760|P2|18 Month Follow up|Overall Study|33 of 193 in the LPN control group had missing blood pressure measurement|160
186861|NCT01390272|453761|P1|18 Month Follow up|Overall Study|37 of 192 participants in the Titration Intervention group had missing blood pressure measurement|155
186862|NCT01390272|453760|P2|12 Month Follow up|Overall Study|34 of 193 in the LPN control group had missing blood pressure measurement|159
186863|NCT01390272|453761|P1|12 Month Follow up|Overall Study|53 of 192 participants in the Titration Intervention group had missing measurement|139
186864|NCT01390272|453760|P2|6 Month Follow up|Overall Study|22 of 193 in the LPN control group had missing blood pressure measurement|171
186865|NCT01390272|453761|P1|6 Month Follow up|Overall Study|30 of 192 participants in the Titration Intervention group had missing blood pressure measurement|162
186866|NCT01390272|453760|P2|STARTED|Overall Study||193
186867|NCT01390272|453761|P1|STARTED|Overall Study||192
186868|NCT01390259|453791|P2|NOT COMPLETED|Overall Study||0
186869|NCT01390259|453792|P1|NOT COMPLETED|Overall Study||0
186870|NCT01390259|453791|P2|COMPLETED|Overall Study||6
186871|NCT01390259|453792|P1|COMPLETED|Overall Study||5
186872|NCT01390259|453791|P2|STARTED|Overall Study||6
186873|NCT01390259|453792|P1|STARTED|Overall Study||5
186874|NCT01390246|453803|P2|NOT COMPLETED|Overall Study||25
186875|NCT01390246|453804|P1|NOT COMPLETED|Overall Study||20
186876|NCT01390246|453803|P2|COMPLETED|Overall Study||10
186877|NCT01390246|453804|P1|COMPLETED|Overall Study||10
186878|NCT01390246|453803|P2|Visit 7: 36-38 Weeks Gestation|Overall Study||10
186879|NCT01390246|453804|P1|Visit 7: 36-38 Weeks Gestation|Overall Study||10
186880|NCT01390246|453803|P2|Visit 6: End of Treatment|Overall Study||15
186881|NCT01390246|453804|P1|Visit 6: End of Treatment|Overall Study||15
186882|NCT01390246|453803|P2|Visit 2: Quit Day|Overall Study||24
186883|NCT01390246|453804|P1|Visit 2: Quit Day|Overall Study||24
186884|NCT01390246|453803|P2|STARTED|Overall Study||35
186885|NCT01390246|453804|P1|STARTED|Overall Study||30
186886|NCT01390233|453819|P3|NOT COMPLETED|Overall Study||6
186887|NCT01390233|453820|P2|NOT COMPLETED|Overall Study||2
186888|NCT01390233|453821|P1|NOT COMPLETED|Overall Study||5
186889|NCT01390233|453819|P3|COMPLETED|Overall Study||30
186890|NCT01390233|453820|P2|COMPLETED|Overall Study||29
186891|NCT01390233|453821|P1|COMPLETED|Overall Study||30
186892|NCT01390233|453819|P3|STARTED|Overall Study||36
186893|NCT01390233|453820|P2|STARTED|Overall Study||31
186894|NCT01390233|453821|P1|STARTED|Overall Study||35
186895|NCT01390220|453829|P3|NOT COMPLETED|Comparative Phase||0
186896|NCT01390220|453830|P2|NOT COMPLETED|Comparative Phase||1
186897|NCT01390220|453831|P1|NOT COMPLETED|Comparative Phase||0
186898|NCT01390220|453829|P3|COMPLETED|Comparative Phase||67
186899|NCT01390220|453830|P2|COMPLETED|Comparative Phase||133
186900|NCT01390220|453831|P1|COMPLETED|Comparative Phase|This arm not applicable in CP|0
186901|NCT01390220|453829|P3|STARTED|Comparative Phase||67
186902|NCT01390220|453830|P2|STARTED|Comparative Phase||134
186903|NCT01390220|453831|P1|STARTED|Comparative Phase|This arm not applicable in CP|0
186904|NCT01390220|453829|P3|NOT COMPLETED|Test Dose Phase||0
186905|NCT01390220|453830|P2|NOT COMPLETED|Test Dose Phase||0
186906|NCT01390220|453831|P1|NOT COMPLETED|Test Dose Phase||91
186907|NCT01390220|453829|P3|COMPLETED|Test Dose Phase||0
186908|NCT01390220|453830|P2|COMPLETED|Test Dose Phase||0
186909|NCT01390220|453831|P1|COMPLETED|Test Dose Phase||201
186910|NCT01390220|453829|P3|STARTED|Test Dose Phase|This arm not applicable in TDP.|0
186911|NCT01390220|453830|P2|STARTED|Test Dose Phase|This arm not applicable in TDP.|0
186912|NCT01390220|453831|P1|STARTED|Test Dose Phase||292
186913|NCT01390181|453846|P1|NOT COMPLETED|Overall Study||4
186914|NCT01390181|453846|P1|COMPLETED|Overall Study||0
186915|NCT01390181|453846|P1|STARTED|Overall Study||4
186916|NCT01390064|453852|P2|NOT COMPLETED|Overall Study||0
186917|NCT01390064|453853|P1|NOT COMPLETED|Overall Study||0
186918|NCT01390064|453852|P2|COMPLETED|Overall Study||3
186919|NCT01390064|453853|P1|COMPLETED|Overall Study||3
186920|NCT01390064|453852|P2|STARTED|Overall Study||3
186921|NCT01390064|453853|P1|STARTED|Overall Study||3
186922|NCT01390038|453859|P1|NOT COMPLETED|Overall Study||8
186923|NCT01390038|453859|P1|COMPLETED|Overall Study||149
186924|NCT01390038|453859|P1|STARTED|Overall Study||157
186925|NCT01389973|453869|P1|NOT COMPLETED|Overall Study||20
186926|NCT01389973|453869|P1|COMPLETED|Overall Study||0
186927|NCT01389973|453869|P1|STARTED|Overall Study||20
186928|NCT01389882|453879|P2|NOT COMPLETED|Overall Study||4
186929|NCT01389882|453880|P1|NOT COMPLETED|Overall Study||1
186930|NCT01389882|453879|P2|COMPLETED|Overall Study||7
186931|NCT01389882|453880|P1|COMPLETED|Overall Study||12
186932|NCT01389882|453879|P2|STARTED|Overall Study||11
186933|NCT01389882|453880|P1|STARTED|Overall Study||13
186934|NCT01389856|453910|P2|NOT COMPLETED|Overall Study||0
186935|NCT01389856|453911|P1|NOT COMPLETED|Overall Study||0
186936|NCT01389856|453910|P2|COMPLETED|Overall Study||8
186937|NCT01389856|453911|P1|COMPLETED|Overall Study||13
186938|NCT01389856|453910|P2|STARTED|Overall Study|Randomized and treated.|8
186939|NCT01389856|453911|P1|STARTED|Overall Study|Randomized and treated. An additional 2 patients were randomized but not treated.|13
186940|NCT01389817|453968|P2|NOT COMPLETED|Overall Study||0
186941|NCT01389817|453969|P1|NOT COMPLETED|Overall Study||4
186942|NCT01389817|453968|P2|COMPLETED|Overall Study||0
186943|NCT01389817|453969|P1|COMPLETED|Overall Study||0
186944|NCT01389817|453968|P2|STARTED|Overall Study||0
186945|NCT01389817|453969|P1|STARTED|Overall Study||4
186946|NCT01389765|453975|P2|NOT COMPLETED|Second Intervention (Day 1)||0
186947|NCT01389765|453976|P1|NOT COMPLETED|Second Intervention (Day 1)||0
186948|NCT01389765|453975|P2|COMPLETED|Second Intervention (Day 1)||12
186949|NCT01389765|453976|P1|COMPLETED|Second Intervention (Day 1)||12
186950|NCT01389765|453975|P2|STARTED|Second Intervention (Day 1)||12
186951|NCT01389765|453976|P1|STARTED|Second Intervention (Day 1)||12
186952|NCT01389765|453975|P2|NOT COMPLETED|Washout Period (7 Days)||0
186953|NCT01389765|453976|P1|NOT COMPLETED|Washout Period (7 Days)||0
186954|NCT01389765|453975|P2|COMPLETED|Washout Period (7 Days)||12
186955|NCT01389765|453976|P1|COMPLETED|Washout Period (7 Days)||12
186956|NCT01389765|453975|P2|STARTED|Washout Period (7 Days)||12
186957|NCT01389765|453976|P1|STARTED|Washout Period (7 Days)||12
186958|NCT01389765|453975|P2|NOT COMPLETED|First Intervention (Day 1)||0
186959|NCT01389765|453976|P1|NOT COMPLETED|First Intervention (Day 1)||0
186960|NCT01389765|453975|P2|COMPLETED|First Intervention (Day 1)||12
186961|NCT01389765|453976|P1|COMPLETED|First Intervention (Day 1)||12
186962|NCT01389765|453975|P2|STARTED|First Intervention (Day 1)||12
186963|NCT01389765|453976|P1|STARTED|First Intervention (Day 1)||12
186964|NCT01389752|453986|P2|NOT COMPLETED|Study Period 2||0
186965|NCT01389752|453987|P1|NOT COMPLETED|Study Period 2||1
186966|NCT01389752|453986|P2|COMPLETED|Study Period 2||9
186967|NCT01389752|453987|P1|COMPLETED|Study Period 2||10
186968|NCT01389752|453986|P2|STARTED|Study Period 2||9
186969|NCT01389752|453987|P1|STARTED|Study Period 2||11
186970|NCT01389752|453986|P2|NOT COMPLETED|Study Period 1||2
186971|NCT01389752|453987|P1|NOT COMPLETED|Study Period 1||0
186972|NCT01389752|453986|P2|COMPLETED|Study Period 1||9
186973|NCT01389752|453987|P1|COMPLETED|Study Period 1||11
186974|NCT01389752|453986|P2|STARTED|Study Period 1||11
186975|NCT01389752|453987|P1|STARTED|Study Period 1||11
186976|NCT01389596|454000|P3|NOT COMPLETED|Overall Study||10
186977|NCT01389596|454001|P2|NOT COMPLETED|Overall Study||16
186978|NCT01389596|454002|P1|NOT COMPLETED|Overall Study||10
186979|NCT01389596|454000|P3|COMPLETED|Overall Study||84
186980|NCT01389596|454001|P2|COMPLETED|Overall Study||81
186981|NCT01389596|454002|P1|COMPLETED|Overall Study||94
186982|NCT01389596|454000|P3|STARTED|Overall Study||94
186983|NCT01389596|454001|P2|STARTED|Overall Study||97
186984|NCT01389596|454002|P1|STARTED|Overall Study||104
186985|NCT01389323|454061|P1|NOT COMPLETED|Follow-up Period (up to 48 Weeks)||37
186986|NCT01389323|454061|P1|COMPLETED|Follow-up Period (up to 48 Weeks)||184
186987|NCT01389323|454061|P1|STARTED|Follow-up Period (up to 48 Weeks)|Out of 246 participants who entered the treatment period, 221 continued in the follow-up period.|221
186988|NCT01389323|454061|P1|NOT COMPLETED|Treatment Period (up to 48 Weeks)||95
186989|NCT01389323|454061|P1|COMPLETED|Treatment Period (up to 48 Weeks)||151
186990|NCT01389323|454061|P1|STARTED|Treatment Period (up to 48 Weeks)||246
186991|NCT01389284|454084|P3|NOT COMPLETED|Overall Study||0
186992|NCT01389284|454085|P2|NOT COMPLETED|Overall Study||0
186993|NCT01389284|454086|P1|NOT COMPLETED|Overall Study||0
186994|NCT01389284|454084|P3|COMPLETED|Overall Study||60
186995|NCT01389284|454085|P2|COMPLETED|Overall Study||120
186996|NCT01389284|454086|P1|COMPLETED|Overall Study||120
186997|NCT01389284|454084|P3|STARTED|Overall Study||60
186998|NCT01389284|454085|P2|STARTED|Overall Study||120
186999|NCT01389284|454086|P1|STARTED|Overall Study||120
187000|NCT01389258|454118|P1|NOT COMPLETED|Overall Study||5
187001|NCT01389258|454118|P1|COMPLETED|Overall Study||40
187002|NCT01389258|454118|P1|STARTED|Overall Study||45
187003|NCT01389128|454130|P2|NOT COMPLETED|Overall Study||6
187004|NCT01389128|454131|P1|NOT COMPLETED|Overall Study||5
187005|NCT01389128|454130|P2|COMPLETED|Overall Study||34
187006|NCT01389128|454131|P1|COMPLETED|Overall Study||35
187007|NCT01389128|454130|P2|STARTED|Overall Study||40
187008|NCT01389128|454131|P1|STARTED|Overall Study||40
187009|NCT01389102|454155|P6|NOT COMPLETED|Overall Study||8
187010|NCT01389102|454156|P5|NOT COMPLETED|Overall Study||13
187011|NCT01389102|454157|P4|NOT COMPLETED|Overall Study||7
187012|NCT01389102|454158|P3|NOT COMPLETED|Overall Study||19
187013|NCT01389102|454159|P2|NOT COMPLETED|Overall Study||12
187014|NCT01389102|454160|P1|NOT COMPLETED|Overall Study||18
187015|NCT01389102|454155|P6|COMPLETED|Overall Study||68
187016|NCT01389102|454156|P5|COMPLETED|Overall Study||61
187017|NCT01389102|454157|P4|COMPLETED|Overall Study||69
187018|NCT01389102|454158|P3|COMPLETED|Overall Study||58
187019|NCT01389102|454159|P2|COMPLETED|Overall Study||64
187020|NCT01389102|454160|P1|COMPLETED|Overall Study||57
187021|NCT01389102|454155|P6|STARTED|Overall Study||76
187022|NCT01389102|454156|P5|STARTED|Overall Study||74
187023|NCT01389102|454157|P4|STARTED|Overall Study||76
187024|NCT01389102|454158|P3|STARTED|Overall Study||77
187025|NCT01389102|454159|P2|STARTED|Overall Study||76
187026|NCT01389102|454160|P1|STARTED|Overall Study||75
187027|NCT01389076|454180|P1|NOT COMPLETED|Overall Study||0
187028|NCT01389076|454180|P1|COMPLETED|Overall Study||22
187029|NCT01389076|454180|P1|STARTED|Overall Study||22
187030|NCT01388985|454190|P2|NOT COMPLETED|Overall Study||38
187031|NCT01388985|454191|P1|NOT COMPLETED|Overall Study||49
187032|NCT01388985|454190|P2|COMPLETED|Overall Study|From those 200, 28 were excluded from the per protocol analysis.|211
187033|NCT01388985|454191|P1|COMPLETED|Overall Study|From those 200, 15 were excluded from the per protocol analysis.|200
187034|NCT01388985|454190|P2|Primary Vaccination Period|Overall Study||238
187035|NCT01388985|454191|P1|Primary Vaccination Period|Overall Study||231
187036|NCT01388985|454190|P2|STARTED|Overall Study|1 participant (from the 250 enrolled) did not receive any vaccination because of consent withdrawal.|249
187037|NCT01388985|454191|P1|STARTED|Overall Study|1 participant (from the 250 enrolled) did not receive any vaccination because of consent withdrawal.|249
187038|NCT01388946|454207|P2|NOT COMPLETED|Overall Study||3
187039|NCT01388946|454208|P1|NOT COMPLETED|Overall Study||6
187040|NCT01388946|454207|P2|COMPLETED|Overall Study||52
187041|NCT01388946|454208|P1|COMPLETED|Overall Study||49
187042|NCT01388946|454207|P2|STARTED|Overall Study||55
187043|NCT01388946|454208|P1|STARTED|Overall Study||55
187044|NCT01388920|454243|P3|NOT COMPLETED|Overall Study||0
187045|NCT01388920|454244|P2|NOT COMPLETED|Overall Study||0
187046|NCT01388920|454245|P1|NOT COMPLETED|Overall Study||0
187047|NCT01388920|454243|P3|COMPLETED|Overall Study||0
187048|NCT01388920|454244|P2|COMPLETED|Overall Study||1
187049|NCT01388920|454245|P1|COMPLETED|Overall Study||1
187050|NCT01388920|454243|P3|STARTED|Overall Study||0
187051|NCT01388920|454244|P2|STARTED|Overall Study||1
187052|NCT01388920|454245|P1|STARTED|Overall Study||1
187053|NCT01388907|454255|P2|NOT COMPLETED|Overall Study||0
187054|NCT01388907|454256|P1|NOT COMPLETED|Overall Study||2
187055|NCT01388907|454255|P2|COMPLETED|Overall Study||28
187056|NCT01388907|454256|P1|COMPLETED|Overall Study||31
187057|NCT01388907|454255|P2|STARTED|Overall Study||28
187058|NCT01388907|454256|P1|STARTED|Overall Study||33
187059|NCT01388816|454272|P4|NOT COMPLETED|Overall Study||0
187060|NCT01388816|454273|P3|NOT COMPLETED|Overall Study||3
187061|NCT01388816|454274|P2|NOT COMPLETED|Overall Study||4
187062|NCT01388816|454275|P1|NOT COMPLETED|Overall Study||2
187063|NCT01388816|454272|P4|COMPLETED|Overall Study||44
187064|NCT01388816|454273|P3|COMPLETED|Overall Study||41
187065|NCT01388816|454274|P2|COMPLETED|Overall Study||39
187066|NCT01388816|454275|P1|COMPLETED|Overall Study||43
187067|NCT01388816|454272|P4|STARTED|Overall Study||44
187068|NCT01388816|454273|P3|STARTED|Overall Study||44
187069|NCT01388816|454274|P2|STARTED|Overall Study||43
187070|NCT01388816|454275|P1|STARTED|Overall Study||45
187071|NCT01388790|454304|P1|NOT COMPLETED|Overall Study||8
187072|NCT01388790|454304|P1|COMPLETED|Overall Study||32
187073|NCT01388790|454304|P1|STARTED|Overall Study||40
187074|NCT01388777|454309|P1|NOT COMPLETED|Overall Study||0
187075|NCT01388777|454309|P1|COMPLETED|Overall Study||1
187076|NCT01388777|454309|P1|Cryoablation|Overall Study||1
187077|NCT01388777|454309|P1|STARTED|Overall Study||1
187078|NCT01388647|454315|P2|NOT COMPLETED|Overall Study||2
187079|NCT01388647|454316|P1|NOT COMPLETED|Overall Study||1
187080|NCT01388647|454315|P2|COMPLETED|Overall Study|two subjects ended study treatment due to adverse events|4
187081|NCT01388647|454316|P1|COMPLETED|Overall Study|one subject ended study treatment due to adverse events|5
187082|NCT01388647|454315|P2|STARTED|Overall Study||6
187083|NCT01388647|454316|P1|STARTED|Overall Study||6
187084|NCT01388543|454329|P2|NOT COMPLETED|Day 14||4
187085|NCT01388543|454330|P1|NOT COMPLETED|Day 14||1
187086|NCT01388543|454329|P2|COMPLETED|Day 14||12
187087|NCT01388543|454330|P1|COMPLETED|Day 14||14
187088|NCT01388543|454329|P2|STARTED|Day 14||16
187089|NCT01388543|454330|P1|STARTED|Day 14||15
187090|NCT01388543|454329|P2|NOT COMPLETED|Day 7, Primary End Point||0
187091|NCT01388543|454330|P1|NOT COMPLETED|Day 7, Primary End Point||0
187092|NCT01388543|454329|P2|COMPLETED|Day 7, Primary End Point||16
187093|NCT01388543|454330|P1|COMPLETED|Day 7, Primary End Point||15
187094|NCT01388543|454329|P2|STARTED|Day 7, Primary End Point||16
187095|NCT01388543|454330|P1|STARTED|Day 7, Primary End Point||15
187096|NCT01388530|454336|P1|NOT COMPLETED|Overall Study||5
187097|NCT01388530|454336|P1|COMPLETED|Overall Study||20
187098|NCT01388530|454336|P1|STARTED|Overall Study||25
187099|NCT01388491|454345|P2|NOT COMPLETED|Overall Study||29
187100|NCT01388491|454346|P1|NOT COMPLETED|Overall Study||34
187101|NCT01388491|454345|P2|COMPLETED|Overall Study||114
187102|NCT01388491|454346|P1|COMPLETED|Overall Study||116
187103|NCT01388491|454345|P2|Per Protocol (PP) Population|Overall Study||121
187104|NCT01388491|454346|P1|Per Protocol (PP) Population|Overall Study|PP: all data from ITT participants obtained prior to any major protocol violations|125
187105|NCT01388491|454345|P2|Intent-to-Treat (ITT) Population|Overall Study||136
187106|NCT01388491|454346|P1|Intent-to-Treat (ITT) Population|Overall Study|ITT:participants in safety population with baseline (BL) + ≥1 post-BL prothrombin fragment 1+2 value|140
187107|NCT01388491|454345|P2|Safety Population|Overall Study||142
187108|NCT01388491|454346|P1|Safety Population|Overall Study|Safety: all randomized participants who took 1 or more doses of study drug|145
187109|NCT01388491|454345|P2|STARTED|Overall Study||143
187110|NCT01388491|454346|P1|STARTED|Overall Study|number randomized|150
187111|NCT01388361|454381|P3|NOT COMPLETED|Overall Study||14
187112|NCT01388361|454382|P2|NOT COMPLETED|Overall Study||12
187113|NCT01388361|454383|P1|NOT COMPLETED|Overall Study||12
187114|NCT01388361|454381|P3|COMPLETED|Overall Study||75
187115|NCT01388361|454382|P2|COMPLETED|Overall Study||76
187116|NCT01388361|454383|P1|COMPLETED|Overall Study||224
187117|NCT01388361|454381|P3|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug.|86
187118|NCT01388361|454382|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|87
187119|NCT01388361|454383|P1|Exposed|Overall Study|Two subjects withdrew prior to exposure to IDeg during NN1250-3948|234
187120|NCT01388361|454381|P3|STARTED|Overall Study||89
187121|NCT01388361|454382|P2|STARTED|Overall Study||88
187122|NCT01388361|454383|P1|STARTED|Overall Study||236
187123|NCT01388166|454400|P1|NOT COMPLETED|Overall Study||59
187124|NCT01388166|454400|P1|COMPLETED|Overall Study||1194
187125|NCT01388166|454400|P1|STARTED|Overall Study||1253
187126|NCT01387789|454406|P1|NOT COMPLETED|Overall Study||8
187127|NCT01387789|454406|P1|COMPLETED|Overall Study||63
187128|NCT01387789|454406|P1|STARTED|Overall Study||71
187129|NCT01387737|454420|P2|NOT COMPLETED|Overall Study||74
187130|NCT01387737|454421|P1|NOT COMPLETED|Overall Study||52
187131|NCT01387737|454420|P2|COMPLETED|Overall Study||641
187132|NCT01387737|454421|P1|COMPLETED|Overall Study||532
187133|NCT01387737|454420|P2|STARTED|Overall Study||715
187134|NCT01387737|454421|P1|STARTED|Overall Study||584
187135|NCT01387672|454433|P6|NOT COMPLETED|Overall Study||0
187136|NCT01387672|454434|P5|NOT COMPLETED|Overall Study||4
187137|NCT01387672|454435|P4|NOT COMPLETED|Overall Study||4
187138|NCT01387672|454436|P3|NOT COMPLETED|Overall Study||5
187139|NCT01387672|454437|P2|NOT COMPLETED|Overall Study||7
187140|NCT01387672|454438|P1|NOT COMPLETED|Overall Study||7
187141|NCT01387672|454433|P6|COMPLETED|Overall Study||37
187142|NCT01387672|454434|P5|COMPLETED|Overall Study||34
187143|NCT01387672|454435|P4|COMPLETED|Overall Study||35
187144|NCT01387672|454436|P3|COMPLETED|Overall Study||33
187145|NCT01387672|454437|P2|COMPLETED|Overall Study||31
187146|NCT01387672|454438|P1|COMPLETED|Overall Study||32
187147|NCT01387672|454433|P6|STARTED|Overall Study||37
187148|NCT01387672|454434|P5|STARTED|Overall Study||38
187149|NCT01387672|454435|P4|STARTED|Overall Study||39
187150|NCT01387672|454436|P3|STARTED|Overall Study||38
187151|NCT01387672|454437|P2|STARTED|Overall Study||38
187152|NCT01387672|454438|P1|STARTED|Overall Study||39
187153|NCT01387607|454455|P2|NOT COMPLETED|Overall Study||45
187154|NCT01387607|454456|P1|NOT COMPLETED|Overall Study||51
187155|NCT01387607|454455|P2|COMPLETED|Overall Study||125
187156|NCT01387607|454456|P1|COMPLETED|Overall Study||122
187157|NCT01387607|454455|P2|Received Treatment|Overall Study||164
187158|NCT01387607|454456|P1|Received Treatment|Overall Study||170
187159|NCT01387607|454455|P2|STARTED|Overall Study||170
187160|NCT01387607|454456|P1|STARTED|Overall Study||173
187161|NCT01387594|454510|P2|NOT COMPLETED|Overall Study||3
187162|NCT01387594|454511|P1|NOT COMPLETED|Overall Study||0
187163|NCT01387594|454510|P2|COMPLETED|Overall Study||36
187164|NCT01387594|454511|P1|COMPLETED|Overall Study||10
187165|NCT01387594|454510|P2|STARTED|Overall Study||39
187166|NCT01387594|454511|P1|STARTED|Overall Study||10
187167|NCT01387581|454526|P3|NOT COMPLETED|Overall Study||3
187168|NCT01387581|454527|P2|NOT COMPLETED|Overall Study||6
187169|NCT01387581|454528|P1|NOT COMPLETED|Overall Study||7
187170|NCT01387581|454526|P3|COMPLETED|Overall Study||9
187171|NCT01387581|454527|P2|COMPLETED|Overall Study||101
187172|NCT01387581|454528|P1|COMPLETED|Overall Study||101
187173|NCT01387581|454526|P3|STARTED|Overall Study||12
187174|NCT01387581|454527|P2|STARTED|Overall Study||107
187175|NCT01387581|454528|P1|STARTED|Overall Study||108
187176|NCT01387542|454539|P1|NOT COMPLETED|Overall Study||8
187177|NCT01387542|454539|P1|COMPLETED|Overall Study||32
187178|NCT01387542|454539|P1|Treated|Overall Study||38
187179|NCT01387542|454539|P1|STARTED|Overall Study||40
187180|NCT01387464|454548|P2|NOT COMPLETED|Overall Study||1
187181|NCT01387464|454549|P1|NOT COMPLETED|Overall Study||1
187182|NCT01387464|454548|P2|COMPLETED|Overall Study||29
187183|NCT01387464|454549|P1|COMPLETED|Overall Study||29
187184|NCT01387464|454548|P2|Per-Protocol Population|Overall Study||29
187185|NCT01387464|454549|P1|Per-Protocol Population|Overall Study|Safety subjects who completed surgery|29
187186|NCT01387464|454548|P2|Safety Population|Overall Study||29
187187|NCT01387464|454549|P1|Safety Population|Overall Study||30
187188|NCT01387464|454548|P2|STARTED|Overall Study||30
187189|NCT01387464|454549|P1|STARTED|Overall Study||30
187190|NCT01387347|454557|P2|NOT COMPLETED|Overall Study||1
187191|NCT01387347|454558|P1|NOT COMPLETED|Overall Study||2
187192|NCT01387347|454557|P2|COMPLETED|Overall Study||35
187193|NCT01387347|454558|P1|COMPLETED|Overall Study||34
187194|NCT01387347|454557|P2|STARTED|Overall Study||36
187195|NCT01387347|454558|P1|STARTED|Overall Study||36
187196|NCT01387282|454570|P2|NOT COMPLETED|Overall Study||47
187197|NCT01387282|454571|P1|NOT COMPLETED|Overall Study||97
187198|NCT01387282|454570|P2|COMPLETED|Overall Study||118
187199|NCT01387282|454571|P1|COMPLETED|Overall Study||233
187200|NCT01387282|454570|P2|Safety Population|Overall Study||161
187201|NCT01387282|454571|P1|Safety Population|Overall Study||330
187202|NCT01387282|454570|P2|MITT Population|Overall Study||136
187203|NCT01387282|454571|P1|MITT Population|Overall Study||268
187204|NCT01387282|454570|P2|ITT Population|Overall Study||165
187205|NCT01387282|454571|P1|ITT Population|Overall Study||330
187206|NCT01387282|454570|P2|STARTED|Overall Study||165
187207|NCT01387282|454571|P1|STARTED|Overall Study||330
187208|NCT01387269|454587|P2|NOT COMPLETED|Overall Study||40
187209|NCT01387269|454588|P1|NOT COMPLETED|Overall Study||92
187210|NCT01387269|454587|P2|COMPLETED|Overall Study||121
187211|NCT01387269|454588|P1|COMPLETED|Overall Study||231
187212|NCT01387269|454587|P2|Safety Population|Overall Study||161
187213|NCT01387269|454588|P1|Safety Population|Overall Study||320
187214|NCT01387269|454587|P2|MITT Population|Overall Study||141
187215|NCT01387269|454588|P1|MITT Population|Overall Study||284
187216|NCT01387269|454587|P2|ITT Population|Overall Study||161
187217|NCT01387269|454588|P1|ITT Population|Overall Study||323
187218|NCT01387269|454587|P2|STARTED|Overall Study||161
187219|NCT01387269|454588|P1|STARTED|Overall Study||323
187220|NCT01387230|454605|P3|NOT COMPLETED|Overall Study||13
187221|NCT01387230|454606|P2|NOT COMPLETED|Overall Study||7
187222|NCT01387230|454607|P1|NOT COMPLETED|Overall Study||18
187223|NCT01387230|454605|P3|COMPLETED|Overall Study||56
187224|NCT01387230|454606|P2|COMPLETED|Overall Study||62
187225|NCT01387230|454607|P1|COMPLETED|Overall Study||50
187226|NCT01387230|454605|P3|STARTED|Overall Study||69
187227|NCT01387230|454606|P2|STARTED|Overall Study||69
187228|NCT01387230|454607|P1|STARTED|Overall Study||68
187229|NCT01387178|454623|P2|NOT COMPLETED|Overall Study||0
187230|NCT01387178|454624|P1|NOT COMPLETED|Overall Study||0
187231|NCT01387178|454623|P2|COMPLETED|Overall Study||10641
187232|NCT01387178|454624|P1|COMPLETED|Overall Study||11582
187233|NCT01387178|454623|P2|STARTED|Overall Study||10641
187234|NCT01387178|454624|P1|STARTED|Overall Study||11582
187235|NCT01387139|454636|P2|NOT COMPLETED|Overall Study||0
187236|NCT01387139|454637|P1|NOT COMPLETED|Overall Study||0
187237|NCT01387139|454636|P2|COMPLETED|Overall Study||84
187238|NCT01387139|454637|P1|COMPLETED|Overall Study||99
187239|NCT01387139|454636|P2|STARTED|Overall Study||84
187240|NCT01387139|454637|P1|STARTED|Overall Study||99
187241|NCT01387074|454653|P1|NOT COMPLETED|Overall Study||8
187242|NCT01387074|454653|P1|COMPLETED|Overall Study||100
187243|NCT01387074|454653|P1|STARTED|Overall Study||108
187244|NCT01387022|454666|P2|NOT COMPLETED|Overall Study||4
187245|NCT01387022|454667|P1|NOT COMPLETED|Overall Study||1
187246|NCT01387022|454666|P2|COMPLETED|Overall Study||26
187247|NCT01387022|454667|P1|COMPLETED|Overall Study||28
187248|NCT01387022|454666|P2|STARTED|Overall Study||30
187249|NCT01387022|454667|P1|STARTED|Overall Study||29
187250|NCT01386983|454685|P2|NOT COMPLETED|Overall Study||0
187251|NCT01386983|454686|P1|NOT COMPLETED|Overall Study||0
187252|NCT01386983|454685|P2|COMPLETED|Overall Study||68
187253|NCT01386983|454686|P1|COMPLETED|Overall Study||264
187254|NCT01386983|454685|P2|STARTED|Overall Study||68
187255|NCT01386983|454686|P1|STARTED|Overall Study||264
187256|NCT01386944|454694|P1|NOT COMPLETED|Overall Study||56
187257|NCT01386944|454694|P1|COMPLETED|Overall Study||46
187258|NCT01386944|454694|P1|STARTED|Overall Study||102
187259|NCT01386788|454704|P1|NOT COMPLETED|Overall Study||2
187260|NCT01386788|454704|P1|COMPLETED|Overall Study||100
187261|NCT01386788|454704|P1|STARTED|Overall Study||102
187262|NCT01386684|454709|P1|NOT COMPLETED|Overall Study||293
187263|NCT01386684|454709|P1|COMPLETED|Overall Study||259
187264|NCT01386684|454709|P1|STARTED|Overall Study||552
187265|NCT01386658|454750|P2|NOT COMPLETED|Icatibant Exposure 3||0
187266|NCT01386658|454751|P1|NOT COMPLETED|Icatibant Exposure 3||0
187267|NCT01386658|454750|P2|COMPLETED|Icatibant Exposure 3||9
187268|NCT01386658|454751|P1|COMPLETED|Icatibant Exposure 3||0
187269|NCT01386658|454750|P2|STARTED|Icatibant Exposure 3||9
187270|NCT01386658|454751|P1|STARTED|Icatibant Exposure 3||0
187271|NCT01386658|454750|P2|NOT COMPLETED|Icatibant Exposure 2||0
187272|NCT01386658|454751|P1|NOT COMPLETED|Icatibant Exposure 2||0
187273|NCT01386658|454750|P2|COMPLETED|Icatibant Exposure 2||9
187274|NCT01386658|454751|P1|COMPLETED|Icatibant Exposure 2||0
187275|NCT01386658|454750|P2|STARTED|Icatibant Exposure 2||9
187276|NCT01386658|454751|P1|STARTED|Icatibant Exposure 2||0
187277|NCT01386658|454750|P2|NOT COMPLETED|Initial Icatibant Exposure||12
187278|NCT01386658|454751|P1|NOT COMPLETED|Initial Icatibant Exposure||0
187279|NCT01386658|454750|P2|COMPLETED|Initial Icatibant Exposure||9
187280|NCT01386658|454751|P1|COMPLETED|Initial Icatibant Exposure||11
187281|NCT01386658|454750|P2|STARTED|Initial Icatibant Exposure||21
187282|NCT01386658|454751|P1|STARTED|Initial Icatibant Exposure||11
187283|NCT01386632|454816|P2|NOT COMPLETED|Overall Study||4
187284|NCT01386632|454817|P1|NOT COMPLETED|Overall Study||5
187285|NCT01386632|454816|P2|COMPLETED|Overall Study||21
187286|NCT01386632|454817|P1|COMPLETED|Overall Study||20
187287|NCT01386632|454816|P2|STARTED|Overall Study||25
187288|NCT01386632|454817|P1|STARTED|Overall Study||25
187289|NCT01386606|454829|P4|NOT COMPLETED|Overall Study||1
187290|NCT01386606|454830|P3|NOT COMPLETED|Overall Study||3
187291|NCT01386606|454831|P2|NOT COMPLETED|Overall Study||4
187292|NCT01386606|454832|P1|NOT COMPLETED|Overall Study||4
187293|NCT01386606|454829|P4|COMPLETED|Overall Study||13
187294|NCT01386606|454830|P3|COMPLETED|Overall Study||13
187295|NCT01386606|454831|P2|COMPLETED|Overall Study||10
187296|NCT01386606|454832|P1|COMPLETED|Overall Study||12
187297|NCT01386606|454829|P4|STARTED|Overall Study||14
187298|NCT01386606|454830|P3|STARTED|Overall Study||16
187299|NCT01386606|454831|P2|STARTED|Overall Study||14
187300|NCT01386606|454832|P1|STARTED|Overall Study||16
187301|NCT01386554|454863|P3|NOT COMPLETED|Overall Study||6
187302|NCT01386554|454864|P2|NOT COMPLETED|Overall Study||9
187303|NCT01386554|454865|P1|NOT COMPLETED|Overall Study||3
187304|NCT01386554|454863|P3|COMPLETED|Overall Study||15
187305|NCT01386554|454864|P2|COMPLETED|Overall Study||26
187306|NCT01386554|454865|P1|COMPLETED|Overall Study||1
187307|NCT01386554|454863|P3|STARTED|Overall Study||21
187308|NCT01386554|454864|P2|STARTED|Overall Study||35
187309|NCT01386554|454865|P1|STARTED|Overall Study||4
187310|NCT01386528|454876|P1|NOT COMPLETED|Overall Study||0
187311|NCT01386528|454876|P1|COMPLETED|Overall Study||13
187312|NCT01386528|454876|P1|STARTED|Overall Study||13
187313|NCT01386125|454888|P2|NOT COMPLETED|Overall Study||37
187314|NCT01386125|454889|P1|NOT COMPLETED|Overall Study||25
187315|NCT01386125|454888|P2|COMPLETED|Overall Study||336
187316|NCT01386125|454889|P1|COMPLETED|Overall Study||350
187317|NCT01386125|454888|P2|STARTED|Overall Study||373
187318|NCT01386125|454889|P1|STARTED|Overall Study||375
187319|NCT01386008|454897|P1|NOT COMPLETED|Overall Study||20
187320|NCT01386008|454897|P1|COMPLETED|Overall Study||0
187321|NCT01386008|454897|P1|STARTED|Overall Study||20
187322|NCT01385995|454906|P2|NOT COMPLETED|Period 2, 2 Months||0
187323|NCT01385995|454907|P1|NOT COMPLETED|Period 2, 2 Months||0
187324|NCT01385995|454906|P2|COMPLETED|Period 2, 2 Months||25
187325|NCT01385995|454907|P1|COMPLETED|Period 2, 2 Months||24
187326|NCT01385995|454906|P2|STARTED|Period 2, 2 Months||25
187327|NCT01385995|454907|P1|STARTED|Period 2, 2 Months||24
187328|NCT01385995|454906|P2|NOT COMPLETED|Washout Period, 1 Month||0
187329|NCT01385995|454907|P1|NOT COMPLETED|Washout Period, 1 Month||0
187330|NCT01385995|454906|P2|COMPLETED|Washout Period, 1 Month||25
187331|NCT01385995|454907|P1|COMPLETED|Washout Period, 1 Month||24
187332|NCT01385995|454906|P2|STARTED|Washout Period, 1 Month||25
187333|NCT01385995|454907|P1|STARTED|Washout Period, 1 Month||24
187334|NCT01385995|454906|P2|NOT COMPLETED|Period 1, 2 Months||0
187335|NCT01385995|454907|P1|NOT COMPLETED|Period 1, 2 Months||1
187336|NCT01385995|454906|P2|COMPLETED|Period 1, 2 Months||25
187337|NCT01385995|454907|P1|COMPLETED|Period 1, 2 Months||24
187338|NCT01385995|454906|P2|STARTED|Period 1, 2 Months||25
187339|NCT01385995|454907|P1|STARTED|Period 1, 2 Months||25
187340|NCT01385748|454924|P3|NOT COMPLETED|Overall Study||13
187341|NCT01385748|454925|P2|NOT COMPLETED|Overall Study||14
187342|NCT01385748|454926|P1|NOT COMPLETED|Overall Study||15
187343|NCT01385748|454924|P3|COMPLETED|Overall Study||49
187344|NCT01385748|454925|P2|COMPLETED|Overall Study||51
187345|NCT01385748|454926|P1|COMPLETED|Overall Study||41
187346|NCT01385748|454924|P3|STARTED|Overall Study||62
187347|NCT01385748|454925|P2|STARTED|Overall Study||65
187348|NCT01385748|454926|P1|STARTED|Overall Study||56
187349|NCT01385696|454971|P2|NOT COMPLETED|Overall Study||0
187350|NCT01385696|454972|P1|NOT COMPLETED|Overall Study||0
187351|NCT01385696|454971|P2|COMPLETED|Overall Study||64
187352|NCT01385696|454972|P1|COMPLETED|Overall Study||66
187353|NCT01385696|454971|P2|STARTED|Overall Study|1 patient used Handihaler® once only, Genuair® zero times, & was excluded from the safety population|64
187354|NCT01385696|454972|P1|STARTED|Overall Study||66
187355|NCT01385644|454983|P2|NOT COMPLETED|Overall Study||0
187356|NCT01385644|454984|P1|NOT COMPLETED|Overall Study||0
187357|NCT01385644|454983|P2|COMPLETED|Overall Study||4
187358|NCT01385644|454984|P1|COMPLETED|Overall Study||4
187359|NCT01385644|454983|P2|STARTED|Overall Study||4
187360|NCT01385644|454984|P1|STARTED|Overall Study||4
187361|NCT01385579|454998|P2|NOT COMPLETED|Overall Study||0
187362|NCT01385579|454999|P1|NOT COMPLETED|Overall Study||0
187363|NCT01385579|454998|P2|COMPLETED|Overall Study||104
187364|NCT01385579|454999|P1|COMPLETED|Overall Study||98
187365|NCT01385579|454998|P2|STARTED|Overall Study||104
187366|NCT01385579|454999|P1|STARTED|Overall Study||98
187367|NCT01385566|455011|P6|NOT COMPLETED|Overall Study||0
187368|NCT01385566|455012|P5|NOT COMPLETED|Overall Study||0
187369|NCT01385566|455013|P4|NOT COMPLETED|Overall Study||1
187370|NCT01385566|455014|P3|NOT COMPLETED|Overall Study||0
187371|NCT01385566|455015|P2|NOT COMPLETED|Overall Study||0
187372|NCT01385566|455016|P1|NOT COMPLETED|Overall Study||1
187373|NCT01385566|455011|P6|COMPLETED|Overall Study||34
187374|NCT01385566|455012|P5|COMPLETED|Overall Study||34
187375|NCT01385566|455013|P4|COMPLETED|Overall Study||34
187376|NCT01385566|455014|P3|COMPLETED|Overall Study||34
187377|NCT01385566|455015|P2|COMPLETED|Overall Study||34
187378|NCT01385566|455016|P1|COMPLETED|Overall Study||51
187379|NCT01385566|455011|P6|STARTED|Overall Study||34
187380|NCT01385566|455012|P5|STARTED|Overall Study||34
187381|NCT01385566|455013|P4|STARTED|Overall Study||35
187382|NCT01385566|455014|P3|STARTED|Overall Study||34
187383|NCT01385566|455015|P2|STARTED|Overall Study||34
187384|NCT01385566|455016|P1|STARTED|Overall Study||52
187385|NCT01385371|455070|P2|NOT COMPLETED|Overall Study||97
187386|NCT01385371|455071|P1|NOT COMPLETED|Overall Study||149
187387|NCT01385371|455070|P2|COMPLETED|Overall Study||652
187388|NCT01385371|455071|P1|COMPLETED|Overall Study||603
187389|NCT01385371|455070|P2|STARTED|Overall Study||749
187390|NCT01385371|455071|P1|STARTED|Overall Study||752
187391|NCT01385306|455091|P1|NOT COMPLETED|Overall Study||0
187392|NCT01385306|455091|P1|COMPLETED|Overall Study||6
187393|NCT01385306|455091|P1|STARTED|Overall Study||6
187394|NCT01385293|455099|P1|NOT COMPLETED|Overall Study||0
187395|NCT01385293|455099|P1|COMPLETED|Overall Study||30
187396|NCT01385293|455099|P1|STARTED|Overall Study||30
187397|NCT01385280|455109|P1|NOT COMPLETED|Overall Study||0
187398|NCT01385280|455109|P1|COMPLETED|Overall Study||13
187399|NCT01385280|455109|P1|STARTED|Overall Study||13
187400|NCT01385202|455119|P1|NOT COMPLETED|Overall Study||18
187401|NCT01385202|455119|P1|COMPLETED|Overall Study||154
187402|NCT01385202|455119|P1|Undergoing Ablation|Overall Study||160
187403|NCT01385202|455119|P1|Study Catheter Inserted|Overall Study||161
187404|NCT01385202|455119|P1|STARTED|Overall Study|Per protocol, enrolled subjects were defined as those who signed inform consent form.|172
187405|NCT01385189|455131|P5|NOT COMPLETED|Overall Study||2
187406|NCT01385189|455132|P4|NOT COMPLETED|Overall Study||1
187407|NCT01385189|455133|P3|NOT COMPLETED|Overall Study||0
187408|NCT01385189|455134|P2|NOT COMPLETED|Overall Study||1
187409|NCT01385189|455135|P1|NOT COMPLETED|Overall Study||1
187410|NCT01385189|455131|P5|COMPLETED|Overall Study||6
187411|NCT01385189|455132|P4|COMPLETED|Overall Study||3
187412|NCT01385189|455133|P3|COMPLETED|Overall Study||4
187413|NCT01385189|455134|P2|COMPLETED|Overall Study||11
187414|NCT01385189|455135|P1|COMPLETED|Overall Study||11
187415|NCT01385189|455131|P5|STARTED|Overall Study||8
187416|NCT01385189|455132|P4|STARTED|Overall Study||4
187417|NCT01385189|455133|P3|STARTED|Overall Study||4
187418|NCT01385189|455134|P2|STARTED|Overall Study||12
187419|NCT01385189|455135|P1|STARTED|Overall Study||12
187420|NCT01385137|455156|P2|NOT COMPLETED|Evaluable for Primary Endpoint||24
187421|NCT01385137|455157|P1|NOT COMPLETED|Evaluable for Primary Endpoint||29
187422|NCT01385137|455156|P2|COMPLETED|Evaluable for Primary Endpoint||107
187423|NCT01385137|455157|P1|COMPLETED|Evaluable for Primary Endpoint||102
187424|NCT01385137|455156|P2|STARTED|Evaluable for Primary Endpoint||131
187425|NCT01385137|455157|P1|STARTED|Evaluable for Primary Endpoint||131
187426|NCT01385137|455156|P2|NOT COMPLETED|Evaluable at Baseline||4
187427|NCT01385137|455157|P1|NOT COMPLETED|Evaluable at Baseline||9
187428|NCT01385137|455156|P2|COMPLETED|Evaluable at Baseline||127
187429|NCT01385137|455157|P1|COMPLETED|Evaluable at Baseline||122
187430|NCT01385137|455156|P2|STARTED|Evaluable at Baseline||131
187431|NCT01385137|455157|P1|STARTED|Evaluable at Baseline||131
187432|NCT01385098|455171|P1|NOT COMPLETED|Overall Study||14
187433|NCT01385098|455171|P1|COMPLETED|Overall Study|14 subjects did not complete. 4 subjects loss to follow-up & 10 subjects could not tolerate suppl.|23
187434|NCT01385098|455171|P1|STARTED|Overall Study||37
187435|NCT01385033|455179|P6|NOT COMPLETED|Part III||0
187436|NCT01385033|455180|P5|NOT COMPLETED|Part III||0
187437|NCT01385033|455181|P4|NOT COMPLETED|Part III||0
187438|NCT01385033|455182|P3|NOT COMPLETED|Part III||0
187439|NCT01385033|455183|P2|NOT COMPLETED|Part III||0
187440|NCT01385033|455184|P1|NOT COMPLETED|Part III||0
187441|NCT01385033|455179|P6|COMPLETED|Part III||0
187442|NCT01385033|455180|P5|COMPLETED|Part III||0
187443|NCT01385033|455181|P4|COMPLETED|Part III||0
187444|NCT01385033|455182|P3|COMPLETED|Part III||0
187445|NCT01385033|455183|P2|COMPLETED|Part III||0
187446|NCT01385033|455184|P1|COMPLETED|Part III||0
187447|NCT01385033|455179|P6|STARTED|Part III||0
187448|NCT01385033|455180|P5|STARTED|Part III||0
187449|NCT01385033|455181|P4|STARTED|Part III||0
187450|NCT01385033|455182|P3|STARTED|Part III||0
187451|NCT01385033|455183|P2|STARTED|Part III||0
187452|NCT01385033|455184|P1|STARTED|Part III||0
187453|NCT01385033|455179|P6|NOT COMPLETED|Part II||0
187454|NCT01385033|455180|P5|NOT COMPLETED|Part II||0
187455|NCT01385033|455181|P4|NOT COMPLETED|Part II||0
187456|NCT01385033|455182|P3|NOT COMPLETED|Part II||0
187457|NCT01385033|455183|P2|NOT COMPLETED|Part II||0
187458|NCT01385033|455184|P1|NOT COMPLETED|Part II||0
187459|NCT01385033|455179|P6|COMPLETED|Part II||0
187460|NCT01385033|455180|P5|COMPLETED|Part II||0
187461|NCT01385033|455181|P4|COMPLETED|Part II||0
187462|NCT01385033|455182|P3|COMPLETED|Part II||0
187463|NCT01385033|455183|P2|COMPLETED|Part II||0
187464|NCT01385033|455184|P1|COMPLETED|Part II||0
187465|NCT01385033|455179|P6|STARTED|Part II||0
187466|NCT01385033|455180|P5|STARTED|Part II||0
187467|NCT01385033|455181|P4|STARTED|Part II||0
187468|NCT01385033|455182|P3|STARTED|Part II||0
187469|NCT01385033|455183|P2|STARTED|Part II||0
187470|NCT01385033|455184|P1|STARTED|Part II||0
187471|NCT01385033|455179|P6|NOT COMPLETED|Part I||0
187472|NCT01385033|455180|P5|NOT COMPLETED|Part I||0
187473|NCT01385033|455181|P4|NOT COMPLETED|Part I||0
187474|NCT01385033|455182|P3|NOT COMPLETED|Part I||0
187475|NCT01385033|455183|P2|NOT COMPLETED|Part I||0
187476|NCT01385033|455184|P1|NOT COMPLETED|Part I||0
187477|NCT01385033|455179|P6|COMPLETED|Part I||0
187478|NCT01385033|455180|P5|COMPLETED|Part I||0
187479|NCT01385033|455181|P4|COMPLETED|Part I||0
187480|NCT01385033|455182|P3|COMPLETED|Part I||0
187481|NCT01385033|455183|P2|COMPLETED|Part I||14
187482|NCT01385033|455184|P1|COMPLETED|Part I||6
187483|NCT01385033|455179|P6|STARTED|Part I||0
187484|NCT01385033|455180|P5|STARTED|Part I||0
187485|NCT01385033|455181|P4|STARTED|Part I||0
187486|NCT01385033|455182|P3|STARTED|Part I||0
187487|NCT01385033|455183|P2|STARTED|Part I|These subjects did not participate in Part II or III|14
187488|NCT01385033|455184|P1|STARTED|Part I|These subjects did not participate in Part II or III|6
187489|NCT01384877|455193|P2|NOT COMPLETED|Treatment 2||2
187490|NCT01384877|455194|P1|NOT COMPLETED|Treatment 2||2
187491|NCT01384877|455193|P2|COMPLETED|Treatment 2||11
187492|NCT01384877|455194|P1|COMPLETED|Treatment 2||14
187493|NCT01384877|455193|P2|STARTED|Treatment 2|2 Patients died between treatment periods|13
187494|NCT01384877|455194|P1|STARTED|Treatment 2|1 Patient died between treatment periods|16
187495|NCT01384877|455193|P2|NOT COMPLETED|Treatment 1||0
187496|NCT01384877|455194|P1|NOT COMPLETED|Treatment 1||0
187497|NCT01384877|455193|P2|COMPLETED|Treatment 1||15
187498|NCT01384877|455194|P1|COMPLETED|Treatment 1||17
187499|NCT01384877|455193|P2|STARTED|Treatment 1||15
187500|NCT01384877|455194|P1|STARTED|Treatment 1||17
187501|NCT01384760|455220|P2|NOT COMPLETED|Overall Study||6
187502|NCT01384760|455221|P1|NOT COMPLETED|Overall Study||16
187503|NCT01384760|455220|P2|COMPLETED|Overall Study||37
187504|NCT01384760|455221|P1|COMPLETED|Overall Study||45
187505|NCT01384760|455220|P2|Randomized|Overall Study||43
187506|NCT01384760|455221|P1|Randomized|Overall Study||61
187507|NCT01384760|455220|P2|STARTED|Overall Study||43
187508|NCT01384760|455221|P1|STARTED|Overall Study||61
187509|NCT01384734|455234|P5|NOT COMPLETED|Overall Study||29
187510|NCT01384734|455235|P4|NOT COMPLETED|Overall Study||28
187511|NCT01384734|455236|P3|NOT COMPLETED|Overall Study||23
187512|NCT01384734|455237|P2|NOT COMPLETED|Overall Study||24
187513|NCT01384734|455238|P1|NOT COMPLETED|Overall Study||17
187514|NCT01384734|455234|P5|COMPLETED|Overall Study||22
187515|NCT01384734|455235|P4|COMPLETED|Overall Study||22
187516|NCT01384734|455236|P3|COMPLETED|Overall Study||28
187517|NCT01384734|455237|P2|COMPLETED|Overall Study||25
187518|NCT01384734|455238|P1|COMPLETED|Overall Study||33
187519|NCT01384734|455234|P5|STARTED|Overall Study||51
187520|NCT01384734|455235|P4|STARTED|Overall Study||50
187521|NCT01384734|455236|P3|STARTED|Overall Study||51
187522|NCT01384734|455237|P2|STARTED|Overall Study||49
187523|NCT01384734|455238|P1|STARTED|Overall Study||50
187524|NCT01384591|455321|P3|NOT COMPLETED|Overall Study||0
187525|NCT01384591|455322|P2|NOT COMPLETED|Overall Study||0
187526|NCT01384591|455323|P1|NOT COMPLETED|Overall Study||0
187527|NCT01384591|455321|P3|COMPLETED|Overall Study||2
187528|NCT01384591|455322|P2|COMPLETED|Overall Study||2
187529|NCT01384591|455323|P1|COMPLETED|Overall Study||2
187530|NCT01384591|455321|P3|STARTED|Overall Study||2
187531|NCT01384591|455322|P2|STARTED|Overall Study||2
187532|NCT01384591|455323|P1|STARTED|Overall Study||2
187533|NCT01384539|455453|P2|NOT COMPLETED|Overall Study||7
187534|NCT01384539|455454|P1|NOT COMPLETED|Overall Study||6
187535|NCT01384539|455453|P2|COMPLETED|Overall Study||57
187536|NCT01384539|455454|P1|COMPLETED|Overall Study||58
187537|NCT01384539|455453|P2|STARTED|Overall Study||64
187538|NCT01384539|455454|P1|STARTED|Overall Study||64
187539|NCT01384292|455467|P3|NOT COMPLETED|Part B||0
187540|NCT01384292|455468|P2|NOT COMPLETED|Part B||0
187541|NCT01384292|455469|P1|NOT COMPLETED|Part B||1
187542|NCT01384292|455467|P3|COMPLETED|Part B||0
187543|NCT01384292|455468|P2|COMPLETED|Part B||6
187544|NCT01384292|455469|P1|COMPLETED|Part B||2
187545|NCT01384292|455467|P3|STARTED|Part B||0
187546|NCT01384292|455468|P2|STARTED|Part B||6
187547|NCT01384292|455469|P1|STARTED|Part B||3
187548|NCT01384292|455467|P3|NOT COMPLETED|Part A||0
187549|NCT01384292|455468|P2|NOT COMPLETED|Part A||0
187550|NCT01384292|455469|P1|NOT COMPLETED|Part A||0
187551|NCT01384292|455467|P3|COMPLETED|Part A||4
187552|NCT01384292|455468|P2|COMPLETED|Part A||5
187553|NCT01384292|455469|P1|COMPLETED|Part A||5
187554|NCT01384292|455467|P3|STARTED|Part A||4
187555|NCT01384292|455468|P2|STARTED|Part A||5
187556|NCT01384292|455469|P1|STARTED|Part A||5
187557|NCT01384019|455481|P2|NOT COMPLETED|Overall Study||6
187558|NCT01384019|455482|P1|NOT COMPLETED|Overall Study||10
187559|NCT01384019|455481|P2|COMPLETED|Overall Study||55
187560|NCT01384019|455482|P1|COMPLETED|Overall Study||55
187561|NCT01384019|455481|P2|STARTED|Overall Study||61
187562|NCT01384019|455482|P1|STARTED|Overall Study||65
187563|NCT01383993|455491|P3|NOT COMPLETED|Overall Study||1
187564|NCT01383993|455492|P2|NOT COMPLETED|Overall Study||1
187565|NCT01383993|455493|P1|NOT COMPLETED|Overall Study||3
187566|NCT01383993|455491|P3|COMPLETED|Overall Study||1
187567|NCT01383993|455492|P2|COMPLETED|Overall Study||3
187568|NCT01383993|455493|P1|COMPLETED|Overall Study||12
187569|NCT01383993|455491|P3|STARTED|Overall Study||2
187570|NCT01383993|455492|P2|STARTED|Overall Study||4
187571|NCT01383993|455493|P1|STARTED|Overall Study||15
187572|NCT01383954|455540|P1|NOT COMPLETED|Overall Study||14
187573|NCT01383954|455540|P1|COMPLETED|Overall Study||38
187574|NCT01383954|455540|P1|Safety Population: Received Treatment|Overall Study||48
187575|NCT01383954|455540|P1|STARTED|Overall Study||52
187576|NCT01383928|455548|P3|NOT COMPLETED|Overall Study||40
187577|NCT01383928|455549|P2|NOT COMPLETED|Overall Study||7
187578|NCT01383928|455550|P1|NOT COMPLETED|Overall Study||5
187579|NCT01383928|455548|P3|COMPLETED|Overall Study||10
187580|NCT01383928|455549|P2|COMPLETED|Overall Study||0
187581|NCT01383928|455550|P1|COMPLETED|Overall Study||2
187582|NCT01383928|455548|P3|STARTED|Overall Study||50
187583|NCT01383928|455549|P2|STARTED|Overall Study||7
187584|NCT01383928|455550|P1|STARTED|Overall Study||7
187585|NCT01383720|455592|P1|NOT COMPLETED|Overall Study||0
187586|NCT01383720|455592|P1|COMPLETED|Overall Study|Study is continuing to 5 years. All patients are still in the study.|11
187587|NCT01383720|455592|P1|Primary Endpoint (Discharge/7 Days)|Overall Study||11
187588|NCT01383720|455592|P1|STARTED|Overall Study||11
187589|NCT01383707|455614|P1|NOT COMPLETED|Overall Study||72
187590|NCT01383707|455614|P1|COMPLETED|Overall Study||5
187591|NCT01383707|455614|P1|STARTED|Overall Study||77
187592|NCT01383681|455623|P1|NOT COMPLETED|Overall Study||46
187593|NCT01383681|455623|P1|COMPLETED|Overall Study||189
187594|NCT01383681|455623|P1|STARTED|Overall Study||235
187595|NCT01383616|455630|P2|NOT COMPLETED|Overall Study||23
187596|NCT01383616|455631|P1|NOT COMPLETED|Overall Study||17
187597|NCT01383616|455630|P2|COMPLETED|Overall Study||21
187598|NCT01383616|455631|P1|COMPLETED|Overall Study||23
187599|NCT01383616|455630|P2|STARTED|Overall Study||44
187600|NCT01383616|455631|P1|STARTED|Overall Study||40
187601|NCT01383499|455654|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
187602|NCT01383499|455655|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
187603|NCT01383499|455656|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
187604|NCT01383499|455657|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
187605|NCT01383499|455654|P4|COMPLETED|Period 3 (4 Weeks)||25
187606|NCT01383499|455655|P3|COMPLETED|Period 3 (4 Weeks)||25
187607|NCT01383499|455656|P2|COMPLETED|Period 3 (4 Weeks)||24
187608|NCT01383499|455657|P1|COMPLETED|Period 3 (4 Weeks)||26
187609|NCT01383499|455654|P4|STARTED|Period 3 (4 Weeks)||25
187610|NCT01383499|455655|P3|STARTED|Period 3 (4 Weeks)||25
187611|NCT01383499|455656|P2|STARTED|Period 3 (4 Weeks)||24
187612|NCT01383499|455657|P1|STARTED|Period 3 (4 Weeks)||26
187613|NCT01383499|455654|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
187614|NCT01383499|455655|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
187615|NCT01383499|455656|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
187616|NCT01383499|455657|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
187617|NCT01383499|455654|P4|COMPLETED|Period 2 (4 Weeks)||25
187618|NCT01383499|455655|P3|COMPLETED|Period 2 (4 Weeks)||25
187619|NCT01383499|455656|P2|COMPLETED|Period 2 (4 Weeks)||24
187620|NCT01383499|455657|P1|COMPLETED|Period 2 (4 Weeks)||26
187621|NCT01383499|455654|P4|STARTED|Period 2 (4 Weeks)||25
187622|NCT01383499|455655|P3|STARTED|Period 2 (4 Weeks)||25
187623|NCT01383499|455656|P2|STARTED|Period 2 (4 Weeks)||24
187624|NCT01383499|455657|P1|STARTED|Period 2 (4 Weeks)||26
187625|NCT01383499|455654|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
187626|NCT01383499|455655|P3|NOT COMPLETED|Period 1 (4 Weeks)||0
187627|NCT01383499|455656|P2|NOT COMPLETED|Period 1 (4 Weeks)||0
187628|NCT01383499|455657|P1|NOT COMPLETED|Period 1 (4 Weeks)||1
187629|NCT01383499|455654|P4|COMPLETED|Period 1 (4 Weeks)||25
187630|NCT01383499|455655|P3|COMPLETED|Period 1 (4 Weeks)||25
187631|NCT01383499|455656|P2|COMPLETED|Period 1 (4 Weeks)||24
187632|NCT01383499|455657|P1|COMPLETED|Period 1 (4 Weeks)||26
187633|NCT01383499|455654|P4|STARTED|Period 1 (4 Weeks)||25
187634|NCT01383499|455655|P3|STARTED|Period 1 (4 Weeks)||25
187635|NCT01383499|455656|P2|STARTED|Period 1 (4 Weeks)||24
187636|NCT01383499|455657|P1|STARTED|Period 1 (4 Weeks)||27
187637|NCT01383486|455707|P1|NOT COMPLETED|Overall Study||18
187638|NCT01383486|455707|P1|COMPLETED|Overall Study|Took any study medication and gave estimated duration of pain (Selection Evaluation Population)|235
187639|NCT01383486|455707|P1|Treated|Overall Study|Number of participants who took any study medication (Safety Population)|237
187640|NCT01383486|455707|P1|STARTED|Overall Study|Number of participants who were provided with investigational products|253
187641|NCT01383447|455713|P1|NOT COMPLETED|Overall Study||2
187642|NCT01383447|455713|P1|COMPLETED|Overall Study||0
187643|NCT01383447|455713|P1|STARTED|Overall Study||2
187644|NCT01383421|455721|P1|NOT COMPLETED|Overall Study||346
187645|NCT01383421|455721|P1|COMPLETED|Overall Study||679
187646|NCT01383421|455721|P1|STARTED|Overall Study|ITT population: all enrolled participants who received at least 1 dose of study drug.|1025
187647|NCT01383356|455784|P2|NOT COMPLETED|Period 2||0
187648|NCT01383356|455785|P1|NOT COMPLETED|Period 2||0
187649|NCT01383356|455784|P2|COMPLETED|Period 2|Completed period 2.|23
187650|NCT01383356|455785|P1|COMPLETED|Period 2|Completed period 2.|21
187651|NCT01383356|455784|P2|STARTED|Period 2|Entered and treated.|23
187652|NCT01383356|455785|P1|STARTED|Period 2|Entered and treated.|21
187653|NCT01383356|455784|P2|NOT COMPLETED|Washout Period (at Least 35 Days)||0
187654|NCT01383356|455785|P1|NOT COMPLETED|Washout Period (at Least 35 Days)||0
187655|NCT01383356|455784|P2|COMPLETED|Washout Period (at Least 35 Days)||23
187656|NCT01383356|455785|P1|COMPLETED|Washout Period (at Least 35 Days)||21
187657|NCT01383356|455784|P2|STARTED|Washout Period (at Least 35 Days)||23
187658|NCT01383356|455785|P1|STARTED|Washout Period (at Least 35 Days)||21
187659|NCT01383356|455784|P2|NOT COMPLETED|Period 1||6
187660|NCT01383356|455785|P1|NOT COMPLETED|Period 1||8
187661|NCT01383356|455784|P2|COMPLETED|Period 1|Completed period 1.|23
187662|NCT01383356|455785|P1|COMPLETED|Period 1|Completed period 1.|21
187663|NCT01383356|455784|P2|STARTED|Period 1|Entered and treated.|29
187664|NCT01383356|455785|P1|STARTED|Period 1|Entered and treated.|29
187665|NCT01383317|455797|P2|NOT COMPLETED|Overall Study||2
187666|NCT01383317|455798|P1|NOT COMPLETED|Overall Study||3
187667|NCT01383317|455797|P2|COMPLETED|Overall Study||33
187668|NCT01383317|455798|P1|COMPLETED|Overall Study||26
187669|NCT01383317|455797|P2|STARTED|Overall Study||35
187670|NCT01383317|455798|P1|STARTED|Overall Study||29
187671|NCT01383213|455822|P2|NOT COMPLETED|Overall Study||0
187672|NCT01383213|455823|P1|NOT COMPLETED|Overall Study||0
187673|NCT01383213|455822|P2|COMPLETED|Overall Study||41
187674|NCT01383213|455823|P1|COMPLETED|Overall Study||40
187675|NCT01383213|455822|P2|STARTED|Overall Study||41
187676|NCT01383213|455823|P1|STARTED|Overall Study||40
187677|NCT01383200|455831|P2|NOT COMPLETED|Overall Study||0
187678|NCT01383200|455832|P1|NOT COMPLETED|Overall Study||0
187679|NCT01383200|455831|P2|COMPLETED|Overall Study||6
187680|NCT01383200|455832|P1|COMPLETED|Overall Study||5
187681|NCT01383200|455831|P2|STARTED|Overall Study||6
187682|NCT01383200|455832|P1|STARTED|Overall Study||5
187683|NCT01383174|455840|P2|NOT COMPLETED|6 Month Assessment||1
187684|NCT01383174|455841|P1|NOT COMPLETED|6 Month Assessment||5
187685|NCT01383174|455840|P2|COMPLETED|6 Month Assessment|These 73 completed the 6 month assessment and completed the study.|73
187686|NCT01383174|455841|P1|COMPLETED|6 Month Assessment|These 71 completed the 6 month assessment and completed the study.|71
187687|NCT01383174|455840|P2|STARTED|6 Month Assessment||74
187688|NCT01383174|455841|P1|STARTED|6 Month Assessment|All 76 people were contacted at 6 months;1 person returned and 5 did not return to study at 6 months|76
187689|NCT01383174|455840|P2|NOT COMPLETED|3 Month Assessment||1
187690|NCT01383174|455841|P1|NOT COMPLETED|3 Month Assessment||6
187691|NCT01383174|455840|P2|COMPLETED|3 Month Assessment|These 74 completed the 3 month assessment and continued in the study.|74
187692|NCT01383174|455841|P1|COMPLETED|3 Month Assessment|These 70 completed the 3 month assessment and continued in the study.|70
187693|NCT01383174|455840|P2|STARTED|3 Month Assessment||75
187694|NCT01383174|455841|P1|STARTED|3 Month Assessment||76
187695|NCT01383174|455840|P2|NOT COMPLETED|Baseline Assessment||0
187696|NCT01383174|455841|P1|NOT COMPLETED|Baseline Assessment||0
187697|NCT01383174|455840|P2|COMPLETED|Baseline Assessment|These 75 completed the baseline assessment and continued in the study.|75
187698|NCT01383174|455841|P1|COMPLETED|Baseline Assessment|These 76 completed the baseline assessment and continued in the study.|76
187699|NCT01383174|455840|P2|STARTED|Baseline Assessment||75
187700|NCT01383174|455841|P1|STARTED|Baseline Assessment||76
187701|NCT01383161|455867|P2|NOT COMPLETED|Overall Study||4
187702|NCT01383161|455868|P1|NOT COMPLETED|Overall Study||5
187703|NCT01383161|455867|P2|COMPLETED|Overall Study||17
187704|NCT01383161|455868|P1|COMPLETED|Overall Study||20
187705|NCT01383161|455867|P2|STARTED|Overall Study||21
187706|NCT01383161|455868|P1|STARTED|Overall Study||25
187707|NCT01383096|455887|P3|NOT COMPLETED|Fifth Intervention (8 Days)||0
187708|NCT01383096|455888|P2|NOT COMPLETED|Fifth Intervention (8 Days)||0
187709|NCT01383096|455889|P1|NOT COMPLETED|Fifth Intervention (8 Days)||2
187710|NCT01383096|455887|P3|COMPLETED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
187711|NCT01383096|455888|P2|COMPLETED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
187712|NCT01383096|455889|P1|COMPLETED|Fifth Intervention (8 Days)||11
187713|NCT01383096|455887|P3|STARTED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
187714|NCT01383096|455888|P2|STARTED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
187715|NCT01383096|455889|P1|STARTED|Fifth Intervention (8 Days)||13
187716|NCT01383096|455887|P3|NOT COMPLETED|Fourth Intervention (8 Days)||0
187717|NCT01383096|455888|P2|NOT COMPLETED|Fourth Intervention (8 Days)||0
187718|NCT01383096|455889|P1|NOT COMPLETED|Fourth Intervention (8 Days)||2
187719|NCT01383096|455887|P3|COMPLETED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
187720|NCT01383096|455888|P2|COMPLETED|Fourth Intervention (8 Days)||12
187721|NCT01383096|455889|P1|COMPLETED|Fourth Intervention (8 Days)||13
187722|NCT01383096|455887|P3|STARTED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
187723|NCT01383096|455888|P2|STARTED|Fourth Intervention (8 Days)||12
187724|NCT01383096|455889|P1|STARTED|Fourth Intervention (8 Days)||15
187725|NCT01383096|455887|P3|NOT COMPLETED|Third Intervention (8 Days)||0
187726|NCT01383096|455888|P2|NOT COMPLETED|Third Intervention (8 Days)||4
187727|NCT01383096|455889|P1|NOT COMPLETED|Third Intervention (8 Days)||4
187728|NCT01383096|455887|P3|COMPLETED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
187729|NCT01383096|455888|P2|COMPLETED|Third Intervention (8 Days)||12
187730|NCT01383096|455889|P1|COMPLETED|Third Intervention (8 Days)||15
187731|NCT01383096|455887|P3|STARTED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
187732|NCT01383096|455888|P2|STARTED|Third Intervention (8 Days)||16
187733|NCT01383096|455889|P1|STARTED|Third Intervention (8 Days)||19
187734|NCT01383096|455887|P3|NOT COMPLETED|Second Intervention (8 Days)||2
187735|NCT01383096|455888|P2|NOT COMPLETED|Second Intervention (8 Days)||1
187736|NCT01383096|455889|P1|NOT COMPLETED|Second Intervention (8 Days)||0
187737|NCT01383096|455887|P3|COMPLETED|Second Intervention (8 Days)||14
187738|NCT01383096|455888|P2|COMPLETED|Second Intervention (8 Days)||16
187739|NCT01383096|455889|P1|COMPLETED|Second Intervention (8 Days)||19
187740|NCT01383096|455887|P3|STARTED|Second Intervention (8 Days)||16
187741|NCT01383096|455888|P2|STARTED|Second Intervention (8 Days)||17
187742|NCT01383096|455889|P1|STARTED|Second Intervention (8 Days)||19
187743|NCT01383096|455887|P3|NOT COMPLETED|First Intervention (8 Days)||0
187744|NCT01383096|455888|P2|NOT COMPLETED|First Intervention (8 Days)||0
187745|NCT01383096|455889|P1|NOT COMPLETED|First Intervention (8 Days)||0
187746|NCT01383096|455887|P3|COMPLETED|First Intervention (8 Days)||16
187747|NCT01383096|455888|P2|COMPLETED|First Intervention (8 Days)||17
187748|NCT01383096|455889|P1|COMPLETED|First Intervention (8 Days)||19
187749|NCT01383096|455887|P3|STARTED|First Intervention (8 Days)||16
187750|NCT01383096|455888|P2|STARTED|First Intervention (8 Days)||17
187751|NCT01383096|455889|P1|STARTED|First Intervention (8 Days)||19
187752|NCT01383005|455937|P2|NOT COMPLETED|Overall Study||0
187753|NCT01383005|455938|P1|NOT COMPLETED|Overall Study||0
187754|NCT01383005|455937|P2|COMPLETED|Overall Study||60
187755|NCT01383005|455938|P1|COMPLETED|Overall Study||34
187756|NCT01383005|455937|P2|STARTED|Overall Study||60
187757|NCT01383005|455938|P1|STARTED|Overall Study||34
187758|NCT01382940|455957|P1|NOT COMPLETED|Overall Study||73
187759|NCT01382940|455957|P1|COMPLETED|Overall Study||278
187760|NCT01382940|455957|P1|Received Day 182 Infusion|Overall Study||278
187761|NCT01382940|455957|P1|Received Day 168 Infusion|Overall Study||290
187762|NCT01382940|455957|P1|Received Day 15 Infusions|Overall Study||341
187763|NCT01382940|455957|P1|Received Day 1 Infusion|Overall Study||351
187764|NCT01382940|455957|P1|STARTED|Overall Study||351
187765|NCT01382901|455969|P2|NOT COMPLETED|Overall Study||14
187766|NCT01382901|455970|P1|NOT COMPLETED|Overall Study||17
187767|NCT01382901|455969|P2|COMPLETED|Overall Study||7
187768|NCT01382901|455970|P1|COMPLETED|Overall Study||7
187769|NCT01382901|455969|P2|STARTED|Overall Study||21
187770|NCT01382901|455970|P1|STARTED|Overall Study||24
187771|NCT01382719|455980|P4|NOT COMPLETED|Overall Study||33
187772|NCT01382719|455981|P3|NOT COMPLETED|Overall Study||34
187773|NCT01382719|455982|P2|NOT COMPLETED|Overall Study||19
187774|NCT01382719|455983|P1|NOT COMPLETED|Overall Study||18
187775|NCT01382719|455980|P4|COMPLETED|Overall Study||66
187776|NCT01382719|455981|P3|COMPLETED|Overall Study||66
187777|NCT01382719|455982|P2|COMPLETED|Overall Study||81
187778|NCT01382719|455983|P1|COMPLETED|Overall Study||80
187779|NCT01382719|455980|P4|Subjects Not Dosed|Overall Study||1
187780|NCT01382719|455981|P3|Subjects Not Dosed|Overall Study||1
187781|NCT01382719|455982|P2|Subjects Not Dosed|Overall Study||0
187782|NCT01382719|455983|P1|Subjects Not Dosed|Overall Study||1
187783|NCT01382719|455980|P4|STARTED|Overall Study||99
187784|NCT01382719|455981|P3|STARTED|Overall Study||100
187785|NCT01382719|455982|P2|STARTED|Overall Study||100
187786|NCT01382719|455983|P1|STARTED|Overall Study||98
187787|NCT01382602|456019|P2|NOT COMPLETED|Overall Study||4
187788|NCT01382602|456020|P1|NOT COMPLETED|Overall Study||0
187789|NCT01382602|456019|P2|COMPLETED|Overall Study||46
187790|NCT01382602|456020|P1|COMPLETED|Overall Study||93
187791|NCT01382602|456019|P2|STARTED|Overall Study||50
187792|NCT01382602|456020|P1|STARTED|Overall Study||93
187793|NCT01382446|456028|P2|NOT COMPLETED|Overall Study||4
187794|NCT01382446|456029|P1|NOT COMPLETED|Overall Study||3
187795|NCT01382446|456028|P2|COMPLETED|Overall Study||29
187796|NCT01382446|456029|P1|COMPLETED|Overall Study||30
187797|NCT01382446|456028|P2|STARTED|Overall Study||33
187798|NCT01382446|456029|P1|STARTED|Overall Study||33
187799|NCT01382303|456037|P2|NOT COMPLETED|Overall Study||17
187800|NCT01382303|456038|P1|NOT COMPLETED|Overall Study||35
187801|NCT01382303|456037|P2|COMPLETED|Overall Study||70
187802|NCT01382303|456038|P1|COMPLETED|Overall Study||52
187803|NCT01382303|456037|P2|STARTED|Overall Study||87
187804|NCT01382303|456038|P1|STARTED|Overall Study||87
187805|NCT01382251|456056|P2|NOT COMPLETED|Overall Study||21
187806|NCT01382251|456057|P1|NOT COMPLETED|Overall Study||21
187807|NCT01382251|456056|P2|COMPLETED|Overall Study||102
187808|NCT01382251|456057|P1|COMPLETED|Overall Study||102
187809|NCT01382251|456056|P2|STARTED|Overall Study||123
187810|NCT01382251|456057|P1|STARTED|Overall Study||123
187811|NCT01382225|456070|P2|NOT COMPLETED|Overall Study||7
187812|NCT01382225|456071|P1|NOT COMPLETED|Overall Study||14
187813|NCT01382225|456070|P2|COMPLETED|Overall Study||722
187814|NCT01382225|456071|P1|COMPLETED|Overall Study||711
187815|NCT01382225|456070|P2|STARTED|Overall Study||729
187816|NCT01382225|456071|P1|STARTED|Overall Study||725
187817|NCT01382212|456093|P1|NOT COMPLETED|Overall Study||2
187818|NCT01382212|456093|P1|COMPLETED|Overall Study||11
187819|NCT01382212|456093|P1|STARTED|Overall Study||13
187820|NCT01382186|456119|P2|NOT COMPLETED|Overall Study||0
187821|NCT01382186|456120|P1|NOT COMPLETED|Overall Study||1
187822|NCT01382186|456119|P2|COMPLETED|Overall Study||819
187823|NCT01382186|456120|P1|COMPLETED|Overall Study||32
187824|NCT01382186|456119|P2|STARTED|Overall Study||819
187825|NCT01382186|456120|P1|STARTED|Overall Study||33
187826|NCT01382108|456136|P2|NOT COMPLETED|Overall Study||0
187827|NCT01382108|456137|P1|NOT COMPLETED|Overall Study||0
187828|NCT01382108|456136|P2|COMPLETED|Overall Study||19
187829|NCT01382108|456137|P1|COMPLETED|Overall Study||20
187830|NCT01382108|456136|P2|STARTED|Overall Study||19
187831|NCT01382108|456137|P1|STARTED|Overall Study||20
187832|NCT01381952|456147|P1|NOT COMPLETED|Overall Study||0
187833|NCT01381952|456147|P1|COMPLETED|Overall Study||20
187834|NCT01381952|456147|P1|Collected Dose and Image Information|Overall Study||20
187835|NCT01381952|456147|P1|STARTED|Overall Study||20
187836|NCT01381926|456156|P2|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
187837|NCT01381926|456157|P1|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
187838|NCT01381926|456156|P2|COMPLETED|Low/High Dose of 2nd Treatment (2months)||4
187839|NCT01381926|456157|P1|COMPLETED|Low/High Dose of 2nd Treatment (2months)||3
187840|NCT01381926|456156|P2|STARTED|Low/High Dose of 2nd Treatment (2months)||4
187841|NCT01381926|456157|P1|STARTED|Low/High Dose of 2nd Treatment (2months)||3
187842|NCT01381926|456156|P2|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||1
187843|NCT01381926|456157|P1|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||2
187844|NCT01381926|456156|P2|COMPLETED|Low/High Dose of 1st Treatment (2months)||4
187845|NCT01381926|456157|P1|COMPLETED|Low/High Dose of 1st Treatment (2months)||3
187846|NCT01381926|456156|P2|STARTED|Low/High Dose of 1st Treatment (2months)||5
187847|NCT01381926|456157|P1|STARTED|Low/High Dose of 1st Treatment (2months)||5
187848|NCT01381900|456170|P3|NOT COMPLETED|Overall Study||12
187849|NCT01381900|456171|P2|NOT COMPLETED|Overall Study||9
187850|NCT01381900|456172|P1|NOT COMPLETED|Overall Study||9
187851|NCT01381900|456170|P3|COMPLETED|Overall Study||215
187852|NCT01381900|456171|P2|COMPLETED|Overall Study||214
187853|NCT01381900|456172|P1|COMPLETED|Overall Study||217
187854|NCT01381900|456170|P3|STARTED|Overall Study||227
187855|NCT01381900|456171|P2|STARTED|Overall Study||223
187856|NCT01381900|456172|P1|STARTED|Overall Study||226
187857|NCT01381874|456195|P3|NOT COMPLETED|Overall Study||76
187858|NCT01381874|456196|P2|NOT COMPLETED|Overall Study||63
187859|NCT01381874|456197|P1|NOT COMPLETED|Overall Study||77
187860|NCT01381874|456195|P3|COMPLETED|Overall Study||30
187861|NCT01381874|456196|P2|COMPLETED|Overall Study||26
187862|NCT01381874|456197|P1|COMPLETED|Overall Study||25
187863|NCT01381874|456195|P3|Treated|Overall Study||104
187864|NCT01381874|456196|P2|Treated|Overall Study||87
187865|NCT01381874|456197|P1|Treated|Overall Study||102
187866|NCT01381874|456195|P3|STARTED|Overall Study||106
187867|NCT01381874|456196|P2|STARTED|Overall Study||89
187868|NCT01381874|456197|P1|STARTED|Overall Study||102
187869|NCT01381861|456223|P1|NOT COMPLETED|Overall Study||0
187870|NCT01381861|456223|P1|COMPLETED|Overall Study||23
187871|NCT01381861|456223|P1|STARTED|Overall Study||23
187872|NCT01381679|456234|P1|NOT COMPLETED|Overall Study||888
187873|NCT01381679|456234|P1|COMPLETED|Overall Study||794
187874|NCT01381679|456234|P1|STARTED|Overall Study||1682
187875|NCT01381575|456249|P3|NOT COMPLETED|Overall Study||7
187876|NCT01381575|456250|P2|NOT COMPLETED|Overall Study||10
187877|NCT01381575|456251|P1|NOT COMPLETED|Overall Study||2
187878|NCT01381575|456249|P3|COMPLETED|Overall Study||408
187879|NCT01381575|456250|P2|COMPLETED|Overall Study||472
187880|NCT01381575|456251|P1|COMPLETED|Overall Study||548
187881|NCT01381575|456249|P3|STARTED|Overall Study||415
187882|NCT01381575|456250|P2|STARTED|Overall Study||482
187883|NCT01381575|456251|P1|STARTED|Overall Study||550
187884|NCT01381562|456308|P3|NOT COMPLETED|Overall Study||0
187885|NCT01381562|456309|P2|NOT COMPLETED|Overall Study||1
187886|NCT01381562|456310|P1|NOT COMPLETED|Overall Study||0
187887|NCT01381562|456308|P3|COMPLETED|Overall Study||5
187888|NCT01381562|456309|P2|COMPLETED|Overall Study||3
187889|NCT01381562|456310|P1|COMPLETED|Overall Study||5
187890|NCT01381562|456308|P3|STARTED|Overall Study||5
187891|NCT01381562|456309|P2|STARTED|Overall Study||4
187892|NCT01381562|456310|P1|STARTED|Overall Study||5
187893|NCT01381549|456378|P3|NOT COMPLETED|Overall Study||1
187894|NCT01381549|456379|P2|NOT COMPLETED|Overall Study||0
187895|NCT01381549|456380|P1|NOT COMPLETED|Overall Study||0
187896|NCT01381549|456378|P3|COMPLETED|Overall Study||5
187897|NCT01381549|456379|P2|COMPLETED|Overall Study||8
187898|NCT01381549|456380|P1|COMPLETED|Overall Study||6
187899|NCT01381549|456378|P3|STARTED|Overall Study||6
187900|NCT01381549|456379|P2|STARTED|Overall Study||8
187901|NCT01381549|456380|P1|STARTED|Overall Study||6
187902|NCT01381471|456475|P1|NOT COMPLETED|Overall Study||0
187903|NCT01381471|456475|P1|COMPLETED|Overall Study||11060
187904|NCT01381471|456475|P1|STARTED|Overall Study||11060
187905|NCT01381406|456482|P2|NOT COMPLETED|Overall Study||0
187906|NCT01381406|456483|P1|NOT COMPLETED|Overall Study||0
187907|NCT01381406|456482|P2|COMPLETED|Overall Study||852
187908|NCT01381406|456483|P1|COMPLETED|Overall Study||2481
187909|NCT01381406|456482|P2|STARTED|Overall Study||852
187910|NCT01381406|456483|P1|STARTED|Overall Study||2481
187911|NCT01381120|456495|P2|NOT COMPLETED|Overall Study||9
187912|NCT01381120|456496|P1|NOT COMPLETED|Overall Study||11
187913|NCT01381120|456495|P2|COMPLETED|Overall Study||18
187914|NCT01381120|456496|P1|COMPLETED|Overall Study||39
187915|NCT01381120|456495|P2|STARTED|Overall Study||27
187916|NCT01381120|456496|P1|STARTED|Overall Study||50
187917|NCT01381016|456506|P2|NOT COMPLETED|Overall Study||6
187918|NCT01381016|456507|P1|NOT COMPLETED|Overall Study||3
187919|NCT01381016|456506|P2|COMPLETED|Overall Study||11
187920|NCT01381016|456507|P1|COMPLETED|Overall Study||10
187921|NCT01381016|456506|P2|STARTED|Overall Study||17
187922|NCT01381016|456507|P1|STARTED|Overall Study||13
187923|NCT01380834|456517|P2|NOT COMPLETED|Overall Study||0
187924|NCT01380834|456518|P1|NOT COMPLETED|Overall Study||1
187925|NCT01380834|456517|P2|COMPLETED|Overall Study||42
187926|NCT01380834|456518|P1|COMPLETED|Overall Study||41
187927|NCT01380834|456517|P2|STARTED|Overall Study||42
187928|NCT01380834|456518|P1|STARTED|Overall Study||42
187929|NCT01380782|456530|P4|NOT COMPLETED|Overall Study||4
187930|NCT01380782|456531|P3|NOT COMPLETED|Overall Study||11
187931|NCT01380782|456532|P2|NOT COMPLETED|Overall Study||10
187932|NCT01380782|456533|P1|NOT COMPLETED|Overall Study||12
187933|NCT01380782|456530|P4|COMPLETED|Overall Study||0
187934|NCT01380782|456531|P3|COMPLETED|Overall Study||0
187935|NCT01380782|456532|P2|COMPLETED|Overall Study||0
187936|NCT01380782|456533|P1|COMPLETED|Overall Study||0
187937|NCT01380782|456530|P4|STARTED|Overall Study||4
187938|NCT01380782|456531|P3|STARTED|Overall Study||11
187939|NCT01380782|456532|P2|STARTED|Overall Study||10
187940|NCT01380782|456533|P1|STARTED|Overall Study||12
187941|NCT01380769|456556|P2|NOT COMPLETED|Overall Study||14
187942|NCT01380769|456557|P1|NOT COMPLETED|Overall Study||9
187943|NCT01380769|456556|P2|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|43
187944|NCT01380769|456557|P1|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|91
187945|NCT01380769|456556|P2|STARTED|Overall Study||57
187946|NCT01380769|456557|P1|STARTED|Overall Study||100
187947|NCT01380743|456569|P4|NOT COMPLETED|Overall Study||0
187948|NCT01380743|456570|P3|NOT COMPLETED|Overall Study||0
187949|NCT01380743|456571|P2|NOT COMPLETED|Overall Study||0
187950|NCT01380743|456572|P1|NOT COMPLETED|Overall Study||0
187951|NCT01380743|456569|P4|COMPLETED|Overall Study||7
187952|NCT01380743|456570|P3|COMPLETED|Overall Study||6
187953|NCT01380743|456571|P2|COMPLETED|Overall Study||6
187954|NCT01380743|456572|P1|COMPLETED|Overall Study||6
187955|NCT01380743|456569|P4|Received at Least 1 Dose of Study Drug|Overall Study||7
187956|NCT01380743|456570|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
187957|NCT01380743|456571|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
187958|NCT01380743|456572|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
187959|NCT01380743|456569|P4|STARTED|Overall Study||7
187960|NCT01380743|456570|P3|STARTED|Overall Study||6
187961|NCT01380743|456571|P2|STARTED|Overall Study||6
187962|NCT01380743|456572|P1|STARTED|Overall Study||6
187963|NCT01380730|456618|P8|NOT COMPLETED|Overall Study||0
187964|NCT01380730|456619|P7|NOT COMPLETED|Overall Study||0
187965|NCT01380730|456620|P6|NOT COMPLETED|Overall Study||0
187966|NCT01380730|456621|P5|NOT COMPLETED|Overall Study||1
187967|NCT01380730|456622|P4|NOT COMPLETED|Overall Study||0
187968|NCT01380730|456623|P3|NOT COMPLETED|Overall Study||0
187969|NCT01380730|456624|P2|NOT COMPLETED|Overall Study||0
187970|NCT01380730|456625|P1|NOT COMPLETED|Overall Study||0
187971|NCT01380730|456618|P8|COMPLETED|Overall Study||80
187972|NCT01380730|456619|P7|COMPLETED|Overall Study||79
187973|NCT01380730|456620|P6|COMPLETED|Overall Study||79
187974|NCT01380730|456621|P5|COMPLETED|Overall Study||77
187975|NCT01380730|456622|P4|COMPLETED|Overall Study||79
187976|NCT01380730|456623|P3|COMPLETED|Overall Study||79
187977|NCT01380730|456624|P2|COMPLETED|Overall Study||79
187978|NCT01380730|456625|P1|COMPLETED|Overall Study||78
187979|NCT01380730|456618|P8|Received Treatment|Overall Study||80
187980|NCT01380730|456619|P7|Received Treatment|Overall Study||79
187981|NCT01380730|456620|P6|Received Treatment|Overall Study||79
187982|NCT01380730|456621|P5|Received Treatment|Overall Study||78
187983|NCT01380730|456622|P4|Received Treatment|Overall Study||79
187984|NCT01380730|456623|P3|Received Treatment|Overall Study||79
187985|NCT01380730|456624|P2|Received Treatment|Overall Study|2 participants did not receive treatment but were followed until the end of study|77
187986|NCT01380730|456625|P1|Received Treatment|Overall Study||78
187987|NCT01380730|456618|P8|STARTED|Overall Study||80
187988|NCT01380730|456619|P7|STARTED|Overall Study||79
187989|NCT01380730|456620|P6|STARTED|Overall Study||79
187990|NCT01380730|456621|P5|STARTED|Overall Study||78
187991|NCT01380730|456622|P4|STARTED|Overall Study||79
187992|NCT01380730|456623|P3|STARTED|Overall Study||79
187993|NCT01380730|456624|P2|STARTED|Overall Study||79
187994|NCT01380730|456625|P1|STARTED|Overall Study||78
187995|NCT01380691|456683|P4|NOT COMPLETED|Period 2||0
187996|NCT01380691|456684|P3|NOT COMPLETED|Period 2||0
187997|NCT01380691|456685|P2|NOT COMPLETED|Period 2||0
187998|NCT01380691|456686|P1|NOT COMPLETED|Period 2||0
187999|NCT01380691|456683|P4|COMPLETED|Period 2||6
188000|NCT01380691|456684|P3|COMPLETED|Period 2||6
188001|NCT01380691|456685|P2|COMPLETED|Period 2||7
188002|NCT01380691|456686|P1|COMPLETED|Period 2||7
188003|NCT01380691|456683|P4|STARTED|Period 2||6
188004|NCT01380691|456684|P3|STARTED|Period 2||6
188005|NCT01380691|456685|P2|STARTED|Period 2||7
188006|NCT01380691|456686|P1|STARTED|Period 2||7
188007|NCT01380691|456683|P4|NOT COMPLETED|Washout (7 Days)||1
188008|NCT01380691|456684|P3|NOT COMPLETED|Washout (7 Days)||1
188009|NCT01380691|456685|P2|NOT COMPLETED|Washout (7 Days)||0
188010|NCT01380691|456686|P1|NOT COMPLETED|Washout (7 Days)||0
188011|NCT01380691|456683|P4|COMPLETED|Washout (7 Days)||6
188012|NCT01380691|456684|P3|COMPLETED|Washout (7 Days)||6
188013|NCT01380691|456685|P2|COMPLETED|Washout (7 Days)||7
188014|NCT01380691|456686|P1|COMPLETED|Washout (7 Days)||7
188015|NCT01380691|456683|P4|STARTED|Washout (7 Days)||7
188016|NCT01380691|456684|P3|STARTED|Washout (7 Days)||7
188017|NCT01380691|456685|P2|STARTED|Washout (7 Days)||7
188018|NCT01380691|456686|P1|STARTED|Washout (7 Days)||7
188019|NCT01380691|456683|P4|NOT COMPLETED|Period 1||0
188020|NCT01380691|456684|P3|NOT COMPLETED|Period 1||0
188021|NCT01380691|456685|P2|NOT COMPLETED|Period 1||0
188022|NCT01380691|456686|P1|NOT COMPLETED|Period 1||0
188023|NCT01380691|456683|P4|COMPLETED|Period 1||7
188024|NCT01380691|456684|P3|COMPLETED|Period 1||7
188025|NCT01380691|456685|P2|COMPLETED|Period 1||7
188026|NCT01380691|456686|P1|COMPLETED|Period 1||7
188027|NCT01380691|456683|P4|STARTED|Period 1||7
188028|NCT01380691|456684|P3|STARTED|Period 1||7
188029|NCT01380691|456685|P2|STARTED|Period 1||7
188030|NCT01380691|456686|P1|STARTED|Period 1||7
188031|NCT01380639|456738|P2|NOT COMPLETED|Overall Study||4
188032|NCT01380639|456739|P1|NOT COMPLETED|Overall Study||6
188033|NCT01380639|456738|P2|COMPLETED|Overall Study||36
188034|NCT01380639|456739|P1|COMPLETED|Overall Study||36
188035|NCT01380639|456738|P2|STARTED|Overall Study||40
188036|NCT01380639|456739|P1|STARTED|Overall Study||42
188037|NCT01380535|456747|P2|NOT COMPLETED|Overall Study||15
188038|NCT01380535|456748|P1|NOT COMPLETED|Overall Study||7
188039|NCT01380535|456747|P2|COMPLETED|Overall Study||16
188040|NCT01380535|456748|P1|COMPLETED|Overall Study||22
188041|NCT01380535|456747|P2|Intent-to-treat Population|Overall Study||24
188042|NCT01380535|456748|P1|Intent-to-treat Population|Overall Study||29
188043|NCT01380535|456747|P2|Baseline Population|Overall Study||31
188044|NCT01380535|456748|P1|Baseline Population|Overall Study||29
188045|NCT01380535|456747|P2|STARTED|Overall Study||31
188046|NCT01380535|456748|P1|STARTED|Overall Study||29
188047|NCT01380379|456754|P1|NOT COMPLETED|Overall Study||1
188048|NCT01380379|456754|P1|COMPLETED|Overall Study||8
188049|NCT01380379|456754|P1|STARTED|Overall Study||9
188050|NCT01380366|456759|P1|NOT COMPLETED|Overall Study||0
188051|NCT01380366|456759|P1|COMPLETED|Overall Study||15
188052|NCT01380366|456759|P1|STARTED|Overall Study||15
188053|NCT01380327|456767|P3|NOT COMPLETED|Overall Study||7
188054|NCT01380327|456768|P2|NOT COMPLETED|Overall Study||3
188055|NCT01380327|456769|P1|NOT COMPLETED|Overall Study||3
188056|NCT01380327|456767|P3|COMPLETED|Overall Study||21
188057|NCT01380327|456768|P2|COMPLETED|Overall Study||28
188058|NCT01380327|456769|P1|COMPLETED|Overall Study||27
188059|NCT01380327|456767|P3|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|28
188060|NCT01380327|456768|P2|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|31
188061|NCT01380327|456769|P1|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|30
188062|NCT01380197|456791|P2|NOT COMPLETED|Overall Study||0
188063|NCT01380197|456792|P1|NOT COMPLETED|Overall Study||0
188064|NCT01380197|456791|P2|COMPLETED|Overall Study||20
188065|NCT01380197|456792|P1|COMPLETED|Overall Study||20
188066|NCT01380197|456791|P2|STARTED|Overall Study||20
188067|NCT01380197|456792|P1|STARTED|Overall Study||20
188068|NCT01380184|456800|P1|NOT COMPLETED|Part 2||14
188069|NCT01380184|456800|P1|COMPLETED|Part 2||0
188070|NCT01380184|456800|P1|STARTED|Part 2||14
188071|NCT01380184|456800|P1|NOT COMPLETED|Washout Period (≥2 Days)||0
188072|NCT01380184|456800|P1|COMPLETED|Washout Period (≥2 Days)||14
188073|NCT01380184|456800|P1|STARTED|Washout Period (≥2 Days)||14
188074|NCT01380184|456800|P1|NOT COMPLETED|Part 1 (19 Days)||1
188075|NCT01380184|456800|P1|COMPLETED|Part 1 (19 Days)||14
188076|NCT01380184|456800|P1|STARTED|Part 1 (19 Days)||15
188077|NCT01380145|456811|P1|NOT COMPLETED|Overall Study||4
188078|NCT01380145|456811|P1|COMPLETED|Overall Study||9
188079|NCT01380145|456811|P1|STARTED|Overall Study||13
188080|NCT01380093|456819|P9|NOT COMPLETED|Treatment Phase: Third Intervention||2
188081|NCT01380093|456820|P8|NOT COMPLETED|Treatment Phase: Third Intervention||0
188082|NCT01380093|456821|P7|NOT COMPLETED|Treatment Phase: Third Intervention||0
188083|NCT01380093|456822|P6|NOT COMPLETED|Treatment Phase: Third Intervention||0
188084|NCT01380093|456823|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
188085|NCT01380093|456824|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
188086|NCT01380093|456825|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
188087|NCT01380093|456826|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
188088|NCT01380093|456827|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
188089|NCT01380093|456819|P9|COMPLETED|Treatment Phase: Third Intervention||4
188090|NCT01380093|456820|P8|COMPLETED|Treatment Phase: Third Intervention||6
188091|NCT01380093|456821|P7|COMPLETED|Treatment Phase: Third Intervention||6
188092|NCT01380093|456822|P6|COMPLETED|Treatment Phase: Third Intervention||6
188093|NCT01380093|456823|P5|COMPLETED|Treatment Phase: Third Intervention||6
188094|NCT01380093|456824|P4|COMPLETED|Treatment Phase: Third Intervention||5
188095|NCT01380093|456825|P3|COMPLETED|Treatment Phase: Third Intervention||0
188096|NCT01380093|456826|P2|COMPLETED|Treatment Phase: Third Intervention||0
188097|NCT01380093|456827|P1|COMPLETED|Treatment Phase: Third Intervention||0
188098|NCT01380093|456819|P9|STARTED|Treatment Phase: Third Intervention||6
188099|NCT01380093|456820|P8|STARTED|Treatment Phase: Third Intervention||6
188100|NCT01380093|456821|P7|STARTED|Treatment Phase: Third Intervention||6
188101|NCT01380093|456822|P6|STARTED|Treatment Phase: Third Intervention||6
188102|NCT01380093|456823|P5|STARTED|Treatment Phase: Third Intervention||6
188103|NCT01380093|456824|P4|STARTED|Treatment Phase: Third Intervention||5
188104|NCT01380093|456825|P3|STARTED|Treatment Phase: Third Intervention||0
188105|NCT01380093|456826|P2|STARTED|Treatment Phase: Third Intervention||0
188106|NCT01380093|456827|P1|STARTED|Treatment Phase: Third Intervention||0
188107|NCT01380093|456819|P9|NOT COMPLETED|Treatment Phase: Washout Period||0
188108|NCT01380093|456820|P8|NOT COMPLETED|Treatment Phase: Washout Period||0
188109|NCT01380093|456821|P7|NOT COMPLETED|Treatment Phase: Washout Period||0
188110|NCT01380093|456822|P6|NOT COMPLETED|Treatment Phase: Washout Period||0
188111|NCT01380093|456823|P5|NOT COMPLETED|Treatment Phase: Washout Period||0
188112|NCT01380093|456824|P4|NOT COMPLETED|Treatment Phase: Washout Period||0
188113|NCT01380093|456825|P3|NOT COMPLETED|Treatment Phase: Washout Period||0
188114|NCT01380093|456826|P2|NOT COMPLETED|Treatment Phase: Washout Period||0
188115|NCT01380093|456827|P1|NOT COMPLETED|Treatment Phase: Washout Period||0
188116|NCT01380093|456819|P9|COMPLETED|Treatment Phase: Washout Period||6
188117|NCT01380093|456820|P8|COMPLETED|Treatment Phase: Washout Period||6
188118|NCT01380093|456821|P7|COMPLETED|Treatment Phase: Washout Period||6
188119|NCT01380093|456822|P6|COMPLETED|Treatment Phase: Washout Period||6
188120|NCT01380093|456823|P5|COMPLETED|Treatment Phase: Washout Period||6
188121|NCT01380093|456824|P4|COMPLETED|Treatment Phase: Washout Period||5
188122|NCT01380093|456825|P3|COMPLETED|Treatment Phase: Washout Period||0
188123|NCT01380093|456826|P2|COMPLETED|Treatment Phase: Washout Period||0
188124|NCT01380093|456827|P1|COMPLETED|Treatment Phase: Washout Period||0
188125|NCT01380093|456819|P9|STARTED|Treatment Phase: Washout Period||6
188126|NCT01380093|456820|P8|STARTED|Treatment Phase: Washout Period||6
188127|NCT01380093|456821|P7|STARTED|Treatment Phase: Washout Period||6
188128|NCT01380093|456822|P6|STARTED|Treatment Phase: Washout Period||6
188129|NCT01380093|456823|P5|STARTED|Treatment Phase: Washout Period||6
188130|NCT01380093|456824|P4|STARTED|Treatment Phase: Washout Period||5
188131|NCT01380093|456825|P3|STARTED|Treatment Phase: Washout Period||0
188132|NCT01380093|456826|P2|STARTED|Treatment Phase: Washout Period||0
188133|NCT01380093|456827|P1|STARTED|Treatment Phase: Washout Period||0
188134|NCT01380093|456819|P9|NOT COMPLETED|Treatment Phase: Second Intervention||0
188135|NCT01380093|456820|P8|NOT COMPLETED|Treatment Phase: Second Intervention||0
188136|NCT01380093|456821|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
188137|NCT01380093|456822|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
188138|NCT01380093|456823|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
188139|NCT01380093|456824|P4|NOT COMPLETED|Treatment Phase: Second Intervention||1
188140|NCT01380093|456825|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
188141|NCT01380093|456826|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
188142|NCT01380093|456827|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
188143|NCT01380093|456819|P9|COMPLETED|Treatment Phase: Second Intervention||6
188144|NCT01380093|456820|P8|COMPLETED|Treatment Phase: Second Intervention||6
188145|NCT01380093|456821|P7|COMPLETED|Treatment Phase: Second Intervention||6
188146|NCT01380093|456822|P6|COMPLETED|Treatment Phase: Second Intervention||6
188147|NCT01380093|456823|P5|COMPLETED|Treatment Phase: Second Intervention||6
188148|NCT01380093|456824|P4|COMPLETED|Treatment Phase: Second Intervention||5
188149|NCT01380093|456825|P3|COMPLETED|Treatment Phase: Second Intervention||0
188150|NCT01380093|456826|P2|COMPLETED|Treatment Phase: Second Intervention||0
188151|NCT01380093|456827|P1|COMPLETED|Treatment Phase: Second Intervention||0
188152|NCT01380093|456819|P9|STARTED|Treatment Phase: Second Intervention||6
188153|NCT01380093|456820|P8|STARTED|Treatment Phase: Second Intervention||6
188154|NCT01380093|456821|P7|STARTED|Treatment Phase: Second Intervention||6
188155|NCT01380093|456822|P6|STARTED|Treatment Phase: Second Intervention||6
188156|NCT01380093|456823|P5|STARTED|Treatment Phase: Second Intervention||6
188157|NCT01380093|456824|P4|STARTED|Treatment Phase: Second Intervention||6
188158|NCT01380093|456825|P3|STARTED|Treatment Phase: Second Intervention||0
188159|NCT01380093|456826|P2|STARTED|Treatment Phase: Second Intervention||0
188160|NCT01380093|456827|P1|STARTED|Treatment Phase: Second Intervention||0
188161|NCT01380093|456819|P9|NOT COMPLETED|Treatment Phase: Washout Period||0
188162|NCT01380093|456820|P8|NOT COMPLETED|Treatment Phase: Washout Period||0
188163|NCT01380093|456821|P7|NOT COMPLETED|Treatment Phase: Washout Period||0
188164|NCT01380093|456822|P6|NOT COMPLETED|Treatment Phase: Washout Period||0
188165|NCT01380093|456823|P5|NOT COMPLETED|Treatment Phase: Washout Period||0
188166|NCT01380093|456824|P4|NOT COMPLETED|Treatment Phase: Washout Period||0
188167|NCT01380093|456825|P3|NOT COMPLETED|Treatment Phase: Washout Period||0
188168|NCT01380093|456826|P2|NOT COMPLETED|Treatment Phase: Washout Period||0
188169|NCT01380093|456827|P1|NOT COMPLETED|Treatment Phase: Washout Period||0
188170|NCT01380093|456819|P9|COMPLETED|Treatment Phase: Washout Period||6
188171|NCT01380093|456820|P8|COMPLETED|Treatment Phase: Washout Period||6
188172|NCT01380093|456821|P7|COMPLETED|Treatment Phase: Washout Period||6
188173|NCT01380093|456822|P6|COMPLETED|Treatment Phase: Washout Period||6
188174|NCT01380093|456823|P5|COMPLETED|Treatment Phase: Washout Period||6
188175|NCT01380093|456824|P4|COMPLETED|Treatment Phase: Washout Period||6
188176|NCT01380093|456825|P3|COMPLETED|Treatment Phase: Washout Period||0
188177|NCT01380093|456826|P2|COMPLETED|Treatment Phase: Washout Period||0
188178|NCT01380093|456827|P1|COMPLETED|Treatment Phase: Washout Period||0
188179|NCT01380093|456819|P9|STARTED|Treatment Phase: Washout Period||6
188180|NCT01380093|456820|P8|STARTED|Treatment Phase: Washout Period||6
188181|NCT01380093|456821|P7|STARTED|Treatment Phase: Washout Period||6
188182|NCT01380093|456822|P6|STARTED|Treatment Phase: Washout Period||6
188183|NCT01380093|456823|P5|STARTED|Treatment Phase: Washout Period||6
188184|NCT01380093|456824|P4|STARTED|Treatment Phase: Washout Period||6
188185|NCT01380093|456825|P3|STARTED|Treatment Phase: Washout Period||0
188186|NCT01380093|456826|P2|STARTED|Treatment Phase: Washout Period||0
188187|NCT01380093|456827|P1|STARTED|Treatment Phase: Washout Period||0
188188|NCT01380093|456819|P9|NOT COMPLETED|Treatment Phase: First Intervention||0
188189|NCT01380093|456820|P8|NOT COMPLETED|Treatment Phase: First Intervention||0
188190|NCT01380093|456821|P7|NOT COMPLETED|Treatment Phase: First Intervention||0
188191|NCT01380093|456822|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
188192|NCT01380093|456823|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
188193|NCT01380093|456824|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
188194|NCT01380093|456825|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
188195|NCT01380093|456826|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
188196|NCT01380093|456827|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
188197|NCT01380093|456819|P9|COMPLETED|Treatment Phase: First Intervention||6
188198|NCT01380093|456820|P8|COMPLETED|Treatment Phase: First Intervention||6
188199|NCT01380093|456821|P7|COMPLETED|Treatment Phase: First Intervention||6
188200|NCT01380093|456822|P6|COMPLETED|Treatment Phase: First Intervention||6
188201|NCT01380093|456823|P5|COMPLETED|Treatment Phase: First Intervention||6
188202|NCT01380093|456824|P4|COMPLETED|Treatment Phase: First Intervention||6
188203|NCT01380093|456825|P3|COMPLETED|Treatment Phase: First Intervention||0
188204|NCT01380093|456826|P2|COMPLETED|Treatment Phase: First Intervention||0
188205|NCT01380093|456827|P1|COMPLETED|Treatment Phase: First Intervention||0
188206|NCT01380093|456819|P9|STARTED|Treatment Phase: First Intervention||6
188207|NCT01380093|456820|P8|STARTED|Treatment Phase: First Intervention||6
188208|NCT01380093|456821|P7|STARTED|Treatment Phase: First Intervention||6
188209|NCT01380093|456822|P6|STARTED|Treatment Phase: First Intervention||6
188210|NCT01380093|456823|P5|STARTED|Treatment Phase: First Intervention||6
188211|NCT01380093|456824|P4|STARTED|Treatment Phase: First Intervention||6
188212|NCT01380093|456825|P3|STARTED|Treatment Phase: First Intervention||0
188213|NCT01380093|456826|P2|STARTED|Treatment Phase: First Intervention||0
188214|NCT01380093|456827|P1|STARTED|Treatment Phase: First Intervention||0
188215|NCT01380093|456819|P9|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
188216|NCT01380093|456820|P8|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
188217|NCT01380093|456821|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
188218|NCT01380093|456822|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
188219|NCT01380093|456823|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
188220|NCT01380093|456824|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
188221|NCT01380093|456825|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||13
188222|NCT01380093|456826|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||9
188223|NCT01380093|456827|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
188224|NCT01380093|456819|P9|COMPLETED|Drug Discrimination Phase: Day 2||0
188225|NCT01380093|456820|P8|COMPLETED|Drug Discrimination Phase: Day 2||0
188226|NCT01380093|456821|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
188227|NCT01380093|456822|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
188228|NCT01380093|456823|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
188229|NCT01380093|456824|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
188230|NCT01380093|456825|P3|COMPLETED|Drug Discrimination Phase: Day 2||16
188231|NCT01380093|456826|P2|COMPLETED|Drug Discrimination Phase: Day 2||20
188232|NCT01380093|456827|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
188233|NCT01380093|456819|P9|STARTED|Drug Discrimination Phase: Day 2||0
188234|NCT01380093|456820|P8|STARTED|Drug Discrimination Phase: Day 2||0
188235|NCT01380093|456821|P7|STARTED|Drug Discrimination Phase: Day 2||0
188236|NCT01380093|456822|P6|STARTED|Drug Discrimination Phase: Day 2||0
188237|NCT01380093|456823|P5|STARTED|Drug Discrimination Phase: Day 2||0
188238|NCT01380093|456824|P4|STARTED|Drug Discrimination Phase: Day 2||0
188239|NCT01380093|456825|P3|STARTED|Drug Discrimination Phase: Day 2||29
188240|NCT01380093|456826|P2|STARTED|Drug Discrimination Phase: Day 2||29
188241|NCT01380093|456827|P1|STARTED|Drug Discrimination Phase: Day 2||0
188242|NCT01380093|456819|P9|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
188243|NCT01380093|456820|P8|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
188244|NCT01380093|456821|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
188245|NCT01380093|456822|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
188246|NCT01380093|456823|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
188247|NCT01380093|456824|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
188248|NCT01380093|456825|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
188249|NCT01380093|456826|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||1
188250|NCT01380093|456827|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
188251|NCT01380093|456819|P9|COMPLETED|Drug Discrimination Phase: Day 1||0
188252|NCT01380093|456820|P8|COMPLETED|Drug Discrimination Phase: Day 1||0
188253|NCT01380093|456821|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
188254|NCT01380093|456822|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
188255|NCT01380093|456823|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
188256|NCT01380093|456824|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
188257|NCT01380093|456825|P3|COMPLETED|Drug Discrimination Phase: Day 1||29
188258|NCT01380093|456826|P2|COMPLETED|Drug Discrimination Phase: Day 1||29
188259|NCT01380093|456827|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
188260|NCT01380093|456819|P9|STARTED|Drug Discrimination Phase: Day 1||0
188261|NCT01380093|456820|P8|STARTED|Drug Discrimination Phase: Day 1||0
188262|NCT01380093|456821|P7|STARTED|Drug Discrimination Phase: Day 1||0
188263|NCT01380093|456822|P6|STARTED|Drug Discrimination Phase: Day 1||0
188264|NCT01380093|456823|P5|STARTED|Drug Discrimination Phase: Day 1||0
188265|NCT01380093|456824|P4|STARTED|Drug Discrimination Phase: Day 1||0
188266|NCT01380093|456825|P3|STARTED|Drug Discrimination Phase: Day 1||29
188267|NCT01380093|456826|P2|STARTED|Drug Discrimination Phase: Day 1||30
188268|NCT01380093|456827|P1|STARTED|Drug Discrimination Phase: Day 1||0
188269|NCT01380093|456819|P9|NOT COMPLETED|Naloxone Challenge Phase||0
188270|NCT01380093|456820|P8|NOT COMPLETED|Naloxone Challenge Phase||0
188271|NCT01380093|456821|P7|NOT COMPLETED|Naloxone Challenge Phase||0
188272|NCT01380093|456822|P6|NOT COMPLETED|Naloxone Challenge Phase||0
188273|NCT01380093|456823|P5|NOT COMPLETED|Naloxone Challenge Phase||0
188274|NCT01380093|456824|P4|NOT COMPLETED|Naloxone Challenge Phase||0
188275|NCT01380093|456825|P3|NOT COMPLETED|Naloxone Challenge Phase||0
188276|NCT01380093|456826|P2|NOT COMPLETED|Naloxone Challenge Phase||0
188277|NCT01380093|456827|P1|NOT COMPLETED|Naloxone Challenge Phase||21
188278|NCT01380093|456819|P9|COMPLETED|Naloxone Challenge Phase||0
188279|NCT01380093|456820|P8|COMPLETED|Naloxone Challenge Phase||0
188280|NCT01380093|456821|P7|COMPLETED|Naloxone Challenge Phase||0
188281|NCT01380093|456822|P6|COMPLETED|Naloxone Challenge Phase||0
188282|NCT01380093|456823|P5|COMPLETED|Naloxone Challenge Phase||0
188283|NCT01380093|456824|P4|COMPLETED|Naloxone Challenge Phase||0
188284|NCT01380093|456825|P3|COMPLETED|Naloxone Challenge Phase||0
188285|NCT01380093|456826|P2|COMPLETED|Naloxone Challenge Phase||0
188286|NCT01380093|456827|P1|COMPLETED|Naloxone Challenge Phase||59
188287|NCT01380093|456819|P9|TREATED|Naloxone Challenge Phase||0
188288|NCT01380093|456820|P8|TREATED|Naloxone Challenge Phase||0
188289|NCT01380093|456821|P7|TREATED|Naloxone Challenge Phase||0
188290|NCT01380093|456822|P6|TREATED|Naloxone Challenge Phase||0
188291|NCT01380093|456823|P5|TREATED|Naloxone Challenge Phase||0
188292|NCT01380093|456824|P4|TREATED|Naloxone Challenge Phase||0
188293|NCT01380093|456825|P3|TREATED|Naloxone Challenge Phase||0
188294|NCT01380093|456826|P2|TREATED|Naloxone Challenge Phase||0
188295|NCT01380093|456827|P1|TREATED|Naloxone Challenge Phase||59
188296|NCT01380093|456819|P9|STARTED|Naloxone Challenge Phase||0
188297|NCT01380093|456820|P8|STARTED|Naloxone Challenge Phase||0
188298|NCT01380093|456821|P7|STARTED|Naloxone Challenge Phase||0
188299|NCT01380093|456822|P6|STARTED|Naloxone Challenge Phase||0
188300|NCT01380093|456823|P5|STARTED|Naloxone Challenge Phase||0
188301|NCT01380093|456824|P4|STARTED|Naloxone Challenge Phase||0
188302|NCT01380093|456825|P3|STARTED|Naloxone Challenge Phase||0
188303|NCT01380093|456826|P2|STARTED|Naloxone Challenge Phase||0
188304|NCT01380093|456827|P1|STARTED|Naloxone Challenge Phase||80
188305|NCT01380080|457119|P2|NOT COMPLETED|Overall Study||23
188306|NCT01380080|457120|P1|NOT COMPLETED|Overall Study||33
188307|NCT01380080|457119|P2|COMPLETED|Overall Study||403
188308|NCT01380080|457120|P1|COMPLETED|Overall Study||391
188309|NCT01380080|457119|P2|STARTED|Overall Study||426
188310|NCT01380080|457120|P1|STARTED|Overall Study||424
188311|NCT01379963|457136|P1|NOT COMPLETED|Overall Study||0
188312|NCT01379963|457136|P1|COMPLETED|Overall Study||780
188313|NCT01379963|457136|P1|STARTED|Overall Study||780
188314|NCT01379937|457145|P4|NOT COMPLETED|Overall Study||1
188315|NCT01379937|457146|P3|NOT COMPLETED|Overall Study||2
188316|NCT01379937|457147|P2|NOT COMPLETED|Overall Study||3
188317|NCT01379937|457148|P1|NOT COMPLETED|Overall Study||1
188318|NCT01379937|457145|P4|COMPLETED|Overall Study||103
188319|NCT01379937|457146|P3|COMPLETED|Overall Study||102
188320|NCT01379937|457147|P2|COMPLETED|Overall Study||153
188321|NCT01379937|457148|P1|COMPLETED|Overall Study||155
188322|NCT01379937|457145|P4|STARTED|Overall Study||104
188323|NCT01379937|457146|P3|STARTED|Overall Study||104
188324|NCT01379937|457147|P2|STARTED|Overall Study||156
188325|NCT01379937|457148|P1|STARTED|Overall Study||156
188326|NCT01379781|457230|P2|NOT COMPLETED|Overall Study||8
188327|NCT01379781|457231|P1|NOT COMPLETED|Overall Study||11
188328|NCT01379781|457230|P2|COMPLETED|Overall Study||19
188329|NCT01379781|457231|P1|COMPLETED|Overall Study||16
188330|NCT01379781|457230|P2|STARTED|Overall Study||27
188331|NCT01379781|457231|P1|STARTED|Overall Study||27
188332|NCT01379768|457240|P3|NOT COMPLETED|Overall Study||0
188333|NCT01379768|457241|P2|NOT COMPLETED|Overall Study||1
188334|NCT01379768|457242|P1|NOT COMPLETED|Overall Study||3
188335|NCT01379768|457240|P3|COMPLETED|Overall Study||20
188336|NCT01379768|457241|P2|COMPLETED|Overall Study||21
188337|NCT01379768|457242|P1|COMPLETED|Overall Study||20
188338|NCT01379768|457240|P3|STARTED|Overall Study||20
188339|NCT01379768|457241|P2|STARTED|Overall Study||22
188340|NCT01379768|457242|P1|STARTED|Overall Study||23
188341|NCT01379703|457265|P3|NOT COMPLETED|9 Months Through 18 Months||0
188342|NCT01379703|457266|P2|NOT COMPLETED|9 Months Through 18 Months||230
188343|NCT01379703|457267|P1|NOT COMPLETED|9 Months Through 18 Months||0
188344|NCT01379703|457265|P3|COMPLETED|9 Months Through 18 Months||0
188345|NCT01379703|457266|P2|COMPLETED|9 Months Through 18 Months||854
188346|NCT01379703|457267|P1|COMPLETED|9 Months Through 18 Months||0
188347|NCT01379703|457265|P3|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
188348|NCT01379703|457266|P2|STARTED|9 Months Through 18 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
188349|NCT01379703|457267|P1|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
188350|NCT01379703|457265|P3|NOT COMPLETED|Study Start Through 9 Months||143
188351|NCT01379703|457266|P2|NOT COMPLETED|Study Start Through 9 Months||122
188352|NCT01379703|457267|P1|NOT COMPLETED|Study Start Through 9 Months||4
188353|NCT01379703|457265|P3|COMPLETED|Study Start Through 9 Months||873
188354|NCT01379703|457266|P2|COMPLETED|Study Start Through 9 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
188355|NCT01379703|457267|P1|COMPLETED|Study Start Through 9 Months||62
188356|NCT01379703|457265|P3|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir tablet formulation (only) during study (1016/2288)|1016
188357|NCT01379703|457266|P2|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir capsule formulation (only) during study (1206/2288)|1206
188358|NCT01379703|457267|P1|STARTED|Study Start Through 9 Months|Participants taking lopinavir/ritonavir tablets/capsules or oral solution during the study (66/2288)|66
188359|NCT01379664|457330|P2|NOT COMPLETED|Overall Study||0
188360|NCT01379664|457331|P1|NOT COMPLETED|Overall Study||0
188361|NCT01379664|457330|P2|COMPLETED|Overall Study||870
188362|NCT01379664|457331|P1|COMPLETED|Overall Study||714
188363|NCT01379664|457330|P2|STARTED|Overall Study||870
188364|NCT01379664|457331|P1|STARTED|Overall Study||714
188365|NCT01379651|457343|P2|NOT COMPLETED|Overall Study||0
188366|NCT01379651|457344|P1|NOT COMPLETED|Overall Study||0
188367|NCT01379651|457343|P2|COMPLETED|Overall Study||10
188368|NCT01379651|457344|P1|COMPLETED|Overall Study||10
188369|NCT01379651|457343|P2|STARTED|Overall Study||10
188370|NCT01379651|457344|P1|STARTED|Overall Study||10
188371|NCT01379625|457354|P2|NOT COMPLETED|Overall Study||0
188372|NCT01379625|457355|P1|NOT COMPLETED|Overall Study||0
188373|NCT01379625|457354|P2|COMPLETED|Overall Study||16
188374|NCT01379625|457355|P1|COMPLETED|Overall Study||16
188375|NCT01379625|457354|P2|STARTED|Overall Study||16
188376|NCT01379625|457355|P1|STARTED|Overall Study||16
188377|NCT01379534|457367|P2|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||2
188378|NCT01379534|457368|P1|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||4
188379|NCT01379534|457367|P2|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
188380|NCT01379534|457368|P1|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
188381|NCT01379534|457367|P2|STARTED|Tumor Assessment Follow-up (f/u) Phase||2
188382|NCT01379534|457368|P1|STARTED|Tumor Assessment Follow-up (f/u) Phase|All participants discontinued the Treatment Phase. Of these, only 6 qualified for f/u tumor assess..|4
188383|NCT01379534|457367|P2|NOT COMPLETED|Treatment Phase||31
188384|NCT01379534|457368|P1|NOT COMPLETED|Treatment Phase||22
188385|NCT01379534|457367|P2|COMPLETED|Treatment Phase||0
188386|NCT01379534|457368|P1|COMPLETED|Treatment Phase||0
188387|NCT01379534|457367|P2|STARTED|Treatment Phase||31
188388|NCT01379534|457368|P1|STARTED|Treatment Phase||22
188389|NCT01379521|457388|P2|NOT COMPLETED|Post-Treatment Evaluations||21
188390|NCT01379521|457389|P1|NOT COMPLETED|Post-Treatment Evaluations||25
188391|NCT01379521|457388|P2|COMPLETED|Post-Treatment Evaluations||0
188392|NCT01379521|457389|P1|COMPLETED|Post-Treatment Evaluations||0
188393|NCT01379521|457388|P2|STARTED|Post-Treatment Evaluations||21
188394|NCT01379521|457389|P1|STARTED|Post-Treatment Evaluations||25
188395|NCT01379521|457388|P2|NOT COMPLETED|Overall Study -Treatment Period||26
188396|NCT01379521|457389|P1|NOT COMPLETED|Overall Study -Treatment Period||33
188397|NCT01379521|457388|P2|COMPLETED|Overall Study -Treatment Period||0
188398|NCT01379521|457389|P1|COMPLETED|Overall Study -Treatment Period||0
188399|NCT01379521|457388|P2|STARTED|Overall Study -Treatment Period||26
188400|NCT01379521|457389|P1|STARTED|Overall Study -Treatment Period||33
188401|NCT01379508|457411|P4|NOT COMPLETED|Extension Period Weeks 109-156||0
188402|NCT01379508|457412|P3|NOT COMPLETED|Extension Period Weeks 109-156||14
188403|NCT01379508|457413|P2|NOT COMPLETED|Extension Period Weeks 109-156||3
188404|NCT01379508|457414|P1|NOT COMPLETED|Extension Period Weeks 109-156||19
188405|NCT01379508|457411|P4|COMPLETED|Extension Period Weeks 109-156||10
188406|NCT01379508|457412|P3|COMPLETED|Extension Period Weeks 109-156||65
188407|NCT01379508|457413|P2|COMPLETED|Extension Period Weeks 109-156||14
188408|NCT01379508|457414|P1|COMPLETED|Extension Period Weeks 109-156||45
188409|NCT01379508|457411|P4|STARTED|Extension Period Weeks 109-156||10
188410|NCT01379508|457412|P3|STARTED|Extension Period Weeks 109-156||79
188411|NCT01379508|457413|P2|STARTED|Extension Period Weeks 109-156||17
188412|NCT01379508|457414|P1|STARTED|Extension Period Weeks 109-156||64
188413|NCT01379508|457411|P4|NOT COMPLETED|Treatment to Week 104||0
188414|NCT01379508|457412|P3|NOT COMPLETED|Treatment to Week 104||13
188415|NCT01379508|457413|P2|NOT COMPLETED|Treatment to Week 104||3
188416|NCT01379508|457414|P1|NOT COMPLETED|Treatment to Week 104||19
188417|NCT01379508|457411|P4|COMPLETED|Treatment to Week 104||11
188418|NCT01379508|457412|P3|COMPLETED|Treatment to Week 104||96
188419|NCT01379508|457413|P2|COMPLETED|Treatment to Week 104||19
188420|NCT01379508|457414|P1|COMPLETED|Treatment to Week 104||80
188421|NCT01379508|457411|P4|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||11
188422|NCT01379508|457412|P3|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||105
188423|NCT01379508|457413|P2|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||21
188424|NCT01379508|457414|P1|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||91
188425|NCT01379508|457411|P4|Completed Wk 24|Treatment to Week 104||11
188426|NCT01379508|457412|P3|Completed Wk 24|Treatment to Week 104||107
188427|NCT01379508|457413|P2|Completed Wk 24|Treatment to Week 104||22
188428|NCT01379508|457414|P1|Completed Wk 24|Treatment to Week 104||93
188429|NCT01379508|457411|P4|STARTED|Treatment to Week 104||11
188430|NCT01379508|457412|P3|STARTED|Treatment to Week 104||109
188431|NCT01379508|457413|P2|STARTED|Treatment to Week 104||22
188432|NCT01379508|457414|P1|STARTED|Treatment to Week 104||99
188433|NCT01379222|457440|P1|NOT COMPLETED|Overall Study||73
188434|NCT01379222|457440|P1|COMPLETED|Overall Study||105
188435|NCT01379222|457440|P1|STARTED|Overall Study||178
188436|NCT01379183|457446|P2|NOT COMPLETED|Overall Study||0
188437|NCT01379183|457447|P1|NOT COMPLETED|Overall Study||0
188438|NCT01379183|457446|P2|COMPLETED|Overall Study||21
188439|NCT01379183|457447|P1|COMPLETED|Overall Study||19
188440|NCT01379183|457446|P2|STARTED|Overall Study||21
188441|NCT01379183|457447|P1|STARTED|Overall Study||19
188442|NCT01378988|457465|P2|NOT COMPLETED|Overall Study||0
188443|NCT01378988|457466|P1|NOT COMPLETED|Overall Study||0
188444|NCT01378988|457465|P2|COMPLETED|Overall Study||3
188445|NCT01378988|457466|P1|COMPLETED|Overall Study||2
188446|NCT01378988|457465|P2|STARTED|Overall Study||3
188447|NCT01378988|457466|P1|STARTED|Overall Study||2
188448|NCT01378975|457496|P2|NOT COMPLETED|Overall Study||50
188449|NCT01378975|457497|P1|NOT COMPLETED|Overall Study||86
188450|NCT01378975|457496|P2|COMPLETED|Overall Study||6
188451|NCT01378975|457497|P1|COMPLETED|Overall Study||4
188452|NCT01378975|457496|P2|STARTED|Overall Study||56
188453|NCT01378975|457497|P1|STARTED|Overall Study||90
188454|NCT01378962|457523|P1|NOT COMPLETED|Overall Study||17
188455|NCT01378962|457523|P1|COMPLETED|Overall Study||33
188456|NCT01378962|457523|P1|STARTED|Overall Study||50
188457|NCT01378520|457536|P2|NOT COMPLETED|Second Intervention (Day 4-6)||0
188458|NCT01378520|457537|P1|NOT COMPLETED|Second Intervention (Day 4-6)||0
188459|NCT01378520|457536|P2|COMPLETED|Second Intervention (Day 4-6)||10
188460|NCT01378520|457537|P1|COMPLETED|Second Intervention (Day 4-6)||10
188461|NCT01378520|457536|P2|STARTED|Second Intervention (Day 4-6)||10
188462|NCT01378520|457537|P1|STARTED|Second Intervention (Day 4-6)||10
188463|NCT01378520|457536|P2|NOT COMPLETED|First Intervention (Day 2-3)||0
188464|NCT01378520|457537|P1|NOT COMPLETED|First Intervention (Day 2-3)||0
188465|NCT01378520|457536|P2|COMPLETED|First Intervention (Day 2-3)||10
188466|NCT01378520|457537|P1|COMPLETED|First Intervention (Day 2-3)||10
188467|NCT01378520|457536|P2|STARTED|First Intervention (Day 2-3)||10
188468|NCT01378520|457537|P1|STARTED|First Intervention (Day 2-3)||10
188469|NCT01378429|457549|P2|NOT COMPLETED|Overall Study||0
188470|NCT01378429|457550|P1|NOT COMPLETED|Overall Study||1
188471|NCT01378429|457549|P2|COMPLETED|Overall Study||47
188472|NCT01378429|457550|P1|COMPLETED|Overall Study||41
188473|NCT01378429|457549|P2|STARTED|Overall Study||47
188474|NCT01378429|457550|P1|STARTED|Overall Study||42
188475|NCT01378416|457582|P1|NOT COMPLETED|Overall Study||0
188476|NCT01378416|457582|P1|COMPLETED|Overall Study||16
188477|NCT01378416|457582|P1|STARTED|Overall Study||16
188478|NCT01378377|457593|P3|NOT COMPLETED|Overall Study||0
188479|NCT01378377|457594|P2|NOT COMPLETED|Overall Study||0
188480|NCT01378377|457595|P1|NOT COMPLETED|Overall Study||0
188481|NCT01378377|457593|P3|COMPLETED|Overall Study||6
188482|NCT01378377|457594|P2|COMPLETED|Overall Study||23
188483|NCT01378377|457595|P1|COMPLETED|Overall Study||4
188484|NCT01378377|457593|P3|STARTED|Overall Study||6
188485|NCT01378377|457594|P2|STARTED|Overall Study||23
188486|NCT01378377|457595|P1|STARTED|Overall Study||4
188487|NCT01378325|457663|P2|NOT COMPLETED|Overall Study||1
188488|NCT01378325|457664|P1|NOT COMPLETED|Overall Study||0
188489|NCT01378325|457663|P2|COMPLETED|Overall Study||39
188490|NCT01378325|457664|P1|COMPLETED|Overall Study||40
188491|NCT01378325|457663|P2|STARTED|Overall Study||40
188492|NCT01378325|457664|P1|STARTED|Overall Study||40
188493|NCT01378299|457670|P1|NOT COMPLETED|Overall Study||31
188494|NCT01378299|457670|P1|COMPLETED|Overall Study||74
188495|NCT01378299|457670|P1|BMI Group 3|Overall Study||27
188496|NCT01378299|457670|P1|BMI Group 2|Overall Study||40
188497|NCT01378299|457670|P1|BMI group1|Overall Study||38
188498|NCT01378299|457670|P1|STARTED|Overall Study||105
188499|NCT01378221|457709|P2|NOT COMPLETED|Overall Study||9
188500|NCT01378221|457710|P1|NOT COMPLETED|Overall Study||7
188501|NCT01378221|457709|P2|COMPLETED|Overall Study||30
188502|NCT01378221|457710|P1|COMPLETED|Overall Study||29
188503|NCT01378221|457709|P2|STARTED|Overall Study||39
188504|NCT01378221|457710|P1|STARTED|Overall Study||36
188505|NCT01378195|457718|P2|NOT COMPLETED|Overall Study||18
188506|NCT01378195|457719|P1|NOT COMPLETED|Overall Study||29
188507|NCT01378195|457718|P2|COMPLETED|Overall Study||57
188508|NCT01378195|457719|P1|COMPLETED|Overall Study||46
188509|NCT01378195|457718|P2|STARTED|Overall Study||75
188510|NCT01378195|457719|P1|STARTED|Overall Study||75
188511|NCT01378117|457732|P3|NOT COMPLETED|Overall Study||3
188512|NCT01378117|457733|P2|NOT COMPLETED|Overall Study||1
188513|NCT01378117|457734|P1|NOT COMPLETED|Overall Study||4
188514|NCT01378117|457732|P3|COMPLETED|Overall Study||26
188515|NCT01378117|457733|P2|COMPLETED|Overall Study||29
188516|NCT01378117|457734|P1|COMPLETED|Overall Study||27
188517|NCT01378117|457732|P3|STARTED|Overall Study||29
188518|NCT01378117|457733|P2|STARTED|Overall Study||30
188519|NCT01378117|457734|P1|STARTED|Overall Study||31
188520|NCT01378104|457768|P2|NOT COMPLETED|Overall Study||26
188521|NCT01378104|457769|P1|NOT COMPLETED|Overall Study||27
188522|NCT01378104|457768|P2|COMPLETED|Overall Study||60
188523|NCT01378104|457769|P1|COMPLETED|Overall Study||65
188524|NCT01378104|457768|P2|STARTED|Overall Study||86
188525|NCT01378104|457769|P1|STARTED|Overall Study||92
188526|NCT01378065|457777|P1|NOT COMPLETED|Overall Study||0
188527|NCT01378065|457777|P1|COMPLETED|Overall Study||30
188528|NCT01378065|457777|P1|12 Months|Overall Study||30
188529|NCT01378065|457777|P1|6 Months|Overall Study||30
188530|NCT01378065|457777|P1|3 Months|Overall Study||30
188531|NCT01378065|457777|P1|6 Week|Overall Study||30
188532|NCT01378065|457777|P1|STARTED|Overall Study|31 subjects were enrolled/consented. However, 1 subject was not implanted with a study device.|30
188533|NCT01377987|457814|P2|NOT COMPLETED|Second Intervention (7 Days)||0
188534|NCT01377987|457815|P1|NOT COMPLETED|Second Intervention (7 Days)||0
188535|NCT01377987|457814|P2|COMPLETED|Second Intervention (7 Days)||14
188536|NCT01377987|457815|P1|COMPLETED|Second Intervention (7 Days)||13
188537|NCT01377987|457814|P2|STARTED|Second Intervention (7 Days)||14
188538|NCT01377987|457815|P1|STARTED|Second Intervention (7 Days)||13
188539|NCT01377987|457814|P2|NOT COMPLETED|Washout (7 Days)||1
188540|NCT01377987|457815|P1|NOT COMPLETED|Washout (7 Days)||1
188541|NCT01377987|457814|P2|COMPLETED|Washout (7 Days)||14
188542|NCT01377987|457815|P1|COMPLETED|Washout (7 Days)||13
188543|NCT01377987|457814|P2|STARTED|Washout (7 Days)||15
188544|NCT01377987|457815|P1|STARTED|Washout (7 Days)||14
188545|NCT01377987|457814|P2|NOT COMPLETED|First Intervention (7 Days)||0
188546|NCT01377987|457815|P1|NOT COMPLETED|First Intervention (7 Days)||0
188547|NCT01377987|457814|P2|COMPLETED|First Intervention (7 Days)||15
188548|NCT01377987|457815|P1|COMPLETED|First Intervention (7 Days)||14
188549|NCT01377987|457814|P2|STARTED|First Intervention (7 Days)||15
188550|NCT01377987|457815|P1|STARTED|First Intervention (7 Days)||14
188551|NCT01377922|457833|P2|NOT COMPLETED|Overall Study||0
188552|NCT01377922|457834|P1|NOT COMPLETED|Overall Study||1
188553|NCT01377922|457833|P2|COMPLETED|Overall Study||16
188554|NCT01377922|457834|P1|COMPLETED|Overall Study||21
188555|NCT01377922|457833|P2|STARTED|Overall Study||16
188556|NCT01377922|457834|P1|STARTED|Overall Study||22
188557|NCT01377636|457846|P1|NOT COMPLETED|Overall Study||0
188558|NCT01377636|457846|P1|COMPLETED|Overall Study||20
188559|NCT01377636|457846|P1|STARTED|Overall Study||20
188560|NCT01377623|457860|P2|NOT COMPLETED|Overall Study||5
188561|NCT01377623|457861|P1|NOT COMPLETED|Overall Study||7
188562|NCT01377623|457860|P2|COMPLETED|Overall Study||28
188563|NCT01377623|457861|P1|COMPLETED|Overall Study||26
188564|NCT01377623|457860|P2|STARTED|Overall Study||33
188565|NCT01377623|457861|P1|STARTED|Overall Study||33
188566|NCT01377584|457881|P6|NOT COMPLETED|Overall Study||3
188567|NCT01377584|457882|P5|NOT COMPLETED|Overall Study||3
188568|NCT01377584|457883|P4|NOT COMPLETED|Overall Study||4
188569|NCT01377584|457884|P3|NOT COMPLETED|Overall Study||4
188570|NCT01377584|457885|P2|NOT COMPLETED|Overall Study||3
188571|NCT01377584|457886|P1|NOT COMPLETED|Overall Study||3
188572|NCT01377584|457881|P6|COMPLETED|Overall Study||9
188573|NCT01377584|457882|P5|COMPLETED|Overall Study||9
188574|NCT01377584|457883|P4|COMPLETED|Overall Study||6
188575|NCT01377584|457884|P3|COMPLETED|Overall Study||6
188576|NCT01377584|457885|P2|COMPLETED|Overall Study||5
188577|NCT01377584|457886|P1|COMPLETED|Overall Study||5
188578|NCT01377584|457881|P6|STARTED|Overall Study||12
188579|NCT01377584|457882|P5|STARTED|Overall Study||12
188580|NCT01377584|457883|P4|STARTED|Overall Study||10
188581|NCT01377584|457884|P3|STARTED|Overall Study||10
188582|NCT01377584|457885|P2|STARTED|Overall Study||8
188583|NCT01377584|457886|P1|STARTED|Overall Study||8
188584|NCT01377480|457919|P4|NOT COMPLETED|Overall Study||11
188585|NCT01377480|457920|P3|NOT COMPLETED|Overall Study||10
188586|NCT01377480|457921|P2|NOT COMPLETED|Overall Study||1
188587|NCT01377480|457922|P1|NOT COMPLETED|Overall Study||0
188588|NCT01377480|457919|P4|COMPLETED|Overall Study||19
188589|NCT01377480|457920|P3|COMPLETED|Overall Study||18
188590|NCT01377480|457921|P2|COMPLETED|Overall Study||29
188591|NCT01377480|457922|P1|COMPLETED|Overall Study||32
188592|NCT01377480|457919|P4|STARTED|Overall Study||30
188593|NCT01377480|457920|P3|STARTED|Overall Study|2 participants received only POS and were analyzed as part of the posaconazole group|28
188594|NCT01377480|457921|P2|STARTED|Overall Study||30
188595|NCT01377480|457922|P1|STARTED|Overall Study|Includes 2 participants randomized to POS + BNZ but who only received POS|32
188596|NCT01377467|457934|P2|NOT COMPLETED|Overall Study||0
188597|NCT01377467|457935|P1|NOT COMPLETED|Overall Study||0
188598|NCT01377467|457934|P2|COMPLETED|Overall Study||44
188599|NCT01377467|457935|P1|COMPLETED|Overall Study||46
188600|NCT01377467|457934|P2|STARTED|Overall Study||44
188601|NCT01377467|457935|P1|STARTED|Overall Study||46
188602|NCT01377441|457983|P2|NOT COMPLETED|Overall Study||0
188603|NCT01377441|457984|P1|NOT COMPLETED|Overall Study||0
188604|NCT01377441|457983|P2|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
188605|NCT01377441|457984|P1|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
188606|NCT01377441|457983|P2|STARTED|Overall Study||0
188607|NCT01377441|457984|P1|STARTED|Overall Study||0
188608|NCT01377402|457992|P1|NOT COMPLETED|Overall Study||0
188609|NCT01377402|457992|P1|COMPLETED|Overall Study||982
188610|NCT01377402|457992|P1|STARTED|Overall Study||982
188611|NCT01377389|457998|P1|NOT COMPLETED|Overall Study||3
188612|NCT01377389|457998|P1|COMPLETED|Overall Study||27
188613|NCT01377389|457998|P1|STARTED|Overall Study||30
188614|NCT01377233|458012|P5|NOT COMPLETED|Double-blind||2
188615|NCT01377233|458013|P4|NOT COMPLETED|Double-blind||4
188616|NCT01377233|458014|P3|NOT COMPLETED|Double-blind||2
188617|NCT01377233|458015|P2|NOT COMPLETED|Double-blind||1
188618|NCT01377233|458016|P1|NOT COMPLETED|Double-blind||0
188619|NCT01377233|458012|P5|COMPLETED|Double-blind||8
188620|NCT01377233|458013|P4|COMPLETED|Double-blind||7
188621|NCT01377233|458014|P3|COMPLETED|Double-blind||8
188622|NCT01377233|458015|P2|COMPLETED|Double-blind||10
188623|NCT01377233|458016|P1|COMPLETED|Double-blind||0
188624|NCT01377233|458012|P5|STARTED|Double-blind||10
188625|NCT01377233|458013|P4|STARTED|Double-blind||11
188626|NCT01377233|458014|P3|STARTED|Double-blind||10
188627|NCT01377233|458015|P2|STARTED|Double-blind||11
188628|NCT01377233|458016|P1|STARTED|Double-blind||0
188629|NCT01377233|458012|P5|NOT COMPLETED|Open-label||0
188630|NCT01377233|458013|P4|NOT COMPLETED|Open-label||0
188631|NCT01377233|458014|P3|NOT COMPLETED|Open-label||0
188632|NCT01377233|458015|P2|NOT COMPLETED|Open-label||0
188633|NCT01377233|458016|P1|NOT COMPLETED|Open-label||4
188634|NCT01377233|458012|P5|COMPLETED|Open-label||0
188635|NCT01377233|458013|P4|COMPLETED|Open-label||0
188636|NCT01377233|458014|P3|COMPLETED|Open-label||0
188637|NCT01377233|458015|P2|COMPLETED|Open-label||0
188638|NCT01377233|458016|P1|COMPLETED|Open-label||42
188639|NCT01377233|458012|P5|STARTED|Open-label||0
188640|NCT01377233|458013|P4|STARTED|Open-label||0
188641|NCT01377233|458014|P3|STARTED|Open-label||0
188642|NCT01377233|458015|P2|STARTED|Open-label||0
188643|NCT01377233|458016|P1|STARTED|Open-label||46
188644|NCT01377194|458043|P3|NOT COMPLETED|Overall Study||46
188645|NCT01377194|458044|P2|NOT COMPLETED|Overall Study||43
188646|NCT01377194|458045|P1|NOT COMPLETED|Overall Study||32
188647|NCT01377194|458043|P3|COMPLETED|Overall Study||142
188648|NCT01377194|458044|P2|COMPLETED|Overall Study||145
188649|NCT01377194|458045|P1|COMPLETED|Overall Study||154
188650|NCT01377194|458043|P3|STARTED|Overall Study||188
188651|NCT01377194|458044|P2|STARTED|Overall Study||188
188652|NCT01377194|458045|P1|STARTED|Overall Study||186
188653|NCT01377012|458059|P3|NOT COMPLETED|Extension Study, Weeks 104-260||68
188654|NCT01377012|458060|P2|NOT COMPLETED|Extension Study, Weeks 104-260||71
188655|NCT01377012|458061|P1|NOT COMPLETED|Extension Study, Weeks 104-260||57
188656|NCT01377012|458059|P3|COMPLETED|Extension Study, Weeks 104-260||0
188657|NCT01377012|458060|P2|COMPLETED|Extension Study, Weeks 104-260||0
188658|NCT01377012|458061|P1|COMPLETED|Extension Study, Weeks 104-260||0
188659|NCT01377012|458059|P3|STARTED|Extension Study, Weeks 104-260||68
188660|NCT01377012|458060|P2|STARTED|Extension Study, Weeks 104-260||71
188661|NCT01377012|458061|P1|STARTED|Extension Study, Weeks 104-260||57
188662|NCT01377012|458059|P3|NOT COMPLETED|Core Study||134
188663|NCT01377012|458060|P2|NOT COMPLETED|Core Study||132
188664|NCT01377012|458061|P1|NOT COMPLETED|Core Study||134
188665|NCT01377012|458059|P3|COMPLETED|Core Study||80
188666|NCT01377012|458060|P2|COMPLETED|Core Study||81
188667|NCT01377012|458061|P1|COMPLETED|Core Study||76
188668|NCT01377012|458059|P3|wk 24 Re-randomized to AIN 150 mg Res|Core Study||34
188669|NCT01377012|458060|P2|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
188670|NCT01377012|458061|P1|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
188671|NCT01377012|458059|P3|wk 24 Re-randomized to AIN 75 mg Res|Core Study|Res= responder|38
188672|NCT01377012|458060|P2|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
188673|NCT01377012|458061|P1|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
188674|NCT01377012|458059|P3|wk16 Re-randomized to AIN 150mg NR|Core Study||53
188675|NCT01377012|458060|P2|wk16 Re-randomized to AIN 150mg NR|Core Study||0
188676|NCT01377012|458061|P1|wk16 Re-randomized to AIN 150mg NR|Core Study||0
188677|NCT01377012|458059|P3|wk16 Re-randomized to AIN 75mg NR|Core Study|NR=Non-responder|56
188678|NCT01377012|458060|P2|wk16 Re-randomized to AIN 75mg NR|Core Study||0
188679|NCT01377012|458061|P1|wk16 Re-randomized to AIN 75mg NR|Core Study||0
188680|NCT01377012|458059|P3|STARTED|Core Study||214
188681|NCT01377012|458060|P2|STARTED|Core Study||213
188682|NCT01377012|458061|P1|STARTED|Core Study||210
188683|NCT01376908|458098|P2|NOT COMPLETED|Overall Study||3
188684|NCT01376908|458099|P1|NOT COMPLETED|Overall Study||2
188685|NCT01376908|458098|P2|COMPLETED|Overall Study||26
188686|NCT01376908|458099|P1|COMPLETED|Overall Study||25
188687|NCT01376908|458098|P2|STARTED|Overall Study||29
188688|NCT01376908|458099|P1|STARTED|Overall Study||27
188689|NCT01376804|458132|P1|NOT COMPLETED|Follow-up Period||0
188690|NCT01376804|458132|P1|COMPLETED|Follow-up Period||55
188691|NCT01376804|458132|P1|STARTED|Follow-up Period|6 of the 7 patients who withdrew from treatment continued to the Follow-up Period.|55
188692|NCT01376804|458132|P1|NOT COMPLETED|Treatment Period||8
188693|NCT01376804|458132|P1|COMPLETED|Treatment Period||49
188694|NCT01376804|458132|P1|Received Study Drug|Treatment Period||56
188695|NCT01376804|458132|P1|STARTED|Treatment Period||57
188696|NCT01376700|458143|P1|NOT COMPLETED|Overall Study||16
188697|NCT01376700|458143|P1|COMPLETED|Overall Study||3
188698|NCT01376700|458143|P1|STARTED|Overall Study||19
188699|NCT01376557|458164|P5|NOT COMPLETED|Overall Study||7
188700|NCT01376557|458165|P4|NOT COMPLETED|Overall Study||6
188701|NCT01376557|458166|P3|NOT COMPLETED|Overall Study||5
188702|NCT01376557|458167|P2|NOT COMPLETED|Overall Study||6
188703|NCT01376557|458168|P1|NOT COMPLETED|Overall Study||8
188704|NCT01376557|458164|P5|COMPLETED|Overall Study||53
188705|NCT01376557|458165|P4|COMPLETED|Overall Study||54
188706|NCT01376557|458166|P3|COMPLETED|Overall Study||55
188707|NCT01376557|458167|P2|COMPLETED|Overall Study||54
188708|NCT01376557|458168|P1|COMPLETED|Overall Study||51
188709|NCT01376557|458164|P5|STARTED|Overall Study||60
188710|NCT01376557|458165|P4|STARTED|Overall Study||60
188711|NCT01376557|458166|P3|STARTED|Overall Study||60
188712|NCT01376557|458167|P2|STARTED|Overall Study||60
188713|NCT01376557|458168|P1|STARTED|Overall Study||59
188714|NCT01376388|458205|P1|NOT COMPLETED|Overall Study||18
188715|NCT01376388|458205|P1|COMPLETED|Overall Study||112
188716|NCT01376388|458205|P1|STARTED|Overall Study||130
188717|NCT01376362|458220|P1|NOT COMPLETED|Overall Study||0
188718|NCT01376362|458220|P1|COMPLETED|Overall Study||5
188719|NCT01376362|458220|P1|STARTED|Overall Study||5
188720|NCT01376349|458243|P3|NOT COMPLETED|Optional Continuation Phase||0
188721|NCT01376349|458244|P2|NOT COMPLETED|Optional Continuation Phase||0
188722|NCT01376349|458245|P1|NOT COMPLETED|Optional Continuation Phase||0
188723|NCT01376349|458243|P3|COMPLETED|Optional Continuation Phase||94
188724|NCT01376349|458244|P2|COMPLETED|Optional Continuation Phase||0
188725|NCT01376349|458245|P1|COMPLETED|Optional Continuation Phase||0
188726|NCT01376349|458243|P3|STARTED|Optional Continuation Phase|Patients completing Arm III Placebo were offered the option of continuing High Dose DHEA|94
188727|NCT01376349|458244|P2|STARTED|Optional Continuation Phase||0
188728|NCT01376349|458245|P1|STARTED|Optional Continuation Phase||0
188729|NCT01376349|458243|P3|NOT COMPLETED|Raondomized Treatment||29
188730|NCT01376349|458244|P2|NOT COMPLETED|Raondomized Treatment||35
188731|NCT01376349|458245|P1|NOT COMPLETED|Raondomized Treatment||24
188732|NCT01376349|458243|P3|COMPLETED|Raondomized Treatment||118
188733|NCT01376349|458244|P2|COMPLETED|Raondomized Treatment||114
188734|NCT01376349|458245|P1|COMPLETED|Raondomized Treatment||123
188735|NCT01376349|458243|P3|STARTED|Raondomized Treatment||147
188736|NCT01376349|458244|P2|STARTED|Raondomized Treatment||149
188737|NCT01376349|458245|P1|STARTED|Raondomized Treatment||147
188738|NCT01376323|458259|P5|NOT COMPLETED|Overall Study||1
188739|NCT01376323|458260|P4|NOT COMPLETED|Overall Study||5
188740|NCT01376323|458261|P3|NOT COMPLETED|Overall Study||3
188741|NCT01376323|458262|P2|NOT COMPLETED|Overall Study||1
188742|NCT01376323|458263|P1|NOT COMPLETED|Overall Study||2
188743|NCT01376323|458259|P5|COMPLETED|Overall Study||17
188744|NCT01376323|458260|P4|COMPLETED|Overall Study||14
188745|NCT01376323|458261|P3|COMPLETED|Overall Study||16
188746|NCT01376323|458262|P2|COMPLETED|Overall Study||17
188747|NCT01376323|458263|P1|COMPLETED|Overall Study||18
188748|NCT01376323|458259|P5|STARTED|Overall Study||18
188749|NCT01376323|458260|P4|STARTED|Overall Study||19
188750|NCT01376323|458261|P3|STARTED|Overall Study||19
188751|NCT01376323|458262|P2|STARTED|Overall Study||18
188752|NCT01376323|458263|P1|STARTED|Overall Study||20
188753|NCT01376310|458347|P2|NOT COMPLETED|Overall Study||11
188754|NCT01376310|458348|P1|NOT COMPLETED|Overall Study||36
188755|NCT01376310|458347|P2|COMPLETED|Overall Study||22
188756|NCT01376310|458348|P1|COMPLETED|Overall Study||90
188757|NCT01376310|458347|P2|STARTED|Overall Study||33
188758|NCT01376310|458348|P1|STARTED|Overall Study||126
188759|NCT01376297|458356|P2|NOT COMPLETED|Overall Study||49
188760|NCT01376297|458357|P1|NOT COMPLETED|Overall Study||128
188761|NCT01376297|458356|P2|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|55
188762|NCT01376297|458357|P1|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|181
188763|NCT01376297|458356|P2|STARTED|Overall Study|number of randomised patients|104
188764|NCT01376297|458357|P1|STARTED|Overall Study|number of randomised patients|309
188765|NCT01376245|458367|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||26
188766|NCT01376245|458368|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||23
188767|NCT01376245|458369|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||25
188768|NCT01376245|458370|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||32
188769|NCT01376245|458371|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
188770|NCT01376245|458367|P5|COMPLETED|24-week, Double-blind Treatment Period||134
188771|NCT01376245|458368|P4|COMPLETED|24-week, Double-blind Treatment Period||138
188772|NCT01376245|458369|P3|COMPLETED|24-week, Double-blind Treatment Period||135
188773|NCT01376245|458370|P2|COMPLETED|24-week, Double-blind Treatment Period||130
188774|NCT01376245|458371|P1|COMPLETED|24-week, Double-blind Treatment Period||0
188775|NCT01376245|458367|P5|STARTED|24-week, Double-blind Treatment Period||160
188776|NCT01376245|458368|P4|STARTED|24-week, Double-blind Treatment Period||161
188777|NCT01376245|458369|P3|STARTED|24-week, Double-blind Treatment Period||160
188778|NCT01376245|458370|P2|STARTED|24-week, Double-blind Treatment Period||162
188779|NCT01376245|458371|P1|STARTED|24-week, Double-blind Treatment Period||0
188780|NCT01376245|458367|P5|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
188781|NCT01376245|458368|P4|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
188782|NCT01376245|458369|P3|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
188783|NCT01376245|458370|P2|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
188784|NCT01376245|458371|P1|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||101
188785|NCT01376245|458367|P5|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
188786|NCT01376245|458368|P4|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
188787|NCT01376245|458369|P3|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
188788|NCT01376245|458370|P2|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
188789|NCT01376245|458371|P1|COMPLETED|2-wk Single-blind Placebo Run-in Period||643
188790|NCT01376245|458367|P5|STARTED|2-wk Single-blind Placebo Run-in Period||0
188791|NCT01376245|458368|P4|STARTED|2-wk Single-blind Placebo Run-in Period||0
188792|NCT01376245|458369|P3|STARTED|2-wk Single-blind Placebo Run-in Period||0
188793|NCT01376245|458370|P2|STARTED|2-wk Single-blind Placebo Run-in Period||0
188794|NCT01376245|458371|P1|STARTED|2-wk Single-blind Placebo Run-in Period||744
188795|NCT01376167|458388|P3|NOT COMPLETED|Overall Study||6
188796|NCT01376167|458389|P2|NOT COMPLETED|Overall Study||10
188797|NCT01376167|458390|P1|NOT COMPLETED|Overall Study||4
188798|NCT01376167|458388|P3|COMPLETED|Overall Study||123
188799|NCT01376167|458389|P2|COMPLETED|Overall Study||250
188800|NCT01376167|458390|P1|COMPLETED|Overall Study||129
188801|NCT01376167|458388|P3|STARTED|Overall Study||129
188802|NCT01376167|458389|P2|STARTED|Overall Study||260
188803|NCT01376167|458390|P1|STARTED|Overall Study||133
188804|NCT01376089|458461|P2|NOT COMPLETED|Overall Study||4
188805|NCT01376089|458462|P1|NOT COMPLETED|Overall Study||3
188806|NCT01376089|458461|P2|COMPLETED|Overall Study||144
188807|NCT01376089|458462|P1|COMPLETED|Overall Study||148
188808|NCT01376089|458461|P2|STARTED|Overall Study||148
188809|NCT01376089|458462|P1|STARTED|Overall Study||151
188810|NCT01376050|458474|P2|NOT COMPLETED|Overall Study||0
188811|NCT01376050|458475|P1|NOT COMPLETED|Overall Study||0
188812|NCT01376050|458474|P2|COMPLETED|Overall Study||11
188813|NCT01376050|458475|P1|COMPLETED|Overall Study||13
188814|NCT01376050|458474|P2|STARTED|Overall Study||11
188815|NCT01376050|458475|P1|STARTED|Overall Study||13
188816|NCT01376037|458485|P2|NOT COMPLETED|Overall Study||2
188817|NCT01376037|458486|P1|NOT COMPLETED|Overall Study||0
188818|NCT01376037|458485|P2|COMPLETED|Overall Study||29
188819|NCT01376037|458486|P1|COMPLETED|Overall Study||31
188820|NCT01376037|458485|P2|STARTED|Overall Study||31
188821|NCT01376037|458486|P1|STARTED|Overall Study||31
188822|NCT01375946|458492|P6|NOT COMPLETED|Overall Study||0
188823|NCT01375946|458493|P5|NOT COMPLETED|Overall Study||0
188824|NCT01375946|458494|P4|NOT COMPLETED|Overall Study||0
188825|NCT01375946|458495|P3|NOT COMPLETED|Overall Study||0
188826|NCT01375946|458496|P2|NOT COMPLETED|Overall Study||0
188827|NCT01375946|458497|P1|NOT COMPLETED|Overall Study||0
188828|NCT01375946|458492|P6|COMPLETED|Overall Study||4
188829|NCT01375946|458493|P5|COMPLETED|Overall Study||4
188830|NCT01375946|458494|P4|COMPLETED|Overall Study||4
188831|NCT01375946|458495|P3|COMPLETED|Overall Study||4
188832|NCT01375946|458496|P2|COMPLETED|Overall Study||4
188833|NCT01375946|458497|P1|COMPLETED|Overall Study||4
188834|NCT01375946|458492|P6|STARTED|Overall Study||4
188835|NCT01375946|458493|P5|STARTED|Overall Study||4
188836|NCT01375946|458494|P4|STARTED|Overall Study||4
188837|NCT01375946|458495|P3|STARTED|Overall Study||4
188838|NCT01375946|458496|P2|STARTED|Overall Study||4
188839|NCT01375946|458497|P1|STARTED|Overall Study||4
188840|NCT01375777|458514|P9|NOT COMPLETED|Overall Study||2
188841|NCT01375777|458515|P8|NOT COMPLETED|Overall Study||2
188842|NCT01375777|458516|P7|NOT COMPLETED|Overall Study||2
188843|NCT01375777|458517|P6|NOT COMPLETED|Overall Study||1
188844|NCT01375777|458518|P5|NOT COMPLETED|Overall Study||1
188845|NCT01375777|458519|P4|NOT COMPLETED|Overall Study||0
188846|NCT01375777|458520|P3|NOT COMPLETED|Overall Study||1
188847|NCT01375777|458521|P2|NOT COMPLETED|Overall Study||3
188848|NCT01375777|458522|P1|NOT COMPLETED|Overall Study||2
188849|NCT01375777|458514|P9|COMPLETED|Overall Study||44
188850|NCT01375777|458515|P8|COMPLETED|Overall Study||44
188851|NCT01375777|458516|P7|COMPLETED|Overall Study||44
188852|NCT01375777|458517|P6|COMPLETED|Overall Study||44
188853|NCT01375777|458518|P5|COMPLETED|Overall Study||45
188854|NCT01375777|458519|P4|COMPLETED|Overall Study||45
188855|NCT01375777|458520|P3|COMPLETED|Overall Study||45
188856|NCT01375777|458521|P2|COMPLETED|Overall Study||42
188857|NCT01375777|458522|P1|COMPLETED|Overall Study||44
188858|NCT01375777|458514|P9|Received Treatment|Overall Study||45
188859|NCT01375777|458515|P8|Received Treatment|Overall Study||45
188860|NCT01375777|458516|P7|Received Treatment|Overall Study||45
188861|NCT01375777|458517|P6|Received Treatment|Overall Study||45
188862|NCT01375777|458518|P5|Received Treatment|Overall Study||46
188863|NCT01375777|458519|P4|Received Treatment|Overall Study||45
188864|NCT01375777|458520|P3|Received Treatment|Overall Study||45
188865|NCT01375777|458521|P2|Received Treatment|Overall Study||45
188866|NCT01375777|458522|P1|Received Treatment|Overall Study||45
188867|NCT01375777|458514|P9|STARTED|Overall Study||46
188868|NCT01375777|458515|P8|STARTED|Overall Study||46
188869|NCT01375777|458516|P7|STARTED|Overall Study||46
188870|NCT01375777|458517|P6|STARTED|Overall Study||45
188871|NCT01375777|458518|P5|STARTED|Overall Study||46
188872|NCT01375777|458519|P4|STARTED|Overall Study||45
188873|NCT01375777|458520|P3|STARTED|Overall Study||46
188874|NCT01375777|458521|P2|STARTED|Overall Study||45
188875|NCT01375777|458522|P1|STARTED|Overall Study||46
188876|NCT01375764|458592|P5|NOT COMPLETED|Overall Study||1
188877|NCT01375764|458593|P4|NOT COMPLETED|Overall Study||1
188878|NCT01375764|458594|P3|NOT COMPLETED|Overall Study||0
188879|NCT01375764|458595|P2|NOT COMPLETED|Overall Study||1
188880|NCT01375764|458596|P1|NOT COMPLETED|Overall Study||2
188881|NCT01375764|458592|P5|COMPLETED|Overall Study||31
188882|NCT01375764|458593|P4|COMPLETED|Overall Study||31
188883|NCT01375764|458594|P3|COMPLETED|Overall Study||32
188884|NCT01375764|458595|P2|COMPLETED|Overall Study||30
188885|NCT01375764|458596|P1|COMPLETED|Overall Study||31
188886|NCT01375764|458592|P5|Received Treatment|Overall Study||32
188887|NCT01375764|458593|P4|Received Treatment|Overall Study||31
188888|NCT01375764|458594|P3|Received Treatment|Overall Study||32
188889|NCT01375764|458595|P2|Received Treatment|Overall Study||30
188890|NCT01375764|458596|P1|Received Treatment|Overall Study||32
188891|NCT01375764|458592|P5|STARTED|Overall Study||32
188892|NCT01375764|458593|P4|STARTED|Overall Study||32
188893|NCT01375764|458594|P3|STARTED|Overall Study||32
188894|NCT01375764|458595|P2|STARTED|Overall Study||31
188895|NCT01375764|458596|P1|STARTED|Overall Study||33
188896|NCT01375751|458642|P3|NOT COMPLETED|Overall Study||0
188897|NCT01375751|458643|P2|NOT COMPLETED|Overall Study||1
188898|NCT01375751|458644|P1|NOT COMPLETED|Overall Study||0
188899|NCT01375751|458642|P3|COMPLETED|Overall Study||56
188900|NCT01375751|458643|P2|COMPLETED|Overall Study||55
188901|NCT01375751|458644|P1|COMPLETED|Overall Study||56
188902|NCT01375751|458642|P3|Received Treatment|Overall Study||56
188903|NCT01375751|458643|P2|Received Treatment|Overall Study||55
188904|NCT01375751|458644|P1|Received Treatment|Overall Study||56
188905|NCT01375751|458642|P3|STARTED|Overall Study||56
188906|NCT01375751|458643|P2|STARTED|Overall Study||56
188907|NCT01375751|458644|P1|STARTED|Overall Study||56
188908|NCT01375660|458669|P2|NOT COMPLETED|Overall Study||16
188909|NCT01375660|458670|P1|NOT COMPLETED|Overall Study||16
188910|NCT01375660|458669|P2|COMPLETED|Overall Study||87
188911|NCT01375660|458670|P1|COMPLETED|Overall Study||86
188912|NCT01375660|458669|P2|STARTED|Overall Study||103
188913|NCT01375660|458670|P1|STARTED|Overall Study||102
188914|NCT01375608|458688|P1|NOT COMPLETED|Overall Study||2
188915|NCT01375608|458688|P1|COMPLETED|Overall Study||8
188916|NCT01375608|458688|P1|STARTED|Overall Study||10
188917|NCT01375569|458692|P1|NOT COMPLETED|Overall Study||0
188918|NCT01375569|458692|P1|COMPLETED|Overall Study||11
188919|NCT01375569|458692|P1|STARTED|Overall Study||11
188920|NCT01375374|458697|P1|NOT COMPLETED|Overall Study||1
188921|NCT01375374|458697|P1|COMPLETED|Overall Study||10
188922|NCT01375374|458697|P1|STARTED|Overall Study||11
188923|NCT01375205|458706|P2|NOT COMPLETED|Overall Study||13
188924|NCT01375205|458707|P1|NOT COMPLETED|Overall Study||21
188925|NCT01375205|458706|P2|COMPLETED|Overall Study||33
188926|NCT01375205|458707|P1|COMPLETED|Overall Study||33
188927|NCT01375205|458706|P2|STARTED|Overall Study||46
188928|NCT01375205|458707|P1|STARTED|Overall Study||54
188929|NCT01375140|458713|P1|NOT COMPLETED|Overall Study||0
188930|NCT01375140|458713|P1|COMPLETED|Overall Study||31
188931|NCT01375140|458713|P1|STARTED|Overall Study||31
188932|NCT01375127|458723|P6|NOT COMPLETED|Overall Study||0
188933|NCT01375127|458724|P5|NOT COMPLETED|Overall Study||0
188934|NCT01375127|458725|P4|NOT COMPLETED|Overall Study||0
188935|NCT01375127|458726|P3|NOT COMPLETED|Overall Study||0
188936|NCT01375127|458727|P2|NOT COMPLETED|Overall Study||0
188937|NCT01375127|458728|P1|NOT COMPLETED|Overall Study||0
188938|NCT01375127|458723|P6|COMPLETED|Overall Study||3
188939|NCT01375127|458724|P5|COMPLETED|Overall Study||5
188940|NCT01375127|458725|P4|COMPLETED|Overall Study||33
188941|NCT01375127|458726|P3|COMPLETED|Overall Study||40
188942|NCT01375127|458727|P2|COMPLETED|Overall Study||1
188943|NCT01375127|458728|P1|COMPLETED|Overall Study||1
188944|NCT01375127|458723|P6|STARTED|Overall Study||3
188945|NCT01375127|458724|P5|STARTED|Overall Study||5
188946|NCT01375127|458725|P4|STARTED|Overall Study||33
188947|NCT01375127|458726|P3|STARTED|Overall Study||40
188948|NCT01375127|458727|P2|STARTED|Overall Study||1
188949|NCT01375127|458728|P1|STARTED|Overall Study||1
188950|NCT01375075|458766|P6|NOT COMPLETED|Overall Study||3
188951|NCT01375075|458767|P5|NOT COMPLETED|Overall Study||0
188952|NCT01375075|458768|P4|NOT COMPLETED|Overall Study||1
188953|NCT01375075|458769|P3|NOT COMPLETED|Overall Study||3
188954|NCT01375075|458770|P2|NOT COMPLETED|Overall Study||1
188955|NCT01375075|458771|P1|NOT COMPLETED|Overall Study||1
188956|NCT01375075|458766|P6|COMPLETED|Overall Study||25
188957|NCT01375075|458767|P5|COMPLETED|Overall Study||27
188958|NCT01375075|458768|P4|COMPLETED|Overall Study||27
188959|NCT01375075|458769|P3|COMPLETED|Overall Study||24
188960|NCT01375075|458770|P2|COMPLETED|Overall Study||27
188961|NCT01375075|458771|P1|COMPLETED|Overall Study||26
188962|NCT01375075|458766|P6|Received at Least One Dose of Study Drug|Overall Study||28
188963|NCT01375075|458767|P5|Received at Least One Dose of Study Drug|Overall Study||27
188964|NCT01375075|458768|P4|Received at Least One Dose of Study Drug|Overall Study||28
188965|NCT01375075|458769|P3|Received at Least One Dose of Study Drug|Overall Study||27
188966|NCT01375075|458770|P2|Received at Least One Dose of Study Drug|Overall Study||28
188967|NCT01375075|458771|P1|Received at Least One Dose of Study Drug|Overall Study||27
188968|NCT01375075|458766|P6|STARTED|Overall Study||28
188969|NCT01375075|458767|P5|STARTED|Overall Study||27
188970|NCT01375075|458768|P4|STARTED|Overall Study||28
188971|NCT01375075|458769|P3|STARTED|Overall Study||27
188972|NCT01375075|458770|P2|STARTED|Overall Study||28
188973|NCT01375075|458771|P1|STARTED|Overall Study||27
188974|NCT01375049|458855|P1|NOT COMPLETED|Overall Study||50
188975|NCT01375049|458855|P1|COMPLETED|Overall Study||55
188976|NCT01375049|458855|P1|STARTED|Overall Study||105
188977|NCT01375010|458872|P2|NOT COMPLETED|Overall Study||4
188978|NCT01375010|458873|P1|NOT COMPLETED|Overall Study||12
188979|NCT01375010|458872|P2|COMPLETED|Overall Study||38
188980|NCT01375010|458873|P1|COMPLETED|Overall Study||31
188981|NCT01375010|458872|P2|STARTED|Overall Study||42
188982|NCT01375010|458873|P1|STARTED|Overall Study||43
188983|NCT01374971|458887|P1|NOT COMPLETED|Overall Study||1
188984|NCT01374971|458887|P1|COMPLETED|Overall Study||11
188985|NCT01374971|458887|P1|STARTED|Overall Study||12
188986|NCT01374919|458892|P1|NOT COMPLETED|Overall Study||2
188987|NCT01374919|458892|P1|COMPLETED|Overall Study||58
188988|NCT01374919|458892|P1|STARTED|Overall Study||60
188989|NCT01374906|458899|P2|NOT COMPLETED|Overall Study||48
188990|NCT01374906|458900|P1|NOT COMPLETED|Overall Study||40
188991|NCT01374906|458899|P2|COMPLETED|Overall Study||28
188992|NCT01374906|458900|P1|COMPLETED|Overall Study||34
188993|NCT01374906|458899|P2|Completed Extension Phase|Overall Study||15
188994|NCT01374906|458900|P1|Completed Extension Phase|Overall Study||24
188995|NCT01374906|458899|P2|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||26
188996|NCT01374906|458900|P1|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||16
188997|NCT01374906|458899|P2|Completed Core Phase/Entered Ext. Phase|Overall Study||41
188998|NCT01374906|458900|P1|Completed Core Phase/Entered Ext. Phase|Overall Study||40
188999|NCT01374906|458899|P2|Completed Core/Did Not Enter Ext. Phase|Overall Study||13
189000|NCT01374906|458900|P1|Completed Core/Did Not Enter Ext. Phase|Overall Study||10
189001|NCT01374906|458899|P2|Completed Core Phase|Overall Study||54
189002|NCT01374906|458900|P1|Completed Core Phase|Overall Study||50
189003|NCT01374906|458899|P2|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||22
189004|NCT01374906|458900|P1|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||24
189005|NCT01374906|458899|P2|STARTED|Overall Study||76
189006|NCT01374906|458900|P1|STARTED|Overall Study||74
189007|NCT01374802|458967|P1|NOT COMPLETED|Overall Study||0
189008|NCT01374802|458967|P1|COMPLETED|Overall Study||14
189009|NCT01374802|458967|P1|STARTED|Overall Study||14
189010|NCT01374568|458981|P2|NOT COMPLETED|Overall Study||2
189011|NCT01374568|458982|P1|NOT COMPLETED|Overall Study||0
189012|NCT01374568|458981|P2|COMPLETED|Overall Study||1
189013|NCT01374568|458982|P1|COMPLETED|Overall Study||2
189014|NCT01374568|458981|P2|STARTED|Overall Study||3
189015|NCT01374568|458982|P1|STARTED|Overall Study||2
189016|NCT01374516|458992|P2|NOT COMPLETED|Surveillance Expansion Period||1253
189017|NCT01374516|458993|P1|NOT COMPLETED|Surveillance Expansion Period||2349
189018|NCT01374516|458992|P2|COMPLETED|Surveillance Expansion Period||5387
189019|NCT01374516|458993|P1|COMPLETED|Surveillance Expansion Period||10932
189020|NCT01374516|458992|P2|STARTED|Surveillance Expansion Period||6640
189021|NCT01374516|458993|P1|STARTED|Surveillance Expansion Period||13281
189022|NCT01374516|458992|P2|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||309
189023|NCT01374516|458993|P1|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||639
189024|NCT01374516|458992|P2|COMPLETED|Vaccination Phase (Up to 25 Months)||6640
189025|NCT01374516|458993|P1|COMPLETED|Vaccination Phase (Up to 25 Months)||13281
189026|NCT01374516|458992|P2|STARTED|Vaccination Phase (Up to 25 Months)||6949
189027|NCT01374516|458993|P1|STARTED|Vaccination Phase (Up to 25 Months)||13920
189028|NCT01374451|459027|P2|NOT COMPLETED|Overall Study||0
189029|NCT01374451|459028|P1|NOT COMPLETED|Overall Study||1
189030|NCT01374451|459027|P2|COMPLETED|Overall Study||81
189031|NCT01374451|459028|P1|COMPLETED|Overall Study||78
189032|NCT01374451|459027|P2|STARTED|Overall Study||81
189033|NCT01374451|459028|P1|STARTED|Overall Study||79
189034|NCT01374438|459057|P2|NOT COMPLETED|Overall Study||0
189035|NCT01374438|459058|P1|NOT COMPLETED|Overall Study||0
189036|NCT01374438|459057|P2|COMPLETED|Overall Study||13
189037|NCT01374438|459058|P1|COMPLETED|Overall Study||16
189038|NCT01374438|459057|P2|STARTED|Overall Study||13
189039|NCT01374438|459058|P1|STARTED|Overall Study||16
189040|NCT01374425|459074|P2|NOT COMPLETED|Overall Study||188
189041|NCT01374425|459075|P1|NOT COMPLETED|Overall Study||188
189042|NCT01374425|459074|P2|COMPLETED|Overall Study||0
189043|NCT01374425|459075|P1|COMPLETED|Overall Study||0
189044|NCT01374425|459074|P2|STARTED|Overall Study||188
189045|NCT01374425|459075|P1|STARTED|Overall Study||188
189046|NCT01374269|459155|P2|NOT COMPLETED|Overall Study||5
189047|NCT01374269|459156|P1|NOT COMPLETED|Overall Study||6
189048|NCT01374269|459155|P2|COMPLETED|Overall Study||39
189049|NCT01374269|459156|P1|COMPLETED|Overall Study||40
189050|NCT01374269|459155|P2|STARTED|Overall Study||44
189051|NCT01374269|459156|P1|STARTED|Overall Study||46
189052|NCT01374217|459284|P1|NOT COMPLETED|Overall Study||13
189053|NCT01374217|459284|P1|COMPLETED|Overall Study||0
189054|NCT01374217|459284|P1|STARTED|Overall Study||13
189055|NCT01374178|459292|P2|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||0
189056|NCT01374178|459293|P1|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||2
189057|NCT01374178|459292|P2|COMPLETED|Period 2 (up to 24 Hours After Dosing)||5
189058|NCT01374178|459293|P1|COMPLETED|Period 2 (up to 24 Hours After Dosing)||8
189059|NCT01374178|459292|P2|STARTED|Period 2 (up to 24 Hours After Dosing)||5
189060|NCT01374178|459293|P1|STARTED|Period 2 (up to 24 Hours After Dosing)||10
189061|NCT01374178|459292|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
189062|NCT01374178|459293|P1|NOT COMPLETED|Washout Period of at Least 7 Days||1
189063|NCT01374178|459292|P2|COMPLETED|Washout Period of at Least 7 Days||5
189064|NCT01374178|459293|P1|COMPLETED|Washout Period of at Least 7 Days||10
189065|NCT01374178|459292|P2|STARTED|Washout Period of at Least 7 Days||5
189066|NCT01374178|459293|P1|STARTED|Washout Period of at Least 7 Days||11
189067|NCT01374178|459292|P2|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
189068|NCT01374178|459293|P1|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
189069|NCT01374178|459292|P2|COMPLETED|Period 1 (up to 24 Hours After Dosing)||5
189070|NCT01374178|459293|P1|COMPLETED|Period 1 (up to 24 Hours After Dosing)||11
189071|NCT01374178|459292|P2|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||5
189072|NCT01374178|459293|P1|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||11
189073|NCT01374178|459292|P2|STARTED|Period 1 (up to 24 Hours After Dosing)||5
189074|NCT01374178|459293|P1|STARTED|Period 1 (up to 24 Hours After Dosing)||11
189075|NCT01374087|459311|P2|NOT COMPLETED|Overall Study||15
189076|NCT01374087|459312|P1|NOT COMPLETED|Overall Study||16
189077|NCT01374087|459311|P2|COMPLETED|Overall Study||0
189078|NCT01374087|459312|P1|COMPLETED|Overall Study||0
189079|NCT01374087|459311|P2|STARTED|Overall Study||15
189080|NCT01374087|459312|P1|STARTED|Overall Study||16
189081|NCT01373931|459332|P2|NOT COMPLETED|Period 2||0
189082|NCT01373931|459333|P1|NOT COMPLETED|Period 2||0
189083|NCT01373931|459332|P2|COMPLETED|Period 2||8
189084|NCT01373931|459333|P1|COMPLETED|Period 2||6
189085|NCT01373931|459332|P2|STARTED|Period 2||8
189086|NCT01373931|459333|P1|STARTED|Period 2||6
189087|NCT01373931|459332|P2|NOT COMPLETED|Period 1||2
189088|NCT01373931|459333|P1|NOT COMPLETED|Period 1||2
189089|NCT01373931|459332|P2|COMPLETED|Period 1||8
189090|NCT01373931|459333|P1|COMPLETED|Period 1||6
189091|NCT01373931|459332|P2|STARTED|Period 1||10
189092|NCT01373931|459333|P1|STARTED|Period 1||8
189093|NCT01373931|459332|P2|NOT COMPLETED|Lead-in Period||0
189094|NCT01373931|459333|P1|NOT COMPLETED|Lead-in Period||2
189095|NCT01373931|459332|P2|COMPLETED|Lead-in Period||10
189096|NCT01373931|459333|P1|COMPLETED|Lead-in Period||8
189097|NCT01373931|459332|P2|Received at Least 1 Dose of Study Drug|Lead-in Period||10
189098|NCT01373931|459333|P1|Received at Least 1 Dose of Study Drug|Lead-in Period||8
189099|NCT01373931|459332|P2|STARTED|Lead-in Period||10
189100|NCT01373931|459333|P1|STARTED|Lead-in Period||10
189101|NCT01373918|459346|P2|NOT COMPLETED|Overall Study||1
189102|NCT01373918|459347|P1|NOT COMPLETED|Overall Study||0
189103|NCT01373918|459346|P2|COMPLETED|Overall Study||15
189104|NCT01373918|459347|P1|COMPLETED|Overall Study||20
189105|NCT01373918|459346|P2|STARTED|Overall Study||16
189106|NCT01373918|459347|P1|STARTED|Overall Study||20
189107|NCT01373671|459359|P1|NOT COMPLETED|Overall Study||92
189108|NCT01373671|459359|P1|COMPLETED|Overall Study||672
189109|NCT01373671|459359|P1|STARTED|Overall Study||764
189110|NCT01373580|459364|P1|NOT COMPLETED|Overall Study||56
189111|NCT01373580|459364|P1|COMPLETED|Overall Study||317
189112|NCT01373580|459364|P1|STARTED|Overall Study||373
189113|NCT01373489|459372|P2|NOT COMPLETED|Overall Study||13
189114|NCT01373489|459373|P1|NOT COMPLETED|Overall Study||15
189115|NCT01373489|459372|P2|COMPLETED|Overall Study||41
189116|NCT01373489|459373|P1|COMPLETED|Overall Study||44
189117|NCT01373489|459372|P2|STARTED|Overall Study||54
189118|NCT01373489|459373|P1|STARTED|Overall Study||59
189119|NCT01373450|459379|P6|NOT COMPLETED|Crossover Period 4||0
189120|NCT01373450|459380|P5|NOT COMPLETED|Crossover Period 4||0
189121|NCT01373450|459381|P4|NOT COMPLETED|Crossover Period 4||0
189122|NCT01373450|459382|P3|NOT COMPLETED|Crossover Period 4||0
189123|NCT01373450|459383|P2|NOT COMPLETED|Crossover Period 4||0
189124|NCT01373450|459384|P1|NOT COMPLETED|Crossover Period 4||0
189125|NCT01373450|459379|P6|COMPLETED|Crossover Period 4||2
189126|NCT01373450|459380|P5|COMPLETED|Crossover Period 4||2
189127|NCT01373450|459381|P4|COMPLETED|Crossover Period 4||2
189128|NCT01373450|459382|P3|COMPLETED|Crossover Period 4||2
189129|NCT01373450|459383|P2|COMPLETED|Crossover Period 4||2
189130|NCT01373450|459384|P1|COMPLETED|Crossover Period 4||2
189131|NCT01373450|459379|P6|STARTED|Crossover Period 4||2
189132|NCT01373450|459380|P5|STARTED|Crossover Period 4||2
189133|NCT01373450|459381|P4|STARTED|Crossover Period 4||2
189134|NCT01373450|459382|P3|STARTED|Crossover Period 4||2
189135|NCT01373450|459383|P2|STARTED|Crossover Period 4||2
189136|NCT01373450|459384|P1|STARTED|Crossover Period 4||2
189137|NCT01373450|459379|P6|NOT COMPLETED|7 Day Wash-out||0
189138|NCT01373450|459380|P5|NOT COMPLETED|7 Day Wash-out||0
189139|NCT01373450|459381|P4|NOT COMPLETED|7 Day Wash-out||0
189140|NCT01373450|459382|P3|NOT COMPLETED|7 Day Wash-out||0
189141|NCT01373450|459383|P2|NOT COMPLETED|7 Day Wash-out||0
189142|NCT01373450|459384|P1|NOT COMPLETED|7 Day Wash-out||0
189143|NCT01373450|459379|P6|COMPLETED|7 Day Wash-out||2
189144|NCT01373450|459380|P5|COMPLETED|7 Day Wash-out||2
189145|NCT01373450|459381|P4|COMPLETED|7 Day Wash-out||2
189146|NCT01373450|459382|P3|COMPLETED|7 Day Wash-out||2
189147|NCT01373450|459383|P2|COMPLETED|7 Day Wash-out||2
189148|NCT01373450|459384|P1|COMPLETED|7 Day Wash-out||2
189149|NCT01373450|459379|P6|STARTED|7 Day Wash-out||2
189150|NCT01373450|459380|P5|STARTED|7 Day Wash-out||2
189151|NCT01373450|459381|P4|STARTED|7 Day Wash-out||2
189152|NCT01373450|459382|P3|STARTED|7 Day Wash-out||2
189153|NCT01373450|459383|P2|STARTED|7 Day Wash-out||2
189154|NCT01373450|459384|P1|STARTED|7 Day Wash-out||2
189155|NCT01373450|459379|P6|NOT COMPLETED|Crossover Period 3||0
189156|NCT01373450|459380|P5|NOT COMPLETED|Crossover Period 3||0
189157|NCT01373450|459381|P4|NOT COMPLETED|Crossover Period 3||0
189158|NCT01373450|459382|P3|NOT COMPLETED|Crossover Period 3||0
189159|NCT01373450|459383|P2|NOT COMPLETED|Crossover Period 3||0
189160|NCT01373450|459384|P1|NOT COMPLETED|Crossover Period 3||0
189161|NCT01373450|459379|P6|COMPLETED|Crossover Period 3||2
189162|NCT01373450|459380|P5|COMPLETED|Crossover Period 3||2
189163|NCT01373450|459381|P4|COMPLETED|Crossover Period 3||2
189164|NCT01373450|459382|P3|COMPLETED|Crossover Period 3||2
189165|NCT01373450|459383|P2|COMPLETED|Crossover Period 3||2
189166|NCT01373450|459384|P1|COMPLETED|Crossover Period 3||2
189167|NCT01373450|459379|P6|STARTED|Crossover Period 3||2
189168|NCT01373450|459380|P5|STARTED|Crossover Period 3||2
189169|NCT01373450|459381|P4|STARTED|Crossover Period 3||2
189170|NCT01373450|459382|P3|STARTED|Crossover Period 3||2
189171|NCT01373450|459383|P2|STARTED|Crossover Period 3||2
189172|NCT01373450|459384|P1|STARTED|Crossover Period 3||2
189173|NCT01373450|459379|P6|NOT COMPLETED|7 Day Wash-out||0
189174|NCT01373450|459380|P5|NOT COMPLETED|7 Day Wash-out||0
189175|NCT01373450|459381|P4|NOT COMPLETED|7 Day Wash-out||0
189176|NCT01373450|459382|P3|NOT COMPLETED|7 Day Wash-out||0
189177|NCT01373450|459383|P2|NOT COMPLETED|7 Day Wash-out||0
189178|NCT01373450|459384|P1|NOT COMPLETED|7 Day Wash-out||0
189179|NCT01373450|459379|P6|COMPLETED|7 Day Wash-out||2
189180|NCT01373450|459380|P5|COMPLETED|7 Day Wash-out||2
189181|NCT01373450|459381|P4|COMPLETED|7 Day Wash-out||2
189182|NCT01373450|459382|P3|COMPLETED|7 Day Wash-out||2
189183|NCT01373450|459383|P2|COMPLETED|7 Day Wash-out||2
189184|NCT01373450|459384|P1|COMPLETED|7 Day Wash-out||2
189185|NCT01373450|459379|P6|STARTED|7 Day Wash-out||2
189186|NCT01373450|459380|P5|STARTED|7 Day Wash-out||2
189187|NCT01373450|459381|P4|STARTED|7 Day Wash-out||2
189188|NCT01373450|459382|P3|STARTED|7 Day Wash-out||2
189189|NCT01373450|459383|P2|STARTED|7 Day Wash-out||2
189190|NCT01373450|459384|P1|STARTED|7 Day Wash-out||2
189191|NCT01373450|459379|P6|NOT COMPLETED|Crossover Period 2||0
189192|NCT01373450|459380|P5|NOT COMPLETED|Crossover Period 2||0
189193|NCT01373450|459381|P4|NOT COMPLETED|Crossover Period 2||0
189194|NCT01373450|459382|P3|NOT COMPLETED|Crossover Period 2||0
189195|NCT01373450|459383|P2|NOT COMPLETED|Crossover Period 2||0
189196|NCT01373450|459384|P1|NOT COMPLETED|Crossover Period 2||0
189197|NCT01373450|459379|P6|COMPLETED|Crossover Period 2||2
189198|NCT01373450|459380|P5|COMPLETED|Crossover Period 2||2
189199|NCT01373450|459381|P4|COMPLETED|Crossover Period 2||2
189200|NCT01373450|459382|P3|COMPLETED|Crossover Period 2||2
189201|NCT01373450|459383|P2|COMPLETED|Crossover Period 2||2
189202|NCT01373450|459384|P1|COMPLETED|Crossover Period 2||2
189203|NCT01373450|459379|P6|STARTED|Crossover Period 2||2
189204|NCT01373450|459380|P5|STARTED|Crossover Period 2||2
189205|NCT01373450|459381|P4|STARTED|Crossover Period 2||2
189206|NCT01373450|459382|P3|STARTED|Crossover Period 2||2
189207|NCT01373450|459383|P2|STARTED|Crossover Period 2||2
189208|NCT01373450|459384|P1|STARTED|Crossover Period 2||2
189209|NCT01373450|459379|P6|NOT COMPLETED|7 Day Wash-out||0
189210|NCT01373450|459380|P5|NOT COMPLETED|7 Day Wash-out||0
189211|NCT01373450|459381|P4|NOT COMPLETED|7 Day Wash-out||0
189212|NCT01373450|459382|P3|NOT COMPLETED|7 Day Wash-out||0
189213|NCT01373450|459383|P2|NOT COMPLETED|7 Day Wash-out||0
189214|NCT01373450|459384|P1|NOT COMPLETED|7 Day Wash-out||0
189215|NCT01373450|459379|P6|COMPLETED|7 Day Wash-out||2
189216|NCT01373450|459380|P5|COMPLETED|7 Day Wash-out||2
189217|NCT01373450|459381|P4|COMPLETED|7 Day Wash-out||2
189218|NCT01373450|459382|P3|COMPLETED|7 Day Wash-out||2
189219|NCT01373450|459383|P2|COMPLETED|7 Day Wash-out||2
189220|NCT01373450|459384|P1|COMPLETED|7 Day Wash-out||2
189221|NCT01373450|459379|P6|STARTED|7 Day Wash-out||2
189222|NCT01373450|459380|P5|STARTED|7 Day Wash-out||2
189223|NCT01373450|459381|P4|STARTED|7 Day Wash-out||2
189224|NCT01373450|459382|P3|STARTED|7 Day Wash-out||2
189225|NCT01373450|459383|P2|STARTED|7 Day Wash-out||2
189226|NCT01373450|459384|P1|STARTED|7 Day Wash-out||2
189227|NCT01373450|459379|P6|NOT COMPLETED|Crossover Period 1||0
189228|NCT01373450|459380|P5|NOT COMPLETED|Crossover Period 1||0
189229|NCT01373450|459381|P4|NOT COMPLETED|Crossover Period 1||0
189230|NCT01373450|459382|P3|NOT COMPLETED|Crossover Period 1||0
189231|NCT01373450|459383|P2|NOT COMPLETED|Crossover Period 1||0
189232|NCT01373450|459384|P1|NOT COMPLETED|Crossover Period 1||0
189233|NCT01373450|459379|P6|COMPLETED|Crossover Period 1||2
189234|NCT01373450|459380|P5|COMPLETED|Crossover Period 1||2
189235|NCT01373450|459381|P4|COMPLETED|Crossover Period 1||2
189236|NCT01373450|459382|P3|COMPLETED|Crossover Period 1||2
189237|NCT01373450|459383|P2|COMPLETED|Crossover Period 1||2
189238|NCT01373450|459384|P1|COMPLETED|Crossover Period 1||2
189239|NCT01373450|459379|P6|STARTED|Crossover Period 1||2
189240|NCT01373450|459380|P5|STARTED|Crossover Period 1||2
189241|NCT01373450|459381|P4|STARTED|Crossover Period 1||2
189242|NCT01373450|459382|P3|STARTED|Crossover Period 1||2
189243|NCT01373450|459383|P2|STARTED|Crossover Period 1||2
189244|NCT01373450|459384|P1|STARTED|Crossover Period 1||2
189245|NCT01373346|459406|P1|NOT COMPLETED|Overall Study||1
189246|NCT01373346|459406|P1|COMPLETED|Overall Study||14
189247|NCT01373346|459406|P1|STARTED|Overall Study||15
189248|NCT01373294|459429|P2|NOT COMPLETED|Overall Study||0
189249|NCT01373294|459430|P1|NOT COMPLETED|Overall Study||1
189250|NCT01373294|459429|P2|COMPLETED|Overall Study||2
189251|NCT01373294|459430|P1|COMPLETED|Overall Study||14
189252|NCT01373294|459429|P2|STARTED|Overall Study||2
189253|NCT01373294|459430|P1|STARTED|Overall Study||15
189254|NCT01373281|459439|P2|NOT COMPLETED|Surveillance Expansion Period||118
189255|NCT01373281|459440|P1|NOT COMPLETED|Surveillance Expansion Period||202
189256|NCT01373281|459439|P2|COMPLETED|Surveillance Expansion Period||3279
189257|NCT01373281|459440|P1|COMPLETED|Surveillance Expansion Period||6595
189258|NCT01373281|459439|P2|STARTED|Surveillance Expansion Period||3397
189259|NCT01373281|459440|P1|STARTED|Surveillance Expansion Period||6797
189260|NCT01373281|459439|P2|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||27
189261|NCT01373281|459440|P1|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||54
189262|NCT01373281|459439|P2|COMPLETED|Vaccination Phase (Up to 25 Months)||3397
189263|NCT01373281|459440|P1|COMPLETED|Vaccination Phase (Up to 25 Months)||6797
189264|NCT01373281|459439|P2|STARTED|Vaccination Phase (Up to 25 Months)||3424
189265|NCT01373281|459440|P1|STARTED|Vaccination Phase (Up to 25 Months)||6851
189266|NCT01373242|459472|P1|NOT COMPLETED|Overall Study||16
189267|NCT01373242|459472|P1|COMPLETED|Overall Study||38
189268|NCT01373242|459472|P1|STARTED|Overall Study||54
189269|NCT01373229|459488|P1|NOT COMPLETED|Overall Study||6
189270|NCT01373229|459488|P1|COMPLETED|Overall Study||9
189271|NCT01373229|459488|P1|STARTED|Overall Study||15
189272|NCT01373164|459502|P5|NOT COMPLETED|Overall Study||2
189273|NCT01373164|459503|P4|NOT COMPLETED|Overall Study||12
189274|NCT01373164|459504|P3|NOT COMPLETED|Overall Study||1
189275|NCT01373164|459505|P2|NOT COMPLETED|Overall Study||1
189276|NCT01373164|459506|P1|NOT COMPLETED|Overall Study||0
189277|NCT01373164|459502|P5|COMPLETED|Overall Study||50
189278|NCT01373164|459503|P4|COMPLETED|Overall Study||92
189279|NCT01373164|459504|P3|COMPLETED|Overall Study||4
189280|NCT01373164|459505|P2|COMPLETED|Overall Study||3
189281|NCT01373164|459506|P1|COMPLETED|Overall Study||5
189282|NCT01373164|459502|P5|Received at Least One Dose|Overall Study||52
189283|NCT01373164|459503|P4|Received at Least One Dose|Overall Study||103
189284|NCT01373164|459504|P3|Received at Least One Dose|Overall Study||5
189285|NCT01373164|459505|P2|Received at Least One Dose|Overall Study||4
189286|NCT01373164|459506|P1|Received at Least One Dose|Overall Study||5
189287|NCT01373164|459502|P5|STARTED|Overall Study||52
189288|NCT01373164|459503|P4|STARTED|Overall Study||104
189289|NCT01373164|459504|P3|STARTED|Overall Study||5
189290|NCT01373164|459505|P2|STARTED|Overall Study||4
189291|NCT01373164|459506|P1|STARTED|Overall Study||5
189292|NCT01372995|459540|P3|NOT COMPLETED|Overall Study||1
189293|NCT01372995|459541|P2|NOT COMPLETED|Overall Study||1
189294|NCT01372995|459542|P1|NOT COMPLETED|Overall Study||0
189295|NCT01372995|459540|P3|COMPLETED|Overall Study|The transferred participant was included in the intent to treat analyses.|10
189296|NCT01372995|459541|P2|COMPLETED|Overall Study||9
189297|NCT01372995|459542|P1|COMPLETED|Overall Study||10
189298|NCT01372995|459540|P3|STARTED|Overall Study|One participant was transferred to comfort care prior to completing the intervention.|11
189299|NCT01372995|459541|P2|STARTED|Overall Study||10
189300|NCT01372995|459542|P1|STARTED|Overall Study||10
189301|NCT01372878|459589|P1|NOT COMPLETED|Overall Study||184
189302|NCT01372878|459589|P1|COMPLETED|Overall Study||700
189303|NCT01372878|459589|P1|STARTED|Overall Study||884
189304|NCT01372813|459594|P1|NOT COMPLETED|Overall Study||0
189305|NCT01372813|459594|P1|COMPLETED|Overall Study||3
189306|NCT01372813|459594|P1|STARTED|Overall Study||3
189307|NCT01372774|459609|P2|NOT COMPLETED|Overall Study||5
189308|NCT01372774|459610|P1|NOT COMPLETED|Overall Study||4
189309|NCT01372774|459609|P2|COMPLETED|Overall Study||93
189310|NCT01372774|459610|P1|COMPLETED|Overall Study||92
189311|NCT01372774|459609|P2|STARTED|Overall Study||98
189312|NCT01372774|459610|P1|STARTED|Overall Study||96
189313|NCT01372748|459626|P2|NOT COMPLETED|Overall Study||39
189314|NCT01372748|459627|P1|NOT COMPLETED|Overall Study||23
189315|NCT01372748|459626|P2|COMPLETED|Overall Study|defined as having vital status|12603
189316|NCT01372748|459627|P1|COMPLETED|Overall Study|defined as having vital status|11022
189317|NCT01372748|459626|P2|STARTED|Overall Study||12642
189318|NCT01372748|459627|P1|STARTED|Overall Study||11045
189319|NCT01372618|459635|P1|NOT COMPLETED|Overall Study||9
189320|NCT01372618|459635|P1|COMPLETED|Overall Study||0
189321|NCT01372618|459635|P1|STARTED|Overall Study||9
189322|NCT01372605|459643|P2|NOT COMPLETED|Overall Study||10
189323|NCT01372605|459644|P1|NOT COMPLETED|Overall Study||12
189324|NCT01372605|459643|P2|COMPLETED|Overall Study||145
189325|NCT01372605|459644|P1|COMPLETED|Overall Study||137
189326|NCT01372605|459643|P2|STARTED|Overall Study||155
189327|NCT01372605|459644|P1|STARTED|Overall Study||149
189328|NCT01372501|459670|P1|NOT COMPLETED|Overall Study||5
189329|NCT01372501|459670|P1|COMPLETED|Overall Study||14
189330|NCT01372501|459670|P1|STARTED|Overall Study||19
189331|NCT01372462|459675|P1|NOT COMPLETED|No Treatment Control||0
189332|NCT01372462|459675|P1|COMPLETED|No Treatment Control||15
189333|NCT01372462|459675|P1|STARTED|No Treatment Control||15
189334|NCT01372462|459675|P1|NOT COMPLETED|Oxygen Nasal Cannula||0
189335|NCT01372462|459675|P1|COMPLETED|Oxygen Nasal Cannula||15
189336|NCT01372462|459675|P1|STARTED|Oxygen Nasal Cannula||15
189337|NCT01372462|459675|P1|NOT COMPLETED|NIOV - Oxygen||0
189338|NCT01372462|459675|P1|COMPLETED|NIOV - Oxygen||15
189339|NCT01372462|459675|P1|STARTED|NIOV - Oxygen||15
189340|NCT01372462|459675|P1|NOT COMPLETED|NIOV - Room Air||0
189341|NCT01372462|459675|P1|COMPLETED|NIOV - Room Air||15
189342|NCT01372462|459675|P1|STARTED|NIOV - Room Air||15
189343|NCT01372410|459693|P8|NOT COMPLETED|Treatment Period 3 (7 Days)||0
189344|NCT01372410|459694|P7|NOT COMPLETED|Treatment Period 3 (7 Days)||0
189345|NCT01372410|459695|P6|NOT COMPLETED|Treatment Period 3 (7 Days)||1
189346|NCT01372410|459696|P5|NOT COMPLETED|Treatment Period 3 (7 Days)||0
189347|NCT01372410|459697|P4|NOT COMPLETED|Treatment Period 3 (7 Days)||0
189348|NCT01372410|459698|P3|NOT COMPLETED|Treatment Period 3 (7 Days)||1
189349|NCT01372410|459699|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||0
189350|NCT01372410|459700|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
189351|NCT01372410|459693|P8|COMPLETED|Treatment Period 3 (7 Days)||18
189352|NCT01372410|459694|P7|COMPLETED|Treatment Period 3 (7 Days)||15
189353|NCT01372410|459695|P6|COMPLETED|Treatment Period 3 (7 Days)||18
189354|NCT01372410|459696|P5|COMPLETED|Treatment Period 3 (7 Days)||20
189355|NCT01372410|459697|P4|COMPLETED|Treatment Period 3 (7 Days)||22
189356|NCT01372410|459698|P3|COMPLETED|Treatment Period 3 (7 Days)||15
189357|NCT01372410|459699|P2|COMPLETED|Treatment Period 3 (7 Days)||18
189358|NCT01372410|459700|P1|COMPLETED|Treatment Period 3 (7 Days)||21
189359|NCT01372410|459693|P8|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
189360|NCT01372410|459694|P7|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|15
189361|NCT01372410|459695|P6|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
189362|NCT01372410|459696|P5|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|20
189363|NCT01372410|459697|P4|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
189364|NCT01372410|459698|P3|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
189365|NCT01372410|459699|P2|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
189366|NCT01372410|459700|P1|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
189367|NCT01372410|459693|P8|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
189368|NCT01372410|459694|P7|NOT COMPLETED|Washout Period 2 (10-14 Days)||1
189369|NCT01372410|459695|P6|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
189370|NCT01372410|459696|P5|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
189371|NCT01372410|459697|P4|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
189372|NCT01372410|459698|P3|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
189373|NCT01372410|459699|P2|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
189374|NCT01372410|459700|P1|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
189375|NCT01372410|459693|P8|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
189376|NCT01372410|459694|P7|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
189377|NCT01372410|459695|P6|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|16
189378|NCT01372410|459696|P5|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
189379|NCT01372410|459697|P4|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
189380|NCT01372410|459698|P3|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|22
189381|NCT01372410|459699|P2|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
189382|NCT01372410|459700|P1|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
189383|NCT01372410|459693|P8|STARTED|Washout Period 2 (10-14 Days)||19
189384|NCT01372410|459694|P7|STARTED|Washout Period 2 (10-14 Days)||21
189385|NCT01372410|459695|P6|STARTED|Washout Period 2 (10-14 Days)||16
189386|NCT01372410|459696|P5|STARTED|Washout Period 2 (10-14 Days)||19
189387|NCT01372410|459697|P4|STARTED|Washout Period 2 (10-14 Days)||17
189388|NCT01372410|459698|P3|STARTED|Washout Period 2 (10-14 Days)||22
189389|NCT01372410|459699|P2|STARTED|Washout Period 2 (10-14 Days)||21
189390|NCT01372410|459700|P1|STARTED|Washout Period 2 (10-14 Days)||19
189391|NCT01372410|459693|P8|NOT COMPLETED|Treatment Period 2 (7 Days)||0
189392|NCT01372410|459694|P7|NOT COMPLETED|Treatment Period 2 (7 Days)||0
189393|NCT01372410|459695|P6|NOT COMPLETED|Treatment Period 2 (7 Days)||0
189394|NCT01372410|459696|P5|NOT COMPLETED|Treatment Period 2 (7 Days)||0
189395|NCT01372410|459697|P4|NOT COMPLETED|Treatment Period 2 (7 Days)||0
189396|NCT01372410|459698|P3|NOT COMPLETED|Treatment Period 2 (7 Days)||0
189397|NCT01372410|459699|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||0
189398|NCT01372410|459700|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
189399|NCT01372410|459693|P8|COMPLETED|Treatment Period 2 (7 Days)||19
189400|NCT01372410|459694|P7|COMPLETED|Treatment Period 2 (7 Days)||21
189401|NCT01372410|459695|P6|COMPLETED|Treatment Period 2 (7 Days)||16
189402|NCT01372410|459696|P5|COMPLETED|Treatment Period 2 (7 Days)||19
189403|NCT01372410|459697|P4|COMPLETED|Treatment Period 2 (7 Days)||17
189404|NCT01372410|459698|P3|COMPLETED|Treatment Period 2 (7 Days)||22
189405|NCT01372410|459699|P2|COMPLETED|Treatment Period 2 (7 Days)||21
189406|NCT01372410|459700|P1|COMPLETED|Treatment Period 2 (7 Days)||19
189407|NCT01372410|459693|P8|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
189408|NCT01372410|459694|P7|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
189409|NCT01372410|459695|P6|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
189410|NCT01372410|459696|P5|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
189411|NCT01372410|459697|P4|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|17
189412|NCT01372410|459698|P3|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
189413|NCT01372410|459699|P2|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
189414|NCT01372410|459700|P1|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
189415|NCT01372410|459693|P8|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
189416|NCT01372410|459694|P7|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
189417|NCT01372410|459695|P6|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
189418|NCT01372410|459696|P5|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
189419|NCT01372410|459697|P4|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
189420|NCT01372410|459698|P3|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
189421|NCT01372410|459699|P2|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
189422|NCT01372410|459700|P1|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
189423|NCT01372410|459693|P8|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
189424|NCT01372410|459694|P7|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
189425|NCT01372410|459695|P6|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
189426|NCT01372410|459696|P5|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
189427|NCT01372410|459697|P4|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
189428|NCT01372410|459698|P3|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
189429|NCT01372410|459699|P2|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
189430|NCT01372410|459700|P1|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
189431|NCT01372410|459693|P8|STARTED|Washout Period 1 (10-14 Days)||19
189432|NCT01372410|459694|P7|STARTED|Washout Period 1 (10-14 Days)||20
189433|NCT01372410|459695|P6|STARTED|Washout Period 1 (10-14 Days)||21
189434|NCT01372410|459696|P5|STARTED|Washout Period 1 (10-14 Days)||19
189435|NCT01372410|459697|P4|STARTED|Washout Period 1 (10-14 Days)||20
189436|NCT01372410|459698|P3|STARTED|Washout Period 1 (10-14 Days)||19
189437|NCT01372410|459699|P2|STARTED|Washout Period 1 (10-14 Days)||19
189438|NCT01372410|459700|P1|STARTED|Washout Period 1 (10-14 Days)||19
189439|NCT01372410|459693|P8|NOT COMPLETED|Treatment Period 1 (7 Days)||0
189440|NCT01372410|459694|P7|NOT COMPLETED|Treatment Period 1 (7 Days)||2
189441|NCT01372410|459695|P6|NOT COMPLETED|Treatment Period 1 (7 Days)||0
189442|NCT01372410|459696|P5|NOT COMPLETED|Treatment Period 1 (7 Days)||2
189443|NCT01372410|459697|P4|NOT COMPLETED|Treatment Period 1 (7 Days)||0
189444|NCT01372410|459698|P3|NOT COMPLETED|Treatment Period 1 (7 Days)||0
189445|NCT01372410|459699|P2|NOT COMPLETED|Treatment Period 1 (7 Days)||2
189446|NCT01372410|459700|P1|NOT COMPLETED|Treatment Period 1 (7 Days)||1
189447|NCT01372410|459693|P8|COMPLETED|Treatment Period 1 (7 Days)||19
189448|NCT01372410|459694|P7|COMPLETED|Treatment Period 1 (7 Days)||20
189449|NCT01372410|459695|P6|COMPLETED|Treatment Period 1 (7 Days)||21
189450|NCT01372410|459696|P5|COMPLETED|Treatment Period 1 (7 Days)||19
189451|NCT01372410|459697|P4|COMPLETED|Treatment Period 1 (7 Days)||20
189452|NCT01372410|459698|P3|COMPLETED|Treatment Period 1 (7 Days)||19
189453|NCT01372410|459699|P2|COMPLETED|Treatment Period 1 (7 Days)||19
189454|NCT01372410|459700|P1|COMPLETED|Treatment Period 1 (7 Days)||19
189455|NCT01372410|459693|P8|STARTED|Treatment Period 1 (7 Days)||19
189456|NCT01372410|459694|P7|STARTED|Treatment Period 1 (7 Days)||22
189457|NCT01372410|459695|P6|STARTED|Treatment Period 1 (7 Days)||21
189458|NCT01372410|459696|P5|STARTED|Treatment Period 1 (7 Days)||21
189459|NCT01372410|459697|P4|STARTED|Treatment Period 1 (7 Days)||20
189460|NCT01372410|459698|P3|STARTED|Treatment Period 1 (7 Days)||19
189461|NCT01372410|459699|P2|STARTED|Treatment Period 1 (7 Days)||21
189462|NCT01372410|459700|P1|STARTED|Treatment Period 1 (7 Days)||20
189463|NCT01372384|459737|P1|NOT COMPLETED|Overall Study||3
189464|NCT01372384|459737|P1|COMPLETED|Overall Study||3
189465|NCT01372384|459737|P1|STARTED|Overall Study||6
189466|NCT01372202|459747|P3|NOT COMPLETED|Overall Study||0
189467|NCT01372202|459748|P2|NOT COMPLETED|Overall Study||0
189468|NCT01372202|459749|P1|NOT COMPLETED|Overall Study||0
189469|NCT01372202|459747|P3|COMPLETED|Overall Study||9
189470|NCT01372202|459748|P2|COMPLETED|Overall Study||9
189471|NCT01372202|459749|P1|COMPLETED|Overall Study||13
189472|NCT01372202|459747|P3|STARTED|Overall Study||9
189473|NCT01372202|459748|P2|STARTED|Overall Study||9
189474|NCT01372202|459749|P1|STARTED|Overall Study||13
189475|NCT01372150|459769|P3|NOT COMPLETED|Overall Study||16
189476|NCT01372150|459770|P2|NOT COMPLETED|Overall Study||14
189477|NCT01372150|459771|P1|NOT COMPLETED|Overall Study||13
189478|NCT01372150|459769|P3|COMPLETED|Overall Study||99
189479|NCT01372150|459770|P2|COMPLETED|Overall Study||99
189480|NCT01372150|459771|P1|COMPLETED|Overall Study||99
189481|NCT01372150|459769|P3|Treated|Overall Study||115
189482|NCT01372150|459770|P2|Treated|Overall Study||112
189483|NCT01372150|459771|P1|Treated|Overall Study||112
189484|NCT01372150|459769|P3|STARTED|Overall Study||115
189485|NCT01372150|459770|P2|STARTED|Overall Study||113
189486|NCT01372150|459771|P1|STARTED|Overall Study||112
189487|NCT01372085|459798|P10|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
189488|NCT01372085|459799|P9|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
189489|NCT01372085|459800|P8|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
189490|NCT01372085|459801|P7|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
189491|NCT01372085|459802|P6|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
189492|NCT01372085|459803|P5|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
189493|NCT01372085|459804|P4|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
189494|NCT01372085|459805|P3|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
189495|NCT01372085|459806|P2|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
189496|NCT01372085|459807|P1|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
189497|NCT01372085|459798|P10|COMPLETED|Forth Intervention (Period 4a/4b)||1
189498|NCT01372085|459799|P9|COMPLETED|Forth Intervention (Period 4a/4b)||1
189499|NCT01372085|459800|P8|COMPLETED|Forth Intervention (Period 4a/4b)||1
189500|NCT01372085|459801|P7|COMPLETED|Forth Intervention (Period 4a/4b)||3
189501|NCT01372085|459802|P6|COMPLETED|Forth Intervention (Period 4a/4b)||5
189502|NCT01372085|459803|P5|COMPLETED|Forth Intervention (Period 4a/4b)||2
189503|NCT01372085|459804|P4|COMPLETED|Forth Intervention (Period 4a/4b)||1
189504|NCT01372085|459805|P3|COMPLETED|Forth Intervention (Period 4a/4b)||2
189505|NCT01372085|459806|P2|COMPLETED|Forth Intervention (Period 4a/4b)||0
189506|NCT01372085|459807|P1|COMPLETED|Forth Intervention (Period 4a/4b)||0
189507|NCT01372085|459798|P10|STARTED|Forth Intervention (Period 4a/4b)|One pt was enrolled directly into P4b to fulfill requirement for safety and tolerability assessment.|1
189508|NCT01372085|459799|P9|STARTED|Forth Intervention (Period 4a/4b)||1
189509|NCT01372085|459800|P8|STARTED|Forth Intervention (Period 4a/4b)||1
189510|NCT01372085|459801|P7|STARTED|Forth Intervention (Period 4a/4b)||3
189511|NCT01372085|459802|P6|STARTED|Forth Intervention (Period 4a/4b)||5
189512|NCT01372085|459803|P5|STARTED|Forth Intervention (Period 4a/4b)||2
189513|NCT01372085|459804|P4|STARTED|Forth Intervention (Period 4a/4b)||1
189514|NCT01372085|459805|P3|STARTED|Forth Intervention (Period 4a/4b)||2
189515|NCT01372085|459806|P2|STARTED|Forth Intervention (Period 4a/4b)||0
189516|NCT01372085|459807|P1|STARTED|Forth Intervention (Period 4a/4b)||0
189517|NCT01372085|459798|P10|NOT COMPLETED|Washout Period 3||0
189518|NCT01372085|459799|P9|NOT COMPLETED|Washout Period 3||0
189519|NCT01372085|459800|P8|NOT COMPLETED|Washout Period 3||0
189520|NCT01372085|459801|P7|NOT COMPLETED|Washout Period 3||0
189521|NCT01372085|459802|P6|NOT COMPLETED|Washout Period 3||2
189522|NCT01372085|459803|P5|NOT COMPLETED|Washout Period 3||0
189523|NCT01372085|459804|P4|NOT COMPLETED|Washout Period 3||0
189524|NCT01372085|459805|P3|NOT COMPLETED|Washout Period 3||0
189525|NCT01372085|459806|P2|NOT COMPLETED|Washout Period 3||0
189526|NCT01372085|459807|P1|NOT COMPLETED|Washout Period 3||0
189527|NCT01372085|459798|P10|COMPLETED|Washout Period 3||0
189528|NCT01372085|459799|P9|COMPLETED|Washout Period 3||1
189529|NCT01372085|459800|P8|COMPLETED|Washout Period 3||1
189530|NCT01372085|459801|P7|COMPLETED|Washout Period 3||3
189531|NCT01372085|459802|P6|COMPLETED|Washout Period 3|Two participants (pts) discontinued Washout P3 and were replaced in P3.|5
189532|NCT01372085|459803|P5|COMPLETED|Washout Period 3||2
189533|NCT01372085|459804|P4|COMPLETED|Washout Period 3||1
189534|NCT01372085|459805|P3|COMPLETED|Washout Period 3||2
189535|NCT01372085|459806|P2|COMPLETED|Washout Period 3||0
189536|NCT01372085|459807|P1|COMPLETED|Washout Period 3||0
189537|NCT01372085|459798|P10|STARTED|Washout Period 3||0
189538|NCT01372085|459799|P9|STARTED|Washout Period 3||1
189539|NCT01372085|459800|P8|STARTED|Washout Period 3||1
189540|NCT01372085|459801|P7|STARTED|Washout Period 3||3
189541|NCT01372085|459802|P6|STARTED|Washout Period 3||7
189542|NCT01372085|459803|P5|STARTED|Washout Period 3||2
189543|NCT01372085|459804|P4|STARTED|Washout Period 3||1
189544|NCT01372085|459805|P3|STARTED|Washout Period 3||2
189545|NCT01372085|459806|P2|STARTED|Washout Period 3||0
189546|NCT01372085|459807|P1|STARTED|Washout Period 3||0
189547|NCT01372085|459798|P10|NOT COMPLETED|Third Intervention (Period 3)||0
189548|NCT01372085|459799|P9|NOT COMPLETED|Third Intervention (Period 3)||0
189549|NCT01372085|459800|P8|NOT COMPLETED|Third Intervention (Period 3)||0
189550|NCT01372085|459801|P7|NOT COMPLETED|Third Intervention (Period 3)||0
189551|NCT01372085|459802|P6|NOT COMPLETED|Third Intervention (Period 3)||0
189552|NCT01372085|459803|P5|NOT COMPLETED|Third Intervention (Period 3)||0
189553|NCT01372085|459804|P4|NOT COMPLETED|Third Intervention (Period 3)||0
189554|NCT01372085|459805|P3|NOT COMPLETED|Third Intervention (Period 3)||0
189555|NCT01372085|459806|P2|NOT COMPLETED|Third Intervention (Period 3)||0
189556|NCT01372085|459807|P1|NOT COMPLETED|Third Intervention (Period 3)||0
189557|NCT01372085|459798|P10|COMPLETED|Third Intervention (Period 3)||0
189558|NCT01372085|459799|P9|COMPLETED|Third Intervention (Period 3)||1
189559|NCT01372085|459800|P8|COMPLETED|Third Intervention (Period 3)||1
189560|NCT01372085|459801|P7|COMPLETED|Third Intervention (Period 3)||3
189561|NCT01372085|459802|P6|COMPLETED|Third Intervention (Period 3)||7
189562|NCT01372085|459803|P5|COMPLETED|Third Intervention (Period 3)||2
189563|NCT01372085|459804|P4|COMPLETED|Third Intervention (Period 3)||1
189564|NCT01372085|459805|P3|COMPLETED|Third Intervention (Period 3)||2
189565|NCT01372085|459806|P2|COMPLETED|Third Intervention (Period 3)||0
189566|NCT01372085|459807|P1|COMPLETED|Third Intervention (Period 3)||0
189567|NCT01372085|459798|P10|STARTED|Third Intervention (Period 3)||0
189568|NCT01372085|459799|P9|STARTED|Third Intervention (Period 3)||1
189569|NCT01372085|459800|P8|STARTED|Third Intervention (Period 3)||1
189570|NCT01372085|459801|P7|STARTED|Third Intervention (Period 3)||3
189571|NCT01372085|459802|P6|STARTED|Third Intervention (Period 3)|Replacement pts repeated Period (P) 3 to fulfill requirement for P3 versus P4a comparison.|7
189572|NCT01372085|459803|P5|STARTED|Third Intervention (Period 3)||2
189573|NCT01372085|459804|P4|STARTED|Third Intervention (Period 3)||1
189574|NCT01372085|459805|P3|STARTED|Third Intervention (Period 3)||2
189575|NCT01372085|459806|P2|STARTED|Third Intervention (Period 3)||0
189576|NCT01372085|459807|P1|STARTED|Third Intervention (Period 3)||0
189577|NCT01372085|459798|P10|NOT COMPLETED|Washout Period 2||0
189578|NCT01372085|459799|P9|NOT COMPLETED|Washout Period 2||0
189579|NCT01372085|459800|P8|NOT COMPLETED|Washout Period 2||0
189580|NCT01372085|459801|P7|NOT COMPLETED|Washout Period 2||0
189581|NCT01372085|459802|P6|NOT COMPLETED|Washout Period 2||0
189582|NCT01372085|459803|P5|NOT COMPLETED|Washout Period 2||1
189583|NCT01372085|459804|P4|NOT COMPLETED|Washout Period 2||0
189584|NCT01372085|459805|P3|NOT COMPLETED|Washout Period 2||0
189585|NCT01372085|459806|P2|NOT COMPLETED|Washout Period 2||0
189586|NCT01372085|459807|P1|NOT COMPLETED|Washout Period 2||0
189587|NCT01372085|459798|P10|COMPLETED|Washout Period 2||0
189588|NCT01372085|459799|P9|COMPLETED|Washout Period 2||1
189589|NCT01372085|459800|P8|COMPLETED|Washout Period 2||1
189590|NCT01372085|459801|P7|COMPLETED|Washout Period 2||3
189591|NCT01372085|459802|P6|COMPLETED|Washout Period 2||5
189592|NCT01372085|459803|P5|COMPLETED|Washout Period 2|One participant discontinued Washout Period 2 and was replaced in Period 1.|2
189593|NCT01372085|459804|P4|COMPLETED|Washout Period 2||1
189594|NCT01372085|459805|P3|COMPLETED|Washout Period 2||2
189595|NCT01372085|459806|P2|COMPLETED|Washout Period 2||0
189596|NCT01372085|459807|P1|COMPLETED|Washout Period 2||0
189597|NCT01372085|459798|P10|STARTED|Washout Period 2||0
189598|NCT01372085|459799|P9|STARTED|Washout Period 2||1
189599|NCT01372085|459800|P8|STARTED|Washout Period 2||1
189600|NCT01372085|459801|P7|STARTED|Washout Period 2||3
189601|NCT01372085|459802|P6|STARTED|Washout Period 2||5
189602|NCT01372085|459803|P5|STARTED|Washout Period 2||3
189603|NCT01372085|459804|P4|STARTED|Washout Period 2||1
189604|NCT01372085|459805|P3|STARTED|Washout Period 2||2
189605|NCT01372085|459806|P2|STARTED|Washout Period 2||0
189606|NCT01372085|459807|P1|STARTED|Washout Period 2||0
189607|NCT01372085|459798|P10|NOT COMPLETED|Second Intervention (Period 2)||0
189608|NCT01372085|459799|P9|NOT COMPLETED|Second Intervention (Period 2)||0
189609|NCT01372085|459800|P8|NOT COMPLETED|Second Intervention (Period 2)||0
189610|NCT01372085|459801|P7|NOT COMPLETED|Second Intervention (Period 2)||0
189611|NCT01372085|459802|P6|NOT COMPLETED|Second Intervention (Period 2)||0
189612|NCT01372085|459803|P5|NOT COMPLETED|Second Intervention (Period 2)||0
189613|NCT01372085|459804|P4|NOT COMPLETED|Second Intervention (Period 2)||0
189614|NCT01372085|459805|P3|NOT COMPLETED|Second Intervention (Period 2)||0
189615|NCT01372085|459806|P2|NOT COMPLETED|Second Intervention (Period 2)||0
189616|NCT01372085|459807|P1|NOT COMPLETED|Second Intervention (Period 2)||0
189617|NCT01372085|459798|P10|COMPLETED|Second Intervention (Period 2)||0
189618|NCT01372085|459799|P9|COMPLETED|Second Intervention (Period 2)||1
189619|NCT01372085|459800|P8|COMPLETED|Second Intervention (Period 2)||1
189620|NCT01372085|459801|P7|COMPLETED|Second Intervention (Period 2)||3
189621|NCT01372085|459802|P6|COMPLETED|Second Intervention (Period 2)||5
189622|NCT01372085|459803|P5|COMPLETED|Second Intervention (Period 2)||3
189623|NCT01372085|459804|P4|COMPLETED|Second Intervention (Period 2)||1
189624|NCT01372085|459805|P3|COMPLETED|Second Intervention (Period 2)||2
189625|NCT01372085|459806|P2|COMPLETED|Second Intervention (Period 2)||0
189626|NCT01372085|459807|P1|COMPLETED|Second Intervention (Period 2)||0
189627|NCT01372085|459798|P10|STARTED|Second Intervention (Period 2)||0
189628|NCT01372085|459799|P9|STARTED|Second Intervention (Period 2)||1
189629|NCT01372085|459800|P8|STARTED|Second Intervention (Period 2)||1
189630|NCT01372085|459801|P7|STARTED|Second Intervention (Period 2)||3
189631|NCT01372085|459802|P6|STARTED|Second Intervention (Period 2)||5
189632|NCT01372085|459803|P5|STARTED|Second Intervention (Period 2)||3
189633|NCT01372085|459804|P4|STARTED|Second Intervention (Period 2)||1
189634|NCT01372085|459805|P3|STARTED|Second Intervention (Period 2)||2
189635|NCT01372085|459806|P2|STARTED|Second Intervention (Period 2)||0
189636|NCT01372085|459807|P1|STARTED|Second Intervention (Period 2)||0
189637|NCT01372085|459798|P10|NOT COMPLETED|Washout Period 1||0
189638|NCT01372085|459799|P9|NOT COMPLETED|Washout Period 1||0
189639|NCT01372085|459800|P8|NOT COMPLETED|Washout Period 1||0
189640|NCT01372085|459801|P7|NOT COMPLETED|Washout Period 1||0
189641|NCT01372085|459802|P6|NOT COMPLETED|Washout Period 1||0
189642|NCT01372085|459803|P5|NOT COMPLETED|Washout Period 1||0
189643|NCT01372085|459804|P4|NOT COMPLETED|Washout Period 1||0
189644|NCT01372085|459805|P3|NOT COMPLETED|Washout Period 1||0
189645|NCT01372085|459806|P2|NOT COMPLETED|Washout Period 1||0
189646|NCT01372085|459807|P1|NOT COMPLETED|Washout Period 1||0
189647|NCT01372085|459798|P10|COMPLETED|Washout Period 1||0
189648|NCT01372085|459799|P9|COMPLETED|Washout Period 1||1
189649|NCT01372085|459800|P8|COMPLETED|Washout Period 1||1
189650|NCT01372085|459801|P7|COMPLETED|Washout Period 1||3
189651|NCT01372085|459802|P6|COMPLETED|Washout Period 1||5
189652|NCT01372085|459803|P5|COMPLETED|Washout Period 1||3
189653|NCT01372085|459804|P4|COMPLETED|Washout Period 1||1
189654|NCT01372085|459805|P3|COMPLETED|Washout Period 1||2
189655|NCT01372085|459806|P2|COMPLETED|Washout Period 1||0
189656|NCT01372085|459807|P1|COMPLETED|Washout Period 1||0
189657|NCT01372085|459798|P10|STARTED|Washout Period 1||0
189658|NCT01372085|459799|P9|STARTED|Washout Period 1||1
189659|NCT01372085|459800|P8|STARTED|Washout Period 1||1
189660|NCT01372085|459801|P7|STARTED|Washout Period 1||3
189661|NCT01372085|459802|P6|STARTED|Washout Period 1||5
189662|NCT01372085|459803|P5|STARTED|Washout Period 1||3
189663|NCT01372085|459804|P4|STARTED|Washout Period 1||1
189664|NCT01372085|459805|P3|STARTED|Washout Period 1||2
189665|NCT01372085|459806|P2|STARTED|Washout Period 1|Pts completed one period and did not enter washout for Part A.|0
189666|NCT01372085|459807|P1|STARTED|Washout Period 1|Pts completed one period and did not enter washout for Part A.|0
189667|NCT01372085|459798|P10|NOT COMPLETED|First Intervention (Period 1)||0
189668|NCT01372085|459799|P9|NOT COMPLETED|First Intervention (Period 1)||0
189669|NCT01372085|459800|P8|NOT COMPLETED|First Intervention (Period 1)||0
189670|NCT01372085|459801|P7|NOT COMPLETED|First Intervention (Period 1)||0
189671|NCT01372085|459802|P6|NOT COMPLETED|First Intervention (Period 1)||0
189672|NCT01372085|459803|P5|NOT COMPLETED|First Intervention (Period 1)||0
189673|NCT01372085|459804|P4|NOT COMPLETED|First Intervention (Period 1)||0
189674|NCT01372085|459805|P3|NOT COMPLETED|First Intervention (Period 1)||0
189675|NCT01372085|459806|P2|NOT COMPLETED|First Intervention (Period 1)||0
189676|NCT01372085|459807|P1|NOT COMPLETED|First Intervention (Period 1)||0
189677|NCT01372085|459798|P10|COMPLETED|First Intervention (Period 1)||0
189678|NCT01372085|459799|P9|COMPLETED|First Intervention (Period 1)||1
189679|NCT01372085|459800|P8|COMPLETED|First Intervention (Period 1)||1
189680|NCT01372085|459801|P7|COMPLETED|First Intervention (Period 1)||3
189681|NCT01372085|459802|P6|COMPLETED|First Intervention (Period 1)||5
189682|NCT01372085|459803|P5|COMPLETED|First Intervention (Period 1)||3
189683|NCT01372085|459804|P4|COMPLETED|First Intervention (Period 1)||1
189684|NCT01372085|459805|P3|COMPLETED|First Intervention (Period 1)||2
189685|NCT01372085|459806|P2|COMPLETED|First Intervention (Period 1)||2
189686|NCT01372085|459807|P1|COMPLETED|First Intervention (Period 1)||8
189687|NCT01372085|459798|P10|STARTED|First Intervention (Period 1)||0
189688|NCT01372085|459799|P9|STARTED|First Intervention (Period 1)||1
189689|NCT01372085|459800|P8|STARTED|First Intervention (Period 1)||1
189690|NCT01372085|459801|P7|STARTED|First Intervention (Period 1)||3
189691|NCT01372085|459802|P6|STARTED|First Intervention (Period 1)||5
189692|NCT01372085|459803|P5|STARTED|First Intervention (Period 1)|Replacement participant repeated Periods 1, 2 to fulfill treatment arm comparison requirements.|3
189693|NCT01372085|459804|P4|STARTED|First Intervention (Period 1)||1
189694|NCT01372085|459805|P3|STARTED|First Intervention (Period 1)||2
189695|NCT01372085|459806|P2|STARTED|First Intervention (Period 1)||2
189696|NCT01372085|459807|P1|STARTED|First Intervention (Period 1)||8
189697|NCT01371994|459839|P2|NOT COMPLETED|Overall Study||42
189698|NCT01371994|459840|P1|NOT COMPLETED|Overall Study||57
189699|NCT01371994|459839|P2|COMPLETED|Overall Study||278
189700|NCT01371994|459840|P1|COMPLETED|Overall Study||263
189701|NCT01371994|459839|P2|Received Treatment|Overall Study||313
189702|NCT01371994|459840|P1|Received Treatment|Overall Study||310
189703|NCT01371994|459839|P2|STARTED|Overall Study||320
189704|NCT01371994|459840|P1|STARTED|Overall Study||320
189705|NCT01371877|459884|P2|NOT COMPLETED|Overall Study||4
189706|NCT01371877|459885|P1|NOT COMPLETED|Overall Study||0
189707|NCT01371877|459884|P2|COMPLETED|Overall Study||17
189708|NCT01371877|459885|P1|COMPLETED|Overall Study||21
189709|NCT01371877|459884|P2|STARTED|Overall Study||21
189710|NCT01371877|459885|P1|STARTED|Overall Study||21
189711|NCT01371851|459897|P2|NOT COMPLETED|Overall Study||9
189712|NCT01371851|459898|P1|NOT COMPLETED|Overall Study||8
189713|NCT01371851|459897|P2|COMPLETED|Overall Study||2
189714|NCT01371851|459898|P1|COMPLETED|Overall Study||3
189715|NCT01371851|459897|P2|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
189716|NCT01371851|459898|P1|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
189717|NCT01371838|459906|P2|NOT COMPLETED|Overall Study||66
189718|NCT01371838|459907|P1|NOT COMPLETED|Overall Study||49
189719|NCT01371838|459906|P2|COMPLETED|Overall Study||317
189720|NCT01371838|459907|P1|COMPLETED|Overall Study||332
189721|NCT01371838|459906|P2|STARTED|Overall Study||383
189722|NCT01371838|459907|P1|STARTED|Overall Study||381
189723|NCT01371825|459943|P1|NOT COMPLETED|Overall Study||4
189724|NCT01371825|459943|P1|COMPLETED|Overall Study||5
189725|NCT01371825|459943|P1|Received at Least 1 Dose of Study Drug|Overall Study||9
189726|NCT01371825|459943|P1|STARTED|Overall Study||9
189727|NCT01371786|459956|P2|NOT COMPLETED|Overall Study||0
189728|NCT01371786|459957|P1|NOT COMPLETED|Overall Study||0
189729|NCT01371786|459956|P2|COMPLETED|Overall Study||7
189730|NCT01371786|459957|P1|COMPLETED|Overall Study||7
189731|NCT01371786|459956|P2|STARTED|Overall Study||7
189732|NCT01371786|459957|P1|STARTED|Overall Study||7
189733|NCT01371747|459977|P6|NOT COMPLETED|Overall Study||14
189734|NCT01371747|459978|P5|NOT COMPLETED|Overall Study||7
189735|NCT01371747|459979|P4|NOT COMPLETED|Overall Study||9
189736|NCT01371747|459980|P3|NOT COMPLETED|Overall Study||24
189737|NCT01371747|459981|P2|NOT COMPLETED|Overall Study||23
189738|NCT01371747|459982|P1|NOT COMPLETED|Overall Study||18
189739|NCT01371747|459977|P6|COMPLETED|Overall Study||16
189740|NCT01371747|459978|P5|COMPLETED|Overall Study||21
189741|NCT01371747|459979|P4|COMPLETED|Overall Study||17
189742|NCT01371747|459980|P3|COMPLETED|Overall Study||50
189743|NCT01371747|459981|P2|COMPLETED|Overall Study||51
189744|NCT01371747|459982|P1|COMPLETED|Overall Study||56
189745|NCT01371747|459977|P6|STARTED|Overall Study||30
189746|NCT01371747|459978|P5|STARTED|Overall Study||28
189747|NCT01371747|459979|P4|STARTED|Overall Study||26
189748|NCT01371747|459980|P3|STARTED|Overall Study||74
189749|NCT01371747|459981|P2|STARTED|Overall Study||74
189750|NCT01371747|459982|P1|STARTED|Overall Study||74
189751|NCT01371734|460047|P3|NOT COMPLETED|Overall Study||17
189752|NCT01371734|460048|P2|NOT COMPLETED|Overall Study||19
189753|NCT01371734|460049|P1|NOT COMPLETED|Overall Study||23
189754|NCT01371734|460047|P3|COMPLETED|Overall Study||104
189755|NCT01371734|460048|P2|COMPLETED|Overall Study||103
189756|NCT01371734|460049|P1|COMPLETED|Overall Study||97
189757|NCT01371734|460047|P3|STARTED|Overall Study||121
189758|NCT01371734|460048|P2|STARTED|Overall Study||122
189759|NCT01371734|460049|P1|STARTED|Overall Study||120
189760|NCT01371721|460069|P3|NOT COMPLETED|Overall Study||30
189761|NCT01371721|460070|P2|NOT COMPLETED|Overall Study||24
189762|NCT01371721|460071|P1|NOT COMPLETED|Overall Study||29
189763|NCT01371721|460069|P3|COMPLETED|Overall Study||62
189764|NCT01371721|460070|P2|COMPLETED|Overall Study||65
189765|NCT01371721|460071|P1|COMPLETED|Overall Study||59
189766|NCT01371721|460069|P3|Treated|Overall Study||92
189767|NCT01371721|460070|P2|Treated|Overall Study||89
189768|NCT01371721|460071|P1|Treated|Overall Study||87
189769|NCT01371721|460069|P3|STARTED|Overall Study||92
189770|NCT01371721|460070|P2|STARTED|Overall Study||89
189771|NCT01371721|460071|P1|STARTED|Overall Study||88
189772|NCT01371708|460104|P3|NOT COMPLETED|Overall Study||39
189773|NCT01371708|460105|P2|NOT COMPLETED|Overall Study||30
189774|NCT01371708|460106|P1|NOT COMPLETED|Overall Study||26
189775|NCT01371708|460104|P3|COMPLETED|Overall Study||59
189776|NCT01371708|460105|P2|COMPLETED|Overall Study||63
189777|NCT01371708|460106|P1|COMPLETED|Overall Study||66
189778|NCT01371708|460104|P3|Received Treatment|Overall Study||97
189779|NCT01371708|460105|P2|Received Treatment|Overall Study||93
189780|NCT01371708|460106|P1|Received Treatment|Overall Study||91
189781|NCT01371708|460104|P3|STARTED|Overall Study||98
189782|NCT01371708|460105|P2|STARTED|Overall Study||93
189783|NCT01371708|460106|P1|STARTED|Overall Study||92
189784|NCT01371656|460138|P2|NOT COMPLETED|Overall Study||14
189785|NCT01371656|460139|P1|NOT COMPLETED|Overall Study||64
189786|NCT01371656|460138|P2|COMPLETED|Overall Study||296
189787|NCT01371656|460139|P1|COMPLETED|Overall Study||250
189788|NCT01371656|460138|P2|STARTED|Overall Study||310
189789|NCT01371656|460139|P1|STARTED|Overall Study||314
189790|NCT01371643|460159|P2|NOT COMPLETED|Overall Study||0
189791|NCT01371643|460160|P1|NOT COMPLETED|Overall Study||3
189792|NCT01371643|460159|P2|COMPLETED|Overall Study||26
189793|NCT01371643|460160|P1|COMPLETED|Overall Study||12
189794|NCT01371643|460159|P2|STARTED|Overall Study||26
189795|NCT01371643|460160|P1|STARTED|Overall Study||15
189796|NCT01371565|460170|P1|NOT COMPLETED|Overall Study||3
189797|NCT01371565|460170|P1|COMPLETED|Overall Study||1
189798|NCT01371565|460170|P1|STARTED|Overall Study||4
189799|NCT01371552|460174|P6|NOT COMPLETED|Part 2, One Week||0
189800|NCT01371552|460175|P5|NOT COMPLETED|Part 2, One Week||0
189801|NCT01371552|460176|P4|NOT COMPLETED|Part 2, One Week||0
189802|NCT01371552|460177|P3|NOT COMPLETED|Part 2, One Week||0
189803|NCT01371552|460178|P2|NOT COMPLETED|Part 2, One Week||0
189804|NCT01371552|460179|P1|NOT COMPLETED|Part 2, One Week||0
189805|NCT01371552|460174|P6|COMPLETED|Part 2, One Week||18
189806|NCT01371552|460175|P5|COMPLETED|Part 2, One Week||15
189807|NCT01371552|460176|P4|COMPLETED|Part 2, One Week||20
189808|NCT01371552|460177|P3|COMPLETED|Part 2, One Week||18
189809|NCT01371552|460178|P2|COMPLETED|Part 2, One Week||17
189810|NCT01371552|460179|P1|COMPLETED|Part 2, One Week||18
189811|NCT01371552|460174|P6|STARTED|Part 2, One Week||18
189812|NCT01371552|460175|P5|STARTED|Part 2, One Week||15
189813|NCT01371552|460176|P4|STARTED|Part 2, One Week||20
189814|NCT01371552|460177|P3|STARTED|Part 2, One Week||18
189815|NCT01371552|460178|P2|STARTED|Part 2, One Week||17
189816|NCT01371552|460179|P1|STARTED|Part 2, One Week|One participant discontinued between Part 1 and Part 2 due to inconvenience|18
189817|NCT01371552|460174|P6|NOT COMPLETED|Part 1, Third 3 Days||1
189818|NCT01371552|460175|P5|NOT COMPLETED|Part 1, Third 3 Days||1
189819|NCT01371552|460176|P4|NOT COMPLETED|Part 1, Third 3 Days||0
189820|NCT01371552|460177|P3|NOT COMPLETED|Part 1, Third 3 Days||0
189821|NCT01371552|460178|P2|NOT COMPLETED|Part 1, Third 3 Days||0
189822|NCT01371552|460179|P1|NOT COMPLETED|Part 1, Third 3 Days||0
189823|NCT01371552|460174|P6|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to discomfort, but continued into Part 2.|17
189824|NCT01371552|460175|P5|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to randomization error, but continued into Part 2.|14
189825|NCT01371552|460176|P4|COMPLETED|Part 1, Third 3 Days||20
189826|NCT01371552|460177|P3|COMPLETED|Part 1, Third 3 Days||18
189827|NCT01371552|460178|P2|COMPLETED|Part 1, Third 3 Days||17
189828|NCT01371552|460179|P1|COMPLETED|Part 1, Third 3 Days||19
189829|NCT01371552|460174|P6|STARTED|Part 1, Third 3 Days||18
189830|NCT01371552|460175|P5|STARTED|Part 1, Third 3 Days||15
189831|NCT01371552|460176|P4|STARTED|Part 1, Third 3 Days||20
189832|NCT01371552|460177|P3|STARTED|Part 1, Third 3 Days||18
189833|NCT01371552|460178|P2|STARTED|Part 1, Third 3 Days||17
189834|NCT01371552|460179|P1|STARTED|Part 1, Third 3 Days||19
189835|NCT01371552|460174|P6|NOT COMPLETED|Part 1, Second 3 Days||0
189836|NCT01371552|460175|P5|NOT COMPLETED|Part 1, Second 3 Days||0
189837|NCT01371552|460176|P4|NOT COMPLETED|Part 1, Second 3 Days||0
189838|NCT01371552|460177|P3|NOT COMPLETED|Part 1, Second 3 Days||0
189839|NCT01371552|460178|P2|NOT COMPLETED|Part 1, Second 3 Days||0
189840|NCT01371552|460179|P1|NOT COMPLETED|Part 1, Second 3 Days||1
189841|NCT01371552|460174|P6|COMPLETED|Part 1, Second 3 Days||18
189842|NCT01371552|460175|P5|COMPLETED|Part 1, Second 3 Days||15
189843|NCT01371552|460176|P4|COMPLETED|Part 1, Second 3 Days||20
189844|NCT01371552|460177|P3|COMPLETED|Part 1, Second 3 Days||18
189845|NCT01371552|460178|P2|COMPLETED|Part 1, Second 3 Days||17
189846|NCT01371552|460179|P1|COMPLETED|Part 1, Second 3 Days|One subject did not complete period due to discomfort but continued to next, as allowed by protocol|18
189847|NCT01371552|460174|P6|STARTED|Part 1, Second 3 Days||18
189848|NCT01371552|460175|P5|STARTED|Part 1, Second 3 Days||15
189849|NCT01371552|460176|P4|STARTED|Part 1, Second 3 Days||20
189850|NCT01371552|460177|P3|STARTED|Part 1, Second 3 Days|1 subject discontinued after First 3 days due to positive slit lamp findings unrelated to lens wear|18
189851|NCT01371552|460178|P2|STARTED|Part 1, Second 3 Days||17
189852|NCT01371552|460179|P1|STARTED|Part 1, Second 3 Days||19
189853|NCT01371552|460174|P6|NOT COMPLETED|Part 1, First 3 Days||0
189854|NCT01371552|460175|P5|NOT COMPLETED|Part 1, First 3 Days||0
189855|NCT01371552|460176|P4|NOT COMPLETED|Part 1, First 3 Days||0
189856|NCT01371552|460177|P3|NOT COMPLETED|Part 1, First 3 Days||1
189857|NCT01371552|460178|P2|NOT COMPLETED|Part 1, First 3 Days||0
189858|NCT01371552|460179|P1|NOT COMPLETED|Part 1, First 3 Days||0
189859|NCT01371552|460174|P6|COMPLETED|Part 1, First 3 Days||18
189860|NCT01371552|460175|P5|COMPLETED|Part 1, First 3 Days||15
189861|NCT01371552|460176|P4|COMPLETED|Part 1, First 3 Days||20
189862|NCT01371552|460177|P3|COMPLETED|Part 1, First 3 Days||19
189863|NCT01371552|460178|P2|COMPLETED|Part 1, First 3 Days||17
189864|NCT01371552|460179|P1|COMPLETED|Part 1, First 3 Days||19
189865|NCT01371552|460174|P6|STARTED|Part 1, First 3 Days||18
189866|NCT01371552|460175|P5|STARTED|Part 1, First 3 Days||15
189867|NCT01371552|460176|P4|STARTED|Part 1, First 3 Days||20
189868|NCT01371552|460177|P3|STARTED|Part 1, First 3 Days||20
189869|NCT01371552|460178|P2|STARTED|Part 1, First 3 Days||17
189870|NCT01371552|460179|P1|STARTED|Part 1, First 3 Days||19
189871|NCT01371539|460206|P2|NOT COMPLETED|Period Two: One Week||3
189872|NCT01371539|460207|P1|NOT COMPLETED|Period Two: One Week||0
189873|NCT01371539|460206|P2|COMPLETED|Period Two: One Week||47
189874|NCT01371539|460207|P1|COMPLETED|Period Two: One Week||53
189875|NCT01371539|460206|P2|STARTED|Period Two: One Week||50
189876|NCT01371539|460207|P1|STARTED|Period Two: One Week||53
189877|NCT01371539|460206|P2|NOT COMPLETED|Period One: One Week||1
189878|NCT01371539|460207|P1|NOT COMPLETED|Period One: One Week||0
189879|NCT01371539|460206|P2|COMPLETED|Period One: One Week||50
189880|NCT01371539|460207|P1|COMPLETED|Period One: One Week||53
189881|NCT01371539|460206|P2|STARTED|Period One: One Week||51
189882|NCT01371539|460207|P1|STARTED|Period One: One Week||53
189883|NCT01371110|460217|P2|NOT COMPLETED|Overall Study||0
189884|NCT01371110|460218|P1|NOT COMPLETED|Overall Study||0
189885|NCT01371110|460217|P2|COMPLETED|Overall Study||2
189886|NCT01371110|460218|P1|COMPLETED|Overall Study||1
189887|NCT01371110|460217|P2|STARTED|Overall Study||2
189888|NCT01371110|460218|P1|STARTED|Overall Study||1
189889|NCT01371006|460228|P2|NOT COMPLETED|Overall Study||0
189890|NCT01371006|460229|P1|NOT COMPLETED|Overall Study||1
189891|NCT01371006|460228|P2|COMPLETED|Overall Study||15
189892|NCT01371006|460229|P1|COMPLETED|Overall Study||13
189893|NCT01371006|460228|P2|STARTED|Overall Study||15
189894|NCT01371006|460229|P1|STARTED|Overall Study||14
189895|NCT01370863|460270|P2|NOT COMPLETED|Overall Study||3
189896|NCT01370863|460271|P1|NOT COMPLETED|Overall Study||2
189897|NCT01370863|460270|P2|COMPLETED|Overall Study||30
189898|NCT01370863|460271|P1|COMPLETED|Overall Study||32
189899|NCT01370863|460270|P2|STARTED|Overall Study||33
189900|NCT01370863|460271|P1|STARTED|Overall Study||34
189901|NCT01370837|460284|P3|NOT COMPLETED|Overall Study||0
189902|NCT01370837|460285|P2|NOT COMPLETED|Overall Study||0
189903|NCT01370837|460286|P1|NOT COMPLETED|Overall Study||0
189904|NCT01370837|460284|P3|COMPLETED|Overall Study||17
189905|NCT01370837|460285|P2|COMPLETED|Overall Study||12
189906|NCT01370837|460286|P1|COMPLETED|Overall Study||12
189907|NCT01370837|460284|P3|STARTED|Overall Study||17
189908|NCT01370837|460285|P2|STARTED|Overall Study||12
189909|NCT01370837|460286|P1|STARTED|Overall Study||12
189910|NCT01370733|460296|P2|NOT COMPLETED|Overall Study||22
189911|NCT01370733|460297|P1|NOT COMPLETED|Overall Study||17
189912|NCT01370733|460296|P2|COMPLETED|Overall Study||77
189913|NCT01370733|460297|P1|COMPLETED|Overall Study||86
189914|NCT01370733|460296|P2|STARTED|Overall Study||99
189915|NCT01370733|460297|P1|STARTED|Overall Study||103
189916|NCT01370694|460319|P1|NOT COMPLETED|Overall Study||6
189917|NCT01370694|460319|P1|COMPLETED|Overall Study||1
189918|NCT01370694|460319|P1|STARTED|Overall Study||7
189919|NCT01370655|460341|P12|NOT COMPLETED|Period 2||0
189920|NCT01370655|460342|P11|NOT COMPLETED|Period 2||1
189921|NCT01370655|460343|P10|NOT COMPLETED|Period 2||0
189922|NCT01370655|460344|P9|NOT COMPLETED|Period 2||2
189923|NCT01370655|460345|P8|NOT COMPLETED|Period 2||1
189924|NCT01370655|460346|P7|NOT COMPLETED|Period 2||1
189925|NCT01370655|460347|P6|NOT COMPLETED|Period 2||0
189926|NCT01370655|460348|P5|NOT COMPLETED|Period 2||1
189927|NCT01370655|460349|P4|NOT COMPLETED|Period 2||0
189928|NCT01370655|460350|P3|NOT COMPLETED|Period 2||2
189929|NCT01370655|460351|P2|NOT COMPLETED|Period 2||0
189930|NCT01370655|460352|P1|NOT COMPLETED|Period 2||0
189931|NCT01370655|460341|P12|COMPLETED|Period 2||3
189932|NCT01370655|460342|P11|COMPLETED|Period 2||2
189933|NCT01370655|460343|P10|COMPLETED|Period 2||2
189934|NCT01370655|460344|P9|COMPLETED|Period 2||1
189935|NCT01370655|460345|P8|COMPLETED|Period 2||3
189936|NCT01370655|460346|P7|COMPLETED|Period 2||2
189937|NCT01370655|460347|P6|COMPLETED|Period 2||4
189938|NCT01370655|460348|P5|COMPLETED|Period 2||2
189939|NCT01370655|460349|P4|COMPLETED|Period 2||3
189940|NCT01370655|460350|P3|COMPLETED|Period 2||1
189941|NCT01370655|460351|P2|COMPLETED|Period 2||7
189942|NCT01370655|460352|P1|COMPLETED|Period 2||5
189943|NCT01370655|460341|P12|STARTED|Period 2||3
189944|NCT01370655|460342|P11|STARTED|Period 2||3
189945|NCT01370655|460343|P10|STARTED|Period 2||2
189946|NCT01370655|460344|P9|STARTED|Period 2||3
189947|NCT01370655|460345|P8|STARTED|Period 2||4
189948|NCT01370655|460346|P7|STARTED|Period 2||3
189949|NCT01370655|460347|P6|STARTED|Period 2||4
189950|NCT01370655|460348|P5|STARTED|Period 2||3
189951|NCT01370655|460349|P4|STARTED|Period 2||3
189952|NCT01370655|460350|P3|STARTED|Period 2||3
189953|NCT01370655|460351|P2|STARTED|Period 2||7
189954|NCT01370655|460352|P1|STARTED|Period 2||5
189955|NCT01370655|460341|P12|NOT COMPLETED|Period 1||0
189956|NCT01370655|460342|P11|NOT COMPLETED|Period 1||0
189957|NCT01370655|460343|P10|NOT COMPLETED|Period 1||0
189958|NCT01370655|460344|P9|NOT COMPLETED|Period 1||0
189959|NCT01370655|460345|P8|NOT COMPLETED|Period 1||0
189960|NCT01370655|460346|P7|NOT COMPLETED|Period 1||1
189961|NCT01370655|460347|P6|NOT COMPLETED|Period 1||0
189962|NCT01370655|460348|P5|NOT COMPLETED|Period 1||0
189963|NCT01370655|460349|P4|NOT COMPLETED|Period 1||0
189964|NCT01370655|460350|P3|NOT COMPLETED|Period 1||0
189965|NCT01370655|460351|P2|NOT COMPLETED|Period 1||0
189966|NCT01370655|460352|P1|NOT COMPLETED|Period 1||2
189967|NCT01370655|460341|P12|COMPLETED|Period 1||3
189968|NCT01370655|460342|P11|COMPLETED|Period 1||3
189969|NCT01370655|460343|P10|COMPLETED|Period 1||2
189970|NCT01370655|460344|P9|COMPLETED|Period 1||3
189971|NCT01370655|460345|P8|COMPLETED|Period 1||4
189972|NCT01370655|460346|P7|COMPLETED|Period 1||3
189973|NCT01370655|460347|P6|COMPLETED|Period 1||4
189974|NCT01370655|460348|P5|COMPLETED|Period 1||3
189975|NCT01370655|460349|P4|COMPLETED|Period 1||3
189976|NCT01370655|460350|P3|COMPLETED|Period 1||3
189977|NCT01370655|460351|P2|COMPLETED|Period 1||7
189978|NCT01370655|460352|P1|COMPLETED|Period 1||5
189979|NCT01370655|460341|P12|STARTED|Period 1||3
189980|NCT01370655|460342|P11|STARTED|Period 1||3
189981|NCT01370655|460343|P10|STARTED|Period 1||2
189982|NCT01370655|460344|P9|STARTED|Period 1||3
189983|NCT01370655|460345|P8|STARTED|Period 1||4
189984|NCT01370655|460346|P7|STARTED|Period 1||4
189985|NCT01370655|460347|P6|STARTED|Period 1||4
189986|NCT01370655|460348|P5|STARTED|Period 1||3
189987|NCT01370655|460349|P4|STARTED|Period 1||3
189988|NCT01370655|460350|P3|STARTED|Period 1||3
189989|NCT01370655|460351|P2|STARTED|Period 1||7
189990|NCT01370655|460352|P1|STARTED|Period 1||7
189991|NCT01370642|460389|P3|NOT COMPLETED|Overall Study||29
189992|NCT01370642|460390|P2|NOT COMPLETED|Overall Study||6
189993|NCT01370642|460391|P1|NOT COMPLETED|Overall Study||8
189994|NCT01370642|460389|P3|COMPLETED|Overall Study||69
189995|NCT01370642|460390|P2|COMPLETED|Overall Study||92
189996|NCT01370642|460391|P1|COMPLETED|Overall Study||90
189997|NCT01370642|460389|P3|FAS Population|Overall Study||98
189998|NCT01370642|460390|P2|FAS Population|Overall Study||97
189999|NCT01370642|460391|P1|FAS Population|Overall Study||98
190000|NCT01370642|460389|P3|STARTED|Overall Study||98
190001|NCT01370642|460390|P2|STARTED|Overall Study||98
190002|NCT01370642|460391|P1|STARTED|Overall Study||98
190003|NCT01370616|460422|P2|NOT COMPLETED|Overall Study||67
190004|NCT01370616|460423|P1|NOT COMPLETED|Overall Study||62
190005|NCT01370616|460422|P2|COMPLETED|Overall Study||216
190006|NCT01370616|460423|P1|COMPLETED|Overall Study||220
190007|NCT01370616|460422|P2|Treated|Overall Study||275
190008|NCT01370616|460423|P1|Treated|Overall Study||275
190009|NCT01370616|460422|P2|STARTED|Overall Study|Participants randomized|283
190102|NCT01370317|460649|P2|STARTED|Overall Study||9
190010|NCT01370616|460423|P1|STARTED|Overall Study|Participants randomized|282
190011|NCT01370603|460447|P2|NOT COMPLETED|Period 2||4
190012|NCT01370603|460448|P1|NOT COMPLETED|Period 2||3
190013|NCT01370603|460447|P2|COMPLETED|Period 2||146
190014|NCT01370603|460448|P1|COMPLETED|Period 2||138
190015|NCT01370603|460447|P2|STARTED|Period 2||150
190016|NCT01370603|460448|P1|STARTED|Period 2||141
190017|NCT01370603|460447|P2|NOT COMPLETED|Crossover Washout||4
190018|NCT01370603|460448|P1|NOT COMPLETED|Crossover Washout||9
190019|NCT01370603|460447|P2|COMPLETED|Crossover Washout||150
190020|NCT01370603|460448|P1|COMPLETED|Crossover Washout||141
190021|NCT01370603|460447|P2|STARTED|Crossover Washout||154
190022|NCT01370603|460448|P1|STARTED|Crossover Washout||150
190023|NCT01370603|460447|P2|NOT COMPLETED|Period 1||10
190024|NCT01370603|460448|P1|NOT COMPLETED|Period 1||14
190025|NCT01370603|460447|P2|COMPLETED|Period 1||154
190026|NCT01370603|460448|P1|COMPLETED|Period 1||150
190027|NCT01370603|460447|P2|STARTED|Period 1||164
190028|NCT01370603|460448|P1|STARTED|Period 1||164
190029|NCT01370590|460466|P2|NOT COMPLETED|Period 2||2
190030|NCT01370590|460467|P1|NOT COMPLETED|Period 2||1
190031|NCT01370590|460466|P2|COMPLETED|Period 2||184
190032|NCT01370590|460467|P1|COMPLETED|Period 2||180
190033|NCT01370590|460466|P2|STARTED|Period 2||186
190034|NCT01370590|460467|P1|STARTED|Period 2||181
190035|NCT01370590|460466|P2|NOT COMPLETED|Crossover Washout Period||6
190036|NCT01370590|460467|P1|NOT COMPLETED|Crossover Washout Period||6
190037|NCT01370590|460466|P2|COMPLETED|Crossover Washout Period||186
190038|NCT01370590|460467|P1|COMPLETED|Crossover Washout Period||181
190039|NCT01370590|460466|P2|STARTED|Crossover Washout Period||192
190040|NCT01370590|460467|P1|STARTED|Crossover Washout Period||187
190041|NCT01370590|460466|P2|NOT COMPLETED|Period 1||11
190042|NCT01370590|460467|P1|NOT COMPLETED|Period 1||16
190043|NCT01370590|460466|P2|COMPLETED|Period 1||192
190044|NCT01370590|460467|P1|COMPLETED|Period 1||187
190045|NCT01370590|460466|P2|STARTED|Period 1||203
190046|NCT01370590|460467|P1|STARTED|Period 1||203
190047|NCT01370564|460483|P1|NOT COMPLETED|Overall Study||0
190048|NCT01370564|460483|P1|COMPLETED|Overall Study||21
190049|NCT01370564|460483|P1|STARTED|Overall Study||21
190050|NCT01370538|460495|P2|NOT COMPLETED|Overall Study||19
190051|NCT01370538|460496|P1|NOT COMPLETED|Overall Study||19
190052|NCT01370538|460495|P2|COMPLETED|Overall Study||152
190053|NCT01370538|460496|P1|COMPLETED|Overall Study||151
190054|NCT01370538|460495|P2|Patients Who Completed Treatment|Overall Study||152
190055|NCT01370538|460496|P1|Patients Who Completed Treatment|Overall Study||151
190056|NCT01370538|460495|P2|Patients Who Received Treatment|Overall Study||161
190057|NCT01370538|460496|P1|Patients Who Received Treatment|Overall Study||165
190058|NCT01370538|460495|P2|STARTED|Overall Study||171
190059|NCT01370538|460496|P1|STARTED|Overall Study||170
190060|NCT01370525|460512|P2|NOT COMPLETED|Overall Study||11
190061|NCT01370525|460513|P1|NOT COMPLETED|Overall Study||8
190062|NCT01370525|460512|P2|COMPLETED|Overall Study||158
190063|NCT01370525|460513|P1|COMPLETED|Overall Study||163
190064|NCT01370525|460512|P2|Patients Who Completed Treatment|Overall Study||158
190065|NCT01370525|460513|P1|Patients Who Completed Treatment|Overall Study||163
190066|NCT01370525|460512|P2|Patients Who Received Treatment|Overall Study||163
190067|NCT01370525|460513|P1|Patients Who Received Treatment|Overall Study||168
190068|NCT01370525|460512|P2|STARTED|Overall Study||169
190069|NCT01370525|460513|P1|STARTED|Overall Study||171
190070|NCT01370499|460529|P2|NOT COMPLETED|Overall Study||44
190071|NCT01370499|460530|P1|NOT COMPLETED|Overall Study||111
190072|NCT01370499|460529|P2|COMPLETED|Overall Study||49
190073|NCT01370499|460530|P1|COMPLETED|Overall Study||84
190074|NCT01370499|460529|P2|Received at Least 1 Dose of Study Drug|Overall Study||92
190075|NCT01370499|460530|P1|Received at Least 1 Dose of Study Drug|Overall Study||195
190076|NCT01370499|460529|P2|Entered Abrupt Discontinuation Phase|Overall Study|One participant who entered the abrupt discontinuation phase did not receive study drug.|85
190077|NCT01370499|460530|P1|Entered Abrupt Discontinuation Phase|Overall Study||188
190078|NCT01370499|460529|P2|STARTED|Overall Study||93
190079|NCT01370499|460530|P1|STARTED|Overall Study||195
190080|NCT01370460|460564|P2|NOT COMPLETED|Overall Study||0
190081|NCT01370460|460565|P1|NOT COMPLETED|Overall Study||0
190082|NCT01370460|460564|P2|COMPLETED|Overall Study||51
190083|NCT01370460|460565|P1|COMPLETED|Overall Study||50
190084|NCT01370460|460564|P2|STARTED|Overall Study||51
190085|NCT01370460|460565|P1|STARTED|Overall Study||50
190086|NCT01370408|460572|P1|NOT COMPLETED|Overall Study||9
190087|NCT01370408|460572|P1|COMPLETED|Overall Study||76
190088|NCT01370408|460572|P1|STARTED|Overall Study||85
190089|NCT01370369|460583|P1|NOT COMPLETED|Overall Study||0
190090|NCT01370369|460583|P1|COMPLETED|Overall Study||20
190091|NCT01370369|460583|P1|STARTED|Overall Study||20
190092|NCT01370356|460632|P2|NOT COMPLETED|Overall Study||227
190093|NCT01370356|460633|P1|NOT COMPLETED|Overall Study||192
190094|NCT01370356|460632|P2|COMPLETED|Overall Study||515
190095|NCT01370356|460633|P1|COMPLETED|Overall Study||559
190096|NCT01370356|460632|P2|STARTED|Overall Study||742
190097|NCT01370356|460633|P1|STARTED|Overall Study||751
190098|NCT01370317|460649|P2|NOT COMPLETED|Overall Study||1
190099|NCT01370317|460650|P1|NOT COMPLETED|Overall Study||1
190100|NCT01370317|460649|P2|COMPLETED|Overall Study||8
190101|NCT01370317|460650|P1|COMPLETED|Overall Study||17
190103|NCT01370317|460650|P1|STARTED|Overall Study||18
190104|NCT01370265|460661|P2|NOT COMPLETED|Second Intervention||0
190105|NCT01370265|460662|P1|NOT COMPLETED|Second Intervention||0
190106|NCT01370265|460661|P2|COMPLETED|Second Intervention||5
190107|NCT01370265|460662|P1|COMPLETED|Second Intervention||5
190108|NCT01370265|460661|P2|STARTED|Second Intervention||5
190109|NCT01370265|460662|P1|STARTED|Second Intervention||5
190110|NCT01370265|460661|P2|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
190111|NCT01370265|460662|P1|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
190112|NCT01370265|460661|P2|COMPLETED|Washout Period (50-minute Period Decay)||5
190113|NCT01370265|460662|P1|COMPLETED|Washout Period (50-minute Period Decay)||5
190114|NCT01370265|460661|P2|STARTED|Washout Period (50-minute Period Decay)||5
190115|NCT01370265|460662|P1|STARTED|Washout Period (50-minute Period Decay)||5
190116|NCT01370265|460661|P2|NOT COMPLETED|First Intervention||1
190117|NCT01370265|460662|P1|NOT COMPLETED|First Intervention||1
190118|NCT01370265|460661|P2|COMPLETED|First Intervention||5
190119|NCT01370265|460662|P1|COMPLETED|First Intervention||5
190120|NCT01370265|460661|P2|STARTED|First Intervention||6
190121|NCT01370265|460662|P1|STARTED|First Intervention||6
190122|NCT01370265|460661|P2|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
190123|NCT01370265|460662|P1|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
190124|NCT01370265|460661|P2|COMPLETED|Washout Period (50-minute Period Decay)||6
190125|NCT01370265|460662|P1|COMPLETED|Washout Period (50-minute Period Decay)||6
190126|NCT01370265|460661|P2|STARTED|Washout Period (50-minute Period Decay)||6
190127|NCT01370265|460662|P1|STARTED|Washout Period (50-minute Period Decay)||6
190128|NCT01370265|460661|P2|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
190129|NCT01370265|460662|P1|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
190130|NCT01370265|460661|P2|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
190131|NCT01370265|460662|P1|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
190132|NCT01370265|460661|P2|STARTED|Resting Myocardial Blood Flow (MBF)||6
190133|NCT01370265|460662|P1|STARTED|Resting Myocardial Blood Flow (MBF)||6
190134|NCT01370083|460681|P2|NOT COMPLETED|Overall Study||1
190135|NCT01370083|460682|P1|NOT COMPLETED|Overall Study||2
190136|NCT01370083|460681|P2|COMPLETED|Overall Study||6
190137|NCT01370083|460682|P1|COMPLETED|Overall Study||5
190138|NCT01370083|460681|P2|STARTED|Overall Study||7
190139|NCT01370083|460682|P1|STARTED|Overall Study||7
190140|NCT01370005|460695|P3|NOT COMPLETED|Overall Study||11
190141|NCT01370005|460696|P2|NOT COMPLETED|Overall Study||11
190142|NCT01370005|460697|P1|NOT COMPLETED|Overall Study||16
190143|NCT01370005|460695|P3|COMPLETED|Overall Study||266
190144|NCT01370005|460696|P2|COMPLETED|Overall Study||265
190145|NCT01370005|460697|P1|COMPLETED|Overall Study||256
190146|NCT01370005|460695|P3|STARTED|Overall Study||277
190147|NCT01370005|460696|P2|STARTED|Overall Study||276
190148|NCT01370005|460697|P1|STARTED|Overall Study||272
190149|NCT01369888|460754|P4|NOT COMPLETED|Overall Study||0
190150|NCT01369888|460755|P3|NOT COMPLETED|Overall Study||0
190151|NCT01369888|460756|P2|NOT COMPLETED|Overall Study||0
190152|NCT01369888|460757|P1|NOT COMPLETED|Overall Study||0
190153|NCT01369888|460754|P4|COMPLETED|Overall Study||0
190154|NCT01369888|460755|P3|COMPLETED|Overall Study||0
190155|NCT01369888|460756|P2|COMPLETED|Overall Study||2
190156|NCT01369888|460757|P1|COMPLETED|Overall Study||1
190157|NCT01369888|460754|P4|STARTED|Overall Study||0
190158|NCT01369888|460755|P3|STARTED|Overall Study||0
190159|NCT01369888|460756|P2|STARTED|Overall Study||2
190160|NCT01369888|460757|P1|STARTED|Overall Study||1
190161|NCT01369875|460767|P2|NOT COMPLETED|Overall Study||0
190162|NCT01369875|460768|P1|NOT COMPLETED|Overall Study||0
190163|NCT01369875|460767|P2|COMPLETED|Overall Study||1
190164|NCT01369875|460768|P1|COMPLETED|Overall Study||1
190165|NCT01369875|460767|P2|STARTED|Overall Study||1
190166|NCT01369875|460768|P1|STARTED|Overall Study||1
190167|NCT01369849|460779|P3|NOT COMPLETED|Overall Study||1
190168|NCT01369849|460780|P2|NOT COMPLETED|Overall Study||1
190169|NCT01369849|460781|P1|NOT COMPLETED|Overall Study||0
190170|NCT01369849|460779|P3|COMPLETED|Overall Study||4
190171|NCT01369849|460780|P2|COMPLETED|Overall Study||3
190172|NCT01369849|460781|P1|COMPLETED|Overall Study||6
190173|NCT01369849|460779|P3|STARTED|Overall Study||5
190174|NCT01369849|460780|P2|STARTED|Overall Study||4
190175|NCT01369849|460781|P1|STARTED|Overall Study||6
190176|NCT01369784|460803|P1|NOT COMPLETED|Overall Study||12
190177|NCT01369784|460803|P1|COMPLETED|Overall Study||146
190178|NCT01369784|460803|P1|STARTED|Overall Study||158
190179|NCT01369758|460828|P1|NOT COMPLETED|Overall Study||0
190180|NCT01369758|460828|P1|COMPLETED|Overall Study||290
190181|NCT01369758|460828|P1|STARTED|Overall Study||290
190182|NCT01369745|460838|P5|NOT COMPLETED|Overall Study||18
190183|NCT01369745|460839|P4|NOT COMPLETED|Overall Study||20
190184|NCT01369745|460840|P3|NOT COMPLETED|Overall Study||2
190185|NCT01369745|460841|P2|NOT COMPLETED|Overall Study||13
190186|NCT01369745|460842|P1|NOT COMPLETED|Overall Study||7
190187|NCT01369745|460838|P5|COMPLETED|Overall Study||65
190188|NCT01369745|460839|P4|COMPLETED|Overall Study||64
190189|NCT01369745|460840|P3|COMPLETED|Overall Study||16
190190|NCT01369745|460841|P2|COMPLETED|Overall Study||28
190191|NCT01369745|460842|P1|COMPLETED|Overall Study||25
190192|NCT01369745|460838|P5|STARTED|Overall Study||83
190193|NCT01369745|460839|P4|STARTED|Overall Study||84
190194|NCT01369745|460840|P3|STARTED|Overall Study||18
190195|NCT01369745|460841|P2|STARTED|Overall Study||41
190196|NCT01369745|460842|P1|STARTED|Overall Study||32
190197|NCT01369732|460876|P2|NOT COMPLETED|Overall Study||2
190198|NCT01369732|460877|P1|NOT COMPLETED|Overall Study||4
190199|NCT01369732|460876|P2|COMPLETED|Overall Study||31
190200|NCT01369732|460877|P1|COMPLETED|Overall Study||29
190201|NCT01369732|460876|P2|STARTED|Overall Study||33
190202|NCT01369732|460877|P1|STARTED|Overall Study||33
190203|NCT01369706|460883|P1|NOT COMPLETED|Overall Study||0
190204|NCT01369706|460883|P1|COMPLETED|Overall Study||388
190205|NCT01369706|460883|P1|STARTED|Overall Study||388
190206|NCT01369680|460891|P4|NOT COMPLETED|Overall Study||2
190207|NCT01369680|460892|P3|NOT COMPLETED|Overall Study||1
190208|NCT01369680|460893|P2|NOT COMPLETED|Overall Study||0
190209|NCT01369680|460894|P1|NOT COMPLETED|Overall Study||0
190210|NCT01369680|460891|P4|COMPLETED|Overall Study||1
190211|NCT01369680|460892|P3|COMPLETED|Overall Study||2
190212|NCT01369680|460893|P2|COMPLETED|Overall Study||3
190213|NCT01369680|460894|P1|COMPLETED|Overall Study||3
190214|NCT01369680|460891|P4|STARTED|Overall Study||3
190215|NCT01369680|460892|P3|STARTED|Overall Study||3
190216|NCT01369680|460893|P2|STARTED|Overall Study||3
190217|NCT01369680|460894|P1|STARTED|Overall Study||3
190218|NCT01369641|460915|P1|NOT COMPLETED|Overall Study||1
190219|NCT01369641|460915|P1|COMPLETED|Overall Study||0
190220|NCT01369641|460915|P1|STARTED|Overall Study||1
190221|NCT01369615|460921|P2|NOT COMPLETED|Overall Study||2
190222|NCT01369615|460922|P1|NOT COMPLETED|Overall Study||0
190223|NCT01369615|460921|P2|COMPLETED|Overall Study||12
190224|NCT01369615|460922|P1|COMPLETED|Overall Study||9
190225|NCT01369615|460921|P2|STARTED|Overall Study||14
190226|NCT01369615|460922|P1|STARTED|Overall Study||9
190227|NCT01369511|460932|P4|NOT COMPLETED|Overall Study||11
190228|NCT01369511|460933|P3|NOT COMPLETED|Overall Study||11
190229|NCT01369511|460934|P2|NOT COMPLETED|Overall Study||13
190230|NCT01369511|460935|P1|NOT COMPLETED|Overall Study||13
190231|NCT01369511|460932|P4|COMPLETED|Overall Study||89
190232|NCT01369511|460933|P3|COMPLETED|Overall Study||87
190233|NCT01369511|460934|P2|COMPLETED|Overall Study||91
190234|NCT01369511|460935|P1|COMPLETED|Overall Study||85
190235|NCT01369511|460932|P4|Received at Least 1 Dose of Study Drug|Overall Study||100
190236|NCT01369511|460933|P3|Received at Least 1 Dose of Study Drug|Overall Study||98
190237|NCT01369511|460934|P2|Received at Least 1 Dose of Study Drug|Overall Study|One participant was a screen failure and inadvertently randomized but did not receive study drug.|103
190238|NCT01369511|460935|P1|Received at Least 1 Dose of Study Drug|Overall Study||98
190239|NCT01369511|460932|P4|STARTED|Overall Study||100
190240|NCT01369511|460933|P3|STARTED|Overall Study||98
190241|NCT01369511|460934|P2|STARTED|Overall Study||104
190242|NCT01369511|460935|P1|STARTED|Overall Study||98
190243|NCT01369485|460951|P2|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||40
190244|NCT01369485|460952|P1|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||33
190245|NCT01369485|460951|P2|COMPLETED|Open Label Phase (Week 12 to Month 12)||26
190246|NCT01369485|460952|P1|COMPLETED|Open Label Phase (Week 12 to Month 12)||24
190247|NCT01369485|460951|P2|STARTED|Open Label Phase (Week 12 to Month 12)||66
190248|NCT01369485|460952|P1|STARTED|Open Label Phase (Week 12 to Month 12)||57
190249|NCT01369485|460951|P2|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||17
190250|NCT01369485|460952|P1|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||23
190251|NCT01369485|460951|P2|COMPLETED|Randomized Phase (Day 0 to Week 12)||66
190252|NCT01369485|460952|P1|COMPLETED|Randomized Phase (Day 0 to Week 12)||57
190253|NCT01369485|460951|P2|STARTED|Randomized Phase (Day 0 to Week 12)||83
190254|NCT01369485|460952|P1|STARTED|Randomized Phase (Day 0 to Week 12)||80
190255|NCT01369355|460998|P6|NOT COMPLETED|Overall Study||272
190256|NCT01369355|460999|P5|NOT COMPLETED|Overall Study||154
190257|NCT01369355|461000|P4|NOT COMPLETED|Overall Study||30
190258|NCT01369355|461001|P3|NOT COMPLETED|Overall Study||31
190259|NCT01369355|461002|P2|NOT COMPLETED|Overall Study||29
190260|NCT01369355|461003|P1|NOT COMPLETED|Overall Study||31
190261|NCT01369355|460998|P6|COMPLETED|Overall Study||204
190262|NCT01369355|460999|P5|COMPLETED|Overall Study||131
190263|NCT01369355|461000|P4|COMPLETED|Overall Study||93
190264|NCT01369355|461001|P3|COMPLETED|Overall Study||101
190265|NCT01369355|461002|P2|COMPLETED|Overall Study||103
190266|NCT01369355|461003|P1|COMPLETED|Overall Study||102
190267|NCT01369355|460998|P6|Treated|Overall Study||476
190268|NCT01369355|460999|P5|Treated|Overall Study||285
190269|NCT01369355|461000|P4|Treated|Overall Study||123
190270|NCT01369355|461001|P3|Treated|Overall Study||131
190271|NCT01369355|461002|P2|Treated|Overall Study||132
190272|NCT01369355|461003|P1|Treated|Overall Study||133
190273|NCT01369355|460998|P6|STARTED|Overall Study||476
190274|NCT01369355|460999|P5|STARTED|Overall Study||285
190275|NCT01369355|461000|P4|STARTED|Overall Study||123
190276|NCT01369355|461001|P3|STARTED|Overall Study||132
190277|NCT01369355|461002|P2|STARTED|Overall Study||132
190278|NCT01369355|461003|P1|STARTED|Overall Study||133
190279|NCT01369342|461032|P3|NOT COMPLETED|Overall Study||3
190280|NCT01369342|461033|P2|NOT COMPLETED|Overall Study||9
190281|NCT01369342|461034|P1|NOT COMPLETED|Overall Study||13
190282|NCT01369342|461032|P3|COMPLETED|Overall Study||210
190283|NCT01369342|461033|P2|COMPLETED|Overall Study||204
190284|NCT01369342|461034|P1|COMPLETED|Overall Study||201
190285|NCT01369342|461032|P3|STARTED|Overall Study||213
190286|NCT01369342|461033|P2|STARTED|Overall Study||213
190287|NCT01369342|461034|P1|STARTED|Overall Study||214
190288|NCT01369329|461057|P3|NOT COMPLETED|Overall Study||14
190289|NCT01369329|461058|P2|NOT COMPLETED|Overall Study||11
190290|NCT01369329|461059|P1|NOT COMPLETED|Overall Study||12
190291|NCT01369329|461057|P3|COMPLETED|Overall Study||245
190292|NCT01369329|461058|P2|COMPLETED|Overall Study||243
190293|NCT01369329|461059|P1|COMPLETED|Overall Study||244
190294|NCT01369329|461057|P3|STARTED|Overall Study||259
190295|NCT01369329|461058|P2|STARTED|Overall Study||254
190296|NCT01369329|461059|P1|STARTED|Overall Study||256
190297|NCT01369225|461085|P6|NOT COMPLETED|Overall Study||0
190298|NCT01369225|461086|P5|NOT COMPLETED|Overall Study||2
190299|NCT01369225|461087|P4|NOT COMPLETED|Overall Study||2
190300|NCT01369225|461088|P3|NOT COMPLETED|Overall Study||3
190301|NCT01369225|461089|P2|NOT COMPLETED|Overall Study||0
190302|NCT01369225|461090|P1|NOT COMPLETED|Overall Study||2
190303|NCT01369225|461085|P6|COMPLETED|Overall Study||9
190304|NCT01369225|461086|P5|COMPLETED|Overall Study||10
190305|NCT01369225|461087|P4|COMPLETED|Overall Study||8
190306|NCT01369225|461088|P3|COMPLETED|Overall Study||9
190307|NCT01369225|461089|P2|COMPLETED|Overall Study||3
190308|NCT01369225|461090|P1|COMPLETED|Overall Study||4
190309|NCT01369225|461085|P6|STARTED|Overall Study||9
190310|NCT01369225|461086|P5|STARTED|Overall Study||12
190311|NCT01369225|461087|P4|STARTED|Overall Study||10
190312|NCT01369225|461088|P3|STARTED|Overall Study||12
190313|NCT01369225|461089|P2|STARTED|Overall Study||3
190314|NCT01369225|461090|P1|STARTED|Overall Study||6
190315|NCT01369199|461182|P1|NOT COMPLETED|Overall Study||3
190316|NCT01369199|461182|P1|COMPLETED|Overall Study||25
190317|NCT01369199|461182|P1|End of Treatment (EOT)|Overall Study|1 withdrew consent before treatment,1 missed end of treatment (EOT) visit but completed follow-up.|26
190318|NCT01369199|461182|P1|STARTED|Overall Study||28
190319|NCT01369108|461204|P1|NOT COMPLETED|Overall Study||11
190320|NCT01369108|461204|P1|COMPLETED|Overall Study||49
190321|NCT01369108|461204|P1|STARTED|Overall Study|120 teeth|60
190322|NCT01369030|461211|P1|NOT COMPLETED|Overall Study||40
190323|NCT01369030|461211|P1|COMPLETED|Overall Study||554
190324|NCT01369030|461211|P1|STARTED|Overall Study||594
190325|NCT01368965|461217|P1|NOT COMPLETED|Overall Study||12
190326|NCT01368965|461217|P1|COMPLETED|Overall Study||40
190327|NCT01368965|461217|P1|Subject Withdrawal Prior to Treatment|Overall Study||2
190328|NCT01368965|461217|P1|STARTED|Overall Study|Two subjects withdrew consent prior to study treatment. Data analyses are based on 52 subjects.|52
190329|NCT01368900|461226|P1|NOT COMPLETED|Overall Study||7
190330|NCT01368900|461226|P1|COMPLETED|Overall Study||61
190331|NCT01368900|461226|P1|STARTED|Overall Study||68
190332|NCT01368874|461239|P3|NOT COMPLETED|Overall Study||1
190333|NCT01368874|461240|P2|NOT COMPLETED|Overall Study||0
190334|NCT01368874|461241|P1|NOT COMPLETED|Overall Study||3
190335|NCT01368874|461239|P3|COMPLETED|Overall Study||24
190336|NCT01368874|461240|P2|COMPLETED|Overall Study||5
190337|NCT01368874|461241|P1|COMPLETED|Overall Study||31
190338|NCT01368874|461239|P3|STARTED|Overall Study||25
190339|NCT01368874|461240|P2|STARTED|Overall Study||5
190340|NCT01368874|461241|P1|STARTED|Overall Study||34
190341|NCT01368835|461301|P1|NOT COMPLETED|Overall Study||33
190342|NCT01368835|461301|P1|COMPLETED|Overall Study||70
190343|NCT01368835|461301|P1|STARTED|Overall Study|103 Subjects Enrolled|103
190344|NCT01368809|461310|P2|NOT COMPLETED|Overall Study||0
190345|NCT01368809|461311|P1|NOT COMPLETED|Overall Study||0
190346|NCT01368809|461310|P2|COMPLETED|Overall Study||50
190347|NCT01368809|461311|P1|COMPLETED|Overall Study||50
190348|NCT01368809|461310|P2|STARTED|Overall Study||50
190349|NCT01368809|461311|P1|STARTED|Overall Study||50
190350|NCT01368653|461323|P2|NOT COMPLETED|Overall Study||9
190351|NCT01368653|461324|P1|NOT COMPLETED|Overall Study||6
190352|NCT01368653|461323|P2|COMPLETED|Overall Study||37
190353|NCT01368653|461324|P1|COMPLETED|Overall Study||41
190354|NCT01368653|461323|P2|Randomized to Advice Only in Phase 2|Overall Study||10
190355|NCT01368653|461324|P1|Randomized to Advice Only in Phase 2|Overall Study||10
190356|NCT01368653|461323|P2|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|9
190357|NCT01368653|461324|P1|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|11
190358|NCT01368653|461323|P2|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|19
190359|NCT01368653|461324|P1|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|21
190360|NCT01368653|461323|P2|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|20
190361|NCT01368653|461324|P1|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|29
190362|NCT01368653|461323|P2|Completed 4-week Follow-up|Overall Study||37
190363|NCT01368653|461324|P1|Completed 4-week Follow-up|Overall Study||44
190364|NCT01368653|461323|P2|STARTED|Overall Study||46
190365|NCT01368653|461324|P1|STARTED|Overall Study||47
190366|NCT01368614|461340|P4|NOT COMPLETED|Study Period||3
190367|NCT01368614|461341|P3|NOT COMPLETED|Study Period||2
190368|NCT01368614|461342|P2|NOT COMPLETED|Study Period||1
190369|NCT01368614|461343|P1|NOT COMPLETED|Study Period||0
190370|NCT01368614|461340|P4|COMPLETED|Study Period||8
190371|NCT01368614|461341|P3|COMPLETED|Study Period||8
190372|NCT01368614|461342|P2|COMPLETED|Study Period||10
190373|NCT01368614|461343|P1|COMPLETED|Study Period||0
190374|NCT01368614|461340|P4|STARTED|Study Period||11
190375|NCT01368614|461341|P3|STARTED|Study Period||10
190376|NCT01368614|461342|P2|STARTED|Study Period||11
190377|NCT01368614|461343|P1|STARTED|Study Period||0
190378|NCT01368614|461340|P4|NOT COMPLETED|Screening Period||0
190379|NCT01368614|461341|P3|NOT COMPLETED|Screening Period||0
190380|NCT01368614|461342|P2|NOT COMPLETED|Screening Period||0
190381|NCT01368614|461343|P1|NOT COMPLETED|Screening Period||58
190382|NCT01368614|461340|P4|COMPLETED|Screening Period||0
190383|NCT01368614|461341|P3|COMPLETED|Screening Period||0
190384|NCT01368614|461342|P2|COMPLETED|Screening Period||0
190385|NCT01368614|461343|P1|COMPLETED|Screening Period||32
190386|NCT01368614|461340|P4|STARTED|Screening Period||0
190387|NCT01368614|461341|P3|STARTED|Screening Period||0
190388|NCT01368614|461342|P2|STARTED|Screening Period||0
190389|NCT01368614|461343|P1|STARTED|Screening Period||90
190390|NCT01368562|461396|P1|NOT COMPLETED|Overall Study||19
190391|NCT01368562|461396|P1|COMPLETED|Overall Study||7
190392|NCT01368562|461396|P1|Received at Least 1 Dose of Study Drug|Overall Study||25
190393|NCT01368562|461396|P1|STARTED|Overall Study||26
190394|NCT01368536|461403|P3|NOT COMPLETED|Overall Study||59
190395|NCT01368536|461404|P2|NOT COMPLETED|Overall Study||59
190396|NCT01368536|461405|P1|NOT COMPLETED|Overall Study||51
190397|NCT01368536|461403|P3|COMPLETED|Overall Study||83
190398|NCT01368536|461404|P2|COMPLETED|Overall Study||78
190399|NCT01368536|461405|P1|COMPLETED|Overall Study||87
190400|NCT01368536|461403|P3|Full Analysis Set|Overall Study|One patient was excluded from efficacy analysis as there was no post baseline data|141
190401|NCT01368536|461404|P2|Full Analysis Set|Overall Study||137
190402|NCT01368536|461405|P1|Full Analysis Set|Overall Study||138
190403|NCT01368536|461403|P3|STARTED|Overall Study||142
190404|NCT01368536|461404|P2|STARTED|Overall Study||137
190405|NCT01368536|461405|P1|STARTED|Overall Study||138
190406|NCT01368497|461426|P1|NOT COMPLETED|Overall Study||2
190407|NCT01368497|461426|P1|COMPLETED|Overall Study||58
190408|NCT01368497|461426|P1|End of Treatment|Overall Study|Five discontinued study drugs early and completed the follow-up period per protocol.|60
190409|NCT01368497|461426|P1|STARTED|Overall Study||60
190410|NCT01368432|461454|P2|NOT COMPLETED|Overall Study||1
190411|NCT01368432|461455|P1|NOT COMPLETED|Overall Study||0
190412|NCT01368432|461454|P2|COMPLETED|Overall Study||7
190413|NCT01368432|461455|P1|COMPLETED|Overall Study||6
190414|NCT01368432|461454|P2|STARTED|Overall Study||8
190415|NCT01368432|461455|P1|STARTED|Overall Study||6
190416|NCT01368406|461489|P2|NOT COMPLETED|Overall Study||13
190417|NCT01368406|461490|P1|NOT COMPLETED|Overall Study||21
190418|NCT01368406|461489|P2|COMPLETED|Overall Study||66
190419|NCT01368406|461490|P1|COMPLETED|Overall Study||60
190420|NCT01368406|461489|P2|STARTED|Overall Study||79
190421|NCT01368406|461490|P1|STARTED|Overall Study||81
190422|NCT01368276|461498|P2|NOT COMPLETED|Overall Study||10
190423|NCT01368276|461499|P1|NOT COMPLETED|Overall Study||1
190424|NCT01368276|461498|P2|COMPLETED|Overall Study||18
190425|NCT01368276|461499|P1|COMPLETED|Overall Study||2
190426|NCT01368276|461498|P2|STARTED|Overall Study||28
190427|NCT01368276|461499|P1|STARTED|Overall Study||3
190428|NCT01368263|461512|P3|NOT COMPLETED|Overall Study||0
190429|NCT01368263|461513|P2|NOT COMPLETED|Overall Study||0
190430|NCT01368263|461514|P1|NOT COMPLETED|Overall Study||0
190431|NCT01368263|461512|P3|COMPLETED|Overall Study||1
190432|NCT01368263|461513|P2|COMPLETED|Overall Study||1
190433|NCT01368263|461514|P1|COMPLETED|Overall Study||6
190434|NCT01368263|461512|P3|STARTED|Overall Study||1
190435|NCT01368263|461513|P2|STARTED|Overall Study||1
190436|NCT01368263|461514|P1|STARTED|Overall Study||6
190437|NCT01368211|461536|P2|NOT COMPLETED|Second Platelets Transfusion||2
190438|NCT01368211|461537|P1|NOT COMPLETED|Second Platelets Transfusion||1
190439|NCT01368211|461536|P2|COMPLETED|Second Platelets Transfusion||5
190440|NCT01368211|461537|P1|COMPLETED|Second Platelets Transfusion||7
190441|NCT01368211|461536|P2|STARTED|Second Platelets Transfusion||7
190442|NCT01368211|461537|P1|STARTED|Second Platelets Transfusion||8
190443|NCT01368211|461536|P2|NOT COMPLETED|First Platelets Transfusion||0
190444|NCT01368211|461537|P1|NOT COMPLETED|First Platelets Transfusion||0
190445|NCT01368211|461536|P2|COMPLETED|First Platelets Transfusion||7
190446|NCT01368211|461537|P1|COMPLETED|First Platelets Transfusion||8
190447|NCT01368211|461536|P2|STARTED|First Platelets Transfusion||7
190448|NCT01368211|461537|P1|STARTED|First Platelets Transfusion||8
190449|NCT01368185|461545|P1|NOT COMPLETED|Overall Study||0
190450|NCT01368185|461545|P1|COMPLETED|Overall Study||1705
190451|NCT01368185|461545|P1|STARTED|Overall Study||1705
190452|NCT01368081|461565|P13|NOT COMPLETED|Overall Study||7
190453|NCT01368081|461566|P12|NOT COMPLETED|Overall Study||3
190454|NCT01368081|461567|P11|NOT COMPLETED|Overall Study||9
190455|NCT01368081|461568|P10|NOT COMPLETED|Overall Study||10
190456|NCT01368081|461569|P9|NOT COMPLETED|Overall Study||8
190457|NCT01368081|461570|P8|NOT COMPLETED|Overall Study||7
190458|NCT01368081|461571|P7|NOT COMPLETED|Overall Study||12
190459|NCT01368081|461572|P6|NOT COMPLETED|Overall Study||10
190460|NCT01368081|461573|P5|NOT COMPLETED|Overall Study||2
190461|NCT01368081|461574|P4|NOT COMPLETED|Overall Study||5
190462|NCT01368081|461575|P3|NOT COMPLETED|Overall Study||4
190463|NCT01368081|461576|P2|NOT COMPLETED|Overall Study||9
190464|NCT01368081|461577|P1|NOT COMPLETED|Overall Study||10
190465|NCT01368081|461565|P13|COMPLETED|Overall Study||63
190466|NCT01368081|461566|P12|COMPLETED|Overall Study||67
190467|NCT01368081|461567|P11|COMPLETED|Overall Study||62
190468|NCT01368081|461568|P10|COMPLETED|Overall Study||58
190469|NCT01368081|461569|P9|COMPLETED|Overall Study||62
190470|NCT01368081|461570|P8|COMPLETED|Overall Study||62
190471|NCT01368081|461571|P7|COMPLETED|Overall Study||124
190472|NCT01368081|461572|P6|COMPLETED|Overall Study||127
190473|NCT01368081|461573|P5|COMPLETED|Overall Study||63
190474|NCT01368081|461574|P4|COMPLETED|Overall Study||63
190475|NCT01368081|461575|P3|COMPLETED|Overall Study||59
190476|NCT01368081|461576|P2|COMPLETED|Overall Study||128
190477|NCT01368081|461577|P1|COMPLETED|Overall Study||126
190478|NCT01368081|461565|P13|STARTED|Overall Study||70
190479|NCT01368081|461566|P12|STARTED|Overall Study||70
190480|NCT01368081|461567|P11|STARTED|Overall Study||71
190481|NCT01368081|461568|P10|STARTED|Overall Study||68
190482|NCT01368081|461569|P9|STARTED|Overall Study||70
190483|NCT01368081|461570|P8|STARTED|Overall Study||69
190484|NCT01368081|461571|P7|STARTED|Overall Study||136
190485|NCT01368081|461572|P6|STARTED|Overall Study||137
190486|NCT01368081|461573|P5|STARTED|Overall Study||65
190487|NCT01368081|461574|P4|STARTED|Overall Study||68
190488|NCT01368081|461575|P3|STARTED|Overall Study||63
190489|NCT01368081|461576|P2|STARTED|Overall Study||137
190490|NCT01368081|461577|P1|STARTED|Overall Study||136
190491|NCT01368042|461631|P1|NOT COMPLETED|Overall Study||30
190492|NCT01368042|461631|P1|COMPLETED|Overall Study||235
190493|NCT01368042|461631|P1|STARTED|Overall Study||265
190494|NCT01367886|461651|P1|NOT COMPLETED|Overall Study||7
190495|NCT01367886|461651|P1|COMPLETED|Overall Study||14
190496|NCT01367886|461651|P1|STARTED|Overall Study||21
190497|NCT01367860|461660|P2|NOT COMPLETED|Overall Study||0
190498|NCT01367860|461661|P1|NOT COMPLETED|Overall Study||0
190499|NCT01367860|461660|P2|COMPLETED|Overall Study||20
190500|NCT01367860|461661|P1|COMPLETED|Overall Study||20
190501|NCT01367860|461660|P2|STARTED|Overall Study||20
190502|NCT01367860|461661|P1|STARTED|Overall Study||20
190503|NCT01367847|461701|P2|NOT COMPLETED|Overall Study||2
190504|NCT01367847|461702|P1|NOT COMPLETED|Overall Study||2
190505|NCT01367847|461701|P2|COMPLETED|Overall Study||7
190506|NCT01367847|461702|P1|COMPLETED|Overall Study||8
190507|NCT01367847|461701|P2|STARTED|Overall Study||9
190508|NCT01367847|461702|P1|STARTED|Overall Study||10
190509|NCT01367834|461718|P2|NOT COMPLETED|Overall Study||3
190510|NCT01367834|461719|P1|NOT COMPLETED|Overall Study||2
190511|NCT01367834|461718|P2|COMPLETED|Overall Study||3
190512|NCT01367834|461719|P1|COMPLETED|Overall Study||9
190513|NCT01367834|461718|P2|STARTED|Overall Study||6
190514|NCT01367834|461719|P1|STARTED|Overall Study||11
190515|NCT01367704|461743|P2|NOT COMPLETED|Overall Study||161
190516|NCT01367704|461744|P1|NOT COMPLETED|Overall Study||47
190517|NCT01367704|461743|P2|COMPLETED|Overall Study||847
190518|NCT01367704|461744|P1|COMPLETED|Overall Study||951
190519|NCT01367704|461743|P2|STARTED|Overall Study||1008
190520|NCT01367704|461744|P1|STARTED|Overall Study||998
190521|NCT01367665|461756|P2|NOT COMPLETED|Overall Study||55
190522|NCT01367665|461757|P1|NOT COMPLETED|Overall Study||442
190523|NCT01367665|461756|P2|COMPLETED|Overall Study||41
190524|NCT01367665|461757|P1|COMPLETED|Overall Study||677
190525|NCT01367665|461756|P2|STARTED|Overall Study||96
190526|NCT01367665|461757|P1|STARTED|Overall Study||1119
190527|NCT01367457|461788|P3|NOT COMPLETED|Overall Study||0
190528|NCT01367457|461789|P2|NOT COMPLETED|Overall Study||0
190529|NCT01367457|461790|P1|NOT COMPLETED|Overall Study||188
190530|NCT01367457|461788|P3|COMPLETED|Overall Study||26
190531|NCT01367457|461789|P2|COMPLETED|Overall Study||23
190532|NCT01367457|461790|P1|COMPLETED|Overall Study||5
190533|NCT01367457|461788|P3|STARTED|Overall Study||26
190534|NCT01367457|461789|P2|STARTED|Overall Study||23
190535|NCT01367457|461790|P1|STARTED|Overall Study||193
190536|NCT01367262|461810|P1|NOT COMPLETED|Overall Study||0
190537|NCT01367262|461810|P1|COMPLETED|Overall Study||6
190538|NCT01367262|461810|P1|STARTED|Overall Study||6
190539|NCT01367249|461823|P2|NOT COMPLETED|Overall Study||16
190540|NCT01367249|461824|P1|NOT COMPLETED|Overall Study||9
190541|NCT01367249|461823|P2|COMPLETED|Overall Study||202
190542|NCT01367249|461824|P1|COMPLETED|Overall Study||213
190543|NCT01367249|461823|P2|STARTED|Overall Study||218
190544|NCT01367249|461824|P1|STARTED|Overall Study||222
190545|NCT01367236|461834|P2|NOT COMPLETED|Overall Study||1
190546|NCT01367236|461835|P1|NOT COMPLETED|Overall Study||3
190547|NCT01367236|461834|P2|COMPLETED|Overall Study||29
190548|NCT01367236|461835|P1|COMPLETED|Overall Study||27
190549|NCT01367236|461834|P2|STARTED|Overall Study||30
190550|NCT01367236|461835|P1|STARTED|Overall Study||30
190551|NCT01367158|461854|P11|NOT COMPLETED|Overall Study||1
190552|NCT01367158|461855|P10|NOT COMPLETED|Overall Study||0
190553|NCT01367158|461856|P9|NOT COMPLETED|Overall Study||0
190554|NCT01367158|461857|P8|NOT COMPLETED|Overall Study||2
190555|NCT01367158|461858|P7|NOT COMPLETED|Overall Study||0
190556|NCT01367158|461859|P6|NOT COMPLETED|Overall Study||2
190557|NCT01367158|461860|P5|NOT COMPLETED|Overall Study||2
190558|NCT01367158|461861|P4|NOT COMPLETED|Overall Study||1
190559|NCT01367158|461862|P3|NOT COMPLETED|Overall Study||1
190560|NCT01367158|461863|P2|NOT COMPLETED|Overall Study||3
190561|NCT01367158|461864|P1|NOT COMPLETED|Overall Study||0
190562|NCT01367158|461854|P11|COMPLETED|Overall Study||72
190563|NCT01367158|461855|P10|COMPLETED|Overall Study||50
190564|NCT01367158|461856|P9|COMPLETED|Overall Study||23
190565|NCT01367158|461857|P8|COMPLETED|Overall Study||47
190566|NCT01367158|461858|P7|COMPLETED|Overall Study||25
190567|NCT01367158|461859|P6|COMPLETED|Overall Study||46
190568|NCT01367158|461860|P5|COMPLETED|Overall Study||23
190569|NCT01367158|461861|P4|COMPLETED|Overall Study||48
190570|NCT01367158|461862|P3|COMPLETED|Overall Study||23
190571|NCT01367158|461863|P2|COMPLETED|Overall Study||46
190572|NCT01367158|461864|P1|COMPLETED|Overall Study||25
190573|NCT01367158|461854|P11|STARTED|Overall Study||73
190574|NCT01367158|461855|P10|STARTED|Overall Study||50
190575|NCT01367158|461856|P9|STARTED|Overall Study||23
190576|NCT01367158|461857|P8|STARTED|Overall Study||49
190577|NCT01367158|461858|P7|STARTED|Overall Study||25
190578|NCT01367158|461859|P6|STARTED|Overall Study||48
190579|NCT01367158|461860|P5|STARTED|Overall Study||25
190580|NCT01367158|461861|P4|STARTED|Overall Study||49
190581|NCT01367158|461862|P3|STARTED|Overall Study||24
190582|NCT01367158|461863|P2|STARTED|Overall Study||49
190583|NCT01367158|461864|P1|STARTED|Overall Study||25
190584|NCT01367119|462008|P2|NOT COMPLETED|Overall Study||1
190585|NCT01367119|462009|P1|NOT COMPLETED|Overall Study||2
190586|NCT01367119|462008|P2|COMPLETED|Overall Study||16
190587|NCT01367119|462009|P1|COMPLETED|Overall Study||19
190588|NCT01367119|462008|P2|STARTED|Overall Study||17
190589|NCT01367119|462009|P1|STARTED|Overall Study||21
190590|NCT01367080|462021|P2|NOT COMPLETED|2nd Administration||0
190591|NCT01367080|462022|P1|NOT COMPLETED|2nd Administration||0
190592|NCT01367080|462021|P2|COMPLETED|2nd Administration||6
190593|NCT01367080|462022|P1|COMPLETED|2nd Administration||6
190594|NCT01367080|462021|P2|STARTED|2nd Administration||6
190595|NCT01367080|462022|P1|STARTED|2nd Administration||6
190596|NCT01367080|462021|P2|NOT COMPLETED|1st Administration||0
190597|NCT01367080|462022|P1|NOT COMPLETED|1st Administration||0
190598|NCT01367080|462021|P2|COMPLETED|1st Administration||6
190599|NCT01367080|462022|P1|COMPLETED|1st Administration||6
190600|NCT01367080|462021|P2|STARTED|1st Administration||6
190601|NCT01367080|462022|P1|STARTED|1st Administration||6
190602|NCT01366976|462036|P2|NOT COMPLETED|Overall Study||0
190603|NCT01366976|462037|P1|NOT COMPLETED|Overall Study||0
190604|NCT01366976|462036|P2|COMPLETED|Overall Study||30
190605|NCT01366976|462037|P1|COMPLETED|Overall Study||30
190606|NCT01366976|462036|P2|STARTED|Overall Study||30
190607|NCT01366976|462037|P1|STARTED|Overall Study||30
190608|NCT01366885|462049|P1|NOT COMPLETED|Overall Study||1
190609|NCT01366885|462049|P1|COMPLETED|Overall Study|We completed our study when the last child born had reached 36 months of age.|19
190610|NCT01366885|462049|P1|STARTED|Overall Study|We started recruiting in February 2008 and recruited 20 mothers.|20
190611|NCT01366872|462054|P1|NOT COMPLETED|Overall Study||0
190612|NCT01366872|462054|P1|COMPLETED|Overall Study||50
190613|NCT01366872|462054|P1|STARTED|Overall Study||50
190614|NCT01366846|462064|P4|NOT COMPLETED|Overall Study||1
190615|NCT01366846|462065|P3|NOT COMPLETED|Overall Study||1
190616|NCT01366846|462066|P2|NOT COMPLETED|Overall Study||4
190617|NCT01366846|462067|P1|NOT COMPLETED|Overall Study||3
190618|NCT01366846|462064|P4|COMPLETED|Overall Study||45
190619|NCT01366846|462065|P3|COMPLETED|Overall Study||46
190620|NCT01366846|462066|P2|COMPLETED|Overall Study||224
190621|NCT01366846|462067|P1|COMPLETED|Overall Study||232
190622|NCT01366846|462064|P4|STARTED|Overall Study||46
190623|NCT01366846|462065|P3|STARTED|Overall Study||47
190624|NCT01366846|462066|P2|STARTED|Overall Study||228
190625|NCT01366846|462067|P1|STARTED|Overall Study||235
190626|NCT01366638|462090|P3|NOT COMPLETED|Overall Study||6
190627|NCT01366638|462091|P2|NOT COMPLETED|Overall Study||0
190628|NCT01366638|462092|P1|NOT COMPLETED|Overall Study||1
190629|NCT01366638|462090|P3|COMPLETED|Overall Study||20
190630|NCT01366638|462091|P2|COMPLETED|Overall Study||29
190631|NCT01366638|462092|P1|COMPLETED|Overall Study||23
190632|NCT01366638|462090|P3|STARTED|Overall Study||26
190633|NCT01366638|462091|P2|STARTED|Overall Study||29
190634|NCT01366638|462092|P1|STARTED|Overall Study||24
190635|NCT01366534|462129|P3|NOT COMPLETED|Overall Study||0
190636|NCT01366534|462130|P2|NOT COMPLETED|Overall Study||2
190637|NCT01366534|462131|P1|NOT COMPLETED|Overall Study||2
190638|NCT01366534|462129|P3|COMPLETED|Overall Study||12
190639|NCT01366534|462130|P2|COMPLETED|Overall Study||25
190640|NCT01366534|462131|P1|COMPLETED|Overall Study||26
190641|NCT01366534|462129|P3|STARTED|Overall Study||12
190642|NCT01366534|462130|P2|STARTED|Overall Study||27
190643|NCT01366534|462131|P1|STARTED|Overall Study||28
190644|NCT01366521|462181|P4|NOT COMPLETED|Overall Study||0
190645|NCT01366521|462182|P3|NOT COMPLETED|Overall Study||2
190646|NCT01366521|462183|P2|NOT COMPLETED|Overall Study||1
190647|NCT01366521|462184|P1|NOT COMPLETED|Overall Study||1
190648|NCT01366521|462181|P4|COMPLETED|Overall Study||11
190649|NCT01366521|462182|P3|COMPLETED|Overall Study||21
190650|NCT01366521|462183|P2|COMPLETED|Overall Study||14
190651|NCT01366521|462184|P1|COMPLETED|Overall Study||20
190652|NCT01366521|462181|P4|STARTED|Overall Study||11
190653|NCT01366521|462182|P3|STARTED|Overall Study||23
190654|NCT01366521|462183|P2|STARTED|Overall Study||15
190655|NCT01366521|462184|P1|STARTED|Overall Study||21
190656|NCT01366495|462263|P4|NOT COMPLETED|HIV Study||0
190657|NCT01366495|462264|P3|NOT COMPLETED|HIV Study||0
190658|NCT01366495|462265|P2|NOT COMPLETED|HIV Study||0
190659|NCT01366495|462266|P1|NOT COMPLETED|HIV Study||1
190660|NCT01366495|462263|P4|COMPLETED|HIV Study||0
190661|NCT01366495|462264|P3|COMPLETED|HIV Study||0
190662|NCT01366495|462265|P2|COMPLETED|HIV Study||50
190663|NCT01366495|462266|P1|COMPLETED|HIV Study||49
190664|NCT01366495|462263|P4|STARTED|HIV Study||0
190665|NCT01366495|462264|P3|STARTED|HIV Study||0
190666|NCT01366495|462265|P2|STARTED|HIV Study||50
190667|NCT01366495|462266|P1|STARTED|HIV Study||50
190668|NCT01366495|462263|P4|NOT COMPLETED|Testing Study||0
190669|NCT01366495|462264|P3|NOT COMPLETED|Testing Study||0
190670|NCT01366495|462265|P2|NOT COMPLETED|Testing Study||0
190671|NCT01366495|462266|P1|NOT COMPLETED|Testing Study||0
190672|NCT01366495|462263|P4|COMPLETED|Testing Study||348
190673|NCT01366495|462264|P3|COMPLETED|Testing Study||349
190674|NCT01366495|462265|P2|COMPLETED|Testing Study||0
190675|NCT01366495|462266|P1|COMPLETED|Testing Study||0
190676|NCT01366495|462263|P4|STARTED|Testing Study||348
190677|NCT01366495|462264|P3|STARTED|Testing Study||349
190678|NCT01366495|462265|P2|STARTED|Testing Study||0
190679|NCT01366495|462266|P1|STARTED|Testing Study||0
190680|NCT01366443|462280|P1|NOT COMPLETED|Overall Study||3
190681|NCT01366443|462280|P1|COMPLETED|Overall Study||285
190682|NCT01366443|462280|P1|STARTED|Overall Study||288
190683|NCT01366417|462285|P1|NOT COMPLETED|Overall Study||18
190684|NCT01366417|462285|P1|COMPLETED|Overall Study|25 subjects included in the analysis|25
190685|NCT01366417|462285|P1|Excluded From Analysis|Overall Study|3 subjects did not have qualifying Treatment Day microbial counts and were excluded from analysis|3
190686|NCT01366417|462285|P1|Discontinued Prior to Treatment|Overall Study|5 eligible subjects were not treated because enrollment target of 25 was met and enrollment closed.|5
190687|NCT01366417|462285|P1|Completed the Study|Overall Study|treatment baseline microbial counts not available until after treatment; subjects not evaluable|28
190688|NCT01366417|462285|P1|Completed Treatment Visit|Overall Study|28 subjects were treated with ChloraPrep and 70% Isopropyl Alcohol (single topical treatment)|28
190689|NCT01366417|462285|P1|Completed Screen Visit|Overall Study|33 subjects had qualifying screening bacterial counts and were eligible for the Treatment Visit|33
190690|NCT01366417|462285|P1|Signed Informed Consent|Overall Study|Microbial samples were taken from 43 subjects for screening baseline.|43
190691|NCT01366417|462285|P1|STARTED|Overall Study||43
190692|NCT01366209|462294|P2|NOT COMPLETED|Overall Study||36
190693|NCT01366209|462295|P1|NOT COMPLETED|Overall Study||35
190694|NCT01366209|462294|P2|COMPLETED|Overall Study||241
190695|NCT01366209|462295|P1|COMPLETED|Overall Study|Participants completing study assessment at Week 52 were completers, even if treatment was withdrawn|243
190696|NCT01366209|462294|P2|STARTED|Overall Study||277
190697|NCT01366209|462295|P1|STARTED|Overall Study||278
190698|NCT01366196|462303|P2|NOT COMPLETED|Overall Study||0
190699|NCT01366196|462304|P1|NOT COMPLETED|Overall Study||0
190700|NCT01366196|462303|P2|COMPLETED|Overall Study||43
190701|NCT01366196|462304|P1|COMPLETED|Overall Study||43
190702|NCT01366196|462303|P2|STARTED|Overall Study||43
190703|NCT01366196|462304|P1|STARTED|Overall Study||43
190704|NCT01366092|462318|P1|NOT COMPLETED|Overall Study||4
190705|NCT01366092|462318|P1|COMPLETED|Overall Study||31
190706|NCT01366092|462318|P1|STARTED|Overall Study||35
190707|NCT01365910|462327|P1|NOT COMPLETED|Overall Study||30
190708|NCT01365910|462327|P1|COMPLETED|Overall Study||0
190709|NCT01365910|462327|P1|STARTED|Overall Study||30
190710|NCT01365845|462334|P3|NOT COMPLETED|Treatment Phase||0
190711|NCT01365845|462335|P2|NOT COMPLETED|Treatment Phase||0
190712|NCT01365845|462336|P1|NOT COMPLETED|Treatment Phase||0
190713|NCT01365845|462334|P3|COMPLETED|Treatment Phase||18
190714|NCT01365845|462335|P2|COMPLETED|Treatment Phase||0
190715|NCT01365845|462336|P1|COMPLETED|Treatment Phase||0
190716|NCT01365845|462334|P3|STARTED|Treatment Phase||18
190717|NCT01365845|462335|P2|STARTED|Treatment Phase||0
190718|NCT01365845|462336|P1|STARTED|Treatment Phase||0
190719|NCT01365845|462334|P3|NOT COMPLETED|Induction Phase||0
190720|NCT01365845|462335|P2|NOT COMPLETED|Induction Phase||0
190721|NCT01365845|462336|P1|NOT COMPLETED|Induction Phase||0
190722|NCT01365845|462334|P3|COMPLETED|Induction Phase||0
190723|NCT01365845|462335|P2|COMPLETED|Induction Phase||0
190724|NCT01365845|462336|P1|COMPLETED|Induction Phase||18
190725|NCT01365845|462334|P3|STARTED|Induction Phase||0
190726|NCT01365845|462335|P2|STARTED|Induction Phase||0
190727|NCT01365845|462336|P1|STARTED|Induction Phase||18
190728|NCT01365819|462343|P2|NOT COMPLETED|Overall Study||13
190729|NCT01365819|462344|P1|NOT COMPLETED|Overall Study||13
190730|NCT01365819|462343|P2|COMPLETED|Overall Study||14
190731|NCT01365819|462344|P1|COMPLETED|Overall Study||12
190732|NCT01365819|462343|P2|STARTED|Overall Study||27
190733|NCT01365819|462344|P1|STARTED|Overall Study||25
190734|NCT01365793|462362|P4|NOT COMPLETED|Overall Study||2
190735|NCT01365793|462363|P3|NOT COMPLETED|Overall Study||7
190736|NCT01365793|462364|P2|NOT COMPLETED|Overall Study||7
190737|NCT01365793|462365|P1|NOT COMPLETED|Overall Study||2
190738|NCT01365793|462362|P4|COMPLETED|Overall Study||347
190739|NCT01365793|462363|P3|COMPLETED|Overall Study||338
190740|NCT01365793|462364|P2|COMPLETED|Overall Study||344
190741|NCT01365793|462365|P1|COMPLETED|Overall Study||342
190742|NCT01365793|462362|P4|STARTED|Overall Study||349
190743|NCT01365793|462363|P3|STARTED|Overall Study||345
190744|NCT01365793|462364|P2|STARTED|Overall Study||351
190745|NCT01365793|462365|P1|STARTED|Overall Study||344
190746|NCT01365650|462391|P1|NOT COMPLETED|Treatment C||0
190747|NCT01365650|462391|P1|COMPLETED|Treatment C||24
190748|NCT01365650|462391|P1|STARTED|Treatment C||24
190749|NCT01365650|462391|P1|NOT COMPLETED|Treatment B||0
190750|NCT01365650|462391|P1|COMPLETED|Treatment B||24
190751|NCT01365650|462391|P1|STARTED|Treatment B||24
190752|NCT01365650|462391|P1|NOT COMPLETED|Treatment A||0
190753|NCT01365650|462391|P1|COMPLETED|Treatment A||24
190754|NCT01365650|462391|P1|STARTED|Treatment A||24
190755|NCT01365624|462416|P2|NOT COMPLETED|Overall Study||0
190756|NCT01365624|462417|P1|NOT COMPLETED|Overall Study||0
190757|NCT01365624|462416|P2|COMPLETED|Overall Study||15
190758|NCT01365624|462417|P1|COMPLETED|Overall Study||15
190759|NCT01365624|462416|P2|STARTED|Overall Study||15
190760|NCT01365624|462417|P1|STARTED|Overall Study||15
190761|NCT01365611|462433|P1|NOT COMPLETED|Overall Study||0
190762|NCT01365611|462433|P1|COMPLETED|Overall Study||36
190763|NCT01365611|462433|P1|STARTED|Overall Study||36
190764|NCT01365585|462449|P1|NOT COMPLETED|Overall Study||0
190765|NCT01365585|462449|P1|COMPLETED|Overall Study||227
190766|NCT01365585|462449|P1|STARTED|Overall Study||227
190767|NCT01365546|462463|P1|NOT COMPLETED|Overall Study||11
190768|NCT01365546|462463|P1|COMPLETED|Overall Study||30
190769|NCT01365546|462463|P1|STARTED|Overall Study|in this study 41 patients were screened but only 30 patients completed the study.|41
190770|NCT01365507|462473|P2|NOT COMPLETED|Overall Study||9
190771|NCT01365507|462474|P1|NOT COMPLETED|Overall Study||9
190772|NCT01365507|462473|P2|COMPLETED|Overall Study||131
190773|NCT01365507|462474|P1|COMPLETED|Overall Study||127
190774|NCT01365507|462473|P2|Exposed|Overall Study||140
190775|NCT01365507|462474|P1|Exposed|Overall Study|Two subjects withdrew before exposure to trial drug|134
190776|NCT01365507|462473|P2|STARTED|Overall Study||140
190777|NCT01365507|462474|P1|STARTED|Overall Study||136
190778|NCT01365494|462490|P2|NOT COMPLETED|Overall Study||3
190779|NCT01365494|462491|P1|NOT COMPLETED|Overall Study||2
190780|NCT01365494|462490|P2|COMPLETED|Overall Study||121
190781|NCT01365494|462491|P1|COMPLETED|Overall Study||124
190782|NCT01365494|462490|P2|STARTED|Overall Study||124
190783|NCT01365494|462491|P1|STARTED|Overall Study||126
190784|NCT01365481|462507|P4|NOT COMPLETED|Overall Study||7
190785|NCT01365481|462508|P3|NOT COMPLETED|Overall Study||4
190786|NCT01365481|462509|P2|NOT COMPLETED|Overall Study||15
190787|NCT01365481|462510|P1|NOT COMPLETED|Overall Study||7
190788|NCT01365481|462507|P4|COMPLETED|Overall Study||50
190789|NCT01365481|462508|P3|COMPLETED|Overall Study||14
190790|NCT01365481|462509|P2|COMPLETED|Overall Study||37
190791|NCT01365481|462510|P1|COMPLETED|Overall Study||16
190792|NCT01365481|462507|P4|STARTED|Overall Study||57
190793|NCT01365481|462508|P3|STARTED|Overall Study||18
190794|NCT01365481|462509|P2|STARTED|Overall Study||52
190795|NCT01365481|462510|P1|STARTED|Overall Study||23
190796|NCT01365468|462530|P2|NOT COMPLETED|Overall Study||0
190797|NCT01365468|462531|P1|NOT COMPLETED|Overall Study||4
190798|NCT01365468|462530|P2|COMPLETED|Overall Study||5
190799|NCT01365468|462531|P1|COMPLETED|Overall Study||0
190800|NCT01365468|462530|P2|STARTED|Overall Study||5
190801|NCT01365468|462531|P1|STARTED|Overall Study||4
190802|NCT01365455|462546|P5|NOT COMPLETED|Follow-up Period||0
190803|NCT01365455|462547|P4|NOT COMPLETED|Follow-up Period||0
190804|NCT01365455|462548|P3|NOT COMPLETED|Follow-up Period||0
190805|NCT01365455|462549|P2|NOT COMPLETED|Follow-up Period||0
190806|NCT01365455|462550|P1|NOT COMPLETED|Follow-up Period||0
190807|NCT01365455|462546|P5|COMPLETED|Follow-up Period||0
190808|NCT01365455|462547|P4|COMPLETED|Follow-up Period||0
190809|NCT01365455|462548|P3|COMPLETED|Follow-up Period||18
190810|NCT01365455|462549|P2|COMPLETED|Follow-up Period||47
190811|NCT01365455|462550|P1|COMPLETED|Follow-up Period||58
190812|NCT01365455|462546|P5|STARTED|Follow-up Period||0
190813|NCT01365455|462547|P4|STARTED|Follow-up Period||0
190814|NCT01365455|462548|P3|STARTED|Follow-up Period||18
190815|NCT01365455|462549|P2|STARTED|Follow-up Period||47
190816|NCT01365455|462550|P1|STARTED|Follow-up Period||58
190817|NCT01365455|462546|P5|NOT COMPLETED|Maintenance Period||13
190818|NCT01365455|462547|P4|NOT COMPLETED|Maintenance Period||9
190819|NCT01365455|462548|P3|NOT COMPLETED|Maintenance Period||3
190820|NCT01365455|462549|P2|NOT COMPLETED|Maintenance Period||23
190821|NCT01365455|462550|P1|NOT COMPLETED|Maintenance Period||29
190822|NCT01365455|462546|P5|COMPLETED|Maintenance Period||92
190823|NCT01365455|462547|P4|COMPLETED|Maintenance Period||100
190824|NCT01365455|462548|P3|COMPLETED|Maintenance Period||15
190825|NCT01365455|462549|P2|COMPLETED|Maintenance Period||215
190826|NCT01365455|462550|P1|COMPLETED|Maintenance Period||201
190827|NCT01365455|462546|P5|STARTED|Maintenance Period||105
190828|NCT01365455|462547|P4|STARTED|Maintenance Period||109
190829|NCT01365455|462548|P3|STARTED|Maintenance Period||18
190830|NCT01365455|462549|P2|STARTED|Maintenance Period||238
190831|NCT01365455|462550|P1|STARTED|Maintenance Period||230
190832|NCT01365455|462546|P5|NOT COMPLETED|Induction Period||0
190833|NCT01365455|462547|P4|NOT COMPLETED|Induction Period||0
190834|NCT01365455|462548|P3|NOT COMPLETED|Induction Period||16
190835|NCT01365455|462549|P2|NOT COMPLETED|Induction Period||7
190836|NCT01365455|462550|P1|NOT COMPLETED|Induction Period||15
190837|NCT01365455|462546|P5|COMPLETED|Induction Period||0
190838|NCT01365455|462547|P4|COMPLETED|Induction Period||0
190839|NCT01365455|462548|P3|COMPLETED|Induction Period||232
190840|NCT01365455|462549|P2|COMPLETED|Induction Period||238
190841|NCT01365455|462550|P1|COMPLETED|Induction Period||230
190842|NCT01365455|462546|P5|STARTED|Induction Period||0
190843|NCT01365455|462547|P4|STARTED|Induction Period||0
190844|NCT01365455|462548|P3|STARTED|Induction Period||248
190845|NCT01365455|462549|P2|STARTED|Induction Period||245
190846|NCT01365455|462550|P1|STARTED|Induction Period||245
190847|NCT01365273|462640|P2|NOT COMPLETED|Overall Study||1
190848|NCT01365273|462641|P1|NOT COMPLETED|Overall Study||2
190849|NCT01365273|462640|P2|COMPLETED|Overall Study||20
190850|NCT01365273|462641|P1|COMPLETED|Overall Study||20
190851|NCT01365273|462640|P2|Compl. Pts, Not Evaluable for Pain.|Overall Study||4
190852|NCT01365273|462641|P1|Compl. Pts, Not Evaluable for Pain.|Overall Study||2
190853|NCT01365273|462640|P2|STARTED|Overall Study||21
190854|NCT01365273|462641|P1|STARTED|Overall Study||22
190855|NCT01365130|462651|P1|NOT COMPLETED|Overall Study||2
190856|NCT01365130|462651|P1|COMPLETED|Overall Study||13
190857|NCT01365130|462651|P1|STARTED|Overall Study|15 patients were enrolled to the study but only 13 went on to begin treatment|15
190858|NCT01365091|462660|P4|NOT COMPLETED|Period 2||0
190859|NCT01365091|462661|P3|NOT COMPLETED|Period 2||1
190860|NCT01365091|462662|P2|NOT COMPLETED|Period 2||0
190861|NCT01365091|462663|P1|NOT COMPLETED|Period 2||1
190862|NCT01365091|462660|P4|COMPLETED|Period 2||25
190863|NCT01365091|462661|P3|COMPLETED|Period 2||24
190864|NCT01365091|462662|P2|COMPLETED|Period 2||26
190865|NCT01365091|462663|P1|COMPLETED|Period 2||25
190866|NCT01365091|462660|P4|STARTED|Period 2||25
190867|NCT01365091|462661|P3|STARTED|Period 2||25
190868|NCT01365091|462662|P2|STARTED|Period 2||26
190869|NCT01365091|462663|P1|STARTED|Period 2||26
190870|NCT01365091|462660|P4|NOT COMPLETED|Period 1||3
190871|NCT01365091|462661|P3|NOT COMPLETED|Period 1||3
190872|NCT01365091|462662|P2|NOT COMPLETED|Period 1||2
190873|NCT01365091|462663|P1|NOT COMPLETED|Period 1||2
190874|NCT01365091|462660|P4|COMPLETED|Period 1||25
190875|NCT01365091|462661|P3|COMPLETED|Period 1||25
190876|NCT01365091|462662|P2|COMPLETED|Period 1||26
190877|NCT01365091|462663|P1|COMPLETED|Period 1||26
190878|NCT01365091|462660|P4|STARTED|Period 1||28
190879|NCT01365091|462661|P3|STARTED|Period 1||28
190880|NCT01365091|462662|P2|STARTED|Period 1||28
190881|NCT01365091|462663|P1|STARTED|Period 1||28
190882|NCT01365052|462691|P2|NOT COMPLETED|Overall Study||4
190883|NCT01365052|462692|P1|NOT COMPLETED|Overall Study||4
190884|NCT01365052|462691|P2|COMPLETED|Overall Study||105
190885|NCT01365052|462692|P1|COMPLETED|Overall Study||213
190886|NCT01365052|462691|P2|STARTED|Overall Study||109
190887|NCT01365052|462692|P1|STARTED|Overall Study||217
190888|NCT01365039|462708|P2|NOT COMPLETED|Overall Study||0
190889|NCT01365039|462709|P1|NOT COMPLETED|Overall Study||1
190890|NCT01365039|462708|P2|COMPLETED|Overall Study||87
190891|NCT01365039|462709|P1|COMPLETED|Overall Study||85
190892|NCT01365039|462708|P2|STARTED|Overall Study||87
190893|NCT01365039|462709|P1|STARTED|Overall Study||86
190894|NCT01364922|462720|P3|NOT COMPLETED|Double-Blind (DB) Period||5
190895|NCT01364922|462721|P2|NOT COMPLETED|Double-Blind (DB) Period||5
190896|NCT01364922|462722|P1|NOT COMPLETED|Double-Blind (DB) Period||0
190897|NCT01364922|462720|P3|COMPLETED|Double-Blind (DB) Period||42
190898|NCT01364922|462721|P2|COMPLETED|Double-Blind (DB) Period||94
190899|NCT01364922|462722|P1|COMPLETED|Double-Blind (DB) Period||0
190900|NCT01364922|462720|P3|STARTED|Double-Blind (DB) Period||47
190901|NCT01364922|462721|P2|STARTED|Double-Blind (DB) Period||99
190902|NCT01364922|462722|P1|STARTED|Double-Blind (DB) Period||0
190903|NCT01364922|462720|P3|NOT COMPLETED|Open-label (OL) Period||0
190904|NCT01364922|462721|P2|NOT COMPLETED|Open-label (OL) Period||0
190905|NCT01364922|462722|P1|NOT COMPLETED|Open-label (OL) Period||22
190906|NCT01364922|462720|P3|COMPLETED|Open-label (OL) Period||0
190907|NCT01364922|462721|P2|COMPLETED|Open-label (OL) Period||0
190908|NCT01364922|462722|P1|COMPLETED|Open-label (OL) Period||146
190909|NCT01364922|462720|P3|STARTED|Open-label (OL) Period||0
190910|NCT01364922|462721|P2|STARTED|Open-label (OL) Period||0
190911|NCT01364922|462722|P1|STARTED|Open-label (OL) Period||168
190912|NCT01364896|462733|P1|NOT COMPLETED|Overall Study||0
190913|NCT01364896|462733|P1|COMPLETED|Overall Study||46
190914|NCT01364896|462733|P1|STARTED|Overall Study||46
190915|NCT01364870|462744|P3|NOT COMPLETED|Overall Study||14
190916|NCT01364870|462745|P2|NOT COMPLETED|Overall Study||30
190917|NCT01364870|462746|P1|NOT COMPLETED|Overall Study||22
190918|NCT01364870|462744|P3|COMPLETED|Overall Study||58
190919|NCT01364870|462745|P2|COMPLETED|Overall Study||93
190920|NCT01364870|462746|P1|COMPLETED|Overall Study||100
190921|NCT01364870|462744|P3|STARTED|Overall Study||72
190922|NCT01364870|462745|P2|STARTED|Overall Study||123
190923|NCT01364870|462746|P1|STARTED|Overall Study||122
190924|NCT01364740|462757|P1|NOT COMPLETED|Overall Study||0
190925|NCT01364740|462757|P1|COMPLETED|Overall Study||10
190926|NCT01364740|462757|P1|STARTED|Overall Study||10
190927|NCT01364727|462765|P1|NOT COMPLETED|Overall Study||2
190928|NCT01364727|462765|P1|COMPLETED|Overall Study||33
190929|NCT01364727|462765|P1|STARTED|Overall Study||35
190930|NCT01364649|462773|P2|NOT COMPLETED|Overall Study||43
190931|NCT01364649|462774|P1|NOT COMPLETED|Overall Study||56
190932|NCT01364649|462773|P2|COMPLETED|Overall Study||179
190933|NCT01364649|462774|P1|COMPLETED|Overall Study||169
190934|NCT01364649|462773|P2|STARTED|Overall Study||222
190935|NCT01364649|462774|P1|STARTED|Overall Study||225
190936|NCT01364623|462787|P4|NOT COMPLETED|Multiple Dose||0
190937|NCT01364623|462788|P3|NOT COMPLETED|Multiple Dose||0
190938|NCT01364623|462789|P2|NOT COMPLETED|Multiple Dose||0
190939|NCT01364623|462790|P1|NOT COMPLETED|Multiple Dose||0
190940|NCT01364623|462787|P4|COMPLETED|Multiple Dose||8
190941|NCT01364623|462788|P3|COMPLETED|Multiple Dose||0
190942|NCT01364623|462789|P2|COMPLETED|Multiple Dose||0
190943|NCT01364623|462790|P1|COMPLETED|Multiple Dose||0
190944|NCT01364623|462787|P4|STARTED|Multiple Dose||8
190945|NCT01364623|462788|P3|STARTED|Multiple Dose||0
190946|NCT01364623|462789|P2|STARTED|Multiple Dose||0
190947|NCT01364623|462790|P1|STARTED|Multiple Dose||0
190948|NCT01364623|462787|P4|NOT COMPLETED|Single Dose||0
190949|NCT01364623|462788|P3|NOT COMPLETED|Single Dose||0
190950|NCT01364623|462789|P2|NOT COMPLETED|Single Dose||0
190951|NCT01364623|462790|P1|NOT COMPLETED|Single Dose||0
190952|NCT01364623|462787|P4|COMPLETED|Single Dose||0
190953|NCT01364623|462788|P3|COMPLETED|Single Dose||8
190954|NCT01364623|462789|P2|COMPLETED|Single Dose||8
190955|NCT01364623|462790|P1|COMPLETED|Single Dose||8
190956|NCT01364623|462787|P4|STARTED|Single Dose||0
190957|NCT01364623|462788|P3|STARTED|Single Dose||8
190958|NCT01364623|462789|P2|STARTED|Single Dose||8
190959|NCT01364623|462790|P1|STARTED|Single Dose||8
190960|NCT01364584|462815|P2|NOT COMPLETED|Overall Study||0
190961|NCT01364584|462816|P1|NOT COMPLETED|Overall Study||0
190962|NCT01364584|462815|P2|COMPLETED|Overall Study||12
190963|NCT01364584|462816|P1|COMPLETED|Overall Study||11
190964|NCT01364584|462815|P2|STARTED|Overall Study||12
190965|NCT01364584|462816|P1|STARTED|Overall Study||11
190966|NCT01364558|462850|P3|NOT COMPLETED|Dose Three||0
190967|NCT01364558|462851|P2|NOT COMPLETED|Dose Three||0
190968|NCT01364558|462852|P1|NOT COMPLETED|Dose Three||0
190969|NCT01364558|462850|P3|COMPLETED|Dose Three||8
190970|NCT01364558|462851|P2|COMPLETED|Dose Three||8
190971|NCT01364558|462852|P1|COMPLETED|Dose Three||8
190972|NCT01364558|462850|P3|STARTED|Dose Three||8
190973|NCT01364558|462851|P2|STARTED|Dose Three||8
190974|NCT01364558|462852|P1|STARTED|Dose Three||8
190975|NCT01364558|462850|P3|NOT COMPLETED|Dose Two||0
190976|NCT01364558|462851|P2|NOT COMPLETED|Dose Two||0
190977|NCT01364558|462852|P1|NOT COMPLETED|Dose Two||0
190978|NCT01364558|462850|P3|COMPLETED|Dose Two||8
190979|NCT01364558|462851|P2|COMPLETED|Dose Two||8
190980|NCT01364558|462852|P1|COMPLETED|Dose Two||8
190981|NCT01364558|462850|P3|STARTED|Dose Two||8
190982|NCT01364558|462851|P2|STARTED|Dose Two||8
190983|NCT01364558|462852|P1|STARTED|Dose Two||8
190984|NCT01364558|462850|P3|NOT COMPLETED|Dose One||0
190985|NCT01364558|462851|P2|NOT COMPLETED|Dose One||0
190986|NCT01364558|462852|P1|NOT COMPLETED|Dose One||0
190987|NCT01364558|462850|P3|COMPLETED|Dose One||8
190988|NCT01364558|462851|P2|COMPLETED|Dose One||8
190989|NCT01364558|462852|P1|COMPLETED|Dose One||8
190990|NCT01364558|462850|P3|STARTED|Dose One||8
190991|NCT01364558|462851|P2|STARTED|Dose One||8
190992|NCT01364558|462852|P1|STARTED|Dose One||8
190993|NCT01364428|462862|P2|NOT COMPLETED|Overall Study||15
190994|NCT01364428|462863|P1|NOT COMPLETED|Overall Study||20
190995|NCT01364428|462862|P2|COMPLETED|Overall Study||172
190996|NCT01364428|462863|P1|COMPLETED|Overall Study||166
190997|NCT01364428|462862|P2|Exposed|Overall Study||187
190998|NCT01364428|462863|P1|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|184
190999|NCT01364428|462862|P2|STARTED|Overall Study||187
191000|NCT01364428|462863|P1|STARTED|Overall Study||186
191001|NCT01364389|462880|P3|NOT COMPLETED|Overall Study||1
191002|NCT01364389|462881|P2|NOT COMPLETED|Overall Study||1
191003|NCT01364389|462882|P1|NOT COMPLETED|Overall Study||2
191004|NCT01364389|462880|P3|COMPLETED|Overall Study||4
191005|NCT01364389|462881|P2|COMPLETED|Overall Study||5
191006|NCT01364389|462882|P1|COMPLETED|Overall Study||3
191007|NCT01364389|462880|P3|Pharmacodynamic (PD) Analysis Set|Overall Study|One patient excluded: did not receive study drug; received placebo caps. and infusion only in error.|4
191008|NCT01364389|462881|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||6
191009|NCT01364389|462882|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||5
191010|NCT01364389|462880|P3|STARTED|Overall Study||5
191011|NCT01364389|462881|P2|STARTED|Overall Study||6
191012|NCT01364389|462882|P1|STARTED|Overall Study||5
191013|NCT01364298|462901|P2|NOT COMPLETED|Overall Study||23
191014|NCT01364298|462902|P1|NOT COMPLETED|Overall Study||14
191015|NCT01364298|462901|P2|COMPLETED|Overall Study||154
191016|NCT01364298|462902|P1|COMPLETED|Overall Study||162
191017|NCT01364298|462901|P2|Treated|Overall Study||174
191018|NCT01364298|462902|P1|Treated|Overall Study||174
191019|NCT01364298|462901|P2|STARTED|Overall Study||177
191020|NCT01364298|462902|P1|STARTED|Overall Study||176
191021|NCT01364259|462926|P2|NOT COMPLETED|Overall Study||0
191022|NCT01364259|462927|P1|NOT COMPLETED|Overall Study||0
191023|NCT01364259|462926|P2|COMPLETED|Overall Study||8
191024|NCT01364259|462927|P1|COMPLETED|Overall Study||9
191025|NCT01364259|462926|P2|STARTED|Overall Study||8
191026|NCT01364259|462927|P1|STARTED|Overall Study||9
191027|NCT01364233|462935|P1|NOT COMPLETED|Overall Study||1
191028|NCT01364233|462935|P1|COMPLETED|Overall Study||9
191029|NCT01364233|462935|P1|STARTED|Overall Study||10
191030|NCT01364207|462939|P2|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
191031|NCT01364207|462940|P1|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
191032|NCT01364207|462939|P2|COMPLETED|Second Visit (~1.5-2 Hours)||54
191033|NCT01364207|462940|P1|COMPLETED|Second Visit (~1.5-2 Hours)||52
191034|NCT01364207|462939|P2|STARTED|Second Visit (~1.5-2 Hours)||54
191035|NCT01364207|462940|P1|STARTED|Second Visit (~1.5-2 Hours)||52
191036|NCT01364207|462939|P2|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||4
191037|NCT01364207|462940|P1|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||2
191038|NCT01364207|462939|P2|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||54
191039|NCT01364207|462940|P1|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||52
191040|NCT01364207|462939|P2|STARTED|Time Between Visits (2 Days to 4 Weeks)||58
191041|NCT01364207|462940|P1|STARTED|Time Between Visits (2 Days to 4 Weeks)||54
191042|NCT01364207|462939|P2|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
191043|NCT01364207|462940|P1|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
191044|NCT01364207|462939|P2|COMPLETED|First Visit (~1.5-2 Hours)||58
191045|NCT01364207|462940|P1|COMPLETED|First Visit (~1.5-2 Hours)||54
191046|NCT01364207|462939|P2|STARTED|First Visit (~1.5-2 Hours)||58
191047|NCT01364207|462940|P1|STARTED|First Visit (~1.5-2 Hours)||54
191048|NCT01364090|462951|P3|NOT COMPLETED|Overall Study||6
191049|NCT01364090|462952|P2|NOT COMPLETED|Overall Study||14
191050|NCT01364090|462953|P1|NOT COMPLETED|Overall Study||3
191051|NCT01364090|462951|P3|COMPLETED|Overall Study||0
191052|NCT01364090|462952|P2|COMPLETED|Overall Study||12
191053|NCT01364090|462953|P1|COMPLETED|Overall Study||58
191054|NCT01364090|462951|P3|STARTED|Overall Study||6
191055|NCT01364090|462952|P2|STARTED|Overall Study||26
191056|NCT01364090|462953|P1|STARTED|Overall Study||61
191057|NCT01363986|462961|P1|NOT COMPLETED|Overall Study||1
191058|NCT01363986|462961|P1|COMPLETED|Overall Study||2
191059|NCT01363986|462961|P1|STARTED|Overall Study||3
191060|NCT01363908|462971|P2|NOT COMPLETED|Chronic Dosing (CD) Phase||6
191061|NCT01363908|462972|P1|NOT COMPLETED|Chronic Dosing (CD) Phase||10
191062|NCT01363908|462971|P2|COMPLETED|Chronic Dosing (CD) Phase||10
191063|NCT01363908|462972|P1|COMPLETED|Chronic Dosing (CD) Phase||3
191064|NCT01363908|462971|P2|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|16
191065|NCT01363908|462972|P1|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|13
191066|NCT01363908|462971|P2|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
191067|NCT01363908|462972|P1|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
191068|NCT01363908|462971|P2|COMPLETED|Pharmacokinetic (PK) Phase||8
191069|NCT01363908|462972|P1|COMPLETED|Pharmacokinetic (PK) Phase||8
191070|NCT01363908|462971|P2|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
191071|NCT01363908|462972|P1|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
191072|NCT01363908|462971|P2|NOT COMPLETED|Screening/Enrollment||0
191073|NCT01363908|462972|P1|NOT COMPLETED|Screening/Enrollment||1
191074|NCT01363908|462971|P2|COMPLETED|Screening/Enrollment||16
191075|NCT01363908|462972|P1|COMPLETED|Screening/Enrollment|One participant did not receive investigational product.|13
191076|NCT01363908|462971|P2|STARTED|Screening/Enrollment||16
191077|NCT01363908|462972|P1|STARTED|Screening/Enrollment||14
191078|NCT01363843|463002|P1|NOT COMPLETED|Overall Study||1
191079|NCT01363843|463002|P1|COMPLETED|Overall Study|39 enrolled, 36 completed 8 cycles of mFOLFOX6, 35 completed chemo-radiation, 38 underwent surgery.|38
191080|NCT01363843|463002|P1|STARTED|Overall Study||39
191081|NCT01363765|463009|P2|NOT COMPLETED|Overall Study||4731
191082|NCT01363765|463010|P1|NOT COMPLETED|Overall Study||5800
191083|NCT01363765|463009|P2|COMPLETED|Overall Study|Samples contributing to observation arm. Excluded were duplicates, non-residents, missing age.|11705
191084|NCT01363765|463010|P1|COMPLETED|Overall Study|Excluded were duplicates, non-residents, missing age, unavailability of system (smears done instead)|12522
191085|NCT01363765|463009|P2|STARTED|Overall Study|This is number of participants enrolled, each with one sample considered in baseline arm.|16436
191086|NCT01363765|463010|P1|STARTED|Overall Study|This is number of participants enrolled, each with one sample submitted to Xpert in intervention arm|18322
191087|NCT01363713|463022|P1|NOT COMPLETED|Overall Study||6
191088|NCT01363713|463022|P1|COMPLETED|Overall Study|Analysed (n=130)|124
191089|NCT01363713|463022|P1|ALLOCATED|Overall Study||130
191090|NCT01363713|463022|P1|STARTED|Overall Study|Assessed for eligibility|130
191091|NCT01363700|463031|P5|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
191092|NCT01363700|463032|P4|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
191093|NCT01363700|463033|P3|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
191094|NCT01363700|463034|P2|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
191095|NCT01363700|463035|P1|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
191096|NCT01363700|463031|P5|COMPLETED|Epinastine vs Olopatadine Period2||43
191097|NCT01363700|463032|P4|COMPLETED|Epinastine vs Olopatadine Period2||43
191098|NCT01363700|463033|P3|COMPLETED|Epinastine vs Olopatadine Period2||0
191099|NCT01363700|463034|P2|COMPLETED|Epinastine vs Olopatadine Period2||0
191100|NCT01363700|463035|P1|COMPLETED|Epinastine vs Olopatadine Period2||0
191101|NCT01363700|463031|P5|STARTED|Epinastine vs Olopatadine Period2||43
191102|NCT01363700|463032|P4|STARTED|Epinastine vs Olopatadine Period2||43
191103|NCT01363700|463033|P3|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
191104|NCT01363700|463034|P2|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
191105|NCT01363700|463035|P1|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
191106|NCT01363700|463031|P5|NOT COMPLETED|Epinastine vs Placebo Period1||0
191107|NCT01363700|463032|P4|NOT COMPLETED|Epinastine vs Placebo Period1||0
191108|NCT01363700|463033|P3|NOT COMPLETED|Epinastine vs Placebo Period1||0
191109|NCT01363700|463034|P2|NOT COMPLETED|Epinastine vs Placebo Period1||1
191110|NCT01363700|463035|P1|NOT COMPLETED|Epinastine vs Placebo Period1||0
191111|NCT01363700|463031|P5|COMPLETED|Epinastine vs Placebo Period1||0
191112|NCT01363700|463032|P4|COMPLETED|Epinastine vs Placebo Period1||0
191113|NCT01363700|463033|P3|COMPLETED|Epinastine vs Placebo Period1||22
191114|NCT01363700|463034|P2|COMPLETED|Epinastine vs Placebo Period1||21
191115|NCT01363700|463035|P1|COMPLETED|Epinastine vs Placebo Period1||43
191116|NCT01363700|463031|P5|STARTED|Epinastine vs Placebo Period1|No Allocation|0
191117|NCT01363700|463032|P4|STARTED|Epinastine vs Placebo Period1|No Allocation|0
191118|NCT01363700|463033|P3|STARTED|Epinastine vs Placebo Period1||22
191119|NCT01363700|463034|P2|STARTED|Epinastine vs Placebo Period1||22
191120|NCT01363700|463035|P1|STARTED|Epinastine vs Placebo Period1||43
191121|NCT01363661|463054|P2|NOT COMPLETED|Overall Study||4
191122|NCT01363661|463055|P1|NOT COMPLETED|Overall Study||14
191123|NCT01363661|463054|P2|COMPLETED|Overall Study||28
191124|NCT01363661|463055|P1|COMPLETED|Overall Study||18
191125|NCT01363661|463054|P2|STARTED|Overall Study||32
191126|NCT01363661|463055|P1|STARTED|Overall Study||32
191127|NCT01363492|463071|P1|NOT COMPLETED|Overall Study||0
191128|NCT01363492|463071|P1|COMPLETED|Overall Study||14
191129|NCT01363492|463071|P1|STARTED|Overall Study||14
191130|NCT01363479|463086|P2|NOT COMPLETED|Overall Study||21
191131|NCT01363479|463087|P1|NOT COMPLETED|Overall Study||12
191132|NCT01363479|463086|P2|COMPLETED|Overall Study||351
191133|NCT01363479|463087|P1|COMPLETED|Overall Study||359
191134|NCT01363479|463086|P2|STARTED|Overall Study|number of randomised patients|372
191135|NCT01363479|463087|P1|STARTED|Overall Study|number of randomised patients|371
191136|NCT01363440|463096|P3|NOT COMPLETED|Overall Study||27
191137|NCT01363440|463097|P2|NOT COMPLETED|Overall Study||31
191138|NCT01363440|463098|P1|NOT COMPLETED|Overall Study||23
191139|NCT01363440|463096|P3|COMPLETED|Overall Study|Completed Week 100|127
191140|NCT01363440|463097|P2|COMPLETED|Overall Study|Completed Week 100|125
191141|NCT01363440|463098|P1|COMPLETED|Overall Study|Completed Week 100|133
191142|NCT01363440|463096|P3|Completed Week 100|Overall Study||127
191143|NCT01363440|463097|P2|Completed Week 100|Overall Study||125
191144|NCT01363440|463098|P1|Completed Week 100|Overall Study||133
191145|NCT01363440|463096|P3|Completed Week 52|Overall Study||144
191146|NCT01363440|463097|P2|Completed Week 52|Overall Study||146
191147|NCT01363440|463098|P1|Completed Week 52|Overall Study||145
191148|NCT01363440|463096|P3|Participants Received Treatment|Overall Study|safety analysis set (SAF)|152
191149|NCT01363440|463097|P2|Participants Received Treatment|Overall Study|safety analysis set (SAF)|155
191150|NCT01363440|463098|P1|Participants Received Treatment|Overall Study|safety analysis set (SAF)|154
191151|NCT01363440|463096|P3|STARTED|Overall Study|randomized|154
191152|NCT01363440|463097|P2|STARTED|Overall Study|randomized|156
191153|NCT01363440|463098|P1|STARTED|Overall Study|randomized|156
191154|NCT01363401|463129|P2|NOT COMPLETED|Overall Study||4
191155|NCT01363401|463130|P1|NOT COMPLETED|Overall Study||2
191156|NCT01363401|463129|P2|COMPLETED|Overall Study||27
191157|NCT01363401|463130|P1|COMPLETED|Overall Study||39
191158|NCT01363401|463129|P2|STARTED|Overall Study||31
191159|NCT01363401|463130|P1|STARTED|Overall Study|"Including 8 subjects of Phase 1 safety assessment. (Called Modified ITT in this clinical trials)"|41
191160|NCT01363349|463144|P2|NOT COMPLETED|Overall Study||70
191161|NCT01363349|463145|P1|NOT COMPLETED|Overall Study||67
191162|NCT01363349|463144|P2|COMPLETED|Overall Study||66
191163|NCT01363349|463145|P1|COMPLETED|Overall Study||66
191164|NCT01363349|463144|P2|Randomized|Overall Study||136
191165|NCT01363349|463145|P1|Randomized|Overall Study||133
191166|NCT01363349|463144|P2|STARTED|Overall Study||136
191167|NCT01363349|463145|P1|STARTED|Overall Study||133
191168|NCT01363297|463156|P5|NOT COMPLETED|Overall Study||31
191169|NCT01363297|463157|P4|NOT COMPLETED|Overall Study||10
191170|NCT01363297|463158|P3|NOT COMPLETED|Overall Study||6
191171|NCT01363297|463159|P2|NOT COMPLETED|Overall Study||6
191172|NCT01363297|463160|P1|NOT COMPLETED|Overall Study||3
191173|NCT01363297|463156|P5|COMPLETED|Overall Study||4
191174|NCT01363297|463157|P4|COMPLETED|Overall Study||3
191175|NCT01363297|463158|P3|COMPLETED|Overall Study||3
191176|NCT01363297|463159|P2|COMPLETED|Overall Study||6
191177|NCT01363297|463160|P1|COMPLETED|Overall Study||0
191178|NCT01363297|463156|P5|STARTED|Overall Study||35
191179|NCT01363297|463157|P4|STARTED|Overall Study||13
191180|NCT01363297|463158|P3|STARTED|Overall Study||9
191181|NCT01363297|463159|P2|STARTED|Overall Study||12
191182|NCT01363297|463160|P1|STARTED|Overall Study||3
191183|NCT01363258|463252|P2|NOT COMPLETED|Overall Study||0
191184|NCT01363258|463253|P1|NOT COMPLETED|Overall Study||0
191185|NCT01363258|463252|P2|COMPLETED|Overall Study||46
191186|NCT01363258|463253|P1|COMPLETED|Overall Study||54
191187|NCT01363258|463252|P2|STARTED|Overall Study||46
191188|NCT01363258|463253|P1|STARTED|Overall Study||54
191189|NCT01363076|463263|P2|NOT COMPLETED|Overall Study||1
191190|NCT01363076|463264|P1|NOT COMPLETED|Overall Study||0
191191|NCT01363076|463263|P2|COMPLETED|Overall Study||12
191192|NCT01363076|463264|P1|COMPLETED|Overall Study||7
191193|NCT01363076|463263|P2|STARTED|Overall Study||13
191194|NCT01363076|463264|P1|STARTED|Overall Study||7
191195|NCT01363050|463282|P1|NOT COMPLETED|Overall Study||0
191196|NCT01363050|463282|P1|COMPLETED|Overall Study||15
191197|NCT01363050|463282|P1|STARTED|Overall Study||15
191198|NCT01363011|463296|P2|NOT COMPLETED|Extension Phase||8
191199|NCT01363011|463297|P1|NOT COMPLETED|Extension Phase||5
191200|NCT01363011|463296|P2|COMPLETED|Extension Phase||41
191201|NCT01363011|463297|P1|COMPLETED|Extension Phase||13
191202|NCT01363011|463296|P2|STARTED|Extension Phase|15 participants who completed the main study did not enroll into the extension phase.|49
191203|NCT01363011|463297|P1|STARTED|Extension Phase|11 participants who completed the main study did not enroll into the extension phase.|18
191204|NCT01363011|463296|P2|NOT COMPLETED|Main Study||9
191205|NCT01363011|463297|P1|NOT COMPLETED|Main Study||4
191206|NCT01363011|463296|P2|COMPLETED|Main Study||64
191207|NCT01363011|463297|P1|COMPLETED|Main Study||29
191208|NCT01363011|463296|P2|STARTED|Main Study||73
191209|NCT01363011|463297|P1|STARTED|Main Study||33
191210|NCT01362959|463339|P2|NOT COMPLETED|Overall Study||0
191211|NCT01362959|463340|P1|NOT COMPLETED|Overall Study||0
191212|NCT01362959|463339|P2|COMPLETED|Overall Study||26
191213|NCT01362959|463340|P1|COMPLETED|Overall Study||21
191214|NCT01362959|463339|P2|STARTED|Overall Study||26
191215|NCT01362959|463340|P1|STARTED|Overall Study||21
191216|NCT01362946|463354|P2|NOT COMPLETED|Second Behavior Modification Block||0
191217|NCT01362946|463355|P1|NOT COMPLETED|Second Behavior Modification Block||0
191218|NCT01362946|463354|P2|COMPLETED|Second Behavior Modification Block||24
191219|NCT01362946|463355|P1|COMPLETED|Second Behavior Modification Block||23
191220|NCT01362946|463354|P2|STARTED|Second Behavior Modification Block||24
191221|NCT01362946|463355|P1|STARTED|Second Behavior Modification Block|1 participant withdrew after last but before this treatment period - illness unrelated to study.|23
191222|NCT01362946|463354|P2|NOT COMPLETED|First Behavior Modification Block||0
191223|NCT01362946|463355|P1|NOT COMPLETED|First Behavior Modification Block||0
191224|NCT01362946|463354|P2|COMPLETED|First Behavior Modification Block||24
191225|NCT01362946|463355|P1|COMPLETED|First Behavior Modification Block||24
191226|NCT01362946|463354|P2|STARTED|First Behavior Modification Block||24
191227|NCT01362946|463355|P1|STARTED|First Behavior Modification Block||24
191228|NCT01362907|463388|P2|NOT COMPLETED|Period 2, One Week||0
191229|NCT01362907|463389|P1|NOT COMPLETED|Period 2, One Week||0
191230|NCT01362907|463388|P2|COMPLETED|Period 2, One Week||20
191231|NCT01362907|463389|P1|COMPLETED|Period 2, One Week||20
191232|NCT01362907|463388|P2|STARTED|Period 2, One Week||20
191233|NCT01362907|463389|P1|STARTED|Period 2, One Week||20
191234|NCT01362907|463388|P2|NOT COMPLETED|Period 1, One Week||0
191235|NCT01362907|463389|P1|NOT COMPLETED|Period 1, One Week||0
191236|NCT01362907|463388|P2|COMPLETED|Period 1, One Week||20
191237|NCT01362907|463389|P1|COMPLETED|Period 1, One Week||20
191238|NCT01362907|463388|P2|STARTED|Period 1, One Week||20
191239|NCT01362907|463389|P1|STARTED|Period 1, One Week||20
191240|NCT01362894|463403|P2|NOT COMPLETED|Period Two, 1 Week||0
191241|NCT01362894|463404|P1|NOT COMPLETED|Period Two, 1 Week||0
191242|NCT01362894|463403|P2|COMPLETED|Period Two, 1 Week||115
191243|NCT01362894|463404|P1|COMPLETED|Period Two, 1 Week||118
191244|NCT01362894|463403|P2|STARTED|Period Two, 1 Week|Three participants discontinued between Periods 1 and 2 due to unacceptable vision.|115
191245|NCT01362894|463404|P1|STARTED|Period Two, 1 Week|Two participants discontinued between Periods 1 and 2 due to discomfort (1) and poor fit (1).|118
191246|NCT01362894|463403|P2|NOT COMPLETED|Period One, 1 Week||0
191247|NCT01362894|463404|P1|NOT COMPLETED|Period One, 1 Week||0
191248|NCT01362894|463403|P2|COMPLETED|Period One, 1 Week||117
191249|NCT01362894|463404|P1|COMPLETED|Period One, 1 Week||119
191250|NCT01362894|463403|P2|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|117
191251|NCT01362894|463404|P1|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|119
191252|NCT01362790|463424|P7|NOT COMPLETED|Dose De-escalation of Regimen A||0
191253|NCT01362790|463425|P6|NOT COMPLETED|Dose De-escalation of Regimen A||0
191254|NCT01362790|463426|P5|NOT COMPLETED|Dose De-escalation of Regimen A||6
191255|NCT01362790|463427|P4|NOT COMPLETED|Dose De-escalation of Regimen A||0
191256|NCT01362790|463428|P3|NOT COMPLETED|Dose De-escalation of Regimen A||0
191257|NCT01362790|463429|P2|NOT COMPLETED|Dose De-escalation of Regimen A||0
191258|NCT01362790|463430|P1|NOT COMPLETED|Dose De-escalation of Regimen A||0
191259|NCT01362790|463424|P7|COMPLETED|Dose De-escalation of Regimen A||0
191260|NCT01362790|463425|P6|COMPLETED|Dose De-escalation of Regimen A||0
191261|NCT01362790|463426|P5|COMPLETED|Dose De-escalation of Regimen A||2
191262|NCT01362790|463427|P4|COMPLETED|Dose De-escalation of Regimen A||0
191263|NCT01362790|463428|P3|COMPLETED|Dose De-escalation of Regimen A||0
191264|NCT01362790|463429|P2|COMPLETED|Dose De-escalation of Regimen A||0
191265|NCT01362790|463430|P1|COMPLETED|Dose De-escalation of Regimen A||0
191266|NCT01362790|463424|P7|STARTED|Dose De-escalation of Regimen A||0
191267|NCT01362790|463425|P6|STARTED|Dose De-escalation of Regimen A||0
191268|NCT01362790|463426|P5|STARTED|Dose De-escalation of Regimen A||8
191269|NCT01362790|463427|P4|STARTED|Dose De-escalation of Regimen A||0
191270|NCT01362790|463428|P3|STARTED|Dose De-escalation of Regimen A||0
191271|NCT01362790|463429|P2|STARTED|Dose De-escalation of Regimen A||0
191272|NCT01362790|463430|P1|STARTED|Dose De-escalation of Regimen A||0
191273|NCT01362790|463424|P7|NOT COMPLETED|Pilot Phase & Phase 2||0
191274|NCT01362790|463425|P6|NOT COMPLETED|Pilot Phase & Phase 2||4
191275|NCT01362790|463426|P5|NOT COMPLETED|Pilot Phase & Phase 2||0
191276|NCT01362790|463427|P4|NOT COMPLETED|Pilot Phase & Phase 2||14
191277|NCT01362790|463428|P3|NOT COMPLETED|Pilot Phase & Phase 2||5
191278|NCT01362790|463429|P2|NOT COMPLETED|Pilot Phase & Phase 2||8
191279|NCT01362790|463430|P1|NOT COMPLETED|Pilot Phase & Phase 2||10
191280|NCT01362790|463424|P7|COMPLETED|Pilot Phase & Phase 2||0
191281|NCT01362790|463425|P6|COMPLETED|Pilot Phase & Phase 2||0
191282|NCT01362790|463426|P5|COMPLETED|Pilot Phase & Phase 2||0
191283|NCT01362790|463427|P4|COMPLETED|Pilot Phase & Phase 2||1
191284|NCT01362790|463428|P3|COMPLETED|Pilot Phase & Phase 2||2
191285|NCT01362790|463429|P2|COMPLETED|Pilot Phase & Phase 2||0
191286|NCT01362790|463430|P1|COMPLETED|Pilot Phase & Phase 2||1
191287|NCT01362790|463424|P7|STARTED|Pilot Phase & Phase 2||0
191288|NCT01362790|463425|P6|STARTED|Pilot Phase & Phase 2||4
191289|NCT01362790|463426|P5|STARTED|Pilot Phase & Phase 2||0
191290|NCT01362790|463427|P4|STARTED|Pilot Phase & Phase 2||15
191291|NCT01362790|463428|P3|STARTED|Pilot Phase & Phase 2||7
191292|NCT01362790|463429|P2|STARTED|Pilot Phase & Phase 2||8
191293|NCT01362790|463430|P1|STARTED|Pilot Phase & Phase 2||11
191294|NCT01362686|463480|P3|NOT COMPLETED|Overall Study||10
191295|NCT01362686|463481|P2|NOT COMPLETED|Overall Study||12
191296|NCT01362686|463482|P1|NOT COMPLETED|Overall Study||8
191297|NCT01362686|463480|P3|COMPLETED|Overall Study||53
191298|NCT01362686|463481|P2|COMPLETED|Overall Study||54
191299|NCT01362686|463482|P1|COMPLETED|Overall Study||59
191300|NCT01362686|463480|P3|STARTED|Overall Study||63
191301|NCT01362686|463481|P2|STARTED|Overall Study||66
191302|NCT01362686|463482|P1|STARTED|Overall Study||67
191303|NCT01362608|463498|P2|NOT COMPLETED|Overall Study||8
191304|NCT01362608|463499|P1|NOT COMPLETED|Overall Study||4
191305|NCT01362608|463498|P2|COMPLETED|Overall Study||61
191306|NCT01362608|463499|P1|COMPLETED|Overall Study||63
191307|NCT01362608|463498|P2|STARTED|Overall Study||69
191308|NCT01362608|463499|P1|STARTED|Overall Study||67
191309|NCT01362530|463537|P2|NOT COMPLETED|Optional Extension (Cycles 2-6)||0
191310|NCT01362530|463538|P1|NOT COMPLETED|Optional Extension (Cycles 2-6)||125
191311|NCT01362530|463537|P2|COMPLETED|Optional Extension (Cycles 2-6)||0
191312|NCT01362530|463538|P1|COMPLETED|Optional Extension (Cycles 2-6)||46
191313|NCT01362530|463537|P2|STARTED|Optional Extension (Cycles 2-6)||0
191314|NCT01362530|463538|P1|STARTED|Optional Extension (Cycles 2-6)||171
191315|NCT01362530|463537|P2|NOT COMPLETED|Base Study (Cycle 1)||3
191316|NCT01362530|463538|P1|NOT COMPLETED|Base Study (Cycle 1)||5
191317|NCT01362530|463537|P2|COMPLETED|Base Study (Cycle 1)||149
191318|NCT01362530|463538|P1|COMPLETED|Base Study (Cycle 1)||150
191319|NCT01362530|463537|P2|Received Study Treatment|Base Study (Cycle 1)||150
191320|NCT01362530|463538|P1|Received Study Treatment|Base Study (Cycle 1)||152
191321|NCT01362530|463537|P2|STARTED|Base Study (Cycle 1)||152
191322|NCT01362530|463538|P1|STARTED|Base Study (Cycle 1)||155
191323|NCT01362517|463551|P1|NOT COMPLETED|Overall Study||2
191324|NCT01362517|463551|P1|COMPLETED|Overall Study||129
191325|NCT01362517|463551|P1|STARTED|Overall Study||131
191326|NCT01362491|463562|P3|NOT COMPLETED|Overall Study||0
191327|NCT01362491|463563|P2|NOT COMPLETED|Overall Study||0
191328|NCT01362491|463564|P1|NOT COMPLETED|Overall Study||1
191329|NCT01362491|463562|P3|COMPLETED|Overall Study||46
191330|NCT01362491|463563|P2|COMPLETED|Overall Study||89
191331|NCT01362491|463564|P1|COMPLETED|Overall Study||90
191332|NCT01362491|463562|P3|STARTED|Overall Study||46
191333|NCT01362491|463563|P2|STARTED|Overall Study||89
191334|NCT01362491|463564|P1|STARTED|Overall Study||91
191335|NCT01362439|463612|P1|NOT COMPLETED|Overall Study||15
191336|NCT01362439|463612|P1|COMPLETED|Overall Study||118
191337|NCT01362439|463612|P1|STARTED|Overall Study||133
191338|NCT01362348|463627|P1|NOT COMPLETED|Overall Study||14
191339|NCT01362348|463627|P1|COMPLETED|Overall Study||5
191340|NCT01362348|463627|P1|STARTED|Overall Study||19
191341|NCT01362322|463646|P2|NOT COMPLETED|Overall Study||7
191342|NCT01362322|463647|P1|NOT COMPLETED|Overall Study||5
191343|NCT01362322|463646|P2|COMPLETED|Overall Study||329
191344|NCT01362322|463647|P1|COMPLETED|Overall Study||330
191345|NCT01362322|463646|P2|STARTED|Overall Study||336
191346|NCT01362322|463647|P1|STARTED|Overall Study||335
191347|NCT01362296|463679|P4|NOT COMPLETED|Crossover Phase||2
191348|NCT01362296|463680|P3|NOT COMPLETED|Crossover Phase||23
191349|NCT01362296|463681|P2|NOT COMPLETED|Crossover Phase||0
191350|NCT01362296|463682|P1|NOT COMPLETED|Crossover Phase||0
191351|NCT01362296|463679|P4|COMPLETED|Crossover Phase||0
191352|NCT01362296|463680|P3|COMPLETED|Crossover Phase||0
191353|NCT01362296|463681|P2|COMPLETED|Crossover Phase||0
191354|NCT01362296|463682|P1|COMPLETED|Crossover Phase||0
191355|NCT01362296|463679|P4|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|2
191356|NCT01362296|463680|P3|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|23
191357|NCT01362296|463681|P2|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
191358|NCT01362296|463682|P1|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
191359|NCT01362296|463679|P4|NOT COMPLETED|Randomized Phase (RP)||0
191360|NCT01362296|463680|P3|NOT COMPLETED|Randomized Phase (RP)||0
191361|NCT01362296|463681|P2|NOT COMPLETED|Randomized Phase (RP)||43
191362|NCT01362296|463682|P1|NOT COMPLETED|Randomized Phase (RP)||87
191363|NCT01362296|463679|P4|COMPLETED|Randomized Phase (RP)||0
191364|NCT01362296|463680|P3|COMPLETED|Randomized Phase (RP)||0
191365|NCT01362296|463681|P2|COMPLETED|Randomized Phase (RP)||0
191366|NCT01362296|463682|P1|COMPLETED|Randomized Phase (RP)||0
191367|NCT01362296|463679|P4|STARTED|Randomized Phase (RP)||0
191368|NCT01362296|463680|P3|STARTED|Randomized Phase (RP)||0
191369|NCT01362296|463681|P2|STARTED|Randomized Phase (RP)||43
191370|NCT01362296|463682|P1|STARTED|Randomized Phase (RP)||87
191371|NCT01362244|463730|P2|NOT COMPLETED|Overall Study||32
191372|NCT01362244|463731|P1|NOT COMPLETED|Overall Study||32
191373|NCT01362244|463730|P2|COMPLETED|Overall Study||19
191374|NCT01362244|463731|P1|COMPLETED|Overall Study||22
191375|NCT01362244|463730|P2|STARTED|Overall Study||51
191376|NCT01362244|463731|P1|STARTED|Overall Study||54
191377|NCT01362205|463804|P2|NOT COMPLETED|Overall Study||0
191378|NCT01362205|463805|P1|NOT COMPLETED|Overall Study||0
191379|NCT01362205|463804|P2|COMPLETED|Overall Study||27
191380|NCT01362205|463805|P1|COMPLETED|Overall Study||22
191381|NCT01362205|463804|P2|STARTED|Overall Study||27
191382|NCT01362205|463805|P1|STARTED|Overall Study||22
191383|NCT01362192|463831|P1|NOT COMPLETED|Overall Study||4
191384|NCT01362192|463831|P1|COMPLETED|Overall Study||16
191385|NCT01362192|463831|P1|STARTED|Overall Study||20
191386|NCT01362140|463843|P2|NOT COMPLETED|Overall Study||11
191387|NCT01362140|463844|P1|NOT COMPLETED|Overall Study||10
191388|NCT01362140|463843|P2|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|87
191389|NCT01362140|463844|P1|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|39
191390|NCT01362140|463843|P2|Received Treatment|Overall Study||97
191391|NCT01362140|463844|P1|Received Treatment|Overall Study||49
191392|NCT01362140|463843|P2|STARTED|Overall Study||98
191393|NCT01362140|463844|P1|STARTED|Overall Study||49
191394|NCT01362062|463868|P2|NOT COMPLETED|Overall Study||0
191395|NCT01362062|463869|P1|NOT COMPLETED|Overall Study||26
191396|NCT01362062|463868|P2|COMPLETED|Overall Study||62
191397|NCT01362062|463869|P1|COMPLETED|Overall Study||22
191398|NCT01362062|463868|P2|STARTED|Overall Study||62
191399|NCT01362062|463869|P1|STARTED|Overall Study||48
191400|NCT01362049|463890|P4|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
191401|NCT01362049|463891|P3|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||2
191402|NCT01362049|463892|P2|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
191403|NCT01362049|463893|P1|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||5
191404|NCT01362049|463890|P4|COMPLETED|Follow-Up at 52 Weeks (12 Months)||21
191405|NCT01362049|463891|P3|COMPLETED|Follow-Up at 52 Weeks (12 Months)||28
191406|NCT01362049|463892|P2|COMPLETED|Follow-Up at 52 Weeks (12 Months)||13
191407|NCT01362049|463893|P1|COMPLETED|Follow-Up at 52 Weeks (12 Months)||18
191408|NCT01362049|463890|P4|STARTED|Follow-Up at 52 Weeks (12 Months)||24
191409|NCT01362049|463891|P3|STARTED|Follow-Up at 52 Weeks (12 Months)||30
191410|NCT01362049|463892|P2|STARTED|Follow-Up at 52 Weeks (12 Months)||16
191411|NCT01362049|463893|P1|STARTED|Follow-Up at 52 Weeks (12 Months)||23
191412|NCT01362049|463890|P4|NOT COMPLETED|Follow-Up at 7 Weeks||1
191413|NCT01362049|463891|P3|NOT COMPLETED|Follow-Up at 7 Weeks||2
191414|NCT01362049|463892|P2|NOT COMPLETED|Follow-Up at 7 Weeks||3
191415|NCT01362049|463893|P1|NOT COMPLETED|Follow-Up at 7 Weeks||3
191416|NCT01362049|463890|P4|COMPLETED|Follow-Up at 7 Weeks||24
191417|NCT01362049|463891|P3|COMPLETED|Follow-Up at 7 Weeks||30
191418|NCT01362049|463892|P2|COMPLETED|Follow-Up at 7 Weeks||16
191419|NCT01362049|463893|P1|COMPLETED|Follow-Up at 7 Weeks||23
191420|NCT01362049|463890|P4|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||25
191421|NCT01362049|463891|P3|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||32
191422|NCT01362049|463892|P2|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||18
191423|NCT01362049|463893|P1|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||26
191424|NCT01362049|463890|P4|STARTED|Follow-Up at 7 Weeks||25
191425|NCT01362049|463891|P3|STARTED|Follow-Up at 7 Weeks||32
191426|NCT01362049|463892|P2|STARTED|Follow-Up at 7 Weeks||19
191427|NCT01362049|463893|P1|STARTED|Follow-Up at 7 Weeks||26
191428|NCT01361919|463934|P3|NOT COMPLETED|Overall Study||10
191429|NCT01361919|463935|P2|NOT COMPLETED|Overall Study||12
191430|NCT01361919|463936|P1|NOT COMPLETED|Overall Study||10
191431|NCT01361919|463934|P3|COMPLETED|Overall Study||88
191432|NCT01361919|463935|P2|COMPLETED|Overall Study||88
191433|NCT01361919|463936|P1|COMPLETED|Overall Study||90
191434|NCT01361919|463934|P3|STARTED|Overall Study||98
191435|NCT01361919|463935|P2|STARTED|Overall Study||100
191436|NCT01361919|463936|P1|STARTED|Overall Study||100
191437|NCT01361867|463950|P1|NOT COMPLETED|Overall Study||0
191438|NCT01361867|463950|P1|COMPLETED|Overall Study||15
191439|NCT01361867|463950|P1|STARTED|Overall Study||15
191440|NCT01361854|463955|P2|NOT COMPLETED|Second Intervention||0
191441|NCT01361854|463956|P1|NOT COMPLETED|Second Intervention||0
191442|NCT01361854|463955|P2|COMPLETED|Second Intervention||48
191443|NCT01361854|463956|P1|COMPLETED|Second Intervention||47
191444|NCT01361854|463955|P2|STARTED|Second Intervention||48
191445|NCT01361854|463956|P1|STARTED|Second Intervention||47
191446|NCT01361854|463955|P2|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
191447|NCT01361854|463956|P1|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
191448|NCT01361854|463955|P2|COMPLETED|Wash-out, Maximum 2 Weeks||48
191449|NCT01361854|463956|P1|COMPLETED|Wash-out, Maximum 2 Weeks||47
191450|NCT01361854|463955|P2|STARTED|Wash-out, Maximum 2 Weeks||48
191451|NCT01361854|463956|P1|STARTED|Wash-out, Maximum 2 Weeks||47
191452|NCT01361854|463955|P2|NOT COMPLETED|Day 1||3
191453|NCT01361854|463956|P1|NOT COMPLETED|Day 1||4
191454|NCT01361854|463955|P2|COMPLETED|Day 1||48
191455|NCT01361854|463956|P1|COMPLETED|Day 1||47
191456|NCT01361854|463955|P2|STARTED|Day 1||51
191457|NCT01361854|463956|P1|STARTED|Day 1||51
191458|NCT01361633|463964|P2|NOT COMPLETED|Overall Study||3
191459|NCT01361633|463965|P1|NOT COMPLETED|Overall Study||6
191460|NCT01361633|463964|P2|COMPLETED|Overall Study||23
191461|NCT01361633|463965|P1|COMPLETED|Overall Study||19
191462|NCT01361633|463964|P2|STARTED|Overall Study||26
191463|NCT01361633|463965|P1|STARTED|Overall Study||25
191464|NCT01361620|463971|P1|NOT COMPLETED|Overall Study||0
191465|NCT01361620|463971|P1|COMPLETED|Overall Study||132
191466|NCT01361620|463971|P1|STARTED|Overall Study||132
191467|NCT01361607|463977|P2|NOT COMPLETED|Overall Study||41
191468|NCT01361607|463978|P1|NOT COMPLETED|Overall Study||64
191469|NCT01361607|463977|P2|COMPLETED|Overall Study||158
191470|NCT01361607|463978|P1|COMPLETED|Overall Study||136
191471|NCT01361607|463977|P2|ITT Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as placebo-treated|199
191472|NCT01361607|463978|P1|ITT Population|Overall Study||198
191473|NCT01361607|463977|P2|Safety Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as nabiximols-treated|198
191474|NCT01361607|463978|P1|Safety Population|Overall Study|One participant randomized to nabiximols received placebo Day 22 but analyzed as nabiximols-treated|199
191475|NCT01361607|463977|P2|Received at Least 1 Dose of Study Drug|Overall Study||199
191476|NCT01361607|463978|P1|Received at Least 1 Dose of Study Drug|Overall Study||198
191477|NCT01361607|463977|P2|STARTED|Overall Study||199
191478|NCT01361607|463978|P1|STARTED|Overall Study|Two participants randomized to nabiximols did not receive any study drug|200
191479|NCT01361594|464006|P2|NOT COMPLETED|Overall Study||2
191480|NCT01361594|464007|P1|NOT COMPLETED|Overall Study||1
191481|NCT01361594|464006|P2|COMPLETED|Overall Study||151
191482|NCT01361594|464007|P1|COMPLETED|Overall Study||151
191483|NCT01361594|464006|P2|STARTED|Overall Study||153
191484|NCT01361594|464007|P1|STARTED|Overall Study||152
191485|NCT01361568|464021|P6|NOT COMPLETED|Overall Study||2
191486|NCT01361568|464022|P5|NOT COMPLETED|Overall Study||1
191487|NCT01361568|464023|P4|NOT COMPLETED|Overall Study||0
191488|NCT01361568|464024|P3|NOT COMPLETED|Overall Study||0
191489|NCT01361568|464025|P2|NOT COMPLETED|Overall Study||1
191490|NCT01361568|464026|P1|NOT COMPLETED|Overall Study||2
191491|NCT01361568|464021|P6|COMPLETED|Overall Study||11
191492|NCT01361568|464022|P5|COMPLETED|Overall Study||6
191493|NCT01361568|464023|P4|COMPLETED|Overall Study||21
191494|NCT01361568|464024|P3|COMPLETED|Overall Study||20
191495|NCT01361568|464025|P2|COMPLETED|Overall Study||70
191496|NCT01361568|464026|P1|COMPLETED|Overall Study||69
191497|NCT01361568|464021|P6|STARTED|Overall Study||13
191498|NCT01361568|464022|P5|STARTED|Overall Study||7
191499|NCT01361568|464023|P4|STARTED|Overall Study||21
191500|NCT01361568|464024|P3|STARTED|Overall Study||20
191501|NCT01361568|464025|P2|STARTED|Overall Study||71
191502|NCT01361568|464026|P1|STARTED|Overall Study||71
191503|NCT01361464|464056|P1|NOT COMPLETED|Overall Study||3
191504|NCT01361464|464056|P1|COMPLETED|Overall Study||18
191505|NCT01361464|464056|P1|STARTED|Overall Study||21
191506|NCT01361308|464065|P2|NOT COMPLETED|Overall Study||30
191507|NCT01361308|464066|P1|NOT COMPLETED|Overall Study||35
191508|NCT01361308|464065|P2|COMPLETED|Overall Study||278
191509|NCT01361308|464066|P1|COMPLETED|Overall Study||271
191510|NCT01361308|464065|P2|STARTED|Overall Study||308
191511|NCT01361308|464066|P1|STARTED|Overall Study||306
191512|NCT01361217|464106|P1|NOT COMPLETED|Overall Study||0
191513|NCT01361217|464106|P1|COMPLETED|Overall Study||10
191514|NCT01361217|464106|P1|STARTED|Overall Study||10
191515|NCT01361178|464114|P2|NOT COMPLETED|Overall Study||0
191516|NCT01361178|464115|P1|NOT COMPLETED|Overall Study||13
191517|NCT01361178|464114|P2|COMPLETED|Overall Study||11
191518|NCT01361178|464115|P1|COMPLETED|Overall Study||109
191519|NCT01361178|464114|P2|STARTED|Overall Study||11
191520|NCT01361178|464115|P1|STARTED|Overall Study||122
191521|NCT01361126|464123|P2|NOT COMPLETED|Overall Study||2
191522|NCT01361126|464124|P1|NOT COMPLETED|Overall Study||0
191523|NCT01361126|464123|P2|COMPLETED|Overall Study||2
191524|NCT01361126|464124|P1|COMPLETED|Overall Study||13
191525|NCT01361126|464123|P2|STARTED|Overall Study||4
191526|NCT01361126|464124|P1|STARTED|Overall Study||13
191527|NCT01361113|464139|P1|NOT COMPLETED|Overall Study||0
191528|NCT01361113|464139|P1|COMPLETED|Overall Study||21
191529|NCT01361113|464139|P1|STARTED|Overall Study||21
191530|NCT01361048|464150|P3|NOT COMPLETED|Overall Study||1
191531|NCT01361048|464151|P2|NOT COMPLETED|Overall Study||0
191532|NCT01361048|464152|P1|NOT COMPLETED|Overall Study||0
191533|NCT01361048|464150|P3|COMPLETED|Overall Study||9
191534|NCT01361048|464151|P2|COMPLETED|Overall Study||10
191535|NCT01361048|464152|P1|COMPLETED|Overall Study||20
191536|NCT01361048|464150|P3|STARTED|Overall Study||10
191537|NCT01361048|464151|P2|STARTED|Overall Study||10
191538|NCT01361048|464152|P1|STARTED|Overall Study||20
191539|NCT01361009|464163|P1|NOT COMPLETED|Overall Study||116
191540|NCT01361009|464163|P1|COMPLETED|Overall Study||1901
191541|NCT01361009|464163|P1|STARTED|Overall Study||2017
191542|NCT01360996|464173|P3|NOT COMPLETED|Overall Study||2
191543|NCT01360996|464174|P2|NOT COMPLETED|Overall Study||3
191544|NCT01360996|464175|P1|NOT COMPLETED|Overall Study||6
191545|NCT01360996|464173|P3|COMPLETED|Overall Study||21
191546|NCT01360996|464174|P2|COMPLETED|Overall Study||18
191547|NCT01360996|464175|P1|COMPLETED|Overall Study||14
191548|NCT01360996|464173|P3|STARTED|Overall Study||23
191549|NCT01360996|464174|P2|STARTED|Overall Study||21
191550|NCT01360996|464175|P1|STARTED|Overall Study||20
191551|NCT01360866|464198|P4|NOT COMPLETED|Overall Study||22
191552|NCT01360866|464199|P3|NOT COMPLETED|Overall Study||519
191553|NCT01360866|464200|P2|NOT COMPLETED|Overall Study||287
191554|NCT01360866|464201|P1|NOT COMPLETED|Overall Study||221
191555|NCT01360866|464198|P4|COMPLETED|Overall Study||54
191556|NCT01360866|464199|P3|COMPLETED|Overall Study||1126
191557|NCT01360866|464200|P2|COMPLETED|Overall Study||420
191558|NCT01360866|464201|P1|COMPLETED|Overall Study||295
191559|NCT01360866|464198|P4|STARTED|Overall Study||76
191560|NCT01360866|464199|P3|STARTED|Overall Study||1645
191561|NCT01360866|464200|P2|STARTED|Overall Study||707
191562|NCT01360866|464201|P1|STARTED|Overall Study||516
191563|NCT01360840|464230|P3|NOT COMPLETED|Overall Study||9
191564|NCT01360840|464231|P2|NOT COMPLETED|Overall Study||10
191565|NCT01360840|464232|P1|NOT COMPLETED|Overall Study||10
191566|NCT01360840|464230|P3|COMPLETED|Overall Study||51
191567|NCT01360840|464231|P2|COMPLETED|Overall Study||50
191568|NCT01360840|464232|P1|COMPLETED|Overall Study||50
191569|NCT01360840|464230|P3|STARTED|Overall Study||60
191570|NCT01360840|464231|P2|STARTED|Overall Study||60
191571|NCT01360840|464232|P1|STARTED|Overall Study||60
191572|NCT01360762|464282|P1|NOT COMPLETED|Whole Study Period||36
191573|NCT01360762|464282|P1|COMPLETED|Whole Study Period||38
191574|NCT01360762|464282|P1|STARTED|Whole Study Period||74
191575|NCT01360762|464282|P1|NOT COMPLETED|Main Study Period (12-month Treatment)||29
191576|NCT01360762|464282|P1|COMPLETED|Main Study Period (12-month Treatment)||45
191577|NCT01360762|464282|P1|STARTED|Main Study Period (12-month Treatment)||74
191578|NCT01360645|464292|P4|NOT COMPLETED|Phase A+||24
191579|NCT01360645|464293|P3|NOT COMPLETED|Phase A+||0
191580|NCT01360645|464294|P2|NOT COMPLETED|Phase A+||0
191581|NCT01360645|464295|P1|NOT COMPLETED|Phase A+||0
191582|NCT01360645|464292|P4|COMPLETED|Phase A+||307
191583|NCT01360645|464293|P3|COMPLETED|Phase A+||0
191584|NCT01360645|464294|P2|COMPLETED|Phase A+||0
191585|NCT01360645|464295|P1|COMPLETED|Phase A+||0
191586|NCT01360645|464292|P4|STARTED|Phase A+||331
191587|NCT01360645|464293|P3|STARTED|Phase A+||0
191588|NCT01360645|464294|P2|STARTED|Phase A+||0
191589|NCT01360645|464295|P1|STARTED|Phase A+||0
191590|NCT01360645|464292|P4|NOT COMPLETED|Phase B (6 Weeks)||0
191591|NCT01360645|464293|P3|NOT COMPLETED|Phase B (6 Weeks)||13
191592|NCT01360645|464294|P2|NOT COMPLETED|Phase B (6 Weeks)||14
191593|NCT01360645|464295|P1|NOT COMPLETED|Phase B (6 Weeks)||0
191594|NCT01360645|464292|P4|COMPLETED|Phase B (6 Weeks)||0
191595|NCT01360645|464293|P3|COMPLETED|Phase B (6 Weeks)||178
191596|NCT01360645|464294|P2|COMPLETED|Phase B (6 Weeks)||174
191597|NCT01360645|464295|P1|COMPLETED|Phase B (6 Weeks)||0
191598|NCT01360645|464292|P4|STARTED|Phase B (6 Weeks)||0
191599|NCT01360645|464293|P3|STARTED|Phase B (6 Weeks)||191
191600|NCT01360645|464294|P2|STARTED|Phase B (6 Weeks)||188
191601|NCT01360645|464295|P1|STARTED|Phase B (6 Weeks)||0
191602|NCT01360645|464292|P4|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
191603|NCT01360645|464293|P3|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
191604|NCT01360645|464294|P2|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
191605|NCT01360645|464295|P1|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||114
191606|NCT01360645|464292|P4|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
191607|NCT01360645|464293|P3|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
191608|NCT01360645|464294|P2|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
191609|NCT01360645|464295|P1|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||710
191610|NCT01360645|464292|P4|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
191611|NCT01360645|464293|P3|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
191612|NCT01360645|464294|P2|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
191613|NCT01360645|464295|P1|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)|826 participants were enrolled but 2 participants discontinued trial before taking study medication.|824
191614|NCT01360632|464350|P5|NOT COMPLETED|Phase A+||25
191615|NCT01360632|464351|P4|NOT COMPLETED|Phase A+||0
191616|NCT01360632|464352|P3|NOT COMPLETED|Phase A+||0
191617|NCT01360632|464353|P2|NOT COMPLETED|Phase A+||0
191618|NCT01360632|464354|P1|NOT COMPLETED|Phase A+||0
191619|NCT01360632|464350|P5|COMPLETED|Phase A+||575
191620|NCT01360632|464351|P4|COMPLETED|Phase A+||0
191621|NCT01360632|464352|P3|COMPLETED|Phase A+||0
191622|NCT01360632|464353|P2|COMPLETED|Phase A+||0
191623|NCT01360632|464354|P1|COMPLETED|Phase A+||0
191624|NCT01360632|464350|P5|STARTED|Phase A+||600
191625|NCT01360632|464351|P4|STARTED|Phase A+||0
191626|NCT01360632|464352|P3|STARTED|Phase A+||0
191627|NCT01360632|464353|P2|STARTED|Phase A+||0
191628|NCT01360632|464354|P1|STARTED|Phase A+||0
191629|NCT01360632|464350|P5|NOT COMPLETED|Phase B (6 Weeks)||0
191630|NCT01360632|464351|P4|NOT COMPLETED|Phase B (6 Weeks)||13
191631|NCT01360632|464352|P3|NOT COMPLETED|Phase B (6 Weeks)||20
191632|NCT01360632|464353|P2|NOT COMPLETED|Phase B (6 Weeks)||10
191633|NCT01360632|464354|P1|NOT COMPLETED|Phase B (6 Weeks)||0
191634|NCT01360632|464350|P5|COMPLETED|Phase B (6 Weeks)||0
191635|NCT01360632|464351|P4|COMPLETED|Phase B (6 Weeks)||208
191636|NCT01360632|464352|P3|COMPLETED|Phase B (6 Weeks)||210
191637|NCT01360632|464353|P2|COMPLETED|Phase B (6 Weeks)||216
191638|NCT01360632|464354|P1|COMPLETED|Phase B (6 Weeks)||0
191639|NCT01360632|464350|P5|STARTED|Phase B (6 Weeks)||0
191640|NCT01360632|464351|P4|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|221
191641|NCT01360632|464352|P3|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|230
191642|NCT01360632|464353|P2|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|226
191643|NCT01360632|464354|P1|STARTED|Phase B (6 Weeks)||0
191644|NCT01360632|464350|P5|NOT COMPLETED|Phase A (8 Weeks)||0
191645|NCT01360632|464351|P4|NOT COMPLETED|Phase A (8 Weeks)||0
191646|NCT01360632|464352|P3|NOT COMPLETED|Phase A (8 Weeks)||0
191647|NCT01360632|464353|P2|NOT COMPLETED|Phase A (8 Weeks)||0
191648|NCT01360632|464354|P1|NOT COMPLETED|Phase A (8 Weeks)||255
191649|NCT01360632|464350|P5|COMPLETED|Phase A (8 Weeks)||0
191650|NCT01360632|464351|P4|COMPLETED|Phase A (8 Weeks)||0
191651|NCT01360632|464352|P3|COMPLETED|Phase A (8 Weeks)||0
191652|NCT01360632|464353|P2|COMPLETED|Phase A (8 Weeks)||0
191653|NCT01360632|464354|P1|COMPLETED|Phase A (8 Weeks)||1277
191654|NCT01360632|464350|P5|STARTED|Phase A (8 Weeks)||0
191655|NCT01360632|464351|P4|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
191656|NCT01360632|464352|P3|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
191657|NCT01360632|464353|P2|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
191658|NCT01360632|464354|P1|STARTED|Phase A (8 Weeks)|A total of 1539 participants were enrolled, 7 discontinued before taking any sponsor-provided ADT|1532
191659|NCT01360554|464433|P2|NOT COMPLETED|Overall Study||439
191660|NCT01360554|464434|P1|NOT COMPLETED|Overall Study||439
191661|NCT01360554|464433|P2|COMPLETED|Overall Study||0
191662|NCT01360554|464434|P1|COMPLETED|Overall Study||0
191663|NCT01360554|464433|P2|Treated|Overall Study||436
191664|NCT01360554|464434|P1|Treated|Overall Study||436
191665|NCT01360554|464433|P2|STARTED|Overall Study|Three participants were randomized but not treated.|439
191666|NCT01360554|464434|P1|STARTED|Overall Study|Three participants were randomized but not treated.|439
191667|NCT01360450|464472|P2|NOT COMPLETED|Overall Study||0
191668|NCT01360450|464473|P1|NOT COMPLETED|Overall Study||0
191669|NCT01360450|464472|P2|COMPLETED|Overall Study||6
191670|NCT01360450|464473|P1|COMPLETED|Overall Study||6
191671|NCT01360450|464472|P2|Completed Treatment|Overall Study||6
191672|NCT01360450|464473|P1|Completed Treatment|Overall Study||6
191673|NCT01360450|464472|P2|STARTED|Overall Study||6
191674|NCT01360450|464473|P1|STARTED|Overall Study||6
191675|NCT01360398|464483|P1|NOT COMPLETED|Overall Study||22
191676|NCT01360398|464483|P1|COMPLETED|Overall Study||105
191677|NCT01360398|464483|P1|STARTED|Overall Study||127
191678|NCT01360229|464507|P2|NOT COMPLETED|Overall Study||2
191679|NCT01360229|464508|P1|NOT COMPLETED|Overall Study||3
191680|NCT01360229|464507|P2|COMPLETED|Overall Study||45
191681|NCT01360229|464508|P1|COMPLETED|Overall Study||44
191682|NCT01360229|464507|P2|STARTED|Overall Study||47
191683|NCT01360229|464508|P1|STARTED|Overall Study||47
191684|NCT01360021|464517|P3|NOT COMPLETED|Overall Study||7
191685|NCT01360021|464518|P2|NOT COMPLETED|Overall Study||4
191686|NCT01360021|464519|P1|NOT COMPLETED|Overall Study||8
191687|NCT01360021|464517|P3|COMPLETED|Overall Study|Patients who completed study|65
191688|NCT01360021|464518|P2|COMPLETED|Overall Study|Patients who completed study|67
191689|NCT01360021|464519|P1|COMPLETED|Overall Study|Patients who completed study|63
191690|NCT01360021|464517|P3|STARTED|Overall Study|Patients randomized|72
191691|NCT01360021|464518|P2|STARTED|Overall Study|Patients randomized|71
191692|NCT01360021|464519|P1|STARTED|Overall Study|Patients randomized|71
191693|NCT01359943|464545|P3|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
191694|NCT01359943|464546|P2|NOT COMPLETED|Follow-up (Weeks 52 - 60)||15
191695|NCT01359943|464547|P1|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
191696|NCT01359943|464545|P3|COMPLETED|Follow-up (Weeks 52 - 60)||36
191697|NCT01359943|464546|P2|COMPLETED|Follow-up (Weeks 52 - 60)||69
191698|NCT01359943|464547|P1|COMPLETED|Follow-up (Weeks 52 - 60)||78
191699|NCT01359943|464545|P3|STARTED|Follow-up (Weeks 52 - 60)||44
191700|NCT01359943|464546|P2|STARTED|Follow-up (Weeks 52 - 60)||84
191701|NCT01359943|464547|P1|STARTED|Follow-up (Weeks 52 - 60)||86
191702|NCT01359943|464545|P3|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
191703|NCT01359943|464546|P2|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||13
191704|NCT01359943|464547|P1|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
191705|NCT01359943|464545|P3|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||36
191706|NCT01359943|464546|P2|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||71
191707|NCT01359943|464547|P1|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||78
191708|NCT01359943|464545|P3|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||44
191709|NCT01359943|464546|P2|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)|One participant, who was continuing as of week 12, did not receive study drug at week 16.|84
191710|NCT01359943|464547|P1|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||86
191711|NCT01359943|464545|P3|NOT COMPLETED|Double-blind (Weeks 0 - 16)||0
191712|NCT01359943|464546|P2|NOT COMPLETED|Double-blind (Weeks 0 - 16)||4
191713|NCT01359943|464547|P1|NOT COMPLETED|Double-blind (Weeks 0 - 16)||2
191714|NCT01359943|464545|P3|COMPLETED|Double-blind (Weeks 0 - 16)||44
191715|NCT01359943|464546|P2|COMPLETED|Double-blind (Weeks 0 - 16)||85
191716|NCT01359943|464547|P1|COMPLETED|Double-blind (Weeks 0 - 16)||86
191717|NCT01359943|464545|P3|STARTED|Double-blind (Weeks 0 - 16)||44
191718|NCT01359943|464546|P2|STARTED|Double-blind (Weeks 0 - 16)||89
191719|NCT01359943|464547|P1|STARTED|Double-blind (Weeks 0 - 16)||88
191720|NCT01359904|464595|P2|NOT COMPLETED|Overall Study||0
191721|NCT01359904|464596|P1|NOT COMPLETED|Overall Study||1
191722|NCT01359904|464595|P2|COMPLETED|Overall Study||19
191723|NCT01359904|464596|P1|COMPLETED|Overall Study||14
191724|NCT01359904|464595|P2|STARTED|Overall Study||19
191725|NCT01359904|464596|P1|STARTED|Overall Study||15
191726|NCT01359748|464612|P4|NOT COMPLETED|Overall Study||0
191727|NCT01359748|464613|P3|NOT COMPLETED|Overall Study||0
191728|NCT01359748|464614|P2|NOT COMPLETED|Overall Study||0
191729|NCT01359748|464615|P1|NOT COMPLETED|Overall Study||0
191730|NCT01359748|464612|P4|COMPLETED|Overall Study||11
191731|NCT01359748|464613|P3|COMPLETED|Overall Study||10
191732|NCT01359748|464614|P2|COMPLETED|Overall Study||20
191733|NCT01359748|464615|P1|COMPLETED|Overall Study||48
191734|NCT01359748|464612|P4|STARTED|Overall Study||11
191735|NCT01359748|464613|P3|STARTED|Overall Study||10
191736|NCT01359748|464614|P2|STARTED|Overall Study||20
191737|NCT01359748|464615|P1|STARTED|Overall Study||48
191738|NCT01359735|464625|P2|NOT COMPLETED|Overall Study||0
191739|NCT01359735|464626|P1|NOT COMPLETED|Overall Study||0
191740|NCT01359735|464625|P2|COMPLETED|Overall Study||4
191741|NCT01359735|464626|P1|COMPLETED|Overall Study||4
191742|NCT01359735|464625|P2|STARTED|Overall Study||4
191743|NCT01359735|464626|P1|STARTED|Overall Study||4
191744|NCT01359644|464650|P10|NOT COMPLETED|Follow-up Period||0
191745|NCT01359644|464651|P9|NOT COMPLETED|Follow-up Period||0
191746|NCT01359644|464652|P8|NOT COMPLETED|Follow-up Period||2
191747|NCT01359644|464653|P7|NOT COMPLETED|Follow-up Period||1
191748|NCT01359644|464654|P6|NOT COMPLETED|Follow-up Period||1
191749|NCT01359644|464655|P5|NOT COMPLETED|Follow-up Period||0
191750|NCT01359644|464656|P4|NOT COMPLETED|Follow-up Period||0
191751|NCT01359644|464657|P3|NOT COMPLETED|Follow-up Period||0
191752|NCT01359644|464658|P2|NOT COMPLETED|Follow-up Period||0
191753|NCT01359644|464659|P1|NOT COMPLETED|Follow-up Period||0
191754|NCT01359644|464650|P10|COMPLETED|Follow-up Period||20
191755|NCT01359644|464651|P9|COMPLETED|Follow-up Period||21
191756|NCT01359644|464652|P8|COMPLETED|Follow-up Period||39
191757|NCT01359644|464653|P7|COMPLETED|Follow-up Period||40
191758|NCT01359644|464654|P6|COMPLETED|Follow-up Period||12
191759|NCT01359644|464655|P5|COMPLETED|Follow-up Period||15
191760|NCT01359644|464656|P4|COMPLETED|Follow-up Period||14
191761|NCT01359644|464657|P3|COMPLETED|Follow-up Period||14
191762|NCT01359644|464658|P2|COMPLETED|Follow-up Period||16
191763|NCT01359644|464659|P1|COMPLETED|Follow-up Period||15
191764|NCT01359644|464650|P10|STARTED|Follow-up Period||20
191765|NCT01359644|464651|P9|STARTED|Follow-up Period||21
191766|NCT01359644|464652|P8|STARTED|Follow-up Period||41
191767|NCT01359644|464653|P7|STARTED|Follow-up Period||41
191768|NCT01359644|464654|P6|STARTED|Follow-up Period||13
191769|NCT01359644|464655|P5|STARTED|Follow-up Period||15
191770|NCT01359644|464656|P4|STARTED|Follow-up Period||14
191771|NCT01359644|464657|P3|STARTED|Follow-up Period||14
191772|NCT01359644|464658|P2|STARTED|Follow-up Period||16
191773|NCT01359644|464659|P1|STARTED|Follow-up Period||15
191774|NCT01359644|464650|P10|NOT COMPLETED|Treatment Period||0
191775|NCT01359644|464651|P9|NOT COMPLETED|Treatment Period||0
191776|NCT01359644|464652|P8|NOT COMPLETED|Treatment Period||0
191777|NCT01359644|464653|P7|NOT COMPLETED|Treatment Period||0
191778|NCT01359644|464654|P6|NOT COMPLETED|Treatment Period||2
191779|NCT01359644|464655|P5|NOT COMPLETED|Treatment Period||0
191780|NCT01359644|464656|P4|NOT COMPLETED|Treatment Period||0
191781|NCT01359644|464657|P3|NOT COMPLETED|Treatment Period||1
191782|NCT01359644|464658|P2|NOT COMPLETED|Treatment Period||1
191783|NCT01359644|464659|P1|NOT COMPLETED|Treatment Period||0
191784|NCT01359644|464650|P10|COMPLETED|Treatment Period||20
191785|NCT01359644|464651|P9|COMPLETED|Treatment Period||21
191786|NCT01359644|464652|P8|COMPLETED|Treatment Period||41
191787|NCT01359644|464653|P7|COMPLETED|Treatment Period||41
191788|NCT01359644|464654|P6|COMPLETED|Treatment Period||12
191789|NCT01359644|464655|P5|COMPLETED|Treatment Period||15
191790|NCT01359644|464656|P4|COMPLETED|Treatment Period||14
191791|NCT01359644|464657|P3|COMPLETED|Treatment Period||13
191792|NCT01359644|464658|P2|COMPLETED|Treatment Period||15
191793|NCT01359644|464659|P1|COMPLETED|Treatment Period||15
191794|NCT01359644|464650|P10|STARTED|Treatment Period||20
191795|NCT01359644|464651|P9|STARTED|Treatment Period||21
191796|NCT01359644|464652|P8|STARTED|Treatment Period||41
191797|NCT01359644|464653|P7|STARTED|Treatment Period||41
191798|NCT01359644|464654|P6|STARTED|Treatment Period||14
191799|NCT01359644|464655|P5|STARTED|Treatment Period||15
191800|NCT01359644|464656|P4|STARTED|Treatment Period||14
191801|NCT01359644|464657|P3|STARTED|Treatment Period||14
191802|NCT01359644|464658|P2|STARTED|Treatment Period||16
191803|NCT01359644|464659|P1|STARTED|Treatment Period||15
191804|NCT01359449|464703|P2|NOT COMPLETED|Overall Study||4
191805|NCT01359449|464704|P1|NOT COMPLETED|Overall Study||4
191806|NCT01359449|464703|P2|COMPLETED|Overall Study||58
191807|NCT01359449|464704|P1|COMPLETED|Overall Study||57
191808|NCT01359449|464703|P2|STARTED|Overall Study||62
191809|NCT01359449|464704|P1|STARTED|Overall Study||61
191810|NCT01359410|464728|P2|NOT COMPLETED|Overall Study||0
191811|NCT01359410|464729|P1|NOT COMPLETED|Overall Study||0
191812|NCT01359410|464728|P2|COMPLETED|Overall Study||46
191813|NCT01359410|464729|P1|COMPLETED|Overall Study||54
191814|NCT01359410|464728|P2|STARTED|Overall Study||46
191815|NCT01359410|464729|P1|STARTED|Overall Study||54
191816|NCT01359371|464743|P1|NOT COMPLETED|Overall Study||0
191817|NCT01359371|464743|P1|COMPLETED|Overall Study||41
191818|NCT01359371|464743|P1|STARTED|Overall Study||41
191819|NCT01359254|464750|P2|NOT COMPLETED|Overall Study||0
191820|NCT01359254|464751|P1|NOT COMPLETED|Overall Study||1
191821|NCT01359254|464750|P2|COMPLETED|Overall Study||0
191822|NCT01359254|464751|P1|COMPLETED|Overall Study||0
191823|NCT01359254|464750|P2|STARTED|Overall Study||0
191824|NCT01359254|464751|P1|STARTED|Overall Study||1
191825|NCT01359150|464761|P2|NOT COMPLETED|Overall Study||5
191826|NCT01359150|464762|P1|NOT COMPLETED|Overall Study||7
191827|NCT01359150|464761|P2|COMPLETED|Overall Study||106
191828|NCT01359150|464762|P1|COMPLETED|Overall Study||105
191829|NCT01359150|464761|P2|STARTED|Overall Study||111
191830|NCT01359150|464762|P1|STARTED|Overall Study||112
191831|NCT01359111|464784|P1|NOT COMPLETED|Overall Study||0
191832|NCT01359111|464784|P1|COMPLETED|Overall Study||20
191833|NCT01359111|464784|P1|STARTED|Overall Study||20
191834|NCT01359046|464793|P2|NOT COMPLETED|Overall Study||17
191835|NCT01359046|464794|P1|NOT COMPLETED|Overall Study||7
191836|NCT01359046|464793|P2|COMPLETED|Overall Study||127
191837|NCT01359046|464794|P1|COMPLETED|Overall Study||137
191838|NCT01359046|464793|P2|STARTED|Overall Study||144
191839|NCT01359046|464794|P1|STARTED|Overall Study||144
191840|NCT01359007|464802|P1|NOT COMPLETED|Overall Study||2
191841|NCT01359007|464802|P1|COMPLETED|Overall Study||3
191842|NCT01359007|464802|P1|STARTED|Overall Study||5
191843|NCT01358981|464817|P7|NOT COMPLETED|Period 4||0
191844|NCT01358981|464818|P6|NOT COMPLETED|Period 4||0
191845|NCT01358981|464819|P5|NOT COMPLETED|Period 4||0
191846|NCT01358981|464820|P4|NOT COMPLETED|Period 4||0
191847|NCT01358981|464821|P3|NOT COMPLETED|Period 4||0
191848|NCT01358981|464822|P2|NOT COMPLETED|Period 4||0
191849|NCT01358981|464823|P1|NOT COMPLETED|Period 4||0
191850|NCT01358981|464817|P7|COMPLETED|Period 4||0
191851|NCT01358981|464818|P6|COMPLETED|Period 4||0
191852|NCT01358981|464819|P5|COMPLETED|Period 4||0
191853|NCT01358981|464820|P4|COMPLETED|Period 4||2
191854|NCT01358981|464821|P3|COMPLETED|Period 4||2
191855|NCT01358981|464822|P2|COMPLETED|Period 4||2
191856|NCT01358981|464823|P1|COMPLETED|Period 4||2
191857|NCT01358981|464817|P7|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
191858|NCT01358981|464818|P6|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
191859|NCT01358981|464819|P5|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
191860|NCT01358981|464820|P4|STARTED|Period 4||2
191861|NCT01358981|464821|P3|STARTED|Period 4||2
191862|NCT01358981|464822|P2|STARTED|Period 4||2
191863|NCT01358981|464823|P1|STARTED|Period 4||2
191864|NCT01358981|464817|P7|NOT COMPLETED|Period 3||0
191865|NCT01358981|464818|P6|NOT COMPLETED|Period 3||0
191866|NCT01358981|464819|P5|NOT COMPLETED|Period 3||0
191867|NCT01358981|464820|P4|NOT COMPLETED|Period 3||0
191868|NCT01358981|464821|P3|NOT COMPLETED|Period 3||0
191869|NCT01358981|464822|P2|NOT COMPLETED|Period 3||0
191870|NCT01358981|464823|P1|NOT COMPLETED|Period 3||0
191871|NCT01358981|464817|P7|COMPLETED|Period 3||3
191872|NCT01358981|464818|P6|COMPLETED|Period 3||3
191873|NCT01358981|464819|P5|COMPLETED|Period 3||3
191874|NCT01358981|464820|P4|COMPLETED|Period 3||2
191875|NCT01358981|464821|P3|COMPLETED|Period 3||2
191876|NCT01358981|464822|P2|COMPLETED|Period 3||2
191877|NCT01358981|464823|P1|COMPLETED|Period 3||2
191878|NCT01358981|464817|P7|STARTED|Period 3||3
191879|NCT01358981|464818|P6|STARTED|Period 3||3
191880|NCT01358981|464819|P5|STARTED|Period 3||3
191881|NCT01358981|464820|P4|STARTED|Period 3||2
191882|NCT01358981|464821|P3|STARTED|Period 3||2
191883|NCT01358981|464822|P2|STARTED|Period 3||2
191884|NCT01358981|464823|P1|STARTED|Period 3||2
191885|NCT01358981|464817|P7|NOT COMPLETED|Period 2||0
191886|NCT01358981|464818|P6|NOT COMPLETED|Period 2||0
191887|NCT01358981|464819|P5|NOT COMPLETED|Period 2||0
191888|NCT01358981|464820|P4|NOT COMPLETED|Period 2||0
191889|NCT01358981|464821|P3|NOT COMPLETED|Period 2||0
191890|NCT01358981|464822|P2|NOT COMPLETED|Period 2||0
191891|NCT01358981|464823|P1|NOT COMPLETED|Period 2||0
191892|NCT01358981|464817|P7|COMPLETED|Period 2||3
191893|NCT01358981|464818|P6|COMPLETED|Period 2||3
191894|NCT01358981|464819|P5|COMPLETED|Period 2||3
191895|NCT01358981|464820|P4|COMPLETED|Period 2||2
191896|NCT01358981|464821|P3|COMPLETED|Period 2||2
191897|NCT01358981|464822|P2|COMPLETED|Period 2||2
191898|NCT01358981|464823|P1|COMPLETED|Period 2||2
191899|NCT01358981|464817|P7|STARTED|Period 2||3
191900|NCT01358981|464818|P6|STARTED|Period 2||3
191901|NCT01358981|464819|P5|STARTED|Period 2||3
191902|NCT01358981|464820|P4|STARTED|Period 2|One participant who withdrew in period 1 was replaced by another participant in period 2.|2
191903|NCT01358981|464821|P3|STARTED|Period 2||2
191904|NCT01358981|464822|P2|STARTED|Period 2||2
191905|NCT01358981|464823|P1|STARTED|Period 2||2
191906|NCT01358981|464817|P7|NOT COMPLETED|Period 1||0
191907|NCT01358981|464818|P6|NOT COMPLETED|Period 1||0
191908|NCT01358981|464819|P5|NOT COMPLETED|Period 1||0
191909|NCT01358981|464820|P4|NOT COMPLETED|Period 1||1
191910|NCT01358981|464821|P3|NOT COMPLETED|Period 1||0
191911|NCT01358981|464822|P2|NOT COMPLETED|Period 1||0
191912|NCT01358981|464823|P1|NOT COMPLETED|Period 1||0
191913|NCT01358981|464817|P7|COMPLETED|Period 1||3
191914|NCT01358981|464818|P6|COMPLETED|Period 1||3
191915|NCT01358981|464819|P5|COMPLETED|Period 1||3
191916|NCT01358981|464820|P4|COMPLETED|Period 1||1
191917|NCT01358981|464821|P3|COMPLETED|Period 1||2
191918|NCT01358981|464822|P2|COMPLETED|Period 1||2
191919|NCT01358981|464823|P1|COMPLETED|Period 1||2
191920|NCT01358981|464817|P7|Received at Least 1dose of Study Drug|Period 1||3
191921|NCT01358981|464818|P6|Received at Least 1dose of Study Drug|Period 1||3
191922|NCT01358981|464819|P5|Received at Least 1dose of Study Drug|Period 1||3
191923|NCT01358981|464820|P4|Received at Least 1dose of Study Drug|Period 1||2
191924|NCT01358981|464821|P3|Received at Least 1dose of Study Drug|Period 1||2
191925|NCT01358981|464822|P2|Received at Least 1dose of Study Drug|Period 1||2
191926|NCT01358981|464823|P1|Received at Least 1dose of Study Drug|Period 1||2
191927|NCT01358981|464817|P7|STARTED|Period 1||3
191928|NCT01358981|464818|P6|STARTED|Period 1||3
191929|NCT01358981|464819|P5|STARTED|Period 1||3
191930|NCT01358981|464820|P4|STARTED|Period 1||2
191931|NCT01358981|464821|P3|STARTED|Period 1||2
191932|NCT01358981|464822|P2|STARTED|Period 1||2
191933|NCT01358981|464823|P1|STARTED|Period 1||2
191934|NCT01358968|464884|P4|NOT COMPLETED|Continued Access Phase||7
191935|NCT01358968|464885|P3|NOT COMPLETED|Continued Access Phase||12
191936|NCT01358968|464886|P2|NOT COMPLETED|Continued Access Phase||0
191937|NCT01358968|464887|P1|NOT COMPLETED|Continued Access Phase||0
191938|NCT01358968|464884|P4|COMPLETED|Continued Access Phase||0
191939|NCT01358968|464885|P3|COMPLETED|Continued Access Phase||0
191940|NCT01358968|464886|P2|COMPLETED|Continued Access Phase||0
191941|NCT01358968|464887|P1|COMPLETED|Continued Access Phase||0
191942|NCT01358968|464884|P4|Received at Least 1 Dose of Study Drug|Continued Access Phase||7
191943|NCT01358968|464885|P3|Received at Least 1 Dose of Study Drug|Continued Access Phase||12
191944|NCT01358968|464886|P2|Received at Least 1 Dose of Study Drug|Continued Access Phase||0
191945|NCT01358968|464887|P1|Received at Least 1 Dose of Study Drug|Continued Access Phase||0
191946|NCT01358968|464884|P4|STARTED|Continued Access Phase||7
191947|NCT01358968|464885|P3|STARTED|Continued Access Phase||12
191948|NCT01358968|464886|P2|STARTED|Continued Access Phase||0
191949|NCT01358968|464887|P1|STARTED|Continued Access Phase||0
191950|NCT01358968|464884|P4|NOT COMPLETED|Period 2||0
191951|NCT01358968|464885|P3|NOT COMPLETED|Period 2||0
191952|NCT01358968|464886|P2|NOT COMPLETED|Period 2||1
191953|NCT01358968|464887|P1|NOT COMPLETED|Period 2||0
191954|NCT01358968|464884|P4|COMPLETED|Period 2||0
191955|NCT01358968|464885|P3|COMPLETED|Period 2||0
191956|NCT01358968|464886|P2|COMPLETED|Period 2||19
191957|NCT01358968|464887|P1|COMPLETED|Period 2||0
191958|NCT01358968|464884|P4|Received at Least 1 Dose of Study Drug|Period 2||0
191959|NCT01358968|464885|P3|Received at Least 1 Dose of Study Drug|Period 2||0
191960|NCT01358968|464886|P2|Received at Least 1 Dose of Study Drug|Period 2||19
191961|NCT01358968|464887|P1|Received at Least 1 Dose of Study Drug|Period 2||0
191962|NCT01358968|464884|P4|STARTED|Period 2||0
191963|NCT01358968|464885|P3|STARTED|Period 2||0
191964|NCT01358968|464886|P2|STARTED|Period 2||20
191965|NCT01358968|464887|P1|STARTED|Period 2||0
191966|NCT01358968|464884|P4|NOT COMPLETED|Period 1||0
191967|NCT01358968|464885|P3|NOT COMPLETED|Period 1||0
191968|NCT01358968|464886|P2|NOT COMPLETED|Period 1||0
191969|NCT01358968|464887|P1|NOT COMPLETED|Period 1||0
191970|NCT01358968|464884|P4|COMPLETED|Period 1||0
191971|NCT01358968|464885|P3|COMPLETED|Period 1||0
191972|NCT01358968|464886|P2|COMPLETED|Period 1||0
191973|NCT01358968|464887|P1|COMPLETED|Period 1||20
191974|NCT01358968|464884|P4|Received at Least 1 Dose of Study Drug|Period 1||0
191975|NCT01358968|464885|P3|Received at Least 1 Dose of Study Drug|Period 1||0
191976|NCT01358968|464886|P2|Received at Least 1 Dose of Study Drug|Period 1||0
191977|NCT01358968|464887|P1|Received at Least 1 Dose of Study Drug|Period 1||20
191978|NCT01358968|464884|P4|STARTED|Period 1||0
191979|NCT01358968|464885|P3|STARTED|Period 1||0
191980|NCT01358968|464886|P2|STARTED|Period 1||0
191981|NCT01358968|464887|P1|STARTED|Period 1||20
191982|NCT01358877|464903|P2|NOT COMPLETED|Overall Study||2404
191983|NCT01358877|464904|P1|NOT COMPLETED|Overall Study||2400
191984|NCT01358877|464903|P2|COMPLETED|Overall Study||0
191985|NCT01358877|464904|P1|COMPLETED|Overall Study||0
191986|NCT01358877|464903|P2|Received Study Drug (Safety Population)|Overall Study|38 pertuzumab participants did not receive pertuzumab and were included in placebo arm.|2405
191987|NCT01358877|464904|P1|Received Study Drug (Safety Population)|Overall Study|24 placebo participants received at least 1 dose of pertuzumab and were included in pertuzumab arm.|2364
191988|NCT01358877|464903|P2|Did Not Receive Study Drug|Overall Study||13
191989|NCT01358877|464904|P1|Did Not Receive Study Drug|Overall Study||22
191990|NCT01358877|464903|P2|STARTED|Overall Study||2404
191991|NCT01358877|464904|P1|STARTED|Overall Study||2400
191992|NCT01358864|464974|P8|NOT COMPLETED|Overall Study||55
191993|NCT01358864|464975|P7|NOT COMPLETED|Overall Study||65
191994|NCT01358864|464976|P6|NOT COMPLETED|Overall Study||13
191995|NCT01358864|464977|P5|NOT COMPLETED|Overall Study||11
191996|NCT01358864|464978|P4|NOT COMPLETED|Overall Study||19
191997|NCT01358864|464979|P3|NOT COMPLETED|Overall Study||16
191998|NCT01358864|464980|P2|NOT COMPLETED|Overall Study||13
191999|NCT01358864|464981|P1|NOT COMPLETED|Overall Study||31
192000|NCT01358864|464974|P8|COMPLETED|Overall Study||85
192001|NCT01358864|464975|P7|COMPLETED|Overall Study||81
192002|NCT01358864|464976|P6|COMPLETED|Overall Study||42
192003|NCT01358864|464977|P5|COMPLETED|Overall Study||46
192004|NCT01358864|464978|P4|COMPLETED|Overall Study||10
192005|NCT01358864|464979|P3|COMPLETED|Overall Study||87
192006|NCT01358864|464980|P2|COMPLETED|Overall Study||86
192007|NCT01358864|464981|P1|COMPLETED|Overall Study||18
192008|NCT01358864|464974|P8|STARTED|Overall Study||140
192009|NCT01358864|464975|P7|STARTED|Overall Study||146
192010|NCT01358864|464976|P6|STARTED|Overall Study||55
192011|NCT01358864|464977|P5|STARTED|Overall Study||57
192012|NCT01358864|464978|P4|STARTED|Overall Study||29
192013|NCT01358864|464979|P3|STARTED|Overall Study||103
192014|NCT01358864|464980|P2|STARTED|Overall Study||99
192015|NCT01358864|464981|P1|STARTED|Overall Study||49
192016|NCT01358825|465072|P2|NOT COMPLETED|Overall Study||1
192017|NCT01358825|465073|P1|NOT COMPLETED|Overall Study||0
192018|NCT01358825|465072|P2|COMPLETED|Overall Study||45
192019|NCT01358825|465073|P1|COMPLETED|Overall Study||12
192020|NCT01358825|465072|P2|STARTED|Overall Study||46
192021|NCT01358825|465073|P1|STARTED|Overall Study||12
192022|NCT01358760|465097|P3|NOT COMPLETED|Overall Study||25
192023|NCT01358760|465098|P2|NOT COMPLETED|Overall Study||20
192024|NCT01358760|465099|P1|NOT COMPLETED|Overall Study||22
192025|NCT01358760|465097|P3|COMPLETED|Overall Study||125
192026|NCT01358760|465098|P2|COMPLETED|Overall Study||128
192027|NCT01358760|465099|P1|COMPLETED|Overall Study||130
192028|NCT01358760|465097|P3|ITT Population|Overall Study||134
192029|NCT01358760|465098|P2|ITT Population|Overall Study||134
192030|NCT01358760|465099|P1|ITT Population|Overall Study||139
192031|NCT01358760|465097|P3|Safety Population|Overall Study||148
192032|NCT01358760|465098|P2|Safety Population|Overall Study||143
192033|NCT01358760|465099|P1|Safety Population|Overall Study||150
192034|NCT01358760|465097|P3|STARTED|Overall Study||150
192035|NCT01358760|465098|P2|STARTED|Overall Study||148
192036|NCT01358760|465099|P1|STARTED|Overall Study||152
192037|NCT01358734|465134|P3|NOT COMPLETED|Overall Study||34
192038|NCT01358734|465135|P2|NOT COMPLETED|Overall Study||39
192039|NCT01358734|465136|P1|NOT COMPLETED|Overall Study||15
192040|NCT01358734|465134|P3|COMPLETED|Overall Study||0
192041|NCT01358734|465135|P2|COMPLETED|Overall Study||0
192042|NCT01358734|465136|P1|COMPLETED|Overall Study||0
192043|NCT01358734|465134|P3|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|32
192044|NCT01358734|465135|P2|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|38
192045|NCT01358734|465136|P1|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|14
192046|NCT01358734|465134|P3|STARTED|Overall Study||34
192047|NCT01358734|465135|P2|STARTED|Overall Study||39
192048|NCT01358734|465136|P1|STARTED|Overall Study||15
192049|NCT01358721|465184|P4|NOT COMPLETED|Overall Study||24
192050|NCT01358721|465185|P3|NOT COMPLETED|Overall Study||22
192051|NCT01358721|465186|P2|NOT COMPLETED|Overall Study||22
192052|NCT01358721|465187|P1|NOT COMPLETED|Overall Study||21
192053|NCT01358721|465184|P4|COMPLETED|Overall Study||0
192054|NCT01358721|465185|P3|COMPLETED|Overall Study||1
192055|NCT01358721|465186|P2|COMPLETED|Overall Study||0
192056|NCT01358721|465187|P1|COMPLETED|Overall Study||1
192057|NCT01358721|465184|P4|STARTED|Overall Study||24
192058|NCT01358721|465185|P3|STARTED|Overall Study||23
192059|NCT01358721|465186|P2|STARTED|Overall Study||22
192060|NCT01358721|465187|P1|STARTED|Overall Study||22
192061|NCT01358708|465239|P2|NOT COMPLETED|Open-Label Treatment Phase||0
192062|NCT01358708|465240|P1|NOT COMPLETED|Open-Label Treatment Phase||0
192063|NCT01358708|465239|P2|COMPLETED|Open-Label Treatment Phase||12
192064|NCT01358708|465240|P1|COMPLETED|Open-Label Treatment Phase||5
192065|NCT01358708|465239|P2|STARTED|Open-Label Treatment Phase|Number of subjects on PLACEBO during double-blind treatment and entering the Open-Label Phase|12
192066|NCT01358708|465240|P1|STARTED|Open-Label Treatment Phase|Number of subjects on LACTEOL® during double-blind treatment and entering the Open-Label Phase|5
192067|NCT01358708|465239|P2|NOT COMPLETED|Double-Blind Treatment Phase||0
192068|NCT01358708|465240|P1|NOT COMPLETED|Double-Blind Treatment Phase||3
192069|NCT01358708|465239|P2|COMPLETED|Double-Blind Treatment Phase||13
192070|NCT01358708|465240|P1|COMPLETED|Double-Blind Treatment Phase||10
192071|NCT01358708|465239|P2|Received Study Medication|Double-Blind Treatment Phase||13
192072|NCT01358708|465240|P1|Received Study Medication|Double-Blind Treatment Phase|For 1 subject, unused med not returned to the site and intake of study medication not confirmed.|12
192073|NCT01358708|465239|P2|Randomized|Double-Blind Treatment Phase||13
192074|NCT01358708|465240|P1|Randomized|Double-Blind Treatment Phase||13
192075|NCT01358708|465239|P2|STARTED|Double-Blind Treatment Phase||13
192076|NCT01358708|465240|P1|STARTED|Double-Blind Treatment Phase||13
192077|NCT01358578|465263|P6|NOT COMPLETED|Follow-up Period||0
192078|NCT01358578|465264|P5|NOT COMPLETED|Follow-up Period||0
192079|NCT01358578|465265|P4|NOT COMPLETED|Follow-up Period||19
192080|NCT01358578|465266|P3|NOT COMPLETED|Follow-up Period||5
192081|NCT01358578|465267|P2|NOT COMPLETED|Follow-up Period||6
192082|NCT01358578|465268|P1|NOT COMPLETED|Follow-up Period||10
192083|NCT01358578|465263|P6|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
192084|NCT01358578|465264|P5|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
192085|NCT01358578|465265|P4|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|260
192086|NCT01358578|465266|P3|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|21
192087|NCT01358578|465267|P2|COMPLETED|Follow-up Period||119
192088|NCT01358578|465268|P1|COMPLETED|Follow-up Period||138
192089|NCT01358578|465263|P6|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
192090|NCT01358578|465264|P5|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
192091|NCT01358578|465265|P4|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|279
192092|NCT01358578|465266|P3|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|26
192093|NCT01358578|465267|P2|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 300 mg dose|125
192094|NCT01358578|465268|P1|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 150 mg dose|148
192095|NCT01358578|465263|P6|NOT COMPLETED|Maintenance Period||11
192096|NCT01358578|465264|P5|NOT COMPLETED|Maintenance Period||17
192097|NCT01358578|465265|P4|NOT COMPLETED|Maintenance Period||42
192098|NCT01358578|465266|P3|NOT COMPLETED|Maintenance Period||2
192099|NCT01358578|465267|P2|NOT COMPLETED|Maintenance Period||22
192100|NCT01358578|465268|P1|NOT COMPLETED|Maintenance Period||39
192101|NCT01358578|465263|P6|COMPLETED|Maintenance Period||131
192102|NCT01358578|465264|P5|COMPLETED|Maintenance Period||125
192103|NCT01358578|465265|P4|COMPLETED|Maintenance Period||263
192104|NCT01358578|465266|P3|COMPLETED|Maintenance Period||15
192105|NCT01358578|465267|P2|COMPLETED|Maintenance Period||290
192106|NCT01358578|465268|P1|COMPLETED|Maintenance Period||276
192107|NCT01358578|465263|P6|STARTED|Maintenance Period||142
192108|NCT01358578|465264|P5|STARTED|Maintenance Period||142
192109|NCT01358578|465265|P4|STARTED|Maintenance Period||305
192110|NCT01358578|465266|P3|STARTED|Maintenance Period||17
192111|NCT01358578|465267|P2|STARTED|Maintenance Period||312
192112|NCT01358578|465268|P1|STARTED|Maintenance Period||315
192113|NCT01358578|465263|P6|NOT COMPLETED|Induction Period||0
192114|NCT01358578|465264|P5|NOT COMPLETED|Induction Period||0
192115|NCT01358578|465265|P4|NOT COMPLETED|Induction Period||21
192116|NCT01358578|465266|P3|NOT COMPLETED|Induction Period||25
192117|NCT01358578|465267|P2|NOT COMPLETED|Induction Period||15
192118|NCT01358578|465268|P1|NOT COMPLETED|Induction Period||12
192119|NCT01358578|465263|P6|COMPLETED|Induction Period|These groups are populated after the induction period|0
192120|NCT01358578|465264|P5|COMPLETED|Induction Period|These groups are populated after the induction period|0
192121|NCT01358578|465265|P4|COMPLETED|Induction Period||305
192122|NCT01358578|465266|P3|COMPLETED|Induction Period||301
192123|NCT01358578|465267|P2|COMPLETED|Induction Period||312
192124|NCT01358578|465268|P1|COMPLETED|Induction Period||315
192125|NCT01358578|465263|P6|STARTED|Induction Period|These groups are populated after the induction period|0
192126|NCT01358578|465264|P5|STARTED|Induction Period|These groups are populated after the induction period|0
192127|NCT01358578|465265|P4|STARTED|Induction Period||326
192128|NCT01358578|465266|P3|STARTED|Induction Period||326
192129|NCT01358578|465267|P2|STARTED|Induction Period||327
192130|NCT01358578|465268|P1|STARTED|Induction Period||327
192131|NCT01358526|465320|P3|NOT COMPLETED|Double-blind Phase||121
192132|NCT01358526|465321|P2|NOT COMPLETED|Double-blind Phase||80
192133|NCT01358526|465322|P1|NOT COMPLETED|Double-blind Phase||0
192134|NCT01358526|465320|P3|COMPLETED|Double-blind Phase||181
192135|NCT01358526|465321|P2|COMPLETED|Double-blind Phase||218
192136|NCT01358526|465322|P1|COMPLETED|Double-blind Phase||0
192137|NCT01358526|465320|P3|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|302
192138|NCT01358526|465321|P2|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|298
192139|NCT01358526|465322|P1|STARTED|Double-blind Phase||0
192140|NCT01358526|465320|P3|NOT COMPLETED|Open-label Titration Period||0
192141|NCT01358526|465321|P2|NOT COMPLETED|Open-label Titration Period||0
192142|NCT01358526|465322|P1|NOT COMPLETED|Open-label Titration Period||494
192143|NCT01358526|465320|P3|COMPLETED|Open-label Titration Period||0
192144|NCT01358526|465321|P2|COMPLETED|Open-label Titration Period||0
192145|NCT01358526|465322|P1|COMPLETED|Open-label Titration Period|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|601
192146|NCT01358526|465320|P3|STARTED|Open-label Titration Period||0
192147|NCT01358526|465321|P2|STARTED|Open-label Titration Period||0
192148|NCT01358526|465322|P1|STARTED|Open-label Titration Period||1095
192149|NCT01358357|465339|P3|NOT COMPLETED|Double-Blind Phase||0
192150|NCT01358357|465340|P2|NOT COMPLETED|Double-Blind Phase||100
192151|NCT01358357|465341|P1|NOT COMPLETED|Double-Blind Phase||80
192152|NCT01358357|465339|P3|COMPLETED|Double-Blind Phase||0
192153|NCT01358357|465340|P2|COMPLETED|Double-Blind Phase||150
192154|NCT01358357|465341|P1|COMPLETED|Double-Blind Phase||166
192155|NCT01358357|465339|P3|STARTED|Double-Blind Phase||0
192156|NCT01358357|465340|P2|STARTED|Double-Blind Phase||250
192157|NCT01358357|465341|P1|STARTED|Double-Blind Phase||246
192158|NCT01358357|465339|P3|NOT COMPLETED|Open Label Phase||462
192159|NCT01358357|465340|P2|NOT COMPLETED|Open Label Phase||0
192160|NCT01358357|465341|P1|NOT COMPLETED|Open Label Phase||0
192161|NCT01358357|465339|P3|COMPLETED|Open Label Phase||503
192162|NCT01358357|465340|P2|COMPLETED|Open Label Phase||0
192163|NCT01358357|465341|P1|COMPLETED|Open Label Phase||0
192164|NCT01358357|465339|P3|STARTED|Open Label Phase||965
192165|NCT01358357|465340|P2|STARTED|Open Label Phase||0
192166|NCT01358357|465341|P1|STARTED|Open Label Phase||0
192167|NCT01358266|465377|P3|NOT COMPLETED|Open-Label Period||70
192168|NCT01358266|465378|P2|NOT COMPLETED|Open-Label Period||44
192169|NCT01358266|465379|P1|NOT COMPLETED|Open-Label Period||56
192170|NCT01358266|465377|P3|COMPLETED|Open-Label Period||44
192171|NCT01358266|465378|P2|COMPLETED|Open-Label Period||58
192172|NCT01358266|465379|P1|COMPLETED|Open-Label Period||63
192173|NCT01358266|465377|P3|STARTED|Open-Label Period||114
192174|NCT01358266|465378|P2|STARTED|Open-Label Period||102
192175|NCT01358266|465379|P1|STARTED|Open-Label Period||119
192176|NCT01358266|465377|P3|NOT COMPLETED|Double-Masked Period||39
192177|NCT01358266|465378|P2|NOT COMPLETED|Double-Masked Period||46
192178|NCT01358266|465379|P1|NOT COMPLETED|Double-Masked Period||33
192179|NCT01358266|465377|P3|COMPLETED|Double-Masked Period||137
192180|NCT01358266|465378|P2|COMPLETED|Double-Masked Period||162
192181|NCT01358266|465379|P1|COMPLETED|Double-Masked Period||175
192182|NCT01358266|465377|P3|STARTED|Double-Masked Period||176
192183|NCT01358266|465378|P2|STARTED|Double-Masked Period||208
192184|NCT01358266|465379|P1|STARTED|Double-Masked Period||208
192185|NCT01358175|465406|P3|NOT COMPLETED|Overall Study||32
192186|NCT01358175|465407|P2|NOT COMPLETED|Overall Study||28
192187|NCT01358175|465408|P1|NOT COMPLETED|Overall Study||21
192188|NCT01358175|465406|P3|COMPLETED|Overall Study||90
192189|NCT01358175|465407|P2|COMPLETED|Overall Study||97
192190|NCT01358175|465408|P1|COMPLETED|Overall Study||103
192191|NCT01358175|465406|P3|STARTED|Overall Study||122
192192|NCT01358175|465407|P2|STARTED|Overall Study||125
192193|NCT01358175|465408|P1|STARTED|Overall Study||124
192194|NCT01357980|465445|P4|NOT COMPLETED|Overall Study||0
192195|NCT01357980|465446|P3|NOT COMPLETED|Overall Study||1
192196|NCT01357980|465447|P2|NOT COMPLETED|Overall Study||1
192197|NCT01357980|465448|P1|NOT COMPLETED|Overall Study||0
192198|NCT01357980|465445|P4|COMPLETED|Overall Study||7
192199|NCT01357980|465446|P3|COMPLETED|Overall Study||16
192200|NCT01357980|465447|P2|COMPLETED|Overall Study||6
192201|NCT01357980|465448|P1|COMPLETED|Overall Study||16
192202|NCT01357980|465445|P4|STARTED|Overall Study||7
192203|NCT01357980|465446|P3|STARTED|Overall Study||17
192204|NCT01357980|465447|P2|STARTED|Overall Study||7
192205|NCT01357980|465448|P1|STARTED|Overall Study||16
192206|NCT01357915|465492|P2|NOT COMPLETED|Overall Study||0
192207|NCT01357915|465493|P1|NOT COMPLETED|Overall Study||3
192208|NCT01357915|465492|P2|COMPLETED|Overall Study||17
192209|NCT01357915|465493|P1|COMPLETED|Overall Study||27
192210|NCT01357915|465492|P2|STARTED|Overall Study||17
192211|NCT01357915|465493|P1|STARTED|Overall Study||30
192212|NCT01357889|465508|P2|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||4
192213|NCT01357889|465509|P1|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||3
192214|NCT01357889|465508|P2|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
192215|NCT01357889|465509|P1|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
192216|NCT01357889|465508|P2|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|142
192217|NCT01357889|465509|P1|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|141
192218|NCT01357889|465508|P2|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
192219|NCT01357889|465509|P1|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
192220|NCT01357889|465508|P2|COMPLETED|Multiple-dose Phase (MDP) (Overall)||126
192221|NCT01357889|465509|P1|COMPLETED|Multiple-dose Phase (MDP) (Overall)||125
192222|NCT01357889|465508|P2|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|142
192223|NCT01357889|465509|P1|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|141
192224|NCT01357889|465508|P2|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||2
192225|NCT01357889|465509|P1|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||4
192226|NCT01357889|465508|P2|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||79
192227|NCT01357889|465509|P1|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||82
192228|NCT01357889|465508|P2|STARTED|Single-dose Phase (BE Phase: 28 Days)||81
192229|NCT01357889|465509|P1|STARTED|Single-dose Phase (BE Phase: 28 Days)||86
192230|NCT01357850|465553|P4|NOT COMPLETED|Overall Study||0
192231|NCT01357850|465554|P3|NOT COMPLETED|Overall Study||0
192232|NCT01357850|465555|P2|NOT COMPLETED|Overall Study||0
192233|NCT01357850|465556|P1|NOT COMPLETED|Overall Study||1
192234|NCT01357850|465553|P4|COMPLETED|Overall Study||27
192235|NCT01357850|465554|P3|COMPLETED|Overall Study||13
192236|NCT01357850|465555|P2|COMPLETED|Overall Study||12
192237|NCT01357850|465556|P1|COMPLETED|Overall Study||29
192238|NCT01357850|465553|P4|STARTED|Overall Study||27
192239|NCT01357850|465554|P3|STARTED|Overall Study||13
192240|NCT01357850|465555|P2|STARTED|Overall Study||12
192241|NCT01357850|465556|P1|STARTED|Overall Study||30
192242|NCT01357720|465630|P2|NOT COMPLETED|Overall Study||5
192243|NCT01357720|465631|P1|NOT COMPLETED|Overall Study||2
192244|NCT01357720|465630|P2|COMPLETED|Overall Study||195
192245|NCT01357720|465631|P1|COMPLETED|Overall Study||198
192246|NCT01357720|465630|P2|STARTED|Overall Study||200
192247|NCT01357720|465631|P1|STARTED|Overall Study||200
192248|NCT01357655|465647|P2|NOT COMPLETED|Overall Study||0
192249|NCT01357655|465648|P1|NOT COMPLETED|Overall Study||66
192250|NCT01357655|465647|P2|COMPLETED|Overall Study||0
192251|NCT01357655|465648|P1|COMPLETED|Overall Study||0
192252|NCT01357655|465647|P2|STARTED|Overall Study||0
192253|NCT01357655|465648|P1|STARTED|Overall Study||66
192254|NCT01357616|465665|P2|NOT COMPLETED|Overall Study||9
192255|NCT01357616|465666|P1|NOT COMPLETED|Overall Study||10
192256|NCT01357616|465665|P2|COMPLETED|Overall Study||153
192257|NCT01357616|465666|P1|COMPLETED|Overall Study||156
192258|NCT01357616|465665|P2|STARTED|Overall Study||162
192259|NCT01357616|465666|P1|STARTED|Overall Study||166
192260|NCT01357564|465680|P2|NOT COMPLETED|Long-term (8-month) Follow-up||16
192261|NCT01357564|465681|P1|NOT COMPLETED|Long-term (8-month) Follow-up||2
192262|NCT01357564|465680|P2|COMPLETED|Long-term (8-month) Follow-up||102
192263|NCT01357564|465681|P1|COMPLETED|Long-term (8-month) Follow-up||104
192264|NCT01357564|465680|P2|STARTED|Long-term (8-month) Follow-up||118
192265|NCT01357564|465681|P1|STARTED|Long-term (8-month) Follow-up||106
192266|NCT01357564|465680|P2|NOT COMPLETED|Short-term (4-month) Follow up||50
192267|NCT01357564|465681|P1|NOT COMPLETED|Short-term (4-month) Follow up||48
192268|NCT01357564|465680|P2|COMPLETED|Short-term (4-month) Follow up||118
192269|NCT01357564|465681|P1|COMPLETED|Short-term (4-month) Follow up||106
192270|NCT01357564|465680|P2|STARTED|Short-term (4-month) Follow up||168
192271|NCT01357564|465681|P1|STARTED|Short-term (4-month) Follow up||154
192272|NCT01357551|465691|P2|NOT COMPLETED|Overall Study||11
192273|NCT01357551|465692|P1|NOT COMPLETED|Overall Study||22
192274|NCT01357551|465691|P2|COMPLETED|Overall Study||101
192275|NCT01357551|465692|P1|COMPLETED|Overall Study||88
192276|NCT01357551|465691|P2|STARTED|Overall Study||112
192277|NCT01357551|465692|P1|STARTED|Overall Study||110
192278|NCT01357512|465706|P2|NOT COMPLETED|Overall Study||5
192279|NCT01357512|465707|P1|NOT COMPLETED|Overall Study||12
192280|NCT01357512|465706|P2|COMPLETED|Overall Study||60
192281|NCT01357512|465707|P1|COMPLETED|Overall Study||53
192282|NCT01357512|465706|P2|STARTED|Overall Study||65
192283|NCT01357512|465707|P1|STARTED|Overall Study||65
192284|NCT01357239|465719|P4|NOT COMPLETED|Stratum II: Partially-Methylated||2
192285|NCT01357239|465720|P3|NOT COMPLETED|Stratum II: Partially-Methylated||1
192286|NCT01357239|465721|P2|NOT COMPLETED|Stratum II: Partially-Methylated||0
192287|NCT01357239|465722|P1|NOT COMPLETED|Stratum II: Partially-Methylated||0
192288|NCT01357239|465719|P4|COMPLETED|Stratum II: Partially-Methylated||18
192289|NCT01357239|465720|P3|COMPLETED|Stratum II: Partially-Methylated||21
192290|NCT01357239|465721|P2|COMPLETED|Stratum II: Partially-Methylated||21
192291|NCT01357239|465722|P1|COMPLETED|Stratum II: Partially-Methylated||23
192292|NCT01357239|465719|P4|STARTED|Stratum II: Partially-Methylated||20
192293|NCT01357239|465720|P3|STARTED|Stratum II: Partially-Methylated||22
192294|NCT01357239|465721|P2|STARTED|Stratum II: Partially-Methylated||21
192295|NCT01357239|465722|P1|STARTED|Stratum II: Partially-Methylated||23
192296|NCT01357239|465719|P4|NOT COMPLETED|Stratum I: Fully-Methylated||0
192297|NCT01357239|465720|P3|NOT COMPLETED|Stratum I: Fully-Methylated||1
192298|NCT01357239|465721|P2|NOT COMPLETED|Stratum I: Fully-Methylated||0
192299|NCT01357239|465722|P1|NOT COMPLETED|Stratum I: Fully-Methylated||0
192300|NCT01357239|465719|P4|COMPLETED|Stratum I: Fully-Methylated||22
192301|NCT01357239|465720|P3|COMPLETED|Stratum I: Fully-Methylated||16
192302|NCT01357239|465721|P2|COMPLETED|Stratum I: Fully-Methylated||6
192303|NCT01357239|465722|P1|COMPLETED|Stratum I: Fully-Methylated||8
192304|NCT01357239|465719|P4|STARTED|Stratum I: Fully-Methylated||22
192305|NCT01357239|465720|P3|STARTED|Stratum I: Fully-Methylated||17
192306|NCT01357239|465721|P2|STARTED|Stratum I: Fully-Methylated||6
192307|NCT01357239|465722|P1|STARTED|Stratum I: Fully-Methylated||8
192308|NCT01357239|465719|P4|NOT COMPLETED|Stratum: All Patients||2
192309|NCT01357239|465720|P3|NOT COMPLETED|Stratum: All Patients||2
192310|NCT01357239|465721|P2|NOT COMPLETED|Stratum: All Patients||0
192311|NCT01357239|465722|P1|NOT COMPLETED|Stratum: All Patients||0
192312|NCT01357239|465719|P4|COMPLETED|Stratum: All Patients||40
192313|NCT01357239|465720|P3|COMPLETED|Stratum: All Patients||37
192314|NCT01357239|465721|P2|COMPLETED|Stratum: All Patients||27
192315|NCT01357239|465722|P1|COMPLETED|Stratum: All Patients||31
192316|NCT01357239|465719|P4|STARTED|Stratum: All Patients||42
192317|NCT01357239|465720|P3|STARTED|Stratum: All Patients||39
192318|NCT01357239|465721|P2|STARTED|Stratum: All Patients||27
192319|NCT01357239|465722|P1|STARTED|Stratum: All Patients||31
192320|NCT01357161|465780|P3|NOT COMPLETED|Part 2 (Double-Blind Comparison)||62
192321|NCT01357161|465781|P2|NOT COMPLETED|Part 2 (Double-Blind Comparison)||59
192322|NCT01357161|465782|P1|NOT COMPLETED|Part 2 (Double-Blind Comparison)||0
192323|NCT01357161|465780|P3|COMPLETED|Part 2 (Double-Blind Comparison)||0
192324|NCT01357161|465781|P2|COMPLETED|Part 2 (Double-Blind Comparison)||0
192325|NCT01357161|465782|P1|COMPLETED|Part 2 (Double-Blind Comparison)||0
192326|NCT01357161|465780|P3|Treated|Part 2 (Double-Blind Comparison)||60
192327|NCT01357161|465781|P2|Treated|Part 2 (Double-Blind Comparison)||59
192328|NCT01357161|465782|P1|Treated|Part 2 (Double-Blind Comparison)||0
192329|NCT01357161|465780|P3|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|62
192330|NCT01357161|465781|P2|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|59
192331|NCT01357161|465782|P1|STARTED|Part 2 (Double-Blind Comparison)||0
192332|NCT01357161|465780|P3|NOT COMPLETED|Part 1 (Open Label Run-in)||0
192333|NCT01357161|465781|P2|NOT COMPLETED|Part 1 (Open Label Run-in)||0
192334|NCT01357161|465782|P1|NOT COMPLETED|Part 1 (Open Label Run-in)||15
192335|NCT01357161|465780|P3|COMPLETED|Part 1 (Open Label Run-in)||0
192336|NCT01357161|465781|P2|COMPLETED|Part 1 (Open Label Run-in)||0
192337|NCT01357161|465782|P1|COMPLETED|Part 1 (Open Label Run-in)||0
192338|NCT01357161|465780|P3|STARTED|Part 1 (Open Label Run-in)||0
192339|NCT01357161|465781|P2|STARTED|Part 1 (Open Label Run-in)||0
192340|NCT01357161|465782|P1|STARTED|Part 1 (Open Label Run-in)||15
192341|NCT01357148|465811|P1|NOT COMPLETED|Overall Study||0
192342|NCT01357148|465811|P1|COMPLETED|Overall Study||143
192343|NCT01357148|465811|P1|STARTED|Overall Study||143
192344|NCT01357135|465821|P3|NOT COMPLETED|Overall Study||263
192345|NCT01357135|465822|P2|NOT COMPLETED|Overall Study||223
192346|NCT01357135|465823|P1|NOT COMPLETED|Overall Study||598
192347|NCT01357135|465821|P3|COMPLETED|Overall Study||583
192348|NCT01357135|465822|P2|COMPLETED|Overall Study||510
192349|NCT01357135|465823|P1|COMPLETED|Overall Study||1276
192350|NCT01357135|465821|P3|STARTED|Overall Study||846
192351|NCT01357135|465822|P2|STARTED|Overall Study||733
192352|NCT01357135|465823|P1|STARTED|Overall Study||1874
192353|NCT01356966|465834|P2|NOT COMPLETED|Overall Study||2
192354|NCT01356966|465835|P1|NOT COMPLETED|Overall Study||2
192355|NCT01356966|465834|P2|COMPLETED|Overall Study||12
192356|NCT01356966|465835|P1|COMPLETED|Overall Study||16
192357|NCT01356966|465834|P2|STARTED|Overall Study||14
192358|NCT01356966|465835|P1|STARTED|Overall Study||18
192359|NCT01356940|465847|P2|NOT COMPLETED|Second Intervention (28 Days)||0
192360|NCT01356940|465848|P1|NOT COMPLETED|Second Intervention (28 Days)||1
192361|NCT01356940|465847|P2|COMPLETED|Second Intervention (28 Days)||21
192362|NCT01356940|465848|P1|COMPLETED|Second Intervention (28 Days)||20
192363|NCT01356940|465847|P2|STARTED|Second Intervention (28 Days)||21
192364|NCT01356940|465848|P1|STARTED|Second Intervention (28 Days)||21
192365|NCT01356940|465847|P2|NOT COMPLETED|Washout (14 Days)||0
192366|NCT01356940|465848|P1|NOT COMPLETED|Washout (14 Days)||0
192367|NCT01356940|465847|P2|COMPLETED|Washout (14 Days)||21
192368|NCT01356940|465848|P1|COMPLETED|Washout (14 Days)||21
192369|NCT01356940|465847|P2|STARTED|Washout (14 Days)||21
192370|NCT01356940|465848|P1|STARTED|Washout (14 Days)||21
192371|NCT01356940|465847|P2|NOT COMPLETED|First Intervention (28 Days)||0
192372|NCT01356940|465848|P1|NOT COMPLETED|First Intervention (28 Days)||1
192373|NCT01356940|465847|P2|COMPLETED|First Intervention (28 Days)||21
192374|NCT01356940|465848|P1|COMPLETED|First Intervention (28 Days)||21
192375|NCT01356940|465847|P2|STARTED|First Intervention (28 Days)||21
192376|NCT01356940|465848|P1|STARTED|First Intervention (28 Days)||22
192377|NCT01356667|465858|P2|NOT COMPLETED|Overall Study||6
192378|NCT01356667|465859|P1|NOT COMPLETED|Overall Study||4
192379|NCT01356667|465858|P2|COMPLETED|Overall Study||0
192380|NCT01356667|465859|P1|COMPLETED|Overall Study||0
192381|NCT01356667|465858|P2|STARTED|Overall Study||6
192382|NCT01356667|465859|P1|STARTED|Overall Study||4
192383|NCT01356628|465869|P1|NOT COMPLETED|Overall Study||0
192384|NCT01356628|465869|P1|COMPLETED|Overall Study||23
192385|NCT01356628|465869|P1|STARTED|Overall Study||23
192386|NCT01356602|465877|P3|NOT COMPLETED|Overall Study||24
192387|NCT01356602|465878|P2|NOT COMPLETED|Overall Study||15
192388|NCT01356602|465879|P1|NOT COMPLETED|Overall Study||9
192389|NCT01356602|465877|P3|COMPLETED|Overall Study||108
192390|NCT01356602|465878|P2|COMPLETED|Overall Study||117
192391|NCT01356602|465879|P1|COMPLETED|Overall Study||124
192392|NCT01356602|465877|P3|Full Analysis Set|Overall Study||129
192393|NCT01356602|465878|P2|Full Analysis Set|Overall Study||129
192394|NCT01356602|465879|P1|Full Analysis Set|Overall Study||131
192395|NCT01356602|465877|P3|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
192396|NCT01356602|465878|P2|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
192397|NCT01356602|465879|P1|Safety Set|Overall Study|In this arm, 1 patient had only 3 placebo injections and 3 patients also took other active drug.|133
192398|NCT01356602|465877|P3|STARTED|Overall Study||132
192399|NCT01356602|465878|P2|STARTED|Overall Study||132
192400|NCT01356602|465879|P1|STARTED|Overall Study||133
192401|NCT01356589|465938|P1|NOT COMPLETED|Overall Study||5
192402|NCT01356589|465938|P1|COMPLETED|Overall Study||1283
192403|NCT01356589|465938|P1|Treated|Overall Study||1285
192404|NCT01356589|465938|P1|STARTED|Overall Study||1288
192405|NCT01356498|465950|P6|NOT COMPLETED|Overall Study||14
192406|NCT01356498|465951|P5|NOT COMPLETED|Overall Study||20
192407|NCT01356498|465952|P4|NOT COMPLETED|Overall Study||14
192408|NCT01356498|465953|P3|NOT COMPLETED|Overall Study||12
192409|NCT01356498|465954|P2|NOT COMPLETED|Overall Study||8
192410|NCT01356498|465955|P1|NOT COMPLETED|Overall Study||11
192411|NCT01356498|465950|P6|COMPLETED|Overall Study||2
192412|NCT01356498|465951|P5|COMPLETED|Overall Study||8
192413|NCT01356498|465952|P4|COMPLETED|Overall Study||8
192414|NCT01356498|465953|P3|COMPLETED|Overall Study||11
192415|NCT01356498|465954|P2|COMPLETED|Overall Study||17
192416|NCT01356498|465955|P1|COMPLETED|Overall Study||24
192417|NCT01356498|465950|P6|STARTED|Overall Study||16
192418|NCT01356498|465951|P5|STARTED|Overall Study||28
192419|NCT01356498|465952|P4|STARTED|Overall Study||22
192420|NCT01356498|465953|P3|STARTED|Overall Study||23
192421|NCT01356498|465954|P2|STARTED|Overall Study|2 other patients received no investigational drug in C0407 but elected to be followed in Observation|25
192422|NCT01356498|465955|P1|STARTED|Overall Study||35
192423|NCT01356407|465995|P2|NOT COMPLETED|Overall Study||4
192424|NCT01356407|465996|P1|NOT COMPLETED|Overall Study||6
192425|NCT01356407|465995|P2|COMPLETED|Overall Study||146
192426|NCT01356407|465996|P1|COMPLETED|Overall Study||144
192427|NCT01356407|465995|P2|STARTED|Overall Study||150
192428|NCT01356407|465996|P1|STARTED|Overall Study||150
192429|NCT01356277|466014|P2|NOT COMPLETED|Intervention Interval||7
192430|NCT01356277|466015|P1|NOT COMPLETED|Intervention Interval||10
192431|NCT01356277|466014|P2|COMPLETED|Intervention Interval||81
192432|NCT01356277|466015|P1|COMPLETED|Intervention Interval||66
192433|NCT01356277|466014|P2|STARTED|Intervention Interval||88
192434|NCT01356277|466015|P1|STARTED|Intervention Interval||76
192435|NCT01356277|466014|P2|NOT COMPLETED|Run-in||0
192436|NCT01356277|466015|P1|NOT COMPLETED|Run-in||5
192437|NCT01356277|466014|P2|COMPLETED|Run-in||88
192438|NCT01356277|466015|P1|COMPLETED|Run-in||76
192439|NCT01356277|466014|P2|STARTED|Run-in||88
192440|NCT01356277|466015|P1|STARTED|Run-in||81
192441|NCT01356147|466035|P2|NOT COMPLETED|Overall Study||0
192442|NCT01356147|466036|P1|NOT COMPLETED|Overall Study||0
192443|NCT01356147|466035|P2|COMPLETED|Overall Study||6
192444|NCT01356147|466036|P1|COMPLETED|Overall Study||5
192445|NCT01356147|466035|P2|STARTED|Overall Study||6
192446|NCT01356147|466036|P1|STARTED|Overall Study||5
192447|NCT01355978|466046|P1|NOT COMPLETED|Overall Study||4
192448|NCT01355978|466046|P1|COMPLETED|Overall Study||18
192449|NCT01355978|466046|P1|STARTED|Overall Study||22
192450|NCT01355796|466052|P2|NOT COMPLETED|Overall Study||0
192451|NCT01355796|466053|P1|NOT COMPLETED|Overall Study||0
192452|NCT01355796|466052|P2|COMPLETED|Overall Study||15
192453|NCT01355796|466053|P1|COMPLETED|Overall Study||15
192454|NCT01355796|466052|P2|Second Intervention for 14 Days|Overall Study||15
192455|NCT01355796|466053|P1|Second Intervention for 14 Days|Overall Study||15
192456|NCT01355796|466052|P2|Washout Period for 7 Days|Overall Study||15
192457|NCT01355796|466053|P1|Washout Period for 7 Days|Overall Study||15
192458|NCT01355796|466052|P2|First Intervention for 14 Days|Overall Study||15
192459|NCT01355796|466053|P1|First Intervention for 14 Days|Overall Study||15
192460|NCT01355796|466052|P2|STARTED|Overall Study||15
192461|NCT01355796|466053|P1|STARTED|Overall Study||15
192462|NCT01355705|466061|P1|NOT COMPLETED|Overall Study||0
192463|NCT01355705|466061|P1|COMPLETED|Overall Study||14
192464|NCT01355705|466061|P1|STARTED|Overall Study||14
192465|NCT01355679|466068|P1|NOT COMPLETED|Overall Study||2
192466|NCT01355679|466068|P1|COMPLETED|Overall Study||14
192467|NCT01355679|466068|P1|STARTED|Overall Study||16
192468|NCT01355627|466077|P2|NOT COMPLETED|Overall Study||38
192469|NCT01355627|466078|P1|NOT COMPLETED|Overall Study||33
192470|NCT01355627|466077|P2|COMPLETED|Overall Study||326
192471|NCT01355627|466078|P1|COMPLETED|Overall Study||329
192472|NCT01355627|466077|P2|Full Analysis Set|Overall Study|One participant randomized to Current Practice actually received TachoSil®.|365
192473|NCT01355627|466078|P1|Full Analysis Set|Overall Study|One participant's data for final follow-up is missing, completion status could not be confirmed.|361
192474|NCT01355627|466077|P2|Safety Analysis Set|Overall Study||364
192475|NCT01355627|466078|P1|Safety Analysis Set|Overall Study||362
192476|NCT01355627|466077|P2|STARTED|Overall Study||364
192477|NCT01355627|466078|P1|STARTED|Overall Study||362
192478|NCT01355588|466090|P4|NOT COMPLETED|Fourth Intervention (After Washout)||0
192479|NCT01355588|466091|P3|NOT COMPLETED|Fourth Intervention (After Washout)||0
192480|NCT01355588|466092|P2|NOT COMPLETED|Fourth Intervention (After Washout)||0
192481|NCT01355588|466093|P1|NOT COMPLETED|Fourth Intervention (After Washout)||0
192482|NCT01355588|466090|P4|COMPLETED|Fourth Intervention (After Washout)||4
192483|NCT01355588|466091|P3|COMPLETED|Fourth Intervention (After Washout)||4
192484|NCT01355588|466092|P2|COMPLETED|Fourth Intervention (After Washout)||4
192485|NCT01355588|466093|P1|COMPLETED|Fourth Intervention (After Washout)||4
192486|NCT01355588|466090|P4|STARTED|Fourth Intervention (After Washout)||4
192487|NCT01355588|466091|P3|STARTED|Fourth Intervention (After Washout)||4
192488|NCT01355588|466092|P2|STARTED|Fourth Intervention (After Washout)||4
192489|NCT01355588|466093|P1|STARTED|Fourth Intervention (After Washout)||4
192490|NCT01355588|466090|P4|NOT COMPLETED|Washout (3-7 Days)||0
192491|NCT01355588|466091|P3|NOT COMPLETED|Washout (3-7 Days)||0
192492|NCT01355588|466092|P2|NOT COMPLETED|Washout (3-7 Days)||0
192493|NCT01355588|466093|P1|NOT COMPLETED|Washout (3-7 Days)||0
192494|NCT01355588|466090|P4|COMPLETED|Washout (3-7 Days)||4
192495|NCT01355588|466091|P3|COMPLETED|Washout (3-7 Days)||4
192496|NCT01355588|466092|P2|COMPLETED|Washout (3-7 Days)||4
192497|NCT01355588|466093|P1|COMPLETED|Washout (3-7 Days)||4
192498|NCT01355588|466090|P4|STARTED|Washout (3-7 Days)||4
192499|NCT01355588|466091|P3|STARTED|Washout (3-7 Days)||4
192500|NCT01355588|466092|P2|STARTED|Washout (3-7 Days)||4
192501|NCT01355588|466093|P1|STARTED|Washout (3-7 Days)||4
192502|NCT01355588|466090|P4|NOT COMPLETED|Third Intervention (After Washout)||0
192503|NCT01355588|466091|P3|NOT COMPLETED|Third Intervention (After Washout)||0
192504|NCT01355588|466092|P2|NOT COMPLETED|Third Intervention (After Washout)||0
192505|NCT01355588|466093|P1|NOT COMPLETED|Third Intervention (After Washout)||0
192506|NCT01355588|466090|P4|COMPLETED|Third Intervention (After Washout)||4
192507|NCT01355588|466091|P3|COMPLETED|Third Intervention (After Washout)||4
192508|NCT01355588|466092|P2|COMPLETED|Third Intervention (After Washout)||4
192509|NCT01355588|466093|P1|COMPLETED|Third Intervention (After Washout)||4
192510|NCT01355588|466090|P4|STARTED|Third Intervention (After Washout)||4
192511|NCT01355588|466091|P3|STARTED|Third Intervention (After Washout)||4
192512|NCT01355588|466092|P2|STARTED|Third Intervention (After Washout)||4
192513|NCT01355588|466093|P1|STARTED|Third Intervention (After Washout)||4
192514|NCT01355588|466090|P4|NOT COMPLETED|Washout (3-7 Days)||0
192515|NCT01355588|466091|P3|NOT COMPLETED|Washout (3-7 Days)||0
192516|NCT01355588|466092|P2|NOT COMPLETED|Washout (3-7 Days)||0
192517|NCT01355588|466093|P1|NOT COMPLETED|Washout (3-7 Days)||0
192518|NCT01355588|466090|P4|COMPLETED|Washout (3-7 Days)||4
192519|NCT01355588|466091|P3|COMPLETED|Washout (3-7 Days)||4
192520|NCT01355588|466092|P2|COMPLETED|Washout (3-7 Days)||4
192521|NCT01355588|466093|P1|COMPLETED|Washout (3-7 Days)||4
192522|NCT01355588|466090|P4|STARTED|Washout (3-7 Days)||4
192523|NCT01355588|466091|P3|STARTED|Washout (3-7 Days)||4
192524|NCT01355588|466092|P2|STARTED|Washout (3-7 Days)||4
192525|NCT01355588|466093|P1|STARTED|Washout (3-7 Days)||4
192526|NCT01355588|466090|P4|NOT COMPLETED|Second Intervention (After Washout)||0
192527|NCT01355588|466091|P3|NOT COMPLETED|Second Intervention (After Washout)||0
192528|NCT01355588|466092|P2|NOT COMPLETED|Second Intervention (After Washout)||0
192529|NCT01355588|466093|P1|NOT COMPLETED|Second Intervention (After Washout)||0
192530|NCT01355588|466090|P4|COMPLETED|Second Intervention (After Washout)||4
192531|NCT01355588|466091|P3|COMPLETED|Second Intervention (After Washout)||4
192532|NCT01355588|466092|P2|COMPLETED|Second Intervention (After Washout)||4
192533|NCT01355588|466093|P1|COMPLETED|Second Intervention (After Washout)||4
192534|NCT01355588|466090|P4|STARTED|Second Intervention (After Washout)||4
192535|NCT01355588|466091|P3|STARTED|Second Intervention (After Washout)||4
192536|NCT01355588|466092|P2|STARTED|Second Intervention (After Washout)||4
192537|NCT01355588|466093|P1|STARTED|Second Intervention (After Washout)||4
192538|NCT01355588|466090|P4|NOT COMPLETED|Washout (3-7 Days)||0
192539|NCT01355588|466091|P3|NOT COMPLETED|Washout (3-7 Days)||0
192540|NCT01355588|466092|P2|NOT COMPLETED|Washout (3-7 Days)||0
192541|NCT01355588|466093|P1|NOT COMPLETED|Washout (3-7 Days)||0
192542|NCT01355588|466090|P4|COMPLETED|Washout (3-7 Days)||4
192543|NCT01355588|466091|P3|COMPLETED|Washout (3-7 Days)||4
192544|NCT01355588|466092|P2|COMPLETED|Washout (3-7 Days)||4
192545|NCT01355588|466093|P1|COMPLETED|Washout (3-7 Days)||4
192546|NCT01355588|466090|P4|STARTED|Washout (3-7 Days)||4
192547|NCT01355588|466091|P3|STARTED|Washout (3-7 Days)||4
192548|NCT01355588|466092|P2|STARTED|Washout (3-7 Days)||4
192549|NCT01355588|466093|P1|STARTED|Washout (3-7 Days)||4
192550|NCT01355588|466090|P4|NOT COMPLETED|First Intervention (Day 1)||0
192551|NCT01355588|466091|P3|NOT COMPLETED|First Intervention (Day 1)||0
192552|NCT01355588|466092|P2|NOT COMPLETED|First Intervention (Day 1)||0
192553|NCT01355588|466093|P1|NOT COMPLETED|First Intervention (Day 1)||0
192554|NCT01355588|466090|P4|COMPLETED|First Intervention (Day 1)||4
192555|NCT01355588|466091|P3|COMPLETED|First Intervention (Day 1)||4
192556|NCT01355588|466092|P2|COMPLETED|First Intervention (Day 1)||4
192557|NCT01355588|466093|P1|COMPLETED|First Intervention (Day 1)||4
192558|NCT01355588|466090|P4|STARTED|First Intervention (Day 1)||4
192559|NCT01355588|466091|P3|STARTED|First Intervention (Day 1)||4
192560|NCT01355588|466092|P2|STARTED|First Intervention (Day 1)||4
192561|NCT01355588|466093|P1|STARTED|First Intervention (Day 1)||4
192562|NCT01355523|466117|P2|NOT COMPLETED|Overall Study||10
192563|NCT01355523|466118|P1|NOT COMPLETED|Overall Study||1
192564|NCT01355523|466117|P2|COMPLETED|Overall Study||16
192565|NCT01355523|466118|P1|COMPLETED|Overall Study||27
192566|NCT01355523|466117|P2|STARTED|Overall Study||26
192567|NCT01355523|466118|P1|STARTED|Overall Study||28
192568|NCT01355484|466162|P2|NOT COMPLETED|Overall Study||54
192569|NCT01355484|466163|P1|NOT COMPLETED|Overall Study||51
192570|NCT01355484|466162|P2|COMPLETED|Overall Study||107
192571|NCT01355484|466163|P1|COMPLETED|Overall Study||109
192572|NCT01355484|466162|P2|STARTED|Overall Study||161
192573|NCT01355484|466163|P1|STARTED|Overall Study||160
192574|NCT01355471|466173|P2|NOT COMPLETED|Overall Study||3
192575|NCT01355471|466174|P1|NOT COMPLETED|Overall Study||7
192576|NCT01355471|466173|P2|COMPLETED|Overall Study||142
192577|NCT01355471|466174|P1|COMPLETED|Overall Study||141
192578|NCT01355471|466173|P2|STARTED|Overall Study||145
192579|NCT01355471|466174|P1|STARTED|Overall Study||148
192580|NCT01355458|466182|P2|NOT COMPLETED|Overall Study||4
192581|NCT01355458|466183|P1|NOT COMPLETED|Overall Study||2
192582|NCT01355458|466182|P2|COMPLETED|Overall Study||127
192583|NCT01355458|466183|P1|COMPLETED|Overall Study||127
192584|NCT01355458|466182|P2|STARTED|Overall Study||131
192585|NCT01355458|466183|P1|STARTED|Overall Study||129
192586|NCT01355419|466189|P1|NOT COMPLETED|Overall Study||8
192587|NCT01355419|466189|P1|COMPLETED|Overall Study||142
192588|NCT01355419|466189|P1|STARTED|Overall Study||150
192589|NCT01355302|466194|P3|NOT COMPLETED|Phase 2||0
192590|NCT01355302|466195|P2|NOT COMPLETED|Phase 2||0
192591|NCT01355302|466196|P1|NOT COMPLETED|Phase 2||0
192592|NCT01355302|466194|P3|COMPLETED|Phase 2||0
192593|NCT01355302|466195|P2|COMPLETED|Phase 2||0
192594|NCT01355302|466196|P1|COMPLETED|Phase 2||0
192595|NCT01355302|466194|P3|STARTED|Phase 2|The study was terminated prior to enrollment|0
192596|NCT01355302|466195|P2|STARTED|Phase 2|The study was terminated prior to enrollment|0
192597|NCT01355302|466196|P1|STARTED|Phase 2|Treatment arm not designated for phase 2.|0
192598|NCT01355302|466194|P3|NOT COMPLETED|Phase 1b||0
192599|NCT01355302|466195|P2|NOT COMPLETED|Phase 1b||0
192600|NCT01355302|466196|P1|NOT COMPLETED|Phase 1b||6
192601|NCT01355302|466194|P3|COMPLETED|Phase 1b||0
192602|NCT01355302|466195|P2|COMPLETED|Phase 1b||0
192603|NCT01355302|466196|P1|COMPLETED|Phase 1b|The subject who completed 6 cycles was withdrawn by sponsor request.|1
192604|NCT01355302|466194|P3|STARTED|Phase 1b||0
192605|NCT01355302|466195|P2|STARTED|Phase 1b||0
192606|NCT01355302|466196|P1|STARTED|Phase 1b|Replaced 1 subject; who discontinued study drug in first cycle|7
192607|NCT01355289|466211|P5|NOT COMPLETED|Open Label Extension||34
192608|NCT01355289|466212|P4|NOT COMPLETED|Open Label Extension||0
192609|NCT01355289|466213|P3|NOT COMPLETED|Open Label Extension||0
192610|NCT01355289|466214|P2|NOT COMPLETED|Open Label Extension||0
192611|NCT01355289|466215|P1|NOT COMPLETED|Open Label Extension||0
192612|NCT01355289|466211|P5|COMPLETED|Open Label Extension||28
192613|NCT01355289|466212|P4|COMPLETED|Open Label Extension||0
192614|NCT01355289|466213|P3|COMPLETED|Open Label Extension||0
192615|NCT01355289|466214|P2|COMPLETED|Open Label Extension||0
192616|NCT01355289|466215|P1|COMPLETED|Open Label Extension||0
192617|NCT01355289|466211|P5|STARTED|Open Label Extension||62
192618|NCT01355289|466212|P4|STARTED|Open Label Extension||0
192619|NCT01355289|466213|P3|STARTED|Open Label Extension||0
192620|NCT01355289|466214|P2|STARTED|Open Label Extension||0
192621|NCT01355289|466215|P1|STARTED|Open Label Extension||0
192622|NCT01355289|466211|P5|NOT COMPLETED|Core Study||0
192623|NCT01355289|466212|P4|NOT COMPLETED|Core Study||2
192624|NCT01355289|466213|P3|NOT COMPLETED|Core Study||0
192625|NCT01355289|466214|P2|NOT COMPLETED|Core Study||0
192626|NCT01355289|466215|P1|NOT COMPLETED|Core Study||1
192627|NCT01355289|466211|P5|COMPLETED|Core Study||0
192628|NCT01355289|466212|P4|COMPLETED|Core Study||12
192629|NCT01355289|466213|P3|COMPLETED|Core Study||18
192630|NCT01355289|466214|P2|COMPLETED|Core Study||16
192631|NCT01355289|466215|P1|COMPLETED|Core Study||16
192632|NCT01355289|466211|P5|STARTED|Core Study||0
192633|NCT01355289|466212|P4|STARTED|Core Study||14
192634|NCT01355289|466213|P3|STARTED|Core Study||18
192635|NCT01355289|466214|P2|STARTED|Core Study||16
192636|NCT01355289|466215|P1|STARTED|Core Study||17
192637|NCT01355224|466242|P4|NOT COMPLETED|Overall Study||29
192638|NCT01355224|466243|P3|NOT COMPLETED|Overall Study||19
192639|NCT01355224|466244|P2|NOT COMPLETED|Overall Study||23
192640|NCT01355224|466245|P1|NOT COMPLETED|Overall Study||31
192641|NCT01355224|466242|P4|COMPLETED|Overall Study||172
192642|NCT01355224|466243|P3|COMPLETED|Overall Study||177
192643|NCT01355224|466244|P2|COMPLETED|Overall Study||180
192644|NCT01355224|466245|P1|COMPLETED|Overall Study||167
192645|NCT01355224|466242|P4|Competed Baseline|Overall Study||193
192646|NCT01355224|466243|P3|Competed Baseline|Overall Study||193
192647|NCT01355224|466244|P2|Competed Baseline|Overall Study||200
192648|NCT01355224|466245|P1|Competed Baseline|Overall Study||191
192649|NCT01355224|466242|P4|STARTED|Overall Study||201
192650|NCT01355224|466243|P3|STARTED|Overall Study||196
192651|NCT01355224|466244|P2|STARTED|Overall Study||203
192652|NCT01355224|466245|P1|STARTED|Overall Study||198
192653|NCT01355081|466268|P3|NOT COMPLETED|Overall Study||11
192654|NCT01355081|466269|P2|NOT COMPLETED|Overall Study||10
192655|NCT01355081|466270|P1|NOT COMPLETED|Overall Study||7
192656|NCT01355081|466268|P3|COMPLETED|Overall Study||113
192657|NCT01355081|466269|P2|COMPLETED|Overall Study||113
192658|NCT01355081|466270|P1|COMPLETED|Overall Study||112
192659|NCT01355081|466268|P3|STARTED|Overall Study||124
192660|NCT01355081|466269|P2|STARTED|Overall Study||123
192661|NCT01355081|466270|P1|STARTED|Overall Study||119
192662|NCT01355068|466293|P2|NOT COMPLETED|Second Intervention Period||0
192663|NCT01355068|466294|P1|NOT COMPLETED|Second Intervention Period||0
192664|NCT01355068|466293|P2|COMPLETED|Second Intervention Period||11
192665|NCT01355068|466294|P1|COMPLETED|Second Intervention Period||13
192666|NCT01355068|466293|P2|STARTED|Second Intervention Period||11
192667|NCT01355068|466294|P1|STARTED|Second Intervention Period||13
192668|NCT01355068|466293|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
192669|NCT01355068|466294|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
192670|NCT01355068|466293|P2|COMPLETED|Washout Period (at Least 7 Days)||11
192671|NCT01355068|466294|P1|COMPLETED|Washout Period (at Least 7 Days)||13
192672|NCT01355068|466293|P2|STARTED|Washout Period (at Least 7 Days)||11
192673|NCT01355068|466294|P1|STARTED|Washout Period (at Least 7 Days)||13
192674|NCT01355068|466293|P2|NOT COMPLETED|First Intervention Period||2
192675|NCT01355068|466294|P1|NOT COMPLETED|First Intervention Period||0
192676|NCT01355068|466293|P2|COMPLETED|First Intervention Period||11
192677|NCT01355068|466294|P1|COMPLETED|First Intervention Period||13
192678|NCT01355068|466293|P2|STARTED|First Intervention Period||13
192679|NCT01355068|466294|P1|STARTED|First Intervention Period||13
192680|NCT01354990|466310|P1|NOT COMPLETED|Overall Study||0
192681|NCT01354990|466310|P1|COMPLETED|Overall Study||2974
192682|NCT01354990|466310|P1|STARTED|Overall Study||2974
192683|NCT01354951|466317|P1|NOT COMPLETED|Overall Study||2
192684|NCT01354951|466317|P1|COMPLETED|Overall Study||1
192685|NCT01354951|466317|P1|STARTED|Overall Study||3
192686|NCT01354938|466324|P1|NOT COMPLETED|Overall Study||1
192687|NCT01354938|466324|P1|COMPLETED|Overall Study||219
192688|NCT01354938|466324|P1|STARTED|Overall Study||220
192689|NCT01354899|466330|P1|NOT COMPLETED|Overall Study||3
192690|NCT01354899|466330|P1|COMPLETED|Overall Study||21
192691|NCT01354899|466330|P1|STARTED|Overall Study||24
192692|NCT01354652|466338|P3|NOT COMPLETED|Overall Study||0
192693|NCT01354652|466339|P2|NOT COMPLETED|Overall Study||2
192694|NCT01354652|466340|P1|NOT COMPLETED|Overall Study||3
192695|NCT01354652|466338|P3|COMPLETED|Overall Study||0
192696|NCT01354652|466339|P2|COMPLETED|Overall Study||0
192697|NCT01354652|466340|P1|COMPLETED|Overall Study||0
192698|NCT01354652|466338|P3|STARTED|Overall Study||0
192699|NCT01354652|466339|P2|STARTED|Overall Study||2
192700|NCT01354652|466340|P1|STARTED|Overall Study||3
192701|NCT01354496|466365|P6|NOT COMPLETED|Period 3||0
192702|NCT01354496|466366|P5|NOT COMPLETED|Period 3||0
192703|NCT01354496|466367|P4|NOT COMPLETED|Period 3||0
192704|NCT01354496|466368|P3|NOT COMPLETED|Period 3||0
192705|NCT01354496|466369|P2|NOT COMPLETED|Period 3||0
192706|NCT01354496|466370|P1|NOT COMPLETED|Period 3||0
192707|NCT01354496|466365|P6|COMPLETED|Period 3||6
192708|NCT01354496|466366|P5|COMPLETED|Period 3||5
192709|NCT01354496|466367|P4|COMPLETED|Period 3||4
192710|NCT01354496|466368|P3|COMPLETED|Period 3||4
192711|NCT01354496|466369|P2|COMPLETED|Period 3||5
192712|NCT01354496|466370|P1|COMPLETED|Period 3||6
192713|NCT01354496|466365|P6|STARTED|Period 3||6
192714|NCT01354496|466366|P5|STARTED|Period 3||5
192715|NCT01354496|466367|P4|STARTED|Period 3||4
192716|NCT01354496|466368|P3|STARTED|Period 3||4
192717|NCT01354496|466369|P2|STARTED|Period 3||5
192718|NCT01354496|466370|P1|STARTED|Period 3||6
192719|NCT01354496|466365|P6|NOT COMPLETED|Washout (at Least 14 Days)||0
192720|NCT01354496|466366|P5|NOT COMPLETED|Washout (at Least 14 Days)||0
192721|NCT01354496|466367|P4|NOT COMPLETED|Washout (at Least 14 Days)||1
192722|NCT01354496|466368|P3|NOT COMPLETED|Washout (at Least 14 Days)||0
192723|NCT01354496|466369|P2|NOT COMPLETED|Washout (at Least 14 Days)||1
192724|NCT01354496|466370|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
192725|NCT01354496|466365|P6|COMPLETED|Washout (at Least 14 Days)||6
192726|NCT01354496|466366|P5|COMPLETED|Washout (at Least 14 Days)||5
192727|NCT01354496|466367|P4|COMPLETED|Washout (at Least 14 Days)||4
192728|NCT01354496|466368|P3|COMPLETED|Washout (at Least 14 Days)||4
192729|NCT01354496|466369|P2|COMPLETED|Washout (at Least 14 Days)||5
192730|NCT01354496|466370|P1|COMPLETED|Washout (at Least 14 Days)||6
192731|NCT01354496|466365|P6|STARTED|Washout (at Least 14 Days)||6
192732|NCT01354496|466366|P5|STARTED|Washout (at Least 14 Days)||5
192733|NCT01354496|466367|P4|STARTED|Washout (at Least 14 Days)||5
192734|NCT01354496|466368|P3|STARTED|Washout (at Least 14 Days)||4
192735|NCT01354496|466369|P2|STARTED|Washout (at Least 14 Days)||6
192736|NCT01354496|466370|P1|STARTED|Washout (at Least 14 Days)||6
192737|NCT01354496|466365|P6|NOT COMPLETED|Period 2||0
192738|NCT01354496|466366|P5|NOT COMPLETED|Period 2||0
192739|NCT01354496|466367|P4|NOT COMPLETED|Period 2||1
192740|NCT01354496|466368|P3|NOT COMPLETED|Period 2||0
192741|NCT01354496|466369|P2|NOT COMPLETED|Period 2||0
192742|NCT01354496|466370|P1|NOT COMPLETED|Period 2||0
192743|NCT01354496|466365|P6|COMPLETED|Period 2||6
192744|NCT01354496|466366|P5|COMPLETED|Period 2||5
192745|NCT01354496|466367|P4|COMPLETED|Period 2||5
192746|NCT01354496|466368|P3|COMPLETED|Period 2||4
192747|NCT01354496|466369|P2|COMPLETED|Period 2||6
192748|NCT01354496|466370|P1|COMPLETED|Period 2||6
192749|NCT01354496|466365|P6|STARTED|Period 2||6
192750|NCT01354496|466366|P5|STARTED|Period 2||5
192751|NCT01354496|466367|P4|STARTED|Period 2||6
192752|NCT01354496|466368|P3|STARTED|Period 2||4
192753|NCT01354496|466369|P2|STARTED|Period 2||6
192754|NCT01354496|466370|P1|STARTED|Period 2||6
192755|NCT01354496|466365|P6|NOT COMPLETED|Washout (at Least 14 Days)||0
192756|NCT01354496|466366|P5|NOT COMPLETED|Washout (at Least 14 Days)||0
192757|NCT01354496|466367|P4|NOT COMPLETED|Washout (at Least 14 Days)||0
192758|NCT01354496|466368|P3|NOT COMPLETED|Washout (at Least 14 Days)||0
192759|NCT01354496|466369|P2|NOT COMPLETED|Washout (at Least 14 Days)||0
192760|NCT01354496|466370|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
192761|NCT01354496|466365|P6|COMPLETED|Washout (at Least 14 Days)||6
192762|NCT01354496|466366|P5|COMPLETED|Washout (at Least 14 Days)||5
192763|NCT01354496|466367|P4|COMPLETED|Washout (at Least 14 Days)||6
192764|NCT01354496|466368|P3|COMPLETED|Washout (at Least 14 Days)||4
192765|NCT01354496|466369|P2|COMPLETED|Washout (at Least 14 Days)||6
192766|NCT01354496|466370|P1|COMPLETED|Washout (at Least 14 Days)||6
192767|NCT01354496|466365|P6|STARTED|Washout (at Least 14 Days)||6
192768|NCT01354496|466366|P5|STARTED|Washout (at Least 14 Days)||5
192769|NCT01354496|466367|P4|STARTED|Washout (at Least 14 Days)||6
192770|NCT01354496|466368|P3|STARTED|Washout (at Least 14 Days)||4
192771|NCT01354496|466369|P2|STARTED|Washout (at Least 14 Days)||6
192772|NCT01354496|466370|P1|STARTED|Washout (at Least 14 Days)||6
192773|NCT01354496|466365|P6|NOT COMPLETED|Period 1||0
192774|NCT01354496|466366|P5|NOT COMPLETED|Period 1||0
192775|NCT01354496|466367|P4|NOT COMPLETED|Period 1||0
192776|NCT01354496|466368|P3|NOT COMPLETED|Period 1||2
192777|NCT01354496|466369|P2|NOT COMPLETED|Period 1||0
192778|NCT01354496|466370|P1|NOT COMPLETED|Period 1||0
192779|NCT01354496|466365|P6|COMPLETED|Period 1||6
192780|NCT01354496|466366|P5|COMPLETED|Period 1||5
192781|NCT01354496|466367|P4|COMPLETED|Period 1||6
192782|NCT01354496|466368|P3|COMPLETED|Period 1||4
192783|NCT01354496|466369|P2|COMPLETED|Period 1||6
192784|NCT01354496|466370|P1|COMPLETED|Period 1||6
192785|NCT01354496|466365|P6|Received at Least 1 Dose of Study Drug|Period 1||6
192786|NCT01354496|466366|P5|Received at Least 1 Dose of Study Drug|Period 1||5
192787|NCT01354496|466367|P4|Received at Least 1 Dose of Study Drug|Period 1||6
192788|NCT01354496|466368|P3|Received at Least 1 Dose of Study Drug|Period 1||6
192789|NCT01354496|466369|P2|Received at Least 1 Dose of Study Drug|Period 1||6
192790|NCT01354496|466370|P1|Received at Least 1 Dose of Study Drug|Period 1||6
192791|NCT01354496|466365|P6|STARTED|Period 1||6
192792|NCT01354496|466366|P5|STARTED|Period 1||5
192793|NCT01354496|466367|P4|STARTED|Period 1||6
192794|NCT01354496|466368|P3|STARTED|Period 1||6
192795|NCT01354496|466369|P2|STARTED|Period 1||6
192796|NCT01354496|466370|P1|STARTED|Period 1||6
192797|NCT01354444|466399|P2|NOT COMPLETED|Overall Study||4
192798|NCT01354444|466400|P1|NOT COMPLETED|Overall Study||8
192799|NCT01354444|466399|P2|COMPLETED|Overall Study||11
192800|NCT01354444|466400|P1|COMPLETED|Overall Study||6
192801|NCT01354444|466399|P2|STARTED|Overall Study||15
192802|NCT01354444|466400|P1|STARTED|Overall Study||14
192803|NCT01354431|466413|P3|NOT COMPLETED|Participants Treated||54
192804|NCT01354431|466414|P2|NOT COMPLETED|Participants Treated||54
192805|NCT01354431|466415|P1|NOT COMPLETED|Participants Treated||59
192806|NCT01354431|466413|P3|COMPLETED|Participants Treated||0
192807|NCT01354431|466414|P2|COMPLETED|Participants Treated||0
192808|NCT01354431|466415|P1|COMPLETED|Participants Treated||0
192809|NCT01354431|466413|P3|STARTED|Participants Treated||54
192810|NCT01354431|466414|P2|STARTED|Participants Treated||54
192811|NCT01354431|466415|P1|STARTED|Participants Treated||59
192812|NCT01354431|466413|P3|NOT COMPLETED|Randomized to Enter Treatment Period||0
192813|NCT01354431|466414|P2|NOT COMPLETED|Randomized to Enter Treatment Period||0
192814|NCT01354431|466415|P1|NOT COMPLETED|Randomized to Enter Treatment Period||1
192815|NCT01354431|466413|P3|COMPLETED|Randomized to Enter Treatment Period||54
192816|NCT01354431|466414|P2|COMPLETED|Randomized to Enter Treatment Period||54
192817|NCT01354431|466415|P1|COMPLETED|Randomized to Enter Treatment Period||59
192818|NCT01354431|466413|P3|STARTED|Randomized to Enter Treatment Period||54
192819|NCT01354431|466414|P2|STARTED|Randomized to Enter Treatment Period||54
192820|NCT01354431|466415|P1|STARTED|Randomized to Enter Treatment Period||60
192821|NCT01354314|466439|P4|NOT COMPLETED|Overall Study||6
192822|NCT01354314|466440|P3|NOT COMPLETED|Overall Study||8
192823|NCT01354314|466441|P2|NOT COMPLETED|Overall Study||3
192824|NCT01354314|466442|P1|NOT COMPLETED|Overall Study||6
192825|NCT01354314|466439|P4|COMPLETED|Overall Study||5
192826|NCT01354314|466440|P3|COMPLETED|Overall Study||3
192827|NCT01354314|466441|P2|COMPLETED|Overall Study||8
192828|NCT01354314|466442|P1|COMPLETED|Overall Study||6
192829|NCT01354314|466439|P4|Completed (ITT)|Overall Study||10
192830|NCT01354314|466440|P3|Completed (ITT)|Overall Study||9
192831|NCT01354314|466441|P2|Completed (ITT)|Overall Study||11
192832|NCT01354314|466442|P1|Completed (ITT)|Overall Study||11
192833|NCT01354314|466439|P4|STARTED|Overall Study||11
192834|NCT01354314|466440|P3|STARTED|Overall Study||11
192835|NCT01354314|466441|P2|STARTED|Overall Study||11
192836|NCT01354314|466442|P1|STARTED|Overall Study||12
192837|NCT01354223|466578|P2|NOT COMPLETED|Overall Study||1
192838|NCT01354223|466579|P1|NOT COMPLETED|Overall Study||3
192839|NCT01354223|466578|P2|COMPLETED|Overall Study||29
192840|NCT01354223|466579|P1|COMPLETED|Overall Study||57
192841|NCT01354223|466578|P2|STARTED|Overall Study||30
192842|NCT01354223|466579|P1|STARTED|Overall Study||60
192843|NCT01354197|466595|P1|NOT COMPLETED|Overall Study||0
192844|NCT01354197|466595|P1|COMPLETED|Overall Study||4652
192845|NCT01354197|466595|P1|STARTED|Overall Study||4652
192846|NCT01354145|466603|P2|NOT COMPLETED|Overall Study||34
192847|NCT01354145|466604|P1|NOT COMPLETED|Overall Study||39
192848|NCT01354145|466603|P2|COMPLETED|Overall Study||63
192849|NCT01354145|466604|P1|COMPLETED|Overall Study||58
192850|NCT01354145|466603|P2|STARTED|Overall Study||97
192851|NCT01354145|466604|P1|STARTED|Overall Study||97
192852|NCT01354132|466638|P2|NOT COMPLETED|1 Month Post Study Medication||3
192853|NCT01354132|466639|P1|NOT COMPLETED|1 Month Post Study Medication||1
192854|NCT01354132|466638|P2|COMPLETED|1 Month Post Study Medication||16
192855|NCT01354132|466639|P1|COMPLETED|1 Month Post Study Medication||21
192856|NCT01354132|466638|P2|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||16
192857|NCT01354132|466639|P1|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||21
192858|NCT01354132|466638|P2|STARTED|1 Month Post Study Medication||19
192859|NCT01354132|466639|P1|STARTED|1 Month Post Study Medication||22
192860|NCT01354132|466638|P2|NOT COMPLETED|Double Blind (Visits 1-7)||11
192861|NCT01354132|466639|P1|NOT COMPLETED|Double Blind (Visits 1-7)||9
192862|NCT01354132|466638|P2|COMPLETED|Double Blind (Visits 1-7)||19
192863|NCT01354132|466639|P1|COMPLETED|Double Blind (Visits 1-7)||22
192864|NCT01354132|466638|P2|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||4
192865|NCT01354132|466639|P1|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||2
192866|NCT01354132|466638|P2|Stopped After First Visit|Double Blind (Visits 1-7)||2
192867|NCT01354132|466639|P1|Stopped After First Visit|Double Blind (Visits 1-7)||3
192868|NCT01354132|466638|P2|Completed More Than 1 Visit|Double Blind (Visits 1-7)||5
192869|NCT01354132|466639|P1|Completed More Than 1 Visit|Double Blind (Visits 1-7)||4
192870|NCT01354132|466638|P2|STARTED|Double Blind (Visits 1-7)|11 did not compete 7 study visits|30
192871|NCT01354132|466639|P1|STARTED|Double Blind (Visits 1-7)|9 did not compete 7 study visits|31
192872|NCT01354132|466638|P2|NOT COMPLETED|Randomization||1
192873|NCT01354132|466639|P1|NOT COMPLETED|Randomization||1
192874|NCT01354132|466638|P2|COMPLETED|Randomization||30
192875|NCT01354132|466639|P1|COMPLETED|Randomization||31
192876|NCT01354132|466638|P2|STARTED|Randomization|1 never took study medication due to subject withdrawal|31
192877|NCT01354132|466639|P1|STARTED|Randomization|1 never took study medication dropped by physician decision (White matter lesion on MRI)|32
192878|NCT01354106|466677|P1|NOT COMPLETED|Overall Study||2
192879|NCT01354106|466677|P1|COMPLETED|Overall Study||24
192880|NCT01354106|466677|P1|STARTED|Overall Study||26
192881|NCT01354028|466683|P2|NOT COMPLETED|Overall Study||5
192882|NCT01354028|466684|P1|NOT COMPLETED|Overall Study||2
192883|NCT01354028|466683|P2|COMPLETED|Overall Study||10
192884|NCT01354028|466684|P1|COMPLETED|Overall Study||13
192885|NCT01354028|466683|P2|STARTED|Overall Study||15
192886|NCT01354028|466684|P1|STARTED|Overall Study||15
192887|NCT01354015|466698|P2|NOT COMPLETED|Overall Study||5
192888|NCT01354015|466699|P1|NOT COMPLETED|Overall Study||6
192889|NCT01354015|466698|P2|COMPLETED|Overall Study||43
192890|NCT01354015|466699|P1|COMPLETED|Overall Study||44
192891|NCT01354015|466698|P2|STARTED|Overall Study||48
192892|NCT01354015|466699|P1|STARTED|Overall Study||50
192893|NCT01353976|466709|P2|NOT COMPLETED|Overall Study||51
192894|NCT01353976|466710|P1|NOT COMPLETED|Overall Study||48
192895|NCT01353976|466709|P2|COMPLETED|Overall Study||83
192896|NCT01353976|466710|P1|COMPLETED|Overall Study||82
192897|NCT01353976|466709|P2|STARTED|Overall Study||134
192898|NCT01353976|466710|P1|STARTED|Overall Study||130
192899|NCT01353963|466720|P1|NOT COMPLETED|Overall Study||2
192900|NCT01353963|466720|P1|COMPLETED|Overall Study||11
192901|NCT01353963|466720|P1|STARTED|Overall Study||13
192902|NCT01353911|466738|P8|NOT COMPLETED|Overall Study||15
192903|NCT01353911|466739|P7|NOT COMPLETED|Overall Study||6
192904|NCT01353911|466740|P6|NOT COMPLETED|Overall Study||7
192905|NCT01353911|466741|P5|NOT COMPLETED|Overall Study||6
192906|NCT01353911|466742|P4|NOT COMPLETED|Overall Study||2
192907|NCT01353911|466743|P3|NOT COMPLETED|Overall Study||9
192908|NCT01353911|466744|P2|NOT COMPLETED|Overall Study||9
192909|NCT01353911|466745|P1|NOT COMPLETED|Overall Study||8
192910|NCT01353911|466738|P8|COMPLETED|Overall Study||51
192911|NCT01353911|466739|P7|COMPLETED|Overall Study||30
192912|NCT01353911|466740|P6|COMPLETED|Overall Study||36
192913|NCT01353911|466741|P5|COMPLETED|Overall Study||23
192914|NCT01353911|466742|P4|COMPLETED|Overall Study||22
192915|NCT01353911|466743|P3|COMPLETED|Overall Study||59
192916|NCT01353911|466744|P2|COMPLETED|Overall Study||57
192917|NCT01353911|466745|P1|COMPLETED|Overall Study||28
192918|NCT01353911|466738|P8|STARTED|Overall Study||66
192919|NCT01353911|466739|P7|STARTED|Overall Study||36
192920|NCT01353911|466740|P6|STARTED|Overall Study||43
192921|NCT01353911|466741|P5|STARTED|Overall Study||29
192922|NCT01353911|466742|P4|STARTED|Overall Study||24
192923|NCT01353911|466743|P3|STARTED|Overall Study||68
192924|NCT01353911|466744|P2|STARTED|Overall Study||66
192925|NCT01353911|466745|P1|STARTED|Overall Study||36
192926|NCT01353898|466825|P6|NOT COMPLETED|Overall Study||1
192927|NCT01353898|466826|P5|NOT COMPLETED|Overall Study||0
192928|NCT01353898|466827|P4|NOT COMPLETED|Overall Study||0
192929|NCT01353898|466828|P3|NOT COMPLETED|Overall Study||0
192930|NCT01353898|466829|P2|NOT COMPLETED|Overall Study||0
192931|NCT01353898|466830|P1|NOT COMPLETED|Overall Study||0
192932|NCT01353898|466825|P6|COMPLETED|Overall Study||1
192933|NCT01353898|466826|P5|COMPLETED|Overall Study||2
192934|NCT01353898|466827|P4|COMPLETED|Overall Study||2
192935|NCT01353898|466828|P3|COMPLETED|Overall Study||2
192936|NCT01353898|466829|P2|COMPLETED|Overall Study||2
192937|NCT01353898|466830|P1|COMPLETED|Overall Study||2
192938|NCT01353898|466825|P6|STARTED|Overall Study||2
192939|NCT01353898|466826|P5|STARTED|Overall Study||2
192940|NCT01353898|466827|P4|STARTED|Overall Study||2
192941|NCT01353898|466828|P3|STARTED|Overall Study||2
192942|NCT01353898|466829|P2|STARTED|Overall Study||2
192943|NCT01353898|466830|P1|STARTED|Overall Study||2
192944|NCT01353859|466856|P1|NOT COMPLETED|Overall Study||4
192945|NCT01353859|466856|P1|COMPLETED|Overall Study||35
192946|NCT01353859|466856|P1|STARTED|Overall Study||39
192947|NCT01353703|466871|P2|NOT COMPLETED|Overall Study||0
192948|NCT01353703|466872|P1|NOT COMPLETED|Overall Study||1
192949|NCT01353703|466871|P2|COMPLETED|Overall Study||112
192950|NCT01353703|466872|P1|COMPLETED|Overall Study||111
192951|NCT01353703|466871|P2|STARTED|Overall Study||112
192952|NCT01353703|466872|P1|STARTED|Overall Study||112
192953|NCT01353664|466918|P1|NOT COMPLETED|Overall Study||19
192954|NCT01353664|466918|P1|COMPLETED|Overall Study|Completed = Number of participants who continued on Romidepsin treatment|0
192955|NCT01353664|466918|P1|STARTED|Overall Study|Participants who received at least 1 dose of study drug.|19
192956|NCT01353586|466924|P2|NOT COMPLETED|Overall Study||2
192957|NCT01353586|466925|P1|NOT COMPLETED|Overall Study||7
192958|NCT01353586|466924|P2|COMPLETED|Overall Study||17
192959|NCT01353586|466925|P1|COMPLETED|Overall Study||160
192960|NCT01353586|466924|P2|Participated in SNA Substudy|Overall Study||19
192961|NCT01353586|466925|P1|Participated in SNA Substudy|Overall Study||19
192962|NCT01353586|466924|P2|Participated in Roll-in Phase|Overall Study||0
192963|NCT01353586|466925|P1|Participated in Roll-in Phase|Overall Study||22
192964|NCT01353586|466924|P2|Participated in Workflow Phase|Overall Study||0
192965|NCT01353586|466925|P1|Participated in Workflow Phase|Overall Study||20
192966|NCT01353586|466924|P2|STARTED|Overall Study||19
192967|NCT01353586|466925|P1|STARTED|Overall Study||167
192968|NCT01353508|466943|P4|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
192969|NCT01353508|466944|P3|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
192970|NCT01353508|466945|P2|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
192971|NCT01353508|466946|P1|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||1
192972|NCT01353508|466943|P4|COMPLETED|Period 2 - Second Intervention (7 Days)||7
192973|NCT01353508|466944|P3|COMPLETED|Period 2 - Second Intervention (7 Days)||8
192974|NCT01353508|466945|P2|COMPLETED|Period 2 - Second Intervention (7 Days)||8
192975|NCT01353508|466946|P1|COMPLETED|Period 2 - Second Intervention (7 Days)||7
192976|NCT01353508|466943|P4|STARTED|Period 2 - Second Intervention (7 Days)||7
192977|NCT01353508|466944|P3|STARTED|Period 2 - Second Intervention (7 Days)||8
192978|NCT01353508|466945|P2|STARTED|Period 2 - Second Intervention (7 Days)||8
192979|NCT01353508|466946|P1|STARTED|Period 2 - Second Intervention (7 Days)||8
192980|NCT01353508|466943|P4|NOT COMPLETED|Period 1 - First Intervention (7 Days)||1
192981|NCT01353508|466944|P3|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
192982|NCT01353508|466945|P2|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
192983|NCT01353508|466946|P1|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
192984|NCT01353508|466943|P4|COMPLETED|Period 1 - First Intervention (7 Days)||7
192985|NCT01353508|466944|P3|COMPLETED|Period 1 - First Intervention (7 Days)||8
192986|NCT01353508|466945|P2|COMPLETED|Period 1 - First Intervention (7 Days)||8
192987|NCT01353508|466946|P1|COMPLETED|Period 1 - First Intervention (7 Days)||8
192988|NCT01353508|466943|P4|STARTED|Period 1 - First Intervention (7 Days)||8
192989|NCT01353508|466944|P3|STARTED|Period 1 - First Intervention (7 Days)||8
192990|NCT01353508|466945|P2|STARTED|Period 1 - First Intervention (7 Days)||8
192991|NCT01353508|466946|P1|STARTED|Period 1 - First Intervention (7 Days)||8
192992|NCT01353274|467024|P1|NOT COMPLETED|Overall Study||28
192993|NCT01353274|467024|P1|COMPLETED|Overall Study||1129
192994|NCT01353274|467024|P1|STARTED|Overall Study||1157
192995|NCT01353222|467034|P2|NOT COMPLETED|Overall Study||72
192996|NCT01353222|467035|P1|NOT COMPLETED|Overall Study||70
192997|NCT01353222|467034|P2|COMPLETED|Overall Study||0
192998|NCT01353222|467035|P1|COMPLETED|Overall Study||0
192999|NCT01353222|467034|P2|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||72
193000|NCT01353222|467035|P1|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||0
193001|NCT01353222|467034|P2|DN24-02 Arm ≥1 Leukapheresis|Overall Study||0
193002|NCT01353222|467035|P1|DN24-02 Arm ≥1 Leukapheresis|Overall Study||67
193003|NCT01353222|467034|P2|STARTED|Overall Study||72
193004|NCT01353222|467035|P1|STARTED|Overall Study||70
193005|NCT01353196|467043|P2|NOT COMPLETED|Overall Study||11
193006|NCT01353196|467044|P1|NOT COMPLETED|Overall Study||29
193007|NCT01353196|467043|P2|COMPLETED|Overall Study||59
193008|NCT01353196|467044|P1|COMPLETED|Overall Study||71
193009|NCT01353196|467043|P2|STARTED|Overall Study||70
193010|NCT01353196|467044|P1|STARTED|Overall Study||100
193011|NCT01353144|467052|P2|NOT COMPLETED|Overall Study||8
193012|NCT01353144|467053|P1|NOT COMPLETED|Overall Study||9
193013|NCT01353144|467052|P2|COMPLETED|Overall Study||81
193014|NCT01353144|467053|P1|COMPLETED|Overall Study||80
193015|NCT01353144|467052|P2|STARTED|Overall Study||89
193016|NCT01353144|467053|P1|STARTED|Overall Study||89
193017|NCT01353079|467063|P2|NOT COMPLETED|Overall Study||21
193018|NCT01353079|467064|P1|NOT COMPLETED|Overall Study||27
193019|NCT01353079|467063|P2|COMPLETED|Overall Study||190
193020|NCT01353079|467064|P1|COMPLETED|Overall Study||191
193021|NCT01353079|467063|P2|STARTED|Overall Study||211
193022|NCT01353079|467064|P1|STARTED|Overall Study||218
193023|NCT01352845|467078|P2|NOT COMPLETED|Overall Study||203
193024|NCT01352845|467079|P1|NOT COMPLETED|Overall Study||671
193025|NCT01352845|467078|P2|COMPLETED|Overall Study||619
193026|NCT01352845|467079|P1|COMPLETED|Overall Study||1800
193027|NCT01352845|467078|P2|STARTED|Overall Study||822
193028|NCT01352845|467079|P1|STARTED|Overall Study||2471
193029|NCT01352793|467168|P2|NOT COMPLETED|Overall Study||245
193030|NCT01352793|467169|P1|NOT COMPLETED|Overall Study||585
193031|NCT01352793|467168|P2|COMPLETED|Overall Study||1663
193032|NCT01352793|467169|P1|COMPLETED|Overall Study||3219
193033|NCT01352793|467168|P2|Vaccination 3|Overall Study||1710
193034|NCT01352793|467169|P1|Vaccination 3|Overall Study||3314
193035|NCT01352793|467168|P2|Vaccination 2|Overall Study||1806
193036|NCT01352793|467169|P1|Vaccination 2|Overall Study||3530
193037|NCT01352793|467168|P2|Vaccination 1|Overall Study||1908
193038|NCT01352793|467169|P1|Vaccination 1|Overall Study||3796
193039|NCT01352793|467168|P2|STARTED|Overall Study||1908
193040|NCT01352793|467169|P1|STARTED|Overall Study||3804
193041|NCT01352741|467193|P2|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
193042|NCT01352741|467194|P1|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
193043|NCT01352741|467193|P2|COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
193044|NCT01352741|467194|P1|COMPLETED|Open-Label Tapentadol Pick-Up Arm||37
193045|NCT01352741|467193|P2|STARTED|Open-Label Tapentadol Pick-Up Arm|Participants did not continue treatment. They were switched to tapentadol PR or discontinued.|0
193046|NCT01352741|467194|P1|STARTED|Open-Label Tapentadol Pick-Up Arm|19 from tapentadol in the comparative phase and 18 from tapentadol & pregabalin entered this arm.|37
193047|NCT01352741|467193|P2|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||0
193048|NCT01352741|467194|P1|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||8
193049|NCT01352741|467193|P2|COMPLETED|Open-Label Tapentadol Continuation Arm||0
193050|NCT01352741|467194|P1|COMPLETED|Open-Label Tapentadol Continuation Arm||51
193051|NCT01352741|467193|P2|Full Analysis Set|Open-Label Tapentadol Continuation Arm||0
193052|NCT01352741|467194|P1|Full Analysis Set|Open-Label Tapentadol Continuation Arm||57
193053|NCT01352741|467193|P2|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||0
193054|NCT01352741|467194|P1|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||2
193055|NCT01352741|467193|P2|STARTED|Open-Label Tapentadol Continuation Arm|In this period no tapentadol PR and pregabalin treatment was planned by the protocol.|0
193056|NCT01352741|467194|P1|STARTED|Open-Label Tapentadol Continuation Arm|59 of the 73 participants that did not qualify for the comparative period entered this arm.|59
193057|NCT01352741|467193|P2|NOT COMPLETED|Double-blind Comparative Period||26
193058|NCT01352741|467194|P1|NOT COMPLETED|Double-blind Comparative Period||28
193059|NCT01352741|467193|P2|COMPLETED|Double-blind Comparative Period||133
193060|NCT01352741|467194|P1|COMPLETED|Double-blind Comparative Period||126
193061|NCT01352741|467193|P2|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||137
193062|NCT01352741|467194|P1|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||123
193063|NCT01352741|467193|P2|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||137
193064|NCT01352741|467194|P1|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||123
193065|NCT01352741|467193|P2|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||137
193066|NCT01352741|467194|P1|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||123
193067|NCT01352741|467193|P2|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||137
193068|NCT01352741|467194|P1|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||123
193069|NCT01352741|467193|P2|EQ-5D Per Protocol Set|Double-blind Comparative Period||143
193070|NCT01352741|467194|P1|EQ-5D Per Protocol Set|Double-blind Comparative Period||131
193071|NCT01352741|467193|P2|SF-12 Per Protocol Set|Double-blind Comparative Period||143
193072|NCT01352741|467194|P1|SF-12 Per Protocol Set|Double-blind Comparative Period||131
193073|NCT01352741|467193|P2|painDetect Per Protocol Set|Double-blind Comparative Period||127
193074|NCT01352741|467194|P1|painDetect Per Protocol Set|Double-blind Comparative Period||109
193075|NCT01352741|467193|P2|Per Protocol Set|Double-blind Comparative Period||149
193076|NCT01352741|467194|P1|Per Protocol Set|Double-blind Comparative Period||139
193077|NCT01352741|467193|P2|Major Protocol Deviations|Double-blind Comparative Period||8
193078|NCT01352741|467194|P1|Major Protocol Deviations|Double-blind Comparative Period||13
193079|NCT01352741|467193|P2|Full Analysis Set|Double-blind Comparative Period||157
193080|NCT01352741|467194|P1|Full Analysis Set|Double-blind Comparative Period||152
193081|NCT01352741|467193|P2|No Pain Assessments Available|Double-blind Comparative Period||2
193082|NCT01352741|467194|P1|No Pain Assessments Available|Double-blind Comparative Period||2
193083|NCT01352741|467193|P2|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||18
193084|NCT01352741|467194|P1|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||19
193085|NCT01352741|467193|P2|STARTED|Double-blind Comparative Period|159 of the 313 participants that qualified were randomized to tapentadol and pregabalin treatment.|159
193086|NCT01352741|467194|P1|STARTED|Double-blind Comparative Period|Of the 313 participants that qualified for randomization 154 were randomized to tapentadol.|154
193087|NCT01352741|467193|P2|NOT COMPLETED|Open-label Tapentadol Titration Period||0
193088|NCT01352741|467194|P1|NOT COMPLETED|Open-label Tapentadol Titration Period||73
193089|NCT01352741|467193|P2|COMPLETED|Open-label Tapentadol Titration Period||0
193090|NCT01352741|467194|P1|COMPLETED|Open-label Tapentadol Titration Period|59 of 73 participants not completing the titration period entered the open-label continuation arm.|372
193091|NCT01352741|467193|P2|Full Analysis Set|Open-label Tapentadol Titration Period||0
193092|NCT01352741|467194|P1|Full Analysis Set|Open-label Tapentadol Titration Period||436
193093|NCT01352741|467193|P2|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||0
193094|NCT01352741|467194|P1|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||59
193095|NCT01352741|467193|P2|STARTED|Open-label Tapentadol Titration Period||0
193096|NCT01352741|467194|P1|STARTED|Open-label Tapentadol Titration Period|All participants started with 2 x 50 mg tapentadol PR and titrated upwards in steps of 100 mg/day.|445
193097|NCT01352715|467288|P2|NOT COMPLETED|Overall Study||46
193098|NCT01352715|467289|P1|NOT COMPLETED|Overall Study||45
193099|NCT01352715|467288|P2|COMPLETED|Overall Study||209
193100|NCT01352715|467289|P1|COMPLETED|Overall Study||215
193101|NCT01352715|467288|P2|STARTED|Overall Study||255
193102|NCT01352715|467289|P1|STARTED|Overall Study||260
193103|NCT01352637|467315|P4|NOT COMPLETED|Drug||35
193104|NCT01352637|467316|P3|NOT COMPLETED|Drug||25
193105|NCT01352637|467317|P2|NOT COMPLETED|Drug||0
193106|NCT01352637|467318|P1|NOT COMPLETED|Drug||0
193107|NCT01352637|467315|P4|COMPLETED|Drug||62
193108|NCT01352637|467316|P3|COMPLETED|Drug||70
193109|NCT01352637|467317|P2|COMPLETED|Drug||0
193110|NCT01352637|467318|P1|COMPLETED|Drug||0
193111|NCT01352637|467315|P4|STARTED|Drug||97
193112|NCT01352637|467316|P3|STARTED|Drug||95
193113|NCT01352637|467317|P2|STARTED|Drug||0
193114|NCT01352637|467318|P1|STARTED|Drug||0
193115|NCT01352637|467315|P4|NOT COMPLETED|Exposure Therapy||0
193116|NCT01352637|467316|P3|NOT COMPLETED|Exposure Therapy||0
193117|NCT01352637|467317|P2|NOT COMPLETED|Exposure Therapy||33
193118|NCT01352637|467318|P1|NOT COMPLETED|Exposure Therapy||27
193119|NCT01352637|467315|P4|COMPLETED|Exposure Therapy||0
193120|NCT01352637|467316|P3|COMPLETED|Exposure Therapy||0
193121|NCT01352637|467317|P2|COMPLETED|Exposure Therapy||62
193122|NCT01352637|467318|P1|COMPLETED|Exposure Therapy||70
193123|NCT01352637|467315|P4|STARTED|Exposure Therapy||0
193124|NCT01352637|467316|P3|STARTED|Exposure Therapy||0
193125|NCT01352637|467317|P2|STARTED|Exposure Therapy||95
193126|NCT01352637|467318|P1|STARTED|Exposure Therapy||97
193127|NCT01352585|467328|P1|NOT COMPLETED|Overall Study||11
193128|NCT01352585|467328|P1|COMPLETED|Overall Study||36
193129|NCT01352585|467328|P1|STARTED|Overall Study||47
193130|NCT01352546|467339|P1|NOT COMPLETED|Overall Study||0
193131|NCT01352546|467339|P1|COMPLETED|Overall Study||31
193132|NCT01352546|467339|P1|STARTED|Overall Study||31
193133|NCT01352507|467345|P2|NOT COMPLETED|Extension Phase||0
193134|NCT01352507|467346|P1|NOT COMPLETED|Extension Phase||0
193135|NCT01352507|467345|P2|COMPLETED|Extension Phase||173
193136|NCT01352507|467346|P1|COMPLETED|Extension Phase||164
193137|NCT01352507|467345|P2|STARTED|Extension Phase||173
193138|NCT01352507|467346|P1|STARTED|Extension Phase||164
193139|NCT01352507|467345|P2|NOT COMPLETED|Treatment Period 2||3
193140|NCT01352507|467346|P1|NOT COMPLETED|Treatment Period 2||6
193141|NCT01352507|467345|P2|COMPLETED|Treatment Period 2|Seven participants who completed Treatment Period 2 chose not to enter the Extension Phase.|180
193142|NCT01352507|467346|P1|COMPLETED|Treatment Period 2|Six participants who completed Treatment Period 2 chose not to enter the Extension Phase.|170
193143|NCT01352507|467345|P2|Received Treatment|Treatment Period 2||181
193144|NCT01352507|467346|P1|Received Treatment|Treatment Period 2||173
193145|NCT01352507|467345|P2|STARTED|Treatment Period 2||183
193146|NCT01352507|467346|P1|STARTED|Treatment Period 2||176
193147|NCT01352507|467345|P2|NOT COMPLETED|Washout Period||1
193148|NCT01352507|467346|P1|NOT COMPLETED|Washout Period||0
193149|NCT01352507|467345|P2|COMPLETED|Washout Period||183
193150|NCT01352507|467346|P1|COMPLETED|Washout Period||176
193151|NCT01352507|467345|P2|STARTED|Washout Period||184
193152|NCT01352507|467346|P1|STARTED|Washout Period||176
193153|NCT01352507|467345|P2|NOT COMPLETED|Treatment Period 1||9
193154|NCT01352507|467346|P1|NOT COMPLETED|Treatment Period 1||14
193155|NCT01352507|467345|P2|COMPLETED|Treatment Period 1||184
193156|NCT01352507|467346|P1|COMPLETED|Treatment Period 1||176
193157|NCT01352507|467345|P2|Received Treatment|Treatment Period 1||188
193158|NCT01352507|467346|P1|Received Treatment|Treatment Period 1||182
193159|NCT01352507|467345|P2|STARTED|Treatment Period 1||193
193160|NCT01352507|467346|P1|STARTED|Treatment Period 1||190
193161|NCT01352468|467379|P2|NOT COMPLETED|Overall Study||4
193162|NCT01352468|467380|P1|NOT COMPLETED|Overall Study||5
193163|NCT01352468|467379|P2|COMPLETED|Overall Study||18
193164|NCT01352468|467380|P1|COMPLETED|Overall Study||17
193165|NCT01352468|467379|P2|STARTED|Overall Study||22
193166|NCT01352468|467380|P1|STARTED|Overall Study||22
193167|NCT01352442|467390|P1|NOT COMPLETED|Overall Study||12
193168|NCT01352442|467390|P1|COMPLETED|Overall Study||139
193169|NCT01352442|467390|P1|STARTED|Overall Study||151
193170|NCT01352416|467399|P4|NOT COMPLETED|Overall Study||1
193171|NCT01352416|467400|P3|NOT COMPLETED|Overall Study||2
193172|NCT01352416|467401|P2|NOT COMPLETED|Overall Study||2
193173|NCT01352416|467402|P1|NOT COMPLETED|Overall Study||1
193174|NCT01352416|467399|P4|COMPLETED|Overall Study||1
193175|NCT01352416|467400|P3|COMPLETED|Overall Study||0
193176|NCT01352416|467401|P2|COMPLETED|Overall Study||5
193177|NCT01352416|467402|P1|COMPLETED|Overall Study||3
193178|NCT01352416|467399|P4|STARTED|Overall Study||2
193179|NCT01352416|467400|P3|STARTED|Overall Study||2
193180|NCT01352416|467401|P2|STARTED|Overall Study||7
193181|NCT01352416|467402|P1|STARTED|Overall Study||4
193182|NCT01352286|467412|P1|NOT COMPLETED|Overall Study||0
193183|NCT01352286|467412|P1|COMPLETED|Overall Study||25
193184|NCT01352286|467412|P1|Received T-cells|Overall Study||25
193185|NCT01352286|467412|P1|STARTED|Overall Study||25
193186|NCT01352221|467424|P4|NOT COMPLETED|Open-label Phase||11
193187|NCT01352221|467425|P3|NOT COMPLETED|Open-label Phase||13
193188|NCT01352221|467426|P2|NOT COMPLETED|Open-label Phase||0
193189|NCT01352221|467427|P1|NOT COMPLETED|Open-label Phase||0
193190|NCT01352221|467424|P4|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|36
193191|NCT01352221|467425|P3|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|37
193192|NCT01352221|467426|P2|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
193193|NCT01352221|467427|P1|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
193282|NCT01351090|467740|P3|COMPLETED|Overall Study||36
193194|NCT01352221|467424|P4|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
193195|NCT01352221|467425|P3|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
193196|NCT01352221|467426|P2|STARTED|Open-label Phase|Not Applicable to open-label phase|0
193197|NCT01352221|467427|P1|STARTED|Open-label Phase|Not Applicable to open-label phase|0
193198|NCT01352221|467424|P4|NOT COMPLETED|Double-blind Phase||0
193199|NCT01352221|467425|P3|NOT COMPLETED|Double-blind Phase||0
193200|NCT01352221|467426|P2|NOT COMPLETED|Double-blind Phase||11
193201|NCT01352221|467427|P1|NOT COMPLETED|Double-blind Phase||9
193202|NCT01352221|467424|P4|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
193203|NCT01352221|467425|P3|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
193204|NCT01352221|467426|P2|COMPLETED|Double-blind Phase||53
193205|NCT01352221|467427|P1|COMPLETED|Double-blind Phase||55
193206|NCT01352221|467424|P4|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
193207|NCT01352221|467425|P3|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
193208|NCT01352221|467426|P2|STARTED|Double-blind Phase||64
193209|NCT01352221|467427|P1|STARTED|Double-blind Phase||64
193210|NCT01352117|467487|P2|NOT COMPLETED|Overall Study||24
193211|NCT01352117|467488|P1|NOT COMPLETED|Overall Study||21
193212|NCT01352117|467487|P2|COMPLETED|Overall Study||72
193213|NCT01352117|467488|P1|COMPLETED|Overall Study||75
193214|NCT01352117|467487|P2|Study Week 96 Data Potential|Overall Study||61
193215|NCT01352117|467488|P1|Study Week 96 Data Potential|Overall Study||58
193216|NCT01352117|467487|P2|Study Week 48 Data Potential|Overall Study||83
193217|NCT01352117|467488|P1|Study Week 48 Data Potential|Overall Study||80
193218|NCT01352117|467487|P2|Entered Step 2 to Initiate Delayed ET|Overall Study|Only Arm A participants could enter Step 2 to receive delayed ET.|0
193219|NCT01352117|467488|P1|Entered Step 2 to Initiate Delayed ET|Overall Study||32
193220|NCT01352117|467487|P2|STARTED|Overall Study||96
193221|NCT01352117|467488|P1|STARTED|Overall Study||96
193222|NCT01351740|467542|P2|NOT COMPLETED|Overall Study||6
193223|NCT01351740|467543|P1|NOT COMPLETED|Overall Study||2
193224|NCT01351740|467542|P2|COMPLETED|Overall Study||19
193225|NCT01351740|467543|P1|COMPLETED|Overall Study||23
193226|NCT01351740|467542|P2|STARTED|Overall Study||25
193227|NCT01351740|467543|P1|STARTED|Overall Study||25
193228|NCT01351623|467551|P1|NOT COMPLETED|Overall Study||9
193229|NCT01351623|467551|P1|COMPLETED|Overall Study||35
193230|NCT01351623|467551|P1|STARTED|Overall Study||44
193231|NCT01351506|467557|P1|NOT COMPLETED|Overall Study||137
193232|NCT01351506|467557|P1|COMPLETED|Overall Study||465
193233|NCT01351506|467557|P1|STARTED|Overall Study||602
193234|NCT01351480|467567|P1|NOT COMPLETED|Overall Study||8
193235|NCT01351480|467567|P1|COMPLETED|Overall Study||26
193236|NCT01351480|467567|P1|STARTED|Overall Study||34
193237|NCT01351415|467577|P2|NOT COMPLETED|Overall Study||240
193238|NCT01351415|467578|P1|NOT COMPLETED|Overall Study||245
193239|NCT01351415|467577|P2|COMPLETED|Overall Study||0
193240|NCT01351415|467578|P1|COMPLETED|Overall Study||0
193241|NCT01351415|467577|P2|Treated Participants|Overall Study||232
193242|NCT01351415|467578|P1|Treated Participants|Overall Study||243
193243|NCT01351415|467577|P2|STARTED|Overall Study||240
193244|NCT01351415|467578|P1|STARTED|Overall Study||245
193245|NCT01351376|467600|P2|NOT COMPLETED|Overall Study||0
193246|NCT01351376|467601|P1|NOT COMPLETED|Overall Study||0
193247|NCT01351376|467600|P2|COMPLETED|Overall Study||11
193248|NCT01351376|467601|P1|COMPLETED|Overall Study||10
193249|NCT01351376|467600|P2|STARTED|Overall Study||11
193250|NCT01351376|467601|P1|STARTED|Overall Study||10
193251|NCT01351350|467614|P5|NOT COMPLETED|Overall Study||7
193252|NCT01351350|467615|P4|NOT COMPLETED|Overall Study||13
193253|NCT01351350|467616|P3|NOT COMPLETED|Overall Study||11
193254|NCT01351350|467617|P2|NOT COMPLETED|Overall Study||29
193255|NCT01351350|467618|P1|NOT COMPLETED|Overall Study||8
193256|NCT01351350|467614|P5|COMPLETED|Overall Study||0
193257|NCT01351350|467615|P4|COMPLETED|Overall Study||0
193258|NCT01351350|467616|P3|COMPLETED|Overall Study||0
193259|NCT01351350|467617|P2|COMPLETED|Overall Study||0
193260|NCT01351350|467618|P1|COMPLETED|Overall Study||0
193261|NCT01351350|467614|P5|Dose-escalation Evaluable|Overall Study||0
193262|NCT01351350|467615|P4|Dose-escalation Evaluable|Overall Study||0
193263|NCT01351350|467616|P3|Dose-escalation Evaluable|Overall Study||10
193264|NCT01351350|467617|P2|Dose-escalation Evaluable|Overall Study||23
193265|NCT01351350|467618|P1|Dose-escalation Evaluable|Overall Study||7
193266|NCT01351350|467614|P5|Treated|Overall Study||7
193267|NCT01351350|467615|P4|Treated|Overall Study||13
193268|NCT01351350|467616|P3|Treated|Overall Study||10
193269|NCT01351350|467617|P2|Treated|Overall Study||29
193270|NCT01351350|467618|P1|Treated|Overall Study||8
193271|NCT01351350|467614|P5|STARTED|Overall Study||7
193272|NCT01351350|467615|P4|STARTED|Overall Study||13
193273|NCT01351350|467616|P3|STARTED|Overall Study||11
193274|NCT01351350|467617|P2|STARTED|Overall Study||29
193275|NCT01351350|467618|P1|STARTED|Overall Study||8
193276|NCT01351337|467731|P1|NOT COMPLETED|Overall Study||0
193277|NCT01351337|467731|P1|COMPLETED|Overall Study||58
193278|NCT01351337|467731|P1|STARTED|Overall Study||58
193279|NCT01351090|467740|P3|NOT COMPLETED|Overall Study||6
193280|NCT01351090|467741|P2|NOT COMPLETED|Overall Study||11
193281|NCT01351090|467742|P1|NOT COMPLETED|Overall Study||11
193283|NCT01351090|467741|P2|COMPLETED|Overall Study||31
193284|NCT01351090|467742|P1|COMPLETED|Overall Study||32
193285|NCT01351090|467740|P3|STARTED|Overall Study||42
193286|NCT01351090|467741|P2|STARTED|Overall Study||42
193287|NCT01351090|467742|P1|STARTED|Overall Study||43
193288|NCT01351077|467761|P2|NOT COMPLETED|Overall Study||0
193289|NCT01351077|467762|P1|NOT COMPLETED|Overall Study||0
193290|NCT01351077|467761|P2|COMPLETED|Overall Study||180
193291|NCT01351077|467762|P1|COMPLETED|Overall Study||180
193292|NCT01351077|467761|P2|STARTED|Overall Study||180
193293|NCT01351077|467762|P1|STARTED|Overall Study||180
193294|NCT01351064|467778|P2|NOT COMPLETED|Overall Study||0
193295|NCT01351064|467779|P1|NOT COMPLETED|Overall Study||0
193296|NCT01351064|467778|P2|COMPLETED|Overall Study||42
193297|NCT01351064|467779|P1|COMPLETED|Overall Study||42
193298|NCT01351064|467778|P2|STARTED|Overall Study||42
193299|NCT01351064|467779|P1|STARTED|Overall Study||42
193300|NCT01351025|467789|P2|NOT COMPLETED|Week 44 - 48||0
193301|NCT01351025|467790|P1|NOT COMPLETED|Week 44 - 48||0
193302|NCT01351025|467789|P2|COMPLETED|Week 44 - 48||43
193303|NCT01351025|467790|P1|COMPLETED|Week 44 - 48||42
193304|NCT01351025|467789|P2|STARTED|Week 44 - 48||43
193305|NCT01351025|467790|P1|STARTED|Week 44 - 48||42
193306|NCT01351025|467789|P2|NOT COMPLETED|Week 24 - 44||4
193307|NCT01351025|467790|P1|NOT COMPLETED|Week 24 - 44||1
193308|NCT01351025|467789|P2|COMPLETED|Week 24 - 44||43
193309|NCT01351025|467790|P1|COMPLETED|Week 24 - 44||42
193310|NCT01351025|467789|P2|STARTED|Week 24 - 44||47
193311|NCT01351025|467790|P1|STARTED|Week 24 - 44||43
193312|NCT01351025|467789|P2|NOT COMPLETED|Week 20 - 24||0
193313|NCT01351025|467790|P1|NOT COMPLETED|Week 20 - 24||0
193314|NCT01351025|467789|P2|COMPLETED|Week 20 - 24||47
193315|NCT01351025|467790|P1|COMPLETED|Week 20 - 24||43
193316|NCT01351025|467789|P2|STARTED|Week 20 - 24||47
193317|NCT01351025|467790|P1|STARTED|Week 20 - 24||43
193318|NCT01351025|467789|P2|NOT COMPLETED|Week 0 - 20||1
193319|NCT01351025|467790|P1|NOT COMPLETED|Week 0 - 20||3
193320|NCT01351025|467789|P2|COMPLETED|Week 0 - 20||47
193321|NCT01351025|467790|P1|COMPLETED|Week 0 - 20||43
193322|NCT01351025|467789|P2|STARTED|Week 0 - 20||48
193323|NCT01351025|467790|P1|STARTED|Week 0 - 20||46
193324|NCT01350999|467823|P3|NOT COMPLETED|Overall Study||21
193325|NCT01350999|467824|P2|NOT COMPLETED|Overall Study||14
193326|NCT01350999|467825|P1|NOT COMPLETED|Overall Study||8
193327|NCT01350999|467823|P3|COMPLETED|Overall Study||146
193328|NCT01350999|467824|P2|COMPLETED|Overall Study||157
193329|NCT01350999|467825|P1|COMPLETED|Overall Study||157
193330|NCT01350999|467823|P3|Treated|Overall Study||167
193331|NCT01350999|467824|P2|Treated|Overall Study||171
193332|NCT01350999|467825|P1|Treated|Overall Study||165
193333|NCT01350999|467823|P3|STARTED|Overall Study||167
193334|NCT01350999|467824|P2|STARTED|Overall Study||171
193335|NCT01350999|467825|P1|STARTED|Overall Study||165
193336|NCT01350973|467863|P3|NOT COMPLETED|Overall Study||8
193337|NCT01350973|467864|P2|NOT COMPLETED|Overall Study||8
193338|NCT01350973|467865|P1|NOT COMPLETED|Overall Study||6
193339|NCT01350973|467863|P3|COMPLETED|Overall Study||187
193340|NCT01350973|467864|P2|COMPLETED|Overall Study||202
193341|NCT01350973|467865|P1|COMPLETED|Overall Study||200
193342|NCT01350973|467863|P3|Received Treatment|Overall Study||195
193343|NCT01350973|467864|P2|Received Treatment|Overall Study||210
193344|NCT01350973|467865|P1|Received Treatment|Overall Study||205
193345|NCT01350973|467863|P3|STARTED|Overall Study||195
193346|NCT01350973|467864|P2|STARTED|Overall Study||210
193347|NCT01350973|467865|P1|STARTED|Overall Study||206
193348|NCT01350947|467900|P1|NOT COMPLETED|Overall Study||0
193349|NCT01350947|467900|P1|COMPLETED|Overall Study||11
193350|NCT01350947|467900|P1|STARTED|Overall Study||11
193351|NCT01350934|467906|P2|NOT COMPLETED|Extension Study||4
193352|NCT01350934|467907|P1|NOT COMPLETED|Extension Study||5
193353|NCT01350934|467906|P2|COMPLETED|Extension Study||101
193354|NCT01350934|467907|P1|COMPLETED|Extension Study||95
193355|NCT01350934|467906|P2|STARTED|Extension Study||105
193356|NCT01350934|467907|P1|STARTED|Extension Study||100
193357|NCT01350934|467906|P2|NOT COMPLETED|Base Study||3
193358|NCT01350934|467907|P1|NOT COMPLETED|Base Study||11
193359|NCT01350934|467906|P2|COMPLETED|Base Study||105
193360|NCT01350934|467907|P1|COMPLETED|Base Study||100
193361|NCT01350934|467906|P2|STARTED|Base Study||108
193362|NCT01350934|467907|P1|STARTED|Base Study||111
193363|NCT01350804|467929|P4|NOT COMPLETED|Extension Study, Weeks 52 - 260||23
193364|NCT01350804|467930|P3|NOT COMPLETED|Extension Study, Weeks 52 - 260||72
193365|NCT01350804|467931|P2|NOT COMPLETED|Extension Study, Weeks 52 - 260||79
193366|NCT01350804|467932|P1|NOT COMPLETED|Extension Study, Weeks 52 - 260||80
193367|NCT01350804|467929|P4|COMPLETED|Extension Study, Weeks 52 - 260||0
193368|NCT01350804|467930|P3|COMPLETED|Extension Study, Weeks 52 - 260||0
193369|NCT01350804|467931|P2|COMPLETED|Extension Study, Weeks 52 - 260||0
193370|NCT01350804|467932|P1|COMPLETED|Extension Study, Weeks 52 - 260||0
193371|NCT01350804|467929|P4|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|23
193372|NCT01350804|467930|P3|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|72
193373|NCT01350804|467931|P2|STARTED|Extension Study, Weeks 52 - 260||79
193374|NCT01350804|467932|P1|STARTED|Extension Study, Weeks 52 - 260||80
193375|NCT01350804|467929|P4|NOT COMPLETED|Core Study||26
193376|NCT01350804|467930|P3|NOT COMPLETED|Core Study||47
193377|NCT01350804|467931|P2|NOT COMPLETED|Core Study||47
193378|NCT01350804|467932|P1|NOT COMPLETED|Core Study||41
193379|NCT01350804|467929|P4|COMPLETED|Core Study||112
193380|NCT01350804|467930|P3|COMPLETED|Core Study||91
193381|NCT01350804|467931|P2|COMPLETED|Core Study||90
193382|NCT01350804|467932|P1|COMPLETED|Core Study||97
193383|NCT01350804|467929|P4|Full Analysis Set|Core Study||138
193384|NCT01350804|467930|P3|Full Analysis Set|Core Study||138
193385|NCT01350804|467931|P2|Full Analysis Set|Core Study||137
193386|NCT01350804|467932|P1|Full Analysis Set|Core Study||138
193387|NCT01350804|467929|P4|Treatment Switch to AIN457 at Week 24|Core Study||37
193388|NCT01350804|467930|P3|Treatment Switch to AIN457 at Week 24|Core Study||45
193389|NCT01350804|467931|P2|Treatment Switch to AIN457 at Week 24|Core Study||0
193390|NCT01350804|467932|P1|Treatment Switch to AIN457 at Week 24|Core Study||0
193391|NCT01350804|467929|P4|Tratment Switch to AIN457 at Week 16|Core Study||0
193392|NCT01350804|467930|P3|Tratment Switch to AIN457 at Week 16|Core Study|15 participantsdiscontinued prior to the treatment switch|78
193393|NCT01350804|467931|P2|Tratment Switch to AIN457 at Week 16|Core Study||0
193394|NCT01350804|467932|P1|Tratment Switch to AIN457 at Week 16|Core Study||0
193395|NCT01350804|467929|P4|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|137
193396|NCT01350804|467930|P3|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|139
193397|NCT01350804|467931|P2|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|136
193398|NCT01350804|467932|P1|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|137
193399|NCT01350804|467929|P4|STARTED|Core Study||138
193400|NCT01350804|467930|P3|STARTED|Core Study||138
193401|NCT01350804|467931|P2|STARTED|Core Study||137
193402|NCT01350804|467932|P1|STARTED|Core Study||138
193403|NCT01350583|468021|P1|NOT COMPLETED|Overall Study||0
193404|NCT01350583|468021|P1|COMPLETED|Overall Study||2
193405|NCT01350583|468021|P1|STARTED|Overall Study||2
193406|NCT01350544|468029|P2|NOT COMPLETED|Overall Study||22
193407|NCT01350544|468030|P1|NOT COMPLETED|Overall Study||23
193408|NCT01350544|468029|P2|COMPLETED|Overall Study||86
193409|NCT01350544|468030|P1|COMPLETED|Overall Study||85
193410|NCT01350544|468029|P2|STARTED|Overall Study||108
193411|NCT01350544|468030|P1|STARTED|Overall Study||108
193412|NCT01350505|468036|P1|NOT COMPLETED|Overall Study||4
193413|NCT01350505|468036|P1|COMPLETED|Overall Study||17
193414|NCT01350505|468036|P1|STARTED|Overall Study||21
193415|NCT01350479|468042|P2|NOT COMPLETED|Overall Study||0
193416|NCT01350479|468043|P1|NOT COMPLETED|Overall Study||0
193417|NCT01350479|468042|P2|COMPLETED|Overall Study||106
193418|NCT01350479|468043|P1|COMPLETED|Overall Study||94
193419|NCT01350479|468042|P2|STARTED|Overall Study||106
193420|NCT01350479|468043|P1|STARTED|Overall Study||94
193421|NCT01350453|468051|P2|NOT COMPLETED|Overall Study||1
193422|NCT01350453|468052|P1|NOT COMPLETED|Overall Study||2
193423|NCT01350453|468051|P2|COMPLETED|Overall Study||7
193424|NCT01350453|468052|P1|COMPLETED|Overall Study||9
193425|NCT01350453|468051|P2|STARTED|Overall Study||8
193426|NCT01350453|468052|P1|STARTED|Overall Study||11
193427|NCT01350414|468066|P1|NOT COMPLETED|Overall Study||19
193428|NCT01350414|468066|P1|COMPLETED|Overall Study||162
193429|NCT01350414|468066|P1|Year 5|Overall Study||162
193430|NCT01350414|468066|P1|Year 4|Overall Study||159
193431|NCT01350414|468066|P1|Year 3|Overall Study||162
193432|NCT01350414|468066|P1|Year 2|Overall Study||165
193433|NCT01350414|468066|P1|STARTED|Overall Study||181
193434|NCT01350401|468083|P1|NOT COMPLETED|Overall Study||0
193435|NCT01350401|468083|P1|COMPLETED|Overall Study||4
193436|NCT01350401|468083|P1|STARTED|Overall Study||4
193437|NCT01350388|468095|P2|NOT COMPLETED|Overall Study||1
193438|NCT01350388|468096|P1|NOT COMPLETED|Overall Study||3
193439|NCT01350388|468095|P2|COMPLETED|Overall Study||39
193440|NCT01350388|468096|P1|COMPLETED|Overall Study||37
193441|NCT01350388|468095|P2|STARTED|Overall Study||40
193442|NCT01350388|468096|P1|STARTED|Overall Study||40
193443|NCT01350271|468115|P3|NOT COMPLETED|Overall Study||26
193444|NCT01350271|468116|P2|NOT COMPLETED|Overall Study||17
193445|NCT01350271|468117|P1|NOT COMPLETED|Overall Study||21
193446|NCT01350271|468115|P3|COMPLETED|Overall Study||48
193447|NCT01350271|468116|P2|COMPLETED|Overall Study||53
193448|NCT01350271|468117|P1|COMPLETED|Overall Study||49
193449|NCT01350271|468115|P3|STARTED|Overall Study||74
193450|NCT01350271|468116|P2|STARTED|Overall Study||70
193451|NCT01350271|468117|P1|STARTED|Overall Study||70
193452|NCT01350258|468131|P1|NOT COMPLETED|Overall Study||0
193453|NCT01350258|468131|P1|COMPLETED|Overall Study||8
193454|NCT01350258|468131|P1|STARTED|Overall Study||8
193455|NCT01350245|468140|P1|NOT COMPLETED|Overall Study||0
193456|NCT01350245|468140|P1|COMPLETED|Overall Study||28
193457|NCT01350245|468140|P1|STARTED|Overall Study||28
193458|NCT01350232|468145|P1|NOT COMPLETED|Overall Study||0
193459|NCT01350232|468145|P1|COMPLETED|Overall Study||2
193460|NCT01350232|468145|P1|STARTED|Overall Study||2
193461|NCT01350141|468159|P3|NOT COMPLETED|Overall Study||1
193462|NCT01350141|468160|P2|NOT COMPLETED|Overall Study||0
193463|NCT01350141|468161|P1|NOT COMPLETED|Overall Study||3
193464|NCT01350141|468159|P3|COMPLETED|Overall Study||15
193465|NCT01350141|468160|P2|COMPLETED|Overall Study||15
193466|NCT01350141|468161|P1|COMPLETED|Overall Study||12
193467|NCT01350141|468159|P3|Treated|Overall Study||16
193468|NCT01350141|468160|P2|Treated|Overall Study||15
193469|NCT01350141|468161|P1|Treated|Overall Study||14
193470|NCT01350141|468159|P3|STARTED|Overall Study||16
193471|NCT01350141|468160|P2|STARTED|Overall Study||15
193472|NCT01350141|468161|P1|STARTED|Overall Study||15
193473|NCT01350128|468195|P1|NOT COMPLETED|Overall Study||14
193474|NCT01350128|468195|P1|COMPLETED|Overall Study||89
193475|NCT01350128|468195|P1|Atrovent HFA 34 µg BID|Overall Study||48
193476|NCT01350128|468195|P1|Placebo MDI BID|Overall Study||48
193477|NCT01350128|468195|P1|GP MDI 4.6 µg BID|Overall Study||45
193478|NCT01350128|468195|P1|GP MDI 9 µg BID|Overall Study||49
193479|NCT01350128|468195|P1|GP MDI 18 µg BID|Overall Study||49
193480|NCT01350128|468195|P1|GP MDI 36 µg BID|Overall Study|Glycopyrronium Metered Dose Inhaler|49
193481|NCT01350128|468195|P1|STARTED|Overall Study||103
193482|NCT01350115|468259|P2|NOT COMPLETED|Long Term Follow-Up (All Patients)||2
193483|NCT01350115|468260|P1|NOT COMPLETED|Long Term Follow-Up (All Patients)||1
193484|NCT01350115|468259|P2|COMPLETED|Long Term Follow-Up (All Patients)||0
193485|NCT01350115|468260|P1|COMPLETED|Long Term Follow-Up (All Patients)||7
193486|NCT01350115|468259|P2|STARTED|Long Term Follow-Up (All Patients)||2
193487|NCT01350115|468260|P1|STARTED|Long Term Follow-Up (All Patients)||8
193488|NCT01350115|468259|P2|NOT COMPLETED|Core Study (All Patients)||0
193489|NCT01350115|468260|P1|NOT COMPLETED|Core Study (All Patients)||0
193490|NCT01350115|468259|P2|COMPLETED|Core Study (All Patients)||2
193491|NCT01350115|468260|P1|COMPLETED|Core Study (All Patients)||8
193492|NCT01350115|468259|P2|Pharmacodynamic Set|Core Study (All Patients)||2
193493|NCT01350115|468260|P1|Pharmacodynamic Set|Core Study (All Patients)||7
193494|NCT01350115|468259|P2|Safety Anlysis Set|Core Study (All Patients)||2
193495|NCT01350115|468260|P1|Safety Anlysis Set|Core Study (All Patients)||8
193496|NCT01350115|468259|P2|STARTED|Core Study (All Patients)||2
193497|NCT01350115|468260|P1|STARTED|Core Study (All Patients)||8
193498|NCT01350102|468276|P4|NOT COMPLETED|Overall Study||0
193499|NCT01350102|468277|P3|NOT COMPLETED|Overall Study||1
193500|NCT01350102|468278|P2|NOT COMPLETED|Overall Study||0
193501|NCT01350102|468279|P1|NOT COMPLETED|Overall Study||0
193502|NCT01350102|468276|P4|COMPLETED|Overall Study||0
193503|NCT01350102|468277|P3|COMPLETED|Overall Study||0
193504|NCT01350102|468278|P2|COMPLETED|Overall Study||1
193505|NCT01350102|468279|P1|COMPLETED|Overall Study||0
193506|NCT01350102|468276|P4|STARTED|Overall Study||0
193507|NCT01350102|468277|P3|STARTED|Overall Study||1
193508|NCT01350102|468278|P2|STARTED|Overall Study||1
193509|NCT01350102|468279|P1|STARTED|Overall Study||0
193510|NCT01349972|468299|P2|NOT COMPLETED|Overall Study||2
193511|NCT01349972|468300|P1|NOT COMPLETED|Overall Study||5
193512|NCT01349972|468299|P2|COMPLETED|Overall Study||56
193513|NCT01349972|468300|P1|COMPLETED|Overall Study||109
193514|NCT01349972|468299|P2|STARTED|Overall Study||58
193515|NCT01349972|468300|P1|STARTED|Overall Study||114
193516|NCT01349959|468316|P1|NOT COMPLETED|Overall Study||7
193517|NCT01349959|468316|P1|COMPLETED|Overall Study||33
193518|NCT01349959|468316|P1|STARTED|Overall Study||40
193519|NCT01349933|468327|P1|NOT COMPLETED|Overall Study||0
193520|NCT01349933|468327|P1|COMPLETED|Overall Study||21
193521|NCT01349933|468327|P1|STARTED|Overall Study||21
193522|NCT01349920|468337|P1|NOT COMPLETED|Overall Study||0
193523|NCT01349920|468337|P1|COMPLETED|Overall Study||15
193524|NCT01349920|468337|P1|STARTED|Overall Study||15
193525|NCT01349907|468357|P2|NOT COMPLETED|Overall Study||43
193526|NCT01349907|468358|P1|NOT COMPLETED|Overall Study||139
193527|NCT01349907|468357|P2|COMPLETED|Overall Study||38
193528|NCT01349907|468358|P1|COMPLETED|Overall Study||102
193529|NCT01349907|468357|P2|STARTED|Overall Study|Enrolled and Treated|81
193530|NCT01349907|468358|P1|STARTED|Overall Study|Enrolled and Treated|241
193531|NCT01349829|468396|P2|NOT COMPLETED|Overall Study||23
193532|NCT01349829|468397|P1|NOT COMPLETED|Overall Study||9
193533|NCT01349829|468396|P2|COMPLETED|Overall Study||102
193534|NCT01349829|468397|P1|COMPLETED|Overall Study||117
193535|NCT01349829|468396|P2|STARTED|Overall Study||125
193536|NCT01349829|468397|P1|STARTED|Overall Study||126
193537|NCT01349816|468415|P1|NOT COMPLETED|Overall Study||30
193538|NCT01349816|468415|P1|COMPLETED|Overall Study||155
193539|NCT01349816|468415|P1|FF MDI 9.6 µg|Overall Study||61
193540|NCT01349816|468415|P1|GFF MDI 9/9.6 µg|Overall Study||57
193541|NCT01349816|468415|P1|GFF MDI 18/9.6 µg|Overall Study||57
193542|NCT01349816|468415|P1|GFF MDI 36/9.6 µg|Overall Study||56
193543|NCT01349816|468415|P1|GFF MDI 36/7.2 µg|Overall Study||58
193544|NCT01349816|468415|P1|GP MDI 36 µg|Overall Study||61
193545|NCT01349816|468415|P1|STARTED|Overall Study||185
193546|NCT01349803|468481|P4|NOT COMPLETED|Overall Study||2
193547|NCT01349803|468482|P3|NOT COMPLETED|Overall Study||3
193548|NCT01349803|468483|P2|NOT COMPLETED|Overall Study||1
193549|NCT01349803|468484|P1|NOT COMPLETED|Overall Study||1
193550|NCT01349803|468481|P4|COMPLETED|Overall Study||57
193551|NCT01349803|468482|P3|COMPLETED|Overall Study||57
193552|NCT01349803|468483|P2|COMPLETED|Overall Study||57
193553|NCT01349803|468484|P1|COMPLETED|Overall Study||59
193554|NCT01349803|468481|P4|STARTED|Overall Study||59
193555|NCT01349803|468482|P3|STARTED|Overall Study||60
193556|NCT01349803|468483|P2|STARTED|Overall Study||58
193557|NCT01349803|468484|P1|STARTED|Overall Study||60
193558|NCT01349790|468554|P1|NOT COMPLETED|Overall Study||9
193559|NCT01349790|468554|P1|COMPLETED|Overall Study||31
193560|NCT01349790|468554|P1|STARTED|Overall Study||40
193561|NCT01349673|468573|P1|NOT COMPLETED|Overall Study||114
193562|NCT01349673|468573|P1|COMPLETED|Overall Study||0
193563|NCT01349673|468573|P1|Received At Least 1 Dose Of Study Drug|Overall Study||114
193564|NCT01349673|468573|P1|Participants Entered Cycle 8|Overall Study||1
193565|NCT01349673|468573|P1|Participants Entered Cycle 7|Overall Study||3
193566|NCT01349673|468573|P1|Participants Entered Cycle 6|Overall Study||5
193567|NCT01349673|468573|P1|Participants Entered Cycle 5|Overall Study||12
193568|NCT01349673|468573|P1|Participants Entered Cycle 4|Overall Study||22
193569|NCT01349673|468573|P1|Participants Entered Cycle 3|Overall Study||41
193570|NCT01349673|468573|P1|Participants Entered Cycle 2|Overall Study||65
193571|NCT01349673|468573|P1|Participants Entered Cycle 1|Overall Study||114
193572|NCT01349673|468573|P1|STARTED|Overall Study||114
193573|NCT01349660|468583|P3|NOT COMPLETED|Overall Study||76
193574|NCT01349660|468584|P2|NOT COMPLETED|Overall Study||6
193575|NCT01349660|468585|P1|NOT COMPLETED|Overall Study||6
193576|NCT01349660|468583|P3|COMPLETED|Overall Study||0
193577|NCT01349660|468584|P2|COMPLETED|Overall Study||0
193578|NCT01349660|468585|P1|COMPLETED|Overall Study||0
193579|NCT01349660|468583|P3|STARTED|Overall Study||76
193580|NCT01349660|468584|P2|STARTED|Overall Study||6
193581|NCT01349660|468585|P1|STARTED|Overall Study||6
193582|NCT01349595|468603|P2|NOT COMPLETED|Overall Study||2
193583|NCT01349595|468604|P1|NOT COMPLETED|Overall Study||2
193584|NCT01349595|468603|P2|COMPLETED|Overall Study||0
193585|NCT01349595|468604|P1|COMPLETED|Overall Study||0
193586|NCT01349595|468603|P2|STARTED|Overall Study||2
193587|NCT01349595|468604|P1|STARTED|Overall Study||2
193588|NCT01349569|468610|P1|NOT COMPLETED|Overall Study||4
193589|NCT01349569|468610|P1|COMPLETED|Overall Study||12
193590|NCT01349569|468610|P1|STARTED|Overall Study||16
193591|NCT01349491|468622|P2|NOT COMPLETED|Overall Study||0
193592|NCT01349491|468623|P1|NOT COMPLETED|Overall Study||0
193593|NCT01349491|468622|P2|COMPLETED|Overall Study||5
193594|NCT01349491|468623|P1|COMPLETED|Overall Study||5
193595|NCT01349491|468622|P2|STARTED|Overall Study||5
193596|NCT01349491|468623|P1|STARTED|Overall Study||5
193597|NCT01349465|468631|P2|NOT COMPLETED|Overall Study||22
193598|NCT01349465|468632|P1|NOT COMPLETED|Overall Study||18
193599|NCT01349465|468631|P2|COMPLETED|Overall Study||27
193600|NCT01349465|468632|P1|COMPLETED|Overall Study||182
193601|NCT01349465|468631|P2|STARTED|Overall Study||49
193602|NCT01349465|468632|P1|STARTED|Overall Study||200
193603|NCT01349231|468644|P1|NOT COMPLETED|Overall Study||0
193604|NCT01349231|468644|P1|COMPLETED|Overall Study||10
193605|NCT01349231|468644|P1|STARTED|Overall Study||10
193606|NCT01349192|468653|P2|NOT COMPLETED|Overall Study||6
193607|NCT01349192|468654|P1|NOT COMPLETED|Overall Study||3
193608|NCT01349192|468653|P2|COMPLETED|Overall Study||17
193609|NCT01349192|468654|P1|COMPLETED|Overall Study||21
193610|NCT01349192|468653|P2|Withdrawals|Overall Study||6
193611|NCT01349192|468654|P1|Withdrawals|Overall Study||3
193612|NCT01349192|468653|P2|Evaluable for Primary Endpoint|Overall Study||19
193613|NCT01349192|468654|P1|Evaluable for Primary Endpoint|Overall Study||22
193614|NCT01349192|468653|P2|STARTED|Overall Study||23
193615|NCT01349192|468654|P1|STARTED|Overall Study||24
193616|NCT01349114|468668|P2|NOT COMPLETED|Overall Study||0
193617|NCT01349114|468669|P1|NOT COMPLETED|Overall Study||0
193618|NCT01349114|468668|P2|COMPLETED|Overall Study||11
193619|NCT01349114|468669|P1|COMPLETED|Overall Study||10
193620|NCT01349114|468668|P2|STARTED|Overall Study||11
193621|NCT01349114|468669|P1|STARTED|Overall Study||10
193622|NCT01349049|468686|P9|NOT COMPLETED|Overall Study||55
193623|NCT01349049|468687|P8|NOT COMPLETED|Overall Study||4
193624|NCT01349049|468688|P7|NOT COMPLETED|Overall Study||5
193625|NCT01349049|468689|P6|NOT COMPLETED|Overall Study||6
193626|NCT01349049|468690|P5|NOT COMPLETED|Overall Study||3
193627|NCT01349049|468691|P4|NOT COMPLETED|Overall Study||3
193628|NCT01349049|468692|P3|NOT COMPLETED|Overall Study||3
193629|NCT01349049|468693|P2|NOT COMPLETED|Overall Study||7
193630|NCT01349049|468694|P1|NOT COMPLETED|Overall Study||3
193631|NCT01349049|468686|P9|COMPLETED|Overall Study||1
193632|NCT01349049|468687|P8|COMPLETED|Overall Study||0
193633|NCT01349049|468688|P7|COMPLETED|Overall Study||0
193634|NCT01349049|468689|P6|COMPLETED|Overall Study||0
193635|NCT01349049|468690|P5|COMPLETED|Overall Study||0
193636|NCT01349049|468691|P4|COMPLETED|Overall Study||0
193637|NCT01349049|468692|P3|COMPLETED|Overall Study||0
193638|NCT01349049|468693|P2|COMPLETED|Overall Study||0
193639|NCT01349049|468694|P1|COMPLETED|Overall Study||0
193640|NCT01349049|468686|P9|STARTED|Overall Study||56
193641|NCT01349049|468687|P8|STARTED|Overall Study||4
193642|NCT01349049|468688|P7|STARTED|Overall Study||5
193643|NCT01349049|468689|P6|STARTED|Overall Study||6
193644|NCT01349049|468690|P5|STARTED|Overall Study||3
193645|NCT01349049|468691|P4|STARTED|Overall Study||3
193646|NCT01349049|468692|P3|STARTED|Overall Study||3
193647|NCT01349049|468693|P2|STARTED|Overall Study||7
193648|NCT01349049|468694|P1|STARTED|Overall Study||3
193649|NCT01348854|468748|P2|NOT COMPLETED|Overall Study||1
193650|NCT01348854|468749|P1|NOT COMPLETED|Overall Study||3
193651|NCT01348854|468748|P2|COMPLETED|Overall Study|9 eyes of 5 participants|5
193652|NCT01348854|468749|P1|COMPLETED|Overall Study|47 eyes of 31 participants|31
193653|NCT01348854|468748|P2|STARTED|Overall Study|10 eyes of 6 participants|6
193654|NCT01348854|468749|P1|STARTED|Overall Study|53 eyes of 34 participants|34
193655|NCT01348789|468757|P1|NOT COMPLETED|Overall Study||4
193656|NCT01348789|468757|P1|COMPLETED|Overall Study|4 subjects did not complete all 3 treatments but were evaluated for primary and secondary endpoints.|33
193657|NCT01348789|468757|P1|STARTED|Overall Study||37
193658|NCT01348776|468768|P1|NOT COMPLETED|Overall Study||3
193659|NCT01348776|468768|P1|COMPLETED|Overall Study||84
193660|NCT01348776|468768|P1|STARTED|Overall Study|3 subjects were lost to follow-up: 2 after the 1-month follow-up, 1 after performing 4 treatments|87
193661|NCT01348763|468781|P1|NOT COMPLETED|Without Tenofovir/Emtricitabine (11 Day)||0
193662|NCT01348763|468781|P1|COMPLETED|Without Tenofovir/Emtricitabine (11 Day)||11
193663|NCT01348763|468781|P1|STARTED|Without Tenofovir/Emtricitabine (11 Day)||11
193664|NCT01348763|468781|P1|NOT COMPLETED|With Tenofovir/Emtricitabine (10 Days)||2
193665|NCT01348763|468781|P1|COMPLETED|With Tenofovir/Emtricitabine (10 Days)||11
193666|NCT01348763|468781|P1|STARTED|With Tenofovir/Emtricitabine (10 Days)||13
193667|NCT01348698|468786|P1|NOT COMPLETED|Overall Study||72
193668|NCT01348698|468786|P1|COMPLETED|Overall Study||2
193669|NCT01348698|468786|P1|STARTED|Overall Study||74
193670|NCT01348607|468796|P3|NOT COMPLETED|Overall Study||0
193671|NCT01348607|468797|P2|NOT COMPLETED|Overall Study||0
193672|NCT01348607|468798|P1|NOT COMPLETED|Overall Study||0
193673|NCT01348607|468796|P3|COMPLETED|Overall Study||0
193674|NCT01348607|468797|P2|COMPLETED|Overall Study||0
193675|NCT01348607|468798|P1|COMPLETED|Overall Study||1
193676|NCT01348607|468796|P3|STARTED|Overall Study||0
193677|NCT01348607|468797|P2|STARTED|Overall Study||0
193678|NCT01348607|468798|P1|STARTED|Overall Study||1
193679|NCT01348542|468811|P2|NOT COMPLETED|Overall Study||0
193680|NCT01348542|468812|P1|NOT COMPLETED|Overall Study||3
193681|NCT01348542|468811|P2|COMPLETED|Overall Study||11
193682|NCT01348542|468812|P1|COMPLETED|Overall Study||10
193683|NCT01348542|468811|P2|STARTED|Overall Study||11
193684|NCT01348542|468812|P1|STARTED|Overall Study||13
193685|NCT01348425|468830|P2|NOT COMPLETED|Overall Study||1
193686|NCT01348425|468831|P1|NOT COMPLETED|Overall Study||1
193687|NCT01348425|468830|P2|COMPLETED|Overall Study||13
193688|NCT01348425|468831|P1|COMPLETED|Overall Study||30
193689|NCT01348425|468830|P2|STARTED|Overall Study||14
193690|NCT01348425|468831|P1|STARTED|Overall Study||31
193691|NCT01348347|468839|P3|NOT COMPLETED|Overall Study||6
193692|NCT01348347|468840|P2|NOT COMPLETED|Overall Study||6
193693|NCT01348347|468841|P1|NOT COMPLETED|Overall Study||3
193694|NCT01348347|468839|P3|COMPLETED|Overall Study||0
193695|NCT01348347|468840|P2|COMPLETED|Overall Study||0
193696|NCT01348347|468841|P1|COMPLETED|Overall Study||0
193697|NCT01348347|468839|P3|STARTED|Overall Study||6
193698|NCT01348347|468840|P2|STARTED|Overall Study||6
193699|NCT01348347|468841|P1|STARTED|Overall Study||3
193700|NCT01348165|468872|P7|NOT COMPLETED|Overall Study||1
193701|NCT01348165|468873|P6|NOT COMPLETED|Overall Study||0
193702|NCT01348165|468874|P5|NOT COMPLETED|Overall Study||0
193703|NCT01348165|468875|P4|NOT COMPLETED|Overall Study||0
193704|NCT01348165|468876|P3|NOT COMPLETED|Overall Study||0
193705|NCT01348165|468877|P2|NOT COMPLETED|Overall Study||0
193706|NCT01348165|468878|P1|NOT COMPLETED|Overall Study||0
193707|NCT01348165|468872|P7|COMPLETED|Overall Study||5
193708|NCT01348165|468873|P6|COMPLETED|Overall Study||1
193709|NCT01348165|468874|P5|COMPLETED|Overall Study||6
193710|NCT01348165|468875|P4|COMPLETED|Overall Study||6
193711|NCT01348165|468876|P3|COMPLETED|Overall Study||6
193712|NCT01348165|468877|P2|COMPLETED|Overall Study||5
193713|NCT01348165|468878|P1|COMPLETED|Overall Study||10
193714|NCT01348165|468872|P7|STARTED|Overall Study||6
193715|NCT01348165|468873|P6|STARTED|Overall Study||1
193716|NCT01348165|468874|P5|STARTED|Overall Study||6
193717|NCT01348165|468875|P4|STARTED|Overall Study||6
193718|NCT01348165|468876|P3|STARTED|Overall Study||6
193719|NCT01348165|468877|P2|STARTED|Overall Study||5
193720|NCT01348165|468878|P1|STARTED|Overall Study||10
193721|NCT01348139|469007|P6|NOT COMPLETED|Period 6||0
193722|NCT01348139|469008|P5|NOT COMPLETED|Period 6||0
193723|NCT01348139|469009|P4|NOT COMPLETED|Period 6||0
193724|NCT01348139|469010|P3|NOT COMPLETED|Period 6||0
193725|NCT01348139|469011|P2|NOT COMPLETED|Period 6||0
193726|NCT01348139|469012|P1|NOT COMPLETED|Period 6||0
193727|NCT01348139|469007|P6|COMPLETED|Period 6||4
193728|NCT01348139|469008|P5|COMPLETED|Period 6||5
193729|NCT01348139|469009|P4|COMPLETED|Period 6||4
193730|NCT01348139|469010|P3|COMPLETED|Period 6||4
193731|NCT01348139|469011|P2|COMPLETED|Period 6||4
193732|NCT01348139|469012|P1|COMPLETED|Period 6||4
193733|NCT01348139|469007|P6|STARTED|Period 6||4
193734|NCT01348139|469008|P5|STARTED|Period 6||5
193735|NCT01348139|469009|P4|STARTED|Period 6||4
193736|NCT01348139|469010|P3|STARTED|Period 6||4
193737|NCT01348139|469011|P2|STARTED|Period 6||4
193738|NCT01348139|469012|P1|STARTED|Period 6||4
193739|NCT01348139|469007|P6|NOT COMPLETED|Period 5||0
193740|NCT01348139|469008|P5|NOT COMPLETED|Period 5||0
193741|NCT01348139|469009|P4|NOT COMPLETED|Period 5||0
193742|NCT01348139|469010|P3|NOT COMPLETED|Period 5||0
193743|NCT01348139|469011|P2|NOT COMPLETED|Period 5||0
193744|NCT01348139|469012|P1|NOT COMPLETED|Period 5||0
193745|NCT01348139|469007|P6|COMPLETED|Period 5||4
193746|NCT01348139|469008|P5|COMPLETED|Period 5||5
193747|NCT01348139|469009|P4|COMPLETED|Period 5||4
193748|NCT01348139|469010|P3|COMPLETED|Period 5||4
193749|NCT01348139|469011|P2|COMPLETED|Period 5||4
193750|NCT01348139|469012|P1|COMPLETED|Period 5||4
193751|NCT01348139|469007|P6|STARTED|Period 5||4
193752|NCT01348139|469008|P5|STARTED|Period 5||5
193753|NCT01348139|469009|P4|STARTED|Period 5||4
193754|NCT01348139|469010|P3|STARTED|Period 5||4
193755|NCT01348139|469011|P2|STARTED|Period 5||4
193756|NCT01348139|469012|P1|STARTED|Period 5||4
193757|NCT01348139|469007|P6|NOT COMPLETED|Period 4||0
193758|NCT01348139|469008|P5|NOT COMPLETED|Period 4||0
193759|NCT01348139|469009|P4|NOT COMPLETED|Period 4||0
193760|NCT01348139|469010|P3|NOT COMPLETED|Period 4||0
193761|NCT01348139|469011|P2|NOT COMPLETED|Period 4||0
193762|NCT01348139|469012|P1|NOT COMPLETED|Period 4||0
193763|NCT01348139|469007|P6|COMPLETED|Period 4||4
193764|NCT01348139|469008|P5|COMPLETED|Period 4||5
193765|NCT01348139|469009|P4|COMPLETED|Period 4||4
193766|NCT01348139|469010|P3|COMPLETED|Period 4||4
193767|NCT01348139|469011|P2|COMPLETED|Period 4||4
193768|NCT01348139|469012|P1|COMPLETED|Period 4||4
193769|NCT01348139|469007|P6|STARTED|Period 4||4
193770|NCT01348139|469008|P5|STARTED|Period 4||5
193771|NCT01348139|469009|P4|STARTED|Period 4||4
193772|NCT01348139|469010|P3|STARTED|Period 4||4
193773|NCT01348139|469011|P2|STARTED|Period 4||4
193774|NCT01348139|469012|P1|STARTED|Period 4||4
193775|NCT01348139|469007|P6|NOT COMPLETED|Period 3||0
193776|NCT01348139|469008|P5|NOT COMPLETED|Period 3||0
193777|NCT01348139|469009|P4|NOT COMPLETED|Period 3||0
193778|NCT01348139|469010|P3|NOT COMPLETED|Period 3||0
193779|NCT01348139|469011|P2|NOT COMPLETED|Period 3||0
193780|NCT01348139|469012|P1|NOT COMPLETED|Period 3||0
193781|NCT01348139|469007|P6|COMPLETED|Period 3||4
193782|NCT01348139|469008|P5|COMPLETED|Period 3||5
193783|NCT01348139|469009|P4|COMPLETED|Period 3||4
193784|NCT01348139|469010|P3|COMPLETED|Period 3||4
193785|NCT01348139|469011|P2|COMPLETED|Period 3||4
193786|NCT01348139|469012|P1|COMPLETED|Period 3||4
193787|NCT01348139|469007|P6|STARTED|Period 3||4
193788|NCT01348139|469008|P5|STARTED|Period 3||5
193789|NCT01348139|469009|P4|STARTED|Period 3||4
193790|NCT01348139|469010|P3|STARTED|Period 3||4
193791|NCT01348139|469011|P2|STARTED|Period 3||4
193792|NCT01348139|469012|P1|STARTED|Period 3||4
193793|NCT01348139|469007|P6|NOT COMPLETED|Period 2||0
193794|NCT01348139|469008|P5|NOT COMPLETED|Period 2||0
193795|NCT01348139|469009|P4|NOT COMPLETED|Period 2||0
193796|NCT01348139|469010|P3|NOT COMPLETED|Period 2||0
193797|NCT01348139|469011|P2|NOT COMPLETED|Period 2||0
193798|NCT01348139|469012|P1|NOT COMPLETED|Period 2||0
193799|NCT01348139|469007|P6|COMPLETED|Period 2||4
193800|NCT01348139|469008|P5|COMPLETED|Period 2||5
193801|NCT01348139|469009|P4|COMPLETED|Period 2||4
193802|NCT01348139|469010|P3|COMPLETED|Period 2||4
193803|NCT01348139|469011|P2|COMPLETED|Period 2||4
193804|NCT01348139|469012|P1|COMPLETED|Period 2||4
193805|NCT01348139|469007|P6|STARTED|Period 2||4
193806|NCT01348139|469008|P5|STARTED|Period 2||5
193807|NCT01348139|469009|P4|STARTED|Period 2||4
193808|NCT01348139|469010|P3|STARTED|Period 2||4
193809|NCT01348139|469011|P2|STARTED|Period 2||4
193810|NCT01348139|469012|P1|STARTED|Period 2||4
193811|NCT01348139|469007|P6|NOT COMPLETED|Period 1||0
193812|NCT01348139|469008|P5|NOT COMPLETED|Period 1||0
193813|NCT01348139|469009|P4|NOT COMPLETED|Period 1||0
193814|NCT01348139|469010|P3|NOT COMPLETED|Period 1||0
193815|NCT01348139|469011|P2|NOT COMPLETED|Period 1||0
193816|NCT01348139|469012|P1|NOT COMPLETED|Period 1||1
193817|NCT01348139|469007|P6|COMPLETED|Period 1||4
193818|NCT01348139|469008|P5|COMPLETED|Period 1||5
193819|NCT01348139|469009|P4|COMPLETED|Period 1||4
193820|NCT01348139|469010|P3|COMPLETED|Period 1||4
193821|NCT01348139|469011|P2|COMPLETED|Period 1||4
193822|NCT01348139|469012|P1|COMPLETED|Period 1||4
193823|NCT01348139|469007|P6|STARTED|Period 1||4
193824|NCT01348139|469008|P5|STARTED|Period 1||5
193825|NCT01348139|469009|P4|STARTED|Period 1||4
193826|NCT01348139|469010|P3|STARTED|Period 1||4
193827|NCT01348139|469011|P2|STARTED|Period 1||4
193828|NCT01348139|469012|P1|STARTED|Period 1||5
193829|NCT01348100|469093|P7|NOT COMPLETED|Overall Study||3
193830|NCT01348100|469094|P6|NOT COMPLETED|Overall Study||2
193831|NCT01348100|469095|P5|NOT COMPLETED|Overall Study||1
193832|NCT01348100|469096|P4|NOT COMPLETED|Overall Study||1
193833|NCT01348100|469097|P3|NOT COMPLETED|Overall Study||2
193834|NCT01348100|469098|P2|NOT COMPLETED|Overall Study||0
193835|NCT01348100|469099|P1|NOT COMPLETED|Overall Study||0
193836|NCT01348100|469093|P7|COMPLETED|Overall Study||13
193837|NCT01348100|469094|P6|COMPLETED|Overall Study||14
193838|NCT01348100|469095|P5|COMPLETED|Overall Study||14
193839|NCT01348100|469096|P4|COMPLETED|Overall Study||14
193840|NCT01348100|469097|P3|COMPLETED|Overall Study||13
193841|NCT01348100|469098|P2|COMPLETED|Overall Study||2
193842|NCT01348100|469099|P1|COMPLETED|Overall Study||2
193843|NCT01348100|469093|P7|STARTED|Overall Study||16
193844|NCT01348100|469094|P6|STARTED|Overall Study||16
193845|NCT01348100|469095|P5|STARTED|Overall Study||15
193846|NCT01348100|469096|P4|STARTED|Overall Study||15
193847|NCT01348100|469097|P3|STARTED|Overall Study||15
193848|NCT01348100|469098|P2|STARTED|Overall Study||2
193849|NCT01348100|469099|P1|STARTED|Overall Study||2
193850|NCT01348087|469144|P1|NOT COMPLETED|Overall Study||148
193851|NCT01348087|469144|P1|COMPLETED|Overall Study||0
193852|NCT01348087|469144|P1|STARTED|Overall Study||148
193853|NCT01347931|469158|P1|NOT COMPLETED|NIOV System||0
193854|NCT01347931|469158|P1|COMPLETED|NIOV System||29
193855|NCT01347931|469158|P1|STARTED|NIOV System||29
193856|NCT01347931|469158|P1|NOT COMPLETED|Standard Oxygen Therapy||1
193857|NCT01347931|469158|P1|COMPLETED|Standard Oxygen Therapy||29
193858|NCT01347931|469158|P1|STARTED|Standard Oxygen Therapy||30
193859|NCT01347879|469170|P2|NOT COMPLETED|Overall Study||17
193860|NCT01347879|469171|P1|NOT COMPLETED|Overall Study||7
193861|NCT01347879|469170|P2|COMPLETED|Overall Study||83
193862|NCT01347879|469171|P1|COMPLETED|Overall Study||46
193863|NCT01347879|469170|P2|STARTED|Overall Study||100
193864|NCT01347879|469171|P1|STARTED|Overall Study||53
193865|NCT01347866|469220|P17|NOT COMPLETED|Overall Study||2
193866|NCT01347866|469221|P16|NOT COMPLETED|Overall Study||4
193867|NCT01347866|469222|P15|NOT COMPLETED|Overall Study||3
193868|NCT01347866|469223|P14|NOT COMPLETED|Overall Study||7
193869|NCT01347866|469224|P13|NOT COMPLETED|Overall Study||7
193870|NCT01347866|469225|P12|NOT COMPLETED|Overall Study||4
193871|NCT01347866|469226|P11|NOT COMPLETED|Overall Study||3
193872|NCT01347866|469227|P10|NOT COMPLETED|Overall Study||7
193873|NCT01347866|469228|P9|NOT COMPLETED|Overall Study||31
193874|NCT01347866|469229|P8|NOT COMPLETED|Overall Study||4
193875|NCT01347866|469230|P7|NOT COMPLETED|Overall Study||6
193876|NCT01347866|469231|P6|NOT COMPLETED|Overall Study||3
193877|NCT01347866|469232|P5|NOT COMPLETED|Overall Study||7
193878|NCT01347866|469233|P4|NOT COMPLETED|Overall Study||7
193879|NCT01347866|469234|P3|NOT COMPLETED|Overall Study||1
193880|NCT01347866|469235|P2|NOT COMPLETED|Overall Study||1
193881|NCT01347866|469236|P1|NOT COMPLETED|Overall Study||5
193882|NCT01347866|469220|P17|COMPLETED|Overall Study||0
193883|NCT01347866|469221|P16|COMPLETED|Overall Study||0
193884|NCT01347866|469222|P15|COMPLETED|Overall Study||0
193885|NCT01347866|469223|P14|COMPLETED|Overall Study||0
193886|NCT01347866|469224|P13|COMPLETED|Overall Study||0
193887|NCT01347866|469225|P12|COMPLETED|Overall Study||0
193888|NCT01347866|469226|P11|COMPLETED|Overall Study||0
193889|NCT01347866|469227|P10|COMPLETED|Overall Study||0
193890|NCT01347866|469228|P9|COMPLETED|Overall Study||0
193891|NCT01347866|469229|P8|COMPLETED|Overall Study||0
193892|NCT01347866|469230|P7|COMPLETED|Overall Study||0
193893|NCT01347866|469231|P6|COMPLETED|Overall Study||0
193894|NCT01347866|469232|P5|COMPLETED|Overall Study||0
193895|NCT01347866|469233|P4|COMPLETED|Overall Study||0
193896|NCT01347866|469234|P3|COMPLETED|Overall Study||0
193897|NCT01347866|469235|P2|COMPLETED|Overall Study||0
193898|NCT01347866|469236|P1|COMPLETED|Overall Study||0
193899|NCT01347866|469220|P17|STARTED|Overall Study||2
193900|NCT01347866|469221|P16|STARTED|Overall Study||4
193901|NCT01347866|469222|P15|STARTED|Overall Study||3
193902|NCT01347866|469223|P14|STARTED|Overall Study||7
193903|NCT01347866|469224|P13|STARTED|Overall Study||7
193904|NCT01347866|469225|P12|STARTED|Overall Study||4
193905|NCT01347866|469226|P11|STARTED|Overall Study||3
193906|NCT01347866|469227|P10|STARTED|Overall Study||7
193907|NCT01347866|469228|P9|STARTED|Overall Study||31
193908|NCT01347866|469229|P8|STARTED|Overall Study||4
193909|NCT01347866|469230|P7|STARTED|Overall Study||6
193910|NCT01347866|469231|P6|STARTED|Overall Study||3
193911|NCT01347866|469232|P5|STARTED|Overall Study||7
193912|NCT01347866|469233|P4|STARTED|Overall Study||7
193913|NCT01347866|469234|P3|STARTED|Overall Study||1
193914|NCT01347866|469235|P2|STARTED|Overall Study||1
193915|NCT01347866|469236|P1|STARTED|Overall Study||5
193916|NCT01347840|469610|P1|NOT COMPLETED|Overall Study||1
193917|NCT01347840|469610|P1|COMPLETED|Overall Study||0
193918|NCT01347840|469610|P1|STARTED|Overall Study|1 subject enrolled but withdrew consent|1
193919|NCT01347788|469623|P3|NOT COMPLETED|Overall Study||0
193920|NCT01347788|469624|P2|NOT COMPLETED|Overall Study||0
193921|NCT01347788|469625|P1|NOT COMPLETED|Overall Study||0
193922|NCT01347788|469623|P3|COMPLETED|Overall Study||13
193923|NCT01347788|469624|P2|COMPLETED|Overall Study||10
193924|NCT01347788|469625|P1|COMPLETED|Overall Study||11
193925|NCT01347788|469623|P3|STARTED|Overall Study||13
193926|NCT01347788|469624|P2|STARTED|Overall Study||10
193927|NCT01347788|469625|P1|STARTED|Overall Study||11
193928|NCT01347762|469637|P4|NOT COMPLETED|Overall Study||8
193929|NCT01347762|469638|P3|NOT COMPLETED|Overall Study||9
193930|NCT01347762|469639|P2|NOT COMPLETED|Overall Study||2
193931|NCT01347762|469640|P1|NOT COMPLETED|Overall Study||4
193932|NCT01347762|469637|P4|COMPLETED|Overall Study||10
193933|NCT01347762|469638|P3|COMPLETED|Overall Study||7
193934|NCT01347762|469639|P2|COMPLETED|Overall Study||6
193935|NCT01347762|469640|P1|COMPLETED|Overall Study||6
193936|NCT01347762|469637|P4|STARTED|Overall Study||18
193937|NCT01347762|469638|P3|STARTED|Overall Study||16
193938|NCT01347762|469639|P2|STARTED|Overall Study||8
193939|NCT01347762|469640|P1|STARTED|Overall Study||10
193940|NCT01347710|469666|P1|NOT COMPLETED|Overall Study||31
193941|NCT01347710|469666|P1|COMPLETED|Overall Study||764
193942|NCT01347710|469666|P1|STARTED|Overall Study||795
193943|NCT01347632|469681|P1|NOT COMPLETED|Overall Study||2
193944|NCT01347632|469681|P1|COMPLETED|Overall Study||33
193945|NCT01347632|469681|P1|STARTED|Overall Study||35
193946|NCT01347580|469688|P2|NOT COMPLETED|Overall Study||56
193947|NCT01347580|469689|P1|NOT COMPLETED|Overall Study||65
193948|NCT01347580|469688|P2|COMPLETED|Overall Study|based on randomized treatment|897
193949|NCT01347580|469689|P1|COMPLETED|Overall Study|based on randomized treatment|844
193950|NCT01347580|469688|P2|Safety Population|Overall Study|based on actual treatment|950
193951|NCT01347580|469689|P1|Safety Population|Overall Study|based on actual treatment|908
193952|NCT01347580|469688|P2|Modified Intent to Treat Population|Overall Study|based on randomized treatment|952
193953|NCT01347580|469689|P1|Modified Intent to Treat Population|Overall Study|based on randomized treatment|906
193954|NCT01347580|469688|P2|STARTED|Overall Study|based on randomized treatment|953
193955|NCT01347580|469689|P1|STARTED|Overall Study|based on randomized treatment|909
193956|NCT01347554|469719|P2|NOT COMPLETED|Overall Study||11
193957|NCT01347554|469720|P1|NOT COMPLETED|Overall Study||7
193958|NCT01347554|469719|P2|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=11) were excluded.|231
193959|NCT01347554|469720|P1|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=7) were excluded.|230
193960|NCT01347554|469719|P2|STARTED|Overall Study||242
193961|NCT01347554|469720|P1|STARTED|Overall Study||237
193962|NCT01347255|469732|P1|NOT COMPLETED|Overall Study||0
193963|NCT01347255|469732|P1|COMPLETED|Overall Study||24
193964|NCT01347255|469732|P1|STARTED|Overall Study||24
193965|NCT01347112|469757|P2|NOT COMPLETED|Overall Study||12
193966|NCT01347112|469758|P1|NOT COMPLETED|Overall Study||4
193967|NCT01347112|469757|P2|COMPLETED|Overall Study||5
193968|NCT01347112|469758|P1|COMPLETED|Overall Study||12
193969|NCT01347112|469757|P2|STARTED|Overall Study||17
193970|NCT01347112|469758|P1|STARTED|Overall Study||16
193971|NCT01347086|469778|P10|NOT COMPLETED|Overall Study||1
193972|NCT01347086|469779|P9|NOT COMPLETED|Overall Study||0
193973|NCT01347086|469780|P8|NOT COMPLETED|Overall Study||1
193974|NCT01347086|469781|P7|NOT COMPLETED|Overall Study||1
193975|NCT01347086|469782|P6|NOT COMPLETED|Overall Study||0
193976|NCT01347086|469783|P5|NOT COMPLETED|Overall Study||0
193977|NCT01347086|469784|P4|NOT COMPLETED|Overall Study||0
193978|NCT01347086|469785|P3|NOT COMPLETED|Overall Study||1
193979|NCT01347086|469786|P2|NOT COMPLETED|Overall Study||0
193980|NCT01347086|469787|P1|NOT COMPLETED|Overall Study||0
193981|NCT01347086|469778|P10|COMPLETED|Overall Study||6
193982|NCT01347086|469779|P9|COMPLETED|Overall Study||6
193983|NCT01347086|469780|P8|COMPLETED|Overall Study||6
193984|NCT01347086|469781|P7|COMPLETED|Overall Study||6
193985|NCT01347086|469782|P6|COMPLETED|Overall Study||6
193986|NCT01347086|469783|P5|COMPLETED|Overall Study||6
193987|NCT01347086|469784|P4|COMPLETED|Overall Study||6
193988|NCT01347086|469785|P3|COMPLETED|Overall Study||6
193989|NCT01347086|469786|P2|COMPLETED|Overall Study||6
193990|NCT01347086|469787|P1|COMPLETED|Overall Study||2
193991|NCT01347086|469778|P10|STARTED|Overall Study|One subject was not treated.|7
193992|NCT01347086|469779|P9|STARTED|Overall Study||6
193993|NCT01347086|469780|P8|STARTED|Overall Study|One subject was not treated.|7
193994|NCT01347086|469781|P7|STARTED|Overall Study|"2 participants treated together with each dose level of Deleobuvir.~1 subject was not treated."|7
193995|NCT01347086|469782|P6|STARTED|Overall Study||6
193996|NCT01347086|469783|P5|STARTED|Overall Study||6
193997|NCT01347086|469784|P4|STARTED|Overall Study||6
193998|NCT01347086|469785|P3|STARTED|Overall Study|"2 participants were treated together with each dose level of Deleobuvir.~1 subject was not treated."|7
193999|NCT01347086|469786|P2|STARTED|Overall Study||6
194000|NCT01347086|469787|P1|STARTED|Overall Study||2
194001|NCT01347073|469886|P1|NOT COMPLETED|Overall Study||2
194002|NCT01347073|469886|P1|COMPLETED|Overall Study||21
194003|NCT01347073|469886|P1|STARTED|Overall Study||23
194004|NCT01347060|469900|P2|NOT COMPLETED|Overall Study||0
194005|NCT01347060|469901|P1|NOT COMPLETED|Overall Study||0
194006|NCT01347060|469900|P2|COMPLETED|Overall Study||7580
194007|NCT01347060|469901|P1|COMPLETED|Overall Study||9868
194008|NCT01347060|469900|P2|STARTED|Overall Study||7580
194009|NCT01347060|469901|P1|STARTED|Overall Study||9868
194010|NCT01347034|469913|P2|NOT COMPLETED|Overall Study||0
194011|NCT01347034|469914|P1|NOT COMPLETED|Overall Study||0
194012|NCT01347034|469913|P2|COMPLETED|Overall Study||14
194013|NCT01347034|469914|P1|COMPLETED|Overall Study||6
194014|NCT01347034|469913|P2|STARTED|Overall Study||14
194015|NCT01347034|469914|P1|STARTED|Overall Study||6
194016|NCT01347008|469924|P2|NOT COMPLETED|Overall Study||0
194017|NCT01347008|469925|P1|NOT COMPLETED|Overall Study||0
194018|NCT01347008|469924|P2|COMPLETED|Overall Study||20
194019|NCT01347008|469925|P1|COMPLETED|Overall Study||21
194020|NCT01347008|469924|P2|STARTED|Overall Study||20
194021|NCT01347008|469925|P1|STARTED|Overall Study||21
194022|NCT01346852|469937|P2|NOT COMPLETED|Overall Study||0
194023|NCT01346852|469938|P1|NOT COMPLETED|Overall Study||0
194024|NCT01346852|469937|P2|COMPLETED|Overall Study||59684
194025|NCT01346852|469938|P1|COMPLETED|Overall Study||41753
194026|NCT01346852|469937|P2|STARTED|Overall Study||59684
194027|NCT01346852|469938|P1|STARTED|Overall Study||41753
194028|NCT01346839|469948|P2|NOT COMPLETED|Overall Study||209
194029|NCT01346839|469949|P1|NOT COMPLETED|Overall Study||314
194030|NCT01346839|469948|P2|COMPLETED|Overall Study|All triggers were applied retrospectively on 7/19/2012.|364
194031|NCT01346839|469949|P1|COMPLETED|Overall Study||369
194032|NCT01346839|469948|P2|STARTED|Overall Study||573
194033|NCT01346839|469949|P1|STARTED|Overall Study||683
194034|NCT01346774|469965|P2|NOT COMPLETED|Overall Study||17
194035|NCT01346774|469966|P1|NOT COMPLETED|Overall Study||13
194036|NCT01346774|469965|P2|COMPLETED|Overall Study||63
194037|NCT01346774|469966|P1|COMPLETED|Overall Study||67
194038|NCT01346774|469965|P2|STARTED|Overall Study||80
194039|NCT01346774|469966|P1|STARTED|Overall Study||80
194040|NCT01346696|469972|P1|NOT COMPLETED|Overall Study||1
194041|NCT01346696|469972|P1|COMPLETED|Overall Study||44
194042|NCT01346696|469972|P1|STARTED|Overall Study||45
194043|NCT01346683|469983|P1|NOT COMPLETED|Overall Study||0
194044|NCT01346683|469983|P1|COMPLETED|Overall Study||45
194045|NCT01346683|469983|P1|STARTED|Overall Study||45
194046|NCT01346592|469994|P3|NOT COMPLETED|Overall Study||78
194047|NCT01346592|469995|P2|NOT COMPLETED|Overall Study||89
194048|NCT01346592|469996|P1|NOT COMPLETED|Overall Study||153
194049|NCT01346592|469994|P3|COMPLETED|Overall Study||1408
194050|NCT01346592|469995|P2|COMPLETED|Overall Study||1389
194051|NCT01346592|469996|P1|COMPLETED|Overall Study||2983
194052|NCT01346592|469994|P3|STARTED|Overall Study||1486
194053|NCT01346592|469995|P2|STARTED|Overall Study||1478
194054|NCT01346592|469996|P1|STARTED|Overall Study||3136
194055|NCT01346540|470088|P2|NOT COMPLETED|Overall Study||12
194056|NCT01346540|470089|P1|NOT COMPLETED|Overall Study||3
194057|NCT01346540|470088|P2|COMPLETED|Overall Study||0
194058|NCT01346540|470089|P1|COMPLETED|Overall Study||1
194059|NCT01346540|470088|P2|STARTED|Overall Study||12
194060|NCT01346540|470089|P1|STARTED|Overall Study||4
194061|NCT01346514|470100|P2|NOT COMPLETED|Overall Study||37
194062|NCT01346514|470101|P1|NOT COMPLETED|Overall Study||29
194063|NCT01346514|470100|P2|COMPLETED|Overall Study|Number of patients completing BL-12 months.|53
194064|NCT01346514|470101|P1|COMPLETED|Overall Study|Number of patients completing BL-12 months|62
194065|NCT01346514|470100|P2|12 Month Assessment|Overall Study||53
194066|NCT01346514|470101|P1|12 Month Assessment|Overall Study||62
194067|NCT01346514|470100|P2|9 Month Assessment|Overall Study||59
194068|NCT01346514|470101|P1|9 Month Assessment|Overall Study||67
194069|NCT01346514|470100|P2|6 Month Assessment|Overall Study||61
194070|NCT01346514|470101|P1|6 Month Assessment|Overall Study||74
194071|NCT01346514|470100|P2|3 Month Assessment|Overall Study||68
194072|NCT01346514|470101|P1|3 Month Assessment|Overall Study||83
194073|NCT01346514|470100|P2|STARTED|Overall Study||90
194074|NCT01346514|470101|P1|STARTED|Overall Study||91
194075|NCT01346501|470121|P2|NOT COMPLETED|Overall Study||13
194076|NCT01346501|470122|P1|NOT COMPLETED|Overall Study||11
194077|NCT01346501|470121|P2|COMPLETED|Overall Study||80
194078|NCT01346501|470122|P1|COMPLETED|Overall Study||68
194079|NCT01346501|470121|P2|STARTED|Overall Study||93
194080|NCT01346501|470122|P1|STARTED|Overall Study||79
194081|NCT01346488|470135|P1|NOT COMPLETED|Overall Study||706
194082|NCT01346488|470135|P1|COMPLETED|Overall Study||1262
194083|NCT01346488|470135|P1|STARTED|Overall Study||1968
194084|NCT01346475|470155|P2|NOT COMPLETED|Second Intervention||0
194085|NCT01346475|470156|P1|NOT COMPLETED|Second Intervention||0
194086|NCT01346475|470155|P2|COMPLETED|Second Intervention||25
194087|NCT01346475|470156|P1|COMPLETED|Second Intervention||18
194088|NCT01346475|470155|P2|STARTED|Second Intervention||25
194089|NCT01346475|470156|P1|STARTED|Second Intervention||18
194090|NCT01346475|470155|P2|NOT COMPLETED|First Intervention||3
194091|NCT01346475|470156|P1|NOT COMPLETED|First Intervention||4
194092|NCT01346475|470155|P2|COMPLETED|First Intervention||25
194093|NCT01346475|470156|P1|COMPLETED|First Intervention||18
194094|NCT01346475|470155|P2|STARTED|First Intervention||28
194095|NCT01346475|470156|P1|STARTED|First Intervention||22
194096|NCT01346410|470168|P1|NOT COMPLETED|Overall Study||1
194097|NCT01346410|470168|P1|COMPLETED|Overall Study||0
194098|NCT01346410|470168|P1|STARTED|Overall Study||1
194099|NCT01346397|470174|P2|NOT COMPLETED|Overall Study||0
194100|NCT01346397|470175|P1|NOT COMPLETED|Overall Study||0
194101|NCT01346397|470174|P2|COMPLETED|Overall Study||85
194102|NCT01346397|470175|P1|COMPLETED|Overall Study||85
194103|NCT01346397|470174|P2|STARTED|Overall Study||85
194104|NCT01346397|470175|P1|STARTED|Overall Study||85
194105|NCT01346293|470185|P2|NOT COMPLETED|Overall Study||21
194106|NCT01346293|470186|P1|NOT COMPLETED|Overall Study||67
194107|NCT01346293|470185|P2|COMPLETED|Overall Study||608
194108|NCT01346293|470186|P1|COMPLETED|Overall Study||2676
194109|NCT01346293|470185|P2|STARTED|Overall Study||629
194110|NCT01346293|470186|P1|STARTED|Overall Study||2743
194111|NCT01346189|470216|P4|NOT COMPLETED|Overall Study||11
194112|NCT01346189|470217|P3|NOT COMPLETED|Overall Study||14
194113|NCT01346189|470218|P2|NOT COMPLETED|Overall Study||17
194114|NCT01346189|470219|P1|NOT COMPLETED|Overall Study||16
194115|NCT01346189|470216|P4|COMPLETED|Overall Study|366 patients (58 primary care physicians) included in analysis|355
194116|NCT01346189|470217|P3|COMPLETED|Overall Study|346 patients (58 primary care physicians) included in analysis|332
194117|NCT01346189|470218|P2|COMPLETED|Overall Study|358 Patients (58 primary care physicians) included in analysis|341
194118|NCT01346189|470219|P1|COMPLETED|Overall Study|433 patients (64 primary care physicians) included in analysis|417
194119|NCT01346189|470216|P4|STARTED|Overall Study||366
194120|NCT01346189|470217|P3|STARTED|Overall Study||346
194121|NCT01346189|470218|P2|STARTED|Overall Study||358
194122|NCT01346189|470219|P1|STARTED|Overall Study||433
194123|NCT01346176|470236|P3|NOT COMPLETED|Completed Satisfaction Survey||6
194124|NCT01346176|470237|P2|NOT COMPLETED|Completed Satisfaction Survey||4
194125|NCT01346176|470238|P1|NOT COMPLETED|Completed Satisfaction Survey||6
194126|NCT01346176|470236|P3|COMPLETED|Completed Satisfaction Survey||27
194127|NCT01346176|470237|P2|COMPLETED|Completed Satisfaction Survey||22
194128|NCT01346176|470238|P1|COMPLETED|Completed Satisfaction Survey||29
194129|NCT01346176|470236|P3|STARTED|Completed Satisfaction Survey||33
194130|NCT01346176|470237|P2|STARTED|Completed Satisfaction Survey||26
194131|NCT01346176|470238|P1|STARTED|Completed Satisfaction Survey||35
194132|NCT01346176|470236|P3|NOT COMPLETED|Completed Advance Directive||10
194133|NCT01346176|470237|P2|NOT COMPLETED|Completed Advance Directive||14
194134|NCT01346176|470238|P1|NOT COMPLETED|Completed Advance Directive||13
194135|NCT01346176|470236|P3|COMPLETED|Completed Advance Directive||33
194136|NCT01346176|470237|P2|COMPLETED|Completed Advance Directive||26
194137|NCT01346176|470238|P1|COMPLETED|Completed Advance Directive||35
194138|NCT01346176|470236|P3|STARTED|Completed Advance Directive||43
194139|NCT01346176|470237|P2|STARTED|Completed Advance Directive||40
194140|NCT01346176|470238|P1|STARTED|Completed Advance Directive||48
194141|NCT01346176|470236|P3|NOT COMPLETED|Recruited||0
194142|NCT01346176|470237|P2|NOT COMPLETED|Recruited||0
194143|NCT01346176|470238|P1|NOT COMPLETED|Recruited||1
194144|NCT01346176|470236|P3|COMPLETED|Recruited||43
194145|NCT01346176|470237|P2|COMPLETED|Recruited||40
194146|NCT01346176|470238|P1|COMPLETED|Recruited||48
194147|NCT01346176|470236|P3|STARTED|Recruited||43
194148|NCT01346176|470237|P2|STARTED|Recruited||40
194149|NCT01346176|470238|P1|STARTED|Recruited||49
194150|NCT01346085|470249|P1|NOT COMPLETED|Overall Study||0
194151|NCT01346085|470249|P1|COMPLETED|Overall Study||10
194152|NCT01346085|470249|P1|STARTED|Overall Study||10
194153|NCT01346072|470256|P2|NOT COMPLETED|Overall Study||0
194154|NCT01346072|470257|P1|NOT COMPLETED|Overall Study||0
194155|NCT01346072|470256|P2|COMPLETED|Overall Study||10
194156|NCT01346072|470257|P1|COMPLETED|Overall Study||11
194157|NCT01346072|470256|P2|STARTED|Overall Study||10
194158|NCT01346072|470257|P1|STARTED|Overall Study||11
194159|NCT01346059|470267|P2|NOT COMPLETED|Overall Study||0
194160|NCT01346059|470268|P1|NOT COMPLETED|Overall Study||1
194161|NCT01346059|470267|P2|COMPLETED|Overall Study||1
194162|NCT01346059|470268|P1|COMPLETED|Overall Study||0
194163|NCT01346059|470267|P2|STARTED|Overall Study||1
194164|NCT01346059|470268|P1|STARTED|Overall Study||1
194165|NCT01345929|470280|P2|NOT COMPLETED|Overall Study||19
194166|NCT01345929|470281|P1|NOT COMPLETED|Overall Study||21
194167|NCT01345929|470280|P2|COMPLETED|Overall Study||516
194168|NCT01345929|470281|P1|COMPLETED|Overall Study||512
194169|NCT01345929|470280|P2|STARTED|Overall Study||535
194170|NCT01345929|470281|P1|STARTED|Overall Study||533
194171|NCT01345786|470293|P4|NOT COMPLETED|Overall Study||3
194172|NCT01345786|470294|P3|NOT COMPLETED|Overall Study||5
194173|NCT01345786|470295|P2|NOT COMPLETED|Overall Study||8
194174|NCT01345786|470296|P1|NOT COMPLETED|Overall Study||6
194175|NCT01345786|470293|P4|COMPLETED|Overall Study||35
194176|NCT01345786|470294|P3|COMPLETED|Overall Study||33
194177|NCT01345786|470295|P2|COMPLETED|Overall Study||33
194178|NCT01345786|470296|P1|COMPLETED|Overall Study||35
194179|NCT01345786|470293|P4|Treated|Overall Study||37
194180|NCT01345786|470294|P3|Treated|Overall Study||37
194181|NCT01345786|470295|P2|Treated|Overall Study||41
194182|NCT01345786|470296|P1|Treated|Overall Study||41
194183|NCT01345786|470293|P4|STARTED|Overall Study|Number randomized|38
194184|NCT01345786|470294|P3|STARTED|Overall Study|Number randomized|38
194185|NCT01345786|470295|P2|STARTED|Overall Study|Number randomized|41
194186|NCT01345786|470296|P1|STARTED|Overall Study|Number randomized|41
194187|NCT01345721|470345|P3|NOT COMPLETED|Overall Study||0
194188|NCT01345721|470346|P2|NOT COMPLETED|Overall Study||0
194189|NCT01345721|470347|P1|NOT COMPLETED|Overall Study||0
194190|NCT01345721|470345|P3|COMPLETED|Overall Study||65
194191|NCT01345721|470346|P2|COMPLETED|Overall Study||66
194192|NCT01345721|470347|P1|COMPLETED|Overall Study||74
194193|NCT01345721|470345|P3|STARTED|Overall Study||65
194194|NCT01345721|470346|P2|STARTED|Overall Study||66
194195|NCT01345721|470347|P1|STARTED|Overall Study||74
194196|NCT01345682|470376|P2|NOT COMPLETED|Overall Study||161
194197|NCT01345682|470377|P1|NOT COMPLETED|Overall Study||322
194198|NCT01345682|470376|P2|COMPLETED|Overall Study||0
194199|NCT01345682|470377|P1|COMPLETED|Overall Study||0
194200|NCT01345682|470376|P2|STARTED|Overall Study|Randomised|161
194201|NCT01345682|470377|P1|STARTED|Overall Study|Randomised|322
194202|NCT01345669|470411|P2|NOT COMPLETED|Overall Study||119
194203|NCT01345669|470412|P1|NOT COMPLETED|Overall Study||287
194204|NCT01345669|470411|P2|COMPLETED|Overall Study||87
194205|NCT01345669|470412|P1|COMPLETED|Overall Study||124
194206|NCT01345669|470411|P2|STARTED|Overall Study||206
194207|NCT01345669|470412|P1|STARTED|Overall Study||411
194208|NCT01345630|470430|P2|NOT COMPLETED|Overall Study||359
194209|NCT01345630|470431|P1|NOT COMPLETED|Overall Study||361
194210|NCT01345630|470430|P2|COMPLETED|Overall Study||42
194211|NCT01345630|470431|P1|COMPLETED|Overall Study||35
194212|NCT01345630|470430|P2|STARTED|Overall Study||401
194213|NCT01345630|470431|P1|STARTED|Overall Study||396
194214|NCT01345591|470487|P1|NOT COMPLETED|Overall Study||1
194215|NCT01345591|470487|P1|COMPLETED|Overall Study||19
194216|NCT01345591|470487|P1|STARTED|Overall Study||20
194217|NCT01345318|470496|P1|NOT COMPLETED|Overall Study||80
194218|NCT01345318|470496|P1|COMPLETED|Overall Study||111
194219|NCT01345318|470496|P1|STARTED|Overall Study||191
194220|NCT01345292|470504|P3|NOT COMPLETED|Overall Study||1
194221|NCT01345292|470505|P2|NOT COMPLETED|Overall Study||0
194222|NCT01345292|470506|P1|NOT COMPLETED|Overall Study||2
194223|NCT01345292|470504|P3|COMPLETED|Overall Study||74
194224|NCT01345292|470505|P2|COMPLETED|Overall Study||76
194225|NCT01345292|470506|P1|COMPLETED|Overall Study||73
194226|NCT01345292|470504|P3|STARTED|Overall Study||75
194227|NCT01345292|470505|P2|STARTED|Overall Study||76
194228|NCT01345292|470506|P1|STARTED|Overall Study||75
194229|NCT01345253|470537|P2|NOT COMPLETED|Open-label Phase (Up to Year 5 Week 44)||144
194230|NCT01345253|470538|P1|NOT COMPLETED|Open-label Phase (Up to Year 5 Week 44)||65
194231|NCT01345253|470537|P2|COMPLETED|Open-label Phase (Up to Year 5 Week 44)||146
194232|NCT01345253|470538|P1|COMPLETED|Open-label Phase (Up to Year 5 Week 44)||69
194233|NCT01345253|470537|P2|STARTED|Open-label Phase (Up to Year 5 Week 44)|Only eligible China par. enrolled in OL phase from MITT + additional 16 China par. from Safety Pop|290
194234|NCT01345253|470538|P1|STARTED|Open-label Phase (Up to Year 5 Week 44)|Only eligible China par. enrolled in OL phase from MITT + additional 9 China par. from Safety Pop|134
194235|NCT01345253|470537|P2|NOT COMPLETED|Double-blind (DB) Phase (52 Weeks)||79
194236|NCT01345253|470538|P1|NOT COMPLETED|Double-blind (DB) Phase (52 Weeks)||56
194237|NCT01345253|470537|P2|COMPLETED|Double-blind (DB) Phase (52 Weeks)||372
194238|NCT01345253|470538|P1|COMPLETED|Double-blind (DB) Phase (52 Weeks)||170
194239|NCT01345253|470537|P2|STARTED|Double-blind (DB) Phase (52 Weeks)||451
194240|NCT01345253|470538|P1|STARTED|Double-blind (DB) Phase (52 Weeks)||226
194241|NCT01345240|470559|P5|NOT COMPLETED|Overall Study||10
194242|NCT01345240|470560|P4|NOT COMPLETED|Overall Study||9
194243|NCT01345240|470561|P3|NOT COMPLETED|Overall Study||18
194244|NCT01345240|470562|P2|NOT COMPLETED|Overall Study||14
194245|NCT01345240|470563|P1|NOT COMPLETED|Overall Study||11
194246|NCT01345240|470559|P5|COMPLETED|Overall Study||129
194247|NCT01345240|470560|P4|COMPLETED|Overall Study||132
194248|NCT01345240|470561|P3|COMPLETED|Overall Study||123
194249|NCT01345240|470562|P2|COMPLETED|Overall Study||128
194250|NCT01345240|470563|P1|COMPLETED|Overall Study||131
194251|NCT01345240|470559|P5|STARTED|Overall Study||139
194252|NCT01345240|470560|P4|STARTED|Overall Study||141
194253|NCT01345240|470561|P3|STARTED|Overall Study||141
194254|NCT01345240|470562|P2|STARTED|Overall Study||142
194255|NCT01345240|470563|P1|STARTED|Overall Study||142
194256|NCT01345188|470683|P1|NOT COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||1
194257|NCT01345188|470683|P1|COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||25
194258|NCT01345188|470683|P1|STARTED|Crossover Ranolazine/Placebo 6 Weeks||26
194259|NCT01345188|470683|P1|NOT COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||2
194260|NCT01345188|470683|P1|COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||26
194261|NCT01345188|470683|P1|STARTED|Randomization Ranolazine/Placebo 6 Weeks||28
194262|NCT01345162|470695|P2|NOT COMPLETED|Overall Study||4
194263|NCT01345162|470696|P1|NOT COMPLETED|Overall Study||2
194264|NCT01345162|470695|P2|COMPLETED|Overall Study||96
194265|NCT01345162|470696|P1|COMPLETED|Overall Study||98
194266|NCT01345162|470695|P2|STARTED|Overall Study||100
194267|NCT01345162|470696|P1|STARTED|Overall Study||100
194268|NCT01345123|470705|P3|NOT COMPLETED|Overall Study||88
194269|NCT01345123|470706|P2|NOT COMPLETED|Overall Study||85
194270|NCT01345123|470707|P1|NOT COMPLETED|Overall Study||79
194271|NCT01345123|470705|P3|COMPLETED|Overall Study|3291 - 88 study participants who were no longer health plan eligible members (zero eligible months)|3203
194272|NCT01345123|470706|P2|COMPLETED|Overall Study|3311 - 85 study participants who were no longer health plan eligible members (zero eligible months)|3226
194273|NCT01345123|470707|P1|COMPLETED|Overall Study|3323 - 79 study participants who were no longer health plan eligible members (zero eligible months)|3244
194274|NCT01345123|470705|P3|STARTED|Overall Study||3291
194275|NCT01345123|470706|P2|STARTED|Overall Study||3311
194276|NCT01345123|470707|P1|STARTED|Overall Study||3323
194277|NCT01345058|470729|P2|NOT COMPLETED|Overall Study||0
194278|NCT01345058|470730|P1|NOT COMPLETED|Overall Study||5
194279|NCT01345058|470729|P2|COMPLETED|Overall Study||36
194280|NCT01345058|470730|P1|COMPLETED|Overall Study||15
194281|NCT01345058|470729|P2|Received Lacosamide|Overall Study||0
194282|NCT01345058|470730|P1|Received Lacosamide|Overall Study||19
194283|NCT01345058|470729|P2|STARTED|Overall Study||36
194284|NCT01345058|470730|P1|STARTED|Overall Study||20
194285|NCT01345019|470746|P2|NOT COMPLETED|Overall Study||272
194286|NCT01345019|470747|P1|NOT COMPLETED|Overall Study||263
194287|NCT01345019|470746|P2|COMPLETED|Overall Study|Still on study as of the data cut-off date|587
194288|NCT01345019|470747|P1|COMPLETED|Overall Study|Still on study as of the data cut-off date|596
194289|NCT01345019|470746|P2|Received Treatment|Overall Study||850
194290|NCT01345019|470747|P1|Received Treatment|Overall Study||852
194291|NCT01345019|470746|P2|STARTED|Overall Study||859
194292|NCT01345019|470747|P1|STARTED|Overall Study||859
194293|NCT01344876|470767|P5|NOT COMPLETED|Overall Study||1
194294|NCT01344876|470768|P4|NOT COMPLETED|Overall Study||3
194295|NCT01344876|470769|P3|NOT COMPLETED|Overall Study||1
194296|NCT01344876|470770|P2|NOT COMPLETED|Overall Study||0
194297|NCT01344876|470771|P1|NOT COMPLETED|Overall Study||1
194298|NCT01344876|470767|P5|COMPLETED|Overall Study||2
194299|NCT01344876|470768|P4|COMPLETED|Overall Study||3
194300|NCT01344876|470769|P3|COMPLETED|Overall Study||3
194301|NCT01344876|470770|P2|COMPLETED|Overall Study||3
194302|NCT01344876|470771|P1|COMPLETED|Overall Study||3
194303|NCT01344876|470767|P5|STARTED|Overall Study||3
194304|NCT01344876|470768|P4|STARTED|Overall Study||6
194305|NCT01344876|470769|P3|STARTED|Overall Study||4
194306|NCT01344876|470770|P2|STARTED|Overall Study||3
194307|NCT01344876|470771|P1|STARTED|Overall Study||4
194308|NCT01344824|470785|P1|NOT COMPLETED|Overall Study||37
194309|NCT01344824|470785|P1|COMPLETED|Overall Study||1
194310|NCT01344824|470785|P1|STARTED|Overall Study||38
194311|NCT01344759|470793|P2|NOT COMPLETED|Overall Study||2
194312|NCT01344759|470794|P1|NOT COMPLETED|Overall Study||0
194313|NCT01344759|470793|P2|COMPLETED|Overall Study|Two of the original DEX group subjects were removed, due to receiving dexmedetomidine and propofol.|28
194314|NCT01344759|470794|P1|COMPLETED|Overall Study||30
194315|NCT01344759|470793|P2|STARTED|Overall Study||30
194316|NCT01344759|470794|P1|STARTED|Overall Study||30
194317|NCT01344629|470826|P2|NOT COMPLETED|Crossover Period 4||0
194318|NCT01344629|470827|P1|NOT COMPLETED|Crossover Period 4||0
194319|NCT01344629|470826|P2|COMPLETED|Crossover Period 4||31
194320|NCT01344629|470827|P1|COMPLETED|Crossover Period 4||32
194321|NCT01344629|470826|P2|STARTED|Crossover Period 4||31
194322|NCT01344629|470827|P1|STARTED|Crossover Period 4||32
194323|NCT01344629|470826|P2|NOT COMPLETED|Crossover Period 3||0
194324|NCT01344629|470827|P1|NOT COMPLETED|Crossover Period 3||0
194325|NCT01344629|470826|P2|COMPLETED|Crossover Period 3||31
194326|NCT01344629|470827|P1|COMPLETED|Crossover Period 3||32
194327|NCT01344629|470826|P2|STARTED|Crossover Period 3||31
194328|NCT01344629|470827|P1|STARTED|Crossover Period 3||32
194329|NCT01344629|470826|P2|NOT COMPLETED|Crossover Period 2||1
194330|NCT01344629|470827|P1|NOT COMPLETED|Crossover Period 2||0
194331|NCT01344629|470826|P2|COMPLETED|Crossover Period 2||31
194332|NCT01344629|470827|P1|COMPLETED|Crossover Period 2||32
194333|NCT01344629|470826|P2|STARTED|Crossover Period 2||32
194334|NCT01344629|470827|P1|STARTED|Crossover Period 2||32
194335|NCT01344629|470826|P2|NOT COMPLETED|Crossover Period 1||0
194336|NCT01344629|470827|P1|NOT COMPLETED|Crossover Period 1||0
194337|NCT01344629|470826|P2|COMPLETED|Crossover Period 1||32
194338|NCT01344629|470827|P1|COMPLETED|Crossover Period 1||32
194339|NCT01344629|470826|P2|STARTED|Crossover Period 1||32
194340|NCT01344629|470827|P1|STARTED|Crossover Period 1||32
194341|NCT01344616|470847|P2|NOT COMPLETED|Overall Study||44
194342|NCT01344616|470848|P1|NOT COMPLETED|Overall Study||35
194343|NCT01344616|470847|P2|COMPLETED|Overall Study||194
194344|NCT01344616|470848|P1|COMPLETED|Overall Study||209
194345|NCT01344616|470847|P2|STARTED|Overall Study||238
194346|NCT01344616|470848|P1|STARTED|Overall Study||244
194347|NCT01344538|470856|P2|NOT COMPLETED|Overall Study||1
194348|NCT01344538|470857|P1|NOT COMPLETED|Overall Study||2
194349|NCT01344538|470856|P2|COMPLETED|Overall Study||16
194350|NCT01344538|470857|P1|COMPLETED|Overall Study||14
194351|NCT01344538|470856|P2|STARTED|Overall Study||17
194352|NCT01344538|470857|P1|STARTED|Overall Study||16
194353|NCT01344460|470863|P1|NOT COMPLETED|Overall Study||3
194354|NCT01344460|470863|P1|COMPLETED|Overall Study||312
194355|NCT01344460|470863|P1|Fulfilled Requirements of FAS Population|Overall Study|Full analysis set (FAS)|292
194356|NCT01344460|470863|P1|STARTED|Overall Study|Participants received study drug; Safety analysis set|315
194357|NCT01344447|470908|P1|NOT COMPLETED|Overall Study||8
194358|NCT01344447|470908|P1|COMPLETED|Overall Study||471
194359|NCT01344447|470908|P1|Fulfilled Requirement of FAS Population|Overall Study|Full Analysis Set (FAS)|457
194360|NCT01344447|470908|P1|STARTED|Overall Study|Participant received study drug; Safety analysis set|479
194361|NCT01344369|470952|P2|NOT COMPLETED|Second Intervention||1
194362|NCT01344369|470953|P1|NOT COMPLETED|Second Intervention||0
194363|NCT01344369|470952|P2|COMPLETED|Second Intervention||16
194364|NCT01344369|470953|P1|COMPLETED|Second Intervention||17
194365|NCT01344369|470952|P2|STARTED|Second Intervention||17
194366|NCT01344369|470953|P1|STARTED|Second Intervention||17
194367|NCT01344369|470952|P2|NOT COMPLETED|Washout of 28 Days||1
194368|NCT01344369|470953|P1|NOT COMPLETED|Washout of 28 Days||1
194369|NCT01344369|470952|P2|COMPLETED|Washout of 28 Days||17
194370|NCT01344369|470953|P1|COMPLETED|Washout of 28 Days||17
194371|NCT01344369|470952|P2|STARTED|Washout of 28 Days||18
194372|NCT01344369|470953|P1|STARTED|Washout of 28 Days||18
194373|NCT01344369|470952|P2|NOT COMPLETED|First Intervention||0
194374|NCT01344369|470953|P1|NOT COMPLETED|First Intervention||0
194375|NCT01344369|470952|P2|COMPLETED|First Intervention||18
194376|NCT01344369|470953|P1|COMPLETED|First Intervention||18
194377|NCT01344369|470952|P2|STARTED|First Intervention||18
194378|NCT01344369|470953|P1|STARTED|First Intervention||18
194379|NCT01344226|470969|P1|NOT COMPLETED|Overall Study||8
194380|NCT01344226|470969|P1|COMPLETED|Overall Study||41
194381|NCT01344226|470969|P1|STARTED|Overall Study||49
194382|NCT01344161|470978|P2|NOT COMPLETED|Overall Study||3
194383|NCT01344161|470979|P1|NOT COMPLETED|Overall Study||5
194384|NCT01344161|470978|P2|COMPLETED|Overall Study||39
194385|NCT01344161|470979|P1|COMPLETED|Overall Study||38
194386|NCT01344161|470978|P2|STARTED|Overall Study||42
194387|NCT01344161|470979|P1|STARTED|Overall Study||43
194388|NCT01344057|470991|P1|NOT COMPLETED|Overall Study||1
194389|NCT01344057|470991|P1|COMPLETED|Overall Study||62
194390|NCT01344057|470991|P1|STARTED|Overall Study||63
194391|NCT01343901|470998|P1|NOT COMPLETED|Overall Study||113
194392|NCT01343901|470998|P1|COMPLETED|Overall Study||97
194393|NCT01343901|470998|P1|Efficacy Population|Overall Study||205
194394|NCT01343901|470998|P1|STARTED|Overall Study||210
194395|NCT01343888|471022|P3|NOT COMPLETED|Overall Study||22
194396|NCT01343888|471023|P2|NOT COMPLETED|Overall Study||39
194397|NCT01343888|471024|P1|NOT COMPLETED|Overall Study||25
194398|NCT01343888|471022|P3|COMPLETED|Overall Study||110
194399|NCT01343888|471023|P2|COMPLETED|Overall Study||222
194400|NCT01343888|471024|P1|COMPLETED|Overall Study||234
194401|NCT01343888|471022|P3|STARTED|Overall Study|133 subject randomized; 132 subjects treated with at least one dose; 1 subject was not treated|132
194402|NCT01343888|471023|P2|STARTED|Overall Study|262 subject randomized; 261 subjects treated with at least one dose; 1 subject was not treated|261
194403|NCT01343888|471024|P1|STARTED|Overall Study|261 subject randomized; 259 subjects treated with at least one dose; 2 subjects were not treated|259
194404|NCT01343823|471066|P4|NOT COMPLETED|Overall Study||1
194405|NCT01343823|471067|P3|NOT COMPLETED|Overall Study||0
194406|NCT01343823|471068|P2|NOT COMPLETED|Overall Study||0
194407|NCT01343823|471069|P1|NOT COMPLETED|Overall Study||2
194408|NCT01343823|471066|P4|COMPLETED|Overall Study||19
194409|NCT01343823|471067|P3|COMPLETED|Overall Study||19
194410|NCT01343823|471068|P2|COMPLETED|Overall Study||20
194411|NCT01343823|471069|P1|COMPLETED|Overall Study||18
194412|NCT01343823|471066|P4|STARTED|Overall Study||20
194413|NCT01343823|471067|P3|STARTED|Overall Study||19
194414|NCT01343823|471068|P2|STARTED|Overall Study||20
194415|NCT01343823|471069|P1|STARTED|Overall Study||20
194416|NCT01343667|471085|P2|NOT COMPLETED|Overall Study||56
194417|NCT01343667|471086|P1|NOT COMPLETED|Overall Study||12
194418|NCT01343667|471085|P2|COMPLETED|Overall Study||916
194419|NCT01343667|471086|P1|COMPLETED|Overall Study||413
194420|NCT01343667|471085|P2|STARTED|Overall Study||972
194421|NCT01343667|471086|P1|STARTED|Overall Study||425
194422|NCT01343485|471094|P2|NOT COMPLETED|Overall Study||134
194423|NCT01343485|471095|P1|NOT COMPLETED|Overall Study||149
194424|NCT01343485|471094|P2|COMPLETED|Overall Study||46
194425|NCT01343485|471095|P1|COMPLETED|Overall Study||36
194426|NCT01343485|471094|P2|STARTED|Overall Study||180
194427|NCT01343485|471095|P1|STARTED|Overall Study||185
194428|NCT01343407|471101|P6|NOT COMPLETED|Third Treatment Period (Part 2)||0
194429|NCT01343407|471102|P5|NOT COMPLETED|Third Treatment Period (Part 2)||0
194430|NCT01343407|471103|P4|NOT COMPLETED|Third Treatment Period (Part 2)||0
194431|NCT01343407|471104|P3|NOT COMPLETED|Third Treatment Period (Part 2)||0
194432|NCT01343407|471105|P2|NOT COMPLETED|Third Treatment Period (Part 2)||0
194433|NCT01343407|471106|P1|NOT COMPLETED|Third Treatment Period (Part 2)||0
194434|NCT01343407|471101|P6|COMPLETED|Third Treatment Period (Part 2)||3
194435|NCT01343407|471102|P5|COMPLETED|Third Treatment Period (Part 2)||3
194436|NCT01343407|471103|P4|COMPLETED|Third Treatment Period (Part 2)||3
194437|NCT01343407|471104|P3|COMPLETED|Third Treatment Period (Part 2)||1
194438|NCT01343407|471105|P2|COMPLETED|Third Treatment Period (Part 2)||2
194439|NCT01343407|471106|P1|COMPLETED|Third Treatment Period (Part 2)||2
194440|NCT01343407|471101|P6|STARTED|Third Treatment Period (Part 2)||3
194441|NCT01343407|471102|P5|STARTED|Third Treatment Period (Part 2)||3
194442|NCT01343407|471103|P4|STARTED|Third Treatment Period (Part 2)||3
194443|NCT01343407|471104|P3|STARTED|Third Treatment Period (Part 2)||1
194444|NCT01343407|471105|P2|STARTED|Third Treatment Period (Part 2)||2
194445|NCT01343407|471106|P1|STARTED|Third Treatment Period (Part 2)||2
194446|NCT01343407|471101|P6|NOT COMPLETED|Second Washout (Part 2)||0
194447|NCT01343407|471102|P5|NOT COMPLETED|Second Washout (Part 2)||0
194448|NCT01343407|471103|P4|NOT COMPLETED|Second Washout (Part 2)||0
194449|NCT01343407|471104|P3|NOT COMPLETED|Second Washout (Part 2)||1
194450|NCT01343407|471105|P2|NOT COMPLETED|Second Washout (Part 2)||0
194451|NCT01343407|471106|P1|NOT COMPLETED|Second Washout (Part 2)||0
194452|NCT01343407|471101|P6|COMPLETED|Second Washout (Part 2)||3
194453|NCT01343407|471102|P5|COMPLETED|Second Washout (Part 2)||3
194454|NCT01343407|471103|P4|COMPLETED|Second Washout (Part 2)||3
194455|NCT01343407|471104|P3|COMPLETED|Second Washout (Part 2)||1
194456|NCT01343407|471105|P2|COMPLETED|Second Washout (Part 2)||2
194457|NCT01343407|471106|P1|COMPLETED|Second Washout (Part 2)||2
194458|NCT01343407|471101|P6|STARTED|Second Washout (Part 2)||3
194459|NCT01343407|471102|P5|STARTED|Second Washout (Part 2)||3
194460|NCT01343407|471103|P4|STARTED|Second Washout (Part 2)||3
194461|NCT01343407|471104|P3|STARTED|Second Washout (Part 2)||2
194462|NCT01343407|471105|P2|STARTED|Second Washout (Part 2)||2
194463|NCT01343407|471106|P1|STARTED|Second Washout (Part 2)||2
194464|NCT01343407|471101|P6|NOT COMPLETED|Second Treatment Period (Part 2)||0
194465|NCT01343407|471102|P5|NOT COMPLETED|Second Treatment Period (Part 2)||0
194466|NCT01343407|471103|P4|NOT COMPLETED|Second Treatment Period (Part 2)||0
194467|NCT01343407|471104|P3|NOT COMPLETED|Second Treatment Period (Part 2)||1
194468|NCT01343407|471105|P2|NOT COMPLETED|Second Treatment Period (Part 2)||0
194469|NCT01343407|471106|P1|NOT COMPLETED|Second Treatment Period (Part 2)||0
194470|NCT01343407|471101|P6|COMPLETED|Second Treatment Period (Part 2)||3
194471|NCT01343407|471102|P5|COMPLETED|Second Treatment Period (Part 2)||3
194472|NCT01343407|471103|P4|COMPLETED|Second Treatment Period (Part 2)||3
194473|NCT01343407|471104|P3|COMPLETED|Second Treatment Period (Part 2)||2
194474|NCT01343407|471105|P2|COMPLETED|Second Treatment Period (Part 2)||2
194475|NCT01343407|471106|P1|COMPLETED|Second Treatment Period (Part 2)||2
194476|NCT01343407|471101|P6|STARTED|Second Treatment Period (Part 2)||3
194477|NCT01343407|471102|P5|STARTED|Second Treatment Period (Part 2)||3
194478|NCT01343407|471103|P4|STARTED|Second Treatment Period (Part 2)||3
194479|NCT01343407|471104|P3|STARTED|Second Treatment Period (Part 2)||3
194480|NCT01343407|471105|P2|STARTED|Second Treatment Period (Part 2)||2
194481|NCT01343407|471106|P1|STARTED|Second Treatment Period (Part 2)||2
194482|NCT01343407|471101|P6|NOT COMPLETED|First Washout (Part 2)||0
194483|NCT01343407|471102|P5|NOT COMPLETED|First Washout (Part 2)||0
194484|NCT01343407|471103|P4|NOT COMPLETED|First Washout (Part 2)||0
194485|NCT01343407|471104|P3|NOT COMPLETED|First Washout (Part 2)||0
194486|NCT01343407|471105|P2|NOT COMPLETED|First Washout (Part 2)||0
194487|NCT01343407|471106|P1|NOT COMPLETED|First Washout (Part 2)||0
194488|NCT01343407|471101|P6|COMPLETED|First Washout (Part 2)||3
194489|NCT01343407|471102|P5|COMPLETED|First Washout (Part 2)||3
194490|NCT01343407|471103|P4|COMPLETED|First Washout (Part 2)||3
194491|NCT01343407|471104|P3|COMPLETED|First Washout (Part 2)||3
194492|NCT01343407|471105|P2|COMPLETED|First Washout (Part 2)||2
194493|NCT01343407|471106|P1|COMPLETED|First Washout (Part 2)||2
194494|NCT01343407|471101|P6|STARTED|First Washout (Part 2)||3
194495|NCT01343407|471102|P5|STARTED|First Washout (Part 2)||3
194496|NCT01343407|471103|P4|STARTED|First Washout (Part 2)||3
194497|NCT01343407|471104|P3|STARTED|First Washout (Part 2)||3
194498|NCT01343407|471105|P2|STARTED|First Washout (Part 2)||2
194499|NCT01343407|471106|P1|STARTED|First Washout (Part 2)||2
194500|NCT01343407|471101|P6|NOT COMPLETED|First Treatment Period (Part 2)||0
194501|NCT01343407|471102|P5|NOT COMPLETED|First Treatment Period (Part 2)||0
194502|NCT01343407|471103|P4|NOT COMPLETED|First Treatment Period (Part 2)||0
194503|NCT01343407|471104|P3|NOT COMPLETED|First Treatment Period (Part 2)||0
194504|NCT01343407|471105|P2|NOT COMPLETED|First Treatment Period (Part 2)||0
194505|NCT01343407|471106|P1|NOT COMPLETED|First Treatment Period (Part 2)||0
194506|NCT01343407|471101|P6|COMPLETED|First Treatment Period (Part 2)||3
194507|NCT01343407|471102|P5|COMPLETED|First Treatment Period (Part 2)||3
194508|NCT01343407|471103|P4|COMPLETED|First Treatment Period (Part 2)||3
194509|NCT01343407|471104|P3|COMPLETED|First Treatment Period (Part 2)||3
194510|NCT01343407|471105|P2|COMPLETED|First Treatment Period (Part 2)||2
194511|NCT01343407|471106|P1|COMPLETED|First Treatment Period (Part 2)||2
194512|NCT01343407|471101|P6|STARTED|First Treatment Period (Part 2)||3
194513|NCT01343407|471102|P5|STARTED|First Treatment Period (Part 2)||3
194514|NCT01343407|471103|P4|STARTED|First Treatment Period (Part 2)||3
194515|NCT01343407|471104|P3|STARTED|First Treatment Period (Part 2)||3
194516|NCT01343407|471105|P2|STARTED|First Treatment Period (Part 2)||2
194517|NCT01343407|471106|P1|STARTED|First Treatment Period (Part 2)||2
194518|NCT01343368|471134|P2|NOT COMPLETED|Overall Study||0
194519|NCT01343368|471135|P1|NOT COMPLETED|Overall Study||2
194520|NCT01343368|471134|P2|COMPLETED|Overall Study||10
194521|NCT01343368|471135|P1|COMPLETED|Overall Study||7
194522|NCT01343368|471134|P2|STARTED|Overall Study||10
194523|NCT01343368|471135|P1|STARTED|Overall Study||9
194524|NCT01343277|471171|P2|NOT COMPLETED|Overall Study||193
194525|NCT01343277|471172|P1|NOT COMPLETED|Overall Study||384
194526|NCT01343277|471171|P2|COMPLETED|Overall Study||0
194527|NCT01343277|471172|P1|COMPLETED|Overall Study||0
194528|NCT01343277|471171|P2|Treated|Overall Study||172
194529|NCT01343277|471172|P1|Treated|Overall Study||378
194530|NCT01343277|471171|P2|STARTED|Overall Study||193
194531|NCT01343277|471172|P1|STARTED|Overall Study||384
194532|NCT01343251|471190|P2|NOT COMPLETED|Overall Study||0
194533|NCT01343251|471191|P1|NOT COMPLETED|Overall Study||0
194534|NCT01343251|471190|P2|COMPLETED|Overall Study||17
194535|NCT01343251|471191|P1|COMPLETED|Overall Study||16
194536|NCT01343251|471190|P2|STARTED|Overall Study||17
194537|NCT01343251|471191|P1|STARTED|Overall Study||16
194538|NCT01343095|471208|P3|NOT COMPLETED|Overall Study||0
194539|NCT01343095|471209|P2|NOT COMPLETED|Overall Study||0
194540|NCT01343095|471210|P1|NOT COMPLETED|Overall Study||0
194541|NCT01343095|471208|P3|COMPLETED|Overall Study||3
194542|NCT01343095|471209|P2|COMPLETED|Overall Study||3
194543|NCT01343095|471210|P1|COMPLETED|Overall Study||2
194544|NCT01343095|471208|P3|STARTED|Overall Study||3
194545|NCT01343095|471209|P2|STARTED|Overall Study||3
194546|NCT01343095|471210|P1|STARTED|Overall Study||2
194547|NCT01343082|471233|P3|NOT COMPLETED|Treatment Period , Switched to DE-111||12
194548|NCT01343082|471234|P2|NOT COMPLETED|Treatment Period , Switched to DE-111||9
194549|NCT01343082|471235|P1|NOT COMPLETED|Treatment Period , Switched to DE-111||5
194550|NCT01343082|471233|P3|COMPLETED|Treatment Period , Switched to DE-111||31
194551|NCT01343082|471234|P2|COMPLETED|Treatment Period , Switched to DE-111||36
194552|NCT01343082|471235|P1|COMPLETED|Treatment Period , Switched to DE-111||43
194553|NCT01343082|471233|P3|STARTED|Treatment Period , Switched to DE-111||43
194554|NCT01343082|471234|P2|STARTED|Treatment Period , Switched to DE-111||45
194555|NCT01343082|471235|P1|STARTED|Treatment Period , Switched to DE-111||48
194556|NCT01343082|471233|P3|NOT COMPLETED|The run-in Period||5
194557|NCT01343082|471234|P2|NOT COMPLETED|The run-in Period||4
194558|NCT01343082|471235|P1|NOT COMPLETED|The run-in Period||3
194559|NCT01343082|471233|P3|COMPLETED|The run-in Period||43
194560|NCT01343082|471234|P2|COMPLETED|The run-in Period||45
194561|NCT01343082|471235|P1|COMPLETED|The run-in Period||48
194562|NCT01343082|471233|P3|STARTED|The run-in Period||48
194563|NCT01343082|471234|P2|STARTED|The run-in Period||49
194564|NCT01343082|471235|P1|STARTED|The run-in Period||51
194565|NCT01343056|471243|P4|NOT COMPLETED|Overall Study||9
194566|NCT01343056|471244|P3|NOT COMPLETED|Overall Study||3
194567|NCT01343056|471245|P2|NOT COMPLETED|Overall Study||5
194568|NCT01343056|471246|P1|NOT COMPLETED|Overall Study||7
194569|NCT01343056|471243|P4|COMPLETED|Overall Study||29
194570|NCT01343056|471244|P3|COMPLETED|Overall Study||29
194571|NCT01343056|471245|P2|COMPLETED|Overall Study||31
194572|NCT01343056|471246|P1|COMPLETED|Overall Study||28
194573|NCT01343056|471243|P4|STARTED|Overall Study||38
194574|NCT01343056|471244|P3|STARTED|Overall Study||32
194575|NCT01343056|471245|P2|STARTED|Overall Study||36
194576|NCT01343056|471246|P1|STARTED|Overall Study||35
194577|NCT01343004|471287|P3|NOT COMPLETED|Overall Study||160
194578|NCT01343004|471288|P2|NOT COMPLETED|Overall Study||218
194579|NCT01343004|471289|P1|NOT COMPLETED|Overall Study||184
194580|NCT01343004|471287|P3|COMPLETED|Overall Study||658
194581|NCT01343004|471288|P2|COMPLETED|Overall Study||606
194582|NCT01343004|471289|P1|COMPLETED|Overall Study||637
194583|NCT01343004|471287|P3|STARTED|Overall Study||818
194584|NCT01343004|471288|P2|STARTED|Overall Study||824
194585|NCT01343004|471289|P1|STARTED|Overall Study||821
194586|NCT01342965|471314|P2|NOT COMPLETED|Overall Study||107
194587|NCT01342965|471315|P1|NOT COMPLETED|Overall Study||109
194588|NCT01342965|471314|P2|COMPLETED|Overall Study||0
194589|NCT01342965|471315|P1|COMPLETED|Overall Study||1
194590|NCT01342965|471314|P2|Received Treatment|Overall Study||104
194591|NCT01342965|471315|P1|Received Treatment|Overall Study||110
194592|NCT01342965|471314|P2|STARTED|Overall Study||107
194593|NCT01342965|471315|P1|STARTED|Overall Study||110
194594|NCT01342926|471333|P4|NOT COMPLETED|Overall Study||12
194595|NCT01342926|471334|P3|NOT COMPLETED|Overall Study||14
194596|NCT01342926|471335|P2|NOT COMPLETED|Overall Study||15
194597|NCT01342926|471336|P1|NOT COMPLETED|Overall Study||9
194598|NCT01342926|471333|P4|COMPLETED|Overall Study||39
194599|NCT01342926|471334|P3|COMPLETED|Overall Study||34
194600|NCT01342926|471335|P2|COMPLETED|Overall Study||31
194601|NCT01342926|471336|P1|COMPLETED|Overall Study||37
194602|NCT01342926|471333|P4|STARTED|Overall Study||51
194603|NCT01342926|471334|P3|STARTED|Overall Study||48
194604|NCT01342926|471335|P2|STARTED|Overall Study||46
194605|NCT01342926|471336|P1|STARTED|Overall Study||46
194606|NCT01342913|471416|P3|NOT COMPLETED|Double-Blind Treatment Period||23
194607|NCT01342913|471417|P2|NOT COMPLETED|Double-Blind Treatment Period||16
194608|NCT01342913|471418|P1|NOT COMPLETED|Double-Blind Treatment Period||0
194609|NCT01342913|471416|P3|COMPLETED|Double-Blind Treatment Period||243
194610|NCT01342913|471417|P2|COMPLETED|Double-Blind Treatment Period||246
194611|NCT01342913|471418|P1|COMPLETED|Double-Blind Treatment Period||0
194612|NCT01342913|471416|P3|STARTED|Double-Blind Treatment Period||266
194613|NCT01342913|471417|P2|STARTED|Double-Blind Treatment Period||262
194614|NCT01342913|471418|P1|STARTED|Double-Blind Treatment Period||0
194615|NCT01342913|471416|P3|NOT COMPLETED|2-week Run-in Period||0
194616|NCT01342913|471417|P2|NOT COMPLETED|2-week Run-in Period||0
194617|NCT01342913|471418|P1|NOT COMPLETED|2-week Run-in Period||174
194618|NCT01342913|471416|P3|COMPLETED|2-week Run-in Period||0
194619|NCT01342913|471417|P2|COMPLETED|2-week Run-in Period||0
194620|NCT01342913|471418|P1|COMPLETED|2-week Run-in Period||528
194621|NCT01342913|471416|P3|STARTED|2-week Run-in Period||0
194622|NCT01342913|471417|P2|STARTED|2-week Run-in Period||0
194623|NCT01342913|471418|P1|STARTED|2-week Run-in Period||702
194624|NCT01342887|471428|P1|NOT COMPLETED|Overall Study||2
194625|NCT01342887|471428|P1|COMPLETED|Overall Study||4
194626|NCT01342887|471428|P1|STARTED|Overall Study||6
194627|NCT01342770|471435|P1|NOT COMPLETED|Overall Study||0
194628|NCT01342770|471435|P1|COMPLETED|Overall Study||6
194629|NCT01342770|471435|P1|STARTED|Overall Study||6
194630|NCT01342757|471453|P1|NOT COMPLETED|Overall Study||0
194631|NCT01342757|471453|P1|COMPLETED|Overall Study||12
194632|NCT01342757|471453|P1|STARTED|Overall Study||12
194633|NCT01342666|471462|P2|NOT COMPLETED|Overall Study||0
194634|NCT01342666|471463|P1|NOT COMPLETED|Overall Study||0
194635|NCT01342666|471462|P2|COMPLETED|Overall Study||24
194636|NCT01342666|471463|P1|COMPLETED|Overall Study||26
194637|NCT01342666|471462|P2|STARTED|Overall Study||24
194638|NCT01342666|471463|P1|STARTED|Overall Study||26
194639|NCT01342640|471469|P1|NOT COMPLETED|Overall Study||41
194640|NCT01342640|471469|P1|COMPLETED|Overall Study||29
194641|NCT01342640|471469|P1|STARTED|Overall Study||70
194642|NCT01342549|471477|P2|NOT COMPLETED|Overall Study||0
194643|NCT01342549|471478|P1|NOT COMPLETED|Overall Study||0
194644|NCT01342549|471477|P2|COMPLETED|Overall Study||31
194645|NCT01342549|471478|P1|COMPLETED|Overall Study||31
194646|NCT01342549|471477|P2|STARTED|Overall Study||31
194647|NCT01342549|471478|P1|STARTED|Overall Study||31
194648|NCT01342523|471516|P32|NOT COMPLETED|Overall Study||1
194649|NCT01342523|471517|P31|NOT COMPLETED|Overall Study||1
194650|NCT01342523|471518|P30|NOT COMPLETED|Overall Study||1
194651|NCT01342523|471519|P29|NOT COMPLETED|Overall Study||1
194652|NCT01342523|471520|P28|NOT COMPLETED|Overall Study||1
194653|NCT01342523|471521|P27|NOT COMPLETED|Overall Study||1
194654|NCT01342523|471522|P26|NOT COMPLETED|Overall Study||2
194655|NCT01342523|471523|P25|NOT COMPLETED|Overall Study||1
194656|NCT01342523|471524|P24|NOT COMPLETED|Overall Study||1
194657|NCT01342523|471525|P23|NOT COMPLETED|Overall Study||0
194658|NCT01342523|471526|P22|NOT COMPLETED|Overall Study||0
194659|NCT01342523|471527|P21|NOT COMPLETED|Overall Study||0
194660|NCT01342523|471528|P20|NOT COMPLETED|Overall Study||0
194661|NCT01342523|471529|P19|NOT COMPLETED|Overall Study||0
194662|NCT01342523|471530|P18|NOT COMPLETED|Overall Study||0
194663|NCT01342523|471531|P17|NOT COMPLETED|Overall Study||1
194664|NCT01342523|471532|P16|NOT COMPLETED|Overall Study||0
194665|NCT01342523|471533|P15|NOT COMPLETED|Overall Study||1
194666|NCT01342523|471534|P14|NOT COMPLETED|Overall Study||2
194667|NCT01342523|471535|P13|NOT COMPLETED|Overall Study||0
194668|NCT01342523|471536|P12|NOT COMPLETED|Overall Study||2
194669|NCT01342523|471537|P11|NOT COMPLETED|Overall Study||0
194670|NCT01342523|471538|P10|NOT COMPLETED|Overall Study||0
194671|NCT01342523|471539|P9|NOT COMPLETED|Overall Study||0
194672|NCT01342523|471540|P8|NOT COMPLETED|Overall Study||0
194673|NCT01342523|471541|P7|NOT COMPLETED|Overall Study||0
194674|NCT01342523|471542|P6|NOT COMPLETED|Overall Study||0
194675|NCT01342523|471543|P5|NOT COMPLETED|Overall Study||0
194676|NCT01342523|471544|P4|NOT COMPLETED|Overall Study||1
194677|NCT01342523|471545|P3|NOT COMPLETED|Overall Study||0
194678|NCT01342523|471546|P2|NOT COMPLETED|Overall Study||0
194679|NCT01342523|471547|P1|NOT COMPLETED|Overall Study||1
194680|NCT01342523|471516|P32|COMPLETED|Overall Study||27
194681|NCT01342523|471517|P31|COMPLETED|Overall Study||30
194682|NCT01342523|471518|P30|COMPLETED|Overall Study||28
194683|NCT01342523|471519|P29|COMPLETED|Overall Study||34
194684|NCT01342523|471520|P28|COMPLETED|Overall Study||30
194685|NCT01342523|471521|P27|COMPLETED|Overall Study||33
194686|NCT01342523|471522|P26|COMPLETED|Overall Study||36
194687|NCT01342523|471523|P25|COMPLETED|Overall Study||36
194688|NCT01342523|471524|P24|COMPLETED|Overall Study||35
194689|NCT01342523|471525|P23|COMPLETED|Overall Study||36
194690|NCT01342523|471526|P22|COMPLETED|Overall Study||30
194691|NCT01342523|471527|P21|COMPLETED|Overall Study||29
194692|NCT01342523|471528|P20|COMPLETED|Overall Study||27
194693|NCT01342523|471529|P19|COMPLETED|Overall Study||21
194694|NCT01342523|471530|P18|COMPLETED|Overall Study||27
194695|NCT01342523|471531|P17|COMPLETED|Overall Study||28
194696|NCT01342523|471532|P16|COMPLETED|Overall Study||32
194697|NCT01342523|471533|P15|COMPLETED|Overall Study||37
194698|NCT01342523|471534|P14|COMPLETED|Overall Study||36
194699|NCT01342523|471535|P13|COMPLETED|Overall Study||39
194700|NCT01342523|471536|P12|COMPLETED|Overall Study||36
194701|NCT01342523|471537|P11|COMPLETED|Overall Study||38
194702|NCT01342523|471538|P10|COMPLETED|Overall Study||28
194703|NCT01342523|471539|P9|COMPLETED|Overall Study||28
194704|NCT01342523|471540|P8|COMPLETED|Overall Study||27
194705|NCT01342523|471541|P7|COMPLETED|Overall Study||22
194706|NCT01342523|471542|P6|COMPLETED|Overall Study||36
194707|NCT01342523|471543|P5|COMPLETED|Overall Study||36
194708|NCT01342523|471544|P4|COMPLETED|Overall Study||32
194709|NCT01342523|471545|P3|COMPLETED|Overall Study||36
194710|NCT01342523|471546|P2|COMPLETED|Overall Study||32
194711|NCT01342523|471547|P1|COMPLETED|Overall Study||34
194712|NCT01342523|471516|P32|STARTED|Overall Study||28
194713|NCT01342523|471517|P31|STARTED|Overall Study||31
194714|NCT01342523|471518|P30|STARTED|Overall Study||29
194715|NCT01342523|471519|P29|STARTED|Overall Study||35
194716|NCT01342523|471520|P28|STARTED|Overall Study||31
194717|NCT01342523|471521|P27|STARTED|Overall Study||34
194718|NCT01342523|471522|P26|STARTED|Overall Study||38
194719|NCT01342523|471523|P25|STARTED|Overall Study||37
194720|NCT01342523|471524|P24|STARTED|Overall Study||36
194721|NCT01342523|471525|P23|STARTED|Overall Study||36
194722|NCT01342523|471526|P22|STARTED|Overall Study||30
194723|NCT01342523|471527|P21|STARTED|Overall Study||29
194724|NCT01342523|471528|P20|STARTED|Overall Study||27
194725|NCT01342523|471529|P19|STARTED|Overall Study||21
194726|NCT01342523|471530|P18|STARTED|Overall Study||27
194727|NCT01342523|471531|P17|STARTED|Overall Study||29
194728|NCT01342523|471532|P16|STARTED|Overall Study||32
194729|NCT01342523|471533|P15|STARTED|Overall Study||38
194730|NCT01342523|471534|P14|STARTED|Overall Study||38
194731|NCT01342523|471535|P13|STARTED|Overall Study||39
194732|NCT01342523|471536|P12|STARTED|Overall Study||38
194733|NCT01342523|471537|P11|STARTED|Overall Study||38
194734|NCT01342523|471538|P10|STARTED|Overall Study||28
194735|NCT01342523|471539|P9|STARTED|Overall Study||28
194736|NCT01342523|471540|P8|STARTED|Overall Study||27
194737|NCT01342523|471541|P7|STARTED|Overall Study||22
194738|NCT01342523|471542|P6|STARTED|Overall Study||36
194739|NCT01342523|471543|P5|STARTED|Overall Study||36
194740|NCT01342523|471544|P4|STARTED|Overall Study||33
194741|NCT01342523|471545|P3|STARTED|Overall Study||36
194742|NCT01342523|471546|P2|STARTED|Overall Study||32
194743|NCT01342523|471547|P1|STARTED|Overall Study||35
194744|NCT01342510|471564|P4|NOT COMPLETED|Overall Study||11
194745|NCT01342510|471565|P3|NOT COMPLETED|Overall Study||13
194746|NCT01342510|471566|P2|NOT COMPLETED|Overall Study||6
194747|NCT01342510|471567|P1|NOT COMPLETED|Overall Study||12
194748|NCT01342510|471564|P4|COMPLETED|Overall Study||39
194749|NCT01342510|471565|P3|COMPLETED|Overall Study||37
194750|NCT01342510|471566|P2|COMPLETED|Overall Study||44
194751|NCT01342510|471567|P1|COMPLETED|Overall Study||38
194752|NCT01342510|471564|P4|STARTED|Overall Study||50
194753|NCT01342510|471565|P3|STARTED|Overall Study||50
194754|NCT01342510|471566|P2|STARTED|Overall Study||50
194755|NCT01342510|471567|P1|STARTED|Overall Study||50
194756|NCT01342484|471584|P3|NOT COMPLETED|Overall Study||1
194757|NCT01342484|471585|P2|NOT COMPLETED|Overall Study||0
194758|NCT01342484|471586|P1|NOT COMPLETED|Overall Study||2
194759|NCT01342484|471584|P3|COMPLETED|Overall Study||13
194760|NCT01342484|471585|P2|COMPLETED|Overall Study||10
194761|NCT01342484|471586|P1|COMPLETED|Overall Study||13
194762|NCT01342484|471584|P3|STARTED|Overall Study||14
194763|NCT01342484|471585|P2|STARTED|Overall Study||10
194764|NCT01342484|471586|P1|STARTED|Overall Study||15
194765|NCT01342471|471602|P2|NOT COMPLETED|Overall Study||6
194766|NCT01342471|471603|P1|NOT COMPLETED|Overall Study||5
194767|NCT01342471|471602|P2|COMPLETED|Overall Study||23
194768|NCT01342471|471603|P1|COMPLETED|Overall Study||24
194769|NCT01342471|471602|P2|STARTED|Overall Study||29
194770|NCT01342471|471603|P1|STARTED|Overall Study||29
194771|NCT01342458|471619|P2|NOT COMPLETED|Overall Study||4
194772|NCT01342458|471620|P1|NOT COMPLETED|Overall Study||2
194773|NCT01342458|471619|P2|COMPLETED|Overall Study||24
194774|NCT01342458|471620|P1|COMPLETED|Overall Study||26
194775|NCT01342458|471619|P2|STARTED|Overall Study||28
194776|NCT01342458|471620|P1|STARTED|Overall Study||28
194777|NCT01342445|471642|P2|NOT COMPLETED|Overall Study||2
194778|NCT01342445|471643|P1|NOT COMPLETED|Overall Study||0
194779|NCT01342445|471642|P2|COMPLETED|Overall Study||22
194780|NCT01342445|471643|P1|COMPLETED|Overall Study||26
194781|NCT01342445|471642|P2|STARTED|Overall Study||24
194782|NCT01342445|471643|P1|STARTED|Overall Study||26
194783|NCT01342341|471659|P2|NOT COMPLETED|Overall Study||4
194784|NCT01342341|471660|P1|NOT COMPLETED|Overall Study||4
194785|NCT01342341|471659|P2|COMPLETED|Overall Study||20
194786|NCT01342341|471660|P1|COMPLETED|Overall Study||20
194787|NCT01342341|471659|P2|STARTED|Overall Study||24
194788|NCT01342341|471660|P1|STARTED|Overall Study||24
194789|NCT01342211|471671|P5|NOT COMPLETED|Overall Study||2
194790|NCT01342211|471672|P4|NOT COMPLETED|Overall Study||2
194791|NCT01342211|471673|P3|NOT COMPLETED|Overall Study||0
194792|NCT01342211|471674|P2|NOT COMPLETED|Overall Study||2
194793|NCT01342211|471675|P1|NOT COMPLETED|Overall Study||0
194794|NCT01342211|471671|P5|COMPLETED|Overall Study||16
194795|NCT01342211|471672|P4|COMPLETED|Overall Study||17
194796|NCT01342211|471673|P3|COMPLETED|Overall Study||18
194797|NCT01342211|471674|P2|COMPLETED|Overall Study||17
194798|NCT01342211|471675|P1|COMPLETED|Overall Study||19
194799|NCT01342211|471671|P5|Treated|Overall Study||17
194800|NCT01342211|471672|P4|Treated|Overall Study||19
194801|NCT01342211|471673|P3|Treated|Overall Study||18
194802|NCT01342211|471674|P2|Treated|Overall Study||17
194803|NCT01342211|471675|P1|Treated|Overall Study||19
194804|NCT01342211|471671|P5|STARTED|Overall Study||18
194805|NCT01342211|471672|P4|STARTED|Overall Study||19
194806|NCT01342211|471673|P3|STARTED|Overall Study||18
194807|NCT01342211|471674|P2|STARTED|Overall Study||19
194808|NCT01342211|471675|P1|STARTED|Overall Study||19
194809|NCT01342172|471741|P1|NOT COMPLETED|Overall Study||0
194810|NCT01342172|471741|P1|COMPLETED|Overall Study||9
194811|NCT01342172|471741|P1|STARTED|Overall Study||9
194812|NCT01342107|471754|P2|NOT COMPLETED|Overall Study||0
194813|NCT01342107|471755|P1|NOT COMPLETED|Overall Study||0
194814|NCT01342107|471754|P2|COMPLETED|Overall Study||32
194815|NCT01342107|471755|P1|COMPLETED|Overall Study||34
194816|NCT01342107|471754|P2|STARTED|Overall Study||32
194817|NCT01342107|471755|P1|STARTED|Overall Study||34
194818|NCT01342094|471763|P2|NOT COMPLETED|Overall Study||3
194819|NCT01342094|471764|P1|NOT COMPLETED|Overall Study||5
194820|NCT01342094|471763|P2|COMPLETED|Overall Study||81
194821|NCT01342094|471764|P1|COMPLETED|Overall Study||77
194822|NCT01342094|471763|P2|STARTED|Overall Study||84
194823|NCT01342094|471764|P1|STARTED|Overall Study||82
194824|NCT01342081|471773|P3|NOT COMPLETED|Overall Study||1
194825|NCT01342081|471774|P2|NOT COMPLETED|Overall Study||2
194826|NCT01342081|471775|P1|NOT COMPLETED|Overall Study||2
194827|NCT01342081|471773|P3|COMPLETED|Overall Study||163
194828|NCT01342081|471774|P2|COMPLETED|Overall Study||162
194829|NCT01342081|471775|P1|COMPLETED|Overall Study||159
194830|NCT01342081|471773|P3|STARTED|Overall Study||164
194831|NCT01342081|471774|P2|STARTED|Overall Study||164
194832|NCT01342081|471775|P1|STARTED|Overall Study||161
194833|NCT01342029|471783|P2|NOT COMPLETED|Period 2||0
194834|NCT01342029|471784|P1|NOT COMPLETED|Period 2||2
194835|NCT01342029|471783|P2|COMPLETED|Period 2||67
194836|NCT01342029|471784|P1|COMPLETED|Period 2||65
194837|NCT01342029|471783|P2|Dropout|Period 2||0
194838|NCT01342029|471784|P1|Dropout|Period 2||2
194839|NCT01342029|471783|P2|STARTED|Period 2||67
194840|NCT01342029|471784|P1|STARTED|Period 2||67
194841|NCT01342029|471783|P2|NOT COMPLETED|Washout||4
194842|NCT01342029|471784|P1|NOT COMPLETED|Washout||0
194843|NCT01342029|471783|P2|COMPLETED|Washout||67
194844|NCT01342029|471784|P1|COMPLETED|Washout||67
194845|NCT01342029|471783|P2|STARTED|Washout||71
194846|NCT01342029|471784|P1|STARTED|Washout||67
194847|NCT01342029|471783|P2|NOT COMPLETED|Period 1||1
194848|NCT01342029|471784|P1|NOT COMPLETED|Period 1||3
194849|NCT01342029|471783|P2|COMPLETED|Period 1||71
194850|NCT01342029|471784|P1|COMPLETED|Period 1||67
194851|NCT01342029|471783|P2|Dropout|Period 1||1
194852|NCT01342029|471784|P1|Dropout|Period 1||3
194853|NCT01342029|471783|P2|STARTED|Period 1||72
194854|NCT01342029|471784|P1|STARTED|Period 1||70
194855|NCT01341990|471794|P2|NOT COMPLETED|Overall Study||1
194856|NCT01341990|471795|P1|NOT COMPLETED|Overall Study||3
194857|NCT01341990|471794|P2|COMPLETED|Overall Study||32
194858|NCT01341990|471795|P1|COMPLETED|Overall Study||32
194859|NCT01341990|471794|P2|STARTED|Overall Study||33
194860|NCT01341990|471795|P1|STARTED|Overall Study||35
194861|NCT01341977|471805|P2|NOT COMPLETED|Overall Study||15
194862|NCT01341977|471806|P1|NOT COMPLETED|Overall Study||14
194863|NCT01341977|471805|P2|COMPLETED|Overall Study||270
194864|NCT01341977|471806|P1|COMPLETED|Overall Study||274
194865|NCT01341977|471805|P2|STARTED|Overall Study||285
194866|NCT01341977|471806|P1|STARTED|Overall Study||288
194867|NCT01341912|471812|P1|NOT COMPLETED|Overall Study||0
194868|NCT01341912|471812|P1|COMPLETED|Overall Study||3
194869|NCT01341912|471812|P1|STARTED|Overall Study||3
194870|NCT01341782|471819|P2|NOT COMPLETED|Overall Study||14
194871|NCT01341782|471820|P1|NOT COMPLETED|Overall Study||15
194872|NCT01341782|471819|P2|COMPLETED|Overall Study||114
194873|NCT01341782|471820|P1|COMPLETED|Overall Study||112
194874|NCT01341782|471819|P2|STARTED|Overall Study||128
194875|NCT01341782|471820|P1|STARTED|Overall Study||127
194876|NCT01341639|471838|P2|NOT COMPLETED|Post-Treatment||3
194877|NCT01341639|471839|P1|NOT COMPLETED|Post-Treatment||0
194878|NCT01341639|471838|P2|COMPLETED|Post-Treatment||545
194879|NCT01341639|471839|P1|COMPLETED|Post-Treatment||539
194880|NCT01341639|471838|P2|STARTED|Post-Treatment||548
194881|NCT01341639|471839|P1|STARTED|Post-Treatment||539
194882|NCT01341639|471838|P2|NOT COMPLETED|Toddler Dose||34
194883|NCT01341639|471839|P1|NOT COMPLETED|Toddler Dose||51
194884|NCT01341639|471838|P2|COMPLETED|Toddler Dose||548
194885|NCT01341639|471839|P1|COMPLETED|Toddler Dose||539
194886|NCT01341639|471838|P2|STARTED|Toddler Dose|One participant randomized to the PR5I group mistakenly received INFANRIX™ hexa instead|582
194887|NCT01341639|471839|P1|STARTED|Toddler Dose|One participant randomized to the PR5I group mistakenly received INFANRIX™ hexa instead|590
194888|NCT01341639|471838|P2|NOT COMPLETED|Interim Period||9
194889|NCT01341639|471839|P1|NOT COMPLETED|Interim Period||8
194890|NCT01341639|471838|P2|COMPLETED|Interim Period||581
194891|NCT01341639|471839|P1|COMPLETED|Interim Period||591
194892|NCT01341639|471838|P2|STARTED|Interim Period||590
194893|NCT01341639|471839|P1|STARTED|Interim Period||599
194894|NCT01341639|471838|P2|NOT COMPLETED|Infant Series||32
194895|NCT01341639|471839|P1|NOT COMPLETED|Infant Series||29
194896|NCT01341639|471838|P2|COMPLETED|Infant Series||590
194897|NCT01341639|471839|P1|COMPLETED|Infant Series||599
194898|NCT01341639|471838|P2|Treated|Infant Series||605
194899|NCT01341639|471839|P1|Treated|Infant Series||610
194900|NCT01341639|471838|P2|Site 0048 Excluded|Infant Series||606
194901|NCT01341639|471839|P1|Site 0048 Excluded|Infant Series||611
194902|NCT01341639|471838|P2|STARTED|Infant Series||622
194903|NCT01341639|471839|P1|STARTED|Infant Series||628
194904|NCT01341600|471863|P3|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
194905|NCT01341600|471864|P2|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
194906|NCT01341600|471865|P1|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
194907|NCT01341600|471863|P3|COMPLETED|Clopidogrel Plus Omeprazole||4
194908|NCT01341600|471864|P2|COMPLETED|Clopidogrel Plus Omeprazole||5
194909|NCT01341600|471865|P1|COMPLETED|Clopidogrel Plus Omeprazole||5
194910|NCT01341600|471863|P3|STARTED|Clopidogrel Plus Omeprazole||4
194911|NCT01341600|471864|P2|STARTED|Clopidogrel Plus Omeprazole||5
194912|NCT01341600|471865|P1|STARTED|Clopidogrel Plus Omeprazole||5
194913|NCT01341600|471863|P3|NOT COMPLETED|Clopidogrel 225 mg||0
194914|NCT01341600|471864|P2|NOT COMPLETED|Clopidogrel 225 mg||0
194915|NCT01341600|471865|P1|NOT COMPLETED|Clopidogrel 225 mg||0
194916|NCT01341600|471863|P3|COMPLETED|Clopidogrel 225 mg||6
194917|NCT01341600|471864|P2|COMPLETED|Clopidogrel 225 mg||6
194918|NCT01341600|471865|P1|COMPLETED|Clopidogrel 225 mg||6
194919|NCT01341600|471863|P3|STARTED|Clopidogrel 225 mg||6
194920|NCT01341600|471864|P2|STARTED|Clopidogrel 225 mg||6
194921|NCT01341600|471865|P1|STARTED|Clopidogrel 225 mg||6
194922|NCT01341600|471863|P3|NOT COMPLETED|Clopidogrel 150 mg||0
194923|NCT01341600|471864|P2|NOT COMPLETED|Clopidogrel 150 mg||0
194924|NCT01341600|471865|P1|NOT COMPLETED|Clopidogrel 150 mg||0
194925|NCT01341600|471863|P3|COMPLETED|Clopidogrel 150 mg||6
194926|NCT01341600|471864|P2|COMPLETED|Clopidogrel 150 mg||6
194927|NCT01341600|471865|P1|COMPLETED|Clopidogrel 150 mg||6
194928|NCT01341600|471863|P3|STARTED|Clopidogrel 150 mg||6
194929|NCT01341600|471864|P2|STARTED|Clopidogrel 150 mg||6
194930|NCT01341600|471865|P1|STARTED|Clopidogrel 150 mg||6
194931|NCT01341600|471863|P3|NOT COMPLETED|Clopidogrel 75 mg||0
194932|NCT01341600|471864|P2|NOT COMPLETED|Clopidogrel 75 mg||0
194933|NCT01341600|471865|P1|NOT COMPLETED|Clopidogrel 75 mg||0
194934|NCT01341600|471863|P3|COMPLETED|Clopidogrel 75 mg||6
194935|NCT01341600|471864|P2|COMPLETED|Clopidogrel 75 mg||6
194936|NCT01341600|471865|P1|COMPLETED|Clopidogrel 75 mg||6
194937|NCT01341600|471863|P3|STARTED|Clopidogrel 75 mg||6
194938|NCT01341600|471864|P2|STARTED|Clopidogrel 75 mg||6
194939|NCT01341600|471865|P1|STARTED|Clopidogrel 75 mg||6
194940|NCT01341587|471884|P2|NOT COMPLETED|Overall Study||10
194941|NCT01341587|471885|P1|NOT COMPLETED|Overall Study||4
194942|NCT01341587|471884|P2|COMPLETED|Overall Study||0
194943|NCT01341587|471885|P1|COMPLETED|Overall Study||0
194944|NCT01341587|471884|P2|STARTED|Overall Study||10
194945|NCT01341587|471885|P1|STARTED|Overall Study||4
194946|NCT01341470|471897|P6|NOT COMPLETED|Overall Study||1
194947|NCT01341470|471898|P5|NOT COMPLETED|Overall Study||0
194948|NCT01341470|471899|P4|NOT COMPLETED|Overall Study||1
194949|NCT01341470|471900|P3|NOT COMPLETED|Overall Study||1
194950|NCT01341470|471901|P2|NOT COMPLETED|Overall Study||0
194951|NCT01341470|471902|P1|NOT COMPLETED|Overall Study||0
194952|NCT01341470|471897|P6|COMPLETED|Overall Study||9
194953|NCT01341470|471898|P5|COMPLETED|Overall Study||2
194954|NCT01341470|471899|P4|COMPLETED|Overall Study||9
194955|NCT01341470|471900|P3|COMPLETED|Overall Study||9
194956|NCT01341470|471901|P2|COMPLETED|Overall Study||9
194957|NCT01341470|471902|P1|COMPLETED|Overall Study||6
194958|NCT01341470|471897|P6|Received at Least 1 Dose of Study Drug|Overall Study||10
194959|NCT01341470|471898|P5|Received at Least 1 Dose of Study Drug|Overall Study||2
194960|NCT01341470|471899|P4|Received at Least 1 Dose of Study Drug|Overall Study||10
194961|NCT01341470|471900|P3|Received at Least 1 Dose of Study Drug|Overall Study||10
194962|NCT01341470|471901|P2|Received at Least 1 Dose of Study Drug|Overall Study||9
194963|NCT01341470|471902|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
194964|NCT01341470|471897|P6|STARTED|Overall Study||10
194965|NCT01341470|471898|P5|STARTED|Overall Study||2
194966|NCT01341470|471899|P4|STARTED|Overall Study||10
194967|NCT01341470|471900|P3|STARTED|Overall Study||10
194968|NCT01341470|471901|P2|STARTED|Overall Study||9
194969|NCT01341470|471902|P1|STARTED|Overall Study||6
194970|NCT01341457|471936|P2|NOT COMPLETED|Overall Study||0
194971|NCT01341457|471937|P1|NOT COMPLETED|Overall Study||2
194972|NCT01341457|471936|P2|COMPLETED|Overall Study||10
194973|NCT01341457|471937|P1|COMPLETED|Overall Study||5
194974|NCT01341457|471936|P2|Received at Least One Dose of Study Drug|Overall Study||10
194975|NCT01341457|471937|P1|Received at Least One Dose of Study Drug|Overall Study||7
194976|NCT01341457|471936|P2|STARTED|Overall Study||10
194977|NCT01341457|471937|P1|STARTED|Overall Study||7
194978|NCT01341444|471955|P2|NOT COMPLETED|Overall Study||3
194979|NCT01341444|471956|P1|NOT COMPLETED|Overall Study||5
194980|NCT01341444|471955|P2|COMPLETED|Overall Study||29
194981|NCT01341444|471956|P1|COMPLETED|Overall Study||26
194982|NCT01341444|471955|P2|STARTED|Overall Study||32
194983|NCT01341444|471956|P1|STARTED|Overall Study||31
194984|NCT01341301|471962|P1|NOT COMPLETED|Overall Study||0
194985|NCT01341301|471962|P1|COMPLETED|Overall Study||25
194986|NCT01341301|471962|P1|STARTED|Overall Study||25
194987|NCT01341067|471969|P1|NOT COMPLETED|Overall Study||4
194988|NCT01341067|471969|P1|COMPLETED|Overall Study||26
194989|NCT01341067|471969|P1|STARTED|Overall Study||30
194990|NCT01340976|471982|P6|NOT COMPLETED|Overall Study||1
194991|NCT01340976|471983|P5|NOT COMPLETED|Overall Study||2
194992|NCT01340976|471984|P4|NOT COMPLETED|Overall Study||3
194993|NCT01340976|471985|P3|NOT COMPLETED|Overall Study||3
194994|NCT01340976|471986|P2|NOT COMPLETED|Overall Study||2
194995|NCT01340976|471987|P1|NOT COMPLETED|Overall Study||4
194996|NCT01340976|471982|P6|COMPLETED|Overall Study||6
194997|NCT01340976|471983|P5|COMPLETED|Overall Study||5
194998|NCT01340976|471984|P4|COMPLETED|Overall Study||2
194999|NCT01340976|471985|P3|COMPLETED|Overall Study||4
195000|NCT01340976|471986|P2|COMPLETED|Overall Study||1
195001|NCT01340976|471987|P1|COMPLETED|Overall Study||0
195002|NCT01340976|471982|P6|Received at Least 1 Dose of Study Drug|Overall Study||7
195003|NCT01340976|471983|P5|Received at Least 1 Dose of Study Drug|Overall Study||7
195004|NCT01340976|471984|P4|Received at Least 1 Dose of Study Drug|Overall Study||5
195005|NCT01340976|471985|P3|Received at Least 1 Dose of Study Drug|Overall Study||7
195006|NCT01340976|471986|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
195007|NCT01340976|471987|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
195008|NCT01340976|471982|P6|STARTED|Overall Study||7
195009|NCT01340976|471983|P5|STARTED|Overall Study||7
195010|NCT01340976|471984|P4|STARTED|Overall Study||5
195011|NCT01340976|471985|P3|STARTED|Overall Study||7
195012|NCT01340976|471986|P2|STARTED|Overall Study||3
195013|NCT01340976|471987|P1|STARTED|Overall Study||4
195014|NCT01340937|472025|P4|NOT COMPLETED|Period 3: Toddler Vaccinations||10
195015|NCT01340937|472026|P3|NOT COMPLETED|Period 3: Toddler Vaccinations||9
195016|NCT01340937|472027|P2|NOT COMPLETED|Period 3: Toddler Vaccinations||17
195017|NCT01340937|472028|P1|NOT COMPLETED|Period 3: Toddler Vaccinations||9
195018|NCT01340937|472025|P4|COMPLETED|Period 3: Toddler Vaccinations||319
195019|NCT01340937|472026|P3|COMPLETED|Period 3: Toddler Vaccinations||660
195020|NCT01340937|472027|P2|COMPLETED|Period 3: Toddler Vaccinations||641
195021|NCT01340937|472028|P1|COMPLETED|Period 3: Toddler Vaccinations||666
195022|NCT01340937|472025|P4|STARTED|Period 3: Toddler Vaccinations||329
195023|NCT01340937|472026|P3|STARTED|Period 3: Toddler Vaccinations||669
195024|NCT01340937|472027|P2|STARTED|Period 3: Toddler Vaccinations||658
195025|NCT01340937|472028|P1|STARTED|Period 3: Toddler Vaccinations||675
195026|NCT01340937|472025|P4|NOT COMPLETED|Period 2: Interim Period||41
195027|NCT01340937|472026|P3|NOT COMPLETED|Period 2: Interim Period||84
195028|NCT01340937|472027|P2|NOT COMPLETED|Period 2: Interim Period||79
195029|NCT01340937|472028|P1|NOT COMPLETED|Period 2: Interim Period||67
195030|NCT01340937|472025|P4|COMPLETED|Period 2: Interim Period||329
195031|NCT01340937|472026|P3|COMPLETED|Period 2: Interim Period||669
195032|NCT01340937|472027|P2|COMPLETED|Period 2: Interim Period||658
195033|NCT01340937|472028|P1|COMPLETED|Period 2: Interim Period||675
195034|NCT01340937|472025|P4|STARTED|Period 2: Interim Period||370
195035|NCT01340937|472026|P3|STARTED|Period 2: Interim Period||753
195036|NCT01340937|472027|P2|STARTED|Period 2: Interim Period||737
195037|NCT01340937|472028|P1|STARTED|Period 2: Interim Period||742
195038|NCT01340937|472025|P4|NOT COMPLETED|Period 1: Infant Series||32
195039|NCT01340937|472026|P3|NOT COMPLETED|Period 1: Infant Series||56
195040|NCT01340937|472027|P2|NOT COMPLETED|Period 1: Infant Series||60
195041|NCT01340937|472028|P1|NOT COMPLETED|Period 1: Infant Series||58
195042|NCT01340937|472025|P4|COMPLETED|Period 1: Infant Series||370
195043|NCT01340937|472026|P3|COMPLETED|Period 1: Infant Series||753
195044|NCT01340937|472027|P2|COMPLETED|Period 1: Infant Series||737
195045|NCT01340937|472028|P1|COMPLETED|Period 1: Infant Series||742
195046|NCT01340937|472025|P4|STARTED|Period 1: Infant Series||402
195047|NCT01340937|472026|P3|STARTED|Period 1: Infant Series||809
195048|NCT01340937|472027|P2|STARTED|Period 1: Infant Series||797
195049|NCT01340937|472028|P1|STARTED|Period 1: Infant Series||800
195050|NCT01340898|472188|P3|NOT COMPLETED|Booster Phase||7
195051|NCT01340898|472189|P2|NOT COMPLETED|Booster Phase||2
195052|NCT01340898|472190|P1|NOT COMPLETED|Booster Phase||10
195053|NCT01340898|472188|P3|COMPLETED|Booster Phase||163
195054|NCT01340898|472189|P2|COMPLETED|Booster Phase||164
195055|NCT01340898|472190|P1|COMPLETED|Booster Phase||332
195056|NCT01340898|472188|P3|STARTED|Booster Phase||170
195057|NCT01340898|472189|P2|STARTED|Booster Phase||166
195058|NCT01340898|472190|P1|STARTED|Booster Phase||342
195059|NCT01340898|472188|P3|NOT COMPLETED|Primary Phase||6
195060|NCT01340898|472189|P2|NOT COMPLETED|Primary Phase||9
195061|NCT01340898|472190|P1|NOT COMPLETED|Primary Phase||16
195062|NCT01340898|472188|P3|COMPLETED|Primary Phase||181
195063|NCT01340898|472189|P2|COMPLETED|Primary Phase||178
195064|NCT01340898|472190|P1|COMPLETED|Primary Phase||360
195065|NCT01340898|472188|P3|STARTED|Primary Phase||187
195066|NCT01340898|472189|P2|STARTED|Primary Phase||187
195067|NCT01340898|472190|P1|STARTED|Primary Phase||376
195068|NCT01340872|472292|P4|NOT COMPLETED|Open-label Phase||11
195069|NCT01340872|472293|P3|NOT COMPLETED|Open-label Phase||13
195070|NCT01340872|472294|P2|NOT COMPLETED|Open-label Phase||0
195071|NCT01340872|472295|P1|NOT COMPLETED|Open-label Phase||0
195072|NCT01340872|472292|P4|COMPLETED|Open-label Phase||36
195073|NCT01340872|472293|P3|COMPLETED|Open-label Phase||37
195074|NCT01340872|472294|P2|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
195075|NCT01340872|472295|P1|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
195076|NCT01340872|472292|P4|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
195077|NCT01340872|472293|P3|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
195078|NCT01340872|472294|P2|STARTED|Open-label Phase|Not Applicable to open-label phase|0
195079|NCT01340872|472295|P1|STARTED|Open-label Phase|Not Applicable to open-label phase|0
195080|NCT01340872|472292|P4|NOT COMPLETED|Double-blind Phase||0
195081|NCT01340872|472293|P3|NOT COMPLETED|Double-blind Phase||0
195082|NCT01340872|472294|P2|NOT COMPLETED|Double-blind Phase||11
195083|NCT01340872|472295|P1|NOT COMPLETED|Double-blind Phase||9
195084|NCT01340872|472292|P4|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
195085|NCT01340872|472293|P3|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
195086|NCT01340872|472294|P2|COMPLETED|Double-blind Phase||53
195087|NCT01340872|472295|P1|COMPLETED|Double-blind Phase||55
195088|NCT01340872|472292|P4|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
195089|NCT01340872|472293|P3|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
195090|NCT01340872|472294|P2|STARTED|Double-blind Phase||64
195091|NCT01340872|472295|P1|STARTED|Double-blind Phase||64
195092|NCT01340794|472355|P2|NOT COMPLETED|Overall Study||1
195093|NCT01340794|472356|P1|NOT COMPLETED|Overall Study||0
195094|NCT01340794|472355|P2|COMPLETED|Overall Study||4
195095|NCT01340794|472356|P1|COMPLETED|Overall Study||2
195096|NCT01340794|472355|P2|STARTED|Overall Study||5
195097|NCT01340794|472356|P1|STARTED|Overall Study||2
195098|NCT01340768|472372|P2|NOT COMPLETED|Overall Study||5
195099|NCT01340768|472373|P1|NOT COMPLETED|Overall Study||17
195100|NCT01340768|472372|P2|COMPLETED|Overall Study||429
195101|NCT01340768|472373|P1|COMPLETED|Overall Study||419
195102|NCT01340768|472372|P2|STARTED|Overall Study||434
195103|NCT01340768|472373|P1|STARTED|Overall Study||436
195104|NCT01340664|472384|P3|NOT COMPLETED|Overall Study||13
195105|NCT01340664|472385|P2|NOT COMPLETED|Overall Study||8
195106|NCT01340664|472386|P1|NOT COMPLETED|Overall Study||7
195107|NCT01340664|472384|P3|COMPLETED|Overall Study||80
195108|NCT01340664|472385|P2|COMPLETED|Overall Study||85
195109|NCT01340664|472386|P1|COMPLETED|Overall Study||86
195110|NCT01340664|472384|P3|STARTED|Overall Study||93
195111|NCT01340664|472385|P2|STARTED|Overall Study||93
195112|NCT01340664|472386|P1|STARTED|Overall Study||93
195113|NCT01340651|472403|P1|NOT COMPLETED|Overall Study||17
195114|NCT01340651|472403|P1|COMPLETED|Overall Study||24
195115|NCT01340651|472403|P1|STARTED|Overall Study||41
195116|NCT01340625|472419|P2|NOT COMPLETED|Second Intervention||0
195117|NCT01340625|472420|P1|NOT COMPLETED|Second Intervention||0
195118|NCT01340625|472419|P2|COMPLETED|Second Intervention||18
195119|NCT01340625|472420|P1|COMPLETED|Second Intervention||16
195120|NCT01340625|472419|P2|STARTED|Second Intervention||18
195121|NCT01340625|472420|P1|STARTED|Second Intervention||16
195122|NCT01340625|472419|P2|NOT COMPLETED|Washout Period of 28 Days||0
195123|NCT01340625|472420|P1|NOT COMPLETED|Washout Period of 28 Days||1
195124|NCT01340625|472419|P2|COMPLETED|Washout Period of 28 Days||18
195125|NCT01340625|472420|P1|COMPLETED|Washout Period of 28 Days||16
195126|NCT01340625|472419|P2|STARTED|Washout Period of 28 Days||18
195127|NCT01340625|472420|P1|STARTED|Washout Period of 28 Days||17
195128|NCT01340625|472419|P2|NOT COMPLETED|First Intervention||0
195129|NCT01340625|472420|P1|NOT COMPLETED|First Intervention||1
195130|NCT01340625|472419|P2|COMPLETED|First Intervention||18
195131|NCT01340625|472420|P1|COMPLETED|First Intervention||17
195132|NCT01340625|472419|P2|STARTED|First Intervention||18
195133|NCT01340625|472420|P1|STARTED|First Intervention||18
195134|NCT01340586|472438|P2|NOT COMPLETED|Overall Study||0
195135|NCT01340586|472439|P1|NOT COMPLETED|Overall Study||0
195136|NCT01340586|472438|P2|COMPLETED|Overall Study||8
195137|NCT01340586|472439|P1|COMPLETED|Overall Study||8
195138|NCT01340586|472438|P2|STARTED|Overall Study||8
195139|NCT01340586|472439|P1|STARTED|Overall Study||8
195140|NCT01340573|472504|P1|NOT COMPLETED|Overall Study||3
195141|NCT01340573|472504|P1|COMPLETED|Overall Study||0
195142|NCT01340573|472504|P1|STARTED|Overall Study||3
195143|NCT01340495|472525|P1|NOT COMPLETED|Overall Study||1
195144|NCT01340495|472525|P1|COMPLETED|Overall Study||69
195145|NCT01340495|472525|P1|STARTED|Overall Study||70
195146|NCT01340300|472536|P4|NOT COMPLETED|Overall Study||14
195147|NCT01340300|472537|P3|NOT COMPLETED|Overall Study||15
195148|NCT01340300|472538|P2|NOT COMPLETED|Overall Study||9
195149|NCT01340300|472539|P1|NOT COMPLETED|Overall Study||9
195150|NCT01340300|472536|P4|COMPLETED|Overall Study||20
195151|NCT01340300|472537|P3|COMPLETED|Overall Study||20
195152|NCT01340300|472538|P2|COMPLETED|Overall Study||26
195153|NCT01340300|472539|P1|COMPLETED|Overall Study||26
195154|NCT01340300|472536|P4|Follow-up Blood Sample|Overall Study||18
195155|NCT01340300|472537|P3|Follow-up Blood Sample|Overall Study||19
195156|NCT01340300|472538|P2|Follow-up Blood Sample|Overall Study||26
195157|NCT01340300|472539|P1|Follow-up Blood Sample|Overall Study||25
195158|NCT01340300|472536|P4|Baseline Blood Sample|Overall Study||29
195159|NCT01340300|472537|P3|Baseline Blood Sample|Overall Study||32
195160|NCT01340300|472538|P2|Baseline Blood Sample|Overall Study||34
195161|NCT01340300|472539|P1|Baseline Blood Sample|Overall Study||33
195162|NCT01340300|472536|P4|STARTED|Overall Study||34
195163|NCT01340300|472537|P3|STARTED|Overall Study||35
195164|NCT01340300|472538|P2|STARTED|Overall Study||35
195165|NCT01340300|472539|P1|STARTED|Overall Study||35
195166|NCT01340209|472572|P3|NOT COMPLETED|Overall Study||8
195167|NCT01340209|472573|P2|NOT COMPLETED|Overall Study||8
195168|NCT01340209|472574|P1|NOT COMPLETED|Overall Study||5
195169|NCT01340209|472572|P3|COMPLETED|Overall Study||106
195170|NCT01340209|472573|P2|COMPLETED|Overall Study||106
195171|NCT01340209|472574|P1|COMPLETED|Overall Study||52
195172|NCT01340209|472572|P3|STARTED|Overall Study||114
195173|NCT01340209|472573|P2|STARTED|Overall Study||114
195174|NCT01340209|472574|P1|STARTED|Overall Study||57
195175|NCT01340196|472609|P1|NOT COMPLETED|Treat. Period 3 (Faldaprevir)||2
195176|NCT01340196|472609|P1|COMPLETED|Treat. Period 3 (Faldaprevir)||14
195177|NCT01340196|472609|P1|STARTED|Treat. Period 3 (Faldaprevir)||16
195178|NCT01340196|472609|P1|NOT COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||0
195179|NCT01340196|472609|P1|COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
195180|NCT01340196|472609|P1|STARTED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
195181|NCT01340196|472609|P1|NOT COMPLETED|Treat. Period 1 (Tenofovir)||0
195182|NCT01340196|472609|P1|COMPLETED|Treat. Period 1 (Tenofovir)||16
195183|NCT01340196|472609|P1|STARTED|Treat. Period 1 (Tenofovir)||16
195184|NCT01340144|472640|P2|NOT COMPLETED|Overall Study||58
195185|NCT01340144|472641|P1|NOT COMPLETED|Overall Study||72
195186|NCT01340144|472640|P2|COMPLETED|Overall Study||567
195187|NCT01340144|472641|P1|COMPLETED|Overall Study||553
195188|NCT01340144|472640|P2|STARTED|Overall Study||625
195189|NCT01340144|472641|P1|STARTED|Overall Study||625
195190|NCT01340066|472649|P3|NOT COMPLETED|5 Week Double Blind Randomization Period||3
195191|NCT01340066|472650|P2|NOT COMPLETED|5 Week Double Blind Randomization Period||5
195192|NCT01340066|472651|P1|NOT COMPLETED|5 Week Double Blind Randomization Period||0
195193|NCT01340066|472649|P3|COMPLETED|5 Week Double Blind Randomization Period||31
195194|NCT01340066|472650|P2|COMPLETED|5 Week Double Blind Randomization Period||28
195195|NCT01340066|472651|P1|COMPLETED|5 Week Double Blind Randomization Period||0
195196|NCT01340066|472649|P3|STARTED|5 Week Double Blind Randomization Period||34
195197|NCT01340066|472650|P2|STARTED|5 Week Double Blind Randomization Period||33
195198|NCT01340066|472651|P1|STARTED|5 Week Double Blind Randomization Period||0
195199|NCT01340066|472649|P3|NOT COMPLETED|Placebo Run in Period||0
195200|NCT01340066|472650|P2|NOT COMPLETED|Placebo Run in Period||0
195201|NCT01340066|472651|P1|NOT COMPLETED|Placebo Run in Period||27
195202|NCT01340066|472649|P3|COMPLETED|Placebo Run in Period||0
195203|NCT01340066|472650|P2|COMPLETED|Placebo Run in Period||0
195204|NCT01340066|472651|P1|COMPLETED|Placebo Run in Period|Completed run in period and were eligible for randomization|67
195205|NCT01340066|472649|P3|STARTED|Placebo Run in Period||0
195206|NCT01340066|472650|P2|STARTED|Placebo Run in Period||0
195207|NCT01340066|472651|P1|STARTED|Placebo Run in Period||94
195208|NCT01340053|472662|P4|NOT COMPLETED|Overall Study||3
195209|NCT01340053|472663|P3|NOT COMPLETED|Overall Study||4
195210|NCT01340053|472664|P2|NOT COMPLETED|Overall Study||2
195211|NCT01340053|472665|P1|NOT COMPLETED|Overall Study||4
195212|NCT01340053|472662|P4|COMPLETED|Overall Study||43
195213|NCT01340053|472663|P3|COMPLETED|Overall Study||43
195214|NCT01340053|472664|P2|COMPLETED|Overall Study||44
195215|NCT01340053|472665|P1|COMPLETED|Overall Study||43
195216|NCT01340053|472662|P4|STARTED|Overall Study||46
195217|NCT01340053|472663|P3|STARTED|Overall Study||47
195218|NCT01340053|472664|P2|STARTED|Overall Study||46
195219|NCT01340053|472665|P1|STARTED|Overall Study||47
195220|NCT01340027|472691|P12|NOT COMPLETED|Overall Study||4
195221|NCT01340027|472692|P11|NOT COMPLETED|Overall Study||2
195222|NCT01340027|472693|P10|NOT COMPLETED|Overall Study||6
195223|NCT01340027|472694|P9|NOT COMPLETED|Overall Study||8
195224|NCT01340027|472695|P8|NOT COMPLETED|Overall Study||7
195225|NCT01340027|472696|P7|NOT COMPLETED|Overall Study||7
195226|NCT01340027|472697|P6|NOT COMPLETED|Overall Study||4
195227|NCT01340027|472698|P5|NOT COMPLETED|Overall Study||10
195228|NCT01340027|472699|P4|NOT COMPLETED|Overall Study||4
195229|NCT01340027|472700|P3|NOT COMPLETED|Overall Study||4
195230|NCT01340027|472701|P2|NOT COMPLETED|Overall Study||7
195231|NCT01340027|472702|P1|NOT COMPLETED|Overall Study||5
195232|NCT01340027|472691|P12|COMPLETED|Overall Study||77
195233|NCT01340027|472692|P11|COMPLETED|Overall Study||79
195234|NCT01340027|472693|P10|COMPLETED|Overall Study||146
195235|NCT01340027|472694|P9|COMPLETED|Overall Study||136
195236|NCT01340027|472695|P8|COMPLETED|Overall Study||142
195237|NCT01340027|472696|P7|COMPLETED|Overall Study||142
195238|NCT01340027|472697|P6|COMPLETED|Overall Study||74
195239|NCT01340027|472698|P5|COMPLETED|Overall Study||146
195240|NCT01340027|472699|P4|COMPLETED|Overall Study||75
195241|NCT01340027|472700|P3|COMPLETED|Overall Study||75
195242|NCT01340027|472701|P2|COMPLETED|Overall Study||71
195243|NCT01340027|472702|P1|COMPLETED|Overall Study||76
195244|NCT01340027|472691|P12|Received Treatment|Overall Study||81
195245|NCT01340027|472692|P11|Received Treatment|Overall Study||81
195246|NCT01340027|472693|P10|Received Treatment|Overall Study||152
195247|NCT01340027|472694|P9|Received Treatment|Overall Study||144
195248|NCT01340027|472695|P8|Received Treatment|Overall Study||149
195249|NCT01340027|472696|P7|Received Treatment|Overall Study||149
195250|NCT01340027|472697|P6|Received Treatment|Overall Study||78
195251|NCT01340027|472698|P5|Received Treatment|Overall Study||156
195252|NCT01340027|472699|P4|Received Treatment|Overall Study||79
195253|NCT01340027|472700|P3|Received Treatment|Overall Study||78
195254|NCT01340027|472701|P2|Received Treatment|Overall Study||78
195255|NCT01340027|472702|P1|Received Treatment|Overall Study||81
195256|NCT01340027|472691|P12|STARTED|Overall Study||81
195257|NCT01340027|472692|P11|STARTED|Overall Study||81
195258|NCT01340027|472693|P10|STARTED|Overall Study||152
195259|NCT01340027|472694|P9|STARTED|Overall Study||144
195260|NCT01340027|472695|P8|STARTED|Overall Study||149
195261|NCT01340027|472696|P7|STARTED|Overall Study||149
195262|NCT01340027|472697|P6|STARTED|Overall Study||78
195263|NCT01340027|472698|P5|STARTED|Overall Study||156
195264|NCT01340027|472699|P4|STARTED|Overall Study||79
195265|NCT01340027|472700|P3|STARTED|Overall Study||79
195266|NCT01340027|472701|P2|STARTED|Overall Study||78
195267|NCT01340027|472702|P1|STARTED|Overall Study||81
195268|NCT01340014|473078|P2|NOT COMPLETED|Period 2, Second 7 Days||1
195269|NCT01340014|473079|P1|NOT COMPLETED|Period 2, Second 7 Days||0
195270|NCT01340014|473078|P2|COMPLETED|Period 2, Second 7 Days||56
195271|NCT01340014|473079|P1|COMPLETED|Period 2, Second 7 Days||53
195272|NCT01340014|473078|P2|STARTED|Period 2, Second 7 Days||57
195273|NCT01340014|473079|P1|STARTED|Period 2, Second 7 Days||53
195274|NCT01340014|473078|P2|NOT COMPLETED|Period 1, First 7 Days||0
195275|NCT01340014|473079|P1|NOT COMPLETED|Period 1, First 7 Days||2
195276|NCT01340014|473078|P2|COMPLETED|Period 1, First 7 Days||57
195277|NCT01340014|473079|P1|COMPLETED|Period 1, First 7 Days||53
195278|NCT01340014|473078|P2|STARTED|Period 1, First 7 Days||57
195279|NCT01340014|473079|P1|STARTED|Period 1, First 7 Days||55
195280|NCT01339936|473087|P1|NOT COMPLETED|Overall Study||2
195281|NCT01339936|473087|P1|COMPLETED|Overall Study|plus 1 excluded from analysis set|36
195282|NCT01339936|473087|P1|STARTED|Overall Study|plus 2 screen failures|38
195283|NCT01339923|473100|P7|NOT COMPLETED|Overall Study||14
195284|NCT01339923|473101|P6|NOT COMPLETED|Overall Study||9
195285|NCT01339923|473102|P5|NOT COMPLETED|Overall Study||5
195286|NCT01339923|473103|P4|NOT COMPLETED|Overall Study||4
195287|NCT01339923|473104|P3|NOT COMPLETED|Overall Study||8
195288|NCT01339923|473105|P2|NOT COMPLETED|Overall Study||16
195289|NCT01339923|473106|P1|NOT COMPLETED|Overall Study||14
195290|NCT01339923|473100|P7|COMPLETED|Overall Study||111
195291|NCT01339923|473101|P6|COMPLETED|Overall Study||117
195292|NCT01339923|473102|P5|COMPLETED|Overall Study||295
195293|NCT01339923|473103|P4|COMPLETED|Overall Study||100
195294|NCT01339923|473104|P3|COMPLETED|Overall Study||243
195295|NCT01339923|473105|P2|COMPLETED|Overall Study||234
195296|NCT01339923|473106|P1|COMPLETED|Overall Study||239
195297|NCT01339923|473100|P7|STARTED|Overall Study||125
195298|NCT01339923|473101|P6|STARTED|Overall Study||126
195299|NCT01339923|473102|P5|STARTED|Overall Study||300
195300|NCT01339923|473103|P4|STARTED|Overall Study||104
195301|NCT01339923|473104|P3|STARTED|Overall Study||251
195302|NCT01339923|473105|P2|STARTED|Overall Study||250
195303|NCT01339923|473106|P1|STARTED|Overall Study||253
195304|NCT01339910|473177|P2|NOT COMPLETED|Overall Study||4
195305|NCT01339910|473178|P1|NOT COMPLETED|Overall Study||3
195306|NCT01339910|473177|P2|COMPLETED|Overall Study||133
195307|NCT01339910|473178|P1|COMPLETED|Overall Study||132
195308|NCT01339910|473177|P2|STARTED|Overall Study||137
195309|NCT01339910|473178|P1|STARTED|Overall Study||135
195310|NCT01339897|473216|P4|NOT COMPLETED|Overall Study||1
195311|NCT01339897|473217|P3|NOT COMPLETED|Overall Study||0
195312|NCT01339897|473218|P2|NOT COMPLETED|Overall Study||0
195313|NCT01339897|473219|P1|NOT COMPLETED|Overall Study||1
195314|NCT01339897|473216|P4|COMPLETED|Overall Study||5
195315|NCT01339897|473217|P3|COMPLETED|Overall Study||6
195316|NCT01339897|473218|P2|COMPLETED|Overall Study||6
195317|NCT01339897|473219|P1|COMPLETED|Overall Study||6
195318|NCT01339897|473216|P4|STARTED|Overall Study||6
195319|NCT01339897|473217|P3|STARTED|Overall Study||6
195320|NCT01339897|473218|P2|STARTED|Overall Study||6
195321|NCT01339897|473219|P1|STARTED|Overall Study||7
195322|NCT01339858|473247|P2|NOT COMPLETED|Overall Study||12
195323|NCT01339858|473248|P1|NOT COMPLETED|Overall Study||16
195324|NCT01339858|473247|P2|COMPLETED|Overall Study||18
195325|NCT01339858|473248|P1|COMPLETED|Overall Study||14
195326|NCT01339858|473247|P2|STARTED|Overall Study||30
195327|NCT01339858|473248|P1|STARTED|Overall Study||30
195328|NCT01339832|473272|P1|NOT COMPLETED|Overall Study||14
195329|NCT01339832|473272|P1|COMPLETED|Overall Study||37
195330|NCT01339832|473272|P1|STARTED|Overall Study||51
195331|NCT01339429|473283|P1|NOT COMPLETED|Overall Study||4
195332|NCT01339429|473283|P1|COMPLETED|Overall Study||37
195333|NCT01339429|473283|P1|STARTED|Overall Study||41
195334|NCT01339416|473288|P1|NOT COMPLETED|Overall Study||0
195335|NCT01339416|473288|P1|COMPLETED|Overall Study||8202
195336|NCT01339416|473288|P1|STARTED|Overall Study||8202
195337|NCT01339403|473300|P2|NOT COMPLETED|Overall Study||0
195338|NCT01339403|473301|P1|NOT COMPLETED|Overall Study||0
195339|NCT01339403|473300|P2|COMPLETED|Overall Study||257600
195340|NCT01339403|473301|P1|COMPLETED|Overall Study||24768
195341|NCT01339403|473300|P2|STARTED|Overall Study||257600
195342|NCT01339403|473301|P1|STARTED|Overall Study||24768
195343|NCT01339390|473323|P2|NOT COMPLETED|Overall Study||156
195344|NCT01339390|473324|P1|NOT COMPLETED|Overall Study||157
195345|NCT01339390|473323|P2|COMPLETED|Overall Study||1442
195346|NCT01339390|473324|P1|COMPLETED|Overall Study||1414
195347|NCT01339390|473323|P2|STARTED|Overall Study||1598
195348|NCT01339390|473324|P1|STARTED|Overall Study||1571
195349|NCT01339299|473332|P2|NOT COMPLETED|Overall Study||0
195350|NCT01339299|473333|P1|NOT COMPLETED|Overall Study||0
195351|NCT01339299|473332|P2|COMPLETED|Overall Study||50
195352|NCT01339299|473333|P1|COMPLETED|Overall Study||50
195353|NCT01339299|473332|P2|STARTED|Overall Study||50
195354|NCT01339299|473333|P1|STARTED|Overall Study||50
195355|NCT01339260|473341|P2|NOT COMPLETED|Multi-cycle Extension||193
195356|NCT01339260|473342|P1|NOT COMPLETED|Multi-cycle Extension||186
195357|NCT01339260|473341|P2|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|458
195358|NCT01339260|473342|P1|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|449
195359|NCT01339260|473341|P2|Safety Population|Multi-cycle Extension|Patients receiving palonosetron|651
195360|NCT01339260|473342|P1|Safety Population|Multi-cycle Extension|Patients receiving netupitant/palonosetron combination|635
195361|NCT01339260|473341|P2|STARTED|Multi-cycle Extension|Patients scheduled to palonosetron|651
195362|NCT01339260|473342|P1|STARTED|Multi-cycle Extension|Patients scheduled to netupitant/palonosetron combination|635
195363|NCT01339260|473341|P2|NOT COMPLETED|Cycle 1||10
195364|NCT01339260|473342|P1|NOT COMPLETED|Cycle 1||7
195365|NCT01339260|473341|P2|COMPLETED|Cycle 1||719
195366|NCT01339260|473342|P1|COMPLETED|Cycle 1||719
195367|NCT01339260|473341|P2|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to palonosetron|725
195368|NCT01339260|473342|P1|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to netupitant/palonosetron combination|724
195369|NCT01339260|473341|P2|Safety Population|Cycle 1|Patients receiving palonosetron|725
195370|NCT01339260|473342|P1|Safety Population|Cycle 1|Patients receiving netupitant/palonosetron combination|725
195371|NCT01339260|473341|P2|STARTED|Cycle 1|Intent-To-Treat: randomized patients|729
195372|NCT01339260|473342|P1|STARTED|Cycle 1|Intent-To-Treat: randomized patients|726
195373|NCT01339247|473354|P2|NOT COMPLETED|Period 2||0
195374|NCT01339247|473355|P1|NOT COMPLETED|Period 2||0
195375|NCT01339247|473354|P2|COMPLETED|Period 2||30
195376|NCT01339247|473355|P1|COMPLETED|Period 2||30
195377|NCT01339247|473354|P2|STARTED|Period 2||30
195378|NCT01339247|473355|P1|STARTED|Period 2||30
195379|NCT01339247|473354|P2|NOT COMPLETED|Period 1||0
195380|NCT01339247|473355|P1|NOT COMPLETED|Period 1||0
195381|NCT01339247|473354|P2|COMPLETED|Period 1||30
195382|NCT01339247|473355|P1|COMPLETED|Period 1||30
195383|NCT01339247|473354|P2|STARTED|Period 1||30
195384|NCT01339247|473355|P1|STARTED|Period 1||30
195385|NCT01339091|473367|P2|NOT COMPLETED|Overall Study||28
195386|NCT01339091|473368|P1|NOT COMPLETED|Overall Study||27
195387|NCT01339091|473367|P2|COMPLETED|Overall Study||257
195388|NCT01339091|473368|P1|COMPLETED|Overall Study||261
195389|NCT01339091|473367|P2|Safety Population|Overall Study||284
195390|NCT01339091|473368|P1|Safety Population|Overall Study||284
195391|NCT01339091|473367|P2|STARTED|Overall Study||285
195392|NCT01339091|473368|P1|STARTED|Overall Study||288
195393|NCT01339052|473382|P2|NOT COMPLETED|Overall Study||50
195394|NCT01339052|473383|P1|NOT COMPLETED|Overall Study||15
195395|NCT01339052|473382|P2|COMPLETED|Overall Study||0
195396|NCT01339052|473383|P1|COMPLETED|Overall Study||0
195397|NCT01339052|473382|P2|Evaluable Plasma Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
195398|NCT01339052|473383|P1|Evaluable Plasma Sample at Surgery|Overall Study||13
195399|NCT01339052|473382|P2|Evaluable Tumor Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
195400|NCT01339052|473383|P1|Evaluable Tumor Sample at Surgery|Overall Study||14
195401|NCT01339052|473382|P2|Measurable Disease|Overall Study|Radiographic response evaluated on participants with measurable disease only.|40
195402|NCT01339052|473383|P1|Measurable Disease|Overall Study||11
195403|NCT01339052|473382|P2|STARTED|Overall Study||50
195404|NCT01339052|473383|P1|STARTED|Overall Study||15
195405|NCT01339013|473403|P1|NOT COMPLETED|Overall Study||0
195406|NCT01339013|473403|P1|COMPLETED|Overall Study||6
195407|NCT01339013|473403|P1|STARTED|Overall Study||6
195408|NCT01339000|473409|P2|NOT COMPLETED|Overall Study||0
195409|NCT01339000|473410|P1|NOT COMPLETED|Overall Study||1
195410|NCT01339000|473409|P2|COMPLETED|Overall Study||0
195411|NCT01339000|473410|P1|COMPLETED|Overall Study||0
195412|NCT01339000|473409|P2|STARTED|Overall Study||0
195413|NCT01339000|473410|P1|STARTED|Overall Study|The patient received day 1, 29, 36, 43, 50, and 57 vaccines but did not receive interleukin-7 (IL-7)|1
195414|NCT01338987|473429|P5|NOT COMPLETED|Overall Study||0
195415|NCT01338987|473430|P4|NOT COMPLETED|Overall Study||0
195416|NCT01338987|473431|P3|NOT COMPLETED|Overall Study||2
195417|NCT01338987|473432|P2|NOT COMPLETED|Overall Study||1
195418|NCT01338987|473433|P1|NOT COMPLETED|Overall Study||2
195419|NCT01338987|473429|P5|COMPLETED|Overall Study||2
195420|NCT01338987|473430|P4|COMPLETED|Overall Study||31
195421|NCT01338987|473431|P3|COMPLETED|Overall Study||20
195422|NCT01338987|473432|P2|COMPLETED|Overall Study||8
195423|NCT01338987|473433|P1|COMPLETED|Overall Study||10
195424|NCT01338987|473429|P5|STARTED|Overall Study||2
195425|NCT01338987|473430|P4|STARTED|Overall Study||31
195426|NCT01338987|473431|P3|STARTED|Overall Study||22
195427|NCT01338987|473432|P2|STARTED|Overall Study||9
195428|NCT01338987|473433|P1|STARTED|Overall Study||12
195429|NCT01338870|473454|P6|NOT COMPLETED|Overall Study||6
195430|NCT01338870|473455|P5|NOT COMPLETED|Overall Study||6
195431|NCT01338870|473456|P4|NOT COMPLETED|Overall Study||9
195432|NCT01338870|473457|P3|NOT COMPLETED|Overall Study||11
195433|NCT01338870|473458|P2|NOT COMPLETED|Overall Study||12
195434|NCT01338870|473459|P1|NOT COMPLETED|Overall Study||9
195435|NCT01338870|473454|P6|COMPLETED|Overall Study||44
195436|NCT01338870|473455|P5|COMPLETED|Overall Study||46
195437|NCT01338870|473456|P4|COMPLETED|Overall Study||41
195438|NCT01338870|473457|P3|COMPLETED|Overall Study||39
195439|NCT01338870|473458|P2|COMPLETED|Overall Study||37
195440|NCT01338870|473459|P1|COMPLETED|Overall Study||41
195441|NCT01338870|473454|P6|STARTED|Overall Study||50
195442|NCT01338870|473455|P5|STARTED|Overall Study||52
195443|NCT01338870|473456|P4|STARTED|Overall Study||50
195444|NCT01338870|473457|P3|STARTED|Overall Study||50
195445|NCT01338870|473458|P2|STARTED|Overall Study||49
195446|NCT01338870|473459|P1|STARTED|Overall Study||50
195447|NCT01338857|473509|P1|NOT COMPLETED|Overall Study||11
195448|NCT01338857|473509|P1|COMPLETED|Overall Study||1
195449|NCT01338857|473509|P1|STARTED|Overall Study||12
195450|NCT01338818|473514|P1|NOT COMPLETED|Overall Study||36
195451|NCT01338818|473514|P1|COMPLETED|Overall Study||262
195452|NCT01338818|473514|P1|STARTED|Overall Study||298
195453|NCT01338792|473520|P1|NOT COMPLETED|Overall Study||4
195454|NCT01338792|473520|P1|COMPLETED|Overall Study||43
195455|NCT01338792|473520|P1|STARTED|Overall Study||47
195456|NCT01338649|473528|P2|NOT COMPLETED|Overall Study||0
195457|NCT01338649|473529|P1|NOT COMPLETED|Overall Study||0
195458|NCT01338649|473528|P2|COMPLETED|Overall Study||14
195459|NCT01338649|473529|P1|COMPLETED|Overall Study||13
195460|NCT01338649|473528|P2|STARTED|Overall Study||14
195461|NCT01338649|473529|P1|STARTED|Overall Study||13
195462|NCT01338636|473535|P1|NOT COMPLETED|Overall Study||8
195463|NCT01338636|473535|P1|COMPLETED|Overall Study||22
195464|NCT01338636|473535|P1|STARTED|Overall Study||30
195465|NCT01338610|473549|P3|NOT COMPLETED|Overall Study||1
195466|NCT01338610|473550|P2|NOT COMPLETED|Overall Study||1
195467|NCT01338610|473551|P1|NOT COMPLETED|Overall Study||5
195468|NCT01338610|473549|P3|COMPLETED|Overall Study||28
195469|NCT01338610|473550|P2|COMPLETED|Overall Study||55
195470|NCT01338610|473551|P1|COMPLETED|Overall Study||34
195471|NCT01338610|473549|P3|STARTED|Overall Study||29
195472|NCT01338610|473550|P2|STARTED|Overall Study||56
195473|NCT01338610|473551|P1|STARTED|Overall Study||39
195474|NCT01338493|473558|P1|NOT COMPLETED|24 Months Follow up||0
195475|NCT01338493|473558|P1|COMPLETED|24 Months Follow up||104
195476|NCT01338493|473558|P1|STARTED|24 Months Follow up||104
195477|NCT01338493|473558|P1|NOT COMPLETED|12 Months Follow up||9
195478|NCT01338493|473558|P1|COMPLETED|12 Months Follow up||104
195479|NCT01338493|473558|P1|STARTED|12 Months Follow up||113
195480|NCT01338493|473558|P1|NOT COMPLETED|6 Months Follow up||19
195481|NCT01338493|473558|P1|COMPLETED|6 Months Follow up||113
195482|NCT01338493|473558|P1|STARTED|6 Months Follow up||132
195483|NCT01338493|473558|P1|NOT COMPLETED|Discharge||2
195484|NCT01338493|473558|P1|COMPLETED|Discharge||132
195485|NCT01338493|473558|P1|STARTED|Discharge||134
195486|NCT01338493|473558|P1|NOT COMPLETED|Implant||0
195487|NCT01338493|473558|P1|COMPLETED|Implant||134
195488|NCT01338493|473558|P1|STARTED|Implant||134
195489|NCT01338493|473558|P1|NOT COMPLETED|Enrolled||5
195490|NCT01338493|473558|P1|COMPLETED|Enrolled||134
195491|NCT01338493|473558|P1|STARTED|Enrolled||139
195492|NCT01338415|473565|P2|NOT COMPLETED|Overall Study||9
195493|NCT01338415|473566|P1|NOT COMPLETED|Overall Study||10
195494|NCT01338415|473565|P2|COMPLETED|Overall Study||22
195495|NCT01338415|473566|P1|COMPLETED|Overall Study||23
195496|NCT01338415|473565|P2|Enrolled in FUTURE 3 Extension|Overall Study||27
195497|NCT01338415|473566|P1|Enrolled in FUTURE 3 Extension|Overall Study||31
195498|NCT01338415|473565|P2|STARTED|Overall Study||31
195499|NCT01338415|473566|P1|STARTED|Overall Study||33
195500|NCT01338298|473588|P2|NOT COMPLETED|Overall Study||3
195501|NCT01338298|473589|P1|NOT COMPLETED|Overall Study||4
195502|NCT01338298|473588|P2|COMPLETED|Overall Study||15
195503|NCT01338298|473589|P1|COMPLETED|Overall Study||20
195504|NCT01338298|473588|P2|STARTED|Overall Study||18
195505|NCT01338298|473589|P1|STARTED|Overall Study||24
195506|NCT01338025|473599|P2|NOT COMPLETED|Overall Study||11
195507|NCT01338025|473600|P1|NOT COMPLETED|Overall Study||11
195508|NCT01338025|473599|P2|COMPLETED|Overall Study||6
195509|NCT01338025|473600|P1|COMPLETED|Overall Study||5
195510|NCT01338025|473599|P2|STARTED|Overall Study||17
195511|NCT01338025|473600|P1|STARTED|Overall Study||16
195512|NCT01338012|473612|P1|NOT COMPLETED|Overall Study||8
195513|NCT01338012|473612|P1|COMPLETED|Overall Study||0
195514|NCT01338012|473612|P1|STARTED|Overall Study||8
195515|NCT01337973|473619|P3|NOT COMPLETED|Overall Study||11
195516|NCT01337973|473620|P2|NOT COMPLETED|Overall Study||15
195517|NCT01337973|473621|P1|NOT COMPLETED|Overall Study||16
195518|NCT01337973|473619|P3|COMPLETED|Overall Study||49
195519|NCT01337973|473620|P2|COMPLETED|Overall Study||45
195520|NCT01337973|473621|P1|COMPLETED|Overall Study||44
195521|NCT01337973|473619|P3|STARTED|Overall Study||60
195522|NCT01337973|473620|P2|STARTED|Overall Study||60
195523|NCT01337973|473621|P1|STARTED|Overall Study||60
195524|NCT01337960|473635|P3|NOT COMPLETED|Overall Study||0
195525|NCT01337960|473636|P2|NOT COMPLETED|Overall Study||0
195526|NCT01337960|473637|P1|NOT COMPLETED|Overall Study||2
195527|NCT01337960|473635|P3|COMPLETED|Overall Study||6
195528|NCT01337960|473636|P2|COMPLETED|Overall Study||14
195529|NCT01337960|473637|P1|COMPLETED|Overall Study||12
195530|NCT01337960|473635|P3|STARTED|Overall Study||6
195531|NCT01337960|473636|P2|STARTED|Overall Study||14
195532|NCT01337960|473637|P1|STARTED|Overall Study||14
195533|NCT01337739|473659|P2|NOT COMPLETED|Overall Study||0
195534|NCT01337739|473660|P1|NOT COMPLETED|Overall Study||0
195535|NCT01337739|473659|P2|COMPLETED|Overall Study||4
195536|NCT01337739|473660|P1|COMPLETED|Overall Study||6
195537|NCT01337739|473659|P2|STARTED|Overall Study||4
195538|NCT01337739|473660|P1|STARTED|Overall Study||6
195539|NCT01337674|473670|P4|NOT COMPLETED|Treatment Period 2||0
195540|NCT01337674|473671|P3|NOT COMPLETED|Treatment Period 2||1
195541|NCT01337674|473672|P2|NOT COMPLETED|Treatment Period 2||0
195542|NCT01337674|473673|P1|NOT COMPLETED|Treatment Period 2||0
195543|NCT01337674|473670|P4|COMPLETED|Treatment Period 2||6
195544|NCT01337674|473671|P3|COMPLETED|Treatment Period 2||5
195545|NCT01337674|473672|P2|COMPLETED|Treatment Period 2||6
195546|NCT01337674|473673|P1|COMPLETED|Treatment Period 2||6
195547|NCT01337674|473670|P4|STARTED|Treatment Period 2||6
195548|NCT01337674|473671|P3|STARTED|Treatment Period 2||6
195549|NCT01337674|473672|P2|STARTED|Treatment Period 2||6
195550|NCT01337674|473673|P1|STARTED|Treatment Period 2||6
195551|NCT01337674|473670|P4|NOT COMPLETED|Two-week Washout Period||0
195552|NCT01337674|473671|P3|NOT COMPLETED|Two-week Washout Period||0
195553|NCT01337674|473672|P2|NOT COMPLETED|Two-week Washout Period||0
195554|NCT01337674|473673|P1|NOT COMPLETED|Two-week Washout Period||0
195555|NCT01337674|473670|P4|COMPLETED|Two-week Washout Period||6
195556|NCT01337674|473671|P3|COMPLETED|Two-week Washout Period||6
195557|NCT01337674|473672|P2|COMPLETED|Two-week Washout Period||6
195558|NCT01337674|473673|P1|COMPLETED|Two-week Washout Period||6
195559|NCT01337674|473670|P4|STARTED|Two-week Washout Period||6
195560|NCT01337674|473671|P3|STARTED|Two-week Washout Period||6
195561|NCT01337674|473672|P2|STARTED|Two-week Washout Period||6
195562|NCT01337674|473673|P1|STARTED|Two-week Washout Period||6
195563|NCT01337674|473670|P4|NOT COMPLETED|Treatment Period 1||1
195564|NCT01337674|473671|P3|NOT COMPLETED|Treatment Period 1||0
195565|NCT01337674|473672|P2|NOT COMPLETED|Treatment Period 1||1
195566|NCT01337674|473673|P1|NOT COMPLETED|Treatment Period 1||0
195567|NCT01337674|473670|P4|COMPLETED|Treatment Period 1||6
195568|NCT01337674|473671|P3|COMPLETED|Treatment Period 1||6
195569|NCT01337674|473672|P2|COMPLETED|Treatment Period 1||6
195570|NCT01337674|473673|P1|COMPLETED|Treatment Period 1||6
195571|NCT01337674|473670|P4|STARTED|Treatment Period 1|The discontinued participant was replaced|7
195572|NCT01337674|473671|P3|STARTED|Treatment Period 1||6
195573|NCT01337674|473672|P2|STARTED|Treatment Period 1|The discontinued participant was replaced|7
195574|NCT01337674|473673|P1|STARTED|Treatment Period 1||6
195575|NCT01337635|473691|P2|NOT COMPLETED|Overall Study||1
195576|NCT01337635|473692|P1|NOT COMPLETED|Overall Study||0
195577|NCT01337635|473691|P2|COMPLETED|Overall Study||3
195578|NCT01337635|473692|P1|COMPLETED|Overall Study||3
195579|NCT01337635|473691|P2|STARTED|Overall Study||4
195580|NCT01337635|473692|P1|STARTED|Overall Study||3
195581|NCT01337609|473703|P3|NOT COMPLETED|Overall Study||0
195582|NCT01337609|473704|P2|NOT COMPLETED|Overall Study||0
195583|NCT01337609|473705|P1|NOT COMPLETED|Overall Study||1
195584|NCT01337609|473703|P3|COMPLETED|Overall Study||2
195585|NCT01337609|473704|P2|COMPLETED|Overall Study||2
195586|NCT01337609|473705|P1|COMPLETED|Overall Study||0
195587|NCT01337609|473703|P3|STARTED|Overall Study||2
195588|NCT01337609|473704|P2|STARTED|Overall Study||2
195589|NCT01337609|473705|P1|STARTED|Overall Study||1
195590|NCT01337596|473734|P9|NOT COMPLETED|Overall Study||0
195591|NCT01337596|473735|P8|NOT COMPLETED|Overall Study||0
195592|NCT01337596|473736|P7|NOT COMPLETED|Overall Study||0
195593|NCT01337596|473737|P6|NOT COMPLETED|Overall Study||0
195594|NCT01337596|473738|P5|NOT COMPLETED|Overall Study||2
195595|NCT01337596|473739|P4|NOT COMPLETED|Overall Study||0
195596|NCT01337596|473740|P3|NOT COMPLETED|Overall Study||0
195597|NCT01337596|473741|P2|NOT COMPLETED|Overall Study||0
195598|NCT01337596|473742|P1|NOT COMPLETED|Overall Study||0
195599|NCT01337596|473734|P9|COMPLETED|Overall Study||7
195600|NCT01337596|473735|P8|COMPLETED|Overall Study||2
195601|NCT01337596|473736|P7|COMPLETED|Overall Study||12
195602|NCT01337596|473737|P6|COMPLETED|Overall Study||7
195603|NCT01337596|473738|P5|COMPLETED|Overall Study||5
195604|NCT01337596|473739|P4|COMPLETED|Overall Study||7
195605|NCT01337596|473740|P3|COMPLETED|Overall Study||7
195606|NCT01337596|473741|P2|COMPLETED|Overall Study||7
195607|NCT01337596|473742|P1|COMPLETED|Overall Study||7
195608|NCT01337596|473734|P9|Safety Population|Overall Study||7
195609|NCT01337596|473735|P8|Safety Population|Overall Study||2
195610|NCT01337596|473736|P7|Safety Population|Overall Study||12
195611|NCT01337596|473737|P6|Safety Population|Overall Study||7
195612|NCT01337596|473738|P5|Safety Population|Overall Study||7
195613|NCT01337596|473739|P4|Safety Population|Overall Study||7
195614|NCT01337596|473740|P3|Safety Population|Overall Study||7
195615|NCT01337596|473741|P2|Safety Population|Overall Study||7
195616|NCT01337596|473742|P1|Safety Population|Overall Study||7
195617|NCT01337596|473734|P9|STARTED|Overall Study||7
195618|NCT01337596|473735|P8|STARTED|Overall Study||2
195619|NCT01337596|473736|P7|STARTED|Overall Study||12
195620|NCT01337596|473737|P6|STARTED|Overall Study||7
195621|NCT01337596|473738|P5|STARTED|Overall Study||7
195622|NCT01337596|473739|P4|STARTED|Overall Study||7
195623|NCT01337596|473740|P3|STARTED|Overall Study||7
195624|NCT01337596|473741|P2|STARTED|Overall Study||7
195625|NCT01337596|473742|P1|STARTED|Overall Study||7
195626|NCT01337336|473778|P2|NOT COMPLETED|Overall Study||0
195627|NCT01337336|473779|P1|NOT COMPLETED|Overall Study||0
195628|NCT01337336|473778|P2|COMPLETED|Overall Study||2923
195629|NCT01337336|473779|P1|COMPLETED|Overall Study||1078
195630|NCT01337336|473778|P2|STARTED|Overall Study||2923
195631|NCT01337336|473779|P1|STARTED|Overall Study||1078
195632|NCT01337297|473793|P2|NOT COMPLETED|Overall Study||6
195633|NCT01337297|473794|P1|NOT COMPLETED|Overall Study||5
195634|NCT01337297|473793|P2|COMPLETED|Overall Study||3
195635|NCT01337297|473794|P1|COMPLETED|Overall Study||6
195636|NCT01337297|473793|P2|STARTED|Overall Study||9
195637|NCT01337297|473794|P1|STARTED|Overall Study||11
195638|NCT01337167|473802|P2|NOT COMPLETED|Toddler Vaccinations||13
195639|NCT01337167|473803|P1|NOT COMPLETED|Toddler Vaccinations||14
195640|NCT01337167|473802|P2|COMPLETED|Toddler Vaccinations||407
195641|NCT01337167|473803|P1|COMPLETED|Toddler Vaccinations||829
195642|NCT01337167|473802|P2|STARTED|Toddler Vaccinations||420
195643|NCT01337167|473803|P1|STARTED|Toddler Vaccinations||843
195644|NCT01337167|473802|P2|NOT COMPLETED|Interim Period||40
195645|NCT01337167|473803|P1|NOT COMPLETED|Interim Period||81
195646|NCT01337167|473802|P2|COMPLETED|Interim Period||420
195647|NCT01337167|473803|P1|COMPLETED|Interim Period||843
195648|NCT01337167|473802|P2|STARTED|Interim Period||460
195649|NCT01337167|473803|P1|STARTED|Interim Period||924
195650|NCT01337167|473802|P2|NOT COMPLETED|Infant Series||27
195651|NCT01337167|473803|P1|NOT COMPLETED|Infant Series||62
195652|NCT01337167|473802|P2|COMPLETED|Infant Series||460
195653|NCT01337167|473803|P1|COMPLETED|Infant Series||924
195654|NCT01337167|473802|P2|STARTED|Infant Series||487
195655|NCT01337167|473803|P1|STARTED|Infant Series||986
195656|NCT01337115|473871|P2|NOT COMPLETED|Overall Study||0
195657|NCT01337115|473872|P1|NOT COMPLETED|Overall Study||2
195658|NCT01337115|473871|P2|COMPLETED|Overall Study||25
195659|NCT01337115|473872|P1|COMPLETED|Overall Study|2 patients could not be assessed after 12h because of catheter dislocation|23
195660|NCT01337115|473871|P2|STARTED|Overall Study||25
195661|NCT01337115|473872|P1|STARTED|Overall Study||25
195662|NCT01337089|473884|P1|NOT COMPLETED|Overall Study||404
195663|NCT01337089|473884|P1|COMPLETED|Overall Study||256
195664|NCT01337089|473884|P1|Efficacy Dataset|Overall Study|One participant withdrew after administering nabiximols, but no efficacy data were collected.|659
195665|NCT01337089|473884|P1|Safety Population|Overall Study||660
195666|NCT01337089|473884|P1|Received at Least 1 Dose of Study Drug|Overall Study||660
195667|NCT01337089|473884|P1|STARTED|Overall Study||660
195668|NCT01337076|473892|P1|NOT COMPLETED|Overall Study||2
195669|NCT01337076|473892|P1|COMPLETED|Overall Study|subjects met the primary endpoint of 6 months postimplant activation|19
195670|NCT01337076|473892|P1|STARTED|Overall Study|subjects implanted|21
195671|NCT01337050|473899|P3|NOT COMPLETED|Overall Study||19
195672|NCT01337050|473900|P2|NOT COMPLETED|Overall Study||13
195673|NCT01337050|473901|P1|NOT COMPLETED|Overall Study||4
195674|NCT01337050|473899|P3|COMPLETED|Overall Study||0
195675|NCT01337050|473900|P2|COMPLETED|Overall Study||0
195676|NCT01337050|473901|P1|COMPLETED|Overall Study||0
195677|NCT01337050|473899|P3|STARTED|Overall Study||19
195678|NCT01337050|473900|P2|STARTED|Overall Study||13
195679|NCT01337050|473901|P1|STARTED|Overall Study||4
195680|NCT01336972|473962|P3|NOT COMPLETED|Overall Study||0
195681|NCT01336972|473963|P2|NOT COMPLETED|Overall Study||1
195682|NCT01336972|473964|P1|NOT COMPLETED|Overall Study||1
195683|NCT01336972|473962|P3|COMPLETED|Overall Study||9
195684|NCT01336972|473963|P2|COMPLETED|Overall Study||9
195685|NCT01336972|473964|P1|COMPLETED|Overall Study||9
195686|NCT01336972|473962|P3|STARTED|Overall Study||9
195687|NCT01336972|473963|P2|STARTED|Overall Study||10
195688|NCT01336972|473964|P1|STARTED|Overall Study||10
195689|NCT01336959|474002|P3|NOT COMPLETED|Overall Study||1
195690|NCT01336959|474003|P2|NOT COMPLETED|Overall Study||5
195691|NCT01336959|474004|P1|NOT COMPLETED|Overall Study||0
195692|NCT01336959|474002|P3|COMPLETED|Overall Study||40
195693|NCT01336959|474003|P2|COMPLETED|Overall Study||37
195694|NCT01336959|474004|P1|COMPLETED|Overall Study||8
195695|NCT01336959|474002|P3|STARTED|Overall Study||41
195696|NCT01336959|474003|P2|STARTED|Overall Study||42
195697|NCT01336959|474004|P1|STARTED|Overall Study||8
195698|NCT01336933|474015|P1|NOT COMPLETED|Overall Study||1
195699|NCT01336933|474015|P1|COMPLETED|Overall Study||33
195700|NCT01336933|474015|P1|STARTED|Overall Study||34
195701|NCT01336894|474026|P2|NOT COMPLETED|Follow-up||7
195702|NCT01336894|474027|P1|NOT COMPLETED|Follow-up||2
195703|NCT01336894|474026|P2|COMPLETED|Follow-up||0
195704|NCT01336894|474027|P1|COMPLETED|Follow-up||2
195705|NCT01336894|474026|P2|STARTED|Follow-up||7
195706|NCT01336894|474027|P1|STARTED|Follow-up||4
195707|NCT01336894|474026|P2|NOT COMPLETED|Protocol Interventions||0
195708|NCT01336894|474027|P1|NOT COMPLETED|Protocol Interventions||0
195709|NCT01336894|474026|P2|COMPLETED|Protocol Interventions||7
195710|NCT01336894|474027|P1|COMPLETED|Protocol Interventions||4
195711|NCT01336894|474026|P2|STARTED|Protocol Interventions||7
195712|NCT01336894|474027|P1|STARTED|Protocol Interventions||4
195713|NCT01336803|474045|P1|NOT COMPLETED|Overall Study||0
195714|NCT01336803|474045|P1|COMPLETED|Overall Study||21
195715|NCT01336803|474045|P1|Lymphoma|Overall Study||7
195716|NCT01336803|474045|P1|Osteomyelitis|Overall Study||4
195717|NCT01336803|474045|P1|Bone Sarcoma|Overall Study||10
195718|NCT01336803|474045|P1|STARTED|Overall Study||21
195719|NCT01336764|474059|P2|NOT COMPLETED|Overall Study||5
195720|NCT01336764|474060|P1|NOT COMPLETED|Overall Study||5
195721|NCT01336764|474059|P2|COMPLETED|Overall Study||5
195722|NCT01336764|474060|P1|COMPLETED|Overall Study||7
195723|NCT01336764|474059|P2|STARTED|Overall Study||10
195724|NCT01336764|474060|P1|STARTED|Overall Study||12
195725|NCT01336738|474071|P5|NOT COMPLETED|Overall Study||10
195726|NCT01336738|474072|P4|NOT COMPLETED|Overall Study||7
195727|NCT01336738|474073|P3|NOT COMPLETED|Overall Study||8
195728|NCT01336738|474074|P2|NOT COMPLETED|Overall Study||9
195729|NCT01336738|474075|P1|NOT COMPLETED|Overall Study||7
195730|NCT01336738|474071|P5|COMPLETED|Overall Study||43
195731|NCT01336738|474072|P4|COMPLETED|Overall Study||47
195732|NCT01336738|474073|P3|COMPLETED|Overall Study||45
195733|NCT01336738|474074|P2|COMPLETED|Overall Study||45
195734|NCT01336738|474075|P1|COMPLETED|Overall Study||45
195735|NCT01336738|474071|P5|STARTED|Overall Study||53
195736|NCT01336738|474072|P4|STARTED|Overall Study||54
195737|NCT01336738|474073|P3|STARTED|Overall Study||53
195738|NCT01336738|474074|P2|STARTED|Overall Study||54
195739|NCT01336738|474075|P1|STARTED|Overall Study||52
195740|NCT01336712|474117|P1|NOT COMPLETED|Overall Study||3
195741|NCT01336712|474117|P1|COMPLETED|Overall Study||27
195742|NCT01336712|474117|P1|STARTED|Overall Study||30
195743|NCT01336647|474130|P3|NOT COMPLETED|Overall Study||3
195744|NCT01336647|474131|P2|NOT COMPLETED|Overall Study||1
195745|NCT01336647|474132|P1|NOT COMPLETED|Overall Study||4
195746|NCT01336647|474130|P3|COMPLETED|Overall Study||44
195747|NCT01336647|474131|P2|COMPLETED|Overall Study||48
195748|NCT01336647|474132|P1|COMPLETED|Overall Study||42
195749|NCT01336647|474130|P3|STARTED|Overall Study||47
195750|NCT01336647|474131|P2|STARTED|Overall Study||49
195751|NCT01336647|474132|P1|STARTED|Overall Study||46
195752|NCT01336634|474146|P3|NOT COMPLETED|Overall Study||36
195753|NCT01336634|474147|P2|NOT COMPLETED|Overall Study||57
195754|NCT01336634|474148|P1|NOT COMPLETED|Overall Study||84
195755|NCT01336634|474146|P3|COMPLETED|Overall Study||0
195756|NCT01336634|474147|P2|COMPLETED|Overall Study||0
195757|NCT01336634|474148|P1|COMPLETED|Overall Study||0
195758|NCT01336634|474146|P3|STARTED|Overall Study||36
195759|NCT01336634|474147|P2|STARTED|Overall Study||57
195760|NCT01336634|474148|P1|STARTED|Overall Study||84
195761|NCT01336621|474189|P1|NOT COMPLETED|SFUCP (up to 2.6 Years)||9
195762|NCT01336621|474189|P1|COMPLETED|SFUCP (up to 2.6 Years)||0
195763|NCT01336621|474189|P1|STARTED|SFUCP (up to 2.6 Years)||9
195764|NCT01336621|474189|P1|NOT COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||98
195765|NCT01336621|474189|P1|COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||0
195766|NCT01336621|474189|P1|STARTED|Primary Reporting Phase (Upto 5.8 Years)||98
195767|NCT01336608|474239|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||24
195768|NCT01336608|474240|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||30
195769|NCT01336608|474241|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||44
195770|NCT01336608|474242|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
195771|NCT01336608|474239|P4|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|111
195772|NCT01336608|474240|P3|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|124
195773|NCT01336608|474241|P2|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|97
195774|NCT01336608|474242|P1|COMPLETED|24-week, Double-blind Treatment Period||0
195775|NCT01336608|474239|P4|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|110
195776|NCT01336608|474240|P3|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|124
195777|NCT01336608|474241|P2|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|96
195778|NCT01336608|474242|P1|Completed the Treatment Period|24-week, Double-blind Treatment Period||0
195779|NCT01336608|474239|P4|STARTED|24-week, Double-blind Treatment Period||135
195780|NCT01336608|474240|P3|STARTED|24-week, Double-blind Treatment Period||154
195781|NCT01336608|474241|P2|STARTED|24-week, Double-blind Treatment Period||141
195782|NCT01336608|474242|P1|STARTED|24-week, Double-blind Treatment Period||0
195783|NCT01336608|474239|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
195784|NCT01336608|474240|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
195785|NCT01336608|474241|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
195786|NCT01336608|474242|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||115
195787|NCT01336608|474239|P4|COMPLETED|2-week, Single-blind Run-In Period||0
195788|NCT01336608|474240|P3|COMPLETED|2-week, Single-blind Run-In Period||0
195789|NCT01336608|474241|P2|COMPLETED|2-week, Single-blind Run-In Period||0
195790|NCT01336608|474242|P1|COMPLETED|2-week, Single-blind Run-In Period||444
195791|NCT01336608|474239|P4|STARTED|2-week, Single-blind Run-In Period||0
195792|NCT01336608|474240|P3|STARTED|2-week, Single-blind Run-In Period||0
195793|NCT01336608|474241|P2|STARTED|2-week, Single-blind Run-In Period||0
195794|NCT01336608|474242|P1|STARTED|2-week, Single-blind Run-In Period||559
195795|NCT01336569|474256|P1|NOT COMPLETED|Overall Study||4
195796|NCT01336569|474256|P1|COMPLETED|Overall Study||45
195797|NCT01336569|474256|P1|STARTED|Overall Study||49
195798|NCT01336413|474262|P2|NOT COMPLETED|Overall Study||8
195799|NCT01336413|474263|P1|NOT COMPLETED|Overall Study||1
195800|NCT01336413|474262|P2|COMPLETED|Overall Study||18
195801|NCT01336413|474263|P1|COMPLETED|Overall Study||26
195802|NCT01336413|474262|P2|STARTED|Overall Study||26
195803|NCT01336413|474263|P1|STARTED|Overall Study||27
195804|NCT01336296|474287|P2|NOT COMPLETED|Overall Study||4
195805|NCT01336296|474288|P1|NOT COMPLETED|Overall Study||5
195806|NCT01336296|474287|P2|COMPLETED|Overall Study||17
195807|NCT01336296|474288|P1|COMPLETED|Overall Study||35
195808|NCT01336296|474287|P2|STARTED|Overall Study||21
195809|NCT01336296|474288|P1|STARTED|Overall Study||40
195810|NCT01336205|474304|P2|NOT COMPLETED|Overall Study||89
195811|NCT01336205|474305|P1|NOT COMPLETED|Overall Study||233
195812|NCT01336205|474304|P2|COMPLETED|Overall Study||192
195813|NCT01336205|474305|P1|COMPLETED|Overall Study||330
195814|NCT01336205|474304|P2|STARTED|Overall Study||281
195815|NCT01336205|474305|P1|STARTED|Overall Study||563
195816|NCT01336140|474317|P2|NOT COMPLETED|Overall Study||0
195817|NCT01336140|474318|P1|NOT COMPLETED|Overall Study||0
195818|NCT01336140|474317|P2|COMPLETED|Overall Study||150
195819|NCT01336140|474318|P1|COMPLETED|Overall Study||150
195820|NCT01336140|474317|P2|STARTED|Overall Study||150
195821|NCT01336140|474318|P1|STARTED|Overall Study||150
195822|NCT01336023|474333|P3|NOT COMPLETED|Week 27 to 52||28
195823|NCT01336023|474334|P2|NOT COMPLETED|Week 27 to 52||44
195824|NCT01336023|474335|P1|NOT COMPLETED|Week 27 to 52||28
195825|NCT01336023|474333|P3|COMPLETED|Week 27 to 52||285
195826|NCT01336023|474334|P2|COMPLETED|Week 27 to 52||621
195827|NCT01336023|474335|P1|COMPLETED|Week 27 to 52||305
195828|NCT01336023|474333|P3|STARTED|Week 27 to 52|From the main trial, 29 subjects were not enrolled in the extension (week 27-52).|313
195829|NCT01336023|474334|P2|STARTED|Week 27 to 52|From the main trial, 71 subjects were not enrolled in the extension (week 27-52).|665
195830|NCT01336023|474335|P1|STARTED|Week 27 to 52|From the main trial, 33 subjects were not enrolled in the extension (week 27-52).|333
195831|NCT01336023|474333|P3|NOT COMPLETED|Week 0 to Week 26||73
195832|NCT01336023|474334|P2|NOT COMPLETED|Week 0 to Week 26||98
195833|NCT01336023|474335|P1|NOT COMPLETED|Week 0 to Week 26||48
195834|NCT01336023|474333|P3|COMPLETED|Week 0 to Week 26||342
195835|NCT01336023|474334|P2|COMPLETED|Week 0 to Week 26||736
195836|NCT01336023|474335|P1|COMPLETED|Week 0 to Week 26||366
195837|NCT01336023|474333|P3|Exposed|Week 0 to Week 26|2 subjects withdrew before exposure to trial drug and were not included in the analysis|413
195838|NCT01336023|474334|P2|Exposed|Week 0 to Week 26|8 subjects withdrew before exposure to trial drug and were not included in the analysis|826
195839|NCT01336023|474335|P1|Exposed|Week 0 to Week 26|1 subject withdrew before exposure to trial drug and was not included in the analysis|413
195840|NCT01336023|474333|P3|STARTED|Week 0 to Week 26||415
195841|NCT01336023|474334|P2|STARTED|Week 0 to Week 26||834
195842|NCT01336023|474335|P1|STARTED|Week 0 to Week 26||414
195843|NCT01335997|474356|P2|NOT COMPLETED|Period III||79
195844|NCT01335997|474357|P1|NOT COMPLETED|Period III||78
195845|NCT01335997|474356|P2|COMPLETED|Period III||4
195846|NCT01335997|474357|P1|COMPLETED|Period III||6
195847|NCT01335997|474356|P2|STARTED|Period III||83
195848|NCT01335997|474357|P1|STARTED|Period III||84
195849|NCT01335997|474356|P2|NOT COMPLETED|Period I and II||479
195850|NCT01335997|474357|P1|NOT COMPLETED|Period I and II||493
195851|NCT01335997|474356|P2|COMPLETED|Period I and II||83
195852|NCT01335997|474357|P1|COMPLETED|Period I and II||84
195853|NCT01335997|474356|P2|STARTED|Period I and II||562
195854|NCT01335997|474357|P1|STARTED|Period I and II||577
195855|NCT01335971|474370|P3|NOT COMPLETED|Overall Study||1
195856|NCT01335971|474371|P2|NOT COMPLETED|Overall Study||1
195857|NCT01335971|474372|P1|NOT COMPLETED|Overall Study||2
195858|NCT01335971|474370|P3|COMPLETED|Overall Study||28
195859|NCT01335971|474371|P2|COMPLETED|Overall Study||28
195860|NCT01335971|474372|P1|COMPLETED|Overall Study||29
195861|NCT01335971|474370|P3|STARTED|Overall Study||29
195862|NCT01335971|474371|P2|STARTED|Overall Study||29
195863|NCT01335971|474372|P1|STARTED|Overall Study||31
195864|NCT01335932|474409|P2|NOT COMPLETED|Overall Study||4
195865|NCT01335932|474410|P1|NOT COMPLETED|Overall Study||0
195866|NCT01335932|474409|P2|COMPLETED|Overall Study||72
195867|NCT01335932|474410|P1|COMPLETED|Overall Study||84
195868|NCT01335932|474409|P2|STARTED|Overall Study||76
195869|NCT01335932|474410|P1|STARTED|Overall Study||84
195870|NCT01335867|474550|P2|NOT COMPLETED|Overall Study||4
195871|NCT01335867|474551|P1|NOT COMPLETED|Overall Study||7
195872|NCT01335867|474550|P2|COMPLETED|Overall Study||12
195873|NCT01335867|474551|P1|COMPLETED|Overall Study||9
195874|NCT01335867|474550|P2|STARTED|Overall Study||16
195875|NCT01335867|474551|P1|STARTED|Overall Study||16
195876|NCT01335789|474567|P2|NOT COMPLETED|Overall Study||0
195877|NCT01335789|474568|P1|NOT COMPLETED|Overall Study||0
195878|NCT01335789|474567|P2|COMPLETED|Overall Study||8
195879|NCT01335789|474568|P1|COMPLETED|Overall Study||8
195880|NCT01335789|474567|P2|STARTED|Overall Study||8
195881|NCT01335789|474568|P1|STARTED|Overall Study||8
195882|NCT01335750|474578|P1|NOT COMPLETED|Overall Study||0
195883|NCT01335750|474578|P1|COMPLETED|Overall Study||32
195884|NCT01335750|474578|P1|STARTED|Overall Study||32
195885|NCT01335724|474599|P2|NOT COMPLETED|Overall Study||0
195886|NCT01335724|474600|P1|NOT COMPLETED|Overall Study||0
195887|NCT01335724|474599|P2|COMPLETED|Overall Study||36
195888|NCT01335724|474600|P1|COMPLETED|Overall Study||36
195889|NCT01335724|474599|P2|STARTED|Overall Study||36
195890|NCT01335724|474600|P1|STARTED|Overall Study||36
195891|NCT01335698|474615|P5|NOT COMPLETED|Treatment Stage 2||1
195892|NCT01335698|474616|P4|NOT COMPLETED|Treatment Stage 2||8
195893|NCT01335698|474617|P3|NOT COMPLETED|Treatment Stage 2||5
195894|NCT01335698|474618|P2|NOT COMPLETED|Treatment Stage 2||3
195895|NCT01335698|474619|P1|NOT COMPLETED|Treatment Stage 2||11
195896|NCT01335698|474615|P5|COMPLETED|Treatment Stage 2||5
195897|NCT01335698|474616|P4|COMPLETED|Treatment Stage 2||18
195898|NCT01335698|474617|P3|COMPLETED|Treatment Stage 2||11
195899|NCT01335698|474618|P2|COMPLETED|Treatment Stage 2||1
195900|NCT01335698|474619|P1|COMPLETED|Treatment Stage 2||4
195901|NCT01335698|474615|P5|STARTED|Treatment Stage 2||6
195902|NCT01335698|474616|P4|STARTED|Treatment Stage 2||26
195903|NCT01335698|474617|P3|STARTED|Treatment Stage 2||16
195904|NCT01335698|474618|P2|STARTED|Treatment Stage 2||4
195905|NCT01335698|474619|P1|STARTED|Treatment Stage 2||15
195906|NCT01335698|474615|P5|NOT COMPLETED|Treatment Stage 1||2
195907|NCT01335698|474616|P4|NOT COMPLETED|Treatment Stage 1||9
195908|NCT01335698|474617|P3|NOT COMPLETED|Treatment Stage 1||5
195909|NCT01335698|474618|P2|NOT COMPLETED|Treatment Stage 1||8
195910|NCT01335698|474619|P1|NOT COMPLETED|Treatment Stage 1||8
195911|NCT01335698|474615|P5|COMPLETED|Treatment Stage 1||6
195912|NCT01335698|474616|P4|COMPLETED|Treatment Stage 1||26
195913|NCT01335698|474617|P3|COMPLETED|Treatment Stage 1||16
195914|NCT01335698|474618|P2|COMPLETED|Treatment Stage 1||4
195915|NCT01335698|474619|P1|COMPLETED|Treatment Stage 1||15
195916|NCT01335698|474615|P5|STARTED|Treatment Stage 1||8
195917|NCT01335698|474616|P4|STARTED|Treatment Stage 1||35
195918|NCT01335698|474617|P3|STARTED|Treatment Stage 1||21
195919|NCT01335698|474618|P2|STARTED|Treatment Stage 1||12
195920|NCT01335698|474619|P1|STARTED|Treatment Stage 1||23
195921|NCT01335685|474684|P8|NOT COMPLETED|Overall Study||3
195922|NCT01335685|474685|P7|NOT COMPLETED|Overall Study||2
195923|NCT01335685|474686|P6|NOT COMPLETED|Overall Study||5
195924|NCT01335685|474687|P5|NOT COMPLETED|Overall Study||0
195925|NCT01335685|474688|P4|NOT COMPLETED|Overall Study||11
195926|NCT01335685|474689|P3|NOT COMPLETED|Overall Study||2
195927|NCT01335685|474690|P2|NOT COMPLETED|Overall Study||1
195928|NCT01335685|474691|P1|NOT COMPLETED|Overall Study||3
195929|NCT01335685|474684|P8|COMPLETED|Overall Study||3
195930|NCT01335685|474685|P7|COMPLETED|Overall Study||2
195931|NCT01335685|474686|P6|COMPLETED|Overall Study||1
195932|NCT01335685|474687|P5|COMPLETED|Overall Study||5
195933|NCT01335685|474688|P4|COMPLETED|Overall Study||15
195934|NCT01335685|474689|P3|COMPLETED|Overall Study||1
195935|NCT01335685|474690|P2|COMPLETED|Overall Study||3
195936|NCT01335685|474691|P1|COMPLETED|Overall Study||4
195937|NCT01335685|474684|P8|STARTED|Overall Study||6
195938|NCT01335685|474685|P7|STARTED|Overall Study||4
195939|NCT01335685|474686|P6|STARTED|Overall Study||6
195940|NCT01335685|474687|P5|STARTED|Overall Study||5
195941|NCT01335685|474688|P4|STARTED|Overall Study||26
195942|NCT01335685|474689|P3|STARTED|Overall Study||3
195943|NCT01335685|474690|P2|STARTED|Overall Study||4
195944|NCT01335685|474691|P1|STARTED|Overall Study||7
195945|NCT01335620|474793|P1|NOT COMPLETED|Overall Study||0
195946|NCT01335620|474793|P1|COMPLETED|Overall Study||19
195947|NCT01335620|474793|P1|STARTED|Overall Study||19
195948|NCT01335542|474802|P2|NOT COMPLETED|Overall Study||0
195949|NCT01335542|474803|P1|NOT COMPLETED|Overall Study||0
195950|NCT01335542|474802|P2|COMPLETED|Overall Study||45
195951|NCT01335542|474803|P1|COMPLETED|Overall Study||45
195952|NCT01335542|474802|P2|STARTED|Overall Study||45
195953|NCT01335542|474803|P1|STARTED|Overall Study||45
195954|NCT01335477|474811|P2|NOT COMPLETED|Overall Study||59
195955|NCT01335477|474812|P1|NOT COMPLETED|Overall Study||41
195956|NCT01335477|474811|P2|COMPLETED|Overall Study||272
195957|NCT01335477|474812|P1|COMPLETED|Overall Study||179
195958|NCT01335477|474811|P2|STARTED|Overall Study||331
195959|NCT01335477|474812|P1|STARTED|Overall Study||220
195960|NCT01335464|474876|P2|NOT COMPLETED|Overall Study||49
195961|NCT01335464|474877|P1|NOT COMPLETED|Overall Study||32
195962|NCT01335464|474876|P2|COMPLETED|Overall Study||260
195963|NCT01335464|474877|P1|COMPLETED|Overall Study||174
195964|NCT01335464|474876|P2|STARTED|Overall Study||309
195965|NCT01335464|474877|P1|STARTED|Overall Study||206
195966|NCT01335308|474942|P3|NOT COMPLETED|Overall Study||81
195967|NCT01335308|474943|P2|NOT COMPLETED|Overall Study||67
195968|NCT01335308|474944|P1|NOT COMPLETED|Overall Study||40
195969|NCT01335308|474942|P3|COMPLETED|Overall Study||154
195970|NCT01335308|474943|P2|COMPLETED|Overall Study||145
195971|NCT01335308|474944|P1|COMPLETED|Overall Study||158
195972|NCT01335308|474942|P3|STARTED|Overall Study||235
195973|NCT01335308|474943|P2|STARTED|Overall Study||212
195974|NCT01335308|474944|P1|STARTED|Overall Study||198
195975|NCT01335230|474965|P4|NOT COMPLETED|Overall Study||0
195976|NCT01335230|474966|P3|NOT COMPLETED|Overall Study||0
195977|NCT01335230|474967|P2|NOT COMPLETED|Overall Study||0
195978|NCT01335230|474968|P1|NOT COMPLETED|Overall Study||0
195979|NCT01335230|474965|P4|COMPLETED|Overall Study|subjects|10
195980|NCT01335230|474966|P3|COMPLETED|Overall Study|subjects|10
195981|NCT01335230|474967|P2|COMPLETED|Overall Study|subjects|10
195982|NCT01335230|474968|P1|COMPLETED|Overall Study|subjects|10
195983|NCT01335230|474965|P4|STARTED|Overall Study|subjects|10
195984|NCT01335230|474966|P3|STARTED|Overall Study|subjects|10
195985|NCT01335230|474967|P2|STARTED|Overall Study|subjects|10
195986|NCT01335230|474968|P1|STARTED|Overall Study|subjects|10
195987|NCT01335204|474978|P1|NOT COMPLETED|Overall Study||0
195988|NCT01335204|474978|P1|COMPLETED|Overall Study||4
195989|NCT01335204|474978|P1|STARTED|Overall Study||4
195990|NCT01335191|474989|P2|NOT COMPLETED|Overall Study||0
195991|NCT01335191|474990|P1|NOT COMPLETED|Overall Study||0
195992|NCT01335191|474989|P2|COMPLETED|Overall Study||11
195993|NCT01335191|474990|P1|COMPLETED|Overall Study||16
195994|NCT01335191|474989|P2|STARTED|Overall Study||11
195995|NCT01335191|474990|P1|STARTED|Overall Study||16
195996|NCT01335061|474996|P1|NOT COMPLETED|Overall Study||0
195997|NCT01335061|474996|P1|COMPLETED|Overall Study||25
195998|NCT01335061|474996|P1|STARTED|Overall Study||25
195999|NCT01334957|475011|P1|NOT COMPLETED|Overall Study||0
196000|NCT01334957|475011|P1|COMPLETED|Overall Study||300
196001|NCT01334957|475011|P1|Received Multiple Doses|Overall Study||48
196002|NCT01334957|475011|P1|Received Single Dose|Overall Study||252
196003|NCT01334957|475011|P1|STARTED|Overall Study||300
196004|NCT01334944|475019|P2|NOT COMPLETED|Overall Study||0
196005|NCT01334944|475020|P1|NOT COMPLETED|Overall Study||0
196006|NCT01334944|475019|P2|COMPLETED|Overall Study||139
196007|NCT01334944|475020|P1|COMPLETED|Overall Study||11
196008|NCT01334944|475019|P2|Received Multiple Doses|Overall Study||43
196009|NCT01334944|475020|P1|Received Multiple Doses|Overall Study||10
196010|NCT01334944|475019|P2|Received Singel Dose|Overall Study||96
196011|NCT01334944|475020|P1|Received Singel Dose|Overall Study||1
196012|NCT01334944|475019|P2|STARTED|Overall Study||139
196013|NCT01334944|475020|P1|STARTED|Overall Study||11
196014|NCT01334918|475046|P2|NOT COMPLETED|Overall Study||1
196015|NCT01334918|475047|P1|NOT COMPLETED|Overall Study||8
196016|NCT01334918|475046|P2|COMPLETED|Overall Study||60
196017|NCT01334918|475047|P1|COMPLETED|Overall Study||55
196018|NCT01334918|475046|P2|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|61
196019|NCT01334918|475047|P1|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|57
196020|NCT01334918|475046|P2|STARTED|Overall Study||61
196021|NCT01334918|475047|P1|STARTED|Overall Study||63
196022|NCT01334866|475073|P1|NOT COMPLETED|Overall Study||19
196023|NCT01334866|475073|P1|COMPLETED|Overall Study||72
196024|NCT01334866|475073|P1|STARTED|Overall Study|91 subjects were enrolled in the study; with 89 subjects receiving the study treatment.|91
196025|NCT01334723|475083|P2|NOT COMPLETED|Overall Study||0
196026|NCT01334723|475084|P1|NOT COMPLETED|Overall Study||0
196027|NCT01334723|475083|P2|COMPLETED|Overall Study||17739
196028|NCT01334723|475084|P1|COMPLETED|Overall Study||17293
196029|NCT01334723|475083|P2|STARTED|Overall Study||17739
196030|NCT01334723|475084|P1|STARTED|Overall Study||17293
196031|NCT01334710|475110|P1|NOT COMPLETED|Overall Study||3
196032|NCT01334710|475110|P1|COMPLETED|Overall Study|Due to safety signals in a parallel trial ON OSI906 in hepatocellular cancer the trial was stopped.|0
196033|NCT01334710|475110|P1|STARTED|Overall Study||3
196034|NCT01334606|475115|P1|NOT COMPLETED|Overall Study||18
196035|NCT01334606|475115|P1|COMPLETED|Overall Study||3
196036|NCT01334606|475115|P1|STARTED|Overall Study||21
196037|NCT01334554|475123|P2|NOT COMPLETED|Overall Study||2
196038|NCT01334554|475124|P1|NOT COMPLETED|Overall Study||4
196039|NCT01334554|475123|P2|COMPLETED|Overall Study||21
196040|NCT01334554|475124|P1|COMPLETED|Overall Study||19
196041|NCT01334554|475123|P2|STARTED|Overall Study||23
196042|NCT01334554|475124|P1|STARTED|Overall Study||23
196043|NCT01334515|475134|P2|NOT COMPLETED|Overall Study||29
196044|NCT01334515|475135|P1|NOT COMPLETED|Overall Study||12
196045|NCT01334515|475134|P2|COMPLETED|Overall Study||7
196046|NCT01334515|475135|P1|COMPLETED|Overall Study||4
196047|NCT01334515|475134|P2|STARTED|Overall Study||36
196048|NCT01334515|475135|P1|STARTED|Overall Study||16
196049|NCT01334229|475145|P2|NOT COMPLETED|Overall Study||0
196050|NCT01334229|475146|P1|NOT COMPLETED|Overall Study||0
196051|NCT01334229|475145|P2|COMPLETED|Overall Study||11
196052|NCT01334229|475146|P1|COMPLETED|Overall Study||11
196053|NCT01334229|475145|P2|STARTED|Overall Study||11
196054|NCT01334229|475146|P1|STARTED|Overall Study||11
196055|NCT01334216|475164|P2|NOT COMPLETED|Overall Study||0
196056|NCT01334216|475165|P1|NOT COMPLETED|Overall Study||0
196057|NCT01334216|475164|P2|COMPLETED|Overall Study||194
196058|NCT01334216|475165|P1|COMPLETED|Overall Study||168
196059|NCT01334216|475164|P2|STARTED|Overall Study||194
196060|NCT01334216|475165|P1|STARTED|Overall Study||168
196061|NCT01334125|475173|P2|NOT COMPLETED|Overall Study||3
196062|NCT01334125|475174|P1|NOT COMPLETED|Overall Study||3
196063|NCT01334125|475173|P2|COMPLETED|Overall Study|3 subjects left for college and moved out of the area|10
196064|NCT01334125|475174|P1|COMPLETED|Overall Study|3 subjects move to another city|12
196065|NCT01334125|475173|P2|STARTED|Overall Study||13
196066|NCT01334125|475174|P1|STARTED|Overall Study||15
196067|NCT01333956|475190|P4|NOT COMPLETED|Overall Study||2
196068|NCT01333956|475191|P3|NOT COMPLETED|Overall Study||1
196069|NCT01333956|475192|P2|NOT COMPLETED|Overall Study||4
196070|NCT01333956|475193|P1|NOT COMPLETED|Overall Study||2
196071|NCT01333956|475190|P4|COMPLETED|Overall Study||28
196072|NCT01333956|475191|P3|COMPLETED|Overall Study||29
196073|NCT01333956|475192|P2|COMPLETED|Overall Study||26
196074|NCT01333956|475193|P1|COMPLETED|Overall Study||28
196075|NCT01333956|475190|P4|STARTED|Overall Study||30
196076|NCT01333956|475191|P3|STARTED|Overall Study||30
196077|NCT01333956|475192|P2|STARTED|Overall Study||30
196078|NCT01333956|475193|P1|STARTED|Overall Study||30
196079|NCT01333943|475229|P2|NOT COMPLETED|Overall Study||0
196080|NCT01333943|475230|P1|NOT COMPLETED|Overall Study||1
196081|NCT01333943|475229|P2|COMPLETED|Overall Study||47
196082|NCT01333943|475230|P1|COMPLETED|Overall Study||46
196083|NCT01333943|475229|P2|STARTED|Overall Study||47
196084|NCT01333943|475230|P1|STARTED|Overall Study||47
196085|NCT01333865|475246|P1|NOT COMPLETED|Overall Study||2
196086|NCT01333865|475246|P1|COMPLETED|Overall Study|2 participants were withdrawn. One was still analyzed, but one was withdrawn too early for analysis|17
196087|NCT01333865|475246|P1|STARTED|Overall Study|25 participants signed consent, but only 19 completed screening and were analyzed at baseline.|19
196088|NCT01333813|475251|P1|NOT COMPLETED|Overall Study||0
196089|NCT01333813|475251|P1|COMPLETED|Overall Study||297
196090|NCT01333813|475251|P1|STARTED|Overall Study||297
196091|NCT01333722|475266|P2|NOT COMPLETED|Overall Study||3
196092|NCT01333722|475267|P1|NOT COMPLETED|Overall Study||0
196093|NCT01333722|475266|P2|COMPLETED|Overall Study||46
196094|NCT01333722|475267|P1|COMPLETED|Overall Study||51
196095|NCT01333722|475266|P2|STARTED|Overall Study||49
196096|NCT01333722|475267|P1|STARTED|Overall Study||51
196097|NCT01333592|475281|P2|NOT COMPLETED|Overall Study||17
196098|NCT01333592|475282|P1|NOT COMPLETED|Overall Study||9
196099|NCT01333592|475281|P2|COMPLETED|Overall Study||52
196100|NCT01333592|475282|P1|COMPLETED|Overall Study||58
196101|NCT01333592|475281|P2|STARTED|Overall Study||69
196102|NCT01333592|475282|P1|STARTED|Overall Study||67
196103|NCT01333501|475292|P2|NOT COMPLETED|Overall Study||21
196104|NCT01333501|475293|P1|NOT COMPLETED|Overall Study||9
196105|NCT01333501|475292|P2|COMPLETED|Overall Study||30
196106|NCT01333501|475293|P1|COMPLETED|Overall Study||97
196107|NCT01333501|475292|P2|Safety Population|Overall Study||47
196108|NCT01333501|475293|P1|Safety Population|Overall Study||104
196109|NCT01333501|475292|P2|Full Analysis Set (FAS)|Overall Study||28
196110|NCT01333501|475293|P1|Full Analysis Set (FAS)|Overall Study||80
196111|NCT01333501|475292|P2|STARTED|Overall Study||51
196112|NCT01333501|475293|P1|STARTED|Overall Study||106
196113|NCT01333488|475342|P3|NOT COMPLETED|Overall Study||0
196114|NCT01333488|475343|P2|NOT COMPLETED|Overall Study||0
196115|NCT01333488|475344|P1|NOT COMPLETED|Overall Study||0
196116|NCT01333488|475342|P3|COMPLETED|Overall Study||3
196117|NCT01333488|475343|P2|COMPLETED|Overall Study||1
196118|NCT01333488|475344|P1|COMPLETED|Overall Study||2
196119|NCT01333488|475342|P3|STARTED|Overall Study||3
196120|NCT01333488|475343|P2|STARTED|Overall Study||1
196121|NCT01333488|475344|P1|STARTED|Overall Study||2
196122|NCT01333475|475360|P2|NOT COMPLETED|Overall Study||3
196123|NCT01333475|475361|P1|NOT COMPLETED|Overall Study||2
196124|NCT01333475|475360|P2|COMPLETED|Overall Study||6
196125|NCT01333475|475361|P1|COMPLETED|Overall Study||10
196126|NCT01333475|475360|P2|STARTED|Overall Study||9
196127|NCT01333475|475361|P1|STARTED|Overall Study||12
196128|NCT01333436|475371|P2|NOT COMPLETED|Overall Study||0
196129|NCT01333436|475372|P1|NOT COMPLETED|Overall Study||0
196130|NCT01333436|475371|P2|COMPLETED|Overall Study||50
196131|NCT01333436|475372|P1|COMPLETED|Overall Study||43
196132|NCT01333436|475371|P2|STARTED|Overall Study||50
196133|NCT01333436|475372|P1|STARTED|Overall Study||43
196134|NCT01333397|475387|P5|NOT COMPLETED|Overall Study||0
196135|NCT01333397|475388|P4|NOT COMPLETED|Overall Study||1
196136|NCT01333397|475389|P3|NOT COMPLETED|Overall Study||0
196137|NCT01333397|475390|P2|NOT COMPLETED|Overall Study||0
196138|NCT01333397|475391|P1|NOT COMPLETED|Overall Study||1
196139|NCT01333397|475387|P5|COMPLETED|Overall Study||35
196140|NCT01333397|475388|P4|COMPLETED|Overall Study||34
196141|NCT01333397|475389|P3|COMPLETED|Overall Study||35
196142|NCT01333397|475390|P2|COMPLETED|Overall Study||36
196143|NCT01333397|475391|P1|COMPLETED|Overall Study||34
196144|NCT01333397|475387|P5|STARTED|Overall Study||35
196145|NCT01333397|475388|P4|STARTED|Overall Study||35
196146|NCT01333397|475389|P3|STARTED|Overall Study||35
196147|NCT01333397|475390|P2|STARTED|Overall Study||36
196148|NCT01333397|475391|P1|STARTED|Overall Study||35
196149|NCT01333189|475465|P2|NOT COMPLETED|Overall Study||2
196150|NCT01333189|475466|P1|NOT COMPLETED|Overall Study||2
196151|NCT01333189|475465|P2|COMPLETED|Overall Study||11
196152|NCT01333189|475466|P1|COMPLETED|Overall Study||11
196153|NCT01333189|475465|P2|STARTED|Overall Study||13
196154|NCT01333189|475466|P1|STARTED|Overall Study||13
196155|NCT01333111|475497|P3|NOT COMPLETED|Overall Study||2
196156|NCT01333111|475498|P2|NOT COMPLETED|Overall Study||3
196157|NCT01333111|475499|P1|NOT COMPLETED|Overall Study||2
196158|NCT01333111|475497|P3|COMPLETED|Overall Study||13
196159|NCT01333111|475498|P2|COMPLETED|Overall Study||26
196160|NCT01333111|475499|P1|COMPLETED|Overall Study||28
196161|NCT01333111|475497|P3|STARTED|Overall Study||15
196162|NCT01333111|475498|P2|STARTED|Overall Study||29
196163|NCT01333111|475499|P1|STARTED|Overall Study||30
196164|NCT01333098|475523|P1|NOT COMPLETED|Overall Study||3
196165|NCT01333098|475523|P1|COMPLETED|Overall Study||12
196166|NCT01333098|475523|P1|STARTED|Overall Study||15
196167|NCT01333072|475534|P2|NOT COMPLETED|Overall Study||4
196168|NCT01333072|475535|P1|NOT COMPLETED|Overall Study||6
196169|NCT01333072|475534|P2|COMPLETED|Overall Study||27
196170|NCT01333072|475535|P1|COMPLETED|Overall Study||24
196171|NCT01333072|475534|P2|STARTED|Overall Study||31
196172|NCT01333072|475535|P1|STARTED|Overall Study||30
196173|NCT01333059|475543|P2|NOT COMPLETED|Overall Study||3
196174|NCT01333059|475544|P1|NOT COMPLETED|Overall Study||6
196175|NCT01333059|475543|P2|COMPLETED|Overall Study||8
196176|NCT01333059|475544|P1|COMPLETED|Overall Study||8
196177|NCT01333059|475543|P2|STARTED|Overall Study||11
196178|NCT01333059|475544|P1|STARTED|Overall Study||14
196179|NCT01332994|475554|P1|NOT COMPLETED|Overall Study||71
196180|NCT01332994|475554|P1|COMPLETED|Overall Study||448
196181|NCT01332994|475554|P1|Completed Week 66 (TCZ/RTX)|Overall Study||25
196182|NCT01332994|475554|P1|Completed Week 32 (TCZ/RTX)|Overall Study||26
196183|NCT01332994|475554|P1|Completed Week 32 (TCZ/TCZ)|Overall Study||200
196184|NCT01332994|475554|P1|Completed Week 16|Overall Study||463
196185|NCT01332994|475554|P1|STARTED|Overall Study||519
196186|NCT01332981|475610|P1|NOT COMPLETED|Overall Study||0
196187|NCT01332981|475610|P1|COMPLETED|Overall Study||220
196188|NCT01332981|475610|P1|STARTED|Overall Study||220
196189|NCT01332968|475623|P8|NOT COMPLETED|Follow-Up Period||531
196190|NCT01332968|475624|P7|NOT COMPLETED|Follow-Up Period||542
196191|NCT01332968|475625|P6|NOT COMPLETED|Follow-Up Period||0
196192|NCT01332968|475626|P5|NOT COMPLETED|Follow-Up Period||0
196193|NCT01332968|475627|P4|NOT COMPLETED|Follow-Up Period||0
196194|NCT01332968|475628|P3|NOT COMPLETED|Follow-Up Period||0
196195|NCT01332968|475629|P2|NOT COMPLETED|Follow-Up Period||0
196196|NCT01332968|475630|P1|NOT COMPLETED|Follow-Up Period||0
196197|NCT01332968|475623|P8|COMPLETED|Follow-Up Period||0
196198|NCT01332968|475624|P7|COMPLETED|Follow-Up Period||0
196199|NCT01332968|475625|P6|COMPLETED|Follow-Up Period||0
196200|NCT01332968|475626|P5|COMPLETED|Follow-Up Period||0
196201|NCT01332968|475627|P4|COMPLETED|Follow-Up Period||0
196202|NCT01332968|475628|P3|COMPLETED|Follow-Up Period||0
196203|NCT01332968|475629|P2|COMPLETED|Follow-Up Period||0
196204|NCT01332968|475630|P1|COMPLETED|Follow-Up Period||0
196205|NCT01332968|475623|P8|STARTED|Follow-Up Period||531
196206|NCT01332968|475624|P7|STARTED|Follow-Up Period||542
196207|NCT01332968|475625|P6|STARTED|Follow-Up Period||0
196208|NCT01332968|475626|P5|STARTED|Follow-Up Period||0
196209|NCT01332968|475627|P4|STARTED|Follow-Up Period||0
196210|NCT01332968|475628|P3|STARTED|Follow-Up Period||0
196211|NCT01332968|475629|P2|STARTED|Follow-Up Period||0
196212|NCT01332968|475630|P1|STARTED|Follow-Up Period||0
196213|NCT01332968|475623|P8|NOT COMPLETED|Maintenance/Observation Period||0
196214|NCT01332968|475624|P7|NOT COMPLETED|Maintenance/Observation Period||0
196215|NCT01332968|475625|P6|NOT COMPLETED|Maintenance/Observation Period||9
196216|NCT01332968|475626|P5|NOT COMPLETED|Maintenance/Observation Period||10
196217|NCT01332968|475627|P4|NOT COMPLETED|Maintenance/Observation Period||207
196218|NCT01332968|475628|P3|NOT COMPLETED|Maintenance/Observation Period||213
196219|NCT01332968|475629|P2|NOT COMPLETED|Maintenance/Observation Period||0
196220|NCT01332968|475630|P1|NOT COMPLETED|Maintenance/Observation Period||0
196221|NCT01332968|475623|P8|COMPLETED|Maintenance/Observation Period||0
196222|NCT01332968|475624|P7|COMPLETED|Maintenance/Observation Period||0
196223|NCT01332968|475625|P6|COMPLETED|Maintenance/Observation Period||2
196224|NCT01332968|475626|P5|COMPLETED|Maintenance/Observation Period||2
196225|NCT01332968|475627|P4|COMPLETED|Maintenance/Observation Period||417
196226|NCT01332968|475628|P3|COMPLETED|Maintenance/Observation Period||399
196227|NCT01332968|475629|P2|COMPLETED|Maintenance/Observation Period||0
196228|NCT01332968|475630|P1|COMPLETED|Maintenance/Observation Period||0
196229|NCT01332968|475623|P8|STARTED|Maintenance/Observation Period||0
196230|NCT01332968|475624|P7|STARTED|Maintenance/Observation Period||0
196231|NCT01332968|475625|P6|STARTED|Maintenance/Observation Period||11
196232|NCT01332968|475626|P5|STARTED|Maintenance/Observation Period||12
196233|NCT01332968|475627|P4|STARTED|Maintenance/Observation Period||624
196234|NCT01332968|475628|P3|STARTED|Maintenance/Observation Period||612
196235|NCT01332968|475629|P2|STARTED|Maintenance/Observation Period||0
196236|NCT01332968|475630|P1|STARTED|Maintenance/Observation Period||0
196237|NCT01332968|475623|P8|NOT COMPLETED|Induction Period||0
196238|NCT01332968|475624|P7|NOT COMPLETED|Induction Period||0
196239|NCT01332968|475625|P6|NOT COMPLETED|Induction Period||0
196240|NCT01332968|475626|P5|NOT COMPLETED|Induction Period||0
196241|NCT01332968|475627|P4|NOT COMPLETED|Induction Period||0
196242|NCT01332968|475628|P3|NOT COMPLETED|Induction Period||0
196243|NCT01332968|475629|P2|NOT COMPLETED|Induction Period||56
196244|NCT01332968|475630|P1|NOT COMPLETED|Induction Period||58
196245|NCT01332968|475623|P8|COMPLETED|Induction Period||0
196246|NCT01332968|475624|P7|COMPLETED|Induction Period||0
196247|NCT01332968|475625|P6|COMPLETED|Induction Period||0
196248|NCT01332968|475626|P5|COMPLETED|Induction Period||0
196249|NCT01332968|475627|P4|COMPLETED|Induction Period||0
196250|NCT01332968|475628|P3|COMPLETED|Induction Period||0
196251|NCT01332968|475629|P2|COMPLETED|Induction Period||646
196252|NCT01332968|475630|P1|COMPLETED|Induction Period||641
196253|NCT01332968|475623|P8|STARTED|Induction Period||0
196254|NCT01332968|475624|P7|STARTED|Induction Period||0
196255|NCT01332968|475625|P6|STARTED|Induction Period||0
196256|NCT01332968|475626|P5|STARTED|Induction Period||0
196257|NCT01332968|475627|P4|STARTED|Induction Period||0
196258|NCT01332968|475628|P3|STARTED|Induction Period||0
196259|NCT01332968|475629|P2|STARTED|Induction Period||702
196260|NCT01332968|475630|P1|STARTED|Induction Period||699
196261|NCT01332851|475696|P2|NOT COMPLETED|Overall Study||13
196262|NCT01332851|475697|P1|NOT COMPLETED|Overall Study||11
196263|NCT01332851|475696|P2|COMPLETED|Overall Study||110
196264|NCT01332851|475697|P1|COMPLETED|Overall Study||113
196265|NCT01332851|475696|P2|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|110
196266|NCT01332851|475697|P1|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|113
196267|NCT01332851|475696|P2|Completed Follow up 2|Overall Study|Includes 4 new caregivers enrolled due to initial parent no longer parenting|111
196268|NCT01332851|475697|P1|Completed Follow up 2|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|111
196269|NCT01332851|475696|P2|Completed Follow up 1|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|112
196270|NCT01332851|475697|P1|Completed Follow up 1|Overall Study||116
196271|NCT01332851|475696|P2|Completed Intervention|Overall Study|4 no intervention, 9 <full dose, 110 full dose; 4 new caregivers enrolled-initial parent dropped out|110
196272|NCT01332851|475697|P1|Completed Intervention|Overall Study|9 no intervention, 8 <full dose, 107 full dose; 3 new caregivers enrolled-initial parent dropped out|107
196273|NCT01332851|475696|P2|STARTED|Overall Study||123
196274|NCT01332851|475697|P1|STARTED|Overall Study||124
196275|NCT01332799|475731|P2|NOT COMPLETED|Overall Study||10
196276|NCT01332799|475732|P1|NOT COMPLETED|Overall Study||10
196277|NCT01332799|475731|P2|COMPLETED|Overall Study||0
196278|NCT01332799|475732|P1|COMPLETED|Overall Study||0
196279|NCT01332799|475731|P2|STARTED|Overall Study||10
196280|NCT01332799|475732|P1|STARTED|Overall Study||10
196281|NCT01332721|475742|P1|NOT COMPLETED|Overall Study||0
196282|NCT01332721|475742|P1|COMPLETED|Overall Study||38
196283|NCT01332721|475742|P1|STARTED|Overall Study||38
196284|NCT01332630|475748|P1|NOT COMPLETED|Overall Study||3
196285|NCT01332630|475748|P1|COMPLETED|Overall Study||21
196286|NCT01332630|475748|P1|STARTED|Overall Study||24
196287|NCT01332578|475752|P2|NOT COMPLETED|Period II||0
196288|NCT01332578|475753|P1|NOT COMPLETED|Period II||0
196289|NCT01332578|475752|P2|COMPLETED|Period II||13
196290|NCT01332578|475753|P1|COMPLETED|Period II||12
196291|NCT01332578|475752|P2|STARTED|Period II||13
196292|NCT01332578|475753|P1|STARTED|Period II||12
196293|NCT01332578|475752|P2|NOT COMPLETED|Washout Period||0
196294|NCT01332578|475753|P1|NOT COMPLETED|Washout Period||0
196295|NCT01332578|475752|P2|COMPLETED|Washout Period||13
196296|NCT01332578|475753|P1|COMPLETED|Washout Period||12
196297|NCT01332578|475752|P2|STARTED|Washout Period||13
196298|NCT01332578|475753|P1|STARTED|Washout Period||12
196299|NCT01332578|475752|P2|NOT COMPLETED|Period I||0
196300|NCT01332578|475753|P1|NOT COMPLETED|Period I||0
196301|NCT01332578|475752|P2|COMPLETED|Period I||13
196302|NCT01332578|475753|P1|COMPLETED|Period I||12
196303|NCT01332578|475752|P2|STARTED|Period I||13
196304|NCT01332578|475753|P1|STARTED|Period I||12
196305|NCT01332500|475776|P4|NOT COMPLETED|Overall Study||0
196306|NCT01332500|475777|P3|NOT COMPLETED|Overall Study||0
196307|NCT01332500|475778|P2|NOT COMPLETED|Overall Study||0
196308|NCT01332500|475779|P1|NOT COMPLETED|Overall Study||0
196309|NCT01332500|475776|P4|COMPLETED|Overall Study||5806
196310|NCT01332500|475777|P3|COMPLETED|Overall Study||2903
196311|NCT01332500|475778|P2|COMPLETED|Overall Study||39771
196312|NCT01332500|475779|P1|COMPLETED|Overall Study||13257
196313|NCT01332500|475776|P4|STARTED|Overall Study||5806
196314|NCT01332500|475777|P3|STARTED|Overall Study||2903
196315|NCT01332500|475778|P2|STARTED|Overall Study||39771
196316|NCT01332500|475779|P1|STARTED|Overall Study||13257
196317|NCT01332487|475799|P2|NOT COMPLETED|Overall Study||0
196318|NCT01332487|475800|P1|NOT COMPLETED|Overall Study||0
196319|NCT01332487|475799|P2|COMPLETED|Overall Study||3063
196320|NCT01332487|475800|P1|COMPLETED|Overall Study||5554
196321|NCT01332487|475799|P2|STARTED|Overall Study||3063
196322|NCT01332487|475800|P1|STARTED|Overall Study||5554
196323|NCT01332461|475810|P2|NOT COMPLETED|Overall Study||0
196324|NCT01332461|475811|P1|NOT COMPLETED|Overall Study||0
196325|NCT01332461|475810|P2|COMPLETED|Overall Study||4386
196326|NCT01332461|475811|P1|COMPLETED|Overall Study||1291
196327|NCT01332461|475810|P2|STARTED|Overall Study||4386
196328|NCT01332461|475811|P1|STARTED|Overall Study||1291
196329|NCT01332435|475825|P4|NOT COMPLETED|Overall Study||0
196330|NCT01332435|475826|P3|NOT COMPLETED|Overall Study||0
196331|NCT01332435|475827|P2|NOT COMPLETED|Overall Study||0
196332|NCT01332435|475828|P1|NOT COMPLETED|Overall Study||0
196333|NCT01332435|475825|P4|COMPLETED|Overall Study||1656
196334|NCT01332435|475826|P3|COMPLETED|Overall Study||2604
196335|NCT01332435|475827|P2|COMPLETED|Overall Study||1064
196336|NCT01332435|475828|P1|COMPLETED|Overall Study||1572
196337|NCT01332435|475825|P4|STARTED|Overall Study||1656
196338|NCT01332435|475826|P3|STARTED|Overall Study||2604
196339|NCT01332435|475827|P2|STARTED|Overall Study||1064
196340|NCT01332435|475828|P1|STARTED|Overall Study||1572
196341|NCT01332357|475858|P1|NOT COMPLETED|Overall Study||0
196342|NCT01332357|475858|P1|COMPLETED|Overall Study||6139
196343|NCT01332357|475858|P1|STARTED|Overall Study||6139
196344|NCT01332331|475864|P2|NOT COMPLETED|Overall Study||2
196345|NCT01332331|475865|P1|NOT COMPLETED|Overall Study||2
196346|NCT01332331|475864|P2|COMPLETED|Overall Study||18
196347|NCT01332331|475865|P1|COMPLETED|Overall Study||19
196348|NCT01332331|475864|P2|STARTED|Overall Study||20
196349|NCT01332331|475865|P1|STARTED|Overall Study||21
196350|NCT01332318|475917|P4|NOT COMPLETED|Overall Study||2
196351|NCT01332318|475918|P3|NOT COMPLETED|Overall Study||1
196352|NCT01332318|475919|P2|NOT COMPLETED|Overall Study||4
196353|NCT01332318|475920|P1|NOT COMPLETED|Overall Study||2
196354|NCT01332318|475917|P4|COMPLETED|Overall Study||28
196355|NCT01332318|475918|P3|COMPLETED|Overall Study||33
196356|NCT01332318|475919|P2|COMPLETED|Overall Study||28
196357|NCT01332318|475920|P1|COMPLETED|Overall Study||32
196358|NCT01332318|475917|P4|STARTED|Overall Study||30
196359|NCT01332318|475918|P3|STARTED|Overall Study||34
196360|NCT01332318|475919|P2|STARTED|Overall Study||32
196361|NCT01332318|475920|P1|STARTED|Overall Study||34
196362|NCT01332305|476031|P5|NOT COMPLETED|Overall Study||12
196363|NCT01332305|476032|P4|NOT COMPLETED|Overall Study||8
196364|NCT01332305|476033|P3|NOT COMPLETED|Overall Study||14
196365|NCT01332305|476034|P2|NOT COMPLETED|Overall Study||14
196366|NCT01332305|476035|P1|NOT COMPLETED|Overall Study||10
196367|NCT01332305|476031|P5|COMPLETED|Overall Study||33
196368|NCT01332305|476032|P4|COMPLETED|Overall Study||30
196369|NCT01332305|476033|P3|COMPLETED|Overall Study||31
196370|NCT01332305|476034|P2|COMPLETED|Overall Study||34
196371|NCT01332305|476035|P1|COMPLETED|Overall Study||31
196372|NCT01332305|476031|P5|STARTED|Overall Study||45
196373|NCT01332305|476032|P4|STARTED|Overall Study||38
196374|NCT01332305|476033|P3|STARTED|Overall Study||45
196375|NCT01332305|476034|P2|STARTED|Overall Study||48
196376|NCT01332305|476035|P1|STARTED|Overall Study||41
196377|NCT01332292|476057|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
196378|NCT01332292|476058|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||1
196379|NCT01332292|476057|P2|COMPLETED|Treatment Period 2 (14 Days)||11
196380|NCT01332292|476058|P1|COMPLETED|Treatment Period 2 (14 Days)||11
196381|NCT01332292|476057|P2|STARTED|Treatment Period 2 (14 Days)||12
196382|NCT01332292|476058|P1|STARTED|Treatment Period 2 (14 Days)||12
196383|NCT01332292|476057|P2|NOT COMPLETED|Washout Period (>=7 Days)||0
196384|NCT01332292|476058|P1|NOT COMPLETED|Washout Period (>=7 Days)||0
196385|NCT01332292|476057|P2|COMPLETED|Washout Period (>=7 Days)||12
196386|NCT01332292|476058|P1|COMPLETED|Washout Period (>=7 Days)||12
196387|NCT01332292|476057|P2|STARTED|Washout Period (>=7 Days)||12
196388|NCT01332292|476058|P1|STARTED|Washout Period (>=7 Days)||12
196389|NCT01332292|476057|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
196390|NCT01332292|476058|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
196391|NCT01332292|476057|P2|COMPLETED|Treatment Period 1 (14 Days)||12
196392|NCT01332292|476058|P1|COMPLETED|Treatment Period 1 (14 Days)||12
196393|NCT01332292|476057|P2|STARTED|Treatment Period 1 (14 Days)||13
196394|NCT01332292|476058|P1|STARTED|Treatment Period 1 (14 Days)||14
196395|NCT01332253|476120|P2|NOT COMPLETED|Overall Study||0
196396|NCT01332253|476121|P1|NOT COMPLETED|Overall Study||0
196397|NCT01332253|476120|P2|COMPLETED|Overall Study||79
196398|NCT01332253|476121|P1|COMPLETED|Overall Study||82
196399|NCT01332253|476120|P2|STARTED|Overall Study||79
196400|NCT01332253|476121|P1|STARTED|Overall Study||82
196401|NCT01332227|476149|P2|NOT COMPLETED|Overall Study||5
196402|NCT01332227|476150|P1|NOT COMPLETED|Overall Study||16
196403|NCT01332227|476149|P2|COMPLETED|Overall Study||32
196404|NCT01332227|476150|P1|COMPLETED|Overall Study||56
196405|NCT01332227|476149|P2|STARTED|Overall Study|Participants who received treatment|37
196406|NCT01332227|476150|P1|STARTED|Overall Study|Participants who received treatment|72
196407|NCT01332188|476172|P4|NOT COMPLETED|Overall Study||0
196408|NCT01332188|476173|P3|NOT COMPLETED|Overall Study||4
196409|NCT01332188|476174|P2|NOT COMPLETED|Overall Study||1
196410|NCT01332188|476175|P1|NOT COMPLETED|Overall Study||2
196411|NCT01332188|476172|P4|COMPLETED|Overall Study||25
196412|NCT01332188|476173|P3|COMPLETED|Overall Study||21
196413|NCT01332188|476174|P2|COMPLETED|Overall Study||25
196414|NCT01332188|476175|P1|COMPLETED|Overall Study||23
196415|NCT01332188|476172|P4|STARTED|Overall Study||25
196416|NCT01332188|476173|P3|STARTED|Overall Study||25
196417|NCT01332188|476174|P2|STARTED|Overall Study||26
196418|NCT01332188|476175|P1|STARTED|Overall Study||25
196419|NCT01332149|476331|P2|NOT COMPLETED|Overall Study||38
196420|NCT01332149|476332|P1|NOT COMPLETED|Overall Study||30
196421|NCT01332149|476331|P2|COMPLETED|Overall Study||271
196422|NCT01332149|476332|P1|COMPLETED|Overall Study||284
196423|NCT01332149|476331|P2|Treated|Overall Study||307
196424|NCT01332149|476332|P1|Treated|Overall Study||313
196425|NCT01332149|476331|P2|STARTED|Overall Study|Assigned to study treatment.|309
196426|NCT01332149|476332|P1|STARTED|Overall Study|Assigned to study treatment.|314
196427|NCT01332123|476386|P1|NOT COMPLETED|Overall Study||0
196428|NCT01332123|476386|P1|COMPLETED|Overall Study||10
196429|NCT01332123|476386|P1|STARTED|Overall Study||10
196430|NCT01332071|476391|P2|NOT COMPLETED|Period 2||0
196431|NCT01332071|476392|P1|NOT COMPLETED|Period 2||0
196432|NCT01332071|476391|P2|COMPLETED|Period 2||13
196433|NCT01332071|476392|P1|COMPLETED|Period 2||13
196434|NCT01332071|476391|P2|STARTED|Period 2||13
196435|NCT01332071|476392|P1|STARTED|Period 2||13
196436|NCT01332071|476391|P2|NOT COMPLETED|7-Day Washout Period||0
196437|NCT01332071|476392|P1|NOT COMPLETED|7-Day Washout Period||0
196438|NCT01332071|476391|P2|COMPLETED|7-Day Washout Period||13
196439|NCT01332071|476392|P1|COMPLETED|7-Day Washout Period||13
196440|NCT01332071|476391|P2|STARTED|7-Day Washout Period||13
196441|NCT01332071|476392|P1|STARTED|7-Day Washout Period||13
196442|NCT01332071|476391|P2|NOT COMPLETED|Period 1||0
196443|NCT01332071|476392|P1|NOT COMPLETED|Period 1||0
196444|NCT01332071|476391|P2|COMPLETED|Period 1||13
196445|NCT01332071|476392|P1|COMPLETED|Period 1||13
196446|NCT01332071|476391|P2|STARTED|Period 1||13
196447|NCT01332071|476392|P1|STARTED|Period 1||13
196448|NCT01332019|476410|P2|NOT COMPLETED|Overall Study||122
196449|NCT01332019|476411|P1|NOT COMPLETED|Overall Study||113
196450|NCT01332019|476410|P2|COMPLETED|Overall Study||425
196451|NCT01332019|476411|P1|COMPLETED|Overall Study||417
196452|NCT01332019|476410|P2|STARTED|Overall Study||547
196453|NCT01332019|476411|P1|STARTED|Overall Study||530
196454|NCT01331837|476495|P2|NOT COMPLETED|Overall Study||67
196455|NCT01331837|476496|P1|NOT COMPLETED|Overall Study||56
196456|NCT01331837|476495|P2|COMPLETED|Overall Study||1475
196457|NCT01331837|476496|P1|COMPLETED|Overall Study||1482
196458|NCT01331837|476495|P2|STARTED|Overall Study||1542
196459|NCT01331837|476496|P1|STARTED|Overall Study||1538
196460|NCT01331824|476536|P1|NOT COMPLETED|Overall Study||13
196461|NCT01331824|476536|P1|COMPLETED|Overall Study||9
196462|NCT01331824|476536|P1|STARTED|Overall Study||22
196463|NCT01331694|476549|P6|NOT COMPLETED|Overall Study||0
196464|NCT01331694|476550|P5|NOT COMPLETED|Overall Study||0
196465|NCT01331694|476551|P4|NOT COMPLETED|Overall Study||0
196466|NCT01331694|476552|P3|NOT COMPLETED|Overall Study||0
196467|NCT01331694|476553|P2|NOT COMPLETED|Overall Study||0
196468|NCT01331694|476554|P1|NOT COMPLETED|Overall Study||0
196469|NCT01331694|476549|P6|COMPLETED|Overall Study||9126
196470|NCT01331694|476550|P5|COMPLETED|Overall Study||10617
196471|NCT01331694|476551|P4|COMPLETED|Overall Study||12595
196472|NCT01331694|476552|P3|COMPLETED|Overall Study||12659
196473|NCT01331694|476553|P2|COMPLETED|Overall Study||14449
196474|NCT01331694|476554|P1|COMPLETED|Overall Study||16684
196475|NCT01331694|476549|P6|STARTED|Overall Study||9126
196476|NCT01331694|476550|P5|STARTED|Overall Study||10617
196477|NCT01331694|476551|P4|STARTED|Overall Study||12595
196478|NCT01331694|476552|P3|STARTED|Overall Study||12659
196479|NCT01331694|476553|P2|STARTED|Overall Study||14449
196480|NCT01331694|476554|P1|STARTED|Overall Study||16684
196481|NCT01331681|476571|P3|NOT COMPLETED|Overall Study||35
196482|NCT01331681|476572|P2|NOT COMPLETED|Overall Study||34
196483|NCT01331681|476573|P1|NOT COMPLETED|Overall Study||35
196484|NCT01331681|476571|P3|COMPLETED|Overall Study|Completed Week 148|100
196485|NCT01331681|476572|P2|COMPLETED|Overall Study|Completed Week 148|101
196486|NCT01331681|476573|P1|COMPLETED|Overall Study|Completed Week 148|101
196487|NCT01331681|476571|P3|Completed Week 148|Overall Study||100
196488|NCT01331681|476572|P2|Completed Week 148|Overall Study||101
196489|NCT01331681|476573|P1|Completed Week 148|Overall Study||101
196490|NCT01331681|476571|P3|Completed Week 100|Overall Study||105
196491|NCT01331681|476572|P2|Completed Week 100|Overall Study||110
196492|NCT01331681|476573|P1|Completed Week 100|Overall Study||115
196493|NCT01331681|476571|P3|Completed Week 52|Overall Study||115
196494|NCT01331681|476572|P2|Completed Week 52|Overall Study||121
196495|NCT01331681|476573|P1|Completed Week 52|Overall Study||125
196496|NCT01331681|476571|P3|Participants Received Treatment|Overall Study|safety population|133
196497|NCT01331681|476572|P2|Participants Received Treatment|Overall Study|safety population|135
196498|NCT01331681|476573|P1|Participants Received Treatment|Overall Study|safety population|136
196499|NCT01331681|476571|P3|STARTED|Overall Study|randomized|135
196500|NCT01331681|476572|P2|STARTED|Overall Study|randomized|135
196501|NCT01331681|476573|P1|STARTED|Overall Study|randomized|136
196502|NCT01331408|476599|P1|NOT COMPLETED|Overall Study||11
196503|NCT01331408|476599|P1|COMPLETED|Overall Study||50
196504|NCT01331408|476599|P1|STARTED|Overall Study||61
196505|NCT01331304|476607|P2|NOT COMPLETED|Overall Study||60
196506|NCT01331304|476608|P1|NOT COMPLETED|Overall Study||58
196507|NCT01331304|476607|P2|COMPLETED|Overall Study||182
196508|NCT01331304|476608|P1|COMPLETED|Overall Study||182
196509|NCT01331304|476607|P2|STARTED|Overall Study||242
196510|NCT01331304|476608|P1|STARTED|Overall Study||240
196511|NCT01331291|476622|P2|NOT COMPLETED|Overall Study||9
196512|NCT01331291|476623|P1|NOT COMPLETED|Overall Study||2
196513|NCT01331291|476622|P2|COMPLETED|Overall Study||0
196514|NCT01331291|476623|P1|COMPLETED|Overall Study||0
196515|NCT01331291|476622|P2|STARTED|Overall Study||9
196516|NCT01331291|476623|P1|STARTED|Overall Study||2
196517|NCT01331213|476636|P2|NOT COMPLETED|Overall Study||0
196518|NCT01331213|476637|P1|NOT COMPLETED|Overall Study||0
196519|NCT01331213|476636|P2|COMPLETED|Overall Study||10
196520|NCT01331213|476637|P1|COMPLETED|Overall Study||8
196521|NCT01331213|476636|P2|STARTED|Overall Study||10
196522|NCT01331213|476637|P1|STARTED|Overall Study||8
196523|NCT01331161|476657|P2|NOT COMPLETED|Overall Study||2
196524|NCT01331161|476658|P1|NOT COMPLETED|Overall Study||1
196525|NCT01331161|476657|P2|COMPLETED|Overall Study||31
196526|NCT01331161|476658|P1|COMPLETED|Overall Study||43
196527|NCT01331161|476657|P2|STARTED|Overall Study||33
196528|NCT01331161|476658|P1|STARTED|Overall Study||44
196529|NCT01331109|476666|P1|NOT COMPLETED|Overall Study||57
196530|NCT01331109|476666|P1|COMPLETED|Overall Study||0
196531|NCT01331109|476666|P1|STARTED|Overall Study||57
196532|NCT01331005|476678|P2|NOT COMPLETED|Overall Study||4
196533|NCT01331005|476679|P1|NOT COMPLETED|Overall Study||4
196534|NCT01331005|476678|P2|COMPLETED|Overall Study||57
196535|NCT01331005|476679|P1|COMPLETED|Overall Study||60
196536|NCT01331005|476678|P2|STARTED|Overall Study||61
196537|NCT01331005|476679|P1|STARTED|Overall Study||64
196538|NCT01330953|476694|P5|NOT COMPLETED|Overall Study||0
196539|NCT01330953|476695|P4|NOT COMPLETED|Overall Study||0
196540|NCT01330953|476696|P3|NOT COMPLETED|Overall Study||0
196541|NCT01330953|476697|P2|NOT COMPLETED|Overall Study||0
196542|NCT01330953|476698|P1|NOT COMPLETED|Overall Study||0
196543|NCT01330953|476694|P5|COMPLETED|Overall Study||6
196544|NCT01330953|476695|P4|COMPLETED|Overall Study||6
196545|NCT01330953|476696|P3|COMPLETED|Overall Study||6
196546|NCT01330953|476697|P2|COMPLETED|Overall Study||6
196547|NCT01330953|476698|P1|COMPLETED|Overall Study||8
196548|NCT01330953|476694|P5|STARTED|Overall Study||6
196549|NCT01330953|476695|P4|STARTED|Overall Study||6
196550|NCT01330953|476696|P3|STARTED|Overall Study||6
196551|NCT01330953|476697|P2|STARTED|Overall Study||6
196552|NCT01330953|476698|P1|STARTED|Overall Study||8
196553|NCT01330914|476744|P1|NOT COMPLETED|Overall Study||7
196554|NCT01330914|476744|P1|COMPLETED|Overall Study||48
196555|NCT01330914|476744|P1|STARTED|Overall Study||55
196556|NCT01330628|476752|P2|NOT COMPLETED|Overall Study||40
196557|NCT01330628|476753|P1|NOT COMPLETED|Overall Study||70
196558|NCT01330628|476752|P2|COMPLETED|Overall Study||42
196559|NCT01330628|476753|P1|COMPLETED|Overall Study||100
196560|NCT01330628|476752|P2|6 Month Follow-up|Overall Study||60
196561|NCT01330628|476753|P1|6 Month Follow-up|Overall Study||135
196562|NCT01330628|476752|P2|30 Day Follow-up|Overall Study||73
196563|NCT01330628|476753|P1|30 Day Follow-up|Overall Study||165
196564|NCT01330628|476752|P2|STARTED|Overall Study||82
196565|NCT01330628|476753|P1|STARTED|Overall Study||170
196566|NCT01330459|476763|P2|NOT COMPLETED|Overall Study||2
196567|NCT01330459|476764|P1|NOT COMPLETED|Overall Study||0
196568|NCT01330459|476763|P2|COMPLETED|Overall Study||58
196569|NCT01330459|476764|P1|COMPLETED|Overall Study||61
196570|NCT01330459|476763|P2|STARTED|Overall Study||60
196571|NCT01330459|476764|P1|STARTED|Overall Study||61
196572|NCT01330433|476780|P2|NOT COMPLETED|Overall Study||3
196573|NCT01330433|476781|P1|NOT COMPLETED|Overall Study||2
196574|NCT01330433|476780|P2|COMPLETED|Overall Study||16
196575|NCT01330433|476781|P1|COMPLETED|Overall Study||14
196576|NCT01330433|476780|P2|STARTED|Overall Study||19
196577|NCT01330433|476781|P1|STARTED|Overall Study||16
196578|NCT01330420|476801|P1|NOT COMPLETED|Overall Study||4
196579|NCT01330420|476801|P1|COMPLETED|Overall Study||24
196580|NCT01330420|476801|P1|STARTED|Overall Study||28
196581|NCT01330394|476811|P2|NOT COMPLETED|Overall Study||0
196582|NCT01330394|476812|P1|NOT COMPLETED|Overall Study||0
196583|NCT01330394|476811|P2|COMPLETED|Overall Study||16
196584|NCT01330394|476812|P1|COMPLETED|Overall Study||17
196585|NCT01330394|476811|P2|STARTED|Overall Study||16
196586|NCT01330394|476812|P1|STARTED|Overall Study||17
196587|NCT01330381|476820|P3|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||18
196588|NCT01330381|476821|P2|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||0
196589|NCT01330381|476822|P1|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||10
196590|NCT01330381|476820|P3|COMPLETED|Open-label Treatment Period (16 Weeks)||81
196591|NCT01330381|476821|P2|COMPLETED|Open-label Treatment Period (16 Weeks)||0
196592|NCT01330381|476822|P1|COMPLETED|Open-label Treatment Period (16 Weeks)||88
196593|NCT01330381|476820|P3|STARTED|Open-label Treatment Period (16 Weeks)||99
196594|NCT01330381|476821|P2|STARTED|Open-label Treatment Period (16 Weeks)||0
196595|NCT01330381|476822|P1|STARTED|Open-label Treatment Period (16 Weeks)||98
196596|NCT01330381|476820|P3|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||0
196597|NCT01330381|476821|P2|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||7
196598|NCT01330381|476822|P1|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||11
196599|NCT01330381|476820|P3|COMPLETED|Double-blind Treatment Period (8 Weeks)||0
196600|NCT01330381|476821|P2|COMPLETED|Double-blind Treatment Period (8 Weeks)||101
196601|NCT01330381|476822|P1|COMPLETED|Double-blind Treatment Period (8 Weeks)||96
196602|NCT01330381|476820|P3|Received Treatment|Double-blind Treatment Period (8 Weeks)||0
196603|NCT01330381|476821|P2|Received Treatment|Double-blind Treatment Period (8 Weeks)||107
196604|NCT01330381|476822|P1|Received Treatment|Double-blind Treatment Period (8 Weeks)||106
196605|NCT01330381|476820|P3|STARTED|Double-blind Treatment Period (8 Weeks)||0
196606|NCT01330381|476821|P2|STARTED|Double-blind Treatment Period (8 Weeks)||108
196607|NCT01330381|476822|P1|STARTED|Double-blind Treatment Period (8 Weeks)||107
196608|NCT01330355|476868|P2|NOT COMPLETED|Overall Study||0
196609|NCT01330355|476869|P1|NOT COMPLETED|Overall Study||0
196610|NCT01330355|476868|P2|COMPLETED|Overall Study||17
196611|NCT01330355|476869|P1|COMPLETED|Overall Study||16
196612|NCT01330355|476868|P2|STARTED|Overall Study||17
196613|NCT01330355|476869|P1|STARTED|Overall Study||16
196614|NCT01330316|476883|P2|NOT COMPLETED|Overall Study||15
196615|NCT01330316|476884|P1|NOT COMPLETED|Overall Study||2
196616|NCT01330316|476883|P2|COMPLETED|Overall Study||60
196617|NCT01330316|476884|P1|COMPLETED|Overall Study||41
196618|NCT01330316|476883|P2|STARTED|Overall Study||75
196619|NCT01330316|476884|P1|STARTED|Overall Study||43
196620|NCT01330303|476920|P2|NOT COMPLETED|Period 2||0
196621|NCT01330303|476921|P1|NOT COMPLETED|Period 2||0
196622|NCT01330303|476920|P2|COMPLETED|Period 2||18
196623|NCT01330303|476921|P1|COMPLETED|Period 2||19
196624|NCT01330303|476920|P2|STARTED|Period 2||18
196625|NCT01330303|476921|P1|STARTED|Period 2||19
196626|NCT01330303|476920|P2|NOT COMPLETED|7-Day Washout Period||0
196627|NCT01330303|476921|P1|NOT COMPLETED|7-Day Washout Period||0
196628|NCT01330303|476920|P2|COMPLETED|7-Day Washout Period||18
196629|NCT01330303|476921|P1|COMPLETED|7-Day Washout Period||19
196630|NCT01330303|476920|P2|STARTED|7-Day Washout Period||18
196631|NCT01330303|476921|P1|STARTED|7-Day Washout Period||19
196632|NCT01330303|476920|P2|NOT COMPLETED|Period 1||2
196633|NCT01330303|476921|P1|NOT COMPLETED|Period 1||1
196634|NCT01330303|476920|P2|COMPLETED|Period 1||18
196635|NCT01330303|476921|P1|COMPLETED|Period 1||19
196636|NCT01330303|476920|P2|STARTED|Period 1||20
196637|NCT01330303|476921|P1|STARTED|Period 1||20
196638|NCT01330290|476931|P1|NOT COMPLETED|Overall Study||0
196639|NCT01330290|476931|P1|COMPLETED|Overall Study|As this is a cross-sectional study, the terms completed/not completed are not applicable.|148
196640|NCT01330290|476931|P1|STARTED|Overall Study||148
196641|NCT01330134|476957|P2|NOT COMPLETED|Overall Study||0
196642|NCT01330134|476958|P1|NOT COMPLETED|Overall Study||0
196643|NCT01330134|476957|P2|COMPLETED|Overall Study||237
196644|NCT01330134|476958|P1|COMPLETED|Overall Study||244
196645|NCT01330134|476957|P2|STARTED|Overall Study||237
196646|NCT01330134|476958|P1|STARTED|Overall Study||244
196647|NCT01330108|476968|P1|NOT COMPLETED|Overall Study||4
196648|NCT01330108|476968|P1|COMPLETED|Overall Study||28
196649|NCT01330108|476968|P1|STARTED|Overall Study||32
196650|NCT01330043|476975|P2|NOT COMPLETED|Overall Study||4
196651|NCT01330043|476976|P1|NOT COMPLETED|Overall Study||0
196652|NCT01330043|476975|P2|COMPLETED|Overall Study||108
196653|NCT01330043|476976|P1|COMPLETED|Overall Study||111
196654|NCT01330043|476975|P2|STARTED|Overall Study||112
196655|NCT01330043|476976|P1|STARTED|Overall Study||111
196656|NCT01330030|476986|P2|NOT COMPLETED|Overall Study||17
196657|NCT01330030|476987|P1|NOT COMPLETED|Overall Study||16
196658|NCT01330030|476986|P2|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
196659|NCT01330030|476987|P1|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
196660|NCT01330030|476986|P2|STARTED|Overall Study||122
196661|NCT01330030|476987|P1|STARTED|Overall Study||121
196662|NCT01330017|476998|P5|NOT COMPLETED|Overall Study||3
196663|NCT01330017|476999|P4|NOT COMPLETED|Overall Study||12
196664|NCT01330017|477000|P3|NOT COMPLETED|Overall Study||8
196665|NCT01330017|477001|P2|NOT COMPLETED|Overall Study||4
196666|NCT01330017|477002|P1|NOT COMPLETED|Overall Study||5
196667|NCT01330017|476998|P5|COMPLETED|Overall Study||100
196668|NCT01330017|476999|P4|COMPLETED|Overall Study||100
196669|NCT01330017|477000|P3|COMPLETED|Overall Study||99
196670|NCT01330017|477001|P2|COMPLETED|Overall Study||104
196671|NCT01330017|477002|P1|COMPLETED|Overall Study||104
196672|NCT01330017|476998|P5|STARTED|Overall Study||103
196673|NCT01330017|476999|P4|STARTED|Overall Study||112
196674|NCT01330017|477000|P3|STARTED|Overall Study||107
196675|NCT01330017|477001|P2|STARTED|Overall Study||108
196676|NCT01330017|477002|P1|STARTED|Overall Study||109
196677|NCT01329978|477051|P5|NOT COMPLETED|Rerandomization Treatment Period||4
196678|NCT01329978|477052|P4|NOT COMPLETED|Rerandomization Treatment Period||5
196679|NCT01329978|477053|P3|NOT COMPLETED|Rerandomization Treatment Period||0
196680|NCT01329978|477054|P2|NOT COMPLETED|Rerandomization Treatment Period||0
196681|NCT01329978|477055|P1|NOT COMPLETED|Rerandomization Treatment Period||0
196682|NCT01329978|477051|P5|COMPLETED|Rerandomization Treatment Period||71
196683|NCT01329978|477052|P4|COMPLETED|Rerandomization Treatment Period||70
196684|NCT01329978|477053|P3|COMPLETED|Rerandomization Treatment Period||0
196685|NCT01329978|477054|P2|COMPLETED|Rerandomization Treatment Period||0
196686|NCT01329978|477055|P1|COMPLETED|Rerandomization Treatment Period||0
196687|NCT01329978|477051|P5|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
196688|NCT01329978|477052|P4|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
196689|NCT01329978|477053|P3|STARTED|Rerandomization Treatment Period||0
196690|NCT01329978|477054|P2|STARTED|Rerandomization Treatment Period||0
196691|NCT01329978|477055|P1|STARTED|Rerandomization Treatment Period||0
196692|NCT01329978|477051|P5|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
196693|NCT01329978|477052|P4|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
196694|NCT01329978|477053|P3|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||5
196695|NCT01329978|477054|P2|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||13
196696|NCT01329978|477055|P1|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||4
196697|NCT01329978|477051|P5|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
196698|NCT01329978|477052|P4|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
196699|NCT01329978|477053|P3|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|150 participants were re-randomized after 12 weeks of treatment.|150
196700|NCT01329978|477054|P2|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|112
196701|NCT01329978|477055|P1|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|48
196702|NCT01329978|477051|P5|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
196703|NCT01329978|477052|P4|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
196704|NCT01329978|477053|P3|STARTED|Sofosbuvir+PEG+RBV Treatment Period||155
196705|NCT01329978|477054|P2|STARTED|Sofosbuvir+PEG+RBV Treatment Period||125
196706|NCT01329978|477055|P1|STARTED|Sofosbuvir+PEG+RBV Treatment Period||52
196707|NCT01329939|477129|P4|NOT COMPLETED|Overall Study||5
196708|NCT01329939|477130|P3|NOT COMPLETED|Overall Study||1
196709|NCT01329939|477131|P2|NOT COMPLETED|Overall Study||1
196710|NCT01329939|477132|P1|NOT COMPLETED|Overall Study||3
196711|NCT01329939|477129|P4|COMPLETED|Overall Study||4
196712|NCT01329939|477130|P3|COMPLETED|Overall Study||4
196713|NCT01329939|477131|P2|COMPLETED|Overall Study||4
196714|NCT01329939|477132|P1|COMPLETED|Overall Study||4
196715|NCT01329939|477129|P4|STARTED|Overall Study||9
196716|NCT01329939|477130|P3|STARTED|Overall Study||5
196717|NCT01329939|477131|P2|STARTED|Overall Study||5
196718|NCT01329939|477132|P1|STARTED|Overall Study||7
196719|NCT01329848|477170|P1|NOT COMPLETED|Overall Study||29
196720|NCT01329848|477170|P1|COMPLETED|Overall Study||54
196721|NCT01329848|477170|P1|STARTED|Overall Study||83
196722|NCT01329679|477175|P2|NOT COMPLETED|Overall Study||0
196723|NCT01329679|477176|P1|NOT COMPLETED|Overall Study||0
196724|NCT01329679|477175|P2|COMPLETED|Overall Study||13
196725|NCT01329679|477176|P1|COMPLETED|Overall Study||13
196726|NCT01329679|477175|P2|STARTED|Overall Study||13
196727|NCT01329679|477176|P1|STARTED|Overall Study||13
196728|NCT01329562|477196|P2|NOT COMPLETED|Overall Study||7
196729|NCT01329562|477197|P1|NOT COMPLETED|Overall Study||9
196730|NCT01329562|477196|P2|COMPLETED|Overall Study||14
196731|NCT01329562|477197|P1|COMPLETED|Overall Study||11
196732|NCT01329562|477196|P2|STARTED|Overall Study||21
196733|NCT01329562|477197|P1|STARTED|Overall Study||20
196734|NCT01329549|477246|P1|NOT COMPLETED|Overall Study||2
196735|NCT01329549|477246|P1|COMPLETED|Overall Study||0
196736|NCT01329549|477246|P1|STARTED|Overall Study||2
196737|NCT01329419|477257|P1|NOT COMPLETED|Overall Study||235
196738|NCT01329419|477257|P1|COMPLETED|Overall Study||4158
196739|NCT01329419|477257|P1|STARTED|Overall Study||4393
196740|NCT01329380|477263|P1|NOT COMPLETED|Overall Study||29
196741|NCT01329380|477263|P1|COMPLETED|Overall Study||374
196742|NCT01329380|477263|P1|Safety Population|Overall Study||396
196743|NCT01329380|477263|P1|STARTED|Overall Study||403
196744|NCT01329263|477275|P2|NOT COMPLETED|Overall Study||23
196745|NCT01329263|477276|P1|NOT COMPLETED|Overall Study||5
196746|NCT01329263|477275|P2|COMPLETED|Overall Study||22
196747|NCT01329263|477276|P1|COMPLETED|Overall Study||10
196748|NCT01329263|477275|P2|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||22
196749|NCT01329263|477276|P1|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||10
196750|NCT01329263|477275|P2|Completed Period 2 Own or CCrush Menthol|Overall Study||30
196751|NCT01329263|477276|P1|Completed Period 2 Own or CCrush Menthol|Overall Study||10
196752|NCT01329263|477275|P2|Completed Period 1 Own Menthol|Overall Study||45
196753|NCT01329263|477276|P1|Completed Period 1 Own Menthol|Overall Study||15
196754|NCT01329263|477275|P2|STARTED|Overall Study||45
196755|NCT01329263|477276|P1|STARTED|Overall Study||15
196756|NCT01329198|477290|P2|NOT COMPLETED|Overall Study||0
196757|NCT01329198|477291|P1|NOT COMPLETED|Overall Study||0
196758|NCT01329198|477290|P2|COMPLETED|Overall Study||2
196759|NCT01329198|477291|P1|COMPLETED|Overall Study||3
196760|NCT01329198|477290|P2|STARTED|Overall Study||2
196761|NCT01329198|477291|P1|STARTED|Overall Study||3
196762|NCT01329185|477304|P2|NOT COMPLETED|Overall Study||0
196763|NCT01329185|477305|P1|NOT COMPLETED|Overall Study||0
196764|NCT01329185|477304|P2|COMPLETED|Overall Study||7
196765|NCT01329185|477305|P1|COMPLETED|Overall Study||10
196766|NCT01329185|477304|P2|PTLD|Overall Study||0
196767|NCT01329185|477305|P1|PTLD|Overall Study||1
196768|NCT01329185|477304|P2|CMV Disease|Overall Study||0
196769|NCT01329185|477305|P1|CMV Disease|Overall Study||1
196770|NCT01329185|477304|P2|STARTED|Overall Study||7
196771|NCT01329185|477305|P1|STARTED|Overall Study||10
196772|NCT01329029|477313|P2|NOT COMPLETED|Overall Study||192
196773|NCT01329029|477314|P1|NOT COMPLETED|Overall Study||269
196774|NCT01329029|477313|P2|COMPLETED|Overall Study||780
196775|NCT01329029|477314|P1|COMPLETED|Overall Study||704
196776|NCT01329029|477313|P2|Safety Population|Overall Study||967
196777|NCT01329029|477314|P1|Safety Population|Overall Study||968
196778|NCT01329029|477313|P2|Full Analysis Set (FAS)|Overall Study||966
196779|NCT01329029|477314|P1|Full Analysis Set (FAS)|Overall Study||969
196780|NCT01329029|477313|P2|STARTED|Overall Study||972
196781|NCT01329029|477314|P1|STARTED|Overall Study||973
196782|NCT01328964|477387|P3|NOT COMPLETED|Overall Study||0
196783|NCT01328964|477388|P2|NOT COMPLETED|Overall Study||0
196784|NCT01328964|477389|P1|NOT COMPLETED|Overall Study||0
196785|NCT01328964|477387|P3|COMPLETED|Overall Study||4424
196786|NCT01328964|477388|P2|COMPLETED|Overall Study||3270
196787|NCT01328964|477389|P1|COMPLETED|Overall Study||2212
196788|NCT01328964|477387|P3|STARTED|Overall Study||4424
196789|NCT01328964|477388|P2|STARTED|Overall Study||3270
196790|NCT01328964|477389|P1|STARTED|Overall Study||2212
196791|NCT01328951|477404|P2|NOT COMPLETED|Overall Study||322
196792|NCT01328951|477405|P1|NOT COMPLETED|Overall Study||321
196793|NCT01328951|477404|P2|COMPLETED|Overall Study||0
196794|NCT01328951|477405|P1|COMPLETED|Overall Study||0
196795|NCT01328951|477404|P2|STARTED|Overall Study||322
196796|NCT01328951|477405|P1|STARTED|Overall Study||321
196797|NCT01328873|477429|P1|NOT COMPLETED|Overall Study||0
196798|NCT01328873|477429|P1|COMPLETED|Overall Study||49
196799|NCT01328873|477429|P1|STARTED|Overall Study||49
196800|NCT01328782|477441|P3|NOT COMPLETED|Overall Study||0
196801|NCT01328782|477442|P2|NOT COMPLETED|Overall Study||0
196802|NCT01328782|477443|P1|NOT COMPLETED|Overall Study||0
196803|NCT01328782|477441|P3|COMPLETED|Overall Study||39
196804|NCT01328782|477442|P2|COMPLETED|Overall Study||42
196805|NCT01328782|477443|P1|COMPLETED|Overall Study||43
196806|NCT01328782|477441|P3|STARTED|Overall Study||39
196807|NCT01328782|477442|P2|STARTED|Overall Study||42
196808|NCT01328782|477443|P1|STARTED|Overall Study||43
196809|NCT01328769|477465|P2|NOT COMPLETED|Overall Study||1
196810|NCT01328769|477466|P1|NOT COMPLETED|Overall Study||0
196811|NCT01328769|477465|P2|COMPLETED|Overall Study||23
196812|NCT01328769|477466|P1|COMPLETED|Overall Study||25
196813|NCT01328769|477465|P2|STARTED|Overall Study||24
196814|NCT01328769|477466|P1|STARTED|Overall Study||25
196815|NCT01328756|477474|P1|NOT COMPLETED|Overall Study||123
196816|NCT01328756|477474|P1|COMPLETED|Overall Study||191
196817|NCT01328756|477474|P1|STARTED|Overall Study||314
196818|NCT01328743|477493|P2|NOT COMPLETED|Overall Study||10
196819|NCT01328743|477494|P1|NOT COMPLETED|Overall Study||9
196820|NCT01328743|477493|P2|COMPLETED|Overall Study||79
196821|NCT01328743|477494|P1|COMPLETED|Overall Study||82
196822|NCT01328743|477493|P2|STARTED|Overall Study||89
196823|NCT01328743|477494|P1|STARTED|Overall Study||91
196824|NCT01328717|477510|P1|NOT COMPLETED|Overall Study||1
196825|NCT01328717|477510|P1|COMPLETED|Overall Study||77
196826|NCT01328717|477510|P1|STARTED|Overall Study||78
196827|NCT01328587|477515|P1|NOT COMPLETED|Overall Study||0
196828|NCT01328587|477515|P1|COMPLETED|Overall Study||34
196829|NCT01328587|477515|P1|STARTED|Overall Study||34
196830|NCT01328574|477519|P1|NOT COMPLETED|Overall Study||1
196831|NCT01328574|477519|P1|COMPLETED|Overall Study||12
196832|NCT01328574|477519|P1|STARTED|Overall Study||13
196833|NCT01328548|477533|P2|NOT COMPLETED|Overall Study||0
196834|NCT01328548|477534|P1|NOT COMPLETED|Overall Study||4
196835|NCT01328548|477533|P2|COMPLETED|Overall Study||50
196836|NCT01328548|477534|P1|COMPLETED|Overall Study||187
196837|NCT01328548|477533|P2|STARTED|Overall Study||50
196838|NCT01328548|477534|P1|STARTED|Overall Study||191
196839|NCT01328535|477552|P1|NOT COMPLETED|Overall Study||1
196840|NCT01328535|477552|P1|COMPLETED|Overall Study||24
196841|NCT01328535|477552|P1|STARTED|Overall Study||25
196842|NCT01328496|477563|P2|NOT COMPLETED|Overall Study||0
196843|NCT01328496|477564|P1|NOT COMPLETED|Overall Study||1
196844|NCT01328496|477563|P2|COMPLETED|Overall Study||4
196845|NCT01328496|477564|P1|COMPLETED|Overall Study||9
196846|NCT01328496|477563|P2|STARTED|Overall Study||4
196847|NCT01328496|477564|P1|STARTED|Overall Study||10
196848|NCT01328444|477582|P6|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
196849|NCT01328444|477583|P5|NOT COMPLETED|Treatment Period 2 (12 Weeks)||8
196850|NCT01328444|477584|P4|NOT COMPLETED|Treatment Period 2 (12 Weeks)||5
196851|NCT01328444|477585|P3|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
196852|NCT01328444|477586|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
196853|NCT01328444|477587|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||11
196854|NCT01328444|477582|P6|COMPLETED|Treatment Period 2 (12 Weeks)||59
196855|NCT01328444|477583|P5|COMPLETED|Treatment Period 2 (12 Weeks)||63
196856|NCT01328444|477584|P4|COMPLETED|Treatment Period 2 (12 Weeks)||30
196857|NCT01328444|477585|P3|COMPLETED|Treatment Period 2 (12 Weeks)||19
196858|NCT01328444|477586|P2|COMPLETED|Treatment Period 2 (12 Weeks)||22
196859|NCT01328444|477587|P1|COMPLETED|Treatment Period 2 (12 Weeks)||65
196860|NCT01328444|477582|P6|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|66
196861|NCT01328444|477583|P5|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|71
196862|NCT01328444|477584|P4|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|35
196863|NCT01328444|477585|P3|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|22
196864|NCT01328444|477586|P2|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|23
196865|NCT01328444|477587|P1|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|76
196866|NCT01328444|477582|P6|NOT COMPLETED|Washout Period (14 Days)||4
196867|NCT01328444|477583|P5|NOT COMPLETED|Washout Period (14 Days)||1
196868|NCT01328444|477584|P4|NOT COMPLETED|Washout Period (14 Days)||1
196869|NCT01328444|477585|P3|NOT COMPLETED|Washout Period (14 Days)||0
196870|NCT01328444|477586|P2|NOT COMPLETED|Washout Period (14 Days)||1
196871|NCT01328444|477587|P1|NOT COMPLETED|Washout Period (14 Days)||1
196872|NCT01328444|477582|P6|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|68
196873|NCT01328444|477583|P5|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|66
196874|NCT01328444|477584|P4|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|32
196875|NCT01328444|477585|P3|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|25
196876|NCT01328444|477586|P2|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
196877|NCT01328444|477587|P1|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|82
196878|NCT01328444|477582|P6|STARTED|Washout Period (14 Days)||72
196879|NCT01328444|477583|P5|STARTED|Washout Period (14 Days)||67
196880|NCT01328444|477584|P4|STARTED|Washout Period (14 Days)||33
196881|NCT01328444|477585|P3|STARTED|Washout Period (14 Days)||25
196882|NCT01328444|477586|P2|STARTED|Washout Period (14 Days)||21
196883|NCT01328444|477587|P1|STARTED|Washout Period (14 Days)||83
196884|NCT01328444|477582|P6|NOT COMPLETED|Treatment Period 1 (12 Weeks)||6
196885|NCT01328444|477583|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||14
196886|NCT01328444|477584|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
196887|NCT01328444|477585|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
196888|NCT01328444|477586|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
196889|NCT01328444|477587|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
196890|NCT01328444|477582|P6|COMPLETED|Treatment Period 1 (12 Weeks)||72
196891|NCT01328444|477583|P5|COMPLETED|Treatment Period 1 (12 Weeks)||67
196892|NCT01328444|477584|P4|COMPLETED|Treatment Period 1 (12 Weeks)||33
196893|NCT01328444|477585|P3|COMPLETED|Treatment Period 1 (12 Weeks)||25
196894|NCT01328444|477586|P2|COMPLETED|Treatment Period 1 (12 Weeks)||21
196895|NCT01328444|477587|P1|COMPLETED|Treatment Period 1 (12 Weeks)||83
196896|NCT01328444|477582|P6|STARTED|Treatment Period 1 (12 Weeks)||78
196897|NCT01328444|477583|P5|STARTED|Treatment Period 1 (12 Weeks)||81
196898|NCT01328444|477584|P4|STARTED|Treatment Period 1 (12 Weeks)||41
196899|NCT01328444|477585|P3|STARTED|Treatment Period 1 (12 Weeks)||28
196900|NCT01328444|477586|P2|STARTED|Treatment Period 1 (12 Weeks)||26
196901|NCT01328444|477587|P1|STARTED|Treatment Period 1 (12 Weeks)||94
196902|NCT01328431|477633|P2|NOT COMPLETED|12 Month (12M)||97
196903|NCT01328431|477634|P1|NOT COMPLETED|12 Month (12M)||84
196904|NCT01328431|477633|P2|COMPLETED|12 Month (12M)||289
196905|NCT01328431|477634|P1|COMPLETED|12 Month (12M)||304
196906|NCT01328431|477633|P2|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|386
196907|NCT01328431|477634|P1|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|388
196908|NCT01328431|477633|P2|NOT COMPLETED|3 Month (3M)||72
196909|NCT01328431|477634|P1|NOT COMPLETED|3 Month (3M)||77
196910|NCT01328431|477633|P2|COMPLETED|3 Month (3M)||316
196911|NCT01328431|477634|P1|COMPLETED|3 Month (3M)||313
196912|NCT01328431|477633|P2|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|388
196913|NCT01328431|477634|P1|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|390
196914|NCT01328431|477633|P2|NOT COMPLETED|1 Month (1M)||58
196915|NCT01328431|477634|P1|NOT COMPLETED|1 Month (1M)||55
196916|NCT01328431|477633|P2|COMPLETED|1 Month (1M)||330
196917|NCT01328431|477634|P1|COMPLETED|1 Month (1M)||335
196918|NCT01328431|477633|P2|STARTED|1 Month (1M)||388
196919|NCT01328431|477634|P1|STARTED|1 Month (1M)||390
196920|NCT01328431|477633|P2|NOT COMPLETED|Baseline||2
196921|NCT01328431|477634|P1|NOT COMPLETED|Baseline||0
196922|NCT01328431|477633|P2|COMPLETED|Baseline|Two subjects enrolled in study twice. Protocol violation.|388
196923|NCT01328431|477634|P1|COMPLETED|Baseline||390
196924|NCT01328431|477633|P2|STARTED|Baseline||390
196925|NCT01328431|477634|P1|STARTED|Baseline||390
196926|NCT01328405|477644|P2|NOT COMPLETED|Overall Study||0
196927|NCT01328405|477645|P1|NOT COMPLETED|Overall Study||0
196928|NCT01328405|477644|P2|COMPLETED|Overall Study||48
196929|NCT01328405|477645|P1|COMPLETED|Overall Study||52
196930|NCT01328405|477644|P2|STARTED|Overall Study||48
196931|NCT01328405|477645|P1|STARTED|Overall Study||52
196932|NCT01328379|477662|P3|NOT COMPLETED|Overall Study||0
196933|NCT01328379|477663|P2|NOT COMPLETED|Overall Study||0
196934|NCT01328379|477664|P1|NOT COMPLETED|Overall Study||1
196935|NCT01328379|477662|P3|COMPLETED|Overall Study||143
196936|NCT01328379|477663|P2|COMPLETED|Overall Study||144
196937|NCT01328379|477664|P1|COMPLETED|Overall Study||142
196938|NCT01328379|477662|P3|STARTED|Overall Study||143
196939|NCT01328379|477663|P2|STARTED|Overall Study||144
196940|NCT01328379|477664|P1|STARTED|Overall Study||143
196941|NCT01328366|477690|P1|NOT COMPLETED|Overall Study||10
196942|NCT01328366|477690|P1|COMPLETED|Overall Study||143
196943|NCT01328366|477690|P1|STARTED|Overall Study||153
196944|NCT01328249|477710|P2|NOT COMPLETED|Overall Study||3
196945|NCT01328249|477711|P1|NOT COMPLETED|Overall Study||7
196946|NCT01328249|477710|P2|COMPLETED|Overall Study||23
196947|NCT01328249|477711|P1|COMPLETED|Overall Study||48
196948|NCT01328249|477710|P2|STARTED|Overall Study||26
196949|NCT01328249|477711|P1|STARTED|Overall Study||55
196950|NCT01328184|477719|P1|NOT COMPLETED|Overall Study||0
196951|NCT01328184|477719|P1|COMPLETED|Overall Study||18
196952|NCT01328184|477719|P1|STARTED|Overall Study||18
196953|NCT01328158|477759|P1|NOT COMPLETED|Overall Study||0
196954|NCT01328158|477759|P1|COMPLETED|Overall Study||220
196955|NCT01328158|477759|P1|STARTED|Overall Study||220
196956|NCT01328080|477797|P1|NOT COMPLETED|Overall Study||5
196957|NCT01328080|477797|P1|COMPLETED|Overall Study||6
196958|NCT01328080|477797|P1|STARTED|Overall Study|11 subjects consented; 1 withdrew consent before first UVB treatment|11
196959|NCT01328054|477801|P2|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||5
196960|NCT01328054|477802|P1|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
196961|NCT01328054|477801|P2|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||53
196962|NCT01328054|477802|P1|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
196963|NCT01328054|477801|P2|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)|One par. was double dosed with lapatinib due to a dosing error - reason for difference in # Started.|58
196964|NCT01328054|477802|P1|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)||0
196965|NCT01328054|477801|P2|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
196966|NCT01328054|477802|P1|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
196967|NCT01328054|477801|P2|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
196968|NCT01328054|477802|P1|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||57
196969|NCT01328054|477801|P2|STARTED|Placebo on Day 1 and Day 2 (2 Days)||0
196970|NCT01328054|477802|P1|STARTED|Placebo on Day 1 and Day 2 (2 Days)||57
196971|NCT01328041|477827|P1|NOT COMPLETED|Overall Study||57
196972|NCT01328041|477827|P1|COMPLETED|Overall Study||126
196973|NCT01328041|477827|P1|STARTED|Overall Study||183
196974|NCT01328002|477849|P2|NOT COMPLETED|Double-Blind Period||0
196975|NCT01328002|477850|P1|NOT COMPLETED|Double-Blind Period||2
196976|NCT01328002|477849|P2|COMPLETED|Double-Blind Period||6
196977|NCT01328002|477850|P1|COMPLETED|Double-Blind Period||12
196978|NCT01328002|477849|P2|STARTED|Double-Blind Period||6
196979|NCT01328002|477850|P1|STARTED|Double-Blind Period||14
196980|NCT01328002|477849|P2|NOT COMPLETED|Open-Label Period||0
196981|NCT01328002|477850|P1|NOT COMPLETED|Open-Label Period||96
196982|NCT01328002|477849|P2|COMPLETED|Open-Label Period||0
196983|NCT01328002|477850|P1|COMPLETED|Open-Label Period||20
196984|NCT01328002|477849|P2|STARTED|Open-Label Period||0
196985|NCT01328002|477850|P1|STARTED|Open-Label Period||116
196986|NCT01327989|477859|P1|NOT COMPLETED|Overall Study||14
196987|NCT01327989|477859|P1|COMPLETED|Overall Study||188
196988|NCT01327989|477859|P1|STARTED|Overall Study||202
196989|NCT01327976|477873|P2|NOT COMPLETED|Overall Study||7
196990|NCT01327976|477874|P1|NOT COMPLETED|Overall Study||8
196991|NCT01327976|477873|P2|COMPLETED|Overall Study||70
196992|NCT01327976|477874|P1|COMPLETED|Overall Study||154
196993|NCT01327976|477873|P2|STARTED|Overall Study||77
196994|NCT01327976|477874|P1|STARTED|Overall Study||162
196995|NCT01327885|477886|P2|NOT COMPLETED|Overall Study||224
196996|NCT01327885|477887|P1|NOT COMPLETED|Overall Study||228
196997|NCT01327885|477886|P2|COMPLETED|Overall Study||0
196998|NCT01327885|477887|P1|COMPLETED|Overall Study||0
196999|NCT01327885|477886|P2|STARTED|Overall Study||224
197000|NCT01327885|477887|P1|STARTED|Overall Study||228
197001|NCT01327703|477899|P2|NOT COMPLETED|Second Treatment Period||2
197002|NCT01327703|477900|P1|NOT COMPLETED|Second Treatment Period||1
197003|NCT01327703|477899|P2|COMPLETED|Second Treatment Period||42
197004|NCT01327703|477900|P1|COMPLETED|Second Treatment Period||39
197005|NCT01327703|477899|P2|STARTED|Second Treatment Period|One participant discontinued between first and second treatment periods due to adverse event.|44
197006|NCT01327703|477900|P1|STARTED|Second Treatment Period|Two participants discontinued between first and second treatment periods due to adverse event.|40
197007|NCT01327703|477899|P2|NOT COMPLETED|First Treatment Period||0
197008|NCT01327703|477900|P1|NOT COMPLETED|First Treatment Period||0
197009|NCT01327703|477899|P2|COMPLETED|First Treatment Period||45
197010|NCT01327703|477900|P1|COMPLETED|First Treatment Period||42
197011|NCT01327703|477899|P2|STARTED|First Treatment Period||45
197012|NCT01327703|477900|P1|STARTED|First Treatment Period||42
197013|NCT01327677|477934|P2|NOT COMPLETED|Overall Study||13
197014|NCT01327677|477935|P1|NOT COMPLETED|Overall Study||20
197015|NCT01327677|477934|P2|COMPLETED|Overall Study||56
197016|NCT01327677|477935|P1|COMPLETED|Overall Study||48
197017|NCT01327677|477934|P2|STARTED|Overall Study||69
197018|NCT01327677|477935|P1|STARTED|Overall Study||68
197019|NCT01327651|477956|P9|NOT COMPLETED|Post Study Follow-up||2
197020|NCT01327651|477957|P8|NOT COMPLETED|Post Study Follow-up||1
197021|NCT01327651|477958|P7|NOT COMPLETED|Post Study Follow-up||4
197022|NCT01327651|477959|P6|NOT COMPLETED|Post Study Follow-up||0
197023|NCT01327651|477960|P5|NOT COMPLETED|Post Study Follow-up||0
197024|NCT01327651|477961|P4|NOT COMPLETED|Post Study Follow-up||0
197025|NCT01327651|477962|P3|NOT COMPLETED|Post Study Follow-up||1
197026|NCT01327651|477963|P2|NOT COMPLETED|Post Study Follow-up||1
197027|NCT01327651|477964|P1|NOT COMPLETED|Post Study Follow-up||0
197028|NCT01327651|477956|P9|COMPLETED|Post Study Follow-up||47
197029|NCT01327651|477957|P8|COMPLETED|Post Study Follow-up||49
197030|NCT01327651|477958|P7|COMPLETED|Post Study Follow-up||45
197031|NCT01327651|477959|P6|COMPLETED|Post Study Follow-up||59
197032|NCT01327651|477960|P5|COMPLETED|Post Study Follow-up||56
197033|NCT01327651|477961|P4|COMPLETED|Post Study Follow-up||57
197034|NCT01327651|477962|P3|COMPLETED|Post Study Follow-up||55
197035|NCT01327651|477963|P2|COMPLETED|Post Study Follow-up||55
197036|NCT01327651|477964|P1|COMPLETED|Post Study Follow-up||56
197037|NCT01327651|477956|P9|STARTED|Post Study Follow-up||49
197038|NCT01327651|477957|P8|STARTED|Post Study Follow-up||50
197039|NCT01327651|477958|P7|STARTED|Post Study Follow-up||49
197040|NCT01327651|477959|P6|STARTED|Post Study Follow-up||59
197041|NCT01327651|477960|P5|STARTED|Post Study Follow-up||56
197042|NCT01327651|477961|P4|STARTED|Post Study Follow-up||57
197043|NCT01327651|477962|P3|STARTED|Post Study Follow-up||56
197044|NCT01327651|477963|P2|STARTED|Post Study Follow-up||56
197045|NCT01327651|477964|P1|STARTED|Post Study Follow-up||56
197046|NCT01327651|477956|P9|NOT COMPLETED|Self-administered Dosing Period||11
197047|NCT01327651|477957|P8|NOT COMPLETED|Self-administered Dosing Period||10
197048|NCT01327651|477958|P7|NOT COMPLETED|Self-administered Dosing Period||10
197049|NCT01327651|477959|P6|NOT COMPLETED|Self-administered Dosing Period||0
197050|NCT01327651|477960|P5|NOT COMPLETED|Self-administered Dosing Period||3
197051|NCT01327651|477961|P4|NOT COMPLETED|Self-administered Dosing Period||3
197052|NCT01327651|477962|P3|NOT COMPLETED|Self-administered Dosing Period||4
197053|NCT01327651|477963|P2|NOT COMPLETED|Self-administered Dosing Period||3
197054|NCT01327651|477964|P1|NOT COMPLETED|Self-administered Dosing Period||4
197055|NCT01327651|477956|P9|COMPLETED|Self-administered Dosing Period||49
197056|NCT01327651|477957|P8|COMPLETED|Self-administered Dosing Period||50
197057|NCT01327651|477958|P7|COMPLETED|Self-administered Dosing Period||49
197058|NCT01327651|477959|P6|COMPLETED|Self-administered Dosing Period||59
197059|NCT01327651|477960|P5|COMPLETED|Self-administered Dosing Period||56
197060|NCT01327651|477961|P4|COMPLETED|Self-administered Dosing Period||57
197061|NCT01327651|477962|P3|COMPLETED|Self-administered Dosing Period||56
197062|NCT01327651|477963|P2|COMPLETED|Self-administered Dosing Period||56
197063|NCT01327651|477964|P1|COMPLETED|Self-administered Dosing Period||56
197064|NCT01327651|477956|P9|Week 26|Self-administered Dosing Period||49
197065|NCT01327651|477957|P8|Week 26|Self-administered Dosing Period||51
197066|NCT01327651|477958|P7|Week 26|Self-administered Dosing Period||50
197067|NCT01327651|477959|P6|Week 26|Self-administered Dosing Period||58
197068|NCT01327651|477960|P5|Week 26|Self-administered Dosing Period||56
197069|NCT01327651|477961|P4|Week 26|Self-administered Dosing Period||57
197070|NCT01327651|477962|P3|Week 26|Self-administered Dosing Period||53
197071|NCT01327651|477963|P2|Week 26|Self-administered Dosing Period||56
197072|NCT01327651|477964|P1|Week 26|Self-administered Dosing Period||58
197073|NCT01327651|477956|P9|Week 22|Self-administered Dosing Period||51
197074|NCT01327651|477957|P8|Week 22|Self-administered Dosing Period||50
197075|NCT01327651|477958|P7|Week 22|Self-administered Dosing Period||50
197076|NCT01327651|477959|P6|Week 22|Self-administered Dosing Period||59
197077|NCT01327651|477960|P5|Week 22|Self-administered Dosing Period||56
197078|NCT01327651|477961|P4|Week 22|Self-administered Dosing Period||58
197079|NCT01327651|477962|P3|Week 22|Self-administered Dosing Period||55
197080|NCT01327651|477963|P2|Week 22|Self-administered Dosing Period||56
197081|NCT01327651|477964|P1|Week 22|Self-administered Dosing Period||59
197082|NCT01327651|477956|P9|Week 18|Self-administered Dosing Period||53
197083|NCT01327651|477957|P8|Week 18|Self-administered Dosing Period||49
197084|NCT01327651|477958|P7|Week 18|Self-administered Dosing Period||53
197085|NCT01327651|477959|P6|Week 18|Self-administered Dosing Period||59
197086|NCT01327651|477960|P5|Week 18|Self-administered Dosing Period||57
197087|NCT01327651|477961|P4|Week 18|Self-administered Dosing Period||60
197088|NCT01327651|477962|P3|Week 18|Self-administered Dosing Period||56
197089|NCT01327651|477963|P2|Week 18|Self-administered Dosing Period||56
197090|NCT01327651|477964|P1|Week 18|Self-administered Dosing Period||57
197091|NCT01327651|477956|P9|Week 14|Self-administered Dosing Period||54
197092|NCT01327651|477957|P8|Week 14|Self-administered Dosing Period||51
197093|NCT01327651|477958|P7|Week 14|Self-administered Dosing Period||54
197094|NCT01327651|477959|P6|Week 14|Self-administered Dosing Period||59
197095|NCT01327651|477960|P5|Week 14|Self-administered Dosing Period||58
197096|NCT01327651|477961|P4|Week 14|Self-administered Dosing Period||60
197097|NCT01327651|477962|P3|Week 14|Self-administered Dosing Period||57
197098|NCT01327651|477963|P2|Week 14|Self-administered Dosing Period||55
197099|NCT01327651|477964|P1|Week 14|Self-administered Dosing Period||59
197100|NCT01327651|477956|P9|Week 10|Self-administered Dosing Period||56
197101|NCT01327651|477957|P8|Week 10|Self-administered Dosing Period||57
197102|NCT01327651|477958|P7|Week 10|Self-administered Dosing Period||57
197103|NCT01327651|477959|P6|Week 10|Self-administered Dosing Period||59
197104|NCT01327651|477960|P5|Week 10|Self-administered Dosing Period||59
197105|NCT01327651|477961|P4|Week 10|Self-administered Dosing Period||60
197106|NCT01327651|477962|P3|Week 10|Self-administered Dosing Period||60
197107|NCT01327651|477963|P2|Week 10|Self-administered Dosing Period||58
197108|NCT01327651|477964|P1|Week 10|Self-administered Dosing Period||59
197109|NCT01327651|477956|P9|STARTED|Self-administered Dosing Period||60
197110|NCT01327651|477957|P8|STARTED|Self-administered Dosing Period||60
197111|NCT01327651|477958|P7|STARTED|Self-administered Dosing Period||59
197112|NCT01327651|477959|P6|STARTED|Self-administered Dosing Period||59
197113|NCT01327651|477960|P5|STARTED|Self-administered Dosing Period||59
197114|NCT01327651|477961|P4|STARTED|Self-administered Dosing Period||60
197115|NCT01327651|477962|P3|STARTED|Self-administered Dosing Period||60
197116|NCT01327651|477963|P2|STARTED|Self-administered Dosing Period||59
197117|NCT01327651|477964|P1|STARTED|Self-administered Dosing Period||60
197118|NCT01327599|478083|P1|NOT COMPLETED|Overall Study||3
197119|NCT01327599|478083|P1|COMPLETED|Overall Study||57
197120|NCT01327599|478083|P1|STARTED|Overall Study||60
197121|NCT01327573|478093|P2|NOT COMPLETED|Overall Study||1
197122|NCT01327573|478094|P1|NOT COMPLETED|Overall Study||3
197123|NCT01327573|478093|P2|COMPLETED|Overall Study||4
197124|NCT01327573|478094|P1|COMPLETED|Overall Study||8
197125|NCT01327573|478093|P2|Received Treatment/Control as Allocated|Overall Study||5
197126|NCT01327573|478094|P1|Received Treatment/Control as Allocated|Overall Study||10
197127|NCT01327573|478093|P2|STARTED|Overall Study||5
197128|NCT01327573|478094|P1|STARTED|Overall Study||11
197129|NCT01327547|478105|P2|NOT COMPLETED|Overall Study||22
197130|NCT01327547|478106|P1|NOT COMPLETED|Overall Study||20
197131|NCT01327547|478105|P2|COMPLETED|Overall Study||45
197132|NCT01327547|478106|P1|COMPLETED|Overall Study||50
197133|NCT01327547|478105|P2|Randomized and Not Treated|Overall Study|Randomized but was withdrawn prior to receiving treatment due to poor venous access.|1
197134|NCT01327547|478106|P1|Randomized and Not Treated|Overall Study||0
197135|NCT01327547|478105|P2|STARTED|Overall Study||67
197136|NCT01327547|478106|P1|STARTED|Overall Study||70
197137|NCT01327508|478159|P2|NOT COMPLETED|Overall Study||0
197138|NCT01327508|478160|P1|NOT COMPLETED|Overall Study||0
197139|NCT01327508|478159|P2|COMPLETED|Overall Study||30
197140|NCT01327508|478160|P1|COMPLETED|Overall Study||30
197141|NCT01327508|478159|P2|STARTED|Overall Study||30
197142|NCT01327508|478160|P1|STARTED|Overall Study||30
197143|NCT01327495|478174|P6|NOT COMPLETED|Overall Study||2
197144|NCT01327495|478175|P5|NOT COMPLETED|Overall Study||3
197145|NCT01327495|478176|P4|NOT COMPLETED|Overall Study||0
197146|NCT01327495|478177|P3|NOT COMPLETED|Overall Study||2
197147|NCT01327495|478178|P2|NOT COMPLETED|Overall Study||2
197148|NCT01327495|478179|P1|NOT COMPLETED|Overall Study||2
197149|NCT01327495|478174|P6|COMPLETED|Overall Study|1 subject withdrawn d/t elevated LFTs, 1 dropped out d/t ski accident|9
197150|NCT01327495|478175|P5|COMPLETED|Overall Study|1 dropped out pre drug finish, 2 non-compliant subjects dropped|8
197151|NCT01327495|478176|P4|COMPLETED|Overall Study||9
197152|NCT01327495|478177|P3|COMPLETED|Overall Study|1 withdrawn due to injection AE. 1 drop-out (declined prostate biopsy and final visit).|8
197153|NCT01327495|478178|P2|COMPLETED|Overall Study|1 subject declined prostate biopsy & no-showed to final visit, 1 subject dropped d/t elevated LFTs.|9
197154|NCT01327495|478179|P1|COMPLETED|Overall Study|1 dropped due to decreased libido & energy, 1 dropped due to too much pain with acyline injections|8
197155|NCT01327495|478174|P6|STARTED|Overall Study||11
197156|NCT01327495|478175|P5|STARTED|Overall Study||11
197157|NCT01327495|478176|P4|STARTED|Overall Study||9
197158|NCT01327495|478177|P3|STARTED|Overall Study||10
197159|NCT01327495|478178|P2|STARTED|Overall Study||11
197160|NCT01327495|478179|P1|STARTED|Overall Study||10
197161|NCT01327482|478271|P1|NOT COMPLETED|Overall Study||1
197162|NCT01327482|478271|P1|COMPLETED|Overall Study|The 10th participant completed 2/3 visits|9
197163|NCT01327482|478271|P1|STARTED|Overall Study||10
197164|NCT01327339|478276|P1|NOT COMPLETED|Overall Study||8
197165|NCT01327339|478276|P1|COMPLETED|Overall Study||747
197166|NCT01327339|478276|P1|STARTED|Overall Study||755
197167|NCT01327313|478286|P4|NOT COMPLETED|Overall Study||0
197168|NCT01327313|478287|P3|NOT COMPLETED|Overall Study||0
197169|NCT01327313|478288|P2|NOT COMPLETED|Overall Study||0
197170|NCT01327313|478289|P1|NOT COMPLETED|Overall Study||0
197171|NCT01327313|478286|P4|COMPLETED|Overall Study||7
197172|NCT01327313|478287|P3|COMPLETED|Overall Study||6
197173|NCT01327313|478288|P2|COMPLETED|Overall Study||6
197174|NCT01327313|478289|P1|COMPLETED|Overall Study||8
197175|NCT01327313|478286|P4|STARTED|Overall Study||7
197176|NCT01327313|478287|P3|STARTED|Overall Study||6
197177|NCT01327313|478288|P2|STARTED|Overall Study||6
197178|NCT01327313|478289|P1|STARTED|Overall Study||8
197179|NCT01327300|478411|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
197180|NCT01327300|478412|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
197181|NCT01327300|478411|P2|COMPLETED|Second Intervention (12 Weeks)||2
197182|NCT01327300|478412|P1|COMPLETED|Second Intervention (12 Weeks)||4
197183|NCT01327300|478411|P2|STARTED|Second Intervention (12 Weeks)||2
197184|NCT01327300|478412|P1|STARTED|Second Intervention (12 Weeks)||4
197185|NCT01327300|478411|P2|NOT COMPLETED|Washout (3 Weeks)||0
197186|NCT01327300|478412|P1|NOT COMPLETED|Washout (3 Weeks)||1
197187|NCT01327300|478411|P2|COMPLETED|Washout (3 Weeks)||2
197188|NCT01327300|478412|P1|COMPLETED|Washout (3 Weeks)||4
197189|NCT01327300|478411|P2|STARTED|Washout (3 Weeks)||2
197190|NCT01327300|478412|P1|STARTED|Washout (3 Weeks)||5
197191|NCT01327300|478411|P2|NOT COMPLETED|First Intervention (12 Weeks)||0
197192|NCT01327300|478412|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
197193|NCT01327300|478411|P2|COMPLETED|First Intervention (12 Weeks)||2
197194|NCT01327300|478412|P1|COMPLETED|First Intervention (12 Weeks)||5
197195|NCT01327300|478411|P2|STARTED|First Intervention (12 Weeks)||2
197196|NCT01327300|478412|P1|STARTED|First Intervention (12 Weeks)||5
197197|NCT01327274|478428|P1|NOT COMPLETED|Overall Study||0
197198|NCT01327274|478428|P1|COMPLETED|Overall Study||15
197199|NCT01327274|478428|P1|STARTED|Overall Study||15
197200|NCT01327157|478437|P2|NOT COMPLETED|91-180||0
197201|NCT01327157|478438|P1|NOT COMPLETED|91-180||0
197202|NCT01327157|478437|P2|COMPLETED|91-180||0
197203|NCT01327157|478438|P1|COMPLETED|91-180||7
197204|NCT01327157|478437|P2|STARTED|91-180||0
197205|NCT01327157|478438|P1|STARTED|91-180||7
197206|NCT01327157|478437|P2|NOT COMPLETED|01-90||0
197207|NCT01327157|478438|P1|NOT COMPLETED|01-90||0
197208|NCT01327157|478437|P2|COMPLETED|01-90||7
197209|NCT01327157|478438|P1|COMPLETED|01-90||7
197210|NCT01327157|478437|P2|STARTED|01-90||7
197211|NCT01327157|478438|P1|STARTED|01-90||7
197212|NCT01327053|478452|P2|NOT COMPLETED|Overall Study||151
197213|NCT01327053|478453|P1|NOT COMPLETED|Overall Study||79
197214|NCT01327053|478452|P2|COMPLETED|Overall Study||0
197215|NCT01327053|478453|P1|COMPLETED|Overall Study||0
197216|NCT01327053|478452|P2|Post-treatment Follow-up|Overall Study||40
197217|NCT01327053|478453|P1|Post-treatment Follow-up|Overall Study||19
197218|NCT01327053|478452|P2|Survival Follow-up|Overall Study||49
197219|NCT01327053|478453|P1|Survival Follow-up|Overall Study||33
197220|NCT01327053|478452|P2|Patients Cont. to Next Phase of Trial|Overall Study||89
197221|NCT01327053|478453|P1|Patients Cont. to Next Phase of Trial|Overall Study||52
197222|NCT01327053|478452|P2|Untreated|Overall Study|one patient randomized to LDE225 (sonidegib) 800 mg did not receive study treatment|1
197223|NCT01327053|478453|P1|Untreated|Overall Study||0
197224|NCT01327053|478452|P2|STARTED|Overall Study||151
197225|NCT01327053|478453|P1|STARTED|Overall Study||79
197226|NCT01326962|478527|P1|NOT COMPLETED|Overall Study||7
197227|NCT01326962|478527|P1|COMPLETED|Overall Study||21
197228|NCT01326962|478527|P1|STARTED|Overall Study||28
197229|NCT01326910|478545|P2|NOT COMPLETED|Overall Study||3
197230|NCT01326910|478546|P1|NOT COMPLETED|Overall Study||4
197231|NCT01326910|478545|P2|COMPLETED|Overall Study||42
197232|NCT01326910|478546|P1|COMPLETED|Overall Study||41
197233|NCT01326910|478545|P2|STARTED|Overall Study||45
197234|NCT01326910|478546|P1|STARTED|Overall Study||45
197235|NCT01326845|478560|P2|NOT COMPLETED|Overall Study||5
197236|NCT01326845|478561|P1|NOT COMPLETED|Overall Study||7
197237|NCT01326845|478560|P2|COMPLETED|Overall Study|Study terminated early|0
197238|NCT01326845|478561|P1|COMPLETED|Overall Study|Study terminated early|0
197239|NCT01326845|478560|P2|STARTED|Overall Study||5
197240|NCT01326845|478561|P1|STARTED|Overall Study||7
197241|NCT01326780|478587|P4|NOT COMPLETED|Overall Study||13
197242|NCT01326780|478588|P3|NOT COMPLETED|Overall Study||6
197243|NCT01326780|478589|P2|NOT COMPLETED|Overall Study||9
197244|NCT01326780|478590|P1|NOT COMPLETED|Overall Study||13
197245|NCT01326780|478587|P4|COMPLETED|Overall Study||94
197246|NCT01326780|478588|P3|COMPLETED|Overall Study||103
197247|NCT01326780|478589|P2|COMPLETED|Overall Study||100
197248|NCT01326780|478590|P1|COMPLETED|Overall Study||93
197249|NCT01326780|478587|P4|STARTED|Overall Study||107
197250|NCT01326780|478588|P3|STARTED|Overall Study||109
197251|NCT01326780|478589|P2|STARTED|Overall Study||109
197252|NCT01326780|478590|P1|STARTED|Overall Study||106
197253|NCT01326728|478622|P2|NOT COMPLETED|Overall Study||9
197254|NCT01326728|478623|P1|NOT COMPLETED|Overall Study||47
197255|NCT01326728|478622|P2|COMPLETED|Overall Study||0
197256|NCT01326728|478623|P1|COMPLETED|Overall Study||0
197257|NCT01326728|478622|P2|STARTED|Overall Study||9
197258|NCT01326728|478623|P1|STARTED|Overall Study||47
197259|NCT01326546|478642|P2|NOT COMPLETED|Overall Study||13
197260|NCT01326546|478643|P1|NOT COMPLETED|Overall Study||17
197261|NCT01326546|478642|P2|COMPLETED|Overall Study||176
197262|NCT01326546|478643|P1|COMPLETED|Overall Study||172
197263|NCT01326546|478642|P2|STARTED|Overall Study||189
197264|NCT01326546|478643|P1|STARTED|Overall Study||189
197265|NCT01326533|478651|P2|NOT COMPLETED|Overall Study||0
197266|NCT01326533|478652|P1|NOT COMPLETED|Overall Study||4
197267|NCT01326533|478651|P2|COMPLETED|Overall Study||15
197268|NCT01326533|478652|P1|COMPLETED|Overall Study||13
197269|NCT01326533|478651|P2|STARTED|Overall Study||15
197270|NCT01326533|478652|P1|STARTED|Overall Study||17
197271|NCT01326481|478660|P1|NOT COMPLETED|10 mg/kg TRC105, 1000 mg/m2 Cape||0
197272|NCT01326481|478660|P1|COMPLETED|10 mg/kg TRC105, 1000 mg/m2 Cape||15
197273|NCT01326481|478660|P1|STARTED|10 mg/kg TRC105, 1000 mg/m2 Cape||15
197274|NCT01326481|478660|P1|NOT COMPLETED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||1
197275|NCT01326481|478660|P1|COMPLETED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||3
197276|NCT01326481|478660|P1|STARTED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||4
197277|NCT01326026|478669|P2|NOT COMPLETED|Overall Study||13
197278|NCT01326026|478670|P1|NOT COMPLETED|Overall Study||12
197279|NCT01326026|478669|P2|COMPLETED|Overall Study||98
197280|NCT01326026|478670|P1|COMPLETED|Overall Study||99
197281|NCT01326026|478669|P2|Exposed|Overall Study||111
197282|NCT01326026|478670|P1|Exposed|Overall Study|One subject withdrew before exposure to trial drug|110
197283|NCT01326026|478669|P2|STARTED|Overall Study||111
197284|NCT01326026|478670|P1|STARTED|Overall Study||111
197285|NCT01325870|478687|P3|NOT COMPLETED|Overall Study||8
197286|NCT01325870|478688|P2|NOT COMPLETED|Overall Study||13
197287|NCT01325870|478689|P1|NOT COMPLETED|Overall Study||11
197288|NCT01325870|478687|P3|COMPLETED|Overall Study||6
197289|NCT01325870|478688|P2|COMPLETED|Overall Study||3
197290|NCT01325870|478689|P1|COMPLETED|Overall Study||7
197291|NCT01325870|478687|P3|STARTED|Overall Study||14
197292|NCT01325870|478688|P2|STARTED|Overall Study||16
197293|NCT01325870|478689|P1|STARTED|Overall Study||18
197294|NCT01325792|478703|P1|NOT COMPLETED|Overall Study||17
197295|NCT01325792|478703|P1|COMPLETED|Overall Study||87
197296|NCT01325792|478703|P1|STARTED|Overall Study||104
197297|NCT01325714|478710|P2|NOT COMPLETED|Overall Study||31
197298|NCT01325714|478711|P1|NOT COMPLETED|Overall Study||34
197299|NCT01325714|478710|P2|COMPLETED|Overall Study||71
197300|NCT01325714|478711|P1|COMPLETED|Overall Study||67
197301|NCT01325714|478710|P2|12 Month Assessment|Overall Study||71
197302|NCT01325714|478711|P1|12 Month Assessment|Overall Study||67
197303|NCT01325714|478710|P2|6 Month Asessment|Overall Study||82
197304|NCT01325714|478711|P1|6 Month Asessment|Overall Study||75
197305|NCT01325714|478710|P2|3 Month Assessment|Overall Study||86
197306|NCT01325714|478711|P1|3 Month Assessment|Overall Study||82
197307|NCT01325714|478710|P2|STARTED|Overall Study||102
197308|NCT01325714|478711|P1|STARTED|Overall Study||101
197309|NCT01325701|478735|P2|NOT COMPLETED|Overall Study||3
197310|NCT01325701|478736|P1|NOT COMPLETED|Overall Study||21
197311|NCT01325701|478735|P2|COMPLETED|Overall Study||5
197312|NCT01325701|478736|P1|COMPLETED|Overall Study||49
197313|NCT01325701|478735|P2|STARTED|Overall Study||8
197314|NCT01325701|478736|P1|STARTED|Overall Study||70
197315|NCT01325623|478746|P1|NOT COMPLETED|Overall Study||3
197316|NCT01325623|478746|P1|COMPLETED|Overall Study||28
197317|NCT01325623|478746|P1|STARTED|Overall Study||31
197318|NCT01325584|478788|P1|NOT COMPLETED|Overall Study||1
197319|NCT01325584|478788|P1|COMPLETED|Overall Study||11
197320|NCT01325584|478788|P1|STARTED|Overall Study||12
197321|NCT01325532|478798|P2|NOT COMPLETED|Overall Study||0
197322|NCT01325532|478799|P1|NOT COMPLETED|Overall Study||2
197323|NCT01325532|478798|P2|COMPLETED|Overall Study||13
197324|NCT01325532|478799|P1|COMPLETED|Overall Study||15
197325|NCT01325532|478798|P2|STARTED|Overall Study||13
197326|NCT01325532|478799|P1|STARTED|Overall Study||17
197327|NCT01325493|478811|P2|NOT COMPLETED|Overall Study||3
197328|NCT01325493|478812|P1|NOT COMPLETED|Overall Study||1
197329|NCT01325493|478811|P2|COMPLETED|Overall Study||21
197330|NCT01325493|478812|P1|COMPLETED|Overall Study||29
197331|NCT01325493|478811|P2|STARTED|Overall Study||24
197332|NCT01325493|478812|P1|STARTED|Overall Study||30
197333|NCT01325428|478824|P1|NOT COMPLETED|Part B||3
197334|NCT01325428|478824|P1|COMPLETED|Part B||7
197335|NCT01325428|478824|P1|STARTED|Part B||10
197336|NCT01325428|478824|P1|NOT COMPLETED|Part A||16
197337|NCT01325428|478824|P1|COMPLETED|Part A||10
197338|NCT01325428|478824|P1|STARTED|Part A||26
197339|NCT01325350|478844|P5|NOT COMPLETED|Overall Study||12
197340|NCT01325350|478845|P4|NOT COMPLETED|Overall Study||9
197341|NCT01325350|478846|P3|NOT COMPLETED|Overall Study||17
197342|NCT01325350|478847|P2|NOT COMPLETED|Overall Study||5
197343|NCT01325350|478848|P1|NOT COMPLETED|Overall Study||6
197344|NCT01325350|478844|P5|COMPLETED|Overall Study||50
197345|NCT01325350|478845|P4|COMPLETED|Overall Study||52
197346|NCT01325350|478846|P3|COMPLETED|Overall Study||44
197347|NCT01325350|478847|P2|COMPLETED|Overall Study||56
197348|NCT01325350|478848|P1|COMPLETED|Overall Study||55
197349|NCT01325350|478844|P5|STARTED|Overall Study||62
197350|NCT01325350|478845|P4|STARTED|Overall Study||61
197351|NCT01325350|478846|P3|STARTED|Overall Study||61
197352|NCT01325350|478847|P2|STARTED|Overall Study||61
197353|NCT01325350|478848|P1|STARTED|Overall Study||61
197354|NCT01325337|478890|P5|NOT COMPLETED|Overall Study||8
197355|NCT01325337|478891|P4|NOT COMPLETED|Overall Study||10
197356|NCT01325337|478892|P3|NOT COMPLETED|Overall Study||9
197357|NCT01325337|478893|P2|NOT COMPLETED|Overall Study||9
197358|NCT01325337|478894|P1|NOT COMPLETED|Overall Study||5
197359|NCT01325337|478890|P5|COMPLETED|Overall Study||53
197360|NCT01325337|478891|P4|COMPLETED|Overall Study||52
197361|NCT01325337|478892|P3|COMPLETED|Overall Study||53
197362|NCT01325337|478893|P2|COMPLETED|Overall Study||52
197363|NCT01325337|478894|P1|COMPLETED|Overall Study||56
197364|NCT01325337|478890|P5|STARTED|Overall Study||61
197365|NCT01325337|478891|P4|STARTED|Overall Study||62
197366|NCT01325337|478892|P3|STARTED|Overall Study||62
197367|NCT01325337|478893|P2|STARTED|Overall Study||61
197368|NCT01325337|478894|P1|STARTED|Overall Study||61
197369|NCT01325311|478933|P2|NOT COMPLETED|Overall Study||0
197370|NCT01325311|478934|P1|NOT COMPLETED|Overall Study||0
197371|NCT01325311|478933|P2|COMPLETED|Overall Study||7
197372|NCT01325311|478934|P1|COMPLETED|Overall Study||8
197373|NCT01325311|478933|P2|STARTED|Overall Study||7
197374|NCT01325311|478934|P1|STARTED|Overall Study||8
197375|NCT01325207|478974|P6|NOT COMPLETED|Follow-up Every 3 Months Until Death||1
197376|NCT01325207|478975|P5|NOT COMPLETED|Follow-up Every 3 Months Until Death||1
197377|NCT01325207|478976|P4|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
197378|NCT01325207|478977|P3|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
197379|NCT01325207|478978|P2|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
197380|NCT01325207|478979|P1|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
197381|NCT01325207|478974|P6|COMPLETED|Follow-up Every 3 Months Until Death||18
197382|NCT01325207|478975|P5|COMPLETED|Follow-up Every 3 Months Until Death||6
197383|NCT01325207|478976|P4|COMPLETED|Follow-up Every 3 Months Until Death||1
197384|NCT01325207|478977|P3|COMPLETED|Follow-up Every 3 Months Until Death||1
197385|NCT01325207|478978|P2|COMPLETED|Follow-up Every 3 Months Until Death||3
197386|NCT01325207|478979|P1|COMPLETED|Follow-up Every 3 Months Until Death||3
197387|NCT01325207|478974|P6|STARTED|Follow-up Every 3 Months Until Death||19
197388|NCT01325207|478975|P5|STARTED|Follow-up Every 3 Months Until Death||7
197389|NCT01325207|478976|P4|STARTED|Follow-up Every 3 Months Until Death||1
197390|NCT01325207|478977|P3|STARTED|Follow-up Every 3 Months Until Death||1
197391|NCT01325207|478978|P2|STARTED|Follow-up Every 3 Months Until Death||3
197392|NCT01325207|478979|P1|STARTED|Follow-up Every 3 Months Until Death||3
197393|NCT01325207|478974|P6|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||5
197394|NCT01325207|478975|P5|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
197395|NCT01325207|478976|P4|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
197396|NCT01325207|478977|P3|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
197397|NCT01325207|478978|P2|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||2
197398|NCT01325207|478979|P1|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
197399|NCT01325207|478974|P6|COMPLETED|Started 9th Week/Cycle 3 of Treatment||9
197400|NCT01325207|478975|P5|COMPLETED|Started 9th Week/Cycle 3 of Treatment||3
197401|NCT01325207|478976|P4|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
197402|NCT01325207|478977|P3|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
197403|NCT01325207|478978|P2|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
197404|NCT01325207|478979|P1|COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
197405|NCT01325207|478974|P6|STARTED|Started 9th Week/Cycle 3 of Treatment||14
197406|NCT01325207|478975|P5|STARTED|Started 9th Week/Cycle 3 of Treatment||3
197407|NCT01325207|478976|P4|STARTED|Started 9th Week/Cycle 3 of Treatment||1
197408|NCT01325207|478977|P3|STARTED|Started 9th Week/Cycle 3 of Treatment||1
197409|NCT01325207|478978|P2|STARTED|Started 9th Week/Cycle 3 of Treatment||2
197410|NCT01325207|478979|P1|STARTED|Started 9th Week/Cycle 3 of Treatment||2
197411|NCT01325207|478974|P6|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||5
197412|NCT01325207|478975|P5|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
197413|NCT01325207|478976|P4|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||0
197414|NCT01325207|478977|P3|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||0
197415|NCT01325207|478978|P2|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
197416|NCT01325207|478979|P1|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
197417|NCT01325207|478974|P6|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||14
197418|NCT01325207|478975|P5|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||3
197419|NCT01325207|478976|P4|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
197420|NCT01325207|478977|P3|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
197421|NCT01325207|478978|P2|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
197422|NCT01325207|478979|P1|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
197423|NCT01325207|478974|P6|STARTED|Completed 8 Weeks/2 Cycles of Treatment||19
197424|NCT01325207|478975|P5|STARTED|Completed 8 Weeks/2 Cycles of Treatment||5
197425|NCT01325207|478976|P4|STARTED|Completed 8 Weeks/2 Cycles of Treatment||1
197426|NCT01325207|478977|P3|STARTED|Completed 8 Weeks/2 Cycles of Treatment||1
197427|NCT01325207|478978|P2|STARTED|Completed 8 Weeks/2 Cycles of Treatment||3
197428|NCT01325207|478979|P1|STARTED|Completed 8 Weeks/2 Cycles of Treatment||3
197429|NCT01325207|478974|P6|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
197430|NCT01325207|478975|P5|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||2
197431|NCT01325207|478976|P4|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
197432|NCT01325207|478977|P3|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
197433|NCT01325207|478978|P2|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
197434|NCT01325207|478979|P1|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
197435|NCT01325207|478974|P6|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||19
197436|NCT01325207|478975|P5|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||5
197437|NCT01325207|478976|P4|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||1
197438|NCT01325207|478977|P3|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||1
197439|NCT01325207|478978|P2|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||3
197440|NCT01325207|478979|P1|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||3
197441|NCT01325207|478974|P6|STARTED|Completed 4 Weeks/1 Cycle of Treatment||19
197442|NCT01325207|478975|P5|STARTED|Completed 4 Weeks/1 Cycle of Treatment||7
197443|NCT01325207|478976|P4|STARTED|Completed 4 Weeks/1 Cycle of Treatment||1
197444|NCT01325207|478977|P3|STARTED|Completed 4 Weeks/1 Cycle of Treatment||1
197445|NCT01325207|478978|P2|STARTED|Completed 4 Weeks/1 Cycle of Treatment||3
197446|NCT01325207|478979|P1|STARTED|Completed 4 Weeks/1 Cycle of Treatment||3
197447|NCT01325181|479004|P2|NOT COMPLETED|Overall Study||2
197448|NCT01325181|479005|P1|NOT COMPLETED|Overall Study||0
197449|NCT01325181|479004|P2|COMPLETED|Overall Study||14
197450|NCT01325181|479005|P1|COMPLETED|Overall Study||18
197451|NCT01325181|479004|P2|STARTED|Overall Study||16
197452|NCT01325181|479005|P1|STARTED|Overall Study||18
197453|NCT01324999|479011|P1|NOT COMPLETED|Overall Study||5
197454|NCT01324999|479011|P1|COMPLETED|Overall Study||7
197455|NCT01324999|479011|P1|STARTED|Overall Study||12
197456|NCT01324947|479022|P1|NOT COMPLETED|Overall Study||74
197457|NCT01324947|479022|P1|COMPLETED|Overall Study||0
197458|NCT01324947|479022|P1|Efficacy Evaluable Population (EEP)|Overall Study|Participants who received ≥ 1 dose of study drug and had at least 1 postbaseline efficacy assessment|64
197459|NCT01324947|479022|P1|Safety Population|Overall Study|Safety Population includes those who were enrolled and received at least one dose of study drug|73
197460|NCT01324947|479022|P1|STARTED|Overall Study||74
197461|NCT01324882|479035|P2|NOT COMPLETED|Overall Study||0
197462|NCT01324882|479036|P1|NOT COMPLETED|Overall Study||0
197463|NCT01324882|479035|P2|COMPLETED|Overall Study|30 patients had the colonoscopy|30
197464|NCT01324882|479036|P1|COMPLETED|Overall Study|27 patients had the colonoscopy|27
197465|NCT01324882|479035|P2|STARTED|Overall Study|30 patients were randomized to this arm|30
197466|NCT01324882|479036|P1|STARTED|Overall Study|27 patients were randomized to this arm.|27
197467|NCT01324830|479063|P19|NOT COMPLETED|Overall Study||6
197468|NCT01324830|479064|P18|NOT COMPLETED|Overall Study||6
197469|NCT01324830|479065|P17|NOT COMPLETED|Overall Study||3
197470|NCT01324830|479066|P16|NOT COMPLETED|Overall Study||3
197471|NCT01324830|479067|P15|NOT COMPLETED|Overall Study||1
197472|NCT01324830|479068|P14|NOT COMPLETED|Overall Study||1
197473|NCT01324830|479069|P13|NOT COMPLETED|Overall Study||1
197474|NCT01324830|479070|P12|NOT COMPLETED|Overall Study||1
197475|NCT01324830|479071|P11|NOT COMPLETED|Overall Study||4
197476|NCT01324830|479072|P10|NOT COMPLETED|Overall Study||6
197477|NCT01324830|479073|P9|NOT COMPLETED|Overall Study||5
197478|NCT01324830|479074|P8|NOT COMPLETED|Overall Study||3
197479|NCT01324830|479075|P7|NOT COMPLETED|Overall Study||3
197480|NCT01324830|479076|P6|NOT COMPLETED|Overall Study||7
197481|NCT01324830|479077|P5|NOT COMPLETED|Overall Study||7
197482|NCT01324830|479078|P4|NOT COMPLETED|Overall Study||3
197483|NCT01324830|479079|P3|NOT COMPLETED|Overall Study||3
197484|NCT01324830|479080|P2|NOT COMPLETED|Overall Study||3
197485|NCT01324830|479081|P1|NOT COMPLETED|Overall Study||3
197486|NCT01324830|479063|P19|COMPLETED|Overall Study||0
197487|NCT01324830|479064|P18|COMPLETED|Overall Study||0
197488|NCT01324830|479065|P17|COMPLETED|Overall Study||0
197489|NCT01324830|479066|P16|COMPLETED|Overall Study||0
197490|NCT01324830|479067|P15|COMPLETED|Overall Study||0
197491|NCT01324830|479068|P14|COMPLETED|Overall Study||0
197492|NCT01324830|479069|P13|COMPLETED|Overall Study||0
197493|NCT01324830|479070|P12|COMPLETED|Overall Study||0
197494|NCT01324830|479071|P11|COMPLETED|Overall Study||0
197495|NCT01324830|479072|P10|COMPLETED|Overall Study||0
197496|NCT01324830|479073|P9|COMPLETED|Overall Study||0
197497|NCT01324830|479074|P8|COMPLETED|Overall Study||0
197498|NCT01324830|479075|P7|COMPLETED|Overall Study||0
197499|NCT01324830|479076|P6|COMPLETED|Overall Study||0
197500|NCT01324830|479077|P5|COMPLETED|Overall Study||0
197501|NCT01324830|479078|P4|COMPLETED|Overall Study||0
197502|NCT01324830|479079|P3|COMPLETED|Overall Study||0
197503|NCT01324830|479080|P2|COMPLETED|Overall Study||0
197504|NCT01324830|479081|P1|COMPLETED|Overall Study||0
197505|NCT01324830|479063|P19|STARTED|Overall Study||6
197506|NCT01324830|479064|P18|STARTED|Overall Study||6
197507|NCT01324830|479065|P17|STARTED|Overall Study||3
197508|NCT01324830|479066|P16|STARTED|Overall Study||3
197509|NCT01324830|479067|P15|STARTED|Overall Study||1
197510|NCT01324830|479068|P14|STARTED|Overall Study||1
197511|NCT01324830|479069|P13|STARTED|Overall Study||1
197512|NCT01324830|479070|P12|STARTED|Overall Study||1
197513|NCT01324830|479071|P11|STARTED|Overall Study||4
197514|NCT01324830|479072|P10|STARTED|Overall Study||6
197515|NCT01324830|479073|P9|STARTED|Overall Study||5
197516|NCT01324830|479074|P8|STARTED|Overall Study||3
197517|NCT01324830|479075|P7|STARTED|Overall Study||3
197518|NCT01324830|479076|P6|STARTED|Overall Study||7
197519|NCT01324830|479077|P5|STARTED|Overall Study||7
197520|NCT01324830|479078|P4|STARTED|Overall Study||3
197521|NCT01324830|479079|P3|STARTED|Overall Study||3
197522|NCT01324830|479080|P2|STARTED|Overall Study||3
197523|NCT01324830|479081|P1|STARTED|Overall Study||3
197524|NCT01324700|479197|P4|NOT COMPLETED|Overall Study||11
197525|NCT01324700|479198|P3|NOT COMPLETED|Overall Study||16
197526|NCT01324700|479199|P2|NOT COMPLETED|Overall Study||4
197527|NCT01324700|479200|P1|NOT COMPLETED|Overall Study||9
197528|NCT01324700|479197|P4|COMPLETED|Overall Study||37
197529|NCT01324700|479198|P3|COMPLETED|Overall Study||33
197530|NCT01324700|479199|P2|COMPLETED|Overall Study||16
197531|NCT01324700|479200|P1|COMPLETED|Overall Study||13
197532|NCT01324700|479197|P4|STARTED|Overall Study||48
197533|NCT01324700|479198|P3|STARTED|Overall Study||49
197534|NCT01324700|479199|P2|STARTED|Overall Study||20
197535|NCT01324700|479200|P1|STARTED|Overall Study||22
197536|NCT01324687|479216|P2|NOT COMPLETED|Overall Study||15
197537|NCT01324687|479217|P1|NOT COMPLETED|Overall Study||0
197538|NCT01324687|479216|P2|COMPLETED|Overall Study||479
197539|NCT01324687|479217|P1|COMPLETED|Overall Study||1058
197540|NCT01324687|479216|P2|STARTED|Overall Study||494
197541|NCT01324687|479217|P1|STARTED|Overall Study||1058
197542|NCT01324622|479227|P2|NOT COMPLETED|Overall Study||7
197543|NCT01324622|479228|P1|NOT COMPLETED|Overall Study||9
197544|NCT01324622|479227|P2|COMPLETED|Overall Study||4
197545|NCT01324622|479228|P1|COMPLETED|Overall Study||4
197546|NCT01324622|479227|P2|STARTED|Overall Study||11
197547|NCT01324622|479228|P1|STARTED|Overall Study||13
197548|NCT01324570|479258|P2|NOT COMPLETED|Overall Study||14
197549|NCT01324570|479259|P1|NOT COMPLETED|Overall Study||4
197550|NCT01324570|479258|P2|COMPLETED|Overall Study||21
197551|NCT01324570|479259|P1|COMPLETED|Overall Study||2
197552|NCT01324570|479258|P2|STARTED|Overall Study||35
197553|NCT01324570|479259|P1|STARTED|Overall Study||6
197554|NCT01324453|479273|P2|NOT COMPLETED|Overall Study||0
197555|NCT01324453|479274|P1|NOT COMPLETED|Overall Study||0
197556|NCT01324453|479273|P2|COMPLETED|Overall Study||49
197557|NCT01324453|479274|P1|COMPLETED|Overall Study||54
197558|NCT01324453|479273|P2|STARTED|Overall Study||49
197559|NCT01324453|479274|P1|STARTED|Overall Study||54
197560|NCT01324440|479296|P2|NOT COMPLETED|Overall Study||1
197561|NCT01324440|479297|P1|NOT COMPLETED|Overall Study||0
197562|NCT01324440|479296|P2|COMPLETED|Overall Study||31
197563|NCT01324440|479297|P1|COMPLETED|Overall Study||32
197564|NCT01324440|479296|P2|STARTED|Overall Study||32
197565|NCT01324440|479297|P1|STARTED|Overall Study||32
197566|NCT01324401|479311|P2|NOT COMPLETED|Overall Study||6
197567|NCT01324401|479312|P1|NOT COMPLETED|Overall Study||1
197568|NCT01324401|479311|P2|COMPLETED|Overall Study|three (3) unable to complete due to adverse events|20
197569|NCT01324401|479312|P1|COMPLETED|Overall Study|one (1) could not tolerate minimum starting dose|3
197570|NCT01324401|479311|P2|STARTED|Overall Study|3 excluded from ITT analysis: 1 screen fail, 2 voluntary withdrawal pre-treatment|26
197571|NCT01324401|479312|P1|STARTED|Overall Study||4
197572|NCT01324388|479323|P4|NOT COMPLETED|Part 2 of Study: Second Intervention||0
197573|NCT01324388|479324|P3|NOT COMPLETED|Part 2 of Study: Second Intervention||1
197574|NCT01324388|479325|P2|NOT COMPLETED|Part 2 of Study: Second Intervention||0
197575|NCT01324388|479326|P1|NOT COMPLETED|Part 2 of Study: Second Intervention||0
197576|NCT01324388|479323|P4|COMPLETED|Part 2 of Study: Second Intervention||9
197577|NCT01324388|479324|P3|COMPLETED|Part 2 of Study: Second Intervention||9
197578|NCT01324388|479325|P2|COMPLETED|Part 2 of Study: Second Intervention||0
197579|NCT01324388|479326|P1|COMPLETED|Part 2 of Study: Second Intervention||0
197580|NCT01324388|479323|P4|STARTED|Part 2 of Study: Second Intervention||9
197581|NCT01324388|479324|P3|STARTED|Part 2 of Study: Second Intervention||10
197582|NCT01324388|479325|P2|STARTED|Part 2 of Study: Second Intervention||0
197583|NCT01324388|479326|P1|STARTED|Part 2 of Study: Second Intervention||0
197584|NCT01324388|479323|P4|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
197585|NCT01324388|479324|P3|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
197586|NCT01324388|479325|P2|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
197587|NCT01324388|479326|P1|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
197588|NCT01324388|479323|P4|COMPLETED|Part 2: Washout of at Least 21 Days||9
197589|NCT01324388|479324|P3|COMPLETED|Part 2: Washout of at Least 21 Days||10
197590|NCT01324388|479325|P2|COMPLETED|Part 2: Washout of at Least 21 Days||0
197591|NCT01324388|479326|P1|COMPLETED|Part 2: Washout of at Least 21 Days||0
197592|NCT01324388|479323|P4|STARTED|Part 2: Washout of at Least 21 Days||9
197593|NCT01324388|479324|P3|STARTED|Part 2: Washout of at Least 21 Days||10
197594|NCT01324388|479325|P2|STARTED|Part 2: Washout of at Least 21 Days||0
197595|NCT01324388|479326|P1|STARTED|Part 2: Washout of at Least 21 Days||0
197596|NCT01324388|479323|P4|NOT COMPLETED|Part 2 of Study: First Intervention||1
197597|NCT01324388|479324|P3|NOT COMPLETED|Part 2 of Study: First Intervention||0
197598|NCT01324388|479325|P2|NOT COMPLETED|Part 2 of Study: First Intervention||0
197599|NCT01324388|479326|P1|NOT COMPLETED|Part 2 of Study: First Intervention||0
197600|NCT01324388|479323|P4|COMPLETED|Part 2 of Study: First Intervention||9
197601|NCT01324388|479324|P3|COMPLETED|Part 2 of Study: First Intervention||10
197602|NCT01324388|479325|P2|COMPLETED|Part 2 of Study: First Intervention||0
197603|NCT01324388|479326|P1|COMPLETED|Part 2 of Study: First Intervention||0
197604|NCT01324388|479323|P4|STARTED|Part 2 of Study: First Intervention||10
197605|NCT01324388|479324|P3|STARTED|Part 2 of Study: First Intervention||10
197606|NCT01324388|479325|P2|STARTED|Part 2 of Study: First Intervention||0
197607|NCT01324388|479326|P1|STARTED|Part 2 of Study: First Intervention||0
197608|NCT01324388|479323|P4|NOT COMPLETED|Part 1 of Study||0
197609|NCT01324388|479324|P3|NOT COMPLETED|Part 1 of Study||0
197610|NCT01324388|479325|P2|NOT COMPLETED|Part 1 of Study||2
197611|NCT01324388|479326|P1|NOT COMPLETED|Part 1 of Study||4
197612|NCT01324388|479323|P4|COMPLETED|Part 1 of Study||0
197613|NCT01324388|479324|P3|COMPLETED|Part 1 of Study||0
197614|NCT01324388|479325|P2|COMPLETED|Part 1 of Study||6
197615|NCT01324388|479326|P1|COMPLETED|Part 1 of Study||19
197616|NCT01324388|479323|P4|Received at Least 1 Dose|Part 1 of Study||0
197617|NCT01324388|479324|P3|Received at Least 1 Dose|Part 1 of Study||0
197618|NCT01324388|479325|P2|Received at Least 1 Dose|Part 1 of Study||8
197619|NCT01324388|479326|P1|Received at Least 1 Dose|Part 1 of Study||23
197620|NCT01324388|479323|P4|STARTED|Part 1 of Study||0
197621|NCT01324388|479324|P3|STARTED|Part 1 of Study||0
197622|NCT01324388|479325|P2|STARTED|Part 1 of Study||8
197623|NCT01324388|479326|P1|STARTED|Part 1 of Study||23
197624|NCT01324349|479347|P2|NOT COMPLETED|Overall Study||2
197625|NCT01324349|479348|P1|NOT COMPLETED|Overall Study||1
197626|NCT01324349|479347|P2|COMPLETED|Overall Study||16
197627|NCT01324349|479348|P1|COMPLETED|Overall Study||31
197628|NCT01324349|479347|P2|STARTED|Overall Study||18
197629|NCT01324349|479348|P1|STARTED|Overall Study||32
197630|NCT01324323|479358|P1|NOT COMPLETED|Overall Study||1
197631|NCT01324323|479358|P1|COMPLETED|Overall Study||13
197632|NCT01324323|479358|P1|STARTED|Overall Study||14
197633|NCT01324310|479378|P1|NOT COMPLETED|Overall Study||2
197634|NCT01324310|479378|P1|COMPLETED|Overall Study||13
197635|NCT01324310|479378|P1|STARTED|Overall Study||15
197636|NCT01324271|479398|P2|NOT COMPLETED|Overall Study||0
197637|NCT01324271|479399|P1|NOT COMPLETED|Overall Study||4
197638|NCT01324271|479398|P2|COMPLETED|Overall Study||28
197639|NCT01324271|479399|P1|COMPLETED|Overall Study||53
197640|NCT01324271|479398|P2|STARTED|Overall Study||28
197641|NCT01324271|479399|P1|STARTED|Overall Study||57
197642|NCT01324128|479407|P4|NOT COMPLETED|Stage 2||3
197643|NCT01324128|479408|P3|NOT COMPLETED|Stage 2||8
197644|NCT01324128|479409|P2|NOT COMPLETED|Stage 2||0
197645|NCT01324128|479410|P1|NOT COMPLETED|Stage 2||0
197646|NCT01324128|479407|P4|COMPLETED|Stage 2||46
197647|NCT01324128|479408|P3|COMPLETED|Stage 2||42
197648|NCT01324128|479409|P2|COMPLETED|Stage 2||0
197649|NCT01324128|479410|P1|COMPLETED|Stage 2||0
197650|NCT01324128|479407|P4|STARTED|Stage 2||49
197651|NCT01324128|479408|P3|STARTED|Stage 2||50
197652|NCT01324128|479409|P2|STARTED|Stage 2||0
197653|NCT01324128|479410|P1|STARTED|Stage 2||0
197654|NCT01324128|479407|P4|NOT COMPLETED|Stage 1||0
197655|NCT01324128|479408|P3|NOT COMPLETED|Stage 1||0
197656|NCT01324128|479409|P2|NOT COMPLETED|Stage 1||56
197657|NCT01324128|479410|P1|NOT COMPLETED|Stage 1||195
197658|NCT01324128|479407|P4|COMPLETED|Stage 1||0
197659|NCT01324128|479408|P3|COMPLETED|Stage 1||0
197660|NCT01324128|479409|P2|COMPLETED|Stage 1||293
197661|NCT01324128|479410|P1|COMPLETED|Stage 1||515
197662|NCT01324128|479407|P4|STARTED|Stage 1||0
197663|NCT01324128|479408|P3|STARTED|Stage 1||0
197664|NCT01324128|479409|P2|STARTED|Stage 1||349
197665|NCT01324128|479410|P1|STARTED|Stage 1||710
197666|NCT01324102|479422|P2|NOT COMPLETED|Overall Study||6
197667|NCT01324102|479423|P1|NOT COMPLETED|Overall Study||1
197668|NCT01324102|479422|P2|COMPLETED|Overall Study||6
197669|NCT01324102|479423|P1|COMPLETED|Overall Study||10
197670|NCT01324102|479422|P2|STARTED|Overall Study|Yoga group 4 and 6|12
197671|NCT01324102|479423|P1|STARTED|Overall Study|Yoga groups 3 and 5 (not including pre-randomization group)|11
197672|NCT01324024|479430|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
197673|NCT01324024|479431|P1|NOT COMPLETED|Second Intervention (4 Weeks)||2
197674|NCT01324024|479430|P2|COMPLETED|Second Intervention (4 Weeks)||16
197675|NCT01324024|479431|P1|COMPLETED|Second Intervention (4 Weeks)||16
197676|NCT01324024|479430|P2|STARTED|Second Intervention (4 Weeks)||17
197677|NCT01324024|479431|P1|STARTED|Second Intervention (4 Weeks)||18
197678|NCT01324024|479430|P2|NOT COMPLETED|Washout (2 Weeks)||0
197679|NCT01324024|479431|P1|NOT COMPLETED|Washout (2 Weeks)||0
197680|NCT01324024|479430|P2|COMPLETED|Washout (2 Weeks)||17
197681|NCT01324024|479431|P1|COMPLETED|Washout (2 Weeks)||18
197682|NCT01324024|479430|P2|STARTED|Washout (2 Weeks)||17
197683|NCT01324024|479431|P1|STARTED|Washout (2 Weeks)||18
197684|NCT01324024|479430|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
197685|NCT01324024|479431|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
197686|NCT01324024|479430|P2|COMPLETED|First Intervention (4 Weeks)||17
197687|NCT01324024|479431|P1|COMPLETED|First Intervention (4 Weeks)||18
197688|NCT01324024|479430|P2|STARTED|First Intervention (4 Weeks)||17
197689|NCT01324024|479431|P1|STARTED|First Intervention (4 Weeks)||18
197690|NCT01323998|479449|P5|NOT COMPLETED|Overall Study||0
197691|NCT01323998|479450|P4|NOT COMPLETED|Overall Study||0
197692|NCT01323998|479451|P3|NOT COMPLETED|Overall Study||0
197693|NCT01323998|479452|P2|NOT COMPLETED|Overall Study||0
197694|NCT01323998|479453|P1|NOT COMPLETED|Overall Study||0
197695|NCT01323998|479449|P5|COMPLETED|Overall Study||6735
197696|NCT01323998|479450|P4|COMPLETED|Overall Study||12052
197697|NCT01323998|479451|P3|COMPLETED|Overall Study||10294
197698|NCT01323998|479452|P2|COMPLETED|Overall Study||18681
197699|NCT01323998|479453|P1|COMPLETED|Overall Study||200631
197700|NCT01323998|479449|P5|STARTED|Overall Study||6735
197701|NCT01323998|479450|P4|STARTED|Overall Study||12052
197702|NCT01323998|479451|P3|STARTED|Overall Study||10294
197703|NCT01323998|479452|P2|STARTED|Overall Study||18681
197704|NCT01323998|479453|P1|STARTED|Overall Study||200631
197705|NCT01323972|479469|P4|NOT COMPLETED|Overall Study||1
197706|NCT01323972|479470|P3|NOT COMPLETED|Overall Study||2
197707|NCT01323972|479471|P2|NOT COMPLETED|Overall Study||3
197708|NCT01323972|479472|P1|NOT COMPLETED|Overall Study||2
197709|NCT01323972|479469|P4|COMPLETED|Overall Study||79
197710|NCT01323972|479470|P3|COMPLETED|Overall Study||78
197711|NCT01323972|479471|P2|COMPLETED|Overall Study||76
197712|NCT01323972|479472|P1|COMPLETED|Overall Study||79
197713|NCT01323972|479469|P4|STARTED|Overall Study||80
197714|NCT01323972|479470|P3|STARTED|Overall Study||80
197715|NCT01323972|479471|P2|STARTED|Overall Study||79
197716|NCT01323972|479472|P1|STARTED|Overall Study||81
197717|NCT01323959|479507|P3|NOT COMPLETED|Overall Study||0
197718|NCT01323959|479508|P2|NOT COMPLETED|Overall Study||0
197719|NCT01323959|479509|P1|NOT COMPLETED|Overall Study||0
197720|NCT01323959|479507|P3|COMPLETED|Overall Study||72
197721|NCT01323959|479508|P2|COMPLETED|Overall Study||72
197722|NCT01323959|479509|P1|COMPLETED|Overall Study||67
197723|NCT01323959|479507|P3|STARTED|Overall Study||72
197724|NCT01323959|479508|P2|STARTED|Overall Study||72
197725|NCT01323959|479509|P1|STARTED|Overall Study||67
197726|NCT01323946|479568|P3|NOT COMPLETED|Overall Study||0
197727|NCT01323946|479569|P2|NOT COMPLETED|Overall Study||3
197728|NCT01323946|479570|P1|NOT COMPLETED|Overall Study||3
197729|NCT01323946|479568|P3|COMPLETED|Overall Study||33
197730|NCT01323946|479569|P2|COMPLETED|Overall Study||31
197731|NCT01323946|479570|P1|COMPLETED|Overall Study||43
197732|NCT01323946|479568|P3|STARTED|Overall Study||33
197733|NCT01323946|479569|P2|STARTED|Overall Study||34
197734|NCT01323946|479570|P1|STARTED|Overall Study||46
197735|NCT01323920|479691|P1|NOT COMPLETED|Overall Study||6
197736|NCT01323920|479691|P1|COMPLETED|Overall Study||29
197737|NCT01323920|479691|P1|STARTED|Overall Study||35
197738|NCT01323855|479703|P5|NOT COMPLETED|Overall Study||0
197739|NCT01323855|479704|P4|NOT COMPLETED|Overall Study||0
197740|NCT01323855|479705|P3|NOT COMPLETED|Overall Study||0
197741|NCT01323855|479706|P2|NOT COMPLETED|Overall Study||0
197742|NCT01323855|479707|P1|NOT COMPLETED|Overall Study||0
197743|NCT01323855|479703|P5|COMPLETED|Overall Study||11
197744|NCT01323855|479704|P4|COMPLETED|Overall Study||9
197745|NCT01323855|479705|P3|COMPLETED|Overall Study||8
197746|NCT01323855|479706|P2|COMPLETED|Overall Study||9
197747|NCT01323855|479707|P1|COMPLETED|Overall Study||9
197748|NCT01323855|479703|P5|STARTED|Overall Study||11
197749|NCT01323855|479704|P4|STARTED|Overall Study||9
197750|NCT01323855|479705|P3|STARTED|Overall Study||8
197751|NCT01323855|479706|P2|STARTED|Overall Study||9
197752|NCT01323855|479707|P1|STARTED|Overall Study||9
197753|NCT01323790|479732|P3|NOT COMPLETED|Overall Study||45
197754|NCT01323790|479733|P2|NOT COMPLETED|Overall Study||60
197755|NCT01323790|479734|P1|NOT COMPLETED|Overall Study||55
197756|NCT01323790|479732|P3|COMPLETED|Overall Study||188
197757|NCT01323790|479733|P2|COMPLETED|Overall Study||174
197758|NCT01323790|479734|P1|COMPLETED|Overall Study||178
197759|NCT01323790|479732|P3|STARTED|Overall Study||233
197760|NCT01323790|479733|P2|STARTED|Overall Study||234
197761|NCT01323790|479734|P1|STARTED|Overall Study||233
197762|NCT01323777|479772|P1|NOT COMPLETED|Overall Study||0
197763|NCT01323777|479772|P1|COMPLETED|Overall Study||65
197764|NCT01323777|479772|P1|STARTED|Overall Study||65
197765|NCT01323673|479785|P2|NOT COMPLETED|Overall Study||5
197766|NCT01323673|479786|P1|NOT COMPLETED|Overall Study||3
197767|NCT01323673|479785|P2|COMPLETED|Overall Study||58
197768|NCT01323673|479786|P1|COMPLETED|Overall Study||59
197769|NCT01323673|479785|P2|STARTED|Overall Study||63
197770|NCT01323673|479786|P1|STARTED|Overall Study||62
197771|NCT01323660|479806|P6|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
197772|NCT01323660|479807|P5|NOT COMPLETED|Treatment Period 2 (12 Weeks)||4
197773|NCT01323660|479808|P4|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
197774|NCT01323660|479809|P3|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
197775|NCT01323660|479810|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
197776|NCT01323660|479811|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||12
197777|NCT01323660|479806|P6|COMPLETED|Treatment Period 2 (12 Weeks)||51
197778|NCT01323660|479807|P5|COMPLETED|Treatment Period 2 (12 Weeks)||55
197779|NCT01323660|479808|P4|COMPLETED|Treatment Period 2 (12 Weeks)||25
197780|NCT01323660|479809|P3|COMPLETED|Treatment Period 2 (12 Weeks)||14
197781|NCT01323660|479810|P2|COMPLETED|Treatment Period 2 (12 Weeks)||17
197782|NCT01323660|479811|P1|COMPLETED|Treatment Period 2 (12 Weeks)||55
197783|NCT01323660|479806|P6|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|58
197784|NCT01323660|479807|P5|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|59
197785|NCT01323660|479808|P4|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|28
197786|NCT01323660|479809|P3|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|17
197787|NCT01323660|479810|P2|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|18
197788|NCT01323660|479811|P1|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|67
197789|NCT01323660|479806|P6|NOT COMPLETED|Washout Period (14 Days)||2
197790|NCT01323660|479807|P5|NOT COMPLETED|Washout Period (14 Days)||3
197791|NCT01323660|479808|P4|NOT COMPLETED|Washout Period (14 Days)||3
197792|NCT01323660|479809|P3|NOT COMPLETED|Washout Period (14 Days)||1
197793|NCT01323660|479810|P2|NOT COMPLETED|Washout Period (14 Days)||0
197794|NCT01323660|479811|P1|NOT COMPLETED|Washout Period (14 Days)||0
197795|NCT01323660|479806|P6|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|59
197796|NCT01323660|479807|P5|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|58
197797|NCT01323660|479808|P4|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|28
197798|NCT01323660|479809|P3|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
197799|NCT01323660|479810|P2|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
197800|NCT01323660|479811|P1|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|65
197801|NCT01323660|479806|P6|STARTED|Washout Period (14 Days)||61
197802|NCT01323660|479807|P5|STARTED|Washout Period (14 Days)||61
197803|NCT01323660|479808|P4|STARTED|Washout Period (14 Days)||31
197804|NCT01323660|479809|P3|STARTED|Washout Period (14 Days)||19
197805|NCT01323660|479810|P2|STARTED|Washout Period (14 Days)||21
197806|NCT01323660|479811|P1|STARTED|Washout Period (14 Days)||65
197807|NCT01323660|479806|P6|NOT COMPLETED|Treatment Period 1 (12 Weeks)||9
197808|NCT01323660|479807|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||10
197809|NCT01323660|479808|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
197810|NCT01323660|479809|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
197811|NCT01323660|479810|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||1
197812|NCT01323660|479811|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||19
197813|NCT01323660|479806|P6|COMPLETED|Treatment Period 1 (12 Weeks)||61
197814|NCT01323660|479807|P5|COMPLETED|Treatment Period 1 (12 Weeks)||61
197815|NCT01323660|479808|P4|COMPLETED|Treatment Period 1 (12 Weeks)||31
197816|NCT01323660|479809|P3|COMPLETED|Treatment Period 1 (12 Weeks)||19
197817|NCT01323660|479810|P2|COMPLETED|Treatment Period 1 (12 Weeks)||21
197818|NCT01323660|479811|P1|COMPLETED|Treatment Period 1 (12 Weeks)||65
197819|NCT01323660|479806|P6|STARTED|Treatment Period 1 (12 Weeks)||70
197820|NCT01323660|479807|P5|STARTED|Treatment Period 1 (12 Weeks)||71
197821|NCT01323660|479808|P4|STARTED|Treatment Period 1 (12 Weeks)||36
197822|NCT01323660|479809|P3|STARTED|Treatment Period 1 (12 Weeks)||24
197823|NCT01323660|479810|P2|STARTED|Treatment Period 1 (12 Weeks)||22
197824|NCT01323660|479811|P1|STARTED|Treatment Period 1 (12 Weeks)||84
197825|NCT01323647|479857|P2|NOT COMPLETED|Overall Study||0
197826|NCT01323647|479858|P1|NOT COMPLETED|Overall Study||9
197827|NCT01323647|479857|P2|COMPLETED|Overall Study||487
197828|NCT01323647|479858|P1|COMPLETED|Overall Study||461
197829|NCT01323647|479857|P2|STARTED|Overall Study||487
197830|NCT01323647|479858|P1|STARTED|Overall Study||470
197831|NCT01323634|479875|P3|NOT COMPLETED|Double-Blind (DB) Treatment Period||22
197832|NCT01323634|479876|P2|NOT COMPLETED|Double-Blind (DB) Treatment Period||25
197833|NCT01323634|479877|P1|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
197834|NCT01323634|479875|P3|COMPLETED|Double-Blind (DB) Treatment Period||239
197835|NCT01323634|479876|P2|COMPLETED|Double-Blind (DB) Treatment Period||235
197836|NCT01323634|479877|P1|COMPLETED|Double-Blind (DB) Treatment Period||0
197837|NCT01323634|479875|P3|STARTED|Double-Blind (DB) Treatment Period||261
197838|NCT01323634|479876|P2|STARTED|Double-Blind (DB) Treatment Period||260
197839|NCT01323634|479877|P1|STARTED|Double-Blind (DB) Treatment Period||0
197840|NCT01323634|479875|P3|NOT COMPLETED|2-week Run-in Period||0
197841|NCT01323634|479876|P2|NOT COMPLETED|2-week Run-in Period||0
197842|NCT01323634|479877|P1|NOT COMPLETED|2-week Run-in Period||212
197843|NCT01323634|479875|P3|COMPLETED|2-week Run-in Period||0
197844|NCT01323634|479876|P2|COMPLETED|2-week Run-in Period||0
197845|NCT01323634|479877|P1|COMPLETED|2-week Run-in Period||521
197846|NCT01323634|479875|P3|STARTED|2-week Run-in Period||0
197847|NCT01323634|479876|P2|STARTED|2-week Run-in Period||0
197848|NCT01323634|479877|P1|STARTED|2-week Run-in Period||733
197849|NCT01323621|479887|P3|NOT COMPLETED|12-week, Double-blind Treatment Period||20
197850|NCT01323621|479888|P2|NOT COMPLETED|12-week, Double-blind Treatment Period||15
197851|NCT01323621|479889|P1|NOT COMPLETED|12-week, Double-blind Treatment Period||0
197852|NCT01323621|479887|P3|COMPLETED|12-week, Double-blind Treatment Period||239
197853|NCT01323621|479888|P2|COMPLETED|12-week, Double-blind Treatment Period||237
197854|NCT01323621|479889|P1|COMPLETED|12-week, Double-blind Treatment Period||0
197855|NCT01323621|479887|P3|STARTED|12-week, Double-blind Treatment Period||259
197856|NCT01323621|479888|P2|STARTED|12-week, Double-blind Treatment Period||252
197857|NCT01323621|479889|P1|STARTED|12-week, Double-blind Treatment Period||0
197858|NCT01323621|479887|P3|NOT COMPLETED|2-week, Single-blind Run In Period||0
197859|NCT01323621|479888|P2|NOT COMPLETED|2-week, Single-blind Run In Period||0
197860|NCT01323621|479889|P1|NOT COMPLETED|2-week, Single-blind Run In Period||228
197861|NCT01323621|479887|P3|COMPLETED|2-week, Single-blind Run In Period||0
197862|NCT01323621|479888|P2|COMPLETED|2-week, Single-blind Run In Period||0
197863|NCT01323621|479889|P1|COMPLETED|2-week, Single-blind Run In Period||511
197864|NCT01323621|479887|P3|STARTED|2-week, Single-blind Run In Period||0
197865|NCT01323621|479888|P2|STARTED|2-week, Single-blind Run In Period||0
197866|NCT01323621|479889|P1|STARTED|2-week, Single-blind Run In Period||739
197867|NCT01323595|479899|P2|NOT COMPLETED|Overall Study||21
197868|NCT01323595|479900|P1|NOT COMPLETED|Overall Study||23
197869|NCT01323595|479899|P2|COMPLETED|Overall Study|Remaining subjects did not return questionaire|18
197870|NCT01323595|479900|P1|COMPLETED|Overall Study|Remaining subjects did not return questionnaire|16
197871|NCT01323595|479899|P2|STARTED|Overall Study||39
197872|NCT01323595|479900|P1|STARTED|Overall Study||39
197873|NCT01323582|479910|P2|NOT COMPLETED|Weeks 8-11 (Period 2)||1
197874|NCT01323582|479911|P1|NOT COMPLETED|Weeks 8-11 (Period 2)||0
197875|NCT01323582|479910|P2|COMPLETED|Weeks 8-11 (Period 2)||10
197876|NCT01323582|479911|P1|COMPLETED|Weeks 8-11 (Period 2)||10
197877|NCT01323582|479910|P2|STARTED|Weeks 8-11 (Period 2)||11
197878|NCT01323582|479911|P1|STARTED|Weeks 8-11 (Period 2)||10
197879|NCT01323582|479910|P2|NOT COMPLETED|Weeks 5-7 (Washout)||1
197880|NCT01323582|479911|P1|NOT COMPLETED|Weeks 5-7 (Washout)||0
197881|NCT01323582|479910|P2|COMPLETED|Weeks 5-7 (Washout)||11
197882|NCT01323582|479911|P1|COMPLETED|Weeks 5-7 (Washout)||10
197883|NCT01323582|479910|P2|STARTED|Weeks 5-7 (Washout)||12
197884|NCT01323582|479911|P1|STARTED|Weeks 5-7 (Washout)||10
197885|NCT01323582|479910|P2|NOT COMPLETED|Weeks 1-4 (First Period)||2
197886|NCT01323582|479911|P1|NOT COMPLETED|Weeks 1-4 (First Period)||2
197887|NCT01323582|479910|P2|COMPLETED|Weeks 1-4 (First Period)||12
197888|NCT01323582|479911|P1|COMPLETED|Weeks 1-4 (First Period)||10
197889|NCT01323582|479910|P2|STARTED|Weeks 1-4 (First Period)||14
197890|NCT01323582|479911|P1|STARTED|Weeks 1-4 (First Period)||12
197891|NCT01323517|479927|P1|NOT COMPLETED|Overall Study||0
197892|NCT01323517|479927|P1|COMPLETED|Overall Study||26
197893|NCT01323517|479927|P1|STARTED|Overall Study||26
197894|NCT01323478|479934|P1|NOT COMPLETED|Overall Study||24
197895|NCT01323478|479934|P1|COMPLETED|Overall Study||47
197896|NCT01323478|479934|P1|STARTED|Overall Study||71
197897|NCT01323387|479947|P1|NOT COMPLETED|Overall Study||84
197898|NCT01323387|479947|P1|COMPLETED|Overall Study||94
197899|NCT01323387|479947|P1|STARTED|Overall Study||178
197900|NCT01323270|479960|P2|NOT COMPLETED|Overall Study||29
197901|NCT01323270|479961|P1|NOT COMPLETED|Overall Study||43
197902|NCT01323270|479960|P2|COMPLETED|Overall Study||347
197903|NCT01323270|479961|P1|COMPLETED|Overall Study||330
197904|NCT01323270|479960|P2|STARTED|Overall Study||376
197905|NCT01323270|479961|P1|STARTED|Overall Study||373
197906|NCT01323192|479983|P2|NOT COMPLETED|Overall Study||6
197907|NCT01323192|479984|P1|NOT COMPLETED|Overall Study||9
197908|NCT01323192|479983|P2|COMPLETED|Overall Study||135
197909|NCT01323192|479984|P1|COMPLETED|Overall Study||134
197910|NCT01323192|479983|P2|STARTED|Overall Study||141
197911|NCT01323192|479984|P1|STARTED|Overall Study||143
197912|NCT01323153|480002|P2|NOT COMPLETED|Overall Study||8
197913|NCT01323153|480003|P1|NOT COMPLETED|Overall Study||17
197914|NCT01323153|480002|P2|COMPLETED|Overall Study||142
197915|NCT01323153|480003|P1|COMPLETED|Overall Study||133
197916|NCT01323153|480002|P2|STARTED|Overall Study||150
197917|NCT01323153|480003|P1|STARTED|Overall Study||150
197918|NCT01323140|480009|P1|NOT COMPLETED|Overall Study||2
197919|NCT01323140|480009|P1|COMPLETED|Overall Study||38
197920|NCT01323140|480009|P1|STARTED|Overall Study||40
197921|NCT01323010|480015|P2|NOT COMPLETED|Overall Study||0
197922|NCT01323010|480016|P1|NOT COMPLETED|Overall Study||0
197923|NCT01323010|480015|P2|COMPLETED|Overall Study||59
197924|NCT01323010|480016|P1|COMPLETED|Overall Study||60
197925|NCT01323010|480015|P2|STARTED|Overall Study||59
197926|NCT01323010|480016|P1|STARTED|Overall Study||60
197927|NCT01322971|480067|P2|NOT COMPLETED|Overall Study||1
197928|NCT01322971|480068|P1|NOT COMPLETED|Overall Study||1
197929|NCT01322971|480067|P2|COMPLETED|Overall Study||0
197930|NCT01322971|480068|P1|COMPLETED|Overall Study||0
197931|NCT01322971|480067|P2|STARTED|Overall Study||1
197932|NCT01322971|480068|P1|STARTED|Overall Study||1
197933|NCT01322945|480082|P2|NOT COMPLETED|Overall Study||0
197934|NCT01322945|480083|P1|NOT COMPLETED|Overall Study||0
197935|NCT01322945|480082|P2|COMPLETED|Overall Study||42
197936|NCT01322945|480083|P1|COMPLETED|Overall Study||52
197937|NCT01322945|480082|P2|STARTED|Overall Study||42
197938|NCT01322945|480083|P1|STARTED|Overall Study||52
197939|NCT01322841|480093|P2|NOT COMPLETED|Overall Study||0
197940|NCT01322841|480094|P1|NOT COMPLETED|Overall Study||0
197941|NCT01322841|480093|P2|COMPLETED|Overall Study||1123
197942|NCT01322841|480094|P1|COMPLETED|Overall Study||1116
197943|NCT01322841|480093|P2|STARTED|Overall Study||1123
197944|NCT01322841|480094|P1|STARTED|Overall Study||1116
197945|NCT01322815|480104|P2|NOT COMPLETED|Overall Study||0
197946|NCT01322815|480105|P1|NOT COMPLETED|Overall Study||0
197947|NCT01322815|480104|P2|COMPLETED|Overall Study||4
197948|NCT01322815|480105|P1|COMPLETED|Overall Study||7
197949|NCT01322815|480104|P2|STARTED|Overall Study||4
197950|NCT01322815|480105|P1|STARTED|Overall Study||7
197951|NCT01322633|480113|P2|NOT COMPLETED|Overall Study||0
197952|NCT01322633|480114|P1|NOT COMPLETED|Overall Study||0
197953|NCT01322633|480113|P2|COMPLETED|Overall Study||27686
197954|NCT01322633|480114|P1|COMPLETED|Overall Study||34178
197955|NCT01322633|480113|P2|STARTED|Overall Study||27686
197956|NCT01322633|480114|P1|STARTED|Overall Study||34178
197957|NCT01322607|480126|P2|NOT COMPLETED|Overall Study||0
197958|NCT01322607|480127|P1|NOT COMPLETED|Overall Study||1
197959|NCT01322607|480126|P2|COMPLETED|Overall Study||9
197960|NCT01322607|480127|P1|COMPLETED|Overall Study||10
197961|NCT01322607|480126|P2|STARTED|Overall Study||9
197962|NCT01322607|480127|P1|STARTED|Overall Study||11
197963|NCT01322594|480145|P6|NOT COMPLETED|Overall Study||0
197964|NCT01322594|480146|P5|NOT COMPLETED|Overall Study||0
197965|NCT01322594|480147|P4|NOT COMPLETED|Overall Study||0
197966|NCT01322594|480148|P3|NOT COMPLETED|Overall Study||0
197967|NCT01322594|480149|P2|NOT COMPLETED|Overall Study||0
197968|NCT01322594|480150|P1|NOT COMPLETED|Overall Study||0
197969|NCT01322594|480145|P6|COMPLETED|Overall Study||6
197970|NCT01322594|480146|P5|COMPLETED|Overall Study||7
197971|NCT01322594|480147|P4|COMPLETED|Overall Study||6
197972|NCT01322594|480148|P3|COMPLETED|Overall Study||3
197973|NCT01322594|480149|P2|COMPLETED|Overall Study||3
197974|NCT01322594|480150|P1|COMPLETED|Overall Study||6
197975|NCT01322594|480145|P6|STARTED|Overall Study||6
197976|NCT01322594|480146|P5|STARTED|Overall Study||7
197977|NCT01322594|480147|P4|STARTED|Overall Study||6
197978|NCT01322594|480148|P3|STARTED|Overall Study||3
197979|NCT01322594|480149|P2|STARTED|Overall Study||3
197980|NCT01322594|480150|P1|STARTED|Overall Study|RANDOMIZED SUBJECTS THROUGH STUDY DAY 240-300|6
197981|NCT01322490|480233|P3|NOT COMPLETED|Long Term Follow-up Period||413
197982|NCT01322490|480234|P2|NOT COMPLETED|Long Term Follow-up Period||408
197983|NCT01322490|480235|P1|NOT COMPLETED|Long Term Follow-up Period||409
197984|NCT01322490|480233|P3|COMPLETED|Long Term Follow-up Period||0
197985|NCT01322490|480234|P2|COMPLETED|Long Term Follow-up Period||0
197986|NCT01322490|480235|P1|COMPLETED|Long Term Follow-up Period||0
197987|NCT01322490|480233|P3|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|413
197988|NCT01322490|480234|P2|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|408
197989|NCT01322490|480235|P1|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|409
197990|NCT01322490|480233|P3|NOT COMPLETED|Treatment Period||153
197991|NCT01322490|480234|P2|NOT COMPLETED|Treatment Period||153
197992|NCT01322490|480235|P1|NOT COMPLETED|Treatment Period||132
197993|NCT01322490|480233|P3|COMPLETED|Treatment Period||280
197994|NCT01322490|480234|P2|COMPLETED|Treatment Period||279
197995|NCT01322490|480235|P1|COMPLETED|Treatment Period||300
197996|NCT01322490|480233|P3|Treated|Treatment Period||428
197997|NCT01322490|480234|P2|Treated|Treatment Period||429
197998|NCT01322490|480235|P1|Treated|Treatment Period||429
197999|NCT01322490|480233|P3|STARTED|Treatment Period||433
198000|NCT01322490|480234|P2|STARTED|Treatment Period||432
198001|NCT01322490|480235|P1|STARTED|Treatment Period||432
198002|NCT01322386|480248|P2|NOT COMPLETED|Overall Study||2
198003|NCT01322386|480249|P1|NOT COMPLETED|Overall Study||0
198004|NCT01322386|480248|P2|COMPLETED|Overall Study||9
198005|NCT01322386|480249|P1|COMPLETED|Overall Study||10
198006|NCT01322386|480248|P2|STARTED|Overall Study||11
198007|NCT01322386|480249|P1|STARTED|Overall Study||10
198008|NCT01322360|480257|P1|NOT COMPLETED|Overall Study||0
198009|NCT01322360|480257|P1|COMPLETED|Overall Study||50
198010|NCT01322360|480257|P1|STARTED|Overall Study||50
198011|NCT01322347|480264|P2|NOT COMPLETED|Overall Study||35
198012|NCT01322347|480265|P1|NOT COMPLETED|Overall Study||51
198013|NCT01322347|480264|P2|COMPLETED|Overall Study||112
198014|NCT01322347|480265|P1|COMPLETED|Overall Study||96
198015|NCT01322347|480264|P2|Completed St 3|Overall Study||86
198016|NCT01322347|480265|P1|Completed St 3|Overall Study||82
198017|NCT01322347|480264|P2|Enrolled in St 3|Overall Study||113
198018|NCT01322347|480265|P1|Enrolled in St 3|Overall Study||101
198019|NCT01322347|480264|P2|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||90
198020|NCT01322347|480265|P1|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||68
198021|NCT01322347|480264|P2|Completed 48 Wks in St 2|Overall Study||22
198022|NCT01322347|480265|P1|Completed 48 Wks in St 2|Overall Study||28
198023|NCT01322347|480264|P2|STARTED|Overall Study||147
198024|NCT01322347|480265|P1|STARTED|Overall Study||147
198025|NCT01322048|480302|P2|NOT COMPLETED|Overall Study||0
198026|NCT01322048|480303|P1|NOT COMPLETED|Overall Study||0
198027|NCT01322048|480302|P2|COMPLETED|Overall Study||26
198028|NCT01322048|480303|P1|COMPLETED|Overall Study||21
198029|NCT01322048|480302|P2|STARTED|Overall Study||26
198030|NCT01322048|480303|P1|STARTED|Overall Study||21
198031|NCT01322022|480313|P2|NOT COMPLETED|Overall Study||2
198032|NCT01322022|480314|P1|NOT COMPLETED|Overall Study||5
198033|NCT01322022|480313|P2|COMPLETED|Overall Study||18
198034|NCT01322022|480314|P1|COMPLETED|Overall Study||15
198035|NCT01322022|480313|P2|Week 4|Overall Study||18
198036|NCT01322022|480314|P1|Week 4|Overall Study||15
198037|NCT01322022|480313|P2|STARTED|Overall Study||20
198038|NCT01322022|480314|P1|STARTED|Overall Study||20
198039|NCT01322009|480328|P2|NOT COMPLETED|Overall Study||3
198040|NCT01322009|480329|P1|NOT COMPLETED|Overall Study||0
198041|NCT01322009|480328|P2|COMPLETED|Overall Study||4
198042|NCT01322009|480329|P1|COMPLETED|Overall Study||7
198043|NCT01322009|480328|P2|STARTED|Overall Study||7
198044|NCT01322009|480329|P1|STARTED|Overall Study||7
198045|NCT01321749|480339|P2|NOT COMPLETED|Overall Study||22
198046|NCT01321749|480340|P1|NOT COMPLETED|Overall Study||13
198047|NCT01321749|480339|P2|COMPLETED|Overall Study||30
198048|NCT01321749|480340|P1|COMPLETED|Overall Study||38
198049|NCT01321749|480339|P2|STARTED|Overall Study||52
198050|NCT01321749|480340|P1|STARTED|Overall Study||51
198051|NCT01321723|480349|P3|NOT COMPLETED|Overall Study||4
198052|NCT01321723|480350|P2|NOT COMPLETED|Overall Study||5
198053|NCT01321723|480351|P1|NOT COMPLETED|Overall Study||5
198054|NCT01321723|480349|P3|COMPLETED|Overall Study||28
198055|NCT01321723|480350|P2|COMPLETED|Overall Study||28
198056|NCT01321723|480351|P1|COMPLETED|Overall Study||27
198057|NCT01321723|480349|P3|STARTED|Overall Study||32
198058|NCT01321723|480350|P2|STARTED|Overall Study||33
198059|NCT01321723|480351|P1|STARTED|Overall Study||32
198060|NCT01321710|480373|P3|NOT COMPLETED|Overall Study||0
198061|NCT01321710|480374|P2|NOT COMPLETED|Overall Study||5
198062|NCT01321710|480375|P1|NOT COMPLETED|Overall Study||4
198063|NCT01321710|480373|P3|COMPLETED|Overall Study||44
198064|NCT01321710|480374|P2|COMPLETED|Overall Study||53
198065|NCT01321710|480375|P1|COMPLETED|Overall Study||46
198066|NCT01321710|480373|P3|STARTED|Overall Study||44
198067|NCT01321710|480374|P2|STARTED|Overall Study||58
198068|NCT01321710|480375|P1|STARTED|Overall Study||50
198069|NCT01321697|480390|P1|NOT COMPLETED|Overall Study||7
198070|NCT01321697|480390|P1|COMPLETED|Overall Study||0
198071|NCT01321697|480390|P1|STARTED|Overall Study||7
198072|NCT01321606|480396|P4|NOT COMPLETED|Overall Study||1
198073|NCT01321606|480397|P3|NOT COMPLETED|Overall Study||0
198074|NCT01321606|480398|P2|NOT COMPLETED|Overall Study||0
198075|NCT01321606|480399|P1|NOT COMPLETED|Overall Study||0
198076|NCT01321606|480396|P4|COMPLETED|Overall Study||28
198077|NCT01321606|480397|P3|COMPLETED|Overall Study||34
198078|NCT01321606|480398|P2|COMPLETED|Overall Study||32
198079|NCT01321606|480399|P1|COMPLETED|Overall Study||18
198080|NCT01321606|480396|P4|STARTED|Overall Study||29
198081|NCT01321606|480397|P3|STARTED|Overall Study||34
198082|NCT01321606|480398|P2|STARTED|Overall Study||32
198083|NCT01321606|480399|P1|STARTED|Overall Study||18
198084|NCT01321554|480419|P4|NOT COMPLETED|OOL Lenvatinib Treatment Period||2
198085|NCT01321554|480420|P3|NOT COMPLETED|OOL Lenvatinib Treatment Period||28
198086|NCT01321554|480421|P2|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
198087|NCT01321554|480422|P1|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
198088|NCT01321554|480419|P4|COMPLETED|OOL Lenvatinib Treatment Period|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|25
198089|NCT01321554|480420|P3|COMPLETED|OOL Lenvatinib Treatment Period|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|54
198090|NCT01321554|480421|P2|COMPLETED|OOL Lenvatinib Treatment Period||0
198091|NCT01321554|480422|P1|COMPLETED|OOL Lenvatinib Treatment Period||0
198092|NCT01321554|480419|P4|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||3
198093|NCT01321554|480420|P3|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||18
198094|NCT01321554|480421|P2|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||0
198095|NCT01321554|480422|P1|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||0
198096|NCT01321554|480419|P4|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||22
198097|NCT01321554|480420|P3|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||36
198098|NCT01321554|480421|P2|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||0
198099|NCT01321554|480422|P1|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||0
198100|NCT01321554|480419|P4|STARTED|OOL Lenvatinib Treatment Period||27
198101|NCT01321554|480420|P3|STARTED|OOL Lenvatinib Treatment Period||82
198102|NCT01321554|480421|P2|STARTED|OOL Lenvatinib Treatment Period||0
198103|NCT01321554|480422|P1|STARTED|OOL Lenvatinib Treatment Period||0
198104|NCT01321554|480419|P4|NOT COMPLETED|Randomization Phase||0
198105|NCT01321554|480420|P3|NOT COMPLETED|Randomization Phase||0
198106|NCT01321554|480421|P2|NOT COMPLETED|Randomization Phase||4
198107|NCT01321554|480422|P1|NOT COMPLETED|Randomization Phase||45
198108|NCT01321554|480419|P4|COMPLETED|Randomization Phase||0
198109|NCT01321554|480420|P3|COMPLETED|Randomization Phase||0
198110|NCT01321554|480421|P2|COMPLETED|Randomization Phase|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|127
198111|NCT01321554|480422|P1|COMPLETED|Randomization Phase|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|216
198112|NCT01321554|480419|P4|Discontinued Due to Disease Progression|Randomization Phase||0
198113|NCT01321554|480420|P3|Discontinued Due to Disease Progression|Randomization Phase||0
198114|NCT01321554|480421|P2|Discontinued Due to Disease Progression|Randomization Phase||119
198115|NCT01321554|480422|P1|Discontinued Due to Disease Progression|Randomization Phase||94
198116|NCT01321554|480419|P4|Treatment Ongoing at Data Cutoff|Randomization Phase||0
198117|NCT01321554|480420|P3|Treatment Ongoing at Data Cutoff|Randomization Phase||0
198118|NCT01321554|480421|P2|Treatment Ongoing at Data Cutoff|Randomization Phase||8
198119|NCT01321554|480422|P1|Treatment Ongoing at Data Cutoff|Randomization Phase||122
198120|NCT01321554|480419|P4|STARTED|Randomization Phase||0
198121|NCT01321554|480420|P3|STARTED|Randomization Phase||0
198122|NCT01321554|480421|P2|STARTED|Randomization Phase||131
198123|NCT01321554|480422|P1|STARTED|Randomization Phase||261
198124|NCT01321073|480435|P1|NOT COMPLETED|Overall Study||7
198125|NCT01321073|480435|P1|COMPLETED|Overall Study||57
198126|NCT01321073|480435|P1|STARTED|Overall Study||64
198127|NCT01321008|480439|P1|NOT COMPLETED|Overall Study||1
198128|NCT01321008|480439|P1|COMPLETED|Overall Study||0
198129|NCT01321008|480439|P1|STARTED|Overall Study||1
198130|NCT01320943|480445|P2|NOT COMPLETED|Overall Study||2
198131|NCT01320943|480446|P1|NOT COMPLETED|Overall Study||1
198132|NCT01320943|480445|P2|COMPLETED|Overall Study||20
198133|NCT01320943|480446|P1|COMPLETED|Overall Study||20
198134|NCT01320943|480445|P2|STARTED|Overall Study||22
198135|NCT01320943|480446|P1|STARTED|Overall Study|13 participants did not restart TDF; 8 participants restarted TDF during the study.|21
198136|NCT01320826|480465|P1|NOT COMPLETED|Overall Study||0
198137|NCT01320826|480465|P1|COMPLETED|Overall Study||577
198138|NCT01320826|480465|P1|STARTED|Overall Study||577
198139|NCT01320735|480480|P1|NOT COMPLETED|Overall Study||106
198140|NCT01320735|480480|P1|COMPLETED|Overall Study||194
198141|NCT01320735|480480|P1|STARTED|Overall Study||300
198142|NCT01320722|480502|P5|NOT COMPLETED|Overall Study||8
198143|NCT01320722|480503|P4|NOT COMPLETED|Overall Study||14
198144|NCT01320722|480504|P3|NOT COMPLETED|Overall Study||7
198145|NCT01320722|480505|P2|NOT COMPLETED|Overall Study||6
198146|NCT01320722|480506|P1|NOT COMPLETED|Overall Study||3
198147|NCT01320722|480502|P5|COMPLETED|Overall Study||45
198148|NCT01320722|480503|P4|COMPLETED|Overall Study||35
198149|NCT01320722|480504|P3|COMPLETED|Overall Study||40
198150|NCT01320722|480505|P2|COMPLETED|Overall Study||41
198151|NCT01320722|480506|P1|COMPLETED|Overall Study||43
198152|NCT01320722|480502|P5|Received Intervention|Overall Study||51
198153|NCT01320722|480503|P4|Received Intervention|Overall Study||48
198154|NCT01320722|480504|P3|Received Intervention|Overall Study||46
198155|NCT01320722|480505|P2|Received Intervention|Overall Study||45
198156|NCT01320722|480506|P1|Received Intervention|Overall Study||43
198157|NCT01320722|480502|P5|STARTED|Overall Study||53
198158|NCT01320722|480503|P4|STARTED|Overall Study||49
198159|NCT01320722|480504|P3|STARTED|Overall Study||47
198160|NCT01320722|480505|P2|STARTED|Overall Study||47
198161|NCT01320722|480506|P1|STARTED|Overall Study||46
198162|NCT01320683|480543|P1|NOT COMPLETED|Overall Study||1
198163|NCT01320683|480543|P1|COMPLETED|Overall Study||0
198164|NCT01320683|480543|P1|STARTED|Overall Study||1
198165|NCT01320553|480552|P4|NOT COMPLETED|Overall Study||1
198166|NCT01320553|480553|P3|NOT COMPLETED|Overall Study||2
198167|NCT01320553|480554|P2|NOT COMPLETED|Overall Study||4
198168|NCT01320553|480555|P1|NOT COMPLETED|Overall Study||1
198169|NCT01320553|480552|P4|COMPLETED|Overall Study||29
198170|NCT01320553|480553|P3|COMPLETED|Overall Study||29
198171|NCT01320553|480554|P2|COMPLETED|Overall Study||26
198172|NCT01320553|480555|P1|COMPLETED|Overall Study||30
198173|NCT01320553|480552|P4|STARTED|Overall Study||30
198174|NCT01320553|480553|P3|STARTED|Overall Study||31
198175|NCT01320553|480554|P2|STARTED|Overall Study||30
198176|NCT01320553|480555|P1|STARTED|Overall Study||31
198177|NCT01320293|480569|P1|NOT COMPLETED|Overall Study||2
198178|NCT01320293|480569|P1|COMPLETED|Overall Study||16
198179|NCT01320293|480569|P1|STARTED|Overall Study||18
198180|NCT01320202|480577|P2|NOT COMPLETED|Overall Study||44
198181|NCT01320202|480578|P1|NOT COMPLETED|Overall Study||56
198182|NCT01320202|480577|P2|COMPLETED|Overall Study||109
198183|NCT01320202|480578|P1|COMPLETED|Overall Study||96
198184|NCT01320202|480577|P2|Completed St 3|Overall Study||82
198185|NCT01320202|480578|P1|Completed St 3|Overall Study||79
198186|NCT01320202|480577|P2|Enrolled in St 3|Overall Study||109
198187|NCT01320202|480578|P1|Enrolled in St 3|Overall Study||98
198188|NCT01320202|480577|P2|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||82
198189|NCT01320202|480578|P1|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||69
198190|NCT01320202|480577|P2|Comp 48 Wks in St 2|Overall Study||27
198191|NCT01320202|480578|P1|Comp 48 Wks in St 2|Overall Study||27
198192|NCT01320202|480577|P2|STARTED|Overall Study||153
198193|NCT01320202|480578|P1|STARTED|Overall Study||152
198194|NCT01320137|480615|P2|NOT COMPLETED|Overall Study||0
198195|NCT01320137|480616|P1|NOT COMPLETED|Overall Study||0
198196|NCT01320137|480615|P2|COMPLETED|Overall Study||40
198197|NCT01320137|480616|P1|COMPLETED|Overall Study||40
198198|NCT01320137|480615|P2|STARTED|Overall Study||40
198199|NCT01320137|480616|P1|STARTED|Overall Study||40
198200|NCT01320072|480630|P2|NOT COMPLETED|Overall Study||0
198201|NCT01320072|480631|P1|NOT COMPLETED|Overall Study||0
198202|NCT01320072|480630|P2|COMPLETED|Overall Study||13
198203|NCT01320072|480631|P1|COMPLETED|Overall Study||16
198204|NCT01320072|480630|P2|STARTED|Overall Study||13
198205|NCT01320072|480631|P1|STARTED|Overall Study||16
198206|NCT01319994|480642|P2|NOT COMPLETED|Overall Study||6
198207|NCT01319994|480643|P1|NOT COMPLETED|Overall Study||7
198208|NCT01319994|480642|P2|COMPLETED|Overall Study||21
198209|NCT01319994|480643|P1|COMPLETED|Overall Study||19
198210|NCT01319994|480642|P2|Did Not Develop Overt Diabetes|Overall Study||21
198211|NCT01319994|480643|P1|Did Not Develop Overt Diabetes|Overall Study||19
198212|NCT01319994|480642|P2|Glucocorticoid Dose as Inc Cri|Overall Study||22
198213|NCT01319994|480643|P1|Glucocorticoid Dose as Inc Cri|Overall Study||19
198214|NCT01319994|480642|P2|Tolerated at Least 1.7g/Day Dose|Overall Study||24
198215|NCT01319994|480643|P1|Tolerated at Least 1.7g/Day Dose|Overall Study||19
198216|NCT01319994|480642|P2|Abto Keep Appoinment Shedule|Overall Study||24
198217|NCT01319994|480643|P1|Abto Keep Appoinment Shedule|Overall Study||23
198218|NCT01319994|480642|P2|STARTED|Overall Study||27
198219|NCT01319994|480643|P1|STARTED|Overall Study||26
198220|NCT01319877|480653|P2|NOT COMPLETED|Overall Study||45
198221|NCT01319877|480654|P1|NOT COMPLETED|Overall Study||108
198222|NCT01319877|480653|P2|COMPLETED|Overall Study||108
198223|NCT01319877|480654|P1|COMPLETED|Overall Study||345
198224|NCT01319877|480653|P2|STARTED|Overall Study||153
198225|NCT01319877|480654|P1|STARTED|Overall Study||453
198226|NCT01319851|480689|P1|NOT COMPLETED|Overall Study||0
198227|NCT01319851|480689|P1|COMPLETED|Overall Study||3
198228|NCT01319851|480689|P1|STARTED|Overall Study||3
198229|NCT01319812|480701|P2|NOT COMPLETED|Overall Study||22
198230|NCT01319812|480702|P1|NOT COMPLETED|Overall Study||16
198231|NCT01319812|480701|P2|COMPLETED|Overall Study||280
198232|NCT01319812|480702|P1|COMPLETED|Overall Study||145
198233|NCT01319812|480701|P2|STARTED|Overall Study||302
198234|NCT01319812|480702|P1|STARTED|Overall Study||161
198235|NCT01319799|480783|P1|NOT COMPLETED|Overall Study||0
198236|NCT01319799|480783|P1|COMPLETED|Overall Study||10
198237|NCT01319799|480783|P1|STARTED|Overall Study||10
198238|NCT01319773|480793|P5|NOT COMPLETED|Overall Study||0
198239|NCT01319773|480794|P4|NOT COMPLETED|Overall Study||0
198240|NCT01319773|480795|P3|NOT COMPLETED|Overall Study||0
198241|NCT01319773|480796|P2|NOT COMPLETED|Overall Study||0
198242|NCT01319773|480797|P1|NOT COMPLETED|Overall Study||0
198243|NCT01319773|480793|P5|COMPLETED|Overall Study||8
198244|NCT01319773|480794|P4|COMPLETED|Overall Study||8
198245|NCT01319773|480795|P3|COMPLETED|Overall Study||8
198246|NCT01319773|480796|P2|COMPLETED|Overall Study||10
198247|NCT01319773|480797|P1|COMPLETED|Overall Study||10
198248|NCT01319773|480793|P5|STARTED|Overall Study||8
198249|NCT01319773|480794|P4|STARTED|Overall Study||8
198250|NCT01319773|480795|P3|STARTED|Overall Study||8
198251|NCT01319773|480796|P2|STARTED|Overall Study||10
198252|NCT01319773|480797|P1|STARTED|Overall Study||10
198253|NCT01319760|480813|P2|NOT COMPLETED|Overall Study||0
198254|NCT01319760|480814|P1|NOT COMPLETED|Overall Study||0
198255|NCT01319760|480813|P2|COMPLETED|Overall Study||5
198256|NCT01319760|480814|P1|COMPLETED|Overall Study|The study experienced a very low enrollment rate. the sponsor decided to stop the study.|0
198257|NCT01319760|480813|P2|STARTED|Overall Study||5
198258|NCT01319760|480814|P1|STARTED|Overall Study|The study experienced a very low enrollment rate. the sponsor decided to stop the study.|0
198259|NCT01319721|480822|P2|NOT COMPLETED|Overall Study||6
198260|NCT01319721|480823|P1|NOT COMPLETED|Overall Study||1
198261|NCT01319721|480822|P2|COMPLETED|Overall Study|The unit of measure is eyes.|42
198262|NCT01319721|480823|P1|COMPLETED|Overall Study|The unit of measure is eyes.|47
198263|NCT01319721|480822|P2|STARTED|Overall Study|The unit of measure is eyes.|48
198264|NCT01319721|480823|P1|STARTED|Overall Study|The unit of measure is eyes.|48
198265|NCT01319617|480837|P1|NOT COMPLETED|Overall Study||1
198266|NCT01319617|480837|P1|COMPLETED|Overall Study||40
198267|NCT01319617|480837|P1|STARTED|Overall Study||41
198268|NCT01319552|480841|P1|NOT COMPLETED|Overall Study||0
198269|NCT01319552|480841|P1|COMPLETED|Overall Study||14
198270|NCT01319552|480841|P1|STARTED|Overall Study||14
198271|NCT01319539|480846|P1|NOT COMPLETED|Overall Study||0
198272|NCT01319539|480846|P1|COMPLETED|Overall Study||12
198273|NCT01319539|480846|P1|STARTED|Overall Study||12
198274|NCT01319500|480856|P2|NOT COMPLETED|Overall Study||0
198275|NCT01319500|480857|P1|NOT COMPLETED|Overall Study||0
198276|NCT01319500|480856|P2|COMPLETED|Overall Study||2589
198277|NCT01319500|480857|P1|COMPLETED|Overall Study||1187
198278|NCT01319500|480856|P2|STARTED|Overall Study||2589
198279|NCT01319500|480857|P1|STARTED|Overall Study||1187
198280|NCT01319422|480876|P2|NOT COMPLETED|Overall Study||0
198281|NCT01319422|480877|P1|NOT COMPLETED|Overall Study||1
198282|NCT01319422|480876|P2|COMPLETED|Overall Study||20
198283|NCT01319422|480877|P1|COMPLETED|Overall Study||19
198284|NCT01319422|480876|P2|STARTED|Overall Study||20
198285|NCT01319422|480877|P1|STARTED|Overall Study||20
198286|NCT01319396|480891|P1|NOT COMPLETED|Overall Study||0
198287|NCT01319396|480891|P1|COMPLETED|Overall Study||24
198288|NCT01319396|480891|P1|STARTED|Overall Study||24
198289|NCT01319383|480895|P2|NOT COMPLETED|Overall Study||10
198290|NCT01319383|480896|P1|NOT COMPLETED|Overall Study||12
198291|NCT01319383|480895|P2|COMPLETED|Overall Study||3
198292|NCT01319383|480896|P1|COMPLETED|Overall Study||0
198293|NCT01319383|480895|P2|Step 4|Overall Study|Only 3/6 completed the study.|3
198294|NCT01319383|480896|P1|Step 4|Overall Study|Arm 1 did not have a Step 4|0
198295|NCT01319383|480895|P2|Step 3|Overall Study|3 Arm 1 participants enrolled here; 6/7 had in vivo response to 2 VOR doses given 72 hours apart.|6
198296|NCT01319383|480896|P1|Step 3|Overall Study|None who qualified for the 2 series of 11 doses of VOR (taken M-T-W & off for 4 days for 4 wks).|0
198297|NCT01319383|480895|P2|Step 2|Overall Study||0
198298|NCT01319383|480896|P1|Step 2|Overall Study|The 4 without ex vivo response (Step 1) took a single dose to see if in vivo response would occur|4
198299|NCT01319383|480895|P2|Step 2|Overall Study|The 7 participants without an in vivo response to single dose of VOR 400 mg PO were terminated.|4
198300|NCT01319383|480896|P1|Step 2|Overall Study|These participants demonstrated an ex vivo response in Step 1|8
198301|NCT01319383|480895|P2|Step 1|Overall Study|The 2 participants without an ex vivo response were terminated from the study.|11
198302|NCT01319383|480896|P1|Step 1|Overall Study||8
198303|NCT01319383|480895|P2|STARTED|Overall Study||13
198304|NCT01319383|480896|P1|STARTED|Overall Study||12
198305|NCT01319318|480913|P1|NOT COMPLETED|Overall Study||0
198306|NCT01319318|480913|P1|COMPLETED|Overall Study||25
198307|NCT01319318|480913|P1|STARTED|Overall Study||25
198308|NCT01319110|480919|P2|NOT COMPLETED|Overall Study||0
198309|NCT01319110|480920|P1|NOT COMPLETED|Overall Study||0
198310|NCT01319110|480919|P2|COMPLETED|Overall Study||5
198311|NCT01319110|480920|P1|COMPLETED|Overall Study||5
198312|NCT01319110|480919|P2|STARTED|Overall Study||5
198313|NCT01319110|480920|P1|STARTED|Overall Study||5
198314|NCT01319045|480928|P1|NOT COMPLETED|Overall Study||2
198315|NCT01319045|480928|P1|COMPLETED|Overall Study|Study was discontinued due to low enrollment|3
198316|NCT01319045|480928|P1|STARTED|Overall Study||5
198317|NCT01318993|480935|P1|NOT COMPLETED|Overall Study||398
198318|NCT01318993|480935|P1|COMPLETED|Overall Study||0
198319|NCT01318993|480935|P1|STARTED|Overall Study||398
198320|NCT01318967|480951|P1|NOT COMPLETED|Overall Study||0
198321|NCT01318967|480951|P1|COMPLETED|Overall Study||10
198322|NCT01318967|480951|P1|STARTED|Overall Study||10
198323|NCT01318915|480956|P1|NOT COMPLETED|Overall Study||1
198324|NCT01318915|480956|P1|COMPLETED|Overall Study||9
198325|NCT01318915|480956|P1|STARTED|Overall Study||10
198326|NCT01318876|480981|P1|NOT COMPLETED|Day 29 Survey||1825
198327|NCT01318876|480981|P1|COMPLETED|Day 29 Survey||5724
198328|NCT01318876|480981|P1|STARTED|Day 29 Survey|All participants with a valid e-mail, have received the second survey|7549
198329|NCT01318876|480981|P1|NOT COMPLETED|Day 8 Survey||1820
198330|NCT01318876|480981|P1|COMPLETED|Day 8 Survey||5825
198331|NCT01318876|480981|P1|STARTED|Day 8 Survey||7645
198332|NCT01318811|480988|P2|NOT COMPLETED|Overall Study||4
198333|NCT01318811|480989|P1|NOT COMPLETED|Overall Study||1
198334|NCT01318811|480988|P2|COMPLETED|Overall Study||4
198335|NCT01318811|480989|P1|COMPLETED|Overall Study||3
198336|NCT01318811|480988|P2|STARTED|Overall Study||8
198337|NCT01318811|480989|P1|STARTED|Overall Study||4
198338|NCT01318733|480997|P1|NOT COMPLETED|Overall Study||170
198339|NCT01318733|480997|P1|COMPLETED|Overall Study||279
198340|NCT01318733|480997|P1|STARTED|Overall Study||449
198341|NCT01318694|481005|P4|NOT COMPLETED|Overall Study||68
198342|NCT01318694|481006|P3|NOT COMPLETED|Overall Study||43
198343|NCT01318694|481007|P2|NOT COMPLETED|Overall Study||58
198344|NCT01318694|481008|P1|NOT COMPLETED|Overall Study||52
198345|NCT01318694|481005|P4|COMPLETED|Overall Study||200
198346|NCT01318694|481006|P3|COMPLETED|Overall Study||225
198347|NCT01318694|481007|P2|COMPLETED|Overall Study||212
198348|NCT01318694|481008|P1|COMPLETED|Overall Study||223
198349|NCT01318694|481005|P4|Safety Set|Overall Study||265
198350|NCT01318694|481006|P3|Safety Set|Overall Study||265
198351|NCT01318694|481007|P2|Safety Set|Overall Study||268
198352|NCT01318694|481008|P1|Safety Set|Overall Study||273
198353|NCT01318694|481005|P4|Full Analysis Set|Overall Study||268
198354|NCT01318694|481006|P3|Full Analysis Set|Overall Study||265
198355|NCT01318694|481007|P2|Full Analysis Set|Overall Study||270
198356|NCT01318694|481008|P1|Full Analysis Set|Overall Study||274
198357|NCT01318694|481005|P4|STARTED|Overall Study||268
198358|NCT01318694|481006|P3|STARTED|Overall Study||268
198359|NCT01318694|481007|P2|STARTED|Overall Study||270
198360|NCT01318694|481008|P1|STARTED|Overall Study||275
198361|NCT01318538|481064|P3|NOT COMPLETED|Overall Study||0
198362|NCT01318538|481065|P2|NOT COMPLETED|Overall Study||0
198363|NCT01318538|481066|P1|NOT COMPLETED|Overall Study||0
198364|NCT01318538|481064|P3|COMPLETED|Overall Study||8
198365|NCT01318538|481065|P2|COMPLETED|Overall Study||106
198366|NCT01318538|481066|P1|COMPLETED|Overall Study||52
198367|NCT01318538|481064|P3|STARTED|Overall Study||8
198368|NCT01318538|481065|P2|STARTED|Overall Study||106
198369|NCT01318538|481066|P1|STARTED|Overall Study||52
198370|NCT01318512|481090|P1|NOT COMPLETED|Maintenance Period (6 Months)||11
198371|NCT01318512|481090|P1|COMPLETED|Maintenance Period (6 Months)||329
198372|NCT01318512|481090|P1|STARTED|Maintenance Period (6 Months)||340
198373|NCT01318512|481090|P1|NOT COMPLETED|Titration Period (4 Months)||0
198374|NCT01318512|481090|P1|COMPLETED|Titration Period (4 Months)||340
198375|NCT01318512|481090|P1|STARTED|Titration Period (4 Months)||340
198376|NCT01318499|481109|P3|NOT COMPLETED|Overall Study||147
198377|NCT01318499|481110|P2|NOT COMPLETED|Overall Study||76
198378|NCT01318499|481111|P1|NOT COMPLETED|Overall Study||65
198379|NCT01318499|481109|P3|COMPLETED|Overall Study||121
198380|NCT01318499|481110|P2|COMPLETED|Overall Study||458
198381|NCT01318499|481111|P1|COMPLETED|Overall Study||475
198382|NCT01318499|481109|P3|STARTED|Overall Study||268
198383|NCT01318499|481110|P2|STARTED|Overall Study||534
198384|NCT01318499|481111|P1|STARTED|Overall Study||540
198385|NCT01318408|481129|P1|NOT COMPLETED|Overall Study||8
198386|NCT01318408|481129|P1|COMPLETED|Overall Study||16
198387|NCT01318408|481129|P1|STARTED|Overall Study||24
198388|NCT01318382|481134|P1|NOT COMPLETED|Overall Study||13
198389|NCT01318382|481134|P1|COMPLETED|Overall Study||289
198390|NCT01318382|481134|P1|STARTED|Overall Study||302
198391|NCT01318278|481144|P3|NOT COMPLETED|Overall Study||0
198392|NCT01318278|481145|P2|NOT COMPLETED|Overall Study||0
198393|NCT01318278|481146|P1|NOT COMPLETED|Overall Study||0
198394|NCT01318278|481144|P3|COMPLETED|Overall Study||50
198395|NCT01318278|481145|P2|COMPLETED|Overall Study||10
198396|NCT01318278|481146|P1|COMPLETED|Overall Study||10
198397|NCT01318278|481144|P3|STARTED|Overall Study||50
198398|NCT01318278|481145|P2|STARTED|Overall Study||10
198399|NCT01318278|481146|P1|STARTED|Overall Study||10
198400|NCT01318135|481192|P8|NOT COMPLETED|Entered - Long-Term Extension Study||3
198401|NCT01318135|481193|P7|NOT COMPLETED|Entered - Long-Term Extension Study||1
198402|NCT01318135|481194|P6|NOT COMPLETED|Entered - Long-Term Extension Study||4
198403|NCT01318135|481195|P5|NOT COMPLETED|Entered - Long-Term Extension Study||9
198404|NCT01318135|481196|P4|NOT COMPLETED|Entered - Long-Term Extension Study||7
198405|NCT01318135|481197|P3|NOT COMPLETED|Entered - Long-Term Extension Study||8
198406|NCT01318135|481198|P2|NOT COMPLETED|Entered - Long-Term Extension Study||13
198407|NCT01318135|481199|P1|NOT COMPLETED|Entered - Long-Term Extension Study||17
198408|NCT01318135|481192|P8|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|46
198409|NCT01318135|481193|P7|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|49
198410|NCT01318135|481194|P6|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|83
198411|NCT01318135|481195|P5|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|81
198412|NCT01318135|481196|P4|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|42
198413|NCT01318135|481197|P3|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|38
198414|NCT01318135|481198|P2|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|89
198415|NCT01318135|481199|P1|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|80
198416|NCT01318135|481192|P8|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|49
198417|NCT01318135|481193|P7|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|50
198418|NCT01318135|481194|P6|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|87
198419|NCT01318135|481195|P5|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|90
198420|NCT01318135|481196|P4|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|49
198421|NCT01318135|481197|P3|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|46
198422|NCT01318135|481198|P2|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|102
198423|NCT01318135|481199|P1|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|97
198424|NCT01318135|481192|P8|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
198425|NCT01318135|481193|P7|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
198426|NCT01318135|481194|P6|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
198427|NCT01318135|481195|P5|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
198428|NCT01318135|481196|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
198429|NCT01318135|481197|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
198430|NCT01318135|481198|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
198431|NCT01318135|481199|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
198432|NCT01318135|481192|P8|COMPLETED|Enrolled - Long-Term Extension Study||49
198433|NCT01318135|481193|P7|COMPLETED|Enrolled - Long-Term Extension Study||50
198434|NCT01318135|481194|P6|COMPLETED|Enrolled - Long-Term Extension Study||90
198435|NCT01318135|481195|P5|COMPLETED|Enrolled - Long-Term Extension Study||91
198436|NCT01318135|481196|P4|COMPLETED|Enrolled - Long-Term Extension Study||49
198437|NCT01318135|481197|P3|COMPLETED|Enrolled - Long-Term Extension Study||46
198438|NCT01318135|481198|P2|COMPLETED|Enrolled - Long-Term Extension Study||102
198439|NCT01318135|481199|P1|COMPLETED|Enrolled - Long-Term Extension Study||97
198440|NCT01318135|481192|P8|STARTED|Enrolled - Long-Term Extension Study||49
198441|NCT01318135|481193|P7|STARTED|Enrolled - Long-Term Extension Study||50
198442|NCT01318135|481194|P6|STARTED|Enrolled - Long-Term Extension Study||90
198443|NCT01318135|481195|P5|STARTED|Enrolled - Long-Term Extension Study||91
198444|NCT01318135|481196|P4|STARTED|Enrolled - Long-Term Extension Study||49
198445|NCT01318135|481197|P3|STARTED|Enrolled - Long-Term Extension Study||46
198446|NCT01318135|481198|P2|STARTED|Enrolled - Long-Term Extension Study||102
198447|NCT01318135|481199|P1|STARTED|Enrolled - Long-Term Extension Study||99
198448|NCT01318122|481331|P4|NOT COMPLETED|Entered - Long-Term Extension Study||4
198449|NCT01318122|481332|P3|NOT COMPLETED|Entered - Long-Term Extension Study||6
198450|NCT01318122|481333|P2|NOT COMPLETED|Entered - Long-Term Extension Study||11
198451|NCT01318122|481334|P1|NOT COMPLETED|Entered - Long-Term Extension Study||9
198452|NCT01318122|481331|P4|COMPLETED|Entered - Long-Term Extension Study||48
198453|NCT01318122|481332|P3|COMPLETED|Entered - Long-Term Extension Study||49
198454|NCT01318122|481333|P2|COMPLETED|Entered - Long-Term Extension Study||99
198455|NCT01318122|481334|P1|COMPLETED|Entered - Long-Term Extension Study||96
198456|NCT01318122|481331|P4|STARTED|Entered - Long-Term Extension Study||52
198457|NCT01318122|481332|P3|STARTED|Entered - Long-Term Extension Study||55
198458|NCT01318122|481333|P2|STARTED|Entered - Long-Term Extension Study||110
198459|NCT01318122|481334|P1|STARTED|Entered - Long-Term Extension Study||105
198460|NCT01318122|481331|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
198461|NCT01318122|481332|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
198462|NCT01318122|481333|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
198463|NCT01318122|481334|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
198464|NCT01318122|481331|P4|COMPLETED|Enrolled - Long-Term Extension Study||52
198465|NCT01318122|481332|P3|COMPLETED|Enrolled - Long-Term Extension Study||55
198466|NCT01318122|481333|P2|COMPLETED|Enrolled - Long-Term Extension Study||110
198467|NCT01318122|481334|P1|COMPLETED|Enrolled - Long-Term Extension Study||105
198468|NCT01318122|481331|P4|STARTED|Enrolled - Long-Term Extension Study||53
198469|NCT01318122|481332|P3|STARTED|Enrolled - Long-Term Extension Study||57
198470|NCT01318122|481333|P2|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|110
198471|NCT01318122|481334|P1|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|106
198472|NCT01318109|481403|P3|NOT COMPLETED|Overall Study||0
198473|NCT01318109|481404|P2|NOT COMPLETED|Overall Study||3
198474|NCT01318109|481405|P1|NOT COMPLETED|Overall Study||1
198475|NCT01318109|481403|P3|COMPLETED|Overall Study||100
198476|NCT01318109|481404|P2|COMPLETED|Overall Study||93
198477|NCT01318109|481405|P1|COMPLETED|Overall Study||91
198478|NCT01318109|481403|P3|STARTED|Overall Study||100
198479|NCT01318109|481404|P2|STARTED|Overall Study||96
198480|NCT01318109|481405|P1|STARTED|Overall Study||92
198481|NCT01318083|481440|P3|NOT COMPLETED|Overall Study||5
198482|NCT01318083|481441|P2|NOT COMPLETED|Overall Study||2
198483|NCT01318083|481442|P1|NOT COMPLETED|Overall Study||6
198484|NCT01318083|481440|P3|COMPLETED|Overall Study||98
198485|NCT01318083|481441|P2|COMPLETED|Overall Study||102
198486|NCT01318083|481442|P1|COMPLETED|Overall Study||99
198487|NCT01318083|481440|P3|STARTED|Overall Study||103
198488|NCT01318083|481441|P2|STARTED|Overall Study||104
198489|NCT01318083|481442|P1|STARTED|Overall Study||105
198490|NCT01318070|481477|P3|NOT COMPLETED|Overall Study||7
198491|NCT01318070|481478|P2|NOT COMPLETED|Overall Study||2
198492|NCT01318070|481479|P1|NOT COMPLETED|Overall Study||2
198493|NCT01318070|481477|P3|COMPLETED|Overall Study||108
198494|NCT01318070|481478|P2|COMPLETED|Overall Study||111
198495|NCT01318070|481479|P1|COMPLETED|Overall Study||109
198496|NCT01318070|481477|P3|STARTED|Overall Study||115
198497|NCT01318070|481478|P2|STARTED|Overall Study||113
198498|NCT01318070|481479|P1|STARTED|Overall Study||111
198499|NCT01318018|481513|P2|NOT COMPLETED|Overall Study||0
198500|NCT01318018|481514|P1|NOT COMPLETED|Overall Study||0
198501|NCT01318018|481513|P2|COMPLETED|Overall Study||10
198502|NCT01318018|481514|P1|COMPLETED|Overall Study||10
198503|NCT01318018|481513|P2|STARTED|Overall Study||10
198504|NCT01318018|481514|P1|STARTED|Overall Study||10
198505|NCT01317901|481522|P2|NOT COMPLETED|Overall Study||0
198506|NCT01317901|481523|P1|NOT COMPLETED|Overall Study||0
198507|NCT01317901|481522|P2|COMPLETED|Overall Study||6
198508|NCT01317901|481523|P1|COMPLETED|Overall Study||6
198509|NCT01317901|481522|P2|STARTED|Overall Study||6
198510|NCT01317901|481523|P1|STARTED|Overall Study||6
198511|NCT01317797|481532|P3|NOT COMPLETED|Overall Study||1
198512|NCT01317797|481533|P2|NOT COMPLETED|Overall Study||1
198513|NCT01317797|481534|P1|NOT COMPLETED|Overall Study||0
198514|NCT01317797|481532|P3|COMPLETED|Overall Study||8
198515|NCT01317797|481533|P2|COMPLETED|Overall Study||6
198516|NCT01317797|481534|P1|COMPLETED|Overall Study||8
198517|NCT01317797|481532|P3|STARTED|Overall Study||9
198518|NCT01317797|481533|P2|STARTED|Overall Study||7
198519|NCT01317797|481534|P1|STARTED|Overall Study||8
198520|NCT01317667|481589|P3|NOT COMPLETED|Overall Study||0
198521|NCT01317667|481590|P2|NOT COMPLETED|Overall Study||0
198522|NCT01317667|481591|P1|NOT COMPLETED|Overall Study||0
198523|NCT01317667|481589|P3|COMPLETED|Overall Study|The original trial design was modified to limit the number of vaccinations in Group 3 to 1 dose.|10
198524|NCT01317667|481590|P2|COMPLETED|Overall Study||10
198525|NCT01317667|481591|P1|COMPLETED|Overall Study||10
198526|NCT01317667|481589|P3|STARTED|Overall Study||10
198527|NCT01317667|481590|P2|STARTED|Overall Study||10
198528|NCT01317667|481591|P1|STARTED|Overall Study||10
198529|NCT01317641|481611|P9|NOT COMPLETED|Overall Study||5
198530|NCT01317641|481612|P8|NOT COMPLETED|Overall Study||5
198531|NCT01317641|481613|P7|NOT COMPLETED|Overall Study||3
198532|NCT01317641|481614|P6|NOT COMPLETED|Overall Study||0
198533|NCT01317641|481615|P5|NOT COMPLETED|Overall Study||0
198534|NCT01317641|481616|P4|NOT COMPLETED|Overall Study||1
198535|NCT01317641|481617|P3|NOT COMPLETED|Overall Study||0
198536|NCT01317641|481618|P2|NOT COMPLETED|Overall Study||1
198537|NCT01317641|481619|P1|NOT COMPLETED|Overall Study||1
198538|NCT01317641|481611|P9|COMPLETED|Overall Study||31
198539|NCT01317641|481612|P8|COMPLETED|Overall Study||33
198540|NCT01317641|481613|P7|COMPLETED|Overall Study||35
198541|NCT01317641|481614|P6|COMPLETED|Overall Study||3
198542|NCT01317641|481615|P5|COMPLETED|Overall Study||3
198543|NCT01317641|481616|P4|COMPLETED|Overall Study||3
198544|NCT01317641|481617|P3|COMPLETED|Overall Study||3
198545|NCT01317641|481618|P2|COMPLETED|Overall Study||6
198546|NCT01317641|481619|P1|COMPLETED|Overall Study||3
198547|NCT01317641|481611|P9|STARTED|Overall Study||36
198548|NCT01317641|481612|P8|STARTED|Overall Study||38
198549|NCT01317641|481613|P7|STARTED|Overall Study||38
198550|NCT01317641|481614|P6|STARTED|Overall Study||3
198551|NCT01317641|481615|P5|STARTED|Overall Study||3
198552|NCT01317641|481616|P4|STARTED|Overall Study||4
198553|NCT01317641|481617|P3|STARTED|Overall Study||3
198554|NCT01317641|481618|P2|STARTED|Overall Study||7
198555|NCT01317641|481619|P1|STARTED|Overall Study||4
198556|NCT01317615|481721|P1|NOT COMPLETED|Overall Study||49
198557|NCT01317615|481721|P1|COMPLETED|Overall Study||0
198558|NCT01317615|481721|P1|STARTED|Overall Study||49
198559|NCT01317472|481732|P2|NOT COMPLETED|Overall Study||0
198560|NCT01317472|481733|P1|NOT COMPLETED|Overall Study||2
198561|NCT01317472|481732|P2|COMPLETED|Overall Study||2
198562|NCT01317472|481733|P1|COMPLETED|Overall Study||7
198563|NCT01317472|481732|P2|STARTED|Overall Study||2
198564|NCT01317472|481733|P1|STARTED|Overall Study||9
198565|NCT01317199|481743|P4|NOT COMPLETED|Randomized Phase 2||17
198566|NCT01317199|481744|P3|NOT COMPLETED|Randomized Phase 2||21
198567|NCT01317199|481745|P2|NOT COMPLETED|Randomized Phase 2||11
198568|NCT01317199|481746|P1|NOT COMPLETED|Randomized Phase 2||0
198569|NCT01317199|481743|P4|COMPLETED|Randomized Phase 2||32
198570|NCT01317199|481744|P3|COMPLETED|Randomized Phase 2||35
198571|NCT01317199|481745|P2|COMPLETED|Randomized Phase 2||13
198572|NCT01317199|481746|P1|COMPLETED|Randomized Phase 2||0
198573|NCT01317199|481743|P4|STARTED|Randomized Phase 2||49
198574|NCT01317199|481744|P3|STARTED|Randomized Phase 2||56
198575|NCT01317199|481745|P2|STARTED|Randomized Phase 2||24
198576|NCT01317199|481746|P1|STARTED|Randomized Phase 2||0
198577|NCT01317199|481743|P4|NOT COMPLETED|Dose-escalation Phase 1||0
198578|NCT01317199|481744|P3|NOT COMPLETED|Dose-escalation Phase 1||0
198579|NCT01317199|481745|P2|NOT COMPLETED|Dose-escalation Phase 1||0
198580|NCT01317199|481746|P1|NOT COMPLETED|Dose-escalation Phase 1||7
198581|NCT01317199|481743|P4|COMPLETED|Dose-escalation Phase 1||0
198582|NCT01317199|481744|P3|COMPLETED|Dose-escalation Phase 1||0
198583|NCT01317199|481745|P2|COMPLETED|Dose-escalation Phase 1||0
198584|NCT01317199|481746|P1|COMPLETED|Dose-escalation Phase 1||7
198585|NCT01317199|481743|P4|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
198586|NCT01317199|481744|P3|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
198587|NCT01317199|481745|P2|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
198588|NCT01317199|481746|P1|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||6
198589|NCT01317199|481743|P4|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
198590|NCT01317199|481744|P3|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
198591|NCT01317199|481745|P2|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
198592|NCT01317199|481746|P1|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
198593|NCT01317199|481743|P4|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
198594|NCT01317199|481744|P3|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
198595|NCT01317199|481745|P2|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
198596|NCT01317199|481746|P1|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
198597|NCT01317199|481743|P4|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
198598|NCT01317199|481744|P3|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
198599|NCT01317199|481745|P2|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
198600|NCT01317199|481746|P1|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
198601|NCT01317199|481743|P4|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
198602|NCT01317199|481744|P3|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
198603|NCT01317199|481745|P2|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
198604|NCT01317199|481746|P1|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||2
198605|NCT01317199|481743|P4|STARTED|Dose-escalation Phase 1||0
198606|NCT01317199|481744|P3|STARTED|Dose-escalation Phase 1||0
198607|NCT01317199|481745|P2|STARTED|Dose-escalation Phase 1||0
198608|NCT01317199|481746|P1|STARTED|Dose-escalation Phase 1||14
198609|NCT01317160|481775|P2|NOT COMPLETED|Overall Study||6
198610|NCT01317160|481776|P1|NOT COMPLETED|Overall Study||4
198611|NCT01317160|481775|P2|COMPLETED|Overall Study||69
198612|NCT01317160|481776|P1|COMPLETED|Overall Study||71
198613|NCT01317160|481775|P2|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
198614|NCT01317160|481776|P1|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
198615|NCT01317160|481775|P2|STARTED|Overall Study||75
198616|NCT01317160|481776|P1|STARTED|Overall Study||75
198617|NCT01317095|481786|P2|NOT COMPLETED|Overall Study||0
198618|NCT01317095|481787|P1|NOT COMPLETED|Overall Study||0
198619|NCT01317095|481786|P2|COMPLETED|Overall Study||41
198620|NCT01317095|481787|P1|COMPLETED|Overall Study||39
198621|NCT01317095|481786|P2|STARTED|Overall Study||41
198622|NCT01317095|481787|P1|STARTED|Overall Study||39
198623|NCT01317004|481801|P2|NOT COMPLETED|Overall Study||9
198624|NCT01317004|481802|P1|NOT COMPLETED|Overall Study||4
198625|NCT01317004|481801|P2|COMPLETED|Overall Study||5
198626|NCT01317004|481802|P1|COMPLETED|Overall Study||47
198627|NCT01317004|481801|P2|Safety Set|Overall Study||11
198628|NCT01317004|481802|P1|Safety Set|Overall Study||50
198629|NCT01317004|481801|P2|STARTED|Overall Study||14
198630|NCT01317004|481802|P1|STARTED|Overall Study||51
198631|NCT01316939|481823|P3|NOT COMPLETED|Overall Study||69
198632|NCT01316939|481824|P2|NOT COMPLETED|Overall Study||68
198633|NCT01316939|481825|P1|NOT COMPLETED|Overall Study||63
198634|NCT01316939|481823|P3|COMPLETED|Overall Study||7
198635|NCT01316939|481824|P2|COMPLETED|Overall Study||9
198636|NCT01316939|481825|P1|COMPLETED|Overall Study||13
198637|NCT01316939|481823|P3|STARTED|Overall Study||76
198638|NCT01316939|481824|P2|STARTED|Overall Study||77
198639|NCT01316939|481825|P1|STARTED|Overall Study||76
198640|NCT01316926|481905|P2|NOT COMPLETED|Period 2||0
198641|NCT01316926|481906|P1|NOT COMPLETED|Period 2||0
198642|NCT01316926|481905|P2|COMPLETED|Period 2||30
198643|NCT01316926|481906|P1|COMPLETED|Period 2||29
198644|NCT01316926|481905|P2|STARTED|Period 2||30
198645|NCT01316926|481906|P1|STARTED|Period 2|One participant completed Period 1, but did not appear in Period 2|29
198646|NCT01316926|481905|P2|NOT COMPLETED|Period 1||0
198647|NCT01316926|481906|P1|NOT COMPLETED|Period 1||0
198648|NCT01316926|481905|P2|COMPLETED|Period 1||30
198649|NCT01316926|481906|P1|COMPLETED|Period 1||30
198650|NCT01316926|481905|P2|STARTED|Period 1||30
198651|NCT01316926|481906|P1|STARTED|Period 1||30
198652|NCT01316913|481920|P4|NOT COMPLETED|Overall Study||39
198653|NCT01316913|481921|P3|NOT COMPLETED|Overall Study||49
198654|NCT01316913|481922|P2|NOT COMPLETED|Overall Study||54
198655|NCT01316913|481923|P1|NOT COMPLETED|Overall Study||57
198656|NCT01316913|481920|P4|COMPLETED|Overall Study||176
198657|NCT01316913|481921|P3|COMPLETED|Overall Study||166
198658|NCT01316913|481922|P2|COMPLETED|Overall Study||163
198659|NCT01316913|481923|P1|COMPLETED|Overall Study||165
198660|NCT01316913|481920|P4|STARTED|Overall Study||215
198661|NCT01316913|481921|P3|STARTED|Overall Study||215
198662|NCT01316913|481922|P2|STARTED|Overall Study||217
198663|NCT01316913|481923|P1|STARTED|Overall Study||222
198664|NCT01316900|481945|P4|NOT COMPLETED|Overall Study||31
198665|NCT01316900|481946|P3|NOT COMPLETED|Overall Study||41
198666|NCT01316900|481947|P2|NOT COMPLETED|Overall Study||31
198667|NCT01316900|481948|P1|NOT COMPLETED|Overall Study||44
198668|NCT01316900|481945|P4|COMPLETED|Overall Study||177
198669|NCT01316900|481946|P3|COMPLETED|Overall Study||173
198670|NCT01316900|481947|P2|COMPLETED|Overall Study||181
198671|NCT01316900|481948|P1|COMPLETED|Overall Study||165
198672|NCT01316900|481945|P4|STARTED|Overall Study||208
198673|NCT01316900|481946|P3|STARTED|Overall Study||214
198674|NCT01316900|481947|P2|STARTED|Overall Study||212
198675|NCT01316900|481948|P1|STARTED|Overall Study||209
198676|NCT01316887|481969|P3|NOT COMPLETED|Overall Study||83
198677|NCT01316887|481970|P2|NOT COMPLETED|Overall Study||94
198678|NCT01316887|481971|P1|NOT COMPLETED|Overall Study||43
198679|NCT01316887|481969|P3|COMPLETED|Overall Study||143
198680|NCT01316887|481970|P2|COMPLETED|Overall Study||133
198681|NCT01316887|481971|P1|COMPLETED|Overall Study||66
198682|NCT01316887|481969|P3|STARTED|Overall Study||226
198683|NCT01316887|481970|P2|STARTED|Overall Study||227
198684|NCT01316887|481971|P1|STARTED|Overall Study||109
198685|NCT01316770|482033|P2|NOT COMPLETED|Overall Study||0
198686|NCT01316770|482034|P1|NOT COMPLETED|Overall Study||0
198687|NCT01316770|482033|P2|COMPLETED|Overall Study||9
198688|NCT01316770|482034|P1|COMPLETED|Overall Study||9
198689|NCT01316770|482033|P2|STARTED|Overall Study|Each study participant received the placebo parotid irrigation on the other side of mouth.|9
198690|NCT01316770|482034|P1|STARTED|Overall Study|Each study participant received the dexamethasone parotid irrigation on one side of mouth.|9
198691|NCT01316692|482096|P1|NOT COMPLETED|Overall Study||12
198692|NCT01316692|482096|P1|COMPLETED|Overall Study||0
198693|NCT01316692|482096|P1|STARTED|Overall Study||12
198694|NCT01316614|482105|P1|NOT COMPLETED|Overall Study||37
198695|NCT01316614|482105|P1|COMPLETED|Overall Study||100
198696|NCT01316614|482105|P1|STARTED|Overall Study||137
198697|NCT01316575|482122|P2|NOT COMPLETED|Overall Study||1
198698|NCT01316575|482123|P1|NOT COMPLETED|Overall Study||2
198699|NCT01316575|482122|P2|COMPLETED|Overall Study||19
198700|NCT01316575|482123|P1|COMPLETED|Overall Study||18
198701|NCT01316575|482122|P2|STARTED|Overall Study||20
198702|NCT01316575|482123|P1|STARTED|Overall Study||20
198703|NCT01316510|482137|P2|NOT COMPLETED|Overall Study||0
198704|NCT01316510|482138|P1|NOT COMPLETED|Overall Study||0
198705|NCT01316510|482137|P2|COMPLETED|Overall Study||12
198706|NCT01316510|482138|P1|COMPLETED|Overall Study||12
198707|NCT01316510|482137|P2|STARTED|Overall Study||12
198708|NCT01316510|482138|P1|STARTED|Overall Study||12
198709|NCT01316419|482146|P1|NOT COMPLETED|Overall Study||265
198710|NCT01316419|482146|P1|COMPLETED|Overall Study||1824
198711|NCT01316419|482146|P1|STARTED|Overall Study||2089
198712|NCT01316380|482172|P3|NOT COMPLETED|Overall Study||3
198713|NCT01316380|482173|P2|NOT COMPLETED|Overall Study||5
198714|NCT01316380|482174|P1|NOT COMPLETED|Overall Study||2
198715|NCT01316380|482172|P3|COMPLETED|Overall Study||152
198716|NCT01316380|482173|P2|COMPLETED|Overall Study||149
198717|NCT01316380|482174|P1|COMPLETED|Overall Study||154
198718|NCT01316380|482172|P3|STARTED|Overall Study||155
198719|NCT01316380|482173|P2|STARTED|Overall Study||154
198720|NCT01316380|482174|P1|STARTED|Overall Study||156
198721|NCT01316341|482215|P3|NOT COMPLETED|Overall Study||0
198722|NCT01316341|482216|P2|NOT COMPLETED|Overall Study||0
198723|NCT01316341|482217|P1|NOT COMPLETED|Overall Study||0
198724|NCT01316341|482215|P3|COMPLETED|Overall Study||9
198725|NCT01316341|482216|P2|COMPLETED|Overall Study||9
198726|NCT01316341|482217|P1|COMPLETED|Overall Study||6
198727|NCT01316341|482215|P3|STARTED|Overall Study||9
198728|NCT01316341|482216|P2|STARTED|Overall Study||9
198729|NCT01316341|482217|P1|STARTED|Overall Study||6
198730|NCT01316315|482285|P2|NOT COMPLETED|Sequence 2||0
198731|NCT01316315|482286|P1|NOT COMPLETED|Sequence 2||0
198732|NCT01316315|482285|P2|COMPLETED|Sequence 2||7
198733|NCT01316315|482286|P1|COMPLETED|Sequence 2||7
198734|NCT01316315|482285|P2|STARTED|Sequence 2||7
198735|NCT01316315|482286|P1|STARTED|Sequence 2||7
198736|NCT01316315|482285|P2|NOT COMPLETED|Sequence 1||0
198737|NCT01316315|482286|P1|NOT COMPLETED|Sequence 1||0
198738|NCT01316315|482285|P2|COMPLETED|Sequence 1||7
198739|NCT01316315|482286|P1|COMPLETED|Sequence 1||7
198740|NCT01316315|482285|P2|STARTED|Sequence 1||7
198741|NCT01316315|482286|P1|STARTED|Sequence 1||7
198742|NCT01316302|482300|P2|NOT COMPLETED|Overall Study||11
198743|NCT01316302|482301|P1|NOT COMPLETED|Overall Study||10
198744|NCT01316302|482300|P2|COMPLETED|Overall Study||22
198745|NCT01316302|482301|P1|COMPLETED|Overall Study||20
198746|NCT01316302|482300|P2|STARTED|Overall Study||33
198747|NCT01316302|482301|P1|STARTED|Overall Study||30
198748|NCT01316276|482311|P1|NOT COMPLETED|Overall Study||67
198749|NCT01316276|482311|P1|COMPLETED|Overall Study||139
198750|NCT01316276|482311|P1|STARTED|Overall Study||206
198751|NCT01316263|482332|P2|NOT COMPLETED|Overall Study||0
198752|NCT01316263|482333|P1|NOT COMPLETED|Overall Study||0
198753|NCT01316263|482332|P2|COMPLETED|Overall Study||14
198754|NCT01316263|482333|P1|COMPLETED|Overall Study||7
198755|NCT01316263|482332|P2|Received Any Study Drug|Overall Study||14
198756|NCT01316263|482333|P1|Received Any Study Drug|Overall Study||7
198757|NCT01316263|482332|P2|STARTED|Overall Study||14
198758|NCT01316263|482333|P1|STARTED|Overall Study||7
198759|NCT01316224|482359|P1|NOT COMPLETED|Overall Study||10
198760|NCT01316224|482359|P1|COMPLETED|Overall Study||42
198761|NCT01316224|482359|P1|Completed Visit 4 to Rheumatologist|Overall Study||28
198762|NCT01316224|482359|P1|Completed Visit 4 to Dermatologist|Overall Study||42
198763|NCT01316224|482359|P1|Completed Visit 3 to Rheumatologist|Overall Study||39
198764|NCT01316224|482359|P1|Completed Visit 3 to Dermatologist|Overall Study||48
198765|NCT01316224|482359|P1|Completed Visit 2 to Dermatologist|Overall Study||51
198766|NCT01316224|482359|P1|Completed Visit 1 to Rheumatologist|Overall Study||49
198767|NCT01316224|482359|P1|Completed Visit 1 to Dermatologist|Overall Study||52
198768|NCT01316224|482359|P1|STARTED|Overall Study||52
198769|NCT01316055|482376|P3|NOT COMPLETED|Overall Study||0
198770|NCT01316055|482377|P2|NOT COMPLETED|Overall Study||0
198771|NCT01316055|482378|P1|NOT COMPLETED|Overall Study||1
198772|NCT01316055|482376|P3|COMPLETED|Overall Study||12
198773|NCT01316055|482377|P2|COMPLETED|Overall Study||17
198774|NCT01316055|482378|P1|COMPLETED|Overall Study||12
198775|NCT01316055|482376|P3|STARTED|Overall Study||12
198776|NCT01316055|482377|P2|STARTED|Overall Study||17
198777|NCT01316055|482378|P1|STARTED|Overall Study||13
198778|NCT01316042|482394|P2|NOT COMPLETED|Overall Study||1
198779|NCT01316042|482395|P1|NOT COMPLETED|Overall Study||0
198780|NCT01316042|482394|P2|COMPLETED|Overall Study||1
198781|NCT01316042|482395|P1|COMPLETED|Overall Study||2
198782|NCT01316042|482394|P2|STARTED|Overall Study||2
198783|NCT01316042|482395|P1|STARTED|Overall Study||2
198784|NCT01315873|482401|P1|NOT COMPLETED|Overall Study||0
198785|NCT01315873|482401|P1|COMPLETED|Overall Study||24
198786|NCT01315873|482401|P1|STARTED|Overall Study||24
198787|NCT01315847|482409|P2|NOT COMPLETED|Part III, Period 2||0
198788|NCT01315847|482410|P1|NOT COMPLETED|Part III, Period 2||0
198789|NCT01315847|482409|P2|COMPLETED|Part III, Period 2||3
198790|NCT01315847|482410|P1|COMPLETED|Part III, Period 2||0
198791|NCT01315847|482409|P2|Received [11C]MK-4232|Part III, Period 2||3
198792|NCT01315847|482410|P1|Received [11C]MK-4232|Part III, Period 2||0
198793|NCT01315847|482409|P2|Received Telcagepant|Part III, Period 2||3
198794|NCT01315847|482410|P1|Received Telcagepant|Part III, Period 2||0
198795|NCT01315847|482409|P2|STARTED|Part III, Period 2||3
198796|NCT01315847|482410|P1|STARTED|Part III, Period 2||0
198797|NCT01315847|482409|P2|NOT COMPLETED|Part III, Period 1||1
198798|NCT01315847|482410|P1|NOT COMPLETED|Part III, Period 1||0
198799|NCT01315847|482409|P2|COMPLETED|Part III, Period 1||3
198800|NCT01315847|482410|P1|COMPLETED|Part III, Period 1||0
198801|NCT01315847|482409|P2|Received [11C]MK-4232|Part III, Period 1|One of these participants received [11C]MK-4232 only at baseline.|4
198802|NCT01315847|482410|P1|Received [11C]MK-4232|Part III, Period 1||0
198803|NCT01315847|482409|P2|Received Telcagepant|Part III, Period 1||4
198804|NCT01315847|482410|P1|Received Telcagepant|Part III, Period 1||0
198805|NCT01315847|482409|P2|STARTED|Part III, Period 1|Subjects who participated in Part III did not participate in Part I.|4
198806|NCT01315847|482410|P1|STARTED|Part III, Period 1||0
198807|NCT01315847|482409|P2|NOT COMPLETED|Part I, Period 2||0
198808|NCT01315847|482410|P1|NOT COMPLETED|Part I, Period 2||0
198809|NCT01315847|482409|P2|COMPLETED|Part I, Period 2||0
198810|NCT01315847|482410|P1|COMPLETED|Part I, Period 2||3
198811|NCT01315847|482409|P2|Received [11C]MK-4232|Part I, Period 2||0
198812|NCT01315847|482410|P1|Received [11C]MK-4232|Part I, Period 2||3
198813|NCT01315847|482409|P2|Received Telcagepant|Part I, Period 2||0
198814|NCT01315847|482410|P1|Received Telcagepant|Part I, Period 2||3
198815|NCT01315847|482409|P2|STARTED|Part I, Period 2||0
198816|NCT01315847|482410|P1|STARTED|Part I, Period 2|One of these subjects did not participate in Part I, Period 1.|3
198817|NCT01315847|482409|P2|NOT COMPLETED|Part I, Period 1||0
198818|NCT01315847|482410|P1|NOT COMPLETED|Part I, Period 1||3
198819|NCT01315847|482409|P2|COMPLETED|Part I, Period 1||0
198820|NCT01315847|482410|P1|COMPLETED|Part I, Period 1||2
198821|NCT01315847|482409|P2|Received [11C]MK-4232|Part I, Period 1||0
198822|NCT01315847|482410|P1|Received [11C]MK-4232|Part I, Period 1|One of these participants received [11C]MK-4232 only at baseline.|5
198823|NCT01315847|482409|P2|Received Telcagepant|Part I, Period 1||0
198824|NCT01315847|482410|P1|Received Telcagepant|Part I, Period 1||5
198825|NCT01315847|482409|P2|STARTED|Part I, Period 1||0
198826|NCT01315847|482410|P1|STARTED|Part I, Period 1|Subjects who participated in Part I did not participate in Part III.|5
198827|NCT01315678|482424|P2|NOT COMPLETED|Overall Study||6
198828|NCT01315678|482425|P1|NOT COMPLETED|Overall Study||14
198829|NCT01315678|482424|P2|COMPLETED|Overall Study||140
198830|NCT01315678|482425|P1|COMPLETED|Overall Study||134
198831|NCT01315678|482424|P2|STARTED|Overall Study||146
198832|NCT01315678|482425|P1|STARTED|Overall Study||148
198833|NCT01315665|482445|P2|NOT COMPLETED|Overall Study||0
198834|NCT01315665|482446|P1|NOT COMPLETED|Overall Study||0
198835|NCT01315665|482445|P2|COMPLETED|Overall Study||5
198836|NCT01315665|482446|P1|COMPLETED|Overall Study||10
198837|NCT01315665|482445|P2|STARTED|Overall Study||5
198838|NCT01315665|482446|P1|STARTED|Overall Study||10
198839|NCT01315574|482462|P2|NOT COMPLETED|Overall Study||0
198840|NCT01315574|482463|P1|NOT COMPLETED|Overall Study||0
198841|NCT01315574|482462|P2|COMPLETED|Overall Study||7
198842|NCT01315574|482463|P1|COMPLETED|Overall Study||7
198843|NCT01315574|482462|P2|STARTED|Overall Study||7
198844|NCT01315574|482463|P1|STARTED|Overall Study||7
198845|NCT01315353|482476|P3|NOT COMPLETED|Overall Study||13
198846|NCT01315353|482477|P2|NOT COMPLETED|Overall Study||23
198847|NCT01315353|482478|P1|NOT COMPLETED|Overall Study||29
198848|NCT01315353|482476|P3|COMPLETED|Overall Study||166
198849|NCT01315353|482477|P2|COMPLETED|Overall Study||120
198850|NCT01315353|482478|P1|COMPLETED|Overall Study||116
198851|NCT01315353|482476|P3|STARTED|Overall Study||179
198852|NCT01315353|482477|P2|STARTED|Overall Study||143
198853|NCT01315353|482478|P1|STARTED|Overall Study||145
198854|NCT01315249|482505|P2|NOT COMPLETED|Overall Study||47
198855|NCT01315249|482506|P1|NOT COMPLETED|Overall Study||44
198856|NCT01315249|482505|P2|COMPLETED|Overall Study||217
198857|NCT01315249|482506|P1|COMPLETED|Overall Study||215
198858|NCT01315249|482505|P2|STARTED|Overall Study||264
198859|NCT01315249|482506|P1|STARTED|Overall Study||259
198860|NCT01315236|482534|P2|NOT COMPLETED|12-Month Follow-up Period||1
198861|NCT01315236|482535|P1|NOT COMPLETED|12-Month Follow-up Period||1
198862|NCT01315236|482534|P2|COMPLETED|12-Month Follow-up Period||31
198863|NCT01315236|482535|P1|COMPLETED|12-Month Follow-up Period||26
198864|NCT01315236|482534|P2|STARTED|12-Month Follow-up Period|Some subjects did not consent to the 12 month safety.|32
198865|NCT01315236|482535|P1|STARTED|12-Month Follow-up Period|Some subjects did not consent to the 12 month safety.|27
198866|NCT01315236|482534|P2|NOT COMPLETED|Open-label Phase||2
198867|NCT01315236|482535|P1|NOT COMPLETED|Open-label Phase||1
198868|NCT01315236|482534|P2|COMPLETED|Open-label Phase||41
198869|NCT01315236|482535|P1|COMPLETED|Open-label Phase||34
198870|NCT01315236|482534|P2|STARTED|Open-label Phase|Some subjects did not consent to the open label after the double blind phase.|43
198871|NCT01315236|482535|P1|STARTED|Open-label Phase|Some subjects did not consent to the open label after the double blind phase.|35
198872|NCT01315236|482534|P2|NOT COMPLETED|Double-blind Phase||0
198873|NCT01315236|482535|P1|NOT COMPLETED|Double-blind Phase||4
198874|NCT01315236|482534|P2|COMPLETED|Double-blind Phase||45
198875|NCT01315236|482535|P1|COMPLETED|Double-blind Phase||40
198876|NCT01315236|482534|P2|STARTED|Double-blind Phase||45
198877|NCT01315236|482535|P1|STARTED|Double-blind Phase||44
198878|NCT01315158|482559|P2|NOT COMPLETED|Overall Study||0
198879|NCT01315158|482560|P1|NOT COMPLETED|Overall Study||0
198880|NCT01315158|482559|P2|COMPLETED|Overall Study||19
198881|NCT01315158|482560|P1|COMPLETED|Overall Study||17
198882|NCT01315158|482559|P2|STARTED|Overall Study||19
198883|NCT01315158|482560|P1|STARTED|Overall Study||17
198884|NCT01315145|482584|P2|NOT COMPLETED|Overall Study||5
198885|NCT01315145|482585|P1|NOT COMPLETED|Overall Study||17
198886|NCT01315145|482584|P2|COMPLETED|Overall Study||11
198887|NCT01315145|482585|P1|COMPLETED|Overall Study||105
198888|NCT01315145|482584|P2|STARTED|Overall Study||16
198889|NCT01315145|482585|P1|STARTED|Overall Study||122
198890|NCT01315132|482591|P1|NOT COMPLETED|Overall Study||1
198891|NCT01315132|482591|P1|COMPLETED|Overall Study||46
198892|NCT01315132|482591|P1|STARTED|Overall Study||47
198893|NCT01315028|482598|P2|NOT COMPLETED|Overall Study||1
198894|NCT01315028|482599|P1|NOT COMPLETED|Overall Study||1
198895|NCT01315028|482598|P2|COMPLETED|Overall Study||9
198896|NCT01315028|482599|P1|COMPLETED|Overall Study||9
198897|NCT01315028|482598|P2|STARTED|Overall Study||10
198898|NCT01315028|482599|P1|STARTED|Overall Study||10
198899|NCT01315002|482611|P2|NOT COMPLETED|Overall Study||5
198900|NCT01315002|482612|P1|NOT COMPLETED|Overall Study||5
198901|NCT01315002|482611|P2|COMPLETED|Overall Study||55
198902|NCT01315002|482612|P1|COMPLETED|Overall Study||56
198903|NCT01315002|482611|P2|STARTED|Overall Study||60
198904|NCT01315002|482612|P1|STARTED|Overall Study||61
198905|NCT01314963|482618|P1|NOT COMPLETED|Overall Study||0
198906|NCT01314963|482618|P1|COMPLETED|Overall Study||50
198907|NCT01314963|482618|P1|STARTED|Overall Study||50
198908|NCT01314911|482626|P2|NOT COMPLETED|Overall Study||6
198909|NCT01314911|482627|P1|NOT COMPLETED|Overall Study||5
198910|NCT01314911|482626|P2|COMPLETED|Overall Study||274
198911|NCT01314911|482627|P1|COMPLETED|Overall Study||273
198912|NCT01314911|482626|P2|STARTED|Overall Study||280
198913|NCT01314911|482627|P1|STARTED|Overall Study||278
198914|NCT01314872|482678|P15|NOT COMPLETED|Period 2||24
198915|NCT01314872|482679|P14|NOT COMPLETED|Period 2||53
198916|NCT01314872|482680|P13|NOT COMPLETED|Period 2||60
198917|NCT01314872|482681|P12|NOT COMPLETED|Period 2||48
198918|NCT01314872|482682|P11|NOT COMPLETED|Period 2||0
198919|NCT01314872|482683|P10|NOT COMPLETED|Period 2||0
198920|NCT01314872|482684|P9|NOT COMPLETED|Period 2||0
198921|NCT01314872|482685|P8|NOT COMPLETED|Period 2||0
198922|NCT01314872|482686|P7|NOT COMPLETED|Period 2||0
198923|NCT01314872|482687|P6|NOT COMPLETED|Period 2||0
198924|NCT01314872|482688|P5|NOT COMPLETED|Period 2||0
198925|NCT01314872|482689|P4|NOT COMPLETED|Period 2||0
198926|NCT01314872|482690|P3|NOT COMPLETED|Period 2||0
198927|NCT01314872|482691|P2|NOT COMPLETED|Period 2||0
198928|NCT01314872|482692|P1|NOT COMPLETED|Period 2||0
198929|NCT01314872|482678|P15|COMPLETED|Period 2||110
198930|NCT01314872|482679|P14|COMPLETED|Period 2||187
198931|NCT01314872|482680|P13|COMPLETED|Period 2||188
198932|NCT01314872|482681|P12|COMPLETED|Period 2||175
198933|NCT01314872|482682|P11|COMPLETED|Period 2||0
198934|NCT01314872|482683|P10|COMPLETED|Period 2||0
198935|NCT01314872|482684|P9|COMPLETED|Period 2||0
198936|NCT01314872|482685|P8|COMPLETED|Period 2||0
198937|NCT01314872|482686|P7|COMPLETED|Period 2||0
198938|NCT01314872|482687|P6|COMPLETED|Period 2||0
198939|NCT01314872|482688|P5|COMPLETED|Period 2||0
198940|NCT01314872|482689|P4|COMPLETED|Period 2||0
198941|NCT01314872|482690|P3|COMPLETED|Period 2||0
198942|NCT01314872|482691|P2|COMPLETED|Period 2||0
198943|NCT01314872|482692|P1|COMPLETED|Period 2||0
198944|NCT01314872|482678|P15|STARTED|Period 2||134
198945|NCT01314872|482679|P14|STARTED|Period 2||240
198946|NCT01314872|482680|P13|STARTED|Period 2||248
198947|NCT01314872|482681|P12|STARTED|Period 2||223
198948|NCT01314872|482682|P11|STARTED|Period 2||0
198949|NCT01314872|482683|P10|STARTED|Period 2||0
198950|NCT01314872|482684|P9|STARTED|Period 2||0
198951|NCT01314872|482685|P8|STARTED|Period 2||0
198952|NCT01314872|482686|P7|STARTED|Period 2||0
198953|NCT01314872|482687|P6|STARTED|Period 2||0
198954|NCT01314872|482688|P5|STARTED|Period 2||0
198955|NCT01314872|482689|P4|STARTED|Period 2||0
198956|NCT01314872|482690|P3|STARTED|Period 2||0
198957|NCT01314872|482691|P2|STARTED|Period 2||0
198958|NCT01314872|482692|P1|STARTED|Period 2||0
198959|NCT01314872|482678|P15|NOT COMPLETED|Treatment Period 1||0
198960|NCT01314872|482679|P14|NOT COMPLETED|Treatment Period 1||0
198961|NCT01314872|482680|P13|NOT COMPLETED|Treatment Period 1||0
198962|NCT01314872|482681|P12|NOT COMPLETED|Treatment Period 1||0
198963|NCT01314872|482682|P11|NOT COMPLETED|Treatment Period 1||3
198964|NCT01314872|482683|P10|NOT COMPLETED|Treatment Period 1||4
198965|NCT01314872|482684|P9|NOT COMPLETED|Treatment Period 1||6
198966|NCT01314872|482685|P8|NOT COMPLETED|Treatment Period 1||7
198967|NCT01314872|482686|P7|NOT COMPLETED|Treatment Period 1||8
198968|NCT01314872|482687|P6|NOT COMPLETED|Treatment Period 1||7
198969|NCT01314872|482688|P5|NOT COMPLETED|Treatment Period 1||7
198970|NCT01314872|482689|P4|NOT COMPLETED|Treatment Period 1||7
198971|NCT01314872|482690|P3|NOT COMPLETED|Treatment Period 1||6
198972|NCT01314872|482691|P2|NOT COMPLETED|Treatment Period 1||6
198973|NCT01314872|482692|P1|NOT COMPLETED|Treatment Period 1||10
198974|NCT01314872|482678|P15|COMPLETED|Treatment Period 1||0
198975|NCT01314872|482679|P14|COMPLETED|Treatment Period 1||0
198976|NCT01314872|482680|P13|COMPLETED|Treatment Period 1||0
198977|NCT01314872|482681|P12|COMPLETED|Treatment Period 1||0
198978|NCT01314872|482682|P11|COMPLETED|Treatment Period 1||107
198979|NCT01314872|482683|P10|COMPLETED|Treatment Period 1||118
198980|NCT01314872|482684|P9|COMPLETED|Treatment Period 1||106
198981|NCT01314872|482685|P8|COMPLETED|Treatment Period 1||57
198982|NCT01314872|482686|P7|COMPLETED|Treatment Period 1||126
198983|NCT01314872|482687|P6|COMPLETED|Treatment Period 1||128
198984|NCT01314872|482688|P5|COMPLETED|Treatment Period 1||142
198985|NCT01314872|482689|P4|COMPLETED|Treatment Period 1||143
198986|NCT01314872|482690|P3|COMPLETED|Treatment Period 1||128
198987|NCT01314872|482691|P2|COMPLETED|Treatment Period 1||138
198988|NCT01314872|482692|P1|COMPLETED|Treatment Period 1||131
198989|NCT01314872|482678|P15|STARTED|Treatment Period 1||0
198990|NCT01314872|482679|P14|STARTED|Treatment Period 1||0
198991|NCT01314872|482680|P13|STARTED|Treatment Period 1||0
198992|NCT01314872|482681|P12|STARTED|Treatment Period 1||0
198993|NCT01314872|482682|P11|STARTED|Treatment Period 1||110
198994|NCT01314872|482683|P10|STARTED|Treatment Period 1||122
198995|NCT01314872|482684|P9|STARTED|Treatment Period 1||112
198996|NCT01314872|482685|P8|STARTED|Treatment Period 1||64
198997|NCT01314872|482686|P7|STARTED|Treatment Period 1||134
198998|NCT01314872|482687|P6|STARTED|Treatment Period 1||135
198999|NCT01314872|482688|P5|STARTED|Treatment Period 1||149
199000|NCT01314872|482689|P4|STARTED|Treatment Period 1||150
199001|NCT01314872|482690|P3|STARTED|Treatment Period 1||134
199002|NCT01314872|482691|P2|STARTED|Treatment Period 1||144
199003|NCT01314872|482692|P1|STARTED|Treatment Period 1||141
199004|NCT01314742|482785|P2|NOT COMPLETED|Overall Study||0
199005|NCT01314742|482786|P1|NOT COMPLETED|Overall Study||0
199006|NCT01314742|482785|P2|COMPLETED|Overall Study||21
199007|NCT01314742|482786|P1|COMPLETED|Overall Study||20
199008|NCT01314742|482785|P2|STARTED|Overall Study||21
199009|NCT01314742|482786|P1|STARTED|Overall Study||20
199010|NCT01314716|482796|P2|NOT COMPLETED|Open-Label Phase||12
199011|NCT01314716|482797|P1|NOT COMPLETED|Open-Label Phase||10
199012|NCT01314716|482796|P2|COMPLETED|Open-Label Phase||98
199013|NCT01314716|482797|P1|COMPLETED|Open-Label Phase||102
199014|NCT01314716|482796|P2|STARTED|Open-Label Phase|13 participants in this group did not continue from the randomized to the open-label phase.|110
199015|NCT01314716|482797|P1|STARTED|Open-Label Phase|7 participants in this group did not continue from the randomized to the open-label phase.|112
199016|NCT01314716|482796|P2|NOT COMPLETED|Double-Blind Phase||15
199017|NCT01314716|482797|P1|NOT COMPLETED|Double-Blind Phase||17
199018|NCT01314716|482796|P2|COMPLETED|Double-Blind Phase||123
199019|NCT01314716|482797|P1|COMPLETED|Double-Blind Phase||119
199020|NCT01314716|482796|P2|Randomized and Treated|Double-Blind Phase||137
199021|NCT01314716|482797|P1|Randomized and Treated|Double-Blind Phase||135
199022|NCT01314716|482796|P2|STARTED|Double-Blind Phase||138
199023|NCT01314716|482797|P1|STARTED|Double-Blind Phase||136
199024|NCT01314703|482809|P1|NOT COMPLETED|Overall Study||8
199025|NCT01314703|482809|P1|COMPLETED|Overall Study||27
199026|NCT01314703|482809|P1|Discontinued When Enrollment Completed|Overall Study||3
199027|NCT01314703|482809|P1|Non Qualified Bacterial Screening Counts|Overall Study||3
199028|NCT01314703|482809|P1|Excluded Prior to Screening Baseline|Overall Study||2
199029|NCT01314703|482809|P1|Completed Study|Overall Study||27
199030|NCT01314703|482809|P1|Completed Treatment Visit|Overall Study||27
199031|NCT01314703|482809|P1|Completed Screen Visit|Overall Study||33
199032|NCT01314703|482809|P1|Signed Informed Consent|Overall Study||35
199033|NCT01314703|482809|P1|STARTED|Overall Study||35
199034|NCT01314443|482818|P4|NOT COMPLETED|Overall Study||2
199035|NCT01314443|482819|P3|NOT COMPLETED|Overall Study||2
199036|NCT01314443|482820|P2|NOT COMPLETED|Overall Study||3
199037|NCT01314443|482821|P1|NOT COMPLETED|Overall Study||4
199038|NCT01314443|482818|P4|COMPLETED|Overall Study||13
199039|NCT01314443|482819|P3|COMPLETED|Overall Study||13
199040|NCT01314443|482820|P2|COMPLETED|Overall Study||16
199041|NCT01314443|482821|P1|COMPLETED|Overall Study||14
199042|NCT01314443|482818|P4|STARTED|Overall Study||15
199043|NCT01314443|482819|P3|STARTED|Overall Study||15
199044|NCT01314443|482820|P2|STARTED|Overall Study||19
199045|NCT01314443|482821|P1|STARTED|Overall Study||18
199046|NCT01314417|482839|P1|NOT COMPLETED|Overall Study||0
199047|NCT01314417|482839|P1|COMPLETED|Overall Study||2
199048|NCT01314417|482839|P1|STARTED|Overall Study||2
199049|NCT01314313|482870|P2|NOT COMPLETED|Overall Study||311
199050|NCT01314313|482871|P1|NOT COMPLETED|Overall Study||227
199051|NCT01314313|482870|P2|COMPLETED|Overall Study||710
199052|NCT01314313|482871|P1|COMPLETED|Overall Study||784
199053|NCT01314313|482870|P2|Valve Implanted|Overall Study||936
199054|NCT01314313|482871|P1|Valve Implanted|Overall Study||974
199055|NCT01314313|482870|P2|As Treated|Overall Study||944
199056|NCT01314313|482871|P1|As Treated|Overall Study||994
199057|NCT01314313|482870|P2|STARTED|Overall Study||1021
199058|NCT01314313|482871|P1|STARTED|Overall Study||1011
199059|NCT01314261|482891|P4|NOT COMPLETED|Overall Study||3
199060|NCT01314261|482892|P3|NOT COMPLETED|Overall Study||3
199061|NCT01314261|482893|P2|NOT COMPLETED|Overall Study||4
199062|NCT01314261|482894|P1|NOT COMPLETED|Overall Study||2
199063|NCT01314261|482891|P4|COMPLETED|Overall Study||6
199064|NCT01314261|482892|P3|COMPLETED|Overall Study||7
199065|NCT01314261|482893|P2|COMPLETED|Overall Study||5
199066|NCT01314261|482894|P1|COMPLETED|Overall Study||7
199067|NCT01314261|482891|P4|Discontinued pegIFN/RBV|Overall Study||1
199068|NCT01314261|482892|P3|Discontinued pegIFN/RBV|Overall Study||5
199069|NCT01314261|482893|P2|Discontinued pegIFN/RBV|Overall Study||4
199070|NCT01314261|482894|P1|Discontinued pegIFN/RBV|Overall Study||1
199071|NCT01314261|482891|P4|Discontinued ABT-267 or Placebo|Overall Study||0
199072|NCT01314261|482892|P3|Discontinued ABT-267 or Placebo|Overall Study||1
199073|NCT01314261|482893|P2|Discontinued ABT-267 or Placebo|Overall Study||0
199074|NCT01314261|482894|P1|Discontinued ABT-267 or Placebo|Overall Study||1
199075|NCT01314261|482891|P4|STARTED|Overall Study||9
199076|NCT01314261|482892|P3|STARTED|Overall Study||10
199077|NCT01314261|482893|P2|STARTED|Overall Study||9
199078|NCT01314261|482894|P1|STARTED|Overall Study||9
199079|NCT01314118|482945|P1|NOT COMPLETED|Overall Study||131
199080|NCT01314118|482945|P1|COMPLETED|Overall Study||0
199081|NCT01314118|482945|P1|STARTED|Overall Study||131
199082|NCT01314105|482954|P2|NOT COMPLETED|Overall Study||12
199083|NCT01314105|482955|P1|NOT COMPLETED|Overall Study||7
199084|NCT01314105|482954|P2|COMPLETED|Overall Study||0
199085|NCT01314105|482955|P1|COMPLETED|Overall Study||0
199086|NCT01314105|482954|P2|STARTED|Overall Study||12
199087|NCT01314105|482955|P1|STARTED|Overall Study||7
199088|NCT01314014|482997|P1|NOT COMPLETED|Overall Study||0
199089|NCT01314014|482997|P1|COMPLETED|Overall Study|Treatment continued for as long as the subject derived benefit.|22
199090|NCT01314014|482997|P1|STARTED|Overall Study||22
199091|NCT01314001|483008|P6|NOT COMPLETED|Overall Study||71
199092|NCT01314001|483009|P5|NOT COMPLETED|Overall Study||72
199093|NCT01314001|483010|P4|NOT COMPLETED|Overall Study||69
199094|NCT01314001|483011|P3|NOT COMPLETED|Overall Study||69
199095|NCT01314001|483012|P2|NOT COMPLETED|Overall Study||69
199096|NCT01314001|483013|P1|NOT COMPLETED|Overall Study||75
199097|NCT01314001|483008|P6|COMPLETED|Overall Study||129
199098|NCT01314001|483009|P5|COMPLETED|Overall Study||148
199099|NCT01314001|483010|P4|COMPLETED|Overall Study||122
199100|NCT01314001|483011|P3|COMPLETED|Overall Study||158
199101|NCT01314001|483012|P2|COMPLETED|Overall Study||124
199102|NCT01314001|483013|P1|COMPLETED|Overall Study||140
199103|NCT01314001|483008|P6|6-Month Follow Up Survey|Overall Study||139
199104|NCT01314001|483009|P5|6-Month Follow Up Survey|Overall Study||157
199105|NCT01314001|483010|P4|6-Month Follow Up Survey|Overall Study||135
199106|NCT01314001|483011|P3|6-Month Follow Up Survey|Overall Study||165
199107|NCT01314001|483012|P2|6-Month Follow Up Survey|Overall Study||137
199108|NCT01314001|483013|P1|6-Month Follow Up Survey|Overall Study||146
199109|NCT01314001|483008|P6|End-of-Treatment Visit|Overall Study||160
199110|NCT01314001|483009|P5|End-of-Treatment Visit|Overall Study||174
199111|NCT01314001|483010|P4|End-of-Treatment Visit|Overall Study||146
199112|NCT01314001|483011|P3|End-of-Treatment Visit|Overall Study||179
199113|NCT01314001|483012|P2|End-of-Treatment Visit|Overall Study||141
199114|NCT01314001|483013|P1|End-of-Treatment Visit|Overall Study||156
199115|NCT01314001|483008|P6|STARTED|Overall Study||200
199116|NCT01314001|483009|P5|STARTED|Overall Study||220
199117|NCT01314001|483010|P4|STARTED|Overall Study||191
199118|NCT01314001|483011|P3|STARTED|Overall Study||227
199119|NCT01314001|483012|P2|STARTED|Overall Study||193
199120|NCT01314001|483013|P1|STARTED|Overall Study||215
199121|NCT01313936|483059|P2|NOT COMPLETED|Overall Study||0
199122|NCT01313936|483060|P1|NOT COMPLETED|Overall Study||0
199123|NCT01313936|483059|P2|COMPLETED|Overall Study||26
199124|NCT01313936|483060|P1|COMPLETED|Overall Study||6
199125|NCT01313936|483059|P2|STARTED|Overall Study||26
199126|NCT01313936|483060|P1|STARTED|Overall Study||6
199127|NCT01313923|483073|P1|NOT COMPLETED|Overall Study||3
199128|NCT01313923|483073|P1|COMPLETED|Overall Study||0
199129|NCT01313923|483073|P1|STARTED|Overall Study||3
199130|NCT01313910|483077|P1|NOT COMPLETED|Overall Study||0
199131|NCT01313910|483077|P1|COMPLETED|Overall Study||8
199132|NCT01313910|483077|P1|STARTED|Overall Study||8
199133|NCT01313897|483085|P1|NOT COMPLETED|Overall Study||2
199134|NCT01313897|483085|P1|COMPLETED|Overall Study||8
199135|NCT01313897|483085|P1|STARTED|Overall Study||10
199136|NCT01313884|483089|P1|NOT COMPLETED|Overall Study||1
199137|NCT01313884|483089|P1|COMPLETED|Overall Study||2
199138|NCT01313884|483089|P1|STARTED|Overall Study||3
199139|NCT01313858|483097|P3|NOT COMPLETED|Overall Study||238
199140|NCT01313858|483098|P2|NOT COMPLETED|Overall Study||270
199141|NCT01313858|483099|P1|NOT COMPLETED|Overall Study||286
199142|NCT01313858|483097|P3|COMPLETED|Overall Study||305
199143|NCT01313858|483098|P2|COMPLETED|Overall Study||276
199144|NCT01313858|483099|P1|COMPLETED|Overall Study||238
199145|NCT01313858|483097|P3|STARTED|Overall Study||543
199146|NCT01313858|483098|P2|STARTED|Overall Study||546
199147|NCT01313858|483099|P1|STARTED|Overall Study||524
199148|NCT01313780|483122|P2|NOT COMPLETED|Overall Study||28
199149|NCT01313780|483123|P1|NOT COMPLETED|Overall Study||25
199150|NCT01313780|483122|P2|COMPLETED|Overall Study|PPS|31
199151|NCT01313780|483123|P1|COMPLETED|Overall Study|PPS|33
199152|NCT01313780|483122|P2|STARTED|Overall Study|FAS|59
199153|NCT01313780|483123|P1|STARTED|Overall Study|FAS|58
199154|NCT01313767|483133|P2|NOT COMPLETED|Overall Study||2
199155|NCT01313767|483134|P1|NOT COMPLETED|Overall Study||7
199156|NCT01313767|483133|P2|COMPLETED|Overall Study||96
199157|NCT01313767|483134|P1|COMPLETED|Overall Study||91
199158|NCT01313767|483133|P2|STARTED|Overall Study||98
199159|NCT01313767|483134|P1|STARTED|Overall Study||98
199160|NCT01313728|483176|P1|NOT COMPLETED|Baseline to Completion||0
199161|NCT01313728|483176|P1|COMPLETED|Baseline to Completion||25
199162|NCT01313728|483176|P1|STARTED|Baseline to Completion||25
199163|NCT01313728|483176|P1|NOT COMPLETED|Informed Consent to Baseline||1
199164|NCT01313728|483176|P1|COMPLETED|Informed Consent to Baseline|One subject withdrew after signing informed consent, but prior to Baseline measurements being taken.|25
199165|NCT01313728|483176|P1|STARTED|Informed Consent to Baseline||26
199166|NCT01313689|483196|P5|NOT COMPLETED|24-Week Randomization 2||15
199167|NCT01313689|483197|P4|NOT COMPLETED|24-Week Randomization 2||1
199168|NCT01313689|483198|P3|NOT COMPLETED|24-Week Randomization 2||3
199169|NCT01313689|483199|P2|NOT COMPLETED|24-Week Randomization 2||0
199170|NCT01313689|483200|P1|NOT COMPLETED|24-Week Randomization 2||0
199171|NCT01313689|483196|P5|COMPLETED|24-Week Randomization 2||27
199172|NCT01313689|483197|P4|COMPLETED|24-Week Randomization 2||12
199173|NCT01313689|483198|P3|COMPLETED|24-Week Randomization 2||21
199174|NCT01313689|483199|P2|COMPLETED|24-Week Randomization 2||0
199175|NCT01313689|483200|P1|COMPLETED|24-Week Randomization 2||0
199176|NCT01313689|483196|P5|STARTED|24-Week Randomization 2|OFA Participants who did not enter Randomization 2.|42
199177|NCT01313689|483197|P4|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|13
199178|NCT01313689|483198|P3|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|24
199179|NCT01313689|483199|P2|STARTED|24-Week Randomization 2||0
199180|NCT01313689|483200|P1|STARTED|24-Week Randomization 2||0
199181|NCT01313689|483196|P5|NOT COMPLETED|24-Week Randomization 1||0
199182|NCT01313689|483197|P4|NOT COMPLETED|24-Week Randomization 1||0
199183|NCT01313689|483198|P3|NOT COMPLETED|24-Week Randomization 1||0
199184|NCT01313689|483199|P2|NOT COMPLETED|24-Week Randomization 1||10
199185|NCT01313689|483200|P1|NOT COMPLETED|24-Week Randomization 1||19
199186|NCT01313689|483196|P5|COMPLETED|24-Week Randomization 1||0
199187|NCT01313689|483197|P4|COMPLETED|24-Week Randomization 1||0
199188|NCT01313689|483198|P3|COMPLETED|24-Week Randomization 1||0
199189|NCT01313689|483199|P2|COMPLETED|24-Week Randomization 1|Par. that did not receive OFA salvage continued visits for Follow-up and overall survival assessment|33
199190|NCT01313689|483200|P1|COMPLETED|24-Week Randomization 1|Par. not entering Randomization 2 continued visits for Follow-up and overall survival assessment|60
199191|NCT01313689|483196|P5|STARTED|24-Week Randomization 1||0
199192|NCT01313689|483197|P4|STARTED|24-Week Randomization 1||0
199193|NCT01313689|483198|P3|STARTED|24-Week Randomization 1||0
199194|NCT01313689|483199|P2|STARTED|24-Week Randomization 1|Of the 43 participants in the PC arm, 22 entered the OFA Salvage arm.|43
199195|NCT01313689|483200|P1|STARTED|24-Week Randomization 1||79
199196|NCT01313676|483279|P4|NOT COMPLETED|Overall Study||994
199197|NCT01313676|483280|P3|NOT COMPLETED|Overall Study||1088
199198|NCT01313676|483281|P2|NOT COMPLETED|Overall Study||1113
199199|NCT01313676|483282|P1|NOT COMPLETED|Overall Study||1250
199200|NCT01313676|483279|P4|COMPLETED|Overall Study||3146
199201|NCT01313676|483280|P3|COMPLETED|Overall Study||3052
199202|NCT01313676|483281|P2|COMPLETED|Overall Study||3044
199203|NCT01313676|483282|P1|COMPLETED|Overall Study||2881
199204|NCT01313676|483279|P4|STARTED|Overall Study||4140
199205|NCT01313676|483280|P3|STARTED|Overall Study||4140
199206|NCT01313676|483281|P2|STARTED|Overall Study||4157
199207|NCT01313676|483282|P1|STARTED|Overall Study||4131
199208|NCT01313663|483302|P2|NOT COMPLETED|Overall Study||8
199209|NCT01313663|483303|P1|NOT COMPLETED|Overall Study||4
199210|NCT01313663|483302|P2|COMPLETED|Overall Study||3
199211|NCT01313663|483303|P1|COMPLETED|Overall Study||5
199212|NCT01313663|483302|P2|STARTED|Overall Study||11
199213|NCT01313663|483303|P1|STARTED|Overall Study||9
199214|NCT01313650|483341|P4|NOT COMPLETED|Overall Study||81
199215|NCT01313650|483342|P3|NOT COMPLETED|Overall Study||103
199216|NCT01313650|483343|P2|NOT COMPLETED|Overall Study||94
199217|NCT01313650|483344|P1|NOT COMPLETED|Overall Study||76
199218|NCT01313650|483341|P4|COMPLETED|Overall Study||332
199219|NCT01313650|483342|P3|COMPLETED|Overall Study||318
199220|NCT01313650|483343|P2|COMPLETED|Overall Study||324
199221|NCT01313650|483344|P1|COMPLETED|Overall Study||204
199222|NCT01313650|483341|P4|STARTED|Overall Study||413
199223|NCT01313650|483342|P3|STARTED|Overall Study||421
199224|NCT01313650|483343|P2|STARTED|Overall Study||418
199225|NCT01313650|483344|P1|STARTED|Overall Study||280
199226|NCT01313637|483370|P4|NOT COMPLETED|Overall Study||78
199227|NCT01313637|483371|P3|NOT COMPLETED|Overall Study||106
199228|NCT01313637|483372|P2|NOT COMPLETED|Overall Study||95
199229|NCT01313637|483373|P1|NOT COMPLETED|Overall Study||92
199230|NCT01313637|483370|P4|COMPLETED|Overall Study||325
199231|NCT01313637|483371|P3|COMPLETED|Overall Study||298
199232|NCT01313637|483372|P2|COMPLETED|Overall Study||312
199233|NCT01313637|483373|P1|COMPLETED|Overall Study||183
199234|NCT01313637|483370|P4|STARTED|Overall Study||403
199235|NCT01313637|483371|P3|STARTED|Overall Study||404
199236|NCT01313637|483372|P2|STARTED|Overall Study||407
199237|NCT01313637|483373|P1|STARTED|Overall Study||275
199238|NCT01313624|483397|P2|NOT COMPLETED|Open-Label Phase||13
199239|NCT01313624|483398|P1|NOT COMPLETED|Open-Label Phase||4
199240|NCT01313624|483397|P2|COMPLETED|Open-Label Phase||109
199241|NCT01313624|483398|P1|COMPLETED|Open-Label Phase||92
199242|NCT01313624|483397|P2|STARTED|Open-Label Phase||122
199243|NCT01313624|483398|P1|STARTED|Open-Label Phase||96
199244|NCT01313624|483397|P2|NOT COMPLETED|Double-Blind Phase||10
199245|NCT01313624|483398|P1|NOT COMPLETED|Double-Blind Phase||38
199246|NCT01313624|483397|P2|COMPLETED|Double-Blind Phase||122
199247|NCT01313624|483398|P1|COMPLETED|Double-Blind Phase||96
199248|NCT01313624|483397|P2|STARTED|Double-Blind Phase||132
199249|NCT01313624|483398|P1|STARTED|Double-Blind Phase||134
199250|NCT01313559|483412|P2|NOT COMPLETED|Overall Study||2
199251|NCT01313559|483413|P1|NOT COMPLETED|Overall Study||4
199252|NCT01313559|483412|P2|COMPLETED|Overall Study||0
199253|NCT01313559|483413|P1|COMPLETED|Overall Study||0
199254|NCT01313559|483412|P2|STARTED|Overall Study||2
199255|NCT01313559|483413|P1|STARTED|Overall Study||4
199256|NCT01313520|483427|P2|NOT COMPLETED|Overall Study||0
199257|NCT01313520|483428|P1|NOT COMPLETED|Overall Study||0
199258|NCT01313520|483427|P2|COMPLETED|Overall Study||31
199259|NCT01313520|483428|P1|COMPLETED|Overall Study||30
199260|NCT01313520|483427|P2|STARTED|Overall Study||31
199261|NCT01313520|483428|P1|STARTED|Overall Study||30
199262|NCT01313507|483448|P1|NOT COMPLETED|Overall Study||0
199263|NCT01313507|483448|P1|COMPLETED|Overall Study||21
199264|NCT01313507|483448|P1|STARTED|Overall Study||21
199265|NCT01313494|483456|P2|NOT COMPLETED|Overall Study||50
199266|NCT01313494|483457|P1|NOT COMPLETED|Overall Study||67
199267|NCT01313494|483456|P2|COMPLETED|Overall Study||263
199268|NCT01313494|483457|P1|COMPLETED|Overall Study||246
199269|NCT01313494|483456|P2|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|311
199270|NCT01313494|483457|P1|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|315
199271|NCT01313494|483456|P2|STARTED|Overall Study||313
199272|NCT01313494|483457|P1|STARTED|Overall Study||313
199273|NCT01313416|483509|P1|NOT COMPLETED|Overall Study||0
199274|NCT01313416|483509|P1|COMPLETED|Overall Study||2
199275|NCT01313416|483509|P1|STARTED|Overall Study||2
199276|NCT01313312|483514|P1|NOT COMPLETED|Overall Study||36
199277|NCT01313312|483514|P1|COMPLETED|Overall Study||222
199278|NCT01313312|483514|P1|Cycle 5|Overall Study||11
199279|NCT01313312|483514|P1|Cycle 4|Overall Study||81
199280|NCT01313312|483514|P1|Cycle 3|Overall Study||175
199281|NCT01313312|483514|P1|Cycle 2|Overall Study||229
199282|NCT01313312|483514|P1|Cycle 1|Overall Study||254
199283|NCT01313312|483514|P1|STARTED|Overall Study||258
199284|NCT01313299|483561|P3|NOT COMPLETED|Overall Study||4
199285|NCT01313299|483562|P2|NOT COMPLETED|Overall Study||3
199286|NCT01313299|483563|P1|NOT COMPLETED|Overall Study||7
199287|NCT01313299|483561|P3|COMPLETED|Overall Study||77
199288|NCT01313299|483562|P2|COMPLETED|Overall Study||78
199289|NCT01313299|483563|P1|COMPLETED|Overall Study||74
199290|NCT01313299|483561|P3|STARTED|Overall Study||81
199291|NCT01313299|483562|P2|STARTED|Overall Study||81
199292|NCT01313299|483563|P1|STARTED|Overall Study||81
199293|NCT01313286|483577|P2|NOT COMPLETED|Period 2||0
199294|NCT01313286|483578|P1|NOT COMPLETED|Period 2||0
199295|NCT01313286|483577|P2|COMPLETED|Period 2||8
199296|NCT01313286|483578|P1|COMPLETED|Period 2||6
199297|NCT01313286|483577|P2|STARTED|Period 2||8
199298|NCT01313286|483578|P1|STARTED|Period 2||6
199299|NCT01313286|483577|P2|NOT COMPLETED|Period 1||0
199300|NCT01313286|483578|P1|NOT COMPLETED|Period 1||2
199301|NCT01313286|483577|P2|COMPLETED|Period 1||8
199302|NCT01313286|483578|P1|COMPLETED|Period 1||6
199303|NCT01313286|483577|P2|STARTED|Period 1||8
199304|NCT01313286|483578|P1|STARTED|Period 1||8
199305|NCT01313273|483588|P2|NOT COMPLETED|Overall Study||1
199306|NCT01313273|483589|P1|NOT COMPLETED|Overall Study||2
199307|NCT01313273|483588|P2|COMPLETED|Overall Study||0
199308|NCT01313273|483589|P1|COMPLETED|Overall Study||0
199309|NCT01313273|483588|P2|STARTED|Overall Study||1
199310|NCT01313273|483589|P1|STARTED|Overall Study||2
199311|NCT01313221|483604|P3|NOT COMPLETED|Overall Study||23
199312|NCT01313221|483605|P2|NOT COMPLETED|Overall Study||8
199313|NCT01313221|483606|P1|NOT COMPLETED|Overall Study||12
199314|NCT01313221|483604|P3|COMPLETED|Overall Study||0
199315|NCT01313221|483605|P2|COMPLETED|Overall Study||135
199316|NCT01313221|483606|P1|COMPLETED|Overall Study||132
199317|NCT01313221|483604|P3|Randomized|Overall Study||0
199318|NCT01313221|483605|P2|Randomized|Overall Study||143
199319|NCT01313221|483606|P1|Randomized|Overall Study||144
199320|NCT01313221|483604|P3|STARTED|Overall Study||23
199321|NCT01313221|483605|P2|STARTED|Overall Study||143
199322|NCT01313221|483606|P1|STARTED|Overall Study||144
199323|NCT01313208|483658|P2|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||3
199324|NCT01313208|483659|P1|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||6
199325|NCT01313208|483658|P2|COMPLETED|Open-label Phase (Weeks 13 - 24)||98
199326|NCT01313208|483659|P1|COMPLETED|Open-label Phase (Weeks 13 - 24)||92
199327|NCT01313208|483658|P2|STARTED|Open-label Phase (Weeks 13 - 24)||101
199328|NCT01313208|483659|P1|STARTED|Open-label Phase (Weeks 13 - 24)||98
199329|NCT01313208|483658|P2|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||5
199330|NCT01313208|483659|P1|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||6
199331|NCT01313208|483658|P2|COMPLETED|Double-blind Phase (Weeks 1 - 12)||101
199332|NCT01313208|483659|P1|COMPLETED|Double-blind Phase (Weeks 1 - 12)||98
199333|NCT01313208|483658|P2|STARTED|Double-blind Phase (Weeks 1 - 12)||106
199334|NCT01313208|483659|P1|STARTED|Double-blind Phase (Weeks 1 - 12)||104
199335|NCT01313182|483749|P2|NOT COMPLETED|Overall Study||92
199336|NCT01313182|483750|P1|NOT COMPLETED|Overall Study||66
199337|NCT01313182|483749|P2|COMPLETED|Overall Study||763
199338|NCT01313182|483750|P1|COMPLETED|Overall Study||776
199339|NCT01313182|483749|P2|STARTED|Overall Study||855
199340|NCT01313182|483750|P1|STARTED|Overall Study||842
199341|NCT01313117|483756|P1|NOT COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
199342|NCT01313117|483756|P1|COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||0
199343|NCT01313117|483756|P1|STARTED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
199344|NCT01313117|483756|P1|NOT COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||0
199345|NCT01313117|483756|P1|COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
199346|NCT01313117|483756|P1|STARTED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
199347|NCT01313117|483756|P1|NOT COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||0
199348|NCT01313117|483756|P1|COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
199349|NCT01313117|483756|P1|STARTED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
199350|NCT01313117|483756|P1|NOT COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
199351|NCT01313117|483756|P1|COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
199352|NCT01313117|483756|P1|STARTED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||2
199353|NCT01313117|483756|P1|NOT COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||0
199354|NCT01313117|483756|P1|COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
199355|NCT01313117|483756|P1|STARTED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
199356|NCT01313078|483763|P1|NOT COMPLETED|Overall Study||3
199357|NCT01313078|483763|P1|COMPLETED|Overall Study||1
199358|NCT01313078|483763|P1|STARTED|Overall Study||4
199359|NCT01313039|483768|P1|NOT COMPLETED|Overall Study||2
199360|NCT01313039|483768|P1|COMPLETED|Overall Study||2
199361|NCT01313039|483768|P1|STARTED|Overall Study||4
199362|NCT01312961|483774|P2|NOT COMPLETED|Overall Study||7
199363|NCT01312961|483775|P1|NOT COMPLETED|Overall Study||17
199364|NCT01312961|483774|P2|COMPLETED|Overall Study||45
199365|NCT01312961|483775|P1|COMPLETED|Overall Study||35
199366|NCT01312961|483774|P2|Treated|Overall Study||52
199367|NCT01312961|483775|P1|Treated|Overall Study||52
199368|NCT01312961|483774|P2|STARTED|Overall Study||52
199369|NCT01312961|483775|P1|STARTED|Overall Study||52
199370|NCT01312948|483801|P1|NOT COMPLETED|Overall Study||0
199371|NCT01312948|483801|P1|COMPLETED|Overall Study||6
199372|NCT01312948|483801|P1|STARTED|Overall Study||6
199373|NCT01312909|483811|P3|NOT COMPLETED|Overall Study||47
199374|NCT01312909|483812|P2|NOT COMPLETED|Overall Study||36
199375|NCT01312909|483813|P1|NOT COMPLETED|Overall Study||42
199376|NCT01312909|483811|P3|COMPLETED|Overall Study||53
199377|NCT01312909|483812|P2|COMPLETED|Overall Study||67
199378|NCT01312909|483813|P1|COMPLETED|Overall Study||67
199379|NCT01312909|483811|P3|Treated|Overall Study||99
199380|NCT01312909|483812|P2|Treated|Overall Study||100
199381|NCT01312909|483813|P1|Treated|Overall Study||108
199382|NCT01312909|483811|P3|STARTED|Overall Study||100
199383|NCT01312909|483812|P2|STARTED|Overall Study||103
199384|NCT01312909|483813|P1|STARTED|Overall Study||109
199385|NCT01312844|483862|P2|NOT COMPLETED|Overall Study||0
199386|NCT01312844|483863|P1|NOT COMPLETED|Overall Study||0
199387|NCT01312844|483862|P2|COMPLETED|Overall Study||3
199388|NCT01312844|483863|P1|COMPLETED|Overall Study||4
199389|NCT01312844|483862|P2|STARTED|Overall Study||3
199390|NCT01312844|483863|P1|STARTED|Overall Study||4
199391|NCT01312818|483885|P1|NOT COMPLETED|Overall Study||0
199392|NCT01312818|483885|P1|COMPLETED|Overall Study||2
199393|NCT01312818|483885|P1|STARTED|Overall Study||2
199394|NCT01312805|483893|P2|NOT COMPLETED|Overall Study||0
199395|NCT01312805|483894|P1|NOT COMPLETED|Overall Study||0
199396|NCT01312805|483893|P2|COMPLETED|Overall Study||1082
199397|NCT01312805|483894|P1|COMPLETED|Overall Study||1016
199398|NCT01312805|483893|P2|STARTED|Overall Study||1082
199399|NCT01312805|483894|P1|STARTED|Overall Study||1016
199400|NCT01312766|483902|P2|NOT COMPLETED|Overall Study||5
199401|NCT01312766|483903|P1|NOT COMPLETED|Overall Study||6
199402|NCT01312766|483902|P2|COMPLETED|Overall Study||130
199403|NCT01312766|483903|P1|COMPLETED|Overall Study||129
199404|NCT01312766|483902|P2|STARTED|Overall Study||135
199405|NCT01312766|483903|P1|STARTED|Overall Study||135
199406|NCT01312675|483935|P2|NOT COMPLETED|Overall Study||0
199407|NCT01312675|483936|P1|NOT COMPLETED|Overall Study||0
199408|NCT01312675|483935|P2|COMPLETED|Overall Study||7
199409|NCT01312675|483936|P1|COMPLETED|Overall Study||9
199410|NCT01312675|483935|P2|STARTED|Overall Study||7
199411|NCT01312675|483936|P1|STARTED|Overall Study||9
199412|NCT01312519|483944|P2|NOT COMPLETED|Overall Study||0
199413|NCT01312519|483945|P1|NOT COMPLETED|Overall Study||0
199414|NCT01312519|483944|P2|COMPLETED|Overall Study||24
199415|NCT01312519|483945|P1|COMPLETED|Overall Study||26
199416|NCT01312519|483944|P2|STARTED|Overall Study||24
199417|NCT01312519|483945|P1|STARTED|Overall Study||26
199418|NCT01312467|483953|P1|NOT COMPLETED|Overall Study||13
199419|NCT01312467|483953|P1|COMPLETED|Overall Study||32
199420|NCT01312467|483953|P1|STARTED|Overall Study||45
199421|NCT01312428|483962|P2|NOT COMPLETED|Overall Study||4
199422|NCT01312428|483963|P1|NOT COMPLETED|Overall Study||3
199423|NCT01312428|483962|P2|COMPLETED|Overall Study||0
199424|NCT01312428|483963|P1|COMPLETED|Overall Study||0
199425|NCT01312428|483962|P2|STARTED|Overall Study||4
199426|NCT01312428|483963|P1|STARTED|Overall Study||3
199427|NCT01312272|483973|P2|NOT COMPLETED|Overall Study||1
199428|NCT01312272|483974|P1|NOT COMPLETED|Overall Study||0
199429|NCT01312272|483973|P2|COMPLETED|Overall Study||11
199430|NCT01312272|483974|P1|COMPLETED|Overall Study||12
199431|NCT01312272|483973|P2|STARTED|Overall Study||12
199432|NCT01312272|483974|P1|STARTED|Overall Study||12
199433|NCT01312233|483993|P3|NOT COMPLETED|Overall Study||7
199434|NCT01312233|483994|P2|NOT COMPLETED|Overall Study||0
199435|NCT01312233|483995|P1|NOT COMPLETED|Overall Study||2
199436|NCT01312233|483993|P3|COMPLETED|Overall Study||36
199437|NCT01312233|483994|P2|COMPLETED|Overall Study||44
199438|NCT01312233|483995|P1|COMPLETED|Overall Study||42
199439|NCT01312233|483993|P3|STARTED|Overall Study||43
199440|NCT01312233|483994|P2|STARTED|Overall Study||44
199441|NCT01312233|483995|P1|STARTED|Overall Study||44
199442|NCT01312181|484018|P3|NOT COMPLETED|Overall Study||8
199443|NCT01312181|484019|P2|NOT COMPLETED|Overall Study||6
199444|NCT01312181|484020|P1|NOT COMPLETED|Overall Study||2
199445|NCT01312181|484018|P3|COMPLETED|Overall Study||75
199446|NCT01312181|484019|P2|COMPLETED|Overall Study||71
199447|NCT01312181|484020|P1|COMPLETED|Overall Study||78
199448|NCT01312181|484018|P3|STARTED|Overall Study||83
199449|NCT01312181|484019|P2|STARTED|Overall Study||77
199450|NCT01312181|484020|P1|STARTED|Overall Study||80
199451|NCT01312129|484033|P2|NOT COMPLETED|Second Intervention (24 Hours)||1
199452|NCT01312129|484034|P1|NOT COMPLETED|Second Intervention (24 Hours)||0
199453|NCT01312129|484033|P2|COMPLETED|Second Intervention (24 Hours)||6
199454|NCT01312129|484034|P1|COMPLETED|Second Intervention (24 Hours)||6
199455|NCT01312129|484033|P2|Alcohol Cue|Second Intervention (24 Hours)||6
199456|NCT01312129|484034|P1|Alcohol Cue|Second Intervention (24 Hours)||6
199457|NCT01312129|484033|P2|Control Cue|Second Intervention (24 Hours)||6
199458|NCT01312129|484034|P1|Control Cue|Second Intervention (24 Hours)||6
199459|NCT01312129|484033|P2|STARTED|Second Intervention (24 Hours)||7
199460|NCT01312129|484034|P1|STARTED|Second Intervention (24 Hours)||6
199461|NCT01312129|484033|P2|NOT COMPLETED|Washout (1 Week)||0
199462|NCT01312129|484034|P1|NOT COMPLETED|Washout (1 Week)||0
199463|NCT01312129|484033|P2|COMPLETED|Washout (1 Week)||7
199464|NCT01312129|484034|P1|COMPLETED|Washout (1 Week)||6
199465|NCT01312129|484033|P2|STARTED|Washout (1 Week)||7
199466|NCT01312129|484034|P1|STARTED|Washout (1 Week)||6
199467|NCT01312129|484033|P2|NOT COMPLETED|First Intervention (24 Hours)||0
199468|NCT01312129|484034|P1|NOT COMPLETED|First Intervention (24 Hours)||0
199469|NCT01312129|484033|P2|COMPLETED|First Intervention (24 Hours)||7
199470|NCT01312129|484034|P1|COMPLETED|First Intervention (24 Hours)||6
199471|NCT01312129|484033|P2|Alcohol Cue|First Intervention (24 Hours)||7
199472|NCT01312129|484034|P1|Alcohol Cue|First Intervention (24 Hours)||6
199473|NCT01312129|484033|P2|Control Cue|First Intervention (24 Hours)||7
199474|NCT01312129|484034|P1|Control Cue|First Intervention (24 Hours)||6
199475|NCT01312129|484033|P2|STARTED|First Intervention (24 Hours)||7
199476|NCT01312129|484034|P1|STARTED|First Intervention (24 Hours)||6
199477|NCT01312038|484042|P2|NOT COMPLETED|Overall Study||0
199478|NCT01312038|484043|P1|NOT COMPLETED|Overall Study||0
199479|NCT01312038|484042|P2|COMPLETED|Overall Study||12
199480|NCT01312038|484043|P1|COMPLETED|Overall Study||13
199481|NCT01312038|484042|P2|STARTED|Overall Study||12
199482|NCT01312038|484043|P1|STARTED|Overall Study||13
199483|NCT01311895|484051|P2|NOT COMPLETED|Overall Study||0
199484|NCT01311895|484052|P1|NOT COMPLETED|Overall Study||0
199485|NCT01311895|484051|P2|COMPLETED|Overall Study||175
199486|NCT01311895|484052|P1|COMPLETED|Overall Study||175
199487|NCT01311895|484051|P2|STARTED|Overall Study||175
199488|NCT01311895|484052|P1|STARTED|Overall Study||175
199489|NCT01311687|484064|P2|NOT COMPLETED|PFS Follow-up Phase||0
199490|NCT01311687|484065|P1|NOT COMPLETED|PFS Follow-up Phase||0
199491|NCT01311687|484064|P2|COMPLETED|PFS Follow-up Phase||8
199492|NCT01311687|484065|P1|COMPLETED|PFS Follow-up Phase||11
199493|NCT01311687|484064|P2|Crossed-over to Pomalidomide|PFS Follow-up Phase||0
199494|NCT01311687|484065|P1|Crossed-over to Pomalidomide|PFS Follow-up Phase||11
199495|NCT01311687|484064|P2|STARTED|PFS Follow-up Phase||8
199496|NCT01311687|484065|P1|STARTED|PFS Follow-up Phase||11
199497|NCT01311687|484064|P2|NOT COMPLETED|Treatment Phase||0
199498|NCT01311687|484065|P1|NOT COMPLETED|Treatment Phase||0
199499|NCT01311687|484064|P2|COMPLETED|Treatment Phase||153
199500|NCT01311687|484065|P1|COMPLETED|Treatment Phase||302
199501|NCT01311687|484064|P2|Crossed-over to Pomalidomide|Treatment Phase|After Amendment 4 participants still on HD-Dex treatment were permitted to crossover to pomalidomide|11
199502|NCT01311687|484065|P1|Crossed-over to Pomalidomide|Treatment Phase|Not applicable to participants initially randomized to receive pomalidomide|0
199503|NCT01311687|484064|P2|Received Study Drug|Treatment Phase||150
199504|NCT01311687|484065|P1|Received Study Drug|Treatment Phase||300
199505|NCT01311687|484064|P2|STARTED|Treatment Phase||153
199506|NCT01311687|484065|P1|STARTED|Treatment Phase||302
199507|NCT01311661|484119|P1|NOT COMPLETED|Overall Study||7
199508|NCT01311661|484119|P1|COMPLETED|Overall Study||199
199509|NCT01311661|484119|P1|Received Olo 10 mcg qd|Overall Study||102
199510|NCT01311661|484119|P1|Received Olo 5 mcg Bid|Overall Study||101
199511|NCT01311661|484119|P1|Received Olo 5 mcg qd|Overall Study||101
199512|NCT01311661|484119|P1|Received Olo 2.5 mcg Bid|Overall Study||101
199513|NCT01311661|484119|P1|Received Placebo|Overall Study||201
199514|NCT01311661|484119|P1|STARTED|Overall Study|Entered and treated|206
199515|NCT01311557|484263|P2|NOT COMPLETED|Overall Study||6
199516|NCT01311557|484264|P1|NOT COMPLETED|Overall Study||5
199517|NCT01311557|484263|P2|COMPLETED|Overall Study||645
199518|NCT01311557|484264|P1|COMPLETED|Overall Study||646
199519|NCT01311557|484263|P2|STARTED|Overall Study||651
199520|NCT01311557|484264|P1|STARTED|Overall Study||651
199521|NCT01311505|484280|P2|NOT COMPLETED|Second Intervention Period||0
199522|NCT01311505|484281|P1|NOT COMPLETED|Second Intervention Period||0
199523|NCT01311505|484280|P2|COMPLETED|Second Intervention Period||10
199524|NCT01311505|484281|P1|COMPLETED|Second Intervention Period||10
199525|NCT01311505|484280|P2|STARTED|Second Intervention Period||10
199526|NCT01311505|484281|P1|STARTED|Second Intervention Period||10
199527|NCT01311505|484280|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
199528|NCT01311505|484281|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
199529|NCT01311505|484280|P2|COMPLETED|Washout Period (at Least 7 Days)||10
199530|NCT01311505|484281|P1|COMPLETED|Washout Period (at Least 7 Days)||10
199531|NCT01311505|484280|P2|STARTED|Washout Period (at Least 7 Days)||10
199532|NCT01311505|484281|P1|STARTED|Washout Period (at Least 7 Days)||10
199533|NCT01311505|484280|P2|NOT COMPLETED|First Intervention Period||1
199534|NCT01311505|484281|P1|NOT COMPLETED|First Intervention Period||0
199535|NCT01311505|484280|P2|COMPLETED|First Intervention Period||10
199536|NCT01311505|484281|P1|COMPLETED|First Intervention Period||10
199537|NCT01311505|484280|P2|STARTED|First Intervention Period||11
199538|NCT01311505|484281|P1|STARTED|First Intervention Period||10
199539|NCT01311362|484309|P1|NOT COMPLETED|Ambrisentan and SJW||0
199540|NCT01311362|484309|P1|COMPLETED|Ambrisentan and SJW||20
199541|NCT01311362|484309|P1|STARTED|Ambrisentan and SJW||20
199542|NCT01311362|484309|P1|NOT COMPLETED|Ambrisentan Steady-state||0
199543|NCT01311362|484309|P1|COMPLETED|Ambrisentan Steady-state||20
199544|NCT01311362|484309|P1|STARTED|Ambrisentan Steady-state||20
199545|NCT01311362|484309|P1|NOT COMPLETED|Ambrisentan Single Dose||0
199546|NCT01311362|484309|P1|COMPLETED|Ambrisentan Single Dose||20
199547|NCT01311362|484309|P1|STARTED|Ambrisentan Single Dose|All 20 study participants completed each study period. Total number of study participants: 20|20
199548|NCT01311102|484322|P2|NOT COMPLETED|Overall Study||0
199549|NCT01311102|484323|P1|NOT COMPLETED|Overall Study||0
199550|NCT01311102|484322|P2|COMPLETED|Overall Study||20
199551|NCT01311102|484323|P1|COMPLETED|Overall Study||20
199552|NCT01311102|484322|P2|STARTED|Overall Study||20
199553|NCT01311102|484323|P1|STARTED|Overall Study||20
199554|NCT01311024|484337|P2|NOT COMPLETED|Overall Study||22
199555|NCT01311024|484338|P1|NOT COMPLETED|Overall Study||35
199556|NCT01311024|484337|P2|COMPLETED|Overall Study||789
199557|NCT01311024|484338|P1|COMPLETED|Overall Study||1495
199558|NCT01311024|484337|P2|STARTED|Overall Study||811
199559|NCT01311024|484338|P1|STARTED|Overall Study||1530
199560|NCT01310868|484344|P1|NOT COMPLETED|Overall Study||13
199561|NCT01310868|484344|P1|COMPLETED|Overall Study||59
199562|NCT01310868|484344|P1|STARTED|Overall Study||72
199563|NCT01310855|484352|P2|NOT COMPLETED|Overall Study||0
199564|NCT01310855|484353|P1|NOT COMPLETED|Overall Study||0
199565|NCT01310855|484352|P2|COMPLETED|Overall Study||19
199566|NCT01310855|484353|P1|COMPLETED|Overall Study||19
199567|NCT01310855|484352|P2|STARTED|Overall Study||19
199568|NCT01310855|484353|P1|STARTED|Overall Study||19
199569|NCT01310803|484361|P2|NOT COMPLETED|Overall Study||0
199570|NCT01310803|484362|P1|NOT COMPLETED|Overall Study||1
199571|NCT01310803|484361|P2|COMPLETED|Overall Study||0
199572|NCT01310803|484362|P1|COMPLETED|Overall Study||0
199573|NCT01310803|484361|P2|STARTED|Overall Study||0
199574|NCT01310803|484362|P1|STARTED|Overall Study||1
199575|NCT01310777|484373|P3|NOT COMPLETED|Overall Study||30
199576|NCT01310777|484374|P2|NOT COMPLETED|Overall Study||14
199577|NCT01310777|484375|P1|NOT COMPLETED|Overall Study||33
199578|NCT01310777|484373|P3|COMPLETED|Overall Study||145
199579|NCT01310777|484374|P2|COMPLETED|Overall Study||178
199580|NCT01310777|484375|P1|COMPLETED|Overall Study||160
199581|NCT01310777|484373|P3|STARTED|Overall Study||175
199582|NCT01310777|484374|P2|STARTED|Overall Study||192
199583|NCT01310777|484375|P1|STARTED|Overall Study||193
199584|NCT01310699|484385|P2|NOT COMPLETED|Overall Study||6
199585|NCT01310699|484386|P1|NOT COMPLETED|Overall Study||4
199586|NCT01310699|484385|P2|COMPLETED|Overall Study||143
199587|NCT01310699|484386|P1|COMPLETED|Overall Study||128
199588|NCT01310699|484385|P2|STARTED|Overall Study||149
199589|NCT01310699|484386|P1|STARTED|Overall Study||132
199590|NCT01310582|484398|P2|NOT COMPLETED|Overall Study||0
199591|NCT01310582|484399|P1|NOT COMPLETED|Overall Study||0
199592|NCT01310582|484398|P2|COMPLETED|Overall Study||26
199593|NCT01310582|484399|P1|COMPLETED|Overall Study||31
199594|NCT01310582|484398|P2|STARTED|Overall Study||26
199595|NCT01310582|484399|P1|STARTED|Overall Study||31
199596|NCT01310413|484413|P7|NOT COMPLETED|From Day U0 to Day U385||3
199597|NCT01310413|484414|P6|NOT COMPLETED|From Day U0 to Day U385||0
199598|NCT01310413|484415|P5|NOT COMPLETED|From Day U0 to Day U385||0
199599|NCT01310413|484416|P4|NOT COMPLETED|From Day U0 to Day U385||0
199600|NCT01310413|484417|P3|NOT COMPLETED|From Day U0 to Day U385||0
199601|NCT01310413|484418|P2|NOT COMPLETED|From Day U0 to Day U385||0
199602|NCT01310413|484419|P1|NOT COMPLETED|From Day U0 to Day U385||0
199603|NCT01310413|484413|P7|COMPLETED|From Day U0 to Day U385|Upto Day U42|152
199604|NCT01310413|484414|P6|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
199605|NCT01310413|484415|P5|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
199606|NCT01310413|484416|P4|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
199607|NCT01310413|484417|P3|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
199608|NCT01310413|484418|P2|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
199609|NCT01310413|484419|P1|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
199610|NCT01310413|484413|P7|STARTED|From Day U0 to Day U385|Upto Day U42|155
199611|NCT01310413|484414|P6|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
199612|NCT01310413|484415|P5|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
199613|NCT01310413|484416|P4|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
199614|NCT01310413|484417|P3|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
199615|NCT01310413|484418|P2|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
199616|NCT01310413|484419|P1|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
199617|NCT01310413|484413|P7|NOT COMPLETED|Day 0 to Day 385||0
199618|NCT01310413|484414|P6|NOT COMPLETED|Day 0 to Day 385||3
199619|NCT01310413|484415|P5|NOT COMPLETED|Day 0 to Day 385||3
199620|NCT01310413|484416|P4|NOT COMPLETED|Day 0 to Day 385||8
199621|NCT01310413|484417|P3|NOT COMPLETED|Day 0 to Day 385||7
199622|NCT01310413|484418|P2|NOT COMPLETED|Day 0 to Day 385||8
199623|NCT01310413|484419|P1|NOT COMPLETED|Day 0 to Day 385||27
199624|NCT01310413|484413|P7|COMPLETED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
199625|NCT01310413|484414|P6|COMPLETED|Day 0 to Day 385||77
199626|NCT01310413|484415|P5|COMPLETED|Day 0 to Day 385||73
199627|NCT01310413|484416|P4|COMPLETED|Day 0 to Day 385||67
199628|NCT01310413|484417|P3|COMPLETED|Day 0 to Day 385||203
199629|NCT01310413|484418|P2|COMPLETED|Day 0 to Day 385||190
199630|NCT01310413|484419|P1|COMPLETED|Day 0 to Day 385||172
199631|NCT01310413|484413|P7|STARTED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
199632|NCT01310413|484414|P6|STARTED|Day 0 to Day 385||80
199633|NCT01310413|484415|P5|STARTED|Day 0 to Day 385||76
199634|NCT01310413|484416|P4|STARTED|Day 0 to Day 385||75
199635|NCT01310413|484417|P3|STARTED|Day 0 to Day 385||210
199636|NCT01310413|484418|P2|STARTED|Day 0 to Day 385||198
199637|NCT01310413|484419|P1|STARTED|Day 0 to Day 385||199
199638|NCT01310400|484575|P3|NOT COMPLETED|Overall Study||30
199639|NCT01310400|484576|P2|NOT COMPLETED|Overall Study||32
199640|NCT01310400|484577|P1|NOT COMPLETED|Overall Study||28
199641|NCT01310400|484575|P3|COMPLETED|Overall Study||422
199642|NCT01310400|484576|P2|COMPLETED|Overall Study||420
199643|NCT01310400|484577|P1|COMPLETED|Overall Study||424
199644|NCT01310400|484575|P3|STARTED|Overall Study||452
199645|NCT01310400|484576|P2|STARTED|Overall Study||452
199646|NCT01310400|484577|P1|STARTED|Overall Study||452
199647|NCT01310179|484594|P1|NOT COMPLETED|Overall Study||0
199648|NCT01310179|484594|P1|COMPLETED|Overall Study||12
199649|NCT01310179|484594|P1|STARTED|Overall Study||12
199650|NCT01310127|484601|P2|NOT COMPLETED|Overall Study||1
199651|NCT01310127|484602|P1|NOT COMPLETED|Overall Study||2
199652|NCT01310127|484601|P2|COMPLETED|Overall Study||10
199653|NCT01310127|484602|P1|COMPLETED|Overall Study||10
199654|NCT01310127|484601|P2|STARTED|Overall Study||11
199655|NCT01310127|484602|P1|STARTED|Overall Study||12
199656|NCT01310075|484616|P2|NOT COMPLETED|Overall Study||10
199657|NCT01310075|484617|P1|NOT COMPLETED|Overall Study||14
199658|NCT01310075|484616|P2|COMPLETED|Overall Study||35
199659|NCT01310075|484617|P1|COMPLETED|Overall Study||31
199660|NCT01310075|484616|P2|STARTED|Overall Study||45
199661|NCT01310075|484617|P1|STARTED|Overall Study||45
199662|NCT01310036|484623|P1|NOT COMPLETED|Overall Study||202
199663|NCT01310036|484623|P1|COMPLETED|Overall Study||6
199664|NCT01310036|484623|P1|STARTED|Overall Study||208
199665|NCT01309997|484636|P2|NOT COMPLETED|Overall Study||6
199666|NCT01309997|484637|P1|NOT COMPLETED|Overall Study||5
199667|NCT01309997|484636|P2|COMPLETED|Overall Study||31
199668|NCT01309997|484637|P1|COMPLETED|Overall Study||30
199669|NCT01309997|484636|P2|Crossed Over to Second Arm|Overall Study||23
199670|NCT01309997|484637|P1|Crossed Over to Second Arm|Overall Study||19
199671|NCT01309997|484636|P2|Remained on First Arm Only|Overall Study||14
199672|NCT01309997|484637|P1|Remained on First Arm Only|Overall Study||16
199673|NCT01309997|484636|P2|STARTED|Overall Study||37
199674|NCT01309997|484637|P1|STARTED|Overall Study||35
199675|NCT01309919|484661|P2|NOT COMPLETED|Overall Study||48
199676|NCT01309919|484662|P1|NOT COMPLETED|Overall Study||17
199677|NCT01309919|484661|P2|COMPLETED|Overall Study||27
199678|NCT01309919|484662|P1|COMPLETED|Overall Study||58
199679|NCT01309919|484661|P2|STARTED|Overall Study||75
199680|NCT01309919|484662|P1|STARTED|Overall Study||75
199681|NCT01309893|484674|P2|NOT COMPLETED|Week 2 - Crossover Intervention||1
199682|NCT01309893|484675|P1|NOT COMPLETED|Week 2 - Crossover Intervention||1
199683|NCT01309893|484674|P2|COMPLETED|Week 2 - Crossover Intervention||32
199684|NCT01309893|484675|P1|COMPLETED|Week 2 - Crossover Intervention||32
199685|NCT01309893|484674|P2|STARTED|Week 2 - Crossover Intervention||33
199686|NCT01309893|484675|P1|STARTED|Week 2 - Crossover Intervention||33
199687|NCT01309893|484674|P2|NOT COMPLETED|Week 1 - First Intervention||0
199688|NCT01309893|484675|P1|NOT COMPLETED|Week 1 - First Intervention||0
199689|NCT01309893|484674|P2|COMPLETED|Week 1 - First Intervention||33
199690|NCT01309893|484675|P1|COMPLETED|Week 1 - First Intervention||33
199691|NCT01309893|484674|P2|STARTED|Week 1 - First Intervention||33
199692|NCT01309893|484675|P1|STARTED|Week 1 - First Intervention||33
199693|NCT01309880|484685|P2|NOT COMPLETED|Overall Study||0
199694|NCT01309880|484686|P1|NOT COMPLETED|Overall Study||0
199695|NCT01309880|484685|P2|COMPLETED|Overall Study||33
199696|NCT01309880|484686|P1|COMPLETED|Overall Study||33
199697|NCT01309880|484685|P2|STARTED|Overall Study||33
199698|NCT01309880|484686|P1|STARTED|Overall Study||33
199699|NCT01309841|484699|P3|NOT COMPLETED|Overall Study||37
199700|NCT01309841|484700|P2|NOT COMPLETED|Overall Study||41
199701|NCT01309841|484701|P1|NOT COMPLETED|Overall Study||39
199702|NCT01309841|484699|P3|COMPLETED|Overall Study||180
199703|NCT01309841|484700|P2|COMPLETED|Overall Study||177
199704|NCT01309841|484701|P1|COMPLETED|Overall Study||178
199705|NCT01309841|484699|P3|STARTED|Overall Study||217
199706|NCT01309841|484700|P2|STARTED|Overall Study||218
199707|NCT01309841|484701|P1|STARTED|Overall Study||217
199708|NCT01309828|484741|P2|NOT COMPLETED|Overall Study||16
199709|NCT01309828|484742|P1|NOT COMPLETED|Overall Study||16
199710|NCT01309828|484741|P2|COMPLETED|Overall Study||60
199711|NCT01309828|484742|P1|COMPLETED|Overall Study||61
199712|NCT01309828|484741|P2|STARTED|Overall Study||76
199713|NCT01309828|484742|P1|STARTED|Overall Study||77
199714|NCT01309802|484756|P2|NOT COMPLETED|Overall Study||9
199715|NCT01309802|484757|P1|NOT COMPLETED|Overall Study||12
199716|NCT01309802|484756|P2|COMPLETED|Overall Study||14
199717|NCT01309802|484757|P1|COMPLETED|Overall Study||13
199718|NCT01309802|484756|P2|STARTED|Overall Study||23
199719|NCT01309802|484757|P1|STARTED|Overall Study||25
199720|NCT01309737|484776|P5|NOT COMPLETED|Week 16 to 52||33
199721|NCT01309737|484777|P4|NOT COMPLETED|Week 16 to 52||34
199722|NCT01309737|484778|P3|NOT COMPLETED|Week 16 to 52||0
199723|NCT01309737|484779|P2|NOT COMPLETED|Week 16 to 52||103
199724|NCT01309737|484780|P1|NOT COMPLETED|Week 16 to 52||133
199725|NCT01309737|484776|P5|COMPLETED|Week 16 to 52||44
199726|NCT01309737|484777|P4|COMPLETED|Week 16 to 52||41
199727|NCT01309737|484778|P3|COMPLETED|Week 16 to 52||0
199728|NCT01309737|484779|P2|COMPLETED|Week 16 to 52||238
199729|NCT01309737|484780|P1|COMPLETED|Week 16 to 52||198
199730|NCT01309737|484776|P5|STARTED|Week 16 to 52||77
199731|NCT01309737|484777|P4|STARTED|Week 16 to 52||75
199732|NCT01309737|484778|P3|STARTED|Week 16 to 52||0
199733|NCT01309737|484779|P2|STARTED|Week 16 to 52||341
199734|NCT01309737|484780|P1|STARTED|Week 16 to 52||331
199735|NCT01309737|484776|P5|NOT COMPLETED|Week 0 to 16||0
199736|NCT01309737|484777|P4|NOT COMPLETED|Week 0 to 16||0
199737|NCT01309737|484778|P3|NOT COMPLETED|Week 0 to 16||44
199738|NCT01309737|484779|P2|NOT COMPLETED|Week 0 to 16||40
199739|NCT01309737|484780|P1|NOT COMPLETED|Week 0 to 16||52
199740|NCT01309737|484776|P5|COMPLETED|Week 0 to 16||0
199741|NCT01309737|484777|P4|COMPLETED|Week 0 to 16||0
199742|NCT01309737|484778|P3|COMPLETED|Week 0 to 16||152
199743|NCT01309737|484779|P2|COMPLETED|Week 0 to 16||341
199744|NCT01309737|484780|P1|COMPLETED|Week 0 to 16||331
199745|NCT01309737|484776|P5|Treated|Week 0 to 16||0
199746|NCT01309737|484777|P4|Treated|Week 0 to 16||0
199747|NCT01309737|484778|P3|Treated|Week 0 to 16||196
199748|NCT01309737|484779|P2|Treated|Week 0 to 16||381
199749|NCT01309737|484780|P1|Treated|Week 0 to 16||382
199750|NCT01309737|484776|P5|STARTED|Week 0 to 16||0
199751|NCT01309737|484777|P4|STARTED|Week 0 to 16||0
199752|NCT01309737|484778|P3|STARTED|Week 0 to 16||196
199753|NCT01309737|484779|P2|STARTED|Week 0 to 16||381
199754|NCT01309737|484780|P1|STARTED|Week 0 to 16||383
199755|NCT01309672|484975|P1|NOT COMPLETED|Overall Study||37
199756|NCT01309672|484975|P1|COMPLETED|Overall Study||4
199757|NCT01309672|484975|P1|Received Protocol Treatment|Overall Study||40
199758|NCT01309672|484975|P1|STARTED|Overall Study||41
199759|NCT01309659|484985|P2|NOT COMPLETED|Overall Study||1
199760|NCT01309659|484986|P1|NOT COMPLETED|Overall Study||0
199761|NCT01309659|484985|P2|COMPLETED|Overall Study||9
199762|NCT01309659|484986|P1|COMPLETED|Overall Study||9
199763|NCT01309659|484985|P2|STARTED|Overall Study||10
199764|NCT01309659|484986|P1|STARTED|Overall Study||9
199765|NCT01309646|485028|P2|NOT COMPLETED|Overall Study||0
199766|NCT01309646|485029|P1|NOT COMPLETED|Overall Study||0
199767|NCT01309646|485028|P2|COMPLETED|Overall Study||227
199768|NCT01309646|485029|P1|COMPLETED|Overall Study||224
199769|NCT01309646|485028|P2|STARTED|Overall Study||227
199770|NCT01309646|485029|P1|STARTED|Overall Study||224
199771|NCT01309581|485069|P2|NOT COMPLETED|Overall Study||0
199772|NCT01309581|485070|P1|NOT COMPLETED|Overall Study||0
199773|NCT01309581|485069|P2|COMPLETED|Overall Study||1
199774|NCT01309581|485070|P1|COMPLETED|Overall Study||2
199775|NCT01309581|485069|P2|STARTED|Overall Study||1
199776|NCT01309581|485070|P1|STARTED|Overall Study||2
199777|NCT01309451|485080|P2|NOT COMPLETED|Overall Study||3
199778|NCT01309451|485081|P1|NOT COMPLETED|Overall Study||2
199779|NCT01309451|485080|P2|COMPLETED|Overall Study|unit of measure is number of eyes|18
199780|NCT01309451|485081|P1|COMPLETED|Overall Study|unit of measure is number of eyes|17
199781|NCT01309451|485080|P2|STARTED|Overall Study|unit of measure is number of eyes|21
199782|NCT01309451|485081|P1|STARTED|Overall Study|unit of measure is number of eyes|19
199783|NCT01309386|485091|P2|NOT COMPLETED|Overall Study||21
199784|NCT01309386|485092|P1|NOT COMPLETED|Overall Study||22
199785|NCT01309386|485091|P2|COMPLETED|Overall Study||29
199786|NCT01309386|485092|P1|COMPLETED|Overall Study||28
199787|NCT01309386|485091|P2|STARTED|Overall Study||50
199788|NCT01309386|485092|P1|STARTED|Overall Study||50
199789|NCT01309360|485113|P3|NOT COMPLETED|Overall Study||0
199790|NCT01309360|485114|P2|NOT COMPLETED|Overall Study||0
199791|NCT01309360|485115|P1|NOT COMPLETED|Overall Study||0
199792|NCT01309360|485113|P3|COMPLETED|Overall Study||40
199793|NCT01309360|485114|P2|COMPLETED|Overall Study||40
199794|NCT01309360|485115|P1|COMPLETED|Overall Study||40
199795|NCT01309360|485113|P3|STARTED|Overall Study||40
199796|NCT01309360|485114|P2|STARTED|Overall Study||40
199797|NCT01309360|485115|P1|STARTED|Overall Study||40
199798|NCT01309308|485140|P2|NOT COMPLETED|Overall Study||4
199799|NCT01309308|485141|P1|NOT COMPLETED|Overall Study||6
199800|NCT01309308|485140|P2|COMPLETED|Overall Study||71
199801|NCT01309308|485141|P1|COMPLETED|Overall Study||69
199802|NCT01309308|485140|P2|STARTED|Overall Study||75
199803|NCT01309308|485141|P1|STARTED|Overall Study||75
199804|NCT01309282|485149|P1|NOT COMPLETED|Overall Study||1
199805|NCT01309282|485149|P1|COMPLETED|Overall Study||8
199806|NCT01309282|485149|P1|STARTED|Overall Study||9
199807|NCT01309269|485166|P1|NOT COMPLETED|Overall Study||840
199808|NCT01309269|485166|P1|COMPLETED|Overall Study||245
199809|NCT01309269|485166|P1|Treated|Overall Study||978
199810|NCT01309269|485166|P1|STARTED|Overall Study||1085
199811|NCT01309243|485174|P2|NOT COMPLETED|Extension Phase||0
199812|NCT01309243|485175|P1|NOT COMPLETED|Extension Phase||6
199813|NCT01309243|485174|P2|COMPLETED|Extension Phase||117
199814|NCT01309243|485175|P1|COMPLETED|Extension Phase||34
199815|NCT01309243|485174|P2|STARTED|Extension Phase|117 participants from the Randomized Phase continued the study in the Extension Phase.|117
199816|NCT01309243|485175|P1|STARTED|Extension Phase|40 participants from the Randomized Phase continued the study in the Extension Phase.|40
199817|NCT01309243|485174|P2|NOT COMPLETED|Randomized Phase Through Week 96||109
199818|NCT01309243|485175|P1|NOT COMPLETED|Randomized Phase Through Week 96||84
199819|NCT01309243|485174|P2|COMPLETED|Randomized Phase Through Week 96||290
199820|NCT01309243|485175|P1|COMPLETED|Randomized Phase Through Week 96||316
199821|NCT01309243|485174|P2|Randomized and Treated|Randomized Phase Through Week 96||392
199822|NCT01309243|485175|P1|Randomized and Treated|Randomized Phase Through Week 96||394
199823|NCT01309243|485174|P2|STARTED|Randomized Phase Through Week 96||399
199824|NCT01309243|485175|P1|STARTED|Randomized Phase Through Week 96||400
199825|NCT01309204|485201|P2|NOT COMPLETED|Overall Study||75
199826|NCT01309204|485202|P1|NOT COMPLETED|Overall Study||67
199827|NCT01309204|485201|P2|COMPLETED|Overall Study||361
199828|NCT01309204|485202|P1|COMPLETED|Overall Study||385
199829|NCT01309204|485201|P2|STARTED|Overall Study||436
199830|NCT01309204|485202|P1|STARTED|Overall Study||452
199831|NCT01309165|485210|P2|NOT COMPLETED|Overall Study||7
199832|NCT01309165|485211|P1|NOT COMPLETED|Overall Study||6
199833|NCT01309165|485210|P2|COMPLETED|Overall Study||9
199834|NCT01309165|485211|P1|COMPLETED|Overall Study||13
199835|NCT01309165|485210|P2|Included in Primary Analysis|Overall Study||12
199836|NCT01309165|485211|P1|Included in Primary Analysis|Overall Study||14
199837|NCT01309165|485210|P2|Received Allocated Intervention|Overall Study||14
199838|NCT01309165|485211|P1|Received Allocated Intervention|Overall Study||16
199839|NCT01309165|485210|P2|STARTED|Overall Study||16
199840|NCT01309165|485211|P1|STARTED|Overall Study||19
199841|NCT01309100|485223|P1|NOT COMPLETED|Overall Study||2
199842|NCT01309100|485223|P1|COMPLETED|Overall Study||142
199843|NCT01309100|485223|P1|STARTED|Overall Study||144
199844|NCT01308918|485234|P1|NOT COMPLETED|Overall Study||0
199845|NCT01308918|485234|P1|COMPLETED|Overall Study||50
199846|NCT01308918|485234|P1|STARTED|Overall Study||50
199847|NCT01308853|485241|P1|NOT COMPLETED|Overall Study||4
199848|NCT01308853|485241|P1|COMPLETED|Overall Study||20
199849|NCT01308853|485241|P1|STARTED|Overall Study||24
199850|NCT01308840|485246|P1|NOT COMPLETED|Overall Study||0
199851|NCT01308840|485246|P1|COMPLETED|Overall Study||31
199852|NCT01308840|485246|P1|STARTED|Overall Study||31
199853|NCT01308814|485255|P2|NOT COMPLETED|Overall Study||23
199854|NCT01308814|485256|P1|NOT COMPLETED|Overall Study||17
199855|NCT01308814|485255|P2|COMPLETED|Overall Study||63
199856|NCT01308814|485256|P1|COMPLETED|Overall Study||69
199857|NCT01308814|485255|P2|STARTED|Overall Study||86
199858|NCT01308814|485256|P1|STARTED|Overall Study||86
199859|NCT01308788|485276|P2|NOT COMPLETED|2-year Treatment||11
199860|NCT01308788|485277|P1|NOT COMPLETED|2-year Treatment||4
199861|NCT01308788|485276|P2|COMPLETED|2-year Treatment||10
199862|NCT01308788|485277|P1|COMPLETED|2-year Treatment||10
199863|NCT01308788|485276|P2|STARTED|2-year Treatment||21
199864|NCT01308788|485277|P1|STARTED|2-year Treatment||14
199865|NCT01308788|485276|P2|NOT COMPLETED|6-month Treatment||0
199866|NCT01308788|485277|P1|NOT COMPLETED|6-month Treatment||0
199867|NCT01308788|485276|P2|COMPLETED|6-month Treatment||21
199868|NCT01308788|485277|P1|COMPLETED|6-month Treatment||14
199869|NCT01308788|485276|P2|STARTED|6-month Treatment||21
199870|NCT01308788|485277|P1|STARTED|6-month Treatment||14
199871|NCT01308762|485312|P3|NOT COMPLETED|Overall Study||0
199872|NCT01308762|485313|P2|NOT COMPLETED|Overall Study||1
199873|NCT01308762|485314|P1|NOT COMPLETED|Overall Study||0
199874|NCT01308762|485312|P3|COMPLETED|Overall Study||6
199875|NCT01308762|485313|P2|COMPLETED|Overall Study|One patient was withdrawn as they were retrospecively found to have been ineligible at study entry|6
199876|NCT01308762|485314|P1|COMPLETED|Overall Study||6
199877|NCT01308762|485312|P3|STARTED|Overall Study||6
199878|NCT01308762|485313|P2|STARTED|Overall Study||7
199879|NCT01308762|485314|P1|STARTED|Overall Study||6
199880|NCT01308749|485327|P2|NOT COMPLETED|Period 2: Open Label Treatment||2
199881|NCT01308749|485328|P1|NOT COMPLETED|Period 2: Open Label Treatment||0
199882|NCT01308749|485327|P2|COMPLETED|Period 2: Open Label Treatment||11
199883|NCT01308749|485328|P1|COMPLETED|Period 2: Open Label Treatment||11
199884|NCT01308749|485327|P2|STARTED|Period 2: Open Label Treatment||13
199885|NCT01308749|485328|P1|STARTED|Period 2: Open Label Treatment||11
199886|NCT01308749|485327|P2|NOT COMPLETED|Period 1: Double Blind Treatment||0
199887|NCT01308749|485328|P1|NOT COMPLETED|Period 1: Double Blind Treatment||1
199888|NCT01308749|485327|P2|COMPLETED|Period 1: Double Blind Treatment||13
199889|NCT01308749|485328|P1|COMPLETED|Period 1: Double Blind Treatment||11
199890|NCT01308749|485327|P2|STARTED|Period 1: Double Blind Treatment||13
199891|NCT01308749|485328|P1|STARTED|Period 1: Double Blind Treatment||12
199892|NCT01308736|485358|P2|NOT COMPLETED|Overall Study||5
199893|NCT01308736|485359|P1|NOT COMPLETED|Overall Study||6
199894|NCT01308736|485358|P2|COMPLETED|Overall Study||27
199895|NCT01308736|485359|P1|COMPLETED|Overall Study||25
199896|NCT01308736|485358|P2|STARTED|Overall Study||32
199897|NCT01308736|485359|P1|STARTED|Overall Study||31
199898|NCT01308619|485367|P2|NOT COMPLETED|Overall Study||3
199899|NCT01308619|485368|P1|NOT COMPLETED|Overall Study||7
199900|NCT01308619|485367|P2|COMPLETED|Overall Study||83
199901|NCT01308619|485368|P1|COMPLETED|Overall Study||77
199902|NCT01308619|485367|P2|STARTED|Overall Study||86
199903|NCT01308619|485368|P1|STARTED|Overall Study||84
199904|NCT01308580|485382|P2|NOT COMPLETED|Overall Study||7
199905|NCT01308580|485383|P1|NOT COMPLETED|Overall Study||12
199906|NCT01308580|485382|P2|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|595
199907|NCT01308580|485383|P1|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|586
199908|NCT01308580|485382|P2|Treated|Overall Study|Random assignment, was not actual treatment in some cases|588
199909|NCT01308580|485383|P1|Treated|Overall Study|Random assignment, was not actual treatment in some cases|587
199910|NCT01308580|485382|P2|STARTED|Overall Study||602
199911|NCT01308580|485383|P1|STARTED|Overall Study||598
199912|NCT01308567|485426|P3|NOT COMPLETED|Overall Study||4
199913|NCT01308567|485427|P2|NOT COMPLETED|Overall Study||4
199914|NCT01308567|485428|P1|NOT COMPLETED|Overall Study||2
199915|NCT01308567|485426|P3|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|384
199916|NCT01308567|485427|P2|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|385
199917|NCT01308567|485428|P1|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|389
199918|NCT01308567|485426|P3|Treated|Overall Study|For 2 participants, actual treatment received was Cabazitaxel 20 mg/m^2.|377
199919|NCT01308567|485427|P2|Treated|Overall Study|For 15 participants, actual treatment received was Cabazitaxel 25 mg/m^2.|382
199920|NCT01308567|485428|P1|Treated|Overall Study|For 1 participant, actual treatment received was Cabazitaxel 25 mg/m^2.|388
199921|NCT01308567|485426|P3|STARTED|Overall Study|Randomized|388
199922|NCT01308567|485427|P2|STARTED|Overall Study|Randomized|389
199923|NCT01308567|485428|P1|STARTED|Overall Study|Randomized|391
199924|NCT01308476|485468|P2|NOT COMPLETED|Overall Study||2
199925|NCT01308476|485469|P1|NOT COMPLETED|Overall Study||3
199926|NCT01308476|485468|P2|COMPLETED|Overall Study||45
199927|NCT01308476|485469|P1|COMPLETED|Overall Study||45
199928|NCT01308476|485468|P2|STARTED|Overall Study|Entered and treated.|47
199929|NCT01308476|485469|P1|STARTED|Overall Study|Entered and treated.|48
199930|NCT01308463|485489|P1|NOT COMPLETED|Overall Study||29
199931|NCT01308463|485489|P1|COMPLETED|Overall Study||0
199932|NCT01308463|485489|P1|12 Years|Overall Study||2
199933|NCT01308463|485489|P1|11 Years|Overall Study||8
199934|NCT01308463|485489|P1|10 Years|Overall Study||8
199935|NCT01308463|485489|P1|9 Years|Overall Study||11
199936|NCT01308463|485489|P1|8 Years|Overall Study||14
199937|NCT01308463|485489|P1|7 Years|Overall Study||12
199938|NCT01308463|485489|P1|6 Years|Overall Study||11
199939|NCT01308463|485489|P1|5 Years|Overall Study||20
199940|NCT01308463|485489|P1|4 Years|Overall Study||20
199941|NCT01308463|485489|P1|3 Years|Overall Study||17
199942|NCT01308463|485489|P1|2 Years|Overall Study||18
199943|NCT01308463|485489|P1|1 Year|Overall Study||21
199944|NCT01308463|485489|P1|6 Months|Overall Study||23
199945|NCT01308463|485489|P1|STARTED|Overall Study||29
199946|NCT01308450|485496|P1|NOT COMPLETED|Overall Study||2
199947|NCT01308450|485496|P1|COMPLETED|Overall Study|Last subject was enrolled 06/28/2011|300
199948|NCT01308450|485496|P1|STARTED|Overall Study|302 subjects were screen. 300 subjects were enrolled in this one site, one visit study.|302
199949|NCT01308424|485502|P3|NOT COMPLETED|Randomization||2
199950|NCT01308424|485503|P2|NOT COMPLETED|Randomization||3
199951|NCT01308424|485504|P1|NOT COMPLETED|Randomization||0
199952|NCT01308424|485502|P3|COMPLETED|Randomization||82
199953|NCT01308424|485503|P2|COMPLETED|Randomization||84
199954|NCT01308424|485504|P1|COMPLETED|Randomization||0
199955|NCT01308424|485502|P3|STARTED|Randomization||84
199956|NCT01308424|485503|P2|STARTED|Randomization||87
199957|NCT01308424|485504|P1|STARTED|Randomization||0
199958|NCT01308424|485502|P3|NOT COMPLETED|Baseline Eligibility||0
199959|NCT01308424|485503|P2|NOT COMPLETED|Baseline Eligibility||0
199960|NCT01308424|485504|P1|NOT COMPLETED|Baseline Eligibility||71
199961|NCT01308424|485502|P3|COMPLETED|Baseline Eligibility||0
199962|NCT01308424|485503|P2|COMPLETED|Baseline Eligibility||0
199963|NCT01308424|485504|P1|COMPLETED|Baseline Eligibility|Completed baseline run in and were eligible for randomization|171
199964|NCT01308424|485502|P3|STARTED|Baseline Eligibility||0
199965|NCT01308424|485503|P2|STARTED|Baseline Eligibility||0
199966|NCT01308424|485504|P1|STARTED|Baseline Eligibility||242
199967|NCT01308008|485513|P2|NOT COMPLETED|12 Months||4
199968|NCT01308008|485514|P1|NOT COMPLETED|12 Months||8
199969|NCT01308008|485513|P2|COMPLETED|12 Months||58
199970|NCT01308008|485514|P1|COMPLETED|12 Months||46
199971|NCT01308008|485513|P2|STARTED|12 Months||62
199972|NCT01308008|485514|P1|STARTED|12 Months||54
199973|NCT01308008|485513|P2|NOT COMPLETED|6 Months||9
199974|NCT01308008|485514|P1|NOT COMPLETED|6 Months||8
199975|NCT01308008|485513|P2|COMPLETED|6 Months||62
199976|NCT01308008|485514|P1|COMPLETED|6 Months||54
199977|NCT01308008|485513|P2|STARTED|6 Months||71
199978|NCT01308008|485514|P1|STARTED|6 Months||62
199979|NCT01308008|485513|P2|NOT COMPLETED|4 Weeks||2
199980|NCT01308008|485514|P1|NOT COMPLETED|4 Weeks||9
199981|NCT01308008|485513|P2|COMPLETED|4 Weeks||71
199982|NCT01308008|485514|P1|COMPLETED|4 Weeks||62
199983|NCT01308008|485513|P2|STARTED|4 Weeks||73
199984|NCT01308008|485514|P1|STARTED|4 Weeks||71
199985|NCT01307956|485524|P1|NOT COMPLETED|Overall Study||0
199986|NCT01307956|485524|P1|COMPLETED|Overall Study||11
199987|NCT01307956|485524|P1|STARTED|Overall Study||11
199988|NCT01307930|485531|P1|NOT COMPLETED|Overall Study||2
199989|NCT01307930|485531|P1|COMPLETED|Overall Study||18
199990|NCT01307930|485531|P1|STARTED|Overall Study||20
199991|NCT01307891|485537|P2|NOT COMPLETED|Overall Study||1
199992|NCT01307891|485538|P1|NOT COMPLETED|Overall Study||3
199993|NCT01307891|485537|P2|COMPLETED|Overall Study||21
199994|NCT01307891|485538|P1|COMPLETED|Overall Study||39
199995|NCT01307891|485537|P2|STARTED|Overall Study||22
199996|NCT01307891|485538|P1|STARTED|Overall Study||42
199997|NCT01307787|485550|P2|NOT COMPLETED|Overall Study||0
199998|NCT01307787|485551|P1|NOT COMPLETED|Overall Study||2
199999|NCT01307787|485550|P2|COMPLETED|Overall Study||15
200000|NCT01307787|485551|P1|COMPLETED|Overall Study||17
200001|NCT01307787|485550|P2|T2= After 22 Weeks at Follow-up|Overall Study||15
200002|NCT01307787|485551|P1|T2= After 22 Weeks at Follow-up|Overall Study||17
200003|NCT01307787|485550|P2|T1= After 9 Weeks Post Intervention|Overall Study||15
200004|NCT01307787|485551|P1|T1= After 9 Weeks Post Intervention|Overall Study||18
200005|NCT01307787|485550|P2|STARTED|Overall Study||15
200006|NCT01307787|485551|P1|STARTED|Overall Study||19
200007|NCT01307748|485574|P3|NOT COMPLETED|Overall Study||0
200008|NCT01307748|485575|P2|NOT COMPLETED|Overall Study||0
200009|NCT01307748|485576|P1|NOT COMPLETED|Overall Study||0
200010|NCT01307748|485574|P3|COMPLETED|Overall Study||30
200011|NCT01307748|485575|P2|COMPLETED|Overall Study||31
200012|NCT01307748|485576|P1|COMPLETED|Overall Study||31
200013|NCT01307748|485574|P3|STARTED|Overall Study||30
200014|NCT01307748|485575|P2|STARTED|Overall Study||31
200015|NCT01307748|485576|P1|STARTED|Overall Study||31
200016|NCT01307631|485590|P2|NOT COMPLETED|Overall Study||0
200017|NCT01307631|485591|P1|NOT COMPLETED|Overall Study||0
200018|NCT01307631|485590|P2|COMPLETED|Overall Study||28
200019|NCT01307631|485591|P1|COMPLETED|Overall Study||9
200020|NCT01307631|485590|P2|STARTED|Overall Study||28
200021|NCT01307631|485591|P1|STARTED|Overall Study||9
200022|NCT01307618|485601|P2|NOT COMPLETED|Overall Study||0
200023|NCT01307618|485602|P1|NOT COMPLETED|Overall Study||0
200024|NCT01307618|485601|P2|COMPLETED|Overall Study||5
200025|NCT01307618|485602|P1|COMPLETED|Overall Study||5
200026|NCT01307618|485601|P2|STARTED|Overall Study||5
200027|NCT01307618|485602|P1|STARTED|Overall Study||5
200028|NCT01307579|485620|P2|NOT COMPLETED|Overall Study||145
200029|NCT01307579|485621|P1|NOT COMPLETED|Overall Study||140
200030|NCT01307579|485620|P2|COMPLETED|Overall Study||115
200031|NCT01307579|485621|P1|COMPLETED|Overall Study||117
200032|NCT01307579|485620|P2|STARTED|Overall Study||260
200033|NCT01307579|485621|P1|STARTED|Overall Study||257
200034|NCT01307501|485633|P1|NOT COMPLETED|Overall Study||23
200035|NCT01307501|485633|P1|COMPLETED|Overall Study||17
200036|NCT01307501|485633|P1|Intent-to-Treat (ITT) Population|Overall Study||40
200037|NCT01307501|485633|P1|STARTED|Overall Study||40
200038|NCT01307462|485646|P1|NOT COMPLETED|Overall Study||1
200039|NCT01307462|485646|P1|COMPLETED|Overall Study||35
200040|NCT01307462|485646|P1|STARTED|Overall Study||36
200041|NCT01307449|485663|P4|NOT COMPLETED|Overall Study||0
200042|NCT01307449|485664|P3|NOT COMPLETED|Overall Study||0
200043|NCT01307449|485665|P2|NOT COMPLETED|Overall Study||0
200044|NCT01307449|485666|P1|NOT COMPLETED|Overall Study||1
200045|NCT01307449|485663|P4|COMPLETED|Overall Study||11
200046|NCT01307449|485664|P3|COMPLETED|Overall Study||11
200047|NCT01307449|485665|P2|COMPLETED|Overall Study||33
200048|NCT01307449|485666|P1|COMPLETED|Overall Study||32
200049|NCT01307449|485663|P4|STARTED|Overall Study||11
200050|NCT01307449|485664|P3|STARTED|Overall Study||11
200051|NCT01307449|485665|P2|STARTED|Overall Study||33
200052|NCT01307449|485666|P1|STARTED|Overall Study||33
200053|NCT01307423|485699|P9|NOT COMPLETED|Long-term Safety Phase (Year 5)||3
200054|NCT01307423|485700|P8|NOT COMPLETED|Long-term Safety Phase (Year 5)||1
200055|NCT01307423|485701|P7|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
200056|NCT01307423|485702|P6|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
200057|NCT01307423|485703|P5|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
200058|NCT01307423|485704|P4|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
200059|NCT01307423|485705|P3|NOT COMPLETED|Long-term Safety Phase (Year 5)||6
200060|NCT01307423|485706|P2|NOT COMPLETED|Long-term Safety Phase (Year 5)||10
200061|NCT01307423|485707|P1|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
200062|NCT01307423|485699|P9|COMPLETED|Long-term Safety Phase (Year 5)||41
200063|NCT01307423|485700|P8|COMPLETED|Long-term Safety Phase (Year 5)||37
200064|NCT01307423|485701|P7|COMPLETED|Long-term Safety Phase (Year 5)||0
200065|NCT01307423|485702|P6|COMPLETED|Long-term Safety Phase (Year 5)||0
200066|NCT01307423|485703|P5|COMPLETED|Long-term Safety Phase (Year 5)||0
200067|NCT01307423|485704|P4|COMPLETED|Long-term Safety Phase (Year 5)||0
200068|NCT01307423|485705|P3|COMPLETED|Long-term Safety Phase (Year 5)||80
200069|NCT01307423|485706|P2|COMPLETED|Long-term Safety Phase (Year 5)||71
200070|NCT01307423|485707|P1|COMPLETED|Long-term Safety Phase (Year 5)||0
200071|NCT01307423|485699|P9|STARTED|Long-term Safety Phase (Year 5)||44
200072|NCT01307423|485700|P8|STARTED|Long-term Safety Phase (Year 5)||38
200073|NCT01307423|485701|P7|STARTED|Long-term Safety Phase (Year 5)||0
200074|NCT01307423|485702|P6|STARTED|Long-term Safety Phase (Year 5)||0
200075|NCT01307423|485703|P5|STARTED|Long-term Safety Phase (Year 5)||0
200076|NCT01307423|485704|P4|STARTED|Long-term Safety Phase (Year 5)||0
200077|NCT01307423|485705|P3|STARTED|Long-term Safety Phase (Year 5)||86
200078|NCT01307423|485706|P2|STARTED|Long-term Safety Phase (Year 5)||81
200079|NCT01307423|485707|P1|STARTED|Long-term Safety Phase (Year 5)||0
200080|NCT01307423|485699|P9|NOT COMPLETED|Long-term Safety Phase (Year 4)||5
200081|NCT01307423|485700|P8|NOT COMPLETED|Long-term Safety Phase (Year 4)||2
200082|NCT01307423|485701|P7|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
200083|NCT01307423|485702|P6|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
200084|NCT01307423|485703|P5|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
200085|NCT01307423|485704|P4|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
200086|NCT01307423|485705|P3|NOT COMPLETED|Long-term Safety Phase (Year 4)||5
200087|NCT01307423|485706|P2|NOT COMPLETED|Long-term Safety Phase (Year 4)||8
200088|NCT01307423|485707|P1|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
200089|NCT01307423|485699|P9|COMPLETED|Long-term Safety Phase (Year 4)||44
200090|NCT01307423|485700|P8|COMPLETED|Long-term Safety Phase (Year 4)||38
200091|NCT01307423|485701|P7|COMPLETED|Long-term Safety Phase (Year 4)||0
200092|NCT01307423|485702|P6|COMPLETED|Long-term Safety Phase (Year 4)||0
200093|NCT01307423|485703|P5|COMPLETED|Long-term Safety Phase (Year 4)||0
200094|NCT01307423|485704|P4|COMPLETED|Long-term Safety Phase (Year 4)||0
200095|NCT01307423|485705|P3|COMPLETED|Long-term Safety Phase (Year 4)||86
200096|NCT01307423|485706|P2|COMPLETED|Long-term Safety Phase (Year 4)||81
200097|NCT01307423|485707|P1|COMPLETED|Long-term Safety Phase (Year 4)||0
200098|NCT01307423|485699|P9|STARTED|Long-term Safety Phase (Year 4)||49
200099|NCT01307423|485700|P8|STARTED|Long-term Safety Phase (Year 4)||40
200100|NCT01307423|485701|P7|STARTED|Long-term Safety Phase (Year 4)||0
200101|NCT01307423|485702|P6|STARTED|Long-term Safety Phase (Year 4)||0
200102|NCT01307423|485703|P5|STARTED|Long-term Safety Phase (Year 4)||0
200103|NCT01307423|485704|P4|STARTED|Long-term Safety Phase (Year 4)||0
200104|NCT01307423|485705|P3|STARTED|Long-term Safety Phase (Year 4)||91
200105|NCT01307423|485706|P2|STARTED|Long-term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|89
200106|NCT01307423|485707|P1|STARTED|Long-term Safety Phase (Year 4)||0
200107|NCT01307423|485699|P9|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
200108|NCT01307423|485700|P8|NOT COMPLETED|Long-term Safety Phase (Year 3)||8
200109|NCT01307423|485701|P7|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
200110|NCT01307423|485702|P6|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
200111|NCT01307423|485703|P5|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
200112|NCT01307423|485704|P4|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
200113|NCT01307423|485705|P3|NOT COMPLETED|Long-term Safety Phase (Year 3)||18
200114|NCT01307423|485706|P2|NOT COMPLETED|Long-term Safety Phase (Year 3)||9
200115|NCT01307423|485707|P1|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
200116|NCT01307423|485699|P9|COMPLETED|Long-term Safety Phase (Year 3)||49
200117|NCT01307423|485700|P8|COMPLETED|Long-term Safety Phase (Year 3)||40
200118|NCT01307423|485701|P7|COMPLETED|Long-term Safety Phase (Year 3)||0
200119|NCT01307423|485702|P6|COMPLETED|Long-term Safety Phase (Year 3)||0
200120|NCT01307423|485703|P5|COMPLETED|Long-term Safety Phase (Year 3)||0
200121|NCT01307423|485704|P4|COMPLETED|Long-term Safety Phase (Year 3)||0
200122|NCT01307423|485705|P3|COMPLETED|Long-term Safety Phase (Year 3)||91
200123|NCT01307423|485706|P2|COMPLETED|Long-term Safety Phase (Year 3)||90
200124|NCT01307423|485707|P1|COMPLETED|Long-term Safety Phase (Year 3)||0
200125|NCT01307423|485699|P9|STARTED|Long-term Safety Phase (Year 3)||60
200126|NCT01307423|485700|P8|STARTED|Long-term Safety Phase (Year 3)||48
200127|NCT01307423|485701|P7|STARTED|Long-term Safety Phase (Year 3)||0
200128|NCT01307423|485702|P6|STARTED|Long-term Safety Phase (Year 3)||0
200129|NCT01307423|485703|P5|STARTED|Long-term Safety Phase (Year 3)||0
200130|NCT01307423|485704|P4|STARTED|Long-term Safety Phase (Year 3)||0
200131|NCT01307423|485705|P3|STARTED|Long-term Safety Phase (Year 3)||109
200132|NCT01307423|485706|P2|STARTED|Long-term Safety Phase (Year 3)||99
200133|NCT01307423|485707|P1|STARTED|Long-term Safety Phase (Year 3)||0
200134|NCT01307423|485699|P9|NOT COMPLETED|Long-term Safety Phase (Year 2)||7
200135|NCT01307423|485700|P8|NOT COMPLETED|Long-term Safety Phase (Year 2)||9
200136|NCT01307423|485701|P7|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
200137|NCT01307423|485702|P6|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
200138|NCT01307423|485703|P5|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
200139|NCT01307423|485704|P4|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
200140|NCT01307423|485705|P3|NOT COMPLETED|Long-term Safety Phase (Year 2)||25
200141|NCT01307423|485706|P2|NOT COMPLETED|Long-term Safety Phase (Year 2)||23
200142|NCT01307423|485707|P1|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
200143|NCT01307423|485699|P9|COMPLETED|Long-term Safety Phase (Year 2)||60
200144|NCT01307423|485700|P8|COMPLETED|Long-term Safety Phase (Year 2)||48
200145|NCT01307423|485701|P7|COMPLETED|Long-term Safety Phase (Year 2)||0
200146|NCT01307423|485702|P6|COMPLETED|Long-term Safety Phase (Year 2)||0
200147|NCT01307423|485703|P5|COMPLETED|Long-term Safety Phase (Year 2)||0
200148|NCT01307423|485704|P4|COMPLETED|Long-term Safety Phase (Year 2)||0
200149|NCT01307423|485705|P3|COMPLETED|Long-term Safety Phase (Year 2)||109
200150|NCT01307423|485706|P2|COMPLETED|Long-term Safety Phase (Year 2)||99
200151|NCT01307423|485707|P1|COMPLETED|Long-term Safety Phase (Year 2)||0
200152|NCT01307423|485699|P9|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|67
200153|NCT01307423|485700|P8|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;15 patients finished Wk 52;no entry into LTSP|57
200154|NCT01307423|485701|P7|STARTED|Long-term Safety Phase (Year 2)||0
200155|NCT01307423|485702|P6|STARTED|Long-term Safety Phase (Year 2)||0
200156|NCT01307423|485703|P5|STARTED|Long-term Safety Phase (Year 2)||0
200157|NCT01307423|485704|P4|STARTED|Long-term Safety Phase (Year 2)||0
200158|NCT01307423|485705|P3|STARTED|Long-term Safety Phase (Year 2)|7 participants who completed Week 52 did not enter the long-term safety phase|134
200159|NCT01307423|485706|P2|STARTED|Long-term Safety Phase (Year 2)|10 participants who completed Week 52 did not enter the long-term safety phase|122
200160|NCT01307423|485707|P1|STARTED|Long-term Safety Phase (Year 2)||0
200161|NCT01307423|485699|P9|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
200162|NCT01307423|485700|P8|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
200163|NCT01307423|485701|P7|NOT COMPLETED|Active Treatment Phase (Week 25-52)||1
200164|NCT01307423|485702|P6|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
200165|NCT01307423|485703|P5|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
200166|NCT01307423|485704|P4|NOT COMPLETED|Active Treatment Phase (Week 25-52)||8
200167|NCT01307423|485705|P3|NOT COMPLETED|Active Treatment Phase (Week 25-52)||9
200168|NCT01307423|485706|P2|NOT COMPLETED|Active Treatment Phase (Week 25-52)||19
200169|NCT01307423|485707|P1|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
200170|NCT01307423|485699|P9|COMPLETED|Active Treatment Phase (Week 25-52)||0
200171|NCT01307423|485700|P8|COMPLETED|Active Treatment Phase (Week 25-52)||0
200172|NCT01307423|485701|P7|COMPLETED|Active Treatment Phase (Week 25-52)||25
200173|NCT01307423|485702|P6|COMPLETED|Active Treatment Phase (Week 25-52)||43
200174|NCT01307423|485703|P5|COMPLETED|Active Treatment Phase (Week 25-52)||23
200175|NCT01307423|485704|P4|COMPLETED|Active Treatment Phase (Week 25-52)||38
200176|NCT01307423|485705|P3|COMPLETED|Active Treatment Phase (Week 25-52)||141
200177|NCT01307423|485706|P2|COMPLETED|Active Treatment Phase (Week 25-52)||132
200178|NCT01307423|485707|P1|COMPLETED|Active Treatment Phase (Week 25-52)||0
200179|NCT01307423|485699|P9|STARTED|Active Treatment Phase (Week 25-52)||0
200180|NCT01307423|485700|P8|STARTED|Active Treatment Phase (Week 25-52)||0
200181|NCT01307423|485701|P7|STARTED|Active Treatment Phase (Week 25-52)||26
200182|NCT01307423|485702|P6|STARTED|Active Treatment Phase (Week 25-52)|Six participants who escaped early and completed Week 24 did not enter the active treatment phase|46
200183|NCT01307423|485703|P5|STARTED|Active Treatment Phase (Week 25-52)||26
200184|NCT01307423|485704|P4|STARTED|Active Treatment Phase (Week 25-52)|Four participants who escaped early and completed Week 24 did not enter the active treatment phase.|46
200185|NCT01307423|485705|P3|STARTED|Active Treatment Phase (Week 25-52)|Five participants who completed Week 24 did not enter active treatment phase|150
200186|NCT01307423|485706|P2|STARTED|Active Treatment Phase (Week 25-52)|Nine participants who completed Week 24 did not enter active treatment phase|151
200187|NCT01307423|485707|P1|STARTED|Active Treatment Phase (Week 25-52)||0
200188|NCT01307423|485699|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
200189|NCT01307423|485700|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
200190|NCT01307423|485701|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
200191|NCT01307423|485702|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
200192|NCT01307423|485703|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
200193|NCT01307423|485704|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
200194|NCT01307423|485705|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
200195|NCT01307423|485706|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||15
200196|NCT01307423|485707|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
200197|NCT01307423|485699|P9|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
200198|NCT01307423|485700|P8|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
200199|NCT01307423|485701|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
200200|NCT01307423|485702|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
200201|NCT01307423|485703|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
200202|NCT01307423|485704|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
200203|NCT01307423|485705|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||155
200204|NCT01307423|485706|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||160
200205|NCT01307423|485707|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants did not escape early and finished Week 24 did not enter the active treatment phase|156
200206|NCT01307423|485699|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
200207|NCT01307423|485700|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
200208|NCT01307423|485701|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
200209|NCT01307423|485702|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
200210|NCT01307423|485703|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
200211|NCT01307423|485704|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
200212|NCT01307423|485705|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||79
200213|NCT01307423|485706|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||73
200214|NCT01307423|485707|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|One participant who escaped early did not complete Week 24|103
200215|NCT01307423|485699|P9|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
200216|NCT01307423|485700|P8|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
200217|NCT01307423|485701|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
200218|NCT01307423|485702|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
200219|NCT01307423|485703|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
200220|NCT01307423|485704|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
200221|NCT01307423|485705|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
200222|NCT01307423|485706|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||168
200223|NCT01307423|485707|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
200224|NCT01307423|485699|P9|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
200225|NCT01307423|485700|P8|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
200226|NCT01307423|485701|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
200227|NCT01307423|485702|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
200228|NCT01307423|485703|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
200229|NCT01307423|485704|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
200230|NCT01307423|485705|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
200231|NCT01307423|485706|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
200232|NCT01307423|485707|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||176
200233|NCT01307423|485699|P9|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
200234|NCT01307423|485700|P8|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
200235|NCT01307423|485701|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
200236|NCT01307423|485702|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
200237|NCT01307423|485703|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
200238|NCT01307423|485704|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
200239|NCT01307423|485705|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||177
200240|NCT01307423|485706|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||175
200241|NCT01307423|485707|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||176
200242|NCT01307397|485891|P1|NOT COMPLETED|Overall Study||0
200243|NCT01307397|485891|P1|COMPLETED|Overall Study|A participant completed study in case of progressive disease, adverse events or consent withdrawn|3219
200244|NCT01307397|485891|P1|STARTED|Overall Study||3219
200245|NCT01307319|485913|P3|NOT COMPLETED|Overall Study||7
200246|NCT01307319|485914|P2|NOT COMPLETED|Overall Study||8
200247|NCT01307319|485915|P1|NOT COMPLETED|Overall Study||4
200248|NCT01307319|485913|P3|COMPLETED|Overall Study||227
200249|NCT01307319|485914|P2|COMPLETED|Overall Study||234
200250|NCT01307319|485915|P1|COMPLETED|Overall Study||235
200251|NCT01307319|485913|P3|ITT Population|Overall Study||234
200252|NCT01307319|485914|P2|ITT Population|Overall Study||241
200253|NCT01307319|485915|P1|ITT Population|Overall Study|One participant provided no post-baseline assessment.|238
200254|NCT01307319|485913|P3|Safety Population|Overall Study||234
200255|NCT01307319|485914|P2|Safety Population|Overall Study|One participant was randomized in error and did not receive study medication.|241
200256|NCT01307319|485915|P1|Safety Population|Overall Study||239
200257|NCT01307319|485913|P3|STARTED|Overall Study|Randomized|234
200258|NCT01307319|485914|P2|STARTED|Overall Study|Randomized|242
200259|NCT01307319|485915|P1|STARTED|Overall Study|Randomized|239
200260|NCT01307111|485929|P2|NOT COMPLETED|1-2 Week IUD Check up||2
200261|NCT01307111|485930|P1|NOT COMPLETED|1-2 Week IUD Check up||2
200262|NCT01307111|485929|P2|COMPLETED|1-2 Week IUD Check up||38
200263|NCT01307111|485930|P1|COMPLETED|1-2 Week IUD Check up||38
200264|NCT01307111|485929|P2|STARTED|1-2 Week IUD Check up||40
200265|NCT01307111|485930|P1|STARTED|1-2 Week IUD Check up||40
200266|NCT01307111|485929|P2|NOT COMPLETED|IUD Insertion||0
200267|NCT01307111|485930|P1|NOT COMPLETED|IUD Insertion||2
200268|NCT01307111|485929|P2|COMPLETED|IUD Insertion||40
200269|NCT01307111|485930|P1|COMPLETED|IUD Insertion||40
200270|NCT01307111|485929|P2|STARTED|IUD Insertion||40
200271|NCT01307111|485930|P1|STARTED|IUD Insertion||42
200272|NCT01307098|485941|P3|NOT COMPLETED|Overall Study||0
200273|NCT01307098|485942|P2|NOT COMPLETED|Overall Study||0
200274|NCT01307098|485943|P1|NOT COMPLETED|Overall Study||0
200275|NCT01307098|485941|P3|COMPLETED|Overall Study||3
200276|NCT01307098|485942|P2|COMPLETED|Overall Study||3
200277|NCT01307098|485943|P1|COMPLETED|Overall Study||3
200278|NCT01307098|485941|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
200279|NCT01307098|485942|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
200280|NCT01307098|485943|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
200281|NCT01307098|485941|P3|STARTED|Overall Study||3
200282|NCT01307098|485942|P2|STARTED|Overall Study||3
200283|NCT01307098|485943|P1|STARTED|Overall Study||3
200284|NCT01307046|485953|P2|NOT COMPLETED|Overall Study||11
200285|NCT01307046|485954|P1|NOT COMPLETED|Overall Study||12
200286|NCT01307046|485953|P2|COMPLETED|Overall Study||159
200287|NCT01307046|485954|P1|COMPLETED|Overall Study||154
200288|NCT01307046|485953|P2|STARTED|Overall Study||170
200289|NCT01307046|485954|P1|STARTED|Overall Study||166
200290|NCT01307033|485966|P4|NOT COMPLETED|44-week Open-label Extension||12
200291|NCT01307033|485967|P3|NOT COMPLETED|44-week Open-label Extension||11
200292|NCT01307033|485968|P2|NOT COMPLETED|44-week Open-label Extension||0
200293|NCT01307033|485969|P1|NOT COMPLETED|44-week Open-label Extension||0
200294|NCT01307033|485966|P4|COMPLETED|44-week Open-label Extension||115
200295|NCT01307033|485967|P3|COMPLETED|44-week Open-label Extension||120
200296|NCT01307033|485968|P2|COMPLETED|44-week Open-label Extension||0
200297|NCT01307033|485969|P1|COMPLETED|44-week Open-label Extension||0
200298|NCT01307033|485966|P4|STARTED|44-week Open-label Extension||127
200299|NCT01307033|485967|P3|STARTED|44-week Open-label Extension||131
200300|NCT01307033|485968|P2|STARTED|44-week Open-label Extension||0
200301|NCT01307033|485969|P1|STARTED|44-week Open-label Extension||0
200302|NCT01307033|485966|P4|NOT COMPLETED|8-week Double-blind Period||0
200303|NCT01307033|485967|P3|NOT COMPLETED|8-week Double-blind Period||0
200304|NCT01307033|485968|P2|NOT COMPLETED|8-week Double-blind Period||7
200305|NCT01307033|485969|P1|NOT COMPLETED|8-week Double-blind Period||13
200306|NCT01307033|485966|P4|COMPLETED|8-week Double-blind Period||0
200307|NCT01307033|485967|P3|COMPLETED|8-week Double-blind Period||0
200308|NCT01307033|485968|P2|COMPLETED|8-week Double-blind Period||127
200309|NCT01307033|485969|P1|COMPLETED|8-week Double-blind Period||131
200310|NCT01307033|485966|P4|STARTED|8-week Double-blind Period||0
200311|NCT01307033|485967|P3|STARTED|8-week Double-blind Period||0
200312|NCT01307033|485968|P2|STARTED|8-week Double-blind Period||134
200313|NCT01307033|485969|P1|STARTED|8-week Double-blind Period||144
200314|NCT01307020|485991|P10|NOT COMPLETED|Overall Study||0
200315|NCT01307020|485992|P9|NOT COMPLETED|Overall Study||0
200316|NCT01307020|485993|P8|NOT COMPLETED|Overall Study||0
200317|NCT01307020|485994|P7|NOT COMPLETED|Overall Study||1
200318|NCT01307020|485995|P6|NOT COMPLETED|Overall Study||0
200319|NCT01307020|485996|P5|NOT COMPLETED|Overall Study||0
200320|NCT01307020|485997|P4|NOT COMPLETED|Overall Study||1
200321|NCT01307020|485998|P3|NOT COMPLETED|Overall Study||1
200322|NCT01307020|485999|P2|NOT COMPLETED|Overall Study||1
200323|NCT01307020|486000|P1|NOT COMPLETED|Overall Study||0
200324|NCT01307020|485991|P10|COMPLETED|Overall Study||62
200325|NCT01307020|485992|P9|COMPLETED|Overall Study||61
200326|NCT01307020|485993|P8|COMPLETED|Overall Study||60
200327|NCT01307020|485994|P7|COMPLETED|Overall Study||58
200328|NCT01307020|485995|P6|COMPLETED|Overall Study||61
200329|NCT01307020|485996|P5|COMPLETED|Overall Study||60
200330|NCT01307020|485997|P4|COMPLETED|Overall Study||60
200331|NCT01307020|485998|P3|COMPLETED|Overall Study||62
200332|NCT01307020|485999|P2|COMPLETED|Overall Study||62
200333|NCT01307020|486000|P1|COMPLETED|Overall Study||61
200334|NCT01307020|485991|P10|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
200335|NCT01307020|485992|P9|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
200336|NCT01307020|485993|P8|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
200337|NCT01307020|485994|P7|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
200338|NCT01307020|485995|P6|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
200339|NCT01307020|485996|P5|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
200340|NCT01307020|485997|P4|ITT (>= 1 Assessment Post Randomization)|Overall Study||61
200341|NCT01307020|485998|P3|ITT (>= 1 Assessment Post Randomization)|Overall Study||63
200342|NCT01307020|485999|P2|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
200343|NCT01307020|486000|P1|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
200344|NCT01307020|485991|P10|Safety Population|Overall Study||62
200345|NCT01307020|485992|P9|Safety Population|Overall Study||61
200346|NCT01307020|485993|P8|Safety Population|Overall Study||60
200347|NCT01307020|485994|P7|Safety Population|Overall Study||59
200348|NCT01307020|485995|P6|Safety Population|Overall Study||61
200349|NCT01307020|485996|P5|Safety Population|Overall Study||60
200350|NCT01307020|485997|P4|Safety Population|Overall Study||61
200351|NCT01307020|485998|P3|Safety Population|Overall Study||63
200352|NCT01307020|485999|P2|Safety Population|Overall Study||63
200353|NCT01307020|486000|P1|Safety Population|Overall Study||61
200354|NCT01307020|485991|P10|STARTED|Overall Study||62
200355|NCT01307020|485992|P9|STARTED|Overall Study||61
200356|NCT01307020|485993|P8|STARTED|Overall Study||60
200357|NCT01307020|485994|P7|STARTED|Overall Study||59
200358|NCT01307020|485995|P6|STARTED|Overall Study||61
200359|NCT01307020|485996|P5|STARTED|Overall Study||60
200360|NCT01307020|485997|P4|STARTED|Overall Study||61
200361|NCT01307020|485998|P3|STARTED|Overall Study||63
200362|NCT01307020|485999|P2|STARTED|Overall Study||63
200363|NCT01307020|486000|P1|STARTED|Overall Study||61
200364|NCT01307007|486044|P2|NOT COMPLETED|Overall Study||0
200365|NCT01307007|486045|P1|NOT COMPLETED|Overall Study||0
200366|NCT01307007|486044|P2|COMPLETED|Overall Study||30
200367|NCT01307007|486045|P1|COMPLETED|Overall Study||25
200368|NCT01307007|486044|P2|STARTED|Overall Study||30
200369|NCT01307007|486045|P1|STARTED|Overall Study||25
200370|NCT01306968|486055|P4|NOT COMPLETED|Overall Study||4
200371|NCT01306968|486056|P3|NOT COMPLETED|Overall Study||1
200372|NCT01306968|486057|P2|NOT COMPLETED|Overall Study||3
200373|NCT01306968|486058|P1|NOT COMPLETED|Overall Study||1
200374|NCT01306968|486055|P4|COMPLETED|Overall Study||21
200375|NCT01306968|486056|P3|COMPLETED|Overall Study||23
200376|NCT01306968|486057|P2|COMPLETED|Overall Study||20
200377|NCT01306968|486058|P1|COMPLETED|Overall Study||6
200378|NCT01306968|486055|P4|STARTED|Overall Study|2 participants withdrew before chamber sessions were initiated|25
200379|NCT01306968|486056|P3|STARTED|Overall Study||24
200380|NCT01306968|486057|P2|STARTED|Overall Study||23
200381|NCT01306968|486058|P1|STARTED|Overall Study||7
200382|NCT01306942|486083|P4|NOT COMPLETED|Phase II||16
200383|NCT01306942|486084|P3|NOT COMPLETED|Phase II||0
200384|NCT01306942|486085|P2|NOT COMPLETED|Phase II||0
200385|NCT01306942|486086|P1|NOT COMPLETED|Phase II||2
200386|NCT01306942|486083|P4|COMPLETED|Phase II||11
200387|NCT01306942|486084|P3|COMPLETED|Phase II||0
200388|NCT01306942|486085|P2|COMPLETED|Phase II||0
200389|NCT01306942|486086|P1|COMPLETED|Phase II||0
200390|NCT01306942|486083|P4|STARTED|Phase II||27
200391|NCT01306942|486084|P3|STARTED|Phase II||0
200392|NCT01306942|486085|P2|STARTED|Phase II|Dasatinib 140mg was not the RP2D, so these patients were not included in the phase II analyses.|0
200393|NCT01306942|486086|P1|STARTED|Phase II|Two patients from phase I with measurable disease and RP2D were included in the phase II analyses.|2
200394|NCT01306942|486083|P4|NOT COMPLETED|Phase I||0
200395|NCT01306942|486084|P3|NOT COMPLETED|Phase I||0
200396|NCT01306942|486085|P2|NOT COMPLETED|Phase I||3
200397|NCT01306942|486086|P1|NOT COMPLETED|Phase I||5
200398|NCT01306942|486083|P4|COMPLETED|Phase I||0
200399|NCT01306942|486084|P3|COMPLETED|Phase I||0
200400|NCT01306942|486085|P2|COMPLETED|Phase I||1
200401|NCT01306942|486086|P1|COMPLETED|Phase I||1
200402|NCT01306942|486083|P4|STARTED|Phase I||0
200403|NCT01306942|486084|P3|STARTED|Phase I||0
200404|NCT01306942|486085|P2|STARTED|Phase I||4
200405|NCT01306942|486086|P1|STARTED|Phase I||6
200406|NCT01306890|486118|P1|NOT COMPLETED|Overall Study||1519
200407|NCT01306890|486118|P1|COMPLETED|Overall Study|Subjects were alive at the end of the study and had completed at least 3 years of follow up.|457
200408|NCT01306890|486118|P1|STARTED|Overall Study||1976
200409|NCT01306877|486125|P2|NOT COMPLETED|Overall Study||4
200410|NCT01306877|486126|P1|NOT COMPLETED|Overall Study||3
200411|NCT01306877|486125|P2|COMPLETED|Overall Study||67
200412|NCT01306877|486126|P1|COMPLETED|Overall Study||75
200413|NCT01306877|486125|P2|STARTED|Overall Study||71
200414|NCT01306877|486126|P1|STARTED|Overall Study||78
200415|NCT01306656|486146|P2|NOT COMPLETED|Overall Study||0
200416|NCT01306656|486147|P1|NOT COMPLETED|Overall Study||1
200417|NCT01306656|486146|P2|COMPLETED|Overall Study||2
200418|NCT01306656|486147|P1|COMPLETED|Overall Study||6
200419|NCT01306656|486146|P2|STARTED|Overall Study||2
200420|NCT01306656|486147|P1|STARTED|Overall Study||7
200421|NCT01306643|486159|P1|NOT COMPLETED|Overall Study||13
200422|NCT01306643|486159|P1|COMPLETED|Overall Study|Completed Study was defined as participants who completed through Cycle 12 (Week 48) per protocol.|5
200423|NCT01306643|486159|P1|STARTED|Overall Study||18
200424|NCT01306617|486171|P3|NOT COMPLETED|Overall Study||5
200425|NCT01306617|486172|P2|NOT COMPLETED|Overall Study||1
200426|NCT01306617|486173|P1|NOT COMPLETED|Overall Study||1
200427|NCT01306617|486171|P3|COMPLETED|Overall Study|The number of participants who completed study drug|12
200428|NCT01306617|486172|P2|COMPLETED|Overall Study|The number of participants who completed study drug|13
200429|NCT01306617|486173|P1|COMPLETED|Overall Study|The number of participants who completed study drug|18
200430|NCT01306617|486171|P3|STARTED|Overall Study||17
200431|NCT01306617|486172|P2|STARTED|Overall Study||14
200432|NCT01306617|486173|P1|STARTED|Overall Study||19
200433|NCT01306305|486216|P2|NOT COMPLETED|Overall Study||0
200434|NCT01306305|486217|P1|NOT COMPLETED|Overall Study||2
200435|NCT01306305|486216|P2|COMPLETED|Overall Study||55
200436|NCT01306305|486217|P1|COMPLETED|Overall Study||53
200437|NCT01306305|486216|P2|STARTED|Overall Study||55
200438|NCT01306305|486217|P1|STARTED|Overall Study||55
200439|NCT01306292|486233|P4|NOT COMPLETED|Second Injection||0
200440|NCT01306292|486234|P3|NOT COMPLETED|Second Injection||1
200441|NCT01306292|486235|P2|NOT COMPLETED|Second Injection||0
200442|NCT01306292|486236|P1|NOT COMPLETED|Second Injection||0
200443|NCT01306292|486233|P4|COMPLETED|Second Injection||10
200444|NCT01306292|486234|P3|COMPLETED|Second Injection|1 subject completed both injections but not 24-hour follow-up; all other values were recorded.|7
200445|NCT01306292|486235|P2|COMPLETED|Second Injection||8
200446|NCT01306292|486236|P1|COMPLETED|Second Injection||10
200447|NCT01306292|486233|P4|STARTED|Second Injection||10
200448|NCT01306292|486234|P3|STARTED|Second Injection||8
200449|NCT01306292|486235|P2|STARTED|Second Injection||8
200450|NCT01306292|486236|P1|STARTED|Second Injection||10
200451|NCT01306292|486233|P4|NOT COMPLETED|Washout (at Least 10 Minutes)||0
200452|NCT01306292|486234|P3|NOT COMPLETED|Washout (at Least 10 Minutes)||0
200453|NCT01306292|486235|P2|NOT COMPLETED|Washout (at Least 10 Minutes)||0
200454|NCT01306292|486236|P1|NOT COMPLETED|Washout (at Least 10 Minutes)||0
200455|NCT01306292|486233|P4|COMPLETED|Washout (at Least 10 Minutes)||10
200456|NCT01306292|486234|P3|COMPLETED|Washout (at Least 10 Minutes)||8
200457|NCT01306292|486235|P2|COMPLETED|Washout (at Least 10 Minutes)||8
200458|NCT01306292|486236|P1|COMPLETED|Washout (at Least 10 Minutes)||10
200459|NCT01306292|486233|P4|STARTED|Washout (at Least 10 Minutes)||10
200460|NCT01306292|486234|P3|STARTED|Washout (at Least 10 Minutes)||8
200461|NCT01306292|486235|P2|STARTED|Washout (at Least 10 Minutes)||8
200462|NCT01306292|486236|P1|STARTED|Washout (at Least 10 Minutes)||10
200463|NCT01306292|486233|P4|NOT COMPLETED|First Injection||0
200464|NCT01306292|486234|P3|NOT COMPLETED|First Injection||0
200465|NCT01306292|486235|P2|NOT COMPLETED|First Injection||0
200466|NCT01306292|486236|P1|NOT COMPLETED|First Injection||0
200467|NCT01306292|486233|P4|COMPLETED|First Injection||10
200468|NCT01306292|486234|P3|COMPLETED|First Injection||8
200469|NCT01306292|486235|P2|COMPLETED|First Injection||8
200470|NCT01306292|486236|P1|COMPLETED|First Injection||10
200471|NCT01306292|486233|P4|STARTED|First Injection||10
200472|NCT01306292|486234|P3|STARTED|First Injection||8
200473|NCT01306292|486235|P2|STARTED|First Injection||8
200474|NCT01306292|486236|P1|STARTED|First Injection||10
200475|NCT01306253|486254|P2|NOT COMPLETED|Overall Study||1
200476|NCT01306253|486255|P1|NOT COMPLETED|Overall Study||1
200477|NCT01306253|486254|P2|COMPLETED|Overall Study||56
200478|NCT01306253|486255|P1|COMPLETED|Overall Study||56
200479|NCT01306253|486254|P2|STARTED|Overall Study||57
200480|NCT01306253|486255|P1|STARTED|Overall Study||57
200481|NCT01306214|486272|P3|NOT COMPLETED|Overall Study||22
200482|NCT01306214|486273|P2|NOT COMPLETED|Overall Study||28
200483|NCT01306214|486274|P1|NOT COMPLETED|Overall Study||28
200484|NCT01306214|486272|P3|COMPLETED|Overall Study||168
200485|NCT01306214|486273|P2|COMPLETED|Overall Study||159
200486|NCT01306214|486274|P1|COMPLETED|Overall Study||161
200487|NCT01306214|486272|P3|STARTED|Overall Study||190
200488|NCT01306214|486273|P2|STARTED|Overall Study||187
200489|NCT01306214|486274|P1|STARTED|Overall Study||189
200490|NCT01306201|486291|P1|NOT COMPLETED|Overall Study||10
200491|NCT01306201|486291|P1|COMPLETED|Overall Study|Total of 10 subjects were excluded from analysis|53
200492|NCT01306201|486291|P1|STARTED|Overall Study||63
200493|NCT01306175|486299|P1|NOT COMPLETED|Second Intervention||0
200494|NCT01306175|486299|P1|COMPLETED|Second Intervention||20
200495|NCT01306175|486299|P1|STARTED|Second Intervention||20
200496|NCT01306175|486299|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
200497|NCT01306175|486299|P1|COMPLETED|Washout Period of at Least 14 Days||20
200498|NCT01306175|486299|P1|STARTED|Washout Period of at Least 14 Days||20
200499|NCT01306175|486299|P1|NOT COMPLETED|First Intervention||0
200500|NCT01306175|486299|P1|COMPLETED|First Intervention||20
200501|NCT01306175|486299|P1|STARTED|First Intervention||20
200502|NCT01306162|486313|P4|NOT COMPLETED|Period 4||0
200503|NCT01306162|486314|P3|NOT COMPLETED|Period 4||0
200504|NCT01306162|486315|P2|NOT COMPLETED|Period 4||0
200505|NCT01306162|486316|P1|NOT COMPLETED|Period 4||0
200506|NCT01306162|486313|P4|COMPLETED|Period 4||8
200507|NCT01306162|486314|P3|COMPLETED|Period 4||9
200508|NCT01306162|486315|P2|COMPLETED|Period 4||8
200509|NCT01306162|486316|P1|COMPLETED|Period 4||9
200510|NCT01306162|486313|P4|STARTED|Period 4||8
200511|NCT01306162|486314|P3|STARTED|Period 4||9
200512|NCT01306162|486315|P2|STARTED|Period 4||8
200513|NCT01306162|486316|P1|STARTED|Period 4||9
200514|NCT01306162|486313|P4|NOT COMPLETED|Washout 2||0
200515|NCT01306162|486314|P3|NOT COMPLETED|Washout 2||0
200516|NCT01306162|486315|P2|NOT COMPLETED|Washout 2||0
200517|NCT01306162|486316|P1|NOT COMPLETED|Washout 2||0
200518|NCT01306162|486313|P4|COMPLETED|Washout 2||8
200519|NCT01306162|486314|P3|COMPLETED|Washout 2||9
200520|NCT01306162|486315|P2|COMPLETED|Washout 2||8
200521|NCT01306162|486316|P1|COMPLETED|Washout 2||9
200522|NCT01306162|486313|P4|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|8
200523|NCT01306162|486314|P3|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|9
200524|NCT01306162|486315|P2|STARTED|Washout 2|No washout period. Treatment D followed directly after treatment E.|8
200525|NCT01306162|486316|P1|STARTED|Washout 2|No washout period. Treatment E followed directly after treatment D.|9
200526|NCT01306162|486313|P4|NOT COMPLETED|Period 3||0
200527|NCT01306162|486314|P3|NOT COMPLETED|Period 3||0
200528|NCT01306162|486315|P2|NOT COMPLETED|Period 3||0
200529|NCT01306162|486316|P1|NOT COMPLETED|Period 3||0
200530|NCT01306162|486313|P4|COMPLETED|Period 3||8
200531|NCT01306162|486314|P3|COMPLETED|Period 3||9
200532|NCT01306162|486315|P2|COMPLETED|Period 3||8
200533|NCT01306162|486316|P1|COMPLETED|Period 3||9
200534|NCT01306162|486313|P4|STARTED|Period 3||8
200535|NCT01306162|486314|P3|STARTED|Period 3||9
200536|NCT01306162|486315|P2|STARTED|Period 3||8
200537|NCT01306162|486316|P1|STARTED|Period 3||9
200538|NCT01306162|486313|P4|NOT COMPLETED|Period 2||0
200539|NCT01306162|486314|P3|NOT COMPLETED|Period 2||0
200540|NCT01306162|486315|P2|NOT COMPLETED|Period 2||0
200541|NCT01306162|486316|P1|NOT COMPLETED|Period 2||0
200542|NCT01306162|486313|P4|COMPLETED|Period 2||8
200543|NCT01306162|486314|P3|COMPLETED|Period 2||9
200544|NCT01306162|486315|P2|COMPLETED|Period 2||8
200545|NCT01306162|486316|P1|COMPLETED|Period 2||9
200546|NCT01306162|486313|P4|STARTED|Period 2|No washout phase after Period 2.|8
200547|NCT01306162|486314|P3|STARTED|Period 2|No washout phase after Period 2.|9
200548|NCT01306162|486315|P2|STARTED|Period 2|No washout phase after Period 2.|8
200549|NCT01306162|486316|P1|STARTED|Period 2|No washout phase after Period 2.|9
200550|NCT01306162|486313|P4|NOT COMPLETED|Washout 1||0
200551|NCT01306162|486314|P3|NOT COMPLETED|Washout 1||0
200552|NCT01306162|486315|P2|NOT COMPLETED|Washout 1||1
200553|NCT01306162|486316|P1|NOT COMPLETED|Washout 1||0
200554|NCT01306162|486313|P4|COMPLETED|Washout 1||8
200555|NCT01306162|486314|P3|COMPLETED|Washout 1||9
200556|NCT01306162|486315|P2|COMPLETED|Washout 1||8
200557|NCT01306162|486316|P1|COMPLETED|Washout 1||9
200558|NCT01306162|486313|P4|STARTED|Washout 1|No washout period.Treatment E followed directly after treatment C.|8
200559|NCT01306162|486314|P3|STARTED|Washout 1|No washout period. Treatment D followed directly after treatment B.|9
200560|NCT01306162|486315|P2|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
200561|NCT01306162|486316|P1|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
200562|NCT01306162|486313|P4|NOT COMPLETED|Period 1||1
200563|NCT01306162|486314|P3|NOT COMPLETED|Period 1||0
200564|NCT01306162|486315|P2|NOT COMPLETED|Period 1||0
200565|NCT01306162|486316|P1|NOT COMPLETED|Period 1||0
200566|NCT01306162|486313|P4|COMPLETED|Period 1||8
200567|NCT01306162|486314|P3|COMPLETED|Period 1||9
200568|NCT01306162|486315|P2|COMPLETED|Period 1||9
200569|NCT01306162|486316|P1|COMPLETED|Period 1||9
200570|NCT01306162|486313|P4|STARTED|Period 1||9
200571|NCT01306162|486314|P3|STARTED|Period 1||9
200572|NCT01306162|486315|P2|STARTED|Period 1||9
200573|NCT01306162|486316|P1|STARTED|Period 1||9
200574|NCT01306058|486344|P1|NOT COMPLETED|Overall Study||2
200575|NCT01306058|486344|P1|COMPLETED|Overall Study||25
200576|NCT01306058|486344|P1|STARTED|Overall Study||27
200577|NCT01306032|486371|P6|NOT COMPLETED|Disease Progression/Crossover||0
200578|NCT01306032|486372|P5|NOT COMPLETED|Disease Progression/Crossover||0
200579|NCT01306032|486373|P4|NOT COMPLETED|Disease Progression/Crossover||3
200580|NCT01306032|486374|P3|NOT COMPLETED|Disease Progression/Crossover||0
200581|NCT01306032|486375|P2|NOT COMPLETED|Disease Progression/Crossover||2
200582|NCT01306032|486376|P1|NOT COMPLETED|Disease Progression/Crossover||0
200583|NCT01306032|486371|P6|COMPLETED|Disease Progression/Crossover||0
200584|NCT01306032|486372|P5|COMPLETED|Disease Progression/Crossover||0
200585|NCT01306032|486373|P4|COMPLETED|Disease Progression/Crossover||26
200586|NCT01306032|486374|P3|COMPLETED|Disease Progression/Crossover||0
200587|NCT01306032|486375|P2|COMPLETED|Disease Progression/Crossover||14
200588|NCT01306032|486376|P1|COMPLETED|Disease Progression/Crossover||0
200589|NCT01306032|486371|P6|STARTED|Disease Progression/Crossover||0
200590|NCT01306032|486372|P5|STARTED|Disease Progression/Crossover||0
200591|NCT01306032|486373|P4|STARTED|Disease Progression/Crossover||29
200592|NCT01306032|486374|P3|STARTED|Disease Progression/Crossover||0
200593|NCT01306032|486375|P2|STARTED|Disease Progression/Crossover||16
200594|NCT01306032|486376|P1|STARTED|Disease Progression/Crossover||0
200595|NCT01306032|486371|P6|NOT COMPLETED|First Intervention||2
200596|NCT01306032|486372|P5|NOT COMPLETED|First Intervention||2
200597|NCT01306032|486373|P4|NOT COMPLETED|First Intervention||1
200598|NCT01306032|486374|P3|NOT COMPLETED|First Intervention||2
200599|NCT01306032|486375|P2|NOT COMPLETED|First Intervention||2
200600|NCT01306032|486376|P1|NOT COMPLETED|First Intervention||1
200601|NCT01306032|486371|P6|COMPLETED|First Intervention||0
200602|NCT01306032|486372|P5|COMPLETED|First Intervention||0
200603|NCT01306032|486373|P4|COMPLETED|First Intervention||37
200604|NCT01306032|486374|P3|COMPLETED|First Intervention||35
200605|NCT01306032|486375|P2|COMPLETED|First Intervention||18
200606|NCT01306032|486376|P1|COMPLETED|First Intervention||21
200607|NCT01306032|486371|P6|STARTED|First Intervention||2
200608|NCT01306032|486372|P5|STARTED|First Intervention||2
200609|NCT01306032|486373|P4|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|38
200610|NCT01306032|486374|P3|STARTED|First Intervention||37
200611|NCT01306032|486375|P2|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|20
200612|NCT01306032|486376|P1|STARTED|First Intervention||22
200613|NCT01305941|486428|P1|NOT COMPLETED|Overall Study||10
200614|NCT01305941|486428|P1|COMPLETED|Overall Study||22
200615|NCT01305941|486428|P1|STARTED|Overall Study||32
200616|NCT01305811|486442|P2|NOT COMPLETED|Overall Study||11
200617|NCT01305811|486443|P1|NOT COMPLETED|Overall Study||8
200618|NCT01305811|486442|P2|COMPLETED|Overall Study||41
200619|NCT01305811|486443|P1|COMPLETED|Overall Study||44
200620|NCT01305811|486442|P2|STARTED|Overall Study||52
200621|NCT01305811|486443|P1|STARTED|Overall Study||52
200622|NCT01305772|486453|P2|NOT COMPLETED|Overall Study||0
200623|NCT01305772|486454|P1|NOT COMPLETED|Overall Study||0
200624|NCT01305772|486453|P2|COMPLETED|Overall Study||1
200625|NCT01305772|486454|P1|COMPLETED|Overall Study||5
200626|NCT01305772|486453|P2|RT + Panitumumab Dose #2 / #3|Overall Study||1
200627|NCT01305772|486454|P1|RT + Panitumumab Dose #2 / #3|Overall Study|RT and doses #2 and #3 of panitumumab administered to patients regardless of 2nd biopsy status.|5
200628|NCT01305772|486453|P2|Surgery/Biopsy #2|Overall Study||1
200629|NCT01305772|486454|P1|Surgery/Biopsy #2|Overall Study|2nd research tissue sample not collected for 4 patients due to safety risk to subject.|1
200630|NCT01305772|486453|P2|Research PET/CT #2|Overall Study||1
200631|NCT01305772|486454|P1|Research PET/CT #2|Overall Study||5
200632|NCT01305772|486453|P2|Panitumumab Dose #1|Overall Study||1
200633|NCT01305772|486454|P1|Panitumumab Dose #1|Overall Study||5
200634|NCT01305772|486453|P2|Research PET/CT #1|Overall Study||1
200635|NCT01305772|486454|P1|Research PET/CT #1|Overall Study||5
200636|NCT01305772|486453|P2|Genomic Screening + Biopsy #1|Overall Study||1
200637|NCT01305772|486454|P1|Genomic Screening + Biopsy #1|Overall Study||5
200638|NCT01305772|486453|P2|STARTED|Overall Study||1
200639|NCT01305772|486454|P1|STARTED|Overall Study||5
200640|NCT01305655|486461|P1|NOT COMPLETED|Overall Study||0
200641|NCT01305655|486461|P1|COMPLETED|Overall Study|December 31, 2014|47
200642|NCT01305655|486461|P1|STARTED|Overall Study|July 2008|47
200643|NCT01305577|486468|P3|NOT COMPLETED|Overall Study||10
200644|NCT01305577|486469|P2|NOT COMPLETED|Overall Study||11
200645|NCT01305577|486470|P1|NOT COMPLETED|Overall Study||13
200646|NCT01305577|486468|P3|COMPLETED|Overall Study||112
200647|NCT01305577|486469|P2|COMPLETED|Overall Study||110
200648|NCT01305577|486470|P1|COMPLETED|Overall Study||107
200649|NCT01305577|486468|P3|Received Treatment|Overall Study||122
200650|NCT01305577|486469|P2|Received Treatment|Overall Study||121
200651|NCT01305577|486470|P1|Received Treatment|Overall Study||119
200652|NCT01305577|486468|P3|STARTED|Overall Study||122
200653|NCT01305577|486469|P2|STARTED|Overall Study||121
200654|NCT01305577|486470|P1|STARTED|Overall Study||120
200655|NCT01305564|486499|P1|NOT COMPLETED|Overall Study||37
200656|NCT01305564|486499|P1|COMPLETED|Overall Study||163
200657|NCT01305564|486499|P1|STARTED|Overall Study||200
200658|NCT01305473|486514|P1|NOT COMPLETED|Overall Study||0
200659|NCT01305473|486514|P1|COMPLETED|Overall Study||90
200660|NCT01305473|486514|P1|STARTED|Overall Study||90
200661|NCT01305408|486526|P2|NOT COMPLETED|Overall Study||31
200662|NCT01305408|486527|P1|NOT COMPLETED|Overall Study||32
200663|NCT01305408|486526|P2|COMPLETED|Overall Study||169
200664|NCT01305408|486527|P1|COMPLETED|Overall Study||167
200665|NCT01305408|486526|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
200666|NCT01305408|486527|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
200667|NCT01305408|486526|P2|Safety Population|Overall Study|Treated participants.|200
200668|NCT01305408|486527|P1|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|198
200669|NCT01305408|486526|P2|STARTED|Overall Study||200
200670|NCT01305408|486527|P1|STARTED|Overall Study||199
200671|NCT01305356|486579|P2|NOT COMPLETED|Overall Study||0
200672|NCT01305356|486580|P1|NOT COMPLETED|Overall Study||0
200673|NCT01305356|486579|P2|COMPLETED|Overall Study||167
200674|NCT01305356|486580|P1|COMPLETED|Overall Study||132
200675|NCT01305356|486579|P2|STARTED|Overall Study||167
200676|NCT01305356|486580|P1|STARTED|Overall Study||132
200677|NCT01305265|486596|P2|NOT COMPLETED|Overall Study||6
200678|NCT01305265|486597|P1|NOT COMPLETED|Overall Study||2
200679|NCT01305265|486596|P2|COMPLETED|Overall Study||64
200680|NCT01305265|486597|P1|COMPLETED|Overall Study||69
200681|NCT01305265|486596|P2|STARTED|Overall Study||70
200682|NCT01305265|486597|P1|STARTED|Overall Study||71
200683|NCT01305252|486605|P2|NOT COMPLETED|Overall Study||0
200684|NCT01305252|486606|P1|NOT COMPLETED|Overall Study||1
200685|NCT01305252|486605|P2|COMPLETED|Overall Study||11
200686|NCT01305252|486606|P1|COMPLETED|Overall Study||9
200687|NCT01305252|486605|P2|STARTED|Overall Study||11
200688|NCT01305252|486606|P1|STARTED|Overall Study||10
200689|NCT01305239|486620|P1|NOT COMPLETED|Overall Study||23
200690|NCT01305239|486620|P1|COMPLETED|Overall Study||375
200691|NCT01305239|486620|P1|Intent to Treat Population|Overall Study||287
200692|NCT01305239|486620|P1|Safety Set|Overall Study||397
200693|NCT01305239|486620|P1|STARTED|Overall Study||398
200694|NCT01305213|486630|P2|NOT COMPLETED|Overall Study||0
200695|NCT01305213|486631|P1|NOT COMPLETED|Overall Study||0
200696|NCT01305213|486630|P2|COMPLETED|Overall Study||54
200697|NCT01305213|486631|P1|COMPLETED|Overall Study||53
200698|NCT01305213|486630|P2|STARTED|Overall Study||54
200699|NCT01305213|486631|P1|STARTED|Overall Study||53
200700|NCT01305200|486650|P3|NOT COMPLETED|Overall Study||3
200701|NCT01305200|486651|P2|NOT COMPLETED|Overall Study||31
200702|NCT01305200|486652|P1|NOT COMPLETED|Overall Study||29
200703|NCT01305200|486650|P3|COMPLETED|Overall Study||0
200704|NCT01305200|486651|P2|COMPLETED|Overall Study||81
200705|NCT01305200|486652|P1|COMPLETED|Overall Study||82
200706|NCT01305200|486650|P3|STARTED|Overall Study||3
200707|NCT01305200|486651|P2|STARTED|Overall Study||112
200708|NCT01305200|486652|P1|STARTED|Overall Study||111
200709|NCT01305044|486682|P2|NOT COMPLETED|Overall Study||6
200710|NCT01305044|486683|P1|NOT COMPLETED|Overall Study||3
200711|NCT01305044|486682|P2|COMPLETED|Overall Study||25
200712|NCT01305044|486683|P1|COMPLETED|Overall Study||29
200713|NCT01305044|486682|P2|STARTED|Overall Study||31
200714|NCT01305044|486683|P1|STARTED|Overall Study||32
200715|NCT01304966|486707|P1|NOT COMPLETED|Overall Study||0
200716|NCT01304966|486707|P1|COMPLETED|Overall Study||15
200717|NCT01304966|486707|P1|STARTED|Overall Study||15
200718|NCT01304940|486715|P2|NOT COMPLETED|Overall Study||0
200719|NCT01304940|486716|P1|NOT COMPLETED|Overall Study||3
200720|NCT01304940|486715|P2|COMPLETED|Overall Study||25
200721|NCT01304940|486716|P1|COMPLETED|Overall Study|these participants met severity requirement and were included in study analyses|22
200722|NCT01304940|486715|P2|Completed Study|Overall Study|recruitment ended when 25 participants completed study procedures|25
200723|NCT01304940|486716|P1|Completed Study|Overall Study|recruitment ended when 25 participants completed study procedures|25
200724|NCT01304940|486715|P2|STARTED|Overall Study||25
200725|NCT01304940|486716|P1|STARTED|Overall Study||25
200726|NCT01304706|486722|P1|NOT COMPLETED|Overall Study||17
200727|NCT01304706|486722|P1|COMPLETED|Overall Study||104
200728|NCT01304706|486722|P1|STARTED|Overall Study||121
200729|NCT01304693|486731|P5|NOT COMPLETED|Overall Study||1
200730|NCT01304693|486732|P4|NOT COMPLETED|Overall Study||1
200731|NCT01304693|486733|P3|NOT COMPLETED|Overall Study||1
200732|NCT01304693|486734|P2|NOT COMPLETED|Overall Study||0
200733|NCT01304693|486735|P1|NOT COMPLETED|Overall Study||0
200734|NCT01304693|486731|P5|COMPLETED|Overall Study||60
200735|NCT01304693|486732|P4|COMPLETED|Overall Study||39
200736|NCT01304693|486733|P3|COMPLETED|Overall Study||47
200737|NCT01304693|486734|P2|COMPLETED|Overall Study||35
200738|NCT01304693|486735|P1|COMPLETED|Overall Study||10
200739|NCT01304693|486731|P5|STARTED|Overall Study||61
200740|NCT01304693|486732|P4|STARTED|Overall Study||40
200741|NCT01304693|486733|P3|STARTED|Overall Study||48
200742|NCT01304693|486734|P2|STARTED|Overall Study||35
200743|NCT01304693|486735|P1|STARTED|Overall Study||10
200744|NCT01304641|486754|P2|NOT COMPLETED|Overall Study||0
200745|NCT01304641|486755|P1|NOT COMPLETED|Overall Study||0
200746|NCT01304641|486754|P2|COMPLETED|Overall Study||20132
200747|NCT01304641|486755|P1|COMPLETED|Overall Study||11470
200748|NCT01304641|486754|P2|STARTED|Overall Study||20132
200749|NCT01304641|486755|P1|STARTED|Overall Study||11470
200750|NCT01304589|486773|P1|NOT COMPLETED|Overall Study||13
200751|NCT01304589|486773|P1|COMPLETED|Overall Study||18
200752|NCT01304589|486773|P1|STARTED|Overall Study||31
200753|NCT01304498|486782|P2|NOT COMPLETED|Overall Study||5
200754|NCT01304498|486783|P1|NOT COMPLETED|Overall Study||6
200755|NCT01304498|486782|P2|COMPLETED|Overall Study||295
200756|NCT01304498|486783|P1|COMPLETED|Overall Study||294
200757|NCT01304498|486782|P2|Received ≥1 Dose|Overall Study||300
200758|NCT01304498|486783|P1|Received ≥1 Dose|Overall Study||300
200759|NCT01304498|486782|P2|STARTED|Overall Study||300
200760|NCT01304498|486783|P1|STARTED|Overall Study||300
200761|NCT01304329|486803|P6|NOT COMPLETED|Third Intervention (3 Days)||0
200762|NCT01304329|486804|P5|NOT COMPLETED|Third Intervention (3 Days)||0
200763|NCT01304329|486805|P4|NOT COMPLETED|Third Intervention (3 Days)||0
200764|NCT01304329|486806|P3|NOT COMPLETED|Third Intervention (3 Days)||0
200765|NCT01304329|486807|P2|NOT COMPLETED|Third Intervention (3 Days)||1
200766|NCT01304329|486808|P1|NOT COMPLETED|Third Intervention (3 Days)||0
200767|NCT01304329|486803|P6|COMPLETED|Third Intervention (3 Days)||3
200768|NCT01304329|486804|P5|COMPLETED|Third Intervention (3 Days)||3
200769|NCT01304329|486805|P4|COMPLETED|Third Intervention (3 Days)||3
200770|NCT01304329|486806|P3|COMPLETED|Third Intervention (3 Days)||3
200771|NCT01304329|486807|P2|COMPLETED|Third Intervention (3 Days)||2
200772|NCT01304329|486808|P1|COMPLETED|Third Intervention (3 Days)||3
200773|NCT01304329|486803|P6|STARTED|Third Intervention (3 Days)||3
200774|NCT01304329|486804|P5|STARTED|Third Intervention (3 Days)||3
200775|NCT01304329|486805|P4|STARTED|Third Intervention (3 Days)||3
200776|NCT01304329|486806|P3|STARTED|Third Intervention (3 Days)||3
200777|NCT01304329|486807|P2|STARTED|Third Intervention (3 Days)||3
200778|NCT01304329|486808|P1|STARTED|Third Intervention (3 Days)||3
200779|NCT01304329|486803|P6|NOT COMPLETED|Second Intervention (3 Days)||0
200780|NCT01304329|486804|P5|NOT COMPLETED|Second Intervention (3 Days)||0
200781|NCT01304329|486805|P4|NOT COMPLETED|Second Intervention (3 Days)||0
200782|NCT01304329|486806|P3|NOT COMPLETED|Second Intervention (3 Days)||0
200783|NCT01304329|486807|P2|NOT COMPLETED|Second Intervention (3 Days)||0
200784|NCT01304329|486808|P1|NOT COMPLETED|Second Intervention (3 Days)||0
200785|NCT01304329|486803|P6|COMPLETED|Second Intervention (3 Days)||3
200786|NCT01304329|486804|P5|COMPLETED|Second Intervention (3 Days)||3
200787|NCT01304329|486805|P4|COMPLETED|Second Intervention (3 Days)||3
200788|NCT01304329|486806|P3|COMPLETED|Second Intervention (3 Days)||3
200789|NCT01304329|486807|P2|COMPLETED|Second Intervention (3 Days)||3
200790|NCT01304329|486808|P1|COMPLETED|Second Intervention (3 Days)||3
200791|NCT01304329|486803|P6|STARTED|Second Intervention (3 Days)||3
200792|NCT01304329|486804|P5|STARTED|Second Intervention (3 Days)||3
200793|NCT01304329|486805|P4|STARTED|Second Intervention (3 Days)||3
200794|NCT01304329|486806|P3|STARTED|Second Intervention (3 Days)||3
200795|NCT01304329|486807|P2|STARTED|Second Intervention (3 Days)||3
200796|NCT01304329|486808|P1|STARTED|Second Intervention (3 Days)||3
200797|NCT01304329|486803|P6|NOT COMPLETED|First Intervention (3 Days)||0
200798|NCT01304329|486804|P5|NOT COMPLETED|First Intervention (3 Days)||0
200799|NCT01304329|486805|P4|NOT COMPLETED|First Intervention (3 Days)||0
200800|NCT01304329|486806|P3|NOT COMPLETED|First Intervention (3 Days)||0
200801|NCT01304329|486807|P2|NOT COMPLETED|First Intervention (3 Days)||0
200802|NCT01304329|486808|P1|NOT COMPLETED|First Intervention (3 Days)||0
200803|NCT01304329|486803|P6|COMPLETED|First Intervention (3 Days)||3
200804|NCT01304329|486804|P5|COMPLETED|First Intervention (3 Days)||3
200805|NCT01304329|486805|P4|COMPLETED|First Intervention (3 Days)||3
200806|NCT01304329|486806|P3|COMPLETED|First Intervention (3 Days)||3
200807|NCT01304329|486807|P2|COMPLETED|First Intervention (3 Days)||3
200808|NCT01304329|486808|P1|COMPLETED|First Intervention (3 Days)||3
200809|NCT01304329|486803|P6|STARTED|First Intervention (3 Days)||3
200810|NCT01304329|486804|P5|STARTED|First Intervention (3 Days)||3
200811|NCT01304329|486805|P4|STARTED|First Intervention (3 Days)||3
200812|NCT01304329|486806|P3|STARTED|First Intervention (3 Days)||3
200813|NCT01304329|486807|P2|STARTED|First Intervention (3 Days)||3
200814|NCT01304329|486808|P1|STARTED|First Intervention (3 Days)||3
200815|NCT01304316|486825|P1|NOT COMPLETED|Overall Study||0
200816|NCT01304316|486825|P1|COMPLETED|Overall Study||12
200817|NCT01304316|486825|P1|STARTED|Overall Study||12
200818|NCT01304277|486839|P1|NOT COMPLETED|Treatment (Replagal AF, Week 2- EOS)||0
200819|NCT01304277|486839|P1|COMPLETED|Treatment (Replagal AF, Week 2- EOS)||17
200820|NCT01304277|486839|P1|STARTED|Treatment (Replagal AF, Week 2- EOS)||17
200821|NCT01304277|486839|P1|NOT COMPLETED|Screening (Replagal RB, Week 0- Week 2)||0
200822|NCT01304277|486839|P1|COMPLETED|Screening (Replagal RB, Week 0- Week 2)||17
200823|NCT01304277|486839|P1|STARTED|Screening (Replagal RB, Week 0- Week 2)||17
200824|NCT01304238|486861|P10|NOT COMPLETED|Overall Study||0
200825|NCT01304238|486862|P9|NOT COMPLETED|Overall Study||0
200826|NCT01304238|486863|P8|NOT COMPLETED|Overall Study||0
200827|NCT01304238|486864|P7|NOT COMPLETED|Overall Study||0
200828|NCT01304238|486865|P6|NOT COMPLETED|Overall Study||0
200829|NCT01304238|486866|P5|NOT COMPLETED|Overall Study||0
200830|NCT01304238|486867|P4|NOT COMPLETED|Overall Study||0
200831|NCT01304238|486868|P3|NOT COMPLETED|Overall Study||0
200832|NCT01304238|486869|P2|NOT COMPLETED|Overall Study||0
200833|NCT01304238|486870|P1|NOT COMPLETED|Overall Study||0
200834|NCT01304238|486861|P10|COMPLETED|Overall Study||3
200835|NCT01304238|486862|P9|COMPLETED|Overall Study||1
200836|NCT01304238|486863|P8|COMPLETED|Overall Study||4
200837|NCT01304238|486864|P7|COMPLETED|Overall Study||5
200838|NCT01304238|486865|P6|COMPLETED|Overall Study||11
200839|NCT01304238|486866|P5|COMPLETED|Overall Study||11
200840|NCT01304238|486867|P4|COMPLETED|Overall Study||78
200841|NCT01304238|486868|P3|COMPLETED|Overall Study||46
200842|NCT01304238|486869|P2|COMPLETED|Overall Study||4
200843|NCT01304238|486870|P1|COMPLETED|Overall Study||32
200844|NCT01304238|486861|P10|STARTED|Overall Study||3
200845|NCT01304238|486862|P9|STARTED|Overall Study||1
200846|NCT01304238|486863|P8|STARTED|Overall Study||4
200847|NCT01304238|486864|P7|STARTED|Overall Study||5
200848|NCT01304238|486865|P6|STARTED|Overall Study||11
200849|NCT01304238|486866|P5|STARTED|Overall Study||11
200850|NCT01304238|486867|P4|STARTED|Overall Study||78
200851|NCT01304238|486868|P3|STARTED|Overall Study||46
200852|NCT01304238|486869|P2|STARTED|Overall Study||4
200853|NCT01304238|486870|P1|STARTED|Overall Study||32
200854|NCT01304147|486942|P2|NOT COMPLETED|Second Intervention (7days)||1
200855|NCT01304147|486943|P1|NOT COMPLETED|Second Intervention (7days)||1
200856|NCT01304147|486942|P2|COMPLETED|Second Intervention (7days)||9
200857|NCT01304147|486943|P1|COMPLETED|Second Intervention (7days)||9
200858|NCT01304147|486942|P2|STARTED|Second Intervention (7days)||10
200859|NCT01304147|486943|P1|STARTED|Second Intervention (7days)||10
200860|NCT01304147|486942|P2|NOT COMPLETED|Washout (1 Day)||0
200861|NCT01304147|486943|P1|NOT COMPLETED|Washout (1 Day)||0
200862|NCT01304147|486942|P2|COMPLETED|Washout (1 Day)||10
200863|NCT01304147|486943|P1|COMPLETED|Washout (1 Day)||10
200864|NCT01304147|486942|P2|STARTED|Washout (1 Day)||10
200865|NCT01304147|486943|P1|STARTED|Washout (1 Day)||10
200866|NCT01304147|486942|P2|NOT COMPLETED|First Intervention (7days)||0
200867|NCT01304147|486943|P1|NOT COMPLETED|First Intervention (7days)||0
200868|NCT01304147|486942|P2|COMPLETED|First Intervention (7days)||10
200869|NCT01304147|486943|P1|COMPLETED|First Intervention (7days)||10
200870|NCT01304147|486942|P2|STARTED|First Intervention (7days)||10
200871|NCT01304147|486943|P1|STARTED|First Intervention (7days)||10
200872|NCT01304082|486951|P5|NOT COMPLETED|Overall Study||0
200873|NCT01304082|486952|P4|NOT COMPLETED|Overall Study||0
200874|NCT01304082|486953|P3|NOT COMPLETED|Overall Study||0
200875|NCT01304082|486954|P2|NOT COMPLETED|Overall Study||0
200876|NCT01304082|486955|P1|NOT COMPLETED|Overall Study||0
200877|NCT01304082|486951|P5|COMPLETED|Overall Study||5
200878|NCT01304082|486952|P4|COMPLETED|Overall Study||8
200879|NCT01304082|486953|P3|COMPLETED|Overall Study||11
200880|NCT01304082|486954|P2|COMPLETED|Overall Study||2
200881|NCT01304082|486955|P1|COMPLETED|Overall Study||3
200882|NCT01304082|486951|P5|Third Intervention|Overall Study||5
200883|NCT01304082|486952|P4|Third Intervention|Overall Study||8
200884|NCT01304082|486953|P3|Third Intervention|Overall Study||11
200885|NCT01304082|486954|P2|Third Intervention|Overall Study||2
200886|NCT01304082|486955|P1|Third Intervention|Overall Study||3
200887|NCT01304082|486951|P5|Second Intervention|Overall Study||5
200888|NCT01304082|486952|P4|Second Intervention|Overall Study||8
200889|NCT01304082|486953|P3|Second Intervention|Overall Study||11
200890|NCT01304082|486954|P2|Second Intervention|Overall Study||2
200891|NCT01304082|486955|P1|Second Intervention|Overall Study||3
200892|NCT01304082|486951|P5|First Intervention|Overall Study||5
200893|NCT01304082|486952|P4|First Intervention|Overall Study||8
200894|NCT01304082|486953|P3|First Intervention|Overall Study||11
200895|NCT01304082|486954|P2|First Intervention|Overall Study||2
200896|NCT01304082|486955|P1|First Intervention|Overall Study||3
200897|NCT01304082|486951|P5|STARTED|Overall Study||5
200898|NCT01304082|486952|P4|STARTED|Overall Study||8
200899|NCT01304082|486953|P3|STARTED|Overall Study||11
200900|NCT01304082|486954|P2|STARTED|Overall Study||2
200901|NCT01304082|486955|P1|STARTED|Overall Study||3
200902|NCT01303965|486974|P2|NOT COMPLETED|Overall Study||10
200903|NCT01303965|486975|P1|NOT COMPLETED|Overall Study||3
200904|NCT01303965|486974|P2|COMPLETED|Overall Study||1
200905|NCT01303965|486975|P1|COMPLETED|Overall Study||0
200906|NCT01303965|486974|P2|STARTED|Overall Study||11
200907|NCT01303965|486975|P1|STARTED|Overall Study||3
200908|NCT01303939|486989|P2|NOT COMPLETED|Overall Study||0
200909|NCT01303939|486990|P1|NOT COMPLETED|Overall Study||7
200910|NCT01303939|486989|P2|COMPLETED|Overall Study||15
200911|NCT01303939|486990|P1|COMPLETED|Overall Study|Matched controls not found for comparisons. Only best matched glaucoma patients were included.|15
200912|NCT01303939|486989|P2|STARTED|Overall Study||15
200913|NCT01303939|486990|P1|STARTED|Overall Study||22
200914|NCT01303861|487003|P4|NOT COMPLETED|Overall Study||59
200915|NCT01303861|487004|P3|NOT COMPLETED|Overall Study||36
200916|NCT01303861|487005|P2|NOT COMPLETED|Overall Study||25
200917|NCT01303861|487006|P1|NOT COMPLETED|Overall Study||58
200918|NCT01303861|487003|P4|COMPLETED|Overall Study||54
200919|NCT01303861|487004|P3|COMPLETED|Overall Study||19
200920|NCT01303861|487005|P2|COMPLETED|Overall Study||25
200921|NCT01303861|487006|P1|COMPLETED|Overall Study||51
200922|NCT01303861|487003|P4|Finished Treatment Phase|Overall Study||72
200923|NCT01303861|487004|P3|Finished Treatment Phase|Overall Study||39
200924|NCT01303861|487005|P2|Finished Treatment Phase|Overall Study||34
200925|NCT01303861|487006|P1|Finished Treatment Phase|Overall Study||71
200926|NCT01303861|487003|P4|STARTED|Overall Study||113
200927|NCT01303861|487004|P3|STARTED|Overall Study||55
200928|NCT01303861|487005|P2|STARTED|Overall Study||50
200929|NCT01303861|487006|P1|STARTED|Overall Study||109
200930|NCT01303835|487027|P2|NOT COMPLETED|Overall Study||25
200931|NCT01303835|487028|P1|NOT COMPLETED|Overall Study||19
200932|NCT01303835|487027|P2|COMPLETED|Overall Study||31
200933|NCT01303835|487028|P1|COMPLETED|Overall Study||35
200934|NCT01303835|487027|P2|STARTED|Overall Study||56
200935|NCT01303835|487028|P1|STARTED|Overall Study||54
200936|NCT01303744|487042|P4|NOT COMPLETED|Overall Study||0
200937|NCT01303744|487043|P3|NOT COMPLETED|Overall Study||0
200938|NCT01303744|487044|P2|NOT COMPLETED|Overall Study||0
200939|NCT01303744|487045|P1|NOT COMPLETED|Overall Study||0
200940|NCT01303744|487042|P4|COMPLETED|Overall Study||24
200941|NCT01303744|487043|P3|COMPLETED|Overall Study||24
200942|NCT01303744|487044|P2|COMPLETED|Overall Study||24
200943|NCT01303744|487045|P1|COMPLETED|Overall Study||24
200944|NCT01303744|487042|P4|STARTED|Overall Study||24
200945|NCT01303744|487043|P3|STARTED|Overall Study||24
200946|NCT01303744|487044|P2|STARTED|Overall Study||24
200947|NCT01303744|487045|P1|STARTED|Overall Study||24
200948|NCT01303627|487065|P2|NOT COMPLETED|Overall Study||1
200949|NCT01303627|487066|P1|NOT COMPLETED|Overall Study||0
200950|NCT01303627|487065|P2|COMPLETED|Overall Study|One patient excluded from the study because of the failure while performing uretero-renoscopy|20
200951|NCT01303627|487066|P1|COMPLETED|Overall Study||21
200952|NCT01303627|487065|P2|STARTED|Overall Study||21
200953|NCT01303627|487066|P1|STARTED|Overall Study||21
200954|NCT01303510|487074|P2|NOT COMPLETED|Overall Study||0
200955|NCT01303510|487075|P1|NOT COMPLETED|Overall Study||1
200956|NCT01303510|487074|P2|COMPLETED|Overall Study||56
200957|NCT01303510|487075|P1|COMPLETED|Overall Study||54
200958|NCT01303510|487074|P2|STARTED|Overall Study||56
200959|NCT01303510|487075|P1|STARTED|Overall Study||55
200960|NCT01303445|487089|P2|NOT COMPLETED|Follow-up Period (14 Days)||1
200961|NCT01303445|487090|P1|NOT COMPLETED|Follow-up Period (14 Days)||0
200962|NCT01303445|487089|P2|COMPLETED|Follow-up Period (14 Days)||25
200963|NCT01303445|487090|P1|COMPLETED|Follow-up Period (14 Days)||26
200964|NCT01303445|487089|P2|STARTED|Follow-up Period (14 Days)||26
200965|NCT01303445|487090|P1|STARTED|Follow-up Period (14 Days)||26
200966|NCT01303445|487089|P2|NOT COMPLETED|Fourth Intervention (7 Days)||0
200967|NCT01303445|487090|P1|NOT COMPLETED|Fourth Intervention (7 Days)||1
200968|NCT01303445|487089|P2|COMPLETED|Fourth Intervention (7 Days)||26
200969|NCT01303445|487090|P1|COMPLETED|Fourth Intervention (7 Days)||26
200970|NCT01303445|487089|P2|STARTED|Fourth Intervention (7 Days)||26
200971|NCT01303445|487090|P1|STARTED|Fourth Intervention (7 Days)||27
200972|NCT01303445|487089|P2|NOT COMPLETED|Third Intervention (7 Days)||0
200973|NCT01303445|487090|P1|NOT COMPLETED|Third Intervention (7 Days)||0
200974|NCT01303445|487089|P2|COMPLETED|Third Intervention (7 Days)||26
200975|NCT01303445|487090|P1|COMPLETED|Third Intervention (7 Days)||27
200976|NCT01303445|487089|P2|STARTED|Third Intervention (7 Days)||26
200977|NCT01303445|487090|P1|STARTED|Third Intervention (7 Days)||27
200978|NCT01303445|487089|P2|NOT COMPLETED|Washout (14 Days)||2
200979|NCT01303445|487090|P1|NOT COMPLETED|Washout (14 Days)||1
200980|NCT01303445|487089|P2|COMPLETED|Washout (14 Days)||26
200981|NCT01303445|487090|P1|COMPLETED|Washout (14 Days)||27
200982|NCT01303445|487089|P2|STARTED|Washout (14 Days)||28
200983|NCT01303445|487090|P1|STARTED|Washout (14 Days)||28
200984|NCT01303445|487089|P2|NOT COMPLETED|Second Intervention (7 Days)||2
200985|NCT01303445|487090|P1|NOT COMPLETED|Second Intervention (7 Days)||1
200986|NCT01303445|487089|P2|COMPLETED|Second Intervention (7 Days)||28
200987|NCT01303445|487090|P1|COMPLETED|Second Intervention (7 Days)||28
200988|NCT01303445|487089|P2|STARTED|Second Intervention (7 Days)||30
200989|NCT01303445|487090|P1|STARTED|Second Intervention (7 Days)||29
200990|NCT01303445|487089|P2|NOT COMPLETED|First Intervention (7 Days)||0
200991|NCT01303445|487090|P1|NOT COMPLETED|First Intervention (7 Days)||1
200992|NCT01303445|487089|P2|COMPLETED|First Intervention (7 Days)||30
200993|NCT01303445|487090|P1|COMPLETED|First Intervention (7 Days)||29
200994|NCT01303445|487089|P2|STARTED|First Intervention (7 Days)||30
200995|NCT01303445|487090|P1|STARTED|First Intervention (7 Days)||30
200996|NCT01303419|487120|P1|NOT COMPLETED|Overall Study||96
200997|NCT01303419|487120|P1|COMPLETED|Overall Study||128
200998|NCT01303419|487120|P1|STARTED|Overall Study|Subjects who met all Inclusion and none of the Exclusion criteria|224
200999|NCT01303406|487130|P2|NOT COMPLETED|Overall Study||1
201000|NCT01303406|487131|P1|NOT COMPLETED|Overall Study||0
201001|NCT01303406|487130|P2|COMPLETED|Overall Study||15
201002|NCT01303406|487131|P1|COMPLETED|Overall Study||13
201003|NCT01303406|487130|P2|STARTED|Overall Study||16
201004|NCT01303406|487131|P1|STARTED|Overall Study||13
201005|NCT01303380|487139|P1|NOT COMPLETED|Overall Study||1
201006|NCT01303380|487139|P1|COMPLETED|Overall Study||8
201007|NCT01303380|487139|P1|STARTED|Overall Study||9
201008|NCT01303224|487169|P4|NOT COMPLETED|Overall Study||10
201009|NCT01303224|487170|P3|NOT COMPLETED|Overall Study||6
201010|NCT01303224|487171|P2|NOT COMPLETED|Overall Study||11
201011|NCT01303224|487172|P1|NOT COMPLETED|Overall Study||11
201012|NCT01303224|487169|P4|COMPLETED|Overall Study||133
201013|NCT01303224|487170|P3|COMPLETED|Overall Study||133
201014|NCT01303224|487171|P2|COMPLETED|Overall Study||131
201015|NCT01303224|487172|P1|COMPLETED|Overall Study||130
201016|NCT01303224|487169|P4|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|142
201017|NCT01303224|487170|P3|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|139
201018|NCT01303224|487171|P2|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|138
201019|NCT01303224|487172|P1|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|140
201020|NCT01303224|487169|P4|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|143
201021|NCT01303224|487170|P3|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|139
201022|NCT01303224|487171|P2|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|142
201023|NCT01303224|487172|P1|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|141
201024|NCT01303159|487198|P1|NOT COMPLETED|Overall Study||23
201025|NCT01303159|487198|P1|COMPLETED|Overall Study||6
201026|NCT01303159|487198|P1|STARTED|Overall Study||29
201027|NCT01303003|487205|P2|NOT COMPLETED|Overall Study||0
201028|NCT01303003|487206|P1|NOT COMPLETED|Overall Study||0
201029|NCT01303003|487205|P2|COMPLETED|Overall Study||0
201030|NCT01303003|487206|P1|COMPLETED|Overall Study||0
201031|NCT01303003|487205|P2|STARTED|Overall Study||0
201032|NCT01303003|487206|P1|STARTED|Overall Study||0
201033|NCT01302964|487216|P2|NOT COMPLETED|Overall Study||0
201034|NCT01302964|487217|P1|NOT COMPLETED|Overall Study||1
201035|NCT01302964|487216|P2|COMPLETED|Overall Study||10
201036|NCT01302964|487217|P1|COMPLETED|Overall Study||19
201037|NCT01302964|487216|P2|STARTED|Overall Study||10
201038|NCT01302964|487217|P1|STARTED|Overall Study||20
201039|NCT01302938|487227|P2|NOT COMPLETED|Overall Study||0
201040|NCT01302938|487228|P1|NOT COMPLETED|Overall Study||2
201041|NCT01302938|487227|P2|COMPLETED|Overall Study||6
201042|NCT01302938|487228|P1|COMPLETED|Overall Study||10
201043|NCT01302938|487227|P2|STARTED|Overall Study||6
201044|NCT01302938|487228|P1|STARTED|Overall Study||12
201045|NCT01302899|487273|P2|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
201046|NCT01302899|487274|P1|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
201047|NCT01302899|487273|P2|COMPLETED|Period 4 (Weeks 19 to 26)||3
201048|NCT01302899|487274|P1|COMPLETED|Period 4 (Weeks 19 to 26)||3
201049|NCT01302899|487273|P2|STARTED|Period 4 (Weeks 19 to 26)||3
201050|NCT01302899|487274|P1|STARTED|Period 4 (Weeks 19 to 26)||3
201051|NCT01302899|487273|P2|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
201052|NCT01302899|487274|P1|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
201053|NCT01302899|487273|P2|COMPLETED|Period 3 (Weeks 13 to 18)||3
201054|NCT01302899|487274|P1|COMPLETED|Period 3 (Weeks 13 to 18)||3
201055|NCT01302899|487273|P2|STARTED|Period 3 (Weeks 13 to 18)||3
201056|NCT01302899|487274|P1|STARTED|Period 3 (Weeks 13 to 18)||3
201057|NCT01302899|487273|P2|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
201058|NCT01302899|487274|P1|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
201059|NCT01302899|487273|P2|COMPLETED|Period 2 (Weeks 7 to 12)||3
201060|NCT01302899|487274|P1|COMPLETED|Period 2 (Weeks 7 to 12)||3
201061|NCT01302899|487273|P2|STARTED|Period 2 (Weeks 7 to 12)||4
201062|NCT01302899|487274|P1|STARTED|Period 2 (Weeks 7 to 12)||4
201063|NCT01302899|487273|P2|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
201064|NCT01302899|487274|P1|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
201065|NCT01302899|487273|P2|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
201066|NCT01302899|487274|P1|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
201067|NCT01302899|487273|P2|STARTED|Period 1 (Day 1 to End of Week 6)||4
201068|NCT01302899|487274|P1|STARTED|Period 1 (Day 1 to End of Week 6)||4
201069|NCT01302860|487324|P1|NOT COMPLETED|Overall Study||0
201070|NCT01302860|487324|P1|COMPLETED|Overall Study||17
201071|NCT01302860|487324|P1|STARTED|Overall Study||17
201072|NCT01302743|487339|P3|NOT COMPLETED|Overall Study||2
201073|NCT01302743|487340|P2|NOT COMPLETED|Overall Study||1
201074|NCT01302743|487341|P1|NOT COMPLETED|Overall Study||1
201075|NCT01302743|487339|P3|COMPLETED|Overall Study||8
201076|NCT01302743|487340|P2|COMPLETED|Overall Study||7
201077|NCT01302743|487341|P1|COMPLETED|Overall Study||6
201078|NCT01302743|487339|P3|STARTED|Overall Study||10
201079|NCT01302743|487340|P2|STARTED|Overall Study||8
201080|NCT01302743|487341|P1|STARTED|Overall Study||7
201081|NCT01302691|487354|P2|NOT COMPLETED|Overall Study||6
201082|NCT01302691|487355|P1|NOT COMPLETED|Overall Study||10
201083|NCT01302691|487354|P2|COMPLETED|Overall Study||157
201084|NCT01302691|487355|P1|COMPLETED|Overall Study||154
201085|NCT01302691|487354|P2|STARTED|Overall Study||163
201086|NCT01302691|487355|P1|STARTED|Overall Study||164
201087|NCT01302548|487375|P2|NOT COMPLETED|Overall Study||1
201088|NCT01302548|487376|P1|NOT COMPLETED|Overall Study||2
201089|NCT01302548|487375|P2|COMPLETED|Overall Study||18
201090|NCT01302548|487376|P1|COMPLETED|Overall Study||12
201091|NCT01302548|487375|P2|STARTED|Overall Study||19
201092|NCT01302548|487376|P1|STARTED|Overall Study||14
201093|NCT01302483|487388|P2|NOT COMPLETED|Overall Study||0
201094|NCT01302483|487389|P1|NOT COMPLETED|Overall Study||0
201095|NCT01302483|487388|P2|COMPLETED|Overall Study||15
201096|NCT01302483|487389|P1|COMPLETED|Overall Study||30
201097|NCT01302483|487388|P2|STARTED|Overall Study||15
201098|NCT01302483|487389|P1|STARTED|Overall Study||30
201099|NCT01302444|487405|P2|NOT COMPLETED|Overall Study||0
201100|NCT01302444|487406|P1|NOT COMPLETED|Overall Study||0
201101|NCT01302444|487405|P2|COMPLETED|Overall Study||0
201102|NCT01302444|487406|P1|COMPLETED|Overall Study||1
201103|NCT01302444|487405|P2|STARTED|Overall Study||0
201104|NCT01302444|487406|P1|STARTED|Overall Study||1
201105|NCT01302418|487426|P1|NOT COMPLETED|Overall Study||18
201106|NCT01302418|487426|P1|COMPLETED|Overall Study||254
201107|NCT01302418|487426|P1|STARTED|Overall Study||272
201108|NCT01302392|487432|P2|NOT COMPLETED|Overall Study||1
201109|NCT01302392|487433|P1|NOT COMPLETED|Overall Study||7
201110|NCT01302392|487432|P2|COMPLETED|Overall Study||156
201111|NCT01302392|487433|P1|COMPLETED|Overall Study||151
201112|NCT01302392|487432|P2|Treated|Overall Study||157
201113|NCT01302392|487433|P1|Treated|Overall Study||153
201114|NCT01302392|487432|P2|STARTED|Overall Study||157
201115|NCT01302392|487433|P1|STARTED|Overall Study||158
201116|NCT01302366|487453|P1|NOT COMPLETED|Overall Study||5
201117|NCT01302366|487453|P1|COMPLETED|Overall Study||15
201118|NCT01302366|487453|P1|STARTED|Overall Study||20
201119|NCT01302119|487461|P2|NOT COMPLETED|Overall Study||28
201120|NCT01302119|487462|P1|NOT COMPLETED|Overall Study||50
201121|NCT01302119|487461|P2|COMPLETED|Overall Study||177
201122|NCT01302119|487462|P1|COMPLETED|Overall Study||349
201123|NCT01302119|487461|P2|STARTED|Overall Study||205
201124|NCT01302119|487462|P1|STARTED|Overall Study||399
201125|NCT01302067|487477|P3|NOT COMPLETED|Overall Study||98
201126|NCT01302067|487478|P2|NOT COMPLETED|Overall Study||34
201127|NCT01302067|487479|P1|NOT COMPLETED|Overall Study||78
201128|NCT01302067|487477|P3|COMPLETED|Overall Study||681
201129|NCT01302067|487478|P2|COMPLETED|Overall Study||352
201130|NCT01302067|487479|P1|COMPLETED|Overall Study||712
201131|NCT01302067|487477|P3|STARTED|Overall Study||779
201132|NCT01302067|487478|P2|STARTED|Overall Study||386
201133|NCT01302067|487479|P1|STARTED|Overall Study||790
201134|NCT01302054|487550|P3|NOT COMPLETED|Double-Blind Treatment Phase||46
201135|NCT01302054|487551|P2|NOT COMPLETED|Double-Blind Treatment Phase||27
201136|NCT01302054|487552|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
201137|NCT01302054|487550|P3|COMPLETED|Double-Blind Treatment Phase||255
201138|NCT01302054|487551|P2|COMPLETED|Double-Blind Treatment Phase||281
201139|NCT01302054|487552|P1|COMPLETED|Double-Blind Treatment Phase||0
201140|NCT01302054|487550|P3|STARTED|Double-Blind Treatment Phase||301
201141|NCT01302054|487551|P2|STARTED|Double-Blind Treatment Phase||308
201142|NCT01302054|487552|P1|STARTED|Double-Blind Treatment Phase||0
201143|NCT01302054|487550|P3|NOT COMPLETED|Between Open-Label and Double Blind||0
201144|NCT01302054|487551|P2|NOT COMPLETED|Between Open-Label and Double Blind||0
201145|NCT01302054|487552|P1|NOT COMPLETED|Between Open-Label and Double Blind||2
201146|NCT01302054|487550|P3|COMPLETED|Between Open-Label and Double Blind||0
201147|NCT01302054|487551|P2|COMPLETED|Between Open-Label and Double Blind||0
201148|NCT01302054|487552|P1|COMPLETED|Between Open-Label and Double Blind||609
201149|NCT01302054|487550|P3|STARTED|Between Open-Label and Double Blind||0
201150|NCT01302054|487551|P2|STARTED|Between Open-Label and Double Blind||0
201151|NCT01302054|487552|P1|STARTED|Between Open-Label and Double Blind||611
201152|NCT01302054|487550|P3|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
201153|NCT01302054|487551|P2|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
201154|NCT01302054|487552|P1|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||379
201155|NCT01302054|487550|P3|COMPLETED|Tolterodine Open-Label Run-In Phase||0
201156|NCT01302054|487551|P2|COMPLETED|Tolterodine Open-Label Run-In Phase||0
201157|NCT01302054|487552|P1|COMPLETED|Tolterodine Open-Label Run-In Phase||611
201158|NCT01302054|487550|P3|STARTED|Tolterodine Open-Label Run-In Phase||0
201159|NCT01302054|487551|P2|STARTED|Tolterodine Open-Label Run-In Phase||0
201160|NCT01302054|487552|P1|STARTED|Tolterodine Open-Label Run-In Phase||990
201161|NCT01302041|487579|P1|NOT COMPLETED|Overall Study||40
201162|NCT01302041|487579|P1|COMPLETED|Overall Study|Participants who discontinued treatment and completed the 30-day follow-up visit|27
201163|NCT01302041|487579|P1|Treatment Received|Overall Study||67
201164|NCT01302041|487579|P1|STARTED|Overall Study||67
201165|NCT01301963|487610|P2|NOT COMPLETED|Overall Study||0
201166|NCT01301963|487611|P1|NOT COMPLETED|Overall Study||0
201167|NCT01301963|487610|P2|COMPLETED|Overall Study||4
201168|NCT01301963|487611|P1|COMPLETED|Overall Study||5
201169|NCT01301963|487610|P2|STARTED|Overall Study||4
201170|NCT01301963|487611|P1|STARTED|Overall Study||5
201171|NCT01301950|487621|P2|NOT COMPLETED|Overall Study||1
201172|NCT01301950|487622|P1|NOT COMPLETED|Overall Study||0
201173|NCT01301950|487621|P2|COMPLETED|Overall Study||14
201174|NCT01301950|487622|P1|COMPLETED|Overall Study||15
201175|NCT01301950|487621|P2|STARTED|Overall Study||15
201176|NCT01301950|487622|P1|STARTED|Overall Study||15
201177|NCT01301833|487640|P4|NOT COMPLETED|Overall Study||7
201178|NCT01301833|487641|P3|NOT COMPLETED|Overall Study||7
201179|NCT01301833|487642|P2|NOT COMPLETED|Overall Study||8
201180|NCT01301833|487643|P1|NOT COMPLETED|Overall Study||15
201181|NCT01301833|487640|P4|COMPLETED|Overall Study||68
201182|NCT01301833|487641|P3|COMPLETED|Overall Study||88
201183|NCT01301833|487642|P2|COMPLETED|Overall Study||72
201184|NCT01301833|487643|P1|COMPLETED|Overall Study||197
201185|NCT01301833|487640|P4|STARTED|Overall Study||75
201186|NCT01301833|487641|P3|STARTED|Overall Study||95
201187|NCT01301833|487642|P2|STARTED|Overall Study||80
201188|NCT01301833|487643|P1|STARTED|Overall Study||212
201189|NCT01301742|487669|P2|NOT COMPLETED|Second Intervention||0
201190|NCT01301742|487670|P1|NOT COMPLETED|Second Intervention||0
201191|NCT01301742|487669|P2|COMPLETED|Second Intervention||9
201192|NCT01301742|487670|P1|COMPLETED|Second Intervention||9
201193|NCT01301742|487669|P2|STARTED|Second Intervention||9
201194|NCT01301742|487670|P1|STARTED|Second Intervention||9
201195|NCT01301742|487669|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
201196|NCT01301742|487670|P1|NOT COMPLETED|Washout Period of at Least 7 Days||0
201197|NCT01301742|487669|P2|COMPLETED|Washout Period of at Least 7 Days||9
201198|NCT01301742|487670|P1|COMPLETED|Washout Period of at Least 7 Days||9
201199|NCT01301742|487669|P2|STARTED|Washout Period of at Least 7 Days||9
201200|NCT01301742|487670|P1|STARTED|Washout Period of at Least 7 Days||9
201201|NCT01301742|487669|P2|NOT COMPLETED|First Intervention||0
201202|NCT01301742|487670|P1|NOT COMPLETED|First Intervention||0
201203|NCT01301742|487669|P2|COMPLETED|First Intervention||9
201204|NCT01301742|487670|P1|COMPLETED|First Intervention||9
201205|NCT01301742|487669|P2|STARTED|First Intervention||9
201206|NCT01301742|487670|P1|STARTED|First Intervention||9
201207|NCT01301729|487681|P1|NOT COMPLETED|Overall Study||4
201208|NCT01301729|487681|P1|COMPLETED|Overall Study||28
201209|NCT01301729|487681|P1|STARTED|Overall Study||32
201210|NCT01301625|487692|P1|NOT COMPLETED|Overall Study||35
201211|NCT01301625|487692|P1|COMPLETED|Overall Study||43
201212|NCT01301625|487692|P1|STARTED|Overall Study||78
201213|NCT01301508|487764|P2|NOT COMPLETED|Overall Study||3
201214|NCT01301508|487765|P1|NOT COMPLETED|Overall Study||1
201215|NCT01301508|487764|P2|COMPLETED|Overall Study||22
201216|NCT01301508|487765|P1|COMPLETED|Overall Study||20
201217|NCT01301508|487764|P2|STARTED|Overall Study||25
201218|NCT01301508|487765|P1|STARTED|Overall Study||21
201219|NCT01301456|487795|P12|NOT COMPLETED|Stage 2||0
201220|NCT01301456|487796|P11|NOT COMPLETED|Stage 2||1
201221|NCT01301456|487797|P10|NOT COMPLETED|Stage 2||0
201222|NCT01301456|487798|P9|NOT COMPLETED|Stage 2||0
201223|NCT01301456|487799|P8|NOT COMPLETED|Stage 2||0
201224|NCT01301456|487800|P7|NOT COMPLETED|Stage 2||0
201225|NCT01301456|487801|P6|NOT COMPLETED|Stage 2||0
201226|NCT01301456|487802|P5|NOT COMPLETED|Stage 2||0
201227|NCT01301456|487803|P4|NOT COMPLETED|Stage 2||0
201228|NCT01301456|487804|P3|NOT COMPLETED|Stage 2||0
201229|NCT01301456|487805|P2|NOT COMPLETED|Stage 2||0
201230|NCT01301456|487806|P1|NOT COMPLETED|Stage 2||0
201231|NCT01301456|487795|P12|COMPLETED|Stage 2||6
201232|NCT01301456|487796|P11|COMPLETED|Stage 2||6
201233|NCT01301456|487797|P10|COMPLETED|Stage 2||7
201234|NCT01301456|487798|P9|COMPLETED|Stage 2||5
201235|NCT01301456|487799|P8|COMPLETED|Stage 2||7
201236|NCT01301456|487800|P7|COMPLETED|Stage 2||0
201237|NCT01301456|487801|P6|COMPLETED|Stage 2||0
201238|NCT01301456|487802|P5|COMPLETED|Stage 2||0
201239|NCT01301456|487803|P4|COMPLETED|Stage 2||0
201240|NCT01301456|487804|P3|COMPLETED|Stage 2||0
201241|NCT01301456|487805|P2|COMPLETED|Stage 2||0
201242|NCT01301456|487806|P1|COMPLETED|Stage 2||0
201243|NCT01301456|487795|P12|Received Treatment|Stage 2||6
201244|NCT01301456|487796|P11|Received Treatment|Stage 2||7
201245|NCT01301456|487797|P10|Received Treatment|Stage 2||7
201246|NCT01301456|487798|P9|Received Treatment|Stage 2||5
201247|NCT01301456|487799|P8|Received Treatment|Stage 2||7
201248|NCT01301456|487800|P7|Received Treatment|Stage 2||0
201249|NCT01301456|487801|P6|Received Treatment|Stage 2||0
201250|NCT01301456|487802|P5|Received Treatment|Stage 2||0
201251|NCT01301456|487803|P4|Received Treatment|Stage 2||0
201252|NCT01301456|487804|P3|Received Treatment|Stage 2||0
201253|NCT01301456|487805|P2|Received Treatment|Stage 2||0
201254|NCT01301456|487806|P1|Received Treatment|Stage 2||0
201255|NCT01301456|487795|P12|STARTED|Stage 2||6
201256|NCT01301456|487796|P11|STARTED|Stage 2||7
201257|NCT01301456|487797|P10|STARTED|Stage 2||7
201258|NCT01301456|487798|P9|STARTED|Stage 2||5
201259|NCT01301456|487799|P8|STARTED|Stage 2||7
201260|NCT01301456|487800|P7|STARTED|Stage 2||0
201261|NCT01301456|487801|P6|STARTED|Stage 2||0
201262|NCT01301456|487802|P5|STARTED|Stage 2||0
201263|NCT01301456|487803|P4|STARTED|Stage 2||0
201264|NCT01301456|487804|P3|STARTED|Stage 2||0
201265|NCT01301456|487805|P2|STARTED|Stage 2||0
201266|NCT01301456|487806|P1|STARTED|Stage 2||0
201267|NCT01301456|487795|P12|NOT COMPLETED|Stage 1||0
201268|NCT01301456|487796|P11|NOT COMPLETED|Stage 1||0
201269|NCT01301456|487797|P10|NOT COMPLETED|Stage 1||0
201270|NCT01301456|487798|P9|NOT COMPLETED|Stage 1||0
201271|NCT01301456|487799|P8|NOT COMPLETED|Stage 1||0
201272|NCT01301456|487800|P7|NOT COMPLETED|Stage 1||1
201273|NCT01301456|487801|P6|NOT COMPLETED|Stage 1||0
201274|NCT01301456|487802|P5|NOT COMPLETED|Stage 1||1
201275|NCT01301456|487803|P4|NOT COMPLETED|Stage 1||0
201276|NCT01301456|487804|P3|NOT COMPLETED|Stage 1||1
201277|NCT01301456|487805|P2|NOT COMPLETED|Stage 1||0
201278|NCT01301456|487806|P1|NOT COMPLETED|Stage 1||0
201279|NCT01301456|487795|P12|COMPLETED|Stage 1||0
201280|NCT01301456|487796|P11|COMPLETED|Stage 1||0
201281|NCT01301456|487797|P10|COMPLETED|Stage 1||0
201282|NCT01301456|487798|P9|COMPLETED|Stage 1||0
201283|NCT01301456|487799|P8|COMPLETED|Stage 1||0
201284|NCT01301456|487800|P7|COMPLETED|Stage 1||7
201285|NCT01301456|487801|P6|COMPLETED|Stage 1||5
201286|NCT01301456|487802|P5|COMPLETED|Stage 1||6
201287|NCT01301456|487803|P4|COMPLETED|Stage 1||6
201288|NCT01301456|487804|P3|COMPLETED|Stage 1||5
201289|NCT01301456|487805|P2|COMPLETED|Stage 1||5
201290|NCT01301456|487806|P1|COMPLETED|Stage 1||15
201291|NCT01301456|487795|P12|Received Treatment|Stage 1||0
201292|NCT01301456|487796|P11|Received Treatment|Stage 1||0
201293|NCT01301456|487797|P10|Received Treatment|Stage 1||0
201294|NCT01301456|487798|P9|Received Treatment|Stage 1||0
201295|NCT01301456|487799|P8|Received Treatment|Stage 1||0
201296|NCT01301456|487800|P7|Received Treatment|Stage 1||7
201297|NCT01301456|487801|P6|Received Treatment|Stage 1||5
201298|NCT01301456|487802|P5|Received Treatment|Stage 1||7
201299|NCT01301456|487803|P4|Received Treatment|Stage 1||6
201300|NCT01301456|487804|P3|Received Treatment|Stage 1||6
201301|NCT01301456|487805|P2|Received Treatment|Stage 1||5
201302|NCT01301456|487806|P1|Received Treatment|Stage 1||15
201303|NCT01301456|487795|P12|STARTED|Stage 1||0
201304|NCT01301456|487796|P11|STARTED|Stage 1||0
201305|NCT01301456|487797|P10|STARTED|Stage 1||0
201306|NCT01301456|487798|P9|STARTED|Stage 1||0
201307|NCT01301456|487799|P8|STARTED|Stage 1||0
201308|NCT01301456|487800|P7|STARTED|Stage 1||8
201309|NCT01301456|487801|P6|STARTED|Stage 1||5
201310|NCT01301456|487802|P5|STARTED|Stage 1||7
201311|NCT01301456|487803|P4|STARTED|Stage 1||6
201312|NCT01301456|487804|P3|STARTED|Stage 1||6
201313|NCT01301456|487805|P2|STARTED|Stage 1||5
201314|NCT01301456|487806|P1|STARTED|Stage 1||15
201315|NCT01301391|488032|P1|NOT COMPLETED|Overall Study||26
201316|NCT01301391|488032|P1|COMPLETED|Overall Study||4
201317|NCT01301391|488032|P1|STARTED|Overall Study|On treatment until disease progression, patient withdrawal of consent, or unacceptable toxicity.|30
201318|NCT01301274|488044|P2|NOT COMPLETED|Overall Study||1
201319|NCT01301274|488045|P1|NOT COMPLETED|Overall Study||2
201320|NCT01301274|488044|P2|COMPLETED|Overall Study||31
201321|NCT01301274|488045|P1|COMPLETED|Overall Study||32
201322|NCT01301274|488044|P2|STARTED|Overall Study||32
201323|NCT01301274|488045|P1|STARTED|Overall Study||34
201324|NCT01301092|488060|P3|NOT COMPLETED|Overall Study||1
201325|NCT01301092|488061|P2|NOT COMPLETED|Overall Study||0
201326|NCT01301092|488062|P1|NOT COMPLETED|Overall Study||0
201327|NCT01301092|488060|P3|COMPLETED|Overall Study||7
201328|NCT01301092|488061|P2|COMPLETED|Overall Study||16
201329|NCT01301092|488062|P1|COMPLETED|Overall Study||6
201330|NCT01301092|488060|P3|STARTED|Overall Study||8
201331|NCT01301092|488061|P2|STARTED|Overall Study||16
201332|NCT01301092|488062|P1|STARTED|Overall Study||6
201333|NCT01301079|488079|P2|NOT COMPLETED|Overall Study||2
201334|NCT01301079|488080|P1|NOT COMPLETED|Overall Study||2
201335|NCT01301079|488079|P2|COMPLETED|Overall Study||28
201336|NCT01301079|488080|P1|COMPLETED|Overall Study||28
201337|NCT01301079|488079|P2|STARTED|Overall Study||30
201338|NCT01301079|488080|P1|STARTED|Overall Study||30
201339|NCT01301066|488158|P2|NOT COMPLETED|Overall Study||35
201340|NCT01301066|488159|P1|NOT COMPLETED|Overall Study||27
201341|NCT01301066|488158|P2|COMPLETED|Overall Study||91
201342|NCT01301066|488159|P1|COMPLETED|Overall Study||99
201343|NCT01301066|488158|P2|STARTED|Overall Study||126
201344|NCT01301066|488159|P1|STARTED|Overall Study||126
201345|NCT01301027|488167|P2|NOT COMPLETED|Overall Study||10
201346|NCT01301027|488168|P1|NOT COMPLETED|Overall Study||8
201347|NCT01301027|488167|P2|COMPLETED|Overall Study||37
201348|NCT01301027|488168|P1|COMPLETED|Overall Study||40
201349|NCT01301027|488167|P2|STARTED|Overall Study||47
201350|NCT01301027|488168|P1|STARTED|Overall Study||48
201351|NCT01301001|488180|P2|NOT COMPLETED|Second Intervention||0
201352|NCT01301001|488181|P1|NOT COMPLETED|Second Intervention||4
201353|NCT01301001|488180|P2|COMPLETED|Second Intervention||36
201354|NCT01301001|488181|P1|COMPLETED|Second Intervention||30
201355|NCT01301001|488180|P2|STARTED|Second Intervention||36
201356|NCT01301001|488181|P1|STARTED|Second Intervention||34
201357|NCT01301001|488180|P2|NOT COMPLETED|Washout (2 Weeks)||0
201358|NCT01301001|488181|P1|NOT COMPLETED|Washout (2 Weeks)||0
201359|NCT01301001|488180|P2|COMPLETED|Washout (2 Weeks)||36
201360|NCT01301001|488181|P1|COMPLETED|Washout (2 Weeks)||34
201361|NCT01301001|488180|P2|STARTED|Washout (2 Weeks)||36
201362|NCT01301001|488181|P1|STARTED|Washout (2 Weeks)||34
201363|NCT01301001|488180|P2|NOT COMPLETED|First Intervention||9
201364|NCT01301001|488181|P1|NOT COMPLETED|First Intervention||10
201365|NCT01301001|488180|P2|COMPLETED|First Intervention||36
201366|NCT01301001|488181|P1|COMPLETED|First Intervention||34
201367|NCT01301001|488180|P2|STARTED|First Intervention||45
201368|NCT01301001|488181|P1|STARTED|First Intervention||44
201369|NCT01300949|488194|P3|NOT COMPLETED|Overall Study||0
201370|NCT01300949|488195|P2|NOT COMPLETED|Overall Study||0
201371|NCT01300949|488196|P1|NOT COMPLETED|Overall Study||0
201372|NCT01300949|488194|P3|COMPLETED|Overall Study||35
201373|NCT01300949|488195|P2|COMPLETED|Overall Study||125
201374|NCT01300949|488196|P1|COMPLETED|Overall Study||154
201375|NCT01300949|488194|P3|STARTED|Overall Study||35
201376|NCT01300949|488195|P2|STARTED|Overall Study||125
201377|NCT01300949|488196|P1|STARTED|Overall Study||154
201378|NCT01300923|488204|P2|NOT COMPLETED|Overall Study||2
201379|NCT01300923|488205|P1|NOT COMPLETED|Overall Study||0
201380|NCT01300923|488204|P2|COMPLETED|Overall Study||0
201381|NCT01300923|488205|P1|COMPLETED|Overall Study||12
201382|NCT01300923|488204|P2|STARTED|Overall Study||2
201383|NCT01300923|488205|P1|STARTED|Overall Study||12
201384|NCT01300819|488218|P2|NOT COMPLETED|Overall Study||44
201385|NCT01300819|488219|P1|NOT COMPLETED|Overall Study||22
201386|NCT01300819|488218|P2|COMPLETED|Overall Study||180
201387|NCT01300819|488219|P1|COMPLETED|Overall Study||103
201388|NCT01300819|488218|P2|STARTED|Overall Study||224
201389|NCT01300819|488219|P1|STARTED|Overall Study||125
201390|NCT01300767|488247|P1|NOT COMPLETED|Overall Study||4
201391|NCT01300767|488247|P1|COMPLETED|Overall Study||70
201392|NCT01300767|488247|P1|STARTED|Overall Study||74
201393|NCT01300741|488275|P1|NOT COMPLETED|Overall Study||3
201394|NCT01300741|488275|P1|COMPLETED|Overall Study||72
201395|NCT01300741|488275|P1|STARTED|Overall Study||75
201396|NCT01300728|488305|P2|NOT COMPLETED|Overall Study||1
201397|NCT01300728|488306|P1|NOT COMPLETED|Overall Study||2
201398|NCT01300728|488305|P2|COMPLETED|Overall Study||25
201399|NCT01300728|488306|P1|COMPLETED|Overall Study||24
201400|NCT01300728|488305|P2|STARTED|Overall Study||26
201401|NCT01300728|488306|P1|STARTED|Overall Study||26
201402|NCT01300650|488320|P1|NOT COMPLETED|Overall Study||1
201403|NCT01300650|488320|P1|COMPLETED|Overall Study||7
201404|NCT01300650|488320|P1|STARTED|Overall Study||8
201405|NCT01300624|488326|P1|NOT COMPLETED|Overall Study||0
201406|NCT01300624|488326|P1|COMPLETED|Overall Study||11
201407|NCT01300624|488326|P1|STARTED|Overall Study||11
201408|NCT01300572|488336|P1|NOT COMPLETED|Overall Study||1
201409|NCT01300572|488336|P1|COMPLETED|Overall Study||15
201410|NCT01300572|488336|P1|STARTED|Overall Study||16
201411|NCT01300559|488351|P2|NOT COMPLETED|Overall Study||0
201412|NCT01300559|488352|P1|NOT COMPLETED|Overall Study||0
201413|NCT01300559|488351|P2|COMPLETED|Overall Study||30
201414|NCT01300559|488352|P1|COMPLETED|Overall Study||30
201415|NCT01300559|488351|P2|STARTED|Overall Study||30
201416|NCT01300559|488352|P1|STARTED|Overall Study||30
201417|NCT01300546|488360|P2|NOT COMPLETED|Overall Study||6
201418|NCT01300546|488361|P1|NOT COMPLETED|Overall Study||1
201419|NCT01300546|488360|P2|COMPLETED|Overall Study||14
201420|NCT01300546|488361|P1|COMPLETED|Overall Study||18
201421|NCT01300546|488360|P2|STARTED|Overall Study||20
201422|NCT01300546|488361|P1|STARTED|Overall Study||19
201423|NCT01300455|488391|P2|NOT COMPLETED|Period 2||0
201424|NCT01300455|488392|P1|NOT COMPLETED|Period 2||0
201425|NCT01300455|488391|P2|COMPLETED|Period 2||13
201426|NCT01300455|488392|P1|COMPLETED|Period 2||12
201427|NCT01300455|488391|P2|STARTED|Period 2||13
201428|NCT01300455|488392|P1|STARTED|Period 2||12
201429|NCT01300455|488391|P2|NOT COMPLETED|Washout||0
201430|NCT01300455|488392|P1|NOT COMPLETED|Washout||1
201431|NCT01300455|488391|P2|COMPLETED|Washout||13
201432|NCT01300455|488392|P1|COMPLETED|Washout||12
201433|NCT01300455|488391|P2|STARTED|Washout||13
201434|NCT01300455|488392|P1|STARTED|Washout||13
201435|NCT01300455|488391|P2|NOT COMPLETED|Period 1||0
201436|NCT01300455|488392|P1|NOT COMPLETED|Period 1||0
201437|NCT01300455|488391|P2|COMPLETED|Period 1||13
201438|NCT01300455|488392|P1|COMPLETED|Period 1||13
201439|NCT01300455|488391|P2|STARTED|Period 1||13
201440|NCT01300455|488392|P1|STARTED|Period 1||13
201441|NCT01300351|488412|P2|NOT COMPLETED|Overall Study||38
201442|NCT01300351|488413|P1|NOT COMPLETED|Overall Study||36
201443|NCT01300351|488412|P2|COMPLETED|Overall Study||72
201444|NCT01300351|488413|P1|COMPLETED|Overall Study||75
201445|NCT01300351|488412|P2|Received Study Treatment|Overall Study||110
201446|NCT01300351|488413|P1|Received Study Treatment|Overall Study||109
201447|NCT01300351|488412|P2|STARTED|Overall Study||110
201448|NCT01300351|488413|P1|STARTED|Overall Study||111
201449|NCT01300338|488429|P2|NOT COMPLETED|Overall Study||0
201450|NCT01300338|488430|P1|NOT COMPLETED|Overall Study||5
201451|NCT01300338|488429|P2|COMPLETED|Overall Study||25
201452|NCT01300338|488430|P1|COMPLETED|Overall Study||20
201453|NCT01300338|488429|P2|STARTED|Overall Study||25
201454|NCT01300338|488430|P1|STARTED|Overall Study||25
201455|NCT01300286|488438|P1|NOT COMPLETED|Overall Study||1
201456|NCT01300286|488438|P1|COMPLETED|Overall Study||22
201457|NCT01300286|488438|P1|STARTED|Overall Study||23
201458|NCT01300260|488448|P2|NOT COMPLETED|Period 2 of Study: Second Intervention||1
201459|NCT01300260|488449|P1|NOT COMPLETED|Period 2 of Study: Second Intervention||0
201460|NCT01300260|488448|P2|COMPLETED|Period 2 of Study: Second Intervention||15
201461|NCT01300260|488449|P1|COMPLETED|Period 2 of Study: Second Intervention||14
201462|NCT01300260|488448|P2|STARTED|Period 2 of Study: Second Intervention||16
201463|NCT01300260|488449|P1|STARTED|Period 2 of Study: Second Intervention||14
201464|NCT01300260|488448|P2|NOT COMPLETED|Washout Period of at Least 28 Days||0
201465|NCT01300260|488449|P1|NOT COMPLETED|Washout Period of at Least 28 Days||0
201466|NCT01300260|488448|P2|COMPLETED|Washout Period of at Least 28 Days||16
201467|NCT01300260|488449|P1|COMPLETED|Washout Period of at Least 28 Days||14
201468|NCT01300260|488448|P2|STARTED|Washout Period of at Least 28 Days||16
201469|NCT01300260|488449|P1|STARTED|Washout Period of at Least 28 Days||14
201470|NCT01300260|488448|P2|NOT COMPLETED|Period 1 of Study: First Intervention||1
201471|NCT01300260|488449|P1|NOT COMPLETED|Period 1 of Study: First Intervention||1
201472|NCT01300260|488448|P2|COMPLETED|Period 1 of Study: First Intervention||16
201473|NCT01300260|488449|P1|COMPLETED|Period 1 of Study: First Intervention||14
201474|NCT01300260|488448|P2|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||17
201475|NCT01300260|488449|P1|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||15
201476|NCT01300260|488448|P2|STARTED|Period 1 of Study: First Intervention||17
201477|NCT01300260|488449|P1|STARTED|Period 1 of Study: First Intervention||15
201478|NCT01300247|488481|P2|NOT COMPLETED|Overall Study||2
201479|NCT01300247|488482|P1|NOT COMPLETED|Overall Study||4
201480|NCT01300247|488481|P2|COMPLETED|Overall Study||18
201481|NCT01300247|488482|P1|COMPLETED|Overall Study||17
201482|NCT01300247|488481|P2|STARTED|Overall Study||20
201483|NCT01300247|488482|P1|STARTED|Overall Study||21
201484|NCT01300234|488514|P2|NOT COMPLETED|Overall Study||27
201485|NCT01300234|488515|P1|NOT COMPLETED|Overall Study||28
201486|NCT01300234|488514|P2|COMPLETED|Overall Study||228
201487|NCT01300234|488515|P1|COMPLETED|Overall Study||229
201488|NCT01300234|488514|P2|STARTED|Overall Study||255
201489|NCT01300234|488515|P1|STARTED|Overall Study||257
201490|NCT01300052|488551|P2|NOT COMPLETED|Overall Study||3
201491|NCT01300052|488552|P1|NOT COMPLETED|Overall Study||6
201492|NCT01300052|488551|P2|COMPLETED|Overall Study||19
201493|NCT01300052|488552|P1|COMPLETED|Overall Study||40
201494|NCT01300052|488551|P2|STARTED|Overall Study||22
201495|NCT01300052|488552|P1|STARTED|Overall Study||46
201496|NCT01299961|488570|P1|NOT COMPLETED|Overall Study||6
201497|NCT01299961|488570|P1|COMPLETED|Overall Study||19
201498|NCT01299961|488570|P1|STARTED|Overall Study||25
201499|NCT01299909|488579|P3|NOT COMPLETED|Overall Study||17
201500|NCT01299909|488580|P2|NOT COMPLETED|Overall Study||18
201501|NCT01299909|488581|P1|NOT COMPLETED|Overall Study||22
201502|NCT01299909|488579|P3|COMPLETED|Overall Study||23
201503|NCT01299909|488580|P2|COMPLETED|Overall Study||49
201504|NCT01299909|488581|P1|COMPLETED|Overall Study||46
201505|NCT01299909|488579|P3|STARTED|Overall Study||40
201506|NCT01299909|488580|P2|STARTED|Overall Study||67
201507|NCT01299909|488581|P1|STARTED|Overall Study||68
201508|NCT01299896|488596|P2|NOT COMPLETED|Overall Study||18
201509|NCT01299896|488597|P1|NOT COMPLETED|Overall Study||1
201510|NCT01299896|488596|P2|COMPLETED|Overall Study||296
201511|NCT01299896|488597|P1|COMPLETED|Overall Study||318
201512|NCT01299896|488596|P2|STARTED|Overall Study||314
201513|NCT01299896|488597|P1|STARTED|Overall Study||319
201514|NCT01299805|488605|P2|NOT COMPLETED|Overall Study||0
201515|NCT01299805|488606|P1|NOT COMPLETED|Overall Study||2
201516|NCT01299805|488605|P2|COMPLETED|Overall Study||5
201517|NCT01299805|488606|P1|COMPLETED|Overall Study||10
201518|NCT01299805|488605|P2|STARTED|Overall Study||5
201519|NCT01299805|488606|P1|STARTED|Overall Study||12
201520|NCT01299766|488636|P2|NOT COMPLETED|Overall Study||23
201521|NCT01299766|488637|P1|NOT COMPLETED|Overall Study||34
201522|NCT01299766|488636|P2|COMPLETED|Overall Study||87
201523|NCT01299766|488637|P1|COMPLETED|Overall Study||77
201524|NCT01299766|488636|P2|STARTED|Overall Study||110
201525|NCT01299766|488637|P1|STARTED|Overall Study||111
201526|NCT01299610|488648|P3|NOT COMPLETED|Overall Study||0
201527|NCT01299610|488649|P2|NOT COMPLETED|Overall Study||0
201528|NCT01299610|488650|P1|NOT COMPLETED|Overall Study||0
201529|NCT01299610|488648|P3|COMPLETED|Overall Study||10
201530|NCT01299610|488649|P2|COMPLETED|Overall Study||5
201531|NCT01299610|488650|P1|COMPLETED|Overall Study||10
201532|NCT01299610|488648|P3|STARTED|Overall Study||10
201533|NCT01299610|488649|P2|STARTED|Overall Study||5
201534|NCT01299610|488650|P1|STARTED|Overall Study||10
201535|NCT01299584|488695|P1|NOT COMPLETED|Overall Study||9
201536|NCT01299584|488695|P1|COMPLETED|Overall Study||766
201537|NCT01299584|488695|P1|STARTED|Overall Study||775
201538|NCT01299571|488702|P1|NOT COMPLETED|Overall Study||107
201539|NCT01299571|488702|P1|COMPLETED|Overall Study||3870
201540|NCT01299571|488702|P1|STARTED|Overall Study||3977
201541|NCT01299480|488713|P5|NOT COMPLETED|Overall Study||20
201542|NCT01299480|488714|P4|NOT COMPLETED|Overall Study||25
201543|NCT01299480|488715|P3|NOT COMPLETED|Overall Study||41
201544|NCT01299480|488716|P2|NOT COMPLETED|Overall Study||35
201545|NCT01299480|488717|P1|NOT COMPLETED|Overall Study||42
201546|NCT01299480|488713|P5|COMPLETED|Overall Study||123
201547|NCT01299480|488714|P4|COMPLETED|Overall Study||261
201548|NCT01299480|488715|P3|COMPLETED|Overall Study||386
201549|NCT01299480|488716|P2|COMPLETED|Overall Study||395
201550|NCT01299480|488717|P1|COMPLETED|Overall Study||385
201551|NCT01299480|488713|P5|STARTED|Overall Study||143
201552|NCT01299480|488714|P4|STARTED|Overall Study||286
201553|NCT01299480|488715|P3|STARTED|Overall Study||427
201554|NCT01299480|488716|P2|STARTED|Overall Study||430
201555|NCT01299480|488717|P1|STARTED|Overall Study||427
201556|NCT01299454|488756|P4|NOT COMPLETED|Overall Study||0
201557|NCT01299454|488757|P3|NOT COMPLETED|Overall Study||0
201558|NCT01299454|488758|P2|NOT COMPLETED|Overall Study||0
201559|NCT01299454|488759|P1|NOT COMPLETED|Overall Study||0
201560|NCT01299454|488756|P4|COMPLETED|Overall Study||23
201561|NCT01299454|488757|P3|COMPLETED|Overall Study||6
201562|NCT01299454|488758|P2|COMPLETED|Overall Study||8
201563|NCT01299454|488759|P1|COMPLETED|Overall Study||8
201564|NCT01299454|488756|P4|STARTED|Overall Study||23
201565|NCT01299454|488757|P3|STARTED|Overall Study||6
201566|NCT01299454|488758|P2|STARTED|Overall Study||8
201567|NCT01299454|488759|P1|STARTED|Overall Study||8
201568|NCT01299389|488919|P4|NOT COMPLETED|Post-observational||6
201569|NCT01299389|488920|P3|NOT COMPLETED|Post-observational||12
201570|NCT01299389|488921|P2|NOT COMPLETED|Post-observational||0
201571|NCT01299389|488922|P1|NOT COMPLETED|Post-observational||0
201572|NCT01299389|488919|P4|COMPLETED|Post-observational||149
201573|NCT01299389|488920|P3|COMPLETED|Post-observational||144
201574|NCT01299389|488921|P2|COMPLETED|Post-observational||0
201575|NCT01299389|488922|P1|COMPLETED|Post-observational||0
201576|NCT01299389|488919|P4|STARTED|Post-observational||155
201577|NCT01299389|488920|P3|STARTED|Post-observational||156
201578|NCT01299389|488921|P2|STARTED|Post-observational||0
201579|NCT01299389|488922|P1|STARTED|Post-observational||0
201580|NCT01299389|488919|P4|NOT COMPLETED|Double-blind||0
201581|NCT01299389|488920|P3|NOT COMPLETED|Double-blind||0
201582|NCT01299389|488921|P2|NOT COMPLETED|Double-blind||64
201583|NCT01299389|488922|P1|NOT COMPLETED|Double-blind||109
201584|NCT01299389|488919|P4|COMPLETED|Double-blind||0
201585|NCT01299389|488920|P3|COMPLETED|Double-blind||0
201586|NCT01299389|488921|P2|COMPLETED|Double-blind||95
201587|NCT01299389|488922|P1|COMPLETED|Double-blind||55
201588|NCT01299389|488919|P4|STARTED|Double-blind||0
201589|NCT01299389|488920|P3|STARTED|Double-blind||0
201590|NCT01299389|488921|P2|STARTED|Double-blind||159
201591|NCT01299389|488922|P1|STARTED|Double-blind||164
201592|NCT01299376|488944|P2|NOT COMPLETED|Extension (Weeks 9 to 52)||15
201593|NCT01299376|488945|P1|NOT COMPLETED|Extension (Weeks 9 to 52)||10
201594|NCT01299376|488944|P2|COMPLETED|Extension (Weeks 9 to 52)||118
201595|NCT01299376|488945|P1|COMPLETED|Extension (Weeks 9 to 52)||124
201596|NCT01299376|488944|P2|STARTED|Extension (Weeks 9 to 52)||133
201597|NCT01299376|488945|P1|STARTED|Extension (Weeks 9 to 52)||134
201598|NCT01299376|488944|P2|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||12
201599|NCT01299376|488945|P1|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||7
201600|NCT01299376|488944|P2|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||133
201601|NCT01299376|488945|P1|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||134
201602|NCT01299376|488944|P2|STARTED|Double-blind Treatment (Weeks 1 to 8)||145
201603|NCT01299376|488945|P1|STARTED|Double-blind Treatment (Weeks 1 to 8)||141
201604|NCT01299285|488975|P1|NOT COMPLETED|Overall Study||0
201605|NCT01299285|488975|P1|COMPLETED|Overall Study||6
201606|NCT01299285|488975|P1|STARTED|Overall Study||6
201607|NCT01299272|488988|P4|NOT COMPLETED|Double-blind (DB) Randomized Period||58
201608|NCT01299272|488989|P3|NOT COMPLETED|Double-blind (DB) Randomized Period||70
201609|NCT01299272|488990|P2|NOT COMPLETED|Double-blind (DB) Randomized Period||0
201610|NCT01299272|488991|P1|NOT COMPLETED|Double-blind (DB) Randomized Period||0
201611|NCT01299272|488988|P4|COMPLETED|Double-blind (DB) Randomized Period||234
201612|NCT01299272|488989|P3|COMPLETED|Double-blind (DB) Randomized Period||224
201613|NCT01299272|488990|P2|COMPLETED|Double-blind (DB) Randomized Period||0
201614|NCT01299272|488991|P1|COMPLETED|Double-blind (DB) Randomized Period||0
201615|NCT01299272|488988|P4|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period entered the DC Period.|268
201616|NCT01299272|488989|P3|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the abrupt DC Period.|132
201617|NCT01299272|488990|P2|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
201618|NCT01299272|488991|P1|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
201619|NCT01299272|488988|P4|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
201620|NCT01299272|488989|P3|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the taper DC Period.|129
201621|NCT01299272|488990|P2|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
201622|NCT01299272|488991|P1|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
201623|NCT01299272|488988|P4|STARTED|Double-blind (DB) Randomized Period||292
201624|NCT01299272|488989|P3|STARTED|Double-blind (DB) Randomized Period||294
201625|NCT01299272|488990|P2|STARTED|Double-blind (DB) Randomized Period||0
201626|NCT01299272|488991|P1|STARTED|Double-blind (DB) Randomized Period||0
201627|NCT01299272|488988|P4|NOT COMPLETED|Stabilization Open-label (OL) Period||0
201628|NCT01299272|488989|P3|NOT COMPLETED|Stabilization Open-label (OL) Period||0
201629|NCT01299272|488990|P2|NOT COMPLETED|Stabilization Open-label (OL) Period||249
201630|NCT01299272|488991|P1|NOT COMPLETED|Stabilization Open-label (OL) Period||0
201631|NCT01299272|488988|P4|COMPLETED|Stabilization Open-label (OL) Period||0
201632|NCT01299272|488989|P3|COMPLETED|Stabilization Open-label (OL) Period||0
201633|NCT01299272|488990|P2|COMPLETED|Stabilization Open-label (OL) Period|Participants who completed the Stabilization OL Period were randomized to the DB Period.|586
201634|NCT01299272|488991|P1|COMPLETED|Stabilization Open-label (OL) Period||0
201635|NCT01299272|488988|P4|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
201636|NCT01299272|488989|P3|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
201637|NCT01299272|488990|P2|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period|Participants who discontinued the Stabilization OL Period had the option to enter the DC Period.|164
201638|NCT01299272|488991|P1|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
201639|NCT01299272|488988|P4|STARTED|Stabilization Open-label (OL) Period||0
201640|NCT01299272|488989|P3|STARTED|Stabilization Open-label (OL) Period||0
201641|NCT01299272|488990|P2|STARTED|Stabilization Open-label (OL) Period||835
201642|NCT01299272|488991|P1|STARTED|Stabilization Open-label (OL) Period||0
201643|NCT01299272|488988|P4|NOT COMPLETED|Acute Open-label (OL) Period||0
201644|NCT01299272|488989|P3|NOT COMPLETED|Acute Open-label (OL) Period||0
201645|NCT01299272|488990|P2|NOT COMPLETED|Acute Open-label (OL) Period||0
201646|NCT01299272|488991|P1|NOT COMPLETED|Acute Open-label (OL) Period||414
201647|NCT01299272|488988|P4|COMPLETED|Acute Open-label (OL) Period||0
201648|NCT01299272|488989|P3|COMPLETED|Acute Open-label (OL) Period||0
201649|NCT01299272|488990|P2|COMPLETED|Acute Open-label (OL) Period||0
201650|NCT01299272|488991|P1|COMPLETED|Acute Open-label (OL) Period|Participants who completed the Acute OL Period entered the Stabilization OL Period.|835
201651|NCT01299272|488988|P4|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
201652|NCT01299272|488989|P3|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
201653|NCT01299272|488990|P2|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
201654|NCT01299272|488991|P1|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period|Participants who discontinued the Acute OL Period had the option to enter the DC Period.|271
201655|NCT01299272|488988|P4|STARTED|Acute Open-label (OL) Period||0
201656|NCT01299272|488989|P3|STARTED|Acute Open-label (OL) Period||0
201657|NCT01299272|488990|P2|STARTED|Acute Open-label (OL) Period||0
201658|NCT01299272|488991|P1|STARTED|Acute Open-label (OL) Period||1249
201659|NCT01299116|489046|P3|NOT COMPLETED|Overall Study||11
201660|NCT01299116|489047|P2|NOT COMPLETED|Overall Study||9
201661|NCT01299116|489048|P1|NOT COMPLETED|Overall Study||65
201662|NCT01299116|489046|P3|COMPLETED|Overall Study||184
201663|NCT01299116|489047|P2|COMPLETED|Overall Study||168
201664|NCT01299116|489048|P1|COMPLETED|Overall Study||457
201665|NCT01299116|489046|P3|STARTED|Overall Study||195
201666|NCT01299116|489047|P2|STARTED|Overall Study||177
201667|NCT01299116|489048|P1|STARTED|Overall Study||522
201668|NCT01299103|489065|P3|NOT COMPLETED|Overall Study||2
201669|NCT01299103|489066|P2|NOT COMPLETED|Overall Study||2
201670|NCT01299103|489067|P1|NOT COMPLETED|Overall Study||0
201671|NCT01299103|489065|P3|COMPLETED|Overall Study||8
201672|NCT01299103|489066|P2|COMPLETED|Overall Study||13
201673|NCT01299103|489067|P1|COMPLETED|Overall Study||15
201674|NCT01299103|489065|P3|STARTED|Overall Study||10
201675|NCT01299103|489066|P2|STARTED|Overall Study||15
201676|NCT01299103|489067|P1|STARTED|Overall Study||15
201677|NCT01299090|489078|P1|NOT COMPLETED|Overall Study||0
201678|NCT01299090|489078|P1|COMPLETED|Overall Study||49
201679|NCT01299090|489078|P1|STARTED|Overall Study||49
201680|NCT01299077|489083|P1|NOT COMPLETED|Overall Study||0
201681|NCT01299077|489083|P1|COMPLETED|Overall Study||478
201682|NCT01299077|489083|P1|STARTED|Overall Study||478
201683|NCT01299025|489093|P2|NOT COMPLETED|Overall Study||1
201684|NCT01299025|489094|P1|NOT COMPLETED|Overall Study||3
201685|NCT01299025|489093|P2|COMPLETED|Overall Study||41
201686|NCT01299025|489094|P1|COMPLETED|Overall Study||39
201687|NCT01299025|489093|P2|STARTED|Overall Study||42
201688|NCT01299025|489094|P1|STARTED|Overall Study||42
201689|NCT01298921|489108|P2|NOT COMPLETED|Overall Study||0
201690|NCT01298921|489109|P1|NOT COMPLETED|Overall Study||0
201691|NCT01298921|489108|P2|COMPLETED|Overall Study||0
201692|NCT01298921|489109|P1|COMPLETED|Overall Study||0
201693|NCT01298921|489108|P2|STARTED|Overall Study||0
201694|NCT01298921|489109|P1|STARTED|Overall Study||0
201695|NCT01298778|489119|P2|NOT COMPLETED|Overall Study||6
201696|NCT01298778|489120|P1|NOT COMPLETED|Overall Study||3
201697|NCT01298778|489119|P2|COMPLETED|Overall Study||30
201698|NCT01298778|489120|P1|COMPLETED|Overall Study||30
201699|NCT01298778|489119|P2|STARTED|Overall Study||36
201700|NCT01298778|489120|P1|STARTED|Overall Study||33
201701|NCT01298765|489140|P1|NOT COMPLETED|Long-Term Treatment Period||99
201702|NCT01298765|489140|P1|COMPLETED|Long-Term Treatment Period||127
201703|NCT01298765|489140|P1|STARTED|Long-Term Treatment Period||226
201704|NCT01298765|489140|P1|NOT COMPLETED|Titration Period||76
201705|NCT01298765|489140|P1|COMPLETED|Titration Period||226
201706|NCT01298765|489140|P1|STARTED|Titration Period||302
201707|NCT01298700|489150|P2|NOT COMPLETED|Overall Study||100
201708|NCT01298700|489151|P1|NOT COMPLETED|Overall Study||101
201709|NCT01298700|489150|P2|COMPLETED|Overall Study||303
201710|NCT01298700|489151|P1|COMPLETED|Overall Study||302
201711|NCT01298700|489150|P2|Safety Population: Received Study Drug|Overall Study||398
201712|NCT01298700|489151|P1|Safety Population: Received Study Drug|Overall Study||400
201713|NCT01298700|489150|P2|STARTED|Overall Study||403
201714|NCT01298700|489151|P1|STARTED|Overall Study||403
201715|NCT01298661|489162|P3|NOT COMPLETED|Overall Study||2
201716|NCT01298661|489163|P2|NOT COMPLETED|Overall Study||0
201717|NCT01298661|489164|P1|NOT COMPLETED|Overall Study||2
201718|NCT01298661|489162|P3|COMPLETED|Overall Study||32
201719|NCT01298661|489163|P2|COMPLETED|Overall Study||24
201720|NCT01298661|489164|P1|COMPLETED|Overall Study||31
201721|NCT01298661|489162|P3|STARTED|Overall Study||34
201722|NCT01298661|489163|P2|STARTED|Overall Study||24
201723|NCT01298661|489164|P1|STARTED|Overall Study||33
201724|NCT01298648|489242|P1|NOT COMPLETED|Overall Study||23
201725|NCT01298648|489242|P1|COMPLETED|Overall Study||1693
201726|NCT01298648|489242|P1|STARTED|Overall Study||1716
201727|NCT01298596|489253|P2|NOT COMPLETED|Overall Study||33
201728|NCT01298596|489254|P1|NOT COMPLETED|Overall Study||28
201729|NCT01298596|489253|P2|COMPLETED|Overall Study||167
201730|NCT01298596|489254|P1|COMPLETED|Overall Study||172
201731|NCT01298596|489253|P2|STARTED|Overall Study||200
201732|NCT01298596|489254|P1|STARTED|Overall Study||200
201733|NCT01298570|489264|P2|NOT COMPLETED|Overall Study||61
201734|NCT01298570|489265|P1|NOT COMPLETED|Overall Study||120
201735|NCT01298570|489264|P2|COMPLETED|Overall Study||0
201736|NCT01298570|489265|P1|COMPLETED|Overall Study||0
201737|NCT01298570|489264|P2|STARTED|Overall Study||61
201738|NCT01298570|489265|P1|STARTED|Overall Study||120
201739|NCT01298544|489281|P1|NOT COMPLETED|Overall Study||0
201740|NCT01298544|489281|P1|COMPLETED|Overall Study||335
201741|NCT01298544|489281|P1|STARTED|Overall Study||335
201742|NCT01298531|489292|P2|NOT COMPLETED|Overall Study||7
201743|NCT01298531|489293|P1|NOT COMPLETED|Overall Study||9
201744|NCT01298531|489292|P2|COMPLETED|Overall Study||41
201745|NCT01298531|489293|P1|COMPLETED|Overall Study||33
201746|NCT01298531|489292|P2|STARTED|Overall Study||48
201747|NCT01298531|489293|P1|STARTED|Overall Study||42
201748|NCT01298518|489422|P3|NOT COMPLETED|Overall Study||1
201749|NCT01298518|489423|P2|NOT COMPLETED|Overall Study||0
201750|NCT01298518|489424|P1|NOT COMPLETED|Overall Study||0
201751|NCT01298518|489422|P3|COMPLETED|Overall Study||15
201752|NCT01298518|489423|P2|COMPLETED|Overall Study||16
201753|NCT01298518|489424|P1|COMPLETED|Overall Study||16
201754|NCT01298518|489422|P3|STARTED|Overall Study||16
201755|NCT01298518|489423|P2|STARTED|Overall Study||16
201756|NCT01298518|489424|P1|STARTED|Overall Study||16
201757|NCT01298492|489476|P1|NOT COMPLETED|Overall Study||119
201758|NCT01298492|489476|P1|COMPLETED|Overall Study||149
201759|NCT01298492|489476|P1|STARTED|Overall Study||268
201760|NCT01298362|489484|P2|NOT COMPLETED|Overall Study||43
201761|NCT01298362|489485|P1|NOT COMPLETED|Overall Study||38
201762|NCT01298362|489484|P2|COMPLETED|Overall Study||123
201763|NCT01298362|489485|P1|COMPLETED|Overall Study||86
201764|NCT01298362|489484|P2|STARTED|Overall Study||166
201765|NCT01298362|489485|P1|STARTED|Overall Study||124
201766|NCT01298323|489505|P2|NOT COMPLETED|Overall Study||88
201767|NCT01298323|489506|P1|NOT COMPLETED|Overall Study||86
201768|NCT01298323|489505|P2|COMPLETED|Overall Study||15
201769|NCT01298323|489506|P1|COMPLETED|Overall Study||16
201770|NCT01298323|489505|P2|Ongoing|Overall Study||55
201771|NCT01298323|489506|P1|Ongoing|Overall Study||55
201772|NCT01298323|489505|P2|STARTED|Overall Study||103
201773|NCT01298323|489506|P1|STARTED|Overall Study||102
201774|NCT01298193|489512|P1|NOT COMPLETED|Efficacy Phase (Second Cycle)||1
201775|NCT01298193|489512|P1|COMPLETED|Efficacy Phase (Second Cycle)||23
201776|NCT01298193|489512|P1|STARTED|Efficacy Phase (Second Cycle)||24
201777|NCT01298193|489512|P1|NOT COMPLETED|Observational Phase (First Cycle)||27
201778|NCT01298193|489512|P1|COMPLETED|Observational Phase (First Cycle)|From these 185 completed patients, only 24 experiment emesis on Cycle 1 (NCR) (efficacy phase).|185
201779|NCT01298193|489512|P1|STARTED|Observational Phase (First Cycle)||212
201780|NCT01298167|489527|P2|NOT COMPLETED|Overall Study||0
201781|NCT01298167|489528|P1|NOT COMPLETED|Overall Study||1
201782|NCT01298167|489527|P2|COMPLETED|Overall Study||8
201783|NCT01298167|489528|P1|COMPLETED|Overall Study||5
201784|NCT01298167|489527|P2|STARTED|Overall Study||8
201785|NCT01298167|489528|P1|STARTED|Overall Study||6
201786|NCT01298141|489534|P1|NOT COMPLETED|Overall Study||31
201787|NCT01298141|489534|P1|COMPLETED|Overall Study||140
201788|NCT01298141|489534|P1|Treated|Overall Study||167
201789|NCT01298141|489534|P1|STARTED|Overall Study||171
201790|NCT01298128|489546|P2|NOT COMPLETED|Overall Study||8
201791|NCT01298128|489547|P1|NOT COMPLETED|Overall Study||9
201792|NCT01298128|489546|P2|COMPLETED|Overall Study||27
201793|NCT01298128|489547|P1|COMPLETED|Overall Study||26
201794|NCT01298128|489546|P2|STARTED|Overall Study||35
201795|NCT01298128|489547|P1|STARTED|Overall Study||35
201796|NCT01298063|489558|P5|NOT COMPLETED|Overall Study||0
201797|NCT01298063|489559|P4|NOT COMPLETED|Overall Study||0
201798|NCT01298063|489560|P3|NOT COMPLETED|Overall Study||0
201799|NCT01298063|489561|P2|NOT COMPLETED|Overall Study||0
201800|NCT01298063|489562|P1|NOT COMPLETED|Overall Study||0
201801|NCT01298063|489558|P5|COMPLETED|Overall Study||8
201802|NCT01298063|489559|P4|COMPLETED|Overall Study||8
201803|NCT01298063|489560|P3|COMPLETED|Overall Study||8
201804|NCT01298063|489561|P2|COMPLETED|Overall Study||3
201805|NCT01298063|489562|P1|COMPLETED|Overall Study||8
201806|NCT01298063|489558|P5|STARTED|Overall Study||8
201807|NCT01298063|489559|P4|STARTED|Overall Study||8
201808|NCT01298063|489560|P3|STARTED|Overall Study||8
201809|NCT01298063|489561|P2|STARTED|Overall Study||3
201810|NCT01298063|489562|P1|STARTED|Overall Study||8
201811|NCT01297920|489592|P3|NOT COMPLETED|Overall Study||57
201812|NCT01297920|489593|P2|NOT COMPLETED|Overall Study||27
201813|NCT01297920|489594|P1|NOT COMPLETED|Overall Study||58
201814|NCT01297920|489592|P3|COMPLETED|Overall Study||178
201815|NCT01297920|489593|P2|COMPLETED|Overall Study||207
201816|NCT01297920|489594|P1|COMPLETED|Overall Study||163
201817|NCT01297920|489592|P3|STARTED|Overall Study||235
201818|NCT01297920|489593|P2|STARTED|Overall Study||234
201819|NCT01297920|489594|P1|STARTED|Overall Study||221
201820|NCT01297595|489602|P2|NOT COMPLETED|Second Intervention Period||0
201821|NCT01297595|489603|P1|NOT COMPLETED|Second Intervention Period||0
201822|NCT01297595|489602|P2|COMPLETED|Second Intervention Period||11
201823|NCT01297595|489603|P1|COMPLETED|Second Intervention Period||11
201824|NCT01297595|489602|P2|STARTED|Second Intervention Period||11
201825|NCT01297595|489603|P1|STARTED|Second Intervention Period||11
201826|NCT01297595|489602|P2|NOT COMPLETED|Washout Period (At Least 14 Days)||0
201827|NCT01297595|489603|P1|NOT COMPLETED|Washout Period (At Least 14 Days)||0
201828|NCT01297595|489602|P2|COMPLETED|Washout Period (At Least 14 Days)||11
201829|NCT01297595|489603|P1|COMPLETED|Washout Period (At Least 14 Days)||11
201830|NCT01297595|489602|P2|STARTED|Washout Period (At Least 14 Days)||11
201831|NCT01297595|489603|P1|STARTED|Washout Period (At Least 14 Days)||11
201832|NCT01297595|489602|P2|NOT COMPLETED|First Intervention Period||0
201833|NCT01297595|489603|P1|NOT COMPLETED|First Intervention Period||0
201834|NCT01297595|489602|P2|COMPLETED|First Intervention Period||11
201835|NCT01297595|489603|P1|COMPLETED|First Intervention Period||11
201836|NCT01297595|489602|P2|STARTED|First Intervention Period||11
201837|NCT01297595|489603|P1|STARTED|First Intervention Period||11
201838|NCT01297517|489638|P3|NOT COMPLETED|Overall Study||27
201839|NCT01297517|489639|P2|NOT COMPLETED|Overall Study||12
201840|NCT01297517|489640|P1|NOT COMPLETED|Overall Study||27
201841|NCT01297517|489638|P3|COMPLETED|Overall Study||193
201842|NCT01297517|489639|P2|COMPLETED|Overall Study||214
201843|NCT01297517|489640|P1|COMPLETED|Overall Study||187
201844|NCT01297517|489638|P3|STARTED|Overall Study||220
201845|NCT01297517|489639|P2|STARTED|Overall Study||226
201846|NCT01297517|489640|P1|STARTED|Overall Study||214
201847|NCT01297504|489648|P1|NOT COMPLETED|Overall Study||67
201848|NCT01297504|489648|P1|COMPLETED|Overall Study||397
201849|NCT01297504|489648|P1|Participants Studied|Overall Study|Six participants were eliminated due to invalid consent, previous palivizumab or no study visits|458
201850|NCT01297504|489648|P1|STARTED|Overall Study||464
201851|NCT01297491|489662|P2|NOT COMPLETED|Overall Study||33
201852|NCT01297491|489663|P1|NOT COMPLETED|Overall Study||30
201853|NCT01297491|489662|P2|COMPLETED|Overall Study||0
201854|NCT01297491|489663|P1|COMPLETED|Overall Study||0
201855|NCT01297491|489662|P2|STARTED|Overall Study||33
201856|NCT01297491|489663|P1|STARTED|Overall Study||30
201857|NCT01297465|489681|P2|NOT COMPLETED|Overall Study||10
201858|NCT01297465|489682|P1|NOT COMPLETED|Overall Study||8
201859|NCT01297465|489681|P2|COMPLETED|Overall Study||93
201860|NCT01297465|489682|P1|COMPLETED|Overall Study||91
201861|NCT01297465|489681|P2|STARTED|Overall Study||103
201862|NCT01297465|489682|P1|STARTED|Overall Study||99
201863|NCT01297348|489716|P2|NOT COMPLETED|Overall Study||0
201864|NCT01297348|489717|P1|NOT COMPLETED|Overall Study||0
201865|NCT01297348|489716|P2|COMPLETED|Overall Study||586401
201866|NCT01297348|489717|P1|COMPLETED|Overall Study||12281
201867|NCT01297348|489716|P2|STARTED|Overall Study||586401
201868|NCT01297348|489717|P1|STARTED|Overall Study||12281
201869|NCT01297335|489727|P1|NOT COMPLETED|Overall Study||0
201870|NCT01297335|489727|P1|COMPLETED|Overall Study||10
201871|NCT01297335|489727|P1|STARTED|Overall Study||10
201872|NCT01297322|489735|P2|NOT COMPLETED|Overall Study||1
201873|NCT01297322|489736|P1|NOT COMPLETED|Overall Study||1
201874|NCT01297322|489735|P2|COMPLETED|Overall Study||274
201875|NCT01297322|489736|P1|COMPLETED|Overall Study||141
201876|NCT01297322|489735|P2|STARTED|Overall Study||275
201877|NCT01297322|489736|P1|STARTED|Overall Study||142
201878|NCT01297309|489756|P1|NOT COMPLETED|Overall Study||14
201879|NCT01297309|489756|P1|COMPLETED|Overall Study||37
201880|NCT01297309|489756|P1|Started Extension Period|Overall Study||46
201881|NCT01297309|489756|P1|Treated|Overall Study||49
201882|NCT01297309|489756|P1|STARTED|Overall Study||51
201883|NCT01297283|489773|P1|NOT COMPLETED|Overall Study||19
201884|NCT01297283|489773|P1|COMPLETED|Overall Study||176
201885|NCT01297283|489773|P1|STARTED|Overall Study||195
201886|NCT01297270|489781|P3|NOT COMPLETED|Overall Study||29
201887|NCT01297270|489782|P2|NOT COMPLETED|Overall Study||72
201888|NCT01297270|489783|P1|NOT COMPLETED|Overall Study||45
201889|NCT01297270|489781|P3|COMPLETED|Overall Study||103
201890|NCT01297270|489782|P2|COMPLETED|Overall Study||192
201891|NCT01297270|489783|P1|COMPLETED|Overall Study||217
201892|NCT01297270|489781|P3|STARTED|Overall Study||132
201893|NCT01297270|489782|P2|STARTED|Overall Study||264
201894|NCT01297270|489783|P1|STARTED|Overall Study||262
201895|NCT01297257|489821|P1|NOT COMPLETED|Overall Study||0
201896|NCT01297257|489821|P1|COMPLETED|Overall Study||7740
201897|NCT01297257|489821|P1|STARTED|Overall Study||7740
201898|NCT01297062|489832|P7|NOT COMPLETED|Overall Study||8
201899|NCT01297062|489833|P6|NOT COMPLETED|Overall Study||1
201900|NCT01297062|489834|P5|NOT COMPLETED|Overall Study||2
201901|NCT01297062|489835|P4|NOT COMPLETED|Overall Study||1
201902|NCT01297062|489836|P3|NOT COMPLETED|Overall Study||2
201903|NCT01297062|489837|P2|NOT COMPLETED|Overall Study||1
201904|NCT01297062|489838|P1|NOT COMPLETED|Overall Study||4
201905|NCT01297062|489832|P7|COMPLETED|Overall Study||0
201906|NCT01297062|489833|P6|COMPLETED|Overall Study||13
201907|NCT01297062|489834|P5|COMPLETED|Overall Study||13
201908|NCT01297062|489835|P4|COMPLETED|Overall Study||13
201909|NCT01297062|489836|P3|COMPLETED|Overall Study||12
201910|NCT01297062|489837|P2|COMPLETED|Overall Study||13
201911|NCT01297062|489838|P1|COMPLETED|Overall Study||11
201912|NCT01297062|489832|P7|Evaluable Population|Overall Study||0
201913|NCT01297062|489833|P6|Evaluable Population|Overall Study||13
201914|NCT01297062|489834|P5|Evaluable Population|Overall Study||13
201915|NCT01297062|489835|P4|Evaluable Population|Overall Study||13
201916|NCT01297062|489836|P3|Evaluable Population|Overall Study||12
201917|NCT01297062|489837|P2|Evaluable Population|Overall Study||12
201918|NCT01297062|489838|P1|Evaluable Population|Overall Study||11
201919|NCT01297062|489832|P7|Intent to Treat (ITT)|Overall Study||0
201920|NCT01297062|489833|P6|Intent to Treat (ITT)|Overall Study||14
201921|NCT01297062|489834|P5|Intent to Treat (ITT)|Overall Study||15
201922|NCT01297062|489835|P4|Intent to Treat (ITT)|Overall Study||14
201923|NCT01297062|489836|P3|Intent to Treat (ITT)|Overall Study||14
201924|NCT01297062|489837|P2|Intent to Treat (ITT)|Overall Study||14
201925|NCT01297062|489838|P1|Intent to Treat (ITT)|Overall Study||15
201926|NCT01297062|489832|P7|STARTED|Overall Study||8
201927|NCT01297062|489833|P6|STARTED|Overall Study||14
201928|NCT01297062|489834|P5|STARTED|Overall Study||15
201929|NCT01297062|489835|P4|STARTED|Overall Study||14
201930|NCT01297062|489836|P3|STARTED|Overall Study||14
201931|NCT01297062|489837|P2|STARTED|Overall Study||14
201932|NCT01297062|489838|P1|STARTED|Overall Study||15
201933|NCT01296841|489862|P2|NOT COMPLETED|Overall Study||0
201934|NCT01296841|489863|P1|NOT COMPLETED|Overall Study||0
201935|NCT01296841|489862|P2|COMPLETED|Overall Study||15
201936|NCT01296841|489863|P1|COMPLETED|Overall Study||19
201937|NCT01296841|489862|P2|STARTED|Overall Study||15
201938|NCT01296841|489863|P1|STARTED|Overall Study||19
201939|NCT01296815|489875|P2|NOT COMPLETED|Overall Study||0
201940|NCT01296815|489876|P1|NOT COMPLETED|Overall Study||0
201941|NCT01296815|489875|P2|COMPLETED|Overall Study||7
201942|NCT01296815|489876|P1|COMPLETED|Overall Study||7
201943|NCT01296815|489875|P2|STARTED|Overall Study||7
201944|NCT01296815|489876|P1|STARTED|Overall Study||7
201945|NCT01296763|489885|P3|NOT COMPLETED|Overall Study||0
201946|NCT01296763|489886|P2|NOT COMPLETED|Overall Study||0
201947|NCT01296763|489887|P1|NOT COMPLETED|Overall Study||0
201948|NCT01296763|489885|P3|COMPLETED|Overall Study||6
201949|NCT01296763|489886|P2|COMPLETED|Overall Study||5
201950|NCT01296763|489887|P1|COMPLETED|Overall Study||7
201951|NCT01296763|489885|P3|STARTED|Overall Study||6
201952|NCT01296763|489886|P2|STARTED|Overall Study||5
201953|NCT01296763|489887|P1|STARTED|Overall Study||7
201954|NCT01296698|489900|P2|NOT COMPLETED|Overall Study||13
201955|NCT01296698|489901|P1|NOT COMPLETED|Overall Study||244
201956|NCT01296698|489900|P2|COMPLETED|Overall Study||0
201957|NCT01296698|489901|P1|COMPLETED|Overall Study||0
201958|NCT01296698|489900|P2|STARTED|Overall Study||13
201959|NCT01296698|489901|P1|STARTED|Overall Study||244
201960|NCT01296672|489955|P2|NOT COMPLETED|Overall Study||18
201961|NCT01296672|489956|P1|NOT COMPLETED|Overall Study||73
201962|NCT01296672|489955|P2|COMPLETED|Overall Study||59
201963|NCT01296672|489956|P1|COMPLETED|Overall Study||233
201964|NCT01296672|489955|P2|STARTED|Overall Study||77
201965|NCT01296672|489956|P1|STARTED|Overall Study||306
201966|NCT01296646|489968|P2|NOT COMPLETED|Overall Study||11
201967|NCT01296646|489969|P1|NOT COMPLETED|Overall Study||11
201968|NCT01296646|489968|P2|COMPLETED|Overall Study||29
201969|NCT01296646|489969|P1|COMPLETED|Overall Study||29
201970|NCT01296646|489968|P2|STARTED|Overall Study||40
201971|NCT01296646|489969|P1|STARTED|Overall Study||40
201972|NCT01296568|489977|P1|NOT COMPLETED|Continued Access Phase||3
201973|NCT01296568|489977|P1|COMPLETED|Continued Access Phase|After study discontinuation participants assessed for disease progression (21-day safety follow-up).|0
201974|NCT01296568|489977|P1|STARTED|Continued Access Phase||3
201975|NCT01296568|489977|P1|NOT COMPLETED|[^14C]LY2603618 Single Dose and Washout||0
201976|NCT01296568|489977|P1|COMPLETED|[^14C]LY2603618 Single Dose and Washout||3
201977|NCT01296568|489977|P1|STARTED|[^14C]LY2603618 Single Dose and Washout||3
201978|NCT01296412|489993|P2|NOT COMPLETED|Overall Study||70
201979|NCT01296412|489994|P1|NOT COMPLETED|Overall Study||51
201980|NCT01296412|489993|P2|COMPLETED|Overall Study||257
201981|NCT01296412|489994|P1|COMPLETED|Overall Study||275
201982|NCT01296412|489993|P2|STARTED|Overall Study||327
201983|NCT01296412|489994|P1|STARTED|Overall Study||326
201984|NCT01296360|490008|P2|NOT COMPLETED|Overall Study||8
201985|NCT01296360|490009|P1|NOT COMPLETED|Overall Study||6
201986|NCT01296360|490008|P2|COMPLETED|Overall Study||142
201987|NCT01296360|490009|P1|COMPLETED|Overall Study||144
201988|NCT01296360|490008|P2|Visit 2a (Month 13)|Overall Study||0
201989|NCT01296360|490009|P1|Visit 2a (Month 13)|Overall Study|visit in Booster Group only: ~13 months after immunization in IC51-323 (i.e., 1 month post booster)|148
201990|NCT01296360|490008|P2|Visit 2 (Month 12)|Overall Study||149
201991|NCT01296360|490009|P1|Visit 2 (Month 12)|Overall Study|booster was administered|148
201992|NCT01296360|490008|P2|STARTED|Overall Study||150
201993|NCT01296360|490009|P1|STARTED|Overall Study||150
201994|NCT01296347|490017|P2|NOT COMPLETED|12 Month Follow up||3
201995|NCT01296347|490018|P1|NOT COMPLETED|12 Month Follow up||4
201996|NCT01296347|490017|P2|COMPLETED|12 Month Follow up||28
201997|NCT01296347|490018|P1|COMPLETED|12 Month Follow up||28
201998|NCT01296347|490017|P2|STARTED|12 Month Follow up||31
201999|NCT01296347|490018|P1|STARTED|12 Month Follow up||32
202000|NCT01296347|490017|P2|NOT COMPLETED|6 Month Follow up||2
202001|NCT01296347|490018|P1|NOT COMPLETED|6 Month Follow up||2
202002|NCT01296347|490017|P2|COMPLETED|6 Month Follow up||31
202003|NCT01296347|490018|P1|COMPLETED|6 Month Follow up||32
202004|NCT01296347|490017|P2|STARTED|6 Month Follow up||33
202005|NCT01296347|490018|P1|STARTED|6 Month Follow up||34
202006|NCT01296347|490017|P2|NOT COMPLETED|3 Month Follow up||1
202007|NCT01296347|490018|P1|NOT COMPLETED|3 Month Follow up||1
202008|NCT01296347|490017|P2|COMPLETED|3 Month Follow up||33
202009|NCT01296347|490018|P1|COMPLETED|3 Month Follow up||34
202010|NCT01296347|490017|P2|STARTED|3 Month Follow up||34
202011|NCT01296347|490018|P1|STARTED|3 Month Follow up||35
202012|NCT01296347|490017|P2|NOT COMPLETED|6 Week Follow up||1
202013|NCT01296347|490018|P1|NOT COMPLETED|6 Week Follow up||0
202014|NCT01296347|490017|P2|COMPLETED|6 Week Follow up||34
202015|NCT01296347|490018|P1|COMPLETED|6 Week Follow up||35
202016|NCT01296347|490017|P2|STARTED|6 Week Follow up||35
202017|NCT01296347|490018|P1|STARTED|6 Week Follow up||35
202018|NCT01296347|490017|P2|NOT COMPLETED|Allocation||4
202019|NCT01296347|490018|P1|NOT COMPLETED|Allocation||3
202020|NCT01296347|490017|P2|COMPLETED|Allocation||35
202021|NCT01296347|490018|P1|COMPLETED|Allocation||35
202022|NCT01296347|490017|P2|STARTED|Allocation||39
202023|NCT01296347|490018|P1|STARTED|Allocation||38
202024|NCT01296191|490036|P2|NOT COMPLETED|Overall Study||1
202025|NCT01296191|490037|P1|NOT COMPLETED|Overall Study||3
202026|NCT01296191|490036|P2|COMPLETED|Overall Study||59
202027|NCT01296191|490037|P1|COMPLETED|Overall Study||57
202028|NCT01296191|490036|P2|STARTED|Overall Study||60
202029|NCT01296191|490037|P1|STARTED|Overall Study||60
202030|NCT01296152|490043|P1|NOT COMPLETED|Overall Study||1
202031|NCT01296152|490043|P1|COMPLETED|Overall Study||24
202032|NCT01296152|490043|P1|STARTED|Overall Study||25
202033|NCT01296035|490070|P1|NOT COMPLETED|Overall Study||1
202034|NCT01296035|490070|P1|COMPLETED|Overall Study||7
202035|NCT01296035|490070|P1|STARTED|Overall Study||8
202036|NCT01295905|490077|P2|NOT COMPLETED|Overall Study||0
202037|NCT01295905|490078|P1|NOT COMPLETED|Overall Study||2
202038|NCT01295905|490077|P2|COMPLETED|Overall Study||30
202039|NCT01295905|490078|P1|COMPLETED|Overall Study||58
202040|NCT01295905|490077|P2|STARTED|Overall Study||30
202041|NCT01295905|490078|P1|STARTED|Overall Study||60
202042|NCT01295879|490090|P1|NOT COMPLETED|Overall Study||0
202043|NCT01295879|490090|P1|COMPLETED|Overall Study||29
202044|NCT01295879|490090|P1|STARTED|Overall Study||29
202045|NCT01295840|490096|P1|NOT COMPLETED|Overall Study||1
202046|NCT01295840|490096|P1|COMPLETED|Overall Study||50
202047|NCT01295840|490096|P1|STARTED|Overall Study||51
202048|NCT01295814|490112|P2|NOT COMPLETED|Overall Study||2
202049|NCT01295814|490113|P1|NOT COMPLETED|Overall Study||2
202050|NCT01295814|490112|P2|COMPLETED|Overall Study||19
202051|NCT01295814|490113|P1|COMPLETED|Overall Study||20
202052|NCT01295814|490112|P2|STARTED|Overall Study||21
202053|NCT01295814|490113|P1|STARTED|Overall Study||22
202054|NCT01295710|490129|P2|NOT COMPLETED|Overall Study||50
202055|NCT01295710|490130|P1|NOT COMPLETED|Overall Study||78
202056|NCT01295710|490129|P2|COMPLETED|Overall Study||78
202057|NCT01295710|490130|P1|COMPLETED|Overall Study||48
202058|NCT01295710|490129|P2|STARTED|Overall Study|Randomized and treated|128
202059|NCT01295710|490130|P1|STARTED|Overall Study|Randomized and treated|126
202060|NCT01295671|490193|P3|NOT COMPLETED|Overall Study||3
202061|NCT01295671|490194|P2|NOT COMPLETED|Overall Study||7
202062|NCT01295671|490195|P1|NOT COMPLETED|Overall Study||7
202063|NCT01295671|490193|P3|COMPLETED|Overall Study||66
202064|NCT01295671|490194|P2|COMPLETED|Overall Study||60
202065|NCT01295671|490195|P1|COMPLETED|Overall Study||60
202066|NCT01295671|490193|P3|STARTED|Overall Study||69
202067|NCT01295671|490194|P2|STARTED|Overall Study||67
202068|NCT01295671|490195|P1|STARTED|Overall Study||67
202069|NCT01295515|490233|P1|NOT COMPLETED|Overall Study||0
202070|NCT01295515|490233|P1|COMPLETED|Overall Study||7
202071|NCT01295515|490233|P1|STARTED|Overall Study||7
202072|NCT01295320|490241|P1|NOT COMPLETED|Overall Study||10
202073|NCT01295320|490241|P1|COMPLETED|Overall Study||119
202074|NCT01295320|490241|P1|STARTED|Overall Study||129
202075|NCT01295281|490258|P2|NOT COMPLETED|Second Intervention (7days)||0
202076|NCT01295281|490259|P1|NOT COMPLETED|Second Intervention (7days)||0
202077|NCT01295281|490258|P2|COMPLETED|Second Intervention (7days)||51
202078|NCT01295281|490259|P1|COMPLETED|Second Intervention (7days)||53
202079|NCT01295281|490258|P2|STARTED|Second Intervention (7days)||51
202080|NCT01295281|490259|P1|STARTED|Second Intervention (7days)||53
202081|NCT01295281|490258|P2|NOT COMPLETED|First Intervention (7 Days)||1
202082|NCT01295281|490259|P1|NOT COMPLETED|First Intervention (7 Days)||0
202083|NCT01295281|490258|P2|COMPLETED|First Intervention (7 Days)||51
202084|NCT01295281|490259|P1|COMPLETED|First Intervention (7 Days)||53
202085|NCT01295281|490258|P2|STARTED|First Intervention (7 Days)||52
202086|NCT01295281|490259|P1|STARTED|First Intervention (7 Days)||53
202087|NCT01295216|490267|P2|NOT COMPLETED|Overall Study||34
202088|NCT01295216|490268|P1|NOT COMPLETED|Overall Study||50
202089|NCT01295216|490267|P2|COMPLETED|Overall Study||287
202090|NCT01295216|490268|P1|COMPLETED|Overall Study||266
202091|NCT01295216|490267|P2|STARTED|Overall Study||321
202092|NCT01295216|490268|P1|STARTED|Overall Study||316
202093|NCT01295112|490286|P2|NOT COMPLETED|Overall Study||0
202094|NCT01295112|490287|P1|NOT COMPLETED|Overall Study||0
202095|NCT01295112|490286|P2|COMPLETED|Overall Study||33
202096|NCT01295112|490287|P1|COMPLETED|Overall Study||35
202097|NCT01295112|490286|P2|STARTED|Overall Study||33
202098|NCT01295112|490287|P1|STARTED|Overall Study||35
202099|NCT01295034|490297|P2|NOT COMPLETED|Overall Study||5
202100|NCT01295034|490298|P1|NOT COMPLETED|Overall Study||5
202101|NCT01295034|490297|P2|COMPLETED|Overall Study||25
202102|NCT01295034|490298|P1|COMPLETED|Overall Study||27
202103|NCT01295034|490297|P2|STARTED|Overall Study||30
202104|NCT01295034|490298|P1|STARTED|Overall Study||32
202105|NCT01294917|490306|P1|NOT COMPLETED|Overall Study||6
202106|NCT01294917|490306|P1|COMPLETED|Overall Study||36
202107|NCT01294917|490306|P1|Received OptiFree RepleniSH MPS|Overall Study||36
202108|NCT01294917|490306|P1|Received Clear Care|Overall Study||36
202109|NCT01294917|490306|P1|Received Investigational MPS|Overall Study||36
202110|NCT01294917|490306|P1|STARTED|Overall Study||42
202111|NCT01294800|490316|P4|NOT COMPLETED|Overall Study||16
202112|NCT01294800|490317|P3|NOT COMPLETED|Overall Study||17
202113|NCT01294800|490318|P2|NOT COMPLETED|Overall Study||10
202114|NCT01294800|490319|P1|NOT COMPLETED|Overall Study||11
202115|NCT01294800|490316|P4|COMPLETED|Overall Study||97
202116|NCT01294800|490317|P3|COMPLETED|Overall Study||96
202117|NCT01294800|490318|P2|COMPLETED|Overall Study||103
202118|NCT01294800|490319|P1|COMPLETED|Overall Study||100
202119|NCT01294800|490316|P4|STARTED|Overall Study||113
202120|NCT01294800|490317|P3|STARTED|Overall Study||113
202121|NCT01294800|490318|P2|STARTED|Overall Study||113
202122|NCT01294800|490319|P1|STARTED|Overall Study||111
202123|NCT01294787|490345|P6|NOT COMPLETED|Period 3||0
202124|NCT01294787|490346|P5|NOT COMPLETED|Period 3||1
202125|NCT01294787|490347|P4|NOT COMPLETED|Period 3||0
202126|NCT01294787|490348|P3|NOT COMPLETED|Period 3||0
202127|NCT01294787|490349|P2|NOT COMPLETED|Period 3||0
202128|NCT01294787|490350|P1|NOT COMPLETED|Period 3||0
202129|NCT01294787|490345|P6|COMPLETED|Period 3||13
202130|NCT01294787|490346|P5|COMPLETED|Period 3||13
202131|NCT01294787|490347|P4|COMPLETED|Period 3||9
202132|NCT01294787|490348|P3|COMPLETED|Period 3||13
202133|NCT01294787|490349|P2|COMPLETED|Period 3||13
202134|NCT01294787|490350|P1|COMPLETED|Period 3||12
202135|NCT01294787|490345|P6|STARTED|Period 3||13
202136|NCT01294787|490346|P5|STARTED|Period 3||14
202137|NCT01294787|490347|P4|STARTED|Period 3||9
202138|NCT01294787|490348|P3|STARTED|Period 3||13
202139|NCT01294787|490349|P2|STARTED|Period 3||13
202140|NCT01294787|490350|P1|STARTED|Period 3||12
202141|NCT01294787|490345|P6|NOT COMPLETED|Period 2||0
202142|NCT01294787|490346|P5|NOT COMPLETED|Period 2||0
202143|NCT01294787|490347|P4|NOT COMPLETED|Period 2||2
202144|NCT01294787|490348|P3|NOT COMPLETED|Period 2||0
202145|NCT01294787|490349|P2|NOT COMPLETED|Period 2||3
202146|NCT01294787|490350|P1|NOT COMPLETED|Period 2||0
202147|NCT01294787|490345|P6|COMPLETED|Period 2||13
202148|NCT01294787|490346|P5|COMPLETED|Period 2||14
202149|NCT01294787|490347|P4|COMPLETED|Period 2||9
202150|NCT01294787|490348|P3|COMPLETED|Period 2||13
202151|NCT01294787|490349|P2|COMPLETED|Period 2||13
202152|NCT01294787|490350|P1|COMPLETED|Period 2||12
202153|NCT01294787|490345|P6|STARTED|Period 2||13
202154|NCT01294787|490346|P5|STARTED|Period 2||14
202155|NCT01294787|490347|P4|STARTED|Period 2||11
202156|NCT01294787|490348|P3|STARTED|Period 2||13
202157|NCT01294787|490349|P2|STARTED|Period 2||16
202158|NCT01294787|490350|P1|STARTED|Period 2||12
202159|NCT01294787|490345|P6|NOT COMPLETED|Period 1||2
202160|NCT01294787|490346|P5|NOT COMPLETED|Period 1||2
202161|NCT01294787|490347|P4|NOT COMPLETED|Period 1||1
202162|NCT01294787|490348|P3|NOT COMPLETED|Period 1||1
202163|NCT01294787|490349|P2|NOT COMPLETED|Period 1||0
202164|NCT01294787|490350|P1|NOT COMPLETED|Period 1||0
202165|NCT01294787|490345|P6|COMPLETED|Period 1||13
202166|NCT01294787|490346|P5|COMPLETED|Period 1||14
202167|NCT01294787|490347|P4|COMPLETED|Period 1||11
202168|NCT01294787|490348|P3|COMPLETED|Period 1||13
202169|NCT01294787|490349|P2|COMPLETED|Period 1||16
202170|NCT01294787|490350|P1|COMPLETED|Period 1||12
202171|NCT01294787|490345|P6|STARTED|Period 1|One randomized participant did not receive study drug|15
202172|NCT01294787|490346|P5|STARTED|Period 1||16
202173|NCT01294787|490347|P4|STARTED|Period 1||12
202174|NCT01294787|490348|P3|STARTED|Period 1||14
202175|NCT01294787|490349|P2|STARTED|Period 1||16
202176|NCT01294787|490350|P1|STARTED|Period 1||12
202177|NCT01294748|490394|P2|NOT COMPLETED|Overall Study||2
202178|NCT01294748|490395|P1|NOT COMPLETED|Overall Study||5
202179|NCT01294748|490394|P2|COMPLETED|Overall Study|At 270 days|59
202180|NCT01294748|490395|P1|COMPLETED|Overall Study|At 270 days|118
202181|NCT01294748|490394|P2|STARTED|Overall Study||61
202182|NCT01294748|490395|P1|STARTED|Overall Study||123
202183|NCT01294709|490421|P2|NOT COMPLETED|Period 2||0
202184|NCT01294709|490422|P1|NOT COMPLETED|Period 2||1
202185|NCT01294709|490421|P2|COMPLETED|Period 2||31
202186|NCT01294709|490422|P1|COMPLETED|Period 2||28
202187|NCT01294709|490421|P2|STARTED|Period 2||31
202188|NCT01294709|490422|P1|STARTED|Period 2||29
202189|NCT01294709|490421|P2|NOT COMPLETED|Washout Period||1
202190|NCT01294709|490422|P1|NOT COMPLETED|Washout Period||1
202191|NCT01294709|490421|P2|COMPLETED|Washout Period||31
202192|NCT01294709|490422|P1|COMPLETED|Washout Period||29
202193|NCT01294709|490421|P2|STARTED|Washout Period||32
202194|NCT01294709|490422|P1|STARTED|Washout Period||30
202195|NCT01294709|490421|P2|NOT COMPLETED|Period 1||1
202196|NCT01294709|490422|P1|NOT COMPLETED|Period 1||1
202197|NCT01294709|490421|P2|COMPLETED|Period 1||32
202198|NCT01294709|490422|P1|COMPLETED|Period 1||30
202199|NCT01294709|490421|P2|STARTED|Period 1||33
202200|NCT01294709|490422|P1|STARTED|Period 1||31
202201|NCT01294696|490441|P1|NOT COMPLETED|Overall Study||74
202202|NCT01294696|490441|P1|COMPLETED|Overall Study||1187
202203|NCT01294696|490441|P1|STARTED|Overall Study||1261
202204|NCT01294683|490455|P2|NOT COMPLETED|Post Crossover (Period III)||32
202205|NCT01294683|490456|P1|NOT COMPLETED|Post Crossover (Period III)||33
202206|NCT01294683|490455|P2|COMPLETED|Post Crossover (Period III)||190
202207|NCT01294683|490456|P1|COMPLETED|Post Crossover (Period III)||199
202208|NCT01294683|490455|P2|STARTED|Post Crossover (Period III)||222
202209|NCT01294683|490456|P1|STARTED|Post Crossover (Period III)||232
202210|NCT01294683|490455|P2|NOT COMPLETED|Precrossover (Periods I/II)||266
202211|NCT01294683|490456|P1|NOT COMPLETED|Precrossover (Periods I/II)||257
202212|NCT01294683|490455|P2|COMPLETED|Precrossover (Periods I/II)||222
202213|NCT01294683|490456|P1|COMPLETED|Precrossover (Periods I/II)||232
202214|NCT01294683|490455|P2|Treated|Precrossover (Periods I/II)||486
202215|NCT01294683|490456|P1|Treated|Precrossover (Periods I/II)||486
202216|NCT01294683|490455|P2|STARTED|Precrossover (Periods I/II)||488
202217|NCT01294683|490456|P1|STARTED|Precrossover (Periods I/II)||489
202218|NCT01294644|490509|P3|NOT COMPLETED|Overall Study||14
202219|NCT01294644|490510|P2|NOT COMPLETED|Overall Study||10
202220|NCT01294644|490511|P1|NOT COMPLETED|Overall Study||10
202221|NCT01294644|490509|P3|COMPLETED|Overall Study||103
202222|NCT01294644|490510|P2|COMPLETED|Overall Study||112
202223|NCT01294644|490511|P1|COMPLETED|Overall Study||111
202224|NCT01294644|490509|P3|Received Treatment|Overall Study||114
202225|NCT01294644|490510|P2|Received Treatment|Overall Study||122
202226|NCT01294644|490511|P1|Received Treatment|Overall Study||118
202227|NCT01294644|490509|P3|STARTED|Overall Study||117
202228|NCT01294644|490510|P2|STARTED|Overall Study||122
202229|NCT01294644|490511|P1|STARTED|Overall Study||121
202230|NCT01294592|490542|P2|NOT COMPLETED|Overall Study||73
202231|NCT01294592|490543|P1|NOT COMPLETED|Overall Study||77
202232|NCT01294592|490542|P2|COMPLETED|Overall Study||300
202233|NCT01294592|490543|P1|COMPLETED|Overall Study||292
202234|NCT01294592|490542|P2|STARTED|Overall Study||373
202235|NCT01294592|490543|P1|STARTED|Overall Study||369
202236|NCT01294579|490571|P1|NOT COMPLETED|Overall Study||35
202237|NCT01294579|490571|P1|COMPLETED|Overall Study||14
202238|NCT01294579|490571|P1|STARTED|Overall Study||49
202239|NCT01294553|490581|P1|NOT COMPLETED|Overall Study||269
202240|NCT01294553|490581|P1|COMPLETED|Overall Study||713
202241|NCT01294553|490581|P1|STARTED|Overall Study||982
202242|NCT01294514|490587|P1|NOT COMPLETED|Overall Study||1
202243|NCT01294514|490587|P1|COMPLETED|Overall Study||26
202244|NCT01294514|490587|P1|STARTED|Overall Study||27
202245|NCT01294462|490597|P2|NOT COMPLETED|Overall Study||63
202246|NCT01294462|490598|P1|NOT COMPLETED|Overall Study||66
202247|NCT01294462|490597|P2|COMPLETED|Overall Study||337
202248|NCT01294462|490598|P1|COMPLETED|Overall Study||335
202249|NCT01294462|490597|P2|Received Randomized Treatment|Overall Study||380
202250|NCT01294462|490598|P1|Received Randomized Treatment|Overall Study||387
202251|NCT01294462|490597|P2|STARTED|Overall Study||400
202252|NCT01294462|490598|P1|STARTED|Overall Study||401
202253|NCT01294449|490612|P2|NOT COMPLETED|Overall Study||15
202254|NCT01294449|490613|P1|NOT COMPLETED|Overall Study||12
202255|NCT01294449|490612|P2|COMPLETED|Overall Study||237
202256|NCT01294449|490613|P1|COMPLETED|Overall Study||144
202257|NCT01294449|490612|P2|Consent to Registry|Overall Study||245
202258|NCT01294449|490613|P1|Consent to Registry|Overall Study||149
202259|NCT01294449|490612|P2|STARTED|Overall Study||252
202260|NCT01294449|490613|P1|STARTED|Overall Study||156
202261|NCT01294436|490621|P2|NOT COMPLETED|Overall Study||70
202262|NCT01294436|490622|P1|NOT COMPLETED|Overall Study||28
202263|NCT01294436|490621|P2|COMPLETED|Overall Study||409
202264|NCT01294436|490622|P1|COMPLETED|Overall Study||221
202265|NCT01294436|490621|P2|STARTED|Overall Study||479
202266|NCT01294436|490622|P1|STARTED|Overall Study||249
202267|NCT01294423|490657|P3|NOT COMPLETED|Overall Study||8
202268|NCT01294423|490658|P2|NOT COMPLETED|Overall Study||9
202269|NCT01294423|490659|P1|NOT COMPLETED|Overall Study||5
202270|NCT01294423|490657|P3|COMPLETED|Overall Study||79
202271|NCT01294423|490658|P2|COMPLETED|Overall Study||79
202272|NCT01294423|490659|P1|COMPLETED|Overall Study||81
202273|NCT01294423|490657|P3|STARTED|Overall Study||87
202274|NCT01294423|490658|P2|STARTED|Overall Study||88
202275|NCT01294423|490659|P1|STARTED|Overall Study||86
202276|NCT01294397|490673|P1|NOT COMPLETED|Overall Study||2
202277|NCT01294397|490673|P1|COMPLETED|Overall Study||17
202278|NCT01294397|490673|P1|STARTED|Overall Study||19
202279|NCT01294384|490686|P3|NOT COMPLETED|Overall Study||9
202280|NCT01294384|490687|P2|NOT COMPLETED|Overall Study||6
202281|NCT01294384|490688|P1|NOT COMPLETED|Overall Study||4
202282|NCT01294384|490686|P3|COMPLETED|Overall Study||95
202283|NCT01294384|490687|P2|COMPLETED|Overall Study||94
202284|NCT01294384|490688|P1|COMPLETED|Overall Study||97
202285|NCT01294384|490686|P3|STARTED|Overall Study||104
202286|NCT01294384|490687|P2|STARTED|Overall Study||100
202287|NCT01294384|490688|P1|STARTED|Overall Study||101
202288|NCT01294371|490717|P1|NOT COMPLETED|Overall Study||34
202289|NCT01294371|490717|P1|COMPLETED|Overall Study||357
202290|NCT01294371|490717|P1|Treated|Overall Study||390
202291|NCT01294371|490717|P1|STARTED|Overall Study||391
202292|NCT01294358|490725|P5|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||1
202293|NCT01294358|490726|P4|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
202294|NCT01294358|490727|P3|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
202295|NCT01294358|490728|P2|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
202296|NCT01294358|490729|P1|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
202297|NCT01294358|490725|P5|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
202298|NCT01294358|490726|P4|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
202299|NCT01294358|490727|P3|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
202300|NCT01294358|490728|P2|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
202301|NCT01294358|490729|P1|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
202302|NCT01294358|490725|P5|STARTED|Cohort 5: 3/8/12-3/9/12|1 participant from 96mg move to 115mg.|1
202303|NCT01294358|490726|P4|STARTED|Cohort 5: 3/8/12-3/9/12||0
202304|NCT01294358|490727|P3|STARTED|Cohort 5: 3/8/12-3/9/12||0
202305|NCT01294358|490728|P2|STARTED|Cohort 5: 3/8/12-3/9/12||0
202306|NCT01294358|490729|P1|STARTED|Cohort 5: 3/8/12-3/9/12||0
202307|NCT01294358|490725|P5|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
202308|NCT01294358|490726|P4|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||1
202309|NCT01294358|490727|P3|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
202310|NCT01294358|490728|P2|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
202311|NCT01294358|490729|P1|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
202312|NCT01294358|490725|P5|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
202313|NCT01294358|490726|P4|COMPLETED|Cohort 4: 12/30/11-2/17/17||1
202314|NCT01294358|490727|P3|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
202315|NCT01294358|490728|P2|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
202316|NCT01294358|490729|P1|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
202317|NCT01294358|490725|P5|STARTED|Cohort 4: 12/30/11-2/17/17||0
202318|NCT01294358|490726|P4|STARTED|Cohort 4: 12/30/11-2/17/17|2 participants from 72mg move to 96mg.|2
202319|NCT01294358|490727|P3|STARTED|Cohort 4: 12/30/11-2/17/17||0
202320|NCT01294358|490728|P2|STARTED|Cohort 4: 12/30/11-2/17/17||0
202321|NCT01294358|490729|P1|STARTED|Cohort 4: 12/30/11-2/17/17||0
202322|NCT01294358|490725|P5|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
202323|NCT01294358|490726|P4|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
202324|NCT01294358|490727|P3|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||2
202325|NCT01294358|490728|P2|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
202326|NCT01294358|490729|P1|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
202327|NCT01294358|490725|P5|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
202328|NCT01294358|490726|P4|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
202329|NCT01294358|490727|P3|COMPLETED|Cohort 3: 12/1/11-10/6/12||2
202330|NCT01294358|490728|P2|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
202331|NCT01294358|490729|P1|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
202332|NCT01294358|490725|P5|STARTED|Cohort 3: 12/1/11-10/6/12||0
202333|NCT01294358|490726|P4|STARTED|Cohort 3: 12/1/11-10/6/12||0
202334|NCT01294358|490727|P3|STARTED|Cohort 3: 12/1/11-10/6/12|4 participants from 36mg move to 72mg.|4
202335|NCT01294358|490728|P2|STARTED|Cohort 3: 12/1/11-10/6/12||0
202336|NCT01294358|490729|P1|STARTED|Cohort 3: 12/1/11-10/6/12||0
202337|NCT01294358|490725|P5|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
202338|NCT01294358|490726|P4|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
202339|NCT01294358|490727|P3|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
202340|NCT01294358|490728|P2|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||2
202341|NCT01294358|490729|P1|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
202342|NCT01294358|490725|P5|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
202343|NCT01294358|490726|P4|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
202344|NCT01294358|490727|P3|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
202345|NCT01294358|490728|P2|COMPLETED|Cohort 2: 6/9/11-9/17/12||4
202346|NCT01294358|490729|P1|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
202347|NCT01294358|490725|P5|STARTED|Cohort 2: 6/9/11-9/17/12||0
202348|NCT01294358|490726|P4|STARTED|Cohort 2: 6/9/11-9/17/12||0
202349|NCT01294358|490727|P3|STARTED|Cohort 2: 6/9/11-9/17/12||0
202350|NCT01294358|490728|P2|STARTED|Cohort 2: 6/9/11-9/17/12|4 participants from 18mg move to 36mg and 2 additional participants were enrolled at this dose.|6
202351|NCT01294358|490729|P1|STARTED|Cohort 2: 6/9/11-9/17/12||0
202352|NCT01294358|490725|P5|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
202353|NCT01294358|490726|P4|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
202354|NCT01294358|490727|P3|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
202355|NCT01294358|490728|P2|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
202356|NCT01294358|490729|P1|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
202357|NCT01294358|490725|P5|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
202358|NCT01294358|490726|P4|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
202359|NCT01294358|490727|P3|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
202360|NCT01294358|490728|P2|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
202361|NCT01294358|490729|P1|COMPLETED|Cohort 1: 5/11/11-11/9/11||4
202362|NCT01294358|490725|P5|STARTED|Cohort 1: 5/11/11-11/9/11||0
202363|NCT01294358|490726|P4|STARTED|Cohort 1: 5/11/11-11/9/11||0
202364|NCT01294358|490727|P3|STARTED|Cohort 1: 5/11/11-11/9/11||0
202365|NCT01294358|490728|P2|STARTED|Cohort 1: 5/11/11-11/9/11||0
202366|NCT01294358|490729|P1|STARTED|Cohort 1: 5/11/11-11/9/11||4
202367|NCT01294319|490791|P8|NOT COMPLETED|Overall Study||0
202368|NCT01294319|490792|P7|NOT COMPLETED|Overall Study||0
202369|NCT01294319|490793|P6|NOT COMPLETED|Overall Study||0
202370|NCT01294319|490794|P5|NOT COMPLETED|Overall Study||0
202371|NCT01294319|490795|P4|NOT COMPLETED|Overall Study||0
202372|NCT01294319|490796|P3|NOT COMPLETED|Overall Study||0
202373|NCT01294319|490797|P2|NOT COMPLETED|Overall Study||0
202374|NCT01294319|490798|P1|NOT COMPLETED|Overall Study||0
202375|NCT01294319|490791|P8|COMPLETED|Overall Study||5
202376|NCT01294319|490792|P7|COMPLETED|Overall Study||5
202377|NCT01294319|490793|P6|COMPLETED|Overall Study||4
202378|NCT01294319|490794|P5|COMPLETED|Overall Study||5
202379|NCT01294319|490795|P4|COMPLETED|Overall Study||5
202380|NCT01294319|490796|P3|COMPLETED|Overall Study||5
202381|NCT01294319|490797|P2|COMPLETED|Overall Study||6
202382|NCT01294319|490798|P1|COMPLETED|Overall Study||4
202383|NCT01294319|490791|P8|STARTED|Overall Study||5
202384|NCT01294319|490792|P7|STARTED|Overall Study||5
202385|NCT01294319|490793|P6|STARTED|Overall Study||4
202386|NCT01294319|490794|P5|STARTED|Overall Study||5
202387|NCT01294319|490795|P4|STARTED|Overall Study||5
202388|NCT01294319|490796|P3|STARTED|Overall Study||5
202389|NCT01294319|490797|P2|STARTED|Overall Study||6
202390|NCT01294319|490798|P1|STARTED|Overall Study||4
202391|NCT01294306|490808|P2|NOT COMPLETED|Overall Study||0
202392|NCT01294306|490809|P1|NOT COMPLETED|Overall Study||0
202393|NCT01294306|490808|P2|COMPLETED|Overall Study||35
202394|NCT01294306|490809|P1|COMPLETED|Overall Study||45
202395|NCT01294306|490808|P2|STARTED|Overall Study||35
202396|NCT01294306|490809|P1|STARTED|Overall Study||45
202397|NCT01294267|490823|P1|NOT COMPLETED|Overall Study||0
202398|NCT01294267|490823|P1|COMPLETED|Overall Study||20
202399|NCT01294267|490823|P1|STARTED|Overall Study||20
202400|NCT01294241|490829|P1|NOT COMPLETED|Overall Study||0
202401|NCT01294241|490829|P1|COMPLETED|Overall Study||10
202402|NCT01294241|490829|P1|STARTED|Overall Study||10
202403|NCT01294228|490837|P1|NOT COMPLETED|Overall Study||0
202404|NCT01294228|490837|P1|COMPLETED|Overall Study||1001
202405|NCT01294228|490837|P1|STARTED|Overall Study||1001
202406|NCT01294163|490844|P3|NOT COMPLETED|Overall Study||3
202407|NCT01294163|490845|P2|NOT COMPLETED|Overall Study||0
202408|NCT01294163|490846|P1|NOT COMPLETED|Overall Study||1
202409|NCT01294163|490844|P3|COMPLETED|Overall Study||163
202410|NCT01294163|490845|P2|COMPLETED|Overall Study||165
202411|NCT01294163|490846|P1|COMPLETED|Overall Study||177
202412|NCT01294163|490844|P3|STARTED|Overall Study||166
202413|NCT01294163|490845|P2|STARTED|Overall Study||165
202414|NCT01294163|490846|P1|STARTED|Overall Study||178
202415|NCT01294150|490857|P2|NOT COMPLETED|Overall Study||2
202416|NCT01294150|490858|P1|NOT COMPLETED|Overall Study||2
202417|NCT01294150|490857|P2|COMPLETED|Overall Study||64
202418|NCT01294150|490858|P1|COMPLETED|Overall Study||138
202419|NCT01294150|490857|P2|STARTED|Overall Study||66
202420|NCT01294150|490858|P1|STARTED|Overall Study||140
202421|NCT01294098|490871|P3|NOT COMPLETED|Overall Study||1
202422|NCT01294098|490872|P2|NOT COMPLETED|Overall Study||1
202423|NCT01294098|490873|P1|NOT COMPLETED|Overall Study||0
202424|NCT01294098|490871|P3|COMPLETED|Overall Study||0
202425|NCT01294098|490872|P2|COMPLETED|Overall Study||0
202426|NCT01294098|490873|P1|COMPLETED|Overall Study||0
202427|NCT01294098|490871|P3|STARTED|Overall Study||1
202428|NCT01294098|490872|P2|STARTED|Overall Study||1
202429|NCT01294098|490873|P1|STARTED|Overall Study||0
202430|NCT01294046|490887|P1|NOT COMPLETED|Overall Study||3
202431|NCT01294046|490887|P1|COMPLETED|Overall Study||0
202432|NCT01294046|490887|P1|STARTED|Overall Study||3
202433|NCT01293968|490902|P2|NOT COMPLETED|Overall Study||3
202434|NCT01293968|490903|P1|NOT COMPLETED|Overall Study||3
202435|NCT01293968|490902|P2|COMPLETED|Overall Study||14
202436|NCT01293968|490903|P1|COMPLETED|Overall Study||17
202437|NCT01293968|490902|P2|STARTED|Overall Study||17
202438|NCT01293968|490903|P1|STARTED|Overall Study||20
202439|NCT01293825|490909|P1|NOT COMPLETED|Overall Study||10
202440|NCT01293825|490909|P1|COMPLETED|Overall Study||20
202441|NCT01293825|490909|P1|STARTED|Overall Study||30
202442|NCT01293695|490923|P2|NOT COMPLETED|Overall Study||7
202443|NCT01293695|490924|P1|NOT COMPLETED|Overall Study||15
202444|NCT01293695|490923|P2|COMPLETED|Overall Study||87
202445|NCT01293695|490924|P1|COMPLETED|Overall Study||78
202446|NCT01293695|490923|P2|STARTED|Overall Study||94
202447|NCT01293695|490924|P1|STARTED|Overall Study||93
202448|NCT01293539|490938|P1|NOT COMPLETED|Overall Study||1
202449|NCT01293539|490938|P1|COMPLETED|Overall Study||9
202450|NCT01293539|490938|P1|STARTED|Overall Study||10
202451|NCT01293240|490942|P1|NOT COMPLETED|Overall Study||2
202452|NCT01293240|490942|P1|COMPLETED|Overall Study||115
202453|NCT01293240|490942|P1|STARTED|Overall Study||117
202454|NCT01293123|490959|P2|NOT COMPLETED|Overall Study||1
202455|NCT01293123|490960|P1|NOT COMPLETED|Overall Study||0
202456|NCT01293123|490959|P2|COMPLETED|Overall Study||0
202457|NCT01293123|490960|P1|COMPLETED|Overall Study||1
202458|NCT01293123|490959|P2|STARTED|Overall Study||1
202459|NCT01293123|490960|P1|STARTED|Overall Study||1
202460|NCT01293084|490974|P1|NOT COMPLETED|Overall Study||5
202461|NCT01293084|490974|P1|COMPLETED|Overall Study||12
202462|NCT01293084|490974|P1|STARTED|Overall Study||17
202463|NCT01293032|490986|P4|NOT COMPLETED|Treatment||1
202464|NCT01293032|490987|P3|NOT COMPLETED|Treatment||1
202465|NCT01293032|490988|P2|NOT COMPLETED|Treatment||5
202466|NCT01293032|490989|P1|NOT COMPLETED|Treatment||2
202467|NCT01293032|490986|P4|COMPLETED|Treatment||13
202468|NCT01293032|490987|P3|COMPLETED|Treatment||10
202469|NCT01293032|490988|P2|COMPLETED|Treatment||14
202470|NCT01293032|490989|P1|COMPLETED|Treatment||10
202471|NCT01293032|490986|P4|STARTED|Treatment||14
202472|NCT01293032|490987|P3|STARTED|Treatment||11
202473|NCT01293032|490988|P2|STARTED|Treatment|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|19
202474|NCT01293032|490989|P1|STARTED|Treatment||12
202475|NCT01293032|490986|P4|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
202476|NCT01293032|490987|P3|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||5
202477|NCT01293032|490988|P2|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
202478|NCT01293032|490989|P1|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
202479|NCT01293032|490986|P4|COMPLETED|Recurrence Score(RS)Assigned/Randomized||14
202480|NCT01293032|490987|P3|COMPLETED|Recurrence Score(RS)Assigned/Randomized|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|11
202481|NCT01293032|490988|P2|COMPLETED|Recurrence Score(RS)Assigned/Randomized||17
202482|NCT01293032|490989|P1|COMPLETED|Recurrence Score(RS)Assigned/Randomized||12
202483|NCT01293032|490986|P4|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||14
202484|NCT01293032|490987|P3|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||16
202485|NCT01293032|490988|P2|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||17
202486|NCT01293032|490989|P1|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||12
202487|NCT01293032|490986|P4|STARTED|Recurrence Score(RS)Assigned/Randomized||14
202488|NCT01293032|490987|P3|STARTED|Recurrence Score(RS)Assigned/Randomized||16
202489|NCT01293032|490988|P2|STARTED|Recurrence Score(RS)Assigned/Randomized||17
202490|NCT01293032|490989|P1|STARTED|Recurrence Score(RS)Assigned/Randomized||12
202491|NCT01293006|491000|P4|NOT COMPLETED|Period 2||0
202492|NCT01293006|491001|P3|NOT COMPLETED|Period 2||0
202493|NCT01293006|491002|P2|NOT COMPLETED|Period 2||0
202494|NCT01293006|491003|P1|NOT COMPLETED|Period 2||1
202495|NCT01293006|491000|P4|COMPLETED|Period 2||3
202496|NCT01293006|491001|P3|COMPLETED|Period 2||9
202497|NCT01293006|491002|P2|COMPLETED|Period 2||2
202498|NCT01293006|491003|P1|COMPLETED|Period 2||10
202499|NCT01293006|491000|P4|STARTED|Period 2||3
202500|NCT01293006|491001|P3|STARTED|Period 2||9
202501|NCT01293006|491002|P2|STARTED|Period 2||2
202502|NCT01293006|491003|P1|STARTED|Period 2||11
202503|NCT01293006|491000|P4|NOT COMPLETED|Washout||0
202504|NCT01293006|491001|P3|NOT COMPLETED|Washout||0
202505|NCT01293006|491002|P2|NOT COMPLETED|Washout||0
202506|NCT01293006|491003|P1|NOT COMPLETED|Washout||0
202507|NCT01293006|491000|P4|COMPLETED|Washout||3
202508|NCT01293006|491001|P3|COMPLETED|Washout||9
202509|NCT01293006|491002|P2|COMPLETED|Washout||2
202510|NCT01293006|491003|P1|COMPLETED|Washout||11
202511|NCT01293006|491000|P4|STARTED|Washout||3
202512|NCT01293006|491001|P3|STARTED|Washout||9
202513|NCT01293006|491002|P2|STARTED|Washout||2
202514|NCT01293006|491003|P1|STARTED|Washout||11
202515|NCT01293006|491000|P4|NOT COMPLETED|Period 1||0
202516|NCT01293006|491001|P3|NOT COMPLETED|Period 1||0
202517|NCT01293006|491002|P2|NOT COMPLETED|Period 1||0
202518|NCT01293006|491003|P1|NOT COMPLETED|Period 1||0
202519|NCT01293006|491000|P4|COMPLETED|Period 1||3
202520|NCT01293006|491001|P3|COMPLETED|Period 1||9
202521|NCT01293006|491002|P2|COMPLETED|Period 1||2
202522|NCT01293006|491003|P1|COMPLETED|Period 1||11
202523|NCT01293006|491000|P4|STARTED|Period 1||3
202524|NCT01293006|491001|P3|STARTED|Period 1||9
202525|NCT01293006|491002|P2|STARTED|Period 1||2
202526|NCT01293006|491003|P1|STARTED|Period 1||11
202527|NCT01292928|491024|P1|NOT COMPLETED|Overall Study||24
202528|NCT01292928|491024|P1|COMPLETED|Overall Study||275
202529|NCT01292928|491024|P1|Completed 12-Month Clinical Follow-up|Overall Study||266
202530|NCT01292928|491024|P1|STARTED|Overall Study||299
202531|NCT01292876|491041|P1|NOT COMPLETED|Overall Study||4
202532|NCT01292876|491041|P1|COMPLETED|Overall Study||13
202533|NCT01292876|491041|P1|STARTED|Overall Study||17
202534|NCT01292837|491047|P1|NOT COMPLETED|Overall Study||2
202535|NCT01292837|491047|P1|COMPLETED|Overall Study||11
202536|NCT01292837|491047|P1|STARTED|Overall Study||13
202537|NCT01292798|491056|P1|NOT COMPLETED|Overall Study||0
202538|NCT01292798|491056|P1|COMPLETED|Overall Study||43
202539|NCT01292798|491056|P1|Persistent DME After 3 Months|Overall Study|Subjects with persistent DME after 3 monthly injections of 0.5 mg of ranibizumab|29
202540|NCT01292798|491056|P1|STARTED|Overall Study||43
202541|NCT01292746|491062|P1|NOT COMPLETED|Overall Study||0
202542|NCT01292746|491062|P1|COMPLETED|Overall Study||14
202543|NCT01292746|491062|P1|STARTED|Overall Study||14
202544|NCT01292642|491066|P1|NOT COMPLETED|Overall Study||5
202545|NCT01292642|491066|P1|COMPLETED|Overall Study||7
202546|NCT01292642|491066|P1|STARTED|Overall Study||12
202547|NCT01292629|491074|P1|NOT COMPLETED|Overall Study||0
202548|NCT01292629|491074|P1|COMPLETED|Overall Study||125
202549|NCT01292629|491074|P1|STARTED|Overall Study||125
202550|NCT01292603|491084|P6|NOT COMPLETED|Overall Survival Status||10
202551|NCT01292603|491085|P5|NOT COMPLETED|Overall Survival Status||16
202552|NCT01292603|491086|P4|NOT COMPLETED|Overall Survival Status||1
202553|NCT01292603|491087|P3|NOT COMPLETED|Overall Survival Status||3
202554|NCT01292603|491088|P2|NOT COMPLETED|Overall Survival Status||1
202555|NCT01292603|491089|P1|NOT COMPLETED|Overall Survival Status||3
202556|NCT01292603|491084|P6|COMPLETED|Overall Survival Status||78
202557|NCT01292603|491085|P5|COMPLETED|Overall Survival Status||72
202558|NCT01292603|491086|P4|COMPLETED|Overall Survival Status||7
202559|NCT01292603|491087|P3|COMPLETED|Overall Survival Status||20
202560|NCT01292603|491088|P2|COMPLETED|Overall Survival Status||16
202561|NCT01292603|491089|P1|COMPLETED|Overall Survival Status||13
202562|NCT01292603|491084|P6|STARTED|Overall Survival Status||88
202563|NCT01292603|491085|P5|STARTED|Overall Survival Status||88
202564|NCT01292603|491086|P4|STARTED|Overall Survival Status||8
202565|NCT01292603|491087|P3|STARTED|Overall Survival Status||23
202566|NCT01292603|491088|P2|STARTED|Overall Survival Status||17
202567|NCT01292603|491089|P1|STARTED|Overall Survival Status||16
202568|NCT01292603|491084|P6|NOT COMPLETED|Part 2: Regular Follow-Up||12
202569|NCT01292603|491085|P5|NOT COMPLETED|Part 2: Regular Follow-Up||19
202570|NCT01292603|491086|P4|NOT COMPLETED|Part 2: Regular Follow-Up||0
202571|NCT01292603|491087|P3|NOT COMPLETED|Part 2: Regular Follow-Up||0
202572|NCT01292603|491088|P2|NOT COMPLETED|Part 2: Regular Follow-Up||0
202573|NCT01292603|491089|P1|NOT COMPLETED|Part 2: Regular Follow-Up||0
202574|NCT01292603|491084|P6|COMPLETED|Part 2: Regular Follow-Up||75
202575|NCT01292603|491085|P5|COMPLETED|Part 2: Regular Follow-Up||68
202576|NCT01292603|491086|P4|COMPLETED|Part 2: Regular Follow-Up||0
202577|NCT01292603|491087|P3|COMPLETED|Part 2: Regular Follow-Up||0
202578|NCT01292603|491088|P2|COMPLETED|Part 2: Regular Follow-Up||0
202579|NCT01292603|491089|P1|COMPLETED|Part 2: Regular Follow-Up||0
202580|NCT01292603|491084|P6|STARTED|Part 2: Regular Follow-Up|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|87
202581|NCT01292603|491085|P5|STARTED|Part 2: Regular Follow-Up|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|87
202582|NCT01292603|491086|P4|STARTED|Part 2: Regular Follow-Up||0
202583|NCT01292603|491087|P3|STARTED|Part 2: Regular Follow-Up||0
202584|NCT01292603|491088|P2|STARTED|Part 2: Regular Follow-Up||0
202585|NCT01292603|491089|P1|STARTED|Part 2: Regular Follow-Up||0
202586|NCT01292603|491084|P6|NOT COMPLETED|Part 2: Dose Confirmation Period||15
202587|NCT01292603|491085|P5|NOT COMPLETED|Part 2: Dose Confirmation Period||16
202588|NCT01292603|491086|P4|NOT COMPLETED|Part 2: Dose Confirmation Period||0
202589|NCT01292603|491087|P3|NOT COMPLETED|Part 2: Dose Confirmation Period||0
202590|NCT01292603|491088|P2|NOT COMPLETED|Part 2: Dose Confirmation Period||0
202591|NCT01292603|491089|P1|NOT COMPLETED|Part 2: Dose Confirmation Period||0
202592|NCT01292603|491084|P6|COMPLETED|Part 2: Dose Confirmation Period||73
202593|NCT01292603|491085|P5|COMPLETED|Part 2: Dose Confirmation Period||72
202594|NCT01292603|491086|P4|COMPLETED|Part 2: Dose Confirmation Period||0
202595|NCT01292603|491087|P3|COMPLETED|Part 2: Dose Confirmation Period||0
202596|NCT01292603|491088|P2|COMPLETED|Part 2: Dose Confirmation Period||0
202597|NCT01292603|491089|P1|COMPLETED|Part 2: Dose Confirmation Period||0
202598|NCT01292603|491084|P6|STARTED|Part 2: Dose Confirmation Period||88
202599|NCT01292603|491085|P5|STARTED|Part 2: Dose Confirmation Period||88
202600|NCT01292603|491086|P4|STARTED|Part 2: Dose Confirmation Period||0
202601|NCT01292603|491087|P3|STARTED|Part 2: Dose Confirmation Period||0
202602|NCT01292603|491088|P2|STARTED|Part 2: Dose Confirmation Period||0
202603|NCT01292603|491089|P1|STARTED|Part 2: Dose Confirmation Period||0
202604|NCT01292603|491084|P6|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
202605|NCT01292603|491085|P5|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
202606|NCT01292603|491086|P4|NOT COMPLETED|Part 1: Regular Follow-Up Period||1
202607|NCT01292603|491087|P3|NOT COMPLETED|Part 1: Regular Follow-Up Period||6
202608|NCT01292603|491088|P2|NOT COMPLETED|Part 1: Regular Follow-Up Period||7
202609|NCT01292603|491089|P1|NOT COMPLETED|Part 1: Regular Follow-Up Period||6
202610|NCT01292603|491084|P6|COMPLETED|Part 1: Regular Follow-Up Period||0
202611|NCT01292603|491085|P5|COMPLETED|Part 1: Regular Follow-Up Period||0
202612|NCT01292603|491086|P4|COMPLETED|Part 1: Regular Follow-Up Period||7
202613|NCT01292603|491087|P3|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|17
202614|NCT01292603|491088|P2|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|10
202615|NCT01292603|491089|P1|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|10
202616|NCT01292603|491084|P6|STARTED|Part 1: Regular Follow-Up Period||0
202617|NCT01292603|491085|P5|STARTED|Part 1: Regular Follow-Up Period||0
202618|NCT01292603|491086|P4|STARTED|Part 1: Regular Follow-Up Period||8
202619|NCT01292603|491087|P3|STARTED|Part 1: Regular Follow-Up Period||23
202620|NCT01292603|491088|P2|STARTED|Part 1: Regular Follow-Up Period||17
202621|NCT01292603|491089|P1|STARTED|Part 1: Regular Follow-Up Period||16
202622|NCT01292603|491084|P6|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
202623|NCT01292603|491085|P5|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
202624|NCT01292603|491086|P4|NOT COMPLETED|Part 1: Pilot Dose Selection Period||8
202625|NCT01292603|491087|P3|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
202626|NCT01292603|491088|P2|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
202627|NCT01292603|491089|P1|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
202628|NCT01292603|491084|P6|COMPLETED|Part 1: Pilot Dose Selection Period||0
202629|NCT01292603|491085|P5|COMPLETED|Part 1: Pilot Dose Selection Period||0
202630|NCT01292603|491086|P4|COMPLETED|Part 1: Pilot Dose Selection Period||0
202631|NCT01292603|491087|P3|COMPLETED|Part 1: Pilot Dose Selection Period||23
202632|NCT01292603|491088|P2|COMPLETED|Part 1: Pilot Dose Selection Period||17
202633|NCT01292603|491089|P1|COMPLETED|Part 1: Pilot Dose Selection Period||16
202634|NCT01292603|491084|P6|STARTED|Part 1: Pilot Dose Selection Period||0
202635|NCT01292603|491085|P5|STARTED|Part 1: Pilot Dose Selection Period||0
202636|NCT01292603|491086|P4|STARTED|Part 1: Pilot Dose Selection Period|These participants were withdrawn prior to SC treatment.|8
202637|NCT01292603|491087|P3|STARTED|Part 1: Pilot Dose Selection Period|1 participant received a dose of 1000mg of rituximab by oversight.|23
202638|NCT01292603|491088|P2|STARTED|Part 1: Pilot Dose Selection Period||17
202639|NCT01292603|491089|P1|STARTED|Part 1: Pilot Dose Selection Period||16
202640|NCT01292538|491135|P2|NOT COMPLETED|Overall Study||0
202641|NCT01292538|491136|P1|NOT COMPLETED|Overall Study||0
202642|NCT01292538|491135|P2|COMPLETED|Overall Study||32
202643|NCT01292538|491136|P1|COMPLETED|Overall Study||35
202644|NCT01292538|491135|P2|STARTED|Overall Study||32
202645|NCT01292538|491136|P1|STARTED|Overall Study||35
202646|NCT01292486|491142|P1|NOT COMPLETED|Overall Study||6
202647|NCT01292486|491142|P1|COMPLETED|Overall Study||26
202648|NCT01292486|491142|P1|STARTED|Overall Study||32
202649|NCT01292473|491156|P4|NOT COMPLETED|Overall Study||12
202650|NCT01292473|491157|P3|NOT COMPLETED|Overall Study||9
202651|NCT01292473|491158|P2|NOT COMPLETED|Overall Study||7
202652|NCT01292473|491159|P1|NOT COMPLETED|Overall Study||5
202653|NCT01292473|491156|P4|COMPLETED|Overall Study||67
202654|NCT01292473|491157|P3|COMPLETED|Overall Study||74
202655|NCT01292473|491158|P2|COMPLETED|Overall Study||75
202656|NCT01292473|491159|P1|COMPLETED|Overall Study||74
202657|NCT01292473|491156|P4|STARTED|Overall Study||79
202658|NCT01292473|491157|P3|STARTED|Overall Study||83
202659|NCT01292473|491158|P2|STARTED|Overall Study||82
202660|NCT01292473|491159|P1|STARTED|Overall Study||79
202661|NCT01292304|491201|P1|NOT COMPLETED|Overall Study||0
202662|NCT01292304|491201|P1|COMPLETED|Overall Study||10
202663|NCT01292304|491201|P1|STARTED|Overall Study||10
202664|NCT01292265|491209|P1|NOT COMPLETED|Overall Study||0
202665|NCT01292265|491209|P1|COMPLETED|Overall Study||3
202666|NCT01292265|491209|P1|STARTED|Overall Study||3
202667|NCT01292239|491218|P2|NOT COMPLETED|Overall Study||7
202668|NCT01292239|491219|P1|NOT COMPLETED|Overall Study||4
202669|NCT01292239|491218|P2|COMPLETED|Overall Study||53
202670|NCT01292239|491219|P1|COMPLETED|Overall Study||119
202671|NCT01292239|491218|P2|STARTED|Overall Study||60
202672|NCT01292239|491219|P1|STARTED|Overall Study||123
202673|NCT01292226|491240|P1|NOT COMPLETED|Overall Study||13
202674|NCT01292226|491240|P1|COMPLETED|Overall Study||32
202675|NCT01292226|491240|P1|STARTED|Overall Study||45
202676|NCT01292187|491273|P2|NOT COMPLETED|Overall Study||13
202677|NCT01292187|491274|P1|NOT COMPLETED|Overall Study||17
202678|NCT01292187|491273|P2|COMPLETED|Overall Study||30
202679|NCT01292187|491274|P1|COMPLETED|Overall Study||69
202680|NCT01292187|491273|P2|STARTED|Overall Study||43
202681|NCT01292187|491274|P1|STARTED|Overall Study||86
202682|NCT01292135|491284|P2|NOT COMPLETED|Overall Study||9
202683|NCT01292135|491285|P1|NOT COMPLETED|Overall Study||0
202684|NCT01292135|491284|P2|COMPLETED|Overall Study||21
202685|NCT01292135|491285|P1|COMPLETED|Overall Study||3
202686|NCT01292135|491284|P2|STARTED|Overall Study||30
202687|NCT01292135|491285|P1|STARTED|Overall Study||3
202688|NCT01292070|491303|P1|NOT COMPLETED|Overall Study||0
202689|NCT01292070|491303|P1|COMPLETED|Overall Study||4
202690|NCT01292070|491303|P1|STARTED|Overall Study||4
202691|NCT01292057|491309|P2|NOT COMPLETED|Overall Study||2
202692|NCT01292057|491310|P1|NOT COMPLETED|Overall Study||2
202693|NCT01292057|491309|P2|COMPLETED|Overall Study||48
202694|NCT01292057|491310|P1|COMPLETED|Overall Study||47
202695|NCT01292057|491309|P2|STARTED|Overall Study||50
202696|NCT01292057|491310|P1|STARTED|Overall Study||49
202697|NCT01292005|491320|P2|NOT COMPLETED|Overall Study||0
202698|NCT01292005|491321|P1|NOT COMPLETED|Overall Study||0
202699|NCT01292005|491320|P2|COMPLETED|Overall Study||14
202700|NCT01292005|491321|P1|COMPLETED|Overall Study||14
202701|NCT01292005|491320|P2|STARTED|Overall Study||14
202702|NCT01292005|491321|P1|STARTED|Overall Study||14
202703|NCT01291836|491345|P2|NOT COMPLETED|Overall Study||0
202704|NCT01291836|491346|P1|NOT COMPLETED|Overall Study||0
202705|NCT01291836|491345|P2|COMPLETED|Overall Study||71
202706|NCT01291836|491346|P1|COMPLETED|Overall Study||930
202707|NCT01291836|491345|P2|STARTED|Overall Study||71
202708|NCT01291836|491346|P1|STARTED|Overall Study||930
202709|NCT01291784|491352|P3|NOT COMPLETED|Overall Study||0
202710|NCT01291784|491353|P2|NOT COMPLETED|Overall Study||1
202711|NCT01291784|491354|P1|NOT COMPLETED|Overall Study||0
202712|NCT01291784|491352|P3|COMPLETED|Overall Study||1
202713|NCT01291784|491353|P2|COMPLETED|Overall Study||0
202714|NCT01291784|491354|P1|COMPLETED|Overall Study||1
202715|NCT01291784|491352|P3|STARTED|Overall Study||1
202716|NCT01291784|491353|P2|STARTED|Overall Study||1
202717|NCT01291784|491354|P1|STARTED|Overall Study||1
202718|NCT01291498|491374|P1|NOT COMPLETED|Overall Study||1
202719|NCT01291498|491374|P1|COMPLETED|Overall Study||0
202720|NCT01291498|491374|P1|STARTED|Overall Study||1
202721|NCT01291277|491382|P2|NOT COMPLETED|Overall Study||3
202722|NCT01291277|491383|P1|NOT COMPLETED|Overall Study||5
202723|NCT01291277|491382|P2|COMPLETED|Overall Study||42
202724|NCT01291277|491383|P1|COMPLETED|Overall Study||40
202725|NCT01291277|491382|P2|STARTED|Overall Study||45
202726|NCT01291277|491383|P1|STARTED|Overall Study||45
202727|NCT01291264|491389|P1|NOT COMPLETED|Overall Study||0
202728|NCT01291264|491389|P1|COMPLETED|Overall Study||260
202729|NCT01291264|491389|P1|STARTED|Overall Study||260
202730|NCT01291225|491395|P2|NOT COMPLETED|Overall Study||39
202731|NCT01291225|491396|P1|NOT COMPLETED|Overall Study||85
202732|NCT01291225|491395|P2|COMPLETED|Overall Study||121
202733|NCT01291225|491396|P1|COMPLETED|Overall Study||66
202734|NCT01291225|491395|P2|STARTED|Overall Study||160
202735|NCT01291225|491396|P1|STARTED|Overall Study||151
202736|NCT01291173|491410|P4|NOT COMPLETED|Overall Study||13
202737|NCT01291173|491411|P3|NOT COMPLETED|Overall Study||13
202738|NCT01291173|491412|P2|NOT COMPLETED|Overall Study||15
202739|NCT01291173|491413|P1|NOT COMPLETED|Overall Study||17
202740|NCT01291173|491410|P4|COMPLETED|Overall Study||52
202741|NCT01291173|491411|P3|COMPLETED|Overall Study||52
202742|NCT01291173|491412|P2|COMPLETED|Overall Study||51
202743|NCT01291173|491413|P1|COMPLETED|Overall Study||47
202744|NCT01291173|491410|P4|STARTED|Overall Study||65
202745|NCT01291173|491411|P3|STARTED|Overall Study||65
202746|NCT01291173|491412|P2|STARTED|Overall Study||66
202747|NCT01291173|491413|P1|STARTED|Overall Study||64
202748|NCT01291160|491477|P2|NOT COMPLETED|Overall Study||16
202749|NCT01291160|491478|P1|NOT COMPLETED|Overall Study||18
202750|NCT01291160|491477|P2|COMPLETED|Overall Study||48
202751|NCT01291160|491478|P1|COMPLETED|Overall Study||48
202752|NCT01291160|491477|P2|STARTED|Overall Study||64
202753|NCT01291160|491478|P1|STARTED|Overall Study||66
202754|NCT01291108|491488|P6|NOT COMPLETED|Month 2 (Adjunctive Therapy)||1
202755|NCT01291108|491489|P5|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
202756|NCT01291108|491490|P4|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
202757|NCT01291108|491491|P3|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
202758|NCT01291108|491492|P2|NOT COMPLETED|Month 2 (Adjunctive Therapy)||2
202759|NCT01291108|491493|P1|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
202760|NCT01291108|491488|P6|COMPLETED|Month 2 (Adjunctive Therapy)||25
202761|NCT01291108|491489|P5|COMPLETED|Month 2 (Adjunctive Therapy)||34
202762|NCT01291108|491490|P4|COMPLETED|Month 2 (Adjunctive Therapy)||0
202763|NCT01291108|491491|P3|COMPLETED|Month 2 (Adjunctive Therapy)||24
202764|NCT01291108|491492|P2|COMPLETED|Month 2 (Adjunctive Therapy)||38
202765|NCT01291108|491493|P1|COMPLETED|Month 2 (Adjunctive Therapy)||0
202766|NCT01291108|491488|P6|STARTED|Month 2 (Adjunctive Therapy)||26
202767|NCT01291108|491489|P5|STARTED|Month 2 (Adjunctive Therapy)||34
202768|NCT01291108|491490|P4|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
202769|NCT01291108|491491|P3|STARTED|Month 2 (Adjunctive Therapy)||24
202770|NCT01291108|491492|P2|STARTED|Month 2 (Adjunctive Therapy)||40
202771|NCT01291108|491493|P1|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
202772|NCT01291108|491488|P6|NOT COMPLETED|Month 1 (Monotherapy)||0
202773|NCT01291108|491489|P5|NOT COMPLETED|Month 1 (Monotherapy)||0
202774|NCT01291108|491490|P4|NOT COMPLETED|Month 1 (Monotherapy)||0
202775|NCT01291108|491491|P3|NOT COMPLETED|Month 1 (Monotherapy)||0
202776|NCT01291108|491492|P2|NOT COMPLETED|Month 1 (Monotherapy)||0
202777|NCT01291108|491493|P1|NOT COMPLETED|Month 1 (Monotherapy)||1
202778|NCT01291108|491488|P6|COMPLETED|Month 1 (Monotherapy)||0
202779|NCT01291108|491489|P5|COMPLETED|Month 1 (Monotherapy)||0
202780|NCT01291108|491490|P4|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|60
202781|NCT01291108|491491|P3|COMPLETED|Month 1 (Monotherapy)||0
202782|NCT01291108|491492|P2|COMPLETED|Month 1 (Monotherapy)||0
202783|NCT01291108|491493|P1|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|64
202784|NCT01291108|491488|P6|STARTED|Month 1 (Monotherapy)||0
202785|NCT01291108|491489|P5|STARTED|Month 1 (Monotherapy)||0
202786|NCT01291108|491490|P4|STARTED|Month 1 (Monotherapy)||60
202787|NCT01291108|491491|P3|STARTED|Month 1 (Monotherapy)||0
202788|NCT01291108|491492|P2|STARTED|Month 1 (Monotherapy)||0
202789|NCT01291108|491493|P1|STARTED|Month 1 (Monotherapy)||65
202790|NCT01291056|491509|P2|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
202791|NCT01291056|491510|P1|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
202792|NCT01291056|491509|P2|COMPLETED|Intervention Two (Menstration Days 3-7)||10
202793|NCT01291056|491510|P1|COMPLETED|Intervention Two (Menstration Days 3-7)||10
202794|NCT01291056|491509|P2|STARTED|Intervention Two (Menstration Days 3-7)||10
202795|NCT01291056|491510|P1|STARTED|Intervention Two (Menstration Days 3-7)||10
202796|NCT01291056|491509|P2|NOT COMPLETED|Washout||0
202797|NCT01291056|491510|P1|NOT COMPLETED|Washout||0
202798|NCT01291056|491509|P2|COMPLETED|Washout||10
202799|NCT01291056|491510|P1|COMPLETED|Washout||10
202800|NCT01291056|491509|P2|STARTED|Washout||10
202801|NCT01291056|491510|P1|STARTED|Washout||10
202802|NCT01291056|491509|P2|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
202803|NCT01291056|491510|P1|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
202804|NCT01291056|491509|P2|COMPLETED|Intervention One (Menstraution Day 3-7)||10
202805|NCT01291056|491510|P1|COMPLETED|Intervention One (Menstraution Day 3-7)||10
202806|NCT01291056|491509|P2|STARTED|Intervention One (Menstraution Day 3-7)||10
202807|NCT01291056|491510|P1|STARTED|Intervention One (Menstraution Day 3-7)||10
202808|NCT01291017|491522|P1|NOT COMPLETED|Overall Study||5
202809|NCT01291017|491522|P1|COMPLETED|Overall Study||14
202810|NCT01291017|491522|P1|STARTED|Overall Study||19
202811|NCT01290978|491530|P1|NOT COMPLETED|Overall Study||0
202812|NCT01290978|491530|P1|COMPLETED|Overall Study||22
202813|NCT01290978|491530|P1|STARTED|Overall Study||22
202814|NCT01290952|491539|P2|NOT COMPLETED|Overall Study||14
202815|NCT01290952|491540|P1|NOT COMPLETED|Overall Study||12
202816|NCT01290952|491539|P2|COMPLETED|Overall Study||193
202817|NCT01290952|491540|P1|COMPLETED|Overall Study||192
202818|NCT01290952|491539|P2|STARTED|Overall Study||207
202819|NCT01290952|491540|P1|STARTED|Overall Study||204
202820|NCT01290913|491548|P1|NOT COMPLETED|Overall Study||1
202821|NCT01290913|491548|P1|COMPLETED|Overall Study||12
202822|NCT01290913|491548|P1|STARTED|Overall Study||13
202823|NCT01290887|491555|P2|NOT COMPLETED|Overall Study||536
202824|NCT01290887|491556|P1|NOT COMPLETED|Overall Study||466
202825|NCT01290887|491555|P2|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|35
202826|NCT01290887|491556|P1|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|15
202827|NCT01290887|491555|P2|Safety Analysis Set|Overall Study||571
202828|NCT01290887|491556|P1|Safety Analysis Set|Overall Study|One patient was enrolled but not treated.|480
202829|NCT01290887|491555|P2|STARTED|Overall Study||571
202830|NCT01290887|491556|P1|STARTED|Overall Study||481
202831|NCT01290874|491596|P2|NOT COMPLETED|Overall Study||404
202832|NCT01290874|491597|P1|NOT COMPLETED|Overall Study||410
202833|NCT01290874|491596|P2|COMPLETED|Overall Study||134
202834|NCT01290874|491597|P1|COMPLETED|Overall Study||122
202835|NCT01290874|491596|P2|STARTED|Overall Study||538
202836|NCT01290874|491597|P1|STARTED|Overall Study||532
202837|NCT01290822|491617|P1|NOT COMPLETED|Overall Study||11
202838|NCT01290822|491617|P1|COMPLETED|Overall Study||1
202839|NCT01290822|491617|P1|STARTED|Overall Study||12
202840|NCT01290796|491626|P1|NOT COMPLETED|Overall Study||30
202841|NCT01290796|491626|P1|COMPLETED|Overall Study||123
202842|NCT01290796|491626|P1|STARTED|Overall Study||153
202843|NCT01290757|491642|P2|NOT COMPLETED|Overall Study||2
202844|NCT01290757|491643|P1|NOT COMPLETED|Overall Study||2
202845|NCT01290757|491642|P2|COMPLETED|Overall Study||88
202846|NCT01290757|491643|P1|COMPLETED|Overall Study||88
202847|NCT01290757|491642|P2|STARTED|Overall Study||90
202848|NCT01290757|491643|P1|STARTED|Overall Study||90
202849|NCT01290731|491659|P1|NOT COMPLETED|Overall Study||1
202850|NCT01290731|491659|P1|COMPLETED|Overall Study||48
202851|NCT01290731|491659|P1|STARTED|Overall Study||49
202852|NCT01290718|491671|P1|NOT COMPLETED|Overall Study||4
202853|NCT01290718|491671|P1|COMPLETED|Overall Study||0
202854|NCT01290718|491671|P1|STARTED|Overall Study||4
202855|NCT01290679|491680|P2|NOT COMPLETED|Overall Study||21
202856|NCT01290679|491681|P1|NOT COMPLETED|Overall Study||16
202857|NCT01290679|491680|P2|COMPLETED|Overall Study||113
202858|NCT01290679|491681|P1|COMPLETED|Overall Study||241
202859|NCT01290679|491680|P2|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|134
202860|NCT01290679|491681|P1|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|257
202861|NCT01290666|491750|P1|NOT COMPLETED|Overall Study||38
202862|NCT01290666|491750|P1|COMPLETED|Overall Study||55
202863|NCT01290666|491750|P1|STARTED|Overall Study||93
202864|NCT01290640|491756|P2|NOT COMPLETED|Overall Study||0
202865|NCT01290640|491757|P1|NOT COMPLETED|Overall Study||0
202866|NCT01290640|491756|P2|COMPLETED|Overall Study||10
202867|NCT01290640|491757|P1|COMPLETED|Overall Study||12
202868|NCT01290640|491756|P2|STARTED|Overall Study||10
202869|NCT01290640|491757|P1|STARTED|Overall Study||12
202870|NCT01290627|491768|P3|NOT COMPLETED|Overall Study||0
202871|NCT01290627|491769|P2|NOT COMPLETED|Overall Study||0
202872|NCT01290627|491770|P1|NOT COMPLETED|Overall Study||0
202873|NCT01290627|491768|P3|COMPLETED|Overall Study||10
202874|NCT01290627|491769|P2|COMPLETED|Overall Study||10
202875|NCT01290627|491770|P1|COMPLETED|Overall Study||10
202876|NCT01290627|491768|P3|STARTED|Overall Study||10
202877|NCT01290627|491769|P2|STARTED|Overall Study||10
202878|NCT01290627|491770|P1|STARTED|Overall Study||10
202879|NCT01290614|491792|P2|NOT COMPLETED|Overall Study||0
202880|NCT01290614|491793|P1|NOT COMPLETED|Overall Study||552
202881|NCT01290614|491792|P2|COMPLETED|Overall Study||1129
202882|NCT01290614|491793|P1|COMPLETED|Overall Study||518
202883|NCT01290614|491792|P2|STARTED|Overall Study||1129
202884|NCT01290614|491793|P1|STARTED|Overall Study||1070
202885|NCT01290601|491803|P4|NOT COMPLETED|Overall Study||0
202886|NCT01290601|491804|P3|NOT COMPLETED|Overall Study||0
202887|NCT01290601|491805|P2|NOT COMPLETED|Overall Study||5
202888|NCT01290601|491806|P1|NOT COMPLETED|Overall Study||11
202889|NCT01290601|491803|P4|COMPLETED|Overall Study||0
202890|NCT01290601|491804|P3|COMPLETED|Overall Study||0
202891|NCT01290601|491805|P2|COMPLETED|Overall Study||19
202892|NCT01290601|491806|P1|COMPLETED|Overall Study||35
202893|NCT01290601|491803|P4|STARTED|Overall Study||0
202894|NCT01290601|491804|P3|STARTED|Overall Study||0
202895|NCT01290601|491805|P2|STARTED|Overall Study||24
202896|NCT01290601|491806|P1|STARTED|Overall Study||46
202897|NCT01290536|491820|P1|NOT COMPLETED|Overall Study||0
202898|NCT01290536|491820|P1|COMPLETED|Overall Study||42
202899|NCT01290536|491820|P1|STARTED|Overall Study||42
202900|NCT01290523|491827|P1|NOT COMPLETED|Overall Study||3
202901|NCT01290523|491827|P1|COMPLETED|Overall Study||11
202902|NCT01290523|491827|P1|STARTED|Overall Study||14
202903|NCT01290484|491832|P1|NOT COMPLETED|Overall Study||0
202904|NCT01290484|491832|P1|COMPLETED|Overall Study||7
202905|NCT01290484|491832|P1|STARTED|Overall Study||7
202906|NCT01290445|491839|P3|NOT COMPLETED|Overall Study||0
202907|NCT01290445|491840|P2|NOT COMPLETED|Overall Study||0
202908|NCT01290445|491841|P1|NOT COMPLETED|Overall Study||0
202909|NCT01290445|491839|P3|COMPLETED|Overall Study||806438
202910|NCT01290445|491840|P2|COMPLETED|Overall Study||78412
202911|NCT01290445|491841|P1|COMPLETED|Overall Study||335
202912|NCT01290445|491839|P3|STARTED|Overall Study||806438
202913|NCT01290445|491840|P2|STARTED|Overall Study||78412
202914|NCT01290445|491841|P1|STARTED|Overall Study||335
202915|NCT01290341|491866|P2|NOT COMPLETED|Overall Study||29
202916|NCT01290341|491867|P1|NOT COMPLETED|Overall Study||92
202917|NCT01290341|491866|P2|COMPLETED|Overall Study||258
202918|NCT01290341|491867|P1|COMPLETED|Overall Study||481
202919|NCT01290341|491866|P2|STARTED|Overall Study||287
202920|NCT01290341|491867|P1|STARTED|Overall Study||573
202921|NCT01290315|491879|P4|NOT COMPLETED|Overall Study||5
202922|NCT01290315|491880|P3|NOT COMPLETED|Overall Study||0
202923|NCT01290315|491881|P2|NOT COMPLETED|Overall Study||3
202924|NCT01290315|491882|P1|NOT COMPLETED|Overall Study||3
202925|NCT01290315|491879|P4|COMPLETED|Overall Study||8
202926|NCT01290315|491880|P3|COMPLETED|Overall Study||10
202927|NCT01290315|491881|P2|COMPLETED|Overall Study||9
202928|NCT01290315|491882|P1|COMPLETED|Overall Study||11
202929|NCT01290315|491879|P4|STARTED|Overall Study||13
202930|NCT01290315|491880|P3|STARTED|Overall Study||10
202931|NCT01290315|491881|P2|STARTED|Overall Study||12
202932|NCT01290315|491882|P1|STARTED|Overall Study||14
202933|NCT01290263|491904|P5|NOT COMPLETED|Overall Study||37
202934|NCT01290263|491905|P4|NOT COMPLETED|Overall Study||27
202935|NCT01290263|491906|P3|NOT COMPLETED|Overall Study||7
202936|NCT01290263|491907|P2|NOT COMPLETED|Overall Study||3
202937|NCT01290263|491908|P1|NOT COMPLETED|Overall Study||11
202938|NCT01290263|491904|P5|COMPLETED|Overall Study||0
202939|NCT01290263|491905|P4|COMPLETED|Overall Study||0
202940|NCT01290263|491906|P3|COMPLETED|Overall Study||0
202941|NCT01290263|491907|P2|COMPLETED|Overall Study||0
202942|NCT01290263|491908|P1|COMPLETED|Overall Study||0
202943|NCT01290263|491904|P5|STARTED|Overall Study||37
202944|NCT01290263|491905|P4|STARTED|Overall Study||27
202945|NCT01290263|491906|P3|STARTED|Overall Study||7
202946|NCT01290263|491907|P2|STARTED|Overall Study||3
202947|NCT01290263|491908|P1|STARTED|Overall Study||11
202948|NCT01290237|491926|P2|NOT COMPLETED|Overall Study||2
202949|NCT01290237|491927|P1|NOT COMPLETED|Overall Study||11
202950|NCT01290237|491926|P2|COMPLETED|Overall Study||27
202951|NCT01290237|491927|P1|COMPLETED|Overall Study||19
202952|NCT01290237|491926|P2|STARTED|Overall Study||29
202953|NCT01290237|491927|P1|STARTED|Overall Study||30
202954|NCT01290224|491935|P1|NOT COMPLETED|Overall Study||5
202955|NCT01290224|491935|P1|COMPLETED|Overall Study||5
202956|NCT01290224|491935|P1|STARTED|Overall Study||10
202957|NCT01290094|491946|P1|NOT COMPLETED|Overall Study||6
202958|NCT01290094|491946|P1|COMPLETED|Overall Study||35
202959|NCT01290094|491946|P1|STARTED|Overall Study||41
202960|NCT01290068|491959|P2|NOT COMPLETED|Overall Study||6
202961|NCT01290068|491960|P1|NOT COMPLETED|Overall Study||7
202962|NCT01290068|491959|P2|COMPLETED|Overall Study||94
202963|NCT01290068|491960|P1|COMPLETED|Overall Study||101
202964|NCT01290068|491959|P2|Implanted|Overall Study||98
202965|NCT01290068|491960|P1|Implanted|Overall Study||108
202966|NCT01290068|491959|P2|STARTED|Overall Study||100
202967|NCT01290068|491960|P1|STARTED|Overall Study||108
202968|NCT01290029|491972|P1|NOT COMPLETED|Overall Study||2
202969|NCT01290029|491972|P1|COMPLETED|Overall Study||12
202970|NCT01290029|491972|P1|Received Study Treatment|Overall Study||12
202971|NCT01290029|491972|P1|STARTED|Overall Study||14
202972|NCT01289990|491998|P13|NOT COMPLETED|Overall Study||98
202973|NCT01289990|491999|P12|NOT COMPLETED|Overall Study||68
202974|NCT01289990|492000|P11|NOT COMPLETED|Overall Study||76
202975|NCT01289990|492001|P10|NOT COMPLETED|Overall Study||86
202976|NCT01289990|492002|P9|NOT COMPLETED|Overall Study||75
202977|NCT01289990|492003|P8|NOT COMPLETED|Overall Study||55
202978|NCT01289990|492004|P7|NOT COMPLETED|Overall Study||88
202979|NCT01289990|492005|P6|NOT COMPLETED|Overall Study||74
202980|NCT01289990|492006|P5|NOT COMPLETED|Overall Study||72
202981|NCT01289990|492007|P4|NOT COMPLETED|Overall Study||87
202982|NCT01289990|492008|P3|NOT COMPLETED|Overall Study||109
202983|NCT01289990|492009|P2|NOT COMPLETED|Overall Study||81
202984|NCT01289990|492010|P1|NOT COMPLETED|Overall Study||77
202985|NCT01289990|491998|P13|COMPLETED|Overall Study||127
202986|NCT01289990|491999|P12|COMPLETED|Overall Study||150
202987|NCT01289990|492000|P11|COMPLETED|Overall Study||150
202988|NCT01289990|492001|P10|COMPLETED|Overall Study||121
202989|NCT01289990|492002|P9|COMPLETED|Overall Study||139
202990|NCT01289990|492003|P8|COMPLETED|Overall Study||162
202991|NCT01289990|492004|P7|COMPLETED|Overall Study||78
202992|NCT01289990|492005|P6|COMPLETED|Overall Study||94
202993|NCT01289990|492006|P5|COMPLETED|Overall Study||93
202994|NCT01289990|492007|P4|COMPLETED|Overall Study||136
202995|NCT01289990|492008|P3|COMPLETED|Overall Study||119
202996|NCT01289990|492009|P2|COMPLETED|Overall Study||143
202997|NCT01289990|492010|P1|COMPLETED|Overall Study||147
202998|NCT01289990|491998|P13|STARTED|Overall Study||225
202999|NCT01289990|491999|P12|STARTED|Overall Study||218
203000|NCT01289990|492000|P11|STARTED|Overall Study||226
203001|NCT01289990|492001|P10|STARTED|Overall Study||207
203002|NCT01289990|492002|P9|STARTED|Overall Study||214
203003|NCT01289990|492003|P8|STARTED|Overall Study||217
203004|NCT01289990|492004|P7|STARTED|Overall Study||166
203005|NCT01289990|492005|P6|STARTED|Overall Study||168
203006|NCT01289990|492006|P5|STARTED|Overall Study||165
203007|NCT01289990|492007|P4|STARTED|Overall Study||223
203008|NCT01289990|492008|P3|STARTED|Overall Study||228
203009|NCT01289990|492009|P2|STARTED|Overall Study||224
203010|NCT01289990|492010|P1|STARTED|Overall Study||224
203011|NCT01289912|492196|P2|NOT COMPLETED|Overall Study||2
203012|NCT01289912|492197|P1|NOT COMPLETED|Overall Study||3
203013|NCT01289912|492196|P2|COMPLETED|Overall Study||13
203014|NCT01289912|492197|P1|COMPLETED|Overall Study||29
203015|NCT01289912|492196|P2|STARTED|Overall Study||15
203016|NCT01289912|492197|P1|STARTED|Overall Study||32
203017|NCT01289847|492227|P1|NOT COMPLETED|Overall Study||1
203018|NCT01289847|492227|P1|COMPLETED|Overall Study||24
203019|NCT01289847|492227|P1|STARTED|Overall Study||25
203020|NCT01289821|492236|P1|NOT COMPLETED|Survival Follow-up Period||18
203021|NCT01289821|492236|P1|COMPLETED|Survival Follow-up Period|34 participants died and completed survival follow-up period.|34
203022|NCT01289821|492236|P1|STARTED|Survival Follow-up Period||52
203023|NCT01289821|492236|P1|NOT COMPLETED|Safety Follow-up Period||5
203024|NCT01289821|492236|P1|COMPLETED|Safety Follow-up Period||49
203025|NCT01289821|492236|P1|STARTED|Safety Follow-up Period||54
203026|NCT01289821|492236|P1|NOT COMPLETED|Treatment Period||54
203027|NCT01289821|492236|P1|COMPLETED|Treatment Period||0
203028|NCT01289821|492236|P1|Participants Received Regorafenib|Treatment Period||54
203029|NCT01289821|492236|P1|STARTED|Treatment Period||54
203030|NCT01289782|492247|P2|NOT COMPLETED|Overall Study||12
203031|NCT01289782|492248|P1|NOT COMPLETED|Overall Study||25
203032|NCT01289782|492247|P2|COMPLETED|Overall Study||118
203033|NCT01289782|492248|P1|COMPLETED|Overall Study||239
203034|NCT01289782|492247|P2|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|130
203035|NCT01289782|492248|P1|STARTED|Overall Study||264
203036|NCT01289678|492317|P1|NOT COMPLETED|Overall Study||6
203037|NCT01289678|492317|P1|COMPLETED|Overall Study||12
203038|NCT01289678|492317|P1|STARTED|Overall Study||18
203039|NCT01289639|492324|P3|NOT COMPLETED|Overall Study||0
203040|NCT01289639|492325|P2|NOT COMPLETED|Overall Study||0
203041|NCT01289639|492326|P1|NOT COMPLETED|Overall Study||1
203042|NCT01289639|492324|P3|COMPLETED|Overall Study||0
203043|NCT01289639|492325|P2|COMPLETED|Overall Study||6
203044|NCT01289639|492326|P1|COMPLETED|Overall Study||4
203045|NCT01289639|492324|P3|STARTED|Overall Study||0
203046|NCT01289639|492325|P2|STARTED|Overall Study||6
203047|NCT01289639|492326|P1|STARTED|Overall Study||5
203048|NCT01289574|492352|P3|NOT COMPLETED|Overall Study||3
203049|NCT01289574|492353|P2|NOT COMPLETED|Overall Study||3
203050|NCT01289574|492354|P1|NOT COMPLETED|Overall Study||7
203051|NCT01289574|492352|P3|COMPLETED|Overall Study||60
203052|NCT01289574|492353|P2|COMPLETED|Overall Study||57
203053|NCT01289574|492354|P1|COMPLETED|Overall Study||51
203054|NCT01289574|492352|P3|STARTED|Overall Study||63
203055|NCT01289574|492353|P2|STARTED|Overall Study||60
203056|NCT01289574|492354|P1|STARTED|Overall Study||58
203057|NCT01289548|492371|P3|NOT COMPLETED|Overall Study||0
203058|NCT01289548|492372|P2|NOT COMPLETED|Overall Study||0
203059|NCT01289548|492373|P1|NOT COMPLETED|Overall Study||0
203060|NCT01289548|492371|P3|COMPLETED|Overall Study||40
203061|NCT01289548|492372|P2|COMPLETED|Overall Study||40
203062|NCT01289548|492373|P1|COMPLETED|Overall Study||40
203063|NCT01289548|492371|P3|Recipients|Overall Study||20
203064|NCT01289548|492372|P2|Recipients|Overall Study||20
203065|NCT01289548|492373|P1|Recipients|Overall Study||20
203066|NCT01289548|492371|P3|Donors|Overall Study||20
203067|NCT01289548|492372|P2|Donors|Overall Study||20
203068|NCT01289548|492373|P1|Donors|Overall Study||20
203069|NCT01289548|492371|P3|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
203070|NCT01289548|492372|P2|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
203071|NCT01289548|492373|P1|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
203072|NCT01289522|492417|P1|NOT COMPLETED|Overall Study||11
203073|NCT01289522|492417|P1|COMPLETED|Overall Study||43
203074|NCT01289522|492417|P1|STARTED|Overall Study||54
203075|NCT01289418|492426|P1|NOT COMPLETED|Day 29 Survey||2468
203076|NCT01289418|492426|P1|COMPLETED|Day 29 Survey||4057
203077|NCT01289418|492426|P1|STARTED|Day 29 Survey||6525
203078|NCT01289418|492426|P1|NOT COMPLETED|Day 8 Survey||2218
203079|NCT01289418|492426|P1|COMPLETED|Day 8 Survey||4307
203080|NCT01289418|492426|P1|STARTED|Day 8 Survey||6525
203081|NCT01289392|492435|P3|NOT COMPLETED|Overall Study||0
203082|NCT01289392|492436|P2|NOT COMPLETED|Overall Study||0
203083|NCT01289392|492437|P1|NOT COMPLETED|Overall Study||0
203084|NCT01289392|492435|P3|COMPLETED|Overall Study||7
203085|NCT01289392|492436|P2|COMPLETED|Overall Study||9
203086|NCT01289392|492437|P1|COMPLETED|Overall Study||9
203087|NCT01289392|492435|P3|STARTED|Overall Study||7
203088|NCT01289392|492436|P2|STARTED|Overall Study||9
203089|NCT01289392|492437|P1|STARTED|Overall Study||9
203090|NCT01289275|492449|P4|NOT COMPLETED|Overall Study||0
203091|NCT01289275|492450|P3|NOT COMPLETED|Overall Study||0
203092|NCT01289275|492451|P2|NOT COMPLETED|Overall Study||0
203093|NCT01289275|492452|P1|NOT COMPLETED|Overall Study||0
203094|NCT01289275|492449|P4|COMPLETED|Overall Study||316
203095|NCT01289275|492450|P3|COMPLETED|Overall Study||317
203096|NCT01289275|492451|P2|COMPLETED|Overall Study||320
203097|NCT01289275|492452|P1|COMPLETED|Overall Study||317
203098|NCT01289275|492449|P4|STARTED|Overall Study||316
203099|NCT01289275|492450|P3|STARTED|Overall Study||317
203100|NCT01289275|492451|P2|STARTED|Overall Study||320
203101|NCT01289275|492452|P1|STARTED|Overall Study||317
203102|NCT01289210|492474|P1|NOT COMPLETED|Overall Study||1
203103|NCT01289210|492474|P1|COMPLETED|Overall Study||1
203104|NCT01289210|492474|P1|STARTED|Overall Study||2
203105|NCT01289119|492484|P6|NOT COMPLETED|Overall Study||4
203106|NCT01289119|492485|P5|NOT COMPLETED|Overall Study||5
203107|NCT01289119|492486|P4|NOT COMPLETED|Overall Study||6
203108|NCT01289119|492487|P3|NOT COMPLETED|Overall Study||9
203109|NCT01289119|492488|P2|NOT COMPLETED|Overall Study||9
203110|NCT01289119|492489|P1|NOT COMPLETED|Overall Study||9
203111|NCT01289119|492484|P6|COMPLETED|Overall Study||57
203112|NCT01289119|492485|P5|COMPLETED|Overall Study||58
203113|NCT01289119|492486|P4|COMPLETED|Overall Study||93
203114|NCT01289119|492487|P3|COMPLETED|Overall Study||89
203115|NCT01289119|492488|P2|COMPLETED|Overall Study||83
203116|NCT01289119|492489|P1|COMPLETED|Overall Study||84
203117|NCT01289119|492484|P6|Treated|Overall Study||61
203118|NCT01289119|492485|P5|Treated|Overall Study||63
203119|NCT01289119|492486|P4|Treated|Overall Study||99
203120|NCT01289119|492487|P3|Treated|Overall Study||98
203121|NCT01289119|492488|P2|Treated|Overall Study||92
203122|NCT01289119|492489|P1|Treated|Overall Study|Patients who took at least one dose of double-blind study drug.|92
203123|NCT01289119|492484|P6|STARTED|Overall Study||61
203124|NCT01289119|492485|P5|STARTED|Overall Study||63
203125|NCT01289119|492486|P4|STARTED|Overall Study||99
203126|NCT01289119|492487|P3|STARTED|Overall Study||98
203127|NCT01289119|492488|P2|STARTED|Overall Study||92
203128|NCT01289119|492489|P1|STARTED|Overall Study||93
203129|NCT01289080|492571|P2|NOT COMPLETED|Overall Study||0
203130|NCT01289080|492572|P1|NOT COMPLETED|Overall Study||0
203131|NCT01289080|492571|P2|COMPLETED|Overall Study||10
203132|NCT01289080|492572|P1|COMPLETED|Overall Study||9
203133|NCT01289080|492571|P2|STARTED|Overall Study||10
203134|NCT01289080|492572|P1|STARTED|Overall Study||9
203135|NCT01289067|492603|P1|NOT COMPLETED|Overall Study||0
203136|NCT01289067|492603|P1|COMPLETED|Overall Study||13
203137|NCT01289067|492603|P1|STARTED|Overall Study||13
203138|NCT01289041|492610|P1|NOT COMPLETED|Overall Study||70
203139|NCT01289041|492610|P1|COMPLETED|Overall Study||0
203140|NCT01289041|492610|P1|STARTED|Overall Study||70
203141|NCT01289028|492622|P1|NOT COMPLETED|Overall Study||83
203142|NCT01289028|492622|P1|COMPLETED|Overall Study||42
203143|NCT01289028|492622|P1|STARTED|Overall Study||125
203144|NCT01289015|492636|P2|NOT COMPLETED|Overall Study||54
203145|NCT01289015|492637|P1|NOT COMPLETED|Overall Study||99
203146|NCT01289015|492636|P2|COMPLETED|Overall Study||230
203147|NCT01289015|492637|P1|COMPLETED|Overall Study||472
203148|NCT01289015|492636|P2|STARTED|Overall Study||284
203149|NCT01289015|492637|P1|STARTED|Overall Study||571
203150|NCT01288989|492650|P5|NOT COMPLETED|Overall Study||6
203151|NCT01288989|492651|P4|NOT COMPLETED|Overall Study||1
203152|NCT01288989|492652|P3|NOT COMPLETED|Overall Study||0
203153|NCT01288989|492653|P2|NOT COMPLETED|Overall Study||0
203154|NCT01288989|492654|P1|NOT COMPLETED|Overall Study||1
203155|NCT01288989|492650|P5|COMPLETED|Overall Study||15
203156|NCT01288989|492651|P4|COMPLETED|Overall Study||10
203157|NCT01288989|492652|P3|COMPLETED|Overall Study||3
203158|NCT01288989|492653|P2|COMPLETED|Overall Study||3
203159|NCT01288989|492654|P1|COMPLETED|Overall Study||5
203160|NCT01288989|492650|P5|Received at Least 1 Dose of Study Drug|Overall Study||21
203161|NCT01288989|492651|P4|Received at Least 1 Dose of Study Drug|Overall Study||11
203162|NCT01288989|492652|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
203163|NCT01288989|492653|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
203164|NCT01288989|492654|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
203165|NCT01288989|492650|P5|STARTED|Overall Study||21
203166|NCT01288989|492651|P4|STARTED|Overall Study||11
203167|NCT01288989|492652|P3|STARTED|Overall Study||3
203168|NCT01288989|492653|P2|STARTED|Overall Study||3
203169|NCT01288989|492654|P1|STARTED|Overall Study||6
203170|NCT01288976|492715|P3|NOT COMPLETED|Overall Study||20
203171|NCT01288976|492716|P2|NOT COMPLETED|Overall Study||27
203172|NCT01288976|492717|P1|NOT COMPLETED|Overall Study||178
203173|NCT01288976|492715|P3|COMPLETED|Overall Study||85
203174|NCT01288976|492716|P2|COMPLETED|Overall Study||22
203175|NCT01288976|492717|P1|COMPLETED|Overall Study||389
203176|NCT01288976|492715|P3|STARTED|Overall Study||105
203177|NCT01288976|492716|P2|STARTED|Overall Study||49
203178|NCT01288976|492717|P1|STARTED|Overall Study||567
203179|NCT01288911|492746|P2|NOT COMPLETED|Open-label Period (All Enzalutamide)||9
203180|NCT01288911|492747|P1|NOT COMPLETED|Open-label Period (All Enzalutamide)||42
203181|NCT01288911|492746|P2|COMPLETED|Open-label Period (All Enzalutamide)||0
203182|NCT01288911|492747|P1|COMPLETED|Open-label Period (All Enzalutamide)||0
203183|NCT01288911|492746|P2|Received Treatment|Open-label Period (All Enzalutamide)||9
203184|NCT01288911|492747|P1|Received Treatment|Open-label Period (All Enzalutamide)||42
203185|NCT01288911|492746|P2|STARTED|Open-label Period (All Enzalutamide)||9
203186|NCT01288911|492747|P1|STARTED|Open-label Period (All Enzalutamide)||42
203187|NCT01288911|492746|P2|NOT COMPLETED|Double-blind Period||182
203188|NCT01288911|492747|P1|NOT COMPLETED|Double-blind Period||142
203189|NCT01288911|492746|P2|COMPLETED|Double-blind Period|Indicates participants were still receiving treatment at the data cut-off date of 19 October 2014.|9
203190|NCT01288911|492747|P1|COMPLETED|Double-blind Period|Indicates participants were still receiving treatment at the data cut-off date of 19 October 2014.|42
203191|NCT01288911|492746|P2|Received Treatment|Double-blind Period||189
203192|NCT01288911|492747|P1|Received Treatment|Double-blind Period||183
203193|NCT01288911|492746|P2|STARTED|Double-blind Period||191
203194|NCT01288911|492747|P1|STARTED|Double-blind Period||184
203195|NCT01288859|492778|P6|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
203196|NCT01288859|492779|P5|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
203197|NCT01288859|492780|P4|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
203198|NCT01288859|492781|P3|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
203199|NCT01288859|492782|P2|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
203200|NCT01288859|492783|P1|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
203201|NCT01288859|492778|P6|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
203202|NCT01288859|492779|P5|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
203203|NCT01288859|492780|P4|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
203204|NCT01288859|492781|P3|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
203205|NCT01288859|492782|P2|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
203206|NCT01288859|492783|P1|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
203207|NCT01288859|492778|P6|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
203208|NCT01288859|492779|P5|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
203209|NCT01288859|492780|P4|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
203210|NCT01288859|492781|P3|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
203211|NCT01288859|492782|P2|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
203212|NCT01288859|492783|P1|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
203213|NCT01288859|492778|P6|NOT COMPLETED|Washout Period of 1 Week||0
203214|NCT01288859|492779|P5|NOT COMPLETED|Washout Period of 1 Week||0
203215|NCT01288859|492780|P4|NOT COMPLETED|Washout Period of 1 Week||0
203216|NCT01288859|492781|P3|NOT COMPLETED|Washout Period of 1 Week||0
203217|NCT01288859|492782|P2|NOT COMPLETED|Washout Period of 1 Week||0
203218|NCT01288859|492783|P1|NOT COMPLETED|Washout Period of 1 Week||0
203219|NCT01288859|492778|P6|COMPLETED|Washout Period of 1 Week||0
203220|NCT01288859|492779|P5|COMPLETED|Washout Period of 1 Week||5
203221|NCT01288859|492780|P4|COMPLETED|Washout Period of 1 Week||5
203222|NCT01288859|492781|P3|COMPLETED|Washout Period of 1 Week||0
203223|NCT01288859|492782|P2|COMPLETED|Washout Period of 1 Week||0
203224|NCT01288859|492783|P1|COMPLETED|Washout Period of 1 Week||0
203225|NCT01288859|492778|P6|STARTED|Washout Period of 1 Week||0
203226|NCT01288859|492779|P5|STARTED|Washout Period of 1 Week||5
203227|NCT01288859|492780|P4|STARTED|Washout Period of 1 Week||5
203228|NCT01288859|492781|P3|STARTED|Washout Period of 1 Week||0
203229|NCT01288859|492782|P2|STARTED|Washout Period of 1 Week||0
203230|NCT01288859|492783|P1|STARTED|Washout Period of 1 Week||0
203231|NCT01288859|492778|P6|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
203232|NCT01288859|492779|P5|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
203233|NCT01288859|492780|P4|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
203234|NCT01288859|492781|P3|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
203235|NCT01288859|492782|P2|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
203236|NCT01288859|492783|P1|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
203237|NCT01288859|492778|P6|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
203238|NCT01288859|492779|P5|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
203239|NCT01288859|492780|P4|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
203240|NCT01288859|492781|P3|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
203241|NCT01288859|492782|P2|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
203242|NCT01288859|492783|P1|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
203243|NCT01288859|492778|P6|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
203244|NCT01288859|492779|P5|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
203245|NCT01288859|492780|P4|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
203246|NCT01288859|492781|P3|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
203247|NCT01288859|492782|P2|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
203248|NCT01288859|492783|P1|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
203249|NCT01288859|492778|P6|NOT COMPLETED|Washout Period of 1 Week||0
203250|NCT01288859|492779|P5|NOT COMPLETED|Washout Period of 1 Week||0
203251|NCT01288859|492780|P4|NOT COMPLETED|Washout Period of 1 Week||0
203252|NCT01288859|492781|P3|NOT COMPLETED|Washout Period of 1 Week||0
203253|NCT01288859|492782|P2|NOT COMPLETED|Washout Period of 1 Week||0
203254|NCT01288859|492783|P1|NOT COMPLETED|Washout Period of 1 Week||0
203255|NCT01288859|492778|P6|COMPLETED|Washout Period of 1 Week||0
203256|NCT01288859|492779|P5|COMPLETED|Washout Period of 1 Week||5
203257|NCT01288859|492780|P4|COMPLETED|Washout Period of 1 Week||5
203258|NCT01288859|492781|P3|COMPLETED|Washout Period of 1 Week||0
203259|NCT01288859|492782|P2|COMPLETED|Washout Period of 1 Week||0
203260|NCT01288859|492783|P1|COMPLETED|Washout Period of 1 Week||0
203261|NCT01288859|492778|P6|STARTED|Washout Period of 1 Week||0
203262|NCT01288859|492779|P5|STARTED|Washout Period of 1 Week||5
203263|NCT01288859|492780|P4|STARTED|Washout Period of 1 Week||5
203264|NCT01288859|492781|P3|STARTED|Washout Period of 1 Week||0
203265|NCT01288859|492782|P2|STARTED|Washout Period of 1 Week||0
203266|NCT01288859|492783|P1|STARTED|Washout Period of 1 Week||0
203267|NCT01288859|492778|P6|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
203268|NCT01288859|492779|P5|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
203269|NCT01288859|492780|P4|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
203270|NCT01288859|492781|P3|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
203271|NCT01288859|492782|P2|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
203272|NCT01288859|492783|P1|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
203273|NCT01288859|492778|P6|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
203274|NCT01288859|492779|P5|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
203275|NCT01288859|492780|P4|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
203276|NCT01288859|492781|P3|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
203277|NCT01288859|492782|P2|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
203278|NCT01288859|492783|P1|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
203279|NCT01288859|492778|P6|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
203280|NCT01288859|492779|P5|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
203281|NCT01288859|492780|P4|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
203282|NCT01288859|492781|P3|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
203283|NCT01288859|492782|P2|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
203284|NCT01288859|492783|P1|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
203285|NCT01288859|492778|P6|NOT COMPLETED|Washout Period of 1 Week||0
203286|NCT01288859|492779|P5|NOT COMPLETED|Washout Period of 1 Week||0
203287|NCT01288859|492780|P4|NOT COMPLETED|Washout Period of 1 Week||0
203288|NCT01288859|492781|P3|NOT COMPLETED|Washout Period of 1 Week||0
203289|NCT01288859|492782|P2|NOT COMPLETED|Washout Period of 1 Week||0
203290|NCT01288859|492783|P1|NOT COMPLETED|Washout Period of 1 Week||0
203291|NCT01288859|492778|P6|COMPLETED|Washout Period of 1 Week||0
203292|NCT01288859|492779|P5|COMPLETED|Washout Period of 1 Week||0
203293|NCT01288859|492780|P4|COMPLETED|Washout Period of 1 Week||0
203294|NCT01288859|492781|P3|COMPLETED|Washout Period of 1 Week||5
203295|NCT01288859|492782|P2|COMPLETED|Washout Period of 1 Week||5
203296|NCT01288859|492783|P1|COMPLETED|Washout Period of 1 Week||0
203297|NCT01288859|492778|P6|STARTED|Washout Period of 1 Week||0
203298|NCT01288859|492779|P5|STARTED|Washout Period of 1 Week||0
203299|NCT01288859|492780|P4|STARTED|Washout Period of 1 Week||0
203300|NCT01288859|492781|P3|STARTED|Washout Period of 1 Week||5
203301|NCT01288859|492782|P2|STARTED|Washout Period of 1 Week||5
203302|NCT01288859|492783|P1|STARTED|Washout Period of 1 Week||0
203303|NCT01288859|492778|P6|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
203304|NCT01288859|492779|P5|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
203305|NCT01288859|492780|P4|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
203306|NCT01288859|492781|P3|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
203307|NCT01288859|492782|P2|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
203308|NCT01288859|492783|P1|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
203309|NCT01288859|492778|P6|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
203310|NCT01288859|492779|P5|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
203311|NCT01288859|492780|P4|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
203312|NCT01288859|492781|P3|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
203313|NCT01288859|492782|P2|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
203314|NCT01288859|492783|P1|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
203315|NCT01288859|492778|P6|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
203316|NCT01288859|492779|P5|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
203317|NCT01288859|492780|P4|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
203318|NCT01288859|492781|P3|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
203319|NCT01288859|492782|P2|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
203320|NCT01288859|492783|P1|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
203321|NCT01288859|492778|P6|NOT COMPLETED|Washout Period of 1 Week||0
203322|NCT01288859|492779|P5|NOT COMPLETED|Washout Period of 1 Week||0
203323|NCT01288859|492780|P4|NOT COMPLETED|Washout Period of 1 Week||0
203324|NCT01288859|492781|P3|NOT COMPLETED|Washout Period of 1 Week||0
203325|NCT01288859|492782|P2|NOT COMPLETED|Washout Period of 1 Week||0
203326|NCT01288859|492783|P1|NOT COMPLETED|Washout Period of 1 Week||0
203327|NCT01288859|492778|P6|COMPLETED|Washout Period of 1 Week||5
203328|NCT01288859|492779|P5|COMPLETED|Washout Period of 1 Week||0
203329|NCT01288859|492780|P4|COMPLETED|Washout Period of 1 Week||0
203330|NCT01288859|492781|P3|COMPLETED|Washout Period of 1 Week||0
203331|NCT01288859|492782|P2|COMPLETED|Washout Period of 1 Week||0
203332|NCT01288859|492783|P1|COMPLETED|Washout Period of 1 Week||5
203333|NCT01288859|492778|P6|STARTED|Washout Period of 1 Week||5
203334|NCT01288859|492779|P5|STARTED|Washout Period of 1 Week||0
203335|NCT01288859|492780|P4|STARTED|Washout Period of 1 Week||0
203336|NCT01288859|492781|P3|STARTED|Washout Period of 1 Week||0
203337|NCT01288859|492782|P2|STARTED|Washout Period of 1 Week||0
203338|NCT01288859|492783|P1|STARTED|Washout Period of 1 Week||5
203339|NCT01288859|492778|P6|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
203340|NCT01288859|492779|P5|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
203341|NCT01288859|492780|P4|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
203342|NCT01288859|492781|P3|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
203343|NCT01288859|492782|P2|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
203344|NCT01288859|492783|P1|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
203345|NCT01288859|492778|P6|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
203346|NCT01288859|492779|P5|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
203347|NCT01288859|492780|P4|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
203348|NCT01288859|492781|P3|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
203349|NCT01288859|492782|P2|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
203350|NCT01288859|492783|P1|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
203351|NCT01288859|492778|P6|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
203352|NCT01288859|492779|P5|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
203353|NCT01288859|492780|P4|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
203354|NCT01288859|492781|P3|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
203355|NCT01288859|492782|P2|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
203356|NCT01288859|492783|P1|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
203357|NCT01288859|492778|P6|NOT COMPLETED|Washout Period of 1 Week||0
203358|NCT01288859|492779|P5|NOT COMPLETED|Washout Period of 1 Week||0
203359|NCT01288859|492780|P4|NOT COMPLETED|Washout Period of 1 Week||0
203360|NCT01288859|492781|P3|NOT COMPLETED|Washout Period of 1 Week||0
203361|NCT01288859|492782|P2|NOT COMPLETED|Washout Period of 1 Week||0
203362|NCT01288859|492783|P1|NOT COMPLETED|Washout Period of 1 Week||0
203363|NCT01288859|492778|P6|COMPLETED|Washout Period of 1 Week||5
203364|NCT01288859|492779|P5|COMPLETED|Washout Period of 1 Week||0
203365|NCT01288859|492780|P4|COMPLETED|Washout Period of 1 Week||0
203366|NCT01288859|492781|P3|COMPLETED|Washout Period of 1 Week||0
203367|NCT01288859|492782|P2|COMPLETED|Washout Period of 1 Week||0
203368|NCT01288859|492783|P1|COMPLETED|Washout Period of 1 Week||5
203369|NCT01288859|492778|P6|STARTED|Washout Period of 1 Week||5
203370|NCT01288859|492779|P5|STARTED|Washout Period of 1 Week||0
203371|NCT01288859|492780|P4|STARTED|Washout Period of 1 Week||0
203372|NCT01288859|492781|P3|STARTED|Washout Period of 1 Week||0
203373|NCT01288859|492782|P2|STARTED|Washout Period of 1 Week||0
203374|NCT01288859|492783|P1|STARTED|Washout Period of 1 Week||5
203375|NCT01288859|492778|P6|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
203376|NCT01288859|492779|P5|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
203377|NCT01288859|492780|P4|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
203378|NCT01288859|492781|P3|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
203379|NCT01288859|492782|P2|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
203380|NCT01288859|492783|P1|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
203381|NCT01288859|492778|P6|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
203382|NCT01288859|492779|P5|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
203383|NCT01288859|492780|P4|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
203384|NCT01288859|492781|P3|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
203385|NCT01288859|492782|P2|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
203386|NCT01288859|492783|P1|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
203387|NCT01288859|492778|P6|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
203388|NCT01288859|492779|P5|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
203389|NCT01288859|492780|P4|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
203390|NCT01288859|492781|P3|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
203391|NCT01288859|492782|P2|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
203392|NCT01288859|492783|P1|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
203393|NCT01288833|492811|P2|NOT COMPLETED|Overall Study||0
203394|NCT01288833|492812|P1|NOT COMPLETED|Overall Study||0
203395|NCT01288833|492811|P2|COMPLETED|Overall Study||281
203396|NCT01288833|492812|P1|COMPLETED|Overall Study||277
203397|NCT01288833|492811|P2|STARTED|Overall Study||281
203398|NCT01288833|492812|P1|STARTED|Overall Study||277
203399|NCT01288807|492826|P1|NOT COMPLETED|Overall Study||0
203400|NCT01288807|492826|P1|COMPLETED|Overall Study||8
203401|NCT01288807|492826|P1|STARTED|Overall Study||8
203402|NCT01288781|492836|P2|NOT COMPLETED|Overall Study||0
203403|NCT01288781|492837|P1|NOT COMPLETED|Overall Study||0
203404|NCT01288781|492836|P2|COMPLETED|Overall Study||12
203405|NCT01288781|492837|P1|COMPLETED|Overall Study||11
203406|NCT01288781|492836|P2|STARTED|Overall Study||12
203407|NCT01288781|492837|P1|STARTED|Overall Study||11
203408|NCT01288729|492857|P2|NOT COMPLETED|Overall Study||0
203409|NCT01288729|492858|P1|NOT COMPLETED|Overall Study||1
203410|NCT01288729|492857|P2|COMPLETED|Overall Study||10
203411|NCT01288729|492858|P1|COMPLETED|Overall Study||9
203412|NCT01288729|492857|P2|STARTED|Overall Study||10
203413|NCT01288729|492858|P1|STARTED|Overall Study||10
203414|NCT01288612|492867|P3|NOT COMPLETED|Overall Study||82
203415|NCT01288612|492868|P2|NOT COMPLETED|Overall Study||82
203416|NCT01288612|492869|P1|NOT COMPLETED|Overall Study||89
203417|NCT01288612|492867|P3|COMPLETED|Overall Study||76
203418|NCT01288612|492868|P2|COMPLETED|Overall Study||69
203419|NCT01288612|492869|P1|COMPLETED|Overall Study||61
203420|NCT01288612|492867|P3|Agreed to Take Part|Overall Study||76
203421|NCT01288612|492868|P2|Agreed to Take Part|Overall Study||72
203422|NCT01288612|492869|P1|Agreed to Take Part|Overall Study||61
203423|NCT01288612|492867|P3|Contacted|Overall Study||138
203424|NCT01288612|492868|P2|Contacted|Overall Study||135
203425|NCT01288612|492869|P1|Contacted|Overall Study||139
203426|NCT01288612|492867|P3|STARTED|Overall Study||158
203427|NCT01288612|492868|P2|STARTED|Overall Study||151
203428|NCT01288612|492869|P1|STARTED|Overall Study||150
203429|NCT01288534|492898|P1|NOT COMPLETED|Overall Study||0
203430|NCT01288534|492898|P1|COMPLETED|Overall Study||68
203431|NCT01288534|492898|P1|STARTED|Overall Study||68
203432|NCT01288521|492908|P2|NOT COMPLETED|Overall Study||0
203433|NCT01288521|492909|P1|NOT COMPLETED|Overall Study||0
203434|NCT01288521|492908|P2|COMPLETED|Overall Study||5
203435|NCT01288521|492909|P1|COMPLETED|Overall Study||3
203436|NCT01288521|492908|P2|STARTED|Overall Study||5
203437|NCT01288521|492909|P1|STARTED|Overall Study||3
203438|NCT01288469|492918|P3|NOT COMPLETED|Overall Study||2
203439|NCT01288469|492919|P2|NOT COMPLETED|Overall Study||3
203440|NCT01288469|492920|P1|NOT COMPLETED|Overall Study||7
203441|NCT01288469|492918|P3|COMPLETED|Overall Study||28
203442|NCT01288469|492919|P2|COMPLETED|Overall Study||28
203443|NCT01288469|492920|P1|COMPLETED|Overall Study||24
203444|NCT01288469|492918|P3|Treated|Overall Study||30
203445|NCT01288469|492919|P2|Treated|Overall Study||31
203446|NCT01288469|492920|P1|Treated|Overall Study||31
203447|NCT01288469|492918|P3|STARTED|Overall Study|Randomized|30
203448|NCT01288469|492919|P2|STARTED|Overall Study|Randomized|31
203449|NCT01288469|492920|P1|STARTED|Overall Study|Randomized|31
203450|NCT01288443|492952|P6|NOT COMPLETED|Overall Study||5
203451|NCT01288443|492953|P5|NOT COMPLETED|Overall Study||7
203452|NCT01288443|492954|P4|NOT COMPLETED|Overall Study||4
203453|NCT01288443|492955|P3|NOT COMPLETED|Overall Study||1
203454|NCT01288443|492956|P2|NOT COMPLETED|Overall Study||1
203455|NCT01288443|492957|P1|NOT COMPLETED|Overall Study||0
203456|NCT01288443|492952|P6|COMPLETED|Overall Study||25
203457|NCT01288443|492953|P5|COMPLETED|Overall Study||23
203458|NCT01288443|492954|P4|COMPLETED|Overall Study||27
203459|NCT01288443|492955|P3|COMPLETED|Overall Study||30
203460|NCT01288443|492956|P2|COMPLETED|Overall Study||29
203461|NCT01288443|492957|P1|COMPLETED|Overall Study||31
203462|NCT01288443|492952|P6|Treated|Overall Study||30
203463|NCT01288443|492953|P5|Treated|Overall Study||29
203464|NCT01288443|492954|P4|Treated|Overall Study||31
203465|NCT01288443|492955|P3|Treated|Overall Study||31
203466|NCT01288443|492956|P2|Treated|Overall Study||30
203467|NCT01288443|492957|P1|Treated|Overall Study||31
203468|NCT01288443|492952|P6|STARTED|Overall Study|Randomized|30
203469|NCT01288443|492953|P5|STARTED|Overall Study|Randomized|30
203470|NCT01288443|492954|P4|STARTED|Overall Study|Randomized|31
203471|NCT01288443|492955|P3|STARTED|Overall Study|Randomized|31
203472|NCT01288443|492956|P2|STARTED|Overall Study|Randomized|30
203473|NCT01288443|492957|P1|STARTED|Overall Study|Randomized|31
203474|NCT01288287|493007|P1|NOT COMPLETED|Overall Study||46
203475|NCT01288287|493007|P1|COMPLETED|Overall Study||103
203476|NCT01288287|493007|P1|Full Analysis Set|Overall Study||111
203477|NCT01288287|493007|P1|Safety Set|Overall Study||147
203478|NCT01288287|493007|P1|STARTED|Overall Study||149
203479|NCT01288209|493022|P2|NOT COMPLETED|Overall Study||3
203480|NCT01288209|493023|P1|NOT COMPLETED|Overall Study||2
203481|NCT01288209|493022|P2|COMPLETED|Overall Study||50
203482|NCT01288209|493023|P1|COMPLETED|Overall Study||51
203483|NCT01288209|493022|P2|STARTED|Overall Study||53
203484|NCT01288209|493023|P1|STARTED|Overall Study||53
203485|NCT01288079|493053|P4|NOT COMPLETED|Overall Study||17
203486|NCT01288079|493054|P3|NOT COMPLETED|Overall Study||19
203487|NCT01288079|493055|P2|NOT COMPLETED|Overall Study||27
203488|NCT01288079|493056|P1|NOT COMPLETED|Overall Study||20
203489|NCT01288079|493053|P4|COMPLETED|Overall Study||18
203490|NCT01288079|493054|P3|COMPLETED|Overall Study||18
203491|NCT01288079|493055|P2|COMPLETED|Overall Study||9
203492|NCT01288079|493056|P1|COMPLETED|Overall Study||17
203493|NCT01288079|493053|P4|STARTED|Overall Study||35
203494|NCT01288079|493054|P3|STARTED|Overall Study||37
203495|NCT01288079|493055|P2|STARTED|Overall Study||36
203496|NCT01288079|493056|P1|STARTED|Overall Study||37
203497|NCT01288053|493066|P1|NOT COMPLETED|Overall Study||1
203498|NCT01288053|493066|P1|COMPLETED|Overall Study||8
203499|NCT01288053|493066|P1|STARTED|Overall Study||9
203500|NCT01288027|493070|P1|NOT COMPLETED|Overall Study||0
203501|NCT01288027|493070|P1|COMPLETED|Overall Study||16
203502|NCT01288027|493070|P1|Full Analysis Set (FAS)|Overall Study|All participants who received at least 1 complete infusion of alglucosidase alfa.|16
203503|NCT01288027|493070|P1|STARTED|Overall Study||16
203504|NCT01287897|493084|P4|NOT COMPLETED|Overall Study||7
203505|NCT01287897|493085|P3|NOT COMPLETED|Overall Study||12
203506|NCT01287897|493086|P2|NOT COMPLETED|Overall Study||11
203507|NCT01287897|493087|P1|NOT COMPLETED|Overall Study||11
203508|NCT01287897|493084|P4|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|33
203509|NCT01287897|493085|P3|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
203510|NCT01287897|493086|P2|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|58
203511|NCT01287897|493087|P1|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
203512|NCT01287897|493084|P4|Enrolled in NCT01345318|Overall Study||29
203513|NCT01287897|493085|P3|Enrolled in NCT01345318|Overall Study||56
203514|NCT01287897|493086|P2|Enrolled in NCT01345318|Overall Study||50
203515|NCT01287897|493087|P1|Enrolled in NCT01345318|Overall Study||56
203516|NCT01287897|493084|P4|Completed Follow-up Period|Overall Study||4
203517|NCT01287897|493085|P3|Completed Follow-up Period|Overall Study||3
203518|NCT01287897|493086|P2|Completed Follow-up Period|Overall Study||8
203519|NCT01287897|493087|P1|Completed Follow-up Period|Overall Study||3
203520|NCT01287897|493084|P4|Completed Treatment Period|Overall Study||29
203521|NCT01287897|493085|P3|Completed Treatment Period|Overall Study||58
203522|NCT01287897|493086|P2|Completed Treatment Period|Overall Study||52
203523|NCT01287897|493087|P1|Completed Treatment Period|Overall Study||58
203524|NCT01287897|493084|P4|Treated|Overall Study||40
203525|NCT01287897|493085|P3|Treated|Overall Study||71
203526|NCT01287897|493086|P2|Treated|Overall Study||67
203527|NCT01287897|493087|P1|Treated|Overall Study||69
203528|NCT01287897|493084|P4|STARTED|Overall Study|Enrollment was halted before reaching the planned sample size due to safety findings in NCT01405196.|40
203529|NCT01287897|493085|P3|STARTED|Overall Study||71
203530|NCT01287897|493086|P2|STARTED|Overall Study||69
203531|NCT01287897|493087|P1|STARTED|Overall Study||70
203532|NCT01287832|493138|P2|NOT COMPLETED|Overall Study||1
203533|NCT01287832|493139|P1|NOT COMPLETED|Overall Study||1
203534|NCT01287832|493138|P2|COMPLETED|Overall Study||4
203535|NCT01287832|493139|P1|COMPLETED|Overall Study||5
203536|NCT01287832|493138|P2|STARTED|Overall Study||5
203537|NCT01287832|493139|P1|STARTED|Overall Study||6
203538|NCT01287754|493147|P2|NOT COMPLETED|Overall Study||21
203539|NCT01287754|493148|P1|NOT COMPLETED|Overall Study||3
203540|NCT01287754|493147|P2|COMPLETED|Overall Study||0
203541|NCT01287754|493148|P1|COMPLETED|Overall Study||0
203542|NCT01287754|493147|P2|STARTED|Overall Study||21
203543|NCT01287754|493148|P1|STARTED|Overall Study||3
203544|NCT01287741|493160|P2|NOT COMPLETED|Overall Study||615
203545|NCT01287741|493161|P1|NOT COMPLETED|Overall Study||626
203546|NCT01287741|493160|P2|COMPLETED|Overall Study||91
203547|NCT01287741|493161|P1|COMPLETED|Overall Study||86
203548|NCT01287741|493160|P2|STARTED|Overall Study||706
203549|NCT01287741|493161|P1|STARTED|Overall Study||712
203550|NCT01287611|493197|P2|NOT COMPLETED|Overall Study||19
203551|NCT01287611|493198|P1|NOT COMPLETED|Overall Study||33
203552|NCT01287611|493197|P2|COMPLETED|Overall Study||65
203553|NCT01287611|493198|P1|COMPLETED|Overall Study||51
203554|NCT01287611|493197|P2|The Number of Patients Who Underwent C/S|Overall Study||84
203555|NCT01287611|493198|P1|The Number of Patients Who Underwent C/S|Overall Study||84
203556|NCT01287611|493197|P2|STARTED|Overall Study||84
203557|NCT01287611|493198|P1|STARTED|Overall Study||84
203558|NCT01287520|493215|P9|NOT COMPLETED|Overall Study||5
203559|NCT01287520|493216|P8|NOT COMPLETED|Overall Study||5
203560|NCT01287520|493217|P7|NOT COMPLETED|Overall Study||2
203561|NCT01287520|493218|P6|NOT COMPLETED|Overall Study||4
203562|NCT01287520|493219|P5|NOT COMPLETED|Overall Study||3
203563|NCT01287520|493220|P4|NOT COMPLETED|Overall Study||7
203564|NCT01287520|493221|P3|NOT COMPLETED|Overall Study||5
203565|NCT01287520|493222|P2|NOT COMPLETED|Overall Study||7
203566|NCT01287520|493223|P1|NOT COMPLETED|Overall Study||3
203567|NCT01287520|493215|P9|COMPLETED|Overall Study||0
203568|NCT01287520|493216|P8|COMPLETED|Overall Study||0
203569|NCT01287520|493217|P7|COMPLETED|Overall Study||0
203570|NCT01287520|493218|P6|COMPLETED|Overall Study||0
203571|NCT01287520|493219|P5|COMPLETED|Overall Study||0
203572|NCT01287520|493220|P4|COMPLETED|Overall Study||0
203573|NCT01287520|493221|P3|COMPLETED|Overall Study||0
203574|NCT01287520|493222|P2|COMPLETED|Overall Study||0
203575|NCT01287520|493223|P1|COMPLETED|Overall Study||0
203576|NCT01287520|493215|P9|STARTED|Overall Study||5
203577|NCT01287520|493216|P8|STARTED|Overall Study||5
203578|NCT01287520|493217|P7|STARTED|Overall Study||2
203579|NCT01287520|493218|P6|STARTED|Overall Study||4
203580|NCT01287520|493219|P5|STARTED|Overall Study||3
203581|NCT01287520|493220|P4|STARTED|Overall Study|One participant who received study drug but did not complete Cycle 1 was replaced.|7
203582|NCT01287520|493221|P3|STARTED|Overall Study||5
203583|NCT01287520|493222|P2|STARTED|Overall Study|One participant who received study drug but did not complete Cycle 1 was replaced.|7
203584|NCT01287520|493223|P1|STARTED|Overall Study||3
203585|NCT01287416|493287|P2|NOT COMPLETED|6 Month Follow-up||2
203586|NCT01287416|493288|P1|NOT COMPLETED|6 Month Follow-up||3
203587|NCT01287416|493287|P2|COMPLETED|6 Month Follow-up||22
203588|NCT01287416|493288|P1|COMPLETED|6 Month Follow-up||28
203589|NCT01287416|493287|P2|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|24
203590|NCT01287416|493288|P1|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|31
203591|NCT01287416|493287|P2|NOT COMPLETED|Pre-post Training||25
203592|NCT01287416|493288|P1|NOT COMPLETED|Pre-post Training||22
203593|NCT01287416|493287|P2|COMPLETED|Pre-post Training||23
203594|NCT01287416|493288|P1|COMPLETED|Pre-post Training||26
203595|NCT01287416|493287|P2|Post Training Questionnaire|Pre-post Training||23
203596|NCT01287416|493288|P1|Post Training Questionnaire|Pre-post Training||26
203597|NCT01287416|493287|P2|Training Workshop|Pre-post Training|number of people that showed up for the training session|24
203598|NCT01287416|493288|P1|Training Workshop|Pre-post Training|number of people that showed up for the training session|31
203599|NCT01287416|493287|P2|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
203600|NCT01287416|493288|P1|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
203601|NCT01287403|493324|P1|NOT COMPLETED|6th and Last Intervention (1 Day)||0
203602|NCT01287403|493324|P1|COMPLETED|6th and Last Intervention (1 Day)||13
203603|NCT01287403|493324|P1|STARTED|6th and Last Intervention (1 Day)||13
203604|NCT01287403|493324|P1|NOT COMPLETED|Washout (7 Days)||0
203605|NCT01287403|493324|P1|COMPLETED|Washout (7 Days)||13
203606|NCT01287403|493324|P1|STARTED|Washout (7 Days)||13
203607|NCT01287403|493324|P1|NOT COMPLETED|5th Intervention (1 Day)||0
203608|NCT01287403|493324|P1|COMPLETED|5th Intervention (1 Day)||13
203609|NCT01287403|493324|P1|STARTED|5th Intervention (1 Day)||13
203610|NCT01287403|493324|P1|NOT COMPLETED|Washout (7 Days)||0
203611|NCT01287403|493324|P1|COMPLETED|Washout (7 Days)||13
203612|NCT01287403|493324|P1|STARTED|Washout (7 Days)||13
203613|NCT01287403|493324|P1|NOT COMPLETED|4th Intervention (1 Day)||0
203614|NCT01287403|493324|P1|COMPLETED|4th Intervention (1 Day)||13
203615|NCT01287403|493324|P1|STARTED|4th Intervention (1 Day)||13
203616|NCT01287403|493324|P1|NOT COMPLETED|Washout (7 Days)||0
203617|NCT01287403|493324|P1|COMPLETED|Washout (7 Days)||13
203618|NCT01287403|493324|P1|STARTED|Washout (7 Days)||13
203619|NCT01287403|493324|P1|NOT COMPLETED|3rd Intervention (1 Day)||0
203620|NCT01287403|493324|P1|COMPLETED|3rd Intervention (1 Day)||13
203621|NCT01287403|493324|P1|STARTED|3rd Intervention (1 Day)||13
203622|NCT01287403|493324|P1|NOT COMPLETED|Washout (7 Days)||0
203623|NCT01287403|493324|P1|COMPLETED|Washout (7 Days)||13
203624|NCT01287403|493324|P1|STARTED|Washout (7 Days)||13
203625|NCT01287403|493324|P1|NOT COMPLETED|2nd Intervention (1 Day)||0
203626|NCT01287403|493324|P1|COMPLETED|2nd Intervention (1 Day)||13
203627|NCT01287403|493324|P1|STARTED|2nd Intervention (1 Day)||13
203628|NCT01287403|493324|P1|NOT COMPLETED|Washout 7 Days||0
203629|NCT01287403|493324|P1|COMPLETED|Washout 7 Days||13
203630|NCT01287403|493324|P1|STARTED|Washout 7 Days||13
203631|NCT01287403|493324|P1|NOT COMPLETED|1st Intervention (1 Day)||1
203632|NCT01287403|493324|P1|COMPLETED|1st Intervention (1 Day)|"The adverse event was linked to the intake of refined wheat flour"|13
203633|NCT01287403|493324|P1|STARTED|1st Intervention (1 Day)||14
203634|NCT01287403|493324|P1|NOT COMPLETED|Diet Restriction (7 Days)||0
203635|NCT01287403|493324|P1|COMPLETED|Diet Restriction (7 Days)||14
203636|NCT01287403|493324|P1|STARTED|Diet Restriction (7 Days)||14
203637|NCT01287377|493341|P3|NOT COMPLETED|Overall Study||0
203638|NCT01287377|493342|P2|NOT COMPLETED|Overall Study||0
203639|NCT01287377|493343|P1|NOT COMPLETED|Overall Study||0
203640|NCT01287377|493341|P3|COMPLETED|Overall Study|Study Complete|82
203641|NCT01287377|493342|P2|COMPLETED|Overall Study|Study Complete|81
203642|NCT01287377|493343|P1|COMPLETED|Overall Study|Study Complete|80
203643|NCT01287377|493341|P3|STARTED|Overall Study||82
203644|NCT01287377|493342|P2|STARTED|Overall Study||81
203645|NCT01287377|493343|P1|STARTED|Overall Study||80
203646|NCT01287364|493356|P2|NOT COMPLETED|Overall Study||10
203647|NCT01287364|493357|P1|NOT COMPLETED|Overall Study||9
203648|NCT01287364|493356|P2|COMPLETED|Overall Study||81
203649|NCT01287364|493357|P1|COMPLETED|Overall Study||85
203650|NCT01287364|493356|P2|STARTED|Overall Study||91
203651|NCT01287364|493357|P1|STARTED|Overall Study||94
203652|NCT01287221|493379|P2|NOT COMPLETED|Overall Study||5
203653|NCT01287221|493380|P1|NOT COMPLETED|Overall Study||4
203654|NCT01287221|493379|P2|COMPLETED|Overall Study||45
203655|NCT01287221|493380|P1|COMPLETED|Overall Study||46
203656|NCT01287221|493379|P2|Completed 12 Months Follow-up|Overall Study||39
203657|NCT01287221|493380|P1|Completed 12 Months Follow-up|Overall Study||40
203658|NCT01287221|493379|P2|Completed 9 Months Follow-up|Overall Study||40
203659|NCT01287221|493380|P1|Completed 9 Months Follow-up|Overall Study||42
203660|NCT01287221|493379|P2|Completed 6 Months Follow-up|Overall Study||43
203661|NCT01287221|493380|P1|Completed 6 Months Follow-up|Overall Study||47
203662|NCT01287221|493379|P2|Completed 3 Months Follow-up|Overall Study||50
203663|NCT01287221|493380|P1|Completed 3 Months Follow-up|Overall Study||49
203664|NCT01287221|493379|P2|STARTED|Overall Study||50
203665|NCT01287221|493380|P1|STARTED|Overall Study||50
203666|NCT01287208|493400|P2|NOT COMPLETED|Phase 2: Team Competition||0
203667|NCT01287208|493401|P1|NOT COMPLETED|Phase 2: Team Competition||0
203668|NCT01287208|493400|P2|COMPLETED|Phase 2: Team Competition||49
203669|NCT01287208|493401|P1|COMPLETED|Phase 2: Team Competition||50
203670|NCT01287208|493400|P2|STARTED|Phase 2: Team Competition||49
203671|NCT01287208|493401|P1|STARTED|Phase 2: Team Competition||50
203672|NCT01287208|493400|P2|NOT COMPLETED|Phase 1: Randomized Phase||3
203673|NCT01287208|493401|P1|NOT COMPLETED|Phase 1: Randomized Phase||2
203674|NCT01287208|493400|P2|COMPLETED|Phase 1: Randomized Phase||49
203675|NCT01287208|493401|P1|COMPLETED|Phase 1: Randomized Phase||50
203676|NCT01287208|493400|P2|STARTED|Phase 1: Randomized Phase||52
203677|NCT01287208|493401|P1|STARTED|Phase 1: Randomized Phase||52
203678|NCT01287195|493415|P1|NOT COMPLETED|Overall Study||2
203679|NCT01287195|493415|P1|COMPLETED|Overall Study||4
203680|NCT01287195|493415|P1|STARTED|Overall Study||6
203681|NCT01287117|493430|P4|NOT COMPLETED|Overall Study||12
203682|NCT01287117|493431|P3|NOT COMPLETED|Overall Study||16
203683|NCT01287117|493432|P2|NOT COMPLETED|Overall Study||14
203684|NCT01287117|493433|P1|NOT COMPLETED|Overall Study||15
203685|NCT01287117|493430|P4|COMPLETED|Overall Study||69
203686|NCT01287117|493431|P3|COMPLETED|Overall Study||64
203687|NCT01287117|493432|P2|COMPLETED|Overall Study||64
203688|NCT01287117|493433|P1|COMPLETED|Overall Study||65
203689|NCT01287117|493430|P4|Received Treatment|Overall Study||81
203690|NCT01287117|493431|P3|Received Treatment|Overall Study||80
203691|NCT01287117|493432|P2|Received Treatment|Overall Study||77
203692|NCT01287117|493433|P1|Received Treatment|Overall Study||80
203693|NCT01287117|493430|P4|STARTED|Overall Study||81
203694|NCT01287117|493431|P3|STARTED|Overall Study||80
203695|NCT01287117|493432|P2|STARTED|Overall Study||78
203696|NCT01287117|493433|P1|STARTED|Overall Study||80
203697|NCT01287104|493483|P4|NOT COMPLETED|Overall Study||3
203698|NCT01287104|493484|P3|NOT COMPLETED|Overall Study||7
203699|NCT01287104|493485|P2|NOT COMPLETED|Overall Study||5
203700|NCT01287104|493486|P1|NOT COMPLETED|Overall Study||1
203701|NCT01287104|493483|P4|COMPLETED|Overall Study||8
203702|NCT01287104|493484|P3|COMPLETED|Overall Study||5
203703|NCT01287104|493485|P2|COMPLETED|Overall Study||2
203704|NCT01287104|493486|P1|COMPLETED|Overall Study||3
203705|NCT01287104|493483|P4|STARTED|Overall Study||11
203706|NCT01287104|493484|P3|STARTED|Overall Study||12
203707|NCT01287104|493485|P2|STARTED|Overall Study||7
203708|NCT01287104|493486|P1|STARTED|Overall Study||4
203709|NCT01287065|493519|P6|NOT COMPLETED|Treatment Period 3||0
203710|NCT01287065|493520|P5|NOT COMPLETED|Treatment Period 3||0
203711|NCT01287065|493521|P4|NOT COMPLETED|Treatment Period 3||0
203712|NCT01287065|493522|P3|NOT COMPLETED|Treatment Period 3||0
203713|NCT01287065|493523|P2|NOT COMPLETED|Treatment Period 3||0
203714|NCT01287065|493524|P1|NOT COMPLETED|Treatment Period 3||0
203715|NCT01287065|493519|P6|COMPLETED|Treatment Period 3||4
203716|NCT01287065|493520|P5|COMPLETED|Treatment Period 3||4
203717|NCT01287065|493521|P4|COMPLETED|Treatment Period 3||4
203718|NCT01287065|493522|P3|COMPLETED|Treatment Period 3||4
203719|NCT01287065|493523|P2|COMPLETED|Treatment Period 3||4
203720|NCT01287065|493524|P1|COMPLETED|Treatment Period 3||4
203721|NCT01287065|493519|P6|STARTED|Treatment Period 3||4
203722|NCT01287065|493520|P5|STARTED|Treatment Period 3||4
203723|NCT01287065|493521|P4|STARTED|Treatment Period 3||4
203724|NCT01287065|493522|P3|STARTED|Treatment Period 3||4
203725|NCT01287065|493523|P2|STARTED|Treatment Period 3||4
203726|NCT01287065|493524|P1|STARTED|Treatment Period 3||4
203727|NCT01287065|493519|P6|NOT COMPLETED|Washout Period 2||0
203728|NCT01287065|493520|P5|NOT COMPLETED|Washout Period 2||0
203729|NCT01287065|493521|P4|NOT COMPLETED|Washout Period 2||0
203730|NCT01287065|493522|P3|NOT COMPLETED|Washout Period 2||0
203731|NCT01287065|493523|P2|NOT COMPLETED|Washout Period 2||0
203732|NCT01287065|493524|P1|NOT COMPLETED|Washout Period 2||0
203733|NCT01287065|493519|P6|COMPLETED|Washout Period 2||4
203734|NCT01287065|493520|P5|COMPLETED|Washout Period 2||4
203735|NCT01287065|493521|P4|COMPLETED|Washout Period 2||4
203736|NCT01287065|493522|P3|COMPLETED|Washout Period 2||4
203737|NCT01287065|493523|P2|COMPLETED|Washout Period 2||4
203738|NCT01287065|493524|P1|COMPLETED|Washout Period 2||4
203739|NCT01287065|493519|P6|STARTED|Washout Period 2||4
203740|NCT01287065|493520|P5|STARTED|Washout Period 2||4
203741|NCT01287065|493521|P4|STARTED|Washout Period 2||4
203742|NCT01287065|493522|P3|STARTED|Washout Period 2||4
203743|NCT01287065|493523|P2|STARTED|Washout Period 2||4
203744|NCT01287065|493524|P1|STARTED|Washout Period 2||4
203745|NCT01287065|493519|P6|NOT COMPLETED|Treatment Period 2||0
203746|NCT01287065|493520|P5|NOT COMPLETED|Treatment Period 2||0
203747|NCT01287065|493521|P4|NOT COMPLETED|Treatment Period 2||0
203748|NCT01287065|493522|P3|NOT COMPLETED|Treatment Period 2||0
203749|NCT01287065|493523|P2|NOT COMPLETED|Treatment Period 2||0
203750|NCT01287065|493524|P1|NOT COMPLETED|Treatment Period 2||0
203751|NCT01287065|493519|P6|COMPLETED|Treatment Period 2||4
203752|NCT01287065|493520|P5|COMPLETED|Treatment Period 2||4
203753|NCT01287065|493521|P4|COMPLETED|Treatment Period 2||4
203754|NCT01287065|493522|P3|COMPLETED|Treatment Period 2||4
203755|NCT01287065|493523|P2|COMPLETED|Treatment Period 2||4
203756|NCT01287065|493524|P1|COMPLETED|Treatment Period 2||4
203757|NCT01287065|493519|P6|STARTED|Treatment Period 2||4
203758|NCT01287065|493520|P5|STARTED|Treatment Period 2||4
203759|NCT01287065|493521|P4|STARTED|Treatment Period 2||4
203760|NCT01287065|493522|P3|STARTED|Treatment Period 2||4
203761|NCT01287065|493523|P2|STARTED|Treatment Period 2||4
203762|NCT01287065|493524|P1|STARTED|Treatment Period 2||4
203763|NCT01287065|493519|P6|NOT COMPLETED|Washout Period 1||0
203764|NCT01287065|493520|P5|NOT COMPLETED|Washout Period 1||0
203765|NCT01287065|493521|P4|NOT COMPLETED|Washout Period 1||0
203766|NCT01287065|493522|P3|NOT COMPLETED|Washout Period 1||0
203767|NCT01287065|493523|P2|NOT COMPLETED|Washout Period 1||0
203768|NCT01287065|493524|P1|NOT COMPLETED|Washout Period 1||0
203769|NCT01287065|493519|P6|COMPLETED|Washout Period 1||4
203770|NCT01287065|493520|P5|COMPLETED|Washout Period 1||4
203771|NCT01287065|493521|P4|COMPLETED|Washout Period 1||4
203772|NCT01287065|493522|P3|COMPLETED|Washout Period 1||4
203773|NCT01287065|493523|P2|COMPLETED|Washout Period 1||4
203774|NCT01287065|493524|P1|COMPLETED|Washout Period 1||4
203775|NCT01287065|493519|P6|STARTED|Washout Period 1||4
203776|NCT01287065|493520|P5|STARTED|Washout Period 1||4
203777|NCT01287065|493521|P4|STARTED|Washout Period 1||4
203778|NCT01287065|493522|P3|STARTED|Washout Period 1||4
203779|NCT01287065|493523|P2|STARTED|Washout Period 1||4
203780|NCT01287065|493524|P1|STARTED|Washout Period 1||4
203781|NCT01287065|493519|P6|NOT COMPLETED|Treatment Period 1||1
203782|NCT01287065|493520|P5|NOT COMPLETED|Treatment Period 1||1
203783|NCT01287065|493521|P4|NOT COMPLETED|Treatment Period 1||0
203784|NCT01287065|493522|P3|NOT COMPLETED|Treatment Period 1||0
203785|NCT01287065|493523|P2|NOT COMPLETED|Treatment Period 1||0
203786|NCT01287065|493524|P1|NOT COMPLETED|Treatment Period 1||0
203787|NCT01287065|493519|P6|COMPLETED|Treatment Period 1||4
203788|NCT01287065|493520|P5|COMPLETED|Treatment Period 1||4
203789|NCT01287065|493521|P4|COMPLETED|Treatment Period 1||4
203790|NCT01287065|493522|P3|COMPLETED|Treatment Period 1||4
203791|NCT01287065|493523|P2|COMPLETED|Treatment Period 1||4
203792|NCT01287065|493524|P1|COMPLETED|Treatment Period 1||4
203793|NCT01287065|493519|P6|STARTED|Treatment Period 1||5
203794|NCT01287065|493520|P5|STARTED|Treatment Period 1||5
203795|NCT01287065|493521|P4|STARTED|Treatment Period 1||4
203796|NCT01287065|493522|P3|STARTED|Treatment Period 1||4
203797|NCT01287065|493523|P2|STARTED|Treatment Period 1||4
203798|NCT01287065|493524|P1|STARTED|Treatment Period 1||4
203799|NCT01287039|493543|P2|NOT COMPLETED|Overall Study||27
203800|NCT01287039|493544|P1|NOT COMPLETED|Overall Study||29
203801|NCT01287039|493543|P2|COMPLETED|Overall Study||218
203802|NCT01287039|493544|P1|COMPLETED|Overall Study||215
203803|NCT01287039|493543|P2|STARTED|Overall Study||245
203804|NCT01287039|493544|P1|STARTED|Overall Study||244
203805|NCT01287013|493577|P3|NOT COMPLETED|Overall Study||21
203806|NCT01287013|493578|P2|NOT COMPLETED|Overall Study||5
203807|NCT01287013|493579|P1|NOT COMPLETED|Overall Study||3
203808|NCT01287013|493577|P3|COMPLETED|Overall Study||0
203809|NCT01287013|493578|P2|COMPLETED|Overall Study||29
203810|NCT01287013|493579|P1|COMPLETED|Overall Study||29
203811|NCT01287013|493577|P3|STARTED|Overall Study||21
203812|NCT01287013|493578|P2|STARTED|Overall Study||34
203813|NCT01287013|493579|P1|STARTED|Overall Study||32
203814|NCT01286987|493609|P15|NOT COMPLETED|Part 2: Dose Expansion||2
203815|NCT01286987|493610|P14|NOT COMPLETED|Part 2: Dose Expansion||24
203816|NCT01286987|493611|P13|NOT COMPLETED|Part 2: Dose Expansion||12
203817|NCT01286987|493612|P12|NOT COMPLETED|Part 2: Dose Expansion||10
203818|NCT01286987|493613|P11|NOT COMPLETED|Part 2: Dose Expansion||10
203819|NCT01286987|493614|P10|NOT COMPLETED|Part 2: Dose Expansion||11
203820|NCT01286987|493615|P9|NOT COMPLETED|Part 2: Dose Expansion||0
203821|NCT01286987|493616|P8|NOT COMPLETED|Part 2: Dose Expansion||0
203822|NCT01286987|493617|P7|NOT COMPLETED|Part 2: Dose Expansion||0
203823|NCT01286987|493618|P6|NOT COMPLETED|Part 2: Dose Expansion||0
203824|NCT01286987|493619|P5|NOT COMPLETED|Part 2: Dose Expansion||0
203825|NCT01286987|493620|P4|NOT COMPLETED|Part 2: Dose Expansion||0
203826|NCT01286987|493621|P3|NOT COMPLETED|Part 2: Dose Expansion||0
203827|NCT01286987|493622|P2|NOT COMPLETED|Part 2: Dose Expansion||0
203828|NCT01286987|493623|P1|NOT COMPLETED|Part 2: Dose Expansion||0
203829|NCT01286987|493609|P15|COMPLETED|Part 2: Dose Expansion||1
203830|NCT01286987|493610|P14|COMPLETED|Part 2: Dose Expansion||0
203831|NCT01286987|493611|P13|COMPLETED|Part 2: Dose Expansion||0
203832|NCT01286987|493612|P12|COMPLETED|Part 2: Dose Expansion||1
203833|NCT01286987|493613|P11|COMPLETED|Part 2: Dose Expansion||2
203834|NCT01286987|493614|P10|COMPLETED|Part 2: Dose Expansion||1
203835|NCT01286987|493615|P9|COMPLETED|Part 2: Dose Expansion||0
203836|NCT01286987|493616|P8|COMPLETED|Part 2: Dose Expansion||0
203837|NCT01286987|493617|P7|COMPLETED|Part 2: Dose Expansion||0
203838|NCT01286987|493618|P6|COMPLETED|Part 2: Dose Expansion||0
203839|NCT01286987|493619|P5|COMPLETED|Part 2: Dose Expansion||0
203840|NCT01286987|493620|P4|COMPLETED|Part 2: Dose Expansion||0
203841|NCT01286987|493621|P3|COMPLETED|Part 2: Dose Expansion||0
203842|NCT01286987|493622|P2|COMPLETED|Part 2: Dose Expansion||0
203843|NCT01286987|493623|P1|COMPLETED|Part 2: Dose Expansion||0
203844|NCT01286987|493609|P15|Treated|Part 2: Dose Expansion||3
203845|NCT01286987|493610|P14|Treated|Part 2: Dose Expansion||23
203846|NCT01286987|493611|P13|Treated|Part 2: Dose Expansion||12
203847|NCT01286987|493612|P12|Treated|Part 2: Dose Expansion||10
203848|NCT01286987|493613|P11|Treated|Part 2: Dose Expansion||11
203849|NCT01286987|493614|P10|Treated|Part 2: Dose Expansion||12
203850|NCT01286987|493615|P9|Treated|Part 2: Dose Expansion||0
203851|NCT01286987|493616|P8|Treated|Part 2: Dose Expansion||0
203852|NCT01286987|493617|P7|Treated|Part 2: Dose Expansion||0
203853|NCT01286987|493618|P6|Treated|Part 2: Dose Expansion||0
203854|NCT01286987|493619|P5|Treated|Part 2: Dose Expansion||0
203855|NCT01286987|493620|P4|Treated|Part 2: Dose Expansion||0
203856|NCT01286987|493621|P3|Treated|Part 2: Dose Expansion||0
203857|NCT01286987|493622|P2|Treated|Part 2: Dose Expansion||0
203858|NCT01286987|493623|P1|Treated|Part 2: Dose Expansion||0
203859|NCT01286987|493609|P15|STARTED|Part 2: Dose Expansion||3
203860|NCT01286987|493610|P14|STARTED|Part 2: Dose Expansion||24
203861|NCT01286987|493611|P13|STARTED|Part 2: Dose Expansion||12
203862|NCT01286987|493612|P12|STARTED|Part 2: Dose Expansion||11
203863|NCT01286987|493613|P11|STARTED|Part 2: Dose Expansion||12
203864|NCT01286987|493614|P10|STARTED|Part 2: Dose Expansion||12
203865|NCT01286987|493615|P9|STARTED|Part 2: Dose Expansion||0
203866|NCT01286987|493616|P8|STARTED|Part 2: Dose Expansion||0
203867|NCT01286987|493617|P7|STARTED|Part 2: Dose Expansion||0
203868|NCT01286987|493618|P6|STARTED|Part 2: Dose Expansion||0
203869|NCT01286987|493619|P5|STARTED|Part 2: Dose Expansion||0
203870|NCT01286987|493620|P4|STARTED|Part 2: Dose Expansion||0
203871|NCT01286987|493621|P3|STARTED|Part 2: Dose Expansion||0
203872|NCT01286987|493622|P2|STARTED|Part 2: Dose Expansion||0
203873|NCT01286987|493623|P1|STARTED|Part 2: Dose Expansion||0
203874|NCT01286987|493609|P15|NOT COMPLETED|Part 1: Dose Escalation||0
203875|NCT01286987|493610|P14|NOT COMPLETED|Part 1: Dose Escalation||0
203876|NCT01286987|493611|P13|NOT COMPLETED|Part 1: Dose Escalation||0
203877|NCT01286987|493612|P12|NOT COMPLETED|Part 1: Dose Escalation||0
203878|NCT01286987|493613|P11|NOT COMPLETED|Part 1: Dose Escalation||0
203879|NCT01286987|493614|P10|NOT COMPLETED|Part 1: Dose Escalation||0
203880|NCT01286987|493615|P9|NOT COMPLETED|Part 1: Dose Escalation||6
203881|NCT01286987|493616|P8|NOT COMPLETED|Part 1: Dose Escalation||5
203882|NCT01286987|493617|P7|NOT COMPLETED|Part 1: Dose Escalation||5
203883|NCT01286987|493618|P6|NOT COMPLETED|Part 1: Dose Escalation||6
203884|NCT01286987|493619|P5|NOT COMPLETED|Part 1: Dose Escalation||3
203885|NCT01286987|493620|P4|NOT COMPLETED|Part 1: Dose Escalation||3
203886|NCT01286987|493621|P3|NOT COMPLETED|Part 1: Dose Escalation||3
203887|NCT01286987|493622|P2|NOT COMPLETED|Part 1: Dose Escalation||3
203888|NCT01286987|493623|P1|NOT COMPLETED|Part 1: Dose Escalation||3
203889|NCT01286987|493609|P15|COMPLETED|Part 1: Dose Escalation||0
203890|NCT01286987|493610|P14|COMPLETED|Part 1: Dose Escalation||0
203891|NCT01286987|493611|P13|COMPLETED|Part 1: Dose Escalation||0
203892|NCT01286987|493612|P12|COMPLETED|Part 1: Dose Escalation||0
203893|NCT01286987|493613|P11|COMPLETED|Part 1: Dose Escalation||0
203894|NCT01286987|493614|P10|COMPLETED|Part 1: Dose Escalation||0
203895|NCT01286987|493615|P9|COMPLETED|Part 1: Dose Escalation||0
203896|NCT01286987|493616|P8|COMPLETED|Part 1: Dose Escalation||1
203897|NCT01286987|493617|P7|COMPLETED|Part 1: Dose Escalation||1
203898|NCT01286987|493618|P6|COMPLETED|Part 1: Dose Escalation||0
203899|NCT01286987|493619|P5|COMPLETED|Part 1: Dose Escalation||0
203900|NCT01286987|493620|P4|COMPLETED|Part 1: Dose Escalation||0
203901|NCT01286987|493621|P3|COMPLETED|Part 1: Dose Escalation||0
203902|NCT01286987|493622|P2|COMPLETED|Part 1: Dose Escalation||0
203903|NCT01286987|493623|P1|COMPLETED|Part 1: Dose Escalation||0
203904|NCT01286987|493609|P15|Breast Cancer|Part 1: Dose Escalation||0
203905|NCT01286987|493610|P14|Breast Cancer|Part 1: Dose Escalation||0
203906|NCT01286987|493611|P13|Breast Cancer|Part 1: Dose Escalation||0
203907|NCT01286987|493612|P12|Breast Cancer|Part 1: Dose Escalation||0
203908|NCT01286987|493613|P11|Breast Cancer|Part 1: Dose Escalation||0
203909|NCT01286987|493614|P10|Breast Cancer|Part 1: Dose Escalation||0
203910|NCT01286987|493615|P9|Breast Cancer|Part 1: Dose Escalation||3
203911|NCT01286987|493616|P8|Breast Cancer|Part 1: Dose Escalation||2
203912|NCT01286987|493617|P7|Breast Cancer|Part 1: Dose Escalation||2
203913|NCT01286987|493618|P6|Breast Cancer|Part 1: Dose Escalation||1
203914|NCT01286987|493619|P5|Breast Cancer|Part 1: Dose Escalation||0
203915|NCT01286987|493620|P4|Breast Cancer|Part 1: Dose Escalation||0
203916|NCT01286987|493621|P3|Breast Cancer|Part 1: Dose Escalation||0
203917|NCT01286987|493622|P2|Breast Cancer|Part 1: Dose Escalation||0
203918|NCT01286987|493623|P1|Breast Cancer|Part 1: Dose Escalation||0
203919|NCT01286987|493609|P15|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
203920|NCT01286987|493610|P14|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
203921|NCT01286987|493611|P13|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
203922|NCT01286987|493612|P12|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
203923|NCT01286987|493613|P11|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
203924|NCT01286987|493614|P10|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
203925|NCT01286987|493615|P9|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||2
203926|NCT01286987|493616|P8|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
203927|NCT01286987|493617|P7|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||4
203928|NCT01286987|493618|P6|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||4
203929|NCT01286987|493619|P5|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
203930|NCT01286987|493620|P4|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
203931|NCT01286987|493621|P3|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||2
203932|NCT01286987|493622|P2|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||1
203933|NCT01286987|493623|P1|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||1
203934|NCT01286987|493609|P15|Pancreatic Cancer|Part 1: Dose Escalation||0
203935|NCT01286987|493610|P14|Pancreatic Cancer|Part 1: Dose Escalation||0
203936|NCT01286987|493611|P13|Pancreatic Cancer|Part 1: Dose Escalation||0
203937|NCT01286987|493612|P12|Pancreatic Cancer|Part 1: Dose Escalation||0
203938|NCT01286987|493613|P11|Pancreatic Cancer|Part 1: Dose Escalation||0
203939|NCT01286987|493614|P10|Pancreatic Cancer|Part 1: Dose Escalation||0
203940|NCT01286987|493615|P9|Pancreatic Cancer|Part 1: Dose Escalation||0
203941|NCT01286987|493616|P8|Pancreatic Cancer|Part 1: Dose Escalation||0
203942|NCT01286987|493617|P7|Pancreatic Cancer|Part 1: Dose Escalation||0
203943|NCT01286987|493618|P6|Pancreatic Cancer|Part 1: Dose Escalation||0
203944|NCT01286987|493619|P5|Pancreatic Cancer|Part 1: Dose Escalation||0
203945|NCT01286987|493620|P4|Pancreatic Cancer|Part 1: Dose Escalation||0
203946|NCT01286987|493621|P3|Pancreatic Cancer|Part 1: Dose Escalation||0
203947|NCT01286987|493622|P2|Pancreatic Cancer|Part 1: Dose Escalation||2
203948|NCT01286987|493623|P1|Pancreatic Cancer|Part 1: Dose Escalation||1
203949|NCT01286987|493609|P15|Ewing Cancer|Part 1: Dose Escalation||0
203950|NCT01286987|493610|P14|Ewing Cancer|Part 1: Dose Escalation||0
203951|NCT01286987|493611|P13|Ewing Cancer|Part 1: Dose Escalation||0
203952|NCT01286987|493612|P12|Ewing Cancer|Part 1: Dose Escalation||0
203953|NCT01286987|493613|P11|Ewing Cancer|Part 1: Dose Escalation||0
203954|NCT01286987|493614|P10|Ewing Cancer|Part 1: Dose Escalation||0
203955|NCT01286987|493615|P9|Ewing Cancer|Part 1: Dose Escalation||1
203956|NCT01286987|493616|P8|Ewing Cancer|Part 1: Dose Escalation||1
203957|NCT01286987|493617|P7|Ewing Cancer|Part 1: Dose Escalation||0
203958|NCT01286987|493618|P6|Ewing Cancer|Part 1: Dose Escalation||0
203959|NCT01286987|493619|P5|Ewing Cancer|Part 1: Dose Escalation||0
203960|NCT01286987|493620|P4|Ewing Cancer|Part 1: Dose Escalation||0
203961|NCT01286987|493621|P3|Ewing Cancer|Part 1: Dose Escalation||0
203962|NCT01286987|493622|P2|Ewing Cancer|Part 1: Dose Escalation||0
203963|NCT01286987|493623|P1|Ewing Cancer|Part 1: Dose Escalation||0
203964|NCT01286987|493609|P15|Prostate Cancer|Part 1: Dose Escalation||0
203965|NCT01286987|493610|P14|Prostate Cancer|Part 1: Dose Escalation||0
203966|NCT01286987|493611|P13|Prostate Cancer|Part 1: Dose Escalation||0
203967|NCT01286987|493612|P12|Prostate Cancer|Part 1: Dose Escalation||0
203968|NCT01286987|493613|P11|Prostate Cancer|Part 1: Dose Escalation||0
203969|NCT01286987|493614|P10|Prostate Cancer|Part 1: Dose Escalation||0
203970|NCT01286987|493615|P9|Prostate Cancer|Part 1: Dose Escalation||0
203971|NCT01286987|493616|P8|Prostate Cancer|Part 1: Dose Escalation||0
203972|NCT01286987|493617|P7|Prostate Cancer|Part 1: Dose Escalation||0
203973|NCT01286987|493618|P6|Prostate Cancer|Part 1: Dose Escalation||1
203974|NCT01286987|493619|P5|Prostate Cancer|Part 1: Dose Escalation||0
203975|NCT01286987|493620|P4|Prostate Cancer|Part 1: Dose Escalation||0
203976|NCT01286987|493621|P3|Prostate Cancer|Part 1: Dose Escalation||0
203977|NCT01286987|493622|P2|Prostate Cancer|Part 1: Dose Escalation||0
203978|NCT01286987|493623|P1|Prostate Cancer|Part 1: Dose Escalation||0
203979|NCT01286987|493609|P15|Colorectal Cancer|Part 1: Dose Escalation||0
203980|NCT01286987|493610|P14|Colorectal Cancer|Part 1: Dose Escalation||0
203981|NCT01286987|493611|P13|Colorectal Cancer|Part 1: Dose Escalation||0
203982|NCT01286987|493612|P12|Colorectal Cancer|Part 1: Dose Escalation||0
203983|NCT01286987|493613|P11|Colorectal Cancer|Part 1: Dose Escalation||0
203984|NCT01286987|493614|P10|Colorectal Cancer|Part 1: Dose Escalation||0
203985|NCT01286987|493615|P9|Colorectal Cancer|Part 1: Dose Escalation||0
203986|NCT01286987|493616|P8|Colorectal Cancer|Part 1: Dose Escalation||0
203987|NCT01286987|493617|P7|Colorectal Cancer|Part 1: Dose Escalation||0
203988|NCT01286987|493618|P6|Colorectal Cancer|Part 1: Dose Escalation||0
203989|NCT01286987|493619|P5|Colorectal Cancer|Part 1: Dose Escalation||0
203990|NCT01286987|493620|P4|Colorectal Cancer|Part 1: Dose Escalation||0
203991|NCT01286987|493621|P3|Colorectal Cancer|Part 1: Dose Escalation||1
203992|NCT01286987|493622|P2|Colorectal Cancer|Part 1: Dose Escalation||0
203993|NCT01286987|493623|P1|Colorectal Cancer|Part 1: Dose Escalation||1
203994|NCT01286987|493609|P15|STARTED|Part 1: Dose Escalation||0
203995|NCT01286987|493610|P14|STARTED|Part 1: Dose Escalation||0
203996|NCT01286987|493611|P13|STARTED|Part 1: Dose Escalation||0
203997|NCT01286987|493612|P12|STARTED|Part 1: Dose Escalation||0
203998|NCT01286987|493613|P11|STARTED|Part 1: Dose Escalation||0
203999|NCT01286987|493614|P10|STARTED|Part 1: Dose Escalation||0
204000|NCT01286987|493615|P9|STARTED|Part 1: Dose Escalation||6
204001|NCT01286987|493616|P8|STARTED|Part 1: Dose Escalation||6
204002|NCT01286987|493617|P7|STARTED|Part 1: Dose Escalation||6
204003|NCT01286987|493618|P6|STARTED|Part 1: Dose Escalation||6
204004|NCT01286987|493619|P5|STARTED|Part 1: Dose Escalation||3
204005|NCT01286987|493620|P4|STARTED|Part 1: Dose Escalation||3
204006|NCT01286987|493621|P3|STARTED|Part 1: Dose Escalation||3
204007|NCT01286987|493622|P2|STARTED|Part 1: Dose Escalation||3
204008|NCT01286987|493623|P1|STARTED|Part 1: Dose Escalation||3
204009|NCT01286870|493764|P1|NOT COMPLETED|Overall Study||0
204010|NCT01286870|493764|P1|COMPLETED|Overall Study||11
204011|NCT01286870|493764|P1|STARTED|Overall Study||11
204012|NCT01286818|493769|P1|NOT COMPLETED|Overall Study||0
204013|NCT01286818|493769|P1|COMPLETED|Overall Study||6
204014|NCT01286818|493769|P1|Completed DLT Assessment Period|Overall Study||5
204015|NCT01286818|493769|P1|STARTED|Overall Study||6
204016|NCT01286805|493783|P2|NOT COMPLETED|Overall Study||1
204017|NCT01286805|493784|P1|NOT COMPLETED|Overall Study||0
204018|NCT01286805|493783|P2|COMPLETED|Overall Study||41
204019|NCT01286805|493784|P1|COMPLETED|Overall Study||41
204020|NCT01286805|493783|P2|STARTED|Overall Study||42
204021|NCT01286805|493784|P1|STARTED|Overall Study||41
204022|NCT01286779|493804|P1|NOT COMPLETED|Overall Study||19
204023|NCT01286779|493804|P1|COMPLETED|Overall Study||96
204024|NCT01286779|493804|P1|STARTED|Overall Study||115
204025|NCT01286753|493856|P2|NOT COMPLETED|Overall Study||25
204026|NCT01286753|493857|P1|NOT COMPLETED|Overall Study||26
204027|NCT01286753|493856|P2|COMPLETED|Overall Study||0
204028|NCT01286753|493857|P1|COMPLETED|Overall Study||0
204029|NCT01286753|493856|P2|STARTED|Overall Study||25
204030|NCT01286753|493857|P1|STARTED|Overall Study||26
204031|NCT01286740|493875|P1|NOT COMPLETED|Overall Study||2
204032|NCT01286740|493875|P1|COMPLETED|Overall Study||48
204033|NCT01286740|493875|P1|Week 12 (Primary Endpoint)|Overall Study||49
204034|NCT01286740|493875|P1|Enrolled and Treated|Overall Study||49
204035|NCT01286740|493875|P1|STARTED|Overall Study||50
204036|NCT01286558|493893|P2|NOT COMPLETED|Overall Study||2
204037|NCT01286558|493894|P1|NOT COMPLETED|Overall Study||1
204038|NCT01286558|493893|P2|COMPLETED|Overall Study||111
204039|NCT01286558|493894|P1|COMPLETED|Overall Study||111
204040|NCT01286558|493893|P2|STARTED|Overall Study||113
204041|NCT01286558|493894|P1|STARTED|Overall Study||112
204042|NCT01286493|493924|P1|NOT COMPLETED|Overall Study||3
204043|NCT01286493|493924|P1|COMPLETED|Overall Study||30
204044|NCT01286493|493924|P1|STARTED|Overall Study||33
204045|NCT01286480|493930|P2|NOT COMPLETED|Overall Study||3
204046|NCT01286480|493931|P1|NOT COMPLETED|Overall Study||5
204047|NCT01286480|493930|P2|COMPLETED|Overall Study||31
204048|NCT01286480|493931|P1|COMPLETED|Overall Study||27
204049|NCT01286480|493930|P2|STARTED|Overall Study||34
204050|NCT01286480|493931|P1|STARTED|Overall Study||32
204051|NCT01286454|493939|P11|NOT COMPLETED|Part II- Sixth Intervention Period||0
204052|NCT01286454|493940|P10|NOT COMPLETED|Part II- Sixth Intervention Period||0
204053|NCT01286454|493941|P9|NOT COMPLETED|Part II- Sixth Intervention Period||0
204054|NCT01286454|493942|P8|NOT COMPLETED|Part II- Sixth Intervention Period||0
204055|NCT01286454|493943|P7|NOT COMPLETED|Part II- Sixth Intervention Period||0
204056|NCT01286454|493944|P6|NOT COMPLETED|Part II- Sixth Intervention Period||0
204057|NCT01286454|493945|P5|NOT COMPLETED|Part II- Sixth Intervention Period||0
204058|NCT01286454|493946|P4|NOT COMPLETED|Part II- Sixth Intervention Period||0
204059|NCT01286454|493947|P3|NOT COMPLETED|Part II- Sixth Intervention Period||0
204060|NCT01286454|493948|P2|NOT COMPLETED|Part II- Sixth Intervention Period||0
204061|NCT01286454|493949|P1|NOT COMPLETED|Part II- Sixth Intervention Period||0
204062|NCT01286454|493939|P11|COMPLETED|Part II- Sixth Intervention Period||20
204063|NCT01286454|493940|P10|COMPLETED|Part II- Sixth Intervention Period||0
204064|NCT01286454|493941|P9|COMPLETED|Part II- Sixth Intervention Period||0
204065|NCT01286454|493942|P8|COMPLETED|Part II- Sixth Intervention Period||0
204066|NCT01286454|493943|P7|COMPLETED|Part II- Sixth Intervention Period||0
204067|NCT01286454|493944|P6|COMPLETED|Part II- Sixth Intervention Period||0
204068|NCT01286454|493945|P5|COMPLETED|Part II- Sixth Intervention Period||0
204069|NCT01286454|493946|P4|COMPLETED|Part II- Sixth Intervention Period||0
204070|NCT01286454|493947|P3|COMPLETED|Part II- Sixth Intervention Period||0
204071|NCT01286454|493948|P2|COMPLETED|Part II- Sixth Intervention Period||0
204072|NCT01286454|493949|P1|COMPLETED|Part II- Sixth Intervention Period||0
204073|NCT01286454|493939|P11|STARTED|Part II- Sixth Intervention Period||20
204074|NCT01286454|493940|P10|STARTED|Part II- Sixth Intervention Period||0
204075|NCT01286454|493941|P9|STARTED|Part II- Sixth Intervention Period||0
204076|NCT01286454|493942|P8|STARTED|Part II- Sixth Intervention Period||0
204077|NCT01286454|493943|P7|STARTED|Part II- Sixth Intervention Period||0
204078|NCT01286454|493944|P6|STARTED|Part II- Sixth Intervention Period||0
204079|NCT01286454|493945|P5|STARTED|Part II- Sixth Intervention Period||0
204080|NCT01286454|493946|P4|STARTED|Part II- Sixth Intervention Period||0
204081|NCT01286454|493947|P3|STARTED|Part II- Sixth Intervention Period||0
204082|NCT01286454|493948|P2|STARTED|Part II- Sixth Intervention Period||0
204083|NCT01286454|493949|P1|STARTED|Part II- Sixth Intervention Period||0
204084|NCT01286454|493939|P11|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
204085|NCT01286454|493940|P10|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
204086|NCT01286454|493941|P9|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
204087|NCT01286454|493942|P8|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
204088|NCT01286454|493943|P7|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
204089|NCT01286454|493944|P6|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
204090|NCT01286454|493945|P5|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
204091|NCT01286454|493946|P4|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
204092|NCT01286454|493947|P3|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
204093|NCT01286454|493948|P2|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
204094|NCT01286454|493949|P1|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
204095|NCT01286454|493939|P11|COMPLETED|Washout Period (Approximately 2 Weeks)||0
204096|NCT01286454|493940|P10|COMPLETED|Washout Period (Approximately 2 Weeks)||2
204097|NCT01286454|493941|P9|COMPLETED|Washout Period (Approximately 2 Weeks)||2
204098|NCT01286454|493942|P8|COMPLETED|Washout Period (Approximately 2 Weeks)||2
204099|NCT01286454|493943|P7|COMPLETED|Washout Period (Approximately 2 Weeks)||2
204100|NCT01286454|493944|P6|COMPLETED|Washout Period (Approximately 2 Weeks)||2
204101|NCT01286454|493945|P5|COMPLETED|Washout Period (Approximately 2 Weeks)||2
204102|NCT01286454|493946|P4|COMPLETED|Washout Period (Approximately 2 Weeks)||2
204103|NCT01286454|493947|P3|COMPLETED|Washout Period (Approximately 2 Weeks)||2
204104|NCT01286454|493948|P2|COMPLETED|Washout Period (Approximately 2 Weeks)||2
204105|NCT01286454|493949|P1|COMPLETED|Washout Period (Approximately 2 Weeks)||2
204106|NCT01286454|493939|P11|STARTED|Washout Period (Approximately 2 Weeks)||0
204107|NCT01286454|493940|P10|STARTED|Washout Period (Approximately 2 Weeks)||2
204108|NCT01286454|493941|P9|STARTED|Washout Period (Approximately 2 Weeks)||2
204109|NCT01286454|493942|P8|STARTED|Washout Period (Approximately 2 Weeks)||2
204110|NCT01286454|493943|P7|STARTED|Washout Period (Approximately 2 Weeks)||2
204111|NCT01286454|493944|P6|STARTED|Washout Period (Approximately 2 Weeks)||2
204112|NCT01286454|493945|P5|STARTED|Washout Period (Approximately 2 Weeks)||2
204113|NCT01286454|493946|P4|STARTED|Washout Period (Approximately 2 Weeks)||2
204114|NCT01286454|493947|P3|STARTED|Washout Period (Approximately 2 Weeks)||2
204115|NCT01286454|493948|P2|STARTED|Washout Period (Approximately 2 Weeks)||2
204116|NCT01286454|493949|P1|STARTED|Washout Period (Approximately 2 Weeks)||2
204117|NCT01286454|493939|P11|NOT COMPLETED|Fifth Intervention Period||0
204118|NCT01286454|493940|P10|NOT COMPLETED|Fifth Intervention Period||0
204119|NCT01286454|493941|P9|NOT COMPLETED|Fifth Intervention Period||0
204120|NCT01286454|493942|P8|NOT COMPLETED|Fifth Intervention Period||0
204121|NCT01286454|493943|P7|NOT COMPLETED|Fifth Intervention Period||0
204122|NCT01286454|493944|P6|NOT COMPLETED|Fifth Intervention Period||0
204123|NCT01286454|493945|P5|NOT COMPLETED|Fifth Intervention Period||0
204124|NCT01286454|493946|P4|NOT COMPLETED|Fifth Intervention Period||0
204125|NCT01286454|493947|P3|NOT COMPLETED|Fifth Intervention Period||0
204126|NCT01286454|493948|P2|NOT COMPLETED|Fifth Intervention Period||0
204127|NCT01286454|493949|P1|NOT COMPLETED|Fifth Intervention Period||0
204128|NCT01286454|493939|P11|COMPLETED|Fifth Intervention Period||0
204129|NCT01286454|493940|P10|COMPLETED|Fifth Intervention Period||2
204130|NCT01286454|493941|P9|COMPLETED|Fifth Intervention Period||2
204131|NCT01286454|493942|P8|COMPLETED|Fifth Intervention Period||2
204132|NCT01286454|493943|P7|COMPLETED|Fifth Intervention Period||2
204133|NCT01286454|493944|P6|COMPLETED|Fifth Intervention Period||2
204134|NCT01286454|493945|P5|COMPLETED|Fifth Intervention Period||2
204135|NCT01286454|493946|P4|COMPLETED|Fifth Intervention Period||2
204136|NCT01286454|493947|P3|COMPLETED|Fifth Intervention Period||2
204137|NCT01286454|493948|P2|COMPLETED|Fifth Intervention Period||2
204138|NCT01286454|493949|P1|COMPLETED|Fifth Intervention Period||2
204139|NCT01286454|493939|P11|STARTED|Fifth Intervention Period||0
204140|NCT01286454|493940|P10|STARTED|Fifth Intervention Period||2
204141|NCT01286454|493941|P9|STARTED|Fifth Intervention Period||2
204142|NCT01286454|493942|P8|STARTED|Fifth Intervention Period||2
204143|NCT01286454|493943|P7|STARTED|Fifth Intervention Period||2
204144|NCT01286454|493944|P6|STARTED|Fifth Intervention Period||2
204145|NCT01286454|493945|P5|STARTED|Fifth Intervention Period||2
204146|NCT01286454|493946|P4|STARTED|Fifth Intervention Period||2
204147|NCT01286454|493947|P3|STARTED|Fifth Intervention Period||2
204148|NCT01286454|493948|P2|STARTED|Fifth Intervention Period||2
204149|NCT01286454|493949|P1|STARTED|Fifth Intervention Period||2
204150|NCT01286454|493939|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204151|NCT01286454|493940|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204152|NCT01286454|493941|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204153|NCT01286454|493942|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204154|NCT01286454|493943|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204155|NCT01286454|493944|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204156|NCT01286454|493945|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204157|NCT01286454|493946|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204158|NCT01286454|493947|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204159|NCT01286454|493948|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204160|NCT01286454|493949|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204161|NCT01286454|493939|P11|COMPLETED|Washout Period (At Least 3 Days)||0
204162|NCT01286454|493940|P10|COMPLETED|Washout Period (At Least 3 Days)||2
204163|NCT01286454|493941|P9|COMPLETED|Washout Period (At Least 3 Days)||2
204164|NCT01286454|493942|P8|COMPLETED|Washout Period (At Least 3 Days)||2
204165|NCT01286454|493943|P7|COMPLETED|Washout Period (At Least 3 Days)||2
204166|NCT01286454|493944|P6|COMPLETED|Washout Period (At Least 3 Days)||2
204167|NCT01286454|493945|P5|COMPLETED|Washout Period (At Least 3 Days)||2
204168|NCT01286454|493946|P4|COMPLETED|Washout Period (At Least 3 Days)||2
204169|NCT01286454|493947|P3|COMPLETED|Washout Period (At Least 3 Days)||2
204170|NCT01286454|493948|P2|COMPLETED|Washout Period (At Least 3 Days)||2
204171|NCT01286454|493949|P1|COMPLETED|Washout Period (At Least 3 Days)||2
204172|NCT01286454|493939|P11|STARTED|Washout Period (At Least 3 Days)||0
204173|NCT01286454|493940|P10|STARTED|Washout Period (At Least 3 Days)||2
204174|NCT01286454|493941|P9|STARTED|Washout Period (At Least 3 Days)||2
204175|NCT01286454|493942|P8|STARTED|Washout Period (At Least 3 Days)||2
204176|NCT01286454|493943|P7|STARTED|Washout Period (At Least 3 Days)||2
204177|NCT01286454|493944|P6|STARTED|Washout Period (At Least 3 Days)||2
204178|NCT01286454|493945|P5|STARTED|Washout Period (At Least 3 Days)||2
204179|NCT01286454|493946|P4|STARTED|Washout Period (At Least 3 Days)||2
204180|NCT01286454|493947|P3|STARTED|Washout Period (At Least 3 Days)||2
204181|NCT01286454|493948|P2|STARTED|Washout Period (At Least 3 Days)||2
204182|NCT01286454|493949|P1|STARTED|Washout Period (At Least 3 Days)||2
204183|NCT01286454|493939|P11|NOT COMPLETED|Fourth Intervention Period||0
204184|NCT01286454|493940|P10|NOT COMPLETED|Fourth Intervention Period||0
204185|NCT01286454|493941|P9|NOT COMPLETED|Fourth Intervention Period||0
204186|NCT01286454|493942|P8|NOT COMPLETED|Fourth Intervention Period||0
204187|NCT01286454|493943|P7|NOT COMPLETED|Fourth Intervention Period||0
204188|NCT01286454|493944|P6|NOT COMPLETED|Fourth Intervention Period||0
204189|NCT01286454|493945|P5|NOT COMPLETED|Fourth Intervention Period||0
204190|NCT01286454|493946|P4|NOT COMPLETED|Fourth Intervention Period||0
204191|NCT01286454|493947|P3|NOT COMPLETED|Fourth Intervention Period||0
204192|NCT01286454|493948|P2|NOT COMPLETED|Fourth Intervention Period||0
204193|NCT01286454|493949|P1|NOT COMPLETED|Fourth Intervention Period||0
204194|NCT01286454|493939|P11|COMPLETED|Fourth Intervention Period||0
204195|NCT01286454|493940|P10|COMPLETED|Fourth Intervention Period||2
204196|NCT01286454|493941|P9|COMPLETED|Fourth Intervention Period||2
204197|NCT01286454|493942|P8|COMPLETED|Fourth Intervention Period||2
204198|NCT01286454|493943|P7|COMPLETED|Fourth Intervention Period||2
204199|NCT01286454|493944|P6|COMPLETED|Fourth Intervention Period||2
204200|NCT01286454|493945|P5|COMPLETED|Fourth Intervention Period||2
204201|NCT01286454|493946|P4|COMPLETED|Fourth Intervention Period||2
204202|NCT01286454|493947|P3|COMPLETED|Fourth Intervention Period||2
204203|NCT01286454|493948|P2|COMPLETED|Fourth Intervention Period||2
204204|NCT01286454|493949|P1|COMPLETED|Fourth Intervention Period||2
204205|NCT01286454|493939|P11|STARTED|Fourth Intervention Period||0
204206|NCT01286454|493940|P10|STARTED|Fourth Intervention Period||2
204207|NCT01286454|493941|P9|STARTED|Fourth Intervention Period||2
204208|NCT01286454|493942|P8|STARTED|Fourth Intervention Period||2
204209|NCT01286454|493943|P7|STARTED|Fourth Intervention Period||2
204210|NCT01286454|493944|P6|STARTED|Fourth Intervention Period||2
204211|NCT01286454|493945|P5|STARTED|Fourth Intervention Period||2
204212|NCT01286454|493946|P4|STARTED|Fourth Intervention Period||2
204213|NCT01286454|493947|P3|STARTED|Fourth Intervention Period||2
204214|NCT01286454|493948|P2|STARTED|Fourth Intervention Period||2
204215|NCT01286454|493949|P1|STARTED|Fourth Intervention Period||2
204216|NCT01286454|493939|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204217|NCT01286454|493940|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204218|NCT01286454|493941|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204219|NCT01286454|493942|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204220|NCT01286454|493943|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204221|NCT01286454|493944|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204222|NCT01286454|493945|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204223|NCT01286454|493946|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204224|NCT01286454|493947|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204225|NCT01286454|493948|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204226|NCT01286454|493949|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204227|NCT01286454|493939|P11|COMPLETED|Washout Period (At Least 3 Days)||0
204228|NCT01286454|493940|P10|COMPLETED|Washout Period (At Least 3 Days)||2
204229|NCT01286454|493941|P9|COMPLETED|Washout Period (At Least 3 Days)||2
204230|NCT01286454|493942|P8|COMPLETED|Washout Period (At Least 3 Days)||2
204231|NCT01286454|493943|P7|COMPLETED|Washout Period (At Least 3 Days)||2
204232|NCT01286454|493944|P6|COMPLETED|Washout Period (At Least 3 Days)||2
204233|NCT01286454|493945|P5|COMPLETED|Washout Period (At Least 3 Days)||2
204234|NCT01286454|493946|P4|COMPLETED|Washout Period (At Least 3 Days)||2
204235|NCT01286454|493947|P3|COMPLETED|Washout Period (At Least 3 Days)||2
204236|NCT01286454|493948|P2|COMPLETED|Washout Period (At Least 3 Days)||2
204237|NCT01286454|493949|P1|COMPLETED|Washout Period (At Least 3 Days)||2
204238|NCT01286454|493939|P11|STARTED|Washout Period (At Least 3 Days)||0
204239|NCT01286454|493940|P10|STARTED|Washout Period (At Least 3 Days)||2
204240|NCT01286454|493941|P9|STARTED|Washout Period (At Least 3 Days)||2
204241|NCT01286454|493942|P8|STARTED|Washout Period (At Least 3 Days)||2
204242|NCT01286454|493943|P7|STARTED|Washout Period (At Least 3 Days)||2
204243|NCT01286454|493944|P6|STARTED|Washout Period (At Least 3 Days)||2
204244|NCT01286454|493945|P5|STARTED|Washout Period (At Least 3 Days)||2
204245|NCT01286454|493946|P4|STARTED|Washout Period (At Least 3 Days)||2
204246|NCT01286454|493947|P3|STARTED|Washout Period (At Least 3 Days)||2
204247|NCT01286454|493948|P2|STARTED|Washout Period (At Least 3 Days)||2
204248|NCT01286454|493949|P1|STARTED|Washout Period (At Least 3 Days)||2
204249|NCT01286454|493939|P11|NOT COMPLETED|Third Intervention Period||0
204250|NCT01286454|493940|P10|NOT COMPLETED|Third Intervention Period||0
204251|NCT01286454|493941|P9|NOT COMPLETED|Third Intervention Period||0
204252|NCT01286454|493942|P8|NOT COMPLETED|Third Intervention Period||0
204253|NCT01286454|493943|P7|NOT COMPLETED|Third Intervention Period||0
204254|NCT01286454|493944|P6|NOT COMPLETED|Third Intervention Period||0
204255|NCT01286454|493945|P5|NOT COMPLETED|Third Intervention Period||0
204256|NCT01286454|493946|P4|NOT COMPLETED|Third Intervention Period||0
204257|NCT01286454|493947|P3|NOT COMPLETED|Third Intervention Period||0
204258|NCT01286454|493948|P2|NOT COMPLETED|Third Intervention Period||0
204259|NCT01286454|493949|P1|NOT COMPLETED|Third Intervention Period||0
204260|NCT01286454|493939|P11|COMPLETED|Third Intervention Period||0
204261|NCT01286454|493940|P10|COMPLETED|Third Intervention Period||2
204262|NCT01286454|493941|P9|COMPLETED|Third Intervention Period||2
204263|NCT01286454|493942|P8|COMPLETED|Third Intervention Period||2
204264|NCT01286454|493943|P7|COMPLETED|Third Intervention Period||2
204265|NCT01286454|493944|P6|COMPLETED|Third Intervention Period||2
204266|NCT01286454|493945|P5|COMPLETED|Third Intervention Period||2
204267|NCT01286454|493946|P4|COMPLETED|Third Intervention Period||2
204268|NCT01286454|493947|P3|COMPLETED|Third Intervention Period||2
204269|NCT01286454|493948|P2|COMPLETED|Third Intervention Period||2
204270|NCT01286454|493949|P1|COMPLETED|Third Intervention Period||2
204271|NCT01286454|493939|P11|STARTED|Third Intervention Period||0
204272|NCT01286454|493940|P10|STARTED|Third Intervention Period||2
204273|NCT01286454|493941|P9|STARTED|Third Intervention Period||2
204274|NCT01286454|493942|P8|STARTED|Third Intervention Period||2
204275|NCT01286454|493943|P7|STARTED|Third Intervention Period||2
204276|NCT01286454|493944|P6|STARTED|Third Intervention Period||2
204277|NCT01286454|493945|P5|STARTED|Third Intervention Period||2
204278|NCT01286454|493946|P4|STARTED|Third Intervention Period||2
204279|NCT01286454|493947|P3|STARTED|Third Intervention Period||2
204280|NCT01286454|493948|P2|STARTED|Third Intervention Period||2
204281|NCT01286454|493949|P1|STARTED|Third Intervention Period||2
204282|NCT01286454|493939|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204283|NCT01286454|493940|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204284|NCT01286454|493941|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204285|NCT01286454|493942|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204286|NCT01286454|493943|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204287|NCT01286454|493944|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204288|NCT01286454|493945|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204289|NCT01286454|493946|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204290|NCT01286454|493947|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204291|NCT01286454|493948|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204292|NCT01286454|493949|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204293|NCT01286454|493939|P11|COMPLETED|Washout Period (At Least 3 Days)||0
204294|NCT01286454|493940|P10|COMPLETED|Washout Period (At Least 3 Days)||2
204295|NCT01286454|493941|P9|COMPLETED|Washout Period (At Least 3 Days)||2
204296|NCT01286454|493942|P8|COMPLETED|Washout Period (At Least 3 Days)||2
204297|NCT01286454|493943|P7|COMPLETED|Washout Period (At Least 3 Days)||2
204298|NCT01286454|493944|P6|COMPLETED|Washout Period (At Least 3 Days)||2
204299|NCT01286454|493945|P5|COMPLETED|Washout Period (At Least 3 Days)||2
204300|NCT01286454|493946|P4|COMPLETED|Washout Period (At Least 3 Days)||2
204301|NCT01286454|493947|P3|COMPLETED|Washout Period (At Least 3 Days)||2
204302|NCT01286454|493948|P2|COMPLETED|Washout Period (At Least 3 Days)||2
204303|NCT01286454|493949|P1|COMPLETED|Washout Period (At Least 3 Days)||2
204304|NCT01286454|493939|P11|STARTED|Washout Period (At Least 3 Days)||0
204305|NCT01286454|493940|P10|STARTED|Washout Period (At Least 3 Days)||2
204306|NCT01286454|493941|P9|STARTED|Washout Period (At Least 3 Days)||2
204307|NCT01286454|493942|P8|STARTED|Washout Period (At Least 3 Days)||2
204308|NCT01286454|493943|P7|STARTED|Washout Period (At Least 3 Days)||2
204309|NCT01286454|493944|P6|STARTED|Washout Period (At Least 3 Days)||2
204310|NCT01286454|493945|P5|STARTED|Washout Period (At Least 3 Days)||2
204311|NCT01286454|493946|P4|STARTED|Washout Period (At Least 3 Days)||2
204312|NCT01286454|493947|P3|STARTED|Washout Period (At Least 3 Days)||2
204313|NCT01286454|493948|P2|STARTED|Washout Period (At Least 3 Days)||2
204314|NCT01286454|493949|P1|STARTED|Washout Period (At Least 3 Days)||2
204315|NCT01286454|493939|P11|NOT COMPLETED|Second Intervention Period||0
204316|NCT01286454|493940|P10|NOT COMPLETED|Second Intervention Period||0
204317|NCT01286454|493941|P9|NOT COMPLETED|Second Intervention Period||0
204318|NCT01286454|493942|P8|NOT COMPLETED|Second Intervention Period||0
204319|NCT01286454|493943|P7|NOT COMPLETED|Second Intervention Period||0
204320|NCT01286454|493944|P6|NOT COMPLETED|Second Intervention Period||0
204321|NCT01286454|493945|P5|NOT COMPLETED|Second Intervention Period||0
204322|NCT01286454|493946|P4|NOT COMPLETED|Second Intervention Period||0
204323|NCT01286454|493947|P3|NOT COMPLETED|Second Intervention Period||0
204324|NCT01286454|493948|P2|NOT COMPLETED|Second Intervention Period||0
204325|NCT01286454|493949|P1|NOT COMPLETED|Second Intervention Period||0
204326|NCT01286454|493939|P11|COMPLETED|Second Intervention Period||0
204327|NCT01286454|493940|P10|COMPLETED|Second Intervention Period||2
204328|NCT01286454|493941|P9|COMPLETED|Second Intervention Period||2
204329|NCT01286454|493942|P8|COMPLETED|Second Intervention Period||2
204330|NCT01286454|493943|P7|COMPLETED|Second Intervention Period||2
204331|NCT01286454|493944|P6|COMPLETED|Second Intervention Period||2
204332|NCT01286454|493945|P5|COMPLETED|Second Intervention Period||2
204333|NCT01286454|493946|P4|COMPLETED|Second Intervention Period||2
204334|NCT01286454|493947|P3|COMPLETED|Second Intervention Period||2
204335|NCT01286454|493948|P2|COMPLETED|Second Intervention Period||2
204336|NCT01286454|493949|P1|COMPLETED|Second Intervention Period||2
204337|NCT01286454|493939|P11|STARTED|Second Intervention Period||0
204338|NCT01286454|493940|P10|STARTED|Second Intervention Period||2
204339|NCT01286454|493941|P9|STARTED|Second Intervention Period||2
204340|NCT01286454|493942|P8|STARTED|Second Intervention Period||2
204341|NCT01286454|493943|P7|STARTED|Second Intervention Period||2
204342|NCT01286454|493944|P6|STARTED|Second Intervention Period||2
204343|NCT01286454|493945|P5|STARTED|Second Intervention Period||2
204344|NCT01286454|493946|P4|STARTED|Second Intervention Period||2
204345|NCT01286454|493947|P3|STARTED|Second Intervention Period||2
204346|NCT01286454|493948|P2|STARTED|Second Intervention Period||2
204347|NCT01286454|493949|P1|STARTED|Second Intervention Period||2
204348|NCT01286454|493939|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204349|NCT01286454|493940|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204350|NCT01286454|493941|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204351|NCT01286454|493942|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204352|NCT01286454|493943|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204353|NCT01286454|493944|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204354|NCT01286454|493945|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204355|NCT01286454|493946|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204356|NCT01286454|493947|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204357|NCT01286454|493948|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204358|NCT01286454|493949|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
204359|NCT01286454|493939|P11|COMPLETED|Washout Period (At Least 3 Days)||0
204360|NCT01286454|493940|P10|COMPLETED|Washout Period (At Least 3 Days)||2
204361|NCT01286454|493941|P9|COMPLETED|Washout Period (At Least 3 Days)||2
204362|NCT01286454|493942|P8|COMPLETED|Washout Period (At Least 3 Days)||2
204363|NCT01286454|493943|P7|COMPLETED|Washout Period (At Least 3 Days)||2
204364|NCT01286454|493944|P6|COMPLETED|Washout Period (At Least 3 Days)||2
204365|NCT01286454|493945|P5|COMPLETED|Washout Period (At Least 3 Days)||2
204366|NCT01286454|493946|P4|COMPLETED|Washout Period (At Least 3 Days)||2
204367|NCT01286454|493947|P3|COMPLETED|Washout Period (At Least 3 Days)||2
204368|NCT01286454|493948|P2|COMPLETED|Washout Period (At Least 3 Days)||2
204369|NCT01286454|493949|P1|COMPLETED|Washout Period (At Least 3 Days)||2
204370|NCT01286454|493939|P11|STARTED|Washout Period (At Least 3 Days)||0
204371|NCT01286454|493940|P10|STARTED|Washout Period (At Least 3 Days)||2
204372|NCT01286454|493941|P9|STARTED|Washout Period (At Least 3 Days)||2
204373|NCT01286454|493942|P8|STARTED|Washout Period (At Least 3 Days)||2
204374|NCT01286454|493943|P7|STARTED|Washout Period (At Least 3 Days)||2
204375|NCT01286454|493944|P6|STARTED|Washout Period (At Least 3 Days)||2
204376|NCT01286454|493945|P5|STARTED|Washout Period (At Least 3 Days)||2
204377|NCT01286454|493946|P4|STARTED|Washout Period (At Least 3 Days)||2
204378|NCT01286454|493947|P3|STARTED|Washout Period (At Least 3 Days)||2
204379|NCT01286454|493948|P2|STARTED|Washout Period (At Least 3 Days)||2
204380|NCT01286454|493949|P1|STARTED|Washout Period (At Least 3 Days)||2
204381|NCT01286454|493939|P11|NOT COMPLETED|Part I- First Intervention Period||0
204382|NCT01286454|493940|P10|NOT COMPLETED|Part I- First Intervention Period||0
204383|NCT01286454|493941|P9|NOT COMPLETED|Part I- First Intervention Period||0
204384|NCT01286454|493942|P8|NOT COMPLETED|Part I- First Intervention Period||0
204385|NCT01286454|493943|P7|NOT COMPLETED|Part I- First Intervention Period||0
204386|NCT01286454|493944|P6|NOT COMPLETED|Part I- First Intervention Period||0
204387|NCT01286454|493945|P5|NOT COMPLETED|Part I- First Intervention Period||0
204388|NCT01286454|493946|P4|NOT COMPLETED|Part I- First Intervention Period||0
204389|NCT01286454|493947|P3|NOT COMPLETED|Part I- First Intervention Period||0
204390|NCT01286454|493948|P2|NOT COMPLETED|Part I- First Intervention Period||0
204391|NCT01286454|493949|P1|NOT COMPLETED|Part I- First Intervention Period||0
204392|NCT01286454|493939|P11|COMPLETED|Part I- First Intervention Period||0
204393|NCT01286454|493940|P10|COMPLETED|Part I- First Intervention Period||2
204394|NCT01286454|493941|P9|COMPLETED|Part I- First Intervention Period||2
204395|NCT01286454|493942|P8|COMPLETED|Part I- First Intervention Period||2
204396|NCT01286454|493943|P7|COMPLETED|Part I- First Intervention Period||2
204397|NCT01286454|493944|P6|COMPLETED|Part I- First Intervention Period||2
204398|NCT01286454|493945|P5|COMPLETED|Part I- First Intervention Period||2
204399|NCT01286454|493946|P4|COMPLETED|Part I- First Intervention Period||2
204400|NCT01286454|493947|P3|COMPLETED|Part I- First Intervention Period||2
204401|NCT01286454|493948|P2|COMPLETED|Part I- First Intervention Period||2
204402|NCT01286454|493949|P1|COMPLETED|Part I- First Intervention Period||2
204403|NCT01286454|493939|P11|STARTED|Part I- First Intervention Period||0
204404|NCT01286454|493940|P10|STARTED|Part I- First Intervention Period||2
204405|NCT01286454|493941|P9|STARTED|Part I- First Intervention Period||2
204406|NCT01286454|493942|P8|STARTED|Part I- First Intervention Period||2
204407|NCT01286454|493943|P7|STARTED|Part I- First Intervention Period||2
204408|NCT01286454|493944|P6|STARTED|Part I- First Intervention Period||2
204409|NCT01286454|493945|P5|STARTED|Part I- First Intervention Period||2
204410|NCT01286454|493946|P4|STARTED|Part I- First Intervention Period||2
204411|NCT01286454|493947|P3|STARTED|Part I- First Intervention Period||2
204412|NCT01286454|493948|P2|STARTED|Part I- First Intervention Period||2
204413|NCT01286454|493949|P1|STARTED|Part I- First Intervention Period||2
204414|NCT01286441|493991|P4|NOT COMPLETED|Overall Study||11
204415|NCT01286441|493992|P3|NOT COMPLETED|Overall Study||7
204416|NCT01286441|493993|P2|NOT COMPLETED|Overall Study||7
204417|NCT01286441|493994|P1|NOT COMPLETED|Overall Study||7
204418|NCT01286441|493991|P4|COMPLETED|Overall Study||37
204419|NCT01286441|493992|P3|COMPLETED|Overall Study||39
204420|NCT01286441|493993|P2|COMPLETED|Overall Study||37
204421|NCT01286441|493994|P1|COMPLETED|Overall Study||38
204422|NCT01286441|493991|P4|STARTED|Overall Study||48
204423|NCT01286441|493992|P3|STARTED|Overall Study||46
204424|NCT01286441|493993|P2|STARTED|Overall Study||44
204425|NCT01286441|493994|P1|STARTED|Overall Study||45
204426|NCT01286402|494010|P2|NOT COMPLETED|Overall Study||0
204427|NCT01286402|494011|P1|NOT COMPLETED|Overall Study||0
204428|NCT01286402|494010|P2|COMPLETED|Overall Study||6
204429|NCT01286402|494011|P1|COMPLETED|Overall Study||5
204430|NCT01286402|494010|P2|STARTED|Overall Study||6
204431|NCT01286402|494011|P1|STARTED|Overall Study||5
204432|NCT01286324|494019|P2|NOT COMPLETED|Overall Study||0
204433|NCT01286324|494020|P1|NOT COMPLETED|Overall Study||0
204434|NCT01286324|494019|P2|COMPLETED|Overall Study||17
204435|NCT01286324|494020|P1|COMPLETED|Overall Study||17
204436|NCT01286324|494019|P2|STARTED|Overall Study||17
204437|NCT01286324|494020|P1|STARTED|Overall Study||17
204438|NCT01286311|494038|P2|NOT COMPLETED|Overall Study||0
204439|NCT01286311|494039|P1|NOT COMPLETED|Overall Study||14
204440|NCT01286311|494038|P2|COMPLETED|Overall Study|217 patients (of the 15 physician randomized to the intervention) completed the study.|232
204441|NCT01286311|494039|P1|COMPLETED|Overall Study|204 patients (of the 14 physician randomized to the intervention) completed the study.|218
204442|NCT01286311|494038|P2|STARTED|Overall Study|217 patients (of the 15 physician randomized to the intervention) started the study.|232
204443|NCT01286311|494039|P1|STARTED|Overall Study|218 patients (of the 14 physician randomized to the intervention) started the study.|232
204444|NCT01286272|494055|P2|NOT COMPLETED|Overall Study||3
204445|NCT01286272|494056|P1|NOT COMPLETED|Overall Study||1
204446|NCT01286272|494055|P2|COMPLETED|Overall Study||62
204447|NCT01286272|494056|P1|COMPLETED|Overall Study||66
204448|NCT01286272|494055|P2|STARTED|Overall Study||65
204449|NCT01286272|494056|P1|STARTED|Overall Study||67
204450|NCT01286207|494065|P3|NOT COMPLETED|Overall Study||90
204451|NCT01286207|494066|P2|NOT COMPLETED|Overall Study||248
204452|NCT01286207|494067|P1|NOT COMPLETED|Overall Study||298
204453|NCT01286207|494065|P3|COMPLETED|Overall Study||261
204454|NCT01286207|494066|P2|COMPLETED|Overall Study||609
204455|NCT01286207|494067|P1|COMPLETED|Overall Study||453
204456|NCT01286207|494065|P3|STARTED|Overall Study||351
204457|NCT01286207|494066|P2|STARTED|Overall Study||857
204458|NCT01286207|494067|P1|STARTED|Overall Study||751
204459|NCT01286168|494087|P1|NOT COMPLETED|Overall Study||3
204460|NCT01286168|494087|P1|COMPLETED|Overall Study||101
204461|NCT01286168|494087|P1|STARTED|Overall Study||104
204462|NCT01286129|494101|P2|NOT COMPLETED|Overall Study||5
204463|NCT01286129|494102|P1|NOT COMPLETED|Overall Study||8
204464|NCT01286129|494101|P2|COMPLETED|Overall Study||13
204465|NCT01286129|494102|P1|COMPLETED|Overall Study||19
204466|NCT01286129|494101|P2|STARTED|Overall Study||18
204467|NCT01286129|494102|P1|STARTED|Overall Study||27
204468|NCT01286077|494112|P2|NOT COMPLETED|Overall Study||7
204469|NCT01286077|494113|P1|NOT COMPLETED|Overall Study||10
204470|NCT01286077|494112|P2|COMPLETED|Overall Study||46
204471|NCT01286077|494113|P1|COMPLETED|Overall Study||41
204472|NCT01286077|494112|P2|STARTED|Overall Study|One patient did not have any post-baseline assessment and was excluded from the ITT population.|53
204473|NCT01286077|494113|P1|STARTED|Overall Study|One patient did not start treatment and was excluded from the Intent to Treat (ITT) population.|51
204474|NCT01286012|494149|P2|NOT COMPLETED|Overall Study||14
204475|NCT01286012|494150|P1|NOT COMPLETED|Overall Study||13
204476|NCT01286012|494149|P2|COMPLETED|Overall Study||40
204477|NCT01286012|494150|P1|COMPLETED|Overall Study||41
204478|NCT01286012|494149|P2|STARTED|Overall Study|3 patients randomized to placebo did not receive study drug.|54
204479|NCT01286012|494150|P1|STARTED|Overall Study|2 patients randomized to SFP did not receive study drug.|54
204480|NCT01285960|494164|P1|NOT COMPLETED|Overall Study||6
204481|NCT01285960|494164|P1|COMPLETED|Overall Study|An additional 2 subjects receiving fewer than 10 sonications were included in the safety population|102
204482|NCT01285960|494164|P1|STARTED|Overall Study|2 subjects receiving fewer than 10 sonications were added to the 106 for safety population of 108|108
204483|NCT01285947|494170|P2|NOT COMPLETED|Overall Study||0
204484|NCT01285947|494171|P1|NOT COMPLETED|Overall Study||0
204485|NCT01285947|494170|P2|COMPLETED|Overall Study||10
204486|NCT01285947|494171|P1|COMPLETED|Overall Study||10
204487|NCT01285947|494170|P2|STARTED|Overall Study||10
204488|NCT01285947|494171|P1|STARTED|Overall Study||10
204489|NCT01285908|494177|P3|NOT COMPLETED|Treatment Crossover||0
204490|NCT01285908|494178|P2|NOT COMPLETED|Treatment Crossover||0
204491|NCT01285908|494179|P1|NOT COMPLETED|Treatment Crossover||0
204492|NCT01285908|494177|P3|COMPLETED|Treatment Crossover||2
204493|NCT01285908|494178|P2|COMPLETED|Treatment Crossover||2
204494|NCT01285908|494179|P1|COMPLETED|Treatment Crossover||0
204495|NCT01285908|494177|P3|STARTED|Treatment Crossover||2
204496|NCT01285908|494178|P2|STARTED|Treatment Crossover|One subject in treatment crossover did not complete baseline testing as unable to complete tasks|2
204497|NCT01285908|494179|P1|STARTED|Treatment Crossover||0
204498|NCT01285908|494177|P3|NOT COMPLETED|Baseline Measurement||0
204499|NCT01285908|494178|P2|NOT COMPLETED|Baseline Measurement||0
204500|NCT01285908|494179|P1|NOT COMPLETED|Baseline Measurement||3
204501|NCT01285908|494177|P3|COMPLETED|Baseline Measurement||0
204502|NCT01285908|494178|P2|COMPLETED|Baseline Measurement||0
204503|NCT01285908|494179|P1|COMPLETED|Baseline Measurement||3
204504|NCT01285908|494177|P3|STARTED|Baseline Measurement||0
204505|NCT01285908|494178|P2|STARTED|Baseline Measurement||0
204506|NCT01285908|494179|P1|STARTED|Baseline Measurement||6
204507|NCT01285843|494213|P2|NOT COMPLETED|Overall Study||2
204508|NCT01285843|494214|P1|NOT COMPLETED|Overall Study||2
204509|NCT01285843|494213|P2|COMPLETED|Overall Study||18
204510|NCT01285843|494214|P1|COMPLETED|Overall Study||18
204511|NCT01285843|494213|P2|STARTED|Overall Study||20
204512|NCT01285843|494214|P1|STARTED|Overall Study||20
204513|NCT01285791|494229|P3|NOT COMPLETED|Overall Study||0
204514|NCT01285791|494230|P2|NOT COMPLETED|Overall Study||0
204515|NCT01285791|494231|P1|NOT COMPLETED|Overall Study||0
204516|NCT01285791|494229|P3|COMPLETED|Overall Study||13
204517|NCT01285791|494230|P2|COMPLETED|Overall Study||15
204518|NCT01285791|494231|P1|COMPLETED|Overall Study||11
204519|NCT01285791|494229|P3|STARTED|Overall Study||13
204520|NCT01285791|494230|P2|STARTED|Overall Study||15
204521|NCT01285791|494231|P1|STARTED|Overall Study||11
204522|NCT01285713|494241|P2|NOT COMPLETED|Overall Study||0
204523|NCT01285713|494242|P1|NOT COMPLETED|Overall Study||0
204524|NCT01285713|494241|P2|COMPLETED|Overall Study||41
204525|NCT01285713|494242|P1|COMPLETED|Overall Study||42
204526|NCT01285713|494241|P2|STARTED|Overall Study||41
204527|NCT01285713|494242|P1|STARTED|Overall Study||42
204528|NCT01285635|494251|P3|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
204529|NCT01285635|494252|P2|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
204530|NCT01285635|494253|P1|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
204531|NCT01285635|494251|P3|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
204532|NCT01285635|494252|P2|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
204533|NCT01285635|494253|P1|COMPLETED|Second Intervention (10, 3 Week Cycles)||13
204534|NCT01285635|494251|P3|STARTED|Second Intervention (10, 3 Week Cycles)||11
204535|NCT01285635|494252|P2|STARTED|Second Intervention (10, 3 Week Cycles)||11
204536|NCT01285635|494253|P1|STARTED|Second Intervention (10, 3 Week Cycles)||13
204537|NCT01285635|494251|P3|NOT COMPLETED|First Intervention (2 Weeks)||0
204538|NCT01285635|494252|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
204539|NCT01285635|494253|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
204540|NCT01285635|494251|P3|COMPLETED|First Intervention (2 Weeks)||11
204541|NCT01285635|494252|P2|COMPLETED|First Intervention (2 Weeks)||11
204542|NCT01285635|494253|P1|COMPLETED|First Intervention (2 Weeks)||13
204543|NCT01285635|494251|P3|STARTED|First Intervention (2 Weeks)||11
204544|NCT01285635|494252|P2|STARTED|First Intervention (2 Weeks)||11
204545|NCT01285635|494253|P1|STARTED|First Intervention (2 Weeks)||13
204546|NCT01285609|494273|P2|NOT COMPLETED|Treated With Blinded Therapy||359
204547|NCT01285609|494274|P1|NOT COMPLETED|Treated With Blinded Therapy||387
204548|NCT01285609|494273|P2|COMPLETED|Treated With Blinded Therapy||2
204549|NCT01285609|494274|P1|COMPLETED|Treated With Blinded Therapy||1
204550|NCT01285609|494273|P2|STARTED|Treated With Blinded Therapy||361
204551|NCT01285609|494274|P1|STARTED|Treated With Blinded Therapy||388
204552|NCT01285609|494273|P2|NOT COMPLETED|Randomized||116
204553|NCT01285609|494274|P1|NOT COMPLETED|Randomized||91
204554|NCT01285609|494273|P2|COMPLETED|Randomized||361
204555|NCT01285609|494274|P1|COMPLETED|Randomized||388
204556|NCT01285609|494273|P2|Treated With Chemotherapy (1st Dose)|Randomized||473
204557|NCT01285609|494274|P1|Treated With Chemotherapy (1st Dose)|Randomized||475
204558|NCT01285609|494273|P2|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|477
204559|NCT01285609|494274|P1|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|479
204560|NCT01285518|494292|P8|NOT COMPLETED|Overall Study||0
204561|NCT01285518|494293|P7|NOT COMPLETED|Overall Study||0
204562|NCT01285518|494294|P6|NOT COMPLETED|Overall Study||1
204563|NCT01285518|494295|P5|NOT COMPLETED|Overall Study||0
204564|NCT01285518|494296|P4|NOT COMPLETED|Overall Study||0
204565|NCT01285518|494297|P3|NOT COMPLETED|Overall Study||0
204566|NCT01285518|494298|P2|NOT COMPLETED|Overall Study||0
204567|NCT01285518|494299|P1|NOT COMPLETED|Overall Study||0
204568|NCT01285518|494292|P8|COMPLETED|Overall Study||14
204569|NCT01285518|494293|P7|COMPLETED|Overall Study||10
204570|NCT01285518|494294|P6|COMPLETED|Overall Study||9
204571|NCT01285518|494295|P5|COMPLETED|Overall Study||10
204572|NCT01285518|494296|P4|COMPLETED|Overall Study||10
204573|NCT01285518|494297|P3|COMPLETED|Overall Study||10
204574|NCT01285518|494298|P2|COMPLETED|Overall Study||10
204575|NCT01285518|494299|P1|COMPLETED|Overall Study||10
204576|NCT01285518|494292|P8|STARTED|Overall Study||14
204577|NCT01285518|494293|P7|STARTED|Overall Study||10
204578|NCT01285518|494294|P6|STARTED|Overall Study||10
204579|NCT01285518|494295|P5|STARTED|Overall Study||10
204580|NCT01285518|494296|P4|STARTED|Overall Study||10
204581|NCT01285518|494297|P3|STARTED|Overall Study||10
204582|NCT01285518|494298|P2|STARTED|Overall Study||10
204583|NCT01285518|494299|P1|STARTED|Overall Study||10
204584|NCT01285492|494559|P2|NOT COMPLETED|Overall Study||1
204585|NCT01285492|494560|P1|NOT COMPLETED|Overall Study||17
204586|NCT01285492|494559|P2|COMPLETED|Overall Study||38
204587|NCT01285492|494560|P1|COMPLETED|Overall Study||104
204588|NCT01285492|494559|P2|Safety Set (for Demographics)|Overall Study|All patients who took study drug|39
204589|NCT01285492|494560|P1|Safety Set (for Demographics)|Overall Study|All patients who took study drug; 2 patients did not|119
204590|NCT01285492|494559|P2|STARTED|Overall Study|All patients randomized to this group|39
204591|NCT01285492|494560|P1|STARTED|Overall Study|All patients randomized to this group|121
204592|NCT01285427|494578|P1|NOT COMPLETED|Overall Study||1
204593|NCT01285427|494578|P1|COMPLETED|Overall Study|One sample be discarded per FDA, sample drawn with heparin tube, not specified in protocol.|299
204594|NCT01285427|494578|P1|STARTED|Overall Study||300
204595|NCT01285401|494592|P2|NOT COMPLETED|Overall Study||29
204596|NCT01285401|494593|P1|NOT COMPLETED|Overall Study||17
204597|NCT01285401|494592|P2|COMPLETED|Overall Study||88
204598|NCT01285401|494593|P1|COMPLETED|Overall Study||98
204599|NCT01285401|494592|P2|Treated|Overall Study||116
204600|NCT01285401|494593|P1|Treated|Overall Study||113
204601|NCT01285401|494592|P2|STARTED|Overall Study||117
204602|NCT01285401|494593|P1|STARTED|Overall Study||115
204603|NCT01285349|494634|P3|NOT COMPLETED|Overall Study||27
204604|NCT01285349|494635|P2|NOT COMPLETED|Overall Study||20
204605|NCT01285349|494636|P1|NOT COMPLETED|Overall Study||27
204606|NCT01285349|494634|P3|COMPLETED|Overall Study||157
204607|NCT01285349|494635|P2|COMPLETED|Overall Study||170
204608|NCT01285349|494636|P1|COMPLETED|Overall Study||163
204609|NCT01285349|494634|P3|STARTED|Overall Study||184
204610|NCT01285349|494635|P2|STARTED|Overall Study||190
204611|NCT01285349|494636|P1|STARTED|Overall Study||190
204612|NCT01285323|494649|P2|NOT COMPLETED|Overall Study||30
204613|NCT01285323|494650|P1|NOT COMPLETED|Overall Study||33
204614|NCT01285323|494649|P2|COMPLETED|Overall Study||202
204615|NCT01285323|494650|P1|COMPLETED|Overall Study||199
204616|NCT01285323|494649|P2|Safety Analysis Set|Overall Study||232
204617|NCT01285323|494650|P1|Safety Analysis Set|Overall Study|Participants who received at least 1 dose of study drug|232
204618|NCT01285323|494649|P2|Full Analysis Set|Overall Study||232
204619|NCT01285323|494650|P1|Full Analysis Set|Overall Study|Randomized participants who received at least 1 dose of study drug|232
204620|NCT01285323|494649|P2|STARTED|Overall Study||232
204621|NCT01285323|494650|P1|STARTED|Overall Study||232
204622|NCT01285310|494685|P5|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||19
204623|NCT01285310|494686|P4|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||10
204624|NCT01285310|494687|P3|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||26
204625|NCT01285310|494688|P2|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||32
204626|NCT01285310|494689|P1|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||0
204627|NCT01285310|494685|P5|COMPLETED|Active Treatment Phase: Weeks 25-52||23
204628|NCT01285310|494686|P4|COMPLETED|Active Treatment Phase: Weeks 25-52||17
204629|NCT01285310|494687|P3|COMPLETED|Active Treatment Phase: Weeks 25-52||34
204630|NCT01285310|494688|P2|COMPLETED|Active Treatment Phase: Weeks 25-52||31
204631|NCT01285310|494689|P1|COMPLETED|Active Treatment Phase: Weeks 25-52||0
204632|NCT01285310|494685|P5|STARTED|Active Treatment Phase: Weeks 25-52||42
204633|NCT01285310|494686|P4|STARTED|Active Treatment Phase: Weeks 25-52||27
204634|NCT01285310|494687|P3|STARTED|Active Treatment Phase: Weeks 25-52||60
204635|NCT01285310|494688|P2|STARTED|Active Treatment Phase: Weeks 25-52||63
204636|NCT01285310|494689|P1|STARTED|Active Treatment Phase: Weeks 25-52||0
204637|NCT01285310|494685|P5|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
204638|NCT01285310|494686|P4|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
204639|NCT01285310|494687|P3|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
204640|NCT01285310|494688|P2|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
204641|NCT01285310|494689|P1|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||9
204642|NCT01285310|494685|P5|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
204643|NCT01285310|494686|P4|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
204644|NCT01285310|494687|P3|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter active treatment phase|61
204645|NCT01285310|494688|P2|COMPLETED|Placebo Controlled Phase: Weeks 0-24|Four participants chose not to enter the active treatment phase|67
204646|NCT01285310|494689|P1|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter the active treatment phase|70
204647|NCT01285310|494685|P5|STARTED|Placebo Controlled Phase: Weeks 0-24||0
204648|NCT01285310|494686|P4|STARTED|Placebo Controlled Phase: Weeks 0-24||0
204649|NCT01285310|494687|P3|STARTED|Placebo Controlled Phase: Weeks 0-24||76
204650|NCT01285310|494688|P2|STARTED|Placebo Controlled Phase: Weeks 0-24||82
204651|NCT01285310|494689|P1|STARTED|Placebo Controlled Phase: Weeks 0-24||79
204652|NCT01285076|494922|P1|NOT COMPLETED|Overall Study||0
204653|NCT01285076|494922|P1|COMPLETED|Overall Study||834
204654|NCT01285076|494922|P1|STARTED|Overall Study||834
204655|NCT01285050|494935|P1|NOT COMPLETED|Overall Study||1
204656|NCT01285050|494935|P1|COMPLETED|Overall Study||19
204657|NCT01285050|494935|P1|STARTED|Overall Study||20
204658|NCT01285024|494942|P2|NOT COMPLETED|Overall Study||0
204659|NCT01285024|494943|P1|NOT COMPLETED|Overall Study||0
204660|NCT01285024|494942|P2|COMPLETED|Overall Study||60
204661|NCT01285024|494943|P1|COMPLETED|Overall Study||49
204662|NCT01285024|494942|P2|STARTED|Overall Study||60
204663|NCT01285024|494943|P1|STARTED|Overall Study||49
204664|NCT01284959|494954|P3|NOT COMPLETED|Overall Study||1
204665|NCT01284959|494955|P2|NOT COMPLETED|Overall Study||0
204666|NCT01284959|494956|P1|NOT COMPLETED|Overall Study||1
204667|NCT01284959|494954|P3|COMPLETED|Overall Study||10
204668|NCT01284959|494955|P2|COMPLETED|Overall Study||12
204669|NCT01284959|494956|P1|COMPLETED|Overall Study||10
204670|NCT01284959|494954|P3|STARTED|Overall Study||11
204671|NCT01284959|494955|P2|STARTED|Overall Study||12
204672|NCT01284959|494956|P1|STARTED|Overall Study||11
204673|NCT01284634|494986|P4|NOT COMPLETED|Overall Study||1
204674|NCT01284634|494987|P3|NOT COMPLETED|Overall Study||2
204675|NCT01284634|494988|P2|NOT COMPLETED|Overall Study||0
204676|NCT01284634|494989|P1|NOT COMPLETED|Overall Study||1
204677|NCT01284634|494986|P4|COMPLETED|Overall Study||4
204678|NCT01284634|494987|P3|COMPLETED|Overall Study||5
204679|NCT01284634|494988|P2|COMPLETED|Overall Study||6
204680|NCT01284634|494989|P1|COMPLETED|Overall Study||6
204681|NCT01284634|494986|P4|Intent to Treat (ITT) Analysis Set|Overall Study||5
204682|NCT01284634|494987|P3|Intent to Treat (ITT) Analysis Set|Overall Study||7
204683|NCT01284634|494988|P2|Intent to Treat (ITT) Analysis Set|Overall Study||6
204684|NCT01284634|494989|P1|Intent to Treat (ITT) Analysis Set|Overall Study||7
204685|NCT01284634|494986|P4|Received at Least 1 Dose of Study Drug|Overall Study||5
204686|NCT01284634|494987|P3|Received at Least 1 Dose of Study Drug|Overall Study||7
204687|NCT01284634|494988|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
204688|NCT01284634|494989|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
204689|NCT01284634|494986|P4|STARTED|Overall Study||5
204690|NCT01284634|494987|P3|STARTED|Overall Study||7
204691|NCT01284634|494988|P2|STARTED|Overall Study||6
204692|NCT01284634|494989|P1|STARTED|Overall Study||7
204693|NCT01284621|495019|P6|NOT COMPLETED|Third Intervention (8 Days)||0
204694|NCT01284621|495020|P5|NOT COMPLETED|Third Intervention (8 Days)||0
204695|NCT01284621|495021|P4|NOT COMPLETED|Third Intervention (8 Days)||0
204696|NCT01284621|495022|P3|NOT COMPLETED|Third Intervention (8 Days)||0
204697|NCT01284621|495023|P2|NOT COMPLETED|Third Intervention (8 Days)||0
204698|NCT01284621|495024|P1|NOT COMPLETED|Third Intervention (8 Days)||0
204699|NCT01284621|495019|P6|COMPLETED|Third Intervention (8 Days)||4
204700|NCT01284621|495020|P5|COMPLETED|Third Intervention (8 Days)||3
204701|NCT01284621|495021|P4|COMPLETED|Third Intervention (8 Days)||4
204702|NCT01284621|495022|P3|COMPLETED|Third Intervention (8 Days)||4
204703|NCT01284621|495023|P2|COMPLETED|Third Intervention (8 Days)||4
204704|NCT01284621|495024|P1|COMPLETED|Third Intervention (8 Days)||3
204705|NCT01284621|495019|P6|STARTED|Third Intervention (8 Days)||4
204706|NCT01284621|495020|P5|STARTED|Third Intervention (8 Days)||3
204707|NCT01284621|495021|P4|STARTED|Third Intervention (8 Days)||4
204708|NCT01284621|495022|P3|STARTED|Third Intervention (8 Days)||4
204709|NCT01284621|495023|P2|STARTED|Third Intervention (8 Days)||4
204710|NCT01284621|495024|P1|STARTED|Third Intervention (8 Days)||3
204711|NCT01284621|495019|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
204712|NCT01284621|495020|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
204713|NCT01284621|495021|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
204714|NCT01284621|495022|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
204715|NCT01284621|495023|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
204716|NCT01284621|495024|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
204717|NCT01284621|495019|P6|COMPLETED|Washout Period 2 (7 Days)||4
204718|NCT01284621|495020|P5|COMPLETED|Washout Period 2 (7 Days)||3
204719|NCT01284621|495021|P4|COMPLETED|Washout Period 2 (7 Days)||4
204720|NCT01284621|495022|P3|COMPLETED|Washout Period 2 (7 Days)||4
204721|NCT01284621|495023|P2|COMPLETED|Washout Period 2 (7 Days)||4
204722|NCT01284621|495024|P1|COMPLETED|Washout Period 2 (7 Days)||3
204723|NCT01284621|495019|P6|STARTED|Washout Period 2 (7 Days)||4
204724|NCT01284621|495020|P5|STARTED|Washout Period 2 (7 Days)||3
204725|NCT01284621|495021|P4|STARTED|Washout Period 2 (7 Days)||4
204726|NCT01284621|495022|P3|STARTED|Washout Period 2 (7 Days)||4
204727|NCT01284621|495023|P2|STARTED|Washout Period 2 (7 Days)||4
204728|NCT01284621|495024|P1|STARTED|Washout Period 2 (7 Days)||3
204729|NCT01284621|495019|P6|NOT COMPLETED|Second Intervention (8 Days)||0
204730|NCT01284621|495020|P5|NOT COMPLETED|Second Intervention (8 Days)||0
204731|NCT01284621|495021|P4|NOT COMPLETED|Second Intervention (8 Days)||0
204732|NCT01284621|495022|P3|NOT COMPLETED|Second Intervention (8 Days)||0
204733|NCT01284621|495023|P2|NOT COMPLETED|Second Intervention (8 Days)||0
204734|NCT01284621|495024|P1|NOT COMPLETED|Second Intervention (8 Days)||0
204735|NCT01284621|495019|P6|COMPLETED|Second Intervention (8 Days)||4
204736|NCT01284621|495020|P5|COMPLETED|Second Intervention (8 Days)||3
204737|NCT01284621|495021|P4|COMPLETED|Second Intervention (8 Days)||4
204738|NCT01284621|495022|P3|COMPLETED|Second Intervention (8 Days)||4
204739|NCT01284621|495023|P2|COMPLETED|Second Intervention (8 Days)||4
204740|NCT01284621|495024|P1|COMPLETED|Second Intervention (8 Days)||3
204741|NCT01284621|495019|P6|STARTED|Second Intervention (8 Days)||4
204742|NCT01284621|495020|P5|STARTED|Second Intervention (8 Days)||3
204743|NCT01284621|495021|P4|STARTED|Second Intervention (8 Days)||4
204744|NCT01284621|495022|P3|STARTED|Second Intervention (8 Days)||4
204745|NCT01284621|495023|P2|STARTED|Second Intervention (8 Days)||4
204746|NCT01284621|495024|P1|STARTED|Second Intervention (8 Days)||3
204747|NCT01284621|495019|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
204748|NCT01284621|495020|P5|NOT COMPLETED|Washout Period 1 (7 Days)||1
204749|NCT01284621|495021|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
204750|NCT01284621|495022|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
204751|NCT01284621|495023|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
204752|NCT01284621|495024|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
204753|NCT01284621|495019|P6|COMPLETED|Washout Period 1 (7 Days)||4
204754|NCT01284621|495020|P5|COMPLETED|Washout Period 1 (7 Days)||3
204755|NCT01284621|495021|P4|COMPLETED|Washout Period 1 (7 Days)||4
204756|NCT01284621|495022|P3|COMPLETED|Washout Period 1 (7 Days)||4
204757|NCT01284621|495023|P2|COMPLETED|Washout Period 1 (7 Days)||4
204758|NCT01284621|495024|P1|COMPLETED|Washout Period 1 (7 Days)||3
204759|NCT01284621|495019|P6|STARTED|Washout Period 1 (7 Days)||4
204760|NCT01284621|495020|P5|STARTED|Washout Period 1 (7 Days)||4
204761|NCT01284621|495021|P4|STARTED|Washout Period 1 (7 Days)||4
204762|NCT01284621|495022|P3|STARTED|Washout Period 1 (7 Days)||4
204763|NCT01284621|495023|P2|STARTED|Washout Period 1 (7 Days)||4
204764|NCT01284621|495024|P1|STARTED|Washout Period 1 (7 Days)||3
204765|NCT01284621|495019|P6|NOT COMPLETED|First Intervention (8 Days)||0
204766|NCT01284621|495020|P5|NOT COMPLETED|First Intervention (8 Days)||0
204767|NCT01284621|495021|P4|NOT COMPLETED|First Intervention (8 Days)||0
204768|NCT01284621|495022|P3|NOT COMPLETED|First Intervention (8 Days)||0
204769|NCT01284621|495023|P2|NOT COMPLETED|First Intervention (8 Days)||0
204770|NCT01284621|495024|P1|NOT COMPLETED|First Intervention (8 Days)||0
204771|NCT01284621|495019|P6|COMPLETED|First Intervention (8 Days)||4
204772|NCT01284621|495020|P5|COMPLETED|First Intervention (8 Days)||4
204773|NCT01284621|495021|P4|COMPLETED|First Intervention (8 Days)||4
204774|NCT01284621|495022|P3|COMPLETED|First Intervention (8 Days)||4
204775|NCT01284621|495023|P2|COMPLETED|First Intervention (8 Days)||4
204776|NCT01284621|495024|P1|COMPLETED|First Intervention (8 Days)||3
204777|NCT01284621|495019|P6|STARTED|First Intervention (8 Days)||4
204778|NCT01284621|495020|P5|STARTED|First Intervention (8 Days)||4
204779|NCT01284621|495021|P4|STARTED|First Intervention (8 Days)||4
204780|NCT01284621|495022|P3|STARTED|First Intervention (8 Days)||4
204781|NCT01284621|495023|P2|STARTED|First Intervention (8 Days)||4
204782|NCT01284621|495024|P1|STARTED|First Intervention (8 Days)||3
204783|NCT01284517|495068|P2|NOT COMPLETED|Overall Study||36
204784|NCT01284517|495069|P1|NOT COMPLETED|Overall Study||32
204785|NCT01284517|495068|P2|COMPLETED|Overall Study||140
204786|NCT01284517|495069|P1|COMPLETED|Overall Study||148
204787|NCT01284517|495068|P2|STARTED|Overall Study||176
204788|NCT01284517|495069|P1|STARTED|Overall Study||180
204789|NCT01284504|495081|P2|NOT COMPLETED|Overall Study||0
204790|NCT01284504|495082|P1|NOT COMPLETED|Overall Study||0
204791|NCT01284504|495081|P2|COMPLETED|Overall Study||0
204792|NCT01284504|495082|P1|COMPLETED|Overall Study||0
204793|NCT01284504|495081|P2|STARTED|Overall Study||0
204794|NCT01284504|495082|P1|STARTED|Overall Study||0
204795|NCT01284491|495092|P1|NOT COMPLETED|Overall Study||13
204796|NCT01284491|495092|P1|COMPLETED|Overall Study||0
204797|NCT01284491|495092|P1|STARTED|Overall Study||13
204798|NCT01284426|495098|P1|NOT COMPLETED|Overall Study||2
204799|NCT01284426|495098|P1|COMPLETED|Overall Study||92
204800|NCT01284426|495098|P1|STARTED|Overall Study||94
204801|NCT01284361|495102|P1|NOT COMPLETED|Overall Study||9
204802|NCT01284361|495102|P1|COMPLETED|Overall Study||82
204803|NCT01284361|495102|P1|STARTED|Overall Study||91
204804|NCT01284335|495122|P13|NOT COMPLETED|Overall Study||0
204805|NCT01284335|495123|P12|NOT COMPLETED|Overall Study||0
204806|NCT01284335|495124|P11|NOT COMPLETED|Overall Study||0
204807|NCT01284335|495125|P10|NOT COMPLETED|Overall Study||0
204808|NCT01284335|495126|P9|NOT COMPLETED|Overall Study||0
204809|NCT01284335|495127|P8|NOT COMPLETED|Overall Study||0
204810|NCT01284335|495128|P7|NOT COMPLETED|Overall Study||0
204811|NCT01284335|495129|P6|NOT COMPLETED|Overall Study||0
204812|NCT01284335|495130|P5|NOT COMPLETED|Overall Study||0
204813|NCT01284335|495131|P4|NOT COMPLETED|Overall Study||0
204814|NCT01284335|495132|P3|NOT COMPLETED|Overall Study||0
204815|NCT01284335|495133|P2|NOT COMPLETED|Overall Study||0
204816|NCT01284335|495134|P1|NOT COMPLETED|Overall Study||0
204817|NCT01284335|495122|P13|COMPLETED|Overall Study||12
204818|NCT01284335|495123|P12|COMPLETED|Overall Study||16
204819|NCT01284335|495124|P11|COMPLETED|Overall Study||45
204820|NCT01284335|495125|P10|COMPLETED|Overall Study||14
204821|NCT01284335|495126|P9|COMPLETED|Overall Study||4
204822|NCT01284335|495127|P8|COMPLETED|Overall Study||6
204823|NCT01284335|495128|P7|COMPLETED|Overall Study||19
204824|NCT01284335|495129|P6|COMPLETED|Overall Study||26
204825|NCT01284335|495130|P5|COMPLETED|Overall Study||24
204826|NCT01284335|495131|P4|COMPLETED|Overall Study||5
204827|NCT01284335|495132|P3|COMPLETED|Overall Study||5
204828|NCT01284335|495133|P2|COMPLETED|Overall Study||33
204829|NCT01284335|495134|P1|COMPLETED|Overall Study||25
204830|NCT01284335|495122|P13|Received at Least One Dose of Study Drug|Overall Study||12
204831|NCT01284335|495123|P12|Received at Least One Dose of Study Drug|Overall Study||16
204832|NCT01284335|495124|P11|Received at Least One Dose of Study Drug|Overall Study||45
204833|NCT01284335|495125|P10|Received at Least One Dose of Study Drug|Overall Study||14
204834|NCT01284335|495126|P9|Received at Least One Dose of Study Drug|Overall Study||4
204835|NCT01284335|495127|P8|Received at Least One Dose of Study Drug|Overall Study||6
204836|NCT01284335|495128|P7|Received at Least One Dose of Study Drug|Overall Study||19
204837|NCT01284335|495129|P6|Received at Least One Dose of Study Drug|Overall Study||26
204838|NCT01284335|495130|P5|Received at Least One Dose of Study Drug|Overall Study||24
204839|NCT01284335|495131|P4|Received at Least One Dose of Study Drug|Overall Study||5
204840|NCT01284335|495132|P3|Received at Least One Dose of Study Drug|Overall Study||5
204841|NCT01284335|495133|P2|Received at Least One Dose of Study Drug|Overall Study||33
204842|NCT01284335|495134|P1|Received at Least One Dose of Study Drug|Overall Study||25
204843|NCT01284335|495122|P13|STARTED|Overall Study||12
204844|NCT01284335|495123|P12|STARTED|Overall Study||16
204845|NCT01284335|495124|P11|STARTED|Overall Study||45
204846|NCT01284335|495125|P10|STARTED|Overall Study||14
204847|NCT01284335|495126|P9|STARTED|Overall Study||4
204848|NCT01284335|495127|P8|STARTED|Overall Study||6
204849|NCT01284335|495128|P7|STARTED|Overall Study||19
204850|NCT01284335|495129|P6|STARTED|Overall Study||26
204851|NCT01284335|495130|P5|STARTED|Overall Study||24
204852|NCT01284335|495131|P4|STARTED|Overall Study||5
204853|NCT01284335|495132|P3|STARTED|Overall Study||5
204854|NCT01284335|495133|P2|STARTED|Overall Study||33
204855|NCT01284335|495134|P1|STARTED|Overall Study||25
204856|NCT01284296|495182|P1|NOT COMPLETED|Overall Study||0
204857|NCT01284296|495182|P1|COMPLETED|Overall Study||20
204858|NCT01284296|495182|P1|STARTED|Overall Study||20
204859|NCT01284244|495189|P2|NOT COMPLETED|Overall Study||0
204860|NCT01284244|495190|P1|NOT COMPLETED|Overall Study||0
204861|NCT01284244|495189|P2|COMPLETED|Overall Study||18
204862|NCT01284244|495190|P1|COMPLETED|Overall Study||18
204863|NCT01284244|495189|P2|STARTED|Overall Study||18
204864|NCT01284244|495190|P1|STARTED|Overall Study||18
204865|NCT01284140|495198|P2|NOT COMPLETED|Subjects With Paired 24hr Collections||6
204866|NCT01284140|495199|P1|NOT COMPLETED|Subjects With Paired 24hr Collections||5
204867|NCT01284140|495198|P2|COMPLETED|Subjects With Paired 24hr Collections||5
204868|NCT01284140|495199|P1|COMPLETED|Subjects With Paired 24hr Collections||6
204869|NCT01284140|495198|P2|STARTED|Subjects With Paired 24hr Collections||11
204870|NCT01284140|495199|P1|STARTED|Subjects With Paired 24hr Collections||11
204871|NCT01284140|495198|P2|NOT COMPLETED|Randomization and Intervention||0
204872|NCT01284140|495199|P1|NOT COMPLETED|Randomization and Intervention||0
204873|NCT01284140|495198|P2|COMPLETED|Randomization and Intervention||11
204874|NCT01284140|495199|P1|COMPLETED|Randomization and Intervention||11
204875|NCT01284140|495198|P2|STARTED|Randomization and Intervention||11
204876|NCT01284140|495199|P1|STARTED|Randomization and Intervention||11
204877|NCT01284127|495213|P1|NOT COMPLETED|Overall Study||7
204878|NCT01284127|495213|P1|COMPLETED|Overall Study||31
204879|NCT01284127|495213|P1|STARTED|Overall Study||38
204880|NCT01284114|495222|P1|NOT COMPLETED|Overall Study||4
204881|NCT01284114|495222|P1|COMPLETED|Overall Study||19
204882|NCT01284114|495222|P1|STARTED|Overall Study||23
204883|NCT01284062|495234|P4|NOT COMPLETED|Overall Study||14
204884|NCT01284062|495235|P3|NOT COMPLETED|Overall Study||6
204885|NCT01284062|495236|P2|NOT COMPLETED|Overall Study||8
204886|NCT01284062|495237|P1|NOT COMPLETED|Overall Study||11
204887|NCT01284062|495234|P4|COMPLETED|Overall Study||7
204888|NCT01284062|495235|P3|COMPLETED|Overall Study||15
204889|NCT01284062|495236|P2|COMPLETED|Overall Study||13
204890|NCT01284062|495237|P1|COMPLETED|Overall Study||10
204891|NCT01284062|495234|P4|STARTED|Overall Study||21
204892|NCT01284062|495235|P3|STARTED|Overall Study||21
204893|NCT01284062|495236|P2|STARTED|Overall Study||21
204894|NCT01284062|495237|P1|STARTED|Overall Study||21
204895|NCT01283971|495311|P2|NOT COMPLETED|Overall Study||12
204896|NCT01283971|495312|P1|NOT COMPLETED|Overall Study||15
204897|NCT01283971|495311|P2|COMPLETED|Overall Study||36
204898|NCT01283971|495312|P1|COMPLETED|Overall Study||33
204899|NCT01283971|495311|P2|Intent to Treat Population|Overall Study||48
204900|NCT01283971|495312|P1|Intent to Treat Population|Overall Study||46
204901|NCT01283971|495311|P2|STARTED|Overall Study||48
204902|NCT01283971|495312|P1|STARTED|Overall Study||48
204903|NCT01283581|495359|P3|NOT COMPLETED|Overall Study||20
204904|NCT01283581|495360|P2|NOT COMPLETED|Overall Study||14
204905|NCT01283581|495361|P1|NOT COMPLETED|Overall Study||12
204906|NCT01283581|495359|P3|COMPLETED|Overall Study||78
204907|NCT01283581|495360|P2|COMPLETED|Overall Study||63
204908|NCT01283581|495361|P1|COMPLETED|Overall Study||69
204909|NCT01283581|495359|P3|STARTED|Overall Study||98
204910|NCT01283581|495360|P2|STARTED|Overall Study||77
204911|NCT01283581|495361|P1|STARTED|Overall Study||81
204912|NCT01283555|495387|P2|NOT COMPLETED|Second Intervention||0
204913|NCT01283555|495388|P1|NOT COMPLETED|Second Intervention||0
204914|NCT01283555|495387|P2|COMPLETED|Second Intervention||12
204915|NCT01283555|495388|P1|COMPLETED|Second Intervention||13
204916|NCT01283555|495387|P2|STARTED|Second Intervention||12
204917|NCT01283555|495388|P1|STARTED|Second Intervention||13
204918|NCT01283555|495387|P2|NOT COMPLETED|Washout Period of at Least 21 Days||0
204919|NCT01283555|495388|P1|NOT COMPLETED|Washout Period of at Least 21 Days||0
204920|NCT01283555|495387|P2|COMPLETED|Washout Period of at Least 21 Days||12
204921|NCT01283555|495388|P1|COMPLETED|Washout Period of at Least 21 Days||13
204922|NCT01283555|495387|P2|STARTED|Washout Period of at Least 21 Days||12
204923|NCT01283555|495388|P1|STARTED|Washout Period of at Least 21 Days||13
204924|NCT01283555|495387|P2|NOT COMPLETED|First Intervention||0
204925|NCT01283555|495388|P1|NOT COMPLETED|First Intervention||0
204926|NCT01283555|495387|P2|COMPLETED|First Intervention||12
204927|NCT01283555|495388|P1|COMPLETED|First Intervention||13
204928|NCT01283555|495387|P2|STARTED|First Intervention||12
204929|NCT01283555|495388|P1|STARTED|First Intervention||13
204930|NCT01283542|495431|P1|NOT COMPLETED|Extension Phase||3
204931|NCT01283542|495431|P1|COMPLETED|Extension Phase||10
204932|NCT01283542|495431|P1|Safety Analysis Set|Extension Phase||13
204933|NCT01283542|495431|P1|Full Analysis Set (FAS)|Extension Phase||13
204934|NCT01283542|495431|P1|STARTED|Extension Phase||13
204935|NCT01283542|495431|P1|NOT COMPLETED|Main Phase||7
204936|NCT01283542|495431|P1|COMPLETED|Main Phase||13
204937|NCT01283542|495431|P1|Safety Analysis Set|Main Phase||20
204938|NCT01283542|495431|P1|Full Analysis Set (FAS)|Main Phase||20
204939|NCT01283542|495431|P1|STARTED|Main Phase||20
204940|NCT01283516|495496|P9|NOT COMPLETED|Overall Study||255
204941|NCT01283516|495497|P8|NOT COMPLETED|Overall Study||5
204942|NCT01283516|495498|P7|NOT COMPLETED|Overall Study||10
204943|NCT01283516|495499|P6|NOT COMPLETED|Overall Study||10
204944|NCT01283516|495500|P5|NOT COMPLETED|Overall Study||14
204945|NCT01283516|495501|P4|NOT COMPLETED|Overall Study||3
204946|NCT01283516|495502|P3|NOT COMPLETED|Overall Study||3
204947|NCT01283516|495503|P2|NOT COMPLETED|Overall Study||2
204948|NCT01283516|495504|P1|NOT COMPLETED|Overall Study||2
204949|NCT01283516|495496|P9|COMPLETED|Overall Study||0
204950|NCT01283516|495497|P8|COMPLETED|Overall Study||0
204951|NCT01283516|495498|P7|COMPLETED|Overall Study||0
204952|NCT01283516|495499|P6|COMPLETED|Overall Study||0
204953|NCT01283516|495500|P5|COMPLETED|Overall Study||0
204954|NCT01283516|495501|P4|COMPLETED|Overall Study||0
204955|NCT01283516|495502|P3|COMPLETED|Overall Study||0
204956|NCT01283516|495503|P2|COMPLETED|Overall Study||0
204957|NCT01283516|495504|P1|COMPLETED|Overall Study|Completed - see explanation in Recruitment Details.|0
204958|NCT01283516|495496|P9|Non-NSCLC|Overall Study|Small number of patients at 750 mg - non-NSCLC, assessment limited, not included in efficacy tables|9
204959|NCT01283516|495497|P8|Non-NSCLC|Overall Study||0
204960|NCT01283516|495498|P7|Non-NSCLC|Overall Study||1
204961|NCT01283516|495499|P6|Non-NSCLC|Overall Study||0
204962|NCT01283516|495500|P5|Non-NSCLC|Overall Study||2
204963|NCT01283516|495501|P4|Non-NSCLC|Overall Study||0
204964|NCT01283516|495502|P3|Non-NSCLC|Overall Study||1
204965|NCT01283516|495503|P2|Non-NSCLC|Overall Study||1
204966|NCT01283516|495504|P1|Non-NSCLC|Overall Study||0
204967|NCT01283516|495496|P9|Dose-Determining Set (DDS)|Overall Study||8
204968|NCT01283516|495497|P8|Dose-Determining Set (DDS)|Overall Study||5
204969|NCT01283516|495498|P7|Dose-Determining Set (DDS)|Overall Study||10
204970|NCT01283516|495499|P6|Dose-Determining Set (DDS)|Overall Study||8
204971|NCT01283516|495500|P5|Dose-Determining Set (DDS)|Overall Study||14
204972|NCT01283516|495501|P4|Dose-Determining Set (DDS)|Overall Study||3
204973|NCT01283516|495502|P3|Dose-Determining Set (DDS)|Overall Study||3
204974|NCT01283516|495503|P2|Dose-Determining Set (DDS)|Overall Study||1
204975|NCT01283516|495504|P1|Dose-Determining Set (DDS)|Overall Study||2
204976|NCT01283516|495496|P9|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||246
204977|NCT01283516|495497|P8|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||5
204978|NCT01283516|495498|P7|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||9
204979|NCT01283516|495499|P6|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||10
204980|NCT01283516|495500|P5|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||12
204981|NCT01283516|495501|P4|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||3
204982|NCT01283516|495502|P3|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
204983|NCT01283516|495503|P2|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||1
204984|NCT01283516|495504|P1|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
204985|NCT01283516|495496|P9|STARTED|Overall Study||255
204986|NCT01283516|495497|P8|STARTED|Overall Study||5
204987|NCT01283516|495498|P7|STARTED|Overall Study||10
204988|NCT01283516|495499|P6|STARTED|Overall Study||10
204989|NCT01283516|495500|P5|STARTED|Overall Study||14
204990|NCT01283516|495501|P4|STARTED|Overall Study||3
204991|NCT01283516|495502|P3|STARTED|Overall Study||3
204992|NCT01283516|495503|P2|STARTED|Overall Study||2
204993|NCT01283516|495504|P1|STARTED|Overall Study|Started = Full Analysis Set and Safety Set|2
204994|NCT01283464|495626|P2|NOT COMPLETED|Overall Study||1
204995|NCT01283464|495627|P1|NOT COMPLETED|Overall Study||2
204996|NCT01283464|495626|P2|COMPLETED|Overall Study||11
204997|NCT01283464|495627|P1|COMPLETED|Overall Study||10
204998|NCT01283464|495626|P2|STARTED|Overall Study||12
204999|NCT01283464|495627|P1|STARTED|Overall Study||12
205000|NCT01283386|495635|P2|NOT COMPLETED|Overall Study||12
205001|NCT01283386|495636|P1|NOT COMPLETED|Overall Study||8
205002|NCT01283386|495635|P2|COMPLETED|Overall Study||4
205003|NCT01283386|495636|P1|COMPLETED|Overall Study||2
205004|NCT01283386|495635|P2|STARTED|Overall Study||16
205005|NCT01283386|495636|P1|STARTED|Overall Study||10
205006|NCT01283334|495660|P1|NOT COMPLETED|Overall Study||7
205007|NCT01283334|495660|P1|COMPLETED|Overall Study||13
205008|NCT01283334|495660|P1|STARTED|Overall Study||20
205009|NCT01283321|495668|P2|NOT COMPLETED|Overall Study||0
205010|NCT01283321|495669|P1|NOT COMPLETED|Overall Study||0
205011|NCT01283321|495668|P2|COMPLETED|Overall Study||10
205012|NCT01283321|495669|P1|COMPLETED|Overall Study||10
205013|NCT01283321|495668|P2|STARTED|Overall Study||10
205014|NCT01283321|495669|P1|STARTED|Overall Study||10
205015|NCT01283282|495683|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
205016|NCT01283282|495684|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
205017|NCT01283282|495683|P2|COMPLETED|Second Intervention (6 Weeks)||19
205018|NCT01283282|495684|P1|COMPLETED|Second Intervention (6 Weeks)||22
205019|NCT01283282|495683|P2|STARTED|Second Intervention (6 Weeks)||19
205020|NCT01283282|495684|P1|STARTED|Second Intervention (6 Weeks)||22
205021|NCT01283282|495683|P2|NOT COMPLETED|First Intervention (6 Weeks)||4
205022|NCT01283282|495684|P1|NOT COMPLETED|First Intervention (6 Weeks)||3
205023|NCT01283282|495683|P2|COMPLETED|First Intervention (6 Weeks)||19
205024|NCT01283282|495684|P1|COMPLETED|First Intervention (6 Weeks)||22
205025|NCT01283282|495683|P2|STARTED|First Intervention (6 Weeks)||23
205026|NCT01283282|495684|P1|STARTED|First Intervention (6 Weeks)||25
205027|NCT01283152|495704|P2|NOT COMPLETED|Overall Study||0
205028|NCT01283152|495705|P1|NOT COMPLETED|Overall Study||2
205029|NCT01283152|495704|P2|COMPLETED|Overall Study||25
205030|NCT01283152|495705|P1|COMPLETED|Overall Study||23
205031|NCT01283152|495704|P2|24-hr HESA Attempted|Overall Study||25
205032|NCT01283152|495705|P1|24-hr HESA Attempted|Overall Study||25
205033|NCT01283152|495704|P2|Study Treatment Received|Overall Study||25
205034|NCT01283152|495705|P1|Study Treatment Received|Overall Study||25
205035|NCT01283152|495704|P2|ITT Population|Overall Study||25
205036|NCT01283152|495705|P1|ITT Population|Overall Study||25
205037|NCT01283152|495704|P2|STARTED|Overall Study||25
205038|NCT01283152|495705|P1|STARTED|Overall Study||25
205039|NCT01283139|495719|P4|NOT COMPLETED|Overall Study||15
205040|NCT01283139|495720|P3|NOT COMPLETED|Overall Study||18
205041|NCT01283139|495721|P2|NOT COMPLETED|Overall Study||18
205042|NCT01283139|495722|P1|NOT COMPLETED|Overall Study||17
205043|NCT01283139|495719|P4|COMPLETED|Overall Study||92
205044|NCT01283139|495720|P3|COMPLETED|Overall Study||91
205045|NCT01283139|495721|P2|COMPLETED|Overall Study||90
205046|NCT01283139|495722|P1|COMPLETED|Overall Study||91
205047|NCT01283139|495719|P4|STARTED|Overall Study||107
205048|NCT01283139|495720|P3|STARTED|Overall Study||109
205049|NCT01283139|495721|P2|STARTED|Overall Study||108
205050|NCT01283139|495722|P1|STARTED|Overall Study||108
205051|NCT01283035|495764|P1|NOT COMPLETED|Overall Study||1
205052|NCT01283035|495764|P1|COMPLETED|Overall Study||5
205053|NCT01283035|495764|P1|STARTED|Overall Study||6
205054|NCT01283022|495773|P1|NOT COMPLETED|Overall Study||0
205055|NCT01283022|495773|P1|COMPLETED|Overall Study||24
205056|NCT01283022|495773|P1|STARTED|Overall Study||24
205057|NCT01282866|495779|P1|NOT COMPLETED|Overall Study||1
205058|NCT01282866|495779|P1|COMPLETED|Overall Study||34
205059|NCT01282866|495779|P1|STARTED|Overall Study||35
205060|NCT01282814|495787|P2|NOT COMPLETED|Second Intervention||0
205061|NCT01282814|495788|P1|NOT COMPLETED|Second Intervention||0
205062|NCT01282814|495787|P2|COMPLETED|Second Intervention||9
205063|NCT01282814|495788|P1|COMPLETED|Second Intervention||10
205064|NCT01282814|495787|P2|STARTED|Second Intervention||9
205065|NCT01282814|495788|P1|STARTED|Second Intervention||10
205066|NCT01282814|495787|P2|NOT COMPLETED|Washout of 7 Days||0
205067|NCT01282814|495788|P1|NOT COMPLETED|Washout of 7 Days||2
205068|NCT01282814|495787|P2|COMPLETED|Washout of 7 Days||9
205069|NCT01282814|495788|P1|COMPLETED|Washout of 7 Days||10
205070|NCT01282814|495787|P2|STARTED|Washout of 7 Days||9
205071|NCT01282814|495788|P1|STARTED|Washout of 7 Days||12
205072|NCT01282814|495787|P2|NOT COMPLETED|First Intervention||3
205073|NCT01282814|495788|P1|NOT COMPLETED|First Intervention||0
205074|NCT01282814|495787|P2|COMPLETED|First Intervention||9
205075|NCT01282814|495788|P1|COMPLETED|First Intervention||12
205076|NCT01282814|495787|P2|STARTED|First Intervention||12
205077|NCT01282814|495788|P1|STARTED|First Intervention||12
205078|NCT01282801|495800|P2|NOT COMPLETED|Second Intervention||1
205079|NCT01282801|495801|P1|NOT COMPLETED|Second Intervention||0
205080|NCT01282801|495800|P2|COMPLETED|Second Intervention||8
205081|NCT01282801|495801|P1|COMPLETED|Second Intervention||9
205082|NCT01282801|495800|P2|STARTED|Second Intervention||9
205083|NCT01282801|495801|P1|STARTED|Second Intervention||9
205084|NCT01282801|495800|P2|NOT COMPLETED|Washout of 7 Days||0
205085|NCT01282801|495801|P1|NOT COMPLETED|Washout of 7 Days||0
205086|NCT01282801|495800|P2|COMPLETED|Washout of 7 Days||9
205087|NCT01282801|495801|P1|COMPLETED|Washout of 7 Days||9
205088|NCT01282801|495800|P2|STARTED|Washout of 7 Days||9
205089|NCT01282801|495801|P1|STARTED|Washout of 7 Days||9
205090|NCT01282801|495800|P2|NOT COMPLETED|First Intervention||0
205091|NCT01282801|495801|P1|NOT COMPLETED|First Intervention||0
205092|NCT01282801|495800|P2|COMPLETED|First Intervention||9
205093|NCT01282801|495801|P1|COMPLETED|First Intervention||9
205094|NCT01282801|495800|P2|STARTED|First Intervention||9
205095|NCT01282801|495801|P1|STARTED|First Intervention||9
205096|NCT01282723|495817|P1|NOT COMPLETED|Overall Study||0
205097|NCT01282723|495817|P1|COMPLETED|Overall Study||20
205098|NCT01282723|495817|P1|STARTED|Overall Study||20
205099|NCT01282710|495821|P1|NOT COMPLETED|Overall Study||0
205100|NCT01282710|495821|P1|COMPLETED|Overall Study||20
205101|NCT01282710|495821|P1|STARTED|Overall Study||20
205102|NCT01282476|495825|P1|NOT COMPLETED|Overall Study||11
205103|NCT01282476|495825|P1|COMPLETED|Overall Study||7
205104|NCT01282476|495825|P1|STARTED|Overall Study||18
205105|NCT01282463|495834|P3|NOT COMPLETED|Overall Study||4
205106|NCT01282463|495835|P2|NOT COMPLETED|Overall Study||4
205107|NCT01282463|495836|P1|NOT COMPLETED|Overall Study||8
205108|NCT01282463|495834|P3|COMPLETED|Overall Study||46
205109|NCT01282463|495835|P2|COMPLETED|Overall Study||45
205110|NCT01282463|495836|P1|COMPLETED|Overall Study||41
205111|NCT01282463|495834|P3|Received at Least 1 Dose of Study Drug|Overall Study||49
205112|NCT01282463|495835|P2|Received at Least 1 Dose of Study Drug|Overall Study||46
205113|NCT01282463|495836|P1|Received at Least 1 Dose of Study Drug|Overall Study||45
205114|NCT01282463|495834|P3|STARTED|Overall Study||50
205115|NCT01282463|495835|P2|STARTED|Overall Study||49
205116|NCT01282463|495836|P1|STARTED|Overall Study||49
205117|NCT01282424|495874|P1|NOT COMPLETED|Long-term Follow-up Period (5 Years)||64
205118|NCT01282424|495874|P1|COMPLETED|Long-term Follow-up Period (5 Years)||20
205119|NCT01282424|495874|P1|STARTED|Long-term Follow-up Period (5 Years)|Participants did not have to complete the TP in order to enter the Long-term Follow-up Period.|84
205120|NCT01282424|495874|P1|NOT COMPLETED|Treatment Period (TP) (81 Months)||46
205121|NCT01282424|495874|P1|COMPLETED|Treatment Period (TP) (81 Months)||79
205122|NCT01282424|495874|P1|Completed: Death|Treatment Period (TP) (81 Months)||9
205123|NCT01282424|495874|P1|Completed: Disease Progression|Treatment Period (TP) (81 Months)||70
205124|NCT01282424|495874|P1|STARTED|Treatment Period (TP) (81 Months)||125
205125|NCT01282372|495891|P1|NOT COMPLETED|Overall Study||79
205126|NCT01282372|495891|P1|COMPLETED|Overall Study||421
205127|NCT01282372|495891|P1|STARTED|Overall Study||500
205128|NCT01282294|495919|P1|NOT COMPLETED|Overall Study||19
205129|NCT01282294|495919|P1|COMPLETED|Overall Study||81
205130|NCT01282294|495919|P1|12 Months|Overall Study||86
205131|NCT01282294|495919|P1|6 Months|Overall Study||94
205132|NCT01282294|495919|P1|3 Months|Overall Study||95
205133|NCT01282294|495919|P1|6 Weeks|Overall Study||95
205134|NCT01282294|495919|P1|Post-operative|Overall Study||99
205135|NCT01282294|495919|P1|Intra-operative|Overall Study||99
205136|NCT01282294|495919|P1|STARTED|Overall Study||100
205137|NCT01282242|495939|P2|NOT COMPLETED|Overall Study||0
205138|NCT01282242|495940|P1|NOT COMPLETED|Overall Study||0
205139|NCT01282242|495939|P2|COMPLETED|Overall Study||8
205140|NCT01282242|495940|P1|COMPLETED|Overall Study||80
205141|NCT01282242|495939|P2|STARTED|Overall Study||8
205142|NCT01282242|495940|P1|STARTED|Overall Study||80
205143|NCT01282229|495948|P1|NOT COMPLETED|Overall Study||2
205144|NCT01282229|495948|P1|COMPLETED|Overall Study|57 Participants contributed 228 quadrants (57*4)|57
205145|NCT01282229|495948|P1|STARTED|Overall Study|59 Participants contributed 236 quadrants (59*4)|59
205146|NCT01282216|495980|P4|NOT COMPLETED|Overall Study||8
205147|NCT01282216|495981|P3|NOT COMPLETED|Overall Study||33
205148|NCT01282216|495982|P2|NOT COMPLETED|Overall Study||0
205149|NCT01282216|495983|P1|NOT COMPLETED|Overall Study||0
205150|NCT01282216|495980|P4|COMPLETED|Overall Study||0
205151|NCT01282216|495981|P3|COMPLETED|Overall Study||19
205152|NCT01282216|495982|P2|COMPLETED|Overall Study||26
205153|NCT01282216|495983|P1|COMPLETED|Overall Study||18
205154|NCT01282216|495980|P4|STARTED|Overall Study||8
205155|NCT01282216|495981|P3|STARTED|Overall Study||52
205156|NCT01282216|495982|P2|STARTED|Overall Study||26
205157|NCT01282216|495983|P1|STARTED|Overall Study||18
205158|NCT01282203|495993|P1|NOT COMPLETED|Overall Study||1
205159|NCT01282203|495993|P1|COMPLETED|Overall Study||1121
205160|NCT01282203|495993|P1|STARTED|Overall Study||1122
205161|NCT01282164|496015|P2|NOT COMPLETED|Overall Study||0
205162|NCT01282164|496016|P1|NOT COMPLETED|Overall Study||1
205163|NCT01282164|496015|P2|COMPLETED|Overall Study||14
205164|NCT01282164|496016|P1|COMPLETED|Overall Study||28
205165|NCT01282164|496015|P2|STARTED|Overall Study||14
205166|NCT01282164|496016|P1|STARTED|Overall Study||29
205167|NCT01282138|496041|P2|NOT COMPLETED|CAPT||0
205168|NCT01282138|496042|P1|NOT COMPLETED|CAPT||0
205169|NCT01282138|496041|P2|COMPLETED|CAPT||7
205170|NCT01282138|496042|P1|COMPLETED|CAPT||6
205171|NCT01282138|496041|P2|STARTED|CAPT||7
205172|NCT01282138|496042|P1|STARTED|CAPT||6
205173|NCT01282138|496041|P2|NOT COMPLETED|EEC||0
205174|NCT01282138|496042|P1|NOT COMPLETED|EEC||0
205175|NCT01282138|496041|P2|COMPLETED|EEC||7
205176|NCT01282138|496042|P1|COMPLETED|EEC||6
205177|NCT01282138|496041|P2|STARTED|EEC||7
205178|NCT01282138|496042|P1|STARTED|EEC||6
205179|NCT01282086|496050|P1|NOT COMPLETED|Overall Study||0
205180|NCT01282086|496050|P1|COMPLETED|Overall Study||1365
205181|NCT01282086|496050|P1|STARTED|Overall Study||1365
205182|NCT01281956|496067|P2|NOT COMPLETED|2nd Intervention (3 Months)||0
205183|NCT01281956|496068|P1|NOT COMPLETED|2nd Intervention (3 Months)||1
205184|NCT01281956|496067|P2|COMPLETED|2nd Intervention (3 Months)||5
205185|NCT01281956|496068|P1|COMPLETED|2nd Intervention (3 Months)||4
205186|NCT01281956|496067|P2|STARTED|2nd Intervention (3 Months)||5
205187|NCT01281956|496068|P1|STARTED|2nd Intervention (3 Months)||5
205188|NCT01281956|496067|P2|NOT COMPLETED|1st Intervention (3 Months)||0
205189|NCT01281956|496068|P1|NOT COMPLETED|1st Intervention (3 Months)||0
205190|NCT01281956|496067|P2|COMPLETED|1st Intervention (3 Months)||5
205191|NCT01281956|496068|P1|COMPLETED|1st Intervention (3 Months)||5
205192|NCT01281956|496067|P2|STARTED|1st Intervention (3 Months)||5
205193|NCT01281956|496068|P1|STARTED|1st Intervention (3 Months)||5
205194|NCT01281917|496099|P1|NOT COMPLETED|Overall Study||1
205195|NCT01281917|496099|P1|COMPLETED|Overall Study||39
205196|NCT01281917|496099|P1|STARTED|Overall Study||40
205197|NCT01281865|496111|P2|NOT COMPLETED|Overall Study||1
205198|NCT01281865|496112|P1|NOT COMPLETED|Overall Study||3
205199|NCT01281865|496111|P2|COMPLETED|Overall Study||1
205200|NCT01281865|496112|P1|COMPLETED|Overall Study||9
205201|NCT01281865|496111|P2|STARTED|Overall Study||2
205202|NCT01281865|496112|P1|STARTED|Overall Study||12
205203|NCT01281839|496120|P2|NOT COMPLETED|Overall Study||14
205204|NCT01281839|496121|P1|NOT COMPLETED|Overall Study||10
205205|NCT01281839|496120|P2|COMPLETED|Overall Study||119
205206|NCT01281839|496121|P1|COMPLETED|Overall Study||250
205207|NCT01281839|496120|P2|STARTED|Overall Study||133
205208|NCT01281839|496121|P1|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|260
205209|NCT01281644|496182|P1|NOT COMPLETED|Overall Study||5
205210|NCT01281644|496182|P1|COMPLETED|Overall Study||18
205211|NCT01281644|496182|P1|STARTED|Overall Study||23
205212|NCT01281501|496192|P2|NOT COMPLETED|Overall Study||0
205213|NCT01281501|496193|P1|NOT COMPLETED|Overall Study||0
205214|NCT01281501|496192|P2|COMPLETED|Overall Study||43
205215|NCT01281501|496193|P1|COMPLETED|Overall Study||44
205216|NCT01281501|496192|P2|STARTED|Overall Study||43
205217|NCT01281501|496193|P1|STARTED|Overall Study||44
205218|NCT01281475|496207|P2|NOT COMPLETED|Overall Study||8
205219|NCT01281475|496208|P1|NOT COMPLETED|Overall Study||4
205220|NCT01281475|496207|P2|COMPLETED|Overall Study||26
205221|NCT01281475|496208|P1|COMPLETED|Overall Study||29
205222|NCT01281475|496207|P2|STARTED|Overall Study||34
205223|NCT01281475|496208|P1|STARTED|Overall Study||33
205224|NCT01281306|496223|P7|NOT COMPLETED|Overall Study||7
205225|NCT01281306|496224|P6|NOT COMPLETED|Overall Study||7
205226|NCT01281306|496225|P5|NOT COMPLETED|Overall Study||9
205227|NCT01281306|496226|P4|NOT COMPLETED|Overall Study||11
205228|NCT01281306|496227|P3|NOT COMPLETED|Overall Study||8
205229|NCT01281306|496228|P2|NOT COMPLETED|Overall Study||4
205230|NCT01281306|496229|P1|NOT COMPLETED|Overall Study||8
205231|NCT01281306|496223|P7|COMPLETED|Overall Study||51
205232|NCT01281306|496224|P6|COMPLETED|Overall Study||135
205233|NCT01281306|496225|P5|COMPLETED|Overall Study||134
205234|NCT01281306|496226|P4|COMPLETED|Overall Study||123
205235|NCT01281306|496227|P3|COMPLETED|Overall Study||133
205236|NCT01281306|496228|P2|COMPLETED|Overall Study||141
205237|NCT01281306|496229|P1|COMPLETED|Overall Study||136
205238|NCT01281306|496223|P7|Ambulatory Blood Pressure Monitoring Set|Overall Study||35
205239|NCT01281306|496224|P6|Ambulatory Blood Pressure Monitoring Set|Overall Study||91
205240|NCT01281306|496225|P5|Ambulatory Blood Pressure Monitoring Set|Overall Study||93
205241|NCT01281306|496226|P4|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
205242|NCT01281306|496227|P3|Ambulatory Blood Pressure Monitoring Set|Overall Study||92
205243|NCT01281306|496228|P2|Ambulatory Blood Pressure Monitoring Set|Overall Study||99
205244|NCT01281306|496229|P1|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
205245|NCT01281306|496223|P7|Safety Set|Overall Study||58
205246|NCT01281306|496224|P6|Safety Set|Overall Study||142
205247|NCT01281306|496225|P5|Safety Set|Overall Study||143
205248|NCT01281306|496226|P4|Safety Set|Overall Study||133
205249|NCT01281306|496227|P3|Safety Set|Overall Study||141
205250|NCT01281306|496228|P2|Safety Set|Overall Study||145
205251|NCT01281306|496229|P1|Safety Set|Overall Study||143
205252|NCT01281306|496223|P7|Full Analysis Set|Overall Study||58
205253|NCT01281306|496224|P6|Full Analysis Set|Overall Study||142
205254|NCT01281306|496225|P5|Full Analysis Set|Overall Study||143
205255|NCT01281306|496226|P4|Full Analysis Set|Overall Study||133
205256|NCT01281306|496227|P3|Full Analysis Set|Overall Study||141
205257|NCT01281306|496228|P2|Full Analysis Set|Overall Study||145
205258|NCT01281306|496229|P1|Full Analysis Set|Overall Study||143
205259|NCT01281306|496223|P7|STARTED|Overall Study||58
205260|NCT01281306|496224|P6|STARTED|Overall Study||142
205261|NCT01281306|496225|P5|STARTED|Overall Study||143
205262|NCT01281306|496226|P4|STARTED|Overall Study||134
205263|NCT01281306|496227|P3|STARTED|Overall Study||141
205264|NCT01281306|496228|P2|STARTED|Overall Study||145
205265|NCT01281306|496229|P1|STARTED|Overall Study||144
205266|NCT01281202|496345|P2|NOT COMPLETED|Overall Study||36
205267|NCT01281202|496346|P1|NOT COMPLETED|Overall Study||28
205268|NCT01281202|496345|P2|COMPLETED|Overall Study||68
205269|NCT01281202|496346|P1|COMPLETED|Overall Study||75
205270|NCT01281202|496345|P2|STARTED|Overall Study||104
205271|NCT01281202|496346|P1|STARTED|Overall Study||103
205272|NCT01281124|496354|P1|NOT COMPLETED|Overall Study||1
205273|NCT01281124|496354|P1|COMPLETED|Overall Study||0
205274|NCT01281124|496354|P1|STARTED|Overall Study||1
205275|NCT01281007|496362|P2|NOT COMPLETED|Overall Study||8
205276|NCT01281007|496363|P1|NOT COMPLETED|Overall Study||4
205277|NCT01281007|496362|P2|COMPLETED|Overall Study||67
205278|NCT01281007|496363|P1|COMPLETED|Overall Study||71
205279|NCT01281007|496362|P2|STARTED|Overall Study||75
205280|NCT01281007|496363|P1|STARTED|Overall Study||75
205281|NCT01280981|496369|P1|NOT COMPLETED|Overall Study||92
205282|NCT01280981|496369|P1|COMPLETED|Overall Study||196
205283|NCT01280981|496369|P1|Intent to Treat (ITT) Population|Overall Study|Participants who took drug during at least one menstrual cycle|260
205284|NCT01280981|496369|P1|STARTED|Overall Study||288
205285|NCT01280968|496380|P2|NOT COMPLETED|Overall Study||3
205286|NCT01280968|496381|P1|NOT COMPLETED|Overall Study||18
205287|NCT01280968|496380|P2|COMPLETED|Overall Study||4
205288|NCT01280968|496381|P1|COMPLETED|Overall Study||27
205289|NCT01280968|496380|P2|STARTED|Overall Study||7
205290|NCT01280968|496381|P1|STARTED|Overall Study||45
205291|NCT01280955|496397|P1|NOT COMPLETED|Overall Study||3
205292|NCT01280955|496397|P1|COMPLETED|Overall Study||27
205293|NCT01280955|496397|P1|STARTED|Overall Study||30
205294|NCT01280942|496430|P2|NOT COMPLETED|Overall Study||0
205295|NCT01280942|496431|P1|NOT COMPLETED|Overall Study||0
205296|NCT01280942|496430|P2|COMPLETED|Overall Study||9911
205297|NCT01280942|496431|P1|COMPLETED|Overall Study||10120
205298|NCT01280942|496430|P2|STARTED|Overall Study||9911
205299|NCT01280942|496431|P1|STARTED|Overall Study||10120
205300|NCT01280903|496441|P2|NOT COMPLETED|Overall Study||16
205301|NCT01280903|496442|P1|NOT COMPLETED|Overall Study||23
205302|NCT01280903|496441|P2|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|75
205303|NCT01280903|496442|P1|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|68
205304|NCT01280903|496441|P2|STARTED|Overall Study||91
205305|NCT01280903|496442|P1|STARTED|Overall Study||91
205306|NCT01280721|496506|P1|NOT COMPLETED|Overall Study||22
205307|NCT01280721|496506|P1|COMPLETED|Overall Study||113
205308|NCT01280721|496506|P1|STARTED|Overall Study||135
205309|NCT01280695|496526|P5|NOT COMPLETED|Overall Study||2
205310|NCT01280695|496527|P4|NOT COMPLETED|Overall Study||4
205311|NCT01280695|496528|P3|NOT COMPLETED|Overall Study||5
205312|NCT01280695|496529|P2|NOT COMPLETED|Overall Study||1
205313|NCT01280695|496530|P1|NOT COMPLETED|Overall Study||0
205314|NCT01280695|496526|P5|COMPLETED|Overall Study||24
205315|NCT01280695|496527|P4|COMPLETED|Overall Study||22
205316|NCT01280695|496528|P3|COMPLETED|Overall Study||21
205317|NCT01280695|496529|P2|COMPLETED|Overall Study||24
205318|NCT01280695|496530|P1|COMPLETED|Overall Study||26
205319|NCT01280695|496526|P5|STARTED|Overall Study||26
205320|NCT01280695|496527|P4|STARTED|Overall Study||26
205321|NCT01280695|496528|P3|STARTED|Overall Study||26
205322|NCT01280695|496529|P2|STARTED|Overall Study||25
205323|NCT01280695|496530|P1|STARTED|Overall Study||26
205324|NCT01280656|496570|P3|NOT COMPLETED|Overall Study||63
205325|NCT01280656|496571|P2|NOT COMPLETED|Overall Study||47
205326|NCT01280656|496572|P1|NOT COMPLETED|Overall Study||3
205327|NCT01280656|496570|P3|COMPLETED|Overall Study||223
205328|NCT01280656|496571|P2|COMPLETED|Overall Study||265
205329|NCT01280656|496572|P1|COMPLETED|Overall Study||59
205330|NCT01280656|496570|P3|STARTED|Overall Study||286
205331|NCT01280656|496571|P2|STARTED|Overall Study||312
205332|NCT01280656|496572|P1|STARTED|Overall Study||62
205333|NCT01280604|496618|P2|NOT COMPLETED|Overall Study||5
205334|NCT01280604|496619|P1|NOT COMPLETED|Overall Study||9
205335|NCT01280604|496618|P2|COMPLETED|Overall Study||28
205336|NCT01280604|496619|P1|COMPLETED|Overall Study||24
205337|NCT01280604|496618|P2|Subjects Meeting All Inclusion Criteria|Overall Study||29
205338|NCT01280604|496619|P1|Subjects Meeting All Inclusion Criteria|Overall Study||25
205339|NCT01280604|496618|P2|STARTED|Overall Study||33
205340|NCT01280604|496619|P1|STARTED|Overall Study||33
205341|NCT01280591|496639|P4|NOT COMPLETED|Overall Study||3
205342|NCT01280591|496640|P3|NOT COMPLETED|Overall Study||0
205343|NCT01280591|496641|P2|NOT COMPLETED|Overall Study||0
205344|NCT01280591|496642|P1|NOT COMPLETED|Overall Study||0
205345|NCT01280591|496639|P4|COMPLETED|Overall Study||99
205346|NCT01280591|496640|P3|COMPLETED|Overall Study||203
205347|NCT01280591|496641|P2|COMPLETED|Overall Study||204
205348|NCT01280591|496642|P1|COMPLETED|Overall Study||203
205349|NCT01280591|496639|P4|STARTED|Overall Study||102
205350|NCT01280591|496640|P3|STARTED|Overall Study||203
205351|NCT01280591|496641|P2|STARTED|Overall Study||204
205352|NCT01280591|496642|P1|STARTED|Overall Study||203
205353|NCT01280552|496734|P2|NOT COMPLETED|Overall Study||1
205354|NCT01280552|496735|P1|NOT COMPLETED|Overall Study||6
205355|NCT01280552|496734|P2|COMPLETED|Overall Study||42
205356|NCT01280552|496735|P1|COMPLETED|Overall Study|Survival is still being assessed|75
205357|NCT01280552|496734|P2|STARTED|Overall Study||43
205358|NCT01280552|496735|P1|STARTED|Overall Study||81
205359|NCT01280409|496749|P2|NOT COMPLETED|Overall Study||19
205360|NCT01280409|496750|P1|NOT COMPLETED|Overall Study||16
205361|NCT01280409|496749|P2|COMPLETED|Overall Study||36
205362|NCT01280409|496750|P1|COMPLETED|Overall Study||43
205363|NCT01280409|496749|P2|STARTED|Overall Study||55
205364|NCT01280409|496750|P1|STARTED|Overall Study||59
205365|NCT01280357|496780|P1|NOT COMPLETED|Overall Study||26
205366|NCT01280357|496780|P1|COMPLETED|Overall Study||34
205367|NCT01280357|496780|P1|STARTED|Overall Study||60
205368|NCT01280266|496789|P2|NOT COMPLETED|Second Intervention (Week 5-9)||0
205369|NCT01280266|496790|P1|NOT COMPLETED|Second Intervention (Week 5-9)||0
205370|NCT01280266|496789|P2|COMPLETED|Second Intervention (Week 5-9)||12
205371|NCT01280266|496790|P1|COMPLETED|Second Intervention (Week 5-9)||14
205372|NCT01280266|496789|P2|STARTED|Second Intervention (Week 5-9)||12
205373|NCT01280266|496790|P1|STARTED|Second Intervention (Week 5-9)||14
205374|NCT01280266|496789|P2|NOT COMPLETED|Washout Period (Week 4-5)||0
205375|NCT01280266|496790|P1|NOT COMPLETED|Washout Period (Week 4-5)||0
205376|NCT01280266|496789|P2|COMPLETED|Washout Period (Week 4-5)||12
205377|NCT01280266|496790|P1|COMPLETED|Washout Period (Week 4-5)||14
205378|NCT01280266|496789|P2|STARTED|Washout Period (Week 4-5)||12
205379|NCT01280266|496790|P1|STARTED|Washout Period (Week 4-5)||14
205380|NCT01280266|496789|P2|NOT COMPLETED|First Intervention (Week 1-4)||2
205381|NCT01280266|496790|P1|NOT COMPLETED|First Intervention (Week 1-4)||1
205382|NCT01280266|496789|P2|COMPLETED|First Intervention (Week 1-4)||12
205383|NCT01280266|496790|P1|COMPLETED|First Intervention (Week 1-4)||14
205384|NCT01280266|496789|P2|STARTED|First Intervention (Week 1-4)||14
205385|NCT01280266|496790|P1|STARTED|First Intervention (Week 1-4)||15
205386|NCT01280201|496812|P1|NOT COMPLETED|Overall Study||0
205387|NCT01280201|496812|P1|COMPLETED|Overall Study||44
205388|NCT01280201|496812|P1|STARTED|Overall Study||44
205389|NCT01280123|496824|P3|NOT COMPLETED|Overall Study||1
205390|NCT01280123|496825|P2|NOT COMPLETED|Overall Study||4
205391|NCT01280123|496826|P1|NOT COMPLETED|Overall Study||1
205392|NCT01280123|496824|P3|COMPLETED|Overall Study||70
205393|NCT01280123|496825|P2|COMPLETED|Overall Study||63
205394|NCT01280123|496826|P1|COMPLETED|Overall Study||71
205395|NCT01280123|496824|P3|STARTED|Overall Study||71
205396|NCT01280123|496825|P2|STARTED|Overall Study||67
205397|NCT01280123|496826|P1|STARTED|Overall Study||72
205398|NCT01280110|496851|P2|NOT COMPLETED|Overall Study||0
205399|NCT01280110|496852|P1|NOT COMPLETED|Overall Study||0
205400|NCT01280110|496851|P2|COMPLETED|Overall Study||22
205401|NCT01280110|496852|P1|COMPLETED|Overall Study||22
205402|NCT01280110|496851|P2|STARTED|Overall Study||22
205403|NCT01280110|496852|P1|STARTED|Overall Study||22
205404|NCT01280058|496862|P2|NOT COMPLETED|Overall Study||0
205405|NCT01280058|496863|P1|NOT COMPLETED|Overall Study||0
205406|NCT01280058|496862|P2|COMPLETED|Overall Study||37
205407|NCT01280058|496863|P1|COMPLETED|Overall Study||36
205408|NCT01280058|496862|P2|STARTED|Overall Study||37
205409|NCT01280058|496863|P1|STARTED|Overall Study||36
205410|NCT01279954|496881|P2|NOT COMPLETED|Overall Study||4
205411|NCT01279954|496882|P1|NOT COMPLETED|Overall Study||3
205412|NCT01279954|496881|P2|COMPLETED|Overall Study||1
205413|NCT01279954|496882|P1|COMPLETED|Overall Study||2
205414|NCT01279954|496881|P2|STARTED|Overall Study||5
205415|NCT01279954|496882|P1|STARTED|Overall Study||5
205416|NCT01279850|496893|P1|NOT COMPLETED|Overall Study||91
205417|NCT01279850|496893|P1|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|800
205418|NCT01279850|496893|P1|STARTED|Overall Study||891
205419|NCT01279681|496909|P2|NOT COMPLETED|Overall Study||17
205420|NCT01279681|496910|P1|NOT COMPLETED|Overall Study||15
205421|NCT01279681|496909|P2|COMPLETED|Overall Study||0
205422|NCT01279681|496910|P1|COMPLETED|Overall Study||0
205423|NCT01279681|496909|P2|STARTED|Overall Study||17
205424|NCT01279681|496910|P1|STARTED|Overall Study||15
205425|NCT01279616|496922|P1|NOT COMPLETED|Overall Study||7
205426|NCT01279616|496922|P1|COMPLETED|Overall Study||1
205427|NCT01279616|496922|P1|STARTED|Overall Study||8
205428|NCT01279564|496928|P2|NOT COMPLETED|Overall Study||0
205429|NCT01279564|496929|P1|NOT COMPLETED|Overall Study||0
205430|NCT01279564|496928|P2|COMPLETED|Overall Study||32
205431|NCT01279564|496929|P1|COMPLETED|Overall Study||40
205432|NCT01279564|496928|P2|STARTED|Overall Study||32
205433|NCT01279564|496929|P1|STARTED|Overall Study||40
205434|NCT01279486|496935|P1|NOT COMPLETED|Overall Study||1
205435|NCT01279486|496935|P1|COMPLETED|Overall Study|1 result questionnaire was not returned so 119 volunteers results were used for consumer accuracy.|119
205436|NCT01279486|496935|P1|STARTED|Overall Study||120
205437|NCT01279447|496941|P2|NOT COMPLETED|Overall Study||1
205438|NCT01279447|496942|P1|NOT COMPLETED|Overall Study||3
205439|NCT01279447|496941|P2|COMPLETED|Overall Study||33
205440|NCT01279447|496942|P1|COMPLETED|Overall Study||31
205441|NCT01279447|496941|P2|STARTED|Overall Study||34
205442|NCT01279447|496942|P1|STARTED|Overall Study||34
205443|NCT01279343|496950|P2|NOT COMPLETED|Overall Study||6
205444|NCT01279343|496951|P1|NOT COMPLETED|Overall Study||2
205445|NCT01279343|496950|P2|COMPLETED|Overall Study||58
205446|NCT01279343|496951|P1|COMPLETED|Overall Study||57
205447|NCT01279343|496950|P2|STARTED|Overall Study||64
205448|NCT01279343|496951|P1|STARTED|Overall Study||59
205449|NCT01279317|496975|P2|NOT COMPLETED|Period 2||0
205450|NCT01279317|496976|P1|NOT COMPLETED|Period 2||0
205451|NCT01279317|496975|P2|COMPLETED|Period 2||6
205452|NCT01279317|496976|P1|COMPLETED|Period 2||6
205453|NCT01279317|496975|P2|STARTED|Period 2||6
205454|NCT01279317|496976|P1|STARTED|Period 2||6
205455|NCT01279317|496975|P2|NOT COMPLETED|Washout||0
205456|NCT01279317|496976|P1|NOT COMPLETED|Washout||0
205457|NCT01279317|496975|P2|COMPLETED|Washout||6
205458|NCT01279317|496976|P1|COMPLETED|Washout||6
205459|NCT01279317|496975|P2|STARTED|Washout||6
205460|NCT01279317|496976|P1|STARTED|Washout||6
205461|NCT01279317|496975|P2|NOT COMPLETED|Period 1||0
205462|NCT01279317|496976|P1|NOT COMPLETED|Period 1||0
205463|NCT01279317|496975|P2|COMPLETED|Period 1||6
205464|NCT01279317|496976|P1|COMPLETED|Period 1||6
205465|NCT01279317|496975|P2|STARTED|Period 1||6
205466|NCT01279317|496976|P1|STARTED|Period 1||6
205467|NCT01279265|496983|P2|NOT COMPLETED|Overall Study||6
205468|NCT01279265|496984|P1|NOT COMPLETED|Overall Study||4
205469|NCT01279265|496983|P2|COMPLETED|Overall Study||11
205470|NCT01279265|496984|P1|COMPLETED|Overall Study||9
205471|NCT01279265|496983|P2|STARTED|Overall Study||17
205472|NCT01279265|496984|P1|STARTED|Overall Study||13
205473|NCT01279200|496996|P2|NOT COMPLETED|Overall Study||7
205474|NCT01279200|496997|P1|NOT COMPLETED|Overall Study||2
205475|NCT01279200|496996|P2|COMPLETED|Overall Study||4
205476|NCT01279200|496997|P1|COMPLETED|Overall Study||8
205477|NCT01279200|496996|P2|STARTED|Overall Study||11
205478|NCT01279200|496997|P1|STARTED|Overall Study||10
205479|NCT01279187|497007|P2|NOT COMPLETED|Overall Study||0
205480|NCT01279187|497008|P1|NOT COMPLETED|Overall Study||0
205481|NCT01279187|497007|P2|COMPLETED|Overall Study||13
205482|NCT01279187|497008|P1|COMPLETED|Overall Study||14
205483|NCT01279187|497007|P2|STARTED|Overall Study||13
205484|NCT01279187|497008|P1|STARTED|Overall Study||14
205485|NCT01279109|497024|P2|NOT COMPLETED|Overall Study||12
205486|NCT01279109|497025|P1|NOT COMPLETED|Overall Study||13
205487|NCT01279109|497024|P2|COMPLETED|Overall Study||55
205488|NCT01279109|497025|P1|COMPLETED|Overall Study||55
205489|NCT01279109|497024|P2|STARTED|Overall Study||67
205490|NCT01279109|497025|P1|STARTED|Overall Study||68
205491|NCT01279070|497035|P2|NOT COMPLETED|Overall Study||4
205492|NCT01279070|497036|P1|NOT COMPLETED|Overall Study||5
205493|NCT01279070|497035|P2|COMPLETED|Overall Study|4 outpatients left the leisure group up to 2 months after starting Leisure group.|24
205494|NCT01279070|497036|P1|COMPLETED|Overall Study|5 outpatients left the treatment up to 2 months after starting REPYFLEC.|29
205495|NCT01279070|497035|P2|STARTED|Overall Study|28 outpatients were randomly assigned to 32 sessions of leisure group.|28
205496|NCT01279070|497036|P1|STARTED|Overall Study|34 outpatients were randomly assigned to 32 sessions of REPYFLEC.|34
205497|NCT01279044|497055|P3|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||3
205498|NCT01279044|497056|P2|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||11
205499|NCT01279044|497057|P1|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||0
205500|NCT01279044|497055|P3|COMPLETED|PHASE 2 - Randmonized Controlled Trial||161
205501|NCT01279044|497056|P2|COMPLETED|PHASE 2 - Randmonized Controlled Trial||151
205502|NCT01279044|497057|P1|COMPLETED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
205503|NCT01279044|497055|P3|STARTED|PHASE 2 - Randmonized Controlled Trial||164
205504|NCT01279044|497056|P2|STARTED|PHASE 2 - Randmonized Controlled Trial||162
205505|NCT01279044|497057|P1|STARTED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
205506|NCT01279044|497055|P3|NOT COMPLETED|PHASE 1 - Formative||0
205507|NCT01279044|497056|P2|NOT COMPLETED|PHASE 1 - Formative||0
205508|NCT01279044|497057|P1|NOT COMPLETED|PHASE 1 - Formative||0
205600|NCT01278407|497216|P5|STARTED|Confirmatory Phase||0
205509|NCT01279044|497055|P3|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
205510|NCT01279044|497056|P2|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
205511|NCT01279044|497057|P1|COMPLETED|PHASE 1 - Formative||59
205512|NCT01279044|497055|P3|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
205513|NCT01279044|497056|P2|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
205514|NCT01279044|497057|P1|STARTED|PHASE 1 - Formative||59
205515|NCT01278953|497077|P2|NOT COMPLETED|Overall Study||11
205516|NCT01278953|497078|P1|NOT COMPLETED|Overall Study||9
205517|NCT01278953|497077|P2|COMPLETED|Overall Study||134
205518|NCT01278953|497078|P1|COMPLETED|Overall Study||146
205519|NCT01278953|497077|P2|STARTED|Overall Study||145
205520|NCT01278953|497078|P1|STARTED|Overall Study||155
205521|NCT01278927|497090|P4|NOT COMPLETED|Overall Study||0
205522|NCT01278927|497091|P3|NOT COMPLETED|Overall Study||0
205523|NCT01278927|497092|P2|NOT COMPLETED|Overall Study||0
205524|NCT01278927|497093|P1|NOT COMPLETED|Overall Study||0
205525|NCT01278927|497090|P4|COMPLETED|Overall Study||175
205526|NCT01278927|497091|P3|COMPLETED|Overall Study||178
205527|NCT01278927|497092|P2|COMPLETED|Overall Study||178
205528|NCT01278927|497093|P1|COMPLETED|Overall Study||180
205529|NCT01278927|497090|P4|STARTED|Overall Study||175
205530|NCT01278927|497091|P3|STARTED|Overall Study||178
205531|NCT01278927|497092|P2|STARTED|Overall Study||178
205532|NCT01278927|497093|P1|STARTED|Overall Study||180
205533|NCT01278862|497133|P2|NOT COMPLETED|Overall Study||1
205534|NCT01278862|497134|P1|NOT COMPLETED|Overall Study||1
205535|NCT01278862|497133|P2|COMPLETED|Overall Study||42
205536|NCT01278862|497134|P1|COMPLETED|Overall Study||44
205537|NCT01278862|497133|P2|STARTED|Overall Study||43
205538|NCT01278862|497134|P1|STARTED|Overall Study||45
205539|NCT01278797|497142|P2|NOT COMPLETED|Period 2||0
205540|NCT01278797|497143|P1|NOT COMPLETED|Period 2||0
205541|NCT01278797|497142|P2|COMPLETED|Period 2||13
205542|NCT01278797|497143|P1|COMPLETED|Period 2||13
205543|NCT01278797|497142|P2|STARTED|Period 2||13
205544|NCT01278797|497143|P1|STARTED|Period 2||13
205545|NCT01278797|497142|P2|NOT COMPLETED|Washout Period of 21 Days||0
205546|NCT01278797|497143|P1|NOT COMPLETED|Washout Period of 21 Days||0
205547|NCT01278797|497142|P2|COMPLETED|Washout Period of 21 Days||13
205548|NCT01278797|497143|P1|COMPLETED|Washout Period of 21 Days||13
205549|NCT01278797|497142|P2|STARTED|Washout Period of 21 Days||13
205550|NCT01278797|497143|P1|STARTED|Washout Period of 21 Days||13
205551|NCT01278797|497142|P2|NOT COMPLETED|Period 1||1
205552|NCT01278797|497143|P1|NOT COMPLETED|Period 1||1
205553|NCT01278797|497142|P2|COMPLETED|Period 1||13
205554|NCT01278797|497143|P1|COMPLETED|Period 1||13
205555|NCT01278797|497142|P2|STARTED|Period 1||14
205556|NCT01278797|497143|P1|STARTED|Period 1||14
205557|NCT01278745|497155|P4|NOT COMPLETED|Overall Study||78
205558|NCT01278745|497156|P3|NOT COMPLETED|Overall Study||121
205559|NCT01278745|497157|P2|NOT COMPLETED|Overall Study||6
205560|NCT01278745|497158|P1|NOT COMPLETED|Overall Study||5
205561|NCT01278745|497155|P4|COMPLETED|Overall Study||0
205562|NCT01278745|497156|P3|COMPLETED|Overall Study||0
205563|NCT01278745|497157|P2|COMPLETED|Overall Study||68
205564|NCT01278745|497158|P1|COMPLETED|Overall Study||84
205565|NCT01278745|497155|P4|STARTED|Overall Study||78
205566|NCT01278745|497156|P3|STARTED|Overall Study||121
205567|NCT01278745|497157|P2|STARTED|Overall Study||74
205568|NCT01278745|497158|P1|STARTED|Overall Study||89
205569|NCT01278615|497190|P1|NOT COMPLETED|Overall Study||2
205570|NCT01278615|497190|P1|COMPLETED|Overall Study||14
205571|NCT01278615|497190|P1|STARTED|Overall Study||16
205572|NCT01278485|497200|P1|NOT COMPLETED|Overall Study||0
205573|NCT01278485|497200|P1|COMPLETED|Overall Study||719
205574|NCT01278485|497200|P1|STARTED|Overall Study||719
205575|NCT01278407|497216|P5|NOT COMPLETED|Extension Phase||30
205576|NCT01278407|497217|P4|NOT COMPLETED|Extension Phase||12
205577|NCT01278407|497218|P3|NOT COMPLETED|Extension Phase||0
205578|NCT01278407|497219|P2|NOT COMPLETED|Extension Phase||0
205579|NCT01278407|497220|P1|NOT COMPLETED|Extension Phase||0
205580|NCT01278407|497216|P5|COMPLETED|Extension Phase||66
205581|NCT01278407|497217|P4|COMPLETED|Extension Phase||34
205582|NCT01278407|497218|P3|COMPLETED|Extension Phase||0
205583|NCT01278407|497219|P2|COMPLETED|Extension Phase||0
205584|NCT01278407|497220|P1|COMPLETED|Extension Phase||0
205585|NCT01278407|497216|P5|STARTED|Extension Phase||96
205586|NCT01278407|497217|P4|STARTED|Extension Phase||46
205587|NCT01278407|497218|P3|STARTED|Extension Phase||0
205588|NCT01278407|497219|P2|STARTED|Extension Phase||0
205589|NCT01278407|497220|P1|STARTED|Extension Phase||0
205590|NCT01278407|497216|P5|NOT COMPLETED|Confirmatory Phase||0
205591|NCT01278407|497217|P4|NOT COMPLETED|Confirmatory Phase||0
205592|NCT01278407|497218|P3|NOT COMPLETED|Confirmatory Phase||6
205593|NCT01278407|497219|P2|NOT COMPLETED|Confirmatory Phase||16
205594|NCT01278407|497220|P1|NOT COMPLETED|Confirmatory Phase||9
205595|NCT01278407|497216|P5|COMPLETED|Confirmatory Phase||0
205596|NCT01278407|497217|P4|COMPLETED|Confirmatory Phase||0
205597|NCT01278407|497218|P3|COMPLETED|Confirmatory Phase||43
205598|NCT01278407|497219|P2|COMPLETED|Confirmatory Phase||31
205599|NCT01278407|497220|P1|COMPLETED|Confirmatory Phase||37
205601|NCT01278407|497217|P4|STARTED|Confirmatory Phase||0
205602|NCT01278407|497218|P3|STARTED|Confirmatory Phase||49
205603|NCT01278407|497219|P2|STARTED|Confirmatory Phase||47
205604|NCT01278407|497220|P1|STARTED|Confirmatory Phase||46
205605|NCT01278394|497233|P1|NOT COMPLETED|Overall Study||1
205606|NCT01278394|497233|P1|COMPLETED|Overall Study||28
205607|NCT01278394|497233|P1|STARTED|Overall Study||29
205608|NCT01278342|497246|P3|NOT COMPLETED|Overall Study||0
205609|NCT01278342|497247|P2|NOT COMPLETED|Overall Study||1
205610|NCT01278342|497248|P1|NOT COMPLETED|Overall Study||4
205611|NCT01278342|497246|P3|COMPLETED|Overall Study||32
205612|NCT01278342|497247|P2|COMPLETED|Overall Study||30
205613|NCT01278342|497248|P1|COMPLETED|Overall Study||3
205614|NCT01278342|497246|P3|STARTED|Overall Study||32
205615|NCT01278342|497247|P2|STARTED|Overall Study||31
205616|NCT01278342|497248|P1|STARTED|Overall Study||7
205617|NCT01278303|497262|P1|NOT COMPLETED|Overall Study||0
205618|NCT01278303|497262|P1|COMPLETED|Overall Study||82
205619|NCT01278303|497262|P1|STARTED|Overall Study||82
205620|NCT01278173|497268|P1|NOT COMPLETED|Overall Study||27
205621|NCT01278173|497268|P1|COMPLETED|Overall Study||38
205622|NCT01278173|497268|P1|STARTED|Overall Study||65
205623|NCT01278160|497275|P2|NOT COMPLETED|Overall Study||6
205624|NCT01278160|497276|P1|NOT COMPLETED|Overall Study||5
205625|NCT01278160|497275|P2|COMPLETED|Overall Study||84
205626|NCT01278160|497276|P1|COMPLETED|Overall Study||84
205627|NCT01278160|497275|P2|STARTED|Overall Study||90
205628|NCT01278160|497276|P1|STARTED|Overall Study||89
205629|NCT01278030|497292|P2|NOT COMPLETED|Overall Study||4
205630|NCT01278030|497293|P1|NOT COMPLETED|Overall Study||8
205631|NCT01278030|497292|P2|COMPLETED|Overall Study||31
205632|NCT01278030|497293|P1|COMPLETED|Overall Study||35
205633|NCT01278030|497292|P2|STARTED|Overall Study||35
205634|NCT01278030|497293|P1|STARTED|Overall Study||43
205635|NCT01277887|497301|P2|NOT COMPLETED|Post-Quit Treatment Phase||5
205636|NCT01277887|497302|P1|NOT COMPLETED|Post-Quit Treatment Phase||3
205637|NCT01277887|497301|P2|COMPLETED|Post-Quit Treatment Phase||5
205638|NCT01277887|497302|P1|COMPLETED|Post-Quit Treatment Phase||3
205639|NCT01277887|497301|P2|STARTED|Post-Quit Treatment Phase||10
205640|NCT01277887|497302|P1|STARTED|Post-Quit Treatment Phase||6
205641|NCT01277887|497301|P2|NOT COMPLETED|Pre-Quit Treatment Phase||0
205642|NCT01277887|497302|P1|NOT COMPLETED|Pre-Quit Treatment Phase||3
205643|NCT01277887|497301|P2|COMPLETED|Pre-Quit Treatment Phase||10
205644|NCT01277887|497302|P1|COMPLETED|Pre-Quit Treatment Phase||6
205645|NCT01277887|497301|P2|Entered Study|Pre-Quit Treatment Phase||10
205646|NCT01277887|497302|P1|Entered Study|Pre-Quit Treatment Phase||7
205647|NCT01277887|497301|P2|STARTED|Pre-Quit Treatment Phase||10
205648|NCT01277887|497302|P1|STARTED|Pre-Quit Treatment Phase||9
205649|NCT01277861|497314|P2|NOT COMPLETED|Overall Study||2
205650|NCT01277861|497315|P1|NOT COMPLETED|Overall Study||2
205651|NCT01277861|497314|P2|COMPLETED|Overall Study||47
205652|NCT01277861|497315|P1|COMPLETED|Overall Study||49
205653|NCT01277861|497314|P2|STARTED|Overall Study||49
205654|NCT01277861|497315|P1|STARTED|Overall Study||51
205655|NCT01277822|497327|P2|NOT COMPLETED|Overall Study||11
205656|NCT01277822|497328|P1|NOT COMPLETED|Overall Study||15
205657|NCT01277822|497327|P2|COMPLETED|Overall Study||155
205658|NCT01277822|497328|P1|COMPLETED|Overall Study||153
205659|NCT01277822|497327|P2|STARTED|Overall Study||166
205660|NCT01277822|497328|P1|STARTED|Overall Study||168
205661|NCT01277783|497348|P1|NOT COMPLETED|Overall Study||0
205662|NCT01277783|497348|P1|COMPLETED|Overall Study||138
205663|NCT01277783|497348|P1|STARTED|Overall Study||138
205664|NCT01277757|497364|P1|NOT COMPLETED|Overall Study||2
205665|NCT01277757|497364|P1|COMPLETED|Overall Study||28
205666|NCT01277757|497364|P1|STARTED|Overall Study||30
205667|NCT01277744|497371|P1|NOT COMPLETED|Overall Study||2
205668|NCT01277744|497371|P1|COMPLETED|Overall Study||20
205669|NCT01277744|497371|P1|STARTED|Overall Study||22
205670|NCT01277718|497376|P2|NOT COMPLETED|Period 3 - Third Intervention||0
205671|NCT01277718|497377|P1|NOT COMPLETED|Period 3 - Third Intervention||0
205672|NCT01277718|497376|P2|COMPLETED|Period 3 - Third Intervention||7
205673|NCT01277718|497377|P1|COMPLETED|Period 3 - Third Intervention||10
205674|NCT01277718|497376|P2|STARTED|Period 3 - Third Intervention||7
205675|NCT01277718|497377|P1|STARTED|Period 3 - Third Intervention||10
205676|NCT01277718|497376|P2|NOT COMPLETED|Washout Period of 13 Days||0
205677|NCT01277718|497377|P1|NOT COMPLETED|Washout Period of 13 Days||0
205678|NCT01277718|497376|P2|COMPLETED|Washout Period of 13 Days||7
205679|NCT01277718|497377|P1|COMPLETED|Washout Period of 13 Days||10
205680|NCT01277718|497376|P2|STARTED|Washout Period of 13 Days||7
205681|NCT01277718|497377|P1|STARTED|Washout Period of 13 Days||10
205682|NCT01277718|497376|P2|NOT COMPLETED|Period 2 - Second Intervention||3
205683|NCT01277718|497377|P1|NOT COMPLETED|Period 2 - Second Intervention||0
205684|NCT01277718|497376|P2|COMPLETED|Period 2 - Second Intervention||7
205685|NCT01277718|497377|P1|COMPLETED|Period 2 - Second Intervention||10
205686|NCT01277718|497376|P2|STARTED|Period 2 - Second Intervention||10
205687|NCT01277718|497377|P1|STARTED|Period 2 - Second Intervention||10
205688|NCT01277718|497376|P2|NOT COMPLETED|Washout Period of 13 Days||0
205689|NCT01277718|497377|P1|NOT COMPLETED|Washout Period of 13 Days||0
205690|NCT01277718|497376|P2|COMPLETED|Washout Period of 13 Days||10
205691|NCT01277718|497377|P1|COMPLETED|Washout Period of 13 Days||10
205692|NCT01277718|497376|P2|STARTED|Washout Period of 13 Days||10
205693|NCT01277718|497377|P1|STARTED|Washout Period of 13 Days||10
205694|NCT01277718|497376|P2|NOT COMPLETED|Period 1 - First Intervention||0
205695|NCT01277718|497377|P1|NOT COMPLETED|Period 1 - First Intervention||0
205696|NCT01277718|497376|P2|COMPLETED|Period 1 - First Intervention||10
205697|NCT01277718|497377|P1|COMPLETED|Period 1 - First Intervention||10
205698|NCT01277718|497376|P2|STARTED|Period 1 - First Intervention||10
205699|NCT01277718|497377|P1|STARTED|Period 1 - First Intervention||10
205700|NCT01277666|497391|P3|NOT COMPLETED|Overall Study||49
205701|NCT01277666|497392|P2|NOT COMPLETED|Overall Study||59
205702|NCT01277666|497393|P1|NOT COMPLETED|Overall Study||45
205703|NCT01277666|497391|P3|COMPLETED|Overall Study||153
205704|NCT01277666|497392|P2|COMPLETED|Overall Study||144
205705|NCT01277666|497393|P1|COMPLETED|Overall Study||158
205706|NCT01277666|497391|P3|STARTED|Overall Study||202
205707|NCT01277666|497392|P2|STARTED|Overall Study||203
205708|NCT01277666|497393|P1|STARTED|Overall Study||203
205709|NCT01277601|497426|P4|NOT COMPLETED|Overall Study||36
205710|NCT01277601|497427|P3|NOT COMPLETED|Overall Study||27
205711|NCT01277601|497428|P2|NOT COMPLETED|Overall Study||48
205712|NCT01277601|497429|P1|NOT COMPLETED|Overall Study||37
205713|NCT01277601|497426|P4|COMPLETED|Overall Study||150
205714|NCT01277601|497427|P3|COMPLETED|Overall Study||163
205715|NCT01277601|497428|P2|COMPLETED|Overall Study||139
205716|NCT01277601|497429|P1|COMPLETED|Overall Study||151
205717|NCT01277601|497426|P4|STARTED|Overall Study||186
205718|NCT01277601|497427|P3|STARTED|Overall Study||190
205719|NCT01277601|497428|P2|STARTED|Overall Study||187
205720|NCT01277601|497429|P1|STARTED|Overall Study||188
205721|NCT01277549|497520|P2|NOT COMPLETED|Overall Study||14
205722|NCT01277549|497521|P1|NOT COMPLETED|Overall Study||26
205723|NCT01277549|497520|P2|COMPLETED|Overall Study||15
205724|NCT01277549|497521|P1|COMPLETED|Overall Study||15
205725|NCT01277549|497520|P2|STARTED|Overall Study||29
205726|NCT01277549|497521|P1|STARTED|Overall Study||41
205727|NCT01277523|497538|P3|NOT COMPLETED|Overall Study||0
205728|NCT01277523|497539|P2|NOT COMPLETED|Overall Study||1
205729|NCT01277523|497540|P1|NOT COMPLETED|Overall Study||3
205730|NCT01277523|497538|P3|COMPLETED|Overall Study||130
205731|NCT01277523|497539|P2|COMPLETED|Overall Study||126
205732|NCT01277523|497540|P1|COMPLETED|Overall Study||132
205733|NCT01277523|497538|P3|STARTED|Overall Study||130
205734|NCT01277523|497539|P2|STARTED|Overall Study||127
205735|NCT01277523|497540|P1|STARTED|Overall Study||135
205736|NCT01277510|497592|P2|NOT COMPLETED|Open-label Phase||3
205737|NCT01277510|497593|P1|NOT COMPLETED|Open-label Phase||7
205738|NCT01277510|497592|P2|COMPLETED|Open-label Phase|Completed investigational product|1
205739|NCT01277510|497593|P1|COMPLETED|Open-label Phase|Completed investigational product|1
205740|NCT01277510|497592|P2|Received Investigational Product|Open-label Phase||4
205741|NCT01277510|497593|P1|Received Investigational Product|Open-label Phase||6
205742|NCT01277510|497592|P2|STARTED|Open-label Phase||4
205743|NCT01277510|497593|P1|STARTED|Open-label Phase||8
205744|NCT01277510|497592|P2|NOT COMPLETED|Double-blind Phase||18
205745|NCT01277510|497593|P1|NOT COMPLETED|Double-blind Phase||13
205746|NCT01277510|497592|P2|COMPLETED|Double-blind Phase|Completed investigational product|4
205747|NCT01277510|497593|P1|COMPLETED|Double-blind Phase|Completed investigational product|8
205748|NCT01277510|497592|P2|Received Investigational Product|Double-blind Phase||22
205749|NCT01277510|497593|P1|Received Investigational Product|Double-blind Phase||21
205750|NCT01277510|497592|P2|STARTED|Double-blind Phase||22
205751|NCT01277510|497593|P1|STARTED|Double-blind Phase||21
205752|NCT01277354|497617|P2|NOT COMPLETED|Overall Study||0
205753|NCT01277354|497618|P1|NOT COMPLETED|Overall Study||0
205754|NCT01277354|497617|P2|COMPLETED|Overall Study||1
205755|NCT01277354|497618|P1|COMPLETED|Overall Study||1
205756|NCT01277354|497617|P2|STARTED|Overall Study||1
205757|NCT01277354|497618|P1|STARTED|Overall Study||1
205758|NCT01277302|497627|P3|NOT COMPLETED|8-Month Alternate Dose Regimen Period||6
205759|NCT01277302|497628|P2|NOT COMPLETED|8-Month Alternate Dose Regimen Period||4
205760|NCT01277302|497629|P1|NOT COMPLETED|8-Month Alternate Dose Regimen Period||5
205761|NCT01277302|497627|P3|COMPLETED|8-Month Alternate Dose Regimen Period||13
205762|NCT01277302|497628|P2|COMPLETED|8-Month Alternate Dose Regimen Period||82
205763|NCT01277302|497629|P1|COMPLETED|8-Month Alternate Dose Regimen Period||80
205764|NCT01277302|497627|P3|STARTED|8-Month Alternate Dose Regimen Period||19
205765|NCT01277302|497628|P2|STARTED|8-Month Alternate Dose Regimen Period||86
205766|NCT01277302|497629|P1|STARTED|8-Month Alternate Dose Regimen Period||85
205767|NCT01277302|497627|P3|NOT COMPLETED|7-Month Fixed Treatment Period||12
205768|NCT01277302|497628|P2|NOT COMPLETED|7-Month Fixed Treatment Period||0
205769|NCT01277302|497629|P1|NOT COMPLETED|7-Month Fixed Treatment Period||0
205770|NCT01277302|497627|P3|COMPLETED|7-Month Fixed Treatment Period||19
205771|NCT01277302|497628|P2|COMPLETED|7-Month Fixed Treatment Period||86
205772|NCT01277302|497629|P1|COMPLETED|7-Month Fixed Treatment Period||85
205773|NCT01277302|497627|P3|STARTED|7-Month Fixed Treatment Period||31
205774|NCT01277302|497628|P2|STARTED|7-Month Fixed Treatment Period||86
205775|NCT01277302|497629|P1|STARTED|7-Month Fixed Treatment Period||85
205776|NCT01277211|497661|P2|NOT COMPLETED|Overall Study||63
205777|NCT01277211|497662|P1|NOT COMPLETED|Overall Study||150
205778|NCT01277211|497661|P2|COMPLETED|Overall Study||182
205779|NCT01277211|497662|P1|COMPLETED|Overall Study||588
205780|NCT01277211|497661|P2|Treated|Overall Study||232
205781|NCT01277211|497662|P1|Treated|Overall Study||714
205782|NCT01277211|497661|P2|STARTED|Overall Study||245
205783|NCT01277211|497662|P1|STARTED|Overall Study||738
205784|NCT01277159|497677|P5|NOT COMPLETED|Overall Study||5
205785|NCT01277159|497678|P4|NOT COMPLETED|Overall Study||3
205786|NCT01277159|497679|P3|NOT COMPLETED|Overall Study||3
205787|NCT01277159|497680|P2|NOT COMPLETED|Overall Study||1
205788|NCT01277159|497681|P1|NOT COMPLETED|Overall Study||4
205789|NCT01277159|497677|P5|COMPLETED|Overall Study||16
205790|NCT01277159|497678|P4|COMPLETED|Overall Study||19
205791|NCT01277159|497679|P3|COMPLETED|Overall Study||19
205792|NCT01277159|497680|P2|COMPLETED|Overall Study||21
205793|NCT01277159|497681|P1|COMPLETED|Overall Study||17
205794|NCT01277159|497677|P5|STARTED|Overall Study||21
205795|NCT01277159|497678|P4|STARTED|Overall Study||22
205796|NCT01277159|497679|P3|STARTED|Overall Study||22
205797|NCT01277159|497680|P2|STARTED|Overall Study||22
205798|NCT01277159|497681|P1|STARTED|Overall Study||21
205799|NCT01277081|497695|P2|NOT COMPLETED|Overall Study||0
205800|NCT01277081|497696|P1|NOT COMPLETED|Overall Study||0
205801|NCT01277081|497695|P2|COMPLETED|Overall Study||100
205802|NCT01277081|497696|P1|COMPLETED|Overall Study||100
205803|NCT01277081|497695|P2|STARTED|Overall Study||100
205804|NCT01277081|497696|P1|STARTED|Overall Study||100
205805|NCT01277042|497714|P2|NOT COMPLETED|Overall Study||5
205806|NCT01277042|497715|P1|NOT COMPLETED|Overall Study||8
205807|NCT01277042|497714|P2|COMPLETED|Overall Study||601
205808|NCT01277042|497715|P1|COMPLETED|Overall Study||598
205809|NCT01277042|497714|P2|STARTED|Overall Study||606
205810|NCT01277042|497715|P1|STARTED|Overall Study||606
205811|NCT01276847|497740|P3|NOT COMPLETED|Overall Study||0
205812|NCT01276847|497741|P2|NOT COMPLETED|Overall Study||0
205813|NCT01276847|497742|P1|NOT COMPLETED|Overall Study||1
205814|NCT01276847|497740|P3|COMPLETED|Overall Study||20
205815|NCT01276847|497741|P2|COMPLETED|Overall Study||10
205816|NCT01276847|497742|P1|COMPLETED|Overall Study||9
205817|NCT01276847|497740|P3|STARTED|Overall Study||20
205818|NCT01276847|497741|P2|STARTED|Overall Study||10
205819|NCT01276847|497742|P1|STARTED|Overall Study||10
205820|NCT01276821|497752|P2|NOT COMPLETED|Overall Study||1
205821|NCT01276821|497753|P1|NOT COMPLETED|Overall Study||0
205822|NCT01276821|497752|P2|COMPLETED|Overall Study||49
205823|NCT01276821|497753|P1|COMPLETED|Overall Study||50
205824|NCT01276821|497752|P2|STARTED|Overall Study||50
205825|NCT01276821|497753|P1|STARTED|Overall Study||50
205826|NCT01276756|497773|P2|NOT COMPLETED|Overall Study||2
205827|NCT01276756|497774|P1|NOT COMPLETED|Overall Study||5
205828|NCT01276756|497773|P2|COMPLETED|Overall Study||48
205829|NCT01276756|497774|P1|COMPLETED|Overall Study||45
205830|NCT01276756|497773|P2|STARTED|Overall Study||50
205831|NCT01276756|497774|P1|STARTED|Overall Study||50
205832|NCT01276652|497791|P3|NOT COMPLETED|Period 2: Observational||0
205833|NCT01276652|497792|P2|NOT COMPLETED|Period 2: Observational||0
205834|NCT01276652|497793|P1|NOT COMPLETED|Period 2: Observational||0
205835|NCT01276652|497791|P3|COMPLETED|Period 2: Observational||5
205836|NCT01276652|497792|P2|COMPLETED|Period 2: Observational||8
205837|NCT01276652|497793|P1|COMPLETED|Period 2: Observational||9
205838|NCT01276652|497791|P3|STARTED|Period 2: Observational|Subjects were only enrolled in the Observational arm during Period 2.|5
205839|NCT01276652|497792|P2|STARTED|Period 2: Observational||8
205840|NCT01276652|497793|P1|STARTED|Period 2: Observational||9
205841|NCT01276652|497791|P3|NOT COMPLETED|Period 1: Randomization||0
205842|NCT01276652|497792|P2|NOT COMPLETED|Period 1: Randomization||0
205843|NCT01276652|497793|P1|NOT COMPLETED|Period 1: Randomization||0
205844|NCT01276652|497791|P3|COMPLETED|Period 1: Randomization||0
205845|NCT01276652|497792|P2|COMPLETED|Period 1: Randomization||8
205846|NCT01276652|497793|P1|COMPLETED|Period 1: Randomization||9
205847|NCT01276652|497791|P3|STARTED|Period 1: Randomization|No subjects were enrolled in this arm during Period 1.|0
205848|NCT01276652|497792|P2|STARTED|Period 1: Randomization||8
205849|NCT01276652|497793|P1|STARTED|Period 1: Randomization||9
205850|NCT01276639|497819|P5|NOT COMPLETED|Week 16 to 52||21
205851|NCT01276639|497820|P4|NOT COMPLETED|Week 16 to 52||16
205852|NCT01276639|497821|P3|NOT COMPLETED|Week 16 to 52||0
205853|NCT01276639|497822|P2|NOT COMPLETED|Week 16 to 52||101
205854|NCT01276639|497823|P1|NOT COMPLETED|Week 16 to 52||127
205855|NCT01276639|497819|P5|COMPLETED|Week 16 to 52||45
205856|NCT01276639|497820|P4|COMPLETED|Week 16 to 52||50
205857|NCT01276639|497821|P3|COMPLETED|Week 16 to 52||0
205858|NCT01276639|497822|P2|COMPLETED|Week 16 to 52||219
205859|NCT01276639|497823|P1|COMPLETED|Week 16 to 52||186
205860|NCT01276639|497819|P5|STARTED|Week 16 to 52||66
205861|NCT01276639|497820|P4|STARTED|Week 16 to 52||66
205862|NCT01276639|497821|P3|STARTED|Week 16 to 52||0
205863|NCT01276639|497822|P2|STARTED|Week 16 to 52||320
205864|NCT01276639|497823|P1|STARTED|Week 16 to 52||313
205865|NCT01276639|497819|P5|NOT COMPLETED|Week 0 to 16||0
205866|NCT01276639|497820|P4|NOT COMPLETED|Week 0 to 16||0
205867|NCT01276639|497821|P3|NOT COMPLETED|Week 0 to 16||45
205868|NCT01276639|497822|P2|NOT COMPLETED|Week 0 to 16||41
205869|NCT01276639|497823|P1|NOT COMPLETED|Week 0 to 16||50
205870|NCT01276639|497819|P5|COMPLETED|Week 0 to 16||0
205871|NCT01276639|497820|P4|COMPLETED|Week 0 to 16||0
205872|NCT01276639|497821|P3|COMPLETED|Week 0 to 16||132
205873|NCT01276639|497822|P2|COMPLETED|Week 0 to 16||320
205874|NCT01276639|497823|P1|COMPLETED|Week 0 to 16||313
205875|NCT01276639|497819|P5|Treated|Week 0 to 16||0
205876|NCT01276639|497820|P4|Treated|Week 0 to 16||0
205877|NCT01276639|497821|P3|Treated|Week 0 to 16||177
205878|NCT01276639|497822|P2|Treated|Week 0 to 16||360
205879|NCT01276639|497823|P1|Treated|Week 0 to 16||363
205880|NCT01276639|497819|P5|STARTED|Week 0 to 16||0
205881|NCT01276639|497820|P4|STARTED|Week 0 to 16||0
205882|NCT01276639|497821|P3|STARTED|Week 0 to 16||177
205883|NCT01276639|497822|P2|STARTED|Week 0 to 16||361
205884|NCT01276639|497823|P1|STARTED|Week 0 to 16||363
205885|NCT01276535|498018|P1|NOT COMPLETED|Overall Study||0
205886|NCT01276535|498018|P1|COMPLETED|Overall Study||12
205887|NCT01276535|498018|P1|STARTED|Overall Study||12
205888|NCT01276509|498028|P4|NOT COMPLETED|Overall Study||5
205889|NCT01276509|498029|P3|NOT COMPLETED|Overall Study||5
205890|NCT01276509|498030|P2|NOT COMPLETED|Overall Study||12
205891|NCT01276509|498031|P1|NOT COMPLETED|Overall Study||13
205892|NCT01276509|498028|P4|COMPLETED|Overall Study||58
205893|NCT01276509|498029|P3|COMPLETED|Overall Study||63
205894|NCT01276509|498030|P2|COMPLETED|Overall Study||53
205895|NCT01276509|498031|P1|COMPLETED|Overall Study||53
205896|NCT01276509|498028|P4|STARTED|Overall Study||63
205897|NCT01276509|498029|P3|STARTED|Overall Study||68
205898|NCT01276509|498030|P2|STARTED|Overall Study||65
205899|NCT01276509|498031|P1|STARTED|Overall Study||66
205900|NCT01276457|498084|P2|NOT COMPLETED|Extension Study||2
205901|NCT01276457|498085|P1|NOT COMPLETED|Extension Study||6
205902|NCT01276457|498084|P2|COMPLETED|Extension Study||110
205903|NCT01276457|498085|P1|COMPLETED|Extension Study||105
205904|NCT01276457|498084|P2|STARTED|Extension Study||112
205905|NCT01276457|498085|P1|STARTED|Extension Study||111
205906|NCT01276457|498084|P2|NOT COMPLETED|Core Study||20
205907|NCT01276457|498085|P1|NOT COMPLETED|Core Study||13
205908|NCT01276457|498084|P2|COMPLETED|Core Study||123
205909|NCT01276457|498085|P1|COMPLETED|Core Study||129
205910|NCT01276457|498084|P2|STARTED|Core Study||143
205911|NCT01276457|498085|P1|STARTED|Core Study||142
205912|NCT01276353|498099|P2|NOT COMPLETED|Extension||9
205913|NCT01276353|498100|P1|NOT COMPLETED|Extension||7
205914|NCT01276353|498099|P2|COMPLETED|Extension||14
205915|NCT01276353|498100|P1|COMPLETED|Extension||12
205916|NCT01276353|498099|P2|STARTED|Extension||23
205917|NCT01276353|498100|P1|STARTED|Extension||19
205918|NCT01276353|498099|P2|NOT COMPLETED|Double-blind||0
205919|NCT01276353|498100|P1|NOT COMPLETED|Double-blind||3
205920|NCT01276353|498099|P2|COMPLETED|Double-blind||23
205921|NCT01276353|498100|P1|COMPLETED|Double-blind||19
205922|NCT01276353|498099|P2|STARTED|Double-blind||23
205923|NCT01276353|498100|P1|STARTED|Double-blind||22
205924|NCT01276327|498112|P2|NOT COMPLETED|Overall Study||3
205925|NCT01276327|498113|P1|NOT COMPLETED|Overall Study||2
205926|NCT01276327|498112|P2|COMPLETED|Overall Study||29
205927|NCT01276327|498113|P1|COMPLETED|Overall Study||30
205928|NCT01276327|498112|P2|STARTED|Overall Study||32
205929|NCT01276327|498113|P1|STARTED|Overall Study||32
205930|NCT01276314|498139|P4|NOT COMPLETED|Overall Study||5
205931|NCT01276314|498140|P3|NOT COMPLETED|Overall Study||4
205932|NCT01276314|498141|P2|NOT COMPLETED|Overall Study||10
205933|NCT01276314|498142|P1|NOT COMPLETED|Overall Study||10
205934|NCT01276314|498139|P4|COMPLETED|Overall Study||17
205935|NCT01276314|498140|P3|COMPLETED|Overall Study||18
205936|NCT01276314|498141|P2|COMPLETED|Overall Study||33
205937|NCT01276314|498142|P1|COMPLETED|Overall Study||38
205938|NCT01276314|498139|P4|STARTED|Overall Study||22
205939|NCT01276314|498140|P3|STARTED|Overall Study||22
205940|NCT01276314|498141|P2|STARTED|Overall Study||43
205941|NCT01276314|498142|P1|STARTED|Overall Study||48
205942|NCT01276301|498152|P2|NOT COMPLETED|Second Intervention||0
205943|NCT01276301|498153|P1|NOT COMPLETED|Second Intervention||0
205944|NCT01276301|498152|P2|COMPLETED|Second Intervention||8
205945|NCT01276301|498153|P1|COMPLETED|Second Intervention||8
205946|NCT01276301|498152|P2|STARTED|Second Intervention||8
205947|NCT01276301|498153|P1|STARTED|Second Intervention||8
205948|NCT01276301|498152|P2|NOT COMPLETED|Washout Period of 7 Days||0
205949|NCT01276301|498153|P1|NOT COMPLETED|Washout Period of 7 Days||0
205950|NCT01276301|498152|P2|COMPLETED|Washout Period of 7 Days||8
205951|NCT01276301|498153|P1|COMPLETED|Washout Period of 7 Days||8
205952|NCT01276301|498152|P2|STARTED|Washout Period of 7 Days||8
205953|NCT01276301|498153|P1|STARTED|Washout Period of 7 Days||8
205954|NCT01276301|498152|P2|NOT COMPLETED|First Intervention||0
205955|NCT01276301|498153|P1|NOT COMPLETED|First Intervention||0
205956|NCT01276301|498152|P2|COMPLETED|First Intervention||8
205957|NCT01276301|498153|P1|COMPLETED|First Intervention||8
205958|NCT01276301|498152|P2|STARTED|First Intervention||8
205959|NCT01276301|498153|P1|STARTED|First Intervention||8
205960|NCT01276288|498180|P4|NOT COMPLETED|Overall Study||0
205961|NCT01276288|498181|P3|NOT COMPLETED|Overall Study||0
205962|NCT01276288|498182|P2|NOT COMPLETED|Overall Study||1
205963|NCT01276288|498183|P1|NOT COMPLETED|Overall Study||2
205964|NCT01276288|498180|P4|COMPLETED|Overall Study||5
205965|NCT01276288|498181|P3|COMPLETED|Overall Study||5
205966|NCT01276288|498182|P2|COMPLETED|Overall Study||5
205967|NCT01276288|498183|P1|COMPLETED|Overall Study||5
205968|NCT01276288|498180|P4|Received EMPA+TOR|Overall Study||5
205969|NCT01276288|498181|P3|Received EMPA+TOR|Overall Study||5
205970|NCT01276288|498182|P2|Received EMPA+TOR|Overall Study||0
205971|NCT01276288|498183|P1|Received EMPA+TOR|Overall Study||0
205972|NCT01276288|498180|P4|Received EMPA+HCT|Overall Study||0
205973|NCT01276288|498181|P3|Received EMPA+HCT|Overall Study||0
205974|NCT01276288|498182|P2|Received EMPA+HCT|Overall Study||5
205975|NCT01276288|498183|P1|Received EMPA+HCT|Overall Study||5
205976|NCT01276288|498180|P4|Received EMPA|Overall Study||5
205977|NCT01276288|498181|P3|Received EMPA|Overall Study||5
205978|NCT01276288|498182|P2|Received EMPA|Overall Study||5
205979|NCT01276288|498183|P1|Received EMPA|Overall Study||6
205980|NCT01276288|498180|P4|STARTED|Overall Study||5
205981|NCT01276288|498181|P3|STARTED|Overall Study||5
205982|NCT01276288|498182|P2|STARTED|Overall Study||6
205983|NCT01276288|498183|P1|STARTED|Overall Study||7
205984|NCT01276223|498310|P3|NOT COMPLETED|Overall Study||3
205985|NCT01276223|498311|P2|NOT COMPLETED|Overall Study||4
205986|NCT01276223|498312|P1|NOT COMPLETED|Overall Study||11
205987|NCT01276223|498310|P3|COMPLETED|Overall Study||101
205988|NCT01276223|498311|P2|COMPLETED|Overall Study||103
205989|NCT01276223|498312|P1|COMPLETED|Overall Study||67
205990|NCT01276223|498310|P3|STARTED|Overall Study||104
205991|NCT01276223|498311|P2|STARTED|Overall Study||107
205992|NCT01276223|498312|P1|STARTED|Overall Study||78
205993|NCT01276197|498321|P2|NOT COMPLETED|Overall Study||110
205994|NCT01276197|498322|P1|NOT COMPLETED|Overall Study||108
205995|NCT01276197|498321|P2|COMPLETED|Overall Study||200
205996|NCT01276197|498322|P1|COMPLETED|Overall Study||200
205997|NCT01276197|498321|P2|STARTED|Overall Study||310
205998|NCT01276197|498322|P1|STARTED|Overall Study||308
205999|NCT01276171|498333|P3|NOT COMPLETED|Overall Study||0
206000|NCT01276171|498334|P2|NOT COMPLETED|Overall Study||0
206001|NCT01276171|498335|P1|NOT COMPLETED|Overall Study||0
206002|NCT01276171|498333|P3|COMPLETED|Overall Study||256
206003|NCT01276171|498334|P2|COMPLETED|Overall Study||244
206004|NCT01276171|498335|P1|COMPLETED|Overall Study||249
206005|NCT01276171|498333|P3|STARTED|Overall Study||256
206006|NCT01276171|498334|P2|STARTED|Overall Study||244
206007|NCT01276171|498335|P1|STARTED|Overall Study||249
206008|NCT01276106|498353|P4|NOT COMPLETED|Overall Study||13
206009|NCT01276106|498354|P3|NOT COMPLETED|Overall Study||16
206010|NCT01276106|498355|P2|NOT COMPLETED|Overall Study||9
206011|NCT01276106|498356|P1|NOT COMPLETED|Overall Study||12
206012|NCT01276106|498353|P4|COMPLETED|Overall Study||52
206013|NCT01276106|498354|P3|COMPLETED|Overall Study||49
206014|NCT01276106|498355|P2|COMPLETED|Overall Study||55
206015|NCT01276106|498356|P1|COMPLETED|Overall Study||53
206016|NCT01276106|498353|P4|STARTED|Overall Study||65
206017|NCT01276106|498354|P3|STARTED|Overall Study||65
206018|NCT01276106|498355|P2|STARTED|Overall Study||64
206019|NCT01276106|498356|P1|STARTED|Overall Study||65
206020|NCT01276054|498368|P2|NOT COMPLETED|Overall Study||2
206021|NCT01276054|498369|P1|NOT COMPLETED|Overall Study||2
206022|NCT01276054|498368|P2|COMPLETED|Overall Study||0
206023|NCT01276054|498369|P1|COMPLETED|Overall Study||0
206024|NCT01276054|498368|P2|STARTED|Overall Study||2
206025|NCT01276054|498369|P1|STARTED|Overall Study||2
206026|NCT01275833|498377|P2|NOT COMPLETED|Overall Study||1
206027|NCT01275833|498378|P1|NOT COMPLETED|Overall Study||1
206028|NCT01275833|498377|P2|COMPLETED|Overall Study||0
206029|NCT01275833|498378|P1|COMPLETED|Overall Study||0
206030|NCT01275833|498377|P2|STARTED|Overall Study||1
206031|NCT01275833|498378|P1|STARTED|Overall Study||1
206032|NCT01275755|498386|P2|NOT COMPLETED|Run-out Placebo Period||0
206033|NCT01275755|498387|P1|NOT COMPLETED|Run-out Placebo Period||1
206034|NCT01275755|498386|P2|COMPLETED|Run-out Placebo Period||37
206035|NCT01275755|498387|P1|COMPLETED|Run-out Placebo Period||38
206036|NCT01275755|498386|P2|STARTED|Run-out Placebo Period||37
206037|NCT01275755|498387|P1|STARTED|Run-out Placebo Period||39
206038|NCT01275755|498386|P2|NOT COMPLETED|Double-blind Treatment Period||3
206039|NCT01275755|498387|P1|NOT COMPLETED|Double-blind Treatment Period||2
206040|NCT01275755|498386|P2|COMPLETED|Double-blind Treatment Period||37
206041|NCT01275755|498387|P1|COMPLETED|Double-blind Treatment Period||39
206042|NCT01275755|498386|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||40
206043|NCT01275755|498387|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||41
206044|NCT01275755|498386|P2|STARTED|Double-blind Treatment Period||40
206045|NCT01275755|498387|P1|STARTED|Double-blind Treatment Period||41
206046|NCT01275755|498386|P2|NOT COMPLETED|Run-in Placebo Period||0
206047|NCT01275755|498387|P1|NOT COMPLETED|Run-in Placebo Period||0
206048|NCT01275755|498386|P2|COMPLETED|Run-in Placebo Period||40
206049|NCT01275755|498387|P1|COMPLETED|Run-in Placebo Period||41
206050|NCT01275755|498386|P2|STARTED|Run-in Placebo Period||40
206051|NCT01275755|498387|P1|STARTED|Run-in Placebo Period||41
206052|NCT01275664|498393|P1|NOT COMPLETED|Overall Study||0
206053|NCT01275664|498393|P1|COMPLETED|Overall Study||4
206054|NCT01275664|498393|P1|STARTED|Overall Study||4
206055|NCT01275625|498401|P1|NOT COMPLETED|Overall Study||13
206056|NCT01275625|498401|P1|COMPLETED|Overall Study||64
206057|NCT01275625|498401|P1|Treated|Overall Study||77
206058|NCT01275625|498401|P1|STARTED|Overall Study||77
206059|NCT01275586|498415|P1|NOT COMPLETED|Overall Study||3
206060|NCT01275586|498415|P1|COMPLETED|Overall Study||3
206061|NCT01275586|498415|P1|STARTED|Overall Study||6
206062|NCT01275430|498419|P1|NOT COMPLETED|Overall Study||9
206063|NCT01275430|498419|P1|COMPLETED|Overall Study||18
206064|NCT01275430|498419|P1|STARTED|Overall Study||27
206065|NCT01275365|498431|P4|NOT COMPLETED|Overall Study||3
206066|NCT01275365|498432|P3|NOT COMPLETED|Overall Study||5
206067|NCT01275365|498433|P2|NOT COMPLETED|Overall Study||3
206068|NCT01275365|498434|P1|NOT COMPLETED|Overall Study||3
206069|NCT01275365|498431|P4|COMPLETED|Overall Study||19
206070|NCT01275365|498432|P3|COMPLETED|Overall Study||17
206071|NCT01275365|498433|P2|COMPLETED|Overall Study||21
206072|NCT01275365|498434|P1|COMPLETED|Overall Study||21
206073|NCT01275365|498431|P4|STARTED|Overall Study||22
206074|NCT01275365|498432|P3|STARTED|Overall Study||22
206075|NCT01275365|498433|P2|STARTED|Overall Study||24
206076|NCT01275365|498434|P1|STARTED|Overall Study||24
206077|NCT01275339|498484|P4|NOT COMPLETED|Overall Study||0
206078|NCT01275339|498485|P3|NOT COMPLETED|Overall Study||1
206079|NCT01275339|498486|P2|NOT COMPLETED|Overall Study||0
206080|NCT01275339|498487|P1|NOT COMPLETED|Overall Study||1
206081|NCT01275339|498484|P4|COMPLETED|Overall Study||4
206082|NCT01275339|498485|P3|COMPLETED|Overall Study||3
206083|NCT01275339|498486|P2|COMPLETED|Overall Study||0
206084|NCT01275339|498487|P1|COMPLETED|Overall Study||1
206085|NCT01275339|498484|P4|STARTED|Overall Study||4
206086|NCT01275339|498485|P3|STARTED|Overall Study||4
206087|NCT01275339|498486|P2|STARTED|Overall Study||0
206088|NCT01275339|498487|P1|STARTED|Overall Study||2
206089|NCT01275313|498499|P2|NOT COMPLETED|Overall Study||52
206090|NCT01275313|498500|P1|NOT COMPLETED|Overall Study||25
206091|NCT01275313|498499|P2|COMPLETED|Overall Study||79
206092|NCT01275313|498500|P1|COMPLETED|Overall Study||102
206093|NCT01275313|498499|P2|STARTED|Overall Study||131
206094|NCT01275313|498500|P1|STARTED|Overall Study||127
206095|NCT01275196|498508|P2|NOT COMPLETED|Overall Study||21
206096|NCT01275196|498509|P1|NOT COMPLETED|Overall Study||20
206097|NCT01275196|498508|P2|COMPLETED|Overall Study||113
206098|NCT01275196|498509|P1|COMPLETED|Overall Study||113
206099|NCT01275196|498508|P2|Intended to Continue Into Extension|Overall Study||113
206100|NCT01275196|498509|P1|Intended to Continue Into Extension|Overall Study||112
206101|NCT01275196|498508|P2|STARTED|Overall Study||134
206102|NCT01275196|498509|P1|STARTED|Overall Study||133
206103|NCT01275170|498556|P8|NOT COMPLETED|Part 2: Period 2||0
206104|NCT01275170|498557|P7|NOT COMPLETED|Part 2: Period 2||0
206105|NCT01275170|498558|P6|NOT COMPLETED|Part 2: Period 2||0
206106|NCT01275170|498559|P5|NOT COMPLETED|Part 2: Period 2||0
206107|NCT01275170|498560|P4|NOT COMPLETED|Part 2: Period 2||0
206108|NCT01275170|498561|P3|NOT COMPLETED|Part 2: Period 2||0
206109|NCT01275170|498562|P2|NOT COMPLETED|Part 2: Period 2||0
206110|NCT01275170|498563|P1|NOT COMPLETED|Part 2: Period 2||0
206111|NCT01275170|498556|P8|COMPLETED|Part 2: Period 2||6
206112|NCT01275170|498557|P7|COMPLETED|Part 2: Period 2||6
206113|NCT01275170|498558|P6|COMPLETED|Part 2: Period 2||0
206114|NCT01275170|498559|P5|COMPLETED|Part 2: Period 2||0
206115|NCT01275170|498560|P4|COMPLETED|Part 2: Period 2||0
206116|NCT01275170|498561|P3|COMPLETED|Part 2: Period 2||0
206117|NCT01275170|498562|P2|COMPLETED|Part 2: Period 2||0
206118|NCT01275170|498563|P1|COMPLETED|Part 2: Period 2||0
206119|NCT01275170|498556|P8|STARTED|Part 2: Period 2||6
206120|NCT01275170|498557|P7|STARTED|Part 2: Period 2||6
206121|NCT01275170|498558|P6|STARTED|Part 2: Period 2|Panel F participated in Part 1, Period 1 and Part 2, Period 1.|0
206122|NCT01275170|498559|P5|STARTED|Part 2: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
206123|NCT01275170|498560|P4|STARTED|Part 2: Period 2||0
206124|NCT01275170|498561|P3|STARTED|Part 2: Period 2||0
206125|NCT01275170|498562|P2|STARTED|Part 2: Period 2||0
206126|NCT01275170|498563|P1|STARTED|Part 2: Period 2||0
206127|NCT01275170|498556|P8|NOT COMPLETED|Part 2: Period 1||0
206128|NCT01275170|498557|P7|NOT COMPLETED|Part 2: Period 1||0
206129|NCT01275170|498558|P6|NOT COMPLETED|Part 2: Period 1||0
206130|NCT01275170|498559|P5|NOT COMPLETED|Part 2: Period 1||0
206131|NCT01275170|498560|P4|NOT COMPLETED|Part 2: Period 1||0
206132|NCT01275170|498561|P3|NOT COMPLETED|Part 2: Period 1||0
206133|NCT01275170|498562|P2|NOT COMPLETED|Part 2: Period 1||0
206134|NCT01275170|498563|P1|NOT COMPLETED|Part 2: Period 1||0
206135|NCT01275170|498556|P8|COMPLETED|Part 2: Period 1||6
206136|NCT01275170|498557|P7|COMPLETED|Part 2: Period 1||6
206137|NCT01275170|498558|P6|COMPLETED|Part 2: Period 1||6
206138|NCT01275170|498559|P5|COMPLETED|Part 2: Period 1||6
206139|NCT01275170|498560|P4|COMPLETED|Part 2: Period 1||0
206140|NCT01275170|498561|P3|COMPLETED|Part 2: Period 1||0
206141|NCT01275170|498562|P2|COMPLETED|Part 2: Period 1||0
206142|NCT01275170|498563|P1|COMPLETED|Part 2: Period 1||0
206143|NCT01275170|498556|P8|STARTED|Part 2: Period 1||6
206144|NCT01275170|498557|P7|STARTED|Part 2: Period 1||6
206145|NCT01275170|498558|P6|STARTED|Part 2: Period 1||6
206146|NCT01275170|498559|P5|STARTED|Part 2: Period 1||6
206147|NCT01275170|498560|P4|STARTED|Part 2: Period 1||0
206148|NCT01275170|498561|P3|STARTED|Part 2: Period 1||0
206149|NCT01275170|498562|P2|STARTED|Part 2: Period 1||0
206150|NCT01275170|498563|P1|STARTED|Part 2: Period 1||0
206151|NCT01275170|498556|P8|NOT COMPLETED|Part 1: Period 2||0
206152|NCT01275170|498557|P7|NOT COMPLETED|Part 1: Period 2||0
206153|NCT01275170|498558|P6|NOT COMPLETED|Part 1: Period 2||0
206154|NCT01275170|498559|P5|NOT COMPLETED|Part 1: Period 2||0
206155|NCT01275170|498560|P4|NOT COMPLETED|Part 1: Period 2||0
206156|NCT01275170|498561|P3|NOT COMPLETED|Part 1: Period 2||0
206157|NCT01275170|498562|P2|NOT COMPLETED|Part 1: Period 2||0
206158|NCT01275170|498563|P1|NOT COMPLETED|Part 1: Period 2||0
206159|NCT01275170|498556|P8|COMPLETED|Part 1: Period 2||6
206160|NCT01275170|498557|P7|COMPLETED|Part 1: Period 2||6
206161|NCT01275170|498558|P6|COMPLETED|Part 1: Period 2||0
206162|NCT01275170|498559|P5|COMPLETED|Part 1: Period 2||0
206163|NCT01275170|498560|P4|COMPLETED|Part 1: Period 2||0
206164|NCT01275170|498561|P3|COMPLETED|Part 1: Period 2||0
206165|NCT01275170|498562|P2|COMPLETED|Part 1: Period 2||0
206166|NCT01275170|498563|P1|COMPLETED|Part 1: Period 2||0
206167|NCT01275170|498556|P8|STARTED|Part 1: Period 2||6
206168|NCT01275170|498557|P7|STARTED|Part 1: Period 2||6
206169|NCT01275170|498558|P6|STARTED|Part 1: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
206170|NCT01275170|498559|P5|STARTED|Part 1: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
206171|NCT01275170|498560|P4|STARTED|Part 1: Period 2|Panel D participated in Part 1, Period 1 only.|0
206172|NCT01275170|498561|P3|STARTED|Part 1: Period 2|Panel C participated in Part 1, Period 1 only.|0
206173|NCT01275170|498562|P2|STARTED|Part 1: Period 2|Panel B participated in Part 1, Period 1 only.|0
206174|NCT01275170|498563|P1|STARTED|Part 1: Period 2|Panel A participated in Part 1, Period 1 only.|0
206175|NCT01275170|498556|P8|NOT COMPLETED|Part 1: Period 1||0
206176|NCT01275170|498557|P7|NOT COMPLETED|Part 1: Period 1||0
206177|NCT01275170|498558|P6|NOT COMPLETED|Part 1: Period 1||0
206178|NCT01275170|498559|P5|NOT COMPLETED|Part 1: Period 1||0
206179|NCT01275170|498560|P4|NOT COMPLETED|Part 1: Period 1||0
206180|NCT01275170|498561|P3|NOT COMPLETED|Part 1: Period 1||0
206181|NCT01275170|498562|P2|NOT COMPLETED|Part 1: Period 1||0
206182|NCT01275170|498563|P1|NOT COMPLETED|Part 1: Period 1||1
206183|NCT01275170|498556|P8|COMPLETED|Part 1: Period 1||6
206184|NCT01275170|498557|P7|COMPLETED|Part 1: Period 1||6
206185|NCT01275170|498558|P6|COMPLETED|Part 1: Period 1||6
206186|NCT01275170|498559|P5|COMPLETED|Part 1: Period 1||6
206187|NCT01275170|498560|P4|COMPLETED|Part 1: Period 1||6
206188|NCT01275170|498561|P3|COMPLETED|Part 1: Period 1||6
206189|NCT01275170|498562|P2|COMPLETED|Part 1: Period 1||6
206190|NCT01275170|498563|P1|COMPLETED|Part 1: Period 1||6
206191|NCT01275170|498556|P8|Treated|Part 1: Period 1||6
206192|NCT01275170|498557|P7|Treated|Part 1: Period 1||6
206193|NCT01275170|498558|P6|Treated|Part 1: Period 1||6
206194|NCT01275170|498559|P5|Treated|Part 1: Period 1||6
206195|NCT01275170|498560|P4|Treated|Part 1: Period 1||6
206196|NCT01275170|498561|P3|Treated|Part 1: Period 1||6
206197|NCT01275170|498562|P2|Treated|Part 1: Period 1||6
206198|NCT01275170|498563|P1|Treated|Part 1: Period 1||6
206199|NCT01275170|498556|P8|STARTED|Part 1: Period 1||6
206200|NCT01275170|498557|P7|STARTED|Part 1: Period 1||6
206201|NCT01275170|498558|P6|STARTED|Part 1: Period 1||6
206202|NCT01275170|498559|P5|STARTED|Part 1: Period 1||6
206203|NCT01275170|498560|P4|STARTED|Part 1: Period 1||6
206204|NCT01275170|498561|P3|STARTED|Part 1: Period 1||6
206205|NCT01275170|498562|P2|STARTED|Part 1: Period 1||6
206206|NCT01275170|498563|P1|STARTED|Part 1: Period 1||7
206207|NCT01275144|498781|P2|NOT COMPLETED|Second Intervention (6 Days)||0
206208|NCT01275144|498782|P1|NOT COMPLETED|Second Intervention (6 Days)||1
206209|NCT01275144|498781|P2|COMPLETED|Second Intervention (6 Days)||14
206210|NCT01275144|498782|P1|COMPLETED|Second Intervention (6 Days)||13
206211|NCT01275144|498781|P2|STARTED|Second Intervention (6 Days)||14
206212|NCT01275144|498782|P1|STARTED|Second Intervention (6 Days)||14
206213|NCT01275144|498781|P2|NOT COMPLETED|Washout (7 Days)||0
206214|NCT01275144|498782|P1|NOT COMPLETED|Washout (7 Days)||0
206215|NCT01275144|498781|P2|COMPLETED|Washout (7 Days)||14
206216|NCT01275144|498782|P1|COMPLETED|Washout (7 Days)||14
206217|NCT01275144|498781|P2|STARTED|Washout (7 Days)||14
206218|NCT01275144|498782|P1|STARTED|Washout (7 Days)||14
206219|NCT01275144|498781|P2|NOT COMPLETED|First Intervention (6 Days)||0
206220|NCT01275144|498782|P1|NOT COMPLETED|First Intervention (6 Days)||0
206221|NCT01275144|498781|P2|COMPLETED|First Intervention (6 Days)||14
206222|NCT01275144|498782|P1|COMPLETED|First Intervention (6 Days)||14
206223|NCT01275144|498781|P2|Received at Least 1 Dose of Study Drug|First Intervention (6 Days)||14
206224|NCT01275144|498782|P1|Received at Least 1 Dose of Study Drug|First Intervention (6 Days)||14
206225|NCT01275144|498781|P2|STARTED|First Intervention (6 Days)||14
206226|NCT01275144|498782|P1|STARTED|First Intervention (6 Days)||14
206227|NCT01275131|498840|P4|NOT COMPLETED|Period 2 (Crossover)||2
206228|NCT01275131|498841|P3|NOT COMPLETED|Period 2 (Crossover)||1
206229|NCT01275131|498842|P2|NOT COMPLETED|Period 2 (Crossover)||1
206230|NCT01275131|498843|P1|NOT COMPLETED|Period 2 (Crossover)||1
206231|NCT01275131|498840|P4|COMPLETED|Period 2 (Crossover)||8
206232|NCT01275131|498841|P3|COMPLETED|Period 2 (Crossover)||9
206233|NCT01275131|498842|P2|COMPLETED|Period 2 (Crossover)||8
206234|NCT01275131|498843|P1|COMPLETED|Period 2 (Crossover)||8
206235|NCT01275131|498840|P4|STARTED|Period 2 (Crossover)||10
206236|NCT01275131|498841|P3|STARTED|Period 2 (Crossover)||10
206237|NCT01275131|498842|P2|STARTED|Period 2 (Crossover)||9
206238|NCT01275131|498843|P1|STARTED|Period 2 (Crossover)||9
206239|NCT01275131|498840|P4|NOT COMPLETED|5- to 14-Day Washout Period||0
206240|NCT01275131|498841|P3|NOT COMPLETED|5- to 14-Day Washout Period||0
206241|NCT01275131|498842|P2|NOT COMPLETED|5- to 14-Day Washout Period||0
206242|NCT01275131|498843|P1|NOT COMPLETED|5- to 14-Day Washout Period||0
206243|NCT01275131|498840|P4|COMPLETED|5- to 14-Day Washout Period||10
206244|NCT01275131|498841|P3|COMPLETED|5- to 14-Day Washout Period||10
206245|NCT01275131|498842|P2|COMPLETED|5- to 14-Day Washout Period||9
206246|NCT01275131|498843|P1|COMPLETED|5- to 14-Day Washout Period||9
206247|NCT01275131|498840|P4|STARTED|5- to 14-Day Washout Period||10
206248|NCT01275131|498841|P3|STARTED|5- to 14-Day Washout Period||10
206249|NCT01275131|498842|P2|STARTED|5- to 14-Day Washout Period||9
206250|NCT01275131|498843|P1|STARTED|5- to 14-Day Washout Period||9
206251|NCT01275131|498840|P4|NOT COMPLETED|Period 1||2
206252|NCT01275131|498841|P3|NOT COMPLETED|Period 1||3
206253|NCT01275131|498842|P2|NOT COMPLETED|Period 1||0
206254|NCT01275131|498843|P1|NOT COMPLETED|Period 1||2
206255|NCT01275131|498840|P4|COMPLETED|Period 1||10
206256|NCT01275131|498841|P3|COMPLETED|Period 1||10
206257|NCT01275131|498842|P2|COMPLETED|Period 1||9
206258|NCT01275131|498843|P1|COMPLETED|Period 1||9
206259|NCT01275131|498840|P4|Received at Least One Dose of Study Drug|Period 1||12
206260|NCT01275131|498841|P3|Received at Least One Dose of Study Drug|Period 1||13
206261|NCT01275131|498842|P2|Received at Least One Dose of Study Drug|Period 1||9
206262|NCT01275131|498843|P1|Received at Least One Dose of Study Drug|Period 1||11
206263|NCT01275131|498840|P4|STARTED|Period 1||12
206264|NCT01275131|498841|P3|STARTED|Period 1||13
206265|NCT01275131|498842|P2|STARTED|Period 1||9
206266|NCT01275131|498843|P1|STARTED|Period 1||11
206267|NCT01275092|498877|P1|NOT COMPLETED|Overall Study||0
206268|NCT01275092|498877|P1|COMPLETED|Overall Study||164
206269|NCT01275092|498877|P1|STARTED|Overall Study||164
206270|NCT01275066|498886|P3|NOT COMPLETED|Overall Study||1
206271|NCT01275066|498887|P2|NOT COMPLETED|Overall Study||0
206272|NCT01275066|498888|P1|NOT COMPLETED|Overall Study||1
206273|NCT01275066|498886|P3|COMPLETED|Overall Study||57
206274|NCT01275066|498887|P2|COMPLETED|Overall Study||59
206275|NCT01275066|498888|P1|COMPLETED|Overall Study||59
206276|NCT01275066|498886|P3|Treated|Overall Study||58
206277|NCT01275066|498887|P2|Treated|Overall Study||59
206278|NCT01275066|498888|P1|Treated|Overall Study||59
206279|NCT01275066|498886|P3|STARTED|Overall Study||58
206280|NCT01275066|498887|P2|STARTED|Overall Study||59
206281|NCT01275066|498888|P1|STARTED|Overall Study||60
206282|NCT01275053|498902|P1|NOT COMPLETED|Overall Study||0
206283|NCT01275053|498902|P1|COMPLETED|Overall Study||12
206284|NCT01275053|498902|P1|STARTED|Overall Study||12
206285|NCT01274897|498908|P2|NOT COMPLETED|Overall Study||0
206286|NCT01274897|498909|P1|NOT COMPLETED|Overall Study||0
206287|NCT01274897|498908|P2|COMPLETED|Overall Study||153
206288|NCT01274897|498909|P1|COMPLETED|Overall Study||297
206289|NCT01274897|498908|P2|STARTED|Overall Study||153
206290|NCT01274897|498909|P1|STARTED|Overall Study||297
206291|NCT01274715|498921|P1|NOT COMPLETED|Overall Study||4
206292|NCT01274715|498921|P1|COMPLETED|Overall Study||8
206293|NCT01274715|498921|P1|Screened Out at Baseline|Overall Study||3
206294|NCT01274715|498921|P1|STARTED|Overall Study||12
206295|NCT01274637|498928|P2|NOT COMPLETED|Overall Study||2
206296|NCT01274637|498929|P1|NOT COMPLETED|Overall Study||0
206297|NCT01274637|498928|P2|COMPLETED|Overall Study||30
206298|NCT01274637|498929|P1|COMPLETED|Overall Study||30
206299|NCT01274637|498928|P2|STARTED|Overall Study||32
206300|NCT01274637|498929|P1|STARTED|Overall Study||30
206301|NCT01274611|498945|P1|NOT COMPLETED|Overall Study||0
206302|NCT01274611|498945|P1|COMPLETED|Overall Study||20
206303|NCT01274611|498945|P1|STARTED|Overall Study||20
206304|NCT01274585|498955|P2|NOT COMPLETED|Overall Study||0
206305|NCT01274585|498956|P1|NOT COMPLETED|Overall Study||0
206306|NCT01274585|498955|P2|COMPLETED|Overall Study||3
206307|NCT01274585|498956|P1|COMPLETED|Overall Study||2
206308|NCT01274585|498955|P2|STARTED|Overall Study||3
206309|NCT01274585|498956|P1|STARTED|Overall Study||2
206310|NCT01274559|498968|P2|NOT COMPLETED|Overall Study||145
206311|NCT01274559|498969|P1|NOT COMPLETED|Overall Study||197
206312|NCT01274559|498968|P2|COMPLETED|Overall Study||441
206313|NCT01274559|498969|P1|COMPLETED|Overall Study||390
206314|NCT01274559|498968|P2|Treated|Overall Study||572
206315|NCT01274559|498969|P1|Treated|Overall Study||572
206316|NCT01274559|498968|P2|STARTED|Overall Study||586
206317|NCT01274559|498969|P1|STARTED|Overall Study||587
206318|NCT01274533|499019|P1|NOT COMPLETED|Overall Study||4
206319|NCT01274533|499019|P1|COMPLETED|Overall Study||0
206320|NCT01274533|499019|P1|STARTED|Overall Study||4
206321|NCT01274429|499024|P1|NOT COMPLETED|Overall Study||5
206322|NCT01274429|499024|P1|COMPLETED|Overall Study||0
206323|NCT01274429|499024|P1|STARTED|Overall Study||5
206324|NCT01274182|499032|P3|NOT COMPLETED|Overall Study||12
206325|NCT01274182|499033|P2|NOT COMPLETED|Overall Study||18
206326|NCT01274182|499034|P1|NOT COMPLETED|Overall Study||21
206327|NCT01274182|499032|P3|COMPLETED|Overall Study||80
206328|NCT01274182|499033|P2|COMPLETED|Overall Study||69
206329|NCT01274182|499034|P1|COMPLETED|Overall Study||112
206330|NCT01274182|499032|P3|24 Weeks|Overall Study||84
206331|NCT01274182|499033|P2|24 Weeks|Overall Study||83
206332|NCT01274182|499034|P1|24 Weeks|Overall Study||123
206333|NCT01274182|499032|P3|STARTED|Overall Study||92
206334|NCT01274182|499033|P2|STARTED|Overall Study||87
206335|NCT01274182|499034|P1|STARTED|Overall Study||133
206336|NCT01273896|499071|P1|NOT COMPLETED|Overall Study||0
206337|NCT01273896|499071|P1|COMPLETED|Overall Study||22
206338|NCT01273896|499071|P1|STARTED|Overall Study||22
206339|NCT01273883|499075|P2|NOT COMPLETED|Second Intervention||1
206340|NCT01273883|499076|P1|NOT COMPLETED|Second Intervention||2
206341|NCT01273883|499075|P2|COMPLETED|Second Intervention||17
206342|NCT01273883|499076|P1|COMPLETED|Second Intervention||15
206343|NCT01273883|499075|P2|STARTED|Second Intervention||18
206344|NCT01273883|499076|P1|STARTED|Second Intervention||17
206345|NCT01273883|499075|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
206346|NCT01273883|499076|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
206347|NCT01273883|499075|P2|COMPLETED|Washout Period of 2 Weeks||18
206348|NCT01273883|499076|P1|COMPLETED|Washout Period of 2 Weeks||17
206349|NCT01273883|499075|P2|STARTED|Washout Period of 2 Weeks||18
206350|NCT01273883|499076|P1|STARTED|Washout Period of 2 Weeks||17
206351|NCT01273883|499075|P2|NOT COMPLETED|First Intervention||1
206352|NCT01273883|499076|P1|NOT COMPLETED|First Intervention||2
206353|NCT01273883|499075|P2|COMPLETED|First Intervention||18
206354|NCT01273883|499076|P1|COMPLETED|First Intervention||17
206355|NCT01273883|499075|P2|STARTED|First Intervention|Received at least 1 dose of study drug.|19
206356|NCT01273883|499076|P1|STARTED|First Intervention|Received at least 1 dose of study drug.|19
206357|NCT01273857|499090|P2|NOT COMPLETED|Overall Study||0
206358|NCT01273857|499091|P1|NOT COMPLETED|Overall Study||0
206359|NCT01273857|499090|P2|COMPLETED|Overall Study||7
206360|NCT01273857|499091|P1|COMPLETED|Overall Study||7
206361|NCT01273857|499090|P2|STARTED|Overall Study||7
206362|NCT01273857|499091|P1|STARTED|Overall Study||7
206363|NCT01273818|499102|P3|NOT COMPLETED|Overall Study||9
206364|NCT01273818|499103|P2|NOT COMPLETED|Overall Study||2
206365|NCT01273818|499104|P1|NOT COMPLETED|Overall Study||13
206366|NCT01273818|499102|P3|COMPLETED|Overall Study||91
206367|NCT01273818|499103|P2|COMPLETED|Overall Study||98
206368|NCT01273818|499104|P1|COMPLETED|Overall Study||87
206369|NCT01273818|499102|P3|STARTED|Overall Study||100
206370|NCT01273818|499103|P2|STARTED|Overall Study||100
206371|NCT01273818|499104|P1|STARTED|Overall Study||100
206372|NCT01273805|499114|P2|NOT COMPLETED|Overall Study||10
206373|NCT01273805|499115|P1|NOT COMPLETED|Overall Study||10
206374|NCT01273805|499114|P2|COMPLETED|Overall Study||0
206375|NCT01273805|499115|P1|COMPLETED|Overall Study||0
206376|NCT01273805|499114|P2|STARTED|Overall Study||10
206377|NCT01273805|499115|P1|STARTED|Overall Study||10
206378|NCT01273766|499134|P3|NOT COMPLETED|Overall Study||0
206379|NCT01273766|499135|P2|NOT COMPLETED|Overall Study||0
206380|NCT01273766|499136|P1|NOT COMPLETED|Overall Study||0
206381|NCT01273766|499134|P3|COMPLETED|Overall Study||5
206382|NCT01273766|499135|P2|COMPLETED|Overall Study||7
206383|NCT01273766|499136|P1|COMPLETED|Overall Study||4
206384|NCT01273766|499134|P3|STARTED|Overall Study||5
206385|NCT01273766|499135|P2|STARTED|Overall Study||7
206386|NCT01273766|499136|P1|STARTED|Overall Study||4
206387|NCT01273623|499146|P1|NOT COMPLETED|Overall Study||29
206388|NCT01273623|499146|P1|COMPLETED|Overall Study|met IVUS criteria|26
206389|NCT01273623|499146|P1|STARTED|Overall Study|met angiographic criteria|55
206390|NCT01273597|499153|P1|NOT COMPLETED|Overall Study||8
206391|NCT01273597|499153|P1|COMPLETED|Overall Study||52
206392|NCT01273597|499153|P1|STARTED|Overall Study||60
206393|NCT01273519|499168|P3|NOT COMPLETED|Overall Study||8
206394|NCT01273519|499169|P2|NOT COMPLETED|Overall Study||5
206395|NCT01273519|499170|P1|NOT COMPLETED|Overall Study||19
206396|NCT01273519|499168|P3|COMPLETED|Overall Study||39
206397|NCT01273519|499169|P2|COMPLETED|Overall Study||25
206398|NCT01273519|499170|P1|COMPLETED|Overall Study||59
206399|NCT01273519|499168|P3|STARTED|Overall Study||47
206400|NCT01273519|499169|P2|STARTED|Overall Study||30
206401|NCT01273519|499170|P1|STARTED|Overall Study||78
206402|NCT01273181|499207|P4|NOT COMPLETED|Phase 2, Dose 2||1
206403|NCT01273181|499208|P3|NOT COMPLETED|Phase 2, Dose 2||0
206404|NCT01273181|499209|P2|NOT COMPLETED|Phase 2, Dose 2||0
206405|NCT01273181|499210|P1|NOT COMPLETED|Phase 2, Dose 2||0
206406|NCT01273181|499207|P4|COMPLETED|Phase 2, Dose 2||0
206407|NCT01273181|499208|P3|COMPLETED|Phase 2, Dose 2||0
206408|NCT01273181|499209|P2|COMPLETED|Phase 2, Dose 2||0
206409|NCT01273181|499210|P1|COMPLETED|Phase 2, Dose 2||0
206410|NCT01273181|499207|P4|STARTED|Phase 2, Dose 2||1
206411|NCT01273181|499208|P3|STARTED|Phase 2, Dose 2||0
206412|NCT01273181|499209|P2|STARTED|Phase 2, Dose 2||0
206413|NCT01273181|499210|P1|STARTED|Phase 2, Dose 2||0
206414|NCT01273181|499207|P4|NOT COMPLETED|Phase 2, Dose 1||0
206415|NCT01273181|499208|P3|NOT COMPLETED|Phase 2, Dose 1||1
206416|NCT01273181|499209|P2|NOT COMPLETED|Phase 2, Dose 1||0
206417|NCT01273181|499210|P1|NOT COMPLETED|Phase 2, Dose 1||0
206418|NCT01273181|499207|P4|COMPLETED|Phase 2, Dose 1||0
206419|NCT01273181|499208|P3|COMPLETED|Phase 2, Dose 1||1
206420|NCT01273181|499209|P2|COMPLETED|Phase 2, Dose 1||0
206421|NCT01273181|499210|P1|COMPLETED|Phase 2, Dose 1||0
206422|NCT01273181|499207|P4|STARTED|Phase 2, Dose 1||0
206423|NCT01273181|499208|P3|STARTED|Phase 2, Dose 1||2
206424|NCT01273181|499209|P2|STARTED|Phase 2, Dose 1||0
206425|NCT01273181|499210|P1|STARTED|Phase 2, Dose 1||0
206426|NCT01273181|499207|P4|NOT COMPLETED|Phase I, Dose 2||0
206427|NCT01273181|499208|P3|NOT COMPLETED|Phase I, Dose 2||0
206428|NCT01273181|499209|P2|NOT COMPLETED|Phase I, Dose 2||1
206429|NCT01273181|499210|P1|NOT COMPLETED|Phase I, Dose 2||0
206430|NCT01273181|499207|P4|COMPLETED|Phase I, Dose 2||0
206431|NCT01273181|499208|P3|COMPLETED|Phase I, Dose 2||0
206432|NCT01273181|499209|P2|COMPLETED|Phase I, Dose 2||2
206433|NCT01273181|499210|P1|COMPLETED|Phase I, Dose 2||0
206434|NCT01273181|499207|P4|STARTED|Phase I, Dose 2||0
206435|NCT01273181|499208|P3|STARTED|Phase I, Dose 2||0
206436|NCT01273181|499209|P2|STARTED|Phase I, Dose 2||3
206437|NCT01273181|499210|P1|STARTED|Phase I, Dose 2||0
206438|NCT01273181|499207|P4|NOT COMPLETED|Phase I, Dose 1||0
206439|NCT01273181|499208|P3|NOT COMPLETED|Phase I, Dose 1||0
206440|NCT01273181|499209|P2|NOT COMPLETED|Phase I, Dose 1||0
206441|NCT01273181|499210|P1|NOT COMPLETED|Phase I, Dose 1||1
206442|NCT01273181|499207|P4|COMPLETED|Phase I, Dose 1||0
206443|NCT01273181|499208|P3|COMPLETED|Phase I, Dose 1||0
206444|NCT01273181|499209|P2|COMPLETED|Phase I, Dose 1||0
206445|NCT01273181|499210|P1|COMPLETED|Phase I, Dose 1||2
206446|NCT01273181|499207|P4|STARTED|Phase I, Dose 1||0
206447|NCT01273181|499208|P3|STARTED|Phase I, Dose 1||0
206448|NCT01273181|499209|P2|STARTED|Phase I, Dose 1||0
206449|NCT01273181|499210|P1|STARTED|Phase I, Dose 1||3
206450|NCT01273155|499228|P7|NOT COMPLETED|Overall Study||6
206451|NCT01273155|499229|P6|NOT COMPLETED|Overall Study||5
206452|NCT01273155|499230|P5|NOT COMPLETED|Overall Study||2
206453|NCT01273155|499231|P4|NOT COMPLETED|Overall Study||1
206454|NCT01273155|499232|P3|NOT COMPLETED|Overall Study||12
206455|NCT01273155|499233|P2|NOT COMPLETED|Overall Study||4
206456|NCT01273155|499234|P1|NOT COMPLETED|Overall Study||2
206457|NCT01273155|499228|P7|COMPLETED|Overall Study||2
206458|NCT01273155|499229|P6|COMPLETED|Overall Study||5
206459|NCT01273155|499230|P5|COMPLETED|Overall Study||3
206460|NCT01273155|499231|P4|COMPLETED|Overall Study||4
206461|NCT01273155|499232|P3|COMPLETED|Overall Study||6
206462|NCT01273155|499233|P2|COMPLETED|Overall Study||8
206463|NCT01273155|499234|P1|COMPLETED|Overall Study||12
206464|NCT01273155|499228|P7|STARTED|Overall Study||8
206465|NCT01273155|499229|P6|STARTED|Overall Study||10
206466|NCT01273155|499230|P5|STARTED|Overall Study||5
206467|NCT01273155|499231|P4|STARTED|Overall Study||5
206468|NCT01273155|499232|P3|STARTED|Overall Study||18
206469|NCT01273155|499233|P2|STARTED|Overall Study||12
206470|NCT01273155|499234|P1|STARTED|Overall Study||14
206471|NCT01273064|499311|P5|NOT COMPLETED|Overall Study||10
206472|NCT01273064|499312|P4|NOT COMPLETED|Overall Study||20
206473|NCT01273064|499313|P3|NOT COMPLETED|Overall Study||31
206474|NCT01273064|499314|P2|NOT COMPLETED|Overall Study||30
206475|NCT01273064|499315|P1|NOT COMPLETED|Overall Study||23
206476|NCT01273064|499311|P5|COMPLETED|Overall Study||0
206477|NCT01273064|499312|P4|COMPLETED|Overall Study||0
206478|NCT01273064|499313|P3|COMPLETED|Overall Study||0
206479|NCT01273064|499314|P2|COMPLETED|Overall Study||0
206480|NCT01273064|499315|P1|COMPLETED|Overall Study||0
206481|NCT01273064|499311|P5|STARTED|Overall Study|Began study on the placebo arm, and crossed over to CTS-1027 15 mg at Wk 12 due to lack of response|10
206482|NCT01273064|499312|P4|STARTED|Overall Study||20
206483|NCT01273064|499313|P3|STARTED|Overall Study||31
206484|NCT01273064|499314|P2|STARTED|Overall Study||30
206485|NCT01273064|499315|P1|STARTED|Overall Study||23
206486|NCT01273038|499334|P2|NOT COMPLETED|Second Intervention (14 Days)||2
206487|NCT01273038|499335|P1|NOT COMPLETED|Second Intervention (14 Days)||0
206488|NCT01273038|499334|P2|COMPLETED|Second Intervention (14 Days)||8
206489|NCT01273038|499335|P1|COMPLETED|Second Intervention (14 Days)||10
206490|NCT01273038|499334|P2|STARTED|Second Intervention (14 Days)||10
206491|NCT01273038|499335|P1|STARTED|Second Intervention (14 Days)||10
206492|NCT01273038|499334|P2|NOT COMPLETED|First Intervention (14 Days)||0
206493|NCT01273038|499335|P1|NOT COMPLETED|First Intervention (14 Days)||0
206494|NCT01273038|499334|P2|COMPLETED|First Intervention (14 Days)||10
206495|NCT01273038|499335|P1|COMPLETED|First Intervention (14 Days)||10
206496|NCT01273038|499334|P2|STARTED|First Intervention (14 Days)||10
206497|NCT01273038|499335|P1|STARTED|First Intervention (14 Days)||10
206498|NCT01272960|499343|P2|NOT COMPLETED|Overall Study||0
206499|NCT01272960|499344|P1|NOT COMPLETED|Overall Study||0
206500|NCT01272960|499343|P2|COMPLETED|Overall Study||15
206501|NCT01272960|499344|P1|COMPLETED|Overall Study||14
206502|NCT01272960|499343|P2|STARTED|Overall Study||15
206503|NCT01272960|499344|P1|STARTED|Overall Study||14
206504|NCT01272947|499358|P2|NOT COMPLETED|Overall Study||2
206505|NCT01272947|499359|P1|NOT COMPLETED|Overall Study||2
206506|NCT01272947|499358|P2|COMPLETED|Overall Study||98
206507|NCT01272947|499359|P1|COMPLETED|Overall Study||102
206508|NCT01272947|499358|P2|STARTED|Overall Study||100
206509|NCT01272947|499359|P1|STARTED|Overall Study||104
206510|NCT01272934|499369|P2|NOT COMPLETED|Overall Study||2
206511|NCT01272934|499370|P1|NOT COMPLETED|Overall Study||0
206512|NCT01272934|499369|P2|COMPLETED|Overall Study||101
206513|NCT01272934|499370|P1|COMPLETED|Overall Study||102
206514|NCT01272934|499369|P2|STARTED|Overall Study||103
206515|NCT01272934|499370|P1|STARTED|Overall Study||102
206516|NCT01272921|499380|P2|NOT COMPLETED|Overall Study||1
206517|NCT01272921|499381|P1|NOT COMPLETED|Overall Study||2
206518|NCT01272921|499380|P2|COMPLETED|Overall Study||70
206519|NCT01272921|499381|P1|COMPLETED|Overall Study||69
206520|NCT01272921|499380|P2|STARTED|Overall Study||71
206521|NCT01272921|499381|P1|STARTED|Overall Study||71
206522|NCT01272908|499389|P1|NOT COMPLETED|Re-Treatment Period||6
206523|NCT01272908|499389|P1|COMPLETED|Re-Treatment Period||71
206524|NCT01272908|499389|P1|STARTED|Re-Treatment Period|Only participants with active disease as characterized by DAS-28 score ≥2.6 were included.|77
206525|NCT01272908|499389|P1|NOT COMPLETED|Initial Treatment Period||8
206526|NCT01272908|499389|P1|COMPLETED|Initial Treatment Period||112
206527|NCT01272908|499389|P1|STARTED|Initial Treatment Period||120
206528|NCT01272882|499423|P1|NOT COMPLETED|Overall Study||0
206529|NCT01272882|499423|P1|COMPLETED|Overall Study||13
206530|NCT01272882|499423|P1|STARTED|Overall Study||13
206531|NCT01272869|499429|P2|NOT COMPLETED|Period 2 (14 Days)||0
206532|NCT01272869|499430|P1|NOT COMPLETED|Period 2 (14 Days)||1
206533|NCT01272869|499429|P2|COMPLETED|Period 2 (14 Days)||10
206534|NCT01272869|499430|P1|COMPLETED|Period 2 (14 Days)||9
206535|NCT01272869|499429|P2|STARTED|Period 2 (14 Days)||10
206536|NCT01272869|499430|P1|STARTED|Period 2 (14 Days)||10
206537|NCT01272869|499429|P2|NOT COMPLETED|Period 1 (14 Days)||0
206538|NCT01272869|499430|P1|NOT COMPLETED|Period 1 (14 Days)||0
206539|NCT01272869|499429|P2|COMPLETED|Period 1 (14 Days)||10
206540|NCT01272869|499430|P1|COMPLETED|Period 1 (14 Days)||10
206541|NCT01272869|499429|P2|STARTED|Period 1 (14 Days)||10
206542|NCT01272869|499430|P1|STARTED|Period 1 (14 Days)||10
206543|NCT01272830|499438|P2|NOT COMPLETED|Overall Study||5
206544|NCT01272830|499439|P1|NOT COMPLETED|Overall Study||8
206545|NCT01272830|499438|P2|COMPLETED|Overall Study||21
206546|NCT01272830|499439|P1|COMPLETED|Overall Study||17
206547|NCT01272830|499438|P2|STARTED|Overall Study||26
206548|NCT01272830|499439|P1|STARTED|Overall Study||25
206549|NCT01272804|499457|P6|NOT COMPLETED|Overall Study||1
206550|NCT01272804|499458|P5|NOT COMPLETED|Overall Study||2
206551|NCT01272804|499459|P4|NOT COMPLETED|Overall Study||0
206552|NCT01272804|499460|P3|NOT COMPLETED|Overall Study||0
206553|NCT01272804|499461|P2|NOT COMPLETED|Overall Study||0
206554|NCT01272804|499462|P1|NOT COMPLETED|Overall Study||1
206555|NCT01272804|499457|P6|COMPLETED|Overall Study||15
206556|NCT01272804|499458|P5|COMPLETED|Overall Study||7
206557|NCT01272804|499459|P4|COMPLETED|Overall Study||9
206558|NCT01272804|499460|P3|COMPLETED|Overall Study||9
206559|NCT01272804|499461|P2|COMPLETED|Overall Study||9
206560|NCT01272804|499462|P1|COMPLETED|Overall Study||8
206561|NCT01272804|499457|P6|STARTED|Overall Study||16
206562|NCT01272804|499458|P5|STARTED|Overall Study||9
206563|NCT01272804|499459|P4|STARTED|Overall Study||9
206564|NCT01272804|499460|P3|STARTED|Overall Study||9
206565|NCT01272804|499461|P2|STARTED|Overall Study||9
206566|NCT01272804|499462|P1|STARTED|Overall Study||9
206567|NCT01272661|499620|P3|NOT COMPLETED|Overall Study||72
206568|NCT01272661|499621|P2|NOT COMPLETED|Overall Study||209
206569|NCT01272661|499622|P1|NOT COMPLETED|Overall Study||126
206570|NCT01272661|499620|P3|COMPLETED|Overall Study||314
206571|NCT01272661|499621|P2|COMPLETED|Overall Study||288
206572|NCT01272661|499622|P1|COMPLETED|Overall Study||287
206573|NCT01272661|499620|P3|STARTED|Overall Study||386
206574|NCT01272661|499621|P2|STARTED|Overall Study||497
206575|NCT01272661|499622|P1|STARTED|Overall Study||413
206576|NCT01272635|499647|P4|NOT COMPLETED|Overall Study||23
206577|NCT01272635|499648|P3|NOT COMPLETED|Overall Study||31
206578|NCT01272635|499649|P2|NOT COMPLETED|Overall Study||20
206579|NCT01272635|499650|P1|NOT COMPLETED|Overall Study||31
206580|NCT01272635|499647|P4|COMPLETED|Overall Study||129
206581|NCT01272635|499648|P3|COMPLETED|Overall Study||117
206582|NCT01272635|499649|P2|COMPLETED|Overall Study||134
206583|NCT01272635|499650|P1|COMPLETED|Overall Study||122
206584|NCT01272635|499647|P4|STARTED|Overall Study||152
206585|NCT01272635|499648|P3|STARTED|Overall Study||148
206586|NCT01272635|499649|P2|STARTED|Overall Study||154
206587|NCT01272635|499650|P1|STARTED|Overall Study||153
206588|NCT01272583|499668|P2|NOT COMPLETED|Overall Study||0
206589|NCT01272583|499669|P1|NOT COMPLETED|Overall Study||0
206590|NCT01272583|499668|P2|COMPLETED|Overall Study||8
206591|NCT01272583|499669|P1|COMPLETED|Overall Study||8
206592|NCT01272583|499668|P2|STARTED|Overall Study||8
206593|NCT01272583|499669|P1|STARTED|Overall Study||8
206594|NCT01272388|499700|P2|NOT COMPLETED|Overall Study||0
206595|NCT01272388|499701|P1|NOT COMPLETED|Overall Study||0
206596|NCT01272388|499700|P2|COMPLETED|Overall Study||0
206597|NCT01272388|499701|P1|COMPLETED|Overall Study||1
206598|NCT01272388|499700|P2|STARTED|Overall Study||0
206599|NCT01272388|499701|P1|STARTED|Overall Study||1
206600|NCT01272284|499709|P1|NOT COMPLETED|12-month Follow-up Visit||4
206601|NCT01272284|499709|P1|COMPLETED|12-month Follow-up Visit||105
206602|NCT01272284|499709|P1|STARTED|12-month Follow-up Visit||109
206603|NCT01272284|499709|P1|NOT COMPLETED|6-month Follow-up Visit||3
206604|NCT01272284|499709|P1|COMPLETED|6-month Follow-up Visit||109
206605|NCT01272284|499709|P1|STARTED|6-month Follow-up Visit||112
206606|NCT01272284|499709|P1|NOT COMPLETED|3-month Follow-up Visit||1
206607|NCT01272284|499709|P1|COMPLETED|3-month Follow-up Visit||112
206608|NCT01272284|499709|P1|STARTED|3-month Follow-up Visit||113
206609|NCT01272245|499723|P1|NOT COMPLETED|Overall Study||0
206610|NCT01272245|499723|P1|COMPLETED|Overall Study||36
206611|NCT01272245|499723|P1|STARTED|Overall Study||36
206612|NCT01272232|499734|P3|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||5
206613|NCT01272232|499735|P2|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||10
206614|NCT01272232|499736|P1|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||14
206615|NCT01272232|499734|P3|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||135
206616|NCT01272232|499735|P2|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||154
206617|NCT01272232|499736|P1|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||310
206618|NCT01272232|499734|P3|STARTED|Off Drug Follow-up Period (Weeks 56-68)||140
206619|NCT01272232|499735|P2|STARTED|Off Drug Follow-up Period (Weeks 56-68)||164
206620|NCT01272232|499736|P1|STARTED|Off Drug Follow-up Period (Weeks 56-68)||324
206621|NCT01272232|499734|P3|NOT COMPLETED|Weeks 0-56||72
206622|NCT01272232|499735|P2|NOT COMPLETED|Weeks 0-56||47
206623|NCT01272232|499736|P1|NOT COMPLETED|Weeks 0-56||99
206624|NCT01272232|499734|P3|COMPLETED|Weeks 0-56||140
206625|NCT01272232|499735|P2|COMPLETED|Weeks 0-56||164
206626|NCT01272232|499736|P1|COMPLETED|Weeks 0-56||324
206627|NCT01272232|499734|P3|Exposed|Weeks 0-56||212
206628|NCT01272232|499735|P2|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|210
206629|NCT01272232|499736|P1|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|422
206630|NCT01272232|499734|P3|STARTED|Weeks 0-56||212
206631|NCT01272232|499735|P2|STARTED|Weeks 0-56||211
206632|NCT01272232|499736|P1|STARTED|Weeks 0-56||423
206633|NCT01272219|499781|P6|NOT COMPLETED|Main + Extension Period: Week 0-172||422
206634|NCT01272219|499782|P5|NOT COMPLETED|Main + Extension Period: Week 0-172||722
206635|NCT01272219|499783|P4|NOT COMPLETED|Main + Extension Period: Week 0-172||0
206636|NCT01272219|499784|P3|NOT COMPLETED|Main + Extension Period: Week 0-172||0
206637|NCT01272219|499785|P2|NOT COMPLETED|Main + Extension Period: Week 0-172||0
206638|NCT01272219|499786|P1|NOT COMPLETED|Main + Extension Period: Week 0-172||0
206639|NCT01272219|499781|P6|COMPLETED|Main + Extension Period: Week 0-172||327
206640|NCT01272219|499782|P5|COMPLETED|Main + Extension Period: Week 0-172||783
206641|NCT01272219|499783|P4|COMPLETED|Main + Extension Period: Week 0-172||0
206642|NCT01272219|499784|P3|COMPLETED|Main + Extension Period: Week 0-172||0
206643|NCT01272219|499785|P2|COMPLETED|Main + Extension Period: Week 0-172||0
206644|NCT01272219|499786|P1|COMPLETED|Main + Extension Period: Week 0-172||0
206645|NCT01272219|499781|P6|Exposed|Main + Extension Period: Week 0-172||747
206646|NCT01272219|499782|P5|Exposed|Main + Extension Period: Week 0-172||1501
206647|NCT01272219|499783|P4|Exposed|Main + Extension Period: Week 0-172||0
206648|NCT01272219|499784|P3|Exposed|Main + Extension Period: Week 0-172||0
206649|NCT01272219|499785|P2|Exposed|Main + Extension Period: Week 0-172||0
206650|NCT01272219|499786|P1|Exposed|Main + Extension Period: Week 0-172||0
206651|NCT01272219|499781|P6|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|749
206652|NCT01272219|499782|P5|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|1505
206653|NCT01272219|499783|P4|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main and re-randomised period|0
206654|NCT01272219|499784|P3|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
206655|NCT01272219|499785|P2|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
206656|NCT01272219|499786|P1|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main period|0
206657|NCT01272219|499781|P6|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
206658|NCT01272219|499782|P5|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
206659|NCT01272219|499783|P4|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||15
206660|NCT01272219|499784|P3|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||7
206661|NCT01272219|499785|P2|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||9
206662|NCT01272219|499786|P1|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
206663|NCT01272219|499781|P6|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
206664|NCT01272219|499782|P5|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
206665|NCT01272219|499783|P4|COMPLETED|Re-randomised Period: Week 56 to Week 68||289
206666|NCT01272219|499784|P3|COMPLETED|Re-randomised Period: Week 56 to Week 68||343
206667|NCT01272219|499785|P2|COMPLETED|Re-randomised Period: Week 56 to Week 68||342
206668|NCT01272219|499786|P1|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
206669|NCT01272219|499781|P6|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
206670|NCT01272219|499782|P5|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
206671|NCT01272219|499783|P4|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|304
206672|NCT01272219|499784|P3|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|350
206673|NCT01272219|499785|P2|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|351
206674|NCT01272219|499786|P1|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
206675|NCT01272219|499781|P6|NOT COMPLETED|Main Period: Week 0 to Week 56||252
206676|NCT01272219|499782|P5|NOT COMPLETED|Main Period: Week 0 to Week 56||418
206677|NCT01272219|499783|P4|NOT COMPLETED|Main Period: Week 0 to Week 56||191
206678|NCT01272219|499784|P3|NOT COMPLETED|Main Period: Week 0 to Week 56||0
206679|NCT01272219|499785|P2|NOT COMPLETED|Main Period: Week 0 to Week 56||0
206680|NCT01272219|499786|P1|NOT COMPLETED|Main Period: Week 0 to Week 56||280
206681|NCT01272219|499781|P6|COMPLETED|Main Period: Week 0 to Week 56||505
206682|NCT01272219|499782|P5|COMPLETED|Main Period: Week 0 to Week 56||1110
206683|NCT01272219|499783|P4|COMPLETED|Main Period: Week 0 to Week 56||296
206684|NCT01272219|499784|P3|COMPLETED|Main Period: Week 0 to Week 56||0
206685|NCT01272219|499785|P2|COMPLETED|Main Period: Week 0 to Week 56||0
206686|NCT01272219|499786|P1|COMPLETED|Main Period: Week 0 to Week 56||679
206687|NCT01272219|499781|P6|Exposed|Main Period: Week 0 to Week 56||755
206688|NCT01272219|499782|P5|Exposed|Main Period: Week 0 to Week 56||1524
206689|NCT01272219|499783|P4|Exposed|Main Period: Week 0 to Week 56||487
206690|NCT01272219|499784|P3|Exposed|Main Period: Week 0 to Week 56||0
206691|NCT01272219|499785|P2|Exposed|Main Period: Week 0 to Week 56||0
206692|NCT01272219|499786|P1|Exposed|Main Period: Week 0 to Week 56||957
206693|NCT01272219|499781|P6|STARTED|Main Period: Week 0 to Week 56||757
206694|NCT01272219|499782|P5|STARTED|Main Period: Week 0 to Week 56||1528
206695|NCT01272219|499783|P4|STARTED|Main Period: Week 0 to Week 56||487
206696|NCT01272219|499784|P3|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
206697|NCT01272219|499785|P2|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
206698|NCT01272219|499786|P1|STARTED|Main Period: Week 0 to Week 56||959
206699|NCT01272193|499820|P2|NOT COMPLETED|Overall Study||12
206700|NCT01272193|499821|P1|NOT COMPLETED|Overall Study||10
206701|NCT01272193|499820|P2|COMPLETED|Overall Study||137
206702|NCT01272193|499821|P1|COMPLETED|Overall Study||137
206703|NCT01272193|499820|P2|STARTED|Overall Study||149
206704|NCT01272193|499821|P1|STARTED|Overall Study||147
206705|NCT01272180|499841|P4|NOT COMPLETED|Overall Study||14
206706|NCT01272180|499842|P3|NOT COMPLETED|Overall Study||13
206707|NCT01272180|499843|P2|NOT COMPLETED|Overall Study||21
206708|NCT01272180|499844|P1|NOT COMPLETED|Overall Study||17
206709|NCT01272180|499841|P4|COMPLETED|Overall Study||107
206710|NCT01272180|499842|P3|COMPLETED|Overall Study||109
206711|NCT01272180|499843|P2|COMPLETED|Overall Study||100
206712|NCT01272180|499844|P1|COMPLETED|Overall Study||103
206713|NCT01272180|499841|P4|STARTED|Overall Study||121
206714|NCT01272180|499842|P3|STARTED|Overall Study||122
206715|NCT01272180|499843|P2|STARTED|Overall Study||121
206716|NCT01272180|499844|P1|STARTED|Overall Study||120
206717|NCT01272141|499881|P1|NOT COMPLETED|Overall Study||0
206718|NCT01272141|499881|P1|COMPLETED|Overall Study||5
206719|NCT01272141|499881|P1|STARTED|Overall Study||5
206720|NCT01272076|499886|P1|NOT COMPLETED|Overall Study||0
206721|NCT01272076|499886|P1|COMPLETED|Overall Study||52
206722|NCT01272076|499886|P1|STARTED|Overall Study||52
206723|NCT01272011|499893|P3|NOT COMPLETED|Overall Study||0
206724|NCT01272011|499894|P2|NOT COMPLETED|Overall Study||2
206725|NCT01272011|499895|P1|NOT COMPLETED|Overall Study||0
206726|NCT01272011|499893|P3|COMPLETED|Overall Study||3
206727|NCT01272011|499894|P2|COMPLETED|Overall Study||8
206728|NCT01272011|499895|P1|COMPLETED|Overall Study||3
206729|NCT01272011|499893|P3|STARTED|Overall Study||3
206730|NCT01272011|499894|P2|STARTED|Overall Study||10
206731|NCT01272011|499895|P1|STARTED|Overall Study||3
206732|NCT01271946|499908|P2|NOT COMPLETED|Overall Study||0
206733|NCT01271946|499909|P1|NOT COMPLETED|Overall Study||0
206734|NCT01271946|499908|P2|COMPLETED|Overall Study||5
206735|NCT01271946|499909|P1|COMPLETED|Overall Study||346
206736|NCT01271946|499908|P2|STARTED|Overall Study||5
206737|NCT01271946|499909|P1|STARTED|Overall Study||346
206738|NCT01271933|499931|P3|NOT COMPLETED|Double-Blind Phase||12
206739|NCT01271933|499932|P2|NOT COMPLETED|Double-Blind Phase||17
206740|NCT01271933|499933|P1|NOT COMPLETED|Double-Blind Phase||0
206741|NCT01271933|499931|P3|COMPLETED|Double-Blind Phase||47
206742|NCT01271933|499932|P2|COMPLETED|Double-Blind Phase||46
206743|NCT01271933|499933|P1|COMPLETED|Double-Blind Phase||0
206744|NCT01271933|499931|P3|Treated|Double-Blind Phase||58
206745|NCT01271933|499932|P2|Treated|Double-Blind Phase||63
206746|NCT01271933|499933|P1|Treated|Double-Blind Phase||0
206747|NCT01271933|499931|P3|STARTED|Double-Blind Phase||59
206748|NCT01271933|499932|P2|STARTED|Double-Blind Phase||63
206749|NCT01271933|499933|P1|STARTED|Double-Blind Phase||0
206750|NCT01271933|499931|P3|NOT COMPLETED|Single-Blind Phase||0
206751|NCT01271933|499932|P2|NOT COMPLETED|Single-Blind Phase||0
206752|NCT01271933|499933|P1|NOT COMPLETED|Single-Blind Phase||121
206753|NCT01271933|499931|P3|COMPLETED|Single-Blind Phase||0
206754|NCT01271933|499932|P2|COMPLETED|Single-Blind Phase||0
206755|NCT01271933|499933|P1|COMPLETED|Single-Blind Phase||320
206756|NCT01271933|499931|P3|STARTED|Single-Blind Phase||0
206757|NCT01271933|499932|P2|STARTED|Single-Blind Phase||0
206758|NCT01271933|499933|P1|STARTED|Single-Blind Phase||441
206759|NCT01271907|500033|P3|NOT COMPLETED|Overall Study||0
206760|NCT01271907|500034|P2|NOT COMPLETED|Overall Study||0
206761|NCT01271907|500035|P1|NOT COMPLETED|Overall Study||0
206762|NCT01271907|500033|P3|COMPLETED|Overall Study||0
206763|NCT01271907|500034|P2|COMPLETED|Overall Study||0
206764|NCT01271907|500035|P1|COMPLETED|Overall Study||3
206765|NCT01271907|500033|P3|STARTED|Overall Study||0
206766|NCT01271907|500034|P2|STARTED|Overall Study||0
206767|NCT01271907|500035|P1|STARTED|Overall Study||3
206768|NCT01271868|500049|P1|NOT COMPLETED|Treatment Study||0
206769|NCT01271868|500049|P1|COMPLETED|Treatment Study||9
206770|NCT01271868|500049|P1|STARTED|Treatment Study||9
206771|NCT01271868|500049|P1|NOT COMPLETED|Pharmacokinetic Study||0
206772|NCT01271868|500049|P1|COMPLETED|Pharmacokinetic Study||9
206773|NCT01271868|500049|P1|STARTED|Pharmacokinetic Study||9
206774|NCT01271855|500062|P2|NOT COMPLETED|Overall Study||0
206775|NCT01271855|500063|P1|NOT COMPLETED|Overall Study||0
206776|NCT01271855|500062|P2|COMPLETED|Overall Study||52
206777|NCT01271855|500063|P1|COMPLETED|Overall Study||48
206778|NCT01271855|500062|P2|STARTED|Overall Study||52
206779|NCT01271855|500063|P1|STARTED|Overall Study||48
206780|NCT01271803|500076|P3|NOT COMPLETED|Overall Study||2
206781|NCT01271803|500077|P2|NOT COMPLETED|Overall Study||39
206782|NCT01271803|500078|P1|NOT COMPLETED|Overall Study||55
206783|NCT01271803|500076|P3|COMPLETED|Overall Study||0
206784|NCT01271803|500077|P2|COMPLETED|Overall Study||24
206785|NCT01271803|500078|P1|COMPLETED|Overall Study||11
206786|NCT01271803|500076|P3|STARTED|Overall Study||2
206787|NCT01271803|500077|P2|STARTED|Overall Study||63
206788|NCT01271803|500078|P1|STARTED|Overall Study||66
206789|NCT01271725|500240|P2|NOT COMPLETED|Part B||12
206790|NCT01271725|500241|P1|NOT COMPLETED|Part B||0
206791|NCT01271725|500240|P2|COMPLETED|Part B|Patient deemed to have completed the trial once they showed progressive disease according to RECIST|27
206792|NCT01271725|500241|P1|COMPLETED|Part B||0
206793|NCT01271725|500240|P2|STARTED|Part B||39
206794|NCT01271725|500241|P1|STARTED|Part B||0
206795|NCT01271725|500240|P2|NOT COMPLETED|Part A||0
206796|NCT01271725|500241|P1|NOT COMPLETED|Part A||35
206797|NCT01271725|500240|P2|COMPLETED|Part A||0
206798|NCT01271725|500241|P1|COMPLETED|Part A||39
206799|NCT01271725|500240|P2|STARTED|Part A||0
206800|NCT01271725|500241|P1|STARTED|Part A|Started are the treated patients|74
206801|NCT01271712|500270|P2|NOT COMPLETED|Survival Follow-up||6
206802|NCT01271712|500271|P1|NOT COMPLETED|Survival Follow-up||15
206803|NCT01271712|500270|P2|COMPLETED|Survival Follow-up|33 participants died and completed survival follow-up.|33
206804|NCT01271712|500271|P1|COMPLETED|Survival Follow-up|85 participants died and completed survival follow-up.|85
206805|NCT01271712|500270|P2|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|39
206806|NCT01271712|500271|P1|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|100
206807|NCT01271712|500270|P2|NOT COMPLETED|Safety Follow-up||15
206808|NCT01271712|500271|P1|NOT COMPLETED|Safety Follow-up||21
206809|NCT01271712|500270|P2|COMPLETED|Safety Follow-up||37
206810|NCT01271712|500271|P1|COMPLETED|Safety Follow-up||97
206811|NCT01271712|500270|P2|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|52
206812|NCT01271712|500271|P1|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|118
206813|NCT01271712|500270|P2|NOT COMPLETED|Open Label Treatment||58
206814|NCT01271712|500271|P1|NOT COMPLETED|Open Label Treatment||91
206815|NCT01271712|500270|P2|COMPLETED|Open Label Treatment||0
206816|NCT01271712|500271|P1|COMPLETED|Open Label Treatment||0
206817|NCT01271712|500270|P2|STARTED|Open Label Treatment||58
206818|NCT01271712|500271|P1|STARTED|Open Label Treatment||91
206819|NCT01271712|500270|P2|NOT COMPLETED|Double Blind Treatment||8
206820|NCT01271712|500271|P1|NOT COMPLETED|Double Blind Treatment||42
206821|NCT01271712|500270|P2|COMPLETED|Double Blind Treatment|58 participants started open-label treatment with regorafenib|58
206822|NCT01271712|500271|P1|COMPLETED|Double Blind Treatment|91 participants started open-label treatment with regorafenib|91
206823|NCT01271712|500270|P2|Participants Received Treatment|Double Blind Treatment||66
206824|NCT01271712|500271|P1|Participants Received Treatment|Double Blind Treatment||132
206825|NCT01271712|500270|P2|STARTED|Double Blind Treatment||66
206826|NCT01271712|500271|P1|STARTED|Double Blind Treatment||133
206827|NCT01271686|500292|P1|NOT COMPLETED|Overall Study||0
206828|NCT01271686|500292|P1|COMPLETED|Overall Study||16
206829|NCT01271686|500292|P1|STARTED|Overall Study||16
206830|NCT01271543|500298|P2|NOT COMPLETED|Overall Study||1
206831|NCT01271543|500299|P1|NOT COMPLETED|Overall Study||1
206832|NCT01271543|500298|P2|COMPLETED|Overall Study||29
206833|NCT01271543|500299|P1|COMPLETED|Overall Study||29
206834|NCT01271543|500298|P2|STARTED|Overall Study||30
206835|NCT01271543|500299|P1|STARTED|Overall Study||30
206836|NCT01271452|500309|P2|NOT COMPLETED|Overall Study||8
206837|NCT01271452|500310|P1|NOT COMPLETED|Overall Study||7
206838|NCT01271452|500309|P2|COMPLETED|Overall Study||104
206839|NCT01271452|500310|P1|COMPLETED|Overall Study||105
206840|NCT01271452|500309|P2|STARTED|Overall Study||112
206841|NCT01271452|500310|P1|STARTED|Overall Study||112
206842|NCT01271413|500332|P2|NOT COMPLETED|Overall Study||8
206843|NCT01271413|500333|P1|NOT COMPLETED|Overall Study||9
206844|NCT01271413|500332|P2|COMPLETED|Overall Study||28
206845|NCT01271413|500333|P1|COMPLETED|Overall Study||28
206846|NCT01271413|500332|P2|STARTED|Overall Study||36
206847|NCT01271413|500333|P1|STARTED|Overall Study||37
206848|NCT01271244|500341|P2|NOT COMPLETED|Overall Study||3
206849|NCT01271244|500342|P1|NOT COMPLETED|Overall Study||7
206850|NCT01271244|500341|P2|COMPLETED|Overall Study||5
206851|NCT01271244|500342|P1|COMPLETED|Overall Study||11
206852|NCT01271244|500341|P2|STARTED|Overall Study||8
206853|NCT01271244|500342|P1|STARTED|Overall Study||18
206854|NCT01271036|500352|P2|NOT COMPLETED|Overall Study||0
206855|NCT01271036|500353|P1|NOT COMPLETED|Overall Study||0
206856|NCT01271036|500352|P2|COMPLETED|Overall Study||62
206857|NCT01271036|500353|P1|COMPLETED|Overall Study||62
206858|NCT01271036|500352|P2|STARTED|Overall Study||62
206859|NCT01271036|500353|P1|STARTED|Overall Study||62
206860|NCT01271010|500367|P1|NOT COMPLETED|Overall Study||61
206861|NCT01271010|500367|P1|COMPLETED|Overall Study||28
206862|NCT01271010|500367|P1|STARTED|Overall Study||89
206863|NCT01270971|500382|P2|NOT COMPLETED|Overall Study||23
206864|NCT01270971|500383|P1|NOT COMPLETED|Overall Study||52
206865|NCT01270971|500382|P2|COMPLETED|Overall Study||171
206866|NCT01270971|500383|P1|COMPLETED|Overall Study||348
206867|NCT01270971|500382|P2|STARTED|Overall Study||194
206868|NCT01270971|500383|P1|STARTED|Overall Study||400
206869|NCT01270958|500395|P1|NOT COMPLETED|Overall Study||4
206870|NCT01270958|500395|P1|COMPLETED|Overall Study||56
206871|NCT01270958|500395|P1|STARTED|Overall Study||60
206872|NCT01270919|500419|P1|NOT COMPLETED|Overall Study||0
206873|NCT01270919|500419|P1|COMPLETED|Overall Study||0
206874|NCT01270919|500419|P1|STARTED|Overall Study|One participant was enrolled but was censored.|0
206875|NCT01270880|500424|P1|NOT COMPLETED|Overall Study||1
206876|NCT01270880|500424|P1|COMPLETED|Overall Study||17
206877|NCT01270880|500424|P1|STARTED|Overall Study||18
206878|NCT01270867|500435|P2|NOT COMPLETED|Overall Study||0
206879|NCT01270867|500436|P1|NOT COMPLETED|Overall Study||1
206880|NCT01270867|500435|P2|COMPLETED|Overall Study||88
206881|NCT01270867|500436|P1|COMPLETED|Overall Study||89
206882|NCT01270867|500435|P2|STARTED|Overall Study||88
206883|NCT01270867|500436|P1|STARTED|Overall Study||90
206884|NCT01270841|500454|P4|NOT COMPLETED|Overall Study||13
206885|NCT01270841|500455|P3|NOT COMPLETED|Overall Study||11
206886|NCT01270841|500456|P2|NOT COMPLETED|Overall Study||14
206887|NCT01270841|500457|P1|NOT COMPLETED|Overall Study||13
206888|NCT01270841|500454|P4|COMPLETED|Overall Study||20
206889|NCT01270841|500455|P3|COMPLETED|Overall Study||18
206890|NCT01270841|500456|P2|COMPLETED|Overall Study||19
206891|NCT01270841|500457|P1|COMPLETED|Overall Study||16
206892|NCT01270841|500454|P4|STARTED|Overall Study||33
206893|NCT01270841|500455|P3|STARTED|Overall Study||29
206894|NCT01270841|500456|P2|STARTED|Overall Study||33
206895|NCT01270841|500457|P1|STARTED|Overall Study||29
206896|NCT01270828|500481|P3|NOT COMPLETED|Double Blind Phase||0
206897|NCT01270828|500482|P2|NOT COMPLETED|Double Blind Phase||45
206898|NCT01270828|500483|P1|NOT COMPLETED|Double Blind Phase||26
206899|NCT01270828|500481|P3|COMPLETED|Double Blind Phase||0
206900|NCT01270828|500482|P2|COMPLETED|Double Blind Phase||160
206901|NCT01270828|500483|P1|COMPLETED|Double Blind Phase||182
206902|NCT01270828|500481|P3|STARTED|Double Blind Phase||0
206903|NCT01270828|500482|P2|STARTED|Double Blind Phase||205
206904|NCT01270828|500483|P1|STARTED|Double Blind Phase||208
206905|NCT01270828|500481|P3|NOT COMPLETED|Pregabalin CR SB||146
206906|NCT01270828|500482|P2|NOT COMPLETED|Pregabalin CR SB||0
206907|NCT01270828|500483|P1|NOT COMPLETED|Pregabalin CR SB||0
206908|NCT01270828|500481|P3|COMPLETED|Pregabalin CR SB||660
206909|NCT01270828|500482|P2|COMPLETED|Pregabalin CR SB||0
206910|NCT01270828|500483|P1|COMPLETED|Pregabalin CR SB||0
206911|NCT01270828|500481|P3|STARTED|Pregabalin CR SB||806
206912|NCT01270828|500482|P2|STARTED|Pregabalin CR SB||0
206913|NCT01270828|500483|P1|STARTED|Pregabalin CR SB||0
206914|NCT01270802|500525|P2|NOT COMPLETED|Overall Study||1
206915|NCT01270802|500526|P1|NOT COMPLETED|Overall Study||2
206916|NCT01270802|500525|P2|COMPLETED|Overall Study||14
206917|NCT01270802|500526|P1|COMPLETED|Overall Study||13
206918|NCT01270802|500525|P2|STARTED|Overall Study||15
206919|NCT01270802|500526|P1|STARTED|Overall Study||15
206920|NCT01270711|500542|P8|NOT COMPLETED|Part 2: Effectiveness||0
206921|NCT01270711|500543|P7|NOT COMPLETED|Part 2: Effectiveness||0
206922|NCT01270711|500544|P6|NOT COMPLETED|Part 2: Effectiveness||0
206923|NCT01270711|500545|P5|NOT COMPLETED|Part 2: Effectiveness||0
206924|NCT01270711|500546|P4|NOT COMPLETED|Part 2: Effectiveness||0
206925|NCT01270711|500547|P3|NOT COMPLETED|Part 2: Effectiveness||0
206926|NCT01270711|500548|P2|NOT COMPLETED|Part 2: Effectiveness||0
206927|NCT01270711|500549|P1|NOT COMPLETED|Part 2: Effectiveness||0
206928|NCT01270711|500542|P8|COMPLETED|Part 2: Effectiveness||48
206929|NCT01270711|500543|P7|COMPLETED|Part 2: Effectiveness||2
206930|NCT01270711|500544|P6|COMPLETED|Part 2: Effectiveness||11
206931|NCT01270711|500545|P5|COMPLETED|Part 2: Effectiveness||0
206932|NCT01270711|500546|P4|COMPLETED|Part 2: Effectiveness||0
206933|NCT01270711|500547|P3|COMPLETED|Part 2: Effectiveness||0
206934|NCT01270711|500548|P2|COMPLETED|Part 2: Effectiveness||0
206935|NCT01270711|500549|P1|COMPLETED|Part 2: Effectiveness||0
206936|NCT01270711|500542|P8|STARTED|Part 2: Effectiveness||48
206937|NCT01270711|500543|P7|STARTED|Part 2: Effectiveness||2
206938|NCT01270711|500544|P6|STARTED|Part 2: Effectiveness||11
206939|NCT01270711|500545|P5|STARTED|Part 2: Effectiveness||0
206940|NCT01270711|500546|P4|STARTED|Part 2: Effectiveness||0
206941|NCT01270711|500547|P3|STARTED|Part 2: Effectiveness||0
206942|NCT01270711|500548|P2|STARTED|Part 2: Effectiveness||0
206943|NCT01270711|500549|P1|STARTED|Part 2: Effectiveness||0
206944|NCT01270711|500542|P8|NOT COMPLETED|Part 1: Compliance||0
206945|NCT01270711|500543|P7|NOT COMPLETED|Part 1: Compliance||0
206946|NCT01270711|500544|P6|NOT COMPLETED|Part 1: Compliance||0
206947|NCT01270711|500545|P5|NOT COMPLETED|Part 1: Compliance||0
206948|NCT01270711|500546|P4|NOT COMPLETED|Part 1: Compliance||0
206949|NCT01270711|500547|P3|NOT COMPLETED|Part 1: Compliance||0
206950|NCT01270711|500548|P2|NOT COMPLETED|Part 1: Compliance||0
206951|NCT01270711|500549|P1|NOT COMPLETED|Part 1: Compliance||0
206952|NCT01270711|500542|P8|COMPLETED|Part 1: Compliance||0
206953|NCT01270711|500543|P7|COMPLETED|Part 1: Compliance||0
206954|NCT01270711|500544|P6|COMPLETED|Part 1: Compliance||0
206955|NCT01270711|500545|P5|COMPLETED|Part 1: Compliance||2024
206956|NCT01270711|500546|P4|COMPLETED|Part 1: Compliance||5486
206957|NCT01270711|500547|P3|COMPLETED|Part 1: Compliance||326
206958|NCT01270711|500548|P2|COMPLETED|Part 1: Compliance||6580
206959|NCT01270711|500549|P1|COMPLETED|Part 1: Compliance||7537
206960|NCT01270711|500542|P8|STARTED|Part 1: Compliance||0
206961|NCT01270711|500543|P7|STARTED|Part 1: Compliance||0
206962|NCT01270711|500544|P6|STARTED|Part 1: Compliance||0
206963|NCT01270711|500545|P5|STARTED|Part 1: Compliance||2024
206964|NCT01270711|500546|P4|STARTED|Part 1: Compliance||5486
206965|NCT01270711|500547|P3|STARTED|Part 1: Compliance||326
206966|NCT01270711|500548|P2|STARTED|Part 1: Compliance||6580
206967|NCT01270711|500549|P1|STARTED|Part 1: Compliance||7537
206968|NCT01270659|500650|P4|NOT COMPLETED|Overall Study||0
206969|NCT01270659|500651|P3|NOT COMPLETED|Overall Study||0
206970|NCT01270659|500652|P2|NOT COMPLETED|Overall Study||0
206971|NCT01270659|500653|P1|NOT COMPLETED|Overall Study||0
206972|NCT01270659|500650|P4|COMPLETED|Overall Study||25
206973|NCT01270659|500651|P3|COMPLETED|Overall Study||4
206974|NCT01270659|500652|P2|COMPLETED|Overall Study||25
206975|NCT01270659|500653|P1|COMPLETED|Overall Study||6
206976|NCT01270659|500650|P4|STARTED|Overall Study||25
206977|NCT01270659|500651|P3|STARTED|Overall Study||4
206978|NCT01270659|500652|P2|STARTED|Overall Study||25
206979|NCT01270659|500653|P1|STARTED|Overall Study||6
206980|NCT01270620|500673|P2|NOT COMPLETED|Overall Study||3
206981|NCT01270620|500674|P1|NOT COMPLETED|Overall Study||1
206982|NCT01270620|500673|P2|COMPLETED|Overall Study||47
206983|NCT01270620|500674|P1|COMPLETED|Overall Study||49
206984|NCT01270620|500673|P2|STARTED|Overall Study||50
206985|NCT01270620|500674|P1|STARTED|Overall Study||50
206986|NCT01270581|500726|P2|NOT COMPLETED|Overall Study||0
206987|NCT01270581|500727|P1|NOT COMPLETED|Overall Study||1
206988|NCT01270581|500726|P2|COMPLETED|Overall Study||3
206989|NCT01270581|500727|P1|COMPLETED|Overall Study||3
206990|NCT01270581|500726|P2|STARTED|Overall Study||3
206991|NCT01270581|500727|P1|STARTED|Overall Study||4
206992|NCT01270555|500733|P1|NOT COMPLETED|Overall Study||13
206993|NCT01270555|500733|P1|COMPLETED|Overall Study||19
206994|NCT01270555|500733|P1|STARTED|Overall Study||32
206995|NCT01270542|500745|P2|NOT COMPLETED|Overall Study||1
206996|NCT01270542|500746|P1|NOT COMPLETED|Overall Study||1
206997|NCT01270542|500745|P2|COMPLETED|Overall Study||8
206998|NCT01270542|500746|P1|COMPLETED|Overall Study||9
206999|NCT01270542|500745|P2|STARTED|Overall Study||9
207000|NCT01270542|500746|P1|STARTED|Overall Study||10
207001|NCT01270529|500759|P3|NOT COMPLETED|Overall Study||0
207002|NCT01270529|500760|P2|NOT COMPLETED|Overall Study||0
207003|NCT01270529|500761|P1|NOT COMPLETED|Overall Study||0
207004|NCT01270529|500759|P3|COMPLETED|Overall Study||25
207005|NCT01270529|500760|P2|COMPLETED|Overall Study||7
207006|NCT01270529|500761|P1|COMPLETED|Overall Study||12
207007|NCT01270529|500759|P3|STARTED|Overall Study||25
207008|NCT01270529|500760|P2|STARTED|Overall Study||7
207009|NCT01270529|500761|P1|STARTED|Overall Study||12
207010|NCT01270503|500769|P1|NOT COMPLETED|Overall Study||1
207011|NCT01270503|500769|P1|COMPLETED|Overall Study||537
207012|NCT01270503|500769|P1|STARTED|Overall Study||538
207013|NCT01270464|500777|P3|NOT COMPLETED|Overall Study||18
207014|NCT01270464|500778|P2|NOT COMPLETED|Overall Study||12
207015|NCT01270464|500779|P1|NOT COMPLETED|Overall Study||20
207016|NCT01270464|500777|P3|COMPLETED|Overall Study||88
207017|NCT01270464|500778|P2|COMPLETED|Overall Study||92
207018|NCT01270464|500779|P1|COMPLETED|Overall Study||85
207019|NCT01270464|500777|P3|Pharmacokinetic Analysis Set|Overall Study||103
207020|NCT01270464|500778|P2|Pharmacokinetic Analysis Set|Overall Study||103
207021|NCT01270464|500779|P1|Pharmacokinetic Analysis Set|Overall Study||105
207022|NCT01270464|500777|P3|Full Analysis Set|Overall Study||103
207023|NCT01270464|500778|P2|Full Analysis Set|Overall Study||103
207024|NCT01270464|500779|P1|Full Analysis Set|Overall Study||105
207025|NCT01270464|500777|P3|Safety Analysis Set|Overall Study||103
207026|NCT01270464|500778|P2|Safety Analysis Set|Overall Study||103
207027|NCT01270464|500779|P1|Safety Analysis Set|Overall Study||105
207028|NCT01270464|500777|P3|STARTED|Overall Study||106
207029|NCT01270464|500778|P2|STARTED|Overall Study||104
207030|NCT01270464|500779|P1|STARTED|Overall Study||105
207031|NCT01270256|500828|P2|NOT COMPLETED|Overall Study||0
207032|NCT01270256|500829|P1|NOT COMPLETED|Overall Study||1
207033|NCT01270256|500828|P2|COMPLETED|Overall Study||20
207034|NCT01270256|500829|P1|COMPLETED|Overall Study||20
207035|NCT01270256|500828|P2|STARTED|Overall Study||20
207036|NCT01270256|500829|P1|STARTED|Overall Study||21
207037|NCT01270139|500838|P3|NOT COMPLETED|Overall Study||20
207038|NCT01270139|500839|P2|NOT COMPLETED|Overall Study||26
207039|NCT01270139|500840|P1|NOT COMPLETED|Overall Study||18
207040|NCT01270139|500838|P3|COMPLETED|Overall Study|Pre-treatment evaluable population|40
207041|NCT01270139|500839|P2|COMPLETED|Overall Study|Pre-treatment evaluable population|34
207042|NCT01270139|500840|P1|COMPLETED|Overall Study|Pre-treatment evaluable population|42
207043|NCT01270139|500838|P3|STARTED|Overall Study|Intention-to-treat population|60
207044|NCT01270139|500839|P2|STARTED|Overall Study|Intention-to-treat population|60
207045|NCT01270139|500840|P1|STARTED|Overall Study|Intention-to-treat population|60
207046|NCT01270126|500900|P2|NOT COMPLETED|Overall Study||0
207047|NCT01270126|500901|P1|NOT COMPLETED|Overall Study||0
207048|NCT01270126|500900|P2|COMPLETED|Overall Study||10
207049|NCT01270126|500901|P1|COMPLETED|Overall Study||12
207050|NCT01270126|500900|P2|STARTED|Overall Study||10
207051|NCT01270126|500901|P1|STARTED|Overall Study||12
207052|NCT01269918|500909|P2|NOT COMPLETED|Overall Study||3
207053|NCT01269918|500910|P1|NOT COMPLETED|Overall Study||0
207054|NCT01269918|500909|P2|COMPLETED|Overall Study||68
207055|NCT01269918|500910|P1|COMPLETED|Overall Study||71
207056|NCT01269918|500909|P2|STARTED|Overall Study||71
207057|NCT01269918|500910|P1|STARTED|Overall Study||71
207058|NCT01269801|500944|P2|NOT COMPLETED|Overall Study||3
207059|NCT01269801|500945|P1|NOT COMPLETED|Overall Study||0
207060|NCT01269801|500944|P2|COMPLETED|Overall Study||77
207061|NCT01269801|500945|P1|COMPLETED|Overall Study||74
207062|NCT01269801|500944|P2|STARTED|Overall Study||80
207063|NCT01269801|500945|P1|STARTED|Overall Study||74
207064|NCT01269749|500953|P2|NOT COMPLETED|Overall Study||0
207065|NCT01269749|500954|P1|NOT COMPLETED|Overall Study||0
207066|NCT01269749|500953|P2|COMPLETED|Overall Study||3
207067|NCT01269749|500954|P1|COMPLETED|Overall Study||16
207068|NCT01269749|500953|P2|STARTED|Overall Study||3
207069|NCT01269749|500954|P1|STARTED|Overall Study||16
207070|NCT01269736|500964|P2|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
207071|NCT01269736|500965|P1|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
207072|NCT01269736|500964|P2|COMPLETED|Patient Outcomes (Hospital Admissions)|43799 unique patients assessed overall (at any time point) by end of study.|43799
207073|NCT01269736|500965|P1|COMPLETED|Patient Outcomes (Hospital Admissions)|52085 unique patients assessed overall (at any time point) by end of study.|52085
207074|NCT01269736|500964|P2|30 Months Assessment|Patient Outcomes (Hospital Admissions)|13265 unique patients, assessed at 6 hospitals.|13265
207075|NCT01269736|500965|P1|30 Months Assessment|Patient Outcomes (Hospital Admissions)|16702 unique patients, assessed at 7 hospitals.|16702
207076|NCT01269736|500964|P2|15 Months Assessment|Patient Outcomes (Hospital Admissions)|14075 unique patients, assessed at 6 hospitals.|14075
207077|NCT01269736|500965|P1|15 Months Assessment|Patient Outcomes (Hospital Admissions)|18031 unique patients, assessed at 7 hospitals.|18031
207078|NCT01269736|500964|P2|Baseline Assessment|Patient Outcomes (Hospital Admissions)|16549 unique patients, assessed at 6 hospitals.|16549
207079|NCT01269736|500965|P1|Baseline Assessment|Patient Outcomes (Hospital Admissions)|17352 unique patients, assessed at 7 hospitals.|17352
207080|NCT01269736|500964|P2|STARTED|Patient Outcomes (Hospital Admissions)|16459 unique patients were assessed at 6 hospitals at the initiation of the study.|43799
207081|NCT01269736|500965|P1|STARTED|Patient Outcomes (Hospital Admissions)|17352 unique patients were assessed at 7 hospitals at the initiation of the study.|52085
207082|NCT01269736|500964|P2|NOT COMPLETED|Patient Quality of Care Assessments||0
207083|NCT01269736|500965|P1|NOT COMPLETED|Patient Quality of Care Assessments||0
207084|NCT01269736|500964|P2|COMPLETED|Patient Quality of Care Assessments|2288 unique patients assessed overall (at any time point) by end of study.|2288
207085|NCT01269736|500965|P1|COMPLETED|Patient Quality of Care Assessments|2299 unique patients assessed overall (at any time point) by end of study.|2299
207086|NCT01269736|500964|P2|30 Months Assessment|Patient Quality of Care Assessments|626 unique patients, assessed at 7 hospitals.|626
207087|NCT01269736|500965|P1|30 Months Assessment|Patient Quality of Care Assessments|697 unique patients, assessed at 8 hospitals.|697
207088|NCT01269736|500964|P2|15 Months Assessment|Patient Quality of Care Assessments|773 unique patients, assessed at 8 hospitals.|773
207089|NCT01269736|500965|P1|15 Months Assessment|Patient Quality of Care Assessments|687 unique patients, assessed at 8 hospitals.|687
207090|NCT01269736|500964|P2|Baseline Assessment|Patient Quality of Care Assessments|889 unique patients, assessed at 8 hospitals.|889
207091|NCT01269736|500965|P1|Baseline Assessment|Patient Quality of Care Assessments|915 unique patients, assessed at 9 hospitals.|915
207092|NCT01269736|500964|P2|STARTED|Patient Quality of Care Assessments|889 unique patients were assessed at 8 hospitals at the initiation of the study.|2288
207093|NCT01269736|500965|P1|STARTED|Patient Quality of Care Assessments|915 unique patients were assessed at 9 hospitals at the initiation of the study.|2299
207094|NCT01269736|500964|P2|NOT COMPLETED|Nurses' Knowledge Assessments||0
207095|NCT01269736|500965|P1|NOT COMPLETED|Nurses' Knowledge Assessments||0
207096|NCT01269736|500964|P2|COMPLETED|Nurses' Knowledge Assessments|1428 unique nurses assessed overall (at any time point) by end of study.|1428
207097|NCT01269736|500965|P1|COMPLETED|Nurses' Knowledge Assessments|1585 unique nurses assessed overall (at any time point) by end of study.|1585
207098|NCT01269736|500964|P2|30 Months Assessment|Nurses' Knowledge Assessments|926 unique nurses, assessed at 8 hospitals.|926
207099|NCT01269736|500965|P1|30 Months Assessment|Nurses' Knowledge Assessments|741 unique nurses, assessed at 8 hospitals.|741
207100|NCT01269736|500964|P2|15 Months Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|782
207101|NCT01269736|500965|P1|15 Months Assessment|Nurses' Knowledge Assessments|1108 unique nurses, assessed at 9 hospitals.|1108
207102|NCT01269736|500964|P2|Baseline Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|866
207103|NCT01269736|500965|P1|Baseline Assessment|Nurses' Knowledge Assessments|873 unique nurses, assessed at 9 hospitals.|873
207104|NCT01269736|500964|P2|STARTED|Nurses' Knowledge Assessments|866 unique nurses were assessed at 8 hospitals at the initiation of the study.|1428
207105|NCT01269736|500965|P1|STARTED|Nurses' Knowledge Assessments|873 unique nurses were assessed at 9 hospitals at the initiation of the study.|1585
207106|NCT01269710|500977|P1|NOT COMPLETED|Overall Study||3
207107|NCT01269710|500977|P1|COMPLETED|Overall Study|This refers to Week 52.|1
207108|NCT01269710|500977|P1|Week 36|Overall Study||2
207109|NCT01269710|500977|P1|Week 12|Overall Study||3
207110|NCT01269710|500977|P1|STARTED|Overall Study||4
207111|NCT01269346|500985|P1|NOT COMPLETED|Extension Phase||43
207112|NCT01269346|500985|P1|COMPLETED|Extension Phase||0
207113|NCT01269346|500985|P1|STARTED|Extension Phase|Out of 52 participants randomized, only 43 continued into the Extension Phase of the study.|43
207114|NCT01269346|500985|P1|NOT COMPLETED|Treatment Phase||9
207115|NCT01269346|500985|P1|COMPLETED|Treatment Phase||43
207116|NCT01269346|500985|P1|Completed 6 Cycles|Treatment Phase||45
207117|NCT01269346|500985|P1|STARTED|Treatment Phase||52
207118|NCT01269125|500996|P3|NOT COMPLETED|Overall Study||0
207119|NCT01269125|500997|P2|NOT COMPLETED|Overall Study||5
207120|NCT01269125|500998|P1|NOT COMPLETED|Overall Study||7
207121|NCT01269125|500996|P3|COMPLETED|Overall Study||60
207122|NCT01269125|500997|P2|COMPLETED|Overall Study|OHSS:4; premature luteinization: 1|55
207123|NCT01269125|500998|P1|COMPLETED|Overall Study|lost to follow up:4; OHSS: 2; premature luteinization: 1|53
207124|NCT01269125|500996|P3|STARTED|Overall Study||60
207125|NCT01269125|500997|P2|STARTED|Overall Study||60
207126|NCT01269125|500998|P1|STARTED|Overall Study||60
207127|NCT01269047|501021|P3|NOT COMPLETED|Overall Study||1
207128|NCT01269047|501022|P2|NOT COMPLETED|Overall Study||2
207129|NCT01269047|501023|P1|NOT COMPLETED|Overall Study||1
207130|NCT01269047|501021|P3|COMPLETED|Overall Study||10
207131|NCT01269047|501022|P2|COMPLETED|Overall Study||11
207132|NCT01269047|501023|P1|COMPLETED|Overall Study||12
207133|NCT01269047|501021|P3|STARTED|Overall Study||11
207134|NCT01269047|501022|P2|STARTED|Overall Study||13
207135|NCT01269047|501023|P1|STARTED|Overall Study||13
207136|NCT01268943|501042|P4|NOT COMPLETED|Overall Study||0
207137|NCT01268943|501043|P3|NOT COMPLETED|Overall Study||0
207138|NCT01268943|501044|P2|NOT COMPLETED|Overall Study||0
207139|NCT01268943|501045|P1|NOT COMPLETED|Overall Study||0
207140|NCT01268943|501042|P4|COMPLETED|Overall Study||6
207141|NCT01268943|501043|P3|COMPLETED|Overall Study||3
207142|NCT01268943|501044|P2|COMPLETED|Overall Study||3
207143|NCT01268943|501045|P1|COMPLETED|Overall Study||6
207144|NCT01268943|501042|P4|STARTED|Overall Study||6
207145|NCT01268943|501043|P3|STARTED|Overall Study||3
207146|NCT01268943|501044|P2|STARTED|Overall Study||3
207147|NCT01268943|501045|P1|STARTED|Overall Study||6
207148|NCT01268891|501057|P2|NOT COMPLETED|Overall Study||8
207149|NCT01268891|501058|P1|NOT COMPLETED|Overall Study||8
207150|NCT01268891|501057|P2|COMPLETED|Overall Study||58
207151|NCT01268891|501058|P1|COMPLETED|Overall Study||58
207152|NCT01268891|501057|P2|STARTED|Overall Study||66
207153|NCT01268891|501058|P1|STARTED|Overall Study||66
207154|NCT01268683|501070|P1|NOT COMPLETED|Overall Study||0
207155|NCT01268683|501070|P1|COMPLETED|Overall Study||10
207156|NCT01268683|501070|P1|STARTED|Overall Study||10
207157|NCT01268644|501077|P1|NOT COMPLETED|Phase C (Weeks 20-24) Off Leptin Therapy||0
207158|NCT01268644|501077|P1|COMPLETED|Phase C (Weeks 20-24) Off Leptin Therapy||7
207159|NCT01268644|501077|P1|STARTED|Phase C (Weeks 20-24) Off Leptin Therapy||7
207160|NCT01268644|501077|P1|NOT COMPLETED|Phase B (Weeks 12-20) Leptin Therapy||0
207161|NCT01268644|501077|P1|COMPLETED|Phase B (Weeks 12-20) Leptin Therapy||7
207162|NCT01268644|501077|P1|STARTED|Phase B (Weeks 12-20) Leptin Therapy|One subject withdrew after 12 weeks .|7
207163|NCT01268644|501077|P1|NOT COMPLETED|Phase A (Weeks 0–12) Leptin Therapy||0
207164|NCT01268644|501077|P1|COMPLETED|Phase A (Weeks 0–12) Leptin Therapy||8
207165|NCT01268644|501077|P1|STARTED|Phase A (Weeks 0–12) Leptin Therapy||8
207166|NCT01268644|501077|P1|NOT COMPLETED|Baseline Period (Week 0)||0
207167|NCT01268644|501077|P1|COMPLETED|Baseline Period (Week 0)||8
207168|NCT01268644|501077|P1|STARTED|Baseline Period (Week 0)||8
207169|NCT01268566|501084|P1|NOT COMPLETED|Overall Study||43
207170|NCT01268566|501084|P1|COMPLETED|Overall Study||13
207171|NCT01268566|501084|P1|STARTED|Overall Study||56
207172|NCT01268553|501102|P1|NOT COMPLETED|Overall Study||0
207173|NCT01268553|501102|P1|COMPLETED|Overall Study||6
207174|NCT01268553|501102|P1|STARTED|Overall Study||6
207175|NCT01268514|501111|P1|NOT COMPLETED|Overall Study||41
207176|NCT01268514|501111|P1|COMPLETED|Overall Study||74
207177|NCT01268514|501111|P1|Participants Who Received the Device|Overall Study||114
207178|NCT01268514|501111|P1|STARTED|Overall Study||115
207179|NCT01268501|501120|P1|NOT COMPLETED|Overall Study||9
207180|NCT01268501|501120|P1|COMPLETED|Overall Study||87
207181|NCT01268501|501120|P1|STARTED|Overall Study||96
207182|NCT01268488|501124|P1|NOT COMPLETED|Overall Study||5
207183|NCT01268488|501124|P1|COMPLETED|Overall Study||93
207184|NCT01268488|501124|P1|STARTED|Overall Study||98
207185|NCT01268306|501131|P1|NOT COMPLETED|Overall Study||1
207186|NCT01268306|501131|P1|COMPLETED|Overall Study||7
207187|NCT01268306|501131|P1|STARTED|Overall Study||8
207188|NCT01268293|501135|P1|NOT COMPLETED|Overall Study||9
207189|NCT01268293|501135|P1|COMPLETED|Overall Study||0
207190|NCT01268293|501135|P1|Completed Cycle 1|Overall Study||9
207191|NCT01268293|501135|P1|STARTED|Overall Study||9
207192|NCT01268267|501140|P1|NOT COMPLETED|Overall Study||1
207193|NCT01268267|501140|P1|COMPLETED|Overall Study||93
207194|NCT01268267|501140|P1|STARTED|Overall Study||94
207195|NCT01268189|501147|P1|NOT COMPLETED|Overall Study||3
207196|NCT01268189|501147|P1|COMPLETED|Overall Study||17
207197|NCT01268189|501147|P1|STARTED|Overall Study||20
207198|NCT01268150|501161|P1|NOT COMPLETED|Extension Phase||27
207199|NCT01268150|501161|P1|COMPLETED|Extension Phase||1
207200|NCT01268150|501161|P1|Treatment Ongoing at Data Cutoff Date|Extension Phase||1
207201|NCT01268150|501161|P1|STARTED|Extension Phase|28 participants discontinued study drug in Treatment Phase so did not enter the Extension Phase|28
207202|NCT01268150|501161|P1|NOT COMPLETED|Treatment Phase||28
207203|NCT01268150|501161|P1|COMPLETED|Treatment Phase||28
207204|NCT01268150|501161|P1|STARTED|Treatment Phase||56
207205|NCT01268111|501171|P2|NOT COMPLETED|Overall Study||0
207206|NCT01268111|501172|P1|NOT COMPLETED|Overall Study||0
207207|NCT01268111|501171|P2|COMPLETED|Overall Study||6
207208|NCT01268111|501172|P1|COMPLETED|Overall Study||6
207209|NCT01268111|501171|P2|STARTED|Overall Study||6
207210|NCT01268111|501172|P1|STARTED|Overall Study||6
207211|NCT01268098|501180|P2|NOT COMPLETED|Overall Study||0
207212|NCT01268098|501181|P1|NOT COMPLETED|Overall Study||1
207213|NCT01268098|501180|P2|COMPLETED|Overall Study||23
207214|NCT01268098|501181|P1|COMPLETED|Overall Study||18
207215|NCT01268098|501180|P2|STARTED|Overall Study||23
207216|NCT01268098|501181|P1|STARTED|Overall Study||19
207217|NCT01268046|501193|P4|NOT COMPLETED|Overall Study||1
207218|NCT01268046|501194|P3|NOT COMPLETED|Overall Study||1
207219|NCT01268046|501195|P2|NOT COMPLETED|Overall Study||0
207220|NCT01268046|501196|P1|NOT COMPLETED|Overall Study||1
207221|NCT01268046|501193|P4|COMPLETED|Overall Study||7
207222|NCT01268046|501194|P3|COMPLETED|Overall Study||7
207223|NCT01268046|501195|P2|COMPLETED|Overall Study||9
207224|NCT01268046|501196|P1|COMPLETED|Overall Study||12
207225|NCT01268046|501193|P4|STARTED|Overall Study||8
207226|NCT01268046|501194|P3|STARTED|Overall Study||8
207227|NCT01268046|501195|P2|STARTED|Overall Study||9
207228|NCT01268046|501196|P1|STARTED|Overall Study||13
207229|NCT01267994|501206|P1|NOT COMPLETED|Overall Study||2
207230|NCT01267994|501206|P1|COMPLETED|Overall Study|Excluded from analysis, could not reach first milestone (day 28) for efficacy assessment, n=2|10
207231|NCT01267994|501206|P1|STARTED|Overall Study|Declined to participate. n=1 Did not receive intervention due to infeciton, n=1|12
207232|NCT01267955|501211|P1|NOT COMPLETED|Stage 2 (6 Months)||6
207233|NCT01267955|501211|P1|COMPLETED|Stage 2 (6 Months)||39
207234|NCT01267955|501211|P1|STARTED|Stage 2 (6 Months)||45
207235|NCT01267955|501211|P1|NOT COMPLETED|Stage 1 (6 Months)||3
207236|NCT01267955|501211|P1|COMPLETED|Stage 1 (6 Months)||17
207237|NCT01267955|501211|P1|STARTED|Stage 1 (6 Months)||20
207238|NCT01267929|501217|P2|NOT COMPLETED|Overall Study||0
207239|NCT01267929|501218|P1|NOT COMPLETED|Overall Study||0
207240|NCT01267929|501217|P2|COMPLETED|Overall Study||15
207241|NCT01267929|501218|P1|COMPLETED|Overall Study||15
207242|NCT01267929|501217|P2|STARTED|Overall Study||15
207243|NCT01267929|501218|P1|STARTED|Overall Study||15
207244|NCT01267864|501227|P3|NOT COMPLETED|Overall Study||0
207245|NCT01267864|501228|P2|NOT COMPLETED|Overall Study||0
207246|NCT01267864|501229|P1|NOT COMPLETED|Overall Study||0
207247|NCT01267864|501227|P3|COMPLETED|Overall Study||110
207248|NCT01267864|501228|P2|COMPLETED|Overall Study||110
207249|NCT01267864|501229|P1|COMPLETED|Overall Study||110
207250|NCT01267864|501227|P3|STARTED|Overall Study||110
207251|NCT01267864|501228|P2|STARTED|Overall Study||110
207252|NCT01267864|501229|P1|STARTED|Overall Study||110
207253|NCT01267825|501248|P2|NOT COMPLETED|Overall Study||0
207254|NCT01267825|501249|P1|NOT COMPLETED|Overall Study||1
207255|NCT01267825|501248|P2|COMPLETED|Overall Study||0
207256|NCT01267825|501249|P1|COMPLETED|Overall Study||0
207257|NCT01267825|501248|P2|STARTED|Overall Study||0
207258|NCT01267825|501249|P1|STARTED|Overall Study||1
207259|NCT01267422|501259|P2|NOT COMPLETED|Safety and Efficacy Study||0
207260|NCT01267422|501260|P1|NOT COMPLETED|Safety and Efficacy Study||0
207261|NCT01267422|501259|P2|COMPLETED|Safety and Efficacy Study||4
207262|NCT01267422|501260|P1|COMPLETED|Safety and Efficacy Study||5
207263|NCT01267422|501259|P2|STARTED|Safety and Efficacy Study||4
207264|NCT01267422|501260|P1|STARTED|Safety and Efficacy Study||5
207265|NCT01267422|501259|P2|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
207266|NCT01267422|501260|P1|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
207267|NCT01267422|501259|P2|COMPLETED|Intravitreal rAAV2-ND4 Injection||4
207268|NCT01267422|501260|P1|COMPLETED|Intravitreal rAAV2-ND4 Injection||5
207269|NCT01267422|501259|P2|STARTED|Intravitreal rAAV2-ND4 Injection||4
207270|NCT01267422|501260|P1|STARTED|Intravitreal rAAV2-ND4 Injection||5
207271|NCT01267292|501280|P2|NOT COMPLETED|Overall Study||6
207272|NCT01267292|501281|P1|NOT COMPLETED|Overall Study||4
207273|NCT01267292|501280|P2|COMPLETED|Overall Study||20
207274|NCT01267292|501281|P1|COMPLETED|Overall Study||20
207275|NCT01267292|501280|P2|STARTED|Overall Study||26
207276|NCT01267292|501281|P1|STARTED|Overall Study||24
207277|NCT01267279|501317|P2|NOT COMPLETED|Overall Study||6
207278|NCT01267279|501318|P1|NOT COMPLETED|Overall Study||2
207279|NCT01267279|501317|P2|COMPLETED|Overall Study||21
207280|NCT01267279|501318|P1|COMPLETED|Overall Study||22
207281|NCT01267279|501317|P2|STARTED|Overall Study||27
207282|NCT01267279|501318|P1|STARTED|Overall Study||24
207283|NCT01267266|501324|P2|NOT COMPLETED|Randomized Phase||0
207284|NCT01267266|501325|P1|NOT COMPLETED|Randomized Phase||0
207285|NCT01267266|501324|P2|COMPLETED|Randomized Phase||5
207286|NCT01267266|501325|P1|COMPLETED|Randomized Phase||3
207287|NCT01267266|501324|P2|STARTED|Randomized Phase|5 of 8 patients randomized to placebo.|5
207288|NCT01267266|501325|P1|STARTED|Randomized Phase|3 of 8 patients randomized to saracatinib.|3
207289|NCT01267266|501324|P2|NOT COMPLETED|Lead-in Phase||0
207290|NCT01267266|501325|P1|NOT COMPLETED|Lead-in Phase||23
207291|NCT01267266|501324|P2|COMPLETED|Lead-in Phase||0
207292|NCT01267266|501325|P1|COMPLETED|Lead-in Phase|12 patients had radiographic progression, 8 clinical progression, 2 toxicity, 1 withdrawal.|8
207293|NCT01267266|501324|P2|STARTED|Lead-in Phase||0
207294|NCT01267266|501325|P1|STARTED|Lead-in Phase||31
207295|NCT01267266|501324|P2|NOT COMPLETED|Enrollment Phase||0
207296|NCT01267266|501325|P1|NOT COMPLETED|Enrollment Phase||2
207297|NCT01267266|501324|P2|COMPLETED|Enrollment Phase||0
207298|NCT01267266|501325|P1|COMPLETED|Enrollment Phase|Two patients signed consent but did not proceed to treatment.|31
207299|NCT01267266|501324|P2|STARTED|Enrollment Phase||0
207300|NCT01267266|501325|P1|STARTED|Enrollment Phase||33
207301|NCT01267253|501338|P1|NOT COMPLETED|Overall Study||3
207302|NCT01267253|501338|P1|COMPLETED|Overall Study|Eligible and treated patients|28
207303|NCT01267253|501338|P1|STARTED|Overall Study||31
207304|NCT01267240|501346|P1|NOT COMPLETED|Overall Study||0
207305|NCT01267240|501346|P1|COMPLETED|Overall Study||25
207306|NCT01267240|501346|P1|STARTED|Overall Study||25
207307|NCT01267227|501356|P4|NOT COMPLETED|Overall Study||3
207308|NCT01267227|501357|P3|NOT COMPLETED|Overall Study||2
207309|NCT01267227|501358|P2|NOT COMPLETED|Overall Study||1
207310|NCT01267227|501359|P1|NOT COMPLETED|Overall Study||1
207311|NCT01267227|501356|P4|COMPLETED|Overall Study||17
207312|NCT01267227|501357|P3|COMPLETED|Overall Study||18
207313|NCT01267227|501358|P2|COMPLETED|Overall Study||19
207314|NCT01267227|501359|P1|COMPLETED|Overall Study||19
207315|NCT01267227|501356|P4|STARTED|Overall Study||20
207316|NCT01267227|501357|P3|STARTED|Overall Study||20
207317|NCT01267227|501358|P2|STARTED|Overall Study||20
207318|NCT01267227|501359|P1|STARTED|Overall Study||20
207319|NCT01267201|501377|P6|NOT COMPLETED|Third Intervention Period||0
207320|NCT01267201|501378|P5|NOT COMPLETED|Third Intervention Period||0
207321|NCT01267201|501379|P4|NOT COMPLETED|Third Intervention Period||0
207322|NCT01267201|501380|P3|NOT COMPLETED|Third Intervention Period||0
207323|NCT01267201|501381|P2|NOT COMPLETED|Third Intervention Period||0
207324|NCT01267201|501382|P1|NOT COMPLETED|Third Intervention Period||0
207325|NCT01267201|501377|P6|COMPLETED|Third Intervention Period||4
207326|NCT01267201|501378|P5|COMPLETED|Third Intervention Period||4
207327|NCT01267201|501379|P4|COMPLETED|Third Intervention Period||4
207328|NCT01267201|501380|P3|COMPLETED|Third Intervention Period||4
207329|NCT01267201|501381|P2|COMPLETED|Third Intervention Period||3
207330|NCT01267201|501382|P1|COMPLETED|Third Intervention Period||3
207331|NCT01267201|501377|P6|STARTED|Third Intervention Period||4
207332|NCT01267201|501378|P5|STARTED|Third Intervention Period||4
207333|NCT01267201|501379|P4|STARTED|Third Intervention Period||4
207334|NCT01267201|501380|P3|STARTED|Third Intervention Period||4
207335|NCT01267201|501381|P2|STARTED|Third Intervention Period||3
207336|NCT01267201|501382|P1|STARTED|Third Intervention Period||3
207337|NCT01267201|501377|P6|NOT COMPLETED|Washout Period (At Least 2 Days)||0
207338|NCT01267201|501378|P5|NOT COMPLETED|Washout Period (At Least 2 Days)||0
207339|NCT01267201|501379|P4|NOT COMPLETED|Washout Period (At Least 2 Days)||0
207340|NCT01267201|501380|P3|NOT COMPLETED|Washout Period (At Least 2 Days)||0
207341|NCT01267201|501381|P2|NOT COMPLETED|Washout Period (At Least 2 Days)||0
207342|NCT01267201|501382|P1|NOT COMPLETED|Washout Period (At Least 2 Days)||0
207343|NCT01267201|501377|P6|COMPLETED|Washout Period (At Least 2 Days)||4
207344|NCT01267201|501378|P5|COMPLETED|Washout Period (At Least 2 Days)||4
207345|NCT01267201|501379|P4|COMPLETED|Washout Period (At Least 2 Days)||4
207346|NCT01267201|501380|P3|COMPLETED|Washout Period (At Least 2 Days)||4
207347|NCT01267201|501381|P2|COMPLETED|Washout Period (At Least 2 Days)||3
207348|NCT01267201|501382|P1|COMPLETED|Washout Period (At Least 2 Days)||3
207349|NCT01267201|501377|P6|STARTED|Washout Period (At Least 2 Days)||4
207350|NCT01267201|501378|P5|STARTED|Washout Period (At Least 2 Days)||4
207351|NCT01267201|501379|P4|STARTED|Washout Period (At Least 2 Days)||4
207352|NCT01267201|501380|P3|STARTED|Washout Period (At Least 2 Days)||4
207353|NCT01267201|501381|P2|STARTED|Washout Period (At Least 2 Days)||3
207354|NCT01267201|501382|P1|STARTED|Washout Period (At Least 2 Days)||3
207355|NCT01267201|501377|P6|NOT COMPLETED|Second Intervention Period||0
207356|NCT01267201|501378|P5|NOT COMPLETED|Second Intervention Period||0
207357|NCT01267201|501379|P4|NOT COMPLETED|Second Intervention Period||0
207358|NCT01267201|501380|P3|NOT COMPLETED|Second Intervention Period||0
207359|NCT01267201|501381|P2|NOT COMPLETED|Second Intervention Period||1
207360|NCT01267201|501382|P1|NOT COMPLETED|Second Intervention Period||0
207361|NCT01267201|501377|P6|COMPLETED|Second Intervention Period||4
207362|NCT01267201|501378|P5|COMPLETED|Second Intervention Period||4
207363|NCT01267201|501379|P4|COMPLETED|Second Intervention Period||4
207364|NCT01267201|501380|P3|COMPLETED|Second Intervention Period||4
207365|NCT01267201|501381|P2|COMPLETED|Second Intervention Period||3
207366|NCT01267201|501382|P1|COMPLETED|Second Intervention Period||3
207367|NCT01267201|501377|P6|STARTED|Second Intervention Period||4
207368|NCT01267201|501378|P5|STARTED|Second Intervention Period||4
207369|NCT01267201|501379|P4|STARTED|Second Intervention Period||4
207370|NCT01267201|501380|P3|STARTED|Second Intervention Period||4
207371|NCT01267201|501381|P2|STARTED|Second Intervention Period||4
207372|NCT01267201|501382|P1|STARTED|Second Intervention Period||3
207373|NCT01267201|501377|P6|NOT COMPLETED|Washout Period (At Least 2 Days)||0
207374|NCT01267201|501378|P5|NOT COMPLETED|Washout Period (At Least 2 Days)||0
207375|NCT01267201|501379|P4|NOT COMPLETED|Washout Period (At Least 2 Days)||0
207376|NCT01267201|501380|P3|NOT COMPLETED|Washout Period (At Least 2 Days)||0
207377|NCT01267201|501381|P2|NOT COMPLETED|Washout Period (At Least 2 Days)||0
207378|NCT01267201|501382|P1|NOT COMPLETED|Washout Period (At Least 2 Days)||0
207379|NCT01267201|501377|P6|COMPLETED|Washout Period (At Least 2 Days)||4
207380|NCT01267201|501378|P5|COMPLETED|Washout Period (At Least 2 Days)||4
207381|NCT01267201|501379|P4|COMPLETED|Washout Period (At Least 2 Days)||4
207382|NCT01267201|501380|P3|COMPLETED|Washout Period (At Least 2 Days)||4
207383|NCT01267201|501381|P2|COMPLETED|Washout Period (At Least 2 Days)||4
207384|NCT01267201|501382|P1|COMPLETED|Washout Period (At Least 2 Days)||3
207385|NCT01267201|501377|P6|STARTED|Washout Period (At Least 2 Days)||4
207386|NCT01267201|501378|P5|STARTED|Washout Period (At Least 2 Days)||4
207387|NCT01267201|501379|P4|STARTED|Washout Period (At Least 2 Days)||4
207388|NCT01267201|501380|P3|STARTED|Washout Period (At Least 2 Days)||4
207389|NCT01267201|501381|P2|STARTED|Washout Period (At Least 2 Days)||4
207390|NCT01267201|501382|P1|STARTED|Washout Period (At Least 2 Days)||3
207391|NCT01267201|501377|P6|NOT COMPLETED|First Intervention Period||0
207392|NCT01267201|501378|P5|NOT COMPLETED|First Intervention Period||0
207393|NCT01267201|501379|P4|NOT COMPLETED|First Intervention Period||0
207394|NCT01267201|501380|P3|NOT COMPLETED|First Intervention Period||0
207395|NCT01267201|501381|P2|NOT COMPLETED|First Intervention Period||0
207396|NCT01267201|501382|P1|NOT COMPLETED|First Intervention Period||1
207397|NCT01267201|501377|P6|COMPLETED|First Intervention Period||4
207398|NCT01267201|501378|P5|COMPLETED|First Intervention Period||4
207399|NCT01267201|501379|P4|COMPLETED|First Intervention Period||4
207400|NCT01267201|501380|P3|COMPLETED|First Intervention Period||4
207401|NCT01267201|501381|P2|COMPLETED|First Intervention Period||4
207402|NCT01267201|501382|P1|COMPLETED|First Intervention Period||3
207403|NCT01267201|501377|P6|STARTED|First Intervention Period||4
207404|NCT01267201|501378|P5|STARTED|First Intervention Period||4
207405|NCT01267201|501379|P4|STARTED|First Intervention Period||4
207406|NCT01267201|501380|P3|STARTED|First Intervention Period||4
207407|NCT01267201|501381|P2|STARTED|First Intervention Period||4
207408|NCT01267201|501382|P1|STARTED|First Intervention Period||4
207409|NCT01267175|501399|P1|NOT COMPLETED|Overall Study||2
207410|NCT01267175|501399|P1|COMPLETED|Overall Study||29
207411|NCT01267175|501399|P1|STARTED|Overall Study||31
207412|NCT01267136|501406|P2|NOT COMPLETED|Overall Study||6
207413|NCT01267136|501407|P1|NOT COMPLETED|Overall Study||4
207414|NCT01267136|501406|P2|COMPLETED|Overall Study||36
207415|NCT01267136|501407|P1|COMPLETED|Overall Study||38
207416|NCT01267136|501406|P2|STARTED|Overall Study||42
207417|NCT01267136|501407|P1|STARTED|Overall Study||42
207418|NCT01267045|501417|P2|NOT COMPLETED|6-month Outcome||3
207419|NCT01267045|501418|P1|NOT COMPLETED|6-month Outcome||0
207420|NCT01267045|501417|P2|COMPLETED|6-month Outcome||23
207421|NCT01267045|501418|P1|COMPLETED|6-month Outcome||22
207422|NCT01267045|501417|P2|STARTED|6-month Outcome||26
207423|NCT01267045|501418|P1|STARTED|6-month Outcome||22
207424|NCT01267045|501417|P2|NOT COMPLETED|2-month Outcomes||3
207425|NCT01267045|501418|P1|NOT COMPLETED|2-month Outcomes||4
207426|NCT01267045|501417|P2|COMPLETED|2-month Outcomes||26
207427|NCT01267045|501418|P1|COMPLETED|2-month Outcomes||22
207428|NCT01267045|501417|P2|STARTED|2-month Outcomes||29
207429|NCT01267045|501418|P1|STARTED|2-month Outcomes||26
207430|NCT01267019|501453|P3|NOT COMPLETED|Overall Study||6
207431|NCT01267019|501454|P2|NOT COMPLETED|Overall Study||6
207432|NCT01267019|501455|P1|NOT COMPLETED|Overall Study||6
207433|NCT01267019|501453|P3|COMPLETED|Overall Study||47
207434|NCT01267019|501454|P2|COMPLETED|Overall Study||47
207435|NCT01267019|501455|P1|COMPLETED|Overall Study||41
207436|NCT01267019|501453|P3|STARTED|Overall Study||53
207437|NCT01267019|501454|P2|STARTED|Overall Study||53
207438|NCT01267019|501455|P1|STARTED|Overall Study||47
207439|NCT01266993|501471|P2|NOT COMPLETED|Booster Phase (Month 69)||2
207440|NCT01266993|501472|P1|NOT COMPLETED|Booster Phase (Month 69)||5
207441|NCT01266993|501471|P2|COMPLETED|Booster Phase (Month 69)||60
207442|NCT01266993|501472|P1|COMPLETED|Booster Phase (Month 69)||174
207443|NCT01266993|501471|P2|STARTED|Booster Phase (Month 69)||62
207444|NCT01266993|501472|P1|STARTED|Booster Phase (Month 69)||179
207445|NCT01266993|501471|P2|NOT COMPLETED|Persistence Phase (Month 68)||0
207446|NCT01266993|501472|P1|NOT COMPLETED|Persistence Phase (Month 68)||0
207447|NCT01266993|501471|P2|COMPLETED|Persistence Phase (Month 68)||62
207448|NCT01266993|501472|P1|COMPLETED|Persistence Phase (Month 68)||179
207449|NCT01266993|501471|P2|STARTED|Persistence Phase (Month 68)||62
207450|NCT01266993|501472|P1|STARTED|Persistence Phase (Month 68)||179
207451|NCT01266993|501471|P2|NOT COMPLETED|Persistence Phase (Month 56)||0
207452|NCT01266993|501472|P1|NOT COMPLETED|Persistence Phase (Month 56)||0
207453|NCT01266993|501471|P2|COMPLETED|Persistence Phase (Month 56)||67
207454|NCT01266993|501472|P1|COMPLETED|Persistence Phase (Month 56)||193
207455|NCT01266993|501471|P2|STARTED|Persistence Phase (Month 56)||67
207456|NCT01266993|501472|P1|STARTED|Persistence Phase (Month 56)||193
207457|NCT01266993|501471|P2|NOT COMPLETED|Persistence Phase (Month 44)||0
207458|NCT01266993|501472|P1|NOT COMPLETED|Persistence Phase (Month 44)||0
207459|NCT01266993|501471|P2|COMPLETED|Persistence Phase (Month 44)||68
207460|NCT01266993|501472|P1|COMPLETED|Persistence Phase (Month 44)||193
207461|NCT01266993|501471|P2|STARTED|Persistence Phase (Month 44)||68
207462|NCT01266993|501472|P1|STARTED|Persistence Phase (Month 44)||193
207463|NCT01266993|501471|P2|NOT COMPLETED|Persistence Phase (Month 32)||0
207464|NCT01266993|501472|P1|NOT COMPLETED|Persistence Phase (Month 32)||0
207465|NCT01266993|501471|P2|COMPLETED|Persistence Phase (Month 32)||72
207466|NCT01266993|501472|P1|COMPLETED|Persistence Phase (Month 32)||199
207467|NCT01266993|501471|P2|STARTED|Persistence Phase (Month 32)||72
207468|NCT01266993|501472|P1|STARTED|Persistence Phase (Month 32)||199
207469|NCT01266967|501542|P2|NOT COMPLETED|Overall Study||83
207470|NCT01266967|501543|P1|NOT COMPLETED|Overall Study||89
207471|NCT01266967|501542|P2|COMPLETED|Overall Study||0
207472|NCT01266967|501543|P1|COMPLETED|Overall Study||0
207473|NCT01266967|501542|P2|STARTED|Overall Study||83
207474|NCT01266967|501543|P1|STARTED|Overall Study||89
207475|NCT01266876|501595|P5|NOT COMPLETED|Overall Study||0
207476|NCT01266876|501596|P4|NOT COMPLETED|Overall Study||1
207477|NCT01266876|501597|P3|NOT COMPLETED|Overall Study||0
207478|NCT01266876|501598|P2|NOT COMPLETED|Overall Study||0
207479|NCT01266876|501599|P1|NOT COMPLETED|Overall Study||0
207480|NCT01266876|501595|P5|COMPLETED|Overall Study||16
207481|NCT01266876|501596|P4|COMPLETED|Overall Study||14
207482|NCT01266876|501597|P3|COMPLETED|Overall Study||16
207483|NCT01266876|501598|P2|COMPLETED|Overall Study||15
207484|NCT01266876|501599|P1|COMPLETED|Overall Study||15
207485|NCT01266876|501595|P5|STARTED|Overall Study||16
207486|NCT01266876|501596|P4|STARTED|Overall Study||15
207487|NCT01266876|501597|P3|STARTED|Overall Study||16
207488|NCT01266876|501598|P2|STARTED|Overall Study||15
207489|NCT01266876|501599|P1|STARTED|Overall Study||15
207490|NCT01266850|501706|P5|NOT COMPLETED|Overall Study||30
207491|NCT01266850|501707|P4|NOT COMPLETED|Overall Study||28
207492|NCT01266850|501708|P3|NOT COMPLETED|Overall Study||24
207493|NCT01266850|501709|P2|NOT COMPLETED|Overall Study||36
207494|NCT01266850|501710|P1|NOT COMPLETED|Overall Study||30
207495|NCT01266850|501706|P5|COMPLETED|Overall Study||297
207496|NCT01266850|501707|P4|COMPLETED|Overall Study||301
207497|NCT01266850|501708|P3|COMPLETED|Overall Study||214
207498|NCT01266850|501709|P2|COMPLETED|Overall Study||212
207499|NCT01266850|501710|P1|COMPLETED|Overall Study||212
207500|NCT01266850|501706|P5|Received Third Vaccine|Overall Study||299
207501|NCT01266850|501707|P4|Received Third Vaccine|Overall Study||0
207502|NCT01266850|501708|P3|Received Third Vaccine|Overall Study||217
207503|NCT01266850|501709|P2|Received Third Vaccine|Overall Study||221
207504|NCT01266850|501710|P1|Received Third Vaccine|Overall Study||221
207505|NCT01266850|501706|P5|Received Second Vaccine|Overall Study||307
207506|NCT01266850|501707|P4|Received Second Vaccine|Overall Study||311
207507|NCT01266850|501708|P3|Received Second Vaccine|Overall Study||227
207508|NCT01266850|501709|P2|Received Second Vaccine|Overall Study||233
207509|NCT01266850|501710|P1|Received Second Vaccine|Overall Study||231
207510|NCT01266850|501706|P5|STARTED|Overall Study||327
207511|NCT01266850|501707|P4|STARTED|Overall Study||329
207512|NCT01266850|501708|P3|STARTED|Overall Study||238
207513|NCT01266850|501709|P2|STARTED|Overall Study||248
207514|NCT01266850|501710|P1|STARTED|Overall Study||242
207515|NCT01266824|501764|P2|NOT COMPLETED|Overall Study||3
207516|NCT01266824|501765|P1|NOT COMPLETED|Overall Study||2
207517|NCT01266824|501764|P2|COMPLETED|Overall Study||0
207518|NCT01266824|501765|P1|COMPLETED|Overall Study||0
207519|NCT01266824|501764|P2|STARTED|Overall Study||3
207520|NCT01266824|501765|P1|STARTED|Overall Study||2
207521|NCT01266590|501777|P1|NOT COMPLETED|Overall Study||6
207522|NCT01266590|501777|P1|COMPLETED|Overall Study||24
207523|NCT01266590|501777|P1|STARTED|Overall Study||30
207524|NCT01266447|501788|P1|NOT COMPLETED|Overall Study||0
207525|NCT01266447|501788|P1|COMPLETED|Overall Study|Eligible and treated patients|27
207526|NCT01266447|501788|P1|STARTED|Overall Study||27
207527|NCT01266317|501797|P1|NOT COMPLETED|Overall Study||2
207528|NCT01266317|501797|P1|COMPLETED|Overall Study||7
207529|NCT01266317|501797|P1|STARTED|Overall Study|One additional patient was a protocol violation post consent when autoantibodies returned positive|9
207530|NCT01266291|501802|P1|NOT COMPLETED|Overall Study||1
207531|NCT01266291|501802|P1|COMPLETED|Overall Study||0
207532|NCT01266291|501802|P1|STARTED|Overall Study||1
207533|NCT01266265|501809|P2|NOT COMPLETED|Overall Study||190
207534|NCT01266265|501810|P1|NOT COMPLETED|Overall Study||205
207535|NCT01266265|501809|P2|COMPLETED|Overall Study||477
207536|NCT01266265|501810|P1|COMPLETED|Overall Study||461
207537|NCT01266265|501809|P2|STARTED|Overall Study||667
207538|NCT01266265|501810|P1|STARTED|Overall Study||666
207539|NCT01266161|501818|P2|NOT COMPLETED|Overall Study||1
207540|NCT01266161|501819|P1|NOT COMPLETED|Overall Study||4
207541|NCT01266161|501818|P2|COMPLETED|Overall Study||53
207542|NCT01266161|501819|P1|COMPLETED|Overall Study||48
207543|NCT01266161|501818|P2|STARTED|Overall Study||54
207544|NCT01266161|501819|P1|STARTED|Overall Study||52
207545|NCT01266148|501851|P2|NOT COMPLETED|Overall Study||3
207546|NCT01266148|501852|P1|NOT COMPLETED|Overall Study||7
207547|NCT01266148|501851|P2|COMPLETED|Overall Study||56
207548|NCT01266148|501852|P1|COMPLETED|Overall Study||49
207549|NCT01266148|501851|P2|STARTED|Overall Study||59
207550|NCT01266148|501852|P1|STARTED|Overall Study||56
207551|NCT01266122|501880|P2|NOT COMPLETED|Overall Study||6
207552|NCT01266122|501881|P1|NOT COMPLETED|Overall Study||6
207553|NCT01266122|501880|P2|COMPLETED|Overall Study||42
207554|NCT01266122|501881|P1|COMPLETED|Overall Study||42
207555|NCT01266122|501880|P2|STARTED|Overall Study||48
207556|NCT01266122|501881|P1|STARTED|Overall Study||48
207557|NCT01266070|501889|P1|NOT COMPLETED|Overall Study||4
207558|NCT01266070|501889|P1|COMPLETED|Overall Study||2
207559|NCT01266070|501889|P1|STARTED|Overall Study||6
207560|NCT01266031|501897|P3|NOT COMPLETED|Overall Study||2
207561|NCT01266031|501898|P2|NOT COMPLETED|Overall Study||3
207562|NCT01266031|501899|P1|NOT COMPLETED|Overall Study||0
207563|NCT01266031|501897|P3|COMPLETED|Overall Study||47
207564|NCT01266031|501898|P2|COMPLETED|Overall Study||38
207565|NCT01266031|501899|P1|COMPLETED|Overall Study||6
207566|NCT01266031|501897|P3|STARTED|Overall Study||49
207567|NCT01266031|501898|P2|STARTED|Overall Study||41
207568|NCT01266031|501899|P1|STARTED|Overall Study||6
207569|NCT01266018|501926|P2|NOT COMPLETED|Overall Study||1
207570|NCT01266018|501927|P1|NOT COMPLETED|Overall Study||1
207571|NCT01266018|501926|P2|COMPLETED|Overall Study||12
207572|NCT01266018|501927|P1|COMPLETED|Overall Study|Defined as evaluable for the primary endpoint|8
207573|NCT01266018|501926|P2|STARTED|Overall Study||13
207574|NCT01266018|501927|P1|STARTED|Overall Study||9
207575|NCT01265992|501938|P1|NOT COMPLETED|Overall Study||9
207576|NCT01265992|501938|P1|COMPLETED|Overall Study||41
207577|NCT01265992|501938|P1|Received Treatment|Overall Study||49
207578|NCT01265992|501938|P1|STARTED|Overall Study||50
207579|NCT01265966|501954|P3|NOT COMPLETED|Overall Study||2
207580|NCT01265966|501955|P2|NOT COMPLETED|Overall Study||2
207581|NCT01265966|501956|P1|NOT COMPLETED|Overall Study||3
207582|NCT01265966|501954|P3|COMPLETED|Overall Study||27
207583|NCT01265966|501955|P2|COMPLETED|Overall Study||39
207584|NCT01265966|501956|P1|COMPLETED|Overall Study||44
207585|NCT01265966|501954|P3|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
207586|NCT01265966|501955|P2|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
207587|NCT01265966|501956|P1|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|3
207588|NCT01265966|501954|P3|STARTED|Overall Study||29
207589|NCT01265966|501955|P2|STARTED|Overall Study||41
207590|NCT01265966|501956|P1|STARTED|Overall Study||47
207591|NCT01265953|501966|P2|NOT COMPLETED|Overall Study||3
207592|NCT01265953|501967|P1|NOT COMPLETED|Overall Study||5
207593|NCT01265953|501966|P2|COMPLETED|Overall Study||45
207594|NCT01265953|501967|P1|COMPLETED|Overall Study||45
207595|NCT01265953|501966|P2|STARTED|Overall Study||48
207596|NCT01265953|501967|P1|STARTED|Overall Study||50
207597|NCT01265875|501979|P1|NOT COMPLETED|Overall Study||1
207598|NCT01265875|501979|P1|COMPLETED|Overall Study||11
207599|NCT01265875|501979|P1|STARTED|Overall Study||12
207600|NCT01265823|501987|P1|NOT COMPLETED|Overall Study||7
207601|NCT01265823|501987|P1|COMPLETED|Overall Study||143
207602|NCT01265823|501987|P1|STARTED|Overall Study||150
207603|NCT01265797|502016|P2|NOT COMPLETED|Open Label Month||1
207604|NCT01265797|502017|P1|NOT COMPLETED|Open Label Month||0
207605|NCT01265797|502016|P2|COMPLETED|Open Label Month||26
207606|NCT01265797|502017|P1|COMPLETED|Open Label Month||24
207607|NCT01265797|502016|P2|STARTED|Open Label Month||27
207608|NCT01265797|502017|P1|STARTED|Open Label Month||24
207609|NCT01265797|502016|P2|NOT COMPLETED|Blinded Month||2
207610|NCT01265797|502017|P1|NOT COMPLETED|Blinded Month||10
207611|NCT01265797|502016|P2|COMPLETED|Blinded Month||27
207612|NCT01265797|502017|P1|COMPLETED|Blinded Month||24
207613|NCT01265797|502016|P2|STARTED|Blinded Month||29
207614|NCT01265797|502017|P1|STARTED|Blinded Month||34
207615|NCT01265797|502016|P2|NOT COMPLETED|Run-in Month||5
207616|NCT01265797|502017|P1|NOT COMPLETED|Run-in Month||0
207617|NCT01265797|502016|P2|COMPLETED|Run-in Month||29
207618|NCT01265797|502017|P1|COMPLETED|Run-in Month||34
207619|NCT01265797|502016|P2|STARTED|Run-in Month||34
207620|NCT01265797|502017|P1|STARTED|Run-in Month||34
207621|NCT01265784|502048|P3|NOT COMPLETED|Overall Study||4
207622|NCT01265784|502049|P2|NOT COMPLETED|Overall Study||8
207623|NCT01265784|502050|P1|NOT COMPLETED|Overall Study||12
207624|NCT01265784|502048|P3|COMPLETED|Overall Study||26
207625|NCT01265784|502049|P2|COMPLETED|Overall Study||49
207626|NCT01265784|502050|P1|COMPLETED|Overall Study||44
207627|NCT01265784|502048|P3|Received at Least 1 Dose of Study Drug|Overall Study||29
207628|NCT01265784|502049|P2|Received at Least 1 Dose of Study Drug|Overall Study||56
207629|NCT01265784|502050|P1|Received at Least 1 Dose of Study Drug|Overall Study|1 participant randomized to TP-434 1.5 mg/kg took ertapenem. Results are included in ertapenem arm.|54
207630|NCT01265784|502048|P3|STARTED|Overall Study||30
207631|NCT01265784|502049|P2|STARTED|Overall Study||57
207632|NCT01265784|502050|P1|STARTED|Overall Study||56
207633|NCT01265719|502118|P2|NOT COMPLETED|Overall Study||13
207634|NCT01265719|502119|P1|NOT COMPLETED|Overall Study||14
207635|NCT01265719|502118|P2|COMPLETED|Overall Study||60
207636|NCT01265719|502119|P1|COMPLETED|Overall Study||88
207637|NCT01265719|502118|P2|STARTED|Overall Study||73
207638|NCT01265719|502119|P1|STARTED|Overall Study||102
207639|NCT01265667|502153|P2|NOT COMPLETED|Overall Study||13
207640|NCT01265667|502154|P1|NOT COMPLETED|Overall Study||20
207641|NCT01265667|502153|P2|COMPLETED|Overall Study||135
207642|NCT01265667|502154|P1|COMPLETED|Overall Study||125
207643|NCT01265667|502153|P2|STARTED|Overall Study||148
207644|NCT01265667|502154|P1|STARTED|Overall Study||145
207645|NCT01265615|502170|P4|NOT COMPLETED|Overall Study||3
207646|NCT01265615|502171|P3|NOT COMPLETED|Overall Study||4
207647|NCT01265615|502172|P2|NOT COMPLETED|Overall Study||2
207648|NCT01265615|502173|P1|NOT COMPLETED|Overall Study||2
207649|NCT01265615|502170|P4|COMPLETED|Overall Study||27
207650|NCT01265615|502171|P3|COMPLETED|Overall Study||26
207651|NCT01265615|502172|P2|COMPLETED|Overall Study||28
207652|NCT01265615|502173|P1|COMPLETED|Overall Study||28
207653|NCT01265615|502170|P4|STARTED|Overall Study||30
207654|NCT01265615|502171|P3|STARTED|Overall Study||30
207655|NCT01265615|502172|P2|STARTED|Overall Study||30
207656|NCT01265615|502173|P1|STARTED|Overall Study||30
207657|NCT01265563|502224|P5|NOT COMPLETED|Overall Study||2
207658|NCT01265563|502225|P4|NOT COMPLETED|Overall Study||0
207659|NCT01265563|502226|P3|NOT COMPLETED|Overall Study||1
207660|NCT01265563|502227|P2|NOT COMPLETED|Overall Study||1
207661|NCT01265563|502228|P1|NOT COMPLETED|Overall Study||0
207662|NCT01265563|502224|P5|COMPLETED|Overall Study||14
207663|NCT01265563|502225|P4|COMPLETED|Overall Study||16
207664|NCT01265563|502226|P3|COMPLETED|Overall Study||16
207665|NCT01265563|502227|P2|COMPLETED|Overall Study||12
207666|NCT01265563|502228|P1|COMPLETED|Overall Study||16
207667|NCT01265563|502224|P5|STARTED|Overall Study||16
207668|NCT01265563|502225|P4|STARTED|Overall Study||16
207669|NCT01265563|502226|P3|STARTED|Overall Study||17
207670|NCT01265563|502227|P2|STARTED|Overall Study||13
207671|NCT01265563|502228|P1|STARTED|Overall Study||16
207672|NCT01265550|502253|P3|NOT COMPLETED|Overall Study||20
207673|NCT01265550|502254|P2|NOT COMPLETED|Overall Study||8
207674|NCT01265550|502255|P1|NOT COMPLETED|Overall Study||15
207675|NCT01265550|502253|P3|COMPLETED|Overall Study||6
207676|NCT01265550|502254|P2|COMPLETED|Overall Study||19
207677|NCT01265550|502255|P1|COMPLETED|Overall Study||10
207678|NCT01265550|502253|P3|STARTED|Overall Study||26
207679|NCT01265550|502254|P2|STARTED|Overall Study||27
207680|NCT01265550|502255|P1|STARTED|Overall Study||25
207681|NCT01265524|502307|P2|NOT COMPLETED|Overall Study||6
207682|NCT01265524|502308|P1|NOT COMPLETED|Overall Study||18
207683|NCT01265524|502307|P2|COMPLETED|Overall Study||46
207684|NCT01265524|502308|P1|COMPLETED|Overall Study||41
207685|NCT01265524|502307|P2|STARTED|Overall Study||52
207686|NCT01265524|502308|P1|STARTED|Overall Study||59
207687|NCT01265511|502328|P2|NOT COMPLETED|Overall Study||3
207688|NCT01265511|502329|P1|NOT COMPLETED|Overall Study||2
207689|NCT01265511|502328|P2|COMPLETED|Overall Study||5
207690|NCT01265511|502329|P1|COMPLETED|Overall Study||0
207691|NCT01265511|502328|P2|STARTED|Overall Study||8
207692|NCT01265511|502329|P1|STARTED|Overall Study||2
207693|NCT01265498|502343|P2|NOT COMPLETED|Overall Study||33
207694|NCT01265498|502344|P1|NOT COMPLETED|Overall Study||31
207695|NCT01265498|502343|P2|COMPLETED|Overall Study||109
207696|NCT01265498|502344|P1|COMPLETED|Overall Study||110
207697|NCT01265498|502343|P2|Both Baseline and Week 72 Biopsy|Overall Study||98
207698|NCT01265498|502344|P1|Both Baseline and Week 72 Biopsy|Overall Study||102
207699|NCT01265498|502343|P2|STARTED|Overall Study||142
207700|NCT01265498|502344|P1|STARTED|Overall Study||141
207701|NCT01265459|502447|P3|NOT COMPLETED|Overall Study||2
207702|NCT01265459|502448|P2|NOT COMPLETED|Overall Study||0
207703|NCT01265459|502449|P1|NOT COMPLETED|Overall Study||0
207704|NCT01265459|502447|P3|COMPLETED|Overall Study||20
207705|NCT01265459|502448|P2|COMPLETED|Overall Study||23
207706|NCT01265459|502449|P1|COMPLETED|Overall Study||23
207707|NCT01265459|502447|P3|STARTED|Overall Study||22
207708|NCT01265459|502448|P2|STARTED|Overall Study||23
207709|NCT01265459|502449|P1|STARTED|Overall Study||23
207710|NCT01265446|502471|P2|NOT COMPLETED|Overall Study||0
207711|NCT01265446|502472|P1|NOT COMPLETED|Overall Study||1
207712|NCT01265446|502471|P2|COMPLETED|Overall Study||125
207713|NCT01265446|502472|P1|COMPLETED|Overall Study||124
207714|NCT01265446|502471|P2|STARTED|Overall Study||125
207715|NCT01265446|502472|P1|STARTED|Overall Study||125
207716|NCT01265420|502480|P1|NOT COMPLETED|Overall Study||1
207717|NCT01265420|502480|P1|COMPLETED|Overall Study|One patient was seen at Day 10 but did not return for Day 30 evaluation|6
207718|NCT01265420|502480|P1|STARTED|Overall Study||7
207719|NCT01265394|502484|P1|NOT COMPLETED|Overall Study||37
207720|NCT01265394|502484|P1|COMPLETED|Overall Study||181
207721|NCT01265394|502484|P1|STARTED|Overall Study||218
207722|NCT01265056|502491|P2|NOT COMPLETED|Follow up||3
207723|NCT01265056|502492|P1|NOT COMPLETED|Follow up||7
207724|NCT01265056|502491|P2|COMPLETED|Follow up||24
207725|NCT01265056|502492|P1|COMPLETED|Follow up||19
207726|NCT01265056|502491|P2|STARTED|Follow up||27
207727|NCT01265056|502492|P1|STARTED|Follow up||26
207728|NCT01265056|502491|P2|NOT COMPLETED|Initial Study Period||2
207729|NCT01265056|502492|P1|NOT COMPLETED|Initial Study Period||2
207730|NCT01265056|502491|P2|COMPLETED|Initial Study Period||25
207731|NCT01265056|502492|P1|COMPLETED|Initial Study Period||24
207732|NCT01265056|502491|P2|STARTED|Initial Study Period||27
207733|NCT01265056|502492|P1|STARTED|Initial Study Period||26
207734|NCT01264952|502505|P3|NOT COMPLETED|Overall Study||0
207735|NCT01264952|502506|P2|NOT COMPLETED|Overall Study||0
207736|NCT01264952|502507|P1|NOT COMPLETED|Overall Study||0
207737|NCT01264952|502505|P3|COMPLETED|Overall Study||8
207738|NCT01264952|502506|P2|COMPLETED|Overall Study||2
207739|NCT01264952|502507|P1|COMPLETED|Overall Study||6
207740|NCT01264952|502505|P3|STARTED|Overall Study||8
207741|NCT01264952|502506|P2|STARTED|Overall Study||2
207742|NCT01264952|502507|P1|STARTED|Overall Study||6
207743|NCT01264939|502523|P2|NOT COMPLETED|Overall Study||28
207744|NCT01264939|502524|P1|NOT COMPLETED|Overall Study||18
207745|NCT01264939|502523|P2|COMPLETED|Overall Study||224
207746|NCT01264939|502524|P1|COMPLETED|Overall Study||66
207747|NCT01264939|502523|P2|STARTED|Overall Study||252
207748|NCT01264939|502524|P1|STARTED|Overall Study||84
207749|NCT01264887|502550|P1|NOT COMPLETED|Overall Study||31
207750|NCT01264887|502550|P1|COMPLETED|Overall Study||0
207751|NCT01264887|502550|P1|STARTED|Overall Study||31
207752|NCT01264835|502561|P1|NOT COMPLETED|Overall Study||1
207753|NCT01264835|502561|P1|COMPLETED|Overall Study||1
207754|NCT01264835|502561|P1|STARTED|Overall Study||2
207755|NCT01264770|502571|P6|NOT COMPLETED|Overall Study||6
207756|NCT01264770|502572|P5|NOT COMPLETED|Overall Study||8
207757|NCT01264770|502573|P4|NOT COMPLETED|Overall Study||6
207758|NCT01264770|502574|P3|NOT COMPLETED|Overall Study||16
207759|NCT01264770|502575|P2|NOT COMPLETED|Overall Study||10
207760|NCT01264770|502576|P1|NOT COMPLETED|Overall Study||18
207761|NCT01264770|502571|P6|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
207762|NCT01264770|502572|P5|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
207763|NCT01264770|502573|P4|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|48
207764|NCT01264770|502574|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|41
207765|NCT01264770|502575|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|38
207766|NCT01264770|502576|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|36
207767|NCT01264770|502571|P6|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|0
207768|NCT01264770|502572|P5|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
207769|NCT01264770|502573|P4|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|3
207770|NCT01264770|502574|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
207771|NCT01264770|502575|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|5
207772|NCT01264770|502576|P1|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
207773|NCT01264770|502571|P6|STARTED|Overall Study|Patients who received treatment|25
207774|NCT01264770|502572|P5|STARTED|Overall Study|Patients who received treatment|27
207775|NCT01264770|502573|P4|STARTED|Overall Study|Patients who received treatment|54
207776|NCT01264770|502574|P3|STARTED|Overall Study|Patients who received treatment|57
207777|NCT01264770|502575|P2|STARTED|Overall Study|Patients who received treatment|48
207778|NCT01264770|502576|P1|STARTED|Overall Study|Patients who received treatment|54
207779|NCT01264718|502662|P2|NOT COMPLETED|Overall Study||43
207780|NCT01264718|502663|P1|NOT COMPLETED|Overall Study||49
207781|NCT01264718|502662|P2|COMPLETED|Overall Study||114
207782|NCT01264718|502663|P1|COMPLETED|Overall Study||123
207783|NCT01264718|502662|P2|STARTED|Overall Study||157
207784|NCT01264718|502663|P1|STARTED|Overall Study||172
207785|NCT01264679|502675|P1|NOT COMPLETED|Overall Study||5
207786|NCT01264679|502675|P1|COMPLETED|Overall Study||3
207787|NCT01264679|502675|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
207788|NCT01264679|502675|P1|STARTED|Overall Study||8
207789|NCT01264614|502683|P2|NOT COMPLETED|Overall Study||2
207790|NCT01264614|502684|P1|NOT COMPLETED|Overall Study||1
207791|NCT01264614|502683|P2|COMPLETED|Overall Study||7
207792|NCT01264614|502684|P1|COMPLETED|Overall Study||12
207793|NCT01264614|502683|P2|STARTED|Overall Study||9
207794|NCT01264614|502684|P1|STARTED|Overall Study||13
207795|NCT01264601|502700|P2|NOT COMPLETED|Overall Study||0
207796|NCT01264601|502701|P1|NOT COMPLETED|Overall Study||0
207797|NCT01264601|502700|P2|COMPLETED|Overall Study||14
207798|NCT01264601|502701|P1|COMPLETED|Overall Study||17
207799|NCT01264601|502700|P2|STARTED|Overall Study||14
207800|NCT01264601|502701|P1|STARTED|Overall Study||17
207801|NCT01264419|502709|P1|NOT COMPLETED|Overall Study||3
207802|NCT01264419|502709|P1|COMPLETED|Overall Study||72
207803|NCT01264419|502709|P1|STARTED|Overall Study||75
207804|NCT01264380|502714|P3|NOT COMPLETED|Period C||14
207805|NCT01264380|502715|P2|NOT COMPLETED|Period C||0
207806|NCT01264380|502716|P1|NOT COMPLETED|Period C||0
207807|NCT01264380|502714|P3|COMPLETED|Period C||2
207808|NCT01264380|502715|P2|COMPLETED|Period C||0
207809|NCT01264380|502716|P1|COMPLETED|Period C||0
207810|NCT01264380|502714|P3|STARTED|Period C||16
207811|NCT01264380|502715|P2|STARTED|Period C||0
207812|NCT01264380|502716|P1|STARTED|Period C||0
207813|NCT01264380|502714|P3|NOT COMPLETED|Period B||0
207814|NCT01264380|502715|P2|NOT COMPLETED|Period B||0
207815|NCT01264380|502716|P1|NOT COMPLETED|Period B||0
207816|NCT01264380|502714|P3|COMPLETED|Period B||0
207817|NCT01264380|502715|P2|COMPLETED|Period B||8
207818|NCT01264380|502716|P1|COMPLETED|Period B||8
207819|NCT01264380|502714|P3|STARTED|Period B||0
207820|NCT01264380|502715|P2|STARTED|Period B||8
207821|NCT01264380|502716|P1|STARTED|Period B||8
207822|NCT01264380|502714|P3|NOT COMPLETED|Period A||0
207823|NCT01264380|502715|P2|NOT COMPLETED|Period A||0
207824|NCT01264380|502716|P1|NOT COMPLETED|Period A||0
207825|NCT01264380|502714|P3|COMPLETED|Period A||0
207826|NCT01264380|502715|P2|COMPLETED|Period A||8
207827|NCT01264380|502716|P1|COMPLETED|Period A||8
207828|NCT01264380|502714|P3|STARTED|Period A||0
207829|NCT01264380|502715|P2|STARTED|Period A||8
207830|NCT01264380|502716|P1|STARTED|Period A||8
207831|NCT01264081|502737|P1|NOT COMPLETED|Analysis||0
207832|NCT01264081|502737|P1|COMPLETED|Analysis||2
207833|NCT01264081|502737|P1|STARTED|Analysis||2
207834|NCT01264081|502737|P1|NOT COMPLETED|Started Treatment||2
207835|NCT01264081|502737|P1|COMPLETED|Started Treatment||2
207836|NCT01264081|502737|P1|STARTED|Started Treatment||4
207837|NCT01264081|502737|P1|NOT COMPLETED|Participants Screened||30
207838|NCT01264081|502737|P1|COMPLETED|Participants Screened||4
207839|NCT01264081|502737|P1|STARTED|Participants Screened||34
207840|NCT01264016|502742|P1|NOT COMPLETED|Overall Study||2
207841|NCT01264016|502742|P1|COMPLETED|Overall Study||94
207842|NCT01264016|502742|P1|STARTED|Overall Study||96
207843|NCT01263938|502748|P1|NOT COMPLETED|Overall Study||0
207844|NCT01263938|502748|P1|COMPLETED|Overall Study||5
207845|NCT01263938|502748|P1|STARTED|Overall Study||5
207846|NCT01263925|502757|P2|NOT COMPLETED|Overall Study||52
207847|NCT01263925|502758|P1|NOT COMPLETED|Overall Study||51
207848|NCT01263925|502757|P2|COMPLETED|Overall Study||233
207849|NCT01263925|502758|P1|COMPLETED|Overall Study||225
207850|NCT01263925|502757|P2|Full Analysis Set|Overall Study||272
207851|NCT01263925|502758|P1|Full Analysis Set|Overall Study||269
207852|NCT01263925|502757|P2|STARTED|Overall Study||285
207853|NCT01263925|502758|P1|STARTED|Overall Study||276
207854|NCT01263873|502792|P2|NOT COMPLETED|Overall Study||1
207855|NCT01263873|502793|P1|NOT COMPLETED|Overall Study||1
207856|NCT01263873|502792|P2|COMPLETED|Overall Study||29
207857|NCT01263873|502793|P1|COMPLETED|Overall Study||29
207858|NCT01263873|502792|P2|STARTED|Overall Study||30
207859|NCT01263873|502793|P1|STARTED|Overall Study||30
207860|NCT01263782|502807|P4|NOT COMPLETED|Overall Study||1
207861|NCT01263782|502808|P3|NOT COMPLETED|Overall Study||3
207862|NCT01263782|502809|P2|NOT COMPLETED|Overall Study||0
207863|NCT01263782|502810|P1|NOT COMPLETED|Overall Study||0
207864|NCT01263782|502807|P4|COMPLETED|Overall Study||5
207865|NCT01263782|502808|P3|COMPLETED|Overall Study||3
207866|NCT01263782|502809|P2|COMPLETED|Overall Study||6
207867|NCT01263782|502810|P1|COMPLETED|Overall Study||6
207868|NCT01263782|502807|P4|STARTED|Overall Study||6
207869|NCT01263782|502808|P3|STARTED|Overall Study||6
207870|NCT01263782|502809|P2|STARTED|Overall Study||6
207871|NCT01263782|502810|P1|STARTED|Overall Study||6
207872|NCT01263717|502826|P2|NOT COMPLETED|Overall Study||6
207873|NCT01263717|502827|P1|NOT COMPLETED|Overall Study||5
207874|NCT01263717|502826|P2|COMPLETED|Overall Study||20
207875|NCT01263717|502827|P1|COMPLETED|Overall Study||23
207876|NCT01263717|502826|P2|Baseline Visit|Overall Study||22
207877|NCT01263717|502827|P1|Baseline Visit|Overall Study||28
207878|NCT01263717|502826|P2|STARTED|Overall Study||26
207879|NCT01263717|502827|P1|STARTED|Overall Study||28
207880|NCT01263704|502855|P1|NOT COMPLETED|Overall Study||29
207881|NCT01263704|502855|P1|COMPLETED|Overall Study||13
207882|NCT01263704|502855|P1|STARTED|Overall Study||42
207883|NCT01263691|502870|P6|NOT COMPLETED|Overall Study||0
207884|NCT01263691|502871|P5|NOT COMPLETED|Overall Study||0
207885|NCT01263691|502872|P4|NOT COMPLETED|Overall Study||1
207886|NCT01263691|502873|P3|NOT COMPLETED|Overall Study||1
207887|NCT01263691|502874|P2|NOT COMPLETED|Overall Study||0
207888|NCT01263691|502875|P1|NOT COMPLETED|Overall Study||3
207889|NCT01263691|502870|P6|COMPLETED|Overall Study||15
207890|NCT01263691|502871|P5|COMPLETED|Overall Study||18
207891|NCT01263691|502872|P4|COMPLETED|Overall Study||18
207892|NCT01263691|502873|P3|COMPLETED|Overall Study||16
207893|NCT01263691|502874|P2|COMPLETED|Overall Study||18
207894|NCT01263691|502875|P1|COMPLETED|Overall Study||15
207895|NCT01263691|502870|P6|STARTED|Overall Study||15
207896|NCT01263691|502871|P5|STARTED|Overall Study||18
207897|NCT01263691|502872|P4|STARTED|Overall Study||19
207898|NCT01263691|502873|P3|STARTED|Overall Study||17
207899|NCT01263691|502874|P2|STARTED|Overall Study||18
207900|NCT01263691|502875|P1|STARTED|Overall Study||18
207901|NCT01263665|502985|P1|NOT COMPLETED|Overall Study||9
207902|NCT01263665|502985|P1|COMPLETED|Overall Study||62
207903|NCT01263665|502985|P1|STARTED|Overall Study||71
207904|NCT01263639|502992|P2|NOT COMPLETED|Overall Study||79
207905|NCT01263639|502993|P1|NOT COMPLETED|Overall Study||73
207906|NCT01263639|502992|P2|COMPLETED|Overall Study||42
207907|NCT01263639|502993|P1|COMPLETED|Overall Study||34
207908|NCT01263639|502992|P2|STARTED|Overall Study||121
207909|NCT01263639|502993|P1|STARTED|Overall Study||107
207910|NCT01263561|503001|P2|NOT COMPLETED|Overall Study||2
207911|NCT01263561|503002|P1|NOT COMPLETED|Overall Study||1
207912|NCT01263561|503001|P2|COMPLETED|Overall Study||31
207913|NCT01263561|503002|P1|COMPLETED|Overall Study||30
207914|NCT01263561|503001|P2|STARTED|Overall Study||33
207915|NCT01263561|503002|P1|STARTED|Overall Study||31
207916|NCT01263509|503014|P4|NOT COMPLETED|Entered - Long-Term Extension Study||2
207917|NCT01263509|503015|P3|NOT COMPLETED|Entered - Long-Term Extension Study||5
207918|NCT01263509|503016|P2|NOT COMPLETED|Entered - Long-Term Extension Study||12
207919|NCT01263509|503017|P1|NOT COMPLETED|Entered - Long-Term Extension Study||8
207920|NCT01263509|503014|P4|COMPLETED|Entered - Long-Term Extension Study||24
207921|NCT01263509|503015|P3|COMPLETED|Entered - Long-Term Extension Study||27
207922|NCT01263509|503016|P2|COMPLETED|Entered - Long-Term Extension Study||48
207923|NCT01263509|503017|P1|COMPLETED|Entered - Long-Term Extension Study||53
207924|NCT01263509|503014|P4|STARTED|Entered - Long-Term Extension Study||26
207925|NCT01263509|503015|P3|STARTED|Entered - Long-Term Extension Study||32
207926|NCT01263509|503016|P2|STARTED|Entered - Long-Term Extension Study||60
207927|NCT01263509|503017|P1|STARTED|Entered - Long-Term Extension Study||61
207928|NCT01263509|503014|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
207929|NCT01263509|503015|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
207930|NCT01263509|503016|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
207931|NCT01263509|503017|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
207932|NCT01263509|503014|P4|COMPLETED|Enrolled - Long-Term Extension Study||26
207933|NCT01263509|503015|P3|COMPLETED|Enrolled - Long-Term Extension Study||32
207934|NCT01263509|503016|P2|COMPLETED|Enrolled - Long-Term Extension Study||60
207935|NCT01263509|503017|P1|COMPLETED|Enrolled - Long-Term Extension Study||61
207936|NCT01263509|503014|P4|STARTED|Enrolled - Long-Term Extension Study||26
207937|NCT01263509|503015|P3|STARTED|Enrolled - Long-Term Extension Study||32
207938|NCT01263509|503016|P2|STARTED|Enrolled - Long-Term Extension Study||60
207939|NCT01263509|503017|P1|STARTED|Enrolled - Long-Term Extension Study||61
207940|NCT01263496|503146|P9|NOT COMPLETED|Entered - Long-Term Extension Study||3
207941|NCT01263496|503147|P8|NOT COMPLETED|Entered - Long-Term Extension Study||1
207942|NCT01263496|503148|P7|NOT COMPLETED|Entered - Long-Term Extension Study||1
207943|NCT01263496|503149|P6|NOT COMPLETED|Entered - Long-Term Extension Study||1
207944|NCT01263496|503150|P5|NOT COMPLETED|Entered - Long-Term Extension Study||10
207945|NCT01263496|503151|P4|NOT COMPLETED|Entered - Long-Term Extension Study||6
207946|NCT01263496|503152|P3|NOT COMPLETED|Entered - Long-Term Extension Study||10
207947|NCT01263496|503153|P2|NOT COMPLETED|Entered - Long-Term Extension Study||13
207948|NCT01263496|503154|P1|NOT COMPLETED|Entered - Long-Term Extension Study||9
207949|NCT01263496|503146|P9|COMPLETED|Entered - Long-Term Extension Study||15
207950|NCT01263496|503147|P8|COMPLETED|Entered - Long-Term Extension Study||16
207951|NCT01263496|503148|P7|COMPLETED|Entered - Long-Term Extension Study||16
207952|NCT01263496|503149|P6|COMPLETED|Entered - Long-Term Extension Study||16
207953|NCT01263496|503150|P5|COMPLETED|Entered - Long-Term Extension Study||61
207954|NCT01263496|503151|P4|COMPLETED|Entered - Long-Term Extension Study||68
207955|NCT01263496|503152|P3|COMPLETED|Entered - Long-Term Extension Study||62
207956|NCT01263496|503153|P2|COMPLETED|Entered - Long-Term Extension Study||59
207957|NCT01263496|503154|P1|COMPLETED|Entered - Long-Term Extension Study||62
207958|NCT01263496|503146|P9|STARTED|Entered - Long-Term Extension Study||18
207959|NCT01263496|503147|P8|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|17
207960|NCT01263496|503148|P7|STARTED|Entered - Long-Term Extension Study||17
207961|NCT01263496|503149|P6|STARTED|Entered - Long-Term Extension Study||17
207962|NCT01263496|503150|P5|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|71
207963|NCT01263496|503151|P4|STARTED|Entered - Long-Term Extension Study||74
207964|NCT01263496|503152|P3|STARTED|Entered - Long-Term Extension Study||72
207965|NCT01263496|503153|P2|STARTED|Entered - Long-Term Extension Study|3 participants did not enter from previous period (1 voluntary withdraw; 2 did not meet criteria).|72
207966|NCT01263496|503154|P1|STARTED|Entered - Long-Term Extension Study||71
207967|NCT01263496|503146|P9|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
207968|NCT01263496|503147|P8|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
207969|NCT01263496|503148|P7|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
207970|NCT01263496|503149|P6|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
207971|NCT01263496|503150|P5|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
207972|NCT01263496|503151|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
207973|NCT01263496|503152|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
207974|NCT01263496|503153|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
207975|NCT01263496|503154|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
207976|NCT01263496|503146|P9|COMPLETED|Enrolled - Long-Term Extension Study||18
207977|NCT01263496|503147|P8|COMPLETED|Enrolled - Long-Term Extension Study||18
207978|NCT01263496|503148|P7|COMPLETED|Enrolled - Long-Term Extension Study||17
207979|NCT01263496|503149|P6|COMPLETED|Enrolled - Long-Term Extension Study||17
207980|NCT01263496|503150|P5|COMPLETED|Enrolled - Long-Term Extension Study||72
207981|NCT01263496|503151|P4|COMPLETED|Enrolled - Long-Term Extension Study||74
207982|NCT01263496|503152|P3|COMPLETED|Enrolled - Long-Term Extension Study||72
207983|NCT01263496|503153|P2|COMPLETED|Enrolled - Long-Term Extension Study||75
207984|NCT01263496|503154|P1|COMPLETED|Enrolled - Long-Term Extension Study||71
207985|NCT01263496|503146|P9|STARTED|Enrolled - Long-Term Extension Study||18
207986|NCT01263496|503147|P8|STARTED|Enrolled - Long-Term Extension Study||18
208085|NCT01263314|503642|P3|COMPLETED|Period 1||2
207987|NCT01263496|503148|P7|STARTED|Enrolled - Long-Term Extension Study||17
207988|NCT01263496|503149|P6|STARTED|Enrolled - Long-Term Extension Study||17
207989|NCT01263496|503150|P5|STARTED|Enrolled - Long-Term Extension Study||74
207990|NCT01263496|503151|P4|STARTED|Enrolled - Long-Term Extension Study||75
207991|NCT01263496|503152|P3|STARTED|Enrolled - Long-Term Extension Study||72
207992|NCT01263496|503153|P2|STARTED|Enrolled - Long-Term Extension Study||75
207993|NCT01263496|503154|P1|STARTED|Enrolled - Long-Term Extension Study||72
207994|NCT01263483|503449|P3|NOT COMPLETED|Overall Study||5
207995|NCT01263483|503450|P2|NOT COMPLETED|Overall Study||2
207996|NCT01263483|503451|P1|NOT COMPLETED|Overall Study||7
207997|NCT01263483|503449|P3|COMPLETED|Overall Study||74
207998|NCT01263483|503450|P2|COMPLETED|Overall Study||74
207999|NCT01263483|503451|P1|COMPLETED|Overall Study||68
208000|NCT01263483|503449|P3|STARTED|Overall Study||79
208001|NCT01263483|503450|P2|STARTED|Overall Study||76
208002|NCT01263483|503451|P1|STARTED|Overall Study||75
208003|NCT01263470|503513|P6|NOT COMPLETED|Overall Study||5
208004|NCT01263470|503514|P5|NOT COMPLETED|Overall Study||3
208005|NCT01263470|503515|P4|NOT COMPLETED|Overall Study||3
208006|NCT01263470|503516|P3|NOT COMPLETED|Overall Study||4
208007|NCT01263470|503517|P2|NOT COMPLETED|Overall Study||5
208008|NCT01263470|503518|P1|NOT COMPLETED|Overall Study||2
208009|NCT01263470|503513|P6|COMPLETED|Overall Study||78
208010|NCT01263470|503514|P5|COMPLETED|Overall Study||76
208011|NCT01263470|503515|P4|COMPLETED|Overall Study||77
208012|NCT01263470|503516|P3|COMPLETED|Overall Study||80
208013|NCT01263470|503517|P2|COMPLETED|Overall Study||74
208014|NCT01263470|503518|P1|COMPLETED|Overall Study||73
208015|NCT01263470|503513|P6|STARTED|Overall Study||83
208016|NCT01263470|503514|P5|STARTED|Overall Study||79
208017|NCT01263470|503515|P4|STARTED|Overall Study||80
208018|NCT01263470|503516|P3|STARTED|Overall Study||84
208019|NCT01263470|503517|P2|STARTED|Overall Study||79
208020|NCT01263470|503518|P1|STARTED|Overall Study||75
208021|NCT01263444|503628|P1|NOT COMPLETED|Overall Study||10
208022|NCT01263444|503628|P1|COMPLETED|Overall Study||37
208023|NCT01263444|503628|P1|STARTED|Overall Study||47
208024|NCT01263314|503637|P8|NOT COMPLETED|Period 3||0
208025|NCT01263314|503638|P7|NOT COMPLETED|Period 3||0
208026|NCT01263314|503639|P6|NOT COMPLETED|Period 3||0
208027|NCT01263314|503640|P5|NOT COMPLETED|Period 3||0
208028|NCT01263314|503641|P4|NOT COMPLETED|Period 3||0
208029|NCT01263314|503642|P3|NOT COMPLETED|Period 3||0
208030|NCT01263314|503643|P2|NOT COMPLETED|Period 3||0
208031|NCT01263314|503644|P1|NOT COMPLETED|Period 3||0
208032|NCT01263314|503637|P8|COMPLETED|Period 3||2
208033|NCT01263314|503638|P7|COMPLETED|Period 3||2
208034|NCT01263314|503639|P6|COMPLETED|Period 3||2
208035|NCT01263314|503640|P5|COMPLETED|Period 3||2
208036|NCT01263314|503641|P4|COMPLETED|Period 3||2
208037|NCT01263314|503642|P3|COMPLETED|Period 3||2
208038|NCT01263314|503643|P2|COMPLETED|Period 3||2
208039|NCT01263314|503644|P1|COMPLETED|Period 3||2
208040|NCT01263314|503637|P8|STARTED|Period 3||2
208041|NCT01263314|503638|P7|STARTED|Period 3||2
208042|NCT01263314|503639|P6|STARTED|Period 3||2
208043|NCT01263314|503640|P5|STARTED|Period 3||2
208044|NCT01263314|503641|P4|STARTED|Period 3||2
208045|NCT01263314|503642|P3|STARTED|Period 3||2
208046|NCT01263314|503643|P2|STARTED|Period 3||2
208047|NCT01263314|503644|P1|STARTED|Period 3||2
208048|NCT01263314|503637|P8|NOT COMPLETED|Period 2||0
208049|NCT01263314|503638|P7|NOT COMPLETED|Period 2||0
208050|NCT01263314|503639|P6|NOT COMPLETED|Period 2||0
208051|NCT01263314|503640|P5|NOT COMPLETED|Period 2||0
208052|NCT01263314|503641|P4|NOT COMPLETED|Period 2||0
208053|NCT01263314|503642|P3|NOT COMPLETED|Period 2||0
208054|NCT01263314|503643|P2|NOT COMPLETED|Period 2||0
208055|NCT01263314|503644|P1|NOT COMPLETED|Period 2||0
208056|NCT01263314|503637|P8|COMPLETED|Period 2||2
208057|NCT01263314|503638|P7|COMPLETED|Period 2||2
208058|NCT01263314|503639|P6|COMPLETED|Period 2||2
208059|NCT01263314|503640|P5|COMPLETED|Period 2||2
208060|NCT01263314|503641|P4|COMPLETED|Period 2||2
208061|NCT01263314|503642|P3|COMPLETED|Period 2||2
208062|NCT01263314|503643|P2|COMPLETED|Period 2||2
208063|NCT01263314|503644|P1|COMPLETED|Period 2||2
208064|NCT01263314|503637|P8|STARTED|Period 2||2
208065|NCT01263314|503638|P7|STARTED|Period 2||2
208066|NCT01263314|503639|P6|STARTED|Period 2||2
208067|NCT01263314|503640|P5|STARTED|Period 2||2
208068|NCT01263314|503641|P4|STARTED|Period 2||2
208069|NCT01263314|503642|P3|STARTED|Period 2||2
208070|NCT01263314|503643|P2|STARTED|Period 2||2
208071|NCT01263314|503644|P1|STARTED|Period 2||2
208072|NCT01263314|503637|P8|NOT COMPLETED|Period 1||0
208073|NCT01263314|503638|P7|NOT COMPLETED|Period 1||0
208074|NCT01263314|503639|P6|NOT COMPLETED|Period 1||0
208075|NCT01263314|503640|P5|NOT COMPLETED|Period 1||0
208076|NCT01263314|503641|P4|NOT COMPLETED|Period 1||0
208077|NCT01263314|503642|P3|NOT COMPLETED|Period 1||0
208078|NCT01263314|503643|P2|NOT COMPLETED|Period 1||0
208079|NCT01263314|503644|P1|NOT COMPLETED|Period 1||0
208080|NCT01263314|503637|P8|COMPLETED|Period 1||2
208081|NCT01263314|503638|P7|COMPLETED|Period 1||2
208082|NCT01263314|503639|P6|COMPLETED|Period 1||2
208083|NCT01263314|503640|P5|COMPLETED|Period 1||2
208084|NCT01263314|503641|P4|COMPLETED|Period 1||2
208086|NCT01263314|503643|P2|COMPLETED|Period 1||2
208087|NCT01263314|503644|P1|COMPLETED|Period 1||2
208088|NCT01263314|503637|P8|STARTED|Period 1||2
208089|NCT01263314|503638|P7|STARTED|Period 1||2
208090|NCT01263314|503639|P6|STARTED|Period 1||2
208091|NCT01263314|503640|P5|STARTED|Period 1||2
208092|NCT01263314|503641|P4|STARTED|Period 1||2
208093|NCT01263314|503642|P3|STARTED|Period 1||2
208094|NCT01263314|503643|P2|STARTED|Period 1||2
208095|NCT01263314|503644|P1|STARTED|Period 1||2
208096|NCT01263301|503752|P2|NOT COMPLETED|Overall Study||0
208097|NCT01263301|503753|P1|NOT COMPLETED|Overall Study||0
208098|NCT01263301|503752|P2|COMPLETED|Overall Study||11
208099|NCT01263301|503753|P1|COMPLETED|Overall Study||5
208100|NCT01263301|503752|P2|STARTED|Overall Study||11
208101|NCT01263301|503753|P1|STARTED|Overall Study||5
208102|NCT01263223|503765|P2|NOT COMPLETED|7-day Follow-up||1
208103|NCT01263223|503766|P1|NOT COMPLETED|7-day Follow-up||1
208104|NCT01263223|503765|P2|COMPLETED|7-day Follow-up|One participant who did not complete received 36-mg LY2216684 in Period 3.|10
208105|NCT01263223|503766|P1|COMPLETED|7-day Follow-up|One participant who did not complete received Placebo in Period 3.|11
208106|NCT01263223|503765|P2|STARTED|7-day Follow-up||11
208107|NCT01263223|503766|P1|STARTED|7-day Follow-up||12
208108|NCT01263223|503765|P2|NOT COMPLETED|Period 3||0
208109|NCT01263223|503766|P1|NOT COMPLETED|Period 3||0
208110|NCT01263223|503765|P2|COMPLETED|Period 3||11
208111|NCT01263223|503766|P1|COMPLETED|Period 3||12
208112|NCT01263223|503765|P2|STARTED|Period 3||11
208113|NCT01263223|503766|P1|STARTED|Period 3||12
208114|NCT01263223|503765|P2|NOT COMPLETED|Period 2||1
208115|NCT01263223|503766|P1|NOT COMPLETED|Period 2||0
208116|NCT01263223|503765|P2|COMPLETED|Period 2||11
208117|NCT01263223|503766|P1|COMPLETED|Period 2||12
208118|NCT01263223|503765|P2|STARTED|Period 2||12
208119|NCT01263223|503766|P1|STARTED|Period 2||12
208120|NCT01263223|503765|P2|NOT COMPLETED|3-Day Washout||0
208121|NCT01263223|503766|P1|NOT COMPLETED|3-Day Washout||0
208122|NCT01263223|503765|P2|COMPLETED|3-Day Washout||12
208123|NCT01263223|503766|P1|COMPLETED|3-Day Washout||12
208124|NCT01263223|503765|P2|STARTED|3-Day Washout||12
208125|NCT01263223|503766|P1|STARTED|3-Day Washout||12
208126|NCT01263223|503765|P2|NOT COMPLETED|Period 1||0
208127|NCT01263223|503766|P1|NOT COMPLETED|Period 1||0
208128|NCT01263223|503765|P2|COMPLETED|Period 1||12
208129|NCT01263223|503766|P1|COMPLETED|Period 1||12
208130|NCT01263223|503765|P2|STARTED|Period 1||12
208131|NCT01263223|503766|P1|STARTED|Period 1||12
208132|NCT01263197|503789|P6|NOT COMPLETED|Third Intervention (Period 3)||0
208133|NCT01263197|503790|P5|NOT COMPLETED|Third Intervention (Period 3)||0
208134|NCT01263197|503791|P4|NOT COMPLETED|Third Intervention (Period 3)||0
208135|NCT01263197|503792|P3|NOT COMPLETED|Third Intervention (Period 3)||0
208136|NCT01263197|503793|P2|NOT COMPLETED|Third Intervention (Period 3)||1
208137|NCT01263197|503794|P1|NOT COMPLETED|Third Intervention (Period 3)||0
208138|NCT01263197|503789|P6|COMPLETED|Third Intervention (Period 3)||6
208139|NCT01263197|503790|P5|COMPLETED|Third Intervention (Period 3)||7
208140|NCT01263197|503791|P4|COMPLETED|Third Intervention (Period 3)||7
208141|NCT01263197|503792|P3|COMPLETED|Third Intervention (Period 3)||8
208142|NCT01263197|503793|P2|COMPLETED|Third Intervention (Period 3)||7
208143|NCT01263197|503794|P1|COMPLETED|Third Intervention (Period 3)||8
208144|NCT01263197|503789|P6|STARTED|Third Intervention (Period 3)||6
208145|NCT01263197|503790|P5|STARTED|Third Intervention (Period 3)||7
208146|NCT01263197|503791|P4|STARTED|Third Intervention (Period 3)||7
208147|NCT01263197|503792|P3|STARTED|Third Intervention (Period 3)||8
208148|NCT01263197|503793|P2|STARTED|Third Intervention (Period 3)||8
208149|NCT01263197|503794|P1|STARTED|Third Intervention (Period 3)||8
208150|NCT01263197|503789|P6|NOT COMPLETED|Washout Period 2||1
208151|NCT01263197|503790|P5|NOT COMPLETED|Washout Period 2||0
208152|NCT01263197|503791|P4|NOT COMPLETED|Washout Period 2||1
208153|NCT01263197|503792|P3|NOT COMPLETED|Washout Period 2||0
208154|NCT01263197|503793|P2|NOT COMPLETED|Washout Period 2||0
208155|NCT01263197|503794|P1|NOT COMPLETED|Washout Period 2||0
208156|NCT01263197|503789|P6|COMPLETED|Washout Period 2||6
208157|NCT01263197|503790|P5|COMPLETED|Washout Period 2||7
208158|NCT01263197|503791|P4|COMPLETED|Washout Period 2||7
208159|NCT01263197|503792|P3|COMPLETED|Washout Period 2||8
208160|NCT01263197|503793|P2|COMPLETED|Washout Period 2||8
208161|NCT01263197|503794|P1|COMPLETED|Washout Period 2||8
208162|NCT01263197|503789|P6|STARTED|Washout Period 2||7
208163|NCT01263197|503790|P5|STARTED|Washout Period 2||7
208164|NCT01263197|503791|P4|STARTED|Washout Period 2||8
208165|NCT01263197|503792|P3|STARTED|Washout Period 2||8
208166|NCT01263197|503793|P2|STARTED|Washout Period 2||8
208167|NCT01263197|503794|P1|STARTED|Washout Period 2||8
208168|NCT01263197|503789|P6|NOT COMPLETED|Second Intervention (Period 2)||0
208169|NCT01263197|503790|P5|NOT COMPLETED|Second Intervention (Period 2)||0
208170|NCT01263197|503791|P4|NOT COMPLETED|Second Intervention (Period 2)||0
208171|NCT01263197|503792|P3|NOT COMPLETED|Second Intervention (Period 2)||0
208172|NCT01263197|503793|P2|NOT COMPLETED|Second Intervention (Period 2)||0
208173|NCT01263197|503794|P1|NOT COMPLETED|Second Intervention (Period 2)||0
208174|NCT01263197|503789|P6|COMPLETED|Second Intervention (Period 2)||7
208175|NCT01263197|503790|P5|COMPLETED|Second Intervention (Period 2)||7
208176|NCT01263197|503791|P4|COMPLETED|Second Intervention (Period 2)||8
208177|NCT01263197|503792|P3|COMPLETED|Second Intervention (Period 2)||8
208178|NCT01263197|503793|P2|COMPLETED|Second Intervention (Period 2)||8
208179|NCT01263197|503794|P1|COMPLETED|Second Intervention (Period 2)||8
208180|NCT01263197|503789|P6|STARTED|Second Intervention (Period 2)||7
208181|NCT01263197|503790|P5|STARTED|Second Intervention (Period 2)||7
208182|NCT01263197|503791|P4|STARTED|Second Intervention (Period 2)||8
208183|NCT01263197|503792|P3|STARTED|Second Intervention (Period 2)||8
208184|NCT01263197|503793|P2|STARTED|Second Intervention (Period 2)||8
208185|NCT01263197|503794|P1|STARTED|Second Intervention (Period 2)||8
208186|NCT01263197|503789|P6|NOT COMPLETED|Washout Period 1||0
208187|NCT01263197|503790|P5|NOT COMPLETED|Washout Period 1||1
208188|NCT01263197|503791|P4|NOT COMPLETED|Washout Period 1||0
208189|NCT01263197|503792|P3|NOT COMPLETED|Washout Period 1||0
208190|NCT01263197|503793|P2|NOT COMPLETED|Washout Period 1||0
208191|NCT01263197|503794|P1|NOT COMPLETED|Washout Period 1||0
208192|NCT01263197|503789|P6|COMPLETED|Washout Period 1||7
208193|NCT01263197|503790|P5|COMPLETED|Washout Period 1||7
208194|NCT01263197|503791|P4|COMPLETED|Washout Period 1||8
208195|NCT01263197|503792|P3|COMPLETED|Washout Period 1||8
208196|NCT01263197|503793|P2|COMPLETED|Washout Period 1||8
208197|NCT01263197|503794|P1|COMPLETED|Washout Period 1||8
208198|NCT01263197|503789|P6|STARTED|Washout Period 1||7
208199|NCT01263197|503790|P5|STARTED|Washout Period 1||8
208200|NCT01263197|503791|P4|STARTED|Washout Period 1||8
208201|NCT01263197|503792|P3|STARTED|Washout Period 1||8
208202|NCT01263197|503793|P2|STARTED|Washout Period 1||8
208203|NCT01263197|503794|P1|STARTED|Washout Period 1||8
208204|NCT01263197|503789|P6|NOT COMPLETED|First Intervention (Period 1)||1
208205|NCT01263197|503790|P5|NOT COMPLETED|First Intervention (Period 1)||0
208206|NCT01263197|503791|P4|NOT COMPLETED|First Intervention (Period 1)||0
208207|NCT01263197|503792|P3|NOT COMPLETED|First Intervention (Period 1)||0
208208|NCT01263197|503793|P2|NOT COMPLETED|First Intervention (Period 1)||0
208209|NCT01263197|503794|P1|NOT COMPLETED|First Intervention (Period 1)||0
208210|NCT01263197|503789|P6|COMPLETED|First Intervention (Period 1)||7
208211|NCT01263197|503790|P5|COMPLETED|First Intervention (Period 1)||8
208212|NCT01263197|503791|P4|COMPLETED|First Intervention (Period 1)||8
208213|NCT01263197|503792|P3|COMPLETED|First Intervention (Period 1)||8
208214|NCT01263197|503793|P2|COMPLETED|First Intervention (Period 1)||8
208215|NCT01263197|503794|P1|COMPLETED|First Intervention (Period 1)||8
208216|NCT01263197|503789|P6|STARTED|First Intervention (Period 1)||8
208217|NCT01263197|503790|P5|STARTED|First Intervention (Period 1)||8
208218|NCT01263197|503791|P4|STARTED|First Intervention (Period 1)||8
208219|NCT01263197|503792|P3|STARTED|First Intervention (Period 1)||8
208220|NCT01263197|503793|P2|STARTED|First Intervention (Period 1)||8
208221|NCT01263197|503794|P1|STARTED|First Intervention (Period 1)||8
208222|NCT01263132|503822|P2|NOT COMPLETED|Overall Study||0
208223|NCT01263132|503823|P1|NOT COMPLETED|Overall Study||0
208224|NCT01263132|503822|P2|COMPLETED|Overall Study||37
208225|NCT01263132|503823|P1|COMPLETED|Overall Study||38
208226|NCT01263132|503822|P2|STARTED|Overall Study||37
208227|NCT01263132|503823|P1|STARTED|Overall Study||38
208228|NCT01263119|503837|P1|NOT COMPLETED|Period 2||2
208229|NCT01263119|503837|P1|COMPLETED|Period 2||14
208230|NCT01263119|503837|P1|STARTED|Period 2||16
208231|NCT01263119|503837|P1|NOT COMPLETED|Period 1||2
208232|NCT01263119|503837|P1|COMPLETED|Period 1||16
208233|NCT01263119|503837|P1|STARTED|Period 1||18
208234|NCT01263106|503858|P2|NOT COMPLETED|Period 2 (7 Days)||0
208235|NCT01263106|503859|P1|NOT COMPLETED|Period 2 (7 Days)||0
208236|NCT01263106|503858|P2|COMPLETED|Period 2 (7 Days)||9
208237|NCT01263106|503859|P1|COMPLETED|Period 2 (7 Days)||10
208238|NCT01263106|503858|P2|STARTED|Period 2 (7 Days)||9
208239|NCT01263106|503859|P1|STARTED|Period 2 (7 Days)||10
208240|NCT01263106|503858|P2|NOT COMPLETED|Washout (at Least 7 Days)||1
208241|NCT01263106|503859|P1|NOT COMPLETED|Washout (at Least 7 Days)||1
208242|NCT01263106|503858|P2|COMPLETED|Washout (at Least 7 Days)||9
208243|NCT01263106|503859|P1|COMPLETED|Washout (at Least 7 Days)||10
208244|NCT01263106|503858|P2|STARTED|Washout (at Least 7 Days)||10
208245|NCT01263106|503859|P1|STARTED|Washout (at Least 7 Days)||11
208246|NCT01263106|503858|P2|NOT COMPLETED|Period 1 (7 Days)||0
208247|NCT01263106|503859|P1|NOT COMPLETED|Period 1 (7 Days)||0
208248|NCT01263106|503858|P2|COMPLETED|Period 1 (7 Days)|Period 1: 1 participant took LY + theophylline but was not given theophylline alone.|10
208249|NCT01263106|503859|P1|COMPLETED|Period 1 (7 Days)|Period 1: 1 participant took theophylline alone but was not given LY + theophylline.|11
208250|NCT01263106|503858|P2|STARTED|Period 1 (7 Days)||10
208251|NCT01263106|503859|P1|STARTED|Period 1 (7 Days)||11
208252|NCT01263093|503874|P2|NOT COMPLETED|Period 2||0
208253|NCT01263093|503875|P1|NOT COMPLETED|Period 2||1
208254|NCT01263093|503874|P2|COMPLETED|Period 2||23
208255|NCT01263093|503875|P1|COMPLETED|Period 2||22
208256|NCT01263093|503874|P2|STARTED|Period 2||23
208257|NCT01263093|503875|P1|STARTED|Period 2||23
208258|NCT01263093|503874|P2|NOT COMPLETED|Washout||0
208259|NCT01263093|503875|P1|NOT COMPLETED|Washout||1
208260|NCT01263093|503874|P2|COMPLETED|Washout||23
208261|NCT01263093|503875|P1|COMPLETED|Washout||23
208262|NCT01263093|503874|P2|STARTED|Washout||23
208263|NCT01263093|503875|P1|STARTED|Washout||24
208264|NCT01263093|503874|P2|NOT COMPLETED|Period 1||0
208265|NCT01263093|503875|P1|NOT COMPLETED|Period 1||0
208266|NCT01263093|503874|P2|COMPLETED|Period 1||23
208267|NCT01263093|503875|P1|COMPLETED|Period 1||24
208268|NCT01263093|503874|P2|STARTED|Period 1||23
208269|NCT01263093|503875|P1|STARTED|Period 1||24
208270|NCT01263054|503892|P2|NOT COMPLETED|Overall Study||6
208271|NCT01263054|503893|P1|NOT COMPLETED|Overall Study||5
208272|NCT01263054|503892|P2|COMPLETED|Overall Study||28
208273|NCT01263054|503893|P1|COMPLETED|Overall Study||24
208274|NCT01263054|503892|P2|STARTED|Overall Study||34
208275|NCT01263054|503893|P1|STARTED|Overall Study||29
208276|NCT01263028|503911|P1|NOT COMPLETED|Overall Study||6
208277|NCT01263028|503911|P1|COMPLETED|Overall Study||0
208278|NCT01263028|503911|P1|STARTED|Overall Study||6
208279|NCT01263015|503921|P2|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||31
208280|NCT01263015|503922|P1|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||24
208281|NCT01263015|503921|P2|COMPLETED|Open-label Phase: 48 Weeks Duration||278
208282|NCT01263015|503922|P1|COMPLETED|Open-label Phase: 48 Weeks Duration||317
208283|NCT01263015|503921|P2|STARTED|Open-label Phase: 48 Weeks Duration||309
208284|NCT01263015|503922|P1|STARTED|Open-label Phase: 48 Weeks Duration||341
208285|NCT01263015|503921|P2|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||109
208286|NCT01263015|503922|P1|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||72
208287|NCT01263015|503921|P2|COMPLETED|Double-blind Phase: 96 Weeks Duration||310
208288|NCT01263015|503922|P1|COMPLETED|Double-blind Phase: 96 Weeks Duration||342
208289|NCT01263015|503921|P2|STARTED|Double-blind Phase: 96 Weeks Duration||419
208290|NCT01263015|503922|P1|STARTED|Double-blind Phase: 96 Weeks Duration||414
208291|NCT01262989|503948|P2|NOT COMPLETED|Period 2||1
208292|NCT01262989|503949|P1|NOT COMPLETED|Period 2||0
208293|NCT01262989|503948|P2|COMPLETED|Period 2||16
208294|NCT01262989|503949|P1|COMPLETED|Period 2||19
208295|NCT01262989|503948|P2|STARTED|Period 2||17
208296|NCT01262989|503949|P1|STARTED|Period 2||19
208297|NCT01262989|503948|P2|NOT COMPLETED|7-Day Washout Period||0
208298|NCT01262989|503949|P1|NOT COMPLETED|7-Day Washout Period||0
208299|NCT01262989|503948|P2|COMPLETED|7-Day Washout Period||17
208300|NCT01262989|503949|P1|COMPLETED|7-Day Washout Period||19
208301|NCT01262989|503948|P2|STARTED|7-Day Washout Period||17
208302|NCT01262989|503949|P1|STARTED|7-Day Washout Period||19
208303|NCT01262989|503948|P2|NOT COMPLETED|Period 1||3
208304|NCT01262989|503949|P1|NOT COMPLETED|Period 1||1
208305|NCT01262989|503948|P2|COMPLETED|Period 1||17
208306|NCT01262989|503949|P1|COMPLETED|Period 1||19
208307|NCT01262989|503948|P2|STARTED|Period 1||20
208308|NCT01262989|503949|P1|STARTED|Period 1||20
208309|NCT01262976|503965|P6|NOT COMPLETED|Up to Year 3||4
208310|NCT01262976|503966|P5|NOT COMPLETED|Up to Year 3||2
208311|NCT01262976|503967|P4|NOT COMPLETED|Up to Year 3||5
208312|NCT01262976|503968|P3|NOT COMPLETED|Up to Year 3||7
208313|NCT01262976|503969|P2|NOT COMPLETED|Up to Year 3||2
208314|NCT01262976|503970|P1|NOT COMPLETED|Up to Year 3||6
208315|NCT01262976|503965|P6|COMPLETED|Up to Year 3||36
208316|NCT01262976|503966|P5|COMPLETED|Up to Year 3||38
208317|NCT01262976|503967|P4|COMPLETED|Up to Year 3||35
208318|NCT01262976|503968|P3|COMPLETED|Up to Year 3||33
208319|NCT01262976|503969|P2|COMPLETED|Up to Year 3||38
208320|NCT01262976|503970|P1|COMPLETED|Up to Year 3||34
208321|NCT01262976|503965|P6|STARTED|Up to Year 3||40
208322|NCT01262976|503966|P5|STARTED|Up to Year 3||40
208323|NCT01262976|503967|P4|STARTED|Up to Year 3||40
208324|NCT01262976|503968|P3|STARTED|Up to Year 3||40
208325|NCT01262976|503969|P2|STARTED|Up to Year 3||40
208326|NCT01262976|503970|P1|STARTED|Up to Year 3||40
208327|NCT01262976|503965|P6|NOT COMPLETED|Up to Year 2||5
208328|NCT01262976|503966|P5|NOT COMPLETED|Up to Year 2||4
208329|NCT01262976|503967|P4|NOT COMPLETED|Up to Year 2||4
208330|NCT01262976|503968|P3|NOT COMPLETED|Up to Year 2||5
208331|NCT01262976|503969|P2|NOT COMPLETED|Up to Year 2||1
208332|NCT01262976|503970|P1|NOT COMPLETED|Up to Year 2||5
208333|NCT01262976|503965|P6|COMPLETED|Up to Year 2||35
208334|NCT01262976|503966|P5|COMPLETED|Up to Year 2||36
208335|NCT01262976|503967|P4|COMPLETED|Up to Year 2||36
208336|NCT01262976|503968|P3|COMPLETED|Up to Year 2||35
208337|NCT01262976|503969|P2|COMPLETED|Up to Year 2||39
208338|NCT01262976|503970|P1|COMPLETED|Up to Year 2||35
208339|NCT01262976|503965|P6|STARTED|Up to Year 2||40
208340|NCT01262976|503966|P5|STARTED|Up to Year 2||40
208341|NCT01262976|503967|P4|STARTED|Up to Year 2||40
208342|NCT01262976|503968|P3|STARTED|Up to Year 2||40
208343|NCT01262976|503969|P2|STARTED|Up to Year 2||40
208344|NCT01262976|503970|P1|STARTED|Up to Year 2||40
208345|NCT01262976|503965|P6|NOT COMPLETED|Up to Year 1||9
208346|NCT01262976|503966|P5|NOT COMPLETED|Up to Year 1||11
208347|NCT01262976|503967|P4|NOT COMPLETED|Up to Year 1||4
208348|NCT01262976|503968|P3|NOT COMPLETED|Up to Year 1||3
208349|NCT01262976|503969|P2|NOT COMPLETED|Up to Year 1||1
208350|NCT01262976|503970|P1|NOT COMPLETED|Up to Year 1||9
208351|NCT01262976|503965|P6|COMPLETED|Up to Year 1||31
208352|NCT01262976|503966|P5|COMPLETED|Up to Year 1||29
208353|NCT01262976|503967|P4|COMPLETED|Up to Year 1||36
208354|NCT01262976|503968|P3|COMPLETED|Up to Year 1||37
208355|NCT01262976|503969|P2|COMPLETED|Up to Year 1||39
208356|NCT01262976|503970|P1|COMPLETED|Up to Year 1||31
208357|NCT01262976|503965|P6|STARTED|Up to Year 1||40
208358|NCT01262976|503966|P5|STARTED|Up to Year 1||40
208359|NCT01262976|503967|P4|STARTED|Up to Year 1||40
208360|NCT01262976|503968|P3|STARTED|Up to Year 1||40
208361|NCT01262976|503969|P2|STARTED|Up to Year 1||40
208362|NCT01262976|503970|P1|STARTED|Up to Year 1||40
208363|NCT01262976|503965|P6|NOT COMPLETED|Up to Month 7||4
208364|NCT01262976|503966|P5|NOT COMPLETED|Up to Month 7||2
208365|NCT01262976|503967|P4|NOT COMPLETED|Up to Month 7||6
208366|NCT01262976|503968|P3|NOT COMPLETED|Up to Month 7||6
208367|NCT01262976|503969|P2|NOT COMPLETED|Up to Month 7||0
208368|NCT01262976|503970|P1|NOT COMPLETED|Up to Month 7||5
208369|NCT01262976|503965|P6|COMPLETED|Up to Month 7||36
208370|NCT01262976|503966|P5|COMPLETED|Up to Month 7||38
208371|NCT01262976|503967|P4|COMPLETED|Up to Month 7||34
208372|NCT01262976|503968|P3|COMPLETED|Up to Month 7||34
208373|NCT01262976|503969|P2|COMPLETED|Up to Month 7||40
208374|NCT01262976|503970|P1|COMPLETED|Up to Month 7||35
208375|NCT01262976|503965|P6|STARTED|Up to Month 7||40
208376|NCT01262976|503966|P5|STARTED|Up to Month 7||40
208377|NCT01262976|503967|P4|STARTED|Up to Month 7||40
208378|NCT01262976|503968|P3|STARTED|Up to Month 7||40
208379|NCT01262976|503969|P2|STARTED|Up to Month 7||40
208380|NCT01262976|503970|P1|STARTED|Up to Month 7||40
208381|NCT01262976|503965|P6|NOT COMPLETED|Up to Month 2||4
208382|NCT01262976|503966|P5|NOT COMPLETED|Up to Month 2||2
208383|NCT01262976|503967|P4|NOT COMPLETED|Up to Month 2||2
208384|NCT01262976|503968|P3|NOT COMPLETED|Up to Month 2||1
208385|NCT01262976|503969|P2|NOT COMPLETED|Up to Month 2||1
208386|NCT01262976|503970|P1|NOT COMPLETED|Up to Month 2||3
208387|NCT01262976|503965|P6|COMPLETED|Up to Month 2||36
208388|NCT01262976|503966|P5|COMPLETED|Up to Month 2||38
208389|NCT01262976|503967|P4|COMPLETED|Up to Month 2||38
208390|NCT01262976|503968|P3|COMPLETED|Up to Month 2||39
208391|NCT01262976|503969|P2|COMPLETED|Up to Month 2||39
208392|NCT01262976|503970|P1|COMPLETED|Up to Month 2||37
208393|NCT01262976|503965|P6|STARTED|Up to Month 2||40
208394|NCT01262976|503966|P5|STARTED|Up to Month 2||40
208395|NCT01262976|503967|P4|STARTED|Up to Month 2||40
208396|NCT01262976|503968|P3|STARTED|Up to Month 2||40
208397|NCT01262976|503969|P2|STARTED|Up to Month 2||40
208398|NCT01262976|503970|P1|STARTED|Up to Month 2||40
208399|NCT01262898|504126|P4|NOT COMPLETED|Overall Study||0
208400|NCT01262898|504127|P3|NOT COMPLETED|Overall Study||0
208401|NCT01262898|504128|P2|NOT COMPLETED|Overall Study||2
208402|NCT01262898|504129|P1|NOT COMPLETED|Overall Study||3
208403|NCT01262898|504126|P4|COMPLETED|Overall Study||22
208404|NCT01262898|504127|P3|COMPLETED|Overall Study||18
208405|NCT01262898|504128|P2|COMPLETED|Overall Study||16
208406|NCT01262898|504129|P1|COMPLETED|Overall Study||18
208407|NCT01262898|504126|P4|STARTED|Overall Study||22
208408|NCT01262898|504127|P3|STARTED|Overall Study||18
208409|NCT01262898|504128|P2|STARTED|Overall Study||18
208410|NCT01262898|504129|P1|STARTED|Overall Study||21
208411|NCT01262872|504257|P8|NOT COMPLETED|Step 2||6
208412|NCT01262872|504258|P7|NOT COMPLETED|Step 2||9
208413|NCT01262872|504259|P6|NOT COMPLETED|Step 2||9
208414|NCT01262872|504260|P5|NOT COMPLETED|Step 2||5
208415|NCT01262872|504261|P4|NOT COMPLETED|Step 2||10
208416|NCT01262872|504262|P3|NOT COMPLETED|Step 2||9
208417|NCT01262872|504263|P2|NOT COMPLETED|Step 2||0
208418|NCT01262872|504264|P1|NOT COMPLETED|Step 2||0
208419|NCT01262872|504257|P8|COMPLETED|Step 2||194
208420|NCT01262872|504258|P7|COMPLETED|Step 2||191
208421|NCT01262872|504259|P6|COMPLETED|Step 2||191
208422|NCT01262872|504260|P5|COMPLETED|Step 2||195
208423|NCT01262872|504261|P4|COMPLETED|Step 2||190
208424|NCT01262872|504262|P3|COMPLETED|Step 2||191
208425|NCT01262872|504263|P2|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
208426|NCT01262872|504264|P1|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
208427|NCT01262872|504257|P8|STARTED|Step 2||200
208428|NCT01262872|504258|P7|STARTED|Step 2||200
208429|NCT01262872|504259|P6|STARTED|Step 2||200
208430|NCT01262872|504260|P5|STARTED|Step 2||200
208431|NCT01262872|504261|P4|STARTED|Step 2||200
208432|NCT01262872|504262|P3|STARTED|Step 2||200
208433|NCT01262872|504263|P2|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
208434|NCT01262872|504264|P1|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
208435|NCT01262872|504257|P8|NOT COMPLETED|Step 1||0
208436|NCT01262872|504258|P7|NOT COMPLETED|Step 1||0
208437|NCT01262872|504259|P6|NOT COMPLETED|Step 1||0
208438|NCT01262872|504260|P5|NOT COMPLETED|Step 1||0
208439|NCT01262872|504261|P4|NOT COMPLETED|Step 1||0
208440|NCT01262872|504262|P3|NOT COMPLETED|Step 1||0
208441|NCT01262872|504263|P2|NOT COMPLETED|Step 1||0
208442|NCT01262872|504264|P1|NOT COMPLETED|Step 1||0
208443|NCT01262872|504257|P8|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
208444|NCT01262872|504258|P7|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
208445|NCT01262872|504259|P6|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
208446|NCT01262872|504260|P5|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
208447|NCT01262872|504261|P4|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone|0
208448|NCT01262872|504262|P3|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
208449|NCT01262872|504263|P2|COMPLETED|Step 1||60
208450|NCT01262872|504264|P1|COMPLETED|Step 1||60
208451|NCT01262872|504257|P8|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
208452|NCT01262872|504258|P7|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
208453|NCT01262872|504259|P6|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
208454|NCT01262872|504260|P5|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
208455|NCT01262872|504261|P4|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
208456|NCT01262872|504262|P3|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
208457|NCT01262872|504263|P2|STARTED|Step 1||60
208458|NCT01262872|504264|P1|STARTED|Step 1||60
208459|NCT01262846|504531|P2|NOT COMPLETED|Overall Study||3
208460|NCT01262846|504532|P1|NOT COMPLETED|Overall Study||2
208461|NCT01262846|504531|P2|COMPLETED|Overall Study||97
208462|NCT01262846|504532|P1|COMPLETED|Overall Study||93
208463|NCT01262846|504531|P2|STARTED|Overall Study||100
208464|NCT01262846|504532|P1|STARTED|Overall Study||95
208465|NCT01262820|504538|P1|NOT COMPLETED|Overall Study||15
208466|NCT01262820|504538|P1|COMPLETED|Overall Study||0
208467|NCT01262820|504538|P1|STARTED|Overall Study||15
208468|NCT01262755|504545|P1|NOT COMPLETED|Overall Study||0
208469|NCT01262755|504545|P1|COMPLETED|Overall Study||450
208470|NCT01262755|504545|P1|STARTED|Overall Study||450
208471|NCT01262677|504552|P3|NOT COMPLETED|Overall Study||12
208472|NCT01262677|504553|P2|NOT COMPLETED|Overall Study||15
208473|NCT01262677|504554|P1|NOT COMPLETED|Overall Study||9
208474|NCT01262677|504552|P3|COMPLETED|Overall Study||98
208475|NCT01262677|504553|P2|COMPLETED|Overall Study||98
208476|NCT01262677|504554|P1|COMPLETED|Overall Study||91
208477|NCT01262677|504552|P3|STARTED|Overall Study||110
208478|NCT01262677|504553|P2|STARTED|Overall Study||113
208479|NCT01262677|504554|P1|STARTED|Overall Study||100
208480|NCT01262651|504645|P2|NOT COMPLETED|Overall Study||48
208481|NCT01262651|504646|P1|NOT COMPLETED|Overall Study||58
208482|NCT01262651|504645|P2|COMPLETED|Overall Study||150
208483|NCT01262651|504646|P1|COMPLETED|Overall Study||141
208484|NCT01262651|504645|P2|ITT Population|Overall Study||198
208485|NCT01262651|504646|P1|ITT Population|Overall Study||199
208486|NCT01262651|504645|P2|Safety Population|Overall Study||198
208487|NCT01262651|504646|P1|Safety Population|Overall Study||199
208488|NCT01262651|504645|P2|Received at Least 1 Dose of Study Drug|Overall Study||198
208489|NCT01262651|504646|P1|Received at Least 1 Dose of Study Drug|Overall Study||199
208490|NCT01262651|504645|P2|STARTED|Overall Study||198
208491|NCT01262651|504646|P1|STARTED|Overall Study||199
208492|NCT01262599|504674|P2|NOT COMPLETED|Overall Study||0
208493|NCT01262599|504675|P1|NOT COMPLETED|Overall Study||0
208494|NCT01262599|504674|P2|COMPLETED|Overall Study||16
208495|NCT01262599|504675|P1|COMPLETED|Overall Study||16
208496|NCT01262599|504674|P2|STARTED|Overall Study||16
208497|NCT01262599|504675|P1|STARTED|Overall Study||16
208498|NCT01262573|504687|P2|NOT COMPLETED|Overall Study||1
208499|NCT01262573|504688|P1|NOT COMPLETED|Overall Study||0
208500|NCT01262573|504687|P2|COMPLETED|Overall Study||31
208501|NCT01262573|504688|P1|COMPLETED|Overall Study||32
208502|NCT01262573|504687|P2|STARTED|Overall Study||32
208503|NCT01262573|504688|P1|STARTED|Overall Study||32
208504|NCT01262560|504699|P3|NOT COMPLETED|Overall Study||2
208505|NCT01262560|504700|P2|NOT COMPLETED|Overall Study||1
208506|NCT01262560|504701|P1|NOT COMPLETED|Overall Study||0
208507|NCT01262560|504699|P3|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|54
208508|NCT01262560|504700|P2|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
208509|NCT01262560|504701|P1|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
208510|NCT01262560|504699|P3|STARTED|Overall Study||56
208511|NCT01262560|504700|P2|STARTED|Overall Study||54
208512|NCT01262560|504701|P1|STARTED|Overall Study||53
208513|NCT01262547|504736|P1|NOT COMPLETED|Overall Study||0
208514|NCT01262547|504736|P1|COMPLETED|Overall Study||3
208515|NCT01262547|504736|P1|STARTED|Overall Study||3
208516|NCT01262456|504750|P3|NOT COMPLETED|1-Month Open-Label Extension Period||5
208517|NCT01262456|504751|P2|NOT COMPLETED|1-Month Open-Label Extension Period||3
208518|NCT01262456|504752|P1|NOT COMPLETED|1-Month Open-Label Extension Period||4
208519|NCT01262456|504750|P3|COMPLETED|1-Month Open-Label Extension Period||98
208520|NCT01262456|504751|P2|COMPLETED|1-Month Open-Label Extension Period||97
208521|NCT01262456|504752|P1|COMPLETED|1-Month Open-Label Extension Period||120
208522|NCT01262456|504750|P3|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period|1 subject was randomized to Desmopressin 75 μg but received 50 μg. Also true in Double-Blind Period|102
208523|NCT01262456|504751|P2|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||101
208524|NCT01262456|504752|P1|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||124
208525|NCT01262456|504750|P3|STARTED|1-Month Open-Label Extension Period||103
208526|NCT01262456|504751|P2|STARTED|1-Month Open-Label Extension Period||100
208527|NCT01262456|504752|P1|STARTED|1-Month Open-Label Extension Period||124
208528|NCT01262456|504750|P3|NOT COMPLETED|3-Month Double-Blind Period||26
208529|NCT01262456|504751|P2|NOT COMPLETED|3-Month Double-Blind Period||23
208530|NCT01262456|504752|P1|NOT COMPLETED|3-Month Double-Blind Period||19
208531|NCT01262456|504750|P3|COMPLETED|3-Month Double-Blind Period||103
208532|NCT01262456|504751|P2|COMPLETED|3-Month Double-Blind Period||100
208533|NCT01262456|504752|P1|COMPLETED|3-Month Double-Blind Period||124
208534|NCT01262456|504750|P3|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|122
208535|NCT01262456|504751|P2|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|119
208536|NCT01262456|504752|P1|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|143
208537|NCT01262456|504750|P3|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|124
208538|NCT01262456|504751|P2|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|119
208539|NCT01262456|504752|P1|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|142
208540|NCT01262456|504750|P3|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|129
208541|NCT01262456|504751|P2|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|123
208542|NCT01262456|504752|P1|STARTED|3-Month Double-Blind Period|Intent-to-Treat (ITT) population: randomized participants regardless of exposure to treatment|143
208543|NCT01262365|504796|P3|NOT COMPLETED|Overall Study||94
208544|NCT01262365|504797|P2|NOT COMPLETED|Overall Study||81
208545|NCT01262365|504798|P1|NOT COMPLETED|Overall Study||90
208546|NCT01262365|504796|P3|COMPLETED|Overall Study||171
208547|NCT01262365|504797|P2|COMPLETED|Overall Study||181
208548|NCT01262365|504798|P1|COMPLETED|Overall Study||176
208549|NCT01262365|504796|P3|STARTED|Overall Study||265
208550|NCT01262365|504797|P2|STARTED|Overall Study||262
208551|NCT01262365|504798|P1|STARTED|Overall Study||266
208552|NCT01262352|504823|P2|NOT COMPLETED|Period 2||0
208553|NCT01262352|504824|P1|NOT COMPLETED|Period 2||0
208554|NCT01262352|504823|P2|COMPLETED|Period 2||8
208555|NCT01262352|504824|P1|COMPLETED|Period 2||9
208556|NCT01262352|504823|P2|Dosed|Period 2||8
208557|NCT01262352|504824|P1|Dosed|Period 2||9
208558|NCT01262352|504823|P2|STARTED|Period 2||8
208559|NCT01262352|504824|P1|STARTED|Period 2||9
208560|NCT01262352|504823|P2|NOT COMPLETED|Washout||2
208561|NCT01262352|504824|P1|NOT COMPLETED|Washout||1
208562|NCT01262352|504823|P2|COMPLETED|Washout||8
208563|NCT01262352|504824|P1|COMPLETED|Washout||9
208564|NCT01262352|504823|P2|STARTED|Washout||10
208565|NCT01262352|504824|P1|STARTED|Washout||10
208566|NCT01262352|504823|P2|NOT COMPLETED|Period 1||0
208567|NCT01262352|504824|P1|NOT COMPLETED|Period 1||1
208568|NCT01262352|504823|P2|COMPLETED|Period 1||10
208569|NCT01262352|504824|P1|COMPLETED|Period 1||10
208570|NCT01262352|504823|P2|Dosed|Period 1||10
208571|NCT01262352|504824|P1|Dosed|Period 1||10
208572|NCT01262352|504823|P2|STARTED|Period 1||10
208573|NCT01262352|504824|P1|STARTED|Period 1||11
208574|NCT01262339|504836|P1|NOT COMPLETED|Overall Study||0
208575|NCT01262339|504836|P1|COMPLETED|Overall Study||2
208576|NCT01262339|504836|P1|STARTED|Overall Study||2
208577|NCT01262287|504842|P2|NOT COMPLETED|Overall Study||1
208578|NCT01262287|504843|P1|NOT COMPLETED|Overall Study||2
208579|NCT01262287|504842|P2|COMPLETED|Overall Study||18
208580|NCT01262287|504843|P1|COMPLETED|Overall Study||18
208581|NCT01262287|504842|P2|STARTED|Overall Study||19
208582|NCT01262287|504843|P1|STARTED|Overall Study||20
208583|NCT01262131|504856|P3|NOT COMPLETED|Overall Study||0
208584|NCT01262131|504857|P2|NOT COMPLETED|Overall Study||0
208585|NCT01262131|504858|P1|NOT COMPLETED|Overall Study||0
208586|NCT01262131|504856|P3|COMPLETED|Overall Study||4
208587|NCT01262131|504857|P2|COMPLETED|Overall Study||4
208588|NCT01262131|504858|P1|COMPLETED|Overall Study||5
208589|NCT01262131|504856|P3|STARTED|Overall Study||4
208590|NCT01262131|504857|P2|STARTED|Overall Study||4
208591|NCT01262131|504858|P1|STARTED|Overall Study||5
208592|NCT01262118|504868|P2|NOT COMPLETED|Treatment Period (6 Weeks)||0
208593|NCT01262118|504869|P1|NOT COMPLETED|Treatment Period (6 Weeks)||0
208594|NCT01262118|504868|P2|COMPLETED|Treatment Period (6 Weeks)||0
208595|NCT01262118|504869|P1|COMPLETED|Treatment Period (6 Weeks)||36
208596|NCT01262118|504868|P2|STARTED|Treatment Period (6 Weeks)||0
208597|NCT01262118|504869|P1|STARTED|Treatment Period (6 Weeks)||36
208598|NCT01262118|504868|P2|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
208599|NCT01262118|504869|P1|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
208600|NCT01262118|504868|P2|COMPLETED|Baseline Assessment Period (3 Days)||33
208601|NCT01262118|504869|P1|COMPLETED|Baseline Assessment Period (3 Days)||36
208602|NCT01262118|504868|P2|STARTED|Baseline Assessment Period (3 Days)||33
208603|NCT01262118|504869|P1|STARTED|Baseline Assessment Period (3 Days)||36
208604|NCT01262105|504895|P2|NOT COMPLETED|Overall Study||0
208605|NCT01262105|504896|P1|NOT COMPLETED|Overall Study||0
208606|NCT01262105|504895|P2|COMPLETED|Overall Study||10
208607|NCT01262105|504896|P1|COMPLETED|Overall Study||13
208608|NCT01262105|504895|P2|STARTED|Overall Study||10
208609|NCT01262105|504896|P1|STARTED|Overall Study||13
208610|NCT01262092|504904|P2|NOT COMPLETED|Gabapentin Taper||0
208611|NCT01262092|504905|P1|NOT COMPLETED|Gabapentin Taper||1
208612|NCT01262092|504904|P2|COMPLETED|Gabapentin Taper||11
208613|NCT01262092|504905|P1|COMPLETED|Gabapentin Taper||9
208614|NCT01262092|504904|P2|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|11
208615|NCT01262092|504905|P1|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|10
208616|NCT01262092|504904|P2|NOT COMPLETED|Buprenorphine Taper||1
208617|NCT01262092|504905|P1|NOT COMPLETED|Buprenorphine Taper||1
208618|NCT01262092|504904|P2|COMPLETED|Buprenorphine Taper||12
208619|NCT01262092|504905|P1|COMPLETED|Buprenorphine Taper||11
208620|NCT01262092|504904|P2|STARTED|Buprenorphine Taper||13
208621|NCT01262092|504905|P1|STARTED|Buprenorphine Taper|One left the study prior to starting the taper due to pharmacy error (started taper in wk 2)|12
208622|NCT01262092|504904|P2|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||1
208623|NCT01262092|504905|P1|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||3
208624|NCT01262092|504904|P2|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
208625|NCT01262092|504905|P1|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
208626|NCT01262092|504904|P2|STARTED|Buprenorphine+Gabapentin/Plac Induction||14
208627|NCT01262092|504905|P1|STARTED|Buprenorphine+Gabapentin/Plac Induction||16
208628|NCT01262027|504911|P1|NOT COMPLETED|Overall Study||5
208629|NCT01262027|504911|P1|COMPLETED|Overall Study||17
208630|NCT01262027|504911|P1|STARTED|Overall Study||22
208631|NCT01261975|504916|P1|NOT COMPLETED|Overall Study||1
208632|NCT01261975|504916|P1|COMPLETED|Overall Study|35 Participants 70 eyes completed|35
208633|NCT01261975|504916|P1|STARTED|Overall Study|36 Participants 72 eyes started|36
208634|NCT01261793|504938|P3|NOT COMPLETED|Overall Study||82
208635|NCT01261793|504939|P2|NOT COMPLETED|Overall Study||91
208636|NCT01261793|504940|P1|NOT COMPLETED|Overall Study||85
208637|NCT01261793|504938|P3|COMPLETED|Overall Study||184
208638|NCT01261793|504939|P2|COMPLETED|Overall Study||171
208639|NCT01261793|504940|P1|COMPLETED|Overall Study||178
208640|NCT01261793|504938|P3|STARTED|Overall Study||266
208641|NCT01261793|504939|P2|STARTED|Overall Study||262
208642|NCT01261793|504940|P1|STARTED|Overall Study||263
208643|NCT01261780|504965|P2|NOT COMPLETED|Overall Study||2
208644|NCT01261780|504966|P1|NOT COMPLETED|Overall Study||2
208645|NCT01261780|504965|P2|COMPLETED|Overall Study||5
208646|NCT01261780|504966|P1|COMPLETED|Overall Study||5
208647|NCT01261780|504965|P2|STARTED|Overall Study||7
208648|NCT01261780|504966|P1|STARTED|Overall Study||7
208649|NCT01261624|504976|P2|NOT COMPLETED|Week 13 to Week 24||1
208650|NCT01261624|504977|P1|NOT COMPLETED|Week 13 to Week 24||0
208651|NCT01261624|504976|P2|COMPLETED|Week 13 to Week 24||10
208652|NCT01261624|504977|P1|COMPLETED|Week 13 to Week 24||1
208653|NCT01261624|504976|P2|STARTED|Week 13 to Week 24|Of 6 pts of HDTC: 3 non-responders went out of study, 3 continued. 8 swithched from LDTC to HDTC|11
208654|NCT01261624|504977|P1|STARTED|Week 13 to Week 24|Of 9 pts from LDTC: 5 non-responders switched to HDTC; 4 pts responded, but 3 switched to HDTC|1
208655|NCT01261624|504976|P2|NOT COMPLETED|Week 0 to Week 12||3
208656|NCT01261624|504977|P1|NOT COMPLETED|Week 0 to Week 12||1
208657|NCT01261624|504976|P2|COMPLETED|Week 0 to Week 12||3
208658|NCT01261624|504977|P1|COMPLETED|Week 0 to Week 12||9
208659|NCT01261624|504976|P2|STARTED|Week 0 to Week 12||6
208660|NCT01261624|504977|P1|STARTED|Week 0 to Week 12||10
208661|NCT01261611|504997|P3|NOT COMPLETED|Treatment Cycle 5||0
208662|NCT01261611|504998|P2|NOT COMPLETED|Treatment Cycle 5||0
208663|NCT01261611|504999|P1|NOT COMPLETED|Treatment Cycle 5||3
208664|NCT01261611|504997|P3|COMPLETED|Treatment Cycle 5||0
208665|NCT01261611|504998|P2|COMPLETED|Treatment Cycle 5||0
208666|NCT01261611|504999|P1|COMPLETED|Treatment Cycle 5||217
208667|NCT01261611|504997|P3|STARTED|Treatment Cycle 5||0
208668|NCT01261611|504998|P2|STARTED|Treatment Cycle 5||0
208669|NCT01261611|504999|P1|STARTED|Treatment Cycle 5||220
208670|NCT01261611|504997|P3|NOT COMPLETED|Treatment Cycle 4||0
208671|NCT01261611|504998|P2|NOT COMPLETED|Treatment Cycle 4||0
208672|NCT01261611|504999|P1|NOT COMPLETED|Treatment Cycle 4||96
208673|NCT01261611|504997|P3|COMPLETED|Treatment Cycle 4||0
208674|NCT01261611|504998|P2|COMPLETED|Treatment Cycle 4||0
208675|NCT01261611|504999|P1|COMPLETED|Treatment Cycle 4||220
208676|NCT01261611|504997|P3|STARTED|Treatment Cycle 4||0
208677|NCT01261611|504998|P2|STARTED|Treatment Cycle 4||0
208678|NCT01261611|504999|P1|STARTED|Treatment Cycle 4||316
208679|NCT01261611|504997|P3|NOT COMPLETED|Treatment Cycle 3||0
208680|NCT01261611|504998|P2|NOT COMPLETED|Treatment Cycle 3||0
208681|NCT01261611|504999|P1|NOT COMPLETED|Treatment Cycle 3||30
208682|NCT01261611|504997|P3|COMPLETED|Treatment Cycle 3||0
208683|NCT01261611|504998|P2|COMPLETED|Treatment Cycle 3||0
208684|NCT01261611|504999|P1|COMPLETED|Treatment Cycle 3||316
208685|NCT01261611|504997|P3|STARTED|Treatment Cycle 3||0
208686|NCT01261611|504998|P2|STARTED|Treatment Cycle 3||0
208687|NCT01261611|504999|P1|STARTED|Treatment Cycle 3||346
208688|NCT01261611|504997|P3|NOT COMPLETED|Treatment Cycle 2||0
208689|NCT01261611|504998|P2|NOT COMPLETED|Treatment Cycle 2||0
208690|NCT01261611|504999|P1|NOT COMPLETED|Treatment Cycle 2||13
208691|NCT01261611|504997|P3|COMPLETED|Treatment Cycle 2||0
208692|NCT01261611|504998|P2|COMPLETED|Treatment Cycle 2||0
208693|NCT01261611|504999|P1|COMPLETED|Treatment Cycle 2||346
208694|NCT01261611|504997|P3|STARTED|Treatment Cycle 2||0
208695|NCT01261611|504998|P2|STARTED|Treatment Cycle 2||0
208696|NCT01261611|504999|P1|STARTED|Treatment Cycle 2|All but 1 who completed DB period entered the open label period. This subject remained at Cycle 1.|359
208697|NCT01261611|504997|P3|NOT COMPLETED|Treatment Cycle 1||2
208698|NCT01261611|504998|P2|NOT COMPLETED|Treatment Cycle 1||3
208699|NCT01261611|504999|P1|NOT COMPLETED|Treatment Cycle 1||4
208700|NCT01261611|504997|P3|COMPLETED|Treatment Cycle 1||52
208701|NCT01261611|504998|P2|COMPLETED|Treatment Cycle 1||156
208702|NCT01261611|504999|P1|COMPLETED|Treatment Cycle 1||152
208703|NCT01261611|504997|P3|STARTED|Treatment Cycle 1||54
208704|NCT01261611|504998|P2|STARTED|Treatment Cycle 1||159
208705|NCT01261611|504999|P1|STARTED|Treatment Cycle 1||156
208706|NCT01261559|505037|P2|NOT COMPLETED|Overall Study||0
208707|NCT01261559|505038|P1|NOT COMPLETED|Overall Study||0
208708|NCT01261559|505037|P2|COMPLETED|Overall Study||36
208709|NCT01261559|505038|P1|COMPLETED|Overall Study||36
208710|NCT01261559|505037|P2|STARTED|Overall Study||36
208711|NCT01261559|505038|P1|STARTED|Overall Study||36
208712|NCT01261507|505050|P1|NOT COMPLETED|Overall Study||0
208713|NCT01261507|505050|P1|COMPLETED|Overall Study||15
208714|NCT01261507|505050|P1|STARTED|Overall Study||15
208715|NCT01261390|505063|P4|NOT COMPLETED|Overall Study||8
208716|NCT01261390|505064|P3|NOT COMPLETED|Overall Study||7
208717|NCT01261390|505065|P2|NOT COMPLETED|Overall Study||9
208718|NCT01261390|505066|P1|NOT COMPLETED|Overall Study||7
208719|NCT01261390|505063|P4|COMPLETED|Overall Study|14 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
208720|NCT01261390|505064|P3|COMPLETED|Overall Study|16 of the 35 participants that completed the study in this arm were under the 6-Month protocol.|35
208721|NCT01261390|505065|P2|COMPLETED|Overall Study|12 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
208722|NCT01261390|505066|P1|COMPLETED|Overall Study|14 of the 37 participants that completed the study in this arm were under the 6-Month protocol.|37
208723|NCT01261390|505063|P4|12-Month Visit|Overall Study||19
208724|NCT01261390|505064|P3|12-Month Visit|Overall Study||19
208725|NCT01261390|505065|P2|12-Month Visit|Overall Study||21
208726|NCT01261390|505066|P1|12-Month Visit|Overall Study||23
208727|NCT01261390|505063|P4|6-Month Visit|Overall Study|For 14 of the 32 participants in this arm, this was their final visit.|32
208728|NCT01261390|505064|P3|6-Month Visit|Overall Study|For 16 of the 34 participants in this arm, this was their final visit.|34
208729|NCT01261390|505065|P2|6-Month Visit|Overall Study|For 12 of the 34 participants in this arm, this was their final visit.|34
208730|NCT01261390|505066|P1|6-Month Visit|Overall Study|For 14 of the 30 participants in this arm, this was their final visit.|37
208731|NCT01261390|505063|P4|STARTED|Overall Study|15 of the 41 participants only had to complete a 6-month follow-up assessment.|41
208732|NCT01261390|505064|P3|STARTED|Overall Study|16 of the 42 participants only had to complete a 6-month follow-up assessment.|42
208733|NCT01261390|505065|P2|STARTED|Overall Study|15 of the 42 participants only had to complete a 6-month follow-up assessment.|42
208734|NCT01261390|505066|P1|STARTED|Overall Study|15 of the 44 participants only had to complete a 6-month follow-up assessment.|44
208735|NCT01261325|505231|P3|NOT COMPLETED|Overall Study||26
208736|NCT01261325|505232|P2|NOT COMPLETED|Overall Study||29
208737|NCT01261325|505233|P1|NOT COMPLETED|Overall Study||17
208738|NCT01261325|505231|P3|COMPLETED|Overall Study||225
208739|NCT01261325|505232|P2|COMPLETED|Overall Study||225
208740|NCT01261325|505233|P1|COMPLETED|Overall Study||246
208741|NCT01261325|505231|P3|STARTED|Overall Study||251
208742|NCT01261325|505232|P2|STARTED|Overall Study||254
208743|NCT01261325|505233|P1|STARTED|Overall Study||263
208744|NCT01261247|505265|P1|NOT COMPLETED|Overall Study||2
208745|NCT01261247|505265|P1|COMPLETED|Overall Study||39
208746|NCT01261247|505265|P1|STARTED|Overall Study||41
208747|NCT01261052|505272|P1|NOT COMPLETED|APD Only Intervention (33 Hours)||0
208748|NCT01261052|505272|P1|COMPLETED|APD Only Intervention (33 Hours)||14
208749|NCT01261052|505272|P1|STARTED|APD Only Intervention (33 Hours)||14
208750|NCT01261052|505272|P1|NOT COMPLETED|FMPD/APD Intervention (33 Hours)||0
208751|NCT01261052|505272|P1|COMPLETED|FMPD/APD Intervention (33 Hours)||14
208752|NCT01261052|505272|P1|STARTED|FMPD/APD Intervention (33 Hours)||14
208753|NCT01261000|505278|P1|NOT COMPLETED|Overall Study||1
208754|NCT01261000|505278|P1|COMPLETED|Overall Study||7
208755|NCT01261000|505278|P1|STARTED|Overall Study||8
208756|NCT01260948|505284|P2|NOT COMPLETED|Second Intervention||1
208757|NCT01260948|505285|P1|NOT COMPLETED|Second Intervention||0
208758|NCT01260948|505284|P2|COMPLETED|Second Intervention||9
208759|NCT01260948|505285|P1|COMPLETED|Second Intervention||12
208760|NCT01260948|505284|P2|STARTED|Second Intervention||10
208761|NCT01260948|505285|P1|STARTED|Second Intervention||12
208762|NCT01260948|505284|P2|NOT COMPLETED|Washout of 28 Days||3
208763|NCT01260948|505285|P1|NOT COMPLETED|Washout of 28 Days||1
208764|NCT01260948|505284|P2|COMPLETED|Washout of 28 Days||10
208765|NCT01260948|505285|P1|COMPLETED|Washout of 28 Days||12
208766|NCT01260948|505284|P2|STARTED|Washout of 28 Days||13
208767|NCT01260948|505285|P1|STARTED|Washout of 28 Days||13
208768|NCT01260948|505284|P2|NOT COMPLETED|First Intervention||0
208769|NCT01260948|505285|P1|NOT COMPLETED|First Intervention||0
208770|NCT01260948|505284|P2|COMPLETED|First Intervention||13
208771|NCT01260948|505285|P1|COMPLETED|First Intervention||13
208772|NCT01260948|505284|P2|STARTED|First Intervention||13
208773|NCT01260948|505285|P1|STARTED|First Intervention||13
208774|NCT01260922|505295|P2|NOT COMPLETED|Second Intervention||2
208775|NCT01260922|505296|P1|NOT COMPLETED|Second Intervention||0
208776|NCT01260922|505295|P2|COMPLETED|Second Intervention||8
208777|NCT01260922|505296|P1|COMPLETED|Second Intervention||9
208778|NCT01260922|505295|P2|STARTED|Second Intervention||10
208779|NCT01260922|505296|P1|STARTED|Second Intervention||9
208780|NCT01260922|505295|P2|NOT COMPLETED|Washout of 28 Days||2
208781|NCT01260922|505296|P1|NOT COMPLETED|Washout of 28 Days||4
208782|NCT01260922|505295|P2|COMPLETED|Washout of 28 Days||10
208783|NCT01260922|505296|P1|COMPLETED|Washout of 28 Days||9
208784|NCT01260922|505295|P2|STARTED|Washout of 28 Days||12
208785|NCT01260922|505296|P1|STARTED|Washout of 28 Days||13
208786|NCT01260922|505295|P2|NOT COMPLETED|First Intervention||1
208787|NCT01260922|505296|P1|NOT COMPLETED|First Intervention||0
208788|NCT01260922|505295|P2|COMPLETED|First Intervention||12
208789|NCT01260922|505296|P1|COMPLETED|First Intervention||13
208790|NCT01260922|505295|P2|STARTED|First Intervention||13
208791|NCT01260922|505296|P1|STARTED|First Intervention||13
208792|NCT01260896|505306|P2|NOT COMPLETED|Second Intervention||0
208793|NCT01260896|505307|P1|NOT COMPLETED|Second Intervention||0
208794|NCT01260896|505306|P2|COMPLETED|Second Intervention||12
208795|NCT01260896|505307|P1|COMPLETED|Second Intervention||10
208796|NCT01260896|505306|P2|STARTED|Second Intervention||12
208797|NCT01260896|505307|P1|STARTED|Second Intervention||10
208798|NCT01260896|505306|P2|NOT COMPLETED|Washout of 7 Days||0
208799|NCT01260896|505307|P1|NOT COMPLETED|Washout of 7 Days||0
208800|NCT01260896|505306|P2|COMPLETED|Washout of 7 Days||12
208801|NCT01260896|505307|P1|COMPLETED|Washout of 7 Days||10
208802|NCT01260896|505306|P2|STARTED|Washout of 7 Days||12
208803|NCT01260896|505307|P1|STARTED|Washout of 7 Days||10
208804|NCT01260896|505306|P2|NOT COMPLETED|First Intervention||0
208805|NCT01260896|505307|P1|NOT COMPLETED|First Intervention||2
208806|NCT01260896|505306|P2|COMPLETED|First Intervention||12
208807|NCT01260896|505307|P1|COMPLETED|First Intervention||10
208808|NCT01260896|505306|P2|STARTED|First Intervention||12
208809|NCT01260896|505307|P1|STARTED|First Intervention||12
208810|NCT01260883|505326|P3|NOT COMPLETED|Overall Study||0
208811|NCT01260883|505327|P2|NOT COMPLETED|Overall Study||0
208812|NCT01260883|505328|P1|NOT COMPLETED|Overall Study||0
208813|NCT01260883|505326|P3|COMPLETED|Overall Study||18
208814|NCT01260883|505327|P2|COMPLETED|Overall Study||11
208815|NCT01260883|505328|P1|COMPLETED|Overall Study||22
208816|NCT01260883|505326|P3|STARTED|Overall Study||18
208817|NCT01260883|505327|P2|STARTED|Overall Study||11
208818|NCT01260883|505328|P1|STARTED|Overall Study||22
208819|NCT01260701|505365|P1|NOT COMPLETED|Overall Study||75
208820|NCT01260701|505365|P1|COMPLETED|Overall Study||0
208821|NCT01260701|505365|P1|Eligible and Began Protocol Therapy|Overall Study||70
208822|NCT01260701|505365|P1|Eligible|Overall Study||71
208823|NCT01260701|505365|P1|STARTED|Overall Study||75
208824|NCT01260688|505374|P2|NOT COMPLETED|Overall Study||0
208825|NCT01260688|505375|P1|NOT COMPLETED|Overall Study||0
208826|NCT01260688|505374|P2|COMPLETED|Overall Study||11
208827|NCT01260688|505375|P1|COMPLETED|Overall Study||11
208828|NCT01260688|505374|P2|STARTED|Overall Study||11
208829|NCT01260688|505375|P1|STARTED|Overall Study||11
208830|NCT01260662|505412|P3|NOT COMPLETED|Overall Study||0
208831|NCT01260662|505413|P2|NOT COMPLETED|Overall Study||0
208832|NCT01260662|505414|P1|NOT COMPLETED|Overall Study||0
208833|NCT01260662|505412|P3|COMPLETED|Overall Study||96
208834|NCT01260662|505413|P2|COMPLETED|Overall Study||85
208835|NCT01260662|505414|P1|COMPLETED|Overall Study||90
208836|NCT01260662|505412|P3|STARTED|Overall Study||96
208837|NCT01260662|505413|P2|STARTED|Overall Study||85
208838|NCT01260662|505414|P1|STARTED|Overall Study||90
208839|NCT01260649|505433|P2|NOT COMPLETED|Overall Study||1
208840|NCT01260649|505434|P1|NOT COMPLETED|Overall Study||2
208841|NCT01260649|505433|P2|COMPLETED|Overall Study||8
208842|NCT01260649|505434|P1|COMPLETED|Overall Study||6
208843|NCT01260649|505433|P2|STARTED|Overall Study||9
208844|NCT01260649|505434|P1|STARTED|Overall Study||8
208845|NCT01260584|505446|P4|NOT COMPLETED|Period 2||1
208846|NCT01260584|505447|P3|NOT COMPLETED|Period 2||5
208847|NCT01260584|505448|P2|NOT COMPLETED|Period 2||3
208848|NCT01260584|505449|P1|NOT COMPLETED|Period 2||1
208849|NCT01260584|505446|P4|COMPLETED|Period 2||26
208850|NCT01260584|505447|P3|COMPLETED|Period 2||20
208851|NCT01260584|505448|P2|COMPLETED|Period 2||25
208852|NCT01260584|505449|P1|COMPLETED|Period 2||26
208853|NCT01260584|505446|P4|STARTED|Period 2||27
208854|NCT01260584|505447|P3|STARTED|Period 2||25
208855|NCT01260584|505448|P2|STARTED|Period 2||28
208856|NCT01260584|505449|P1|STARTED|Period 2||27
208857|NCT01260584|505446|P4|NOT COMPLETED|Period 1||1
208858|NCT01260584|505447|P3|NOT COMPLETED|Period 1||2
208859|NCT01260584|505448|P2|NOT COMPLETED|Period 1||0
208860|NCT01260584|505449|P1|NOT COMPLETED|Period 1||0
208861|NCT01260584|505446|P4|COMPLETED|Period 1||27
208862|NCT01260584|505447|P3|COMPLETED|Period 1||25
208863|NCT01260584|505448|P2|COMPLETED|Period 1||28
208864|NCT01260584|505449|P1|COMPLETED|Period 1||27
208865|NCT01260584|505446|P4|STARTED|Period 1||28
208866|NCT01260584|505447|P3|STARTED|Period 1||27
208867|NCT01260584|505448|P2|STARTED|Period 1||28
208868|NCT01260584|505449|P1|STARTED|Period 1||27
208869|NCT01260493|505485|P2|NOT COMPLETED|Overall Study||4
208870|NCT01260493|505486|P1|NOT COMPLETED|Overall Study||16
208871|NCT01260493|505485|P2|COMPLETED|Overall Study||85
208872|NCT01260493|505486|P1|COMPLETED|Overall Study||76
208873|NCT01260493|505485|P2|STARTED|Overall Study||89
208874|NCT01260493|505486|P1|STARTED|Overall Study||92
208875|NCT01260467|505492|P1|NOT COMPLETED|Overall Study||2
208876|NCT01260467|505492|P1|COMPLETED|Overall Study||2
208877|NCT01260467|505492|P1|STARTED|Overall Study||4
208878|NCT01260454|505498|P1|NOT COMPLETED|Overall Study||0
208879|NCT01260454|505498|P1|COMPLETED|Overall Study||6
208880|NCT01260454|505498|P1|STARTED|Overall Study||6
208881|NCT01260350|505524|P22|NOT COMPLETED|Overall Study||0
208882|NCT01260350|505525|P21|NOT COMPLETED|Overall Study||3
208883|NCT01260350|505526|P20|NOT COMPLETED|Overall Study||0
208884|NCT01260350|505527|P19|NOT COMPLETED|Overall Study||0
208885|NCT01260350|505528|P18|NOT COMPLETED|Overall Study||1
208886|NCT01260350|505529|P17|NOT COMPLETED|Overall Study||0
208887|NCT01260350|505530|P16|NOT COMPLETED|Overall Study||0
208888|NCT01260350|505531|P15|NOT COMPLETED|Overall Study||0
208889|NCT01260350|505532|P14|NOT COMPLETED|Overall Study||0
208890|NCT01260350|505533|P13|NOT COMPLETED|Overall Study||0
208891|NCT01260350|505534|P12|NOT COMPLETED|Overall Study||0
208892|NCT01260350|505535|P11|NOT COMPLETED|Overall Study||0
208893|NCT01260350|505536|P10|NOT COMPLETED|Overall Study||0
208894|NCT01260350|505537|P9|NOT COMPLETED|Overall Study||1
208895|NCT01260350|505538|P8|NOT COMPLETED|Overall Study||0
208896|NCT01260350|505539|P7|NOT COMPLETED|Overall Study||0
208897|NCT01260350|505540|P6|NOT COMPLETED|Overall Study||0
208898|NCT01260350|505541|P5|NOT COMPLETED|Overall Study||0
208899|NCT01260350|505542|P4|NOT COMPLETED|Overall Study||0
208900|NCT01260350|505543|P3|NOT COMPLETED|Overall Study||0
208901|NCT01260350|505544|P2|NOT COMPLETED|Overall Study||0
208902|NCT01260350|505545|P1|NOT COMPLETED|Overall Study||0
208903|NCT01260350|505524|P22|COMPLETED|Overall Study||0
208904|NCT01260350|505525|P21|COMPLETED|Overall Study||22
208905|NCT01260350|505526|P20|COMPLETED|Overall Study||14
208906|NCT01260350|505527|P19|COMPLETED|Overall Study||0
208907|NCT01260350|505528|P18|COMPLETED|Overall Study||9
208908|NCT01260350|505529|P17|COMPLETED|Overall Study||9
208909|NCT01260350|505530|P16|COMPLETED|Overall Study||10
208910|NCT01260350|505531|P15|COMPLETED|Overall Study||25
208911|NCT01260350|505532|P14|COMPLETED|Overall Study||10
208912|NCT01260350|505533|P13|COMPLETED|Overall Study||25
208913|NCT01260350|505534|P12|COMPLETED|Overall Study||9
208914|NCT01260350|505535|P11|COMPLETED|Overall Study||10
208915|NCT01260350|505536|P10|COMPLETED|Overall Study||25
208916|NCT01260350|505537|P9|COMPLETED|Overall Study||24
208917|NCT01260350|505538|P8|COMPLETED|Overall Study||25
208918|NCT01260350|505539|P7|COMPLETED|Overall Study||10
208919|NCT01260350|505540|P6|COMPLETED|Overall Study||10
208920|NCT01260350|505541|P5|COMPLETED|Overall Study||10
208921|NCT01260350|505542|P4|COMPLETED|Overall Study||11
208922|NCT01260350|505543|P3|COMPLETED|Overall Study||10
208923|NCT01260350|505544|P2|COMPLETED|Overall Study||9
208924|NCT01260350|505545|P1|COMPLETED|Overall Study||10
208925|NCT01260350|505524|P22|STARTED|Overall Study||0
208926|NCT01260350|505525|P21|STARTED|Overall Study||25
208927|NCT01260350|505526|P20|STARTED|Overall Study||14
208928|NCT01260350|505527|P19|STARTED|Overall Study||0
208929|NCT01260350|505528|P18|STARTED|Overall Study||10
208930|NCT01260350|505529|P17|STARTED|Overall Study||9
208931|NCT01260350|505530|P16|STARTED|Overall Study||10
208932|NCT01260350|505531|P15|STARTED|Overall Study||25
208933|NCT01260350|505532|P14|STARTED|Overall Study||10
208934|NCT01260350|505533|P13|STARTED|Overall Study||25
208935|NCT01260350|505534|P12|STARTED|Overall Study||9
208936|NCT01260350|505535|P11|STARTED|Overall Study||10
208937|NCT01260350|505536|P10|STARTED|Overall Study||25
208938|NCT01260350|505537|P9|STARTED|Overall Study||25
208939|NCT01260350|505538|P8|STARTED|Overall Study||25
208940|NCT01260350|505539|P7|STARTED|Overall Study||10
208941|NCT01260350|505540|P6|STARTED|Overall Study||10
208942|NCT01260350|505541|P5|STARTED|Overall Study||10
208943|NCT01260350|505542|P4|STARTED|Overall Study||11
208944|NCT01260350|505543|P3|STARTED|Overall Study||10
208945|NCT01260350|505544|P2|STARTED|Overall Study||9
208946|NCT01260350|505545|P1|STARTED|Overall Study||10
208947|NCT01260324|505737|P2|NOT COMPLETED|Overall Study||0
208948|NCT01260324|505738|P1|NOT COMPLETED|Overall Study||0
208949|NCT01260324|505737|P2|COMPLETED|Overall Study||20000
208950|NCT01260324|505738|P1|COMPLETED|Overall Study||1283
208951|NCT01260324|505737|P2|STARTED|Overall Study||20000
208952|NCT01260324|505738|P1|STARTED|Overall Study||1283
208953|NCT01260311|505752|P1|NOT COMPLETED|Overall Study||127
208954|NCT01260311|505752|P1|COMPLETED|Overall Study||381
208955|NCT01260311|505752|P1|STARTED|Overall Study||508
208956|NCT01260272|505762|P2|NOT COMPLETED|Overall Study||2
208957|NCT01260272|505763|P1|NOT COMPLETED|Overall Study||2
208958|NCT01260272|505762|P2|COMPLETED|Overall Study||30
208959|NCT01260272|505763|P1|COMPLETED|Overall Study||15
208960|NCT01260272|505762|P2|STARTED|Overall Study||32
208961|NCT01260272|505763|P1|STARTED|Overall Study||17
208962|NCT01260194|505783|P1|NOT COMPLETED|Overall Study||1
208963|NCT01260194|505783|P1|COMPLETED|Overall Study||3
208964|NCT01260194|505783|P1|STARTED|Overall Study||4
208965|NCT01260181|505795|P1|NOT COMPLETED|Overall Study||1
208966|NCT01260181|505795|P1|COMPLETED|Overall Study||29
208967|NCT01260181|505795|P1|STARTED|Overall Study||30
208968|NCT01260142|505810|P6|NOT COMPLETED|Treatment Period 2||0
208969|NCT01260142|505811|P5|NOT COMPLETED|Treatment Period 2||0
208970|NCT01260142|505812|P4|NOT COMPLETED|Treatment Period 2||0
208971|NCT01260142|505813|P3|NOT COMPLETED|Treatment Period 2||0
208972|NCT01260142|505814|P2|NOT COMPLETED|Treatment Period 2||0
208973|NCT01260142|505815|P1|NOT COMPLETED|Treatment Period 2||0
208974|NCT01260142|505810|P6|COMPLETED|Treatment Period 2||3
208975|NCT01260142|505811|P5|COMPLETED|Treatment Period 2||4
208976|NCT01260142|505812|P4|COMPLETED|Treatment Period 2||6
208977|NCT01260142|505813|P3|COMPLETED|Treatment Period 2||6
208978|NCT01260142|505814|P2|COMPLETED|Treatment Period 2||5
208979|NCT01260142|505815|P1|COMPLETED|Treatment Period 2||5
208980|NCT01260142|505810|P6|STARTED|Treatment Period 2||3
208981|NCT01260142|505811|P5|STARTED|Treatment Period 2||4
208982|NCT01260142|505812|P4|STARTED|Treatment Period 2||6
208983|NCT01260142|505813|P3|STARTED|Treatment Period 2||6
208984|NCT01260142|505814|P2|STARTED|Treatment Period 2||5
208985|NCT01260142|505815|P1|STARTED|Treatment Period 2||5
208986|NCT01260142|505810|P6|NOT COMPLETED|Treatment Period 1||3
208987|NCT01260142|505811|P5|NOT COMPLETED|Treatment Period 1||2
208988|NCT01260142|505812|P4|NOT COMPLETED|Treatment Period 1||0
208989|NCT01260142|505813|P3|NOT COMPLETED|Treatment Period 1||0
208990|NCT01260142|505814|P2|NOT COMPLETED|Treatment Period 1||1
208991|NCT01260142|505815|P1|NOT COMPLETED|Treatment Period 1||1
208992|NCT01260142|505810|P6|COMPLETED|Treatment Period 1||3
208993|NCT01260142|505811|P5|COMPLETED|Treatment Period 1||4
208994|NCT01260142|505812|P4|COMPLETED|Treatment Period 1||6
208995|NCT01260142|505813|P3|COMPLETED|Treatment Period 1||6
208996|NCT01260142|505814|P2|COMPLETED|Treatment Period 1||5
208997|NCT01260142|505815|P1|COMPLETED|Treatment Period 1||5
208998|NCT01260142|505810|P6|STARTED|Treatment Period 1||6
208999|NCT01260142|505811|P5|STARTED|Treatment Period 1||6
209000|NCT01260142|505812|P4|STARTED|Treatment Period 1||6
209001|NCT01260142|505813|P3|STARTED|Treatment Period 1||6
209002|NCT01260142|505814|P2|STARTED|Treatment Period 1||6
209003|NCT01260142|505815|P1|STARTED|Treatment Period 1||6
209004|NCT01259856|505867|P2|NOT COMPLETED|Overall Study||74
209005|NCT01259856|505868|P1|NOT COMPLETED|Overall Study||69
209006|NCT01259856|505867|P2|COMPLETED|Overall Study||12
209007|NCT01259856|505868|P1|COMPLETED|Overall Study||13
209008|NCT01259856|505867|P2|STARTED|Overall Study||86
209009|NCT01259856|505868|P1|STARTED|Overall Study||82
209010|NCT01259726|505892|P4|NOT COMPLETED|Overall Study||5
209011|NCT01259726|505893|P3|NOT COMPLETED|Overall Study||4
209012|NCT01259726|505894|P2|NOT COMPLETED|Overall Study||4
209013|NCT01259726|505895|P1|NOT COMPLETED|Overall Study||5
209014|NCT01259726|505892|P4|COMPLETED|Overall Study||36
209015|NCT01259726|505893|P3|COMPLETED|Overall Study||39
209016|NCT01259726|505894|P2|COMPLETED|Overall Study||37
209017|NCT01259726|505895|P1|COMPLETED|Overall Study||38
209018|NCT01259726|505892|P4|Treated|Overall Study||39
209019|NCT01259726|505893|P3|Treated|Overall Study||41
209020|NCT01259726|505894|P2|Treated|Overall Study||37
209021|NCT01259726|505895|P1|Treated|Overall Study||40
209022|NCT01259726|505892|P4|STARTED|Overall Study||41
209023|NCT01259726|505893|P3|STARTED|Overall Study||43
209024|NCT01259726|505894|P2|STARTED|Overall Study||41
209025|NCT01259726|505895|P1|STARTED|Overall Study||43
209026|NCT01259713|505927|P2|NOT COMPLETED|Overall Study||41
209027|NCT01259713|505928|P1|NOT COMPLETED|Overall Study||95
209028|NCT01259713|505927|P2|COMPLETED|Overall Study||77
209029|NCT01259713|505928|P1|COMPLETED|Overall Study||142
209030|NCT01259713|505927|P2|STARTED|Overall Study||118
209031|NCT01259713|505928|P1|STARTED|Overall Study||237
209032|NCT01259596|505952|P2|NOT COMPLETED|Overall Study||6
209033|NCT01259596|505953|P1|NOT COMPLETED|Overall Study||4
209034|NCT01259596|505952|P2|COMPLETED|Overall Study||65
209035|NCT01259596|505953|P1|COMPLETED|Overall Study||66
209036|NCT01259596|505952|P2|STARTED|Overall Study||71
209037|NCT01259596|505953|P1|STARTED|Overall Study||70
209038|NCT01259492|505975|P4|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||81
209039|NCT01259492|505976|P3|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||50
209040|NCT01259492|505977|P2|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||69
209041|NCT01259492|505978|P1|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||54
209042|NCT01259492|505975|P4|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|42
209043|NCT01259492|505976|P3|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|70
209044|NCT01259492|505977|P2|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|63
209045|NCT01259492|505978|P1|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|60
209046|NCT01259492|505975|P4|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||115
209047|NCT01259492|505976|P3|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||114
209048|NCT01259492|505977|P2|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||128
209049|NCT01259492|505978|P1|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||110
209050|NCT01259492|505975|P4|STARTED|Period 3 (Week 15 to End of Week 40)||123
209051|NCT01259492|505976|P3|STARTED|Period 3 (Week 15 to End of Week 40)||120
209052|NCT01259492|505977|P2|STARTED|Period 3 (Week 15 to End of Week 40)||132
209053|NCT01259492|505978|P1|STARTED|Period 3 (Week 15 to End of Week 40)|In period 3, all 489 patients who completed period 2 were re-randomized to 4 arms.|114
209054|NCT01259492|505975|P4|NOT COMPLETED|Period 2 (Week 10 to Week 14)||28
209055|NCT01259492|505976|P3|NOT COMPLETED|Period 2 (Week 10 to Week 14)||24
209056|NCT01259492|505977|P2|NOT COMPLETED|Period 2 (Week 10 to Week 14)||18
209057|NCT01259492|505978|P1|NOT COMPLETED|Period 2 (Week 10 to Week 14)||25
209058|NCT01259492|505975|P4|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|125
209059|NCT01259492|505976|P3|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|114
209060|NCT01259492|505977|P2|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|123
209061|NCT01259492|505978|P1|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|127
209062|NCT01259492|505975|P4|STARTED|Period 2 (Week 10 to Week 14)||153
209063|NCT01259492|505976|P3|STARTED|Period 2 (Week 10 to Week 14)||138
209064|NCT01259492|505977|P2|STARTED|Period 2 (Week 10 to Week 14)||141
209065|NCT01259492|505978|P1|STARTED|Period 2 (Week 10 to Week 14)|Treatment arms including Placebo indicate patients belong to respective treatment arms in Period 1|152
209066|NCT01259492|505975|P4|NOT COMPLETED|Period 1 (9 Weeks)||28
209067|NCT01259492|505976|P3|NOT COMPLETED|Period 1 (9 Weeks)||43
209068|NCT01259492|505977|P2|NOT COMPLETED|Period 1 (9 Weeks)||41
209069|NCT01259492|505978|P1|NOT COMPLETED|Period 1 (9 Weeks)||29
209070|NCT01259492|505975|P4|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|153
209071|NCT01259492|505976|P3|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|138
209072|NCT01259492|505977|P2|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|141
209073|NCT01259492|505978|P1|COMPLETED|Period 1 (9 Weeks)|"Completed indicates patients entered Period 2."|152
209074|NCT01259492|505975|P4|Full Analysis Set|Period 1 (9 Weeks)||172
209075|NCT01259492|505976|P3|Full Analysis Set|Period 1 (9 Weeks)||179
209076|NCT01259492|505977|P2|Full Analysis Set|Period 1 (9 Weeks)||175
209077|NCT01259492|505978|P1|Full Analysis Set|Period 1 (9 Weeks)||174
209078|NCT01259492|505975|P4|STARTED|Period 1 (9 Weeks)||181
209079|NCT01259492|505976|P3|STARTED|Period 1 (9 Weeks)||181
209080|NCT01259492|505977|P2|STARTED|Period 1 (9 Weeks)||182
209081|NCT01259492|505978|P1|STARTED|Period 1 (9 Weeks)||181
209082|NCT01259466|506027|P2|NOT COMPLETED|Overall Study||9
209083|NCT01259466|506028|P1|NOT COMPLETED|Overall Study||1
209084|NCT01259466|506027|P2|COMPLETED|Overall Study||18
209085|NCT01259466|506028|P1|COMPLETED|Overall Study||26
209086|NCT01259466|506027|P2|STARTED|Overall Study||27
209087|NCT01259466|506028|P1|STARTED|Overall Study||27
209088|NCT01259440|506038|P2|NOT COMPLETED|Overall Study||0
209089|NCT01259440|506039|P1|NOT COMPLETED|Overall Study||0
209090|NCT01259440|506038|P2|COMPLETED|Overall Study||10
209091|NCT01259440|506039|P1|COMPLETED|Overall Study||13
209092|NCT01259440|506038|P2|STARTED|Overall Study||10
209093|NCT01259440|506039|P1|STARTED|Overall Study||13
209094|NCT01259427|506047|P2|NOT COMPLETED|Overall Study||14
209095|NCT01259427|506048|P1|NOT COMPLETED|Overall Study||18
209096|NCT01259427|506047|P2|COMPLETED|Overall Study||110
209097|NCT01259427|506048|P1|COMPLETED|Overall Study||106
209098|NCT01259427|506047|P2|STARTED|Overall Study||124
209099|NCT01259427|506048|P1|STARTED|Overall Study||124
209100|NCT01259401|506066|P2|NOT COMPLETED|4-month Follow-up||2
209101|NCT01259401|506067|P1|NOT COMPLETED|4-month Follow-up||0
209102|NCT01259401|506066|P2|COMPLETED|4-month Follow-up||19
209103|NCT01259401|506067|P1|COMPLETED|4-month Follow-up||21
209104|NCT01259401|506066|P2|STARTED|4-month Follow-up||21
209105|NCT01259401|506067|P1|STARTED|4-month Follow-up||21
209106|NCT01259401|506066|P2|NOT COMPLETED|End of 4-week Intervention||0
209107|NCT01259401|506067|P1|NOT COMPLETED|End of 4-week Intervention||0
209108|NCT01259401|506066|P2|COMPLETED|End of 4-week Intervention||21
209109|NCT01259401|506067|P1|COMPLETED|End of 4-week Intervention||21
209110|NCT01259401|506066|P2|STARTED|End of 4-week Intervention||21
209111|NCT01259401|506067|P1|STARTED|End of 4-week Intervention||21
209112|NCT01259388|506077|P2|NOT COMPLETED|Overall Study||1
209113|NCT01259388|506078|P1|NOT COMPLETED|Overall Study||5
209114|NCT01259388|506077|P2|COMPLETED|Overall Study||11
209115|NCT01259388|506078|P1|COMPLETED|Overall Study||6
209116|NCT01259388|506077|P2|STARTED|Overall Study||12
209117|NCT01259388|506078|P1|STARTED|Overall Study||11
209118|NCT01259375|506088|P1|NOT COMPLETED|Overall Study||1
209119|NCT01259375|506088|P1|COMPLETED|Overall Study||23
209120|NCT01259375|506088|P1|STARTED|Overall Study||24
209121|NCT01259297|506105|P8|NOT COMPLETED|Double Blind Randomized Period||3
209122|NCT01259297|506106|P7|NOT COMPLETED|Double Blind Randomized Period||6
209123|NCT01259297|506107|P6|NOT COMPLETED|Double Blind Randomized Period||8
209124|NCT01259297|506108|P5|NOT COMPLETED|Double Blind Randomized Period||4
209125|NCT01259297|506109|P4|NOT COMPLETED|Double Blind Randomized Period||4
209126|NCT01259297|506110|P3|NOT COMPLETED|Double Blind Randomized Period||1
209127|NCT01259297|506111|P2|NOT COMPLETED|Double Blind Randomized Period||3
209128|NCT01259297|506112|P1|NOT COMPLETED|Double Blind Randomized Period||2
209129|NCT01259297|506105|P8|COMPLETED|Double Blind Randomized Period||196
209130|NCT01259297|506106|P7|COMPLETED|Double Blind Randomized Period||190
209131|NCT01259297|506107|P6|COMPLETED|Double Blind Randomized Period||245
209132|NCT01259297|506108|P5|COMPLETED|Double Blind Randomized Period||247
209133|NCT01259297|506109|P4|COMPLETED|Double Blind Randomized Period||191
209134|NCT01259297|506110|P3|COMPLETED|Double Blind Randomized Period||188
209135|NCT01259297|506111|P2|COMPLETED|Double Blind Randomized Period||229
209136|NCT01259297|506112|P1|COMPLETED|Double Blind Randomized Period||242
209137|NCT01259297|506105|P8|STARTED|Double Blind Randomized Period||199
209138|NCT01259297|506106|P7|STARTED|Double Blind Randomized Period||196
209139|NCT01259297|506107|P6|STARTED|Double Blind Randomized Period||253
209140|NCT01259297|506108|P5|STARTED|Double Blind Randomized Period||251
209141|NCT01259297|506109|P4|STARTED|Double Blind Randomized Period||195
209142|NCT01259297|506110|P3|STARTED|Double Blind Randomized Period||189
209143|NCT01259297|506111|P2|STARTED|Double Blind Randomized Period||232
209144|NCT01259297|506112|P1|STARTED|Double Blind Randomized Period||244
209145|NCT01259297|506105|P8|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
209146|NCT01259297|506106|P7|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
209147|NCT01259297|506107|P6|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
209148|NCT01259297|506108|P5|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
209149|NCT01259297|506109|P4|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
209150|NCT01259297|506110|P3|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||222
209151|NCT01259297|506111|P2|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
209152|NCT01259297|506112|P1|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||355
209153|NCT01259297|506105|P8|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
209154|NCT01259297|506106|P7|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
209155|NCT01259297|506107|P6|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
209156|NCT01259297|506108|P5|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
209157|NCT01259297|506109|P4|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
209158|NCT01259297|506110|P3|COMPLETED|Run-in Open Label Period (4-5 Weeks)||779
209159|NCT01259297|506111|P2|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
209160|NCT01259297|506112|P1|COMPLETED|Run-in Open Label Period (4-5 Weeks)||980
209161|NCT01259297|506105|P8|STARTED|Run-in Open Label Period (4-5 Weeks)||0
209162|NCT01259297|506106|P7|STARTED|Run-in Open Label Period (4-5 Weeks)||0
209163|NCT01259297|506107|P6|STARTED|Run-in Open Label Period (4-5 Weeks)||0
209164|NCT01259297|506108|P5|STARTED|Run-in Open Label Period (4-5 Weeks)||0
209165|NCT01259297|506109|P4|STARTED|Run-in Open Label Period (4-5 Weeks)||0
209166|NCT01259297|506110|P3|STARTED|Run-in Open Label Period (4-5 Weeks)||1001
209167|NCT01259297|506111|P2|STARTED|Run-in Open Label Period (4-5 Weeks)||0
209168|NCT01259297|506112|P1|STARTED|Run-in Open Label Period (4-5 Weeks)||1335
209169|NCT01259284|506143|P3|NOT COMPLETED|Overall Study||0
209170|NCT01259284|506144|P2|NOT COMPLETED|Overall Study||0
209171|NCT01259284|506145|P1|NOT COMPLETED|Overall Study||2
209172|NCT01259284|506143|P3|COMPLETED|Overall Study||0
209173|NCT01259284|506144|P2|COMPLETED|Overall Study||0
209174|NCT01259284|506145|P1|COMPLETED|Overall Study||0
209175|NCT01259284|506143|P3|STARTED|Overall Study||0
209176|NCT01259284|506144|P2|STARTED|Overall Study||0
209177|NCT01259284|506145|P1|STARTED|Overall Study||2
209178|NCT01259245|506155|P2|NOT COMPLETED|Overall Study||26
209179|NCT01259245|506156|P1|NOT COMPLETED|Overall Study||28
209180|NCT01259245|506155|P2|COMPLETED|Overall Study|24 discontinued intervention and 2 deceased|68
209181|NCT01259245|506156|P1|COMPLETED|Overall Study|27 were lost to follow-up and 1 deceased|70
209182|NCT01259245|506155|P2|STARTED|Overall Study||94
209183|NCT01259245|506156|P1|STARTED|Overall Study||98
209184|NCT01259115|506180|P2|NOT COMPLETED|Period 2||0
209185|NCT01259115|506181|P1|NOT COMPLETED|Period 2||1
209186|NCT01259115|506180|P2|COMPLETED|Period 2||9
209187|NCT01259115|506181|P1|COMPLETED|Period 2||6
209188|NCT01259115|506180|P2|STARTED|Period 2||9
209189|NCT01259115|506181|P1|STARTED|Period 2||7
209190|NCT01259115|506180|P2|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
209191|NCT01259115|506181|P1|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
209192|NCT01259115|506180|P2|COMPLETED|Period: Washout Period of 4 to 18 Days||9
209193|NCT01259115|506181|P1|COMPLETED|Period: Washout Period of 4 to 18 Days||7
209194|NCT01259115|506180|P2|STARTED|Period: Washout Period of 4 to 18 Days||9
209195|NCT01259115|506181|P1|STARTED|Period: Washout Period of 4 to 18 Days||7
209196|NCT01259115|506180|P2|NOT COMPLETED|Period 1||1
209197|NCT01259115|506181|P1|NOT COMPLETED|Period 1||3
209198|NCT01259115|506180|P2|COMPLETED|Period 1||9
209199|NCT01259115|506181|P1|COMPLETED|Period 1||7
209200|NCT01259115|506180|P2|STARTED|Period 1||10
209201|NCT01259115|506181|P1|STARTED|Period 1||10
209202|NCT01259102|506217|P5|NOT COMPLETED|Overall Study||1
209203|NCT01259102|506218|P4|NOT COMPLETED|Overall Study||2
209204|NCT01259102|506219|P3|NOT COMPLETED|Overall Study||2
209205|NCT01259102|506220|P2|NOT COMPLETED|Overall Study||0
209206|NCT01259102|506221|P1|NOT COMPLETED|Overall Study||1
209207|NCT01259102|506217|P5|COMPLETED|Overall Study||13
209208|NCT01259102|506218|P4|COMPLETED|Overall Study||12
209209|NCT01259102|506219|P3|COMPLETED|Overall Study||13
209210|NCT01259102|506220|P2|COMPLETED|Overall Study||14
209211|NCT01259102|506221|P1|COMPLETED|Overall Study||12
209212|NCT01259102|506217|P5|STARTED|Overall Study||14
209213|NCT01259102|506218|P4|STARTED|Overall Study||14
209214|NCT01259102|506219|P3|STARTED|Overall Study||15
209215|NCT01259102|506220|P2|STARTED|Overall Study||14
209216|NCT01259102|506221|P1|STARTED|Overall Study||13
209217|NCT01259089|506278|P6|NOT COMPLETED|Survival Follow up for Two Years||19
209218|NCT01259089|506279|P5|NOT COMPLETED|Survival Follow up for Two Years||6
209219|NCT01259089|506280|P4|NOT COMPLETED|Survival Follow up for Two Years||3
209220|NCT01259089|506281|P3|NOT COMPLETED|Survival Follow up for Two Years||2
209221|NCT01259089|506282|P2|NOT COMPLETED|Survival Follow up for Two Years||2
209222|NCT01259089|506283|P1|NOT COMPLETED|Survival Follow up for Two Years||3
209223|NCT01259089|506278|P6|COMPLETED|Survival Follow up for Two Years||0
209224|NCT01259089|506279|P5|COMPLETED|Survival Follow up for Two Years||0
209225|NCT01259089|506280|P4|COMPLETED|Survival Follow up for Two Years||0
209226|NCT01259089|506281|P3|COMPLETED|Survival Follow up for Two Years||1
209227|NCT01259089|506282|P2|COMPLETED|Survival Follow up for Two Years||1
209228|NCT01259089|506283|P1|COMPLETED|Survival Follow up for Two Years||0
209229|NCT01259089|506278|P6|STARTED|Survival Follow up for Two Years||19
209230|NCT01259089|506279|P5|STARTED|Survival Follow up for Two Years||6
209231|NCT01259089|506280|P4|STARTED|Survival Follow up for Two Years||3
209232|NCT01259089|506281|P3|STARTED|Survival Follow up for Two Years||3
209233|NCT01259089|506282|P2|STARTED|Survival Follow up for Two Years||3
209234|NCT01259089|506283|P1|STARTED|Survival Follow up for Two Years||3
209235|NCT01259089|506278|P6|NOT COMPLETED|Continued Treatment After 8 Weeks||1
209236|NCT01259089|506279|P5|NOT COMPLETED|Continued Treatment After 8 Weeks||2
209237|NCT01259089|506280|P4|NOT COMPLETED|Continued Treatment After 8 Weeks||1
209238|NCT01259089|506281|P3|NOT COMPLETED|Continued Treatment After 8 Weeks||1
209239|NCT01259089|506282|P2|NOT COMPLETED|Continued Treatment After 8 Weeks||1
209240|NCT01259089|506283|P1|NOT COMPLETED|Continued Treatment After 8 Weeks||2
209241|NCT01259089|506278|P6|COMPLETED|Continued Treatment After 8 Weeks||7
209242|NCT01259089|506279|P5|COMPLETED|Continued Treatment After 8 Weeks||0
209243|NCT01259089|506280|P4|COMPLETED|Continued Treatment After 8 Weeks||1
209244|NCT01259089|506281|P3|COMPLETED|Continued Treatment After 8 Weeks||1
209245|NCT01259089|506282|P2|COMPLETED|Continued Treatment After 8 Weeks||2
209246|NCT01259089|506283|P1|COMPLETED|Continued Treatment After 8 Weeks||1
209247|NCT01259089|506278|P6|STARTED|Continued Treatment After 8 Weeks||8
209248|NCT01259089|506279|P5|STARTED|Continued Treatment After 8 Weeks||2
209249|NCT01259089|506280|P4|STARTED|Continued Treatment After 8 Weeks||2
209250|NCT01259089|506281|P3|STARTED|Continued Treatment After 8 Weeks||2
209251|NCT01259089|506282|P2|STARTED|Continued Treatment After 8 Weeks||3
209252|NCT01259089|506283|P1|STARTED|Continued Treatment After 8 Weeks||3
209253|NCT01259089|506278|P6|NOT COMPLETED|Confirmed Response at 8 Weeks||10
209254|NCT01259089|506279|P5|NOT COMPLETED|Confirmed Response at 8 Weeks||4
209255|NCT01259089|506280|P4|NOT COMPLETED|Confirmed Response at 8 Weeks||1
209256|NCT01259089|506281|P3|NOT COMPLETED|Confirmed Response at 8 Weeks||1
209257|NCT01259089|506282|P2|NOT COMPLETED|Confirmed Response at 8 Weeks||0
209258|NCT01259089|506283|P1|NOT COMPLETED|Confirmed Response at 8 Weeks||0
209259|NCT01259089|506278|P6|COMPLETED|Confirmed Response at 8 Weeks||8
209260|NCT01259089|506279|P5|COMPLETED|Confirmed Response at 8 Weeks||2
209261|NCT01259089|506280|P4|COMPLETED|Confirmed Response at 8 Weeks||2
209262|NCT01259089|506281|P3|COMPLETED|Confirmed Response at 8 Weeks||2
209263|NCT01259089|506282|P2|COMPLETED|Confirmed Response at 8 Weeks||3
209264|NCT01259089|506283|P1|COMPLETED|Confirmed Response at 8 Weeks||3
209265|NCT01259089|506278|P6|STARTED|Confirmed Response at 8 Weeks||18
209266|NCT01259089|506279|P5|STARTED|Confirmed Response at 8 Weeks||6
209267|NCT01259089|506280|P4|STARTED|Confirmed Response at 8 Weeks||3
209268|NCT01259089|506281|P3|STARTED|Confirmed Response at 8 Weeks||3
209269|NCT01259089|506282|P2|STARTED|Confirmed Response at 8 Weeks||3
209270|NCT01259089|506283|P1|STARTED|Confirmed Response at 8 Weeks||3
209271|NCT01259089|506278|P6|NOT COMPLETED|Reached First Response at 4 Weeks||2
209272|NCT01259089|506279|P5|NOT COMPLETED|Reached First Response at 4 Weeks||0
209273|NCT01259089|506280|P4|NOT COMPLETED|Reached First Response at 4 Weeks||0
209274|NCT01259089|506281|P3|NOT COMPLETED|Reached First Response at 4 Weeks||0
209275|NCT01259089|506282|P2|NOT COMPLETED|Reached First Response at 4 Weeks||0
209276|NCT01259089|506283|P1|NOT COMPLETED|Reached First Response at 4 Weeks||0
209277|NCT01259089|506278|P6|COMPLETED|Reached First Response at 4 Weeks||18
209278|NCT01259089|506279|P5|COMPLETED|Reached First Response at 4 Weeks||6
209279|NCT01259089|506280|P4|COMPLETED|Reached First Response at 4 Weeks||3
209280|NCT01259089|506281|P3|COMPLETED|Reached First Response at 4 Weeks||3
209281|NCT01259089|506282|P2|COMPLETED|Reached First Response at 4 Weeks||3
209282|NCT01259089|506283|P1|COMPLETED|Reached First Response at 4 Weeks||3
209283|NCT01259089|506278|P6|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||18
209284|NCT01259089|506279|P5|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||6
209285|NCT01259089|506280|P4|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
209286|NCT01259089|506281|P3|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
209287|NCT01259089|506282|P2|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
209288|NCT01259089|506283|P1|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
209289|NCT01259089|506278|P6|Started Treatment on Study|Reached First Response at 4 Weeks||19
209290|NCT01259089|506279|P5|Started Treatment on Study|Reached First Response at 4 Weeks||6
209291|NCT01259089|506280|P4|Started Treatment on Study|Reached First Response at 4 Weeks||3
209292|NCT01259089|506281|P3|Started Treatment on Study|Reached First Response at 4 Weeks||3
209293|NCT01259089|506282|P2|Started Treatment on Study|Reached First Response at 4 Weeks||3
209294|NCT01259089|506283|P1|Started Treatment on Study|Reached First Response at 4 Weeks||3
209295|NCT01259089|506278|P6|STARTED|Reached First Response at 4 Weeks||20
209296|NCT01259089|506279|P5|STARTED|Reached First Response at 4 Weeks||6
209297|NCT01259089|506280|P4|STARTED|Reached First Response at 4 Weeks||3
209298|NCT01259089|506281|P3|STARTED|Reached First Response at 4 Weeks||3
209299|NCT01259089|506282|P2|STARTED|Reached First Response at 4 Weeks||3
209300|NCT01259089|506283|P1|STARTED|Reached First Response at 4 Weeks||3
209301|NCT01259063|506302|P1|NOT COMPLETED|Overall Study||0
209302|NCT01259063|506302|P1|COMPLETED|Overall Study||33
209303|NCT01259063|506302|P1|STARTED|Overall Study||33
209304|NCT01259024|506311|P1|NOT COMPLETED|Overall Study||1
209305|NCT01259024|506311|P1|COMPLETED|Overall Study||0
209306|NCT01259024|506311|P1|STARTED|Overall Study||1
209307|NCT01259011|506320|P2|NOT COMPLETED|After Patient Death||0
209308|NCT01259011|506321|P1|NOT COMPLETED|After Patient Death||0
209309|NCT01259011|506320|P2|COMPLETED|After Patient Death||28
209310|NCT01259011|506321|P1|COMPLETED|After Patient Death||17
209311|NCT01259011|506320|P2|STARTED|After Patient Death|of 109 patient-surrogate dyads/pairs randomized, 28 surrogates of patients who died|28
209312|NCT01259011|506321|P1|STARTED|After Patient Death|of 101 patient-surrogate dyads/pairs randomized, 17 surrogates of patients who died|17
209313|NCT01259011|506320|P2|NOT COMPLETED|Main Study Period||0
209314|NCT01259011|506321|P1|NOT COMPLETED|Main Study Period||0
209315|NCT01259011|506320|P2|COMPLETED|Main Study Period||109
209316|NCT01259011|506321|P1|COMPLETED|Main Study Period||101
209317|NCT01259011|506320|P2|STARTED|Main Study Period|109 dyads (=218 individuals)|109
209318|NCT01259011|506321|P1|STARTED|Main Study Period|101 dyads (=202 individuals)|101
209319|NCT01258998|506331|P1|NOT COMPLETED|Overall Study||1
209320|NCT01258998|506331|P1|COMPLETED|Overall Study||59
209321|NCT01258998|506331|P1|STARTED|Overall Study||60
209322|NCT01258985|506337|P2|NOT COMPLETED|Overall Study||0
209323|NCT01258985|506338|P1|NOT COMPLETED|Overall Study||0
209324|NCT01258985|506337|P2|COMPLETED|Overall Study||98
209325|NCT01258985|506338|P1|COMPLETED|Overall Study||106
209326|NCT01258985|506337|P2|STARTED|Overall Study||98
209327|NCT01258985|506338|P1|STARTED|Overall Study||106
209328|NCT01258855|506366|P2|NOT COMPLETED|Overall Study||0
209329|NCT01258855|506367|P1|NOT COMPLETED|Overall Study||0
209330|NCT01258855|506366|P2|COMPLETED|Overall Study||29
209331|NCT01258855|506367|P1|COMPLETED|Overall Study||55
209332|NCT01258855|506366|P2|STARTED|Overall Study||29
209333|NCT01258855|506367|P1|STARTED|Overall Study||55
209334|NCT01258803|506385|P6|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
209335|NCT01258803|506386|P5|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
209336|NCT01258803|506387|P4|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
209337|NCT01258803|506388|P3|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
209338|NCT01258803|506389|P2|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
209339|NCT01258803|506390|P1|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
209340|NCT01258803|506385|P6|COMPLETED|Treatment Period 4 (1 Dose)||15
209341|NCT01258803|506386|P5|COMPLETED|Treatment Period 4 (1 Dose)||15
209342|NCT01258803|506387|P4|COMPLETED|Treatment Period 4 (1 Dose)||15
209343|NCT01258803|506388|P3|COMPLETED|Treatment Period 4 (1 Dose)||14
209344|NCT01258803|506389|P2|COMPLETED|Treatment Period 4 (1 Dose)||14
209345|NCT01258803|506390|P1|COMPLETED|Treatment Period 4 (1 Dose)||14
209346|NCT01258803|506385|P6|STARTED|Treatment Period 4 (1 Dose)||15
209347|NCT01258803|506386|P5|STARTED|Treatment Period 4 (1 Dose)||15
209348|NCT01258803|506387|P4|STARTED|Treatment Period 4 (1 Dose)||15
209349|NCT01258803|506388|P3|STARTED|Treatment Period 4 (1 Dose)||14
209350|NCT01258803|506389|P2|STARTED|Treatment Period 4 (1 Dose)||14
209351|NCT01258803|506390|P1|STARTED|Treatment Period 4 (1 Dose)||14
209352|NCT01258803|506385|P6|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
209353|NCT01258803|506386|P5|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
209354|NCT01258803|506387|P4|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
209355|NCT01258803|506388|P3|NOT COMPLETED|Treatment Period 3 (1 Dose)||1
209356|NCT01258803|506389|P2|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
209357|NCT01258803|506390|P1|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
209358|NCT01258803|506385|P6|COMPLETED|Treatment Period 3 (1 Dose)||15
209359|NCT01258803|506386|P5|COMPLETED|Treatment Period 3 (1 Dose)||15
209360|NCT01258803|506387|P4|COMPLETED|Treatment Period 3 (1 Dose)||15
209361|NCT01258803|506388|P3|COMPLETED|Treatment Period 3 (1 Dose)||14
209362|NCT01258803|506389|P2|COMPLETED|Treatment Period 3 (1 Dose)||14
209363|NCT01258803|506390|P1|COMPLETED|Treatment Period 3 (1 Dose)||14
209364|NCT01258803|506385|P6|STARTED|Treatment Period 3 (1 Dose)||15
209365|NCT01258803|506386|P5|STARTED|Treatment Period 3 (1 Dose)||15
209366|NCT01258803|506387|P4|STARTED|Treatment Period 3 (1 Dose)||15
209367|NCT01258803|506388|P3|STARTED|Treatment Period 3 (1 Dose)||15
209368|NCT01258803|506389|P2|STARTED|Treatment Period 3 (1 Dose)||14
209369|NCT01258803|506390|P1|STARTED|Treatment Period 3 (1 Dose)||14
209370|NCT01258803|506385|P6|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
209371|NCT01258803|506386|P5|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
209372|NCT01258803|506387|P4|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
209373|NCT01258803|506388|P3|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
209374|NCT01258803|506389|P2|NOT COMPLETED|Treatment Period 2 (1 Dose)||2
209375|NCT01258803|506390|P1|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
209376|NCT01258803|506385|P6|COMPLETED|Treatment Period 2 (1 Dose)||15
209377|NCT01258803|506386|P5|COMPLETED|Treatment Period 2 (1 Dose)||15
209378|NCT01258803|506387|P4|COMPLETED|Treatment Period 2 (1 Dose)||15
209379|NCT01258803|506388|P3|COMPLETED|Treatment Period 2 (1 Dose)||15
209380|NCT01258803|506389|P2|COMPLETED|Treatment Period 2 (1 Dose)||14
209381|NCT01258803|506390|P1|COMPLETED|Treatment Period 2 (1 Dose)||14
209382|NCT01258803|506385|P6|STARTED|Treatment Period 2 (1 Dose)||16
209383|NCT01258803|506386|P5|STARTED|Treatment Period 2 (1 Dose)||15
209384|NCT01258803|506387|P4|STARTED|Treatment Period 2 (1 Dose)||15
209385|NCT01258803|506388|P3|STARTED|Treatment Period 2 (1 Dose)||15
209386|NCT01258803|506389|P2|STARTED|Treatment Period 2 (1 Dose)||16
209387|NCT01258803|506390|P1|STARTED|Treatment Period 2 (1 Dose)||15
209388|NCT01258803|506385|P6|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
209389|NCT01258803|506386|P5|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
209390|NCT01258803|506387|P4|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
209391|NCT01258803|506388|P3|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
209392|NCT01258803|506389|P2|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
209393|NCT01258803|506390|P1|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
209394|NCT01258803|506385|P6|COMPLETED|Treatment Period 1 (1 Dose)||16
209395|NCT01258803|506386|P5|COMPLETED|Treatment Period 1 (1 Dose)||15
209396|NCT01258803|506387|P4|COMPLETED|Treatment Period 1 (1 Dose)||15
209397|NCT01258803|506388|P3|COMPLETED|Treatment Period 1 (1 Dose)||15
209398|NCT01258803|506389|P2|COMPLETED|Treatment Period 1 (1 Dose)||16
209399|NCT01258803|506390|P1|COMPLETED|Treatment Period 1 (1 Dose)||15
209400|NCT01258803|506385|P6|STARTED|Treatment Period 1 (1 Dose)||16
209401|NCT01258803|506386|P5|STARTED|Treatment Period 1 (1 Dose)||15
209402|NCT01258803|506387|P4|STARTED|Treatment Period 1 (1 Dose)||15
209403|NCT01258803|506388|P3|STARTED|Treatment Period 1 (1 Dose)||15
209404|NCT01258803|506389|P2|STARTED|Treatment Period 1 (1 Dose)||16
209405|NCT01258803|506390|P1|STARTED|Treatment Period 1 (1 Dose)||15
209406|NCT01258790|506418|P2|NOT COMPLETED|Overall Study||0
209407|NCT01258790|506419|P1|NOT COMPLETED|Overall Study||0
209408|NCT01258790|506418|P2|COMPLETED|Overall Study||6
209409|NCT01258790|506419|P1|COMPLETED|Overall Study||6
209410|NCT01258790|506418|P2|STARTED|Overall Study||6
209411|NCT01258790|506419|P1|STARTED|Overall Study||6
209412|NCT01258738|506427|P2|NOT COMPLETED|Open-label Period||21
209413|NCT01258738|506428|P1|NOT COMPLETED|Open-label Period||17
209414|NCT01258738|506427|P2|COMPLETED|Open-label Period||85
209415|NCT01258738|506428|P1|COMPLETED|Open-label Period||85
209416|NCT01258738|506427|P2|STARTED|Open-label Period||106
209417|NCT01258738|506428|P1|STARTED|Open-label Period||102
209418|NCT01258738|506427|P2|NOT COMPLETED|Double-blind Period||7
209419|NCT01258738|506428|P1|NOT COMPLETED|Double-blind Period||9
209420|NCT01258738|506427|P2|COMPLETED|Double-blind Period|Only 106 participants entered the open label period.|107
209421|NCT01258738|506428|P1|COMPLETED|Double-blind Period||102
209422|NCT01258738|506427|P2|Treated|Double-blind Period||113
209423|NCT01258738|506428|P1|Treated|Double-blind Period||111
209424|NCT01258738|506427|P2|STARTED|Double-blind Period||114
209425|NCT01258738|506428|P1|STARTED|Double-blind Period||111
209426|NCT01258660|506566|P2|NOT COMPLETED|Overall Study||11
209427|NCT01258660|506567|P1|NOT COMPLETED|Overall Study||11
209428|NCT01258660|506566|P2|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
209429|NCT01258660|506567|P1|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
209430|NCT01258660|506566|P2|Completed Treatment|Overall Study||81
209431|NCT01258660|506567|P1|Completed Treatment|Overall Study||79
209432|NCT01258660|506566|P2|Received Treatment|Overall Study||82
209433|NCT01258660|506567|P1|Received Treatment|Overall Study||79
209434|NCT01258660|506566|P2|STARTED|Overall Study|randomized and received at least one dose of treatment|86
209435|NCT01258660|506567|P1|STARTED|Overall Study|randomized and received at least one dose of treatment|86
209436|NCT01258608|506586|P2|NOT COMPLETED|Overall Study||19
209437|NCT01258608|506587|P1|NOT COMPLETED|Overall Study||21
209438|NCT01258608|506586|P2|COMPLETED|Overall Study||31
209439|NCT01258608|506587|P1|COMPLETED|Overall Study||30
209440|NCT01258608|506586|P2|STARTED|Overall Study||50
209441|NCT01258608|506587|P1|STARTED|Overall Study||51
209442|NCT01258595|506635|P2|NOT COMPLETED|Overall Study||1
209443|NCT01258595|506636|P1|NOT COMPLETED|Overall Study||1
209444|NCT01258595|506635|P2|COMPLETED|Overall Study||151
209445|NCT01258595|506636|P1|COMPLETED|Overall Study||147
209446|NCT01258595|506635|P2|STARTED|Overall Study||152
209447|NCT01258595|506636|P1|STARTED|Overall Study||148
209448|NCT01258582|506652|P2|NOT COMPLETED|Overall Study||258
209449|NCT01258582|506653|P1|NOT COMPLETED|Overall Study||282
209450|NCT01258582|506652|P2|COMPLETED|Overall Study||563
209451|NCT01258582|506653|P1|COMPLETED|Overall Study||548
209452|NCT01258582|506652|P2|STARTED|Overall Study||821
209453|NCT01258582|506653|P1|STARTED|Overall Study||830
209454|NCT01258504|506659|P1|NOT COMPLETED|Bosentan and SJW||0
209455|NCT01258504|506659|P1|COMPLETED|Bosentan and SJW||13
209456|NCT01258504|506659|P1|STARTED|Bosentan and SJW||13
209457|NCT01258504|506659|P1|NOT COMPLETED|Bosentan Steady-state||0
209458|NCT01258504|506659|P1|COMPLETED|Bosentan Steady-state||13
209459|NCT01258504|506659|P1|STARTED|Bosentan Steady-state||13
209460|NCT01258504|506659|P1|NOT COMPLETED|Bosentan Single Dose||0
209461|NCT01258504|506659|P1|COMPLETED|Bosentan Single Dose||13
209462|NCT01258504|506659|P1|STARTED|Bosentan Single Dose||13
209463|NCT01258387|506678|P7|NOT COMPLETED|Overall Study||0
209464|NCT01258387|506679|P6|NOT COMPLETED|Overall Study||0
209465|NCT01258387|506680|P5|NOT COMPLETED|Overall Study||0
209466|NCT01258387|506681|P4|NOT COMPLETED|Overall Study||0
209467|NCT01258387|506682|P3|NOT COMPLETED|Overall Study||0
209468|NCT01258387|506683|P2|NOT COMPLETED|Overall Study||0
209469|NCT01258387|506684|P1|NOT COMPLETED|Overall Study||0
209470|NCT01258387|506678|P7|COMPLETED|Overall Study||4
209471|NCT01258387|506679|P6|COMPLETED|Overall Study||6
209472|NCT01258387|506680|P5|COMPLETED|Overall Study||6
209473|NCT01258387|506681|P4|COMPLETED|Overall Study||6
209474|NCT01258387|506682|P3|COMPLETED|Overall Study||6
209475|NCT01258387|506683|P2|COMPLETED|Overall Study||6
209476|NCT01258387|506684|P1|COMPLETED|Overall Study||6
209477|NCT01258387|506678|P7|Patients Randomized to Placebo|Overall Study||1
209478|NCT01258387|506679|P6|Patients Randomized to Placebo|Overall Study||2
209479|NCT01258387|506680|P5|Patients Randomized to Placebo|Overall Study||2
209480|NCT01258387|506681|P4|Patients Randomized to Placebo|Overall Study||2
209481|NCT01258387|506682|P3|Patients Randomized to Placebo|Overall Study||2
209482|NCT01258387|506683|P2|Patients Randomized to Placebo|Overall Study||2
209483|NCT01258387|506684|P1|Patients Randomized to Placebo|Overall Study||2
209484|NCT01258387|506678|P7|Patients Randomized to GGF2|Overall Study||3
209485|NCT01258387|506679|P6|Patients Randomized to GGF2|Overall Study||4
209486|NCT01258387|506680|P5|Patients Randomized to GGF2|Overall Study||4
209487|NCT01258387|506681|P4|Patients Randomized to GGF2|Overall Study||4
209488|NCT01258387|506682|P3|Patients Randomized to GGF2|Overall Study||4
209489|NCT01258387|506683|P2|Patients Randomized to GGF2|Overall Study||4
209490|NCT01258387|506684|P1|Patients Randomized to GGF2|Overall Study||4
209491|NCT01258387|506678|P7|STARTED|Overall Study||4
209492|NCT01258387|506679|P6|STARTED|Overall Study||6
209493|NCT01258387|506680|P5|STARTED|Overall Study||6
209494|NCT01258387|506681|P4|STARTED|Overall Study||6
209495|NCT01258387|506682|P3|STARTED|Overall Study||6
209496|NCT01258387|506683|P2|STARTED|Overall Study||6
209497|NCT01258387|506684|P1|STARTED|Overall Study||6
209498|NCT01258374|506726|P1|NOT COMPLETED|Overall Study||0
209499|NCT01258374|506726|P1|COMPLETED|Overall Study||15
209500|NCT01258374|506726|P1|STARTED|Overall Study||15
209501|NCT01258348|506733|P5|NOT COMPLETED|Overall Study||6
209502|NCT01258348|506734|P4|NOT COMPLETED|Overall Study||6
209503|NCT01258348|506735|P3|NOT COMPLETED|Overall Study||3
209504|NCT01258348|506736|P2|NOT COMPLETED|Overall Study||5
209505|NCT01258348|506737|P1|NOT COMPLETED|Overall Study||1
209506|NCT01258348|506733|P5|COMPLETED|Overall Study||0
209507|NCT01258348|506734|P4|COMPLETED|Overall Study||0
209508|NCT01258348|506735|P3|COMPLETED|Overall Study||0
209509|NCT01258348|506736|P2|COMPLETED|Overall Study||0
209510|NCT01258348|506737|P1|COMPLETED|Overall Study||0
209511|NCT01258348|506733|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
209512|NCT01258348|506734|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
209513|NCT01258348|506735|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
209514|NCT01258348|506736|P2|Received at Least 1 Dose of Study Drug|Overall Study||5
209515|NCT01258348|506737|P1|Received at Least 1 Dose of Study Drug|Overall Study||1
209516|NCT01258348|506733|P5|STARTED|Overall Study||6
209517|NCT01258348|506734|P4|STARTED|Overall Study||6
209518|NCT01258348|506735|P3|STARTED|Overall Study||3
209519|NCT01258348|506736|P2|STARTED|Overall Study||5
209520|NCT01258348|506737|P1|STARTED|Overall Study||1
209521|NCT01258153|506765|P3|NOT COMPLETED|Overall Study||1
209522|NCT01258153|506766|P2|NOT COMPLETED|Overall Study||1
209523|NCT01258153|506767|P1|NOT COMPLETED|Overall Study||1
209524|NCT01258153|506765|P3|COMPLETED|Overall Study||36
209525|NCT01258153|506766|P2|COMPLETED|Overall Study||37
209526|NCT01258153|506767|P1|COMPLETED|Overall Study||39
209527|NCT01258153|506765|P3|STARTED|Overall Study||37
209528|NCT01258153|506766|P2|STARTED|Overall Study||38
209529|NCT01258153|506767|P1|STARTED|Overall Study||40
209530|NCT01258101|506794|P4|NOT COMPLETED|Overall Study||25
209531|NCT01258101|506795|P3|NOT COMPLETED|Overall Study||11
209532|NCT01258101|506796|P2|NOT COMPLETED|Overall Study||34
209533|NCT01258101|506797|P1|NOT COMPLETED|Overall Study||33
209534|NCT01258101|506794|P4|COMPLETED|Overall Study||27
209535|NCT01258101|506795|P3|COMPLETED|Overall Study||22
209536|NCT01258101|506796|P2|COMPLETED|Overall Study||110
209537|NCT01258101|506797|P1|COMPLETED|Overall Study||118
209538|NCT01258101|506794|P4|Standard Analysis Population|Overall Study||26
209539|NCT01258101|506795|P3|Standard Analysis Population|Overall Study||21
209540|NCT01258101|506796|P2|Standard Analysis Population|Overall Study||110
209541|NCT01258101|506797|P1|Standard Analysis Population|Overall Study||115
209542|NCT01258101|506794|P4|Safety Analysis Population|Overall Study||48
209543|NCT01258101|506795|P3|Safety Analysis Population|Overall Study||30
209544|NCT01258101|506796|P2|Safety Analysis Population|Overall Study||141
209545|NCT01258101|506797|P1|Safety Analysis Population|Overall Study||144
209546|NCT01258101|506794|P4|STARTED|Overall Study||52
209547|NCT01258101|506795|P3|STARTED|Overall Study||33
209548|NCT01258101|506796|P2|STARTED|Overall Study||144
209549|NCT01258101|506797|P1|STARTED|Overall Study||151
209550|NCT01258049|506849|P2|NOT COMPLETED|Overall Study||2
209551|NCT01258049|506850|P1|NOT COMPLETED|Overall Study||2
209552|NCT01258049|506849|P2|COMPLETED|Overall Study||72
209553|NCT01258049|506850|P1|COMPLETED|Overall Study||75
209554|NCT01258049|506849|P2|STARTED|Overall Study||74
209555|NCT01258049|506850|P1|STARTED|Overall Study||77
209556|NCT01257880|506888|P2|NOT COMPLETED|Overall Study||0
209557|NCT01257880|506889|P1|NOT COMPLETED|Overall Study||0
209558|NCT01257880|506888|P2|COMPLETED|Overall Study||19
209559|NCT01257880|506889|P1|COMPLETED|Overall Study||12
209560|NCT01257880|506888|P2|STARTED|Overall Study||19
209561|NCT01257880|506889|P1|STARTED|Overall Study||12
209562|NCT01257802|506899|P2|NOT COMPLETED|Overall Study||6
209563|NCT01257802|506900|P1|NOT COMPLETED|Overall Study||1
209564|NCT01257802|506899|P2|COMPLETED|Overall Study||2
209565|NCT01257802|506900|P1|COMPLETED|Overall Study||5
209566|NCT01257802|506899|P2|6 Month / 24 Week Visit|Overall Study||2
209567|NCT01257802|506900|P1|6 Month / 24 Week Visit|Overall Study||5
209568|NCT01257802|506899|P2|STARTED|Overall Study||8
209569|NCT01257802|506900|P1|STARTED|Overall Study||6
209570|NCT01257750|506914|P1|NOT COMPLETED|Overall Study||0
209571|NCT01257750|506914|P1|COMPLETED|Overall Study||20
209572|NCT01257750|506914|P1|STARTED|Overall Study||20
209573|NCT01257737|506927|P2|NOT COMPLETED|Overall Study||4
209574|NCT01257737|506928|P1|NOT COMPLETED|Overall Study||2
209575|NCT01257737|506927|P2|COMPLETED|Overall Study||39
209576|NCT01257737|506928|P1|COMPLETED|Overall Study||43
209577|NCT01257737|506927|P2|STARTED|Overall Study||43
209578|NCT01257737|506928|P1|STARTED|Overall Study||45
209579|NCT01257698|506948|P2|NOT COMPLETED|Overall Study||0
209580|NCT01257698|506949|P1|NOT COMPLETED|Overall Study||4
209581|NCT01257698|506948|P2|COMPLETED|Overall Study||9
209582|NCT01257698|506949|P1|COMPLETED|Overall Study||8
209583|NCT01257698|506948|P2|STARTED|Overall Study||9
209584|NCT01257698|506949|P1|STARTED|Overall Study||12
209585|NCT01257581|506958|P3|NOT COMPLETED|Overall Study||6
209586|NCT01257581|506959|P2|NOT COMPLETED|Overall Study||3
209587|NCT01257581|506960|P1|NOT COMPLETED|Overall Study||5
209588|NCT01257581|506958|P3|COMPLETED|Overall Study||11
209589|NCT01257581|506959|P2|COMPLETED|Overall Study||18
209590|NCT01257581|506960|P1|COMPLETED|Overall Study||17
209591|NCT01257581|506958|P3|STARTED|Overall Study||17
209592|NCT01257581|506959|P2|STARTED|Overall Study||21
209593|NCT01257581|506960|P1|STARTED|Overall Study||22
209594|NCT01257568|506998|P1|NOT COMPLETED|Overall Study||33
209595|NCT01257568|506998|P1|COMPLETED|Overall Study||7
209596|NCT01257568|506998|P1|STARTED|Overall Study||40
209597|NCT01257542|507012|P2|NOT COMPLETED|Overall Study||7
209598|NCT01257542|507013|P1|NOT COMPLETED|Overall Study||3
209599|NCT01257542|507012|P2|COMPLETED|Overall Study||45
209600|NCT01257542|507013|P1|COMPLETED|Overall Study||52
209601|NCT01257542|507012|P2|STARTED|Overall Study||52
209602|NCT01257542|507013|P1|STARTED|Overall Study||55
209603|NCT01257503|507033|P2|NOT COMPLETED|Overall Study||11
209604|NCT01257503|507034|P1|NOT COMPLETED|Overall Study||8
209605|NCT01257503|507033|P2|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|119
209606|NCT01257503|507034|P1|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|125
209607|NCT01257503|507033|P2|Returned Dosage Logbooks|Overall Study||80
209608|NCT01257503|507034|P1|Returned Dosage Logbooks|Overall Study||75
209609|NCT01257503|507033|P2|Returned Symptom Diaries|Overall Study||83
209610|NCT01257503|507034|P1|Returned Symptom Diaries|Overall Study||80
209611|NCT01257503|507033|P2|STARTED|Overall Study||130
209612|NCT01257503|507034|P1|STARTED|Overall Study||133
209613|NCT01257438|507050|P2|NOT COMPLETED|Overall Study||46
209614|NCT01257438|507051|P1|NOT COMPLETED|Overall Study||30
209615|NCT01257438|507050|P2|COMPLETED|Overall Study||97
209616|NCT01257438|507051|P1|COMPLETED|Overall Study||102
209617|NCT01257438|507050|P2|STARTED|Overall Study||143
209618|NCT01257438|507051|P1|STARTED|Overall Study||132
209619|NCT01257425|507063|P2|NOT COMPLETED|Overall Study||6
209620|NCT01257425|507064|P1|NOT COMPLETED|Overall Study||6
209621|NCT01257425|507063|P2|COMPLETED|Overall Study||45
209622|NCT01257425|507064|P1|COMPLETED|Overall Study||46
209623|NCT01257425|507063|P2|STARTED|Overall Study||51
209624|NCT01257425|507064|P1|STARTED|Overall Study||52
209625|NCT01257347|507086|P4|NOT COMPLETED|Overall Study||0
209626|NCT01257347|507087|P3|NOT COMPLETED|Overall Study||0
209627|NCT01257347|507088|P2|NOT COMPLETED|Overall Study||0
209628|NCT01257347|507089|P1|NOT COMPLETED|Overall Study||0
209629|NCT01257347|507086|P4|COMPLETED|Overall Study||65
209630|NCT01257347|507087|P3|COMPLETED|Overall Study||35
209631|NCT01257347|507088|P2|COMPLETED|Overall Study||12
209632|NCT01257347|507089|P1|COMPLETED|Overall Study||12
209633|NCT01257347|507086|P4|STARTED|Overall Study||65
209634|NCT01257347|507087|P3|STARTED|Overall Study||35
209635|NCT01257347|507088|P2|STARTED|Overall Study|Median patients per provider = 4; range 1-13 (65 patients)|12
209636|NCT01257347|507089|P1|STARTED|Overall Study|Median patients per provider = 3; range 1-10 (35 patients)|12
209637|NCT01257230|507106|P3|NOT COMPLETED|Overall Study||6
209638|NCT01257230|507107|P2|NOT COMPLETED|Overall Study||10
209639|NCT01257230|507108|P1|NOT COMPLETED|Overall Study||6
209640|NCT01257230|507106|P3|COMPLETED|Overall Study||129
209641|NCT01257230|507107|P2|COMPLETED|Overall Study||115
209642|NCT01257230|507108|P1|COMPLETED|Overall Study||132
209643|NCT01257230|507106|P3|STARTED|Overall Study||135
209644|NCT01257230|507107|P2|STARTED|Overall Study||125
209645|NCT01257230|507108|P1|STARTED|Overall Study||138
209646|NCT01257217|507163|P2|NOT COMPLETED|Overall Study||0
209647|NCT01257217|507164|P1|NOT COMPLETED|Overall Study||2
209648|NCT01257217|507163|P2|COMPLETED|Overall Study||10
209649|NCT01257217|507164|P1|COMPLETED|Overall Study||13
209650|NCT01257217|507163|P2|STARTED|Overall Study||10
209651|NCT01257217|507164|P1|STARTED|Overall Study||15
209652|NCT01257204|507185|P3|NOT COMPLETED|Follow-up Period (up to Week 48)||10
209653|NCT01257204|507186|P2|NOT COMPLETED|Follow-up Period (up to Week 48)||6
209654|NCT01257204|507187|P1|NOT COMPLETED|Follow-up Period (up to Week 48)||1
209655|NCT01257204|507185|P3|COMPLETED|Follow-up Period (up to Week 48)||39
209656|NCT01257204|507186|P2|COMPLETED|Follow-up Period (up to Week 48)||41
209657|NCT01257204|507187|P1|COMPLETED|Follow-up Period (up to Week 48)||48
209739|NCT01256658|507369|P1|Lost to Follow up|Period 2 - Follow up Only - No Treatment||71
209658|NCT01257204|507185|P3|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
209659|NCT01257204|507186|P2|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|47
209660|NCT01257204|507187|P1|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
209661|NCT01257204|507185|P3|NOT COMPLETED|Treatment Period (up to Week 24)||9
209662|NCT01257204|507186|P2|NOT COMPLETED|Treatment Period (up to Week 24)||6
209663|NCT01257204|507187|P1|NOT COMPLETED|Treatment Period (up to Week 24)||5
209664|NCT01257204|507185|P3|COMPLETED|Treatment Period (up to Week 24)||42
209665|NCT01257204|507186|P2|COMPLETED|Treatment Period (up to Week 24)||44
209666|NCT01257204|507187|P1|COMPLETED|Treatment Period (up to Week 24)||45
209667|NCT01257204|507185|P3|STARTED|Treatment Period (up to Week 24)||51
209668|NCT01257204|507186|P2|STARTED|Treatment Period (up to Week 24)||50
209669|NCT01257204|507187|P1|STARTED|Treatment Period (up to Week 24)||50
209670|NCT01256983|507233|P2|NOT COMPLETED|Overall Study||3
209671|NCT01256983|507234|P1|NOT COMPLETED|Overall Study||1
209672|NCT01256983|507233|P2|COMPLETED|Overall Study||12
209673|NCT01256983|507234|P1|COMPLETED|Overall Study||14
209674|NCT01256983|507233|P2|STARTED|Overall Study||15
209675|NCT01256983|507234|P1|STARTED|Overall Study||15
209676|NCT01256944|507242|P2|NOT COMPLETED|Overall Study||0
209677|NCT01256944|507243|P1|NOT COMPLETED|Overall Study||0
209678|NCT01256944|507242|P2|COMPLETED|Overall Study||220
209679|NCT01256944|507243|P1|COMPLETED|Overall Study||70
209680|NCT01256944|507242|P2|STARTED|Overall Study||220
209681|NCT01256944|507243|P1|STARTED|Overall Study||70
209682|NCT01256918|507271|P1|NOT COMPLETED|Overall Study||0
209683|NCT01256918|507271|P1|COMPLETED|Overall Study||200
209684|NCT01256918|507271|P1|Full Thickness Nuclear Crack Achieved|Overall Study||200
209685|NCT01256918|507271|P1|STARTED|Overall Study||200
209686|NCT01256879|507282|P1|NOT COMPLETED|Overall Study||1
209687|NCT01256879|507282|P1|COMPLETED|Overall Study||24
209688|NCT01256879|507282|P1|Commercial Cimetidine Solution|Overall Study|24 started this intervention and 24 completed|24
209689|NCT01256879|507282|P1|Sorbitol-free Cimetidine Solution|Overall Study|24 started this intervention and 24 completed|24
209690|NCT01256879|507282|P1|CimTest-B|Overall Study|24 started this intervention and 24 completed|24
209691|NCT01256879|507282|P1|CimTest-A|Overall Study|25 started this intervention but only 24 completed|25
209692|NCT01256879|507282|P1|STARTED|Overall Study|25 started in this cross-over study but only 24 completed|25
209693|NCT01256840|507295|P3|NOT COMPLETED|Overall Study||0
209694|NCT01256840|507296|P2|NOT COMPLETED|Overall Study||0
209695|NCT01256840|507297|P1|NOT COMPLETED|Overall Study||0
209696|NCT01256840|507295|P3|COMPLETED|Overall Study||25
209697|NCT01256840|507296|P2|COMPLETED|Overall Study||16
209698|NCT01256840|507297|P1|COMPLETED|Overall Study||30
209699|NCT01256840|507295|P3|STARTED|Overall Study||25
209700|NCT01256840|507296|P2|STARTED|Overall Study||16
209701|NCT01256840|507297|P1|STARTED|Overall Study||30
209702|NCT01256788|507308|P3|NOT COMPLETED|Overall Study||3
209703|NCT01256788|507309|P2|NOT COMPLETED|Overall Study||8
209704|NCT01256788|507310|P1|NOT COMPLETED|Overall Study||5
209705|NCT01256788|507308|P3|COMPLETED|Overall Study||5
209706|NCT01256788|507309|P2|COMPLETED|Overall Study||6
209707|NCT01256788|507310|P1|COMPLETED|Overall Study||7
209708|NCT01256788|507308|P3|STARTED|Overall Study||8
209709|NCT01256788|507309|P2|STARTED|Overall Study||14
209710|NCT01256788|507310|P1|STARTED|Overall Study||12
209711|NCT01256684|507321|P3|NOT COMPLETED|Overall Study||11
209712|NCT01256684|507322|P2|NOT COMPLETED|Overall Study||13
209713|NCT01256684|507323|P1|NOT COMPLETED|Overall Study||9
209714|NCT01256684|507321|P3|COMPLETED|Overall Study||76
209715|NCT01256684|507322|P2|COMPLETED|Overall Study||74
209716|NCT01256684|507323|P1|COMPLETED|Overall Study||72
209717|NCT01256684|507321|P3|ITT Population|Overall Study||81
209718|NCT01256684|507322|P2|ITT Population|Overall Study||79
209719|NCT01256684|507323|P1|ITT Population|Overall Study||77
209720|NCT01256684|507321|P3|Safety Population|Overall Study||87
209721|NCT01256684|507322|P2|Safety Population|Overall Study||86
209722|NCT01256684|507323|P1|Safety Population|Overall Study||80
209723|NCT01256684|507321|P3|STARTED|Overall Study||87
209724|NCT01256684|507322|P2|STARTED|Overall Study||87
209725|NCT01256684|507323|P1|STARTED|Overall Study||81
209726|NCT01256671|507355|P1|NOT COMPLETED|Overall Study||95
209727|NCT01256671|507355|P1|COMPLETED|Overall Study||435
209728|NCT01256671|507355|P1|Safety Population|Overall Study||521
209729|NCT01256671|507355|P1|STARTED|Overall Study||530
209730|NCT01256658|507368|P2|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||6372
209731|NCT01256658|507369|P1|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||5854
209732|NCT01256658|507368|P2|COMPLETED|Period 2 - Follow up Only - No Treatment||0
209733|NCT01256658|507369|P1|COMPLETED|Period 2 - Follow up Only - No Treatment||0
209734|NCT01256658|507368|P2|Study Termination|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6287
209735|NCT01256658|507369|P1|Study Termination|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5777
209736|NCT01256658|507368|P2|Death|Period 2 - Follow up Only - No Treatment||8
209737|NCT01256658|507369|P1|Death|Period 2 - Follow up Only - No Treatment||6
209738|NCT01256658|507368|P2|Lost to Follow up|Period 2 - Follow up Only - No Treatment||77
209740|NCT01256658|507368|P2|STARTED|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6372
209741|NCT01256658|507369|P1|STARTED|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5854
209742|NCT01256658|507368|P2|NOT COMPLETED|Period 1||748
209743|NCT01256658|507369|P1|NOT COMPLETED|Period 1||920
209744|NCT01256658|507368|P2|COMPLETED|Period 1||6510
209745|NCT01256658|507369|P1|COMPLETED|Period 1||5897
209746|NCT01256658|507368|P2|STARTED|Period 1||7258
209747|NCT01256658|507369|P1|STARTED|Period 1||6817
209748|NCT01256593|507419|P1|NOT COMPLETED|Overall Study||214
209749|NCT01256593|507419|P1|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|3613
209750|NCT01256593|507419|P1|STARTED|Overall Study||3827
209751|NCT01256567|507433|P1|NOT COMPLETED|Overall Study||1
209752|NCT01256567|507433|P1|COMPLETED|Overall Study||6
209753|NCT01256567|507433|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
209754|NCT01256567|507433|P1|STARTED|Overall Study||7
209755|NCT01256502|507443|P1|NOT COMPLETED|Overall Study||10
209756|NCT01256502|507443|P1|COMPLETED|Overall Study||129
209757|NCT01256502|507443|P1|STARTED|Overall Study|Implanted with SERI during Stage I breast reconstruction surgery|139
209758|NCT01256476|507455|P2|NOT COMPLETED|Overall Study||7
209759|NCT01256476|507456|P1|NOT COMPLETED|Overall Study||6
209760|NCT01256476|507455|P2|COMPLETED|Overall Study||157
209761|NCT01256476|507456|P1|COMPLETED|Overall Study||158
209762|NCT01256476|507455|P2|STARTED|Overall Study||164
209763|NCT01256476|507456|P1|STARTED|Overall Study||164
209764|NCT01256450|507464|P3|NOT COMPLETED|Double-blind Treatment||37
209765|NCT01256450|507465|P2|NOT COMPLETED|Double-blind Treatment||28
209766|NCT01256450|507466|P1|NOT COMPLETED|Double-blind Treatment||0
209767|NCT01256450|507464|P3|COMPLETED|Double-blind Treatment||81
209768|NCT01256450|507465|P2|COMPLETED|Double-blind Treatment||89
209769|NCT01256450|507466|P1|COMPLETED|Double-blind Treatment||0
209770|NCT01256450|507464|P3|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|118
209771|NCT01256450|507465|P2|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|117
209772|NCT01256450|507466|P1|STARTED|Double-blind Treatment|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
209773|NCT01256450|507464|P3|NOT COMPLETED|Open-label Titration||0
209774|NCT01256450|507465|P2|NOT COMPLETED|Open-label Titration||0
209775|NCT01256450|507466|P1|NOT COMPLETED|Open-label Titration||99
209776|NCT01256450|507464|P3|COMPLETED|Open-label Titration||0
209777|NCT01256450|507465|P2|COMPLETED|Open-label Titration||0
209778|NCT01256450|507466|P1|COMPLETED|Open-label Titration||235
209779|NCT01256450|507464|P3|STARTED|Open-label Titration||0
209780|NCT01256450|507465|P2|STARTED|Open-label Titration||0
209781|NCT01256450|507466|P1|STARTED|Open-label Titration||334
209782|NCT01256424|507495|P4|NOT COMPLETED|Overall Study||7
209783|NCT01256424|507496|P3|NOT COMPLETED|Overall Study||7
209784|NCT01256424|507497|P2|NOT COMPLETED|Overall Study||8
209785|NCT01256424|507498|P1|NOT COMPLETED|Overall Study||9
209786|NCT01256424|507495|P4|COMPLETED|Overall Study||61
209787|NCT01256424|507496|P3|COMPLETED|Overall Study||55
209788|NCT01256424|507497|P2|COMPLETED|Overall Study||59
209789|NCT01256424|507498|P1|COMPLETED|Overall Study||56
209790|NCT01256424|507495|P4|STARTED|Overall Study||68
209791|NCT01256424|507496|P3|STARTED|Overall Study||62
209792|NCT01256424|507497|P2|STARTED|Overall Study||67
209793|NCT01256424|507498|P1|STARTED|Overall Study||65
209794|NCT01256411|507524|P6|NOT COMPLETED|Extension by Mono or Combination Therapy||4
209795|NCT01256411|507525|P5|NOT COMPLETED|Extension by Mono or Combination Therapy||17
209796|NCT01256411|507526|P4|NOT COMPLETED|Extension by Mono or Combination Therapy||0
209797|NCT01256411|507527|P3|NOT COMPLETED|Extension by Mono or Combination Therapy||0
209798|NCT01256411|507528|P2|NOT COMPLETED|Extension by Mono or Combination Therapy||0
209799|NCT01256411|507529|P1|NOT COMPLETED|Extension by Mono or Combination Therapy||0
209800|NCT01256411|507524|P6|COMPLETED|Extension by Mono or Combination Therapy||109
209801|NCT01256411|507525|P5|COMPLETED|Extension by Mono or Combination Therapy||211
209802|NCT01256411|507526|P4|COMPLETED|Extension by Mono or Combination Therapy||0
209803|NCT01256411|507527|P3|COMPLETED|Extension by Mono or Combination Therapy||0
209804|NCT01256411|507528|P2|COMPLETED|Extension by Mono or Combination Therapy||0
209805|NCT01256411|507529|P1|COMPLETED|Extension by Mono or Combination Therapy||0
209806|NCT01256411|507524|P6|STARTED|Extension by Mono or Combination Therapy||113
209807|NCT01256411|507525|P5|STARTED|Extension by Mono or Combination Therapy||228
209808|NCT01256411|507526|P4|STARTED|Extension by Mono or Combination Therapy||0
209809|NCT01256411|507527|P3|STARTED|Extension by Mono or Combination Therapy||0
209810|NCT01256411|507528|P2|STARTED|Extension by Mono or Combination Therapy||0
209811|NCT01256411|507529|P1|STARTED|Extension by Mono or Combination Therapy||0
209812|NCT01256411|507524|P6|NOT COMPLETED|Extension by Maximum Treatment||0
209813|NCT01256411|507525|P5|NOT COMPLETED|Extension by Maximum Treatment||0
209814|NCT01256411|507526|P4|NOT COMPLETED|Extension by Maximum Treatment||0
209815|NCT01256411|507527|P3|NOT COMPLETED|Extension by Maximum Treatment||4
209816|NCT01256411|507528|P2|NOT COMPLETED|Extension by Maximum Treatment||10
209817|NCT01256411|507529|P1|NOT COMPLETED|Extension by Maximum Treatment||7
209818|NCT01256411|507524|P6|COMPLETED|Extension by Maximum Treatment||0
209819|NCT01256411|507525|P5|COMPLETED|Extension by Maximum Treatment||0
209820|NCT01256411|507526|P4|COMPLETED|Extension by Maximum Treatment||4
209821|NCT01256411|507527|P3|COMPLETED|Extension by Maximum Treatment||105
209822|NCT01256411|507528|P2|COMPLETED|Extension by Maximum Treatment||79
209823|NCT01256411|507529|P1|COMPLETED|Extension by Maximum Treatment||132
209824|NCT01256411|507524|P6|Down Titrated to 100 mg|Extension by Maximum Treatment||0
209825|NCT01256411|507525|P5|Down Titrated to 100 mg|Extension by Maximum Treatment||0
209826|NCT01256411|507526|P4|Down Titrated to 100 mg|Extension by Maximum Treatment||0
209827|NCT01256411|507527|P3|Down Titrated to 100 mg|Extension by Maximum Treatment||0
209828|NCT01256411|507528|P2|Down Titrated to 100 mg|Extension by Maximum Treatment||0
209829|NCT01256411|507529|P1|Down Titrated to 100 mg|Extension by Maximum Treatment||12
209830|NCT01256411|507524|P6|STARTED|Extension by Maximum Treatment||0
209831|NCT01256411|507525|P5|STARTED|Extension by Maximum Treatment||0
209832|NCT01256411|507526|P4|STARTED|Extension by Maximum Treatment||4
209833|NCT01256411|507527|P3|STARTED|Extension by Maximum Treatment||109
209834|NCT01256411|507528|P2|STARTED|Extension by Maximum Treatment||89
209835|NCT01256411|507529|P1|STARTED|Extension by Maximum Treatment||139
209836|NCT01256398|507553|P1|NOT COMPLETED|Overall Study||1
209837|NCT01256398|507553|P1|COMPLETED|Overall Study||65
209838|NCT01256398|507553|P1|STARTED|Overall Study||66
209839|NCT01256385|507559|P2|NOT COMPLETED|Overall Study||3
209840|NCT01256385|507560|P1|NOT COMPLETED|Overall Study||3
209841|NCT01256385|507559|P2|COMPLETED|Overall Study||40
209842|NCT01256385|507560|P1|COMPLETED|Overall Study||40
209843|NCT01256385|507559|P2|Crossover From Arm B to Arm A|Overall Study||15
209844|NCT01256385|507560|P1|Crossover From Arm B to Arm A|Overall Study||0
209845|NCT01256385|507559|P2|STARTED|Overall Study||43
209846|NCT01256385|507560|P1|STARTED|Overall Study||43
209847|NCT01256294|507580|P2|NOT COMPLETED|Overall Study||2
209848|NCT01256294|507581|P1|NOT COMPLETED|Overall Study||4
209849|NCT01256294|507580|P2|COMPLETED|Overall Study||33
209850|NCT01256294|507581|P1|COMPLETED|Overall Study||32
209851|NCT01256294|507580|P2|STARTED|Overall Study||35
209852|NCT01256294|507581|P1|STARTED|Overall Study||36
209853|NCT01256281|507597|P1|NOT COMPLETED|Overall Study||0
209854|NCT01256281|507597|P1|COMPLETED|Overall Study||2
209855|NCT01256281|507597|P1|STARTED|Overall Study||2
209856|NCT01256190|507603|P2|NOT COMPLETED|Overall Study||0
209857|NCT01256190|507604|P1|NOT COMPLETED|Overall Study||2
209858|NCT01256190|507603|P2|COMPLETED|Overall Study||17
209859|NCT01256190|507604|P1|COMPLETED|Overall Study||37
209860|NCT01256190|507603|P2|STARTED|Overall Study||17
209861|NCT01256190|507604|P1|STARTED|Overall Study||39
209862|NCT01256177|507620|P2|NOT COMPLETED|Overall Study||37
209863|NCT01256177|507621|P1|NOT COMPLETED|Overall Study||50
209864|NCT01256177|507620|P2|COMPLETED|Overall Study||111
209865|NCT01256177|507621|P1|COMPLETED|Overall Study||98
209866|NCT01256177|507620|P2|STARTED|Overall Study||148
209867|NCT01256177|507621|P1|STARTED|Overall Study||148
209868|NCT01256164|507645|P2|NOT COMPLETED|Overall Study||0
209869|NCT01256164|507646|P1|NOT COMPLETED|Overall Study||0
209870|NCT01256164|507645|P2|COMPLETED|Overall Study||23
209871|NCT01256164|507646|P1|COMPLETED|Overall Study||47
209872|NCT01256164|507645|P2|STARTED|Overall Study||23
209873|NCT01256164|507646|P1|STARTED|Overall Study||47
209874|NCT01256086|507664|P4|NOT COMPLETED|Treatment Day 4||0
209875|NCT01256086|507665|P3|NOT COMPLETED|Treatment Day 4||0
209876|NCT01256086|507666|P2|NOT COMPLETED|Treatment Day 4||0
209877|NCT01256086|507667|P1|NOT COMPLETED|Treatment Day 4||0
209878|NCT01256086|507664|P4|COMPLETED|Treatment Day 4||11
209879|NCT01256086|507665|P3|COMPLETED|Treatment Day 4||9
209880|NCT01256086|507666|P2|COMPLETED|Treatment Day 4||10
209881|NCT01256086|507667|P1|COMPLETED|Treatment Day 4||11
209882|NCT01256086|507664|P4|STARTED|Treatment Day 4||11
209883|NCT01256086|507665|P3|STARTED|Treatment Day 4||9
209884|NCT01256086|507666|P2|STARTED|Treatment Day 4||10
209885|NCT01256086|507667|P1|STARTED|Treatment Day 4||11
209886|NCT01256086|507664|P4|NOT COMPLETED|Treatment Day 3||0
209887|NCT01256086|507665|P3|NOT COMPLETED|Treatment Day 3||0
209888|NCT01256086|507666|P2|NOT COMPLETED|Treatment Day 3||0
209889|NCT01256086|507667|P1|NOT COMPLETED|Treatment Day 3||0
209890|NCT01256086|507664|P4|COMPLETED|Treatment Day 3||11
209891|NCT01256086|507665|P3|COMPLETED|Treatment Day 3||9
209892|NCT01256086|507666|P2|COMPLETED|Treatment Day 3||10
209893|NCT01256086|507667|P1|COMPLETED|Treatment Day 3||11
209894|NCT01256086|507664|P4|STARTED|Treatment Day 3||11
209895|NCT01256086|507665|P3|STARTED|Treatment Day 3||9
209896|NCT01256086|507666|P2|STARTED|Treatment Day 3||10
209897|NCT01256086|507667|P1|STARTED|Treatment Day 3||11
209898|NCT01256086|507664|P4|NOT COMPLETED|Treatment Day 2||0
209899|NCT01256086|507665|P3|NOT COMPLETED|Treatment Day 2||0
209900|NCT01256086|507666|P2|NOT COMPLETED|Treatment Day 2||0
209901|NCT01256086|507667|P1|NOT COMPLETED|Treatment Day 2||0
209902|NCT01256086|507664|P4|COMPLETED|Treatment Day 2||11
209903|NCT01256086|507665|P3|COMPLETED|Treatment Day 2||9
209904|NCT01256086|507666|P2|COMPLETED|Treatment Day 2||10
209905|NCT01256086|507667|P1|COMPLETED|Treatment Day 2||11
209906|NCT01256086|507664|P4|STARTED|Treatment Day 2||11
209907|NCT01256086|507665|P3|STARTED|Treatment Day 2||9
209908|NCT01256086|507666|P2|STARTED|Treatment Day 2||10
209909|NCT01256086|507667|P1|STARTED|Treatment Day 2||11
209910|NCT01256086|507664|P4|NOT COMPLETED|Treatment Day 1||0
209911|NCT01256086|507665|P3|NOT COMPLETED|Treatment Day 1||0
209912|NCT01256086|507666|P2|NOT COMPLETED|Treatment Day 1||0
209913|NCT01256086|507667|P1|NOT COMPLETED|Treatment Day 1||0
209914|NCT01256086|507664|P4|COMPLETED|Treatment Day 1||11
209915|NCT01256086|507665|P3|COMPLETED|Treatment Day 1||11
209916|NCT01256086|507666|P2|COMPLETED|Treatment Day 1||11
209917|NCT01256086|507667|P1|COMPLETED|Treatment Day 1||11
209918|NCT01256086|507664|P4|STARTED|Treatment Day 1||11
209919|NCT01256086|507665|P3|STARTED|Treatment Day 1||11
209920|NCT01256086|507666|P2|STARTED|Treatment Day 1||11
209921|NCT01256086|507667|P1|STARTED|Treatment Day 1||11
209922|NCT01256060|507677|P4|NOT COMPLETED|Overall Study||0
209923|NCT01256060|507678|P3|NOT COMPLETED|Overall Study||0
209924|NCT01256060|507679|P2|NOT COMPLETED|Overall Study||1
209925|NCT01256060|507680|P1|NOT COMPLETED|Overall Study||0
209926|NCT01256060|507677|P4|COMPLETED|Overall Study||6
209927|NCT01256060|507678|P3|COMPLETED|Overall Study||3
209928|NCT01256060|507679|P2|COMPLETED|Overall Study||2
209929|NCT01256060|507680|P1|COMPLETED|Overall Study||3
209930|NCT01256060|507677|P4|STARTED|Overall Study||6
209931|NCT01256060|507678|P3|STARTED|Overall Study||3
209932|NCT01256060|507679|P2|STARTED|Overall Study||3
209933|NCT01256060|507680|P1|STARTED|Overall Study||3
209934|NCT01256034|507689|P2|NOT COMPLETED|Overall Study||25
209935|NCT01256034|507690|P1|NOT COMPLETED|Overall Study||25
209936|NCT01256034|507689|P2|COMPLETED|Overall Study||0
209937|NCT01256034|507690|P1|COMPLETED|Overall Study||0
209938|NCT01256034|507689|P2|STARTED|Overall Study||25
209939|NCT01256034|507690|P1|STARTED|Overall Study||25
209940|NCT01256008|507699|P3|NOT COMPLETED|Overall Study||21
209941|NCT01256008|507700|P2|NOT COMPLETED|Overall Study||7
209942|NCT01256008|507701|P1|NOT COMPLETED|Overall Study||8
209943|NCT01256008|507699|P3|COMPLETED|Overall Study||175
209944|NCT01256008|507700|P2|COMPLETED|Overall Study||91
209945|NCT01256008|507701|P1|COMPLETED|Overall Study||90
209946|NCT01256008|507699|P3|STARTED|Overall Study||196
209947|NCT01256008|507700|P2|STARTED|Overall Study||98
209948|NCT01256008|507701|P1|STARTED|Overall Study||98
209949|NCT01255904|507723|P2|NOT COMPLETED|Overall Study||4
209950|NCT01255904|507724|P1|NOT COMPLETED|Overall Study||1
209951|NCT01255904|507723|P2|COMPLETED|Overall Study||41
209952|NCT01255904|507724|P1|COMPLETED|Overall Study||44
209953|NCT01255904|507723|P2|STARTED|Overall Study||45
209954|NCT01255904|507724|P1|STARTED|Overall Study||45
209955|NCT01255787|507734|P4|NOT COMPLETED|Overall Study||22
209956|NCT01255787|507735|P3|NOT COMPLETED|Overall Study||18
209957|NCT01255787|507736|P2|NOT COMPLETED|Overall Study||17
209958|NCT01255787|507737|P1|NOT COMPLETED|Overall Study||16
209959|NCT01255787|507734|P4|COMPLETED|Overall Study||132
209960|NCT01255787|507735|P3|COMPLETED|Overall Study||132
209961|NCT01255787|507736|P2|COMPLETED|Overall Study||127
209962|NCT01255787|507737|P1|COMPLETED|Overall Study||136
209963|NCT01255787|507734|P4|Treated|Overall Study||150
209964|NCT01255787|507735|P3|Treated|Overall Study||148
209965|NCT01255787|507736|P2|Treated|Overall Study||144
209966|NCT01255787|507737|P1|Treated|Overall Study||152
209967|NCT01255787|507734|P4|STARTED|Overall Study||154
209968|NCT01255787|507735|P3|STARTED|Overall Study||150
209969|NCT01255787|507736|P2|STARTED|Overall Study||144
209970|NCT01255787|507737|P1|STARTED|Overall Study||152
209971|NCT01255761|507765|P2|NOT COMPLETED|Overall Study||175
209972|NCT01255761|507766|P1|NOT COMPLETED|Overall Study||182
209973|NCT01255761|507765|P2|COMPLETED|Overall Study||192
209974|NCT01255761|507766|P1|COMPLETED|Overall Study||187
209975|NCT01255761|507765|P2|STARTED|Overall Study||367
209976|NCT01255761|507766|P1|STARTED|Overall Study||369
209977|NCT01255722|507851|P3|NOT COMPLETED|Overall Study||1
209978|NCT01255722|507852|P2|NOT COMPLETED|Overall Study||1
209979|NCT01255722|507853|P1|NOT COMPLETED|Overall Study||3
209980|NCT01255722|507851|P3|COMPLETED|Overall Study||152
209981|NCT01255722|507852|P2|COMPLETED|Overall Study||159
209982|NCT01255722|507853|P1|COMPLETED|Overall Study||152
209983|NCT01255722|507851|P3|STARTED|Overall Study||153
209984|NCT01255722|507852|P2|STARTED|Overall Study||160
209985|NCT01255722|507853|P1|STARTED|Overall Study||155
209986|NCT01255631|507878|P2|NOT COMPLETED|Overall Study||6
209987|NCT01255631|507879|P1|NOT COMPLETED|Overall Study||9
209988|NCT01255631|507878|P2|COMPLETED|Overall Study|study terminated due to poor enrollment|3
209989|NCT01255631|507879|P1|COMPLETED|Overall Study|study terminated due to poor enrollment|4
209990|NCT01255631|507878|P2|STARTED|Overall Study||9
209991|NCT01255631|507879|P1|STARTED|Overall Study||13
209992|NCT01255592|507897|P2|NOT COMPLETED|Overall Study||1
209993|NCT01255592|507898|P1|NOT COMPLETED|Overall Study||6
209994|NCT01255592|507897|P2|COMPLETED|Overall Study||25
209995|NCT01255592|507898|P1|COMPLETED|Overall Study||20
209996|NCT01255592|507897|P2|STARTED|Overall Study||26
209997|NCT01255592|507898|P1|STARTED|Overall Study||26
209998|NCT01255449|507954|P1|NOT COMPLETED|Overall Study||0
209999|NCT01255449|507954|P1|COMPLETED|Overall Study||26
210000|NCT01255449|507954|P1|STARTED|Overall Study||26
210001|NCT01255436|507961|P2|NOT COMPLETED|Overall Study||194
210002|NCT01255436|507962|P1|NOT COMPLETED|Overall Study||182
210003|NCT01255436|507961|P2|COMPLETED|Overall Study||135
210004|NCT01255436|507962|P1|COMPLETED|Overall Study||151
210005|NCT01255436|507961|P2|STARTED|Overall Study|350 patients enrolled but 21 excluded because of missing baseline data|329
210006|NCT01255436|507962|P1|STARTED|Overall Study|350 patients enrolled but 17 excluded because of missing baseline data.|333
210007|NCT01255423|507976|P2|NOT COMPLETED|Overall Study||3
210008|NCT01255423|507977|P1|NOT COMPLETED|Overall Study||3
210009|NCT01255423|507976|P2|COMPLETED|Overall Study||99
210010|NCT01255423|507977|P1|COMPLETED|Overall Study||101
210011|NCT01255423|507976|P2|STARTED|Overall Study||102
210012|NCT01255423|507977|P1|STARTED|Overall Study||104
210013|NCT01255306|507993|P2|NOT COMPLETED|Overall Study||1
210014|NCT01255306|507994|P1|NOT COMPLETED|Overall Study||1
210015|NCT01255306|507993|P2|COMPLETED|Overall Study||32
210016|NCT01255306|507994|P1|COMPLETED|Overall Study||25
210017|NCT01255306|507993|P2|STARTED|Overall Study||33
210018|NCT01255306|507994|P1|STARTED|Overall Study||26
210019|NCT01255163|508005|P2|NOT COMPLETED|Overall Study||5
210020|NCT01255163|508006|P1|NOT COMPLETED|Overall Study||4
210021|NCT01255163|508005|P2|COMPLETED|Overall Study||9
210022|NCT01255163|508006|P1|COMPLETED|Overall Study||9
210023|NCT01255163|508005|P2|STARTED|Overall Study||14
210024|NCT01255163|508006|P1|STARTED|Overall Study||13
210025|NCT01255137|508028|P1|NOT COMPLETED|Overall Study||0
210026|NCT01255137|508028|P1|COMPLETED|Overall Study||13
210027|NCT01255137|508028|P1|STARTED|Overall Study||13
210028|NCT01254890|508035|P2|NOT COMPLETED|Overall Study||10
210029|NCT01254890|508036|P1|NOT COMPLETED|Overall Study||1
210030|NCT01254890|508035|P2|COMPLETED|Overall Study||47
210031|NCT01254890|508036|P1|COMPLETED|Overall Study||2
210032|NCT01254890|508035|P2|STARTED|Overall Study||57
210033|NCT01254890|508036|P1|STARTED|Overall Study||3
210034|NCT01254877|508045|P3|NOT COMPLETED|Overall Study||5
210035|NCT01254877|508046|P2|NOT COMPLETED|Overall Study||11
210036|NCT01254877|508047|P1|NOT COMPLETED|Overall Study||10
210037|NCT01254877|508045|P3|COMPLETED|Overall Study||64
210038|NCT01254877|508046|P2|COMPLETED|Overall Study||58
210039|NCT01254877|508047|P1|COMPLETED|Overall Study||57
210040|NCT01254877|508045|P3|STARTED|Overall Study||69
210041|NCT01254877|508046|P2|STARTED|Overall Study||69
210042|NCT01254877|508047|P1|STARTED|Overall Study||67
210043|NCT01254851|508072|P2|NOT COMPLETED|Overall Study||9
210044|NCT01254851|508073|P1|NOT COMPLETED|Overall Study||8
210045|NCT01254851|508072|P2|COMPLETED|Overall Study||68
210046|NCT01254851|508073|P1|COMPLETED|Overall Study||61
210047|NCT01254851|508072|P2|STARTED|Overall Study||77
210048|NCT01254851|508073|P1|STARTED|Overall Study||69
210049|NCT01254760|508079|P2|NOT COMPLETED|Second Period, 5 Days of Wear||0
210050|NCT01254760|508080|P1|NOT COMPLETED|Second Period, 5 Days of Wear||0
210051|NCT01254760|508079|P2|COMPLETED|Second Period, 5 Days of Wear||38
210052|NCT01254760|508080|P1|COMPLETED|Second Period, 5 Days of Wear||34
210053|NCT01254760|508079|P2|STARTED|Second Period, 5 Days of Wear||38
210054|NCT01254760|508080|P1|STARTED|Second Period, 5 Days of Wear||34
210055|NCT01254760|508079|P2|NOT COMPLETED|First Period, 5 Days of Wear||0
210056|NCT01254760|508080|P1|NOT COMPLETED|First Period, 5 Days of Wear||0
210057|NCT01254760|508079|P2|COMPLETED|First Period, 5 Days of Wear||38
210058|NCT01254760|508080|P1|COMPLETED|First Period, 5 Days of Wear||34
210059|NCT01254760|508079|P2|STARTED|First Period, 5 Days of Wear||38
210060|NCT01254760|508080|P1|STARTED|First Period, 5 Days of Wear||34
210061|NCT01254747|508098|P4|NOT COMPLETED|Overall Study||2
210062|NCT01254747|508099|P3|NOT COMPLETED|Overall Study||4
210063|NCT01254747|508100|P2|NOT COMPLETED|Overall Study||6
210064|NCT01254747|508101|P1|NOT COMPLETED|Overall Study||0
210065|NCT01254747|508098|P4|COMPLETED|Overall Study||28
210066|NCT01254747|508099|P3|COMPLETED|Overall Study||26
210067|NCT01254747|508100|P2|COMPLETED|Overall Study||23
210068|NCT01254747|508101|P1|COMPLETED|Overall Study||40
210069|NCT01254747|508098|P4|STARTED|Overall Study||30
210070|NCT01254747|508099|P3|STARTED|Overall Study||30
210071|NCT01254747|508100|P2|STARTED|Overall Study||29
210072|NCT01254747|508101|P1|STARTED|Overall Study||40
210073|NCT01254721|508141|P2|NOT COMPLETED|Overall Study||22
210074|NCT01254721|508142|P1|NOT COMPLETED|Overall Study||15
210075|NCT01254721|508141|P2|COMPLETED|Overall Study||42
210076|NCT01254721|508142|P1|COMPLETED|Overall Study||52
210077|NCT01254721|508141|P2|STARTED|Overall Study|Seroquel XR: 300mg Lithium: 900mg|64
210078|NCT01254721|508142|P1|STARTED|Overall Study|Seroquel XR: 300mg|67
210079|NCT01254669|508152|P2|NOT COMPLETED|Overall Study||4
210080|NCT01254669|508153|P1|NOT COMPLETED|Overall Study||3
210081|NCT01254669|508152|P2|COMPLETED|Overall Study||96
210082|NCT01254669|508153|P1|COMPLETED|Overall Study||97
210083|NCT01254669|508152|P2|STARTED|Overall Study||100
210084|NCT01254669|508153|P1|STARTED|Overall Study||100
210085|NCT01254656|508164|P3|NOT COMPLETED|Overall Study||18
210086|NCT01254656|508165|P2|NOT COMPLETED|Overall Study||43
210087|NCT01254656|508166|P1|NOT COMPLETED|Overall Study||47
210088|NCT01254656|508164|P3|COMPLETED|Overall Study||0
210089|NCT01254656|508165|P2|COMPLETED|Overall Study||0
210090|NCT01254656|508166|P1|COMPLETED|Overall Study||0
210091|NCT01254656|508164|P3|Treated|Overall Study||18
210092|NCT01254656|508165|P2|Treated|Overall Study||43
210093|NCT01254656|508166|P1|Treated|Overall Study||47
210094|NCT01254656|508164|P3|STARTED|Overall Study||18
210095|NCT01254656|508165|P2|STARTED|Overall Study||43
210096|NCT01254656|508166|P1|STARTED|Overall Study||47
210097|NCT01254643|508192|P1|NOT COMPLETED|Overall Study||1
210098|NCT01254643|508192|P1|COMPLETED|Overall Study||99
210099|NCT01254643|508192|P1|Vaccination 3|Overall Study||99
210100|NCT01254643|508192|P1|Vaccination 2|Overall Study||99
210101|NCT01254643|508192|P1|Vaccination 1|Overall Study||100
210102|NCT01254643|508192|P1|STARTED|Overall Study||100
210103|NCT01254630|508204|P4|NOT COMPLETED|Overall Study||1285
210104|NCT01254630|508205|P3|NOT COMPLETED|Overall Study||812
210105|NCT01254630|508206|P2|NOT COMPLETED|Overall Study||1288
210106|NCT01254630|508207|P1|NOT COMPLETED|Overall Study||802
210107|NCT01254630|508204|P4|COMPLETED|Overall Study||0
210108|NCT01254630|508205|P3|COMPLETED|Overall Study||552
210109|NCT01254630|508206|P2|COMPLETED|Overall Study||0
210110|NCT01254630|508207|P1|COMPLETED|Overall Study||546
210111|NCT01254630|508204|P4|Received Vaccination 4|Overall Study||1160
210112|NCT01254630|508205|P3|Received Vaccination 4|Overall Study||1212
210113|NCT01254630|508206|P2|Received Vaccination 4|Overall Study||1145
210114|NCT01254630|508207|P1|Received Vaccination 4|Overall Study||1155
210115|NCT01254630|508204|P4|Received Vaccination 3|Overall Study||1194
210116|NCT01254630|508205|P3|Received Vaccination 3|Overall Study||1247
210117|NCT01254630|508206|P2|Received Vaccination 3|Overall Study||1178
210118|NCT01254630|508207|P1|Received Vaccination 3|Overall Study||1198
210119|NCT01254630|508204|P4|Received Vaccination 2|Overall Study||1226
210120|NCT01254630|508205|P3|Received Vaccination 2|Overall Study||1286
210121|NCT01254630|508206|P2|Received Vaccination 2|Overall Study||1217
210122|NCT01254630|508207|P1|Received Vaccination 2|Overall Study||1255
210123|NCT01254630|508204|P4|Received Vaccination 1|Overall Study||1275
210124|NCT01254630|508205|P3|Received Vaccination 1|Overall Study||1350
210125|NCT01254630|508206|P2|Received Vaccination 1|Overall Study||1277
210126|NCT01254630|508207|P1|Received Vaccination 1|Overall Study||1328
210127|NCT01254630|508204|P4|STARTED|Overall Study||1285
210128|NCT01254630|508205|P3|STARTED|Overall Study||1364
210129|NCT01254630|508206|P2|STARTED|Overall Study||1288
210130|NCT01254630|508207|P1|STARTED|Overall Study||1348
210131|NCT01254604|508227|P2|NOT COMPLETED|Overall Study||9
210132|NCT01254604|508228|P1|NOT COMPLETED|Overall Study||8
210133|NCT01254604|508227|P2|COMPLETED|Overall Study||86
210134|NCT01254604|508228|P1|COMPLETED|Overall Study||87
210135|NCT01254604|508227|P2|Treated|Overall Study|"The 1 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|94
210136|NCT01254604|508228|P1|Treated|Overall Study|"The 2 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|93
210137|NCT01254604|508227|P2|STARTED|Overall Study||95
210138|NCT01254604|508228|P1|STARTED|Overall Study||95
210139|NCT01254565|508246|P6|NOT COMPLETED|Overall Study||4
210140|NCT01254565|508247|P5|NOT COMPLETED|Overall Study||4
210141|NCT01254565|508248|P4|NOT COMPLETED|Overall Study||1
210142|NCT01254565|508249|P3|NOT COMPLETED|Overall Study||0
210143|NCT01254565|508250|P2|NOT COMPLETED|Overall Study||1
210144|NCT01254565|508251|P1|NOT COMPLETED|Overall Study||1
210145|NCT01254565|508246|P6|COMPLETED|Overall Study||13
210146|NCT01254565|508247|P5|COMPLETED|Overall Study||12
210147|NCT01254565|508248|P4|COMPLETED|Overall Study||20
210148|NCT01254565|508249|P3|COMPLETED|Overall Study||21
210149|NCT01254565|508250|P2|COMPLETED|Overall Study||6
210150|NCT01254565|508251|P1|COMPLETED|Overall Study||4
210151|NCT01254565|508246|P6|Received Treatment|Overall Study||13
210152|NCT01254565|508247|P5|Received Treatment|Overall Study||13
210153|NCT01254565|508248|P4|Received Treatment|Overall Study||21
210154|NCT01254565|508249|P3|Received Treatment|Overall Study||21
210155|NCT01254565|508250|P2|Received Treatment|Overall Study||6
210156|NCT01254565|508251|P1|Received Treatment|Overall Study||4
210157|NCT01254565|508246|P6|STARTED|Overall Study||17
210158|NCT01254565|508247|P5|STARTED|Overall Study||16
210159|NCT01254565|508248|P4|STARTED|Overall Study||21
210160|NCT01254565|508249|P3|STARTED|Overall Study||21
210161|NCT01254565|508250|P2|STARTED|Overall Study||7
210162|NCT01254565|508251|P1|STARTED|Overall Study||5
210163|NCT01254552|508301|P1|NOT COMPLETED|CCTA With Xenetix 350||6
210164|NCT01254552|508301|P1|COMPLETED|CCTA With Xenetix 350||322
210165|NCT01254552|508301|P1|STARTED|CCTA With Xenetix 350||328
210166|NCT01254552|508301|P1|NOT COMPLETED|Delayed-enhanced MRI With Dotarem||20
210167|NCT01254552|508301|P1|COMPLETED|Delayed-enhanced MRI With Dotarem||328
210168|NCT01254552|508301|P1|STARTED|Delayed-enhanced MRI With Dotarem||348
210169|NCT01254552|508301|P1|NOT COMPLETED|Screening Visit||3
210170|NCT01254552|508301|P1|COMPLETED|Screening Visit||348
210171|NCT01254552|508301|P1|STARTED|Screening Visit||351
210172|NCT01254422|508311|P2|NOT COMPLETED|Overall Study||1
210173|NCT01254422|508312|P1|NOT COMPLETED|Overall Study||3
210174|NCT01254422|508311|P2|COMPLETED|Overall Study||50
210175|NCT01254422|508312|P1|COMPLETED|Overall Study||196
210176|NCT01254422|508311|P2|STARTED|Overall Study||51
210177|NCT01254422|508312|P1|STARTED|Overall Study||199
210178|NCT01254409|508340|P4|NOT COMPLETED|Overall Study||0
210179|NCT01254409|508341|P3|NOT COMPLETED|Overall Study||0
210180|NCT01254409|508342|P2|NOT COMPLETED|Overall Study||1
210181|NCT01254409|508343|P1|NOT COMPLETED|Overall Study||0
210182|NCT01254409|508340|P4|COMPLETED|Overall Study||4
210183|NCT01254409|508341|P3|COMPLETED|Overall Study||5
210184|NCT01254409|508342|P2|COMPLETED|Overall Study||5
210185|NCT01254409|508343|P1|COMPLETED|Overall Study||6
210186|NCT01254409|508340|P4|STARTED|Overall Study||4
210187|NCT01254409|508341|P3|STARTED|Overall Study||5
210188|NCT01254409|508342|P2|STARTED|Overall Study||6
210189|NCT01254409|508343|P1|STARTED|Overall Study||6
210190|NCT01254396|508395|P2|NOT COMPLETED|Second Intervention Period||0
210191|NCT01254396|508396|P1|NOT COMPLETED|Second Intervention Period||0
210192|NCT01254396|508395|P2|COMPLETED|Second Intervention Period||6
210193|NCT01254396|508396|P1|COMPLETED|Second Intervention Period||6
210194|NCT01254396|508395|P2|STARTED|Second Intervention Period||6
210195|NCT01254396|508396|P1|STARTED|Second Intervention Period||6
210196|NCT01254396|508395|P2|NOT COMPLETED|Washout Period (at Least 1 Day)||0
210197|NCT01254396|508396|P1|NOT COMPLETED|Washout Period (at Least 1 Day)||0
210198|NCT01254396|508395|P2|COMPLETED|Washout Period (at Least 1 Day)||6
210199|NCT01254396|508396|P1|COMPLETED|Washout Period (at Least 1 Day)||6
210200|NCT01254396|508395|P2|STARTED|Washout Period (at Least 1 Day)||6
210201|NCT01254396|508396|P1|STARTED|Washout Period (at Least 1 Day)||6
210202|NCT01254396|508395|P2|NOT COMPLETED|First Intervention Period||0
210203|NCT01254396|508396|P1|NOT COMPLETED|First Intervention Period||0
210204|NCT01254396|508395|P2|COMPLETED|First Intervention Period||6
210205|NCT01254396|508396|P1|COMPLETED|First Intervention Period||6
210206|NCT01254396|508395|P2|STARTED|First Intervention Period||6
210207|NCT01254396|508396|P1|STARTED|First Intervention Period||6
210208|NCT01254344|508412|P2|NOT COMPLETED|Overall Study||19
210209|NCT01254344|508413|P1|NOT COMPLETED|Overall Study||13
210210|NCT01254344|508412|P2|COMPLETED|Overall Study||281
210211|NCT01254344|508413|P1|COMPLETED|Overall Study||286
210212|NCT01254344|508412|P2|Treated|Overall Study||297
210213|NCT01254344|508413|P1|Treated|Overall Study||290
210214|NCT01254344|508412|P2|STARTED|Overall Study||300
210215|NCT01254344|508413|P1|STARTED|Overall Study||299
210216|NCT01254331|508421|P1|NOT COMPLETED|Extension Phase||4
210217|NCT01254331|508421|P1|COMPLETED|Extension Phase||41
210218|NCT01254331|508421|P1|STARTED|Extension Phase|1 participant withdrew consent after completing initial phase and did not enter the extension phase|45
210219|NCT01254331|508421|P1|NOT COMPLETED|Initial Phase||5
210220|NCT01254331|508421|P1|COMPLETED|Initial Phase||46
210221|NCT01254331|508421|P1|STARTED|Initial Phase||51
210222|NCT01254318|508439|P1|NOT COMPLETED|Overall Study||52
210223|NCT01254318|508439|P1|COMPLETED|Overall Study|Alive at end of study|78
210224|NCT01254318|508439|P1|STARTED|Overall Study|Alive at start of study|130
210225|NCT01254305|508448|P3|NOT COMPLETED|Overall Study||17
210226|NCT01254305|508449|P2|NOT COMPLETED|Overall Study||18
210227|NCT01254305|508450|P1|NOT COMPLETED|Overall Study||22
210228|NCT01254305|508448|P3|COMPLETED|Overall Study||62
210229|NCT01254305|508449|P2|COMPLETED|Overall Study||72
210230|NCT01254305|508450|P1|COMPLETED|Overall Study||71
210231|NCT01254305|508448|P3|Safety Population|Overall Study||77
210232|NCT01254305|508449|P2|Safety Population|Overall Study||85
210233|NCT01254305|508450|P1|Safety Population|Overall Study||89
210234|NCT01254305|508448|P3|STARTED|Overall Study||79
210235|NCT01254305|508449|P2|STARTED|Overall Study||90
210236|NCT01254305|508450|P1|STARTED|Overall Study||93
210237|NCT01254292|508466|P2|NOT COMPLETED|LCS12 Extension Phase||0
210238|NCT01254292|508467|P1|NOT COMPLETED|LCS12 Extension Phase||37
210239|NCT01254292|508466|P2|COMPLETED|LCS12 Extension Phase||0
210240|NCT01254292|508467|P1|COMPLETED|LCS12 Extension Phase||163
210241|NCT01254292|508466|P2|STARTED|LCS12 Extension Phase|Optional Extension Phase was for LCS12 group only.|0
210242|NCT01254292|508467|P1|STARTED|LCS12 Extension Phase|A total of 200 participants elected to enter this optional Extension Phase.|200
210243|NCT01254292|508466|P2|NOT COMPLETED|Comparative Phase||81
210244|NCT01254292|508467|P1|NOT COMPLETED|Comparative Phase||55
210245|NCT01254292|508466|P2|COMPLETED|Comparative Phase||204
210246|NCT01254292|508467|P1|COMPLETED|Comparative Phase||227
210247|NCT01254292|508466|P2|Participants Received Treatment|Comparative Phase|safety population|281
210248|NCT01254292|508467|P1|Participants Received Treatment|Comparative Phase|safety population|279
210249|NCT01254292|508466|P2|STARTED|Comparative Phase||285
210250|NCT01254292|508467|P1|STARTED|Comparative Phase||282
210251|NCT01254214|508529|P2|NOT COMPLETED|Overall Study||1
210252|NCT01254214|508530|P1|NOT COMPLETED|Overall Study||3
210253|NCT01254214|508529|P2|COMPLETED|Overall Study||27
210254|NCT01254214|508530|P1|COMPLETED|Overall Study||24
210255|NCT01254214|508529|P2|STARTED|Overall Study||28
210256|NCT01254214|508530|P1|STARTED|Overall Study||27
210257|NCT01254188|508544|P1|NOT COMPLETED|Overall Study||93
210258|NCT01254188|508544|P1|COMPLETED|Overall Study||328
210259|NCT01254188|508544|P1|STARTED|Overall Study||421
210260|NCT01254045|508555|P6|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
210261|NCT01254045|508556|P5|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
210262|NCT01254045|508557|P4|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
210263|NCT01254045|508558|P3|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
210264|NCT01254045|508559|P2|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
210265|NCT01254045|508560|P1|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
210266|NCT01254045|508555|P6|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
210267|NCT01254045|508556|P5|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
210268|NCT01254045|508557|P4|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
210269|NCT01254045|508558|P3|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
210270|NCT01254045|508559|P2|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
210271|NCT01254045|508560|P1|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
210272|NCT01254045|508555|P6|STARTED|Third/Time 3 (1 Day at Week 3)||1
210273|NCT01254045|508556|P5|STARTED|Third/Time 3 (1 Day at Week 3)||1
210274|NCT01254045|508557|P4|STARTED|Third/Time 3 (1 Day at Week 3)||1
210275|NCT01254045|508558|P3|STARTED|Third/Time 3 (1 Day at Week 3)||2
210276|NCT01254045|508559|P2|STARTED|Third/Time 3 (1 Day at Week 3)||2
210277|NCT01254045|508560|P1|STARTED|Third/Time 3 (1 Day at Week 3)||1
210278|NCT01254045|508555|P6|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
210279|NCT01254045|508556|P5|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
210280|NCT01254045|508557|P4|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
210281|NCT01254045|508558|P3|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
210282|NCT01254045|508559|P2|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
210283|NCT01254045|508560|P1|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
210284|NCT01254045|508555|P6|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
210285|NCT01254045|508556|P5|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
210286|NCT01254045|508557|P4|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
210287|NCT01254045|508558|P3|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
210288|NCT01254045|508559|P2|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
210289|NCT01254045|508560|P1|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
210290|NCT01254045|508555|P6|STARTED|Second/Time 2 (1 Day at Week 2)||1
210291|NCT01254045|508556|P5|STARTED|Second/Time 2 (1 Day at Week 2)||1
210292|NCT01254045|508557|P4|STARTED|Second/Time 2 (1 Day at Week 2)||1
210293|NCT01254045|508558|P3|STARTED|Second/Time 2 (1 Day at Week 2)||2
210294|NCT01254045|508559|P2|STARTED|Second/Time 2 (1 Day at Week 2)||2
210295|NCT01254045|508560|P1|STARTED|Second/Time 2 (1 Day at Week 2)||1
210296|NCT01254045|508555|P6|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
210297|NCT01254045|508556|P5|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
210298|NCT01254045|508557|P4|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
210299|NCT01254045|508558|P3|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
210300|NCT01254045|508559|P2|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
210301|NCT01254045|508560|P1|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||1
210302|NCT01254045|508555|P6|COMPLETED|First/Baseline (1 Day at Week 1 )||1
210303|NCT01254045|508556|P5|COMPLETED|First/Baseline (1 Day at Week 1 )||1
210304|NCT01254045|508557|P4|COMPLETED|First/Baseline (1 Day at Week 1 )||1
210305|NCT01254045|508558|P3|COMPLETED|First/Baseline (1 Day at Week 1 )||2
210306|NCT01254045|508559|P2|COMPLETED|First/Baseline (1 Day at Week 1 )||2
210307|NCT01254045|508560|P1|COMPLETED|First/Baseline (1 Day at Week 1 )||1
210308|NCT01254045|508555|P6|STARTED|First/Baseline (1 Day at Week 1 )||1
210309|NCT01254045|508556|P5|STARTED|First/Baseline (1 Day at Week 1 )||1
210310|NCT01254045|508557|P4|STARTED|First/Baseline (1 Day at Week 1 )||1
210311|NCT01254045|508558|P3|STARTED|First/Baseline (1 Day at Week 1 )||2
210312|NCT01254045|508559|P2|STARTED|First/Baseline (1 Day at Week 1 )||2
210313|NCT01254045|508560|P1|STARTED|First/Baseline (1 Day at Week 1 )|One completed all baseline measures including administration of placebo, but then lost to follow-up.|2
210314|NCT01254019|508573|P2|NOT COMPLETED|Overall Study||4
210315|NCT01254019|508574|P1|NOT COMPLETED|Overall Study||1
210316|NCT01254019|508573|P2|COMPLETED|Overall Study||121
210317|NCT01254019|508574|P1|COMPLETED|Overall Study||60
210318|NCT01254019|508573|P2|STARTED|Overall Study||125
210319|NCT01254019|508574|P1|STARTED|Overall Study||61
210320|NCT01253980|508627|P2|NOT COMPLETED|Overall Study||0
210321|NCT01253980|508628|P1|NOT COMPLETED|Overall Study||0
210322|NCT01253980|508627|P2|COMPLETED|Overall Study||39
210323|NCT01253980|508628|P1|COMPLETED|Overall Study||35
210324|NCT01253980|508627|P2|STARTED|Overall Study||39
210325|NCT01253980|508628|P1|STARTED|Overall Study||35
210326|NCT01253902|508637|P3|NOT COMPLETED|Overall Study||4
210327|NCT01253902|508638|P2|NOT COMPLETED|Overall Study||2
210328|NCT01253902|508639|P1|NOT COMPLETED|Overall Study||5
210329|NCT01253902|508637|P3|COMPLETED|Overall Study||51
210330|NCT01253902|508638|P2|COMPLETED|Overall Study||51
210331|NCT01253902|508639|P1|COMPLETED|Overall Study||51
210332|NCT01253902|508637|P3|STARTED|Overall Study||55
210333|NCT01253902|508638|P2|STARTED|Overall Study||53
210334|NCT01253902|508639|P1|STARTED|Overall Study||56
210335|NCT01253824|508655|P2|NOT COMPLETED|Overall Study||0
210336|NCT01253824|508656|P1|NOT COMPLETED|Overall Study||0
210337|NCT01253824|508655|P2|COMPLETED|Overall Study||7
210338|NCT01253824|508656|P1|COMPLETED|Overall Study||7
210339|NCT01253824|508655|P2|STARTED|Overall Study||7
210340|NCT01253824|508656|P1|STARTED|Overall Study||7
210341|NCT01253811|508668|P1|NOT COMPLETED|Overall Study||1
210342|NCT01253811|508668|P1|COMPLETED|Overall Study||5
210343|NCT01253811|508668|P1|Exposed|Overall Study||6
210344|NCT01253811|508668|P1|STARTED|Overall Study||6
210345|NCT01253642|508687|P1|NOT COMPLETED|Overall Study||5
210346|NCT01253642|508687|P1|COMPLETED|Overall Study||6
210347|NCT01253642|508687|P1|STARTED|Overall Study||11
210348|NCT01253577|508699|P1|NOT COMPLETED|Overall Study||3
210349|NCT01253577|508699|P1|COMPLETED|Overall Study||102
210350|NCT01253577|508699|P1|STARTED|Overall Study||105
210351|NCT01253564|508707|P1|NOT COMPLETED|Overall Study||24
210352|NCT01253564|508707|P1|COMPLETED|Overall Study||0
210353|NCT01253564|508707|P1|STARTED|Overall Study||24
210354|NCT01253525|508724|P1|NOT COMPLETED|Overall Study||0
210355|NCT01253525|508724|P1|COMPLETED|Overall Study||6
210356|NCT01253525|508724|P1|Received Any Quantity of Study Drug|Overall Study||6
210357|NCT01253525|508724|P1|STARTED|Overall Study||6
210358|NCT01253460|508751|P1|NOT COMPLETED|Overall Study||0
210359|NCT01253460|508751|P1|COMPLETED|Overall Study||18
210360|NCT01253460|508751|P1|STARTED|Overall Study||18
210361|NCT01253447|508756|P1|NOT COMPLETED|Overall Study||2
210362|NCT01253447|508756|P1|COMPLETED|Overall Study||17
210363|NCT01253447|508756|P1|STARTED|Overall Study||19
210364|NCT01253421|508766|P5|NOT COMPLETED|Drug+Scanning Visit||1
210365|NCT01253421|508767|P4|NOT COMPLETED|Drug+Scanning Visit||0
210366|NCT01253421|508768|P3|NOT COMPLETED|Drug+Scanning Visit||0
210367|NCT01253421|508769|P2|NOT COMPLETED|Drug+Scanning Visit||0
210368|NCT01253421|508770|P1|NOT COMPLETED|Drug+Scanning Visit||0
210369|NCT01253421|508766|P5|COMPLETED|Drug+Scanning Visit||14
210370|NCT01253421|508767|P4|COMPLETED|Drug+Scanning Visit||16
210371|NCT01253421|508768|P3|COMPLETED|Drug+Scanning Visit||14
210372|NCT01253421|508769|P2|COMPLETED|Drug+Scanning Visit||15
210373|NCT01253421|508770|P1|COMPLETED|Drug+Scanning Visit||0
210374|NCT01253421|508766|P5|Received Drug Challenge|Drug+Scanning Visit||15
210375|NCT01253421|508767|P4|Received Drug Challenge|Drug+Scanning Visit||16
210376|NCT01253421|508768|P3|Received Drug Challenge|Drug+Scanning Visit||14
210377|NCT01253421|508769|P2|Received Drug Challenge|Drug+Scanning Visit||15
210378|NCT01253421|508770|P1|Received Drug Challenge|Drug+Scanning Visit||0
210379|NCT01253421|508766|P5|STARTED|Drug+Scanning Visit||15
210380|NCT01253421|508767|P4|STARTED|Drug+Scanning Visit||16
210381|NCT01253421|508768|P3|STARTED|Drug+Scanning Visit||14
210382|NCT01253421|508769|P2|STARTED|Drug+Scanning Visit||15
210383|NCT01253421|508770|P1|STARTED|Drug+Scanning Visit|Arm has no participants once randomization has occurred.|0
210384|NCT01253421|508766|P5|NOT COMPLETED|Assessment and Scheduling||0
210385|NCT01253421|508767|P4|NOT COMPLETED|Assessment and Scheduling||0
210386|NCT01253421|508768|P3|NOT COMPLETED|Assessment and Scheduling||0
210387|NCT01253421|508769|P2|NOT COMPLETED|Assessment and Scheduling||0
210388|NCT01253421|508770|P1|NOT COMPLETED|Assessment and Scheduling||99
210389|NCT01253421|508766|P5|COMPLETED|Assessment and Scheduling||0
210390|NCT01253421|508767|P4|COMPLETED|Assessment and Scheduling||0
210391|NCT01253421|508768|P3|COMPLETED|Assessment and Scheduling||0
210392|NCT01253421|508769|P2|COMPLETED|Assessment and Scheduling||0
210393|NCT01253421|508770|P1|COMPLETED|Assessment and Scheduling||60
210394|NCT01253421|508766|P5|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
210395|NCT01253421|508767|P4|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
210396|NCT01253421|508768|P3|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
210397|NCT01253421|508769|P2|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
210398|NCT01253421|508770|P1|Returned for Drug+Scanning Visit|Assessment and Scheduling||60
210399|NCT01253421|508766|P5|Eligible After Screening Visit|Assessment and Scheduling||0
210400|NCT01253421|508767|P4|Eligible After Screening Visit|Assessment and Scheduling||0
210401|NCT01253421|508768|P3|Eligible After Screening Visit|Assessment and Scheduling||0
210402|NCT01253421|508769|P2|Eligible After Screening Visit|Assessment and Scheduling||0
210403|NCT01253421|508770|P1|Eligible After Screening Visit|Assessment and Scheduling||85
210404|NCT01253421|508766|P5|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
210405|NCT01253421|508767|P4|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
210406|NCT01253421|508768|P3|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
210407|NCT01253421|508769|P2|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
210408|NCT01253421|508770|P1|STARTED|Assessment and Scheduling||159
210409|NCT01253408|508819|P3|NOT COMPLETED|Overall Study||0
210410|NCT01253408|508820|P2|NOT COMPLETED|Overall Study||1
210411|NCT01253408|508821|P1|NOT COMPLETED|Overall Study||0
210412|NCT01253408|508819|P3|COMPLETED|Overall Study||13
210413|NCT01253408|508820|P2|COMPLETED|Overall Study||12
210414|NCT01253408|508821|P1|COMPLETED|Overall Study||10
210415|NCT01253408|508819|P3|STARTED|Overall Study||13
210416|NCT01253408|508820|P2|STARTED|Overall Study||13
210417|NCT01253408|508821|P1|STARTED|Overall Study||10
210418|NCT01253369|508844|P1|NOT COMPLETED|Overall Study||33
210419|NCT01253369|508844|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
210420|NCT01253369|508844|P1|Evaluable|Overall Study|Evaluable pts were w/ measurable disease, min 1 cycle of trt rcvd and 1 on-trt disease assessment.|30
210421|NCT01253369|508844|P1|STARTED|Overall Study||33
210422|NCT01253343|508851|P2|NOT COMPLETED|Overall Study||0
210423|NCT01253343|508852|P1|NOT COMPLETED|Overall Study||0
210424|NCT01253343|508851|P2|COMPLETED|Overall Study||8
210425|NCT01253343|508852|P1|COMPLETED|Overall Study||9
210426|NCT01253343|508851|P2|STARTED|Overall Study||8
210427|NCT01253343|508852|P1|STARTED|Overall Study||9
210428|NCT01253317|508874|P1|NOT COMPLETED|Overall Study||2
210429|NCT01253317|508874|P1|COMPLETED|Overall Study||10
210430|NCT01253317|508874|P1|STARTED|Overall Study||12
210431|NCT01253304|508886|P4|NOT COMPLETED|Overall Study||1
210432|NCT01253304|508887|P3|NOT COMPLETED|Overall Study||0
210433|NCT01253304|508888|P2|NOT COMPLETED|Overall Study||0
210434|NCT01253304|508889|P1|NOT COMPLETED|Overall Study||0
210435|NCT01253304|508886|P4|COMPLETED|Overall Study||2
210436|NCT01253304|508887|P3|COMPLETED|Overall Study||6
210437|NCT01253304|508888|P2|COMPLETED|Overall Study||6
210438|NCT01253304|508889|P1|COMPLETED|Overall Study||11
210439|NCT01253304|508886|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
210440|NCT01253304|508887|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
210441|NCT01253304|508888|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
210442|NCT01253304|508889|P1|Received at Least 1 Dose of Study Drug|Overall Study||11
210443|NCT01253304|508886|P4|STARTED|Overall Study||3
210444|NCT01253304|508887|P3|STARTED|Overall Study||6
210445|NCT01253304|508888|P2|STARTED|Overall Study||6
210446|NCT01253304|508889|P1|STARTED|Overall Study||11
210447|NCT01253291|508928|P5|NOT COMPLETED|Overall Study||2
210448|NCT01253291|508929|P4|NOT COMPLETED|Overall Study||0
210449|NCT01253291|508930|P3|NOT COMPLETED|Overall Study||0
210450|NCT01253291|508931|P2|NOT COMPLETED|Overall Study||2
210451|NCT01253291|508932|P1|NOT COMPLETED|Overall Study||4
210452|NCT01253291|508928|P5|COMPLETED|Overall Study||3
210453|NCT01253291|508929|P4|COMPLETED|Overall Study||5
210454|NCT01253291|508930|P3|COMPLETED|Overall Study||4
210455|NCT01253291|508931|P2|COMPLETED|Overall Study||4
210456|NCT01253291|508932|P1|COMPLETED|Overall Study||2
210457|NCT01253291|508928|P5|Received Study Drug During BCDL|Overall Study||5
210458|NCT01253291|508929|P4|Received Study Drug During BCDL|Overall Study||5
210459|NCT01253291|508930|P3|Received Study Drug During BCDL|Overall Study||4
210460|NCT01253291|508931|P2|Received Study Drug During BCDL|Overall Study||6
210461|NCT01253291|508932|P1|Received Study Drug During BCDL|Overall Study||6
210462|NCT01253291|508928|P5|STARTED|Overall Study||5
210463|NCT01253291|508929|P4|STARTED|Overall Study||5
210464|NCT01253291|508930|P3|STARTED|Overall Study||4
210465|NCT01253291|508931|P2|STARTED|Overall Study||6
210466|NCT01253291|508932|P1|STARTED|Overall Study||6
210467|NCT01253265|508956|P5|NOT COMPLETED|Overall Study||1
210468|NCT01253265|508957|P4|NOT COMPLETED|Overall Study||0
210469|NCT01253265|508958|P3|NOT COMPLETED|Overall Study||0
210470|NCT01253265|508959|P2|NOT COMPLETED|Overall Study||0
210471|NCT01253265|508960|P1|NOT COMPLETED|Overall Study||1
210472|NCT01253265|508956|P5|COMPLETED|Overall Study||7
210473|NCT01253265|508957|P4|COMPLETED|Overall Study||6
210474|NCT01253265|508958|P3|COMPLETED|Overall Study||6
210475|NCT01253265|508959|P2|COMPLETED|Overall Study||6
210476|NCT01253265|508960|P1|COMPLETED|Overall Study||5
210477|NCT01253265|508956|P5|STARTED|Overall Study||8
210478|NCT01253265|508957|P4|STARTED|Overall Study||6
210479|NCT01253265|508958|P3|STARTED|Overall Study||6
210480|NCT01253265|508959|P2|STARTED|Overall Study||6
210481|NCT01253265|508960|P1|STARTED|Overall Study||6
210482|NCT01253226|509009|P5|NOT COMPLETED|Overall Study||2
210483|NCT01253226|509010|P4|NOT COMPLETED|Overall Study||1
210484|NCT01253226|509011|P3|NOT COMPLETED|Overall Study||1
210485|NCT01253226|509012|P2|NOT COMPLETED|Overall Study||1
210486|NCT01253226|509013|P1|NOT COMPLETED|Overall Study||0
210487|NCT01253226|509009|P5|COMPLETED|Overall Study||6
210488|NCT01253226|509010|P4|COMPLETED|Overall Study||5
210489|NCT01253226|509011|P3|COMPLETED|Overall Study||5
210490|NCT01253226|509012|P2|COMPLETED|Overall Study||5
210491|NCT01253226|509013|P1|COMPLETED|Overall Study||6
210492|NCT01253226|509009|P5|Received at Least 1 Dose of Study Drug|Overall Study||8
210493|NCT01253226|509010|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
210494|NCT01253226|509011|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
210495|NCT01253226|509012|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
210496|NCT01253226|509013|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
210497|NCT01253226|509009|P5|STARTED|Overall Study||8
210498|NCT01253226|509010|P4|STARTED|Overall Study||6
210499|NCT01253226|509011|P3|STARTED|Overall Study||6
210500|NCT01253226|509012|P2|STARTED|Overall Study||6
210501|NCT01253226|509013|P1|STARTED|Overall Study||6
210502|NCT01253200|509073|P5|NOT COMPLETED|Overall Study||5
210503|NCT01253200|509074|P4|NOT COMPLETED|Overall Study||5
210504|NCT01253200|509075|P3|NOT COMPLETED|Overall Study||2
210505|NCT01253200|509076|P2|NOT COMPLETED|Overall Study||19
210506|NCT01253200|509077|P1|NOT COMPLETED|Overall Study||21
210507|NCT01253200|509073|P5|COMPLETED|Overall Study||0
210508|NCT01253200|509074|P4|COMPLETED|Overall Study||12
210509|NCT01253200|509075|P3|COMPLETED|Overall Study||28
210510|NCT01253200|509076|P2|COMPLETED|Overall Study||106
210511|NCT01253200|509077|P1|COMPLETED|Overall Study||104
210512|NCT01253200|509073|P5|3 Month Follow-up|Overall Study||0
210513|NCT01253200|509074|P4|3 Month Follow-up|Overall Study||12
210514|NCT01253200|509075|P3|3 Month Follow-up|Overall Study||28
210515|NCT01253200|509076|P2|3 Month Follow-up|Overall Study||106
210516|NCT01253200|509077|P1|3 Month Follow-up|Overall Study||104
210517|NCT01253200|509073|P5|10 Day Follow-up|Overall Study||0
210518|NCT01253200|509074|P4|10 Day Follow-up|Overall Study||12
210519|NCT01253200|509075|P3|10 Day Follow-up|Overall Study||28
210520|NCT01253200|509076|P2|10 Day Follow-up|Overall Study||111
210521|NCT01253200|509077|P1|10 Day Follow-up|Overall Study||106
210522|NCT01253200|509073|P5|Procedure|Overall Study||0
210523|NCT01253200|509074|P4|Procedure|Overall Study||12
210524|NCT01253200|509075|P3|Procedure|Overall Study||28
210525|NCT01253200|509076|P2|Procedure|Overall Study||111
210526|NCT01253200|509077|P1|Procedure|Overall Study||109
210527|NCT01253200|509073|P5|STARTED|Overall Study||5
210528|NCT01253200|509074|P4|STARTED|Overall Study||17
210529|NCT01253200|509075|P3|STARTED|Overall Study||30
210530|NCT01253200|509076|P2|STARTED|Overall Study||125
210531|NCT01253200|509077|P1|STARTED|Overall Study||125
210532|NCT01253187|509092|P6|NOT COMPLETED|Period 3||0
210533|NCT01253187|509093|P5|NOT COMPLETED|Period 3||1
210534|NCT01253187|509094|P4|NOT COMPLETED|Period 3||0
210535|NCT01253187|509095|P3|NOT COMPLETED|Period 3||0
210536|NCT01253187|509096|P2|NOT COMPLETED|Period 3||1
210537|NCT01253187|509097|P1|NOT COMPLETED|Period 3||1
210538|NCT01253187|509092|P6|COMPLETED|Period 3||6
210539|NCT01253187|509093|P5|COMPLETED|Period 3||7
210540|NCT01253187|509094|P4|COMPLETED|Period 3||7
210541|NCT01253187|509095|P3|COMPLETED|Period 3||7
210542|NCT01253187|509096|P2|COMPLETED|Period 3||7
210543|NCT01253187|509097|P1|COMPLETED|Period 3||6
210544|NCT01253187|509092|P6|STARTED|Period 3||6
210545|NCT01253187|509093|P5|STARTED|Period 3||8
210546|NCT01253187|509094|P4|STARTED|Period 3||7
210547|NCT01253187|509095|P3|STARTED|Period 3||7
210548|NCT01253187|509096|P2|STARTED|Period 3||8
210549|NCT01253187|509097|P1|STARTED|Period 3||7
210550|NCT01253187|509092|P6|NOT COMPLETED|Period 2||0
210551|NCT01253187|509093|P5|NOT COMPLETED|Period 2||1
210552|NCT01253187|509094|P4|NOT COMPLETED|Period 2||0
210553|NCT01253187|509095|P3|NOT COMPLETED|Period 2||0
210554|NCT01253187|509096|P2|NOT COMPLETED|Period 2||0
210555|NCT01253187|509097|P1|NOT COMPLETED|Period 2||0
210556|NCT01253187|509092|P6|COMPLETED|Period 2||6
210557|NCT01253187|509093|P5|COMPLETED|Period 2||8
210558|NCT01253187|509094|P4|COMPLETED|Period 2||7
210559|NCT01253187|509095|P3|COMPLETED|Period 2||7
210560|NCT01253187|509096|P2|COMPLETED|Period 2||8
210561|NCT01253187|509097|P1|COMPLETED|Period 2||7
210562|NCT01253187|509092|P6|STARTED|Period 2||6
210563|NCT01253187|509093|P5|STARTED|Period 2||9
210564|NCT01253187|509094|P4|STARTED|Period 2||7
210565|NCT01253187|509095|P3|STARTED|Period 2||7
210566|NCT01253187|509096|P2|STARTED|Period 2||8
210567|NCT01253187|509097|P1|STARTED|Period 2||7
210568|NCT01253187|509092|P6|NOT COMPLETED|Period 1||0
210569|NCT01253187|509093|P5|NOT COMPLETED|Period 1||0
210570|NCT01253187|509094|P4|NOT COMPLETED|Period 1||0
210571|NCT01253187|509095|P3|NOT COMPLETED|Period 1||0
210572|NCT01253187|509096|P2|NOT COMPLETED|Period 1||0
210573|NCT01253187|509097|P1|NOT COMPLETED|Period 1||0
210574|NCT01253187|509092|P6|COMPLETED|Period 1||6
210575|NCT01253187|509093|P5|COMPLETED|Period 1||9
210576|NCT01253187|509094|P4|COMPLETED|Period 1||7
210577|NCT01253187|509095|P3|COMPLETED|Period 1||7
210578|NCT01253187|509096|P2|COMPLETED|Period 1||8
210579|NCT01253187|509097|P1|COMPLETED|Period 1||7
210580|NCT01253187|509092|P6|STARTED|Period 1||6
210581|NCT01253187|509093|P5|STARTED|Period 1||9
210582|NCT01253187|509094|P4|STARTED|Period 1||7
210583|NCT01253187|509095|P3|STARTED|Period 1||7
210584|NCT01253187|509096|P2|STARTED|Period 1||8
210585|NCT01253187|509097|P1|STARTED|Period 1||7
210586|NCT01253174|509126|P6|NOT COMPLETED|Period 3||0
210587|NCT01253174|509127|P5|NOT COMPLETED|Period 3||1
210588|NCT01253174|509128|P4|NOT COMPLETED|Period 3||0
210589|NCT01253174|509129|P3|NOT COMPLETED|Period 3||1
210590|NCT01253174|509130|P2|NOT COMPLETED|Period 3||1
210591|NCT01253174|509131|P1|NOT COMPLETED|Period 3||0
210592|NCT01253174|509126|P6|COMPLETED|Period 3||7
210593|NCT01253174|509127|P5|COMPLETED|Period 3||7
210594|NCT01253174|509128|P4|COMPLETED|Period 3||7
210595|NCT01253174|509129|P3|COMPLETED|Period 3||6
210596|NCT01253174|509130|P2|COMPLETED|Period 3||8
210597|NCT01253174|509131|P1|COMPLETED|Period 3||6
210598|NCT01253174|509126|P6|STARTED|Period 3||7
210599|NCT01253174|509127|P5|STARTED|Period 3||8
210600|NCT01253174|509128|P4|STARTED|Period 3||7
210601|NCT01253174|509129|P3|STARTED|Period 3||7
210602|NCT01253174|509130|P2|STARTED|Period 3||9
210603|NCT01253174|509131|P1|STARTED|Period 3||6
210604|NCT01253174|509126|P6|NOT COMPLETED|Period 2||0
210605|NCT01253174|509127|P5|NOT COMPLETED|Period 2||0
210606|NCT01253174|509128|P4|NOT COMPLETED|Period 2||0
210607|NCT01253174|509129|P3|NOT COMPLETED|Period 2||1
210608|NCT01253174|509130|P2|NOT COMPLETED|Period 2||0
210609|NCT01253174|509131|P1|NOT COMPLETED|Period 2||0
210610|NCT01253174|509126|P6|COMPLETED|Period 2||7
210611|NCT01253174|509127|P5|COMPLETED|Period 2||8
210612|NCT01253174|509128|P4|COMPLETED|Period 2||7
210613|NCT01253174|509129|P3|COMPLETED|Period 2||7
210614|NCT01253174|509130|P2|COMPLETED|Period 2||9
210615|NCT01253174|509131|P1|COMPLETED|Period 2||6
210616|NCT01253174|509126|P6|STARTED|Period 2||7
210617|NCT01253174|509127|P5|STARTED|Period 2||8
210618|NCT01253174|509128|P4|STARTED|Period 2||7
210619|NCT01253174|509129|P3|STARTED|Period 2||8
210620|NCT01253174|509130|P2|STARTED|Period 2||9
210621|NCT01253174|509131|P1|STARTED|Period 2||6
210622|NCT01253174|509126|P6|NOT COMPLETED|Period 1||0
210623|NCT01253174|509127|P5|NOT COMPLETED|Period 1||1
210624|NCT01253174|509128|P4|NOT COMPLETED|Period 1||0
210625|NCT01253174|509129|P3|NOT COMPLETED|Period 1||1
210626|NCT01253174|509130|P2|NOT COMPLETED|Period 1||1
210627|NCT01253174|509131|P1|NOT COMPLETED|Period 1||0
210628|NCT01253174|509126|P6|COMPLETED|Period 1||7
210629|NCT01253174|509127|P5|COMPLETED|Period 1||8
210630|NCT01253174|509128|P4|COMPLETED|Period 1||7
210631|NCT01253174|509129|P3|COMPLETED|Period 1||8
210632|NCT01253174|509130|P2|COMPLETED|Period 1||9
210633|NCT01253174|509131|P1|COMPLETED|Period 1||6
210634|NCT01253174|509126|P6|STARTED|Period 1||7
210635|NCT01253174|509127|P5|STARTED|Period 1||9
210636|NCT01253174|509128|P4|STARTED|Period 1||7
210637|NCT01253174|509129|P3|STARTED|Period 1||9
210638|NCT01253174|509130|P2|STARTED|Period 1||10
210639|NCT01253174|509131|P1|STARTED|Period 1||6
210640|NCT01253148|509160|P1|NOT COMPLETED|Overall Study||0
210641|NCT01253148|509160|P1|COMPLETED|Overall Study||25
210642|NCT01253148|509160|P1|STARTED|Overall Study||25
210643|NCT01253135|509166|P1|NOT COMPLETED|Amended Protocol||1
210644|NCT01253135|509166|P1|COMPLETED|Amended Protocol||24
210645|NCT01253135|509166|P1|STARTED|Amended Protocol||25
210646|NCT01253135|509166|P1|NOT COMPLETED|Original Protocol||15
210647|NCT01253135|509166|P1|COMPLETED|Original Protocol||0
210648|NCT01253135|509166|P1|STARTED|Original Protocol||15
210649|NCT01253070|509174|P1|NOT COMPLETED|Overall Study||0
210650|NCT01253070|509174|P1|COMPLETED|Overall Study||54
210651|NCT01253070|509174|P1|STARTED|Overall Study||54
210652|NCT01253044|509185|P2|NOT COMPLETED|Overall Study||29
210653|NCT01253044|509186|P1|NOT COMPLETED|Overall Study||38
210654|NCT01253044|509185|P2|COMPLETED|Overall Study||51
210655|NCT01253044|509186|P1|COMPLETED|Overall Study||42
210656|NCT01253044|509185|P2|STARTED|Overall Study||80
210657|NCT01253044|509186|P1|STARTED|Overall Study||80
210658|NCT01253018|509196|P2|NOT COMPLETED|Overall Study||2
210659|NCT01253018|509197|P1|NOT COMPLETED|Overall Study||4
210660|NCT01253018|509196|P2|COMPLETED|Overall Study||21
210661|NCT01253018|509197|P1|COMPLETED|Overall Study||18
210662|NCT01253018|509196|P2|STARTED|Overall Study||23
210663|NCT01253018|509197|P1|STARTED|Overall Study||22
210664|NCT01252966|509211|P2|NOT COMPLETED|Overall Study||13
210665|NCT01252966|509212|P1|NOT COMPLETED|Overall Study||23
210666|NCT01252966|509211|P2|COMPLETED|Overall Study||92
210667|NCT01252966|509212|P1|COMPLETED|Overall Study||85
210668|NCT01252966|509211|P2|STARTED|Overall Study||105
210669|NCT01252966|509212|P1|STARTED|Overall Study||108
210670|NCT01252953|509228|P2|NOT COMPLETED|Overall Study||38
210671|NCT01252953|509229|P1|NOT COMPLETED|Overall Study||38
210672|NCT01252953|509228|P2|COMPLETED|Overall Study||15186
210673|NCT01252953|509229|P1|COMPLETED|Overall Study||15187
210674|NCT01252953|509228|P2|STARTED|Overall Study||15224
210675|NCT01252953|509229|P1|STARTED|Overall Study||15225
210676|NCT01252940|509243|P2|NOT COMPLETED|Extension Phase||3
210677|NCT01252940|509244|P1|NOT COMPLETED|Extension Phase||10
210678|NCT01252940|509243|P2|COMPLETED|Extension Phase||46
210679|NCT01252940|509244|P1|COMPLETED|Extension Phase||100
210680|NCT01252940|509243|P2|STARTED|Extension Phase|SBR/Delayed Switch Group: 49 participants completing the main study continued in extension phase.|49
210681|NCT01252940|509244|P1|STARTED|Extension Phase|FTC/RPV/TDF group: 110 participants completing the main study continued in extension phase.|110
210682|NCT01252940|509243|P2|NOT COMPLETED|Main Study Phase||12
210683|NCT01252940|509244|P1|NOT COMPLETED|Main Study Phase||26
210684|NCT01252940|509243|P2|COMPLETED|Main Study Phase|Discontinuations after switch: withdrawal by subject, 2; adverse event, 1; protocol violation, 1.|149
210685|NCT01252940|509244|P1|COMPLETED|Main Study Phase||295
210686|NCT01252940|509243|P2|Completed 24 Weeks|Main Study Phase|152 participants switched regimens at Week 24.|153
210687|NCT01252940|509244|P1|Completed 24 Weeks|Main Study Phase||0
210688|NCT01252940|509243|P2|STARTED|Main Study Phase||161
210689|NCT01252940|509244|P1|STARTED|Main Study Phase||321
210690|NCT01252810|509275|P2|NOT COMPLETED|Overall Study||3
210691|NCT01252810|509276|P1|NOT COMPLETED|Overall Study||14
210692|NCT01252810|509275|P2|COMPLETED|Overall Study||139
210693|NCT01252810|509276|P1|COMPLETED|Overall Study||128
210694|NCT01252810|509275|P2|STARTED|Overall Study||142
210695|NCT01252810|509276|P1|STARTED|Overall Study||142
210696|NCT01252745|509289|P3|NOT COMPLETED|Overall Study||0
210697|NCT01252745|509290|P2|NOT COMPLETED|Overall Study||0
210698|NCT01252745|509291|P1|NOT COMPLETED|Overall Study||0
210699|NCT01252745|509289|P3|COMPLETED|Overall Study||7
210700|NCT01252745|509290|P2|COMPLETED|Overall Study||7
210701|NCT01252745|509291|P1|COMPLETED|Overall Study||8
210702|NCT01252745|509289|P3|STARTED|Overall Study||7
210703|NCT01252745|509290|P2|STARTED|Overall Study||7
210704|NCT01252745|509291|P1|STARTED|Overall Study||8
210705|NCT01252563|509305|P1|NOT COMPLETED|Overall Study||432
210706|NCT01252563|509305|P1|COMPLETED|Overall Study||13343
210707|NCT01252563|509305|P1|STARTED|Overall Study||13775
210708|NCT01252355|509345|P3|NOT COMPLETED|Overall Study||179
210709|NCT01252355|509346|P2|NOT COMPLETED|Overall Study||178
210710|NCT01252355|509347|P1|NOT COMPLETED|Overall Study||177
210711|NCT01252355|509345|P3|COMPLETED|Overall Study||0
210712|NCT01252355|509346|P2|COMPLETED|Overall Study||0
210713|NCT01252355|509347|P1|COMPLETED|Overall Study||0
210714|NCT01252355|509345|P3|Treated|Overall Study|One participant received teriflunomide 7 mg.|179
210715|NCT01252355|509346|P2|Treated|Overall Study||178
210716|NCT01252355|509347|P1|Treated|Overall Study||175
210717|NCT01252355|509345|P3|STARTED|Overall Study|Randomized.|179
210718|NCT01252355|509346|P2|STARTED|Overall Study|Randomized.|178
210719|NCT01252355|509347|P1|STARTED|Overall Study|Randomized.|177
210720|NCT01252290|509385|P1|NOT COMPLETED|Overall Study||1
210721|NCT01252290|509385|P1|COMPLETED|Overall Study||34
210722|NCT01252290|509385|P1|STARTED|Overall Study||35
210723|NCT01252277|509393|P1|NOT COMPLETED|Overall Study||2
210724|NCT01252277|509393|P1|COMPLETED|Overall Study||34
210725|NCT01252277|509393|P1|STARTED|Overall Study||36
210726|NCT01252251|509401|P1|NOT COMPLETED|Overall Study||1
210727|NCT01252251|509401|P1|COMPLETED|Overall Study||13
210728|NCT01252251|509401|P1|STARTED|Overall Study||14
210729|NCT01252238|509413|P3|NOT COMPLETED|Overall Study||4
210730|NCT01252238|509414|P2|NOT COMPLETED|Overall Study||4
210731|NCT01252238|509415|P1|NOT COMPLETED|Overall Study||4
210732|NCT01252238|509413|P3|COMPLETED|Overall Study|sponsor terminated study|4
210733|NCT01252238|509414|P2|COMPLETED|Overall Study|sponsor terminated study|4
210734|NCT01252238|509415|P1|COMPLETED|Overall Study|sponsor terminated study|4
210735|NCT01252238|509413|P3|STARTED|Overall Study||8
210736|NCT01252238|509414|P2|STARTED|Overall Study||8
210737|NCT01252238|509415|P1|STARTED|Overall Study||8
210738|NCT01252186|509432|P3|NOT COMPLETED|Overall Study||34
210739|NCT01252186|509433|P2|NOT COMPLETED|Overall Study||32
210740|NCT01252186|509434|P1|NOT COMPLETED|Overall Study||30
210741|NCT01252186|509432|P3|COMPLETED|Overall Study||53
210742|NCT01252186|509433|P2|COMPLETED|Overall Study||59
210743|NCT01252186|509434|P1|COMPLETED|Overall Study||57
210744|NCT01252186|509432|P3|Received Study Drug|Overall Study||80
210745|NCT01252186|509433|P2|Received Study Drug|Overall Study||89
210746|NCT01252186|509434|P1|Received Study Drug|Overall Study||83
210747|NCT01252186|509432|P3|STARTED|Overall Study||87
210748|NCT01252186|509433|P2|STARTED|Overall Study||91
210749|NCT01252186|509434|P1|STARTED|Overall Study||87
210750|NCT01252147|509502|P1|NOT COMPLETED|Overall Study||0
210751|NCT01252147|509502|P1|COMPLETED|Overall Study||68
210752|NCT01252147|509502|P1|STARTED|Overall Study||68
210753|NCT01252134|509507|P6|NOT COMPLETED|Period 3, 8 Hours||0
210754|NCT01252134|509508|P5|NOT COMPLETED|Period 3, 8 Hours||0
210755|NCT01252134|509509|P4|NOT COMPLETED|Period 3, 8 Hours||0
210756|NCT01252134|509510|P3|NOT COMPLETED|Period 3, 8 Hours||0
210757|NCT01252134|509511|P2|NOT COMPLETED|Period 3, 8 Hours||0
210758|NCT01252134|509512|P1|NOT COMPLETED|Period 3, 8 Hours||0
210759|NCT01252134|509507|P6|COMPLETED|Period 3, 8 Hours||4
210760|NCT01252134|509508|P5|COMPLETED|Period 3, 8 Hours||3
210761|NCT01252134|509509|P4|COMPLETED|Period 3, 8 Hours||5
210762|NCT01252134|509510|P3|COMPLETED|Period 3, 8 Hours||2
210763|NCT01252134|509511|P2|COMPLETED|Period 3, 8 Hours||3
210764|NCT01252134|509512|P1|COMPLETED|Period 3, 8 Hours||3
210765|NCT01252134|509507|P6|STARTED|Period 3, 8 Hours||4
210766|NCT01252134|509508|P5|STARTED|Period 3, 8 Hours||3
210767|NCT01252134|509509|P4|STARTED|Period 3, 8 Hours||5
210768|NCT01252134|509510|P3|STARTED|Period 3, 8 Hours||2
210769|NCT01252134|509511|P2|STARTED|Period 3, 8 Hours||3
210770|NCT01252134|509512|P1|STARTED|Period 3, 8 Hours||3
210771|NCT01252134|509507|P6|NOT COMPLETED|Period 2, 8 Hours||0
210772|NCT01252134|509508|P5|NOT COMPLETED|Period 2, 8 Hours||0
210773|NCT01252134|509509|P4|NOT COMPLETED|Period 2, 8 Hours||0
210774|NCT01252134|509510|P3|NOT COMPLETED|Period 2, 8 Hours||0
210775|NCT01252134|509511|P2|NOT COMPLETED|Period 2, 8 Hours||0
210776|NCT01252134|509512|P1|NOT COMPLETED|Period 2, 8 Hours||0
210777|NCT01252134|509507|P6|COMPLETED|Period 2, 8 Hours||4
210778|NCT01252134|509508|P5|COMPLETED|Period 2, 8 Hours||3
210779|NCT01252134|509509|P4|COMPLETED|Period 2, 8 Hours||5
210780|NCT01252134|509510|P3|COMPLETED|Period 2, 8 Hours||2
210781|NCT01252134|509511|P2|COMPLETED|Period 2, 8 Hours||3
210782|NCT01252134|509512|P1|COMPLETED|Period 2, 8 Hours||3
210783|NCT01252134|509507|P6|STARTED|Period 2, 8 Hours||4
210784|NCT01252134|509508|P5|STARTED|Period 2, 8 Hours||3
210785|NCT01252134|509509|P4|STARTED|Period 2, 8 Hours||5
210786|NCT01252134|509510|P3|STARTED|Period 2, 8 Hours||2
210787|NCT01252134|509511|P2|STARTED|Period 2, 8 Hours||3
210788|NCT01252134|509512|P1|STARTED|Period 2, 8 Hours||3
210789|NCT01252134|509507|P6|NOT COMPLETED|Period 1, 8 Hours||0
210790|NCT01252134|509508|P5|NOT COMPLETED|Period 1, 8 Hours||0
210791|NCT01252134|509509|P4|NOT COMPLETED|Period 1, 8 Hours||0
210792|NCT01252134|509510|P3|NOT COMPLETED|Period 1, 8 Hours||1
210793|NCT01252134|509511|P2|NOT COMPLETED|Period 1, 8 Hours||1
210794|NCT01252134|509512|P1|NOT COMPLETED|Period 1, 8 Hours||0
210795|NCT01252134|509507|P6|COMPLETED|Period 1, 8 Hours||4
210796|NCT01252134|509508|P5|COMPLETED|Period 1, 8 Hours||3
210797|NCT01252134|509509|P4|COMPLETED|Period 1, 8 Hours||5
210798|NCT01252134|509510|P3|COMPLETED|Period 1, 8 Hours||2
210799|NCT01252134|509511|P2|COMPLETED|Period 1, 8 Hours||3
210800|NCT01252134|509512|P1|COMPLETED|Period 1, 8 Hours||3
210801|NCT01252134|509507|P6|STARTED|Period 1, 8 Hours||4
210802|NCT01252134|509508|P5|STARTED|Period 1, 8 Hours||3
210803|NCT01252134|509509|P4|STARTED|Period 1, 8 Hours||5
210804|NCT01252134|509510|P3|STARTED|Period 1, 8 Hours||3
210805|NCT01252134|509511|P2|STARTED|Period 1, 8 Hours||4
210806|NCT01252134|509512|P1|STARTED|Period 1, 8 Hours||3
210807|NCT01252095|509531|P2|NOT COMPLETED|Overall Study||0
210808|NCT01252095|509532|P1|NOT COMPLETED|Overall Study||1
210809|NCT01252095|509531|P2|COMPLETED|Overall Study||1
210810|NCT01252095|509532|P1|COMPLETED|Overall Study||2
210811|NCT01252095|509531|P2|STARTED|Overall Study||1
210812|NCT01252095|509532|P1|STARTED|Overall Study||3
210813|NCT01251978|509540|P2|NOT COMPLETED|Overall Study||0
210814|NCT01251978|509541|P1|NOT COMPLETED|Overall Study||0
210815|NCT01251978|509540|P2|COMPLETED|Overall Study||3
210816|NCT01251978|509541|P1|COMPLETED|Overall Study||5
210817|NCT01251978|509540|P2|STARTED|Overall Study||3
210818|NCT01251978|509541|P1|STARTED|Overall Study||5
210819|NCT01251965|509553|P3|NOT COMPLETED|Overall Study||11
210820|NCT01251965|509554|P2|NOT COMPLETED|Overall Study||2
210821|NCT01251965|509555|P1|NOT COMPLETED|Overall Study||1
210822|NCT01251965|509553|P3|COMPLETED|Overall Study||7
210823|NCT01251965|509554|P2|COMPLETED|Overall Study||3
210824|NCT01251965|509555|P1|COMPLETED|Overall Study||3
210825|NCT01251965|509553|P3|STARTED|Overall Study||18
210826|NCT01251965|509554|P2|STARTED|Overall Study||5
210827|NCT01251965|509555|P1|STARTED|Overall Study||4
210828|NCT01251952|509567|P1|NOT COMPLETED|Overall Study||1
210829|NCT01251952|509567|P1|COMPLETED|Overall Study||1
210830|NCT01251952|509567|P1|STARTED|Overall Study||2
210831|NCT01251770|509573|P2|NOT COMPLETED|Overall Study||7
210832|NCT01251770|509574|P1|NOT COMPLETED|Overall Study||13
210833|NCT01251770|509573|P2|COMPLETED|Overall Study||29
210834|NCT01251770|509574|P1|COMPLETED|Overall Study||29
210835|NCT01251770|509573|P2|STARTED|Overall Study||36
210836|NCT01251770|509574|P1|STARTED|Overall Study||42
210837|NCT01251757|509585|P3|NOT COMPLETED|Overall Study||0
210838|NCT01251757|509586|P2|NOT COMPLETED|Overall Study||0
210839|NCT01251757|509587|P1|NOT COMPLETED|Overall Study||0
210840|NCT01251757|509585|P3|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.5) mos, but we computed an adherence score for everyone.|7250
210841|NCT01251757|509586|P2|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.4) mos, but we computed an adherence score for everyone.|7247
210842|NCT01251757|509587|P1|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.7 (2.3) mos, but we computed an adherence score for everyone.|7255
210843|NCT01251757|509585|P3|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7250
210844|NCT01251757|509586|P2|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7247
210845|NCT01251757|509587|P1|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7255
210846|NCT01251653|509625|P9|NOT COMPLETED|Overall Study||6
210847|NCT01251653|509626|P8|NOT COMPLETED|Overall Study||12
210848|NCT01251653|509627|P7|NOT COMPLETED|Overall Study||18
210849|NCT01251653|509628|P6|NOT COMPLETED|Overall Study||18
210850|NCT01251653|509629|P5|NOT COMPLETED|Overall Study||2
210851|NCT01251653|509630|P4|NOT COMPLETED|Overall Study||6
210852|NCT01251653|509631|P3|NOT COMPLETED|Overall Study||20
210853|NCT01251653|509632|P2|NOT COMPLETED|Overall Study||8
210854|NCT01251653|509633|P1|NOT COMPLETED|Overall Study||3
210855|NCT01251653|509625|P9|COMPLETED|Overall Study||0
210856|NCT01251653|509626|P8|COMPLETED|Overall Study||0
210857|NCT01251653|509627|P7|COMPLETED|Overall Study||0
210858|NCT01251653|509628|P6|COMPLETED|Overall Study||0
210859|NCT01251653|509629|P5|COMPLETED|Overall Study||0
210860|NCT01251653|509630|P4|COMPLETED|Overall Study||0
210861|NCT01251653|509631|P3|COMPLETED|Overall Study||0
210862|NCT01251653|509632|P2|COMPLETED|Overall Study||0
210863|NCT01251653|509633|P1|COMPLETED|Overall Study||0
210864|NCT01251653|509625|P9|STARTED|Overall Study||6
210865|NCT01251653|509626|P8|STARTED|Overall Study||12
210866|NCT01251653|509627|P7|STARTED|Overall Study||18
210867|NCT01251653|509628|P6|STARTED|Overall Study||18
210868|NCT01251653|509629|P5|STARTED|Overall Study||2
210869|NCT01251653|509630|P4|STARTED|Overall Study||6
210870|NCT01251653|509631|P3|STARTED|Overall Study||20
210871|NCT01251653|509632|P2|STARTED|Overall Study||8
210872|NCT01251653|509633|P1|STARTED|Overall Study||3
210873|NCT01251614|509761|P3|NOT COMPLETED|Overall Study||8
210874|NCT01251614|509762|P2|NOT COMPLETED|Overall Study||13
210875|NCT01251614|509763|P1|NOT COMPLETED|Overall Study||3
210876|NCT01251614|509761|P3|COMPLETED|Overall Study||30
210877|NCT01251614|509762|P2|COMPLETED|Overall Study||26
210878|NCT01251614|509763|P1|COMPLETED|Overall Study||34
210879|NCT01251614|509761|P3|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
210880|NCT01251614|509762|P2|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
210881|NCT01251614|509763|P1|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
210882|NCT01251614|509761|P3|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|19
210883|NCT01251614|509762|P2|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|11
210884|NCT01251614|509763|P1|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|8
210885|NCT01251614|509761|P3|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|23
210886|NCT01251614|509762|P2|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|18
210887|NCT01251614|509763|P1|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|13
210888|NCT01251614|509761|P3|STARTED|Overall Study||38
210889|NCT01251614|509762|P2|STARTED|Overall Study||39
210890|NCT01251614|509763|P1|STARTED|Overall Study||37
210891|NCT01251588|509837|P2|NOT COMPLETED|Overall Study||4
210892|NCT01251588|509838|P1|NOT COMPLETED|Overall Study||0
210893|NCT01251588|509837|P2|COMPLETED|Overall Study||59
210894|NCT01251588|509838|P1|COMPLETED|Overall Study||65
210895|NCT01251588|509837|P2|STARTED|Overall Study||63
210896|NCT01251588|509838|P1|STARTED|Overall Study||65
210897|NCT01251536|509873|P3|NOT COMPLETED|Overall Study||0
210898|NCT01251536|509874|P2|NOT COMPLETED|Overall Study||0
210899|NCT01251536|509875|P1|NOT COMPLETED|Overall Study||0
210900|NCT01251536|509873|P3|COMPLETED|Overall Study||7
210901|NCT01251536|509874|P2|COMPLETED|Overall Study||93
210902|NCT01251536|509875|P1|COMPLETED|Overall Study||8
210903|NCT01251536|509873|P3|STARTED|Overall Study||7
210904|NCT01251536|509874|P2|STARTED|Overall Study||93
210905|NCT01251536|509875|P1|STARTED|Overall Study||8
210906|NCT01251380|509945|P1|NOT COMPLETED|Overall Study||22
210907|NCT01251380|509945|P1|COMPLETED|Overall Study||194
210908|NCT01251380|509945|P1|Cycle 4|Overall Study||11
210909|NCT01251380|509945|P1|Cycle 3|Overall Study||86
210910|NCT01251380|509945|P1|Cycle 2|Overall Study||175
210911|NCT01251380|509945|P1|Cycle 1|Overall Study||207
210912|NCT01251380|509945|P1|STARTED|Overall Study|Safety population.|216
210913|NCT01251367|509969|P1|NOT COMPLETED|Overall Study||76
210914|NCT01251367|509969|P1|COMPLETED|Overall Study||269
210915|NCT01251367|509969|P1|Cycle 4|Overall Study||139
210916|NCT01251367|509969|P1|Cycle 3|Overall Study||224
210917|NCT01251367|509969|P1|Cycle 2|Overall Study||297
210918|NCT01251367|509969|P1|Cycle 1|Overall Study||345
210919|NCT01251367|509969|P1|STARTED|Overall Study||345
210920|NCT01251354|510004|P1|NOT COMPLETED|Overall Study||6
210921|NCT01251354|510004|P1|COMPLETED|Overall Study||0
210922|NCT01251354|510004|P1|STARTED|Overall Study||6
210923|NCT01251315|510020|P6|NOT COMPLETED|Overall Study||0
210924|NCT01251315|510021|P5|NOT COMPLETED|Overall Study||0
210925|NCT01251315|510022|P4|NOT COMPLETED|Overall Study||0
210926|NCT01251315|510023|P3|NOT COMPLETED|Overall Study||0
210927|NCT01251315|510024|P2|NOT COMPLETED|Overall Study||0
210928|NCT01251315|510025|P1|NOT COMPLETED|Overall Study||0
210929|NCT01251315|510020|P6|COMPLETED|Overall Study||4
210930|NCT01251315|510021|P5|COMPLETED|Overall Study||4
210931|NCT01251315|510022|P4|COMPLETED|Overall Study||4
210932|NCT01251315|510023|P3|COMPLETED|Overall Study||4
210933|NCT01251315|510024|P2|COMPLETED|Overall Study||4
210934|NCT01251315|510025|P1|COMPLETED|Overall Study||4
210935|NCT01251315|510020|P6|STARTED|Overall Study||4
210936|NCT01251315|510021|P5|STARTED|Overall Study||4
210937|NCT01251315|510022|P4|STARTED|Overall Study||4
210938|NCT01251315|510023|P3|STARTED|Overall Study||4
210939|NCT01251315|510024|P2|STARTED|Overall Study||4
210940|NCT01251315|510025|P1|STARTED|Overall Study||4
210941|NCT01251276|510047|P2|NOT COMPLETED|Overall Study||1
210942|NCT01251276|510048|P1|NOT COMPLETED|Overall Study||1
210943|NCT01251276|510047|P2|COMPLETED|Overall Study||107
210944|NCT01251276|510048|P1|COMPLETED|Overall Study||95
210945|NCT01251276|510047|P2|Vaccinated|Overall Study||108
210946|NCT01251276|510048|P1|Vaccinated|Overall Study||96
210947|NCT01251276|510047|P2|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|108
210948|NCT01251276|510048|P1|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|96
210949|NCT01251146|510066|P2|NOT COMPLETED|Overall Study||10
210950|NCT01251146|510067|P1|NOT COMPLETED|Overall Study||3
210951|NCT01251146|510066|P2|COMPLETED|Overall Study||81
210952|NCT01251146|510067|P1|COMPLETED|Overall Study||83
210953|NCT01251146|510066|P2|STARTED|Overall Study||91
210954|NCT01251146|510067|P1|STARTED|Overall Study||86
210955|NCT01251120|510089|P2|NOT COMPLETED|Overall Study||1
210956|NCT01251120|510090|P1|NOT COMPLETED|Overall Study||0
210957|NCT01251120|510089|P2|COMPLETED|Overall Study||0
210958|NCT01251120|510090|P1|COMPLETED|Overall Study||1
210959|NCT01251120|510089|P2|STARTED|Overall Study||1
210960|NCT01251120|510090|P1|STARTED|Overall Study||1
210961|NCT01251042|510112|P2|NOT COMPLETED|Overall Study||0
210962|NCT01251042|510113|P1|NOT COMPLETED|Overall Study||0
210963|NCT01251042|510112|P2|COMPLETED|Overall Study||23
210964|NCT01251042|510113|P1|COMPLETED|Overall Study||26
210965|NCT01251042|510112|P2|STARTED|Overall Study||23
210966|NCT01251042|510113|P1|STARTED|Overall Study||26
210967|NCT01250990|510145|P2|NOT COMPLETED|Overall Study||2
210968|NCT01250990|510146|P1|NOT COMPLETED|Overall Study||4
210969|NCT01250990|510145|P2|COMPLETED|Overall Study||9
210970|NCT01250990|510146|P1|COMPLETED|Overall Study||7
210971|NCT01250990|510145|P2|STARTED|Overall Study||11
210972|NCT01250990|510146|P1|STARTED|Overall Study||11
210973|NCT01250977|510154|P2|NOT COMPLETED|Overall Study||2
210974|NCT01250977|510155|P1|NOT COMPLETED|Overall Study||0
210975|NCT01250977|510154|P2|COMPLETED|Overall Study||12
210976|NCT01250977|510155|P1|COMPLETED|Overall Study||6
210977|NCT01250977|510154|P2|STARTED|Overall Study||14
210978|NCT01250977|510155|P1|STARTED|Overall Study||6
210979|NCT01250925|510170|P3|NOT COMPLETED|Overall Study||2
210980|NCT01250925|510171|P2|NOT COMPLETED|Overall Study||3
210981|NCT01250925|510172|P1|NOT COMPLETED|Overall Study||5
210982|NCT01250925|510170|P3|COMPLETED|Overall Study||30
210983|NCT01250925|510171|P2|COMPLETED|Overall Study||28
210984|NCT01250925|510172|P1|COMPLETED|Overall Study||26
210985|NCT01250925|510170|P3|STARTED|Overall Study||32
210986|NCT01250925|510171|P2|STARTED|Overall Study||31
210987|NCT01250925|510172|P1|STARTED|Overall Study||31
210988|NCT01250899|510212|P2|NOT COMPLETED|Overall Study||0
210989|NCT01250899|510213|P1|NOT COMPLETED|Overall Study||0
210990|NCT01250899|510212|P2|COMPLETED|Overall Study||82
210991|NCT01250899|510213|P1|COMPLETED|Overall Study||40
210992|NCT01250899|510212|P2|STARTED|Overall Study||82
210993|NCT01250899|510213|P1|STARTED|Overall Study||40
210994|NCT01250873|510217|P1|NOT COMPLETED|Period 3:LY2216684+Sertraline(Days11-13)||1
210995|NCT01250873|510217|P1|COMPLETED|Period 3:LY2216684+Sertraline(Days11-13)||17
210996|NCT01250873|510217|P1|STARTED|Period 3:LY2216684+Sertraline(Days11-13)||18
210997|NCT01250873|510217|P1|NOT COMPLETED|Period 2: Sertraline (Day 4, 5-10)||0
210998|NCT01250873|510217|P1|COMPLETED|Period 2: Sertraline (Day 4, 5-10)||18
210999|NCT01250873|510217|P1|STARTED|Period 2: Sertraline (Day 4, 5-10)||18
211000|NCT01250873|510217|P1|NOT COMPLETED|Period 1: LY2216684 (Days 1-3)||2
211001|NCT01250873|510217|P1|COMPLETED|Period 1: LY2216684 (Days 1-3)||18
211002|NCT01250873|510217|P1|STARTED|Period 1: LY2216684 (Days 1-3)||20
211003|NCT01250834|510228|P1|NOT COMPLETED|Overall Study||0
211004|NCT01250834|510228|P1|COMPLETED|Overall Study||27
211005|NCT01250834|510228|P1|STARTED|Overall Study||27
211006|NCT01250769|510249|P4|NOT COMPLETED|Overall Study||0
211007|NCT01250769|510250|P3|NOT COMPLETED|Overall Study||2
211008|NCT01250769|510251|P2|NOT COMPLETED|Overall Study||1
211009|NCT01250769|510252|P1|NOT COMPLETED|Overall Study||0
211010|NCT01250769|510249|P4|COMPLETED|Overall Study||11
211011|NCT01250769|510250|P3|COMPLETED|Overall Study||73
211012|NCT01250769|510251|P2|COMPLETED|Overall Study||72
211013|NCT01250769|510252|P1|COMPLETED|Overall Study||11
211014|NCT01250769|510249|P4|Day 14|Overall Study||11
211015|NCT01250769|510250|P3|Day 14|Overall Study||74
211016|NCT01250769|510251|P2|Day 14|Overall Study||72
211017|NCT01250769|510252|P1|Day 14|Overall Study||11
211018|NCT01250769|510249|P4|STARTED|Overall Study||11
211019|NCT01250769|510250|P3|STARTED|Overall Study||75
211020|NCT01250769|510251|P2|STARTED|Overall Study||73
211021|NCT01250769|510252|P1|STARTED|Overall Study||11
211022|NCT01250756|510284|P2|NOT COMPLETED|After Toddler Dose||1
211023|NCT01250756|510285|P1|NOT COMPLETED|After Toddler Dose||0
211024|NCT01250756|510284|P2|COMPLETED|After Toddler Dose||147
211025|NCT01250756|510285|P1|COMPLETED|After Toddler Dose||0
211026|NCT01250756|510284|P2|STARTED|After Toddler Dose||148
211027|NCT01250756|510285|P1|STARTED|After Toddler Dose||0
211028|NCT01250756|510284|P2|NOT COMPLETED|Toddler Dose||1
211029|NCT01250756|510285|P1|NOT COMPLETED|Toddler Dose||0
211030|NCT01250756|510284|P2|COMPLETED|Toddler Dose||148
211031|NCT01250756|510285|P1|COMPLETED|Toddler Dose||122
211032|NCT01250756|510284|P2|STARTED|Toddler Dose||149
211033|NCT01250756|510285|P1|STARTED|Toddler Dose||122
211034|NCT01250756|510284|P2|NOT COMPLETED|After Infant Series||4
211035|NCT01250756|510285|P1|NOT COMPLETED|After Infant Series||11
211036|NCT01250756|510284|P2|COMPLETED|After Infant Series||149
211037|NCT01250756|510285|P1|COMPLETED|After Infant Series||122
211038|NCT01250756|510284|P2|STARTED|After Infant Series||153
211039|NCT01250756|510285|P1|STARTED|After Infant Series||133
211040|NCT01250756|510284|P2|NOT COMPLETED|Infant Series||7
211041|NCT01250756|510285|P1|NOT COMPLETED|Infant Series||28
211042|NCT01250756|510284|P2|COMPLETED|Infant Series||153
211043|NCT01250756|510285|P1|COMPLETED|Infant Series||133
211044|NCT01250756|510284|P2|Vaccinated Dose 3|Infant Series||155
211045|NCT01250756|510285|P1|Vaccinated Dose 3|Infant Series||133
211046|NCT01250756|510284|P2|Vaccinated Dose 2|Infant Series||157
211047|NCT01250756|510285|P1|Vaccinated Dose 2|Infant Series||147
211048|NCT01250756|510284|P2|Vaccinated Dose 1|Infant Series||158
211049|NCT01250756|510285|P1|Vaccinated Dose 1|Infant Series||159
211050|NCT01250756|510284|P2|STARTED|Infant Series||160
211051|NCT01250756|510285|P1|STARTED|Infant Series||161
211052|NCT01250730|510338|P3|NOT COMPLETED|Overall Study||0
211053|NCT01250730|510339|P2|NOT COMPLETED|Overall Study||0
211054|NCT01250730|510340|P1|NOT COMPLETED|Overall Study||0
211055|NCT01250730|510338|P3|COMPLETED|Overall Study||6
211056|NCT01250730|510339|P2|COMPLETED|Overall Study||6
211057|NCT01250730|510340|P1|COMPLETED|Overall Study||6
211058|NCT01250730|510338|P3|STARTED|Overall Study||6
211059|NCT01250730|510339|P2|STARTED|Overall Study||6
211060|NCT01250730|510340|P1|STARTED|Overall Study||6
211061|NCT01250717|510396|P1|NOT COMPLETED|Overall Study||0
211062|NCT01250717|510396|P1|COMPLETED|Overall Study||28
211063|NCT01250717|510396|P1|STARTED|Overall Study||28
211064|NCT01250509|510402|P2|NOT COMPLETED|Overall Study||2
211065|NCT01250509|510403|P1|NOT COMPLETED|Overall Study||5
211066|NCT01250509|510402|P2|COMPLETED|Overall Study||21
211067|NCT01250509|510403|P1|COMPLETED|Overall Study||19
211068|NCT01250509|510402|P2|STARTED|Overall Study||23
211069|NCT01250509|510403|P1|STARTED|Overall Study||24
211070|NCT01250418|510417|P2|NOT COMPLETED|Overall Study||1
211071|NCT01250418|510418|P1|NOT COMPLETED|Overall Study||1
211072|NCT01250418|510417|P2|COMPLETED|Overall Study||15
211073|NCT01250418|510418|P1|COMPLETED|Overall Study||8
211074|NCT01250418|510417|P2|STARTED|Overall Study||16
211075|NCT01250418|510418|P1|STARTED|Overall Study||9
211076|NCT01250379|510426|P2|NOT COMPLETED|Overall Study||193
211077|NCT01250379|510427|P1|NOT COMPLETED|Overall Study||202
211078|NCT01250379|510426|P2|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|54
211079|NCT01250379|510427|P1|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|45
211080|NCT01250379|510426|P2|STARTED|Overall Study||247
211081|NCT01250379|510427|P1|STARTED|Overall Study||247
211082|NCT01250210|510488|P3|NOT COMPLETED|Overall Study||8
211083|NCT01250210|510489|P2|NOT COMPLETED|Overall Study||4
211084|NCT01250210|510490|P1|NOT COMPLETED|Overall Study||4
211085|NCT01250210|510488|P3|COMPLETED|Overall Study||25
211086|NCT01250210|510489|P2|COMPLETED|Overall Study||41
211087|NCT01250210|510490|P1|COMPLETED|Overall Study||41
211088|NCT01250210|510488|P3|STARTED|Overall Study||33
211089|NCT01250210|510489|P2|STARTED|Overall Study||45
211090|NCT01250210|510490|P1|STARTED|Overall Study||45
211091|NCT01250184|510504|P3|NOT COMPLETED|Overall Study||0
211092|NCT01250184|510505|P2|NOT COMPLETED|Overall Study||0
211093|NCT01250184|510506|P1|NOT COMPLETED|Overall Study||0
211094|NCT01250184|510504|P3|COMPLETED|Overall Study||43
211095|NCT01250184|510505|P2|COMPLETED|Overall Study||41
211096|NCT01250184|510506|P1|COMPLETED|Overall Study||43
211097|NCT01250184|510504|P3|STARTED|Overall Study||43
211098|NCT01250184|510505|P2|STARTED|Overall Study||41
211099|NCT01250184|510506|P1|STARTED|Overall Study||43
211100|NCT01250171|510532|P3|NOT COMPLETED|Overall Study||0
211101|NCT01250171|510533|P2|NOT COMPLETED|Overall Study||0
211102|NCT01250171|510534|P1|NOT COMPLETED|Overall Study||1
211103|NCT01250171|510532|P3|COMPLETED|Overall Study||24
211104|NCT01250171|510533|P2|COMPLETED|Overall Study||22
211105|NCT01250171|510534|P1|COMPLETED|Overall Study||25
211106|NCT01250171|510532|P3|STARTED|Overall Study||24
211107|NCT01250171|510533|P2|STARTED|Overall Study||22
211108|NCT01250171|510534|P1|STARTED|Overall Study||26
211109|NCT01250145|510565|P2|NOT COMPLETED|Overall Study||5
211110|NCT01250145|510566|P1|NOT COMPLETED|Overall Study||2
211111|NCT01250145|510565|P2|COMPLETED|Overall Study||205
211112|NCT01250145|510566|P1|COMPLETED|Overall Study||39
211113|NCT01250145|510565|P2|STARTED|Overall Study||210
211114|NCT01250145|510566|P1|STARTED|Overall Study||41
211115|NCT01250119|510586|P2|NOT COMPLETED|Treatment Phase||41
211116|NCT01250119|510587|P1|NOT COMPLETED|Treatment Phase||0
211117|NCT01250119|510586|P2|COMPLETED|Treatment Phase||0
211118|NCT01250119|510587|P1|COMPLETED|Treatment Phase||0
211119|NCT01250119|510586|P2|STARTED|Treatment Phase|Out of 52 participants with positive EGFR mutation test result, only 41 participants were treated.|41
211120|NCT01250119|510587|P1|STARTED|Treatment Phase||0
211121|NCT01250119|510586|P2|NOT COMPLETED|Diagnostic Phase||0
211122|NCT01250119|510587|P1|NOT COMPLETED|Diagnostic Phase||113
211123|NCT01250119|510586|P2|COMPLETED|Diagnostic Phase||0
211124|NCT01250119|510587|P1|COMPLETED|Diagnostic Phase|Completed refers to participants with both positive and negative EGFR mutation test result.|575
211125|NCT01250119|510586|P2|STARTED|Diagnostic Phase||0
211126|NCT01250119|510587|P1|STARTED|Diagnostic Phase||688
211127|NCT01250054|510602|P2|NOT COMPLETED|Period 2, One Week of Wear||0
211128|NCT01250054|510603|P1|NOT COMPLETED|Period 2, One Week of Wear||1
211129|NCT01250054|510602|P2|COMPLETED|Period 2, One Week of Wear||8
211130|NCT01250054|510603|P1|COMPLETED|Period 2, One Week of Wear||6
211131|NCT01250054|510602|P2|STARTED|Period 2, One Week of Wear||8
211132|NCT01250054|510603|P1|STARTED|Period 2, One Week of Wear||7
211133|NCT01250054|510602|P2|NOT COMPLETED|Period 1, One Week of Wear||0
211134|NCT01250054|510603|P1|NOT COMPLETED|Period 1, One Week of Wear||0
211135|NCT01250054|510602|P2|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to noncompliance.|8
211136|NCT01250054|510603|P1|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to power availability.|8
211137|NCT01250054|510602|P2|STARTED|Period 1, One Week of Wear|One subject did not wear Period 1 lenses due to power availability and proceeded to Period 2 lenses.|8
211138|NCT01250054|510603|P1|STARTED|Period 1, One Week of Wear||8
211139|NCT01250002|510611|P2|NOT COMPLETED|Overall Study||3
211140|NCT01250002|510612|P1|NOT COMPLETED|Overall Study||4
211141|NCT01250002|510611|P2|COMPLETED|Overall Study||32
211142|NCT01250002|510612|P1|COMPLETED|Overall Study||31
211143|NCT01250002|510611|P2|STARTED|Overall Study||35
211144|NCT01250002|510612|P1|STARTED|Overall Study||35
211145|NCT01249872|510626|P6|NOT COMPLETED|Overall Study||0
211146|NCT01249872|510627|P5|NOT COMPLETED|Overall Study||0
211147|NCT01249872|510628|P4|NOT COMPLETED|Overall Study||0
211148|NCT01249872|510629|P3|NOT COMPLETED|Overall Study||0
211149|NCT01249872|510630|P2|NOT COMPLETED|Overall Study||0
211150|NCT01249872|510631|P1|NOT COMPLETED|Overall Study||0
211151|NCT01249872|510626|P6|COMPLETED|Overall Study||16
211152|NCT01249872|510627|P5|COMPLETED|Overall Study||16
211153|NCT01249872|510628|P4|COMPLETED|Overall Study||16
211154|NCT01249872|510629|P3|COMPLETED|Overall Study||16
211155|NCT01249872|510630|P2|COMPLETED|Overall Study||16
211156|NCT01249872|510631|P1|COMPLETED|Overall Study||16
211157|NCT01249872|510626|P6|STARTED|Overall Study||16
211158|NCT01249872|510627|P5|STARTED|Overall Study||16
211159|NCT01249872|510628|P4|STARTED|Overall Study||16
211160|NCT01249872|510629|P3|STARTED|Overall Study||16
211161|NCT01249872|510630|P2|STARTED|Overall Study||16
211162|NCT01249872|510631|P1|STARTED|Overall Study||16
211163|NCT01249833|510677|P2|NOT COMPLETED|Overall Study||1
211164|NCT01249833|510678|P1|NOT COMPLETED|Overall Study||0
211165|NCT01249833|510677|P2|COMPLETED|Overall Study||62
211166|NCT01249833|510678|P1|COMPLETED|Overall Study||59
211167|NCT01249833|510677|P2|STARTED|Overall Study||63
211168|NCT01249833|510678|P1|STARTED|Overall Study||59
211169|NCT01249664|510692|P2|NOT COMPLETED|Overall Study||0
211170|NCT01249664|510693|P1|NOT COMPLETED|Overall Study||6
211171|NCT01249664|510692|P2|COMPLETED|Overall Study|Completers of study visits up to week 48|31
211172|NCT01249664|510693|P1|COMPLETED|Overall Study|Completers of study visits up to week 48|85
211173|NCT01249664|510692|P2|Completed 48 Weeks Treatment|Overall Study||24
211174|NCT01249664|510693|P1|Completed 48 Weeks Treatment|Overall Study||78
211175|NCT01249664|510692|P2|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|25
211176|NCT01249664|510693|P1|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|83
211177|NCT01249664|510692|P2|Fulfilled Requirements of FAS Population|Overall Study|FAS population: Basis of efficacy evaluation|31
211178|NCT01249664|510693|P1|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) population: Basis of efficacy evaluation|90
211179|NCT01249664|510692|P2|Participants Received Treatment|Overall Study|Safety population|31
211180|NCT01249664|510693|P1|Participants Received Treatment|Overall Study|Safety population|91
211181|NCT01249664|510692|P2|STARTED|Overall Study||31
211182|NCT01249664|510693|P1|STARTED|Overall Study||91
211183|NCT01249651|510743|P1|NOT COMPLETED|Overall Study||7
211184|NCT01249651|510743|P1|COMPLETED|Overall Study|Completed the 8-week treatment period|94
211185|NCT01249651|510743|P1|STARTED|Overall Study|Enrolled|101
211186|NCT01249625|510752|P2|NOT COMPLETED|Overall Study||0
211187|NCT01249625|510753|P1|NOT COMPLETED|Overall Study||0
211188|NCT01249625|510752|P2|COMPLETED|Overall Study||1488
211189|NCT01249625|510753|P1|COMPLETED|Overall Study||1374
211190|NCT01249625|510752|P2|STARTED|Overall Study||1488
211191|NCT01249625|510753|P1|STARTED|Overall Study||1374
211192|NCT01249417|510772|P3|NOT COMPLETED|Treatment Phase - ITT Population||4
211193|NCT01249417|510773|P2|NOT COMPLETED|Treatment Phase - ITT Population||4
211194|NCT01249417|510774|P1|NOT COMPLETED|Treatment Phase - ITT Population||1
211195|NCT01249417|510772|P3|COMPLETED|Treatment Phase - ITT Population||73
211196|NCT01249417|510773|P2|COMPLETED|Treatment Phase - ITT Population||75
211197|NCT01249417|510774|P1|COMPLETED|Treatment Phase - ITT Population||78
211198|NCT01249417|510772|P3|STARTED|Treatment Phase - ITT Population||77
211199|NCT01249417|510773|P2|STARTED|Treatment Phase - ITT Population||79
211200|NCT01249417|510774|P1|STARTED|Treatment Phase - ITT Population||79
211201|NCT01249417|510772|P3|NOT COMPLETED|Randomised Population||4
211202|NCT01249417|510773|P2|NOT COMPLETED|Randomised Population||1
211203|NCT01249417|510774|P1|NOT COMPLETED|Randomised Population||1
211204|NCT01249417|510772|P3|COMPLETED|Randomised Population||77
211205|NCT01249417|510773|P2|COMPLETED|Randomised Population||79
211206|NCT01249417|510774|P1|COMPLETED|Randomised Population||79
211207|NCT01249417|510772|P3|Treated|Randomised Population||79
211208|NCT01249417|510773|P2|Treated|Randomised Population||80
211209|NCT01249417|510774|P1|Treated|Randomised Population||80
211210|NCT01249417|510772|P3|STARTED|Randomised Population||81
211211|NCT01249417|510773|P2|STARTED|Randomised Population||80
211212|NCT01249417|510774|P1|STARTED|Randomised Population||80
211213|NCT01249404|510791|P3|NOT COMPLETED|Overall Study||7
211214|NCT01249404|510792|P2|NOT COMPLETED|Overall Study||8
211215|NCT01249404|510793|P1|NOT COMPLETED|Overall Study||7
211216|NCT01249404|510791|P3|COMPLETED|Overall Study||125
211217|NCT01249404|510792|P2|COMPLETED|Overall Study||121
211218|NCT01249404|510793|P1|COMPLETED|Overall Study||120
211219|NCT01249404|510791|P3|STARTED|Overall Study||132
211220|NCT01249404|510792|P2|STARTED|Overall Study||129
211221|NCT01249404|510793|P1|STARTED|Overall Study||127
211222|NCT01249365|510870|P1|NOT COMPLETED|Overall Study||1
211223|NCT01249365|510870|P1|COMPLETED|Overall Study||198
211224|NCT01249365|510870|P1|STARTED|Overall Study||199
211225|NCT01249274|510878|P2|NOT COMPLETED|Overall Study||6
211226|NCT01249274|510879|P1|NOT COMPLETED|Overall Study||4
211227|NCT01249274|510878|P2|COMPLETED|Overall Study||19
211228|NCT01249274|510879|P1|COMPLETED|Overall Study||21
211229|NCT01249274|510878|P2|Completed Post Trial Visit But Not tx|Overall Study||2
211230|NCT01249274|510879|P1|Completed Post Trial Visit But Not tx|Overall Study||1
211231|NCT01249274|510878|P2|Completed Treatment & Post Trial Visit|Overall Study||17
211232|NCT01249274|510879|P1|Completed Treatment & Post Trial Visit|Overall Study||20
211233|NCT01249274|510878|P2|Completed Treatment|Overall Study||19
211234|NCT01249274|510879|P1|Completed Treatment|Overall Study||21
211235|NCT01249274|510878|P2|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
211236|NCT01249274|510879|P1|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
211237|NCT01249261|510905|P2|NOT COMPLETED|Overall Study||0
211238|NCT01249261|510906|P1|NOT COMPLETED|Overall Study||1
211239|NCT01249261|510905|P2|COMPLETED|Overall Study||31
211240|NCT01249261|510906|P1|COMPLETED|Overall Study||29
211241|NCT01249261|510905|P2|STARTED|Overall Study||31
211242|NCT01249261|510906|P1|STARTED|Overall Study||30
211243|NCT01249157|510934|P1|NOT COMPLETED|Overall Study||1
211244|NCT01249157|510934|P1|COMPLETED|Overall Study|No data displayed because Outcome Measure has zero total participants analyzed.|0
211245|NCT01249157|510934|P1|STARTED|Overall Study||1
211246|NCT01249131|510938|P6|NOT COMPLETED|Third Intervention||0
211247|NCT01249131|510939|P5|NOT COMPLETED|Third Intervention||0
211248|NCT01249131|510940|P4|NOT COMPLETED|Third Intervention||0
211249|NCT01249131|510941|P3|NOT COMPLETED|Third Intervention||0
211250|NCT01249131|510942|P2|NOT COMPLETED|Third Intervention||0
211251|NCT01249131|510943|P1|NOT COMPLETED|Third Intervention||0
211252|NCT01249131|510938|P6|COMPLETED|Third Intervention||4
211253|NCT01249131|510939|P5|COMPLETED|Third Intervention||2
211254|NCT01249131|510940|P4|COMPLETED|Third Intervention||3
211255|NCT01249131|510941|P3|COMPLETED|Third Intervention||4
211256|NCT01249131|510942|P2|COMPLETED|Third Intervention||3
211257|NCT01249131|510943|P1|COMPLETED|Third Intervention||3
211258|NCT01249131|510938|P6|STARTED|Third Intervention||4
211259|NCT01249131|510939|P5|STARTED|Third Intervention||2
211260|NCT01249131|510940|P4|STARTED|Third Intervention||3
211261|NCT01249131|510941|P3|STARTED|Third Intervention||4
211262|NCT01249131|510942|P2|STARTED|Third Intervention||3
211263|NCT01249131|510943|P1|STARTED|Third Intervention||3
211264|NCT01249131|510938|P6|NOT COMPLETED|Washout Period of 10 Days||0
211265|NCT01249131|510939|P5|NOT COMPLETED|Washout Period of 10 Days||0
211266|NCT01249131|510940|P4|NOT COMPLETED|Washout Period of 10 Days||0
211267|NCT01249131|510941|P3|NOT COMPLETED|Washout Period of 10 Days||0
211268|NCT01249131|510942|P2|NOT COMPLETED|Washout Period of 10 Days||0
211269|NCT01249131|510943|P1|NOT COMPLETED|Washout Period of 10 Days||0
211270|NCT01249131|510938|P6|COMPLETED|Washout Period of 10 Days||4
211271|NCT01249131|510939|P5|COMPLETED|Washout Period of 10 Days||2
211272|NCT01249131|510940|P4|COMPLETED|Washout Period of 10 Days||3
211273|NCT01249131|510941|P3|COMPLETED|Washout Period of 10 Days||4
211274|NCT01249131|510942|P2|COMPLETED|Washout Period of 10 Days||3
211275|NCT01249131|510943|P1|COMPLETED|Washout Period of 10 Days||3
211276|NCT01249131|510938|P6|STARTED|Washout Period of 10 Days||4
211277|NCT01249131|510939|P5|STARTED|Washout Period of 10 Days||2
211278|NCT01249131|510940|P4|STARTED|Washout Period of 10 Days||3
211279|NCT01249131|510941|P3|STARTED|Washout Period of 10 Days||4
211280|NCT01249131|510942|P2|STARTED|Washout Period of 10 Days||3
211281|NCT01249131|510943|P1|STARTED|Washout Period of 10 Days||3
211282|NCT01249131|510938|P6|NOT COMPLETED|Second Intervention||0
211283|NCT01249131|510939|P5|NOT COMPLETED|Second Intervention||0
211284|NCT01249131|510940|P4|NOT COMPLETED|Second Intervention||0
211285|NCT01249131|510941|P3|NOT COMPLETED|Second Intervention||0
211286|NCT01249131|510942|P2|NOT COMPLETED|Second Intervention||0
211287|NCT01249131|510943|P1|NOT COMPLETED|Second Intervention||0
211288|NCT01249131|510938|P6|COMPLETED|Second Intervention||4
211289|NCT01249131|510939|P5|COMPLETED|Second Intervention||2
211290|NCT01249131|510940|P4|COMPLETED|Second Intervention||3
211291|NCT01249131|510941|P3|COMPLETED|Second Intervention||4
211292|NCT01249131|510942|P2|COMPLETED|Second Intervention||3
211293|NCT01249131|510943|P1|COMPLETED|Second Intervention||3
211294|NCT01249131|510938|P6|STARTED|Second Intervention||4
211295|NCT01249131|510939|P5|STARTED|Second Intervention||2
211296|NCT01249131|510940|P4|STARTED|Second Intervention||3
211297|NCT01249131|510941|P3|STARTED|Second Intervention||4
211298|NCT01249131|510942|P2|STARTED|Second Intervention||3
211299|NCT01249131|510943|P1|STARTED|Second Intervention||3
211300|NCT01249131|510938|P6|NOT COMPLETED|Washout Period of 10 Days||0
211301|NCT01249131|510939|P5|NOT COMPLETED|Washout Period of 10 Days||1
211302|NCT01249131|510940|P4|NOT COMPLETED|Washout Period of 10 Days||0
211303|NCT01249131|510941|P3|NOT COMPLETED|Washout Period of 10 Days||0
211304|NCT01249131|510942|P2|NOT COMPLETED|Washout Period of 10 Days||0
211305|NCT01249131|510943|P1|NOT COMPLETED|Washout Period of 10 Days||0
211306|NCT01249131|510938|P6|COMPLETED|Washout Period of 10 Days||4
211307|NCT01249131|510939|P5|COMPLETED|Washout Period of 10 Days||2
211308|NCT01249131|510940|P4|COMPLETED|Washout Period of 10 Days||3
211309|NCT01249131|510941|P3|COMPLETED|Washout Period of 10 Days||4
211310|NCT01249131|510942|P2|COMPLETED|Washout Period of 10 Days||3
211311|NCT01249131|510943|P1|COMPLETED|Washout Period of 10 Days||3
211312|NCT01249131|510938|P6|STARTED|Washout Period of 10 Days||4
211313|NCT01249131|510939|P5|STARTED|Washout Period of 10 Days||3
211314|NCT01249131|510940|P4|STARTED|Washout Period of 10 Days||3
211315|NCT01249131|510941|P3|STARTED|Washout Period of 10 Days||4
211316|NCT01249131|510942|P2|STARTED|Washout Period of 10 Days||3
211317|NCT01249131|510943|P1|STARTED|Washout Period of 10 Days||3
211318|NCT01249131|510938|P6|NOT COMPLETED|First Intervention||0
211319|NCT01249131|510939|P5|NOT COMPLETED|First Intervention||0
211320|NCT01249131|510940|P4|NOT COMPLETED|First Intervention||0
211321|NCT01249131|510941|P3|NOT COMPLETED|First Intervention||0
211322|NCT01249131|510942|P2|NOT COMPLETED|First Intervention||0
211323|NCT01249131|510943|P1|NOT COMPLETED|First Intervention||0
211324|NCT01249131|510938|P6|COMPLETED|First Intervention||4
211325|NCT01249131|510939|P5|COMPLETED|First Intervention||3
211326|NCT01249131|510940|P4|COMPLETED|First Intervention||3
211327|NCT01249131|510941|P3|COMPLETED|First Intervention||4
211328|NCT01249131|510942|P2|COMPLETED|First Intervention||3
211329|NCT01249131|510943|P1|COMPLETED|First Intervention||3
211330|NCT01249131|510938|P6|STARTED|First Intervention||4
211331|NCT01249131|510939|P5|STARTED|First Intervention||3
211332|NCT01249131|510940|P4|STARTED|First Intervention||3
211333|NCT01249131|510941|P3|STARTED|First Intervention||4
211334|NCT01249131|510942|P2|STARTED|First Intervention||3
211335|NCT01249131|510943|P1|STARTED|First Intervention||3
211336|NCT01249118|510963|P3|NOT COMPLETED|Second Washout Period||0
211337|NCT01249118|510964|P2|NOT COMPLETED|Second Washout Period||0
211338|NCT01249118|510965|P1|NOT COMPLETED|Second Washout Period||0
211339|NCT01249118|510963|P3|COMPLETED|Second Washout Period||5
211340|NCT01249118|510964|P2|COMPLETED|Second Washout Period||5
211341|NCT01249118|510965|P1|COMPLETED|Second Washout Period||2
211342|NCT01249118|510963|P3|STARTED|Second Washout Period||5
211343|NCT01249118|510964|P2|STARTED|Second Washout Period||5
211344|NCT01249118|510965|P1|STARTED|Second Washout Period||2
211345|NCT01249118|510963|P3|NOT COMPLETED|Second Intervention Period||0
211346|NCT01249118|510964|P2|NOT COMPLETED|Second Intervention Period||0
211347|NCT01249118|510965|P1|NOT COMPLETED|Second Intervention Period||0
211348|NCT01249118|510963|P3|COMPLETED|Second Intervention Period||5
211349|NCT01249118|510964|P2|COMPLETED|Second Intervention Period||5
211350|NCT01249118|510965|P1|COMPLETED|Second Intervention Period||2
211351|NCT01249118|510963|P3|STARTED|Second Intervention Period||5
211352|NCT01249118|510964|P2|STARTED|Second Intervention Period||5
211353|NCT01249118|510965|P1|STARTED|Second Intervention Period||2
211354|NCT01249118|510963|P3|NOT COMPLETED|First Washout Period||0
211355|NCT01249118|510964|P2|NOT COMPLETED|First Washout Period||1
211356|NCT01249118|510965|P1|NOT COMPLETED|First Washout Period||0
211357|NCT01249118|510963|P3|COMPLETED|First Washout Period||5
211358|NCT01249118|510964|P2|COMPLETED|First Washout Period||5
211359|NCT01249118|510965|P1|COMPLETED|First Washout Period||2
211360|NCT01249118|510963|P3|STARTED|First Washout Period||5
211361|NCT01249118|510964|P2|STARTED|First Washout Period||6
211362|NCT01249118|510965|P1|STARTED|First Washout Period||2
211363|NCT01249118|510963|P3|NOT COMPLETED|First Intervention Period||0
211364|NCT01249118|510964|P2|NOT COMPLETED|First Intervention Period||0
211365|NCT01249118|510965|P1|NOT COMPLETED|First Intervention Period||0
211366|NCT01249118|510963|P3|COMPLETED|First Intervention Period||5
211367|NCT01249118|510964|P2|COMPLETED|First Intervention Period||6
211368|NCT01249118|510965|P1|COMPLETED|First Intervention Period||2
211369|NCT01249118|510963|P3|STARTED|First Intervention Period||5
211370|NCT01249118|510964|P2|STARTED|First Intervention Period||6
211371|NCT01249118|510965|P1|STARTED|First Intervention Period||2
211372|NCT01249092|510999|P1|NOT COMPLETED|Overall Study||2
211373|NCT01249092|510999|P1|COMPLETED|Overall Study||18
211374|NCT01249092|510999|P1|STARTED|Overall Study||20
211375|NCT01249027|511005|P1|NOT COMPLETED|5 Years Clinical Follow up||68
211376|NCT01249027|511005|P1|COMPLETED|5 Years Clinical Follow up||2142
211377|NCT01249027|511005|P1|STARTED|5 Years Clinical Follow up||2210
211378|NCT01249027|511005|P1|NOT COMPLETED|4 Years Clinical Follow up||13
211379|NCT01249027|511005|P1|COMPLETED|4 Years Clinical Follow up||2210
211380|NCT01249027|511005|P1|STARTED|4 Years Clinical Follow up||2223
211381|NCT01249027|511005|P1|NOT COMPLETED|3 Years Clinical Follow up||31
211382|NCT01249027|511005|P1|COMPLETED|3 Years Clinical Follow up||2223
211383|NCT01249027|511005|P1|STARTED|3 Years Clinical Follow up||2254
211384|NCT01249027|511005|P1|NOT COMPLETED|2 Years Clinical Follow up||137
211385|NCT01249027|511005|P1|COMPLETED|2 Years Clinical Follow up||2254
211386|NCT01249027|511005|P1|STARTED|2 Years Clinical Follow up||2391
211387|NCT01249027|511005|P1|NOT COMPLETED|1 Year Clinical Follow up||91
211388|NCT01249027|511005|P1|COMPLETED|1 Year Clinical Follow up||2391
211389|NCT01249027|511005|P1|STARTED|1 Year Clinical Follow up||2482
211390|NCT01248962|511076|P2|NOT COMPLETED|Overall Study||16
211391|NCT01248962|511077|P1|NOT COMPLETED|Overall Study||16
211392|NCT01248962|511076|P2|COMPLETED|Overall Study||56
211393|NCT01248962|511077|P1|COMPLETED|Overall Study||58
211394|NCT01248962|511076|P2|STARTED|Overall Study||72
211395|NCT01248962|511077|P1|STARTED|Overall Study||74
211396|NCT01248949|511093|P5|NOT COMPLETED|Overall Study||4
211397|NCT01248949|511094|P4|NOT COMPLETED|Overall Study||10
211398|NCT01248949|511095|P3|NOT COMPLETED|Overall Study||37
211399|NCT01248949|511096|P2|NOT COMPLETED|Overall Study||13
211400|NCT01248949|511097|P1|NOT COMPLETED|Overall Study||33
211401|NCT01248949|511093|P5|COMPLETED|Overall Study||3
211402|NCT01248949|511094|P4|COMPLETED|Overall Study||3
211403|NCT01248949|511095|P3|COMPLETED|Overall Study||1
211404|NCT01248949|511096|P2|COMPLETED|Overall Study||3
211405|NCT01248949|511097|P1|COMPLETED|Overall Study||9
211406|NCT01248949|511093|P5|STARTED|Overall Study||7
211407|NCT01248949|511094|P4|STARTED|Overall Study||13
211408|NCT01248949|511095|P3|STARTED|Overall Study||38
211409|NCT01248949|511096|P2|STARTED|Overall Study||16
211410|NCT01248949|511097|P1|STARTED|Overall Study||42
211411|NCT01248936|511209|P1|NOT COMPLETED|Overall Study||374
211412|NCT01248936|511209|P1|COMPLETED|Overall Study||0
211413|NCT01248936|511209|P1|STARTED|Overall Study||374
211414|NCT01248884|511222|P3|NOT COMPLETED|Overall Study||1
211415|NCT01248884|511223|P2|NOT COMPLETED|Overall Study||3
211416|NCT01248884|511224|P1|NOT COMPLETED|Overall Study||2
211417|NCT01248884|511222|P3|COMPLETED|Overall Study||238
211418|NCT01248884|511223|P2|COMPLETED|Overall Study||239
211419|NCT01248884|511224|P1|COMPLETED|Overall Study||238
211420|NCT01248884|511222|P3|STARTED|Overall Study||239
211421|NCT01248884|511223|P2|STARTED|Overall Study||242
211422|NCT01248884|511224|P1|STARTED|Overall Study||240
211423|NCT01248793|511282|P2|NOT COMPLETED|Overall Study||6
211424|NCT01248793|511283|P1|NOT COMPLETED|Overall Study||4
211425|NCT01248793|511282|P2|COMPLETED|Overall Study||102
211426|NCT01248793|511283|P1|COMPLETED|Overall Study||101
211427|NCT01248793|511282|P2|STARTED|Overall Study||108
211428|NCT01248793|511283|P1|STARTED|Overall Study||105
211429|NCT01248780|511297|P2|NOT COMPLETED|Overall Study||15
211430|NCT01248780|511298|P1|NOT COMPLETED|Overall Study||9
211431|NCT01248780|511297|P2|COMPLETED|Overall Study||117
211432|NCT01248780|511298|P1|COMPLETED|Overall Study||123
211433|NCT01248780|511297|P2|STARTED|Overall Study||132
211434|NCT01248780|511298|P1|STARTED|Overall Study||132
211435|NCT01248728|511312|P2|NOT COMPLETED|Overall Study||2
211436|NCT01248728|511313|P1|NOT COMPLETED|Overall Study||4
211437|NCT01248728|511312|P2|COMPLETED|Overall Study||17
211438|NCT01248728|511313|P1|COMPLETED|Overall Study||15
211439|NCT01248728|511312|P2|STARTED|Overall Study||19
211440|NCT01248728|511313|P1|STARTED|Overall Study||19
211441|NCT01248715|511329|P2|NOT COMPLETED|Overall Study||510
211442|NCT01248715|511330|P1|NOT COMPLETED|Overall Study||501
211443|NCT01248715|511329|P2|COMPLETED|Overall Study||41
211444|NCT01248715|511330|P1|COMPLETED|Overall Study||55
211445|NCT01248715|511329|P2|STARTED|Overall Study||551
211446|NCT01248715|511330|P1|STARTED|Overall Study||556
211447|NCT01248468|511351|P3|NOT COMPLETED|Overall Study||4
211448|NCT01248468|511352|P2|NOT COMPLETED|Overall Study||14
211449|NCT01248468|511353|P1|NOT COMPLETED|Overall Study||15
211450|NCT01248468|511351|P3|COMPLETED|Overall Study||145
211451|NCT01248468|511352|P2|COMPLETED|Overall Study||290
211452|NCT01248468|511353|P1|COMPLETED|Overall Study||284
211453|NCT01248468|511351|P3|ITT Population|Overall Study||125
211454|NCT01248468|511352|P2|ITT Population|Overall Study||261
211455|NCT01248468|511353|P1|ITT Population|Overall Study||256
211456|NCT01248468|511351|P3|Safety Population|Overall Study||133
211457|NCT01248468|511352|P2|Safety Population|Overall Study||271
211458|NCT01248468|511353|P1|Safety Population|Overall Study||266
211459|NCT01248468|511351|P3|STARTED|Overall Study||149
211460|NCT01248468|511352|P2|STARTED|Overall Study||304
211461|NCT01248468|511353|P1|STARTED|Overall Study||299
211462|NCT01248455|511370|P1|NOT COMPLETED|Overall Study||1
211463|NCT01248455|511370|P1|COMPLETED|Overall Study||8
211464|NCT01248455|511370|P1|STARTED|Overall Study||9
211465|NCT01248416|511378|P3|NOT COMPLETED|Overall Study||1
211466|NCT01248416|511379|P2|NOT COMPLETED|Overall Study||0
211467|NCT01248416|511380|P1|NOT COMPLETED|Overall Study||4
211468|NCT01248416|511378|P3|COMPLETED|Overall Study||25
211469|NCT01248416|511379|P2|COMPLETED|Overall Study||25
211470|NCT01248416|511380|P1|COMPLETED|Overall Study||21
211471|NCT01248416|511378|P3|STARTED|Overall Study||26
211472|NCT01248416|511379|P2|STARTED|Overall Study||25
211473|NCT01248416|511380|P1|STARTED|Overall Study||25
211474|NCT01248364|511415|P4|NOT COMPLETED|Overall Study||0
211475|NCT01248364|511416|P3|NOT COMPLETED|Overall Study||0
211476|NCT01248364|511417|P2|NOT COMPLETED|Overall Study||1
211477|NCT01248364|511418|P1|NOT COMPLETED|Overall Study||0
211478|NCT01248364|511415|P4|COMPLETED|Overall Study||12
211479|NCT01248364|511416|P3|COMPLETED|Overall Study||13
211480|NCT01248364|511417|P2|COMPLETED|Overall Study||33
211481|NCT01248364|511418|P1|COMPLETED|Overall Study||32
211482|NCT01248364|511415|P4|Completed Chronic Phase:28-day Treatment|Overall Study||0
211483|NCT01248364|511416|P3|Completed Chronic Phase:28-day Treatment|Overall Study||13
211484|NCT01248364|511417|P2|Completed Chronic Phase:28-day Treatment|Overall Study||33
211485|NCT01248364|511418|P1|Completed Chronic Phase:28-day Treatment|Overall Study||32
211486|NCT01248364|511415|P4|Completed Acute Phase:Single Dose, Day 1|Overall Study||12
211487|NCT01248364|511416|P3|Completed Acute Phase:Single Dose, Day 1|Overall Study||13
211488|NCT01248364|511417|P2|Completed Acute Phase:Single Dose, Day 1|Overall Study||34
211489|NCT01248364|511418|P1|Completed Acute Phase:Single Dose, Day 1|Overall Study||32
211490|NCT01248364|511415|P4|STARTED|Overall Study||12
211491|NCT01248364|511416|P3|STARTED|Overall Study||13
211492|NCT01248364|511417|P2|STARTED|Overall Study||34
211493|NCT01248364|511418|P1|STARTED|Overall Study||32
211494|NCT01248221|511466|P2|NOT COMPLETED|Overall Study||0
211495|NCT01248221|511467|P1|NOT COMPLETED|Overall Study||0
211496|NCT01248221|511466|P2|COMPLETED|Overall Study||15
211497|NCT01248221|511467|P1|COMPLETED|Overall Study||15
211498|NCT01248221|511466|P2|STARTED|Overall Study||15
211499|NCT01248221|511467|P1|STARTED|Overall Study||15
211500|NCT01248130|511481|P2|NOT COMPLETED|Overall Study||0
211501|NCT01248130|511482|P1|NOT COMPLETED|Overall Study||2
211502|NCT01248130|511481|P2|COMPLETED|Overall Study||4
211503|NCT01248130|511482|P1|COMPLETED|Overall Study||1
211504|NCT01248130|511481|P2|STARTED|Overall Study||4
211505|NCT01248130|511482|P1|STARTED|Overall Study||3
211506|NCT01248065|511492|P2|NOT COMPLETED|Overall Study||22
211507|NCT01248065|511493|P1|NOT COMPLETED|Overall Study||26
211508|NCT01248065|511492|P2|COMPLETED|Overall Study|All 201 participants were included in the primary time-to-event analysis.|179
211509|NCT01248065|511493|P1|COMPLETED|Overall Study|All 207 participants were included in the primary time-to-event analysis.|181
211510|NCT01248065|511492|P2|STARTED|Overall Study||201
211511|NCT01248065|511493|P1|STARTED|Overall Study||207
211512|NCT01248013|511503|P1|NOT COMPLETED|Overall Study||14
211513|NCT01248013|511503|P1|COMPLETED|Overall Study||75
211514|NCT01248013|511503|P1|Irritable Bowel Syndrome Hypnotherapy|Overall Study||75
211515|NCT01248013|511503|P1|STARTED|Overall Study||89
211516|NCT01247974|511509|P2|NOT COMPLETED|Overall Study||19
211517|NCT01247974|511510|P1|NOT COMPLETED|Overall Study||26
211518|NCT01247974|511509|P2|COMPLETED|Overall Study||203
211519|NCT01247974|511510|P1|COMPLETED|Overall Study||191
211520|NCT01247974|511509|P2|STARTED|Overall Study||222
211521|NCT01247974|511510|P1|STARTED|Overall Study||217
211522|NCT01247922|511518|P1|NOT COMPLETED|Overall Study||4
211523|NCT01247922|511518|P1|COMPLETED|Overall Study||0
211524|NCT01247922|511518|P1|Treated|Overall Study||4
211525|NCT01247922|511518|P1|STARTED|Overall Study||4
211526|NCT01247675|511528|P4|NOT COMPLETED|Overall Study||0
211527|NCT01247675|511529|P3|NOT COMPLETED|Overall Study||0
211528|NCT01247675|511530|P2|NOT COMPLETED|Overall Study||2
211529|NCT01247675|511531|P1|NOT COMPLETED|Overall Study||2
211530|NCT01247675|511528|P4|COMPLETED|Overall Study||8
211531|NCT01247675|511529|P3|COMPLETED|Overall Study||9
211532|NCT01247675|511530|P2|COMPLETED|Overall Study||8
211533|NCT01247675|511531|P1|COMPLETED|Overall Study||8
211534|NCT01247675|511528|P4|STARTED|Overall Study||8
211535|NCT01247675|511529|P3|STARTED|Overall Study||9
211536|NCT01247675|511530|P2|STARTED|Overall Study||10
211537|NCT01247675|511531|P1|STARTED|Overall Study||10
211538|NCT01247571|511553|P1|NOT COMPLETED|Overall Study||3
211539|NCT01247571|511553|P1|COMPLETED|Overall Study||19
211540|NCT01247571|511553|P1|STARTED|Overall Study||22
211541|NCT01247428|511561|P1|NOT COMPLETED|Overall Study||0
211542|NCT01247428|511561|P1|COMPLETED|Overall Study||30
211543|NCT01247428|511561|P1|STARTED|Overall Study||30
211544|NCT01247363|511582|P1|NOT COMPLETED|Overall Study||0
211545|NCT01247363|511582|P1|COMPLETED|Overall Study||20
211546|NCT01247363|511582|P1|STARTED|Overall Study||20
211547|NCT01247350|511616|P5|NOT COMPLETED|Overall Study||1
211548|NCT01247350|511617|P4|NOT COMPLETED|Overall Study||1
211549|NCT01247350|511618|P3|NOT COMPLETED|Overall Study||1
211550|NCT01247350|511619|P2|NOT COMPLETED|Overall Study||0
211551|NCT01247350|511620|P1|NOT COMPLETED|Overall Study||0
211552|NCT01247350|511616|P5|COMPLETED|Overall Study||8
211553|NCT01247350|511617|P4|COMPLETED|Overall Study||6
211554|NCT01247350|511618|P3|COMPLETED|Overall Study||5
211555|NCT01247350|511619|P2|COMPLETED|Overall Study||6
211556|NCT01247350|511620|P1|COMPLETED|Overall Study||6
211557|NCT01247350|511616|P5|Received Multiple Doses of Study Drug|Overall Study||5
211558|NCT01247350|511617|P4|Received Multiple Doses of Study Drug|Overall Study||6
211559|NCT01247350|511618|P3|Received Multiple Doses of Study Drug|Overall Study||6
211560|NCT01247350|511619|P2|Received Multiple Doses of Study Drug|Overall Study||0
211561|NCT01247350|511620|P1|Received Multiple Doses of Study Drug|Overall Study||0
211562|NCT01247350|511616|P5|STARTED|Overall Study||9
211563|NCT01247350|511617|P4|STARTED|Overall Study||7
211564|NCT01247350|511618|P3|STARTED|Overall Study||6
211565|NCT01247350|511619|P2|STARTED|Overall Study||6
211566|NCT01247350|511620|P1|STARTED|Overall Study||6
211567|NCT01247324|511678|P2|NOT COMPLETED|Overall Study||44
211568|NCT01247324|511679|P1|NOT COMPLETED|Overall Study||71
211569|NCT01247324|511678|P2|COMPLETED|Overall Study||366
211570|NCT01247324|511679|P1|COMPLETED|Overall Study||340
211571|NCT01247324|511678|P2|STARTED|Overall Study||410
211572|NCT01247324|511679|P1|STARTED|Overall Study||411
211573|NCT01247298|511710|P1|NOT COMPLETED|Overall Study||0
211574|NCT01247298|511710|P1|COMPLETED|Overall Study||17
211575|NCT01247298|511710|P1|STARTED|Overall Study||17
211576|NCT01247285|511720|P2|NOT COMPLETED|Second Intervention||0
211577|NCT01247285|511721|P1|NOT COMPLETED|Second Intervention||0
211578|NCT01247285|511720|P2|COMPLETED|Second Intervention||13
211579|NCT01247285|511721|P1|COMPLETED|Second Intervention||13
211580|NCT01247285|511720|P2|STARTED|Second Intervention||13
211581|NCT01247285|511721|P1|STARTED|Second Intervention||13
211582|NCT01247285|511720|P2|NOT COMPLETED|Washout of 28 Days||0
211583|NCT01247285|511721|P1|NOT COMPLETED|Washout of 28 Days||0
211584|NCT01247285|511720|P2|COMPLETED|Washout of 28 Days||13
211585|NCT01247285|511721|P1|COMPLETED|Washout of 28 Days||13
211586|NCT01247285|511720|P2|STARTED|Washout of 28 Days||13
211587|NCT01247285|511721|P1|STARTED|Washout of 28 Days||13
211588|NCT01247285|511720|P2|NOT COMPLETED|First Intervention||0
211589|NCT01247285|511721|P1|NOT COMPLETED|First Intervention||0
211590|NCT01247285|511720|P2|COMPLETED|First Intervention||13
211591|NCT01247285|511721|P1|COMPLETED|First Intervention||13
211592|NCT01247285|511720|P2|STARTED|First Intervention||13
211593|NCT01247285|511721|P1|STARTED|First Intervention||13
211594|NCT01247272|511739|P2|NOT COMPLETED|Second Intervention||0
211595|NCT01247272|511740|P1|NOT COMPLETED|Second Intervention||0
211596|NCT01247272|511739|P2|COMPLETED|Second Intervention||13
211597|NCT01247272|511740|P1|COMPLETED|Second Intervention||13
211598|NCT01247272|511739|P2|STARTED|Second Intervention||13
211599|NCT01247272|511740|P1|STARTED|Second Intervention||13
211600|NCT01247272|511739|P2|NOT COMPLETED|Washout of 28 Days||0
211601|NCT01247272|511740|P1|NOT COMPLETED|Washout of 28 Days||0
211602|NCT01247272|511739|P2|COMPLETED|Washout of 28 Days||13
211603|NCT01247272|511740|P1|COMPLETED|Washout of 28 Days||13
211604|NCT01247272|511739|P2|STARTED|Washout of 28 Days||13
211605|NCT01247272|511740|P1|STARTED|Washout of 28 Days||13
211606|NCT01247272|511739|P2|NOT COMPLETED|First Intervention||0
211607|NCT01247272|511740|P1|NOT COMPLETED|First Intervention||0
211608|NCT01247272|511739|P2|COMPLETED|First Intervention||13
211609|NCT01247272|511740|P1|COMPLETED|First Intervention||13
211610|NCT01247272|511739|P2|STARTED|First Intervention||13
211611|NCT01247272|511740|P1|STARTED|First Intervention||13
211612|NCT01247220|511758|P2|NOT COMPLETED|Overall Study||0
211613|NCT01247220|511759|P1|NOT COMPLETED|Overall Study||0
211614|NCT01247220|511758|P2|COMPLETED|Overall Study||6
211615|NCT01247220|511759|P1|COMPLETED|Overall Study||6
211616|NCT01247220|511758|P2|STARTED|Overall Study||6
211617|NCT01247220|511759|P1|STARTED|Overall Study||6
211618|NCT01247090|511772|P3|NOT COMPLETED|Overall Study||0
211619|NCT01247090|511773|P2|NOT COMPLETED|Overall Study||1
211620|NCT01247090|511774|P1|NOT COMPLETED|Overall Study||1
211621|NCT01247090|511772|P3|COMPLETED|Overall Study||4
211622|NCT01247090|511773|P2|COMPLETED|Overall Study||3
211623|NCT01247090|511774|P1|COMPLETED|Overall Study||3
211624|NCT01247090|511772|P3|STARTED|Overall Study||4
211625|NCT01247090|511773|P2|STARTED|Overall Study||4
211626|NCT01247090|511774|P1|STARTED|Overall Study||4
211627|NCT01247064|511784|P2|NOT COMPLETED|Overall Study||0
211628|NCT01247064|511785|P1|NOT COMPLETED|Overall Study||0
211629|NCT01247064|511784|P2|COMPLETED|Overall Study||31
211630|NCT01247064|511785|P1|COMPLETED|Overall Study||31
211631|NCT01247064|511784|P2|STARTED|Overall Study||31
211632|NCT01247064|511785|P1|STARTED|Overall Study||31
211633|NCT01246999|511803|P4|NOT COMPLETED|Overall Study||2
211634|NCT01246999|511804|P3|NOT COMPLETED|Overall Study||0
211635|NCT01246999|511805|P2|NOT COMPLETED|Overall Study||1
211636|NCT01246999|511806|P1|NOT COMPLETED|Overall Study||0
211637|NCT01246999|511803|P4|COMPLETED|Overall Study||15
211638|NCT01246999|511804|P3|COMPLETED|Overall Study||2
211639|NCT01246999|511805|P2|COMPLETED|Overall Study||3
211640|NCT01246999|511806|P1|COMPLETED|Overall Study||11
211641|NCT01246999|511803|P4|STARTED|Overall Study||17
211642|NCT01246999|511804|P3|STARTED|Overall Study||2
211643|NCT01246999|511805|P2|STARTED|Overall Study||4
211644|NCT01246999|511806|P1|STARTED|Overall Study||11
211645|NCT01246973|511841|P2|NOT COMPLETED|Overall Study||47
211646|NCT01246973|511842|P1|NOT COMPLETED|Overall Study||61
211647|NCT01246973|511841|P2|COMPLETED|Overall Study||295
211648|NCT01246973|511842|P1|COMPLETED|Overall Study||283
211649|NCT01246973|511841|P2|STARTED|Overall Study||342
211650|NCT01246973|511842|P1|STARTED|Overall Study||344
211651|NCT01246960|511852|P2|NOT COMPLETED|Overall Study||4
211652|NCT01246960|511853|P1|NOT COMPLETED|Overall Study||6
211653|NCT01246960|511852|P2|COMPLETED|Overall Study||80
211654|NCT01246960|511853|P1|COMPLETED|Overall Study||78
211655|NCT01246960|511852|P2|Received Any Quantity of Study Drug|Overall Study||80
211656|NCT01246960|511853|P1|Received Any Quantity of Study Drug|Overall Study||82
211657|NCT01246960|511852|P2|STARTED|Overall Study||84
211658|NCT01246960|511853|P1|STARTED|Overall Study||84
211659|NCT01246895|511873|P2|NOT COMPLETED|Overall Study||4
211660|NCT01246895|511874|P1|NOT COMPLETED|Overall Study||3
211661|NCT01246895|511873|P2|COMPLETED|Overall Study||26
211662|NCT01246895|511874|P1|COMPLETED|Overall Study||34
211663|NCT01246895|511873|P2|STARTED|Overall Study||30
211664|NCT01246895|511874|P1|STARTED|Overall Study||37
211665|NCT01246791|511888|P1|NOT COMPLETED|Overall Study||0
211666|NCT01246791|511888|P1|COMPLETED|Overall Study||12
211667|NCT01246791|511888|P1|STARTED|Overall Study||12
211668|NCT01246713|511903|P2|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
211669|NCT01246713|511904|P1|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
211670|NCT01246713|511903|P2|COMPLETED|Second Acetaminophen Dosing (1 Day)||9
211671|NCT01246713|511904|P1|COMPLETED|Second Acetaminophen Dosing (1 Day)||6
211672|NCT01246713|511903|P2|STARTED|Second Acetaminophen Dosing (1 Day)||9
211673|NCT01246713|511904|P1|STARTED|Second Acetaminophen Dosing (1 Day)||6
211674|NCT01246713|511903|P2|NOT COMPLETED|Washout (at Least 14 Days)||0
211675|NCT01246713|511904|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
211676|NCT01246713|511903|P2|COMPLETED|Washout (at Least 14 Days)||9
211677|NCT01246713|511904|P1|COMPLETED|Washout (at Least 14 Days)||6
211678|NCT01246713|511903|P2|STARTED|Washout (at Least 14 Days)||9
211679|NCT01246713|511904|P1|STARTED|Washout (at Least 14 Days)||6
211680|NCT01246713|511903|P2|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
211681|NCT01246713|511904|P1|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
211682|NCT01246713|511903|P2|COMPLETED|First Acetaminophen Dosing (1 Day)||9
211683|NCT01246713|511904|P1|COMPLETED|First Acetaminophen Dosing (1 Day)||6
211684|NCT01246713|511903|P2|STARTED|First Acetaminophen Dosing (1 Day)||9
211685|NCT01246713|511904|P1|STARTED|First Acetaminophen Dosing (1 Day)||6
211686|NCT01246479|511910|P1|NOT COMPLETED|Overall Study||5
211687|NCT01246479|511910|P1|COMPLETED|Overall Study|primary endpoint at Month 12|18
211688|NCT01246479|511910|P1|STARTED|Overall Study||23
211689|NCT01246401|511916|P2|NOT COMPLETED|Overall Study||0
211690|NCT01246401|511917|P1|NOT COMPLETED|Overall Study||0
211691|NCT01246401|511916|P2|COMPLETED|Overall Study||27
211692|NCT01246401|511917|P1|COMPLETED|Overall Study||66
211693|NCT01246401|511916|P2|STARTED|Overall Study||27
211694|NCT01246401|511917|P1|STARTED|Overall Study||66
211695|NCT01246349|511943|P2|NOT COMPLETED|Overall Study||0
211696|NCT01246349|511944|P1|NOT COMPLETED|Overall Study||0
211697|NCT01246349|511943|P2|COMPLETED|Overall Study||20
211698|NCT01246349|511944|P1|COMPLETED|Overall Study||20
211699|NCT01246349|511943|P2|STARTED|Overall Study||20
211700|NCT01246349|511944|P1|STARTED|Overall Study||20
211701|NCT01246258|511956|P1|NOT COMPLETED|Overall Study||0
211702|NCT01246258|511956|P1|COMPLETED|Overall Study||5
211703|NCT01246258|511956|P1|STARTED|Overall Study||5
211704|NCT01246206|511961|P1|NOT COMPLETED|Overall Study||1
211705|NCT01246206|511961|P1|COMPLETED|Overall Study||20
211706|NCT01246206|511961|P1|STARTED|Overall Study||21
211707|NCT01246076|511972|P1|NOT COMPLETED|Overall Study||0
211708|NCT01246076|511972|P1|COMPLETED|Overall Study||24
211709|NCT01246076|511972|P1|STARTED|Overall Study||24
211710|NCT01246063|511987|P6|NOT COMPLETED|Overall Study||0
211711|NCT01246063|511988|P5|NOT COMPLETED|Overall Study||0
211712|NCT01246063|511989|P4|NOT COMPLETED|Overall Study||0
211713|NCT01246063|511990|P3|NOT COMPLETED|Overall Study||0
211714|NCT01246063|511991|P2|NOT COMPLETED|Overall Study||0
211715|NCT01246063|511992|P1|NOT COMPLETED|Overall Study||0
211716|NCT01246063|511987|P6|COMPLETED|Overall Study||17
211717|NCT01246063|511988|P5|COMPLETED|Overall Study||7
211718|NCT01246063|511989|P4|COMPLETED|Overall Study||5
211719|NCT01246063|511990|P3|COMPLETED|Overall Study||4
211720|NCT01246063|511991|P2|COMPLETED|Overall Study||4
211721|NCT01246063|511992|P1|COMPLETED|Overall Study||3
211722|NCT01246063|511987|P6|STARTED|Overall Study||17
211723|NCT01246063|511988|P5|STARTED|Overall Study||7
211724|NCT01246063|511989|P4|STARTED|Overall Study||5
211725|NCT01246063|511990|P3|STARTED|Overall Study||4
211726|NCT01246063|511991|P2|STARTED|Overall Study||4
211727|NCT01246063|511992|P1|STARTED|Overall Study||3
211728|NCT01246050|512029|P2|NOT COMPLETED|Overall Study||0
211729|NCT01246050|512030|P1|NOT COMPLETED|Overall Study||0
211730|NCT01246050|512029|P2|COMPLETED|Overall Study|Control providers were other providers in the same Primary Care Clinic, not enrolled in the study|6
211731|NCT01246050|512030|P1|COMPLETED|Overall Study||6
211732|NCT01246050|512029|P2|STARTED|Overall Study|Control providers were other providers in the same Primary Care Clinic, not enrolled in the study|6
211733|NCT01246050|512030|P1|STARTED|Overall Study||6
211734|NCT01246011|512039|P3|NOT COMPLETED|Overall Study||4
211735|NCT01246011|512040|P2|NOT COMPLETED|Overall Study||0
211736|NCT01246011|512041|P1|NOT COMPLETED|Overall Study||0
211737|NCT01246011|512039|P3|COMPLETED|Overall Study||5
211738|NCT01246011|512040|P2|COMPLETED|Overall Study||0
211739|NCT01246011|512041|P1|COMPLETED|Overall Study||0
211740|NCT01246011|512039|P3|STARTED|Overall Study||9
211741|NCT01246011|512040|P2|STARTED|Overall Study||0
211742|NCT01246011|512041|P1|STARTED|Overall Study||0
211743|NCT01245972|512055|P3|NOT COMPLETED|Overall Study||0
211744|NCT01245972|512056|P2|NOT COMPLETED|Overall Study||0
211745|NCT01245972|512057|P1|NOT COMPLETED|Overall Study||0
211746|NCT01245972|512055|P3|COMPLETED|Overall Study||8
211747|NCT01245972|512056|P2|COMPLETED|Overall Study||8
211748|NCT01245972|512057|P1|COMPLETED|Overall Study||7
211749|NCT01245972|512055|P3|STARTED|Overall Study||8
211750|NCT01245972|512056|P2|STARTED|Overall Study||8
211751|NCT01245972|512057|P1|STARTED|Overall Study||7
211752|NCT01245764|512069|P4|NOT COMPLETED|Study Phase B||0
211753|NCT01245764|512070|P3|NOT COMPLETED|Study Phase B||0
211754|NCT01245764|512071|P2|NOT COMPLETED|Study Phase B||0
211755|NCT01245764|512072|P1|NOT COMPLETED|Study Phase B||0
211756|NCT01245764|512069|P4|COMPLETED|Study Phase B||17
211757|NCT01245764|512070|P3|COMPLETED|Study Phase B||0
211758|NCT01245764|512071|P2|COMPLETED|Study Phase B||0
211759|NCT01245764|512072|P1|COMPLETED|Study Phase B||0
211760|NCT01245764|512069|P4|Completed Vaccinations in Study Phase B|Study Phase B||17
211761|NCT01245764|512070|P3|Completed Vaccinations in Study Phase B|Study Phase B||0
211762|NCT01245764|512071|P2|Completed Vaccinations in Study Phase B|Study Phase B||0
211763|NCT01245764|512072|P1|Completed Vaccinations in Study Phase B|Study Phase B||0
211764|NCT01245764|512069|P4|STARTED|Study Phase B||17
211765|NCT01245764|512070|P3|STARTED|Study Phase B||0
211766|NCT01245764|512071|P2|STARTED|Study Phase B||0
211767|NCT01245764|512072|P1|STARTED|Study Phase B||0
211768|NCT01245764|512069|P4|NOT COMPLETED|Study Phase A||3
211769|NCT01245764|512070|P3|NOT COMPLETED|Study Phase A||10
211770|NCT01245764|512071|P2|NOT COMPLETED|Study Phase A||5
211771|NCT01245764|512072|P1|NOT COMPLETED|Study Phase A||9
211772|NCT01245764|512069|P4|COMPLETED|Study Phase A||17
211773|NCT01245764|512070|P3|COMPLETED|Study Phase A||110
211774|NCT01245764|512071|P2|COMPLETED|Study Phase A||25
211775|NCT01245764|512072|P1|COMPLETED|Study Phase A||71
211776|NCT01245764|512069|P4|Completed Vaccinations in Study Phase A|Study Phase A||19
211777|NCT01245764|512070|P3|Completed Vaccinations in Study Phase A|Study Phase A||117
211778|NCT01245764|512071|P2|Completed Vaccinations in Study Phase A|Study Phase A||28
211779|NCT01245764|512072|P1|Completed Vaccinations in Study Phase A|Study Phase A||77
211780|NCT01245764|512069|P4|STARTED|Study Phase A||20
211781|NCT01245764|512070|P3|STARTED|Study Phase A||120
211782|NCT01245764|512071|P2|STARTED|Study Phase A||30
211783|NCT01245764|512072|P1|STARTED|Study Phase A||80
211784|NCT01245751|512110|P4|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
211785|NCT01245751|512111|P3|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
211786|NCT01245751|512112|P2|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
211787|NCT01245751|512113|P1|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
211788|NCT01245751|512110|P4|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
211789|NCT01245751|512111|P3|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
211790|NCT01245751|512112|P2|COMPLETED|Part 2: Week 156 (3 Year) Visit||139
211791|NCT01245751|512113|P1|COMPLETED|Part 2: Week 156 (3 Year) Visit||161
211792|NCT01245751|512110|P4|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
211793|NCT01245751|512111|P3|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
211794|NCT01245751|512112|P2|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|139
211795|NCT01245751|512113|P1|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|161
211796|NCT01245751|512110|P4|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
211797|NCT01245751|512111|P3|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||0
211798|NCT01245751|512112|P2|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||5
211799|NCT01245751|512113|P1|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
211800|NCT01245751|512110|P4|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||98
211801|NCT01245751|512111|P3|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||100
211802|NCT01245751|512112|P2|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||194
211803|NCT01245751|512113|P1|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||199
211804|NCT01245751|512110|P4|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
211805|NCT01245751|512111|P3|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
211806|NCT01245751|512112|P2|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||199
211807|NCT01245751|512113|P1|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||201
211808|NCT01245751|512110|P4|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
211809|NCT01245751|512111|P3|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
211810|NCT01245751|512112|P2|STARTED|Part 1: Day 1 to Week 52 (1 Year)||199
211811|NCT01245751|512113|P1|STARTED|Part 1: Day 1 to Week 52 (1 Year)||201
211812|NCT01245738|512126|P1|NOT COMPLETED|Overall Study||40
211813|NCT01245738|512126|P1|COMPLETED|Overall Study||474
211814|NCT01245738|512126|P1|STARTED|Overall Study||514
211815|NCT01245699|512145|P2|NOT COMPLETED|Overall Study||5
211816|NCT01245699|512146|P1|NOT COMPLETED|Overall Study||9
211817|NCT01245699|512145|P2|COMPLETED|Overall Study||49
211818|NCT01245699|512146|P1|COMPLETED|Overall Study||52
211819|NCT01245699|512145|P2|STARTED|Overall Study||54
211820|NCT01245699|512146|P1|STARTED|Overall Study||61
211821|NCT01245647|512164|P2|NOT COMPLETED|Overall Study||4
211822|NCT01245647|512165|P1|NOT COMPLETED|Overall Study||0
211823|NCT01245647|512164|P2|COMPLETED|Overall Study||8
211824|NCT01245647|512165|P1|COMPLETED|Overall Study||7
211825|NCT01245647|512164|P2|STARTED|Overall Study||12
211826|NCT01245647|512165|P1|STARTED|Overall Study||7
211827|NCT01245595|512181|P2|NOT COMPLETED|Overall Study||0
211828|NCT01245595|512182|P1|NOT COMPLETED|Overall Study||0
211829|NCT01245595|512181|P2|COMPLETED|Overall Study||72
211830|NCT01245595|512182|P1|COMPLETED|Overall Study||72
211831|NCT01245595|512181|P2|Completed Full Course of Study Drug|Overall Study||61
211832|NCT01245595|512182|P1|Completed Full Course of Study Drug|Overall Study||57
211833|NCT01245595|512181|P2|STARTED|Overall Study||72
211834|NCT01245595|512182|P1|STARTED|Overall Study||72
211835|NCT01245439|512188|P1|NOT COMPLETED|Overall Study||0
211836|NCT01245439|512188|P1|COMPLETED|Overall Study||65
211837|NCT01245439|512188|P1|STARTED|Overall Study||65
211838|NCT01245413|512219|P2|NOT COMPLETED|Athena First,||0
211839|NCT01245413|512220|P1|NOT COMPLETED|Athena First,||0
211840|NCT01245413|512219|P2|COMPLETED|Athena First,||16
211841|NCT01245413|512220|P1|COMPLETED|Athena First,||16
211842|NCT01245413|512219|P2|STARTED|Athena First,||16
211843|NCT01245413|512220|P1|STARTED|Athena First,||16
211844|NCT01245413|512219|P2|NOT COMPLETED|Sensura First,||0
211845|NCT01245413|512220|P1|NOT COMPLETED|Sensura First,||0
211846|NCT01245413|512219|P2|COMPLETED|Sensura First,||16
211847|NCT01245413|512220|P1|COMPLETED|Sensura First,||16
211848|NCT01245413|512219|P2|STARTED|Sensura First,||16
211849|NCT01245413|512220|P1|STARTED|Sensura First,||16
211850|NCT01245387|512226|P1|NOT COMPLETED|Overall Study||813
211851|NCT01245387|512226|P1|COMPLETED|Overall Study||188
211852|NCT01245387|512226|P1|STARTED|Overall Study||1001
211853|NCT01245374|512275|P1|NOT COMPLETED|Overall Study||4
211854|NCT01245374|512275|P1|COMPLETED|Overall Study||99
211855|NCT01245374|512275|P1|STARTED|Overall Study||103
211856|NCT01245283|512298|P3|NOT COMPLETED|Overall Study||11
211857|NCT01245283|512299|P2|NOT COMPLETED|Overall Study||11
211858|NCT01245283|512300|P1|NOT COMPLETED|Overall Study||14
211859|NCT01245283|512298|P3|COMPLETED|Overall Study||19
211860|NCT01245283|512299|P2|COMPLETED|Overall Study||17
211861|NCT01245283|512300|P1|COMPLETED|Overall Study||18
211862|NCT01245283|512298|P3|STARTED|Overall Study||30
211863|NCT01245283|512299|P2|STARTED|Overall Study||28
211864|NCT01245283|512300|P1|STARTED|Overall Study||32
211865|NCT01245270|512334|P2|NOT COMPLETED|Overall Study||0
211866|NCT01245270|512335|P1|NOT COMPLETED|Overall Study||0
211867|NCT01245270|512334|P2|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
211868|NCT01245270|512335|P1|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
211869|NCT01245270|512334|P2|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
211870|NCT01245270|512335|P1|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
211871|NCT01245140|512345|P2|NOT COMPLETED|Overall Study||10
211872|NCT01245140|512346|P1|NOT COMPLETED|Overall Study||3
211873|NCT01245140|512345|P2|COMPLETED|Overall Study||14
211874|NCT01245140|512346|P1|COMPLETED|Overall Study||6
211875|NCT01245140|512345|P2|STARTED|Overall Study||24
211876|NCT01245140|512346|P1|STARTED|Overall Study||9
211877|NCT01245101|512402|P2|NOT COMPLETED|Period 3 (Treatment)||0
211878|NCT01245101|512403|P1|NOT COMPLETED|Period 3 (Treatment)||1
211879|NCT01245101|512402|P2|COMPLETED|Period 3 (Treatment)||0
211880|NCT01245101|512403|P1|COMPLETED|Period 3 (Treatment)||11
211881|NCT01245101|512402|P2|STARTED|Period 3 (Treatment)||0
211882|NCT01245101|512403|P1|STARTED|Period 3 (Treatment)||12
211883|NCT01245101|512402|P2|NOT COMPLETED|Period 2 (Washout)||0
211884|NCT01245101|512403|P1|NOT COMPLETED|Period 2 (Washout)||1
211885|NCT01245101|512402|P2|COMPLETED|Period 2 (Washout)||0
211886|NCT01245101|512403|P1|COMPLETED|Period 2 (Washout)||12
211887|NCT01245101|512402|P2|STARTED|Period 2 (Washout)||0
211888|NCT01245101|512403|P1|STARTED|Period 2 (Washout)||13
211889|NCT01245101|512402|P2|NOT COMPLETED|Period 1 (Treatment)||0
211890|NCT01245101|512403|P1|NOT COMPLETED|Period 1 (Treatment)||2
211891|NCT01245101|512402|P2|COMPLETED|Period 1 (Treatment)||0
211892|NCT01245101|512403|P1|COMPLETED|Period 1 (Treatment)||13
211893|NCT01245101|512402|P2|STARTED|Period 1 (Treatment)||0
211894|NCT01245101|512403|P1|STARTED|Period 1 (Treatment)||15
211895|NCT01245062|512413|P3|NOT COMPLETED|Cross-over Phase||17
211896|NCT01245062|512414|P2|NOT COMPLETED|Cross-over Phase||0
211897|NCT01245062|512415|P1|NOT COMPLETED|Cross-over Phase||0
211898|NCT01245062|512413|P3|COMPLETED|Cross-over Phase||53
211899|NCT01245062|512414|P2|COMPLETED|Cross-over Phase||0
211900|NCT01245062|512415|P1|COMPLETED|Cross-over Phase||0
211901|NCT01245062|512413|P3|STARTED|Cross-over Phase|As of the data cut on December 16, 2016, 70 of 108 participants crossed over from CT to trametinib.|70
211902|NCT01245062|512414|P2|STARTED|Cross-over Phase||0
211903|NCT01245062|512415|P1|STARTED|Cross-over Phase||0
211904|NCT01245062|512413|P3|NOT COMPLETED|Randomization and Crossover Phase||0
211905|NCT01245062|512414|P2|NOT COMPLETED|Randomization and Crossover Phase||31
211906|NCT01245062|512415|P1|NOT COMPLETED|Randomization and Crossover Phase||41
211907|NCT01245062|512413|P3|COMPLETED|Randomization and Crossover Phase||0
211908|NCT01245062|512414|P2|COMPLETED|Randomization and Crossover Phase||77
211909|NCT01245062|512415|P1|COMPLETED|Randomization and Crossover Phase||173
211910|NCT01245062|512413|P3|STARTED|Randomization and Crossover Phase||0
211911|NCT01245062|512414|P2|STARTED|Randomization and Crossover Phase||108
211912|NCT01245062|512415|P1|STARTED|Randomization and Crossover Phase||214
211913|NCT01245049|512453|P2|NOT COMPLETED|Overall Study||4
211914|NCT01245049|512454|P1|NOT COMPLETED|Overall Study||1
211915|NCT01245049|512453|P2|COMPLETED|Overall Study||126
211916|NCT01245049|512454|P1|COMPLETED|Overall Study||254
211917|NCT01245049|512453|P2|STARTED|Overall Study||130
211918|NCT01245049|512454|P1|STARTED|Overall Study||255
211919|NCT01244984|512507|P3|NOT COMPLETED|Overall Study||4
211920|NCT01244984|512508|P2|NOT COMPLETED|Overall Study||14
211921|NCT01244984|512509|P1|NOT COMPLETED|Overall Study||5
211922|NCT01244984|512507|P3|COMPLETED|Overall Study||86
211923|NCT01244984|512508|P2|COMPLETED|Overall Study||79
211924|NCT01244984|512509|P1|COMPLETED|Overall Study||55
211925|NCT01244984|512507|P3|STARTED|Overall Study||90
211926|NCT01244984|512508|P2|STARTED|Overall Study||93
211927|NCT01244984|512509|P1|STARTED|Overall Study||60
211928|NCT01244906|512583|P1|NOT COMPLETED|Overall Study||8
211929|NCT01244906|512583|P1|COMPLETED|Overall Study||18
211930|NCT01244906|512583|P1|STARTED|Overall Study||26
211931|NCT01244893|512592|P2|NOT COMPLETED|Final Visit||0
211932|NCT01244893|512593|P1|NOT COMPLETED|Final Visit||0
211933|NCT01244893|512592|P2|COMPLETED|Final Visit||21
211934|NCT01244893|512593|P1|COMPLETED|Final Visit||21
211935|NCT01244893|512592|P2|STARTED|Final Visit||21
211936|NCT01244893|512593|P1|STARTED|Final Visit||21
211937|NCT01244893|512592|P2|NOT COMPLETED|1-Week Follow Up||0
211938|NCT01244893|512593|P1|NOT COMPLETED|1-Week Follow Up||1
211939|NCT01244893|512592|P2|COMPLETED|1-Week Follow Up||21
211940|NCT01244893|512593|P1|COMPLETED|1-Week Follow Up||21
211941|NCT01244893|512592|P2|STARTED|1-Week Follow Up||21
211942|NCT01244893|512593|P1|STARTED|1-Week Follow Up||22
211943|NCT01244893|512592|P2|NOT COMPLETED|Baseline||1
211944|NCT01244893|512593|P1|NOT COMPLETED|Baseline||0
211945|NCT01244893|512592|P2|COMPLETED|Baseline||21
211946|NCT01244893|512593|P1|COMPLETED|Baseline||22
211947|NCT01244893|512592|P2|STARTED|Baseline||22
211948|NCT01244893|512593|P1|STARTED|Baseline||22
211949|NCT01244828|512605|P1|NOT COMPLETED|Overall Study||78
211950|NCT01244828|512605|P1|COMPLETED|Overall Study||79
211951|NCT01244828|512605|P1|STARTED|Overall Study|Received study drug|157
211952|NCT01244815|512621|P4|NOT COMPLETED|Overall Study||12
211953|NCT01244815|512622|P3|NOT COMPLETED|Overall Study||11
211954|NCT01244815|512623|P2|NOT COMPLETED|Overall Study||17
211955|NCT01244815|512624|P1|NOT COMPLETED|Overall Study||14
211956|NCT01244815|512621|P4|COMPLETED|Overall Study||87
211957|NCT01244815|512622|P3|COMPLETED|Overall Study||88
211958|NCT01244815|512623|P2|COMPLETED|Overall Study||88
211959|NCT01244815|512624|P1|COMPLETED|Overall Study||87
211960|NCT01244815|512621|P4|Treated|Overall Study||99
211961|NCT01244815|512622|P3|Treated|Overall Study||99
211962|NCT01244815|512623|P2|Treated|Overall Study||104
211963|NCT01244815|512624|P1|Treated|Overall Study||101
211964|NCT01244815|512621|P4|STARTED|Overall Study|Randomized|99
211965|NCT01244815|512622|P3|STARTED|Overall Study|Randomized|99
211966|NCT01244815|512623|P2|STARTED|Overall Study|Randomized|105
211967|NCT01244815|512624|P1|STARTED|Overall Study|Randomized|101
211968|NCT01244724|512698|P1|NOT COMPLETED|Overall Study||8
211969|NCT01244724|512698|P1|COMPLETED|Overall Study||9
211970|NCT01244724|512698|P1|Week 2 Visit|Overall Study||15
211971|NCT01244724|512698|P1|STARTED|Overall Study|Of these 15 returned for a week 2 visit and are included in the efficacy analysis.|17
211972|NCT01244711|512703|P1|NOT COMPLETED|Overall Study||0
211973|NCT01244711|512703|P1|COMPLETED|Overall Study||1
211974|NCT01244711|512703|P1|STARTED|Overall Study||1
211975|NCT01244633|512707|P1|NOT COMPLETED|Overall Study||3
211976|NCT01244633|512707|P1|COMPLETED|Overall Study||15
211977|NCT01244633|512707|P1|STARTED|Overall Study||18
211978|NCT01244620|512711|P4|NOT COMPLETED|Overall Study||4
211979|NCT01244620|512712|P3|NOT COMPLETED|Overall Study||4
211980|NCT01244620|512713|P2|NOT COMPLETED|Overall Study||4
211981|NCT01244620|512714|P1|NOT COMPLETED|Overall Study||4
211982|NCT01244620|512711|P4|COMPLETED|Overall Study||0
211983|NCT01244620|512712|P3|COMPLETED|Overall Study||0
211984|NCT01244620|512713|P2|COMPLETED|Overall Study||0
211985|NCT01244620|512714|P1|COMPLETED|Overall Study||0
211986|NCT01244620|512711|P4|STARTED|Overall Study||4
211987|NCT01244620|512712|P3|STARTED|Overall Study||4
211988|NCT01244620|512713|P2|STARTED|Overall Study||4
211989|NCT01244620|512714|P1|STARTED|Overall Study||4
211990|NCT01244529|512748|P1|NOT COMPLETED|Overall Study||0
211991|NCT01244529|512748|P1|COMPLETED|Overall Study||41
211992|NCT01244529|512748|P1|STARTED|Overall Study||41
211993|NCT01244516|512773|P3|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||2
211994|NCT01244516|512774|P2|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||1
211995|NCT01244516|512775|P1|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||3
211996|NCT01244516|512773|P3|COMPLETED|Period 2 (1-week to 2-week Visit)||168
211997|NCT01244516|512774|P2|COMPLETED|Period 2 (1-week to 2-week Visit)||170
211998|NCT01244516|512775|P1|COMPLETED|Period 2 (1-week to 2-week Visit)||163
211999|NCT01244516|512773|P3|STARTED|Period 2 (1-week to 2-week Visit)||170
212000|NCT01244516|512774|P2|STARTED|Period 2 (1-week to 2-week Visit)||171
212001|NCT01244516|512775|P1|STARTED|Period 2 (1-week to 2-week Visit)||166
212002|NCT01244516|512773|P3|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||3
212003|NCT01244516|512774|P2|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||6
212004|NCT01244516|512775|P1|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||4
212005|NCT01244516|512773|P3|COMPLETED|Period 1 (Baseline to 1-week Visit)||170
212006|NCT01244516|512774|P2|COMPLETED|Period 1 (Baseline to 1-week Visit)||171
212007|NCT01244516|512775|P1|COMPLETED|Period 1 (Baseline to 1-week Visit)||166
212008|NCT01244516|512773|P3|STARTED|Period 1 (Baseline to 1-week Visit)||173
212009|NCT01244516|512774|P2|STARTED|Period 1 (Baseline to 1-week Visit)||177
212010|NCT01244516|512775|P1|STARTED|Period 1 (Baseline to 1-week Visit)||170
212011|NCT01244503|512788|P1|NOT COMPLETED|Overall Study||0
212012|NCT01244503|512788|P1|COMPLETED|Overall Study||61
212013|NCT01244503|512788|P1|STARTED|Overall Study||61
212014|NCT01244490|512796|P3|NOT COMPLETED|Overall Study||23
212015|NCT01244490|512797|P2|NOT COMPLETED|Overall Study||24
212016|NCT01244490|512798|P1|NOT COMPLETED|Overall Study||19
212017|NCT01244490|512796|P3|COMPLETED|Overall Study||89
212018|NCT01244490|512797|P2|COMPLETED|Overall Study||91
212019|NCT01244490|512798|P1|COMPLETED|Overall Study||92
212020|NCT01244490|512796|P3|STARTED|Overall Study||112
212021|NCT01244490|512797|P2|STARTED|Overall Study||115
212022|NCT01244490|512798|P1|STARTED|Overall Study||111
212023|NCT01244477|512853|P2|NOT COMPLETED|Overall Study||3
212024|NCT01244477|512854|P1|NOT COMPLETED|Overall Study||20
212025|NCT01244477|512853|P2|COMPLETED|Overall Study||20
212026|NCT01244477|512854|P1|COMPLETED|Overall Study||18
212027|NCT01244477|512853|P2|STARTED|Overall Study||23
212028|NCT01244477|512854|P1|STARTED|Overall Study||38
212029|NCT01244451|512866|P1|NOT COMPLETED|Overall Study||13
212030|NCT01244451|512866|P1|COMPLETED|Overall Study||36
212031|NCT01244451|512866|P1|STARTED|Overall Study||49
212032|NCT01244425|512875|P2|NOT COMPLETED|Overall Study||3
212033|NCT01244425|512876|P1|NOT COMPLETED|Overall Study||3
212034|NCT01244425|512875|P2|COMPLETED|Overall Study|Adverse Event: septic shock with multi-organ failure due to liver abscess (death)|32
212035|NCT01244425|512876|P1|COMPLETED|Overall Study|Adverse Event: multi-organ failure (death)|32
212036|NCT01244425|512875|P2|STARTED|Overall Study||35
212037|NCT01244425|512876|P1|STARTED|Overall Study||35
212038|NCT01244412|512896|P1|NOT COMPLETED|Overall Study||0
212039|NCT01244412|512896|P1|COMPLETED|Overall Study||1
212040|NCT01244412|512896|P1|STARTED|Overall Study||1
212041|NCT01244243|512900|P1|NOT COMPLETED|Overall Study||0
212042|NCT01244243|512900|P1|COMPLETED|Overall Study||41
212043|NCT01244243|512900|P1|STARTED|Overall Study||41
212044|NCT01244126|512908|P3|NOT COMPLETED|Overall Study||9
212045|NCT01244126|512909|P2|NOT COMPLETED|Overall Study||3
212046|NCT01244126|512910|P1|NOT COMPLETED|Overall Study||3
212047|NCT01244126|512908|P3|COMPLETED|Overall Study||48
212048|NCT01244126|512909|P2|COMPLETED|Overall Study||52
212049|NCT01244126|512910|P1|COMPLETED|Overall Study||56
212050|NCT01244126|512908|P3|STARTED|Overall Study||57
212051|NCT01244126|512909|P2|STARTED|Overall Study||55
212052|NCT01244126|512910|P1|STARTED|Overall Study||59
212053|NCT01244061|512923|P2|NOT COMPLETED|Overall Study||103
212054|NCT01244061|512924|P1|NOT COMPLETED|Overall Study||82
212055|NCT01244061|512923|P2|COMPLETED|Overall Study||144
212056|NCT01244061|512924|P1|COMPLETED|Overall Study||169
212057|NCT01244061|512923|P2|STARTED|Overall Study||247
212058|NCT01244061|512924|P1|STARTED|Overall Study||251
212059|NCT01244035|512936|P6|NOT COMPLETED|Part 1: Period 3||1
212060|NCT01244035|512937|P5|NOT COMPLETED|Part 1: Period 3||1
212061|NCT01244035|512938|P4|NOT COMPLETED|Part 1: Period 3||0
212062|NCT01244035|512939|P3|NOT COMPLETED|Part 1: Period 3||0
212063|NCT01244035|512940|P2|NOT COMPLETED|Part 1: Period 3||1
212064|NCT01244035|512941|P1|NOT COMPLETED|Part 1: Period 3||0
212065|NCT01244035|512936|P6|COMPLETED|Part 1: Period 3||2
212066|NCT01244035|512937|P5|COMPLETED|Part 1: Period 3||3
212067|NCT01244035|512938|P4|COMPLETED|Part 1: Period 3||5
212068|NCT01244035|512939|P3|COMPLETED|Part 1: Period 3||3
212069|NCT01244035|512940|P2|COMPLETED|Part 1: Period 3||2
212070|NCT01244035|512941|P1|COMPLETED|Part 1: Period 3||4
212071|NCT01244035|512936|P6|STARTED|Part 1: Period 3||3
212072|NCT01244035|512937|P5|STARTED|Part 1: Period 3||4
212073|NCT01244035|512938|P4|STARTED|Part 1: Period 3||5
212074|NCT01244035|512939|P3|STARTED|Part 1: Period 3||3
212075|NCT01244035|512940|P2|STARTED|Part 1: Period 3||3
212076|NCT01244035|512941|P1|STARTED|Part 1: Period 3||4
212077|NCT01244035|512936|P6|NOT COMPLETED|Part 1: Period 2||0
212078|NCT01244035|512937|P5|NOT COMPLETED|Part 1: Period 2||0
212079|NCT01244035|512938|P4|NOT COMPLETED|Part 1: Period 2||0
212080|NCT01244035|512939|P3|NOT COMPLETED|Part 1: Period 2||1
212081|NCT01244035|512940|P2|NOT COMPLETED|Part 1: Period 2||0
212082|NCT01244035|512941|P1|NOT COMPLETED|Part 1: Period 2||0
212083|NCT01244035|512936|P6|COMPLETED|Part 1: Period 2||3
212084|NCT01244035|512937|P5|COMPLETED|Part 1: Period 2||4
212085|NCT01244035|512938|P4|COMPLETED|Part 1: Period 2||5
212086|NCT01244035|512939|P3|COMPLETED|Part 1: Period 2||3
212087|NCT01244035|512940|P2|COMPLETED|Part 1: Period 2||3
212088|NCT01244035|512941|P1|COMPLETED|Part 1: Period 2||4
212089|NCT01244035|512936|P6|STARTED|Part 1: Period 2||3
212090|NCT01244035|512937|P5|STARTED|Part 1: Period 2||4
212091|NCT01244035|512938|P4|STARTED|Part 1: Period 2||5
212092|NCT01244035|512939|P3|STARTED|Part 1: Period 2||4
212093|NCT01244035|512940|P2|STARTED|Part 1: Period 2||3
212094|NCT01244035|512941|P1|STARTED|Part 1: Period 2||4
212095|NCT01244035|512936|P6|NOT COMPLETED|Part 1: Period 1||2
212096|NCT01244035|512937|P5|NOT COMPLETED|Part 1: Period 1||1
212097|NCT01244035|512938|P4|NOT COMPLETED|Part 1: Period 1||0
212098|NCT01244035|512939|P3|NOT COMPLETED|Part 1: Period 1||2
212099|NCT01244035|512940|P2|NOT COMPLETED|Part 1: Period 1||2
212100|NCT01244035|512941|P1|NOT COMPLETED|Part 1: Period 1||1
212101|NCT01244035|512936|P6|COMPLETED|Part 1: Period 1||3
212102|NCT01244035|512937|P5|COMPLETED|Part 1: Period 1||4
212103|NCT01244035|512938|P4|COMPLETED|Part 1: Period 1||5
212104|NCT01244035|512939|P3|COMPLETED|Part 1: Period 1||4
212105|NCT01244035|512940|P2|COMPLETED|Part 1: Period 1||3
212106|NCT01244035|512941|P1|COMPLETED|Part 1: Period 1||4
212107|NCT01244035|512936|P6|STARTED|Part 1: Period 1||5
212108|NCT01244035|512937|P5|STARTED|Part 1: Period 1||5
212109|NCT01244035|512938|P4|STARTED|Part 1: Period 1||5
212110|NCT01244035|512939|P3|STARTED|Part 1: Period 1||6
212111|NCT01244035|512940|P2|STARTED|Part 1: Period 1||5
212112|NCT01244035|512941|P1|STARTED|Part 1: Period 1||5
212113|NCT01243957|512969|P1|NOT COMPLETED|Overall Study||0
212114|NCT01243957|512969|P1|COMPLETED|Overall Study||20
212115|NCT01243957|512969|P1|STARTED|Overall Study||20
212116|NCT01243944|512982|P2|NOT COMPLETED|Overall Study||51
212117|NCT01243944|512983|P1|NOT COMPLETED|Overall Study||45
212118|NCT01243944|512982|P2|COMPLETED|Overall Study|Study evaluation completion is reported for participants that were treated & those never treatment.|61
212119|NCT01243944|512983|P1|COMPLETED|Overall Study||65
212120|NCT01243944|512982|P2|Followed for Survival|Overall Study||21
212121|NCT01243944|512983|P1|Followed for Survival|Overall Study||22
212122|NCT01243944|512982|P2|Treated|Overall Study||111
212123|NCT01243944|512983|P1|Treated|Overall Study||110
212124|NCT01243944|512982|P2|STARTED|Overall Study|One participant withdrew consent 5 days after randomization to BAT & wasn't treated while on study.|112
212125|NCT01243944|512983|P1|STARTED|Overall Study||110
212126|NCT01243892|513011|P2|NOT COMPLETED|Overall Study||0
212127|NCT01243892|513012|P1|NOT COMPLETED|Overall Study||2
212128|NCT01243892|513011|P2|COMPLETED|Overall Study||3
212129|NCT01243892|513012|P1|COMPLETED|Overall Study||13
212130|NCT01243892|513011|P2|STARTED|Overall Study||3
212131|NCT01243892|513012|P1|STARTED|Overall Study||15
212132|NCT01243775|513022|P1|NOT COMPLETED|Overall Study||2
212133|NCT01243775|513022|P1|COMPLETED|Overall Study||31
212134|NCT01243775|513022|P1|STARTED|Overall Study||33
212135|NCT01243762|513036|P7|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||6
212136|NCT01243762|513037|P6|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
212137|NCT01243762|513038|P5|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||4
212138|NCT01243762|513039|P4|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||2
212139|NCT01243762|513040|P3|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
212140|NCT01243762|513041|P2|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||5
212141|NCT01243762|513042|P1|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||1
212142|NCT01243762|513036|P7|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
212143|NCT01243762|513037|P6|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
212144|NCT01243762|513038|P5|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
212145|NCT01243762|513039|P4|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
212146|NCT01243762|513040|P3|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
212147|NCT01243762|513041|P2|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
212148|NCT01243762|513042|P1|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
212149|NCT01243762|513036|P7|STARTED|Part 2 (Dose Confirmation/Efficacy)|New participants were enrolled in Part 2 of the study that did not participate in Part 1|6
212150|NCT01243762|513037|P6|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
212151|NCT01243762|513038|P5|STARTED|Part 2 (Dose Confirmation/Efficacy)||4
212152|NCT01243762|513039|P4|STARTED|Part 2 (Dose Confirmation/Efficacy)||2
212153|NCT01243762|513040|P3|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
212154|NCT01243762|513041|P2|STARTED|Part 2 (Dose Confirmation/Efficacy)||5
212155|NCT01243762|513042|P1|STARTED|Part 2 (Dose Confirmation/Efficacy)||1
212156|NCT01243762|513036|P7|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||0
212157|NCT01243762|513037|P6|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
212158|NCT01243762|513038|P5|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
212159|NCT01243762|513039|P4|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
212160|NCT01243762|513040|P3|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
212161|NCT01243762|513041|P2|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||8
212162|NCT01243762|513042|P1|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
212163|NCT01243762|513036|P7|COMPLETED|Part 1 (Dose Escalation/MTD)||0
212164|NCT01243762|513037|P6|COMPLETED|Part 1 (Dose Escalation/MTD)||0
212165|NCT01243762|513038|P5|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|4
212166|NCT01243762|513039|P4|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|2
212167|NCT01243762|513040|P3|COMPLETED|Part 1 (Dose Escalation/MTD)||0
212168|NCT01243762|513041|P2|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|5
212169|NCT01243762|513042|P1|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|1
212170|NCT01243762|513036|P7|STARTED|Part 1 (Dose Escalation/MTD)||0
212171|NCT01243762|513037|P6|STARTED|Part 1 (Dose Escalation/MTD)||3
212172|NCT01243762|513038|P5|STARTED|Part 1 (Dose Escalation/MTD)||10
212173|NCT01243762|513039|P4|STARTED|Part 1 (Dose Escalation/MTD)||8
212174|NCT01243762|513040|P3|STARTED|Part 1 (Dose Escalation/MTD)||3
212175|NCT01243762|513041|P2|STARTED|Part 1 (Dose Escalation/MTD)||13
212176|NCT01243762|513042|P1|STARTED|Part 1 (Dose Escalation/MTD)||4
212177|NCT01243671|513061|P1|NOT COMPLETED|Overall Study||5
212178|NCT01243671|513061|P1|COMPLETED|Overall Study|Completed 136 weeks of treatment.|15
212179|NCT01243671|513061|P1|Completed 52 Weeks of Treatment|Overall Study||17
212180|NCT01243671|513061|P1|Completed 24 Weeks of Treatment|Overall Study||18
212181|NCT01243671|513061|P1|STARTED|Overall Study||20
212182|NCT01243619|513074|P1|NOT COMPLETED|Overall Study||0
212183|NCT01243619|513074|P1|COMPLETED|Overall Study|Patient enrollment is complete, data analysis is ongoing|5
212184|NCT01243619|513074|P1|STARTED|Overall Study||5
212185|NCT01243580|513080|P2|NOT COMPLETED|Overall Study||2
212186|NCT01243580|513081|P1|NOT COMPLETED|Overall Study||0
212187|NCT01243580|513080|P2|COMPLETED|Overall Study||16
212188|NCT01243580|513081|P1|COMPLETED|Overall Study||18
212189|NCT01243580|513080|P2|STARTED|Overall Study||18
212190|NCT01243580|513081|P1|STARTED|Overall Study||18
212191|NCT01243567|513110|P2|NOT COMPLETED|Overall Study||0
212192|NCT01243567|513111|P1|NOT COMPLETED|Overall Study||1
212193|NCT01243567|513110|P2|COMPLETED|Overall Study||38
212194|NCT01243567|513111|P1|COMPLETED|Overall Study||42
212195|NCT01243567|513110|P2|STARTED|Overall Study||38
212196|NCT01243567|513111|P1|STARTED|Overall Study||43
212197|NCT01243450|513128|P3|NOT COMPLETED|Overall Study||67
212198|NCT01243450|513129|P2|NOT COMPLETED|Overall Study||25
212199|NCT01243450|513130|P1|NOT COMPLETED|Overall Study||83
212200|NCT01243450|513128|P3|COMPLETED|Overall Study||337
212201|NCT01243450|513129|P2|COMPLETED|Overall Study||110
212202|NCT01243450|513130|P1|COMPLETED|Overall Study||318
212203|NCT01243450|513128|P3|STARTED|Overall Study||404
212204|NCT01243450|513129|P2|STARTED|Overall Study||135
212205|NCT01243450|513130|P1|STARTED|Overall Study||401
212206|NCT01243411|513138|P1|NOT COMPLETED|Overall Study||41
212207|NCT01243411|513138|P1|COMPLETED|Overall Study||306
212208|NCT01243411|513138|P1|STARTED|Overall Study||347
212209|NCT01243333|513150|P1|NOT COMPLETED|Overall Study||8
212210|NCT01243333|513150|P1|COMPLETED|Overall Study||18
212211|NCT01243333|513150|P1|STARTED|Overall Study||26
212212|NCT01243320|513156|P1|NOT COMPLETED|32ppm Oral Silver (14 Days)||0
212213|NCT01243320|513156|P1|COMPLETED|32ppm Oral Silver (14 Days)||24
212214|NCT01243320|513156|P1|STARTED|32ppm Oral Silver (14 Days)||24
212215|NCT01243320|513156|P1|NOT COMPLETED|Washout (3 Days)||0
212216|NCT01243320|513156|P1|COMPLETED|Washout (3 Days)||36
212217|NCT01243320|513156|P1|STARTED|Washout (3 Days)||36
212218|NCT01243320|513156|P1|NOT COMPLETED|10ppm Oral Silver (14 Days)||0
212219|NCT01243320|513156|P1|COMPLETED|10ppm Oral Silver (14 Days)||36
212220|NCT01243320|513156|P1|STARTED|10ppm Oral Silver (14 Days)||36
212221|NCT01243320|513156|P1|NOT COMPLETED|10ppm Oral Silver (7 Days)||0
212222|NCT01243320|513156|P1|COMPLETED|10ppm Oral Silver (7 Days)||36
212223|NCT01243320|513156|P1|STARTED|10ppm Oral Silver (7 Days)||36
212224|NCT01243320|513156|P1|NOT COMPLETED|10ppm Oral Silver (3 Days)||0
212225|NCT01243320|513156|P1|COMPLETED|10ppm Oral Silver (3 Days)||36
212226|NCT01243320|513156|P1|STARTED|10ppm Oral Silver (3 Days)||36
212227|NCT01243294|513232|P2|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
212228|NCT01243294|513233|P1|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
212229|NCT01243294|513232|P2|COMPLETED|Second Intervention (10 Days +/- 2 Days)||26
212230|NCT01243294|513233|P1|COMPLETED|Second Intervention (10 Days +/- 2 Days)||28
212231|NCT01243294|513232|P2|STARTED|Second Intervention (10 Days +/- 2 Days)||26
212232|NCT01243294|513233|P1|STARTED|Second Intervention (10 Days +/- 2 Days)||28
212233|NCT01243294|513232|P2|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
212234|NCT01243294|513233|P1|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
212235|NCT01243294|513232|P2|COMPLETED|First Intervention (10 Days +/- 2 Days)||26
212236|NCT01243294|513233|P1|COMPLETED|First Intervention (10 Days +/- 2 Days)||28
212237|NCT01243294|513232|P2|STARTED|First Intervention (10 Days +/- 2 Days)||26
212238|NCT01243294|513233|P1|STARTED|First Intervention (10 Days +/- 2 Days)||28
212239|NCT01243268|513249|P1|NOT COMPLETED|Overall Study||64
212240|NCT01243268|513249|P1|COMPLETED|Overall Study||610
212241|NCT01243268|513249|P1|STARTED|Overall Study||674
212242|NCT01243242|513259|P2|NOT COMPLETED|Overall Study||4
212243|NCT01243242|513260|P1|NOT COMPLETED|Overall Study||3
212244|NCT01243242|513259|P2|COMPLETED|Overall Study||56
212245|NCT01243242|513260|P1|COMPLETED|Overall Study||57
212246|NCT01243242|513259|P2|STARTED|Overall Study||60
212247|NCT01243242|513260|P1|STARTED|Overall Study||60
212248|NCT01243177|513274|P2|NOT COMPLETED|Overall Study||178
212249|NCT01243177|513275|P1|NOT COMPLETED|Overall Study||178
212250|NCT01243177|513274|P2|COMPLETED|Overall Study||264
212251|NCT01243177|513275|P1|COMPLETED|Overall Study||266
212252|NCT01243177|513274|P2|STARTED|Overall Study||442
212253|NCT01243177|513275|P1|STARTED|Overall Study||444
212254|NCT01243151|513296|P5|NOT COMPLETED|Overall Study||0
212255|NCT01243151|513297|P4|NOT COMPLETED|Overall Study||2
212256|NCT01243151|513298|P3|NOT COMPLETED|Overall Study||1
212257|NCT01243151|513299|P2|NOT COMPLETED|Overall Study||1
212258|NCT01243151|513300|P1|NOT COMPLETED|Overall Study||0
212259|NCT01243151|513296|P5|COMPLETED|Overall Study||14
212260|NCT01243151|513297|P4|COMPLETED|Overall Study||12
212261|NCT01243151|513298|P3|COMPLETED|Overall Study||13
212262|NCT01243151|513299|P2|COMPLETED|Overall Study||13
212263|NCT01243151|513300|P1|COMPLETED|Overall Study||12
212264|NCT01243151|513296|P5|Treated|Overall Study||14
212265|NCT01243151|513297|P4|Treated|Overall Study||13
212266|NCT01243151|513298|P3|Treated|Overall Study||14
212267|NCT01243151|513299|P2|Treated|Overall Study||14
212268|NCT01243151|513300|P1|Treated|Overall Study||12
212269|NCT01243151|513296|P5|STARTED|Overall Study||14
212270|NCT01243151|513297|P4|STARTED|Overall Study||14
212271|NCT01243151|513298|P3|STARTED|Overall Study||14
212272|NCT01243151|513299|P2|STARTED|Overall Study||14
212273|NCT01243151|513300|P1|STARTED|Overall Study||12
212274|NCT01243112|513539|P1|NOT COMPLETED|Overall Study||0
212275|NCT01243112|513539|P1|COMPLETED|Overall Study||25
212276|NCT01243112|513539|P1|STARTED|Overall Study||25
212277|NCT01242813|513544|P1|NOT COMPLETED|Overall Study||2
212278|NCT01242813|513544|P1|COMPLETED|Overall Study||18
212279|NCT01242813|513544|P1|STARTED|Overall Study||20
212280|NCT01242748|513566|P2|NOT COMPLETED|Overall Study||14
212281|NCT01242748|513567|P1|NOT COMPLETED|Overall Study||38
212282|NCT01242748|513566|P2|COMPLETED|Overall Study||80
212283|NCT01242748|513567|P1|COMPLETED|Overall Study|These participants were ongoing when the trial was closed by the Sponsor.|156
212284|NCT01242748|513566|P2|CS35/CS35A Full Analysis Set (FAS)|Overall Study||282
212285|NCT01242748|513567|P1|CS35/CS35A Full Analysis Set (FAS)|Overall Study|Received at least 1 dose of trial drug during CS35+had at least 1 efficacy assessment after dosing.|565
212286|NCT01242748|513566|P2|CS35/CS35A Safety Analysis Set|Overall Study||283
212287|NCT01242748|513567|P1|CS35/CS35A Safety Analysis Set|Overall Study|Received at least 1 dose of trial drug during the main CS35 trial.|565
212288|NCT01242748|513566|P2|STARTED|Overall Study||94
212289|NCT01242748|513567|P1|STARTED|Overall Study|Enrolled in CS35A, CS35A Full Analysis Set.|194
212290|NCT01242527|513591|P4|NOT COMPLETED|Overall Study||9
212291|NCT01242527|513592|P3|NOT COMPLETED|Overall Study||14
212292|NCT01242527|513593|P2|NOT COMPLETED|Overall Study||7
212293|NCT01242527|513594|P1|NOT COMPLETED|Overall Study||5
212294|NCT01242527|513591|P4|COMPLETED|Overall Study||90
212295|NCT01242527|513592|P3|COMPLETED|Overall Study||87
212296|NCT01242527|513593|P2|COMPLETED|Overall Study||93
212297|NCT01242527|513594|P1|COMPLETED|Overall Study||94
212298|NCT01242527|513591|P4|STARTED|Overall Study||99
212299|NCT01242527|513592|P3|STARTED|Overall Study||101
212300|NCT01242527|513593|P2|STARTED|Overall Study||100
212301|NCT01242527|513594|P1|STARTED|Overall Study||99
212302|NCT01242514|513607|P3|NOT COMPLETED|Overall Study||212
212303|NCT01242514|513608|P2|NOT COMPLETED|Overall Study||357
212304|NCT01242514|513609|P1|NOT COMPLETED|Overall Study||1343
212305|NCT01242514|513607|P3|COMPLETED|Overall Study|Due to project closure.|0
212306|NCT01242514|513608|P2|COMPLETED|Overall Study|Due to project closure.|0
212307|NCT01242514|513609|P1|COMPLETED|Overall Study|Due to project closure.|0
212308|NCT01242514|513607|P3|Enrolled But Did Not Receive Treatment|Overall Study|Adverse event/other|2
212309|NCT01242514|513608|P2|Enrolled But Did Not Receive Treatment|Overall Study||0
212310|NCT01242514|513609|P1|Enrolled But Did Not Receive Treatment|Overall Study|Other|3
212311|NCT01242514|513607|P3|STARTED|Overall Study|Patients who received treatment|212
212312|NCT01242514|513608|P2|STARTED|Overall Study|Patients who received treatment|357
212313|NCT01242514|513609|P1|STARTED|Overall Study|Patients who received treatment|1343
212314|NCT01242371|513628|P2|NOT COMPLETED|Overall Study||5
212315|NCT01242371|513629|P1|NOT COMPLETED|Overall Study||2
212316|NCT01242371|513628|P2|COMPLETED|Overall Study||27
212317|NCT01242371|513629|P1|COMPLETED|Overall Study||31
212318|NCT01242371|513628|P2|STARTED|Overall Study||32
212319|NCT01242371|513629|P1|STARTED|Overall Study||33
212320|NCT01242176|513635|P2|NOT COMPLETED|Second Intervention||0
212321|NCT01242176|513636|P1|NOT COMPLETED|Second Intervention||0
212322|NCT01242176|513635|P2|COMPLETED|Second Intervention||10
212323|NCT01242176|513636|P1|COMPLETED|Second Intervention||11
212324|NCT01242176|513635|P2|STARTED|Second Intervention||10
212325|NCT01242176|513636|P1|STARTED|Second Intervention||11
212326|NCT01242176|513635|P2|NOT COMPLETED|Washout Period of 7 Days||2
212327|NCT01242176|513636|P1|NOT COMPLETED|Washout Period of 7 Days||1
212328|NCT01242176|513635|P2|COMPLETED|Washout Period of 7 Days||10
212329|NCT01242176|513636|P1|COMPLETED|Washout Period of 7 Days||11
212330|NCT01242176|513635|P2|STARTED|Washout Period of 7 Days||12
212331|NCT01242176|513636|P1|STARTED|Washout Period of 7 Days||12
212332|NCT01242176|513635|P2|NOT COMPLETED|First Intervention||0
212333|NCT01242176|513636|P1|NOT COMPLETED|First Intervention||0
212334|NCT01242176|513635|P2|COMPLETED|First Intervention||12
212335|NCT01242176|513636|P1|COMPLETED|First Intervention||12
212336|NCT01242176|513635|P2|STARTED|First Intervention||12
212337|NCT01242176|513636|P1|STARTED|First Intervention||12
212338|NCT01242111|513646|P1|NOT COMPLETED|Overall Study||3
212339|NCT01242111|513646|P1|COMPLETED|Overall Study||17
212340|NCT01242111|513646|P1|STARTED|Overall Study||20
212341|NCT01242085|513658|P3|NOT COMPLETED|Overall Study||0
212342|NCT01242085|513659|P2|NOT COMPLETED|Overall Study||7
212343|NCT01242085|513660|P1|NOT COMPLETED|Overall Study||8
212344|NCT01242085|513658|P3|COMPLETED|Overall Study||1
212345|NCT01242085|513659|P2|COMPLETED|Overall Study|7 patients did not receive allocated intervention since 5 had medical problems and 2 withdrew|26
212346|NCT01242085|513660|P1|COMPLETED|Overall Study|8 patients did not undergo intervention since 4 had medical problems and 4 withdrew|22
212347|NCT01242085|513658|P3|STARTED|Overall Study||1
212348|NCT01242085|513659|P2|STARTED|Overall Study||33
212349|NCT01242085|513660|P1|STARTED|Overall Study||30
212350|NCT01242020|513670|P2|NOT COMPLETED|Overall Study||0
212351|NCT01242020|513671|P1|NOT COMPLETED|Overall Study||3
212352|NCT01242020|513670|P2|COMPLETED|Overall Study||0
212353|NCT01242020|513671|P1|COMPLETED|Overall Study||3
212354|NCT01242020|513670|P2|STARTED|Overall Study||0
212355|NCT01242020|513671|P1|STARTED|Overall Study||6
212356|NCT01241916|513681|P2|NOT COMPLETED|Overall Study||10
212357|NCT01241916|513682|P1|NOT COMPLETED|Overall Study||7
212358|NCT01241916|513681|P2|COMPLETED|Overall Study||21
212359|NCT01241916|513682|P1|COMPLETED|Overall Study||28
212360|NCT01241916|513681|P2|STARTED|Overall Study||31
212361|NCT01241916|513682|P1|STARTED|Overall Study||35
212362|NCT01241903|513692|P2|NOT COMPLETED|Overall Study||0
212363|NCT01241903|513693|P1|NOT COMPLETED|Overall Study||1
212364|NCT01241903|513692|P2|COMPLETED|Overall Study||27
212365|NCT01241903|513693|P1|COMPLETED|Overall Study||26
212366|NCT01241903|513692|P2|STARTED|Overall Study||27
212367|NCT01241903|513693|P1|STARTED|Overall Study||27
212368|NCT01241760|513701|P2|NOT COMPLETED|Overall Study||40
212369|NCT01241760|513702|P1|NOT COMPLETED|Overall Study||34
212370|NCT01241760|513701|P2|COMPLETED|Overall Study||329
212371|NCT01241760|513702|P1|COMPLETED|Overall Study||337
212372|NCT01241760|513701|P2|STARTED|Overall Study||369
212373|NCT01241760|513702|P1|STARTED|Overall Study||371
212374|NCT01241604|513721|P3|NOT COMPLETED|Study Period||0
212375|NCT01241604|513722|P2|NOT COMPLETED|Study Period||0
212376|NCT01241604|513723|P1|NOT COMPLETED|Study Period||0
212377|NCT01241604|513721|P3|COMPLETED|Study Period||3
212378|NCT01241604|513722|P2|COMPLETED|Study Period||5
212379|NCT01241604|513723|P1|COMPLETED|Study Period||0
212380|NCT01241604|513721|P3|STARTED|Study Period||3
212381|NCT01241604|513722|P2|STARTED|Study Period||5
212382|NCT01241604|513723|P1|STARTED|Study Period||0
212383|NCT01241604|513721|P3|NOT COMPLETED|Screening Period||0
212384|NCT01241604|513722|P2|NOT COMPLETED|Screening Period||0
212385|NCT01241604|513723|P1|NOT COMPLETED|Screening Period||3
212386|NCT01241604|513721|P3|COMPLETED|Screening Period||0
212387|NCT01241604|513722|P2|COMPLETED|Screening Period||0
212388|NCT01241604|513723|P1|COMPLETED|Screening Period||8
212389|NCT01241604|513721|P3|STARTED|Screening Period||0
212390|NCT01241604|513722|P2|STARTED|Screening Period||0
212391|NCT01241604|513723|P1|STARTED|Screening Period||11
212392|NCT01241591|513768|P4|NOT COMPLETED|Overall Study||12
212393|NCT01241591|513769|P3|NOT COMPLETED|Overall Study||22
212394|NCT01241591|513770|P2|NOT COMPLETED|Overall Study||24
212395|NCT01241591|513771|P1|NOT COMPLETED|Overall Study||23
212396|NCT01241591|513768|P4|COMPLETED|Overall Study||95
212397|NCT01241591|513769|P3|COMPLETED|Overall Study||313
212398|NCT01241591|513770|P2|COMPLETED|Overall Study||306
212399|NCT01241591|513771|P1|COMPLETED|Overall Study||306
212400|NCT01241591|513768|P4|STARTED|Overall Study||107
212401|NCT01241591|513769|P3|STARTED|Overall Study||335
212402|NCT01241591|513770|P2|STARTED|Overall Study||330
212403|NCT01241591|513771|P1|STARTED|Overall Study||329
212404|NCT01241565|513961|P1|NOT COMPLETED|Overall Study||0
212405|NCT01241565|513961|P1|COMPLETED|Overall Study||50
212406|NCT01241565|513961|P1|STARTED|Overall Study||50
212407|NCT01241552|513974|P4|NOT COMPLETED|Overall Study||64
212408|NCT01241552|513975|P3|NOT COMPLETED|Overall Study||60
212409|NCT01241552|513976|P2|NOT COMPLETED|Overall Study||63
212410|NCT01241552|513977|P1|NOT COMPLETED|Overall Study||41
212411|NCT01241552|513974|P4|COMPLETED|Overall Study||340
212412|NCT01241552|513975|P3|COMPLETED|Overall Study||343
212413|NCT01241552|513976|P2|COMPLETED|Overall Study||340
212414|NCT01241552|513977|P1|COMPLETED|Overall Study||201
212415|NCT01241552|513974|P4|Treated|Overall Study||397
212416|NCT01241552|513975|P3|Treated|Overall Study||388
212417|NCT01241552|513976|P2|Treated|Overall Study||392
212418|NCT01241552|513977|P1|Treated|Overall Study||235
212419|NCT01241552|513974|P4|STARTED|Overall Study||404
212420|NCT01241552|513975|P3|STARTED|Overall Study||403
212421|NCT01241552|513976|P2|STARTED|Overall Study||403
212422|NCT01241552|513977|P1|STARTED|Overall Study||242
212423|NCT01241539|514043|P1|NOT COMPLETED|Period 2||0
212424|NCT01241539|514043|P1|COMPLETED|Period 2||7
212425|NCT01241539|514043|P1|STARTED|Period 2|After a wash-out phase of at least 6 weeks.|7
212426|NCT01241539|514043|P1|NOT COMPLETED|Period 1||0
212427|NCT01241539|514043|P1|COMPLETED|Period 1||7
212428|NCT01241539|514043|P1|STARTED|Period 1||7
212429|NCT01241513|514064|P2|NOT COMPLETED|Overall Study||0
212430|NCT01241513|514065|P1|NOT COMPLETED|Overall Study||0
212431|NCT01241513|514064|P2|COMPLETED|Overall Study||9
212432|NCT01241513|514065|P1|COMPLETED|Overall Study|Study has been completed|10
212433|NCT01241513|514064|P2|STARTED|Overall Study||9
212434|NCT01241513|514065|P1|STARTED|Overall Study||10
212435|NCT01241461|514072|P2|NOT COMPLETED|Overall Study||6
212436|NCT01241461|514073|P1|NOT COMPLETED|Overall Study||3
212437|NCT01241461|514072|P2|COMPLETED|Overall Study||0
212438|NCT01241461|514073|P1|COMPLETED|Overall Study||0
212439|NCT01241461|514072|P2|STARTED|Overall Study||6
212440|NCT01241461|514073|P1|STARTED|Overall Study||3
212441|NCT01241448|514093|P4|NOT COMPLETED|Overall Study||23
212442|NCT01241448|514094|P3|NOT COMPLETED|Overall Study||23
212443|NCT01241448|514095|P2|NOT COMPLETED|Overall Study||29
212444|NCT01241448|514096|P1|NOT COMPLETED|Overall Study||37
212445|NCT01241448|514093|P4|COMPLETED|Overall Study||43
212446|NCT01241448|514094|P3|COMPLETED|Overall Study||43
212447|NCT01241448|514095|P2|COMPLETED|Overall Study||36
212448|NCT01241448|514096|P1|COMPLETED|Overall Study||29
212449|NCT01241448|514093|P4|ITT With ≥1 Post-Baseline Measure|Overall Study||62
212450|NCT01241448|514094|P3|ITT With ≥1 Post-Baseline Measure|Overall Study||64
212451|NCT01241448|514095|P2|ITT With ≥1 Post-Baseline Measure|Overall Study||61
212452|NCT01241448|514096|P1|ITT With ≥1 Post-Baseline Measure|Overall Study||61
212453|NCT01241448|514093|P4|Intent-to-Treat Population (ITT)|Overall Study||64
212454|NCT01241448|514094|P3|Intent-to-Treat Population (ITT)|Overall Study||64
212455|NCT01241448|514095|P2|Intent-to-Treat Population (ITT)|Overall Study||63
212456|NCT01241448|514096|P1|Intent-to-Treat Population (ITT)|Overall Study||63
212457|NCT01241448|514093|P4|STARTED|Overall Study||66
212458|NCT01241448|514094|P3|STARTED|Overall Study||66
212459|NCT01241448|514095|P2|STARTED|Overall Study||65
212460|NCT01241448|514096|P1|STARTED|Overall Study||66
212461|NCT01241435|514164|P4|NOT COMPLETED|Overall Study||0
212462|NCT01241435|514165|P3|NOT COMPLETED|Overall Study||0
212463|NCT01241435|514166|P2|NOT COMPLETED|Overall Study||0
212464|NCT01241435|514167|P1|NOT COMPLETED|Overall Study||0
212465|NCT01241435|514164|P4|COMPLETED|Overall Study||8
212466|NCT01241435|514165|P3|COMPLETED|Overall Study||8
212467|NCT01241435|514166|P2|COMPLETED|Overall Study||8
212468|NCT01241435|514167|P1|COMPLETED|Overall Study||12
212469|NCT01241435|514164|P4|Received at Least 1 Dose of Study Drug|Overall Study||8
212470|NCT01241435|514165|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
212471|NCT01241435|514166|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
212472|NCT01241435|514167|P1|Received at Least 1 Dose of Study Drug|Overall Study||12
212473|NCT01241435|514164|P4|STARTED|Overall Study||8
212474|NCT01241435|514165|P3|STARTED|Overall Study||8
212475|NCT01241435|514166|P2|STARTED|Overall Study||8
212476|NCT01241435|514167|P1|STARTED|Overall Study||12
212477|NCT01241318|514187|P2|NOT COMPLETED|Overall Study||742
212478|NCT01241318|514188|P1|NOT COMPLETED|Overall Study||1179
212479|NCT01241318|514187|P2|COMPLETED|Overall Study|Infants|19308
212480|NCT01241318|514188|P1|COMPLETED|Overall Study|Infants|18450
212481|NCT01241318|514187|P2|Liveborn Infant|Overall Study|Infants|19346
212482|NCT01241318|514188|P1|Liveborn Infant|Overall Study|Infants|18510
212483|NCT01241318|514187|P2|STARTED|Overall Study|Women enrolled|20050
212484|NCT01241318|514188|P1|STARTED|Overall Study|Women enrolled|19629
212485|NCT01241292|514201|P2|NOT COMPLETED|Overall Study||3
212486|NCT01241292|514202|P1|NOT COMPLETED|Overall Study||3
212487|NCT01241292|514201|P2|COMPLETED|Overall Study|completed=treatment on-going|0
212488|NCT01241292|514202|P1|COMPLETED|Overall Study|completed=treatment on-going|0
212489|NCT01241292|514201|P2|Entered Treatment Period|Overall Study||3
212490|NCT01241292|514202|P1|Entered Treatment Period|Overall Study||3
212491|NCT01241292|514201|P2|STARTED|Overall Study||3
212492|NCT01241292|514202|P1|STARTED|Overall Study||3
212493|NCT01241279|514226|P2|NOT COMPLETED|Overall Study||1
212494|NCT01241279|514227|P1|NOT COMPLETED|Overall Study||0
212495|NCT01241279|514226|P2|COMPLETED|Overall Study||1
212496|NCT01241279|514227|P1|COMPLETED|Overall Study||4
212497|NCT01241279|514226|P2|STARTED|Overall Study||2
212498|NCT01241279|514227|P1|STARTED|Overall Study||4
212499|NCT01241240|514237|P2|NOT COMPLETED|Overall Study||9
212500|NCT01241240|514238|P1|NOT COMPLETED|Overall Study||8
212501|NCT01241240|514237|P2|COMPLETED|Overall Study||89
212502|NCT01241240|514238|P1|COMPLETED|Overall Study||86
212503|NCT01241240|514237|P2|STARTED|Overall Study||98
212504|NCT01241240|514238|P1|STARTED|Overall Study||94
212505|NCT01240915|514256|P9|NOT COMPLETED|Overall Study||8
212506|NCT01240915|514257|P8|NOT COMPLETED|Overall Study||4
212507|NCT01240915|514258|P7|NOT COMPLETED|Overall Study||8
212508|NCT01240915|514259|P6|NOT COMPLETED|Overall Study||10
212509|NCT01240915|514260|P5|NOT COMPLETED|Overall Study||4
212510|NCT01240915|514261|P4|NOT COMPLETED|Overall Study||3
212511|NCT01240915|514262|P3|NOT COMPLETED|Overall Study||0
212512|NCT01240915|514263|P2|NOT COMPLETED|Overall Study||1
212513|NCT01240915|514264|P1|NOT COMPLETED|Overall Study||2
212514|NCT01240915|514256|P9|COMPLETED|Overall Study||13
212515|NCT01240915|514257|P8|COMPLETED|Overall Study||15
212516|NCT01240915|514258|P7|COMPLETED|Overall Study||17
212517|NCT01240915|514259|P6|COMPLETED|Overall Study||13
212518|NCT01240915|514260|P5|COMPLETED|Overall Study||2
212519|NCT01240915|514261|P4|COMPLETED|Overall Study||1
212520|NCT01240915|514262|P3|COMPLETED|Overall Study||2
212521|NCT01240915|514263|P2|COMPLETED|Overall Study||2
212522|NCT01240915|514264|P1|COMPLETED|Overall Study||0
212523|NCT01240915|514256|P9|STARTED|Overall Study||21
212524|NCT01240915|514257|P8|STARTED|Overall Study||19
212525|NCT01240915|514258|P7|STARTED|Overall Study||25
212526|NCT01240915|514259|P6|STARTED|Overall Study||23
212527|NCT01240915|514260|P5|STARTED|Overall Study||6
212528|NCT01240915|514261|P4|STARTED|Overall Study||4
212529|NCT01240915|514262|P3|STARTED|Overall Study||2
212530|NCT01240915|514263|P2|STARTED|Overall Study||3
212531|NCT01240915|514264|P1|STARTED|Overall Study||2
212532|NCT01240902|514447|P4|NOT COMPLETED|Overall Study||165
212533|NCT01240902|514448|P3|NOT COMPLETED|Overall Study||100
212534|NCT01240902|514449|P2|NOT COMPLETED|Overall Study||79
212535|NCT01240902|514450|P1|NOT COMPLETED|Overall Study||211
212536|NCT01240902|514447|P4|COMPLETED|Overall Study||237
212537|NCT01240902|514448|P3|COMPLETED|Overall Study||295
212538|NCT01240902|514449|P2|COMPLETED|Overall Study||77
212539|NCT01240902|514450|P1|COMPLETED|Overall Study||289
212540|NCT01240902|514447|P4|STARTED|Overall Study||402
212541|NCT01240902|514448|P3|STARTED|Overall Study||395
212542|NCT01240902|514449|P2|STARTED|Overall Study||156
212543|NCT01240902|514450|P1|STARTED|Overall Study||500
212544|NCT01240863|514538|P3|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||52
212545|NCT01240863|514539|P2|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||46
212546|NCT01240863|514540|P1|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
212547|NCT01240863|514538|P3|COMPLETED|Double-blind Treatment Period (12 Weeks)||94
212548|NCT01240863|514539|P2|COMPLETED|Double-blind Treatment Period (12 Weeks)||102
212549|NCT01240863|514540|P1|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
212550|NCT01240863|514538|P3|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||146
212551|NCT01240863|514539|P2|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||147
212552|NCT01240863|514540|P1|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||0
212553|NCT01240863|514538|P3|STARTED|Double-blind Treatment Period (12 Weeks)||146
212554|NCT01240863|514539|P2|STARTED|Double-blind Treatment Period (12 Weeks)||148
212555|NCT01240863|514540|P1|STARTED|Double-blind Treatment Period (12 Weeks)||0
212556|NCT01240863|514538|P3|NOT COMPLETED|Open-label Titration Period||0
212557|NCT01240863|514539|P2|NOT COMPLETED|Open-label Titration Period||0
212558|NCT01240863|514540|P1|NOT COMPLETED|Open-label Titration Period||97
212559|NCT01240863|514538|P3|COMPLETED|Open-label Titration Period||0
212560|NCT01240863|514539|P2|COMPLETED|Open-label Titration Period||0
212561|NCT01240863|514540|P1|COMPLETED|Open-label Titration Period||294
212562|NCT01240863|514538|P3|Safety Analysis Set|Open-label Titration Period||0
212563|NCT01240863|514539|P2|Safety Analysis Set|Open-label Titration Period||0
212564|NCT01240863|514540|P1|Safety Analysis Set|Open-label Titration Period||389
212565|NCT01240863|514538|P3|STARTED|Open-label Titration Period||0
212566|NCT01240863|514539|P2|STARTED|Open-label Titration Period||0
212567|NCT01240863|514540|P1|STARTED|Open-label Titration Period||391
212568|NCT01240811|514602|P3|NOT COMPLETED|Overall Study||1
212569|NCT01240811|514603|P2|NOT COMPLETED|Overall Study||1
212570|NCT01240811|514604|P1|NOT COMPLETED|Overall Study||0
212571|NCT01240811|514602|P3|COMPLETED|Overall Study||16
212572|NCT01240811|514603|P2|COMPLETED|Overall Study||16
212573|NCT01240811|514604|P1|COMPLETED|Overall Study||8
212574|NCT01240811|514602|P3|STARTED|Overall Study||17
212575|NCT01240811|514603|P2|STARTED|Overall Study||17
212576|NCT01240811|514604|P1|STARTED|Overall Study||8
212577|NCT01240785|514620|P2|NOT COMPLETED|Overall Study||3
212578|NCT01240785|514621|P1|NOT COMPLETED|Overall Study||1
212579|NCT01240785|514620|P2|COMPLETED|Overall Study||107
212580|NCT01240785|514621|P1|COMPLETED|Overall Study|110 women completed in the metformin arm and 107 women completed in the insulin arm.|110
212581|NCT01240785|514620|P2|STARTED|Overall Study||110
212582|NCT01240785|514621|P1|STARTED|Overall Study||111
212583|NCT01240746|514652|P3|NOT COMPLETED|Overall Study||243
212584|NCT01240746|514653|P2|NOT COMPLETED|Overall Study||48
212585|NCT01240746|514654|P1|NOT COMPLETED|Overall Study||59
212586|NCT01240746|514652|P3|COMPLETED|Overall Study||2659
212587|NCT01240746|514653|P2|COMPLETED|Overall Study||677
212588|NCT01240746|514654|P1|COMPLETED|Overall Study||677
212589|NCT01240746|514652|P3|STARTED|Overall Study||2902
212590|NCT01240746|514653|P2|STARTED|Overall Study||725
212591|NCT01240746|514654|P1|STARTED|Overall Study||736
212592|NCT01240590|514709|P5|NOT COMPLETED|Phase II||1
212593|NCT01240590|514710|P4|NOT COMPLETED|Phase II||2
212594|NCT01240590|514711|P3|NOT COMPLETED|Phase II||0
212595|NCT01240590|514712|P2|NOT COMPLETED|Phase II||0
212596|NCT01240590|514713|P1|NOT COMPLETED|Phase II||0
212597|NCT01240590|514709|P5|COMPLETED|Phase II||0
212598|NCT01240590|514710|P4|COMPLETED|Phase II||15
212599|NCT01240590|514711|P3|COMPLETED|Phase II||0
212600|NCT01240590|514712|P2|COMPLETED|Phase II||0
212601|NCT01240590|514713|P1|COMPLETED|Phase II||0
212602|NCT01240590|514709|P5|STARTED|Phase II||1
212603|NCT01240590|514710|P4|STARTED|Phase II||17
212604|NCT01240590|514711|P3|STARTED|Phase II||0
212605|NCT01240590|514712|P2|STARTED|Phase II||0
212606|NCT01240590|514713|P1|STARTED|Phase II||0
212607|NCT01240590|514709|P5|NOT COMPLETED|Phase I||0
212608|NCT01240590|514710|P4|NOT COMPLETED|Phase I||0
212609|NCT01240590|514711|P3|NOT COMPLETED|Phase I||3
212610|NCT01240590|514712|P2|NOT COMPLETED|Phase I||0
212611|NCT01240590|514713|P1|NOT COMPLETED|Phase I||0
212612|NCT01240590|514709|P5|COMPLETED|Phase I||0
212613|NCT01240590|514710|P4|COMPLETED|Phase I||0
212614|NCT01240590|514711|P3|COMPLETED|Phase I||0
212615|NCT01240590|514712|P2|COMPLETED|Phase I||6
212616|NCT01240590|514713|P1|COMPLETED|Phase I||0
212617|NCT01240590|514709|P5|STARTED|Phase I||0
212618|NCT01240590|514710|P4|STARTED|Phase I||0
212619|NCT01240590|514711|P3|STARTED|Phase I||3
212620|NCT01240590|514712|P2|STARTED|Phase I||6
212621|NCT01240590|514713|P1|STARTED|Phase I||0
212622|NCT01240551|514741|P2|NOT COMPLETED|Overall Study||3
212623|NCT01240551|514742|P1|NOT COMPLETED|Overall Study||4
212624|NCT01240551|514741|P2|COMPLETED|Overall Study||27
212625|NCT01240551|514742|P1|COMPLETED|Overall Study||26
212626|NCT01240551|514741|P2|STARTED|Overall Study||30
212627|NCT01240551|514742|P1|STARTED|Overall Study||30
212628|NCT01240382|514752|P2|NOT COMPLETED|Overall Study||4
212629|NCT01240382|514753|P1|NOT COMPLETED|Overall Study||2
212630|NCT01240382|514752|P2|COMPLETED|Overall Study||139
212631|NCT01240382|514753|P1|COMPLETED|Overall Study||142
212632|NCT01240382|514752|P2|STARTED|Overall Study||143
212633|NCT01240382|514753|P1|STARTED|Overall Study||144
212634|NCT01240356|514763|P2|NOT COMPLETED|Overall Study||0
212635|NCT01240356|514764|P1|NOT COMPLETED|Overall Study||3
212636|NCT01240356|514763|P2|COMPLETED|Overall Study||20
212637|NCT01240356|514764|P1|COMPLETED|Overall Study||15
212638|NCT01240356|514763|P2|STARTED|Overall Study||20
212639|NCT01240356|514764|P1|STARTED|Overall Study||18
212640|NCT01240330|514775|P1|NOT COMPLETED|Overall Study||0
212641|NCT01240330|514775|P1|COMPLETED|Overall Study||33
212642|NCT01240330|514775|P1|STARTED|Overall Study||33
212643|NCT01240200|514783|P2|NOT COMPLETED|12-week Crossover Phase - Period 2||0
212644|NCT01240200|514784|P1|NOT COMPLETED|12-week Crossover Phase - Period 2||0
212645|NCT01240200|514783|P2|COMPLETED|12-week Crossover Phase - Period 2||23
212646|NCT01240200|514784|P1|COMPLETED|12-week Crossover Phase - Period 2||23
212647|NCT01240200|514783|P2|STARTED|12-week Crossover Phase - Period 2||23
212648|NCT01240200|514784|P1|STARTED|12-week Crossover Phase - Period 2||23
212649|NCT01240200|514783|P2|NOT COMPLETED|12-week Crossover Phase - Period 1||1
212650|NCT01240200|514784|P1|NOT COMPLETED|12-week Crossover Phase - Period 1||2
212651|NCT01240200|514783|P2|COMPLETED|12-week Crossover Phase - Period 1||23
212652|NCT01240200|514784|P1|COMPLETED|12-week Crossover Phase - Period 1||23
212653|NCT01240200|514783|P2|STARTED|12-week Crossover Phase - Period 1||24
212654|NCT01240200|514784|P1|STARTED|12-week Crossover Phase - Period 1||25
212655|NCT01240135|514802|P2|NOT COMPLETED|Period Two, 14 Days of Wear||2
212656|NCT01240135|514803|P1|NOT COMPLETED|Period Two, 14 Days of Wear||1
212657|NCT01240135|514802|P2|COMPLETED|Period Two, 14 Days of Wear||43
212658|NCT01240135|514803|P1|COMPLETED|Period Two, 14 Days of Wear||43
212659|NCT01240135|514802|P2|STARTED|Period Two, 14 Days of Wear||45
212660|NCT01240135|514803|P1|STARTED|Period Two, 14 Days of Wear||44
212661|NCT01240135|514802|P2|NOT COMPLETED|Period One, 14 Days of Wear||0
212662|NCT01240135|514803|P1|NOT COMPLETED|Period One, 14 Days of Wear||0
212663|NCT01240135|514802|P2|COMPLETED|Period One, 14 Days of Wear||45
212664|NCT01240135|514803|P1|COMPLETED|Period One, 14 Days of Wear||44
212665|NCT01240135|514802|P2|STARTED|Period One, 14 Days of Wear||45
212666|NCT01240135|514803|P1|STARTED|Period One, 14 Days of Wear||44
212667|NCT01240122|514811|P1|NOT COMPLETED|Overall Study||0
212668|NCT01240122|514811|P1|COMPLETED|Overall Study||29
212669|NCT01240122|514811|P1|STARTED|Overall Study||29
212670|NCT01239992|514820|P1|NOT COMPLETED|Overall Study||2
212671|NCT01239992|514820|P1|COMPLETED|Overall Study||10
212672|NCT01239992|514820|P1|STARTED|Overall Study||12
212673|NCT01239797|514829|P2|NOT COMPLETED|Treated Participants||274
212674|NCT01239797|514830|P1|NOT COMPLETED|Treated Participants||235
212675|NCT01239797|514829|P2|COMPLETED|Treated Participants|Completed = Still on Treatment|43
212676|NCT01239797|514830|P1|COMPLETED|Treated Participants|Completed = Still on Treatment|83
212677|NCT01239797|514829|P2|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|317
212678|NCT01239797|514830|P1|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|318
212679|NCT01239797|514829|P2|NOT COMPLETED|Randomized Participants||9
212680|NCT01239797|514830|P1|NOT COMPLETED|Randomized Participants||2
212681|NCT01239797|514829|P2|COMPLETED|Randomized Participants||316
212682|NCT01239797|514830|P1|COMPLETED|Randomized Participants||319
212683|NCT01239797|514829|P2|STARTED|Randomized Participants||325
212684|NCT01239797|514830|P1|STARTED|Randomized Participants||321
212685|NCT01239745|514838|P1|NOT COMPLETED|Overall Study||46
212686|NCT01239745|514838|P1|COMPLETED|Overall Study||0
212687|NCT01239745|514838|P1|STARTED|Overall Study||46
212688|NCT01239732|514849|P1|NOT COMPLETED|Overall Study||1021
212689|NCT01239732|514849|P1|COMPLETED|Overall Study||0
212690|NCT01239732|514849|P1|STARTED|Overall Study||1021
212691|NCT01239680|514862|P2|NOT COMPLETED|Overall Study||0
212692|NCT01239680|514863|P1|NOT COMPLETED|Overall Study||2
212693|NCT01239680|514862|P2|COMPLETED|Overall Study||2
212694|NCT01239680|514863|P1|COMPLETED|Overall Study||1
212695|NCT01239680|514862|P2|STARTED|Overall Study||2
212696|NCT01239680|514863|P1|STARTED|Overall Study||3
212697|NCT01239511|514873|P4|NOT COMPLETED|Overall Study||9
212698|NCT01239511|514874|P3|NOT COMPLETED|Overall Study||4
212699|NCT01239511|514875|P2|NOT COMPLETED|Overall Study||5
212700|NCT01239511|514876|P1|NOT COMPLETED|Overall Study||1
212701|NCT01239511|514873|P4|COMPLETED|Overall Study||38
212702|NCT01239511|514874|P3|COMPLETED|Overall Study||43
212703|NCT01239511|514875|P2|COMPLETED|Overall Study||40
212704|NCT01239511|514876|P1|COMPLETED|Overall Study||46
212705|NCT01239511|514873|P4|STARTED|Overall Study||47
212706|NCT01239511|514874|P3|STARTED|Overall Study||47
212707|NCT01239511|514875|P2|STARTED|Overall Study||45
212708|NCT01239511|514876|P1|STARTED|Overall Study||47
212709|NCT01239472|514888|P2|NOT COMPLETED|Overall Study||3
212710|NCT01239472|514889|P1|NOT COMPLETED|Overall Study||5
212711|NCT01239472|514888|P2|COMPLETED|Overall Study||12
212712|NCT01239472|514889|P1|COMPLETED|Overall Study||10
212713|NCT01239472|514888|P2|STARTED|Overall Study||15
212714|NCT01239472|514889|P1|STARTED|Overall Study||15
212715|NCT01239394|514897|P1|NOT COMPLETED|Overall Study||1
212716|NCT01239394|514897|P1|COMPLETED|Overall Study||41
212717|NCT01239394|514897|P1|STARTED|Overall Study||42
212718|NCT01239381|514904|P1|NOT COMPLETED|Overall Study||2
212719|NCT01239381|514904|P1|COMPLETED|Overall Study||90
212720|NCT01239381|514904|P1|STARTED|Overall Study||92
212721|NCT01239368|514924|P10|NOT COMPLETED|Overall Study||4
212722|NCT01239368|514925|P9|NOT COMPLETED|Overall Study||0
212723|NCT01239368|514926|P8|NOT COMPLETED|Overall Study||0
212724|NCT01239368|514927|P7|NOT COMPLETED|Overall Study||6
212725|NCT01239368|514928|P6|NOT COMPLETED|Overall Study||4
212726|NCT01239368|514929|P5|NOT COMPLETED|Overall Study||5
212727|NCT01239368|514930|P4|NOT COMPLETED|Overall Study||1
212728|NCT01239368|514931|P3|NOT COMPLETED|Overall Study||1
212729|NCT01239368|514932|P2|NOT COMPLETED|Overall Study||1
212730|NCT01239368|514933|P1|NOT COMPLETED|Overall Study||2
212731|NCT01239368|514924|P10|COMPLETED|Overall Study||1
212732|NCT01239368|514925|P9|COMPLETED|Overall Study||1
212733|NCT01239368|514926|P8|COMPLETED|Overall Study||0
212734|NCT01239368|514927|P7|COMPLETED|Overall Study||1
212735|NCT01239368|514928|P6|COMPLETED|Overall Study||1
212736|NCT01239368|514929|P5|COMPLETED|Overall Study||2
212737|NCT01239368|514930|P4|COMPLETED|Overall Study||1
212738|NCT01239368|514931|P3|COMPLETED|Overall Study||0
212739|NCT01239368|514932|P2|COMPLETED|Overall Study||0
212740|NCT01239368|514933|P1|COMPLETED|Overall Study||0
212741|NCT01239368|514924|P10|STARTED|Overall Study||5
212742|NCT01239368|514925|P9|STARTED|Overall Study||1
212743|NCT01239368|514926|P8|STARTED|Overall Study||0
212744|NCT01239368|514927|P7|STARTED|Overall Study||7
212745|NCT01239368|514928|P6|STARTED|Overall Study||5
212746|NCT01239368|514929|P5|STARTED|Overall Study||7
212747|NCT01239368|514930|P4|STARTED|Overall Study||2
212748|NCT01239368|514931|P3|STARTED|Overall Study||1
212749|NCT01239368|514932|P2|STARTED|Overall Study||1
212750|NCT01239368|514933|P1|STARTED|Overall Study||2
212751|NCT01239355|514977|P1|NOT COMPLETED|Overall Study||0
212752|NCT01239355|514977|P1|COMPLETED|Overall Study||15
212753|NCT01239355|514977|P1|STARTED|Overall Study||15
212754|NCT01239342|514985|P2|NOT COMPLETED|Overall Study||6
212755|NCT01239342|514986|P1|NOT COMPLETED|Overall Study||3
212756|NCT01239342|514985|P2|COMPLETED|Overall Study||8
212757|NCT01239342|514986|P1|COMPLETED|Overall Study||26
212758|NCT01239342|514985|P2|STARTED|Overall Study||14
212759|NCT01239342|514986|P1|STARTED|Overall Study||29
212760|NCT01239316|515002|P1|NOT COMPLETED|Overall Study||12
212761|NCT01239316|515002|P1|COMPLETED|Overall Study||0
212762|NCT01239316|515002|P1|STARTED|Overall Study||12
212763|NCT01239212|515010|P1|NOT COMPLETED|Overall Study||0
212764|NCT01239212|515010|P1|COMPLETED|Overall Study||7
212765|NCT01239212|515010|P1|STARTED|Overall Study||7
212766|NCT01239121|515017|P3|NOT COMPLETED|Overall Study||0
212767|NCT01239121|515018|P2|NOT COMPLETED|Overall Study||4
212768|NCT01239121|515019|P1|NOT COMPLETED|Overall Study||2
212769|NCT01239121|515017|P3|COMPLETED|Overall Study||15
212770|NCT01239121|515018|P2|COMPLETED|Overall Study||195
212771|NCT01239121|515019|P1|COMPLETED|Overall Study||186
212772|NCT01239121|515017|P3|STARTED|Overall Study||15
212773|NCT01239121|515018|P2|STARTED|Overall Study||199
212774|NCT01239121|515019|P1|STARTED|Overall Study||188
212775|NCT01239056|515033|P1|NOT COMPLETED|Overall Study||0
212776|NCT01239056|515033|P1|COMPLETED|Overall Study||20
212777|NCT01239056|515033|P1|STARTED|Overall Study||20
212778|NCT01239043|515041|P2|NOT COMPLETED|Overall Study||1
212779|NCT01239043|515042|P1|NOT COMPLETED|Overall Study||2
212780|NCT01239043|515041|P2|COMPLETED|Overall Study||102
212781|NCT01239043|515042|P1|COMPLETED|Overall Study||34
212782|NCT01239043|515041|P2|STARTED|Overall Study||103
212783|NCT01239043|515042|P1|STARTED|Overall Study|For safety analysis number includes 1 participant randomized to Menactra who received Menomune.|36
212784|NCT01238991|515070|P10|NOT COMPLETED|Overall Study||2
212785|NCT01238991|515071|P9|NOT COMPLETED|Overall Study||4
212786|NCT01238991|515072|P8|NOT COMPLETED|Overall Study||5
212787|NCT01238991|515073|P7|NOT COMPLETED|Overall Study||8
212788|NCT01238991|515074|P6|NOT COMPLETED|Overall Study||0
212789|NCT01238991|515075|P5|NOT COMPLETED|Overall Study||2
212790|NCT01238991|515076|P4|NOT COMPLETED|Overall Study||2
212791|NCT01238991|515077|P3|NOT COMPLETED|Overall Study||6
212792|NCT01238991|515078|P2|NOT COMPLETED|Overall Study||0
212793|NCT01238991|515079|P1|NOT COMPLETED|Overall Study||2
212794|NCT01238991|515070|P10|COMPLETED|Overall Study||0
212795|NCT01238991|515071|P9|COMPLETED|Overall Study||0
212796|NCT01238991|515072|P8|COMPLETED|Overall Study||0
212797|NCT01238991|515073|P7|COMPLETED|Overall Study||0
212798|NCT01238991|515074|P6|COMPLETED|Overall Study||2
212799|NCT01238991|515075|P5|COMPLETED|Overall Study||3
212800|NCT01238991|515076|P4|COMPLETED|Overall Study||4
212801|NCT01238991|515077|P3|COMPLETED|Overall Study||5
212802|NCT01238991|515078|P2|COMPLETED|Overall Study||3
212803|NCT01238991|515079|P1|COMPLETED|Overall Study||5
212804|NCT01238991|515070|P10|Received Treatment|Overall Study||2
212805|NCT01238991|515071|P9|Received Treatment|Overall Study||4
212806|NCT01238991|515072|P8|Received Treatment|Overall Study||5
212807|NCT01238991|515073|P7|Received Treatment|Overall Study||8
212808|NCT01238991|515074|P6|Received Treatment|Overall Study||2
212809|NCT01238991|515075|P5|Received Treatment|Overall Study||5
212810|NCT01238991|515076|P4|Received Treatment|Overall Study||6
212811|NCT01238991|515077|P3|Received Treatment|Overall Study||11
212812|NCT01238991|515078|P2|Received Treatment|Overall Study||3
212813|NCT01238991|515079|P1|Received Treatment|Overall Study||7
212814|NCT01238991|515070|P10|STARTED|Overall Study||2
212815|NCT01238991|515071|P9|STARTED|Overall Study||4
212816|NCT01238991|515072|P8|STARTED|Overall Study||5
212817|NCT01238991|515073|P7|STARTED|Overall Study||8
212818|NCT01238991|515074|P6|STARTED|Overall Study||2
212819|NCT01238991|515075|P5|STARTED|Overall Study||5
212820|NCT01238991|515076|P4|STARTED|Overall Study||6
212821|NCT01238991|515077|P3|STARTED|Overall Study||11
212822|NCT01238991|515078|P2|STARTED|Overall Study||3
212823|NCT01238991|515079|P1|STARTED|Overall Study||7
212824|NCT01238900|515166|P1|NOT COMPLETED|<12 Months Post Stent Removal||5
212825|NCT01238900|515166|P1|COMPLETED|<12 Months Post Stent Removal||18
212826|NCT01238900|515166|P1|STARTED|<12 Months Post Stent Removal||23
212827|NCT01238900|515166|P1|NOT COMPLETED|6 Months Post Stent Placement||0
212828|NCT01238900|515166|P1|COMPLETED|6 Months Post Stent Placement||23
212829|NCT01238900|515166|P1|STARTED|6 Months Post Stent Placement||23
212830|NCT01238861|515180|P6|NOT COMPLETED|Overall Study||15
212831|NCT01238861|515181|P5|NOT COMPLETED|Overall Study||13
212832|NCT01238861|515182|P4|NOT COMPLETED|Overall Study||13
212833|NCT01238861|515183|P3|NOT COMPLETED|Overall Study||11
212834|NCT01238861|515184|P2|NOT COMPLETED|Overall Study||8
212835|NCT01238861|515185|P1|NOT COMPLETED|Overall Study||11
212836|NCT01238861|515180|P6|COMPLETED|Overall Study||125
212837|NCT01238861|515181|P5|COMPLETED|Overall Study||129
212838|NCT01238861|515182|P4|COMPLETED|Overall Study||69
212839|NCT01238861|515183|P3|COMPLETED|Overall Study||70
212840|NCT01238861|515184|P2|COMPLETED|Overall Study||73
212841|NCT01238861|515185|P1|COMPLETED|Overall Study||69
212842|NCT01238861|515180|P6|STARTED|Overall Study||140
212843|NCT01238861|515181|P5|STARTED|Overall Study||142
212844|NCT01238861|515182|P4|STARTED|Overall Study||82
212845|NCT01238861|515183|P3|STARTED|Overall Study||81
212846|NCT01238861|515184|P2|STARTED|Overall Study||81
212847|NCT01238861|515185|P1|STARTED|Overall Study||80
212848|NCT01238848|515265|P2|NOT COMPLETED|Overall Study||5
212849|NCT01238848|515266|P1|NOT COMPLETED|Overall Study||13
212850|NCT01238848|515265|P2|COMPLETED|Overall Study||45
212851|NCT01238848|515266|P1|COMPLETED|Overall Study||37
212852|NCT01238848|515265|P2|STARTED|Overall Study||50
212853|NCT01238848|515266|P1|STARTED|Overall Study||50
212854|NCT01238822|515274|P1|NOT COMPLETED|Overall Study||3
212855|NCT01238822|515274|P1|COMPLETED|Overall Study||93
212856|NCT01238822|515274|P1|Received High Dosage|Overall Study||93
212857|NCT01238822|515274|P1|Received Medium Dosage|Overall Study||93
212858|NCT01238822|515274|P1|Received Low Dosage|Overall Study||93
212859|NCT01238822|515274|P1|Received Placebo|Overall Study||93
212860|NCT01238822|515274|P1|STARTED|Overall Study||96
212861|NCT01238640|515284|P1|NOT COMPLETED|Overall Study||0
212862|NCT01238640|515284|P1|COMPLETED|Overall Study||84
212863|NCT01238640|515284|P1|STARTED|Overall Study||84
212864|NCT01238588|515301|P1|NOT COMPLETED|Overall Study||3
212865|NCT01238588|515301|P1|COMPLETED|Overall Study||9
212866|NCT01238588|515301|P1|STARTED|Overall Study||12
212867|NCT01238575|515314|P2|NOT COMPLETED|Overall Study||4
212868|NCT01238575|515315|P1|NOT COMPLETED|Overall Study||4
212869|NCT01238575|515314|P2|COMPLETED|Overall Study||28
212870|NCT01238575|515315|P1|COMPLETED|Overall Study||26
212871|NCT01238575|515314|P2|STARTED|Overall Study||32
212872|NCT01238575|515315|P1|STARTED|Overall Study||30
212873|NCT01238549|515351|P1|NOT COMPLETED|Overall Study||36
212874|NCT01238549|515351|P1|COMPLETED|Overall Study||248
212875|NCT01238549|515351|P1|STARTED|Overall Study||284
212876|NCT01238536|515370|P2|NOT COMPLETED|Overall Study||50
212877|NCT01238536|515371|P1|NOT COMPLETED|Overall Study||47
212878|NCT01238536|515370|P2|COMPLETED|Overall Study||150
212879|NCT01238536|515371|P1|COMPLETED|Overall Study||153
212880|NCT01238536|515370|P2|STARTED|Overall Study||200
212881|NCT01238536|515371|P1|STARTED|Overall Study||200
212882|NCT01238471|515385|P2|NOT COMPLETED|Overall Study||0
212883|NCT01238471|515386|P1|NOT COMPLETED|Overall Study||0
212884|NCT01238471|515385|P2|COMPLETED|Overall Study||10
212885|NCT01238471|515386|P1|COMPLETED|Overall Study||10
212886|NCT01238471|515385|P2|STARTED|Overall Study||10
212887|NCT01238471|515386|P1|STARTED|Overall Study||10
212888|NCT01238341|515392|P1|NOT COMPLETED|Overall Study||0
212889|NCT01238341|515392|P1|COMPLETED|Overall Study||7
212890|NCT01238341|515392|P1|STARTED|Overall Study||7
212891|NCT01238211|515399|P1|NOT COMPLETED|Overall Study||58
212892|NCT01238211|515399|P1|COMPLETED|Overall Study||3
212893|NCT01238211|515399|P1|STARTED|Overall Study||61
212894|NCT01238172|515405|P2|NOT COMPLETED|Overall Study||24
212895|NCT01238172|515406|P1|NOT COMPLETED|Overall Study||11
212896|NCT01238172|515405|P2|COMPLETED|Overall Study||217
212897|NCT01238172|515406|P1|COMPLETED|Overall Study||226
212898|NCT01238172|515405|P2|STARTED|Overall Study||241
212899|NCT01238172|515406|P1|STARTED|Overall Study||237
212900|NCT01237899|515429|P11|NOT COMPLETED|Second Dosing Period||0
212901|NCT01237899|515430|P10|NOT COMPLETED|Second Dosing Period||0
212902|NCT01237899|515431|P9|NOT COMPLETED|Second Dosing Period||0
212903|NCT01237899|515432|P8|NOT COMPLETED|Second Dosing Period||0
212904|NCT01237899|515433|P7|NOT COMPLETED|Second Dosing Period||0
212905|NCT01237899|515434|P6|NOT COMPLETED|Second Dosing Period||0
212906|NCT01237899|515435|P5|NOT COMPLETED|Second Dosing Period||0
212907|NCT01237899|515436|P4|NOT COMPLETED|Second Dosing Period||0
212908|NCT01237899|515437|P3|NOT COMPLETED|Second Dosing Period||0
212909|NCT01237899|515438|P2|NOT COMPLETED|Second Dosing Period||0
212910|NCT01237899|515439|P1|NOT COMPLETED|Second Dosing Period||0
212911|NCT01237899|515429|P11|COMPLETED|Second Dosing Period||4
212912|NCT01237899|515430|P10|COMPLETED|Second Dosing Period||3
212913|NCT01237899|515431|P9|COMPLETED|Second Dosing Period||4
212914|NCT01237899|515432|P8|COMPLETED|Second Dosing Period||3
212915|NCT01237899|515433|P7|COMPLETED|Second Dosing Period||1
212916|NCT01237899|515434|P6|COMPLETED|Second Dosing Period||4
212917|NCT01237899|515435|P5|COMPLETED|Second Dosing Period||2
212918|NCT01237899|515436|P4|COMPLETED|Second Dosing Period||3
212919|NCT01237899|515437|P3|COMPLETED|Second Dosing Period||3
212920|NCT01237899|515438|P2|COMPLETED|Second Dosing Period||3
212921|NCT01237899|515439|P1|COMPLETED|Second Dosing Period||1
212922|NCT01237899|515429|P11|STARTED|Second Dosing Period||4
212923|NCT01237899|515430|P10|STARTED|Second Dosing Period||3
212924|NCT01237899|515431|P9|STARTED|Second Dosing Period||4
212925|NCT01237899|515432|P8|STARTED|Second Dosing Period||3
212926|NCT01237899|515433|P7|STARTED|Second Dosing Period||1
212927|NCT01237899|515434|P6|STARTED|Second Dosing Period||4
212928|NCT01237899|515435|P5|STARTED|Second Dosing Period||2
212929|NCT01237899|515436|P4|STARTED|Second Dosing Period||3
212930|NCT01237899|515437|P3|STARTED|Second Dosing Period||3
212931|NCT01237899|515438|P2|STARTED|Second Dosing Period||3
212932|NCT01237899|515439|P1|STARTED|Second Dosing Period||1
212933|NCT01237899|515429|P11|NOT COMPLETED|Washout Period of at Least 7 Days||0
212934|NCT01237899|515430|P10|NOT COMPLETED|Washout Period of at Least 7 Days||0
212935|NCT01237899|515431|P9|NOT COMPLETED|Washout Period of at Least 7 Days||0
212936|NCT01237899|515432|P8|NOT COMPLETED|Washout Period of at Least 7 Days||0
212937|NCT01237899|515433|P7|NOT COMPLETED|Washout Period of at Least 7 Days||0
212938|NCT01237899|515434|P6|NOT COMPLETED|Washout Period of at Least 7 Days||0
212939|NCT01237899|515435|P5|NOT COMPLETED|Washout Period of at Least 7 Days||0
212940|NCT01237899|515436|P4|NOT COMPLETED|Washout Period of at Least 7 Days||0
212941|NCT01237899|515437|P3|NOT COMPLETED|Washout Period of at Least 7 Days||1
212942|NCT01237899|515438|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
212943|NCT01237899|515439|P1|NOT COMPLETED|Washout Period of at Least 7 Days||0
212944|NCT01237899|515429|P11|COMPLETED|Washout Period of at Least 7 Days||4
212945|NCT01237899|515430|P10|COMPLETED|Washout Period of at Least 7 Days||3
212946|NCT01237899|515431|P9|COMPLETED|Washout Period of at Least 7 Days||4
212947|NCT01237899|515432|P8|COMPLETED|Washout Period of at Least 7 Days||3
212948|NCT01237899|515433|P7|COMPLETED|Washout Period of at Least 7 Days||1
212949|NCT01237899|515434|P6|COMPLETED|Washout Period of at Least 7 Days||4
212950|NCT01237899|515435|P5|COMPLETED|Washout Period of at Least 7 Days||2
212951|NCT01237899|515436|P4|COMPLETED|Washout Period of at Least 7 Days||3
212952|NCT01237899|515437|P3|COMPLETED|Washout Period of at Least 7 Days||3
212953|NCT01237899|515438|P2|COMPLETED|Washout Period of at Least 7 Days||3
212954|NCT01237899|515439|P1|COMPLETED|Washout Period of at Least 7 Days||1
212955|NCT01237899|515429|P11|STARTED|Washout Period of at Least 7 Days||4
212956|NCT01237899|515430|P10|STARTED|Washout Period of at Least 7 Days||3
212957|NCT01237899|515431|P9|STARTED|Washout Period of at Least 7 Days||4
212958|NCT01237899|515432|P8|STARTED|Washout Period of at Least 7 Days||3
212959|NCT01237899|515433|P7|STARTED|Washout Period of at Least 7 Days||1
212960|NCT01237899|515434|P6|STARTED|Washout Period of at Least 7 Days||4
212961|NCT01237899|515435|P5|STARTED|Washout Period of at Least 7 Days||2
212962|NCT01237899|515436|P4|STARTED|Washout Period of at Least 7 Days||3
212963|NCT01237899|515437|P3|STARTED|Washout Period of at Least 7 Days||4
212964|NCT01237899|515438|P2|STARTED|Washout Period of at Least 7 Days||3
212965|NCT01237899|515439|P1|STARTED|Washout Period of at Least 7 Days||1
212966|NCT01237899|515429|P11|NOT COMPLETED|First Dosing Period||0
212967|NCT01237899|515430|P10|NOT COMPLETED|First Dosing Period||0
212968|NCT01237899|515431|P9|NOT COMPLETED|First Dosing Period||0
212969|NCT01237899|515432|P8|NOT COMPLETED|First Dosing Period||0
212970|NCT01237899|515433|P7|NOT COMPLETED|First Dosing Period||0
212971|NCT01237899|515434|P6|NOT COMPLETED|First Dosing Period||0
212972|NCT01237899|515435|P5|NOT COMPLETED|First Dosing Period||0
212973|NCT01237899|515436|P4|NOT COMPLETED|First Dosing Period||0
212974|NCT01237899|515437|P3|NOT COMPLETED|First Dosing Period||0
212975|NCT01237899|515438|P2|NOT COMPLETED|First Dosing Period||0
212976|NCT01237899|515439|P1|NOT COMPLETED|First Dosing Period||0
212977|NCT01237899|515429|P11|COMPLETED|First Dosing Period||4
212978|NCT01237899|515430|P10|COMPLETED|First Dosing Period||3
212979|NCT01237899|515431|P9|COMPLETED|First Dosing Period||4
212980|NCT01237899|515432|P8|COMPLETED|First Dosing Period||3
212981|NCT01237899|515433|P7|COMPLETED|First Dosing Period||1
212982|NCT01237899|515434|P6|COMPLETED|First Dosing Period||4
212983|NCT01237899|515435|P5|COMPLETED|First Dosing Period||2
212984|NCT01237899|515436|P4|COMPLETED|First Dosing Period||3
212985|NCT01237899|515437|P3|COMPLETED|First Dosing Period||4
212986|NCT01237899|515438|P2|COMPLETED|First Dosing Period||3
212987|NCT01237899|515439|P1|COMPLETED|First Dosing Period||1
212988|NCT01237899|515429|P11|STARTED|First Dosing Period||4
212989|NCT01237899|515430|P10|STARTED|First Dosing Period||3
212990|NCT01237899|515431|P9|STARTED|First Dosing Period||4
212991|NCT01237899|515432|P8|STARTED|First Dosing Period||3
212992|NCT01237899|515433|P7|STARTED|First Dosing Period||1
212993|NCT01237899|515434|P6|STARTED|First Dosing Period||4
212994|NCT01237899|515435|P5|STARTED|First Dosing Period||2
212995|NCT01237899|515436|P4|STARTED|First Dosing Period||3
212996|NCT01237899|515437|P3|STARTED|First Dosing Period||4
212997|NCT01237899|515438|P2|STARTED|First Dosing Period||3
212998|NCT01237899|515439|P1|STARTED|First Dosing Period||1
212999|NCT01237821|515469|P2|NOT COMPLETED|Overall Study||0
213000|NCT01237821|515470|P1|NOT COMPLETED|Overall Study||6
213001|NCT01237821|515469|P2|COMPLETED|Overall Study||34
213002|NCT01237821|515470|P1|COMPLETED|Overall Study||26
213003|NCT01237821|515469|P2|STARTED|Overall Study||34
213004|NCT01237821|515470|P1|STARTED|Overall Study||32
213005|NCT01237678|515519|P3|NOT COMPLETED|Phase II||50
213006|NCT01237678|515520|P2|NOT COMPLETED|Phase II||98
213007|NCT01237678|515521|P1|NOT COMPLETED|Phase II||0
213008|NCT01237678|515519|P3|COMPLETED|Phase II||0
213009|NCT01237678|515520|P2|COMPLETED|Phase II||0
213010|NCT01237678|515521|P1|COMPLETED|Phase II||0
213011|NCT01237678|515519|P3|Received Intervention|Phase II||47
213012|NCT01237678|515520|P2|Received Intervention|Phase II||94
213013|NCT01237678|515521|P1|Received Intervention|Phase II||0
213014|NCT01237678|515519|P3|STARTED|Phase II|50 subjects were randomized, 47 subjects treated|50
213015|NCT01237678|515520|P2|STARTED|Phase II|98 subjects were randomized, 94 subjects treated|98
213016|NCT01237678|515521|P1|STARTED|Phase II||0
213017|NCT01237678|515519|P3|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
213018|NCT01237678|515520|P2|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
213019|NCT01237678|515521|P1|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||33
213020|NCT01237678|515519|P3|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
213021|NCT01237678|515520|P2|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
213022|NCT01237678|515521|P1|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
213023|NCT01237678|515519|P3|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
213024|NCT01237678|515520|P2|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
213025|NCT01237678|515521|P1|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||33
213026|NCT01237678|515519|P3|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
213027|NCT01237678|515520|P2|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
213028|NCT01237678|515521|P1|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||33
213029|NCT01237613|515540|P1|NOT COMPLETED|Overall Study||0
213030|NCT01237613|515540|P1|COMPLETED|Overall Study||4
213031|NCT01237613|515540|P1|STARTED|Overall Study||4
213032|NCT01237587|515566|P2|NOT COMPLETED|Taper Phase||10
213033|NCT01237587|515567|P1|NOT COMPLETED|Taper Phase||5
213034|NCT01237587|515566|P2|COMPLETED|Taper Phase||34
213035|NCT01237587|515567|P1|COMPLETED|Taper Phase||31
213036|NCT01237587|515566|P2|STARTED|Taper Phase|Participants who discontinued Acute or Extension phase had an option to enter tapering phase.|44
213037|NCT01237587|515567|P1|STARTED|Taper Phase|Participants who discontinued Acute or Extension phase had an option to enter tapering phase.|36
213038|NCT01237587|515566|P2|NOT COMPLETED|Open Label Treatment (Extension Phase)||25
213039|NCT01237587|515567|P1|NOT COMPLETED|Open Label Treatment (Extension Phase)||18
213040|NCT01237587|515566|P2|COMPLETED|Open Label Treatment (Extension Phase)||50
213041|NCT01237587|515567|P1|COMPLETED|Open Label Treatment (Extension Phase)||56
213042|NCT01237587|515566|P2|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||75
213043|NCT01237587|515567|P1|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||74
213044|NCT01237587|515566|P2|STARTED|Open Label Treatment (Extension Phase)||75
213045|NCT01237587|515567|P1|STARTED|Open Label Treatment (Extension Phase)||74
213046|NCT01237587|515566|P2|NOT COMPLETED|Double Blind Treatment (Acute Phase)||18
213047|NCT01237587|515567|P1|NOT COMPLETED|Double Blind Treatment (Acute Phase)||17
213048|NCT01237587|515566|P2|COMPLETED|Double Blind Treatment (Acute Phase)||75
213049|NCT01237587|515567|P1|COMPLETED|Double Blind Treatment (Acute Phase)||74
213050|NCT01237587|515566|P2|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||93
213051|NCT01237587|515567|P1|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||91
213052|NCT01237587|515566|P2|STARTED|Double Blind Treatment (Acute Phase)||93
213053|NCT01237587|515567|P1|STARTED|Double Blind Treatment (Acute Phase)||91
213054|NCT01237353|515614|P1|NOT COMPLETED|Overall Study||0
213055|NCT01237353|515614|P1|COMPLETED|Overall Study||6
213056|NCT01237353|515614|P1|STARTED|Overall Study||6
213057|NCT01237340|515619|P1|NOT COMPLETED|Overall Study||40
213058|NCT01237340|515619|P1|COMPLETED|Overall Study||19
213059|NCT01237340|515619|P1|STARTED|Overall Study||59
213060|NCT01237327|515633|P2|NOT COMPLETED|Overall Study||40
213061|NCT01237327|515634|P1|NOT COMPLETED|Overall Study||42
213062|NCT01237327|515633|P2|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
213063|NCT01237327|515634|P1|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
213064|NCT01237327|515633|P2|Continued Treatment in Extension Study|Overall Study||17
213065|NCT01237327|515634|P1|Continued Treatment in Extension Study|Overall Study||21
213066|NCT01237327|515633|P2|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|2
213067|NCT01237327|515634|P1|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|3
213068|NCT01237327|515633|P2|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|24
213069|NCT01237327|515634|P1|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|22
213070|NCT01237327|515633|P2|STARTED|Overall Study||41
213071|NCT01237327|515634|P1|STARTED|Overall Study||43
213072|NCT01237301|515650|P2|NOT COMPLETED|Overall Study||4
213073|NCT01237301|515651|P1|NOT COMPLETED|Overall Study||5
213074|NCT01237301|515650|P2|COMPLETED|Overall Study||55
213075|NCT01237301|515651|P1|COMPLETED|Overall Study||60
213076|NCT01237301|515650|P2|STARTED|Overall Study||59
213077|NCT01237301|515651|P1|STARTED|Overall Study||65
213078|NCT01237223|515669|P6|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
213079|NCT01237223|515670|P5|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||4
213080|NCT01237223|515671|P4|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
213081|NCT01237223|515672|P3|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
213082|NCT01237223|515673|P2|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
213083|NCT01237223|515674|P1|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||33
213084|NCT01237223|515669|P6|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||154
213085|NCT01237223|515670|P5|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||155
213086|NCT01237223|515671|P4|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||153
213087|NCT01237223|515672|P3|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||143
213088|NCT01237223|515673|P2|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||142
213089|NCT01237223|515674|P1|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||120
213090|NCT01237223|515669|P6|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
213091|NCT01237223|515670|P5|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
213092|NCT01237223|515671|P4|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
213093|NCT01237223|515672|P3|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
213094|NCT01237223|515673|P2|STARTED|Double Blind (Treatment Period, 8 Weeks)||157
213095|NCT01237223|515674|P1|STARTED|Double Blind (Treatment Period, 8 Weeks)||153
213096|NCT01237223|515669|P6|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
213097|NCT01237223|515670|P5|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
213098|NCT01237223|515671|P4|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
213099|NCT01237223|515672|P3|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
213100|NCT01237223|515673|P2|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
213101|NCT01237223|515674|P1|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||398
213102|NCT01237223|515669|P6|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
213103|NCT01237223|515670|P5|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
213104|NCT01237223|515671|P4|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
213105|NCT01237223|515672|P3|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
213106|NCT01237223|515673|P2|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
213107|NCT01237223|515674|P1|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||944
213108|NCT01237223|515669|P6|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
213109|NCT01237223|515670|P5|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
213110|NCT01237223|515671|P4|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
213111|NCT01237223|515672|P3|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
213112|NCT01237223|515673|P2|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
213113|NCT01237223|515674|P1|STARTED|Single Blind(Run-in Period, 4 Weeks)|All the patients enrolled to single blind period received only placebo treatment.|1342
213114|NCT01237197|515715|P2|NOT COMPLETED|Open Label Period||0
213115|NCT01237197|515716|P1|NOT COMPLETED|Open Label Period||0
213116|NCT01237197|515715|P2|COMPLETED|Open Label Period||10
213117|NCT01237197|515716|P1|COMPLETED|Open Label Period||12
213118|NCT01237197|515715|P2|STARTED|Open Label Period||10
213119|NCT01237197|515716|P1|STARTED|Open Label Period||12
213120|NCT01237197|515715|P2|NOT COMPLETED|Randomization Period||3
213121|NCT01237197|515716|P1|NOT COMPLETED|Randomization Period||1
213122|NCT01237197|515715|P2|COMPLETED|Randomization Period||10
213123|NCT01237197|515716|P1|COMPLETED|Randomization Period||12
213124|NCT01237197|515715|P2|STARTED|Randomization Period||13
213125|NCT01237197|515716|P1|STARTED|Randomization Period||13
213126|NCT01237080|515724|P2|NOT COMPLETED|Overall Study||0
213127|NCT01237080|515725|P1|NOT COMPLETED|Overall Study||0
213128|NCT01237080|515724|P2|COMPLETED|Overall Study||50
213129|NCT01237080|515725|P1|COMPLETED|Overall Study||50
213130|NCT01237080|515724|P2|STARTED|Overall Study||50
213131|NCT01237080|515725|P1|STARTED|Overall Study||50
213132|NCT01237054|515733|P1|NOT COMPLETED|Overall Study||1
213133|NCT01237054|515733|P1|COMPLETED|Overall Study||30
213134|NCT01237054|515733|P1|STARTED|Overall Study||31
213135|NCT01237041|515759|P5|NOT COMPLETED|Overall Study||0
213136|NCT01237041|515760|P4|NOT COMPLETED|Overall Study||0
213137|NCT01237041|515761|P3|NOT COMPLETED|Overall Study||0
213138|NCT01237041|515762|P2|NOT COMPLETED|Overall Study||0
213139|NCT01237041|515763|P1|NOT COMPLETED|Overall Study||0
213140|NCT01237041|515759|P5|COMPLETED|Overall Study||5
213141|NCT01237041|515760|P4|COMPLETED|Overall Study||5
213142|NCT01237041|515761|P3|COMPLETED|Overall Study||2
213143|NCT01237041|515762|P2|COMPLETED|Overall Study||3
213144|NCT01237041|515763|P1|COMPLETED|Overall Study||2
213145|NCT01237041|515759|P5|STARTED|Overall Study||5
213146|NCT01237041|515760|P4|STARTED|Overall Study||5
213147|NCT01237041|515761|P3|STARTED|Overall Study||2
213148|NCT01237041|515762|P2|STARTED|Overall Study||3
213149|NCT01237041|515763|P1|STARTED|Overall Study||2
213150|NCT01236768|515787|P2|NOT COMPLETED|Overall Study||61
213151|NCT01236768|515788|P1|NOT COMPLETED|Overall Study||89
213152|NCT01236768|515787|P2|COMPLETED|Overall Study||145
213153|NCT01236768|515788|P1|COMPLETED|Overall Study||112
213154|NCT01236768|515787|P2|STARTED|Overall Study||206
213155|NCT01236768|515788|P1|STARTED|Overall Study||201
213156|NCT01236755|515802|P1|NOT COMPLETED|Orthokeratology Wearing Phase||8
213157|NCT01236755|515802|P1|COMPLETED|Orthokeratology Wearing Phase||66
213158|NCT01236755|515802|P1|STARTED|Orthokeratology Wearing Phase||74
213159|NCT01236755|515802|P1|NOT COMPLETED|Spectacles Wearing Phase||17
213160|NCT01236755|515802|P1|COMPLETED|Spectacles Wearing Phase||74
213161|NCT01236755|515802|P1|STARTED|Spectacles Wearing Phase||91
213162|NCT01236742|515810|P3|NOT COMPLETED|Overall Study||3
213163|NCT01236742|515811|P2|NOT COMPLETED|Overall Study||3
213164|NCT01236742|515812|P1|NOT COMPLETED|Overall Study||3
213165|NCT01236742|515810|P3|COMPLETED|Overall Study||13
213166|NCT01236742|515811|P2|COMPLETED|Overall Study||16
213167|NCT01236742|515812|P1|COMPLETED|Overall Study||15
213168|NCT01236742|515810|P3|STARTED|Overall Study||16
213169|NCT01236742|515811|P2|STARTED|Overall Study||19
213170|NCT01236742|515812|P1|STARTED|Overall Study||18
213171|NCT01236573|515834|P11|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||1
213172|NCT01236573|515835|P10|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
213173|NCT01236573|515836|P9|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
213174|NCT01236573|515837|P8|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
213175|NCT01236573|515838|P7|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
213176|NCT01236573|515839|P6|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
213177|NCT01236573|515840|P5|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
213178|NCT01236573|515841|P4|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
213179|NCT01236573|515842|P3|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
213180|NCT01236573|515843|P2|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
213181|NCT01236573|515844|P1|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
213182|NCT01236573|515834|P11|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||5
213183|NCT01236573|515835|P10|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
213184|NCT01236573|515836|P9|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
213185|NCT01236573|515837|P8|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
213186|NCT01236573|515838|P7|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
213187|NCT01236573|515839|P6|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
213188|NCT01236573|515840|P5|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
213189|NCT01236573|515841|P4|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
213190|NCT01236573|515842|P3|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
213191|NCT01236573|515843|P2|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
213192|NCT01236573|515844|P1|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
213193|NCT01236573|515834|P11|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||6
213194|NCT01236573|515835|P10|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
213195|NCT01236573|515836|P9|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
213196|NCT01236573|515837|P8|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
213197|NCT01236573|515838|P7|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
213198|NCT01236573|515839|P6|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
213199|NCT01236573|515840|P5|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
213200|NCT01236573|515841|P4|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
213201|NCT01236573|515842|P3|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
213202|NCT01236573|515843|P2|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
213203|NCT01236573|515844|P1|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
213204|NCT01236573|515834|P11|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
213205|NCT01236573|515835|P10|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
213206|NCT01236573|515836|P9|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
213207|NCT01236573|515837|P8|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
213208|NCT01236573|515838|P7|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
213209|NCT01236573|515839|P6|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
213210|NCT01236573|515840|P5|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
213211|NCT01236573|515841|P4|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
213212|NCT01236573|515842|P3|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
213213|NCT01236573|515843|P2|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
213214|NCT01236573|515844|P1|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
213215|NCT01236573|515834|P11|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
213216|NCT01236573|515835|P10|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
213217|NCT01236573|515836|P9|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
213218|NCT01236573|515837|P8|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
213219|NCT01236573|515838|P7|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
213220|NCT01236573|515839|P6|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||4
213221|NCT01236573|515840|P5|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
213222|NCT01236573|515841|P4|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
213223|NCT01236573|515842|P3|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
213224|NCT01236573|515843|P2|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
213225|NCT01236573|515844|P1|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
213226|NCT01236573|515834|P11|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
213227|NCT01236573|515835|P10|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
213228|NCT01236573|515836|P9|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
213229|NCT01236573|515837|P8|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
213230|NCT01236573|515838|P7|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
213231|NCT01236573|515839|P6|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
213232|NCT01236573|515840|P5|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||1
213233|NCT01236573|515841|P4|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
213234|NCT01236573|515842|P3|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
213235|NCT01236573|515843|P2|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
213236|NCT01236573|515844|P1|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
213237|NCT01236573|515834|P11|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
213238|NCT01236573|515835|P10|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
213239|NCT01236573|515836|P9|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
213240|NCT01236573|515837|P8|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
213241|NCT01236573|515838|P7|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
213242|NCT01236573|515839|P6|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
213243|NCT01236573|515840|P5|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
213244|NCT01236573|515841|P4|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
213245|NCT01236573|515842|P3|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
213246|NCT01236573|515843|P2|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
213247|NCT01236573|515844|P1|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
213248|NCT01236573|515834|P11|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
213249|NCT01236573|515835|P10|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
213250|NCT01236573|515836|P9|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
213251|NCT01236573|515837|P8|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
213252|NCT01236573|515838|P7|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
213253|NCT01236573|515839|P6|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
213254|NCT01236573|515840|P5|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
213255|NCT01236573|515841|P4|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
213256|NCT01236573|515842|P3|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||6
213257|NCT01236573|515843|P2|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
213258|NCT01236573|515844|P1|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
213259|NCT01236573|515834|P11|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
213260|NCT01236573|515835|P10|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
213261|NCT01236573|515836|P9|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
213262|NCT01236573|515837|P8|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
213263|NCT01236573|515838|P7|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
213264|NCT01236573|515839|P6|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
213265|NCT01236573|515840|P5|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
213266|NCT01236573|515841|P4|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
213267|NCT01236573|515842|P3|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||6
213268|NCT01236573|515843|P2|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
213269|NCT01236573|515844|P1|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
213270|NCT01236534|515882|P2|NOT COMPLETED|Overall Study||0
213271|NCT01236534|515883|P1|NOT COMPLETED|Overall Study||3
213272|NCT01236534|515882|P2|COMPLETED|Overall Study||10
213273|NCT01236534|515883|P1|COMPLETED|Overall Study|2 subjects stopped treatment due to diarrhea, and 1 stopped treatment due to constipation.|8
213274|NCT01236534|515882|P2|STARTED|Overall Study||10
213275|NCT01236534|515883|P1|STARTED|Overall Study||11
213276|NCT01236521|515893|P2|NOT COMPLETED|Overall Study||25
213277|NCT01236521|515894|P1|NOT COMPLETED|Overall Study||21
213278|NCT01236521|515893|P2|COMPLETED|Overall Study||105
213279|NCT01236521|515894|P1|COMPLETED|Overall Study||110
213280|NCT01236521|515893|P2|12-moth Completed|Overall Study||105
213281|NCT01236521|515894|P1|12-moth Completed|Overall Study||110
213282|NCT01236521|515893|P2|9-month Completed|Overall Study||101
213283|NCT01236521|515894|P1|9-month Completed|Overall Study||115
213284|NCT01236521|515893|P2|6-month Completed|Overall Study||116
213285|NCT01236521|515894|P1|6-month Completed|Overall Study||122
213286|NCT01236521|515893|P2|3-month Completed|Overall Study||119
213287|NCT01236521|515894|P1|3-month Completed|Overall Study||122
213288|NCT01236521|515893|P2|STARTED|Overall Study||130
213289|NCT01236521|515894|P1|STARTED|Overall Study||131
213290|NCT01236391|515922|P1|NOT COMPLETED|Overall Study||16
213291|NCT01236391|515922|P1|COMPLETED|Overall Study|Participants who were on treatment or discontinued treatment due to disease progression or death|95
213292|NCT01236391|515922|P1|STARTED|Overall Study|Participants who received study treatment|111
213293|NCT01236378|515930|P1|NOT COMPLETED|Overall Study||0
213294|NCT01236378|515930|P1|COMPLETED|Overall Study||24
213295|NCT01236378|515930|P1|STARTED|Overall Study||24
213296|NCT01236365|515944|P2|NOT COMPLETED|Overall Study||2
213297|NCT01236365|515945|P1|NOT COMPLETED|Overall Study||2
213298|NCT01236365|515944|P2|COMPLETED|Overall Study||19
213299|NCT01236365|515945|P1|COMPLETED|Overall Study||19
213300|NCT01236365|515944|P2|STARTED|Overall Study||21
213301|NCT01236365|515945|P1|STARTED|Overall Study||21
213302|NCT01236352|515978|P11|NOT COMPLETED|Overall Study||20
213303|NCT01236352|515979|P10|NOT COMPLETED|Overall Study||22
213304|NCT01236352|515980|P9|NOT COMPLETED|Overall Study||3
213305|NCT01236352|515981|P8|NOT COMPLETED|Overall Study||7
213306|NCT01236352|515982|P7|NOT COMPLETED|Overall Study||8
213307|NCT01236352|515983|P6|NOT COMPLETED|Overall Study||4
213308|NCT01236352|515984|P5|NOT COMPLETED|Overall Study||4
213309|NCT01236352|515985|P4|NOT COMPLETED|Overall Study||3
213310|NCT01236352|515986|P3|NOT COMPLETED|Overall Study||4
213311|NCT01236352|515987|P2|NOT COMPLETED|Overall Study||4
213312|NCT01236352|515988|P1|NOT COMPLETED|Overall Study||4
213313|NCT01236352|515978|P11|COMPLETED|Overall Study||0
213314|NCT01236352|515979|P10|COMPLETED|Overall Study||0
213315|NCT01236352|515980|P9|COMPLETED|Overall Study||0
213316|NCT01236352|515981|P8|COMPLETED|Overall Study||0
213317|NCT01236352|515982|P7|COMPLETED|Overall Study||0
213318|NCT01236352|515983|P6|COMPLETED|Overall Study||0
213319|NCT01236352|515984|P5|COMPLETED|Overall Study||0
213320|NCT01236352|515985|P4|COMPLETED|Overall Study||1
213321|NCT01236352|515986|P3|COMPLETED|Overall Study||0
213322|NCT01236352|515987|P2|COMPLETED|Overall Study||0
213323|NCT01236352|515988|P1|COMPLETED|Overall Study||0
213324|NCT01236352|515978|P11|STARTED|Overall Study||20
213325|NCT01236352|515979|P10|STARTED|Overall Study||22
213326|NCT01236352|515980|P9|STARTED|Overall Study||3
213327|NCT01236352|515981|P8|STARTED|Overall Study||7
213328|NCT01236352|515982|P7|STARTED|Overall Study||8
213329|NCT01236352|515983|P6|STARTED|Overall Study||4
213330|NCT01236352|515984|P5|STARTED|Overall Study||4
213331|NCT01236352|515985|P4|STARTED|Overall Study||4
213332|NCT01236352|515986|P3|STARTED|Overall Study||4
213333|NCT01236352|515987|P2|STARTED|Overall Study||4
213334|NCT01236352|515988|P1|STARTED|Overall Study||4
213335|NCT01236339|516157|P2|NOT COMPLETED|Overall Study||13
213336|NCT01236339|516158|P1|NOT COMPLETED|Overall Study||11
213337|NCT01236339|516157|P2|COMPLETED|Overall Study||0
213338|NCT01236339|516158|P1|COMPLETED|Overall Study||2
213339|NCT01236339|516157|P2|LVP Crossover to TIPS|Overall Study|ONLY patients failing LVP and meeting crossover according to protocol definition|4
213340|NCT01236339|516158|P1|LVP Crossover to TIPS|Overall Study||0
213341|NCT01236339|516157|P2|STARTED|Overall Study||13
213342|NCT01236339|516158|P1|STARTED|Overall Study||13
213343|NCT01236326|516178|P2|NOT COMPLETED|Overall Study||4
213344|NCT01236326|516179|P1|NOT COMPLETED|Overall Study||1
213345|NCT01236326|516178|P2|COMPLETED|Overall Study||51
213346|NCT01236326|516179|P1|COMPLETED|Overall Study||49
213347|NCT01236326|516178|P2|STARTED|Overall Study||55
213348|NCT01236326|516179|P1|STARTED|Overall Study||50
213349|NCT01236300|516193|P1|NOT COMPLETED|Overall Study||0
213350|NCT01236300|516193|P1|COMPLETED|Overall Study||66
213351|NCT01236300|516193|P1|STARTED|Overall Study||66
213352|NCT01236196|516203|P2|NOT COMPLETED|Overall Study||8
213353|NCT01236196|516204|P1|NOT COMPLETED|Overall Study||1
213354|NCT01236196|516203|P2|COMPLETED|Overall Study||13
213355|NCT01236196|516204|P1|COMPLETED|Overall Study||17
213356|NCT01236196|516203|P2|STARTED|Overall Study||21
213357|NCT01236196|516204|P1|STARTED|Overall Study||18
213358|NCT01236170|516216|P1|NOT COMPLETED|Overall Study||15
213359|NCT01236170|516216|P1|COMPLETED|Overall Study||482
213360|NCT01236170|516216|P1|STARTED|Overall Study||497
213361|NCT01236118|516227|P3|NOT COMPLETED|Overall Study||3
213362|NCT01236118|516228|P2|NOT COMPLETED|Overall Study||1
213363|NCT01236118|516229|P1|NOT COMPLETED|Overall Study||2
213364|NCT01236118|516227|P3|COMPLETED|Overall Study||14
213365|NCT01236118|516228|P2|COMPLETED|Overall Study||4
213366|NCT01236118|516229|P1|COMPLETED|Overall Study||4
213367|NCT01236118|516227|P3|STARTED|Overall Study||17
213368|NCT01236118|516228|P2|STARTED|Overall Study||5
213369|NCT01236118|516229|P1|STARTED|Overall Study||6
213370|NCT01236105|516237|P1|NOT COMPLETED|Overall Study||0
213371|NCT01236105|516237|P1|COMPLETED|Overall Study||21
213372|NCT01236105|516237|P1|STARTED|Overall Study||21
213373|NCT01236053|516273|P22|NOT COMPLETED|Overall Study||0
213374|NCT01236053|516274|P21|NOT COMPLETED|Overall Study||0
213375|NCT01236053|516275|P20|NOT COMPLETED|Overall Study||0
213376|NCT01236053|516276|P19|NOT COMPLETED|Overall Study||0
213377|NCT01236053|516277|P18|NOT COMPLETED|Overall Study||0
213378|NCT01236053|516278|P17|NOT COMPLETED|Overall Study||0
213379|NCT01236053|516279|P16|NOT COMPLETED|Overall Study||0
213380|NCT01236053|516280|P15|NOT COMPLETED|Overall Study||0
213381|NCT01236053|516281|P14|NOT COMPLETED|Overall Study||0
213382|NCT01236053|516282|P13|NOT COMPLETED|Overall Study||0
213383|NCT01236053|516283|P12|NOT COMPLETED|Overall Study||0
213384|NCT01236053|516284|P11|NOT COMPLETED|Overall Study||0
213385|NCT01236053|516285|P10|NOT COMPLETED|Overall Study||0
213386|NCT01236053|516286|P9|NOT COMPLETED|Overall Study||0
213387|NCT01236053|516287|P8|NOT COMPLETED|Overall Study||0
213388|NCT01236053|516288|P7|NOT COMPLETED|Overall Study||0
213389|NCT01236053|516289|P6|NOT COMPLETED|Overall Study||0
213390|NCT01236053|516290|P5|NOT COMPLETED|Overall Study||0
213391|NCT01236053|516291|P4|NOT COMPLETED|Overall Study||0
213392|NCT01236053|516292|P3|NOT COMPLETED|Overall Study||0
213393|NCT01236053|516293|P2|NOT COMPLETED|Overall Study||0
213394|NCT01236053|516294|P1|NOT COMPLETED|Overall Study||0
213395|NCT01236053|516273|P22|COMPLETED|Overall Study||12167
213396|NCT01236053|516274|P21|COMPLETED|Overall Study||1272
213397|NCT01236053|516275|P20|COMPLETED|Overall Study||20382
213398|NCT01236053|516276|P19|COMPLETED|Overall Study||2155
213399|NCT01236053|516277|P18|COMPLETED|Overall Study||380
213400|NCT01236053|516278|P17|COMPLETED|Overall Study||38
213401|NCT01236053|516279|P16|COMPLETED|Overall Study||43559
213402|NCT01236053|516280|P15|COMPLETED|Overall Study||4600
213403|NCT01236053|516281|P14|COMPLETED|Overall Study||1396
213404|NCT01236053|516282|P13|COMPLETED|Overall Study||148
213405|NCT01236053|516283|P12|COMPLETED|Overall Study||188924
213406|NCT01236053|516284|P11|COMPLETED|Overall Study||19564
213407|NCT01236053|516285|P10|COMPLETED|Overall Study||2935
213408|NCT01236053|516286|P9|COMPLETED|Overall Study||300
213409|NCT01236053|516287|P8|COMPLETED|Overall Study||102836
213410|NCT01236053|516288|P7|COMPLETED|Overall Study||10855
213411|NCT01236053|516289|P6|COMPLETED|Overall Study||2067
213412|NCT01236053|516290|P5|COMPLETED|Overall Study||212
213413|NCT01236053|516291|P4|COMPLETED|Overall Study||17853
213414|NCT01236053|516292|P3|COMPLETED|Overall Study||1877
213415|NCT01236053|516293|P2|COMPLETED|Overall Study||1710950
213416|NCT01236053|516294|P1|COMPLETED|Overall Study||179138
213417|NCT01236053|516273|P22|STARTED|Overall Study||12167
213418|NCT01236053|516274|P21|STARTED|Overall Study||1272
213419|NCT01236053|516275|P20|STARTED|Overall Study||20382
213420|NCT01236053|516276|P19|STARTED|Overall Study||2155
213421|NCT01236053|516277|P18|STARTED|Overall Study||380
213422|NCT01236053|516278|P17|STARTED|Overall Study||38
213423|NCT01236053|516279|P16|STARTED|Overall Study||43559
213424|NCT01236053|516280|P15|STARTED|Overall Study||4600
213425|NCT01236053|516281|P14|STARTED|Overall Study||1396
213426|NCT01236053|516282|P13|STARTED|Overall Study||148
213427|NCT01236053|516283|P12|STARTED|Overall Study||188924
213428|NCT01236053|516284|P11|STARTED|Overall Study||19564
213429|NCT01236053|516285|P10|STARTED|Overall Study||2935
213430|NCT01236053|516286|P9|STARTED|Overall Study||300
213431|NCT01236053|516287|P8|STARTED|Overall Study||102836
213432|NCT01236053|516288|P7|STARTED|Overall Study||10855
213433|NCT01236053|516289|P6|STARTED|Overall Study||2067
213434|NCT01236053|516290|P5|STARTED|Overall Study||212
213435|NCT01236053|516291|P4|STARTED|Overall Study||17853
213436|NCT01236053|516292|P3|STARTED|Overall Study||1877
213437|NCT01236053|516293|P2|STARTED|Overall Study||1710950
213438|NCT01236053|516294|P1|STARTED|Overall Study||179138
213439|NCT01236001|516430|P2|NOT COMPLETED|Overall Study||22
213440|NCT01236001|516431|P1|NOT COMPLETED|Overall Study||18
213441|NCT01236001|516430|P2|COMPLETED|Overall Study||65
213442|NCT01236001|516431|P1|COMPLETED|Overall Study||87
213443|NCT01236001|516430|P2|STARTED|Overall Study||87
213444|NCT01236001|516431|P1|STARTED|Overall Study||105
213445|NCT01235975|516463|P2|NOT COMPLETED|Overall Study||7
213446|NCT01235975|516464|P1|NOT COMPLETED|Overall Study||17
213447|NCT01235975|516463|P2|COMPLETED|Overall Study||88
213448|NCT01235975|516464|P1|COMPLETED|Overall Study||257
213449|NCT01235975|516463|P2|STARTED|Overall Study||95
213450|NCT01235975|516464|P1|STARTED|Overall Study||274
213451|NCT01235949|516514|P18|NOT COMPLETED|Booster Phase||2
213452|NCT01235949|516515|P17|NOT COMPLETED|Booster Phase||0
213453|NCT01235949|516516|P16|NOT COMPLETED|Booster Phase||1
213454|NCT01235949|516517|P15|NOT COMPLETED|Booster Phase||2
213455|NCT01235949|516518|P14|NOT COMPLETED|Booster Phase||0
213456|NCT01235949|516519|P13|NOT COMPLETED|Booster Phase||3
213457|NCT01235949|516520|P12|NOT COMPLETED|Booster Phase||3
213458|NCT01235949|516521|P11|NOT COMPLETED|Booster Phase||2
213459|NCT01235949|516522|P10|NOT COMPLETED|Booster Phase||1
213460|NCT01235949|516523|P9|NOT COMPLETED|Booster Phase||2
213461|NCT01235949|516524|P8|NOT COMPLETED|Booster Phase||1
213462|NCT01235949|516525|P7|NOT COMPLETED|Booster Phase||0
213463|NCT01235949|516526|P6|NOT COMPLETED|Booster Phase||0
213464|NCT01235949|516527|P5|NOT COMPLETED|Booster Phase||0
213465|NCT01235949|516528|P4|NOT COMPLETED|Booster Phase||0
213466|NCT01235949|516529|P3|NOT COMPLETED|Booster Phase||0
213467|NCT01235949|516530|P2|NOT COMPLETED|Booster Phase||0
213468|NCT01235949|516531|P1|NOT COMPLETED|Booster Phase||0
213469|NCT01235949|516514|P18|COMPLETED|Booster Phase||65
213470|NCT01235949|516515|P17|COMPLETED|Booster Phase||68
213471|NCT01235949|516516|P16|COMPLETED|Booster Phase||66
213472|NCT01235949|516517|P15|COMPLETED|Booster Phase||60
213473|NCT01235949|516518|P14|COMPLETED|Booster Phase||65
213474|NCT01235949|516519|P13|COMPLETED|Booster Phase||60
213475|NCT01235949|516520|P12|COMPLETED|Booster Phase||60
213476|NCT01235949|516521|P11|COMPLETED|Booster Phase||61
213477|NCT01235949|516522|P10|COMPLETED|Booster Phase||62
213478|NCT01235949|516523|P9|COMPLETED|Booster Phase||61
213479|NCT01235949|516524|P8|COMPLETED|Booster Phase||59
213480|NCT01235949|516525|P7|COMPLETED|Booster Phase||64
213481|NCT01235949|516526|P6|COMPLETED|Booster Phase||0
213482|NCT01235949|516527|P5|COMPLETED|Booster Phase||0
213483|NCT01235949|516528|P4|COMPLETED|Booster Phase||0
213484|NCT01235949|516529|P3|COMPLETED|Booster Phase||0
213485|NCT01235949|516530|P2|COMPLETED|Booster Phase||0
213486|NCT01235949|516531|P1|COMPLETED|Booster Phase||0
213487|NCT01235949|516514|P18|STARTED|Booster Phase|subjects from the primary NPARA group continuing in booster phase with different treatment|67
213488|NCT01235949|516515|P17|STARTED|Booster Phase|subjects from the primary DPARA group continuing in booster phase with different treatment|68
213489|NCT01235949|516516|P16|STARTED|Booster Phase|subjects from the primary IPARA group continuing in booster phase with different treatment|67
213490|NCT01235949|516517|P15|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|62
213491|NCT01235949|516518|P14|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|65
213492|NCT01235949|516519|P13|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|63
213493|NCT01235949|516520|P12|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
213494|NCT01235949|516521|P11|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
213495|NCT01235949|516522|P10|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
213496|NCT01235949|516523|P9|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|63
213497|NCT01235949|516524|P8|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|60
213498|NCT01235949|516525|P7|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|64
213499|NCT01235949|516526|P6|STARTED|Booster Phase|subjects re-randomized to NPARA-IPARA Group in booster phase|0
213500|NCT01235949|516527|P5|STARTED|Booster Phase|subjects re-randomized to DPARA-IPARA Group in booster phase|0
213501|NCT01235949|516528|P4|STARTED|Booster Phase|subjects re-randomized to IPARA-NPARA Group in booster phase|0
213502|NCT01235949|516529|P3|STARTED|Booster Phase|re-randomized to diverse treatments (NIBU-IIBU, NIBU-DIBU and NIBU-NIBU Groups) in booster phase|0
213503|NCT01235949|516530|P2|STARTED|Booster Phase|re-randomized to diverse treatments (DIBU-IIBU, DIBU-DIBU and DIBU-NIBU Groups) in booster phase|0
213504|NCT01235949|516531|P1|STARTED|Booster Phase|re-randomized to diverse treatments (IIBU-IIBU, IIBU-DIBU and IIBU-NIBU Groups) in booster phase|0
213505|NCT01235949|516514|P18|NOT COMPLETED|Primary Phase||0
213506|NCT01235949|516515|P17|NOT COMPLETED|Primary Phase||0
213507|NCT01235949|516516|P16|NOT COMPLETED|Primary Phase||0
213508|NCT01235949|516517|P15|NOT COMPLETED|Primary Phase||0
213509|NCT01235949|516518|P14|NOT COMPLETED|Primary Phase||0
213510|NCT01235949|516519|P13|NOT COMPLETED|Primary Phase||0
213511|NCT01235949|516520|P12|NOT COMPLETED|Primary Phase||0
213512|NCT01235949|516521|P11|NOT COMPLETED|Primary Phase||0
213513|NCT01235949|516522|P10|NOT COMPLETED|Primary Phase||0
213514|NCT01235949|516523|P9|NOT COMPLETED|Primary Phase||0
213515|NCT01235949|516524|P8|NOT COMPLETED|Primary Phase||0
213516|NCT01235949|516525|P7|NOT COMPLETED|Primary Phase||0
213517|NCT01235949|516526|P6|NOT COMPLETED|Primary Phase||7
213518|NCT01235949|516527|P5|NOT COMPLETED|Primary Phase||1
213519|NCT01235949|516528|P4|NOT COMPLETED|Primary Phase||2
213520|NCT01235949|516529|P3|NOT COMPLETED|Primary Phase||3
213521|NCT01235949|516530|P2|NOT COMPLETED|Primary Phase||3
213522|NCT01235949|516531|P1|NOT COMPLETED|Primary Phase||4
213523|NCT01235949|516514|P18|COMPLETED|Primary Phase||0
213524|NCT01235949|516515|P17|COMPLETED|Primary Phase||0
213525|NCT01235949|516516|P16|COMPLETED|Primary Phase||0
213526|NCT01235949|516517|P15|COMPLETED|Primary Phase||0
213527|NCT01235949|516518|P14|COMPLETED|Primary Phase||0
213528|NCT01235949|516519|P13|COMPLETED|Primary Phase||0
213529|NCT01235949|516520|P12|COMPLETED|Primary Phase||0
213530|NCT01235949|516521|P11|COMPLETED|Primary Phase||0
213531|NCT01235949|516522|P10|COMPLETED|Primary Phase||0
213532|NCT01235949|516523|P9|COMPLETED|Primary Phase||0
213533|NCT01235949|516524|P8|COMPLETED|Primary Phase||0
213534|NCT01235949|516525|P7|COMPLETED|Primary Phase||0
213535|NCT01235949|516526|P6|COMPLETED|Primary Phase|After Primary Phase completion, all subjects were willing to participate in the Booster Phase|67
213536|NCT01235949|516527|P5|COMPLETED|Primary Phase|After Primary Phase completion, 3 subjects were not willing to participate in the Booster Phase|71
213537|NCT01235949|516528|P4|COMPLETED|Primary Phase|After Primary Phase completion, 2 subjects were not willing to participate in the Booster Phase|69
213538|NCT01235949|516529|P3|COMPLETED|Primary Phase|After Primary Phase completion, 6 subjects were not willing to participate in the Booster Phase|196
213539|NCT01235949|516530|P2|COMPLETED|Primary Phase|After Primary Phase completion, 6 subjects were not willing to participate in the Booster Phase|195
213540|NCT01235949|516531|P1|COMPLETED|Primary Phase|After Primary Phase completion, 7 subjects were not willing to participate in the Booster Phase|194
213541|NCT01235949|516514|P18|STARTED|Primary Phase||0
213542|NCT01235949|516515|P17|STARTED|Primary Phase||0
213543|NCT01235949|516516|P16|STARTED|Primary Phase||0
213544|NCT01235949|516517|P15|STARTED|Primary Phase||0
213545|NCT01235949|516518|P14|STARTED|Primary Phase||0
213546|NCT01235949|516519|P13|STARTED|Primary Phase||0
213547|NCT01235949|516520|P12|STARTED|Primary Phase||0
213548|NCT01235949|516521|P11|STARTED|Primary Phase||0
213549|NCT01235949|516522|P10|STARTED|Primary Phase||0
213550|NCT01235949|516523|P9|STARTED|Primary Phase||0
213551|NCT01235949|516524|P8|STARTED|Primary Phase||0
213552|NCT01235949|516525|P7|STARTED|Primary Phase||0
213553|NCT01235949|516526|P6|STARTED|Primary Phase||74
213554|NCT01235949|516527|P5|STARTED|Primary Phase||72
213555|NCT01235949|516528|P4|STARTED|Primary Phase||71
213556|NCT01235949|516529|P3|STARTED|Primary Phase||199
213557|NCT01235949|516530|P2|STARTED|Primary Phase||198
213558|NCT01235949|516531|P1|STARTED|Primary Phase||198
213559|NCT01235923|516769|P2|NOT COMPLETED|Overall Study||0
213560|NCT01235923|516770|P1|NOT COMPLETED|Overall Study||0
213561|NCT01235923|516769|P2|COMPLETED|Overall Study||10
213562|NCT01235923|516770|P1|COMPLETED|Overall Study||10
213563|NCT01235923|516769|P2|STARTED|Overall Study||10
213564|NCT01235923|516770|P1|STARTED|Overall Study||10
213565|NCT01235910|516778|P1|NOT COMPLETED|Overall Study||0
213566|NCT01235910|516778|P1|COMPLETED|Overall Study||1
213567|NCT01235910|516778|P1|STARTED|Overall Study||1
213568|NCT01235897|516784|P1|NOT COMPLETED|Overall Study||0
213569|NCT01235897|516784|P1|COMPLETED|Overall Study||16
213570|NCT01235897|516784|P1|STARTED|Overall Study||16
213571|NCT01235793|516789|P1|NOT COMPLETED|Overall Study||6
213572|NCT01235793|516789|P1|COMPLETED|Overall Study||5
213573|NCT01235793|516789|P1|STARTED|Overall Study||11
213574|NCT01235741|516797|P3|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||7
213575|NCT01235741|516798|P2|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||9
213576|NCT01235741|516799|P1|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||0
213577|NCT01235741|516797|P3|COMPLETED|Follow-Up Post Treatment up to Month 6|7 participants did not complete the 6 month follow up period|29
213578|NCT01235741|516798|P2|COMPLETED|Follow-Up Post Treatment up to Month 6|9 participants did not complete the 6 month follow up period|27
213579|NCT01235741|516799|P1|COMPLETED|Follow-Up Post Treatment up to Month 6||0
213580|NCT01235741|516797|P3|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with drug (36) were followed up 6 months post treatment.|36
213581|NCT01235741|516798|P2|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with placebo (36) were followed up 6 Months post treatment.|36
213582|NCT01235741|516799|P1|STARTED|Follow-Up Post Treatment up to Month 6||0
213583|NCT01235741|516797|P3|NOT COMPLETED|Randomized to Treatment||36
213584|NCT01235741|516798|P2|NOT COMPLETED|Randomized to Treatment||36
213585|NCT01235741|516799|P1|NOT COMPLETED|Randomized to Treatment||0
213586|NCT01235741|516797|P3|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
213587|NCT01235741|516798|P2|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
213588|NCT01235741|516799|P1|COMPLETED|Randomized to Treatment||0
213589|NCT01235741|516797|P3|STARTED|Randomized to Treatment||36
213590|NCT01235741|516798|P2|STARTED|Randomized to Treatment||36
213591|NCT01235741|516799|P1|STARTED|Randomized to Treatment||0
213592|NCT01235741|516797|P3|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
213593|NCT01235741|516798|P2|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
213594|NCT01235741|516799|P1|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||141
213595|NCT01235741|516797|P3|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
213596|NCT01235741|516798|P2|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
213597|NCT01235741|516799|P1|COMPLETED|Non-Randomized Low Calorie Diet Lead-In|Study terminated by Sponsor. 72 randomized to treatment at time study halted.|72
213598|NCT01235741|516797|P3|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
213599|NCT01235741|516798|P2|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
213600|NCT01235741|516799|P1|STARTED|Non-Randomized Low Calorie Diet Lead-In|6 Week LCD period. Those who lost >=2% of body weight were randomized to treatment.|213
213601|NCT01235728|516826|P8|NOT COMPLETED|Overall Study||0
213602|NCT01235728|516827|P7|NOT COMPLETED|Overall Study||0
213603|NCT01235728|516828|P6|NOT COMPLETED|Overall Study||0
213604|NCT01235728|516829|P5|NOT COMPLETED|Overall Study||0
213605|NCT01235728|516830|P4|NOT COMPLETED|Overall Study||1
213606|NCT01235728|516831|P3|NOT COMPLETED|Overall Study||0
213607|NCT01235728|516832|P2|NOT COMPLETED|Overall Study||0
213608|NCT01235728|516833|P1|NOT COMPLETED|Overall Study||0
213609|NCT01235728|516826|P8|COMPLETED|Overall Study||3
213610|NCT01235728|516827|P7|COMPLETED|Overall Study||3
213611|NCT01235728|516828|P6|COMPLETED|Overall Study||3
213612|NCT01235728|516829|P5|COMPLETED|Overall Study||3
213613|NCT01235728|516830|P4|COMPLETED|Overall Study||2
213614|NCT01235728|516831|P3|COMPLETED|Overall Study||3
213615|NCT01235728|516832|P2|COMPLETED|Overall Study||3
213616|NCT01235728|516833|P1|COMPLETED|Overall Study||3
213617|NCT01235728|516826|P8|STARTED|Overall Study||3
213618|NCT01235728|516827|P7|STARTED|Overall Study||3
213619|NCT01235728|516828|P6|STARTED|Overall Study||3
213620|NCT01235728|516829|P5|STARTED|Overall Study||3
213621|NCT01235728|516830|P4|STARTED|Overall Study||3
213622|NCT01235728|516831|P3|STARTED|Overall Study||3
213623|NCT01235728|516832|P2|STARTED|Overall Study||3
213624|NCT01235728|516833|P1|STARTED|Overall Study||3
213625|NCT01235715|516843|P2|NOT COMPLETED|Overall Study||2
213626|NCT01235715|516844|P1|NOT COMPLETED|Overall Study||0
213627|NCT01235715|516843|P2|COMPLETED|Overall Study||100
213628|NCT01235715|516844|P1|COMPLETED|Overall Study||98
213629|NCT01235715|516843|P2|STARTED|Overall Study||102
213630|NCT01235715|516844|P1|STARTED|Overall Study||98
213631|NCT01235689|516884|P2|NOT COMPLETED|Overall Study||32
213632|NCT01235689|516885|P1|NOT COMPLETED|Overall Study||29
213633|NCT01235689|516884|P2|COMPLETED|Overall Study||90
213634|NCT01235689|516885|P1|COMPLETED|Overall Study||93
213635|NCT01235689|516884|P2|Randomized at Week 9|Overall Study||53
213636|NCT01235689|516885|P1|Randomized at Week 9|Overall Study||59
213637|NCT01235689|516884|P2|Early Randomized (Baseline to Week 9)|Overall Study||69
213638|NCT01235689|516885|P1|Early Randomized (Baseline to Week 9)|Overall Study||63
213639|NCT01235689|516884|P2|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
213640|NCT01235689|516885|P1|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
213641|NCT01235598|516957|P2|NOT COMPLETED|Overall Study||4
213642|NCT01235598|516958|P1|NOT COMPLETED|Overall Study||1
213643|NCT01235598|516957|P2|COMPLETED|Overall Study||24
213644|NCT01235598|516958|P1|COMPLETED|Overall Study||12
213645|NCT01235598|516957|P2|STARTED|Overall Study|One subject was randomized to the CZP Arm but never received an injection (due to pre-treatment AE)|28
213646|NCT01235598|516958|P1|STARTED|Overall Study||13
213647|NCT01235546|517003|P2|NOT COMPLETED|Overall Study||1
213648|NCT01235546|517004|P1|NOT COMPLETED|Overall Study||2
213649|NCT01235546|517003|P2|COMPLETED|Overall Study||1018
213650|NCT01235546|517004|P1|COMPLETED|Overall Study||992
213651|NCT01235546|517003|P2|STARTED|Overall Study||1019
213652|NCT01235546|517004|P1|STARTED|Overall Study||994
213653|NCT01235507|517028|P1|NOT COMPLETED|Overall Study||2
213654|NCT01235507|517028|P1|COMPLETED|Overall Study||69
213655|NCT01235507|517028|P1|STARTED|Overall Study||71
213656|NCT01235442|517042|P2|NOT COMPLETED|Overall Study||44
213657|NCT01235442|517043|P1|NOT COMPLETED|Overall Study||44
213658|NCT01235442|517042|P2|COMPLETED|Overall Study||251
213659|NCT01235442|517043|P1|COMPLETED|Overall Study||253
213660|NCT01235442|517042|P2|STARTED|Overall Study||295
213661|NCT01235442|517043|P1|STARTED|Overall Study||297
213662|NCT01235403|517061|P1|NOT COMPLETED|Overall Study||26
213663|NCT01235403|517061|P1|COMPLETED|Overall Study||74
213664|NCT01235403|517061|P1|STARTED|Overall Study||100
213665|NCT01235377|517069|P2|NOT COMPLETED|Overall Study||1
213666|NCT01235377|517070|P1|NOT COMPLETED|Overall Study||1
213667|NCT01235377|517069|P2|COMPLETED|Overall Study||8
213668|NCT01235377|517070|P1|COMPLETED|Overall Study||10
213669|NCT01235377|517069|P2|STARTED|Overall Study||9
213670|NCT01235377|517070|P1|STARTED|Overall Study||11
213671|NCT01235351|517078|P2|NOT COMPLETED|Treatment With Different Dose Sequences||0
213672|NCT01235351|517079|P1|NOT COMPLETED|Treatment With Different Dose Sequences||0
213673|NCT01235351|517078|P2|COMPLETED|Treatment With Different Dose Sequences||82
213674|NCT01235351|517079|P1|COMPLETED|Treatment With Different Dose Sequences||233
213675|NCT01235351|517078|P2|300 mg First Then 225 mg|Treatment With Different Dose Sequences||41
213676|NCT01235351|517079|P1|300 mg First Then 225 mg|Treatment With Different Dose Sequences||0
213677|NCT01235351|517078|P2|225 mg First Then 300 mg|Treatment With Different Dose Sequences||41
213678|NCT01235351|517079|P1|225 mg First Then 300 mg|Treatment With Different Dose Sequences||0
213679|NCT01235351|517078|P2|150 mg First Then 75 mg|Treatment With Different Dose Sequences||0
213680|NCT01235351|517079|P1|150 mg First Then 75 mg|Treatment With Different Dose Sequences||117
213681|NCT01235351|517078|P2|75 mg First and Then 150 mg|Treatment With Different Dose Sequences||0
213682|NCT01235351|517079|P1|75 mg First and Then 150 mg|Treatment With Different Dose Sequences||116
213683|NCT01235351|517078|P2|STARTED|Treatment With Different Dose Sequences||82
213684|NCT01235351|517079|P1|STARTED|Treatment With Different Dose Sequences||233
213685|NCT01235351|517078|P2|NOT COMPLETED|Initial Treatment With 75 mg and 150 mg||4
213686|NCT01235351|517079|P1|NOT COMPLETED|Initial Treatment With 75 mg and 150 mg||10
213687|NCT01235351|517078|P2|COMPLETED|Initial Treatment With 75 mg and 150 mg||82
213688|NCT01235351|517079|P1|COMPLETED|Initial Treatment With 75 mg and 150 mg|4 allocated to initial treatment included in primary analysis|237
213689|NCT01235351|517078|P2|STARTED|Initial Treatment With 75 mg and 150 mg||86
213690|NCT01235351|517079|P1|STARTED|Initial Treatment With 75 mg and 150 mg||247
213691|NCT01235338|517091|P2|NOT COMPLETED|Overall Study||5
213692|NCT01235338|517092|P1|NOT COMPLETED|Overall Study||11
213693|NCT01235338|517091|P2|COMPLETED|Overall Study||33
213694|NCT01235338|517092|P1|COMPLETED|Overall Study||31
213695|NCT01235338|517091|P2|STARTED|Overall Study||38
213696|NCT01235338|517092|P1|STARTED|Overall Study||42
213697|NCT01235234|517137|P3|NOT COMPLETED|Overall Study||1
213698|NCT01235234|517138|P2|NOT COMPLETED|Overall Study||2
213699|NCT01235234|517139|P1|NOT COMPLETED|Overall Study||2
213700|NCT01235234|517137|P3|COMPLETED|Overall Study||80
213701|NCT01235234|517138|P2|COMPLETED|Overall Study||76
213702|NCT01235234|517139|P1|COMPLETED|Overall Study||75
213703|NCT01235234|517137|P3|STARTED|Overall Study||81
213704|NCT01235234|517138|P2|STARTED|Overall Study||78
213705|NCT01235234|517139|P1|STARTED|Overall Study||77
213706|NCT01235195|517147|P2|NOT COMPLETED|Second Intervention||0
213707|NCT01235195|517148|P1|NOT COMPLETED|Second Intervention||0
213708|NCT01235195|517147|P2|COMPLETED|Second Intervention||15
213709|NCT01235195|517148|P1|COMPLETED|Second Intervention||15
213710|NCT01235195|517147|P2|STARTED|Second Intervention||15
213711|NCT01235195|517148|P1|STARTED|Second Intervention||15
213712|NCT01235195|517147|P2|NOT COMPLETED|Washout Period of At Least 8 Days||0
213713|NCT01235195|517148|P1|NOT COMPLETED|Washout Period of At Least 8 Days||0
213714|NCT01235195|517147|P2|COMPLETED|Washout Period of At Least 8 Days||15
213715|NCT01235195|517148|P1|COMPLETED|Washout Period of At Least 8 Days||15
213716|NCT01235195|517147|P2|STARTED|Washout Period of At Least 8 Days||15
213717|NCT01235195|517148|P1|STARTED|Washout Period of At Least 8 Days||15
213718|NCT01235195|517147|P2|NOT COMPLETED|First Intervention||0
213719|NCT01235195|517148|P1|NOT COMPLETED|First Intervention||0
213720|NCT01235195|517147|P2|COMPLETED|First Intervention||15
213721|NCT01235195|517148|P1|COMPLETED|First Intervention||15
213722|NCT01235195|517147|P2|STARTED|First Intervention||15
213723|NCT01235195|517148|P1|STARTED|First Intervention||15
213724|NCT01234922|517168|P4|NOT COMPLETED|Overall Study||0
213725|NCT01234922|517169|P3|NOT COMPLETED|Overall Study||0
213726|NCT01234922|517170|P2|NOT COMPLETED|Overall Study||0
213727|NCT01234922|517171|P1|NOT COMPLETED|Overall Study||0
213728|NCT01234922|517168|P4|COMPLETED|Overall Study||2
213729|NCT01234922|517169|P3|COMPLETED|Overall Study||2
213730|NCT01234922|517170|P2|COMPLETED|Overall Study||1
213731|NCT01234922|517171|P1|COMPLETED|Overall Study||1
213732|NCT01234922|517168|P4|STARTED|Overall Study||2
213733|NCT01234922|517169|P3|STARTED|Overall Study||2
213734|NCT01234922|517170|P2|STARTED|Overall Study||1
213735|NCT01234922|517171|P1|STARTED|Overall Study||1
213736|NCT01234883|517187|P2|NOT COMPLETED|Overall Study||13
213737|NCT01234883|517188|P1|NOT COMPLETED|Overall Study||10
213738|NCT01234883|517187|P2|COMPLETED|Overall Study||36
213739|NCT01234883|517188|P1|COMPLETED|Overall Study||41
213740|NCT01234883|517187|P2|STARTED|Overall Study||49
213741|NCT01234883|517188|P1|STARTED|Overall Study||51
213742|NCT01234870|517194|P1|NOT COMPLETED|Overall Study||0
213743|NCT01234870|517194|P1|COMPLETED|Overall Study||40
213744|NCT01234870|517194|P1|STARTED|Overall Study||40
213745|NCT01234831|517201|P2|NOT COMPLETED|Overall Study||4
213746|NCT01234831|517202|P1|NOT COMPLETED|Overall Study||2
213747|NCT01234831|517201|P2|COMPLETED|Overall Study||198
213748|NCT01234831|517202|P1|COMPLETED|Overall Study||259
213749|NCT01234831|517201|P2|STARTED|Overall Study||202
213750|NCT01234831|517202|P1|STARTED|Overall Study||261
213751|NCT01234766|517214|P1|NOT COMPLETED|Overall Study||4
213752|NCT01234766|517214|P1|COMPLETED|Overall Study||35
213753|NCT01234766|517214|P1|STARTED|Overall Study||39
213754|NCT01234714|517218|P1|NOT COMPLETED|Overall Study||0
213755|NCT01234714|517218|P1|COMPLETED|Overall Study||84
213756|NCT01234714|517218|P1|STARTED|Overall Study||84
213757|NCT01234675|517235|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
213758|NCT01234675|517236|P1|NOT COMPLETED|Second Intervention (6 Weeks)||2
213759|NCT01234675|517235|P2|COMPLETED|Second Intervention (6 Weeks)||8
213760|NCT01234675|517236|P1|COMPLETED|Second Intervention (6 Weeks)||7
213761|NCT01234675|517235|P2|STARTED|Second Intervention (6 Weeks)||8
213762|NCT01234675|517236|P1|STARTED|Second Intervention (6 Weeks)||9
213763|NCT01234675|517235|P2|NOT COMPLETED|First Intervention (6 Weeks)||1
213764|NCT01234675|517236|P1|NOT COMPLETED|First Intervention (6 Weeks)||1
213765|NCT01234675|517235|P2|COMPLETED|First Intervention (6 Weeks)||8
213766|NCT01234675|517236|P1|COMPLETED|First Intervention (6 Weeks)||9
213767|NCT01234675|517235|P2|STARTED|First Intervention (6 Weeks)||9
213768|NCT01234675|517236|P1|STARTED|First Intervention (6 Weeks)||10
213769|NCT01234649|517268|P2|NOT COMPLETED|Overall Study||38
213770|NCT01234649|517269|P1|NOT COMPLETED|Overall Study||43
213771|NCT01234649|517268|P2|COMPLETED|Overall Study||37
213772|NCT01234649|517269|P1|COMPLETED|Overall Study||35
213773|NCT01234649|517268|P2|STARTED|Overall Study||75
213774|NCT01234649|517269|P1|STARTED|Overall Study||78
213775|NCT01234467|517317|P1|NOT COMPLETED|Overall Study||12
213776|NCT01234467|517317|P1|COMPLETED|Overall Study||11
213777|NCT01234467|517317|P1|STARTED|Overall Study||23
213778|NCT01234402|517329|P3|NOT COMPLETED|Overall Study||8
213779|NCT01234402|517330|P2|NOT COMPLETED|Overall Study||6
213780|NCT01234402|517331|P1|NOT COMPLETED|Overall Study||1
213781|NCT01234402|517329|P3|COMPLETED|Overall Study||42
213782|NCT01234402|517330|P2|COMPLETED|Overall Study||45
213783|NCT01234402|517331|P1|COMPLETED|Overall Study||51
213784|NCT01234402|517329|P3|Capecitabine Crossover to Icrucumab|Overall Study||1
213785|NCT01234402|517330|P2|Capecitabine Crossover to Icrucumab|Overall Study||0
213786|NCT01234402|517331|P1|Capecitabine Crossover to Icrucumab|Overall Study||0
213787|NCT01234402|517329|P3|Capecitabine Crossover to Ramucirumab|Overall Study||29
213788|NCT01234402|517330|P2|Capecitabine Crossover to Ramucirumab|Overall Study||0
213789|NCT01234402|517331|P1|Capecitabine Crossover to Ramucirumab|Overall Study||0
213790|NCT01234402|517329|P3|Received at Least One Dose of Study Drug|Overall Study||49
213791|NCT01234402|517330|P2|Received at Least One Dose of Study Drug|Overall Study||49
213792|NCT01234402|517331|P1|Received at Least One Dose of Study Drug|Overall Study||52
213793|NCT01234402|517329|P3|STARTED|Overall Study||50
213794|NCT01234402|517330|P2|STARTED|Overall Study||51
213795|NCT01234402|517331|P1|STARTED|Overall Study||52
213796|NCT01234350|517372|P2|NOT COMPLETED|Overall Study||267
213797|NCT01234350|517373|P1|NOT COMPLETED|Overall Study||687
213798|NCT01234350|517372|P2|COMPLETED|Overall Study||226
213799|NCT01234350|517373|P1|COMPLETED|Overall Study||313
213800|NCT01234350|517372|P2|STARTED|Overall Study||493
213801|NCT01234350|517373|P1|STARTED|Overall Study||1000
213802|NCT01234337|517399|P2|NOT COMPLETED|Overall Study||271
213803|NCT01234337|517400|P1|NOT COMPLETED|Overall Study||266
213804|NCT01234337|517399|P2|COMPLETED|Overall Study||0
213805|NCT01234337|517400|P1|COMPLETED|Overall Study||0
213806|NCT01234337|517399|P2|Participants Received Treatment|Overall Study||267
213807|NCT01234337|517400|P1|Participants Received Treatment|Overall Study||260
213808|NCT01234337|517399|P2|STARTED|Overall Study||271
213809|NCT01234337|517400|P1|STARTED|Overall Study||266
213810|NCT01234207|517428|P2|NOT COMPLETED|Second Intervention||0
213811|NCT01234207|517429|P1|NOT COMPLETED|Second Intervention||0
213812|NCT01234207|517428|P2|COMPLETED|Second Intervention||48
213813|NCT01234207|517429|P1|COMPLETED|Second Intervention||47
213814|NCT01234207|517428|P2|STARTED|Second Intervention||48
213815|NCT01234207|517429|P1|STARTED|Second Intervention||47
213816|NCT01234207|517428|P2|NOT COMPLETED|1-Week Washout Period||0
213817|NCT01234207|517429|P1|NOT COMPLETED|1-Week Washout Period||0
213818|NCT01234207|517428|P2|COMPLETED|1-Week Washout Period||48
213819|NCT01234207|517429|P1|COMPLETED|1-Week Washout Period||47
213820|NCT01234207|517428|P2|STARTED|1-Week Washout Period||48
213821|NCT01234207|517429|P1|STARTED|1-Week Washout Period||47
213822|NCT01234207|517428|P2|NOT COMPLETED|First Intervention||0
213823|NCT01234207|517429|P1|NOT COMPLETED|First Intervention||0
213824|NCT01234207|517428|P2|COMPLETED|First Intervention||48
213825|NCT01234207|517429|P1|COMPLETED|First Intervention||47
213826|NCT01234207|517428|P2|STARTED|First Intervention||48
213827|NCT01234207|517429|P1|STARTED|First Intervention||47
213828|NCT01234103|517451|P2|NOT COMPLETED|Overall Study||0
213829|NCT01234103|517452|P1|NOT COMPLETED|Overall Study||0
213830|NCT01234103|517451|P2|COMPLETED|Overall Study||391
213831|NCT01234103|517452|P1|COMPLETED|Overall Study||542
213832|NCT01234103|517451|P2|STARTED|Overall Study||391
213833|NCT01234103|517452|P1|STARTED|Overall Study||542
213834|NCT01233999|517460|P1|NOT COMPLETED|Overall Study||2
213835|NCT01233999|517460|P1|COMPLETED|Overall Study||8
213836|NCT01233999|517460|P1|STARTED|Overall Study||10
213837|NCT01233921|517466|P2|NOT COMPLETED|Overall Study||0
213838|NCT01233921|517467|P1|NOT COMPLETED|Overall Study||0
213839|NCT01233921|517466|P2|COMPLETED|Overall Study||3
213840|NCT01233921|517467|P1|COMPLETED|Overall Study||3
213841|NCT01233921|517466|P2|STARTED|Overall Study||3
213842|NCT01233921|517467|P1|STARTED|Overall Study||3
213843|NCT01233869|517479|P4|NOT COMPLETED|Extended Treatment Period (46 Months)||16
213844|NCT01233869|517480|P3|NOT COMPLETED|Extended Treatment Period (46 Months)||5
213845|NCT01233869|517481|P2|NOT COMPLETED|Extended Treatment Period (46 Months)||3
213846|NCT01233869|517482|P1|NOT COMPLETED|Extended Treatment Period (46 Months)||14
213847|NCT01233869|517479|P4|COMPLETED|Extended Treatment Period (46 Months)||18
213848|NCT01233869|517480|P3|COMPLETED|Extended Treatment Period (46 Months)||17
213849|NCT01233869|517481|P2|COMPLETED|Extended Treatment Period (46 Months)||0
213850|NCT01233869|517482|P1|COMPLETED|Extended Treatment Period (46 Months)||20
213851|NCT01233869|517479|P4|STARTED|Extended Treatment Period (46 Months)||34
213852|NCT01233869|517480|P3|STARTED|Extended Treatment Period (46 Months)||22
213853|NCT01233869|517481|P2|STARTED|Extended Treatment Period (46 Months)||3
213854|NCT01233869|517482|P1|STARTED|Extended Treatment Period (46 Months)||34
213855|NCT01233869|517479|P4|NOT COMPLETED|Washout Period 30 Days||0
213856|NCT01233869|517480|P3|NOT COMPLETED|Washout Period 30 Days||0
213857|NCT01233869|517481|P2|NOT COMPLETED|Washout Period 30 Days||0
213858|NCT01233869|517482|P1|NOT COMPLETED|Washout Period 30 Days||0
213859|NCT01233869|517479|P4|COMPLETED|Washout Period 30 Days||34
213860|NCT01233869|517480|P3|COMPLETED|Washout Period 30 Days||22
213861|NCT01233869|517481|P2|COMPLETED|Washout Period 30 Days||3
213862|NCT01233869|517482|P1|COMPLETED|Washout Period 30 Days||34
213863|NCT01233869|517479|P4|STARTED|Washout Period 30 Days||34
213864|NCT01233869|517480|P3|STARTED|Washout Period 30 Days||22
213865|NCT01233869|517481|P2|STARTED|Washout Period 30 Days||3
213866|NCT01233869|517482|P1|STARTED|Washout Period 30 Days||34
213867|NCT01233869|517479|P4|NOT COMPLETED|Initial Treatment Period (24 Months)||22
213868|NCT01233869|517480|P3|NOT COMPLETED|Initial Treatment Period (24 Months)||2
213869|NCT01233869|517481|P2|NOT COMPLETED|Initial Treatment Period (24 Months)||28
213870|NCT01233869|517482|P1|NOT COMPLETED|Initial Treatment Period (24 Months)||24
213871|NCT01233869|517479|P4|COMPLETED|Initial Treatment Period (24 Months)||34
213872|NCT01233869|517480|P3|COMPLETED|Initial Treatment Period (24 Months)||22
213873|NCT01233869|517481|P2|COMPLETED|Initial Treatment Period (24 Months)||3
213874|NCT01233869|517482|P1|COMPLETED|Initial Treatment Period (24 Months)||34
213875|NCT01233869|517479|P4|STARTED|Initial Treatment Period (24 Months)||56
213876|NCT01233869|517480|P3|STARTED|Initial Treatment Period (24 Months)||24
213877|NCT01233869|517481|P2|STARTED|Initial Treatment Period (24 Months)||31
213878|NCT01233869|517482|P1|STARTED|Initial Treatment Period (24 Months)||58
213879|NCT01233817|517568|P1|NOT COMPLETED|Overall Study||3
213880|NCT01233817|517568|P1|COMPLETED|Overall Study||9
213881|NCT01233817|517568|P1|STARTED|Overall Study||12
213882|NCT01233726|517575|P3|NOT COMPLETED|Overall Study||1
213883|NCT01233726|517576|P2|NOT COMPLETED|Overall Study||0
213884|NCT01233726|517577|P1|NOT COMPLETED|Overall Study||1
213885|NCT01233726|517575|P3|COMPLETED|Overall Study||52
213886|NCT01233726|517576|P2|COMPLETED|Overall Study||53
213887|NCT01233726|517577|P1|COMPLETED|Overall Study||52
213888|NCT01233726|517575|P3|STARTED|Overall Study||53
213889|NCT01233726|517576|P2|STARTED|Overall Study||53
213890|NCT01233726|517577|P1|STARTED|Overall Study||53
213891|NCT01233687|517615|P1|NOT COMPLETED|Phase II AMG 102 + Erlotinib||4
213892|NCT01233687|517615|P1|COMPLETED|Phase II AMG 102 + Erlotinib||45
213893|NCT01233687|517615|P1|Response-Evaluable|Phase II AMG 102 + Erlotinib||45
213894|NCT01233687|517615|P1|STARTED|Phase II AMG 102 + Erlotinib|Includes 7 participants from Phase 1 part of study.|49
213895|NCT01233687|517615|P1|NOT COMPLETED|Phase I RP2D AMG 102 + Erlotinib||0
213896|NCT01233687|517615|P1|COMPLETED|Phase I RP2D AMG 102 + Erlotinib||7
213897|NCT01233687|517615|P1|STARTED|Phase I RP2D AMG 102 + Erlotinib||7
213898|NCT01233609|517625|P2|NOT COMPLETED|Overall Study||2
213899|NCT01233609|517626|P1|NOT COMPLETED|Overall Study||9
213900|NCT01233609|517625|P2|COMPLETED|Overall Study||42
213901|NCT01233609|517626|P1|COMPLETED|Overall Study||37
213902|NCT01233609|517625|P2|STARTED|Overall Study||44
213903|NCT01233609|517626|P1|STARTED|Overall Study||46
213904|NCT01233284|517650|P5|NOT COMPLETED|Period 4 (4 Weeks)||0
213905|NCT01233284|517651|P4|NOT COMPLETED|Period 4 (4 Weeks)||1
213906|NCT01233284|517652|P3|NOT COMPLETED|Period 4 (4 Weeks)||0
213907|NCT01233284|517653|P2|NOT COMPLETED|Period 4 (4 Weeks)||1
213908|NCT01233284|517654|P1|NOT COMPLETED|Period 4 (4 Weeks)||0
213909|NCT01233284|517650|P5|COMPLETED|Period 4 (4 Weeks)||1
213910|NCT01233284|517651|P4|COMPLETED|Period 4 (4 Weeks)||33
213911|NCT01233284|517652|P3|COMPLETED|Period 4 (4 Weeks)||35
213912|NCT01233284|517653|P2|COMPLETED|Period 4 (4 Weeks)||36
213913|NCT01233284|517654|P1|COMPLETED|Period 4 (4 Weeks)||36
213914|NCT01233284|517650|P5|STARTED|Period 4 (4 Weeks)||1
213915|NCT01233284|517651|P4|STARTED|Period 4 (4 Weeks)||34
213916|NCT01233284|517652|P3|STARTED|Period 4 (4 Weeks)||35
213917|NCT01233284|517653|P2|STARTED|Period 4 (4 Weeks)||37
213918|NCT01233284|517654|P1|STARTED|Period 4 (4 Weeks)||36
213919|NCT01233284|517650|P5|NOT COMPLETED|Period 3 (4 Weeks)||0
213920|NCT01233284|517651|P4|NOT COMPLETED|Period 3 (4 Weeks)||1
213921|NCT01233284|517652|P3|NOT COMPLETED|Period 3 (4 Weeks)||1
213922|NCT01233284|517653|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
213923|NCT01233284|517654|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
213924|NCT01233284|517650|P5|COMPLETED|Period 3 (4 Weeks)||1
213925|NCT01233284|517651|P4|COMPLETED|Period 3 (4 Weeks)||34
213926|NCT01233284|517652|P3|COMPLETED|Period 3 (4 Weeks)||35
213927|NCT01233284|517653|P2|COMPLETED|Period 3 (4 Weeks)||37
213928|NCT01233284|517654|P1|COMPLETED|Period 3 (4 Weeks)||36
213929|NCT01233284|517650|P5|STARTED|Period 3 (4 Weeks)||1
213930|NCT01233284|517651|P4|STARTED|Period 3 (4 Weeks)||35
213931|NCT01233284|517652|P3|STARTED|Period 3 (4 Weeks)||36
213932|NCT01233284|517653|P2|STARTED|Period 3 (4 Weeks)||37
213933|NCT01233284|517654|P1|STARTED|Period 3 (4 Weeks)||36
213934|NCT01233284|517650|P5|NOT COMPLETED|Period 2 (4 Weeks)||0
213935|NCT01233284|517651|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
213936|NCT01233284|517652|P3|NOT COMPLETED|Period 2 (4 Weeks)||1
213937|NCT01233284|517653|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
213938|NCT01233284|517654|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
213939|NCT01233284|517650|P5|COMPLETED|Period 2 (4 Weeks)||1
213940|NCT01233284|517651|P4|COMPLETED|Period 2 (4 Weeks)||35
213941|NCT01233284|517652|P3|COMPLETED|Period 2 (4 Weeks)||36
213942|NCT01233284|517653|P2|COMPLETED|Period 2 (4 Weeks)||37
213943|NCT01233284|517654|P1|COMPLETED|Period 2 (4 Weeks)||36
213944|NCT01233284|517650|P5|STARTED|Period 2 (4 Weeks)||1
213945|NCT01233284|517651|P4|STARTED|Period 2 (4 Weeks)||35
213946|NCT01233284|517652|P3|STARTED|Period 2 (4 Weeks)||37
213947|NCT01233284|517653|P2|STARTED|Period 2 (4 Weeks)||37
213948|NCT01233284|517654|P1|STARTED|Period 2 (4 Weeks)||36
213949|NCT01233284|517650|P5|NOT COMPLETED|Period 1 (4 Weeks)||0
213950|NCT01233284|517651|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
213951|NCT01233284|517652|P3|NOT COMPLETED|Period 1 (4 Weeks)||1
213952|NCT01233284|517653|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
213953|NCT01233284|517654|P1|NOT COMPLETED|Period 1 (4 Weeks)||1
213954|NCT01233284|517650|P5|COMPLETED|Period 1 (4 Weeks)||1
213955|NCT01233284|517651|P4|COMPLETED|Period 1 (4 Weeks)||35
213956|NCT01233284|517652|P3|COMPLETED|Period 1 (4 Weeks)||37
213957|NCT01233284|517653|P2|COMPLETED|Period 1 (4 Weeks)||37
213958|NCT01233284|517654|P1|COMPLETED|Period 1 (4 Weeks)||36
213959|NCT01233284|517650|P5|STARTED|Period 1 (4 Weeks)||1
213960|NCT01233284|517651|P4|STARTED|Period 1 (4 Weeks)||35
213961|NCT01233284|517652|P3|STARTED|Period 1 (4 Weeks)||38
213962|NCT01233284|517653|P2|STARTED|Period 1 (4 Weeks)||38
213963|NCT01233284|517654|P1|STARTED|Period 1 (4 Weeks)||37
213964|NCT01233258|517735|P6|NOT COMPLETED|Second Intervention (6 Months)||0
213965|NCT01233258|517736|P5|NOT COMPLETED|Second Intervention (6 Months)||0
213966|NCT01233258|517737|P4|NOT COMPLETED|Second Intervention (6 Months)||0
213967|NCT01233258|517738|P3|NOT COMPLETED|Second Intervention (6 Months)||0
213968|NCT01233258|517739|P2|NOT COMPLETED|Second Intervention (6 Months)||0
213969|NCT01233258|517740|P1|NOT COMPLETED|Second Intervention (6 Months)||0
213970|NCT01233258|517735|P6|COMPLETED|Second Intervention (6 Months)||15
213971|NCT01233258|517736|P5|COMPLETED|Second Intervention (6 Months)||16
213972|NCT01233258|517737|P4|COMPLETED|Second Intervention (6 Months)||15
213973|NCT01233258|517738|P3|COMPLETED|Second Intervention (6 Months)||13
213974|NCT01233258|517739|P2|COMPLETED|Second Intervention (6 Months)||10
213975|NCT01233258|517740|P1|COMPLETED|Second Intervention (6 Months)||10
213976|NCT01233258|517735|P6|STARTED|Second Intervention (6 Months)||15
213977|NCT01233258|517736|P5|STARTED|Second Intervention (6 Months)||16
213978|NCT01233258|517737|P4|STARTED|Second Intervention (6 Months)||15
213979|NCT01233258|517738|P3|STARTED|Second Intervention (6 Months)||13
213980|NCT01233258|517739|P2|STARTED|Second Intervention (6 Months)||10
213981|NCT01233258|517740|P1|STARTED|Second Intervention (6 Months)||10
213982|NCT01233258|517735|P6|NOT COMPLETED|Washout (2-3 Days)||0
213983|NCT01233258|517736|P5|NOT COMPLETED|Washout (2-3 Days)||0
213984|NCT01233258|517737|P4|NOT COMPLETED|Washout (2-3 Days)||0
213985|NCT01233258|517738|P3|NOT COMPLETED|Washout (2-3 Days)||0
213986|NCT01233258|517739|P2|NOT COMPLETED|Washout (2-3 Days)||0
213987|NCT01233258|517740|P1|NOT COMPLETED|Washout (2-3 Days)||0
213988|NCT01233258|517735|P6|COMPLETED|Washout (2-3 Days)||15
213989|NCT01233258|517736|P5|COMPLETED|Washout (2-3 Days)||16
213990|NCT01233258|517737|P4|COMPLETED|Washout (2-3 Days)||15
213991|NCT01233258|517738|P3|COMPLETED|Washout (2-3 Days)||13
213992|NCT01233258|517739|P2|COMPLETED|Washout (2-3 Days)||10
213993|NCT01233258|517740|P1|COMPLETED|Washout (2-3 Days)||10
213994|NCT01233258|517735|P6|STARTED|Washout (2-3 Days)||15
213995|NCT01233258|517736|P5|STARTED|Washout (2-3 Days)||16
213996|NCT01233258|517737|P4|STARTED|Washout (2-3 Days)||15
213997|NCT01233258|517738|P3|STARTED|Washout (2-3 Days)||13
213998|NCT01233258|517739|P2|STARTED|Washout (2-3 Days)||10
213999|NCT01233258|517740|P1|STARTED|Washout (2-3 Days)||10
214000|NCT01233258|517735|P6|NOT COMPLETED|First Intervention (6 Months)||1
214001|NCT01233258|517736|P5|NOT COMPLETED|First Intervention (6 Months)||0
214002|NCT01233258|517737|P4|NOT COMPLETED|First Intervention (6 Months)||1
214003|NCT01233258|517738|P3|NOT COMPLETED|First Intervention (6 Months)||1
214004|NCT01233258|517739|P2|NOT COMPLETED|First Intervention (6 Months)||0
214005|NCT01233258|517740|P1|NOT COMPLETED|First Intervention (6 Months)||1
214006|NCT01233258|517735|P6|COMPLETED|First Intervention (6 Months)||15
214007|NCT01233258|517736|P5|COMPLETED|First Intervention (6 Months)||16
214008|NCT01233258|517737|P4|COMPLETED|First Intervention (6 Months)||15
214009|NCT01233258|517738|P3|COMPLETED|First Intervention (6 Months)||13
214010|NCT01233258|517739|P2|COMPLETED|First Intervention (6 Months)||10
214011|NCT01233258|517740|P1|COMPLETED|First Intervention (6 Months)||10
214012|NCT01233258|517735|P6|Participants Received Treatment|First Intervention (6 Months)||15
214013|NCT01233258|517736|P5|Participants Received Treatment|First Intervention (6 Months)||16
214014|NCT01233258|517737|P4|Participants Received Treatment|First Intervention (6 Months)||15
214015|NCT01233258|517738|P3|Participants Received Treatment|First Intervention (6 Months)||13
214016|NCT01233258|517739|P2|Participants Received Treatment|First Intervention (6 Months)||10
214017|NCT01233258|517740|P1|Participants Received Treatment|First Intervention (6 Months)||11
214018|NCT01233258|517735|P6|STARTED|First Intervention (6 Months)||16
214019|NCT01233258|517736|P5|STARTED|First Intervention (6 Months)||16
214020|NCT01233258|517737|P4|STARTED|First Intervention (6 Months)||16
214021|NCT01233258|517738|P3|STARTED|First Intervention (6 Months)||14
214022|NCT01233258|517739|P2|STARTED|First Intervention (6 Months)||10
214023|NCT01233258|517740|P1|STARTED|First Intervention (6 Months)||11
214024|NCT01233232|517760|P3|NOT COMPLETED|Overall Study||0
214025|NCT01233232|517761|P2|NOT COMPLETED|Overall Study||0
214026|NCT01233232|517762|P1|NOT COMPLETED|Overall Study||1
214027|NCT01233232|517760|P3|COMPLETED|Overall Study||28
214028|NCT01233232|517761|P2|COMPLETED|Overall Study||30
214029|NCT01233232|517762|P1|COMPLETED|Overall Study||28
214030|NCT01233232|517760|P3|STARTED|Overall Study||28
214031|NCT01233232|517761|P2|STARTED|Overall Study||30
214032|NCT01233232|517762|P1|STARTED|Overall Study||29
214033|NCT01233076|517815|P2|NOT COMPLETED|Period 2, One Week||0
214034|NCT01233076|517816|P1|NOT COMPLETED|Period 2, One Week||1
214035|NCT01233076|517815|P2|COMPLETED|Period 2, One Week||30
214036|NCT01233076|517816|P1|COMPLETED|Period 2, One Week||29
214037|NCT01233076|517815|P2|STARTED|Period 2, One Week||30
214038|NCT01233076|517816|P1|STARTED|Period 2, One Week||30
214039|NCT01233076|517815|P2|NOT COMPLETED|Period 1, One Week||0
214040|NCT01233076|517816|P1|NOT COMPLETED|Period 1, One Week||0
214041|NCT01233076|517815|P2|COMPLETED|Period 1, One Week||30
214042|NCT01233076|517816|P1|COMPLETED|Period 1, One Week||30
214043|NCT01233076|517815|P2|STARTED|Period 1, One Week||30
214044|NCT01233076|517816|P1|STARTED|Period 1, One Week||30
214045|NCT01233050|517824|P2|NOT COMPLETED|Overall Study||6
214046|NCT01233050|517825|P1|NOT COMPLETED|Overall Study||8
214047|NCT01233050|517824|P2|COMPLETED|Overall Study|6 participants were excluded after treatment administered due to inclusion/exclusion criteria|396
214048|NCT01233050|517825|P1|COMPLETED|Overall Study|8 participants were excluded after treatment administered due to inclusion/exclusion criteria|392
214049|NCT01233050|517824|P2|STARTED|Overall Study||402
214050|NCT01233050|517825|P1|STARTED|Overall Study||400
214051|NCT01232946|517844|P3|NOT COMPLETED|Overall Study||2
214052|NCT01232946|517845|P2|NOT COMPLETED|Overall Study||1
214053|NCT01232946|517846|P1|NOT COMPLETED|Overall Study||0
214054|NCT01232946|517844|P3|COMPLETED|Overall Study|2 withdrew after baseline measurements|9
214055|NCT01232946|517845|P2|COMPLETED|Overall Study|1 participant died unrelated to study|9
214056|NCT01232946|517846|P1|COMPLETED|Overall Study||9
214057|NCT01232946|517844|P3|STARTED|Overall Study||11
214058|NCT01232946|517845|P2|STARTED|Overall Study||10
214059|NCT01232946|517846|P1|STARTED|Overall Study||9
214060|NCT01232920|517862|P2|NOT COMPLETED|Overall Study||7
214061|NCT01232920|517863|P1|NOT COMPLETED|Overall Study||6
214062|NCT01232920|517862|P2|COMPLETED|Overall Study||32
214063|NCT01232920|517863|P1|COMPLETED|Overall Study||35
214064|NCT01232920|517862|P2|STARTED|Overall Study||39
214065|NCT01232920|517863|P1|STARTED|Overall Study||41
214066|NCT01232894|517877|P2|NOT COMPLETED|Overall Study||8
214067|NCT01232894|517878|P1|NOT COMPLETED|Overall Study||12
214068|NCT01232894|517877|P2|COMPLETED|Overall Study||22
214069|NCT01232894|517878|P1|COMPLETED|Overall Study||48
214070|NCT01232894|517877|P2|Received Study Drug|Overall Study||28
214071|NCT01232894|517878|P1|Received Study Drug|Overall Study||59
214072|NCT01232894|517877|P2|STARTED|Overall Study||30
214073|NCT01232894|517878|P1|STARTED|Overall Study||60
214074|NCT01232868|517886|P2|NOT COMPLETED|Overall Study||4
214075|NCT01232868|517887|P1|NOT COMPLETED|Overall Study||2
214076|NCT01232868|517886|P2|COMPLETED|Overall Study||40
214077|NCT01232868|517887|P1|COMPLETED|Overall Study||20
214078|NCT01232868|517886|P2|STARTED|Overall Study||44
214079|NCT01232868|517887|P1|STARTED|Overall Study||22
214080|NCT01232829|517895|P1|NOT COMPLETED|Overall Study||0
214081|NCT01232829|517895|P1|COMPLETED|Overall Study||18
214082|NCT01232829|517895|P1|STARTED|Overall Study||18
214083|NCT01232790|517901|P2|NOT COMPLETED|Second Crossover||2
214084|NCT01232790|517902|P1|NOT COMPLETED|Second Crossover||1
214085|NCT01232790|517901|P2|COMPLETED|Second Crossover||9
214086|NCT01232790|517902|P1|COMPLETED|Second Crossover||10
214087|NCT01232790|517901|P2|STARTED|Second Crossover||11
214088|NCT01232790|517902|P1|STARTED|Second Crossover||11
214089|NCT01232790|517901|P2|NOT COMPLETED|First Crossover||0
214090|NCT01232790|517902|P1|NOT COMPLETED|First Crossover||1
214091|NCT01232790|517901|P2|COMPLETED|First Crossover||11
214092|NCT01232790|517902|P1|COMPLETED|First Crossover||11
214093|NCT01232790|517901|P2|STARTED|First Crossover||11
214094|NCT01232790|517902|P1|STARTED|First Crossover||12
214095|NCT01232790|517901|P2|NOT COMPLETED|Initial Assessment||1
214096|NCT01232790|517902|P1|NOT COMPLETED|Initial Assessment||0
214097|NCT01232790|517901|P2|COMPLETED|Initial Assessment||11
214098|NCT01232790|517902|P1|COMPLETED|Initial Assessment||12
214099|NCT01232790|517901|P2|STARTED|Initial Assessment||12
214100|NCT01232790|517902|P1|STARTED|Initial Assessment||12
214101|NCT01232790|517901|P2|NOT COMPLETED|Randomization||2
214102|NCT01232790|517902|P1|NOT COMPLETED|Randomization||2
214103|NCT01232790|517901|P2|COMPLETED|Randomization||12
214104|NCT01232790|517902|P1|COMPLETED|Randomization||12
214105|NCT01232790|517901|P2|STARTED|Randomization||14
214106|NCT01232790|517902|P1|STARTED|Randomization||14
214107|NCT01232738|517956|P1|NOT COMPLETED|Overall Study||13
214108|NCT01232738|517956|P1|COMPLETED|Overall Study||23
214109|NCT01232738|517956|P1|STARTED|Overall Study||36
214110|NCT01232569|517972|P4|NOT COMPLETED|Open-label Extension Period||27
214111|NCT01232569|517973|P3|NOT COMPLETED|Open-label Extension Period||27
214112|NCT01232569|517974|P2|NOT COMPLETED|Open-label Extension Period||0
214113|NCT01232569|517975|P1|NOT COMPLETED|Open-label Extension Period||0
214114|NCT01232569|517972|P4|COMPLETED|Open-label Extension Period||200
214115|NCT01232569|517973|P3|COMPLETED|Open-label Extension Period||203
214116|NCT01232569|517974|P2|COMPLETED|Open-label Extension Period||0
214117|NCT01232569|517975|P1|COMPLETED|Open-label Extension Period||0
214118|NCT01232569|517972|P4|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|227
214119|NCT01232569|517973|P3|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|230
214120|NCT01232569|517974|P2|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
214121|NCT01232569|517975|P1|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
214122|NCT01232569|517972|P4|NOT COMPLETED|Double-blind Treatment Period||0
214123|NCT01232569|517973|P3|NOT COMPLETED|Double-blind Treatment Period||0
214124|NCT01232569|517974|P2|NOT COMPLETED|Double-blind Treatment Period||9
214125|NCT01232569|517975|P1|NOT COMPLETED|Double-blind Treatment Period||28
214126|NCT01232569|517972|P4|COMPLETED|Double-blind Treatment Period||0
214127|NCT01232569|517973|P3|COMPLETED|Double-blind Treatment Period||0
214128|NCT01232569|517974|P2|COMPLETED|Double-blind Treatment Period||209
214129|NCT01232569|517975|P1|COMPLETED|Double-blind Treatment Period||410
214130|NCT01232569|517972|P4|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
214131|NCT01232569|517973|P3|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
214132|NCT01232569|517974|P2|STARTED|Double-blind Treatment Period||218
214133|NCT01232569|517975|P1|STARTED|Double-blind Treatment Period||438
214134|NCT01232556|518018|P2|NOT COMPLETED|Overall Study||171
214135|NCT01232556|518019|P1|NOT COMPLETED|Overall Study||159
214136|NCT01232556|518018|P2|COMPLETED|Overall Study||1
214137|NCT01232556|518019|P1|COMPLETED|Overall Study||7
214138|NCT01232556|518018|P2|Treated|Overall Study||167
214139|NCT01232556|518019|P1|Treated|Overall Study|One subject in this arm received rituximab only and was excluded from the safety population.|165
214140|NCT01232556|518018|P2|STARTED|Overall Study||172
214141|NCT01232556|518019|P1|STARTED|Overall Study||166
214142|NCT01232504|518042|P3|NOT COMPLETED|Overall Study||8
214143|NCT01232504|518043|P2|NOT COMPLETED|Overall Study||2
214144|NCT01232504|518044|P1|NOT COMPLETED|Overall Study||9
214145|NCT01232504|518042|P3|COMPLETED|Overall Study||61
214146|NCT01232504|518043|P2|COMPLETED|Overall Study||67
214147|NCT01232504|518044|P1|COMPLETED|Overall Study||59
214148|NCT01232504|518042|P3|STARTED|Overall Study||69
214149|NCT01232504|518043|P2|STARTED|Overall Study||69
214150|NCT01232504|518044|P1|STARTED|Overall Study||68
214151|NCT01232491|518078|P2|NOT COMPLETED|Overall Study||63
214152|NCT01232491|518079|P1|NOT COMPLETED|Overall Study||60
214153|NCT01232491|518078|P2|COMPLETED|Overall Study||242
214154|NCT01232491|518079|P1|COMPLETED|Overall Study||246
214155|NCT01232491|518078|P2|Exposed (Safety Analysis Set)|Overall Study|Four subjects withdrew prior to exposure to trial drug.|301
214156|NCT01232491|518079|P1|Exposed (Safety Analysis Set)|Overall Study|One subject withdrew prior to exposure to trial drug.|305
214157|NCT01232491|518078|P2|STARTED|Overall Study||305
214158|NCT01232491|518079|P1|STARTED|Overall Study||306
214159|NCT01232465|518099|P2|NOT COMPLETED|Overall Study||0
214160|NCT01232465|518100|P1|NOT COMPLETED|Overall Study||0
214161|NCT01232465|518099|P2|COMPLETED|Overall Study||402
214162|NCT01232465|518100|P1|COMPLETED|Overall Study||337
214163|NCT01232465|518099|P2|STARTED|Overall Study||402
214164|NCT01232465|518100|P1|STARTED|Overall Study||337
214165|NCT01232452|518108|P2|NOT COMPLETED|Overall Study||39
214166|NCT01232452|518109|P1|NOT COMPLETED|Overall Study||39
214167|NCT01232452|518108|P2|COMPLETED|Overall Study||46
214168|NCT01232452|518109|P1|COMPLETED|Overall Study||48
214169|NCT01232452|518108|P2|Received at Least One Dose of Study Drug|Overall Study||81
214170|NCT01232452|518109|P1|Received at Least One Dose of Study Drug|Overall Study||85
214171|NCT01232452|518108|P2|STARTED|Overall Study||85
214172|NCT01232452|518109|P1|STARTED|Overall Study||87
214173|NCT01232296|518135|P2|NOT COMPLETED|Overall Study||83
214174|NCT01232296|518136|P1|NOT COMPLETED|Overall Study||82
214175|NCT01232296|518135|P2|COMPLETED|Overall Study||0
214176|NCT01232296|518136|P1|COMPLETED|Overall Study||0
214177|NCT01232296|518135|P2|Safety Set|Overall Study||83
214178|NCT01232296|518136|P1|Safety Set|Overall Study|The Safety Set includes all patients who received at least one dose of study medication|79
214179|NCT01232296|518135|P2|Full Analysis Set|Overall Study||83
214180|NCT01232296|518136|P1|Full Analysis Set|Overall Study||82
214181|NCT01232296|518135|P2|STARTED|Overall Study||83
214182|NCT01232296|518136|P1|STARTED|Overall Study||82
214183|NCT01232283|518153|P10|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||61
214184|NCT01232283|518154|P9|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||108
214185|NCT01232283|518155|P8|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
214186|NCT01232283|518156|P7|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
214187|NCT01232283|518157|P6|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
214188|NCT01232283|518158|P5|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
214189|NCT01232283|518159|P4|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
214190|NCT01232283|518160|P3|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
214191|NCT01232283|518161|P2|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
214192|NCT01232283|518162|P1|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
214193|NCT01232283|518153|P10|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||19
214194|NCT01232283|518154|P9|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||29
214195|NCT01232283|518155|P8|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
214196|NCT01232283|518156|P7|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
214197|NCT01232283|518157|P6|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
214198|NCT01232283|518158|P5|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
214199|NCT01232283|518159|P4|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
214200|NCT01232283|518160|P3|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
214201|NCT01232283|518161|P2|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
214202|NCT01232283|518162|P1|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
214203|NCT01232283|518153|P10|STARTED|Long-Term Extension Phase (Weeks 52-260)||80
214204|NCT01232283|518154|P9|STARTED|Long-Term Extension Phase (Weeks 52-260)||137
214205|NCT01232283|518155|P8|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
214206|NCT01232283|518156|P7|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
214207|NCT01232283|518157|P6|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
214208|NCT01232283|518158|P5|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
214209|NCT01232283|518159|P4|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
214210|NCT01232283|518160|P3|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
214211|NCT01232283|518161|P2|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
214212|NCT01232283|518162|P1|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
214213|NCT01232283|518153|P10|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
214214|NCT01232283|518154|P9|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
214215|NCT01232283|518155|P8|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
214216|NCT01232283|518156|P7|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||17
214217|NCT01232283|518157|P6|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||5
214218|NCT01232283|518158|P5|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
214219|NCT01232283|518159|P4|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
214220|NCT01232283|518160|P3|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
214221|NCT01232283|518161|P2|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
214222|NCT01232283|518162|P1|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
214375|NCT01231984|518232|P1|COMPLETED|Study Period 1||57
214223|NCT01232283|518153|P10|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
214224|NCT01232283|518154|P9|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
214225|NCT01232283|518155|P8|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||84
214226|NCT01232283|518156|P7|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||41
214227|NCT01232283|518157|P6|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||56
214228|NCT01232283|518158|P5|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||50
214229|NCT01232283|518159|P4|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
214230|NCT01232283|518160|P3|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
214231|NCT01232283|518161|P2|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
214232|NCT01232283|518162|P1|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
214233|NCT01232283|518153|P10|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
214234|NCT01232283|518154|P9|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
214235|NCT01232283|518155|P8|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||17
214236|NCT01232283|518156|P7|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||28
214237|NCT01232283|518157|P6|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
214238|NCT01232283|518158|P5|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
214239|NCT01232283|518159|P4|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
214240|NCT01232283|518160|P3|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
214241|NCT01232283|518161|P2|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
214242|NCT01232283|518162|P1|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
214243|NCT01232283|518153|P10|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
214244|NCT01232283|518154|P9|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
214245|NCT01232283|518155|P8|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||96
214246|NCT01232283|518156|P7|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||58
214247|NCT01232283|518157|P6|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|13 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|61
214248|NCT01232283|518158|P5|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|4 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|62
214249|NCT01232283|518159|P4|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
214250|NCT01232283|518160|P3|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
214251|NCT01232283|518161|P2|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
214252|NCT01232283|518162|P1|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
214253|NCT01232283|518153|P10|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
214254|NCT01232283|518154|P9|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
214255|NCT01232283|518155|P8|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
214256|NCT01232283|518156|P7|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
214257|NCT01232283|518157|P6|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
214258|NCT01232283|518158|P5|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
214259|NCT01232283|518159|P4|NOT COMPLETED|Maintenance Phase (Weeks16-32)||8
214260|NCT01232283|518160|P3|NOT COMPLETED|Maintenance Phase (Weeks16-32)||40
214261|NCT01232283|518161|P2|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
214262|NCT01232283|518162|P1|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
214263|NCT01232283|518153|P10|COMPLETED|Maintenance Phase (Weeks16-32)||0
214264|NCT01232283|518154|P9|COMPLETED|Maintenance Phase (Weeks16-32)||0
214265|NCT01232283|518155|P8|COMPLETED|Maintenance Phase (Weeks16-32)||0
214266|NCT01232283|518156|P7|COMPLETED|Maintenance Phase (Weeks16-32)||0
214267|NCT01232283|518157|P6|COMPLETED|Maintenance Phase (Weeks16-32)||0
214268|NCT01232283|518158|P5|COMPLETED|Maintenance Phase (Weeks16-32)||0
214269|NCT01232283|518159|P4|COMPLETED|Maintenance Phase (Weeks16-32)||100
214270|NCT01232283|518160|P3|COMPLETED|Maintenance Phase (Weeks16-32)||194
214271|NCT01232283|518161|P2|COMPLETED|Maintenance Phase (Weeks16-32)||0
214272|NCT01232283|518162|P1|COMPLETED|Maintenance Phase (Weeks16-32)||0
214273|NCT01232283|518153|P10|STARTED|Maintenance Phase (Weeks16-32)||0
214274|NCT01232283|518154|P9|STARTED|Maintenance Phase (Weeks16-32)||0
214275|NCT01232283|518155|P8|STARTED|Maintenance Phase (Weeks16-32)||0
214276|NCT01232283|518156|P7|STARTED|Maintenance Phase (Weeks16-32)||0
214277|NCT01232283|518157|P6|STARTED|Maintenance Phase (Weeks16-32)||0
214278|NCT01232283|518158|P5|STARTED|Maintenance Phase (Weeks16-32)||0
214279|NCT01232283|518159|P4|STARTED|Maintenance Phase (Weeks16-32)|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|108
214280|NCT01232283|518160|P3|STARTED|Maintenance Phase (Weeks16-32)|5 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|234
214281|NCT01232283|518161|P2|STARTED|Maintenance Phase (Weeks16-32)||0
214282|NCT01232283|518162|P1|STARTED|Maintenance Phase (Weeks16-32)||0
214283|NCT01232283|518153|P10|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
214284|NCT01232283|518154|P9|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
214285|NCT01232283|518155|P8|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
214286|NCT01232283|518156|P7|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
214287|NCT01232283|518157|P6|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
214288|NCT01232283|518158|P5|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
214289|NCT01232283|518159|P4|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
214290|NCT01232283|518160|P3|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
214291|NCT01232283|518161|P2|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||26
214292|NCT01232283|518162|P1|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||36
214293|NCT01232283|518153|P10|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
214294|NCT01232283|518154|P9|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
214295|NCT01232283|518155|P8|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
214296|NCT01232283|518156|P7|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
214297|NCT01232283|518157|P6|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
214298|NCT01232283|518158|P5|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
214299|NCT01232283|518159|P4|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
214300|NCT01232283|518160|P3|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
214301|NCT01232283|518161|P2|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||112
214302|NCT01232283|518162|P1|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||239
214303|NCT01232283|518153|P10|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
214304|NCT01232283|518154|P9|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
214305|NCT01232283|518155|P8|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
214306|NCT01232283|518156|P7|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
214307|NCT01232283|518157|P6|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
214308|NCT01232283|518158|P5|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
214309|NCT01232283|518159|P4|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
214310|NCT01232283|518160|P3|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
214311|NCT01232283|518161|P2|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|136
214312|NCT01232283|518162|P1|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|272
214313|NCT01232283|518153|P10|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
214314|NCT01232283|518154|P9|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
214315|NCT01232283|518155|P8|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
214316|NCT01232283|518156|P7|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
214317|NCT01232283|518157|P6|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
214318|NCT01232283|518158|P5|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
214319|NCT01232283|518159|P4|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
214320|NCT01232283|518160|P3|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
214321|NCT01232283|518161|P2|STARTED|Placebo Controlled Phase (Weeks 0-16)||138
214322|NCT01232283|518162|P1|STARTED|Placebo Controlled Phase (Weeks 0-16)||275
214323|NCT01232205|518196|P2|NOT COMPLETED|Overall Study||3
214324|NCT01232205|518197|P1|NOT COMPLETED|Overall Study||3
214325|NCT01232205|518196|P2|COMPLETED|Overall Study||55
214326|NCT01232205|518197|P1|COMPLETED|Overall Study||49
214327|NCT01232205|518196|P2|STARTED|Overall Study||58
214328|NCT01232205|518197|P1|STARTED|Overall Study||52
214329|NCT01232127|518203|P3|NOT COMPLETED|Period 3: Days 18-24||0
214330|NCT01232127|518204|P2|NOT COMPLETED|Period 3: Days 18-24||0
214331|NCT01232127|518205|P1|NOT COMPLETED|Period 3: Days 18-24||0
214332|NCT01232127|518203|P3|COMPLETED|Period 3: Days 18-24||24
214333|NCT01232127|518204|P2|COMPLETED|Period 3: Days 18-24||0
214334|NCT01232127|518205|P1|COMPLETED|Period 3: Days 18-24||0
214335|NCT01232127|518203|P3|STARTED|Period 3: Days 18-24|Participants who received treatment.|24
214336|NCT01232127|518204|P2|STARTED|Period 3: Days 18-24||0
214337|NCT01232127|518205|P1|STARTED|Period 3: Days 18-24||0
214338|NCT01232127|518203|P3|NOT COMPLETED|Period 2: Days 11-17||0
214339|NCT01232127|518204|P2|NOT COMPLETED|Period 2: Days 11-17||0
214340|NCT01232127|518205|P1|NOT COMPLETED|Period 2: Days 11-17||0
214341|NCT01232127|518203|P3|COMPLETED|Period 2: Days 11-17||0
214342|NCT01232127|518204|P2|COMPLETED|Period 2: Days 11-17||24
214343|NCT01232127|518205|P1|COMPLETED|Period 2: Days 11-17||0
214344|NCT01232127|518203|P3|STARTED|Period 2: Days 11-17||0
214345|NCT01232127|518204|P2|STARTED|Period 2: Days 11-17|Participants who received treatment.|24
214346|NCT01232127|518205|P1|STARTED|Period 2: Days 11-17||0
214347|NCT01232127|518203|P3|NOT COMPLETED|Period 1: Days 1-10||0
214348|NCT01232127|518204|P2|NOT COMPLETED|Period 1: Days 1-10||0
214349|NCT01232127|518205|P1|NOT COMPLETED|Period 1: Days 1-10||1
214350|NCT01232127|518203|P3|COMPLETED|Period 1: Days 1-10||0
214351|NCT01232127|518204|P2|COMPLETED|Period 1: Days 1-10||0
214352|NCT01232127|518205|P1|COMPLETED|Period 1: Days 1-10||24
214353|NCT01232127|518203|P3|STARTED|Period 1: Days 1-10||0
214354|NCT01232127|518204|P2|STARTED|Period 1: Days 1-10||0
214355|NCT01232127|518205|P1|STARTED|Period 1: Days 1-10|Participants who received treatment.|25
214356|NCT01231984|518229|P4|NOT COMPLETED|Study Period 2||4
214357|NCT01231984|518230|P3|NOT COMPLETED|Study Period 2||0
214358|NCT01231984|518231|P2|NOT COMPLETED|Study Period 2||2
214359|NCT01231984|518232|P1|NOT COMPLETED|Study Period 2||3
214360|NCT01231984|518229|P4|COMPLETED|Study Period 2||56
214361|NCT01231984|518230|P3|COMPLETED|Study Period 2||59
214362|NCT01231984|518231|P2|COMPLETED|Study Period 2||61
214363|NCT01231984|518232|P1|COMPLETED|Study Period 2||54
214364|NCT01231984|518229|P4|STARTED|Study Period 2||60
214365|NCT01231984|518230|P3|STARTED|Study Period 2||59
214366|NCT01231984|518231|P2|STARTED|Study Period 2||63
214367|NCT01231984|518232|P1|STARTED|Study Period 2||57
214368|NCT01231984|518229|P4|NOT COMPLETED|Study Period 1||9
214369|NCT01231984|518230|P3|NOT COMPLETED|Study Period 1||7
214370|NCT01231984|518231|P2|NOT COMPLETED|Study Period 1||7
214371|NCT01231984|518232|P1|NOT COMPLETED|Study Period 1||12
214372|NCT01231984|518229|P4|COMPLETED|Study Period 1||60
214373|NCT01231984|518230|P3|COMPLETED|Study Period 1||59
214374|NCT01231984|518231|P2|COMPLETED|Study Period 1||63
214376|NCT01231984|518229|P4|STARTED|Study Period 1||69
214377|NCT01231984|518230|P3|STARTED|Study Period 1||66
214378|NCT01231984|518231|P2|STARTED|Study Period 1||70
214379|NCT01231984|518232|P1|STARTED|Study Period 1||69
214380|NCT01231841|518253|P1|NOT COMPLETED|Overall Study||0
214381|NCT01231841|518253|P1|COMPLETED|Overall Study||20
214382|NCT01231841|518253|P1|STARTED|Overall Study||20
214383|NCT01231750|518259|P2|NOT COMPLETED|Overall Study||0
214384|NCT01231750|518260|P1|NOT COMPLETED|Overall Study||0
214385|NCT01231750|518259|P2|COMPLETED|Overall Study||4
214386|NCT01231750|518260|P1|COMPLETED|Overall Study||3
214387|NCT01231750|518259|P2|STARTED|Overall Study||4
214388|NCT01231750|518260|P1|STARTED|Overall Study||3
214389|NCT01231646|518278|P2|NOT COMPLETED|Overall Study||0
214390|NCT01231646|518279|P1|NOT COMPLETED|Overall Study||0
214391|NCT01231646|518278|P2|COMPLETED|Overall Study||10
214392|NCT01231646|518279|P1|COMPLETED|Overall Study||28
214393|NCT01231646|518278|P2|STARTED|Overall Study||10
214394|NCT01231646|518279|P1|STARTED|Overall Study||28
214395|NCT01231633|518287|P2|NOT COMPLETED|Overall Study||0
214396|NCT01231633|518288|P1|NOT COMPLETED|Overall Study||0
214397|NCT01231633|518287|P2|COMPLETED|Overall Study||13
214398|NCT01231633|518288|P1|COMPLETED|Overall Study||14
214399|NCT01231633|518287|P2|STARTED|Overall Study||13
214400|NCT01231633|518288|P1|STARTED|Overall Study||14
214401|NCT01231620|518301|P3|NOT COMPLETED|Overall Study||39
214402|NCT01231620|518302|P2|NOT COMPLETED|Overall Study||31
214403|NCT01231620|518303|P1|NOT COMPLETED|Overall Study||26
214404|NCT01231620|518301|P3|COMPLETED|Overall Study||166
214405|NCT01231620|518302|P2|COMPLETED|Overall Study||178
214406|NCT01231620|518303|P1|COMPLETED|Overall Study||175
214407|NCT01231620|518301|P3|STARTED|Overall Study||205
214408|NCT01231620|518302|P2|STARTED|Overall Study||209
214409|NCT01231620|518303|P1|STARTED|Overall Study||201
214410|NCT01231607|518409|P5|NOT COMPLETED|Overall Study||24
214411|NCT01231607|518410|P4|NOT COMPLETED|Overall Study||38
214412|NCT01231607|518411|P3|NOT COMPLETED|Overall Study||31
214413|NCT01231607|518412|P2|NOT COMPLETED|Overall Study||34
214414|NCT01231607|518413|P1|NOT COMPLETED|Overall Study||29
214415|NCT01231607|518409|P5|COMPLETED|Overall Study||157
214416|NCT01231607|518410|P4|COMPLETED|Overall Study||141
214417|NCT01231607|518411|P3|COMPLETED|Overall Study||153
214418|NCT01231607|518412|P2|COMPLETED|Overall Study||154
214419|NCT01231607|518413|P1|COMPLETED|Overall Study||156
214420|NCT01231607|518409|P5|STARTED|Overall Study||181
214421|NCT01231607|518410|P4|STARTED|Overall Study||179
214422|NCT01231607|518411|P3|STARTED|Overall Study||184
214423|NCT01231607|518412|P2|STARTED|Overall Study||188
214424|NCT01231607|518413|P1|STARTED|Overall Study||185
214425|NCT01231581|518505|P2|NOT COMPLETED|Overall Study||80
214426|NCT01231581|518506|P1|NOT COMPLETED|Overall Study||80
214427|NCT01231581|518505|P2|COMPLETED|Overall Study||0
214428|NCT01231581|518506|P1|COMPLETED|Overall Study||0
214429|NCT01231581|518505|P2|Ongoing|Overall Study||0
214430|NCT01231581|518506|P1|Ongoing|Overall Study|Participant is continuing treatment with trametinib and gemcitabine under roll over study MEK114375.|1
214431|NCT01231581|518505|P2|STARTED|Overall Study||80
214432|NCT01231581|518506|P1|STARTED|Overall Study||80
214433|NCT01231555|518527|P3|NOT COMPLETED|Overall Study||8
214434|NCT01231555|518528|P2|NOT COMPLETED|Overall Study||7
214435|NCT01231555|518529|P1|NOT COMPLETED|Overall Study||8
214436|NCT01231555|518527|P3|COMPLETED|Overall Study||0
214437|NCT01231555|518528|P2|COMPLETED|Overall Study||0
214438|NCT01231555|518529|P1|COMPLETED|Overall Study||0
214439|NCT01231555|518527|P3|STARTED|Overall Study||8
214440|NCT01231555|518528|P2|STARTED|Overall Study||7
214441|NCT01231555|518529|P1|STARTED|Overall Study||8
214442|NCT01231516|518560|P2|NOT COMPLETED|Open-label Phase||26
214443|NCT01231516|518561|P1|NOT COMPLETED|Open-label Phase||295
214444|NCT01231516|518560|P2|COMPLETED|Open-label Phase||1
214445|NCT01231516|518561|P1|COMPLETED|Open-label Phase||0
214446|NCT01231516|518560|P2|Ongoing at the Time of Analysis|Open-label Phase||23
214447|NCT01231516|518561|P1|Ongoing at the Time of Analysis|Open-label Phase||282
214448|NCT01231516|518560|P2|STARTED|Open-label Phase|256 participants completed the Double-blind Phase but did not enter the Open-label Phase.|27
214449|NCT01231516|518561|P1|STARTED|Open-label Phase|4 participants completed the Double-blind Phase but did not enter the Open-label Phase.|295
214450|NCT01231516|518560|P2|NOT COMPLETED|48 Week Double-blind Phase||79
214451|NCT01231516|518561|P1|NOT COMPLETED|48 Week Double-blind Phase||58
214452|NCT01231516|518560|P2|COMPLETED|48 Week Double-blind Phase||283
214453|NCT01231516|518561|P1|COMPLETED|48 Week Double-blind Phase||299
214454|NCT01231516|518560|P2|STARTED|48 Week Double-blind Phase||362
214455|NCT01231516|518561|P1|STARTED|48 Week Double-blind Phase||357
214456|NCT01231503|518591|P8|NOT COMPLETED|Overall Study||8
214457|NCT01231503|518592|P7|NOT COMPLETED|Overall Study||7
214458|NCT01231503|518593|P6|NOT COMPLETED|Overall Study||16
214459|NCT01231503|518594|P5|NOT COMPLETED|Overall Study||10
214460|NCT01231503|518595|P4|NOT COMPLETED|Overall Study||8
214461|NCT01231503|518596|P3|NOT COMPLETED|Overall Study||12
214462|NCT01231503|518597|P2|NOT COMPLETED|Overall Study||13
214463|NCT01231503|518598|P1|NOT COMPLETED|Overall Study||14
214464|NCT01231503|518591|P8|COMPLETED|Overall Study||52
214465|NCT01231503|518592|P7|COMPLETED|Overall Study||53
214466|NCT01231503|518593|P6|COMPLETED|Overall Study||44
214467|NCT01231503|518594|P5|COMPLETED|Overall Study||50
214468|NCT01231503|518595|P4|COMPLETED|Overall Study||52
214469|NCT01231503|518596|P3|COMPLETED|Overall Study||48
214470|NCT01231503|518597|P2|COMPLETED|Overall Study||46
214471|NCT01231503|518598|P1|COMPLETED|Overall Study||46
214472|NCT01231503|518591|P8|STARTED|Overall Study||60
214473|NCT01231503|518592|P7|STARTED|Overall Study||60
214474|NCT01231503|518593|P6|STARTED|Overall Study||60
214475|NCT01231503|518594|P5|STARTED|Overall Study||60
214476|NCT01231503|518595|P4|STARTED|Overall Study||60
214477|NCT01231503|518596|P3|STARTED|Overall Study||60
214478|NCT01231503|518597|P2|STARTED|Overall Study||59
214479|NCT01231503|518598|P1|STARTED|Overall Study||60
214480|NCT01231464|518838|P2|NOT COMPLETED|Overall Study||7
214481|NCT01231464|518839|P1|NOT COMPLETED|Overall Study||5
214482|NCT01231464|518838|P2|COMPLETED|Overall Study||176
214483|NCT01231464|518839|P1|COMPLETED|Overall Study||177
214484|NCT01231464|518838|P2|STARTED|Overall Study||183
214485|NCT01231464|518839|P1|STARTED|Overall Study||182
214486|NCT01231412|518852|P3|NOT COMPLETED|Overall Study||0
214487|NCT01231412|518853|P2|NOT COMPLETED|Overall Study||1
214488|NCT01231412|518854|P1|NOT COMPLETED|Overall Study||0
214489|NCT01231412|518852|P3|COMPLETED|Overall Study||6
214490|NCT01231412|518853|P2|COMPLETED|Overall Study||90
214491|NCT01231412|518854|P1|COMPLETED|Overall Study||77
214492|NCT01231412|518852|P3|STARTED|Overall Study||6
214493|NCT01231412|518853|P2|STARTED|Overall Study||91
214494|NCT01231412|518854|P1|STARTED|Overall Study||77
214495|NCT01231399|518877|P1|NOT COMPLETED|Overall Study||0
214496|NCT01231399|518877|P1|COMPLETED|Overall Study||6
214497|NCT01231399|518877|P1|STARTED|Overall Study||6
214498|NCT01231373|518888|P4|NOT COMPLETED|Overall Study||1
214499|NCT01231373|518889|P3|NOT COMPLETED|Overall Study||0
214500|NCT01231373|518890|P2|NOT COMPLETED|Overall Study||1
214501|NCT01231373|518891|P1|NOT COMPLETED|Overall Study||3
214502|NCT01231373|518888|P4|COMPLETED|Overall Study||57
214503|NCT01231373|518889|P3|COMPLETED|Overall Study||60
214504|NCT01231373|518890|P2|COMPLETED|Overall Study||57
214505|NCT01231373|518891|P1|COMPLETED|Overall Study||56
214506|NCT01231373|518888|P4|Patients Receiving Blinded Treatment|Overall Study||58
214507|NCT01231373|518889|P3|Patients Receiving Blinded Treatment|Overall Study||60
214508|NCT01231373|518890|P2|Patients Receiving Blinded Treatment|Overall Study||57
214509|NCT01231373|518891|P1|Patients Receiving Blinded Treatment|Overall Study||57
214510|NCT01231373|518888|P4|STARTED|Overall Study||58
214511|NCT01231373|518889|P3|STARTED|Overall Study||60
214512|NCT01231373|518890|P2|STARTED|Overall Study||58
214513|NCT01231373|518891|P1|STARTED|Overall Study||59
214514|NCT01231334|518911|P2|NOT COMPLETED|Overall Study||21
214515|NCT01231334|518912|P1|NOT COMPLETED|Overall Study||19
214516|NCT01231334|518911|P2|COMPLETED|Overall Study||120
214517|NCT01231334|518912|P1|COMPLETED|Overall Study||126
214518|NCT01231334|518911|P2|STARTED|Overall Study||141
214519|NCT01231334|518912|P1|STARTED|Overall Study||145
214520|NCT01231321|518930|P1|NOT COMPLETED|Overall Study||5
214521|NCT01231321|518930|P1|COMPLETED|Overall Study||95
214522|NCT01231321|518930|P1|STARTED|Overall Study||100
214523|NCT01231230|518941|P1|NOT COMPLETED|Overall Study||0
214524|NCT01231230|518941|P1|COMPLETED|Overall Study||14
214525|NCT01231230|518941|P1|Placebo|Overall Study||14
214526|NCT01231230|518941|P1|Fluticasone/Salmeterol|Overall Study||14
214527|NCT01231230|518941|P1|Salmeterol|Overall Study||14
214528|NCT01231230|518941|P1|Fluticasone|Overall Study||14
214529|NCT01231230|518941|P1|STARTED|Overall Study||14
214530|NCT01230931|518953|P2|NOT COMPLETED|Overall Study||0
214531|NCT01230931|518954|P1|NOT COMPLETED|Overall Study||0
214532|NCT01230931|518953|P2|COMPLETED|Overall Study||10
214533|NCT01230931|518954|P1|COMPLETED|Overall Study||10
214534|NCT01230931|518953|P2|STARTED|Overall Study||10
214535|NCT01230931|518954|P1|STARTED|Overall Study||10
214536|NCT01230892|518978|P2|NOT COMPLETED|Overall Study||1
214537|NCT01230892|518979|P1|NOT COMPLETED|Overall Study||3
214538|NCT01230892|518978|P2|COMPLETED|Overall Study||13
214539|NCT01230892|518979|P1|COMPLETED|Overall Study||12
214540|NCT01230892|518978|P2|STARTED|Overall Study||14
214541|NCT01230892|518979|P1|STARTED|Overall Study||15
214542|NCT01230827|518989|P4|NOT COMPLETED|Overall Study||78
214543|NCT01230827|518990|P3|NOT COMPLETED|Overall Study||65
214544|NCT01230827|518991|P2|NOT COMPLETED|Overall Study||11
214545|NCT01230827|518992|P1|NOT COMPLETED|Overall Study||19
214546|NCT01230827|518989|P4|COMPLETED|Overall Study||0
214547|NCT01230827|518990|P3|COMPLETED|Overall Study||0
214548|NCT01230827|518991|P2|COMPLETED|Overall Study||0
214549|NCT01230827|518992|P1|COMPLETED|Overall Study||0
214550|NCT01230827|518989|P4|STARTED|Overall Study||78
214551|NCT01230827|518990|P3|STARTED|Overall Study||65
214552|NCT01230827|518991|P2|STARTED|Overall Study||11
214553|NCT01230827|518992|P1|STARTED|Overall Study||19
214554|NCT01230814|519008|P2|NOT COMPLETED|Overall Study||4
214555|NCT01230814|519009|P1|NOT COMPLETED|Overall Study||13
214556|NCT01230814|519008|P2|COMPLETED|Overall Study||112
214557|NCT01230814|519009|P1|COMPLETED|Overall Study||105
214558|NCT01230814|519008|P2|STARTED|Overall Study||116
214559|NCT01230814|519009|P1|STARTED|Overall Study||118
214560|NCT01230801|519024|P3|NOT COMPLETED|Overall Study||1
214561|NCT01230801|519025|P2|NOT COMPLETED|Overall Study||0
214562|NCT01230801|519026|P1|NOT COMPLETED|Overall Study||0
214563|NCT01230801|519024|P3|COMPLETED|Overall Study||15
214564|NCT01230801|519025|P2|COMPLETED|Overall Study||3
214565|NCT01230801|519026|P1|COMPLETED|Overall Study||3
214566|NCT01230801|519024|P3|STARTED|Overall Study||16
214567|NCT01230801|519025|P2|STARTED|Overall Study||3
214568|NCT01230801|519026|P1|STARTED|Overall Study||3
214569|NCT01230788|519059|P1|NOT COMPLETED|Overall Study||1
214570|NCT01230788|519059|P1|COMPLETED|Overall Study||0
214571|NCT01230788|519059|P1|STARTED|Overall Study||1
214572|NCT01230749|519071|P4|NOT COMPLETED|Overall Study||2
214573|NCT01230749|519072|P3|NOT COMPLETED|Overall Study||2
214574|NCT01230749|519073|P2|NOT COMPLETED|Overall Study||2
214575|NCT01230749|519074|P1|NOT COMPLETED|Overall Study||0
214576|NCT01230749|519071|P4|COMPLETED|Overall Study||20
214577|NCT01230749|519072|P3|COMPLETED|Overall Study||21
214578|NCT01230749|519073|P2|COMPLETED|Overall Study||20
214579|NCT01230749|519074|P1|COMPLETED|Overall Study||22
214580|NCT01230749|519071|P4|STARTED|Overall Study||22
214581|NCT01230749|519072|P3|STARTED|Overall Study||23
214582|NCT01230749|519073|P2|STARTED|Overall Study||22
214583|NCT01230749|519074|P1|STARTED|Overall Study||22
214584|NCT01230710|519109|P1|NOT COMPLETED|Overall Study||49
214585|NCT01230710|519109|P1|COMPLETED|Overall Study||2
214586|NCT01230710|519109|P1|STARTED|Overall Study||51
214587|NCT01230593|519120|P3|NOT COMPLETED|Overall Study||12
214588|NCT01230593|519121|P2|NOT COMPLETED|Overall Study||18
214589|NCT01230593|519122|P1|NOT COMPLETED|Overall Study||15
214590|NCT01230593|519120|P3|COMPLETED|Overall Study||38
214591|NCT01230593|519121|P2|COMPLETED|Overall Study||32
214592|NCT01230593|519122|P1|COMPLETED|Overall Study||35
214593|NCT01230593|519120|P3|STARTED|Overall Study||50
214594|NCT01230593|519121|P2|STARTED|Overall Study||50
214595|NCT01230593|519122|P1|STARTED|Overall Study||50
214596|NCT01230554|519133|P1|NOT COMPLETED|Overall Study||3
214597|NCT01230554|519133|P1|COMPLETED|Overall Study||209
214598|NCT01230554|519133|P1|STARTED|Overall Study||212
214599|NCT01230502|519143|P3|NOT COMPLETED|Overall Study||0
214600|NCT01230502|519144|P2|NOT COMPLETED|Overall Study||0
214601|NCT01230502|519145|P1|NOT COMPLETED|Overall Study||0
214602|NCT01230502|519143|P3|COMPLETED|Overall Study||0
214603|NCT01230502|519144|P2|COMPLETED|Overall Study||0
214604|NCT01230502|519145|P1|COMPLETED|Overall Study||9
214605|NCT01230502|519143|P3|STARTED|Overall Study||0
214606|NCT01230502|519144|P2|STARTED|Overall Study||0
214607|NCT01230502|519145|P1|STARTED|Overall Study||9
214608|NCT01230489|519156|P1|NOT COMPLETED|Overall Study||5
214609|NCT01230489|519156|P1|COMPLETED|Overall Study||8
214610|NCT01230489|519156|P1|STARTED|Overall Study||13
214611|NCT01230424|519162|P2|NOT COMPLETED|Overall Study||0
214612|NCT01230424|519163|P1|NOT COMPLETED|Overall Study||0
214613|NCT01230424|519162|P2|COMPLETED|Overall Study||70
214614|NCT01230424|519163|P1|COMPLETED|Overall Study||70
214615|NCT01230424|519162|P2|STARTED|Overall Study||70
214616|NCT01230424|519163|P1|STARTED|Overall Study||70
214617|NCT01230307|519191|P2|NOT COMPLETED|Overall Study||2
214618|NCT01230307|519192|P1|NOT COMPLETED|Overall Study||0
214619|NCT01230307|519191|P2|COMPLETED|Overall Study||4
214620|NCT01230307|519192|P1|COMPLETED|Overall Study||6
214621|NCT01230307|519191|P2|STARTED|Overall Study||6
214622|NCT01230307|519192|P1|STARTED|Overall Study||6
214623|NCT01230177|519204|P1|NOT COMPLETED|Overall Study||0
214624|NCT01230177|519204|P1|COMPLETED|Overall Study||3
214625|NCT01230177|519204|P1|STARTED|Overall Study||3
214626|NCT01230060|519212|P1|NOT COMPLETED|Overall Study||1
214627|NCT01230060|519212|P1|COMPLETED|Overall Study||121
214628|NCT01230060|519212|P1|STARTED|Overall Study||122
214629|NCT01230021|519216|P1|NOT COMPLETED|Overall Study||0
214630|NCT01230021|519216|P1|COMPLETED|Overall Study||6
214631|NCT01230021|519216|P1|STARTED|Overall Study||6
214632|NCT01229943|519238|P2|NOT COMPLETED|Overall Study||17
214633|NCT01229943|519239|P1|NOT COMPLETED|Overall Study||18
214634|NCT01229943|519238|P2|COMPLETED|Overall Study||58
214635|NCT01229943|519239|P1|COMPLETED|Overall Study||57
214636|NCT01229943|519238|P2|STARTED|Overall Study||75
214637|NCT01229943|519239|P1|STARTED|Overall Study||75
214638|NCT01229891|519252|P3|NOT COMPLETED|Overall Study||0
214639|NCT01229891|519253|P2|NOT COMPLETED|Overall Study||0
214640|NCT01229891|519254|P1|NOT COMPLETED|Overall Study||0
214641|NCT01229891|519252|P3|COMPLETED|Overall Study||30
214642|NCT01229891|519253|P2|COMPLETED|Overall Study||30
214643|NCT01229891|519254|P1|COMPLETED|Overall Study||30
214644|NCT01229891|519252|P3|STARTED|Overall Study||30
214645|NCT01229891|519253|P2|STARTED|Overall Study||30
214646|NCT01229891|519254|P1|STARTED|Overall Study||30
214647|NCT01229735|519285|P2|NOT COMPLETED|Overall Study||66
214648|NCT01229735|519286|P1|NOT COMPLETED|Overall Study||66
214649|NCT01229735|519285|P2|COMPLETED|Overall Study||100
214650|NCT01229735|519286|P1|COMPLETED|Overall Study||111
214651|NCT01229735|519285|P2|STARTED|Overall Study||166
214652|NCT01229735|519286|P1|STARTED|Overall Study||177
214653|NCT01229722|519302|P2|NOT COMPLETED|Overall Study||4
214654|NCT01229722|519303|P1|NOT COMPLETED|Overall Study||0
214655|NCT01229722|519302|P2|COMPLETED|Overall Study||30
214656|NCT01229722|519303|P1|COMPLETED|Overall Study||36
214657|NCT01229722|519302|P2|STARTED|Overall Study||34
214658|NCT01229722|519303|P1|STARTED|Overall Study||36
214659|NCT01229527|519316|P3|NOT COMPLETED|Overall Study||0
214660|NCT01229527|519317|P2|NOT COMPLETED|Overall Study||0
214661|NCT01229527|519318|P1|NOT COMPLETED|Overall Study||0
214662|NCT01229527|519316|P3|COMPLETED|Overall Study||30
214663|NCT01229527|519317|P2|COMPLETED|Overall Study||30
214664|NCT01229527|519318|P1|COMPLETED|Overall Study||30
214665|NCT01229527|519316|P3|STARTED|Overall Study||30
214666|NCT01229527|519317|P2|STARTED|Overall Study||30
214667|NCT01229527|519318|P1|STARTED|Overall Study||30
214668|NCT01229462|519331|P2|NOT COMPLETED|Overall Study||9
214669|NCT01229462|519332|P1|NOT COMPLETED|Overall Study||5
214670|NCT01229462|519331|P2|COMPLETED|Overall Study||109
214671|NCT01229462|519332|P1|COMPLETED|Overall Study||115
214672|NCT01229462|519331|P2|STARTED|Overall Study||118
214673|NCT01229462|519332|P1|STARTED|Overall Study||120
214674|NCT01229449|519343|P5|NOT COMPLETED|Overall Study||1
214675|NCT01229449|519344|P4|NOT COMPLETED|Overall Study||1
214676|NCT01229449|519345|P3|NOT COMPLETED|Overall Study||2
214677|NCT01229449|519346|P2|NOT COMPLETED|Overall Study||4
214678|NCT01229449|519347|P1|NOT COMPLETED|Overall Study||1
214679|NCT01229449|519343|P5|COMPLETED|Overall Study||54
214680|NCT01229449|519344|P4|COMPLETED|Overall Study||112
214681|NCT01229449|519345|P3|COMPLETED|Overall Study||167
214682|NCT01229449|519346|P2|COMPLETED|Overall Study||164
214683|NCT01229449|519347|P1|COMPLETED|Overall Study||172
214684|NCT01229449|519343|P5|STARTED|Overall Study||55
214685|NCT01229449|519344|P4|STARTED|Overall Study||113
214686|NCT01229449|519345|P3|STARTED|Overall Study||169
214687|NCT01229449|519346|P2|STARTED|Overall Study||168
214688|NCT01229449|519347|P1|STARTED|Overall Study||173
214689|NCT01229436|519404|P1|NOT COMPLETED|Overall Study||5
214690|NCT01229436|519404|P1|COMPLETED|Overall Study||249
214691|NCT01229436|519404|P1|STARTED|Overall Study||254
214692|NCT01229423|519442|P1|NOT COMPLETED|Overall Study||15
214693|NCT01229423|519442|P1|COMPLETED|Overall Study||47
214694|NCT01229423|519442|P1|STARTED|Overall Study||62
214695|NCT01229410|519453|P2|NOT COMPLETED|Overall Study||3
214696|NCT01229410|519454|P1|NOT COMPLETED|Overall Study||5
214697|NCT01229410|519453|P2|COMPLETED|Overall Study||9
214698|NCT01229410|519454|P1|COMPLETED|Overall Study||7
214699|NCT01229410|519453|P2|STARTED|Overall Study||12
214700|NCT01229410|519454|P1|STARTED|Overall Study||12
214701|NCT01229397|519466|P2|NOT COMPLETED|Overall Study||9
214702|NCT01229397|519467|P1|NOT COMPLETED|Overall Study||11
214703|NCT01229397|519466|P2|COMPLETED|Overall Study||93
214704|NCT01229397|519467|P1|COMPLETED|Overall Study||92
214705|NCT01229397|519466|P2|STARTED|Overall Study||102
214706|NCT01229397|519467|P1|STARTED|Overall Study||103
214707|NCT01229371|519485|P4|NOT COMPLETED|Overall Study||0
214708|NCT01229371|519486|P3|NOT COMPLETED|Overall Study||0
214709|NCT01229371|519487|P2|NOT COMPLETED|Overall Study||1
214710|NCT01229371|519488|P1|NOT COMPLETED|Overall Study||0
214711|NCT01229371|519485|P4|COMPLETED|Overall Study||110
214712|NCT01229371|519486|P3|COMPLETED|Overall Study||110
214713|NCT01229371|519487|P2|COMPLETED|Overall Study||110
214714|NCT01229371|519488|P1|COMPLETED|Overall Study||109
214715|NCT01229371|519485|P4|STARTED|Overall Study||110
214716|NCT01229371|519486|P3|STARTED|Overall Study||110
214717|NCT01229371|519487|P2|STARTED|Overall Study||111
214718|NCT01229371|519488|P1|STARTED|Overall Study||109
214719|NCT01229267|519515|P5|NOT COMPLETED|Overall Study||220
214720|NCT01229267|519516|P4|NOT COMPLETED|Overall Study||35
214721|NCT01229267|519517|P3|NOT COMPLETED|Overall Study||86
214722|NCT01229267|519518|P2|NOT COMPLETED|Overall Study||82
214723|NCT01229267|519519|P1|NOT COMPLETED|Overall Study||81
214724|NCT01229267|519515|P5|COMPLETED|Overall Study||344
214725|NCT01229267|519516|P4|COMPLETED|Overall Study||71
214726|NCT01229267|519517|P3|COMPLETED|Overall Study||101
214727|NCT01229267|519518|P2|COMPLETED|Overall Study||102
214728|NCT01229267|519519|P1|COMPLETED|Overall Study||108
214729|NCT01229267|519515|P5|Received Vaccination 4|Overall Study||477
214730|NCT01229267|519516|P4|Received Vaccination 4|Overall Study||87
214731|NCT01229267|519517|P3|Received Vaccination 4|Overall Study||149
214732|NCT01229267|519518|P2|Received Vaccination 4|Overall Study||149
214733|NCT01229267|519519|P1|Received Vaccination 4|Overall Study||155
214734|NCT01229267|519515|P5|Received Vaccination 3|Overall Study||491
214735|NCT01229267|519516|P4|Received Vaccination 3|Overall Study||89
214736|NCT01229267|519517|P3|Received Vaccination 3|Overall Study||160
214737|NCT01229267|519518|P2|Received Vaccination 3|Overall Study||155
214738|NCT01229267|519519|P1|Received Vaccination 3|Overall Study||163
214739|NCT01229267|519515|P5|Received Vaccination 2|Overall Study||511
214740|NCT01229267|519516|P4|Received Vaccination 2|Overall Study||94
214741|NCT01229267|519517|P3|Received Vaccination 2|Overall Study||168
214742|NCT01229267|519518|P2|Received Vaccination 2|Overall Study||163
214743|NCT01229267|519519|P1|Received Vaccination 2|Overall Study||171
214744|NCT01229267|519515|P5|Received Vaccination 1|Overall Study||556
214745|NCT01229267|519516|P4|Received Vaccination 1|Overall Study||104
214746|NCT01229267|519517|P3|Received Vaccination 1|Overall Study||186
214747|NCT01229267|519518|P2|Received Vaccination 1|Overall Study||180
214748|NCT01229267|519519|P1|Received Vaccination 1|Overall Study||188
214749|NCT01229267|519515|P5|STARTED|Overall Study||564
214750|NCT01229267|519516|P4|STARTED|Overall Study||106
214751|NCT01229267|519517|P3|STARTED|Overall Study||187
214752|NCT01229267|519518|P2|STARTED|Overall Study||184
214753|NCT01229267|519519|P1|STARTED|Overall Study||189
214754|NCT01229254|519538|P3|NOT COMPLETED|Overall Study||12
214755|NCT01229254|519539|P2|NOT COMPLETED|Overall Study||16
214756|NCT01229254|519540|P1|NOT COMPLETED|Overall Study||15
214757|NCT01229254|519538|P3|COMPLETED|Overall Study||61
214758|NCT01229254|519539|P2|COMPLETED|Overall Study||58
214759|NCT01229254|519540|P1|COMPLETED|Overall Study||27
214760|NCT01229254|519538|P3|STARTED|Overall Study||73
214761|NCT01229254|519539|P2|STARTED|Overall Study||74
214762|NCT01229254|519540|P1|STARTED|Overall Study||42
214763|NCT01229228|519554|P5|NOT COMPLETED|Overall Study||1
214764|NCT01229228|519555|P4|NOT COMPLETED|Overall Study||0
214765|NCT01229228|519556|P3|NOT COMPLETED|Overall Study||1
214766|NCT01229228|519557|P2|NOT COMPLETED|Overall Study||0
214767|NCT01229228|519558|P1|NOT COMPLETED|Overall Study||1
214768|NCT01229228|519554|P5|COMPLETED|Overall Study||50
214769|NCT01229228|519555|P4|COMPLETED|Overall Study||51
214770|NCT01229228|519556|P3|COMPLETED|Overall Study||49
214771|NCT01229228|519557|P2|COMPLETED|Overall Study||51
214772|NCT01229228|519558|P1|COMPLETED|Overall Study||50
214773|NCT01229228|519554|P5|STARTED|Overall Study||51
214774|NCT01229228|519555|P4|STARTED|Overall Study||51
214775|NCT01229228|519556|P3|STARTED|Overall Study||50
214776|NCT01229228|519557|P2|STARTED|Overall Study||51
214777|NCT01229228|519558|P1|STARTED|Overall Study||51
214778|NCT01229176|519578|P8|NOT COMPLETED|Overall Study||3
214779|NCT01229176|519579|P7|NOT COMPLETED|Overall Study||0
214780|NCT01229176|519580|P6|NOT COMPLETED|Overall Study||2
214781|NCT01229176|519581|P5|NOT COMPLETED|Overall Study||2
214782|NCT01229176|519582|P4|NOT COMPLETED|Overall Study||1
214783|NCT01229176|519583|P3|NOT COMPLETED|Overall Study||0
214784|NCT01229176|519584|P2|NOT COMPLETED|Overall Study||3
214785|NCT01229176|519585|P1|NOT COMPLETED|Overall Study||0
214786|NCT01229176|519578|P8|COMPLETED|Overall Study||17
214787|NCT01229176|519579|P7|COMPLETED|Overall Study||20
214788|NCT01229176|519580|P6|COMPLETED|Overall Study||18
214789|NCT01229176|519581|P5|COMPLETED|Overall Study||18
214790|NCT01229176|519582|P4|COMPLETED|Overall Study||19
214791|NCT01229176|519583|P3|COMPLETED|Overall Study||20
214792|NCT01229176|519584|P2|COMPLETED|Overall Study||37
214793|NCT01229176|519585|P1|COMPLETED|Overall Study||40
214794|NCT01229176|519578|P8|STARTED|Overall Study||20
214795|NCT01229176|519579|P7|STARTED|Overall Study||20
214796|NCT01229176|519580|P6|STARTED|Overall Study||20
214797|NCT01229176|519581|P5|STARTED|Overall Study||20
214798|NCT01229176|519582|P4|STARTED|Overall Study||20
214799|NCT01229176|519583|P3|STARTED|Overall Study||20
214800|NCT01229176|519584|P2|STARTED|Overall Study||40
214801|NCT01229176|519585|P1|STARTED|Overall Study||40
214802|NCT01229150|519639|P4|NOT COMPLETED|Overall Study||0
214803|NCT01229150|519640|P3|NOT COMPLETED|Overall Study||0
214804|NCT01229150|519641|P2|NOT COMPLETED|Overall Study||2
214805|NCT01229150|519642|P1|NOT COMPLETED|Overall Study||2
214806|NCT01229150|519639|P4|COMPLETED|Overall Study||19
214807|NCT01229150|519640|P3|COMPLETED|Overall Study||19
214808|NCT01229150|519641|P2|COMPLETED|Overall Study||9
214809|NCT01229150|519642|P1|COMPLETED|Overall Study||28
214810|NCT01229150|519639|P4|STARTED|Overall Study||19
214811|NCT01229150|519640|P3|STARTED|Overall Study||19
214812|NCT01229150|519641|P2|STARTED|Overall Study||11
214813|NCT01229150|519642|P1|STARTED|Overall Study||30
214814|NCT01229111|519699|P1|NOT COMPLETED|Overall Study||1
214815|NCT01229111|519699|P1|COMPLETED|Overall Study||13
214816|NCT01229111|519699|P1|STARTED|Overall Study||14
214817|NCT01228968|519707|P1|NOT COMPLETED|Overall Study||0
214818|NCT01228968|519707|P1|COMPLETED|Overall Study||9
214819|NCT01228968|519707|P1|STARTED|Overall Study||9
214820|NCT01228929|519717|P3|NOT COMPLETED|High Temperature Condition||0
214821|NCT01228929|519718|P2|NOT COMPLETED|High Temperature Condition||0
214822|NCT01228929|519719|P1|NOT COMPLETED|High Temperature Condition||0
214823|NCT01228929|519717|P3|COMPLETED|High Temperature Condition||6
214824|NCT01228929|519718|P2|COMPLETED|High Temperature Condition||6
214825|NCT01228929|519719|P1|COMPLETED|High Temperature Condition||6
214826|NCT01228929|519717|P3|STARTED|High Temperature Condition||6
214827|NCT01228929|519718|P2|STARTED|High Temperature Condition||6
214828|NCT01228929|519719|P1|STARTED|High Temperature Condition||6
214829|NCT01228929|519717|P3|NOT COMPLETED|Low Humidity Condition||0
214830|NCT01228929|519718|P2|NOT COMPLETED|Low Humidity Condition||0
214831|NCT01228929|519719|P1|NOT COMPLETED|Low Humidity Condition||0
214832|NCT01228929|519717|P3|COMPLETED|Low Humidity Condition||6
214833|NCT01228929|519718|P2|COMPLETED|Low Humidity Condition||6
214834|NCT01228929|519719|P1|COMPLETED|Low Humidity Condition||6
214835|NCT01228929|519717|P3|STARTED|Low Humidity Condition||6
214836|NCT01228929|519718|P2|STARTED|Low Humidity Condition||6
214837|NCT01228929|519719|P1|STARTED|Low Humidity Condition||6
214838|NCT01228929|519717|P3|NOT COMPLETED|Nominal Condition||0
214839|NCT01228929|519718|P2|NOT COMPLETED|Nominal Condition||0
214840|NCT01228929|519719|P1|NOT COMPLETED|Nominal Condition||0
214841|NCT01228929|519717|P3|COMPLETED|Nominal Condition||6
214842|NCT01228929|519718|P2|COMPLETED|Nominal Condition||6
214843|NCT01228929|519719|P1|COMPLETED|Nominal Condition||6
214844|NCT01228929|519717|P3|STARTED|Nominal Condition||6
214845|NCT01228929|519718|P2|STARTED|Nominal Condition||6
214846|NCT01228929|519719|P1|STARTED|Nominal Condition||6
214847|NCT01228903|519729|P2|NOT COMPLETED|Overall Study||5
214848|NCT01228903|519730|P1|NOT COMPLETED|Overall Study||5
214849|NCT01228903|519729|P2|COMPLETED|Overall Study||34
214850|NCT01228903|519730|P1|COMPLETED|Overall Study||36
214851|NCT01228903|519729|P2|STARTED|Overall Study||39
214852|NCT01228903|519730|P1|STARTED|Overall Study||41
214853|NCT01228747|519748|P2|NOT COMPLETED|Overall Study||45
214854|NCT01228747|519749|P1|NOT COMPLETED|Overall Study||65
214855|NCT01228747|519748|P2|COMPLETED|Overall Study||81
214856|NCT01228747|519749|P1|COMPLETED|Overall Study||60
214857|NCT01228747|519748|P2|STARTED|Overall Study||126
214858|NCT01228747|519749|P1|STARTED|Overall Study||125
214859|NCT01228734|519765|P2|NOT COMPLETED|Overall Study||4
214860|NCT01228734|519766|P1|NOT COMPLETED|Overall Study||0
214861|NCT01228734|519765|P2|COMPLETED|Overall Study||200
214862|NCT01228734|519766|P1|COMPLETED|Overall Study||193
214863|NCT01228734|519765|P2|Modified Safety Population|Overall Study||199
214864|NCT01228734|519766|P1|Modified Safety Population|Overall Study|One subject was randomized to FOLFOX-4 group but received cetuximab + FOLFOX-4 treatment instead|194
214865|NCT01228734|519765|P2|Modified Intent-to-treat Population|Overall Study||200
214866|NCT01228734|519766|P1|Modified Intent-to-treat Population|Overall Study||193
214867|NCT01228734|519765|P2|STARTED|Overall Study||204
214868|NCT01228734|519766|P1|STARTED|Overall Study||193
214869|NCT01228591|519780|P2|NOT COMPLETED|Final Visit||0
214870|NCT01228591|519781|P1|NOT COMPLETED|Final Visit||0
214871|NCT01228591|519780|P2|COMPLETED|Final Visit||16
214872|NCT01228591|519781|P1|COMPLETED|Final Visit||17
214873|NCT01228591|519780|P2|STARTED|Final Visit||16
214874|NCT01228591|519781|P1|STARTED|Final Visit||17
214875|NCT01228591|519780|P2|NOT COMPLETED|1-Week Follow-Up||0
214876|NCT01228591|519781|P1|NOT COMPLETED|1-Week Follow-Up||0
214877|NCT01228591|519780|P2|COMPLETED|1-Week Follow-Up||16
214878|NCT01228591|519781|P1|COMPLETED|1-Week Follow-Up||17
214879|NCT01228591|519780|P2|STARTED|1-Week Follow-Up||16
214880|NCT01228591|519781|P1|STARTED|1-Week Follow-Up||17
214881|NCT01228591|519780|P2|NOT COMPLETED|Baseline||2
214882|NCT01228591|519781|P1|NOT COMPLETED|Baseline||1
214883|NCT01228591|519780|P2|COMPLETED|Baseline||16
214884|NCT01228591|519781|P1|COMPLETED|Baseline||17
214885|NCT01228591|519780|P2|STARTED|Baseline||18
214886|NCT01228591|519781|P1|STARTED|Baseline||18
214887|NCT01228435|519799|P2|NOT COMPLETED|Overall Study||0
214888|NCT01228435|519800|P1|NOT COMPLETED|Overall Study||0
214889|NCT01228435|519799|P2|COMPLETED|Overall Study||2
214890|NCT01228435|519800|P1|COMPLETED|Overall Study||1
214891|NCT01228435|519799|P2|STARTED|Overall Study||2
214892|NCT01228435|519800|P1|STARTED|Overall Study||1
214893|NCT01228318|519810|P2|NOT COMPLETED|Overall Study||7
214894|NCT01228318|519811|P1|NOT COMPLETED|Overall Study||4
214895|NCT01228318|519810|P2|COMPLETED|Overall Study||22
214896|NCT01228318|519811|P1|COMPLETED|Overall Study||30
214897|NCT01228318|519810|P2|STARTED|Overall Study||29
214898|NCT01228318|519811|P1|STARTED|Overall Study||34
214899|NCT01228175|519827|P2|NOT COMPLETED|Overall Study||53
214900|NCT01228175|519828|P1|NOT COMPLETED|Overall Study||66
214901|NCT01228175|519827|P2|COMPLETED|Overall Study||46
214902|NCT01228175|519828|P1|COMPLETED|Overall Study||53
214903|NCT01228175|519827|P2|STARTED|Overall Study||99
214904|NCT01228175|519828|P1|STARTED|Overall Study||119
214905|NCT01228149|519836|P2|NOT COMPLETED|Overall Study||4
214906|NCT01228149|519837|P1|NOT COMPLETED|Overall Study||5
214907|NCT01228149|519836|P2|COMPLETED|Overall Study||26
214908|NCT01228149|519837|P1|COMPLETED|Overall Study||27
214909|NCT01228149|519836|P2|STARTED|Overall Study||30
214910|NCT01228149|519837|P1|STARTED|Overall Study||32
214911|NCT01228084|519859|P1|NOT COMPLETED|Overall Study||4
214912|NCT01228084|519859|P1|COMPLETED|Overall Study||16
214913|NCT01228084|519859|P1|STARTED|Overall Study||20
214914|NCT01228071|519870|P1|NOT COMPLETED|Overall Study||2
214915|NCT01228071|519870|P1|COMPLETED|Overall Study||32
214916|NCT01228071|519870|P1|STARTED|Overall Study||34
214917|NCT01228019|519876|P1|NOT COMPLETED|Overall Study||304
214918|NCT01228019|519876|P1|COMPLETED|Overall Study||862
214919|NCT01228019|519876|P1|STARTED|Overall Study||1166
214920|NCT01227993|519891|P1|NOT COMPLETED|Overall Study||0
214921|NCT01227993|519891|P1|COMPLETED|Overall Study||3
214922|NCT01227993|519891|P1|STARTED|Overall Study||3
214923|NCT01227980|519903|P2|NOT COMPLETED|Overall Study||5
214924|NCT01227980|519904|P1|NOT COMPLETED|Overall Study||2
214925|NCT01227980|519903|P2|COMPLETED|Overall Study||25
214926|NCT01227980|519904|P1|COMPLETED|Overall Study|Two subjects did not complete the scripts sessions but completed the remainder of the protocol|38
214927|NCT01227980|519903|P2|Measure Drug Level Concentration|Overall Study|No placebo subjects completed this milestone which measured active drug levels|0
214928|NCT01227980|519904|P1|Measure Drug Level Concentration|Overall Study||10
214929|NCT01227980|519903|P2|Scripts Challenge Sessions|Overall Study||25
214930|NCT01227980|519904|P1|Scripts Challenge Sessions|Overall Study||26
214931|NCT01227980|519903|P2|STARTED|Overall Study||30
214932|NCT01227980|519904|P1|STARTED|Overall Study||40
214933|NCT01227967|519942|P2|NOT COMPLETED|Overall Study||13
214934|NCT01227967|519943|P1|NOT COMPLETED|Overall Study||16
214935|NCT01227967|519942|P2|COMPLETED|Overall Study||303
214936|NCT01227967|519943|P1|COMPLETED|Overall Study||298
214937|NCT01227967|519942|P2|STARTED|Overall Study||316
214938|NCT01227967|519943|P1|STARTED|Overall Study||314
214939|NCT01227954|519977|P1|NOT COMPLETED|Overall Study||13
214940|NCT01227954|519977|P1|COMPLETED|Overall Study|Eligible subjects available for analysis|100
214941|NCT01227954|519977|P1|STARTED|Overall Study||113
214942|NCT01227928|519991|P2|NOT COMPLETED|Overall Study||17
214943|NCT01227928|519992|P1|NOT COMPLETED|Overall Study||22
214944|NCT01227928|519991|P2|COMPLETED|Overall Study||56
214945|NCT01227928|519992|P1|COMPLETED|Overall Study||50
214946|NCT01227928|519991|P2|STARTED|Overall Study||73
214947|NCT01227928|519992|P1|STARTED|Overall Study||72
214948|NCT01227902|520030|P4|NOT COMPLETED|Overall Study||10
214949|NCT01227902|520031|P3|NOT COMPLETED|Overall Study||19
214950|NCT01227902|520032|P2|NOT COMPLETED|Overall Study||13
214951|NCT01227902|520033|P1|NOT COMPLETED|Overall Study||18
214952|NCT01227902|520030|P4|COMPLETED|Overall Study||42
214953|NCT01227902|520031|P3|COMPLETED|Overall Study||25
214954|NCT01227902|520032|P2|COMPLETED|Overall Study||38
214955|NCT01227902|520033|P1|COMPLETED|Overall Study||38
214956|NCT01227902|520030|P4|STARTED|Overall Study||52
214957|NCT01227902|520031|P3|STARTED|Overall Study||44
214958|NCT01227902|520032|P2|STARTED|Overall Study||51
214959|NCT01227902|520033|P1|STARTED|Overall Study||56
214960|NCT01227889|520126|P2|NOT COMPLETED|Crossover Phase||37
214961|NCT01227889|520127|P1|NOT COMPLETED|Crossover Phase||0
214962|NCT01227889|520126|P2|COMPLETED|Crossover Phase||0
214963|NCT01227889|520127|P1|COMPLETED|Crossover Phase||0
214964|NCT01227889|520126|P2|STARTED|Crossover Phase|As of the data cut on December 18, 2012, 36 of 63 participants crossed over from DTIC to GSK2118436.|37
214965|NCT01227889|520127|P1|STARTED|Crossover Phase||0
214966|NCT01227889|520126|P2|NOT COMPLETED|Randomized Phase (RP)||63
214967|NCT01227889|520127|P1|NOT COMPLETED|Randomized Phase (RP)||187
214968|NCT01227889|520126|P2|COMPLETED|Randomized Phase (RP)||0
214969|NCT01227889|520127|P1|COMPLETED|Randomized Phase (RP)||0
214970|NCT01227889|520126|P2|STARTED|Randomized Phase (RP)||63
214971|NCT01227889|520127|P1|STARTED|Randomized Phase (RP)||187
214972|NCT01227824|520154|P3|NOT COMPLETED|Open-label Phase: Median of 1267 Days||44
214973|NCT01227824|520155|P2|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
214974|NCT01227824|520156|P1|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
214975|NCT01227824|520154|P3|COMPLETED|Open-label Phase: Median of 1267 Days||294
214976|NCT01227824|520155|P2|COMPLETED|Open-label Phase: Median of 1267 Days||0
214977|NCT01227824|520156|P1|COMPLETED|Open-label Phase: Median of 1267 Days||0
214978|NCT01227824|520154|P3|STARTED|Open-label Phase: Median of 1267 Days|338 participants continued into the Open-label phase on completing the Double-blind Phase|338
214979|NCT01227824|520155|P2|STARTED|Open-label Phase: Median of 1267 Days||0
214980|NCT01227824|520156|P1|STARTED|Open-label Phase: Median of 1267 Days||0
214981|NCT01227824|520154|P3|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||0
214982|NCT01227824|520155|P2|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||79
214983|NCT01227824|520156|P1|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||107
214984|NCT01227824|520154|P3|COMPLETED|Double-blind Phase: 96 Weeks Duration||0
214985|NCT01227824|520155|P2|COMPLETED|Double-blind Phase: 96 Weeks Duration||332
214986|NCT01227824|520156|P1|COMPLETED|Double-blind Phase: 96 Weeks Duration||304
214987|NCT01227824|520154|P3|STARTED|Double-blind Phase: 96 Weeks Duration||0
214988|NCT01227824|520155|P2|STARTED|Double-blind Phase: 96 Weeks Duration||411
214989|NCT01227824|520156|P1|STARTED|Double-blind Phase: 96 Weeks Duration||411
214990|NCT01227785|520185|P1|NOT COMPLETED|Overall Study||12
214991|NCT01227785|520185|P1|COMPLETED|Overall Study||108
214992|NCT01227785|520185|P1|STARTED|Overall Study||120
214993|NCT01227707|520251|P1|NOT COMPLETED|Overall Study||24
214994|NCT01227707|520251|P1|COMPLETED|Overall Study||19
214995|NCT01227707|520251|P1|STARTED|Overall Study||43
214996|NCT01227681|520270|P3|NOT COMPLETED|Overall Study||0
214997|NCT01227681|520271|P2|NOT COMPLETED|Overall Study||0
214998|NCT01227681|520272|P1|NOT COMPLETED|Overall Study||0
214999|NCT01227681|520270|P3|COMPLETED|Overall Study||0
215000|NCT01227681|520271|P2|COMPLETED|Overall Study||0
215001|NCT01227681|520272|P1|COMPLETED|Overall Study||4
215002|NCT01227681|520270|P3|STARTED|Overall Study||0
215003|NCT01227681|520271|P2|STARTED|Overall Study||0
215004|NCT01227681|520272|P1|STARTED|Overall Study||4
215005|NCT01227668|520278|P2|NOT COMPLETED|Phase 2 (Randomization Phase)||25
215006|NCT01227668|520279|P1|NOT COMPLETED|Phase 2 (Randomization Phase)||19
215007|NCT01227668|520278|P2|COMPLETED|Phase 2 (Randomization Phase)||19
215008|NCT01227668|520279|P1|COMPLETED|Phase 2 (Randomization Phase)||22
215009|NCT01227668|520278|P2|Received Treatment|Phase 2 (Randomization Phase)||43
215010|NCT01227668|520279|P1|Received Treatment|Phase 2 (Randomization Phase)||39
215011|NCT01227668|520278|P2|STARTED|Phase 2 (Randomization Phase)|Randomized|44
215012|NCT01227668|520279|P1|STARTED|Phase 2 (Randomization Phase)|Randomized|41
215013|NCT01227668|520278|P2|NOT COMPLETED|Phase 1 (Stabilization Phase)||0
215014|NCT01227668|520279|P1|NOT COMPLETED|Phase 1 (Stabilization Phase)||72
215015|NCT01227668|520278|P2|COMPLETED|Phase 1 (Stabilization Phase)||0
215016|NCT01227668|520279|P1|COMPLETED|Phase 1 (Stabilization Phase)||85
215017|NCT01227668|520278|P2|Received Treatment|Phase 1 (Stabilization Phase)||0
215018|NCT01227668|520279|P1|Received Treatment|Phase 1 (Stabilization Phase)||155
215019|NCT01227668|520278|P2|STARTED|Phase 1 (Stabilization Phase)||0
215020|NCT01227668|520279|P1|STARTED|Phase 1 (Stabilization Phase)|Randomized|157
215021|NCT01227655|520296|P3|NOT COMPLETED|Overall Study||14
215022|NCT01227655|520297|P2|NOT COMPLETED|Overall Study||26
215023|NCT01227655|520298|P1|NOT COMPLETED|Overall Study||11
215024|NCT01227655|520296|P3|COMPLETED|Overall Study||130
215025|NCT01227655|520297|P2|COMPLETED|Overall Study||128
215026|NCT01227655|520298|P1|COMPLETED|Overall Study||118
215027|NCT01227655|520296|P3|Full Analysis Set|Overall Study||135
215028|NCT01227655|520297|P2|Full Analysis Set|Overall Study||147
215029|NCT01227655|520298|P1|Full Analysis Set|Overall Study||125
215030|NCT01227655|520296|P3|Safety Set|Overall Study||136
215031|NCT01227655|520297|P2|Safety Set|Overall Study||150
215032|NCT01227655|520298|P1|Safety Set|Overall Study||125
215033|NCT01227655|520296|P3|STARTED|Overall Study||144
215034|NCT01227655|520297|P2|STARTED|Overall Study||154
215035|NCT01227655|520298|P1|STARTED|Overall Study||129
215036|NCT01227629|520325|P10|NOT COMPLETED|Overall Study||2
215037|NCT01227629|520326|P9|NOT COMPLETED|Overall Study||6
215038|NCT01227629|520327|P8|NOT COMPLETED|Overall Study||6
215039|NCT01227629|520328|P7|NOT COMPLETED|Overall Study||8
215040|NCT01227629|520329|P6|NOT COMPLETED|Overall Study||1
215041|NCT01227629|520330|P5|NOT COMPLETED|Overall Study||2
215042|NCT01227629|520331|P4|NOT COMPLETED|Overall Study||8
215043|NCT01227629|520332|P3|NOT COMPLETED|Overall Study||1
215044|NCT01227629|520333|P2|NOT COMPLETED|Overall Study||2
215045|NCT01227629|520334|P1|NOT COMPLETED|Overall Study||2
215046|NCT01227629|520325|P10|COMPLETED|Overall Study||68
215047|NCT01227629|520326|P9|COMPLETED|Overall Study||24
215048|NCT01227629|520327|P8|COMPLETED|Overall Study||27
215049|NCT01227629|520328|P7|COMPLETED|Overall Study||90
215050|NCT01227629|520329|P6|COMPLETED|Overall Study||32
215051|NCT01227629|520330|P5|COMPLETED|Overall Study||32
215052|NCT01227629|520331|P4|COMPLETED|Overall Study||91
215053|NCT01227629|520332|P3|COMPLETED|Overall Study||26
215054|NCT01227629|520333|P2|COMPLETED|Overall Study||18
215055|NCT01227629|520334|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|56
215056|NCT01227629|520325|P10|STARTED|Overall Study||70
215057|NCT01227629|520326|P9|STARTED|Overall Study||30
215058|NCT01227629|520327|P8|STARTED|Overall Study||33
215059|NCT01227629|520328|P7|STARTED|Overall Study||98
215060|NCT01227629|520329|P6|STARTED|Overall Study||33
215061|NCT01227629|520330|P5|STARTED|Overall Study||34
215062|NCT01227629|520331|P4|STARTED|Overall Study||99
215063|NCT01227629|520332|P3|STARTED|Overall Study||27
215064|NCT01227629|520333|P2|STARTED|Overall Study||20
215065|NCT01227629|520334|P1|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|58
215066|NCT01227616|520572|P2|NOT COMPLETED|Overall Study||23
215067|NCT01227616|520573|P1|NOT COMPLETED|Overall Study||54
215068|NCT01227616|520572|P2|COMPLETED|Overall Study||74
215069|NCT01227616|520573|P1|COMPLETED|Overall Study||142
215070|NCT01227616|520572|P2|STARTED|Overall Study||97
215071|NCT01227616|520573|P1|STARTED|Overall Study||196
215072|NCT01227577|520583|P1|NOT COMPLETED|Overall Study||35
215073|NCT01227577|520583|P1|COMPLETED|Overall Study||93
215074|NCT01227577|520583|P1|STARTED|Overall Study||128
215075|NCT01227564|520598|P3|NOT COMPLETED|Overall Study||6
215076|NCT01227564|520599|P2|NOT COMPLETED|Overall Study||2
215077|NCT01227564|520600|P1|NOT COMPLETED|Overall Study||4
215078|NCT01227564|520598|P3|COMPLETED|Overall Study|Completed study|15
215079|NCT01227564|520599|P2|COMPLETED|Overall Study|Completed study|18
215080|NCT01227564|520600|P1|COMPLETED|Overall Study|Completed study|18
215081|NCT01227564|520598|P3|Completed Treatment|Overall Study|1 participant stopped treatment due to lack of efficacy, 3 due to no longer willing to participate.|17
215082|NCT01227564|520599|P2|Completed Treatment|Overall Study|2 participants discontinued treatment due to no longer willing to participate in study.|18
215083|NCT01227564|520600|P1|Completed Treatment|Overall Study|1 participant discontinued treatment due to an adverse event (AE).|21
215084|NCT01227564|520598|P3|Treated|Overall Study||21
215085|NCT01227564|520599|P2|Treated|Overall Study||20
215086|NCT01227564|520600|P1|Treated|Overall Study||22
215087|NCT01227564|520598|P3|STARTED|Overall Study||21
215088|NCT01227564|520599|P2|STARTED|Overall Study||20
215089|NCT01227564|520600|P1|STARTED|Overall Study||22
215090|NCT01227551|520731|P1|NOT COMPLETED|Overall Study||34
215091|NCT01227551|520731|P1|COMPLETED|Overall Study||23
215092|NCT01227551|520731|P1|STARTED|Overall Study||57
215093|NCT01227512|520738|P2|NOT COMPLETED|Overall Study||10
215094|NCT01227512|520739|P1|NOT COMPLETED|Overall Study||13
215095|NCT01227512|520738|P2|COMPLETED|Overall Study||48
215096|NCT01227512|520739|P1|COMPLETED|Overall Study||53
215097|NCT01227512|520738|P2|STARTED|Overall Study||58
215098|NCT01227512|520739|P1|STARTED|Overall Study||66
215099|NCT01227434|520761|P2|NOT COMPLETED|Overall Study||0
215100|NCT01227434|520762|P1|NOT COMPLETED|Overall Study||0
215101|NCT01227434|520761|P2|COMPLETED|Overall Study||16
215102|NCT01227434|520762|P1|COMPLETED|Overall Study||6
215103|NCT01227434|520761|P2|STARTED|Overall Study||16
215104|NCT01227434|520762|P1|STARTED|Overall Study||6
215105|NCT01227421|520773|P3|NOT COMPLETED|Overall Study||10
215106|NCT01227421|520774|P2|NOT COMPLETED|Overall Study||18
215107|NCT01227421|520775|P1|NOT COMPLETED|Overall Study||11
215108|NCT01227421|520773|P3|COMPLETED|Overall Study||201
215109|NCT01227421|520774|P2|COMPLETED|Overall Study||194
215110|NCT01227421|520775|P1|COMPLETED|Overall Study||190
215111|NCT01227421|520773|P3|STARTED|Overall Study||211
215112|NCT01227421|520774|P2|STARTED|Overall Study||212
215113|NCT01227421|520775|P1|STARTED|Overall Study||201
215114|NCT01227395|520827|P2|NOT COMPLETED|Overall Study||1
215115|NCT01227395|520828|P1|NOT COMPLETED|Overall Study||0
215116|NCT01227395|520827|P2|COMPLETED|Overall Study||84
215117|NCT01227395|520828|P1|COMPLETED|Overall Study||391
215118|NCT01227395|520827|P2|STARTED|Overall Study||85
215119|NCT01227395|520828|P1|STARTED|Overall Study||391
215120|NCT01227382|520856|P1|NOT COMPLETED|Overall Study||0
215121|NCT01227382|520856|P1|COMPLETED|Overall Study||26
215122|NCT01227382|520856|P1|STARTED|Overall Study||26
215123|NCT01227278|520868|P2|NOT COMPLETED|Overall Study||8
215124|NCT01227278|520869|P1|NOT COMPLETED|Overall Study||5
215125|NCT01227278|520868|P2|COMPLETED|Overall Study||43
215126|NCT01227278|520869|P1|COMPLETED|Overall Study||45
215127|NCT01227278|520868|P2|STARTED|Overall Study||51
215128|NCT01227278|520869|P1|STARTED|Overall Study||50
215129|NCT01227265|520896|P3|NOT COMPLETED|Overall Study||14
215130|NCT01227265|520897|P2|NOT COMPLETED|Overall Study||20
215131|NCT01227265|520898|P1|NOT COMPLETED|Overall Study||19
215132|NCT01227265|520896|P3|COMPLETED|Overall Study||145
215133|NCT01227265|520897|P2|COMPLETED|Overall Study||139
215134|NCT01227265|520898|P1|COMPLETED|Overall Study||139
215135|NCT01227265|520896|P3|Treated|Overall Study||159
215136|NCT01227265|520897|P2|Treated|Overall Study||157
215137|NCT01227265|520898|P1|Treated|Overall Study||157
215138|NCT01227265|520896|P3|STARTED|Overall Study||159
215139|NCT01227265|520897|P2|STARTED|Overall Study||159
215140|NCT01227265|520898|P1|STARTED|Overall Study||158
215141|NCT01227252|520928|P4|NOT COMPLETED|Overall Study||0
215142|NCT01227252|520929|P3|NOT COMPLETED|Overall Study||0
215143|NCT01227252|520930|P2|NOT COMPLETED|Overall Study||3
215144|NCT01227252|520931|P1|NOT COMPLETED|Overall Study||0
215145|NCT01227252|520928|P4|COMPLETED|Overall Study||10
215146|NCT01227252|520929|P3|COMPLETED|Overall Study||10
215147|NCT01227252|520930|P2|COMPLETED|Overall Study||7
215148|NCT01227252|520931|P1|COMPLETED|Overall Study||12
215149|NCT01227252|520928|P4|Received at Least 1 Dose of Study Drug|Overall Study||10
215150|NCT01227252|520929|P3|Received at Least 1 Dose of Study Drug|Overall Study||10
215151|NCT01227252|520930|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
215152|NCT01227252|520931|P1|Received at Least 1 Dose of Study Drug|Overall Study||12
215153|NCT01227252|520928|P4|STARTED|Overall Study||10
215154|NCT01227252|520929|P3|STARTED|Overall Study||10
215155|NCT01227252|520930|P2|STARTED|Overall Study||10
215156|NCT01227252|520931|P1|STARTED|Overall Study||12
215157|NCT01227057|520960|P2|NOT COMPLETED|Overall Study||8
215158|NCT01227057|520961|P1|NOT COMPLETED|Overall Study||6
215159|NCT01227057|520960|P2|COMPLETED|Overall Study||19
215160|NCT01227057|520961|P1|COMPLETED|Overall Study||25
215161|NCT01227057|520960|P2|STARTED|Overall Study||27
215162|NCT01227057|520961|P1|STARTED|Overall Study||31
215163|NCT01227044|520973|P2|NOT COMPLETED|Overall Study||9
215164|NCT01227044|520974|P1|NOT COMPLETED|Overall Study||6
215165|NCT01227044|520973|P2|COMPLETED|Overall Study||17
215166|NCT01227044|520974|P1|COMPLETED|Overall Study||19
215167|NCT01227044|520973|P2|STARTED|Overall Study||26
215168|NCT01227044|520974|P1|STARTED|Overall Study||25
215169|NCT01227018|520982|P1|NOT COMPLETED|Overall Study||15
215170|NCT01227018|520982|P1|COMPLETED|Overall Study||0
215171|NCT01227018|520982|P1|STARTED|Overall Study||15
215172|NCT01227005|520992|P2|NOT COMPLETED|Overall Study||1
215173|NCT01227005|520993|P1|NOT COMPLETED|Overall Study||5
215174|NCT01227005|520992|P2|COMPLETED|Overall Study||51
215175|NCT01227005|520993|P1|COMPLETED|Overall Study||50
215176|NCT01227005|520992|P2|STARTED|Overall Study||52
215177|NCT01227005|520993|P1|STARTED|Overall Study||55
215178|NCT01226914|521005|P2|NOT COMPLETED|Overall Study||0
215179|NCT01226914|521006|P1|NOT COMPLETED|Overall Study||0
215180|NCT01226914|521005|P2|COMPLETED|Overall Study||27
215181|NCT01226914|521006|P1|COMPLETED|Overall Study||28
215182|NCT01226914|521005|P2|STARTED|Overall Study||27
215183|NCT01226914|521006|P1|STARTED|Overall Study||28
215184|NCT01226745|521018|P6|NOT COMPLETED|Overall Study||5
215185|NCT01226745|521019|P5|NOT COMPLETED|Overall Study||4
215186|NCT01226745|521020|P4|NOT COMPLETED|Overall Study||5
215187|NCT01226745|521021|P3|NOT COMPLETED|Overall Study||20
215188|NCT01226745|521022|P2|NOT COMPLETED|Overall Study||16
215189|NCT01226745|521023|P1|NOT COMPLETED|Overall Study||17
215190|NCT01226745|521018|P6|COMPLETED|Overall Study||24
215191|NCT01226745|521019|P5|COMPLETED|Overall Study||22
215192|NCT01226745|521020|P4|COMPLETED|Overall Study||24
215193|NCT01226745|521021|P3|COMPLETED|Overall Study||69
215194|NCT01226745|521022|P2|COMPLETED|Overall Study||71
215195|NCT01226745|521023|P1|COMPLETED|Overall Study||63
215196|NCT01226745|521018|P6|STARTED|Overall Study||29
215197|NCT01226745|521019|P5|STARTED|Overall Study||26
215198|NCT01226745|521020|P4|STARTED|Overall Study||29
215199|NCT01226745|521021|P3|STARTED|Overall Study||89
215200|NCT01226745|521022|P2|STARTED|Overall Study||87
215201|NCT01226745|521023|P1|STARTED|Overall Study||80
215202|NCT01226732|521103|P6|NOT COMPLETED|Overall Study||6
215203|NCT01226732|521104|P5|NOT COMPLETED|Overall Study||3
215204|NCT01226732|521105|P4|NOT COMPLETED|Overall Study||5
215205|NCT01226732|521106|P3|NOT COMPLETED|Overall Study||3
215206|NCT01226732|521107|P2|NOT COMPLETED|Overall Study||3
215207|NCT01226732|521108|P1|NOT COMPLETED|Overall Study||3
215208|NCT01226732|521103|P6|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
215209|NCT01226732|521104|P5|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
215210|NCT01226732|521105|P4|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
215211|NCT01226732|521106|P3|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
215212|NCT01226732|521107|P2|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
215213|NCT01226732|521108|P1|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
215214|NCT01226732|521103|P6|STARTED|Overall Study||6
215215|NCT01226732|521104|P5|STARTED|Overall Study||3
215216|NCT01226732|521105|P4|STARTED|Overall Study||5
215217|NCT01226732|521106|P3|STARTED|Overall Study||3
215218|NCT01226732|521107|P2|STARTED|Overall Study||3
215219|NCT01226732|521108|P1|STARTED|Overall Study||3
215220|NCT01226719|521124|P1|NOT COMPLETED|Overall Study||13
215221|NCT01226719|521124|P1|COMPLETED|Overall Study|Completed = patient is surgical candidate, underwent resection, received treatment to week 24.|2
215222|NCT01226719|521124|P1|STARTED|Overall Study||15
215223|NCT01226706|521134|P2|NOT COMPLETED|Overall Study||0
215224|NCT01226706|521135|P1|NOT COMPLETED|Overall Study||0
215225|NCT01226706|521134|P2|COMPLETED|Overall Study||11
215226|NCT01226706|521135|P1|COMPLETED|Overall Study||10
215227|NCT01226706|521134|P2|STARTED|Overall Study||11
215228|NCT01226706|521135|P1|STARTED|Overall Study||10
215229|NCT01226511|521219|P2|NOT COMPLETED|Taper Period||3
215230|NCT01226511|521220|P1|NOT COMPLETED|Taper Period||5
215231|NCT01226511|521219|P2|COMPLETED|Taper Period||54
215232|NCT01226511|521220|P1|COMPLETED|Taper Period||46
215233|NCT01226511|521219|P2|STARTED|Taper Period||57
215234|NCT01226511|521220|P1|STARTED|Taper Period||51
215235|NCT01226511|521219|P2|NOT COMPLETED|Extension Treatment Period||27
215236|NCT01226511|521220|P1|NOT COMPLETED|Extension Treatment Period||27
215237|NCT01226511|521219|P2|COMPLETED|Extension Treatment Period|Thirty-five (35) participants who completed extension treatment did not enter the taper period.|83
215238|NCT01226511|521220|P1|COMPLETED|Extension Treatment Period|Thirty-nine (39) participants who completed extension treatment did not enter the taper period.|81
215239|NCT01226511|521219|P2|STARTED|Extension Treatment Period|Twenty-three (23) participants who discontinued extension treatment did not enter the taper period.|110
215240|NCT01226511|521220|P1|STARTED|Extension Treatment Period|Nineteen (19) participants who discontinued extension treatment did not enter the taper period.|108
215241|NCT01226511|521219|P2|NOT COMPLETED|Acute Treatment Period||31
215242|NCT01226511|521220|P1|NOT COMPLETED|Acute Treatment Period||32
215243|NCT01226511|521219|P2|COMPLETED|Acute Treatment Period||110
215244|NCT01226511|521220|P1|COMPLETED|Acute Treatment Period||108
215245|NCT01226511|521219|P2|STARTED|Acute Treatment Period|Twenty-six (26) participants who discontinued acute treatment did not enter the taper period.|141
215246|NCT01226511|521220|P1|STARTED|Acute Treatment Period|Thirty-one (31) participants who discontinued acute treatment did not enter the taper period.|140
215247|NCT01226485|521263|P7|NOT COMPLETED|Overall Study||0
215248|NCT01226485|521264|P6|NOT COMPLETED|Overall Study||0
215249|NCT01226485|521265|P5|NOT COMPLETED|Overall Study||0
215250|NCT01226485|521266|P4|NOT COMPLETED|Overall Study||0
215251|NCT01226485|521267|P3|NOT COMPLETED|Overall Study||0
215252|NCT01226485|521268|P2|NOT COMPLETED|Overall Study||0
215253|NCT01226485|521269|P1|NOT COMPLETED|Overall Study||0
215254|NCT01226485|521263|P7|COMPLETED|Overall Study||40
215255|NCT01226485|521264|P6|COMPLETED|Overall Study||19
215256|NCT01226485|521265|P5|COMPLETED|Overall Study||7
215257|NCT01226485|521266|P4|COMPLETED|Overall Study||6
215258|NCT01226485|521267|P3|COMPLETED|Overall Study||3
215259|NCT01226485|521268|P2|COMPLETED|Overall Study||6
215260|NCT01226485|521269|P1|COMPLETED|Overall Study||3
215261|NCT01226485|521263|P7|Received at Least One Dose of Drug|Overall Study||40
215262|NCT01226485|521264|P6|Received at Least One Dose of Drug|Overall Study||19
215263|NCT01226485|521265|P5|Received at Least One Dose of Drug|Overall Study||7
215264|NCT01226485|521266|P4|Received at Least One Dose of Drug|Overall Study||6
215265|NCT01226485|521267|P3|Received at Least One Dose of Drug|Overall Study||3
215266|NCT01226485|521268|P2|Received at Least One Dose of Drug|Overall Study||6
215267|NCT01226485|521269|P1|Received at Least One Dose of Drug|Overall Study||3
215268|NCT01226485|521263|P7|STARTED|Overall Study||40
215269|NCT01226485|521264|P6|STARTED|Overall Study||19
215270|NCT01226485|521265|P5|STARTED|Overall Study||7
215271|NCT01226485|521266|P4|STARTED|Overall Study||6
215272|NCT01226485|521267|P3|STARTED|Overall Study||3
215273|NCT01226485|521268|P2|STARTED|Overall Study||6
215274|NCT01226485|521269|P1|STARTED|Overall Study||3
215275|NCT01226459|521320|P2|NOT COMPLETED|Overall Study||32
215276|NCT01226459|521321|P1|NOT COMPLETED|Overall Study||21
215277|NCT01226459|521320|P2|COMPLETED|Overall Study||171
215278|NCT01226459|521321|P1|COMPLETED|Overall Study||180
215279|NCT01226459|521320|P2|STARTED|Overall Study||203
215280|NCT01226459|521321|P1|STARTED|Overall Study||201
215281|NCT01226420|521331|P1|NOT COMPLETED|Overall Study||0
215282|NCT01226420|521331|P1|COMPLETED|Overall Study||6
215283|NCT01226420|521331|P1|STARTED|Overall Study||6
215284|NCT01226121|521339|P3|NOT COMPLETED|Overall Study||1
215285|NCT01226121|521340|P2|NOT COMPLETED|Overall Study||0
215286|NCT01226121|521341|P1|NOT COMPLETED|Overall Study||2
215287|NCT01226121|521339|P3|COMPLETED|Overall Study||12
215288|NCT01226121|521340|P2|COMPLETED|Overall Study||11
215289|NCT01226121|521341|P1|COMPLETED|Overall Study||11
215290|NCT01226121|521339|P3|30 Day Evaluation|Overall Study||13
215291|NCT01226121|521340|P2|30 Day Evaluation|Overall Study||11
215292|NCT01226121|521341|P1|30 Day Evaluation|Overall Study||12
215293|NCT01226121|521339|P3|STARTED|Overall Study||13
215294|NCT01226121|521340|P2|STARTED|Overall Study||11
215295|NCT01226121|521341|P1|STARTED|Overall Study||13
215296|NCT01226095|521352|P1|NOT COMPLETED|Overall Study||1
215297|NCT01226095|521352|P1|COMPLETED|Overall Study||518
215298|NCT01226095|521352|P1|STARTED|Overall Study||519
215299|NCT01226043|521377|P4|NOT COMPLETED|30-week Observational Phase||13
215300|NCT01226043|521378|P3|NOT COMPLETED|30-week Observational Phase||6
215301|NCT01226043|521379|P2|NOT COMPLETED|30-week Observational Phase||0
215302|NCT01226043|521380|P1|NOT COMPLETED|30-week Observational Phase||0
215303|NCT01226043|521377|P4|COMPLETED|30-week Observational Phase||140
215304|NCT01226043|521378|P3|COMPLETED|30-week Observational Phase||153
215305|NCT01226043|521379|P2|COMPLETED|30-week Observational Phase||0
215306|NCT01226043|521380|P1|COMPLETED|30-week Observational Phase||0
215307|NCT01226043|521377|P4|TREATED|30-week Observational Phase||153
215308|NCT01226043|521378|P3|TREATED|30-week Observational Phase||159
215309|NCT01226043|521379|P2|TREATED|30-week Observational Phase||0
215310|NCT01226043|521380|P1|TREATED|30-week Observational Phase||0
215311|NCT01226043|521377|P4|STARTED|30-week Observational Phase||153
215312|NCT01226043|521378|P3|STARTED|30-week Observational Phase||159
215313|NCT01226043|521379|P2|STARTED|30-week Observational Phase||0
215314|NCT01226043|521380|P1|STARTED|30-week Observational Phase||0
215315|NCT01226043|521377|P4|NOT COMPLETED|6-week Re-randomization Phase||11
215316|NCT01226043|521378|P3|NOT COMPLETED|6-week Re-randomization Phase||7
215317|NCT01226043|521379|P2|NOT COMPLETED|6-week Re-randomization Phase||0
215318|NCT01226043|521380|P1|NOT COMPLETED|6-week Re-randomization Phase||0
215319|NCT01226043|521377|P4|COMPLETED|6-week Re-randomization Phase|3 patients did not enter the observational phase of the study|156
215320|NCT01226043|521378|P3|COMPLETED|6-week Re-randomization Phase||159
215321|NCT01226043|521379|P2|COMPLETED|6-week Re-randomization Phase||0
215322|NCT01226043|521380|P1|COMPLETED|6-week Re-randomization Phase||0
215323|NCT01226043|521377|P4|TREATED|6-week Re-randomization Phase||165
215324|NCT01226043|521378|P3|TREATED|6-week Re-randomization Phase||165
215325|NCT01226043|521379|P2|TREATED|6-week Re-randomization Phase||0
215326|NCT01226043|521380|P1|TREATED|6-week Re-randomization Phase||0
215327|NCT01226043|521377|P4|STARTED|6-week Re-randomization Phase||167
215328|NCT01226043|521378|P3|STARTED|6-week Re-randomization Phase||166
215329|NCT01226043|521379|P2|STARTED|6-week Re-randomization Phase||0
215330|NCT01226043|521380|P1|STARTED|6-week Re-randomization Phase||0
215331|NCT01226043|521377|P4|NOT COMPLETED|4-week Crossover Phase - Period 2||0
215332|NCT01226043|521378|P3|NOT COMPLETED|4-week Crossover Phase - Period 2||0
215333|NCT01226043|521379|P2|NOT COMPLETED|4-week Crossover Phase - Period 2||6
215334|NCT01226043|521380|P1|NOT COMPLETED|4-week Crossover Phase - Period 2||4
215335|NCT01226043|521377|P4|COMPLETED|4-week Crossover Phase - Period 2||0
215336|NCT01226043|521378|P3|COMPLETED|4-week Crossover Phase - Period 2||0
215337|NCT01226043|521379|P2|COMPLETED|4-week Crossover Phase - Period 2|22 patients were not re-randomized to the second phase of the study|188
215338|NCT01226043|521380|P1|COMPLETED|4-week Crossover Phase - Period 2|28 patients were not re-randomized to the second phase of the study|195
215339|NCT01226043|521377|P4|TREATED|4-week Crossover Phase - Period 2||0
215340|NCT01226043|521378|P3|TREATED|4-week Crossover Phase - Period 2||0
215341|NCT01226043|521379|P2|TREATED|4-week Crossover Phase - Period 2||194
215342|NCT01226043|521380|P1|TREATED|4-week Crossover Phase - Period 2||199
215343|NCT01226043|521377|P4|STARTED|4-week Crossover Phase - Period 2||0
215344|NCT01226043|521378|P3|STARTED|4-week Crossover Phase - Period 2||0
215345|NCT01226043|521379|P2|STARTED|4-week Crossover Phase - Period 2||194
215346|NCT01226043|521380|P1|STARTED|4-week Crossover Phase - Period 2||199
215347|NCT01226043|521377|P4|NOT COMPLETED|4-week Crossover Phase - Period 1||0
215348|NCT01226043|521378|P3|NOT COMPLETED|4-week Crossover Phase - Period 1||0
215349|NCT01226043|521379|P2|NOT COMPLETED|4-week Crossover Phase - Period 1||9
215350|NCT01226043|521380|P1|NOT COMPLETED|4-week Crossover Phase - Period 1||3
215351|NCT01226043|521377|P4|COMPLETED|4-week Crossover Phase - Period 1||0
215352|NCT01226043|521378|P3|COMPLETED|4-week Crossover Phase - Period 1||0
215353|NCT01226043|521379|P2|COMPLETED|4-week Crossover Phase - Period 1||194
215354|NCT01226043|521380|P1|COMPLETED|4-week Crossover Phase - Period 1||199
215355|NCT01226043|521377|P4|TREATED|4-week Crossover Phase - Period 1||0
215356|NCT01226043|521378|P3|TREATED|4-week Crossover Phase - Period 1||0
215357|NCT01226043|521379|P2|TREATED|4-week Crossover Phase - Period 1||200
215358|NCT01226043|521380|P1|TREATED|4-week Crossover Phase - Period 1||202
215359|NCT01226043|521377|P4|STARTED|4-week Crossover Phase - Period 1||0
215360|NCT01226043|521378|P3|STARTED|4-week Crossover Phase - Period 1||0
215361|NCT01226043|521379|P2|STARTED|4-week Crossover Phase - Period 1||203
215362|NCT01226043|521380|P1|STARTED|4-week Crossover Phase - Period 1||202
215363|NCT01225991|521418|P1|NOT COMPLETED|Overall Study||6
215364|NCT01225991|521418|P1|COMPLETED|Overall Study||12
215365|NCT01225991|521418|P1|STARTED|Overall Study||18
215366|NCT01225952|521429|P3|NOT COMPLETED|Overall Study||6
215367|NCT01225952|521430|P2|NOT COMPLETED|Overall Study||4
215368|NCT01225952|521431|P1|NOT COMPLETED|Overall Study||6
215369|NCT01225952|521429|P3|COMPLETED|Overall Study||25
215370|NCT01225952|521430|P2|COMPLETED|Overall Study||27
215371|NCT01225952|521431|P1|COMPLETED|Overall Study||25
215372|NCT01225952|521429|P3|STARTED|Overall Study||31
215373|NCT01225952|521430|P2|STARTED|Overall Study||31
215374|NCT01225952|521431|P1|STARTED|Overall Study||31
215375|NCT01225926|521516|P2|NOT COMPLETED|Overall Study||0
215376|NCT01225926|521517|P1|NOT COMPLETED|Overall Study||0
215377|NCT01225926|521516|P2|COMPLETED|Overall Study||12
215378|NCT01225926|521517|P1|COMPLETED|Overall Study||12
215379|NCT01225926|521516|P2|STARTED|Overall Study||12
215380|NCT01225926|521517|P1|STARTED|Overall Study||12
215381|NCT01225887|521523|P1|NOT COMPLETED|Overall Study||5
215382|NCT01225887|521523|P1|COMPLETED|Overall Study||32
215383|NCT01225887|521523|P1|STARTED|Overall Study||37
215384|NCT01225835|521533|P2|NOT COMPLETED|Overall Study||3
215385|NCT01225835|521534|P1|NOT COMPLETED|Overall Study||7
215386|NCT01225835|521533|P2|COMPLETED|Overall Study|hCG criterion met|59
215387|NCT01225835|521534|P1|COMPLETED|Overall Study|hCG criterion met|55
215388|NCT01225835|521533|P2|Per Protocol Population|Overall Study||58
215389|NCT01225835|521534|P1|Per Protocol Population|Overall Study||48
215390|NCT01225835|521533|P2|STARTED|Overall Study||62
215391|NCT01225835|521534|P1|STARTED|Overall Study||62
215392|NCT01225822|521582|P5|NOT COMPLETED|Overall Study||31
215393|NCT01225822|521583|P4|NOT COMPLETED|Overall Study||52
215394|NCT01225822|521584|P3|NOT COMPLETED|Overall Study||38
215395|NCT01225822|521585|P2|NOT COMPLETED|Overall Study||56
215396|NCT01225822|521586|P1|NOT COMPLETED|Overall Study||38
215397|NCT01225822|521582|P5|COMPLETED|Overall Study||361
215398|NCT01225822|521583|P4|COMPLETED|Overall Study||333
215399|NCT01225822|521584|P3|COMPLETED|Overall Study||355
215400|NCT01225822|521585|P2|COMPLETED|Overall Study||334
215401|NCT01225822|521586|P1|COMPLETED|Overall Study||351
215402|NCT01225822|521582|P5|STARTED|Overall Study||392
215403|NCT01225822|521583|P4|STARTED|Overall Study||385
215404|NCT01225822|521584|P3|STARTED|Overall Study||393
215405|NCT01225822|521585|P2|STARTED|Overall Study||390
215406|NCT01225822|521586|P1|STARTED|Overall Study||389
215407|NCT01225731|521653|P13|NOT COMPLETED|Part 3||7
215408|NCT01225731|521654|P12|NOT COMPLETED|Part 3||10
215409|NCT01225731|521655|P11|NOT COMPLETED|Part 3||6
215410|NCT01225731|521656|P10|NOT COMPLETED|Part 3||0
215411|NCT01225731|521657|P9|NOT COMPLETED|Part 3||0
215412|NCT01225731|521658|P8|NOT COMPLETED|Part 3||0
215413|NCT01225731|521659|P7|NOT COMPLETED|Part 3||0
215414|NCT01225731|521660|P6|NOT COMPLETED|Part 3||0
215415|NCT01225731|521661|P5|NOT COMPLETED|Part 3||0
215416|NCT01225731|521662|P4|NOT COMPLETED|Part 3||0
215417|NCT01225731|521663|P3|NOT COMPLETED|Part 3||0
215418|NCT01225731|521664|P2|NOT COMPLETED|Part 3||0
215419|NCT01225731|521665|P1|NOT COMPLETED|Part 3||0
215420|NCT01225731|521653|P13|COMPLETED|Part 3||60
215421|NCT01225731|521654|P12|COMPLETED|Part 3||116
215422|NCT01225731|521655|P11|COMPLETED|Part 3||80
215423|NCT01225731|521656|P10|COMPLETED|Part 3||10
215424|NCT01225731|521657|P9|COMPLETED|Part 3||0
215425|NCT01225731|521658|P8|COMPLETED|Part 3||0
215426|NCT01225731|521659|P7|COMPLETED|Part 3||0
215427|NCT01225731|521660|P6|COMPLETED|Part 3||0
215428|NCT01225731|521661|P5|COMPLETED|Part 3||0
215429|NCT01225731|521662|P4|COMPLETED|Part 3||0
215430|NCT01225731|521663|P3|COMPLETED|Part 3||0
215431|NCT01225731|521664|P2|COMPLETED|Part 3||0
215432|NCT01225731|521665|P1|COMPLETED|Part 3||0
215433|NCT01225731|521653|P13|STARTED|Part 3|Not all participants entered follow-up|67
215434|NCT01225731|521654|P12|STARTED|Part 3|Not all participants entered follow-up|126
215435|NCT01225731|521655|P11|STARTED|Part 3|Not all participants entered follow-up|86
215436|NCT01225731|521656|P10|STARTED|Part 3|Not all participants entered follow-up|10
215437|NCT01225731|521657|P9|STARTED|Part 3|Participants could enter the follow-up period|0
215438|NCT01225731|521658|P8|STARTED|Part 3|Participants could enter the follow-up period|0
215439|NCT01225731|521659|P7|STARTED|Part 3|Participants could enter the follow-up period|0
215440|NCT01225731|521660|P6|STARTED|Part 3|Participants could enter the follow-up period|0
215441|NCT01225731|521661|P5|STARTED|Part 3||0
215442|NCT01225731|521662|P4|STARTED|Part 3||0
215443|NCT01225731|521663|P3|STARTED|Part 3||0
215444|NCT01225731|521664|P2|STARTED|Part 3||0
215445|NCT01225731|521665|P1|STARTED|Part 3||0
215446|NCT01225731|521653|P13|NOT COMPLETED|Part 2||0
215447|NCT01225731|521654|P12|NOT COMPLETED|Part 2||0
215448|NCT01225731|521655|P11|NOT COMPLETED|Part 2||0
215449|NCT01225731|521656|P10|NOT COMPLETED|Part 2||0
215450|NCT01225731|521657|P9|NOT COMPLETED|Part 2||11
215451|NCT01225731|521658|P8|NOT COMPLETED|Part 2||25
215452|NCT01225731|521659|P7|NOT COMPLETED|Part 2||8
215453|NCT01225731|521660|P6|NOT COMPLETED|Part 2||3
215454|NCT01225731|521661|P5|NOT COMPLETED|Part 2||0
215455|NCT01225731|521662|P4|NOT COMPLETED|Part 2||0
215456|NCT01225731|521663|P3|NOT COMPLETED|Part 2||0
215457|NCT01225731|521664|P2|NOT COMPLETED|Part 2||0
215458|NCT01225731|521665|P1|NOT COMPLETED|Part 2||0
215459|NCT01225731|521653|P13|COMPLETED|Part 2||0
215460|NCT01225731|521654|P12|COMPLETED|Part 2||0
215461|NCT01225731|521655|P11|COMPLETED|Part 2||0
215462|NCT01225731|521656|P10|COMPLETED|Part 2||0
215463|NCT01225731|521657|P9|COMPLETED|Part 2||68
215464|NCT01225731|521658|P8|COMPLETED|Part 2||128
215465|NCT01225731|521659|P7|COMPLETED|Part 2||86
215466|NCT01225731|521660|P6|COMPLETED|Part 2||10
215467|NCT01225731|521661|P5|COMPLETED|Part 2||0
215468|NCT01225731|521662|P4|COMPLETED|Part 2||0
215469|NCT01225731|521663|P3|COMPLETED|Part 2||0
215470|NCT01225731|521664|P2|COMPLETED|Part 2||0
215471|NCT01225731|521665|P1|COMPLETED|Part 2||0
215472|NCT01225731|521653|P13|STARTED|Part 2||0
215473|NCT01225731|521654|P12|STARTED|Part 2||0
215474|NCT01225731|521655|P11|STARTED|Part 2||0
215475|NCT01225731|521656|P10|STARTED|Part 2||0
215476|NCT01225731|521657|P9|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|79
215477|NCT01225731|521658|P8|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|153
215478|NCT01225731|521659|P7|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|94
215479|NCT01225731|521660|P6|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|13
215480|NCT01225731|521661|P5|STARTED|Part 2|Participants could progress into Part 2; no placebo was given in Part 2|0
215481|NCT01225731|521662|P4|STARTED|Part 2|Participants could progress into Part 2|0
215482|NCT01225731|521663|P3|STARTED|Part 2|Participants could progress into Part 2|0
215483|NCT01225731|521664|P2|STARTED|Part 2|Participants could progress into Part 2|0
215484|NCT01225731|521665|P1|STARTED|Part 2|Participants could progress into Part 2|0
215485|NCT01225731|521653|P13|NOT COMPLETED|Part 1||0
215486|NCT01225731|521654|P12|NOT COMPLETED|Part 1||0
215487|NCT01225731|521655|P11|NOT COMPLETED|Part 1||0
215488|NCT01225731|521656|P10|NOT COMPLETED|Part 1||0
215489|NCT01225731|521657|P9|NOT COMPLETED|Part 1||0
215490|NCT01225731|521658|P8|NOT COMPLETED|Part 1||0
215491|NCT01225731|521659|P7|NOT COMPLETED|Part 1||0
215492|NCT01225731|521660|P6|NOT COMPLETED|Part 1||0
215493|NCT01225731|521661|P5|NOT COMPLETED|Part 1||6
215494|NCT01225731|521662|P4|NOT COMPLETED|Part 1||2
215495|NCT01225731|521663|P3|NOT COMPLETED|Part 1||1
215496|NCT01225731|521664|P2|NOT COMPLETED|Part 1||5
215497|NCT01225731|521665|P1|NOT COMPLETED|Part 1||2
215498|NCT01225731|521653|P13|COMPLETED|Part 1||0
215499|NCT01225731|521654|P12|COMPLETED|Part 1||0
215500|NCT01225731|521655|P11|COMPLETED|Part 1||0
215501|NCT01225731|521656|P10|COMPLETED|Part 1||0
215502|NCT01225731|521657|P9|COMPLETED|Part 1||0
215503|NCT01225731|521658|P8|COMPLETED|Part 1||0
215504|NCT01225731|521659|P7|COMPLETED|Part 1||0
215505|NCT01225731|521660|P6|COMPLETED|Part 1||0
215506|NCT01225731|521661|P5|COMPLETED|Part 1||40
215507|NCT01225731|521662|P4|COMPLETED|Part 1||84
215508|NCT01225731|521663|P3|COMPLETED|Part 1||88
215509|NCT01225731|521664|P2|COMPLETED|Part 1||87
215510|NCT01225731|521665|P1|COMPLETED|Part 1||40
215511|NCT01225731|521653|P13|STARTED|Part 1||0
215512|NCT01225731|521654|P12|STARTED|Part 1||0
215513|NCT01225731|521655|P11|STARTED|Part 1||0
215514|NCT01225731|521656|P10|STARTED|Part 1||0
215515|NCT01225731|521657|P9|STARTED|Part 1||0
215516|NCT01225731|521658|P8|STARTED|Part 1||0
215517|NCT01225731|521659|P7|STARTED|Part 1||0
215518|NCT01225731|521660|P6|STARTED|Part 1||0
215519|NCT01225731|521661|P5|STARTED|Part 1||46
215520|NCT01225731|521662|P4|STARTED|Part 1||86
215521|NCT01225731|521663|P3|STARTED|Part 1||89
215522|NCT01225731|521664|P2|STARTED|Part 1||92
215523|NCT01225731|521665|P1|STARTED|Part 1||42
215524|NCT01225562|521760|P3|NOT COMPLETED|Overall Study||53
215525|NCT01225562|521761|P2|NOT COMPLETED|Overall Study||56
215526|NCT01225562|521762|P1|NOT COMPLETED|Overall Study||55
215527|NCT01225562|521760|P3|COMPLETED|Overall Study||7014
215528|NCT01225562|521761|P2|COMPLETED|Overall Study||6989
215529|NCT01225562|521762|P1|COMPLETED|Overall Study||6995
215530|NCT01225562|521760|P3|STARTED|Overall Study||7067
215531|NCT01225562|521761|P2|STARTED|Overall Study||7045
215532|NCT01225562|521762|P1|STARTED|Overall Study||7050
215533|NCT01225549|521779|P10|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
215534|NCT01225549|521780|P9|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
215535|NCT01225549|521781|P8|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
215536|NCT01225549|521782|P7|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
215537|NCT01225549|521783|P6|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
215538|NCT01225549|521784|P5|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
215539|NCT01225549|521785|P4|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
215540|NCT01225549|521786|P3|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
215541|NCT01225549|521787|P2|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
215542|NCT01225549|521788|P1|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
215543|NCT01225549|521779|P10|COMPLETED|Period 7 - Fourth Treatment Period||1
215544|NCT01225549|521780|P9|COMPLETED|Period 7 - Fourth Treatment Period||4
215545|NCT01225549|521781|P8|COMPLETED|Period 7 - Fourth Treatment Period||1
215546|NCT01225549|521782|P7|COMPLETED|Period 7 - Fourth Treatment Period||3
215547|NCT01225549|521783|P6|COMPLETED|Period 7 - Fourth Treatment Period||1
215548|NCT01225549|521784|P5|COMPLETED|Period 7 - Fourth Treatment Period||1
215549|NCT01225549|521785|P4|COMPLETED|Period 7 - Fourth Treatment Period||0
215550|NCT01225549|521786|P3|COMPLETED|Period 7 - Fourth Treatment Period||3
215551|NCT01225549|521787|P2|COMPLETED|Period 7 - Fourth Treatment Period||3
215552|NCT01225549|521788|P1|COMPLETED|Period 7 - Fourth Treatment Period||1
215553|NCT01225549|521779|P10|STARTED|Period 7 - Fourth Treatment Period||1
215554|NCT01225549|521780|P9|STARTED|Period 7 - Fourth Treatment Period||4
215555|NCT01225549|521781|P8|STARTED|Period 7 - Fourth Treatment Period||1
215556|NCT01225549|521782|P7|STARTED|Period 7 - Fourth Treatment Period||3
215557|NCT01225549|521783|P6|STARTED|Period 7 - Fourth Treatment Period||1
215558|NCT01225549|521784|P5|STARTED|Period 7 - Fourth Treatment Period||1
215559|NCT01225549|521785|P4|STARTED|Period 7 - Fourth Treatment Period||0
215560|NCT01225549|521786|P3|STARTED|Period 7 - Fourth Treatment Period||3
215561|NCT01225549|521787|P2|STARTED|Period 7 - Fourth Treatment Period||3
215562|NCT01225549|521788|P1|STARTED|Period 7 - Fourth Treatment Period||1
215563|NCT01225549|521779|P10|NOT COMPLETED|Period 6 - Washout||0
215564|NCT01225549|521780|P9|NOT COMPLETED|Period 6 - Washout||0
215565|NCT01225549|521781|P8|NOT COMPLETED|Period 6 - Washout||0
215566|NCT01225549|521782|P7|NOT COMPLETED|Period 6 - Washout||0
215567|NCT01225549|521783|P6|NOT COMPLETED|Period 6 - Washout||0
215568|NCT01225549|521784|P5|NOT COMPLETED|Period 6 - Washout||0
215569|NCT01225549|521785|P4|NOT COMPLETED|Period 6 - Washout||1
215570|NCT01225549|521786|P3|NOT COMPLETED|Period 6 - Washout||0
215571|NCT01225549|521787|P2|NOT COMPLETED|Period 6 - Washout||0
215572|NCT01225549|521788|P1|NOT COMPLETED|Period 6 - Washout||0
215573|NCT01225549|521779|P10|COMPLETED|Period 6 - Washout||1
215574|NCT01225549|521780|P9|COMPLETED|Period 6 - Washout||4
215575|NCT01225549|521781|P8|COMPLETED|Period 6 - Washout||1
215576|NCT01225549|521782|P7|COMPLETED|Period 6 - Washout||3
215577|NCT01225549|521783|P6|COMPLETED|Period 6 - Washout||1
215578|NCT01225549|521784|P5|COMPLETED|Period 6 - Washout||1
215579|NCT01225549|521785|P4|COMPLETED|Period 6 - Washout||0
215580|NCT01225549|521786|P3|COMPLETED|Period 6 - Washout||3
215581|NCT01225549|521787|P2|COMPLETED|Period 6 - Washout||3
215582|NCT01225549|521788|P1|COMPLETED|Period 6 - Washout||1
215583|NCT01225549|521779|P10|STARTED|Period 6 - Washout||1
215584|NCT01225549|521780|P9|STARTED|Period 6 - Washout||4
215585|NCT01225549|521781|P8|STARTED|Period 6 - Washout||1
215586|NCT01225549|521782|P7|STARTED|Period 6 - Washout||3
215587|NCT01225549|521783|P6|STARTED|Period 6 - Washout||1
215588|NCT01225549|521784|P5|STARTED|Period 6 - Washout||1
215589|NCT01225549|521785|P4|STARTED|Period 6 - Washout||1
215590|NCT01225549|521786|P3|STARTED|Period 6 - Washout||3
215591|NCT01225549|521787|P2|STARTED|Period 6 - Washout||3
215592|NCT01225549|521788|P1|STARTED|Period 6 - Washout||1
215593|NCT01225549|521779|P10|NOT COMPLETED|Period 5 - Third Treatment Period||0
215594|NCT01225549|521780|P9|NOT COMPLETED|Period 5 - Third Treatment Period||0
215595|NCT01225549|521781|P8|NOT COMPLETED|Period 5 - Third Treatment Period||0
215596|NCT01225549|521782|P7|NOT COMPLETED|Period 5 - Third Treatment Period||0
215597|NCT01225549|521783|P6|NOT COMPLETED|Period 5 - Third Treatment Period||0
215598|NCT01225549|521784|P5|NOT COMPLETED|Period 5 - Third Treatment Period||0
215599|NCT01225549|521785|P4|NOT COMPLETED|Period 5 - Third Treatment Period||0
215600|NCT01225549|521786|P3|NOT COMPLETED|Period 5 - Third Treatment Period||0
215601|NCT01225549|521787|P2|NOT COMPLETED|Period 5 - Third Treatment Period||0
215602|NCT01225549|521788|P1|NOT COMPLETED|Period 5 - Third Treatment Period||0
215603|NCT01225549|521779|P10|COMPLETED|Period 5 - Third Treatment Period||1
215604|NCT01225549|521780|P9|COMPLETED|Period 5 - Third Treatment Period||4
215605|NCT01225549|521781|P8|COMPLETED|Period 5 - Third Treatment Period||1
215606|NCT01225549|521782|P7|COMPLETED|Period 5 - Third Treatment Period||3
215607|NCT01225549|521783|P6|COMPLETED|Period 5 - Third Treatment Period||1
215608|NCT01225549|521784|P5|COMPLETED|Period 5 - Third Treatment Period||1
215609|NCT01225549|521785|P4|COMPLETED|Period 5 - Third Treatment Period||1
215610|NCT01225549|521786|P3|COMPLETED|Period 5 - Third Treatment Period||3
215611|NCT01225549|521787|P2|COMPLETED|Period 5 - Third Treatment Period||3
215612|NCT01225549|521788|P1|COMPLETED|Period 5 - Third Treatment Period||1
215613|NCT01225549|521779|P10|STARTED|Period 5 - Third Treatment Period||1
215614|NCT01225549|521780|P9|STARTED|Period 5 - Third Treatment Period||4
215615|NCT01225549|521781|P8|STARTED|Period 5 - Third Treatment Period||1
215616|NCT01225549|521782|P7|STARTED|Period 5 - Third Treatment Period||3
215617|NCT01225549|521783|P6|STARTED|Period 5 - Third Treatment Period||1
215618|NCT01225549|521784|P5|STARTED|Period 5 - Third Treatment Period||1
215619|NCT01225549|521785|P4|STARTED|Period 5 - Third Treatment Period||1
215620|NCT01225549|521786|P3|STARTED|Period 5 - Third Treatment Period||3
215621|NCT01225549|521787|P2|STARTED|Period 5 - Third Treatment Period||3
215622|NCT01225549|521788|P1|STARTED|Period 5 - Third Treatment Period||1
215623|NCT01225549|521779|P10|NOT COMPLETED|Period 4 - Washout||0
215624|NCT01225549|521780|P9|NOT COMPLETED|Period 4 - Washout||0
215625|NCT01225549|521781|P8|NOT COMPLETED|Period 4 - Washout||0
215626|NCT01225549|521782|P7|NOT COMPLETED|Period 4 - Washout||0
215627|NCT01225549|521783|P6|NOT COMPLETED|Period 4 - Washout||0
215628|NCT01225549|521784|P5|NOT COMPLETED|Period 4 - Washout||0
215629|NCT01225549|521785|P4|NOT COMPLETED|Period 4 - Washout||0
215630|NCT01225549|521786|P3|NOT COMPLETED|Period 4 - Washout||0
215631|NCT01225549|521787|P2|NOT COMPLETED|Period 4 - Washout||1
215632|NCT01225549|521788|P1|NOT COMPLETED|Period 4 - Washout||0
215633|NCT01225549|521779|P10|COMPLETED|Period 4 - Washout||1
215634|NCT01225549|521780|P9|COMPLETED|Period 4 - Washout||4
215635|NCT01225549|521781|P8|COMPLETED|Period 4 - Washout||1
215636|NCT01225549|521782|P7|COMPLETED|Period 4 - Washout||3
215637|NCT01225549|521783|P6|COMPLETED|Period 4 - Washout||1
215638|NCT01225549|521784|P5|COMPLETED|Period 4 - Washout||1
215639|NCT01225549|521785|P4|COMPLETED|Period 4 - Washout||1
215640|NCT01225549|521786|P3|COMPLETED|Period 4 - Washout||3
215641|NCT01225549|521787|P2|COMPLETED|Period 4 - Washout||3
215642|NCT01225549|521788|P1|COMPLETED|Period 4 - Washout||1
215643|NCT01225549|521779|P10|STARTED|Period 4 - Washout||1
215644|NCT01225549|521780|P9|STARTED|Period 4 - Washout||4
215645|NCT01225549|521781|P8|STARTED|Period 4 - Washout||1
215646|NCT01225549|521782|P7|STARTED|Period 4 - Washout||3
215647|NCT01225549|521783|P6|STARTED|Period 4 - Washout||1
215648|NCT01225549|521784|P5|STARTED|Period 4 - Washout||1
215649|NCT01225549|521785|P4|STARTED|Period 4 - Washout||1
215650|NCT01225549|521786|P3|STARTED|Period 4 - Washout||3
215651|NCT01225549|521787|P2|STARTED|Period 4 - Washout||4
215652|NCT01225549|521788|P1|STARTED|Period 4 - Washout||1
215653|NCT01225549|521779|P10|NOT COMPLETED|Period 3 - Second Treatment Period||0
215654|NCT01225549|521780|P9|NOT COMPLETED|Period 3 - Second Treatment Period||0
215655|NCT01225549|521781|P8|NOT COMPLETED|Period 3 - Second Treatment Period||0
215656|NCT01225549|521782|P7|NOT COMPLETED|Period 3 - Second Treatment Period||0
215657|NCT01225549|521783|P6|NOT COMPLETED|Period 3 - Second Treatment Period||0
215658|NCT01225549|521784|P5|NOT COMPLETED|Period 3 - Second Treatment Period||0
215659|NCT01225549|521785|P4|NOT COMPLETED|Period 3 - Second Treatment Period||0
215660|NCT01225549|521786|P3|NOT COMPLETED|Period 3 - Second Treatment Period||0
215661|NCT01225549|521787|P2|NOT COMPLETED|Period 3 - Second Treatment Period||0
215662|NCT01225549|521788|P1|NOT COMPLETED|Period 3 - Second Treatment Period||0
215663|NCT01225549|521779|P10|COMPLETED|Period 3 - Second Treatment Period||1
215664|NCT01225549|521780|P9|COMPLETED|Period 3 - Second Treatment Period||4
215665|NCT01225549|521781|P8|COMPLETED|Period 3 - Second Treatment Period||1
215666|NCT01225549|521782|P7|COMPLETED|Period 3 - Second Treatment Period||3
215667|NCT01225549|521783|P6|COMPLETED|Period 3 - Second Treatment Period||1
215668|NCT01225549|521784|P5|COMPLETED|Period 3 - Second Treatment Period||1
215669|NCT01225549|521785|P4|COMPLETED|Period 3 - Second Treatment Period||1
215670|NCT01225549|521786|P3|COMPLETED|Period 3 - Second Treatment Period||3
215671|NCT01225549|521787|P2|COMPLETED|Period 3 - Second Treatment Period||4
215672|NCT01225549|521788|P1|COMPLETED|Period 3 - Second Treatment Period||1
215673|NCT01225549|521779|P10|STARTED|Period 3 - Second Treatment Period||1
215674|NCT01225549|521780|P9|STARTED|Period 3 - Second Treatment Period||4
215675|NCT01225549|521781|P8|STARTED|Period 3 - Second Treatment Period||1
215676|NCT01225549|521782|P7|STARTED|Period 3 - Second Treatment Period||3
215677|NCT01225549|521783|P6|STARTED|Period 3 - Second Treatment Period||1
215678|NCT01225549|521784|P5|STARTED|Period 3 - Second Treatment Period||1
215679|NCT01225549|521785|P4|STARTED|Period 3 - Second Treatment Period||1
215680|NCT01225549|521786|P3|STARTED|Period 3 - Second Treatment Period||3
215681|NCT01225549|521787|P2|STARTED|Period 3 - Second Treatment Period||4
215682|NCT01225549|521788|P1|STARTED|Period 3 - Second Treatment Period||1
215683|NCT01225549|521779|P10|NOT COMPLETED|Period 2 - Washout||0
215684|NCT01225549|521780|P9|NOT COMPLETED|Period 2 - Washout||0
215685|NCT01225549|521781|P8|NOT COMPLETED|Period 2 - Washout||0
215686|NCT01225549|521782|P7|NOT COMPLETED|Period 2 - Washout||0
215687|NCT01225549|521783|P6|NOT COMPLETED|Period 2 - Washout||0
215688|NCT01225549|521784|P5|NOT COMPLETED|Period 2 - Washout||0
215689|NCT01225549|521785|P4|NOT COMPLETED|Period 2 - Washout||0
215690|NCT01225549|521786|P3|NOT COMPLETED|Period 2 - Washout||0
215691|NCT01225549|521787|P2|NOT COMPLETED|Period 2 - Washout||0
215692|NCT01225549|521788|P1|NOT COMPLETED|Period 2 - Washout||0
215693|NCT01225549|521779|P10|COMPLETED|Period 2 - Washout||1
215694|NCT01225549|521780|P9|COMPLETED|Period 2 - Washout||4
215695|NCT01225549|521781|P8|COMPLETED|Period 2 - Washout||1
215696|NCT01225549|521782|P7|COMPLETED|Period 2 - Washout||3
215697|NCT01225549|521783|P6|COMPLETED|Period 2 - Washout||1
215698|NCT01225549|521784|P5|COMPLETED|Period 2 - Washout||1
215699|NCT01225549|521785|P4|COMPLETED|Period 2 - Washout||1
215700|NCT01225549|521786|P3|COMPLETED|Period 2 - Washout||3
215701|NCT01225549|521787|P2|COMPLETED|Period 2 - Washout||4
215702|NCT01225549|521788|P1|COMPLETED|Period 2 - Washout||1
215703|NCT01225549|521779|P10|STARTED|Period 2 - Washout||1
215704|NCT01225549|521780|P9|STARTED|Period 2 - Washout||4
215705|NCT01225549|521781|P8|STARTED|Period 2 - Washout||1
215706|NCT01225549|521782|P7|STARTED|Period 2 - Washout||3
215707|NCT01225549|521783|P6|STARTED|Period 2 - Washout||1
215708|NCT01225549|521784|P5|STARTED|Period 2 - Washout||1
215709|NCT01225549|521785|P4|STARTED|Period 2 - Washout||1
215710|NCT01225549|521786|P3|STARTED|Period 2 - Washout||3
215711|NCT01225549|521787|P2|STARTED|Period 2 - Washout||4
215712|NCT01225549|521788|P1|STARTED|Period 2 - Washout||1
215713|NCT01225549|521779|P10|NOT COMPLETED|Period 1 - First Treatment Period||0
215714|NCT01225549|521780|P9|NOT COMPLETED|Period 1 - First Treatment Period||0
215715|NCT01225549|521781|P8|NOT COMPLETED|Period 1 - First Treatment Period||0
215716|NCT01225549|521782|P7|NOT COMPLETED|Period 1 - First Treatment Period||0
215717|NCT01225549|521783|P6|NOT COMPLETED|Period 1 - First Treatment Period||0
215718|NCT01225549|521784|P5|NOT COMPLETED|Period 1 - First Treatment Period||0
215719|NCT01225549|521785|P4|NOT COMPLETED|Period 1 - First Treatment Period||0
215720|NCT01225549|521786|P3|NOT COMPLETED|Period 1 - First Treatment Period||0
215721|NCT01225549|521787|P2|NOT COMPLETED|Period 1 - First Treatment Period||0
215722|NCT01225549|521788|P1|NOT COMPLETED|Period 1 - First Treatment Period||0
215723|NCT01225549|521779|P10|COMPLETED|Period 1 - First Treatment Period||1
215724|NCT01225549|521780|P9|COMPLETED|Period 1 - First Treatment Period||4
215725|NCT01225549|521781|P8|COMPLETED|Period 1 - First Treatment Period||1
215726|NCT01225549|521782|P7|COMPLETED|Period 1 - First Treatment Period||3
215727|NCT01225549|521783|P6|COMPLETED|Period 1 - First Treatment Period||1
215728|NCT01225549|521784|P5|COMPLETED|Period 1 - First Treatment Period||1
215729|NCT01225549|521785|P4|COMPLETED|Period 1 - First Treatment Period||1
215730|NCT01225549|521786|P3|COMPLETED|Period 1 - First Treatment Period||3
215731|NCT01225549|521787|P2|COMPLETED|Period 1 - First Treatment Period||4
215732|NCT01225549|521788|P1|COMPLETED|Period 1 - First Treatment Period||1
215733|NCT01225549|521779|P10|STARTED|Period 1 - First Treatment Period||1
215734|NCT01225549|521780|P9|STARTED|Period 1 - First Treatment Period||4
215735|NCT01225549|521781|P8|STARTED|Period 1 - First Treatment Period||1
215736|NCT01225549|521782|P7|STARTED|Period 1 - First Treatment Period||3
215737|NCT01225549|521783|P6|STARTED|Period 1 - First Treatment Period||1
215738|NCT01225549|521784|P5|STARTED|Period 1 - First Treatment Period||1
215739|NCT01225549|521785|P4|STARTED|Period 1 - First Treatment Period||1
215740|NCT01225549|521786|P3|STARTED|Period 1 - First Treatment Period||3
215741|NCT01225549|521787|P2|STARTED|Period 1 - First Treatment Period||4
215742|NCT01225549|521788|P1|STARTED|Period 1 - First Treatment Period||1
215743|NCT01225354|521830|P1|NOT COMPLETED|Overall Study||1
215744|NCT01225354|521830|P1|COMPLETED|Overall Study||19
215745|NCT01225354|521830|P1|STARTED|Overall Study||20
215746|NCT01225289|521837|P2|NOT COMPLETED|Overall Study||1
215747|NCT01225289|521838|P1|NOT COMPLETED|Overall Study||0
215748|NCT01225289|521837|P2|COMPLETED|Overall Study||17
215749|NCT01225289|521838|P1|COMPLETED|Overall Study||18
215750|NCT01225289|521837|P2|STARTED|Overall Study||18
215751|NCT01225289|521838|P1|STARTED|Overall Study||18
215752|NCT01225263|521852|P2|NOT COMPLETED|Weeks 13 to 24||1
215753|NCT01225263|521853|P1|NOT COMPLETED|Weeks 13 to 24||4
215754|NCT01225263|521852|P2|COMPLETED|Weeks 13 to 24||28
215755|NCT01225263|521853|P1|COMPLETED|Weeks 13 to 24||24
215756|NCT01225263|521852|P2|STARTED|Weeks 13 to 24||29
215757|NCT01225263|521853|P1|STARTED|Weeks 13 to 24||28
215758|NCT01225263|521852|P2|NOT COMPLETED|Weeks 1 to 12||0
215759|NCT01225263|521853|P1|NOT COMPLETED|Weeks 1 to 12||0
215760|NCT01225263|521852|P2|COMPLETED|Weeks 1 to 12||29
215761|NCT01225263|521853|P1|COMPLETED|Weeks 1 to 12||28
215762|NCT01225263|521852|P2|STARTED|Weeks 1 to 12||29
215763|NCT01225263|521853|P1|STARTED|Weeks 1 to 12||28
215764|NCT01225211|521871|P10|NOT COMPLETED|Overall Study||5
215765|NCT01225211|521872|P9|NOT COMPLETED|Overall Study||1
215766|NCT01225211|521873|P8|NOT COMPLETED|Overall Study||0
215767|NCT01225211|521874|P7|NOT COMPLETED|Overall Study||1
215768|NCT01225211|521875|P6|NOT COMPLETED|Overall Study||0
215769|NCT01225211|521876|P5|NOT COMPLETED|Overall Study||0
215770|NCT01225211|521877|P4|NOT COMPLETED|Overall Study||0
215771|NCT01225211|521878|P3|NOT COMPLETED|Overall Study||1
215772|NCT01225211|521879|P2|NOT COMPLETED|Overall Study||0
215773|NCT01225211|521880|P1|NOT COMPLETED|Overall Study||0
215774|NCT01225211|521871|P10|COMPLETED|Overall Study||57
215775|NCT01225211|521872|P9|COMPLETED|Overall Study||62
215776|NCT01225211|521873|P8|COMPLETED|Overall Study||11
215777|NCT01225211|521874|P7|COMPLETED|Overall Study||41
215778|NCT01225211|521875|P6|COMPLETED|Overall Study||21
215779|NCT01225211|521876|P5|COMPLETED|Overall Study||23
215780|NCT01225211|521877|P4|COMPLETED|Overall Study||27
215781|NCT01225211|521878|P3|COMPLETED|Overall Study||20
215782|NCT01225211|521879|P2|COMPLETED|Overall Study||20
215783|NCT01225211|521880|P1|COMPLETED|Overall Study||21
215784|NCT01225211|521871|P10|STARTED|Overall Study||62
215785|NCT01225211|521872|P9|STARTED|Overall Study||63
215786|NCT01225211|521873|P8|STARTED|Overall Study||11
215787|NCT01225211|521874|P7|STARTED|Overall Study||42
215788|NCT01225211|521875|P6|STARTED|Overall Study||21
215789|NCT01225211|521876|P5|STARTED|Overall Study||23
215790|NCT01225211|521877|P4|STARTED|Overall Study||27
215791|NCT01225211|521878|P3|STARTED|Overall Study||21
215792|NCT01225211|521879|P2|STARTED|Overall Study||20
215793|NCT01225211|521880|P1|STARTED|Overall Study||21
215794|NCT01225172|521983|P2|NOT COMPLETED|Overall Study||1
215795|NCT01225172|521984|P1|NOT COMPLETED|Overall Study||6
215796|NCT01225172|521983|P2|COMPLETED|Overall Study||6
215797|NCT01225172|521984|P1|COMPLETED|Overall Study||46
215798|NCT01225172|521983|P2|STARTED|Overall Study||7
215799|NCT01225172|521984|P1|STARTED|Overall Study||52
215800|NCT01225159|522006|P2|NOT COMPLETED|Overall Study||0
215801|NCT01225159|522007|P1|NOT COMPLETED|Overall Study||1
215802|NCT01225159|522006|P2|COMPLETED|Overall Study||100
215803|NCT01225159|522007|P1|COMPLETED|Overall Study||99
215804|NCT01225159|522006|P2|STARTED|Overall Study||100
215805|NCT01225159|522007|P1|STARTED|Overall Study||100
215806|NCT01225146|522017|P2|NOT COMPLETED|Overall Study||2
215807|NCT01225146|522018|P1|NOT COMPLETED|Overall Study||0
215808|NCT01225146|522017|P2|COMPLETED|Overall Study||0
215809|NCT01225146|522018|P1|COMPLETED|Overall Study||6
215810|NCT01225146|522017|P2|STARTED|Overall Study||2
215811|NCT01225146|522018|P1|STARTED|Overall Study||6
215812|NCT01225068|522036|P2|NOT COMPLETED|Overall Study||1
215813|NCT01225068|522037|P1|NOT COMPLETED|Overall Study||4
215814|NCT01225068|522036|P2|COMPLETED|Overall Study||19
215815|NCT01225068|522037|P1|COMPLETED|Overall Study||16
215816|NCT01225068|522036|P2|STARTED|Overall Study||20
215817|NCT01225068|522037|P1|STARTED|Overall Study||20
215818|NCT01225055|522046|P3|NOT COMPLETED|Overall Study||3
215819|NCT01225055|522047|P2|NOT COMPLETED|Overall Study||2
215820|NCT01225055|522048|P1|NOT COMPLETED|Overall Study||0
215821|NCT01225055|522046|P3|COMPLETED|Overall Study||18
215822|NCT01225055|522047|P2|COMPLETED|Overall Study||18
215823|NCT01225055|522048|P1|COMPLETED|Overall Study||20
215824|NCT01225055|522046|P3|STARTED|Overall Study||21
215825|NCT01225055|522047|P2|STARTED|Overall Study||20
215826|NCT01225055|522048|P1|STARTED|Overall Study||20
215827|NCT01225029|522073|P2|NOT COMPLETED|Overall Study||0
215828|NCT01225029|522074|P1|NOT COMPLETED|Overall Study||0
215829|NCT01225029|522073|P2|COMPLETED|Overall Study||32
215830|NCT01225029|522074|P1|COMPLETED|Overall Study||32
215831|NCT01225029|522073|P2|STARTED|Overall Study||32
215832|NCT01225029|522074|P1|STARTED|Overall Study||32
215833|NCT01224925|522086|P2|NOT COMPLETED|Overall Study||2
215834|NCT01224925|522087|P1|NOT COMPLETED|Overall Study||3
215835|NCT01224925|522086|P2|COMPLETED|Overall Study||31
215836|NCT01224925|522087|P1|COMPLETED|Overall Study||34
215837|NCT01224925|522086|P2|STARTED|Overall Study||33
215838|NCT01224925|522087|P1|STARTED|Overall Study||37
215839|NCT01224821|522095|P1|NOT COMPLETED|Long-Term Follow-Up||11
215840|NCT01224821|522095|P1|COMPLETED|Long-Term Follow-Up||0
215841|NCT01224821|522095|P1|STARTED|Long-Term Follow-Up|11/47 participants withdrawing from this study enrolled in the LTFU study for continued evaluation.|11
215842|NCT01224821|522095|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||46
215843|NCT01224821|522095|P1|COMPLETED|Dosimetric and Therapeutic Treatment|This participant completed the study per Protocol Amendment 2.|1
215844|NCT01224821|522095|P1|STARTED|Dosimetric and Therapeutic Treatment||47
215845|NCT01224782|522114|P1|NOT COMPLETED|Overall Study||264
215846|NCT01224782|522114|P1|COMPLETED|Overall Study||730
215847|NCT01224782|522114|P1|STARTED|Overall Study||994
215848|NCT01224678|522125|P2|NOT COMPLETED|Overall Study||0
215849|NCT01224678|522126|P1|NOT COMPLETED|Overall Study||0
215850|NCT01224678|522125|P2|COMPLETED|Overall Study||150
215851|NCT01224678|522126|P1|COMPLETED|Overall Study||150
215852|NCT01224678|522125|P2|STARTED|Overall Study||150
215853|NCT01224678|522126|P1|STARTED|Overall Study||150
215854|NCT01224639|522140|P8|NOT COMPLETED|Overall Study||2
215855|NCT01224639|522141|P7|NOT COMPLETED|Overall Study||1
215856|NCT01224639|522142|P6|NOT COMPLETED|Overall Study||0
215857|NCT01224639|522143|P5|NOT COMPLETED|Overall Study||2
215858|NCT01224639|522144|P4|NOT COMPLETED|Overall Study||0
215859|NCT01224639|522145|P3|NOT COMPLETED|Overall Study||0
215860|NCT01224639|522146|P2|NOT COMPLETED|Overall Study||0
215861|NCT01224639|522147|P1|NOT COMPLETED|Overall Study||0
215862|NCT01224639|522140|P8|COMPLETED|Overall Study||3
215863|NCT01224639|522141|P7|COMPLETED|Overall Study||17
215864|NCT01224639|522142|P6|COMPLETED|Overall Study||4
215865|NCT01224639|522143|P5|COMPLETED|Overall Study||19
215866|NCT01224639|522144|P4|COMPLETED|Overall Study||3
215867|NCT01224639|522145|P3|COMPLETED|Overall Study||21
215868|NCT01224639|522146|P2|COMPLETED|Overall Study||5
215869|NCT01224639|522147|P1|COMPLETED|Overall Study||19
215870|NCT01224639|522140|P8|STARTED|Overall Study||5
215871|NCT01224639|522141|P7|STARTED|Overall Study||18
215872|NCT01224639|522142|P6|STARTED|Overall Study||4
215873|NCT01224639|522143|P5|STARTED|Overall Study||21
215874|NCT01224639|522144|P4|STARTED|Overall Study||3
215875|NCT01224639|522145|P3|STARTED|Overall Study||21
215876|NCT01224639|522146|P2|STARTED|Overall Study||5
215877|NCT01224639|522147|P1|STARTED|Overall Study||19
215878|NCT01224626|522253|P1|NOT COMPLETED|Overall Study||1
215879|NCT01224626|522253|P1|COMPLETED|Overall Study||41
215880|NCT01224626|522253|P1|STARTED|Overall Study||42
215881|NCT01224444|522259|P1|NOT COMPLETED|Overall Study||0
215882|NCT01224444|522259|P1|COMPLETED|Overall Study||269
215883|NCT01224444|522259|P1|STARTED|Overall Study||269
215884|NCT01224431|522265|P2|NOT COMPLETED|Overall Study||5
215885|NCT01224431|522266|P1|NOT COMPLETED|Overall Study||0
215886|NCT01224431|522265|P2|COMPLETED|Overall Study||25
215887|NCT01224431|522266|P1|COMPLETED|Overall Study||30
215888|NCT01224431|522265|P2|STARTED|Overall Study||30
215889|NCT01224431|522266|P1|STARTED|Overall Study||30
215890|NCT01224236|522276|P2|NOT COMPLETED|Overall Study||1
215891|NCT01224236|522277|P1|NOT COMPLETED|Overall Study||1
215892|NCT01224236|522276|P2|COMPLETED|Overall Study||73
215893|NCT01224236|522277|P1|COMPLETED|Overall Study||75
215894|NCT01224236|522276|P2|STARTED|Overall Study||74
215895|NCT01224236|522277|P1|STARTED|Overall Study||76
215896|NCT01224171|522287|P2|NOT COMPLETED|Overall Study||13
215897|NCT01224171|522288|P1|NOT COMPLETED|Overall Study||15
215898|NCT01224171|522287|P2|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|196
215899|NCT01224171|522288|P1|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|192
215900|NCT01224171|522287|P2|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|158
215901|NCT01224171|522288|P1|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|157
215902|NCT01224171|522287|P2|STARTED|Overall Study||209
215903|NCT01224171|522288|P1|STARTED|Overall Study||207
215904|NCT01224015|522311|P3|NOT COMPLETED|Overall Study||13
215905|NCT01224015|522312|P2|NOT COMPLETED|Overall Study||16
215906|NCT01224015|522313|P1|NOT COMPLETED|Overall Study||14
215907|NCT01224015|522311|P3|COMPLETED|Overall Study||83
215908|NCT01224015|522312|P2|COMPLETED|Overall Study||211
215909|NCT01224015|522313|P1|COMPLETED|Overall Study||347
215910|NCT01224015|522311|P3|STARTED|Overall Study||96
215911|NCT01224015|522312|P2|STARTED|Overall Study||227
215912|NCT01224015|522313|P1|STARTED|Overall Study||361
215913|NCT01223963|522321|P1|NOT COMPLETED|Overall Study||0
215914|NCT01223963|522321|P1|COMPLETED|Overall Study||93
215915|NCT01223963|522321|P1|STARTED|Overall Study|All subjects treated between May 1 2008 and Dec 31 2009 in selected clinics were to be asked.|93
215916|NCT01223937|522328|P2|NOT COMPLETED|Overall Study||18
215917|NCT01223937|522329|P1|NOT COMPLETED|Overall Study||17
215918|NCT01223937|522328|P2|COMPLETED|Overall Study||119
215919|NCT01223937|522329|P1|COMPLETED|Overall Study||114
215920|NCT01223937|522328|P2|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|135
215921|NCT01223937|522329|P1|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|126
215922|NCT01223937|522328|P2|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|133
215923|NCT01223937|522329|P1|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|128
215924|NCT01223937|522328|P2|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|137
215925|NCT01223937|522329|P1|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|131
215926|NCT01223703|522353|P2|NOT COMPLETED|Overall Study||0
215927|NCT01223703|522354|P1|NOT COMPLETED|Overall Study||0
215928|NCT01223703|522353|P2|COMPLETED|Overall Study||66
215929|NCT01223703|522354|P1|COMPLETED|Overall Study||67
215930|NCT01223703|522353|P2|STARTED|Overall Study||66
215931|NCT01223703|522354|P1|STARTED|Overall Study||67
215932|NCT01223469|522368|P2|NOT COMPLETED|Overall Study||0
215933|NCT01223469|522369|P1|NOT COMPLETED|Overall Study||0
215934|NCT01223469|522368|P2|COMPLETED|Overall Study||43
215935|NCT01223469|522369|P1|COMPLETED|Overall Study||34
215936|NCT01223469|522368|P2|STARTED|Overall Study||43
215937|NCT01223469|522369|P1|STARTED|Overall Study||34
215938|NCT01223404|522375|P6|NOT COMPLETED|Third Intervention (1 Day)||0
215939|NCT01223404|522376|P5|NOT COMPLETED|Third Intervention (1 Day)||0
215940|NCT01223404|522377|P4|NOT COMPLETED|Third Intervention (1 Day)||1
215941|NCT01223404|522378|P3|NOT COMPLETED|Third Intervention (1 Day)||0
215942|NCT01223404|522379|P2|NOT COMPLETED|Third Intervention (1 Day)||0
215943|NCT01223404|522380|P1|NOT COMPLETED|Third Intervention (1 Day)||0
215944|NCT01223404|522375|P6|COMPLETED|Third Intervention (1 Day)||3
215945|NCT01223404|522376|P5|COMPLETED|Third Intervention (1 Day)||2
215946|NCT01223404|522377|P4|COMPLETED|Third Intervention (1 Day)||3
215947|NCT01223404|522378|P3|COMPLETED|Third Intervention (1 Day)||4
215948|NCT01223404|522379|P2|COMPLETED|Third Intervention (1 Day)||3
215949|NCT01223404|522380|P1|COMPLETED|Third Intervention (1 Day)||3
215950|NCT01223404|522375|P6|STARTED|Third Intervention (1 Day)||3
215951|NCT01223404|522376|P5|STARTED|Third Intervention (1 Day)||2
215952|NCT01223404|522377|P4|STARTED|Third Intervention (1 Day)||4
215953|NCT01223404|522378|P3|STARTED|Third Intervention (1 Day)||4
215954|NCT01223404|522379|P2|STARTED|Third Intervention (1 Day)||3
215955|NCT01223404|522380|P1|STARTED|Third Intervention (1 Day)||3
215956|NCT01223404|522375|P6|NOT COMPLETED|Second Intervention (1 Day)||0
215957|NCT01223404|522376|P5|NOT COMPLETED|Second Intervention (1 Day)||0
215958|NCT01223404|522377|P4|NOT COMPLETED|Second Intervention (1 Day)||0
215959|NCT01223404|522378|P3|NOT COMPLETED|Second Intervention (1 Day)||0
215960|NCT01223404|522379|P2|NOT COMPLETED|Second Intervention (1 Day)||0
215961|NCT01223404|522380|P1|NOT COMPLETED|Second Intervention (1 Day)||1
215962|NCT01223404|522375|P6|COMPLETED|Second Intervention (1 Day)||3
215963|NCT01223404|522376|P5|COMPLETED|Second Intervention (1 Day)||2
215964|NCT01223404|522377|P4|COMPLETED|Second Intervention (1 Day)||4
215965|NCT01223404|522378|P3|COMPLETED|Second Intervention (1 Day)||4
215966|NCT01223404|522379|P2|COMPLETED|Second Intervention (1 Day)||3
215967|NCT01223404|522380|P1|COMPLETED|Second Intervention (1 Day)||3
215968|NCT01223404|522375|P6|STARTED|Second Intervention (1 Day)||3
215969|NCT01223404|522376|P5|STARTED|Second Intervention (1 Day)||2
215970|NCT01223404|522377|P4|STARTED|Second Intervention (1 Day)||4
215971|NCT01223404|522378|P3|STARTED|Second Intervention (1 Day)||4
215972|NCT01223404|522379|P2|STARTED|Second Intervention (1 Day)||3
215973|NCT01223404|522380|P1|STARTED|Second Intervention (1 Day)||4
215974|NCT01223404|522375|P6|NOT COMPLETED|First Intervention (1 Day)||0
215975|NCT01223404|522376|P5|NOT COMPLETED|First Intervention (1 Day)||0
215976|NCT01223404|522377|P4|NOT COMPLETED|First Intervention (1 Day)||1
215977|NCT01223404|522378|P3|NOT COMPLETED|First Intervention (1 Day)||0
215978|NCT01223404|522379|P2|NOT COMPLETED|First Intervention (1 Day)||0
215979|NCT01223404|522380|P1|NOT COMPLETED|First Intervention (1 Day)||0
215980|NCT01223404|522375|P6|COMPLETED|First Intervention (1 Day)||3
215981|NCT01223404|522376|P5|COMPLETED|First Intervention (1 Day)||2
215982|NCT01223404|522377|P4|COMPLETED|First Intervention (1 Day)||4
215983|NCT01223404|522378|P3|COMPLETED|First Intervention (1 Day)||4
215984|NCT01223404|522379|P2|COMPLETED|First Intervention (1 Day)||3
215985|NCT01223404|522380|P1|COMPLETED|First Intervention (1 Day)||4
215986|NCT01223404|522375|P6|STARTED|First Intervention (1 Day)||3
215987|NCT01223404|522376|P5|STARTED|First Intervention (1 Day)||2
215988|NCT01223404|522377|P4|STARTED|First Intervention (1 Day)||5
215989|NCT01223404|522378|P3|STARTED|First Intervention (1 Day)||4
215990|NCT01223404|522379|P2|STARTED|First Intervention (1 Day)||3
215991|NCT01223404|522380|P1|STARTED|First Intervention (1 Day)||4
215992|NCT01223378|522408|P5|NOT COMPLETED|Overall Study||3
215993|NCT01223378|522409|P4|NOT COMPLETED|Overall Study||1
215994|NCT01223378|522410|P3|NOT COMPLETED|Overall Study||3
215995|NCT01223378|522411|P2|NOT COMPLETED|Overall Study||4
215996|NCT01223378|522412|P1|NOT COMPLETED|Overall Study||6
215997|NCT01223378|522408|P5|COMPLETED|Overall Study||79
215998|NCT01223378|522409|P4|COMPLETED|Overall Study||80
215999|NCT01223378|522410|P3|COMPLETED|Overall Study||80
216000|NCT01223378|522411|P2|COMPLETED|Overall Study||81
216001|NCT01223378|522412|P1|COMPLETED|Overall Study||76
216002|NCT01223378|522408|P5|STARTED|Overall Study||82
216003|NCT01223378|522409|P4|STARTED|Overall Study||81
216004|NCT01223378|522410|P3|STARTED|Overall Study||83
216005|NCT01223378|522411|P2|STARTED|Overall Study||85
216006|NCT01223378|522412|P1|STARTED|Overall Study||82
216007|NCT01223365|522444|P1|NOT COMPLETED|Open-label Treatment Period||102
216008|NCT01223365|522444|P1|COMPLETED|Open-label Treatment Period||189
216009|NCT01223365|522444|P1|STARTED|Open-label Treatment Period||291
216010|NCT01223365|522444|P1|NOT COMPLETED|Open-label Titration Period||39
216011|NCT01223365|522444|P1|COMPLETED|Open-label Titration Period||291
216012|NCT01223365|522444|P1|Achieved Stable Pain Relief|Open-label Titration Period||294
216013|NCT01223365|522444|P1|Safety Analysis Set|Open-label Titration Period||329
216014|NCT01223365|522444|P1|STARTED|Open-label Titration Period||330
216015|NCT01223352|522487|P2|NOT COMPLETED|Overall Study||0
216016|NCT01223352|522488|P1|NOT COMPLETED|Overall Study||0
216017|NCT01223352|522487|P2|COMPLETED|Overall Study||33
216018|NCT01223352|522488|P1|COMPLETED|Overall Study||31
216019|NCT01223352|522487|P2|STARTED|Overall Study||33
216020|NCT01223352|522488|P1|STARTED|Overall Study||31
216021|NCT01223235|522508|P1|NOT COMPLETED|Overall Study||1
216022|NCT01223235|522508|P1|COMPLETED|Overall Study||21
216023|NCT01223235|522508|P1|STARTED|Overall Study||22
216024|NCT01223196|522516|P2|NOT COMPLETED|Overall Study||0
216025|NCT01223196|522517|P1|NOT COMPLETED|Overall Study||4
216026|NCT01223196|522516|P2|COMPLETED|Overall Study||11
216027|NCT01223196|522517|P1|COMPLETED|Overall Study||9
216028|NCT01223196|522516|P2|STARTED|Overall Study||11
216029|NCT01223196|522517|P1|STARTED|Overall Study||13
216030|NCT01223183|522529|P2|NOT COMPLETED|Imaging Day 2||0
216031|NCT01223183|522530|P1|NOT COMPLETED|Imaging Day 2||0
216032|NCT01223183|522529|P2|COMPLETED|Imaging Day 2||9
216033|NCT01223183|522530|P1|COMPLETED|Imaging Day 2||8
216034|NCT01223183|522529|P2|STARTED|Imaging Day 2||9
216035|NCT01223183|522530|P1|STARTED|Imaging Day 2||8
216036|NCT01223183|522529|P2|NOT COMPLETED|Washout Period (5-24 Days)||0
216037|NCT01223183|522530|P1|NOT COMPLETED|Washout Period (5-24 Days)||2
216038|NCT01223183|522529|P2|COMPLETED|Washout Period (5-24 Days)||9
216039|NCT01223183|522530|P1|COMPLETED|Washout Period (5-24 Days)||8
216040|NCT01223183|522529|P2|STARTED|Washout Period (5-24 Days)||9
216041|NCT01223183|522530|P1|STARTED|Washout Period (5-24 Days)||10
216042|NCT01223183|522529|P2|NOT COMPLETED|Imaging Day 1||1
216043|NCT01223183|522530|P1|NOT COMPLETED|Imaging Day 1||0
216044|NCT01223183|522529|P2|COMPLETED|Imaging Day 1||9
216045|NCT01223183|522530|P1|COMPLETED|Imaging Day 1||10
216046|NCT01223183|522529|P2|STARTED|Imaging Day 1||10
216047|NCT01223183|522530|P1|STARTED|Imaging Day 1||10
216048|NCT01223027|522540|P2|NOT COMPLETED|Overall Study||277
216049|NCT01223027|522541|P1|NOT COMPLETED|Overall Study||274
216050|NCT01223027|522540|P2|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|9
216051|NCT01223027|522541|P1|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|10
216052|NCT01223027|522540|P2|STARTED|Overall Study||286
216053|NCT01223027|522541|P1|STARTED|Overall Study||284
216054|NCT01223001|522564|P2|NOT COMPLETED|Overall Study||4
216055|NCT01223001|522565|P1|NOT COMPLETED|Overall Study||4
216056|NCT01223001|522564|P2|COMPLETED|Overall Study||0
216057|NCT01223001|522565|P1|COMPLETED|Overall Study||0
216058|NCT01223001|522564|P2|STARTED|Overall Study||4
216059|NCT01223001|522565|P1|STARTED|Overall Study||4
216060|NCT01222884|522573|P2|NOT COMPLETED|Overall Study||4
216061|NCT01222884|522574|P1|NOT COMPLETED|Overall Study||24
216062|NCT01222884|522573|P2|COMPLETED|Overall Study||113
216063|NCT01222884|522574|P1|COMPLETED|Overall Study||210
216064|NCT01222884|522573|P2|STARTED|Overall Study||117
216065|NCT01222884|522574|P1|STARTED|Overall Study||234
216066|NCT01222871|522584|P2|NOT COMPLETED|Overall Study||0
216067|NCT01222871|522585|P1|NOT COMPLETED|Overall Study||0
216068|NCT01222871|522584|P2|COMPLETED|Overall Study||0
216069|NCT01222871|522585|P1|COMPLETED|Overall Study||0
216070|NCT01222871|522584|P2|STARTED|Overall Study||0
216071|NCT01222871|522585|P1|STARTED|Overall Study||0
216072|NCT01222832|522594|P2|NOT COMPLETED|Overall Study||1
216073|NCT01222832|522595|P1|NOT COMPLETED|Overall Study||0
216074|NCT01222832|522594|P2|COMPLETED|Overall Study||112
216075|NCT01222832|522595|P1|COMPLETED|Overall Study||113
216076|NCT01222832|522594|P2|STARTED|Overall Study||113
216077|NCT01222832|522595|P1|STARTED|Overall Study||113
216078|NCT01222715|522603|P2|NOT COMPLETED|Overall Study||27
216079|NCT01222715|522604|P1|NOT COMPLETED|Overall Study||36
216080|NCT01222715|522603|P2|COMPLETED|Overall Study||16
216081|NCT01222715|522604|P1|COMPLETED|Overall Study||8
216082|NCT01222715|522603|P2|STARTED|Overall Study||43
216083|NCT01222715|522604|P1|STARTED|Overall Study||44
216084|NCT01222689|522614|P1|NOT COMPLETED|Overall Study||0
216085|NCT01222689|522614|P1|COMPLETED|Overall Study||46
216086|NCT01222689|522614|P1|STARTED|Overall Study||46
216087|NCT01222585|522627|P1|NOT COMPLETED|Overall Study||0
216088|NCT01222585|522627|P1|COMPLETED|Overall Study||24
216089|NCT01222585|522627|P1|STARTED|Overall Study||24
216090|NCT01222572|522637|P3|NOT COMPLETED|Overall Study||0
216091|NCT01222572|522638|P2|NOT COMPLETED|Overall Study||0
216092|NCT01222572|522639|P1|NOT COMPLETED|Overall Study||0
216093|NCT01222572|522637|P3|COMPLETED|Overall Study||0
216094|NCT01222572|522638|P2|COMPLETED|Overall Study||0
216095|NCT01222572|522639|P1|COMPLETED|Overall Study||1
216096|NCT01222572|522637|P3|STARTED|Overall Study||0
216097|NCT01222572|522638|P2|STARTED|Overall Study||0
216098|NCT01222572|522639|P1|STARTED|Overall Study||1
216099|NCT01222533|522643|P1|NOT COMPLETED|Overall Study||14
216100|NCT01222533|522643|P1|COMPLETED|Overall Study|Completed planned observation time (week 21)|140
216101|NCT01222533|522643|P1|Received Tio HH18|Overall Study||146
216102|NCT01222533|522643|P1|Received Tio R5|Overall Study||150
216103|NCT01222533|522643|P1|Received Tio R2.5|Overall Study||145
216104|NCT01222533|522643|P1|Received Tio R1.25|Overall Study||147
216105|NCT01222533|522643|P1|Received Placebo|Overall Study||147
216106|NCT01222533|522643|P1|STARTED|Overall Study|Entered and treated.|154
216107|NCT01222520|522782|P2|NOT COMPLETED|Double-blind Period||2
216108|NCT01222520|522783|P1|NOT COMPLETED|Double-blind Period||1
216109|NCT01222520|522782|P2|COMPLETED|Double-blind Period||85
216110|NCT01222520|522783|P1|COMPLETED|Double-blind Period||86
216111|NCT01222520|522782|P2|STARTED|Double-blind Period||87
216112|NCT01222520|522783|P1|STARTED|Double-blind Period||87
216113|NCT01222520|522782|P2|NOT COMPLETED|Open-label run-in Period||23
216114|NCT01222520|522783|P1|NOT COMPLETED|Open-label run-in Period||0
216115|NCT01222520|522782|P2|COMPLETED|Open-label run-in Period||174
216116|NCT01222520|522783|P1|COMPLETED|Open-label run-in Period||0
216117|NCT01222520|522782|P2|STARTED|Open-label run-in Period||197
216118|NCT01222520|522783|P1|STARTED|Open-label run-in Period||0
216119|NCT01222507|522801|P1|NOT COMPLETED|Overall Study||2
216120|NCT01222507|522801|P1|COMPLETED|Overall Study||60
216121|NCT01222507|522801|P1|STARTED|Overall Study||62
216122|NCT01222494|522808|P3|NOT COMPLETED|Overall Study||4
216123|NCT01222494|522809|P2|NOT COMPLETED|Overall Study||4
216124|NCT01222494|522810|P1|NOT COMPLETED|Overall Study||1
216125|NCT01222494|522808|P3|COMPLETED|Overall Study||17
216126|NCT01222494|522809|P2|COMPLETED|Overall Study||15
216127|NCT01222494|522810|P1|COMPLETED|Overall Study||6
216128|NCT01222494|522808|P3|STARTED|Overall Study||21
216129|NCT01222494|522809|P2|STARTED|Overall Study||19
216130|NCT01222494|522810|P1|STARTED|Overall Study||7
216131|NCT01222416|522829|P2|NOT COMPLETED|Overall Study||0
216132|NCT01222416|522830|P1|NOT COMPLETED|Overall Study||20
216133|NCT01222416|522829|P2|COMPLETED|Overall Study||0
216134|NCT01222416|522830|P1|COMPLETED|Overall Study||30
216135|NCT01222416|522829|P2|STARTED|Overall Study||0
216136|NCT01222416|522830|P1|STARTED|Overall Study||50
216137|NCT01222403|522840|P2|NOT COMPLETED|Overall Study||2
216138|NCT01222403|522841|P1|NOT COMPLETED|Overall Study||0
216139|NCT01222403|522840|P2|COMPLETED|Overall Study||379
216140|NCT01222403|522841|P1|COMPLETED|Overall Study||386
216141|NCT01222403|522840|P2|STARTED|Overall Study||381
216142|NCT01222403|522841|P1|STARTED|Overall Study||386
216143|NCT01222390|522851|P1|NOT COMPLETED|Overall Study||0
216144|NCT01222390|522851|P1|COMPLETED|Overall Study||12
216145|NCT01222390|522851|P1|STARTED|Overall Study||12
216146|NCT01222286|522857|P2|NOT COMPLETED|Overall Study||0
216147|NCT01222286|522858|P1|NOT COMPLETED|Overall Study||0
216148|NCT01222286|522857|P2|COMPLETED|Overall Study||14
216149|NCT01222286|522858|P1|COMPLETED|Overall Study||16
216150|NCT01222286|522857|P2|STARTED|Overall Study||14
216151|NCT01222286|522858|P1|STARTED|Overall Study||16
216152|NCT01222273|522870|P1|NOT COMPLETED|Overall Study||0
216153|NCT01222273|522870|P1|COMPLETED|Overall Study||7
216154|NCT01222273|522870|P1|STARTED|Overall Study||7
216155|NCT01222247|522878|P2|NOT COMPLETED|Overall Study||2
216156|NCT01222247|522879|P1|NOT COMPLETED|Overall Study||2
216157|NCT01222247|522878|P2|COMPLETED|Overall Study||1400
216158|NCT01222247|522879|P1|COMPLETED|Overall Study||1427
216159|NCT01222247|522878|P2|Did Not Receive Assigned Medication|Overall Study||5
216160|NCT01222247|522879|P1|Did Not Receive Assigned Medication|Overall Study||1
216161|NCT01222247|522878|P2|Received 1 Dose|Overall Study||571
216162|NCT01222247|522879|P1|Received 1 Dose|Overall Study||568
216163|NCT01222247|522878|P2|Received 2 Doses|Overall Study||826
216164|NCT01222247|522879|P1|Received 2 Doses|Overall Study||860
216165|NCT01222247|522878|P2|STARTED|Overall Study||1402
216166|NCT01222247|522879|P1|STARTED|Overall Study||1429
216167|NCT01222234|522944|P3|NOT COMPLETED|Overall Study||2
216168|NCT01222234|522945|P2|NOT COMPLETED|Overall Study||2
216169|NCT01222234|522946|P1|NOT COMPLETED|Overall Study||0
216170|NCT01222234|522944|P3|COMPLETED|Overall Study||22
216171|NCT01222234|522945|P2|COMPLETED|Overall Study||15
216172|NCT01222234|522946|P1|COMPLETED|Overall Study||15
216173|NCT01222234|522944|P3|STARTED|Overall Study||24
216174|NCT01222234|522945|P2|STARTED|Overall Study||17
216175|NCT01222234|522946|P1|STARTED|Overall Study||15
216176|NCT01222195|522955|P1|NOT COMPLETED|Overall Study||0
216177|NCT01222195|522955|P1|COMPLETED|Overall Study||1
216178|NCT01222195|522955|P1|STARTED|Overall Study||1
216179|NCT01222117|522970|P11|NOT COMPLETED|Overall Study||0
216180|NCT01222117|522971|P10|NOT COMPLETED|Overall Study||2
216181|NCT01222117|522972|P9|NOT COMPLETED|Overall Study||3
216182|NCT01222117|522973|P8|NOT COMPLETED|Overall Study||0
216183|NCT01222117|522974|P7|NOT COMPLETED|Overall Study||0
216184|NCT01222117|522975|P6|NOT COMPLETED|Overall Study||1
216185|NCT01222117|522976|P5|NOT COMPLETED|Overall Study||1
216186|NCT01222117|522977|P4|NOT COMPLETED|Overall Study||1
216187|NCT01222117|522978|P3|NOT COMPLETED|Overall Study||0
216188|NCT01222117|522979|P2|NOT COMPLETED|Overall Study||1
216189|NCT01222117|522980|P1|NOT COMPLETED|Overall Study||3
216190|NCT01222117|522970|P11|COMPLETED|Overall Study||6
216191|NCT01222117|522971|P10|COMPLETED|Overall Study||17
216192|NCT01222117|522972|P9|COMPLETED|Overall Study||20
216193|NCT01222117|522973|P8|COMPLETED|Overall Study||12
216194|NCT01222117|522974|P7|COMPLETED|Overall Study||13
216195|NCT01222117|522975|P6|COMPLETED|Overall Study||9
216196|NCT01222117|522976|P5|COMPLETED|Overall Study||8
216197|NCT01222117|522977|P4|COMPLETED|Overall Study||19
216198|NCT01222117|522978|P3|COMPLETED|Overall Study||22
216199|NCT01222117|522979|P2|COMPLETED|Overall Study||19
216200|NCT01222117|522980|P1|COMPLETED|Overall Study||17
216201|NCT01222117|522970|P11|STARTED|Overall Study||6
216202|NCT01222117|522971|P10|STARTED|Overall Study||19
216203|NCT01222117|522972|P9|STARTED|Overall Study||23
216204|NCT01222117|522973|P8|STARTED|Overall Study||12
216205|NCT01222117|522974|P7|STARTED|Overall Study||13
216206|NCT01222117|522975|P6|STARTED|Overall Study||10
216207|NCT01222117|522976|P5|STARTED|Overall Study||9
216208|NCT01222117|522977|P4|STARTED|Overall Study||20
216209|NCT01222117|522978|P3|STARTED|Overall Study||22
216210|NCT01222117|522979|P2|STARTED|Overall Study||20
216211|NCT01222117|522980|P1|STARTED|Overall Study||20
216212|NCT01222104|523015|P1|NOT COMPLETED|Overall Study||47
216213|NCT01222104|523015|P1|COMPLETED|Overall Study||587
216214|NCT01222104|523015|P1|Completed 30-day Visit-No Angio-Seal|Overall Study||90
216215|NCT01222104|523015|P1|Completed 30-day Visit-Angio-Seal|Overall Study||497
216216|NCT01222104|523015|P1|Successful Deployment and Hemostasis|Overall Study||524
216217|NCT01222104|523015|P1|Successful Deployment|Overall Study||529
216218|NCT01222104|523015|P1|Angio-Seal Deployment Attempted|Overall Study||534
216219|NCT01222104|523015|P1|STARTED|Overall Study||634
216220|NCT01222091|523029|P2|NOT COMPLETED|Overall Study||0
216221|NCT01222091|523030|P1|NOT COMPLETED|Overall Study||0
216222|NCT01222091|523029|P2|COMPLETED|Overall Study||5
216223|NCT01222091|523030|P1|COMPLETED|Overall Study||5
216224|NCT01222091|523029|P2|STARTED|Overall Study||5
216225|NCT01222091|523030|P1|STARTED|Overall Study||5
216226|NCT01222078|523038|P1|NOT COMPLETED|Overall Study||1
216227|NCT01222078|523038|P1|COMPLETED|Overall Study||0
216228|NCT01222078|523038|P1|STARTED|Overall Study||1
216229|NCT01221948|523072|P1|NOT COMPLETED|Overall Study||14
216230|NCT01221948|523072|P1|COMPLETED|Overall Study||39
216231|NCT01221948|523072|P1|STARTED|Overall Study||53
216232|NCT01221857|523083|P1|NOT COMPLETED|Overall Study||0
216233|NCT01221857|523083|P1|COMPLETED|Overall Study||12
216234|NCT01221857|523083|P1|STARTED|Overall Study||12
216235|NCT01221753|523091|P1|NOT COMPLETED|Overall Study||1
216236|NCT01221753|523091|P1|COMPLETED|Overall Study||6
216237|NCT01221753|523091|P1|STARTED|Overall Study||7
216238|NCT01221727|523098|P2|NOT COMPLETED|Overall Study||1
216239|NCT01221727|523099|P1|NOT COMPLETED|Overall Study||3
216240|NCT01221727|523098|P2|COMPLETED|Overall Study||8
216241|NCT01221727|523099|P1|COMPLETED|Overall Study||18
216242|NCT01221727|523098|P2|Treated|Overall Study|Number of subjects received investigational product|8
216243|NCT01221727|523099|P1|Treated|Overall Study|Number of subjects received investigational product|19
216244|NCT01221727|523098|P2|STARTED|Overall Study|Number of subjects randomized into the study|9
216245|NCT01221727|523099|P1|STARTED|Overall Study|Number of subjects randomized into the study|21
216246|NCT01221623|523120|P2|NOT COMPLETED|Overall Study||14
216247|NCT01221623|523121|P1|NOT COMPLETED|Overall Study||38
216248|NCT01221623|523120|P2|COMPLETED|Overall Study||127
216249|NCT01221623|523121|P1|COMPLETED|Overall Study||236
216250|NCT01221623|523120|P2|STARTED|Overall Study||141
216251|NCT01221623|523121|P1|STARTED|Overall Study||274
216252|NCT01221597|523145|P2|NOT COMPLETED|Overall Study||16
216253|NCT01221597|523146|P1|NOT COMPLETED|Overall Study||36
216254|NCT01221597|523145|P2|COMPLETED|Overall Study||124
216255|NCT01221597|523146|P1|COMPLETED|Overall Study||241
216256|NCT01221597|523145|P2|STARTED|Overall Study||140
216257|NCT01221597|523146|P1|STARTED|Overall Study||277
216258|NCT01221441|523170|P2|NOT COMPLETED|Overall Study||12
216259|NCT01221441|523171|P1|NOT COMPLETED|Overall Study||22
216260|NCT01221441|523170|P2|COMPLETED|Overall Study||23
216261|NCT01221441|523171|P1|COMPLETED|Overall Study||45
216262|NCT01221441|523170|P2|STARTED|Overall Study||35
216263|NCT01221441|523171|P1|STARTED|Overall Study||67
216264|NCT01221363|523203|P2|NOT COMPLETED|Overall Study||5
216265|NCT01221363|523204|P1|NOT COMPLETED|Overall Study||12
216266|NCT01221363|523203|P2|COMPLETED|Overall Study||68
216267|NCT01221363|523204|P1|COMPLETED|Overall Study||81
216268|NCT01221363|523203|P2|STARTED|Overall Study||73
216269|NCT01221363|523204|P1|STARTED|Overall Study||93
216270|NCT01221350|523214|P2|NOT COMPLETED|Overall Study||3
216271|NCT01221350|523215|P1|NOT COMPLETED|Overall Study||5
216272|NCT01221350|523214|P2|COMPLETED|Overall Study||24
216273|NCT01221350|523215|P1|COMPLETED|Overall Study||23
216274|NCT01221350|523214|P2|Analysis Population|Overall Study||24
216275|NCT01221350|523215|P1|Analysis Population|Overall Study||23
216276|NCT01221350|523214|P2|Received Intervention|Overall Study||27
216277|NCT01221350|523215|P1|Received Intervention|Overall Study||28
216278|NCT01221350|523214|P2|STARTED|Overall Study||27
216279|NCT01221350|523215|P1|STARTED|Overall Study||28
216280|NCT01221311|523257|P2|NOT COMPLETED|Overall Study||0
216281|NCT01221311|523258|P1|NOT COMPLETED|Overall Study||0
216282|NCT01221311|523257|P2|COMPLETED|Overall Study||55
216283|NCT01221311|523258|P1|COMPLETED|Overall Study||57
216284|NCT01221311|523257|P2|STARTED|Overall Study||55
216285|NCT01221311|523258|P1|STARTED|Overall Study||57
216286|NCT01221298|523264|P1|NOT COMPLETED|Overall Study||0
216287|NCT01221298|523264|P1|COMPLETED|Overall Study|The number of participants who completed study drug|11
216288|NCT01221298|523264|P1|STARTED|Overall Study||11
216289|NCT01221285|523274|P1|NOT COMPLETED|Overall Study||1
216290|NCT01221285|523274|P1|COMPLETED|Overall Study||10
216291|NCT01221285|523274|P1|STARTED|Overall Study||11
216292|NCT01221272|523283|P2|NOT COMPLETED|Period 2||2
216293|NCT01221272|523284|P1|NOT COMPLETED|Period 2||0
216294|NCT01221272|523283|P2|COMPLETED|Period 2||37
216295|NCT01221272|523284|P1|COMPLETED|Period 2||39
216296|NCT01221272|523283|P2|STARTED|Period 2|1 participant did not complete Period 1, but started and completed Period 2.|39
216297|NCT01221272|523284|P1|STARTED|Period 2||39
216298|NCT01221272|523283|P2|NOT COMPLETED|Period 1||2
216299|NCT01221272|523284|P1|NOT COMPLETED|Period 1||2
216300|NCT01221272|523283|P2|COMPLETED|Period 1||38
216301|NCT01221272|523284|P1|COMPLETED|Period 1||39
216302|NCT01221272|523283|P2|STARTED|Period 1||40
216303|NCT01221272|523284|P1|STARTED|Period 1||41
216304|NCT01221233|523301|P2|NOT COMPLETED|Overall Study||1
216305|NCT01221233|523302|P1|NOT COMPLETED|Overall Study||3
216306|NCT01221233|523301|P2|COMPLETED|Overall Study||19
216307|NCT01221233|523302|P1|COMPLETED|Overall Study||15
216308|NCT01221233|523301|P2|STARTED|Overall Study||20
216309|NCT01221233|523302|P1|STARTED|Overall Study||18
216310|NCT01221181|523308|P1|NOT COMPLETED|Overall Study||1
216311|NCT01221181|523308|P1|COMPLETED|Overall Study||5
216312|NCT01221181|523308|P1|STARTED|Overall Study||6
216313|NCT01221090|523316|P4|NOT COMPLETED|Overall Study||22
216314|NCT01221090|523317|P3|NOT COMPLETED|Overall Study||42
216315|NCT01221090|523318|P2|NOT COMPLETED|Overall Study||34
216316|NCT01221090|523319|P1|NOT COMPLETED|Overall Study||15
216317|NCT01221090|523316|P4|COMPLETED|Overall Study||73
216318|NCT01221090|523317|P3|COMPLETED|Overall Study||57
216319|NCT01221090|523318|P2|COMPLETED|Overall Study||47
216320|NCT01221090|523319|P1|COMPLETED|Overall Study||86
216321|NCT01221090|523316|P4|STARTED|Overall Study||95
216322|NCT01221090|523317|P3|STARTED|Overall Study||99
216323|NCT01221090|523318|P2|STARTED|Overall Study||81
216324|NCT01221090|523319|P1|STARTED|Overall Study||101
216325|NCT01220999|523350|P5|NOT COMPLETED|Overall Study||0
216326|NCT01220999|523351|P4|NOT COMPLETED|Overall Study||0
216327|NCT01220999|523352|P3|NOT COMPLETED|Overall Study||1
216328|NCT01220999|523353|P2|NOT COMPLETED|Overall Study||0
216329|NCT01220999|523354|P1|NOT COMPLETED|Overall Study||0
216330|NCT01220999|523350|P5|COMPLETED|Overall Study||5
216331|NCT01220999|523351|P4|COMPLETED|Overall Study||3
216332|NCT01220999|523352|P3|COMPLETED|Overall Study||4
216333|NCT01220999|523353|P2|COMPLETED|Overall Study||4
216334|NCT01220999|523354|P1|COMPLETED|Overall Study||2
216335|NCT01220999|523350|P5|STARTED|Overall Study||5
216336|NCT01220999|523351|P4|STARTED|Overall Study||3
216337|NCT01220999|523352|P3|STARTED|Overall Study||5
216338|NCT01220999|523353|P2|STARTED|Overall Study||4
216339|NCT01220999|523354|P1|STARTED|Overall Study||2
216340|NCT01220973|523431|P1|NOT COMPLETED|Overall Study||4
216341|NCT01220973|523431|P1|COMPLETED|Overall Study||23
216342|NCT01220973|523431|P1|STARTED|Overall Study||27
216343|NCT01220869|523435|P1|NOT COMPLETED|Overall Study||6
216344|NCT01220869|523435|P1|COMPLETED|Overall Study||104
216345|NCT01220869|523435|P1|STARTED|Overall Study||110
216346|NCT01220739|523445|P2|NOT COMPLETED|Overall Study||0
216347|NCT01220739|523446|P1|NOT COMPLETED|Overall Study||0
216348|NCT01220739|523445|P2|COMPLETED|Overall Study||5
216349|NCT01220739|523446|P1|COMPLETED|Overall Study||7
216350|NCT01220739|523445|P2|STARTED|Overall Study||5
216351|NCT01220739|523446|P1|STARTED|Overall Study||7
216352|NCT01220726|523456|P2|NOT COMPLETED|Overall Study||2
216353|NCT01220726|523457|P1|NOT COMPLETED|Overall Study||0
216354|NCT01220726|523456|P2|COMPLETED|Overall Study||13
216355|NCT01220726|523457|P1|COMPLETED|Overall Study||15
216356|NCT01220726|523456|P2|STARTED|Overall Study||15
216357|NCT01220726|523457|P1|STARTED|Overall Study||15
216358|NCT01220609|523475|P1|NOT COMPLETED|Overall Study||3
216359|NCT01220609|523475|P1|COMPLETED|Overall Study|Eligible and treated patients|23
216360|NCT01220609|523475|P1|STARTED|Overall Study||26
216361|NCT01220557|523489|P2|NOT COMPLETED|Overall Study||5
216362|NCT01220557|523490|P1|NOT COMPLETED|Overall Study||6
216363|NCT01220557|523489|P2|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|74
216364|NCT01220557|523490|P1|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|75
216365|NCT01220557|523489|P2|STARTED|Overall Study||79
216366|NCT01220557|523490|P1|STARTED|Overall Study||81
216367|NCT01220466|523499|P3|NOT COMPLETED|Overall Study||0
216368|NCT01220466|523500|P2|NOT COMPLETED|Overall Study||0
216369|NCT01220466|523501|P1|NOT COMPLETED|Overall Study||0
216370|NCT01220466|523499|P3|COMPLETED|Overall Study|16 eyes|10
216371|NCT01220466|523500|P2|COMPLETED|Overall Study|108 eyes|56
216372|NCT01220466|523501|P1|COMPLETED|Overall Study|19 eyes|11
216373|NCT01220466|523499|P3|STARTED|Overall Study|16 eyes|10
216374|NCT01220466|523500|P2|STARTED|Overall Study|108 eyes|56
216375|NCT01220466|523501|P1|STARTED|Overall Study|19 eyes|11
216376|NCT01220414|523523|P4|NOT COMPLETED|Overall Study||1
216377|NCT01220414|523524|P3|NOT COMPLETED|Overall Study||0
216378|NCT01220414|523525|P2|NOT COMPLETED|Overall Study||0
216379|NCT01220414|523526|P1|NOT COMPLETED|Overall Study||1
216380|NCT01220414|523523|P4|COMPLETED|Overall Study||14
216381|NCT01220414|523524|P3|COMPLETED|Overall Study||14
216382|NCT01220414|523525|P2|COMPLETED|Overall Study||14
216383|NCT01220414|523526|P1|COMPLETED|Overall Study||14
216384|NCT01220414|523523|P4|STARTED|Overall Study||15
216385|NCT01220414|523524|P3|STARTED|Overall Study||14
216386|NCT01220414|523525|P2|STARTED|Overall Study||14
216387|NCT01220414|523526|P1|STARTED|Overall Study||15
216388|NCT01220401|523533|P1|NOT COMPLETED|Overall Study||3
216389|NCT01220401|523533|P1|COMPLETED|Overall Study||18
216390|NCT01220401|523533|P1|STARTED|Overall Study||21
216391|NCT01220297|523542|P1|NOT COMPLETED|Overall Study||3
216392|NCT01220297|523542|P1|COMPLETED|Overall Study||0
216393|NCT01220297|523542|P1|STARTED|Overall Study||3
216394|NCT01220180|523559|P1|NOT COMPLETED|Overall Study||207
216395|NCT01220180|523559|P1|COMPLETED|Overall Study||3968
216396|NCT01220180|523559|P1|Treated|Overall Study||4174
216397|NCT01220180|523559|P1|STARTED|Overall Study||4175
216398|NCT01220128|523589|P7|NOT COMPLETED|Overall Study||5
216399|NCT01220128|523590|P6|NOT COMPLETED|Overall Study||0
216400|NCT01220128|523591|P5|NOT COMPLETED|Overall Study||0
216401|NCT01220128|523592|P4|NOT COMPLETED|Overall Study||0
216402|NCT01220128|523593|P3|NOT COMPLETED|Overall Study||3
216403|NCT01220128|523594|P2|NOT COMPLETED|Overall Study||1
216404|NCT01220128|523595|P1|NOT COMPLETED|Overall Study||4
216405|NCT01220128|523589|P7|COMPLETED|Overall Study||3
216406|NCT01220128|523590|P6|COMPLETED|Overall Study||4
216407|NCT01220128|523591|P5|COMPLETED|Overall Study||11
216408|NCT01220128|523592|P4|COMPLETED|Overall Study||6
216409|NCT01220128|523593|P3|COMPLETED|Overall Study||6
216410|NCT01220128|523594|P2|COMPLETED|Overall Study||6
216411|NCT01220128|523595|P1|COMPLETED|Overall Study||11
216412|NCT01220128|523589|P7|STARTED|Overall Study||8
216413|NCT01220128|523590|P6|STARTED|Overall Study||4
216414|NCT01220128|523591|P5|STARTED|Overall Study||11
216415|NCT01220128|523592|P4|STARTED|Overall Study||6
216416|NCT01220128|523593|P3|STARTED|Overall Study||9
216417|NCT01220128|523594|P2|STARTED|Overall Study||7
216418|NCT01220128|523595|P1|STARTED|Overall Study||15
216419|NCT01219985|523800|P1|NOT COMPLETED|Overall Study||20
216420|NCT01219985|523800|P1|COMPLETED|Overall Study||30
216421|NCT01219985|523800|P1|STARTED|Overall Study||50
216422|NCT01219959|523808|P2|NOT COMPLETED|Overall Study||23
216423|NCT01219959|523809|P1|NOT COMPLETED|Overall Study||7
216424|NCT01219959|523808|P2|COMPLETED|Overall Study||101
216425|NCT01219959|523809|P1|COMPLETED|Overall Study||120
216426|NCT01219959|523808|P2|STARTED|Overall Study||124
216427|NCT01219959|523809|P1|STARTED|Overall Study||127
216428|NCT01219933|523857|P1|NOT COMPLETED|Overall Study||38
216429|NCT01219933|523857|P1|COMPLETED|Overall Study||30
216430|NCT01219933|523857|P1|STARTED|Overall Study||68
216431|NCT01219881|523896|P2|NOT COMPLETED|Overall Study||5
216432|NCT01219881|523897|P1|NOT COMPLETED|Overall Study||4
216433|NCT01219881|523896|P2|COMPLETED|Overall Study||32
216434|NCT01219881|523897|P1|COMPLETED|Overall Study||34
216435|NCT01219881|523896|P2|STARTED|Overall Study||37
216436|NCT01219881|523897|P1|STARTED|Overall Study||38
216437|NCT01219855|523914|P5|NOT COMPLETED|Overall Study||1
216438|NCT01219855|523915|P4|NOT COMPLETED|Overall Study||1
216439|NCT01219855|523916|P3|NOT COMPLETED|Overall Study||1
216440|NCT01219855|523917|P2|NOT COMPLETED|Overall Study||5
216441|NCT01219855|523918|P1|NOT COMPLETED|Overall Study||1
216442|NCT01219855|523914|P5|COMPLETED|Overall Study||13
216443|NCT01219855|523915|P4|COMPLETED|Overall Study||12
216444|NCT01219855|523916|P3|COMPLETED|Overall Study||16
216445|NCT01219855|523917|P2|COMPLETED|Overall Study||12
216446|NCT01219855|523918|P1|COMPLETED|Overall Study||16
216447|NCT01219855|523914|P5|STARTED|Overall Study||14
216448|NCT01219855|523915|P4|STARTED|Overall Study||13
216449|NCT01219855|523916|P3|STARTED|Overall Study||17
216450|NCT01219855|523917|P2|STARTED|Overall Study||17
216451|NCT01219855|523918|P1|STARTED|Overall Study||17
216452|NCT01219777|523954|P1|NOT COMPLETED|Overall Study||0
216453|NCT01219777|523954|P1|COMPLETED|Overall Study||9
216454|NCT01219777|523954|P1|STARTED|Overall Study||9
216455|NCT01219738|523959|P1|NOT COMPLETED|Overall Study||0
216456|NCT01219738|523959|P1|COMPLETED|Overall Study||20
216457|NCT01219738|523959|P1|Budesonide 720- 4 Times|Overall Study||20
216458|NCT01219738|523959|P1|Budesonide 1440|Overall Study||20
216459|NCT01219738|523959|P1|Budesonide 720|Overall Study||20
216460|NCT01219738|523959|P1|Budesonide 360|Overall Study||20
216461|NCT01219738|523959|P1|STARTED|Overall Study||20
216462|NCT01219673|523980|P8|NOT COMPLETED|Overall Study||0
216463|NCT01219673|523981|P7|NOT COMPLETED|Overall Study||0
216464|NCT01219673|523982|P6|NOT COMPLETED|Overall Study||0
216465|NCT01219673|523983|P5|NOT COMPLETED|Overall Study||0
216466|NCT01219673|523984|P4|NOT COMPLETED|Overall Study||0
216467|NCT01219673|523985|P3|NOT COMPLETED|Overall Study||0
216468|NCT01219673|523986|P2|NOT COMPLETED|Overall Study||0
216469|NCT01219673|523987|P1|NOT COMPLETED|Overall Study||0
216470|NCT01219673|523980|P8|COMPLETED|Overall Study||0
216471|NCT01219673|523981|P7|COMPLETED|Overall Study||0
216472|NCT01219673|523982|P6|COMPLETED|Overall Study||0
216473|NCT01219673|523983|P5|COMPLETED|Overall Study||0
216474|NCT01219673|523984|P4|COMPLETED|Overall Study||0
216475|NCT01219673|523985|P3|COMPLETED|Overall Study||1
216476|NCT01219673|523986|P2|COMPLETED|Overall Study||0
216477|NCT01219673|523987|P1|COMPLETED|Overall Study||0
216478|NCT01219673|523980|P8|STARTED|Overall Study||0
216479|NCT01219673|523981|P7|STARTED|Overall Study||0
216480|NCT01219673|523982|P6|STARTED|Overall Study||0
216481|NCT01219673|523983|P5|STARTED|Overall Study||0
216482|NCT01219673|523984|P4|STARTED|Overall Study||0
216483|NCT01219673|523985|P3|STARTED|Overall Study||1
216484|NCT01219673|523986|P2|STARTED|Overall Study||0
216485|NCT01219673|523987|P1|STARTED|Overall Study||0
216486|NCT01218997|524007|P2|NOT COMPLETED|Overall Study||41
216487|NCT01218997|524008|P1|NOT COMPLETED|Overall Study||245
216488|NCT01218997|524007|P2|COMPLETED|Overall Study||24
216489|NCT01218997|524008|P1|COMPLETED|Overall Study||126
216490|NCT01218997|524007|P2|STARTED|Overall Study||65
216491|NCT01218997|524008|P1|STARTED|Overall Study||371
216492|NCT01218984|524017|P3|NOT COMPLETED|Overall Study||3
216493|NCT01218984|524018|P2|NOT COMPLETED|Overall Study||2
216494|NCT01218984|524019|P1|NOT COMPLETED|Overall Study||1
216495|NCT01218984|524017|P3|COMPLETED|Overall Study||7
216496|NCT01218984|524018|P2|COMPLETED|Overall Study||6
216497|NCT01218984|524019|P1|COMPLETED|Overall Study||8
216498|NCT01218984|524017|P3|STARTED|Overall Study||10
216499|NCT01218984|524018|P2|STARTED|Overall Study||8
216500|NCT01218984|524019|P1|STARTED|Overall Study||9
216501|NCT01218971|524029|P2|NOT COMPLETED|Overall Study||80
216502|NCT01218971|524030|P1|NOT COMPLETED|Overall Study||104
216503|NCT01218971|524029|P2|COMPLETED|Overall Study||77
216504|NCT01218971|524030|P1|COMPLETED|Overall Study||71
216505|NCT01218971|524029|P2|STARTED|Overall Study||157
216506|NCT01218971|524030|P1|STARTED|Overall Study||175
216507|NCT01218958|524043|P3|NOT COMPLETED|Overall Study||81
216508|NCT01218958|524044|P2|NOT COMPLETED|Overall Study||81
216509|NCT01218958|524045|P1|NOT COMPLETED|Overall Study||84
216510|NCT01218958|524043|P3|COMPLETED|Overall Study||128
216511|NCT01218958|524044|P2|COMPLETED|Overall Study||124
216512|NCT01218958|524045|P1|COMPLETED|Overall Study||126
216513|NCT01218958|524043|P3|STARTED|Overall Study||209
216514|NCT01218958|524044|P2|STARTED|Overall Study||205
216515|NCT01218958|524045|P1|STARTED|Overall Study||210
216516|NCT01218867|524067|P11|NOT COMPLETED|Overall Study||0
216517|NCT01218867|524068|P10|NOT COMPLETED|Overall Study||0
216518|NCT01218867|524069|P9|NOT COMPLETED|Overall Study||0
216519|NCT01218867|524070|P8|NOT COMPLETED|Overall Study||0
216520|NCT01218867|524071|P7|NOT COMPLETED|Overall Study||1
216521|NCT01218867|524072|P6|NOT COMPLETED|Overall Study||0
216522|NCT01218867|524073|P5|NOT COMPLETED|Overall Study||0
216523|NCT01218867|524074|P4|NOT COMPLETED|Overall Study||0
216524|NCT01218867|524075|P3|NOT COMPLETED|Overall Study||0
216525|NCT01218867|524076|P2|NOT COMPLETED|Overall Study||0
216526|NCT01218867|524077|P1|NOT COMPLETED|Overall Study||0
216527|NCT01218867|524067|P11|COMPLETED|Overall Study||2
216528|NCT01218867|524068|P10|COMPLETED|Overall Study||4
216529|NCT01218867|524069|P9|COMPLETED|Overall Study||3
216530|NCT01218867|524070|P8|COMPLETED|Overall Study||3
216531|NCT01218867|524071|P7|COMPLETED|Overall Study||3
216532|NCT01218867|524072|P6|COMPLETED|Overall Study||1
216533|NCT01218867|524073|P5|COMPLETED|Overall Study||1
216534|NCT01218867|524074|P4|COMPLETED|Overall Study||1
216535|NCT01218867|524075|P3|COMPLETED|Overall Study||3
216536|NCT01218867|524076|P2|COMPLETED|Overall Study||1
216537|NCT01218867|524077|P1|COMPLETED|Overall Study||1
216538|NCT01218867|524067|P11|STARTED|Overall Study||2
216539|NCT01218867|524068|P10|STARTED|Overall Study||4
216540|NCT01218867|524069|P9|STARTED|Overall Study||3
216541|NCT01218867|524070|P8|STARTED|Overall Study||3
216542|NCT01218867|524071|P7|STARTED|Overall Study||4
216543|NCT01218867|524072|P6|STARTED|Overall Study||1
216544|NCT01218867|524073|P5|STARTED|Overall Study||1
216545|NCT01218867|524074|P4|STARTED|Overall Study||1
216546|NCT01218867|524075|P3|STARTED|Overall Study||3
216547|NCT01218867|524076|P2|STARTED|Overall Study||1
216548|NCT01218867|524077|P1|STARTED|Overall Study||1
216549|NCT01218802|524125|P2|NOT COMPLETED|Overall Study||18
216550|NCT01218802|524126|P1|NOT COMPLETED|Overall Study||10
216551|NCT01218802|524125|P2|COMPLETED|Overall Study||57
216552|NCT01218802|524126|P1|COMPLETED|Overall Study||62
216553|NCT01218802|524125|P2|STARTED|Overall Study||75
216554|NCT01218802|524126|P1|STARTED|Overall Study||72
216555|NCT01218659|524136|P3|NOT COMPLETED|12-Month OLE||10
216556|NCT01218659|524137|P2|NOT COMPLETED|12-Month OLE||0
216557|NCT01218659|524138|P1|NOT COMPLETED|12-Month OLE||0
216558|NCT01218659|524136|P3|COMPLETED|12-Month OLE||42
216559|NCT01218659|524137|P2|COMPLETED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
216560|NCT01218659|524138|P1|COMPLETED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
216561|NCT01218659|524136|P3|Modified Intent-to-Treat (mITT)|12-Month OLE||46
216562|NCT01218659|524137|P2|Modified Intent-to-Treat (mITT)|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
216563|NCT01218659|524138|P1|Modified Intent-to-Treat (mITT)|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
216564|NCT01218659|524136|P3|Safety Population|12-Month OLE||51
216565|NCT01218659|524137|P2|Safety Population|12-Month OLE||0
216566|NCT01218659|524138|P1|Safety Population|12-Month OLE||0
216567|NCT01218659|524136|P3|STARTED|12-Month OLE|Fifty-two participants completed the 18-mo. randomized treatment period.|52
216568|NCT01218659|524137|P2|STARTED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
216569|NCT01218659|524138|P1|STARTED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
216570|NCT01218659|524136|P3|NOT COMPLETED|18-Month Randomized Period||0
216571|NCT01218659|524137|P2|NOT COMPLETED|18-Month Randomized Period||6
216572|NCT01218659|524138|P1|NOT COMPLETED|18-Month Randomized Period||2
216573|NCT01218659|524136|P3|COMPLETED|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
216574|NCT01218659|524137|P2|COMPLETED|18-Month Randomized Period||18
216575|NCT01218659|524138|P1|COMPLETED|18-Month Randomized Period||34
216576|NCT01218659|524136|P3|Safety Population|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
216577|NCT01218659|524137|P2|Safety Population|18-Month Randomized Period||21
216578|NCT01218659|524138|P1|Safety Population|18-Month Randomized Period||36
216579|NCT01218659|524136|P3|STARTED|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
216580|NCT01218659|524137|P2|STARTED|18-Month Randomized Period||24
216581|NCT01218659|524138|P1|STARTED|18-Month Randomized Period||36
216582|NCT01218646|524153|P4|NOT COMPLETED|Overall Study||1
216583|NCT01218646|524154|P3|NOT COMPLETED|Overall Study||2
216584|NCT01218646|524155|P2|NOT COMPLETED|Overall Study||0
216585|NCT01218646|524156|P1|NOT COMPLETED|Overall Study||1
216586|NCT01218646|524153|P4|COMPLETED|Overall Study||63
216587|NCT01218646|524154|P3|COMPLETED|Overall Study||223
216588|NCT01218646|524155|P2|COMPLETED|Overall Study||225
216589|NCT01218646|524156|P1|COMPLETED|Overall Study||224
216590|NCT01218646|524153|P4|STARTED|Overall Study||64
216591|NCT01218646|524154|P3|STARTED|Overall Study||225
216592|NCT01218646|524155|P2|STARTED|Overall Study||225
216593|NCT01218646|524156|P1|STARTED|Overall Study||225
216594|NCT01218594|524194|P1|NOT COMPLETED|Overall Study||12
216595|NCT01218594|524194|P1|COMPLETED|Overall Study||36
216596|NCT01218594|524194|P1|STARTED|Overall Study||48
216597|NCT01218477|524202|P4|NOT COMPLETED|Overall Study||2
216598|NCT01218477|524203|P3|NOT COMPLETED|Overall Study||14
216599|NCT01218477|524204|P2|NOT COMPLETED|Overall Study||8
216600|NCT01218477|524205|P1|NOT COMPLETED|Overall Study||3
216601|NCT01218477|524202|P4|COMPLETED|Overall Study|Still receiving study drug|0
216602|NCT01218477|524203|P3|COMPLETED|Overall Study|Still receiving study drug|0
216603|NCT01218477|524204|P2|COMPLETED|Overall Study|Still receiving study drug|0
216604|NCT01218477|524205|P1|COMPLETED|Overall Study|Still receiving study drug|0
216605|NCT01218477|524202|P4|STARTED|Overall Study|Participants who received treatment|2
216606|NCT01218477|524203|P3|STARTED|Overall Study|Participants who received treatment|14
216607|NCT01218477|524204|P2|STARTED|Overall Study|Participants who received treatment|8
216608|NCT01218477|524205|P1|STARTED|Overall Study|Participants who received treatment|3
216609|NCT01218438|524222|P1|NOT COMPLETED|Epoch 4||3
216610|NCT01218438|524222|P1|COMPLETED|Epoch 4||67
216611|NCT01218438|524222|P1|STARTED|Epoch 4||70
216612|NCT01218438|524222|P1|NOT COMPLETED|Epoch 3||4
216613|NCT01218438|524222|P1|COMPLETED|Epoch 3||70
216614|NCT01218438|524222|P1|STARTED|Epoch 3||74
216615|NCT01218438|524222|P1|NOT COMPLETED|Epoch 2||0
216616|NCT01218438|524222|P1|COMPLETED|Epoch 2||45
216617|NCT01218438|524222|P1|STARTED|Epoch 2||45
216618|NCT01218438|524222|P1|NOT COMPLETED|Epoch 1||3
216619|NCT01218438|524222|P1|COMPLETED|Epoch 1||74
216620|NCT01218438|524222|P1|STARTED|Epoch 1||77
216621|NCT01218399|524377|P2|NOT COMPLETED|Overall Study||0
216622|NCT01218399|524378|P1|NOT COMPLETED|Overall Study||0
216623|NCT01218399|524377|P2|COMPLETED|Overall Study||5
216624|NCT01218399|524378|P1|COMPLETED|Overall Study||5
216625|NCT01218399|524377|P2|STARTED|Overall Study||5
216626|NCT01218399|524378|P1|STARTED|Overall Study||5
216627|NCT01218308|524388|P2|NOT COMPLETED|Overall Study||120
216628|NCT01218308|524389|P1|NOT COMPLETED|Overall Study||103
216629|NCT01218308|524388|P2|COMPLETED|Overall Study||2464
216630|NCT01218308|524389|P1|COMPLETED|Overall Study||2481
216631|NCT01218308|524388|P2|STARTED|Overall Study||2584
216632|NCT01218308|524389|P1|STARTED|Overall Study||2584
216633|NCT01218243|524433|P2|NOT COMPLETED|Overall Study||14
216634|NCT01218243|524434|P1|NOT COMPLETED|Overall Study||9
216635|NCT01218243|524433|P2|COMPLETED|Overall Study||36
216636|NCT01218243|524434|P1|COMPLETED|Overall Study||41
216637|NCT01218243|524433|P2|Treatment Completed|Overall Study||42
216638|NCT01218243|524434|P1|Treatment Completed|Overall Study||45
216639|NCT01218243|524433|P2|STARTED|Overall Study||50
216640|NCT01218243|524434|P1|STARTED|Overall Study||50
216641|NCT01218204|524450|P4|NOT COMPLETED|Part B Pooled Treatment Arm||3
216642|NCT01218204|524451|P3|NOT COMPLETED|Part B Pooled Treatment Arm||0
216643|NCT01218204|524452|P2|NOT COMPLETED|Part B Pooled Treatment Arm||0
216644|NCT01218204|524453|P1|NOT COMPLETED|Part B Pooled Treatment Arm||0
216645|NCT01218204|524450|P4|COMPLETED|Part B Pooled Treatment Arm||127
216646|NCT01218204|524451|P3|COMPLETED|Part B Pooled Treatment Arm||0
216647|NCT01218204|524452|P2|COMPLETED|Part B Pooled Treatment Arm||0
216648|NCT01218204|524453|P1|COMPLETED|Part B Pooled Treatment Arm||0
216649|NCT01218204|524450|P4|STARTED|Part B Pooled Treatment Arm||130
216650|NCT01218204|524451|P3|STARTED|Part B Pooled Treatment Arm||0
216651|NCT01218204|524452|P2|STARTED|Part B Pooled Treatment Arm||0
216652|NCT01218204|524453|P1|STARTED|Part B Pooled Treatment Arm||0
216653|NCT01218204|524450|P4|NOT COMPLETED|Part B Run-in||0
216654|NCT01218204|524451|P3|NOT COMPLETED|Part B Run-in||6
216655|NCT01218204|524452|P2|NOT COMPLETED|Part B Run-in||0
216656|NCT01218204|524453|P1|NOT COMPLETED|Part B Run-in||0
216657|NCT01218204|524450|P4|COMPLETED|Part B Run-in||0
216658|NCT01218204|524451|P3|COMPLETED|Part B Run-in||83
216659|NCT01218204|524452|P2|COMPLETED|Part B Run-in||0
216660|NCT01218204|524453|P1|COMPLETED|Part B Run-in||0
216661|NCT01218204|524450|P4|STARTED|Part B Run-in||0
216662|NCT01218204|524451|P3|STARTED|Part B Run-in||89
216663|NCT01218204|524452|P2|STARTED|Part B Run-in||0
216664|NCT01218204|524453|P1|STARTED|Part B Run-in||0
216665|NCT01218204|524450|P4|NOT COMPLETED|Part B Washout||0
216666|NCT01218204|524451|P3|NOT COMPLETED|Part B Washout||0
216667|NCT01218204|524452|P2|NOT COMPLETED|Part B Washout||145
216668|NCT01218204|524453|P1|NOT COMPLETED|Part B Washout||0
216669|NCT01218204|524450|P4|COMPLETED|Part B Washout||0
216670|NCT01218204|524451|P3|COMPLETED|Part B Washout||0
216671|NCT01218204|524452|P2|COMPLETED|Part B Washout||136
216672|NCT01218204|524453|P1|COMPLETED|Part B Washout||0
216673|NCT01218204|524450|P4|STARTED|Part B Washout||0
216674|NCT01218204|524451|P3|STARTED|Part B Washout||0
216675|NCT01218204|524452|P2|STARTED|Part B Washout||281
216676|NCT01218204|524453|P1|STARTED|Part B Washout||0
216677|NCT01218204|524450|P4|NOT COMPLETED|Part A||0
216678|NCT01218204|524451|P3|NOT COMPLETED|Part A||0
216679|NCT01218204|524452|P2|NOT COMPLETED|Part A||0
216680|NCT01218204|524453|P1|NOT COMPLETED|Part A||0
216681|NCT01218204|524450|P4|COMPLETED|Part A||0
216682|NCT01218204|524451|P3|COMPLETED|Part A||0
216683|NCT01218204|524452|P2|COMPLETED|Part A||0
216684|NCT01218204|524453|P1|COMPLETED|Part A||6
216685|NCT01218204|524450|P4|STARTED|Part A||0
216686|NCT01218204|524451|P3|STARTED|Part A||0
216687|NCT01218204|524452|P2|STARTED|Part A||0
216688|NCT01218204|524453|P1|STARTED|Part A||6
216689|NCT01218126|524717|P4|NOT COMPLETED|Overall Study||35
216690|NCT01218126|524718|P3|NOT COMPLETED|Overall Study||24
216691|NCT01218126|524719|P2|NOT COMPLETED|Overall Study||22
216692|NCT01218126|524720|P1|NOT COMPLETED|Overall Study||24
216693|NCT01218126|524717|P4|COMPLETED|Overall Study||114
216694|NCT01218126|524718|P3|COMPLETED|Overall Study||127
216695|NCT01218126|524719|P2|COMPLETED|Overall Study||127
216696|NCT01218126|524720|P1|COMPLETED|Overall Study||129
216697|NCT01218126|524717|P4|STARTED|Overall Study||149
216698|NCT01218126|524718|P3|STARTED|Overall Study||151
216699|NCT01218126|524719|P2|STARTED|Overall Study||149
216700|NCT01218126|524720|P1|STARTED|Overall Study||153
216701|NCT01218113|524761|P3|NOT COMPLETED|Overall Study||6
216702|NCT01218113|524762|P2|NOT COMPLETED|Overall Study||1
216703|NCT01218113|524763|P1|NOT COMPLETED|Overall Study||5
216704|NCT01218113|524761|P3|COMPLETED|Overall Study||58
216705|NCT01218113|524762|P2|COMPLETED|Overall Study||63
216706|NCT01218113|524763|P1|COMPLETED|Overall Study||57
216707|NCT01218113|524761|P3|STARTED|Overall Study||64
216708|NCT01218113|524762|P2|STARTED|Overall Study||64
216709|NCT01218113|524763|P1|STARTED|Overall Study||62
216710|NCT01218100|524944|P4|NOT COMPLETED|Overall Study||34
216711|NCT01218100|524945|P3|NOT COMPLETED|Overall Study||27
216712|NCT01218100|524946|P2|NOT COMPLETED|Overall Study||25
216713|NCT01218100|524947|P1|NOT COMPLETED|Overall Study||24
216714|NCT01218100|524944|P4|COMPLETED|Overall Study||156
216715|NCT01218100|524945|P3|COMPLETED|Overall Study||162
216716|NCT01218100|524946|P2|COMPLETED|Overall Study||165
216717|NCT01218100|524947|P1|COMPLETED|Overall Study||71
216718|NCT01218100|524944|P4|STARTED|Overall Study||190
216719|NCT01218100|524945|P3|STARTED|Overall Study||189
216720|NCT01218100|524946|P2|STARTED|Overall Study||190
216721|NCT01218100|524947|P1|STARTED|Overall Study||95
216722|NCT01218087|524963|P2|NOT COMPLETED|Overall Study||6
216723|NCT01218087|524964|P1|NOT COMPLETED|Overall Study||15
216724|NCT01218087|524963|P2|COMPLETED|Overall Study||35
216725|NCT01218087|524964|P1|COMPLETED|Overall Study||27
216726|NCT01218087|524963|P2|STARTED|Overall Study||41
216727|NCT01218087|524964|P1|STARTED|Overall Study||42
216728|NCT01218048|524972|P1|NOT COMPLETED|Overall Study||0
216729|NCT01218048|524972|P1|COMPLETED|Overall Study||40
216730|NCT01218048|524972|P1|STARTED|Overall Study||40
216731|NCT01218009|524986|P2|NOT COMPLETED|Overall Study||165
216732|NCT01218009|524987|P1|NOT COMPLETED|Overall Study||166
216733|NCT01218009|524986|P2|COMPLETED|Overall Study||0
216734|NCT01218009|524987|P1|COMPLETED|Overall Study||0
216735|NCT01218009|524986|P2|STARTED|Overall Study||165
216736|NCT01218009|524987|P1|STARTED|Overall Study||166
216737|NCT01217957|525010|P5|NOT COMPLETED|Phase 2||1
216738|NCT01217957|525011|P4|NOT COMPLETED|Phase 2||0
216739|NCT01217957|525012|P3|NOT COMPLETED|Phase 2||0
216740|NCT01217957|525013|P2|NOT COMPLETED|Phase 2||0
216741|NCT01217957|525014|P1|NOT COMPLETED|Phase 2||0
216742|NCT01217957|525010|P5|COMPLETED|Phase 2|Completed=Participants who are ongoing or who have died on study.|49
216743|NCT01217957|525011|P4|COMPLETED|Phase 2||0
216744|NCT01217957|525012|P3|COMPLETED|Phase 2||0
216745|NCT01217957|525013|P2|COMPLETED|Phase 2||0
216746|NCT01217957|525014|P1|COMPLETED|Phase 2||0
216747|NCT01217957|525010|P5|STARTED|Phase 2||50
216748|NCT01217957|525011|P4|STARTED|Phase 2||0
216749|NCT01217957|525012|P3|STARTED|Phase 2||0
216750|NCT01217957|525013|P2|STARTED|Phase 2||0
216751|NCT01217957|525014|P1|STARTED|Phase 2||0
216752|NCT01217957|525010|P5|NOT COMPLETED|Phase 1||0
216753|NCT01217957|525011|P4|NOT COMPLETED|Phase 1||1
216754|NCT01217957|525012|P3|NOT COMPLETED|Phase 1||1
216755|NCT01217957|525013|P2|NOT COMPLETED|Phase 1||0
216756|NCT01217957|525014|P1|NOT COMPLETED|Phase 1||1
216757|NCT01217957|525010|P5|COMPLETED|Phase 1||0
216758|NCT01217957|525011|P4|COMPLETED|Phase 1||2
216759|NCT01217957|525012|P3|COMPLETED|Phase 1||5
216760|NCT01217957|525013|P2|COMPLETED|Phase 1||3
216761|NCT01217957|525014|P1|COMPLETED|Phase 1||2
216762|NCT01217957|525010|P5|STARTED|Phase 1||0
216763|NCT01217957|525011|P4|STARTED|Phase 1||3
216764|NCT01217957|525012|P3|STARTED|Phase 1||6
216765|NCT01217957|525013|P2|STARTED|Phase 1||3
216766|NCT01217957|525014|P1|STARTED|Phase 1||3
216767|NCT01217944|525073|P3|NOT COMPLETED|Overall Study||0
216768|NCT01217944|525074|P2|NOT COMPLETED|Overall Study||4
216769|NCT01217944|525075|P1|NOT COMPLETED|Overall Study||6
216770|NCT01217944|525073|P3|COMPLETED|Overall Study||55
216771|NCT01217944|525074|P2|COMPLETED|Overall Study||112
216772|NCT01217944|525075|P1|COMPLETED|Overall Study||100
216773|NCT01217944|525073|P3|Completed 6 Months|Overall Study||55
216774|NCT01217944|525074|P2|Completed 6 Months|Overall Study||116
216775|NCT01217944|525075|P1|Completed 6 Months|Overall Study||103
216776|NCT01217944|525073|P3|Completed 3 Months|Overall Study||55
216777|NCT01217944|525074|P2|Completed 3 Months|Overall Study||116
216778|NCT01217944|525075|P1|Completed 3 Months|Overall Study||105
216779|NCT01217944|525073|P3|STARTED|Overall Study||55
216780|NCT01217944|525074|P2|STARTED|Overall Study||116
216781|NCT01217944|525075|P1|STARTED|Overall Study||106
216782|NCT01217892|525118|P4|NOT COMPLETED|Overall Study||8
216783|NCT01217892|525119|P3|NOT COMPLETED|Overall Study||9
216784|NCT01217892|525120|P2|NOT COMPLETED|Overall Study||6
216785|NCT01217892|525121|P1|NOT COMPLETED|Overall Study||7
216786|NCT01217892|525118|P4|COMPLETED|Overall Study||93
216787|NCT01217892|525119|P3|COMPLETED|Overall Study||90
216788|NCT01217892|525120|P2|COMPLETED|Overall Study||94
216789|NCT01217892|525121|P1|COMPLETED|Overall Study||93
216790|NCT01217892|525118|P4|STARTED|Overall Study||101
216791|NCT01217892|525119|P3|STARTED|Overall Study||99
216792|NCT01217892|525120|P2|STARTED|Overall Study||100
216793|NCT01217892|525121|P1|STARTED|Overall Study||100
216794|NCT01217840|525149|P2|NOT COMPLETED|Overall Study||3
216795|NCT01217840|525150|P1|NOT COMPLETED|Overall Study||6
216796|NCT01217840|525149|P2|COMPLETED|Overall Study||17
216797|NCT01217840|525150|P1|COMPLETED|Overall Study||14
216798|NCT01217840|525149|P2|STARTED|Overall Study||20
216799|NCT01217840|525150|P1|STARTED|Overall Study||20
216800|NCT01217827|525174|P2|NOT COMPLETED|Overall Study||0
216801|NCT01217827|525175|P1|NOT COMPLETED|Overall Study||0
216802|NCT01217827|525174|P2|COMPLETED|Overall Study||43
216803|NCT01217827|525175|P1|COMPLETED|Overall Study||46
216804|NCT01217827|525174|P2|STARTED|Overall Study||43
216805|NCT01217827|525175|P1|STARTED|Overall Study||46
216806|NCT01217814|525184|P3|NOT COMPLETED|Overall Study||1
216807|NCT01217814|525185|P2|NOT COMPLETED|Overall Study||1
216808|NCT01217814|525186|P1|NOT COMPLETED|Overall Study||1
216809|NCT01217814|525184|P3|COMPLETED|Overall Study||6
216810|NCT01217814|525185|P2|COMPLETED|Overall Study||4
216811|NCT01217814|525186|P1|COMPLETED|Overall Study||3
216812|NCT01217814|525184|P3|STARTED|Overall Study||7
216813|NCT01217814|525185|P2|STARTED|Overall Study||5
216814|NCT01217814|525186|P1|STARTED|Overall Study||4
216815|NCT01217801|525212|P2|NOT COMPLETED|Period 2||0
216816|NCT01217801|525213|P1|NOT COMPLETED|Period 2||0
216817|NCT01217801|525212|P2|COMPLETED|Period 2||22
216818|NCT01217801|525213|P1|COMPLETED|Period 2||23
216819|NCT01217801|525212|P2|STARTED|Period 2||22
216820|NCT01217801|525213|P1|STARTED|Period 2||23
216821|NCT01217801|525212|P2|NOT COMPLETED|Period 1||2
216822|NCT01217801|525213|P1|NOT COMPLETED|Period 1||1
216823|NCT01217801|525212|P2|COMPLETED|Period 1||22
216824|NCT01217801|525213|P1|COMPLETED|Period 1||23
216825|NCT01217801|525212|P2|STARTED|Period 1||24
216826|NCT01217801|525213|P1|STARTED|Period 1||24
216827|NCT01217749|525222|P3|NOT COMPLETED|Overall Study||2
216828|NCT01217749|525223|P2|NOT COMPLETED|Overall Study||3
216829|NCT01217749|525224|P1|NOT COMPLETED|Overall Study||3
216830|NCT01217749|525222|P3|COMPLETED|Overall Study||22
216831|NCT01217749|525223|P2|COMPLETED|Overall Study||17
216832|NCT01217749|525224|P1|COMPLETED|Overall Study||24
216833|NCT01217749|525222|P3|STARTED|Overall Study||24
216834|NCT01217749|525223|P2|STARTED|Overall Study||20
216835|NCT01217749|525224|P1|STARTED|Overall Study||27
216836|NCT01217606|525242|P2|NOT COMPLETED|9-Month Masked Extension||11
216837|NCT01217606|525243|P1|NOT COMPLETED|9-Month Masked Extension||13
216838|NCT01217606|525242|P2|COMPLETED|9-Month Masked Extension||62
216839|NCT01217606|525243|P1|COMPLETED|9-Month Masked Extension||54
216840|NCT01217606|525242|P2|Not Enrolled in Masked Extension|9-Month Masked Extension||10
216841|NCT01217606|525243|P1|Not Enrolled in Masked Extension|9-Month Masked Extension||9
216842|NCT01217606|525242|P2|STARTED|9-Month Masked Extension||73
216843|NCT01217606|525243|P1|STARTED|9-Month Masked Extension||67
216844|NCT01217606|525242|P2|NOT COMPLETED|Initial Treatment Phase||12
216845|NCT01217606|525243|P1|NOT COMPLETED|Initial Treatment Phase||14
216846|NCT01217606|525242|P2|COMPLETED|Initial Treatment Phase||83
216847|NCT01217606|525243|P1|COMPLETED|Initial Treatment Phase||76
216848|NCT01217606|525242|P2|STARTED|Initial Treatment Phase||95
216849|NCT01217606|525243|P1|STARTED|Initial Treatment Phase||90
216850|NCT01217515|525256|P3|NOT COMPLETED|Overall Study||10
216851|NCT01217515|525257|P2|NOT COMPLETED|Overall Study||8
216852|NCT01217515|525258|P1|NOT COMPLETED|Overall Study||7
216853|NCT01217515|525256|P3|COMPLETED|Overall Study||145
216854|NCT01217515|525257|P2|COMPLETED|Overall Study||148
216855|NCT01217515|525258|P1|COMPLETED|Overall Study||147
216856|NCT01217515|525256|P3|STARTED|Overall Study||155
216857|NCT01217515|525257|P2|STARTED|Overall Study||156
216858|NCT01217515|525258|P1|STARTED|Overall Study||154
216859|NCT01217476|525274|P2|NOT COMPLETED|Overall Study||7
216860|NCT01217476|525275|P1|NOT COMPLETED|Overall Study||12
216861|NCT01217476|525274|P2|COMPLETED|Overall Study||95
216862|NCT01217476|525275|P1|COMPLETED|Overall Study||93
216863|NCT01217476|525274|P2|STARTED|Overall Study||102
216864|NCT01217476|525275|P1|STARTED|Overall Study||105
216865|NCT01217463|525285|P2|NOT COMPLETED|Overall Study||8
216866|NCT01217463|525286|P1|NOT COMPLETED|Overall Study||13
216867|NCT01217463|525285|P2|COMPLETED|Overall Study||94
216868|NCT01217463|525286|P1|COMPLETED|Overall Study||86
216869|NCT01217463|525285|P2|STARTED|Overall Study||102
216870|NCT01217463|525286|P1|STARTED|Overall Study||99
216871|NCT01217437|525296|P2|NOT COMPLETED|Overall Study||41
216872|NCT01217437|525297|P1|NOT COMPLETED|Overall Study||43
216873|NCT01217437|525296|P2|COMPLETED|Overall Study||12
216874|NCT01217437|525297|P1|COMPLETED|Overall Study||12
216875|NCT01217437|525296|P2|STARTED|Overall Study||53
216876|NCT01217437|525297|P1|STARTED|Overall Study||55
216877|NCT01217411|525309|P2|NOT COMPLETED|Overall Study||2
216878|NCT01217411|525310|P1|NOT COMPLETED|Overall Study||3
216879|NCT01217411|525309|P2|COMPLETED|Overall Study||0
216880|NCT01217411|525310|P1|COMPLETED|Overall Study||0
216881|NCT01217411|525309|P2|20mg|Overall Study||0
216882|NCT01217411|525310|P1|20mg|Overall Study||0
216883|NCT01217411|525309|P2|10mg|Overall Study||0
216884|NCT01217411|525310|P1|10mg|Overall Study||0
216885|NCT01217411|525309|P2|5mg|Overall Study||2
216886|NCT01217411|525310|P1|5mg|Overall Study||3
216887|NCT01217411|525309|P2|STARTED|Overall Study||2
216888|NCT01217411|525310|P1|STARTED|Overall Study||3
216889|NCT01217385|525318|P1|NOT COMPLETED|Overall Study||26
216890|NCT01217385|525318|P1|COMPLETED|Overall Study||34
216891|NCT01217385|525318|P1|STARTED|Overall Study||60
216892|NCT01217307|525330|P2|NOT COMPLETED|Overall Study||1
216893|NCT01217307|525331|P1|NOT COMPLETED|Overall Study||0
216894|NCT01217307|525330|P2|COMPLETED|Overall Study||188
216895|NCT01217307|525331|P1|COMPLETED|Overall Study||191
216896|NCT01217307|525330|P2|STARTED|Overall Study||189
216897|NCT01217307|525331|P1|STARTED|Overall Study||191
216898|NCT01217229|525337|P1|NOT COMPLETED|Overall Study||0
216899|NCT01217229|525337|P1|COMPLETED|Overall Study||20
216900|NCT01217229|525337|P1|STARTED|Overall Study||20
216901|NCT01217112|525346|P5|NOT COMPLETED|Overall Study||1
216902|NCT01217112|525347|P4|NOT COMPLETED|Overall Study||2
216903|NCT01217112|525348|P3|NOT COMPLETED|Overall Study||1
216904|NCT01217112|525349|P2|NOT COMPLETED|Overall Study||2
216905|NCT01217112|525350|P1|NOT COMPLETED|Overall Study||0
216906|NCT01217112|525346|P5|COMPLETED|Overall Study||13
216907|NCT01217112|525347|P4|COMPLETED|Overall Study||10
216908|NCT01217112|525348|P3|COMPLETED|Overall Study||12
216909|NCT01217112|525349|P2|COMPLETED|Overall Study||10
216910|NCT01217112|525350|P1|COMPLETED|Overall Study||11
216911|NCT01217112|525346|P5|STARTED|Overall Study||14
216912|NCT01217112|525347|P4|STARTED|Overall Study||12
216913|NCT01217112|525348|P3|STARTED|Overall Study||13
216914|NCT01217112|525349|P2|STARTED|Overall Study||12
216915|NCT01217112|525350|P1|STARTED|Overall Study||11
216916|NCT01217073|525583|P8|NOT COMPLETED|Extension Period||20
216917|NCT01217073|525584|P7|NOT COMPLETED|Extension Period||91
216918|NCT01217073|525585|P6|NOT COMPLETED|Extension Period||0
216919|NCT01217073|525586|P5|NOT COMPLETED|Extension Period||0
216920|NCT01217073|525587|P4|NOT COMPLETED|Extension Period||0
216921|NCT01217073|525588|P3|NOT COMPLETED|Extension Period||0
216922|NCT01217073|525589|P2|NOT COMPLETED|Extension Period||0
216923|NCT01217073|525590|P1|NOT COMPLETED|Extension Period||0
216924|NCT01217073|525583|P8|COMPLETED|Extension Period||60
216925|NCT01217073|525584|P7|COMPLETED|Extension Period||314
216926|NCT01217073|525585|P6|COMPLETED|Extension Period||0
216927|NCT01217073|525586|P5|COMPLETED|Extension Period||0
216928|NCT01217073|525587|P4|COMPLETED|Extension Period||0
216929|NCT01217073|525588|P3|COMPLETED|Extension Period||0
216930|NCT01217073|525589|P2|COMPLETED|Extension Period||0
216931|NCT01217073|525590|P1|COMPLETED|Extension Period||0
216932|NCT01217073|525583|P8|STARTED|Extension Period||80
216933|NCT01217073|525584|P7|STARTED|Extension Period||405
216934|NCT01217073|525585|P6|STARTED|Extension Period||0
216935|NCT01217073|525586|P5|STARTED|Extension Period||0
216936|NCT01217073|525587|P4|STARTED|Extension Period||0
216937|NCT01217073|525588|P3|STARTED|Extension Period||0
216938|NCT01217073|525589|P2|STARTED|Extension Period||0
216939|NCT01217073|525590|P1|STARTED|Extension Period||0
216940|NCT01217073|525583|P8|NOT COMPLETED|Base Period||0
216941|NCT01217073|525584|P7|NOT COMPLETED|Base Period||0
216942|NCT01217073|525585|P6|NOT COMPLETED|Base Period||9
216943|NCT01217073|525586|P5|NOT COMPLETED|Base Period||15
216944|NCT01217073|525587|P4|NOT COMPLETED|Base Period||2
216945|NCT01217073|525588|P3|NOT COMPLETED|Base Period||7
216946|NCT01217073|525589|P2|NOT COMPLETED|Base Period||5
216947|NCT01217073|525590|P1|NOT COMPLETED|Base Period||7
216948|NCT01217073|525583|P8|COMPLETED|Base Period||0
216949|NCT01217073|525584|P7|COMPLETED|Base Period||0
216950|NCT01217073|525585|P6|COMPLETED|Base Period||105
216951|NCT01217073|525586|P5|COMPLETED|Base Period||99
216952|NCT01217073|525587|P4|COMPLETED|Base Period||113
216953|NCT01217073|525588|P3|COMPLETED|Base Period||107
216954|NCT01217073|525589|P2|COMPLETED|Base Period||110
216955|NCT01217073|525590|P1|COMPLETED|Base Period||106
216956|NCT01217073|525583|P8|STARTED|Base Period||0
216957|NCT01217073|525584|P7|STARTED|Base Period||0
216958|NCT01217073|525585|P6|STARTED|Base Period||114
216959|NCT01217073|525586|P5|STARTED|Base Period||114
216960|NCT01217073|525587|P4|STARTED|Base Period||115
216961|NCT01217073|525588|P3|STARTED|Base Period||114
216962|NCT01217073|525589|P2|STARTED|Base Period||115
216963|NCT01217073|525590|P1|STARTED|Base Period||113
216964|NCT01216943|525658|P1|NOT COMPLETED|Overall Study||13
216965|NCT01216943|525658|P1|COMPLETED|Overall Study||113
216966|NCT01216943|525658|P1|STARTED|Overall Study||126
216967|NCT01216761|525662|P3|NOT COMPLETED|Overall Study||0
216968|NCT01216761|525663|P2|NOT COMPLETED|Overall Study||0
216969|NCT01216761|525664|P1|NOT COMPLETED|Overall Study||0
216970|NCT01216761|525662|P3|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
216971|NCT01216761|525663|P2|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
216972|NCT01216761|525664|P1|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
216973|NCT01216761|525662|P3|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
216974|NCT01216761|525663|P2|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
216975|NCT01216761|525664|P1|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
216976|NCT01216748|525672|P1|NOT COMPLETED|Overall Study||0
216977|NCT01216748|525672|P1|COMPLETED|Overall Study||10
216978|NCT01216748|525672|P1|Eucapnic Hyperventilation|Overall Study||10
216979|NCT01216748|525672|P1|Hypercapnic Hyperventilation|Overall Study||10
216980|NCT01216748|525672|P1|Hypocapnic Hyperventilation|Overall Study||10
216981|NCT01216748|525672|P1|Quiet Breathing|Overall Study||10
216982|NCT01216748|525672|P1|STARTED|Overall Study||10
216983|NCT01216735|525679|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
216984|NCT01216735|525680|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
216985|NCT01216735|525679|P2|COMPLETED|Second Intervention (3 Weeks)||7
216986|NCT01216735|525680|P1|COMPLETED|Second Intervention (3 Weeks)||8
216987|NCT01216735|525679|P2|STARTED|Second Intervention (3 Weeks)||7
216988|NCT01216735|525680|P1|STARTED|Second Intervention (3 Weeks)||8
216989|NCT01216735|525679|P2|NOT COMPLETED|Washout (3 Weeks)||0
216990|NCT01216735|525680|P1|NOT COMPLETED|Washout (3 Weeks)||0
216991|NCT01216735|525679|P2|COMPLETED|Washout (3 Weeks)||7
216992|NCT01216735|525680|P1|COMPLETED|Washout (3 Weeks)||8
216993|NCT01216735|525679|P2|STARTED|Washout (3 Weeks)||7
216994|NCT01216735|525680|P1|STARTED|Washout (3 Weeks)||8
216995|NCT01216735|525679|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
216996|NCT01216735|525680|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
216997|NCT01216735|525679|P2|COMPLETED|First Intervention (3 Weeks)||7
216998|NCT01216735|525680|P1|COMPLETED|First Intervention (3 Weeks)||8
216999|NCT01216735|525679|P2|STARTED|First Intervention (3 Weeks)||7
217000|NCT01216735|525680|P1|STARTED|First Intervention (3 Weeks)||8
217001|NCT01216631|525691|P3|NOT COMPLETED|Overall Study||0
217002|NCT01216631|525692|P2|NOT COMPLETED|Overall Study||0
217003|NCT01216631|525693|P1|NOT COMPLETED|Overall Study||0
217004|NCT01216631|525691|P3|COMPLETED|Overall Study||1
217005|NCT01216631|525692|P2|COMPLETED|Overall Study||0
217006|NCT01216631|525693|P1|COMPLETED|Overall Study||0
217007|NCT01216631|525691|P3|STARTED|Overall Study||1
217008|NCT01216631|525692|P2|STARTED|Overall Study||0
217009|NCT01216631|525693|P1|STARTED|Overall Study||0
217010|NCT01216410|525704|P3|NOT COMPLETED|Overall Study||3
217011|NCT01216410|525705|P2|NOT COMPLETED|Overall Study||1
217012|NCT01216410|525706|P1|NOT COMPLETED|Overall Study||2
217013|NCT01216410|525704|P3|COMPLETED|Overall Study||100
217014|NCT01216410|525705|P2|COMPLETED|Overall Study||99
217015|NCT01216410|525706|P1|COMPLETED|Overall Study||101
217016|NCT01216410|525704|P3|STARTED|Overall Study||103
217017|NCT01216410|525705|P2|STARTED|Overall Study||100
217018|NCT01216410|525706|P1|STARTED|Overall Study||103
217019|NCT01216397|525726|P2|NOT COMPLETED|Period 2||0
217020|NCT01216397|525727|P1|NOT COMPLETED|Period 2||0
217021|NCT01216397|525726|P2|COMPLETED|Period 2||20
217022|NCT01216397|525727|P1|COMPLETED|Period 2||20
217023|NCT01216397|525726|P2|STARTED|Period 2||20
217024|NCT01216397|525727|P1|STARTED|Period 2||20
217025|NCT01216397|525726|P2|NOT COMPLETED|Washout (35 Days)||0
217026|NCT01216397|525727|P1|NOT COMPLETED|Washout (35 Days)||0
217027|NCT01216397|525726|P2|COMPLETED|Washout (35 Days)||20
217028|NCT01216397|525727|P1|COMPLETED|Washout (35 Days)||20
217029|NCT01216397|525726|P2|STARTED|Washout (35 Days)||20
217030|NCT01216397|525727|P1|STARTED|Washout (35 Days)||20
217031|NCT01216397|525726|P2|NOT COMPLETED|Period 1||0
217032|NCT01216397|525727|P1|NOT COMPLETED|Period 1||0
217033|NCT01216397|525726|P2|COMPLETED|Period 1||20
217034|NCT01216397|525727|P1|COMPLETED|Period 1||20
217035|NCT01216397|525726|P2|STARTED|Period 1||20
217036|NCT01216397|525727|P1|STARTED|Period 1||20
217037|NCT01216332|525781|P2|NOT COMPLETED|Overall Study||0
217038|NCT01216332|525782|P1|NOT COMPLETED|Overall Study||4
217039|NCT01216332|525781|P2|COMPLETED|Overall Study||16
217040|NCT01216332|525782|P1|COMPLETED|Overall Study||30
217041|NCT01216332|525781|P2|STARTED|Overall Study||16
217042|NCT01216332|525782|P1|STARTED|Overall Study||34
217043|NCT01216319|525800|P1|NOT COMPLETED|Overall Study||4
217044|NCT01216319|525800|P1|COMPLETED|Overall Study||46
217045|NCT01216319|525800|P1|STARTED|Overall Study||50
217046|NCT01216241|525807|P2|NOT COMPLETED|Overall Study||0
217047|NCT01216241|525808|P1|NOT COMPLETED|Overall Study||0
217048|NCT01216241|525807|P2|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
217049|NCT01216241|525808|P1|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
217050|NCT01216241|525807|P2|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
217051|NCT01216241|525808|P1|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
217052|NCT01216176|525817|P3|NOT COMPLETED|Overall Study||1
217053|NCT01216176|525818|P2|NOT COMPLETED|Overall Study||8
217054|NCT01216176|525819|P1|NOT COMPLETED|Overall Study||0
217055|NCT01216176|525817|P3|COMPLETED|Overall Study||19
217056|NCT01216176|525818|P2|COMPLETED|Overall Study||31
217057|NCT01216176|525819|P1|COMPLETED|Overall Study||12
217058|NCT01216176|525817|P3|STARTED|Overall Study||20
217059|NCT01216176|525818|P2|STARTED|Overall Study||39
217060|NCT01216176|525819|P1|STARTED|Overall Study||12
217061|NCT01216163|525842|P3|NOT COMPLETED|Overall Study||0
217062|NCT01216163|525843|P2|NOT COMPLETED|Overall Study||1
217063|NCT01216163|525844|P1|NOT COMPLETED|Overall Study||1
217064|NCT01216163|525842|P3|COMPLETED|Overall Study||85
217065|NCT01216163|525843|P2|COMPLETED|Overall Study||87
217066|NCT01216163|525844|P1|COMPLETED|Overall Study||44
217067|NCT01216163|525842|P3|STARTED|Overall Study||85
217068|NCT01216163|525843|P2|STARTED|Overall Study||88
217069|NCT01216163|525844|P1|STARTED|Overall Study||45
217070|NCT01216072|525896|P2|NOT COMPLETED|Open-Label Extension Period (3 Months)||14
217071|NCT01216072|525897|P1|NOT COMPLETED|Open-Label Extension Period (3 Months)||0
217072|NCT01216072|525896|P2|COMPLETED|Open-Label Extension Period (3 Months)||181
217073|NCT01216072|525897|P1|COMPLETED|Open-Label Extension Period (3 Months)||0
217074|NCT01216072|525896|P2|Safety Set|Open-Label Extension Period (3 Months)||193
217075|NCT01216072|525897|P1|Safety Set|Open-Label Extension Period (3 Months)||0
217076|NCT01216072|525896|P2|STARTED|Open-Label Extension Period (3 Months)|Only DMT patients, who completed the core study, were eligible for fingolimod.|195
217077|NCT01216072|525897|P1|STARTED|Open-Label Extension Period (3 Months)||0
217078|NCT01216072|525896|P2|NOT COMPLETED|Open-Label Core Period ( 6 Months)||34
217079|NCT01216072|525897|P1|NOT COMPLETED|Open-Label Core Period ( 6 Months)||76
217080|NCT01216072|525896|P2|COMPLETED|Open-Label Core Period ( 6 Months)||229
217081|NCT01216072|525897|P1|COMPLETED|Open-Label Core Period ( 6 Months)||714
217082|NCT01216072|525896|P2|Safety Set|Open-Label Core Period ( 6 Months)||245
217083|NCT01216072|525897|P1|Safety Set|Open-Label Core Period ( 6 Months)||783
217084|NCT01216072|525896|P2|Full Analysis Set|Open-Label Core Period ( 6 Months)||263
217085|NCT01216072|525897|P1|Full Analysis Set|Open-Label Core Period ( 6 Months)|One patient was randomized in error and was not included in FAS.|789
217086|NCT01216072|525896|P2|STARTED|Open-Label Core Period ( 6 Months)||263
217087|NCT01216072|525897|P1|STARTED|Open-Label Core Period ( 6 Months)||790
217088|NCT01215981|525925|P2|NOT COMPLETED|Overall Study||1
217089|NCT01215981|525926|P1|NOT COMPLETED|Overall Study||2
217090|NCT01215981|525925|P2|COMPLETED|Overall Study||32
217091|NCT01215981|525926|P1|COMPLETED|Overall Study||33
217092|NCT01215981|525925|P2|STARTED|Overall Study||33
217093|NCT01215981|525926|P1|STARTED|Overall Study||35
217094|NCT01215968|525936|P2|NOT COMPLETED|Overall Study||7
217095|NCT01215968|525937|P1|NOT COMPLETED|Overall Study||2
217096|NCT01215968|525936|P2|COMPLETED|Overall Study||18
217097|NCT01215968|525937|P1|COMPLETED|Overall Study||11
217098|NCT01215968|525936|P2|Received at Least 1 Dose of Study Drug|Overall Study|25 participants received placebo during Week 1.|24
217099|NCT01215968|525937|P1|Received at Least 1 Dose of Study Drug|Overall Study||13
217100|NCT01215968|525936|P2|STARTED|Overall Study||25
217101|NCT01215968|525937|P1|STARTED|Overall Study||13
217102|NCT01215955|525957|P4|NOT COMPLETED|Overall Study||53
217103|NCT01215955|525958|P3|NOT COMPLETED|Overall Study||48
217104|NCT01215955|525959|P2|NOT COMPLETED|Overall Study||53
217105|NCT01215955|525960|P1|NOT COMPLETED|Overall Study||45
217106|NCT01215955|525957|P4|COMPLETED|Overall Study||241
217107|NCT01215955|525958|P3|COMPLETED|Overall Study||244
217108|NCT01215955|525959|P2|COMPLETED|Overall Study||210
217109|NCT01215955|525960|P1|COMPLETED|Overall Study||223
217110|NCT01215955|525957|P4|Received at Least 1 Dose of Study Drug|Overall Study||290
217111|NCT01215955|525958|P3|Received at Least 1 Dose of Study Drug|Overall Study||288
217112|NCT01215955|525959|P2|Received at Least 1 Dose of Study Drug|Overall Study||261
217113|NCT01215955|525960|P1|Received at Least 1 Dose of Study Drug|Overall Study||267
217114|NCT01215955|525957|P4|STARTED|Overall Study|Two (2) participants from 1 site were excluded due to quality issues and validity of the data.|294
217115|NCT01215955|525958|P3|STARTED|Overall Study|Three (3) participants from 1 site were excluded due to quality issues and validity of data.|292
217116|NCT01215955|525959|P2|STARTED|Overall Study||263
217117|NCT01215955|525960|P1|STARTED|Overall Study||268
217118|NCT01215942|526028|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||146
217119|NCT01215942|526029|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||85
217120|NCT01215942|526028|P2|COMPLETED|Post-Treatment Follow-Up Period||445
217121|NCT01215942|526029|P1|COMPLETED|Post-Treatment Follow-Up Period||283
217122|NCT01215942|526028|P2|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|591
217123|NCT01215942|526029|P1|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|368
217124|NCT01215942|526028|P2|NOT COMPLETED|Treatment Period||672
217125|NCT01215942|526029|P1|NOT COMPLETED|Treatment Period||414
217126|NCT01215942|526028|P2|COMPLETED|Treatment Period||0
217127|NCT01215942|526029|P1|COMPLETED|Treatment Period||0
217128|NCT01215942|526028|P2|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|672
217129|NCT01215942|526029|P1|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|414
217130|NCT01215929|526146|P2|NOT COMPLETED|Overall Study||5
217131|NCT01215929|526147|P1|NOT COMPLETED|Overall Study||6
217132|NCT01215929|526146|P2|COMPLETED|Overall Study||12
217133|NCT01215929|526147|P1|COMPLETED|Overall Study||12
217134|NCT01215929|526146|P2|STARTED|Overall Study||17
217135|NCT01215929|526147|P1|STARTED|Overall Study||18
217136|NCT01215916|526162|P9|NOT COMPLETED|Overall Study||2
217137|NCT01215916|526163|P8|NOT COMPLETED|Overall Study||3
217138|NCT01215916|526164|P7|NOT COMPLETED|Overall Study||9
217139|NCT01215916|526165|P6|NOT COMPLETED|Overall Study||4
217140|NCT01215916|526166|P5|NOT COMPLETED|Overall Study||6
217141|NCT01215916|526167|P4|NOT COMPLETED|Overall Study||6
217142|NCT01215916|526168|P3|NOT COMPLETED|Overall Study||3
217143|NCT01215916|526169|P2|NOT COMPLETED|Overall Study||5
217144|NCT01215916|526170|P1|NOT COMPLETED|Overall Study||1
217145|NCT01215916|526162|P9|COMPLETED|Overall Study||0
217146|NCT01215916|526163|P8|COMPLETED|Overall Study||0
217147|NCT01215916|526164|P7|COMPLETED|Overall Study||0
217148|NCT01215916|526165|P6|COMPLETED|Overall Study||0
217149|NCT01215916|526166|P5|COMPLETED|Overall Study||0
217150|NCT01215916|526167|P4|COMPLETED|Overall Study||0
217151|NCT01215916|526168|P3|COMPLETED|Overall Study||0
217152|NCT01215916|526169|P2|COMPLETED|Overall Study||0
217153|NCT01215916|526170|P1|COMPLETED|Overall Study||0
217154|NCT01215916|526162|P9|Received at Least 1 Dose of Either Drug|Overall Study||2
217155|NCT01215916|526163|P8|Received at Least 1 Dose of Either Drug|Overall Study||3
217156|NCT01215916|526164|P7|Received at Least 1 Dose of Either Drug|Overall Study||9
217157|NCT01215916|526165|P6|Received at Least 1 Dose of Either Drug|Overall Study||4
217158|NCT01215916|526166|P5|Received at Least 1 Dose of Either Drug|Overall Study||6
217159|NCT01215916|526167|P4|Received at Least 1 Dose of Either Drug|Overall Study||6
217160|NCT01215916|526168|P3|Received at Least 1 Dose of Either Drug|Overall Study||3
217161|NCT01215916|526169|P2|Received at Least 1 Dose of Either Drug|Overall Study||5
217162|NCT01215916|526170|P1|Received at Least 1 Dose of Either Drug|Overall Study||1
217163|NCT01215916|526162|P9|STARTED|Overall Study||2
217164|NCT01215916|526163|P8|STARTED|Overall Study||3
217165|NCT01215916|526164|P7|STARTED|Overall Study||9
217166|NCT01215916|526165|P6|STARTED|Overall Study||4
217167|NCT01215916|526166|P5|STARTED|Overall Study||6
217168|NCT01215916|526167|P4|STARTED|Overall Study||6
217169|NCT01215916|526168|P3|STARTED|Overall Study||3
217170|NCT01215916|526169|P2|STARTED|Overall Study||5
217171|NCT01215916|526170|P1|STARTED|Overall Study||1
217172|NCT01215851|526204|P6|NOT COMPLETED|Follow up Period||1
217173|NCT01215851|526205|P5|NOT COMPLETED|Follow up Period||0
217174|NCT01215851|526206|P4|NOT COMPLETED|Follow up Period||0
217175|NCT01215851|526207|P3|NOT COMPLETED|Follow up Period||0
217176|NCT01215851|526208|P2|NOT COMPLETED|Follow up Period||0
217177|NCT01215851|526209|P1|NOT COMPLETED|Follow up Period||0
217178|NCT01215851|526204|P6|COMPLETED|Follow up Period||13
217179|NCT01215851|526205|P5|COMPLETED|Follow up Period||10
217180|NCT01215851|526206|P4|COMPLETED|Follow up Period||12
217181|NCT01215851|526207|P3|COMPLETED|Follow up Period||14
217182|NCT01215851|526208|P2|COMPLETED|Follow up Period||14
217183|NCT01215851|526209|P1|COMPLETED|Follow up Period||14
217184|NCT01215851|526204|P6|STARTED|Follow up Period||14
217185|NCT01215851|526205|P5|STARTED|Follow up Period||10
217186|NCT01215851|526206|P4|STARTED|Follow up Period||12
217187|NCT01215851|526207|P3|STARTED|Follow up Period||14
217188|NCT01215851|526208|P2|STARTED|Follow up Period||14
217189|NCT01215851|526209|P1|STARTED|Follow up Period||14
217190|NCT01215851|526204|P6|NOT COMPLETED|Treatment Period||1
217191|NCT01215851|526205|P5|NOT COMPLETED|Treatment Period||0
217192|NCT01215851|526206|P4|NOT COMPLETED|Treatment Period||3
217193|NCT01215851|526207|P3|NOT COMPLETED|Treatment Period||1
217194|NCT01215851|526208|P2|NOT COMPLETED|Treatment Period||1
217195|NCT01215851|526209|P1|NOT COMPLETED|Treatment Period||1
217196|NCT01215851|526204|P6|COMPLETED|Treatment Period||14
217197|NCT01215851|526205|P5|COMPLETED|Treatment Period||10
217198|NCT01215851|526206|P4|COMPLETED|Treatment Period||12
217199|NCT01215851|526207|P3|COMPLETED|Treatment Period||14
217200|NCT01215851|526208|P2|COMPLETED|Treatment Period||14
217201|NCT01215851|526209|P1|COMPLETED|Treatment Period||14
217202|NCT01215851|526204|P6|STARTED|Treatment Period||15
217203|NCT01215851|526205|P5|STARTED|Treatment Period||10
217204|NCT01215851|526206|P4|STARTED|Treatment Period||15
217205|NCT01215851|526207|P3|STARTED|Treatment Period||15
217206|NCT01215851|526208|P2|STARTED|Treatment Period||15
217207|NCT01215851|526209|P1|STARTED|Treatment Period||15
217208|NCT01215786|526250|P3|NOT COMPLETED|Overall Study||0
217209|NCT01215786|526251|P2|NOT COMPLETED|Overall Study||0
217210|NCT01215786|526252|P1|NOT COMPLETED|Overall Study||0
217211|NCT01215786|526250|P3|COMPLETED|Overall Study||10
217212|NCT01215786|526251|P2|COMPLETED|Overall Study||19
217213|NCT01215786|526252|P1|COMPLETED|Overall Study||21
217214|NCT01215786|526250|P3|STARTED|Overall Study||10
217215|NCT01215786|526251|P2|STARTED|Overall Study||19
217216|NCT01215786|526252|P1|STARTED|Overall Study||21
217217|NCT01215734|526268|P2|NOT COMPLETED|Overall Study||1
217218|NCT01215734|526269|P1|NOT COMPLETED|Overall Study||0
217219|NCT01215734|526268|P2|COMPLETED|Overall Study||14
217220|NCT01215734|526269|P1|COMPLETED|Overall Study||29
217221|NCT01215734|526268|P2|STARTED|Overall Study||15
217222|NCT01215734|526269|P1|STARTED|Overall Study||29
217223|NCT01215721|526277|P1|NOT COMPLETED|Overall Study||2
217224|NCT01215721|526277|P1|COMPLETED|Overall Study||38
217225|NCT01215721|526277|P1|STARTED|Overall Study||40
217226|NCT01215695|526283|P2|NOT COMPLETED|Overall Study||0
217227|NCT01215695|526284|P1|NOT COMPLETED|Overall Study||0
217228|NCT01215695|526283|P2|COMPLETED|Overall Study||70
217229|NCT01215695|526284|P1|COMPLETED|Overall Study||70
217230|NCT01215695|526283|P2|STARTED|Overall Study||70
217231|NCT01215695|526284|P1|STARTED|Overall Study||70
217232|NCT01215643|526303|P5|NOT COMPLETED|Overall Study||11
217233|NCT01215643|526304|P4|NOT COMPLETED|Overall Study||4
217234|NCT01215643|526305|P3|NOT COMPLETED|Overall Study||12
217235|NCT01215643|526306|P2|NOT COMPLETED|Overall Study||4
217236|NCT01215643|526307|P1|NOT COMPLETED|Overall Study||9
217237|NCT01215643|526303|P5|COMPLETED|Overall Study||29
217238|NCT01215643|526304|P4|COMPLETED|Overall Study||35
217239|NCT01215643|526305|P3|COMPLETED|Overall Study||82
217240|NCT01215643|526306|P2|COMPLETED|Overall Study||80
217241|NCT01215643|526307|P1|COMPLETED|Overall Study||74
217242|NCT01215643|526303|P5|STARTED|Overall Study||40
217243|NCT01215643|526304|P4|STARTED|Overall Study||39
217244|NCT01215643|526305|P3|STARTED|Overall Study||94
217245|NCT01215643|526306|P2|STARTED|Overall Study||84
217246|NCT01215643|526307|P1|STARTED|Overall Study||83
217247|NCT01215513|526409|P1|NOT COMPLETED|Overall Study||45
217248|NCT01215513|526409|P1|COMPLETED|Overall Study||112
217249|NCT01215513|526409|P1|CS42A Safety Analysis Set|Overall Study|127 participants were enrolled in the extension study CS42A|127
217250|NCT01215513|526409|P1|CS42 and CS42A Full Analysis Set|Overall Study|155 participants received at least 1 dose of degarelix and had at least 1 efficacy assessment|155
217251|NCT01215513|526409|P1|CS42 and CS42A Safety Analysis Set|Overall Study|156 participants received at least 1 dose of degarelix|156
217252|NCT01215513|526409|P1|STARTED|Overall Study|157 participants were allocated to treatment in CS42 main study (Intent-to-treat analysis set)|157
217253|NCT01215435|526418|P2|NOT COMPLETED|Overall Study||16
217254|NCT01215435|526419|P1|NOT COMPLETED|Overall Study||19
217255|NCT01215435|526418|P2|COMPLETED|Overall Study||107
217256|NCT01215435|526419|P1|COMPLETED|Overall Study||103
217257|NCT01215435|526418|P2|STARTED|Overall Study||123
217258|NCT01215435|526419|P1|STARTED|Overall Study||122
217259|NCT01215422|526433|P4|NOT COMPLETED|Overall Study||8
217260|NCT01215422|526434|P3|NOT COMPLETED|Overall Study||3
217261|NCT01215422|526435|P2|NOT COMPLETED|Overall Study||0
217262|NCT01215422|526436|P1|NOT COMPLETED|Overall Study||8
217263|NCT01215422|526433|P4|COMPLETED|Overall Study||193
217264|NCT01215422|526434|P3|COMPLETED|Overall Study||193
217265|NCT01215422|526435|P2|COMPLETED|Overall Study||249
217266|NCT01215422|526436|P1|COMPLETED|Overall Study||6
217267|NCT01215422|526433|P4|STARTED|Overall Study||201
217268|NCT01215422|526434|P3|STARTED|Overall Study||196
217269|NCT01215422|526435|P2|STARTED|Overall Study||249
217270|NCT01215422|526436|P1|STARTED|Overall Study||14
217271|NCT01215357|526458|P1|NOT COMPLETED|Overall Study||12
217272|NCT01215357|526458|P1|COMPLETED|Overall Study||22
217273|NCT01215357|526458|P1|STARTED|Overall Study||34
217274|NCT01215344|526464|P2|NOT COMPLETED|Overall Study||0
217275|NCT01215344|526465|P1|NOT COMPLETED|Overall Study||10
217276|NCT01215344|526464|P2|COMPLETED|Overall Study||3
217277|NCT01215344|526465|P1|COMPLETED|Overall Study||23
217278|NCT01215344|526464|P2|STARTED|Overall Study||3
217279|NCT01215344|526465|P1|STARTED|Overall Study||33
217280|NCT01215318|526475|P2|NOT COMPLETED|Overall Study||0
217281|NCT01215318|526476|P1|NOT COMPLETED|Overall Study||0
217282|NCT01215318|526475|P2|COMPLETED|Overall Study||24
217283|NCT01215318|526476|P1|COMPLETED|Overall Study||20
217284|NCT01215318|526475|P2|STARTED|Overall Study||24
217285|NCT01215318|526476|P1|STARTED|Overall Study||20
217286|NCT01215292|526489|P5|NOT COMPLETED|Overall Study||0
217287|NCT01215292|526490|P4|NOT COMPLETED|Overall Study||0
217288|NCT01215292|526491|P3|NOT COMPLETED|Overall Study||0
217289|NCT01215292|526492|P2|NOT COMPLETED|Overall Study||0
217290|NCT01215292|526493|P1|NOT COMPLETED|Overall Study||0
217291|NCT01215292|526489|P5|COMPLETED|Overall Study||8
217292|NCT01215292|526490|P4|COMPLETED|Overall Study||8
217293|NCT01215292|526491|P3|COMPLETED|Overall Study||8
217294|NCT01215292|526492|P2|COMPLETED|Overall Study||8
217295|NCT01215292|526493|P1|COMPLETED|Overall Study||8
217296|NCT01215292|526489|P5|STARTED|Overall Study||8
217297|NCT01215292|526490|P4|STARTED|Overall Study||8
217298|NCT01215292|526491|P3|STARTED|Overall Study||8
217299|NCT01215292|526492|P2|STARTED|Overall Study||8
217300|NCT01215292|526493|P1|STARTED|Overall Study||8
217301|NCT01215279|526517|P2|NOT COMPLETED|Overall Study||0
217302|NCT01215279|526518|P1|NOT COMPLETED|Overall Study||0
217303|NCT01215279|526517|P2|COMPLETED|Overall Study||32
217304|NCT01215279|526518|P1|COMPLETED|Overall Study||31
217305|NCT01215279|526517|P2|STARTED|Overall Study||32
217306|NCT01215279|526518|P1|STARTED|Overall Study||31
217307|NCT01215253|526584|P2|NOT COMPLETED|Overall Study||63
217308|NCT01215253|526585|P1|NOT COMPLETED|Overall Study||86
217309|NCT01215253|526584|P2|COMPLETED|Overall Study||439
217310|NCT01215253|526585|P1|COMPLETED|Overall Study||424
217311|NCT01215253|526584|P2|STARTED|Overall Study||502
217312|NCT01215253|526585|P1|STARTED|Overall Study||510
217313|NCT01215240|526615|P2|NOT COMPLETED|Overall Study||0
217314|NCT01215240|526616|P1|NOT COMPLETED|Overall Study||0
217315|NCT01215240|526615|P2|COMPLETED|Overall Study||12
217316|NCT01215240|526616|P1|COMPLETED|Overall Study||10
217317|NCT01215240|526615|P2|STARTED|Overall Study||12
217318|NCT01215240|526616|P1|STARTED|Overall Study||10
217319|NCT01215227|526638|P6|NOT COMPLETED|Overall Study||58
217320|NCT01215227|526639|P5|NOT COMPLETED|Overall Study||48
217321|NCT01215227|526640|P4|NOT COMPLETED|Overall Study||49
217322|NCT01215227|526641|P3|NOT COMPLETED|Overall Study||57
217323|NCT01215227|526642|P2|NOT COMPLETED|Overall Study||119
217324|NCT01215227|526643|P1|NOT COMPLETED|Overall Study||121
217325|NCT01215227|526638|P6|COMPLETED|Overall Study||51
217326|NCT01215227|526639|P5|COMPLETED|Overall Study||45
217327|NCT01215227|526640|P4|COMPLETED|Overall Study||48
217328|NCT01215227|526641|P3|COMPLETED|Overall Study||50
217329|NCT01215227|526642|P2|COMPLETED|Overall Study||96
217330|NCT01215227|526643|P1|COMPLETED|Overall Study||97
217331|NCT01215227|526638|P6|Treated|Overall Study||108
217332|NCT01215227|526639|P5|Treated|Overall Study||93
217333|NCT01215227|526640|P4|Treated|Overall Study||96
217334|NCT01215227|526641|P3|Treated|Overall Study||106
217335|NCT01215227|526642|P2|Treated|Overall Study||215
217336|NCT01215227|526643|P1|Treated|Overall Study||218
217337|NCT01215227|526638|P6|STARTED|Overall Study||109
217338|NCT01215227|526639|P5|STARTED|Overall Study||93
217339|NCT01215227|526640|P4|STARTED|Overall Study||97
217340|NCT01215227|526641|P3|STARTED|Overall Study||107
217341|NCT01215227|526642|P2|STARTED|Overall Study||215
217342|NCT01215227|526643|P1|STARTED|Overall Study||218
217343|NCT01215188|526690|P3|NOT COMPLETED|Overall Study||52
217344|NCT01215188|526691|P2|NOT COMPLETED|Overall Study||59
217345|NCT01215188|526692|P1|NOT COMPLETED|Overall Study||58
217346|NCT01215188|526690|P3|COMPLETED|Overall Study||326
217347|NCT01215188|526691|P2|COMPLETED|Overall Study||327
217348|NCT01215188|526692|P1|COMPLETED|Overall Study||320
217349|NCT01215188|526690|P3|STARTED|Overall Study||378
217350|NCT01215188|526691|P2|STARTED|Overall Study||386
217351|NCT01215188|526692|P1|STARTED|Overall Study||378
217352|NCT01215175|526744|P5|NOT COMPLETED|Overall Study||0
217353|NCT01215175|526745|P4|NOT COMPLETED|Overall Study||1
217354|NCT01215175|526746|P3|NOT COMPLETED|Overall Study||0
217355|NCT01215175|526747|P2|NOT COMPLETED|Overall Study||1
217356|NCT01215175|526748|P1|NOT COMPLETED|Overall Study||0
217357|NCT01215175|526744|P5|COMPLETED|Overall Study||28
217358|NCT01215175|526745|P4|COMPLETED|Overall Study||28
217359|NCT01215175|526746|P3|COMPLETED|Overall Study||33
217360|NCT01215175|526747|P2|COMPLETED|Overall Study||29
217361|NCT01215175|526748|P1|COMPLETED|Overall Study||30
217362|NCT01215175|526744|P5|Treated|Overall Study||28
217363|NCT01215175|526745|P4|Treated|Overall Study||29
217364|NCT01215175|526746|P3|Treated|Overall Study||33
217365|NCT01215175|526747|P2|Treated|Overall Study||30
217366|NCT01215175|526748|P1|Treated|Overall Study||30
217367|NCT01215175|526744|P5|STARTED|Overall Study||28
217368|NCT01215175|526745|P4|STARTED|Overall Study||29
217369|NCT01215175|526746|P3|STARTED|Overall Study||33
217370|NCT01215175|526747|P2|STARTED|Overall Study||30
217371|NCT01215175|526748|P1|STARTED|Overall Study||30
217372|NCT01215123|526790|P1|NOT COMPLETED|Overall Study||0
217373|NCT01215123|526790|P1|COMPLETED|Overall Study||28
217374|NCT01215123|526790|P1|STARTED|Overall Study||28
217375|NCT01215110|526800|P5|NOT COMPLETED|Overall Study||0
217376|NCT01215110|526801|P4|NOT COMPLETED|Overall Study||1
217377|NCT01215110|526802|P3|NOT COMPLETED|Overall Study||2
217378|NCT01215110|526803|P2|NOT COMPLETED|Overall Study||0
217379|NCT01215110|526804|P1|NOT COMPLETED|Overall Study||0
217380|NCT01215110|526800|P5|COMPLETED|Overall Study||8
217381|NCT01215110|526801|P4|COMPLETED|Overall Study||14
217382|NCT01215110|526802|P3|COMPLETED|Overall Study||13
217383|NCT01215110|526803|P2|COMPLETED|Overall Study||15
217384|NCT01215110|526804|P1|COMPLETED|Overall Study||15
217385|NCT01215110|526800|P5|STARTED|Overall Study||8
217386|NCT01215110|526801|P4|STARTED|Overall Study||15
217387|NCT01215110|526802|P3|STARTED|Overall Study||15
217388|NCT01215110|526803|P2|STARTED|Overall Study||15
217389|NCT01215110|526804|P1|STARTED|Overall Study||15
217390|NCT01215097|526865|P2|NOT COMPLETED|Overall Study||14
217391|NCT01215097|526866|P1|NOT COMPLETED|Overall Study||12
217392|NCT01215097|526865|P2|COMPLETED|Overall Study||191
217393|NCT01215097|526866|P1|COMPLETED|Overall Study||88
217394|NCT01215097|526865|P2|STARTED|Overall Study|Patients who are randomised and treated with linagliptin.|205
217395|NCT01215097|526866|P1|STARTED|Overall Study|Patients who are randomised and treated with placebo. 1 patient was not treated then not included.|100
217396|NCT01215032|526898|P1|NOT COMPLETED|Overall Study||20
217397|NCT01215032|526898|P1|COMPLETED|Overall Study||1
217398|NCT01215032|526898|P1|STARTED|Overall Study||21
217399|NCT01214980|526908|P2|NOT COMPLETED|Overall Study||2
217400|NCT01214980|526909|P1|NOT COMPLETED|Overall Study||3
217401|NCT01214980|526908|P2|COMPLETED|Overall Study||14
217402|NCT01214980|526909|P1|COMPLETED|Overall Study||13
217403|NCT01214980|526908|P2|STARTED|Overall Study||16
217404|NCT01214980|526909|P1|STARTED|Overall Study||16
217405|NCT01214915|526923|P1|NOT COMPLETED|Overall Study||11
217406|NCT01214915|526923|P1|COMPLETED|Overall Study||42
217407|NCT01214915|526923|P1|STARTED|Overall Study||53
217408|NCT01214850|526934|P3|NOT COMPLETED|Overall Study||161
217409|NCT01214850|526935|P2|NOT COMPLETED|Overall Study||144
217410|NCT01214850|526936|P1|NOT COMPLETED|Overall Study||183
217411|NCT01214850|526934|P3|COMPLETED|Overall Study||826
217412|NCT01214850|526935|P2|COMPLETED|Overall Study||844
217413|NCT01214850|526936|P1|COMPLETED|Overall Study||796
217414|NCT01214850|526934|P3|STARTED|Overall Study||987
217415|NCT01214850|526935|P2|STARTED|Overall Study||988
217416|NCT01214850|526936|P1|STARTED|Overall Study||979
217417|NCT01214837|527020|P3|NOT COMPLETED|Overall Study||62
217418|NCT01214837|527021|P2|NOT COMPLETED|Overall Study||64
217419|NCT01214837|527022|P1|NOT COMPLETED|Overall Study||54
217420|NCT01214837|527020|P3|COMPLETED|Overall Study||184
217421|NCT01214837|527021|P2|COMPLETED|Overall Study||192
217422|NCT01214837|527022|P1|COMPLETED|Overall Study||195
217423|NCT01214837|527020|P3|STARTED|Overall Study||246
217424|NCT01214837|527021|P2|STARTED|Overall Study||256
217425|NCT01214837|527022|P1|STARTED|Overall Study||249
217426|NCT01214824|527059|P1|NOT COMPLETED|Overall Study||3
217427|NCT01214824|527059|P1|COMPLETED|Overall Study||29
217428|NCT01214824|527059|P1|STARTED|Overall Study||32
217429|NCT01214811|527066|P1|NOT COMPLETED|Overall Study||3
217430|NCT01214811|527066|P1|COMPLETED|Overall Study||24
217431|NCT01214811|527066|P1|STARTED|Overall Study||27
217432|NCT01214759|527070|P1|NOT COMPLETED|Overall Study||48
217433|NCT01214759|527070|P1|COMPLETED|Overall Study||55
217434|NCT01214759|527070|P1|28 Days nPEP Completion|Overall Study||85
217435|NCT01214759|527070|P1|STARTED|Overall Study||103
217436|NCT01214720|527078|P2|NOT COMPLETED|Overall Study||68
217437|NCT01214720|527079|P1|NOT COMPLETED|Overall Study||85
217438|NCT01214720|527078|P2|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|233
217439|NCT01214720|527079|P1|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|221
217440|NCT01214720|527078|P2|STARTED|Overall Study||301
217441|NCT01214720|527079|P1|STARTED|Overall Study||306
217442|NCT01214668|527102|P6|NOT COMPLETED|Overall Study||6
217443|NCT01214668|527103|P5|NOT COMPLETED|Overall Study||6
217444|NCT01214668|527104|P4|NOT COMPLETED|Overall Study||6
217445|NCT01214668|527105|P3|NOT COMPLETED|Overall Study||6
217446|NCT01214668|527106|P2|NOT COMPLETED|Overall Study||3
217447|NCT01214668|527107|P1|NOT COMPLETED|Overall Study||4
217448|NCT01214668|527102|P6|COMPLETED|Overall Study||0
217449|NCT01214668|527103|P5|COMPLETED|Overall Study||0
217450|NCT01214668|527104|P4|COMPLETED|Overall Study||0
217451|NCT01214668|527105|P3|COMPLETED|Overall Study||0
217452|NCT01214668|527106|P2|COMPLETED|Overall Study||0
217453|NCT01214668|527107|P1|COMPLETED|Overall Study||0
217454|NCT01214668|527102|P6|Received at Least One Dose of Study Drug|Overall Study||6
217455|NCT01214668|527103|P5|Received at Least One Dose of Study Drug|Overall Study||6
217456|NCT01214668|527104|P4|Received at Least One Dose of Study Drug|Overall Study||6
217457|NCT01214668|527105|P3|Received at Least One Dose of Study Drug|Overall Study||6
217458|NCT01214668|527106|P2|Received at Least One Dose of Study Drug|Overall Study||3
217459|NCT01214668|527107|P1|Received at Least One Dose of Study Drug|Overall Study||4
217460|NCT01214668|527102|P6|STARTED|Overall Study||6
217461|NCT01214668|527103|P5|STARTED|Overall Study||6
217462|NCT01214668|527104|P4|STARTED|Overall Study||6
217463|NCT01214668|527105|P3|STARTED|Overall Study||6
217464|NCT01214668|527106|P2|STARTED|Overall Study||3
217465|NCT01214668|527107|P1|STARTED|Overall Study||4
217466|NCT01214655|527144|P3|NOT COMPLETED|Part C||7
217467|NCT01214655|527145|P2|NOT COMPLETED|Part C||0
217468|NCT01214655|527146|P1|NOT COMPLETED|Part C||0
217469|NCT01214655|527144|P3|COMPLETED|Part C||1
217470|NCT01214655|527145|P2|COMPLETED|Part C||0
217471|NCT01214655|527146|P1|COMPLETED|Part C||0
217472|NCT01214655|527144|P3|Received at Least 1 Dose of 5 mg/m²/Day|Part C||8
217473|NCT01214655|527145|P2|Received at Least 1 Dose of 5 mg/m²/Day|Part C||0
217474|NCT01214655|527146|P1|Received at Least 1 Dose of 5 mg/m²/Day|Part C||0
217475|NCT01214655|527144|P3|STARTED|Part C|Total on Schedule C, dose days 1,2,3|8
217476|NCT01214655|527145|P2|STARTED|Part C||0
217477|NCT01214655|527146|P1|STARTED|Part C||0
217478|NCT01214655|527144|P3|NOT COMPLETED|Part B||0
217479|NCT01214655|527145|P2|NOT COMPLETED|Part B||13
217480|NCT01214655|527146|P1|NOT COMPLETED|Part B||0
217481|NCT01214655|527144|P3|COMPLETED|Part B||0
217482|NCT01214655|527145|P2|COMPLETED|Part B||2
217483|NCT01214655|527146|P1|COMPLETED|Part B||0
217484|NCT01214655|527144|P3|Joined 14 mg/m²/Day|Part B||0
217485|NCT01214655|527145|P2|Joined 14 mg/m²/Day|Part B||3
217486|NCT01214655|527146|P1|Joined 14 mg/m²/Day|Part B||0
217487|NCT01214655|527144|P3|Escalated From 12 to 14 mg/m²/Day|Part B||0
217488|NCT01214655|527145|P2|Escalated From 12 to 14 mg/m²/Day|Part B||1
217489|NCT01214655|527146|P1|Escalated From 12 to 14 mg/m²/Day|Part B||0
217490|NCT01214655|527144|P3|Joined 12 mg/m²/Day|Part B||0
217491|NCT01214655|527145|P2|Joined 12 mg/m²/Day|Part B||5
217492|NCT01214655|527146|P1|Joined 12 mg/m²/Day|Part B||0
217493|NCT01214655|527144|P3|Escalated to 12 mg/m²/Day|Part B||0
217494|NCT01214655|527145|P2|Escalated to 12 mg/m²/Day|Part B||2
217495|NCT01214655|527146|P1|Escalated to 12 mg/m²/Day|Part B||0
217496|NCT01214655|527144|P3|Joined 10 mg/m²/Day Study D|Part B||0
217497|NCT01214655|527145|P2|Joined 10 mg/m²/Day Study D|Part B||3
217498|NCT01214655|527146|P1|Joined 10 mg/m²/Day Study D|Part B||0
217499|NCT01214655|527144|P3|Escalated From 8 to 10 mg/m²/Day|Part B||0
217500|NCT01214655|527145|P2|Escalated From 8 to 10 mg/m²/Day|Part B||2
217501|NCT01214655|527146|P1|Escalated From 8 to 10 mg/m²/Day|Part B||0
217502|NCT01214655|527144|P3|Recieved 8 mg/m²/Day Study Drug|Part B||0
217503|NCT01214655|527145|P2|Recieved 8 mg/m²/Day Study Drug|Part B||4
217504|NCT01214655|527146|P1|Recieved 8 mg/m²/Day Study Drug|Part B||0
217505|NCT01214655|527144|P3|Received at Least 1 Dose of Study Drug|Part B||0
217506|NCT01214655|527145|P2|Received at Least 1 Dose of Study Drug|Part B||15
217507|NCT01214655|527146|P1|Received at Least 1 Dose of Study Drug|Part B||0
217508|NCT01214655|527144|P3|STARTED|Part B||0
217509|NCT01214655|527145|P2|STARTED|Part B|Total on Schedule B, dose days 1,5,9|15
217510|NCT01214655|527146|P1|STARTED|Part B|Part A participants did not enroll in Part B. Participants in A, B, C are considered Cohorts.|0
217511|NCT01214655|527144|P3|NOT COMPLETED|Part A||0
217512|NCT01214655|527145|P2|NOT COMPLETED|Part A||0
217513|NCT01214655|527146|P1|NOT COMPLETED|Part A||8
217514|NCT01214655|527144|P3|COMPLETED|Part A||0
217515|NCT01214655|527145|P2|COMPLETED|Part A||0
217516|NCT01214655|527146|P1|COMPLETED|Part A||2
217517|NCT01214655|527144|P3|Received 6 mg Study Drug|Part A||0
217518|NCT01214655|527145|P2|Received 6 mg Study Drug|Part A||0
217519|NCT01214655|527146|P1|Received 6 mg Study Drug|Part A||5
217520|NCT01214655|527144|P3|Joined 6 mg Group|Part A||0
217521|NCT01214655|527145|P2|Joined 6 mg Group|Part A||0
217522|NCT01214655|527146|P1|Joined 6 mg Group|Part A||4
217523|NCT01214655|527144|P3|Escalated From 5 mg Study Drug|Part A||0
217524|NCT01214655|527145|P2|Escalated From 5 mg Study Drug|Part A||0
217525|NCT01214655|527146|P1|Escalated From 5 mg Study Drug|Part A||1
217526|NCT01214655|527144|P3|Joined 5 mg Study Drug|Part A||0
217527|NCT01214655|527145|P2|Joined 5 mg Study Drug|Part A||0
217528|NCT01214655|527146|P1|Joined 5 mg Study Drug|Part A||2
217529|NCT01214655|527144|P3|Escalated From 4 mg Study Drug|Part A||0
217530|NCT01214655|527145|P2|Escalated From 4 mg Study Drug|Part A||0
217531|NCT01214655|527146|P1|Escalated From 4 mg Study Drug|Part A||0
217532|NCT01214655|527144|P3|Joined 4 mg Group|Part A||0
217533|NCT01214655|527145|P2|Joined 4 mg Group|Part A||0
217534|NCT01214655|527146|P1|Joined 4 mg Group|Part A||1
217535|NCT01214655|527144|P3|Escalated From 2 to 4 mg/m²/Day|Part A||0
217536|NCT01214655|527145|P2|Escalated From 2 to 4 mg/m²/Day|Part A||0
217537|NCT01214655|527146|P1|Escalated From 2 to 4 mg/m²/Day|Part A||3
217538|NCT01214655|527144|P3|Received 2 mg Study Drug|Part A||0
217539|NCT01214655|527145|P2|Received 2 mg Study Drug|Part A||0
217540|NCT01214655|527146|P1|Received 2 mg Study Drug|Part A||3
217541|NCT01214655|527144|P3|STARTED|Part A||0
217542|NCT01214655|527145|P2|STARTED|Part A||0
217543|NCT01214655|527146|P1|STARTED|Part A|Total on Schedule A, dose days 1,2,3|10
217544|NCT01214642|527219|P12|NOT COMPLETED|Overall Study||6
217545|NCT01214642|527220|P11|NOT COMPLETED|Overall Study||4
217546|NCT01214642|527221|P10|NOT COMPLETED|Overall Study||4
217547|NCT01214642|527222|P9|NOT COMPLETED|Overall Study||13
217548|NCT01214642|527223|P8|NOT COMPLETED|Overall Study||3
217549|NCT01214642|527224|P7|NOT COMPLETED|Overall Study||6
217550|NCT01214642|527225|P6|NOT COMPLETED|Overall Study||3
217551|NCT01214642|527226|P5|NOT COMPLETED|Overall Study||6
217552|NCT01214642|527227|P4|NOT COMPLETED|Overall Study||6
217553|NCT01214642|527228|P3|NOT COMPLETED|Overall Study||6
217554|NCT01214642|527229|P2|NOT COMPLETED|Overall Study||3
217555|NCT01214642|527230|P1|NOT COMPLETED|Overall Study||3
217556|NCT01214642|527219|P12|COMPLETED|Overall Study||0
217557|NCT01214642|527220|P11|COMPLETED|Overall Study||0
217558|NCT01214642|527221|P10|COMPLETED|Overall Study||0
217559|NCT01214642|527222|P9|COMPLETED|Overall Study||0
217560|NCT01214642|527223|P8|COMPLETED|Overall Study||0
217561|NCT01214642|527224|P7|COMPLETED|Overall Study||0
217562|NCT01214642|527225|P6|COMPLETED|Overall Study||0
217563|NCT01214642|527226|P5|COMPLETED|Overall Study||0
217564|NCT01214642|527227|P4|COMPLETED|Overall Study||0
217565|NCT01214642|527228|P3|COMPLETED|Overall Study||0
217566|NCT01214642|527229|P2|COMPLETED|Overall Study||0
217567|NCT01214642|527230|P1|COMPLETED|Overall Study||0
217568|NCT01214642|527219|P12|Complete at Least 2 Cycles of Study Drug|Overall Study||5
217569|NCT01214642|527220|P11|Complete at Least 2 Cycles of Study Drug|Overall Study||2
217570|NCT01214642|527221|P10|Complete at Least 2 Cycles of Study Drug|Overall Study||2
217571|NCT01214642|527222|P9|Complete at Least 2 Cycles of Study Drug|Overall Study||12
217572|NCT01214642|527223|P8|Complete at Least 2 Cycles of Study Drug|Overall Study||3
217573|NCT01214642|527224|P7|Complete at Least 2 Cycles of Study Drug|Overall Study||6
217574|NCT01214642|527225|P6|Complete at Least 2 Cycles of Study Drug|Overall Study||1
217575|NCT01214642|527226|P5|Complete at Least 2 Cycles of Study Drug|Overall Study||6
217576|NCT01214642|527227|P4|Complete at Least 2 Cycles of Study Drug|Overall Study||4
217577|NCT01214642|527228|P3|Complete at Least 2 Cycles of Study Drug|Overall Study||5
217578|NCT01214642|527229|P2|Complete at Least 2 Cycles of Study Drug|Overall Study||1
217579|NCT01214642|527230|P1|Complete at Least 2 Cycles of Study Drug|Overall Study||3
217580|NCT01214642|527219|P12|Received at Least 1 Dose of Study Drug|Overall Study||6
217581|NCT01214642|527220|P11|Received at Least 1 Dose of Study Drug|Overall Study||4
217582|NCT01214642|527221|P10|Received at Least 1 Dose of Study Drug|Overall Study||4
217583|NCT01214642|527222|P9|Received at Least 1 Dose of Study Drug|Overall Study||13
217584|NCT01214642|527223|P8|Received at Least 1 Dose of Study Drug|Overall Study||3
217585|NCT01214642|527224|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
217586|NCT01214642|527225|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
217587|NCT01214642|527226|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
217588|NCT01214642|527227|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
217589|NCT01214642|527228|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
217590|NCT01214642|527229|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
217591|NCT01214642|527230|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
217592|NCT01214642|527219|P12|STARTED|Overall Study||6
217593|NCT01214642|527220|P11|STARTED|Overall Study||4
217594|NCT01214642|527221|P10|STARTED|Overall Study||4
217595|NCT01214642|527222|P9|STARTED|Overall Study|All participants who received 12 mg/m2/day on Days 1 and 5 plus PEG in Part A and Part B.|13
217596|NCT01214642|527223|P8|STARTED|Overall Study||3
217597|NCT01214642|527224|P7|STARTED|Overall Study||6
217598|NCT01214642|527225|P6|STARTED|Overall Study||3
217599|NCT01214642|527226|P5|STARTED|Overall Study||6
217600|NCT01214642|527227|P4|STARTED|Overall Study||6
217601|NCT01214642|527228|P3|STARTED|Overall Study||6
217602|NCT01214642|527229|P2|STARTED|Overall Study||3
217603|NCT01214642|527230|P1|STARTED|Overall Study||3
217604|NCT01214629|527310|P11|NOT COMPLETED|Overall Study||2
217605|NCT01214629|527311|P10|NOT COMPLETED|Overall Study||7
217606|NCT01214629|527312|P9|NOT COMPLETED|Overall Study||1
217607|NCT01214629|527313|P8|NOT COMPLETED|Overall Study||1
217608|NCT01214629|527314|P7|NOT COMPLETED|Overall Study||1
217609|NCT01214629|527315|P6|NOT COMPLETED|Overall Study||4
217610|NCT01214629|527316|P5|NOT COMPLETED|Overall Study||2
217611|NCT01214629|527317|P4|NOT COMPLETED|Overall Study||2
217612|NCT01214629|527318|P3|NOT COMPLETED|Overall Study||0
217613|NCT01214629|527319|P2|NOT COMPLETED|Overall Study||1
217614|NCT01214629|527320|P1|NOT COMPLETED|Overall Study||1
217615|NCT01214629|527310|P11|COMPLETED|Overall Study||1
217616|NCT01214629|527311|P10|COMPLETED|Overall Study||11
217617|NCT01214629|527312|P9|COMPLETED|Overall Study||2
217618|NCT01214629|527313|P8|COMPLETED|Overall Study||2
217619|NCT01214629|527314|P7|COMPLETED|Overall Study||4
217620|NCT01214629|527315|P6|COMPLETED|Overall Study||9
217621|NCT01214629|527316|P5|COMPLETED|Overall Study||1
217622|NCT01214629|527317|P4|COMPLETED|Overall Study||1
217623|NCT01214629|527318|P3|COMPLETED|Overall Study||1
217624|NCT01214629|527319|P2|COMPLETED|Overall Study||0
217625|NCT01214629|527320|P1|COMPLETED|Overall Study||0
217626|NCT01214629|527310|P11|Received at Least 1 Dose of Study Drug|Overall Study||3
217627|NCT01214629|527311|P10|Received at Least 1 Dose of Study Drug|Overall Study||18
217628|NCT01214629|527312|P9|Received at Least 1 Dose of Study Drug|Overall Study||3
217629|NCT01214629|527313|P8|Received at Least 1 Dose of Study Drug|Overall Study||3
217630|NCT01214629|527314|P7|Received at Least 1 Dose of Study Drug|Overall Study||5
217631|NCT01214629|527315|P6|Received at Least 1 Dose of Study Drug|Overall Study||13
217632|NCT01214629|527316|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
217633|NCT01214629|527317|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
217634|NCT01214629|527318|P3|Received at Least 1 Dose of Study Drug|Overall Study||1
217635|NCT01214629|527319|P2|Received at Least 1 Dose of Study Drug|Overall Study||1
217636|NCT01214629|527320|P1|Received at Least 1 Dose of Study Drug|Overall Study||1
217637|NCT01214629|527310|P11|STARTED|Overall Study||3
217638|NCT01214629|527311|P10|STARTED|Overall Study||18
217639|NCT01214629|527312|P9|STARTED|Overall Study||3
217640|NCT01214629|527313|P8|STARTED|Overall Study||3
217641|NCT01214629|527314|P7|STARTED|Overall Study||5
217642|NCT01214629|527315|P6|STARTED|Overall Study||13
217643|NCT01214629|527316|P5|STARTED|Overall Study||3
217644|NCT01214629|527317|P4|STARTED|Overall Study||3
217645|NCT01214629|527318|P3|STARTED|Overall Study||1
217646|NCT01214629|527319|P2|STARTED|Overall Study||1
217647|NCT01214629|527320|P1|STARTED|Overall Study||1
217648|NCT01214616|527385|P4|NOT COMPLETED|Overall Study||6
217649|NCT01214616|527386|P3|NOT COMPLETED|Overall Study||3
217650|NCT01214616|527387|P2|NOT COMPLETED|Overall Study||5
217651|NCT01214616|527388|P1|NOT COMPLETED|Overall Study||3
217652|NCT01214616|527385|P4|COMPLETED|Overall Study||0
217653|NCT01214616|527386|P3|COMPLETED|Overall Study||0
217654|NCT01214616|527387|P2|COMPLETED|Overall Study||0
217655|NCT01214616|527388|P1|COMPLETED|Overall Study||0
217656|NCT01214616|527385|P4|STARTED|Overall Study|Cohort 3 with afatinib/vinorelbine modification. Skipping vinorelbine allowed and not considered DLT|6
217657|NCT01214616|527386|P3|STARTED|Overall Study||3
217658|NCT01214616|527387|P2|STARTED|Overall Study||5
217659|NCT01214616|527388|P1|STARTED|Overall Study||3
217660|NCT01214603|527425|P3|NOT COMPLETED|Overall Study||4
217661|NCT01214603|527426|P2|NOT COMPLETED|Overall Study||1
217662|NCT01214603|527427|P1|NOT COMPLETED|Overall Study||5
217663|NCT01214603|527425|P3|COMPLETED|Overall Study||3
217664|NCT01214603|527426|P2|COMPLETED|Overall Study||5
217665|NCT01214603|527427|P1|COMPLETED|Overall Study||2
217666|NCT01214603|527425|P3|Received at Least 1 Dose of LY2090314|Overall Study||7
217667|NCT01214603|527426|P2|Received at Least 1 Dose of LY2090314|Overall Study||6
217668|NCT01214603|527427|P1|Received at Least 1 Dose of LY2090314|Overall Study||7
217669|NCT01214603|527425|P3|STARTED|Overall Study||7
217670|NCT01214603|527426|P2|STARTED|Overall Study||6
217671|NCT01214603|527427|P1|STARTED|Overall Study||7
217672|NCT01214434|527450|P2|NOT COMPLETED|Overall Study||2
217673|NCT01214434|527451|P1|NOT COMPLETED|Overall Study||4
217674|NCT01214434|527450|P2|COMPLETED|Overall Study||25
217675|NCT01214434|527451|P1|COMPLETED|Overall Study||11
217676|NCT01214434|527450|P2|STARTED|Overall Study||27
217677|NCT01214434|527451|P1|STARTED|Overall Study||15
217678|NCT01214395|527467|P1|NOT COMPLETED|Overall Study||5
217679|NCT01214395|527467|P1|COMPLETED|Overall Study||0
217680|NCT01214395|527467|P1|STARTED|Overall Study||5
217681|NCT01214356|527474|P2|NOT COMPLETED|Overall Study||14
217682|NCT01214356|527475|P1|NOT COMPLETED|Overall Study||17
217683|NCT01214356|527474|P2|COMPLETED|Overall Study||13
217684|NCT01214356|527475|P1|COMPLETED|Overall Study||10
217685|NCT01214356|527474|P2|STARTED|Overall Study||27
217686|NCT01214356|527475|P1|STARTED|Overall Study||27
217687|NCT01214330|527481|P1|NOT COMPLETED|Overall Study||48
217688|NCT01214330|527481|P1|COMPLETED|Overall Study||102
217689|NCT01214330|527481|P1|STARTED|Overall Study||150
217690|NCT01214252|527485|P1|NOT COMPLETED|Overall Study||82
217691|NCT01214252|527485|P1|COMPLETED|Overall Study||343
217692|NCT01214252|527485|P1|STARTED|Overall Study||425
217693|NCT01214239|527493|P2|NOT COMPLETED|Overall Study||18
217694|NCT01214239|527494|P1|NOT COMPLETED|Overall Study||12
217695|NCT01214239|527493|P2|COMPLETED|Overall Study||182
217696|NCT01214239|527494|P1|COMPLETED|Overall Study||87
217697|NCT01214239|527493|P2|STARTED|Overall Study|patients who were randomised and treated with placebo. 1 patient was not treated then not included|200
217698|NCT01214239|527494|P1|STARTED|Overall Study|patients who were randomised and treated with placebo|99
217699|NCT01214200|527526|P1|NOT COMPLETED|Overall Study||11
217700|NCT01214200|527526|P1|COMPLETED|Overall Study||9
217701|NCT01214200|527526|P1|STARTED|Overall Study||20
217702|NCT01214187|527540|P2|NOT COMPLETED|Overall Study||6
217703|NCT01214187|527541|P1|NOT COMPLETED|Overall Study||7
217704|NCT01214187|527540|P2|COMPLETED|Overall Study||23
217705|NCT01214187|527541|P1|COMPLETED|Overall Study||22
217706|NCT01214187|527540|P2|STARTED|Overall Study||29
217707|NCT01214187|527541|P1|STARTED|Overall Study||29
217708|NCT01214174|527558|P3|NOT COMPLETED|Overall Study||1
217709|NCT01214174|527559|P2|NOT COMPLETED|Overall Study||0
217710|NCT01214174|527560|P1|NOT COMPLETED|Overall Study||0
217711|NCT01214174|527558|P3|COMPLETED|Overall Study||13
217712|NCT01214174|527559|P2|COMPLETED|Overall Study||16
217713|NCT01214174|527560|P1|COMPLETED|Overall Study||13
217714|NCT01214174|527558|P3|STARTED|Overall Study||14
217715|NCT01214174|527559|P2|STARTED|Overall Study||16
217716|NCT01214174|527560|P1|STARTED|Overall Study||13
217717|NCT01214161|527570|P2|NOT COMPLETED|Overall Study||0
217718|NCT01214161|527571|P1|NOT COMPLETED|Overall Study||0
217719|NCT01214161|527570|P2|COMPLETED|Overall Study||100
217720|NCT01214161|527571|P1|COMPLETED|Overall Study||100
217721|NCT01214161|527570|P2|STARTED|Overall Study||100
217722|NCT01214161|527571|P1|STARTED|Overall Study||100
217723|NCT01214109|527581|P4|NOT COMPLETED|Overall Study||0
217724|NCT01214109|527582|P3|NOT COMPLETED|Overall Study||0
217725|NCT01214109|527583|P2|NOT COMPLETED|Overall Study||0
217726|NCT01214109|527584|P1|NOT COMPLETED|Overall Study||0
217727|NCT01214109|527581|P4|COMPLETED|Overall Study||24
217728|NCT01214109|527582|P3|COMPLETED|Overall Study||24
217729|NCT01214109|527583|P2|COMPLETED|Overall Study||24
217730|NCT01214109|527584|P1|COMPLETED|Overall Study||24
217731|NCT01214109|527581|P4|STARTED|Overall Study||24
217732|NCT01214109|527582|P3|STARTED|Overall Study||24
217733|NCT01214109|527583|P2|STARTED|Overall Study||24
217734|NCT01214109|527584|P1|STARTED|Overall Study||24
217735|NCT01214083|527676|P3|NOT COMPLETED|Overall Study||10
217736|NCT01214083|527677|P2|NOT COMPLETED|Overall Study||10
217737|NCT01214083|527678|P1|NOT COMPLETED|Overall Study||12
217738|NCT01214083|527676|P3|COMPLETED|Overall Study||21
217739|NCT01214083|527677|P2|COMPLETED|Overall Study||23
217740|NCT01214083|527678|P1|COMPLETED|Overall Study||19
217741|NCT01214083|527676|P3|STARTED|Overall Study||31
217742|NCT01214083|527677|P2|STARTED|Overall Study||33
217743|NCT01214083|527678|P1|STARTED|Overall Study||31
217744|NCT01214044|527710|P1|NOT COMPLETED|Visits 6-11: Escitalopram 20 mg Daily||4
217745|NCT01214044|527710|P1|COMPLETED|Visits 6-11: Escitalopram 20 mg Daily||10
217746|NCT01214044|527710|P1|STARTED|Visits 6-11: Escitalopram 20 mg Daily||14
217747|NCT01214044|527710|P1|NOT COMPLETED|Visits 3-5: Escitalopram 10 mg Daily||3
217748|NCT01214044|527710|P1|COMPLETED|Visits 3-5: Escitalopram 10 mg Daily||14
217749|NCT01214044|527710|P1|STARTED|Visits 3-5: Escitalopram 10 mg Daily||17
217750|NCT01214044|527710|P1|NOT COMPLETED|Visit 2: End Washout & Start Placebo||2
217751|NCT01214044|527710|P1|COMPLETED|Visit 2: End Washout & Start Placebo|2 subjects dropped out during the placebo week (between study visits 2 & 3)|17
217752|NCT01214044|527710|P1|STARTED|Visit 2: End Washout & Start Placebo||19
217753|NCT01214044|527710|P1|NOT COMPLETED|Visit 1: Screening and Consent, Washout||12
217754|NCT01214044|527710|P1|COMPLETED|Visit 1: Screening and Consent, Washout||19
217755|NCT01214044|527710|P1|STARTED|Visit 1: Screening and Consent, Washout||31
217756|NCT01213966|527724|P4|NOT COMPLETED|Overall Study||1
217757|NCT01213966|527725|P3|NOT COMPLETED|Overall Study||3
217758|NCT01213966|527726|P2|NOT COMPLETED|Overall Study||0
217759|NCT01213966|527727|P1|NOT COMPLETED|Overall Study||1
217760|NCT01213966|527724|P4|COMPLETED|Overall Study||20
217761|NCT01213966|527725|P3|COMPLETED|Overall Study||17
217762|NCT01213966|527726|P2|COMPLETED|Overall Study||20
217763|NCT01213966|527727|P1|COMPLETED|Overall Study||19
217764|NCT01213966|527724|P4|STARTED|Overall Study||21
217765|NCT01213966|527725|P3|STARTED|Overall Study||20
217766|NCT01213966|527726|P2|STARTED|Overall Study||20
217767|NCT01213966|527727|P1|STARTED|Overall Study||20
217768|NCT01213836|527739|P2|NOT COMPLETED|Period 2, Second Intervention||0
217769|NCT01213836|527740|P1|NOT COMPLETED|Period 2, Second Intervention||0
217770|NCT01213836|527739|P2|COMPLETED|Period 2, Second Intervention||29
217771|NCT01213836|527740|P1|COMPLETED|Period 2, Second Intervention||31
217772|NCT01213836|527739|P2|STARTED|Period 2, Second Intervention||29
217773|NCT01213836|527740|P1|STARTED|Period 2, Second Intervention||31
217774|NCT01213836|527739|P2|NOT COMPLETED|Period 1, First Intervention||3
217775|NCT01213836|527740|P1|NOT COMPLETED|Period 1, First Intervention||3
217776|NCT01213836|527739|P2|COMPLETED|Period 1, First Intervention||29
217777|NCT01213836|527740|P1|COMPLETED|Period 1, First Intervention||31
217778|NCT01213836|527739|P2|STARTED|Period 1, First Intervention||32
217779|NCT01213836|527740|P1|STARTED|Period 1, First Intervention||34
217780|NCT01213823|527760|P2|NOT COMPLETED|Overall Study||0
217781|NCT01213823|527761|P1|NOT COMPLETED|Overall Study||0
217782|NCT01213823|527760|P2|COMPLETED|Overall Study||467
217783|NCT01213823|527761|P1|COMPLETED|Overall Study||69
217784|NCT01213823|527760|P2|STARTED|Overall Study||467
217785|NCT01213823|527761|P1|STARTED|Overall Study||69
217786|NCT01213706|527767|P1|NOT COMPLETED|WBPA||0
217787|NCT01213706|527767|P1|COMPLETED|WBPA||45
217788|NCT01213706|527767|P1|STARTED|WBPA||45
217789|NCT01213706|527767|P1|NOT COMPLETED|Washout (1 Hour)||0
217790|NCT01213706|527767|P1|COMPLETED|Washout (1 Hour)||45
217791|NCT01213706|527767|P1|STARTED|Washout (1 Hour)||45
217792|NCT01213706|527767|P1|NOT COMPLETED|Sham WBPA||0
217793|NCT01213706|527767|P1|COMPLETED|Sham WBPA||45
217794|NCT01213706|527767|P1|STARTED|Sham WBPA||45
217795|NCT01213589|527776|P3|NOT COMPLETED|Overall Study||8
217796|NCT01213589|527777|P2|NOT COMPLETED|Overall Study||5
217797|NCT01213589|527778|P1|NOT COMPLETED|Overall Study||13
217798|NCT01213589|527776|P3|COMPLETED|Overall Study||18
217799|NCT01213589|527777|P2|COMPLETED|Overall Study||19
217800|NCT01213589|527778|P1|COMPLETED|Overall Study||37
217801|NCT01213589|527776|P3|STARTED|Overall Study||26
217802|NCT01213589|527777|P2|STARTED|Overall Study||24
217803|NCT01213589|527778|P1|STARTED|Overall Study||50
217804|NCT01213576|527808|P4|NOT COMPLETED|Overall Study||4
217805|NCT01213576|527809|P3|NOT COMPLETED|Overall Study||5
217806|NCT01213576|527810|P2|NOT COMPLETED|Overall Study||4
217807|NCT01213576|527811|P1|NOT COMPLETED|Overall Study||3
217808|NCT01213576|527808|P4|COMPLETED|Overall Study||13
217809|NCT01213576|527809|P3|COMPLETED|Overall Study||13
217810|NCT01213576|527810|P2|COMPLETED|Overall Study||13
217811|NCT01213576|527811|P1|COMPLETED|Overall Study||15
217812|NCT01213576|527808|P4|STARTED|Overall Study||17
217813|NCT01213576|527809|P3|STARTED|Overall Study||18
217814|NCT01213576|527810|P2|STARTED|Overall Study||17
217815|NCT01213576|527811|P1|STARTED|Overall Study||18
217816|NCT01213472|527825|P1|NOT COMPLETED|Overall Study||27
217817|NCT01213472|527825|P1|COMPLETED|Overall Study||6
217818|NCT01213472|527825|P1|STARTED|Overall Study||33
217819|NCT01213329|527848|P2|NOT COMPLETED|Phase 2||0
217820|NCT01213329|527849|P1|NOT COMPLETED|Phase 2||0
217821|NCT01213329|527848|P2|COMPLETED|Phase 2||0
217822|NCT01213329|527849|P1|COMPLETED|Phase 2||0
217823|NCT01213329|527848|P2|STARTED|Phase 2|No subjects continued into phase 2.This is due to a loss of samples from a processing inconsistency.|0
217824|NCT01213329|527849|P1|STARTED|Phase 2|No subjects continued into phase 2.This is due to a loss of samples from a processing inconsistency.|0
217825|NCT01213329|527848|P2|NOT COMPLETED|Screening||0
217826|NCT01213329|527849|P1|NOT COMPLETED|Screening||0
217827|NCT01213329|527848|P2|COMPLETED|Screening||25
217828|NCT01213329|527849|P1|COMPLETED|Screening||25
217829|NCT01213329|527848|P2|STARTED|Screening||25
217830|NCT01213329|527849|P1|STARTED|Screening||25
217831|NCT01213316|527855|P1|NOT COMPLETED|Overall Study||0
217832|NCT01213316|527855|P1|COMPLETED|Overall Study||451
217833|NCT01213316|527855|P1|Initial Cohort|Overall Study|Participants >=18 years of age in the initial cohort|272
217834|NCT01213316|527855|P1|Discontinued Treatment Before 48 Weeks|Overall Study||67
217835|NCT01213316|527855|P1|Amendment Cohort: Newly Enrolled|Overall Study|Participants >=50 years of age newly enrolled|179
217836|NCT01213316|527855|P1|Amendment Cohort: Prolonged Participants|Overall Study|Participants >=50 years of age in the initial cohort who accept an additional 48-week observation|48
217837|NCT01213316|527855|P1|STARTED|Overall Study|Participants in the initial and amendment cohorts|451
217838|NCT01213264|527874|P3|NOT COMPLETED|Overall Study||6
217839|NCT01213264|527875|P2|NOT COMPLETED|Overall Study||2
217840|NCT01213264|527876|P1|NOT COMPLETED|Overall Study||2
217841|NCT01213264|527874|P3|COMPLETED|Overall Study||321
217842|NCT01213264|527875|P2|COMPLETED|Overall Study||175
217843|NCT01213264|527876|P1|COMPLETED|Overall Study||153
217844|NCT01213264|527874|P3|STARTED|Overall Study||327
217845|NCT01213264|527875|P2|STARTED|Overall Study||177
217846|NCT01213264|527876|P1|STARTED|Overall Study||155
217847|NCT01213251|527896|P3|NOT COMPLETED|Overall Study||11
217848|NCT01213251|527897|P2|NOT COMPLETED|Overall Study||4
217849|NCT01213251|527898|P1|NOT COMPLETED|Overall Study||6
217850|NCT01213251|527896|P3|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
217851|NCT01213251|527897|P2|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|37
217852|NCT01213251|527898|P1|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
217853|NCT01213251|527896|P3|STARTED|Overall Study||45
217854|NCT01213251|527897|P2|STARTED|Overall Study||41
217855|NCT01213251|527898|P1|STARTED|Overall Study||40
217856|NCT01213199|527919|P1|NOT COMPLETED|Overall Study||4
217857|NCT01213199|527919|P1|COMPLETED|Overall Study||16
217858|NCT01213199|527919|P1|STARTED|Overall Study||20
217859|NCT01213173|527925|P2|NOT COMPLETED|Overall Study||16
217860|NCT01213173|527926|P1|NOT COMPLETED|Overall Study||12
217861|NCT01213173|527925|P2|COMPLETED|Overall Study|Patients who completed the study|110
217862|NCT01213173|527926|P1|COMPLETED|Overall Study|Patients who completed the study|113
217863|NCT01213173|527925|P2|Patients Included in PP Population|Overall Study||89
217864|NCT01213173|527926|P1|Patients Included in PP Population|Overall Study||102
217865|NCT01213173|527925|P2|Patients Included in ITT Population|Overall Study||115
217866|NCT01213173|527926|P1|Patients Included in ITT Population|Overall Study||116
217867|NCT01213173|527925|P2|Patients Included in Safety Population|Overall Study||112
217868|NCT01213173|527926|P1|Patients Included in Safety Population|Overall Study||139
217869|NCT01213173|527925|P2|STARTED|Overall Study|Patients who were randomized and received treatment|126
217870|NCT01213173|527926|P1|STARTED|Overall Study|Patients who were randomized and received treatment|125
217871|NCT01213082|527959|P3|NOT COMPLETED|Overall Study||5
217872|NCT01213082|527960|P2|NOT COMPLETED|Overall Study||7
217873|NCT01213082|527961|P1|NOT COMPLETED|Overall Study||6
217874|NCT01213082|527959|P3|COMPLETED|Overall Study||6
217875|NCT01213082|527960|P2|COMPLETED|Overall Study||4
217876|NCT01213082|527961|P1|COMPLETED|Overall Study||6
217877|NCT01213082|527959|P3|STARTED|Overall Study||11
217878|NCT01213082|527960|P2|STARTED|Overall Study||11
217879|NCT01213082|527961|P1|STARTED|Overall Study||12
217880|NCT01213043|527974|P2|NOT COMPLETED|Follow-up||0
217881|NCT01213043|527975|P1|NOT COMPLETED|Follow-up||0
217882|NCT01213043|527974|P2|COMPLETED|Follow-up||15
217883|NCT01213043|527975|P1|COMPLETED|Follow-up||15
217884|NCT01213043|527974|P2|STARTED|Follow-up||15
217885|NCT01213043|527975|P1|STARTED|Follow-up||15
217886|NCT01213043|527974|P2|NOT COMPLETED|Treatment Period 2||0
217887|NCT01213043|527975|P1|NOT COMPLETED|Treatment Period 2||0
217888|NCT01213043|527974|P2|COMPLETED|Treatment Period 2||15
217889|NCT01213043|527975|P1|COMPLETED|Treatment Period 2||15
217890|NCT01213043|527974|P2|STARTED|Treatment Period 2||15
217891|NCT01213043|527975|P1|STARTED|Treatment Period 2||15
217892|NCT01213043|527974|P2|NOT COMPLETED|Washout Period||0
217893|NCT01213043|527975|P1|NOT COMPLETED|Washout Period||0
217894|NCT01213043|527974|P2|COMPLETED|Washout Period||15
217895|NCT01213043|527975|P1|COMPLETED|Washout Period||15
217896|NCT01213043|527974|P2|STARTED|Washout Period||15
217897|NCT01213043|527975|P1|STARTED|Washout Period||15
217898|NCT01213043|527974|P2|NOT COMPLETED|Treatment Period 1||0
217899|NCT01213043|527975|P1|NOT COMPLETED|Treatment Period 1||0
217900|NCT01213043|527974|P2|COMPLETED|Treatment Period 1||15
217901|NCT01213043|527975|P1|COMPLETED|Treatment Period 1||15
217902|NCT01213043|527974|P2|STARTED|Treatment Period 1||15
217903|NCT01213043|527975|P1|STARTED|Treatment Period 1||15
217904|NCT01212991|528003|P2|NOT COMPLETED|Overall Study||374
217905|NCT01212991|528004|P1|NOT COMPLETED|Overall Study||613
217906|NCT01212991|528003|P2|COMPLETED|Overall Study|Indicates participants continuing in long-term follow-up as of 16SEP2013.|471
217907|NCT01212991|528004|P1|COMPLETED|Overall Study|Indicates participants continuing in long-term follow-up as of 16SEP2013.|259
217908|NCT01212991|528003|P2|STARTED|Overall Study||845
217909|NCT01212991|528004|P1|STARTED|Overall Study||872
217910|NCT01212900|528024|P2|NOT COMPLETED|Overall Study||7
217911|NCT01212900|528025|P1|NOT COMPLETED|Overall Study||12
217912|NCT01212900|528024|P2|COMPLETED|Overall Study||107
217913|NCT01212900|528025|P1|COMPLETED|Overall Study||104
217914|NCT01212900|528024|P2|STARTED|Overall Study||114
217915|NCT01212900|528025|P1|STARTED|Overall Study||116
217916|NCT01212874|528033|P2|NOT COMPLETED|Overall Study||23
217917|NCT01212874|528034|P1|NOT COMPLETED|Overall Study||22
217918|NCT01212874|528033|P2|COMPLETED|Overall Study||12
217919|NCT01212874|528034|P1|COMPLETED|Overall Study||13
217920|NCT01212874|528033|P2|Received Allocated Intervention|Overall Study||12
217921|NCT01212874|528034|P1|Received Allocated Intervention|Overall Study||13
217922|NCT01212874|528033|P2|STARTED|Overall Study||35
217923|NCT01212874|528034|P1|STARTED|Overall Study||35
217924|NCT01212770|528045|P9|NOT COMPLETED|Long-term Safety Phase (Year 5)||1
217925|NCT01212770|528046|P8|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
217926|NCT01212770|528047|P7|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
217927|NCT01212770|528048|P6|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
217928|NCT01212770|528049|P5|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
217929|NCT01212770|528050|P4|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
217930|NCT01212770|528051|P3|NOT COMPLETED|Long-term Safety Phase (Year 5)||11
217931|NCT01212770|528052|P2|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
217932|NCT01212770|528053|P1|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
217933|NCT01212770|528045|P9|COMPLETED|Long-term Safety Phase (Year 5)||41
217934|NCT01212770|528046|P8|COMPLETED|Long-term Safety Phase (Year 5)||30
217935|NCT01212770|528047|P7|COMPLETED|Long-term Safety Phase (Year 5)||0
217936|NCT01212770|528048|P6|COMPLETED|Long-term Safety Phase (Year 5)||0
217937|NCT01212770|528049|P5|COMPLETED|Long-term Safety Phase (Year 5)||0
217938|NCT01212770|528050|P4|COMPLETED|Long-term Safety Phase (Year 5)||0
217939|NCT01212770|528051|P3|COMPLETED|Long-term Safety Phase (Year 5)||72
217940|NCT01212770|528052|P2|COMPLETED|Long-term Safety Phase (Year 5)||68
217941|NCT01212770|528053|P1|COMPLETED|Long-term Safety Phase (Year 5)||0
217942|NCT01212770|528045|P9|STARTED|Long-term Safety Phase (Year 5)||42
217943|NCT01212770|528046|P8|STARTED|Long-term Safety Phase (Year 5)||32
217944|NCT01212770|528047|P7|STARTED|Long-term Safety Phase (Year 5)||0
217945|NCT01212770|528048|P6|STARTED|Long-term Safety Phase (Year 5)||0
217946|NCT01212770|528049|P5|STARTED|Long-term Safety Phase (Year 5)||0
217947|NCT01212770|528050|P4|STARTED|Long-term Safety Phase (Year 5)||0
217948|NCT01212770|528051|P3|STARTED|Long-term Safety Phase (Year 5)||83
217949|NCT01212770|528052|P2|STARTED|Long-term Safety Phase (Year 5)|1 participant who completed Year 4 did not continue treatment in Year 5|70
217950|NCT01212770|528053|P1|STARTED|Long-term Safety Phase (Year 5)||0
217951|NCT01212770|528045|P9|NOT COMPLETED|Long-term Safety Phase (Year 4)||2
217952|NCT01212770|528046|P8|NOT COMPLETED|Long-term Safety Phase (Year 4)||3
217953|NCT01212770|528047|P7|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
217954|NCT01212770|528048|P6|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
217955|NCT01212770|528049|P5|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
217956|NCT01212770|528050|P4|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
217957|NCT01212770|528051|P3|NOT COMPLETED|Long-term Safety Phase (Year 4)||11
217958|NCT01212770|528052|P2|NOT COMPLETED|Long-term Safety Phase (Year 4)||6
217959|NCT01212770|528053|P1|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
217960|NCT01212770|528045|P9|COMPLETED|Long-term Safety Phase (Year 4)||42
217961|NCT01212770|528046|P8|COMPLETED|Long-term Safety Phase (Year 4)||32
217962|NCT01212770|528047|P7|COMPLETED|Long-term Safety Phase (Year 4)||0
217963|NCT01212770|528048|P6|COMPLETED|Long-term Safety Phase (Year 4)||0
217964|NCT01212770|528049|P5|COMPLETED|Long-term Safety Phase (Year 4)||0
217965|NCT01212770|528050|P4|COMPLETED|Long-term Safety Phase (Year 4)||0
217966|NCT01212770|528051|P3|COMPLETED|Long-term Safety Phase (Year 4)||83
217967|NCT01212770|528052|P2|COMPLETED|Long-term Safety Phase (Year 4)||71
217968|NCT01212770|528053|P1|COMPLETED|Long-term Safety Phase (Year 4)||0
217969|NCT01212770|528045|P9|STARTED|Long-term Safety Phase (Year 4)||44
217970|NCT01212770|528046|P8|STARTED|Long-term Safety Phase (Year 4)||35
217971|NCT01212770|528047|P7|STARTED|Long-term Safety Phase (Year 4)||0
217972|NCT01212770|528048|P6|STARTED|Long-term Safety Phase (Year 4)||0
217973|NCT01212770|528049|P5|STARTED|Long-term Safety Phase (Year 4)||0
217974|NCT01212770|528050|P4|STARTED|Long-term Safety Phase (Year 4)||0
217975|NCT01212770|528051|P3|STARTED|Long-term Safety Phase (Year 4)||94
218046|NCT01212770|528050|P4|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||32
217976|NCT01212770|528052|P2|STARTED|Long-term Safety Phase (Year 4)|1 participant was counted in Year 4 but not in year 3 due to late APR dispensing|77
217977|NCT01212770|528053|P1|STARTED|Long-term Safety Phase (Year 4)||0
217978|NCT01212770|528045|P9|NOT COMPLETED|Long-term Safety Phase (Year 3)||5
217979|NCT01212770|528046|P8|NOT COMPLETED|Long-term Safety Phase (Year 3)||7
217980|NCT01212770|528047|P7|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
217981|NCT01212770|528048|P6|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
217982|NCT01212770|528049|P5|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
217983|NCT01212770|528050|P4|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
217984|NCT01212770|528051|P3|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
217985|NCT01212770|528052|P2|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
217986|NCT01212770|528053|P1|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
217987|NCT01212770|528045|P9|COMPLETED|Long-term Safety Phase (Year 3)||44
217988|NCT01212770|528046|P8|COMPLETED|Long-term Safety Phase (Year 3)||35
217989|NCT01212770|528047|P7|COMPLETED|Long-term Safety Phase (Year 3)||0
217990|NCT01212770|528048|P6|COMPLETED|Long-term Safety Phase (Year 3)||0
217991|NCT01212770|528049|P5|COMPLETED|Long-term Safety Phase (Year 3)||0
217992|NCT01212770|528050|P4|COMPLETED|Long-term Safety Phase (Year 3)||0
217993|NCT01212770|528051|P3|COMPLETED|Long-term Safety Phase (Year 3)||94
217994|NCT01212770|528052|P2|COMPLETED|Long-term Safety Phase (Year 3)|1 participant missed due to APR dispensed late|76
217995|NCT01212770|528053|P1|COMPLETED|Long-term Safety Phase (Year 3)||0
217996|NCT01212770|528045|P9|STARTED|Long-term Safety Phase (Year 3)|Patients from the PBO/APR 30 mg EE and XO are combined;1 patient finished Wk 52;no entry into LTSP|49
217997|NCT01212770|528046|P8|STARTED|Long-term Safety Phase (Year 3)|The PBO/APR 20 mg EE and XO participants from week 24-52 are combined within the LTSP.|42
217998|NCT01212770|528047|P7|STARTED|Long-term Safety Phase (Year 3)||0
217999|NCT01212770|528048|P6|STARTED|Long-term Safety Phase (Year 3)||0
218000|NCT01212770|528049|P5|STARTED|Long-term Safety Phase (Year 3)||0
218001|NCT01212770|528050|P4|STARTED|Long-term Safety Phase (Year 3)||0
218002|NCT01212770|528051|P3|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|105
218003|NCT01212770|528052|P2|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|87
218004|NCT01212770|528053|P1|STARTED|Long-term Safety Phase (Year 3)||0
218005|NCT01212770|528045|P9|NOT COMPLETED|Long-term Safety Phase (Year 2)||14
218006|NCT01212770|528046|P8|NOT COMPLETED|Long-term Safety Phase (Year 2)||9
218007|NCT01212770|528047|P7|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
218008|NCT01212770|528048|P6|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
218009|NCT01212770|528049|P5|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
218010|NCT01212770|528050|P4|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
218011|NCT01212770|528051|P3|NOT COMPLETED|Long-term Safety Phase (Year 2)||15
218012|NCT01212770|528052|P2|NOT COMPLETED|Long-term Safety Phase (Year 2)||23
218013|NCT01212770|528053|P1|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
218014|NCT01212770|528045|P9|COMPLETED|Long-term Safety Phase (Year 2)||50
218015|NCT01212770|528046|P8|COMPLETED|Long-term Safety Phase (Year 2)||42
218016|NCT01212770|528047|P7|COMPLETED|Long-term Safety Phase (Year 2)||0
218017|NCT01212770|528048|P6|COMPLETED|Long-term Safety Phase (Year 2)||0
218018|NCT01212770|528049|P5|COMPLETED|Long-term Safety Phase (Year 2)||0
218019|NCT01212770|528050|P4|COMPLETED|Long-term Safety Phase (Year 2)||0
218020|NCT01212770|528051|P3|COMPLETED|Long-term Safety Phase (Year 2)||106
218021|NCT01212770|528052|P2|COMPLETED|Long-term Safety Phase (Year 2)||88
218022|NCT01212770|528053|P1|COMPLETED|Long-term Safety Phase (Year 2)||0
218023|NCT01212770|528045|P9|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;3 patients finished Wk 52;no entry into LTSP|64
218024|NCT01212770|528046|P8|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|51
218025|NCT01212770|528047|P7|STARTED|Long-term Safety Phase (Year 2)||0
218026|NCT01212770|528048|P6|STARTED|Long-term Safety Phase (Year 2)||0
218027|NCT01212770|528049|P5|STARTED|Long-term Safety Phase (Year 2)||0
218028|NCT01212770|528050|P4|STARTED|Long-term Safety Phase (Year 2)||0
218029|NCT01212770|528051|P3|STARTED|Long-term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|121
218030|NCT01212770|528052|P2|STARTED|Long-term Safety Phase (Year 2)|9 participants who completed Week 52 did not enter the long-term safety phase (LTSP)|111
218031|NCT01212770|528053|P1|STARTED|Long-term Safety Phase (Year 2)||0
218032|NCT01212770|528045|P9|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
218033|NCT01212770|528046|P8|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
218034|NCT01212770|528047|P7|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
218035|NCT01212770|528048|P6|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||3
218036|NCT01212770|528049|P5|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
218037|NCT01212770|528050|P4|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||11
218038|NCT01212770|528051|P3|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||12
218039|NCT01212770|528052|P2|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||19
218040|NCT01212770|528053|P1|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
218041|NCT01212770|528045|P9|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
218042|NCT01212770|528046|P8|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
218043|NCT01212770|528047|P7|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
218044|NCT01212770|528048|P6|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||44
218045|NCT01212770|528049|P5|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
218047|NCT01212770|528051|P3|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||126
218048|NCT01212770|528052|P2|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||120
218049|NCT01212770|528053|P1|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
218050|NCT01212770|528045|P9|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
218051|NCT01212770|528046|P8|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
218052|NCT01212770|528047|P7|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
218053|NCT01212770|528048|P6|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|47
218054|NCT01212770|528049|P5|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
218055|NCT01212770|528050|P4|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|43
218056|NCT01212770|528051|P3|STARTED|Active Treatment Phase (Weeks 25 - 52)|7 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|138
218057|NCT01212770|528052|P2|STARTED|Active Treatment Phase (Weeks 25 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|139
218058|NCT01212770|528053|P1|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
218059|NCT01212770|528045|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
218060|NCT01212770|528046|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
218061|NCT01212770|528047|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
218062|NCT01212770|528048|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
218063|NCT01212770|528049|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
218064|NCT01212770|528050|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
218065|NCT01212770|528051|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
218066|NCT01212770|528052|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
218067|NCT01212770|528053|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
218068|NCT01212770|528045|P9|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
218069|NCT01212770|528046|P8|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
218070|NCT01212770|528047|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
218071|NCT01212770|528048|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
218072|NCT01212770|528049|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
218073|NCT01212770|528050|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
218074|NCT01212770|528051|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||145
218075|NCT01212770|528052|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||147
218076|NCT01212770|528053|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||146
218077|NCT01212770|528045|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
218078|NCT01212770|528046|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
218079|NCT01212770|528047|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
218080|NCT01212770|528048|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
218081|NCT01212770|528049|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
218082|NCT01212770|528050|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
218083|NCT01212770|528051|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week 24|53
218084|NCT01212770|528052|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||76
218085|NCT01212770|528053|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week (Wk) 24|97
218086|NCT01212770|528045|P9|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
218087|NCT01212770|528046|P8|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
218088|NCT01212770|528047|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
218089|NCT01212770|528048|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
218090|NCT01212770|528049|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
218091|NCT01212770|528050|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
218092|NCT01212770|528051|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
218093|NCT01212770|528052|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||157
218094|NCT01212770|528053|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
218095|NCT01212770|528045|P9|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
218096|NCT01212770|528046|P8|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
218097|NCT01212770|528047|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
218098|NCT01212770|528048|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
218099|NCT01212770|528049|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
218100|NCT01212770|528050|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
218101|NCT01212770|528051|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||167
218102|NCT01212770|528052|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
218103|NCT01212770|528053|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
218104|NCT01212770|528045|P9|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
218105|NCT01212770|528046|P8|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
218106|NCT01212770|528047|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
218107|NCT01212770|528048|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
218108|NCT01212770|528049|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
218109|NCT01212770|528050|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
218110|NCT01212770|528051|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||167
218111|NCT01212770|528052|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
218112|NCT01212770|528053|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
218113|NCT01212757|528250|P9|NOT COMPLETED|Long-Term Safety Phase (Year 5)||2
218114|NCT01212757|528251|P8|NOT COMPLETED|Long-Term Safety Phase (Year 5)||5
218115|NCT01212757|528252|P7|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
218116|NCT01212757|528253|P6|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
218117|NCT01212757|528254|P5|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
218118|NCT01212757|528255|P4|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
218119|NCT01212757|528256|P3|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
218120|NCT01212757|528257|P2|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
218121|NCT01212757|528258|P1|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
218122|NCT01212757|528250|P9|COMPLETED|Long-Term Safety Phase (Year 5)||37
218123|NCT01212757|528251|P8|COMPLETED|Long-Term Safety Phase (Year 5)||33
218124|NCT01212757|528252|P7|COMPLETED|Long-Term Safety Phase (Year 5)||0
218125|NCT01212757|528253|P6|COMPLETED|Long-Term Safety Phase (Year 5)||0
218126|NCT01212757|528254|P5|COMPLETED|Long-Term Safety Phase (Year 5)||0
218127|NCT01212757|528255|P4|COMPLETED|Long-Term Safety Phase (Year 5)||0
218128|NCT01212757|528256|P3|COMPLETED|Long-Term Safety Phase (Year 5)||69
218129|NCT01212757|528257|P2|COMPLETED|Long-Term Safety Phase (Year 5)||72
218130|NCT01212757|528258|P1|COMPLETED|Long-Term Safety Phase (Year 5)||0
218131|NCT01212757|528250|P9|STARTED|Long-Term Safety Phase (Year 5)||39
218132|NCT01212757|528251|P8|STARTED|Long-Term Safety Phase (Year 5)|1 participant was only counted in year 5 but not in 4 year due to late APR dispensing|38
218133|NCT01212757|528252|P7|STARTED|Long-Term Safety Phase (Year 5)||0
218134|NCT01212757|528253|P6|STARTED|Long-Term Safety Phase (Year 5)||0
218135|NCT01212757|528254|P5|STARTED|Long-Term Safety Phase (Year 5)||0
218136|NCT01212757|528255|P4|STARTED|Long-Term Safety Phase (Year 5)||0
218137|NCT01212757|528256|P3|STARTED|Long-Term Safety Phase (Year 5)||77
218138|NCT01212757|528257|P2|STARTED|Long-Term Safety Phase (Year 5)||80
218139|NCT01212757|528258|P1|STARTED|Long-Term Safety Phase (Year 5)||0
218140|NCT01212757|528250|P9|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
218141|NCT01212757|528251|P8|NOT COMPLETED|Long-Term Safety Phase (Year 4)||4
218142|NCT01212757|528252|P7|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
218143|NCT01212757|528253|P6|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
218144|NCT01212757|528254|P5|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
218145|NCT01212757|528255|P4|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
218146|NCT01212757|528256|P3|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
218147|NCT01212757|528257|P2|NOT COMPLETED|Long-Term Safety Phase (Year 4)||9
218148|NCT01212757|528258|P1|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
218149|NCT01212757|528250|P9|COMPLETED|Long-Term Safety Phase (Year 4)||39
218150|NCT01212757|528251|P8|COMPLETED|Long-Term Safety Phase (Year 4)||37
218151|NCT01212757|528252|P7|COMPLETED|Long-Term Safety Phase (Year 4)||0
218152|NCT01212757|528253|P6|COMPLETED|Long-Term Safety Phase (Year 4)||0
218153|NCT01212757|528254|P5|COMPLETED|Long-Term Safety Phase (Year 4)||0
218154|NCT01212757|528255|P4|COMPLETED|Long-Term Safety Phase (Year 4)||0
218155|NCT01212757|528256|P3|COMPLETED|Long-Term Safety Phase (Year 4)||77
218156|NCT01212757|528257|P2|COMPLETED|Long-Term Safety Phase (Year 4)||80
218157|NCT01212757|528258|P1|COMPLETED|Long-Term Safety Phase (Year 4)||0
218158|NCT01212757|528250|P9|STARTED|Long-Term Safety Phase (Year 4)||46
218159|NCT01212757|528251|P8|STARTED|Long-Term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|41
218160|NCT01212757|528252|P7|STARTED|Long-Term Safety Phase (Year 4)||0
218161|NCT01212757|528253|P6|STARTED|Long-Term Safety Phase (Year 4)||0
218162|NCT01212757|528254|P5|STARTED|Long-Term Safety Phase (Year 4)||0
218163|NCT01212757|528255|P4|STARTED|Long-Term Safety Phase (Year 4)||0
218164|NCT01212757|528256|P3|STARTED|Long-Term Safety Phase (Year 4)||84
218165|NCT01212757|528257|P2|STARTED|Long-Term Safety Phase (Year 4)||89
218166|NCT01212757|528258|P1|STARTED|Long-Term Safety Phase (Year 4)||0
218167|NCT01212757|528250|P9|NOT COMPLETED|Long-Term Safety Phase (Year 3)||5
218168|NCT01212757|528251|P8|NOT COMPLETED|Long-Term Safety Phase (Year 3)||6
218169|NCT01212757|528252|P7|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
218170|NCT01212757|528253|P6|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
218171|NCT01212757|528254|P5|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
218172|NCT01212757|528255|P4|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
218173|NCT01212757|528256|P3|NOT COMPLETED|Long-Term Safety Phase (Year 3)||11
218174|NCT01212757|528257|P2|NOT COMPLETED|Long-Term Safety Phase (Year 3)||18
218175|NCT01212757|528258|P1|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
218176|NCT01212757|528250|P9|COMPLETED|Long-Term Safety Phase (Year 3)||46
218177|NCT01212757|528251|P8|COMPLETED|Long-Term Safety Phase (Year 3)||42
218178|NCT01212757|528252|P7|COMPLETED|Long-Term Safety Phase (Year 3)||0
218179|NCT01212757|528253|P6|COMPLETED|Long-Term Safety Phase (Year 3)||0
218180|NCT01212757|528254|P5|COMPLETED|Long-Term Safety Phase (Year 3)||0
218181|NCT01212757|528255|P4|COMPLETED|Long-Term Safety Phase (Year 3)||0
218182|NCT01212757|528256|P3|COMPLETED|Long-Term Safety Phase (Year 3)||84
218183|NCT01212757|528257|P2|COMPLETED|Long-Term Safety Phase (Year 3)||89
218184|NCT01212757|528258|P1|COMPLETED|Long-Term Safety Phase (Year 3)||0
218185|NCT01212757|528250|P9|STARTED|Long-Term Safety Phase (Year 3)||51
218186|NCT01212757|528251|P8|STARTED|Long-Term Safety Phase (Year 3)||48
218187|NCT01212757|528252|P7|STARTED|Long-Term Safety Phase (Year 3)||0
218188|NCT01212757|528253|P6|STARTED|Long-Term Safety Phase (Year 3)||0
218189|NCT01212757|528254|P5|STARTED|Long-Term Safety Phase (Year 3)||0
218190|NCT01212757|528255|P4|STARTED|Long-Term Safety Phase (Year 3)||0
218191|NCT01212757|528256|P3|STARTED|Long-Term Safety Phase (Year 3)||95
218192|NCT01212757|528257|P2|STARTED|Long-Term Safety Phase (Year 3)||107
218193|NCT01212757|528258|P1|STARTED|Long-Term Safety Phase (Year 3)||0
218194|NCT01212757|528250|P9|NOT COMPLETED|Long-Term Safety Phase (Year 2)||9
218195|NCT01212757|528251|P8|NOT COMPLETED|Long-Term Safety Phase (Year 2)||10
218196|NCT01212757|528252|P7|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
218197|NCT01212757|528253|P6|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
218198|NCT01212757|528254|P5|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
218199|NCT01212757|528255|P4|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
218200|NCT01212757|528256|P3|NOT COMPLETED|Long-Term Safety Phase (Year 2)||14
218201|NCT01212757|528257|P2|NOT COMPLETED|Long-Term Safety Phase (Year 2)||12
218202|NCT01212757|528258|P1|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
218203|NCT01212757|528250|P9|COMPLETED|Long-Term Safety Phase (Year 2)||51
218204|NCT01212757|528251|P8|COMPLETED|Long-Term Safety Phase (Year 2)||48
218205|NCT01212757|528252|P7|COMPLETED|Long-Term Safety Phase (Year 2)||0
218206|NCT01212757|528253|P6|COMPLETED|Long-Term Safety Phase (Year 2)||0
218207|NCT01212757|528254|P5|COMPLETED|Long-Term Safety Phase (Year 2)||0
218208|NCT01212757|528255|P4|COMPLETED|Long-Term Safety Phase (Year 2)||0
218209|NCT01212757|528256|P3|COMPLETED|Long-Term Safety Phase (Year 2)||95
218210|NCT01212757|528257|P2|COMPLETED|Long-Term Safety Phase (Year 2)||107
218211|NCT01212757|528258|P1|COMPLETED|Long-Term Safety Phase (Year 2)||0
218212|NCT01212757|528250|P9|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 30EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|60
218213|NCT01212757|528251|P8|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 20EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|58
218214|NCT01212757|528252|P7|STARTED|Long-Term Safety Phase (Year 2)||0
218215|NCT01212757|528253|P6|STARTED|Long-Term Safety Phase (Year 2)||0
218216|NCT01212757|528254|P5|STARTED|Long-Term Safety Phase (Year 2)||0
218217|NCT01212757|528255|P4|STARTED|Long-Term Safety Phase (Year 2)||0
218218|NCT01212757|528256|P3|STARTED|Long-Term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|109
218219|NCT01212757|528257|P2|STARTED|Long-Term Safety Phase (Year 2)|6 participants who completed Week 52 did not enter the long-term safety phase|119
218220|NCT01212757|528258|P1|STARTED|Long-Term Safety Phase (Year 2)||0
218221|NCT01212757|528250|P9|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
218222|NCT01212757|528251|P8|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
218223|NCT01212757|528252|P7|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
218224|NCT01212757|528253|P6|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||7
218225|NCT01212757|528254|P5|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||2
218226|NCT01212757|528255|P4|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||8
218227|NCT01212757|528256|P3|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||20
218228|NCT01212757|528257|P2|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12
218229|NCT01212757|528258|P1|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
218230|NCT01212757|528250|P9|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
218231|NCT01212757|528251|P8|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
218232|NCT01212757|528252|P7|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||28
218233|NCT01212757|528253|P6|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||34
218234|NCT01212757|528254|P5|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||25
218235|NCT01212757|528255|P4|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||35
218236|NCT01212757|528256|P3|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||114
218237|NCT01212757|528257|P2|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||125
218238|NCT01212757|528258|P1|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
218239|NCT01212757|528250|P9|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
218240|NCT01212757|528251|P8|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
218241|NCT01212757|528252|P7|STARTED|Active Treatment Phase (Weeks 24 - 52)||28
218242|NCT01212757|528253|P6|STARTED|Active Treatment Phase (Weeks 24 - 52)|2 participants who EE and completed Week 24 did not enter the Week 24-52 active treatment phase|41
218243|NCT01212757|528254|P5|STARTED|Active Treatment Phase (Weeks 24 - 52)||27
218244|NCT01212757|528255|P4|STARTED|Active Treatment Phase (Weeks 24 - 52)||43
218245|NCT01212757|528256|P3|STARTED|Active Treatment Phase (Weeks 24 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|134
218246|NCT01212757|528257|P2|STARTED|Active Treatment Phase (Weeks 24 - 52)|6 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|137
218247|NCT01212757|528258|P1|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
218248|NCT01212757|528250|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
218249|NCT01212757|528251|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
218250|NCT01212757|528252|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
218251|NCT01212757|528253|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
218252|NCT01212757|528254|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
218253|NCT01212757|528255|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
218254|NCT01212757|528256|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||21
218255|NCT01212757|528257|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
218256|NCT01212757|528258|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||19
218257|NCT01212757|528250|P9|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
218258|NCT01212757|528251|P8|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
218259|NCT01212757|528252|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
218260|NCT01212757|528253|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
218261|NCT01212757|528254|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
218338|NCT01212445|528510|P3|STARTED|Overall Study||51
218262|NCT01212757|528255|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
218263|NCT01212757|528256|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||142
218264|NCT01212757|528257|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||143
218265|NCT01212757|528258|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants who completed Week 24 did not enter the active treatment phase|143
218266|NCT01212757|528250|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
218267|NCT01212757|528251|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
218268|NCT01212757|528252|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
218269|NCT01212757|528253|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
218270|NCT01212757|528254|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
218271|NCT01212757|528255|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
218272|NCT01212757|528256|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||64
218273|NCT01212757|528257|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Three participants who escaped early did not complete Week 24|59
218274|NCT01212757|528258|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Two participants who escaped early did not complete Week 24|88
218275|NCT01212757|528250|P9|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
218276|NCT01212757|528251|P8|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
218277|NCT01212757|528252|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
218278|NCT01212757|528253|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
218279|NCT01212757|528254|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
218280|NCT01212757|528255|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
218281|NCT01212757|528256|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||149
218282|NCT01212757|528257|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||151
218283|NCT01212757|528258|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||148
218284|NCT01212757|528250|P9|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
218285|NCT01212757|528251|P8|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
218286|NCT01212757|528252|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
218287|NCT01212757|528253|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
218288|NCT01212757|528254|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
218289|NCT01212757|528255|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
218290|NCT01212757|528256|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||162
218291|NCT01212757|528257|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||163
218292|NCT01212757|528258|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||159
218293|NCT01212757|528250|P9|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
218294|NCT01212757|528251|P8|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
218295|NCT01212757|528252|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
218296|NCT01212757|528253|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
218297|NCT01212757|528254|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
218298|NCT01212757|528255|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
218299|NCT01212757|528256|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
218300|NCT01212757|528257|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
218301|NCT01212757|528258|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||162
218302|NCT01212744|528442|P1|NOT COMPLETED|Overall Study||1
218303|NCT01212744|528442|P1|COMPLETED|Overall Study||15
218304|NCT01212744|528442|P1|STARTED|Overall Study||16
218305|NCT01212627|528455|P1|NOT COMPLETED|Overall Study||0
218306|NCT01212627|528455|P1|COMPLETED|Overall Study||12
218307|NCT01212627|528455|P1|STARTED|Overall Study||12
218308|NCT01212588|528461|P2|NOT COMPLETED|Overall Study||2
218309|NCT01212588|528462|P1|NOT COMPLETED|Overall Study||1
218310|NCT01212588|528461|P2|COMPLETED|Overall Study||10
218311|NCT01212588|528462|P1|COMPLETED|Overall Study||9
218312|NCT01212588|528461|P2|STARTED|Overall Study||12
218313|NCT01212588|528462|P1|STARTED|Overall Study||10
218314|NCT01212484|528496|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
218315|NCT01212484|528497|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
218316|NCT01212484|528496|P2|COMPLETED|Second Intervention (4 Weeks)||3
218317|NCT01212484|528497|P1|COMPLETED|Second Intervention (4 Weeks)||5
218318|NCT01212484|528496|P2|STARTED|Second Intervention (4 Weeks)||4
218319|NCT01212484|528497|P1|STARTED|Second Intervention (4 Weeks)||5
218320|NCT01212484|528496|P2|NOT COMPLETED|First Intervention (4 Weeks)||2
218321|NCT01212484|528497|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
218322|NCT01212484|528496|P2|COMPLETED|First Intervention (4 Weeks)||4
218323|NCT01212484|528497|P1|COMPLETED|First Intervention (4 Weeks)||5
218324|NCT01212484|528496|P2|STARTED|First Intervention (4 Weeks)||6
218325|NCT01212484|528497|P1|STARTED|First Intervention (4 Weeks)||5
218326|NCT01212484|528496|P2|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||0
218327|NCT01212484|528497|P1|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||1
218328|NCT01212484|528496|P2|COMPLETED|Carbidopa Titration Period (4 Weeks)||6
218329|NCT01212484|528497|P1|COMPLETED|Carbidopa Titration Period (4 Weeks)||5
218330|NCT01212484|528496|P2|STARTED|Carbidopa Titration Period (4 Weeks)||6
218331|NCT01212484|528497|P1|STARTED|Carbidopa Titration Period (4 Weeks)||6
218332|NCT01212445|528510|P3|NOT COMPLETED|Overall Study||0
218333|NCT01212445|528511|P2|NOT COMPLETED|Overall Study||0
218334|NCT01212445|528512|P1|NOT COMPLETED|Overall Study||0
218335|NCT01212445|528510|P3|COMPLETED|Overall Study||51
218336|NCT01212445|528511|P2|COMPLETED|Overall Study||51
218337|NCT01212445|528512|P1|COMPLETED|Overall Study||52
218339|NCT01212445|528511|P2|STARTED|Overall Study||51
218340|NCT01212445|528512|P1|STARTED|Overall Study||52
218341|NCT01212302|528541|P1|NOT COMPLETED|Overall Study||0
218342|NCT01212302|528541|P1|COMPLETED|Overall Study||504
218343|NCT01212302|528541|P1|STARTED|Overall Study||504
218344|NCT01212185|528547|P2|NOT COMPLETED|Overall Study||1
218345|NCT01212185|528548|P1|NOT COMPLETED|Overall Study||2
218346|NCT01212185|528547|P2|COMPLETED|Overall Study||7
218347|NCT01212185|528548|P1|COMPLETED|Overall Study||4
218348|NCT01212185|528547|P2|STARTED|Overall Study||8
218349|NCT01212185|528548|P1|STARTED|Overall Study||6
218350|NCT01212172|528556|P2|NOT COMPLETED|Overall Study||1
218351|NCT01212172|528557|P1|NOT COMPLETED|Overall Study||1
218352|NCT01212172|528556|P2|COMPLETED|Overall Study||9
218353|NCT01212172|528557|P1|COMPLETED|Overall Study||9
218354|NCT01212172|528556|P2|STARTED|Overall Study||10
218355|NCT01212172|528557|P1|STARTED|Overall Study||10
218356|NCT01212159|528567|P2|NOT COMPLETED|Overall Study||12
218357|NCT01212159|528568|P1|NOT COMPLETED|Overall Study||12
218358|NCT01212159|528567|P2|COMPLETED|Overall Study||32
218359|NCT01212159|528568|P1|COMPLETED|Overall Study||14
218360|NCT01212159|528567|P2|STARTED|Overall Study||44
218361|NCT01212159|528568|P1|STARTED|Overall Study||26
218362|NCT01212107|528590|P12|NOT COMPLETED|Overall Study||32
218363|NCT01212107|528591|P11|NOT COMPLETED|Overall Study||1
218364|NCT01212107|528592|P10|NOT COMPLETED|Overall Study||2
218365|NCT01212107|528593|P9|NOT COMPLETED|Overall Study||2
218366|NCT01212107|528594|P8|NOT COMPLETED|Overall Study||1
218367|NCT01212107|528595|P7|NOT COMPLETED|Overall Study||0
218368|NCT01212107|528596|P6|NOT COMPLETED|Overall Study||1
218369|NCT01212107|528597|P5|NOT COMPLETED|Overall Study||1
218370|NCT01212107|528598|P4|NOT COMPLETED|Overall Study||0
218371|NCT01212107|528599|P3|NOT COMPLETED|Overall Study||3
218372|NCT01212107|528600|P2|NOT COMPLETED|Overall Study||1
218373|NCT01212107|528601|P1|NOT COMPLETED|Overall Study||1
218374|NCT01212107|528590|P12|COMPLETED|Overall Study||26
218375|NCT01212107|528591|P11|COMPLETED|Overall Study||2
218376|NCT01212107|528592|P10|COMPLETED|Overall Study||1
218377|NCT01212107|528593|P9|COMPLETED|Overall Study||1
218378|NCT01212107|528594|P8|COMPLETED|Overall Study||2
218379|NCT01212107|528595|P7|COMPLETED|Overall Study||3
218380|NCT01212107|528596|P6|COMPLETED|Overall Study||2
218381|NCT01212107|528597|P5|COMPLETED|Overall Study||2
218382|NCT01212107|528598|P4|COMPLETED|Overall Study||3
218383|NCT01212107|528599|P3|COMPLETED|Overall Study||3
218384|NCT01212107|528600|P2|COMPLETED|Overall Study||2
218385|NCT01212107|528601|P1|COMPLETED|Overall Study||2
218386|NCT01212107|528590|P12|STARTED|Overall Study||58
218387|NCT01212107|528591|P11|STARTED|Overall Study||3
218388|NCT01212107|528592|P10|STARTED|Overall Study||3
218389|NCT01212107|528593|P9|STARTED|Overall Study||3
218390|NCT01212107|528594|P8|STARTED|Overall Study||3
218391|NCT01212107|528595|P7|STARTED|Overall Study||3
218392|NCT01212107|528596|P6|STARTED|Overall Study||3
218393|NCT01212107|528597|P5|STARTED|Overall Study||3
218394|NCT01212107|528598|P4|STARTED|Overall Study||3
218395|NCT01212107|528599|P3|STARTED|Overall Study||6
218396|NCT01212107|528600|P2|STARTED|Overall Study||3
218397|NCT01212107|528601|P1|STARTED|Overall Study||3
218398|NCT01212094|528667|P3|NOT COMPLETED|Years 2 & 3: Treatment Randomization||11
218399|NCT01212094|528668|P2|NOT COMPLETED|Years 2 & 3: Treatment Randomization||4
218400|NCT01212094|528669|P1|NOT COMPLETED|Years 2 & 3: Treatment Randomization||0
218401|NCT01212094|528667|P3|COMPLETED|Years 2 & 3: Treatment Randomization||7
218402|NCT01212094|528668|P2|COMPLETED|Years 2 & 3: Treatment Randomization||5
218403|NCT01212094|528669|P1|COMPLETED|Years 2 & 3: Treatment Randomization||0
218404|NCT01212094|528667|P3|STARTED|Years 2 & 3: Treatment Randomization||18
218405|NCT01212094|528668|P2|STARTED|Years 2 & 3: Treatment Randomization||9
218406|NCT01212094|528669|P1|STARTED|Years 2 & 3: Treatment Randomization||0
218407|NCT01212094|528667|P3|NOT COMPLETED|Year 1: Baseline Monitoring||0
218408|NCT01212094|528668|P2|NOT COMPLETED|Year 1: Baseline Monitoring||0
218409|NCT01212094|528669|P1|NOT COMPLETED|Year 1: Baseline Monitoring||16
218410|NCT01212094|528667|P3|COMPLETED|Year 1: Baseline Monitoring||0
218411|NCT01212094|528668|P2|COMPLETED|Year 1: Baseline Monitoring||0
218412|NCT01212094|528669|P1|COMPLETED|Year 1: Baseline Monitoring||27
218413|NCT01212094|528667|P3|STARTED|Year 1: Baseline Monitoring||0
218414|NCT01212094|528668|P2|STARTED|Year 1: Baseline Monitoring||0
218415|NCT01212094|528669|P1|STARTED|Year 1: Baseline Monitoring||43
218416|NCT01211873|528703|P3|NOT COMPLETED|Overall Study||2
218417|NCT01211873|528704|P2|NOT COMPLETED|Overall Study||2
218418|NCT01211873|528705|P1|NOT COMPLETED|Overall Study||5
218419|NCT01211873|528703|P3|COMPLETED|Overall Study||36
218420|NCT01211873|528704|P2|COMPLETED|Overall Study||117
218421|NCT01211873|528705|P1|COMPLETED|Overall Study||240
218422|NCT01211873|528703|P3|STARTED|Overall Study||38
218423|NCT01211873|528704|P2|STARTED|Overall Study||119
218424|NCT01211873|528705|P1|STARTED|Overall Study||245
218425|NCT01211769|528728|P4|NOT COMPLETED|Overall Study||11
218426|NCT01211769|528729|P3|NOT COMPLETED|Overall Study||8
218427|NCT01211769|528730|P2|NOT COMPLETED|Overall Study||10
218428|NCT01211769|528731|P1|NOT COMPLETED|Overall Study||9
218429|NCT01211769|528728|P4|COMPLETED|Overall Study||9
218430|NCT01211769|528729|P3|COMPLETED|Overall Study||12
218431|NCT01211769|528730|P2|COMPLETED|Overall Study||10
218432|NCT01211769|528731|P1|COMPLETED|Overall Study||11
218433|NCT01211769|528728|P4|Participants/Group|Overall Study||20
218434|NCT01211769|528729|P3|Participants/Group|Overall Study||20
218435|NCT01211769|528730|P2|Participants/Group|Overall Study||20
218436|NCT01211769|528731|P1|Participants/Group|Overall Study||20
218437|NCT01211769|528728|P4|STARTED|Overall Study||20
218438|NCT01211769|528729|P3|STARTED|Overall Study||20
218439|NCT01211769|528730|P2|STARTED|Overall Study||20
218440|NCT01211769|528731|P1|STARTED|Overall Study||20
218441|NCT01211756|528749|P1|NOT COMPLETED|Overall Study||0
218442|NCT01211756|528749|P1|COMPLETED|Overall Study||1
218443|NCT01211756|528749|P1|STARTED|Overall Study||1
218444|NCT01211730|528767|P2|NOT COMPLETED|Overall Study||0
218445|NCT01211730|528768|P1|NOT COMPLETED|Overall Study||0
218446|NCT01211730|528767|P2|COMPLETED|Overall Study||82
218447|NCT01211730|528768|P1|COMPLETED|Overall Study||82
218448|NCT01211730|528767|P2|STARTED|Overall Study||82
218449|NCT01211730|528768|P1|STARTED|Overall Study||82
218450|NCT01211665|528786|P2|NOT COMPLETED|Overall Study||0
218451|NCT01211665|528787|P1|NOT COMPLETED|Overall Study||2
218452|NCT01211665|528786|P2|COMPLETED|Overall Study|completed treatment with study drug|1
218453|NCT01211665|528787|P1|COMPLETED|Overall Study||0
218454|NCT01211665|528786|P2|STARTED|Overall Study||1
218455|NCT01211665|528787|P1|STARTED|Overall Study||2
218456|NCT01211613|528814|P3|NOT COMPLETED|Overall Study||2
218457|NCT01211613|528815|P2|NOT COMPLETED|Overall Study||2
218458|NCT01211613|528816|P1|NOT COMPLETED|Overall Study||3
218459|NCT01211613|528814|P3|COMPLETED|Overall Study||33
218460|NCT01211613|528815|P2|COMPLETED|Overall Study||33
218461|NCT01211613|528816|P1|COMPLETED|Overall Study||34
218462|NCT01211613|528814|P3|STARTED|Overall Study||35
218463|NCT01211613|528815|P2|STARTED|Overall Study||35
218464|NCT01211613|528816|P1|STARTED|Overall Study||37
218465|NCT01211600|528829|P2|NOT COMPLETED|Overall Study||0
218466|NCT01211600|528830|P1|NOT COMPLETED|Overall Study||0
218467|NCT01211600|528829|P2|COMPLETED|Overall Study||376
218468|NCT01211600|528830|P1|COMPLETED|Overall Study||370
218469|NCT01211600|528829|P2|STARTED|Overall Study||376
218470|NCT01211600|528830|P1|STARTED|Overall Study||370
218471|NCT01211535|528862|P2|NOT COMPLETED|Overall Study||1
218472|NCT01211535|528863|P1|NOT COMPLETED|Overall Study||0
218473|NCT01211535|528862|P2|COMPLETED|Overall Study||51
218474|NCT01211535|528863|P1|COMPLETED|Overall Study||52
218475|NCT01211535|528862|P2|STARTED|Overall Study||52
218476|NCT01211535|528863|P1|STARTED|Overall Study||52
218477|NCT01211522|528872|P3|NOT COMPLETED|Overall Study||5
218478|NCT01211522|528873|P2|NOT COMPLETED|Overall Study||7
218479|NCT01211522|528874|P1|NOT COMPLETED|Overall Study||3
218480|NCT01211522|528872|P3|COMPLETED|Overall Study||179
218481|NCT01211522|528873|P2|COMPLETED|Overall Study||183
218482|NCT01211522|528874|P1|COMPLETED|Overall Study||189
218483|NCT01211522|528872|P3|STARTED|Overall Study||184
218484|NCT01211522|528873|P2|STARTED|Overall Study||190
218485|NCT01211522|528874|P1|STARTED|Overall Study||192
218486|NCT01211340|528911|P2|NOT COMPLETED|Overall Study||0
218487|NCT01211340|528912|P1|NOT COMPLETED|Overall Study||0
218488|NCT01211340|528911|P2|COMPLETED|Overall Study||223
218489|NCT01211340|528912|P1|COMPLETED|Overall Study||223
218490|NCT01211340|528911|P2|STARTED|Overall Study||223
218491|NCT01211340|528912|P1|STARTED|Overall Study||223
218492|NCT01211197|528922|P6|NOT COMPLETED|Treatment Period 3 (1 Day)||0
218493|NCT01211197|528923|P5|NOT COMPLETED|Treatment Period 3 (1 Day)||0
218494|NCT01211197|528924|P4|NOT COMPLETED|Treatment Period 3 (1 Day)||0
218495|NCT01211197|528925|P3|NOT COMPLETED|Treatment Period 3 (1 Day)||0
218496|NCT01211197|528926|P2|NOT COMPLETED|Treatment Period 3 (1 Day)||0
218497|NCT01211197|528927|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
218498|NCT01211197|528922|P6|COMPLETED|Treatment Period 3 (1 Day)||2
218499|NCT01211197|528923|P5|COMPLETED|Treatment Period 3 (1 Day)||2
218500|NCT01211197|528924|P4|COMPLETED|Treatment Period 3 (1 Day)||3
218501|NCT01211197|528925|P3|COMPLETED|Treatment Period 3 (1 Day)||2
218502|NCT01211197|528926|P2|COMPLETED|Treatment Period 3 (1 Day)||3
218503|NCT01211197|528927|P1|COMPLETED|Treatment Period 3 (1 Day)||2
218504|NCT01211197|528922|P6|STARTED|Treatment Period 3 (1 Day)||2
218505|NCT01211197|528923|P5|STARTED|Treatment Period 3 (1 Day)||2
218506|NCT01211197|528924|P4|STARTED|Treatment Period 3 (1 Day)||3
218507|NCT01211197|528925|P3|STARTED|Treatment Period 3 (1 Day)||2
218508|NCT01211197|528926|P2|STARTED|Treatment Period 3 (1 Day)||3
218509|NCT01211197|528927|P1|STARTED|Treatment Period 3 (1 Day)||2
218510|NCT01211197|528922|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
218511|NCT01211197|528923|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
218512|NCT01211197|528924|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
218513|NCT01211197|528925|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
218514|NCT01211197|528926|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
218515|NCT01211197|528927|P1|NOT COMPLETED|Washout Period 2 (7 Days)||1
218516|NCT01211197|528922|P6|COMPLETED|Washout Period 2 (7 Days)||2
218517|NCT01211197|528923|P5|COMPLETED|Washout Period 2 (7 Days)||2
218518|NCT01211197|528924|P4|COMPLETED|Washout Period 2 (7 Days)||3
218519|NCT01211197|528925|P3|COMPLETED|Washout Period 2 (7 Days)||2
218520|NCT01211197|528926|P2|COMPLETED|Washout Period 2 (7 Days)||3
218521|NCT01211197|528927|P1|COMPLETED|Washout Period 2 (7 Days)||2
218522|NCT01211197|528922|P6|STARTED|Washout Period 2 (7 Days)||2
218523|NCT01211197|528923|P5|STARTED|Washout Period 2 (7 Days)||2
218524|NCT01211197|528924|P4|STARTED|Washout Period 2 (7 Days)||3
218525|NCT01211197|528925|P3|STARTED|Washout Period 2 (7 Days)||2
218526|NCT01211197|528926|P2|STARTED|Washout Period 2 (7 Days)||3
218527|NCT01211197|528927|P1|STARTED|Washout Period 2 (7 Days)||3
218528|NCT01211197|528922|P6|NOT COMPLETED|Treatment Period 2 (1 Day)||0
218529|NCT01211197|528923|P5|NOT COMPLETED|Treatment Period 2 (1 Day)||0
218530|NCT01211197|528924|P4|NOT COMPLETED|Treatment Period 2 (1 Day)||0
218531|NCT01211197|528925|P3|NOT COMPLETED|Treatment Period 2 (1 Day)||0
218532|NCT01211197|528926|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
218533|NCT01211197|528927|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
218534|NCT01211197|528922|P6|COMPLETED|Treatment Period 2 (1 Day)||2
218535|NCT01211197|528923|P5|COMPLETED|Treatment Period 2 (1 Day)||2
218536|NCT01211197|528924|P4|COMPLETED|Treatment Period 2 (1 Day)||3
218537|NCT01211197|528925|P3|COMPLETED|Treatment Period 2 (1 Day)||2
218538|NCT01211197|528926|P2|COMPLETED|Treatment Period 2 (1 Day)||3
218539|NCT01211197|528927|P1|COMPLETED|Treatment Period 2 (1 Day)||3
218540|NCT01211197|528922|P6|STARTED|Treatment Period 2 (1 Day)||2
218541|NCT01211197|528923|P5|STARTED|Treatment Period 2 (1 Day)||2
218542|NCT01211197|528924|P4|STARTED|Treatment Period 2 (1 Day)||3
218543|NCT01211197|528925|P3|STARTED|Treatment Period 2 (1 Day)||2
218544|NCT01211197|528926|P2|STARTED|Treatment Period 2 (1 Day)||3
218545|NCT01211197|528927|P1|STARTED|Treatment Period 2 (1 Day)||3
218546|NCT01211197|528922|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
218547|NCT01211197|528923|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
218548|NCT01211197|528924|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
218549|NCT01211197|528925|P3|NOT COMPLETED|Washout Period 1 (7 Days)||1
218550|NCT01211197|528926|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
218551|NCT01211197|528927|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
218552|NCT01211197|528922|P6|COMPLETED|Washout Period 1 (7 Days)||2
218553|NCT01211197|528923|P5|COMPLETED|Washout Period 1 (7 Days)||2
218554|NCT01211197|528924|P4|COMPLETED|Washout Period 1 (7 Days)||3
218555|NCT01211197|528925|P3|COMPLETED|Washout Period 1 (7 Days)||2
218556|NCT01211197|528926|P2|COMPLETED|Washout Period 1 (7 Days)||3
218557|NCT01211197|528927|P1|COMPLETED|Washout Period 1 (7 Days)||3
218558|NCT01211197|528922|P6|STARTED|Washout Period 1 (7 Days)||2
218559|NCT01211197|528923|P5|STARTED|Washout Period 1 (7 Days)||2
218560|NCT01211197|528924|P4|STARTED|Washout Period 1 (7 Days)||3
218561|NCT01211197|528925|P3|STARTED|Washout Period 1 (7 Days)||3
218562|NCT01211197|528926|P2|STARTED|Washout Period 1 (7 Days)||3
218563|NCT01211197|528927|P1|STARTED|Washout Period 1 (7 Days)||3
218564|NCT01211197|528922|P6|NOT COMPLETED|Treatment Period 1 (1 Day)||0
218565|NCT01211197|528923|P5|NOT COMPLETED|Treatment Period 1 (1 Day)||0
218566|NCT01211197|528924|P4|NOT COMPLETED|Treatment Period 1 (1 Day)||0
218567|NCT01211197|528925|P3|NOT COMPLETED|Treatment Period 1 (1 Day)||0
218568|NCT01211197|528926|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
218569|NCT01211197|528927|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
218570|NCT01211197|528922|P6|COMPLETED|Treatment Period 1 (1 Day)||2
218571|NCT01211197|528923|P5|COMPLETED|Treatment Period 1 (1 Day)||2
218572|NCT01211197|528924|P4|COMPLETED|Treatment Period 1 (1 Day)||3
218573|NCT01211197|528925|P3|COMPLETED|Treatment Period 1 (1 Day)||3
218574|NCT01211197|528926|P2|COMPLETED|Treatment Period 1 (1 Day)||3
218575|NCT01211197|528927|P1|COMPLETED|Treatment Period 1 (1 Day)||3
218576|NCT01211197|528922|P6|STARTED|Treatment Period 1 (1 Day)||2
218577|NCT01211197|528923|P5|STARTED|Treatment Period 1 (1 Day)||2
218578|NCT01211197|528924|P4|STARTED|Treatment Period 1 (1 Day)||3
218579|NCT01211197|528925|P3|STARTED|Treatment Period 1 (1 Day)||3
218580|NCT01211197|528926|P2|STARTED|Treatment Period 1 (1 Day)||3
218581|NCT01211197|528927|P1|STARTED|Treatment Period 1 (1 Day)||3
218582|NCT01211184|528974|P3|NOT COMPLETED|Overall Study||1
218583|NCT01211184|528975|P2|NOT COMPLETED|Overall Study||2
218584|NCT01211184|528976|P1|NOT COMPLETED|Overall Study||0
218585|NCT01211184|528974|P3|COMPLETED|Overall Study||19
218586|NCT01211184|528975|P2|COMPLETED|Overall Study||18
218587|NCT01211184|528976|P1|COMPLETED|Overall Study||20
218588|NCT01211184|528974|P3|STARTED|Overall Study||20
218589|NCT01211184|528975|P2|STARTED|Overall Study||20
218590|NCT01211184|528976|P1|STARTED|Overall Study||20
218591|NCT01211145|528991|P4|NOT COMPLETED|Overall Study||20
218592|NCT01211145|528992|P3|NOT COMPLETED|Overall Study||13
218593|NCT01211145|528993|P2|NOT COMPLETED|Overall Study||17
218594|NCT01211145|528994|P1|NOT COMPLETED|Overall Study||26
218595|NCT01211145|528991|P4|COMPLETED|Overall Study||268
218596|NCT01211145|528992|P3|COMPLETED|Overall Study||86
218597|NCT01211145|528993|P2|COMPLETED|Overall Study||98
218598|NCT01211145|528994|P1|COMPLETED|Overall Study|1 patient was not counted as completed or discontinued due to incomplete information (N=270-1=269).|270
218599|NCT01211145|528991|P4|STARTED|Overall Study||288
218600|NCT01211145|528992|P3|STARTED|Overall Study||99
218601|NCT01211145|528993|P2|STARTED|Overall Study||115
218602|NCT01211145|528994|P1|STARTED|Overall Study||296
218603|NCT01211106|529026|P2|NOT COMPLETED|Overall Study||11
218604|NCT01211106|529027|P1|NOT COMPLETED|Overall Study||13
218605|NCT01211106|529026|P2|COMPLETED|Overall Study||77
218606|NCT01211106|529027|P1|COMPLETED|Overall Study||82
218607|NCT01211106|529026|P2|STARTED|Overall Study||88
218608|NCT01211106|529027|P1|STARTED|Overall Study||95
218609|NCT01210820|529037|P2|NOT COMPLETED|Overall Study||0
218610|NCT01210820|529038|P1|NOT COMPLETED|Overall Study||0
218611|NCT01210820|529037|P2|COMPLETED|Overall Study||4
218612|NCT01210820|529038|P1|COMPLETED|Overall Study||17
218613|NCT01210820|529037|P2|STARTED|Overall Study||4
218614|NCT01210820|529038|P1|STARTED|Overall Study||17
218615|NCT01210807|529048|P2|NOT COMPLETED|Overall Study||3
218616|NCT01210807|529049|P1|NOT COMPLETED|Overall Study||3
218617|NCT01210807|529048|P2|COMPLETED|Overall Study||31
218618|NCT01210807|529049|P1|COMPLETED|Overall Study||33
218619|NCT01210807|529048|P2|STARTED|Overall Study||34
218620|NCT01210807|529049|P1|STARTED|Overall Study||36
218621|NCT01210716|529057|P2|NOT COMPLETED|Second TPE Procedure||0
218622|NCT01210716|529058|P1|NOT COMPLETED|Second TPE Procedure||3
218623|NCT01210716|529057|P2|COMPLETED|Second TPE Procedure||15
218624|NCT01210716|529058|P1|COMPLETED|Second TPE Procedure||15
218625|NCT01210716|529057|P2|STARTED|Second TPE Procedure||15
218626|NCT01210716|529058|P1|STARTED|Second TPE Procedure||18
218627|NCT01210716|529057|P2|NOT COMPLETED|First TPE Procedure||2
218628|NCT01210716|529058|P1|NOT COMPLETED|First TPE Procedure||2
218629|NCT01210716|529057|P2|COMPLETED|First TPE Procedure||15
218630|NCT01210716|529058|P1|COMPLETED|First TPE Procedure||18
218631|NCT01210716|529057|P2|STARTED|First TPE Procedure||17
218632|NCT01210716|529058|P1|STARTED|First TPE Procedure||20
218633|NCT01210690|529064|P1|NOT COMPLETED|Overall Study||26
218634|NCT01210690|529064|P1|COMPLETED|Overall Study||75
218635|NCT01210690|529064|P1|STARTED|Overall Study||101
218636|NCT01210664|529077|P4|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||1
218637|NCT01210664|529078|P3|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
218638|NCT01210664|529079|P2|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
218639|NCT01210664|529080|P1|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
218640|NCT01210664|529077|P4|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||4
218641|NCT01210664|529078|P3|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
218642|NCT01210664|529079|P2|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
218643|NCT01210664|529080|P1|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
218644|NCT01210664|529077|P4|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||4
218645|NCT01210664|529078|P3|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
218646|NCT01210664|529079|P2|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
218647|NCT01210664|529080|P1|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
218648|NCT01210664|529077|P4|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||5
218649|NCT01210664|529078|P3|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
218650|NCT01210664|529079|P2|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
218651|NCT01210664|529080|P1|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
218652|NCT01210664|529077|P4|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
218653|NCT01210664|529078|P3|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||2
218654|NCT01210664|529079|P2|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
218655|NCT01210664|529080|P1|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
218656|NCT01210664|529077|P4|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
218657|NCT01210664|529078|P3|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||3
218658|NCT01210664|529079|P2|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
218659|NCT01210664|529080|P1|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
218660|NCT01210664|529077|P4|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
218661|NCT01210664|529078|P3|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||4
218662|NCT01210664|529079|P2|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
218663|NCT01210664|529080|P1|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
218664|NCT01210664|529077|P4|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
218665|NCT01210664|529078|P3|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||5
218666|NCT01210664|529079|P2|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
218667|NCT01210664|529080|P1|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
218668|NCT01210664|529077|P4|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
218669|NCT01210664|529078|P3|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
218670|NCT01210664|529079|P2|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
218671|NCT01210664|529080|P1|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
218672|NCT01210664|529077|P4|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
218673|NCT01210664|529078|P3|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
218674|NCT01210664|529079|P2|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
218675|NCT01210664|529080|P1|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
218676|NCT01210664|529077|P4|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
218677|NCT01210664|529078|P3|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
218678|NCT01210664|529079|P2|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
218679|NCT01210664|529080|P1|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
218680|NCT01210664|529077|P4|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
218681|NCT01210664|529078|P3|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
218682|NCT01210664|529079|P2|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
218683|NCT01210664|529080|P1|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
218684|NCT01210664|529077|P4|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
218685|NCT01210664|529078|P3|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
218686|NCT01210664|529079|P2|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
218687|NCT01210664|529080|P1|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
218688|NCT01210664|529077|P4|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
218689|NCT01210664|529078|P3|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
218690|NCT01210664|529079|P2|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
218691|NCT01210664|529080|P1|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
218692|NCT01210664|529077|P4|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
218693|NCT01210664|529078|P3|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
218694|NCT01210664|529079|P2|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
218695|NCT01210664|529080|P1|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
218696|NCT01210664|529077|P4|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
218697|NCT01210664|529078|P3|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
218698|NCT01210664|529079|P2|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
218699|NCT01210664|529080|P1|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
218700|NCT01210651|529108|P2|NOT COMPLETED|Overall Study||8
218701|NCT01210651|529109|P1|NOT COMPLETED|Overall Study||5
218702|NCT01210651|529108|P2|COMPLETED|Overall Study||10
218703|NCT01210651|529109|P1|COMPLETED|Overall Study||15
218704|NCT01210651|529108|P2|Number Attending 1st Assigned Session|Overall Study||12
218705|NCT01210651|529109|P1|Number Attending 1st Assigned Session|Overall Study||18
218706|NCT01210651|529108|P2|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|18
218707|NCT01210651|529109|P1|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|20
218708|NCT01210560|529125|P9|NOT COMPLETED|Intervention 3 (7 Days)||0
218709|NCT01210560|529126|P8|NOT COMPLETED|Intervention 3 (7 Days)||0
218710|NCT01210560|529127|P7|NOT COMPLETED|Intervention 3 (7 Days)||0
218711|NCT01210560|529128|P6|NOT COMPLETED|Intervention 3 (7 Days)||0
218712|NCT01210560|529129|P5|NOT COMPLETED|Intervention 3 (7 Days)||0
218713|NCT01210560|529130|P4|NOT COMPLETED|Intervention 3 (7 Days)||0
218714|NCT01210560|529131|P3|NOT COMPLETED|Intervention 3 (7 Days)||0
218715|NCT01210560|529132|P2|NOT COMPLETED|Intervention 3 (7 Days)||0
218716|NCT01210560|529133|P1|NOT COMPLETED|Intervention 3 (7 Days)||0
218717|NCT01210560|529125|P9|COMPLETED|Intervention 3 (7 Days)||5
218718|NCT01210560|529126|P8|COMPLETED|Intervention 3 (7 Days)||4
218719|NCT01210560|529127|P7|COMPLETED|Intervention 3 (7 Days)||4
218720|NCT01210560|529128|P6|COMPLETED|Intervention 3 (7 Days)||2
218721|NCT01210560|529129|P5|COMPLETED|Intervention 3 (7 Days)||2
218722|NCT01210560|529130|P4|COMPLETED|Intervention 3 (7 Days)||2
218723|NCT01210560|529131|P3|COMPLETED|Intervention 3 (7 Days)||2
218724|NCT01210560|529132|P2|COMPLETED|Intervention 3 (7 Days)||2
218725|NCT01210560|529133|P1|COMPLETED|Intervention 3 (7 Days)||2
218726|NCT01210560|529125|P9|STARTED|Intervention 3 (7 Days)||5
218727|NCT01210560|529126|P8|STARTED|Intervention 3 (7 Days)||4
218728|NCT01210560|529127|P7|STARTED|Intervention 3 (7 Days)||4
218729|NCT01210560|529128|P6|STARTED|Intervention 3 (7 Days)||2
218730|NCT01210560|529129|P5|STARTED|Intervention 3 (7 Days)||2
218731|NCT01210560|529130|P4|STARTED|Intervention 3 (7 Days)||2
218732|NCT01210560|529131|P3|STARTED|Intervention 3 (7 Days)||2
218733|NCT01210560|529132|P2|STARTED|Intervention 3 (7 Days)||2
218734|NCT01210560|529133|P1|STARTED|Intervention 3 (7 Days)||2
218735|NCT01210560|529125|P9|NOT COMPLETED|Intervention 2 (7 Days)||0
218736|NCT01210560|529126|P8|NOT COMPLETED|Intervention 2 (7 Days)||0
218737|NCT01210560|529127|P7|NOT COMPLETED|Intervention 2 (7 Days)||0
218738|NCT01210560|529128|P6|NOT COMPLETED|Intervention 2 (7 Days)||0
218739|NCT01210560|529129|P5|NOT COMPLETED|Intervention 2 (7 Days)||0
218740|NCT01210560|529130|P4|NOT COMPLETED|Intervention 2 (7 Days)||0
218741|NCT01210560|529131|P3|NOT COMPLETED|Intervention 2 (7 Days)||0
218742|NCT01210560|529132|P2|NOT COMPLETED|Intervention 2 (7 Days)||0
218743|NCT01210560|529133|P1|NOT COMPLETED|Intervention 2 (7 Days)||0
218744|NCT01210560|529125|P9|COMPLETED|Intervention 2 (7 Days)||5
218745|NCT01210560|529126|P8|COMPLETED|Intervention 2 (7 Days)||4
218746|NCT01210560|529127|P7|COMPLETED|Intervention 2 (7 Days)||4
218747|NCT01210560|529128|P6|COMPLETED|Intervention 2 (7 Days)||2
218748|NCT01210560|529129|P5|COMPLETED|Intervention 2 (7 Days)||2
218749|NCT01210560|529130|P4|COMPLETED|Intervention 2 (7 Days)||2
218750|NCT01210560|529131|P3|COMPLETED|Intervention 2 (7 Days)||2
218751|NCT01210560|529132|P2|COMPLETED|Intervention 2 (7 Days)||2
218752|NCT01210560|529133|P1|COMPLETED|Intervention 2 (7 Days)||2
218753|NCT01210560|529125|P9|STARTED|Intervention 2 (7 Days)||5
218754|NCT01210560|529126|P8|STARTED|Intervention 2 (7 Days)||4
218755|NCT01210560|529127|P7|STARTED|Intervention 2 (7 Days)||4
218756|NCT01210560|529128|P6|STARTED|Intervention 2 (7 Days)||2
218757|NCT01210560|529129|P5|STARTED|Intervention 2 (7 Days)||2
218758|NCT01210560|529130|P4|STARTED|Intervention 2 (7 Days)||2
218759|NCT01210560|529131|P3|STARTED|Intervention 2 (7 Days)||2
218760|NCT01210560|529132|P2|STARTED|Intervention 2 (7 Days)||2
218761|NCT01210560|529133|P1|STARTED|Intervention 2 (7 Days)||2
218762|NCT01210560|529125|P9|NOT COMPLETED|Intervention 1 (7 Days)||0
218763|NCT01210560|529126|P8|NOT COMPLETED|Intervention 1 (7 Days)||0
218764|NCT01210560|529127|P7|NOT COMPLETED|Intervention 1 (7 Days)||0
218765|NCT01210560|529128|P6|NOT COMPLETED|Intervention 1 (7 Days)||0
218766|NCT01210560|529129|P5|NOT COMPLETED|Intervention 1 (7 Days)||0
218767|NCT01210560|529130|P4|NOT COMPLETED|Intervention 1 (7 Days)||0
218768|NCT01210560|529131|P3|NOT COMPLETED|Intervention 1 (7 Days)||0
218769|NCT01210560|529132|P2|NOT COMPLETED|Intervention 1 (7 Days)||0
218770|NCT01210560|529133|P1|NOT COMPLETED|Intervention 1 (7 Days)||0
218771|NCT01210560|529125|P9|COMPLETED|Intervention 1 (7 Days)||5
218772|NCT01210560|529126|P8|COMPLETED|Intervention 1 (7 Days)||4
218773|NCT01210560|529127|P7|COMPLETED|Intervention 1 (7 Days)||4
218774|NCT01210560|529128|P6|COMPLETED|Intervention 1 (7 Days)||2
218775|NCT01210560|529129|P5|COMPLETED|Intervention 1 (7 Days)||2
218776|NCT01210560|529130|P4|COMPLETED|Intervention 1 (7 Days)||2
218777|NCT01210560|529131|P3|COMPLETED|Intervention 1 (7 Days)||2
218778|NCT01210560|529132|P2|COMPLETED|Intervention 1 (7 Days)||2
218779|NCT01210560|529133|P1|COMPLETED|Intervention 1 (7 Days)||2
218780|NCT01210560|529125|P9|STARTED|Intervention 1 (7 Days)||5
218781|NCT01210560|529126|P8|STARTED|Intervention 1 (7 Days)||4
218782|NCT01210560|529127|P7|STARTED|Intervention 1 (7 Days)||4
218783|NCT01210560|529128|P6|STARTED|Intervention 1 (7 Days)||2
218784|NCT01210560|529129|P5|STARTED|Intervention 1 (7 Days)||2
218785|NCT01210560|529130|P4|STARTED|Intervention 1 (7 Days)||2
218786|NCT01210560|529131|P3|STARTED|Intervention 1 (7 Days)||2
218787|NCT01210560|529132|P2|STARTED|Intervention 1 (7 Days)||2
218788|NCT01210560|529133|P1|STARTED|Intervention 1 (7 Days)||2
218789|NCT01210495|529229|P4|NOT COMPLETED|Overall Study||68
218790|NCT01210495|529230|P3|NOT COMPLETED|Overall Study||134
218791|NCT01210495|529231|P2|NOT COMPLETED|Overall Study||7
218792|NCT01210495|529232|P1|NOT COMPLETED|Overall Study||15
218793|NCT01210495|529229|P4|COMPLETED|Overall Study||0
218794|NCT01210495|529230|P3|COMPLETED|Overall Study||0
218795|NCT01210495|529231|P2|COMPLETED|Overall Study||0
218796|NCT01210495|529232|P1|COMPLETED|Overall Study||0
218797|NCT01210495|529229|P4|STARTED|Overall Study||68
218798|NCT01210495|529230|P3|STARTED|Overall Study||134
218799|NCT01210495|529231|P2|STARTED|Overall Study||7
218800|NCT01210495|529232|P1|STARTED|Overall Study||15
218801|NCT01210443|529294|P1|NOT COMPLETED|Overall Study||2
218802|NCT01210443|529294|P1|COMPLETED|Overall Study||0
218803|NCT01210443|529294|P1|STARTED|Overall Study||2
218804|NCT01210352|529311|P9|NOT COMPLETED|Overall Study||4
218805|NCT01210352|529312|P8|NOT COMPLETED|Overall Study||3
218806|NCT01210352|529313|P7|NOT COMPLETED|Overall Study||2
218807|NCT01210352|529314|P6|NOT COMPLETED|Overall Study||0
218808|NCT01210352|529315|P5|NOT COMPLETED|Overall Study||0
218809|NCT01210352|529316|P4|NOT COMPLETED|Overall Study||0
218810|NCT01210352|529317|P3|NOT COMPLETED|Overall Study||2
218811|NCT01210352|529318|P2|NOT COMPLETED|Overall Study||0
218812|NCT01210352|529319|P1|NOT COMPLETED|Overall Study||0
218813|NCT01210352|529311|P9|COMPLETED|Overall Study||2
218814|NCT01210352|529312|P8|COMPLETED|Overall Study||7
218815|NCT01210352|529313|P7|COMPLETED|Overall Study||5
218816|NCT01210352|529314|P6|COMPLETED|Overall Study||6
218817|NCT01210352|529315|P5|COMPLETED|Overall Study||6
218818|NCT01210352|529316|P4|COMPLETED|Overall Study||7
218819|NCT01210352|529317|P3|COMPLETED|Overall Study||5
218820|NCT01210352|529318|P2|COMPLETED|Overall Study||6
218821|NCT01210352|529319|P1|COMPLETED|Overall Study||6
218822|NCT01210352|529311|P9|STARTED|Overall Study||6
218823|NCT01210352|529312|P8|STARTED|Overall Study||10
218824|NCT01210352|529313|P7|STARTED|Overall Study||7
218825|NCT01210352|529314|P6|STARTED|Overall Study||6
218826|NCT01210352|529315|P5|STARTED|Overall Study||6
218827|NCT01210352|529316|P4|STARTED|Overall Study||7
218828|NCT01210352|529317|P3|STARTED|Overall Study||7
218829|NCT01210352|529318|P2|STARTED|Overall Study||6
218830|NCT01210352|529319|P1|STARTED|Overall Study||6
218831|NCT01210222|529510|P1|NOT COMPLETED|Overall Study||3
218832|NCT01210222|529510|P1|COMPLETED|Overall Study||32
218833|NCT01210222|529510|P1|STARTED|Overall Study||35
218834|NCT01210170|529523|P1|NOT COMPLETED|Overall Study||7
218835|NCT01210170|529523|P1|COMPLETED|Overall Study||15
218836|NCT01210170|529523|P1|STARTED|Overall Study||22
218837|NCT01210144|529546|P2|NOT COMPLETED|Overall Study||0
218838|NCT01210144|529547|P1|NOT COMPLETED|Overall Study||3
218839|NCT01210144|529546|P2|COMPLETED|Overall Study||11
218840|NCT01210144|529547|P1|COMPLETED|Overall Study||10
218841|NCT01210144|529546|P2|STARTED|Overall Study||11
218842|NCT01210144|529547|P1|STARTED|Overall Study||13
218843|NCT01210118|529569|P2|NOT COMPLETED|Overall Study||5
218844|NCT01210118|529570|P1|NOT COMPLETED|Overall Study||3
218845|NCT01210118|529569|P2|COMPLETED|Overall Study||42
218846|NCT01210118|529570|P1|COMPLETED|Overall Study||42
218847|NCT01210118|529569|P2|STARTED|Overall Study||47
218848|NCT01210118|529570|P1|STARTED|Overall Study||45
218849|NCT01210079|529584|P2|NOT COMPLETED|Overall Study||0
218850|NCT01210079|529585|P1|NOT COMPLETED|Overall Study||0
218851|NCT01210079|529584|P2|COMPLETED|Overall Study||16
218852|NCT01210079|529585|P1|COMPLETED|Overall Study||10
218853|NCT01210079|529584|P2|STARTED|Overall Study||16
218854|NCT01210079|529585|P1|STARTED|Overall Study||10
218855|NCT01210001|529594|P3|NOT COMPLETED|Overall Study||12
218856|NCT01210001|529595|P2|NOT COMPLETED|Overall Study||11
218857|NCT01210001|529596|P1|NOT COMPLETED|Overall Study||19
218858|NCT01210001|529594|P3|COMPLETED|Overall Study||156
218859|NCT01210001|529595|P2|COMPLETED|Overall Study||154
218860|NCT01210001|529596|P1|COMPLETED|Overall Study||147
218861|NCT01210001|529594|P3|STARTED|Overall Study||168
218862|NCT01210001|529595|P2|STARTED|Overall Study||165
218863|NCT01210001|529596|P1|STARTED|Overall Study||166
218864|NCT01209949|529616|P1|NOT COMPLETED|Overall Study||3
218865|NCT01209949|529616|P1|COMPLETED|Overall Study||27
218866|NCT01209949|529616|P1|STARTED|Overall Study||30
218867|NCT01209832|529622|P1|NOT COMPLETED|Maintenance Period 2 (M1)||0
218868|NCT01209832|529622|P1|COMPLETED|Maintenance Period 2 (M1)||3
218869|NCT01209832|529622|P1|STARTED|Maintenance Period 2 (M1)|One participant who completed maintenance period 1 did not enter maintenance period 2.|3
218870|NCT01209832|529622|P1|NOT COMPLETED|Maintenance Period 1 (M1)||0
218871|NCT01209832|529622|P1|COMPLETED|Maintenance Period 1 (M1)||4
218872|NCT01209832|529622|P1|STARTED|Maintenance Period 1 (M1)|Five participants who completed Period 2 did not enroll into Maintenance Period.|4
218873|NCT01209832|529622|P1|NOT COMPLETED|Period 2||1
218874|NCT01209832|529622|P1|COMPLETED|Period 2||9
218875|NCT01209832|529622|P1|STARTED|Period 2||10
218876|NCT01209832|529622|P1|NOT COMPLETED|Period 1||1
218877|NCT01209832|529622|P1|COMPLETED|Period 1||10
218878|NCT01209832|529622|P1|Received At Least 1 Dose of Study Drug|Period 1||10
218879|NCT01209832|529622|P1|STARTED|Period 1||11
218880|NCT01209780|529641|P5|NOT COMPLETED|Overall Study||5
218881|NCT01209780|529642|P4|NOT COMPLETED|Overall Study||10
218882|NCT01209780|529643|P3|NOT COMPLETED|Overall Study||4
218883|NCT01209780|529644|P2|NOT COMPLETED|Overall Study||18
218884|NCT01209780|529645|P1|NOT COMPLETED|Overall Study||26
218885|NCT01209780|529641|P5|COMPLETED|Overall Study||407
218886|NCT01209780|529642|P4|COMPLETED|Overall Study||807
218887|NCT01209780|529643|P3|COMPLETED|Overall Study||44
218888|NCT01209780|529644|P2|COMPLETED|Overall Study||467
218889|NCT01209780|529645|P1|COMPLETED|Overall Study||1016
218890|NCT01209780|529641|P5|STARTED|Overall Study||412
218891|NCT01209780|529642|P4|STARTED|Overall Study||817
218892|NCT01209780|529643|P3|STARTED|Overall Study||48
218893|NCT01209780|529644|P2|STARTED|Overall Study||485
218894|NCT01209780|529645|P1|STARTED|Overall Study||1042
218895|NCT01209767|529671|P1|NOT COMPLETED|Overall Study||4
218896|NCT01209767|529671|P1|COMPLETED|Overall Study||18
218897|NCT01209767|529671|P1|STARTED|Overall Study||22
218898|NCT01209702|529681|P4|NOT COMPLETED|Overall Study||153
218899|NCT01209702|529682|P3|NOT COMPLETED|Overall Study||51
218900|NCT01209702|529683|P2|NOT COMPLETED|Overall Study||51
218901|NCT01209702|529684|P1|NOT COMPLETED|Overall Study||51
218902|NCT01209702|529681|P4|COMPLETED|Overall Study||0
218903|NCT01209702|529682|P3|COMPLETED|Overall Study||0
218904|NCT01209702|529683|P2|COMPLETED|Overall Study||0
218905|NCT01209702|529684|P1|COMPLETED|Overall Study||0
218906|NCT01209702|529681|P4|Completed 24 Weeks Treatment|Overall Study||10
218907|NCT01209702|529682|P3|Completed 24 Weeks Treatment|Overall Study||3
218908|NCT01209702|529683|P2|Completed 24 Weeks Treatment|Overall Study||28
218909|NCT01209702|529684|P1|Completed 24 Weeks Treatment|Overall Study||19
218910|NCT01209702|529681|P4|Completed 12 Weeks Treatment|Overall Study||59
218911|NCT01209702|529682|P3|Completed 12 Weeks Treatment|Overall Study||12
218912|NCT01209702|529683|P2|Completed 12 Weeks Treatment|Overall Study||48
218913|NCT01209702|529684|P1|Completed 12 Weeks Treatment|Overall Study||50
218914|NCT01209702|529681|P4|Escape or Switched to Tocilizumab|Overall Study||0
218915|NCT01209702|529682|P3|Escape or Switched to Tocilizumab|Overall Study||6
218916|NCT01209702|529683|P2|Escape or Switched to Tocilizumab|Overall Study||0
218917|NCT01209702|529684|P1|Escape or Switched to Tocilizumab|Overall Study||51
218918|NCT01209702|529681|P4|Treated|Overall Study||152
218919|NCT01209702|529682|P3|Treated|Overall Study||51
218920|NCT01209702|529683|P2|Treated|Overall Study||51
218921|NCT01209702|529684|P1|Treated|Overall Study||51
218922|NCT01209702|529681|P4|STARTED|Overall Study||153
218923|NCT01209702|529682|P3|STARTED|Overall Study||51
218924|NCT01209702|529683|P2|STARTED|Overall Study||51
218925|NCT01209702|529684|P1|STARTED|Overall Study||51
218926|NCT01209689|529740|P2|NOT COMPLETED|Overall Study||22
218927|NCT01209689|529741|P1|NOT COMPLETED|Overall Study||91
218928|NCT01209689|529740|P2|COMPLETED|Overall Study||0
218929|NCT01209689|529741|P1|COMPLETED|Overall Study||0
218930|NCT01209689|529740|P2|STARTED|Overall Study||22
218931|NCT01209689|529741|P1|STARTED|Overall Study||91
218932|NCT01209624|529747|P1|NOT COMPLETED|Overall Study||326
218933|NCT01209624|529747|P1|COMPLETED|Overall Study||576
218934|NCT01209624|529747|P1|Per Protocol Population|Overall Study||469
218935|NCT01209624|529747|P1|STARTED|Overall Study||902
218936|NCT01209598|529780|P2|NOT COMPLETED|Overall Study||0
218937|NCT01209598|529781|P1|NOT COMPLETED|Overall Study||1
218938|NCT01209598|529780|P2|COMPLETED|Overall Study||60
218939|NCT01209598|529781|P1|COMPLETED|Overall Study||29
218940|NCT01209598|529780|P2|STARTED|Overall Study||60
218941|NCT01209598|529781|P1|STARTED|Overall Study||30
218942|NCT01209520|529789|P1|NOT COMPLETED|Overall Study||3
218943|NCT01209520|529789|P1|COMPLETED|Overall Study||3
218944|NCT01209520|529789|P1|STARTED|Overall Study||6
218945|NCT01209442|529794|P1|NOT COMPLETED|Overall Study||0
218946|NCT01209442|529794|P1|COMPLETED|Overall Study||30
218947|NCT01209442|529794|P1|STARTED|Overall Study||30
218948|NCT01209286|529802|P3|NOT COMPLETED|Overall Study||3
218949|NCT01209286|529803|P2|NOT COMPLETED|Overall Study||10
218950|NCT01209286|529804|P1|NOT COMPLETED|Overall Study||5
218951|NCT01209286|529802|P3|COMPLETED|Overall Study||3
218952|NCT01209286|529803|P2|COMPLETED|Overall Study||13
218953|NCT01209286|529804|P1|COMPLETED|Overall Study||2
218954|NCT01209286|529802|P3|STARTED|Overall Study||6
218955|NCT01209286|529803|P2|STARTED|Overall Study||23
218956|NCT01209286|529804|P1|STARTED|Overall Study||7
218957|NCT01209260|529857|P2|NOT COMPLETED|Overall Study||0
218958|NCT01209260|529858|P1|NOT COMPLETED|Overall Study||0
218959|NCT01209260|529857|P2|COMPLETED|Overall Study||36
218960|NCT01209260|529858|P1|COMPLETED|Overall Study||36
218961|NCT01209260|529857|P2|STARTED|Overall Study||36
218962|NCT01209260|529858|P1|STARTED|Overall Study||36
218963|NCT01209195|529872|P6|NOT COMPLETED|Overall Study||0
218964|NCT01209195|529873|P5|NOT COMPLETED|Overall Study||0
218965|NCT01209195|529874|P4|NOT COMPLETED|Overall Study||0
218966|NCT01209195|529875|P3|NOT COMPLETED|Overall Study||0
218967|NCT01209195|529876|P2|NOT COMPLETED|Overall Study||0
218968|NCT01209195|529877|P1|NOT COMPLETED|Overall Study||0
218969|NCT01209195|529872|P6|COMPLETED|Overall Study||13
218970|NCT01209195|529873|P5|COMPLETED|Overall Study||6
218971|NCT01209195|529874|P4|COMPLETED|Overall Study||6
218972|NCT01209195|529875|P3|COMPLETED|Overall Study||6
218973|NCT01209195|529876|P2|COMPLETED|Overall Study||3
218974|NCT01209195|529877|P1|COMPLETED|Overall Study||7
218975|NCT01209195|529872|P6|STARTED|Overall Study||13
218976|NCT01209195|529873|P5|STARTED|Overall Study||6
218977|NCT01209195|529874|P4|STARTED|Overall Study||6
218978|NCT01209195|529875|P3|STARTED|Overall Study||6
218979|NCT01209195|529876|P2|STARTED|Overall Study||3
218980|NCT01209195|529877|P1|STARTED|Overall Study||7
218981|NCT01209143|529913|P2|NOT COMPLETED|Overall Study||20
218982|NCT01209143|529914|P1|NOT COMPLETED|Overall Study||19
218983|NCT01209143|529913|P2|COMPLETED|Overall Study||8
218984|NCT01209143|529914|P1|COMPLETED|Overall Study||5
218985|NCT01209143|529913|P2|STARTED|Overall Study||28
218986|NCT01209143|529914|P1|STARTED|Overall Study||24
218987|NCT01209078|529924|P2|NOT COMPLETED|Overall Study||3
218988|NCT01209078|529925|P1|NOT COMPLETED|Overall Study||16
218989|NCT01209078|529924|P2|COMPLETED|Overall Study||24
218990|NCT01209078|529925|P1|COMPLETED|Overall Study||41
218991|NCT01209078|529924|P2|STARTED|Overall Study||27
218992|NCT01209078|529925|P1|STARTED|Overall Study||57
218993|NCT01208961|530000|P2|NOT COMPLETED|High-Fat Period IV||0
218994|NCT01208961|530001|P1|NOT COMPLETED|High-Fat Period IV||0
218995|NCT01208961|530000|P2|COMPLETED|High-Fat Period IV||26
218996|NCT01208961|530001|P1|COMPLETED|High-Fat Period IV||25
218997|NCT01208961|530000|P2|STARTED|High-Fat Period IV||26
218998|NCT01208961|530001|P1|STARTED|High-Fat Period IV||25
218999|NCT01208961|530000|P2|NOT COMPLETED|High-Fat Period III||0
219000|NCT01208961|530001|P1|NOT COMPLETED|High-Fat Period III||1
219001|NCT01208961|530000|P2|COMPLETED|High-Fat Period III||26
219002|NCT01208961|530001|P1|COMPLETED|High-Fat Period III||25
219003|NCT01208961|530000|P2|STARTED|High-Fat Period III||26
219004|NCT01208961|530001|P1|STARTED|High-Fat Period III||26
219005|NCT01208961|530000|P2|NOT COMPLETED|Low-Fat Period II||0
219006|NCT01208961|530001|P1|NOT COMPLETED|Low-Fat Period II||0
219007|NCT01208961|530000|P2|COMPLETED|Low-Fat Period II||27
219008|NCT01208961|530001|P1|COMPLETED|Low-Fat Period II||26
219009|NCT01208961|530000|P2|STARTED|Low-Fat Period II||27
219010|NCT01208961|530001|P1|STARTED|Low-Fat Period II||26
219011|NCT01208961|530000|P2|NOT COMPLETED|Low-Fat Period I||0
219012|NCT01208961|530001|P1|NOT COMPLETED|Low-Fat Period I||0
219013|NCT01208961|530000|P2|COMPLETED|Low-Fat Period I||27
219014|NCT01208961|530001|P1|COMPLETED|Low-Fat Period I||27
219015|NCT01208961|530000|P2|STARTED|Low-Fat Period I||27
219016|NCT01208961|530001|P1|STARTED|Low-Fat Period I||27
219017|NCT01208922|530012|P2|NOT COMPLETED|Overall Study||10
219018|NCT01208922|530013|P1|NOT COMPLETED|Overall Study||11
219019|NCT01208922|530012|P2|COMPLETED|Overall Study||405
219020|NCT01208922|530013|P1|COMPLETED|Overall Study||409
219021|NCT01208922|530012|P2|STARTED|Overall Study||415
219022|NCT01208922|530013|P1|STARTED|Overall Study||420
219023|NCT01208870|530023|P2|NOT COMPLETED|Overall Study||8
219024|NCT01208870|530024|P1|NOT COMPLETED|Overall Study||2
219025|NCT01208870|530023|P2|COMPLETED|Overall Study||36
219026|NCT01208870|530024|P1|COMPLETED|Overall Study||44
219027|NCT01208870|530023|P2|Pilot 2|Overall Study||22
219028|NCT01208870|530024|P1|Pilot 2|Overall Study||26
219029|NCT01208870|530023|P2|Pilot 1|Overall Study||22
219030|NCT01208870|530024|P1|Pilot 1|Overall Study||20
219031|NCT01208870|530023|P2|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013.|44
219032|NCT01208870|530024|P1|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013|46
219033|NCT01208415|530040|P1|NOT COMPLETED|Overall Study||40
219034|NCT01208415|530040|P1|COMPLETED|Overall Study||0
219035|NCT01208415|530040|P1|6 Months|Overall Study||37
219036|NCT01208415|530040|P1|STARTED|Overall Study||40
219037|NCT01208402|530046|P2|NOT COMPLETED|Overall Study||0
219038|NCT01208402|530047|P1|NOT COMPLETED|Overall Study||1
219039|NCT01208402|530046|P2|COMPLETED|Overall Study||28
219040|NCT01208402|530047|P1|COMPLETED|Overall Study||30
219041|NCT01208402|530046|P2|STARTED|Overall Study||28
219042|NCT01208402|530047|P1|STARTED|Overall Study||31
219043|NCT01208337|530063|P1|NOT COMPLETED|Overall Study||3
219044|NCT01208337|530063|P1|COMPLETED|Overall Study||20
219045|NCT01208337|530063|P1|Five-year Follow-up|Overall Study||20
219046|NCT01208337|530063|P1|One-year Follow-up|Overall Study||23
219047|NCT01208337|530063|P1|STARTED|Overall Study||23
219048|NCT01208233|530077|P6|NOT COMPLETED|Overall Study||21
219049|NCT01208233|530078|P5|NOT COMPLETED|Overall Study||24
219050|NCT01208233|530079|P4|NOT COMPLETED|Overall Study||1
219051|NCT01208233|530080|P3|NOT COMPLETED|Overall Study||4
219052|NCT01208233|530081|P2|NOT COMPLETED|Overall Study||3
219053|NCT01208233|530082|P1|NOT COMPLETED|Overall Study||5
219054|NCT01208233|530077|P6|COMPLETED|Overall Study||46
219055|NCT01208233|530078|P5|COMPLETED|Overall Study||46
219056|NCT01208233|530079|P4|COMPLETED|Overall Study||9
219057|NCT01208233|530080|P3|COMPLETED|Overall Study||7
219058|NCT01208233|530081|P2|COMPLETED|Overall Study||6
219059|NCT01208233|530082|P1|COMPLETED|Overall Study||6
219060|NCT01208233|530077|P6|STARTED|Overall Study||67
219061|NCT01208233|530078|P5|STARTED|Overall Study||70
219062|NCT01208233|530079|P4|STARTED|Overall Study||10
219063|NCT01208233|530080|P3|STARTED|Overall Study||11
219064|NCT01208233|530081|P2|STARTED|Overall Study||9
219065|NCT01208233|530082|P1|STARTED|Overall Study||11
219066|NCT01208220|530195|P2|NOT COMPLETED|Overall Study||0
219067|NCT01208220|530196|P1|NOT COMPLETED|Overall Study||0
219068|NCT01208220|530195|P2|COMPLETED|Overall Study||1
219069|NCT01208220|530196|P1|COMPLETED|Overall Study||1
219070|NCT01208220|530195|P2|STARTED|Overall Study||1
219071|NCT01208220|530196|P1|STARTED|Overall Study||1
219072|NCT01208207|530207|P7|NOT COMPLETED|Part II||11
219073|NCT01208207|530208|P6|NOT COMPLETED|Part II||16
219074|NCT01208207|530209|P5|NOT COMPLETED|Part II||23
219075|NCT01208207|530210|P4|NOT COMPLETED|Part II||32
219076|NCT01208207|530211|P3|NOT COMPLETED|Part II||0
219077|NCT01208207|530212|P2|NOT COMPLETED|Part II||0
219078|NCT01208207|530213|P1|NOT COMPLETED|Part II||0
219079|NCT01208207|530207|P7|COMPLETED|Part II||131
219080|NCT01208207|530208|P6|COMPLETED|Part II||129
219081|NCT01208207|530209|P5|COMPLETED|Part II||295
219082|NCT01208207|530210|P4|COMPLETED|Part II||282
219083|NCT01208207|530211|P3|COMPLETED|Part II||0
219084|NCT01208207|530212|P2|COMPLETED|Part II||0
219085|NCT01208207|530213|P1|COMPLETED|Part II||0
219086|NCT01208207|530207|P7|STARTED|Part II||142
219087|NCT01208207|530208|P6|STARTED|Part II||145
219088|NCT01208207|530209|P5|STARTED|Part II||318
219089|NCT01208207|530210|P4|STARTED|Part II||314
219090|NCT01208207|530211|P3|STARTED|Part II||0
219091|NCT01208207|530212|P2|STARTED|Part II||0
219092|NCT01208207|530213|P1|STARTED|Part II||0
219093|NCT01208207|530207|P7|NOT COMPLETED|Part I||0
219094|NCT01208207|530208|P6|NOT COMPLETED|Part I||0
219095|NCT01208207|530209|P5|NOT COMPLETED|Part I||0
219096|NCT01208207|530210|P4|NOT COMPLETED|Part I||0
219097|NCT01208207|530211|P3|NOT COMPLETED|Part I||15
219098|NCT01208207|530212|P2|NOT COMPLETED|Part I||11
219099|NCT01208207|530213|P1|NOT COMPLETED|Part I||70
219100|NCT01208207|530207|P7|COMPLETED|Part I||0
219101|NCT01208207|530208|P6|COMPLETED|Part I||0
219102|NCT01208207|530209|P5|COMPLETED|Part I||0
219103|NCT01208207|530210|P4|COMPLETED|Part I||0
219104|NCT01208207|530211|P3|COMPLETED|Part I||142
219105|NCT01208207|530212|P2|COMPLETED|Part I||145
219106|NCT01208207|530213|P1|COMPLETED|Part I||632
219107|NCT01208207|530207|P7|STARTED|Part I||0
219108|NCT01208207|530208|P6|STARTED|Part I||0
219109|NCT01208207|530209|P5|STARTED|Part I||0
219110|NCT01208207|530210|P4|STARTED|Part I||0
219111|NCT01208207|530211|P3|STARTED|Part I||157
219112|NCT01208207|530212|P2|STARTED|Part I||156
219113|NCT01208207|530213|P1|STARTED|Part I||702
219114|NCT01208181|530240|P5|NOT COMPLETED|Part 2||0
219115|NCT01208181|530241|P4|NOT COMPLETED|Part 2||20
219116|NCT01208181|530242|P3|NOT COMPLETED|Part 2||16
219117|NCT01208181|530243|P2|NOT COMPLETED|Part 2||0
219118|NCT01208181|530244|P1|NOT COMPLETED|Part 2||0
219119|NCT01208181|530240|P5|COMPLETED|Part 2||0
219120|NCT01208181|530241|P4|COMPLETED|Part 2||343
219121|NCT01208181|530242|P3|COMPLETED|Part 2||334
219122|NCT01208181|530243|P2|COMPLETED|Part 2||0
219123|NCT01208181|530244|P1|COMPLETED|Part 2||0
219124|NCT01208181|530240|P5|STARTED|Part 2|Per protocol, participants did not receive placebo during Part II of the study|0
219125|NCT01208181|530241|P4|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 90 mg in Part II of the study|363
219126|NCT01208181|530242|P3|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 60 mg in Part II of the study|350
219127|NCT01208181|530243|P2|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
219128|NCT01208181|530244|P1|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
219129|NCT01208181|530240|P5|NOT COMPLETED|Part 1||22
219130|NCT01208181|530241|P4|NOT COMPLETED|Part 1||0
219131|NCT01208181|530242|P3|NOT COMPLETED|Part 1||0
219132|NCT01208181|530243|P2|NOT COMPLETED|Part 1||55
219133|NCT01208181|530244|P1|NOT COMPLETED|Part 1||99
219134|NCT01208181|530240|P5|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|96
219135|NCT01208181|530241|P4|COMPLETED|Part 1||0
219136|NCT01208181|530242|P3|COMPLETED|Part 1||0
219137|NCT01208181|530243|P2|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|413
219138|NCT01208181|530244|P1|COMPLETED|Part 1|Six participants from this arm did not continue into Part II of the study|719
219139|NCT01208181|530240|P5|STARTED|Part 1||118
219140|NCT01208181|530241|P4|STARTED|Part 1||0
219141|NCT01208181|530242|P3|STARTED|Part 1||0
219142|NCT01208181|530243|P2|STARTED|Part 1||468
219143|NCT01208181|530244|P1|STARTED|Part 1||818
219144|NCT01207934|530276|P3|NOT COMPLETED|Overall Study||0
219145|NCT01207934|530277|P2|NOT COMPLETED|Overall Study||0
219146|NCT01207934|530278|P1|NOT COMPLETED|Overall Study||0
219147|NCT01207934|530276|P3|COMPLETED|Overall Study||6
219148|NCT01207934|530277|P2|COMPLETED|Overall Study||6
219149|NCT01207934|530278|P1|COMPLETED|Overall Study||6
219150|NCT01207934|530276|P3|STARTED|Overall Study||6
219151|NCT01207934|530277|P2|STARTED|Overall Study||6
219152|NCT01207934|530278|P1|STARTED|Overall Study||6
219153|NCT01207765|530295|P1|NOT COMPLETED|Overall Study||0
219154|NCT01207765|530295|P1|COMPLETED|Overall Study||8
219155|NCT01207765|530295|P1|STARTED|Overall Study||8
219156|NCT01207726|530303|P2|NOT COMPLETED|Overall Study||0
219157|NCT01207726|530304|P1|NOT COMPLETED|Overall Study||0
219158|NCT01207726|530303|P2|COMPLETED|Overall Study||6
219159|NCT01207726|530304|P1|COMPLETED|Overall Study||7
219160|NCT01207726|530303|P2|STARTED|Overall Study||6
219161|NCT01207726|530304|P1|STARTED|Overall Study||7
219162|NCT01207687|530322|P1|NOT COMPLETED|Overall Study||2
219163|NCT01207687|530322|P1|COMPLETED|Overall Study||12
219164|NCT01207687|530322|P1|STARTED|Overall Study||14
219165|NCT01207648|530352|P1|NOT COMPLETED|Overall Study||0
219166|NCT01207648|530352|P1|COMPLETED|Overall Study||307
219167|NCT01207648|530352|P1|STARTED|Overall Study||307
219168|NCT01207596|530360|P1|NOT COMPLETED|Overall Study||9
219169|NCT01207596|530360|P1|COMPLETED|Overall Study||21
219170|NCT01207596|530360|P1|STARTED|Overall Study||30
219171|NCT01207583|530373|P3|NOT COMPLETED|Overall Study||1
219172|NCT01207583|530374|P2|NOT COMPLETED|Overall Study||5
219173|NCT01207583|530375|P1|NOT COMPLETED|Overall Study||1
219174|NCT01207583|530373|P3|COMPLETED|Overall Study||54
219175|NCT01207583|530374|P2|COMPLETED|Overall Study||26
219176|NCT01207583|530375|P1|COMPLETED|Overall Study||13
219177|NCT01207583|530373|P3|Dose 4|Overall Study||0
219178|NCT01207583|530374|P2|Dose 4|Overall Study||0
219179|NCT01207583|530375|P1|Dose 4|Overall Study||7
219180|NCT01207583|530373|P3|Dose 3|Overall Study||0
219181|NCT01207583|530374|P2|Dose 3|Overall Study||27
219182|NCT01207583|530375|P1|Dose 3|Overall Study||13
219183|NCT01207583|530373|P3|Dose 2|Overall Study||54
219184|NCT01207583|530374|P2|Dose 2|Overall Study||29
219185|NCT01207583|530375|P1|Dose 2|Overall Study||13
219186|NCT01207583|530373|P3|Dose 1|Overall Study||55
219187|NCT01207583|530374|P2|Dose 1|Overall Study||31
219188|NCT01207583|530375|P1|Dose 1|Overall Study||14
219189|NCT01207583|530373|P3|STARTED|Overall Study||55
219190|NCT01207583|530374|P2|STARTED|Overall Study||31
219191|NCT01207583|530375|P1|STARTED|Overall Study||14
219192|NCT01207570|530415|P2|NOT COMPLETED|The Second Stage (After Crossover)||0
219193|NCT01207570|530416|P1|NOT COMPLETED|The Second Stage (After Crossover)||0
219194|NCT01207570|530415|P2|COMPLETED|The Second Stage (After Crossover)||23
219195|NCT01207570|530416|P1|COMPLETED|The Second Stage (After Crossover)||31
219196|NCT01207570|530415|P2|STARTED|The Second Stage (After Crossover)||23
219197|NCT01207570|530416|P1|STARTED|The Second Stage (After Crossover)||31
219198|NCT01207570|530415|P2|NOT COMPLETED|The First Stage (Before Crossover)||0
219199|NCT01207570|530416|P1|NOT COMPLETED|The First Stage (Before Crossover)||0
219200|NCT01207570|530415|P2|COMPLETED|The First Stage (Before Crossover)||31
219201|NCT01207570|530416|P1|COMPLETED|The First Stage (Before Crossover)||23
219202|NCT01207570|530415|P2|STARTED|The First Stage (Before Crossover)||31
219203|NCT01207570|530416|P1|STARTED|The First Stage (Before Crossover)||23
219204|NCT01207492|530428|P1|NOT COMPLETED|Overall Study||15
219205|NCT01207492|530428|P1|COMPLETED|Overall Study||2
219206|NCT01207492|530428|P1|STARTED|Overall Study||17
219207|NCT01207466|530434|P2|NOT COMPLETED|Period 2, One Week of Wear||0
219208|NCT01207466|530435|P1|NOT COMPLETED|Period 2, One Week of Wear||0
219209|NCT01207466|530434|P2|COMPLETED|Period 2, One Week of Wear||48
219210|NCT01207466|530435|P1|COMPLETED|Period 2, One Week of Wear||45
219211|NCT01207466|530434|P2|STARTED|Period 2, One Week of Wear||48
219212|NCT01207466|530435|P1|STARTED|Period 2, One Week of Wear||45
219213|NCT01207466|530434|P2|NOT COMPLETED|Period 1, One Week of Wear||0
219214|NCT01207466|530435|P1|NOT COMPLETED|Period 1, One Week of Wear||0
219215|NCT01207466|530434|P2|COMPLETED|Period 1, One Week of Wear||48
219216|NCT01207466|530435|P1|COMPLETED|Period 1, One Week of Wear|One participant discontinued between Period 1 and Period 2 due to inclusion/exclusion criteria.|46
219217|NCT01207466|530434|P2|STARTED|Period 1, One Week of Wear||48
219218|NCT01207466|530435|P1|STARTED|Period 1, One Week of Wear||46
219219|NCT01207453|530443|P2|NOT COMPLETED|2nd Intervention||2
219220|NCT01207453|530444|P1|NOT COMPLETED|2nd Intervention||2
219221|NCT01207453|530443|P2|COMPLETED|2nd Intervention||15
219222|NCT01207453|530444|P1|COMPLETED|2nd Intervention||17
219223|NCT01207453|530443|P2|STARTED|2nd Intervention||17
219224|NCT01207453|530444|P1|STARTED|2nd Intervention||19
219225|NCT01207453|530443|P2|NOT COMPLETED|Washout||0
219226|NCT01207453|530444|P1|NOT COMPLETED|Washout||2
219227|NCT01207453|530443|P2|COMPLETED|Washout||17
219228|NCT01207453|530444|P1|COMPLETED|Washout||19
219229|NCT01207453|530443|P2|STARTED|Washout||17
219230|NCT01207453|530444|P1|STARTED|Washout||21
219231|NCT01207453|530443|P2|NOT COMPLETED|First Intervention||1
219232|NCT01207453|530444|P1|NOT COMPLETED|First Intervention||2
219233|NCT01207453|530443|P2|COMPLETED|First Intervention||17
219234|NCT01207453|530444|P1|COMPLETED|First Intervention||21
219235|NCT01207453|530443|P2|STARTED|First Intervention||18
219236|NCT01207453|530444|P1|STARTED|First Intervention||23
219237|NCT01207427|530466|P3|NOT COMPLETED|Run-out Placebo Period||0
219238|NCT01207427|530467|P2|NOT COMPLETED|Run-out Placebo Period||0
219239|NCT01207427|530468|P1|NOT COMPLETED|Run-out Placebo Period||0
219240|NCT01207427|530466|P3|COMPLETED|Run-out Placebo Period||41
219241|NCT01207427|530467|P2|COMPLETED|Run-out Placebo Period||43
219242|NCT01207427|530468|P1|COMPLETED|Run-out Placebo Period||40
219243|NCT01207427|530466|P3|STARTED|Run-out Placebo Period||41
219244|NCT01207427|530467|P2|STARTED|Run-out Placebo Period||43
219245|NCT01207427|530468|P1|STARTED|Run-out Placebo Period||40
219246|NCT01207427|530466|P3|NOT COMPLETED|Double-blind Treatment Period||2
219247|NCT01207427|530467|P2|NOT COMPLETED|Double-blind Treatment Period||2
219248|NCT01207427|530468|P1|NOT COMPLETED|Double-blind Treatment Period||3
219249|NCT01207427|530466|P3|COMPLETED|Double-blind Treatment Period||41
219250|NCT01207427|530467|P2|COMPLETED|Double-blind Treatment Period||43
219251|NCT01207427|530468|P1|COMPLETED|Double-blind Treatment Period||40
219252|NCT01207427|530466|P3|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
219253|NCT01207427|530467|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||45
219254|NCT01207427|530468|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
219255|NCT01207427|530466|P3|STARTED|Double-blind Treatment Period||43
219256|NCT01207427|530467|P2|STARTED|Double-blind Treatment Period||45
219257|NCT01207427|530468|P1|STARTED|Double-blind Treatment Period||43
219258|NCT01207427|530466|P3|NOT COMPLETED|Run-in Placebo Period||0
219259|NCT01207427|530467|P2|NOT COMPLETED|Run-in Placebo Period||0
219260|NCT01207427|530468|P1|NOT COMPLETED|Run-in Placebo Period||0
219261|NCT01207427|530466|P3|COMPLETED|Run-in Placebo Period||43
219262|NCT01207427|530467|P2|COMPLETED|Run-in Placebo Period||45
219263|NCT01207427|530468|P1|COMPLETED|Run-in Placebo Period||43
219264|NCT01207427|530466|P3|STARTED|Run-in Placebo Period||43
219265|NCT01207427|530467|P2|STARTED|Run-in Placebo Period||45
219266|NCT01207427|530468|P1|STARTED|Run-in Placebo Period||43
219267|NCT01207414|530478|P2|NOT COMPLETED|Overall Study||82
219268|NCT01207414|530479|P1|NOT COMPLETED|Overall Study||73
219269|NCT01207414|530478|P2|COMPLETED|Overall Study||178
219270|NCT01207414|530479|P1|COMPLETED|Overall Study||168
219271|NCT01207414|530478|P2|Safety Population: Received Study Drug|Overall Study||260
219272|NCT01207414|530479|P1|Safety Population: Received Study Drug|Overall Study||240
219273|NCT01207414|530478|P2|STARTED|Overall Study||260
219274|NCT01207414|530479|P1|STARTED|Overall Study|Includes 1 patient randomized in error.|241
219275|NCT01207401|530497|P2|NOT COMPLETED|Overall Study||0
219276|NCT01207401|530498|P1|NOT COMPLETED|Overall Study||0
219277|NCT01207401|530497|P2|COMPLETED|Overall Study||24
219278|NCT01207401|530498|P1|COMPLETED|Overall Study||26
219279|NCT01207401|530497|P2|STARTED|Overall Study||24
219280|NCT01207401|530498|P1|STARTED|Overall Study||26
219281|NCT01207388|530504|P1|NOT COMPLETED|Overall Study||33
219282|NCT01207388|530504|P1|COMPLETED|Overall Study|Completed the core study|83
219283|NCT01207388|530504|P1|STARTED|Overall Study||116
219284|NCT01207219|530527|P3|NOT COMPLETED|Overall Study||7
219285|NCT01207219|530528|P2|NOT COMPLETED|Overall Study||11
219286|NCT01207219|530529|P1|NOT COMPLETED|Overall Study||11
219287|NCT01207219|530527|P3|COMPLETED|Overall Study||32
219288|NCT01207219|530528|P2|COMPLETED|Overall Study||29
219289|NCT01207219|530529|P1|COMPLETED|Overall Study||34
219290|NCT01207219|530527|P3|Included in ITT Analysis|Overall Study||38
219291|NCT01207219|530528|P2|Included in ITT Analysis|Overall Study||37
219292|NCT01207219|530529|P1|Included in ITT Analysis|Overall Study||40
219293|NCT01207219|530527|P3|STARTED|Overall Study||39
219294|NCT01207219|530528|P2|STARTED|Overall Study||40
219295|NCT01207219|530529|P1|STARTED|Overall Study||45
219296|NCT01207102|530549|P1|NOT COMPLETED|Overall Study||10
219297|NCT01207102|530549|P1|COMPLETED|Overall Study||0
219298|NCT01207102|530549|P1|STARTED|Overall Study||10
219299|NCT01206816|530561|P7|NOT COMPLETED|Overall Study||6
219300|NCT01206816|530562|P6|NOT COMPLETED|Overall Study||19
219301|NCT01206816|530563|P5|NOT COMPLETED|Overall Study||3
219302|NCT01206816|530564|P4|NOT COMPLETED|Overall Study||3
219303|NCT01206816|530565|P3|NOT COMPLETED|Overall Study||20
219304|NCT01206816|530566|P2|NOT COMPLETED|Overall Study||3
219305|NCT01206816|530567|P1|NOT COMPLETED|Overall Study||3
219306|NCT01206816|530561|P7|COMPLETED|Overall Study|1pt dist. due to 'other AE' & 1pt 'other' for vol & since,‘PD’ from aftb.|0
219307|NCT01206816|530562|P6|COMPLETED|Overall Study|1pt dist. due to 'PD' for vol & since, ‘Other AE’ from aftb|0
219308|NCT01206816|530563|P5|COMPLETED|Overall Study||0
219309|NCT01206816|530564|P4|COMPLETED|Overall Study|1pt discontinue (dist.)due to 'PD' for vol.& since, ‘Other AE’ from aftb|0
219310|NCT01206816|530565|P3|COMPLETED|Overall Study|1pt dist.due to 'Other AE' for vol& since 'other' from aftb.1pt 'PD' for vol& since,‘DLT’ from aftb|0
219311|NCT01206816|530566|P2|COMPLETED|Overall Study||0
219312|NCT01206816|530567|P1|COMPLETED|Overall Study||0
219313|NCT01206816|530561|P7|STARTED|Overall Study|Started=Treated|6
219314|NCT01206816|530562|P6|STARTED|Overall Study|Started=Treated|19
219315|NCT01206816|530563|P5|STARTED|Overall Study|Started=Treated|3
219316|NCT01206816|530564|P4|STARTED|Overall Study|Started=Treated|3
219317|NCT01206816|530565|P3|STARTED|Overall Study|Started=Treated|20
219318|NCT01206816|530566|P2|STARTED|Overall Study|Started=Treated|3
219319|NCT01206816|530567|P1|STARTED|Overall Study|Started=Treated|3
219320|NCT01206777|530613|P1|NOT COMPLETED|Overall Study||2
219321|NCT01206777|530613|P1|COMPLETED|Overall Study||50
219322|NCT01206777|530613|P1|Discontinued Trial and Deemed Ineligible|Overall Study||2
219323|NCT01206777|530613|P1|STARTED|Overall Study||52
219324|NCT01206764|530619|P1|NOT COMPLETED|Overall Study||138
219325|NCT01206764|530619|P1|COMPLETED|Overall Study||4
219326|NCT01206764|530619|P1|STARTED|Overall Study||142
219327|NCT01206738|530630|P3|NOT COMPLETED|Overall Study||19
219328|NCT01206738|530631|P2|NOT COMPLETED|Overall Study||25
219329|NCT01206738|530632|P1|NOT COMPLETED|Overall Study||23
219330|NCT01206738|530630|P3|COMPLETED|Overall Study||42
219331|NCT01206738|530631|P2|COMPLETED|Overall Study||49
219332|NCT01206738|530632|P1|COMPLETED|Overall Study||40
219333|NCT01206738|530630|P3|STARTED|Overall Study||61
219334|NCT01206738|530631|P2|STARTED|Overall Study||74
219335|NCT01206738|530632|P1|STARTED|Overall Study||63
219336|NCT01206660|530644|P2|NOT COMPLETED|Overall Study||0
219337|NCT01206660|530645|P1|NOT COMPLETED|Overall Study||0
219338|NCT01206660|530644|P2|COMPLETED|Overall Study||60
219339|NCT01206660|530645|P1|COMPLETED|Overall Study||60
219340|NCT01206660|530644|P2|STARTED|Overall Study||60
219341|NCT01206660|530645|P1|STARTED|Overall Study||60
219342|NCT01206608|530657|P2|NOT COMPLETED|Overall Study||0
219343|NCT01206608|530658|P1|NOT COMPLETED|Overall Study||0
219344|NCT01206608|530657|P2|COMPLETED|Overall Study||20
219345|NCT01206608|530658|P1|COMPLETED|Overall Study||20
219346|NCT01206608|530657|P2|STARTED|Overall Study||20
219347|NCT01206608|530658|P1|STARTED|Overall Study||20
219348|NCT01206595|530666|P2|NOT COMPLETED|Overall Study||0
219349|NCT01206595|530667|P1|NOT COMPLETED|Overall Study||0
219350|NCT01206595|530666|P2|COMPLETED|Overall Study||20
219351|NCT01206595|530667|P1|COMPLETED|Overall Study||38
219352|NCT01206595|530666|P2|STARTED|Overall Study||20
219353|NCT01206595|530667|P1|STARTED|Overall Study||38
219354|NCT01206582|530677|P2|NOT COMPLETED|Overall Study||2
219355|NCT01206582|530678|P1|NOT COMPLETED|Overall Study||2
219356|NCT01206582|530677|P2|COMPLETED|Overall Study||7
219357|NCT01206582|530678|P1|COMPLETED|Overall Study||9
219358|NCT01206582|530677|P2|STARTED|Overall Study||9
219359|NCT01206582|530678|P1|STARTED|Overall Study||11
219360|NCT01206517|530710|P6|NOT COMPLETED|Overall Study||0
219361|NCT01206517|530711|P5|NOT COMPLETED|Overall Study||1
219362|NCT01206517|530712|P4|NOT COMPLETED|Overall Study||0
219363|NCT01206517|530713|P3|NOT COMPLETED|Overall Study||2
219364|NCT01206517|530714|P2|NOT COMPLETED|Overall Study||0
219365|NCT01206517|530715|P1|NOT COMPLETED|Overall Study||0
219366|NCT01206517|530710|P6|COMPLETED|Overall Study||4
219367|NCT01206517|530711|P5|COMPLETED|Overall Study||3
219368|NCT01206517|530712|P4|COMPLETED|Overall Study||4
219369|NCT01206517|530713|P3|COMPLETED|Overall Study||4
219370|NCT01206517|530714|P2|COMPLETED|Overall Study||6
219371|NCT01206517|530715|P1|COMPLETED|Overall Study||6
219372|NCT01206517|530710|P6|STARTED|Overall Study||4
219373|NCT01206517|530711|P5|STARTED|Overall Study||4
219374|NCT01206517|530712|P4|STARTED|Overall Study||4
219375|NCT01206517|530713|P3|STARTED|Overall Study||6
219376|NCT01206517|530714|P2|STARTED|Overall Study||6
219377|NCT01206517|530715|P1|STARTED|Overall Study||6
219378|NCT01206478|530746|P2|NOT COMPLETED|Overall Study||5
219379|NCT01206478|530747|P1|NOT COMPLETED|Overall Study||2
219380|NCT01206478|530746|P2|COMPLETED|Overall Study||7
219381|NCT01206478|530747|P1|COMPLETED|Overall Study||7
219382|NCT01206478|530746|P2|STARTED|Overall Study||12
219383|NCT01206478|530747|P1|STARTED|Overall Study||9
219384|NCT01206465|530755|P5|NOT COMPLETED|Overall Study||0
219385|NCT01206465|530756|P4|NOT COMPLETED|Overall Study||0
219386|NCT01206465|530757|P3|NOT COMPLETED|Overall Study||0
219387|NCT01206465|530758|P2|NOT COMPLETED|Overall Study||0
219388|NCT01206465|530759|P1|NOT COMPLETED|Overall Study||0
219389|NCT01206465|530755|P5|COMPLETED|Overall Study||6
219390|NCT01206465|530756|P4|COMPLETED|Overall Study||6
219391|NCT01206465|530757|P3|COMPLETED|Overall Study||6
219392|NCT01206465|530758|P2|COMPLETED|Overall Study||6
219393|NCT01206465|530759|P1|COMPLETED|Overall Study||3
219394|NCT01206465|530755|P5|STARTED|Overall Study||6
219395|NCT01206465|530756|P4|STARTED|Overall Study||6
219396|NCT01206465|530757|P3|STARTED|Overall Study||6
219397|NCT01206465|530758|P2|STARTED|Overall Study||6
219398|NCT01206465|530759|P1|STARTED|Overall Study||3
219399|NCT01206452|530780|P2|NOT COMPLETED|Overall Study||0
219400|NCT01206452|530781|P1|NOT COMPLETED|Overall Study||0
219401|NCT01206452|530780|P2|COMPLETED|Overall Study||30
219402|NCT01206452|530781|P1|COMPLETED|Overall Study||30
219403|NCT01206452|530780|P2|STARTED|Overall Study||30
219404|NCT01206452|530781|P1|STARTED|Overall Study||30
219405|NCT01206439|530795|P1|NOT COMPLETED|Overall Study||1
219406|NCT01206439|530795|P1|COMPLETED|Overall Study||1
219407|NCT01206439|530795|P1|STARTED|Overall Study||2
219408|NCT01206387|530801|P2|NOT COMPLETED|Overall Study||0
219409|NCT01206387|530802|P1|NOT COMPLETED|Overall Study||1
219410|NCT01206387|530801|P2|COMPLETED|Overall Study||60
219411|NCT01206387|530802|P1|COMPLETED|Overall Study||59
219412|NCT01206387|530801|P2|STARTED|Overall Study||60
219413|NCT01206387|530802|P1|STARTED|Overall Study||60
219414|NCT01206322|530818|P4|NOT COMPLETED|Overall Study||1
219415|NCT01206322|530819|P3|NOT COMPLETED|Overall Study||0
219416|NCT01206322|530820|P2|NOT COMPLETED|Overall Study||0
219417|NCT01206322|530821|P1|NOT COMPLETED|Overall Study||0
219418|NCT01206322|530818|P4|COMPLETED|Overall Study||5
219419|NCT01206322|530819|P3|COMPLETED|Overall Study||9
219420|NCT01206322|530820|P2|COMPLETED|Overall Study||11
219421|NCT01206322|530821|P1|COMPLETED|Overall Study||4
219422|NCT01206322|530818|P4|STARTED|Overall Study||6
219423|NCT01206322|530819|P3|STARTED|Overall Study||9
219424|NCT01206322|530820|P2|STARTED|Overall Study||11
219425|NCT01206322|530821|P1|STARTED|Overall Study||4
219426|NCT01206140|530837|P2|NOT COMPLETED|Overall Study||0
219427|NCT01206140|530838|P1|NOT COMPLETED|Overall Study||1
219428|NCT01206140|530837|P2|COMPLETED|Overall Study||35
219429|NCT01206140|530838|P1|COMPLETED|Overall Study||34
219430|NCT01206140|530837|P2|STARTED|Overall Study||35
219431|NCT01206140|530838|P1|STARTED|Overall Study||35
219432|NCT01206101|530850|P2|NOT COMPLETED|Overall Study||1
219433|NCT01206101|530851|P1|NOT COMPLETED|Overall Study||2
219434|NCT01206101|530850|P2|COMPLETED|Overall Study||0
219435|NCT01206101|530851|P1|COMPLETED|Overall Study||0
219436|NCT01206101|530850|P2|STARTED|Overall Study||1
219437|NCT01206101|530851|P1|STARTED|Overall Study||2
219438|NCT01206062|530869|P2|NOT COMPLETED|Overall Study||0
219439|NCT01206062|530870|P1|NOT COMPLETED|Overall Study||0
219440|NCT01206062|530869|P2|COMPLETED|Overall Study||4683
219441|NCT01206062|530870|P1|COMPLETED|Overall Study||4678
219442|NCT01206062|530869|P2|STARTED|Overall Study||4683
219443|NCT01206062|530870|P1|STARTED|Overall Study||4678
219444|NCT01205828|530882|P1|NOT COMPLETED|Overall Study||0
219445|NCT01205828|530882|P1|COMPLETED|Overall Study|Completed the first stage of the study, terminated as pre-planned due to lack of efficacy|16
219446|NCT01205828|530882|P1|STARTED|Overall Study||16
219447|NCT01205776|530892|P2|NOT COMPLETED|3 Years Follow-up||24
219448|NCT01205776|530893|P1|NOT COMPLETED|3 Years Follow-up||16
219449|NCT01205776|530892|P2|COMPLETED|3 Years Follow-up||889
219450|NCT01205776|530893|P1|COMPLETED|3 Years Follow-up||911
219451|NCT01205776|530892|P2|STARTED|3 Years Follow-up||913
219452|NCT01205776|530893|P1|STARTED|3 Years Follow-up||927
219453|NCT01205776|530892|P2|NOT COMPLETED|2 Years Follow-up||32
219454|NCT01205776|530893|P1|NOT COMPLETED|2 Years Follow-up||16
219455|NCT01205776|530892|P2|COMPLETED|2 Years Follow-up||913
219456|NCT01205776|530893|P1|COMPLETED|2 Years Follow-up||927
219457|NCT01205776|530892|P2|STARTED|2 Years Follow-up||945
219458|NCT01205776|530893|P1|STARTED|2 Years Follow-up||943
219459|NCT01205776|530892|P2|NOT COMPLETED|1 Month Follow-up||12
219460|NCT01205776|530893|P1|NOT COMPLETED|1 Month Follow-up||5
219461|NCT01205776|530892|P2|COMPLETED|1 Month Follow-up||945
219462|NCT01205776|530893|P1|COMPLETED|1 Month Follow-up||943
219463|NCT01205776|530892|P2|STARTED|1 Month Follow-up||957
219464|NCT01205776|530893|P1|STARTED|1 Month Follow-up||948
219465|NCT01205685|531033|P1|NOT COMPLETED|Overall Study||11
219466|NCT01205685|531033|P1|COMPLETED|Overall Study||0
219467|NCT01205685|531033|P1|STARTED|Overall Study||11
219468|NCT01205646|531040|P1|NOT COMPLETED|Overall Study||0
219469|NCT01205646|531040|P1|COMPLETED|Overall Study||11
219470|NCT01205646|531040|P1|STARTED|Overall Study||11
219471|NCT01205581|531053|P6|NOT COMPLETED|Overall Study||0
219472|NCT01205581|531054|P5|NOT COMPLETED|Overall Study||0
219473|NCT01205581|531055|P4|NOT COMPLETED|Overall Study||0
219474|NCT01205581|531056|P3|NOT COMPLETED|Overall Study||0
219475|NCT01205581|531057|P2|NOT COMPLETED|Overall Study||0
219476|NCT01205581|531058|P1|NOT COMPLETED|Overall Study||1
219477|NCT01205581|531053|P6|COMPLETED|Overall Study||20
219478|NCT01205581|531054|P5|COMPLETED|Overall Study||20
219479|NCT01205581|531055|P4|COMPLETED|Overall Study||9
219480|NCT01205581|531056|P3|COMPLETED|Overall Study||8
219481|NCT01205581|531057|P2|COMPLETED|Overall Study||13
219482|NCT01205581|531058|P1|COMPLETED|Overall Study||13
219483|NCT01205581|531053|P6|STARTED|Overall Study||20
219484|NCT01205581|531054|P5|STARTED|Overall Study||20
219485|NCT01205581|531055|P4|STARTED|Overall Study||9
219486|NCT01205581|531056|P3|STARTED|Overall Study||8
219487|NCT01205581|531057|P2|STARTED|Overall Study||13
219488|NCT01205581|531058|P1|STARTED|Overall Study||14
219489|NCT01205568|531122|P2|NOT COMPLETED|Overall Study||0
219490|NCT01205568|531123|P1|NOT COMPLETED|Overall Study||0
219491|NCT01205568|531122|P2|COMPLETED|Overall Study||47
219492|NCT01205568|531123|P1|COMPLETED|Overall Study||65
219493|NCT01205568|531122|P2|STARTED|Overall Study|8 patients received only HPB therapy, 39 patients received both CB and HPB therapy.|47
219494|NCT01205568|531123|P1|STARTED|Overall Study|26 patients received only CB therapy, 39 patients received both CB and HPB therapy.|65
219495|NCT01205529|531128|P1|NOT COMPLETED|Overall Study||55
219496|NCT01205529|531128|P1|COMPLETED|Overall Study||106
219497|NCT01205529|531128|P1|STARTED|Overall Study||161
219498|NCT01205503|531134|P2|NOT COMPLETED|Second Intervention (2nd Cycle)||0
219499|NCT01205503|531135|P1|NOT COMPLETED|Second Intervention (2nd Cycle)||0
219500|NCT01205503|531134|P2|COMPLETED|Second Intervention (2nd Cycle)||16
219501|NCT01205503|531135|P1|COMPLETED|Second Intervention (2nd Cycle)||16
219502|NCT01205503|531134|P2|STARTED|Second Intervention (2nd Cycle)||16
219503|NCT01205503|531135|P1|STARTED|Second Intervention (2nd Cycle)||16
219504|NCT01205503|531134|P2|NOT COMPLETED|First Intervention (1st Cycle)||0
219505|NCT01205503|531135|P1|NOT COMPLETED|First Intervention (1st Cycle)||0
219506|NCT01205503|531134|P2|COMPLETED|First Intervention (1st Cycle)||16
219507|NCT01205503|531135|P1|COMPLETED|First Intervention (1st Cycle)||16
219508|NCT01205503|531134|P2|STARTED|First Intervention (1st Cycle)||16
219509|NCT01205503|531135|P1|STARTED|First Intervention (1st Cycle)||16
219510|NCT01205451|531151|P2|NOT COMPLETED|Overall Study||10
219511|NCT01205451|531152|P1|NOT COMPLETED|Overall Study||6
219512|NCT01205451|531151|P2|COMPLETED|Overall Study||46
219513|NCT01205451|531152|P1|COMPLETED|Overall Study||47
219514|NCT01205451|531151|P2|STARTED|Overall Study||56
219515|NCT01205451|531152|P1|STARTED|Overall Study||53
219516|NCT01205438|531197|P3|NOT COMPLETED|Overall Study||88
219517|NCT01205438|531198|P2|NOT COMPLETED|Overall Study||87
219518|NCT01205438|531199|P1|NOT COMPLETED|Overall Study||77
219519|NCT01205438|531197|P3|COMPLETED|Overall Study||288
219520|NCT01205438|531198|P2|COMPLETED|Overall Study||289
219521|NCT01205438|531199|P1|COMPLETED|Overall Study||295
219522|NCT01205438|531197|P3|Participated in Follow Up|Overall Study||66
219523|NCT01205438|531198|P2|Participated in Follow Up|Overall Study||78
219524|NCT01205438|531199|P1|Participated in Follow Up|Overall Study||72
219525|NCT01205438|531197|P3|Received At Least One Dose of Study Drug|Overall Study||376
219526|NCT01205438|531198|P2|Received At Least One Dose of Study Drug|Overall Study||374
219527|NCT01205438|531199|P1|Received At Least One Dose of Study Drug|Overall Study||371
219528|NCT01205438|531197|P3|STARTED|Overall Study||376
219529|NCT01205438|531198|P2|STARTED|Overall Study||376
219530|NCT01205438|531199|P1|STARTED|Overall Study||372
219531|NCT01205399|531249|P1|NOT COMPLETED|Overall Study||0
219532|NCT01205399|531249|P1|COMPLETED|Overall Study||78
219533|NCT01205399|531249|P1|STARTED|Overall Study||78
219534|NCT01205269|531255|P6|NOT COMPLETED|Period 5 - Third Intervention||0
219535|NCT01205269|531256|P5|NOT COMPLETED|Period 5 - Third Intervention||0
219536|NCT01205269|531257|P4|NOT COMPLETED|Period 5 - Third Intervention||0
219537|NCT01205269|531258|P3|NOT COMPLETED|Period 5 - Third Intervention||0
219538|NCT01205269|531259|P2|NOT COMPLETED|Period 5 - Third Intervention||0
219539|NCT01205269|531260|P1|NOT COMPLETED|Period 5 - Third Intervention||0
219540|NCT01205269|531255|P6|COMPLETED|Period 5 - Third Intervention||5
219541|NCT01205269|531256|P5|COMPLETED|Period 5 - Third Intervention||5
219542|NCT01205269|531257|P4|COMPLETED|Period 5 - Third Intervention||5
219543|NCT01205269|531258|P3|COMPLETED|Period 5 - Third Intervention||4
219544|NCT01205269|531259|P2|COMPLETED|Period 5 - Third Intervention||4
219545|NCT01205269|531260|P1|COMPLETED|Period 5 - Third Intervention||4
219546|NCT01205269|531255|P6|STARTED|Period 5 - Third Intervention||5
219547|NCT01205269|531256|P5|STARTED|Period 5 - Third Intervention||5
219548|NCT01205269|531257|P4|STARTED|Period 5 - Third Intervention||5
219549|NCT01205269|531258|P3|STARTED|Period 5 - Third Intervention||4
219550|NCT01205269|531259|P2|STARTED|Period 5 - Third Intervention||4
219551|NCT01205269|531260|P1|STARTED|Period 5 - Third Intervention||4
219552|NCT01205269|531255|P6|NOT COMPLETED|Period 4 - Washout||0
219553|NCT01205269|531256|P5|NOT COMPLETED|Period 4 - Washout||0
219554|NCT01205269|531257|P4|NOT COMPLETED|Period 4 - Washout||1
219555|NCT01205269|531258|P3|NOT COMPLETED|Period 4 - Washout||0
219556|NCT01205269|531259|P2|NOT COMPLETED|Period 4 - Washout||0
219557|NCT01205269|531260|P1|NOT COMPLETED|Period 4 - Washout||0
219558|NCT01205269|531255|P6|COMPLETED|Period 4 - Washout||5
219559|NCT01205269|531256|P5|COMPLETED|Period 4 - Washout||5
219560|NCT01205269|531257|P4|COMPLETED|Period 4 - Washout||5
219561|NCT01205269|531258|P3|COMPLETED|Period 4 - Washout||4
219562|NCT01205269|531259|P2|COMPLETED|Period 4 - Washout||4
219563|NCT01205269|531260|P1|COMPLETED|Period 4 - Washout||4
219564|NCT01205269|531255|P6|STARTED|Period 4 - Washout||5
219565|NCT01205269|531256|P5|STARTED|Period 4 - Washout||5
219566|NCT01205269|531257|P4|STARTED|Period 4 - Washout||6
219567|NCT01205269|531258|P3|STARTED|Period 4 - Washout||4
219568|NCT01205269|531259|P2|STARTED|Period 4 - Washout||4
219569|NCT01205269|531260|P1|STARTED|Period 4 - Washout||4
219570|NCT01205269|531255|P6|NOT COMPLETED|Period 3 - Second Intervention||0
219571|NCT01205269|531256|P5|NOT COMPLETED|Period 3 - Second Intervention||0
219572|NCT01205269|531257|P4|NOT COMPLETED|Period 3 - Second Intervention||0
219573|NCT01205269|531258|P3|NOT COMPLETED|Period 3 - Second Intervention||0
219574|NCT01205269|531259|P2|NOT COMPLETED|Period 3 - Second Intervention||0
219575|NCT01205269|531260|P1|NOT COMPLETED|Period 3 - Second Intervention||0
219576|NCT01205269|531255|P6|COMPLETED|Period 3 - Second Intervention||5
219577|NCT01205269|531256|P5|COMPLETED|Period 3 - Second Intervention||5
219578|NCT01205269|531257|P4|COMPLETED|Period 3 - Second Intervention||6
219579|NCT01205269|531258|P3|COMPLETED|Period 3 - Second Intervention||4
219580|NCT01205269|531259|P2|COMPLETED|Period 3 - Second Intervention||4
219581|NCT01205269|531260|P1|COMPLETED|Period 3 - Second Intervention||4
219582|NCT01205269|531255|P6|STARTED|Period 3 - Second Intervention||5
219583|NCT01205269|531256|P5|STARTED|Period 3 - Second Intervention||5
219584|NCT01205269|531257|P4|STARTED|Period 3 - Second Intervention||6
219585|NCT01205269|531258|P3|STARTED|Period 3 - Second Intervention||4
219586|NCT01205269|531259|P2|STARTED|Period 3 - Second Intervention||4
219587|NCT01205269|531260|P1|STARTED|Period 3 - Second Intervention||4
219588|NCT01205269|531255|P6|NOT COMPLETED|Period 2 - Washout||0
219589|NCT01205269|531256|P5|NOT COMPLETED|Period 2 - Washout||0
219590|NCT01205269|531257|P4|NOT COMPLETED|Period 2 - Washout||0
219591|NCT01205269|531258|P3|NOT COMPLETED|Period 2 - Washout||0
219592|NCT01205269|531259|P2|NOT COMPLETED|Period 2 - Washout||0
219593|NCT01205269|531260|P1|NOT COMPLETED|Period 2 - Washout||0
219594|NCT01205269|531255|P6|COMPLETED|Period 2 - Washout||5
219595|NCT01205269|531256|P5|COMPLETED|Period 2 - Washout||5
219596|NCT01205269|531257|P4|COMPLETED|Period 2 - Washout||6
219597|NCT01205269|531258|P3|COMPLETED|Period 2 - Washout||4
219598|NCT01205269|531259|P2|COMPLETED|Period 2 - Washout||4
219599|NCT01205269|531260|P1|COMPLETED|Period 2 - Washout||4
219600|NCT01205269|531255|P6|STARTED|Period 2 - Washout||5
219601|NCT01205269|531256|P5|STARTED|Period 2 - Washout||5
219602|NCT01205269|531257|P4|STARTED|Period 2 - Washout||6
219603|NCT01205269|531258|P3|STARTED|Period 2 - Washout||4
219604|NCT01205269|531259|P2|STARTED|Period 2 - Washout||4
219605|NCT01205269|531260|P1|STARTED|Period 2 - Washout||4
219606|NCT01205269|531255|P6|NOT COMPLETED|Period 1 - First Intervention||0
219607|NCT01205269|531256|P5|NOT COMPLETED|Period 1 - First Intervention||0
219608|NCT01205269|531257|P4|NOT COMPLETED|Period 1 - First Intervention||0
219609|NCT01205269|531258|P3|NOT COMPLETED|Period 1 - First Intervention||0
219610|NCT01205269|531259|P2|NOT COMPLETED|Period 1 - First Intervention||0
219611|NCT01205269|531260|P1|NOT COMPLETED|Period 1 - First Intervention||0
219612|NCT01205269|531255|P6|COMPLETED|Period 1 - First Intervention||5
219613|NCT01205269|531256|P5|COMPLETED|Period 1 - First Intervention||5
219614|NCT01205269|531257|P4|COMPLETED|Period 1 - First Intervention||6
219615|NCT01205269|531258|P3|COMPLETED|Period 1 - First Intervention||4
219616|NCT01205269|531259|P2|COMPLETED|Period 1 - First Intervention||4
219617|NCT01205269|531260|P1|COMPLETED|Period 1 - First Intervention||4
219618|NCT01205269|531255|P6|STARTED|Period 1 - First Intervention||5
219619|NCT01205269|531256|P5|STARTED|Period 1 - First Intervention||5
219620|NCT01205269|531257|P4|STARTED|Period 1 - First Intervention||6
219621|NCT01205269|531258|P3|STARTED|Period 1 - First Intervention||4
219622|NCT01205269|531259|P2|STARTED|Period 1 - First Intervention||4
219623|NCT01205269|531260|P1|STARTED|Period 1 - First Intervention||4
219624|NCT01205230|531300|P2|NOT COMPLETED|Overall Study||0
219625|NCT01205230|531301|P1|NOT COMPLETED|Overall Study||5
219626|NCT01205230|531300|P2|COMPLETED|Overall Study||13
219627|NCT01205230|531301|P1|COMPLETED|Overall Study||16
219628|NCT01205230|531300|P2|Combination Therapy|Overall Study||13
219629|NCT01205230|531301|P1|Combination Therapy|Overall Study||21
219630|NCT01205230|531300|P2|STARTED|Overall Study||13
219631|NCT01205230|531301|P1|STARTED|Overall Study||21
219632|NCT01205165|531344|P1|NOT COMPLETED|Overall Study||2
219633|NCT01205165|531344|P1|COMPLETED|Overall Study||102
219634|NCT01205165|531344|P1|STARTED|Overall Study||104
219635|NCT01205152|531357|P1|NOT COMPLETED|Overall Study||1
219636|NCT01205152|531357|P1|COMPLETED|Overall Study||9
219637|NCT01205152|531357|P1|STARTED|Overall Study||10
219638|NCT01205126|531370|P2|NOT COMPLETED|Maintenance Phase||40
219639|NCT01205126|531371|P1|NOT COMPLETED|Maintenance Phase||37
219640|NCT01205126|531370|P2|COMPLETED|Maintenance Phase||67
219641|NCT01205126|531371|P1|COMPLETED|Maintenance Phase||70
219642|NCT01205126|531370|P2|STARTED|Maintenance Phase||107
219643|NCT01205126|531371|P1|STARTED|Maintenance Phase||107
219644|NCT01205126|531370|P2|NOT COMPLETED|Between Titration & Maintenance Phase||4
219645|NCT01205126|531371|P1|NOT COMPLETED|Between Titration & Maintenance Phase||0
219646|NCT01205126|531370|P2|COMPLETED|Between Titration & Maintenance Phase||107
219647|NCT01205126|531371|P1|COMPLETED|Between Titration & Maintenance Phase||107
219648|NCT01205126|531370|P2|STARTED|Between Titration & Maintenance Phase||111
219649|NCT01205126|531371|P1|STARTED|Between Titration & Maintenance Phase||107
219650|NCT01205126|531370|P2|NOT COMPLETED|Titration Phase||19
219651|NCT01205126|531371|P1|NOT COMPLETED|Titration Phase||23
219652|NCT01205126|531370|P2|COMPLETED|Titration Phase||111
219653|NCT01205126|531371|P1|COMPLETED|Titration Phase||107
219654|NCT01205126|531370|P2|STARTED|Titration Phase||130
219655|NCT01205126|531371|P1|STARTED|Titration Phase||130
219656|NCT01205035|531389|P2|NOT COMPLETED|Overall Study||0
219657|NCT01205035|531390|P1|NOT COMPLETED|Overall Study||2
219658|NCT01205035|531389|P2|COMPLETED|Overall Study||3
219659|NCT01205035|531390|P1|COMPLETED|Overall Study||1
219660|NCT01205035|531389|P2|STARTED|Overall Study||3
219661|NCT01205035|531390|P1|STARTED|Overall Study||3
219662|NCT01204918|531407|P3|NOT COMPLETED|Overall Study||5
219663|NCT01204918|531408|P2|NOT COMPLETED|Overall Study||10
219664|NCT01204918|531409|P1|NOT COMPLETED|Overall Study||4
219665|NCT01204918|531407|P3|COMPLETED|Overall Study||35
219666|NCT01204918|531408|P2|COMPLETED|Overall Study||29
219667|NCT01204918|531409|P1|COMPLETED|Overall Study||21
219668|NCT01204918|531407|P3|Stage 2 End|Overall Study||35
219669|NCT01204918|531408|P2|Stage 2 End|Overall Study||29
219670|NCT01204918|531409|P1|Stage 2 End|Overall Study||21
219671|NCT01204918|531407|P3|Stage 2 Begin|Overall Study||36
219672|NCT01204918|531408|P2|Stage 2 Begin|Overall Study||35
219673|NCT01204918|531409|P1|Stage 2 Begin|Overall Study||22
219674|NCT01204918|531407|P3|Stage 1 End|Overall Study||36
219675|NCT01204918|531408|P2|Stage 1 End|Overall Study||35
219676|NCT01204918|531409|P1|Stage 1 End|Overall Study||22
219677|NCT01204918|531407|P3|Stage 1 Begin|Overall Study||40
219678|NCT01204918|531408|P2|Stage 1 Begin|Overall Study||39
219679|NCT01204918|531409|P1|Stage 1 Begin|Overall Study||25
219680|NCT01204918|531407|P3|STARTED|Overall Study||40
219681|NCT01204918|531408|P2|STARTED|Overall Study||39
219682|NCT01204918|531409|P1|STARTED|Overall Study||25
219683|NCT01204905|531426|P1|NOT COMPLETED|Overall Study||2
219684|NCT01204905|531426|P1|COMPLETED|Overall Study||5
219685|NCT01204905|531426|P1|STARTED|Overall Study||7
219686|NCT01204853|531431|P1|NOT COMPLETED|Overall Study||0
219687|NCT01204853|531431|P1|COMPLETED|Overall Study||2
219688|NCT01204853|531431|P1|STARTED|Overall Study||2
219689|NCT01204788|531443|P2|NOT COMPLETED|Overall Study||3
219690|NCT01204788|531444|P1|NOT COMPLETED|Overall Study||1
219691|NCT01204788|531443|P2|COMPLETED|Overall Study||0
219692|NCT01204788|531444|P1|COMPLETED|Overall Study||0
219693|NCT01204788|531443|P2|STARTED|Overall Study||3
219694|NCT01204788|531444|P1|STARTED|Overall Study||1
219695|NCT01204775|531452|P2|NOT COMPLETED|Overall Study||1
219696|NCT01204775|531453|P1|NOT COMPLETED|Overall Study||1
219697|NCT01204775|531452|P2|COMPLETED|Overall Study||3
219698|NCT01204775|531453|P1|COMPLETED|Overall Study||3
219699|NCT01204775|531452|P2|Double-blind Treatment Period|Overall Study||4
219700|NCT01204775|531453|P1|Double-blind Treatment Period|Overall Study||4
219701|NCT01204775|531452|P2|STARTED|Overall Study||4
219702|NCT01204775|531453|P1|STARTED|Overall Study||4
219703|NCT01204736|531463|P4|NOT COMPLETED|Overall Study||0
219704|NCT01204736|531464|P3|NOT COMPLETED|Overall Study||0
219705|NCT01204736|531465|P2|NOT COMPLETED|Overall Study||0
219706|NCT01204736|531466|P1|NOT COMPLETED|Overall Study||0
219707|NCT01204736|531463|P4|COMPLETED|Overall Study||2
219708|NCT01204736|531464|P3|COMPLETED|Overall Study||3
219709|NCT01204736|531465|P2|COMPLETED|Overall Study||5
219710|NCT01204736|531466|P1|COMPLETED|Overall Study||4
219711|NCT01204736|531463|P4|STARTED|Overall Study||2
219712|NCT01204736|531464|P3|STARTED|Overall Study||3
219713|NCT01204736|531465|P2|STARTED|Overall Study||5
219714|NCT01204736|531466|P1|STARTED|Overall Study||4
219715|NCT01204710|531478|P2|NOT COMPLETED|Optional Olaratumab Monotherapy||3
219716|NCT01204710|531479|P1|NOT COMPLETED|Optional Olaratumab Monotherapy||0
219717|NCT01204710|531478|P2|COMPLETED|Optional Olaratumab Monotherapy||16
219718|NCT01204710|531479|P1|COMPLETED|Optional Olaratumab Monotherapy||0
219719|NCT01204710|531478|P2|STARTED|Optional Olaratumab Monotherapy|Among 43 participants who experienced PD, 19 received olaratumab monotherapy.|19
219720|NCT01204710|531479|P1|STARTED|Optional Olaratumab Monotherapy|Olaratumab follow-on treatment was optional for participants in mitoxantrone group only who had PD.|0
219721|NCT01204710|531478|P2|NOT COMPLETED|Randomization Treatment||13
219722|NCT01204710|531479|P1|NOT COMPLETED|Randomization Treatment||14
219723|NCT01204710|531478|P2|COMPLETED|Randomization Treatment||47
219724|NCT01204710|531479|P1|COMPLETED|Randomization Treatment||49
219725|NCT01204710|531478|P2|Received ≥1 Dose of Study Drug|Randomization Treatment||59
219726|NCT01204710|531479|P1|Received ≥1 Dose of Study Drug|Randomization Treatment||62
219727|NCT01204710|531478|P2|STARTED|Randomization Treatment||60
219728|NCT01204710|531479|P1|STARTED|Randomization Treatment||63
219729|NCT01204697|531515|P2|NOT COMPLETED|Overall Study||36
219730|NCT01204697|531516|P1|NOT COMPLETED|Overall Study||31
219731|NCT01204697|531515|P2|COMPLETED|Overall Study||2
219732|NCT01204697|531516|P1|COMPLETED|Overall Study||5
219733|NCT01204697|531515|P2|Treated|Overall Study||37
219734|NCT01204697|531516|P1|Treated|Overall Study||36
219735|NCT01204697|531515|P2|STARTED|Overall Study||38
219736|NCT01204697|531516|P1|STARTED|Overall Study||36
219737|NCT01204671|531537|P5|NOT COMPLETED|Overall Study||4
219738|NCT01204671|531538|P4|NOT COMPLETED|Overall Study||13
219739|NCT01204671|531539|P3|NOT COMPLETED|Overall Study||13
219740|NCT01204671|531540|P2|NOT COMPLETED|Overall Study||15
219741|NCT01204671|531541|P1|NOT COMPLETED|Overall Study||14
219742|NCT01204671|531537|P5|COMPLETED|Overall Study||606
219743|NCT01204671|531538|P4|COMPLETED|Overall Study||997
219744|NCT01204671|531539|P3|COMPLETED|Overall Study||998
219745|NCT01204671|531540|P2|COMPLETED|Overall Study||998
219746|NCT01204671|531541|P1|COMPLETED|Overall Study||998
219747|NCT01204671|531537|P5|STARTED|Overall Study||610
219748|NCT01204671|531538|P4|STARTED|Overall Study||1010
219749|NCT01204671|531539|P3|STARTED|Overall Study||1011
219750|NCT01204671|531540|P2|STARTED|Overall Study||1013
219751|NCT01204671|531541|P1|STARTED|Overall Study||1012
219752|NCT01204658|531603|P4|NOT COMPLETED|Booster Phase||0
219753|NCT01204658|531604|P3|NOT COMPLETED|Booster Phase||0
219754|NCT01204658|531605|P2|NOT COMPLETED|Booster Phase||0
219755|NCT01204658|531606|P1|NOT COMPLETED|Booster Phase||0
219756|NCT01204658|531603|P4|COMPLETED|Booster Phase||140
219757|NCT01204658|531604|P3|COMPLETED|Booster Phase||140
219758|NCT01204658|531605|P2|COMPLETED|Booster Phase||140
219759|NCT01204658|531606|P1|COMPLETED|Booster Phase||144
219760|NCT01204658|531603|P4|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
219761|NCT01204658|531604|P3|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
219762|NCT01204658|531605|P2|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
219763|NCT01204658|531606|P1|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|144
219764|NCT01204658|531603|P4|NOT COMPLETED|Primary Phase||0
219765|NCT01204658|531604|P3|NOT COMPLETED|Primary Phase||1
219766|NCT01204658|531605|P2|NOT COMPLETED|Primary Phase||0
219767|NCT01204658|531606|P1|NOT COMPLETED|Primary Phase||0
219768|NCT01204658|531603|P4|COMPLETED|Primary Phase||142
219769|NCT01204658|531604|P3|COMPLETED|Primary Phase||144
219770|NCT01204658|531605|P2|COMPLETED|Primary Phase||142
219771|NCT01204658|531606|P1|COMPLETED|Primary Phase||146
219772|NCT01204658|531603|P4|STARTED|Primary Phase||142
219773|NCT01204658|531604|P3|STARTED|Primary Phase||145
219774|NCT01204658|531605|P2|STARTED|Primary Phase||142
219775|NCT01204658|531606|P1|STARTED|Primary Phase||146
219776|NCT01204398|531724|P1|NOT COMPLETED|Overall Study||1
219777|NCT01204398|531724|P1|COMPLETED|Overall Study|Completed trial medication.|26
219778|NCT01204398|531724|P1|STARTED|Overall Study|Entered and treated.|27
219779|NCT01204294|531741|P7|NOT COMPLETED|Overall Study||2
219780|NCT01204294|531742|P6|NOT COMPLETED|Overall Study||5
219781|NCT01204294|531743|P5|NOT COMPLETED|Overall Study||2
219782|NCT01204294|531744|P4|NOT COMPLETED|Overall Study||11
219783|NCT01204294|531745|P3|NOT COMPLETED|Overall Study||5
219784|NCT01204294|531746|P2|NOT COMPLETED|Overall Study||8
219785|NCT01204294|531747|P1|NOT COMPLETED|Overall Study||3
219786|NCT01204294|531741|P7|COMPLETED|Overall Study||59
219787|NCT01204294|531742|P6|COMPLETED|Overall Study||58
219788|NCT01204294|531743|P5|COMPLETED|Overall Study||83
219789|NCT01204294|531744|P4|COMPLETED|Overall Study||132
219790|NCT01204294|531745|P3|COMPLETED|Overall Study||69
219791|NCT01204294|531746|P2|COMPLETED|Overall Study||58
219792|NCT01204294|531747|P1|COMPLETED|Overall Study||79
219793|NCT01204294|531741|P7|STARTED|Overall Study||61
219794|NCT01204294|531742|P6|STARTED|Overall Study||63
219795|NCT01204294|531743|P5|STARTED|Overall Study||85
219796|NCT01204294|531744|P4|STARTED|Overall Study||143
219797|NCT01204294|531745|P3|STARTED|Overall Study||74
219798|NCT01204294|531746|P2|STARTED|Overall Study||66
219799|NCT01204294|531747|P1|STARTED|Overall Study||82
219800|NCT01204255|531770|P1|NOT COMPLETED|Overall Study||1
219801|NCT01204255|531770|P1|COMPLETED|Overall Study||10
219802|NCT01204255|531770|P1|STARTED|Overall Study||11
219803|NCT01204203|531775|P1|NOT COMPLETED|Overall Study||0
219804|NCT01204203|531775|P1|COMPLETED|Overall Study||8
219805|NCT01204203|531775|P1|STARTED|Overall Study||8
219806|NCT01203956|531781|P2|NOT COMPLETED|Second Two-week Period||6
219807|NCT01203956|531782|P1|NOT COMPLETED|Second Two-week Period||5
219808|NCT01203956|531781|P2|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|7
219809|NCT01203956|531782|P1|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|10
219810|NCT01203956|531781|P2|Attended Sleep Studies for 14 Nights|Second Two-week Period||13
219811|NCT01203956|531782|P1|Attended Sleep Studies for 14 Nights|Second Two-week Period||15
219812|NCT01203956|531781|P2|STARTED|Second Two-week Period||13
219813|NCT01203956|531782|P1|STARTED|Second Two-week Period||15
219814|NCT01203956|531781|P2|NOT COMPLETED|First Two-week Period||0
219815|NCT01203956|531782|P1|NOT COMPLETED|First Two-week Period||0
219816|NCT01203956|531781|P2|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|13
219817|NCT01203956|531782|P1|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|15
219818|NCT01203956|531781|P2|STARTED|First Two-week Period||13
219819|NCT01203956|531782|P1|STARTED|First Two-week Period||15
219820|NCT01203930|531791|P2|NOT COMPLETED|Overall Study||41
219821|NCT01203930|531792|P1|NOT COMPLETED|Overall Study||21
219822|NCT01203930|531791|P2|COMPLETED|Overall Study||0
219823|NCT01203930|531792|P1|COMPLETED|Overall Study|43 participants completed 12 cycles and were then eligible to enroll in the extension study (101-99)|43
219824|NCT01203930|531791|P2|STARTED|Overall Study||41
219825|NCT01203930|531792|P1|STARTED|Overall Study||64
219826|NCT01203917|531814|P1|NOT COMPLETED|Overall Study||36
219827|NCT01203917|531814|P1|COMPLETED|Overall Study|Patients on-going study at data cut-off(of which 49 were still on study treatment).|71
219828|NCT01203917|531814|P1|STARTED|Overall Study|106 patients were EGFR M+ patients and 1 patient was EGFR M+I|107
219829|NCT01203878|531827|P3|NOT COMPLETED|Overall Study||3
219830|NCT01203878|531828|P2|NOT COMPLETED|Overall Study||0
219831|NCT01203878|531829|P1|NOT COMPLETED|Overall Study||0
219832|NCT01203878|531827|P3|COMPLETED|Overall Study||0
219833|NCT01203878|531828|P2|COMPLETED|Overall Study||9
219834|NCT01203878|531829|P1|COMPLETED|Overall Study||9
219835|NCT01203878|531827|P3|STARTED|Overall Study||3
219836|NCT01203878|531828|P2|STARTED|Overall Study||9
219837|NCT01203878|531829|P1|STARTED|Overall Study||9
219838|NCT01203852|531840|P1|NOT COMPLETED|Chlorthalidone 8 Weeks||0
219839|NCT01203852|531840|P1|COMPLETED|Chlorthalidone 8 Weeks||328
219840|NCT01203852|531840|P1|Continued From Metoprolol|Chlorthalidone 8 Weeks||282
219841|NCT01203852|531840|P1|STARTED|Chlorthalidone 8 Weeks|Subjects were allowed to enter the study at Chlorthalidone without completing Metoprolol.|328
219842|NCT01203852|531840|P1|NOT COMPLETED|Washout 2 Weeks||46
219843|NCT01203852|531840|P1|COMPLETED|Washout 2 Weeks||282
219844|NCT01203852|531840|P1|STARTED|Washout 2 Weeks|Some study subjects did not proceed to the washout phase after the first intervention.|328
219845|NCT01203852|531840|P1|NOT COMPLETED|Metoprolol 8 Weeks||470
219846|NCT01203852|531840|P1|COMPLETED|Metoprolol 8 Weeks||369
219847|NCT01203852|531840|P1|STARTED|Metoprolol 8 Weeks|This is the total number of subjects for both groups.|839
219848|NCT01203826|531849|P2|NOT COMPLETED|Overall Study||0
219849|NCT01203826|531850|P1|NOT COMPLETED|Overall Study||0
219850|NCT01203826|531849|P2|COMPLETED|Overall Study||6
219851|NCT01203826|531850|P1|COMPLETED|Overall Study||6
219852|NCT01203826|531849|P2|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
219853|NCT01203826|531850|P1|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
219854|NCT01203787|531858|P2|NOT COMPLETED|Overall Study||27
219855|NCT01203787|531859|P1|NOT COMPLETED|Overall Study||31
219856|NCT01203787|531858|P2|COMPLETED|Overall Study||30
219857|NCT01203787|531859|P1|COMPLETED|Overall Study||32
219858|NCT01203787|531858|P2|STARTED|Overall Study||57
219859|NCT01203787|531859|P1|STARTED|Overall Study||63
219860|NCT01203644|531879|P2|NOT COMPLETED|Overall Study||0
219861|NCT01203644|531880|P1|NOT COMPLETED|Overall Study||0
219862|NCT01203644|531879|P2|COMPLETED|Overall Study||50
219863|NCT01203644|531880|P1|COMPLETED|Overall Study||26
219864|NCT01203644|531879|P2|STARTED|Overall Study||50
219865|NCT01203644|531880|P1|STARTED|Overall Study||26
219866|NCT01203319|531892|P3|NOT COMPLETED|Overall Study||5
219867|NCT01203319|531893|P2|NOT COMPLETED|Overall Study||9
219868|NCT01203319|531894|P1|NOT COMPLETED|Overall Study||6
219869|NCT01203319|531892|P3|COMPLETED|Overall Study||217
219870|NCT01203319|531893|P2|COMPLETED|Overall Study||426
219871|NCT01203319|531894|P1|COMPLETED|Overall Study||428
219872|NCT01203319|531892|P3|STARTED|Overall Study||222
219873|NCT01203319|531893|P2|STARTED|Overall Study||435
219874|NCT01203319|531894|P1|STARTED|Overall Study||434
219875|NCT01203189|531911|P3|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
219876|NCT01203189|531912|P2|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
219877|NCT01203189|531913|P1|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
219878|NCT01203189|531911|P3|COMPLETED|Cross Over Period 4 Weeks Treatment||3
219879|NCT01203189|531912|P2|COMPLETED|Cross Over Period 4 Weeks Treatment||0
219880|NCT01203189|531913|P1|COMPLETED|Cross Over Period 4 Weeks Treatment||0
219881|NCT01203189|531911|P3|STARTED|Cross Over Period 4 Weeks Treatment||3
219882|NCT01203189|531912|P2|STARTED|Cross Over Period 4 Weeks Treatment||0
219883|NCT01203189|531913|P1|STARTED|Cross Over Period 4 Weeks Treatment||0
219884|NCT01203189|531911|P3|NOT COMPLETED|First 4 Weeks Treatment||0
219885|NCT01203189|531912|P2|NOT COMPLETED|First 4 Weeks Treatment||2
219886|NCT01203189|531913|P1|NOT COMPLETED|First 4 Weeks Treatment||2
219887|NCT01203189|531911|P3|COMPLETED|First 4 Weeks Treatment||3
219888|NCT01203189|531912|P2|COMPLETED|First 4 Weeks Treatment||8
219889|NCT01203189|531913|P1|COMPLETED|First 4 Weeks Treatment||8
219890|NCT01203189|531911|P3|STARTED|First 4 Weeks Treatment||3
219891|NCT01203189|531912|P2|STARTED|First 4 Weeks Treatment||10
219892|NCT01203189|531913|P1|STARTED|First 4 Weeks Treatment||10
219893|NCT01203098|531930|P3|NOT COMPLETED|Overall Study||11
219894|NCT01203098|531931|P2|NOT COMPLETED|Overall Study||4
219895|NCT01203098|531932|P1|NOT COMPLETED|Overall Study||6
219896|NCT01203098|531930|P3|COMPLETED|Overall Study||78
219897|NCT01203098|531931|P2|COMPLETED|Overall Study||82
219898|NCT01203098|531932|P1|COMPLETED|Overall Study||83
219899|NCT01203098|531930|P3|Safety Analysis Dataset|Overall Study||87
219900|NCT01203098|531931|P2|Safety Analysis Dataset|Overall Study||85
219901|NCT01203098|531932|P1|Safety Analysis Dataset|Overall Study||89
219902|NCT01203098|531930|P3|STARTED|Overall Study||89
219903|NCT01203098|531931|P2|STARTED|Overall Study||86
219904|NCT01203098|531932|P1|STARTED|Overall Study||89
219905|NCT01203072|531948|P5|NOT COMPLETED|Overall Study||6
219906|NCT01203072|531949|P4|NOT COMPLETED|Overall Study||6
219907|NCT01203072|531950|P3|NOT COMPLETED|Overall Study||3
219908|NCT01203072|531951|P2|NOT COMPLETED|Overall Study||6
219909|NCT01203072|531952|P1|NOT COMPLETED|Overall Study||10
219910|NCT01203072|531948|P5|COMPLETED|Overall Study||96
219911|NCT01203072|531949|P4|COMPLETED|Overall Study||100
219912|NCT01203072|531950|P3|COMPLETED|Overall Study||101
219913|NCT01203072|531951|P2|COMPLETED|Overall Study||100
219914|NCT01203072|531952|P1|COMPLETED|Overall Study||95
219915|NCT01203072|531948|P5|STARTED|Overall Study||102
219916|NCT01203072|531949|P4|STARTED|Overall Study||106
219917|NCT01203072|531950|P3|STARTED|Overall Study||104
219918|NCT01203072|531951|P2|STARTED|Overall Study||106
219919|NCT01203072|531952|P1|STARTED|Overall Study||105
219920|NCT01203046|531971|P2|NOT COMPLETED|Overall Study||0
219921|NCT01203046|531972|P1|NOT COMPLETED|Overall Study||0
219922|NCT01203046|531971|P2|COMPLETED|Overall Study||28
219923|NCT01203046|531972|P1|COMPLETED|Overall Study||28
219924|NCT01203046|531971|P2|STARTED|Overall Study||28
219925|NCT01203046|531972|P1|STARTED|Overall Study||28
219926|NCT01202994|531980|P1|NOT COMPLETED|Overall Study||0
219927|NCT01202994|531980|P1|COMPLETED|Overall Study||27
219928|NCT01202994|531980|P1|STARTED|Overall Study||27
219929|NCT01202955|531987|P2|NOT COMPLETED|Period 3: 10 Days||0
219930|NCT01202955|531988|P1|NOT COMPLETED|Period 3: 10 Days||0
219931|NCT01202955|531987|P2|COMPLETED|Period 3: 10 Days||8
219932|NCT01202955|531988|P1|COMPLETED|Period 3: 10 Days||9
219933|NCT01202955|531987|P2|STARTED|Period 3: 10 Days||8
219934|NCT01202955|531988|P1|STARTED|Period 3: 10 Days||9
219935|NCT01202955|531987|P2|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
219936|NCT01202955|531988|P1|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
219937|NCT01202955|531987|P2|COMPLETED|Period 2: 7 Days (Wash-Out)||8
219938|NCT01202955|531988|P1|COMPLETED|Period 2: 7 Days (Wash-Out)||9
219939|NCT01202955|531987|P2|STARTED|Period 2: 7 Days (Wash-Out)||8
219940|NCT01202955|531988|P1|STARTED|Period 2: 7 Days (Wash-Out)||9
219941|NCT01202955|531987|P2|NOT COMPLETED|Period 1: 10 Days||2
219942|NCT01202955|531988|P1|NOT COMPLETED|Period 1: 10 Days||0
219943|NCT01202955|531987|P2|COMPLETED|Period 1: 10 Days||8
219944|NCT01202955|531988|P1|COMPLETED|Period 1: 10 Days||9
219945|NCT01202955|531987|P2|STARTED|Period 1: 10 Days||10
219946|NCT01202955|531988|P1|STARTED|Period 1: 10 Days||9
219947|NCT01202903|532000|P2|NOT COMPLETED|Overall Study||16
219948|NCT01202903|532001|P1|NOT COMPLETED|Overall Study||11
219949|NCT01202903|532000|P2|COMPLETED|Overall Study||292
219950|NCT01202903|532001|P1|COMPLETED|Overall Study||297
219951|NCT01202903|532000|P2|Safety Set*|Overall Study||299
219952|NCT01202903|532001|P1|Safety Set*|Overall Study||310
219953|NCT01202903|532000|P2|Full Analysis Set|Overall Study||302
219954|NCT01202903|532001|P1|Full Analysis Set|Overall Study||306
219955|NCT01202903|532000|P2|STARTED|Overall Study||308
219956|NCT01202903|532001|P1|STARTED|Overall Study||308
219957|NCT01202877|532028|P3|NOT COMPLETED|Overall Study||6
219958|NCT01202877|532029|P2|NOT COMPLETED|Overall Study||1
219959|NCT01202877|532030|P1|NOT COMPLETED|Overall Study||0
219960|NCT01202877|532028|P3|COMPLETED|Overall Study||34
219961|NCT01202877|532029|P2|COMPLETED|Overall Study||7
219962|NCT01202877|532030|P1|COMPLETED|Overall Study||6
219963|NCT01202877|532028|P3|STARTED|Overall Study||40
219964|NCT01202877|532029|P2|STARTED|Overall Study||8
219965|NCT01202877|532030|P1|STARTED|Overall Study||6
219966|NCT01202773|532044|P3|NOT COMPLETED|Overall Study||55
219967|NCT01202773|532045|P2|NOT COMPLETED|Overall Study||43
219968|NCT01202773|532046|P1|NOT COMPLETED|Overall Study||57
219969|NCT01202773|532044|P3|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|100
219970|NCT01202773|532045|P2|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|105
219971|NCT01202773|532046|P1|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|96
219972|NCT01202773|532044|P3|Post-Treatment Follow-Up Population|Overall Study||51
219973|NCT01202773|532045|P2|Post-Treatment Follow-Up Population|Overall Study||36
219974|NCT01202773|532046|P1|Post-Treatment Follow-Up Population|Overall Study||46
219975|NCT01202773|532044|P3|Week 16 NR|Overall Study||37
219976|NCT01202773|532045|P2|Week 16 NR|Overall Study||33
219977|NCT01202773|532046|P1|Week 16 NR|Overall Study||23
219978|NCT01202773|532044|P3|Received at Least 1 Dose of Study Drug|Overall Study||154
219979|NCT01202773|532045|P2|Received at Least 1 Dose of Study Drug|Overall Study||147
219980|NCT01202773|532046|P1|Received at Least 1 Dose of Study Drug|Overall Study||153
219981|NCT01202773|532044|P3|STARTED|Overall Study||155
219982|NCT01202773|532045|P2|STARTED|Overall Study||148
219983|NCT01202773|532046|P1|STARTED|Overall Study||153
219984|NCT01202760|532123|P3|NOT COMPLETED|Overall Study||35
219985|NCT01202760|532124|P2|NOT COMPLETED|Overall Study||52
219986|NCT01202760|532125|P1|NOT COMPLETED|Overall Study||47
219987|NCT01202760|532123|P3|COMPLETED|Overall Study||216
219988|NCT01202760|532124|P2|COMPLETED|Overall Study||322
219989|NCT01202760|532125|P1|COMPLETED|Overall Study||332
219990|NCT01202760|532123|P3|Received at Least One Dose of Study Drug|Overall Study||250
219991|NCT01202760|532124|P2|Received at Least One Dose of Study Drug|Overall Study||371
219992|NCT01202760|532125|P1|Received at Least One Dose of Study Drug|Overall Study||379
219993|NCT01202760|532123|P3|STARTED|Overall Study||251
219994|NCT01202760|532124|P2|STARTED|Overall Study||374
219995|NCT01202760|532125|P1|STARTED|Overall Study||379
219996|NCT01202747|532193|P1|NOT COMPLETED|Overall Study||1
219997|NCT01202747|532193|P1|COMPLETED|Overall Study|One subject did not return for the 4 Week visit due to inconvenience.|49
219998|NCT01202747|532193|P1|STARTED|Overall Study||50
219999|NCT01202721|532201|P4|NOT COMPLETED|Overall Study||0
220000|NCT01202721|532202|P3|NOT COMPLETED|Overall Study||0
220001|NCT01202721|532203|P2|NOT COMPLETED|Overall Study||0
220002|NCT01202721|532204|P1|NOT COMPLETED|Overall Study||0
220003|NCT01202721|532201|P4|COMPLETED|Overall Study||27
220004|NCT01202721|532202|P3|COMPLETED|Overall Study||14
220005|NCT01202721|532203|P2|COMPLETED|Overall Study||26
220006|NCT01202721|532204|P1|COMPLETED|Overall Study||18
220007|NCT01202721|532201|P4|STARTED|Overall Study||27
220008|NCT01202721|532202|P3|STARTED|Overall Study||14
220009|NCT01202721|532203|P2|STARTED|Overall Study||26
220010|NCT01202721|532204|P1|STARTED|Overall Study||18
220011|NCT01202656|532220|P2|NOT COMPLETED|CrossoverCycle||0
220012|NCT01202656|532221|P1|NOT COMPLETED|CrossoverCycle||0
220013|NCT01202656|532220|P2|COMPLETED|CrossoverCycle||14
220014|NCT01202656|532221|P1|COMPLETED|CrossoverCycle||18
220015|NCT01202656|532220|P2|STARTED|CrossoverCycle|14 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|14
220016|NCT01202656|532221|P1|STARTED|CrossoverCycle|16 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|18
220017|NCT01202656|532220|P2|NOT COMPLETED|Cycle 1||0
220018|NCT01202656|532221|P1|NOT COMPLETED|Cycle 1||0
220019|NCT01202656|532220|P2|COMPLETED|Cycle 1||62
220020|NCT01202656|532221|P1|COMPLETED|Cycle 1||67
220021|NCT01202656|532220|P2|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|62
220022|NCT01202656|532221|P1|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|67
220023|NCT01202643|532231|P2|NOT COMPLETED|Crossover Cycle||0
220024|NCT01202643|532232|P1|NOT COMPLETED|Crossover Cycle||0
220025|NCT01202643|532231|P2|COMPLETED|Crossover Cycle||2
220026|NCT01202643|532232|P1|COMPLETED|Crossover Cycle||1
220027|NCT01202643|532231|P2|STARTED|Crossover Cycle|Three patients became pregnant after Period 1, 1 patient chose not to cycle again|2
220028|NCT01202643|532232|P1|STARTED|Crossover Cycle|One patient became pregnant following Period 1, Only one non-pregnant chose to cycle again|1
220029|NCT01202643|532231|P2|NOT COMPLETED|Period 1||0
220030|NCT01202643|532232|P1|NOT COMPLETED|Period 1||0
220031|NCT01202643|532231|P2|COMPLETED|Period 1||6
220032|NCT01202643|532232|P1|COMPLETED|Period 1||6
220033|NCT01202643|532231|P2|STARTED|Period 1||6
220034|NCT01202643|532232|P1|STARTED|Period 1||6
220035|NCT01202591|532246|P6|NOT COMPLETED|Overall Study||4
220036|NCT01202591|532247|P5|NOT COMPLETED|Overall Study||5
220037|NCT01202591|532248|P4|NOT COMPLETED|Overall Study||7
220038|NCT01202591|532249|P3|NOT COMPLETED|Overall Study||11
220039|NCT01202591|532250|P2|NOT COMPLETED|Overall Study||5
220040|NCT01202591|532251|P1|NOT COMPLETED|Overall Study||5
220041|NCT01202591|532246|P6|COMPLETED|Overall Study||0
220042|NCT01202591|532247|P5|COMPLETED|Overall Study||0
220043|NCT01202591|532248|P4|COMPLETED|Overall Study||2
220044|NCT01202591|532249|P3|COMPLETED|Overall Study||1
220045|NCT01202591|532250|P2|COMPLETED|Overall Study||0
220046|NCT01202591|532251|P1|COMPLETED|Overall Study||0
220047|NCT01202591|532246|P6|STARTED|Overall Study||4
220048|NCT01202591|532247|P5|STARTED|Overall Study||5
220049|NCT01202591|532248|P4|STARTED|Overall Study||9
220050|NCT01202591|532249|P3|STARTED|Overall Study||12
220051|NCT01202591|532250|P2|STARTED|Overall Study||5
220052|NCT01202591|532251|P1|STARTED|Overall Study||5
220053|NCT01202578|532265|P1|NOT COMPLETED|Overall Study||0
220054|NCT01202578|532265|P1|COMPLETED|Overall Study||53
220055|NCT01202578|532265|P1|STARTED|Overall Study||53
220056|NCT01202565|532272|P1|NOT COMPLETED|Overall Study||67
220057|NCT01202565|532272|P1|COMPLETED|Overall Study|Indicates participants who completed the Month 12 visit|439
220058|NCT01202565|532272|P1|Full Analysis Set|Overall Study|Participants with a signed informed consent and any available data regarding adalimumab treatment.|501
220059|NCT01202565|532272|P1|STARTED|Overall Study||506
220060|NCT01202279|532297|P2|NOT COMPLETED|Overall Study||27
220061|NCT01202279|532298|P1|NOT COMPLETED|Overall Study||37
220062|NCT01202279|532297|P2|COMPLETED|Overall Study||561
220063|NCT01202279|532298|P1|COMPLETED|Overall Study||554
220064|NCT01202279|532297|P2|STARTED|Overall Study||588
220065|NCT01202279|532298|P1|STARTED|Overall Study||591
220066|NCT01202253|532306|P1|NOT COMPLETED|Overall Study||0
220067|NCT01202253|532306|P1|COMPLETED|Overall Study||50
220068|NCT01202253|532306|P1|STARTED|Overall Study||50
220069|NCT01202227|532350|P1|NOT COMPLETED|Overall Study||19
220070|NCT01202227|532350|P1|COMPLETED|Overall Study||84
220071|NCT01202227|532350|P1|STARTED|Overall Study|Treated|103
220072|NCT01202188|532374|P5|NOT COMPLETED|Overall Study||45
220073|NCT01202188|532375|P4|NOT COMPLETED|Overall Study||42
220074|NCT01202188|532376|P3|NOT COMPLETED|Overall Study||53
220075|NCT01202188|532377|P2|NOT COMPLETED|Overall Study||56
220076|NCT01202188|532378|P1|NOT COMPLETED|Overall Study||38
220077|NCT01202188|532374|P5|COMPLETED|Overall Study||189
220078|NCT01202188|532375|P4|COMPLETED|Overall Study||441
220079|NCT01202188|532376|P3|COMPLETED|Overall Study||422
220080|NCT01202188|532377|P2|COMPLETED|Overall Study||421
220081|NCT01202188|532378|P1|COMPLETED|Overall Study||437
220082|NCT01202188|532374|P5|Safety Set; Received Study Drug|Overall Study||232
220083|NCT01202188|532375|P4|Safety Set; Received Study Drug|Overall Study||480
220084|NCT01202188|532376|P3|Safety Set; Received Study Drug|Overall Study||473
220085|NCT01202188|532377|P2|Safety Set; Received Study Drug|Overall Study||476
220086|NCT01202188|532378|P1|Safety Set; Received Study Drug|Overall Study||474
220087|NCT01202188|532374|P5|STARTED|Overall Study||234
220088|NCT01202188|532375|P4|STARTED|Overall Study||483
220089|NCT01202188|532376|P3|STARTED|Overall Study||475
220090|NCT01202188|532377|P2|STARTED|Overall Study||477
220091|NCT01202188|532378|P1|STARTED|Overall Study||475
220092|NCT01202175|532486|P1|NOT COMPLETED|Overall Study||5
220093|NCT01202175|532486|P1|COMPLETED|Overall Study||45
220094|NCT01202175|532486|P1|Pacebo|Overall Study||25
220095|NCT01202175|532486|P1|Nebivolol|Overall Study||25
220096|NCT01202175|532486|P1|STARTED|Overall Study||50
220097|NCT01202162|532515|P2|NOT COMPLETED|Overall Study||2
220098|NCT01202162|532516|P1|NOT COMPLETED|Overall Study||3
220099|NCT01202162|532515|P2|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
220100|NCT01202162|532516|P1|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
220101|NCT01202162|532515|P2|STARTED|Overall Study||42
220102|NCT01202162|532516|P1|STARTED|Overall Study||43
220103|NCT01202110|532526|P2|NOT COMPLETED|Overall Study||0
220104|NCT01202110|532527|P1|NOT COMPLETED|Overall Study||0
220105|NCT01202110|532526|P2|COMPLETED|Overall Study||0
220106|NCT01202110|532527|P1|COMPLETED|Overall Study||10
220107|NCT01202110|532526|P2|STARTED|Overall Study||0
220108|NCT01202110|532527|P1|STARTED|Overall Study||10
220109|NCT01202071|532531|P4|NOT COMPLETED|Overall Study||0
220110|NCT01202071|532532|P3|NOT COMPLETED|Overall Study||0
220111|NCT01202071|532533|P2|NOT COMPLETED|Overall Study||0
220112|NCT01202071|532534|P1|NOT COMPLETED|Overall Study||0
220113|NCT01202071|532531|P4|COMPLETED|Overall Study||6
220114|NCT01202071|532532|P3|COMPLETED|Overall Study||6
220115|NCT01202071|532533|P2|COMPLETED|Overall Study||6
220116|NCT01202071|532534|P1|COMPLETED|Overall Study||6
220117|NCT01202071|532531|P4|STARTED|Overall Study||6
220118|NCT01202071|532532|P3|STARTED|Overall Study||6
220119|NCT01202071|532533|P2|STARTED|Overall Study||6
220120|NCT01202071|532534|P1|STARTED|Overall Study||6
220121|NCT01201967|532554|P2|NOT COMPLETED|Overall Study||5
220122|NCT01201967|532555|P1|NOT COMPLETED|Overall Study||6
220123|NCT01201967|532554|P2|COMPLETED|Overall Study||86
220124|NCT01201967|532555|P1|COMPLETED|Overall Study||86
220125|NCT01201967|532554|P2|STARTED|Overall Study||91
220126|NCT01201967|532555|P1|STARTED|Overall Study||92
220127|NCT01201915|532580|P3|NOT COMPLETED|Overall Study||6
220128|NCT01201915|532581|P2|NOT COMPLETED|Overall Study||11
220129|NCT01201915|532582|P1|NOT COMPLETED|Overall Study||8
220130|NCT01201915|532580|P3|COMPLETED|Overall Study||19
220131|NCT01201915|532581|P2|COMPLETED|Overall Study||14
220132|NCT01201915|532582|P1|COMPLETED|Overall Study||16
220133|NCT01201915|532580|P3|STARTED|Overall Study||25
220134|NCT01201915|532581|P2|STARTED|Overall Study||25
220135|NCT01201915|532582|P1|STARTED|Overall Study||24
220136|NCT01201811|532593|P1|NOT COMPLETED|Overall Study||19
220137|NCT01201811|532593|P1|COMPLETED|Overall Study||25
220138|NCT01201811|532593|P1|STARTED|Overall Study||44
220139|NCT01201798|532615|P2|NOT COMPLETED|Overall Study||15
220140|NCT01201798|532616|P1|NOT COMPLETED|Overall Study||9
220141|NCT01201798|532615|P2|COMPLETED|Overall Study||39
220142|NCT01201798|532616|P1|COMPLETED|Overall Study||47
220143|NCT01201798|532615|P2|STARTED|Overall Study||54
220144|NCT01201798|532616|P1|STARTED|Overall Study||56
220145|NCT01201785|532640|P1|NOT COMPLETED|Overall Study||16
220146|NCT01201785|532640|P1|COMPLETED|Overall Study||20
220147|NCT01201785|532640|P1|STARTED|Overall Study||36
220148|NCT01201772|532647|P3|NOT COMPLETED|Overall Study||0
220149|NCT01201772|532648|P2|NOT COMPLETED|Overall Study||0
220150|NCT01201772|532649|P1|NOT COMPLETED|Overall Study||1
220151|NCT01201772|532647|P3|COMPLETED|Overall Study||21
220152|NCT01201772|532648|P2|COMPLETED|Overall Study||21
220153|NCT01201772|532649|P1|COMPLETED|Overall Study||22
220154|NCT01201772|532647|P3|STARTED|Overall Study||21
220155|NCT01201772|532648|P2|STARTED|Overall Study||21
220156|NCT01201772|532649|P1|STARTED|Overall Study||23
220157|NCT01201759|532657|P2|NOT COMPLETED|Visit 5||0
220158|NCT01201759|532658|P1|NOT COMPLETED|Visit 5||0
220159|NCT01201759|532657|P2|COMPLETED|Visit 5||3
220160|NCT01201759|532658|P1|COMPLETED|Visit 5||7
220161|NCT01201759|532657|P2|STARTED|Visit 5||3
220162|NCT01201759|532658|P1|STARTED|Visit 5||7
220163|NCT01201759|532657|P2|NOT COMPLETED|Visit 4 Crossover||1
220164|NCT01201759|532658|P1|NOT COMPLETED|Visit 4 Crossover||0
220165|NCT01201759|532657|P2|COMPLETED|Visit 4 Crossover||3
220166|NCT01201759|532658|P1|COMPLETED|Visit 4 Crossover||7
220167|NCT01201759|532657|P2|STARTED|Visit 4 Crossover||4
220168|NCT01201759|532658|P1|STARTED|Visit 4 Crossover||7
220169|NCT01201759|532657|P2|NOT COMPLETED|Visit 3 - Washout||3
220170|NCT01201759|532658|P1|NOT COMPLETED|Visit 3 - Washout||1
220171|NCT01201759|532657|P2|COMPLETED|Visit 3 - Washout||4
220172|NCT01201759|532658|P1|COMPLETED|Visit 3 - Washout||7
220173|NCT01201759|532657|P2|STARTED|Visit 3 - Washout||7
220174|NCT01201759|532658|P1|STARTED|Visit 3 - Washout||8
220175|NCT01201759|532657|P2|NOT COMPLETED|Visit 2||0
220176|NCT01201759|532658|P1|NOT COMPLETED|Visit 2||0
220177|NCT01201759|532657|P2|COMPLETED|Visit 2||7
220178|NCT01201759|532658|P1|COMPLETED|Visit 2||8
220179|NCT01201759|532657|P2|STARTED|Visit 2||7
220180|NCT01201759|532658|P1|STARTED|Visit 2||8
220181|NCT01201759|532657|P2|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||1
220182|NCT01201759|532658|P1|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||2
220183|NCT01201759|532657|P2|COMPLETED|Visit 1 Wash-in ( Untreated)||7
220184|NCT01201759|532658|P1|COMPLETED|Visit 1 Wash-in ( Untreated)||8
220185|NCT01201759|532657|P2|STARTED|Visit 1 Wash-in ( Untreated)||8
220186|NCT01201759|532658|P1|STARTED|Visit 1 Wash-in ( Untreated)||10
220187|NCT01201629|532672|P2|NOT COMPLETED|Overall Study||0
220188|NCT01201629|532673|P1|NOT COMPLETED|Overall Study||0
220189|NCT01201629|532672|P2|COMPLETED|Overall Study||8
220190|NCT01201629|532673|P1|COMPLETED|Overall Study||8
220191|NCT01201629|532672|P2|STARTED|Overall Study||8
220192|NCT01201629|532673|P1|STARTED|Overall Study||8
220193|NCT01201486|532683|P1|NOT COMPLETED|Overall Study||0
220194|NCT01201486|532683|P1|COMPLETED|Overall Study||6781
220195|NCT01201486|532683|P1|STARTED|Overall Study||6781
220196|NCT01201356|532687|P1|NOT COMPLETED|Overall Study||644
220197|NCT01201356|532687|P1|COMPLETED|Overall Study||3481
220198|NCT01201356|532687|P1|Fingolimod Full Analysis Set|Overall Study||4046
220199|NCT01201356|532687|P1|Safety Set|Overall Study||4083
220200|NCT01201356|532687|P1|STARTED|Overall Study||4125
220201|NCT01201343|532701|P1|NOT COMPLETED|Overall Study||19
220202|NCT01201343|532701|P1|COMPLETED|Overall Study||60
220203|NCT01201343|532701|P1|Treated|Overall Study||76
220204|NCT01201343|532701|P1|STARTED|Overall Study||79
220205|NCT01201317|532715|P3|NOT COMPLETED|Overall Study||8
220206|NCT01201317|532716|P2|NOT COMPLETED|Overall Study||7
220207|NCT01201317|532717|P1|NOT COMPLETED|Overall Study||9
220208|NCT01201317|532715|P3|COMPLETED|Overall Study||33
220209|NCT01201317|532716|P2|COMPLETED|Overall Study||38
220210|NCT01201317|532717|P1|COMPLETED|Overall Study||39
220211|NCT01201317|532715|P3|STARTED|Overall Study||41
220212|NCT01201317|532716|P2|STARTED|Overall Study||45
220213|NCT01201317|532717|P1|STARTED|Overall Study||48
220214|NCT01201265|532737|P1|NOT COMPLETED|Overall Study||38
220215|NCT01201265|532737|P1|COMPLETED|Overall Study||2
220216|NCT01201265|532737|P1|STARTED|Overall Study||40
220217|NCT01201057|532753|P4|NOT COMPLETED|Overall Study||4
220218|NCT01201057|532754|P3|NOT COMPLETED|Overall Study||5
220219|NCT01201057|532755|P2|NOT COMPLETED|Overall Study||4
220220|NCT01201057|532756|P1|NOT COMPLETED|Overall Study||2
220221|NCT01201057|532753|P4|COMPLETED|Overall Study||29
220222|NCT01201057|532754|P3|COMPLETED|Overall Study||27
220223|NCT01201057|532755|P2|COMPLETED|Overall Study||29
220224|NCT01201057|532756|P1|COMPLETED|Overall Study||32
220225|NCT01201057|532753|P4|STARTED|Overall Study||33
220226|NCT01201057|532754|P3|STARTED|Overall Study||32
220227|NCT01201057|532755|P2|STARTED|Overall Study||33
220228|NCT01201057|532756|P1|STARTED|Overall Study||34
220229|NCT01200992|532784|P2|NOT COMPLETED|Overall Study||41
220230|NCT01200992|532785|P1|NOT COMPLETED|Overall Study||37
220231|NCT01200992|532784|P2|COMPLETED|Overall Study||4
220232|NCT01200992|532785|P1|COMPLETED|Overall Study||2
220233|NCT01200992|532784|P2|STARTED|Overall Study||45
220234|NCT01200992|532785|P1|STARTED|Overall Study||39
220235|NCT01200875|532793|P1|NOT COMPLETED|Overall Study||0
220236|NCT01200875|532793|P1|COMPLETED|Overall Study||25
220237|NCT01200875|532793|P1|STARTED|Overall Study||25
220238|NCT01200810|532799|P2|NOT COMPLETED|Overall Study||5
220239|NCT01200810|532800|P1|NOT COMPLETED|Overall Study||5
220240|NCT01200810|532799|P2|COMPLETED|Overall Study||0
220241|NCT01200810|532800|P1|COMPLETED|Overall Study||0
220242|NCT01200810|532799|P2|STARTED|Overall Study||5
220243|NCT01200810|532800|P1|STARTED|Overall Study||5
220244|NCT01200797|532820|P1|NOT COMPLETED|Overall Study||19
220245|NCT01200797|532820|P1|COMPLETED|Overall Study||0
220246|NCT01200797|532820|P1|STARTED|Overall Study||19
220247|NCT01200758|532830|P4|NOT COMPLETED|Stage 2||50
220248|NCT01200758|532831|P3|NOT COMPLETED|Stage 2||41
220249|NCT01200758|532832|P2|NOT COMPLETED|Stage 2||0
220250|NCT01200758|532833|P1|NOT COMPLETED|Stage 2||0
220251|NCT01200758|532830|P4|COMPLETED|Stage 2|Participants completed treatment period.|92
220252|NCT01200758|532831|P3|COMPLETED|Stage 2|Participants completed treatment period.|100
220253|NCT01200758|532832|P2|COMPLETED|Stage 2||0
220254|NCT01200758|532833|P1|COMPLETED|Stage 2||0
220255|NCT01200758|532830|P4|STARTED|Stage 2||142
220256|NCT01200758|532831|P3|STARTED|Stage 2||141
220257|NCT01200758|532832|P2|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
220258|NCT01200758|532833|P1|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
220259|NCT01200758|532830|P4|NOT COMPLETED|Stage I||0
220260|NCT01200758|532831|P3|NOT COMPLETED|Stage I||0
220261|NCT01200758|532832|P2|NOT COMPLETED|Stage I||17
220262|NCT01200758|532833|P1|NOT COMPLETED|Stage I||18
220263|NCT01200758|532830|P4|COMPLETED|Stage I||0
220264|NCT01200758|532831|P3|COMPLETED|Stage I||0
220265|NCT01200758|532832|P2|COMPLETED|Stage I|Participants completed treatment period.|46
220266|NCT01200758|532833|P1|COMPLETED|Stage I|Participants completed treatment period.|46
220267|NCT01200758|532830|P4|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
220268|NCT01200758|532831|P3|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
220269|NCT01200758|532832|P2|STARTED|Stage I||63
220270|NCT01200758|532833|P1|STARTED|Stage I||64
220271|NCT01200602|532889|P2|NOT COMPLETED|Overall Study||0
220272|NCT01200602|532890|P1|NOT COMPLETED|Overall Study||0
220273|NCT01200602|532889|P2|COMPLETED|Overall Study||0
220274|NCT01200602|532890|P1|COMPLETED|Overall Study||0
220275|NCT01200602|532889|P2|STARTED|Overall Study||0
220276|NCT01200602|532890|P1|STARTED|Overall Study||0
220277|NCT01200589|532906|P2|NOT COMPLETED|Overall Study||189
220278|NCT01200589|532907|P1|NOT COMPLETED|Overall Study||190
220279|NCT01200589|532906|P2|COMPLETED|Overall Study||30
220280|NCT01200589|532907|P1|COMPLETED|Overall Study||29
220281|NCT01200589|532906|P2|Safety Set|Overall Study||218
220282|NCT01200589|532907|P1|Safety Set|Overall Study||217
220283|NCT01200589|532906|P2|Intent-to-treat (ITT) Analysis Set|Overall Study||219
220284|NCT01200589|532907|P1|Intent-to-treat (ITT) Analysis Set|Overall Study||219
220285|NCT01200589|532906|P2|STARTED|Overall Study||219
220286|NCT01200589|532907|P1|STARTED|Overall Study||219
220287|NCT01200524|532934|P3|NOT COMPLETED|Overall Study||4
220288|NCT01200524|532935|P2|NOT COMPLETED|Overall Study||1
220289|NCT01200524|532936|P1|NOT COMPLETED|Overall Study||2
220290|NCT01200524|532934|P3|COMPLETED|Overall Study||40
220291|NCT01200524|532935|P2|COMPLETED|Overall Study||47
220292|NCT01200524|532936|P1|COMPLETED|Overall Study||39
220293|NCT01200524|532934|P3|STARTED|Overall Study||44
220294|NCT01200524|532935|P2|STARTED|Overall Study||48
220295|NCT01200524|532936|P1|STARTED|Overall Study||41
220296|NCT01200511|532956|P1|NOT COMPLETED|Overall Study||5
220297|NCT01200511|532956|P1|COMPLETED|Overall Study||44
220298|NCT01200511|532956|P1|STARTED|Overall Study||49
220299|NCT01200498|532964|P1|NOT COMPLETED|Overall Study||0
220300|NCT01200498|532964|P1|COMPLETED|Overall Study||22
220301|NCT01200498|532964|P1|STARTED|Overall Study||22
220302|NCT01200433|532970|P2|NOT COMPLETED|Overall Study||0
220303|NCT01200433|532971|P1|NOT COMPLETED|Overall Study||0
220304|NCT01200433|532970|P2|COMPLETED|Overall Study||23
220305|NCT01200433|532971|P1|COMPLETED|Overall Study||21
220306|NCT01200433|532970|P2|STARTED|Overall Study||23
220307|NCT01200433|532971|P1|STARTED|Overall Study||21
220308|NCT01200394|532993|P2|NOT COMPLETED|Overall Study||28
220309|NCT01200394|532994|P1|NOT COMPLETED|Overall Study||2
220310|NCT01200394|532993|P2|COMPLETED|Overall Study||164
220311|NCT01200394|532994|P1|COMPLETED|Overall Study||62
220312|NCT01200394|532993|P2|STARTED|Overall Study||192
220313|NCT01200394|532994|P1|STARTED|Overall Study||64
220314|NCT01200368|533032|P3|NOT COMPLETED|Toddler Dose||1
220315|NCT01200368|533033|P2|NOT COMPLETED|Toddler Dose||3
220316|NCT01200368|533034|P1|NOT COMPLETED|Toddler Dose||0
220317|NCT01200368|533032|P3|COMPLETED|Toddler Dose||168
220318|NCT01200368|533033|P2|COMPLETED|Toddler Dose||159
220319|NCT01200368|533034|P1|COMPLETED|Toddler Dose||162
220320|NCT01200368|533032|P3|STARTED|Toddler Dose||169
220321|NCT01200368|533033|P2|STARTED|Toddler Dose||162
220322|NCT01200368|533034|P1|STARTED|Toddler Dose||162
220323|NCT01200368|533032|P3|NOT COMPLETED|After Infant Series||9
220324|NCT01200368|533033|P2|NOT COMPLETED|After Infant Series||16
220325|NCT01200368|533034|P1|NOT COMPLETED|After Infant Series||18
220326|NCT01200368|533032|P3|COMPLETED|After Infant Series||169
220327|NCT01200368|533033|P2|COMPLETED|After Infant Series||162
220328|NCT01200368|533034|P1|COMPLETED|After Infant Series||162
220329|NCT01200368|533032|P3|STARTED|After Infant Series||178
220330|NCT01200368|533033|P2|STARTED|After Infant Series||178
220331|NCT01200368|533034|P1|STARTED|After Infant Series||180
220332|NCT01200368|533032|P3|NOT COMPLETED|Infant Series||6
220333|NCT01200368|533033|P2|NOT COMPLETED|Infant Series||6
220334|NCT01200368|533034|P1|NOT COMPLETED|Infant Series||3
220335|NCT01200368|533032|P3|COMPLETED|Infant Series||178
220336|NCT01200368|533033|P2|COMPLETED|Infant Series||178
220337|NCT01200368|533034|P1|COMPLETED|Infant Series||180
220338|NCT01200368|533032|P3|Vaccinated Dose 3|Infant Series||182
220339|NCT01200368|533033|P2|Vaccinated Dose 3|Infant Series||178
220340|NCT01200368|533034|P1|Vaccinated Dose 3|Infant Series||181
220341|NCT01200368|533032|P3|Vaccinated Dose 2|Infant Series||183
220342|NCT01200368|533033|P2|Vaccinated Dose 2|Infant Series||182
220343|NCT01200368|533034|P1|Vaccinated Dose 2|Infant Series||183
220344|NCT01200368|533032|P3|Vaccinated Dose 1|Infant Series||183
220345|NCT01200368|533033|P2|Vaccinated Dose 1|Infant Series||183
220346|NCT01200368|533034|P1|Vaccinated Dose 1|Infant Series||183
220347|NCT01200368|533032|P3|STARTED|Infant Series||184
220348|NCT01200368|533033|P2|STARTED|Infant Series||184
220349|NCT01200368|533034|P1|STARTED|Infant Series||183
220350|NCT01200355|533100|P2|NOT COMPLETED|Overall Study||2
220351|NCT01200355|533101|P1|NOT COMPLETED|Overall Study||7
220352|NCT01200355|533100|P2|COMPLETED|Overall Study||53
220353|NCT01200355|533101|P1|COMPLETED|Overall Study||51
220354|NCT01200355|533100|P2|STARTED|Overall Study||55
220355|NCT01200355|533101|P1|STARTED|Overall Study||58
220356|NCT01200342|533115|P1|NOT COMPLETED|Overall Study||1
220357|NCT01200342|533115|P1|COMPLETED|Overall Study||6
220358|NCT01200342|533115|P1|STARTED|Overall Study||7
220359|NCT01200290|533120|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||2
220360|NCT01200290|533120|P1|COMPLETED|Post-Treatment Follow-Up Period||16
220361|NCT01200290|533120|P1|STARTED|Post-Treatment Follow-Up Period|Participant who discontinued treatment was included in the post-treatment follow-up period.|18
220362|NCT01200290|533120|P1|NOT COMPLETED|Treatment Period||1
220363|NCT01200290|533120|P1|COMPLETED|Treatment Period||17
220364|NCT01200290|533120|P1|Received at Least 1 Dose of Study Drug|Treatment Period||18
220365|NCT01200290|533120|P1|STARTED|Treatment Period||18
220366|NCT01200238|533133|P2|NOT COMPLETED|Overall Study||10
220367|NCT01200238|533134|P1|NOT COMPLETED|Overall Study||7
220368|NCT01200238|533133|P2|COMPLETED|Overall Study||0
220369|NCT01200238|533134|P1|COMPLETED|Overall Study||0
220370|NCT01200238|533133|P2|STARTED|Overall Study||10
220371|NCT01200238|533134|P1|STARTED|Overall Study||7
220372|NCT01200160|533152|P1|NOT COMPLETED|Overall Study||62
220373|NCT01200160|533152|P1|COMPLETED|Overall Study||66
220374|NCT01200160|533152|P1|STARTED|Overall Study||128
220375|NCT01200069|533158|P2|NOT COMPLETED|Overall Study||1
220376|NCT01200069|533159|P1|NOT COMPLETED|Overall Study||0
220377|NCT01200069|533158|P2|COMPLETED|Overall Study||5
220378|NCT01200069|533159|P1|COMPLETED|Overall Study||8
220379|NCT01200069|533158|P2|STARTED|Overall Study||6
220380|NCT01200069|533159|P1|STARTED|Overall Study||8
220381|NCT01200030|533214|P3|NOT COMPLETED|Overall Study||0
220382|NCT01200030|533215|P2|NOT COMPLETED|Overall Study||0
220383|NCT01200030|533216|P1|NOT COMPLETED|Overall Study||0
220384|NCT01200030|533214|P3|COMPLETED|Overall Study||12
220385|NCT01200030|533215|P2|COMPLETED|Overall Study||13
220386|NCT01200030|533216|P1|COMPLETED|Overall Study||12
220387|NCT01200030|533214|P3|STARTED|Overall Study||12
220388|NCT01200030|533215|P2|STARTED|Overall Study||13
220389|NCT01200030|533216|P1|STARTED|Overall Study||12
220390|NCT01199965|533229|P2|NOT COMPLETED|Overall Study||0
220391|NCT01199965|533230|P1|NOT COMPLETED|Overall Study||1
220392|NCT01199965|533229|P2|COMPLETED|Overall Study||24
220393|NCT01199965|533230|P1|COMPLETED|Overall Study||22
220394|NCT01199965|533229|P2|STARTED|Overall Study||24
220395|NCT01199965|533230|P1|STARTED|Overall Study||23
220396|NCT01199952|533246|P2|NOT COMPLETED|Overall Study||45
220397|NCT01199952|533247|P1|NOT COMPLETED|Overall Study||52
220398|NCT01199952|533246|P2|COMPLETED|Overall Study||59
220399|NCT01199952|533247|P1|COMPLETED|Overall Study||51
220400|NCT01199952|533246|P2|STARTED|Overall Study||104
220401|NCT01199952|533247|P1|STARTED|Overall Study||103
220402|NCT01199939|533255|P1|NOT COMPLETED|Overall Study||13
220403|NCT01199939|533255|P1|COMPLETED|Overall Study||41
220404|NCT01199939|533255|P1|STARTED|Overall Study|Number of enrolled participants|54
220405|NCT01199926|533274|P2|NOT COMPLETED|Overall Study||4
220406|NCT01199926|533275|P1|NOT COMPLETED|Overall Study||7
220407|NCT01199926|533274|P2|COMPLETED|Overall Study||13
220408|NCT01199926|533275|P1|COMPLETED|Overall Study||10
220409|NCT01199926|533274|P2|STARTED|Overall Study||17
220410|NCT01199926|533275|P1|STARTED|Overall Study||17
220411|NCT01199861|533287|P2|NOT COMPLETED|Overall Study||0
220412|NCT01199861|533288|P1|NOT COMPLETED|Overall Study||2
220413|NCT01199861|533287|P2|COMPLETED|Overall Study||43
220414|NCT01199861|533288|P1|COMPLETED|Overall Study||93
220415|NCT01199861|533287|P2|STARTED|Overall Study||43
220416|NCT01199861|533288|P1|STARTED|Overall Study||95
220417|NCT01199822|533309|P3|NOT COMPLETED|Overall Study||0
220418|NCT01199822|533310|P2|NOT COMPLETED|Overall Study||1
220419|NCT01199822|533311|P1|NOT COMPLETED|Overall Study||0
220420|NCT01199822|533309|P3|COMPLETED|Overall Study||6
220421|NCT01199822|533310|P2|COMPLETED|Overall Study||6
220422|NCT01199822|533311|P1|COMPLETED|Overall Study||3
220423|NCT01199822|533309|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
220424|NCT01199822|533310|P2|Received at Least 1 Dose of Study Drug|Overall Study||7
220425|NCT01199822|533311|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
220426|NCT01199822|533309|P3|STARTED|Overall Study||6
220427|NCT01199822|533310|P2|STARTED|Overall Study||7
220428|NCT01199822|533311|P1|STARTED|Overall Study||3
220429|NCT01199744|533344|P1|NOT COMPLETED|Overall Study||0
220430|NCT01199744|533344|P1|COMPLETED|Overall Study||1575
220431|NCT01199744|533344|P1|STARTED|Overall Study||1575
220432|NCT01199731|533360|P3|NOT COMPLETED|Overall Study||10
220433|NCT01199731|533361|P2|NOT COMPLETED|Overall Study||11
220434|NCT01199731|533362|P1|NOT COMPLETED|Overall Study||9
220435|NCT01199731|533360|P3|COMPLETED|Overall Study||0
220436|NCT01199731|533361|P2|COMPLETED|Overall Study||0
220437|NCT01199731|533362|P1|COMPLETED|Overall Study||0
220438|NCT01199731|533360|P3|STARTED|Overall Study||10
220439|NCT01199731|533361|P2|STARTED|Overall Study||11
220440|NCT01199731|533362|P1|STARTED|Overall Study||9
220441|NCT01199705|533400|P1|NOT COMPLETED|SCIG Treatment (Efficacy)||0
220442|NCT01199705|533400|P1|COMPLETED|SCIG Treatment (Efficacy)||24
220443|NCT01199705|533400|P1|STARTED|SCIG Treatment (Efficacy)||24
220444|NCT01199705|533400|P1|NOT COMPLETED|SCIG Treatment (Wash-in/Wash-out)||1
220445|NCT01199705|533400|P1|COMPLETED|SCIG Treatment (Wash-in/Wash-out)||24
220446|NCT01199705|533400|P1|STARTED|SCIG Treatment (Wash-in/Wash-out)||25
220447|NCT01199705|533400|P1|NOT COMPLETED|IVIG Treatment||0
220448|NCT01199705|533400|P1|COMPLETED|IVIG Treatment||25
220449|NCT01199705|533400|P1|STARTED|IVIG Treatment||25
220450|NCT01199601|533432|P2|NOT COMPLETED|Overall Study||78
220451|NCT01199601|533433|P1|NOT COMPLETED|Overall Study||69
220452|NCT01199601|533432|P2|COMPLETED|Overall Study||344
220453|NCT01199601|533433|P1|COMPLETED|Overall Study||353
220454|NCT01199601|533432|P2|STARTED|Overall Study|Intervention Group|422
220455|NCT01199601|533433|P1|STARTED|Overall Study|Control Group|422
220456|NCT01199575|533443|P1|NOT COMPLETED|Overall Study||5
220457|NCT01199575|533443|P1|COMPLETED|Overall Study||25
220458|NCT01199575|533443|P1|STARTED|Overall Study||30
220459|NCT01199471|533448|P1|NOT COMPLETED|Overall Study||6
220460|NCT01199471|533448|P1|COMPLETED|Overall Study||3994
220461|NCT01199471|533448|P1|STARTED|Overall Study|3 patients who did not meet ASA Physical Status Class 1 - 3 were excluded from all analyses.|4000
220462|NCT01199263|533459|P2|NOT COMPLETED|Overall Study||2
220463|NCT01199263|533460|P1|NOT COMPLETED|Overall Study||6
220464|NCT01199263|533459|P2|COMPLETED|Overall Study||52
220465|NCT01199263|533460|P1|COMPLETED|Overall Study||48
220466|NCT01199263|533459|P2|STARTED|Overall Study||54
220467|NCT01199263|533460|P1|STARTED|Overall Study||54
220468|NCT01199237|533476|P2|NOT COMPLETED|Overall Study||0
220469|NCT01199237|533477|P1|NOT COMPLETED|Overall Study||0
220470|NCT01199237|533476|P2|COMPLETED|Overall Study||40
220471|NCT01199237|533477|P1|COMPLETED|Overall Study||41
220472|NCT01199237|533476|P2|STARTED|Overall Study||40
220473|NCT01199237|533477|P1|STARTED|Overall Study||41
220474|NCT01199146|533491|P1|NOT COMPLETED|Overall Study||3
220475|NCT01199146|533491|P1|COMPLETED|Overall Study||39
220476|NCT01199146|533491|P1|STARTED|Overall Study||42
220477|NCT01199042|533497|P1|NOT COMPLETED|At Home (3 Months)||1
220478|NCT01199042|533497|P1|COMPLETED|At Home (3 Months)||26
220479|NCT01199042|533497|P1|STARTED|At Home (3 Months)||27
220480|NCT01199042|533497|P1|NOT COMPLETED|Sleep Laboratory (3 Nights)||2
220481|NCT01199042|533497|P1|COMPLETED|Sleep Laboratory (3 Nights)||27
220482|NCT01199042|533497|P1|STARTED|Sleep Laboratory (3 Nights)||29
220483|NCT01199016|533506|P1|NOT COMPLETED|Overall Study||77
220484|NCT01199016|533506|P1|COMPLETED|Overall Study||162
220485|NCT01199016|533506|P1|Treated|Overall Study||236
220486|NCT01199016|533506|P1|STARTED|Overall Study||239
220487|NCT01198977|533515|P2|NOT COMPLETED|Overall Study||0
220488|NCT01198977|533516|P1|NOT COMPLETED|Overall Study||1
220489|NCT01198977|533515|P2|COMPLETED|Overall Study||33
220490|NCT01198977|533516|P1|COMPLETED|Overall Study||30
220491|NCT01198977|533515|P2|STARTED|Overall Study||33
220492|NCT01198977|533516|P1|STARTED|Overall Study||31
220493|NCT01198873|533528|P2|NOT COMPLETED|Overall Study||32
220494|NCT01198873|533529|P1|NOT COMPLETED|Overall Study||37
220495|NCT01198873|533528|P2|COMPLETED|Overall Study||3
220496|NCT01198873|533529|P1|COMPLETED|Overall Study||4
220497|NCT01198873|533528|P2|Evaluable for Efficacy|Overall Study|9 participants discontinued before completing 3-month treatment and were not assessed post-baseline|26
220498|NCT01198873|533529|P1|Evaluable for Efficacy|Overall Study|8 participants discontinued before completing 3-month treatment and were not assessed post-baseline|33
220499|NCT01198873|533528|P2|Treated|Overall Study||35
220500|NCT01198873|533529|P1|Treated|Overall Study||41
220501|NCT01198873|533528|P2|STARTED|Overall Study||35
220502|NCT01198873|533529|P1|STARTED|Overall Study||41
220503|NCT01198795|533543|P1|NOT COMPLETED|Overall Study||82
220504|NCT01198795|533543|P1|COMPLETED|Overall Study||80
220505|NCT01198795|533543|P1|STARTED|Overall Study||162
220506|NCT01198769|533547|P1|NOT COMPLETED|Overall Study||0
220507|NCT01198769|533547|P1|COMPLETED|Overall Study||15
220508|NCT01198769|533547|P1|STARTED|Overall Study||15
220509|NCT01198756|533560|P4|NOT COMPLETED|Overall Study||26
220510|NCT01198756|533561|P3|NOT COMPLETED|Overall Study||30
220511|NCT01198756|533562|P2|NOT COMPLETED|Overall Study||40
220512|NCT01198756|533563|P1|NOT COMPLETED|Overall Study||38
220513|NCT01198756|533560|P4|COMPLETED|Overall Study||275
220514|NCT01198756|533561|P3|COMPLETED|Overall Study||902
220515|NCT01198756|533562|P2|COMPLETED|Overall Study||889
220516|NCT01198756|533563|P1|COMPLETED|Overall Study||894
220517|NCT01198756|533560|P4|STARTED|Overall Study||301
220518|NCT01198756|533561|P3|STARTED|Overall Study||932
220519|NCT01198756|533562|P2|STARTED|Overall Study||929
220520|NCT01198756|533563|P1|STARTED|Overall Study||932
220521|NCT01198691|533661|P2|NOT COMPLETED|6 Week Post-partum Survey||24
220522|NCT01198691|533662|P1|NOT COMPLETED|6 Week Post-partum Survey||29
220523|NCT01198691|533661|P2|COMPLETED|6 Week Post-partum Survey||26
220524|NCT01198691|533662|P1|COMPLETED|6 Week Post-partum Survey||21
220525|NCT01198691|533661|P2|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
220526|NCT01198691|533662|P1|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
220527|NCT01198691|533661|P2|NOT COMPLETED|Survey Prior to Discharge||33
220528|NCT01198691|533662|P1|NOT COMPLETED|Survey Prior to Discharge||32
220529|NCT01198691|533661|P2|COMPLETED|Survey Prior to Discharge||17
220530|NCT01198691|533662|P1|COMPLETED|Survey Prior to Discharge||18
220531|NCT01198691|533661|P2|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
220532|NCT01198691|533662|P1|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
220533|NCT01198691|533661|P2|NOT COMPLETED|Completed VAS Score at Discharge||6
220534|NCT01198691|533662|P1|NOT COMPLETED|Completed VAS Score at Discharge||5
220535|NCT01198691|533661|P2|COMPLETED|Completed VAS Score at Discharge||44
220536|NCT01198691|533662|P1|COMPLETED|Completed VAS Score at Discharge||45
220537|NCT01198691|533661|P2|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
220538|NCT01198691|533662|P1|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
220539|NCT01198691|533661|P2|NOT COMPLETED|Completed VAS Score Postop Day 1||4
220540|NCT01198691|533662|P1|NOT COMPLETED|Completed VAS Score Postop Day 1||3
220541|NCT01198691|533661|P2|COMPLETED|Completed VAS Score Postop Day 1||46
220542|NCT01198691|533662|P1|COMPLETED|Completed VAS Score Postop Day 1||47
220543|NCT01198691|533661|P2|STARTED|Completed VAS Score Postop Day 1||50
220544|NCT01198691|533662|P1|STARTED|Completed VAS Score Postop Day 1||50
220545|NCT01198691|533661|P2|NOT COMPLETED|Completed Surgery -Received Intervention||0
220546|NCT01198691|533662|P1|NOT COMPLETED|Completed Surgery -Received Intervention||0
220547|NCT01198691|533661|P2|COMPLETED|Completed Surgery -Received Intervention||50
220548|NCT01198691|533662|P1|COMPLETED|Completed Surgery -Received Intervention||50
220549|NCT01198691|533661|P2|STARTED|Completed Surgery -Received Intervention||50
220550|NCT01198691|533662|P1|STARTED|Completed Surgery -Received Intervention||50
220551|NCT01198600|533674|P4|NOT COMPLETED|Phase 3: 43 Days of Wear||0
220552|NCT01198600|533675|P3|NOT COMPLETED|Phase 3: 43 Days of Wear||0
220553|NCT01198600|533676|P2|NOT COMPLETED|Phase 3: 43 Days of Wear||0
220554|NCT01198600|533677|P1|NOT COMPLETED|Phase 3: 43 Days of Wear||0
220555|NCT01198600|533674|P4|COMPLETED|Phase 3: 43 Days of Wear||38
220556|NCT01198600|533675|P3|COMPLETED|Phase 3: 43 Days of Wear||0
220557|NCT01198600|533676|P2|COMPLETED|Phase 3: 43 Days of Wear||0
220558|NCT01198600|533677|P1|COMPLETED|Phase 3: 43 Days of Wear||0
220559|NCT01198600|533674|P4|STARTED|Phase 3: 43 Days of Wear||38
220560|NCT01198600|533675|P3|STARTED|Phase 3: 43 Days of Wear||0
220561|NCT01198600|533676|P2|STARTED|Phase 3: 43 Days of Wear||0
220562|NCT01198600|533677|P1|STARTED|Phase 3: 43 Days of Wear||0
220563|NCT01198600|533674|P4|NOT COMPLETED|Phase 2: 56 Days of Wear||0
220564|NCT01198600|533675|P3|NOT COMPLETED|Phase 2: 56 Days of Wear||5
220565|NCT01198600|533676|P2|NOT COMPLETED|Phase 2: 56 Days of Wear||0
220566|NCT01198600|533677|P1|NOT COMPLETED|Phase 2: 56 Days of Wear||0
220567|NCT01198600|533674|P4|COMPLETED|Phase 2: 56 Days of Wear||0
220568|NCT01198600|533675|P3|COMPLETED|Phase 2: 56 Days of Wear||62
220569|NCT01198600|533676|P2|COMPLETED|Phase 2: 56 Days of Wear||0
220570|NCT01198600|533677|P1|COMPLETED|Phase 2: 56 Days of Wear||0
220571|NCT01198600|533674|P4|STARTED|Phase 2: 56 Days of Wear||0
220572|NCT01198600|533675|P3|STARTED|Phase 2: 56 Days of Wear||67
220573|NCT01198600|533676|P2|STARTED|Phase 2: 56 Days of Wear||0
220574|NCT01198600|533677|P1|STARTED|Phase 2: 56 Days of Wear||0
220575|NCT01198600|533674|P4|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
220576|NCT01198600|533675|P3|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
220577|NCT01198600|533676|P2|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||1
220578|NCT01198600|533677|P1|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
220579|NCT01198600|533674|P4|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
220580|NCT01198600|533675|P3|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
220581|NCT01198600|533676|P2|COMPLETED|Phase 1: Period Two, 30 Days of Wear||35
220582|NCT01198600|533677|P1|COMPLETED|Phase 1: Period Two, 30 Days of Wear||32
220583|NCT01198600|533674|P4|STARTED|Phase 1: Period Two, 30 Days of Wear||0
220584|NCT01198600|533675|P3|STARTED|Phase 1: Period Two, 30 Days of Wear||0
220585|NCT01198600|533676|P2|STARTED|Phase 1: Period Two, 30 Days of Wear||36
220586|NCT01198600|533677|P1|STARTED|Phase 1: Period Two, 30 Days of Wear|One participant discontinued between Period One and Period Two due to unconvenience.|32
220587|NCT01198600|533674|P4|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
220588|NCT01198600|533675|P3|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
220589|NCT01198600|533676|P2|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||1
220590|NCT01198600|533677|P1|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||2
220591|NCT01198600|533674|P4|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
220592|NCT01198600|533675|P3|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
220593|NCT01198600|533676|P2|COMPLETED|Phase 1: Period One, 30 Days of Wear||36
220594|NCT01198600|533677|P1|COMPLETED|Phase 1: Period One, 30 Days of Wear||33
220595|NCT01198600|533674|P4|STARTED|Phase 1: Period One, 30 Days of Wear||0
220596|NCT01198600|533675|P3|STARTED|Phase 1: Period One, 30 Days of Wear||0
220597|NCT01198600|533676|P2|STARTED|Phase 1: Period One, 30 Days of Wear||37
220598|NCT01198600|533677|P1|STARTED|Phase 1: Period One, 30 Days of Wear||35
220599|NCT01198587|533703|P4|NOT COMPLETED|Overall Study||0
220600|NCT01198587|533704|P3|NOT COMPLETED|Overall Study||9
220601|NCT01198587|533705|P2|NOT COMPLETED|Overall Study||0
220602|NCT01198587|533706|P1|NOT COMPLETED|Overall Study||8
220603|NCT01198587|533703|P4|COMPLETED|Overall Study||5
220604|NCT01198587|533704|P3|COMPLETED|Overall Study||21
220605|NCT01198587|533705|P2|COMPLETED|Overall Study||5
220606|NCT01198587|533706|P1|COMPLETED|Overall Study||23
220607|NCT01198587|533703|P4|STARTED|Overall Study||5
220608|NCT01198587|533704|P3|STARTED|Overall Study||30
220609|NCT01198587|533705|P2|STARTED|Overall Study||5
220610|NCT01198587|533706|P1|STARTED|Overall Study||31
220611|NCT01198574|533728|P4|NOT COMPLETED|Overall Study||4
220612|NCT01198574|533729|P3|NOT COMPLETED|Overall Study||1
220613|NCT01198574|533730|P2|NOT COMPLETED|Overall Study||1
220614|NCT01198574|533731|P1|NOT COMPLETED|Overall Study||4
220615|NCT01198574|533728|P4|COMPLETED|Overall Study||98
220616|NCT01198574|533729|P3|COMPLETED|Overall Study||99
220617|NCT01198574|533730|P2|COMPLETED|Overall Study||101
220618|NCT01198574|533731|P1|COMPLETED|Overall Study||94
220619|NCT01198574|533728|P4|STARTED|Overall Study||102
220620|NCT01198574|533729|P3|STARTED|Overall Study||100
220621|NCT01198574|533730|P2|STARTED|Overall Study||102
220622|NCT01198574|533731|P1|STARTED|Overall Study||98
220623|NCT01198548|533749|P1|NOT COMPLETED|Overall Study||10
220624|NCT01198548|533749|P1|COMPLETED|Overall Study||0
220625|NCT01198548|533749|P1|STARTED|Overall Study||10
220626|NCT01198509|533764|P6|NOT COMPLETED|Overall Study||0
220627|NCT01198509|533765|P5|NOT COMPLETED|Overall Study||0
220628|NCT01198509|533766|P4|NOT COMPLETED|Overall Study||0
220629|NCT01198509|533767|P3|NOT COMPLETED|Overall Study||0
220630|NCT01198509|533768|P2|NOT COMPLETED|Overall Study||0
220631|NCT01198509|533769|P1|NOT COMPLETED|Overall Study||1
220632|NCT01198509|533764|P6|COMPLETED|Overall Study||58
220633|NCT01198509|533765|P5|COMPLETED|Overall Study||20
220634|NCT01198509|533766|P4|COMPLETED|Overall Study||66
220635|NCT01198509|533767|P3|COMPLETED|Overall Study||19
220636|NCT01198509|533768|P2|COMPLETED|Overall Study||10
220637|NCT01198509|533769|P1|COMPLETED|Overall Study|Patient declined further participation after enrollment and allocation to treatment group|4
220638|NCT01198509|533764|P6|STARTED|Overall Study||58
220639|NCT01198509|533765|P5|STARTED|Overall Study||20
220640|NCT01198509|533766|P4|STARTED|Overall Study||66
220641|NCT01198509|533767|P3|STARTED|Overall Study||19
220642|NCT01198509|533768|P2|STARTED|Overall Study||10
220643|NCT01198509|533769|P1|STARTED|Overall Study||5
220644|NCT01198470|533786|P1|NOT COMPLETED|Overall Study||2
220645|NCT01198470|533786|P1|COMPLETED|Overall Study||18
220646|NCT01198470|533786|P1|STARTED|Overall Study||20
220647|NCT01198366|533799|P6|NOT COMPLETED|Overall Study||13
220648|NCT01198366|533800|P5|NOT COMPLETED|Overall Study||15
220649|NCT01198366|533801|P4|NOT COMPLETED|Overall Study||5
220650|NCT01198366|533802|P3|NOT COMPLETED|Overall Study||8
220651|NCT01198366|533803|P2|NOT COMPLETED|Overall Study||7
220652|NCT01198366|533804|P1|NOT COMPLETED|Overall Study||12
220653|NCT01198366|533799|P6|COMPLETED|Overall Study||128
220654|NCT01198366|533800|P5|COMPLETED|Overall Study||125
220655|NCT01198366|533801|P4|COMPLETED|Overall Study||47
220656|NCT01198366|533802|P3|COMPLETED|Overall Study||43
220657|NCT01198366|533803|P2|COMPLETED|Overall Study||44
220658|NCT01198366|533804|P1|COMPLETED|Overall Study||40
220659|NCT01198366|533799|P6|STARTED|Overall Study||141
220660|NCT01198366|533800|P5|STARTED|Overall Study||140
220661|NCT01198366|533801|P4|STARTED|Overall Study||52
220662|NCT01198366|533802|P3|STARTED|Overall Study||51
220663|NCT01198366|533803|P2|STARTED|Overall Study||51
220664|NCT01198366|533804|P1|STARTED|Overall Study||52
220665|NCT01198327|533842|P1|NOT COMPLETED|Overall Study||10
220666|NCT01198327|533842|P1|COMPLETED|Overall Study||56
220667|NCT01198327|533842|P1|STARTED|Overall Study||66
220668|NCT01198275|533852|P2|NOT COMPLETED|Overall Study||5
220669|NCT01198275|533853|P1|NOT COMPLETED|Overall Study||6
220670|NCT01198275|533852|P2|COMPLETED|Overall Study||94
220671|NCT01198275|533853|P1|COMPLETED|Overall Study||94
220672|NCT01198275|533852|P2|STARTED|Overall Study||99
220673|NCT01198275|533853|P1|STARTED|Overall Study||100
220674|NCT01198158|533861|P2|NOT COMPLETED|Overall Study||0
220675|NCT01198158|533862|P1|NOT COMPLETED|Overall Study||0
220676|NCT01198158|533861|P2|COMPLETED|Overall Study||36
220677|NCT01198158|533862|P1|COMPLETED|Overall Study||41
220678|NCT01198158|533861|P2|STARTED|Overall Study||36
220679|NCT01198158|533862|P1|STARTED|Overall Study||41
220680|NCT01198145|533876|P2|NOT COMPLETED|Overall Study||1
220681|NCT01198145|533877|P1|NOT COMPLETED|Overall Study||1
220682|NCT01198145|533876|P2|COMPLETED|Overall Study||42
220683|NCT01198145|533877|P1|COMPLETED|Overall Study||43
220684|NCT01198145|533876|P2|STARTED|Overall Study||43
220685|NCT01198145|533877|P1|STARTED|Overall Study||44
220686|NCT01198132|533899|P2|NOT COMPLETED|Overall Study||21
220687|NCT01198132|533900|P1|NOT COMPLETED|Overall Study||18
220688|NCT01198132|533899|P2|COMPLETED|Overall Study||45
220689|NCT01198132|533900|P1|COMPLETED|Overall Study||45
220690|NCT01198132|533899|P2|STARTED|Overall Study||66
220691|NCT01198132|533900|P1|STARTED|Overall Study||63
220692|NCT01198002|533927|P3|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||78
220693|NCT01198002|533928|P2|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||73
220694|NCT01198002|533929|P1|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||69
220695|NCT01198002|533927|P3|COMPLETED|Treatment Period 2 (Weeks 52-100)||2
220696|NCT01198002|533928|P2|COMPLETED|Treatment Period 2 (Weeks 52-100)||0
220697|NCT01198002|533929|P1|COMPLETED|Treatment Period 2 (Weeks 52-100)||1
220698|NCT01198002|533927|P3|STARTED|Treatment Period 2 (Weeks 52-100)||80
220699|NCT01198002|533928|P2|STARTED|Treatment Period 2 (Weeks 52-100)||73
220700|NCT01198002|533929|P1|STARTED|Treatment Period 2 (Weeks 52-100)||70
220701|NCT01198002|533927|P3|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||269
220702|NCT01198002|533928|P2|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||274
220703|NCT01198002|533929|P1|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||275
220704|NCT01198002|533927|P3|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|80
220705|NCT01198002|533928|P2|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|73
220706|NCT01198002|533929|P1|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|70
220707|NCT01198002|533927|P3|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||307
220708|NCT01198002|533928|P2|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||303
220709|NCT01198002|533929|P1|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||293
220710|NCT01198002|533927|P3|Week 16 NR|Treatment Period 1 (Weeks 0-52)||90
220711|NCT01198002|533928|P2|Week 16 NR|Treatment Period 1 (Weeks 0-52)||62
220712|NCT01198002|533929|P1|Week 16 NR|Treatment Period 1 (Weeks 0-52)||58
220713|NCT01198002|533927|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||348
220714|NCT01198002|533928|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
220715|NCT01198002|533929|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
220716|NCT01198002|533927|P3|STARTED|Treatment Period 1 (Weeks 0-52)||349
220717|NCT01198002|533928|P2|STARTED|Treatment Period 1 (Weeks 0-52)||347
220718|NCT01198002|533929|P1|STARTED|Treatment Period 1 (Weeks 0-52)||345
220719|NCT01197911|534044|P3|NOT COMPLETED|Overall Study||1
220720|NCT01197911|534045|P2|NOT COMPLETED|Overall Study||0
220721|NCT01197911|534046|P1|NOT COMPLETED|Overall Study||0
220722|NCT01197911|534044|P3|COMPLETED|Overall Study||9
220723|NCT01197911|534045|P2|COMPLETED|Overall Study||10
220724|NCT01197911|534046|P1|COMPLETED|Overall Study||18
220725|NCT01197911|534044|P3|STARTED|Overall Study||10
220726|NCT01197911|534045|P2|STARTED|Overall Study||10
220727|NCT01197911|534046|P1|STARTED|Overall Study||18
220728|NCT01197898|534131|P2|NOT COMPLETED|Overall Study||0
220729|NCT01197898|534132|P1|NOT COMPLETED|Overall Study||0
220730|NCT01197898|534131|P2|COMPLETED|Overall Study||5
220731|NCT01197898|534132|P1|COMPLETED|Overall Study||5
220732|NCT01197898|534131|P2|STARTED|Overall Study||5
220733|NCT01197898|534132|P1|STARTED|Overall Study||5
220734|NCT01197833|534141|P3|NOT COMPLETED|Overall Study||0
220735|NCT01197833|534142|P2|NOT COMPLETED|Overall Study||0
220736|NCT01197833|534143|P1|NOT COMPLETED|Overall Study||0
220737|NCT01197833|534141|P3|COMPLETED|Overall Study||40
220738|NCT01197833|534142|P2|COMPLETED|Overall Study||39
220739|NCT01197833|534143|P1|COMPLETED|Overall Study||38
220740|NCT01197833|534141|P3|STARTED|Overall Study||40
220741|NCT01197833|534142|P2|STARTED|Overall Study||39
220742|NCT01197833|534143|P1|STARTED|Overall Study||38
220743|NCT01197794|534161|P7|NOT COMPLETED|Overall Study||21
220744|NCT01197794|534162|P6|NOT COMPLETED|Overall Study||19
220745|NCT01197794|534163|P5|NOT COMPLETED|Overall Study||14
220746|NCT01197794|534164|P4|NOT COMPLETED|Overall Study||12
220747|NCT01197794|534165|P3|NOT COMPLETED|Overall Study||13
220748|NCT01197794|534166|P2|NOT COMPLETED|Overall Study||15
220749|NCT01197794|534167|P1|NOT COMPLETED|Overall Study||16
220750|NCT01197794|534161|P7|COMPLETED|Overall Study||142
220751|NCT01197794|534162|P6|COMPLETED|Overall Study||144
220752|NCT01197794|534163|P5|COMPLETED|Overall Study||149
220753|NCT01197794|534164|P4|COMPLETED|Overall Study||152
220754|NCT01197794|534165|P3|COMPLETED|Overall Study||153
220755|NCT01197794|534166|P2|COMPLETED|Overall Study||146
220756|NCT01197794|534167|P1|COMPLETED|Overall Study||148
220757|NCT01197794|534161|P7|STARTED|Overall Study|Two participants excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
220758|NCT01197794|534162|P6|STARTED|Overall Study||163
220759|NCT01197794|534163|P5|STARTED|Overall Study|One participant excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
220760|NCT01197794|534164|P4|STARTED|Overall Study||164
220761|NCT01197794|534165|P3|STARTED|Overall Study|Two participants did not receive study treatment|166
220762|NCT01197794|534166|P2|STARTED|Overall Study|Two participants did not receive study treatment|161
220763|NCT01197794|534167|P1|STARTED|Overall Study||164
220764|NCT01197755|534249|P3|NOT COMPLETED|Overall Study||54
220765|NCT01197755|534250|P2|NOT COMPLETED|Overall Study||43
220766|NCT01197755|534251|P1|NOT COMPLETED|Overall Study||38
220767|NCT01197755|534249|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|55
220768|NCT01197755|534250|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|65
220769|NCT01197755|534251|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|67
220770|NCT01197755|534249|P3|Randomised But Did Not Receive Treatment|Overall Study|Severe non-compliance to the protocol|1
220771|NCT01197755|534250|P2|Randomised But Did Not Receive Treatment|Overall Study||0
220772|NCT01197755|534251|P1|Randomised But Did Not Receive Treatment|Overall Study||0
220773|NCT01197755|534249|P3|STARTED|Overall Study|Patients who received treatment|109
220774|NCT01197755|534250|P2|STARTED|Overall Study|Patients who received treatment|108
220775|NCT01197755|534251|P1|STARTED|Overall Study|Patients who received treatment|105
220776|NCT01197612|534291|P1|NOT COMPLETED|Overall Study||12
220777|NCT01197612|534291|P1|COMPLETED|Overall Study||6
220778|NCT01197612|534291|P1|Returned for Week 24|Overall Study||6
220779|NCT01197612|534291|P1|Week 3|Overall Study||16
220780|NCT01197612|534291|P1|STARTED|Overall Study||18
220781|NCT01197573|534306|P4|NOT COMPLETED|Overall Study||0
220782|NCT01197573|534307|P3|NOT COMPLETED|Overall Study||0
220783|NCT01197573|534308|P2|NOT COMPLETED|Overall Study||0
220784|NCT01197573|534309|P1|NOT COMPLETED|Overall Study||0
220785|NCT01197573|534306|P4|COMPLETED|Overall Study||12
220786|NCT01197573|534307|P3|COMPLETED|Overall Study||12
220787|NCT01197573|534308|P2|COMPLETED|Overall Study||46
220788|NCT01197573|534309|P1|COMPLETED|Overall Study||33
220789|NCT01197573|534306|P4|STARTED|Overall Study||12
220790|NCT01197573|534307|P3|STARTED|Overall Study||12
220791|NCT01197573|534308|P2|STARTED|Overall Study||46
220792|NCT01197573|534309|P1|STARTED|Overall Study||33
220793|NCT01197560|534323|P2|NOT COMPLETED|Overall Study||53
220794|NCT01197560|534324|P1|NOT COMPLETED|Overall Study||54
220795|NCT01197560|534323|P2|COMPLETED|Overall Study||4
220796|NCT01197560|534324|P1|COMPLETED|Overall Study||0
220797|NCT01197560|534323|P2|Discontinued Treatment After ≥ 6 Cycles|Overall Study||0
220798|NCT01197560|534324|P1|Discontinued Treatment After ≥ 6 Cycles|Overall Study||14
220799|NCT01197560|534323|P2|Lenalidomide Crossover|Overall Study||29
220800|NCT01197560|534324|P1|Lenalidomide Crossover|Overall Study||0
220801|NCT01197560|534323|P2|Received ≥ One Dose Study Drug|Overall Study||55
220802|NCT01197560|534324|P1|Received ≥ One Dose Study Drug|Overall Study||54
220803|NCT01197560|534323|P2|STARTED|Overall Study|This is the intent to treat population|57
220804|NCT01197560|534324|P1|STARTED|Overall Study|This is the intent to treat population|54
220805|NCT01197547|534362|P1|NOT COMPLETED|Overall Study||22
220806|NCT01197547|534362|P1|COMPLETED|Overall Study|992 Intent-To-Treat (ITT) 931 evaluable subjects|992
220807|NCT01197547|534362|P1|STARTED|Overall Study||1014
220808|NCT01197534|534371|P3|NOT COMPLETED|Overall Study||173
220809|NCT01197534|534372|P2|NOT COMPLETED|Overall Study||130
220810|NCT01197534|534373|P1|NOT COMPLETED|Overall Study||134
220811|NCT01197534|534371|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|129
220812|NCT01197534|534372|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|168
220813|NCT01197534|534373|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|174
220814|NCT01197534|534371|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled / Severe non-compliance to protocol|3
220815|NCT01197534|534372|P2|Randomised But Did Not Receive Treatment|Overall Study|Adverse event / Other|2
220816|NCT01197534|534373|P1|Randomised But Did Not Receive Treatment|Overall Study||0
220817|NCT01197534|534371|P3|STARTED|Overall Study|Patients who received treatment|302
220818|NCT01197534|534372|P2|STARTED|Overall Study|Patients who received treatment|298
220819|NCT01197534|534373|P1|STARTED|Overall Study|Patients who received treatment|308
220820|NCT01197521|534417|P3|NOT COMPLETED|Overall Study||143
220821|NCT01197521|534418|P2|NOT COMPLETED|Overall Study||113
220822|NCT01197521|534419|P1|NOT COMPLETED|Overall Study||103
220823|NCT01197521|534417|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|161
220824|NCT01197521|534418|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|191
220825|NCT01197521|534419|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|207
220826|NCT01197521|534417|P3|Randomised But Did Not Receive Treatment|Overall Study|Adverse event/eligibility criteria not fulfilled|2
220827|NCT01197521|534418|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/other|2
220828|NCT01197521|534419|P1|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
220829|NCT01197521|534417|P3|STARTED|Overall Study|Patients who received treatment|304
220830|NCT01197521|534418|P2|STARTED|Overall Study|Patients who received treatment|304
220831|NCT01197521|534419|P1|STARTED|Overall Study|Patients who received treatment|310
220832|NCT01197508|534464|P4|NOT COMPLETED|Overall Study||16
220833|NCT01197508|534465|P3|NOT COMPLETED|Overall Study||49
220834|NCT01197508|534466|P2|NOT COMPLETED|Overall Study||30
220835|NCT01197508|534467|P1|NOT COMPLETED|Overall Study||23
220836|NCT01197508|534464|P4|COMPLETED|Overall Study||158
220837|NCT01197508|534465|P3|COMPLETED|Overall Study||125
220838|NCT01197508|534466|P2|COMPLETED|Overall Study||144
220839|NCT01197508|534467|P1|COMPLETED|Overall Study||151
220840|NCT01197508|534464|P4|Received Treatment|Overall Study||174
220841|NCT01197508|534465|P3|Received Treatment|Overall Study||171
220842|NCT01197508|534466|P2|Received Treatment|Overall Study||174
220843|NCT01197508|534467|P1|Received Treatment|Overall Study||174
220844|NCT01197508|534464|P4|STARTED|Overall Study||174
220845|NCT01197508|534465|P3|STARTED|Overall Study||174
220846|NCT01197508|534466|P2|STARTED|Overall Study||174
220847|NCT01197508|534467|P1|STARTED|Overall Study||174
220848|NCT01197495|534563|P2|NOT COMPLETED|Overall Study||7
220849|NCT01197495|534564|P1|NOT COMPLETED|Overall Study||13
220850|NCT01197495|534563|P2|COMPLETED|Overall Study||49
220851|NCT01197495|534564|P1|COMPLETED|Overall Study||144
220852|NCT01197495|534563|P2|STARTED|Overall Study||56
220853|NCT01197495|534564|P1|STARTED|Overall Study||157
220854|NCT01197417|534577|P2|NOT COMPLETED|Overall Study||18
220855|NCT01197417|534578|P1|NOT COMPLETED|Overall Study||8
220856|NCT01197417|534577|P2|COMPLETED|Overall Study||86
220857|NCT01197417|534578|P1|COMPLETED|Overall Study||96
220858|NCT01197417|534577|P2|Received Study Drug|Overall Study||103
220859|NCT01197417|534578|P1|Received Study Drug|Overall Study||101
220860|NCT01197417|534577|P2|STARTED|Overall Study||104
220861|NCT01197417|534578|P1|STARTED|Overall Study||104
220862|NCT01197378|534596|P1|NOT COMPLETED|Overall Study||7
220863|NCT01197378|534596|P1|COMPLETED|Overall Study||53
220864|NCT01197378|534596|P1|Received Treatment|Overall Study||59
220865|NCT01197378|534596|P1|STARTED|Overall Study||60
220866|NCT01197326|534604|P2|NOT COMPLETED|Overall Study||0
220867|NCT01197326|534605|P1|NOT COMPLETED|Overall Study||0
220868|NCT01197326|534604|P2|COMPLETED|Overall Study||209
220869|NCT01197326|534605|P1|COMPLETED|Overall Study||205
220870|NCT01197326|534604|P2|STARTED|Overall Study||209
220871|NCT01197326|534605|P1|STARTED|Overall Study||205
220872|NCT01197300|534615|P2|NOT COMPLETED|Overall Study||2
220873|NCT01197300|534616|P1|NOT COMPLETED|Overall Study||0
220874|NCT01197300|534615|P2|COMPLETED|Overall Study||13
220875|NCT01197300|534616|P1|COMPLETED|Overall Study||10
220876|NCT01197300|534615|P2|STARTED|Overall Study||15
220877|NCT01197300|534616|P1|STARTED|Overall Study||10
220878|NCT01196988|534648|P4|NOT COMPLETED|Overall Study||1
220879|NCT01196988|534649|P3|NOT COMPLETED|Overall Study||25
220880|NCT01196988|534650|P2|NOT COMPLETED|Overall Study||32
220881|NCT01196988|534651|P1|NOT COMPLETED|Overall Study||24
220882|NCT01196988|534648|P4|COMPLETED|Overall Study||276
220883|NCT01196988|534649|P3|COMPLETED|Overall Study||886
220884|NCT01196988|534650|P2|COMPLETED|Overall Study||880
220885|NCT01196988|534651|P1|COMPLETED|Overall Study||891
220886|NCT01196988|534648|P4|STARTED|Overall Study||277
220887|NCT01196988|534649|P3|STARTED|Overall Study||911
220888|NCT01196988|534650|P2|STARTED|Overall Study||912
220889|NCT01196988|534651|P1|STARTED|Overall Study||915
220890|NCT01196975|534745|P5|NOT COMPLETED|Overall Study||13
220891|NCT01196975|534746|P4|NOT COMPLETED|Overall Study||6
220892|NCT01196975|534747|P3|NOT COMPLETED|Overall Study||5
220893|NCT01196975|534748|P2|NOT COMPLETED|Overall Study||9
220894|NCT01196975|534749|P1|NOT COMPLETED|Overall Study||15
220895|NCT01196975|534745|P5|COMPLETED|Overall Study||205
220896|NCT01196975|534746|P4|COMPLETED|Overall Study||207
220897|NCT01196975|534747|P3|COMPLETED|Overall Study||420
220898|NCT01196975|534748|P2|COMPLETED|Overall Study||415
220899|NCT01196975|534749|P1|COMPLETED|Overall Study||408
220900|NCT01196975|534745|P5|STARTED|Overall Study||218
220901|NCT01196975|534746|P4|STARTED|Overall Study||213
220902|NCT01196975|534747|P3|STARTED|Overall Study||425
220903|NCT01196975|534748|P2|STARTED|Overall Study||424
220904|NCT01196975|534749|P1|STARTED|Overall Study||423
220905|NCT01196923|534881|P1|NOT COMPLETED|Overall Study||0
220906|NCT01196923|534881|P1|COMPLETED|Overall Study||20
220907|NCT01196923|534881|P1|STARTED|Overall Study||20
220908|NCT01196871|534891|P6|NOT COMPLETED|Stage 2: Period 2||0
220909|NCT01196871|534892|P5|NOT COMPLETED|Stage 2: Period 2||0
220910|NCT01196871|534893|P4|NOT COMPLETED|Stage 2: Period 2||0
220911|NCT01196871|534894|P3|NOT COMPLETED|Stage 2: Period 2||0
220912|NCT01196871|534895|P2|NOT COMPLETED|Stage 2: Period 2||0
220913|NCT01196871|534896|P1|NOT COMPLETED|Stage 2: Period 2||0
220914|NCT01196871|534891|P6|COMPLETED|Stage 2: Period 2||4
220915|NCT01196871|534892|P5|COMPLETED|Stage 2: Period 2||6
220916|NCT01196871|534893|P4|COMPLETED|Stage 2: Period 2||1
220917|NCT01196871|534894|P3|COMPLETED|Stage 2: Period 2||0
220918|NCT01196871|534895|P2|COMPLETED|Stage 2: Period 2||0
220919|NCT01196871|534896|P1|COMPLETED|Stage 2: Period 2||0
220920|NCT01196871|534891|P6|PK Population|Stage 2: Period 2||4
220921|NCT01196871|534892|P5|PK Population|Stage 2: Period 2||6
220922|NCT01196871|534893|P4|PK Population|Stage 2: Period 2||1
220923|NCT01196871|534894|P3|PK Population|Stage 2: Period 2||0
220924|NCT01196871|534895|P2|PK Population|Stage 2: Period 2||0
220925|NCT01196871|534896|P1|PK Population|Stage 2: Period 2||0
220926|NCT01196871|534891|P6|STARTED|Stage 2: Period 2||4
220927|NCT01196871|534892|P5|STARTED|Stage 2: Period 2|One participant switched agalsidase dose from 0.5 mg/kg in Period 1 to 1.0 mg/kg in Period 2|6
220928|NCT01196871|534893|P4|STARTED|Stage 2: Period 2|One participant switched agalsidase dose from 0.5 mg/kg in Period 1 to 1.0 mg/kg in Period 2|1
220929|NCT01196871|534894|P3|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
220930|NCT01196871|534895|P2|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
220931|NCT01196871|534896|P1|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
220932|NCT01196871|534891|P6|NOT COMPLETED|Stage 2: Period 1||0
220933|NCT01196871|534892|P5|NOT COMPLETED|Stage 2: Period 1||0
220934|NCT01196871|534893|P4|NOT COMPLETED|Stage 2: Period 1||0
220935|NCT01196871|534894|P3|NOT COMPLETED|Stage 2: Period 1||0
220936|NCT01196871|534895|P2|NOT COMPLETED|Stage 2: Period 1||0
220937|NCT01196871|534896|P1|NOT COMPLETED|Stage 2: Period 1||0
220938|NCT01196871|534891|P6|COMPLETED|Stage 2: Period 1||4
220939|NCT01196871|534892|P5|COMPLETED|Stage 2: Period 1||5
220940|NCT01196871|534893|P4|COMPLETED|Stage 2: Period 1||2
220941|NCT01196871|534894|P3|COMPLETED|Stage 2: Period 1||0
220942|NCT01196871|534895|P2|COMPLETED|Stage 2: Period 1||0
220943|NCT01196871|534896|P1|COMPLETED|Stage 2: Period 1||0
220944|NCT01196871|534891|P6|PK Population|Stage 2: Period 1||4
220945|NCT01196871|534892|P5|PK Population|Stage 2: Period 1||5
220946|NCT01196871|534893|P4|PK Population|Stage 2: Period 1||1
220947|NCT01196871|534894|P3|PK Population|Stage 2: Period 1||0
220948|NCT01196871|534895|P2|PK Population|Stage 2: Period 1||0
220949|NCT01196871|534896|P1|PK Population|Stage 2: Period 1||0
220950|NCT01196871|534891|P6|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||4
220951|NCT01196871|534892|P5|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||5
220952|NCT01196871|534893|P4|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||2
220953|NCT01196871|534894|P3|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
220954|NCT01196871|534895|P2|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
220955|NCT01196871|534896|P1|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
220956|NCT01196871|534891|P6|STARTED|Stage 2: Period 1||4
220957|NCT01196871|534892|P5|STARTED|Stage 2: Period 1|One participant re-enrolled into Stage 2 after completing Stage 1|5
220958|NCT01196871|534893|P4|STARTED|Stage 2: Period 1|Both participants re-enrolled into Stage 2 after completing Stage 1|2
220959|NCT01196871|534894|P3|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
220960|NCT01196871|534895|P2|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
220961|NCT01196871|534896|P1|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
220962|NCT01196871|534891|P6|NOT COMPLETED|Stage 1: Period 3||0
220963|NCT01196871|534892|P5|NOT COMPLETED|Stage 1: Period 3||0
220964|NCT01196871|534893|P4|NOT COMPLETED|Stage 1: Period 3||0
220965|NCT01196871|534894|P3|NOT COMPLETED|Stage 1: Period 3||0
220966|NCT01196871|534895|P2|NOT COMPLETED|Stage 1: Period 3||0
220967|NCT01196871|534896|P1|NOT COMPLETED|Stage 1: Period 3||0
220968|NCT01196871|534891|P6|COMPLETED|Stage 1: Period 3||0
220969|NCT01196871|534892|P5|COMPLETED|Stage 1: Period 3||0
220970|NCT01196871|534893|P4|COMPLETED|Stage 1: Period 3||0
220971|NCT01196871|534894|P3|COMPLETED|Stage 1: Period 3||4
220972|NCT01196871|534895|P2|COMPLETED|Stage 1: Period 3||3
220973|NCT01196871|534896|P1|COMPLETED|Stage 1: Period 3||5
220974|NCT01196871|534891|P6|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
220975|NCT01196871|534892|P5|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
220976|NCT01196871|534893|P4|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
220977|NCT01196871|534894|P3|STARTED|Stage 1: Period 3||4
220978|NCT01196871|534895|P2|STARTED|Stage 1: Period 3||3
220979|NCT01196871|534896|P1|STARTED|Stage 1: Period 3||5
220980|NCT01196871|534891|P6|NOT COMPLETED|Stage 1: Period 2||0
220981|NCT01196871|534892|P5|NOT COMPLETED|Stage 1: Period 2||0
220982|NCT01196871|534893|P4|NOT COMPLETED|Stage 1: Period 2||0
220983|NCT01196871|534894|P3|NOT COMPLETED|Stage 1: Period 2||0
220984|NCT01196871|534895|P2|NOT COMPLETED|Stage 1: Period 2||0
220985|NCT01196871|534896|P1|NOT COMPLETED|Stage 1: Period 2||0
220986|NCT01196871|534891|P6|COMPLETED|Stage 1: Period 2||0
220987|NCT01196871|534892|P5|COMPLETED|Stage 1: Period 2||0
220988|NCT01196871|534893|P4|COMPLETED|Stage 1: Period 2||0
220989|NCT01196871|534894|P3|COMPLETED|Stage 1: Period 2||4
220990|NCT01196871|534895|P2|COMPLETED|Stage 1: Period 2||3
220991|NCT01196871|534896|P1|COMPLETED|Stage 1: Period 2||5
220992|NCT01196871|534891|P6|PK Population|Stage 1: Period 2||0
220993|NCT01196871|534892|P5|PK Population|Stage 1: Period 2||0
220994|NCT01196871|534893|P4|PK Population|Stage 1: Period 2||0
220995|NCT01196871|534894|P3|PK Population|Stage 1: Period 2||4
220996|NCT01196871|534895|P2|PK Population|Stage 1: Period 2||3
220997|NCT01196871|534896|P1|PK Population|Stage 1: Period 2||5
220998|NCT01196871|534891|P6|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
220999|NCT01196871|534892|P5|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
221000|NCT01196871|534893|P4|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
221001|NCT01196871|534894|P3|STARTED|Stage 1: Period 2||4
221002|NCT01196871|534895|P2|STARTED|Stage 1: Period 2||3
221003|NCT01196871|534896|P1|STARTED|Stage 1: Period 2||5
221004|NCT01196871|534891|P6|NOT COMPLETED|Stage 1: Period 1||0
221005|NCT01196871|534892|P5|NOT COMPLETED|Stage 1: Period 1||0
221006|NCT01196871|534893|P4|NOT COMPLETED|Stage 1: Period 1||0
221007|NCT01196871|534894|P3|NOT COMPLETED|Stage 1: Period 1||0
221008|NCT01196871|534895|P2|NOT COMPLETED|Stage 1: Period 1||0
221009|NCT01196871|534896|P1|NOT COMPLETED|Stage 1: Period 1||0
221010|NCT01196871|534891|P6|COMPLETED|Stage 1: Period 1||0
221011|NCT01196871|534892|P5|COMPLETED|Stage 1: Period 1||0
221012|NCT01196871|534893|P4|COMPLETED|Stage 1: Period 1||0
221013|NCT01196871|534894|P3|COMPLETED|Stage 1: Period 1||4
221014|NCT01196871|534895|P2|COMPLETED|Stage 1: Period 1||3
221015|NCT01196871|534896|P1|COMPLETED|Stage 1: Period 1||5
221016|NCT01196871|534891|P6|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
221017|NCT01196871|534892|P5|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
221018|NCT01196871|534893|P4|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
221019|NCT01196871|534894|P3|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||4
221020|NCT01196871|534895|P2|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||3
221021|NCT01196871|534896|P1|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||5
221022|NCT01196871|534891|P6|PK Population|Stage 1: Period 1||0
221023|NCT01196871|534892|P5|PK Population|Stage 1: Period 1||0
221024|NCT01196871|534893|P4|PK Population|Stage 1: Period 1||0
221025|NCT01196871|534894|P3|PK Population|Stage 1: Period 1||4
221026|NCT01196871|534895|P2|PK Population|Stage 1: Period 1||3
221027|NCT01196871|534896|P1|PK Population|Stage 1: Period 1||5
221028|NCT01196871|534891|P6|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
221029|NCT01196871|534892|P5|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
221030|NCT01196871|534893|P4|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
221031|NCT01196871|534894|P3|STARTED|Stage 1: Period 1||4
221032|NCT01196871|534895|P2|STARTED|Stage 1: Period 1||3
221033|NCT01196871|534896|P1|STARTED|Stage 1: Period 1||5
221034|NCT01196819|534981|P2|NOT COMPLETED|Overall Study||0
221035|NCT01196819|534982|P1|NOT COMPLETED|Overall Study||6
221036|NCT01196819|534981|P2|COMPLETED|Overall Study||227
221037|NCT01196819|534982|P1|COMPLETED|Overall Study||225
221038|NCT01196819|534981|P2|STARTED|Overall Study||227
221039|NCT01196819|534982|P1|STARTED|Overall Study||231
221040|NCT01196793|535002|P1|NOT COMPLETED|Overall Study||0
221041|NCT01196793|535002|P1|COMPLETED|Overall Study||108
221042|NCT01196793|535002|P1|STARTED|Overall Study||108
221043|NCT01196741|535008|P2|NOT COMPLETED|Overall Study||28
221044|NCT01196741|535009|P1|NOT COMPLETED|Overall Study||60
221045|NCT01196741|535008|P2|COMPLETED|Overall Study||8
221046|NCT01196741|535009|P1|COMPLETED|Overall Study||11
221047|NCT01196741|535008|P2|STARTED|Overall Study||36
221048|NCT01196741|535009|P1|STARTED|Overall Study||71
221049|NCT01196533|535023|P1|NOT COMPLETED|Overall Study||0
221050|NCT01196533|535023|P1|COMPLETED|Overall Study||94
221051|NCT01196533|535023|P1|STARTED|Overall Study||94
221052|NCT01196442|535027|P1|NOT COMPLETED|Overall Study||0
221053|NCT01196442|535027|P1|COMPLETED|Overall Study||39
221054|NCT01196442|535027|P1|STARTED|Overall Study||39
221055|NCT01196429|535039|P2|NOT COMPLETED|Overall Study||0
221056|NCT01196429|535040|P1|NOT COMPLETED|Overall Study||3
221057|NCT01196429|535039|P2|COMPLETED|Overall Study||45
221058|NCT01196429|535040|P1|COMPLETED|Overall Study||42
221059|NCT01196429|535039|P2|STARTED|Overall Study||45
221060|NCT01196429|535040|P1|STARTED|Overall Study||45
221061|NCT01196416|535056|P1|NOT COMPLETED|Overall Study||2
221062|NCT01196416|535056|P1|COMPLETED|Overall Study||12
221063|NCT01196416|535056|P1|STARTED|Overall Study||14
221064|NCT01196377|535074|P4|NOT COMPLETED|Overall Study||0
221065|NCT01196377|535075|P3|NOT COMPLETED|Overall Study||0
221066|NCT01196377|535076|P2|NOT COMPLETED|Overall Study||0
221067|NCT01196377|535077|P1|NOT COMPLETED|Overall Study||0
221068|NCT01196377|535074|P4|COMPLETED|Overall Study||4
221069|NCT01196377|535075|P3|COMPLETED|Overall Study||4
221070|NCT01196377|535076|P2|COMPLETED|Overall Study||4
221071|NCT01196377|535077|P1|COMPLETED|Overall Study||4
221072|NCT01196377|535074|P4|STARTED|Overall Study||4
221073|NCT01196377|535075|P3|STARTED|Overall Study||4
221074|NCT01196377|535076|P2|STARTED|Overall Study||4
221075|NCT01196377|535077|P1|STARTED|Overall Study||4
221076|NCT01196104|535089|P2|NOT COMPLETED|Overall Study||5
221077|NCT01196104|535090|P1|NOT COMPLETED|Overall Study||4
221078|NCT01196104|535089|P2|COMPLETED|Overall Study||15
221079|NCT01196104|535090|P1|COMPLETED|Overall Study||15
221080|NCT01196104|535089|P2|STARTED|Overall Study||20
221081|NCT01196104|535090|P1|STARTED|Overall Study||19
221082|NCT01196091|535133|P3|NOT COMPLETED|Overall Study||104
221083|NCT01196091|535134|P2|NOT COMPLETED|Overall Study||98
221084|NCT01196091|535135|P1|NOT COMPLETED|Overall Study||88
221085|NCT01196091|535133|P3|COMPLETED|Overall Study||284
221086|NCT01196091|535134|P2|COMPLETED|Overall Study||291
221087|NCT01196091|535135|P1|COMPLETED|Overall Study||299
221088|NCT01196091|535133|P3|Follow-Up|Overall Study||128
221089|NCT01196091|535134|P2|Follow-Up|Overall Study||105
221090|NCT01196091|535135|P1|Follow-Up|Overall Study||103
221091|NCT01196091|535133|P3|ITT-Received Drug and Excluded Sites|Overall Study||379
221092|NCT01196091|535134|P2|ITT-Received Drug and Excluded Sites|Overall Study||378
221093|NCT01196091|535135|P1|ITT-Received Drug and Excluded Sites|Overall Study||381
221094|NCT01196091|535133|P3|Received at Least 1 Dose of Study Drug|Overall Study||387
221095|NCT01196091|535134|P2|Received at Least 1 Dose of Study Drug|Overall Study||389
221096|NCT01196091|535135|P1|Received at Least 1 Dose of Study Drug|Overall Study||386
221097|NCT01196091|535133|P3|STARTED|Overall Study||388
221098|NCT01196091|535134|P2|STARTED|Overall Study||389
221099|NCT01196091|535135|P1|STARTED|Overall Study||387
221100|NCT01196078|535187|P2|NOT COMPLETED|Overall Study||37
221101|NCT01196078|535188|P1|NOT COMPLETED|Overall Study||33
221102|NCT01196078|535187|P2|COMPLETED|Overall Study||20
221103|NCT01196078|535188|P1|COMPLETED|Overall Study||24
221104|NCT01196078|535187|P2|STARTED|Overall Study||57
221105|NCT01196078|535188|P1|STARTED|Overall Study||57
221106|NCT01196052|535216|P1|NOT COMPLETED|Overall Study||23
221107|NCT01196052|535216|P1|COMPLETED|Overall Study||130
221108|NCT01196052|535216|P1|Received Trastuzumab Emtansine|Overall Study||148
221109|NCT01196052|535216|P1|STARTED|Overall Study||153
221110|NCT01196026|535233|P6|NOT COMPLETED|Overall Study||0
221111|NCT01196026|535234|P5|NOT COMPLETED|Overall Study||1
221112|NCT01196026|535235|P4|NOT COMPLETED|Overall Study||0
221113|NCT01196026|535236|P3|NOT COMPLETED|Overall Study||0
221114|NCT01196026|535237|P2|NOT COMPLETED|Overall Study||8
221115|NCT01196026|535238|P1|NOT COMPLETED|Overall Study||1
221116|NCT01196026|535233|P6|COMPLETED|Overall Study||24
221117|NCT01196026|535234|P5|COMPLETED|Overall Study||42
221118|NCT01196026|535235|P4|COMPLETED|Overall Study||10
221119|NCT01196026|535236|P3|COMPLETED|Overall Study||23
221120|NCT01196026|535237|P2|COMPLETED|Overall Study||36
221121|NCT01196026|535238|P1|COMPLETED|Overall Study||9
221122|NCT01196026|535233|P6|Completed at Day 28|Overall Study||24
221123|NCT01196026|535234|P5|Completed at Day 28|Overall Study||42
221124|NCT01196026|535235|P4|Completed at Day 28|Overall Study||10
221125|NCT01196026|535236|P3|Completed at Day 28|Overall Study||23
221126|NCT01196026|535237|P2|Completed at Day 28|Overall Study||41
221127|NCT01196026|535238|P1|Completed at Day 28|Overall Study||9
221128|NCT01196026|535233|P6|STARTED|Overall Study||24
221129|NCT01196026|535234|P5|STARTED|Overall Study||43
221130|NCT01196026|535235|P4|STARTED|Overall Study||10
221131|NCT01196026|535236|P3|STARTED|Overall Study||23
221132|NCT01196026|535237|P2|STARTED|Overall Study||44
221133|NCT01196026|535238|P1|STARTED|Overall Study||10
221134|NCT01195948|535472|P3|NOT COMPLETED|Overall Study||2
221135|NCT01195948|535473|P2|NOT COMPLETED|Overall Study||1
221136|NCT01195948|535474|P1|NOT COMPLETED|Overall Study||0
221137|NCT01195948|535472|P3|COMPLETED|Overall Study||9
221138|NCT01195948|535473|P2|COMPLETED|Overall Study||9
221139|NCT01195948|535474|P1|COMPLETED|Overall Study||10
221140|NCT01195948|535472|P3|Week 24|Overall Study||10
221141|NCT01195948|535473|P2|Week 24|Overall Study||10
221142|NCT01195948|535474|P1|Week 24|Overall Study||10
221143|NCT01195948|535472|P3|STARTED|Overall Study||11
221144|NCT01195948|535473|P2|STARTED|Overall Study||10
221145|NCT01195948|535474|P1|STARTED|Overall Study||10
221146|NCT01195922|535506|P1|NOT COMPLETED|Overall Study||0
221147|NCT01195922|535506|P1|COMPLETED|Overall Study||16
221148|NCT01195922|535506|P1|STARTED|Overall Study||16
221149|NCT01195883|535514|P2|NOT COMPLETED|Overall Study||26
221150|NCT01195883|535515|P1|NOT COMPLETED|Overall Study||19
221151|NCT01195883|535514|P2|COMPLETED|Overall Study||523
221152|NCT01195883|535515|P1|COMPLETED|Overall Study||534
221153|NCT01195883|535514|P2|STARTED|Overall Study||549
221154|NCT01195883|535515|P1|STARTED|Overall Study||553
221155|NCT01195844|535527|P1|NOT COMPLETED|Overall Study||40
221156|NCT01195844|535527|P1|COMPLETED|Overall Study||190
221157|NCT01195844|535527|P1|STARTED|Overall Study||230
221158|NCT01195831|535544|P2|NOT COMPLETED|Overall Study||10
221159|NCT01195831|535545|P1|NOT COMPLETED|Overall Study||8
221160|NCT01195831|535544|P2|COMPLETED|Overall Study||114
221161|NCT01195831|535545|P1|COMPLETED|Overall Study||112
221162|NCT01195831|535544|P2|STARTED|Overall Study||124
221163|NCT01195831|535545|P1|STARTED|Overall Study||120
221164|NCT01195779|535573|P14|NOT COMPLETED|Overall Study||0
221165|NCT01195779|535574|P13|NOT COMPLETED|Overall Study||0
221166|NCT01195779|535575|P12|NOT COMPLETED|Overall Study||0
221167|NCT01195779|535576|P11|NOT COMPLETED|Overall Study||0
221168|NCT01195779|535577|P10|NOT COMPLETED|Overall Study||0
221169|NCT01195779|535578|P9|NOT COMPLETED|Overall Study||0
221170|NCT01195779|535579|P8|NOT COMPLETED|Overall Study||0
221171|NCT01195779|535580|P7|NOT COMPLETED|Overall Study||0
221172|NCT01195779|535581|P6|NOT COMPLETED|Overall Study||0
221173|NCT01195779|535582|P5|NOT COMPLETED|Overall Study||0
221174|NCT01195779|535583|P4|NOT COMPLETED|Overall Study||0
221175|NCT01195779|535584|P3|NOT COMPLETED|Overall Study||0
221176|NCT01195779|535585|P2|NOT COMPLETED|Overall Study||0
221177|NCT01195779|535586|P1|NOT COMPLETED|Overall Study||0
221178|NCT01195779|535573|P14|COMPLETED|Overall Study||1
221179|NCT01195779|535574|P13|COMPLETED|Overall Study||0
221180|NCT01195779|535575|P12|COMPLETED|Overall Study||1
221181|NCT01195779|535576|P11|COMPLETED|Overall Study||0
221182|NCT01195779|535577|P10|COMPLETED|Overall Study||0
221183|NCT01195779|535578|P9|COMPLETED|Overall Study||0
221184|NCT01195779|535579|P8|COMPLETED|Overall Study||1
221185|NCT01195779|535580|P7|COMPLETED|Overall Study||0
221186|NCT01195779|535581|P6|COMPLETED|Overall Study||0
221187|NCT01195779|535582|P5|COMPLETED|Overall Study||1
221188|NCT01195779|535583|P4|COMPLETED|Overall Study||0
221189|NCT01195779|535584|P3|COMPLETED|Overall Study||0
221190|NCT01195779|535585|P2|COMPLETED|Overall Study||0
221191|NCT01195779|535586|P1|COMPLETED|Overall Study||0
221192|NCT01195779|535573|P14|STARTED|Overall Study||1
221193|NCT01195779|535574|P13|STARTED|Overall Study||0
221194|NCT01195779|535575|P12|STARTED|Overall Study||1
221195|NCT01195779|535576|P11|STARTED|Overall Study||0
221196|NCT01195779|535577|P10|STARTED|Overall Study||0
221197|NCT01195779|535578|P9|STARTED|Overall Study||0
221198|NCT01195779|535579|P8|STARTED|Overall Study||1
221199|NCT01195779|535580|P7|STARTED|Overall Study||0
221200|NCT01195779|535581|P6|STARTED|Overall Study||0
221201|NCT01195779|535582|P5|STARTED|Overall Study||1
221202|NCT01195779|535583|P4|STARTED|Overall Study||0
221203|NCT01195779|535584|P3|STARTED|Overall Study||0
221204|NCT01195779|535585|P2|STARTED|Overall Study||0
221205|NCT01195779|535586|P1|STARTED|Overall Study||0
221206|NCT01195701|535758|P2|NOT COMPLETED|Overall Study||5
221207|NCT01195701|535759|P1|NOT COMPLETED|Overall Study||0
221208|NCT01195701|535758|P2|COMPLETED|Overall Study||20
221209|NCT01195701|535759|P1|COMPLETED|Overall Study||10
221210|NCT01195701|535758|P2|STARTED|Overall Study||25
221211|NCT01195701|535759|P1|STARTED|Overall Study||10
221212|NCT01195675|535785|P1|NOT COMPLETED|Overall Study||3
221213|NCT01195675|535785|P1|COMPLETED|Overall Study||27
221214|NCT01195675|535785|P1|Received Placebo 2|Overall Study||28
221215|NCT01195675|535785|P1|Received Placebo 1|Overall Study||29
221216|NCT01195675|535785|P1|Received Moxifloxacin|Overall Study||29
221217|NCT01195675|535785|P1|Received Empa 200mg|Overall Study||30
221218|NCT01195675|535785|P1|Received Empa 25mg|Overall Study||28
221219|NCT01195675|535785|P1|STARTED|Overall Study||30
221220|NCT01195662|535818|P3|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||1
221221|NCT01195662|535819|P2|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||0
221222|NCT01195662|535820|P1|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||3
221223|NCT01195662|535818|P3|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||119
221224|NCT01195662|535819|P2|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||209
221225|NCT01195662|535820|P1|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||200
221226|NCT01195662|535818|P3|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in the study and entered the follow up period.|120
221227|NCT01195662|535819|P2|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|2 participants completed treatment period but chose not to enter follow up period.|209
221228|NCT01195662|535820|P1|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in study and entered Follow-Up.|203
221229|NCT01195662|535818|P3|NOT COMPLETED|Double Blind Treatment Period||14
221230|NCT01195662|535819|P2|NOT COMPLETED|Double Blind Treatment Period||14
221231|NCT01195662|535820|P1|NOT COMPLETED|Double Blind Treatment Period||22
221232|NCT01195662|535818|P3|COMPLETED|Double Blind Treatment Period||119
221233|NCT01195662|535819|P2|COMPLETED|Double Blind Treatment Period||211
221234|NCT01195662|535820|P1|COMPLETED|Double Blind Treatment Period||202
221235|NCT01195662|535818|P3|STARTED|Double Blind Treatment Period||133
221236|NCT01195662|535819|P2|STARTED|Double Blind Treatment Period||225
221237|NCT01195662|535820|P1|STARTED|Double Blind Treatment Period||224
221238|NCT01195636|535850|P2|NOT COMPLETED|Second Intervention (3 Weeks)||2
221239|NCT01195636|535851|P1|NOT COMPLETED|Second Intervention (3 Weeks)||1
221240|NCT01195636|535850|P2|COMPLETED|Second Intervention (3 Weeks)||27
221241|NCT01195636|535851|P1|COMPLETED|Second Intervention (3 Weeks)||27
221242|NCT01195636|535850|P2|STARTED|Second Intervention (3 Weeks)||29
221243|NCT01195636|535851|P1|STARTED|Second Intervention (3 Weeks)||28
221244|NCT01195636|535850|P2|NOT COMPLETED|Washout Period (2 Weeks)||3
221245|NCT01195636|535851|P1|NOT COMPLETED|Washout Period (2 Weeks)||2
221246|NCT01195636|535850|P2|COMPLETED|Washout Period (2 Weeks)||29
221247|NCT01195636|535851|P1|COMPLETED|Washout Period (2 Weeks)||28
221248|NCT01195636|535850|P2|STARTED|Washout Period (2 Weeks)||32
221249|NCT01195636|535851|P1|STARTED|Washout Period (2 Weeks)||30
221250|NCT01195636|535850|P2|NOT COMPLETED|First Intervention (3 Weeks)||3
221251|NCT01195636|535851|P1|NOT COMPLETED|First Intervention (3 Weeks)||5
221252|NCT01195636|535850|P2|COMPLETED|First Intervention (3 Weeks)||32
221253|NCT01195636|535851|P1|COMPLETED|First Intervention (3 Weeks)||30
221254|NCT01195636|535850|P2|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||35
221255|NCT01195636|535851|P1|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||33
221256|NCT01195636|535850|P2|STARTED|First Intervention (3 Weeks)||35
221257|NCT01195636|535851|P1|STARTED|First Intervention (3 Weeks)||35
221258|NCT01195623|535877|P2|NOT COMPLETED|Overall Study||37
221259|NCT01195623|535878|P1|NOT COMPLETED|Overall Study||35
221260|NCT01195623|535877|P2|COMPLETED|Overall Study|129 legs|108
221261|NCT01195623|535878|P1|COMPLETED|Overall Study|127 legs|113
221262|NCT01195623|535877|P2|STARTED|Overall Study|177 legs total operated|145
221263|NCT01195623|535878|P1|STARTED|Overall Study|166 legs total operated|148
221264|NCT01195597|535886|P1|NOT COMPLETED|Overall Study||13
221265|NCT01195597|535886|P1|COMPLETED|Overall Study||27
221266|NCT01195597|535886|P1|STARTED|Overall Study||40
221267|NCT01195584|535894|P3|NOT COMPLETED|Overall Study||0
221268|NCT01195584|535895|P2|NOT COMPLETED|Overall Study||0
221269|NCT01195584|535896|P1|NOT COMPLETED|Overall Study||0
221270|NCT01195584|535894|P3|COMPLETED|Overall Study||27
221271|NCT01195584|535895|P2|COMPLETED|Overall Study||25
221272|NCT01195584|535896|P1|COMPLETED|Overall Study||20
221273|NCT01195584|535894|P3|STARTED|Overall Study||27
221274|NCT01195584|535895|P2|STARTED|Overall Study||25
221275|NCT01195584|535896|P1|STARTED|Overall Study||20
221276|NCT01195545|535907|P1|NOT COMPLETED|Overall Study||4
221277|NCT01195545|535907|P1|COMPLETED|Overall Study||16
221278|NCT01195545|535907|P1|STARTED|Overall Study||20
221279|NCT01195467|535914|P1|NOT COMPLETED|Overall Study||10
221280|NCT01195467|535914|P1|COMPLETED|Overall Study||30
221281|NCT01195467|535914|P1|STARTED|Overall Study||40
221282|NCT01195415|535919|P1|NOT COMPLETED|Overall Study||2
221283|NCT01195415|535919|P1|COMPLETED|Overall Study||23
221284|NCT01195415|535919|P1|STARTED|Overall Study||25
221285|NCT01195363|535928|P2|NOT COMPLETED|Overall Study||9
221286|NCT01195363|535929|P1|NOT COMPLETED|Overall Study||11
221287|NCT01195363|535928|P2|COMPLETED|Overall Study||4
221288|NCT01195363|535929|P1|COMPLETED|Overall Study||4
221289|NCT01195363|535928|P2|STARTED|Overall Study||13
221290|NCT01195363|535929|P1|STARTED|Overall Study||15
221291|NCT01195272|535935|P1|NOT COMPLETED|Overall Study||4
221292|NCT01195272|535935|P1|COMPLETED|Overall Study||17
221293|NCT01195272|535935|P1|STARTED|Overall Study||21
221294|NCT01195116|535954|P2|NOT COMPLETED|Overall Study||0
221295|NCT01195116|535955|P1|NOT COMPLETED|Overall Study||0
221296|NCT01195116|535954|P2|COMPLETED|Overall Study||20
221297|NCT01195116|535955|P1|COMPLETED|Overall Study||21
221298|NCT01195116|535954|P2|STARTED|Overall Study||20
221299|NCT01195116|535955|P1|STARTED|Overall Study||21
221300|NCT01195103|535964|P3|NOT COMPLETED|Overall Study||0
221301|NCT01195103|535965|P2|NOT COMPLETED|Overall Study||0
221302|NCT01195103|535966|P1|NOT COMPLETED|Overall Study||1
221303|NCT01195103|535964|P3|COMPLETED|Overall Study||5
221304|NCT01195103|535965|P2|COMPLETED|Overall Study||2
221305|NCT01195103|535966|P1|COMPLETED|Overall Study|One patient withdrew after randomization but before received study drug.|5
221306|NCT01195103|535964|P3|STARTED|Overall Study||5
221307|NCT01195103|535965|P2|STARTED|Overall Study||2
221308|NCT01195103|535966|P1|STARTED|Overall Study||6
221309|NCT01195090|535976|P2|NOT COMPLETED|Overall Study||8
221310|NCT01195090|535977|P1|NOT COMPLETED|Overall Study||6
221311|NCT01195090|535976|P2|COMPLETED|Overall Study||52
221312|NCT01195090|535977|P1|COMPLETED|Overall Study||54
221313|NCT01195090|535976|P2|STARTED|Overall Study||60
221314|NCT01195090|535977|P1|STARTED|Overall Study||60
221315|NCT01195025|536035|P5|NOT COMPLETED|Third Intervention C||0
221316|NCT01195025|536036|P4|NOT COMPLETED|Third Intervention C||0
221317|NCT01195025|536037|P3|NOT COMPLETED|Third Intervention C||0
221318|NCT01195025|536038|P2|NOT COMPLETED|Third Intervention C||0
221319|NCT01195025|536039|P1|NOT COMPLETED|Third Intervention C||0
221320|NCT01195025|536035|P5|COMPLETED|Third Intervention C||1
221321|NCT01195025|536036|P4|COMPLETED|Third Intervention C||2
221322|NCT01195025|536037|P3|COMPLETED|Third Intervention C||2
221323|NCT01195025|536038|P2|COMPLETED|Third Intervention C||3
221324|NCT01195025|536039|P1|COMPLETED|Third Intervention C||2
221325|NCT01195025|536035|P5|STARTED|Third Intervention C||1
221326|NCT01195025|536036|P4|STARTED|Third Intervention C||2
221327|NCT01195025|536037|P3|STARTED|Third Intervention C||2
221328|NCT01195025|536038|P2|STARTED|Third Intervention C||3
221329|NCT01195025|536039|P1|STARTED|Third Intervention C||2
221330|NCT01195025|536035|P5|NOT COMPLETED|Second Intervention B||0
221331|NCT01195025|536036|P4|NOT COMPLETED|Second Intervention B||0
221332|NCT01195025|536037|P3|NOT COMPLETED|Second Intervention B||0
221333|NCT01195025|536038|P2|NOT COMPLETED|Second Intervention B||0
221334|NCT01195025|536039|P1|NOT COMPLETED|Second Intervention B||0
221335|NCT01195025|536035|P5|COMPLETED|Second Intervention B||1
221336|NCT01195025|536036|P4|COMPLETED|Second Intervention B||2
221337|NCT01195025|536037|P3|COMPLETED|Second Intervention B||2
221338|NCT01195025|536038|P2|COMPLETED|Second Intervention B||3
221339|NCT01195025|536039|P1|COMPLETED|Second Intervention B||2
221340|NCT01195025|536035|P5|STARTED|Second Intervention B||1
221341|NCT01195025|536036|P4|STARTED|Second Intervention B||2
221342|NCT01195025|536037|P3|STARTED|Second Intervention B||2
221343|NCT01195025|536038|P2|STARTED|Second Intervention B||3
221344|NCT01195025|536039|P1|STARTED|Second Intervention B||2
221345|NCT01195025|536035|P5|NOT COMPLETED|First Intervention A||0
221346|NCT01195025|536036|P4|NOT COMPLETED|First Intervention A||0
221347|NCT01195025|536037|P3|NOT COMPLETED|First Intervention A||0
221348|NCT01195025|536038|P2|NOT COMPLETED|First Intervention A||0
221349|NCT01195025|536039|P1|NOT COMPLETED|First Intervention A||0
221350|NCT01195025|536035|P5|COMPLETED|First Intervention A||1
221351|NCT01195025|536036|P4|COMPLETED|First Intervention A||2
221352|NCT01195025|536037|P3|COMPLETED|First Intervention A||2
221353|NCT01195025|536038|P2|COMPLETED|First Intervention A||3
221354|NCT01195025|536039|P1|COMPLETED|First Intervention A||2
221355|NCT01195025|536035|P5|STARTED|First Intervention A||1
221356|NCT01195025|536036|P4|STARTED|First Intervention A||2
221357|NCT01195025|536037|P3|STARTED|First Intervention A||2
221358|NCT01195025|536038|P2|STARTED|First Intervention A||3
221359|NCT01195025|536039|P1|STARTED|First Intervention A||2
221360|NCT01194999|536046|P1|NOT COMPLETED|Overall Study||17
221361|NCT01194999|536046|P1|COMPLETED|Overall Study||115
221362|NCT01194999|536046|P1|STARTED|Overall Study||132
221363|NCT01194973|536050|P1|NOT COMPLETED|26 Week Treatment Period||3
221364|NCT01194973|536050|P1|COMPLETED|26 Week Treatment Period||38
221365|NCT01194973|536050|P1|STARTED|26 Week Treatment Period||41
221366|NCT01194973|536050|P1|NOT COMPLETED|Screening Period||3
221367|NCT01194973|536050|P1|COMPLETED|Screening Period||41
221368|NCT01194973|536050|P1|STARTED|Screening Period||44
221369|NCT01194908|536065|P1|NOT COMPLETED|Overall Study||0
221370|NCT01194908|536065|P1|COMPLETED|Overall Study||5
221371|NCT01194908|536065|P1|STARTED|Overall Study||5
221372|NCT01194869|536070|P1|NOT COMPLETED|Overall Study||4
221373|NCT01194869|536070|P1|COMPLETED|Overall Study||21
221374|NCT01194869|536070|P1|STARTED|Overall Study||25
221375|NCT01194856|536078|P2|NOT COMPLETED|Overall Study||0
221376|NCT01194856|536079|P1|NOT COMPLETED|Overall Study||1
221377|NCT01194856|536078|P2|COMPLETED|Overall Study||0
221378|NCT01194856|536079|P1|COMPLETED|Overall Study||0
221379|NCT01194856|536078|P2|STARTED|Overall Study||0
221380|NCT01194856|536079|P1|STARTED|Overall Study||1
221381|NCT01194830|536101|P2|NOT COMPLETED|Overall Study||27
221382|NCT01194830|536102|P1|NOT COMPLETED|Overall Study||36
221383|NCT01194830|536101|P2|COMPLETED|Overall Study||83
221384|NCT01194830|536102|P1|COMPLETED|Overall Study||88
221385|NCT01194830|536101|P2|STARTED|Overall Study||110
221386|NCT01194830|536102|P1|STARTED|Overall Study||124
221387|NCT01194804|536124|P1|NOT COMPLETED|Overall Study||1
221388|NCT01194804|536124|P1|COMPLETED|Overall Study||26
221389|NCT01194804|536124|P1|STARTED|Overall Study||27
221390|NCT01194674|536132|P1|NOT COMPLETED|Overall Study||0
221391|NCT01194674|536132|P1|COMPLETED|Overall Study||2
221392|NCT01194674|536132|P1|STARTED|Overall Study||2
221393|NCT01194570|536146|P2|NOT COMPLETED|Overall Study||488
221394|NCT01194570|536147|P1|NOT COMPLETED|Overall Study||244
221395|NCT01194570|536146|P2|COMPLETED|Overall Study||0
221396|NCT01194570|536147|P1|COMPLETED|Overall Study|"Reason for discontinuation were provided for Core Treatment Completion."|0
221397|NCT01194570|536146|P2|STARTED|Overall Study||488
221398|NCT01194570|536147|P1|STARTED|Overall Study||244
221399|NCT01194531|536167|P2|NOT COMPLETED|Overall Study||3
221400|NCT01194531|536168|P1|NOT COMPLETED|Overall Study||5
221401|NCT01194531|536167|P2|COMPLETED|Overall Study||27
221402|NCT01194531|536168|P1|COMPLETED|Overall Study||24
221403|NCT01194531|536167|P2|STARTED|Overall Study||30
221404|NCT01194531|536168|P1|STARTED|Overall Study||29
221405|NCT01194479|536176|P4|NOT COMPLETED|Overall Study||0
221406|NCT01194479|536177|P3|NOT COMPLETED|Overall Study||0
221407|NCT01194479|536178|P2|NOT COMPLETED|Overall Study||0
221408|NCT01194479|536179|P1|NOT COMPLETED|Overall Study||0
221409|NCT01194479|536176|P4|COMPLETED|Overall Study||5
221410|NCT01194479|536177|P3|COMPLETED|Overall Study||2
221411|NCT01194479|536178|P2|COMPLETED|Overall Study||4
221412|NCT01194479|536179|P1|COMPLETED|Overall Study||3
221413|NCT01194479|536176|P4|Cross-over at Second Visit|Overall Study||5
221414|NCT01194479|536177|P3|Cross-over at Second Visit|Overall Study||2
221415|NCT01194479|536178|P2|Cross-over at Second Visit|Overall Study||4
221416|NCT01194479|536179|P1|Cross-over at Second Visit|Overall Study||3
221417|NCT01194479|536176|P4|STARTED|Overall Study||5
221418|NCT01194479|536177|P3|STARTED|Overall Study||2
221419|NCT01194479|536178|P2|STARTED|Overall Study||4
221420|NCT01194479|536179|P1|STARTED|Overall Study||3
221421|NCT01194466|536201|P3|NOT COMPLETED|Overall Study||0
221422|NCT01194466|536202|P2|NOT COMPLETED|Overall Study||0
221423|NCT01194466|536203|P1|NOT COMPLETED|Overall Study||0
221424|NCT01194466|536201|P3|COMPLETED|Overall Study||13
221425|NCT01194466|536202|P2|COMPLETED|Overall Study||14
221426|NCT01194466|536203|P1|COMPLETED|Overall Study||14
221427|NCT01194466|536201|P3|STARTED|Overall Study||13
221428|NCT01194466|536202|P2|STARTED|Overall Study||14
221429|NCT01194466|536203|P1|STARTED|Overall Study||14
221430|NCT01194453|536213|P2|NOT COMPLETED|Overall Study||17
221431|NCT01194453|536214|P1|NOT COMPLETED|Overall Study||17
221432|NCT01194453|536213|P2|COMPLETED|Overall Study||127
221433|NCT01194453|536214|P1|COMPLETED|Overall Study||127
221434|NCT01194453|536213|P2|STARTED|Overall Study||144
221435|NCT01194453|536214|P1|STARTED|Overall Study||144
221436|NCT01194440|536222|P1|NOT COMPLETED|6-months (2nd Dose)||4
221437|NCT01194440|536222|P1|COMPLETED|6-months (2nd Dose)||48
221438|NCT01194440|536222|P1|STARTED|6-months (2nd Dose)||52
221439|NCT01194440|536222|P1|NOT COMPLETED|Baseline (First Dose)||7
221440|NCT01194440|536222|P1|COMPLETED|Baseline (First Dose)||52
221441|NCT01194440|536222|P1|STARTED|Baseline (First Dose)||59
221442|NCT01194427|536229|P1|NOT COMPLETED|Overall Study||0
221443|NCT01194427|536229|P1|COMPLETED|Overall Study||2
221444|NCT01194427|536229|P1|STARTED|Overall Study||2
221445|NCT01194414|536235|P4|NOT COMPLETED|72 Weeks Open Label Extension||26
221446|NCT01194414|536236|P3|NOT COMPLETED|72 Weeks Open Label Extension||8
221447|NCT01194414|536237|P2|NOT COMPLETED|72 Weeks Open Label Extension||66
221448|NCT01194414|536238|P1|NOT COMPLETED|72 Weeks Open Label Extension||79
221449|NCT01194414|536235|P4|COMPLETED|72 Weeks Open Label Extension||160
221450|NCT01194414|536236|P3|COMPLETED|72 Weeks Open Label Extension||40
221451|NCT01194414|536237|P2|COMPLETED|72 Weeks Open Label Extension||311
221452|NCT01194414|536238|P1|COMPLETED|72 Weeks Open Label Extension||445
221453|NCT01194414|536235|P4|STARTED|72 Weeks Open Label Extension||186
221454|NCT01194414|536236|P3|STARTED|72 Weeks Open Label Extension||48
221455|NCT01194414|536237|P2|STARTED|72 Weeks Open Label Extension||377
221456|NCT01194414|536238|P1|STARTED|72 Weeks Open Label Extension||524
221457|NCT01194414|536235|P4|NOT COMPLETED|24 Weeks Double Blind Period||0
221458|NCT01194414|536236|P3|NOT COMPLETED|24 Weeks Double Blind Period||0
221459|NCT01194414|536237|P2|NOT COMPLETED|24 Weeks Double Blind Period||67
221460|NCT01194414|536238|P1|NOT COMPLETED|24 Weeks Double Blind Period||59
221461|NCT01194414|536235|P4|COMPLETED|24 Weeks Double Blind Period||0
221462|NCT01194414|536236|P3|COMPLETED|24 Weeks Double Blind Period||0
221463|NCT01194414|536237|P2|COMPLETED|24 Weeks Double Blind Period||564
221464|NCT01194414|536238|P1|COMPLETED|24 Weeks Double Blind Period||572
221465|NCT01194414|536235|P4|Per Protocol Population|24 Weeks Double Blind Period||0
221466|NCT01194414|536236|P3|Per Protocol Population|24 Weeks Double Blind Period||0
221467|NCT01194414|536237|P2|Per Protocol Population|24 Weeks Double Blind Period||537
221468|NCT01194414|536238|P1|Per Protocol Population|24 Weeks Double Blind Period||558
221469|NCT01194414|536235|P4|STARTED|24 Weeks Double Blind Period||0
221470|NCT01194414|536236|P3|STARTED|24 Weeks Double Blind Period||0
221471|NCT01194414|536237|P2|STARTED|24 Weeks Double Blind Period||631
221472|NCT01194414|536238|P1|STARTED|24 Weeks Double Blind Period||631
221473|NCT01194297|536300|P2|NOT COMPLETED|Overall Study||0
221474|NCT01194297|536301|P1|NOT COMPLETED|Overall Study||0
221475|NCT01194297|536300|P2|COMPLETED|Overall Study||1
221476|NCT01194297|536301|P1|COMPLETED|Overall Study||2
221477|NCT01194297|536300|P2|STARTED|Overall Study||1
221478|NCT01194297|536301|P1|STARTED|Overall Study||2
221479|NCT01194258|536309|P5|NOT COMPLETED|Period 2 (12 Weeks)||2
221480|NCT01194258|536310|P4|NOT COMPLETED|Period 2 (12 Weeks)||0
221481|NCT01194258|536311|P3|NOT COMPLETED|Period 2 (12 Weeks)||1
221482|NCT01194258|536312|P2|NOT COMPLETED|Period 2 (12 Weeks)||2
221483|NCT01194258|536313|P1|NOT COMPLETED|Period 2 (12 Weeks)||0
221484|NCT01194258|536309|P5|COMPLETED|Period 2 (12 Weeks)||30
221485|NCT01194258|536310|P4|COMPLETED|Period 2 (12 Weeks)||29
221486|NCT01194258|536311|P3|COMPLETED|Period 2 (12 Weeks)||29
221487|NCT01194258|536312|P2|COMPLETED|Period 2 (12 Weeks)||27
221488|NCT01194258|536313|P1|COMPLETED|Period 2 (12 Weeks)||0
221489|NCT01194258|536309|P5|STARTED|Period 2 (12 Weeks)||32
221490|NCT01194258|536310|P4|STARTED|Period 2 (12 Weeks)||29
221491|NCT01194258|536311|P3|STARTED|Period 2 (12 Weeks)||30
221492|NCT01194258|536312|P2|STARTED|Period 2 (12 Weeks)||29
221493|NCT01194258|536313|P1|STARTED|Period 2 (12 Weeks)||0
221494|NCT01194258|536309|P5|NOT COMPLETED|Period 1 (12 Weeks)||1
221495|NCT01194258|536310|P4|NOT COMPLETED|Period 1 (12 Weeks)||0
221496|NCT01194258|536311|P3|NOT COMPLETED|Period 1 (12 Weeks)||0
221497|NCT01194258|536312|P2|NOT COMPLETED|Period 1 (12 Weeks)||0
221498|NCT01194258|536313|P1|NOT COMPLETED|Period 1 (12 Weeks)||0
221499|NCT01194258|536309|P5|COMPLETED|Period 1 (12 Weeks)||32
221500|NCT01194258|536310|P4|COMPLETED|Period 1 (12 Weeks)||29
221501|NCT01194258|536311|P3|COMPLETED|Period 1 (12 Weeks)||30
221502|NCT01194258|536312|P2|COMPLETED|Period 1 (12 Weeks)||29
221503|NCT01194258|536313|P1|COMPLETED|Period 1 (12 Weeks)||0
221504|NCT01194258|536309|P5|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||33
221505|NCT01194258|536310|P4|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
221506|NCT01194258|536311|P3|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||30
221507|NCT01194258|536312|P2|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
221508|NCT01194258|536313|P1|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||0
221509|NCT01194258|536309|P5|STARTED|Period 1 (12 Weeks)|After the titration phase, 33 participants were randomized to the Aspart-PH20/Insulin lispro group.|33
221510|NCT01194258|536310|P4|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Aspart-PH20 group.|29
221511|NCT01194258|536311|P3|STARTED|Period 1 (12 Weeks)|After the titration phase, 30 participants were randomized to the Lispro-PH20/Insulin lispro group.|30
221512|NCT01194258|536312|P2|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Lispro-PH20 group.|29
221513|NCT01194258|536313|P1|STARTED|Period 1 (12 Weeks)|Participants were randomized to the Insulin lispro or an Analog-PH20 group after titration.|0
221514|NCT01194258|536309|P5|NOT COMPLETED|Titration Period||0
221515|NCT01194258|536310|P4|NOT COMPLETED|Titration Period||0
221516|NCT01194258|536311|P3|NOT COMPLETED|Titration Period||0
221517|NCT01194258|536312|P2|NOT COMPLETED|Titration Period||0
221518|NCT01194258|536313|P1|NOT COMPLETED|Titration Period||11
221519|NCT01194258|536309|P5|COMPLETED|Titration Period||0
221520|NCT01194258|536310|P4|COMPLETED|Titration Period||0
221521|NCT01194258|536311|P3|COMPLETED|Titration Period||0
221522|NCT01194258|536312|P2|COMPLETED|Titration Period||0
221523|NCT01194258|536313|P1|COMPLETED|Titration Period||121
221524|NCT01194258|536309|P5|STARTED|Titration Period||0
221525|NCT01194258|536310|P4|STARTED|Titration Period||0
221526|NCT01194258|536311|P3|STARTED|Titration Period||0
221527|NCT01194258|536312|P2|STARTED|Titration Period||0
221528|NCT01194258|536313|P1|STARTED|Titration Period||132
221529|NCT01194245|536337|P5|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
221530|NCT01194245|536338|P4|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
221531|NCT01194245|536339|P3|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
221532|NCT01194245|536340|P2|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
221533|NCT01194245|536341|P1|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
221534|NCT01194245|536337|P5|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||28
221535|NCT01194245|536338|P4|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
221536|NCT01194245|536339|P3|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||27
221537|NCT01194245|536340|P2|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
221538|NCT01194245|536341|P1|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
221539|NCT01194245|536337|P5|STARTED|Treatment Period 2 (Weeks 12 to 24)||28
221540|NCT01194245|536338|P4|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
221541|NCT01194245|536339|P3|STARTED|Treatment Period 2 (Weeks 12 to 24)||27
221542|NCT01194245|536340|P2|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
221543|NCT01194245|536341|P1|STARTED|Treatment Period 2 (Weeks 12 to 24)||0
221544|NCT01194245|536337|P5|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||2
221545|NCT01194245|536338|P4|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
221546|NCT01194245|536339|P3|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
221547|NCT01194245|536340|P2|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
221548|NCT01194245|536341|P1|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
221549|NCT01194245|536337|P5|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||28
221550|NCT01194245|536338|P4|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
221551|NCT01194245|536339|P3|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||27
221552|NCT01194245|536340|P2|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
221553|NCT01194245|536341|P1|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
221554|NCT01194245|536337|P5|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
221555|NCT01194245|536338|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
221556|NCT01194245|536339|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||28
221557|NCT01194245|536340|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||29
221558|NCT01194245|536341|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||0
221559|NCT01194245|536337|P5|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
221560|NCT01194245|536338|P4|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
221561|NCT01194245|536339|P3|STARTED|Treatment Period 1 (Weeks 0 to 12)||28
221562|NCT01194245|536340|P2|STARTED|Treatment Period 1 (Weeks 0 to 12)||29
221563|NCT01194245|536341|P1|STARTED|Treatment Period 1 (Weeks 0 to 12)||0
221564|NCT01194245|536337|P5|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
221565|NCT01194245|536338|P4|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
221566|NCT01194245|536339|P3|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
221567|NCT01194245|536340|P2|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
221568|NCT01194245|536341|P1|NOT COMPLETED|Titration Period (4 to 6 Weeks)||18
221569|NCT01194245|536337|P5|COMPLETED|Titration Period (4 to 6 Weeks)||0
221570|NCT01194245|536338|P4|COMPLETED|Titration Period (4 to 6 Weeks)||0
221571|NCT01194245|536339|P3|COMPLETED|Titration Period (4 to 6 Weeks)||0
221572|NCT01194245|536340|P2|COMPLETED|Titration Period (4 to 6 Weeks)||0
221573|NCT01194245|536341|P1|COMPLETED|Titration Period (4 to 6 Weeks)|Participants that completed the Titration Period were randomized to Treatment Period 1.|117
221574|NCT01194245|536337|P5|STARTED|Titration Period (4 to 6 Weeks)||0
221575|NCT01194245|536338|P4|STARTED|Titration Period (4 to 6 Weeks)||0
221576|NCT01194245|536339|P3|STARTED|Titration Period (4 to 6 Weeks)||0
221577|NCT01194245|536340|P2|STARTED|Titration Period (4 to 6 Weeks)||0
221578|NCT01194245|536341|P1|STARTED|Titration Period (4 to 6 Weeks)||135
221579|NCT01194219|536362|P10|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||112
221580|NCT01194219|536363|P9|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||220
221581|NCT01194219|536364|P8|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
221582|NCT01194219|536365|P7|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
221583|NCT01194219|536366|P6|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
221584|NCT01194219|536367|P5|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
221585|NCT01194219|536368|P4|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
221586|NCT01194219|536369|P3|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
221587|NCT01194219|536370|P2|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
221588|NCT01194219|536371|P1|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
221589|NCT01194219|536362|P10|COMPLETED|Long-Term Extension Weeks 52 to 260||41
221590|NCT01194219|536363|P9|COMPLETED|Long-Term Extension Weeks 52 to 260||86
221591|NCT01194219|536364|P8|COMPLETED|Long-Term Extension Weeks 52 to 260||0
221592|NCT01194219|536365|P7|COMPLETED|Long-Term Extension Weeks 52 to 260||0
221593|NCT01194219|536366|P6|COMPLETED|Long-Term Extension Weeks 52 to 260||0
221594|NCT01194219|536367|P5|COMPLETED|Long-Term Extension Weeks 52 to 260||0
221595|NCT01194219|536368|P4|COMPLETED|Long-Term Extension Weeks 52 to 260||0
221596|NCT01194219|536369|P3|COMPLETED|Long-Term Extension Weeks 52 to 260||0
221597|NCT01194219|536370|P2|COMPLETED|Long-Term Extension Weeks 52 to 260||0
221598|NCT01194219|536371|P1|COMPLETED|Long-Term Extension Weeks 52 to 260||0
221599|NCT01194219|536362|P10|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||153
221600|NCT01194219|536363|P9|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||304
221601|NCT01194219|536364|P8|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
221602|NCT01194219|536365|P7|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
221603|NCT01194219|536366|P6|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
221604|NCT01194219|536367|P5|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
221605|NCT01194219|536368|P4|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
221606|NCT01194219|536369|P3|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
221607|NCT01194219|536370|P2|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
221608|NCT01194219|536371|P1|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
221609|NCT01194219|536362|P10|STARTED|Long-Term Extension Weeks 52 to 260||153
221610|NCT01194219|536363|P9|STARTED|Long-Term Extension Weeks 52 to 260||306
221611|NCT01194219|536364|P8|STARTED|Long-Term Extension Weeks 52 to 260||0
221612|NCT01194219|536365|P7|STARTED|Long-Term Extension Weeks 52 to 260||0
221613|NCT01194219|536366|P6|STARTED|Long-Term Extension Weeks 52 to 260||0
221614|NCT01194219|536367|P5|STARTED|Long-Term Extension Weeks 52 to 260||0
221615|NCT01194219|536368|P4|STARTED|Long-Term Extension Weeks 52 to 260||0
221616|NCT01194219|536369|P3|STARTED|Long-Term Extension Weeks 52 to 260||0
221617|NCT01194219|536370|P2|STARTED|Long-Term Extension Weeks 52 to 260||0
221618|NCT01194219|536371|P1|STARTED|Long-Term Extension Weeks 52 to 260||0
221619|NCT01194219|536362|P10|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
221620|NCT01194219|536363|P9|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
221621|NCT01194219|536364|P8|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||45
221622|NCT01194219|536365|P7|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||61
221623|NCT01194219|536366|P6|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
221624|NCT01194219|536367|P5|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
221625|NCT01194219|536368|P4|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
221626|NCT01194219|536369|P3|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
221627|NCT01194219|536370|P2|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
221628|NCT01194219|536371|P1|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
221629|NCT01194219|536362|P10|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
221630|NCT01194219|536363|P9|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
221631|NCT01194219|536364|P8|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|10 participants discontinued after Week 52 but prior to entry into the long term extension study|163
221632|NCT01194219|536365|P7|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|18 participants discontinued after Week 52 but prior to entry into the long term extension study|184
221633|NCT01194219|536366|P6|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|5 participants discontinued after Week 52 but prior to entry into the long term extension study|73
221634|NCT01194219|536367|P5|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|1 participant discontinued after Week 52 but prior to entry into the long term extension study|73
221635|NCT01194219|536368|P4|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
221636|NCT01194219|536369|P3|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
221637|NCT01194219|536370|P2|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
221638|NCT01194219|536371|P1|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
221639|NCT01194219|536362|P10|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
221640|NCT01194219|536363|P9|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
221641|NCT01194219|536364|P8|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||91
221642|NCT01194219|536365|P7|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||126
221643|NCT01194219|536366|P6|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
221644|NCT01194219|536367|P5|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
221645|NCT01194219|536368|P4|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
221646|NCT01194219|536369|P3|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
221647|NCT01194219|536370|P2|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
221648|NCT01194219|536371|P1|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
221649|NCT01194219|536362|P10|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
221650|NCT01194219|536363|P9|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
221651|NCT01194219|536364|P8|STARTED|Randomized Withdrawal Phase-Weeks 32-52||208
221652|NCT01194219|536365|P7|STARTED|Randomized Withdrawal Phase-Weeks 32-52||245
221653|NCT01194219|536366|P6|STARTED|Randomized Withdrawal Phase-Weeks 32-52|25 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
221654|NCT01194219|536367|P5|STARTED|Randomized Withdrawal Phase-Weeks 32-52|7 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
221655|NCT01194219|536368|P4|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
221656|NCT01194219|536369|P3|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
221657|NCT01194219|536370|P2|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
221658|NCT01194219|536371|P1|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
221659|NCT01194219|536362|P10|NOT COMPLETED|Maintenance Phase Weeks16-32||0
221660|NCT01194219|536363|P9|NOT COMPLETED|Maintenance Phase Weeks16-32||0
221661|NCT01194219|536364|P8|NOT COMPLETED|Maintenance Phase Weeks16-32||0
221662|NCT01194219|536365|P7|NOT COMPLETED|Maintenance Phase Weeks16-32||0
221663|NCT01194219|536366|P6|NOT COMPLETED|Maintenance Phase Weeks16-32||0
221664|NCT01194219|536367|P5|NOT COMPLETED|Maintenance Phase Weeks16-32||0
221665|NCT01194219|536368|P4|NOT COMPLETED|Maintenance Phase Weeks16-32||30
221666|NCT01194219|536369|P3|NOT COMPLETED|Maintenance Phase Weeks16-32||70
221667|NCT01194219|536370|P2|NOT COMPLETED|Maintenance Phase Weeks16-32||0
221668|NCT01194219|536371|P1|NOT COMPLETED|Maintenance Phase Weeks16-32||0
221669|NCT01194219|536362|P10|COMPLETED|Maintenance Phase Weeks16-32||0
221670|NCT01194219|536363|P9|COMPLETED|Maintenance Phase Weeks16-32||0
221671|NCT01194219|536364|P8|COMPLETED|Maintenance Phase Weeks16-32||0
221672|NCT01194219|536365|P7|COMPLETED|Maintenance Phase Weeks16-32||0
221673|NCT01194219|536366|P6|COMPLETED|Maintenance Phase Weeks16-32||0
221674|NCT01194219|536367|P5|COMPLETED|Maintenance Phase Weeks16-32||0
221675|NCT01194219|536368|P4|COMPLETED|Maintenance Phase Weeks16-32||215
221676|NCT01194219|536369|P3|COMPLETED|Maintenance Phase Weeks16-32||424
221677|NCT01194219|536370|P2|COMPLETED|Maintenance Phase Weeks16-32||0
221678|NCT01194219|536371|P1|COMPLETED|Maintenance Phase Weeks16-32||0
221679|NCT01194219|536362|P10|Received Apremilast|Maintenance Phase Weeks16-32||0
221680|NCT01194219|536363|P9|Received Apremilast|Maintenance Phase Weeks16-32||0
221681|NCT01194219|536364|P8|Received Apremilast|Maintenance Phase Weeks16-32||0
221682|NCT01194219|536365|P7|Received Apremilast|Maintenance Phase Weeks16-32||0
221683|NCT01194219|536366|P6|Received Apremilast|Maintenance Phase Weeks16-32||0
221684|NCT01194219|536367|P5|Received Apremilast|Maintenance Phase Weeks16-32||0
221685|NCT01194219|536368|P4|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|244
221686|NCT01194219|536369|P3|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|493
221687|NCT01194219|536370|P2|Received Apremilast|Maintenance Phase Weeks16-32||0
221688|NCT01194219|536371|P1|Received Apremilast|Maintenance Phase Weeks16-32||0
221689|NCT01194219|536362|P10|STARTED|Maintenance Phase Weeks16-32||0
221690|NCT01194219|536363|P9|STARTED|Maintenance Phase Weeks16-32||0
221691|NCT01194219|536364|P8|STARTED|Maintenance Phase Weeks16-32||0
221692|NCT01194219|536365|P7|STARTED|Maintenance Phase Weeks16-32||0
221693|NCT01194219|536366|P6|STARTED|Maintenance Phase Weeks16-32||0
221694|NCT01194219|536367|P5|STARTED|Maintenance Phase Weeks16-32||0
221695|NCT01194219|536368|P4|STARTED|Maintenance Phase Weeks16-32|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|245
221696|NCT01194219|536369|P3|STARTED|Maintenance Phase Weeks16-32|9 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|494
221697|NCT01194219|536370|P2|STARTED|Maintenance Phase Weeks16-32||0
221698|NCT01194219|536371|P1|STARTED|Maintenance Phase Weeks16-32||0
221699|NCT01194219|536362|P10|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
221700|NCT01194219|536363|P9|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
221701|NCT01194219|536364|P8|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
221702|NCT01194219|536365|P7|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
221703|NCT01194219|536366|P6|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
221704|NCT01194219|536367|P5|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
221705|NCT01194219|536368|P4|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
221706|NCT01194219|536369|P3|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
221707|NCT01194219|536370|P2|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||33
221708|NCT01194219|536371|P1|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||59
221709|NCT01194219|536362|P10|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
221710|NCT01194219|536363|P9|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
221711|NCT01194219|536364|P8|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
221712|NCT01194219|536365|P7|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
221713|NCT01194219|536366|P6|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
221714|NCT01194219|536367|P5|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
221715|NCT01194219|536368|P4|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
221716|NCT01194219|536369|P3|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
221717|NCT01194219|536370|P2|COMPLETED|Placebo-Controlled Phase Weeks 0-16||249
221718|NCT01194219|536371|P1|COMPLETED|Placebo-Controlled Phase Weeks 0-16||503
221719|NCT01194219|536362|P10|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
221720|NCT01194219|536363|P9|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
221721|NCT01194219|536364|P8|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
221722|NCT01194219|536365|P7|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
221723|NCT01194219|536366|P6|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
221724|NCT01194219|536367|P5|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
221725|NCT01194219|536368|P4|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
221726|NCT01194219|536369|P3|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
221727|NCT01194219|536370|P2|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||282
221728|NCT01194219|536371|P1|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||560
221729|NCT01194219|536362|P10|STARTED|Placebo-Controlled Phase Weeks 0-16||0
221730|NCT01194219|536363|P9|STARTED|Placebo-Controlled Phase Weeks 0-16||0
221731|NCT01194219|536364|P8|STARTED|Placebo-Controlled Phase Weeks 0-16||0
221732|NCT01194219|536365|P7|STARTED|Placebo-Controlled Phase Weeks 0-16||0
221733|NCT01194219|536366|P6|STARTED|Placebo-Controlled Phase Weeks 0-16||0
221734|NCT01194219|536367|P5|STARTED|Placebo-Controlled Phase Weeks 0-16||0
221735|NCT01194219|536368|P4|STARTED|Placebo-Controlled Phase Weeks 0-16||0
221736|NCT01194219|536369|P3|STARTED|Placebo-Controlled Phase Weeks 0-16||0
221737|NCT01194219|536370|P2|STARTED|Placebo-Controlled Phase Weeks 0-16||282
221738|NCT01194219|536371|P1|STARTED|Placebo-Controlled Phase Weeks 0-16||562
221739|NCT01194154|536405|P2|NOT COMPLETED|Overall Study||33
221740|NCT01194154|536406|P1|NOT COMPLETED|Overall Study||49
221741|NCT01194154|536405|P2|COMPLETED|Overall Study||91
221742|NCT01194154|536406|P1|COMPLETED|Overall Study||68
221743|NCT01194154|536405|P2|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|117
221744|NCT01194154|536406|P1|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|118
221745|NCT01194154|536405|P2|Full Analysis Set|Overall Study||120
221746|NCT01194154|536406|P1|Full Analysis Set|Overall Study||115
221747|NCT01194154|536405|P2|STARTED|Overall Study||124
221748|NCT01194154|536406|P1|STARTED|Overall Study||117
221749|NCT01194089|536426|P2|NOT COMPLETED|Overall Study||0
221750|NCT01194089|536427|P1|NOT COMPLETED|Overall Study||0
221751|NCT01194089|536426|P2|COMPLETED|Overall Study||47
221752|NCT01194089|536427|P1|COMPLETED|Overall Study||42
221753|NCT01194089|536426|P2|STARTED|Overall Study||47
221754|NCT01194089|536427|P1|STARTED|Overall Study||42
221755|NCT01193920|536447|P10|NOT COMPLETED|Overall Study||7
221756|NCT01193920|536448|P9|NOT COMPLETED|Overall Study||5
221757|NCT01193920|536449|P8|NOT COMPLETED|Overall Study||4
221758|NCT01193920|536450|P7|NOT COMPLETED|Overall Study||6
221759|NCT01193920|536451|P6|NOT COMPLETED|Overall Study||4
221760|NCT01193920|536452|P5|NOT COMPLETED|Overall Study||6
221761|NCT01193920|536453|P4|NOT COMPLETED|Overall Study||4
221762|NCT01193920|536454|P3|NOT COMPLETED|Overall Study||6
221763|NCT01193920|536455|P2|NOT COMPLETED|Overall Study||0
221764|NCT01193920|536456|P1|NOT COMPLETED|Overall Study||3
221765|NCT01193920|536447|P10|COMPLETED|Overall Study||74
221766|NCT01193920|536448|P9|COMPLETED|Overall Study||71
221767|NCT01193920|536449|P8|COMPLETED|Overall Study||76
221768|NCT01193920|536450|P7|COMPLETED|Overall Study||74
221769|NCT01193920|536451|P6|COMPLETED|Overall Study||76
221770|NCT01193920|536452|P5|COMPLETED|Overall Study||74
221771|NCT01193920|536453|P4|COMPLETED|Overall Study||76
221772|NCT01193920|536454|P3|COMPLETED|Overall Study||74
221773|NCT01193920|536455|P2|COMPLETED|Overall Study||20
221774|NCT01193920|536456|P1|COMPLETED|Overall Study||37
221775|NCT01193920|536447|P10|STARTED|Overall Study||81
221776|NCT01193920|536448|P9|STARTED|Overall Study||76
221777|NCT01193920|536449|P8|STARTED|Overall Study||80
221778|NCT01193920|536450|P7|STARTED|Overall Study||80
221779|NCT01193920|536451|P6|STARTED|Overall Study||80
221780|NCT01193920|536452|P5|STARTED|Overall Study||80
221781|NCT01193920|536453|P4|STARTED|Overall Study||80
221782|NCT01193920|536454|P3|STARTED|Overall Study||80
221783|NCT01193920|536455|P2|STARTED|Overall Study||20
221784|NCT01193920|536456|P1|STARTED|Overall Study||40
221785|NCT01193907|536510|P4|NOT COMPLETED|Overall Study||1
221786|NCT01193907|536511|P3|NOT COMPLETED|Overall Study||0
221787|NCT01193907|536512|P2|NOT COMPLETED|Overall Study||0
221788|NCT01193907|536513|P1|NOT COMPLETED|Overall Study||1
221789|NCT01193907|536510|P4|COMPLETED|Overall Study||21
221790|NCT01193907|536511|P3|COMPLETED|Overall Study||22
221791|NCT01193907|536512|P2|COMPLETED|Overall Study||22
221792|NCT01193907|536513|P1|COMPLETED|Overall Study||21
221793|NCT01193907|536510|P4|STARTED|Overall Study||22
221794|NCT01193907|536511|P3|STARTED|Overall Study||22
221795|NCT01193907|536512|P2|STARTED|Overall Study||22
221796|NCT01193907|536513|P1|STARTED|Overall Study||22
221797|NCT01193868|536535|P1|NOT COMPLETED|Overall Study||0
221798|NCT01193868|536535|P1|COMPLETED|Overall Study||6
221799|NCT01193868|536535|P1|STARTED|Overall Study||6
221800|NCT01193842|536552|P5|NOT COMPLETED|Phase II: Randomized Groups||10
221801|NCT01193842|536553|P4|NOT COMPLETED|Phase II: Randomized Groups||12
221802|NCT01193842|536554|P3|NOT COMPLETED|Phase II: Randomized Groups||0
221803|NCT01193842|536555|P2|NOT COMPLETED|Phase II: Randomized Groups||0
221804|NCT01193842|536556|P1|NOT COMPLETED|Phase II: Randomized Groups||0
221805|NCT01193842|536552|P5|COMPLETED|Phase II: Randomized Groups||36
221806|NCT01193842|536553|P4|COMPLETED|Phase II: Randomized Groups||33
221807|NCT01193842|536554|P3|COMPLETED|Phase II: Randomized Groups||0
221808|NCT01193842|536555|P2|COMPLETED|Phase II: Randomized Groups||0
221809|NCT01193842|536556|P1|COMPLETED|Phase II: Randomized Groups||0
221810|NCT01193842|536552|P5|STARTED|Phase II: Randomized Groups||46
221811|NCT01193842|536553|P4|STARTED|Phase II: Randomized Groups||45
221812|NCT01193842|536554|P3|STARTED|Phase II: Randomized Groups||0
221813|NCT01193842|536555|P2|STARTED|Phase II: Randomized Groups||0
221814|NCT01193842|536556|P1|STARTED|Phase II: Randomized Groups||0
221815|NCT01193842|536552|P5|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
221816|NCT01193842|536553|P4|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
221817|NCT01193842|536554|P3|NOT COMPLETED|Phase I: VR-CHOP, DL 1||1
221818|NCT01193842|536555|P2|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
221819|NCT01193842|536556|P1|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
221820|NCT01193842|536552|P5|COMPLETED|Phase I: VR-CHOP, DL 1||0
221821|NCT01193842|536553|P4|COMPLETED|Phase I: VR-CHOP, DL 1||0
221822|NCT01193842|536554|P3|COMPLETED|Phase I: VR-CHOP, DL 1||1
221823|NCT01193842|536555|P2|COMPLETED|Phase I: VR-CHOP, DL 1||0
221824|NCT01193842|536556|P1|COMPLETED|Phase I: VR-CHOP, DL 1||0
221825|NCT01193842|536552|P5|STARTED|Phase I: VR-CHOP, DL 1||0
221826|NCT01193842|536553|P4|STARTED|Phase I: VR-CHOP, DL 1||0
221827|NCT01193842|536554|P3|STARTED|Phase I: VR-CHOP, DL 1||2
221828|NCT01193842|536555|P2|STARTED|Phase I: VR-CHOP, DL 1||0
221829|NCT01193842|536556|P1|STARTED|Phase I: VR-CHOP, DL 1||0
221830|NCT01193842|536552|P5|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
221831|NCT01193842|536553|P4|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
221832|NCT01193842|536554|P3|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
221833|NCT01193842|536555|P2|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
221834|NCT01193842|536556|P1|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||1
221835|NCT01193842|536552|P5|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
221836|NCT01193842|536553|P4|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
221837|NCT01193842|536554|P3|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
221838|NCT01193842|536555|P2|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
221839|NCT01193842|536556|P1|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||3
221840|NCT01193842|536552|P5|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
221841|NCT01193842|536553|P4|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
221842|NCT01193842|536554|P3|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
221843|NCT01193842|536555|P2|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
221844|NCT01193842|536556|P1|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||4
221845|NCT01193842|536552|P5|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
221846|NCT01193842|536553|P4|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
221847|NCT01193842|536554|P3|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
221848|NCT01193842|536555|P2|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||1
221849|NCT01193842|536556|P1|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
221850|NCT01193842|536552|P5|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
221851|NCT01193842|536553|P4|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
221852|NCT01193842|536554|P3|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
221853|NCT01193842|536555|P2|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||6
221854|NCT01193842|536556|P1|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
221855|NCT01193842|536552|P5|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
221856|NCT01193842|536553|P4|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
221857|NCT01193842|536554|P3|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
221858|NCT01193842|536555|P2|STARTED|Phase I: VR-DA-EPOCH, DL 2||7
221859|NCT01193842|536556|P1|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
221860|NCT01193842|536552|P5|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
221861|NCT01193842|536553|P4|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
221862|NCT01193842|536554|P3|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
221863|NCT01193842|536555|P2|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
221864|NCT01193842|536556|P1|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
221865|NCT01193842|536552|P5|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
221866|NCT01193842|536553|P4|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
221867|NCT01193842|536554|P3|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
221868|NCT01193842|536555|P2|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
221869|NCT01193842|536556|P1|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3
221870|NCT01193842|536552|P5|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
221871|NCT01193842|536553|P4|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
221872|NCT01193842|536554|P3|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
221873|NCT01193842|536555|P2|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
221874|NCT01193842|536556|P1|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3
221875|NCT01193686|536591|P2|NOT COMPLETED|Overall Study||1
221876|NCT01193686|536592|P1|NOT COMPLETED|Overall Study||7
221877|NCT01193686|536591|P2|COMPLETED|Overall Study||8
221878|NCT01193686|536592|P1|COMPLETED|Overall Study||8
221879|NCT01193686|536591|P2|Completed Visits and Final Assessment|Overall Study||8
221880|NCT01193686|536592|P1|Completed Visits and Final Assessment|Overall Study||8
221881|NCT01193686|536591|P2|Completed Mentor Training|Overall Study|Not applicable. Recipients were not required to complete training.|0
221882|NCT01193686|536592|P1|Completed Mentor Training|Overall Study||9
221883|NCT01193686|536591|P2|Completed Baseline Assessment|Overall Study||9
221884|NCT01193686|536592|P1|Completed Baseline Assessment|Overall Study||15
221885|NCT01193686|536591|P2|STARTED|Overall Study||9
221886|NCT01193686|536592|P1|STARTED|Overall Study||15
221887|NCT01193660|536609|P3|NOT COMPLETED|Overall Study||2
221888|NCT01193660|536610|P2|NOT COMPLETED|Overall Study||3
221889|NCT01193660|536611|P1|NOT COMPLETED|Overall Study||4
221890|NCT01193660|536609|P3|COMPLETED|Overall Study||32
221891|NCT01193660|536610|P2|COMPLETED|Overall Study||33
221892|NCT01193660|536611|P1|COMPLETED|Overall Study||31
221893|NCT01193660|536609|P3|STARTED|Overall Study||34
221894|NCT01193660|536610|P2|STARTED|Overall Study||36
221895|NCT01193660|536611|P1|STARTED|Overall Study||35
221896|NCT01193608|536655|P6|NOT COMPLETED|Overall Study||2
221897|NCT01193608|536656|P5|NOT COMPLETED|Overall Study||5
221898|NCT01193608|536657|P4|NOT COMPLETED|Overall Study||3
221899|NCT01193608|536658|P3|NOT COMPLETED|Overall Study||2
221900|NCT01193608|536659|P2|NOT COMPLETED|Overall Study||2
221901|NCT01193608|536660|P1|NOT COMPLETED|Overall Study||0
221902|NCT01193608|536655|P6|COMPLETED|Overall Study||17
221903|NCT01193608|536656|P5|COMPLETED|Overall Study||19
221904|NCT01193608|536657|P4|COMPLETED|Overall Study||14
221905|NCT01193608|536658|P3|COMPLETED|Overall Study||14
221906|NCT01193608|536659|P2|COMPLETED|Overall Study||4
221907|NCT01193608|536660|P1|COMPLETED|Overall Study||6
221908|NCT01193608|536655|P6|STARTED|Overall Study||19
221909|NCT01193608|536656|P5|STARTED|Overall Study||24
221910|NCT01193608|536657|P4|STARTED|Overall Study||17
221911|NCT01193608|536658|P3|STARTED|Overall Study||16
221912|NCT01193608|536659|P2|STARTED|Overall Study||6
221913|NCT01193608|536660|P1|STARTED|Overall Study||6
221914|NCT01193582|536897|P4|NOT COMPLETED|12 Month Follow-up||11
221915|NCT01193582|536898|P3|NOT COMPLETED|12 Month Follow-up||4
221916|NCT01193582|536899|P2|NOT COMPLETED|12 Month Follow-up||0
221917|NCT01193582|536900|P1|NOT COMPLETED|12 Month Follow-up||6
221918|NCT01193582|536897|P4|COMPLETED|12 Month Follow-up||166
221919|NCT01193582|536898|P3|COMPLETED|12 Month Follow-up||113
221920|NCT01193582|536899|P2|COMPLETED|12 Month Follow-up||88
221921|NCT01193582|536900|P1|COMPLETED|12 Month Follow-up||83
221922|NCT01193582|536897|P4|STARTED|12 Month Follow-up||177
221923|NCT01193582|536898|P3|STARTED|12 Month Follow-up||117
221924|NCT01193582|536899|P2|STARTED|12 Month Follow-up||88
221925|NCT01193582|536900|P1|STARTED|12 Month Follow-up||89
221926|NCT01193582|536897|P4|NOT COMPLETED|Vaccination Series||3
221927|NCT01193582|536898|P3|NOT COMPLETED|Vaccination Series||8
221928|NCT01193582|536899|P2|NOT COMPLETED|Vaccination Series||13
221929|NCT01193582|536900|P1|NOT COMPLETED|Vaccination Series||11
221930|NCT01193582|536897|P4|COMPLETED|Vaccination Series||177
221931|NCT01193582|536898|P3|COMPLETED|Vaccination Series||117
221932|NCT01193582|536899|P2|COMPLETED|Vaccination Series||88
221933|NCT01193582|536900|P1|COMPLETED|Vaccination Series||89
221934|NCT01193582|536897|P4|Vaccinated Dose 4|Vaccination Series||0
221935|NCT01193582|536898|P3|Vaccinated Dose 4|Vaccination Series||0
221936|NCT01193582|536899|P2|Vaccinated Dose 4|Vaccination Series||0
221937|NCT01193582|536900|P1|Vaccinated Dose 4|Vaccination Series||90
221938|NCT01193582|536897|P4|Vaccinated Dose 3|Vaccination Series||0
221939|NCT01193582|536898|P3|Vaccinated Dose 3|Vaccination Series||0
221940|NCT01193582|536899|P2|Vaccinated Dose 3|Vaccination Series||89
221941|NCT01193582|536900|P1|Vaccinated Dose 3|Vaccination Series||90
221942|NCT01193582|536897|P4|Vaccinated Dose 2|Vaccination Series||0
221943|NCT01193582|536898|P3|Vaccinated Dose 2|Vaccination Series||118
221944|NCT01193582|536899|P2|Vaccinated Dose 2|Vaccination Series||91
221945|NCT01193582|536900|P1|Vaccinated Dose 2|Vaccination Series||92
221946|NCT01193582|536897|P4|Vaccinated Dose 1|Vaccination Series||180
221947|NCT01193582|536898|P3|Vaccinated Dose 1|Vaccination Series||125
221948|NCT01193582|536899|P2|Vaccinated Dose 1|Vaccination Series||100
221949|NCT01193582|536900|P1|Vaccinated Dose 1|Vaccination Series||100
221950|NCT01193582|536897|P4|STARTED|Vaccination Series||180
221951|NCT01193582|536898|P3|STARTED|Vaccination Series||125
221952|NCT01193582|536899|P2|STARTED|Vaccination Series||101
221953|NCT01193582|536900|P1|STARTED|Vaccination Series||100
221954|NCT01193556|536930|P2|NOT COMPLETED|Overall Study||25
221955|NCT01193556|536931|P1|NOT COMPLETED|Overall Study||26
221956|NCT01193556|536930|P2|COMPLETED|Overall Study||0
221957|NCT01193556|536931|P1|COMPLETED|Overall Study||0
221958|NCT01193556|536930|P2|STARTED|Overall Study||25
221959|NCT01193556|536931|P1|STARTED|Overall Study||26
221960|NCT01193530|536941|P2|NOT COMPLETED|Overall Study||5
221961|NCT01193530|536942|P1|NOT COMPLETED|Overall Study||3
221962|NCT01193530|536941|P2|COMPLETED|Overall Study||3
221963|NCT01193530|536942|P1|COMPLETED|Overall Study||1
221964|NCT01193530|536941|P2|STARTED|Overall Study||8
221965|NCT01193530|536942|P1|STARTED|Overall Study||4
221966|NCT01193348|536948|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||2
221967|NCT01193348|536948|P1|COMPLETED|Post Treatment Period (Patients Who Disc||8
221968|NCT01193348|536948|P1|STARTED|Post Treatment Period (Patients Who Disc||10
221969|NCT01193348|536948|P1|NOT COMPLETED|Extension Treatment Period||1
221970|NCT01193348|536948|P1|COMPLETED|Extension Treatment Period||16
221971|NCT01193348|536948|P1|STARTED|Extension Treatment Period||17
221972|NCT01193348|536948|P1|NOT COMPLETED|Treatment Period (26 Weeks)||3
221973|NCT01193348|536948|P1|COMPLETED|Treatment Period (26 Weeks)||19
221974|NCT01193348|536948|P1|STARTED|Treatment Period (26 Weeks)||22
221975|NCT01193348|536948|P1|NOT COMPLETED|Screening Period||5
221976|NCT01193348|536948|P1|COMPLETED|Screening Period||22
221977|NCT01193348|536948|P1|STARTED|Screening Period||27
221978|NCT01193335|536968|P2|NOT COMPLETED|2-Year Follow-up||8
221979|NCT01193335|536969|P1|NOT COMPLETED|2-Year Follow-up||7
221980|NCT01193335|536968|P2|COMPLETED|2-Year Follow-up||80
221981|NCT01193335|536969|P1|COMPLETED|2-Year Follow-up||81
221982|NCT01193335|536968|P2|STARTED|2-Year Follow-up||88
221983|NCT01193335|536969|P1|STARTED|2-Year Follow-up||88
221984|NCT01193335|536968|P2|NOT COMPLETED|1-Year Follow-up||9
221985|NCT01193335|536969|P1|NOT COMPLETED|1-Year Follow-up||11
221986|NCT01193335|536968|P2|COMPLETED|1-Year Follow-up||88
221987|NCT01193335|536969|P1|COMPLETED|1-Year Follow-up||88
221988|NCT01193335|536968|P2|STARTED|1-Year Follow-up||97
221989|NCT01193335|536969|P1|STARTED|1-Year Follow-up||99
221990|NCT01193335|536968|P2|NOT COMPLETED|Toddler Dose||0
221991|NCT01193335|536969|P1|NOT COMPLETED|Toddler Dose||0
221992|NCT01193335|536968|P2|COMPLETED|Toddler Dose||97
221993|NCT01193335|536969|P1|COMPLETED|Toddler Dose||99
221994|NCT01193335|536968|P2|STARTED|Toddler Dose||97
221995|NCT01193335|536969|P1|STARTED|Toddler Dose||99
221996|NCT01193335|536968|P2|NOT COMPLETED|After Infant Series||3
221997|NCT01193335|536969|P1|NOT COMPLETED|After Infant Series||1
221998|NCT01193335|536968|P2|COMPLETED|After Infant Series||97
221999|NCT01193335|536969|P1|COMPLETED|After Infant Series||99
222000|NCT01193335|536968|P2|STARTED|After Infant Series||100
222001|NCT01193335|536969|P1|STARTED|After Infant Series||100
222002|NCT01193335|536968|P2|NOT COMPLETED|Infant Series||0
222003|NCT01193335|536969|P1|NOT COMPLETED|Infant Series||0
222004|NCT01193335|536968|P2|COMPLETED|Infant Series||100
222005|NCT01193335|536969|P1|COMPLETED|Infant Series||100
222006|NCT01193335|536968|P2|STARTED|Infant Series||100
222007|NCT01193335|536969|P1|STARTED|Infant Series||100
222008|NCT01193283|537064|P1|NOT COMPLETED|Overall Study||1
222009|NCT01193283|537064|P1|COMPLETED|Overall Study||21
222010|NCT01193283|537064|P1|STARTED|Overall Study||22
222011|NCT01193257|537070|P2|NOT COMPLETED|Overall Study||734
222012|NCT01193257|537071|P1|NOT COMPLETED|Overall Study||365
222013|NCT01193257|537070|P2|COMPLETED|Overall Study||0
222014|NCT01193257|537071|P1|COMPLETED|Overall Study||0
222015|NCT01193257|537070|P2|Treated|Overall Study||732
222016|NCT01193257|537071|P1|Treated|Overall Study||363
222017|NCT01193257|537070|P2|STARTED|Overall Study||734
222018|NCT01193257|537071|P1|STARTED|Overall Study||365
222019|NCT01193244|537121|P2|NOT COMPLETED|Overall Study||390
222020|NCT01193244|537122|P1|NOT COMPLETED|Overall Study||388
222021|NCT01193244|537121|P2|COMPLETED|Overall Study||391
222022|NCT01193244|537122|P1|COMPLETED|Overall Study||391
222023|NCT01193244|537121|P2|Treated|Overall Study|Participants randomized to receive Placebo but crossed-over to receive Orteronel after unblinding.|784
222024|NCT01193244|537122|P1|Treated|Overall Study|Participants who continued to receive Placebo after unblinding.|770
222025|NCT01193244|537121|P2|STARTED|Overall Study||781
222026|NCT01193244|537122|P1|STARTED|Overall Study||779
222027|NCT01193218|537177|P8|NOT COMPLETED|12-52 Weeks||4
222028|NCT01193218|537178|P7|NOT COMPLETED|12-52 Weeks||3
222029|NCT01193218|537179|P6|NOT COMPLETED|12-52 Weeks||5
222030|NCT01193218|537180|P5|NOT COMPLETED|12-52 Weeks||4
222031|NCT01193218|537181|P4|NOT COMPLETED|12-52 Weeks||3
222032|NCT01193218|537182|P3|NOT COMPLETED|12-52 Weeks||4
222033|NCT01193218|537183|P2|NOT COMPLETED|12-52 Weeks||0
222034|NCT01193218|537184|P1|NOT COMPLETED|12-52 Weeks||5
222035|NCT01193218|537177|P8|COMPLETED|12-52 Weeks||49
222036|NCT01193218|537178|P7|COMPLETED|12-52 Weeks||51
222037|NCT01193218|537179|P6|COMPLETED|12-52 Weeks||101
222038|NCT01193218|537180|P5|COMPLETED|12-52 Weeks||104
222039|NCT01193218|537181|P4|COMPLETED|12-52 Weeks||50
222040|NCT01193218|537182|P3|COMPLETED|12-52 Weeks||50
222041|NCT01193218|537183|P2|COMPLETED|12-52 Weeks||50
222042|NCT01193218|537184|P1|COMPLETED|12-52 Weeks||45
222043|NCT01193218|537177|P8|STARTED|12-52 Weeks||53
222044|NCT01193218|537178|P7|STARTED|12-52 Weeks||54
222045|NCT01193218|537179|P6|STARTED|12-52 Weeks||106
222046|NCT01193218|537180|P5|STARTED|12-52 Weeks||108
222047|NCT01193218|537181|P4|STARTED|12-52 Weeks||53
222048|NCT01193218|537182|P3|STARTED|12-52 Weeks||54
222049|NCT01193218|537183|P2|STARTED|12-52 Weeks||50
222050|NCT01193218|537184|P1|STARTED|12-52 Weeks||50
222051|NCT01193218|537177|P8|NOT COMPLETED|0-12 Weeks||0
222052|NCT01193218|537178|P7|NOT COMPLETED|0-12 Weeks||3
222053|NCT01193218|537179|P6|NOT COMPLETED|0-12 Weeks||3
222054|NCT01193218|537180|P5|NOT COMPLETED|0-12 Weeks||1
222055|NCT01193218|537181|P4|NOT COMPLETED|0-12 Weeks||0
222056|NCT01193218|537182|P3|NOT COMPLETED|0-12 Weeks||3
222057|NCT01193218|537183|P2|NOT COMPLETED|0-12 Weeks||0
222058|NCT01193218|537184|P1|NOT COMPLETED|0-12 Weeks||9
222059|NCT01193218|537177|P8|COMPLETED|0-12 Weeks||0
222060|NCT01193218|537178|P7|COMPLETED|0-12 Weeks||107
222061|NCT01193218|537179|P6|COMPLETED|0-12 Weeks||106
222062|NCT01193218|537180|P5|COMPLETED|0-12 Weeks||108
222063|NCT01193218|537181|P4|COMPLETED|0-12 Weeks||0
222064|NCT01193218|537182|P3|COMPLETED|0-12 Weeks||107
222065|NCT01193218|537183|P2|COMPLETED|0-12 Weeks||0
222066|NCT01193218|537184|P1|COMPLETED|0-12 Weeks||100
222067|NCT01193218|537177|P8|STARTED|0-12 Weeks|It is actually N/A|0
222068|NCT01193218|537178|P7|STARTED|0-12 Weeks|It is actually empa 50mg group|110
222069|NCT01193218|537179|P6|STARTED|0-12 Weeks||109
222070|NCT01193218|537180|P5|STARTED|0-12 Weeks||109
222071|NCT01193218|537181|P4|STARTED|0-12 Weeks|It is actually N/A|0
222072|NCT01193218|537182|P3|STARTED|0-12 Weeks|It is actually empa 5mg group|110
222073|NCT01193218|537183|P2|STARTED|0-12 Weeks|It is actually N/A|0
222074|NCT01193218|537184|P1|STARTED|0-12 Weeks|It is actually placebo group|109
222075|NCT01193153|537215|P2|NOT COMPLETED|Double Blind Relapse Prevention Period||105
222076|NCT01193153|537216|P1|NOT COMPLETED|Double Blind Relapse Prevention Period||64
222077|NCT01193153|537215|P2|COMPLETED|Double Blind Relapse Prevention Period||65
222078|NCT01193153|537216|P1|COMPLETED|Double Blind Relapse Prevention Period||100
222079|NCT01193153|537215|P2|STARTED|Double Blind Relapse Prevention Period||170
222080|NCT01193153|537216|P1|STARTED|Double Blind Relapse Prevention Period||164
222081|NCT01193153|537215|P2|NOT COMPLETED|Open-label Stabilization Period||0
222082|NCT01193153|537216|P1|NOT COMPLETED|Open-label Stabilization Period||98
222083|NCT01193153|537215|P2|COMPLETED|Open-label Stabilization Period||0
222084|NCT01193153|537216|P1|COMPLETED|Open-label Stabilization Period||334
222085|NCT01193153|537215|P2|STARTED|Open-label Stabilization Period||0
222086|NCT01193153|537216|P1|STARTED|Open-label Stabilization Period||432
222087|NCT01193153|537215|P2|NOT COMPLETED|Open-label Lead in Period||0
222088|NCT01193153|537216|P1|NOT COMPLETED|Open-label Lead in Period||235
222089|NCT01193153|537215|P2|COMPLETED|Open-label Lead in Period||0
222090|NCT01193153|537216|P1|COMPLETED|Open-label Lead in Period||432
222091|NCT01193153|537215|P2|STARTED|Open-label Lead in Period||0
222092|NCT01193153|537216|P1|STARTED|Open-label Lead in Period||667
222093|NCT01193127|537251|P4|NOT COMPLETED|Treated||1
222094|NCT01193127|537252|P3|NOT COMPLETED|Treated||0
222095|NCT01193127|537253|P2|NOT COMPLETED|Treated||0
222096|NCT01193127|537254|P1|NOT COMPLETED|Treated||0
222097|NCT01193127|537251|P4|COMPLETED|Treated||55
222098|NCT01193127|537252|P3|COMPLETED|Treated||55
222099|NCT01193127|537253|P2|COMPLETED|Treated||54
222100|NCT01193127|537254|P1|COMPLETED|Treated||57
222101|NCT01193127|537251|P4|STARTED|Treated||56
222102|NCT01193127|537252|P3|STARTED|Treated||55
222103|NCT01193127|537253|P2|STARTED|Treated||54
222104|NCT01193127|537254|P1|STARTED|Treated||57
222105|NCT01193127|537251|P4|NOT COMPLETED|Randomized||1
222106|NCT01193127|537252|P3|NOT COMPLETED|Randomized||0
222107|NCT01193127|537253|P2|NOT COMPLETED|Randomized||0
222108|NCT01193127|537254|P1|NOT COMPLETED|Randomized||0
222109|NCT01193127|537251|P4|COMPLETED|Randomized||56
222110|NCT01193127|537252|P3|COMPLETED|Randomized||55
222111|NCT01193127|537253|P2|COMPLETED|Randomized||54
222112|NCT01193127|537254|P1|COMPLETED|Randomized||57
222113|NCT01193127|537251|P4|STARTED|Randomized||57
222114|NCT01193127|537252|P3|STARTED|Randomized||55
222115|NCT01193127|537253|P2|STARTED|Randomized||54
222116|NCT01193127|537254|P1|STARTED|Randomized||57
222117|NCT01193114|537558|P2|NOT COMPLETED|Overall Study||0
222118|NCT01193114|537559|P1|NOT COMPLETED|Overall Study||0
222119|NCT01193114|537558|P2|COMPLETED|Overall Study||30
222120|NCT01193114|537559|P1|COMPLETED|Overall Study||30
222121|NCT01193114|537558|P2|STARTED|Overall Study||30
222122|NCT01193114|537559|P1|STARTED|Overall Study||30
222123|NCT01193101|537579|P4|NOT COMPLETED|Overall Study||12
222124|NCT01193101|537580|P3|NOT COMPLETED|Overall Study||3
222125|NCT01193101|537581|P2|NOT COMPLETED|Overall Study||7
222126|NCT01193101|537582|P1|NOT COMPLETED|Overall Study||5
222127|NCT01193101|537579|P4|COMPLETED|Overall Study||80
222128|NCT01193101|537580|P3|COMPLETED|Overall Study||93
222129|NCT01193101|537581|P2|COMPLETED|Overall Study||94
222130|NCT01193101|537582|P1|COMPLETED|Overall Study||95
222131|NCT01193101|537579|P4|Placebo Withdrawal Set|Overall Study||80
222132|NCT01193101|537580|P3|Placebo Withdrawal Set|Overall Study||93
222133|NCT01193101|537581|P2|Placebo Withdrawal Set|Overall Study||94
222134|NCT01193101|537582|P1|Placebo Withdrawal Set|Overall Study||95
222135|NCT01193101|537579|P4|Full Analysis Set|Overall Study||92
222136|NCT01193101|537580|P3|Full Analysis Set|Overall Study||96
222137|NCT01193101|537581|P2|Full Analysis Set|Overall Study||101
222138|NCT01193101|537582|P1|Full Analysis Set|Overall Study||100
222139|NCT01193101|537579|P4|STARTED|Overall Study||92
222140|NCT01193101|537580|P3|STARTED|Overall Study||96
222141|NCT01193101|537581|P2|STARTED|Overall Study||101
222142|NCT01193101|537582|P1|STARTED|Overall Study||100
222143|NCT01193049|537638|P2|NOT COMPLETED|Period 3 : Double Blind Crossover||0
222144|NCT01193049|537639|P1|NOT COMPLETED|Period 3 : Double Blind Crossover||0
222145|NCT01193049|537638|P2|COMPLETED|Period 3 : Double Blind Crossover||6
222146|NCT01193049|537639|P1|COMPLETED|Period 3 : Double Blind Crossover||5
222147|NCT01193049|537638|P2|STARTED|Period 3 : Double Blind Crossover||6
222148|NCT01193049|537639|P1|STARTED|Period 3 : Double Blind Crossover||5
222149|NCT01193049|537638|P2|NOT COMPLETED|Washout 2 : 21 Day Washout||0
222150|NCT01193049|537639|P1|NOT COMPLETED|Washout 2 : 21 Day Washout||0
222151|NCT01193049|537638|P2|COMPLETED|Washout 2 : 21 Day Washout||6
222152|NCT01193049|537639|P1|COMPLETED|Washout 2 : 21 Day Washout||5
222153|NCT01193049|537638|P2|STARTED|Washout 2 : 21 Day Washout||6
222154|NCT01193049|537639|P1|STARTED|Washout 2 : 21 Day Washout||5
222155|NCT01193049|537638|P2|NOT COMPLETED|Period 2 : Double Blind Crossover||0
222156|NCT01193049|537639|P1|NOT COMPLETED|Period 2 : Double Blind Crossover||0
222157|NCT01193049|537638|P2|COMPLETED|Period 2 : Double Blind Crossover||6
222158|NCT01193049|537639|P1|COMPLETED|Period 2 : Double Blind Crossover||5
222159|NCT01193049|537638|P2|STARTED|Period 2 : Double Blind Crossover||6
222160|NCT01193049|537639|P1|STARTED|Period 2 : Double Blind Crossover||5
222161|NCT01193049|537638|P2|NOT COMPLETED|Washout 1 : 21 Day Washout||0
222162|NCT01193049|537639|P1|NOT COMPLETED|Washout 1 : 21 Day Washout||0
222163|NCT01193049|537638|P2|COMPLETED|Washout 1 : 21 Day Washout||6
222164|NCT01193049|537639|P1|COMPLETED|Washout 1 : 21 Day Washout||5
222165|NCT01193049|537638|P2|STARTED|Washout 1 : 21 Day Washout||6
222166|NCT01193049|537639|P1|STARTED|Washout 1 : 21 Day Washout||5
222167|NCT01193049|537638|P2|NOT COMPLETED|Period 1: Placebo Run-In||0
222168|NCT01193049|537639|P1|NOT COMPLETED|Period 1: Placebo Run-In||0
222169|NCT01193049|537638|P2|COMPLETED|Period 1: Placebo Run-In||6
222170|NCT01193049|537639|P1|COMPLETED|Period 1: Placebo Run-In||5
222171|NCT01193049|537638|P2|STARTED|Period 1: Placebo Run-In||6
222172|NCT01193049|537639|P1|STARTED|Period 1: Placebo Run-In||5
222173|NCT01193010|537671|P2|NOT COMPLETED|Overall Study||0
222174|NCT01193010|537672|P1|NOT COMPLETED|Overall Study||3
222175|NCT01193010|537671|P2|COMPLETED|Overall Study||20
222176|NCT01193010|537672|P1|COMPLETED|Overall Study||17
222177|NCT01193010|537671|P2|STARTED|Overall Study||20
222178|NCT01193010|537672|P1|STARTED|Overall Study||20
222179|NCT01192828|537684|P1|NOT COMPLETED|Overall Study||0
222180|NCT01192828|537684|P1|COMPLETED|Overall Study||14
222181|NCT01192828|537684|P1|STARTED|Overall Study||14
222182|NCT01192776|537703|P4|NOT COMPLETED|Overall Study||20
222183|NCT01192776|537704|P3|NOT COMPLETED|Overall Study||21
222184|NCT01192776|537705|P2|NOT COMPLETED|Overall Study||21
222185|NCT01192776|537706|P1|NOT COMPLETED|Overall Study||11
222186|NCT01192776|537703|P4|COMPLETED|Overall Study||63
222187|NCT01192776|537704|P3|COMPLETED|Overall Study||75
222188|NCT01192776|537705|P2|COMPLETED|Overall Study||69
222189|NCT01192776|537706|P1|COMPLETED|Overall Study||84
222190|NCT01192776|537703|P4|Died After Discharge|Overall Study||1
222191|NCT01192776|537704|P3|Died After Discharge|Overall Study||3
222192|NCT01192776|537705|P2|Died After Discharge|Overall Study||2
222193|NCT01192776|537706|P1|Died After Discharge|Overall Study||1
222194|NCT01192776|537703|P4|Died Prior to Discharge|Overall Study||14
222195|NCT01192776|537704|P3|Died Prior to Discharge|Overall Study||15
222196|NCT01192776|537705|P2|Died Prior to Discharge|Overall Study||13
222197|NCT01192776|537706|P1|Died Prior to Discharge|Overall Study||7
222198|NCT01192776|537703|P4|STARTED|Overall Study||83
222199|NCT01192776|537704|P3|STARTED|Overall Study||96
222200|NCT01192776|537705|P2|STARTED|Overall Study||90
222201|NCT01192776|537706|P1|STARTED|Overall Study||95
222202|NCT01192698|537762|P2|NOT COMPLETED|Overall Study||0
222203|NCT01192698|537763|P1|NOT COMPLETED|Overall Study||0
222204|NCT01192698|537762|P2|COMPLETED|Overall Study||5
222205|NCT01192698|537763|P1|COMPLETED|Overall Study||10
222206|NCT01192698|537762|P2|STARTED|Overall Study||5
222207|NCT01192698|537763|P1|STARTED|Overall Study||10
222208|NCT01192542|537769|P2|NOT COMPLETED|Period 2||0
222209|NCT01192542|537770|P1|NOT COMPLETED|Period 2||0
222210|NCT01192542|537769|P2|COMPLETED|Period 2||20
222211|NCT01192542|537770|P1|COMPLETED|Period 2||18
222212|NCT01192542|537769|P2|STARTED|Period 2||20
222213|NCT01192542|537770|P1|STARTED|Period 2||18
222214|NCT01192542|537769|P2|NOT COMPLETED|Period 1||0
222215|NCT01192542|537770|P1|NOT COMPLETED|Period 1||0
222216|NCT01192542|537769|P2|COMPLETED|Period 1||20
222217|NCT01192542|537770|P1|COMPLETED|Period 1||18
222218|NCT01192542|537769|P2|STARTED|Period 1||20
222219|NCT01192542|537770|P1|STARTED|Period 1||18
222220|NCT01192516|537784|P3|NOT COMPLETED|Overall Study||8
222221|NCT01192516|537785|P2|NOT COMPLETED|Overall Study||17
222222|NCT01192516|537786|P1|NOT COMPLETED|Overall Study||20
222223|NCT01192516|537784|P3|COMPLETED|Overall Study||55
222224|NCT01192516|537785|P2|COMPLETED|Overall Study||49
222225|NCT01192516|537786|P1|COMPLETED|Overall Study||46
222226|NCT01192516|537784|P3|STARTED|Overall Study|Indicates number of people initially randomized to group|63
222227|NCT01192516|537785|P2|STARTED|Overall Study|Indicates number of people initially randomized to group|66
222228|NCT01192516|537786|P1|STARTED|Overall Study|Indicates number of people initially randomized to group|66
222229|NCT01192412|537820|P2|NOT COMPLETED|Overall Study||2
222230|NCT01192412|537821|P1|NOT COMPLETED|Overall Study||4
222231|NCT01192412|537820|P2|COMPLETED|Overall Study||488
222232|NCT01192412|537821|P1|COMPLETED|Overall Study||493
222233|NCT01192412|537820|P2|STARTED|Overall Study||490
222234|NCT01192412|537821|P1|STARTED|Overall Study||497
222235|NCT01192399|537829|P1|NOT COMPLETED|Overall Study||2
222236|NCT01192399|537829|P1|COMPLETED|Overall Study||27
222237|NCT01192399|537829|P1|STARTED|Overall Study||29
222238|NCT01192347|537839|P1|NOT COMPLETED|Overall Study||12
222239|NCT01192347|537839|P1|COMPLETED|Overall Study||163
222240|NCT01192347|537839|P1|STARTED|Overall Study||175
222241|NCT01192295|537862|P2|NOT COMPLETED|Overall Study||23
222242|NCT01192295|537863|P1|NOT COMPLETED|Overall Study||10
222243|NCT01192295|537862|P2|COMPLETED|Overall Study||105
222244|NCT01192295|537863|P1|COMPLETED|Overall Study||17
222245|NCT01192295|537862|P2|STARTED|Overall Study||128
222246|NCT01192295|537863|P1|STARTED|Overall Study||27
222247|NCT01192282|537880|P1|NOT COMPLETED|Overall Study||0
222248|NCT01192282|537880|P1|COMPLETED|Overall Study||156
222249|NCT01192282|537880|P1|STARTED|Overall Study||156
222250|NCT01192204|537897|P2|NOT COMPLETED|Overall Study||0
222251|NCT01192204|537898|P1|NOT COMPLETED|Overall Study||1
222252|NCT01192204|537897|P2|COMPLETED|Overall Study||18
222253|NCT01192204|537898|P1|COMPLETED|Overall Study||22
222254|NCT01192204|537897|P2|STARTED|Overall Study||18
222255|NCT01192204|537898|P1|STARTED|Overall Study||23
222256|NCT01192191|537910|P2|NOT COMPLETED|Overall Study||21
222257|NCT01192191|537911|P1|NOT COMPLETED|Overall Study||11
222258|NCT01192191|537910|P2|COMPLETED|Overall Study||106
222259|NCT01192191|537911|P1|COMPLETED|Overall Study||49
222260|NCT01192191|537910|P2|STARTED|Overall Study||127
222261|NCT01192191|537911|P1|STARTED|Overall Study||60
222262|NCT01192178|537937|P2|NOT COMPLETED|Overall Study||23
222263|NCT01192178|537938|P1|NOT COMPLETED|Overall Study||24
222264|NCT01192178|537937|P2|COMPLETED|Overall Study||145
222265|NCT01192178|537938|P1|COMPLETED|Overall Study||147
222266|NCT01192178|537937|P2|STARTED|Overall Study||168
222267|NCT01192178|537938|P1|STARTED|Overall Study||171
222268|NCT01192152|537958|P2|NOT COMPLETED|Period 3||0
222269|NCT01192152|537959|P1|NOT COMPLETED|Period 3||1
222270|NCT01192152|537958|P2|COMPLETED|Period 3||0
222271|NCT01192152|537959|P1|COMPLETED|Period 3||14
222272|NCT01192152|537958|P2|STARTED|Period 3||0
222273|NCT01192152|537959|P1|STARTED|Period 3||15
222274|NCT01192152|537958|P2|NOT COMPLETED|Period 2||0
222275|NCT01192152|537959|P1|NOT COMPLETED|Period 2||0
222276|NCT01192152|537958|P2|COMPLETED|Period 2||14
222277|NCT01192152|537959|P1|COMPLETED|Period 2||15
222278|NCT01192152|537958|P2|STARTED|Period 2||14
222279|NCT01192152|537959|P1|STARTED|Period 2||15
222280|NCT01192152|537958|P2|NOT COMPLETED|Period 1||1
222281|NCT01192152|537959|P1|NOT COMPLETED|Period 1||0
222282|NCT01192152|537958|P2|COMPLETED|Period 1||14
222283|NCT01192152|537959|P1|COMPLETED|Period 1||15
222284|NCT01192152|537958|P2|STARTED|Period 1||15
222285|NCT01192152|537959|P1|STARTED|Period 1||15
222286|NCT01192139|538060|P6|NOT COMPLETED|Period 3||0
222287|NCT01192139|538061|P5|NOT COMPLETED|Period 3||0
222288|NCT01192139|538062|P4|NOT COMPLETED|Period 3||0
222289|NCT01192139|538063|P3|NOT COMPLETED|Period 3||0
222290|NCT01192139|538064|P2|NOT COMPLETED|Period 3||0
222291|NCT01192139|538065|P1|NOT COMPLETED|Period 3||0
222292|NCT01192139|538060|P6|COMPLETED|Period 3||5
222293|NCT01192139|538061|P5|COMPLETED|Period 3||5
222294|NCT01192139|538062|P4|COMPLETED|Period 3||5
222295|NCT01192139|538063|P3|COMPLETED|Period 3||5
222296|NCT01192139|538064|P2|COMPLETED|Period 3||5
222297|NCT01192139|538065|P1|COMPLETED|Period 3||5
222298|NCT01192139|538060|P6|STARTED|Period 3||5
222299|NCT01192139|538061|P5|STARTED|Period 3||5
222300|NCT01192139|538062|P4|STARTED|Period 3||5
222301|NCT01192139|538063|P3|STARTED|Period 3||5
222302|NCT01192139|538064|P2|STARTED|Period 3||5
222303|NCT01192139|538065|P1|STARTED|Period 3||5
222304|NCT01192139|538060|P6|NOT COMPLETED|Period 2||0
222305|NCT01192139|538061|P5|NOT COMPLETED|Period 2||0
222306|NCT01192139|538062|P4|NOT COMPLETED|Period 2||0
222307|NCT01192139|538063|P3|NOT COMPLETED|Period 2||0
222308|NCT01192139|538064|P2|NOT COMPLETED|Period 2||0
222309|NCT01192139|538065|P1|NOT COMPLETED|Period 2||0
222310|NCT01192139|538060|P6|COMPLETED|Period 2||5
222311|NCT01192139|538061|P5|COMPLETED|Period 2||5
222312|NCT01192139|538062|P4|COMPLETED|Period 2||5
222313|NCT01192139|538063|P3|COMPLETED|Period 2||5
222314|NCT01192139|538064|P2|COMPLETED|Period 2||5
222315|NCT01192139|538065|P1|COMPLETED|Period 2||5
222316|NCT01192139|538060|P6|STARTED|Period 2||5
222317|NCT01192139|538061|P5|STARTED|Period 2||5
222318|NCT01192139|538062|P4|STARTED|Period 2||5
222319|NCT01192139|538063|P3|STARTED|Period 2||5
222320|NCT01192139|538064|P2|STARTED|Period 2||5
222321|NCT01192139|538065|P1|STARTED|Period 2||5
222322|NCT01192139|538060|P6|NOT COMPLETED|Period 1||0
222323|NCT01192139|538061|P5|NOT COMPLETED|Period 1||0
222324|NCT01192139|538062|P4|NOT COMPLETED|Period 1||0
222325|NCT01192139|538063|P3|NOT COMPLETED|Period 1||0
222326|NCT01192139|538064|P2|NOT COMPLETED|Period 1||0
222327|NCT01192139|538065|P1|NOT COMPLETED|Period 1||0
222328|NCT01192139|538060|P6|COMPLETED|Period 1||5
222329|NCT01192139|538061|P5|COMPLETED|Period 1||5
222330|NCT01192139|538062|P4|COMPLETED|Period 1||5
222331|NCT01192139|538063|P3|COMPLETED|Period 1||5
222332|NCT01192139|538064|P2|COMPLETED|Period 1||5
222333|NCT01192139|538065|P1|COMPLETED|Period 1||5
222334|NCT01192139|538060|P6|STARTED|Period 1||5
222335|NCT01192139|538061|P5|STARTED|Period 1||5
222336|NCT01192139|538062|P4|STARTED|Period 1||5
222337|NCT01192139|538063|P3|STARTED|Period 1||5
222338|NCT01192139|538064|P2|STARTED|Period 1||5
222339|NCT01192139|538065|P1|STARTED|Period 1||5
222340|NCT01192126|538130|P2|NOT COMPLETED|Second Intervention (1 Week)||0
222341|NCT01192126|538131|P1|NOT COMPLETED|Second Intervention (1 Week)||0
222342|NCT01192126|538130|P2|COMPLETED|Second Intervention (1 Week)||50
222343|NCT01192126|538131|P1|COMPLETED|Second Intervention (1 Week)||49
222344|NCT01192126|538130|P2|STARTED|Second Intervention (1 Week)||50
222345|NCT01192126|538131|P1|STARTED|Second Intervention (1 Week)||49
222346|NCT01192126|538130|P2|NOT COMPLETED|First Intervention (1 Week)||1
222347|NCT01192126|538131|P1|NOT COMPLETED|First Intervention (1 Week)||2
222348|NCT01192126|538130|P2|COMPLETED|First Intervention (1 Week)||50
222349|NCT01192126|538131|P1|COMPLETED|First Intervention (1 Week)||49
222350|NCT01192126|538130|P2|STARTED|First Intervention (1 Week)||51
222351|NCT01192126|538131|P1|STARTED|First Intervention (1 Week)||51
222352|NCT01192022|538143|P5|NOT COMPLETED|Overall Study||1
222353|NCT01192022|538144|P4|NOT COMPLETED|Overall Study||2
222354|NCT01192022|538145|P3|NOT COMPLETED|Overall Study||1
222355|NCT01192022|538146|P2|NOT COMPLETED|Overall Study||11
222356|NCT01192022|538147|P1|NOT COMPLETED|Overall Study||13
222357|NCT01192022|538143|P5|COMPLETED|Overall Study||11
222358|NCT01192022|538144|P4|COMPLETED|Overall Study||7
222359|NCT01192022|538145|P3|COMPLETED|Overall Study||7
222360|NCT01192022|538146|P2|COMPLETED|Overall Study||99
222361|NCT01192022|538147|P1|COMPLETED|Overall Study||101
222362|NCT01192022|538143|P5|Safety Population-Received Treatment|Overall Study||12
222363|NCT01192022|538144|P4|Safety Population-Received Treatment|Overall Study||9
222364|NCT01192022|538145|P3|Safety Population-Received Treatment|Overall Study||8
222365|NCT01192022|538146|P2|Safety Population-Received Treatment|Overall Study||109
222366|NCT01192022|538147|P1|Safety Population-Received Treatment|Overall Study||114
222367|NCT01192022|538143|P5|STARTED|Overall Study||12
222368|NCT01192022|538144|P4|STARTED|Overall Study||9
222369|NCT01192022|538145|P3|STARTED|Overall Study||8
222370|NCT01192022|538146|P2|STARTED|Overall Study||110
222371|NCT01192022|538147|P1|STARTED|Overall Study||114
222372|NCT01191944|538170|P2|NOT COMPLETED|Overall Study||19
222373|NCT01191944|538171|P1|NOT COMPLETED|Overall Study||17
222374|NCT01191944|538170|P2|COMPLETED|Overall Study|Completed titration/maintenance|220
222375|NCT01191944|538171|P1|COMPLETED|Overall Study|Completed titration/maintenance|217
222376|NCT01191944|538170|P2|STARTED|Overall Study|Treated titration/maintenance|239
222377|NCT01191944|538171|P1|STARTED|Overall Study|Treated titration/maintenance|234
222378|NCT01191840|538217|P2|NOT COMPLETED|Overall Study||15
222379|NCT01191840|538218|P1|NOT COMPLETED|Overall Study||14
222380|NCT01191840|538217|P2|COMPLETED|Overall Study||240
222381|NCT01191840|538218|P1|COMPLETED|Overall Study||240
222382|NCT01191840|538217|P2|STARTED|Overall Study||255
222383|NCT01191840|538218|P1|STARTED|Overall Study||254
222384|NCT01191827|538234|P2|NOT COMPLETED|Overall Study||0
222385|NCT01191827|538235|P1|NOT COMPLETED|Overall Study||0
222386|NCT01191827|538234|P2|COMPLETED|Overall Study||20
222387|NCT01191827|538235|P1|COMPLETED|Overall Study||20
222388|NCT01191827|538234|P2|STARTED|Overall Study||20
222389|NCT01191827|538235|P1|STARTED|Overall Study||20
222390|NCT01191801|538243|P2|NOT COMPLETED|Overall Study||337
222391|NCT01191801|538244|P1|NOT COMPLETED|Overall Study||316
222392|NCT01191801|538243|P2|COMPLETED|Overall Study||18
222393|NCT01191801|538244|P1|COMPLETED|Overall Study||40
222394|NCT01191801|538243|P2|STARTED|Overall Study||355
222395|NCT01191801|538244|P1|STARTED|Overall Study||356
222396|NCT01191788|538264|P2|NOT COMPLETED|Overall Study||22
222397|NCT01191788|538265|P1|NOT COMPLETED|Overall Study||21
222398|NCT01191788|538264|P2|COMPLETED|Overall Study|Completed 3-month followup|137
222399|NCT01191788|538265|P1|COMPLETED|Overall Study|Completed 3-month followup|119
222400|NCT01191788|538264|P2|STARTED|Overall Study||159
222401|NCT01191788|538265|P1|STARTED|Overall Study||140
222402|NCT01191762|538275|P2|NOT COMPLETED|Overall Study||0
222403|NCT01191762|538276|P1|NOT COMPLETED|Overall Study||1
222404|NCT01191762|538275|P2|COMPLETED|Overall Study||15
222405|NCT01191762|538276|P1|COMPLETED|Overall Study|One subject dropped out on the 3rd treatment day because of gastrointestinal complaints.|14
222406|NCT01191762|538275|P2|STARTED|Overall Study||15
222407|NCT01191762|538276|P1|STARTED|Overall Study||15
222408|NCT01191749|538282|P1|NOT COMPLETED|Overall Study||0
222409|NCT01191749|538282|P1|COMPLETED|Overall Study||7
222410|NCT01191749|538282|P1|STARTED|Overall Study||7
222411|NCT01191736|538293|P7|NOT COMPLETED|Overall Study||0
222412|NCT01191736|538294|P6|NOT COMPLETED|Overall Study||0
222413|NCT01191736|538295|P5|NOT COMPLETED|Overall Study||0
222414|NCT01191736|538296|P4|NOT COMPLETED|Overall Study||0
222415|NCT01191736|538297|P3|NOT COMPLETED|Overall Study||0
222416|NCT01191736|538298|P2|NOT COMPLETED|Overall Study||0
222417|NCT01191736|538299|P1|NOT COMPLETED|Overall Study||0
222418|NCT01191736|538293|P7|COMPLETED|Overall Study||45
222419|NCT01191736|538294|P6|COMPLETED|Overall Study||50
222420|NCT01191736|538295|P5|COMPLETED|Overall Study||48
222421|NCT01191736|538296|P4|COMPLETED|Overall Study||46
222422|NCT01191736|538297|P3|COMPLETED|Overall Study||49
222423|NCT01191736|538298|P2|COMPLETED|Overall Study||47
222424|NCT01191736|538299|P1|COMPLETED|Overall Study||51
222425|NCT01191736|538293|P7|STARTED|Overall Study||45
222426|NCT01191736|538294|P6|STARTED|Overall Study||50
222427|NCT01191736|538295|P5|STARTED|Overall Study||48
222428|NCT01191736|538296|P4|STARTED|Overall Study||46
222429|NCT01191736|538297|P3|STARTED|Overall Study||49
222430|NCT01191736|538298|P2|STARTED|Overall Study||47
222431|NCT01191736|538299|P1|STARTED|Overall Study||51
222432|NCT01191723|538322|P6|NOT COMPLETED|Overall Study||0
222433|NCT01191723|538323|P5|NOT COMPLETED|Overall Study||0
222434|NCT01191723|538324|P4|NOT COMPLETED|Overall Study||0
222435|NCT01191723|538325|P3|NOT COMPLETED|Overall Study||0
222436|NCT01191723|538326|P2|NOT COMPLETED|Overall Study||0
222437|NCT01191723|538327|P1|NOT COMPLETED|Overall Study||0
222438|NCT01191723|538322|P6|COMPLETED|Overall Study||9
222439|NCT01191723|538323|P5|COMPLETED|Overall Study||9
222440|NCT01191723|538324|P4|COMPLETED|Overall Study||9
222441|NCT01191723|538325|P3|COMPLETED|Overall Study||9
222442|NCT01191723|538326|P2|COMPLETED|Overall Study||9
222443|NCT01191723|538327|P1|COMPLETED|Overall Study||9
222444|NCT01191723|538322|P6|STARTED|Overall Study||9
222445|NCT01191723|538323|P5|STARTED|Overall Study||9
222446|NCT01191723|538324|P4|STARTED|Overall Study||9
222447|NCT01191723|538325|P3|STARTED|Overall Study||9
222448|NCT01191723|538326|P2|STARTED|Overall Study||9
222449|NCT01191723|538327|P1|STARTED|Overall Study||9
222450|NCT01191476|538348|P3|NOT COMPLETED|Overall Study||0
222451|NCT01191476|538349|P2|NOT COMPLETED|Overall Study||4
222452|NCT01191476|538350|P1|NOT COMPLETED|Overall Study||3
222453|NCT01191476|538348|P3|COMPLETED|Overall Study||111
222454|NCT01191476|538349|P2|COMPLETED|Overall Study||107
222455|NCT01191476|538350|P1|COMPLETED|Overall Study||109
222456|NCT01191476|538348|P3|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
222457|NCT01191476|538349|P2|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
222458|NCT01191476|538350|P1|STARTED|Overall Study||112
222459|NCT01191411|538373|P3|NOT COMPLETED|Overall Study||3427
222460|NCT01191411|538374|P2|NOT COMPLETED|Overall Study||361
222461|NCT01191411|538375|P1|NOT COMPLETED|Overall Study||945
222462|NCT01191411|538373|P3|COMPLETED|Overall Study||471
222463|NCT01191411|538374|P2|COMPLETED|Overall Study||118
222464|NCT01191411|538375|P1|COMPLETED|Overall Study||648
222465|NCT01191411|538373|P3|STARTED|Overall Study||3898
222466|NCT01191411|538374|P2|STARTED|Overall Study||479
222467|NCT01191411|538375|P1|STARTED|Overall Study||1593
222468|NCT01191398|538386|P3|NOT COMPLETED|Overall Study||0
222469|NCT01191398|538387|P2|NOT COMPLETED|Overall Study||0
222470|NCT01191398|538388|P1|NOT COMPLETED|Overall Study||0
222471|NCT01191398|538386|P3|COMPLETED|Overall Study||18
222472|NCT01191398|538387|P2|COMPLETED|Overall Study||17
222473|NCT01191398|538388|P1|COMPLETED|Overall Study||17
222474|NCT01191398|538386|P3|STARTED|Overall Study||18
222475|NCT01191398|538387|P2|STARTED|Overall Study||17
222476|NCT01191398|538388|P1|STARTED|Overall Study||17
222477|NCT01191333|538401|P2|NOT COMPLETED|Overall Study||18
222478|NCT01191333|538402|P1|NOT COMPLETED|Overall Study||21
222479|NCT01191333|538401|P2|COMPLETED|Overall Study||65
222480|NCT01191333|538402|P1|COMPLETED|Overall Study||60
222481|NCT01191333|538401|P2|STARTED|Overall Study||83
222482|NCT01191333|538402|P1|STARTED|Overall Study||81
222483|NCT01191320|538421|P3|NOT COMPLETED|Overall Study||7
222484|NCT01191320|538422|P2|NOT COMPLETED|Overall Study||6
222485|NCT01191320|538423|P1|NOT COMPLETED|Overall Study||7
222486|NCT01191320|538421|P3|COMPLETED|Overall Study||31
222487|NCT01191320|538422|P2|COMPLETED|Overall Study||32
222488|NCT01191320|538423|P1|COMPLETED|Overall Study||36
222489|NCT01191320|538421|P3|STARTED|Overall Study||38
222490|NCT01191320|538422|P2|STARTED|Overall Study||38
222491|NCT01191320|538423|P1|STARTED|Overall Study||43
222492|NCT01191268|538434|P3|NOT COMPLETED|Overall Study||52
222493|NCT01191268|538435|P2|NOT COMPLETED|Overall Study||55
222494|NCT01191268|538436|P1|NOT COMPLETED|Overall Study||58
222495|NCT01191268|538434|P3|COMPLETED|Overall Study||244
222496|NCT01191268|538435|P2|COMPLETED|Overall Study||238
222497|NCT01191268|538436|P1|COMPLETED|Overall Study||237
222498|NCT01191268|538434|P3|Received at Least One Dose of Study Drug|Overall Study||296
222499|NCT01191268|538435|P2|Received at Least One Dose of Study Drug|Overall Study||293
222500|NCT01191268|538436|P1|Received at Least One Dose of Study Drug|Overall Study||295
222501|NCT01191268|538434|P3|STARTED|Overall Study||296
222502|NCT01191268|538435|P2|STARTED|Overall Study||293
222503|NCT01191268|538436|P1|STARTED|Overall Study||295
222504|NCT01191255|538533|P4|NOT COMPLETED|Efficacy Assessment Period||6
222505|NCT01191255|538534|P3|NOT COMPLETED|Efficacy Assessment Period||26
222506|NCT01191255|538535|P2|NOT COMPLETED|Efficacy Assessment Period||0
222507|NCT01191255|538536|P1|NOT COMPLETED|Efficacy Assessment Period||0
222508|NCT01191255|538533|P4|COMPLETED|Efficacy Assessment Period||90
222509|NCT01191255|538534|P3|COMPLETED|Efficacy Assessment Period||70
222510|NCT01191255|538535|P2|COMPLETED|Efficacy Assessment Period||0
222511|NCT01191255|538536|P1|COMPLETED|Efficacy Assessment Period||0
222512|NCT01191255|538533|P4|STARTED|Efficacy Assessment Period||96
222513|NCT01191255|538534|P3|STARTED|Efficacy Assessment Period||96
222514|NCT01191255|538535|P2|STARTED|Efficacy Assessment Period||0
222515|NCT01191255|538536|P1|STARTED|Efficacy Assessment Period||0
222516|NCT01191255|538533|P4|NOT COMPLETED|Safety Assessment Period||0
222517|NCT01191255|538534|P3|NOT COMPLETED|Safety Assessment Period||0
222518|NCT01191255|538535|P2|NOT COMPLETED|Safety Assessment Period||99
222519|NCT01191255|538536|P1|NOT COMPLETED|Safety Assessment Period||38
222520|NCT01191255|538533|P4|COMPLETED|Safety Assessment Period||0
222521|NCT01191255|538534|P3|COMPLETED|Safety Assessment Period||0
222522|NCT01191255|538535|P2|COMPLETED|Safety Assessment Period||193
222523|NCT01191255|538536|P1|COMPLETED|Safety Assessment Period||111
222524|NCT01191255|538533|P4|Safety Population|Safety Assessment Period||0
222525|NCT01191255|538534|P3|Safety Population|Safety Assessment Period||0
222526|NCT01191255|538535|P2|Safety Population|Safety Assessment Period||289
222527|NCT01191255|538536|P1|Safety Population|Safety Assessment Period||149
222528|NCT01191255|538533|P4|STARTED|Safety Assessment Period||0
222529|NCT01191255|538534|P3|STARTED|Safety Assessment Period||0
222530|NCT01191255|538535|P2|STARTED|Safety Assessment Period||292
222531|NCT01191255|538536|P1|STARTED|Safety Assessment Period|3 subjects were assigned to receive KRX-0502 but didn't receive a single dose|149
222532|NCT01191242|538562|P1|NOT COMPLETED|Overall Study||0
222533|NCT01191242|538562|P1|COMPLETED|Overall Study||31
222534|NCT01191242|538562|P1|STARTED|Overall Study||31
222535|NCT01191190|538577|P1|NOT COMPLETED|Overall Study||1
222536|NCT01191190|538577|P1|COMPLETED|Overall Study||20
222537|NCT01191190|538577|P1|STARTED|Overall Study||21
222538|NCT01191086|538590|P1|NOT COMPLETED|Overall Study||62
222539|NCT01191086|538590|P1|COMPLETED|Overall Study||148
222540|NCT01191086|538590|P1|STARTED|Overall Study||210
222541|NCT01191008|538594|P1|NOT COMPLETED|Overall Study||15
222542|NCT01191008|538594|P1|COMPLETED|Overall Study||618
222543|NCT01191008|538594|P1|STARTED|Overall Study||633
222544|NCT01190891|538602|P2|NOT COMPLETED|Overall Study||0
222545|NCT01190891|538603|P1|NOT COMPLETED|Overall Study||6
222546|NCT01190891|538602|P2|COMPLETED|Overall Study||52
222547|NCT01190891|538603|P1|COMPLETED|Overall Study||46
222548|NCT01190891|538602|P2|STARTED|Overall Study||52
222549|NCT01190891|538603|P1|STARTED|Overall Study||52
222550|NCT01190878|538615|P4|NOT COMPLETED|Overall Study||20
222551|NCT01190878|538616|P3|NOT COMPLETED|Overall Study||5
222552|NCT01190878|538617|P2|NOT COMPLETED|Overall Study||3
222553|NCT01190878|538618|P1|NOT COMPLETED|Overall Study||3
222554|NCT01190878|538615|P4|COMPLETED|Overall Study||22
222555|NCT01190878|538616|P3|COMPLETED|Overall Study||37
222556|NCT01190878|538617|P2|COMPLETED|Overall Study||42
222557|NCT01190878|538618|P1|COMPLETED|Overall Study||37
222558|NCT01190878|538615|P4|STARTED|Overall Study||42
222559|NCT01190878|538616|P3|STARTED|Overall Study||42
222560|NCT01190878|538617|P2|STARTED|Overall Study||45
222561|NCT01190878|538618|P1|STARTED|Overall Study||40
222562|NCT01190865|538628|P1|NOT COMPLETED|Overall Study||3
222563|NCT01190865|538628|P1|COMPLETED|Overall Study||25
222564|NCT01190865|538628|P1|STARTED|Overall Study||28
222565|NCT01190839|538635|P2|NOT COMPLETED|Overall Study||147
222566|NCT01190839|538636|P1|NOT COMPLETED|Overall Study||150
222567|NCT01190839|538635|P2|COMPLETED|Overall Study||0
222568|NCT01190839|538636|P1|COMPLETED|Overall Study||0
222569|NCT01190839|538635|P2|Treated|Overall Study||143
222570|NCT01190839|538636|P1|Treated|Overall Study||148
222571|NCT01190839|538635|P2|STARTED|Overall Study||147
222572|NCT01190839|538636|P1|STARTED|Overall Study||150
222573|NCT01190813|538650|P2|NOT COMPLETED|Overall Study||4
222574|NCT01190813|538651|P1|NOT COMPLETED|Overall Study||4
222575|NCT01190813|538650|P2|COMPLETED|Overall Study||45
222576|NCT01190813|538651|P1|COMPLETED|Overall Study||86
222577|NCT01190813|538650|P2|26-week Visit|Overall Study|0 missed, 0 dropped|45
222578|NCT01190813|538651|P1|26-week Visit|Overall Study|0 missed, 0 dropped|86
222579|NCT01190813|538650|P2|23-week Phone Call|Overall Study|4 missed, 0 dropped|41
222580|NCT01190813|538651|P1|23-week Phone Call|Overall Study|4 missed, 1 dropped|82
222581|NCT01190813|538650|P2|18-week Visit (Masked Primary)|Overall Study|1 dropped|45
222582|NCT01190813|538651|P1|18-week Visit (Masked Primary)|Overall Study|0 dropped|87
222583|NCT01190813|538650|P2|16-week Visit|Overall Study|2 dropped|46
222584|NCT01190813|538651|P1|16-week Visit|Overall Study|1 dropped|87
222585|NCT01190813|538650|P2|13-week Phone Call|Overall Study|0 dropped, 0 missed|48
222586|NCT01190813|538651|P1|13-week Phone Call|Overall Study|6 missed, 0 dropped|82
222587|NCT01190813|538650|P2|10-week Visit|Overall Study|0 dropped, 0 missed|48
222588|NCT01190813|538651|P1|10-week Visit|Overall Study|0 missed, 0 dropped|88
222589|NCT01190813|538650|P2|7-week Phone Call|Overall Study|2 missed, 0 dropped|46
222590|NCT01190813|538651|P1|7-week Phone Call|Overall Study|3 missed, 0 dropped|85
222591|NCT01190813|538650|P2|4-week Visit|Overall Study|1 missed, 1 dropped|47
222592|NCT01190813|538651|P1|4-week Visit|Overall Study|0 missed, 1 dropped|88
222593|NCT01190813|538650|P2|2-week Phone Call|Overall Study|1 missed, 0 dropped|48
222594|NCT01190813|538651|P1|2-week Phone Call|Overall Study|2 missed, 1 dropped|87
222595|NCT01190813|538650|P2|STARTED|Overall Study||49
222596|NCT01190813|538651|P1|STARTED|Overall Study||90
222597|NCT01190566|538743|P2|NOT COMPLETED|Overall Study||0
222598|NCT01190566|538744|P1|NOT COMPLETED|Overall Study||0
222599|NCT01190566|538743|P2|COMPLETED|Overall Study||42
222600|NCT01190566|538744|P1|COMPLETED|Overall Study||6
222601|NCT01190566|538743|P2|STARTED|Overall Study||42
222602|NCT01190566|538744|P1|STARTED|Overall Study||6
222603|NCT01190527|538765|P1|NOT COMPLETED|Overall Study||0
222604|NCT01190527|538765|P1|COMPLETED|Overall Study||42
222605|NCT01190527|538765|P1|STARTED|Overall Study||42
222606|NCT01190514|538772|P4|NOT COMPLETED|Fourth Intervention (Period 4)||0
222607|NCT01190514|538773|P3|NOT COMPLETED|Fourth Intervention (Period 4)||0
222608|NCT01190514|538774|P2|NOT COMPLETED|Fourth Intervention (Period 4)||0
222609|NCT01190514|538775|P1|NOT COMPLETED|Fourth Intervention (Period 4)||0
222610|NCT01190514|538772|P4|COMPLETED|Fourth Intervention (Period 4)||10
222611|NCT01190514|538773|P3|COMPLETED|Fourth Intervention (Period 4)||10
222612|NCT01190514|538774|P2|COMPLETED|Fourth Intervention (Period 4)||10
222613|NCT01190514|538775|P1|COMPLETED|Fourth Intervention (Period 4)||9
222614|NCT01190514|538772|P4|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment A|10
222615|NCT01190514|538773|P3|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment B|10
222616|NCT01190514|538774|P2|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment C|10
222617|NCT01190514|538775|P1|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment D|9
222618|NCT01190514|538772|P4|NOT COMPLETED|Third Intervention (Period 3)||0
222619|NCT01190514|538773|P3|NOT COMPLETED|Third Intervention (Period 3)||0
222620|NCT01190514|538774|P2|NOT COMPLETED|Third Intervention (Period 3)||0
222621|NCT01190514|538775|P1|NOT COMPLETED|Third Intervention (Period 3)||1
222622|NCT01190514|538772|P4|COMPLETED|Third Intervention (Period 3)||10
222623|NCT01190514|538773|P3|COMPLETED|Third Intervention (Period 3)||10
222624|NCT01190514|538774|P2|COMPLETED|Third Intervention (Period 3)||10
222625|NCT01190514|538775|P1|COMPLETED|Third Intervention (Period 3)|Discontinued participant received treatments ABC of sequence ABCD.|9
222626|NCT01190514|538772|P4|STARTED|Third Intervention (Period 3)|Period 3 received treatment B|10
222627|NCT01190514|538773|P3|STARTED|Third Intervention (Period 3)|Period 3 received treatment A|10
222628|NCT01190514|538774|P2|STARTED|Third Intervention (Period 3)|Period 3 received treatment D|10
222629|NCT01190514|538775|P1|STARTED|Third Intervention (Period 3)|Period 3 received treatment C|10
222630|NCT01190514|538772|P4|NOT COMPLETED|Second Intervention (Period 2)||0
222631|NCT01190514|538773|P3|NOT COMPLETED|Second Intervention (Period 2)||0
222632|NCT01190514|538774|P2|NOT COMPLETED|Second Intervention (Period 2)||0
222633|NCT01190514|538775|P1|NOT COMPLETED|Second Intervention (Period 2)||0
222634|NCT01190514|538772|P4|COMPLETED|Second Intervention (Period 2)||10
222635|NCT01190514|538773|P3|COMPLETED|Second Intervention (Period 2)||10
222636|NCT01190514|538774|P2|COMPLETED|Second Intervention (Period 2)||10
222637|NCT01190514|538775|P1|COMPLETED|Second Intervention (Period 2)||10
222638|NCT01190514|538772|P4|STARTED|Second Intervention (Period 2)|Period 2 received treatment C|10
222639|NCT01190514|538773|P3|STARTED|Second Intervention (Period 2)|Period 2 received treatment D|10
222640|NCT01190514|538774|P2|STARTED|Second Intervention (Period 2)|Period 2 received treatment A|10
222641|NCT01190514|538775|P1|STARTED|Second Intervention (Period 2)|Period 2 received treatment B|10
222642|NCT01190514|538772|P4|NOT COMPLETED|First Intervention (Period 1)||0
222643|NCT01190514|538773|P3|NOT COMPLETED|First Intervention (Period 1)||0
222644|NCT01190514|538774|P2|NOT COMPLETED|First Intervention (Period 1)||0
222645|NCT01190514|538775|P1|NOT COMPLETED|First Intervention (Period 1)||1
222646|NCT01190514|538772|P4|COMPLETED|First Intervention (Period 1)||10
222647|NCT01190514|538773|P3|COMPLETED|First Intervention (Period 1)||10
222648|NCT01190514|538774|P2|COMPLETED|First Intervention (Period 1)||10
222649|NCT01190514|538775|P1|COMPLETED|First Intervention (Period 1)|Discontinued participant received treatment A of sequence ABCD.|10
222650|NCT01190514|538772|P4|STARTED|First Intervention (Period 1)||10
222651|NCT01190514|538773|P3|STARTED|First Intervention (Period 1)||10
222652|NCT01190514|538774|P2|STARTED|First Intervention (Period 1)||10
222653|NCT01190514|538775|P1|STARTED|First Intervention (Period 1)||11
222654|NCT01190475|538808|P3|NOT COMPLETED|Overall Study||1
222655|NCT01190475|538809|P2|NOT COMPLETED|Overall Study||0
222656|NCT01190475|538810|P1|NOT COMPLETED|Overall Study||0
222657|NCT01190475|538808|P3|COMPLETED|Overall Study||1
222658|NCT01190475|538809|P2|COMPLETED|Overall Study||2
222659|NCT01190475|538810|P1|COMPLETED|Overall Study||2
222660|NCT01190475|538808|P3|STARTED|Overall Study||2
222661|NCT01190475|538809|P2|STARTED|Overall Study||2
222662|NCT01190475|538810|P1|STARTED|Overall Study||2
222663|NCT01190449|538820|P2|NOT COMPLETED|Overall Study||4
222664|NCT01190449|538821|P1|NOT COMPLETED|Overall Study||0
222665|NCT01190449|538820|P2|COMPLETED|Overall Study||32
222666|NCT01190449|538821|P1|COMPLETED|Overall Study||15
222667|NCT01190449|538820|P2|STARTED|Overall Study||36
222668|NCT01190449|538821|P1|STARTED|Overall Study||15
222669|NCT01190436|538829|P1|NOT COMPLETED|Overall Study||39
222670|NCT01190436|538829|P1|COMPLETED|Overall Study||86
222671|NCT01190436|538829|P1|STARTED|Overall Study||125
222672|NCT01190410|538845|P2|NOT COMPLETED|Overall Study||9
222673|NCT01190410|538846|P1|NOT COMPLETED|Overall Study||1
222674|NCT01190410|538845|P2|COMPLETED|Overall Study||3
222675|NCT01190410|538846|P1|COMPLETED|Overall Study||3
222676|NCT01190410|538845|P2|Re-Induction|Overall Study||2
222677|NCT01190410|538846|P1|Re-Induction|Overall Study||0
222678|NCT01190410|538845|P2|STARTED|Overall Study||12
222679|NCT01190410|538846|P1|STARTED|Overall Study||4
222680|NCT01190306|538865|P2|NOT COMPLETED|Overall Study||0
222681|NCT01190306|538866|P1|NOT COMPLETED|Overall Study||0
222682|NCT01190306|538865|P2|COMPLETED|Overall Study||66
222683|NCT01190306|538866|P1|COMPLETED|Overall Study||61
222684|NCT01190306|538865|P2|STARTED|Overall Study||66
222685|NCT01190306|538866|P1|STARTED|Overall Study||61
222686|NCT01190267|538874|P2|NOT COMPLETED|Overall Study||4
222687|NCT01190267|538875|P1|NOT COMPLETED|Overall Study||41
222688|NCT01190267|538874|P2|COMPLETED|Overall Study||4
222689|NCT01190267|538875|P1|COMPLETED|Overall Study||155
222690|NCT01190267|538874|P2|STARTED|Overall Study||8
222691|NCT01190267|538875|P1|STARTED|Overall Study||196
222692|NCT01190254|538886|P3|NOT COMPLETED|Overall Study||22
222693|NCT01190254|538887|P2|NOT COMPLETED|Overall Study||17
222694|NCT01190254|538888|P1|NOT COMPLETED|Overall Study||21
222695|NCT01190254|538886|P3|COMPLETED|Overall Study||84
222696|NCT01190254|538887|P2|COMPLETED|Overall Study||81
222697|NCT01190254|538888|P1|COMPLETED|Overall Study||81
222698|NCT01190254|538886|P3|Treated|Overall Study||106
222699|NCT01190254|538887|P2|Treated|Overall Study||98
222700|NCT01190254|538888|P1|Treated|Overall Study||102
222701|NCT01190254|538886|P3|STARTED|Overall Study||106
222702|NCT01190254|538887|P2|STARTED|Overall Study||98
222703|NCT01190254|538888|P1|STARTED|Overall Study||102
222704|NCT01190228|538953|P3|NOT COMPLETED|Overall Study||0
222705|NCT01190228|538954|P2|NOT COMPLETED|Overall Study||0
222706|NCT01190228|538955|P1|NOT COMPLETED|Overall Study||5
222707|NCT01190228|538953|P3|COMPLETED|Overall Study||59
222708|NCT01190228|538954|P2|COMPLETED|Overall Study||46
222709|NCT01190228|538955|P1|COMPLETED|Overall Study||344
222710|NCT01190228|538953|P3|STARTED|Overall Study||59
222711|NCT01190228|538954|P2|STARTED|Overall Study||46
222712|NCT01190228|538955|P1|STARTED|Overall Study||349
222713|NCT01190215|538978|P2|NOT COMPLETED|Up to Month 6||0
222714|NCT01190215|538979|P1|NOT COMPLETED|Up to Month 6||2
222715|NCT01190215|538978|P2|COMPLETED|Up to Month 6||39
222716|NCT01190215|538979|P1|COMPLETED|Up to Month 6||36
222717|NCT01190215|538978|P2|STARTED|Up to Month 6||39
222718|NCT01190215|538979|P1|STARTED|Up to Month 6||38
222719|NCT01190215|538978|P2|NOT COMPLETED|Up to Day 28||0
222720|NCT01190215|538979|P1|NOT COMPLETED|Up to Day 28||0
222721|NCT01190215|538978|P2|COMPLETED|Up to Day 28||39
222722|NCT01190215|538979|P1|COMPLETED|Up to Day 28||38
222723|NCT01190215|538978|P2|STARTED|Up to Day 28||39
222724|NCT01190215|538979|P1|STARTED|Up to Day 28||38
222725|NCT01190189|539047|P1|NOT COMPLETED|Overall Study||6
222726|NCT01190189|539047|P1|COMPLETED|Overall Study||131
222727|NCT01190189|539047|P1|STARTED|Overall Study||137
222728|NCT01190176|539054|P1|NOT COMPLETED|Overall Study||2
222729|NCT01190176|539054|P1|COMPLETED|Overall Study||30
222730|NCT01190176|539054|P1|STARTED|Overall Study||32
222731|NCT01190150|539075|P2|NOT COMPLETED|Second Treatment||0
222732|NCT01190150|539076|P1|NOT COMPLETED|Second Treatment||0
222733|NCT01190150|539075|P2|COMPLETED|Second Treatment||7
222734|NCT01190150|539076|P1|COMPLETED|Second Treatment||10
222735|NCT01190150|539075|P2|STARTED|Second Treatment||7
222736|NCT01190150|539076|P1|STARTED|Second Treatment||10
222737|NCT01190150|539075|P2|NOT COMPLETED|Washout||2
222738|NCT01190150|539076|P1|NOT COMPLETED|Washout||0
222739|NCT01190150|539075|P2|COMPLETED|Washout||7
222740|NCT01190150|539076|P1|COMPLETED|Washout||10
222741|NCT01190150|539075|P2|STARTED|Washout||9
222742|NCT01190150|539076|P1|STARTED|Washout||10
222743|NCT01190150|539075|P2|NOT COMPLETED|First Treatment||0
222744|NCT01190150|539076|P1|NOT COMPLETED|First Treatment||1
222745|NCT01190150|539075|P2|COMPLETED|First Treatment||9
222746|NCT01190150|539076|P1|COMPLETED|First Treatment||10
222747|NCT01190150|539075|P2|STARTED|First Treatment|Randomized, as well as Safety and PK populations|9
222748|NCT01190150|539076|P1|STARTED|First Treatment|Randomized, as well as Safety and PK populations|11
222749|NCT01190124|539103|P3|NOT COMPLETED|Overall Study||1
222750|NCT01190124|539104|P2|NOT COMPLETED|Overall Study||0
222751|NCT01190124|539105|P1|NOT COMPLETED|Overall Study||17
222752|NCT01190124|539103|P3|COMPLETED|Overall Study||19
222753|NCT01190124|539104|P2|COMPLETED|Overall Study||24
222754|NCT01190124|539105|P1|COMPLETED|Overall Study||90
222755|NCT01190124|539103|P3|STARTED|Overall Study||20
222756|NCT01190124|539104|P2|STARTED|Overall Study||24
222757|NCT01190124|539105|P1|STARTED|Overall Study||107
222758|NCT01190098|539143|P2|NOT COMPLETED|Overall Study||2
222759|NCT01190098|539144|P1|NOT COMPLETED|Overall Study||3
222760|NCT01190098|539143|P2|COMPLETED|Overall Study||8
222761|NCT01190098|539144|P1|COMPLETED|Overall Study||39
222762|NCT01190098|539143|P2|STARTED|Overall Study||10
222763|NCT01190098|539144|P1|STARTED|Overall Study||42
222764|NCT01190085|539167|P3|NOT COMPLETED|Overall Study||0
222765|NCT01190085|539168|P2|NOT COMPLETED|Overall Study||0
222766|NCT01190085|539169|P1|NOT COMPLETED|Overall Study||0
222767|NCT01190085|539167|P3|COMPLETED|Overall Study||18
222768|NCT01190085|539168|P2|COMPLETED|Overall Study||14
222769|NCT01190085|539169|P1|COMPLETED|Overall Study||13
222770|NCT01190085|539167|P3|STARTED|Overall Study||18
222771|NCT01190085|539168|P2|STARTED|Overall Study||14
222772|NCT01190085|539169|P1|STARTED|Overall Study||13
222773|NCT01190020|539185|P2|NOT COMPLETED|Overall Study||0
222774|NCT01190020|539186|P1|NOT COMPLETED|Overall Study||7
222775|NCT01190020|539185|P2|COMPLETED|Overall Study||12
222776|NCT01190020|539186|P1|COMPLETED|Overall Study||22
222777|NCT01190020|539185|P2|STARTED|Overall Study||12
222778|NCT01190020|539186|P1|STARTED|Overall Study||29
222779|NCT01190007|539198|P1|NOT COMPLETED|Overall Study||14
222780|NCT01190007|539198|P1|COMPLETED|Overall Study||145
222781|NCT01190007|539198|P1|STARTED|Overall Study|Treated|159
222782|NCT01189890|539215|P2|NOT COMPLETED|Overall Study||39
222783|NCT01189890|539216|P1|NOT COMPLETED|Overall Study||37
222784|NCT01189890|539215|P2|COMPLETED|Overall Study||200
222785|NCT01189890|539216|P1|COMPLETED|Overall Study||204
222786|NCT01189890|539215|P2|STARTED|Overall Study|3 randomized glimepiride participants did not receive study drug.|239
222787|NCT01189890|539216|P1|STARTED|Overall Study||241
222788|NCT01189812|539238|P2|NOT COMPLETED|Overall Study||8
222789|NCT01189812|539239|P1|NOT COMPLETED|Overall Study||8
222790|NCT01189812|539238|P2|COMPLETED|Overall Study||32
222791|NCT01189812|539239|P1|COMPLETED|Overall Study||32
222792|NCT01189812|539238|P2|STARTED|Overall Study||40
222793|NCT01189812|539239|P1|STARTED|Overall Study||40
222794|NCT01189760|539248|P3|NOT COMPLETED|Overall Study||51
222795|NCT01189760|539249|P2|NOT COMPLETED|Overall Study||23
222796|NCT01189760|539250|P1|NOT COMPLETED|Overall Study||14
222797|NCT01189760|539248|P3|COMPLETED|Overall Study||255
222798|NCT01189760|539249|P2|COMPLETED|Overall Study||283
222799|NCT01189760|539250|P1|COMPLETED|Overall Study||291
222800|NCT01189760|539248|P3|STARTED|Overall Study||306
222801|NCT01189760|539249|P2|STARTED|Overall Study||306
222802|NCT01189760|539250|P1|STARTED|Overall Study||305
222803|NCT01189747|539284|P2|NOT COMPLETED|Overall Study||18
222804|NCT01189747|539285|P1|NOT COMPLETED|Overall Study||12
222805|NCT01189747|539284|P2|COMPLETED|Overall Study||206
222806|NCT01189747|539285|P1|COMPLETED|Overall Study||210
222807|NCT01189747|539284|P2|STARTED|Overall Study||224
222808|NCT01189747|539285|P1|STARTED|Overall Study||222
222809|NCT01189617|539309|P2|NOT COMPLETED|Overall Study||0
222810|NCT01189617|539310|P1|NOT COMPLETED|Overall Study||0
222811|NCT01189617|539309|P2|COMPLETED|Overall Study||35
222812|NCT01189617|539310|P1|COMPLETED|Overall Study||35
222813|NCT01189617|539309|P2|STARTED|Overall Study||35
222814|NCT01189617|539310|P1|STARTED|Overall Study||35
222815|NCT01189604|539323|P7|NOT COMPLETED|Overall Study||1
222816|NCT01189604|539324|P6|NOT COMPLETED|Overall Study||1
222817|NCT01189604|539325|P5|NOT COMPLETED|Overall Study||2
222818|NCT01189604|539326|P4|NOT COMPLETED|Overall Study||0
222819|NCT01189604|539327|P3|NOT COMPLETED|Overall Study||0
222820|NCT01189604|539328|P2|NOT COMPLETED|Overall Study||1
222821|NCT01189604|539329|P1|NOT COMPLETED|Overall Study||1
222822|NCT01189604|539323|P7|COMPLETED|Overall Study||9
222823|NCT01189604|539324|P6|COMPLETED|Overall Study||10
222824|NCT01189604|539325|P5|COMPLETED|Overall Study||18
222825|NCT01189604|539326|P4|COMPLETED|Overall Study||20
222826|NCT01189604|539327|P3|COMPLETED|Overall Study||20
222827|NCT01189604|539328|P2|COMPLETED|Overall Study||20
222828|NCT01189604|539329|P1|COMPLETED|Overall Study||20
222829|NCT01189604|539323|P7|Administered Study Drug|Overall Study||10
222830|NCT01189604|539324|P6|Administered Study Drug|Overall Study||10
222831|NCT01189604|539325|P5|Administered Study Drug|Overall Study||20
222832|NCT01189604|539326|P4|Administered Study Drug|Overall Study||20
222833|NCT01189604|539327|P3|Administered Study Drug|Overall Study||20
222834|NCT01189604|539328|P2|Administered Study Drug|Overall Study||20
222835|NCT01189604|539329|P1|Administered Study Drug|Overall Study||20
222836|NCT01189604|539323|P7|STARTED|Overall Study||10
222837|NCT01189604|539324|P6|STARTED|Overall Study||11
222838|NCT01189604|539325|P5|STARTED|Overall Study||20
222839|NCT01189604|539326|P4|STARTED|Overall Study||20
222840|NCT01189604|539327|P3|STARTED|Overall Study||20
222841|NCT01189604|539328|P2|STARTED|Overall Study||21
222842|NCT01189604|539329|P1|STARTED|Overall Study||21
222843|NCT01189500|539373|P1|NOT COMPLETED|Period 2: Coadministration TAMOX+DVS SR||1
222844|NCT01189500|539373|P1|COMPLETED|Period 2: Coadministration TAMOX+DVS SR||28
222845|NCT01189500|539373|P1|STARTED|Period 2: Coadministration TAMOX+DVS SR||29
222846|NCT01189500|539373|P1|NOT COMPLETED|Period 1: TAMOX Alone||1
222847|NCT01189500|539373|P1|COMPLETED|Period 1: TAMOX Alone||29
222848|NCT01189500|539373|P1|STARTED|Period 1: TAMOX Alone||30
222849|NCT01189487|539434|P1|NOT COMPLETED|Overall Study||3
222850|NCT01189487|539434|P1|COMPLETED|Overall Study||44
222851|NCT01189487|539434|P1|STARTED|Overall Study|Treated participants|47
222852|NCT01189461|539442|P1|NOT COMPLETED|Overall Study||34
222853|NCT01189461|539442|P1|COMPLETED|Overall Study||12
222854|NCT01189461|539442|P1|STARTED|Overall Study||46
222855|NCT01189435|539449|P1|NOT COMPLETED|Overall Study||2
222856|NCT01189435|539449|P1|COMPLETED|Overall Study||0
222857|NCT01189435|539449|P1|STARTED|Overall Study||2
222858|NCT01189409|539455|P2|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||8
222859|NCT01189409|539456|P1|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||6
222860|NCT01189409|539455|P2|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||15
222861|NCT01189409|539456|P1|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||13
222862|NCT01189409|539455|P2|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||23
222863|NCT01189409|539456|P1|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||19
222864|NCT01189409|539455|P2|NOT COMPLETED|First 3 Weeks||10
222865|NCT01189409|539456|P1|NOT COMPLETED|First 3 Weeks||18
222866|NCT01189409|539455|P2|COMPLETED|First 3 Weeks||23
222867|NCT01189409|539456|P1|COMPLETED|First 3 Weeks||19
222868|NCT01189409|539455|P2|STARTED|First 3 Weeks||33
222869|NCT01189409|539456|P1|STARTED|First 3 Weeks||37
222870|NCT01189370|539471|P3|NOT COMPLETED|Dose Level 3||6
222871|NCT01189370|539472|P2|NOT COMPLETED|Dose Level 3||0
222872|NCT01189370|539473|P1|NOT COMPLETED|Dose Level 3||0
222873|NCT01189370|539471|P3|COMPLETED|Dose Level 3||6
222874|NCT01189370|539472|P2|COMPLETED|Dose Level 3||0
222875|NCT01189370|539473|P1|COMPLETED|Dose Level 3||0
222876|NCT01189370|539471|P3|STARTED|Dose Level 3||12
222877|NCT01189370|539472|P2|STARTED|Dose Level 3||0
222878|NCT01189370|539473|P1|STARTED|Dose Level 3||0
222879|NCT01189370|539471|P3|NOT COMPLETED|Dose Level 2||0
222880|NCT01189370|539472|P2|NOT COMPLETED|Dose Level 2||4
222881|NCT01189370|539473|P1|NOT COMPLETED|Dose Level 2||0
222882|NCT01189370|539471|P3|COMPLETED|Dose Level 2||0
222883|NCT01189370|539472|P2|COMPLETED|Dose Level 2||12
222884|NCT01189370|539473|P1|COMPLETED|Dose Level 2||0
222885|NCT01189370|539471|P3|STARTED|Dose Level 2||0
222886|NCT01189370|539472|P2|STARTED|Dose Level 2||16
222887|NCT01189370|539473|P1|STARTED|Dose Level 2||0
222888|NCT01189370|539471|P3|NOT COMPLETED|Dose Level 1||0
222889|NCT01189370|539472|P2|NOT COMPLETED|Dose Level 1||0
222890|NCT01189370|539473|P1|NOT COMPLETED|Dose Level 1||9
222891|NCT01189370|539471|P3|COMPLETED|Dose Level 1||0
222892|NCT01189370|539472|P2|COMPLETED|Dose Level 1||0
222893|NCT01189370|539473|P1|COMPLETED|Dose Level 1||16
222894|NCT01189370|539471|P3|STARTED|Dose Level 1||0
222895|NCT01189370|539472|P2|STARTED|Dose Level 1||0
222896|NCT01189370|539473|P1|STARTED|Dose Level 1||25
222897|NCT01189292|539482|P2|NOT COMPLETED|Per Protocol Analysis||16
222898|NCT01189292|539483|P1|NOT COMPLETED|Per Protocol Analysis||11
222899|NCT01189292|539482|P2|COMPLETED|Per Protocol Analysis||60
222900|NCT01189292|539483|P1|COMPLETED|Per Protocol Analysis||65
222901|NCT01189292|539482|P2|STARTED|Per Protocol Analysis||76
222902|NCT01189292|539483|P1|STARTED|Per Protocol Analysis||76
222903|NCT01189292|539482|P2|NOT COMPLETED|Intention to Treat Analysis||0
222904|NCT01189292|539483|P1|NOT COMPLETED|Intention to Treat Analysis||0
222905|NCT01189292|539482|P2|COMPLETED|Intention to Treat Analysis||76
222906|NCT01189292|539483|P1|COMPLETED|Intention to Treat Analysis||76
222907|NCT01189292|539482|P2|STARTED|Intention to Treat Analysis||76
222908|NCT01189292|539483|P1|STARTED|Intention to Treat Analysis||76
222909|NCT01189279|539504|P3|NOT COMPLETED|Overall Study||1
222910|NCT01189279|539505|P2|NOT COMPLETED|Overall Study||0
222911|NCT01189279|539506|P1|NOT COMPLETED|Overall Study||1
222912|NCT01189279|539504|P3|COMPLETED|Overall Study||13
222913|NCT01189279|539505|P2|COMPLETED|Overall Study||14
222914|NCT01189279|539506|P1|COMPLETED|Overall Study||13
222915|NCT01189279|539504|P3|STARTED|Overall Study||14
222916|NCT01189279|539505|P2|STARTED|Overall Study||14
222917|NCT01189279|539506|P1|STARTED|Overall Study||14
222918|NCT01189240|539526|P3|NOT COMPLETED|Overall Study||0
222919|NCT01189240|539527|P2|NOT COMPLETED|Overall Study||0
222920|NCT01189240|539528|P1|NOT COMPLETED|Overall Study||0
222921|NCT01189240|539526|P3|COMPLETED|Overall Study||3
222922|NCT01189240|539527|P2|COMPLETED|Overall Study||6
222923|NCT01189240|539528|P1|COMPLETED|Overall Study||4
222924|NCT01189240|539526|P3|STARTED|Overall Study||3
222925|NCT01189240|539527|P2|STARTED|Overall Study||6
222926|NCT01189240|539528|P1|STARTED|Overall Study||4
222927|NCT01189227|539549|P2|NOT COMPLETED|Overall Study||3
222928|NCT01189227|539550|P1|NOT COMPLETED|Overall Study||6
222929|NCT01189227|539549|P2|COMPLETED|Overall Study||0
222930|NCT01189227|539550|P1|COMPLETED|Overall Study||0
222931|NCT01189227|539549|P2|STARTED|Overall Study||3
222932|NCT01189227|539550|P1|STARTED|Overall Study||6
222933|NCT01189201|539556|P1|NOT COMPLETED|Overall Study||1
222934|NCT01189201|539556|P1|COMPLETED|Overall Study||41
222935|NCT01189201|539556|P1|Received Empa/Linagliptin FDC A3(Fasted)|Overall Study||24
222936|NCT01189201|539556|P1|Received Empa/Linagliptin FDC A1 (Fed)|Overall Study||18
222937|NCT01189201|539556|P1|Rec. Empa/Linagliptin Ind.Tablet(Fasted)|Overall Study||41
222938|NCT01189201|539556|P1|Received Empa/Linagliptin FDC A1(Fasted)|Overall Study||42
222939|NCT01189201|539556|P1|STARTED|Overall Study||42
222940|NCT01189136|539612|P2|NOT COMPLETED|Overall Study||0
222941|NCT01189136|539613|P1|NOT COMPLETED|Overall Study||0
222942|NCT01189136|539612|P2|COMPLETED|Overall Study||42
222943|NCT01189136|539613|P1|COMPLETED|Overall Study||42
222944|NCT01189136|539612|P2|STARTED|Overall Study||42
222945|NCT01189136|539613|P1|STARTED|Overall Study||42
222946|NCT01189123|539627|P2|NOT COMPLETED|Overall Study||6
222947|NCT01189123|539628|P1|NOT COMPLETED|Overall Study||2
222948|NCT01189123|539627|P2|COMPLETED|Overall Study||47
222949|NCT01189123|539628|P1|COMPLETED|Overall Study||50
222950|NCT01189123|539627|P2|STARTED|Overall Study||53
222951|NCT01189123|539628|P1|STARTED|Overall Study||52
222952|NCT01189110|539638|P2|NOT COMPLETED|Overall Study||0
222953|NCT01189110|539639|P1|NOT COMPLETED|Overall Study||0
222954|NCT01189110|539638|P2|COMPLETED|Overall Study||61
222955|NCT01189110|539639|P1|COMPLETED|Overall Study|February, 2011|64
222956|NCT01189110|539638|P2|STARTED|Overall Study||61
222957|NCT01189110|539639|P1|STARTED|Overall Study|September, 2010|64
222958|NCT01189071|539647|P2|NOT COMPLETED|Overall Study||0
222959|NCT01189071|539648|P1|NOT COMPLETED|Overall Study||0
222960|NCT01189071|539647|P2|COMPLETED|Overall Study||0
222961|NCT01189071|539648|P1|COMPLETED|Overall Study||0
222962|NCT01189071|539647|P2|STARTED|Overall Study||0
222963|NCT01189071|539648|P1|STARTED|Overall Study||0
222964|NCT01189032|539659|P3|NOT COMPLETED|Overall Study||6
222965|NCT01189032|539660|P2|NOT COMPLETED|Overall Study||7
222966|NCT01189032|539661|P1|NOT COMPLETED|Overall Study||5
222967|NCT01189032|539659|P3|COMPLETED|Overall Study||90
222968|NCT01189032|539660|P2|COMPLETED|Overall Study||89
222969|NCT01189032|539661|P1|COMPLETED|Overall Study||89
222970|NCT01189032|539659|P3|STARTED|Overall Study||96
222971|NCT01189032|539660|P2|STARTED|Overall Study||96
222972|NCT01189032|539661|P1|STARTED|Overall Study||94
222973|NCT01188967|539671|P2|NOT COMPLETED|Overall Study||4
222974|NCT01188967|539672|P1|NOT COMPLETED|Overall Study||5
222975|NCT01188967|539671|P2|COMPLETED|Overall Study||4
222976|NCT01188967|539672|P1|COMPLETED|Overall Study||5
222977|NCT01188967|539671|P2|STARTED|Overall Study||8
222978|NCT01188967|539672|P1|STARTED|Overall Study||10
222979|NCT01188928|539688|P4|NOT COMPLETED|Overall Study||18
222980|NCT01188928|539689|P3|NOT COMPLETED|Overall Study||14
222981|NCT01188928|539690|P2|NOT COMPLETED|Overall Study||62
222982|NCT01188928|539691|P1|NOT COMPLETED|Overall Study||38
222983|NCT01188928|539688|P4|COMPLETED|Overall Study||77
222984|NCT01188928|539689|P3|COMPLETED|Overall Study||82
222985|NCT01188928|539690|P2|COMPLETED|Overall Study||417
222986|NCT01188928|539691|P1|COMPLETED|Overall Study||444
222987|NCT01188928|539688|P4|STARTED|Overall Study||95
222988|NCT01188928|539689|P3|STARTED|Overall Study||96
222989|NCT01188928|539690|P2|STARTED|Overall Study||479
222990|NCT01188928|539691|P1|STARTED|Overall Study||482
222991|NCT01188876|539713|P1|NOT COMPLETED|Overall Study||0
222992|NCT01188876|539713|P1|COMPLETED|Overall Study||50
222993|NCT01188876|539713|P1|STARTED|Overall Study||50
222994|NCT01188811|539725|P2|NOT COMPLETED|Overall Study||2
222995|NCT01188811|539726|P1|NOT COMPLETED|Overall Study||6
222996|NCT01188811|539725|P2|COMPLETED|Overall Study||24
222997|NCT01188811|539726|P1|COMPLETED|Overall Study||22
222998|NCT01188811|539725|P2|STARTED|Overall Study||26
222999|NCT01188811|539726|P1|STARTED|Overall Study||28
223000|NCT01188798|539738|P2|NOT COMPLETED|Overall Study||3
223001|NCT01188798|539739|P1|NOT COMPLETED|Overall Study||2
223002|NCT01188798|539738|P2|COMPLETED|Overall Study||1
223003|NCT01188798|539739|P1|COMPLETED|Overall Study||0
223004|NCT01188798|539738|P2|STARTED|Overall Study||4
223005|NCT01188798|539739|P1|STARTED|Overall Study||2
223006|NCT01188772|539751|P4|NOT COMPLETED|Overall Study||1
223007|NCT01188772|539752|P3|NOT COMPLETED|Overall Study||11
223008|NCT01188772|539753|P2|NOT COMPLETED|Overall Study||3
223009|NCT01188772|539754|P1|NOT COMPLETED|Overall Study||5
223010|NCT01188772|539751|P4|COMPLETED|Overall Study||24
223011|NCT01188772|539752|P3|COMPLETED|Overall Study||15
223012|NCT01188772|539753|P2|COMPLETED|Overall Study||45
223013|NCT01188772|539754|P1|COMPLETED|Overall Study||43
223014|NCT01188772|539751|P4|Randomized and Treated|Overall Study||25
223015|NCT01188772|539752|P3|Randomized and Treated|Overall Study||26
223016|NCT01188772|539753|P2|Randomized and Treated|Overall Study||47
223017|NCT01188772|539754|P1|Randomized and Treated|Overall Study||48
223018|NCT01188772|539751|P4|STARTED|Overall Study||25
223019|NCT01188772|539752|P3|STARTED|Overall Study||26
223020|NCT01188772|539753|P2|STARTED|Overall Study||48
223021|NCT01188772|539754|P1|STARTED|Overall Study||48
223022|NCT01188694|539812|P3|NOT COMPLETED|Overall Study||1
223023|NCT01188694|539813|P2|NOT COMPLETED|Overall Study||1
223024|NCT01188694|539814|P1|NOT COMPLETED|Overall Study||5
223025|NCT01188694|539812|P3|COMPLETED|Overall Study||10
223026|NCT01188694|539813|P2|COMPLETED|Overall Study||15
223027|NCT01188694|539814|P1|COMPLETED|Overall Study||10
223028|NCT01188694|539812|P3|STARTED|Overall Study||11
223029|NCT01188694|539813|P2|STARTED|Overall Study||16
223030|NCT01188694|539814|P1|STARTED|Overall Study||15
223031|NCT01188681|539826|P4|NOT COMPLETED|Overall Study||1
223032|NCT01188681|539827|P3|NOT COMPLETED|Overall Study||1
223033|NCT01188681|539828|P2|NOT COMPLETED|Overall Study||0
223034|NCT01188681|539829|P1|NOT COMPLETED|Overall Study||0
223035|NCT01188681|539826|P4|COMPLETED|Overall Study||33
223036|NCT01188681|539827|P3|COMPLETED|Overall Study||32
223037|NCT01188681|539828|P2|COMPLETED|Overall Study||6
223038|NCT01188681|539829|P1|COMPLETED|Overall Study||6
223039|NCT01188681|539826|P4|STARTED|Overall Study|34 patients enrolled, 33 patients treated. One patient withdrew consent and was not treated.|34
223040|NCT01188681|539827|P3|STARTED|Overall Study|33 patients enrolled, 32 patients treated. One patient had bladder cancer and was not treated.|33
223041|NCT01188681|539828|P2|STARTED|Overall Study||6
223042|NCT01188681|539829|P1|STARTED|Overall Study||6
223043|NCT01188668|539843|P1|NOT COMPLETED|Period 2: Coadministration ARIP + DVS SR||3
223044|NCT01188668|539843|P1|COMPLETED|Period 2: Coadministration ARIP + DVS SR||33
223045|NCT01188668|539843|P1|STARTED|Period 2: Coadministration ARIP + DVS SR||36
223046|NCT01188668|539843|P1|NOT COMPLETED|Period 1: ARIP Alone||2
223047|NCT01188668|539843|P1|COMPLETED|Period 1: ARIP Alone||36
223048|NCT01188668|539843|P1|STARTED|Period 1: ARIP Alone||38
223049|NCT01188655|539876|P1|NOT COMPLETED|Overall Study||13
223050|NCT01188655|539876|P1|COMPLETED|Overall Study||76
223051|NCT01188655|539876|P1|STARTED|Overall Study||89
223052|NCT01188603|539891|P1|NOT COMPLETED|Overall Study||0
223053|NCT01188603|539891|P1|COMPLETED|Overall Study||24
223054|NCT01188603|539891|P1|STARTED|Overall Study||24
223055|NCT01188577|539901|P2|NOT COMPLETED|Visit 2||0
223056|NCT01188577|539902|P1|NOT COMPLETED|Visit 2||0
223057|NCT01188577|539901|P2|COMPLETED|Visit 2||12
223058|NCT01188577|539902|P1|COMPLETED|Visit 2||11
223059|NCT01188577|539901|P2|STARTED|Visit 2||12
223060|NCT01188577|539902|P1|STARTED|Visit 2||11
223061|NCT01188577|539901|P2|NOT COMPLETED|3-14 Day Washout||0
223062|NCT01188577|539902|P1|NOT COMPLETED|3-14 Day Washout||0
223063|NCT01188577|539901|P2|COMPLETED|3-14 Day Washout||12
223064|NCT01188577|539902|P1|COMPLETED|3-14 Day Washout||11
223065|NCT01188577|539901|P2|STARTED|3-14 Day Washout||12
223066|NCT01188577|539902|P1|STARTED|3-14 Day Washout||11
223067|NCT01188577|539901|P2|NOT COMPLETED|Visit 1||0
223068|NCT01188577|539902|P1|NOT COMPLETED|Visit 1||0
223069|NCT01188577|539901|P2|COMPLETED|Visit 1||12
223070|NCT01188577|539902|P1|COMPLETED|Visit 1||11
223071|NCT01188577|539901|P2|STARTED|Visit 1||12
223072|NCT01188577|539902|P1|STARTED|Visit 1||11
223073|NCT01188564|539920|P2|NOT COMPLETED|Open Label Phase||0
223074|NCT01188564|539921|P1|NOT COMPLETED|Open Label Phase||0
223075|NCT01188564|539920|P2|COMPLETED|Open Label Phase||20
223076|NCT01188564|539921|P1|COMPLETED|Open Label Phase||24
223077|NCT01188564|539920|P2|STARTED|Open Label Phase|Not all Double Blind Phase participants went on to Open Label Phase|20
223078|NCT01188564|539921|P1|STARTED|Open Label Phase|Not all Double-Blind Phase participants went on to Open Label Phase|24
223079|NCT01188564|539920|P2|NOT COMPLETED|Double-blind Phase||0
223080|NCT01188564|539921|P1|NOT COMPLETED|Double-blind Phase||1
223081|NCT01188564|539920|P2|COMPLETED|Double-blind Phase||31
223082|NCT01188564|539921|P1|COMPLETED|Double-blind Phase||43
223083|NCT01188564|539920|P2|STARTED|Double-blind Phase||31
223084|NCT01188564|539921|P1|STARTED|Double-blind Phase||44
223085|NCT01188551|539933|P4|NOT COMPLETED|Overall Study||0
223086|NCT01188551|539934|P3|NOT COMPLETED|Overall Study||0
223087|NCT01188551|539935|P2|NOT COMPLETED|Overall Study||0
223088|NCT01188551|539936|P1|NOT COMPLETED|Overall Study||1
223089|NCT01188551|539933|P4|COMPLETED|Overall Study||25
223090|NCT01188551|539934|P3|COMPLETED|Overall Study||25
223091|NCT01188551|539935|P2|COMPLETED|Overall Study||25
223092|NCT01188551|539936|P1|COMPLETED|Overall Study||24
223093|NCT01188551|539933|P4|STARTED|Overall Study||25
223094|NCT01188551|539934|P3|STARTED|Overall Study||25
223095|NCT01188551|539935|P2|STARTED|Overall Study||25
223096|NCT01188551|539936|P1|STARTED|Overall Study||25
223097|NCT01188538|539952|P2|NOT COMPLETED|Overall Study||1
223098|NCT01188538|539953|P1|NOT COMPLETED|Overall Study||0
223099|NCT01188538|539952|P2|COMPLETED|Overall Study||19
223100|NCT01188538|539953|P1|COMPLETED|Overall Study||20
223101|NCT01188538|539952|P2|STARTED|Overall Study||20
223102|NCT01188538|539953|P1|STARTED|Overall Study||20
223103|NCT01188499|539966|P5|NOT COMPLETED|Overall Study||0
223104|NCT01188499|539967|P4|NOT COMPLETED|Overall Study||0
223105|NCT01188499|539968|P3|NOT COMPLETED|Overall Study||0
223106|NCT01188499|539969|P2|NOT COMPLETED|Overall Study||0
223107|NCT01188499|539970|P1|NOT COMPLETED|Overall Study||0
223108|NCT01188499|539966|P5|COMPLETED|Overall Study||18
223109|NCT01188499|539967|P4|COMPLETED|Overall Study||18
223110|NCT01188499|539968|P3|COMPLETED|Overall Study||33
223111|NCT01188499|539969|P2|COMPLETED|Overall Study||83
223112|NCT01188499|539970|P1|COMPLETED|Overall Study||24
223113|NCT01188499|539966|P5|STARTED|Overall Study||18
223114|NCT01188499|539967|P4|STARTED|Overall Study||18
223115|NCT01188499|539968|P3|STARTED|Overall Study||33
223116|NCT01188499|539969|P2|STARTED|Overall Study||83
223117|NCT01188499|539970|P1|STARTED|Overall Study||24
223118|NCT01188460|539989|P2|NOT COMPLETED|Overall Study||0
223119|NCT01188460|539990|P1|NOT COMPLETED|Overall Study||0
223120|NCT01188460|539989|P2|COMPLETED|Overall Study||23
223121|NCT01188460|539990|P1|COMPLETED|Overall Study||25
223122|NCT01188460|539989|P2|STARTED|Overall Study||23
223123|NCT01188460|539990|P1|STARTED|Overall Study||25
223124|NCT01188447|540016|P1|NOT COMPLETED|Overall Study||0
223125|NCT01188447|540016|P1|COMPLETED|Overall Study||4034
223126|NCT01188447|540016|P1|STARTED|Overall Study||4034
223127|NCT01188421|540027|P3|NOT COMPLETED|Overall Study||14
223128|NCT01188421|540028|P2|NOT COMPLETED|Overall Study||10
223129|NCT01188421|540029|P1|NOT COMPLETED|Overall Study||3
223130|NCT01188421|540027|P3|COMPLETED|Overall Study||22
223131|NCT01188421|540028|P2|COMPLETED|Overall Study||26
223132|NCT01188421|540029|P1|COMPLETED|Overall Study||28
223133|NCT01188421|540027|P3|STARTED|Overall Study||36
223134|NCT01188421|540028|P2|STARTED|Overall Study||36
223135|NCT01188421|540029|P1|STARTED|Overall Study||31
223136|NCT01188369|540039|P2|NOT COMPLETED|Overall Study||0
223137|NCT01188369|540040|P1|NOT COMPLETED|Overall Study||0
223138|NCT01188369|540039|P2|COMPLETED|Overall Study||10
223139|NCT01188369|540040|P1|COMPLETED|Overall Study||10
223140|NCT01188369|540039|P2|STARTED|Overall Study||10
223141|NCT01188369|540040|P1|STARTED|Overall Study||10
223142|NCT01188343|540049|P3|NOT COMPLETED|Overall Study||1
223143|NCT01188343|540050|P2|NOT COMPLETED|Overall Study||26
223144|NCT01188343|540051|P1|NOT COMPLETED|Overall Study||1
223145|NCT01188343|540049|P3|COMPLETED|Overall Study||220
223146|NCT01188343|540050|P2|COMPLETED|Overall Study||193
223147|NCT01188343|540051|P1|COMPLETED|Overall Study||101
223148|NCT01188343|540049|P3|STARTED|Overall Study||221
223149|NCT01188343|540050|P2|STARTED|Overall Study||219
223150|NCT01188343|540051|P1|STARTED|Overall Study||102
223151|NCT01188226|540077|P1|NOT COMPLETED|Overall Study||4
223152|NCT01188226|540077|P1|COMPLETED|Overall Study||6
223153|NCT01188226|540077|P1|STARTED|Overall Study||10
223154|NCT01188109|540116|P1|NOT COMPLETED|Overall Study||0
223155|NCT01188109|540116|P1|COMPLETED|Overall Study||22
223156|NCT01188109|540116|P1|STARTED|Overall Study||22
223157|NCT01187953|540123|P2|NOT COMPLETED|Overall Study||21
223158|NCT01187953|540124|P1|NOT COMPLETED|Overall Study||15
223159|NCT01187953|540123|P2|COMPLETED|Overall Study||254
223160|NCT01187953|540124|P1|COMPLETED|Overall Study||253
223161|NCT01187953|540123|P2|Dosed|Overall Study||271
223162|NCT01187953|540124|P1|Dosed|Overall Study||266
223163|NCT01187953|540123|P2|STARTED|Overall Study||275
223164|NCT01187953|540124|P1|STARTED|Overall Study||268
223165|NCT01187914|540132|P1|NOT COMPLETED|Overall Study||0
223166|NCT01187914|540132|P1|COMPLETED|Overall Study||40
223167|NCT01187914|540132|P1|STARTED|Overall Study||40
223168|NCT01187901|540138|P2|NOT COMPLETED|Overall Study||10
223169|NCT01187901|540139|P1|NOT COMPLETED|Overall Study||9
223170|NCT01187901|540138|P2|COMPLETED|Overall Study||36
223171|NCT01187901|540139|P1|COMPLETED|Overall Study||37
223172|NCT01187901|540138|P2|STARTED|Overall Study||46
223173|NCT01187901|540139|P1|STARTED|Overall Study||46
223174|NCT01187771|540157|P2|NOT COMPLETED|Overall Study||3
223175|NCT01187771|540158|P1|NOT COMPLETED|Overall Study||3
223176|NCT01187771|540157|P2|COMPLETED|Overall Study||18
223177|NCT01187771|540158|P1|COMPLETED|Overall Study||25
223178|NCT01187771|540157|P2|STARTED|Overall Study||21
223179|NCT01187771|540158|P1|STARTED|Overall Study||28
223180|NCT01187550|540180|P2|NOT COMPLETED|Overall Study||1
223181|NCT01187550|540181|P1|NOT COMPLETED|Overall Study||14
223182|NCT01187550|540180|P2|COMPLETED|Overall Study||29
223183|NCT01187550|540181|P1|COMPLETED|Overall Study||169
223184|NCT01187550|540180|P2|Treated|Overall Study||30
223185|NCT01187550|540181|P1|Treated|Overall Study||175
223186|NCT01187550|540180|P2|STARTED|Overall Study||30
223187|NCT01187550|540181|P1|STARTED|Overall Study||183
223188|NCT01187511|540199|P2|NOT COMPLETED|Overall Study||1
223189|NCT01187511|540200|P1|NOT COMPLETED|Overall Study||8
223190|NCT01187511|540199|P2|COMPLETED|Overall Study||21
223191|NCT01187511|540200|P1|COMPLETED|Overall Study||14
223192|NCT01187511|540199|P2|STARTED|Overall Study||22
223193|NCT01187511|540200|P1|STARTED|Overall Study||22
223194|NCT01187498|540308|P2|NOT COMPLETED|Overall Study||10
223195|NCT01187498|540309|P1|NOT COMPLETED|Overall Study||9
223196|NCT01187498|540308|P2|COMPLETED|Overall Study||60
223197|NCT01187498|540309|P1|COMPLETED|Overall Study||64
223198|NCT01187498|540308|P2|STARTED|Overall Study||70
223199|NCT01187498|540309|P1|STARTED|Overall Study||73
223200|NCT01187446|540337|P2|NOT COMPLETED|Overall Study||1
223201|NCT01187446|540338|P1|NOT COMPLETED|Overall Study||0
223202|NCT01187446|540337|P2|COMPLETED|Overall Study||13
223203|NCT01187446|540338|P1|COMPLETED|Overall Study||14
223204|NCT01187446|540337|P2|STARTED|Overall Study||14
223205|NCT01187446|540338|P1|STARTED|Overall Study||14
223206|NCT01187433|540354|P2|NOT COMPLETED|Overall Study||4
223207|NCT01187433|540355|P1|NOT COMPLETED|Overall Study||11
223208|NCT01187433|540354|P2|COMPLETED|Overall Study||46
223209|NCT01187433|540355|P1|COMPLETED|Overall Study||89
223210|NCT01187433|540354|P2|STARTED|Overall Study||50
223211|NCT01187433|540355|P1|STARTED|Overall Study||100
223212|NCT01187407|540385|P5|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||75
223213|NCT01187407|540386|P4|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||29
223214|NCT01187407|540387|P3|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
223215|NCT01187407|540388|P2|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||36
223216|NCT01187407|540389|P1|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
223217|NCT01187407|540385|P5|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||626
223218|NCT01187407|540386|P4|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||202
223219|NCT01187407|540387|P3|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||191
223220|NCT01187407|540388|P2|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
223221|NCT01187407|540389|P1|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
223222|NCT01187407|540385|P5|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|660
223223|NCT01187407|540386|P4|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|220
223224|NCT01187407|540387|P3|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|215
223225|NCT01187407|540388|P2|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|212
223226|NCT01187407|540389|P1|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
223227|NCT01187407|540385|P5|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||701
223228|NCT01187407|540386|P4|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
223229|NCT01187407|540387|P3|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||226
223230|NCT01187407|540388|P2|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||232
223231|NCT01187407|540389|P1|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
223232|NCT01187407|540385|P5|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
223233|NCT01187407|540386|P4|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
223234|NCT01187407|540387|P3|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
223235|NCT01187407|540388|P2|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
223236|NCT01187407|540389|P1|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||90
223237|NCT01187407|540385|P5|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
223238|NCT01187407|540386|P4|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
223239|NCT01187407|540387|P3|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
223240|NCT01187407|540388|P2|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
223241|NCT01187407|540389|P1|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|1390
223242|NCT01187407|540385|P5|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
223243|NCT01187407|540386|P4|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
223244|NCT01187407|540387|P3|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
223245|NCT01187407|540388|P2|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
223246|NCT01187407|540389|P1|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|25
223247|NCT01187407|540385|P5|STARTED|Confirmation (CF) Phase, 3 Weeks||0
223248|NCT01187407|540386|P4|STARTED|Confirmation (CF) Phase, 3 Weeks||0
223249|NCT01187407|540387|P3|STARTED|Confirmation (CF) Phase, 3 Weeks||0
223250|NCT01187407|540388|P2|STARTED|Confirmation (CF) Phase, 3 Weeks||0
223251|NCT01187407|540389|P1|STARTED|Confirmation (CF) Phase, 3 Weeks||1480
223252|NCT01187381|540459|P1|NOT COMPLETED|Overall Study||0
223253|NCT01187381|540459|P1|COMPLETED|Overall Study|A participant completed study when the trastuzumab treatment was discontinued.|250
223254|NCT01187381|540459|P1|STARTED|Overall Study||250
223255|NCT01187355|540471|P2|NOT COMPLETED|Overall Study||20
223256|NCT01187355|540472|P1|NOT COMPLETED|Overall Study||18
223257|NCT01187355|540471|P2|COMPLETED|Overall Study||277
223258|NCT01187355|540472|P1|COMPLETED|Overall Study||276
223259|NCT01187355|540471|P2|STARTED|Overall Study||297
223260|NCT01187355|540472|P1|STARTED|Overall Study||294
223261|NCT01187329|540484|P2|NOT COMPLETED|Overall Study||2
223262|NCT01187329|540485|P1|NOT COMPLETED|Overall Study||1
223263|NCT01187329|540484|P2|COMPLETED|Overall Study||48
223264|NCT01187329|540485|P1|COMPLETED|Overall Study||49
223265|NCT01187329|540484|P2|STARTED|Overall Study||50
223266|NCT01187329|540485|P1|STARTED|Overall Study||50
223267|NCT01187043|540502|P5|NOT COMPLETED|Overall Study||2
223268|NCT01187043|540503|P4|NOT COMPLETED|Overall Study||0
223269|NCT01187043|540504|P3|NOT COMPLETED|Overall Study||4
223270|NCT01187043|540505|P2|NOT COMPLETED|Overall Study||0
223271|NCT01187043|540506|P1|NOT COMPLETED|Overall Study||1
223272|NCT01187043|540502|P5|COMPLETED|Overall Study||10
223273|NCT01187043|540503|P4|COMPLETED|Overall Study||12
223274|NCT01187043|540504|P3|COMPLETED|Overall Study||8
223275|NCT01187043|540505|P2|COMPLETED|Overall Study||10
223276|NCT01187043|540506|P1|COMPLETED|Overall Study||11
223277|NCT01187043|540502|P5|STARTED|Overall Study||12
223278|NCT01187043|540503|P4|STARTED|Overall Study||12
223279|NCT01187043|540504|P3|STARTED|Overall Study||12
223280|NCT01187043|540505|P2|STARTED|Overall Study||10
223281|NCT01187043|540506|P1|STARTED|Overall Study||12
223282|NCT01187017|540518|P1|NOT COMPLETED|Overall Study||0
223283|NCT01187017|540518|P1|COMPLETED|Overall Study||1
223284|NCT01187017|540518|P1|STARTED|Overall Study||1
223285|NCT01187004|540524|P2|NOT COMPLETED|Overall Study||0
223286|NCT01187004|540525|P1|NOT COMPLETED|Overall Study||0
223287|NCT01187004|540524|P2|COMPLETED|Overall Study||144
223288|NCT01187004|540525|P1|COMPLETED|Overall Study||20
223289|NCT01187004|540524|P2|STARTED|Overall Study||144
223290|NCT01187004|540525|P1|STARTED|Overall Study||20
223291|NCT01186939|540532|P1|NOT COMPLETED|Overall Study||40
223292|NCT01186939|540532|P1|COMPLETED|Overall Study||0
223293|NCT01186939|540532|P1|STARTED|Overall Study||40
223294|NCT01186848|540536|P1|NOT COMPLETED|Overall Study||8
223295|NCT01186848|540536|P1|COMPLETED|Overall Study||22
223296|NCT01186848|540536|P1|STARTED|Overall Study||30
223297|NCT01186809|540542|P1|NOT COMPLETED|Overall Study||30
223298|NCT01186809|540542|P1|COMPLETED|Overall Study||43
223299|NCT01186809|540542|P1|STARTED|Overall Study||73
223300|NCT01186796|540548|P2|NOT COMPLETED|Overall Study||2
223301|NCT01186796|540549|P1|NOT COMPLETED|Overall Study||4
223302|NCT01186796|540548|P2|COMPLETED|Overall Study||14
223303|NCT01186796|540549|P1|COMPLETED|Overall Study||10
223304|NCT01186796|540548|P2|STARTED|Overall Study|1 subject was randomized but withdrew before study interventions.|16
223305|NCT01186796|540549|P1|STARTED|Overall Study||14
223306|NCT01186770|540567|P4|NOT COMPLETED|Overall Study||58
223307|NCT01186770|540568|P3|NOT COMPLETED|Overall Study||52
223308|NCT01186770|540569|P2|NOT COMPLETED|Overall Study||46
223309|NCT01186770|540570|P1|NOT COMPLETED|Overall Study||41
223310|NCT01186770|540567|P4|COMPLETED|Overall Study||143
223311|NCT01186770|540568|P3|COMPLETED|Overall Study||148
223312|NCT01186770|540569|P2|COMPLETED|Overall Study||156
223313|NCT01186770|540570|P1|COMPLETED|Overall Study||160
223314|NCT01186770|540567|P4|Intent-to-treat (ITT Population)|Overall Study||201
223315|NCT01186770|540568|P3|Intent-to-treat (ITT Population)|Overall Study||200
223316|NCT01186770|540569|P2|Intent-to-treat (ITT Population)|Overall Study||201
223317|NCT01186770|540570|P1|Intent-to-treat (ITT Population)|Overall Study||201
223318|NCT01186770|540567|P4|STARTED|Overall Study||201
223319|NCT01186770|540568|P3|STARTED|Overall Study||200
223320|NCT01186770|540569|P2|STARTED|Overall Study||202
223321|NCT01186770|540570|P1|STARTED|Overall Study||201
223322|NCT01186744|540594|P6|NOT COMPLETED|Overall Study||26
223323|NCT01186744|540595|P5|NOT COMPLETED|Overall Study||6
223324|NCT01186744|540596|P4|NOT COMPLETED|Overall Study||12
223325|NCT01186744|540597|P3|NOT COMPLETED|Overall Study||6
223326|NCT01186744|540598|P2|NOT COMPLETED|Overall Study||152
223327|NCT01186744|540599|P1|NOT COMPLETED|Overall Study||208
223328|NCT01186744|540594|P6|COMPLETED|Overall Study||107
223329|NCT01186744|540595|P5|COMPLETED|Overall Study||39
223330|NCT01186744|540596|P4|COMPLETED|Overall Study||70
223331|NCT01186744|540597|P3|COMPLETED|Overall Study||25
223332|NCT01186744|540598|P2|COMPLETED|Overall Study||5
223333|NCT01186744|540599|P1|COMPLETED|Overall Study||10
223334|NCT01186744|540594|P6|STARTED|Overall Study||133
223335|NCT01186744|540595|P5|STARTED|Overall Study||45
223336|NCT01186744|540596|P4|STARTED|Overall Study||82
223337|NCT01186744|540597|P3|STARTED|Overall Study||31
223338|NCT01186744|540598|P2|STARTED|Overall Study||157
223339|NCT01186744|540599|P1|STARTED|Overall Study||218
223340|NCT01186705|541015|P1|NOT COMPLETED|Overall Study||0
223341|NCT01186705|541015|P1|COMPLETED|Overall Study||1
223342|NCT01186705|541015|P1|STARTED|Overall Study||1
223343|NCT01186692|541019|P1|NOT COMPLETED|Overall Study||32
223344|NCT01186692|541019|P1|COMPLETED|Overall Study||99
223345|NCT01186692|541019|P1|STARTED|Overall Study||131
223346|NCT01186562|541029|P2|NOT COMPLETED|Overall Study||2
223347|NCT01186562|541030|P1|NOT COMPLETED|Overall Study||4
223348|NCT01186562|541029|P2|COMPLETED|Overall Study||27
223349|NCT01186562|541030|P1|COMPLETED|Overall Study||50
223350|NCT01186562|541029|P2|STARTED|Overall Study||29
223351|NCT01186562|541030|P1|STARTED|Overall Study||54
223352|NCT01186458|541046|P1|NOT COMPLETED|Overall Study||1
223353|NCT01186458|541046|P1|COMPLETED|Overall Study||3
223354|NCT01186458|541046|P1|STARTED|Overall Study||4
223355|NCT01186419|541055|P2|NOT COMPLETED|Overall Study||9
223356|NCT01186419|541056|P1|NOT COMPLETED|Overall Study||7
223357|NCT01186419|541055|P2|COMPLETED|Overall Study||18
223358|NCT01186419|541056|P1|COMPLETED|Overall Study||17
223359|NCT01186419|541055|P2|STARTED|Overall Study||27
223360|NCT01186419|541056|P1|STARTED|Overall Study||24
223361|NCT01186406|541063|P1|NOT COMPLETED|Overall Study||0
223362|NCT01186406|541063|P1|COMPLETED|Overall Study||41
223363|NCT01186406|541063|P1|STARTED|Overall Study||41
223364|NCT01186328|541070|P3|NOT COMPLETED|Overall Study||0
223365|NCT01186328|541071|P2|NOT COMPLETED|Overall Study||0
223366|NCT01186328|541072|P1|NOT COMPLETED|Overall Study||1
223367|NCT01186328|541070|P3|COMPLETED|Overall Study||0
223368|NCT01186328|541071|P2|COMPLETED|Overall Study||0
223369|NCT01186328|541072|P1|COMPLETED|Overall Study||5
223370|NCT01186328|541070|P3|STARTED|Overall Study||0
223371|NCT01186328|541071|P2|STARTED|Overall Study||0
223372|NCT01186328|541072|P1|STARTED|Overall Study||6
223373|NCT01186250|541080|P2|NOT COMPLETED|Overall Study||0
223374|NCT01186250|541081|P1|NOT COMPLETED|Overall Study||1
223375|NCT01186250|541080|P2|COMPLETED|Overall Study||9
223376|NCT01186250|541081|P1|COMPLETED|Overall Study||8
223377|NCT01186250|541080|P2|STARTED|Overall Study||9
223378|NCT01186250|541081|P1|STARTED|Overall Study||9
223379|NCT01185964|541102|P4|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||5
223380|NCT01185964|541103|P3|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
223381|NCT01185964|541104|P2|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
223382|NCT01185964|541105|P1|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
223383|NCT01185964|541102|P4|COMPLETED|Optional Olaratumab Monotherapy on Dox||25
223384|NCT01185964|541103|P3|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
223385|NCT01185964|541104|P2|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
223386|NCT01185964|541105|P1|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
223387|NCT01185964|541102|P4|STARTED|Optional Olaratumab Monotherapy on Dox|Participants with disease progression after treatment received olaratumab.|30
223388|NCT01185964|541103|P3|STARTED|Optional Olaratumab Monotherapy on Dox||0
223389|NCT01185964|541104|P2|STARTED|Optional Olaratumab Monotherapy on Dox||0
223390|NCT01185964|541105|P1|STARTED|Optional Olaratumab Monotherapy on Dox||0
223391|NCT01185964|541102|P4|NOT COMPLETED|Phase 1b and Phase 2||0
223392|NCT01185964|541103|P3|NOT COMPLETED|Phase 1b and Phase 2||9
223393|NCT01185964|541104|P2|NOT COMPLETED|Phase 1b and Phase 2||10
223394|NCT01185964|541105|P1|NOT COMPLETED|Phase 1b and Phase 2||2
223395|NCT01185964|541102|P4|COMPLETED|Phase 1b and Phase 2||0
223396|NCT01185964|541103|P3|COMPLETED|Phase 1b and Phase 2||58
223397|NCT01185964|541104|P2|COMPLETED|Phase 1b and Phase 2||56
223398|NCT01185964|541105|P1|COMPLETED|Phase 1b and Phase 2||13
223399|NCT01185964|541102|P4|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||0
223400|NCT01185964|541103|P3|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||65
223401|NCT01185964|541104|P2|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||64
223402|NCT01185964|541105|P1|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||15
223403|NCT01185964|541102|P4|STARTED|Phase 1b and Phase 2||0
223404|NCT01185964|541103|P3|STARTED|Phase 1b and Phase 2||67
223405|NCT01185964|541104|P2|STARTED|Phase 1b and Phase 2||66
223406|NCT01185964|541105|P1|STARTED|Phase 1b and Phase 2||15
223407|NCT01185834|541131|P1|NOT COMPLETED|Overall Study||14
223408|NCT01185834|541131|P1|COMPLETED|Overall Study||104
223409|NCT01185834|541131|P1|STARTED|Overall Study||118
223410|NCT01185821|541141|P5|NOT COMPLETED|Overall Study||24
223411|NCT01185821|541142|P4|NOT COMPLETED|Overall Study||6
223412|NCT01185821|541143|P3|NOT COMPLETED|Overall Study||10
223413|NCT01185821|541144|P2|NOT COMPLETED|Overall Study||9
223414|NCT01185821|541145|P1|NOT COMPLETED|Overall Study||7
223415|NCT01185821|541141|P5|COMPLETED|Overall Study||26
223416|NCT01185821|541142|P4|COMPLETED|Overall Study||23
223417|NCT01185821|541143|P3|COMPLETED|Overall Study||33
223418|NCT01185821|541144|P2|COMPLETED|Overall Study||20
223419|NCT01185821|541145|P1|COMPLETED|Overall Study||26
223420|NCT01185821|541141|P5|Patients on Placebo in Core|Overall Study||2
223421|NCT01185821|541142|P4|Patients on Placebo in Core|Overall Study||8
223422|NCT01185821|541143|P3|Patients on Placebo in Core|Overall Study||9
223423|NCT01185821|541144|P2|Patients on Placebo in Core|Overall Study||7
223424|NCT01185821|541145|P1|Patients on Placebo in Core|Overall Study||8
223425|NCT01185821|541141|P5|Patients Without Washout|Overall Study||17
223426|NCT01185821|541142|P4|Patients Without Washout|Overall Study||0
223427|NCT01185821|541143|P3|Patients Without Washout|Overall Study||4
223428|NCT01185821|541144|P2|Patients Without Washout|Overall Study||0
223429|NCT01185821|541145|P1|Patients Without Washout|Overall Study||0
223430|NCT01185821|541141|P5|Patients With Washout|Overall Study||33
223431|NCT01185821|541142|P4|Patients With Washout|Overall Study||29
223432|NCT01185821|541143|P3|Patients With Washout|Overall Study||39
223433|NCT01185821|541144|P2|Patients With Washout|Overall Study||29
223434|NCT01185821|541145|P1|Patients With Washout|Overall Study||33
223435|NCT01185821|541141|P5|STARTED|Overall Study||50
223436|NCT01185821|541142|P4|STARTED|Overall Study||29
223437|NCT01185821|541143|P3|STARTED|Overall Study||43
223438|NCT01185821|541144|P2|STARTED|Overall Study||29
223439|NCT01185821|541145|P1|STARTED|Overall Study||33
223440|NCT01185782|541196|P2|NOT COMPLETED|Overall Study||11
223441|NCT01185782|541197|P1|NOT COMPLETED|Overall Study||6
223442|NCT01185782|541196|P2|COMPLETED|Overall Study||125
223443|NCT01185782|541197|P1|COMPLETED|Overall Study||123
223444|NCT01185782|541196|P2|Treated|Overall Study||132
223445|NCT01185782|541197|P1|Treated|Overall Study||129
223446|NCT01185782|541196|P2|STARTED|Overall Study||136
223447|NCT01185782|541197|P1|STARTED|Overall Study||129
223448|NCT01185704|541225|P2|NOT COMPLETED|Overall Study||8
223449|NCT01185704|541226|P1|NOT COMPLETED|Overall Study||13
223450|NCT01185704|541225|P2|COMPLETED|Overall Study||60
223451|NCT01185704|541226|P1|COMPLETED|Overall Study||55
223452|NCT01185704|541225|P2|Treated|Overall Study||65
223453|NCT01185704|541226|P1|Treated|Overall Study||65
223454|NCT01185704|541225|P2|STARTED|Overall Study||68
223455|NCT01185704|541226|P1|STARTED|Overall Study||68
223456|NCT01185639|541260|P1|NOT COMPLETED|Overall Study||2
223457|NCT01185639|541260|P1|COMPLETED|Overall Study||27
223458|NCT01185639|541260|P1|STARTED|Overall Study||29
223459|NCT01185600|541270|P2|NOT COMPLETED|Overall Study||45
223460|NCT01185600|541271|P1|NOT COMPLETED|Overall Study||32
223461|NCT01185600|541270|P2|COMPLETED|Overall Study||59
223462|NCT01185600|541271|P1|COMPLETED|Overall Study||41
223463|NCT01185600|541270|P2|STARTED|Overall Study||104
223464|NCT01185600|541271|P1|STARTED|Overall Study||73
223465|NCT01185561|541293|P2|NOT COMPLETED|Overall Study||12
223466|NCT01185561|541294|P1|NOT COMPLETED|Overall Study||2
223467|NCT01185561|541293|P2|COMPLETED|Overall Study||26
223468|NCT01185561|541294|P1|COMPLETED|Overall Study||34
223469|NCT01185561|541293|P2|STARTED|Overall Study||38
223470|NCT01185561|541294|P1|STARTED|Overall Study||36
223471|NCT01185548|541306|P1|NOT COMPLETED|Period 3: Tasisulam and Tolbutamide||0
223472|NCT01185548|541306|P1|COMPLETED|Period 3: Tasisulam and Tolbutamide||2
223473|NCT01185548|541306|P1|STARTED|Period 3: Tasisulam and Tolbutamide||2
223474|NCT01185548|541306|P1|NOT COMPLETED|Period 2: Tasisulam and Tolbutamide||2
223475|NCT01185548|541306|P1|COMPLETED|Period 2: Tasisulam and Tolbutamide||2
223476|NCT01185548|541306|P1|STARTED|Period 2: Tasisulam and Tolbutamide||4
223477|NCT01185548|541306|P1|NOT COMPLETED|Period 1 : Tolbutamide||0
223478|NCT01185548|541306|P1|COMPLETED|Period 1 : Tolbutamide||4
223479|NCT01185548|541306|P1|STARTED|Period 1 : Tolbutamide||4
223480|NCT01185522|541319|P1|NOT COMPLETED|Overall Study||108
223481|NCT01185522|541319|P1|COMPLETED|Overall Study||585
223482|NCT01185522|541319|P1|STARTED|Overall Study||693
223483|NCT01185509|541345|P2|NOT COMPLETED|Overall Study||20
223484|NCT01185509|541346|P1|NOT COMPLETED|Overall Study||11
223485|NCT01185509|541345|P2|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
223486|NCT01185509|541346|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
223487|NCT01185509|541345|P2|STARTED|Overall Study||20
223488|NCT01185509|541346|P1|STARTED|Overall Study||11
223489|NCT01185353|541362|P10|NOT COMPLETED|Part D (Weeks 76 Through 128)||1
223490|NCT01185353|541363|P9|NOT COMPLETED|Part D (Weeks 76 Through 128)||7
223491|NCT01185353|541364|P8|NOT COMPLETED|Part D (Weeks 76 Through 128)||3
223492|NCT01185353|541365|P7|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
223493|NCT01185353|541366|P6|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
223494|NCT01185353|541367|P5|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
223495|NCT01185353|541368|P4|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
223496|NCT01185353|541369|P3|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
223497|NCT01185353|541370|P2|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
223498|NCT01185353|541371|P1|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
223499|NCT01185353|541362|P10|COMPLETED|Part D (Weeks 76 Through 128)||17
223500|NCT01185353|541363|P9|COMPLETED|Part D (Weeks 76 Through 128)||40
223501|NCT01185353|541364|P8|COMPLETED|Part D (Weeks 76 Through 128)||76
223502|NCT01185353|541365|P7|COMPLETED|Part D (Weeks 76 Through 128)||0
223503|NCT01185353|541366|P6|COMPLETED|Part D (Weeks 76 Through 128)||0
223504|NCT01185353|541367|P5|COMPLETED|Part D (Weeks 76 Through 128)||0
223505|NCT01185353|541368|P4|COMPLETED|Part D (Weeks 76 Through 128)||0
223506|NCT01185353|541369|P3|COMPLETED|Part D (Weeks 76 Through 128)||0
223507|NCT01185353|541370|P2|COMPLETED|Part D (Weeks 76 Through 128)||0
223508|NCT01185353|541371|P1|COMPLETED|Part D (Weeks 76 Through 128)||0
223509|NCT01185353|541362|P10|STARTED|Part D (Weeks 76 Through 128)||18
223510|NCT01185353|541363|P9|STARTED|Part D (Weeks 76 Through 128)||47
223511|NCT01185353|541364|P8|STARTED|Part D (Weeks 76 Through 128)||79
223512|NCT01185353|541365|P7|STARTED|Part D (Weeks 76 Through 128)||0
223513|NCT01185353|541366|P6|STARTED|Part D (Weeks 76 Through 128)||0
223514|NCT01185353|541367|P5|STARTED|Part D (Weeks 76 Through 128)||0
223515|NCT01185353|541368|P4|STARTED|Part D (Weeks 76 Through 128)||0
223516|NCT01185353|541369|P3|STARTED|Part D (Weeks 76 Through 128)||0
223517|NCT01185353|541370|P2|STARTED|Part D (Weeks 76 Through 128)||0
223518|NCT01185353|541371|P1|STARTED|Part D (Weeks 76 Through 128)||0
223519|NCT01185353|541362|P10|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
223520|NCT01185353|541363|P9|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
223521|NCT01185353|541364|P8|NOT COMPLETED|Part C (Weeks 24 Through 76)||16
223522|NCT01185353|541365|P7|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
223523|NCT01185353|541366|P6|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
223524|NCT01185353|541367|P5|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
223525|NCT01185353|541368|P4|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
223526|NCT01185353|541369|P3|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
223527|NCT01185353|541370|P2|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
223528|NCT01185353|541371|P1|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
223529|NCT01185353|541362|P10|COMPLETED|Part C (Weeks 24 Through 76)||24
223530|NCT01185353|541363|P9|COMPLETED|Part C (Weeks 24 Through 76)||53
223531|NCT01185353|541364|P8|COMPLETED|Part C (Weeks 24 Through 76)||92
223532|NCT01185353|541365|P7|COMPLETED|Part C (Weeks 24 Through 76)||0
223533|NCT01185353|541366|P6|COMPLETED|Part C (Weeks 24 Through 76)||0
223534|NCT01185353|541367|P5|COMPLETED|Part C (Weeks 24 Through 76)||0
223535|NCT01185353|541368|P4|COMPLETED|Part C (Weeks 24 Through 76)||0
223536|NCT01185353|541369|P3|COMPLETED|Part C (Weeks 24 Through 76)||0
223537|NCT01185353|541370|P2|COMPLETED|Part C (Weeks 24 Through 76)||0
223538|NCT01185353|541371|P1|COMPLETED|Part C (Weeks 24 Through 76)||0
223539|NCT01185353|541362|P10|STARTED|Part C (Weeks 24 Through 76)||32
223540|NCT01185353|541363|P9|STARTED|Part C (Weeks 24 Through 76)||61
223541|NCT01185353|541364|P8|STARTED|Part C (Weeks 24 Through 76)||108
223542|NCT01185353|541365|P7|STARTED|Part C (Weeks 24 Through 76)||0
223543|NCT01185353|541366|P6|STARTED|Part C (Weeks 24 Through 76)||0
223544|NCT01185353|541367|P5|STARTED|Part C (Weeks 24 Through 76)||0
223545|NCT01185353|541368|P4|STARTED|Part C (Weeks 24 Through 76)||0
223546|NCT01185353|541369|P3|STARTED|Part C (Weeks 24 Through 76)||0
223547|NCT01185353|541370|P2|STARTED|Part C (Weeks 24 Through 76)||0
223548|NCT01185353|541371|P1|STARTED|Part C (Weeks 24 Through 76)||0
223549|NCT01185353|541362|P10|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
223550|NCT01185353|541363|P9|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
223551|NCT01185353|541364|P8|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
223552|NCT01185353|541365|P7|NOT COMPLETED|Part B (Weeks 12 Through 24)||6
223553|NCT01185353|541366|P6|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
223554|NCT01185353|541367|P5|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
223555|NCT01185353|541368|P4|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
223556|NCT01185353|541369|P3|NOT COMPLETED|Part B (Weeks 12 Through 24)||2
223557|NCT01185353|541370|P2|NOT COMPLETED|Part B (Weeks 12 Through 24)||1
223558|NCT01185353|541371|P1|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
223559|NCT01185353|541362|P10|COMPLETED|Part B (Weeks 12 Through 24)||0
223560|NCT01185353|541363|P9|COMPLETED|Part B (Weeks 12 Through 24)||0
223561|NCT01185353|541364|P8|COMPLETED|Part B (Weeks 12 Through 24)||0
223562|NCT01185353|541365|P7|COMPLETED|Part B (Weeks 12 Through 24)||57
223563|NCT01185353|541366|P6|COMPLETED|Part B (Weeks 12 Through 24)||59
223564|NCT01185353|541367|P5|COMPLETED|Part B (Weeks 12 Through 24)||0
223565|NCT01185353|541368|P4|COMPLETED|Part B (Weeks 12 Through 24)||45
223566|NCT01185353|541369|P3|COMPLETED|Part B (Weeks 12 Through 24)||48
223567|NCT01185353|541370|P2|COMPLETED|Part B (Weeks 12 Through 24)||50
223568|NCT01185353|541371|P1|COMPLETED|Part B (Weeks 12 Through 24)||0
223569|NCT01185353|541362|P10|STARTED|Part B (Weeks 12 Through 24)||0
223570|NCT01185353|541363|P9|STARTED|Part B (Weeks 12 Through 24)||0
223571|NCT01185353|541364|P8|STARTED|Part B (Weeks 12 Through 24)||0
223572|NCT01185353|541365|P7|STARTED|Part B (Weeks 12 Through 24)||63
223573|NCT01185353|541366|P6|STARTED|Part B (Weeks 12 Through 24)||63
223574|NCT01185353|541367|P5|STARTED|Part B (Weeks 12 Through 24)||0
223575|NCT01185353|541368|P4|STARTED|Part B (Weeks 12 Through 24)||49
223576|NCT01185353|541369|P3|STARTED|Part B (Weeks 12 Through 24)||50
223577|NCT01185353|541370|P2|STARTED|Part B (Weeks 12 Through 24)||51
223578|NCT01185353|541371|P1|STARTED|Part B (Weeks 12 Through 24)||0
223579|NCT01185353|541362|P10|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
223580|NCT01185353|541363|P9|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
223581|NCT01185353|541364|P8|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
223582|NCT01185353|541365|P7|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
223583|NCT01185353|541366|P6|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
223584|NCT01185353|541367|P5|NOT COMPLETED|Part A (Weeks 0 Through 12)||16
223585|NCT01185353|541368|P4|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
223586|NCT01185353|541369|P3|NOT COMPLETED|Part A (Weeks 0 Through 12)||2
223587|NCT01185353|541370|P2|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
223588|NCT01185353|541371|P1|NOT COMPLETED|Part A (Weeks 0 Through 12)||5
223589|NCT01185353|541362|P10|COMPLETED|Part A (Weeks 0 Through 12)||0
223590|NCT01185353|541363|P9|COMPLETED|Part A (Weeks 0 Through 12)||0
223591|NCT01185353|541364|P8|COMPLETED|Part A (Weeks 0 Through 12)||0
223592|NCT01185353|541365|P7|COMPLETED|Part A (Weeks 0 Through 12)||0
223593|NCT01185353|541366|P6|COMPLETED|Part A (Weeks 0 Through 12)||0
223594|NCT01185353|541367|P5|COMPLETED|Part A (Weeks 0 Through 12)||82
223595|NCT01185353|541368|P4|COMPLETED|Part A (Weeks 0 Through 12)||49
223596|NCT01185353|541369|P3|COMPLETED|Part A (Weeks 0 Through 12)||50
223597|NCT01185353|541370|P2|COMPLETED|Part A (Weeks 0 Through 12)||51
223598|NCT01185353|541371|P1|COMPLETED|Part A (Weeks 0 Through 12)||44
223599|NCT01185353|541362|P10|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
223600|NCT01185353|541363|P9|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
223601|NCT01185353|541364|P8|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
223602|NCT01185353|541365|P7|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
223603|NCT01185353|541366|P6|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
223604|NCT01185353|541367|P5|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||98
223605|NCT01185353|541368|P4|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||50
223606|NCT01185353|541369|P3|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
223607|NCT01185353|541370|P2|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
223608|NCT01185353|541371|P1|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||49
223609|NCT01185353|541362|P10|STARTED|Part A (Weeks 0 Through 12)||0
223610|NCT01185353|541363|P9|STARTED|Part A (Weeks 0 Through 12)||0
223611|NCT01185353|541364|P8|STARTED|Part A (Weeks 0 Through 12)||0
223612|NCT01185353|541365|P7|STARTED|Part A (Weeks 0 Through 12)||0
223613|NCT01185353|541366|P6|STARTED|Part A (Weeks 0 Through 12)||0
223614|NCT01185353|541367|P5|STARTED|Part A (Weeks 0 Through 12)||98
223615|NCT01185353|541368|P4|STARTED|Part A (Weeks 0 Through 12)||50
223616|NCT01185353|541369|P3|STARTED|Part A (Weeks 0 Through 12)||52
223617|NCT01185353|541370|P2|STARTED|Part A (Weeks 0 Through 12)||52
223618|NCT01185353|541371|P1|STARTED|Part A (Weeks 0 Through 12)||49
223619|NCT01185340|541532|P4|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||61
223620|NCT01185340|541533|P3|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
223621|NCT01185340|541534|P2|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
223622|NCT01185340|541535|P1|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
223623|NCT01185340|541532|P4|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||458
223624|NCT01185340|541533|P3|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||186
223625|NCT01185340|541534|P2|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||195
223626|NCT01185340|541535|P1|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
223627|NCT01185340|541532|P4|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|483
223628|NCT01185340|541533|P3|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|204
223629|NCT01185340|541534|P2|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|206
223630|NCT01185340|541535|P1|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
223631|NCT01185340|541532|P4|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||519
223632|NCT01185340|541533|P3|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||219
223633|NCT01185340|541534|P2|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
223634|NCT01185340|541535|P1|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
223635|NCT01185340|541532|P4|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
223636|NCT01185340|541533|P3|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
223637|NCT01185340|541534|P2|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
223638|NCT01185340|541535|P1|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
223639|NCT01185340|541532|P4|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
223640|NCT01185340|541533|P3|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
223641|NCT01185340|541534|P2|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
223642|NCT01185340|541535|P1|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|968
223643|NCT01185340|541532|P4|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
223644|NCT01185340|541533|P3|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
223645|NCT01185340|541534|P2|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
223646|NCT01185340|541535|P1|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|18
223647|NCT01185340|541532|P4|STARTED|Confirmation (CF) Phase, 3 Weeks||0
223648|NCT01185340|541533|P3|STARTED|Confirmation (CF) Phase, 3 Weeks||0
223649|NCT01185340|541534|P2|STARTED|Confirmation (CF) Phase, 3 Weeks||0
223650|NCT01185340|541535|P1|STARTED|Confirmation (CF) Phase, 3 Weeks||1056
223651|NCT01185301|541587|P4|NOT COMPLETED|Overall Study||9
223652|NCT01185301|541588|P3|NOT COMPLETED|Overall Study||6
223653|NCT01185301|541589|P2|NOT COMPLETED|Overall Study||7
223654|NCT01185301|541590|P1|NOT COMPLETED|Overall Study||15
223655|NCT01185301|541587|P4|COMPLETED|Overall Study||89
223656|NCT01185301|541588|P3|COMPLETED|Overall Study||93
223657|NCT01185301|541589|P2|COMPLETED|Overall Study||93
223658|NCT01185301|541590|P1|COMPLETED|Overall Study||83
223659|NCT01185301|541587|P4|STARTED|Overall Study||98
223660|NCT01185301|541588|P3|STARTED|Overall Study||99
223661|NCT01185301|541589|P2|STARTED|Overall Study||100
223662|NCT01185301|541590|P1|STARTED|Overall Study||98
223663|NCT01185288|541650|P2|NOT COMPLETED|Overall Study||16
223664|NCT01185288|541651|P1|NOT COMPLETED|Overall Study||19
223665|NCT01185288|541650|P2|COMPLETED|Overall Study||139
223666|NCT01185288|541651|P1|COMPLETED|Overall Study||135
223667|NCT01185288|541650|P2|STARTED|Overall Study||155
223668|NCT01185288|541651|P1|STARTED|Overall Study||154
223669|NCT01185249|541669|P1|NOT COMPLETED|Overall Study||42
223670|NCT01185249|541669|P1|COMPLETED|Overall Study|Data was analyzed for patients with three consecutive days of data.|24
223671|NCT01185249|541669|P1|STARTED|Overall Study|Total number of patients consented to participate.|66
223672|NCT01185080|541677|P3|NOT COMPLETED|Overall Study||1
223673|NCT01185080|541678|P2|NOT COMPLETED|Overall Study||1
223674|NCT01185080|541679|P1|NOT COMPLETED|Overall Study||1
223675|NCT01185080|541677|P3|COMPLETED|Overall Study||16
223676|NCT01185080|541678|P2|COMPLETED|Overall Study||15
223677|NCT01185080|541679|P1|COMPLETED|Overall Study||49
223678|NCT01185080|541677|P3|STARTED|Overall Study||17
223679|NCT01185080|541678|P2|STARTED|Overall Study||16
223680|NCT01185080|541679|P1|STARTED|Overall Study||50
223681|NCT01185028|541726|P1|NOT COMPLETED|Overall Study||4
223682|NCT01185028|541726|P1|COMPLETED|Overall Study||4
223683|NCT01185028|541726|P1|STARTED|Overall Study||8
223684|NCT01184989|541731|P1|NOT COMPLETED|Overall Study||12
223685|NCT01184989|541731|P1|COMPLETED|Overall Study||100
223686|NCT01184989|541731|P1|STARTED|Overall Study|Treated Patients|112
223687|NCT01184898|541737|P1|NOT COMPLETED|Overall Study||0
223688|NCT01184898|541737|P1|COMPLETED|Overall Study||36
223689|NCT01184898|541737|P1|STARTED|Overall Study||36
223690|NCT01184885|541744|P1|NOT COMPLETED|Overall Study||0
223691|NCT01184885|541744|P1|COMPLETED|Overall Study||7
223692|NCT01184885|541744|P1|STARTED|Overall Study||7
223693|NCT01184872|541751|P2|NOT COMPLETED|Overall Study||8
223694|NCT01184872|541752|P1|NOT COMPLETED|Overall Study||10
223695|NCT01184872|541751|P2|COMPLETED|Overall Study||31
223696|NCT01184872|541752|P1|COMPLETED|Overall Study||71
223697|NCT01184872|541751|P2|Microbiologically Evaluable Set (MES)|Overall Study||27
223698|NCT01184872|541752|P1|Microbiologically Evaluable Set (MES)|Overall Study||65
223699|NCT01184872|541751|P2|Clinical Evaluable Set (CES)|Overall Study||30
223700|NCT01184872|541752|P1|Clinical Evaluable Set (CES)|Overall Study||73
223701|NCT01184872|541751|P2|Safety Set|Overall Study||40
223702|NCT01184872|541752|P1|Safety Set|Overall Study|One patient randomized to Daptomycin received Vancomycin.|80
223703|NCT01184872|541751|P2|STARTED|Overall Study||39
223704|NCT01184872|541752|P1|STARTED|Overall Study|"Started indicates randomized and full analysis set."|81
223705|NCT01184859|541771|P5|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
223706|NCT01184859|541772|P4|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
223707|NCT01184859|541773|P3|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
223708|NCT01184859|541774|P2|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
223709|NCT01184859|541775|P1|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
223710|NCT01184859|541771|P5|COMPLETED|Period 2: Daily Dose for 28 Days||22
223711|NCT01184859|541772|P4|COMPLETED|Period 2: Daily Dose for 28 Days||22
223712|NCT01184859|541773|P3|COMPLETED|Period 2: Daily Dose for 28 Days||22
223713|NCT01184859|541774|P2|COMPLETED|Period 2: Daily Dose for 28 Days||23
223714|NCT01184859|541775|P1|COMPLETED|Period 2: Daily Dose for 28 Days||22
223715|NCT01184859|541771|P5|STARTED|Period 2: Daily Dose for 28 Days||23
223716|NCT01184859|541772|P4|STARTED|Period 2: Daily Dose for 28 Days||22
223717|NCT01184859|541773|P3|STARTED|Period 2: Daily Dose for 28 Days||22
223718|NCT01184859|541774|P2|STARTED|Period 2: Daily Dose for 28 Days||23
223719|NCT01184859|541775|P1|STARTED|Period 2: Daily Dose for 28 Days||23
223720|NCT01184859|541771|P5|NOT COMPLETED|Washout Period||0
223721|NCT01184859|541772|P4|NOT COMPLETED|Washout Period||0
223722|NCT01184859|541773|P3|NOT COMPLETED|Washout Period||0
223723|NCT01184859|541774|P2|NOT COMPLETED|Washout Period||0
223724|NCT01184859|541775|P1|NOT COMPLETED|Washout Period||0
223725|NCT01184859|541771|P5|COMPLETED|Washout Period||23
223726|NCT01184859|541772|P4|COMPLETED|Washout Period||22
223727|NCT01184859|541773|P3|COMPLETED|Washout Period||22
223728|NCT01184859|541774|P2|COMPLETED|Washout Period||23
223729|NCT01184859|541775|P1|COMPLETED|Washout Period||23
223730|NCT01184859|541771|P5|STARTED|Washout Period||23
223731|NCT01184859|541772|P4|STARTED|Washout Period||22
223732|NCT01184859|541773|P3|STARTED|Washout Period||22
223733|NCT01184859|541774|P2|STARTED|Washout Period||23
223734|NCT01184859|541775|P1|STARTED|Washout Period||23
223735|NCT01184859|541771|P5|NOT COMPLETED|Period 1: Single Dose||1
223736|NCT01184859|541772|P4|NOT COMPLETED|Period 1: Single Dose||0
223737|NCT01184859|541773|P3|NOT COMPLETED|Period 1: Single Dose||0
223738|NCT01184859|541774|P2|NOT COMPLETED|Period 1: Single Dose||2
223739|NCT01184859|541775|P1|NOT COMPLETED|Period 1: Single Dose||0
223740|NCT01184859|541771|P5|COMPLETED|Period 1: Single Dose||23
223741|NCT01184859|541772|P4|COMPLETED|Period 1: Single Dose||22
223742|NCT01184859|541773|P3|COMPLETED|Period 1: Single Dose||22
223743|NCT01184859|541774|P2|COMPLETED|Period 1: Single Dose||23
223744|NCT01184859|541775|P1|COMPLETED|Period 1: Single Dose||23
223745|NCT01184859|541771|P5|Per Protocol (PP)|Period 1: Single Dose|1 additional participant disqualified due to 'other'.|23
223746|NCT01184859|541772|P4|Per Protocol (PP)|Period 1: Single Dose||21
223747|NCT01184859|541773|P3|Per Protocol (PP)|Period 1: Single Dose||22
223748|NCT01184859|541774|P2|Per Protocol (PP)|Period 1: Single Dose||23
223749|NCT01184859|541775|P1|Per Protocol (PP)|Period 1: Single Dose||23
223750|NCT01184859|541771|P5|Full Analysis Set (FAS)|Period 1: Single Dose||24
223751|NCT01184859|541772|P4|Full Analysis Set (FAS)|Period 1: Single Dose|1 participant disqualified due to major entry criteria violation|21
223752|NCT01184859|541773|P3|Full Analysis Set (FAS)|Period 1: Single Dose||22
223753|NCT01184859|541774|P2|Full Analysis Set (FAS)|Period 1: Single Dose|2 participants disqualified due to no post-baseline primary efficacy data, and/or 'other'.|23
223754|NCT01184859|541775|P1|Full Analysis Set (FAS)|Period 1: Single Dose||23
223755|NCT01184859|541771|P5|STARTED|Period 1: Single Dose||24
223756|NCT01184859|541772|P4|STARTED|Period 1: Single Dose||22
223757|NCT01184859|541773|P3|STARTED|Period 1: Single Dose||22
223758|NCT01184859|541774|P2|STARTED|Period 1: Single Dose||25
223759|NCT01184859|541775|P1|STARTED|Period 1: Single Dose||23
223760|NCT01184846|541867|P1|NOT COMPLETED|Overall Study||3
223761|NCT01184846|541867|P1|COMPLETED|Overall Study||25
223762|NCT01184846|541867|P1|STARTED|Overall Study||28
223763|NCT01184755|541888|P3|NOT COMPLETED|Overall Study||6
223764|NCT01184755|541889|P2|NOT COMPLETED|Overall Study||11
223765|NCT01184755|541890|P1|NOT COMPLETED|Overall Study||25
223766|NCT01184755|541888|P3|COMPLETED|Overall Study||56
223767|NCT01184755|541889|P2|COMPLETED|Overall Study||54
223768|NCT01184755|541890|P1|COMPLETED|Overall Study||101
223769|NCT01184755|541888|P3|STARTED|Overall Study||62
223770|NCT01184755|541889|P2|STARTED|Overall Study||65
223771|NCT01184755|541890|P1|STARTED|Overall Study||126
223772|NCT01184508|541900|P2|NOT COMPLETED|Overall Study||15
223773|NCT01184508|541901|P1|NOT COMPLETED|Overall Study||16
223774|NCT01184508|541900|P2|COMPLETED|Overall Study||27
223775|NCT01184508|541901|P1|COMPLETED|Overall Study||29
223776|NCT01184508|541900|P2|Received at Least 1 Dose of Study Drug|Overall Study||41
223777|NCT01184508|541901|P1|Received at Least 1 Dose of Study Drug|Overall Study||45
223778|NCT01184508|541900|P2|STARTED|Overall Study||42
223779|NCT01184508|541901|P1|STARTED|Overall Study||45
223780|NCT01184456|541928|P2|NOT COMPLETED|Overall Study||0
223781|NCT01184456|541929|P1|NOT COMPLETED|Overall Study||0
223782|NCT01184456|541928|P2|COMPLETED|Overall Study||0
223783|NCT01184456|541929|P1|COMPLETED|Overall Study||0
223784|NCT01184456|541928|P2|STARTED|Overall Study||0
223785|NCT01184456|541929|P1|STARTED|Overall Study||0
223786|NCT01184417|541937|P2|NOT COMPLETED|Overall Study||0
223787|NCT01184417|541938|P1|NOT COMPLETED|Overall Study||0
223788|NCT01184417|541937|P2|COMPLETED|Overall Study||51
223789|NCT01184417|541938|P1|COMPLETED|Overall Study||51
223790|NCT01184417|541937|P2|STARTED|Overall Study||51
223791|NCT01184417|541938|P1|STARTED|Overall Study||51
223792|NCT01184326|541961|P3|NOT COMPLETED|Overall Study||14
223793|NCT01184326|541962|P2|NOT COMPLETED|Overall Study||6
223794|NCT01184326|541963|P1|NOT COMPLETED|Overall Study||3
223795|NCT01184326|541961|P3|COMPLETED|Overall Study||0
223796|NCT01184326|541962|P2|COMPLETED|Overall Study||0
223797|NCT01184326|541963|P1|COMPLETED|Overall Study||0
223798|NCT01184326|541961|P3|STARTED|Overall Study||14
223799|NCT01184326|541962|P2|STARTED|Overall Study||6
223800|NCT01184326|541963|P1|STARTED|Overall Study||3
223801|NCT01184118|541977|P1|NOT COMPLETED|Overall Study||18
223802|NCT01184118|541977|P1|COMPLETED|Overall Study||18
223803|NCT01184118|541977|P1|FP MDI as Indicated (2 Weeks)|Overall Study||18
223804|NCT01184118|541977|P1|FP MDI 880 mcg/Day (2 Weeks)|Overall Study||18
223805|NCT01184118|541977|P1|FP MDI 1,760 mcg/Day (16 Weeks)|Overall Study||18
223806|NCT01184118|541977|P1|STARTED|Overall Study||36
223807|NCT01184079|541985|P2|NOT COMPLETED|Overall Study||2
223808|NCT01184079|541986|P1|NOT COMPLETED|Overall Study||14
223809|NCT01184079|541985|P2|COMPLETED|Overall Study||107
223810|NCT01184079|541986|P1|COMPLETED|Overall Study||97
223811|NCT01184079|541985|P2|Final Blood Draw|Overall Study||107
223812|NCT01184079|541986|P1|Final Blood Draw|Overall Study||97
223813|NCT01184079|541985|P2|Dose 3|Overall Study||107
223814|NCT01184079|541986|P1|Dose 3|Overall Study||101
223815|NCT01184079|541985|P2|Dose 2|Overall Study||108
223816|NCT01184079|541986|P1|Dose 2|Overall Study||110
223817|NCT01184079|541985|P2|STARTED|Overall Study||109
223818|NCT01184079|541986|P1|STARTED|Overall Study||111
223819|NCT01184053|541996|P1|NOT COMPLETED|Overall Study||3
223820|NCT01184053|541996|P1|COMPLETED|Overall Study||0
223821|NCT01184053|541996|P1|STARTED|Overall Study||3
223822|NCT01184014|542005|P2|NOT COMPLETED|Overall Study||6
223823|NCT01184014|542006|P1|NOT COMPLETED|Overall Study||5
223824|NCT01184014|542005|P2|COMPLETED|Overall Study||31
223825|NCT01184014|542006|P1|COMPLETED|Overall Study||30
223826|NCT01184014|542005|P2|STARTED|Overall Study||37
223827|NCT01184014|542006|P1|STARTED|Overall Study||35
223828|NCT01183975|542012|P1|NOT COMPLETED|Overall Study||73
223829|NCT01183975|542012|P1|COMPLETED|Overall Study||444
223830|NCT01183975|542012|P1|STARTED|Overall Study||517
223831|NCT01183923|542017|P2|NOT COMPLETED|Intervention 2 (7 Days)||0
223832|NCT01183923|542018|P1|NOT COMPLETED|Intervention 2 (7 Days)||0
223833|NCT01183923|542017|P2|COMPLETED|Intervention 2 (7 Days)||0
223834|NCT01183923|542018|P1|COMPLETED|Intervention 2 (7 Days)||1
223835|NCT01183923|542017|P2|STARTED|Intervention 2 (7 Days)||0
223836|NCT01183923|542018|P1|STARTED|Intervention 2 (7 Days)||1
223837|NCT01183923|542017|P2|NOT COMPLETED|Washout (14 Days)||0
223838|NCT01183923|542018|P1|NOT COMPLETED|Washout (14 Days)||0
223839|NCT01183923|542017|P2|COMPLETED|Washout (14 Days)||0
223840|NCT01183923|542018|P1|COMPLETED|Washout (14 Days)||1
223841|NCT01183923|542017|P2|STARTED|Washout (14 Days)||0
223842|NCT01183923|542018|P1|STARTED|Washout (14 Days)||1
223843|NCT01183923|542017|P2|NOT COMPLETED|Intervention 1 (7 Days)||0
223844|NCT01183923|542018|P1|NOT COMPLETED|Intervention 1 (7 Days)||0
223845|NCT01183923|542017|P2|COMPLETED|Intervention 1 (7 Days)||0
223846|NCT01183923|542018|P1|COMPLETED|Intervention 1 (7 Days)||1
223847|NCT01183923|542017|P2|STARTED|Intervention 1 (7 Days)||0
223848|NCT01183923|542018|P1|STARTED|Intervention 1 (7 Days)||1
223849|NCT01183897|542023|P1|NOT COMPLETED|Overall Study||0
223850|NCT01183897|542023|P1|COMPLETED|Overall Study||31
223851|NCT01183897|542023|P1|STARTED|Overall Study||31
223852|NCT01183884|542029|P1|NOT COMPLETED|Overall Study||38
223853|NCT01183884|542029|P1|COMPLETED|Overall Study||8
223854|NCT01183884|542029|P1|STARTED|Overall Study||46
223855|NCT01183858|542037|P2|NOT COMPLETED|Overall Study||156
223856|NCT01183858|542038|P1|NOT COMPLETED|Overall Study||153
223857|NCT01183858|542037|P2|COMPLETED|Overall Study||3
223858|NCT01183858|542038|P1|COMPLETED|Overall Study||1
223859|NCT01183858|542037|P2|Safety Population|Overall Study||158
223860|NCT01183858|542038|P1|Safety Population|Overall Study||154
223861|NCT01183858|542037|P2|STARTED|Overall Study||159
223862|NCT01183858|542038|P1|STARTED|Overall Study||154
223863|NCT01183780|542060|P2|NOT COMPLETED|Overall Study||25
223864|NCT01183780|542061|P1|NOT COMPLETED|Overall Study||31
223865|NCT01183780|542060|P2|COMPLETED|Overall Study||511
223866|NCT01183780|542061|P1|COMPLETED|Overall Study||505
223867|NCT01183780|542060|P2|Received at Least 1 Dose of Study Drug|Overall Study||529
223868|NCT01183780|542061|P1|Received at Least 1 Dose of Study Drug|Overall Study||528
223869|NCT01183780|542060|P2|STARTED|Overall Study||536
223870|NCT01183780|542061|P1|STARTED|Overall Study||536
223871|NCT01183728|542078|P1|NOT COMPLETED|Overall Study||0
223872|NCT01183728|542078|P1|COMPLETED|Overall Study||12
223873|NCT01183728|542078|P1|STARTED|Overall Study||12
223874|NCT01183689|542086|P3|NOT COMPLETED|Overall Study||0
223875|NCT01183689|542087|P2|NOT COMPLETED|Overall Study||0
223876|NCT01183689|542088|P1|NOT COMPLETED|Overall Study||0
223877|NCT01183689|542086|P3|COMPLETED|Overall Study||197
223878|NCT01183689|542087|P2|COMPLETED|Overall Study||200
223879|NCT01183689|542088|P1|COMPLETED|Overall Study||202
223880|NCT01183689|542086|P3|Year 4 Visit|Overall Study||30
223881|NCT01183689|542087|P2|Year 4 Visit|Overall Study||33
223882|NCT01183689|542088|P1|Year 4 Visit|Overall Study||38
223883|NCT01183689|542086|P3|Year 3 Visit|Overall Study||126
223884|NCT01183689|542087|P2|Year 3 Visit|Overall Study||125
223885|NCT01183689|542088|P1|Year 3 Visit|Overall Study||139
223886|NCT01183689|542086|P3|Year 2 Visit|Overall Study||174
223887|NCT01183689|542087|P2|Year 2 Visit|Overall Study||172
223888|NCT01183689|542088|P1|Year 2 Visit|Overall Study||178
223889|NCT01183689|542086|P3|Year 1 Visit|Overall Study||183
223890|NCT01183689|542087|P2|Year 1 Visit|Overall Study||172
223891|NCT01183689|542088|P1|Year 1 Visit|Overall Study||187
223892|NCT01183689|542086|P3|Month 4 Visit|Overall Study||187
223893|NCT01183689|542087|P2|Month 4 Visit|Overall Study||192
223894|NCT01183689|542088|P1|Month 4 Visit|Overall Study||197
223895|NCT01183689|542086|P3|STARTED|Overall Study||197
223896|NCT01183689|542087|P2|STARTED|Overall Study||200
223897|NCT01183689|542088|P1|STARTED|Overall Study||202
223898|NCT01183650|542158|P2|NOT COMPLETED|Overall Study||0
223899|NCT01183650|542159|P1|NOT COMPLETED|Overall Study||0
223900|NCT01183650|542158|P2|COMPLETED|Overall Study||12
223901|NCT01183650|542159|P1|COMPLETED|Overall Study||12
223902|NCT01183650|542158|P2|STARTED|Overall Study||12
223903|NCT01183650|542159|P1|STARTED|Overall Study||12
223904|NCT01183546|542169|P1|NOT COMPLETED|Overall Study||0
223905|NCT01183546|542169|P1|COMPLETED|Overall Study||53
223906|NCT01183546|542169|P1|STARTED|Overall Study||53
223907|NCT01183533|542176|P1|NOT COMPLETED|Overall Study||0
223908|NCT01183533|542176|P1|COMPLETED|Overall Study|- all pre-planned 40 patients received the study medication.|40
223909|NCT01183533|542176|P1|STARTED|Overall Study|Between Oct 2010 and Oct 2013.|40
223910|NCT01183481|542182|P1|NOT COMPLETED|Overall Study||0
223911|NCT01183481|542182|P1|COMPLETED|Overall Study||19
223912|NCT01183481|542182|P1|STARTED|Overall Study||19
223913|NCT01183468|542194|P4|NOT COMPLETED|Overall Study||0
223914|NCT01183468|542195|P3|NOT COMPLETED|Overall Study||0
223915|NCT01183468|542196|P2|NOT COMPLETED|Overall Study||2
223916|NCT01183468|542197|P1|NOT COMPLETED|Overall Study||3
223917|NCT01183468|542194|P4|COMPLETED|Overall Study||0
223918|NCT01183468|542195|P3|COMPLETED|Overall Study||0
223919|NCT01183468|542196|P2|COMPLETED|Overall Study||7
223920|NCT01183468|542197|P1|COMPLETED|Overall Study||5
223921|NCT01183468|542194|P4|STARTED|Overall Study||0
223922|NCT01183468|542195|P3|STARTED|Overall Study||0
223923|NCT01183468|542196|P2|STARTED|Overall Study||9
223924|NCT01183468|542197|P1|STARTED|Overall Study||8
223925|NCT01183429|542205|P1|NOT COMPLETED|Overall Study||0
223926|NCT01183429|542205|P1|COMPLETED|Overall Study||39
223927|NCT01183429|542205|P1|STARTED|Overall Study||39
223928|NCT01183416|542211|P1|NOT COMPLETED|Overall Study||0
223929|NCT01183416|542211|P1|COMPLETED|Overall Study||4
223930|NCT01183416|542211|P1|STARTED|Overall Study||4
223931|NCT01183390|542219|P2|NOT COMPLETED|Second Intervention||0
223932|NCT01183390|542220|P1|NOT COMPLETED|Second Intervention||0
223933|NCT01183390|542219|P2|COMPLETED|Second Intervention||10
223934|NCT01183390|542220|P1|COMPLETED|Second Intervention||11
223935|NCT01183390|542219|P2|STARTED|Second Intervention||10
223936|NCT01183390|542220|P1|STARTED|Second Intervention||11
223937|NCT01183390|542219|P2|NOT COMPLETED|Washout of 21 Days||0
223938|NCT01183390|542220|P1|NOT COMPLETED|Washout of 21 Days||0
223939|NCT01183390|542219|P2|COMPLETED|Washout of 21 Days||10
223940|NCT01183390|542220|P1|COMPLETED|Washout of 21 Days||11
223941|NCT01183390|542219|P2|STARTED|Washout of 21 Days||10
223942|NCT01183390|542220|P1|STARTED|Washout of 21 Days||11
223943|NCT01183390|542219|P2|NOT COMPLETED|First Intervention||1
223944|NCT01183390|542220|P1|NOT COMPLETED|First Intervention||0
223945|NCT01183390|542219|P2|COMPLETED|First Intervention||10
223946|NCT01183390|542220|P1|COMPLETED|First Intervention||11
223947|NCT01183390|542219|P2|STARTED|First Intervention||11
223948|NCT01183390|542220|P1|STARTED|First Intervention||11
223949|NCT01183312|542230|P2|NOT COMPLETED|Second Intervention Day||0
223950|NCT01183312|542231|P1|NOT COMPLETED|Second Intervention Day||0
223951|NCT01183312|542230|P2|COMPLETED|Second Intervention Day||5
223952|NCT01183312|542231|P1|COMPLETED|Second Intervention Day||5
223953|NCT01183312|542230|P2|STARTED|Second Intervention Day||5
223954|NCT01183312|542231|P1|STARTED|Second Intervention Day||5
223955|NCT01183312|542230|P2|NOT COMPLETED|Washout Period of at Least 1 Week||0
223956|NCT01183312|542231|P1|NOT COMPLETED|Washout Period of at Least 1 Week||0
223957|NCT01183312|542230|P2|COMPLETED|Washout Period of at Least 1 Week||5
223958|NCT01183312|542231|P1|COMPLETED|Washout Period of at Least 1 Week||5
223959|NCT01183312|542230|P2|STARTED|Washout Period of at Least 1 Week||5
223960|NCT01183312|542231|P1|STARTED|Washout Period of at Least 1 Week||5
223961|NCT01183312|542230|P2|NOT COMPLETED|First Intervention Day||0
223962|NCT01183312|542231|P1|NOT COMPLETED|First Intervention Day||0
223963|NCT01183312|542230|P2|COMPLETED|First Intervention Day||5
223964|NCT01183312|542231|P1|COMPLETED|First Intervention Day||5
223965|NCT01183312|542230|P2|STARTED|First Intervention Day||5
223966|NCT01183312|542231|P1|STARTED|First Intervention Day||5
223967|NCT01183260|542253|P2|NOT COMPLETED|Overall Study||2
223968|NCT01183260|542254|P1|NOT COMPLETED|Overall Study||4
223969|NCT01183260|542253|P2|COMPLETED|Overall Study||9
223970|NCT01183260|542254|P1|COMPLETED|Overall Study||10
223971|NCT01183260|542253|P2|STARTED|Overall Study||11
223972|NCT01183260|542254|P1|STARTED|Overall Study||14
223973|NCT01183234|542264|P2|NOT COMPLETED|Second Intervention||0
223974|NCT01183234|542265|P1|NOT COMPLETED|Second Intervention||0
223975|NCT01183234|542264|P2|COMPLETED|Second Intervention||14
223976|NCT01183234|542265|P1|COMPLETED|Second Intervention||13
223977|NCT01183234|542264|P2|STARTED|Second Intervention||14
223978|NCT01183234|542265|P1|STARTED|Second Intervention||13
223979|NCT01183234|542264|P2|NOT COMPLETED|Washout||0
223980|NCT01183234|542265|P1|NOT COMPLETED|Washout||0
223981|NCT01183234|542264|P2|COMPLETED|Washout||14
223982|NCT01183234|542265|P1|COMPLETED|Washout||13
223983|NCT01183234|542264|P2|STARTED|Washout||14
223984|NCT01183234|542265|P1|STARTED|Washout||13
223985|NCT01183234|542264|P2|NOT COMPLETED|First Intervention||0
223986|NCT01183234|542265|P1|NOT COMPLETED|First Intervention||1
223987|NCT01183234|542264|P2|COMPLETED|First Intervention||14
223988|NCT01183234|542265|P1|COMPLETED|First Intervention||13
223989|NCT01183234|542264|P2|STARTED|First Intervention||14
223990|NCT01183234|542265|P1|STARTED|First Intervention||14
223991|NCT01183169|542279|P7|NOT COMPLETED|Post-switch Phase||9
223992|NCT01183169|542280|P6|NOT COMPLETED|Post-switch Phase||14
223993|NCT01183169|542281|P5|NOT COMPLETED|Post-switch Phase||0
223994|NCT01183169|542282|P4|NOT COMPLETED|Post-switch Phase||0
223995|NCT01183169|542283|P3|NOT COMPLETED|Post-switch Phase||0
223996|NCT01183169|542284|P2|NOT COMPLETED|Post-switch Phase||0
223997|NCT01183169|542285|P1|NOT COMPLETED|Post-switch Phase||0
223998|NCT01183169|542279|P7|COMPLETED|Post-switch Phase||21
223999|NCT01183169|542280|P6|COMPLETED|Post-switch Phase||21
224000|NCT01183169|542281|P5|COMPLETED|Post-switch Phase||0
224001|NCT01183169|542282|P4|COMPLETED|Post-switch Phase||0
224002|NCT01183169|542283|P3|COMPLETED|Post-switch Phase||0
224003|NCT01183169|542284|P2|COMPLETED|Post-switch Phase||0
224004|NCT01183169|542285|P1|COMPLETED|Post-switch Phase||0
224005|NCT01183169|542279|P7|Completed Treatment|Post-switch Phase||13
224006|NCT01183169|542280|P6|Completed Treatment|Post-switch Phase||12
224007|NCT01183169|542281|P5|Completed Treatment|Post-switch Phase||0
224008|NCT01183169|542282|P4|Completed Treatment|Post-switch Phase||0
224009|NCT01183169|542283|P3|Completed Treatment|Post-switch Phase||0
224010|NCT01183169|542284|P2|Completed Treatment|Post-switch Phase||0
224011|NCT01183169|542285|P1|Completed Treatment|Post-switch Phase||0
224012|NCT01183169|542279|P7|STARTED|Post-switch Phase|Participants in Treatment C2 who switched to active ALV|30
224013|NCT01183169|542280|P6|STARTED|Post-switch Phase|Participants in Treatment C1 who switched to active ALV|35
224014|NCT01183169|542281|P5|STARTED|Post-switch Phase|Not a post-switch group|0
224015|NCT01183169|542282|P4|STARTED|Post-switch Phase|Not a post-switch group|0
224016|NCT01183169|542283|P3|STARTED|Post-switch Phase|Not a post-switch group|0
224017|NCT01183169|542284|P2|STARTED|Post-switch Phase|Not a post-switch group|0
224018|NCT01183169|542285|P1|STARTED|Post-switch Phase|Not a post-switch group|0
224019|NCT01183169|542279|P7|NOT COMPLETED|Main Phase||0
224020|NCT01183169|542280|P6|NOT COMPLETED|Main Phase||0
224021|NCT01183169|542281|P5|NOT COMPLETED|Main Phase||26
224022|NCT01183169|542282|P4|NOT COMPLETED|Main Phase||37
224023|NCT01183169|542283|P3|NOT COMPLETED|Main Phase||41
224024|NCT01183169|542284|P2|NOT COMPLETED|Main Phase||22
224025|NCT01183169|542285|P1|NOT COMPLETED|Main Phase||27
224026|NCT01183169|542279|P7|COMPLETED|Main Phase||0
224027|NCT01183169|542280|P6|COMPLETED|Main Phase||0
224028|NCT01183169|542281|P5|COMPLETED|Main Phase||83
224029|NCT01183169|542282|P4|COMPLETED|Main Phase||18
224030|NCT01183169|542283|P3|COMPLETED|Main Phase||18
224031|NCT01183169|542284|P2|COMPLETED|Main Phase||93
224032|NCT01183169|542285|P1|COMPLETED|Main Phase||94
224033|NCT01183169|542279|P7|Switched to ALV|Main Phase||0
224034|NCT01183169|542280|P6|Switched to ALV|Main Phase||0
224035|NCT01183169|542281|P5|Switched to ALV|Main Phase||0
224036|NCT01183169|542282|P4|Switched to ALV|Main Phase||30
224037|NCT01183169|542283|P3|Switched to ALV|Main Phase||35
224038|NCT01183169|542284|P2|Switched to ALV|Main Phase||0
224039|NCT01183169|542285|P1|Switched to ALV|Main Phase||0
224040|NCT01183169|542279|P7|Completed Treatment|Main Phase||0
224041|NCT01183169|542280|P6|Completed Treatment|Main Phase||0
224042|NCT01183169|542281|P5|Completed Treatment|Main Phase||77
224043|NCT01183169|542282|P4|Completed Treatment|Main Phase||17
224044|NCT01183169|542283|P3|Completed Treatment|Main Phase||17
224045|NCT01183169|542284|P2|Completed Treatment|Main Phase||78
224046|NCT01183169|542285|P1|Completed Treatment|Main Phase||72
224047|NCT01183169|542279|P7|STARTED|Main Phase||0
224048|NCT01183169|542280|P6|STARTED|Main Phase||0
224049|NCT01183169|542281|P5|STARTED|Main Phase||109
224050|NCT01183169|542282|P4|STARTED|Main Phase||55
224051|NCT01183169|542283|P3|STARTED|Main Phase||59
224052|NCT01183169|542284|P2|STARTED|Main Phase||115
224053|NCT01183169|542285|P1|STARTED|Main Phase||121
224054|NCT01183143|542357|P1|NOT COMPLETED|Overall Study||150
224055|NCT01183143|542357|P1|COMPLETED|Overall Study||65
224056|NCT01183143|542357|P1|Intention to Treat (ITT) Population|Overall Study|ITT=Subjects who received at least 1 dose of the investigational medicinal product (IMP).|204
224057|NCT01183143|542357|P1|STARTED|Overall Study||215
224058|NCT01183104|542373|P2|NOT COMPLETED|Overall Study||92
224059|NCT01183104|542374|P1|NOT COMPLETED|Overall Study||77
224060|NCT01183104|542373|P2|COMPLETED|Overall Study||60
224061|NCT01183104|542374|P1|COMPLETED|Overall Study||76
224062|NCT01183104|542373|P2|Enrolled in Extension Study|Overall Study||61
224063|NCT01183104|542374|P1|Enrolled in Extension Study|Overall Study||80
224064|NCT01183104|542373|P2|Completed 52-week Treatment|Overall Study||111
224065|NCT01183104|542374|P1|Completed 52-week Treatment|Overall Study||119
224066|NCT01183104|542373|P2|Continued Treatment for 12 Weeks|Overall Study||129
224067|NCT01183104|542374|P1|Continued Treatment for 12 Weeks|Overall Study||143
224068|NCT01183104|542373|P2|Received Study Drug|Overall Study||143
224069|NCT01183104|542374|P1|Received Study Drug|Overall Study||148
224070|NCT01183104|542373|P2|STARTED|Overall Study||152
224071|NCT01183104|542374|P1|STARTED|Overall Study||153
224072|NCT01183065|542390|P1|NOT COMPLETED|Overall Study||1
224073|NCT01183065|542390|P1|COMPLETED|Overall Study||12
224074|NCT01183065|542390|P1|STARTED|Overall Study||13
224075|NCT01183013|542401|P7|NOT COMPLETED|Overall Study||37
224076|NCT01183013|542402|P6|NOT COMPLETED|Overall Study||45
224077|NCT01183013|542403|P5|NOT COMPLETED|Overall Study||36
224078|NCT01183013|542404|P4|NOT COMPLETED|Overall Study||30
224079|NCT01183013|542405|P3|NOT COMPLETED|Overall Study||41
224080|NCT01183013|542406|P2|NOT COMPLETED|Overall Study||39
224081|NCT01183013|542407|P1|NOT COMPLETED|Overall Study||45
224082|NCT01183013|542401|P7|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|96
224083|NCT01183013|542402|P6|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|88
224084|NCT01183013|542403|P5|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|90
224085|NCT01183013|542404|P4|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|105
224086|NCT01183013|542405|P3|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|97
224087|NCT01183013|542406|P2|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|101
224088|NCT01183013|542407|P1|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|86
224089|NCT01183013|542401|P7|STARTED|Overall Study||133
224090|NCT01183013|542402|P6|STARTED|Overall Study||133
224091|NCT01183013|542403|P5|STARTED|Overall Study||126
224092|NCT01183013|542404|P4|STARTED|Overall Study||135
224093|NCT01183013|542405|P3|STARTED|Overall Study||138
224094|NCT01183013|542406|P2|STARTED|Overall Study||140
224095|NCT01183013|542407|P1|STARTED|Overall Study||131
224096|NCT01182805|542486|P1|NOT COMPLETED|Overall Study||0
224097|NCT01182805|542486|P1|COMPLETED|Overall Study||50
224098|NCT01182805|542486|P1|STARTED|Overall Study||50
224099|NCT01182727|542495|P1|NOT COMPLETED|Overall Study||0
224100|NCT01182727|542495|P1|COMPLETED|Overall Study||10
224101|NCT01182727|542495|P1|STARTED|Overall Study||10
224102|NCT01182675|542501|P2|NOT COMPLETED|Overall Study||0
224103|NCT01182675|542502|P1|NOT COMPLETED|Overall Study||0
224104|NCT01182675|542501|P2|COMPLETED|Overall Study||0
224105|NCT01182675|542502|P1|COMPLETED|Overall Study||7
224106|NCT01182675|542501|P2|STARTED|Overall Study||0
224107|NCT01182675|542502|P1|STARTED|Overall Study||7
224108|NCT01182610|542518|P1|NOT COMPLETED|Overall Study||0
224109|NCT01182610|542518|P1|COMPLETED|Overall Study||1
224110|NCT01182610|542518|P1|STARTED|Overall Study||1
224111|NCT01182493|542528|P2|NOT COMPLETED|Overall Study||7
224112|NCT01182493|542529|P1|NOT COMPLETED|Overall Study||16
224113|NCT01182493|542528|P2|COMPLETED|Overall Study||156
224114|NCT01182493|542529|P1|COMPLETED|Overall Study||152
224115|NCT01182493|542528|P2|STARTED|Overall Study||163
224116|NCT01182493|542529|P1|STARTED|Overall Study||168
224117|NCT01182480|542547|P1|NOT COMPLETED|Overall Study||0
224118|NCT01182480|542547|P1|COMPLETED|Overall Study||47
224119|NCT01182480|542547|P1|STARTED|Overall Study||47
224120|NCT01182441|542553|P2|NOT COMPLETED|Overall Study||119
224121|NCT01182441|542554|P1|NOT COMPLETED|Overall Study||220
224122|NCT01182441|542553|P2|COMPLETED|Overall Study||19
224123|NCT01182441|542554|P1|COMPLETED|Overall Study||49
224124|NCT01182441|542553|P2|STARTED|Overall Study||138
224125|NCT01182441|542554|P1|STARTED|Overall Study||269
224126|NCT01182428|542565|P2|NOT COMPLETED|Overall Study||1
224127|NCT01182428|542566|P1|NOT COMPLETED|Overall Study||11
224128|NCT01182428|542565|P2|COMPLETED|Overall Study||150
224129|NCT01182428|542566|P1|COMPLETED|Overall Study||293
224130|NCT01182428|542565|P2|STARTED|Overall Study||151
224131|NCT01182428|542566|P1|STARTED|Overall Study||304
224132|NCT01182415|542630|P1|NOT COMPLETED|Overall Study||1
224133|NCT01182415|542630|P1|COMPLETED|Overall Study||29
224134|NCT01182415|542630|P1|STARTED|Overall Study||30
224135|NCT01182376|542639|P2|NOT COMPLETED|Overall Study||5
224136|NCT01182376|542640|P1|NOT COMPLETED|Overall Study||11
224137|NCT01182376|542639|P2|COMPLETED|Overall Study||13
224138|NCT01182376|542640|P1|COMPLETED|Overall Study||4
224139|NCT01182376|542639|P2|STARTED|Overall Study||18
224140|NCT01182376|542640|P1|STARTED|Overall Study||15
224141|NCT01182350|542646|P5|NOT COMPLETED|Overall Study||3
224142|NCT01182350|542647|P4|NOT COMPLETED|Overall Study||3
224143|NCT01182350|542648|P3|NOT COMPLETED|Overall Study||3
224144|NCT01182350|542649|P2|NOT COMPLETED|Overall Study||14
224145|NCT01182350|542650|P1|NOT COMPLETED|Overall Study||27
224146|NCT01182350|542646|P5|COMPLETED|Overall Study||0
224147|NCT01182350|542647|P4|COMPLETED|Overall Study||0
224148|NCT01182350|542648|P3|COMPLETED|Overall Study||0
224149|NCT01182350|542649|P2|COMPLETED|Overall Study||0
224150|NCT01182350|542650|P1|COMPLETED|Overall Study||3
224151|NCT01182350|542646|P5|Started Assigned Chemoradiation|Overall Study||0
224152|NCT01182350|542647|P4|Started Assigned Chemoradiation|Overall Study||2
224153|NCT01182350|542648|P3|Started Assigned Chemoradiation|Overall Study||2
224154|NCT01182350|542649|P2|Started Assigned Chemoradiation|Overall Study||14
224155|NCT01182350|542650|P1|Started Assigned Chemoradiation|Overall Study||27
224156|NCT01182350|542646|P5|Underwent Stereotactic Biopsy|Overall Study||0
224157|NCT01182350|542647|P4|Underwent Stereotactic Biopsy|Overall Study||3
224158|NCT01182350|542648|P3|Underwent Stereotactic Biopsy|Overall Study||3
224159|NCT01182350|542649|P2|Underwent Stereotactic Biopsy|Overall Study||14
224160|NCT01182350|542650|P1|Underwent Stereotactic Biopsy|Overall Study||30
224161|NCT01182350|542646|P5|STARTED|Overall Study||3
224162|NCT01182350|542647|P4|STARTED|Overall Study||3
224163|NCT01182350|542648|P3|STARTED|Overall Study||3
224164|NCT01182350|542649|P2|STARTED|Overall Study||14
224165|NCT01182350|542650|P1|STARTED|Overall Study||30
224166|NCT01182337|542672|P2|NOT COMPLETED|Overall Study||2
224167|NCT01182337|542673|P1|NOT COMPLETED|Overall Study||3
224168|NCT01182337|542672|P2|COMPLETED|Overall Study||7
224169|NCT01182337|542673|P1|COMPLETED|Overall Study||19
224170|NCT01182337|542672|P2|STARTED|Overall Study||9
224171|NCT01182337|542673|P1|STARTED|Overall Study||22
224172|NCT01182298|542691|P1|NOT COMPLETED|Overall Study||6
224173|NCT01182298|542691|P1|COMPLETED|Overall Study||4
224174|NCT01182298|542691|P1|STARTED|Overall Study||10
224175|NCT01182285|542695|P3|NOT COMPLETED|Third Intervention Week 11-52||8
224176|NCT01182285|542696|P2|NOT COMPLETED|Third Intervention Week 11-52||0
224177|NCT01182285|542697|P1|NOT COMPLETED|Third Intervention Week 11-52||0
224178|NCT01182285|542695|P3|COMPLETED|Third Intervention Week 11-52||0
224179|NCT01182285|542696|P2|COMPLETED|Third Intervention Week 11-52||0
224180|NCT01182285|542697|P1|COMPLETED|Third Intervention Week 11-52||0
224181|NCT01182285|542695|P3|STARTED|Third Intervention Week 11-52|2 subj. taken off study after completing ph 1: 1 due to a negative uptake scan & one off due to PD.|8
224182|NCT01182285|542696|P2|STARTED|Third Intervention Week 11-52||0
224183|NCT01182285|542697|P1|STARTED|Third Intervention Week 11-52||0
224184|NCT01182285|542695|P3|NOT COMPLETED|Second Intervention Week 11-17||0
224185|NCT01182285|542696|P2|NOT COMPLETED|Second Intervention Week 11-17||0
224186|NCT01182285|542697|P1|NOT COMPLETED|Second Intervention Week 11-17||0
224187|NCT01182285|542695|P3|COMPLETED|Second Intervention Week 11-17||0
224188|NCT01182285|542696|P2|COMPLETED|Second Intervention Week 11-17||0
224189|NCT01182285|542697|P1|COMPLETED|Second Intervention Week 11-17||0
224190|NCT01182285|542695|P3|STARTED|Second Intervention Week 11-17||0
224191|NCT01182285|542696|P2|STARTED|Second Intervention Week 11-17||0
224192|NCT01182285|542697|P1|STARTED|Second Intervention Week 11-17||0
224193|NCT01182285|542695|P3|NOT COMPLETED|First Intervention Week 1-10||0
224194|NCT01182285|542696|P2|NOT COMPLETED|First Intervention Week 1-10||0
224195|NCT01182285|542697|P1|NOT COMPLETED|First Intervention Week 1-10||3
224196|NCT01182285|542695|P3|COMPLETED|First Intervention Week 1-10||0
224197|NCT01182285|542696|P2|COMPLETED|First Intervention Week 1-10||0
224198|NCT01182285|542697|P1|COMPLETED|First Intervention Week 1-10||10
224199|NCT01182285|542695|P3|STARTED|First Intervention Week 1-10||0
224200|NCT01182285|542696|P2|STARTED|First Intervention Week 1-10||0
224201|NCT01182285|542697|P1|STARTED|First Intervention Week 1-10||13
224202|NCT01182207|542707|P2|NOT COMPLETED|Second Intervention||0
224203|NCT01182207|542708|P1|NOT COMPLETED|Second Intervention||1
224204|NCT01182207|542707|P2|COMPLETED|Second Intervention||14
224205|NCT01182207|542708|P1|COMPLETED|Second Intervention||17
224206|NCT01182207|542707|P2|STARTED|Second Intervention||14
224207|NCT01182207|542708|P1|STARTED|Second Intervention||18
224208|NCT01182207|542707|P2|NOT COMPLETED|Washout of 28 Days||0
224209|NCT01182207|542708|P1|NOT COMPLETED|Washout of 28 Days||0
224210|NCT01182207|542707|P2|COMPLETED|Washout of 28 Days||14
224211|NCT01182207|542708|P1|COMPLETED|Washout of 28 Days||18
224212|NCT01182207|542707|P2|STARTED|Washout of 28 Days||14
224213|NCT01182207|542708|P1|STARTED|Washout of 28 Days||18
224214|NCT01182207|542707|P2|NOT COMPLETED|First Intervention||1
224215|NCT01182207|542708|P1|NOT COMPLETED|First Intervention||0
224216|NCT01182207|542707|P2|COMPLETED|First Intervention||14
224217|NCT01182207|542708|P1|COMPLETED|First Intervention||18
224218|NCT01182207|542707|P2|STARTED|First Intervention||15
224219|NCT01182207|542708|P1|STARTED|First Intervention||18
224220|NCT01182194|542726|P2|NOT COMPLETED|Second Intervention||0
224221|NCT01182194|542727|P1|NOT COMPLETED|Second Intervention||0
224222|NCT01182194|542726|P2|COMPLETED|Second Intervention||16
224223|NCT01182194|542727|P1|COMPLETED|Second Intervention||15
224224|NCT01182194|542726|P2|STARTED|Second Intervention||16
224225|NCT01182194|542727|P1|STARTED|Second Intervention||15
224226|NCT01182194|542726|P2|NOT COMPLETED|Washout of 28 Days||0
224227|NCT01182194|542727|P1|NOT COMPLETED|Washout of 28 Days||1
224228|NCT01182194|542726|P2|COMPLETED|Washout of 28 Days||16
224229|NCT01182194|542727|P1|COMPLETED|Washout of 28 Days||15
224230|NCT01182194|542726|P2|STARTED|Washout of 28 Days||16
224231|NCT01182194|542727|P1|STARTED|Washout of 28 Days||16
224232|NCT01182194|542726|P2|NOT COMPLETED|First Intervention||0
224233|NCT01182194|542727|P1|NOT COMPLETED|First Intervention||0
224234|NCT01182194|542726|P2|COMPLETED|First Intervention||16
224235|NCT01182194|542727|P1|COMPLETED|First Intervention||16
224236|NCT01182194|542726|P2|STARTED|First Intervention||16
224237|NCT01182194|542727|P1|STARTED|First Intervention||16
224238|NCT01182181|542745|P2|NOT COMPLETED|Second Intervention||0
224239|NCT01182181|542746|P1|NOT COMPLETED|Second Intervention||0
224240|NCT01182181|542745|P2|COMPLETED|Second Intervention||10
224241|NCT01182181|542746|P1|COMPLETED|Second Intervention||10
224242|NCT01182181|542745|P2|STARTED|Second Intervention||10
224243|NCT01182181|542746|P1|STARTED|Second Intervention||10
224244|NCT01182181|542745|P2|NOT COMPLETED|Washout of 21 Days||1
224245|NCT01182181|542746|P1|NOT COMPLETED|Washout of 21 Days||0
224246|NCT01182181|542745|P2|COMPLETED|Washout of 21 Days||10
224247|NCT01182181|542746|P1|COMPLETED|Washout of 21 Days||10
224248|NCT01182181|542745|P2|STARTED|Washout of 21 Days||11
224249|NCT01182181|542746|P1|STARTED|Washout of 21 Days||10
224250|NCT01182181|542745|P2|NOT COMPLETED|First Intervention||0
224251|NCT01182181|542746|P1|NOT COMPLETED|First Intervention||1
224252|NCT01182181|542745|P2|COMPLETED|First Intervention||11
224253|NCT01182181|542746|P1|COMPLETED|First Intervention||10
224254|NCT01182181|542745|P2|STARTED|First Intervention||11
224255|NCT01182181|542746|P1|STARTED|First Intervention||11
224256|NCT01182103|542756|P2|NOT COMPLETED|Overall Study||0
224257|NCT01182103|542757|P1|NOT COMPLETED|Overall Study||0
224258|NCT01182103|542756|P2|COMPLETED|Overall Study||62
224259|NCT01182103|542757|P1|COMPLETED|Overall Study||48
224260|NCT01182103|542756|P2|STARTED|Overall Study||62
224261|NCT01182103|542757|P1|STARTED|Overall Study||48
224262|NCT01181986|542771|P3|NOT COMPLETED|Phase 2||0
224263|NCT01181986|542772|P2|NOT COMPLETED|Phase 2||4
224264|NCT01181986|542773|P1|NOT COMPLETED|Phase 2||0
224265|NCT01181986|542771|P3|COMPLETED|Phase 2||0
224266|NCT01181986|542772|P2|COMPLETED|Phase 2||18
224267|NCT01181986|542773|P1|COMPLETED|Phase 2||18
224268|NCT01181986|542771|P3|STARTED|Phase 2|N/A for Sub-study 2|0
224269|NCT01181986|542772|P2|STARTED|Phase 2||22
224270|NCT01181986|542773|P1|STARTED|Phase 2||18
224271|NCT01181986|542771|P3|NOT COMPLETED|Phase 1||2
224272|NCT01181986|542772|P2|NOT COMPLETED|Phase 1||1
224273|NCT01181986|542773|P1|NOT COMPLETED|Phase 1||1
224274|NCT01181986|542771|P3|COMPLETED|Phase 1||32
224275|NCT01181986|542772|P2|COMPLETED|Phase 1||22
224276|NCT01181986|542773|P1|COMPLETED|Phase 1||18
224277|NCT01181986|542771|P3|Exendin-9+Exenatide|Phase 1||33
224278|NCT01181986|542772|P2|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
224279|NCT01181986|542773|P1|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
224280|NCT01181986|542771|P3|Saline+Placebo|Phase 1||33
224281|NCT01181986|542772|P2|Saline+Placebo|Phase 1|N/A for this arm|0
224282|NCT01181986|542773|P1|Saline+Placebo|Phase 1|N/A for this arm|0
224283|NCT01181986|542771|P3|Saline+Exenatide|Phase 1||32
224284|NCT01181986|542772|P2|Saline+Exenatide|Phase 1|N/A for this arm|0
224285|NCT01181986|542773|P1|Saline+Exenatide|Phase 1|N/A for this arm|0
224286|NCT01181986|542771|P3|STARTED|Phase 1||34
224287|NCT01181986|542772|P2|STARTED|Phase 1||23
224288|NCT01181986|542773|P1|STARTED|Phase 1||19
224289|NCT01181947|542789|P1|NOT COMPLETED|Overall Study||0
224290|NCT01181947|542789|P1|COMPLETED|Overall Study||100
224291|NCT01181947|542789|P1|STARTED|Overall Study||100
224292|NCT01181921|542794|P1|NOT COMPLETED|Overall Study||1
224293|NCT01181921|542794|P1|COMPLETED|Overall Study||0
224294|NCT01181921|542794|P1|STARTED|Overall Study||1
224295|NCT01181895|542801|P3|NOT COMPLETED|Overall Study||18
224296|NCT01181895|542802|P2|NOT COMPLETED|Overall Study||14
224297|NCT01181895|542803|P1|NOT COMPLETED|Overall Study||17
224298|NCT01181895|542801|P3|COMPLETED|Overall Study||98
224299|NCT01181895|542802|P2|COMPLETED|Overall Study||101
224300|NCT01181895|542803|P1|COMPLETED|Overall Study||99
224301|NCT01181895|542801|P3|STARTED|Overall Study||116
224302|NCT01181895|542802|P2|STARTED|Overall Study||115
224303|NCT01181895|542803|P1|STARTED|Overall Study||116
224304|NCT01181804|542836|P4|NOT COMPLETED|Period 4, Fasted (Part 2)||0
224305|NCT01181804|542837|P3|NOT COMPLETED|Period 4, Fasted (Part 2)||1
224306|NCT01181804|542838|P2|NOT COMPLETED|Period 4, Fasted (Part 2)||0
224307|NCT01181804|542839|P1|NOT COMPLETED|Period 4, Fasted (Part 2)||0
224308|NCT01181804|542836|P4|COMPLETED|Period 4, Fasted (Part 2)||58
224309|NCT01181804|542837|P3|COMPLETED|Period 4, Fasted (Part 2)||58
224310|NCT01181804|542838|P2|COMPLETED|Period 4, Fasted (Part 2)||0
224311|NCT01181804|542839|P1|COMPLETED|Period 4, Fasted (Part 2)||0
224312|NCT01181804|542836|P4|STARTED|Period 4, Fasted (Part 2)||58
224313|NCT01181804|542837|P3|STARTED|Period 4, Fasted (Part 2)||59
224314|NCT01181804|542838|P2|STARTED|Period 4, Fasted (Part 2)||0
224315|NCT01181804|542839|P1|STARTED|Period 4, Fasted (Part 2)||0
224316|NCT01181804|542836|P4|NOT COMPLETED|Period 3, Fasted (Part 2)||0
224317|NCT01181804|542837|P3|NOT COMPLETED|Period 3, Fasted (Part 2)||0
224318|NCT01181804|542838|P2|NOT COMPLETED|Period 3, Fasted (Part 2)||0
224319|NCT01181804|542839|P1|NOT COMPLETED|Period 3, Fasted (Part 2)||0
224320|NCT01181804|542836|P4|COMPLETED|Period 3, Fasted (Part 2)||58
224321|NCT01181804|542837|P3|COMPLETED|Period 3, Fasted (Part 2)||59
224322|NCT01181804|542838|P2|COMPLETED|Period 3, Fasted (Part 2)||0
224323|NCT01181804|542839|P1|COMPLETED|Period 3, Fasted (Part 2)||0
224324|NCT01181804|542836|P4|STARTED|Period 3, Fasted (Part 2)||58
224325|NCT01181804|542837|P3|STARTED|Period 3, Fasted (Part 2)||59
224326|NCT01181804|542838|P2|STARTED|Period 3, Fasted (Part 2)||0
224327|NCT01181804|542839|P1|STARTED|Period 3, Fasted (Part 2)||0
224328|NCT01181804|542836|P4|NOT COMPLETED|Period 2, Fed (Part 1)||0
224329|NCT01181804|542837|P3|NOT COMPLETED|Period 2, Fed (Part 1)||0
224330|NCT01181804|542838|P2|NOT COMPLETED|Period 2, Fed (Part 1)||0
224331|NCT01181804|542839|P1|NOT COMPLETED|Period 2, Fed (Part 1)||0
224332|NCT01181804|542836|P4|COMPLETED|Period 2, Fed (Part 1)||0
224333|NCT01181804|542837|P3|COMPLETED|Period 2, Fed (Part 1)||0
224334|NCT01181804|542838|P2|COMPLETED|Period 2, Fed (Part 1)||30
224335|NCT01181804|542839|P1|COMPLETED|Period 2, Fed (Part 1)||30
224336|NCT01181804|542836|P4|STARTED|Period 2, Fed (Part 1)||0
224337|NCT01181804|542837|P3|STARTED|Period 2, Fed (Part 1)||0
224338|NCT01181804|542838|P2|STARTED|Period 2, Fed (Part 1)||30
224339|NCT01181804|542839|P1|STARTED|Period 2, Fed (Part 1)||30
224340|NCT01181804|542836|P4|NOT COMPLETED|Period 1, Fed (Part 1)||0
224341|NCT01181804|542837|P3|NOT COMPLETED|Period 1, Fed (Part 1)||0
224342|NCT01181804|542838|P2|NOT COMPLETED|Period 1, Fed (Part 1)||0
224343|NCT01181804|542839|P1|NOT COMPLETED|Period 1, Fed (Part 1)||0
224344|NCT01181804|542836|P4|COMPLETED|Period 1, Fed (Part 1)||0
224345|NCT01181804|542837|P3|COMPLETED|Period 1, Fed (Part 1)||0
224346|NCT01181804|542838|P2|COMPLETED|Period 1, Fed (Part 1)||30
224347|NCT01181804|542839|P1|COMPLETED|Period 1, Fed (Part 1)||30
224348|NCT01181804|542836|P4|STARTED|Period 1, Fed (Part 1)||0
224349|NCT01181804|542837|P3|STARTED|Period 1, Fed (Part 1)||0
224350|NCT01181804|542838|P2|STARTED|Period 1, Fed (Part 1)||30
224351|NCT01181804|542839|P1|STARTED|Period 1, Fed (Part 1)||30
224352|NCT01181778|542861|P1|NOT COMPLETED|Overall Study||48
224353|NCT01181778|542861|P1|COMPLETED|Overall Study||1871
224354|NCT01181778|542861|P1|STARTED|Overall Study||1919
224355|NCT01181726|542869|P2|NOT COMPLETED|Second Intervention||0
224356|NCT01181726|542870|P1|NOT COMPLETED|Second Intervention||0
224357|NCT01181726|542869|P2|COMPLETED|Second Intervention||20
224358|NCT01181726|542870|P1|COMPLETED|Second Intervention||19
224359|NCT01181726|542869|P2|STARTED|Second Intervention||20
224360|NCT01181726|542870|P1|STARTED|Second Intervention||19
224361|NCT01181726|542869|P2|NOT COMPLETED|Washout of 28 Days||0
224362|NCT01181726|542870|P1|NOT COMPLETED|Washout of 28 Days||0
224363|NCT01181726|542869|P2|COMPLETED|Washout of 28 Days||20
224364|NCT01181726|542870|P1|COMPLETED|Washout of 28 Days||19
224365|NCT01181726|542869|P2|STARTED|Washout of 28 Days||20
224366|NCT01181726|542870|P1|STARTED|Washout of 28 Days||19
224367|NCT01181726|542869|P2|NOT COMPLETED|First Intervention||0
224368|NCT01181726|542870|P1|NOT COMPLETED|First Intervention||1
224369|NCT01181726|542869|P2|COMPLETED|First Intervention||20
224370|NCT01181726|542870|P1|COMPLETED|First Intervention||19
224371|NCT01181726|542869|P2|STARTED|First Intervention||20
224372|NCT01181726|542870|P1|STARTED|First Intervention||20
224373|NCT01181609|542916|P1|NOT COMPLETED|Overall Study||53
224374|NCT01181609|542916|P1|COMPLETED|Overall Study||1
224375|NCT01181609|542916|P1|STARTED|Overall Study||54
224376|NCT01181596|542927|P1|NOT COMPLETED|Overall Study||0
224377|NCT01181596|542927|P1|COMPLETED|Overall Study||31
224378|NCT01181596|542927|P1|STARTED|Overall Study||31
224379|NCT01181531|542934|P2|NOT COMPLETED|Overall Study||53
224380|NCT01181531|542935|P1|NOT COMPLETED|Overall Study||61
224381|NCT01181531|542934|P2|COMPLETED|Overall Study||102
224382|NCT01181531|542935|P1|COMPLETED|Overall Study||96
224383|NCT01181531|542934|P2|Received Investigational Product|Overall Study||153
224384|NCT01181531|542935|P1|Received Investigational Product|Overall Study||155
224385|NCT01181531|542934|P2|STARTED|Overall Study|Subjects are randomized after washout.|155
224386|NCT01181531|542935|P1|STARTED|Overall Study|Subjects are randomized after washout.|157
224387|NCT01181492|542948|P3|NOT COMPLETED|Overall Study||0
224388|NCT01181492|542949|P2|NOT COMPLETED|Overall Study||0
224389|NCT01181492|542950|P1|NOT COMPLETED|Overall Study||0
224390|NCT01181492|542948|P3|COMPLETED|Overall Study||7
224391|NCT01181492|542949|P2|COMPLETED|Overall Study||66
224392|NCT01181492|542950|P1|COMPLETED|Overall Study||103
224393|NCT01181492|542948|P3|STARTED|Overall Study||7
224394|NCT01181492|542949|P2|STARTED|Overall Study||66
224395|NCT01181492|542950|P1|STARTED|Overall Study||103
224396|NCT01181479|542966|P3|NOT COMPLETED|Crossover Subjects Recieve AG200-15||99
224397|NCT01181479|542967|P2|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0
224398|NCT01181479|542968|P1|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0
224399|NCT01181479|542966|P3|COMPLETED|Crossover Subjects Recieve AG200-15||150
224400|NCT01181479|542967|P2|COMPLETED|Crossover Subjects Recieve AG200-15||0
224401|NCT01181479|542968|P1|COMPLETED|Crossover Subjects Recieve AG200-15||0
224402|NCT01181479|542966|P3|STARTED|Crossover Subjects Recieve AG200-15|"This column is a subset of the Lessina completers in the Lessina (Cycles 1-6) column."|249
224403|NCT01181479|542967|P2|STARTED|Crossover Subjects Recieve AG200-15||0
224404|NCT01181479|542968|P1|STARTED|Crossover Subjects Recieve AG200-15||0
224405|NCT01181479|542966|P3|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||0
224406|NCT01181479|542967|P2|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||126
224407|NCT01181479|542968|P1|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||644
224408|NCT01181479|542966|P3|COMPLETED|Subjects Receive AG200-15 or Lessina||0
224409|NCT01181479|542967|P2|COMPLETED|Subjects Receive AG200-15 or Lessina||249
224410|NCT01181479|542968|P1|COMPLETED|Subjects Receive AG200-15 or Lessina||485
224411|NCT01181479|542966|P3|STARTED|Subjects Receive AG200-15 or Lessina|"This column is a subset of the Lessina completers in the Lessina (Cycles 1-6) column."|0
224412|NCT01181479|542967|P2|STARTED|Subjects Receive AG200-15 or Lessina||375
224413|NCT01181479|542968|P1|STARTED|Subjects Receive AG200-15 or Lessina||1129
224414|NCT01181349|542983|P1|NOT COMPLETED|Overall Study||0
224415|NCT01181349|542983|P1|COMPLETED|Overall Study||350
224416|NCT01181349|542983|P1|STARTED|Overall Study||350
224417|NCT01181323|542999|P4|NOT COMPLETED|Overall Study||3
224418|NCT01181323|543000|P3|NOT COMPLETED|Overall Study||1
224419|NCT01181323|543001|P2|NOT COMPLETED|Overall Study||3
224420|NCT01181323|543002|P1|NOT COMPLETED|Overall Study||1
224421|NCT01181323|542999|P4|COMPLETED|Overall Study||122
224422|NCT01181323|543000|P3|COMPLETED|Overall Study||123
224423|NCT01181323|543001|P2|COMPLETED|Overall Study||121
224424|NCT01181323|543002|P1|COMPLETED|Overall Study||123
224425|NCT01181323|542999|P4|STARTED|Overall Study||125
224426|NCT01181323|543000|P3|STARTED|Overall Study||124
224427|NCT01181323|543001|P2|STARTED|Overall Study||124
224428|NCT01181323|543002|P1|STARTED|Overall Study||124
224429|NCT01181271|543077|P1|NOT COMPLETED|Allogeneic Transplant||0
224430|NCT01181271|543077|P1|COMPLETED|Allogeneic Transplant||29
224431|NCT01181271|543077|P1|STARTED|Allogeneic Transplant||29
224432|NCT01181271|543077|P1|NOT COMPLETED|Evaluation for Allogeneic Transplant||13
224433|NCT01181271|543077|P1|COMPLETED|Evaluation for Allogeneic Transplant||29
224434|NCT01181271|543077|P1|STARTED|Evaluation for Allogeneic Transplant||42
224435|NCT01181271|543077|P1|NOT COMPLETED|Autologous Transplant||0
224436|NCT01181271|543077|P1|COMPLETED|Autologous Transplant||42
224437|NCT01181271|543077|P1|STARTED|Autologous Transplant||42
224438|NCT01181258|543092|P1|NOT COMPLETED|Overall Study||0
224439|NCT01181258|543092|P1|COMPLETED|Overall Study||16
224440|NCT01181258|543092|P1|STARTED|Overall Study||16
224441|NCT01181167|543101|P2|NOT COMPLETED|Overall Study||32
224442|NCT01181167|543102|P1|NOT COMPLETED|Overall Study||23
224443|NCT01181167|543101|P2|COMPLETED|Overall Study||271
224444|NCT01181167|543102|P1|COMPLETED|Overall Study||284
224445|NCT01181167|543101|P2|Efficacy Analysis Population|Overall Study||248
224446|NCT01181167|543102|P1|Efficacy Analysis Population|Overall Study||255
224447|NCT01181167|543101|P2|STARTED|Overall Study||303
224448|NCT01181167|543102|P1|STARTED|Overall Study||307
224449|NCT01181141|543112|P2|NOT COMPLETED|Overall Study||4
224450|NCT01181141|543113|P1|NOT COMPLETED|Overall Study||12
224451|NCT01181141|543112|P2|COMPLETED|Overall Study||26
224452|NCT01181141|543113|P1|COMPLETED|Overall Study||50
224453|NCT01181141|543112|P2|Safety Analysis Population|Overall Study||29
224454|NCT01181141|543113|P1|Safety Analysis Population|Overall Study||59
224455|NCT01181141|543112|P2|STARTED|Overall Study||30
224456|NCT01181141|543113|P1|STARTED|Overall Study||62
224457|NCT01181128|543122|P3|NOT COMPLETED|Overall Study||1
224458|NCT01181128|543123|P2|NOT COMPLETED|Overall Study||5
224459|NCT01181128|543124|P1|NOT COMPLETED|Overall Study||6
224460|NCT01181128|543122|P3|COMPLETED|Overall Study||22
224461|NCT01181128|543123|P2|COMPLETED|Overall Study||19
224462|NCT01181128|543124|P1|COMPLETED|Overall Study||112
224463|NCT01181128|543122|P3|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|0
224464|NCT01181128|543123|P2|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|1
224465|NCT01181128|543124|P1|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|8
224466|NCT01181128|543122|P3|Pharmacokinetic (PK) Subgroup|Overall Study||0
224467|NCT01181128|543123|P2|Pharmacokinetic (PK) Subgroup|Overall Study||0
224468|NCT01181128|543124|P1|Pharmacokinetic (PK) Subgroup|Overall Study||30
224469|NCT01181128|543122|P3|STARTED|Overall Study||23
224470|NCT01181128|543123|P2|STARTED|Overall Study||24
224471|NCT01181128|543124|P1|STARTED|Overall Study||118
224472|NCT01181102|543212|P2|NOT COMPLETED|Overall Study||46
224473|NCT01181102|543213|P1|NOT COMPLETED|Overall Study||51
224474|NCT01181102|543212|P2|COMPLETED|Overall Study||310
224475|NCT01181102|543213|P1|COMPLETED|Overall Study||309
224476|NCT01181102|543212|P2|Efficacy Analysis Population|Overall Study||295
224477|NCT01181102|543213|P1|Efficacy Analysis Population|Overall Study||299
224478|NCT01181102|543212|P2|Safety Analysis Set|Overall Study||349
224479|NCT01181102|543213|P1|Safety Analysis Set|Overall Study||354
224480|NCT01181102|543212|P2|STARTED|Overall Study||356
224481|NCT01181102|543213|P1|STARTED|Overall Study||360
224482|NCT01181050|543223|P2|NOT COMPLETED|Overall Study||0
224483|NCT01181050|543224|P1|NOT COMPLETED|Overall Study||0
224484|NCT01181050|543223|P2|COMPLETED|Overall Study||22
224485|NCT01181050|543224|P1|COMPLETED|Overall Study||41
224486|NCT01181050|543223|P2|STARTED|Overall Study||22
224487|NCT01181050|543224|P1|STARTED|Overall Study||41
224488|NCT01181011|543234|P1|NOT COMPLETED|Overall Study||3
224489|NCT01181011|543234|P1|COMPLETED|Overall Study||25
224490|NCT01181011|543234|P1|Received Amlodipine 5mg|Overall Study||26
224491|NCT01181011|543234|P1|Received Telmisartan 80mg,Amlodipine 5mg|Overall Study||27
224492|NCT01181011|543234|P1|Received Telmisartan 80mg|Overall Study||27
224493|NCT01181011|543234|P1|STARTED|Overall Study||28
224494|NCT01180998|543284|P3|NOT COMPLETED|Overall Study||10
224495|NCT01180998|543285|P2|NOT COMPLETED|Overall Study||4
224496|NCT01180998|543286|P1|NOT COMPLETED|Overall Study||4
224497|NCT01180998|543284|P3|COMPLETED|Overall Study||51
224498|NCT01180998|543285|P2|COMPLETED|Overall Study||68
224499|NCT01180998|543286|P1|COMPLETED|Overall Study||63
224500|NCT01180998|543284|P3|STARTED|Overall Study||61
224501|NCT01180998|543285|P2|STARTED|Overall Study||72
224502|NCT01180998|543286|P1|STARTED|Overall Study||67
224503|NCT01180985|543300|P2|NOT COMPLETED|Period 2 (7 +/- 1 Days)||0
224504|NCT01180985|543301|P1|NOT COMPLETED|Period 2 (7 +/- 1 Days)||1
224505|NCT01180985|543300|P2|COMPLETED|Period 2 (7 +/- 1 Days)||26
224506|NCT01180985|543301|P1|COMPLETED|Period 2 (7 +/- 1 Days)||26
224507|NCT01180985|543300|P2|STARTED|Period 2 (7 +/- 1 Days)||26
224508|NCT01180985|543301|P1|STARTED|Period 2 (7 +/- 1 Days)||27
224509|NCT01180985|543300|P2|NOT COMPLETED|Period 1 (7 +/- Days)||0
224510|NCT01180985|543301|P1|NOT COMPLETED|Period 1 (7 +/- Days)||0
224511|NCT01180985|543300|P2|COMPLETED|Period 1 (7 +/- Days)||26
224512|NCT01180985|543301|P1|COMPLETED|Period 1 (7 +/- Days)||27
224513|NCT01180985|543300|P2|STARTED|Period 1 (7 +/- Days)||26
224514|NCT01180985|543301|P1|STARTED|Period 1 (7 +/- Days)||27
224515|NCT01180894|543320|P2|NOT COMPLETED|Overall Study||0
224516|NCT01180894|543321|P1|NOT COMPLETED|Overall Study||0
224517|NCT01180894|543320|P2|COMPLETED|Overall Study||75
224518|NCT01180894|543321|P1|COMPLETED|Overall Study||75
224519|NCT01180894|543320|P2|STARTED|Overall Study||75
224520|NCT01180894|543321|P1|STARTED|Overall Study||75
224521|NCT01180790|543340|P7|NOT COMPLETED|Overall Study||1
224522|NCT01180790|543341|P6|NOT COMPLETED|Overall Study||7
224523|NCT01180790|543342|P5|NOT COMPLETED|Overall Study||5
224524|NCT01180790|543343|P4|NOT COMPLETED|Overall Study||9
224525|NCT01180790|543344|P3|NOT COMPLETED|Overall Study||13
224526|NCT01180790|543345|P2|NOT COMPLETED|Overall Study||5
224527|NCT01180790|543346|P1|NOT COMPLETED|Overall Study||9
224528|NCT01180790|543340|P7|COMPLETED|Overall Study||18
224529|NCT01180790|543341|P6|COMPLETED|Overall Study||13
224530|NCT01180790|543342|P5|COMPLETED|Overall Study||14
224531|NCT01180790|543343|P4|COMPLETED|Overall Study||6
224532|NCT01180790|543344|P3|COMPLETED|Overall Study||4
224533|NCT01180790|543345|P2|COMPLETED|Overall Study||11
224534|NCT01180790|543346|P1|COMPLETED|Overall Study||7
224535|NCT01180790|543340|P7|STARTED|Overall Study||19
224536|NCT01180790|543341|P6|STARTED|Overall Study||20
224537|NCT01180790|543342|P5|STARTED|Overall Study||19
224538|NCT01180790|543343|P4|STARTED|Overall Study||15
224539|NCT01180790|543344|P3|STARTED|Overall Study||17
224540|NCT01180790|543345|P2|STARTED|Overall Study||16
224541|NCT01180790|543346|P1|STARTED|Overall Study||16
224542|NCT01180777|543411|P1|NOT COMPLETED|Overall Study||12
224543|NCT01180777|543411|P1|COMPLETED|Overall Study||80
224544|NCT01180777|543411|P1|STARTED|Overall Study||92
224545|NCT01180660|543425|P2|NOT COMPLETED|Overall Study||0
224546|NCT01180660|543426|P1|NOT COMPLETED|Overall Study||1
224547|NCT01180660|543425|P2|COMPLETED|Overall Study||26
224548|NCT01180660|543426|P1|COMPLETED|Overall Study||24
224549|NCT01180660|543425|P2|STARTED|Overall Study||26
224550|NCT01180660|543426|P1|STARTED|Overall Study||25
224551|NCT01180647|543436|P2|NOT COMPLETED|Overall Study||6
224552|NCT01180647|543437|P1|NOT COMPLETED|Overall Study||5
224553|NCT01180647|543436|P2|COMPLETED|Overall Study||11
224554|NCT01180647|543437|P1|COMPLETED|Overall Study||12
224555|NCT01180647|543436|P2|STARTED|Overall Study||17
224556|NCT01180647|543437|P1|STARTED|Overall Study||17
224557|NCT01180478|543455|P2|NOT COMPLETED|Overall Study||188
224558|NCT01180478|543456|P1|NOT COMPLETED|Overall Study||181
224559|NCT01180478|543455|P2|COMPLETED|Overall Study||293
224560|NCT01180478|543456|P1|COMPLETED|Overall Study||303
224561|NCT01180478|543455|P2|STARTED|Overall Study||481
224562|NCT01180478|543456|P1|STARTED|Overall Study||484
224563|NCT01180400|543472|P2|NOT COMPLETED|Overall Study||27
224564|NCT01180400|543473|P1|NOT COMPLETED|Overall Study||25
224565|NCT01180400|543472|P2|COMPLETED|Overall Study||121
224566|NCT01180400|543473|P1|COMPLETED|Overall Study||122
224567|NCT01180400|543472|P2|Received Treatment|Overall Study||146
224568|NCT01180400|543473|P1|Received Treatment|Overall Study||147
224569|NCT01180400|543472|P2|STARTED|Overall Study||148
224570|NCT01180400|543473|P1|STARTED|Overall Study||147
224571|NCT01180296|543521|P2|NOT COMPLETED|Overall Study||2
224572|NCT01180296|543522|P1|NOT COMPLETED|Overall Study||1
224573|NCT01180296|543521|P2|COMPLETED|Overall Study||14
224574|NCT01180296|543522|P1|COMPLETED|Overall Study||19
224575|NCT01180296|543521|P2|STARTED|Overall Study||16
224576|NCT01180296|543522|P1|STARTED|Overall Study||20
224577|NCT01180244|543532|P2|NOT COMPLETED|Overall Study||8
224578|NCT01180244|543533|P1|NOT COMPLETED|Overall Study||6
224579|NCT01180244|543532|P2|COMPLETED|Overall Study|Number of placebo group patients who completed all study visits and are evaluable|38
224580|NCT01180244|543533|P1|COMPLETED|Overall Study|Number of active treatment patients who completed all study visits and are evaluable|39
224581|NCT01180244|543532|P2|Received Treatment|Overall Study|Number of patients in the placebo group that received at least one sham treatment|45
224582|NCT01180244|543533|P1|Received Treatment|Overall Study|Number of patients in the active treatment group that received at least one study treatment|40
224672|NCT01179568|543673|P1|Completed Week 12 Assessment|Overall Study||69
224583|NCT01180244|543532|P2|STARTED|Overall Study|Number of enrolled patients initially randomized to placebo group|46
224584|NCT01180244|543533|P1|STARTED|Overall Study|Number of enrolled patients initially randomized to active treatment group|45
224585|NCT01180127|543551|P4|NOT COMPLETED|Overall Study||1
224586|NCT01180127|543552|P3|NOT COMPLETED|Overall Study||1
224587|NCT01180127|543553|P2|NOT COMPLETED|Overall Study||0
224588|NCT01180127|543554|P1|NOT COMPLETED|Overall Study||2
224589|NCT01180127|543551|P4|COMPLETED|Overall Study||9
224590|NCT01180127|543552|P3|COMPLETED|Overall Study||9
224591|NCT01180127|543553|P2|COMPLETED|Overall Study||11
224592|NCT01180127|543554|P1|COMPLETED|Overall Study||8
224593|NCT01180127|543551|P4|STARTED|Overall Study||10
224594|NCT01180127|543552|P3|STARTED|Overall Study||10
224595|NCT01180127|543553|P2|STARTED|Overall Study||11
224596|NCT01180127|543554|P1|STARTED|Overall Study||10
224597|NCT01180049|543578|P2|NOT COMPLETED|Overall Study||48
224598|NCT01180049|543579|P1|NOT COMPLETED|Overall Study||53
224599|NCT01180049|543578|P2|COMPLETED|Overall Study||0
224600|NCT01180049|543579|P1|COMPLETED|Overall Study||0
224601|NCT01180049|543578|P2|STARTED|Overall Study||48
224602|NCT01180049|543579|P1|STARTED|Overall Study||53
224603|NCT01180036|543601|P2|NOT COMPLETED|Overall Study||0
224604|NCT01180036|543602|P1|NOT COMPLETED|Overall Study||0
224605|NCT01180036|543601|P2|COMPLETED|Overall Study||65
224606|NCT01180036|543602|P1|COMPLETED|Overall Study||65
224607|NCT01180036|543601|P2|STARTED|Overall Study||65
224608|NCT01180036|543602|P1|STARTED|Overall Study||65
224609|NCT01179984|543610|P1|NOT COMPLETED|Overall Study||18
224610|NCT01179984|543610|P1|COMPLETED|Overall Study||58
224611|NCT01179984|543610|P1|STARTED|Overall Study||76
224612|NCT01179919|543616|P1|NOT COMPLETED|Overall Study||2
224613|NCT01179919|543616|P1|COMPLETED|Overall Study||19
224614|NCT01179919|543616|P1|STARTED|Overall Study||21
224615|NCT01179737|543625|P4|NOT COMPLETED|Extension||0
224616|NCT01179737|543626|P3|NOT COMPLETED|Extension||0
224617|NCT01179737|543627|P2|NOT COMPLETED|Extension||0
224618|NCT01179737|543628|P1|NOT COMPLETED|Extension||3
224619|NCT01179737|543625|P4|COMPLETED|Extension||0
224620|NCT01179737|543626|P3|COMPLETED|Extension||0
224621|NCT01179737|543627|P2|COMPLETED|Extension||0
224622|NCT01179737|543628|P1|COMPLETED|Extension||0
224623|NCT01179737|543625|P4|STARTED|Extension||0
224624|NCT01179737|543626|P3|STARTED|Extension||0
224625|NCT01179737|543627|P2|STARTED|Extension|One patient did not enrol in the extension|0
224626|NCT01179737|543628|P1|STARTED|Extension|Two patients did not enrol in the extension|3
224627|NCT01179737|543625|P4|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
224628|NCT01179737|543626|P3|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
224629|NCT01179737|543627|P2|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
224630|NCT01179737|543628|P1|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||1
224631|NCT01179737|543625|P4|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
224632|NCT01179737|543626|P3|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
224633|NCT01179737|543627|P2|COMPLETED|Cohort 1 & Cohort 2 Expansion||1
224634|NCT01179737|543628|P1|COMPLETED|Cohort 1 & Cohort 2 Expansion||4
224635|NCT01179737|543625|P4|STARTED|Cohort 1 & Cohort 2 Expansion||0
224636|NCT01179737|543626|P3|STARTED|Cohort 1 & Cohort 2 Expansion||0
224637|NCT01179737|543627|P2|STARTED|Cohort 1 & Cohort 2 Expansion||1
224638|NCT01179737|543628|P1|STARTED|Cohort 1 & Cohort 2 Expansion|2 participants did not enroll in extension|5
224639|NCT01179737|543625|P4|NOT COMPLETED|Cohort 1 & Cohort 2||4
224640|NCT01179737|543626|P3|NOT COMPLETED|Cohort 1 & Cohort 2||4
224641|NCT01179737|543627|P2|NOT COMPLETED|Cohort 1 & Cohort 2||2
224642|NCT01179737|543628|P1|NOT COMPLETED|Cohort 1 & Cohort 2||5
224643|NCT01179737|543625|P4|COMPLETED|Cohort 1 & Cohort 2||0
224644|NCT01179737|543626|P3|COMPLETED|Cohort 1 & Cohort 2||0
224645|NCT01179737|543627|P2|COMPLETED|Cohort 1 & Cohort 2||1
224646|NCT01179737|543628|P1|COMPLETED|Cohort 1 & Cohort 2||7
224647|NCT01179737|543625|P4|STARTED|Cohort 1 & Cohort 2||4
224648|NCT01179737|543626|P3|STARTED|Cohort 1 & Cohort 2||4
224649|NCT01179737|543627|P2|STARTED|Cohort 1 & Cohort 2|One patient was missing the end of study evaluation|3
224650|NCT01179737|543628|P1|STARTED|Cohort 1 & Cohort 2||12
224651|NCT01179672|543639|P2|NOT COMPLETED|Overall Study||26
224652|NCT01179672|543640|P1|NOT COMPLETED|Overall Study||30
224653|NCT01179672|543639|P2|COMPLETED|Overall Study||176
224654|NCT01179672|543640|P1|COMPLETED|Overall Study||173
224655|NCT01179672|543639|P2|Entered Taper|Overall Study||177
224656|NCT01179672|543640|P1|Entered Taper|Overall Study||181
224657|NCT01179672|543639|P2|Received at Least 1 Dose of Study Drug|Overall Study||202
224658|NCT01179672|543640|P1|Received at Least 1 Dose of Study Drug|Overall Study||202
224659|NCT01179672|543639|P2|STARTED|Overall Study||202
224660|NCT01179672|543640|P1|STARTED|Overall Study||203
224661|NCT01179568|543670|P4|NOT COMPLETED|Overall Study||20
224662|NCT01179568|543671|P3|NOT COMPLETED|Overall Study||23
224663|NCT01179568|543672|P2|NOT COMPLETED|Overall Study||38
224664|NCT01179568|543673|P1|NOT COMPLETED|Overall Study||28
224665|NCT01179568|543670|P4|COMPLETED|Overall Study||76
224666|NCT01179568|543671|P3|COMPLETED|Overall Study||76
224667|NCT01179568|543672|P2|COMPLETED|Overall Study||61
224668|NCT01179568|543673|P1|COMPLETED|Overall Study||73
224669|NCT01179568|543670|P4|Completed Week 12 Assessment|Overall Study||75
224670|NCT01179568|543671|P3|Completed Week 12 Assessment|Overall Study||76
224671|NCT01179568|543672|P2|Completed Week 12 Assessment|Overall Study||69
224673|NCT01179568|543670|P4|STARTED|Overall Study||96
224674|NCT01179568|543671|P3|STARTED|Overall Study||99
224675|NCT01179568|543672|P2|STARTED|Overall Study||99
224676|NCT01179568|543673|P1|STARTED|Overall Study||101
224677|NCT01179516|543696|P3|NOT COMPLETED|Overall Study||31
224678|NCT01179516|543697|P2|NOT COMPLETED|Overall Study||26
224679|NCT01179516|543698|P1|NOT COMPLETED|Overall Study||27
224680|NCT01179516|543696|P3|COMPLETED|Overall Study||121
224681|NCT01179516|543697|P2|COMPLETED|Overall Study||131
224682|NCT01179516|543698|P1|COMPLETED|Overall Study||133
224683|NCT01179516|543696|P3|Treated|Overall Study||151
224684|NCT01179516|543697|P2|Treated|Overall Study||154
224685|NCT01179516|543698|P1|Treated|Overall Study||160
224686|NCT01179516|543696|P3|STARTED|Overall Study||152
224687|NCT01179516|543697|P2|STARTED|Overall Study||157
224688|NCT01179516|543698|P1|STARTED|Overall Study||160
224689|NCT01179490|543721|P1|NOT COMPLETED|Overall Study||0
224690|NCT01179490|543721|P1|COMPLETED|Overall Study||5
224691|NCT01179490|543721|P1|STARTED|Overall Study||5
224692|NCT01179477|543742|P1|NOT COMPLETED|Overall Study||1087
224693|NCT01179477|543742|P1|COMPLETED|Overall Study||843
224694|NCT01179477|543742|P1|STARTED|Overall Study||1930
224695|NCT01179399|543747|P1|NOT COMPLETED|Overall Study||32
224696|NCT01179399|543747|P1|COMPLETED|Overall Study||0
224697|NCT01179399|543747|P1|STARTED|Overall Study||32
224698|NCT01179347|543753|P2|NOT COMPLETED|Open-label Period (12 Weeks)||16
224699|NCT01179347|543754|P1|NOT COMPLETED|Open-label Period (12 Weeks)||15
224700|NCT01179347|543753|P2|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|278
224701|NCT01179347|543754|P1|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|132
224702|NCT01179347|543753|P2|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|294
224703|NCT01179347|543754|P1|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|147
224704|NCT01179347|543753|P2|NOT COMPLETED|Double-blind Period (12 Weeks)||14
224705|NCT01179347|543754|P1|NOT COMPLETED|Double-blind Period (12 Weeks)||8
224706|NCT01179347|543753|P2|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|294
224707|NCT01179347|543754|P1|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|147
224708|NCT01179347|543753|P2|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|308
224709|NCT01179347|543754|P1|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|155
224710|NCT01179334|543776|P2|NOT COMPLETED|Long-term Extension (LTE) Period||6
224711|NCT01179334|543777|P1|NOT COMPLETED|Long-term Extension (LTE) Period||11
224712|NCT01179334|543776|P2|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
224713|NCT01179334|543777|P1|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
224714|NCT01179334|543776|P2|STARTED|Long-term Extension (LTE) Period||6
224715|NCT01179334|543777|P1|STARTED|Long-term Extension (LTE) Period||11
224716|NCT01179334|543776|P2|NOT COMPLETED|Treatment Period||0
224717|NCT01179334|543777|P1|NOT COMPLETED|Treatment Period||1
224718|NCT01179334|543776|P2|COMPLETED|Treatment Period||6
224719|NCT01179334|543777|P1|COMPLETED|Treatment Period||11
224720|NCT01179334|543776|P2|Participants Received Treatment|Treatment Period||6
224721|NCT01179334|543777|P1|Participants Received Treatment|Treatment Period||12
224722|NCT01179334|543776|P2|STARTED|Treatment Period||6
224723|NCT01179334|543777|P1|STARTED|Treatment Period||12
224724|NCT01179217|543807|P2|NOT COMPLETED|Overall Study||19
224725|NCT01179217|543808|P1|NOT COMPLETED|Overall Study||55
224726|NCT01179217|543807|P2|COMPLETED|Overall Study||59
224727|NCT01179217|543808|P1|COMPLETED|Overall Study||97
224728|NCT01179217|543807|P2|STARTED|Overall Study||78
224729|NCT01179217|543808|P1|STARTED|Overall Study||152
224730|NCT01179191|543832|P1|NOT COMPLETED|Maintenance Phase (8 Weeks)||117
224731|NCT01179191|543832|P1|COMPLETED|Maintenance Phase (8 Weeks)||234
224732|NCT01179191|543832|P1|STARTED|Maintenance Phase (8 Weeks)||351
224733|NCT01179191|543832|P1|NOT COMPLETED|Titration Phase (up to 6 Weeks)||333
224734|NCT01179191|543832|P1|COMPLETED|Titration Phase (up to 6 Weeks)||351
224735|NCT01179191|543832|P1|STARTED|Titration Phase (up to 6 Weeks)||684
224736|NCT01179113|543851|P2|NOT COMPLETED|Overall Study||0
224737|NCT01179113|543852|P1|NOT COMPLETED|Overall Study||0
224738|NCT01179113|543851|P2|COMPLETED|Overall Study||16
224739|NCT01179113|543852|P1|COMPLETED|Overall Study||17
224740|NCT01179113|543851|P2|STARTED|Overall Study||16
224741|NCT01179113|543852|P1|STARTED|Overall Study||17
224742|NCT01179048|543864|P2|NOT COMPLETED|Overall Study||159
224743|NCT01179048|543865|P1|NOT COMPLETED|Overall Study||139
224744|NCT01179048|543864|P2|COMPLETED|Overall Study||4513
224745|NCT01179048|543865|P1|COMPLETED|Overall Study||4529
224746|NCT01179048|543864|P2|STARTED|Overall Study||4672
224747|NCT01179048|543865|P1|STARTED|Overall Study||4668
224748|NCT01178944|543881|P1|NOT COMPLETED|Overall Study||0
224749|NCT01178944|543881|P1|COMPLETED|Overall Study||35
224750|NCT01178944|543881|P1|STARTED|Overall Study||35
224751|NCT01178853|543892|P2|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||3
224752|NCT01178853|543893|P1|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||0
224753|NCT01178853|543892|P2|COMPLETED|Period 4 (Warfarin + Study Drug)||19
224754|NCT01178853|543893|P1|COMPLETED|Period 4 (Warfarin + Study Drug)||21
224755|NCT01178853|543892|P2|STARTED|Period 4 (Warfarin + Study Drug)||22
224756|NCT01178853|543893|P1|STARTED|Period 4 (Warfarin + Study Drug)||21
224757|NCT01178853|543892|P2|NOT COMPLETED|Period 3 (Warfarin Titration)||0
224758|NCT01178853|543893|P1|NOT COMPLETED|Period 3 (Warfarin Titration)||1
224759|NCT01178853|543892|P2|COMPLETED|Period 3 (Warfarin Titration)||22
224760|NCT01178853|543893|P1|COMPLETED|Period 3 (Warfarin Titration)||21
224761|NCT01178853|543892|P2|STARTED|Period 3 (Warfarin Titration)||22
224762|NCT01178853|543893|P1|STARTED|Period 3 (Warfarin Titration)||22
224763|NCT01178853|543892|P2|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||0
224764|NCT01178853|543893|P1|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||1
224765|NCT01178853|543892|P2|COMPLETED|Period 2 (Warfarin + Study Drug)||22
224766|NCT01178853|543893|P1|COMPLETED|Period 2 (Warfarin + Study Drug)||22
224767|NCT01178853|543892|P2|STARTED|Period 2 (Warfarin + Study Drug)||22
224768|NCT01178853|543893|P1|STARTED|Period 2 (Warfarin + Study Drug)||23
224769|NCT01178853|543892|P2|NOT COMPLETED|Period 1 (Warfarin Titration)||2
224770|NCT01178853|543893|P1|NOT COMPLETED|Period 1 (Warfarin Titration)||1
224771|NCT01178853|543892|P2|COMPLETED|Period 1 (Warfarin Titration)||22
224772|NCT01178853|543893|P1|COMPLETED|Period 1 (Warfarin Titration)||23
224773|NCT01178853|543892|P2|STARTED|Period 1 (Warfarin Titration)||24
224774|NCT01178853|543893|P1|STARTED|Period 1 (Warfarin Titration)||24
224775|NCT01178827|543902|P3|NOT COMPLETED|Overall Study||0
224776|NCT01178827|543903|P2|NOT COMPLETED|Overall Study||0
224777|NCT01178827|543904|P1|NOT COMPLETED|Overall Study||0
224778|NCT01178827|543902|P3|COMPLETED|Overall Study||4
224779|NCT01178827|543903|P2|COMPLETED|Overall Study||10
224780|NCT01178827|543904|P1|COMPLETED|Overall Study||6
224781|NCT01178827|543902|P3|STARTED|Overall Study||4
224782|NCT01178827|543903|P2|STARTED|Overall Study||10
224783|NCT01178827|543904|P1|STARTED|Overall Study||6
224784|NCT01178762|543933|P1|NOT COMPLETED|Overall Study||15
224785|NCT01178762|543933|P1|COMPLETED|Overall Study||27
224786|NCT01178762|543933|P1|STARTED|Overall Study||42
224787|NCT01178671|543939|P2|NOT COMPLETED|Overall Study||15
224788|NCT01178671|543940|P1|NOT COMPLETED|Overall Study||12
224789|NCT01178671|543939|P2|COMPLETED|Overall Study||3
224790|NCT01178671|543940|P1|COMPLETED|Overall Study||6
224791|NCT01178671|543939|P2|STARTED|Overall Study||18
224792|NCT01178671|543940|P1|STARTED|Overall Study||18
224793|NCT01178528|543967|P3|NOT COMPLETED|Overall Study||0
224794|NCT01178528|543968|P2|NOT COMPLETED|Overall Study||0
224795|NCT01178528|543969|P1|NOT COMPLETED|Overall Study||0
224796|NCT01178528|543967|P3|COMPLETED|Overall Study||42
224797|NCT01178528|543968|P2|COMPLETED|Overall Study||38
224798|NCT01178528|543969|P1|COMPLETED|Overall Study||41
224799|NCT01178528|543967|P3|STARTED|Overall Study||42
224800|NCT01178528|543968|P2|STARTED|Overall Study||38
224801|NCT01178528|543969|P1|STARTED|Overall Study||41
224802|NCT01178385|543988|P2|NOT COMPLETED|Overall Study||0
224803|NCT01178385|543989|P1|NOT COMPLETED|Overall Study||2
224804|NCT01178385|543988|P2|COMPLETED|Overall Study||21
224805|NCT01178385|543989|P1|COMPLETED|Overall Study||22
224806|NCT01178385|543988|P2|STARTED|Overall Study||21
224807|NCT01178385|543989|P1|STARTED|Overall Study||24
224808|NCT01178333|544002|P3|NOT COMPLETED|Overall Study||0
224809|NCT01178333|544003|P2|NOT COMPLETED|Overall Study||0
224810|NCT01178333|544004|P1|NOT COMPLETED|Overall Study||0
224811|NCT01178333|544002|P3|COMPLETED|Overall Study||87
224812|NCT01178333|544003|P2|COMPLETED|Overall Study||284
224813|NCT01178333|544004|P1|COMPLETED|Overall Study||71
224814|NCT01178333|544002|P3|STARTED|Overall Study||87
224815|NCT01178333|544003|P2|STARTED|Overall Study||284
224816|NCT01178333|544004|P1|STARTED|Overall Study||71
224817|NCT01178294|544058|P1|NOT COMPLETED|Overall Study||11
224818|NCT01178294|544058|P1|COMPLETED|Overall Study||18
224819|NCT01178294|544058|P1|STARTED|Overall Study|25 subjects enrolled under OBI-1-301 + 4 subjects enrolled under expanded access OBI-1-301a.|29
224820|NCT01178281|544082|P3|NOT COMPLETED|Overall Study||0
224821|NCT01178281|544083|P2|NOT COMPLETED|Overall Study||0
224822|NCT01178281|544084|P1|NOT COMPLETED|Overall Study||0
224823|NCT01178281|544082|P3|COMPLETED|Overall Study||15
224824|NCT01178281|544083|P2|COMPLETED|Overall Study||84
224825|NCT01178281|544084|P1|COMPLETED|Overall Study||168
224826|NCT01178281|544082|P3|Received Study Drug|Overall Study||15
224827|NCT01178281|544083|P2|Received Study Drug|Overall Study||83
224828|NCT01178281|544084|P1|Received Study Drug|Overall Study||167
224829|NCT01178281|544082|P3|STARTED|Overall Study||15
224830|NCT01178281|544083|P2|STARTED|Overall Study||84
224831|NCT01178281|544084|P1|STARTED|Overall Study||168
224832|NCT01178268|544111|P2|NOT COMPLETED|Overall Study||1
224833|NCT01178268|544112|P1|NOT COMPLETED|Overall Study||7
224834|NCT01178268|544111|P2|COMPLETED|Overall Study||120
224835|NCT01178268|544112|P1|COMPLETED|Overall Study||360
224836|NCT01178268|544111|P2|STARTED|Overall Study||121
224837|NCT01178268|544112|P1|STARTED|Overall Study||367
224838|NCT01178216|544329|P1|NOT COMPLETED|Overall Study||2
224839|NCT01178216|544329|P1|COMPLETED|Overall Study||39
224840|NCT01178216|544329|P1|STARTED|Overall Study||41
224841|NCT01178138|544338|P1|NOT COMPLETED|Overall Study||23
224842|NCT01178138|544338|P1|COMPLETED|Overall Study||1
224843|NCT01178138|544338|P1|Completed 3 Sessions|Overall Study||1
224844|NCT01178138|544338|P1|Completed 5 Sessions|Overall Study||1
224845|NCT01178138|544338|P1|Completed 6 Sessions|Overall Study||1
224846|NCT01178138|544338|P1|STARTED|Overall Study||24
224847|NCT01178125|544359|P1|NOT COMPLETED|Overall Study||1178
224848|NCT01178125|544359|P1|COMPLETED|Overall Study||1680
224849|NCT01178125|544359|P1|Pregnancy ITT (PITT) Population|Overall Study|Participants in the ITT population between the ages of 18 and 35, inclusive.|2401
224850|NCT01178125|544359|P1|Intent to Treat (ITT) Population|Overall Study|Completed at least one 28-day cycle of investigational product.|2607
224851|NCT01178125|544359|P1|Safety Population|Overall Study|Received at least 1 dose of DR-102.|2765
224852|NCT01178125|544359|P1|STARTED|Overall Study|Number enrolled.|2858
224853|NCT01178099|544390|P2|NOT COMPLETED|Overall Study||1
224854|NCT01178099|544391|P1|NOT COMPLETED|Overall Study||0
224855|NCT01178099|544390|P2|COMPLETED|Overall Study||12
224856|NCT01178099|544391|P1|COMPLETED|Overall Study||13
224857|NCT01178099|544390|P2|STARTED|Overall Study||13
224858|NCT01178099|544391|P1|STARTED|Overall Study||13
224859|NCT01178086|544431|P1|NOT COMPLETED|Overall Study||332
224860|NCT01178086|544431|P1|COMPLETED|Overall Study||349
224861|NCT01178086|544431|P1|Effectiveness Analysis Set (EAS)|Overall Study|who received at least 1 dose of rituximab and had data from baseline and at least 1 follow-up visit.|661
224862|NCT01178086|544431|P1|STARTED|Overall Study|Safety analysis set: participants who received at least one dose of rituximab.|681
224863|NCT01178073|544458|P3|NOT COMPLETED|Overall Study||46
224864|NCT01178073|544459|P2|NOT COMPLETED|Overall Study||44
224865|NCT01178073|544460|P1|NOT COMPLETED|Overall Study||62
224866|NCT01178073|544458|P3|COMPLETED|Overall Study||105
224867|NCT01178073|544459|P2|COMPLETED|Overall Study||108
224868|NCT01178073|544460|P1|COMPLETED|Overall Study||240
224869|NCT01178073|544458|P3|STARTED|Overall Study||151
224870|NCT01178073|544459|P2|STARTED|Overall Study||152
224871|NCT01178073|544460|P1|STARTED|Overall Study||302
224872|NCT01177969|544491|P2|NOT COMPLETED|Overall Study||3
224873|NCT01177969|544492|P1|NOT COMPLETED|Overall Study||3
224874|NCT01177969|544491|P2|COMPLETED|Overall Study||11
224875|NCT01177969|544492|P1|COMPLETED|Overall Study||16
224876|NCT01177969|544491|P2|STARTED|Overall Study||14
224877|NCT01177969|544492|P1|STARTED|Overall Study||19
224878|NCT01177956|544500|P1|NOT COMPLETED|Overall Study||0
224879|NCT01177956|544500|P1|COMPLETED|Overall Study||68
224880|NCT01177956|544500|P1|STARTED|Overall Study||68
224881|NCT01177943|544515|P2|NOT COMPLETED|Second Intervention||0
224882|NCT01177943|544516|P1|NOT COMPLETED|Second Intervention||0
224883|NCT01177943|544515|P2|COMPLETED|Second Intervention||21
224884|NCT01177943|544516|P1|COMPLETED|Second Intervention||19
224885|NCT01177943|544515|P2|STARTED|Second Intervention||21
224886|NCT01177943|544516|P1|STARTED|Second Intervention||19
224887|NCT01177943|544515|P2|NOT COMPLETED|First Intervention||0
224888|NCT01177943|544516|P1|NOT COMPLETED|First Intervention||2
224889|NCT01177943|544515|P2|COMPLETED|First Intervention||21
224890|NCT01177943|544516|P1|COMPLETED|First Intervention||19
224891|NCT01177943|544515|P2|STARTED|First Intervention||21
224892|NCT01177943|544516|P1|STARTED|First Intervention||21
224893|NCT01177813|544529|P5|NOT COMPLETED|Overall Study||9
224894|NCT01177813|544530|P4|NOT COMPLETED|Overall Study||17
224895|NCT01177813|544531|P3|NOT COMPLETED|Overall Study||20
224896|NCT01177813|544532|P2|NOT COMPLETED|Overall Study||18
224897|NCT01177813|544533|P1|NOT COMPLETED|Overall Study||41
224898|NCT01177813|544529|P5|COMPLETED|Overall Study||78
224899|NCT01177813|544530|P4|COMPLETED|Overall Study||206
224900|NCT01177813|544531|P3|COMPLETED|Overall Study||204
224901|NCT01177813|544532|P2|COMPLETED|Overall Study||206
224902|NCT01177813|544533|P1|COMPLETED|Overall Study||187
224903|NCT01177813|544529|P5|STARTED|Overall Study||87
224904|NCT01177813|544530|P4|STARTED|Overall Study||223
224905|NCT01177813|544531|P3|STARTED|Overall Study||224
224906|NCT01177813|544532|P2|STARTED|Overall Study||224
224907|NCT01177813|544533|P1|STARTED|Overall Study||228
224908|NCT01177800|544562|P2|NOT COMPLETED|Overall Study||5
224909|NCT01177800|544563|P1|NOT COMPLETED|Overall Study||10
224910|NCT01177800|544562|P2|COMPLETED|Overall Study||40
224911|NCT01177800|544563|P1|COMPLETED|Overall Study||74
224912|NCT01177800|544562|P2|STARTED|Overall Study||45
224913|NCT01177800|544563|P1|STARTED|Overall Study||84
224914|NCT01177735|544577|P1|NOT COMPLETED|Overall Study||71
224915|NCT01177735|544577|P1|COMPLETED|Overall Study||0
224916|NCT01177735|544577|P1|STARTED|Overall Study||71
224917|NCT01177722|544585|P4|NOT COMPLETED|Overall Study||7
224918|NCT01177722|544586|P3|NOT COMPLETED|Overall Study||9
224919|NCT01177722|544587|P2|NOT COMPLETED|Overall Study||10
224920|NCT01177722|544588|P1|NOT COMPLETED|Overall Study||13
224921|NCT01177722|544585|P4|COMPLETED|Overall Study||338
224922|NCT01177722|544586|P3|COMPLETED|Overall Study||333
224923|NCT01177722|544587|P2|COMPLETED|Overall Study||334
224924|NCT01177722|544588|P1|COMPLETED|Overall Study||331
224925|NCT01177722|544585|P4|STARTED|Overall Study||345
224926|NCT01177722|544586|P3|STARTED|Overall Study||342
224927|NCT01177722|544587|P2|STARTED|Overall Study|A randomized participant got Batch A vaccine, analyses was according to actual vaccine administered.|344
224928|NCT01177722|544588|P1|STARTED|Overall Study|A Batch B participant got Batch A vaccine data analyses was according to actual vaccine administered|344
224929|NCT01177709|544614|P1|NOT COMPLETED|Overall Study||0
224930|NCT01177709|544614|P1|COMPLETED|Overall Study||12
224931|NCT01177709|544614|P1|STARTED|Overall Study||12
224932|NCT01177670|544620|P1|NOT COMPLETED|Overall Study||169
224933|NCT01177670|544620|P1|COMPLETED|Overall Study||0
224934|NCT01177670|544620|P1|STARTED|Overall Study||169
224935|NCT01177553|544627|P2|NOT COMPLETED|Overall Study||0
224936|NCT01177553|544628|P1|NOT COMPLETED|Overall Study||1
224937|NCT01177553|544627|P2|COMPLETED|Overall Study|data as of March 2009|2
224938|NCT01177553|544628|P1|COMPLETED|Overall Study|data as of March 2009|2
224939|NCT01177553|544627|P2|STARTED|Overall Study||2
224940|NCT01177553|544628|P1|STARTED|Overall Study||3
224941|NCT01177410|544637|P3|NOT COMPLETED|Overall Study||5
224942|NCT01177410|544638|P2|NOT COMPLETED|Overall Study||7
224943|NCT01177410|544639|P1|NOT COMPLETED|Overall Study||1
224944|NCT01177410|544637|P3|COMPLETED|Overall Study||45
224945|NCT01177410|544638|P2|COMPLETED|Overall Study||40
224946|NCT01177410|544639|P1|COMPLETED|Overall Study||50
224947|NCT01177410|544637|P3|STARTED|Overall Study||50
224948|NCT01177410|544638|P2|STARTED|Overall Study||47
224949|NCT01177410|544639|P1|STARTED|Overall Study||51
224950|NCT01177384|544652|P2|NOT COMPLETED|Overall Study||26
224951|NCT01177384|544653|P1|NOT COMPLETED|Overall Study||14
224952|NCT01177384|544652|P2|COMPLETED|Overall Study||164
224953|NCT01177384|544653|P1|COMPLETED|Overall Study||177
224954|NCT01177384|544652|P2|STARTED|Overall Study|Includes the second randomization of a participant|190
224955|NCT01177384|544653|P1|STARTED|Overall Study||191
224956|NCT01177293|544665|P2|NOT COMPLETED|Second Intervention Period||0
224957|NCT01177293|544666|P1|NOT COMPLETED|Second Intervention Period||0
224958|NCT01177293|544665|P2|COMPLETED|Second Intervention Period||6
224959|NCT01177293|544666|P1|COMPLETED|Second Intervention Period||7
224960|NCT01177293|544665|P2|STARTED|Second Intervention Period||6
224961|NCT01177293|544666|P1|STARTED|Second Intervention Period||7
224962|NCT01177293|544665|P2|NOT COMPLETED|Washout Period (of 14 Days)||1
224963|NCT01177293|544666|P1|NOT COMPLETED|Washout Period (of 14 Days)||0
224964|NCT01177293|544665|P2|COMPLETED|Washout Period (of 14 Days)||6
224965|NCT01177293|544666|P1|COMPLETED|Washout Period (of 14 Days)||7
224966|NCT01177293|544665|P2|STARTED|Washout Period (of 14 Days)||7
224967|NCT01177293|544666|P1|STARTED|Washout Period (of 14 Days)||7
224968|NCT01177293|544665|P2|NOT COMPLETED|First Intervention Period||0
224969|NCT01177293|544666|P1|NOT COMPLETED|First Intervention Period||0
224970|NCT01177293|544665|P2|COMPLETED|First Intervention Period||7
224971|NCT01177293|544666|P1|COMPLETED|First Intervention Period||7
224972|NCT01177293|544665|P2|STARTED|First Intervention Period||7
224973|NCT01177293|544666|P1|STARTED|First Intervention Period||7
224974|NCT01177228|544684|P4|NOT COMPLETED|Overall Study||0
224975|NCT01177228|544685|P3|NOT COMPLETED|Overall Study||0
224976|NCT01177228|544686|P2|NOT COMPLETED|Overall Study||2
224977|NCT01177228|544687|P1|NOT COMPLETED|Overall Study||1
224978|NCT01177228|544684|P4|COMPLETED|Overall Study||11
224979|NCT01177228|544685|P3|COMPLETED|Overall Study||14
224980|NCT01177228|544686|P2|COMPLETED|Overall Study||11
224981|NCT01177228|544687|P1|COMPLETED|Overall Study||8
224982|NCT01177228|544684|P4|Received Treatment|Overall Study||11
224983|NCT01177228|544685|P3|Received Treatment|Overall Study||14
224984|NCT01177228|544686|P2|Received Treatment|Overall Study||12
224985|NCT01177228|544687|P1|Received Treatment|Overall Study||9
224986|NCT01177228|544684|P4|STARTED|Overall Study||11
224987|NCT01177228|544685|P3|STARTED|Overall Study||14
224988|NCT01177228|544686|P2|STARTED|Overall Study||13
224989|NCT01177228|544687|P1|STARTED|Overall Study||9
224990|NCT01177189|544727|P2|NOT COMPLETED|Overall Study||0
224991|NCT01177189|544728|P1|NOT COMPLETED|Overall Study||0
224992|NCT01177189|544727|P2|COMPLETED|Overall Study||45
224993|NCT01177189|544728|P1|COMPLETED|Overall Study||42
224994|NCT01177189|544727|P2|STARTED|Overall Study||45
224995|NCT01177189|544728|P1|STARTED|Overall Study||42
224996|NCT01177137|544741|P3|NOT COMPLETED|Overall Study||2
224997|NCT01177137|544742|P2|NOT COMPLETED|Overall Study||10
224998|NCT01177137|544743|P1|NOT COMPLETED|Overall Study||10
224999|NCT01177137|544741|P3|COMPLETED|Overall Study||47
225000|NCT01177137|544742|P2|COMPLETED|Overall Study||41
225001|NCT01177137|544743|P1|COMPLETED|Overall Study||41
225002|NCT01177137|544741|P3|STARTED|Overall Study||49
225003|NCT01177137|544742|P2|STARTED|Overall Study||51
225004|NCT01177137|544743|P1|STARTED|Overall Study||51
225005|NCT01177098|544810|P2|NOT COMPLETED|Overall Study||12
225006|NCT01177098|544811|P1|NOT COMPLETED|Overall Study||9
225007|NCT01177098|544810|P2|COMPLETED|Overall Study||271
225008|NCT01177098|544811|P1|COMPLETED|Overall Study||269
225009|NCT01177098|544810|P2|STARTED|Overall Study||283
225010|NCT01177098|544811|P1|STARTED|Overall Study||278
225011|NCT01177059|544827|P1|NOT COMPLETED|Overall Study||50
225012|NCT01177059|544827|P1|COMPLETED|Overall Study||18
225013|NCT01177059|544827|P1|STARTED|Overall Study||68
225014|NCT01177007|544833|P1|NOT COMPLETED|Overall Study||38
225015|NCT01177007|544833|P1|COMPLETED|Overall Study||12
225016|NCT01177007|544833|P1|Completed First Clinical and Imaging|Overall Study||43
225017|NCT01177007|544833|P1|Completed First Y90 Treatment|Overall Study||50
225018|NCT01177007|544833|P1|STARTED|Overall Study||50
225019|NCT01176968|544847|P2|NOT COMPLETED|Overall Study||82
225020|NCT01176968|544848|P1|NOT COMPLETED|Overall Study||84
225021|NCT01176968|544847|P2|COMPLETED|Overall Study||424
225022|NCT01176968|544848|P1|COMPLETED|Overall Study||422
225023|NCT01176968|544847|P2|Treated|Overall Study||505
225024|NCT01176968|544848|P1|Treated|Overall Study||505
225025|NCT01176968|544847|P2|STARTED|Overall Study||506
225026|NCT01176968|544848|P1|STARTED|Overall Study||506
225027|NCT01176955|544882|P2|NOT COMPLETED|Overall Study||2
225028|NCT01176955|544883|P1|NOT COMPLETED|Overall Study||3
225029|NCT01176955|544882|P2|COMPLETED|Overall Study||8
225030|NCT01176955|544883|P1|COMPLETED|Overall Study||7
225031|NCT01176955|544882|P2|STARTED|Overall Study||10
225032|NCT01176955|544883|P1|STARTED|Overall Study||10
225033|NCT01176877|544894|P1|NOT COMPLETED|Overall Study||9
225034|NCT01176877|544894|P1|COMPLETED|Overall Study||31
225035|NCT01176877|544894|P1|STARTED|Overall Study||40
225036|NCT01176773|544899|P1|NOT COMPLETED|Overall Study||3
225037|NCT01176773|544899|P1|COMPLETED|Overall Study||59
225038|NCT01176773|544899|P1|STARTED|Overall Study||62
225039|NCT01176617|544910|P3|NOT COMPLETED|6 - 12 Months (Randomized)||0
225040|NCT01176617|544911|P2|NOT COMPLETED|6 - 12 Months (Randomized)||0
225041|NCT01176617|544912|P1|NOT COMPLETED|6 - 12 Months (Randomized)||5
225042|NCT01176617|544910|P3|COMPLETED|6 - 12 Months (Randomized)||0
225043|NCT01176617|544911|P2|COMPLETED|6 - 12 Months (Randomized)||20
225044|NCT01176617|544912|P1|COMPLETED|6 - 12 Months (Randomized)||13
225045|NCT01176617|544910|P3|STARTED|6 - 12 Months (Randomized)||0
225046|NCT01176617|544911|P2|STARTED|6 - 12 Months (Randomized)||20
225047|NCT01176617|544912|P1|STARTED|6 - 12 Months (Randomized)||18
225048|NCT01176617|544910|P3|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
225049|NCT01176617|544911|P2|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
225050|NCT01176617|544912|P1|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
225051|NCT01176617|544910|P3|COMPLETED|1 - 6 Months (Ron-randomized)||38
225052|NCT01176617|544911|P2|COMPLETED|1 - 6 Months (Ron-randomized)||0
225053|NCT01176617|544912|P1|COMPLETED|1 - 6 Months (Ron-randomized)||0
225054|NCT01176617|544910|P3|STARTED|1 - 6 Months (Ron-randomized)||38
225055|NCT01176617|544911|P2|STARTED|1 - 6 Months (Ron-randomized)||0
225056|NCT01176617|544912|P1|STARTED|1 - 6 Months (Ron-randomized)||0
225057|NCT01176565|544923|P2|NOT COMPLETED|Overall Study||19
225058|NCT01176565|544924|P1|NOT COMPLETED|Overall Study||20
225059|NCT01176565|544923|P2|COMPLETED|Overall Study||481
225060|NCT01176565|544924|P1|COMPLETED|Overall Study||480
225061|NCT01176565|544923|P2|STARTED|Overall Study||500
225062|NCT01176565|544924|P1|STARTED|Overall Study||500
225063|NCT01176513|544942|P1|NOT COMPLETED|Overall Study||3
225064|NCT01176513|544942|P1|COMPLETED|Overall Study||22
225065|NCT01176513|544942|P1|STARTED|Overall Study||25
225066|NCT01176448|544947|P1|NOT COMPLETED|Overall Study||0
225067|NCT01176448|544947|P1|COMPLETED|Overall Study||6
225068|NCT01176448|544947|P1|STARTED|Overall Study||6
225069|NCT01176435|544958|P3|NOT COMPLETED|Overall Study||0
225070|NCT01176435|544959|P2|NOT COMPLETED|Overall Study||0
225071|NCT01176435|544960|P1|NOT COMPLETED|Overall Study||0
225072|NCT01176435|544958|P3|COMPLETED|Overall Study||15
225073|NCT01176435|544959|P2|COMPLETED|Overall Study||15
225074|NCT01176435|544960|P1|COMPLETED|Overall Study||15
225075|NCT01176435|544958|P3|STARTED|Overall Study||15
225076|NCT01176435|544959|P2|STARTED|Overall Study||15
225077|NCT01176435|544960|P1|STARTED|Overall Study||15
225078|NCT01176292|544970|P2|NOT COMPLETED|Overall Study||9
225079|NCT01176292|544971|P1|NOT COMPLETED|Overall Study||5
225080|NCT01176292|544970|P2|COMPLETED|Overall Study||62
225081|NCT01176292|544971|P1|COMPLETED|Overall Study||66
225082|NCT01176292|544970|P2|STARTED|Overall Study||71
225083|NCT01176292|544971|P1|STARTED|Overall Study||71
225084|NCT01176266|544989|P1|NOT COMPLETED|Overall Study||9
225085|NCT01176266|544989|P1|COMPLETED|Overall Study||60
225086|NCT01176266|544989|P1|STARTED|Overall Study||69
225087|NCT01176240|545013|P2|NOT COMPLETED|Study 306B||17
225088|NCT01176240|545014|P1|NOT COMPLETED|Study 306B||26
225089|NCT01176240|545013|P2|COMPLETED|Study 306B||68
225090|NCT01176240|545014|P1|COMPLETED|Study 306B||63
225091|NCT01176240|545013|P2|4 wk of Stable Dosing and Visit 6|Study 306B||73
225092|NCT01176240|545014|P1|4 wk of Stable Dosing and Visit 6|Study 306B||67
225093|NCT01176240|545013|P2|2 wk of Stable Dosing and Visit 5|Study 306B||75
225094|NCT01176240|545014|P1|2 wk of Stable Dosing and Visit 5|Study 306B||68
225095|NCT01176240|545013|P2|1 wk of Stable Dosing and Visit 4|Study 306B||78
225096|NCT01176240|545014|P1|1 wk of Stable Dosing and Visit 4|Study 306B||69
225097|NCT01176240|545013|P2|Took at Least 1 Dose of Study Drug|Study 306B|One randomized patient discontinued before receiving study drug.|84
225098|NCT01176240|545014|P1|Took at Least 1 Dose of Study Drug|Study 306B|Two randomized patients discontinued before receiving study drug.|87
225099|NCT01176240|545013|P2|STARTED|Study 306B||85
225100|NCT01176240|545014|P1|STARTED|Study 306B||89
225101|NCT01176240|545013|P2|NOT COMPLETED|Study 306A||3
225102|NCT01176240|545014|P1|NOT COMPLETED|Study 306A||3
225103|NCT01176240|545013|P2|COMPLETED|Study 306A||24
225104|NCT01176240|545014|P1|COMPLETED|Study 306A||21
225105|NCT01176240|545013|P2|STARTED|Study 306A||27
225106|NCT01176240|545014|P1|STARTED|Study 306A||24
225107|NCT01176058|545040|P2|NOT COMPLETED|Overall Study||3
225108|NCT01176058|545041|P1|NOT COMPLETED|Overall Study||4
225109|NCT01176058|545040|P2|COMPLETED|Overall Study||5
225110|NCT01176058|545041|P1|COMPLETED|Overall Study||5
225111|NCT01176058|545040|P2|STARTED|Overall Study||8
225112|NCT01176058|545041|P1|STARTED|Overall Study||9
225113|NCT01176032|545065|P2|NOT COMPLETED|Overall Study||1
225114|NCT01176032|545066|P1|NOT COMPLETED|Overall Study||6
225115|NCT01176032|545065|P2|COMPLETED|Overall Study||36
225116|NCT01176032|545066|P1|COMPLETED|Overall Study||31
225117|NCT01176032|545065|P2|Intention-to-treat (ITT) Population|Overall Study||37
225118|NCT01176032|545066|P1|Intention-to-treat (ITT) Population|Overall Study||32
225119|NCT01176032|545065|P2|STARTED|Overall Study||37
225120|NCT01176032|545066|P1|STARTED|Overall Study|"Started indicates randomized and safety population"|37
225121|NCT01175902|545126|P2|NOT COMPLETED|Overall Study||0
225122|NCT01175902|545127|P1|NOT COMPLETED|Overall Study||0
225123|NCT01175902|545126|P2|COMPLETED|Overall Study||22
225124|NCT01175902|545127|P1|COMPLETED|Overall Study||22
225125|NCT01175902|545126|P2|STARTED|Overall Study||22
225126|NCT01175902|545127|P1|STARTED|Overall Study||22
225127|NCT01175850|545145|P2|NOT COMPLETED|IN.PACT SFA II Phase||5
225128|NCT01175850|545146|P1|NOT COMPLETED|IN.PACT SFA II Phase||12
225129|NCT01175850|545145|P2|COMPLETED|IN.PACT SFA II Phase||55
225130|NCT01175850|545146|P1|COMPLETED|IN.PACT SFA II Phase||109
225131|NCT01175850|545145|P2|STARTED|IN.PACT SFA II Phase||60
225132|NCT01175850|545146|P1|STARTED|IN.PACT SFA II Phase||121
225133|NCT01175850|545145|P2|NOT COMPLETED|IN.PACT SFA I Phase||2
225134|NCT01175850|545146|P1|NOT COMPLETED|IN.PACT SFA I Phase||11
225135|NCT01175850|545145|P2|COMPLETED|IN.PACT SFA I Phase||49
225136|NCT01175850|545146|P1|COMPLETED|IN.PACT SFA I Phase||88
225137|NCT01175850|545145|P2|STARTED|IN.PACT SFA I Phase||51
225138|NCT01175850|545146|P1|STARTED|IN.PACT SFA I Phase||99
225139|NCT01175824|545190|P2|NOT COMPLETED|Overall Study||22
225140|NCT01175824|545191|P1|NOT COMPLETED|Overall Study||16
225141|NCT01175824|545190|P2|COMPLETED|Overall Study||220
225142|NCT01175824|545191|P1|COMPLETED|Overall Study||220
225143|NCT01175824|545190|P2|Received at Least 1 Dose of Study Drug|Overall Study||240
225144|NCT01175824|545191|P1|Received at Least 1 Dose of Study Drug|Overall Study||236
225145|NCT01175824|545190|P2|STARTED|Overall Study||242
225146|NCT01175824|545191|P1|STARTED|Overall Study||236
225147|NCT01175811|545225|P2|NOT COMPLETED|Overall Study||14
225148|NCT01175811|545226|P1|NOT COMPLETED|Overall Study||16
225149|NCT01175811|545225|P2|COMPLETED|Overall Study||189
225150|NCT01175811|545226|P1|COMPLETED|Overall Study||183
225151|NCT01175811|545225|P2|Received at Least 1 Dose of Study Drug|Overall Study||202
225152|NCT01175811|545226|P1|Received at Least 1 Dose of Study Drug|Overall Study||197
225153|NCT01175811|545225|P2|STARTED|Overall Study||203
225154|NCT01175811|545226|P1|STARTED|Overall Study||199
225155|NCT01175798|545252|P2|NOT COMPLETED|Overall Study||21
225156|NCT01175798|545253|P1|NOT COMPLETED|Overall Study||7
225157|NCT01175798|545252|P2|COMPLETED|Overall Study||41
225158|NCT01175798|545253|P1|COMPLETED|Overall Study||27
225159|NCT01175798|545252|P2|STARTED|Overall Study||62
225160|NCT01175798|545253|P1|STARTED|Overall Study||34
225161|NCT01175707|545261|P2|NOT COMPLETED|Overall Study||6
225162|NCT01175707|545262|P1|NOT COMPLETED|Overall Study||4
225163|NCT01175707|545261|P2|COMPLETED|Overall Study||34
225164|NCT01175707|545262|P1|COMPLETED|Overall Study||36
225165|NCT01175707|545261|P2|STARTED|Overall Study||40
225166|NCT01175707|545262|P1|STARTED|Overall Study||40
225167|NCT01175668|545298|P2|NOT COMPLETED|Overall Study||0
225168|NCT01175668|545299|P1|NOT COMPLETED|Overall Study||2
225169|NCT01175668|545298|P2|COMPLETED|Overall Study||34
225170|NCT01175668|545299|P1|COMPLETED|Overall Study||32
225171|NCT01175668|545298|P2|STARTED|Overall Study||34
225172|NCT01175668|545299|P1|STARTED|Overall Study||34
225173|NCT01175590|545309|P2|NOT COMPLETED|Overall Study||10
225174|NCT01175590|545310|P1|NOT COMPLETED|Overall Study||12
225175|NCT01175590|545309|P2|COMPLETED|Overall Study||161
225176|NCT01175590|545310|P1|COMPLETED|Overall Study||335
225177|NCT01175590|545309|P2|Safety Population|Overall Study||170
225178|NCT01175590|545310|P1|Safety Population|Overall Study||344
225179|NCT01175590|545309|P2|Modified Intent to Treat Population|Overall Study||87
225180|NCT01175590|545310|P1|Modified Intent to Treat Population|Overall Study||212
225181|NCT01175590|545309|P2|STARTED|Overall Study||171
225182|NCT01175590|545310|P1|STARTED|Overall Study||347
225183|NCT01175473|545344|P2|NOT COMPLETED|Overall Study||2
225184|NCT01175473|545345|P1|NOT COMPLETED|Overall Study||2
225185|NCT01175473|545344|P2|COMPLETED|Overall Study||69
225186|NCT01175473|545345|P1|COMPLETED|Overall Study||75
225187|NCT01175473|545344|P2|Pharmacodynamic (PD) Population|Overall Study||68
225188|NCT01175473|545345|P1|Pharmacodynamic (PD) Population|Overall Study|All patients who received at least 1 dose; had baseline and at least 1 post-baseline PD assessment.|75
225189|NCT01175473|545344|P2|Safety Population|Overall Study||71
225190|NCT01175473|545345|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|77
225191|NCT01175473|545344|P2|STARTED|Overall Study||71
225192|NCT01175473|545345|P1|STARTED|Overall Study|Randomized and treated.|77
225193|NCT01175434|545371|P2|NOT COMPLETED|Overall Study||0
225194|NCT01175434|545372|P1|NOT COMPLETED|Overall Study||0
225195|NCT01175434|545371|P2|COMPLETED|Overall Study||51
225196|NCT01175434|545372|P1|COMPLETED|Overall Study||48
225197|NCT01175434|545371|P2|STARTED|Overall Study||51
225198|NCT01175434|545372|P1|STARTED|Overall Study||48
225199|NCT01175395|545378|P1|NOT COMPLETED|Overall Study||0
225200|NCT01175395|545378|P1|COMPLETED|Overall Study||10
225201|NCT01175395|545378|P1|STARTED|Overall Study||10
225202|NCT01175382|545386|P3|NOT COMPLETED|Overall Study||6
225203|NCT01175382|545387|P2|NOT COMPLETED|Overall Study||7
225204|NCT01175382|545388|P1|NOT COMPLETED|Overall Study||8
225205|NCT01175382|545386|P3|COMPLETED|Overall Study||59
225206|NCT01175382|545387|P2|COMPLETED|Overall Study||61
225207|NCT01175382|545388|P1|COMPLETED|Overall Study||63
225208|NCT01175382|545386|P3|STARTED|Overall Study||65
225209|NCT01175382|545387|P2|STARTED|Overall Study||68
225210|NCT01175382|545388|P1|STARTED|Overall Study||71
225211|NCT01175369|545467|P2|NOT COMPLETED|Overall Study||5
225212|NCT01175369|545468|P1|NOT COMPLETED|Overall Study||2
225213|NCT01175369|545467|P2|COMPLETED|Overall Study||260
225214|NCT01175369|545468|P1|COMPLETED|Overall Study||263
225215|NCT01175369|545467|P2|STARTED|Overall Study||265
225216|NCT01175369|545468|P1|STARTED|Overall Study||265
225217|NCT01175356|545474|P1|NOT COMPLETED|Overall Study||81
225218|NCT01175356|545474|P1|COMPLETED|Overall Study||18
225219|NCT01175356|545474|P1|STARTED|Overall Study||99
225220|NCT01175343|545480|P1|NOT COMPLETED|Overall Study||0
225221|NCT01175343|545480|P1|COMPLETED|Overall Study||44
225222|NCT01175343|545480|P1|STARTED|Overall Study||44
225223|NCT01175317|545492|P2|NOT COMPLETED|Overall Study||0
225224|NCT01175317|545493|P1|NOT COMPLETED|Overall Study||0
225225|NCT01175317|545492|P2|COMPLETED|Overall Study||31
225226|NCT01175317|545493|P1|COMPLETED|Overall Study||27
225227|NCT01175317|545492|P2|STARTED|Overall Study||31
225228|NCT01175317|545493|P1|STARTED|Overall Study||27
225229|NCT01175226|545503|P2|NOT COMPLETED|Overall Study||5
225230|NCT01175226|545504|P1|NOT COMPLETED|Overall Study||11
225231|NCT01175226|545503|P2|COMPLETED|Overall Study||140
225232|NCT01175226|545504|P1|COMPLETED|Overall Study||144
225233|NCT01175226|545503|P2|STARTED|Overall Study||145
225234|NCT01175226|545504|P1|STARTED|Overall Study||155
225235|NCT01175213|545514|P2|NOT COMPLETED|Safety Follow-up||0
225236|NCT01175213|545515|P1|NOT COMPLETED|Safety Follow-up||1
225237|NCT01175213|545514|P2|COMPLETED|Safety Follow-up||3
225238|NCT01175213|545515|P1|COMPLETED|Safety Follow-up||47
225239|NCT01175213|545514|P2|STARTED|Safety Follow-up||3
225240|NCT01175213|545515|P1|STARTED|Safety Follow-up||48
225241|NCT01175213|545514|P2|NOT COMPLETED|IGSC, 10%/rHuPH20||0
225242|NCT01175213|545515|P1|NOT COMPLETED|IGSC, 10%/rHuPH20||15
225243|NCT01175213|545514|P2|COMPLETED|IGSC, 10%/rHuPH20||3
225244|NCT01175213|545515|P1|COMPLETED|IGSC, 10%/rHuPH20||48
225245|NCT01175213|545514|P2|STARTED|IGSC, 10%/rHuPH20|3 participants treated IV with IGIV,10% without rHuPH20 throughout the study.|3
225246|NCT01175213|545515|P1|STARTED|IGSC, 10%/rHuPH20||63
225247|NCT01175148|545562|P2|NOT COMPLETED|Overall Study||0
225248|NCT01175148|545563|P1|NOT COMPLETED|Overall Study||0
225249|NCT01175148|545562|P2|COMPLETED|Overall Study||30
225250|NCT01175148|545563|P1|COMPLETED|Overall Study||30
225251|NCT01175148|545562|P2|STARTED|Overall Study||30
225252|NCT01175148|545563|P1|STARTED|Overall Study||30
225253|NCT01175135|545572|P4|NOT COMPLETED|Overall Study||14
225254|NCT01175135|545573|P3|NOT COMPLETED|Overall Study||12
225255|NCT01175135|545574|P2|NOT COMPLETED|Overall Study||22
225256|NCT01175135|545575|P1|NOT COMPLETED|Overall Study||16
225257|NCT01175135|545572|P4|COMPLETED|Overall Study||60
225258|NCT01175135|545573|P3|COMPLETED|Overall Study||25
225259|NCT01175135|545574|P2|COMPLETED|Overall Study||52
225260|NCT01175135|545575|P1|COMPLETED|Overall Study||58
225261|NCT01175135|545572|P4|Analyzed for Efficacy|Overall Study||73
225262|NCT01175135|545573|P3|Analyzed for Efficacy|Overall Study||34
225263|NCT01175135|545574|P2|Analyzed for Efficacy|Overall Study||73
225264|NCT01175135|545575|P1|Analyzed for Efficacy|Overall Study||74
225265|NCT01175135|545572|P4|Treated|Overall Study||74
225266|NCT01175135|545573|P3|Treated|Overall Study||36
225267|NCT01175135|545574|P2|Treated|Overall Study||74
225268|NCT01175135|545575|P1|Treated|Overall Study||74
225269|NCT01175135|545572|P4|STARTED|Overall Study||74
225270|NCT01175135|545573|P3|STARTED|Overall Study||37
225271|NCT01175135|545574|P2|STARTED|Overall Study||74
225272|NCT01175135|545575|P1|STARTED|Overall Study||74
225273|NCT01175083|545663|P6|NOT COMPLETED|Booster Epoch||0
225274|NCT01175083|545664|P5|NOT COMPLETED|Booster Epoch||0
225275|NCT01175083|545665|P4|NOT COMPLETED|Booster Epoch||1
225276|NCT01175083|545666|P3|NOT COMPLETED|Booster Epoch||1
225277|NCT01175083|545667|P2|NOT COMPLETED|Booster Epoch||0
225278|NCT01175083|545668|P1|NOT COMPLETED|Booster Epoch||0
225279|NCT01175083|545663|P6|COMPLETED|Booster Epoch||0
225280|NCT01175083|545664|P5|COMPLETED|Booster Epoch||0
225281|NCT01175083|545665|P4|COMPLETED|Booster Epoch||49
225282|NCT01175083|545666|P3|COMPLETED|Booster Epoch||49
225283|NCT01175083|545667|P2|COMPLETED|Booster Epoch||49
225284|NCT01175083|545668|P1|COMPLETED|Booster Epoch||49
225285|NCT01175083|545663|P6|STARTED|Booster Epoch|No subjects participated in the Booster Epoch, as no booster dose was planned per protocol.|0
225286|NCT01175083|545664|P5|STARTED|Booster Epoch|No subjects participated in the Booster Epoch, as no booster dose was planned per protocol.|0
225287|NCT01175083|545665|P4|STARTED|Booster Epoch||50
225288|NCT01175083|545666|P3|STARTED|Booster Epoch||50
225289|NCT01175083|545667|P2|STARTED|Booster Epoch|One subject died between both Epochs and hence did not participate in the Booster Epoch.|49
225290|NCT01175083|545668|P1|STARTED|Booster Epoch|One subject died between both Epochs and hence did not participate in the Booster Epoch.|49
225291|NCT01175083|545663|P6|NOT COMPLETED|Primary Epoch||3
225292|NCT01175083|545664|P5|NOT COMPLETED|Primary Epoch||0
225293|NCT01175083|545665|P4|NOT COMPLETED|Primary Epoch||0
225294|NCT01175083|545666|P3|NOT COMPLETED|Primary Epoch||0
225295|NCT01175083|545667|P2|NOT COMPLETED|Primary Epoch||0
225296|NCT01175083|545668|P1|NOT COMPLETED|Primary Epoch||0
225297|NCT01175083|545663|P6|COMPLETED|Primary Epoch||47
225298|NCT01175083|545664|P5|COMPLETED|Primary Epoch||50
225299|NCT01175083|545665|P4|COMPLETED|Primary Epoch||50
225300|NCT01175083|545666|P3|COMPLETED|Primary Epoch||50
225301|NCT01175083|545667|P2|COMPLETED|Primary Epoch||50
225302|NCT01175083|545668|P1|COMPLETED|Primary Epoch||50
225303|NCT01175083|545663|P6|STARTED|Primary Epoch||50
225304|NCT01175083|545664|P5|STARTED|Primary Epoch||50
225305|NCT01175083|545665|P4|STARTED|Primary Epoch||50
225306|NCT01175083|545666|P3|STARTED|Primary Epoch||50
225307|NCT01175083|545667|P2|STARTED|Primary Epoch||50
225308|NCT01175083|545668|P1|STARTED|Primary Epoch||50
225309|NCT01175031|545750|P1|NOT COMPLETED|Overall Study||0
225310|NCT01175031|545750|P1|COMPLETED|Overall Study||45
225311|NCT01175031|545750|P1|STARTED|Overall Study||45
225312|NCT01175018|545760|P2|NOT COMPLETED|Overall Study||1
225313|NCT01175018|545761|P1|NOT COMPLETED|Overall Study||3
225314|NCT01175018|545760|P2|COMPLETED|Overall Study||14
225315|NCT01175018|545761|P1|COMPLETED|Overall Study||12
225316|NCT01175018|545760|P2|STARTED|Overall Study||15
225317|NCT01175018|545761|P1|STARTED|Overall Study||15
225318|NCT01175005|545797|P1|NOT COMPLETED|Overall Study||0
225319|NCT01175005|545797|P1|COMPLETED|Overall Study||62
225320|NCT01175005|545797|P1|STARTED|Overall Study||62
225321|NCT01174784|545802|P1|NOT COMPLETED|Overall Study||0
225322|NCT01174784|545802|P1|COMPLETED|Overall Study||88
225323|NCT01174784|545802|P1|STARTED|Overall Study||88
225324|NCT01174576|545807|P1|NOT COMPLETED|Overall Study||0
225325|NCT01174576|545807|P1|COMPLETED|Overall Study||16
225326|NCT01174576|545807|P1|STARTED|Overall Study|All participants received all interventions without exception.|16
225327|NCT01174563|545848|P1|NOT COMPLETED|Overall Study||60
225328|NCT01174563|545848|P1|COMPLETED|Overall Study||0
225329|NCT01174563|545848|P1|Safety Set|Overall Study||59
225330|NCT01174563|545848|P1|Efficacy Set|Overall Study||59
225331|NCT01174563|545848|P1|STARTED|Overall Study||60
225332|NCT01174550|545856|P2|NOT COMPLETED|Overall Study||873
225333|NCT01174550|545857|P1|NOT COMPLETED|Overall Study||1270
225334|NCT01174550|545856|P2|COMPLETED|Overall Study||4123
225335|NCT01174550|545857|P1|COMPLETED|Overall Study||3737
225336|NCT01174550|545856|P2|STARTED|Overall Study||4996
225337|NCT01174550|545857|P1|STARTED|Overall Study||5007
225338|NCT01174459|545885|P1|NOT COMPLETED|Overall Study||5
225339|NCT01174459|545885|P1|COMPLETED|Overall Study|Case report form (CRF) collected|566
225340|NCT01174459|545885|P1|STARTED|Overall Study|Registered patients|571
225341|NCT01174446|545890|P4|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
225342|NCT01174446|545891|P3|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
225343|NCT01174446|545892|P2|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
225344|NCT01174446|545893|P1|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
225345|NCT01174446|545890|P4|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
225346|NCT01174446|545891|P3|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
225347|NCT01174446|545892|P2|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
225348|NCT01174446|545893|P1|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
225349|NCT01174446|545890|P4|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
225350|NCT01174446|545891|P3|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
225351|NCT01174446|545892|P2|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
225352|NCT01174446|545893|P1|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
225353|NCT01174446|545890|P4|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
225354|NCT01174446|545891|P3|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||2
225355|NCT01174446|545892|P2|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
225356|NCT01174446|545893|P1|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
225357|NCT01174446|545890|P4|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
225358|NCT01174446|545891|P3|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||29
225359|NCT01174446|545892|P2|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
225360|NCT01174446|545893|P1|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
225361|NCT01174446|545890|P4|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|14
225362|NCT01174446|545891|P3|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|31
225363|NCT01174446|545892|P2|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
225364|NCT01174446|545893|P1|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
225365|NCT01174446|545890|P4|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
225366|NCT01174446|545891|P3|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
225367|NCT01174446|545892|P2|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
225368|NCT01174446|545893|P1|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
225369|NCT01174446|545890|P4|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
225370|NCT01174446|545891|P3|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
225371|NCT01174446|545892|P2|COMPLETED|Part 1 -Pharmacokinetic Crossover||14
225372|NCT01174446|545893|P1|COMPLETED|Part 1 -Pharmacokinetic Crossover|BAX326 was mistakenly infused for second PK infusion (ie should have been BeneFIX) for 1 participant|14
225373|NCT01174446|545890|P4|STARTED|Part 1 -Pharmacokinetic Crossover||0
225374|NCT01174446|545891|P3|STARTED|Part 1 -Pharmacokinetic Crossover||0
225375|NCT01174446|545892|P2|STARTED|Part 1 -Pharmacokinetic Crossover||14
225376|NCT01174446|545893|P1|STARTED|Part 1 -Pharmacokinetic Crossover||14
225377|NCT01174368|546080|P1|NOT COMPLETED|Overall Study||1
225378|NCT01174368|546080|P1|COMPLETED|Overall Study||0
225379|NCT01174368|546080|P1|STARTED|Overall Study||1
225380|NCT01174342|546086|P1|NOT COMPLETED|Overall Study||4
225381|NCT01174342|546086|P1|COMPLETED|Overall Study||26
225382|NCT01174342|546086|P1|STARTED|Overall Study||30
225383|NCT01174264|546093|P3|NOT COMPLETED|Steady-state Pharmacokinetics||2
225384|NCT01174264|546094|P2|NOT COMPLETED|Steady-state Pharmacokinetics||0
225385|NCT01174264|546095|P1|NOT COMPLETED|Steady-state Pharmacokinetics||6
225386|NCT01174264|546093|P3|COMPLETED|Steady-state Pharmacokinetics||27
225387|NCT01174264|546094|P2|COMPLETED|Steady-state Pharmacokinetics||0
225388|NCT01174264|546095|P1|COMPLETED|Steady-state Pharmacokinetics||25
225389|NCT01174264|546093|P3|STARTED|Steady-state Pharmacokinetics|Includes 11 patients from period 1 high-fat arm and 18 patients from period 1 low-fat arm|29
225390|NCT01174264|546094|P2|STARTED|Steady-state Pharmacokinetics|Patients in period 2 were randomized to fasting vs. fed state only.|0
225391|NCT01174264|546095|P1|STARTED|Steady-state Pharmacokinetics|Includes 22 patients from period 1 fasting arm and 9 patients from period 1 high-fat arm|31
225392|NCT01174264|546093|P3|NOT COMPLETED|Single Dose Pharmacokinetics||2
225393|NCT01174264|546094|P2|NOT COMPLETED|Single Dose Pharmacokinetics||0
225394|NCT01174264|546095|P1|NOT COMPLETED|Single Dose Pharmacokinetics||1
225395|NCT01174264|546093|P3|COMPLETED|Single Dose Pharmacokinetics||18
225396|NCT01174264|546094|P2|COMPLETED|Single Dose Pharmacokinetics||20
225397|NCT01174264|546095|P1|COMPLETED|Single Dose Pharmacokinetics||22
225398|NCT01174264|546093|P3|STARTED|Single Dose Pharmacokinetics||20
225399|NCT01174264|546094|P2|STARTED|Single Dose Pharmacokinetics||20
225400|NCT01174264|546095|P1|STARTED|Single Dose Pharmacokinetics||23
225401|NCT01174238|546127|P1|NOT COMPLETED|Overall Study||2
225402|NCT01174238|546127|P1|COMPLETED|Overall Study||36
225403|NCT01174238|546127|P1|Participants That Underwent FLT-PET Scan|Overall Study||6
225404|NCT01174238|546127|P1|STARTED|Overall Study||38
225405|NCT01174186|546138|P2|NOT COMPLETED|Overall Study||3
225406|NCT01174186|546139|P1|NOT COMPLETED|Overall Study||0
225407|NCT01174186|546138|P2|COMPLETED|Overall Study||12
225408|NCT01174186|546139|P1|COMPLETED|Overall Study||15
225409|NCT01174186|546138|P2|STARTED|Overall Study||15
225410|NCT01174186|546139|P1|STARTED|Overall Study|Patients were included over three years|15
225411|NCT01174173|546146|P1|NOT COMPLETED|Overall Study||1
225412|NCT01174173|546146|P1|COMPLETED|Overall Study||10
225413|NCT01174173|546146|P1|STARTED|Overall Study||11
225414|NCT01174160|546157|P2|NOT COMPLETED|Overall Study||6
225415|NCT01174160|546158|P1|NOT COMPLETED|Overall Study||8
225416|NCT01174160|546157|P2|COMPLETED|Overall Study||56
225417|NCT01174160|546158|P1|COMPLETED|Overall Study||53
225418|NCT01174160|546157|P2|Discontinued Post Dose|Overall Study||0
225419|NCT01174160|546158|P1|Discontinued Post Dose|Overall Study||2
225420|NCT01174160|546157|P2|Dosed|Overall Study||56
225421|NCT01174160|546158|P1|Dosed|Overall Study||55
225422|NCT01174160|546157|P2|Discontinued Pre Dose|Overall Study||6
225423|NCT01174160|546158|P1|Discontinued Pre Dose|Overall Study||6
225424|NCT01174160|546157|P2|STARTED|Overall Study||62
225425|NCT01174160|546158|P1|STARTED|Overall Study||61
225426|NCT01174082|546166|P2|NOT COMPLETED|Overall Study||0
225427|NCT01174082|546167|P1|NOT COMPLETED|Overall Study||0
225428|NCT01174082|546166|P2|COMPLETED|Overall Study||1
225429|NCT01174082|546167|P1|COMPLETED|Overall Study||1
225430|NCT01174082|546166|P2|STARTED|Overall Study||1
225431|NCT01174082|546167|P1|STARTED|Overall Study||1
225432|NCT01174043|546173|P1|NOT COMPLETED|Overall Study||11
225433|NCT01174043|546173|P1|COMPLETED|Overall Study||0
225434|NCT01174043|546173|P1|STARTED|Overall Study||11
225435|NCT01174030|546184|P5|NOT COMPLETED|Overall Study||1
225436|NCT01174030|546185|P4|NOT COMPLETED|Overall Study||2
225437|NCT01174030|546186|P3|NOT COMPLETED|Overall Study||2
225438|NCT01174030|546187|P2|NOT COMPLETED|Overall Study||2
225439|NCT01174030|546188|P1|NOT COMPLETED|Overall Study||2
225440|NCT01174030|546184|P5|COMPLETED|Overall Study||52
225441|NCT01174030|546185|P4|COMPLETED|Overall Study||53
225442|NCT01174030|546186|P3|COMPLETED|Overall Study||52
225443|NCT01174030|546187|P2|COMPLETED|Overall Study||52
225444|NCT01174030|546188|P1|COMPLETED|Overall Study||51
225445|NCT01174030|546184|P5|STARTED|Overall Study||53
225446|NCT01174030|546185|P4|STARTED|Overall Study||55
225447|NCT01174030|546186|P3|STARTED|Overall Study||54
225448|NCT01174030|546187|P2|STARTED|Overall Study||54
225449|NCT01174030|546188|P1|STARTED|Overall Study||53
225450|NCT01174004|546212|P2|NOT COMPLETED|Overall Study||16
225451|NCT01174004|546213|P1|NOT COMPLETED|Overall Study||7
225452|NCT01174004|546212|P2|COMPLETED|Overall Study||89
225453|NCT01174004|546213|P1|COMPLETED|Overall Study||87
225454|NCT01174004|546212|P2|STARTED|Overall Study||105
225455|NCT01174004|546213|P1|STARTED|Overall Study||94
225456|NCT01173874|546223|P2|NOT COMPLETED|Overall Study||23
225457|NCT01173874|546224|P1|NOT COMPLETED|Overall Study||23
225458|NCT01173874|546223|P2|COMPLETED|Overall Study||41
225459|NCT01173874|546224|P1|COMPLETED|Overall Study||33
225460|NCT01173874|546223|P2|STARTED|Overall Study||64
225461|NCT01173874|546224|P1|STARTED|Overall Study||56
225462|NCT01173848|546238|P2|NOT COMPLETED|Overall Study||8
225463|NCT01173848|546239|P1|NOT COMPLETED|Overall Study||4
225464|NCT01173848|546238|P2|COMPLETED|Overall Study||3
225465|NCT01173848|546239|P1|COMPLETED|Overall Study||4
225466|NCT01173848|546238|P2|STARTED|Overall Study||11
225467|NCT01173848|546239|P1|STARTED|Overall Study||8
225468|NCT01173718|546244|P1|NOT COMPLETED|Overall Study||44
225469|NCT01173718|546244|P1|COMPLETED|Overall Study||94
225470|NCT01173718|546244|P1|STARTED|Overall Study||138
225471|NCT01173679|546253|P1|NOT COMPLETED|Overall Study||1
225472|NCT01173679|546253|P1|COMPLETED|Overall Study||9
225473|NCT01173679|546253|P1|STARTED|Overall Study||10
225474|NCT01173653|546261|P2|NOT COMPLETED|Overall Study||41
225475|NCT01173653|546262|P1|NOT COMPLETED|Overall Study||53
225476|NCT01173653|546261|P2|COMPLETED|Overall Study||49
225477|NCT01173653|546262|P1|COMPLETED|Overall Study||56
225478|NCT01173653|546261|P2|STARTED|Overall Study||90
225479|NCT01173653|546262|P1|STARTED|Overall Study||109
225480|NCT01173601|546272|P5|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||68
225481|NCT01173601|546273|P4|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||30
225482|NCT01173601|546274|P3|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
225483|NCT01173601|546275|P2|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
225484|NCT01173601|546276|P1|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
225485|NCT01173601|546272|P5|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||559
225486|NCT01173601|546273|P4|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||210
225487|NCT01173601|546274|P3|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||197
225488|NCT01173601|546275|P2|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
225489|NCT01173601|546276|P1|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
225490|NCT01173601|546272|P5|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|586
225491|NCT01173601|546273|P4|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|221
225492|NCT01173601|546274|P3|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|108
225493|NCT01173601|546275|P2|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|100
225494|NCT01173601|546276|P1|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
225495|NCT01173601|546272|P5|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
225496|NCT01173601|546273|P4|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
225497|NCT01173601|546274|P3|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|107
225498|NCT01173601|546275|P2|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|100
225499|NCT01173601|546276|P1|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
225500|NCT01173601|546272|P5|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||627
225501|NCT01173601|546273|P4|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||240
225502|NCT01173601|546274|P3|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
225503|NCT01173601|546275|P2|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
225504|NCT01173601|546276|P1|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
225505|NCT01173601|546272|P5|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
225506|NCT01173601|546273|P4|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
225507|NCT01173601|546274|P3|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
225508|NCT01173601|546275|P2|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
225509|NCT01173601|546276|P1|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
225510|NCT01173601|546272|P5|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
225511|NCT01173601|546273|P4|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
225512|NCT01173601|546274|P3|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
225513|NCT01173601|546275|P2|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
225514|NCT01173601|546276|P1|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the AT Phase.|1328
225515|NCT01173601|546272|P5|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
225516|NCT01173601|546273|P4|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
225517|NCT01173601|546274|P3|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
225518|NCT01173601|546275|P2|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
225519|NCT01173601|546276|P1|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase had the option to enter the DC phase.|21
225520|NCT01173601|546272|P5|STARTED|Confirmation (CF) Phase, 3 Weeks||0
225521|NCT01173601|546273|P4|STARTED|Confirmation (CF) Phase, 3 Weeks||0
225522|NCT01173601|546274|P3|STARTED|Confirmation (CF) Phase, 3 Weeks||0
225523|NCT01173601|546275|P2|STARTED|Confirmation (CF) Phase, 3 Weeks||0
225524|NCT01173601|546276|P1|STARTED|Confirmation (CF) Phase, 3 Weeks||1416
225525|NCT01173523|546353|P2|NOT COMPLETED|Overall Study||12
225526|NCT01173523|546354|P1|NOT COMPLETED|Overall Study||13
225527|NCT01173523|546353|P2|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
225528|NCT01173523|546354|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
225529|NCT01173523|546353|P2|STARTED|Overall Study||12
225530|NCT01173523|546354|P1|STARTED|Overall Study||13
225531|NCT01173471|546370|P4|NOT COMPLETED|Overall Study||1
225532|NCT01173471|546371|P3|NOT COMPLETED|Overall Study||3
225533|NCT01173471|546372|P2|NOT COMPLETED|Overall Study||0
225534|NCT01173471|546373|P1|NOT COMPLETED|Overall Study||2
225535|NCT01173471|546370|P4|COMPLETED|Overall Study|Completed study|18
225536|NCT01173471|546371|P3|COMPLETED|Overall Study|Completed study|15
225537|NCT01173471|546372|P2|COMPLETED|Overall Study|Completed study|7
225538|NCT01173471|546373|P1|COMPLETED|Overall Study|Completed study|4
225539|NCT01173471|546370|P4|Completed Treatment|Overall Study||18
225540|NCT01173471|546371|P3|Completed Treatment|Overall Study||15
225541|NCT01173471|546372|P2|Completed Treatment|Overall Study||7
225542|NCT01173471|546373|P1|Completed Treatment|Overall Study||4
225543|NCT01173471|546370|P4|Received Treatment|Overall Study||19
225544|NCT01173471|546371|P3|Received Treatment|Overall Study||18
225545|NCT01173471|546372|P2|Received Treatment|Overall Study||7
225546|NCT01173471|546373|P1|Received Treatment|Overall Study||6
225547|NCT01173471|546370|P4|STARTED|Overall Study|Randomized|19
225548|NCT01173471|546371|P3|STARTED|Overall Study|Randomized|18
225549|NCT01173471|546372|P2|STARTED|Overall Study|Randomized|7
225550|NCT01173471|546373|P1|STARTED|Overall Study|Randomized|6
225551|NCT01173211|546397|P6|NOT COMPLETED|Overall Study||0
225552|NCT01173211|546398|P5|NOT COMPLETED|Overall Study||0
225553|NCT01173211|546399|P4|NOT COMPLETED|Overall Study||0
225554|NCT01173211|546400|P3|NOT COMPLETED|Overall Study||2
225555|NCT01173211|546401|P2|NOT COMPLETED|Overall Study||1
225556|NCT01173211|546402|P1|NOT COMPLETED|Overall Study||2
225557|NCT01173211|546397|P6|COMPLETED|Overall Study||13
225558|NCT01173211|546398|P5|COMPLETED|Overall Study||16
225559|NCT01173211|546399|P4|COMPLETED|Overall Study||15
225560|NCT01173211|546400|P3|COMPLETED|Overall Study||44
225561|NCT01173211|546401|P2|COMPLETED|Overall Study||44
225562|NCT01173211|546402|P1|COMPLETED|Overall Study||46
225563|NCT01173211|546397|P6|STARTED|Overall Study||13
225564|NCT01173211|546398|P5|STARTED|Overall Study||16
225565|NCT01173211|546399|P4|STARTED|Overall Study||15
225566|NCT01173211|546400|P3|STARTED|Overall Study||46
225567|NCT01173211|546401|P2|STARTED|Overall Study||45
225568|NCT01173211|546402|P1|STARTED|Overall Study||48
225569|NCT01173120|546503|P1|NOT COMPLETED|Overall Study||62
225570|NCT01173120|546503|P1|COMPLETED|Overall Study||0
225571|NCT01173120|546503|P1|Discontinued ACP Substudy and Main Study|Overall Study||5
225572|NCT01173120|546503|P1|Switched Back to Main Study|Overall Study||57
225573|NCT01173120|546503|P1|STARTED|Overall Study||62
225574|NCT01173055|546521|P2|NOT COMPLETED|Period 2 - Day 64 to 112||1
225575|NCT01173055|546522|P1|NOT COMPLETED|Period 2 - Day 64 to 112||0
225576|NCT01173055|546521|P2|COMPLETED|Period 2 - Day 64 to 112||9
225577|NCT01173055|546522|P1|COMPLETED|Period 2 - Day 64 to 112||8
225578|NCT01173055|546521|P2|STARTED|Period 2 - Day 64 to 112||10
225579|NCT01173055|546522|P1|STARTED|Period 2 - Day 64 to 112||8
225580|NCT01173055|546521|P2|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
225581|NCT01173055|546522|P1|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
225582|NCT01173055|546521|P2|COMPLETED|Placebo Washout Period - Day 50 to 63||10
225583|NCT01173055|546522|P1|COMPLETED|Placebo Washout Period - Day 50 to 63||8
225584|NCT01173055|546521|P2|STARTED|Placebo Washout Period - Day 50 to 63||10
225585|NCT01173055|546522|P1|STARTED|Placebo Washout Period - Day 50 to 63||8
225586|NCT01173055|546521|P2|NOT COMPLETED|Period 1 - Day 1 to 49||2
225587|NCT01173055|546522|P1|NOT COMPLETED|Period 1 - Day 1 to 49||2
225588|NCT01173055|546521|P2|COMPLETED|Period 1 - Day 1 to 49||10
225589|NCT01173055|546522|P1|COMPLETED|Period 1 - Day 1 to 49||8
225590|NCT01173055|546521|P2|STARTED|Period 1 - Day 1 to 49||12
225591|NCT01173055|546522|P1|STARTED|Period 1 - Day 1 to 49||10
225592|NCT01173029|546540|P2|NOT COMPLETED|Overall Study||0
225593|NCT01173029|546541|P1|NOT COMPLETED|Overall Study||0
225594|NCT01173029|546540|P2|COMPLETED|Overall Study||31
225595|NCT01173029|546541|P1|COMPLETED|Overall Study||61
225596|NCT01173029|546540|P2|STARTED|Overall Study||31
225597|NCT01173029|546541|P1|STARTED|Overall Study||61
225598|NCT01172938|546561|P9|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||2
225599|NCT01172938|546562|P8|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
225600|NCT01172938|546563|P7|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
225601|NCT01172938|546564|P6|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
225602|NCT01172938|546565|P5|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
225603|NCT01172938|546566|P4|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
225604|NCT01172938|546567|P3|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||8
225605|NCT01172938|546568|P2|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
225606|NCT01172938|546569|P1|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
225607|NCT01172938|546561|P9|COMPLETED|Active-Treatment Phase (Weeks 208-260)||32
225608|NCT01172938|546562|P8|COMPLETED|Active-Treatment Phase (Weeks 208-260)||29
225609|NCT01172938|546563|P7|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
225610|NCT01172938|546564|P6|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
225611|NCT01172938|546565|P5|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
225612|NCT01172938|546566|P4|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
225613|NCT01172938|546567|P3|COMPLETED|Active-Treatment Phase (Weeks 208-260)||80
225614|NCT01172938|546568|P2|COMPLETED|Active-Treatment Phase (Weeks 208-260)||72
225615|NCT01172938|546569|P1|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
225616|NCT01172938|546561|P9|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
225617|NCT01172938|546562|P8|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||25
225618|NCT01172938|546563|P7|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
225619|NCT01172938|546564|P6|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
225620|NCT01172938|546565|P5|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
225621|NCT01172938|546566|P4|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
225622|NCT01172938|546567|P3|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
225623|NCT01172938|546568|P2|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
225624|NCT01172938|546569|P1|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
225625|NCT01172938|546561|P9|STARTED|Active-Treatment Phase (Weeks 208-260)||34
225626|NCT01172938|546562|P8|STARTED|Active-Treatment Phase (Weeks 208-260)||32
225627|NCT01172938|546563|P7|STARTED|Active-Treatment Phase (Weeks 208-260)||0
225628|NCT01172938|546564|P6|STARTED|Active-Treatment Phase (Weeks 208-260)||0
225629|NCT01172938|546565|P5|STARTED|Active-Treatment Phase (Weeks 208-260)||0
225630|NCT01172938|546566|P4|STARTED|Active-Treatment Phase (Weeks 208-260)||0
225631|NCT01172938|546567|P3|STARTED|Active-Treatment Phase (Weeks 208-260)||88
225632|NCT01172938|546568|P2|STARTED|Active-Treatment Phase (Weeks 208-260)||75
225633|NCT01172938|546569|P1|STARTED|Active-Treatment Phase (Weeks 208-260)||0
225634|NCT01172938|546561|P9|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||7
225635|NCT01172938|546562|P8|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
225636|NCT01172938|546563|P7|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
225637|NCT01172938|546564|P6|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
225638|NCT01172938|546565|P5|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
225639|NCT01172938|546566|P4|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
225640|NCT01172938|546567|P3|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||5
225641|NCT01172938|546568|P2|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
225642|NCT01172938|546569|P1|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
225643|NCT01172938|546561|P9|COMPLETED|Active-Treatment Phase (Weeks 156-208)||34
225644|NCT01172938|546562|P8|COMPLETED|Active-Treatment Phase (Weeks 156-208)||32
225645|NCT01172938|546563|P7|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
225646|NCT01172938|546564|P6|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
225647|NCT01172938|546565|P5|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
225648|NCT01172938|546566|P4|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
225649|NCT01172938|546567|P3|COMPLETED|Active-Treatment Phase (Weeks 156-208)||88
225650|NCT01172938|546568|P2|COMPLETED|Active-Treatment Phase (Weeks 156-208)||75
225651|NCT01172938|546569|P1|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
225652|NCT01172938|546561|P9|STARTED|Active-Treatment Phase (Weeks 156-208)||41
225653|NCT01172938|546562|P8|STARTED|Active-Treatment Phase (Weeks 156-208)||41
225654|NCT01172938|546563|P7|STARTED|Active-Treatment Phase (Weeks 156-208)||0
225655|NCT01172938|546564|P6|STARTED|Active-Treatment Phase (Weeks 156-208)||0
225656|NCT01172938|546565|P5|STARTED|Active-Treatment Phase (Weeks 156-208)||0
225657|NCT01172938|546566|P4|STARTED|Active-Treatment Phase (Weeks 156-208)||0
225658|NCT01172938|546567|P3|STARTED|Active-Treatment Phase (Weeks 156-208)||93
225659|NCT01172938|546568|P2|STARTED|Active-Treatment Phase (Weeks 156-208)||84
225660|NCT01172938|546569|P1|STARTED|Active-Treatment Phase (Weeks 156-208)||0
225661|NCT01172938|546561|P9|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||4
225662|NCT01172938|546562|P8|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||5
225663|NCT01172938|546563|P7|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
225664|NCT01172938|546564|P6|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
225665|NCT01172938|546565|P5|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
225666|NCT01172938|546566|P4|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
225667|NCT01172938|546567|P3|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||7
225668|NCT01172938|546568|P2|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||11
225669|NCT01172938|546569|P1|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
225670|NCT01172938|546561|P9|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
225671|NCT01172938|546562|P8|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
225672|NCT01172938|546563|P7|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
225673|NCT01172938|546564|P6|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
225674|NCT01172938|546565|P5|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
225675|NCT01172938|546566|P4|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
225676|NCT01172938|546567|P3|COMPLETED|Active-Treatment Phase Weeks (104-156)||93
225677|NCT01172938|546568|P2|COMPLETED|Active-Treatment Phase Weeks (104-156)||84
225678|NCT01172938|546569|P1|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
225679|NCT01172938|546561|P9|STARTED|Active-Treatment Phase Weeks (104-156)||45
225680|NCT01172938|546562|P8|STARTED|Active-Treatment Phase Weeks (104-156)||46
225681|NCT01172938|546563|P7|STARTED|Active-Treatment Phase Weeks (104-156)||0
225682|NCT01172938|546564|P6|STARTED|Active-Treatment Phase Weeks (104-156)||0
225683|NCT01172938|546565|P5|STARTED|Active-Treatment Phase Weeks (104-156)||0
225684|NCT01172938|546566|P4|STARTED|Active-Treatment Phase Weeks (104-156)||0
225685|NCT01172938|546567|P3|STARTED|Active-Treatment Phase Weeks (104-156)||100
225686|NCT01172938|546568|P2|STARTED|Active-Treatment Phase Weeks (104-156)||95
225687|NCT01172938|546569|P1|STARTED|Active-Treatment Phase Weeks (104-156)||0
225688|NCT01172938|546561|P9|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||4
225689|NCT01172938|546562|P8|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||15
225690|NCT01172938|546563|P7|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
225691|NCT01172938|546564|P6|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
225692|NCT01172938|546565|P5|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
225693|NCT01172938|546566|P4|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
225694|NCT01172938|546567|P3|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||21
225695|NCT01172938|546568|P2|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||23
225696|NCT01172938|546569|P1|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
225697|NCT01172938|546561|P9|COMPLETED|Active-Treatment Phase (Weeks 52-104)||45
225698|NCT01172938|546562|P8|COMPLETED|Active-Treatment Phase (Weeks 52-104)||46
225699|NCT01172938|546563|P7|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
225700|NCT01172938|546564|P6|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
225701|NCT01172938|546565|P5|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
225702|NCT01172938|546566|P4|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
225703|NCT01172938|546567|P3|COMPLETED|Active-Treatment Phase (Weeks 52-104)||100
225704|NCT01172938|546568|P2|COMPLETED|Active-Treatment Phase (Weeks 52-104)||95
225705|NCT01172938|546569|P1|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
225706|NCT01172938|546561|P9|STARTED|Active-Treatment Phase (Weeks 52-104)||49
225707|NCT01172938|546562|P8|STARTED|Active-Treatment Phase (Weeks 52-104)||61
225708|NCT01172938|546563|P7|STARTED|Active-Treatment Phase (Weeks 52-104)||0
225709|NCT01172938|546564|P6|STARTED|Active-Treatment Phase (Weeks 52-104)||0
225710|NCT01172938|546565|P5|STARTED|Active-Treatment Phase (Weeks 52-104)||0
225711|NCT01172938|546566|P4|STARTED|Active-Treatment Phase (Weeks 52-104)||0
225712|NCT01172938|546567|P3|STARTED|Active-Treatment Phase (Weeks 52-104)|Nine participants who completed Week 52 did not enter the next year of active treatment phase|121
225713|NCT01172938|546568|P2|STARTED|Active-Treatment Phase (Weeks 52-104)|Six participants who completed Week 52 did not enter the next year of active treatment phase|118
225714|NCT01172938|546569|P1|STARTED|Active-Treatment Phase (Weeks 52-104)||0
225715|NCT01172938|546561|P9|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
225716|NCT01172938|546562|P8|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
225717|NCT01172938|546563|P7|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||2
225718|NCT01172938|546564|P6|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
225719|NCT01172938|546565|P5|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||4
225720|NCT01172938|546566|P4|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||7
225721|NCT01172938|546567|P3|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
225722|NCT01172938|546568|P2|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||12
225723|NCT01172938|546569|P1|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
225724|NCT01172938|546561|P9|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
225725|NCT01172938|546562|P8|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
225726|NCT01172938|546563|P7|COMPLETED|Active Treatment Phase (Weeks 25-52)||22
225727|NCT01172938|546564|P6|COMPLETED|Active Treatment Phase (Weeks 25-52)||34
225728|NCT01172938|546565|P5|COMPLETED|Active Treatment Phase (Weeks 25-52)||19
225729|NCT01172938|546566|P4|COMPLETED|Active Treatment Phase (Weeks 25-52)||44
225730|NCT01172938|546567|P3|COMPLETED|Active Treatment Phase (Weeks 25-52)||130
225731|NCT01172938|546568|P2|COMPLETED|Active Treatment Phase (Weeks 25-52)||124
225732|NCT01172938|546569|P1|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
225733|NCT01172938|546561|P9|STARTED|Active Treatment Phase (Weeks 25-52)||0
225734|NCT01172938|546562|P8|STARTED|Active Treatment Phase (Weeks 25-52)||0
225735|NCT01172938|546563|P7|STARTED|Active Treatment Phase (Weeks 25-52)||24
225736|NCT01172938|546564|P6|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|49
225737|NCT01172938|546565|P5|STARTED|Active Treatment Phase (Weeks 25-52)||23
225738|NCT01172938|546566|P4|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|51
225739|NCT01172938|546567|P3|STARTED|Active Treatment Phase (Weeks 25-52)|Three participants who completed Week 24 did not enter the active treatment phase|145
225740|NCT01172938|546568|P2|STARTED|Active Treatment Phase (Weeks 25-52)|Ten participants who completed Week 24 did not enter the active treatment phase|136
225741|NCT01172938|546569|P1|STARTED|Active Treatment Phase (Weeks 25-52)||0
225742|NCT01172938|546561|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
225743|NCT01172938|546562|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
225744|NCT01172938|546563|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
225745|NCT01172938|546564|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
225746|NCT01172938|546565|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
225747|NCT01172938|546566|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
225748|NCT01172938|546567|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||20
225749|NCT01172938|546568|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||22
225750|NCT01172938|546569|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||18
225751|NCT01172938|546561|P9|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
225752|NCT01172938|546562|P8|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
225753|NCT01172938|546563|P7|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
225754|NCT01172938|546564|P6|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
225755|NCT01172938|546565|P5|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
225756|NCT01172938|546566|P4|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
225757|NCT01172938|546567|P3|COMPLETED|Placebo-controlled Phase (Week 0-24)||148
225758|NCT01172938|546568|P2|COMPLETED|Placebo-controlled Phase (Week 0-24)||146
225759|NCT01172938|546569|P1|COMPLETED|Placebo-controlled Phase (Week 0-24)|One participant who completed Week 24 did not enter the active treatment phase|150
225760|NCT01172938|546561|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
225761|NCT01172938|546562|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
225762|NCT01172938|546563|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
225763|NCT01172938|546564|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
225764|NCT01172938|546565|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
225765|NCT01172938|546566|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
225766|NCT01172938|546567|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||58
225767|NCT01172938|546568|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Six participants who escaped early did not complete Week 24|78
225768|NCT01172938|546569|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Five participants who escaped early did not complete Week 24|107
225769|NCT01172938|546561|P9|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
225770|NCT01172938|546562|P8|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
225771|NCT01172938|546563|P7|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
225772|NCT01172938|546564|P6|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
225773|NCT01172938|546565|P5|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
225774|NCT01172938|546566|P4|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
225775|NCT01172938|546567|P3|Completed Week 16|Placebo-controlled Phase (Week 0-24)||154
225776|NCT01172938|546568|P2|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
225777|NCT01172938|546569|P1|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
225778|NCT01172938|546561|P9|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
225779|NCT01172938|546562|P8|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
225780|NCT01172938|546563|P7|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
225781|NCT01172938|546564|P6|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
225782|NCT01172938|546565|P5|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
225783|NCT01172938|546566|P4|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
225784|NCT01172938|546567|P3|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
225785|NCT01172938|546568|P2|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
225786|NCT01172938|546569|P1|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
225787|NCT01172938|546561|P9|STARTED|Placebo-controlled Phase (Week 0-24)||0
225788|NCT01172938|546562|P8|STARTED|Placebo-controlled Phase (Week 0-24)||0
225789|NCT01172938|546563|P7|STARTED|Placebo-controlled Phase (Week 0-24)||0
225790|NCT01172938|546564|P6|STARTED|Placebo-controlled Phase (Week 0-24)||0
225791|NCT01172938|546565|P5|STARTED|Placebo-controlled Phase (Week 0-24)||0
225792|NCT01172938|546566|P4|STARTED|Placebo-controlled Phase (Week 0-24)||0
225793|NCT01172938|546567|P3|STARTED|Placebo-controlled Phase (Week 0-24)||168
225794|NCT01172938|546568|P2|STARTED|Placebo-controlled Phase (Week 0-24)||168
225795|NCT01172938|546569|P1|STARTED|Placebo-controlled Phase (Week 0-24)||168
225796|NCT01172873|546755|P2|NOT COMPLETED|Overall Study||2
225797|NCT01172873|546756|P1|NOT COMPLETED|Overall Study||3
225798|NCT01172873|546755|P2|COMPLETED|Overall Study||3
225799|NCT01172873|546756|P1|COMPLETED|Overall Study||8
225800|NCT01172873|546755|P2|STARTED|Overall Study||5
225801|NCT01172873|546756|P1|STARTED|Overall Study||11
225802|NCT01172847|546766|P1|NOT COMPLETED|Overall Study||3
225803|NCT01172847|546766|P1|COMPLETED|Overall Study||21
225804|NCT01172847|546766|P1|Oseltamivir + Rimantadine|Overall Study||21
225805|NCT01172847|546766|P1|Rimantadine|Overall Study||22
225806|NCT01172847|546766|P1|Oseltamivir|Overall Study||24
225807|NCT01172847|546766|P1|STARTED|Overall Study||24
225808|NCT01172821|546795|P4|NOT COMPLETED|Overall Study||17
225809|NCT01172821|546796|P3|NOT COMPLETED|Overall Study||13
225810|NCT01172821|546797|P2|NOT COMPLETED|Overall Study||12
225811|NCT01172821|546798|P1|NOT COMPLETED|Overall Study||14
225812|NCT01172821|546795|P4|COMPLETED|Overall Study||249
225813|NCT01172821|546796|P3|COMPLETED|Overall Study||240
225814|NCT01172821|546797|P2|COMPLETED|Overall Study||245
225815|NCT01172821|546798|P1|COMPLETED|Overall Study||240
225816|NCT01172821|546795|P4|STARTED|Overall Study|Entered and Treated|266
225817|NCT01172821|546796|P3|STARTED|Overall Study|Entered and Treated|253
225818|NCT01172821|546797|P2|STARTED|Overall Study|Entered and Treated|257
225819|NCT01172821|546798|P1|STARTED|Overall Study|Entered and Treated|254
225820|NCT01172808|546888|P4|NOT COMPLETED|Overall Study||15
225821|NCT01172808|546889|P3|NOT COMPLETED|Overall Study||23
225822|NCT01172808|546890|P2|NOT COMPLETED|Overall Study||13
225823|NCT01172808|546891|P1|NOT COMPLETED|Overall Study||21
225824|NCT01172808|546888|P4|COMPLETED|Overall Study||260
225825|NCT01172808|546889|P3|COMPLETED|Overall Study||241
225826|NCT01172808|546890|P2|COMPLETED|Overall Study||249
225827|NCT01172808|546891|P1|COMPLETED|Overall Study||248
225828|NCT01172808|546888|P4|STARTED|Overall Study|Entered and Treated|275
225829|NCT01172808|546889|P3|STARTED|Overall Study|Entered and Treated|264
225830|NCT01172808|546890|P2|STARTED|Overall Study|Entered and Treated|262
225831|NCT01172808|546891|P1|STARTED|Overall Study|Entered and Treated|269
225832|NCT01172639|546982|P5|NOT COMPLETED|Overall Study||6
225833|NCT01172639|546983|P4|NOT COMPLETED|Overall Study||11
225834|NCT01172639|546984|P3|NOT COMPLETED|Overall Study||16
225835|NCT01172639|546985|P2|NOT COMPLETED|Overall Study||11
225836|NCT01172639|546986|P1|NOT COMPLETED|Overall Study||13
225837|NCT01172639|546982|P5|COMPLETED|Overall Study||41
225838|NCT01172639|546983|P4|COMPLETED|Overall Study||32
225839|NCT01172639|546984|P3|COMPLETED|Overall Study||77
225840|NCT01172639|546985|P2|COMPLETED|Overall Study||87
225841|NCT01172639|546986|P1|COMPLETED|Overall Study||85
225842|NCT01172639|546982|P5|Week 52|Overall Study||45
225843|NCT01172639|546983|P4|Week 52|Overall Study||38
225844|NCT01172639|546984|P3|Week 52|Overall Study||88
225845|NCT01172639|546985|P2|Week 52|Overall Study||89
225846|NCT01172639|546986|P1|Week 52|Overall Study||89
225847|NCT01172639|546982|P5|Week 16|Overall Study||47
225848|NCT01172639|546983|P4|Week 16|Overall Study||39
225849|NCT01172639|546984|P3|Week 16|Overall Study||91
225850|NCT01172639|546985|P2|Week 16|Overall Study||96
225851|NCT01172639|546986|P1|Week 16|Overall Study||94
225852|NCT01172639|546982|P5|STARTED|Overall Study||47
225853|NCT01172639|546983|P4|STARTED|Overall Study||43
225854|NCT01172639|546984|P3|STARTED|Overall Study||93
225855|NCT01172639|546985|P2|STARTED|Overall Study||98
225856|NCT01172639|546986|P1|STARTED|Overall Study||98
225857|NCT01172600|547030|P2|NOT COMPLETED|Overall Study||0
225858|NCT01172600|547031|P1|NOT COMPLETED|Overall Study||0
225859|NCT01172600|547030|P2|COMPLETED|Overall Study||39
225860|NCT01172600|547031|P1|COMPLETED|Overall Study||39
225861|NCT01172600|547030|P2|STARTED|Overall Study||39
225862|NCT01172600|547031|P1|STARTED|Overall Study||39
225863|NCT01172535|547061|P1|NOT COMPLETED|Overall Study||8
225864|NCT01172535|547061|P1|COMPLETED|Overall Study||89
225865|NCT01172535|547061|P1|STARTED|Overall Study||97
225866|NCT01172522|547078|P2|NOT COMPLETED|Overall Study||0
225867|NCT01172522|547079|P1|NOT COMPLETED|Overall Study||0
225868|NCT01172522|547078|P2|COMPLETED|Overall Study||15
225869|NCT01172522|547079|P1|COMPLETED|Overall Study||15
225870|NCT01172522|547078|P2|STARTED|Overall Study||15
225871|NCT01172522|547079|P1|STARTED|Overall Study||15
225872|NCT01172418|547086|P2|NOT COMPLETED|Overall Study||0
225873|NCT01172418|547087|P1|NOT COMPLETED|Overall Study||0
225874|NCT01172418|547086|P2|COMPLETED|Overall Study||100
225875|NCT01172418|547087|P1|COMPLETED|Overall Study||100
225876|NCT01172418|547086|P2|STARTED|Overall Study||100
225877|NCT01172418|547087|P1|STARTED|Overall Study||100
225878|NCT01172353|547103|P2|NOT COMPLETED|Overall Study||0
225879|NCT01172353|547104|P1|NOT COMPLETED|Overall Study||0
225880|NCT01172353|547103|P2|COMPLETED|Overall Study||151
225881|NCT01172353|547104|P1|COMPLETED|Overall Study||150
225882|NCT01172353|547103|P2|STARTED|Overall Study||151
225883|NCT01172353|547104|P1|STARTED|Overall Study||150
225884|NCT01172288|547114|P2|NOT COMPLETED|Overall Study||1
225885|NCT01172288|547115|P1|NOT COMPLETED|Overall Study||1
225886|NCT01172288|547114|P2|COMPLETED|Overall Study||13
225887|NCT01172288|547115|P1|COMPLETED|Overall Study||16
225888|NCT01172288|547114|P2|STARTED|Overall Study||14
225889|NCT01172288|547115|P1|STARTED|Overall Study||17
225890|NCT01172275|547131|P2|NOT COMPLETED|Overall Study||0
225891|NCT01172275|547132|P1|NOT COMPLETED|Overall Study||2
225892|NCT01172275|547131|P2|COMPLETED|Overall Study||6
225893|NCT01172275|547132|P1|COMPLETED|Overall Study||3
225894|NCT01172275|547131|P2|STARTED|Overall Study||6
225895|NCT01172275|547132|P1|STARTED|Overall Study||5
225896|NCT01172197|547142|P2|NOT COMPLETED|Overall Study||0
225897|NCT01172197|547143|P1|NOT COMPLETED|Overall Study||0
225898|NCT01172197|547142|P2|COMPLETED|Overall Study||7
225899|NCT01172197|547143|P1|COMPLETED|Overall Study||7
225900|NCT01172197|547142|P2|STARTED|Overall Study||7
225901|NCT01172197|547143|P1|STARTED|Overall Study||7
225902|NCT01172184|547149|P1|NOT COMPLETED|Overall Study||0
225903|NCT01172184|547149|P1|COMPLETED|Overall Study||111
225904|NCT01172184|547149|P1|STARTED|Overall Study||111
225905|NCT01172145|547157|P2|NOT COMPLETED|Overall Study||0
225906|NCT01172145|547158|P1|NOT COMPLETED|Overall Study||0
225907|NCT01172145|547157|P2|COMPLETED|Overall Study||11
225908|NCT01172145|547158|P1|COMPLETED|Overall Study||11
225909|NCT01172145|547157|P2|STARTED|Overall Study||11
225910|NCT01172145|547158|P1|STARTED|Overall Study||11
225911|NCT01172067|547180|P2|NOT COMPLETED|Overall Study||37
225912|NCT01172067|547181|P1|NOT COMPLETED|Overall Study||47
225913|NCT01172067|547180|P2|COMPLETED|Overall Study||163
225914|NCT01172067|547181|P1|COMPLETED|Overall Study||153
225915|NCT01172067|547180|P2|STARTED|Overall Study||200
225916|NCT01172067|547181|P1|STARTED|Overall Study||200
225917|NCT01171989|547190|P3|NOT COMPLETED|Overall Study||1
225918|NCT01171989|547191|P2|NOT COMPLETED|Overall Study||0
225919|NCT01171989|547192|P1|NOT COMPLETED|Overall Study||0
225920|NCT01171989|547190|P3|COMPLETED|Overall Study||120
225921|NCT01171989|547191|P2|COMPLETED|Overall Study||133
225922|NCT01171989|547192|P1|COMPLETED|Overall Study||137
225923|NCT01171989|547190|P3|STARTED|Overall Study||121
225924|NCT01171989|547191|P2|STARTED|Overall Study||133
225925|NCT01171989|547192|P1|STARTED|Overall Study||137
225926|NCT01171976|547266|P3|NOT COMPLETED|Overall Study||15
225927|NCT01171976|547267|P2|NOT COMPLETED|Overall Study||11
225928|NCT01171976|547268|P1|NOT COMPLETED|Overall Study||14
225929|NCT01171976|547266|P3|COMPLETED|Overall Study||108
225930|NCT01171976|547267|P2|COMPLETED|Overall Study||117
225931|NCT01171976|547268|P1|COMPLETED|Overall Study||107
225932|NCT01171976|547266|P3|Safety Set|Overall Study|Exclude 1 who did not get drug and 4 got laser treatment|118
225933|NCT01171976|547267|P2|Safety Set|Overall Study|Exclude 1 who did not get drug and 3 got laser treatment, include 2 from 1st arm with no laser|126
225934|NCT01171976|547268|P1|Safety Set|Overall Study|Include 4 from PRN and 3 from TE alone who got laser treatment, exclude 2 with no laser treatment.|126
225935|NCT01171976|547266|P3|STARTED|Overall Study||123
225936|NCT01171976|547267|P2|STARTED|Overall Study||128
225937|NCT01171976|547268|P1|STARTED|Overall Study||121
225938|NCT01171963|547305|P2|NOT COMPLETED|Overall Study||168
225939|NCT01171963|547306|P1|NOT COMPLETED|Overall Study||148
225940|NCT01171963|547305|P2|COMPLETED|Overall Study||1499
225941|NCT01171963|547306|P1|COMPLETED|Overall Study||1518
225942|NCT01171963|547305|P2|STARTED|Overall Study||1667
225943|NCT01171963|547306|P1|STARTED|Overall Study||1666
225944|NCT01171924|547364|P2|NOT COMPLETED|Overall Study||23
225945|NCT01171924|547365|P1|NOT COMPLETED|Overall Study||23
225946|NCT01171924|547364|P2|COMPLETED|Overall Study||0
225947|NCT01171924|547365|P1|COMPLETED|Overall Study||0
225948|NCT01171924|547364|P2|STARTED|Overall Study||23
225949|NCT01171924|547365|P1|STARTED|Overall Study||23
225950|NCT01171898|547375|P4|NOT COMPLETED|Overall Study||6
225951|NCT01171898|547376|P3|NOT COMPLETED|Overall Study||12
225952|NCT01171898|547377|P2|NOT COMPLETED|Overall Study||19
225953|NCT01171898|547378|P1|NOT COMPLETED|Overall Study||4
225954|NCT01171898|547375|P4|COMPLETED|Overall Study||15
225955|NCT01171898|547376|P3|COMPLETED|Overall Study||13
225956|NCT01171898|547377|P2|COMPLETED|Overall Study||32
225957|NCT01171898|547378|P1|COMPLETED|Overall Study||26
225958|NCT01171898|547375|P4|STARTED|Overall Study||21
225959|NCT01171898|547376|P3|STARTED|Overall Study||25
225960|NCT01171898|547377|P2|STARTED|Overall Study||51
225961|NCT01171898|547378|P1|STARTED|Overall Study||30
225962|NCT01171820|547402|P2|NOT COMPLETED|Overall Study||6
225963|NCT01171820|547403|P1|NOT COMPLETED|Overall Study||6
225964|NCT01171820|547402|P2|COMPLETED|Overall Study||212
225965|NCT01171820|547403|P1|COMPLETED|Overall Study||100
225966|NCT01171820|547402|P2|STARTED|Overall Study||218
225967|NCT01171820|547403|P1|STARTED|Overall Study||106
225968|NCT01171794|547459|P2|NOT COMPLETED|Overall Study||0
225969|NCT01171794|547460|P1|NOT COMPLETED|Overall Study||3
225970|NCT01171794|547459|P2|COMPLETED|Overall Study||42
225971|NCT01171794|547460|P1|COMPLETED|Overall Study||44
225972|NCT01171794|547459|P2|STARTED|Overall Study||42
225973|NCT01171794|547460|P1|STARTED|Overall Study||47
225974|NCT01171690|547470|P2|NOT COMPLETED|Overall Study||0
225975|NCT01171690|547471|P1|NOT COMPLETED|Overall Study||0
225976|NCT01171690|547470|P2|COMPLETED|Overall Study||5
225977|NCT01171690|547471|P1|COMPLETED|Overall Study||5
225978|NCT01171690|547470|P2|STARTED|Overall Study||5
225979|NCT01171690|547471|P1|STARTED|Overall Study||5
225980|NCT01171677|547481|P2|NOT COMPLETED|Overall Study||3
225981|NCT01171677|547482|P1|NOT COMPLETED|Overall Study||6
225982|NCT01171677|547481|P2|COMPLETED|Overall Study||12
225983|NCT01171677|547482|P1|COMPLETED|Overall Study||11
225984|NCT01171677|547481|P2|STARTED|Overall Study||15
225985|NCT01171677|547482|P1|STARTED|Overall Study||17
225986|NCT01171612|547514|P1|NOT COMPLETED|Overall Study||51
225987|NCT01171612|547514|P1|COMPLETED|Overall Study||432
225988|NCT01171612|547514|P1|STARTED|Overall Study||483
225989|NCT01171534|547524|P2|NOT COMPLETED|Overall Study||3
225990|NCT01171534|547525|P1|NOT COMPLETED|Overall Study||0
225991|NCT01171534|547524|P2|COMPLETED|Overall Study||4
225992|NCT01171534|547525|P1|COMPLETED|Overall Study||0
225993|NCT01171534|547524|P2|STARTED|Overall Study||7
225994|NCT01171534|547525|P1|STARTED|Overall Study|retrospective arm never performed on study|0
225995|NCT01171521|547537|P1|NOT COMPLETED|Overall Study||6
225996|NCT01171521|547537|P1|COMPLETED|Overall Study||0
225997|NCT01171521|547537|P1|STARTED|Overall Study||6
225998|NCT01171183|547544|P2|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||5
225999|NCT01171183|547545|P1|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||10
226000|NCT01171183|547544|P2|COMPLETED|Outpatient Participation (Weeks 3-10)||4
226001|NCT01171183|547545|P1|COMPLETED|Outpatient Participation (Weeks 3-10)||2
226002|NCT01171183|547544|P2|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but was discharged due to protocol noncompliance.|9
226003|NCT01171183|547545|P1|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but withdrew prior to starting the outpatient phase.|12
226004|NCT01171183|547544|P2|NOT COMPLETED|Residential Facility (Weeks 1-2)||6
226005|NCT01171183|547545|P1|NOT COMPLETED|Residential Facility (Weeks 1-2)||2
226006|NCT01171183|547544|P2|COMPLETED|Residential Facility (Weeks 1-2)||10
226007|NCT01171183|547545|P1|COMPLETED|Residential Facility (Weeks 1-2)||13
226008|NCT01171183|547544|P2|STARTED|Residential Facility (Weeks 1-2)|Subjects receiving at least one dose of study med. One did not due to BP outside study parameters.|16
226009|NCT01171183|547545|P1|STARTED|Residential Facility (Weeks 1-2)|Those who were admitted to the residential facility and received at least one dose of study med.|15
226010|NCT01171118|547553|P1|NOT COMPLETED|Overall Study||0
226011|NCT01171118|547553|P1|COMPLETED|Overall Study||10
226012|NCT01171118|547553|P1|STARTED|Overall Study||10
226013|NCT01170962|547566|P3|NOT COMPLETED|Follow up Period||6
226014|NCT01170962|547567|P2|NOT COMPLETED|Follow up Period||27
226015|NCT01170962|547568|P1|NOT COMPLETED|Follow up Period||39
226016|NCT01170962|547566|P3|COMPLETED|Follow up Period||9
226017|NCT01170962|547567|P2|COMPLETED|Follow up Period||165
226018|NCT01170962|547568|P1|COMPLETED|Follow up Period||159
226019|NCT01170962|547566|P3|STARTED|Follow up Period|Out of 17 participants who entered the treatment period, 15 continued in the follow-up period.|15
226020|NCT01170962|547567|P2|STARTED|Follow up Period|Out of 199 participants who entered the treatment period, 192 continued in the follow-up period.|192
226021|NCT01170962|547568|P1|STARTED|Follow up Period|Out of 203 participants who entered the treatment period, 198 continued in the follow-up period.|198
226022|NCT01170962|547566|P3|NOT COMPLETED|Treatment Period||12
226023|NCT01170962|547567|P2|NOT COMPLETED|Treatment Period||111
226024|NCT01170962|547568|P1|NOT COMPLETED|Treatment Period||127
226025|NCT01170962|547566|P3|COMPLETED|Treatment Period||5
226026|NCT01170962|547567|P2|COMPLETED|Treatment Period||88
226027|NCT01170962|547568|P1|COMPLETED|Treatment Period||76
226028|NCT01170962|547566|P3|PDR ­Randomized to 48 Weeks Follow­-up|Treatment Period||0
226029|NCT01170962|547567|P2|PDR ­Randomized to 48 Weeks Follow­-up|Treatment Period||36
226030|NCT01170962|547568|P1|PDR ­Randomized to 48 Weeks Follow­-up|Treatment Period||28
226031|NCT01170962|547566|P3|PDR ­Randomized to 24 Weeks pegIFNα­-2a|Treatment Period||0
226032|NCT01170962|547567|P2|PDR ­Randomized to 24 Weeks pegIFNα­-2a|Treatment Period||36
226033|NCT01170962|547568|P1|PDR ­Randomized to 24 Weeks pegIFNα­-2a|Treatment Period||30
226034|NCT01170962|547566|P3|No PDR|Treatment Period||17
226035|NCT01170962|547567|P2|No PDR|Treatment Period||127
226036|NCT01170962|547568|P1|No PDR|Treatment Period||145
226037|NCT01170962|547566|P3|STARTED|Treatment Period||17
226038|NCT01170962|547567|P2|STARTED|Treatment Period||199
226039|NCT01170962|547568|P1|STARTED|Treatment Period||203
226040|NCT01170949|547614|P2|NOT COMPLETED|Overall Study||4
226041|NCT01170949|547615|P1|NOT COMPLETED|Overall Study||7
226042|NCT01170949|547614|P2|COMPLETED|Overall Study||22
226043|NCT01170949|547615|P1|COMPLETED|Overall Study||43
226044|NCT01170949|547614|P2|STARTED|Overall Study||26
226045|NCT01170949|547615|P1|STARTED|Overall Study||50
226046|NCT01170884|547623|P2|NOT COMPLETED|Overall Study||2
226047|NCT01170884|547624|P1|NOT COMPLETED|Overall Study||5
226048|NCT01170884|547623|P2|COMPLETED|Overall Study||60
226049|NCT01170884|547624|P1|COMPLETED|Overall Study||54
226050|NCT01170884|547623|P2|STARTED|Overall Study||62
226051|NCT01170884|547624|P1|STARTED|Overall Study||59
226052|NCT01170754|547632|P2|NOT COMPLETED|Overall Study||0
226053|NCT01170754|547633|P1|NOT COMPLETED|Overall Study||0
226054|NCT01170754|547632|P2|COMPLETED|Overall Study||70
226055|NCT01170754|547633|P1|COMPLETED|Overall Study||66
226056|NCT01170754|547632|P2|STARTED|Overall Study||70
226057|NCT01170754|547633|P1|STARTED|Overall Study||66
226058|NCT01170663|547663|P2|NOT COMPLETED|Overall Study||20
226059|NCT01170663|547664|P1|NOT COMPLETED|Overall Study||14
226060|NCT01170663|547663|P2|COMPLETED|Overall Study||315
226061|NCT01170663|547664|P1|COMPLETED|Overall Study||316
226062|NCT01170663|547663|P2|Received Any Treatment (Safety Pop)|Overall Study||329
226063|NCT01170663|547664|P1|Received Any Treatment (Safety Pop)|Overall Study||327
226064|NCT01170663|547663|P2|STARTED|Overall Study|Participant was included in the placebo/paclitaxel treatment arm (intent-to-treat (ITT) population).|335
226065|NCT01170663|547664|P1|STARTED|Overall Study|Participant was included in ramucirumab (IMC-1121B)/paclitaxel treatment arm (safety population).|330
226066|NCT01170598|547692|P1|NOT COMPLETED|Overall Study||6
226067|NCT01170598|547692|P1|COMPLETED|Overall Study||29
226068|NCT01170598|547692|P1|STARTED|Overall Study||35
226069|NCT01170546|547711|P4|NOT COMPLETED|Overall Study||0
226070|NCT01170546|547712|P3|NOT COMPLETED|Overall Study||0
226071|NCT01170546|547713|P2|NOT COMPLETED|Overall Study||0
226072|NCT01170546|547714|P1|NOT COMPLETED|Overall Study||0
226073|NCT01170546|547711|P4|COMPLETED|Overall Study||8
226074|NCT01170546|547712|P3|COMPLETED|Overall Study||6
226075|NCT01170546|547713|P2|COMPLETED|Overall Study||7
226076|NCT01170546|547714|P1|COMPLETED|Overall Study||7
226077|NCT01170546|547711|P4|STARTED|Overall Study||8
226078|NCT01170546|547712|P3|STARTED|Overall Study||6
226079|NCT01170546|547713|P2|STARTED|Overall Study||7
226080|NCT01170546|547714|P1|STARTED|Overall Study||7
226081|NCT01170533|547724|P2|NOT COMPLETED|Pantoprazole Cross-over||0
226082|NCT01170533|547725|P1|NOT COMPLETED|Pantoprazole Cross-over||0
226083|NCT01170533|547724|P2|COMPLETED|Pantoprazole Cross-over||20
226084|NCT01170533|547725|P1|COMPLETED|Pantoprazole Cross-over||0
226085|NCT01170533|547724|P2|STARTED|Pantoprazole Cross-over|15 participants continued from omeprazole cross-over; the remaining 5 were new participants|20
226086|NCT01170533|547725|P1|STARTED|Pantoprazole Cross-over||0
226087|NCT01170533|547724|P2|NOT COMPLETED|Omeprazole Cross-over||0
226088|NCT01170533|547725|P1|NOT COMPLETED|Omeprazole Cross-over||0
226089|NCT01170533|547724|P2|COMPLETED|Omeprazole Cross-over||0
226090|NCT01170533|547725|P1|COMPLETED|Omeprazole Cross-over||20
226091|NCT01170533|547724|P2|STARTED|Omeprazole Cross-over||0
226092|NCT01170533|547725|P1|STARTED|Omeprazole Cross-over||20
226093|NCT01170390|547737|P3|NOT COMPLETED|Randomized Treatment||0
226094|NCT01170390|547738|P2|NOT COMPLETED|Randomized Treatment||1
226095|NCT01170390|547739|P1|NOT COMPLETED|Randomized Treatment||0
226096|NCT01170390|547737|P3|COMPLETED|Randomized Treatment||15
226097|NCT01170390|547738|P2|COMPLETED|Randomized Treatment||16
226098|NCT01170390|547739|P1|COMPLETED|Randomized Treatment||0
226099|NCT01170390|547737|P3|STARTED|Randomized Treatment||15
226100|NCT01170390|547738|P2|STARTED|Randomized Treatment||17
226101|NCT01170390|547739|P1|STARTED|Randomized Treatment||0
226102|NCT01170390|547737|P3|NOT COMPLETED|Oral Contraceptives||0
226103|NCT01170390|547738|P2|NOT COMPLETED|Oral Contraceptives||0
226104|NCT01170390|547739|P1|NOT COMPLETED|Oral Contraceptives||1
226105|NCT01170390|547737|P3|COMPLETED|Oral Contraceptives||0
226106|NCT01170390|547738|P2|COMPLETED|Oral Contraceptives||0
226107|NCT01170390|547739|P1|COMPLETED|Oral Contraceptives||31
226108|NCT01170390|547737|P3|STARTED|Oral Contraceptives||0
226109|NCT01170390|547738|P2|STARTED|Oral Contraceptives||0
226110|NCT01170390|547739|P1|STARTED|Oral Contraceptives||32
226111|NCT01170364|547755|P2|NOT COMPLETED|Overall Study||1
226112|NCT01170364|547756|P1|NOT COMPLETED|Overall Study||4
226113|NCT01170364|547755|P2|COMPLETED|Overall Study|One participant was unable to begin the second testing period due to scheduling conflicts.|5
226114|NCT01170364|547756|P1|COMPLETED|Overall Study||4
226115|NCT01170364|547755|P2|STARTED|Overall Study||6
226116|NCT01170364|547756|P1|STARTED|Overall Study||8
226117|NCT01170273|547764|P2|NOT COMPLETED|Overall Study||9
226118|NCT01170273|547765|P1|NOT COMPLETED|Overall Study||8
226119|NCT01170273|547764|P2|COMPLETED|Overall Study||57
226120|NCT01170273|547765|P1|COMPLETED|Overall Study||56
226121|NCT01170273|547764|P2|STARTED|Overall Study||66
226122|NCT01170273|547765|P1|STARTED|Overall Study||64
226123|NCT01170247|547773|P2|NOT COMPLETED|Overall Study||0
226124|NCT01170247|547774|P1|NOT COMPLETED|Overall Study||0
226125|NCT01170247|547773|P2|COMPLETED|Overall Study||1
226126|NCT01170247|547774|P1|COMPLETED|Overall Study||2
226127|NCT01170247|547773|P2|STARTED|Overall Study||1
226128|NCT01170247|547774|P1|STARTED|Overall Study||2
226129|NCT01170221|547782|P2|NOT COMPLETED|Overall Study||28
226130|NCT01170221|547783|P1|NOT COMPLETED|Overall Study||33
226131|NCT01170221|547782|P2|COMPLETED|Overall Study||307
226132|NCT01170221|547783|P1|COMPLETED|Overall Study||299
226133|NCT01170221|547782|P2|STARTED|Overall Study||335
226134|NCT01170221|547783|P1|STARTED|Overall Study||332
226135|NCT01170208|547806|P3|NOT COMPLETED|Overall Study||2
226136|NCT01170208|547807|P2|NOT COMPLETED|Overall Study||0
226137|NCT01170208|547808|P1|NOT COMPLETED|Overall Study||6
226138|NCT01170208|547806|P3|COMPLETED|Overall Study||4
226139|NCT01170208|547807|P2|COMPLETED|Overall Study||20
226140|NCT01170208|547808|P1|COMPLETED|Overall Study||14
226141|NCT01170208|547806|P3|STARTED|Overall Study||6
226142|NCT01170208|547807|P2|STARTED|Overall Study||20
226143|NCT01170208|547808|P1|STARTED|Overall Study||20
226144|NCT01170117|547818|P2|NOT COMPLETED|Overall Study||20
226145|NCT01170117|547819|P1|NOT COMPLETED|Overall Study||30
226146|NCT01170117|547818|P2|COMPLETED|Overall Study||55
226147|NCT01170117|547819|P1|COMPLETED|Overall Study||47
226148|NCT01170117|547818|P2|STARTED|Overall Study||75
226149|NCT01170117|547819|P1|STARTED|Overall Study||77
226150|NCT01170091|547827|P1|NOT COMPLETED|Overall Study||24
226151|NCT01170091|547827|P1|COMPLETED|Overall Study||627
226152|NCT01170091|547827|P1|STARTED|Overall Study||651
226153|NCT01170065|547837|P3|NOT COMPLETED|Overall Study||26
226154|NCT01170065|547838|P2|NOT COMPLETED|Overall Study||92
226155|NCT01170065|547839|P1|NOT COMPLETED|Overall Study||28
226156|NCT01170065|547837|P3|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow−up visit|9
226157|NCT01170065|547838|P2|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow−up visit|34
226158|NCT01170065|547839|P1|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow−up visit|9
226159|NCT01170065|547837|P3|STARTED|Overall Study||35
226160|NCT01170065|547838|P2|STARTED|Overall Study||126
226161|NCT01170065|547839|P1|STARTED|Overall Study||37
226162|NCT01170039|547870|P2|NOT COMPLETED|Overall Study||6
226163|NCT01170039|547871|P1|NOT COMPLETED|Overall Study||8
226164|NCT01170039|547870|P2|COMPLETED|Overall Study||33
226165|NCT01170039|547871|P1|COMPLETED|Overall Study||29
226166|NCT01170039|547870|P2|STARTED|Overall Study||39
226167|NCT01170039|547871|P1|STARTED|Overall Study||37
226168|NCT01169987|547883|P1|NOT COMPLETED|Overall Study||31
226169|NCT01169987|547883|P1|COMPLETED|Overall Study||160
226170|NCT01169987|547883|P1|STARTED|Overall Study||191
226171|NCT01169779|547949|P2|NOT COMPLETED|Overall Study||17
226172|NCT01169779|547950|P1|NOT COMPLETED|Overall Study||11
226173|NCT01169779|547949|P2|COMPLETED|Overall Study||179
226174|NCT01169779|547950|P1|COMPLETED|Overall Study||184
226175|NCT01169779|547949|P2|Subgroup for Standardized Meal Test|Overall Study||121
226176|NCT01169779|547950|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|130
226177|NCT01169779|547949|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||195
226178|NCT01169779|547950|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|193
226179|NCT01169779|547949|P2|Treated/Safety Population|Overall Study||196
226180|NCT01169779|547950|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|194
226181|NCT01169779|547949|P2|STARTED|Overall Study||196
226182|NCT01169779|547950|P1|STARTED|Overall Study|Randomized.|195
226183|NCT01169753|547976|P2|NOT COMPLETED|Overall Study||1
226184|NCT01169753|547977|P1|NOT COMPLETED|Overall Study||0
226185|NCT01169753|547976|P2|COMPLETED|Overall Study||0
226186|NCT01169753|547977|P1|COMPLETED|Overall Study||0
226187|NCT01169753|547976|P2|STARTED|Overall Study||1
226188|NCT01169753|547977|P1|STARTED|Overall Study||0
226189|NCT01169701|547985|P2|NOT COMPLETED|Overall Study||10
226190|NCT01169701|547986|P1|NOT COMPLETED|Overall Study||5
226191|NCT01169701|547985|P2|COMPLETED|Overall Study||25
226192|NCT01169701|547986|P1|COMPLETED|Overall Study||31
226193|NCT01169701|547985|P2|Intent to Treat (ITT) Set|Overall Study||28
226194|NCT01169701|547986|P1|Intent to Treat (ITT) Set|Overall Study||32
226195|NCT01169701|547985|P2|Safety Set|Overall Study||35
226196|NCT01169701|547986|P1|Safety Set|Overall Study||36
226197|NCT01169701|547985|P2|STARTED|Overall Study||35
226198|NCT01169701|547986|P1|STARTED|Overall Study||36
226199|NCT01169675|548023|P5|NOT COMPLETED|Overall Study||6
226200|NCT01169675|548024|P4|NOT COMPLETED|Overall Study||17
226201|NCT01169675|548025|P3|NOT COMPLETED|Overall Study||7
226202|NCT01169675|548026|P2|NOT COMPLETED|Overall Study||3
226203|NCT01169675|548027|P1|NOT COMPLETED|Overall Study||20
226204|NCT01169675|548023|P5|COMPLETED|Overall Study||0
226205|NCT01169675|548024|P4|COMPLETED|Overall Study||0
226206|NCT01169675|548025|P3|COMPLETED|Overall Study||0
226207|NCT01169675|548026|P2|COMPLETED|Overall Study||0
226208|NCT01169675|548027|P1|COMPLETED|Overall Study||0
226209|NCT01169675|548023|P5|STARTED|Overall Study||6
226210|NCT01169675|548024|P4|STARTED|Overall Study||17
226211|NCT01169675|548025|P3|STARTED|Overall Study||7
226212|NCT01169675|548026|P2|STARTED|Overall Study||3
226213|NCT01169675|548027|P1|STARTED|Overall Study||20
226214|NCT01169649|548064|P1|NOT COMPLETED|Overall Study||3
226215|NCT01169649|548064|P1|COMPLETED|Overall Study||8
226216|NCT01169649|548064|P1|STARTED|Overall Study||11
226217|NCT01169610|548068|P1|NOT COMPLETED|Overall Study||0
226218|NCT01169610|548068|P1|COMPLETED|Overall Study||1
226219|NCT01169610|548068|P1|STARTED|Overall Study||1
226220|NCT01169558|548076|P1|NOT COMPLETED|Overall Study||156
226221|NCT01169558|548076|P1|COMPLETED|Overall Study||6
226222|NCT01169558|548076|P1|STARTED|Overall Study||162
226223|NCT01169519|548083|P1|NOT COMPLETED|Overall Study||0
226224|NCT01169519|548083|P1|COMPLETED|Overall Study||21
226225|NCT01169519|548083|P1|STARTED|Overall Study|This was a pre-post study, All patients receiving a baseline assessment, also received sildenafil.|21
226226|NCT01169493|548101|P6|NOT COMPLETED|Period 3 (6 Months)||0
226227|NCT01169493|548102|P5|NOT COMPLETED|Period 3 (6 Months)||0
226228|NCT01169493|548103|P4|NOT COMPLETED|Period 3 (6 Months)||0
226229|NCT01169493|548104|P3|NOT COMPLETED|Period 3 (6 Months)||1
226230|NCT01169493|548105|P2|NOT COMPLETED|Period 3 (6 Months)||2
226231|NCT01169493|548106|P1|NOT COMPLETED|Period 3 (6 Months)||0
226232|NCT01169493|548101|P6|COMPLETED|Period 3 (6 Months)||2
226233|NCT01169493|548102|P5|COMPLETED|Period 3 (6 Months)||0
226234|NCT01169493|548103|P4|COMPLETED|Period 3 (6 Months)||0
226235|NCT01169493|548104|P3|COMPLETED|Period 3 (6 Months)||2
226236|NCT01169493|548105|P2|COMPLETED|Period 3 (6 Months)||1
226237|NCT01169493|548106|P1|COMPLETED|Period 3 (6 Months)||2
226238|NCT01169493|548101|P6|STARTED|Period 3 (6 Months)||2
226239|NCT01169493|548102|P5|STARTED|Period 3 (6 Months)||0
226240|NCT01169493|548103|P4|STARTED|Period 3 (6 Months)||0
226241|NCT01169493|548104|P3|STARTED|Period 3 (6 Months)||3
226242|NCT01169493|548105|P2|STARTED|Period 3 (6 Months)||3
226243|NCT01169493|548106|P1|STARTED|Period 3 (6 Months)||2
226244|NCT01169493|548101|P6|NOT COMPLETED|Period 2 (6 Months)||0
226245|NCT01169493|548102|P5|NOT COMPLETED|Period 2 (6 Months)||0
226246|NCT01169493|548103|P4|NOT COMPLETED|Period 2 (6 Months)||0
226247|NCT01169493|548104|P3|NOT COMPLETED|Period 2 (6 Months)||0
226248|NCT01169493|548105|P2|NOT COMPLETED|Period 2 (6 Months)||0
226249|NCT01169493|548106|P1|NOT COMPLETED|Period 2 (6 Months)||0
226250|NCT01169493|548101|P6|COMPLETED|Period 2 (6 Months)||2
226251|NCT01169493|548102|P5|COMPLETED|Period 2 (6 Months)||0
226252|NCT01169493|548103|P4|COMPLETED|Period 2 (6 Months)||0
226253|NCT01169493|548104|P3|COMPLETED|Period 2 (6 Months)||3
226254|NCT01169493|548105|P2|COMPLETED|Period 2 (6 Months)||3
226255|NCT01169493|548106|P1|COMPLETED|Period 2 (6 Months)||2
226256|NCT01169493|548101|P6|STARTED|Period 2 (6 Months)||2
226257|NCT01169493|548102|P5|STARTED|Period 2 (6 Months)||0
226258|NCT01169493|548103|P4|STARTED|Period 2 (6 Months)||0
226259|NCT01169493|548104|P3|STARTED|Period 2 (6 Months)||3
226260|NCT01169493|548105|P2|STARTED|Period 2 (6 Months)||3
226261|NCT01169493|548106|P1|STARTED|Period 2 (6 Months)||2
226262|NCT01169493|548101|P6|NOT COMPLETED|Period 1 (6 Months)||3
226263|NCT01169493|548102|P5|NOT COMPLETED|Period 1 (6 Months)||0
226264|NCT01169493|548103|P4|NOT COMPLETED|Period 1 (6 Months)||0
226265|NCT01169493|548104|P3|NOT COMPLETED|Period 1 (6 Months)||2
226266|NCT01169493|548105|P2|NOT COMPLETED|Period 1 (6 Months)||1
226267|NCT01169493|548106|P1|NOT COMPLETED|Period 1 (6 Months)||0
226268|NCT01169493|548101|P6|COMPLETED|Period 1 (6 Months)||2
226269|NCT01169493|548102|P5|COMPLETED|Period 1 (6 Months)||0
226270|NCT01169493|548103|P4|COMPLETED|Period 1 (6 Months)||0
226271|NCT01169493|548104|P3|COMPLETED|Period 1 (6 Months)||3
226272|NCT01169493|548105|P2|COMPLETED|Period 1 (6 Months)||3
226273|NCT01169493|548106|P1|COMPLETED|Period 1 (6 Months)||2
226274|NCT01169493|548101|P6|STARTED|Period 1 (6 Months)||5
226275|NCT01169493|548102|P5|STARTED|Period 1 (6 Months)||0
226276|NCT01169493|548103|P4|STARTED|Period 1 (6 Months)||0
226277|NCT01169493|548104|P3|STARTED|Period 1 (6 Months)||5
226278|NCT01169493|548105|P2|STARTED|Period 1 (6 Months)||4
226279|NCT01169493|548106|P1|STARTED|Period 1 (6 Months)||2
226280|NCT01169467|548137|P2|NOT COMPLETED|Overall Study||4
226281|NCT01169467|548138|P1|NOT COMPLETED|Overall Study||7
226282|NCT01169467|548137|P2|COMPLETED|Overall Study||36
226283|NCT01169467|548138|P1|COMPLETED|Overall Study||37
226284|NCT01169467|548137|P2|STARTED|Overall Study||40
226285|NCT01169467|548138|P1|STARTED|Overall Study||44
226286|NCT01169350|548152|P1|NOT COMPLETED|Overall Study||5
226287|NCT01169350|548152|P1|COMPLETED|Overall Study||3
226288|NCT01169350|548152|P1|STARTED|Overall Study||8
226289|NCT01169311|548159|P1|NOT COMPLETED|Overall Study||0
226290|NCT01169311|548159|P1|COMPLETED|Overall Study||27
226291|NCT01169311|548159|P1|STARTED|Overall Study||27
226292|NCT01169103|548173|P2|NOT COMPLETED|Overall Study||4
226293|NCT01169103|548174|P1|NOT COMPLETED|Overall Study||6
226294|NCT01169103|548173|P2|COMPLETED|Overall Study||7
226295|NCT01169103|548174|P1|COMPLETED|Overall Study||5
226296|NCT01169103|548173|P2|STARTED|Overall Study||11
226297|NCT01169103|548174|P1|STARTED|Overall Study||11
226298|NCT01169064|548190|P2|NOT COMPLETED|Overall Study||0
226299|NCT01169064|548191|P1|NOT COMPLETED|Overall Study||0
226300|NCT01169064|548190|P2|COMPLETED|Overall Study||236
226301|NCT01169064|548191|P1|COMPLETED|Overall Study||239
226302|NCT01169064|548190|P2|STARTED|Overall Study||236
226303|NCT01169064|548191|P1|STARTED|Overall Study||239
226304|NCT01169038|548201|P1|NOT COMPLETED|Overall Study||7
226305|NCT01169038|548201|P1|COMPLETED|Overall Study||8
226306|NCT01169038|548201|P1|STARTED|Overall Study||15
226307|NCT01168999|548209|P4|NOT COMPLETED|Overall Study||0
226308|NCT01168999|548210|P3|NOT COMPLETED|Overall Study||0
226309|NCT01168999|548211|P2|NOT COMPLETED|Overall Study||1
226310|NCT01168999|548212|P1|NOT COMPLETED|Overall Study||2
226311|NCT01168999|548209|P4|COMPLETED|Overall Study||28
226312|NCT01168999|548210|P3|COMPLETED|Overall Study||27
226313|NCT01168999|548211|P2|COMPLETED|Overall Study||26
226314|NCT01168999|548212|P1|COMPLETED|Overall Study||26
226315|NCT01168999|548209|P4|STARTED|Overall Study||28
226316|NCT01168999|548210|P3|STARTED|Overall Study||27
226317|NCT01168999|548211|P2|STARTED|Overall Study||27
226318|NCT01168999|548212|P1|STARTED|Overall Study||28
226319|NCT01168986|548257|P3|NOT COMPLETED|Overall Study||0
226320|NCT01168986|548258|P2|NOT COMPLETED|Overall Study||1
226321|NCT01168986|548259|P1|NOT COMPLETED|Overall Study||2
226322|NCT01168986|548257|P3|COMPLETED|Overall Study||21
226323|NCT01168986|548258|P2|COMPLETED|Overall Study||20
226324|NCT01168986|548259|P1|COMPLETED|Overall Study||18
226325|NCT01168986|548257|P3|STARTED|Overall Study||21
226326|NCT01168986|548258|P2|STARTED|Overall Study||21
226327|NCT01168986|548259|P1|STARTED|Overall Study||20
226328|NCT01168973|548278|P2|NOT COMPLETED|Overall Study||611
226329|NCT01168973|548279|P1|NOT COMPLETED|Overall Study||613
226330|NCT01168973|548278|P2|COMPLETED|Overall Study||14
226331|NCT01168973|548279|P1|COMPLETED|Overall Study||15
226332|NCT01168973|548278|P2|Received Any Quantity of Any Study Drug|Overall Study|Three participants randomized to placebo and docetaxel received 1 dose of ramucirumab in error.|621
226333|NCT01168973|548279|P1|Received Any Quantity of Any Study Drug|Overall Study||624
226334|NCT01168973|548278|P2|STARTED|Overall Study||625
226335|NCT01168973|548279|P1|STARTED|Overall Study||628
226336|NCT01168934|548300|P2|NOT COMPLETED|Second Intervention Period||0
226337|NCT01168934|548301|P1|NOT COMPLETED|Second Intervention Period||0
226338|NCT01168934|548300|P2|COMPLETED|Second Intervention Period||7
226339|NCT01168934|548301|P1|COMPLETED|Second Intervention Period||7
226340|NCT01168934|548300|P2|STARTED|Second Intervention Period||7
226341|NCT01168934|548301|P1|STARTED|Second Intervention Period||7
226342|NCT01168934|548300|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
226343|NCT01168934|548301|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
226344|NCT01168934|548300|P2|COMPLETED|Washout Period (at Least 14 Days)||7
226345|NCT01168934|548301|P1|COMPLETED|Washout Period (at Least 14 Days)||7
226346|NCT01168934|548300|P2|STARTED|Washout Period (at Least 14 Days)||7
226347|NCT01168934|548301|P1|STARTED|Washout Period (at Least 14 Days)||7
226348|NCT01168934|548300|P2|NOT COMPLETED|First Intervention Period||0
226349|NCT01168934|548301|P1|NOT COMPLETED|First Intervention Period||0
226350|NCT01168934|548300|P2|COMPLETED|First Intervention Period||7
226351|NCT01168934|548301|P1|COMPLETED|First Intervention Period||7
226352|NCT01168934|548300|P2|STARTED|First Intervention Period||7
226353|NCT01168934|548301|P1|STARTED|First Intervention Period||7
226354|NCT01168908|548335|P2|NOT COMPLETED|Open Label||1
226355|NCT01168908|548336|P1|NOT COMPLETED|Open Label||1
226356|NCT01168908|548335|P2|COMPLETED|Open Label||7
226357|NCT01168908|548336|P1|COMPLETED|Open Label||6
226358|NCT01168908|548335|P2|STARTED|Open Label||8
226359|NCT01168908|548336|P1|STARTED|Open Label||7
226360|NCT01168908|548335|P2|NOT COMPLETED|Double Blind, Placebo Controlled||2
226361|NCT01168908|548336|P1|NOT COMPLETED|Double Blind, Placebo Controlled||3
226362|NCT01168908|548335|P2|COMPLETED|Double Blind, Placebo Controlled||8
226363|NCT01168908|548336|P1|COMPLETED|Double Blind, Placebo Controlled||7
226364|NCT01168908|548335|P2|STARTED|Double Blind, Placebo Controlled||10
226365|NCT01168908|548336|P1|STARTED|Double Blind, Placebo Controlled||10
226366|NCT01168856|548354|P2|NOT COMPLETED|Overall Study||343
226367|NCT01168856|548355|P1|NOT COMPLETED|Overall Study||18
226368|NCT01168856|548354|P2|COMPLETED|Overall Study||215
226369|NCT01168856|548355|P1|COMPLETED|Overall Study||158
226370|NCT01168856|548354|P2|STARTED|Overall Study||558
226371|NCT01168856|548355|P1|STARTED|Overall Study||176
226372|NCT01168726|548415|P3|NOT COMPLETED|Overall Study||5
226373|NCT01168726|548416|P2|NOT COMPLETED|Overall Study||9
226374|NCT01168726|548417|P1|NOT COMPLETED|Overall Study||8
226375|NCT01168726|548415|P3|COMPLETED|Overall Study||128
226376|NCT01168726|548416|P2|COMPLETED|Overall Study||112
226377|NCT01168726|548417|P1|COMPLETED|Overall Study||103
226378|NCT01168726|548415|P3|STARTED|Overall Study||133
226379|NCT01168726|548416|P2|STARTED|Overall Study||121
226380|NCT01168726|548417|P1|STARTED|Overall Study||111
226381|NCT01168687|548436|P2|NOT COMPLETED|Overall Study||0
226382|NCT01168687|548437|P1|NOT COMPLETED|Overall Study||0
226383|NCT01168687|548436|P2|COMPLETED|Overall Study||23
226384|NCT01168687|548437|P1|COMPLETED|Overall Study||23
226385|NCT01168687|548436|P2|STARTED|Overall Study||23
226386|NCT01168687|548437|P1|STARTED|Overall Study||23
226387|NCT01168674|548443|P2|NOT COMPLETED|Overall Study||0
226388|NCT01168674|548444|P1|NOT COMPLETED|Overall Study||0
226389|NCT01168674|548443|P2|COMPLETED|Overall Study||24
226390|NCT01168674|548444|P1|COMPLETED|Overall Study||25
226391|NCT01168674|548443|P2|STARTED|Overall Study||24
226392|NCT01168674|548444|P1|STARTED|Overall Study||25
226393|NCT01168596|548453|P2|NOT COMPLETED|Overall Study||1
226394|NCT01168596|548454|P1|NOT COMPLETED|Overall Study||3
226395|NCT01168596|548453|P2|COMPLETED|Overall Study||13
226396|NCT01168596|548454|P1|COMPLETED|Overall Study||13
226397|NCT01168596|548453|P2|STARTED|Overall Study||14
226398|NCT01168596|548454|P1|STARTED|Overall Study||16
226399|NCT01168427|548498|P1|NOT COMPLETED|Overall Study||1
226400|NCT01168427|548498|P1|COMPLETED|Overall Study||65
226401|NCT01168427|548498|P1|STARTED|Overall Study||66
226402|NCT01168401|548514|P11|NOT COMPLETED|Overall Study||0
226403|NCT01168401|548515|P10|NOT COMPLETED|Overall Study||0
226404|NCT01168401|548516|P9|NOT COMPLETED|Overall Study||0
226405|NCT01168401|548517|P8|NOT COMPLETED|Overall Study||0
226406|NCT01168401|548518|P7|NOT COMPLETED|Overall Study||0
226407|NCT01168401|548519|P6|NOT COMPLETED|Overall Study||0
226408|NCT01168401|548520|P5|NOT COMPLETED|Overall Study||0
226409|NCT01168401|548521|P4|NOT COMPLETED|Overall Study||2
226410|NCT01168401|548522|P3|NOT COMPLETED|Overall Study||2
226411|NCT01168401|548523|P2|NOT COMPLETED|Overall Study||1
226412|NCT01168401|548524|P1|NOT COMPLETED|Overall Study||1
226413|NCT01168401|548514|P11|COMPLETED|Overall Study||8
226414|NCT01168401|548515|P10|COMPLETED|Overall Study||8
226415|NCT01168401|548516|P9|COMPLETED|Overall Study||9
226416|NCT01168401|548517|P8|COMPLETED|Overall Study||10
226417|NCT01168401|548518|P7|COMPLETED|Overall Study||10
226418|NCT01168401|548519|P6|COMPLETED|Overall Study||9
226419|NCT01168401|548520|P5|COMPLETED|Overall Study||9
226420|NCT01168401|548521|P4|COMPLETED|Overall Study||7
226421|NCT01168401|548522|P3|COMPLETED|Overall Study||8
226422|NCT01168401|548523|P2|COMPLETED|Overall Study||9
226423|NCT01168401|548524|P1|COMPLETED|Overall Study||9
226424|NCT01168401|548514|P11|STARTED|Overall Study||8
226425|NCT01168401|548515|P10|STARTED|Overall Study||8
226426|NCT01168401|548516|P9|STARTED|Overall Study||9
226427|NCT01168401|548517|P8|STARTED|Overall Study||10
226428|NCT01168401|548518|P7|STARTED|Overall Study||10
226429|NCT01168401|548519|P6|STARTED|Overall Study||9
226430|NCT01168401|548520|P5|STARTED|Overall Study||9
226431|NCT01168401|548521|P4|STARTED|Overall Study||9
226432|NCT01168401|548522|P3|STARTED|Overall Study||10
226433|NCT01168401|548523|P2|STARTED|Overall Study||10
226434|NCT01168401|548524|P1|STARTED|Overall Study||10
226435|NCT01168349|548757|P1|NOT COMPLETED|Overall Study||301
226436|NCT01168349|548757|P1|COMPLETED|Overall Study||754
226437|NCT01168349|548757|P1|STARTED|Overall Study||1055
226438|NCT01168232|548863|P1|NOT COMPLETED|Overall Study||8
226439|NCT01168232|548863|P1|COMPLETED|Overall Study|Eligible and treated patients|34
226440|NCT01168232|548863|P1|STARTED|Overall Study||42
226441|NCT01168219|548870|P1|NOT COMPLETED|Overall Study||5
226442|NCT01168219|548870|P1|COMPLETED|Overall Study||63
226443|NCT01168219|548870|P1|STARTED|Overall Study||68
226444|NCT01168024|548878|P2|NOT COMPLETED|Overall Study||0
226445|NCT01168024|548879|P1|NOT COMPLETED|Overall Study||0
226446|NCT01168024|548878|P2|COMPLETED|Overall Study||3
226447|NCT01168024|548879|P1|COMPLETED|Overall Study||13
226448|NCT01168024|548878|P2|STARTED|Overall Study||3
226449|NCT01168024|548879|P1|STARTED|Overall Study|13 tx/3 controls. Roll-ins occurred for product training, several more treatment cases than control.|13
226450|NCT01167907|548893|P2|NOT COMPLETED|Overall Study||1
226451|NCT01167907|548894|P1|NOT COMPLETED|Overall Study||2
226452|NCT01167907|548893|P2|COMPLETED|Overall Study||14
226453|NCT01167907|548894|P1|COMPLETED|Overall Study||15
226454|NCT01167907|548893|P2|STARTED|Overall Study||15
226455|NCT01167907|548894|P1|STARTED|Overall Study||17
226456|NCT01167881|548912|P2|NOT COMPLETED|Overall Study||191
226457|NCT01167881|548913|P1|NOT COMPLETED|Overall Study||159
226458|NCT01167881|548912|P2|COMPLETED|Overall Study||589
226459|NCT01167881|548913|P1|COMPLETED|Overall Study||610
226460|NCT01167881|548912|P2|Completed After 4 Years Treatment|Overall Study||462
226461|NCT01167881|548913|P1|Completed After 4 Years Treatment|Overall Study||515
226462|NCT01167881|548912|P2|Completed After 2 Years Treatment|Overall Study||127
226463|NCT01167881|548913|P1|Completed After 2 Years Treatment|Overall Study||95
226464|NCT01167881|548912|P2|STARTED|Overall Study||780
226465|NCT01167881|548913|P1|STARTED|Overall Study||769
226466|NCT01167829|548937|P1|NOT COMPLETED|Overall Study||0
226467|NCT01167829|548937|P1|COMPLETED|Overall Study||12
226468|NCT01167829|548937|P1|STARTED|Overall Study||12
226469|NCT01167712|548952|P2|NOT COMPLETED|Overall Study||0
226470|NCT01167712|548953|P1|NOT COMPLETED|Overall Study||0
226471|NCT01167712|548952|P2|COMPLETED|Overall Study||346
226472|NCT01167712|548953|P1|COMPLETED|Overall Study||346
226473|NCT01167712|548952|P2|STARTED|Overall Study||346
226474|NCT01167712|548953|P1|STARTED|Overall Study||346
226475|NCT01167634|548967|P4|NOT COMPLETED|Overall Study||4
226476|NCT01167634|548968|P3|NOT COMPLETED|Overall Study||3
226477|NCT01167634|548969|P2|NOT COMPLETED|Overall Study||4
226478|NCT01167634|548970|P1|NOT COMPLETED|Overall Study||2
226479|NCT01167634|548967|P4|COMPLETED|Overall Study||29
226480|NCT01167634|548968|P3|COMPLETED|Overall Study||30
226481|NCT01167634|548969|P2|COMPLETED|Overall Study||29
226482|NCT01167634|548970|P1|COMPLETED|Overall Study||31
226483|NCT01167634|548967|P4|STARTED|Overall Study||33
226484|NCT01167634|548968|P3|STARTED|Overall Study||33
226485|NCT01167634|548969|P2|STARTED|Overall Study||33
226486|NCT01167634|548970|P1|STARTED|Overall Study||33
226487|NCT01167608|548980|P1|NOT COMPLETED|Overall Study||114
226488|NCT01167608|548980|P1|COMPLETED|Overall Study||769
226489|NCT01167608|548980|P1|STARTED|Overall Study||883
226490|NCT01167582|548991|P2|NOT COMPLETED|Overall Study||1
226491|NCT01167582|548992|P1|NOT COMPLETED|Overall Study||0
226492|NCT01167582|548991|P2|COMPLETED|Overall Study||54
226493|NCT01167582|548992|P1|COMPLETED|Overall Study||55
226494|NCT01167582|548991|P2|STARTED|Overall Study||55
226495|NCT01167582|548992|P1|STARTED|Overall Study||55
226496|NCT01167504|549022|P1|NOT COMPLETED|Overall Study||3
226497|NCT01167504|549022|P1|COMPLETED|Overall Study||12
226498|NCT01167504|549022|P1|STARTED|Overall Study||15
226499|NCT01167452|549027|P1|NOT COMPLETED|Overall Study||0
226500|NCT01167452|549027|P1|COMPLETED|Overall Study||36
226501|NCT01167452|549027|P1|STARTED|Overall Study||36
226502|NCT01167426|549032|P1|NOT COMPLETED|Overall Study||10
226503|NCT01167426|549032|P1|COMPLETED|Overall Study||138
226504|NCT01167426|549032|P1|STARTED|Overall Study||148
226505|NCT01167257|549040|P2|NOT COMPLETED|Overall Study||3
226506|NCT01167257|549041|P1|NOT COMPLETED|Overall Study||3
226507|NCT01167257|549040|P2|COMPLETED|Overall Study||28
226508|NCT01167257|549041|P1|COMPLETED|Overall Study||28
226509|NCT01167257|549040|P2|STARTED|Overall Study||31
226510|NCT01167257|549041|P1|STARTED|Overall Study||31
226511|NCT01167192|549063|P1|NOT COMPLETED|Overall Study||4
226512|NCT01167192|549063|P1|COMPLETED|Overall Study||6
226513|NCT01167192|549063|P1|STARTED|Overall Study||10
226514|NCT01167179|549080|P2|NOT COMPLETED|Overall Study||21
226515|NCT01167179|549081|P1|NOT COMPLETED|Overall Study||15
226516|NCT01167179|549080|P2|COMPLETED|Overall Study||59
226517|NCT01167179|549081|P1|COMPLETED|Overall Study||65
226518|NCT01167179|549080|P2|STARTED|Overall Study||80
226519|NCT01167179|549081|P1|STARTED|Overall Study||80
226520|NCT01167153|549091|P2|NOT COMPLETED|Overall Study||33
226521|NCT01167153|549092|P1|NOT COMPLETED|Overall Study||18
226522|NCT01167153|549091|P2|COMPLETED|Overall Study||249
226523|NCT01167153|549092|P1|COMPLETED|Overall Study||264
226524|NCT01167153|549091|P2|Intention to Treat (ITT)|Overall Study||268
226525|NCT01167153|549092|P1|Intention to Treat (ITT)|Overall Study||272
226526|NCT01167153|549091|P2|STARTED|Overall Study||282
226527|NCT01167153|549092|P1|STARTED|Overall Study||282
226528|NCT01167140|549110|P1|NOT COMPLETED|Overall Study||1
226529|NCT01167140|549110|P1|COMPLETED|Overall Study||41
226530|NCT01167140|549110|P1|STARTED|Overall Study||42
226531|NCT01167023|549118|P3|NOT COMPLETED|Overall Study||2
226532|NCT01167023|549119|P2|NOT COMPLETED|Overall Study||3
226533|NCT01167023|549120|P1|NOT COMPLETED|Overall Study||0
226534|NCT01167023|549118|P3|COMPLETED|Overall Study||39
226535|NCT01167023|549119|P2|COMPLETED|Overall Study||18
226536|NCT01167023|549120|P1|COMPLETED|Overall Study||0
226537|NCT01167023|549118|P3|Received at Least 1 Dose of Study Drug|Overall Study||41
226538|NCT01167023|549119|P2|Received at Least 1 Dose of Study Drug|Overall Study||19
226539|NCT01167023|549120|P1|Received at Least 1 Dose of Study Drug|Overall Study||0
226540|NCT01167023|549118|P3|STARTED|Overall Study||41
226541|NCT01167023|549119|P2|STARTED|Overall Study||21
226542|NCT01167023|549120|P1|STARTED|Overall Study||0
226543|NCT01166997|549140|P2|NOT COMPLETED|Overall Study||0
226544|NCT01166997|549141|P1|NOT COMPLETED|Overall Study||2
226545|NCT01166997|549140|P2|COMPLETED|Overall Study||30
226546|NCT01166997|549141|P1|COMPLETED|Overall Study||27
226547|NCT01166997|549140|P2|STARTED|Overall Study||30
226548|NCT01166997|549141|P1|STARTED|Overall Study||29
226549|NCT01166971|549151|P2|NOT COMPLETED|Overall Study||1
226550|NCT01166971|549152|P1|NOT COMPLETED|Overall Study||1
226551|NCT01166971|549151|P2|COMPLETED|Overall Study||30
226552|NCT01166971|549152|P1|COMPLETED|Overall Study||32
226553|NCT01166971|549151|P2|STARTED|Overall Study||31
226554|NCT01166971|549152|P1|STARTED|Overall Study||33
226555|NCT01166958|549160|P2|NOT COMPLETED|Overall Study||0
226556|NCT01166958|549161|P1|NOT COMPLETED|Overall Study||1
226557|NCT01166958|549160|P2|COMPLETED|Overall Study||13
226558|NCT01166958|549161|P1|COMPLETED|Overall Study||12
226559|NCT01166958|549160|P2|STARTED|Overall Study||13
226560|NCT01166958|549161|P1|STARTED|Overall Study||13
226561|NCT01166945|549177|P2|NOT COMPLETED|Day 30||3
226562|NCT01166945|549178|P1|NOT COMPLETED|Day 30||4
226563|NCT01166945|549177|P2|COMPLETED|Day 30||37
226564|NCT01166945|549178|P1|COMPLETED|Day 30||38
226565|NCT01166945|549177|P2|STARTED|Day 30||40
226566|NCT01166945|549178|P1|STARTED|Day 30||42
226567|NCT01166945|549177|P2|NOT COMPLETED|Day 20||0
226568|NCT01166945|549178|P1|NOT COMPLETED|Day 20||0
226569|NCT01166945|549177|P2|COMPLETED|Day 20||40
226570|NCT01166945|549178|P1|COMPLETED|Day 20||42
226571|NCT01166945|549177|P2|STARTED|Day 20||40
226572|NCT01166945|549178|P1|STARTED|Day 20||42
226573|NCT01166945|549177|P2|NOT COMPLETED|Day 15||1
226574|NCT01166945|549178|P1|NOT COMPLETED|Day 15||2
226575|NCT01166945|549177|P2|COMPLETED|Day 15||40
226576|NCT01166945|549178|P1|COMPLETED|Day 15||42
226577|NCT01166945|549177|P2|STARTED|Day 15||41
226578|NCT01166945|549178|P1|STARTED|Day 15||44
226579|NCT01166945|549177|P2|NOT COMPLETED|Day 10||2
226580|NCT01166945|549178|P1|NOT COMPLETED|Day 10||3
226581|NCT01166945|549177|P2|COMPLETED|Day 10||41
226582|NCT01166945|549178|P1|COMPLETED|Day 10||44
226583|NCT01166945|549177|P2|STARTED|Day 10||43
226584|NCT01166945|549178|P1|STARTED|Day 10||47
226585|NCT01166945|549177|P2|NOT COMPLETED|Day 5||0
226586|NCT01166945|549178|P1|NOT COMPLETED|Day 5||0
226587|NCT01166945|549177|P2|COMPLETED|Day 5||43
226588|NCT01166945|549178|P1|COMPLETED|Day 5||47
226589|NCT01166945|549177|P2|STARTED|Day 5||43
226590|NCT01166945|549178|P1|STARTED|Day 5||47
226591|NCT01166945|549177|P2|NOT COMPLETED|Randomized||4
226592|NCT01166945|549178|P1|NOT COMPLETED|Randomized||4
226593|NCT01166945|549177|P2|COMPLETED|Randomized||43
226594|NCT01166945|549178|P1|COMPLETED|Randomized||47
226595|NCT01166945|549177|P2|STARTED|Randomized||47
226596|NCT01166945|549178|P1|STARTED|Randomized||51
226597|NCT01166763|549186|P1|NOT COMPLETED|Overall Study||3
226598|NCT01166763|549186|P1|COMPLETED|Overall Study||27
226599|NCT01166763|549186|P1|STARTED|Overall Study||30
226600|NCT01166750|549194|P2|NOT COMPLETED|Overall Study||0
226601|NCT01166750|549195|P1|NOT COMPLETED|Overall Study||1
226602|NCT01166750|549194|P2|COMPLETED|Overall Study||13
226603|NCT01166750|549195|P1|COMPLETED|Overall Study||9
226604|NCT01166750|549194|P2|STARTED|Overall Study||13
226605|NCT01166750|549195|P1|STARTED|Overall Study||10
226606|NCT01166724|549203|P2|NOT COMPLETED|Overall Study||5
226607|NCT01166724|549204|P1|NOT COMPLETED|Overall Study||7
226608|NCT01166724|549203|P2|COMPLETED|Overall Study||0
226609|NCT01166724|549204|P1|COMPLETED|Overall Study||0
226610|NCT01166724|549203|P2|STARTED|Overall Study||5
226611|NCT01166724|549204|P1|STARTED|Overall Study||7
226612|NCT01166659|549212|P1|NOT COMPLETED|Overall Study||13
226613|NCT01166659|549212|P1|COMPLETED|Overall Study||35
226614|NCT01166659|549212|P1|STARTED|Overall Study||48
226615|NCT01166646|549221|P2|NOT COMPLETED|Overall Study||1
226616|NCT01166646|549222|P1|NOT COMPLETED|Overall Study||1
226617|NCT01166646|549221|P2|COMPLETED|Overall Study||21
226618|NCT01166646|549222|P1|COMPLETED|Overall Study||20
226619|NCT01166646|549221|P2|STARTED|Overall Study||22
226620|NCT01166646|549222|P1|STARTED|Overall Study||21
226621|NCT01166568|549241|P3|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
226622|NCT01166568|549242|P2|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
226623|NCT01166568|549243|P1|NOT COMPLETED|Implantation- Nonrandomized & Randomized||14
226624|NCT01166568|549241|P3|COMPLETED|Implantation- Nonrandomized & Randomized|(1) Primary eye implanted only subject withdrew consent after implantation of the device.|8
226625|NCT01166568|549242|P2|COMPLETED|Implantation- Nonrandomized & Randomized||32
226626|NCT01166568|549243|P1|COMPLETED|Implantation- Nonrandomized & Randomized||274
226627|NCT01166568|549241|P3|STARTED|Implantation- Nonrandomized & Randomized|15 subjects completed the observation phase and 9 subjects (17 eyes) proceeded with implantation.|9
226628|NCT01166568|549242|P2|STARTED|Implantation- Nonrandomized & Randomized||33
226629|NCT01166568|549243|P1|STARTED|Implantation- Nonrandomized & Randomized||288
226630|NCT01166568|549241|P3|NOT COMPLETED|Deferred Implantation- Randomized||1
226631|NCT01166568|549242|P2|NOT COMPLETED|Deferred Implantation- Randomized||0
226632|NCT01166568|549243|P1|NOT COMPLETED|Deferred Implantation- Randomized||0
226633|NCT01166568|549241|P3|COMPLETED|Deferred Implantation- Randomized|From the randomized sub-study control group (n=16), 1 subject withdrew during the observation phase|15
226634|NCT01166568|549242|P2|COMPLETED|Deferred Implantation- Randomized||0
226635|NCT01166568|549243|P1|COMPLETED|Deferred Implantation- Randomized||0
226636|NCT01166568|549241|P3|STARTED|Deferred Implantation- Randomized||16
226637|NCT01166568|549242|P2|STARTED|Deferred Implantation- Randomized||0
226638|NCT01166568|549243|P1|STARTED|Deferred Implantation- Randomized||0
226639|NCT01166438|549256|P2|NOT COMPLETED|Off Treatment Follow-up Phase||56
226640|NCT01166438|549257|P1|NOT COMPLETED|Off Treatment Follow-up Phase||34
226641|NCT01166438|549256|P2|COMPLETED|Off Treatment Follow-up Phase||33
226642|NCT01166438|549257|P1|COMPLETED|Off Treatment Follow-up Phase||51
226643|NCT01166438|549256|P2|STARTED|Off Treatment Follow-up Phase||89
226644|NCT01166438|549257|P1|STARTED|Off Treatment Follow-up Phase||85
226645|NCT01166438|549256|P2|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
226646|NCT01166438|549257|P1|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
226647|NCT01166438|549256|P2|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|118
226648|NCT01166438|549257|P1|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|113
226649|NCT01166438|549256|P2|Treated|Double-blind Phase: 1st 6 Months||126
226650|NCT01166438|549257|P1|Treated|Double-blind Phase: 1st 6 Months||121
226651|NCT01166438|549256|P2|STARTED|Double-blind Phase: 1st 6 Months||127
226652|NCT01166438|549257|P1|STARTED|Double-blind Phase: 1st 6 Months||122
226653|NCT01166347|549273|P2|NOT COMPLETED|Overall Study||1
226654|NCT01166347|549274|P1|NOT COMPLETED|Overall Study||2
226655|NCT01166347|549273|P2|COMPLETED|Overall Study||148
226656|NCT01166347|549274|P1|COMPLETED|Overall Study||295
226657|NCT01166347|549273|P2|STARTED|Overall Study||149
226658|NCT01166347|549274|P1|STARTED|Overall Study||297
226659|NCT01166282|549306|P3|NOT COMPLETED|Open-label Period||17
226660|NCT01166282|549307|P2|NOT COMPLETED|Open-label Period||0
226661|NCT01166282|549308|P1|NOT COMPLETED|Open-label Period||0
226662|NCT01166282|549306|P3|COMPLETED|Open-label Period||29
226663|NCT01166282|549307|P2|COMPLETED|Open-label Period||0
226664|NCT01166282|549308|P1|COMPLETED|Open-label Period||0
226665|NCT01166282|549306|P3|STARTED|Open-label Period||46
226666|NCT01166282|549307|P2|STARTED|Open-label Period||0
226667|NCT01166282|549308|P1|STARTED|Open-label Period||0
226668|NCT01166282|549306|P3|NOT COMPLETED|Double-blind Period||0
226669|NCT01166282|549307|P2|NOT COMPLETED|Double-blind Period||0
226670|NCT01166282|549308|P1|NOT COMPLETED|Double-blind Period||0
226671|NCT01166282|549306|P3|COMPLETED|Double-blind Period||0
226672|NCT01166282|549307|P2|COMPLETED|Double-blind Period||31
226673|NCT01166282|549308|P1|COMPLETED|Double-blind Period||15
226674|NCT01166282|549306|P3|STARTED|Double-blind Period||0
226675|NCT01166282|549307|P2|STARTED|Double-blind Period||31
226676|NCT01166282|549308|P1|STARTED|Double-blind Period||15
226677|NCT01166230|549332|P2|NOT COMPLETED|Overall Study||16
226678|NCT01166230|549333|P1|NOT COMPLETED|Overall Study||19
226679|NCT01166230|549332|P2|COMPLETED|Overall Study||255
226680|NCT01166230|549333|P1|COMPLETED|Overall Study||261
226681|NCT01166230|549332|P2|STARTED|Overall Study||271
226682|NCT01166230|549333|P1|STARTED|Overall Study||280
226683|NCT01166178|549347|P2|NOT COMPLETED|Overall Study||8
226684|NCT01166178|549348|P1|NOT COMPLETED|Overall Study||21
226685|NCT01166178|549347|P2|COMPLETED|Overall Study||0
226686|NCT01166178|549348|P1|COMPLETED|Overall Study||0
226687|NCT01166178|549347|P2|STARTED|Overall Study||8
226688|NCT01166178|549348|P1|STARTED|Overall Study||21
226689|NCT01166139|549374|P1|NOT COMPLETED|Overall Study||3
226690|NCT01166139|549374|P1|COMPLETED|Overall Study||7
226691|NCT01166139|549374|P1|STARTED|Overall Study||10
226692|NCT01166126|549380|P1|NOT COMPLETED|Overall Study||0
226693|NCT01166126|549380|P1|COMPLETED|Overall Study||4
226694|NCT01166126|549380|P1|STARTED|Overall Study||4
226695|NCT01165996|549387|P1|NOT COMPLETED|Overall Study||2
226696|NCT01165996|549387|P1|COMPLETED|Overall Study||23
226697|NCT01165996|549387|P1|Maintenance Phase|Overall Study||23
226698|NCT01165996|549387|P1|Induction Phase|Overall Study||25
226699|NCT01165996|549387|P1|STARTED|Overall Study||25
226700|NCT01165983|549399|P2|NOT COMPLETED|Overall Study||7
226701|NCT01165983|549400|P1|NOT COMPLETED|Overall Study||5
226702|NCT01165983|549399|P2|COMPLETED|Overall Study||42
226703|NCT01165983|549400|P1|COMPLETED|Overall Study||46
226704|NCT01165983|549399|P2|STARTED|Overall Study||49
226705|NCT01165983|549400|P1|STARTED|Overall Study||51
226706|NCT01165840|549444|P1|NOT COMPLETED|Overall Study||0
226707|NCT01165840|549444|P1|COMPLETED|Overall Study||36
226708|NCT01165840|549444|P1|STARTED|Overall Study||36
226709|NCT01165775|549448|P1|NOT COMPLETED|Overall Study||2
226710|NCT01165775|549448|P1|COMPLETED|Overall Study||15
226711|NCT01165775|549448|P1|STARTED|Overall Study||17
226712|NCT01165684|549458|P2|NOT COMPLETED|Overall Study||52
226713|NCT01165684|549459|P1|NOT COMPLETED|Overall Study||28
226714|NCT01165684|549458|P2|COMPLETED|Overall Study||148
226715|NCT01165684|549459|P1|COMPLETED|Overall Study||173
226716|NCT01165684|549458|P2|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|199
226717|NCT01165684|549459|P1|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|198
226718|NCT01165684|549458|P2|STARTED|Overall Study||200
226719|NCT01165684|549459|P1|STARTED|Overall Study||201
226720|NCT01165554|549493|P1|NOT COMPLETED|Overall Study||23
226721|NCT01165554|549493|P1|COMPLETED|Overall Study||180
226722|NCT01165554|549493|P1|STARTED|Overall Study|This was the number of subjects that started the study.|203
226723|NCT01165541|549500|P1|NOT COMPLETED|Quetiapine XR and Mirtazepine||5
226724|NCT01165541|549500|P1|COMPLETED|Quetiapine XR and Mirtazepine||11
226725|NCT01165541|549500|P1|STARTED|Quetiapine XR and Mirtazepine||16
226726|NCT01165541|549500|P1|NOT COMPLETED|Quetiapine XR Monotherapy||4
226727|NCT01165541|549500|P1|COMPLETED|Quetiapine XR Monotherapy||16
226728|NCT01165541|549500|P1|STARTED|Quetiapine XR Monotherapy||20
226729|NCT01165450|549506|P1|NOT COMPLETED|Overall Study||0
226730|NCT01165450|549506|P1|COMPLETED|Overall Study||2
226731|NCT01165450|549506|P1|STARTED|Overall Study||2
226732|NCT01165424|549516|P1|NOT COMPLETED|Overall Study||4
226733|NCT01165424|549516|P1|COMPLETED|Overall Study||76
226734|NCT01165424|549516|P1|STARTED|Overall Study||80
226735|NCT01165320|549523|P3|NOT COMPLETED|Overall Study||0
226736|NCT01165320|549524|P2|NOT COMPLETED|Overall Study||4
226737|NCT01165320|549525|P1|NOT COMPLETED|Overall Study||3
226738|NCT01165320|549523|P3|COMPLETED|Overall Study||0
226739|NCT01165320|549524|P2|COMPLETED|Overall Study||4
226740|NCT01165320|549525|P1|COMPLETED|Overall Study||9
226741|NCT01165320|549523|P3|STARTED|Overall Study|No participants with esophageal candidiasis were identified for inclusion in the study|0
226742|NCT01165320|549524|P2|STARTED|Overall Study||8
226743|NCT01165320|549525|P1|STARTED|Overall Study||12
226744|NCT01165307|549535|P2|NOT COMPLETED|Overall Study||3
226745|NCT01165307|549536|P1|NOT COMPLETED|Overall Study||14
226746|NCT01165307|549535|P2|COMPLETED|Overall Study||31
226747|NCT01165307|549536|P1|COMPLETED|Overall Study||19
226748|NCT01165307|549535|P2|STARTED|Overall Study||34
226749|NCT01165307|549536|P1|STARTED|Overall Study||33
226750|NCT01165281|549566|P2|NOT COMPLETED|Overall Study||51
226751|NCT01165281|549567|P1|NOT COMPLETED|Overall Study||58
226752|NCT01165281|549566|P2|COMPLETED|Overall Study||121
226753|NCT01165281|549567|P1|COMPLETED|Overall Study||110
226754|NCT01165281|549566|P2|STARTED|Overall Study||172
226755|NCT01165281|549567|P1|STARTED|Overall Study||168
226756|NCT01165242|549588|P3|NOT COMPLETED|Overall Study||14
226757|NCT01165242|549589|P2|NOT COMPLETED|Overall Study||10
226758|NCT01165242|549590|P1|NOT COMPLETED|Overall Study||10
226759|NCT01165242|549588|P3|COMPLETED|Overall Study||324
226760|NCT01165242|549589|P2|COMPLETED|Overall Study||326
226761|NCT01165242|549590|P1|COMPLETED|Overall Study||327
226762|NCT01165242|549588|P3|STARTED|Overall Study||338
226763|NCT01165242|549589|P2|STARTED|Overall Study||336
226764|NCT01165242|549590|P1|STARTED|Overall Study||337
226765|NCT01165229|549624|P2|NOT COMPLETED|Overall Study||1189
226766|NCT01165229|549625|P1|NOT COMPLETED|Overall Study||1180
226767|NCT01165229|549624|P2|COMPLETED|Overall Study||5761
226768|NCT01165229|549625|P1|COMPLETED|Overall Study||5770
226769|NCT01165229|549624|P2|STARTED|Overall Study||6950
226770|NCT01165229|549625|P1|STARTED|Overall Study||6950
226771|NCT01165216|549753|P2|NOT COMPLETED|Overall Study||7
226772|NCT01165216|549754|P1|NOT COMPLETED|Overall Study||8
226773|NCT01165216|549753|P2|COMPLETED|Overall Study|Completed=still on study drug|0
226774|NCT01165216|549754|P1|COMPLETED|Overall Study|Completed=still on study drug|0
226775|NCT01165216|549753|P2|Received at Least 1 Dose of Ipilimumab|Overall Study||6
226776|NCT01165216|549754|P1|Received at Least 1 Dose of Ipilimumab|Overall Study||6
226777|NCT01165216|549753|P2|STARTED|Overall Study|Participants who received any study drug|7
226778|NCT01165216|549754|P1|STARTED|Overall Study|Participants who received any study drug|8
226779|NCT01165203|549776|P2|NOT COMPLETED|Extended Safety Follow-up Phase||4
226780|NCT01165203|549777|P1|NOT COMPLETED|Extended Safety Follow-up Phase||7
226781|NCT01165203|549776|P2|COMPLETED|Extended Safety Follow-up Phase||45
226782|NCT01165203|549777|P1|COMPLETED|Extended Safety Follow-up Phase||67
226783|NCT01165203|549776|P2|STARTED|Extended Safety Follow-up Phase||49
226784|NCT01165203|549777|P1|STARTED|Extended Safety Follow-up Phase||74
226785|NCT01165203|549776|P2|NOT COMPLETED|Active Phase||2
226786|NCT01165203|549777|P1|NOT COMPLETED|Active Phase||5
226787|NCT01165203|549776|P2|COMPLETED|Active Phase||47
226788|NCT01165203|549777|P1|COMPLETED|Active Phase||69
226789|NCT01165203|549776|P2|STARTED|Active Phase||49
226790|NCT01165203|549777|P1|STARTED|Active Phase||74
226791|NCT01165177|549867|P2|NOT COMPLETED|Overall Study||902
226792|NCT01165177|549868|P1|NOT COMPLETED|Overall Study||922
226793|NCT01165177|549867|P2|COMPLETED|Overall Study||6808
226794|NCT01165177|549868|P1|COMPLETED|Overall Study||6773
226795|NCT01165177|549867|P2|STARTED|Overall Study||7710
226796|NCT01165177|549868|P1|STARTED|Overall Study||7695
226797|NCT01165138|549993|P4|NOT COMPLETED|Overall Study||22
226798|NCT01165138|549994|P3|NOT COMPLETED|Overall Study||20
226799|NCT01165138|549995|P2|NOT COMPLETED|Overall Study||52
226800|NCT01165138|549996|P1|NOT COMPLETED|Overall Study||0
226801|NCT01165138|549993|P4|COMPLETED|Overall Study||179
226802|NCT01165138|549994|P3|COMPLETED|Overall Study||185
226803|NCT01165138|549995|P2|COMPLETED|Overall Study||151
226804|NCT01165138|549996|P1|COMPLETED|Overall Study||0
226805|NCT01165138|549993|P4|STARTED|Overall Study||201
226806|NCT01165138|549994|P3|STARTED|Overall Study||205
226807|NCT01165138|549995|P2|STARTED|Overall Study||203
226808|NCT01165138|549996|P1|STARTED|Overall Study||0
226809|NCT01165112|550055|P1|NOT COMPLETED|Overall Study||0
226810|NCT01165112|550055|P1|COMPLETED|Overall Study||48
226811|NCT01165112|550055|P1|STARTED|Overall Study||48
226812|NCT01165047|550062|P1|NOT COMPLETED|Overall Study||0
226813|NCT01165047|550062|P1|COMPLETED|Overall Study||10
226814|NCT01165047|550062|P1|STARTED|Overall Study||10
226815|NCT01165021|550066|P1|NOT COMPLETED|Overall Study||1
226816|NCT01165021|550066|P1|COMPLETED|Overall Study||18
226817|NCT01165021|550066|P1|3 Cycles of Chemo, Then Surgery|Overall Study||15
226818|NCT01165021|550066|P1|≥1 Dose Chemo, Baseline, Cy 3 Assessment|Overall Study||17
226819|NCT01165021|550066|P1|≥1 Dose Chemo|Overall Study||19
226820|NCT01165021|550066|P1|STARTED|Overall Study||19
226821|NCT01164956|550074|P3|NOT COMPLETED|Overall Study||1
226822|NCT01164956|550075|P2|NOT COMPLETED|Overall Study||0
226823|NCT01164956|550076|P1|NOT COMPLETED|Overall Study||1
226824|NCT01164956|550074|P3|COMPLETED|Overall Study||0
226825|NCT01164956|550075|P2|COMPLETED|Overall Study||1
226826|NCT01164956|550076|P1|COMPLETED|Overall Study||0
226827|NCT01164956|550074|P3|Evaluable for pedsFACIT-F Score Change|Overall Study||0
226828|NCT01164956|550075|P2|Evaluable for pedsFACIT-F Score Change|Overall Study||1
226829|NCT01164956|550076|P1|Evaluable for pedsFACIT-F Score Change|Overall Study||0
226830|NCT01164956|550074|P3|STARTED|Overall Study||1
226831|NCT01164956|550075|P2|STARTED|Overall Study||1
226832|NCT01164956|550076|P1|STARTED|Overall Study||1
226833|NCT01164891|550084|P1|NOT COMPLETED|Overall Study||6
226834|NCT01164891|550084|P1|COMPLETED|Overall Study||1
226835|NCT01164891|550084|P1|STARTED|Overall Study||7
226836|NCT01164865|550104|P2|NOT COMPLETED|Overall Study||1
226837|NCT01164865|550105|P1|NOT COMPLETED|Overall Study||2
226838|NCT01164865|550104|P2|COMPLETED|Overall Study||38
226839|NCT01164865|550105|P1|COMPLETED|Overall Study||37
226840|NCT01164865|550104|P2|STARTED|Overall Study||39
226841|NCT01164865|550105|P1|STARTED|Overall Study||39
226842|NCT01164722|550115|P2|NOT COMPLETED|Overall Study||15
226843|NCT01164722|550116|P1|NOT COMPLETED|Overall Study||18
226844|NCT01164722|550115|P2|COMPLETED|Overall Study||45
226845|NCT01164722|550116|P1|COMPLETED|Overall Study||42
226846|NCT01164722|550115|P2|STARTED|Overall Study||60
226847|NCT01164722|550116|P1|STARTED|Overall Study||60
226848|NCT01164644|550132|P2|NOT COMPLETED|Overall Study||1
226849|NCT01164644|550133|P1|NOT COMPLETED|Overall Study||3
226850|NCT01164644|550132|P2|COMPLETED|Overall Study||13
226851|NCT01164644|550133|P1|COMPLETED|Overall Study||9
226852|NCT01164644|550132|P2|STARTED|Overall Study||14
226853|NCT01164644|550133|P1|STARTED|Overall Study||12
226854|NCT01164579|550146|P3|NOT COMPLETED|Overall Study||16
226855|NCT01164579|550147|P2|NOT COMPLETED|Overall Study||9
226856|NCT01164579|550148|P1|NOT COMPLETED|Overall Study||8
226857|NCT01164579|550146|P3|COMPLETED|Overall Study||21
226858|NCT01164579|550147|P2|COMPLETED|Overall Study||27
226859|NCT01164579|550148|P1|COMPLETED|Overall Study||28
226860|NCT01164579|550146|P3|STARTED|Overall Study||37
226861|NCT01164579|550147|P2|STARTED|Overall Study||36
226862|NCT01164579|550148|P1|STARTED|Overall Study||36
226863|NCT01164501|550228|P3|NOT COMPLETED|Overall Study||42
226864|NCT01164501|550229|P2|NOT COMPLETED|Overall Study||10
226865|NCT01164501|550230|P1|NOT COMPLETED|Overall Study||43
226866|NCT01164501|550228|P3|COMPLETED|Overall Study||280
226867|NCT01164501|550229|P2|COMPLETED|Overall Study||88
226868|NCT01164501|550230|P1|COMPLETED|Overall Study||278
226869|NCT01164501|550228|P3|STARTED|Overall Study||322
226870|NCT01164501|550229|P2|STARTED|Overall Study||98
226871|NCT01164501|550230|P1|STARTED|Overall Study||321
226872|NCT01164475|550247|P2|NOT COMPLETED|Overall Study||2
226873|NCT01164475|550248|P1|NOT COMPLETED|Overall Study||2
226874|NCT01164475|550247|P2|COMPLETED|Overall Study||29
226875|NCT01164475|550248|P1|COMPLETED|Overall Study||28
226876|NCT01164475|550247|P2|STARTED|Overall Study||31
226877|NCT01164475|550248|P1|STARTED|Overall Study||30
226878|NCT01164137|550274|P2|NOT COMPLETED|Overall Study||0
226879|NCT01164137|550275|P1|NOT COMPLETED|Overall Study||3
226880|NCT01164137|550274|P2|COMPLETED|Overall Study||76
226881|NCT01164137|550275|P1|COMPLETED|Overall Study||77
226882|NCT01164137|550274|P2|STARTED|Overall Study||76
226883|NCT01164137|550275|P1|STARTED|Overall Study||80
226884|NCT01164098|550291|P2|NOT COMPLETED|Overall Study||0
226885|NCT01164098|550292|P1|NOT COMPLETED|Overall Study||0
226886|NCT01164098|550291|P2|COMPLETED|Overall Study||15
226887|NCT01164098|550292|P1|COMPLETED|Overall Study||15
226888|NCT01164098|550291|P2|STARTED|Overall Study||15
226889|NCT01164098|550292|P1|STARTED|Overall Study||15
226890|NCT01164007|550302|P1|NOT COMPLETED|Overall Study||40
226891|NCT01164007|550302|P1|COMPLETED|Overall Study||0
226892|NCT01164007|550302|P1|Treated|Overall Study||37
226893|NCT01164007|550302|P1|STARTED|Overall Study||40
226894|NCT01163955|550318|P2|NOT COMPLETED|Overall Study||4
226895|NCT01163955|550319|P1|NOT COMPLETED|Overall Study||0
226896|NCT01163955|550318|P2|COMPLETED|Overall Study||26
226897|NCT01163955|550319|P1|COMPLETED|Overall Study||26
226898|NCT01163955|550318|P2|STARTED|Overall Study||30
226899|NCT01163955|550319|P1|STARTED|Overall Study||26
226900|NCT01163916|550328|P3|NOT COMPLETED|Overall Study||20
226901|NCT01163916|550329|P2|NOT COMPLETED|Overall Study||4
226902|NCT01163916|550330|P1|NOT COMPLETED|Overall Study||30
226903|NCT01163916|550328|P3|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|71
226904|NCT01163916|550329|P2|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|31
226905|NCT01163916|550330|P1|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|96
226906|NCT01163916|550328|P3|Safety Population|Overall Study||91
226907|NCT01163916|550329|P2|Safety Population|Overall Study||35
226908|NCT01163916|550330|P1|Safety Population|Overall Study|One patient discontinued prior to receiving treatment with adalimumab due to absence of medication.|125
226909|NCT01163916|550328|P3|STARTED|Overall Study||91
226910|NCT01163916|550329|P2|STARTED|Overall Study||35
226911|NCT01163916|550330|P1|STARTED|Overall Study||126
226912|NCT01163851|550368|P2|NOT COMPLETED|Overall Study||1
226913|NCT01163851|550369|P1|NOT COMPLETED|Overall Study||1
226914|NCT01163851|550368|P2|COMPLETED|Overall Study||11
226915|NCT01163851|550369|P1|COMPLETED|Overall Study||12
226916|NCT01163851|550368|P2|Treated|Overall Study||12
226917|NCT01163851|550369|P1|Treated|Overall Study||12
226918|NCT01163851|550368|P2|STARTED|Overall Study||12
226919|NCT01163851|550369|P1|STARTED|Overall Study||13
226920|NCT01163760|550447|P4|NOT COMPLETED|Period 4 (Follow-up)||0
226921|NCT01163760|550448|P3|NOT COMPLETED|Period 4 (Follow-up)||0
226922|NCT01163760|550449|P2|NOT COMPLETED|Period 4 (Follow-up)||0
226923|NCT01163760|550450|P1|NOT COMPLETED|Period 4 (Follow-up)||0
226924|NCT01163760|550447|P4|COMPLETED|Period 4 (Follow-up)||12
226925|NCT01163760|550448|P3|COMPLETED|Period 4 (Follow-up)||13
226926|NCT01163760|550449|P2|COMPLETED|Period 4 (Follow-up)||13
226927|NCT01163760|550450|P1|COMPLETED|Period 4 (Follow-up)||12
226928|NCT01163760|550447|P4|STARTED|Period 4 (Follow-up)||12
226929|NCT01163760|550448|P3|STARTED|Period 4 (Follow-up)||13
226930|NCT01163760|550449|P2|STARTED|Period 4 (Follow-up)||13
226931|NCT01163760|550450|P1|STARTED|Period 4 (Follow-up)||12
226932|NCT01163760|550447|P4|NOT COMPLETED|Period 3 (Fit)||0
226933|NCT01163760|550448|P3|NOT COMPLETED|Period 3 (Fit)||0
226934|NCT01163760|550449|P2|NOT COMPLETED|Period 3 (Fit)||0
226935|NCT01163760|550450|P1|NOT COMPLETED|Period 3 (Fit)||0
226936|NCT01163760|550447|P4|COMPLETED|Period 3 (Fit)||12
226937|NCT01163760|550448|P3|COMPLETED|Period 3 (Fit)||13
226938|NCT01163760|550449|P2|COMPLETED|Period 3 (Fit)||13
226939|NCT01163760|550450|P1|COMPLETED|Period 3 (Fit)||12
226940|NCT01163760|550447|P4|STARTED|Period 3 (Fit)||12
226941|NCT01163760|550448|P3|STARTED|Period 3 (Fit)||13
226942|NCT01163760|550449|P2|STARTED|Period 3 (Fit)||13
226943|NCT01163760|550450|P1|STARTED|Period 3 (Fit)||12
226944|NCT01163760|550447|P4|NOT COMPLETED|Period 2 (Follow-up)||0
226945|NCT01163760|550448|P3|NOT COMPLETED|Period 2 (Follow-up)||0
226946|NCT01163760|550449|P2|NOT COMPLETED|Period 2 (Follow-up)||0
226947|NCT01163760|550450|P1|NOT COMPLETED|Period 2 (Follow-up)||0
226948|NCT01163760|550447|P4|COMPLETED|Period 2 (Follow-up)||12
226949|NCT01163760|550448|P3|COMPLETED|Period 2 (Follow-up)||13
226950|NCT01163760|550449|P2|COMPLETED|Period 2 (Follow-up)||13
226951|NCT01163760|550450|P1|COMPLETED|Period 2 (Follow-up)||12
226952|NCT01163760|550447|P4|STARTED|Period 2 (Follow-up)||12
226953|NCT01163760|550448|P3|STARTED|Period 2 (Follow-up)||13
226954|NCT01163760|550449|P2|STARTED|Period 2 (Follow-up)||13
226955|NCT01163760|550450|P1|STARTED|Period 2 (Follow-up)||12
226956|NCT01163760|550447|P4|NOT COMPLETED|Period 1 (Fit)||0
226957|NCT01163760|550448|P3|NOT COMPLETED|Period 1 (Fit)||0
226958|NCT01163760|550449|P2|NOT COMPLETED|Period 1 (Fit)||0
226959|NCT01163760|550450|P1|NOT COMPLETED|Period 1 (Fit)||0
226960|NCT01163760|550447|P4|COMPLETED|Period 1 (Fit)||12
226961|NCT01163760|550448|P3|COMPLETED|Period 1 (Fit)||13
226962|NCT01163760|550449|P2|COMPLETED|Period 1 (Fit)||13
226963|NCT01163760|550450|P1|COMPLETED|Period 1 (Fit)||12
226964|NCT01163760|550447|P4|STARTED|Period 1 (Fit)||12
226965|NCT01163760|550448|P3|STARTED|Period 1 (Fit)||13
226966|NCT01163760|550449|P2|STARTED|Period 1 (Fit)||13
226967|NCT01163760|550450|P1|STARTED|Period 1 (Fit)||12
226968|NCT01163747|550464|P2|NOT COMPLETED|Overall Study||11
226969|NCT01163747|550465|P1|NOT COMPLETED|Overall Study||6
226970|NCT01163747|550464|P2|COMPLETED|Overall Study||49
226971|NCT01163747|550465|P1|COMPLETED|Overall Study||25
226972|NCT01163747|550464|P2|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|54
226973|NCT01163747|550465|P1|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|27
226974|NCT01163747|550464|P2|STARTED|Overall Study||60
226975|NCT01163747|550465|P1|STARTED|Overall Study||31
226976|NCT01163721|550485|P2|NOT COMPLETED|Overall Study||12
226977|NCT01163721|550486|P1|NOT COMPLETED|Overall Study||8
226978|NCT01163721|550485|P2|COMPLETED|Overall Study||29
226979|NCT01163721|550486|P1|COMPLETED|Overall Study||31
226980|NCT01163721|550485|P2|STARTED|Overall Study||41
226981|NCT01163721|550486|P1|STARTED|Overall Study||39
226982|NCT01163656|550498|P2|NOT COMPLETED|Overall Study||3
226983|NCT01163656|550499|P1|NOT COMPLETED|Overall Study||3
226984|NCT01163656|550498|P2|COMPLETED|Overall Study||30
226985|NCT01163656|550499|P1|COMPLETED|Overall Study||30
226986|NCT01163656|550498|P2|STARTED|Overall Study||33
226987|NCT01163656|550499|P1|STARTED|Overall Study||33
226988|NCT01163617|550505|P8|NOT COMPLETED|Phase B (Injection Time), Week 4||0
226989|NCT01163617|550506|P7|NOT COMPLETED|Phase B (Injection Time), Week 4||0
226990|NCT01163617|550507|P6|NOT COMPLETED|Phase B (Injection Time), Week 4||0
226991|NCT01163617|550508|P5|NOT COMPLETED|Phase B (Injection Time), Week 4||0
226992|NCT01163617|550509|P4|NOT COMPLETED|Phase B (Injection Time), Week 4||0
226993|NCT01163617|550510|P3|NOT COMPLETED|Phase B (Injection Time), Week 4||0
226994|NCT01163617|550511|P2|NOT COMPLETED|Phase B (Injection Time), Week 4||0
226995|NCT01163617|550512|P1|NOT COMPLETED|Phase B (Injection Time), Week 4||0
226996|NCT01163617|550505|P8|COMPLETED|Phase B (Injection Time), Week 4||20
226997|NCT01163617|550506|P7|COMPLETED|Phase B (Injection Time), Week 4||16
226998|NCT01163617|550507|P6|COMPLETED|Phase B (Injection Time), Week 4||27
226999|NCT01163617|550508|P5|COMPLETED|Phase B (Injection Time), Week 4||18
227000|NCT01163617|550509|P4|COMPLETED|Phase B (Injection Time), Week 4||0
227001|NCT01163617|550510|P3|COMPLETED|Phase B (Injection Time), Week 4||0
227002|NCT01163617|550511|P2|COMPLETED|Phase B (Injection Time), Week 4||0
227003|NCT01163617|550512|P1|COMPLETED|Phase B (Injection Time), Week 4||0
227004|NCT01163617|550505|P8|STARTED|Phase B (Injection Time), Week 4||20
227005|NCT01163617|550506|P7|STARTED|Phase B (Injection Time), Week 4||16
227006|NCT01163617|550507|P6|STARTED|Phase B (Injection Time), Week 4||27
227007|NCT01163617|550508|P5|STARTED|Phase B (Injection Time), Week 4||18
227008|NCT01163617|550509|P4|STARTED|Phase B (Injection Time), Week 4||0
227009|NCT01163617|550510|P3|STARTED|Phase B (Injection Time), Week 4||0
227010|NCT01163617|550511|P2|STARTED|Phase B (Injection Time), Week 4||0
227011|NCT01163617|550512|P1|STARTED|Phase B (Injection Time), Week 4||0
227012|NCT01163617|550505|P8|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
227013|NCT01163617|550506|P7|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
227014|NCT01163617|550507|P6|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
227015|NCT01163617|550508|P5|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
227016|NCT01163617|550509|P4|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
227017|NCT01163617|550510|P3|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||1
227018|NCT01163617|550511|P2|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||2
227019|NCT01163617|550512|P1|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
227020|NCT01163617|550505|P8|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
227021|NCT01163617|550506|P7|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
227022|NCT01163617|550507|P6|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
227023|NCT01163617|550508|P5|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
227024|NCT01163617|550509|P4|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
227025|NCT01163617|550510|P3|COMPLETED|Phase A (User Experience), Weeks 0 and 2||20
227026|NCT01163617|550511|P2|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
227027|NCT01163617|550512|P1|COMPLETED|Phase A (User Experience), Weeks 0 and 2||19
227028|NCT01163617|550505|P8|STARTED|Phase A (User Experience), Weeks 0 and 2||0
227029|NCT01163617|550506|P7|STARTED|Phase A (User Experience), Weeks 0 and 2||0
227030|NCT01163617|550507|P6|STARTED|Phase A (User Experience), Weeks 0 and 2||0
227031|NCT01163617|550508|P5|STARTED|Phase A (User Experience), Weeks 0 and 2||0
227032|NCT01163617|550509|P4|STARTED|Phase A (User Experience), Weeks 0 and 2||21
227033|NCT01163617|550510|P3|STARTED|Phase A (User Experience), Weeks 0 and 2||21
227034|NCT01163617|550511|P2|STARTED|Phase A (User Experience), Weeks 0 and 2||23
227035|NCT01163617|550512|P1|STARTED|Phase A (User Experience), Weeks 0 and 2||19
227036|NCT01163604|550534|P2|NOT COMPLETED|Overall Study||0
227037|NCT01163604|550535|P1|NOT COMPLETED|Overall Study||0
227038|NCT01163604|550534|P2|COMPLETED|Overall Study|August 2011|56
227039|NCT01163604|550535|P1|COMPLETED|Overall Study|August 2011|58
227040|NCT01163604|550534|P2|STARTED|Overall Study|August 2010|56
227041|NCT01163604|550535|P1|STARTED|Overall Study|August 2010|58
227042|NCT01163474|550541|P1|NOT COMPLETED|Overall Study||16
227043|NCT01163474|550541|P1|COMPLETED|Overall Study||24
227044|NCT01163474|550541|P1|STARTED|Overall Study||40
227045|NCT01163461|550548|P2|NOT COMPLETED|Overall Study||0
227046|NCT01163461|550549|P1|NOT COMPLETED|Overall Study||0
227047|NCT01163461|550548|P2|COMPLETED|Overall Study||14
227048|NCT01163461|550549|P1|COMPLETED|Overall Study||14
227049|NCT01163461|550548|P2|STARTED|Overall Study||14
227050|NCT01163461|550549|P1|STARTED|Overall Study||14
227051|NCT01163318|550553|P1|NOT COMPLETED|Overall Study||268
227052|NCT01163318|550553|P1|COMPLETED|Overall Study||284
227053|NCT01163318|550553|P1|STARTED|Overall Study||552
227054|NCT01163292|550562|P2|NOT COMPLETED|Overall Study||22
227055|NCT01163292|550563|P1|NOT COMPLETED|Overall Study||41
227056|NCT01163292|550562|P2|COMPLETED|Overall Study||92
227057|NCT01163292|550563|P1|COMPLETED|Overall Study||65
227058|NCT01163292|550562|P2|STARTED|Overall Study||114
227059|NCT01163292|550563|P1|STARTED|Overall Study||106
227060|NCT01163279|550579|P2|NOT COMPLETED|Overall Study||0
227061|NCT01163279|550580|P1|NOT COMPLETED|Overall Study||2
227062|NCT01163279|550579|P2|COMPLETED|Overall Study||9
227063|NCT01163279|550580|P1|COMPLETED|Overall Study||8
227064|NCT01163279|550579|P2|STARTED|Overall Study||9
227065|NCT01163279|550580|P1|STARTED|Overall Study||10
227066|NCT01163266|550609|P3|NOT COMPLETED|Overall Study||28
227067|NCT01163266|550610|P2|NOT COMPLETED|Overall Study||31
227068|NCT01163266|550611|P1|NOT COMPLETED|Overall Study||18
227069|NCT01163266|550609|P3|COMPLETED|Overall Study||122
227070|NCT01163266|550610|P2|COMPLETED|Overall Study||124
227071|NCT01163266|550611|P1|COMPLETED|Overall Study||139
227072|NCT01163266|550609|P3|Treated|Overall Study||150
227073|NCT01163266|550610|P2|Treated|Overall Study||155
227074|NCT01163266|550611|P1|Treated|Overall Study||157
227075|NCT01163266|550609|P3|STARTED|Overall Study||150
227076|NCT01163266|550610|P2|STARTED|Overall Study||155
227077|NCT01163266|550611|P1|STARTED|Overall Study||157
227078|NCT01163253|550636|P2|NOT COMPLETED|Overall Study||586
227079|NCT01163253|550637|P1|NOT COMPLETED|Overall Study||2281
227080|NCT01163253|550636|P2|COMPLETED|Overall Study||0
227081|NCT01163253|550637|P1|COMPLETED|Overall Study||0
227082|NCT01163253|550636|P2|STARTED|Overall Study||586
227083|NCT01163253|550637|P1|STARTED|Overall Study||2281
227084|NCT01163214|550799|P2|NOT COMPLETED|Overall Study||0
227085|NCT01163214|550800|P1|NOT COMPLETED|Overall Study||0
227086|NCT01163214|550799|P2|COMPLETED|Overall Study||81
227087|NCT01163214|550800|P1|COMPLETED|Overall Study||79
227088|NCT01163214|550799|P2|STARTED|Overall Study||81
227089|NCT01163214|550800|P1|STARTED|Overall Study||79
227090|NCT01163162|550816|P1|NOT COMPLETED|Overall Study||0
227091|NCT01163162|550816|P1|COMPLETED|Overall Study||16
227092|NCT01163162|550816|P1|STARTED|Overall Study||16
227093|NCT01163149|550825|P3|NOT COMPLETED|Extension Treatment Period||2
227094|NCT01163149|550826|P2|NOT COMPLETED|Extension Treatment Period||1
227095|NCT01163149|550827|P1|NOT COMPLETED|Extension Treatment Period||2
227096|NCT01163149|550825|P3|COMPLETED|Extension Treatment Period||4
227097|NCT01163149|550826|P2|COMPLETED|Extension Treatment Period||5
227098|NCT01163149|550827|P1|COMPLETED|Extension Treatment Period||5
227099|NCT01163149|550825|P3|STARTED|Extension Treatment Period||6
227100|NCT01163149|550826|P2|STARTED|Extension Treatment Period||6
227101|NCT01163149|550827|P1|STARTED|Extension Treatment Period||7
227102|NCT01163149|550825|P3|NOT COMPLETED|Primary Treatment Period||0
227103|NCT01163149|550826|P2|NOT COMPLETED|Primary Treatment Period||0
227104|NCT01163149|550827|P1|NOT COMPLETED|Primary Treatment Period||0
227105|NCT01163149|550825|P3|COMPLETED|Primary Treatment Period||6
227106|NCT01163149|550826|P2|COMPLETED|Primary Treatment Period||6
227107|NCT01163149|550827|P1|COMPLETED|Primary Treatment Period||7
227108|NCT01163149|550825|P3|STARTED|Primary Treatment Period||6
227109|NCT01163149|550826|P2|STARTED|Primary Treatment Period||6
227110|NCT01163149|550827|P1|STARTED|Primary Treatment Period||7
227111|NCT01163097|550872|P3|NOT COMPLETED|Overall Study||0
227112|NCT01163097|550873|P2|NOT COMPLETED|Overall Study||0
227113|NCT01163097|550874|P1|NOT COMPLETED|Overall Study||6
227114|NCT01163097|550872|P3|COMPLETED|Overall Study||8
227115|NCT01163097|550873|P2|COMPLETED|Overall Study||16
227116|NCT01163097|550874|P1|COMPLETED|Overall Study||14
227117|NCT01163097|550872|P3|STARTED|Overall Study||8
227118|NCT01163097|550873|P2|STARTED|Overall Study||16
227119|NCT01163097|550874|P1|STARTED|Overall Study|15 subjects were successfully titrated and entered the palifermin treatment|20
227120|NCT01163084|550926|P2|NOT COMPLETED|Overall Study||0
227121|NCT01163084|550927|P1|NOT COMPLETED|Overall Study||0
227122|NCT01163084|550926|P2|COMPLETED|Overall Study||5
227123|NCT01163084|550927|P1|COMPLETED|Overall Study||4
227124|NCT01163084|550926|P2|STARTED|Overall Study||5
227125|NCT01163084|550927|P1|STARTED|Overall Study||4
227126|NCT01163032|550936|P3|NOT COMPLETED|Open Label Extension Phase||16
227127|NCT01163032|550937|P2|NOT COMPLETED|Open Label Extension Phase||0
227128|NCT01163032|550938|P1|NOT COMPLETED|Open Label Extension Phase||0
227129|NCT01163032|550936|P3|COMPLETED|Open Label Extension Phase||39
227130|NCT01163032|550937|P2|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
227131|NCT01163032|550938|P1|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
227132|NCT01163032|550936|P3|STARTED|Open Label Extension Phase|3 randomized patients rolled into extension (2 randomized to tasimelteon and one to placebo)|55
227133|NCT01163032|550937|P2|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
227134|NCT01163032|550938|P1|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
227135|NCT01163032|550936|P3|NOT COMPLETED|Randomization Phase||0
227136|NCT01163032|550937|P2|NOT COMPLETED|Randomization Phase||12
227137|NCT01163032|550938|P1|NOT COMPLETED|Randomization Phase||10
227138|NCT01163032|550936|P3|COMPLETED|Randomization Phase|Not applicable for Randomized Phase|0
227139|NCT01163032|550937|P2|COMPLETED|Randomization Phase||30
227140|NCT01163032|550938|P1|COMPLETED|Randomization Phase||32
227141|NCT01163032|550936|P3|STARTED|Randomization Phase|Not applicable for Randomized Phase|0
227142|NCT01163032|550937|P2|STARTED|Randomization Phase||42
227143|NCT01163032|550938|P1|STARTED|Randomization Phase||42
227144|NCT01162863|550971|P3|NOT COMPLETED|Overall Study||0
227145|NCT01162863|550972|P2|NOT COMPLETED|Overall Study||1
227146|NCT01162863|550973|P1|NOT COMPLETED|Overall Study||1
227147|NCT01162863|550971|P3|COMPLETED|Overall Study||17
227148|NCT01162863|550972|P2|COMPLETED|Overall Study||16
227149|NCT01162863|550973|P1|COMPLETED|Overall Study||17
227150|NCT01162863|550971|P3|STARTED|Overall Study||17
227151|NCT01162863|550972|P2|STARTED|Overall Study||17
227152|NCT01162863|550973|P1|STARTED|Overall Study||18
227153|NCT01162733|550989|P2|NOT COMPLETED|Overall Study||25
227154|NCT01162733|550990|P1|NOT COMPLETED|Overall Study||27
227155|NCT01162733|550989|P2|COMPLETED|Overall Study||25
227156|NCT01162733|550990|P1|COMPLETED|Overall Study||22
227157|NCT01162733|550989|P2|STARTED|Overall Study||50
227158|NCT01162733|550990|P1|STARTED|Overall Study||49
227159|NCT01162551|550998|P1|NOT COMPLETED|Overall Study||0
227160|NCT01162551|550998|P1|COMPLETED|Overall Study||3
227161|NCT01162551|550998|P1|STARTED|Overall Study|2 subjects were enrolled but withdrew before receiving any study treatment|3
227162|NCT01162499|551003|P2|NOT COMPLETED|Intervention 2 (4 Hours)||0
227163|NCT01162499|551004|P1|NOT COMPLETED|Intervention 2 (4 Hours)||0
227164|NCT01162499|551003|P2|COMPLETED|Intervention 2 (4 Hours)||3
227165|NCT01162499|551004|P1|COMPLETED|Intervention 2 (4 Hours)||3
227166|NCT01162499|551003|P2|STARTED|Intervention 2 (4 Hours)||3
227167|NCT01162499|551004|P1|STARTED|Intervention 2 (4 Hours)||3
227168|NCT01162499|551003|P2|NOT COMPLETED|Intervention 1 (4 Hours)||1
227169|NCT01162499|551004|P1|NOT COMPLETED|Intervention 1 (4 Hours)||0
227170|NCT01162499|551003|P2|COMPLETED|Intervention 1 (4 Hours)||3
227171|NCT01162499|551004|P1|COMPLETED|Intervention 1 (4 Hours)||3
227172|NCT01162499|551003|P2|Received Intervention|Intervention 1 (4 Hours)||3
227173|NCT01162499|551004|P1|Received Intervention|Intervention 1 (4 Hours)||3
227174|NCT01162499|551003|P2|STARTED|Intervention 1 (4 Hours)||4
227175|NCT01162499|551004|P1|STARTED|Intervention 1 (4 Hours)||3
227176|NCT01162486|551029|P5|NOT COMPLETED|Overall Study||0
227177|NCT01162486|551030|P4|NOT COMPLETED|Overall Study||1
227178|NCT01162486|551031|P3|NOT COMPLETED|Overall Study||1
227179|NCT01162486|551032|P2|NOT COMPLETED|Overall Study||0
227180|NCT01162486|551033|P1|NOT COMPLETED|Overall Study||2
227181|NCT01162486|551029|P5|COMPLETED|Overall Study||6
227182|NCT01162486|551030|P4|COMPLETED|Overall Study||6
227183|NCT01162486|551031|P3|COMPLETED|Overall Study||5
227184|NCT01162486|551032|P2|COMPLETED|Overall Study||6
227185|NCT01162486|551033|P1|COMPLETED|Overall Study||6
227186|NCT01162486|551029|P5|Took at Least One Dose Study Drug|Overall Study||6
227187|NCT01162486|551030|P4|Took at Least One Dose Study Drug|Overall Study||7
227188|NCT01162486|551031|P3|Took at Least One Dose Study Drug|Overall Study||6
227189|NCT01162486|551032|P2|Took at Least One Dose Study Drug|Overall Study||6
227190|NCT01162486|551033|P1|Took at Least One Dose Study Drug|Overall Study||8
227191|NCT01162486|551029|P5|STARTED|Overall Study||6
227192|NCT01162486|551030|P4|STARTED|Overall Study||7
227193|NCT01162486|551031|P3|STARTED|Overall Study||6
227194|NCT01162486|551032|P2|STARTED|Overall Study||6
227195|NCT01162486|551033|P1|STARTED|Overall Study||8
227196|NCT01162473|551066|P2|NOT COMPLETED|Overall Study||5
227197|NCT01162473|551067|P1|NOT COMPLETED|Overall Study||2
227198|NCT01162473|551066|P2|COMPLETED|Overall Study||12
227199|NCT01162473|551067|P1|COMPLETED|Overall Study||6
227200|NCT01162473|551066|P2|STARTED|Overall Study||17
227201|NCT01162473|551067|P1|STARTED|Overall Study||8
227202|NCT01162421|551075|P2|NOT COMPLETED|Overall Study||13
227203|NCT01162421|551076|P1|NOT COMPLETED|Overall Study||8
227204|NCT01162421|551075|P2|COMPLETED|Overall Study||27
227205|NCT01162421|551076|P1|COMPLETED|Overall Study||29
227206|NCT01162421|551075|P2|STARTED|Overall Study||40
227207|NCT01162421|551076|P1|STARTED|Overall Study||37
227208|NCT01162382|551154|P1|NOT COMPLETED|Overall Study||0
227209|NCT01162382|551154|P1|COMPLETED|Overall Study||0
227210|NCT01162382|551154|P1|STARTED|Overall Study||0
227211|NCT01162343|551159|P1|NOT COMPLETED|Overall Study||92
227212|NCT01162343|551159|P1|COMPLETED|Overall Study||406
227213|NCT01162343|551159|P1|STARTED|Overall Study||498
227214|NCT01162317|551165|P2|NOT COMPLETED|Overall Study||2
227215|NCT01162317|551166|P1|NOT COMPLETED|Overall Study||3
227216|NCT01162317|551165|P2|COMPLETED|Overall Study||28
227217|NCT01162317|551166|P1|COMPLETED|Overall Study||27
227218|NCT01162317|551165|P2|STARTED|Overall Study||30
227219|NCT01162317|551166|P1|STARTED|Overall Study||30
227220|NCT01162304|551174|P1|NOT COMPLETED|Overall Study||11
227221|NCT01162304|551174|P1|COMPLETED|Overall Study||7
227222|NCT01162304|551174|P1|STARTED|Overall Study||18
227223|NCT01162135|551188|P1|NOT COMPLETED|Overall Study||3
227224|NCT01162135|551188|P1|COMPLETED|Overall Study||13
227225|NCT01162135|551188|P1|STARTED|Overall Study||16
227226|NCT01162122|551194|P2|NOT COMPLETED|Overall Study||196
227227|NCT01162122|551195|P1|NOT COMPLETED|Overall Study||191
227228|NCT01162122|551194|P2|COMPLETED|Overall Study||3356
227229|NCT01162122|551195|P1|COMPLETED|Overall Study||3361
227230|NCT01162122|551194|P2|Vaccinated|Overall Study||3541
227231|NCT01162122|551195|P1|Vaccinated|Overall Study||3541
227232|NCT01162122|551194|P2|STARTED|Overall Study||3552
227233|NCT01162122|551195|P1|STARTED|Overall Study||3552
227234|NCT01162096|551252|P1|NOT COMPLETED|Overall Study||0
227235|NCT01162096|551252|P1|COMPLETED|Overall Study||34
227236|NCT01162096|551252|P1|STARTED|Overall Study||34
227237|NCT01162005|551260|P2|NOT COMPLETED|Overall Study||0
227238|NCT01162005|551261|P1|NOT COMPLETED|Overall Study||0
227239|NCT01162005|551260|P2|COMPLETED|Overall Study||33
227240|NCT01162005|551261|P1|COMPLETED|Overall Study||44
227241|NCT01162005|551260|P2|STARTED|Overall Study||33
227242|NCT01162005|551261|P1|STARTED|Overall Study||44
227243|NCT01161862|551271|P2|NOT COMPLETED|Overall Study||0
227244|NCT01161862|551272|P1|NOT COMPLETED|Overall Study||0
227245|NCT01161862|551271|P2|COMPLETED|Overall Study||12
227246|NCT01161862|551272|P1|COMPLETED|Overall Study||12
227247|NCT01161862|551271|P2|STARTED|Overall Study||12
227248|NCT01161862|551272|P1|STARTED|Overall Study||12
227249|NCT01161771|551292|P1|NOT COMPLETED|Overall Study||0
227250|NCT01161771|551292|P1|COMPLETED|Overall Study||32
227251|NCT01161771|551292|P1|STARTED|Overall Study||32
227252|NCT01161628|551301|P1|NOT COMPLETED|Overall Study||8
227253|NCT01161628|551301|P1|COMPLETED|Overall Study||17
227254|NCT01161628|551301|P1|STARTED|Overall Study||25
227255|NCT01161563|551315|P2|NOT COMPLETED|Overall Study||6
227256|NCT01161563|551316|P1|NOT COMPLETED|Overall Study||5
227257|NCT01161563|551315|P2|COMPLETED|Overall Study||49
227258|NCT01161563|551316|P1|COMPLETED|Overall Study||58
227259|NCT01161563|551315|P2|STARTED|Overall Study||55
227260|NCT01161563|551316|P1|STARTED|Overall Study||63
227261|NCT01161537|551324|P1|NOT COMPLETED|Part B||2
227262|NCT01161537|551324|P1|COMPLETED|Part B||7
227263|NCT01161537|551324|P1|STARTED|Part B|4 subjects from Part A continued in Part B of the study.|9
227264|NCT01161537|551324|P1|NOT COMPLETED|Part A||0
227265|NCT01161537|551324|P1|COMPLETED|Part A||8
227266|NCT01161537|551324|P1|STARTED|Part A||8
227267|NCT01161524|551342|P3|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||24
227268|NCT01161524|551343|P2|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||0
227269|NCT01161524|551344|P1|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||0
227270|NCT01161524|551342|P3|COMPLETED|Extension Phase (Approximately 83 Weeks)||90
227271|NCT01161524|551343|P2|COMPLETED|Extension Phase (Approximately 83 Weeks)||0
227272|NCT01161524|551344|P1|COMPLETED|Extension Phase (Approximately 83 Weeks)||0
227273|NCT01161524|551342|P3|STARTED|Extension Phase (Approximately 83 Weeks)||114
227274|NCT01161524|551343|P2|STARTED|Extension Phase (Approximately 83 Weeks)||0
227275|NCT01161524|551344|P1|STARTED|Extension Phase (Approximately 83 Weeks)||0
227276|NCT01161524|551342|P3|NOT COMPLETED|Core Study (23 Weeks)||0
227277|NCT01161524|551343|P2|NOT COMPLETED|Core Study (23 Weeks)||5
227278|NCT01161524|551344|P1|NOT COMPLETED|Core Study (23 Weeks)||9
227279|NCT01161524|551342|P3|COMPLETED|Core Study (23 Weeks)||0
227280|NCT01161524|551343|P2|COMPLETED|Core Study (23 Weeks)||43
227281|NCT01161524|551344|P1|COMPLETED|Core Study (23 Weeks)||76
227282|NCT01161524|551342|P3|STARTED|Core Study (23 Weeks)||0
227283|NCT01161524|551343|P2|STARTED|Core Study (23 Weeks)||48
227284|NCT01161524|551344|P1|STARTED|Core Study (23 Weeks)||85
227285|NCT01161498|551383|P2|NOT COMPLETED|Overall Study||1
227286|NCT01161498|551384|P1|NOT COMPLETED|Overall Study||0
227287|NCT01161498|551383|P2|COMPLETED|Overall Study||1
227288|NCT01161498|551384|P1|COMPLETED|Overall Study||3
227289|NCT01161498|551383|P2|STARTED|Overall Study||2
227290|NCT01161498|551384|P1|STARTED|Overall Study||3
227291|NCT01161472|551408|P4|NOT COMPLETED|Fourth Intervention Period||0
227292|NCT01161472|551409|P3|NOT COMPLETED|Fourth Intervention Period||0
227293|NCT01161472|551410|P2|NOT COMPLETED|Fourth Intervention Period||0
227294|NCT01161472|551411|P1|NOT COMPLETED|Fourth Intervention Period||0
227295|NCT01161472|551408|P4|COMPLETED|Fourth Intervention Period||5
227296|NCT01161472|551409|P3|COMPLETED|Fourth Intervention Period||5
227297|NCT01161472|551410|P2|COMPLETED|Fourth Intervention Period||5
227298|NCT01161472|551411|P1|COMPLETED|Fourth Intervention Period||4
227299|NCT01161472|551408|P4|STARTED|Fourth Intervention Period||5
227300|NCT01161472|551409|P3|STARTED|Fourth Intervention Period||5
227301|NCT01161472|551410|P2|STARTED|Fourth Intervention Period||5
227302|NCT01161472|551411|P1|STARTED|Fourth Intervention Period||4
227303|NCT01161472|551408|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
227304|NCT01161472|551409|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
227305|NCT01161472|551410|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
227306|NCT01161472|551411|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
227307|NCT01161472|551408|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
227308|NCT01161472|551409|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
227309|NCT01161472|551410|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
227310|NCT01161472|551411|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
227311|NCT01161472|551408|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
227312|NCT01161472|551409|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
227313|NCT01161472|551410|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
227314|NCT01161472|551411|P1|STARTED|Washout Period (At Least 3 to 6 Days)||4
227315|NCT01161472|551408|P4|NOT COMPLETED|Third Intervention Period||0
227316|NCT01161472|551409|P3|NOT COMPLETED|Third Intervention Period||0
227317|NCT01161472|551410|P2|NOT COMPLETED|Third Intervention Period||0
227318|NCT01161472|551411|P1|NOT COMPLETED|Third Intervention Period||0
227319|NCT01161472|551408|P4|COMPLETED|Third Intervention Period||5
227320|NCT01161472|551409|P3|COMPLETED|Third Intervention Period||5
227321|NCT01161472|551410|P2|COMPLETED|Third Intervention Period||5
227322|NCT01161472|551411|P1|COMPLETED|Third Intervention Period||4
227323|NCT01161472|551408|P4|STARTED|Third Intervention Period||5
227324|NCT01161472|551409|P3|STARTED|Third Intervention Period||5
227325|NCT01161472|551410|P2|STARTED|Third Intervention Period||5
227326|NCT01161472|551411|P1|STARTED|Third Intervention Period||4
227327|NCT01161472|551408|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
227328|NCT01161472|551409|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
227329|NCT01161472|551410|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
227330|NCT01161472|551411|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||1
227331|NCT01161472|551408|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
227332|NCT01161472|551409|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
227333|NCT01161472|551410|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
227334|NCT01161472|551411|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
227335|NCT01161472|551408|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
227336|NCT01161472|551409|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
227337|NCT01161472|551410|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
227338|NCT01161472|551411|P1|STARTED|Washout Period (At Least 3 to 6 Days)||5
227339|NCT01161472|551408|P4|NOT COMPLETED|Second Intervention Period||0
227340|NCT01161472|551409|P3|NOT COMPLETED|Second Intervention Period||0
227341|NCT01161472|551410|P2|NOT COMPLETED|Second Intervention Period||0
227342|NCT01161472|551411|P1|NOT COMPLETED|Second Intervention Period||0
227343|NCT01161472|551408|P4|COMPLETED|Second Intervention Period||5
227344|NCT01161472|551409|P3|COMPLETED|Second Intervention Period||5
227345|NCT01161472|551410|P2|COMPLETED|Second Intervention Period||5
227346|NCT01161472|551411|P1|COMPLETED|Second Intervention Period||5
227347|NCT01161472|551408|P4|STARTED|Second Intervention Period||5
227348|NCT01161472|551409|P3|STARTED|Second Intervention Period||5
227349|NCT01161472|551410|P2|STARTED|Second Intervention Period||5
227350|NCT01161472|551411|P1|STARTED|Second Intervention Period||5
227351|NCT01161472|551408|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
227352|NCT01161472|551409|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
227353|NCT01161472|551410|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
227354|NCT01161472|551411|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
227355|NCT01161472|551408|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
227356|NCT01161472|551409|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
227357|NCT01161472|551410|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
227358|NCT01161472|551411|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
227359|NCT01161472|551408|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
227360|NCT01161472|551409|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
227361|NCT01161472|551410|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
227362|NCT01161472|551411|P1|STARTED|Washout Period (At Least 3 to 6 Days)||5
227363|NCT01161472|551408|P4|NOT COMPLETED|First Intervention Period||0
227364|NCT01161472|551409|P3|NOT COMPLETED|First Intervention Period||0
227365|NCT01161472|551410|P2|NOT COMPLETED|First Intervention Period||0
227366|NCT01161472|551411|P1|NOT COMPLETED|First Intervention Period||0
227367|NCT01161472|551408|P4|COMPLETED|First Intervention Period||5
227368|NCT01161472|551409|P3|COMPLETED|First Intervention Period||5
227369|NCT01161472|551410|P2|COMPLETED|First Intervention Period||5
227370|NCT01161472|551411|P1|COMPLETED|First Intervention Period||5
227371|NCT01161472|551408|P4|Treated|First Intervention Period||5
227372|NCT01161472|551409|P3|Treated|First Intervention Period||5
227373|NCT01161472|551410|P2|Treated|First Intervention Period||5
227374|NCT01161472|551411|P1|Treated|First Intervention Period||5
227375|NCT01161472|551408|P4|STARTED|First Intervention Period||5
227376|NCT01161472|551409|P3|STARTED|First Intervention Period||5
227377|NCT01161472|551410|P2|STARTED|First Intervention Period||5
227378|NCT01161472|551411|P1|STARTED|First Intervention Period||5
227379|NCT01161446|551467|P2|NOT COMPLETED|Overall Study||15
227380|NCT01161446|551468|P1|NOT COMPLETED|Overall Study||18
227381|NCT01161446|551467|P2|COMPLETED|Overall Study||99
227382|NCT01161446|551468|P1|COMPLETED|Overall Study||98
227383|NCT01161446|551467|P2|STARTED|Overall Study||114
227384|NCT01161446|551468|P1|STARTED|Overall Study||116
227385|NCT01161420|551480|P1|NOT COMPLETED|Withdrawal Study - Withdrawal||0
227386|NCT01161420|551480|P1|COMPLETED|Withdrawal Study - Withdrawal||23
227387|NCT01161420|551480|P1|STARTED|Withdrawal Study - Withdrawal||23
227388|NCT01161420|551480|P1|NOT COMPLETED|Withdrawal Study - Maintenance||0
227389|NCT01161420|551480|P1|COMPLETED|Withdrawal Study - Maintenance||23
227390|NCT01161420|551480|P1|STARTED|Withdrawal Study - Maintenance||23
227391|NCT01161420|551480|P1|NOT COMPLETED|Inspire Therapy||2
227392|NCT01161420|551480|P1|COMPLETED|Inspire Therapy||124
227393|NCT01161420|551480|P1|STARTED|Inspire Therapy||126
227394|NCT01161407|551494|P2|NOT COMPLETED|Overall Study||1
227395|NCT01161407|551495|P1|NOT COMPLETED|Overall Study||3
227396|NCT01161407|551494|P2|COMPLETED|Overall Study||5
227397|NCT01161407|551495|P1|COMPLETED|Overall Study||3
227398|NCT01161407|551494|P2|STARTED|Overall Study||6
227399|NCT01161407|551495|P1|STARTED|Overall Study||6
227400|NCT01161329|551507|P2|NOT COMPLETED|Overall Study||10
227401|NCT01161329|551508|P1|NOT COMPLETED|Overall Study||4
227402|NCT01161329|551507|P2|COMPLETED|Overall Study||24
227403|NCT01161329|551508|P1|COMPLETED|Overall Study||29
227404|NCT01161329|551507|P2|STARTED|Overall Study||34
227405|NCT01161329|551508|P1|STARTED|Overall Study||33
227406|NCT01161225|551519|P3|NOT COMPLETED|Overall Study||2
227407|NCT01161225|551520|P2|NOT COMPLETED|Overall Study||9
227408|NCT01161225|551521|P1|NOT COMPLETED|Overall Study||14
227409|NCT01161225|551519|P3|COMPLETED|Overall Study||12
227410|NCT01161225|551520|P2|COMPLETED|Overall Study||44
227411|NCT01161225|551521|P1|COMPLETED|Overall Study||45
227412|NCT01161225|551519|P3|STARTED|Overall Study||14
227413|NCT01161225|551520|P2|STARTED|Overall Study||53
227414|NCT01161225|551521|P1|STARTED|Overall Study||59
227415|NCT01161173|551550|P1|NOT COMPLETED|Overall Study||347
227416|NCT01161173|551550|P1|COMPLETED|Overall Study||0
227417|NCT01161173|551550|P1|STARTED|Overall Study||347
227418|NCT01161160|551562|P3|NOT COMPLETED|Overall Study||0
227419|NCT01161160|551563|P2|NOT COMPLETED|Overall Study||0
227420|NCT01161160|551564|P1|NOT COMPLETED|Overall Study||0
227421|NCT01161160|551562|P3|COMPLETED|Overall Study||58
227422|NCT01161160|551563|P2|COMPLETED|Overall Study||75
227423|NCT01161160|551564|P1|COMPLETED|Overall Study||76
227424|NCT01161160|551562|P3|STARTED|Overall Study||58
227425|NCT01161160|551563|P2|STARTED|Overall Study||75
227426|NCT01161160|551564|P1|STARTED|Overall Study||76
227427|NCT01161121|551635|P1|NOT COMPLETED|Overall Study||0
227428|NCT01161121|551635|P1|COMPLETED|Overall Study||46
227429|NCT01161121|551635|P1|STARTED|Overall Study||46
227430|NCT01160848|551647|P2|NOT COMPLETED|Overall Study||0
227431|NCT01160848|551648|P1|NOT COMPLETED|Overall Study||0
227432|NCT01160848|551647|P2|COMPLETED|Overall Study||8
227433|NCT01160848|551648|P1|COMPLETED|Overall Study||12
227434|NCT01160848|551647|P2|STARTED|Overall Study||8
227435|NCT01160848|551648|P1|STARTED|Overall Study||12
227436|NCT01160822|551677|P7|NOT COMPLETED|Overall Study||9
227437|NCT01160822|551678|P6|NOT COMPLETED|Overall Study||7
227438|NCT01160822|551679|P5|NOT COMPLETED|Overall Study||9
227439|NCT01160822|551680|P4|NOT COMPLETED|Overall Study||0
227440|NCT01160822|551681|P3|NOT COMPLETED|Overall Study||0
227441|NCT01160822|551682|P2|NOT COMPLETED|Overall Study||0
227442|NCT01160822|551683|P1|NOT COMPLETED|Overall Study||0
227443|NCT01160822|551677|P7|COMPLETED|Overall Study||44
227444|NCT01160822|551678|P6|COMPLETED|Overall Study||40
227445|NCT01160822|551679|P5|COMPLETED|Overall Study||36
227446|NCT01160822|551680|P4|COMPLETED|Overall Study||5
227447|NCT01160822|551681|P3|COMPLETED|Overall Study||6
227448|NCT01160822|551682|P2|COMPLETED|Overall Study||7
227449|NCT01160822|551683|P1|COMPLETED|Overall Study||6
227450|NCT01160822|551677|P7|STARTED|Overall Study||53
227451|NCT01160822|551678|P6|STARTED|Overall Study||47
227452|NCT01160822|551679|P5|STARTED|Overall Study||45
227453|NCT01160822|551680|P4|STARTED|Overall Study||5
227454|NCT01160822|551681|P3|STARTED|Overall Study||6
227455|NCT01160822|551682|P2|STARTED|Overall Study||7
227456|NCT01160822|551683|P1|STARTED|Overall Study||6
227457|NCT01160770|551772|P1|NOT COMPLETED|Overall Study||79
227458|NCT01160770|551772|P1|COMPLETED|Overall Study||188
227459|NCT01160770|551772|P1|STARTED|Overall Study||267
227460|NCT01160744|551785|P4|NOT COMPLETED|Overall Study||4
227461|NCT01160744|551786|P3|NOT COMPLETED|Overall Study||7
227462|NCT01160744|551787|P2|NOT COMPLETED|Overall Study||5
227463|NCT01160744|551788|P1|NOT COMPLETED|Overall Study||11
227464|NCT01160744|551785|P4|COMPLETED|Overall Study||67
227465|NCT01160744|551786|P3|COMPLETED|Overall Study||62
227466|NCT01160744|551787|P2|COMPLETED|Overall Study||64
227467|NCT01160744|551788|P1|COMPLETED|Overall Study||60
227468|NCT01160744|551785|P4|Received Study Drug|Overall Study||71
227469|NCT01160744|551786|P3|Received Study Drug|Overall Study||63
227470|NCT01160744|551787|P2|Received Study Drug|Overall Study||67
227471|NCT01160744|551788|P1|Received Study Drug|Overall Study||69
227472|NCT01160744|551785|P4|STARTED|Overall Study||71
227473|NCT01160744|551786|P3|STARTED|Overall Study||69
227474|NCT01160744|551787|P2|STARTED|Overall Study||69
227475|NCT01160744|551788|P1|STARTED|Overall Study||71
227476|NCT01160640|551824|P2|NOT COMPLETED|Overall Study||6
227477|NCT01160640|551825|P1|NOT COMPLETED|Overall Study||4
227478|NCT01160640|551824|P2|COMPLETED|Overall Study||110
227479|NCT01160640|551825|P1|COMPLETED|Overall Study||113
227480|NCT01160640|551824|P2|STARTED|Overall Study||116
227481|NCT01160640|551825|P1|STARTED|Overall Study||117
227482|NCT01160614|551841|P2|NOT COMPLETED|Overall Study||2
227483|NCT01160614|551842|P1|NOT COMPLETED|Overall Study||0
227484|NCT01160614|551841|P2|COMPLETED|Overall Study||23
227485|NCT01160614|551842|P1|COMPLETED|Overall Study||5
227486|NCT01160614|551841|P2|STARTED|Overall Study||25
227487|NCT01160614|551842|P1|STARTED|Overall Study||5
227488|NCT01160484|551890|P1|NOT COMPLETED|Overall Study||18
227489|NCT01160484|551890|P1|COMPLETED|Overall Study||22
227490|NCT01160484|551890|P1|STARTED|Overall Study||40
227491|NCT01160458|551900|P1|NOT COMPLETED|Overall Study||0
227492|NCT01160458|551900|P1|COMPLETED|Overall Study||20
227493|NCT01160458|551900|P1|STARTED|Overall Study||20
227494|NCT01160445|551910|P2|NOT COMPLETED|Overall Study||0
227495|NCT01160445|551911|P1|NOT COMPLETED|Overall Study||0
227496|NCT01160445|551910|P2|COMPLETED|Overall Study||2
227497|NCT01160445|551911|P1|COMPLETED|Overall Study||7
227498|NCT01160445|551910|P2|STARTED|Overall Study||2
227499|NCT01160445|551911|P1|STARTED|Overall Study||7
227500|NCT01160380|551921|P2|NOT COMPLETED|Overall Study||5
227501|NCT01160380|551922|P1|NOT COMPLETED|Overall Study||8
227502|NCT01160380|551921|P2|COMPLETED|Overall Study||20
227503|NCT01160380|551922|P1|COMPLETED|Overall Study||17
227504|NCT01160380|551921|P2|STARTED|Overall Study||25
227505|NCT01160380|551922|P1|STARTED|Overall Study||25
227506|NCT01160354|551943|P3|NOT COMPLETED|Overall Study||1
227507|NCT01160354|551944|P2|NOT COMPLETED|Overall Study||1
227508|NCT01160354|551945|P1|NOT COMPLETED|Overall Study||0
227509|NCT01160354|551943|P3|COMPLETED|Overall Study||14
227510|NCT01160354|551944|P2|COMPLETED|Overall Study||3
227511|NCT01160354|551945|P1|COMPLETED|Overall Study||3
227512|NCT01160354|551943|P3|STARTED|Overall Study||15
227513|NCT01160354|551944|P2|STARTED|Overall Study||4
227514|NCT01160354|551945|P1|STARTED|Overall Study||3
227515|NCT01160289|551964|P6|NOT COMPLETED|Post-Randomization Period||14
227516|NCT01160289|551965|P5|NOT COMPLETED|Post-Randomization Period||9
227517|NCT01160289|551966|P4|NOT COMPLETED|Post-Randomization Period||21
227518|NCT01160289|551967|P3|NOT COMPLETED|Post-Randomization Period||24
227519|NCT01160289|551968|P2|NOT COMPLETED|Post-Randomization Period||20
227520|NCT01160289|551969|P1|NOT COMPLETED|Post-Randomization Period||0
227521|NCT01160289|551964|P6|COMPLETED|Post-Randomization Period||73
227522|NCT01160289|551965|P5|COMPLETED|Post-Randomization Period||80
227523|NCT01160289|551966|P4|COMPLETED|Post-Randomization Period||31
227524|NCT01160289|551967|P3|COMPLETED|Post-Randomization Period||73
227525|NCT01160289|551968|P2|COMPLETED|Post-Randomization Period||65
227526|NCT01160289|551969|P1|COMPLETED|Post-Randomization Period||0
227527|NCT01160289|551964|P6|Received at Least 1 Dose of Study Drug|Post-Randomization Period||87
227528|NCT01160289|551965|P5|Received at Least 1 Dose of Study Drug|Post-Randomization Period||89
227529|NCT01160289|551966|P4|Received at Least 1 Dose of Study Drug|Post-Randomization Period||52
227530|NCT01160289|551967|P3|Received at Least 1 Dose of Study Drug|Post-Randomization Period||97
227531|NCT01160289|551968|P2|Received at Least 1 Dose of Study Drug|Post-Randomization Period||85
227532|NCT01160289|551969|P1|Received at Least 1 Dose of Study Drug|Post-Randomization Period||0
227533|NCT01160289|551964|P6|STARTED|Post-Randomization Period||87
227534|NCT01160289|551965|P5|STARTED|Post-Randomization Period||89
227535|NCT01160289|551966|P4|STARTED|Post-Randomization Period||52
227536|NCT01160289|551967|P3|STARTED|Post-Randomization Period||97
227537|NCT01160289|551968|P2|STARTED|Post-Randomization Period||85
227538|NCT01160289|551969|P1|STARTED|Post-Randomization Period||0
227539|NCT01160289|551964|P6|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
227540|NCT01160289|551965|P5|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
227541|NCT01160289|551966|P4|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
227542|NCT01160289|551967|P3|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
227543|NCT01160289|551968|P2|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
227544|NCT01160289|551969|P1|NOT COMPLETED|Screening, Washout, and Lead-In Period||484
227545|NCT01160289|551964|P6|COMPLETED|Screening, Washout, and Lead-In Period||0
227546|NCT01160289|551965|P5|COMPLETED|Screening, Washout, and Lead-In Period||0
227547|NCT01160289|551966|P4|COMPLETED|Screening, Washout, and Lead-In Period||0
227548|NCT01160289|551967|P3|COMPLETED|Screening, Washout, and Lead-In Period||0
227549|NCT01160289|551968|P2|COMPLETED|Screening, Washout, and Lead-In Period||0
227550|NCT01160289|551969|P1|COMPLETED|Screening, Washout, and Lead-In Period||410
227551|NCT01160289|551964|P6|STARTED|Screening, Washout, and Lead-In Period||0
227552|NCT01160289|551965|P5|STARTED|Screening, Washout, and Lead-In Period||0
227553|NCT01160289|551966|P4|STARTED|Screening, Washout, and Lead-In Period||0
227554|NCT01160289|551967|P3|STARTED|Screening, Washout, and Lead-In Period||0
227555|NCT01160289|551968|P2|STARTED|Screening, Washout, and Lead-In Period||0
227556|NCT01160289|551969|P1|STARTED|Screening, Washout, and Lead-In Period||894
227557|NCT01160237|552030|P3|NOT COMPLETED|Overall Study||0
227558|NCT01160237|552031|P2|NOT COMPLETED|Overall Study||0
227559|NCT01160237|552032|P1|NOT COMPLETED|Overall Study||0
227560|NCT01160237|552030|P3|COMPLETED|Overall Study||0
227561|NCT01160237|552031|P2|COMPLETED|Overall Study||3
227562|NCT01160237|552032|P1|COMPLETED|Overall Study||4
227563|NCT01160237|552030|P3|STARTED|Overall Study||0
227564|NCT01160237|552031|P2|STARTED|Overall Study||3
227565|NCT01160237|552032|P1|STARTED|Overall Study||4
227566|NCT01160211|552058|P3|NOT COMPLETED|Overall Study||87
227567|NCT01160211|552059|P2|NOT COMPLETED|Overall Study||87
227568|NCT01160211|552060|P1|NOT COMPLETED|Overall Study||99
227569|NCT01160211|552058|P3|COMPLETED|Overall Study||30
227570|NCT01160211|552059|P2|COMPLETED|Overall Study||31
227571|NCT01160211|552060|P1|COMPLETED|Overall Study||21
227572|NCT01160211|552058|P3|Ongoing|Overall Study||79
227573|NCT01160211|552059|P2|Ongoing|Overall Study||75
227574|NCT01160211|552060|P1|Ongoing|Overall Study||90
227575|NCT01160211|552058|P3|STARTED|Overall Study||117
227576|NCT01160211|552059|P2|STARTED|Overall Study||118
227577|NCT01160211|552060|P1|STARTED|Overall Study||120
227578|NCT01160198|552093|P3|NOT COMPLETED|Overall Study||1
227579|NCT01160198|552094|P2|NOT COMPLETED|Overall Study||3
227580|NCT01160198|552095|P1|NOT COMPLETED|Overall Study||2
227581|NCT01160198|552093|P3|COMPLETED|Overall Study||89
227582|NCT01160198|552094|P2|COMPLETED|Overall Study||88
227583|NCT01160198|552095|P1|COMPLETED|Overall Study||87
227584|NCT01160198|552093|P3|STARTED|Overall Study||90
227585|NCT01160198|552094|P2|STARTED|Overall Study||91
227586|NCT01160198|552095|P1|STARTED|Overall Study||89
227587|NCT01159938|552117|P5|NOT COMPLETED|Second Study Period||0
227588|NCT01159938|552118|P4|NOT COMPLETED|Second Study Period||0
227589|NCT01159938|552119|P3|NOT COMPLETED|Second Study Period||0
227590|NCT01159938|552120|P2|NOT COMPLETED|Second Study Period||0
227591|NCT01159938|552121|P1|NOT COMPLETED|Second Study Period||0
227592|NCT01159938|552117|P5|COMPLETED|Second Study Period||12
227593|NCT01159938|552118|P4|COMPLETED|Second Study Period||12
227594|NCT01159938|552119|P3|COMPLETED|Second Study Period||10
227595|NCT01159938|552120|P2|COMPLETED|Second Study Period||11
227596|NCT01159938|552121|P1|COMPLETED|Second Study Period||0
227597|NCT01159938|552117|P5|STARTED|Second Study Period||12
227598|NCT01159938|552118|P4|STARTED|Second Study Period||12
227599|NCT01159938|552119|P3|STARTED|Second Study Period||10
227600|NCT01159938|552120|P2|STARTED|Second Study Period||11
227601|NCT01159938|552121|P1|STARTED|Second Study Period||0
227602|NCT01159938|552117|P5|NOT COMPLETED|First Study Period||0
227603|NCT01159938|552118|P4|NOT COMPLETED|First Study Period||0
227604|NCT01159938|552119|P3|NOT COMPLETED|First Study Period||1
227605|NCT01159938|552120|P2|NOT COMPLETED|First Study Period||0
227606|NCT01159938|552121|P1|NOT COMPLETED|First Study Period||0
227607|NCT01159938|552117|P5|COMPLETED|First Study Period||12
227608|NCT01159938|552118|P4|COMPLETED|First Study Period||12
227609|NCT01159938|552119|P3|COMPLETED|First Study Period||10
227610|NCT01159938|552120|P2|COMPLETED|First Study Period||11
227611|NCT01159938|552121|P1|COMPLETED|First Study Period||26
227612|NCT01159938|552117|P5|Safety and Efficacy Analysis Population|First Study Period||12
227613|NCT01159938|552118|P4|Safety and Efficacy Analysis Population|First Study Period||12
227614|NCT01159938|552119|P3|Safety and Efficacy Analysis Population|First Study Period|Microalbuminuria relaxed with protocol amendment. T2DM albuminuria participant included in analyses.|11
227615|NCT01159938|552120|P2|Safety and Efficacy Analysis Population|First Study Period||11
227616|NCT01159938|552121|P1|Safety and Efficacy Analysis Population|First Study Period|One healthy participant completed study but was excluded from analyses (major protocol violation).|25
227617|NCT01159938|552117|P5|Received at Least 1 Dose of Study Drug|First Study Period||12
227618|NCT01159938|552118|P4|Received at Least 1 Dose of Study Drug|First Study Period||12
227619|NCT01159938|552119|P3|Received at Least 1 Dose of Study Drug|First Study Period||11
227620|NCT01159938|552120|P2|Received at Least 1 Dose of Study Drug|First Study Period||11
227621|NCT01159938|552121|P1|Received at Least 1 Dose of Study Drug|First Study Period||0
227622|NCT01159938|552117|P5|STARTED|First Study Period||12
227623|NCT01159938|552118|P4|STARTED|First Study Period||12
227624|NCT01159938|552119|P3|STARTED|First Study Period||11
227625|NCT01159938|552120|P2|STARTED|First Study Period||11
227626|NCT01159938|552121|P1|STARTED|First Study Period||26
227627|NCT01159912|552184|P3|NOT COMPLETED|Overall Study||26
227628|NCT01159912|552185|P2|NOT COMPLETED|Overall Study||22
227629|NCT01159912|552186|P1|NOT COMPLETED|Overall Study||40
227630|NCT01159912|552184|P3|COMPLETED|Overall Study||88
227631|NCT01159912|552185|P2|COMPLETED|Overall Study||92
227632|NCT01159912|552186|P1|COMPLETED|Overall Study||75
227633|NCT01159912|552184|P3|STARTED|Overall Study||114
227634|NCT01159912|552185|P2|STARTED|Overall Study||114
227635|NCT01159912|552186|P1|STARTED|Overall Study||115
227636|NCT01159769|552209|P1|NOT COMPLETED|Overall Study||1
227637|NCT01159769|552209|P1|COMPLETED|Overall Study||214
227638|NCT01159769|552209|P1|STARTED|Overall Study||215
227639|NCT01159743|552216|P2|NOT COMPLETED|Overall Study||0
227640|NCT01159743|552217|P1|NOT COMPLETED|Overall Study||0
227641|NCT01159743|552216|P2|COMPLETED|Overall Study||109
227642|NCT01159743|552217|P1|COMPLETED|Overall Study||237
227643|NCT01159743|552216|P2|STARTED|Overall Study||109
227644|NCT01159743|552217|P1|STARTED|Overall Study||237
227645|NCT01159691|552229|P1|NOT COMPLETED|Overall Study||22
227646|NCT01159691|552229|P1|COMPLETED|Overall Study|Multiple discontinuation reasons were possible.|54
227647|NCT01159691|552229|P1|STARTED|Overall Study||76
227648|NCT01159665|552242|P6|NOT COMPLETED|Overall Study||0
227649|NCT01159665|552243|P5|NOT COMPLETED|Overall Study||0
227650|NCT01159665|552244|P4|NOT COMPLETED|Overall Study||0
227651|NCT01159665|552245|P3|NOT COMPLETED|Overall Study||0
227652|NCT01159665|552246|P2|NOT COMPLETED|Overall Study||1
227653|NCT01159665|552247|P1|NOT COMPLETED|Overall Study||0
227654|NCT01159665|552242|P6|COMPLETED|Overall Study||4
227655|NCT01159665|552243|P5|COMPLETED|Overall Study||4
227656|NCT01159665|552244|P4|COMPLETED|Overall Study||4
227657|NCT01159665|552245|P3|COMPLETED|Overall Study||8
227658|NCT01159665|552246|P2|COMPLETED|Overall Study||8
227659|NCT01159665|552247|P1|COMPLETED|Overall Study||9
227660|NCT01159665|552242|P6|STARTED|Overall Study||4
227661|NCT01159665|552243|P5|STARTED|Overall Study||4
227662|NCT01159665|552244|P4|STARTED|Overall Study||4
227663|NCT01159665|552245|P3|STARTED|Overall Study||8
227664|NCT01159665|552246|P2|STARTED|Overall Study||9
227665|NCT01159665|552247|P1|STARTED|Overall Study||9
227666|NCT01159600|552275|P8|NOT COMPLETED|Overall Study||18
227667|NCT01159600|552276|P7|NOT COMPLETED|Overall Study||19
227668|NCT01159600|552277|P6|NOT COMPLETED|Overall Study||18
227669|NCT01159600|552278|P5|NOT COMPLETED|Overall Study||24
227670|NCT01159600|552279|P4|NOT COMPLETED|Overall Study||11
227671|NCT01159600|552280|P3|NOT COMPLETED|Overall Study||18
227672|NCT01159600|552281|P2|NOT COMPLETED|Overall Study||8
227673|NCT01159600|552282|P1|NOT COMPLETED|Overall Study||21
227674|NCT01159600|552275|P8|COMPLETED|Overall Study||85
227675|NCT01159600|552276|P7|COMPLETED|Overall Study||199
227676|NCT01159600|552277|P6|COMPLETED|Overall Study||208
227677|NCT01159600|552278|P5|COMPLETED|Overall Study||201
227678|NCT01159600|552279|P4|COMPLETED|Overall Study||58
227679|NCT01159600|552280|P3|COMPLETED|Overall Study||196
227680|NCT01159600|552281|P2|COMPLETED|Overall Study||209
227681|NCT01159600|552282|P1|COMPLETED|Overall Study||186
227682|NCT01159600|552275|P8|STARTED|Overall Study||103
227683|NCT01159600|552276|P7|STARTED|Overall Study||218
227684|NCT01159600|552277|P6|STARTED|Overall Study||226
227685|NCT01159600|552278|P5|STARTED|Overall Study||225
227686|NCT01159600|552279|P4|STARTED|Overall Study||69
227687|NCT01159600|552280|P3|STARTED|Overall Study||214
227688|NCT01159600|552281|P2|STARTED|Overall Study||217
227689|NCT01159600|552282|P1|STARTED|Overall Study||207
227690|NCT01159574|552324|P1|NOT COMPLETED|Follow Up Phase||20
227691|NCT01159574|552324|P1|COMPLETED|Follow Up Phase|Completion defined as those that are no longer in long term follow up due to death.|92
227692|NCT01159574|552324|P1|STARTED|Follow Up Phase||112
227693|NCT01159574|552324|P1|NOT COMPLETED|Treatment Phase||21
227694|NCT01159574|552324|P1|COMPLETED|Treatment Phase||100
227695|NCT01159574|552324|P1|STARTED|Treatment Phase||121
227696|NCT01159535|552333|P3|NOT COMPLETED|Overall Study||31
227697|NCT01159535|552334|P2|NOT COMPLETED|Overall Study||24
227698|NCT01159535|552335|P1|NOT COMPLETED|Overall Study||24
227699|NCT01159535|552333|P3|COMPLETED|Overall Study||64
227700|NCT01159535|552334|P2|COMPLETED|Overall Study||64
227701|NCT01159535|552335|P1|COMPLETED|Overall Study||79
227702|NCT01159535|552333|P3|STARTED|Overall Study||95
227703|NCT01159535|552334|P2|STARTED|Overall Study||88
227704|NCT01159535|552335|P1|STARTED|Overall Study||103
227705|NCT01159431|552345|P2|NOT COMPLETED|Overall Study||6
227706|NCT01159431|552346|P1|NOT COMPLETED|Overall Study||2
227707|NCT01159431|552345|P2|COMPLETED|Overall Study||19
227708|NCT01159431|552346|P1|COMPLETED|Overall Study||23
227709|NCT01159431|552345|P2|STARTED|Overall Study||25
227710|NCT01159431|552346|P1|STARTED|Overall Study||25
227711|NCT01159262|552365|P3|NOT COMPLETED|Overall Study||0
227712|NCT01159262|552366|P2|NOT COMPLETED|Overall Study||0
227713|NCT01159262|552367|P1|NOT COMPLETED|Overall Study||0
227714|NCT01159262|552365|P3|COMPLETED|Overall Study||8
227715|NCT01159262|552366|P2|COMPLETED|Overall Study||14
227716|NCT01159262|552367|P1|COMPLETED|Overall Study||14
227717|NCT01159262|552365|P3|STARTED|Overall Study||8
227718|NCT01159262|552366|P2|STARTED|Overall Study||14
227719|NCT01159262|552367|P1|STARTED|Overall Study||14
227720|NCT01159171|552399|P1|NOT COMPLETED|Overall Study||50
227721|NCT01159171|552399|P1|COMPLETED|Overall Study||0
227722|NCT01159171|552399|P1|STARTED|Overall Study||50
227723|NCT01159067|552414|P1|NOT COMPLETED|Overall Study||0
227724|NCT01159067|552414|P1|COMPLETED|Overall Study||1
227725|NCT01159067|552414|P1|STARTED|Overall Study||1
227726|NCT01159054|552421|P1|NOT COMPLETED|Overall Study||20
227727|NCT01159054|552421|P1|COMPLETED|Overall Study||2
227728|NCT01159054|552421|P1|STARTED|Overall Study||22
227729|NCT01158976|552435|P2|NOT COMPLETED|Overall Study||4
227730|NCT01158976|552436|P1|NOT COMPLETED|Overall Study||9
227731|NCT01158976|552435|P2|COMPLETED|Overall Study||17
227732|NCT01158976|552436|P1|COMPLETED|Overall Study||34
227733|NCT01158976|552435|P2|STARTED|Overall Study||21
227734|NCT01158976|552436|P1|STARTED|Overall Study||43
227735|NCT01158924|552480|P2|NOT COMPLETED|Overall Study||3
227736|NCT01158924|552481|P1|NOT COMPLETED|Overall Study||1
227737|NCT01158924|552480|P2|COMPLETED|Overall Study||23
227738|NCT01158924|552481|P1|COMPLETED|Overall Study||13
227739|NCT01158924|552480|P2|STARTED|Overall Study||26
227740|NCT01158924|552481|P1|STARTED|Overall Study||14
227741|NCT01158885|552495|P1|NOT COMPLETED|Treatment Course 2||0
227742|NCT01158885|552495|P1|COMPLETED|Treatment Course 2||0
227743|NCT01158885|552495|P1|STARTED|Treatment Course 2||0
227744|NCT01158885|552495|P1|NOT COMPLETED|Treatment Course 1||0
227745|NCT01158885|552495|P1|COMPLETED|Treatment Course 1||2
227746|NCT01158885|552495|P1|STARTED|Treatment Course 1||2
227747|NCT01158820|552503|P2|NOT COMPLETED|Overall Study||0
227748|NCT01158820|552504|P1|NOT COMPLETED|Overall Study||0
227749|NCT01158820|552503|P2|COMPLETED|Overall Study||25
227750|NCT01158820|552504|P1|COMPLETED|Overall Study||25
227751|NCT01158820|552503|P2|STARTED|Overall Study||25
227752|NCT01158820|552504|P1|STARTED|Overall Study||25
227753|NCT01158716|552526|P2|NOT COMPLETED|Overall Study||1
227754|NCT01158716|552527|P1|NOT COMPLETED|Overall Study||1
227755|NCT01158716|552526|P2|COMPLETED|Overall Study||47
227756|NCT01158716|552527|P1|COMPLETED|Overall Study||47
227757|NCT01158716|552526|P2|STARTED|Overall Study||48
227758|NCT01158716|552527|P1|STARTED|Overall Study||48
227759|NCT01158703|552535|P2|NOT COMPLETED|Overall Study||0
227760|NCT01158703|552536|P1|NOT COMPLETED|Overall Study||0
227761|NCT01158703|552535|P2|COMPLETED|Overall Study||8
227762|NCT01158703|552536|P1|COMPLETED|Overall Study||12
227763|NCT01158703|552535|P2|STARTED|Overall Study||8
227764|NCT01158703|552536|P1|STARTED|Overall Study||12
227765|NCT01158573|552556|P4|NOT COMPLETED|Overall Study||0
227766|NCT01158573|552557|P3|NOT COMPLETED|Overall Study||0
227767|NCT01158573|552558|P2|NOT COMPLETED|Overall Study||0
227768|NCT01158573|552559|P1|NOT COMPLETED|Overall Study||0
227769|NCT01158573|552556|P4|COMPLETED|Overall Study||28
227770|NCT01158573|552557|P3|COMPLETED|Overall Study||29
227771|NCT01158573|552558|P2|COMPLETED|Overall Study||30
227772|NCT01158573|552559|P1|COMPLETED|Overall Study|Study completed at 117 subjects.|30
227773|NCT01158573|552556|P4|STARTED|Overall Study||28
227774|NCT01158573|552557|P3|STARTED|Overall Study||29
227775|NCT01158573|552558|P2|STARTED|Overall Study||30
227776|NCT01158573|552559|P1|STARTED|Overall Study|Aimed to recruit 160 from July 2010 to May 2013. Each subject studied on one time point only|30
227777|NCT01158534|552581|P1|NOT COMPLETED|Overall Study||3
227778|NCT01158534|552581|P1|COMPLETED|Overall Study|All three pts that did not complete study had some treatment|14
227779|NCT01158534|552581|P1|STARTED|Overall Study||17
227780|NCT01158521|552589|P1|NOT COMPLETED|Overall Study||0
227781|NCT01158521|552589|P1|COMPLETED|Overall Study||25
227782|NCT01158521|552589|P1|STARTED|Overall Study||25
227783|NCT01158404|552606|P8|NOT COMPLETED|Overall Study||2
227784|NCT01158404|552607|P7|NOT COMPLETED|Overall Study||1
227785|NCT01158404|552608|P6|NOT COMPLETED|Overall Study||1
227786|NCT01158404|552609|P5|NOT COMPLETED|Overall Study||3
227787|NCT01158404|552610|P4|NOT COMPLETED|Overall Study||0
227788|NCT01158404|552611|P3|NOT COMPLETED|Overall Study||0
227789|NCT01158404|552612|P2|NOT COMPLETED|Overall Study||1
227790|NCT01158404|552613|P1|NOT COMPLETED|Overall Study||0
227791|NCT01158404|552606|P8|COMPLETED|Overall Study||6
227792|NCT01158404|552607|P7|COMPLETED|Overall Study||2
227793|NCT01158404|552608|P6|COMPLETED|Overall Study||4
227794|NCT01158404|552609|P5|COMPLETED|Overall Study||3
227795|NCT01158404|552610|P4|COMPLETED|Overall Study||3
227796|NCT01158404|552611|P3|COMPLETED|Overall Study||3
227797|NCT01158404|552612|P2|COMPLETED|Overall Study||3
227798|NCT01158404|552613|P1|COMPLETED|Overall Study||3
227799|NCT01158404|552606|P8|Received at Least 1 Dose of Study Drug|Overall Study||8
227800|NCT01158404|552607|P7|Received at Least 1 Dose of Study Drug|Overall Study||3
227801|NCT01158404|552608|P6|Received at Least 1 Dose of Study Drug|Overall Study||5
227802|NCT01158404|552609|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
227803|NCT01158404|552610|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
227804|NCT01158404|552611|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
227805|NCT01158404|552612|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
227806|NCT01158404|552613|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
227807|NCT01158404|552606|P8|STARTED|Overall Study||8
227808|NCT01158404|552607|P7|STARTED|Overall Study||3
227809|NCT01158404|552608|P6|STARTED|Overall Study||5
227810|NCT01158404|552609|P5|STARTED|Overall Study||6
227811|NCT01158404|552610|P4|STARTED|Overall Study||3
227812|NCT01158404|552611|P3|STARTED|Overall Study||3
227813|NCT01158404|552612|P2|STARTED|Overall Study||4
227814|NCT01158404|552613|P1|STARTED|Overall Study||3
227815|NCT01158378|552655|P2|NOT COMPLETED|Overall Study||9
227816|NCT01158378|552656|P1|NOT COMPLETED|Overall Study||10
227817|NCT01158378|552655|P2|COMPLETED|Overall Study||117
227818|NCT01158378|552656|P1|COMPLETED|Overall Study||114
227819|NCT01158378|552655|P2|STARTED|Overall Study||126
227820|NCT01158378|552656|P1|STARTED|Overall Study||124
227821|NCT01158261|552668|P1|NOT COMPLETED|Overall Study||17
227822|NCT01158261|552668|P1|COMPLETED|Overall Study||283
227823|NCT01158261|552668|P1|STARTED|Overall Study||300
227824|NCT01158222|552672|P1|NOT COMPLETED|Overall Study||17
227825|NCT01158222|552672|P1|COMPLETED|Overall Study||20
227826|NCT01158222|552672|P1|STARTED|Overall Study||37
227827|NCT01158157|552678|P1|NOT COMPLETED|Overall Study||0
227828|NCT01158157|552678|P1|COMPLETED|Overall Study||25
227829|NCT01158157|552678|P1|STARTED|Overall Study|61 subjects screened; 25 subjects were vaccinated; 36 subjects were not eligible.|25
227830|NCT01158118|552684|P2|NOT COMPLETED|Overall Study||3
227831|NCT01158118|552685|P1|NOT COMPLETED|Overall Study||1
227832|NCT01158118|552684|P2|COMPLETED|Overall Study||21
227833|NCT01158118|552685|P1|COMPLETED|Overall Study||23
227834|NCT01158118|552684|P2|STARTED|Overall Study||24
227835|NCT01158118|552685|P1|STARTED|Overall Study||24
227836|NCT01157897|552705|P4|NOT COMPLETED|Overall Study||1
227837|NCT01157897|552706|P3|NOT COMPLETED|Overall Study||0
227838|NCT01157897|552707|P2|NOT COMPLETED|Overall Study||2
227839|NCT01157897|552708|P1|NOT COMPLETED|Overall Study||2
227840|NCT01157897|552705|P4|COMPLETED|Overall Study||5
227841|NCT01157897|552706|P3|COMPLETED|Overall Study||10
227842|NCT01157897|552707|P2|COMPLETED|Overall Study||8
227843|NCT01157897|552708|P1|COMPLETED|Overall Study||8
227844|NCT01157897|552705|P4|STARTED|Overall Study||6
227845|NCT01157897|552706|P3|STARTED|Overall Study||10
227846|NCT01157897|552707|P2|STARTED|Overall Study||10
227847|NCT01157897|552708|P1|STARTED|Overall Study||10
227848|NCT01157845|552733|P1|NOT COMPLETED|Overall Study||35
227849|NCT01157845|552733|P1|COMPLETED|Overall Study||130
227850|NCT01157845|552733|P1|STARTED|Overall Study||165
227851|NCT01157533|552738|P1|NOT COMPLETED|Overall Study||0
227852|NCT01157533|552738|P1|COMPLETED|Overall Study||1
227853|NCT01157533|552738|P1|STARTED|Overall Study||1
227854|NCT01157429|552744|P2|NOT COMPLETED|Overall Study||4
227855|NCT01157429|552745|P1|NOT COMPLETED|Overall Study||4
227856|NCT01157429|552744|P2|COMPLETED|Overall Study||8
227857|NCT01157429|552745|P1|COMPLETED|Overall Study||8
227858|NCT01157429|552744|P2|STARTED|Overall Study||12
227859|NCT01157429|552745|P1|STARTED|Overall Study||12
227860|NCT01157416|552753|P2|NOT COMPLETED|Overall Study||0
227861|NCT01157416|552754|P1|NOT COMPLETED|Overall Study||2
227862|NCT01157416|552753|P2|COMPLETED|Overall Study||16
227863|NCT01157416|552754|P1|COMPLETED|Overall Study||15
227864|NCT01157416|552753|P2|STARTED|Overall Study||16
227865|NCT01157416|552754|P1|STARTED|Overall Study||17
227866|NCT01157377|552767|P7|NOT COMPLETED|Overall Study||2
227867|NCT01157377|552768|P6|NOT COMPLETED|Overall Study||3
227868|NCT01157377|552769|P5|NOT COMPLETED|Overall Study||2
227869|NCT01157377|552770|P4|NOT COMPLETED|Overall Study||1
227870|NCT01157377|552771|P3|NOT COMPLETED|Overall Study||1
227871|NCT01157377|552772|P2|NOT COMPLETED|Overall Study||3
227872|NCT01157377|552773|P1|NOT COMPLETED|Overall Study||2
227873|NCT01157377|552767|P7|COMPLETED|Overall Study||27
227874|NCT01157377|552768|P6|COMPLETED|Overall Study||16
227875|NCT01157377|552769|P5|COMPLETED|Overall Study||18
227876|NCT01157377|552770|P4|COMPLETED|Overall Study||14
227877|NCT01157377|552771|P3|COMPLETED|Overall Study||26
227878|NCT01157377|552772|P2|COMPLETED|Overall Study||20
227879|NCT01157377|552773|P1|COMPLETED|Overall Study||21
227880|NCT01157377|552767|P7|STARTED|Overall Study||29
227881|NCT01157377|552768|P6|STARTED|Overall Study||19
227882|NCT01157377|552769|P5|STARTED|Overall Study||20
227883|NCT01157377|552770|P4|STARTED|Overall Study||15
227884|NCT01157377|552771|P3|STARTED|Overall Study||27
227885|NCT01157377|552772|P2|STARTED|Overall Study||23
227886|NCT01157377|552773|P1|STARTED|Overall Study||23
227887|NCT01157351|552791|P2|NOT COMPLETED|Overall Study||132
227888|NCT01157351|552792|P1|NOT COMPLETED|Overall Study||137
227889|NCT01157351|552791|P2|COMPLETED|Overall Study||88
227890|NCT01157351|552792|P1|COMPLETED|Overall Study||93
227891|NCT01157351|552791|P2|Treated|Overall Study||218
227892|NCT01157351|552792|P1|Treated|Overall Study||226
227893|NCT01157351|552791|P2|STARTED|Overall Study||220
227894|NCT01157351|552792|P1|STARTED|Overall Study||230
227895|NCT01157234|552810|P2|NOT COMPLETED|Overall Study||0
227896|NCT01157234|552811|P1|NOT COMPLETED|Overall Study||1
227897|NCT01157234|552810|P2|COMPLETED|Overall Study||15
227898|NCT01157234|552811|P1|COMPLETED|Overall Study||14
227899|NCT01157234|552810|P2|STARTED|Overall Study||15
227900|NCT01157234|552811|P1|STARTED|Overall Study||15
227901|NCT01157182|552843|P2|NOT COMPLETED|Second Intervention||0
227902|NCT01157182|552844|P1|NOT COMPLETED|Second Intervention||0
227903|NCT01157182|552843|P2|COMPLETED|Second Intervention||18
227904|NCT01157182|552844|P1|COMPLETED|Second Intervention||16
227905|NCT01157182|552843|P2|STARTED|Second Intervention||18
227906|NCT01157182|552844|P1|STARTED|Second Intervention||16
227907|NCT01157182|552843|P2|NOT COMPLETED|Washout of 28 Days||0
227908|NCT01157182|552844|P1|NOT COMPLETED|Washout of 28 Days||2
227909|NCT01157182|552843|P2|COMPLETED|Washout of 28 Days||18
227910|NCT01157182|552844|P1|COMPLETED|Washout of 28 Days||16
227911|NCT01157182|552843|P2|STARTED|Washout of 28 Days||18
227912|NCT01157182|552844|P1|STARTED|Washout of 28 Days||18
227913|NCT01157182|552843|P2|NOT COMPLETED|First Intervention||0
227914|NCT01157182|552844|P1|NOT COMPLETED|First Intervention||0
227915|NCT01157182|552843|P2|COMPLETED|First Intervention||18
227916|NCT01157182|552844|P1|COMPLETED|First Intervention||18
227917|NCT01157182|552843|P2|STARTED|First Intervention||18
227918|NCT01157182|552844|P1|STARTED|First Intervention||18
227919|NCT01157169|552892|P2|NOT COMPLETED|Second Intervention||1
227920|NCT01157169|552893|P1|NOT COMPLETED|Second Intervention||0
227921|NCT01157169|552892|P2|COMPLETED|Second Intervention||17
227922|NCT01157169|552893|P1|COMPLETED|Second Intervention||16
227923|NCT01157169|552892|P2|STARTED|Second Intervention||18
227924|NCT01157169|552893|P1|STARTED|Second Intervention||16
227925|NCT01157169|552892|P2|NOT COMPLETED|Washout of 10 Days||0
227926|NCT01157169|552893|P1|NOT COMPLETED|Washout of 10 Days||0
227927|NCT01157169|552892|P2|COMPLETED|Washout of 10 Days||18
227928|NCT01157169|552893|P1|COMPLETED|Washout of 10 Days||16
227929|NCT01157169|552892|P2|STARTED|Washout of 10 Days||18
227930|NCT01157169|552893|P1|STARTED|Washout of 10 Days||16
227931|NCT01157169|552892|P2|NOT COMPLETED|First Intervention||2
227932|NCT01157169|552893|P1|NOT COMPLETED|First Intervention||4
227933|NCT01157169|552892|P2|COMPLETED|First Intervention||18
227934|NCT01157169|552893|P1|COMPLETED|First Intervention||16
227935|NCT01157169|552892|P2|STARTED|First Intervention||20
227936|NCT01157169|552893|P1|STARTED|First Intervention||20
227937|NCT01157117|552912|P3|NOT COMPLETED|Overall Study||15
227938|NCT01157117|552913|P2|NOT COMPLETED|Overall Study||11
227939|NCT01157117|552914|P1|NOT COMPLETED|Overall Study||9
227940|NCT01157117|552912|P3|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|5
227941|NCT01157117|552913|P2|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|18
227942|NCT01157117|552914|P1|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|19
227943|NCT01157117|552912|P3|Completed Final Month 38 Study Visit|Overall Study||3
227944|NCT01157117|552913|P2|Completed Final Month 38 Study Visit|Overall Study||18
227945|NCT01157117|552914|P1|Completed Final Month 38 Study Visit|Overall Study||19
227946|NCT01157117|552912|P3|Completed Month 32 Tolerance OFC|Overall Study||0
227947|NCT01157117|552913|P2|Completed Month 32 Tolerance OFC|Overall Study||20
227948|NCT01157117|552914|P1|Completed Month 32 Tolerance OFC|Overall Study||24
227949|NCT01157117|552912|P3|Discontinued Milk OIT at Month 30|Overall Study||0
227950|NCT01157117|552913|P2|Discontinued Milk OIT at Month 30|Overall Study||20
227951|NCT01157117|552914|P1|Discontinued Milk OIT at Month 30|Overall Study||24
227952|NCT01157117|552912|P3|Completed Month 28 Desensitization OFC|Overall Study||0
227953|NCT01157117|552913|P2|Completed Month 28 Desensitization OFC|Overall Study||24
227954|NCT01157117|552914|P1|Completed Month 28 Desensitization OFC|Overall Study||26
227955|NCT01157117|552912|P3|Unblinded at Month 16|Overall Study||0
227956|NCT01157117|552913|P2|Unblinded at Month 16|Overall Study||26
227957|NCT01157117|552914|P1|Unblinded at Month 16|Overall Study||26
227958|NCT01157117|552912|P3|Reached Milk OIT Maintenance Dosing|Overall Study||0
227959|NCT01157117|552913|P2|Reached Milk OIT Maintenance Dosing|Overall Study||26
227960|NCT01157117|552914|P1|Reached Milk OIT Maintenance Dosing|Overall Study||26
227961|NCT01157117|552912|P3|Began Milk OIT Dosing at Month 4|Overall Study||0
227962|NCT01157117|552913|P2|Began Milk OIT Dosing at Month 4|Overall Study||28
227963|NCT01157117|552914|P1|Began Milk OIT Dosing at Month 4|Overall Study||27
227964|NCT01157117|552912|P3|Began Omalizumab or Placebo Dosing|Overall Study||0
227965|NCT01157117|552913|P2|Began Omalizumab or Placebo Dosing|Overall Study||28
227966|NCT01157117|552914|P1|Began Omalizumab or Placebo Dosing|Overall Study||27
227967|NCT01157117|552912|P3|STARTED|Overall Study||20
227968|NCT01157117|552913|P2|STARTED|Overall Study||29
227969|NCT01157117|552914|P1|STARTED|Overall Study||28
227970|NCT01157078|552955|P2|NOT COMPLETED|Overall Study||36
227971|NCT01157078|552956|P1|NOT COMPLETED|Overall Study||35
227972|NCT01157078|552955|P2|COMPLETED|Overall Study||124
227973|NCT01157078|552956|P1|COMPLETED|Overall Study||124
227974|NCT01157078|552955|P2|Received Treatment|Overall Study||159
227975|NCT01157078|552956|P1|Received Treatment|Overall Study||157
227976|NCT01157078|552955|P2|STARTED|Overall Study||160
227977|NCT01157078|552956|P1|STARTED|Overall Study||159
227978|NCT01157065|553006|P2|NOT COMPLETED|Overall Study||1
227979|NCT01157065|553007|P1|NOT COMPLETED|Overall Study||0
227980|NCT01157065|553006|P2|COMPLETED|Overall Study||10
227981|NCT01157065|553007|P1|COMPLETED|Overall Study||38
227982|NCT01157065|553006|P2|STARTED|Overall Study||11
227983|NCT01157065|553007|P1|STARTED|Overall Study||38
227984|NCT01156987|553017|P2|NOT COMPLETED|Overall Study||11
227985|NCT01156987|553018|P1|NOT COMPLETED|Overall Study||0
227986|NCT01156987|553017|P2|COMPLETED|Overall Study||12
227987|NCT01156987|553018|P1|COMPLETED|Overall Study||8
227988|NCT01156987|553017|P2|STARTED|Overall Study||23
227989|NCT01156987|553018|P1|STARTED|Overall Study||8
227990|NCT01156844|553028|P4|NOT COMPLETED|Overall Study||6
227991|NCT01156844|553029|P3|NOT COMPLETED|Overall Study||6
227992|NCT01156844|553030|P2|NOT COMPLETED|Overall Study||2
227993|NCT01156844|553031|P1|NOT COMPLETED|Overall Study||2
227994|NCT01156844|553028|P4|COMPLETED|Overall Study||41
227995|NCT01156844|553029|P3|COMPLETED|Overall Study||42
227996|NCT01156844|553030|P2|COMPLETED|Overall Study||46
227997|NCT01156844|553031|P1|COMPLETED|Overall Study||46
227998|NCT01156844|553028|P4|PD & Safety Sets: Received Study Drug|Overall Study||46
227999|NCT01156844|553029|P3|PD & Safety Sets: Received Study Drug|Overall Study||48
228000|NCT01156844|553030|P2|PD & Safety Sets: Received Study Drug|Overall Study||47
228001|NCT01156844|553031|P1|PD & Safety Sets: Received Study Drug|Overall Study|PD=Pharmacodynamic|48
228002|NCT01156844|553028|P4|STARTED|Overall Study||47
228003|NCT01156844|553029|P3|STARTED|Overall Study||48
228004|NCT01156844|553030|P2|STARTED|Overall Study||48
228005|NCT01156844|553031|P1|STARTED|Overall Study|Randomized participants.|48
228006|NCT01156792|553050|P1|NOT COMPLETED|Overall Study||69
228007|NCT01156792|553050|P1|COMPLETED|Overall Study||93
228008|NCT01156792|553050|P1|STARTED|Overall Study||162
228009|NCT01156714|553118|P3|NOT COMPLETED|Overall Study||3
228010|NCT01156714|553119|P2|NOT COMPLETED|Overall Study||4
228011|NCT01156714|553120|P1|NOT COMPLETED|Overall Study||9
228012|NCT01156714|553118|P3|COMPLETED|Overall Study||17
228013|NCT01156714|553119|P2|COMPLETED|Overall Study||15
228014|NCT01156714|553120|P1|COMPLETED|Overall Study||11
228015|NCT01156714|553118|P3|STARTED|Overall Study||20
228016|NCT01156714|553119|P2|STARTED|Overall Study||19
228017|NCT01156714|553120|P1|STARTED|Overall Study||20
228018|NCT01156701|553143|P4|NOT COMPLETED|Overall Study||0
228019|NCT01156701|553144|P3|NOT COMPLETED|Overall Study||0
228020|NCT01156701|553145|P2|NOT COMPLETED|Overall Study||0
228021|NCT01156701|553146|P1|NOT COMPLETED|Overall Study||0
228022|NCT01156701|553143|P4|COMPLETED|Overall Study||6725
228023|NCT01156701|553144|P3|COMPLETED|Overall Study||163716
228024|NCT01156701|553145|P2|COMPLETED|Overall Study||1007
228025|NCT01156701|553146|P1|COMPLETED|Overall Study||257
228026|NCT01156701|553143|P4|STARTED|Overall Study||6725
228027|NCT01156701|553144|P3|STARTED|Overall Study||163716
228028|NCT01156701|553145|P2|STARTED|Overall Study||1007
228029|NCT01156701|553146|P1|STARTED|Overall Study||257
228030|NCT01156675|553183|P3|NOT COMPLETED|Overall Study||2
228031|NCT01156675|553184|P2|NOT COMPLETED|Overall Study||25
228032|NCT01156675|553185|P1|NOT COMPLETED|Overall Study||34
228033|NCT01156675|553183|P3|COMPLETED|Overall Study||0
228034|NCT01156675|553184|P2|COMPLETED|Overall Study||81
228035|NCT01156675|553185|P1|COMPLETED|Overall Study||73
228036|NCT01156675|553183|P3|STARTED|Overall Study||2
228037|NCT01156675|553184|P2|STARTED|Overall Study||106
228038|NCT01156675|553185|P1|STARTED|Overall Study||107
228039|NCT01156597|553219|P2|NOT COMPLETED|Overall Study||1
228040|NCT01156597|553220|P1|NOT COMPLETED|Overall Study||3
228041|NCT01156597|553219|P2|COMPLETED|Overall Study||13
228042|NCT01156597|553220|P1|COMPLETED|Overall Study||13
228043|NCT01156597|553219|P2|STARTED|Overall Study||14
228044|NCT01156597|553220|P1|STARTED|Overall Study||16
228045|NCT01156571|553232|P2|NOT COMPLETED|Overall Study||19
228046|NCT01156571|553233|P1|NOT COMPLETED|Overall Study||17
228047|NCT01156571|553232|P2|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5545
228048|NCT01156571|553233|P1|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5564
228049|NCT01156571|553232|P2|STARTED|Overall Study|ITT: defined as all patients randomized.|5564
228050|NCT01156571|553233|P1|STARTED|Overall Study|ITT: defined as all patients randomized.|5581
228051|NCT01156532|553243|P1|NOT COMPLETED|Overall Study||2
228052|NCT01156532|553243|P1|COMPLETED|Overall Study||28
228053|NCT01156532|553243|P1|STARTED|Overall Study||30
228054|NCT01156480|553255|P2|NOT COMPLETED|Overall Study||1
228055|NCT01156480|553256|P1|NOT COMPLETED|Overall Study||0
228056|NCT01156480|553255|P2|COMPLETED|Overall Study||1
228057|NCT01156480|553256|P1|COMPLETED|Overall Study||0
228058|NCT01156480|553255|P2|STARTED|Overall Study||2
228059|NCT01156480|553256|P1|STARTED|Overall Study||0
228060|NCT01156376|553285|P3|NOT COMPLETED|Overall Study||4
228061|NCT01156376|553286|P2|NOT COMPLETED|Overall Study||0
228062|NCT01156376|553287|P1|NOT COMPLETED|Overall Study||1
228063|NCT01156376|553285|P3|COMPLETED|Overall Study||23
228064|NCT01156376|553286|P2|COMPLETED|Overall Study||26
228065|NCT01156376|553287|P1|COMPLETED|Overall Study||26
228066|NCT01156376|553285|P3|STARTED|Overall Study||27
228067|NCT01156376|553286|P2|STARTED|Overall Study||26
228068|NCT01156376|553287|P1|STARTED|Overall Study||27
228069|NCT01156363|553508|P1|NOT COMPLETED|Overall Study||22
228070|NCT01156363|553508|P1|COMPLETED|Overall Study||64
228071|NCT01156363|553508|P1|STARTED|Overall Study||86
228072|NCT01156311|553530|P4|NOT COMPLETED|6-month Add-on Therapy Period||10
228073|NCT01156311|553531|P3|NOT COMPLETED|6-month Add-on Therapy Period||12
228074|NCT01156311|553532|P2|NOT COMPLETED|6-month Add-on Therapy Period||0
228075|NCT01156311|553533|P1|NOT COMPLETED|6-month Add-on Therapy Period||0
228076|NCT01156311|553530|P4|COMPLETED|6-month Add-on Therapy Period||37
228077|NCT01156311|553531|P3|COMPLETED|6-month Add-on Therapy Period||45
228078|NCT01156311|553532|P2|COMPLETED|6-month Add-on Therapy Period||0
228079|NCT01156311|553533|P1|COMPLETED|6-month Add-on Therapy Period||0
228080|NCT01156311|553530|P4|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||38
228081|NCT01156311|553531|P3|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||45
228082|NCT01156311|553532|P2|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
228083|NCT01156311|553533|P1|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
228084|NCT01156311|553530|P4|STARTED|6-month Add-on Therapy Period||47
228085|NCT01156311|553531|P3|STARTED|6-month Add-on Therapy Period||57
228086|NCT01156311|553532|P2|STARTED|6-month Add-on Therapy Period||0
228087|NCT01156311|553533|P1|STARTED|6-month Add-on Therapy Period||0
228088|NCT01156311|553530|P4|NOT COMPLETED|2-Month Monotherapy Period||0
228089|NCT01156311|553531|P3|NOT COMPLETED|2-Month Monotherapy Period||0
228090|NCT01156311|553532|P2|NOT COMPLETED|2-Month Monotherapy Period||2
228091|NCT01156311|553533|P1|NOT COMPLETED|2-Month Monotherapy Period||2
228092|NCT01156311|553530|P4|COMPLETED|2-Month Monotherapy Period||0
228093|NCT01156311|553531|P3|COMPLETED|2-Month Monotherapy Period||0
228094|NCT01156311|553532|P2|COMPLETED|2-Month Monotherapy Period||47
228095|NCT01156311|553533|P1|COMPLETED|2-Month Monotherapy Period||57
228096|NCT01156311|553530|P4|STARTED|2-Month Monotherapy Period||0
228097|NCT01156311|553531|P3|STARTED|2-Month Monotherapy Period||0
228098|NCT01156311|553532|P2|STARTED|2-Month Monotherapy Period||49
228099|NCT01156311|553533|P1|STARTED|2-Month Monotherapy Period||59
228100|NCT01156142|553557|P2|NOT COMPLETED|Overall Study||7
228101|NCT01156142|553558|P1|NOT COMPLETED|Overall Study||8
228102|NCT01156142|553557|P2|COMPLETED|Overall Study||71
228103|NCT01156142|553558|P1|COMPLETED|Overall Study||69
228104|NCT01156142|553557|P2|STARTED|Overall Study||78
228105|NCT01156142|553558|P1|STARTED|Overall Study||77
228106|NCT01156116|553576|P2|NOT COMPLETED|Overall Study||1
228107|NCT01156116|553577|P1|NOT COMPLETED|Overall Study||5
228108|NCT01156116|553576|P2|COMPLETED|Overall Study||12
228109|NCT01156116|553577|P1|COMPLETED|Overall Study||21
228110|NCT01156116|553576|P2|STARTED|Overall Study||13
228111|NCT01156116|553577|P1|STARTED|Overall Study||26
228112|NCT01156051|553591|P2|NOT COMPLETED|Overall Study||1
228113|NCT01156051|553592|P1|NOT COMPLETED|Overall Study||1
228114|NCT01156051|553591|P2|COMPLETED|Overall Study||16
228115|NCT01156051|553592|P1|COMPLETED|Overall Study||11
228116|NCT01156051|553591|P2|STARTED|Overall Study||17
228117|NCT01156051|553592|P1|STARTED|Overall Study||12
228118|NCT01156012|553606|P2|NOT COMPLETED|Overall Study||3
228119|NCT01156012|553607|P1|NOT COMPLETED|Overall Study||7
228120|NCT01156012|553606|P2|COMPLETED|Overall Study||186
228121|NCT01156012|553607|P1|COMPLETED|Overall Study||206
228122|NCT01156012|553606|P2|STARTED|Overall Study||189
228123|NCT01156012|553607|P1|STARTED|Overall Study||213
228124|NCT01155999|553615|P2|NOT COMPLETED|Overall Study||4
228125|NCT01155999|553616|P1|NOT COMPLETED|Overall Study||7
228126|NCT01155999|553615|P2|COMPLETED|Overall Study||136
228127|NCT01155999|553616|P1|COMPLETED|Overall Study||139
228128|NCT01155999|553615|P2|STARTED|Overall Study||140
228129|NCT01155999|553616|P1|STARTED|Overall Study||146
228130|NCT01155869|553624|P2|NOT COMPLETED|Overall Study||1
228131|NCT01155869|553625|P1|NOT COMPLETED|Overall Study||3
228132|NCT01155869|553624|P2|COMPLETED|Overall Study||3
228133|NCT01155869|553625|P1|COMPLETED|Overall Study||0
228134|NCT01155869|553624|P2|STARTED|Overall Study||4
228135|NCT01155869|553625|P1|STARTED|Overall Study||3
228136|NCT01155830|553636|P3|NOT COMPLETED|Overall Study||0
228137|NCT01155830|553637|P2|NOT COMPLETED|Overall Study||0
228138|NCT01155830|553638|P1|NOT COMPLETED|Overall Study||0
228139|NCT01155830|553636|P3|COMPLETED|Overall Study||21
228140|NCT01155830|553637|P2|COMPLETED|Overall Study||0
228141|NCT01155830|553638|P1|COMPLETED|Overall Study||0
228142|NCT01155830|553636|P3|STARTED|Overall Study||21
228143|NCT01155830|553637|P2|STARTED|Overall Study||0
228144|NCT01155830|553638|P1|STARTED|Overall Study||0
228145|NCT01155778|553652|P3|NOT COMPLETED|Overall Study||0
228146|NCT01155778|553653|P2|NOT COMPLETED|Overall Study||0
228147|NCT01155778|553654|P1|NOT COMPLETED|Overall Study||0
228148|NCT01155778|553652|P3|COMPLETED|Overall Study||4
228149|NCT01155778|553653|P2|COMPLETED|Overall Study||4
228150|NCT01155778|553654|P1|COMPLETED|Overall Study||4
228151|NCT01155778|553652|P3|STARTED|Overall Study||4
228152|NCT01155778|553653|P2|STARTED|Overall Study||4
228153|NCT01155778|553654|P1|STARTED|Overall Study||4
228154|NCT01155726|553734|P4|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
228155|NCT01155726|553735|P3|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
228156|NCT01155726|553736|P2|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
228157|NCT01155726|553737|P1|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
228158|NCT01155726|553734|P4|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||25
228159|NCT01155726|553735|P3|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||28
228160|NCT01155726|553736|P2|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||20
228161|NCT01155726|553737|P1|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||23
228162|NCT01155726|553734|P4|STARTED|Period 2, 3 Days (Unmask) or (Partial)||25
228163|NCT01155726|553735|P3|STARTED|Period 2, 3 Days (Unmask) or (Partial)||28
228164|NCT01155726|553736|P2|STARTED|Period 2, 3 Days (Unmask) or (Partial)||20
228165|NCT01155726|553737|P1|STARTED|Period 2, 3 Days (Unmask) or (Partial)||23
228166|NCT01155726|553734|P4|NOT COMPLETED|Period 1, 3 Days (Masked)||0
228167|NCT01155726|553735|P3|NOT COMPLETED|Period 1, 3 Days (Masked)||2
228168|NCT01155726|553736|P2|NOT COMPLETED|Period 1, 3 Days (Masked)||0
228169|NCT01155726|553737|P1|NOT COMPLETED|Period 1, 3 Days (Masked)||1
228170|NCT01155726|553734|P4|COMPLETED|Period 1, 3 Days (Masked)||25
228171|NCT01155726|553735|P3|COMPLETED|Period 1, 3 Days (Masked)||28
228172|NCT01155726|553736|P2|COMPLETED|Period 1, 3 Days (Masked)||20
228173|NCT01155726|553737|P1|COMPLETED|Period 1, 3 Days (Masked)||23
228174|NCT01155726|553734|P4|STARTED|Period 1, 3 Days (Masked)||25
228175|NCT01155726|553735|P3|STARTED|Period 1, 3 Days (Masked)||30
228176|NCT01155726|553736|P2|STARTED|Period 1, 3 Days (Masked)||20
228177|NCT01155726|553737|P1|STARTED|Period 1, 3 Days (Masked)||24
228178|NCT01155661|553759|P1|NOT COMPLETED|Overall Study||280
228179|NCT01155661|553759|P1|COMPLETED|Overall Study||328
228180|NCT01155661|553759|P1|STARTED|Overall Study||608
228181|NCT01155570|553785|P1|NOT COMPLETED|Overall Study||142
228182|NCT01155570|553785|P1|COMPLETED|Overall Study||592
228183|NCT01155570|553785|P1|Efficacy Analysis Population|Overall Study|5 received Humira off-label, 21 did not receive Humira after the first administration|708
228184|NCT01155570|553785|P1|STARTED|Overall Study|Safety Analysis Population|734
228185|NCT01155531|553819|P4|NOT COMPLETED|Overall Study||1
228186|NCT01155531|553820|P3|NOT COMPLETED|Overall Study||2
228187|NCT01155531|553821|P2|NOT COMPLETED|Overall Study||0
228188|NCT01155531|553822|P1|NOT COMPLETED|Overall Study||1
228189|NCT01155531|553819|P4|COMPLETED|Overall Study||9
228190|NCT01155531|553820|P3|COMPLETED|Overall Study||8
228191|NCT01155531|553821|P2|COMPLETED|Overall Study||10
228192|NCT01155531|553822|P1|COMPLETED|Overall Study||9
228193|NCT01155531|553819|P4|STARTED|Overall Study||10
228194|NCT01155531|553820|P3|STARTED|Overall Study||10
228195|NCT01155531|553821|P2|STARTED|Overall Study||10
228196|NCT01155531|553822|P1|STARTED|Overall Study||10
228197|NCT01155518|553846|P6|NOT COMPLETED|Overall Study||0
228198|NCT01155518|553847|P5|NOT COMPLETED|Overall Study||0
228199|NCT01155518|553848|P4|NOT COMPLETED|Overall Study||0
228200|NCT01155518|553849|P3|NOT COMPLETED|Overall Study||0
228201|NCT01155518|553850|P2|NOT COMPLETED|Overall Study||1
228202|NCT01155518|553851|P1|NOT COMPLETED|Overall Study||0
228203|NCT01155518|553846|P6|COMPLETED|Overall Study||2
228204|NCT01155518|553847|P5|COMPLETED|Overall Study||1
228205|NCT01155518|553848|P4|COMPLETED|Overall Study||0
228206|NCT01155518|553849|P3|COMPLETED|Overall Study||0
228207|NCT01155518|553850|P2|COMPLETED|Overall Study|never started the study|0
228208|NCT01155518|553851|P1|COMPLETED|Overall Study||1
228209|NCT01155518|553846|P6|STARTED|Overall Study||2
228210|NCT01155518|553847|P5|STARTED|Overall Study||1
228211|NCT01155518|553848|P4|STARTED|Overall Study||0
228212|NCT01155518|553849|P3|STARTED|Overall Study||0
228213|NCT01155518|553850|P2|STARTED|Overall Study||1
228214|NCT01155518|553851|P1|STARTED|Overall Study||1
228215|NCT01155479|553870|P5|NOT COMPLETED|Part II||55
228216|NCT01155479|553871|P4|NOT COMPLETED|Part II||50
228217|NCT01155479|553872|P3|NOT COMPLETED|Part II||58
228218|NCT01155479|553873|P2|NOT COMPLETED|Part II||61
228219|NCT01155479|553874|P1|NOT COMPLETED|Part II||59
228220|NCT01155479|553870|P5|COMPLETED|Part II||126
228221|NCT01155479|553871|P4|COMPLETED|Part II||127
228222|NCT01155479|553872|P3|COMPLETED|Part II||109
228223|NCT01155479|553873|P2|COMPLETED|Part II||116
228224|NCT01155479|553874|P1|COMPLETED|Part II||107
228225|NCT01155479|553870|P5|STARTED|Part II||181
228226|NCT01155479|553871|P4|STARTED|Part II||177
228227|NCT01155479|553872|P3|STARTED|Part II||167
228228|NCT01155479|553873|P2|STARTED|Part II||177
228229|NCT01155479|553874|P1|STARTED|Part II||166
228230|NCT01155479|553870|P5|NOT COMPLETED|Part I||23
228231|NCT01155479|553871|P4|NOT COMPLETED|Part I||27
228232|NCT01155479|553872|P3|NOT COMPLETED|Part I||39
228233|NCT01155479|553873|P2|NOT COMPLETED|Part I||27
228234|NCT01155479|553874|P1|NOT COMPLETED|Part I||38
228235|NCT01155479|553870|P5|COMPLETED|Part I||181
228236|NCT01155479|553871|P4|COMPLETED|Part I||177
228237|NCT01155479|553872|P3|COMPLETED|Part I||167
228238|NCT01155479|553873|P2|COMPLETED|Part I||177
228239|NCT01155479|553874|P1|COMPLETED|Part I||166
228240|NCT01155479|553870|P5|Treated|Part I||203
228241|NCT01155479|553871|P4|Treated|Part I||198
228242|NCT01155479|553872|P3|Treated|Part I||204
228243|NCT01155479|553873|P2|Treated|Part I||202
228244|NCT01155479|553874|P1|Treated|Part I||200
228245|NCT01155479|553870|P5|STARTED|Part I||204
228246|NCT01155479|553871|P4|STARTED|Part I||204
228247|NCT01155479|553872|P3|STARTED|Part I||206
228248|NCT01155479|553873|P2|STARTED|Part I||204
228249|NCT01155479|553874|P1|STARTED|Part I||204
228250|NCT01155466|553926|P5|NOT COMPLETED|Overall Study||27
228251|NCT01155466|553927|P4|NOT COMPLETED|Overall Study||21
228252|NCT01155466|553928|P3|NOT COMPLETED|Overall Study||20
228253|NCT01155466|553929|P2|NOT COMPLETED|Overall Study||25
228254|NCT01155466|553930|P1|NOT COMPLETED|Overall Study||22
228255|NCT01155466|553926|P5|COMPLETED|Overall Study|Completed treatment phase|129
228256|NCT01155466|553927|P4|COMPLETED|Overall Study|Completed treatment phase|134
228257|NCT01155466|553928|P3|COMPLETED|Overall Study|Completed treatment phase|136
228258|NCT01155466|553929|P2|COMPLETED|Overall Study|Completed treatment phase|130
228259|NCT01155466|553930|P1|COMPLETED|Overall Study|Completed treatment phase|134
228260|NCT01155466|553926|P5|Treated|Overall Study||154
228261|NCT01155466|553927|P4|Treated|Overall Study||155
228262|NCT01155466|553928|P3|Treated|Overall Study||153
228263|NCT01155466|553929|P2|Treated|Overall Study||153
228264|NCT01155466|553930|P1|Treated|Overall Study||154
228265|NCT01155466|553926|P5|STARTED|Overall Study||156
228266|NCT01155466|553927|P4|STARTED|Overall Study||155
228267|NCT01155466|553928|P3|STARTED|Overall Study||156
228268|NCT01155466|553929|P2|STARTED|Overall Study||155
228269|NCT01155466|553930|P1|STARTED|Overall Study||156
228270|NCT01155388|553984|P2|NOT COMPLETED|Overall Study||0
228271|NCT01155388|553985|P1|NOT COMPLETED|Overall Study||1
228272|NCT01155388|553984|P2|COMPLETED|Overall Study||6
228273|NCT01155388|553985|P1|COMPLETED|Overall Study||7
228274|NCT01155388|553984|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
228275|NCT01155388|553985|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
228276|NCT01155388|553984|P2|STARTED|Overall Study||6
228277|NCT01155388|553985|P1|STARTED|Overall Study||8
228278|NCT01155375|553995|P2|NOT COMPLETED|Overall Study||0
228279|NCT01155375|553996|P1|NOT COMPLETED|Overall Study||1
228280|NCT01155375|553995|P2|COMPLETED|Overall Study||6
228281|NCT01155375|553996|P1|COMPLETED|Overall Study||7
228282|NCT01155375|553995|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
228283|NCT01155375|553996|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
228284|NCT01155375|553995|P2|STARTED|Overall Study||6
228285|NCT01155375|553996|P1|STARTED|Overall Study||8
228286|NCT01155336|554006|P2|NOT COMPLETED|Overall Study||0
228287|NCT01155336|554007|P1|NOT COMPLETED|Overall Study||0
228288|NCT01155336|554006|P2|COMPLETED|Overall Study|We did not complete the study.|4
228289|NCT01155336|554007|P1|COMPLETED|Overall Study|We did not complete the study.|0
228290|NCT01155336|554006|P2|STARTED|Overall Study|We did not complete the study.|4
228291|NCT01155336|554007|P1|STARTED|Overall Study|We did not complete the study.|0
228292|NCT01155323|554015|P2|NOT COMPLETED|Second Intervention||1
228293|NCT01155323|554016|P1|NOT COMPLETED|Second Intervention||1
228294|NCT01155323|554015|P2|COMPLETED|Second Intervention||56
228295|NCT01155323|554016|P1|COMPLETED|Second Intervention||58
228296|NCT01155323|554015|P2|STARTED|Second Intervention||57
228297|NCT01155323|554016|P1|STARTED|Second Intervention||59
228298|NCT01155323|554015|P2|NOT COMPLETED|First Intervention||1
228299|NCT01155323|554016|P1|NOT COMPLETED|First Intervention||1
228300|NCT01155323|554015|P2|COMPLETED|First Intervention||57
228301|NCT01155323|554016|P1|COMPLETED|First Intervention||59
228302|NCT01155323|554015|P2|STARTED|First Intervention||58
228303|NCT01155323|554016|P1|STARTED|First Intervention||60
228304|NCT01155284|554034|P2|NOT COMPLETED|Overall Study||5
228305|NCT01155284|554035|P1|NOT COMPLETED|Overall Study||7
228306|NCT01155284|554034|P2|COMPLETED|Overall Study||18
228307|NCT01155284|554035|P1|COMPLETED|Overall Study||40
228308|NCT01155284|554034|P2|STARTED|Overall Study||23
228309|NCT01155284|554035|P1|STARTED|Overall Study||47
228310|NCT01155219|554045|P2|NOT COMPLETED|Overall Study||3
228311|NCT01155219|554046|P1|NOT COMPLETED|Overall Study||4
228312|NCT01155219|554045|P2|COMPLETED|Overall Study||70
228313|NCT01155219|554046|P1|COMPLETED|Overall Study||73
228314|NCT01155219|554045|P2|STARTED|Overall Study||73
228315|NCT01155219|554046|P1|STARTED|Overall Study||77
228316|NCT01155193|554056|P4|NOT COMPLETED|Overall Study||91
228317|NCT01155193|554057|P3|NOT COMPLETED|Overall Study||12
228318|NCT01155193|554058|P2|NOT COMPLETED|Overall Study||13
228319|NCT01155193|554059|P1|NOT COMPLETED|Overall Study||238
228320|NCT01155193|554056|P4|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|13711
228321|NCT01155193|554057|P3|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|2248
228322|NCT01155193|554058|P2|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|3805
228323|NCT01155193|554059|P1|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|10686
228324|NCT01155193|554056|P4|STARTED|Overall Study||13802
228325|NCT01155193|554057|P3|STARTED|Overall Study||2260
228326|NCT01155193|554058|P2|STARTED|Overall Study||3818
228327|NCT01155193|554059|P1|STARTED|Overall Study||10924
228328|NCT01155180|554086|P2|NOT COMPLETED|Overall Study||0
228329|NCT01155180|554087|P1|NOT COMPLETED|Overall Study||0
228330|NCT01155180|554086|P2|COMPLETED|Overall Study||6
228331|NCT01155180|554087|P1|COMPLETED|Overall Study||18
228332|NCT01155180|554086|P2|STARTED|Overall Study||6
228333|NCT01155180|554087|P1|STARTED|Overall Study||18
228334|NCT01155167|554095|P2|NOT COMPLETED|Overall Study||0
228335|NCT01155167|554096|P1|NOT COMPLETED|Overall Study||3
228336|NCT01155167|554095|P2|COMPLETED|Overall Study||43
228337|NCT01155167|554096|P1|COMPLETED|Overall Study||40
228338|NCT01155167|554095|P2|STARTED|Overall Study||43
228339|NCT01155167|554096|P1|STARTED|Overall Study||43
228340|NCT01155154|554109|P3|NOT COMPLETED|Overall Study||0
228341|NCT01155154|554110|P2|NOT COMPLETED|Overall Study||0
228342|NCT01155154|554111|P1|NOT COMPLETED|Overall Study||0
228343|NCT01155154|554109|P3|COMPLETED|Overall Study||24
228344|NCT01155154|554110|P2|COMPLETED|Overall Study||24
228345|NCT01155154|554111|P1|COMPLETED|Overall Study||25
228346|NCT01155154|554109|P3|STARTED|Overall Study||24
228347|NCT01155154|554110|P2|STARTED|Overall Study||24
228348|NCT01155154|554111|P1|STARTED|Overall Study||25
228349|NCT01155141|554119|P1|NOT COMPLETED|Overall Study||2
228350|NCT01155141|554119|P1|COMPLETED|Overall Study||14
228351|NCT01155141|554119|P1|STARTED|Overall Study||16
228352|NCT01155063|554131|P1|NOT COMPLETED|Overall Study||89
228353|NCT01155063|554131|P1|COMPLETED|Overall Study||0
228354|NCT01155063|554131|P1|STARTED|Overall Study||89
228355|NCT01155024|554141|P2|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||6
228356|NCT01155024|554142|P1|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||0
228357|NCT01155024|554141|P2|COMPLETED|Direct Manufactured Socket 3 Month Trial||4
228358|NCT01155024|554142|P1|COMPLETED|Direct Manufactured Socket 3 Month Trial||0
228359|NCT01155024|554141|P2|STARTED|Direct Manufactured Socket 3 Month Trial||10
228360|NCT01155024|554142|P1|STARTED|Direct Manufactured Socket 3 Month Trial||0
228361|NCT01155024|554141|P2|NOT COMPLETED|Second Socket Intervention Fitting||0
228362|NCT01155024|554142|P1|NOT COMPLETED|Second Socket Intervention Fitting||0
228363|NCT01155024|554141|P2|COMPLETED|Second Socket Intervention Fitting||5
228364|NCT01155024|554142|P1|COMPLETED|Second Socket Intervention Fitting||5
228365|NCT01155024|554141|P2|STARTED|Second Socket Intervention Fitting||5
228366|NCT01155024|554142|P1|STARTED|Second Socket Intervention Fitting||5
228367|NCT01155024|554141|P2|NOT COMPLETED|First Socket Intervention Fitting||0
228368|NCT01155024|554142|P1|NOT COMPLETED|First Socket Intervention Fitting||0
228369|NCT01155024|554141|P2|COMPLETED|First Socket Intervention Fitting||5
228370|NCT01155024|554142|P1|COMPLETED|First Socket Intervention Fitting||5
228371|NCT01155024|554141|P2|STARTED|First Socket Intervention Fitting||5
228372|NCT01155024|554142|P1|STARTED|First Socket Intervention Fitting||5
228373|NCT01155011|554152|P2|NOT COMPLETED|6 to 12 Months||10
228374|NCT01155011|554153|P1|NOT COMPLETED|6 to 12 Months||9
228375|NCT01155011|554152|P2|COMPLETED|6 to 12 Months||121
228376|NCT01155011|554153|P1|COMPLETED|6 to 12 Months||120
228377|NCT01155011|554152|P2|STARTED|6 to 12 Months||131
228378|NCT01155011|554153|P1|STARTED|6 to 12 Months||129
228379|NCT01155011|554152|P2|NOT COMPLETED|Baseline to 6 Months||25
228380|NCT01155011|554153|P1|NOT COMPLETED|Baseline to 6 Months||22
228381|NCT01155011|554152|P2|COMPLETED|Baseline to 6 Months||131
228382|NCT01155011|554153|P1|COMPLETED|Baseline to 6 Months||129
228383|NCT01155011|554152|P2|STARTED|Baseline to 6 Months||156
228384|NCT01155011|554153|P1|STARTED|Baseline to 6 Months||151
228385|NCT01154985|554166|P3|NOT COMPLETED|Overall Study||18
228386|NCT01154985|554167|P2|NOT COMPLETED|Overall Study||27
228387|NCT01154985|554168|P1|NOT COMPLETED|Overall Study||17
228388|NCT01154985|554166|P3|COMPLETED|Overall Study||68
228389|NCT01154985|554167|P2|COMPLETED|Overall Study||55
228390|NCT01154985|554168|P1|COMPLETED|Overall Study||58
228391|NCT01154985|554166|P3|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|64
228392|NCT01154985|554167|P2|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
228393|NCT01154985|554168|P1|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
228394|NCT01154985|554166|P3|Valid Biopsy -Baseline and Month 12.5|Overall Study||68
228395|NCT01154985|554167|P2|Valid Biopsy -Baseline and Month 12.5|Overall Study||62
228396|NCT01154985|554168|P1|Valid Biopsy -Baseline and Month 12.5|Overall Study||60
228397|NCT01154985|554166|P3|Full Analysis Set|Overall Study|Received at least one dose of study medication|86
228398|NCT01154985|554167|P2|Full Analysis Set|Overall Study|Received at least one dose of study medication|82
228399|NCT01154985|554168|P1|Full Analysis Set|Overall Study|Received at least one dose of study medication|75
228400|NCT01154985|554166|P3|STARTED|Overall Study|Randomized|86
228401|NCT01154985|554167|P2|STARTED|Overall Study|Randomized|82
228402|NCT01154985|554168|P1|STARTED|Overall Study|Randomized|75
228403|NCT01154816|554194|P12|NOT COMPLETED|Overall Study||4
228404|NCT01154816|554195|P11|NOT COMPLETED|Overall Study||11
228405|NCT01154816|554196|P10|NOT COMPLETED|Overall Study||10
228406|NCT01154816|554197|P9|NOT COMPLETED|Overall Study||9
228407|NCT01154816|554198|P8|NOT COMPLETED|Overall Study||7
228408|NCT01154816|554199|P7|NOT COMPLETED|Overall Study||6
228409|NCT01154816|554200|P6|NOT COMPLETED|Overall Study||8
228410|NCT01154816|554201|P5|NOT COMPLETED|Overall Study||10
228411|NCT01154816|554202|P4|NOT COMPLETED|Overall Study||10
228412|NCT01154816|554203|P3|NOT COMPLETED|Overall Study||10
228413|NCT01154816|554204|P2|NOT COMPLETED|Overall Study||10
228414|NCT01154816|554205|P1|NOT COMPLETED|Overall Study||20
228415|NCT01154816|554194|P12|COMPLETED|Overall Study||0
228416|NCT01154816|554195|P11|COMPLETED|Overall Study||0
228417|NCT01154816|554196|P10|COMPLETED|Overall Study||0
228418|NCT01154816|554197|P9|COMPLETED|Overall Study||1
228419|NCT01154816|554198|P8|COMPLETED|Overall Study||0
228420|NCT01154816|554199|P7|COMPLETED|Overall Study||0
228421|NCT01154816|554200|P6|COMPLETED|Overall Study||0
228422|NCT01154816|554201|P5|COMPLETED|Overall Study||0
228423|NCT01154816|554202|P4|COMPLETED|Overall Study||0
228424|NCT01154816|554203|P3|COMPLETED|Overall Study||0
228425|NCT01154816|554204|P2|COMPLETED|Overall Study||2
228426|NCT01154816|554205|P1|COMPLETED|Overall Study||0
228427|NCT01154816|554194|P12|STARTED|Overall Study||4
228428|NCT01154816|554195|P11|STARTED|Overall Study||11
228429|NCT01154816|554196|P10|STARTED|Overall Study||10
228430|NCT01154816|554197|P9|STARTED|Overall Study||10
228431|NCT01154816|554198|P8|STARTED|Overall Study||7
228432|NCT01154816|554199|P7|STARTED|Overall Study||6
228433|NCT01154816|554200|P6|STARTED|Overall Study||8
228434|NCT01154816|554201|P5|STARTED|Overall Study||10
228435|NCT01154816|554202|P4|STARTED|Overall Study||10
228436|NCT01154816|554203|P3|STARTED|Overall Study||10
228437|NCT01154816|554204|P2|STARTED|Overall Study||12
228438|NCT01154816|554205|P1|STARTED|Overall Study||20
228439|NCT01154751|554238|P1|NOT COMPLETED|3-year Follow-up||49
228440|NCT01154751|554238|P1|COMPLETED|3-year Follow-up||34
228441|NCT01154751|554238|P1|STARTED|3-year Follow-up||83
228442|NCT01154751|554238|P1|NOT COMPLETED|2-year Follow-up||10
228443|NCT01154751|554238|P1|COMPLETED|2-year Follow-up||83
228444|NCT01154751|554238|P1|STARTED|2-year Follow-up||93
228445|NCT01154751|554238|P1|NOT COMPLETED|1-year Follow-up||5
228446|NCT01154751|554238|P1|COMPLETED|1-year Follow-up||93
228447|NCT01154751|554238|P1|STARTED|1-year Follow-up||98
228448|NCT01154751|554238|P1|NOT COMPLETED|6-month Follow-up||11
228449|NCT01154751|554238|P1|COMPLETED|6-month Follow-up||98
228450|NCT01154751|554238|P1|STARTED|6-month Follow-up||109
228451|NCT01154699|554263|P2|NOT COMPLETED|Second Intervention||0
228452|NCT01154699|554264|P1|NOT COMPLETED|Second Intervention||0
228453|NCT01154699|554263|P2|COMPLETED|Second Intervention||8
228454|NCT01154699|554264|P1|COMPLETED|Second Intervention||13
228455|NCT01154699|554263|P2|Subjects With Asthma + OSA|Second Intervention||2
228456|NCT01154699|554264|P1|Subjects With Asthma + OSA|Second Intervention||6
228457|NCT01154699|554263|P2|Subjects With Asthma Only|Second Intervention||6
228458|NCT01154699|554264|P1|Subjects With Asthma Only|Second Intervention||7
228459|NCT01154699|554263|P2|STARTED|Second Intervention||8
228460|NCT01154699|554264|P1|STARTED|Second Intervention||13
228461|NCT01154699|554263|P2|NOT COMPLETED|Washout Period (4 Weeks)||0
228462|NCT01154699|554264|P1|NOT COMPLETED|Washout Period (4 Weeks)||0
228463|NCT01154699|554263|P2|COMPLETED|Washout Period (4 Weeks)||8
228464|NCT01154699|554264|P1|COMPLETED|Washout Period (4 Weeks)||13
228465|NCT01154699|554263|P2|Subjects With Asthma + OSA|Washout Period (4 Weeks)||2
228466|NCT01154699|554264|P1|Subjects With Asthma + OSA|Washout Period (4 Weeks)||6
228467|NCT01154699|554263|P2|Subjects With Asthma Only|Washout Period (4 Weeks)||6
228468|NCT01154699|554264|P1|Subjects With Asthma Only|Washout Period (4 Weeks)||7
228469|NCT01154699|554263|P2|STARTED|Washout Period (4 Weeks)||8
228470|NCT01154699|554264|P1|STARTED|Washout Period (4 Weeks)||13
228471|NCT01154699|554263|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
228472|NCT01154699|554264|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
228473|NCT01154699|554263|P2|COMPLETED|First Intervention (4 Weeks)||8
228474|NCT01154699|554264|P1|COMPLETED|First Intervention (4 Weeks)||13
228475|NCT01154699|554263|P2|Subjects With Asthma + OSA|First Intervention (4 Weeks)||2
228476|NCT01154699|554264|P1|Subjects With Asthma + OSA|First Intervention (4 Weeks)||6
228477|NCT01154699|554263|P2|Subjects With Asthma Only|First Intervention (4 Weeks)||6
228478|NCT01154699|554264|P1|Subjects With Asthma Only|First Intervention (4 Weeks)||7
228479|NCT01154699|554263|P2|STARTED|First Intervention (4 Weeks)||8
228480|NCT01154699|554264|P1|STARTED|First Intervention (4 Weeks)||13
228481|NCT01154673|554282|P2|NOT COMPLETED|Overall Study||0
228482|NCT01154673|554283|P1|NOT COMPLETED|Overall Study||2
228483|NCT01154673|554282|P2|COMPLETED|Overall Study||16
228484|NCT01154673|554283|P1|COMPLETED|Overall Study||14
228485|NCT01154673|554282|P2|STARTED|Overall Study||16
228486|NCT01154673|554283|P1|STARTED|Overall Study||16
228487|NCT01154634|554293|P4|NOT COMPLETED|Period 7 - Fourth Intervention||0
228488|NCT01154634|554294|P3|NOT COMPLETED|Period 7 - Fourth Intervention||0
228489|NCT01154634|554295|P2|NOT COMPLETED|Period 7 - Fourth Intervention||0
228490|NCT01154634|554296|P1|NOT COMPLETED|Period 7 - Fourth Intervention||0
228491|NCT01154634|554293|P4|COMPLETED|Period 7 - Fourth Intervention||5
228492|NCT01154634|554294|P3|COMPLETED|Period 7 - Fourth Intervention||4
228493|NCT01154634|554295|P2|COMPLETED|Period 7 - Fourth Intervention||7
228494|NCT01154634|554296|P1|COMPLETED|Period 7 - Fourth Intervention||4
228495|NCT01154634|554293|P4|STARTED|Period 7 - Fourth Intervention||5
228496|NCT01154634|554294|P3|STARTED|Period 7 - Fourth Intervention||4
228497|NCT01154634|554295|P2|STARTED|Period 7 - Fourth Intervention||7
228498|NCT01154634|554296|P1|STARTED|Period 7 - Fourth Intervention||4
228499|NCT01154634|554293|P4|NOT COMPLETED|Period 6 - Washout||0
228500|NCT01154634|554294|P3|NOT COMPLETED|Period 6 - Washout||0
228501|NCT01154634|554295|P2|NOT COMPLETED|Period 6 - Washout||0
228502|NCT01154634|554296|P1|NOT COMPLETED|Period 6 - Washout||0
228503|NCT01154634|554293|P4|COMPLETED|Period 6 - Washout||5
228504|NCT01154634|554294|P3|COMPLETED|Period 6 - Washout||4
228505|NCT01154634|554295|P2|COMPLETED|Period 6 - Washout||7
228506|NCT01154634|554296|P1|COMPLETED|Period 6 - Washout||4
228507|NCT01154634|554293|P4|STARTED|Period 6 - Washout||5
228508|NCT01154634|554294|P3|STARTED|Period 6 - Washout||4
228509|NCT01154634|554295|P2|STARTED|Period 6 - Washout||7
228510|NCT01154634|554296|P1|STARTED|Period 6 - Washout||4
228511|NCT01154634|554293|P4|NOT COMPLETED|Period 5 - Third Intervention||0
228512|NCT01154634|554294|P3|NOT COMPLETED|Period 5 - Third Intervention||0
228513|NCT01154634|554295|P2|NOT COMPLETED|Period 5 - Third Intervention||0
228514|NCT01154634|554296|P1|NOT COMPLETED|Period 5 - Third Intervention||0
228515|NCT01154634|554293|P4|COMPLETED|Period 5 - Third Intervention||5
228516|NCT01154634|554294|P3|COMPLETED|Period 5 - Third Intervention||4
228517|NCT01154634|554295|P2|COMPLETED|Period 5 - Third Intervention||7
228518|NCT01154634|554296|P1|COMPLETED|Period 5 - Third Intervention||4
228519|NCT01154634|554293|P4|STARTED|Period 5 - Third Intervention||5
228520|NCT01154634|554294|P3|STARTED|Period 5 - Third Intervention||4
228521|NCT01154634|554295|P2|STARTED|Period 5 - Third Intervention||7
228522|NCT01154634|554296|P1|STARTED|Period 5 - Third Intervention||4
228523|NCT01154634|554293|P4|NOT COMPLETED|Period 4 - Washout||0
228524|NCT01154634|554294|P3|NOT COMPLETED|Period 4 - Washout||0
228525|NCT01154634|554295|P2|NOT COMPLETED|Period 4 - Washout||0
228526|NCT01154634|554296|P1|NOT COMPLETED|Period 4 - Washout||0
228527|NCT01154634|554293|P4|COMPLETED|Period 4 - Washout||5
228528|NCT01154634|554294|P3|COMPLETED|Period 4 - Washout||4
228529|NCT01154634|554295|P2|COMPLETED|Period 4 - Washout||7
228530|NCT01154634|554296|P1|COMPLETED|Period 4 - Washout||4
228531|NCT01154634|554293|P4|STARTED|Period 4 - Washout||5
228532|NCT01154634|554294|P3|STARTED|Period 4 - Washout||4
228533|NCT01154634|554295|P2|STARTED|Period 4 - Washout||7
228534|NCT01154634|554296|P1|STARTED|Period 4 - Washout||4
228535|NCT01154634|554293|P4|NOT COMPLETED|Period 3- Second Intervention||0
228536|NCT01154634|554294|P3|NOT COMPLETED|Period 3- Second Intervention||0
228537|NCT01154634|554295|P2|NOT COMPLETED|Period 3- Second Intervention||0
228538|NCT01154634|554296|P1|NOT COMPLETED|Period 3- Second Intervention||0
228539|NCT01154634|554293|P4|COMPLETED|Period 3- Second Intervention||5
228540|NCT01154634|554294|P3|COMPLETED|Period 3- Second Intervention||4
228541|NCT01154634|554295|P2|COMPLETED|Period 3- Second Intervention||7
228542|NCT01154634|554296|P1|COMPLETED|Period 3- Second Intervention||4
228543|NCT01154634|554293|P4|STARTED|Period 3- Second Intervention||5
228544|NCT01154634|554294|P3|STARTED|Period 3- Second Intervention||4
228545|NCT01154634|554295|P2|STARTED|Period 3- Second Intervention||7
228546|NCT01154634|554296|P1|STARTED|Period 3- Second Intervention||4
228547|NCT01154634|554293|P4|NOT COMPLETED|Period 2 - Washout||0
228548|NCT01154634|554294|P3|NOT COMPLETED|Period 2 - Washout||0
228549|NCT01154634|554295|P2|NOT COMPLETED|Period 2 - Washout||0
228550|NCT01154634|554296|P1|NOT COMPLETED|Period 2 - Washout||0
228551|NCT01154634|554293|P4|COMPLETED|Period 2 - Washout||5
228552|NCT01154634|554294|P3|COMPLETED|Period 2 - Washout||4
228553|NCT01154634|554295|P2|COMPLETED|Period 2 - Washout||7
228554|NCT01154634|554296|P1|COMPLETED|Period 2 - Washout||4
228555|NCT01154634|554293|P4|STARTED|Period 2 - Washout||5
228556|NCT01154634|554294|P3|STARTED|Period 2 - Washout||4
228557|NCT01154634|554295|P2|STARTED|Period 2 - Washout||7
228558|NCT01154634|554296|P1|STARTED|Period 2 - Washout||4
228559|NCT01154634|554293|P4|NOT COMPLETED|Period 1 - First Intervention||0
228560|NCT01154634|554294|P3|NOT COMPLETED|Period 1 - First Intervention||0
228561|NCT01154634|554295|P2|NOT COMPLETED|Period 1 - First Intervention||0
228562|NCT01154634|554296|P1|NOT COMPLETED|Period 1 - First Intervention||0
228563|NCT01154634|554293|P4|COMPLETED|Period 1 - First Intervention||5
228564|NCT01154634|554294|P3|COMPLETED|Period 1 - First Intervention||4
228565|NCT01154634|554295|P2|COMPLETED|Period 1 - First Intervention||7
228566|NCT01154634|554296|P1|COMPLETED|Period 1 - First Intervention||4
228567|NCT01154634|554293|P4|STARTED|Period 1 - First Intervention||5
228568|NCT01154634|554294|P3|STARTED|Period 1 - First Intervention||4
228569|NCT01154634|554295|P2|STARTED|Period 1 - First Intervention||7
228570|NCT01154634|554296|P1|STARTED|Period 1 - First Intervention||4
228571|NCT01154452|554338|P4|NOT COMPLETED|Phase II||6
228572|NCT01154452|554339|P3|NOT COMPLETED|Phase II||5
228573|NCT01154452|554340|P2|NOT COMPLETED|Phase II||0
228574|NCT01154452|554341|P1|NOT COMPLETED|Phase II||0
228575|NCT01154452|554338|P4|COMPLETED|Phase II||27
228576|NCT01154452|554339|P3|COMPLETED|Phase II||30
228577|NCT01154452|554340|P2|COMPLETED|Phase II||0
228578|NCT01154452|554341|P1|COMPLETED|Phase II||0
228579|NCT01154452|554338|P4|STARTED|Phase II||33
228580|NCT01154452|554339|P3|STARTED|Phase II||35
228581|NCT01154452|554340|P2|STARTED|Phase II||0
228582|NCT01154452|554341|P1|STARTED|Phase II||0
228583|NCT01154452|554338|P4|NOT COMPLETED|Phase Ib||0
228584|NCT01154452|554339|P3|NOT COMPLETED|Phase Ib||0
228585|NCT01154452|554340|P2|NOT COMPLETED|Phase Ib||1
228586|NCT01154452|554341|P1|NOT COMPLETED|Phase Ib||3
228587|NCT01154452|554338|P4|COMPLETED|Phase Ib||0
228588|NCT01154452|554339|P3|COMPLETED|Phase Ib||0
228589|NCT01154452|554340|P2|COMPLETED|Phase Ib||3
228590|NCT01154452|554341|P1|COMPLETED|Phase Ib||3
228591|NCT01154452|554338|P4|STARTED|Phase Ib||0
228592|NCT01154452|554339|P3|STARTED|Phase Ib||0
228593|NCT01154452|554340|P2|STARTED|Phase Ib||4
228594|NCT01154452|554341|P1|STARTED|Phase Ib||6
228595|NCT01154335|554357|P3|NOT COMPLETED|Overall Study||5
228596|NCT01154335|554358|P2|NOT COMPLETED|Overall Study||6
228597|NCT01154335|554359|P1|NOT COMPLETED|Overall Study||7
228598|NCT01154335|554357|P3|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
228599|NCT01154335|554358|P2|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
228600|NCT01154335|554359|P1|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
228601|NCT01154335|554357|P3|STARTED|Overall Study||5
228602|NCT01154335|554358|P2|STARTED|Overall Study||6
228603|NCT01154335|554359|P1|STARTED|Overall Study||7
228604|NCT01154322|554366|P1|NOT COMPLETED|Overall Study||2
228605|NCT01154322|554366|P1|COMPLETED|Overall Study||14
228606|NCT01154322|554366|P1|STARTED|Overall Study||16
228607|NCT01154296|554373|P2|NOT COMPLETED|6-month Follow-up||328
228608|NCT01154296|554374|P1|NOT COMPLETED|6-month Follow-up||328
228609|NCT01154296|554373|P2|COMPLETED|6-month Follow-up||2179
228610|NCT01154296|554374|P1|COMPLETED|6-month Follow-up||2177
228611|NCT01154296|554373|P2|STARTED|6-month Follow-up||2507
228612|NCT01154296|554374|P1|STARTED|6-month Follow-up||2505
228613|NCT01154296|554373|P2|NOT COMPLETED|Randomization and Intervention||2
228614|NCT01154296|554374|P1|NOT COMPLETED|Randomization and Intervention||5
228615|NCT01154296|554373|P2|COMPLETED|Randomization and Intervention||2505
228616|NCT01154296|554374|P1|COMPLETED|Randomization and Intervention||2500
228617|NCT01154296|554373|P2|STARTED|Randomization and Intervention||2507
228618|NCT01154296|554374|P1|STARTED|Randomization and Intervention||2505
228619|NCT01154283|554392|P2|NOT COMPLETED|7-12 Weeks||1
228620|NCT01154283|554393|P1|NOT COMPLETED|7-12 Weeks||1
228621|NCT01154283|554392|P2|COMPLETED|7-12 Weeks||10
228622|NCT01154283|554393|P1|COMPLETED|7-12 Weeks||6
228623|NCT01154283|554392|P2|STARTED|7-12 Weeks||11
228624|NCT01154283|554393|P1|STARTED|7-12 Weeks||7
228625|NCT01154283|554392|P2|NOT COMPLETED|0-6 Weeks||3
228626|NCT01154283|554393|P1|NOT COMPLETED|0-6 Weeks||7
228627|NCT01154283|554392|P2|COMPLETED|0-6 Weeks||11
228628|NCT01154283|554393|P1|COMPLETED|0-6 Weeks||7
228629|NCT01154283|554392|P2|STARTED|0-6 Weeks||14
228630|NCT01154283|554393|P1|STARTED|0-6 Weeks||14
228631|NCT01154231|554405|P1|NOT COMPLETED|Overall Study||2
228632|NCT01154231|554405|P1|COMPLETED|Overall Study||312
228633|NCT01154231|554405|P1|STARTED|Overall Study||314
228634|NCT01154218|554411|P4|NOT COMPLETED|Fourth Intervention Period||0
228635|NCT01154218|554412|P3|NOT COMPLETED|Fourth Intervention Period||0
228636|NCT01154218|554413|P2|NOT COMPLETED|Fourth Intervention Period||0
228637|NCT01154218|554414|P1|NOT COMPLETED|Fourth Intervention Period||1
228638|NCT01154218|554411|P4|COMPLETED|Fourth Intervention Period||8
228639|NCT01154218|554412|P3|COMPLETED|Fourth Intervention Period||9
228640|NCT01154218|554413|P2|COMPLETED|Fourth Intervention Period||8
228641|NCT01154218|554414|P1|COMPLETED|Fourth Intervention Period||8
228642|NCT01154218|554411|P4|STARTED|Fourth Intervention Period||8
228643|NCT01154218|554412|P3|STARTED|Fourth Intervention Period||9
228644|NCT01154218|554413|P2|STARTED|Fourth Intervention Period||8
228645|NCT01154218|554414|P1|STARTED|Fourth Intervention Period||9
228646|NCT01154218|554411|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||1
228647|NCT01154218|554412|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
228648|NCT01154218|554413|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
228649|NCT01154218|554414|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
228650|NCT01154218|554411|P4|COMPLETED|Washout Period (at Least 14 Days)||8
228651|NCT01154218|554412|P3|COMPLETED|Washout Period (at Least 14 Days)||9
228652|NCT01154218|554413|P2|COMPLETED|Washout Period (at Least 14 Days)||8
228653|NCT01154218|554414|P1|COMPLETED|Washout Period (at Least 14 Days)||9
228654|NCT01154218|554411|P4|STARTED|Washout Period (at Least 14 Days)||9
228655|NCT01154218|554412|P3|STARTED|Washout Period (at Least 14 Days)||9
228656|NCT01154218|554413|P2|STARTED|Washout Period (at Least 14 Days)||8
228657|NCT01154218|554414|P1|STARTED|Washout Period (at Least 14 Days)||9
228658|NCT01154218|554411|P4|NOT COMPLETED|Third Intervention Period||0
228659|NCT01154218|554412|P3|NOT COMPLETED|Third Intervention Period||0
228660|NCT01154218|554413|P2|NOT COMPLETED|Third Intervention Period||1
228661|NCT01154218|554414|P1|NOT COMPLETED|Third Intervention Period||0
228662|NCT01154218|554411|P4|COMPLETED|Third Intervention Period||9
228663|NCT01154218|554412|P3|COMPLETED|Third Intervention Period||9
228664|NCT01154218|554413|P2|COMPLETED|Third Intervention Period||8
228665|NCT01154218|554414|P1|COMPLETED|Third Intervention Period||9
228666|NCT01154218|554411|P4|STARTED|Third Intervention Period||9
228667|NCT01154218|554412|P3|STARTED|Third Intervention Period||9
228668|NCT01154218|554413|P2|STARTED|Third Intervention Period||9
228669|NCT01154218|554414|P1|STARTED|Third Intervention Period||9
228670|NCT01154218|554411|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
228671|NCT01154218|554412|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
228672|NCT01154218|554413|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
228673|NCT01154218|554414|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
228674|NCT01154218|554411|P4|COMPLETED|Washout Period (at Least 14 Days)||9
228675|NCT01154218|554412|P3|COMPLETED|Washout Period (at Least 14 Days)||9
228676|NCT01154218|554413|P2|COMPLETED|Washout Period (at Least 14 Days)||9
228677|NCT01154218|554414|P1|COMPLETED|Washout Period (at Least 14 Days)||9
228678|NCT01154218|554411|P4|STARTED|Washout Period (at Least 14 Days)||9
228679|NCT01154218|554412|P3|STARTED|Washout Period (at Least 14 Days)||9
228680|NCT01154218|554413|P2|STARTED|Washout Period (at Least 14 Days)||9
228681|NCT01154218|554414|P1|STARTED|Washout Period (at Least 14 Days)||9
228682|NCT01154218|554411|P4|NOT COMPLETED|Second Intervention Period||0
228683|NCT01154218|554412|P3|NOT COMPLETED|Second Intervention Period||0
228684|NCT01154218|554413|P2|NOT COMPLETED|Second Intervention Period||0
228685|NCT01154218|554414|P1|NOT COMPLETED|Second Intervention Period||0
228686|NCT01154218|554411|P4|COMPLETED|Second Intervention Period||9
228687|NCT01154218|554412|P3|COMPLETED|Second Intervention Period||9
228688|NCT01154218|554413|P2|COMPLETED|Second Intervention Period||9
228689|NCT01154218|554414|P1|COMPLETED|Second Intervention Period||9
228690|NCT01154218|554411|P4|STARTED|Second Intervention Period||9
228691|NCT01154218|554412|P3|STARTED|Second Intervention Period||9
228692|NCT01154218|554413|P2|STARTED|Second Intervention Period||9
228693|NCT01154218|554414|P1|STARTED|Second Intervention Period||9
228694|NCT01154218|554411|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
228695|NCT01154218|554412|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
228696|NCT01154218|554413|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
228697|NCT01154218|554414|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
228698|NCT01154218|554411|P4|COMPLETED|Washout Period (at Least 14 Days)||9
228699|NCT01154218|554412|P3|COMPLETED|Washout Period (at Least 14 Days)||9
228700|NCT01154218|554413|P2|COMPLETED|Washout Period (at Least 14 Days)||9
228701|NCT01154218|554414|P1|COMPLETED|Washout Period (at Least 14 Days)||9
228702|NCT01154218|554411|P4|STARTED|Washout Period (at Least 14 Days)||9
228703|NCT01154218|554412|P3|STARTED|Washout Period (at Least 14 Days)||9
228704|NCT01154218|554413|P2|STARTED|Washout Period (at Least 14 Days)||9
228705|NCT01154218|554414|P1|STARTED|Washout Period (at Least 14 Days)||9
228706|NCT01154218|554411|P4|NOT COMPLETED|First Intervention Period||0
228707|NCT01154218|554412|P3|NOT COMPLETED|First Intervention Period||0
228708|NCT01154218|554413|P2|NOT COMPLETED|First Intervention Period||0
228709|NCT01154218|554414|P1|NOT COMPLETED|First Intervention Period||0
228710|NCT01154218|554411|P4|COMPLETED|First Intervention Period||9
228711|NCT01154218|554412|P3|COMPLETED|First Intervention Period||9
228712|NCT01154218|554413|P2|COMPLETED|First Intervention Period||9
228713|NCT01154218|554414|P1|COMPLETED|First Intervention Period||9
228714|NCT01154218|554411|P4|STARTED|First Intervention Period||9
228715|NCT01154218|554412|P3|STARTED|First Intervention Period||9
228716|NCT01154218|554413|P2|STARTED|First Intervention Period||9
228717|NCT01154218|554414|P1|STARTED|First Intervention Period||9
228718|NCT01154192|554467|P3|NOT COMPLETED|Overall Study||0
228719|NCT01154192|554468|P2|NOT COMPLETED|Overall Study||0
228720|NCT01154192|554469|P1|NOT COMPLETED|Overall Study||0
228721|NCT01154192|554467|P3|COMPLETED|Overall Study||0
228722|NCT01154192|554468|P2|COMPLETED|Overall Study||10
228723|NCT01154192|554469|P1|COMPLETED|Overall Study||14
228724|NCT01154192|554467|P3|STARTED|Overall Study||0
228725|NCT01154192|554468|P2|STARTED|Overall Study||10
228726|NCT01154192|554469|P1|STARTED|Overall Study||14
228727|NCT01154166|554488|P2|NOT COMPLETED|Overall Study||12
228728|NCT01154166|554489|P1|NOT COMPLETED|Overall Study||34
228729|NCT01154166|554488|P2|COMPLETED|Overall Study||163
228730|NCT01154166|554489|P1|COMPLETED|Overall Study||135
228731|NCT01154166|554488|P2|STARTED|Overall Study||175
228732|NCT01154166|554489|P1|STARTED|Overall Study||169
228733|NCT01154153|554521|P2|NOT COMPLETED|Overall Study||3
228734|NCT01154153|554522|P1|NOT COMPLETED|Overall Study||5
228735|NCT01154153|554521|P2|COMPLETED|Overall Study||66
228736|NCT01154153|554522|P1|COMPLETED|Overall Study||66
228737|NCT01154153|554521|P2|STARTED|Overall Study||69
228738|NCT01154153|554522|P1|STARTED|Overall Study||71
228739|NCT01154140|554540|P2|NOT COMPLETED|Overall Study||102
228740|NCT01154140|554541|P1|NOT COMPLETED|Overall Study||91
228741|NCT01154140|554540|P2|COMPLETED|Overall Study||69
228742|NCT01154140|554541|P1|COMPLETED|Overall Study||81
228743|NCT01154140|554540|P2|Treated|Overall Study||169
228744|NCT01154140|554541|P1|Treated|Overall Study||171
228745|NCT01154140|554540|P2|STARTED|Overall Study||171
228746|NCT01154140|554541|P1|STARTED|Overall Study||172
228747|NCT01154127|554594|P2|NOT COMPLETED|Period 2 (21 Days)||1
228748|NCT01154127|554595|P1|NOT COMPLETED|Period 2 (21 Days)||0
228749|NCT01154127|554594|P2|COMPLETED|Period 2 (21 Days)||46
228750|NCT01154127|554595|P1|COMPLETED|Period 2 (21 Days)||49
228751|NCT01154127|554594|P2|STARTED|Period 2 (21 Days)||47
228752|NCT01154127|554595|P1|STARTED|Period 2 (21 Days)||49
228753|NCT01154127|554594|P2|NOT COMPLETED|Washout (14 - 28 Days)||0
228754|NCT01154127|554595|P1|NOT COMPLETED|Washout (14 - 28 Days)||3
228755|NCT01154127|554594|P2|COMPLETED|Washout (14 - 28 Days)||47
228756|NCT01154127|554595|P1|COMPLETED|Washout (14 - 28 Days)||49
228757|NCT01154127|554594|P2|STARTED|Washout (14 - 28 Days)||47
228758|NCT01154127|554595|P1|STARTED|Washout (14 - 28 Days)||52
228759|NCT01154127|554594|P2|NOT COMPLETED|Period 1 (21 Days)||6
228760|NCT01154127|554595|P1|NOT COMPLETED|Period 1 (21 Days)||3
228761|NCT01154127|554594|P2|COMPLETED|Period 1 (21 Days)||47
228762|NCT01154127|554595|P1|COMPLETED|Period 1 (21 Days)||52
228763|NCT01154127|554594|P2|STARTED|Period 1 (21 Days)||53
228764|NCT01154127|554595|P1|STARTED|Period 1 (21 Days)||55
228765|NCT01154101|554622|P5|NOT COMPLETED|Overall Study||1
228766|NCT01154101|554623|P4|NOT COMPLETED|Overall Study||2
228767|NCT01154101|554624|P3|NOT COMPLETED|Overall Study||3
228768|NCT01154101|554625|P2|NOT COMPLETED|Overall Study||4
228769|NCT01154101|554626|P1|NOT COMPLETED|Overall Study||0
228770|NCT01154101|554622|P5|COMPLETED|Overall Study||0
228771|NCT01154101|554623|P4|COMPLETED|Overall Study||9
228772|NCT01154101|554624|P3|COMPLETED|Overall Study||9
228773|NCT01154101|554625|P2|COMPLETED|Overall Study||5
228774|NCT01154101|554626|P1|COMPLETED|Overall Study||7
228775|NCT01154101|554622|P5|STARTED|Overall Study||1
228776|NCT01154101|554623|P4|STARTED|Overall Study||11
228777|NCT01154101|554624|P3|STARTED|Overall Study||12
228778|NCT01154101|554625|P2|STARTED|Overall Study||9
228779|NCT01154101|554626|P1|STARTED|Overall Study||7
228780|NCT01154088|554681|P3|NOT COMPLETED|Overall Study||7
228781|NCT01154088|554682|P2|NOT COMPLETED|Overall Study||6
228782|NCT01154088|554683|P1|NOT COMPLETED|Overall Study||4
228783|NCT01154088|554681|P3|COMPLETED|Overall Study||383
228784|NCT01154088|554682|P2|COMPLETED|Overall Study||384
228785|NCT01154088|554683|P1|COMPLETED|Overall Study||386
228786|NCT01154088|554681|P3|STARTED|Overall Study||390
228787|NCT01154088|554682|P2|STARTED|Overall Study||390
228788|NCT01154088|554683|P1|STARTED|Overall Study||390
228789|NCT01154036|554723|P8|NOT COMPLETED|Phase II||6
228790|NCT01154036|554724|P7|NOT COMPLETED|Phase II||9
228791|NCT01154036|554725|P6|NOT COMPLETED|Phase II||5
228792|NCT01154036|554726|P5|NOT COMPLETED|Phase II||8
228793|NCT01154036|554727|P4|NOT COMPLETED|Phase II||1
228794|NCT01154036|554728|P3|NOT COMPLETED|Phase II||0
228795|NCT01154036|554729|P2|NOT COMPLETED|Phase II||0
228796|NCT01154036|554730|P1|NOT COMPLETED|Phase II||0
228797|NCT01154036|554723|P8|COMPLETED|Phase II||200
228798|NCT01154036|554724|P7|COMPLETED|Phase II||225
228799|NCT01154036|554725|P6|COMPLETED|Phase II||121
228800|NCT01154036|554726|P5|COMPLETED|Phase II||116
228801|NCT01154036|554727|P4|COMPLETED|Phase II||27
228802|NCT01154036|554728|P3|COMPLETED|Phase II||0
228803|NCT01154036|554729|P2|COMPLETED|Phase II||0
228804|NCT01154036|554730|P1|COMPLETED|Phase II||0
228805|NCT01154036|554723|P8|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|206
228806|NCT01154036|554724|P7|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|234
228807|NCT01154036|554725|P6|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|126
228808|NCT01154036|554726|P5|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|124
228809|NCT01154036|554727|P4|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|28
228810|NCT01154036|554728|P3|STARTED|Phase II||0
228811|NCT01154036|554729|P2|STARTED|Phase II||0
228812|NCT01154036|554730|P1|STARTED|Phase II||0
228813|NCT01154036|554723|P8|NOT COMPLETED|Phase I||0
228814|NCT01154036|554724|P7|NOT COMPLETED|Phase I||0
228815|NCT01154036|554725|P6|NOT COMPLETED|Phase I||0
228816|NCT01154036|554726|P5|NOT COMPLETED|Phase I||0
228817|NCT01154036|554727|P4|NOT COMPLETED|Phase I||0
228818|NCT01154036|554728|P3|NOT COMPLETED|Phase I||56
228819|NCT01154036|554729|P2|NOT COMPLETED|Phase I||28
228820|NCT01154036|554730|P1|NOT COMPLETED|Phase I||3
228821|NCT01154036|554723|P8|COMPLETED|Phase I||0
228822|NCT01154036|554724|P7|COMPLETED|Phase I||0
228823|NCT01154036|554725|P6|COMPLETED|Phase I||0
228824|NCT01154036|554726|P5|COMPLETED|Phase I||0
228825|NCT01154036|554727|P4|COMPLETED|Phase I||0
228826|NCT01154036|554728|P3|COMPLETED|Phase I|Not all completers were eligible for Phase II|888
228827|NCT01154036|554729|P2|COMPLETED|Phase I|Not all completers were eligible for Phase II|455
228828|NCT01154036|554730|P1|COMPLETED|Phase I|Not all completers were eligible for Phase II|117
228829|NCT01154036|554723|P8|STARTED|Phase I||0
228830|NCT01154036|554724|P7|STARTED|Phase I||0
228831|NCT01154036|554725|P6|STARTED|Phase I||0
228832|NCT01154036|554726|P5|STARTED|Phase I||0
228833|NCT01154036|554727|P4|STARTED|Phase I||0
228834|NCT01154036|554728|P3|STARTED|Phase I||944
228835|NCT01154036|554729|P2|STARTED|Phase I||483
228836|NCT01154036|554730|P1|STARTED|Phase I||120
228837|NCT01154010|554854|P2|NOT COMPLETED|Overall Study||1
228838|NCT01154010|554855|P1|NOT COMPLETED|Overall Study||0
228839|NCT01154010|554854|P2|COMPLETED|Overall Study||8
228840|NCT01154010|554855|P1|COMPLETED|Overall Study||9
228841|NCT01154010|554854|P2|STARTED|Overall Study||9
228842|NCT01154010|554855|P1|STARTED|Overall Study||9
228843|NCT01153984|554861|P1|NOT COMPLETED|Overall Study||2
228844|NCT01153984|554861|P1|COMPLETED|Overall Study||21
228845|NCT01153984|554861|P1|STARTED|Overall Study||23
228846|NCT01153971|554872|P1|NOT COMPLETED|Follow-up (Months 17-40 of Study)||4
228847|NCT01153971|554872|P1|COMPLETED|Follow-up (Months 17-40 of Study)||37
228848|NCT01153971|554872|P1|STARTED|Follow-up (Months 17-40 of Study)||41
228849|NCT01153971|554872|P1|NOT COMPLETED|Maintenance Phase (Months 8-16 of Study)||3
228850|NCT01153971|554872|P1|COMPLETED|Maintenance Phase (Months 8-16 of Study)||41
228851|NCT01153971|554872|P1|STARTED|Maintenance Phase (Months 8-16 of Study)||44
228852|NCT01153971|554872|P1|NOT COMPLETED|Induction Phase (Months 1 to 7 of Study)||3
228853|NCT01153971|554872|P1|COMPLETED|Induction Phase (Months 1 to 7 of Study)||44
228854|NCT01153971|554872|P1|STARTED|Induction Phase (Months 1 to 7 of Study)||47
228855|NCT01153958|554895|P2|NOT COMPLETED|Overall Study||32
228856|NCT01153958|554896|P1|NOT COMPLETED|Overall Study||36
228857|NCT01153958|554895|P2|COMPLETED|Overall Study||35
228858|NCT01153958|554896|P1|COMPLETED|Overall Study||30
228859|NCT01153958|554895|P2|STARTED|Overall Study||67
228860|NCT01153958|554896|P1|STARTED|Overall Study||66
228861|NCT01153893|554914|P2|NOT COMPLETED|Overall Study||0
228862|NCT01153893|554915|P1|NOT COMPLETED|Overall Study||1
228863|NCT01153893|554914|P2|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 3.|36
228864|NCT01153893|554915|P1|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 1.|67
228865|NCT01153893|554914|P2|STARTED|Overall Study||36
228866|NCT01153893|554915|P1|STARTED|Overall Study|Issues with the informed consent obtained from one child led to related data not used in this report|68
228867|NCT01153841|554941|P2|NOT COMPLETED|Overall Study||0
228868|NCT01153841|554942|P1|NOT COMPLETED|Overall Study||6
228869|NCT01153841|554941|P2|COMPLETED|Overall Study||99
228870|NCT01153841|554942|P1|COMPLETED|Overall Study||193
228871|NCT01153841|554941|P2|STARTED|Overall Study||99
228872|NCT01153841|554942|P1|STARTED|Overall Study||199
228873|NCT01153815|554958|P2|NOT COMPLETED|Overall Study||5
228874|NCT01153815|554959|P1|NOT COMPLETED|Overall Study||9
228875|NCT01153815|554958|P2|COMPLETED|Overall Study||82
228876|NCT01153815|554959|P1|COMPLETED|Overall Study||74
228877|NCT01153815|554958|P2|STARTED|Overall Study||87
228878|NCT01153815|554959|P1|STARTED|Overall Study||83
228879|NCT01153763|554981|P1|NOT COMPLETED|Overall Study||21
228880|NCT01153763|554981|P1|COMPLETED|Overall Study||71
228881|NCT01153763|554981|P1|STARTED|Overall Study||92
228882|NCT01153724|554997|P1|NOT COMPLETED|Treatment Period 2||2
228883|NCT01153724|554997|P1|COMPLETED|Treatment Period 2||32
228884|NCT01153724|554997|P1|STARTED|Treatment Period 2||34
228885|NCT01153724|554997|P1|NOT COMPLETED|Treatment Period 1||1
228886|NCT01153724|554997|P1|COMPLETED|Treatment Period 1||34
228887|NCT01153724|554997|P1|STARTED|Treatment Period 1||35
228888|NCT01153711|555017|P1|NOT COMPLETED|Overall Study||0
228889|NCT01153711|555017|P1|COMPLETED|Overall Study||32
228890|NCT01153711|555017|P1|STARTED|Overall Study||32
228891|NCT01153698|555037|P1|NOT COMPLETED|Overall Study||29
228892|NCT01153698|555037|P1|COMPLETED|Overall Study|Completed Pradaxa treatment.|139
228893|NCT01153698|555037|P1|STARTED|Overall Study|Entered and treated.|168
228894|NCT01153685|555053|P2|NOT COMPLETED|Overall Study||0
228895|NCT01153685|555054|P1|NOT COMPLETED|Overall Study||0
228896|NCT01153685|555053|P2|COMPLETED|Overall Study||70
228897|NCT01153685|555054|P1|COMPLETED|Overall Study||50
228898|NCT01153685|555053|P2|STARTED|Overall Study||70
228899|NCT01153685|555054|P1|STARTED|Overall Study||50
228900|NCT01153672|555078|P1|NOT COMPLETED|Overall Study||2
228901|NCT01153672|555078|P1|COMPLETED|Overall Study||6
228902|NCT01153672|555078|P1|STARTED|Overall Study||8
228903|NCT01153633|555088|P2|NOT COMPLETED|Overall Study||4
228904|NCT01153633|555089|P1|NOT COMPLETED|Overall Study||4
228905|NCT01153633|555088|P2|COMPLETED|Overall Study||13
228906|NCT01153633|555089|P1|COMPLETED|Overall Study||13
228907|NCT01153633|555088|P2|STARTED|Overall Study||17
228908|NCT01153633|555089|P1|STARTED|Overall Study||17
228909|NCT01153620|555107|P2|NOT COMPLETED|Overall Study||0
228910|NCT01153620|555108|P1|NOT COMPLETED|Overall Study||0
228911|NCT01153620|555107|P2|COMPLETED|Overall Study|30 patients (31 wounds)|30
228912|NCT01153620|555108|P1|COMPLETED|Overall Study||30
228913|NCT01153620|555107|P2|STARTED|Overall Study|30 patients (31 wounds)|30
228914|NCT01153620|555108|P1|STARTED|Overall Study||30
228915|NCT01153581|555114|P1|NOT COMPLETED|Overall Study||0
228916|NCT01153581|555114|P1|COMPLETED|Overall Study||109
228917|NCT01153581|555114|P1|STARTED|Overall Study||109
228918|NCT01153516|555126|P2|NOT COMPLETED|Overall Study||0
228919|NCT01153516|555127|P1|NOT COMPLETED|Overall Study||2
228920|NCT01153516|555126|P2|COMPLETED|Overall Study||10
228921|NCT01153516|555127|P1|COMPLETED|Overall Study||10
228922|NCT01153516|555126|P2|STARTED|Overall Study||10
228923|NCT01153516|555127|P1|STARTED|Overall Study||12
228924|NCT01153503|555140|P3|NOT COMPLETED|Overall Study||0
228925|NCT01153503|555141|P2|NOT COMPLETED|Overall Study||1
228926|NCT01153503|555142|P1|NOT COMPLETED|Overall Study||0
228927|NCT01153503|555140|P3|COMPLETED|Overall Study||25
228928|NCT01153503|555141|P2|COMPLETED|Overall Study||24
228929|NCT01153503|555142|P1|COMPLETED|Overall Study||25
228930|NCT01153503|555140|P3|STARTED|Overall Study||25
228931|NCT01153503|555141|P2|STARTED|Overall Study||25
228932|NCT01153503|555142|P1|STARTED|Overall Study||25
228933|NCT01153425|555152|P2|NOT COMPLETED|Overall Study||3
228934|NCT01153425|555153|P1|NOT COMPLETED|Overall Study||3
228935|NCT01153425|555152|P2|COMPLETED|Overall Study||14
228936|NCT01153425|555153|P1|COMPLETED|Overall Study||13
228937|NCT01153425|555152|P2|STARTED|Overall Study||17
228938|NCT01153425|555153|P1|STARTED|Overall Study||16
228939|NCT01153347|555165|P4|NOT COMPLETED|Overall Study||32
228940|NCT01153347|555166|P3|NOT COMPLETED|Overall Study||50
228941|NCT01153347|555167|P2|NOT COMPLETED|Overall Study||44
228942|NCT01153347|555168|P1|NOT COMPLETED|Overall Study||33
228943|NCT01153347|555165|P4|COMPLETED|Overall Study||129
228944|NCT01153347|555166|P3|COMPLETED|Overall Study||110
228945|NCT01153347|555167|P2|COMPLETED|Overall Study||116
228946|NCT01153347|555168|P1|COMPLETED|Overall Study||127
228947|NCT01153347|555165|P4|Received Treatment|Overall Study||160
228948|NCT01153347|555166|P3|Received Treatment|Overall Study||158
228949|NCT01153347|555167|P2|Received Treatment|Overall Study||158
228950|NCT01153347|555168|P1|Received Treatment|Overall Study||160
228951|NCT01153347|555165|P4|STARTED|Overall Study||161
228952|NCT01153347|555166|P3|STARTED|Overall Study||160
228953|NCT01153347|555167|P2|STARTED|Overall Study||160
228954|NCT01153347|555168|P1|STARTED|Overall Study||160
228955|NCT01153321|555268|P2|NOT COMPLETED|Overall Study||3
228956|NCT01153321|555269|P1|NOT COMPLETED|Overall Study||1
228957|NCT01153321|555268|P2|COMPLETED|Overall Study||19
228958|NCT01153321|555269|P1|COMPLETED|Overall Study||21
228959|NCT01153321|555268|P2|STARTED|Overall Study||22
228960|NCT01153321|555269|P1|STARTED|Overall Study||22
228961|NCT01153269|555381|P1|NOT COMPLETED|Overall Study||2
228962|NCT01153269|555381|P1|COMPLETED|Overall Study||31
228963|NCT01153269|555381|P1|Participants Analyzed|Overall Study||33
228964|NCT01153269|555381|P1|STARTED|Overall Study||33
228965|NCT01153009|555444|P4|NOT COMPLETED|Overall Study||37
228966|NCT01153009|555445|P3|NOT COMPLETED|Overall Study||41
228967|NCT01153009|555446|P2|NOT COMPLETED|Overall Study||34
228968|NCT01153009|555447|P1|NOT COMPLETED|Overall Study||32
228969|NCT01153009|555444|P4|COMPLETED|Overall Study||115
228970|NCT01153009|555445|P3|COMPLETED|Overall Study||113
228971|NCT01153009|555446|P2|COMPLETED|Overall Study||113
228972|NCT01153009|555447|P1|COMPLETED|Overall Study||129
228973|NCT01153009|555444|P4|Treated|Overall Study||150
228974|NCT01153009|555445|P3|Treated|Overall Study||154
228975|NCT01153009|555446|P2|Treated|Overall Study||147
228976|NCT01153009|555447|P1|Treated|Overall Study||159
228977|NCT01153009|555444|P4|STARTED|Overall Study||152
228978|NCT01153009|555445|P3|STARTED|Overall Study||154
228979|NCT01153009|555446|P2|STARTED|Overall Study||147
228980|NCT01153009|555447|P1|STARTED|Overall Study||161
228981|NCT01152996|555477|P1|NOT COMPLETED|Overall Study||537
228982|NCT01152996|555477|P1|COMPLETED|Overall Study||538
228983|NCT01152996|555477|P1|Treated|Overall Study||1073
228984|NCT01152996|555477|P1|STARTED|Overall Study||1075
228985|NCT01152814|555490|P1|NOT COMPLETED|Overall Study||2
228986|NCT01152814|555490|P1|COMPLETED|Overall Study||62
228987|NCT01152814|555490|P1|STARTED|Overall Study||64
228988|NCT01152788|555499|P2|NOT COMPLETED|Overall Study||4
228989|NCT01152788|555500|P1|NOT COMPLETED|Overall Study||0
228990|NCT01152788|555499|P2|COMPLETED|Overall Study||28
228991|NCT01152788|555500|P1|COMPLETED|Overall Study||32
228992|NCT01152788|555499|P2|STARTED|Overall Study||32
228993|NCT01152788|555500|P1|STARTED|Overall Study||32
228994|NCT01152697|555512|P1|NOT COMPLETED|Overall Study||19
228995|NCT01152697|555512|P1|COMPLETED|Overall Study||11
228996|NCT01152697|555512|P1|STARTED|Overall Study||30
228997|NCT01152580|555537|P2|NOT COMPLETED|Overall Study||1
228998|NCT01152580|555538|P1|NOT COMPLETED|Overall Study||0
228999|NCT01152580|555537|P2|COMPLETED|Overall Study||13
229000|NCT01152580|555538|P1|COMPLETED|Overall Study||5
229001|NCT01152580|555537|P2|STARTED|Overall Study||14
229002|NCT01152580|555538|P1|STARTED|Overall Study||5
229003|NCT01152554|555560|P2|NOT COMPLETED|Overall Study||111
229004|NCT01152554|555561|P1|NOT COMPLETED|Overall Study||334
229005|NCT01152554|555560|P2|COMPLETED|Overall Study||92
229006|NCT01152554|555561|P1|COMPLETED|Overall Study||276
229007|NCT01152554|555560|P2|Received Treatment|Overall Study||201
229008|NCT01152554|555561|P1|Received Treatment|Overall Study||607
229009|NCT01152554|555560|P2|STARTED|Overall Study||203
229010|NCT01152554|555561|P1|STARTED|Overall Study||610
229011|NCT01152450|555583|P6|NOT COMPLETED|Period 3 (4 Weeks)||0
229012|NCT01152450|555584|P5|NOT COMPLETED|Period 3 (4 Weeks)||0
229013|NCT01152450|555585|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
229014|NCT01152450|555586|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
229015|NCT01152450|555587|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
229016|NCT01152450|555588|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
229017|NCT01152450|555583|P6|COMPLETED|Period 3 (4 Weeks)||12
229018|NCT01152450|555584|P5|COMPLETED|Period 3 (4 Weeks)||16
229019|NCT01152450|555585|P4|COMPLETED|Period 3 (4 Weeks)||15
229020|NCT01152450|555586|P3|COMPLETED|Period 3 (4 Weeks)||16
229021|NCT01152450|555587|P2|COMPLETED|Period 3 (4 Weeks)||15
229022|NCT01152450|555588|P1|COMPLETED|Period 3 (4 Weeks)||15
229023|NCT01152450|555583|P6|STARTED|Period 3 (4 Weeks)||12
229024|NCT01152450|555584|P5|STARTED|Period 3 (4 Weeks)||16
229025|NCT01152450|555585|P4|STARTED|Period 3 (4 Weeks)||15
229026|NCT01152450|555586|P3|STARTED|Period 3 (4 Weeks)||16
229027|NCT01152450|555587|P2|STARTED|Period 3 (4 Weeks)||15
229028|NCT01152450|555588|P1|STARTED|Period 3 (4 Weeks)||15
229029|NCT01152450|555583|P6|NOT COMPLETED|Period 2 (4 Weeks)||0
229030|NCT01152450|555584|P5|NOT COMPLETED|Period 2 (4 Weeks)||0
229031|NCT01152450|555585|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
229032|NCT01152450|555586|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
229033|NCT01152450|555587|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
229034|NCT01152450|555588|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
229035|NCT01152450|555583|P6|COMPLETED|Period 2 (4 Weeks)||12
229036|NCT01152450|555584|P5|COMPLETED|Period 2 (4 Weeks)||16
229037|NCT01152450|555585|P4|COMPLETED|Period 2 (4 Weeks)||15
229038|NCT01152450|555586|P3|COMPLETED|Period 2 (4 Weeks)||16
229039|NCT01152450|555587|P2|COMPLETED|Period 2 (4 Weeks)||15
229040|NCT01152450|555588|P1|COMPLETED|Period 2 (4 Weeks)||15
229041|NCT01152450|555583|P6|STARTED|Period 2 (4 Weeks)||12
229042|NCT01152450|555584|P5|STARTED|Period 2 (4 Weeks)||16
229043|NCT01152450|555585|P4|STARTED|Period 2 (4 Weeks)||15
229044|NCT01152450|555586|P3|STARTED|Period 2 (4 Weeks)||16
229045|NCT01152450|555587|P2|STARTED|Period 2 (4 Weeks)||15
229046|NCT01152450|555588|P1|STARTED|Period 2 (4 Weeks)||15
229047|NCT01152450|555583|P6|NOT COMPLETED|Period 1 (4 Weeks)||1
229048|NCT01152450|555584|P5|NOT COMPLETED|Period 1 (4 Weeks)||2
229049|NCT01152450|555585|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
229050|NCT01152450|555586|P3|NOT COMPLETED|Period 1 (4 Weeks)||1
229051|NCT01152450|555587|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
229052|NCT01152450|555588|P1|NOT COMPLETED|Period 1 (4 Weeks)||0
229053|NCT01152450|555583|P6|COMPLETED|Period 1 (4 Weeks)||12
229054|NCT01152450|555584|P5|COMPLETED|Period 1 (4 Weeks)||16
229055|NCT01152450|555585|P4|COMPLETED|Period 1 (4 Weeks)||15
229056|NCT01152450|555586|P3|COMPLETED|Period 1 (4 Weeks)||16
229057|NCT01152450|555587|P2|COMPLETED|Period 1 (4 Weeks)||15
229058|NCT01152450|555588|P1|COMPLETED|Period 1 (4 Weeks)||15
229059|NCT01152450|555583|P6|STARTED|Period 1 (4 Weeks)||13
229060|NCT01152450|555584|P5|STARTED|Period 1 (4 Weeks)||18
229061|NCT01152450|555585|P4|STARTED|Period 1 (4 Weeks)||15
229062|NCT01152450|555586|P3|STARTED|Period 1 (4 Weeks)||17
229063|NCT01152450|555587|P2|STARTED|Period 1 (4 Weeks)||16
229064|NCT01152450|555588|P1|STARTED|Period 1 (4 Weeks)||15
229065|NCT01152437|555659|P3|NOT COMPLETED|Overall Study||43
229066|NCT01152437|555660|P2|NOT COMPLETED|Overall Study||15
229067|NCT01152437|555661|P1|NOT COMPLETED|Overall Study||36
229068|NCT01152437|555659|P3|COMPLETED|Overall Study||0
229069|NCT01152437|555660|P2|COMPLETED|Overall Study||0
229070|NCT01152437|555661|P1|COMPLETED|Overall Study||0
229071|NCT01152437|555659|P3|STARTED|Overall Study|entered|43
229072|NCT01152437|555660|P2|STARTED|Overall Study|randomised|15
229073|NCT01152437|555661|P1|STARTED|Overall Study|randomised|36
229074|NCT01152385|555681|P4|NOT COMPLETED|Overall Study||5
229075|NCT01152385|555682|P3|NOT COMPLETED|Overall Study||5
229076|NCT01152385|555683|P2|NOT COMPLETED|Overall Study||6
229077|NCT01152385|555684|P1|NOT COMPLETED|Overall Study||9
229078|NCT01152385|555681|P4|COMPLETED|Overall Study||50
229079|NCT01152385|555682|P3|COMPLETED|Overall Study||51
229080|NCT01152385|555683|P2|COMPLETED|Overall Study||52
229081|NCT01152385|555684|P1|COMPLETED|Overall Study||46
229082|NCT01152385|555681|P4|STARTED|Overall Study||55
229083|NCT01152385|555682|P3|STARTED|Overall Study||56
229084|NCT01152385|555683|P2|STARTED|Overall Study||58
229085|NCT01152385|555684|P1|STARTED|Overall Study||55
229086|NCT01152359|555724|P2|NOT COMPLETED|Overall Study||22
229087|NCT01152359|555725|P1|NOT COMPLETED|Overall Study||24
229088|NCT01152359|555724|P2|COMPLETED|Overall Study||80
229089|NCT01152359|555725|P1|COMPLETED|Overall Study||81
229090|NCT01152359|555724|P2|STARTED|Overall Study||102
229091|NCT01152359|555725|P1|STARTED|Overall Study||105
229092|NCT01152307|555737|P2|NOT COMPLETED|Overall Study||0
229093|NCT01152307|555738|P1|NOT COMPLETED|Overall Study||0
229094|NCT01152307|555737|P2|COMPLETED|Overall Study||214
229095|NCT01152307|555738|P1|COMPLETED|Overall Study||191
229096|NCT01152307|555737|P2|STARTED|Overall Study||214
229097|NCT01152307|555738|P1|STARTED|Overall Study||191
229098|NCT01152294|555746|P2|NOT COMPLETED|Overall Study||0
229099|NCT01152294|555747|P1|NOT COMPLETED|Overall Study||0
229100|NCT01152294|555746|P2|COMPLETED|Overall Study||188
229101|NCT01152294|555747|P1|COMPLETED|Overall Study||213
229102|NCT01152294|555746|P2|STARTED|Overall Study||188
229103|NCT01152294|555747|P1|STARTED|Overall Study||213
229104|NCT01152190|555755|P2|NOT COMPLETED|Overall Study||8
229105|NCT01152190|555756|P1|NOT COMPLETED|Overall Study||5
229106|NCT01152190|555755|P2|COMPLETED|Overall Study||39
229107|NCT01152190|555756|P1|COMPLETED|Overall Study||45
229108|NCT01152190|555755|P2|Received at Least 1 Dose of Study Drug|Overall Study||47
229109|NCT01152190|555756|P1|Received at Least 1 Dose of Study Drug|Overall Study||50
229110|NCT01152190|555755|P2|STARTED|Overall Study||47
229111|NCT01152190|555756|P1|STARTED|Overall Study||50
229112|NCT01152112|555770|P2|NOT COMPLETED|Overall Study||0
229113|NCT01152112|555771|P1|NOT COMPLETED|Overall Study||0
229114|NCT01152112|555770|P2|COMPLETED|Overall Study||32
229115|NCT01152112|555771|P1|COMPLETED|Overall Study||42
229116|NCT01152112|555770|P2|STARTED|Overall Study||32
229117|NCT01152112|555771|P1|STARTED|Overall Study||42
229118|NCT01152021|555779|P2|NOT COMPLETED|Overall Study||6
229119|NCT01152021|555780|P1|NOT COMPLETED|Overall Study||6
229120|NCT01152021|555779|P2|COMPLETED|Overall Study||1
229121|NCT01152021|555780|P1|COMPLETED|Overall Study||2
229122|NCT01152021|555779|P2|STARTED|Overall Study||7
229123|NCT01152021|555780|P1|STARTED|Overall Study||8
229124|NCT01151904|555788|P1|NOT COMPLETED|Overall Study||0
229125|NCT01151904|555788|P1|COMPLETED|Overall Study||17
229126|NCT01151904|555788|P1|STARTED|Overall Study||17
229127|NCT01151852|555796|P2|NOT COMPLETED|Overall Study||0
229128|NCT01151852|555797|P1|NOT COMPLETED|Overall Study||0
229129|NCT01151852|555796|P2|COMPLETED|Overall Study||40
229130|NCT01151852|555797|P1|COMPLETED|Overall Study||41
229131|NCT01151852|555796|P2|STARTED|Overall Study||40
229132|NCT01151852|555797|P1|STARTED|Overall Study||41
229133|NCT01151761|555813|P1|NOT COMPLETED|Overall Study||0
229134|NCT01151761|555813|P1|COMPLETED|Overall Study||2
229135|NCT01151761|555813|P1|STARTED|Overall Study||2
229136|NCT01151618|555824|P1|NOT COMPLETED|Overall Study||9
229137|NCT01151618|555824|P1|COMPLETED|Overall Study||13
229138|NCT01151618|555824|P1|STARTED|Overall Study||22
229139|NCT01151579|555832|P2|NOT COMPLETED|Overall Study||7
229140|NCT01151579|555833|P1|NOT COMPLETED|Overall Study||12
229141|NCT01151579|555832|P2|COMPLETED|Overall Study||24
229142|NCT01151579|555833|P1|COMPLETED|Overall Study||46
229143|NCT01151579|555832|P2|STARTED|Overall Study||31
229144|NCT01151579|555833|P1|STARTED|Overall Study||58
229145|NCT01151553|555843|P1|NOT COMPLETED|Overall Study||0
229146|NCT01151553|555843|P1|COMPLETED|Overall Study||5
229147|NCT01151553|555843|P1|STARTED|Overall Study||5
229148|NCT01151540|555847|P1|NOT COMPLETED|Overall Study||13
229149|NCT01151540|555847|P1|COMPLETED|Overall Study||41
229150|NCT01151540|555847|P1|STARTED|Overall Study||54
229151|NCT01151449|555856|P1|NOT COMPLETED|Overall Study||0
229152|NCT01151449|555856|P1|COMPLETED|Overall Study||6
229153|NCT01151449|555856|P1|STARTED|Overall Study||6
229154|NCT01151436|555864|P1|NOT COMPLETED|Overall Study||1
229155|NCT01151436|555864|P1|COMPLETED|Overall Study||76
229156|NCT01151436|555864|P1|STARTED|Overall Study||77
229157|NCT01151423|555896|P2|NOT COMPLETED|Overall Study||18
229158|NCT01151423|555897|P1|NOT COMPLETED|Overall Study||16
229159|NCT01151423|555896|P2|COMPLETED|Overall Study||21
229160|NCT01151423|555897|P1|COMPLETED|Overall Study||20
229161|NCT01151423|555896|P2|Received Study Drug|Overall Study||37
229162|NCT01151423|555897|P1|Received Study Drug|Overall Study||35
229163|NCT01151423|555896|P2|STARTED|Overall Study||39
229164|NCT01151423|555897|P1|STARTED|Overall Study||36
229165|NCT01151410|555945|P2|NOT COMPLETED|Overall Study||15
229166|NCT01151410|555946|P1|NOT COMPLETED|Overall Study||11
229167|NCT01151410|555945|P2|COMPLETED|Overall Study||89
229168|NCT01151410|555946|P1|COMPLETED|Overall Study||93
229169|NCT01151410|555945|P2|Safety Set (SAF)|Overall Study|Number of patients in SAF differed due to kit dispensing error in 1 patient at Visit 12|103
229170|NCT01151410|555946|P1|Safety Set (SAF)|Overall Study||105
229171|NCT01151410|555945|P2|STARTED|Overall Study||104
229172|NCT01151410|555946|P1|STARTED|Overall Study||104
229173|NCT01151371|555959|P3|NOT COMPLETED|Overall Study||7
229174|NCT01151371|555960|P2|NOT COMPLETED|Overall Study||1
229175|NCT01151371|555961|P1|NOT COMPLETED|Overall Study||5
229176|NCT01151371|555959|P3|COMPLETED|Overall Study||146
229177|NCT01151371|555960|P2|COMPLETED|Overall Study||149
229178|NCT01151371|555961|P1|COMPLETED|Overall Study||144
229179|NCT01151371|555959|P3|STARTED|Overall Study||153
229180|NCT01151371|555960|P2|STARTED|Overall Study||150
229181|NCT01151371|555961|P1|STARTED|Overall Study||149
229182|NCT01151345|555990|P2|NOT COMPLETED|Second Intervention Period||0
229183|NCT01151345|555991|P1|NOT COMPLETED|Second Intervention Period||0
229184|NCT01151345|555990|P2|COMPLETED|Second Intervention Period||12
229185|NCT01151345|555991|P1|COMPLETED|Second Intervention Period||13
229186|NCT01151345|555990|P2|STARTED|Second Intervention Period||12
229187|NCT01151345|555991|P1|STARTED|Second Intervention Period||13
229188|NCT01151345|555990|P2|NOT COMPLETED|Wash-out Period (7 Days)||0
229189|NCT01151345|555991|P1|NOT COMPLETED|Wash-out Period (7 Days)||0
229190|NCT01151345|555990|P2|COMPLETED|Wash-out Period (7 Days)||12
229191|NCT01151345|555991|P1|COMPLETED|Wash-out Period (7 Days)||13
229192|NCT01151345|555990|P2|STARTED|Wash-out Period (7 Days)||12
229193|NCT01151345|555991|P1|STARTED|Wash-out Period (7 Days)||13
229194|NCT01151345|555990|P2|NOT COMPLETED|First Intervention Period||1
229195|NCT01151345|555991|P1|NOT COMPLETED|First Intervention Period||0
229196|NCT01151345|555990|P2|COMPLETED|First Intervention Period||12
229197|NCT01151345|555991|P1|COMPLETED|First Intervention Period||13
229198|NCT01151345|555990|P2|Treated|First Intervention Period||12
229199|NCT01151345|555991|P1|Treated|First Intervention Period||13
229200|NCT01151345|555990|P2|STARTED|First Intervention Period||13
229201|NCT01151345|555991|P1|STARTED|First Intervention Period||13
229202|NCT01151280|556005|P1|NOT COMPLETED|Overall Study||4
229203|NCT01151280|556005|P1|COMPLETED|Overall Study||6
229204|NCT01151280|556005|P1|STARTED|Overall Study||10
229205|NCT01151215|556018|P3|NOT COMPLETED|Overall Study||19
229206|NCT01151215|556019|P2|NOT COMPLETED|Overall Study||23
229207|NCT01151215|556020|P1|NOT COMPLETED|Overall Study||20
229208|NCT01151215|556018|P3|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|102
229209|NCT01151215|556019|P2|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|95
229210|NCT01151215|556020|P1|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|100
229211|NCT01151215|556018|P3|STARTED|Overall Study||121
229212|NCT01151215|556019|P2|STARTED|Overall Study||118
229213|NCT01151215|556020|P1|STARTED|Overall Study||120
229214|NCT01151189|556033|P2|NOT COMPLETED|Overall Study||10
229215|NCT01151189|556034|P1|NOT COMPLETED|Overall Study||15
229216|NCT01151189|556033|P2|COMPLETED|Overall Study||314
229217|NCT01151189|556034|P1|COMPLETED|Overall Study||311
229218|NCT01151189|556033|P2|Received Vaccine|Overall Study||324
229219|NCT01151189|556034|P1|Received Vaccine|Overall Study||325
229220|NCT01151189|556033|P2|STARTED|Overall Study||324
229221|NCT01151189|556034|P1|STARTED|Overall Study||326
229222|NCT01151137|556058|P2|NOT COMPLETED|Overall Study||28
229223|NCT01151137|556059|P1|NOT COMPLETED|Overall Study||16
229224|NCT01151137|556058|P2|COMPLETED|Overall Study||1591
229225|NCT01151137|556059|P1|COMPLETED|Overall Study||1601
229226|NCT01151137|556058|P2|Discontinued Treatment|Overall Study||342
229227|NCT01151137|556059|P1|Discontinued Treatment|Overall Study||171
229228|NCT01151137|556058|P2|Treated|Overall Study||1613
229229|NCT01151137|556059|P1|Treated|Overall Study|One participant randomized to the placebo group received Dronedarone for 7 days by mistake|1610
229230|NCT01151137|556058|P2|STARTED|Overall Study||1619
229231|NCT01151137|556059|P1|STARTED|Overall Study||1617
229232|NCT01151098|556077|P1|NOT COMPLETED|Overall Study||117
229233|NCT01151098|556077|P1|COMPLETED|Overall Study||72
229234|NCT01151098|556077|P1|STARTED|Overall Study|Extension Safety Population|189
229235|NCT01151085|556081|P1|NOT COMPLETED|Overall Study||56
229236|NCT01151085|556081|P1|COMPLETED|Overall Study||946
229237|NCT01151085|556081|P1|STARTED|Overall Study||1002
229238|NCT01151046|556099|P2|NOT COMPLETED|Overall Study||0
229239|NCT01151046|556100|P1|NOT COMPLETED|Overall Study||3
229240|NCT01151046|556099|P2|COMPLETED|Overall Study||59
229241|NCT01151046|556100|P1|COMPLETED|Overall Study||56
229242|NCT01151046|556099|P2|STARTED|Overall Study||59
229243|NCT01151046|556100|P1|STARTED|Overall Study||59
229244|NCT01151020|556112|P1|NOT COMPLETED|Overall Study||110
229245|NCT01151020|556112|P1|COMPLETED|Overall Study||0
229246|NCT01151020|556112|P1|12-month|Overall Study||99
229247|NCT01151020|556112|P1|30-day|Overall Study||110
229248|NCT01151020|556112|P1|STARTED|Overall Study||110
229249|NCT01150981|556119|P2|NOT COMPLETED|Overall Study||2
229250|NCT01150981|556120|P1|NOT COMPLETED|Overall Study||4
229251|NCT01150981|556119|P2|COMPLETED|Overall Study||13
229252|NCT01150981|556120|P1|COMPLETED|Overall Study||16
229253|NCT01150981|556119|P2|STARTED|Overall Study||15
229254|NCT01150981|556120|P1|STARTED|Overall Study||20
229255|NCT01150903|556130|P2|NOT COMPLETED|Overall Study||0
229256|NCT01150903|556131|P1|NOT COMPLETED|Overall Study||0
229257|NCT01150903|556130|P2|COMPLETED|Overall Study||74124
229258|NCT01150903|556131|P1|COMPLETED|Overall Study||24708
229259|NCT01150903|556130|P2|STARTED|Overall Study||74124
229260|NCT01150903|556131|P1|STARTED|Overall Study||24708
229261|NCT01150760|556147|P2|NOT COMPLETED|Overall Study||0
229262|NCT01150760|556148|P1|NOT COMPLETED|Overall Study||0
229263|NCT01150760|556147|P2|COMPLETED|Overall Study||3525
229264|NCT01150760|556148|P1|COMPLETED|Overall Study||3525
229265|NCT01150760|556147|P2|STARTED|Overall Study||3525
229266|NCT01150760|556148|P1|STARTED|Overall Study||3525
229267|NCT01150500|556180|P1|NOT COMPLETED|Overall Study||65
229268|NCT01150500|556180|P1|COMPLETED|Overall Study||0
229269|NCT01150500|556180|P1|STARTED|Overall Study||65
229270|NCT01150474|556191|P2|NOT COMPLETED|Overall Study||3
229271|NCT01150474|556192|P1|NOT COMPLETED|Overall Study||10
229272|NCT01150474|556191|P2|COMPLETED|Overall Study||49
229273|NCT01150474|556192|P1|COMPLETED|Overall Study||41
229274|NCT01150474|556191|P2|STARTED|Overall Study||52
229275|NCT01150474|556192|P1|STARTED|Overall Study||51
229276|NCT01150461|556216|P2|NOT COMPLETED|Overall Study||0
229277|NCT01150461|556217|P1|NOT COMPLETED|Overall Study||0
229278|NCT01150461|556216|P2|COMPLETED|Overall Study||9
229279|NCT01150461|556217|P1|COMPLETED|Overall Study||11
229280|NCT01150461|556216|P2|STARTED|Overall Study||9
229281|NCT01150461|556217|P1|STARTED|Overall Study||11
229282|NCT01150409|556227|P2|NOT COMPLETED|Overall Study||0
229283|NCT01150409|556228|P1|NOT COMPLETED|Overall Study||0
229284|NCT01150409|556227|P2|COMPLETED|Overall Study||0
229285|NCT01150409|556228|P1|COMPLETED|Overall Study||11
229286|NCT01150409|556227|P2|STARTED|Overall Study||0
229287|NCT01150409|556228|P1|STARTED|Overall Study||11
229288|NCT01150357|556237|P3|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||2
229289|NCT01150357|556238|P2|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||0
229290|NCT01150357|556239|P1|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||3
229291|NCT01150357|556237|P3|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||100
229292|NCT01150357|556238|P2|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||51
229293|NCT01150357|556239|P1|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||104
229294|NCT01150357|556237|P3|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||51
229295|NCT01150357|556238|P2|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||21
229296|NCT01150357|556239|P1|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||54
229297|NCT01150357|556237|P3|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||52
229298|NCT01150357|556238|P2|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||21
229299|NCT01150357|556239|P1|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||57
229300|NCT01150357|556237|P3|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||49
229301|NCT01150357|556238|P2|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
229302|NCT01150357|556239|P1|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
229303|NCT01150357|556237|P3|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
229304|NCT01150357|556238|P2|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
229305|NCT01150357|556239|P1|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
229306|NCT01150357|556237|P3|STARTED|Placebo-controlled Withdrawal (Phase 2)||102
229307|NCT01150357|556238|P2|STARTED|Placebo-controlled Withdrawal (Phase 2)||51
229308|NCT01150357|556239|P1|STARTED|Placebo-controlled Withdrawal (Phase 2)||107
229309|NCT01150357|556237|P3|NOT COMPLETED|Dose Response Phase (Phase 1)||3
229310|NCT01150357|556238|P2|NOT COMPLETED|Dose Response Phase (Phase 1)||3
229311|NCT01150357|556239|P1|NOT COMPLETED|Dose Response Phase (Phase 1)||1
229312|NCT01150357|556237|P3|COMPLETED|Dose Response Phase (Phase 1)||102
229313|NCT01150357|556238|P2|COMPLETED|Dose Response Phase (Phase 1)||51
229314|NCT01150357|556239|P1|COMPLETED|Dose Response Phase (Phase 1)||107
229315|NCT01150357|556237|P3|STARTED|Dose Response Phase (Phase 1)||105
229316|NCT01150357|556238|P2|STARTED|Dose Response Phase (Phase 1)||54
229317|NCT01150357|556239|P1|STARTED|Dose Response Phase (Phase 1)||108
229318|NCT01150123|556319|P18|NOT COMPLETED|Overall Study||1
229319|NCT01150123|556320|P17|NOT COMPLETED|Overall Study||0
229320|NCT01150123|556321|P16|NOT COMPLETED|Overall Study||1
229321|NCT01150123|556322|P15|NOT COMPLETED|Overall Study||0
229322|NCT01150123|556323|P14|NOT COMPLETED|Overall Study||0
229323|NCT01150123|556324|P13|NOT COMPLETED|Overall Study||3
229324|NCT01150123|556325|P12|NOT COMPLETED|Overall Study||1
229325|NCT01150123|556326|P11|NOT COMPLETED|Overall Study||2
229326|NCT01150123|556327|P10|NOT COMPLETED|Overall Study||1
229327|NCT01150123|556328|P9|NOT COMPLETED|Overall Study||5
229328|NCT01150123|556329|P8|NOT COMPLETED|Overall Study||3
229329|NCT01150123|556330|P7|NOT COMPLETED|Overall Study||0
229330|NCT01150123|556331|P6|NOT COMPLETED|Overall Study||6
229331|NCT01150123|556332|P5|NOT COMPLETED|Overall Study||3
229332|NCT01150123|556333|P4|NOT COMPLETED|Overall Study||3
229333|NCT01150123|556334|P3|NOT COMPLETED|Overall Study||4
229334|NCT01150123|556335|P2|NOT COMPLETED|Overall Study||2
229335|NCT01150123|556336|P1|NOT COMPLETED|Overall Study||3
229336|NCT01150123|556319|P18|COMPLETED|Overall Study||19
229337|NCT01150123|556320|P17|COMPLETED|Overall Study||40
229338|NCT01150123|556321|P16|COMPLETED|Overall Study||39
229339|NCT01150123|556322|P15|COMPLETED|Overall Study||40
229340|NCT01150123|556323|P14|COMPLETED|Overall Study||40
229341|NCT01150123|556324|P13|COMPLETED|Overall Study||37
229342|NCT01150123|556325|P12|COMPLETED|Overall Study||39
229343|NCT01150123|556326|P11|COMPLETED|Overall Study||38
229344|NCT01150123|556327|P10|COMPLETED|Overall Study||39
229345|NCT01150123|556328|P9|COMPLETED|Overall Study||15
229346|NCT01150123|556329|P8|COMPLETED|Overall Study||37
229347|NCT01150123|556330|P7|COMPLETED|Overall Study||39
229348|NCT01150123|556331|P6|COMPLETED|Overall Study||34
229349|NCT01150123|556332|P5|COMPLETED|Overall Study||37
229350|NCT01150123|556333|P4|COMPLETED|Overall Study||37
229351|NCT01150123|556334|P3|COMPLETED|Overall Study||35
229352|NCT01150123|556335|P2|COMPLETED|Overall Study||38
229353|NCT01150123|556336|P1|COMPLETED|Overall Study||37
229354|NCT01150123|556319|P18|STARTED|Overall Study||20
229355|NCT01150123|556320|P17|STARTED|Overall Study||40
229356|NCT01150123|556321|P16|STARTED|Overall Study||40
229357|NCT01150123|556322|P15|STARTED|Overall Study||40
229358|NCT01150123|556323|P14|STARTED|Overall Study||40
229359|NCT01150123|556324|P13|STARTED|Overall Study||40
229360|NCT01150123|556325|P12|STARTED|Overall Study||40
229361|NCT01150123|556326|P11|STARTED|Overall Study||40
229362|NCT01150123|556327|P10|STARTED|Overall Study||40
229363|NCT01150123|556328|P9|STARTED|Overall Study||20
229364|NCT01150123|556329|P8|STARTED|Overall Study||40
229365|NCT01150123|556330|P7|STARTED|Overall Study||39
229366|NCT01150123|556331|P6|STARTED|Overall Study||40
229367|NCT01150123|556332|P5|STARTED|Overall Study||40
229368|NCT01150123|556333|P4|STARTED|Overall Study||40
229369|NCT01150123|556334|P3|STARTED|Overall Study||39
229370|NCT01150123|556335|P2|STARTED|Overall Study||40
229371|NCT01150123|556336|P1|STARTED|Overall Study||40
229372|NCT01150097|556512|P3|NOT COMPLETED|Months 24 to 48 Post-transplantation||0
229373|NCT01150097|556513|P2|NOT COMPLETED|Months 24 to 48 Post-transplantation||4
229374|NCT01150097|556514|P1|NOT COMPLETED|Months 24 to 48 Post-transplantation||11
229375|NCT01150097|556512|P3|COMPLETED|Months 24 to 48 Post-transplantation||0
229376|NCT01150097|556513|P2|COMPLETED|Months 24 to 48 Post-transplantation||47
229377|NCT01150097|556514|P1|COMPLETED|Months 24 to 48 Post-transplantation||95
229378|NCT01150097|556512|P3|STARTED|Months 24 to 48 Post-transplantation||0
229379|NCT01150097|556513|P2|STARTED|Months 24 to 48 Post-transplantation||51
229380|NCT01150097|556514|P1|STARTED|Months 24 to 48 Post-transplantation||106
229381|NCT01150097|556512|P3|NOT COMPLETED|Months 24 to 36 Post-transplantation||8
229382|NCT01150097|556513|P2|NOT COMPLETED|Months 24 to 36 Post-transplantation||2
229383|NCT01150097|556514|P1|NOT COMPLETED|Months 24 to 36 Post-transplantation||10
229384|NCT01150097|556512|P3|COMPLETED|Months 24 to 36 Post-transplantation||117
229385|NCT01150097|556513|P2|COMPLETED|Months 24 to 36 Post-transplantation||49
229386|NCT01150097|556514|P1|COMPLETED|Months 24 to 36 Post-transplantation||96
229387|NCT01150097|556512|P3|STARTED|Months 24 to 36 Post-transplantation||125
229388|NCT01150097|556513|P2|STARTED|Months 24 to 36 Post-transplantation||51
229389|NCT01150097|556514|P1|STARTED|Months 24 to 36 Post-transplantation||106
229390|NCT01149876|556541|P4|NOT COMPLETED|Overall Study||0
229391|NCT01149876|556542|P3|NOT COMPLETED|Overall Study||1
229392|NCT01149876|556543|P2|NOT COMPLETED|Overall Study||0
229393|NCT01149876|556544|P1|NOT COMPLETED|Overall Study||1
229394|NCT01149876|556541|P4|COMPLETED|Overall Study||18
229395|NCT01149876|556542|P3|COMPLETED|Overall Study||20
229396|NCT01149876|556543|P2|COMPLETED|Overall Study||20
229397|NCT01149876|556544|P1|COMPLETED|Overall Study||20
229398|NCT01149876|556541|P4|STARTED|Overall Study||18
229399|NCT01149876|556542|P3|STARTED|Overall Study||21
229400|NCT01149876|556543|P2|STARTED|Overall Study||20
229401|NCT01149876|556544|P1|STARTED|Overall Study||21
229402|NCT01149863|556558|P1|NOT COMPLETED|Overall Study||3
229403|NCT01149863|556558|P1|COMPLETED|Overall Study||31
229404|NCT01149863|556558|P1|STARTED|Overall Study||34
229405|NCT01149785|556563|P2|NOT COMPLETED|Second Intervention||0
229406|NCT01149785|556564|P1|NOT COMPLETED|Second Intervention||0
229407|NCT01149785|556563|P2|COMPLETED|Second Intervention||15
229408|NCT01149785|556564|P1|COMPLETED|Second Intervention||0
229409|NCT01149785|556563|P2|STARTED|Second Intervention||15
229410|NCT01149785|556564|P1|STARTED|Second Intervention||0
229411|NCT01149785|556563|P2|NOT COMPLETED|Washout Period of at Least 14 Days||0
229412|NCT01149785|556564|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
229413|NCT01149785|556563|P2|COMPLETED|Washout Period of at Least 14 Days||0
229414|NCT01149785|556564|P1|COMPLETED|Washout Period of at Least 14 Days||15
229415|NCT01149785|556563|P2|STARTED|Washout Period of at Least 14 Days||0
229416|NCT01149785|556564|P1|STARTED|Washout Period of at Least 14 Days||15
229417|NCT01149785|556563|P2|NOT COMPLETED|First Intervention||0
229418|NCT01149785|556564|P1|NOT COMPLETED|First Intervention||0
229419|NCT01149785|556563|P2|COMPLETED|First Intervention||0
229420|NCT01149785|556564|P1|COMPLETED|First Intervention||15
229421|NCT01149785|556563|P2|STARTED|First Intervention||0
229422|NCT01149785|556564|P1|STARTED|First Intervention||15
229423|NCT01149772|556598|P2|NOT COMPLETED|Overall Study||21
229424|NCT01149772|556599|P1|NOT COMPLETED|Overall Study||48
229425|NCT01149772|556598|P2|COMPLETED|Overall Study||101
229426|NCT01149772|556599|P1|COMPLETED|Overall Study||132
229427|NCT01149772|556598|P2|STARTED|Overall Study||122
229428|NCT01149772|556599|P1|STARTED|Overall Study||180
229429|NCT01149759|556615|P1|NOT COMPLETED|Overall Study||0
229430|NCT01149759|556615|P1|COMPLETED|Overall Study||9
229431|NCT01149759|556615|P1|STARTED|Overall Study||9
229432|NCT01149733|556622|P2|NOT COMPLETED|Overall Study||0
229433|NCT01149733|556623|P1|NOT COMPLETED|Overall Study||0
229434|NCT01149733|556622|P2|COMPLETED|Overall Study||16
229435|NCT01149733|556623|P1|COMPLETED|Overall Study||16
229436|NCT01149733|556622|P2|STARTED|Overall Study||16
229437|NCT01149733|556623|P1|STARTED|Overall Study||16
229438|NCT01149655|556635|P4|NOT COMPLETED|Period 3-DB Maintenance Phase||42
229439|NCT01149655|556636|P3|NOT COMPLETED|Period 3-DB Maintenance Phase||83
229440|NCT01149655|556637|P2|NOT COMPLETED|Period 3-DB Maintenance Phase||0
229441|NCT01149655|556638|P1|NOT COMPLETED|Period 3-DB Maintenance Phase||0
229442|NCT01149655|556635|P4|COMPLETED|Period 3-DB Maintenance Phase||6
229443|NCT01149655|556636|P3|COMPLETED|Period 3-DB Maintenance Phase||15
229444|NCT01149655|556637|P2|COMPLETED|Period 3-DB Maintenance Phase||0
229445|NCT01149655|556638|P1|COMPLETED|Period 3-DB Maintenance Phase||0
229446|NCT01149655|556635|P4|STARTED|Period 3-DB Maintenance Phase||48
229447|NCT01149655|556636|P3|STARTED|Period 3-DB Maintenance Phase||98
229448|NCT01149655|556637|P2|STARTED|Period 3-DB Maintenance Phase||0
229449|NCT01149655|556638|P1|STARTED|Period 3-DB Maintenance Phase||0
229450|NCT01149655|556635|P4|NOT COMPLETED|Period 2-Stabilization Phase||0
229451|NCT01149655|556636|P3|NOT COMPLETED|Period 2-Stabilization Phase||0
229452|NCT01149655|556637|P2|NOT COMPLETED|Period 2-Stabilization Phase||37
229453|NCT01149655|556638|P1|NOT COMPLETED|Period 2-Stabilization Phase||0
229454|NCT01149655|556635|P4|COMPLETED|Period 2-Stabilization Phase||0
229455|NCT01149655|556636|P3|COMPLETED|Period 2-Stabilization Phase||0
229456|NCT01149655|556637|P2|COMPLETED|Period 2-Stabilization Phase||146
229457|NCT01149655|556638|P1|COMPLETED|Period 2-Stabilization Phase||0
229458|NCT01149655|556635|P4|STARTED|Period 2-Stabilization Phase||0
229459|NCT01149655|556636|P3|STARTED|Period 2-Stabilization Phase||0
229460|NCT01149655|556637|P2|STARTED|Period 2-Stabilization Phase||183
229461|NCT01149655|556638|P1|STARTED|Period 2-Stabilization Phase||0
229462|NCT01149655|556635|P4|NOT COMPLETED|Period 1 - Conversion Phase||0
229463|NCT01149655|556636|P3|NOT COMPLETED|Period 1 - Conversion Phase||0
229464|NCT01149655|556637|P2|NOT COMPLETED|Period 1 - Conversion Phase||0
229465|NCT01149655|556638|P1|NOT COMPLETED|Period 1 - Conversion Phase||18
229466|NCT01149655|556635|P4|COMPLETED|Period 1 - Conversion Phase||0
229467|NCT01149655|556636|P3|COMPLETED|Period 1 - Conversion Phase||0
229468|NCT01149655|556637|P2|COMPLETED|Period 1 - Conversion Phase||0
229469|NCT01149655|556638|P1|COMPLETED|Period 1 - Conversion Phase||168
229470|NCT01149655|556635|P4|STARTED|Period 1 - Conversion Phase||0
229471|NCT01149655|556636|P3|STARTED|Period 1 - Conversion Phase||0
229472|NCT01149655|556637|P2|STARTED|Period 1 - Conversion Phase||0
229473|NCT01149655|556638|P1|STARTED|Period 1 - Conversion Phase||186
229474|NCT01149616|556668|P2|NOT COMPLETED|Overall Study||0
229475|NCT01149616|556669|P1|NOT COMPLETED|Overall Study||0
229476|NCT01149616|556668|P2|COMPLETED|Overall Study||41
229477|NCT01149616|556669|P1|COMPLETED|Overall Study||41
229478|NCT01149616|556668|P2|STARTED|Overall Study||41
229479|NCT01149616|556669|P1|STARTED|Overall Study||41
229480|NCT01149538|556681|P2|NOT COMPLETED|Overall Study||4
229481|NCT01149538|556682|P1|NOT COMPLETED|Overall Study||5
229482|NCT01149538|556681|P2|COMPLETED|Overall Study||25
229483|NCT01149538|556682|P1|COMPLETED|Overall Study||26
229484|NCT01149538|556681|P2|STARTED|Overall Study||29
229485|NCT01149538|556682|P1|STARTED|Overall Study||31
229486|NCT01149512|556696|P1|NOT COMPLETED|Overall Study||0
229487|NCT01149512|556696|P1|COMPLETED|Overall Study||178
229488|NCT01149512|556696|P1|STARTED|Overall Study||178
229489|NCT01149486|556703|P2|NOT COMPLETED|Second Intervention||0
229490|NCT01149486|556704|P1|NOT COMPLETED|Second Intervention||0
229491|NCT01149486|556703|P2|COMPLETED|Second Intervention||9
229492|NCT01149486|556704|P1|COMPLETED|Second Intervention||10
229493|NCT01149486|556703|P2|STARTED|Second Intervention||9
229494|NCT01149486|556704|P1|STARTED|Second Intervention||10
229495|NCT01149486|556703|P2|NOT COMPLETED|Washout of 7 Days||0
229496|NCT01149486|556704|P1|NOT COMPLETED|Washout of 7 Days||0
229497|NCT01149486|556703|P2|COMPLETED|Washout of 7 Days||9
229498|NCT01149486|556704|P1|COMPLETED|Washout of 7 Days||10
229499|NCT01149486|556703|P2|STARTED|Washout of 7 Days||9
229500|NCT01149486|556704|P1|STARTED|Washout of 7 Days||10
229501|NCT01149486|556703|P2|NOT COMPLETED|First Intervention||1
229502|NCT01149486|556704|P1|NOT COMPLETED|First Intervention||0
229503|NCT01149486|556703|P2|COMPLETED|First Intervention||9
229504|NCT01149486|556704|P1|COMPLETED|First Intervention||10
229505|NCT01149486|556703|P2|STARTED|First Intervention||10
229506|NCT01149486|556704|P1|STARTED|First Intervention||10
229507|NCT01149473|556728|P2|NOT COMPLETED|Second Intervention||0
229508|NCT01149473|556729|P1|NOT COMPLETED|Second Intervention||0
229509|NCT01149473|556728|P2|COMPLETED|Second Intervention||38
229510|NCT01149473|556729|P1|COMPLETED|Second Intervention||38
229511|NCT01149473|556728|P2|STARTED|Second Intervention||38
229512|NCT01149473|556729|P1|STARTED|Second Intervention||38
229513|NCT01149473|556728|P2|NOT COMPLETED|Washout of 7 Days||1
229514|NCT01149473|556729|P1|NOT COMPLETED|Washout of 7 Days||1
229515|NCT01149473|556728|P2|COMPLETED|Washout of 7 Days||38
229516|NCT01149473|556729|P1|COMPLETED|Washout of 7 Days||38
229517|NCT01149473|556728|P2|STARTED|Washout of 7 Days||39
229518|NCT01149473|556729|P1|STARTED|Washout of 7 Days||39
229519|NCT01149473|556728|P2|NOT COMPLETED|First Intervention||1
229520|NCT01149473|556729|P1|NOT COMPLETED|First Intervention||1
229521|NCT01149473|556728|P2|COMPLETED|First Intervention||39
229522|NCT01149473|556729|P1|COMPLETED|First Intervention||39
229523|NCT01149473|556728|P2|STARTED|First Intervention||40
229524|NCT01149473|556729|P1|STARTED|First Intervention||40
229525|NCT01149460|556747|P2|NOT COMPLETED|Overall Study||2
229526|NCT01149460|556748|P1|NOT COMPLETED|Overall Study||0
229527|NCT01149460|556747|P2|COMPLETED|Overall Study||16
229528|NCT01149460|556748|P1|COMPLETED|Overall Study||18
229529|NCT01149460|556747|P2|STARTED|Overall Study||18
229530|NCT01149460|556748|P1|STARTED|Overall Study||18
229531|NCT01149434|556766|P2|NOT COMPLETED|Overall Study||5
229532|NCT01149434|556767|P1|NOT COMPLETED|Overall Study||0
229533|NCT01149434|556766|P2|COMPLETED|Overall Study||10
229534|NCT01149434|556767|P1|COMPLETED|Overall Study||4
229535|NCT01149434|556766|P2|STARTED|Overall Study||15
229536|NCT01149434|556767|P1|STARTED|Overall Study||4
229537|NCT01149421|556781|P3|NOT COMPLETED|Overall Study||44
229538|NCT01149421|556782|P2|NOT COMPLETED|Overall Study||29
229539|NCT01149421|556783|P1|NOT COMPLETED|Overall Study||52
229540|NCT01149421|556781|P3|COMPLETED|Overall Study||206
229541|NCT01149421|556782|P2|COMPLETED|Overall Study||225
229542|NCT01149421|556783|P1|COMPLETED|Overall Study||199
229543|NCT01149421|556781|P3|Received at Least One Dose of Study Drug|Overall Study||250
229544|NCT01149421|556782|P2|Received at Least One Dose of Study Drug|Overall Study||254
229545|NCT01149421|556783|P1|Received at Least One Dose of Study Drug|Overall Study||251
229546|NCT01149421|556781|P3|STARTED|Overall Study||250
229547|NCT01149421|556782|P2|STARTED|Overall Study||254
229548|NCT01149421|556783|P1|STARTED|Overall Study||251
229549|NCT01149369|556864|P2|NOT COMPLETED|Overall Study||3
229550|NCT01149369|556865|P1|NOT COMPLETED|Overall Study||6
229551|NCT01149369|556864|P2|COMPLETED|Overall Study||60
229552|NCT01149369|556865|P1|COMPLETED|Overall Study||57
229553|NCT01149369|556864|P2|STARTED|Overall Study||63
229554|NCT01149369|556865|P1|STARTED|Overall Study||63
229555|NCT01149343|557033|P4|NOT COMPLETED|Overall Study||40
229556|NCT01149343|557034|P3|NOT COMPLETED|Overall Study||22
229557|NCT01149343|557035|P2|NOT COMPLETED|Overall Study||24
229558|NCT01149343|557036|P1|NOT COMPLETED|Overall Study||20
229559|NCT01149343|557033|P4|COMPLETED|Overall Study||0
229560|NCT01149343|557034|P3|COMPLETED|Overall Study||0
229561|NCT01149343|557035|P2|COMPLETED|Overall Study||0
229562|NCT01149343|557036|P1|COMPLETED|Overall Study||0
229563|NCT01149343|557033|P4|STARTED|Overall Study||40
229564|NCT01149343|557034|P3|STARTED|Overall Study||22
229565|NCT01149343|557035|P2|STARTED|Overall Study||24
229566|NCT01149343|557036|P1|STARTED|Overall Study||20
229567|NCT01149148|557121|P2|NOT COMPLETED|Overall Study||2
229568|NCT01149148|557122|P1|NOT COMPLETED|Overall Study||2
229569|NCT01149148|557121|P2|COMPLETED|Overall Study||11
229570|NCT01149148|557122|P1|COMPLETED|Overall Study||10
229571|NCT01149148|557121|P2|STARTED|Overall Study||13
229572|NCT01149148|557122|P1|STARTED|Overall Study||12
229573|NCT01149057|557130|P1|NOT COMPLETED|Overall Study||57
229574|NCT01149057|557130|P1|COMPLETED|Overall Study||88
229575|NCT01149057|557130|P1|STARTED|Overall Study||145
229576|NCT01148979|557157|P2|NOT COMPLETED|Overall Study||1
229577|NCT01148979|557158|P1|NOT COMPLETED|Overall Study||0
229578|NCT01148979|557157|P2|COMPLETED|Overall Study||15
229579|NCT01148979|557158|P1|COMPLETED|Overall Study||13
229580|NCT01148979|557157|P2|STARTED|Overall Study||16
229581|NCT01148979|557158|P1|STARTED|Overall Study||13
229582|NCT01148862|557164|P2|NOT COMPLETED|Second Intervention||2
229583|NCT01148862|557165|P1|NOT COMPLETED|Second Intervention||0
229584|NCT01148862|557164|P2|COMPLETED|Second Intervention||23
229585|NCT01148862|557165|P1|COMPLETED|Second Intervention||25
229586|NCT01148862|557164|P2|STARTED|Second Intervention||25
229587|NCT01148862|557165|P1|STARTED|Second Intervention||25
229588|NCT01148862|557164|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
229589|NCT01148862|557165|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
229590|NCT01148862|557164|P2|COMPLETED|Washout Period of 2 Weeks||25
229591|NCT01148862|557165|P1|COMPLETED|Washout Period of 2 Weeks||25
229592|NCT01148862|557164|P2|STARTED|Washout Period of 2 Weeks||25
229593|NCT01148862|557165|P1|STARTED|Washout Period of 2 Weeks||25
229594|NCT01148862|557164|P2|NOT COMPLETED|First Intervention||0
229595|NCT01148862|557165|P1|NOT COMPLETED|First Intervention||0
229596|NCT01148862|557164|P2|COMPLETED|First Intervention||25
229597|NCT01148862|557165|P1|COMPLETED|First Intervention||25
229598|NCT01148862|557164|P2|STARTED|First Intervention||25
229599|NCT01148862|557165|P1|STARTED|First Intervention||25
229600|NCT01148836|557175|P2|NOT COMPLETED|Overall Study||2
229601|NCT01148836|557176|P1|NOT COMPLETED|Overall Study||1
229602|NCT01148836|557175|P2|COMPLETED|Overall Study||8
229603|NCT01148836|557176|P1|COMPLETED|Overall Study|Enrollment completed|7
229604|NCT01148836|557175|P2|STARTED|Overall Study||10
229605|NCT01148836|557176|P1|STARTED|Overall Study|Enrollment completed|8
229606|NCT01148810|557197|P2|NOT COMPLETED|Overall Study||5
229607|NCT01148810|557198|P1|NOT COMPLETED|Overall Study||1
229608|NCT01148810|557197|P2|COMPLETED|Overall Study||5
229609|NCT01148810|557198|P1|COMPLETED|Overall Study||7
229610|NCT01148810|557197|P2|STARTED|Overall Study||10
229611|NCT01148810|557198|P1|STARTED|Overall Study||8
229612|NCT01148771|557225|P2|NOT COMPLETED|Second Intervention||0
229613|NCT01148771|557226|P1|NOT COMPLETED|Second Intervention||0
229614|NCT01148771|557225|P2|COMPLETED|Second Intervention||5
229615|NCT01148771|557226|P1|COMPLETED|Second Intervention||6
229616|NCT01148771|557225|P2|STARTED|Second Intervention||5
229617|NCT01148771|557226|P1|STARTED|Second Intervention||6
229618|NCT01148771|557225|P2|NOT COMPLETED|Washout Period||1
229619|NCT01148771|557226|P1|NOT COMPLETED|Washout Period||0
229620|NCT01148771|557225|P2|COMPLETED|Washout Period||5
229621|NCT01148771|557226|P1|COMPLETED|Washout Period||6
229622|NCT01148771|557225|P2|STARTED|Washout Period||6
229623|NCT01148771|557226|P1|STARTED|Washout Period||6
229624|NCT01148771|557225|P2|NOT COMPLETED|First Intervention||0
229625|NCT01148771|557226|P1|NOT COMPLETED|First Intervention||0
229626|NCT01148771|557225|P2|COMPLETED|First Intervention||6
229627|NCT01148771|557226|P1|COMPLETED|First Intervention||6
229628|NCT01148771|557225|P2|STARTED|First Intervention||6
229629|NCT01148771|557226|P1|STARTED|First Intervention||6
229630|NCT01148745|557238|P1|NOT COMPLETED|Overall Study||0
229631|NCT01148745|557238|P1|COMPLETED|Overall Study||15
229632|NCT01148745|557238|P1|STARTED|Overall Study||15
229633|NCT01148693|557246|P2|NOT COMPLETED|Overall Study||10
229634|NCT01148693|557247|P1|NOT COMPLETED|Overall Study||13
229635|NCT01148693|557246|P2|COMPLETED|Overall Study||57
229636|NCT01148693|557247|P1|COMPLETED|Overall Study||57
229637|NCT01148693|557246|P2|STARTED|Overall Study||67
229638|NCT01148693|557247|P1|STARTED|Overall Study||70
229639|NCT01148563|557255|P2|NOT COMPLETED|Overall Study||30
229640|NCT01148563|557256|P1|NOT COMPLETED|Overall Study||29
229641|NCT01148563|557255|P2|COMPLETED|Overall Study||37
229642|NCT01148563|557256|P1|COMPLETED|Overall Study||40
229643|NCT01148563|557255|P2|STARTED|Overall Study||67
229644|NCT01148563|557256|P1|STARTED|Overall Study||69
229645|NCT01148537|557267|P3|NOT COMPLETED|Overall Study||3
229646|NCT01148537|557268|P2|NOT COMPLETED|Overall Study||0
229647|NCT01148537|557269|P1|NOT COMPLETED|Overall Study||3
229648|NCT01148537|557267|P3|COMPLETED|Overall Study||41
229649|NCT01148537|557268|P2|COMPLETED|Overall Study||44
229650|NCT01148537|557269|P1|COMPLETED|Overall Study||41
229651|NCT01148537|557267|P3|STARTED|Overall Study||44
229652|NCT01148537|557268|P2|STARTED|Overall Study||44
229653|NCT01148537|557269|P1|STARTED|Overall Study||44
229654|NCT01148524|557299|P9|NOT COMPLETED|Overall Study||0
229655|NCT01148524|557300|P8|NOT COMPLETED|Overall Study||0
229656|NCT01148524|557301|P7|NOT COMPLETED|Overall Study||0
229657|NCT01148524|557302|P6|NOT COMPLETED|Overall Study||0
229658|NCT01148524|557303|P5|NOT COMPLETED|Overall Study||0
229659|NCT01148524|557304|P4|NOT COMPLETED|Overall Study||0
229660|NCT01148524|557305|P3|NOT COMPLETED|Overall Study||0
229661|NCT01148524|557306|P2|NOT COMPLETED|Overall Study||0
229662|NCT01148524|557307|P1|NOT COMPLETED|Overall Study||0
229663|NCT01148524|557299|P9|COMPLETED|Overall Study||151
229664|NCT01148524|557300|P8|COMPLETED|Overall Study||51
229665|NCT01148524|557301|P7|COMPLETED|Overall Study||153
229666|NCT01148524|557302|P6|COMPLETED|Overall Study||106
229667|NCT01148524|557303|P5|COMPLETED|Overall Study||57
229668|NCT01148524|557304|P4|COMPLETED|Overall Study||102
229669|NCT01148524|557305|P3|COMPLETED|Overall Study||53
229670|NCT01148524|557306|P2|COMPLETED|Overall Study||95
229671|NCT01148524|557307|P1|COMPLETED|Overall Study||49
229672|NCT01148524|557299|P9|STARTED|Overall Study||151
229673|NCT01148524|557300|P8|STARTED|Overall Study||51
229674|NCT01148524|557301|P7|STARTED|Overall Study||153
229675|NCT01148524|557302|P6|STARTED|Overall Study||106
229676|NCT01148524|557303|P5|STARTED|Overall Study||57
229677|NCT01148524|557304|P4|STARTED|Overall Study||102
229678|NCT01148524|557305|P3|STARTED|Overall Study||53
229679|NCT01148524|557306|P2|STARTED|Overall Study||95
229680|NCT01148524|557307|P1|STARTED|Overall Study||49
229681|NCT01148511|557355|P3|NOT COMPLETED|Randomized||6
229682|NCT01148511|557356|P2|NOT COMPLETED|Randomized||10
229683|NCT01148511|557357|P1|NOT COMPLETED|Randomized||0
229684|NCT01148511|557355|P3|COMPLETED|Randomized||39
229685|NCT01148511|557356|P2|COMPLETED|Randomized||38
229686|NCT01148511|557357|P1|COMPLETED|Randomized||0
229687|NCT01148511|557355|P3|STARTED|Randomized||45
229688|NCT01148511|557356|P2|STARTED|Randomized||48
229689|NCT01148511|557357|P1|STARTED|Randomized|All patients were randomized into the Treat and Extend and the Treat and Observe treatment groups.|0
229690|NCT01148511|557355|P3|NOT COMPLETED|Exposed to Study Drug||0
229691|NCT01148511|557356|P2|NOT COMPLETED|Exposed to Study Drug||0
229692|NCT01148511|557357|P1|NOT COMPLETED|Exposed to Study Drug||6
229693|NCT01148511|557355|P3|COMPLETED|Exposed to Study Drug||0
229694|NCT01148511|557356|P2|COMPLETED|Exposed to Study Drug||0
229695|NCT01148511|557357|P1|COMPLETED|Exposed to Study Drug||93
229696|NCT01148511|557355|P3|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
229697|NCT01148511|557356|P2|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
229698|NCT01148511|557357|P1|STARTED|Exposed to Study Drug||99
229699|NCT01148459|557378|P2|NOT COMPLETED|Overall Study||11
229700|NCT01148459|557379|P1|NOT COMPLETED|Overall Study||12
229701|NCT01148459|557378|P2|COMPLETED|Overall Study||90
229702|NCT01148459|557379|P1|COMPLETED|Overall Study||87
229703|NCT01148459|557378|P2|STARTED|Overall Study||101
229704|NCT01148459|557379|P1|STARTED|Overall Study||99
229705|NCT01148420|557421|P1|NOT COMPLETED|Overall Study||0
229706|NCT01148420|557421|P1|COMPLETED|Overall Study||48
229707|NCT01148420|557421|P1|STARTED|Overall Study||48
229708|NCT01148225|557427|P1|NOT COMPLETED|Overall Study||185
229709|NCT01148225|557427|P1|COMPLETED|Overall Study||239
229710|NCT01148225|557427|P1|STARTED|Overall Study||424
229711|NCT01148056|557465|P1|NOT COMPLETED|Overall Study||0
229712|NCT01148056|557465|P1|COMPLETED|Overall Study||2
229713|NCT01148056|557465|P1|STARTED|Overall Study||2
229714|NCT01148017|557478|P4|NOT COMPLETED|Overall Study||0
229715|NCT01148017|557479|P3|NOT COMPLETED|Overall Study||0
229716|NCT01148017|557480|P2|NOT COMPLETED|Overall Study||34
229717|NCT01148017|557481|P1|NOT COMPLETED|Overall Study||80
229718|NCT01148017|557478|P4|COMPLETED|Overall Study||45
229719|NCT01148017|557479|P3|COMPLETED|Overall Study||53
229720|NCT01148017|557480|P2|COMPLETED|Overall Study||87
229721|NCT01148017|557481|P1|COMPLETED|Overall Study||134
229722|NCT01148017|557478|P4|STARTED|Overall Study||45
229723|NCT01148017|557479|P3|STARTED|Overall Study||53
229724|NCT01148017|557480|P2|STARTED|Overall Study||121
229725|NCT01148017|557481|P1|STARTED|Overall Study||214
229726|NCT01147926|557520|P2|NOT COMPLETED|Overall Study||29
229727|NCT01147926|557521|P1|NOT COMPLETED|Overall Study||27
229728|NCT01147926|557520|P2|COMPLETED|Overall Study||158
229729|NCT01147926|557521|P1|COMPLETED|Overall Study||160
229730|NCT01147926|557520|P2|STARTED|Overall Study||187
229731|NCT01147926|557521|P1|STARTED|Overall Study||187
229732|NCT01147900|557556|P3|NOT COMPLETED|At Year 10||0
229733|NCT01147900|557557|P2|NOT COMPLETED|At Year 10||1
229734|NCT01147900|557558|P1|NOT COMPLETED|At Year 10||0
229735|NCT01147900|557556|P3|COMPLETED|At Year 10||62
229736|NCT01147900|557557|P2|COMPLETED|At Year 10||59
229737|NCT01147900|557558|P1|COMPLETED|At Year 10||55
229738|NCT01147900|557556|P3|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled.|62
229739|NCT01147900|557557|P2|STARTED|At Year 10||60
229740|NCT01147900|557558|P1|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled|55
229741|NCT01147900|557556|P3|NOT COMPLETED|At Year 8.5||0
229742|NCT01147900|557557|P2|NOT COMPLETED|At Year 8.5||0
229743|NCT01147900|557558|P1|NOT COMPLETED|At Year 8.5||0
229744|NCT01147900|557556|P3|COMPLETED|At Year 8.5||66
229745|NCT01147900|557557|P2|COMPLETED|At Year 8.5||60
229746|NCT01147900|557558|P1|COMPLETED|At Year 8.5||54
229747|NCT01147900|557556|P3|STARTED|At Year 8.5||66
229748|NCT01147900|557557|P2|STARTED|At Year 8.5||60
229749|NCT01147900|557558|P1|STARTED|At Year 8.5||54
229750|NCT01147874|557617|P1|NOT COMPLETED|Overall Study||67
229751|NCT01147874|557617|P1|COMPLETED|Overall Study||946
229752|NCT01147874|557617|P1|STARTED|Overall Study||1013
229753|NCT01147848|557625|P3|NOT COMPLETED|Randomized Phase||46
229754|NCT01147848|557626|P2|NOT COMPLETED|Randomized Phase||45
229755|NCT01147848|557627|P1|NOT COMPLETED|Randomized Phase||0
229756|NCT01147848|557625|P3|COMPLETED|Randomized Phase||357
229757|NCT01147848|557626|P2|COMPLETED|Randomized Phase||358
229758|NCT01147848|557627|P1|COMPLETED|Randomized Phase||0
229759|NCT01147848|557625|P3|STARTED|Randomized Phase||403
229760|NCT01147848|557626|P2|STARTED|Randomized Phase||403
229761|NCT01147848|557627|P1|STARTED|Randomized Phase||0
229762|NCT01147848|557625|P3|NOT COMPLETED|Run-in Period||0
229763|NCT01147848|557626|P2|NOT COMPLETED|Run-in Period||0
229764|NCT01147848|557627|P1|NOT COMPLETED|Run-in Period||758
229765|NCT01147848|557625|P3|COMPLETED|Run-in Period||0
229766|NCT01147848|557626|P2|COMPLETED|Run-in Period||0
229767|NCT01147848|557627|P1|COMPLETED|Run-in Period||806
229768|NCT01147848|557625|P3|STARTED|Run-in Period||0
229769|NCT01147848|557626|P2|STARTED|Run-in Period||0
229770|NCT01147848|557627|P1|STARTED|Run-in Period||1564
229771|NCT01147822|557659|P2|NOT COMPLETED|Overall Study||179
229772|NCT01147822|557660|P1|NOT COMPLETED|Overall Study||188
229773|NCT01147822|557659|P2|COMPLETED|Overall Study||0
229774|NCT01147822|557660|P1|COMPLETED|Overall Study||0
229775|NCT01147822|557659|P2|Not Completed/Ongoing|Overall Study||102
229776|NCT01147822|557660|P1|Not Completed/Ongoing|Overall Study||111
229777|NCT01147822|557659|P2|STARTED|Overall Study||179
229778|NCT01147822|557660|P1|STARTED|Overall Study||188
229779|NCT01147809|557680|P6|NOT COMPLETED|Phase II (168 Days)||33
229780|NCT01147809|557681|P5|NOT COMPLETED|Phase II (168 Days)||16
229781|NCT01147809|557682|P4|NOT COMPLETED|Phase II (168 Days)||0
229782|NCT01147809|557683|P3|NOT COMPLETED|Phase II (168 Days)||0
229783|NCT01147809|557684|P2|NOT COMPLETED|Phase II (168 Days)||0
229784|NCT01147809|557685|P1|NOT COMPLETED|Phase II (168 Days)||0
229785|NCT01147809|557680|P6|COMPLETED|Phase II (168 Days)||19
229786|NCT01147809|557681|P5|COMPLETED|Phase II (168 Days)||7
229787|NCT01147809|557682|P4|COMPLETED|Phase II (168 Days)||0
229788|NCT01147809|557683|P3|COMPLETED|Phase II (168 Days)||0
229789|NCT01147809|557684|P2|COMPLETED|Phase II (168 Days)||0
229790|NCT01147809|557685|P1|COMPLETED|Phase II (168 Days)||0
229791|NCT01147809|557680|P6|Ongoing|Phase II (168 Days)||0
229792|NCT01147809|557681|P5|Ongoing|Phase II (168 Days)||1
229793|NCT01147809|557682|P4|Ongoing|Phase II (168 Days)||0
229794|NCT01147809|557683|P3|Ongoing|Phase II (168 Days)||0
229795|NCT01147809|557684|P2|Ongoing|Phase II (168 Days)||0
229796|NCT01147809|557685|P1|Ongoing|Phase II (168 Days)||0
229797|NCT01147809|557680|P6|STARTED|Phase II (168 Days)||52
229798|NCT01147809|557681|P5|STARTED|Phase II (168 Days)||23
229799|NCT01147809|557682|P4|STARTED|Phase II (168 Days)||0
229800|NCT01147809|557683|P3|STARTED|Phase II (168 Days)||0
229801|NCT01147809|557684|P2|STARTED|Phase II (168 Days)||0
229802|NCT01147809|557685|P1|STARTED|Phase II (168 Days)||0
229803|NCT01147809|557680|P6|NOT COMPLETED|Phase I (168 Days)||0
229804|NCT01147809|557681|P5|NOT COMPLETED|Phase I (168 Days)||0
229805|NCT01147809|557682|P4|NOT COMPLETED|Phase I (168 Days)||5
229806|NCT01147809|557683|P3|NOT COMPLETED|Phase I (168 Days)||2
229807|NCT01147809|557684|P2|NOT COMPLETED|Phase I (168 Days)||1
229808|NCT01147809|557685|P1|NOT COMPLETED|Phase I (168 Days)||1
229809|NCT01147809|557680|P6|COMPLETED|Phase I (168 Days)||0
229810|NCT01147809|557681|P5|COMPLETED|Phase I (168 Days)||0
229811|NCT01147809|557682|P4|COMPLETED|Phase I (168 Days)||5
229812|NCT01147809|557683|P3|COMPLETED|Phase I (168 Days)||2
229813|NCT01147809|557684|P2|COMPLETED|Phase I (168 Days)||8
229814|NCT01147809|557685|P1|COMPLETED|Phase I (168 Days)||2
229815|NCT01147809|557680|P6|STARTED|Phase I (168 Days)||0
229816|NCT01147809|557681|P5|STARTED|Phase I (168 Days)||0
229817|NCT01147809|557682|P4|STARTED|Phase I (168 Days)||10
229818|NCT01147809|557683|P3|STARTED|Phase I (168 Days)||4
229819|NCT01147809|557684|P2|STARTED|Phase I (168 Days)||9
229820|NCT01147809|557685|P1|STARTED|Phase I (168 Days)||3
229821|NCT01147744|557806|P7|NOT COMPLETED|Overall Study||19
229822|NCT01147744|557807|P6|NOT COMPLETED|Overall Study||20
229823|NCT01147744|557808|P5|NOT COMPLETED|Overall Study||25
229824|NCT01147744|557809|P4|NOT COMPLETED|Overall Study||18
229825|NCT01147744|557810|P3|NOT COMPLETED|Overall Study||18
229826|NCT01147744|557811|P2|NOT COMPLETED|Overall Study||23
229827|NCT01147744|557812|P1|NOT COMPLETED|Overall Study||29
229828|NCT01147744|557806|P7|COMPLETED|Overall Study||78
229829|NCT01147744|557807|P6|COMPLETED|Overall Study||83
229830|NCT01147744|557808|P5|COMPLETED|Overall Study||76
229831|NCT01147744|557809|P4|COMPLETED|Overall Study||82
229832|NCT01147744|557810|P3|COMPLETED|Overall Study||82
229833|NCT01147744|557811|P2|COMPLETED|Overall Study||76
229834|NCT01147744|557812|P1|COMPLETED|Overall Study||71
229835|NCT01147744|557806|P7|STARTED|Overall Study||97
229836|NCT01147744|557807|P6|STARTED|Overall Study||103
229837|NCT01147744|557808|P5|STARTED|Overall Study||101
229838|NCT01147744|557809|P4|STARTED|Overall Study||100
229839|NCT01147744|557810|P3|STARTED|Overall Study||100
229840|NCT01147744|557811|P2|STARTED|Overall Study||99
229841|NCT01147744|557812|P1|STARTED|Overall Study||100
229842|NCT01147653|557907|P2|NOT COMPLETED|Year 2||3
229843|NCT01147653|557908|P1|NOT COMPLETED|Year 2||2
229844|NCT01147653|557907|P2|COMPLETED|Year 2||28
229845|NCT01147653|557908|P1|COMPLETED|Year 2||30
229846|NCT01147653|557907|P2|STARTED|Year 2||31
229847|NCT01147653|557908|P1|STARTED|Year 2||32
229848|NCT01147653|557907|P2|NOT COMPLETED|Year 1||0
229849|NCT01147653|557908|P1|NOT COMPLETED|Year 1||0
229850|NCT01147653|557907|P2|COMPLETED|Year 1||31
229851|NCT01147653|557908|P1|COMPLETED|Year 1||32
229852|NCT01147653|557907|P2|STARTED|Year 1||31
229853|NCT01147653|557908|P1|STARTED|Year 1||32
229854|NCT01147640|557969|P2|NOT COMPLETED|Overall Study||1
229855|NCT01147640|557970|P1|NOT COMPLETED|Overall Study||5
229856|NCT01147640|557969|P2|COMPLETED|Overall Study||38
229857|NCT01147640|557970|P1|COMPLETED|Overall Study||78
229858|NCT01147640|557969|P2|STARTED|Overall Study||39
229859|NCT01147640|557970|P1|STARTED|Overall Study||83
229860|NCT01147627|557981|P3|NOT COMPLETED|Overall Study||18
229861|NCT01147627|557982|P2|NOT COMPLETED|Overall Study||24
229862|NCT01147627|557983|P1|NOT COMPLETED|Overall Study||32
229863|NCT01147627|557981|P3|COMPLETED|Overall Study||118
229864|NCT01147627|557982|P2|COMPLETED|Overall Study||114
229865|NCT01147627|557983|P1|COMPLETED|Overall Study||110
229866|NCT01147627|557981|P3|STARTED|Overall Study||136
229867|NCT01147627|557982|P2|STARTED|Overall Study||138
229868|NCT01147627|557983|P1|STARTED|Overall Study||142
229869|NCT01147601|557993|P2|NOT COMPLETED|Overall Study||0
229870|NCT01147601|557994|P1|NOT COMPLETED|Overall Study||3
229871|NCT01147601|557993|P2|COMPLETED|Overall Study||1
229872|NCT01147601|557994|P1|COMPLETED|Overall Study||2
229873|NCT01147601|557993|P2|STARTED|Overall Study||1
229874|NCT01147601|557994|P1|STARTED|Overall Study||5
229875|NCT01147497|558002|P2|NOT COMPLETED|Overall Study||0
229876|NCT01147497|558003|P1|NOT COMPLETED|Overall Study||2
229877|NCT01147497|558002|P2|COMPLETED|Overall Study||36
229878|NCT01147497|558003|P1|COMPLETED|Overall Study||35
229879|NCT01147497|558002|P2|STARTED|Overall Study||36
229880|NCT01147497|558003|P1|STARTED|Overall Study||37
229881|NCT01147471|558023|P2|NOT COMPLETED|6 Month Follow Up||2
229882|NCT01147471|558024|P1|NOT COMPLETED|6 Month Follow Up||4
229883|NCT01147471|558023|P2|COMPLETED|6 Month Follow Up||4
229884|NCT01147471|558024|P1|COMPLETED|6 Month Follow Up||8
229885|NCT01147471|558023|P2|STARTED|6 Month Follow Up||6
229886|NCT01147471|558024|P1|STARTED|6 Month Follow Up||12
229887|NCT01147471|558023|P2|NOT COMPLETED|3 Month Follow Up||2
229888|NCT01147471|558024|P1|NOT COMPLETED|3 Month Follow Up||1
229889|NCT01147471|558023|P2|COMPLETED|3 Month Follow Up||6
229890|NCT01147471|558024|P1|COMPLETED|3 Month Follow Up||12
229891|NCT01147471|558023|P2|STARTED|3 Month Follow Up||8
229892|NCT01147471|558024|P1|STARTED|3 Month Follow Up||13
229893|NCT01147471|558023|P2|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||3
229894|NCT01147471|558024|P1|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||0
229895|NCT01147471|558023|P2|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||8
229896|NCT01147471|558024|P1|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||13
229897|NCT01147471|558023|P2|STARTED|Post-discharge Follow Up (Approx 2 Wks)||11
229898|NCT01147471|558024|P1|STARTED|Post-discharge Follow Up (Approx 2 Wks)||13
229899|NCT01147471|558023|P2|NOT COMPLETED|Through Initial Hospital Discharge||0
229900|NCT01147471|558024|P1|NOT COMPLETED|Through Initial Hospital Discharge||0
229901|NCT01147471|558023|P2|COMPLETED|Through Initial Hospital Discharge||11
229902|NCT01147471|558024|P1|COMPLETED|Through Initial Hospital Discharge||13
229903|NCT01147471|558023|P2|STARTED|Through Initial Hospital Discharge||11
229904|NCT01147471|558024|P1|STARTED|Through Initial Hospital Discharge||13
229905|NCT01147458|558038|P4|NOT COMPLETED|Second Intervention||4
229906|NCT01147458|558039|P3|NOT COMPLETED|Second Intervention||8
229907|NCT01147458|558040|P2|NOT COMPLETED|Second Intervention||7
229908|NCT01147458|558041|P1|NOT COMPLETED|Second Intervention||9
229909|NCT01147458|558038|P4|COMPLETED|Second Intervention||30
229910|NCT01147458|558039|P3|COMPLETED|Second Intervention||27
229911|NCT01147458|558040|P2|COMPLETED|Second Intervention||24
229912|NCT01147458|558041|P1|COMPLETED|Second Intervention||25
229913|NCT01147458|558038|P4|STARTED|Second Intervention||34
229914|NCT01147458|558039|P3|STARTED|Second Intervention||35
229915|NCT01147458|558040|P2|STARTED|Second Intervention||31
229916|NCT01147458|558041|P1|STARTED|Second Intervention||34
229917|NCT01147458|558038|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
229918|NCT01147458|558039|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
229919|NCT01147458|558040|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
229920|NCT01147458|558041|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
229921|NCT01147458|558038|P4|COMPLETED|Washout Period of 2 Weeks||34
229922|NCT01147458|558039|P3|COMPLETED|Washout Period of 2 Weeks||35
229923|NCT01147458|558040|P2|COMPLETED|Washout Period of 2 Weeks||31
229924|NCT01147458|558041|P1|COMPLETED|Washout Period of 2 Weeks||34
229925|NCT01147458|558038|P4|STARTED|Washout Period of 2 Weeks||34
229926|NCT01147458|558039|P3|STARTED|Washout Period of 2 Weeks||35
229927|NCT01147458|558040|P2|STARTED|Washout Period of 2 Weeks||31
229928|NCT01147458|558041|P1|STARTED|Washout Period of 2 Weeks||34
229929|NCT01147458|558038|P4|NOT COMPLETED|First Intervention||14
229930|NCT01147458|558039|P3|NOT COMPLETED|First Intervention||12
229931|NCT01147458|558040|P2|NOT COMPLETED|First Intervention||16
229932|NCT01147458|558041|P1|NOT COMPLETED|First Intervention||14
229933|NCT01147458|558038|P4|COMPLETED|First Intervention||34
229934|NCT01147458|558039|P3|COMPLETED|First Intervention||35
229935|NCT01147458|558040|P2|COMPLETED|First Intervention||31
229936|NCT01147458|558041|P1|COMPLETED|First Intervention||34
229937|NCT01147458|558038|P4|STARTED|First Intervention||48
229938|NCT01147458|558039|P3|STARTED|First Intervention||47
229939|NCT01147458|558040|P2|STARTED|First Intervention||47
229940|NCT01147458|558041|P1|STARTED|First Intervention||48
229941|NCT01147406|558095|P6|NOT COMPLETED|Overall Study||0
229942|NCT01147406|558096|P5|NOT COMPLETED|Overall Study||0
229943|NCT01147406|558097|P4|NOT COMPLETED|Overall Study||0
229944|NCT01147406|558098|P3|NOT COMPLETED|Overall Study||0
229945|NCT01147406|558099|P2|NOT COMPLETED|Overall Study||0
229946|NCT01147406|558100|P1|NOT COMPLETED|Overall Study||0
229947|NCT01147406|558095|P6|COMPLETED|Overall Study||10
229948|NCT01147406|558096|P5|COMPLETED|Overall Study||6
229949|NCT01147406|558097|P4|COMPLETED|Overall Study||6
229950|NCT01147406|558098|P3|COMPLETED|Overall Study||1
229951|NCT01147406|558099|P2|COMPLETED|Overall Study||12
229952|NCT01147406|558100|P1|COMPLETED|Overall Study||6
229953|NCT01147406|558095|P6|STARTED|Overall Study||10
229954|NCT01147406|558096|P5|STARTED|Overall Study||6
229955|NCT01147406|558097|P4|STARTED|Overall Study||6
229956|NCT01147406|558098|P3|STARTED|Overall Study||1
229957|NCT01147406|558099|P2|STARTED|Overall Study||12
229958|NCT01147406|558100|P1|STARTED|Overall Study||6
229959|NCT01147393|558120|P1|NOT COMPLETED|Dose Level -1||1
229960|NCT01147393|558120|P1|COMPLETED|Dose Level -1||0
229961|NCT01147393|558120|P1|STARTED|Dose Level -1||1
229962|NCT01147393|558120|P1|NOT COMPLETED|Dose Level 1||2
229963|NCT01147393|558120|P1|COMPLETED|Dose Level 1||1
229964|NCT01147393|558120|P1|STARTED|Dose Level 1||3
229965|NCT01147380|558130|P2|NOT COMPLETED|Overall Study||0
229966|NCT01147380|558131|P1|NOT COMPLETED|Overall Study||0
229967|NCT01147380|558130|P2|COMPLETED|Overall Study||12
229968|NCT01147380|558131|P1|COMPLETED|Overall Study||6
229969|NCT01147380|558130|P2|STARTED|Overall Study||12
229970|NCT01147380|558131|P1|STARTED|Overall Study||6
229971|NCT01147341|558141|P2|NOT COMPLETED|Open Label Period||0
229972|NCT01147341|558142|P1|NOT COMPLETED|Open Label Period||4
229973|NCT01147341|558141|P2|COMPLETED|Open Label Period||8
229974|NCT01147341|558142|P1|COMPLETED|Open Label Period||22
229975|NCT01147341|558141|P2|STARTED|Open Label Period||8
229976|NCT01147341|558142|P1|STARTED|Open Label Period||26
229977|NCT01147341|558141|P2|NOT COMPLETED|Double Blind Period||2
229978|NCT01147341|558142|P1|NOT COMPLETED|Double Blind Period||1
229979|NCT01147341|558141|P2|COMPLETED|Double Blind Period||8
229980|NCT01147341|558142|P1|COMPLETED|Double Blind Period||26
229981|NCT01147341|558141|P2|STARTED|Double Blind Period||10
229982|NCT01147341|558142|P1|STARTED|Double Blind Period||27
229983|NCT01147302|558172|P2|NOT COMPLETED|Overall Study||0
229984|NCT01147302|558173|P1|NOT COMPLETED|Overall Study||0
229985|NCT01147302|558172|P2|COMPLETED|Overall Study||9
229986|NCT01147302|558173|P1|COMPLETED|Overall Study||9
229987|NCT01147302|558172|P2|STARTED|Overall Study||9
229988|NCT01147302|558173|P1|STARTED|Overall Study||9
229989|NCT01147250|558205|P2|NOT COMPLETED|Overall Study||105
229990|NCT01147250|558206|P1|NOT COMPLETED|Overall Study||110
229991|NCT01147250|558205|P2|COMPLETED|Overall Study||2929
229992|NCT01147250|558206|P1|COMPLETED|Overall Study||2924
229993|NCT01147250|558205|P2|Treated|Overall Study||3031
229994|NCT01147250|558206|P1|Treated|Overall Study||3032
229995|NCT01147250|558205|P2|STARTED|Overall Study||3034
229996|NCT01147250|558206|P1|STARTED|Overall Study||3034
229997|NCT01147172|558218|P1|NOT COMPLETED|Overall Study||4
229998|NCT01147172|558218|P1|COMPLETED|Overall Study||96
229999|NCT01147172|558218|P1|STARTED|Overall Study||100
230000|NCT01147068|558236|P7|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
230001|NCT01147068|558237|P6|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
230002|NCT01147068|558238|P5|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
230003|NCT01147068|558239|P4|NOT COMPLETED|Subjects That Completed Safety Follow-up||2
230004|NCT01147068|558240|P3|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
230005|NCT01147068|558241|P2|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
230006|NCT01147068|558242|P1|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
230007|NCT01147068|558236|P7|COMPLETED|Subjects That Completed Safety Follow-up||54
230008|NCT01147068|558237|P6|COMPLETED|Subjects That Completed Safety Follow-up||52
230009|NCT01147068|558238|P5|COMPLETED|Subjects That Completed Safety Follow-up||56
230010|NCT01147068|558239|P4|COMPLETED|Subjects That Completed Safety Follow-up||54
230011|NCT01147068|558240|P3|COMPLETED|Subjects That Completed Safety Follow-up||55
230012|NCT01147068|558241|P2|COMPLETED|Subjects That Completed Safety Follow-up||56
230013|NCT01147068|558242|P1|COMPLETED|Subjects That Completed Safety Follow-up||59
230014|NCT01147068|558236|P7|STARTED|Subjects That Completed Safety Follow-up||55
230015|NCT01147068|558237|P6|STARTED|Subjects That Completed Safety Follow-up|One subject was lost to follow up and one subject did not complete the study.|53
230016|NCT01147068|558238|P5|STARTED|Subjects That Completed Safety Follow-up|Data for one subject is unknown.|56
230017|NCT01147068|558239|P4|STARTED|Subjects That Completed Safety Follow-up||56
230018|NCT01147068|558240|P3|STARTED|Subjects That Completed Safety Follow-up|Data on three subjects is unknown.|55
230019|NCT01147068|558241|P2|STARTED|Subjects That Completed Safety Follow-up|One subject was ineligible, one subject did not complete the study, and the other data is unknown.|57
230020|NCT01147068|558242|P1|STARTED|Subjects That Completed Safety Follow-up|Participants were eligible for follow-up regardless of number of doses received.|60
230021|NCT01147068|558236|P7|NOT COMPLETED|Subjects That Received 2nd Dose||0
230022|NCT01147068|558237|P6|NOT COMPLETED|Subjects That Received 2nd Dose||2
230023|NCT01147068|558238|P5|NOT COMPLETED|Subjects That Received 2nd Dose||1
230024|NCT01147068|558239|P4|NOT COMPLETED|Subjects That Received 2nd Dose||0
230025|NCT01147068|558240|P3|NOT COMPLETED|Subjects That Received 2nd Dose||3
230026|NCT01147068|558241|P2|NOT COMPLETED|Subjects That Received 2nd Dose||5
230027|NCT01147068|558242|P1|NOT COMPLETED|Subjects That Received 2nd Dose||1
230028|NCT01147068|558236|P7|COMPLETED|Subjects That Received 2nd Dose||55
230029|NCT01147068|558237|P6|COMPLETED|Subjects That Received 2nd Dose||51
230030|NCT01147068|558238|P5|COMPLETED|Subjects That Received 2nd Dose||55
230031|NCT01147068|558239|P4|COMPLETED|Subjects That Received 2nd Dose||56
230032|NCT01147068|558240|P3|COMPLETED|Subjects That Received 2nd Dose||52
230033|NCT01147068|558241|P2|COMPLETED|Subjects That Received 2nd Dose||52
230034|NCT01147068|558242|P1|COMPLETED|Subjects That Received 2nd Dose||59
230035|NCT01147068|558236|P7|STARTED|Subjects That Received 2nd Dose||55
230036|NCT01147068|558237|P6|STARTED|Subjects That Received 2nd Dose||53
230037|NCT01147068|558238|P5|STARTED|Subjects That Received 2nd Dose||56
230038|NCT01147068|558239|P4|STARTED|Subjects That Received 2nd Dose||56
230039|NCT01147068|558240|P3|STARTED|Subjects That Received 2nd Dose||55
230040|NCT01147068|558241|P2|STARTED|Subjects That Received 2nd Dose||57
230041|NCT01147068|558242|P1|STARTED|Subjects That Received 2nd Dose||60
230042|NCT01147068|558236|P7|NOT COMPLETED|Subjects That Received 1st Dose||0
230043|NCT01147068|558237|P6|NOT COMPLETED|Subjects That Received 1st Dose||0
230044|NCT01147068|558238|P5|NOT COMPLETED|Subjects That Received 1st Dose||0
230045|NCT01147068|558239|P4|NOT COMPLETED|Subjects That Received 1st Dose||0
230046|NCT01147068|558240|P3|NOT COMPLETED|Subjects That Received 1st Dose||0
230047|NCT01147068|558241|P2|NOT COMPLETED|Subjects That Received 1st Dose||0
230048|NCT01147068|558242|P1|NOT COMPLETED|Subjects That Received 1st Dose||0
230049|NCT01147068|558236|P7|COMPLETED|Subjects That Received 1st Dose||55
230050|NCT01147068|558237|P6|COMPLETED|Subjects That Received 1st Dose||53
230051|NCT01147068|558238|P5|COMPLETED|Subjects That Received 1st Dose||56
230052|NCT01147068|558239|P4|COMPLETED|Subjects That Received 1st Dose||56
230053|NCT01147068|558240|P3|COMPLETED|Subjects That Received 1st Dose||55
230054|NCT01147068|558241|P2|COMPLETED|Subjects That Received 1st Dose||57
230055|NCT01147068|558242|P1|COMPLETED|Subjects That Received 1st Dose||60
230056|NCT01147068|558236|P7|STARTED|Subjects That Received 1st Dose||55
230057|NCT01147068|558237|P6|STARTED|Subjects That Received 1st Dose||53
230058|NCT01147068|558238|P5|STARTED|Subjects That Received 1st Dose||56
230059|NCT01147068|558239|P4|STARTED|Subjects That Received 1st Dose||56
230060|NCT01147068|558240|P3|STARTED|Subjects That Received 1st Dose||55
230061|NCT01147068|558241|P2|STARTED|Subjects That Received 1st Dose||57
230062|NCT01147068|558242|P1|STARTED|Subjects That Received 1st Dose||60
230063|NCT01147055|558272|P2|NOT COMPLETED|Second Intervention Period||0
230064|NCT01147055|558273|P1|NOT COMPLETED|Second Intervention Period||0
230065|NCT01147055|558272|P2|COMPLETED|Second Intervention Period||14
230066|NCT01147055|558273|P1|COMPLETED|Second Intervention Period||0
230067|NCT01147055|558272|P2|STARTED|Second Intervention Period||14
230068|NCT01147055|558273|P1|STARTED|Second Intervention Period||0
230069|NCT01147055|558272|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
230070|NCT01147055|558273|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
230071|NCT01147055|558272|P2|COMPLETED|Washout Period (at Least 14 Days)||0
230072|NCT01147055|558273|P1|COMPLETED|Washout Period (at Least 14 Days)||14
230073|NCT01147055|558272|P2|STARTED|Washout Period (at Least 14 Days)||0
230074|NCT01147055|558273|P1|STARTED|Washout Period (at Least 14 Days)||14
230075|NCT01147055|558272|P2|NOT COMPLETED|First Intervention Period||0
230076|NCT01147055|558273|P1|NOT COMPLETED|First Intervention Period||1
230077|NCT01147055|558272|P2|COMPLETED|First Intervention Period||0
230078|NCT01147055|558273|P1|COMPLETED|First Intervention Period||14
230079|NCT01147055|558272|P2|STARTED|First Intervention Period||0
230080|NCT01147055|558273|P1|STARTED|First Intervention Period||15
230081|NCT01147042|558307|P2|NOT COMPLETED|Overall Study||0
230082|NCT01147042|558308|P1|NOT COMPLETED|Overall Study||0
230083|NCT01147042|558307|P2|COMPLETED|Overall Study||0
230084|NCT01147042|558308|P1|COMPLETED|Overall Study||2
230085|NCT01147042|558307|P2|STARTED|Overall Study||0
230086|NCT01147042|558308|P1|STARTED|Overall Study||2
230087|NCT01146951|558315|P2|NOT COMPLETED|Overall Study||1
230088|NCT01146951|558316|P1|NOT COMPLETED|Overall Study||4
230089|NCT01146951|558315|P2|COMPLETED|Overall Study||29
230090|NCT01146951|558316|P1|COMPLETED|Overall Study||25
230091|NCT01146951|558315|P2|STARTED|Overall Study||30
230092|NCT01146951|558316|P1|STARTED|Overall Study||29
230093|NCT01146912|558337|P8|NOT COMPLETED|Overall Study||0
230094|NCT01146912|558338|P7|NOT COMPLETED|Overall Study||56
230095|NCT01146912|558339|P6|NOT COMPLETED|Overall Study||61
230096|NCT01146912|558340|P5|NOT COMPLETED|Overall Study||41
230097|NCT01146912|558341|P4|NOT COMPLETED|Overall Study||17
230098|NCT01146912|558342|P3|NOT COMPLETED|Overall Study||17
230099|NCT01146912|558343|P2|NOT COMPLETED|Overall Study||822
230100|NCT01146912|558344|P1|NOT COMPLETED|Overall Study||817
230101|NCT01146912|558337|P8|COMPLETED|Overall Study|Parents are considered subjects but outcomes are on child level|14675
230102|NCT01146912|558338|P7|COMPLETED|Overall Study||1764
230103|NCT01146912|558339|P6|COMPLETED|Overall Study||1760
230104|NCT01146912|558340|P5|COMPLETED|Overall Study||1780
230105|NCT01146912|558341|P4|COMPLETED|Overall Study||577
230106|NCT01146912|558342|P3|COMPLETED|Overall Study||576
230107|NCT01146912|558343|P2|COMPLETED|Overall Study||3784
230108|NCT01146912|558344|P1|COMPLETED|Overall Study||3790
230109|NCT01146912|558337|P8|STARTED|Overall Study||14675
230110|NCT01146912|558338|P7|STARTED|Overall Study||1820
230111|NCT01146912|558339|P6|STARTED|Overall Study||1821
230112|NCT01146912|558340|P5|STARTED|Overall Study||1821
230113|NCT01146912|558341|P4|STARTED|Overall Study||594
230114|NCT01146912|558342|P3|STARTED|Overall Study||593
230115|NCT01146912|558343|P2|STARTED|Overall Study||4606
230116|NCT01146912|558344|P1|STARTED|Overall Study||4607
230117|NCT01146873|558366|P2|NOT COMPLETED|Overall Study||6
230118|NCT01146873|558367|P1|NOT COMPLETED|Overall Study||0
230119|NCT01146873|558366|P2|COMPLETED|Overall Study||144
230120|NCT01146873|558367|P1|COMPLETED|Overall Study||148
230121|NCT01146873|558366|P2|STARTED|Overall Study||150
230122|NCT01146873|558367|P1|STARTED|Overall Study||148
230123|NCT01146860|558383|P2|NOT COMPLETED|Overall Study||1
230124|NCT01146860|558384|P1|NOT COMPLETED|Overall Study||0
230125|NCT01146860|558383|P2|COMPLETED|Overall Study||191
230126|NCT01146860|558384|P1|COMPLETED|Overall Study||194
230127|NCT01146860|558383|P2|STARTED|Overall Study||192
230128|NCT01146860|558384|P1|STARTED|Overall Study||194
230129|NCT01146808|558398|P1|NOT COMPLETED|Overall Study||0
230130|NCT01146808|558398|P1|COMPLETED|Overall Study||16
230131|NCT01146808|558398|P1|STARTED|Overall Study||16
230132|NCT01146782|558404|P1|NOT COMPLETED|Primary Endpoint Cohort||6
230133|NCT01146782|558404|P1|COMPLETED|Primary Endpoint Cohort|57 Subjects in the Primary Endpoint Cohort completed the 28 day study|57
230134|NCT01146782|558404|P1|STARTED|Primary Endpoint Cohort|63 Subjects in the Primary Endpoint Cohort|63
230135|NCT01146782|558404|P1|NOT COMPLETED|Safety Cohort||83
230136|NCT01146782|558404|P1|COMPLETED|Safety Cohort||63
230137|NCT01146782|558404|P1|STARTED|Safety Cohort||146
230138|NCT01146782|558404|P1|NOT COMPLETED|Screening Cohort||221
230139|NCT01146782|558404|P1|COMPLETED|Screening Cohort||146
230140|NCT01146782|558404|P1|STARTED|Screening Cohort||367
230141|NCT01146665|558413|P2|NOT COMPLETED|Overall Study||16
230142|NCT01146665|558414|P1|NOT COMPLETED|Overall Study||10
230143|NCT01146665|558413|P2|COMPLETED|Overall Study||10
230144|NCT01146665|558414|P1|COMPLETED|Overall Study||8
230145|NCT01146665|558413|P2|3-month Post-ED Discharge (Follow-up)|Overall Study||10
230146|NCT01146665|558414|P1|3-month Post-ED Discharge (Follow-up)|Overall Study||8
230147|NCT01146665|558413|P2|1-month Post-ED Discharge (Follow-up)|Overall Study||12
230148|NCT01146665|558414|P1|1-month Post-ED Discharge (Follow-up)|Overall Study||9
230149|NCT01146665|558413|P2|STARTED|Overall Study||26
230150|NCT01146665|558414|P1|STARTED|Overall Study||18
230151|NCT01146613|558446|P2|NOT COMPLETED|Overall Study||12
230152|NCT01146613|558447|P1|NOT COMPLETED|Overall Study||7
230153|NCT01146613|558446|P2|COMPLETED|Overall Study||89
230154|NCT01146613|558447|P1|COMPLETED|Overall Study||92
230155|NCT01146613|558446|P2|STARTED|Overall Study||101
230156|NCT01146613|558447|P1|STARTED|Overall Study||99
230157|NCT01146600|558455|P2|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
230158|NCT01146600|558456|P1|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
230159|NCT01146600|558455|P2|COMPLETED|Period 2 (Weeks 4 & 5)||10
230160|NCT01146600|558456|P1|COMPLETED|Period 2 (Weeks 4 & 5)||10
230161|NCT01146600|558455|P2|STARTED|Period 2 (Weeks 4 & 5)||10
230162|NCT01146600|558456|P1|STARTED|Period 2 (Weeks 4 & 5)||10
230163|NCT01146600|558455|P2|NOT COMPLETED|Washout (Week 3)||0
230164|NCT01146600|558456|P1|NOT COMPLETED|Washout (Week 3)||0
230165|NCT01146600|558455|P2|COMPLETED|Washout (Week 3)||10
230166|NCT01146600|558456|P1|COMPLETED|Washout (Week 3)||10
230167|NCT01146600|558455|P2|STARTED|Washout (Week 3)||10
230168|NCT01146600|558456|P1|STARTED|Washout (Week 3)||10
230169|NCT01146600|558455|P2|NOT COMPLETED|Period 1 (Weeks 1 & 2)||0
230170|NCT01146600|558456|P1|NOT COMPLETED|Period 1 (Weeks 1 & 2)||3
230171|NCT01146600|558455|P2|COMPLETED|Period 1 (Weeks 1 & 2)||10
230172|NCT01146600|558456|P1|COMPLETED|Period 1 (Weeks 1 & 2)||10
230173|NCT01146600|558455|P2|STARTED|Period 1 (Weeks 1 & 2)||10
230174|NCT01146600|558456|P1|STARTED|Period 1 (Weeks 1 & 2)||13
230175|NCT01146496|558483|P2|NOT COMPLETED|Overall Study||0
230176|NCT01146496|558484|P1|NOT COMPLETED|Overall Study||0
230177|NCT01146496|558483|P2|COMPLETED|Overall Study||109693
230178|NCT01146496|558484|P1|COMPLETED|Overall Study||114168
230179|NCT01146496|558483|P2|STARTED|Overall Study||109693
230180|NCT01146496|558484|P1|STARTED|Overall Study||114168
230181|NCT01146457|558505|P5|NOT COMPLETED|Overall Study||0
230182|NCT01146457|558506|P4|NOT COMPLETED|Overall Study||0
230183|NCT01146457|558507|P3|NOT COMPLETED|Overall Study||1
230184|NCT01146457|558508|P2|NOT COMPLETED|Overall Study||0
230185|NCT01146457|558509|P1|NOT COMPLETED|Overall Study||0
230186|NCT01146457|558505|P5|COMPLETED|Overall Study||13
230187|NCT01146457|558506|P4|COMPLETED|Overall Study||13
230188|NCT01146457|558507|P3|COMPLETED|Overall Study||20
230189|NCT01146457|558508|P2|COMPLETED|Overall Study||17
230190|NCT01146457|558509|P1|COMPLETED|Overall Study||19
230191|NCT01146457|558505|P5|STARTED|Overall Study||13
230192|NCT01146457|558506|P4|STARTED|Overall Study||13
230193|NCT01146457|558507|P3|STARTED|Overall Study||21
230194|NCT01146457|558508|P2|STARTED|Overall Study||17
230195|NCT01146457|558509|P1|STARTED|Overall Study||19
230196|NCT01146418|558523|P4|NOT COMPLETED|Live-Born Infant Follow Up||5
230197|NCT01146418|558524|P3|NOT COMPLETED|Live-Born Infant Follow Up||6
230198|NCT01146418|558525|P2|NOT COMPLETED|Live-Born Infant Follow Up||0
230199|NCT01146418|558526|P1|NOT COMPLETED|Live-Born Infant Follow Up||0
230200|NCT01146418|558523|P4|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|51
230201|NCT01146418|558524|P3|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|55
230202|NCT01146418|558525|P2|COMPLETED|Live-Born Infant Follow Up||0
230203|NCT01146418|558526|P1|COMPLETED|Live-Born Infant Follow Up||0
230204|NCT01146418|558523|P4|STARTED|Live-Born Infant Follow Up||56
230205|NCT01146418|558524|P3|STARTED|Live-Born Infant Follow Up||61
230206|NCT01146418|558525|P2|STARTED|Live-Born Infant Follow Up||0
230207|NCT01146418|558526|P1|STARTED|Live-Born Infant Follow Up||0
230208|NCT01146418|558523|P4|NOT COMPLETED|Women/Expectant Mother Follow Up||0
230209|NCT01146418|558524|P3|NOT COMPLETED|Women/Expectant Mother Follow Up||0
230210|NCT01146418|558525|P2|NOT COMPLETED|Women/Expectant Mother Follow Up||40
230211|NCT01146418|558526|P1|NOT COMPLETED|Women/Expectant Mother Follow Up||44
230212|NCT01146418|558523|P4|COMPLETED|Women/Expectant Mother Follow Up||0
230213|NCT01146418|558524|P3|COMPLETED|Women/Expectant Mother Follow Up||0
230214|NCT01146418|558525|P2|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|110
230215|NCT01146418|558526|P1|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|113
230216|NCT01146418|558523|P4|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
230217|NCT01146418|558524|P3|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
230218|NCT01146418|558525|P2|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|50
230219|NCT01146418|558526|P1|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|52
230220|NCT01146418|558523|P4|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
230221|NCT01146418|558524|P3|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
230222|NCT01146418|558525|P2|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||147
230223|NCT01146418|558526|P1|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||151
230224|NCT01146418|558523|P4|STARTED|Women/Expectant Mother Follow Up||0
230225|NCT01146418|558524|P3|STARTED|Women/Expectant Mother Follow Up||0
230226|NCT01146418|558525|P2|STARTED|Women/Expectant Mother Follow Up|Participants from base study P06029 with at least one embryo thawed for use in FTET cycle.|150
230227|NCT01146418|558526|P1|STARTED|Women/Expectant Mother Follow Up|Participants from Base Study P06029 with at least one embryo thawed for use in FTET cycle.|157
230228|NCT01146418|558523|P4|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
230229|NCT01146418|558524|P3|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
230230|NCT01146418|558525|P2|NOT COMPLETED|Base Study P06029 (NCT01144416)||49
230231|NCT01146418|558526|P1|NOT COMPLETED|Base Study P06029 (NCT01144416)||62
230232|NCT01146418|558523|P4|COMPLETED|Base Study P06029 (NCT01144416)||0
230233|NCT01146418|558524|P3|COMPLETED|Base Study P06029 (NCT01144416)||0
230234|NCT01146418|558525|P2|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|647
230235|NCT01146418|558526|P1|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|632
230236|NCT01146418|558523|P4|STARTED|Base Study P06029 (NCT01144416)||0
230237|NCT01146418|558524|P3|STARTED|Base Study P06029 (NCT01144416)||0
230238|NCT01146418|558525|P2|STARTED|Base Study P06029 (NCT01144416)||696
230239|NCT01146418|558526|P1|STARTED|Base Study P06029 (NCT01144416)||694
230240|NCT01146379|558542|P4|NOT COMPLETED|Overall Study||1
230241|NCT01146379|558543|P3|NOT COMPLETED|Overall Study||0
230242|NCT01146379|558544|P2|NOT COMPLETED|Overall Study||1
230243|NCT01146379|558545|P1|NOT COMPLETED|Overall Study||1
230244|NCT01146379|558542|P4|COMPLETED|Overall Study||20
230245|NCT01146379|558543|P3|COMPLETED|Overall Study||21
230246|NCT01146379|558544|P2|COMPLETED|Overall Study||21
230247|NCT01146379|558545|P1|COMPLETED|Overall Study||20
230248|NCT01146379|558542|P4|STARTED|Overall Study||21
230249|NCT01146379|558543|P3|STARTED|Overall Study||21
230250|NCT01146379|558544|P2|STARTED|Overall Study||22
230251|NCT01146379|558545|P1|STARTED|Overall Study||21
230252|NCT01146288|558557|P2|NOT COMPLETED|Second Intervention (1 Day)||0
230253|NCT01146288|558558|P1|NOT COMPLETED|Second Intervention (1 Day)||0
230254|NCT01146288|558557|P2|COMPLETED|Second Intervention (1 Day)||5
230255|NCT01146288|558558|P1|COMPLETED|Second Intervention (1 Day)||7
230256|NCT01146288|558557|P2|STARTED|Second Intervention (1 Day)||5
230257|NCT01146288|558558|P1|STARTED|Second Intervention (1 Day)||7
230258|NCT01146288|558557|P2|NOT COMPLETED|First Intervention(1 Day)||1
230259|NCT01146288|558558|P1|NOT COMPLETED|First Intervention(1 Day)||0
230260|NCT01146288|558557|P2|COMPLETED|First Intervention(1 Day)||5
230261|NCT01146288|558558|P1|COMPLETED|First Intervention(1 Day)||7
230262|NCT01146288|558557|P2|STARTED|First Intervention(1 Day)||6
230263|NCT01146288|558558|P1|STARTED|First Intervention(1 Day)||7
230264|NCT01146275|558567|P1|NOT COMPLETED|Overall Study||0
230265|NCT01146275|558567|P1|COMPLETED|Overall Study||6
230266|NCT01146275|558567|P1|STARTED|Overall Study||6
230267|NCT01146054|558572|P1|NOT COMPLETED|Overall Study||10
230268|NCT01146054|558572|P1|COMPLETED|Overall Study||49
230269|NCT01146054|558572|P1|STARTED|Overall Study||59
230270|NCT01145898|558582|P2|NOT COMPLETED|3-year Treatment||16
230271|NCT01145898|558583|P1|NOT COMPLETED|3-year Treatment||3
230272|NCT01145898|558582|P2|COMPLETED|3-year Treatment||28
230273|NCT01145898|558583|P1|COMPLETED|3-year Treatment||9
230274|NCT01145898|558582|P2|STARTED|3-year Treatment||44
230275|NCT01145898|558583|P1|STARTED|3-year Treatment||12
230276|NCT01145898|558582|P2|NOT COMPLETED|6-month Treatment||0
230277|NCT01145898|558583|P1|NOT COMPLETED|6-month Treatment||0
230278|NCT01145898|558582|P2|COMPLETED|6-month Treatment||44
230279|NCT01145898|558583|P1|COMPLETED|6-month Treatment||12
230280|NCT01145898|558582|P2|STARTED|6-month Treatment||44
230281|NCT01145898|558583|P1|STARTED|6-month Treatment||12
230282|NCT01145885|558614|P1|NOT COMPLETED|Overall Study||7
230283|NCT01145885|558614|P1|COMPLETED|Overall Study||0
230284|NCT01145885|558614|P1|STARTED|Overall Study||7
230285|NCT01145755|558649|P3|NOT COMPLETED|Overall Study||25
230286|NCT01145755|558650|P2|NOT COMPLETED|Overall Study||28
230287|NCT01145755|558651|P1|NOT COMPLETED|Overall Study||20
230288|NCT01145755|558649|P3|COMPLETED|Overall Study||19
230289|NCT01145755|558650|P2|COMPLETED|Overall Study||19
230290|NCT01145755|558651|P1|COMPLETED|Overall Study||20
230291|NCT01145755|558649|P3|STARTED|Overall Study||44
230292|NCT01145755|558650|P2|STARTED|Overall Study||47
230293|NCT01145755|558651|P1|STARTED|Overall Study||40
230294|NCT01145638|558667|P2|NOT COMPLETED|Overall Study||57
230295|NCT01145638|558668|P1|NOT COMPLETED|Overall Study||90
230296|NCT01145638|558667|P2|COMPLETED|Overall Study||62
230297|NCT01145638|558668|P1|COMPLETED|Overall Study||141
230298|NCT01145638|558667|P2|STARTED|Overall Study||119
230299|NCT01145638|558668|P1|STARTED|Overall Study||231
230300|NCT01145625|558678|P2|NOT COMPLETED|Overall Study||31
230301|NCT01145625|558679|P1|NOT COMPLETED|Overall Study||24
230302|NCT01145625|558678|P2|COMPLETED|Overall Study||130
230303|NCT01145625|558679|P1|COMPLETED|Overall Study||137
230304|NCT01145625|558678|P2|STARTED|Overall Study||161
230305|NCT01145625|558679|P1|STARTED|Overall Study||161
230306|NCT01145560|558692|P3|NOT COMPLETED|Overall Study||2
230307|NCT01145560|558693|P2|NOT COMPLETED|Overall Study||4
230308|NCT01145560|558694|P1|NOT COMPLETED|Overall Study||4
230309|NCT01145560|558692|P3|COMPLETED|Overall Study|27 patients died during the study. Death was not a reason for treatment or study discontinuation.|98
230310|NCT01145560|558693|P2|COMPLETED|Overall Study|33 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
230311|NCT01145560|558694|P1|COMPLETED|Overall Study|20 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
230312|NCT01145560|558692|P3|Completed Treatment|Overall Study|7 patients died during the treatment period without completing the full course of treatment.|78
230403|NCT01145183|558826|P2|STARTED|Overall Study||26
230313|NCT01145560|558693|P2|Completed Treatment|Overall Study|8 patients died during the treatment period without completing the full course of treatment.|85
230314|NCT01145560|558694|P1|Completed Treatment|Overall Study|9 patients died during the treatment period without completing the full course of treatment.|69
230315|NCT01145560|558692|P3|Received Treatment|Overall Study||99
230316|NCT01145560|558693|P2|Received Treatment|Overall Study||98
230317|NCT01145560|558694|P1|Received Treatment|Overall Study||99
230318|NCT01145560|558692|P3|STARTED|Overall Study||100
230319|NCT01145560|558693|P2|STARTED|Overall Study||100
230320|NCT01145560|558694|P1|STARTED|Overall Study||100
230321|NCT01145547|558711|P2|NOT COMPLETED|Overall Study||0
230322|NCT01145547|558712|P1|NOT COMPLETED|Overall Study||0
230323|NCT01145547|558711|P2|COMPLETED|Overall Study||3
230324|NCT01145547|558712|P1|COMPLETED|Overall Study||4
230325|NCT01145547|558711|P2|STARTED|Overall Study||3
230326|NCT01145547|558712|P1|STARTED|Overall Study||4
230327|NCT01145508|558720|P2|NOT COMPLETED|Overall Study||2
230328|NCT01145508|558721|P1|NOT COMPLETED|Overall Study||5
230329|NCT01145508|558720|P2|COMPLETED|Overall Study||1
230330|NCT01145508|558721|P1|COMPLETED|Overall Study||2
230331|NCT01145508|558720|P2|Treated|Overall Study||2
230332|NCT01145508|558721|P1|Treated|Overall Study||6
230333|NCT01145508|558720|P2|STARTED|Overall Study||3
230334|NCT01145508|558721|P1|STARTED|Overall Study||7
230335|NCT01145495|558727|P1|NOT COMPLETED|Overall Study||12
230336|NCT01145495|558727|P1|COMPLETED|Overall Study||51
230337|NCT01145495|558727|P1|STARTED|Overall Study||63
230338|NCT01145482|558733|P2|NOT COMPLETED|Second Intervention (1 Day)||0
230339|NCT01145482|558734|P1|NOT COMPLETED|Second Intervention (1 Day)||0
230340|NCT01145482|558733|P2|COMPLETED|Second Intervention (1 Day)||6
230341|NCT01145482|558734|P1|COMPLETED|Second Intervention (1 Day)||5
230342|NCT01145482|558733|P2|STARTED|Second Intervention (1 Day)||6
230343|NCT01145482|558734|P1|STARTED|Second Intervention (1 Day)||5
230344|NCT01145482|558733|P2|NOT COMPLETED|First Intervention (1 Day)||1
230345|NCT01145482|558734|P1|NOT COMPLETED|First Intervention (1 Day)||0
230346|NCT01145482|558733|P2|COMPLETED|First Intervention (1 Day)||5
230347|NCT01145482|558734|P1|COMPLETED|First Intervention (1 Day)||6
230348|NCT01145482|558733|P2|STARTED|First Intervention (1 Day)||6
230349|NCT01145482|558734|P1|STARTED|First Intervention (1 Day)||6
230350|NCT01145417|558744|P2|NOT COMPLETED|Overall Study||47
230351|NCT01145417|558745|P1|NOT COMPLETED|Overall Study||41
230352|NCT01145417|558744|P2|COMPLETED|Overall Study||62
230353|NCT01145417|558745|P1|COMPLETED|Overall Study||67
230354|NCT01145417|558744|P2|STARTED|Overall Study||109
230355|NCT01145417|558745|P1|STARTED|Overall Study||108
230356|NCT01145391|558769|P2|NOT COMPLETED|Overall Study||0
230357|NCT01145391|558770|P1|NOT COMPLETED|Overall Study||0
230358|NCT01145391|558769|P2|COMPLETED|Overall Study||298
230359|NCT01145391|558770|P1|COMPLETED|Overall Study||293
230360|NCT01145391|558769|P2|9 Months Post-randomization|Overall Study||298
230361|NCT01145391|558770|P1|9 Months Post-randomization|Overall Study||293
230362|NCT01145391|558769|P2|STARTED|Overall Study||298
230363|NCT01145391|558770|P1|STARTED|Overall Study||293
230364|NCT01145352|558778|P1|NOT COMPLETED|Overall Study||11
230365|NCT01145352|558778|P1|COMPLETED|Overall Study||102
230366|NCT01145352|558778|P1|STARTED|Overall Study||113
230367|NCT01145222|558790|P4|NOT COMPLETED|Overall Study||1
230368|NCT01145222|558791|P3|NOT COMPLETED|Overall Study||1
230369|NCT01145222|558792|P2|NOT COMPLETED|Overall Study||0
230370|NCT01145222|558793|P1|NOT COMPLETED|Overall Study||0
230371|NCT01145222|558790|P4|COMPLETED|Overall Study||40
230372|NCT01145222|558791|P3|COMPLETED|Overall Study||40
230373|NCT01145222|558792|P2|COMPLETED|Overall Study||40
230374|NCT01145222|558793|P1|COMPLETED|Overall Study||40
230375|NCT01145222|558790|P4|Intention to Treat (ITT) Population|Overall Study||40
230376|NCT01145222|558791|P3|Intention to Treat (ITT) Population|Overall Study||40
230377|NCT01145222|558792|P2|Intention to Treat (ITT) Population|Overall Study||40
230378|NCT01145222|558793|P1|Intention to Treat (ITT) Population|Overall Study||40
230379|NCT01145222|558790|P4|Safety Population|Overall Study||41
230380|NCT01145222|558791|P3|Safety Population|Overall Study||40
230381|NCT01145222|558792|P2|Safety Population|Overall Study||40
230382|NCT01145222|558793|P1|Safety Population|Overall Study||40
230383|NCT01145222|558790|P4|STARTED|Overall Study||41
230384|NCT01145222|558791|P3|STARTED|Overall Study||41
230385|NCT01145222|558792|P2|STARTED|Overall Study||40
230386|NCT01145222|558793|P1|STARTED|Overall Study||40
230387|NCT01145209|558813|P2|NOT COMPLETED|Overall Study||1
230388|NCT01145209|558814|P1|NOT COMPLETED|Overall Study||3
230389|NCT01145209|558813|P2|COMPLETED|Overall Study||18
230390|NCT01145209|558814|P1|COMPLETED|Overall Study||10
230391|NCT01145209|558813|P2|STARTED|Overall Study||19
230392|NCT01145209|558814|P1|STARTED|Overall Study||13
230393|NCT01145183|558824|P4|NOT COMPLETED|Overall Study||0
230394|NCT01145183|558825|P3|NOT COMPLETED|Overall Study||0
230395|NCT01145183|558826|P2|NOT COMPLETED|Overall Study||0
230396|NCT01145183|558827|P1|NOT COMPLETED|Overall Study||0
230397|NCT01145183|558824|P4|COMPLETED|Overall Study||10
230398|NCT01145183|558825|P3|COMPLETED|Overall Study||19
230399|NCT01145183|558826|P2|COMPLETED|Overall Study||26
230400|NCT01145183|558827|P1|COMPLETED|Overall Study||21
230401|NCT01145183|558824|P4|STARTED|Overall Study||10
230402|NCT01145183|558825|P3|STARTED|Overall Study||19
230404|NCT01145183|558827|P1|STARTED|Overall Study||21
230405|NCT01145066|558840|P3|NOT COMPLETED|Overall Study||4
230406|NCT01145066|558841|P2|NOT COMPLETED|Overall Study||4
230407|NCT01145066|558842|P1|NOT COMPLETED|Overall Study||4
230408|NCT01145066|558840|P3|COMPLETED|Overall Study||21
230409|NCT01145066|558841|P2|COMPLETED|Overall Study||16
230410|NCT01145066|558842|P1|COMPLETED|Overall Study||22
230411|NCT01145066|558840|P3|STARTED|Overall Study||25
230412|NCT01145066|558841|P2|STARTED|Overall Study||20
230413|NCT01145066|558842|P1|STARTED|Overall Study||26
230414|NCT01145053|558910|P1|NOT COMPLETED|Overall Study||93
230415|NCT01145053|558910|P1|COMPLETED|Overall Study||248
230416|NCT01145053|558910|P1|STARTED|Overall Study||341
230417|NCT01145001|558924|P4|NOT COMPLETED|Overall Study||6
230418|NCT01145001|558925|P3|NOT COMPLETED|Overall Study||5
230419|NCT01145001|558926|P2|NOT COMPLETED|Overall Study||6
230420|NCT01145001|558927|P1|NOT COMPLETED|Overall Study||8
230421|NCT01145001|558924|P4|COMPLETED|Overall Study||31
230422|NCT01145001|558925|P3|COMPLETED|Overall Study||39
230423|NCT01145001|558926|P2|COMPLETED|Overall Study||31
230424|NCT01145001|558927|P1|COMPLETED|Overall Study||28
230425|NCT01145001|558924|P4|STARTED|Overall Study||37
230426|NCT01145001|558925|P3|STARTED|Overall Study||44
230427|NCT01145001|558926|P2|STARTED|Overall Study||37
230428|NCT01145001|558927|P1|STARTED|Overall Study||36
230429|NCT01144949|558943|P2|NOT COMPLETED|Overall Study||14
230430|NCT01144949|558944|P1|NOT COMPLETED|Overall Study||11
230431|NCT01144949|558943|P2|COMPLETED|Overall Study||106
230432|NCT01144949|558944|P1|COMPLETED|Overall Study||108
230433|NCT01144949|558943|P2|STARTED|Overall Study||120
230434|NCT01144949|558944|P1|STARTED|Overall Study||119
230435|NCT01144715|558962|P2|NOT COMPLETED|Overall Study||3
230436|NCT01144715|558963|P1|NOT COMPLETED|Overall Study||4
230437|NCT01144715|558962|P2|COMPLETED|Overall Study||45
230438|NCT01144715|558963|P1|COMPLETED|Overall Study||47
230439|NCT01144715|558962|P2|STARTED|Overall Study||48
230440|NCT01144715|558963|P1|STARTED|Overall Study||51
230441|NCT01144663|558979|P4|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||1
230442|NCT01144663|558980|P3|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||7
230443|NCT01144663|558981|P2|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||9
230444|NCT01144663|558982|P1|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||5
230445|NCT01144663|558979|P4|COMPLETED|Extended Safety Follow-Up (ESFU)||505
230446|NCT01144663|558980|P3|COMPLETED|Extended Safety Follow-Up (ESFU)||496
230447|NCT01144663|558981|P2|COMPLETED|Extended Safety Follow-Up (ESFU)||502
230448|NCT01144663|558982|P1|COMPLETED|Extended Safety Follow-Up (ESFU)||492
230449|NCT01144663|558979|P4|STARTED|Extended Safety Follow-Up (ESFU)||506
230450|NCT01144663|558980|P3|STARTED|Extended Safety Follow-Up (ESFU)||503
230451|NCT01144663|558981|P2|STARTED|Extended Safety Follow-Up (ESFU)||511
230452|NCT01144663|558982|P1|STARTED|Extended Safety Follow-Up (ESFU)||497
230453|NCT01144663|558979|P4|NOT COMPLETED|Booster Vaccination Phase||1
230454|NCT01144663|558980|P3|NOT COMPLETED|Booster Vaccination Phase||5
230455|NCT01144663|558981|P2|NOT COMPLETED|Booster Vaccination Phase||2
230456|NCT01144663|558982|P1|NOT COMPLETED|Booster Vaccination Phase||3
230457|NCT01144663|558979|P4|COMPLETED|Booster Vaccination Phase||505
230458|NCT01144663|558980|P3|COMPLETED|Booster Vaccination Phase||498
230459|NCT01144663|558981|P2|COMPLETED|Booster Vaccination Phase||509
230460|NCT01144663|558982|P1|COMPLETED|Booster Vaccination Phase||494
230461|NCT01144663|558979|P4|STARTED|Booster Vaccination Phase||506
230462|NCT01144663|558980|P3|STARTED|Booster Vaccination Phase||503
230463|NCT01144663|558981|P2|STARTED|Booster Vaccination Phase||511
230464|NCT01144663|558982|P1|STARTED|Booster Vaccination Phase||497
230465|NCT01144663|558979|P4|NOT COMPLETED|Primary Vaccination Phase||18
230466|NCT01144663|558980|P3|NOT COMPLETED|Primary Vaccination Phase||8
230467|NCT01144663|558981|P2|NOT COMPLETED|Primary Vaccination Phase||7
230468|NCT01144663|558982|P1|NOT COMPLETED|Primary Vaccination Phase||20
230469|NCT01144663|558979|P4|COMPLETED|Primary Vaccination Phase||509
230470|NCT01144663|558980|P3|COMPLETED|Primary Vaccination Phase||508
230471|NCT01144663|558981|P2|COMPLETED|Primary Vaccination Phase||517
230472|NCT01144663|558982|P1|COMPLETED|Primary Vaccination Phase||508
230473|NCT01144663|558979|P4|STARTED|Primary Vaccination Phase||527
230474|NCT01144663|558980|P3|STARTED|Primary Vaccination Phase||516
230475|NCT01144663|558981|P2|STARTED|Primary Vaccination Phase||524
230476|NCT01144663|558982|P1|STARTED|Primary Vaccination Phase||528
230477|NCT01144637|559186|P4|NOT COMPLETED|Overall Study||56
230478|NCT01144637|559187|P3|NOT COMPLETED|Overall Study||60
230479|NCT01144637|559188|P2|NOT COMPLETED|Overall Study||76
230480|NCT01144637|559189|P1|NOT COMPLETED|Overall Study||74
230481|NCT01144637|559186|P4|COMPLETED|Overall Study||946
230482|NCT01144637|559187|P3|COMPLETED|Overall Study||939
230483|NCT01144637|559188|P2|COMPLETED|Overall Study||929
230484|NCT01144637|559189|P1|COMPLETED|Overall Study||925
230485|NCT01144637|559186|P4|STARTED|Overall Study||1002
230486|NCT01144637|559187|P3|STARTED|Overall Study||999
230487|NCT01144637|559188|P2|STARTED|Overall Study||1005
230488|NCT01144637|559189|P1|STARTED|Overall Study||999
230489|NCT01144624|559246|P3|NOT COMPLETED|Overall Study||0
230490|NCT01144624|559247|P2|NOT COMPLETED|Overall Study||0
230491|NCT01144624|559248|P1|NOT COMPLETED|Overall Study||0
230492|NCT01144624|559246|P3|COMPLETED|Overall Study|Two patients died during the study. Death was not a reason for treatment or study discontinuation.|6
230493|NCT01144624|559247|P2|COMPLETED|Overall Study||7
230494|NCT01144624|559248|P1|COMPLETED|Overall Study|One patient died during the study. Death was not a reason for treatment or study discontinuation.|7
230495|NCT01144624|559246|P3|Completed Treatment|Overall Study|Two patients died during the dosing period. Death was not a reason for treatment discontinuation.|6
230496|NCT01144624|559247|P2|Completed Treatment|Overall Study||7
230497|NCT01144624|559248|P1|Completed Treatment|Overall Study|One patient died after completing the full course of study treatment.|7
230498|NCT01144624|559246|P3|Received Treatment|Overall Study||6
230499|NCT01144624|559247|P2|Received Treatment|Overall Study||7
230500|NCT01144624|559248|P1|Received Treatment|Overall Study||7
230501|NCT01144624|559246|P3|STARTED|Overall Study||6
230502|NCT01144624|559247|P2|STARTED|Overall Study||7
230503|NCT01144624|559248|P1|STARTED|Overall Study||7
230504|NCT01144598|559262|P1|NOT COMPLETED|Overall Study||0
230505|NCT01144598|559262|P1|COMPLETED|Overall Study||356
230506|NCT01144598|559262|P1|Analysis Population|Overall Study||356
230507|NCT01144598|559262|P1|STARTED|Overall Study||356
230508|NCT01144494|559280|P2|NOT COMPLETED|Overall Study||4
230509|NCT01144494|559281|P1|NOT COMPLETED|Overall Study||0
230510|NCT01144494|559280|P2|COMPLETED|Overall Study||14
230511|NCT01144494|559281|P1|COMPLETED|Overall Study||15
230512|NCT01144494|559280|P2|STARTED|Overall Study||18
230513|NCT01144494|559281|P1|STARTED|Overall Study||15
230514|NCT01144455|559300|P3|NOT COMPLETED|Overall Study||36
230515|NCT01144455|559301|P2|NOT COMPLETED|Overall Study||42
230516|NCT01144455|559302|P1|NOT COMPLETED|Overall Study||50
230517|NCT01144455|559300|P3|COMPLETED|Overall Study||38
230518|NCT01144455|559301|P2|COMPLETED|Overall Study||29
230519|NCT01144455|559302|P1|COMPLETED|Overall Study||19
230520|NCT01144455|559300|P3|STARTED|Overall Study||74
230521|NCT01144455|559301|P2|STARTED|Overall Study||71
230522|NCT01144455|559302|P1|STARTED|Overall Study||69
230523|NCT01144442|559310|P1|NOT COMPLETED|Overall Study||0
230524|NCT01144442|559310|P1|COMPLETED|Overall Study||10
230525|NCT01144442|559310|P1|STARTED|Overall Study||10
230526|NCT01144416|559320|P2|NOT COMPLETED|Pregnancy Follow-up Period||10
230527|NCT01144416|559321|P1|NOT COMPLETED|Pregnancy Follow-up Period||8
230528|NCT01144416|559320|P2|COMPLETED|Pregnancy Follow-up Period||157
230529|NCT01144416|559321|P1|COMPLETED|Pregnancy Follow-up Period||146
230530|NCT01144416|559320|P2|STARTED|Pregnancy Follow-up Period|Participants received daily injections of 300 IU recFSH in Intervention Period and became pregnant.|167
230531|NCT01144416|559321|P1|STARTED|Pregnancy Follow-up Period|Participants received 150 ug SCH 900962 in Intervention Period and became pregnant.|154
230532|NCT01144416|559320|P2|NOT COMPLETED|Intervention Period||49
230533|NCT01144416|559321|P1|NOT COMPLETED|Intervention Period||62
230534|NCT01144416|559320|P2|COMPLETED|Intervention Period||647
230535|NCT01144416|559321|P1|COMPLETED|Intervention Period||632
230536|NCT01144416|559320|P2|STARTED|Intervention Period||696
230537|NCT01144416|559321|P1|STARTED|Intervention Period||694
230538|NCT01144403|559337|P1|NOT COMPLETED|Overall Study||5
230539|NCT01144403|559337|P1|COMPLETED|Overall Study||3
230540|NCT01144403|559337|P1|STARTED|Overall Study||8
230541|NCT01144377|559349|P5|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||2
230542|NCT01144377|559350|P4|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
230543|NCT01144377|559351|P3|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
230544|NCT01144377|559352|P2|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
230545|NCT01144377|559353|P1|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
230546|NCT01144377|559349|P5|COMPLETED|Optional 40 Week Safety Follow-up Period||21
230547|NCT01144377|559350|P4|COMPLETED|Optional 40 Week Safety Follow-up Period||3
230548|NCT01144377|559351|P3|COMPLETED|Optional 40 Week Safety Follow-up Period||23
230549|NCT01144377|559352|P2|COMPLETED|Optional 40 Week Safety Follow-up Period||24
230550|NCT01144377|559353|P1|COMPLETED|Optional 40 Week Safety Follow-up Period||21
230551|NCT01144377|559349|P5|STARTED|Optional 40 Week Safety Follow-up Period||23
230552|NCT01144377|559350|P4|STARTED|Optional 40 Week Safety Follow-up Period||3
230553|NCT01144377|559351|P3|STARTED|Optional 40 Week Safety Follow-up Period||23
230554|NCT01144377|559352|P2|STARTED|Optional 40 Week Safety Follow-up Period||25
230555|NCT01144377|559353|P1|STARTED|Optional 40 Week Safety Follow-up Period||22
230556|NCT01144377|559349|P5|NOT COMPLETED|12 Week Safety Follow-up Period||0
230557|NCT01144377|559350|P4|NOT COMPLETED|12 Week Safety Follow-up Period||0
230558|NCT01144377|559351|P3|NOT COMPLETED|12 Week Safety Follow-up Period||0
230559|NCT01144377|559352|P2|NOT COMPLETED|12 Week Safety Follow-up Period||0
230560|NCT01144377|559353|P1|NOT COMPLETED|12 Week Safety Follow-up Period||0
230561|NCT01144377|559349|P5|COMPLETED|12 Week Safety Follow-up Period|Of the 34 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|34
230562|NCT01144377|559350|P4|COMPLETED|12 Week Safety Follow-up Period|Of the 22 participants who completed this Period, 3 continued to the Optional 40 Week follow-up.|22
230563|NCT01144377|559351|P3|COMPLETED|12 Week Safety Follow-up Period|Of the 25 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|25
230564|NCT01144377|559352|P2|COMPLETED|12 Week Safety Follow-up Period|Of the 29 participants who completed this Period, 25 continued to the Optional 40 Week follow-up.|29
230565|NCT01144377|559353|P1|COMPLETED|12 Week Safety Follow-up Period|Of the 26 participants who completed this Period, 22 continued to the Optional 40 Week follow-up.|26
230566|NCT01144377|559349|P5|STARTED|12 Week Safety Follow-up Period||34
230567|NCT01144377|559350|P4|STARTED|12 Week Safety Follow-up Period||22
230568|NCT01144377|559351|P3|STARTED|12 Week Safety Follow-up Period||25
230569|NCT01144377|559352|P2|STARTED|12 Week Safety Follow-up Period||29
230570|NCT01144377|559353|P1|STARTED|12 Week Safety Follow-up Period||26
230571|NCT01144377|559349|P5|NOT COMPLETED|52 Week Treatment Period||3
230572|NCT01144377|559350|P4|NOT COMPLETED|52 Week Treatment Period||4
230573|NCT01144377|559351|P3|NOT COMPLETED|52 Week Treatment Period||5
230574|NCT01144377|559352|P2|NOT COMPLETED|52 Week Treatment Period||1
230575|NCT01144377|559353|P1|NOT COMPLETED|52 Week Treatment Period||5
230576|NCT01144377|559349|P5|COMPLETED|52 Week Treatment Period||34
230577|NCT01144377|559350|P4|COMPLETED|52 Week Treatment Period||22
230578|NCT01144377|559351|P3|COMPLETED|52 Week Treatment Period||25
230579|NCT01144377|559352|P2|COMPLETED|52 Week Treatment Period||29
230580|NCT01144377|559353|P1|COMPLETED|52 Week Treatment Period||26
230581|NCT01144377|559349|P5|Received at Least One Dose of Study Drug|52 Week Treatment Period||37
230582|NCT01144377|559350|P4|Received at Least One Dose of Study Drug|52 Week Treatment Period||25
230583|NCT01144377|559351|P3|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
230584|NCT01144377|559352|P2|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
230585|NCT01144377|559353|P1|Received at Least One Dose of Study Drug|52 Week Treatment Period||31
230586|NCT01144377|559349|P5|STARTED|52 Week Treatment Period||37
230587|NCT01144377|559350|P4|STARTED|52 Week Treatment Period||26
230588|NCT01144377|559351|P3|STARTED|52 Week Treatment Period||30
230589|NCT01144377|559352|P2|STARTED|52 Week Treatment Period||30
230590|NCT01144377|559353|P1|STARTED|52 Week Treatment Period||31
230591|NCT01144364|559402|P3|NOT COMPLETED|Follow-Up/Maintenance Phase||41
230592|NCT01144364|559403|P2|NOT COMPLETED|Follow-Up/Maintenance Phase||35
230593|NCT01144364|559404|P1|NOT COMPLETED|Follow-Up/Maintenance Phase||0
230594|NCT01144364|559402|P3|COMPLETED|Follow-Up/Maintenance Phase||60
230595|NCT01144364|559403|P2|COMPLETED|Follow-Up/Maintenance Phase||66
230596|NCT01144364|559404|P1|COMPLETED|Follow-Up/Maintenance Phase||0
230597|NCT01144364|559402|P3|STARTED|Follow-Up/Maintenance Phase||101
230598|NCT01144364|559403|P2|STARTED|Follow-Up/Maintenance Phase||101
230599|NCT01144364|559404|P1|STARTED|Follow-Up/Maintenance Phase||0
230600|NCT01144364|559402|P3|NOT COMPLETED|Induction Phase||0
230601|NCT01144364|559403|P2|NOT COMPLETED|Induction Phase||0
230602|NCT01144364|559404|P1|NOT COMPLETED|Induction Phase||32
230603|NCT01144364|559402|P3|COMPLETED|Induction Phase||0
230604|NCT01144364|559403|P2|COMPLETED|Induction Phase||0
230605|NCT01144364|559404|P1|COMPLETED|Induction Phase||202
230606|NCT01144364|559402|P3|STARTED|Induction Phase||0
230607|NCT01144364|559403|P2|STARTED|Induction Phase||0
230608|NCT01144364|559404|P1|STARTED|Induction Phase||234
230609|NCT01144338|559430|P2|NOT COMPLETED|Overall Study||262
230610|NCT01144338|559431|P1|NOT COMPLETED|Overall Study||303
230611|NCT01144338|559430|P2|COMPLETED|Overall Study||7094
230612|NCT01144338|559431|P1|COMPLETED|Overall Study||7093
230613|NCT01144338|559430|P2|STARTED|Overall Study||7356
230614|NCT01144338|559431|P1|STARTED|Overall Study||7396
230615|NCT01144299|559453|P2|NOT COMPLETED|Overall Study||0
230616|NCT01144299|559454|P1|NOT COMPLETED|Overall Study||2
230617|NCT01144299|559453|P2|COMPLETED|Overall Study||54
230618|NCT01144299|559454|P1|COMPLETED|Overall Study||58
230619|NCT01144299|559453|P2|STARTED|Overall Study||54
230620|NCT01144299|559454|P1|STARTED|Overall Study||60
230621|NCT01144286|559480|P4|NOT COMPLETED|Overall Study||0
230622|NCT01144286|559481|P3|NOT COMPLETED|Overall Study||0
230623|NCT01144286|559482|P2|NOT COMPLETED|Overall Study||0
230624|NCT01144286|559483|P1|NOT COMPLETED|Overall Study||0
230625|NCT01144286|559480|P4|COMPLETED|Overall Study||56
230626|NCT01144286|559481|P3|COMPLETED|Overall Study||58
230627|NCT01144286|559482|P2|COMPLETED|Overall Study||58
230628|NCT01144286|559483|P1|COMPLETED|Overall Study||57
230629|NCT01144286|559480|P4|STARTED|Overall Study||56
230630|NCT01144286|559481|P3|STARTED|Overall Study||58
230631|NCT01144286|559482|P2|STARTED|Overall Study||58
230632|NCT01144286|559483|P1|STARTED|Overall Study||57
230633|NCT01144182|559499|P2|NOT COMPLETED|Overall Study||21
230634|NCT01144182|559500|P1|NOT COMPLETED|Overall Study||17
230635|NCT01144182|559499|P2|COMPLETED|Overall Study||47
230636|NCT01144182|559500|P1|COMPLETED|Overall Study||51
230637|NCT01144182|559499|P2|STARTED|Overall Study||68
230638|NCT01144182|559500|P1|STARTED|Overall Study||68
230639|NCT01144143|559533|P3|NOT COMPLETED|Overall Study||0
230640|NCT01144143|559534|P2|NOT COMPLETED|Overall Study||0
230641|NCT01144143|559535|P1|NOT COMPLETED|Overall Study||0
230642|NCT01144143|559533|P3|COMPLETED|Overall Study||4
230643|NCT01144143|559534|P2|COMPLETED|Overall Study||4
230644|NCT01144143|559535|P1|COMPLETED|Overall Study||8
230645|NCT01144143|559533|P3|STARTED|Overall Study||4
230646|NCT01144143|559534|P2|STARTED|Overall Study||4
230647|NCT01144143|559535|P1|STARTED|Overall Study||8
230648|NCT01144052|559560|P2|NOT COMPLETED|Overall Study||1
230649|NCT01144052|559561|P1|NOT COMPLETED|Overall Study||1
230650|NCT01144052|559560|P2|COMPLETED|Overall Study||8
230651|NCT01144052|559561|P1|COMPLETED|Overall Study||9
230652|NCT01144052|559560|P2|STARTED|Overall Study||9
230653|NCT01144052|559561|P1|STARTED|Overall Study||10
230654|NCT01144026|559583|P2|NOT COMPLETED|Overall Study||0
230655|NCT01144026|559584|P1|NOT COMPLETED|Overall Study||0
230656|NCT01144026|559583|P2|COMPLETED|Overall Study||5
230657|NCT01144026|559584|P1|COMPLETED|Overall Study||10
230658|NCT01144026|559583|P2|STARTED|Overall Study||5
230659|NCT01144026|559584|P1|STARTED|Overall Study||10
230660|NCT01143896|559592|P2|NOT COMPLETED|Overall Study||25
230661|NCT01143896|559593|P1|NOT COMPLETED|Overall Study||42
230662|NCT01143896|559592|P2|COMPLETED|Overall Study||128
230663|NCT01143896|559593|P1|COMPLETED|Overall Study||114
230664|NCT01143896|559592|P2|STARTED|Overall Study||153
230665|NCT01143896|559593|P1|STARTED|Overall Study||156
230666|NCT01143883|559611|P2|NOT COMPLETED|Overall Study||0
230667|NCT01143883|559612|P1|NOT COMPLETED|Overall Study||0
230668|NCT01143883|559611|P2|COMPLETED|Overall Study||55
230669|NCT01143883|559612|P1|COMPLETED|Overall Study||55
230670|NCT01143883|559611|P2|STARTED|Overall Study||55
230671|NCT01143883|559612|P1|STARTED|Overall Study||55
230672|NCT01143870|559621|P3|NOT COMPLETED|Overall Study||0
230673|NCT01143870|559622|P2|NOT COMPLETED|Overall Study||0
230674|NCT01143870|559623|P1|NOT COMPLETED|Overall Study||0
230675|NCT01143870|559621|P3|COMPLETED|Overall Study||61
230676|NCT01143870|559622|P2|COMPLETED|Overall Study||58
230677|NCT01143870|559623|P1|COMPLETED|Overall Study||58
230678|NCT01143870|559621|P3|A1C Imputed|Overall Study||30
230679|NCT01143870|559622|P2|A1C Imputed|Overall Study||29
230680|NCT01143870|559623|P1|A1C Imputed|Overall Study||31
230681|NCT01143870|559621|P3|Had Available 6-month A1C|Overall Study||31
230682|NCT01143870|559622|P2|Had Available 6-month A1C|Overall Study||29
230683|NCT01143870|559623|P1|Had Available 6-month A1C|Overall Study||27
230684|NCT01143870|559621|P3|Post-intervention Survey|Overall Study||61
230685|NCT01143870|559622|P2|Post-intervention Survey|Overall Study||50
230686|NCT01143870|559623|P1|Post-intervention Survey|Overall Study||53
230687|NCT01143870|559621|P3|STARTED|Overall Study||61
230688|NCT01143870|559622|P2|STARTED|Overall Study||58
230689|NCT01143870|559623|P1|STARTED|Overall Study||58
230690|NCT01143818|559631|P1|NOT COMPLETED|Overall Study||250
230691|NCT01143818|559631|P1|COMPLETED|Overall Study||799
230692|NCT01143818|559631|P1|STARTED|Overall Study|A total of 1053 participants were enrolled but only 1049 received study drug.|1049
230693|NCT01143792|559641|P3|NOT COMPLETED|Overall Study||0
230694|NCT01143792|559642|P2|NOT COMPLETED|Overall Study||0
230695|NCT01143792|559643|P1|NOT COMPLETED|Overall Study||0
230696|NCT01143792|559641|P3|COMPLETED|Overall Study||91
230697|NCT01143792|559642|P2|COMPLETED|Overall Study||86
230698|NCT01143792|559643|P1|COMPLETED|Overall Study||93
230699|NCT01143792|559641|P3|STARTED|Overall Study||91
230700|NCT01143792|559642|P2|STARTED|Overall Study||86
230701|NCT01143792|559643|P1|STARTED|Overall Study||93
230702|NCT01143766|559677|P2|NOT COMPLETED|Overall Study||0
230703|NCT01143766|559678|P1|NOT COMPLETED|Overall Study||0
230704|NCT01143766|559677|P2|COMPLETED|Overall Study||31
230705|NCT01143766|559678|P1|COMPLETED|Overall Study||25
230706|NCT01143766|559677|P2|STARTED|Overall Study||31
230707|NCT01143766|559678|P1|STARTED|Overall Study||25
230708|NCT01143727|559694|P2|NOT COMPLETED|Overall Study||0
230709|NCT01143727|559695|P1|NOT COMPLETED|Overall Study||0
230710|NCT01143727|559694|P2|COMPLETED|Overall Study||8
230711|NCT01143727|559695|P1|COMPLETED|Overall Study||9
230712|NCT01143727|559694|P2|STARTED|Overall Study||8
230713|NCT01143727|559695|P1|STARTED|Overall Study||9
230714|NCT01143714|559705|P2|NOT COMPLETED|Overall Study||3
230715|NCT01143714|559706|P1|NOT COMPLETED|Overall Study||7
230716|NCT01143714|559705|P2|COMPLETED|Overall Study||25
230717|NCT01143714|559706|P1|COMPLETED|Overall Study||22
230718|NCT01143714|559705|P2|STARTED|Overall Study||28
230719|NCT01143714|559706|P1|STARTED|Overall Study||29
230720|NCT01143701|559716|P2|NOT COMPLETED|Overall Study||32
230721|NCT01143701|559717|P1|NOT COMPLETED|Overall Study||23
230722|NCT01143701|559716|P2|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|287
230723|NCT01143701|559717|P1|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|235
230724|NCT01143701|559716|P2|STARTED|Overall Study||319
230725|NCT01143701|559717|P1|STARTED|Overall Study||258
230726|NCT01143688|559725|P1|NOT COMPLETED|Overall Study||0
230727|NCT01143688|559725|P1|COMPLETED|Overall Study||39
230728|NCT01143688|559725|P1|STARTED|Overall Study||39
230729|NCT01143649|559744|P6|NOT COMPLETED|Overall Study||2
230730|NCT01143649|559745|P5|NOT COMPLETED|Overall Study||1
230731|NCT01143649|559746|P4|NOT COMPLETED|Overall Study||0
230732|NCT01143649|559747|P3|NOT COMPLETED|Overall Study||0
230733|NCT01143649|559748|P2|NOT COMPLETED|Overall Study||0
230734|NCT01143649|559749|P1|NOT COMPLETED|Overall Study||0
230735|NCT01143649|559744|P6|COMPLETED|Overall Study||3
230736|NCT01143649|559745|P5|COMPLETED|Overall Study||4
230737|NCT01143649|559746|P4|COMPLETED|Overall Study||10
230738|NCT01143649|559747|P3|COMPLETED|Overall Study||10
230739|NCT01143649|559748|P2|COMPLETED|Overall Study||7
230740|NCT01143649|559749|P1|COMPLETED|Overall Study||7
230741|NCT01143649|559744|P6|STARTED|Overall Study||5
230742|NCT01143649|559745|P5|STARTED|Overall Study||5
230743|NCT01143649|559746|P4|STARTED|Overall Study||10
230744|NCT01143649|559747|P3|STARTED|Overall Study||10
230745|NCT01143649|559748|P2|STARTED|Overall Study||7
230746|NCT01143649|559749|P1|STARTED|Overall Study||7
230747|NCT01143636|559766|P4|NOT COMPLETED|Overall Study||0
230748|NCT01143636|559767|P3|NOT COMPLETED|Overall Study||0
230749|NCT01143636|559768|P2|NOT COMPLETED|Overall Study||1
230750|NCT01143636|559769|P1|NOT COMPLETED|Overall Study||1
230751|NCT01143636|559766|P4|COMPLETED|Overall Study||7
230752|NCT01143636|559767|P3|COMPLETED|Overall Study||8
230753|NCT01143636|559768|P2|COMPLETED|Overall Study||4
230754|NCT01143636|559769|P1|COMPLETED|Overall Study||5
230755|NCT01143636|559766|P4|STARTED|Overall Study||7
230756|NCT01143636|559767|P3|STARTED|Overall Study||8
230757|NCT01143636|559768|P2|STARTED|Overall Study||5
230758|NCT01143636|559769|P1|STARTED|Overall Study||6
230759|NCT01143610|559799|P2|NOT COMPLETED|Overall Study||0
230760|NCT01143610|559800|P1|NOT COMPLETED|Overall Study||0
230761|NCT01143610|559799|P2|COMPLETED|Overall Study||8
230762|NCT01143610|559800|P1|COMPLETED|Overall Study||7
230763|NCT01143610|559799|P2|STARTED|Overall Study||8
230764|NCT01143610|559800|P1|STARTED|Overall Study||7
230765|NCT01143402|559811|P3|NOT COMPLETED|Overall Study||1
230766|NCT01143402|559812|P2|NOT COMPLETED|Overall Study||1
230767|NCT01143402|559813|P1|NOT COMPLETED|Overall Study||1
230768|NCT01143402|559811|P3|COMPLETED|Overall Study||18
230769|NCT01143402|559812|P2|COMPLETED|Overall Study||49
230770|NCT01143402|559813|P1|COMPLETED|Overall Study||50
230771|NCT01143402|559811|P3|STARTED|Overall Study||19
230772|NCT01143402|559812|P2|STARTED|Overall Study||50
230773|NCT01143402|559813|P1|STARTED|Overall Study||51
230774|NCT01143389|559824|P2|NOT COMPLETED|Overall Study||25
230775|NCT01143389|559825|P1|NOT COMPLETED|Overall Study||26
230776|NCT01143389|559824|P2|COMPLETED|Overall Study||232
230777|NCT01143389|559825|P1|COMPLETED|Overall Study||227
230778|NCT01143389|559824|P2|STARTED|Overall Study||257
230779|NCT01143389|559825|P1|STARTED|Overall Study||253
230780|NCT01143337|559839|P3|NOT COMPLETED|Overall Study||12
230781|NCT01143337|559840|P2|NOT COMPLETED|Overall Study||11
230782|NCT01143337|559841|P1|NOT COMPLETED|Overall Study||10
230783|NCT01143337|559839|P3|COMPLETED|Overall Study|Frequency of this arm AE was higher than assumption before study initiation.|1
230784|NCT01143337|559840|P2|COMPLETED|Overall Study||39
230785|NCT01143337|559841|P1|COMPLETED|Overall Study||39
230786|NCT01143337|559839|P3|STARTED|Overall Study||13
230787|NCT01143337|559840|P2|STARTED|Overall Study||50
230788|NCT01143337|559841|P1|STARTED|Overall Study||49
230789|NCT01143324|559855|P1|NOT COMPLETED|Overall Study||19
230790|NCT01143324|559855|P1|COMPLETED|Overall Study||233
230791|NCT01143324|559855|P1|STARTED|Overall Study||252
230792|NCT01143272|559873|P2|NOT COMPLETED|Overall Study||0
230793|NCT01143272|559874|P1|NOT COMPLETED|Overall Study||0
230794|NCT01143272|559873|P2|COMPLETED|Overall Study||231
230795|NCT01143272|559874|P1|COMPLETED|Overall Study||246
230796|NCT01143272|559873|P2|STARTED|Overall Study||231
230797|NCT01143272|559874|P1|STARTED|Overall Study||246
230798|NCT01143259|559894|P2|NOT COMPLETED|Overall Study||20
230799|NCT01143259|559895|P1|NOT COMPLETED|Overall Study||23
230800|NCT01143259|559894|P2|COMPLETED|Overall Study||118
230801|NCT01143259|559895|P1|COMPLETED|Overall Study||113
230802|NCT01143259|559894|P2|STARTED|Overall Study||138
230803|NCT01143259|559895|P1|STARTED|Overall Study||136
230804|NCT01143207|559903|P1|NOT COMPLETED|Overall Study||2
230805|NCT01143207|559903|P1|COMPLETED|Overall Study||24
230806|NCT01143207|559903|P1|STARTED|Overall Study||26
230807|NCT01143142|559914|P2|NOT COMPLETED|Overall Study||0
230808|NCT01143142|559915|P1|NOT COMPLETED|Overall Study||0
230809|NCT01143142|559914|P2|COMPLETED|Overall Study||34
230810|NCT01143142|559915|P1|COMPLETED|Overall Study||36
230811|NCT01143142|559914|P2|STARTED|Overall Study||34
230812|NCT01143142|559915|P1|STARTED|Overall Study||36
230813|NCT01143090|559923|P1|NOT COMPLETED|Overall Study||51
230814|NCT01143090|559923|P1|COMPLETED|Overall Study||98
230815|NCT01143090|559923|P1|STARTED|Overall Study||149
230816|NCT01143077|559930|P3|NOT COMPLETED|Overall Study||15
230817|NCT01143077|559931|P2|NOT COMPLETED|Overall Study||15
230818|NCT01143077|559932|P1|NOT COMPLETED|Overall Study||16
230819|NCT01143077|559930|P3|COMPLETED|Overall Study||67
230820|NCT01143077|559931|P2|COMPLETED|Overall Study||73
230821|NCT01143077|559932|P1|COMPLETED|Overall Study||58
230822|NCT01143077|559930|P3|STARTED|Overall Study||82
230823|NCT01143077|559931|P2|STARTED|Overall Study||88
230824|NCT01143077|559932|P1|STARTED|Overall Study||74
230825|NCT01143051|559949|P6|NOT COMPLETED|Visit 3||0
230826|NCT01143051|559950|P5|NOT COMPLETED|Visit 3||0
230827|NCT01143051|559951|P4|NOT COMPLETED|Visit 3||0
230828|NCT01143051|559952|P3|NOT COMPLETED|Visit 3||0
230829|NCT01143051|559953|P2|NOT COMPLETED|Visit 3||0
230830|NCT01143051|559954|P1|NOT COMPLETED|Visit 3||0
230831|NCT01143051|559949|P6|COMPLETED|Visit 3||3
230832|NCT01143051|559950|P5|COMPLETED|Visit 3||4
230833|NCT01143051|559951|P4|COMPLETED|Visit 3||4
230834|NCT01143051|559952|P3|COMPLETED|Visit 3||3
230835|NCT01143051|559953|P2|COMPLETED|Visit 3||4
230836|NCT01143051|559954|P1|COMPLETED|Visit 3||4
230837|NCT01143051|559949|P6|STARTED|Visit 3||3
230838|NCT01143051|559950|P5|STARTED|Visit 3||4
230839|NCT01143051|559951|P4|STARTED|Visit 3||4
230840|NCT01143051|559952|P3|STARTED|Visit 3||3
230841|NCT01143051|559953|P2|STARTED|Visit 3||4
230842|NCT01143051|559954|P1|STARTED|Visit 3||4
230843|NCT01143051|559949|P6|NOT COMPLETED|3-14 Day Washout||1
230844|NCT01143051|559950|P5|NOT COMPLETED|3-14 Day Washout||0
230845|NCT01143051|559951|P4|NOT COMPLETED|3-14 Day Washout||0
230846|NCT01143051|559952|P3|NOT COMPLETED|3-14 Day Washout||0
230847|NCT01143051|559953|P2|NOT COMPLETED|3-14 Day Washout||0
230848|NCT01143051|559954|P1|NOT COMPLETED|3-14 Day Washout||0
230849|NCT01143051|559949|P6|COMPLETED|3-14 Day Washout||3
230850|NCT01143051|559950|P5|COMPLETED|3-14 Day Washout||4
230851|NCT01143051|559951|P4|COMPLETED|3-14 Day Washout||4
230852|NCT01143051|559952|P3|COMPLETED|3-14 Day Washout||3
230853|NCT01143051|559953|P2|COMPLETED|3-14 Day Washout||4
230854|NCT01143051|559954|P1|COMPLETED|3-14 Day Washout||4
230855|NCT01143051|559949|P6|STARTED|3-14 Day Washout||4
230856|NCT01143051|559950|P5|STARTED|3-14 Day Washout||4
230857|NCT01143051|559951|P4|STARTED|3-14 Day Washout||4
230858|NCT01143051|559952|P3|STARTED|3-14 Day Washout||3
230859|NCT01143051|559953|P2|STARTED|3-14 Day Washout||4
230860|NCT01143051|559954|P1|STARTED|3-14 Day Washout||4
230861|NCT01143051|559949|P6|NOT COMPLETED|Visit 2||0
230862|NCT01143051|559950|P5|NOT COMPLETED|Visit 2||0
230863|NCT01143051|559951|P4|NOT COMPLETED|Visit 2||0
230864|NCT01143051|559952|P3|NOT COMPLETED|Visit 2||0
230865|NCT01143051|559953|P2|NOT COMPLETED|Visit 2||0
230866|NCT01143051|559954|P1|NOT COMPLETED|Visit 2||0
230867|NCT01143051|559949|P6|COMPLETED|Visit 2||4
230868|NCT01143051|559950|P5|COMPLETED|Visit 2||4
230869|NCT01143051|559951|P4|COMPLETED|Visit 2||4
230870|NCT01143051|559952|P3|COMPLETED|Visit 2||3
230871|NCT01143051|559953|P2|COMPLETED|Visit 2||4
230872|NCT01143051|559954|P1|COMPLETED|Visit 2||4
230873|NCT01143051|559949|P6|STARTED|Visit 2||4
230874|NCT01143051|559950|P5|STARTED|Visit 2||4
230875|NCT01143051|559951|P4|STARTED|Visit 2||4
230876|NCT01143051|559952|P3|STARTED|Visit 2||3
230877|NCT01143051|559953|P2|STARTED|Visit 2||4
230878|NCT01143051|559954|P1|STARTED|Visit 2||4
230879|NCT01143051|559949|P6|NOT COMPLETED|3-14 Day Washout||0
230880|NCT01143051|559950|P5|NOT COMPLETED|3-14 Day Washout||0
230881|NCT01143051|559951|P4|NOT COMPLETED|3-14 Day Washout||0
230882|NCT01143051|559952|P3|NOT COMPLETED|3-14 Day Washout||1
230883|NCT01143051|559953|P2|NOT COMPLETED|3-14 Day Washout||0
230884|NCT01143051|559954|P1|NOT COMPLETED|3-14 Day Washout||0
230885|NCT01143051|559949|P6|COMPLETED|3-14 Day Washout||4
230886|NCT01143051|559950|P5|COMPLETED|3-14 Day Washout||4
230887|NCT01143051|559951|P4|COMPLETED|3-14 Day Washout||4
230888|NCT01143051|559952|P3|COMPLETED|3-14 Day Washout||3
230889|NCT01143051|559953|P2|COMPLETED|3-14 Day Washout||4
230890|NCT01143051|559954|P1|COMPLETED|3-14 Day Washout||4
230891|NCT01143051|559949|P6|STARTED|3-14 Day Washout||4
230892|NCT01143051|559950|P5|STARTED|3-14 Day Washout||4
230893|NCT01143051|559951|P4|STARTED|3-14 Day Washout||4
230894|NCT01143051|559952|P3|STARTED|3-14 Day Washout||4
230895|NCT01143051|559953|P2|STARTED|3-14 Day Washout||4
230896|NCT01143051|559954|P1|STARTED|3-14 Day Washout||4
230897|NCT01143051|559949|P6|NOT COMPLETED|Visit 1||0
230898|NCT01143051|559950|P5|NOT COMPLETED|Visit 1||0
230899|NCT01143051|559951|P4|NOT COMPLETED|Visit 1||0
230900|NCT01143051|559952|P3|NOT COMPLETED|Visit 1||0
230901|NCT01143051|559953|P2|NOT COMPLETED|Visit 1||0
230902|NCT01143051|559954|P1|NOT COMPLETED|Visit 1||0
230903|NCT01143051|559949|P6|COMPLETED|Visit 1||4
230904|NCT01143051|559950|P5|COMPLETED|Visit 1||4
230905|NCT01143051|559951|P4|COMPLETED|Visit 1||4
230906|NCT01143051|559952|P3|COMPLETED|Visit 1||4
230907|NCT01143051|559953|P2|COMPLETED|Visit 1||4
230908|NCT01143051|559954|P1|COMPLETED|Visit 1||4
230909|NCT01143051|559949|P6|STARTED|Visit 1||4
230910|NCT01143051|559950|P5|STARTED|Visit 1||4
230911|NCT01143051|559951|P4|STARTED|Visit 1||4
230912|NCT01143051|559952|P3|STARTED|Visit 1||4
230913|NCT01143051|559953|P2|STARTED|Visit 1||4
230914|NCT01143051|559954|P1|STARTED|Visit 1||4
230915|NCT01143038|560003|P1|NOT COMPLETED|Overall Study||16
230916|NCT01143038|560003|P1|COMPLETED|Overall Study|Defined as completion of romiplostim treatment|59
230917|NCT01143038|560003|P1|STARTED|Overall Study||75
230918|NCT01142947|560011|P1|NOT COMPLETED|Overall Study||118
230919|NCT01142947|560011|P1|COMPLETED|Overall Study||244
230920|NCT01142947|560011|P1|STARTED|Overall Study||362
230921|NCT01142908|560017|P2|NOT COMPLETED|Overall Study||22
230922|NCT01142908|560018|P1|NOT COMPLETED|Overall Study||32
230923|NCT01142908|560017|P2|COMPLETED|Overall Study||191
230924|NCT01142908|560018|P1|COMPLETED|Overall Study||183
230925|NCT01142908|560017|P2|6 Month f/u|Overall Study||196
230926|NCT01142908|560018|P1|6 Month f/u|Overall Study||188
230927|NCT01142908|560017|P2|STARTED|Overall Study||213
230928|NCT01142908|560018|P1|STARTED|Overall Study||215
230929|NCT01142791|560064|P2|NOT COMPLETED|Overall Study||6
230930|NCT01142791|560065|P1|NOT COMPLETED|Overall Study||7
230931|NCT01142791|560064|P2|COMPLETED|Overall Study||0
230932|NCT01142791|560065|P1|COMPLETED|Overall Study||108
230933|NCT01142791|560064|P2|Safety|Overall Study|Safety data only was reported for 6 participants receiving only 1 sonication.|6
230934|NCT01142791|560065|P1|Safety|Overall Study||115
230935|NCT01142791|560064|P2|STARTED|Overall Study|6 participants receiving only 1 sonication were included only in adverse events reporting.|6
230936|NCT01142791|560065|P1|STARTED|Overall Study||115
230937|NCT01142726|560072|P3|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||3
230938|NCT01142726|560073|P2|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||2
230939|NCT01142726|560074|P1|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||1
230940|NCT01142726|560072|P3|COMPLETED|Re-Exposure Phase: Months 24 up to 30||40
230941|NCT01142726|560073|P2|COMPLETED|Re-Exposure Phase: Months 24 up to 30||46
230942|NCT01142726|560074|P1|COMPLETED|Re-Exposure Phase: Months 24 up to 30||54
230943|NCT01142726|560072|P3|STARTED|Re-Exposure Phase: Months 24 up to 30||43
230944|NCT01142726|560073|P2|STARTED|Re-Exposure Phase: Months 24 up to 30||48
230945|NCT01142726|560074|P1|STARTED|Re-Exposure Phase: Months 24 up to 30||55
230946|NCT01142726|560072|P3|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||58
230947|NCT01142726|560073|P2|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||56
230948|NCT01142726|560074|P1|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||70
230949|NCT01142726|560072|P3|COMPLETED|Withdrawal Phase: Months 12 up to 24||17
230950|NCT01142726|560073|P2|COMPLETED|Withdrawal Phase: Months 12 up to 24||10
230951|NCT01142726|560074|P1|COMPLETED|Withdrawal Phase: Months 12 up to 24||14
230952|NCT01142726|560072|P3|STARTED|Withdrawal Phase: Months 12 up to 24||75
230953|NCT01142726|560073|P2|STARTED|Withdrawal Phase: Months 12 up to 24||66
230954|NCT01142726|560074|P1|STARTED|Withdrawal Phase: Months 12 up to 24||84
230955|NCT01142726|560072|P3|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||20
230956|NCT01142726|560073|P2|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||25
230957|NCT01142726|560074|P1|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||16
230958|NCT01142726|560072|P3|COMPLETED|Treatment Phase: Day 1 Through Month 12||96
230959|NCT01142726|560073|P2|COMPLETED|Treatment Phase: Day 1 Through Month 12||91
230960|NCT01142726|560074|P1|COMPLETED|Treatment Phase: Day 1 Through Month 12||103
230961|NCT01142726|560072|P3|STARTED|Treatment Phase: Day 1 Through Month 12||116
230962|NCT01142726|560073|P2|STARTED|Treatment Phase: Day 1 Through Month 12||116
230963|NCT01142726|560074|P1|STARTED|Treatment Phase: Day 1 Through Month 12||119
230964|NCT01142661|560137|P1|NOT COMPLETED|Overall Study||4
230965|NCT01142661|560137|P1|COMPLETED|Overall Study||5
230966|NCT01142661|560137|P1|STARTED|Overall Study||9
230967|NCT01142596|560144|P2|NOT COMPLETED|Overall Study||86
230968|NCT01142596|560145|P1|NOT COMPLETED|Overall Study||29
230969|NCT01142596|560144|P2|COMPLETED|Overall Study||71
230970|NCT01142596|560145|P1|COMPLETED|Overall Study||15
230971|NCT01142596|560144|P2|STARTED|Overall Study||157
230972|NCT01142596|560145|P1|STARTED|Overall Study||44
230973|NCT01142466|560197|P2|NOT COMPLETED|Overall Study||2
230974|NCT01142466|560198|P1|NOT COMPLETED|Overall Study||3
230975|NCT01142466|560197|P2|COMPLETED|Overall Study||13
230976|NCT01142466|560198|P1|COMPLETED|Overall Study||12
230977|NCT01142466|560197|P2|STARTED|Overall Study||15
230978|NCT01142466|560198|P1|STARTED|Overall Study||15
230979|NCT01142388|560218|P2|NOT COMPLETED|Overall Study||47
230980|NCT01142388|560219|P1|NOT COMPLETED|Overall Study||47
230981|NCT01142388|560218|P2|COMPLETED|Overall Study||0
230982|NCT01142388|560219|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|0
230983|NCT01142388|560218|P2|Treated|Overall Study||44
230984|NCT01142388|560219|P1|Treated|Overall Study||40
230985|NCT01142388|560218|P2|Eligible|Overall Study||44
230986|NCT01142388|560219|P1|Eligible|Overall Study||43
230987|NCT01142388|560218|P2|STARTED|Overall Study||47
230988|NCT01142388|560219|P1|STARTED|Overall Study||47
230989|NCT01142336|560231|P2|NOT COMPLETED|Overall Study||2
230990|NCT01142336|560232|P1|NOT COMPLETED|Overall Study||1
230991|NCT01142336|560231|P2|COMPLETED|Overall Study||21
230992|NCT01142336|560232|P1|COMPLETED|Overall Study||25
230993|NCT01142336|560231|P2|STARTED|Overall Study||23
230994|NCT01142336|560232|P1|STARTED|Overall Study||26
230995|NCT01142323|560242|P1|NOT COMPLETED|Overall Study||0
230996|NCT01142323|560242|P1|COMPLETED|Overall Study||8
230997|NCT01142323|560242|P1|STARTED|Overall Study||8
230998|NCT01142310|560250|P2|NOT COMPLETED|Overall Study||12
230999|NCT01142310|560251|P1|NOT COMPLETED|Overall Study||9
231000|NCT01142310|560250|P2|COMPLETED|Overall Study||16
231001|NCT01142310|560251|P1|COMPLETED|Overall Study||17
231002|NCT01142310|560250|P2|STARTED|Overall Study||28
231003|NCT01142310|560251|P1|STARTED|Overall Study||26
231004|NCT01142297|560257|P1|NOT COMPLETED|Overall Study||6
231005|NCT01142297|560257|P1|COMPLETED|Overall Study||18
231006|NCT01142297|560257|P1|STARTED|Overall Study||24
231007|NCT01142232|560269|P5|NOT COMPLETED|Overall Study||34
231008|NCT01142232|560270|P4|NOT COMPLETED|Overall Study||5
231009|NCT01142232|560271|P3|NOT COMPLETED|Overall Study||3
231010|NCT01142232|560272|P2|NOT COMPLETED|Overall Study||4
231011|NCT01142232|560273|P1|NOT COMPLETED|Overall Study||3
231012|NCT01142232|560269|P5|COMPLETED|Overall Study||10
231013|NCT01142232|560270|P4|COMPLETED|Overall Study||1
231014|NCT01142232|560271|P3|COMPLETED|Overall Study||0
231015|NCT01142232|560272|P2|COMPLETED|Overall Study||0
231016|NCT01142232|560273|P1|COMPLETED|Overall Study||0
231017|NCT01142232|560269|P5|STARTED|Overall Study||44
231018|NCT01142232|560270|P4|STARTED|Overall Study||6
231019|NCT01142232|560271|P3|STARTED|Overall Study||3
231020|NCT01142232|560272|P2|STARTED|Overall Study||4
231021|NCT01142232|560273|P1|STARTED|Overall Study||3
231022|NCT01142193|560288|P2|NOT COMPLETED|Overall Study||11
231023|NCT01142193|560289|P1|NOT COMPLETED|Overall Study||21
231024|NCT01142193|560288|P2|COMPLETED|Overall Study||114
231025|NCT01142193|560289|P1|COMPLETED|Overall Study||103
231026|NCT01142193|560288|P2|STARTED|Overall Study||125
231027|NCT01142193|560289|P1|STARTED|Overall Study||124
231028|NCT01142128|560317|P1|NOT COMPLETED|Overall Study||4
231029|NCT01142128|560317|P1|COMPLETED|Overall Study||4
231030|NCT01142128|560317|P1|Viokase 16 Plus Placebo to Nexium|Overall Study||0
231031|NCT01142128|560317|P1|Viokase 16 Plus Nexium|Overall Study||2
231032|NCT01142128|560317|P1|Placebo to Nexium, Alone|Overall Study||3
231033|NCT01142128|560317|P1|Nexium Alone|Overall Study||3
231034|NCT01142128|560317|P1|STARTED|Overall Study||8
231035|NCT01142115|560327|P2|NOT COMPLETED|Second Intervention||0
231036|NCT01142115|560328|P1|NOT COMPLETED|Second Intervention||0
231037|NCT01142115|560327|P2|COMPLETED|Second Intervention||19
231038|NCT01142115|560328|P1|COMPLETED|Second Intervention||19
231039|NCT01142115|560327|P2|STARTED|Second Intervention||19
231040|NCT01142115|560328|P1|STARTED|Second Intervention||19
231041|NCT01142115|560327|P2|NOT COMPLETED|First Intervention||1
231042|NCT01142115|560328|P1|NOT COMPLETED|First Intervention||2
231043|NCT01142115|560327|P2|COMPLETED|First Intervention||19
231044|NCT01142115|560328|P1|COMPLETED|First Intervention||19
231045|NCT01142115|560327|P2|STARTED|First Intervention||20
231046|NCT01142115|560328|P1|STARTED|First Intervention||21
231047|NCT01142089|560345|P2|NOT COMPLETED|Overall Study||21
231048|NCT01142089|560346|P1|NOT COMPLETED|Overall Study||12
231049|NCT01142089|560345|P2|COMPLETED|Overall Study||178
231050|NCT01142089|560346|P1|COMPLETED|Overall Study||53
231051|NCT01142089|560345|P2|STARTED|Overall Study||199
231052|NCT01142089|560346|P1|STARTED|Overall Study||65
231053|NCT01141907|560356|P2|NOT COMPLETED|Overall Study||0
231054|NCT01141907|560357|P1|NOT COMPLETED|Overall Study||0
231055|NCT01141907|560356|P2|COMPLETED|Overall Study||5
231056|NCT01141907|560357|P1|COMPLETED|Overall Study||6
231057|NCT01141907|560356|P2|STARTED|Overall Study||5
231058|NCT01141907|560357|P1|STARTED|Overall Study||6
231059|NCT01141725|560363|P3|NOT COMPLETED|Overall Study||0
231060|NCT01141725|560364|P2|NOT COMPLETED|Overall Study||0
231061|NCT01141725|560365|P1|NOT COMPLETED|Overall Study||0
231062|NCT01141725|560363|P3|COMPLETED|Overall Study||3
231063|NCT01141725|560364|P2|COMPLETED|Overall Study||33
231064|NCT01141725|560365|P1|COMPLETED|Overall Study||3
231065|NCT01141725|560363|P3|STARTED|Overall Study||3
231066|NCT01141725|560364|P2|STARTED|Overall Study||33
231067|NCT01141725|560365|P1|STARTED|Overall Study||3
231068|NCT01141712|560377|P1|NOT COMPLETED|Overall Study||3
231069|NCT01141712|560377|P1|COMPLETED|Overall Study||40
231070|NCT01141712|560377|P1|STARTED|Overall Study||43
231071|NCT01141660|560398|P2|NOT COMPLETED|Overall Study||12
231072|NCT01141660|560399|P1|NOT COMPLETED|Overall Study||0
231073|NCT01141660|560398|P2|COMPLETED|Overall Study||48
231074|NCT01141660|560399|P1|COMPLETED|Overall Study||71
231075|NCT01141660|560398|P2|STARTED|Overall Study||60
231076|NCT01141660|560399|P1|STARTED|Overall Study||71
231077|NCT01141647|560407|P1|NOT COMPLETED|Overall Study||46
231078|NCT01141647|560407|P1|COMPLETED|Overall Study||167
231079|NCT01141647|560407|P1|STARTED|Overall Study||213
231080|NCT01141608|560422|P2|NOT COMPLETED|Overall Study||0
231081|NCT01141608|560423|P1|NOT COMPLETED|Overall Study||0
231082|NCT01141608|560422|P2|COMPLETED|Overall Study||150
231083|NCT01141608|560423|P1|COMPLETED|Overall Study||152
231084|NCT01141608|560422|P2|STARTED|Overall Study||150
231085|NCT01141608|560423|P1|STARTED|Overall Study||152
231086|NCT01141595|560429|P1|NOT COMPLETED|Overall Study||2
231087|NCT01141595|560429|P1|COMPLETED|Overall Study||8
231088|NCT01141595|560429|P1|STARTED|Overall Study||10
231089|NCT01141569|560433|P1|NOT COMPLETED|Overall Study||0
231090|NCT01141569|560433|P1|COMPLETED|Overall Study||12
231091|NCT01141569|560433|P1|STARTED|Overall Study||12
231092|NCT01141491|560444|P2|NOT COMPLETED|Overall Study||47
231093|NCT01141491|560445|P1|NOT COMPLETED|Overall Study||48
231094|NCT01141491|560444|P2|COMPLETED|Overall Study||21
231095|NCT01141491|560445|P1|COMPLETED|Overall Study||20
231096|NCT01141491|560444|P2|STARTED|Overall Study||68
231097|NCT01141491|560445|P1|STARTED|Overall Study||68
231098|NCT01141374|560454|P3|NOT COMPLETED|Overall Study||0
231099|NCT01141374|560455|P2|NOT COMPLETED|Overall Study||0
231100|NCT01141374|560456|P1|NOT COMPLETED|Overall Study||0
231101|NCT01141374|560454|P3|COMPLETED|Overall Study||22
231102|NCT01141374|560455|P2|COMPLETED|Overall Study||27
231103|NCT01141374|560456|P1|COMPLETED|Overall Study||26
231104|NCT01141374|560454|P3|STARTED|Overall Study||22
231105|NCT01141374|560455|P2|STARTED|Overall Study||27
231106|NCT01141374|560456|P1|STARTED|Overall Study||26
231107|NCT01141283|560467|P1|NOT COMPLETED|Overall Study||88
231108|NCT01141283|560467|P1|COMPLETED|Overall Study||202
231109|NCT01141283|560467|P1|STARTED|Overall Study||290
231110|NCT01141205|560473|P2|NOT COMPLETED|Overall Study||2
231111|NCT01141205|560474|P1|NOT COMPLETED|Overall Study||3
231112|NCT01141205|560473|P2|COMPLETED|Overall Study||3
231113|NCT01141205|560474|P1|COMPLETED|Overall Study||15
231114|NCT01141205|560473|P2|STARTED|Overall Study||5
231115|NCT01141205|560474|P1|STARTED|Overall Study||18
231116|NCT01141049|560488|P2|NOT COMPLETED|Overall Study||8
231117|NCT01141049|560489|P1|NOT COMPLETED|Overall Study||5
231118|NCT01141049|560488|P2|COMPLETED|Overall Study||13
231119|NCT01141049|560489|P1|COMPLETED|Overall Study||14
231120|NCT01141049|560488|P2|STARTED|Overall Study||21
231121|NCT01141049|560489|P1|STARTED|Overall Study||19
231122|NCT01140906|560501|P4|NOT COMPLETED|Overall Study||16
231123|NCT01140906|560502|P3|NOT COMPLETED|Overall Study||26
231124|NCT01140906|560503|P2|NOT COMPLETED|Overall Study||34
231125|NCT01140906|560504|P1|NOT COMPLETED|Overall Study||25
231126|NCT01140906|560501|P4|COMPLETED|Overall Study||131
231127|NCT01140906|560502|P3|COMPLETED|Overall Study||125
231128|NCT01140906|560503|P2|COMPLETED|Overall Study||117
231129|NCT01140906|560504|P1|COMPLETED|Overall Study||133
231130|NCT01140906|560501|P4|STARTED|Overall Study||147
231131|NCT01140906|560502|P3|STARTED|Overall Study||151
231132|NCT01140906|560503|P2|STARTED|Overall Study||151
231133|NCT01140906|560504|P1|STARTED|Overall Study||158
231134|NCT01140880|560544|P2|NOT COMPLETED|Overall Study||44
231135|NCT01140880|560545|P1|NOT COMPLETED|Overall Study||14
231136|NCT01140880|560544|P2|COMPLETED|Overall Study||56
231137|NCT01140880|560545|P1|COMPLETED|Overall Study||56
231138|NCT01140880|560544|P2|STARTED|Overall Study||100
231139|NCT01140880|560545|P1|STARTED|Overall Study||70
231140|NCT01140867|560557|P1|NOT COMPLETED|Overall Study||33
231141|NCT01140867|560557|P1|COMPLETED|Overall Study||88
231142|NCT01140867|560557|P1|STARTED|Overall Study||121
231143|NCT01140815|560566|P2|NOT COMPLETED|Overall Study||0
231144|NCT01140815|560567|P1|NOT COMPLETED|Overall Study||0
231145|NCT01140815|560566|P2|COMPLETED|Overall Study||25
231146|NCT01140815|560567|P1|COMPLETED|Overall Study||25
231147|NCT01140815|560566|P2|STARTED|Overall Study||25
231148|NCT01140815|560567|P1|STARTED|Overall Study||25
231149|NCT01140646|560597|P1|NOT COMPLETED|Overall Study||9
231150|NCT01140646|560597|P1|COMPLETED|Overall Study||34
231151|NCT01140646|560597|P1|STARTED|Overall Study||43
231152|NCT01140503|560605|P1|NOT COMPLETED|Overall Study||1
231153|NCT01140503|560605|P1|COMPLETED|Overall Study||4
231154|NCT01140503|560605|P1|STARTED|Overall Study||5
231155|NCT01140477|560613|P2|NOT COMPLETED|Overall Study||6
231156|NCT01140477|560614|P1|NOT COMPLETED|Overall Study||8
231157|NCT01140477|560613|P2|COMPLETED|Overall Study||70
231158|NCT01140477|560614|P1|COMPLETED|Overall Study||145
231159|NCT01140477|560613|P2|STARTED|Overall Study||76
231160|NCT01140477|560614|P1|STARTED|Overall Study||153
231161|NCT01140360|560623|P1|NOT COMPLETED|Overall Study||6
231162|NCT01140360|560623|P1|COMPLETED|Overall Study||15
231163|NCT01140360|560623|P1|STARTED|Overall Study||21
231164|NCT01140347|560629|P2|NOT COMPLETED|Overall Study||14
231165|NCT01140347|560630|P1|NOT COMPLETED|Overall Study||18
231166|NCT01140347|560629|P2|COMPLETED|Overall Study||268
231167|NCT01140347|560630|P1|COMPLETED|Overall Study||265
231168|NCT01140347|560629|P2|Received at Least 1 Dose of Study Drug|Overall Study||276
231169|NCT01140347|560630|P1|Received at Least 1 Dose of Study Drug|Overall Study||277
231170|NCT01140347|560629|P2|STARTED|Overall Study||282
231171|NCT01140347|560630|P1|STARTED|Overall Study||283
231172|NCT01140295|560655|P2|NOT COMPLETED|Overall Study||2
231173|NCT01140295|560656|P1|NOT COMPLETED|Overall Study||1
231174|NCT01140295|560655|P2|COMPLETED|Overall Study||14
231175|NCT01140295|560656|P1|COMPLETED|Overall Study||16
231176|NCT01140295|560655|P2|STARTED|Overall Study||16
231177|NCT01140295|560656|P1|STARTED|Overall Study||17
231178|NCT01140191|560664|P1|NOT COMPLETED|Overall Study||0
231179|NCT01140191|560664|P1|COMPLETED|Overall Study||1
231180|NCT01140191|560664|P1|STARTED|Overall Study||1
231181|NCT01140061|560683|P10|NOT COMPLETED|Extension||1
231182|NCT01140061|560684|P9|NOT COMPLETED|Extension||0
231183|NCT01140061|560685|P8|NOT COMPLETED|Extension||0
231184|NCT01140061|560686|P7|NOT COMPLETED|Extension||0
231185|NCT01140061|560687|P6|NOT COMPLETED|Extension||0
231186|NCT01140061|560688|P5|NOT COMPLETED|Extension||0
231187|NCT01140061|560689|P4|NOT COMPLETED|Extension||0
231188|NCT01140061|560690|P3|NOT COMPLETED|Extension||0
231189|NCT01140061|560691|P2|NOT COMPLETED|Extension||0
231190|NCT01140061|560692|P1|NOT COMPLETED|Extension||0
231191|NCT01140061|560683|P10|COMPLETED|Extension||1
231192|NCT01140061|560684|P9|COMPLETED|Extension||7
231193|NCT01140061|560685|P8|COMPLETED|Extension||0
231194|NCT01140061|560686|P7|COMPLETED|Extension||0
231195|NCT01140061|560687|P6|COMPLETED|Extension||0
231196|NCT01140061|560688|P5|COMPLETED|Extension||0
231197|NCT01140061|560689|P4|COMPLETED|Extension||0
231198|NCT01140061|560690|P3|COMPLETED|Extension||0
231199|NCT01140061|560691|P2|COMPLETED|Extension||0
231200|NCT01140061|560692|P1|COMPLETED|Extension||0
231201|NCT01140061|560683|P10|STARTED|Extension||2
231202|NCT01140061|560684|P9|STARTED|Extension||7
231203|NCT01140061|560685|P8|STARTED|Extension||0
231204|NCT01140061|560686|P7|STARTED|Extension||0
231205|NCT01140061|560687|P6|STARTED|Extension||0
231206|NCT01140061|560688|P5|STARTED|Extension||0
231207|NCT01140061|560689|P4|STARTED|Extension||0
231208|NCT01140061|560690|P3|STARTED|Extension||0
231209|NCT01140061|560691|P2|STARTED|Extension||0
231210|NCT01140061|560692|P1|STARTED|Extension||0
231211|NCT01140061|560683|P10|NOT COMPLETED|Part III||0
231212|NCT01140061|560684|P9|NOT COMPLETED|Part III||0
231213|NCT01140061|560685|P8|NOT COMPLETED|Part III||0
231214|NCT01140061|560686|P7|NOT COMPLETED|Part III||0
231215|NCT01140061|560687|P6|NOT COMPLETED|Part III||0
231216|NCT01140061|560688|P5|NOT COMPLETED|Part III||0
231217|NCT01140061|560689|P4|NOT COMPLETED|Part III||0
231218|NCT01140061|560690|P3|NOT COMPLETED|Part III||0
231219|NCT01140061|560691|P2|NOT COMPLETED|Part III||0
231220|NCT01140061|560692|P1|NOT COMPLETED|Part III||0
231221|NCT01140061|560683|P10|COMPLETED|Part III||2
231222|NCT01140061|560684|P9|COMPLETED|Part III||7
231223|NCT01140061|560685|P8|COMPLETED|Part III||0
231224|NCT01140061|560686|P7|COMPLETED|Part III||0
231225|NCT01140061|560687|P6|COMPLETED|Part III||0
231226|NCT01140061|560688|P5|COMPLETED|Part III||0
231227|NCT01140061|560689|P4|COMPLETED|Part III||0
231228|NCT01140061|560690|P3|COMPLETED|Part III||0
231229|NCT01140061|560691|P2|COMPLETED|Part III||0
231230|NCT01140061|560692|P1|COMPLETED|Part III||0
231231|NCT01140061|560683|P10|STARTED|Part III|Includes 1 replacement participant|2
231232|NCT01140061|560684|P9|STARTED|Part III||7
231233|NCT01140061|560685|P8|STARTED|Part III||0
231234|NCT01140061|560686|P7|STARTED|Part III||0
231235|NCT01140061|560687|P6|STARTED|Part III||0
231236|NCT01140061|560688|P5|STARTED|Part III||0
231237|NCT01140061|560689|P4|STARTED|Part III||0
231238|NCT01140061|560690|P3|STARTED|Part III||0
231239|NCT01140061|560691|P2|STARTED|Part III||0
231240|NCT01140061|560692|P1|STARTED|Part III||0
231241|NCT01140061|560683|P10|NOT COMPLETED|Part II||0
231242|NCT01140061|560684|P9|NOT COMPLETED|Part II||0
231243|NCT01140061|560685|P8|NOT COMPLETED|Part II||0
231244|NCT01140061|560686|P7|NOT COMPLETED|Part II||0
231245|NCT01140061|560687|P6|NOT COMPLETED|Part II||0
231246|NCT01140061|560688|P5|NOT COMPLETED|Part II||0
231247|NCT01140061|560689|P4|NOT COMPLETED|Part II||0
231248|NCT01140061|560690|P3|NOT COMPLETED|Part II||0
231249|NCT01140061|560691|P2|NOT COMPLETED|Part II||0
231250|NCT01140061|560692|P1|NOT COMPLETED|Part II||0
231251|NCT01140061|560683|P10|COMPLETED|Part II||0
231252|NCT01140061|560684|P9|COMPLETED|Part II||0
231253|NCT01140061|560685|P8|COMPLETED|Part II||2
231254|NCT01140061|560686|P7|COMPLETED|Part II||6
231255|NCT01140061|560687|P6|COMPLETED|Part II||2
231256|NCT01140061|560688|P5|COMPLETED|Part II||6
231257|NCT01140061|560689|P4|COMPLETED|Part II||2
231258|NCT01140061|560690|P3|COMPLETED|Part II||6
231259|NCT01140061|560691|P2|COMPLETED|Part II||0
231260|NCT01140061|560692|P1|COMPLETED|Part II||0
231261|NCT01140061|560683|P10|STARTED|Part II||0
231262|NCT01140061|560684|P9|STARTED|Part II||0
231263|NCT01140061|560685|P8|STARTED|Part II||2
231264|NCT01140061|560686|P7|STARTED|Part II||6
231265|NCT01140061|560687|P6|STARTED|Part II||2
231266|NCT01140061|560688|P5|STARTED|Part II||6
231267|NCT01140061|560689|P4|STARTED|Part II||2
231268|NCT01140061|560690|P3|STARTED|Part II||6
231269|NCT01140061|560691|P2|STARTED|Part II||0
231270|NCT01140061|560692|P1|STARTED|Part II||0
231271|NCT01140061|560683|P10|NOT COMPLETED|Part I||0
231272|NCT01140061|560684|P9|NOT COMPLETED|Part I||0
231273|NCT01140061|560685|P8|NOT COMPLETED|Part I||0
231274|NCT01140061|560686|P7|NOT COMPLETED|Part I||0
231275|NCT01140061|560687|P6|NOT COMPLETED|Part I||0
231276|NCT01140061|560688|P5|NOT COMPLETED|Part I||0
231277|NCT01140061|560689|P4|NOT COMPLETED|Part I||0
231278|NCT01140061|560690|P3|NOT COMPLETED|Part I||0
231279|NCT01140061|560691|P2|NOT COMPLETED|Part I||0
231280|NCT01140061|560692|P1|NOT COMPLETED|Part I||1
231281|NCT01140061|560683|P10|COMPLETED|Part I||0
231282|NCT01140061|560684|P9|COMPLETED|Part I||0
231283|NCT01140061|560685|P8|COMPLETED|Part I||0
231284|NCT01140061|560686|P7|COMPLETED|Part I||0
231285|NCT01140061|560687|P6|COMPLETED|Part I||0
231286|NCT01140061|560688|P5|COMPLETED|Part I||0
231287|NCT01140061|560689|P4|COMPLETED|Part I||0
231288|NCT01140061|560690|P3|COMPLETED|Part I||0
231289|NCT01140061|560691|P2|COMPLETED|Part I||2
231290|NCT01140061|560692|P1|COMPLETED|Part I||6
231291|NCT01140061|560683|P10|STARTED|Part I||0
231292|NCT01140061|560684|P9|STARTED|Part I||0
231293|NCT01140061|560685|P8|STARTED|Part I||0
231294|NCT01140061|560686|P7|STARTED|Part I||0
231295|NCT01140061|560687|P6|STARTED|Part I||0
231296|NCT01140061|560688|P5|STARTED|Part I||0
231297|NCT01140061|560689|P4|STARTED|Part I||0
231298|NCT01140061|560690|P3|STARTED|Part I||0
231299|NCT01140061|560691|P2|STARTED|Part I||2
231300|NCT01140061|560692|P1|STARTED|Part I|Includes 1 replacement participant|7
231301|NCT01140048|560719|P1|NOT COMPLETED|Overall Study||45
231302|NCT01140048|560719|P1|COMPLETED|Overall Study||298
231303|NCT01140048|560719|P1|STARTED|Overall Study||343
231304|NCT01139996|560727|P2|NOT COMPLETED|Overall Study||0
231305|NCT01139996|560728|P1|NOT COMPLETED|Overall Study||0
231306|NCT01139996|560727|P2|COMPLETED|Overall Study||11
231307|NCT01139996|560728|P1|COMPLETED|Overall Study||11
231308|NCT01139996|560727|P2|STARTED|Overall Study||11
231309|NCT01139996|560728|P1|STARTED|Overall Study||11
231310|NCT01139879|560734|P1|NOT COMPLETED|Overall Study||0
231311|NCT01139879|560734|P1|COMPLETED|Overall Study||10
231312|NCT01139879|560734|P1|STARTED|Overall Study||10
231313|NCT01139814|560740|P1|NOT COMPLETED|Overall Study||0
231314|NCT01139814|560740|P1|COMPLETED|Overall Study||181
231315|NCT01139814|560740|P1|STARTED|Overall Study||181
231316|NCT01139801|560747|P2|NOT COMPLETED|Overall Study||0
231317|NCT01139801|560748|P1|NOT COMPLETED|Overall Study||0
231318|NCT01139801|560747|P2|COMPLETED|Overall Study||25
231319|NCT01139801|560748|P1|COMPLETED|Overall Study||25
231320|NCT01139801|560747|P2|STARTED|Overall Study||25
231321|NCT01139801|560748|P1|STARTED|Overall Study||25
231322|NCT01139775|560759|P3|NOT COMPLETED|Overall Study||6
231323|NCT01139775|560760|P2|NOT COMPLETED|Overall Study||13
231324|NCT01139775|560761|P1|NOT COMPLETED|Overall Study||1
231325|NCT01139775|560759|P3|COMPLETED|Overall Study||17
231326|NCT01139775|560760|P2|COMPLETED|Overall Study||26
231327|NCT01139775|560761|P1|COMPLETED|Overall Study||13
231328|NCT01139775|560759|P3|Received at Least 1 Dose of Study Drug|Overall Study||22
231329|NCT01139775|560760|P2|Received at Least 1 Dose of Study Drug|Overall Study||39
231330|NCT01139775|560761|P1|Received at Least 1 Dose of Study Drug|Overall Study||14
231331|NCT01139775|560759|P3|STARTED|Overall Study||23
231332|NCT01139775|560760|P2|STARTED|Overall Study||39
231333|NCT01139775|560761|P1|STARTED|Overall Study||14
231334|NCT01139762|560793|P3|NOT COMPLETED|Double-Blind Randomized Active Treatment||64
231335|NCT01139762|560794|P2|NOT COMPLETED|Double-Blind Randomized Active Treatment||40
231336|NCT01139762|560795|P1|NOT COMPLETED|Double-Blind Randomized Active Treatment||0
231337|NCT01139762|560793|P3|COMPLETED|Double-Blind Randomized Active Treatment||286
231338|NCT01139762|560794|P2|COMPLETED|Double-Blind Randomized Active Treatment||306
231339|NCT01139762|560795|P1|COMPLETED|Double-Blind Randomized Active Treatment||0
231340|NCT01139762|560793|P3|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||350
231341|NCT01139762|560794|P2|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||345
231342|NCT01139762|560795|P1|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||0
231343|NCT01139762|560793|P3|STARTED|Double-Blind Randomized Active Treatment||350
231344|NCT01139762|560794|P2|STARTED|Double-Blind Randomized Active Treatment||346
231345|NCT01139762|560795|P1|STARTED|Double-Blind Randomized Active Treatment||0
231346|NCT01139762|560793|P3|NOT COMPLETED|Washout and Placebo Lead-In Period||0
231347|NCT01139762|560794|P2|NOT COMPLETED|Washout and Placebo Lead-In Period||0
231348|NCT01139762|560795|P1|NOT COMPLETED|Washout and Placebo Lead-In Period||374
231349|NCT01139762|560793|P3|COMPLETED|Washout and Placebo Lead-In Period||0
231350|NCT01139762|560794|P2|COMPLETED|Washout and Placebo Lead-In Period||0
231351|NCT01139762|560795|P1|COMPLETED|Washout and Placebo Lead-In Period||696
231352|NCT01139762|560793|P3|STARTED|Washout and Placebo Lead-In Period||0
231353|NCT01139762|560794|P2|STARTED|Washout and Placebo Lead-In Period||0
231354|NCT01139762|560795|P1|STARTED|Washout and Placebo Lead-In Period||1070
231355|NCT01139658|560830|P2|NOT COMPLETED|Overall Study||113
231356|NCT01139658|560831|P1|NOT COMPLETED|Overall Study||56
231357|NCT01139658|560830|P2|COMPLETED|Overall Study||816
231358|NCT01139658|560831|P1|COMPLETED|Overall Study||691
231359|NCT01139658|560830|P2|STARTED|Overall Study||929
231360|NCT01139658|560831|P1|STARTED|Overall Study||747
231361|NCT01139580|560869|P2|NOT COMPLETED|Overall Study||18
231362|NCT01139580|560870|P1|NOT COMPLETED|Overall Study||23
231363|NCT01139580|560869|P2|COMPLETED|Overall Study||164
231364|NCT01139580|560870|P1|COMPLETED|Overall Study||158
231365|NCT01139580|560869|P2|STARTED|Overall Study||182
231366|NCT01139580|560870|P1|STARTED|Overall Study||181
231367|NCT01139515|560886|P4|NOT COMPLETED|Fourth Intervention Period||0
231368|NCT01139515|560887|P3|NOT COMPLETED|Fourth Intervention Period||0
231369|NCT01139515|560888|P2|NOT COMPLETED|Fourth Intervention Period||0
231370|NCT01139515|560889|P1|NOT COMPLETED|Fourth Intervention Period||0
231371|NCT01139515|560886|P4|COMPLETED|Fourth Intervention Period||4
231372|NCT01139515|560887|P3|COMPLETED|Fourth Intervention Period||4
231373|NCT01139515|560888|P2|COMPLETED|Fourth Intervention Period||4
231374|NCT01139515|560889|P1|COMPLETED|Fourth Intervention Period||4
231375|NCT01139515|560886|P4|STARTED|Fourth Intervention Period||4
231376|NCT01139515|560887|P3|STARTED|Fourth Intervention Period||4
231377|NCT01139515|560888|P2|STARTED|Fourth Intervention Period||4
231378|NCT01139515|560889|P1|STARTED|Fourth Intervention Period||4
231379|NCT01139515|560886|P4|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
231380|NCT01139515|560887|P3|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
231381|NCT01139515|560888|P2|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
231382|NCT01139515|560889|P1|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
231383|NCT01139515|560886|P4|COMPLETED|Washout Period 3 (46 Hrs)||4
231384|NCT01139515|560887|P3|COMPLETED|Washout Period 3 (46 Hrs)||4
231385|NCT01139515|560888|P2|COMPLETED|Washout Period 3 (46 Hrs)||4
231386|NCT01139515|560889|P1|COMPLETED|Washout Period 3 (46 Hrs)||4
231387|NCT01139515|560886|P4|STARTED|Washout Period 3 (46 Hrs)||4
231388|NCT01139515|560887|P3|STARTED|Washout Period 3 (46 Hrs)||4
231389|NCT01139515|560888|P2|STARTED|Washout Period 3 (46 Hrs)||4
231390|NCT01139515|560889|P1|STARTED|Washout Period 3 (46 Hrs)||4
231391|NCT01139515|560886|P4|NOT COMPLETED|Third Intervention Period||0
231392|NCT01139515|560887|P3|NOT COMPLETED|Third Intervention Period||0
231393|NCT01139515|560888|P2|NOT COMPLETED|Third Intervention Period||0
231394|NCT01139515|560889|P1|NOT COMPLETED|Third Intervention Period||0
231395|NCT01139515|560886|P4|COMPLETED|Third Intervention Period||4
231396|NCT01139515|560887|P3|COMPLETED|Third Intervention Period||4
231397|NCT01139515|560888|P2|COMPLETED|Third Intervention Period||4
231398|NCT01139515|560889|P1|COMPLETED|Third Intervention Period||4
231399|NCT01139515|560886|P4|STARTED|Third Intervention Period||4
231400|NCT01139515|560887|P3|STARTED|Third Intervention Period||4
231401|NCT01139515|560888|P2|STARTED|Third Intervention Period||4
231402|NCT01139515|560889|P1|STARTED|Third Intervention Period||4
231403|NCT01139515|560886|P4|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
231404|NCT01139515|560887|P3|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
231405|NCT01139515|560888|P2|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
231406|NCT01139515|560889|P1|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
231407|NCT01139515|560886|P4|COMPLETED|Washout Period 2 (46 Hrs)||4
231408|NCT01139515|560887|P3|COMPLETED|Washout Period 2 (46 Hrs)||4
231409|NCT01139515|560888|P2|COMPLETED|Washout Period 2 (46 Hrs)||4
231410|NCT01139515|560889|P1|COMPLETED|Washout Period 2 (46 Hrs)||4
231411|NCT01139515|560886|P4|STARTED|Washout Period 2 (46 Hrs)||4
231412|NCT01139515|560887|P3|STARTED|Washout Period 2 (46 Hrs)||4
231413|NCT01139515|560888|P2|STARTED|Washout Period 2 (46 Hrs)||4
231414|NCT01139515|560889|P1|STARTED|Washout Period 2 (46 Hrs)||4
231415|NCT01139515|560886|P4|NOT COMPLETED|Second Intervention Period||0
231416|NCT01139515|560887|P3|NOT COMPLETED|Second Intervention Period||0
231417|NCT01139515|560888|P2|NOT COMPLETED|Second Intervention Period||0
231418|NCT01139515|560889|P1|NOT COMPLETED|Second Intervention Period||0
231419|NCT01139515|560886|P4|COMPLETED|Second Intervention Period||4
231420|NCT01139515|560887|P3|COMPLETED|Second Intervention Period||4
231421|NCT01139515|560888|P2|COMPLETED|Second Intervention Period||4
231422|NCT01139515|560889|P1|COMPLETED|Second Intervention Period||4
231423|NCT01139515|560886|P4|STARTED|Second Intervention Period||4
231424|NCT01139515|560887|P3|STARTED|Second Intervention Period||4
231425|NCT01139515|560888|P2|STARTED|Second Intervention Period||4
231426|NCT01139515|560889|P1|STARTED|Second Intervention Period||4
231427|NCT01139515|560886|P4|NOT COMPLETED|Washout Period I (46hrs)||0
231428|NCT01139515|560887|P3|NOT COMPLETED|Washout Period I (46hrs)||0
231429|NCT01139515|560888|P2|NOT COMPLETED|Washout Period I (46hrs)||0
231430|NCT01139515|560889|P1|NOT COMPLETED|Washout Period I (46hrs)||0
231431|NCT01139515|560886|P4|COMPLETED|Washout Period I (46hrs)||4
231432|NCT01139515|560887|P3|COMPLETED|Washout Period I (46hrs)||4
231433|NCT01139515|560888|P2|COMPLETED|Washout Period I (46hrs)||4
231434|NCT01139515|560889|P1|COMPLETED|Washout Period I (46hrs)||4
231435|NCT01139515|560886|P4|STARTED|Washout Period I (46hrs)||4
231436|NCT01139515|560887|P3|STARTED|Washout Period I (46hrs)||4
231437|NCT01139515|560888|P2|STARTED|Washout Period I (46hrs)||4
231438|NCT01139515|560889|P1|STARTED|Washout Period I (46hrs)||4
231439|NCT01139515|560886|P4|NOT COMPLETED|First Intervention Period||0
231440|NCT01139515|560887|P3|NOT COMPLETED|First Intervention Period||0
231441|NCT01139515|560888|P2|NOT COMPLETED|First Intervention Period||0
231442|NCT01139515|560889|P1|NOT COMPLETED|First Intervention Period||0
231443|NCT01139515|560886|P4|COMPLETED|First Intervention Period||4
231444|NCT01139515|560887|P3|COMPLETED|First Intervention Period||4
231445|NCT01139515|560888|P2|COMPLETED|First Intervention Period||4
231446|NCT01139515|560889|P1|COMPLETED|First Intervention Period||4
231447|NCT01139515|560886|P4|STARTED|First Intervention Period||4
231448|NCT01139515|560887|P3|STARTED|First Intervention Period||4
231449|NCT01139515|560888|P2|STARTED|First Intervention Period||4
231450|NCT01139515|560889|P1|STARTED|First Intervention Period||4
231451|NCT01139450|560918|P3|NOT COMPLETED|Overall Study||38
231452|NCT01139450|560919|P2|NOT COMPLETED|Overall Study||25
231453|NCT01139450|560920|P1|NOT COMPLETED|Overall Study||27
231454|NCT01139450|560918|P3|COMPLETED|Overall Study||262
231455|NCT01139450|560919|P2|COMPLETED|Overall Study||272
231456|NCT01139450|560920|P1|COMPLETED|Overall Study||275
231457|NCT01139450|560918|P3|STARTED|Overall Study||300
231458|NCT01139450|560919|P2|STARTED|Overall Study||297
231459|NCT01139450|560920|P1|STARTED|Overall Study||302
231460|NCT01139411|560930|P2|NOT COMPLETED|Overall Study||4
231461|NCT01139411|560931|P1|NOT COMPLETED|Overall Study||2
231462|NCT01139411|560930|P2|COMPLETED|Overall Study||19
231463|NCT01139411|560931|P1|COMPLETED|Overall Study||24
231464|NCT01139411|560930|P2|STARTED|Overall Study||23
231465|NCT01139411|560931|P1|STARTED|Overall Study||26
231466|NCT01139294|560951|P2|NOT COMPLETED|Overall Study||0
231467|NCT01139294|560952|P1|NOT COMPLETED|Overall Study||0
231468|NCT01139294|560951|P2|COMPLETED|Overall Study||0
231469|NCT01139294|560952|P1|COMPLETED|Overall Study||0
231470|NCT01139294|560951|P2|STARTED|Overall Study||0
231471|NCT01139294|560952|P1|STARTED|Overall Study||0
231472|NCT01139190|560962|P2|NOT COMPLETED|Overall Study||1
231473|NCT01139190|560963|P1|NOT COMPLETED|Overall Study||0
231474|NCT01139190|560962|P2|COMPLETED|Overall Study||38
231475|NCT01139190|560963|P1|COMPLETED|Overall Study||38
231476|NCT01139190|560962|P2|STARTED|Overall Study||39
231477|NCT01139190|560963|P1|STARTED|Overall Study||38
231478|NCT01139164|560972|P3|NOT COMPLETED|Overall Study||0
231479|NCT01139164|560973|P2|NOT COMPLETED|Overall Study||2
231480|NCT01139164|560974|P1|NOT COMPLETED|Overall Study||0
231481|NCT01139164|560972|P3|COMPLETED|Overall Study||7
231482|NCT01139164|560973|P2|COMPLETED|Overall Study||65
231483|NCT01139164|560974|P1|COMPLETED|Overall Study||4
231484|NCT01139164|560972|P3|STARTED|Overall Study||7
231485|NCT01139164|560973|P2|STARTED|Overall Study||67
231486|NCT01139164|560974|P1|STARTED|Overall Study||4
231487|NCT01139125|560988|P1|NOT COMPLETED|Overall Study||1
231488|NCT01139125|560988|P1|COMPLETED|Overall Study||2
231489|NCT01139125|560988|P1|STARTED|Overall Study||3
231490|NCT01139047|560992|P1|NOT COMPLETED|Overall Study||1
231491|NCT01139047|560992|P1|COMPLETED|Overall Study||76
231492|NCT01139047|560992|P1|STARTED|Overall Study||77
231493|NCT01139021|561007|P6|NOT COMPLETED|Overall Study||0
231494|NCT01139021|561008|P5|NOT COMPLETED|Overall Study||9
231495|NCT01139021|561009|P4|NOT COMPLETED|Overall Study||1
231496|NCT01139021|561010|P3|NOT COMPLETED|Overall Study||0
231497|NCT01139021|561011|P2|NOT COMPLETED|Overall Study||0
231498|NCT01139021|561012|P1|NOT COMPLETED|Overall Study||1
231499|NCT01139021|561007|P6|COMPLETED|Overall Study||1
231500|NCT01139021|561008|P5|COMPLETED|Overall Study||107
231501|NCT01139021|561009|P4|COMPLETED|Overall Study||18
231502|NCT01139021|561010|P3|COMPLETED|Overall Study||67
231503|NCT01139021|561011|P2|COMPLETED|Overall Study||153
231504|NCT01139021|561012|P1|COMPLETED|Overall Study||151
231505|NCT01139021|561007|P6|STARTED|Overall Study||1
231506|NCT01139021|561008|P5|STARTED|Overall Study||116
231507|NCT01139021|561009|P4|STARTED|Overall Study||19
231508|NCT01139021|561010|P3|STARTED|Overall Study||67
231509|NCT01139021|561011|P2|STARTED|Overall Study||153
231510|NCT01139021|561012|P1|STARTED|Overall Study||152
231511|NCT01139008|561048|P1|NOT COMPLETED|Overall Study||6
231512|NCT01139008|561048|P1|COMPLETED|Overall Study||74
231513|NCT01139008|561048|P1|STARTED|Overall Study||80
231514|NCT01138995|561059|P2|NOT COMPLETED|Overall Study||25
231515|NCT01138995|561060|P1|NOT COMPLETED|Overall Study||10
231516|NCT01138995|561059|P2|COMPLETED|Overall Study||74
231517|NCT01138995|561060|P1|COMPLETED|Overall Study||88
231518|NCT01138995|561059|P2|STARTED|Overall Study||99
231519|NCT01138995|561060|P1|STARTED|Overall Study||98
231520|NCT01138969|561072|P2|NOT COMPLETED|Overall Study||0
231521|NCT01138969|561073|P1|NOT COMPLETED|Overall Study||0
231522|NCT01138969|561072|P2|COMPLETED|Overall Study||82
231523|NCT01138969|561073|P1|COMPLETED|Overall Study||83
231524|NCT01138969|561072|P2|STARTED|Overall Study||82
231525|NCT01138969|561073|P1|STARTED|Overall Study||83
231526|NCT01138917|561081|P1|NOT COMPLETED|Overall Study||24
231527|NCT01138917|561081|P1|COMPLETED|Overall Study||77
231528|NCT01138917|561081|P1|STARTED|Overall Study||101
231529|NCT01138826|561095|P6|NOT COMPLETED|Third Intervention Period||0
231530|NCT01138826|561096|P5|NOT COMPLETED|Third Intervention Period||0
231531|NCT01138826|561097|P4|NOT COMPLETED|Third Intervention Period||0
231532|NCT01138826|561098|P3|NOT COMPLETED|Third Intervention Period||0
231533|NCT01138826|561099|P2|NOT COMPLETED|Third Intervention Period||0
231534|NCT01138826|561100|P1|NOT COMPLETED|Third Intervention Period||0
231535|NCT01138826|561095|P6|COMPLETED|Third Intervention Period||3
231536|NCT01138826|561096|P5|COMPLETED|Third Intervention Period||2
231537|NCT01138826|561097|P4|COMPLETED|Third Intervention Period||3
231538|NCT01138826|561098|P3|COMPLETED|Third Intervention Period||3
231539|NCT01138826|561099|P2|COMPLETED|Third Intervention Period||2
231540|NCT01138826|561100|P1|COMPLETED|Third Intervention Period||2
231541|NCT01138826|561095|P6|STARTED|Third Intervention Period||3
231542|NCT01138826|561096|P5|STARTED|Third Intervention Period||2
231543|NCT01138826|561097|P4|STARTED|Third Intervention Period||3
231544|NCT01138826|561098|P3|STARTED|Third Intervention Period||3
231545|NCT01138826|561099|P2|STARTED|Third Intervention Period||2
231546|NCT01138826|561100|P1|STARTED|Third Intervention Period||2
231547|NCT01138826|561095|P6|NOT COMPLETED|Washout Period II (of 16 Days)||0
231548|NCT01138826|561096|P5|NOT COMPLETED|Washout Period II (of 16 Days)||0
231549|NCT01138826|561097|P4|NOT COMPLETED|Washout Period II (of 16 Days)||0
231550|NCT01138826|561098|P3|NOT COMPLETED|Washout Period II (of 16 Days)||0
231551|NCT01138826|561099|P2|NOT COMPLETED|Washout Period II (of 16 Days)||0
231552|NCT01138826|561100|P1|NOT COMPLETED|Washout Period II (of 16 Days)||0
231553|NCT01138826|561095|P6|COMPLETED|Washout Period II (of 16 Days)||3
231554|NCT01138826|561096|P5|COMPLETED|Washout Period II (of 16 Days)||2
231555|NCT01138826|561097|P4|COMPLETED|Washout Period II (of 16 Days)||3
231556|NCT01138826|561098|P3|COMPLETED|Washout Period II (of 16 Days)||3
231557|NCT01138826|561099|P2|COMPLETED|Washout Period II (of 16 Days)||2
231558|NCT01138826|561100|P1|COMPLETED|Washout Period II (of 16 Days)||2
231559|NCT01138826|561095|P6|STARTED|Washout Period II (of 16 Days)||3
231560|NCT01138826|561096|P5|STARTED|Washout Period II (of 16 Days)||2
231561|NCT01138826|561097|P4|STARTED|Washout Period II (of 16 Days)||3
231562|NCT01138826|561098|P3|STARTED|Washout Period II (of 16 Days)||3
231563|NCT01138826|561099|P2|STARTED|Washout Period II (of 16 Days)||2
231564|NCT01138826|561100|P1|STARTED|Washout Period II (of 16 Days)||2
231565|NCT01138826|561095|P6|NOT COMPLETED|Second Intervention Period||0
231566|NCT01138826|561096|P5|NOT COMPLETED|Second Intervention Period||0
231567|NCT01138826|561097|P4|NOT COMPLETED|Second Intervention Period||0
231568|NCT01138826|561098|P3|NOT COMPLETED|Second Intervention Period||0
231569|NCT01138826|561099|P2|NOT COMPLETED|Second Intervention Period||0
231570|NCT01138826|561100|P1|NOT COMPLETED|Second Intervention Period||0
231571|NCT01138826|561095|P6|COMPLETED|Second Intervention Period||3
231572|NCT01138826|561096|P5|COMPLETED|Second Intervention Period||2
231573|NCT01138826|561097|P4|COMPLETED|Second Intervention Period||3
231574|NCT01138826|561098|P3|COMPLETED|Second Intervention Period||3
231575|NCT01138826|561099|P2|COMPLETED|Second Intervention Period||2
231576|NCT01138826|561100|P1|COMPLETED|Second Intervention Period||2
231577|NCT01138826|561095|P6|STARTED|Second Intervention Period||3
231578|NCT01138826|561096|P5|STARTED|Second Intervention Period||2
231579|NCT01138826|561097|P4|STARTED|Second Intervention Period||3
231580|NCT01138826|561098|P3|STARTED|Second Intervention Period||3
231581|NCT01138826|561099|P2|STARTED|Second Intervention Period||2
231582|NCT01138826|561100|P1|STARTED|Second Intervention Period||2
231583|NCT01138826|561095|P6|NOT COMPLETED|Washout Period I (of 16 Days)||0
231584|NCT01138826|561096|P5|NOT COMPLETED|Washout Period I (of 16 Days)||1
231585|NCT01138826|561097|P4|NOT COMPLETED|Washout Period I (of 16 Days)||0
231586|NCT01138826|561098|P3|NOT COMPLETED|Washout Period I (of 16 Days)||0
231587|NCT01138826|561099|P2|NOT COMPLETED|Washout Period I (of 16 Days)||1
231588|NCT01138826|561100|P1|NOT COMPLETED|Washout Period I (of 16 Days)||1
231589|NCT01138826|561095|P6|COMPLETED|Washout Period I (of 16 Days)||3
231590|NCT01138826|561096|P5|COMPLETED|Washout Period I (of 16 Days)||2
231591|NCT01138826|561097|P4|COMPLETED|Washout Period I (of 16 Days)||3
231592|NCT01138826|561098|P3|COMPLETED|Washout Period I (of 16 Days)||3
231593|NCT01138826|561099|P2|COMPLETED|Washout Period I (of 16 Days)||2
231594|NCT01138826|561100|P1|COMPLETED|Washout Period I (of 16 Days)||2
231595|NCT01138826|561095|P6|STARTED|Washout Period I (of 16 Days)||3
231596|NCT01138826|561096|P5|STARTED|Washout Period I (of 16 Days)||3
231597|NCT01138826|561097|P4|STARTED|Washout Period I (of 16 Days)||3
231598|NCT01138826|561098|P3|STARTED|Washout Period I (of 16 Days)||3
231599|NCT01138826|561099|P2|STARTED|Washout Period I (of 16 Days)||3
231600|NCT01138826|561100|P1|STARTED|Washout Period I (of 16 Days)||3
231601|NCT01138826|561095|P6|NOT COMPLETED|First Intervention Period||0
231602|NCT01138826|561096|P5|NOT COMPLETED|First Intervention Period||0
231603|NCT01138826|561097|P4|NOT COMPLETED|First Intervention Period||0
231604|NCT01138826|561098|P3|NOT COMPLETED|First Intervention Period||0
231605|NCT01138826|561099|P2|NOT COMPLETED|First Intervention Period||0
231606|NCT01138826|561100|P1|NOT COMPLETED|First Intervention Period||0
231607|NCT01138826|561095|P6|COMPLETED|First Intervention Period||3
231608|NCT01138826|561096|P5|COMPLETED|First Intervention Period||3
231609|NCT01138826|561097|P4|COMPLETED|First Intervention Period||3
231610|NCT01138826|561098|P3|COMPLETED|First Intervention Period||3
231611|NCT01138826|561099|P2|COMPLETED|First Intervention Period||3
231612|NCT01138826|561100|P1|COMPLETED|First Intervention Period||3
231613|NCT01138826|561095|P6|STARTED|First Intervention Period||3
231614|NCT01138826|561096|P5|STARTED|First Intervention Period||3
231615|NCT01138826|561097|P4|STARTED|First Intervention Period||3
231616|NCT01138826|561098|P3|STARTED|First Intervention Period||3
231617|NCT01138826|561099|P2|STARTED|First Intervention Period||3
231618|NCT01138826|561100|P1|STARTED|First Intervention Period||3
231619|NCT01138735|561122|P2|NOT COMPLETED|Overall Study||17
231620|NCT01138735|561123|P1|NOT COMPLETED|Overall Study||8
231621|NCT01138735|561122|P2|COMPLETED|Overall Study||126
231622|NCT01138735|561123|P1|COMPLETED|Overall Study||134
231623|NCT01138735|561122|P2|STARTED|Overall Study||143
231624|NCT01138735|561123|P1|STARTED|Overall Study||142
231625|NCT01138657|561137|P2|NOT COMPLETED|Overall Study||18
231626|NCT01138657|561138|P1|NOT COMPLETED|Overall Study||8
231627|NCT01138657|561137|P2|COMPLETED|Overall Study||101
231628|NCT01138657|561138|P1|COMPLETED|Overall Study||112
231629|NCT01138657|561137|P2|Enrolled in Japan Sub-study|Overall Study||8
231630|NCT01138657|561138|P1|Enrolled in Japan Sub-study|Overall Study||8
231631|NCT01138657|561137|P2|Enrolled in Main Study|Overall Study||111
231632|NCT01138657|561138|P1|Enrolled in Main Study|Overall Study||112
231633|NCT01138657|561137|P2|STARTED|Overall Study||119
231634|NCT01138657|561138|P1|STARTED|Overall Study||120
231635|NCT01138514|561185|P3|NOT COMPLETED|Overall Study||93
231636|NCT01138514|561186|P2|NOT COMPLETED|Overall Study||53
231637|NCT01138514|561187|P1|NOT COMPLETED|Overall Study||48
231638|NCT01138514|561185|P3|COMPLETED|Overall Study||424
231639|NCT01138514|561186|P2|COMPLETED|Overall Study||463
231640|NCT01138514|561187|P1|COMPLETED|Overall Study||474
231641|NCT01138514|561185|P3|STARTED|Overall Study||517
231642|NCT01138514|561186|P2|STARTED|Overall Study||516
231643|NCT01138514|561187|P1|STARTED|Overall Study||522
231644|NCT01138501|561201|P1|NOT COMPLETED|Overall Study||5
231645|NCT01138501|561201|P1|COMPLETED|Overall Study||60
231646|NCT01138501|561201|P1|Exposed|Overall Study||63
231647|NCT01138501|561201|P1|STARTED|Overall Study|Two subjects withdrew consent after being enrolled but before receiving any trial product.|65
231648|NCT01138475|561209|P3|NOT COMPLETED|Overall Study||0
231649|NCT01138475|561210|P2|NOT COMPLETED|Overall Study||0
231650|NCT01138475|561211|P1|NOT COMPLETED|Overall Study||0
231651|NCT01138475|561209|P3|COMPLETED|Overall Study||17
231652|NCT01138475|561210|P2|COMPLETED|Overall Study||16
231653|NCT01138475|561211|P1|COMPLETED|Overall Study||16
231654|NCT01138475|561209|P3|STARTED|Overall Study||17
231655|NCT01138475|561210|P2|STARTED|Overall Study||16
231656|NCT01138475|561211|P1|STARTED|Overall Study||16
231657|NCT01138150|561245|P2|NOT COMPLETED|Overall Study||1
231658|NCT01138150|561246|P1|NOT COMPLETED|Overall Study||1
231659|NCT01138150|561245|P2|COMPLETED|Overall Study||17
231660|NCT01138150|561246|P1|COMPLETED|Overall Study||17
231661|NCT01138150|561245|P2|STARTED|Overall Study||18
231662|NCT01138150|561246|P1|STARTED|Overall Study||18
231663|NCT01138124|561302|P4|NOT COMPLETED|Overall Study||0
231664|NCT01138124|561303|P3|NOT COMPLETED|Overall Study||0
231665|NCT01138124|561304|P2|NOT COMPLETED|Overall Study||0
231666|NCT01138124|561305|P1|NOT COMPLETED|Overall Study||0
231667|NCT01138124|561302|P4|COMPLETED|Overall Study||19046
231668|NCT01138124|561303|P3|COMPLETED|Overall Study||1981
231669|NCT01138124|561304|P2|COMPLETED|Overall Study||30026
231670|NCT01138124|561305|P1|COMPLETED|Overall Study||3149
231671|NCT01138124|561302|P4|STARTED|Overall Study||19046
231672|NCT01138124|561303|P3|STARTED|Overall Study||1981
231673|NCT01138124|561304|P2|STARTED|Overall Study||30026
231674|NCT01138124|561305|P1|STARTED|Overall Study||3149
231675|NCT01138111|561327|P1|NOT COMPLETED|Overall Study||9
231676|NCT01138111|561327|P1|COMPLETED|Overall Study||36
231677|NCT01138111|561327|P1|STARTED|Overall Study||45
231678|NCT01138098|561358|P2|NOT COMPLETED|Overall Study||0
231679|NCT01138098|561359|P1|NOT COMPLETED|Overall Study||0
231680|NCT01138098|561358|P2|COMPLETED|Overall Study||90
231681|NCT01138098|561359|P1|COMPLETED|Overall Study||95
231682|NCT01138098|561358|P2|STARTED|Overall Study||90
231683|NCT01138098|561359|P1|STARTED|Overall Study||95
231684|NCT01138046|561381|P1|NOT COMPLETED|Overall Study||6
231685|NCT01138046|561381|P1|COMPLETED|Overall Study||6
231686|NCT01138046|561381|P1|STARTED|Overall Study||12
231687|NCT01138007|561401|P3|NOT COMPLETED|Overall Study||48
231688|NCT01138007|561402|P2|NOT COMPLETED|Overall Study||30
231689|NCT01138007|561403|P1|NOT COMPLETED|Overall Study||22
231690|NCT01138007|561401|P3|COMPLETED|Overall Study||144
231691|NCT01138007|561402|P2|COMPLETED|Overall Study||160
231692|NCT01138007|561403|P1|COMPLETED|Overall Study||165
231693|NCT01138007|561401|P3|STARTED|Overall Study||192
231694|NCT01138007|561402|P2|STARTED|Overall Study||190
231695|NCT01138007|561403|P1|STARTED|Overall Study||187
231696|NCT01137890|561437|P2|NOT COMPLETED|Overall Study||3
231697|NCT01137890|561438|P1|NOT COMPLETED|Overall Study||6
231698|NCT01137890|561437|P2|COMPLETED|Overall Study||2
231699|NCT01137890|561438|P1|COMPLETED|Overall Study||8
231700|NCT01137890|561437|P2|STARTED|Overall Study||5
231701|NCT01137890|561438|P1|STARTED|Overall Study||14
231702|NCT01137812|561510|P2|NOT COMPLETED|Overall Study||168
231703|NCT01137812|561511|P1|NOT COMPLETED|Overall Study||123
231704|NCT01137812|561510|P2|COMPLETED|Overall Study||210
231705|NCT01137812|561511|P1|COMPLETED|Overall Study||254
231706|NCT01137812|561510|P2|STARTED|Overall Study||378
231707|NCT01137812|561511|P1|STARTED|Overall Study||377
231708|NCT01137786|561531|P2|NOT COMPLETED|Overall Study||3
231709|NCT01137786|561532|P1|NOT COMPLETED|Overall Study||1
231710|NCT01137786|561531|P2|COMPLETED|Overall Study||21
231711|NCT01137786|561532|P1|COMPLETED|Overall Study||24
231712|NCT01137786|561531|P2|STARTED|Overall Study||24
231713|NCT01137786|561532|P1|STARTED|Overall Study||25
231714|NCT01137773|561542|P2|NOT COMPLETED|Overall Study||3
231715|NCT01137773|561543|P1|NOT COMPLETED|Overall Study||9
231716|NCT01137773|561542|P2|COMPLETED|Overall Study||20
231717|NCT01137773|561543|P1|COMPLETED|Overall Study||24
231718|NCT01137773|561542|P2|STARTED|Overall Study||23
231719|NCT01137773|561543|P1|STARTED|Overall Study||33
231720|NCT01137682|561554|P3|NOT COMPLETED|Overall Study||34
231721|NCT01137682|561555|P2|NOT COMPLETED|Overall Study||40
231722|NCT01137682|561556|P1|NOT COMPLETED|Overall Study||37
231723|NCT01137682|561554|P3|COMPLETED|Overall Study||34
231724|NCT01137682|561555|P2|COMPLETED|Overall Study||25
231725|NCT01137682|561556|P1|COMPLETED|Overall Study||28
231726|NCT01137682|561554|P3|Safety Set - Extension|Overall Study|1 patient did not receive study treatment|62
231727|NCT01137682|561555|P2|Safety Set - Extension|Overall Study||54
231728|NCT01137682|561556|P1|Safety Set - Extension|Overall Study||57
231729|NCT01137682|561554|P3|Safety Set - CORE|Overall Study|2 patients never received drug.|66
231730|NCT01137682|561555|P2|Safety Set - CORE|Overall Study|2 patients never received drug. 1 patient had no post baseline safety assement.|62
231731|NCT01137682|561556|P1|Safety Set - CORE|Overall Study|2 patients never received drug.|63
231732|NCT01137682|561554|P3|Continuing Into Extension|Overall Study||63
231733|NCT01137682|561555|P2|Continuing Into Extension|Overall Study||54
231734|NCT01137682|561556|P1|Continuing Into Extension|Overall Study||57
231735|NCT01137682|561554|P3|Not Continuing Into Extension|Overall Study||2
231736|NCT01137682|561555|P2|Not Continuing Into Extension|Overall Study||3
231737|NCT01137682|561556|P1|Not Continuing Into Extension|Overall Study||2
231738|NCT01137682|561554|P3|Completed 24-Week Core Phase|Overall Study||65
231739|NCT01137682|561555|P2|Completed 24-Week Core Phase|Overall Study||57
231740|NCT01137682|561556|P1|Completed 24-Week Core Phase|Overall Study||59
231741|NCT01137682|561554|P3|Treated|Overall Study||67
231742|NCT01137682|561555|P2|Treated|Overall Study||63
231743|NCT01137682|561556|P1|Treated|Overall Study||63
231744|NCT01137682|561554|P3|Not Treated|Overall Study||1
231745|NCT01137682|561555|P2|Not Treated|Overall Study||2
231746|NCT01137682|561556|P1|Not Treated|Overall Study||2
231747|NCT01137682|561554|P3|STARTED|Overall Study||68
231748|NCT01137682|561555|P2|STARTED|Overall Study||65
231749|NCT01137682|561556|P1|STARTED|Overall Study||65
231750|NCT01137604|561606|P4|NOT COMPLETED|Overall Study||11
231751|NCT01137604|561607|P3|NOT COMPLETED|Overall Study||13
231752|NCT01137604|561608|P2|NOT COMPLETED|Overall Study||10
231753|NCT01137604|561609|P1|NOT COMPLETED|Overall Study||2
231754|NCT01137604|561606|P4|COMPLETED|Overall Study||21
231755|NCT01137604|561607|P3|COMPLETED|Overall Study||26
231756|NCT01137604|561608|P2|COMPLETED|Overall Study||32
231757|NCT01137604|561609|P1|COMPLETED|Overall Study|Participants with disease progression and treatment ongoing at data cutoff (19 Mar 2013)|36
231758|NCT01137604|561606|P4|Treatment Ongoing at Data Cutoff|Overall Study||0
231759|NCT01137604|561607|P3|Treatment Ongoing at Data Cutoff|Overall Study||1
231760|NCT01137604|561608|P2|Treatment Ongoing at Data Cutoff|Overall Study||3
231761|NCT01137604|561609|P1|Treatment Ongoing at Data Cutoff|Overall Study||2
231762|NCT01137604|561606|P4|Disease Progression|Overall Study||21
231763|NCT01137604|561607|P3|Disease Progression|Overall Study||25
231764|NCT01137604|561608|P2|Disease Progression|Overall Study||29
231765|NCT01137604|561609|P1|Disease Progression|Overall Study||34
231766|NCT01137604|561606|P4|STARTED|Overall Study||32
231767|NCT01137604|561607|P3|STARTED|Overall Study||39
231768|NCT01137604|561608|P2|STARTED|Overall Study||42
231769|NCT01137604|561609|P1|STARTED|Overall Study|39 participants were randomized but 1 participant died prior to receiving treatment.|38
231770|NCT01137578|561643|P3|NOT COMPLETED|Overall Study||6
231771|NCT01137578|561644|P2|NOT COMPLETED|Overall Study||2
231772|NCT01137578|561645|P1|NOT COMPLETED|Overall Study||16
231773|NCT01137578|561643|P3|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|37
231774|NCT01137578|561644|P2|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|12
231775|NCT01137578|561645|P1|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|61
231776|NCT01137578|561643|P3|STARTED|Overall Study||43
231777|NCT01137578|561644|P2|STARTED|Overall Study||14
231778|NCT01137578|561645|P1|STARTED|Overall Study||77
231779|NCT01137539|561685|P1|NOT COMPLETED|Overall Study||0
231780|NCT01137539|561685|P1|COMPLETED|Overall Study||50
231781|NCT01137539|561685|P1|STARTED|Overall Study||50
231782|NCT01137474|561694|P4|NOT COMPLETED|Overall Study||21
231783|NCT01137474|561695|P3|NOT COMPLETED|Overall Study||7
231784|NCT01137474|561696|P2|NOT COMPLETED|Overall Study||12
231785|NCT01137474|561697|P1|NOT COMPLETED|Overall Study||24
231786|NCT01137474|561694|P4|COMPLETED|Overall Study||281
231787|NCT01137474|561695|P3|COMPLETED|Overall Study||158
231788|NCT01137474|561696|P2|COMPLETED|Overall Study||154
231789|NCT01137474|561697|P1|COMPLETED|Overall Study||287
231790|NCT01137474|561694|P4|Received Treatment|Overall Study||302
231791|NCT01137474|561695|P3|Received Treatment|Overall Study||165
231792|NCT01137474|561696|P2|Received Treatment|Overall Study||166
231793|NCT01137474|561697|P1|Received Treatment|Overall Study||311
231794|NCT01137474|561694|P4|STARTED|Overall Study||302
231795|NCT01137474|561695|P3|STARTED|Overall Study||165
231796|NCT01137474|561696|P2|STARTED|Overall Study||166
231797|NCT01137474|561697|P1|STARTED|Overall Study||311
231798|NCT01137435|561715|P1|NOT COMPLETED|Overall Study||28
231799|NCT01137435|561715|P1|COMPLETED|Overall Study||659
231800|NCT01137435|561715|P1|STARTED|Overall Study||687
231801|NCT01137396|561724|P2|NOT COMPLETED|Overall Study||2
231802|NCT01137396|561725|P1|NOT COMPLETED|Overall Study||8
231803|NCT01137396|561724|P2|COMPLETED|Overall Study||25
231804|NCT01137396|561725|P1|COMPLETED|Overall Study||22
231805|NCT01137396|561724|P2|STARTED|Overall Study||27
231806|NCT01137396|561725|P1|STARTED|Overall Study||30
231807|NCT01137370|561735|P2|NOT COMPLETED|Overall Study||0
231808|NCT01137370|561736|P1|NOT COMPLETED|Overall Study||0
231809|NCT01137370|561735|P2|COMPLETED|Overall Study||87
231810|NCT01137370|561736|P1|COMPLETED|Overall Study||116
231811|NCT01137370|561735|P2|STARTED|Overall Study||87
231812|NCT01137370|561736|P1|STARTED|Overall Study||116
231813|NCT01137292|561742|P1|NOT COMPLETED|Overall Study||54
231814|NCT01137292|561742|P1|COMPLETED|Overall Study||123
231815|NCT01137292|561742|P1|STARTED|Overall Study||177
231816|NCT01137110|561751|P2|NOT COMPLETED|Overall Study||0
231817|NCT01137110|561752|P1|NOT COMPLETED|Overall Study||1
231818|NCT01137110|561751|P2|COMPLETED|Overall Study||49
231819|NCT01137110|561752|P1|COMPLETED|Overall Study||34
231820|NCT01137110|561751|P2|STARTED|Overall Study||49
231821|NCT01137110|561752|P1|STARTED|Overall Study||35
231822|NCT01137071|561758|P1|NOT COMPLETED|Overall Study||14
231823|NCT01137071|561758|P1|COMPLETED|Overall Study|Of the eligible patients|15
231824|NCT01137071|561758|P1|STARTED|Overall Study|all patients considered eligible were included on the study|29
231825|NCT01137032|561819|P1|NOT COMPLETED|Overall Study||0
231826|NCT01137032|561819|P1|COMPLETED|Overall Study||19
231827|NCT01137032|561819|P1|STARTED|Overall Study||19
231828|NCT01137006|561832|P7|NOT COMPLETED|Overall Study||0
231829|NCT01137006|561833|P6|NOT COMPLETED|Overall Study||0
231830|NCT01137006|561834|P5|NOT COMPLETED|Overall Study||0
231831|NCT01137006|561835|P4|NOT COMPLETED|Overall Study||0
231832|NCT01137006|561836|P3|NOT COMPLETED|Overall Study||0
231833|NCT01137006|561837|P2|NOT COMPLETED|Overall Study||0
231834|NCT01137006|561838|P1|NOT COMPLETED|Overall Study||0
231835|NCT01137006|561832|P7|COMPLETED|Overall Study||3
231836|NCT01137006|561833|P6|COMPLETED|Overall Study||4
231837|NCT01137006|561834|P5|COMPLETED|Overall Study||3
231838|NCT01137006|561835|P4|COMPLETED|Overall Study||3
231839|NCT01137006|561836|P3|COMPLETED|Overall Study||8
231840|NCT01137006|561837|P2|COMPLETED|Overall Study||3
231841|NCT01137006|561838|P1|COMPLETED|Overall Study||3
231842|NCT01137006|561832|P7|Completed at Least 1 Treatment Cycle|Overall Study||3
231843|NCT01137006|561833|P6|Completed at Least 1 Treatment Cycle|Overall Study||4
231844|NCT01137006|561834|P5|Completed at Least 1 Treatment Cycle|Overall Study||3
231845|NCT01137006|561835|P4|Completed at Least 1 Treatment Cycle|Overall Study||3
231846|NCT01137006|561836|P3|Completed at Least 1 Treatment Cycle|Overall Study||8
231847|NCT01137006|561837|P2|Completed at Least 1 Treatment Cycle|Overall Study||3
231848|NCT01137006|561838|P1|Completed at Least 1 Treatment Cycle|Overall Study||3
231849|NCT01137006|561832|P7|STARTED|Overall Study||3
231850|NCT01137006|561833|P6|STARTED|Overall Study||4
231851|NCT01137006|561834|P5|STARTED|Overall Study||3
231852|NCT01137006|561835|P4|STARTED|Overall Study||3
231853|NCT01137006|561836|P3|STARTED|Overall Study||8
231854|NCT01137006|561837|P2|STARTED|Overall Study||3
231855|NCT01137006|561838|P1|STARTED|Overall Study||3
231856|NCT01136967|561914|P2|NOT COMPLETED|Overall Study||27
231857|NCT01136967|561915|P1|NOT COMPLETED|Overall Study||24
231858|NCT01136967|561914|P2|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (15 April 2013)|62
231859|NCT01136967|561915|P1|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (18 January 2012)|69
231860|NCT01136967|561914|P2|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (15 April 2013)|6
231861|NCT01136967|561915|P1|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (18 January 2012)|14
231862|NCT01136967|561914|P2|Disease Progression|Overall Study||56
231863|NCT01136967|561915|P1|Disease Progression|Overall Study||55
231864|NCT01136967|561914|P2|STARTED|Overall Study||89
231865|NCT01136967|561915|P1|STARTED|Overall Study||93
231866|NCT01136954|561937|P2|NOT COMPLETED|Overall Study||21
231867|NCT01136954|561938|P1|NOT COMPLETED|Overall Study||24
231868|NCT01136954|561937|P2|COMPLETED|Overall Study||51
231869|NCT01136954|561938|P1|COMPLETED|Overall Study||48
231870|NCT01136954|561937|P2|STARTED|Overall Study||72
231871|NCT01136954|561938|P1|STARTED|Overall Study||72
231872|NCT01136915|561952|P2|NOT COMPLETED|Overall Study||1
231873|NCT01136915|561953|P1|NOT COMPLETED|Overall Study||2
231874|NCT01136915|561952|P2|COMPLETED|Overall Study||6
231875|NCT01136915|561953|P1|COMPLETED|Overall Study||6
231876|NCT01136915|561952|P2|STARTED|Overall Study||7
231877|NCT01136915|561953|P1|STARTED|Overall Study||8
231878|NCT01136876|561963|P2|NOT COMPLETED|Overall Study||6
231879|NCT01136876|561964|P1|NOT COMPLETED|Overall Study||3
231880|NCT01136876|561963|P2|COMPLETED|Overall Study||23
231881|NCT01136876|561964|P1|COMPLETED|Overall Study||25
231882|NCT01136876|561963|P2|STARTED|Overall Study||29
231883|NCT01136876|561964|P1|STARTED|Overall Study||28
231884|NCT01136798|561974|P2|NOT COMPLETED|Overall Study||0
231885|NCT01136798|561975|P1|NOT COMPLETED|Overall Study||0
231886|NCT01136798|561974|P2|COMPLETED|Overall Study||8
231887|NCT01136798|561975|P1|COMPLETED|Overall Study||10
231888|NCT01136798|561974|P2|STARTED|Overall Study||8
231889|NCT01136798|561975|P1|STARTED|Overall Study||10
231890|NCT01136785|561993|P2|NOT COMPLETED|Overall Study||1
231891|NCT01136785|561994|P1|NOT COMPLETED|Overall Study||2
231892|NCT01136785|561993|P2|COMPLETED|Overall Study||6
231893|NCT01136785|561994|P1|COMPLETED|Overall Study||13
231894|NCT01136785|561993|P2|STARTED|Overall Study||7
231895|NCT01136785|561994|P1|STARTED|Overall Study||15
231896|NCT01136772|562009|P2|NOT COMPLETED|Overall Study||110
231897|NCT01136772|562010|P1|NOT COMPLETED|Overall Study||116
231898|NCT01136772|562009|P2|COMPLETED|Overall Study||44
231899|NCT01136772|562010|P1|COMPLETED|Overall Study||41
231900|NCT01136772|562009|P2|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
231901|NCT01136772|562010|P1|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
231902|NCT01136772|562009|P2|STARTED|Overall Study||154
231903|NCT01136772|562010|P1|STARTED|Overall Study||157
231904|NCT01136746|562020|P2|NOT COMPLETED|Overall Study||3
231905|NCT01136746|562021|P1|NOT COMPLETED|Overall Study||3
231906|NCT01136746|562020|P2|COMPLETED|Overall Study||4
231907|NCT01136746|562021|P1|COMPLETED|Overall Study||6
231908|NCT01136746|562020|P2|STARTED|Overall Study||7
231909|NCT01136746|562021|P1|STARTED|Overall Study||9
231910|NCT01136733|562088|P7|NOT COMPLETED|Phase 2||50
231911|NCT01136733|562089|P6|NOT COMPLETED|Phase 2||52
231912|NCT01136733|562090|P5|NOT COMPLETED|Phase 2||51
231913|NCT01136733|562091|P4|NOT COMPLETED|Phase 2||0
231914|NCT01136733|562092|P3|NOT COMPLETED|Phase 2||0
231915|NCT01136733|562093|P2|NOT COMPLETED|Phase 2||0
231916|NCT01136733|562094|P1|NOT COMPLETED|Phase 2||0
231917|NCT01136733|562088|P7|COMPLETED|Phase 2||0
231918|NCT01136733|562089|P6|COMPLETED|Phase 2||0
231919|NCT01136733|562090|P5|COMPLETED|Phase 2||0
231920|NCT01136733|562091|P4|COMPLETED|Phase 2||0
231921|NCT01136733|562092|P3|COMPLETED|Phase 2||0
231922|NCT01136733|562093|P2|COMPLETED|Phase 2||0
231923|NCT01136733|562094|P1|COMPLETED|Phase 2||0
231924|NCT01136733|562088|P7|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|50
231925|NCT01136733|562089|P6|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|52
231926|NCT01136733|562090|P5|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|51
231927|NCT01136733|562091|P4|STARTED|Phase 2||0
231928|NCT01136733|562092|P3|STARTED|Phase 2||0
231929|NCT01136733|562093|P2|STARTED|Phase 2||0
231930|NCT01136733|562094|P1|STARTED|Phase 2||0
231931|NCT01136733|562088|P7|NOT COMPLETED|Phase 1b||0
231932|NCT01136733|562089|P6|NOT COMPLETED|Phase 1b||0
231933|NCT01136733|562090|P5|NOT COMPLETED|Phase 1b||0
231934|NCT01136733|562091|P4|NOT COMPLETED|Phase 1b||0
231935|NCT01136733|562092|P3|NOT COMPLETED|Phase 1b||2
231936|NCT01136733|562093|P2|NOT COMPLETED|Phase 1b||5
231937|NCT01136733|562094|P1|NOT COMPLETED|Phase 1b||1
231938|NCT01136733|562088|P7|COMPLETED|Phase 1b||0
231939|NCT01136733|562089|P6|COMPLETED|Phase 1b||0
231940|NCT01136733|562090|P5|COMPLETED|Phase 1b||0
231941|NCT01136733|562091|P4|COMPLETED|Phase 1b||0
231942|NCT01136733|562092|P3|COMPLETED|Phase 1b||0
231943|NCT01136733|562093|P2|COMPLETED|Phase 1b||6
231944|NCT01136733|562094|P1|COMPLETED|Phase 1b||6
231945|NCT01136733|562088|P7|STARTED|Phase 1b||0
231946|NCT01136733|562089|P6|STARTED|Phase 1b||0
231947|NCT01136733|562090|P5|STARTED|Phase 1b||0
231948|NCT01136733|562091|P4|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|0
231949|NCT01136733|562092|P3|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|2
231950|NCT01136733|562093|P2|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|11
231951|NCT01136733|562094|P1|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|7
231952|NCT01136655|562177|P1|NOT COMPLETED|Washout After BUD 160/ Foradil (7 Days)||0
231953|NCT01136655|562177|P1|COMPLETED|Washout After BUD 160/ Foradil (7 Days)||50
231954|NCT01136655|562177|P1|STARTED|Washout After BUD 160/ Foradil (7 Days)||50
231955|NCT01136655|562177|P1|NOT COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||0
231956|NCT01136655|562177|P1|COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||50
231957|NCT01136655|562177|P1|STARTED|BUD 160/ Foradil 12.0 (1 Dose)||50
231958|NCT01136655|562177|P1|NOT COMPLETED|Washout After BUD 160 (7 Days)||0
231959|NCT01136655|562177|P1|COMPLETED|Washout After BUD 160 (7 Days)||51
231960|NCT01136655|562177|P1|STARTED|Washout After BUD 160 (7 Days)||51
231961|NCT01136655|562177|P1|NOT COMPLETED|BUD 160 (1 Dose)||0
231962|NCT01136655|562177|P1|COMPLETED|BUD 160 (1 Dose)||51
231963|NCT01136655|562177|P1|STARTED|BUD 160 (1 Dose)||51
231964|NCT01136655|562177|P1|NOT COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||2
231965|NCT01136655|562177|P1|COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||51
231966|NCT01136655|562177|P1|STARTED|Washout After BUD 160/FM 9.0 (7 Days)||53
231967|NCT01136655|562177|P1|NOT COMPLETED|BUD 160/FM 9.0 (1 Dose)||0
231968|NCT01136655|562177|P1|COMPLETED|BUD 160/FM 9.0 (1 Dose)||53
231969|NCT01136655|562177|P1|STARTED|BUD 160/FM 9.0 (1 Dose)||53
231970|NCT01136655|562177|P1|NOT COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||1
231971|NCT01136655|562177|P1|COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||52
231972|NCT01136655|562177|P1|STARTED|Washout After BUD 160/FM 4.5 (7 Days)||53
231973|NCT01136655|562177|P1|NOT COMPLETED|BUD 160/FM 4.5 (1 Dose)||0
231974|NCT01136655|562177|P1|COMPLETED|BUD 160/FM 4.5 (1 Dose)||53
231975|NCT01136655|562177|P1|STARTED|BUD 160/FM 4.5 (1 Dose)||53
231976|NCT01136655|562177|P1|NOT COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||1
231977|NCT01136655|562177|P1|COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||53
231978|NCT01136655|562177|P1|STARTED|Washout After BUD 160/FM 2.25 (7 Days)||54
231979|NCT01136655|562177|P1|NOT COMPLETED|BUD 160/FM 2.25 (1 Dose)||0
231980|NCT01136655|562177|P1|COMPLETED|BUD 160/FM 2.25 (1 Dose)||54
231981|NCT01136655|562177|P1|STARTED|BUD 160/FM 2.25 (1 Dose)||54
231982|NCT01136486|562203|P1|NOT COMPLETED|Overall Study||0
231983|NCT01136486|562203|P1|COMPLETED|Overall Study||56
231984|NCT01136486|562203|P1|STARTED|Overall Study||56
231985|NCT01136408|562210|P3|NOT COMPLETED|Overall Study||5
231986|NCT01136408|562211|P2|NOT COMPLETED|Overall Study||9
231987|NCT01136408|562212|P1|NOT COMPLETED|Overall Study||5
231988|NCT01136408|562210|P3|COMPLETED|Overall Study||57
231989|NCT01136408|562211|P2|COMPLETED|Overall Study||49
231990|NCT01136408|562212|P1|COMPLETED|Overall Study||41
231991|NCT01136408|562210|P3|STARTED|Overall Study||62
231992|NCT01136408|562211|P2|STARTED|Overall Study||58
231993|NCT01136408|562212|P1|STARTED|Overall Study||46
231994|NCT01136382|562269|P2|NOT COMPLETED|Overall Study||31
231995|NCT01136382|562270|P1|NOT COMPLETED|Overall Study||60
231996|NCT01136382|562269|P2|COMPLETED|Overall Study||121
231997|NCT01136382|562270|P1|COMPLETED|Overall Study||92
231998|NCT01136382|562269|P2|STARTED|Overall Study||152
231999|NCT01136382|562270|P1|STARTED|Overall Study||152
232000|NCT01136356|562296|P2|NOT COMPLETED|Second 18-day Withdrawal||1
232001|NCT01136356|562297|P1|NOT COMPLETED|Second 18-day Withdrawal||0
232002|NCT01136356|562296|P2|COMPLETED|Second 18-day Withdrawal||5
232003|NCT01136356|562297|P1|COMPLETED|Second 18-day Withdrawal||2
232004|NCT01136356|562296|P2|STARTED|Second 18-day Withdrawal||6
232005|NCT01136356|562297|P1|STARTED|Second 18-day Withdrawal||2
232006|NCT01136356|562296|P2|NOT COMPLETED|Second Intervention||0
232007|NCT01136356|562297|P1|NOT COMPLETED|Second Intervention||0
232008|NCT01136356|562296|P2|COMPLETED|Second Intervention||6
232009|NCT01136356|562297|P1|COMPLETED|Second Intervention||2
232010|NCT01136356|562296|P2|STARTED|Second Intervention||6
232011|NCT01136356|562297|P1|STARTED|Second Intervention||2
232012|NCT01136356|562296|P2|NOT COMPLETED|First 18-day Withdrawal||0
232013|NCT01136356|562297|P1|NOT COMPLETED|First 18-day Withdrawal||4
232014|NCT01136356|562296|P2|COMPLETED|First 18-day Withdrawal||6
232015|NCT01136356|562297|P1|COMPLETED|First 18-day Withdrawal||2
232016|NCT01136356|562296|P2|STARTED|First 18-day Withdrawal||6
232017|NCT01136356|562297|P1|STARTED|First 18-day Withdrawal||6
232018|NCT01136356|562296|P2|NOT COMPLETED|First Intervention||0
232019|NCT01136356|562297|P1|NOT COMPLETED|First Intervention||0
232020|NCT01136356|562296|P2|COMPLETED|First Intervention||6
232021|NCT01136356|562297|P1|COMPLETED|First Intervention||6
232022|NCT01136356|562296|P2|STARTED|First Intervention||6
232023|NCT01136356|562297|P1|STARTED|First Intervention||6
232024|NCT01136291|562308|P2|NOT COMPLETED|Overall Study||1
232025|NCT01136291|562309|P1|NOT COMPLETED|Overall Study||1
232026|NCT01136291|562308|P2|COMPLETED|Overall Study||41
232027|NCT01136291|562309|P1|COMPLETED|Overall Study||39
232028|NCT01136291|562308|P2|Follow|Overall Study||42
232029|NCT01136291|562309|P1|Follow|Overall Study||40
232030|NCT01136291|562308|P2|STARTED|Overall Study||42
232031|NCT01136291|562309|P1|STARTED|Overall Study||40
232032|NCT01136226|562319|P1|NOT COMPLETED|Overall Study||13
232033|NCT01136226|562319|P1|COMPLETED|Overall Study||29
232034|NCT01136226|562319|P1|STARTED|Overall Study||42
232035|NCT01136174|562328|P4|NOT COMPLETED|Overall Study||4
232036|NCT01136174|562329|P3|NOT COMPLETED|Overall Study||0
232037|NCT01136174|562330|P2|NOT COMPLETED|Overall Study||0
232038|NCT01136174|562331|P1|NOT COMPLETED|Overall Study||0
232039|NCT01136174|562328|P4|COMPLETED|Overall Study||20
232040|NCT01136174|562329|P3|COMPLETED|Overall Study||8
232041|NCT01136174|562330|P2|COMPLETED|Overall Study||6
232042|NCT01136174|562331|P1|COMPLETED|Overall Study||12
232043|NCT01136174|562328|P4|STARTED|Overall Study||24
232044|NCT01136174|562329|P3|STARTED|Overall Study||8
232045|NCT01136174|562330|P2|STARTED|Overall Study||6
232046|NCT01136174|562331|P1|STARTED|Overall Study||12
232047|NCT01135992|562411|P1|NOT COMPLETED|Overall Study||21
232048|NCT01135992|562411|P1|COMPLETED|Overall Study||122
232049|NCT01135992|562411|P1|Full Analysis Set|Overall Study||129
232050|NCT01135992|562411|P1|Exposed|Overall Study|One subject was withdrawn before being exposed.|142
232051|NCT01135992|562411|P1|STARTED|Overall Study||143
232052|NCT01135914|562423|P3|NOT COMPLETED|Overall Study||22
232053|NCT01135914|562424|P2|NOT COMPLETED|Overall Study||5
232054|NCT01135914|562425|P1|NOT COMPLETED|Overall Study||4
232055|NCT01135914|562423|P3|COMPLETED|Overall Study||59
232056|NCT01135914|562424|P2|COMPLETED|Overall Study||75
232057|NCT01135914|562425|P1|COMPLETED|Overall Study||74
232058|NCT01135914|562423|P3|Safety Population|Overall Study||74
232059|NCT01135914|562424|P2|Safety Population|Overall Study||75
232060|NCT01135914|562425|P1|Safety Population|Overall Study||73
232061|NCT01135914|562423|P3|Intent to Treat (ITT) Population|Overall Study||72
232062|NCT01135914|562424|P2|Intent to Treat (ITT) Population|Overall Study||75
232063|NCT01135914|562425|P1|Intent to Treat (ITT) Population|Overall Study||73
232064|NCT01135914|562423|P3|STARTED|Overall Study||81
232065|NCT01135914|562424|P2|STARTED|Overall Study||80
232066|NCT01135914|562425|P1|STARTED|Overall Study||78
232067|NCT01135537|562454|P1|NOT COMPLETED|Overall Study||13
232068|NCT01135537|562454|P1|COMPLETED|Overall Study||17
232069|NCT01135537|562454|P1|STARTED|Overall Study||30
232070|NCT01135524|562458|P1|NOT COMPLETED|Overall Study||196
232071|NCT01135524|562458|P1|COMPLETED|Overall Study||0
232072|NCT01135524|562458|P1|STARTED|Overall Study||196
232073|NCT01135511|562471|P9|NOT COMPLETED|Overall Study||1
232074|NCT01135511|562472|P8|NOT COMPLETED|Overall Study||1
232075|NCT01135511|562473|P7|NOT COMPLETED|Overall Study||1
232076|NCT01135511|562474|P6|NOT COMPLETED|Overall Study||1
232077|NCT01135511|562475|P5|NOT COMPLETED|Overall Study||1
232078|NCT01135511|562476|P4|NOT COMPLETED|Overall Study||3
232079|NCT01135511|562477|P3|NOT COMPLETED|Overall Study||8
232080|NCT01135511|562478|P2|NOT COMPLETED|Overall Study||3
232081|NCT01135511|562479|P1|NOT COMPLETED|Overall Study||0
232082|NCT01135511|562471|P9|COMPLETED|Overall Study||20
232083|NCT01135511|562472|P8|COMPLETED|Overall Study||20
232084|NCT01135511|562473|P7|COMPLETED|Overall Study||18
232085|NCT01135511|562474|P6|COMPLETED|Overall Study||20
232086|NCT01135511|562475|P5|COMPLETED|Overall Study||38
232087|NCT01135511|562476|P4|COMPLETED|Overall Study||37
232088|NCT01135511|562477|P3|COMPLETED|Overall Study||33
232089|NCT01135511|562478|P2|COMPLETED|Overall Study||39
232090|NCT01135511|562479|P1|COMPLETED|Overall Study||41
232091|NCT01135511|562471|P9|STARTED|Overall Study||21
232092|NCT01135511|562472|P8|STARTED|Overall Study||21
232093|NCT01135511|562473|P7|STARTED|Overall Study||19
232094|NCT01135511|562474|P6|STARTED|Overall Study||21
232095|NCT01135511|562475|P5|STARTED|Overall Study||39
232096|NCT01135511|562476|P4|STARTED|Overall Study||40
232097|NCT01135511|562477|P3|STARTED|Overall Study||41
232098|NCT01135511|562478|P2|STARTED|Overall Study||42
232099|NCT01135511|562479|P1|STARTED|Overall Study||41
232100|NCT01135498|562761|P1|NOT COMPLETED|Overall Study||90
232101|NCT01135498|562761|P1|COMPLETED|Overall Study||0
232102|NCT01135498|562761|P1|STARTED|Overall Study||90
232103|NCT01135420|562772|P2|NOT COMPLETED|Overall Study||32
232104|NCT01135420|562773|P1|NOT COMPLETED|Overall Study||44
232105|NCT01135420|562772|P2|COMPLETED|Overall Study||175
232106|NCT01135420|562773|P1|COMPLETED|Overall Study||155
232107|NCT01135420|562772|P2|STARTED|Overall Study||207
232108|NCT01135420|562773|P1|STARTED|Overall Study||199
232109|NCT01135381|562783|P4|NOT COMPLETED|Overall Study||1
232110|NCT01135381|562784|P3|NOT COMPLETED|Overall Study||4
232111|NCT01135381|562785|P2|NOT COMPLETED|Overall Study||7
232112|NCT01135381|562786|P1|NOT COMPLETED|Overall Study||21
232113|NCT01135381|562783|P4|COMPLETED|Overall Study||67
232114|NCT01135381|562784|P3|COMPLETED|Overall Study||65
232115|NCT01135381|562785|P2|COMPLETED|Overall Study||178
232116|NCT01135381|562786|P1|COMPLETED|Overall Study||168
232117|NCT01135381|562783|P4|STARTED|Overall Study||68
232118|NCT01135381|562784|P3|STARTED|Overall Study||69
232119|NCT01135381|562785|P2|STARTED|Overall Study||185
232120|NCT01135381|562786|P1|STARTED|Overall Study||189
232121|NCT01135368|562804|P1|NOT COMPLETED|Overall Study||251
232122|NCT01135368|562804|P1|COMPLETED|Overall Study||255
232123|NCT01135368|562804|P1|STARTED|Overall Study||506
232124|NCT01135329|562920|P1|NOT COMPLETED|Overall Study||0
232125|NCT01135329|562920|P1|COMPLETED|Overall Study||15
232126|NCT01135329|562920|P1|STARTED|Overall Study||15
232127|NCT01135186|562931|P1|NOT COMPLETED|Overall Study||0
232128|NCT01135186|562931|P1|COMPLETED|Overall Study||9
232129|NCT01135186|562931|P1|STARTED|Overall Study||9
232130|NCT01135134|562940|P2|NOT COMPLETED|Overall Study||1
232131|NCT01135134|562941|P1|NOT COMPLETED|Overall Study||2
232132|NCT01135134|562940|P2|COMPLETED|Overall Study||112
232133|NCT01135134|562941|P1|COMPLETED|Overall Study||218
232134|NCT01135134|562940|P2|STARTED|Overall Study||113
232135|NCT01135134|562941|P1|STARTED|Overall Study||220
232136|NCT01135069|562952|P3|NOT COMPLETED|Overall Study||10
232137|NCT01135069|562953|P2|NOT COMPLETED|Overall Study||32
232138|NCT01135069|562954|P1|NOT COMPLETED|Overall Study||36
232139|NCT01135069|562952|P3|COMPLETED|Overall Study||56
232140|NCT01135069|562953|P2|COMPLETED|Overall Study||177
232141|NCT01135069|562954|P1|COMPLETED|Overall Study||169
232142|NCT01135069|562952|P3|STARTED|Overall Study||66
232143|NCT01135069|562953|P2|STARTED|Overall Study||209
232144|NCT01135069|562954|P1|STARTED|Overall Study||205
232145|NCT01135017|562964|P2|NOT COMPLETED|Overall Study||12
232146|NCT01135017|562965|P1|NOT COMPLETED|Overall Study||6
232147|NCT01135017|562964|P2|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|45
232148|NCT01135017|562965|P1|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|49
232149|NCT01135017|562964|P2|Evaluable for Efficacy|Overall Study|Two participants did not have interrogation of the pacemaker after randomization|55
232150|NCT01135017|562965|P1|Evaluable for Efficacy|Overall Study||55
232151|NCT01135017|562964|P2|Treated|Overall Study||57
232152|NCT01135017|562965|P1|Treated|Overall Study||55
232153|NCT01135017|562964|P2|STARTED|Overall Study||57
232154|NCT01135017|562965|P1|STARTED|Overall Study||55
232155|NCT01134952|562981|P1|NOT COMPLETED|Overall Study||0
232156|NCT01134952|562981|P1|COMPLETED|Overall Study||11
232157|NCT01134952|562981|P1|STARTED|Overall Study||11
232158|NCT01134939|563003|P8|NOT COMPLETED|Overall Study||0
232159|NCT01134939|563004|P7|NOT COMPLETED|Overall Study||9
232160|NCT01134939|563005|P6|NOT COMPLETED|Overall Study||9
232161|NCT01134939|563006|P5|NOT COMPLETED|Overall Study||10
232162|NCT01134939|563007|P4|NOT COMPLETED|Overall Study||14
232163|NCT01134939|563008|P3|NOT COMPLETED|Overall Study||10
232164|NCT01134939|563009|P2|NOT COMPLETED|Overall Study||18
232165|NCT01134939|563010|P1|NOT COMPLETED|Overall Study||17
232166|NCT01134939|563003|P8|COMPLETED|Overall Study||1
232167|NCT01134939|563004|P7|COMPLETED|Overall Study||10
232168|NCT01134939|563005|P6|COMPLETED|Overall Study||5
232169|NCT01134939|563006|P5|COMPLETED|Overall Study||23
232170|NCT01134939|563007|P4|COMPLETED|Overall Study||32
232171|NCT01134939|563008|P3|COMPLETED|Overall Study||41
232172|NCT01134939|563009|P2|COMPLETED|Overall Study||24
232173|NCT01134939|563010|P1|COMPLETED|Overall Study||42
232174|NCT01134939|563003|P8|STARTED|Overall Study||1
232175|NCT01134939|563004|P7|STARTED|Overall Study||19
232176|NCT01134939|563005|P6|STARTED|Overall Study||14
232177|NCT01134939|563006|P5|STARTED|Overall Study||33
232178|NCT01134939|563007|P4|STARTED|Overall Study||46
232179|NCT01134939|563008|P3|STARTED|Overall Study||51
232180|NCT01134939|563009|P2|STARTED|Overall Study||42
232181|NCT01134939|563010|P1|STARTED|Overall Study||59
232182|NCT01134900|563122|P2|NOT COMPLETED|Overall Study||0
232183|NCT01134900|563123|P1|NOT COMPLETED|Overall Study||0
232184|NCT01134900|563122|P2|COMPLETED|Overall Study||196
232185|NCT01134900|563123|P1|COMPLETED|Overall Study||200
232186|NCT01134900|563122|P2|STARTED|Overall Study||196
232187|NCT01134900|563123|P1|STARTED|Overall Study||200
232188|NCT01134887|563135|P4|NOT COMPLETED|Overall Study||0
232189|NCT01134887|563136|P3|NOT COMPLETED|Overall Study||0
232190|NCT01134887|563137|P2|NOT COMPLETED|Overall Study||4
232191|NCT01134887|563138|P1|NOT COMPLETED|Overall Study||0
232192|NCT01134887|563135|P4|COMPLETED|Overall Study||5
232193|NCT01134887|563136|P3|COMPLETED|Overall Study||5
232194|NCT01134887|563137|P2|COMPLETED|Overall Study|Four patients in the Veteran-Control arm did not have two clinic visits videotaped and left study.|7
232195|NCT01134887|563138|P1|COMPLETED|Overall Study||9
232196|NCT01134887|563135|P4|STARTED|Overall Study||5
232197|NCT01134887|563136|P3|STARTED|Overall Study||5
232198|NCT01134887|563137|P2|STARTED|Overall Study||11
232199|NCT01134887|563138|P1|STARTED|Overall Study||9
232200|NCT01134783|563148|P2|NOT COMPLETED|Overall Study||37
232201|NCT01134783|563149|P1|NOT COMPLETED|Overall Study||36
232202|NCT01134783|563148|P2|COMPLETED|Overall Study||180
232203|NCT01134783|563149|P1|COMPLETED|Overall Study||188
232204|NCT01134783|563148|P2|STARTED|Overall Study||217
232205|NCT01134783|563149|P1|STARTED|Overall Study||224
232206|NCT01134731|563168|P3|NOT COMPLETED|Overall Study||8
232207|NCT01134731|563169|P2|NOT COMPLETED|Overall Study||11
232208|NCT01134731|563170|P1|NOT COMPLETED|Overall Study||13
232209|NCT01134731|563168|P3|COMPLETED|Overall Study||2
232210|NCT01134731|563169|P2|COMPLETED|Overall Study||10
232211|NCT01134731|563170|P1|COMPLETED|Overall Study||10
232212|NCT01134731|563168|P3|STARTED|Overall Study||10
232213|NCT01134731|563169|P2|STARTED|Overall Study||21
232214|NCT01134731|563170|P1|STARTED|Overall Study||23
232215|NCT01134705|563183|P2|NOT COMPLETED|Overall Study||22
232216|NCT01134705|563184|P1|NOT COMPLETED|Overall Study||15
232217|NCT01134705|563183|P2|COMPLETED|Overall Study||216
232218|NCT01134705|563184|P1|COMPLETED|Overall Study||221
232302|NCT01134393|563432|P1|NOT COMPLETED|Overall Study||52
232219|NCT01134705|563183|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|234
232220|NCT01134705|563184|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|232
232221|NCT01134705|563183|P2|STARTED|Overall Study||238
232222|NCT01134705|563184|P1|STARTED|Overall Study||236
232223|NCT01134627|563196|P2|NOT COMPLETED|Overall Study||67
232224|NCT01134627|563197|P1|NOT COMPLETED|Overall Study||69
232225|NCT01134627|563196|P2|COMPLETED|Overall Study||88
232226|NCT01134627|563197|P1|COMPLETED|Overall Study||80
232227|NCT01134627|563196|P2|STARTED|Overall Study|Number of participants treated.|155
232228|NCT01134627|563197|P1|STARTED|Overall Study|Number of participants treated.|149
232229|NCT01134614|563227|P2|NOT COMPLETED|Overall Study||122
232230|NCT01134614|563228|P1|NOT COMPLETED|Overall Study||123
232231|NCT01134614|563227|P2|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicities|0
232232|NCT01134614|563228|P1|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicity.|0
232233|NCT01134614|563227|P2|Treated and Toxicity Assessed|Overall Study||120
232234|NCT01134614|563228|P1|Treated and Toxicity Assessed|Overall Study||118
232235|NCT01134614|563227|P2|Treated|Overall Study||121
232236|NCT01134614|563228|P1|Treated|Overall Study||119
232237|NCT01134614|563227|P2|STARTED|Overall Study||122
232238|NCT01134614|563228|P1|STARTED|Overall Study||123
232239|NCT01134575|563241|P3|NOT COMPLETED|Overall Study||0
232240|NCT01134575|563242|P2|NOT COMPLETED|Overall Study||0
232241|NCT01134575|563243|P1|NOT COMPLETED|Overall Study||0
232242|NCT01134575|563241|P3|COMPLETED|Overall Study||42
232243|NCT01134575|563242|P2|COMPLETED|Overall Study||45
232244|NCT01134575|563243|P1|COMPLETED|Overall Study||3
232245|NCT01134575|563241|P3|STARTED|Overall Study||42
232246|NCT01134575|563242|P2|STARTED|Overall Study||45
232247|NCT01134575|563243|P1|STARTED|Overall Study||3
232248|NCT01134562|563256|P5|NOT COMPLETED|Overall Study||0
232249|NCT01134562|563257|P4|NOT COMPLETED|Overall Study||0
232250|NCT01134562|563258|P3|NOT COMPLETED|Overall Study||0
232251|NCT01134562|563259|P2|NOT COMPLETED|Overall Study||1
232252|NCT01134562|563260|P1|NOT COMPLETED|Overall Study||0
232253|NCT01134562|563256|P5|COMPLETED|Overall Study||8
232254|NCT01134562|563257|P4|COMPLETED|Overall Study||8
232255|NCT01134562|563258|P3|COMPLETED|Overall Study||4
232256|NCT01134562|563259|P2|COMPLETED|Overall Study||3
232257|NCT01134562|563260|P1|COMPLETED|Overall Study||4
232258|NCT01134562|563256|P5|STARTED|Overall Study||8
232259|NCT01134562|563257|P4|STARTED|Overall Study||8
232260|NCT01134562|563258|P3|STARTED|Overall Study||4
232261|NCT01134562|563259|P2|STARTED|Overall Study||4
232262|NCT01134562|563260|P1|STARTED|Overall Study||4
232263|NCT01134549|563329|P5|NOT COMPLETED|Overall Study||0
232264|NCT01134549|563330|P4|NOT COMPLETED|Overall Study||0
232265|NCT01134549|563331|P3|NOT COMPLETED|Overall Study||0
232266|NCT01134549|563332|P2|NOT COMPLETED|Overall Study||0
232267|NCT01134549|563333|P1|NOT COMPLETED|Overall Study||0
232268|NCT01134549|563329|P5|COMPLETED|Overall Study||6
232269|NCT01134549|563330|P4|COMPLETED|Overall Study||6
232270|NCT01134549|563331|P3|COMPLETED|Overall Study||6
232271|NCT01134549|563332|P2|COMPLETED|Overall Study||6
232272|NCT01134549|563333|P1|COMPLETED|Overall Study||8
232273|NCT01134549|563329|P5|STARTED|Overall Study||6
232274|NCT01134549|563330|P4|STARTED|Overall Study||6
232275|NCT01134549|563331|P3|STARTED|Overall Study||6
232276|NCT01134549|563332|P2|STARTED|Overall Study||6
232277|NCT01134549|563333|P1|STARTED|Overall Study||8
232278|NCT01134510|563419|P2|NOT COMPLETED|Overall Study||1
232279|NCT01134510|563420|P1|NOT COMPLETED|Overall Study||0
232280|NCT01134510|563419|P2|COMPLETED|Overall Study||9
232281|NCT01134510|563420|P1|COMPLETED|Overall Study||10
232282|NCT01134510|563419|P2|Month 3|Overall Study||9
232283|NCT01134510|563420|P1|Month 3|Overall Study||10
232284|NCT01134510|563419|P2|Month 1|Overall Study||10
232285|NCT01134510|563420|P1|Month 1|Overall Study||10
232286|NCT01134510|563419|P2|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
232287|NCT01134510|563420|P1|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
232288|NCT01134510|563419|P2|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
232289|NCT01134510|563420|P1|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
232290|NCT01134510|563419|P2|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
232291|NCT01134510|563420|P1|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
232292|NCT01134510|563419|P2|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
232293|NCT01134510|563420|P1|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
232294|NCT01134510|563419|P2|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
232295|NCT01134510|563420|P1|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
232296|NCT01134510|563419|P2|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
232297|NCT01134510|563420|P1|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
232298|NCT01134510|563419|P2|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
232299|NCT01134510|563420|P1|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
232300|NCT01134510|563419|P2|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
232301|NCT01134510|563420|P1|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
232303|NCT01134393|563432|P1|COMPLETED|Overall Study|Completed trial medication.|449
232304|NCT01134393|563432|P1|STARTED|Overall Study|Entered and treated.|501
232305|NCT01134328|563450|P4|NOT COMPLETED|Overall Study||4
232306|NCT01134328|563451|P3|NOT COMPLETED|Overall Study||3
232307|NCT01134328|563452|P2|NOT COMPLETED|Overall Study||3
232308|NCT01134328|563453|P1|NOT COMPLETED|Overall Study||2
232309|NCT01134328|563450|P4|COMPLETED|Overall Study||17
232310|NCT01134328|563451|P3|COMPLETED|Overall Study||17
232311|NCT01134328|563452|P2|COMPLETED|Overall Study||18
232312|NCT01134328|563453|P1|COMPLETED|Overall Study||19
232313|NCT01134328|563450|P4|STARTED|Overall Study||21
232314|NCT01134328|563451|P3|STARTED|Overall Study||20
232315|NCT01134328|563452|P2|STARTED|Overall Study||21
232316|NCT01134328|563453|P1|STARTED|Overall Study||21
232317|NCT01134315|563553|P2|NOT COMPLETED|Overall Study||19
232318|NCT01134315|563554|P1|NOT COMPLETED|Overall Study||9
232319|NCT01134315|563553|P2|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|21
232320|NCT01134315|563554|P1|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|12
232321|NCT01134315|563553|P2|STARTED|Overall Study||40
232322|NCT01134315|563554|P1|STARTED|Overall Study||21
232323|NCT01134276|563576|P2|NOT COMPLETED|Overall Study||0
232324|NCT01134276|563577|P1|NOT COMPLETED|Overall Study||0
232325|NCT01134276|563576|P2|COMPLETED|Overall Study||107
232326|NCT01134276|563577|P1|COMPLETED|Overall Study||104
232327|NCT01134276|563576|P2|STARTED|Overall Study||107
232328|NCT01134276|563577|P1|STARTED|Overall Study||104
232329|NCT01134263|563592|P5|NOT COMPLETED|Overall Study||9
232330|NCT01134263|563593|P4|NOT COMPLETED|Overall Study||19
232331|NCT01134263|563594|P3|NOT COMPLETED|Overall Study||29
232332|NCT01134263|563595|P2|NOT COMPLETED|Overall Study||20
232333|NCT01134263|563596|P1|NOT COMPLETED|Overall Study||24
232334|NCT01134263|563592|P5|COMPLETED|Overall Study||48
232335|NCT01134263|563593|P4|COMPLETED|Overall Study||149
232336|NCT01134263|563594|P3|COMPLETED|Overall Study||134
232337|NCT01134263|563595|P2|COMPLETED|Overall Study||143
232338|NCT01134263|563596|P1|COMPLETED|Overall Study||140
232339|NCT01134263|563592|P5|Safety Population|Overall Study||57
232340|NCT01134263|563593|P4|Safety Population|Overall Study||167
232341|NCT01134263|563594|P3|Safety Population|Overall Study|1 participant randomized to the Phase III Lot 2 group, received Phase III Lot 3 vaccination.|164
232342|NCT01134263|563595|P2|Safety Population|Overall Study||161
232343|NCT01134263|563596|P1|Safety Population|Overall Study||163
232344|NCT01134263|563592|P5|Received Vaccination 3|Overall Study||49
232345|NCT01134263|563593|P4|Received Vaccination 3|Overall Study||151
232346|NCT01134263|563594|P3|Received Vaccination 3|Overall Study||134
232347|NCT01134263|563595|P2|Received Vaccination 3|Overall Study||145
232348|NCT01134263|563596|P1|Received Vaccination 3|Overall Study||140
232349|NCT01134263|563592|P5|Received Vaccination 2|Overall Study||53
232350|NCT01134263|563593|P4|Received Vaccination 2|Overall Study||154
232351|NCT01134263|563594|P3|Received Vaccination 2|Overall Study||139
232352|NCT01134263|563595|P2|Received Vaccination 2|Overall Study||152
232353|NCT01134263|563596|P1|Received Vaccination 2|Overall Study||151
232354|NCT01134263|563592|P5|Received Vaccination 1|Overall Study||57
232355|NCT01134263|563593|P4|Received Vaccination 1|Overall Study||167
232356|NCT01134263|563594|P3|Received Vaccination 1|Overall Study||163
232357|NCT01134263|563595|P2|Received Vaccination 1|Overall Study||162
232358|NCT01134263|563596|P1|Received Vaccination 1|Overall Study||163
232359|NCT01134263|563592|P5|STARTED|Overall Study||57
232360|NCT01134263|563593|P4|STARTED|Overall Study||168
232361|NCT01134263|563594|P3|STARTED|Overall Study||163
232362|NCT01134263|563595|P2|STARTED|Overall Study||163
232363|NCT01134263|563596|P1|STARTED|Overall Study||164
232364|NCT01134198|563620|P2|NOT COMPLETED|Phase 2||4
232365|NCT01134198|563621|P1|NOT COMPLETED|Phase 2||0
232366|NCT01134198|563620|P2|COMPLETED|Phase 2||7
232367|NCT01134198|563621|P1|COMPLETED|Phase 2||9
232368|NCT01134198|563620|P2|STARTED|Phase 2||11
232369|NCT01134198|563621|P1|STARTED|Phase 2||9
232370|NCT01134198|563620|P2|NOT COMPLETED|Phase 1||2
232371|NCT01134198|563621|P1|NOT COMPLETED|Phase 1||7
232372|NCT01134198|563620|P2|COMPLETED|Phase 1||11
232373|NCT01134198|563621|P1|COMPLETED|Phase 1||9
232374|NCT01134198|563620|P2|STARTED|Phase 1||13
232375|NCT01134198|563621|P1|STARTED|Phase 1||16
232376|NCT01134107|563629|P2|NOT COMPLETED|Period 2-Second Treatment Intervention||0
232377|NCT01134107|563630|P1|NOT COMPLETED|Period 2-Second Treatment Intervention||4
232378|NCT01134107|563629|P2|COMPLETED|Period 2-Second Treatment Intervention||61
232379|NCT01134107|563630|P1|COMPLETED|Period 2-Second Treatment Intervention||57
232380|NCT01134107|563629|P2|STARTED|Period 2-Second Treatment Intervention||61
232381|NCT01134107|563630|P1|STARTED|Period 2-Second Treatment Intervention||61
232382|NCT01134107|563629|P2|NOT COMPLETED|Period 1-First Treatment Intervention||5
232383|NCT01134107|563630|P1|NOT COMPLETED|Period 1-First Treatment Intervention||6
232384|NCT01134107|563629|P2|COMPLETED|Period 1-First Treatment Intervention||61
232385|NCT01134107|563630|P1|COMPLETED|Period 1-First Treatment Intervention||61
232386|NCT01134107|563629|P2|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
232387|NCT01134107|563630|P1|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
232388|NCT01134107|563629|P2|STARTED|Period 1-First Treatment Intervention||66
232389|NCT01134107|563630|P1|STARTED|Period 1-First Treatment Intervention||67
232390|NCT01134081|563662|P1|NOT COMPLETED|Overall Study||0
232391|NCT01134081|563662|P1|COMPLETED|Overall Study||44
232392|NCT01134081|563662|P1|STARTED|Overall Study||44
232393|NCT01134055|563677|P7|NOT COMPLETED|Overall Study||11
232394|NCT01134055|563678|P6|NOT COMPLETED|Overall Study||7
232395|NCT01134055|563679|P5|NOT COMPLETED|Overall Study||6
232396|NCT01134055|563680|P4|NOT COMPLETED|Overall Study||6
232397|NCT01134055|563681|P3|NOT COMPLETED|Overall Study||3
232398|NCT01134055|563682|P2|NOT COMPLETED|Overall Study||6
232399|NCT01134055|563683|P1|NOT COMPLETED|Overall Study||8
232400|NCT01134055|563677|P7|COMPLETED|Overall Study||62
232401|NCT01134055|563678|P6|COMPLETED|Overall Study||65
232402|NCT01134055|563679|P5|COMPLETED|Overall Study||67
232403|NCT01134055|563680|P4|COMPLETED|Overall Study||67
232404|NCT01134055|563681|P3|COMPLETED|Overall Study||71
232405|NCT01134055|563682|P2|COMPLETED|Overall Study||66
232406|NCT01134055|563683|P1|COMPLETED|Overall Study||65
232407|NCT01134055|563677|P7|STARTED|Overall Study||73
232408|NCT01134055|563678|P6|STARTED|Overall Study||72
232409|NCT01134055|563679|P5|STARTED|Overall Study||73
232410|NCT01134055|563680|P4|STARTED|Overall Study||73
232411|NCT01134055|563681|P3|STARTED|Overall Study||74
232412|NCT01134055|563682|P2|STARTED|Overall Study||72
232413|NCT01134055|563683|P1|STARTED|Overall Study||73
232414|NCT01134042|563817|P3|NOT COMPLETED|Overall Study||34
232415|NCT01134042|563818|P2|NOT COMPLETED|Overall Study||28
232416|NCT01134042|563819|P1|NOT COMPLETED|Overall Study||48
232417|NCT01134042|563817|P3|COMPLETED|Overall Study||161
232418|NCT01134042|563818|P2|COMPLETED|Overall Study||169
232419|NCT01134042|563819|P1|COMPLETED|Overall Study||146
232420|NCT01134042|563817|P3|STARTED|Overall Study||195
232421|NCT01134042|563818|P2|STARTED|Overall Study||197
232422|NCT01134042|563819|P1|STARTED|Overall Study||194
232423|NCT01134016|563857|P1|NOT COMPLETED|Overall Study||3
232424|NCT01134016|563857|P1|COMPLETED|Overall Study||10
232425|NCT01134016|563857|P1|STARTED|Overall Study||13
232426|NCT01133977|563895|P5|NOT COMPLETED|Overall Study||38
232427|NCT01133977|563896|P4|NOT COMPLETED|Overall Study||39
232428|NCT01133977|563897|P3|NOT COMPLETED|Overall Study||6
232429|NCT01133977|563898|P2|NOT COMPLETED|Overall Study||7
232430|NCT01133977|563899|P1|NOT COMPLETED|Overall Study||3
232431|NCT01133977|563895|P5|COMPLETED|Overall Study||1
232432|NCT01133977|563896|P4|COMPLETED|Overall Study||3
232433|NCT01133977|563897|P3|COMPLETED|Overall Study||0
232434|NCT01133977|563898|P2|COMPLETED|Overall Study||0
232435|NCT01133977|563899|P1|COMPLETED|Overall Study||0
232436|NCT01133977|563895|P5|STARTED|Overall Study|Treated|39
232437|NCT01133977|563896|P4|STARTED|Overall Study|Treated|42
232438|NCT01133977|563897|P3|STARTED|Overall Study|Treated|6
232439|NCT01133977|563898|P2|STARTED|Overall Study|Treated|7
232440|NCT01133977|563899|P1|STARTED|Overall Study|Treated|3
232441|NCT01133860|563916|P1|NOT COMPLETED|Overall Study||0
232442|NCT01133860|563916|P1|COMPLETED|Overall Study||12
232443|NCT01133860|563916|P1|STARTED|Overall Study||12
232444|NCT01133847|563926|P3|NOT COMPLETED|Follow-Up Phase||7
232445|NCT01133847|563927|P2|NOT COMPLETED|Follow-Up Phase||3
232446|NCT01133847|563928|P1|NOT COMPLETED|Follow-Up Phase||1
232447|NCT01133847|563926|P3|COMPLETED|Follow-Up Phase||60
232448|NCT01133847|563927|P2|COMPLETED|Follow-Up Phase||70
232449|NCT01133847|563928|P1|COMPLETED|Follow-Up Phase||72
232450|NCT01133847|563926|P3|STARTED|Follow-Up Phase||67
232451|NCT01133847|563927|P2|STARTED|Follow-Up Phase||73
232452|NCT01133847|563928|P1|STARTED|Follow-Up Phase||73
232453|NCT01133847|563926|P3|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||3
232454|NCT01133847|563927|P2|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||1
232455|NCT01133847|563928|P1|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||5
232456|NCT01133847|563926|P3|COMPLETED|Active Treatment Phase (Weeks 1-16)||67
232457|NCT01133847|563927|P2|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
232458|NCT01133847|563928|P1|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
232459|NCT01133847|563926|P3|STARTED|Active Treatment Phase (Weeks 1-16)||70
232460|NCT01133847|563927|P2|STARTED|Active Treatment Phase (Weeks 1-16)||74
232461|NCT01133847|563928|P1|STARTED|Active Treatment Phase (Weeks 1-16)||78
232462|NCT01133821|563968|P2|NOT COMPLETED|Overall Study||19
232463|NCT01133821|563969|P1|NOT COMPLETED|Overall Study||18
232464|NCT01133821|563968|P2|COMPLETED|Overall Study||28
232465|NCT01133821|563969|P1|COMPLETED|Overall Study||27
232466|NCT01133821|563968|P2|STARTED|Overall Study||47
232467|NCT01133821|563969|P1|STARTED|Overall Study||45
232468|NCT01133756|563980|P3|NOT COMPLETED|Overall Study||2
232469|NCT01133756|563981|P2|NOT COMPLETED|Overall Study||3
232470|NCT01133756|563982|P1|NOT COMPLETED|Overall Study||2
232471|NCT01133756|563980|P3|COMPLETED|Overall Study||0
232472|NCT01133756|563981|P2|COMPLETED|Overall Study||0
232473|NCT01133756|563982|P1|COMPLETED|Overall Study||0
232474|NCT01133756|563980|P3|Completed 6 Cycles|Overall Study||0
232475|NCT01133756|563981|P2|Completed 6 Cycles|Overall Study||0
232476|NCT01133756|563982|P1|Completed 6 Cycles|Overall Study|One participant completed 6 cycles and remained in the study until 18 Sep 2012.|1
232477|NCT01133756|563980|P3|STARTED|Overall Study||2
232478|NCT01133756|563981|P2|STARTED|Overall Study||3
232479|NCT01133756|563982|P1|STARTED|Overall Study||2
232480|NCT01133704|563998|P2|NOT COMPLETED|Overall Study||26
232481|NCT01133704|563999|P1|NOT COMPLETED|Overall Study||49
232482|NCT01133704|563998|P2|COMPLETED|Overall Study|(including 3 year follow-up)|7
232483|NCT01133704|563999|P1|COMPLETED|Overall Study|(including 3 year follow-up)|16
232484|NCT01133704|563998|P2|STARTED|Overall Study||33
232485|NCT01133704|563999|P1|STARTED|Overall Study||65
232486|NCT01133665|564007|P1|NOT COMPLETED|Overall Study||2
232487|NCT01133665|564007|P1|COMPLETED|Overall Study||40
232488|NCT01133665|564007|P1|STARTED|Overall Study||42
232489|NCT01133639|564050|P2|NOT COMPLETED|Overall Study||0
232490|NCT01133639|564051|P1|NOT COMPLETED|Overall Study||0
232491|NCT01133639|564050|P2|COMPLETED|Overall Study|18 total subjects were enrolled,study was terminated prematurely and data was not analyzed|0
232492|NCT01133639|564051|P1|COMPLETED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
232493|NCT01133639|564050|P2|STARTED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
232494|NCT01133639|564051|P1|STARTED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
232495|NCT01133626|564067|P3|NOT COMPLETED|Overall Study||2
232496|NCT01133626|564068|P2|NOT COMPLETED|Overall Study||5
232497|NCT01133626|564069|P1|NOT COMPLETED|Overall Study||1
232498|NCT01133626|564067|P3|COMPLETED|Overall Study||9
232499|NCT01133626|564068|P2|COMPLETED|Overall Study||41
232500|NCT01133626|564069|P1|COMPLETED|Overall Study||49
232501|NCT01133626|564067|P3|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|9
232502|NCT01133626|564068|P2|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|41
232503|NCT01133626|564069|P1|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|48
232504|NCT01133626|564067|P3|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|11
232505|NCT01133626|564068|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|46
232506|NCT01133626|564069|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|50
232507|NCT01133626|564067|P3|STARTED|Overall Study||11
232508|NCT01133626|564068|P2|STARTED|Overall Study||46
232509|NCT01133626|564069|P1|STARTED|Overall Study||50
232510|NCT01133522|564087|P10|NOT COMPLETED|Overall Study||0
232511|NCT01133522|564088|P9|NOT COMPLETED|Overall Study||0
232512|NCT01133522|564089|P8|NOT COMPLETED|Overall Study||0
232513|NCT01133522|564090|P7|NOT COMPLETED|Overall Study||0
232514|NCT01133522|564091|P6|NOT COMPLETED|Overall Study||0
232515|NCT01133522|564092|P5|NOT COMPLETED|Overall Study||1
232516|NCT01133522|564093|P4|NOT COMPLETED|Overall Study||1
232517|NCT01133522|564094|P3|NOT COMPLETED|Overall Study||0
232518|NCT01133522|564095|P2|NOT COMPLETED|Overall Study||1
232519|NCT01133522|564096|P1|NOT COMPLETED|Overall Study||0
232520|NCT01133522|564087|P10|COMPLETED|Overall Study||4
232521|NCT01133522|564088|P9|COMPLETED|Overall Study||2
232522|NCT01133522|564089|P8|COMPLETED|Overall Study||9
232523|NCT01133522|564090|P7|COMPLETED|Overall Study||2
232524|NCT01133522|564091|P6|COMPLETED|Overall Study||6
232525|NCT01133522|564092|P5|COMPLETED|Overall Study||6
232526|NCT01133522|564093|P4|COMPLETED|Overall Study||6
232527|NCT01133522|564094|P3|COMPLETED|Overall Study||6
232528|NCT01133522|564095|P2|COMPLETED|Overall Study||6
232529|NCT01133522|564096|P1|COMPLETED|Overall Study||10
232530|NCT01133522|564087|P10|Received Treatment|Overall Study||4
232531|NCT01133522|564088|P9|Received Treatment|Overall Study||2
232532|NCT01133522|564089|P8|Received Treatment|Overall Study||9
232533|NCT01133522|564090|P7|Received Treatment|Overall Study||2
232534|NCT01133522|564091|P6|Received Treatment|Overall Study||6
232535|NCT01133522|564092|P5|Received Treatment|Overall Study||6
232536|NCT01133522|564093|P4|Received Treatment|Overall Study||6
232537|NCT01133522|564094|P3|Received Treatment|Overall Study||6
232538|NCT01133522|564095|P2|Received Treatment|Overall Study||6
232539|NCT01133522|564096|P1|Received Treatment|Overall Study||10
232540|NCT01133522|564087|P10|STARTED|Overall Study||4
232541|NCT01133522|564088|P9|STARTED|Overall Study||2
232542|NCT01133522|564089|P8|STARTED|Overall Study||9
232543|NCT01133522|564090|P7|STARTED|Overall Study||2
232544|NCT01133522|564091|P6|STARTED|Overall Study||6
232545|NCT01133522|564092|P5|STARTED|Overall Study||7
232546|NCT01133522|564093|P4|STARTED|Overall Study||7
232547|NCT01133522|564094|P3|STARTED|Overall Study||6
232548|NCT01133522|564095|P2|STARTED|Overall Study||7
232549|NCT01133522|564096|P1|STARTED|Overall Study||10
232550|NCT01133418|564164|P2|NOT COMPLETED|Overall Study||6
232551|NCT01133418|564165|P1|NOT COMPLETED|Overall Study||5
232552|NCT01133418|564164|P2|COMPLETED|Overall Study||32
232553|NCT01133418|564165|P1|COMPLETED|Overall Study||29
232554|NCT01133418|564164|P2|STARTED|Overall Study||38
232555|NCT01133418|564165|P1|STARTED|Overall Study||34
232556|NCT01133405|564187|P10|NOT COMPLETED|Period 3||0
232557|NCT01133405|564188|P9|NOT COMPLETED|Period 3||0
232558|NCT01133405|564189|P8|NOT COMPLETED|Period 3||0
232559|NCT01133405|564190|P7|NOT COMPLETED|Period 3||0
232560|NCT01133405|564191|P6|NOT COMPLETED|Period 3||0
232561|NCT01133405|564192|P5|NOT COMPLETED|Period 3||0
232562|NCT01133405|564193|P4|NOT COMPLETED|Period 3||0
232563|NCT01133405|564194|P3|NOT COMPLETED|Period 3||0
232564|NCT01133405|564195|P2|NOT COMPLETED|Period 3||0
232565|NCT01133405|564196|P1|NOT COMPLETED|Period 3||0
232566|NCT01133405|564187|P10|COMPLETED|Period 3||0
232567|NCT01133405|564188|P9|COMPLETED|Period 3||0
232568|NCT01133405|564189|P8|COMPLETED|Period 3||0
232569|NCT01133405|564190|P7|COMPLETED|Period 3||0
232570|NCT01133405|564191|P6|COMPLETED|Period 3||2
232571|NCT01133405|564192|P5|COMPLETED|Period 3||3
232572|NCT01133405|564193|P4|COMPLETED|Period 3||2
232573|NCT01133405|564194|P3|COMPLETED|Period 3||4
232574|NCT01133405|564195|P2|COMPLETED|Period 3||4
232575|NCT01133405|564196|P1|COMPLETED|Period 3||2
232576|NCT01133405|564187|P10|Received at Least 1 Dose of Study Drug|Period 3||0
232577|NCT01133405|564188|P9|Received at Least 1 Dose of Study Drug|Period 3||0
232578|NCT01133405|564189|P8|Received at Least 1 Dose of Study Drug|Period 3||0
232579|NCT01133405|564190|P7|Received at Least 1 Dose of Study Drug|Period 3||0
232580|NCT01133405|564191|P6|Received at Least 1 Dose of Study Drug|Period 3||2
232581|NCT01133405|564192|P5|Received at Least 1 Dose of Study Drug|Period 3||3
232582|NCT01133405|564193|P4|Received at Least 1 Dose of Study Drug|Period 3||2
232583|NCT01133405|564194|P3|Received at Least 1 Dose of Study Drug|Period 3||4
232584|NCT01133405|564195|P2|Received at Least 1 Dose of Study Drug|Period 3||4
232585|NCT01133405|564196|P1|Received at Least 1 Dose of Study Drug|Period 3||2
232586|NCT01133405|564187|P10|STARTED|Period 3||0
232587|NCT01133405|564188|P9|STARTED|Period 3||0
232588|NCT01133405|564189|P8|STARTED|Period 3||0
232589|NCT01133405|564190|P7|STARTED|Period 3||0
232590|NCT01133405|564191|P6|STARTED|Period 3||2
232591|NCT01133405|564192|P5|STARTED|Period 3||3
232592|NCT01133405|564193|P4|STARTED|Period 3||2
232593|NCT01133405|564194|P3|STARTED|Period 3|One participant started and received 35 mg LY2886721 only in period 3.|4
232594|NCT01133405|564195|P2|STARTED|Period 3|One participant started and received placebo only in period 3.|4
232595|NCT01133405|564196|P1|STARTED|Period 3||2
232596|NCT01133405|564187|P10|NOT COMPLETED|Period 2||0
232597|NCT01133405|564188|P9|NOT COMPLETED|Period 2||0
232598|NCT01133405|564189|P8|NOT COMPLETED|Period 2||0
232599|NCT01133405|564190|P7|NOT COMPLETED|Period 2||0
232600|NCT01133405|564191|P6|NOT COMPLETED|Period 2||2
232601|NCT01133405|564192|P5|NOT COMPLETED|Period 2||0
232602|NCT01133405|564193|P4|NOT COMPLETED|Period 2||1
232603|NCT01133405|564194|P3|NOT COMPLETED|Period 2||1
232604|NCT01133405|564195|P2|NOT COMPLETED|Period 2||1
232605|NCT01133405|564196|P1|NOT COMPLETED|Period 2||0
232606|NCT01133405|564187|P10|COMPLETED|Period 2||0
232607|NCT01133405|564188|P9|COMPLETED|Period 2||0
232608|NCT01133405|564189|P8|COMPLETED|Period 2||0
232609|NCT01133405|564190|P7|COMPLETED|Period 2||0
232610|NCT01133405|564191|P6|COMPLETED|Period 2||2
232611|NCT01133405|564192|P5|COMPLETED|Period 2||3
232612|NCT01133405|564193|P4|COMPLETED|Period 2||2
232613|NCT01133405|564194|P3|COMPLETED|Period 2||3
232614|NCT01133405|564195|P2|COMPLETED|Period 2||3
232615|NCT01133405|564196|P1|COMPLETED|Period 2||2
232616|NCT01133405|564187|P10|Received at Least 1 Dose of Study Drug|Period 2||0
232617|NCT01133405|564188|P9|Received at Least 1 Dose of Study Drug|Period 2||0
232618|NCT01133405|564189|P8|Received at Least 1 Dose of Study Drug|Period 2||0
232619|NCT01133405|564190|P7|Received at Least 1 Dose of Study Drug|Period 2||0
232620|NCT01133405|564191|P6|Received at Least 1 Dose of Study Drug|Period 2||4
232621|NCT01133405|564192|P5|Received at Least 1 Dose of Study Drug|Period 2||3
232622|NCT01133405|564193|P4|Received at Least 1 Dose of Study Drug|Period 2||3
232623|NCT01133405|564194|P3|Received at Least 1 Dose of Study Drug|Period 2||4
232624|NCT01133405|564195|P2|Received at Least 1 Dose of Study Drug|Period 2||4
232625|NCT01133405|564196|P1|Received at Least 1 Dose of Study Drug|Period 2||2
232626|NCT01133405|564187|P10|STARTED|Period 2|Cohort D was planned only for single period.|0
232627|NCT01133405|564188|P9|STARTED|Period 2|Cohort D was planned only for single period.|0
232628|NCT01133405|564189|P8|STARTED|Period 2|Cohort C was planned only for single period.|0
232629|NCT01133405|564190|P7|STARTED|Period 2|Cohort C was planned only for single period.|0
232630|NCT01133405|564191|P6|STARTED|Period 2|One participant started and received 25 mg LY2886721 only in period 2.|4
232631|NCT01133405|564192|P5|STARTED|Period 2||3
232632|NCT01133405|564193|P4|STARTED|Period 2|Two participants started and received 25 mg LY2886721 only in period 2.|3
232633|NCT01133405|564194|P3|STARTED|Period 2||4
232634|NCT01133405|564195|P2|STARTED|Period 2|One participant started and received 15 mg LY2886721 only in period 2.|4
232635|NCT01133405|564196|P1|STARTED|Period 2||2
232636|NCT01133405|564187|P10|NOT COMPLETED|Period 1||0
232637|NCT01133405|564188|P9|NOT COMPLETED|Period 1||0
232638|NCT01133405|564189|P8|NOT COMPLETED|Period 1||0
232639|NCT01133405|564190|P7|NOT COMPLETED|Period 1||1
232640|NCT01133405|564191|P6|NOT COMPLETED|Period 1||2
232641|NCT01133405|564192|P5|NOT COMPLETED|Period 1||0
232642|NCT01133405|564193|P4|NOT COMPLETED|Period 1||4
232643|NCT01133405|564194|P3|NOT COMPLETED|Period 1||1
232644|NCT01133405|564195|P2|NOT COMPLETED|Period 1||3
232645|NCT01133405|564196|P1|NOT COMPLETED|Period 1||1
232646|NCT01133405|564187|P10|COMPLETED|Period 1||2
232647|NCT01133405|564188|P9|COMPLETED|Period 1||4
232648|NCT01133405|564189|P8|COMPLETED|Period 1||2
232649|NCT01133405|564190|P7|COMPLETED|Period 1||4
232650|NCT01133405|564191|P6|COMPLETED|Period 1||3
232651|NCT01133405|564192|P5|COMPLETED|Period 1||3
232652|NCT01133405|564193|P4|COMPLETED|Period 1||1
232653|NCT01133405|564194|P3|COMPLETED|Period 1||4
232654|NCT01133405|564195|P2|COMPLETED|Period 1||3
232655|NCT01133405|564196|P1|COMPLETED|Period 1||2
232656|NCT01133405|564187|P10|Received at Least 1 Dose of Drug|Period 1||2
232657|NCT01133405|564188|P9|Received at Least 1 Dose of Drug|Period 1||4
232658|NCT01133405|564189|P8|Received at Least 1 Dose of Drug|Period 1||2
232659|NCT01133405|564190|P7|Received at Least 1 Dose of Drug|Period 1||4
232660|NCT01133405|564191|P6|Received at Least 1 Dose of Drug|Period 1||4
232661|NCT01133405|564192|P5|Received at Least 1 Dose of Drug|Period 1||3
232662|NCT01133405|564193|P4|Received at Least 1 Dose of Drug|Period 1||3
232663|NCT01133405|564194|P3|Received at Least 1 Dose of Drug|Period 1||4
232664|NCT01133405|564195|P2|Received at Least 1 Dose of Drug|Period 1||4
232665|NCT01133405|564196|P1|Received at Least 1 Dose of Drug|Period 1||2
232666|NCT01133405|564187|P10|Safety Analysis Population|Period 1||2
232667|NCT01133405|564188|P9|Safety Analysis Population|Period 1||4
232668|NCT01133405|564189|P8|Safety Analysis Population|Period 1||2
232669|NCT01133405|564190|P7|Safety Analysis Population|Period 1||5
232670|NCT01133405|564191|P6|Safety Analysis Population|Period 1||5
232671|NCT01133405|564192|P5|Safety Analysis Population|Period 1||3
232672|NCT01133405|564193|P4|Safety Analysis Population|Period 1||5
232673|NCT01133405|564194|P3|Safety Analysis Population|Period 1||5
232674|NCT01133405|564195|P2|Safety Analysis Population|Period 1||6
232675|NCT01133405|564196|P1|Safety Analysis Population|Period 1|One discontinued from study after randomization but before any study procedures.|2
232676|NCT01133405|564187|P10|STARTED|Period 1||2
232677|NCT01133405|564188|P9|STARTED|Period 1||4
232678|NCT01133405|564189|P8|STARTED|Period 1||2
232679|NCT01133405|564190|P7|STARTED|Period 1||5
232680|NCT01133405|564191|P6|STARTED|Period 1||5
232681|NCT01133405|564192|P5|STARTED|Period 1||3
232682|NCT01133405|564193|P4|STARTED|Period 1||5
232683|NCT01133405|564194|P3|STARTED|Period 1||5
232684|NCT01133405|564195|P2|STARTED|Period 1||6
232685|NCT01133405|564196|P1|STARTED|Period 1||3
232686|NCT01133392|564247|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
232687|NCT01133392|564248|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
232688|NCT01133392|564247|P2|COMPLETED|Fourth Intervention (1 Day)||16
232689|NCT01133392|564248|P1|COMPLETED|Fourth Intervention (1 Day)||20
232690|NCT01133392|564247|P2|STARTED|Fourth Intervention (1 Day)||16
232691|NCT01133392|564248|P1|STARTED|Fourth Intervention (1 Day)||20
232692|NCT01133392|564247|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
232693|NCT01133392|564248|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
232694|NCT01133392|564247|P2|COMPLETED|Interval Between Dosing (4-7 Days)||16
232695|NCT01133392|564248|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
232696|NCT01133392|564247|P2|STARTED|Interval Between Dosing (4-7 Days)||17
232697|NCT01133392|564248|P1|STARTED|Interval Between Dosing (4-7 Days)||20
232698|NCT01133392|564247|P2|NOT COMPLETED|Third Intervention (1 Day)||0
232699|NCT01133392|564248|P1|NOT COMPLETED|Third Intervention (1 Day)||0
232700|NCT01133392|564247|P2|COMPLETED|Third Intervention (1 Day)||17
232701|NCT01133392|564248|P1|COMPLETED|Third Intervention (1 Day)||20
232702|NCT01133392|564247|P2|STARTED|Third Intervention (1 Day)||17
232703|NCT01133392|564248|P1|STARTED|Third Intervention (1 Day)||20
232704|NCT01133392|564247|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
232705|NCT01133392|564248|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
232706|NCT01133392|564247|P2|COMPLETED|Interval Between Dosing (4-7 Days)||17
232707|NCT01133392|564248|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
232708|NCT01133392|564247|P2|STARTED|Interval Between Dosing (4-7 Days)||17
232709|NCT01133392|564248|P1|STARTED|Interval Between Dosing (4-7 Days)||20
232710|NCT01133392|564247|P2|NOT COMPLETED|Second Intervention (1 Day)||0
232711|NCT01133392|564248|P1|NOT COMPLETED|Second Intervention (1 Day)||0
232712|NCT01133392|564247|P2|COMPLETED|Second Intervention (1 Day)||17
232713|NCT01133392|564248|P1|COMPLETED|Second Intervention (1 Day)||20
232714|NCT01133392|564247|P2|STARTED|Second Intervention (1 Day)||17
232715|NCT01133392|564248|P1|STARTED|Second Intervention (1 Day)||20
232716|NCT01133392|564247|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
232717|NCT01133392|564248|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
232718|NCT01133392|564247|P2|COMPLETED|Interval Between Dosing (4-7 Days)||17
232719|NCT01133392|564248|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
232720|NCT01133392|564247|P2|STARTED|Interval Between Dosing (4-7 Days)||18
232721|NCT01133392|564248|P1|STARTED|Interval Between Dosing (4-7 Days)||20
232722|NCT01133392|564247|P2|NOT COMPLETED|First Intervention (1 Day )||0
232723|NCT01133392|564248|P1|NOT COMPLETED|First Intervention (1 Day )||0
232724|NCT01133392|564247|P2|COMPLETED|First Intervention (1 Day )||18
232725|NCT01133392|564248|P1|COMPLETED|First Intervention (1 Day )||20
232726|NCT01133392|564247|P2|STARTED|First Intervention (1 Day )||18
232727|NCT01133392|564248|P1|STARTED|First Intervention (1 Day )||20
232728|NCT01133379|564265|P3|NOT COMPLETED|Overall Study||2
232729|NCT01133379|564266|P2|NOT COMPLETED|Overall Study||2
232730|NCT01133379|564267|P1|NOT COMPLETED|Overall Study||1
232731|NCT01133379|564265|P3|COMPLETED|Overall Study||56
232732|NCT01133379|564266|P2|COMPLETED|Overall Study||56
232733|NCT01133379|564267|P1|COMPLETED|Overall Study||57
232734|NCT01133379|564265|P3|STARTED|Overall Study||58
232735|NCT01133379|564266|P2|STARTED|Overall Study||58
232736|NCT01133379|564267|P1|STARTED|Overall Study||58
232737|NCT01133288|564320|P1|NOT COMPLETED|Intervention Allocation||2
232738|NCT01133288|564320|P1|COMPLETED|Intervention Allocation||0
232739|NCT01133288|564320|P1|STARTED|Intervention Allocation||2
232740|NCT01133288|564320|P1|NOT COMPLETED|Eligibility Assessment||5
232741|NCT01133288|564320|P1|COMPLETED|Eligibility Assessment||2
232742|NCT01133288|564320|P1|STARTED|Eligibility Assessment||7
232743|NCT01133275|564325|P1|NOT COMPLETED|Overall Study||2
232744|NCT01133275|564325|P1|COMPLETED|Overall Study||26
232745|NCT01133275|564325|P1|STARTED|Overall Study||28
232746|NCT01133171|564333|P3|NOT COMPLETED|Overall Study||0
232747|NCT01133171|564334|P2|NOT COMPLETED|Overall Study||2
232748|NCT01133171|564335|P1|NOT COMPLETED|Overall Study||1
232749|NCT01133171|564333|P3|COMPLETED|Overall Study||25
232750|NCT01133171|564334|P2|COMPLETED|Overall Study||25
232751|NCT01133171|564335|P1|COMPLETED|Overall Study||24
232752|NCT01133171|564333|P3|STARTED|Overall Study||25
232753|NCT01133171|564334|P2|STARTED|Overall Study||27
232754|NCT01133171|564335|P1|STARTED|Overall Study||25
232755|NCT01133158|564345|P1|NOT COMPLETED|Overall Study||17
232756|NCT01133158|564345|P1|COMPLETED|Overall Study||43
232757|NCT01133158|564345|P1|STARTED|Overall Study||60
232758|NCT01133067|564351|P1|NOT COMPLETED|Overall Study||139
232759|NCT01133067|564351|P1|COMPLETED|Overall Study||61
232760|NCT01133067|564351|P1|STARTED|Overall Study||200
232761|NCT01132846|564359|P3|NOT COMPLETED|Overall Study||11
232762|NCT01132846|564360|P2|NOT COMPLETED|Overall Study||18
232763|NCT01132846|564361|P1|NOT COMPLETED|Overall Study||16
232764|NCT01132846|564359|P3|COMPLETED|Overall Study||108
232765|NCT01132846|564360|P2|COMPLETED|Overall Study||101
232766|NCT01132846|564361|P1|COMPLETED|Overall Study||106
232767|NCT01132846|564359|P3|STARTED|Overall Study||119
232768|NCT01132846|564360|P2|STARTED|Overall Study||119
232769|NCT01132846|564361|P1|STARTED|Overall Study||122
232770|NCT01132820|564411|P1|NOT COMPLETED|Overall Study||5
232771|NCT01132820|564411|P1|COMPLETED|Overall Study||48
232772|NCT01132820|564411|P1|STARTED|Overall Study||53
232773|NCT01132755|564420|P1|NOT COMPLETED|Overall Study||42
232774|NCT01132755|564420|P1|COMPLETED|Overall Study||70
232775|NCT01132755|564420|P1|STARTED|Overall Study||112
232776|NCT01132690|564427|P2|NOT COMPLETED|Overall Study||0
232777|NCT01132690|564428|P1|NOT COMPLETED|Overall Study||0
232778|NCT01132690|564427|P2|COMPLETED|Overall Study||5
232779|NCT01132690|564428|P1|COMPLETED|Overall Study||6
232780|NCT01132690|564427|P2|STARTED|Overall Study||5
232781|NCT01132690|564428|P1|STARTED|Overall Study||6
232782|NCT01132664|564449|P5|NOT COMPLETED|BM Cohort||6
232783|NCT01132664|564450|P4|NOT COMPLETED|BM Cohort||3
232784|NCT01132664|564451|P3|NOT COMPLETED|BM Cohort||0
232785|NCT01132664|564452|P2|NOT COMPLETED|BM Cohort||0
232786|NCT01132664|564453|P1|NOT COMPLETED|BM Cohort||0
232787|NCT01132664|564449|P5|COMPLETED|BM Cohort||0
232788|NCT01132664|564450|P4|COMPLETED|BM Cohort||0
232789|NCT01132664|564451|P3|COMPLETED|BM Cohort||0
232790|NCT01132664|564452|P2|COMPLETED|BM Cohort||0
232791|NCT01132664|564453|P1|COMPLETED|BM Cohort||0
232792|NCT01132664|564449|P5|STARTED|BM Cohort||6
232793|NCT01132664|564450|P4|STARTED|BM Cohort||3
232794|NCT01132664|564451|P3|STARTED|BM Cohort||0
232795|NCT01132664|564452|P2|STARTED|BM Cohort||0
232796|NCT01132664|564453|P1|STARTED|BM Cohort||0
232797|NCT01132664|564449|P5|NOT COMPLETED|Phase ll||0
232798|NCT01132664|564450|P4|NOT COMPLETED|Phase ll||0
232799|NCT01132664|564451|P3|NOT COMPLETED|Phase ll||50
232800|NCT01132664|564452|P2|NOT COMPLETED|Phase ll||0
232801|NCT01132664|564453|P1|NOT COMPLETED|Phase ll||0
232802|NCT01132664|564449|P5|COMPLETED|Phase ll||0
232803|NCT01132664|564450|P4|COMPLETED|Phase ll||0
232804|NCT01132664|564451|P3|COMPLETED|Phase ll||0
232805|NCT01132664|564452|P2|COMPLETED|Phase ll||0
232806|NCT01132664|564453|P1|COMPLETED|Phase ll||0
232807|NCT01132664|564449|P5|STARTED|Phase ll||0
232808|NCT01132664|564450|P4|STARTED|Phase ll||0
232809|NCT01132664|564451|P3|STARTED|Phase ll|Of the 50 patients, 8 were from phase lb & were eligible for inclusion in Phase II|50
232810|NCT01132664|564452|P2|STARTED|Phase ll||0
232811|NCT01132664|564453|P1|STARTED|Phase ll||0
232812|NCT01132664|564449|P5|NOT COMPLETED|Phase lb||0
232813|NCT01132664|564450|P4|NOT COMPLETED|Phase lb||0
232814|NCT01132664|564451|P3|NOT COMPLETED|Phase lb||0
232815|NCT01132664|564452|P2|NOT COMPLETED|Phase lb||12
232816|NCT01132664|564453|P1|NOT COMPLETED|Phase lb||5
232817|NCT01132664|564449|P5|COMPLETED|Phase lb||0
232818|NCT01132664|564450|P4|COMPLETED|Phase lb||0
232819|NCT01132664|564451|P3|COMPLETED|Phase lb||0
232820|NCT01132664|564452|P2|COMPLETED|Phase lb||0
232821|NCT01132664|564453|P1|COMPLETED|Phase lb||0
232822|NCT01132664|564449|P5|STARTED|Phase lb||0
232823|NCT01132664|564450|P4|STARTED|Phase lb||0
232824|NCT01132664|564451|P3|STARTED|Phase lb||0
232825|NCT01132664|564452|P2|STARTED|Phase lb||12
232826|NCT01132664|564453|P1|STARTED|Phase lb||5
232827|NCT01132651|564487|P2|NOT COMPLETED|Overall Study||1
232828|NCT01132651|564488|P1|NOT COMPLETED|Overall Study||1
232829|NCT01132651|564487|P2|COMPLETED|Overall Study||4
232830|NCT01132651|564488|P1|COMPLETED|Overall Study||3
232831|NCT01132651|564487|P2|STARTED|Overall Study||5
232832|NCT01132651|564488|P1|STARTED|Overall Study||4
232833|NCT01132612|564499|P3|NOT COMPLETED|Overall Study||170
232834|NCT01132612|564500|P2|NOT COMPLETED|Overall Study||35
232835|NCT01132612|564501|P1|NOT COMPLETED|Overall Study||40
232836|NCT01132612|564499|P3|COMPLETED|Overall Study||17
232837|NCT01132612|564500|P2|COMPLETED|Overall Study||7
232838|NCT01132612|564501|P1|COMPLETED|Overall Study||6
232839|NCT01132612|564499|P3|STARTED|Overall Study||187
232840|NCT01132612|564500|P2|STARTED|Overall Study||42
232841|NCT01132612|564501|P1|STARTED|Overall Study||46
232842|NCT01132547|564517|P2|NOT COMPLETED|Overall Study||1
232843|NCT01132547|564518|P1|NOT COMPLETED|Overall Study||4
232844|NCT01132547|564517|P2|COMPLETED|Overall Study||12
232845|NCT01132547|564518|P1|COMPLETED|Overall Study||5
232846|NCT01132547|564517|P2|STARTED|Overall Study||13
232847|NCT01132547|564518|P1|STARTED|Overall Study||9
232848|NCT01132508|564528|P1|NOT COMPLETED|Overall Study||9
232849|NCT01132508|564528|P1|COMPLETED|Overall Study||24
232850|NCT01132508|564528|P1|104 Weeks|Overall Study||27
232851|NCT01132508|564528|P1|78 Weeks|Overall Study||28
232852|NCT01132508|564528|P1|52 Weeks|Overall Study||30
232853|NCT01132508|564528|P1|26 Weeks|Overall Study||33
232854|NCT01132508|564528|P1|12 Weeks|Overall Study||33
232855|NCT01132508|564528|P1|6 Weeks|Overall Study||33
232856|NCT01132508|564528|P1|Treated at Baseline|Overall Study||33
232857|NCT01132508|564528|P1|STARTED|Overall Study||33
232858|NCT01132495|564588|P4|NOT COMPLETED|Overall Study||12
232859|NCT01132495|564589|P3|NOT COMPLETED|Overall Study||20
232860|NCT01132495|564590|P2|NOT COMPLETED|Overall Study||38
232861|NCT01132495|564591|P1|NOT COMPLETED|Overall Study||40
232862|NCT01132495|564588|P4|COMPLETED|Overall Study||104
232863|NCT01132495|564589|P3|COMPLETED|Overall Study||146
232864|NCT01132495|564590|P2|COMPLETED|Overall Study||403
232865|NCT01132495|564591|P1|COMPLETED|Overall Study||407
232866|NCT01132495|564588|P4|STARTED|Overall Study||116
232867|NCT01132495|564589|P3|STARTED|Overall Study||166
232868|NCT01132495|564590|P2|STARTED|Overall Study||441
232869|NCT01132495|564591|P1|STARTED|Overall Study||447
232870|NCT01132482|564604|P2|NOT COMPLETED|Overall Study||0
232871|NCT01132482|564605|P1|NOT COMPLETED|Overall Study||1
232872|NCT01132482|564604|P2|COMPLETED|Overall Study||6
232873|NCT01132482|564605|P1|COMPLETED|Overall Study||12
232874|NCT01132482|564604|P2|STARTED|Overall Study||6
232875|NCT01132482|564605|P1|STARTED|Overall Study||13
232876|NCT01132378|564623|P1|NOT COMPLETED|Overall Study||0
232877|NCT01132378|564623|P1|COMPLETED|Overall Study||40
232878|NCT01132378|564623|P1|STARTED|Overall Study||40
232879|NCT01132326|564628|P1|NOT COMPLETED|Overall Study||218
232880|NCT01132326|564628|P1|COMPLETED|Overall Study||132
232881|NCT01132326|564628|P1|STARTED|Overall Study||350
232882|NCT01132313|564644|P12|NOT COMPLETED|Overall Study||0
232883|NCT01132313|564645|P11|NOT COMPLETED|Overall Study||1
232884|NCT01132313|564646|P10|NOT COMPLETED|Overall Study||20
232885|NCT01132313|564647|P9|NOT COMPLETED|Overall Study||21
232886|NCT01132313|564648|P8|NOT COMPLETED|Overall Study||8
232887|NCT01132313|564649|P7|NOT COMPLETED|Overall Study||30
232888|NCT01132313|564650|P6|NOT COMPLETED|Overall Study||25
232889|NCT01132313|564651|P5|NOT COMPLETED|Overall Study||45
232890|NCT01132313|564652|P4|NOT COMPLETED|Overall Study||32
232891|NCT01132313|564653|P3|NOT COMPLETED|Overall Study||20
232892|NCT01132313|564654|P2|NOT COMPLETED|Overall Study||0
232893|NCT01132313|564655|P1|NOT COMPLETED|Overall Study||3
232894|NCT01132313|564644|P12|COMPLETED|Overall Study||2
232895|NCT01132313|564645|P11|COMPLETED|Overall Study||0
232896|NCT01132313|564646|P10|COMPLETED|Overall Study||5
232897|NCT01132313|564647|P9|COMPLETED|Overall Study||5
232898|NCT01132313|564648|P8|COMPLETED|Overall Study||24
232899|NCT01132313|564649|P7|COMPLETED|Overall Study||19
232900|NCT01132313|564650|P6|COMPLETED|Overall Study||54
232901|NCT01132313|564651|P5|COMPLETED|Overall Study||34
232902|NCT01132313|564652|P4|COMPLETED|Overall Study||48
232903|NCT01132313|564653|P3|COMPLETED|Overall Study||61
232904|NCT01132313|564654|P2|COMPLETED|Overall Study||17
232905|NCT01132313|564655|P1|COMPLETED|Overall Study||14
232906|NCT01132313|564644|P12|STARTED|Overall Study||2
232907|NCT01132313|564645|P11|STARTED|Overall Study||1
232908|NCT01132313|564646|P10|STARTED|Overall Study||25
232909|NCT01132313|564647|P9|STARTED|Overall Study||26
232910|NCT01132313|564648|P8|STARTED|Overall Study||32
232911|NCT01132313|564649|P7|STARTED|Overall Study||49
232912|NCT01132313|564650|P6|STARTED|Overall Study||79
232913|NCT01132313|564651|P5|STARTED|Overall Study||79
232914|NCT01132313|564652|P4|STARTED|Overall Study||80
232915|NCT01132313|564653|P3|STARTED|Overall Study||81
232916|NCT01132313|564654|P2|STARTED|Overall Study||17
232917|NCT01132313|564655|P1|STARTED|Overall Study||17
232918|NCT01132144|564712|P2|NOT COMPLETED|Overall Study||0
232919|NCT01132144|564713|P1|NOT COMPLETED|Overall Study||0
232920|NCT01132144|564712|P2|COMPLETED|Overall Study||79
232921|NCT01132144|564713|P1|COMPLETED|Overall Study||79
232922|NCT01132144|564712|P2|STARTED|Overall Study||79
232923|NCT01132144|564713|P1|STARTED|Overall Study||79
232924|NCT01132118|564735|P2|NOT COMPLETED|Second Intervention (8 Weeks)||1
232925|NCT01132118|564736|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
232926|NCT01132118|564735|P2|COMPLETED|Second Intervention (8 Weeks)||11
232927|NCT01132118|564736|P1|COMPLETED|Second Intervention (8 Weeks)||12
232928|NCT01132118|564735|P2|STARTED|Second Intervention (8 Weeks)||12
232929|NCT01132118|564736|P1|STARTED|Second Intervention (8 Weeks)||12
232930|NCT01132118|564735|P2|NOT COMPLETED|First Intervention (8 Weeks)||3
232931|NCT01132118|564736|P1|NOT COMPLETED|First Intervention (8 Weeks)||3
232932|NCT01132118|564735|P2|COMPLETED|First Intervention (8 Weeks)||12
232933|NCT01132118|564736|P1|COMPLETED|First Intervention (8 Weeks)||12
232934|NCT01132118|564735|P2|STARTED|First Intervention (8 Weeks)||15
232935|NCT01132118|564736|P1|STARTED|First Intervention (8 Weeks)||15
232936|NCT01131884|564756|P2|NOT COMPLETED|Overall Study||0
232937|NCT01131884|564757|P1|NOT COMPLETED|Overall Study||0
232938|NCT01131884|564756|P2|COMPLETED|Overall Study||0
232939|NCT01131884|564757|P1|COMPLETED|Overall Study||1
232940|NCT01131884|564756|P2|STARTED|Overall Study||0
232941|NCT01131884|564757|P1|STARTED|Overall Study||1
232942|NCT01131676|564766|P3|NOT COMPLETED|Discontinuation From Study (Treated Set)||63
232943|NCT01131676|564767|P2|NOT COMPLETED|Discontinuation From Study (Treated Set)||81
232944|NCT01131676|564768|P1|NOT COMPLETED|Discontinuation From Study (Treated Set)||67
232945|NCT01131676|564766|P3|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2279
232946|NCT01131676|564767|P2|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2264
232947|NCT01131676|564768|P1|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2266
232948|NCT01131676|564766|P3|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2327
232949|NCT01131676|564767|P2|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2324
232950|NCT01131676|564768|P1|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2316
232951|NCT01131676|564766|P3|STARTED|Discontinuation From Study (Treated Set)||2342
232952|NCT01131676|564767|P2|STARTED|Discontinuation From Study (Treated Set)||2345
232953|NCT01131676|564768|P1|STARTED|Discontinuation From Study (Treated Set)||2333
232954|NCT01131676|564766|P3|NOT COMPLETED|Discontinuation From Treatment||544
232955|NCT01131676|564767|P2|NOT COMPLETED|Discontinuation From Treatment||557
232956|NCT01131676|564768|P1|NOT COMPLETED|Discontinuation From Treatment||687
232957|NCT01131676|564766|P3|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1800
232958|NCT01131676|564767|P2|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1790
232959|NCT01131676|564768|P1|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1650
232960|NCT01131676|564766|P3|STARTED|Discontinuation From Treatment|Randomised|2344
232961|NCT01131676|564767|P2|STARTED|Discontinuation From Treatment|Randomised|2347
232962|NCT01131676|564768|P1|STARTED|Discontinuation From Treatment|Randomised|2337
232963|NCT01131585|564803|P2|NOT COMPLETED|Overall Study||43
232964|NCT01131585|564804|P1|NOT COMPLETED|Overall Study||85
232965|NCT01131585|564803|P2|COMPLETED|Overall Study||0
232966|NCT01131585|564804|P1|COMPLETED|Overall Study||0
232967|NCT01131585|564803|P2|STARTED|Overall Study||43
232968|NCT01131585|564804|P1|STARTED|Overall Study||85
232969|NCT01131520|564812|P2|NOT COMPLETED|Overall Study||4
232970|NCT01131520|564813|P1|NOT COMPLETED|Overall Study||1
232971|NCT01131520|564812|P2|COMPLETED|Overall Study||176
232972|NCT01131520|564813|P1|COMPLETED|Overall Study||179
232973|NCT01131520|564812|P2|STARTED|Overall Study||180
232974|NCT01131520|564813|P1|STARTED|Overall Study||180
232975|NCT01131507|564835|P1|NOT COMPLETED|Overall Study||3
232976|NCT01131507|564835|P1|COMPLETED|Overall Study||12
232977|NCT01131507|564835|P1|STARTED|Overall Study||15
232978|NCT01131494|564840|P1|NOT COMPLETED|Overall Study||2
232979|NCT01131494|564840|P1|COMPLETED|Overall Study||15
232980|NCT01131494|564840|P1|STARTED|Overall Study||17
232981|NCT01131455|564850|P3|NOT COMPLETED|Overall Study||0
232982|NCT01131455|564851|P2|NOT COMPLETED|Overall Study||4
232983|NCT01131455|564852|P1|NOT COMPLETED|Overall Study||6
232984|NCT01131455|564850|P3|COMPLETED|Overall Study||0
232985|NCT01131455|564851|P2|COMPLETED|Overall Study||0
232986|NCT01131455|564852|P1|COMPLETED|Overall Study||0
232987|NCT01131455|564850|P3|STARTED|Overall Study||0
232988|NCT01131455|564851|P2|STARTED|Overall Study||4
232989|NCT01131455|564852|P1|STARTED|Overall Study||6
232990|NCT01131312|564863|P3|NOT COMPLETED|Overall Study||351
232991|NCT01131312|564864|P2|NOT COMPLETED|Overall Study||229
232992|NCT01131312|564865|P1|NOT COMPLETED|Overall Study||425
232993|NCT01131312|564863|P3|COMPLETED|Overall Study||1485
232994|NCT01131312|564864|P2|COMPLETED|Overall Study||1156
232995|NCT01131312|564865|P1|COMPLETED|Overall Study||1414
232996|NCT01131312|564863|P3|STARTED|Overall Study||1836
232997|NCT01131312|564864|P2|STARTED|Overall Study||1385
232998|NCT01131312|564865|P1|STARTED|Overall Study||1839
232999|NCT01131299|564876|P2|NOT COMPLETED|Overall Study||7
233000|NCT01131299|564877|P1|NOT COMPLETED|Overall Study||4
233001|NCT01131299|564876|P2|COMPLETED|Overall Study||37
233002|NCT01131299|564877|P1|COMPLETED|Overall Study||38
233003|NCT01131299|564876|P2|STARTED|Overall Study||44
233004|NCT01131299|564877|P1|STARTED|Overall Study||42
233005|NCT01131260|564890|P2|NOT COMPLETED|Overall Study||47
233006|NCT01131260|564891|P1|NOT COMPLETED|Overall Study||44
233007|NCT01131260|564890|P2|COMPLETED|Overall Study||5529
233008|NCT01131260|564891|P1|COMPLETED|Overall Study||5488
233009|NCT01131260|564890|P2|STARTED|Overall Study||5576
233010|NCT01131260|564891|P1|STARTED|Overall Study||5532
233011|NCT01131182|564939|P2|NOT COMPLETED|Overall Study||16
233012|NCT01131182|564940|P1|NOT COMPLETED|Overall Study||16
233013|NCT01131182|564939|P2|COMPLETED|Overall Study||521
233014|NCT01131182|564940|P1|COMPLETED|Overall Study||513
233015|NCT01131182|564939|P2|STARTED|Overall Study||537
233016|NCT01131182|564940|P1|STARTED|Overall Study||529
233017|NCT01131130|564948|P1|NOT COMPLETED|Period 3- Crossover||1
233018|NCT01131130|564948|P1|COMPLETED|Period 3- Crossover||116
233019|NCT01131130|564948|P1|STARTED|Period 3- Crossover||117
233020|NCT01131130|564948|P1|NOT COMPLETED|Period 2 - Crossover||0
233021|NCT01131130|564948|P1|COMPLETED|Period 2 - Crossover||117
233022|NCT01131130|564948|P1|STARTED|Period 2 - Crossover||117
233023|NCT01131130|564948|P1|NOT COMPLETED|Period 1 - Baseline||1
233024|NCT01131130|564948|P1|COMPLETED|Period 1 - Baseline|Participant was discontinued 1 day following dispensing and not reported in result tables|117
233025|NCT01131130|564948|P1|STARTED|Period 1 - Baseline||118
233026|NCT01131104|564961|P1|NOT COMPLETED|Overall Study||13
233027|NCT01131104|564961|P1|COMPLETED|Overall Study||332
233028|NCT01131104|564961|P1|12-Month Analysis Set|Overall Study||26
233029|NCT01131104|564961|P1|42-Day Analysis Set|Overall Study||28
233030|NCT01131104|564961|P1|30-Day Analysis Set|Overall Study||24
233031|NCT01131104|564961|P1|Adjudication-Confirmed NAION Set|Overall Study||279
233032|NCT01131104|564961|P1|Study Set|Overall Study||344
233033|NCT01131104|564961|P1|STARTED|Overall Study||345
233034|NCT01131078|564968|P3|NOT COMPLETED|Overall Study||102
233035|NCT01131078|564969|P2|NOT COMPLETED|Overall Study||101
233036|NCT01131078|564970|P1|NOT COMPLETED|Overall Study||101
233037|NCT01131078|564968|P3|COMPLETED|Overall Study||1
233038|NCT01131078|564969|P2|COMPLETED|Overall Study||1
233039|NCT01131078|564970|P1|COMPLETED|Overall Study||0
233040|NCT01131078|564968|P3|STARTED|Overall Study||103
233041|NCT01131078|564969|P2|STARTED|Overall Study||102
233042|NCT01131078|564970|P1|STARTED|Overall Study||101
233043|NCT01131065|565026|P1|NOT COMPLETED|Overall Study||0
233044|NCT01131065|565026|P1|COMPLETED|Overall Study||15
233045|NCT01131065|565026|P1|STARTED|Overall Study||15
233046|NCT01131052|565034|P2|NOT COMPLETED|Overall Study||0
233047|NCT01131052|565035|P1|NOT COMPLETED|Overall Study||0
233048|NCT01131052|565034|P2|COMPLETED|Overall Study||75
233049|NCT01131052|565035|P1|COMPLETED|Overall Study||75
233050|NCT01131052|565034|P2|STARTED|Overall Study||75
233051|NCT01131052|565035|P1|STARTED|Overall Study||75
233052|NCT01130974|565057|P2|NOT COMPLETED|Overall Study||13
233053|NCT01130974|565058|P1|NOT COMPLETED|Overall Study||15
233054|NCT01130974|565057|P2|COMPLETED|Overall Study||87
233055|NCT01130974|565058|P1|COMPLETED|Overall Study||85
233056|NCT01130974|565057|P2|STARTED|Overall Study||100
233057|NCT01130974|565058|P1|STARTED|Overall Study||100
233058|NCT01130896|565078|P1|NOT COMPLETED|Overall Study||0
233059|NCT01130896|565078|P1|COMPLETED|Overall Study||1509
233060|NCT01130896|565078|P1|STARTED|Overall Study||1509
233061|NCT01130883|565084|P1|NOT COMPLETED|Overall Study||10
233062|NCT01130883|565084|P1|COMPLETED|Overall Study||3120
233063|NCT01130883|565084|P1|Participants Analyzed|Overall Study||3128
233064|NCT01130883|565084|P1|STARTED|Overall Study||3130
233065|NCT01130844|565101|P3|NOT COMPLETED|Overall Study||0
233066|NCT01130844|565102|P2|NOT COMPLETED|Overall Study||0
233067|NCT01130844|565103|P1|NOT COMPLETED|Overall Study||0
233068|NCT01130844|565101|P3|COMPLETED|Overall Study||9
233069|NCT01130844|565102|P2|COMPLETED|Overall Study||22
233070|NCT01130844|565103|P1|COMPLETED|Overall Study||21
233071|NCT01130844|565101|P3|STARTED|Overall Study||9
233072|NCT01130844|565102|P2|STARTED|Overall Study||22
233073|NCT01130844|565103|P1|STARTED|Overall Study||21
233074|NCT01130831|565141|P1|NOT COMPLETED|Overall Study||14
233075|NCT01130831|565141|P1|COMPLETED|Overall Study||52
233076|NCT01130831|565141|P1|STARTED|Overall Study||66
233077|NCT01130740|565169|P2|NOT COMPLETED|Overall Study||15
233078|NCT01130740|565170|P1|NOT COMPLETED|Overall Study||12
233079|NCT01130740|565169|P2|COMPLETED|Overall Study||136
233080|NCT01130740|565170|P1|COMPLETED|Overall Study||137
233081|NCT01130740|565169|P2|STARTED|Overall Study||151
233082|NCT01130740|565170|P1|STARTED|Overall Study||149
233083|NCT01130597|565180|P1|NOT COMPLETED|Overall Study||7
233084|NCT01130597|565180|P1|COMPLETED|Overall Study||56
233085|NCT01130597|565180|P1|STARTED|Overall Study||63
233086|NCT01130532|565205|P4|NOT COMPLETED|Period IV (Weeks 13-16)||10
233087|NCT01130532|565206|P3|NOT COMPLETED|Period IV (Weeks 13-16)||0
233088|NCT01130532|565207|P2|NOT COMPLETED|Period IV (Weeks 13-16)||0
233089|NCT01130532|565208|P1|NOT COMPLETED|Period IV (Weeks 13-16)||0
233090|NCT01130532|565205|P4|COMPLETED|Period IV (Weeks 13-16)||552
233091|NCT01130532|565206|P3|COMPLETED|Period IV (Weeks 13-16)||0
233092|NCT01130532|565207|P2|COMPLETED|Period IV (Weeks 13-16)||0
233093|NCT01130532|565208|P1|COMPLETED|Period IV (Weeks 13-16)||0
233094|NCT01130532|565205|P4|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||546
233095|NCT01130532|565206|P3|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
233096|NCT01130532|565207|P2|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
233097|NCT01130532|565208|P1|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
233098|NCT01130532|565205|P4|STARTED|Period IV (Weeks 13-16)|Three participants who completed Period III chose not to continue into Period IV.|562
233099|NCT01130532|565206|P3|STARTED|Period IV (Weeks 13-16)||0
233100|NCT01130532|565207|P2|STARTED|Period IV (Weeks 13-16)||0
233101|NCT01130532|565208|P1|STARTED|Period IV (Weeks 13-16)||0
233102|NCT01130532|565205|P4|NOT COMPLETED|Period III (Weeks 0-12)||0
233103|NCT01130532|565206|P3|NOT COMPLETED|Period III (Weeks 0-12)||19
233104|NCT01130532|565207|P2|NOT COMPLETED|Period III (Weeks 0-12)||18
233105|NCT01130532|565208|P1|NOT COMPLETED|Period III (Weeks 0-12)||21
233106|NCT01130532|565205|P4|COMPLETED|Period III (Weeks 0-12)||0
233107|NCT01130532|565206|P3|COMPLETED|Period III (Weeks 0-12)||190
233108|NCT01130532|565207|P2|COMPLETED|Period III (Weeks 0-12)||189
233109|NCT01130532|565208|P1|COMPLETED|Period III (Weeks 0-12)||186
233110|NCT01130532|565205|P4|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||0
233111|NCT01130532|565206|P3|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||207
233112|NCT01130532|565207|P2|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
233113|NCT01130532|565208|P1|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
233114|NCT01130532|565205|P4|STARTED|Period III (Weeks 0-12)||0
233115|NCT01130532|565206|P3|STARTED|Period III (Weeks 0-12)||209
233116|NCT01130532|565207|P2|STARTED|Period III (Weeks 0-12)||207
233117|NCT01130532|565208|P1|STARTED|Period III (Weeks 0-12)||207
233118|NCT01130493|565253|P3|NOT COMPLETED|Part 2: OLE||5
233119|NCT01130493|565254|P2|NOT COMPLETED|Part 2: OLE||3
233120|NCT01130493|565255|P1|NOT COMPLETED|Part 2: OLE||0
233121|NCT01130493|565253|P3|COMPLETED|Part 2: OLE||30
233122|NCT01130493|565254|P2|COMPLETED|Part 2: OLE||36
233123|NCT01130493|565255|P1|COMPLETED|Part 2: OLE||0
233124|NCT01130493|565253|P3|STARTED|Part 2: OLE|No subjects received CLE during OLE|35
233125|NCT01130493|565254|P2|STARTED|Part 2: OLE|All subjects received IPX066 during OLE|39
233126|NCT01130493|565255|P1|STARTED|Part 2: OLE||0
233127|NCT01130493|565253|P3|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||2
233128|NCT01130493|565254|P2|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
233129|NCT01130493|565255|P1|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
233130|NCT01130493|565253|P3|COMPLETED|Part 1: Double-blind Treatment Period 2||39
233131|NCT01130493|565254|P2|COMPLETED|Part 1: Double-blind Treatment Period 2||45
233132|NCT01130493|565255|P1|COMPLETED|Part 1: Double-blind Treatment Period 2||0
233133|NCT01130493|565253|P3|STARTED|Part 1: Double-blind Treatment Period 2||41
233134|NCT01130493|565254|P2|STARTED|Part 1: Double-blind Treatment Period 2||45
233135|NCT01130493|565255|P1|STARTED|Part 1: Double-blind Treatment Period 2||0
233136|NCT01130493|565253|P3|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||2
233137|NCT01130493|565254|P2|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||1
233138|NCT01130493|565255|P1|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||0
233139|NCT01130493|565253|P3|COMPLETED|Part 1: Open-Label IPX066 Washout||41
233140|NCT01130493|565254|P2|COMPLETED|Part 1: Open-Label IPX066 Washout||45
233141|NCT01130493|565255|P1|COMPLETED|Part 1: Open-Label IPX066 Washout||0
233142|NCT01130493|565253|P3|STARTED|Part 1: Open-Label IPX066 Washout||43
233143|NCT01130493|565254|P2|STARTED|Part 1: Open-Label IPX066 Washout||46
233144|NCT01130493|565255|P1|STARTED|Part 1: Open-Label IPX066 Washout||0
233145|NCT01130493|565253|P3|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
233146|NCT01130493|565254|P2|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||2
233147|NCT01130493|565255|P1|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
233148|NCT01130493|565253|P3|COMPLETED|Part 1: Double-blind Treatment Period 1||43
233149|NCT01130493|565254|P2|COMPLETED|Part 1: Double-blind Treatment Period 1||46
233150|NCT01130493|565255|P1|COMPLETED|Part 1: Double-blind Treatment Period 1||0
233151|NCT01130493|565253|P3|STARTED|Part 1: Double-blind Treatment Period 1|43 were randomized to CLE-IPX066 double-blind treatment sequence|43
233152|NCT01130493|565254|P2|STARTED|Part 1: Double-blind Treatment Period 1|48 were randomized to IPX066-CLE double-blind treatment sequence|48
233153|NCT01130493|565255|P1|STARTED|Part 1: Double-blind Treatment Period 1|91 subjects completed IPX066 dose conversion and were then randomized to the two treatment sequences|0
233154|NCT01130493|565253|P3|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
233155|NCT01130493|565254|P2|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
233156|NCT01130493|565255|P1|NOT COMPLETED|Open-label Dose Conversion to IPX066||19
233157|NCT01130493|565253|P3|COMPLETED|Open-label Dose Conversion to IPX066||0
233158|NCT01130493|565254|P2|COMPLETED|Open-label Dose Conversion to IPX066||0
233159|NCT01130493|565255|P1|COMPLETED|Open-label Dose Conversion to IPX066||91
233160|NCT01130493|565253|P3|STARTED|Open-label Dose Conversion to IPX066||0
233161|NCT01130493|565254|P2|STARTED|Open-label Dose Conversion to IPX066||0
233162|NCT01130493|565255|P1|STARTED|Open-label Dose Conversion to IPX066|During the open-label dose conversion to IPX066, all subjects received IPX066|110
233163|NCT01130337|565272|P1|NOT COMPLETED|Overall Study||14
233164|NCT01130337|565272|P1|COMPLETED|Overall Study||22
233165|NCT01130337|565272|P1|STARTED|Overall Study||36
233166|NCT01130272|565284|P5|NOT COMPLETED|Overall Study||52
233167|NCT01130272|565285|P4|NOT COMPLETED|Overall Study||68
233168|NCT01130272|565286|P3|NOT COMPLETED|Overall Study||48
233169|NCT01130272|565287|P2|NOT COMPLETED|Overall Study||42
233170|NCT01130272|565288|P1|NOT COMPLETED|Overall Study||59
233171|NCT01130272|565284|P5|COMPLETED|Overall Study||117
233172|NCT01130272|565285|P4|COMPLETED|Overall Study||103
233173|NCT01130272|565286|P3|COMPLETED|Overall Study||121
233174|NCT01130272|565287|P2|COMPLETED|Overall Study||131
233175|NCT01130272|565288|P1|COMPLETED|Overall Study||48
233176|NCT01130272|565284|P5|Safety Analysis Set: Highest Dose Level|Overall Study|159 total represents 2 patients out to 25 mg arm; 1 patient out to 5 mg arm.|159
233177|NCT01130272|565285|P4|Safety Analysis Set: Highest Dose Level|Overall Study|172 total represents 1 patient in from 5 mg; 3 patients in from 25 mg;1 patient in from 100 mg arms.|172
233178|NCT01130272|565286|P3|Safety Analysis Set: Highest Dose Level|Overall Study|165 total represents 1 patient out to 200 mg arm.|165
233179|NCT01130272|565287|P2|Safety Analysis Set: Highest Dose Level|Overall Study|170 total represents 2 patients in from Placebo arm; 3 patients out to 200 mg arm.|170
233180|NCT01130272|565288|P1|Safety Analysis Set: Highest Dose Level|Overall Study|105 total represents 1 patient in from Placebo arm; 1 patient out to 200 mg arm.|105
233181|NCT01130272|565284|P5|Safety Analysis Set: as Randomized|Overall Study||162
233182|NCT01130272|565285|P4|Safety Analysis Set: as Randomized|Overall Study||167
233183|NCT01130272|565286|P3|Safety Analysis Set: as Randomized|Overall Study||166
233184|NCT01130272|565287|P2|Safety Analysis Set: as Randomized|Overall Study||171
233185|NCT01130272|565288|P1|Safety Analysis Set: as Randomized|Overall Study||105
233186|NCT01130272|565284|P5|STARTED|Overall Study||169
233187|NCT01130272|565285|P4|STARTED|Overall Study||171
233188|NCT01130272|565286|P3|STARTED|Overall Study||169
233189|NCT01130272|565287|P2|STARTED|Overall Study||173
233190|NCT01130272|565288|P1|STARTED|Overall Study||107
233191|NCT01130168|565325|P6|NOT COMPLETED|Period 3||0
233192|NCT01130168|565326|P5|NOT COMPLETED|Period 3||0
233193|NCT01130168|565327|P4|NOT COMPLETED|Period 3||0
233194|NCT01130168|565328|P3|NOT COMPLETED|Period 3||0
233195|NCT01130168|565329|P2|NOT COMPLETED|Period 3||0
233196|NCT01130168|565330|P1|NOT COMPLETED|Period 3||0
233197|NCT01130168|565325|P6|COMPLETED|Period 3||6
233198|NCT01130168|565326|P5|COMPLETED|Period 3||5
233199|NCT01130168|565327|P4|COMPLETED|Period 3||5
233200|NCT01130168|565328|P3|COMPLETED|Period 3||5
233201|NCT01130168|565329|P2|COMPLETED|Period 3||6
233202|NCT01130168|565330|P1|COMPLETED|Period 3||6
233203|NCT01130168|565325|P6|STARTED|Period 3||6
233204|NCT01130168|565326|P5|STARTED|Period 3||5
233205|NCT01130168|565327|P4|STARTED|Period 3||5
233206|NCT01130168|565328|P3|STARTED|Period 3||5
233207|NCT01130168|565329|P2|STARTED|Period 3||6
233208|NCT01130168|565330|P1|STARTED|Period 3||6
233209|NCT01130168|565325|P6|NOT COMPLETED|Period 2||0
233210|NCT01130168|565326|P5|NOT COMPLETED|Period 2||0
233211|NCT01130168|565327|P4|NOT COMPLETED|Period 2||0
233212|NCT01130168|565328|P3|NOT COMPLETED|Period 2||0
233213|NCT01130168|565329|P2|NOT COMPLETED|Period 2||0
233214|NCT01130168|565330|P1|NOT COMPLETED|Period 2||0
233215|NCT01130168|565325|P6|COMPLETED|Period 2||6
233216|NCT01130168|565326|P5|COMPLETED|Period 2||5
233217|NCT01130168|565327|P4|COMPLETED|Period 2||5
233218|NCT01130168|565328|P3|COMPLETED|Period 2||5
233219|NCT01130168|565329|P2|COMPLETED|Period 2||6
233220|NCT01130168|565330|P1|COMPLETED|Period 2||6
233221|NCT01130168|565325|P6|STARTED|Period 2||6
233222|NCT01130168|565326|P5|STARTED|Period 2||5
233223|NCT01130168|565327|P4|STARTED|Period 2||5
233224|NCT01130168|565328|P3|STARTED|Period 2||5
233225|NCT01130168|565329|P2|STARTED|Period 2||6
233226|NCT01130168|565330|P1|STARTED|Period 2||6
233227|NCT01130168|565325|P6|NOT COMPLETED|Period 1||0
233228|NCT01130168|565326|P5|NOT COMPLETED|Period 1||0
233229|NCT01130168|565327|P4|NOT COMPLETED|Period 1||3
233230|NCT01130168|565328|P3|NOT COMPLETED|Period 1||1
233231|NCT01130168|565329|P2|NOT COMPLETED|Period 1||1
233232|NCT01130168|565330|P1|NOT COMPLETED|Period 1||0
233233|NCT01130168|565325|P6|COMPLETED|Period 1||6
233234|NCT01130168|565326|P5|COMPLETED|Period 1||5
233235|NCT01130168|565327|P4|COMPLETED|Period 1||5
233236|NCT01130168|565328|P3|COMPLETED|Period 1||5
233237|NCT01130168|565329|P2|COMPLETED|Period 1||6
233238|NCT01130168|565330|P1|COMPLETED|Period 1||6
233239|NCT01130168|565325|P6|STARTED|Period 1||6
233240|NCT01130168|565326|P5|STARTED|Period 1||5
233241|NCT01130168|565327|P4|STARTED|Period 1||8
233242|NCT01130168|565328|P3|STARTED|Period 1||6
233243|NCT01130168|565329|P2|STARTED|Period 1||7
233244|NCT01130168|565330|P1|STARTED|Period 1||6
233245|NCT01130103|565367|P2|NOT COMPLETED|Maintenance Treatment||2
233246|NCT01130103|565368|P1|NOT COMPLETED|Maintenance Treatment||2
233247|NCT01130103|565367|P2|COMPLETED|Maintenance Treatment||11
233248|NCT01130103|565368|P1|COMPLETED|Maintenance Treatment||11
233249|NCT01130103|565367|P2|STARTED|Maintenance Treatment||13
233250|NCT01130103|565368|P1|STARTED|Maintenance Treatment||13
233251|NCT01130103|565367|P2|NOT COMPLETED|Randomized Treatment||5
233252|NCT01130103|565368|P1|NOT COMPLETED|Randomized Treatment||6
233253|NCT01130103|565367|P2|COMPLETED|Randomized Treatment||13
233254|NCT01130103|565368|P1|COMPLETED|Randomized Treatment||13
233255|NCT01130103|565367|P2|STARTED|Randomized Treatment||18
233256|NCT01130103|565368|P1|STARTED|Randomized Treatment||19
233257|NCT01130051|565382|P2|NOT COMPLETED|Period 2||0
233258|NCT01130051|565383|P1|NOT COMPLETED|Period 2||0
233259|NCT01130051|565382|P2|COMPLETED|Period 2||6
233260|NCT01130051|565383|P1|COMPLETED|Period 2||7
233261|NCT01130051|565382|P2|STARTED|Period 2||6
233262|NCT01130051|565383|P1|STARTED|Period 2||7
233263|NCT01130051|565382|P2|NOT COMPLETED|Washout Period of 14 Days||2
233264|NCT01130051|565383|P1|NOT COMPLETED|Washout Period of 14 Days||1
233265|NCT01130051|565382|P2|COMPLETED|Washout Period of 14 Days||6
233266|NCT01130051|565383|P1|COMPLETED|Washout Period of 14 Days||7
233267|NCT01130051|565382|P2|STARTED|Washout Period of 14 Days||8
233268|NCT01130051|565383|P1|STARTED|Washout Period of 14 Days||8
233269|NCT01130051|565382|P2|NOT COMPLETED|Period 1||0
233270|NCT01130051|565383|P1|NOT COMPLETED|Period 1||0
233271|NCT01130051|565382|P2|COMPLETED|Period 1||8
233272|NCT01130051|565383|P1|COMPLETED|Period 1||8
233273|NCT01130051|565382|P2|STARTED|Period 1||8
233274|NCT01130051|565383|P1|STARTED|Period 1||8
233275|NCT01129960|565397|P4|NOT COMPLETED|Overall Study||13
233276|NCT01129960|565398|P3|NOT COMPLETED|Overall Study||26
233277|NCT01129960|565399|P2|NOT COMPLETED|Overall Study||22
233278|NCT01129960|565400|P1|NOT COMPLETED|Overall Study||30
233279|NCT01129960|565397|P4|COMPLETED|Overall Study||70
233280|NCT01129960|565398|P3|COMPLETED|Overall Study||56
233281|NCT01129960|565399|P2|COMPLETED|Overall Study||61
233282|NCT01129960|565400|P1|COMPLETED|Overall Study||54
233283|NCT01129960|565397|P4|Full Analysis Set (FAS|Overall Study||71
233284|NCT01129960|565398|P3|Full Analysis Set (FAS|Overall Study||68
233285|NCT01129960|565399|P2|Full Analysis Set (FAS|Overall Study||67
233286|NCT01129960|565400|P1|Full Analysis Set (FAS|Overall Study||71
233287|NCT01129960|565397|P4|Per-Protocol|Overall Study||55
233288|NCT01129960|565398|P3|Per-Protocol|Overall Study||49
233289|NCT01129960|565399|P2|Per-Protocol|Overall Study||52
233290|NCT01129960|565400|P1|Per-Protocol|Overall Study||34
233291|NCT01129960|565397|P4|Intent-to-Treat|Overall Study||83
233292|NCT01129960|565398|P3|Intent-to-Treat|Overall Study||82
233293|NCT01129960|565399|P2|Intent-to-Treat|Overall Study||83
233294|NCT01129960|565400|P1|Intent-to-Treat|Overall Study||84
233295|NCT01129960|565397|P4|Safety|Overall Study||82
233296|NCT01129960|565398|P3|Safety|Overall Study|One subject was randomized to placebo, but was dispensed in error with an ESL 800 mg kit at DB Visit|83
233297|NCT01129960|565399|P2|Safety|Overall Study||83
233298|NCT01129960|565400|P1|Safety|Overall Study||84
233299|NCT01129960|565397|P4|STARTED|Overall Study||83
233300|NCT01129960|565398|P3|STARTED|Overall Study||82
233301|NCT01129960|565399|P2|STARTED|Overall Study||83
233302|NCT01129960|565400|P1|STARTED|Overall Study||84
233303|NCT01129921|565412|P2|NOT COMPLETED|After Sham Cross-over to Mild, One Year||7
233304|NCT01129921|565413|P1|NOT COMPLETED|After Sham Cross-over to Mild, One Year||2
233305|NCT01129921|565412|P2|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis prior to x-over. After x-over 13 reported Year 1.|13
233306|NCT01129921|565413|P1|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis. Eighteen reported Year 1 outcomes.|18
233307|NCT01129921|565412|P2|STARTED|After Sham Cross-over to Mild, One Year||20
233308|NCT01129921|565413|P1|STARTED|After Sham Cross-over to Mild, One Year||20
233309|NCT01129921|565412|P2|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
233310|NCT01129921|565413|P1|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
233311|NCT01129921|565412|P2|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
233312|NCT01129921|565413|P1|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
233313|NCT01129921|565412|P2|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
233314|NCT01129921|565413|P1|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
233315|NCT01129778|565423|P1|NOT COMPLETED|Overall Study||7
233316|NCT01129778|565423|P1|COMPLETED|Overall Study||15
233317|NCT01129778|565423|P1|STARTED|Overall Study||22
233318|NCT01129765|565428|P1|NOT COMPLETED|Overall Study||0
233319|NCT01129765|565428|P1|COMPLETED|Overall Study||30
233320|NCT01129765|565428|P1|STARTED|Overall Study||30
233321|NCT01129622|565437|P1|NOT COMPLETED|Overall Study||2
233322|NCT01129622|565437|P1|COMPLETED|Overall Study||14
233323|NCT01129622|565437|P1|STARTED|Overall Study||16
233324|NCT01129609|565442|P1|NOT COMPLETED|Overall Study||2
233325|NCT01129609|565442|P1|COMPLETED|Overall Study||18
233326|NCT01129609|565442|P1|STARTED|Overall Study||20
233327|NCT01129583|565448|P2|NOT COMPLETED|Overall Study||2
233328|NCT01129583|565449|P1|NOT COMPLETED|Overall Study||3
233329|NCT01129583|565448|P2|COMPLETED|Overall Study||7
233330|NCT01129583|565449|P1|COMPLETED|Overall Study||6
233331|NCT01129583|565448|P2|STARTED|Overall Study||9
233332|NCT01129583|565449|P1|STARTED|Overall Study||9
233333|NCT01129557|565462|P3|NOT COMPLETED|Overall Study||4
233334|NCT01129557|565463|P2|NOT COMPLETED|Overall Study||5
233335|NCT01129557|565464|P1|NOT COMPLETED|Overall Study||4
233336|NCT01129557|565462|P3|COMPLETED|Overall Study||10
233337|NCT01129557|565463|P2|COMPLETED|Overall Study||12
233338|NCT01129557|565464|P1|COMPLETED|Overall Study||11
233339|NCT01129557|565462|P3|STARTED|Overall Study||14
233340|NCT01129557|565463|P2|STARTED|Overall Study||17
233341|NCT01129557|565464|P1|STARTED|Overall Study||15
233342|NCT01129531|565535|P3|NOT COMPLETED|Treatment Cycle 2||5
233343|NCT01129531|565536|P2|NOT COMPLETED|Treatment Cycle 2||3
233344|NCT01129531|565537|P1|NOT COMPLETED|Treatment Cycle 2||6
233345|NCT01129531|565535|P3|COMPLETED|Treatment Cycle 2||74
233346|NCT01129531|565536|P2|COMPLETED|Treatment Cycle 2||92
233347|NCT01129531|565537|P1|COMPLETED|Treatment Cycle 2||88
233348|NCT01129531|565535|P3|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|79
233349|NCT01129531|565536|P2|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|95
233350|NCT01129531|565537|P1|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|94
233351|NCT01129531|565535|P3|NOT COMPLETED|Treatment Cycle 1||16
233352|NCT01129531|565536|P2|NOT COMPLETED|Treatment Cycle 1||6
233353|NCT01129531|565537|P1|NOT COMPLETED|Treatment Cycle 1||4
233354|NCT01129531|565535|P3|COMPLETED|Treatment Cycle 1||110
233355|NCT01129531|565536|P2|COMPLETED|Treatment Cycle 1||78
233356|NCT01129531|565537|P1|COMPLETED|Treatment Cycle 1||80
233357|NCT01129531|565535|P3|STARTED|Treatment Cycle 1||126
233358|NCT01129531|565536|P2|STARTED|Treatment Cycle 1||84
233359|NCT01129531|565537|P1|STARTED|Treatment Cycle 1||84
233360|NCT01129336|565559|P2|NOT COMPLETED|Overall Study||16
233361|NCT01129336|565560|P1|NOT COMPLETED|Overall Study||12
233362|NCT01129336|565559|P2|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|13
233363|NCT01129336|565560|P1|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|3
233364|NCT01129336|565559|P2|Completed Treatment|Overall Study||3
233365|NCT01129336|565560|P1|Completed Treatment|Overall Study||1
233366|NCT01129336|565559|P2|STARTED|Overall Study||29
233367|NCT01129336|565560|P1|STARTED|Overall Study||15
233368|NCT01129284|565575|P3|NOT COMPLETED|Overall Study||1
233369|NCT01129284|565576|P2|NOT COMPLETED|Overall Study||0
233370|NCT01129284|565577|P1|NOT COMPLETED|Overall Study||2
233371|NCT01129284|565575|P3|COMPLETED|Overall Study||4
233372|NCT01129284|565576|P2|COMPLETED|Overall Study||5
233373|NCT01129284|565577|P1|COMPLETED|Overall Study||3
233374|NCT01129284|565575|P3|STARTED|Overall Study||5
233375|NCT01129284|565576|P2|STARTED|Overall Study||5
233376|NCT01129284|565577|P1|STARTED|Overall Study||5
233377|NCT01129245|565590|P2|NOT COMPLETED|Treatment Cycle 2||0
233378|NCT01129245|565591|P1|NOT COMPLETED|Treatment Cycle 2||0
233379|NCT01129245|565590|P2|COMPLETED|Treatment Cycle 2||10
233380|NCT01129245|565591|P1|COMPLETED|Treatment Cycle 2||10
233381|NCT01129245|565590|P2|STARTED|Treatment Cycle 2||10
233382|NCT01129245|565591|P1|STARTED|Treatment Cycle 2||10
233383|NCT01129245|565590|P2|NOT COMPLETED|Washout Cycle||0
233384|NCT01129245|565591|P1|NOT COMPLETED|Washout Cycle||0
233385|NCT01129245|565590|P2|COMPLETED|Washout Cycle||10
233386|NCT01129245|565591|P1|COMPLETED|Washout Cycle||10
233387|NCT01129245|565590|P2|STARTED|Washout Cycle||10
233388|NCT01129245|565591|P1|STARTED|Washout Cycle||10
233389|NCT01129245|565590|P2|NOT COMPLETED|Treatment Cycle 1||0
233390|NCT01129245|565591|P1|NOT COMPLETED|Treatment Cycle 1||0
233391|NCT01129245|565590|P2|COMPLETED|Treatment Cycle 1||10
233392|NCT01129245|565591|P1|COMPLETED|Treatment Cycle 1||10
233393|NCT01129245|565590|P2|STARTED|Treatment Cycle 1||10
233394|NCT01129245|565591|P1|STARTED|Treatment Cycle 1||10
233395|NCT01129245|565590|P2|NOT COMPLETED|Control Cycle (no Celecoxib or Placebo)||0
233396|NCT01129245|565591|P1|NOT COMPLETED|Control Cycle (no Celecoxib or Placebo)||0
233397|NCT01129245|565590|P2|COMPLETED|Control Cycle (no Celecoxib or Placebo)||10
233398|NCT01129245|565591|P1|COMPLETED|Control Cycle (no Celecoxib or Placebo)||10
233399|NCT01129245|565590|P2|STARTED|Control Cycle (no Celecoxib or Placebo)||10
233400|NCT01129245|565591|P1|STARTED|Control Cycle (no Celecoxib or Placebo)||10
233401|NCT01129206|565605|P1|NOT COMPLETED|Overall Study||0
233402|NCT01129206|565605|P1|COMPLETED|Overall Study||6
233403|NCT01129206|565605|P1|STARTED|Overall Study||6
233404|NCT01129141|565615|P2|NOT COMPLETED|Overall Study||13
233405|NCT01129141|565616|P1|NOT COMPLETED|Overall Study||15
233406|NCT01129141|565615|P2|COMPLETED|Overall Study||91
233407|NCT01129141|565616|P1|COMPLETED|Overall Study||86
233408|NCT01129141|565615|P2|STARTED|Overall Study||104
233409|NCT01129141|565616|P1|STARTED|Overall Study||101
233410|NCT01129128|565625|P3|NOT COMPLETED|Overall Study||4
233411|NCT01129128|565626|P2|NOT COMPLETED|Overall Study||4
233412|NCT01129128|565627|P1|NOT COMPLETED|Overall Study||3
233413|NCT01129128|565625|P3|COMPLETED|Overall Study||19
233414|NCT01129128|565626|P2|COMPLETED|Overall Study||18
233415|NCT01129128|565627|P1|COMPLETED|Overall Study||19
233416|NCT01129128|565625|P3|STARTED|Overall Study||23
233417|NCT01129128|565626|P2|STARTED|Overall Study||22
233418|NCT01129128|565627|P1|STARTED|Overall Study||22
233419|NCT01129115|565651|P4|NOT COMPLETED|Overall Study||9
233420|NCT01129115|565652|P3|NOT COMPLETED|Overall Study||6
233421|NCT01129115|565653|P2|NOT COMPLETED|Overall Study||7
233422|NCT01129115|565654|P1|NOT COMPLETED|Overall Study||2
233423|NCT01129115|565651|P4|COMPLETED|Overall Study||15
233424|NCT01129115|565652|P3|COMPLETED|Overall Study||21
233425|NCT01129115|565653|P2|COMPLETED|Overall Study||18
233426|NCT01129115|565654|P1|COMPLETED|Overall Study||23
233427|NCT01129115|565651|P4|STARTED|Overall Study||24
233428|NCT01129115|565652|P3|STARTED|Overall Study||27
233429|NCT01129115|565653|P2|STARTED|Overall Study||25
233430|NCT01129115|565654|P1|STARTED|Overall Study||25
233431|NCT01129102|565691|P3|NOT COMPLETED|Overall Study||7
233432|NCT01129102|565692|P2|NOT COMPLETED|Overall Study||6
233433|NCT01129102|565693|P1|NOT COMPLETED|Overall Study||8
233434|NCT01129102|565691|P3|COMPLETED|Overall Study||48
233435|NCT01129102|565692|P2|COMPLETED|Overall Study||44
233436|NCT01129102|565693|P1|COMPLETED|Overall Study||102
233437|NCT01129102|565691|P3|STARTED|Overall Study||55
233438|NCT01129102|565692|P2|STARTED|Overall Study||50
233439|NCT01129102|565693|P1|STARTED|Overall Study||110
233440|NCT01129011|565704|P2|NOT COMPLETED|Overall Study||57
233441|NCT01129011|565705|P1|NOT COMPLETED|Overall Study||59
233442|NCT01129011|565704|P2|COMPLETED|Overall Study||153
233443|NCT01129011|565705|P1|COMPLETED|Overall Study||151
233444|NCT01129011|565704|P2|STARTED|Overall Study|Safety, Intent-to-Treat population|210
233445|NCT01129011|565705|P1|STARTED|Overall Study|Safety, Intent-to-Treat population|210
233446|NCT01128972|565727|P5|NOT COMPLETED|Period V||0
233447|NCT01128972|565728|P4|NOT COMPLETED|Period V||0
233448|NCT01128972|565729|P3|NOT COMPLETED|Period V||0
233449|NCT01128972|565730|P2|NOT COMPLETED|Period V||0
233450|NCT01128972|565731|P1|NOT COMPLETED|Period V||0
233451|NCT01128972|565727|P5|COMPLETED|Period V||7
233452|NCT01128972|565728|P4|COMPLETED|Period V||7
233453|NCT01128972|565729|P3|COMPLETED|Period V||7
233454|NCT01128972|565730|P2|COMPLETED|Period V||7
233455|NCT01128972|565731|P1|COMPLETED|Period V||8
233456|NCT01128972|565727|P5|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
233457|NCT01128972|565728|P4|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
233458|NCT01128972|565729|P3|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
233459|NCT01128972|565730|P2|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
233460|NCT01128972|565731|P1|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|8
233461|NCT01128972|565727|P5|NOT COMPLETED|Period IV||0
233462|NCT01128972|565728|P4|NOT COMPLETED|Period IV||0
233463|NCT01128972|565729|P3|NOT COMPLETED|Period IV||0
233464|NCT01128972|565730|P2|NOT COMPLETED|Period IV||0
233465|NCT01128972|565731|P1|NOT COMPLETED|Period IV||0
233466|NCT01128972|565727|P5|COMPLETED|Period IV||7
233467|NCT01128972|565728|P4|COMPLETED|Period IV||7
233468|NCT01128972|565729|P3|COMPLETED|Period IV||7
233469|NCT01128972|565730|P2|COMPLETED|Period IV||8
233470|NCT01128972|565731|P1|COMPLETED|Period IV||7
233471|NCT01128972|565727|P5|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
233472|NCT01128972|565728|P4|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
233473|NCT01128972|565729|P3|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
233474|NCT01128972|565730|P2|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|8
233475|NCT01128972|565731|P1|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
233476|NCT01128972|565727|P5|NOT COMPLETED|Period III||0
233477|NCT01128972|565728|P4|NOT COMPLETED|Period III||0
233478|NCT01128972|565729|P3|NOT COMPLETED|Period III||0
233479|NCT01128972|565730|P2|NOT COMPLETED|Period III||0
233480|NCT01128972|565731|P1|NOT COMPLETED|Period III||0
233481|NCT01128972|565727|P5|COMPLETED|Period III||7
233482|NCT01128972|565728|P4|COMPLETED|Period III||7
233483|NCT01128972|565729|P3|COMPLETED|Period III||8
233484|NCT01128972|565730|P2|COMPLETED|Period III||7
233485|NCT01128972|565731|P1|COMPLETED|Period III||7
233486|NCT01128972|565727|P5|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
233487|NCT01128972|565728|P4|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
233488|NCT01128972|565729|P3|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|8
233489|NCT01128972|565730|P2|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
233490|NCT01128972|565731|P1|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
233491|NCT01128972|565727|P5|NOT COMPLETED|Period II||0
233492|NCT01128972|565728|P4|NOT COMPLETED|Period II||0
233493|NCT01128972|565729|P3|NOT COMPLETED|Period II||0
233494|NCT01128972|565730|P2|NOT COMPLETED|Period II||0
233495|NCT01128972|565731|P1|NOT COMPLETED|Period II||0
233496|NCT01128972|565727|P5|COMPLETED|Period II||7
233497|NCT01128972|565728|P4|COMPLETED|Period II||8
233498|NCT01128972|565729|P3|COMPLETED|Period II||7
233499|NCT01128972|565730|P2|COMPLETED|Period II||7
233500|NCT01128972|565731|P1|COMPLETED|Period II||7
233501|NCT01128972|565727|P5|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
233502|NCT01128972|565728|P4|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|8
233503|NCT01128972|565729|P3|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
233504|NCT01128972|565730|P2|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
233505|NCT01128972|565731|P1|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
233506|NCT01128972|565727|P5|NOT COMPLETED|Period I||0
233507|NCT01128972|565728|P4|NOT COMPLETED|Period I||0
233508|NCT01128972|565729|P3|NOT COMPLETED|Period I||0
233509|NCT01128972|565730|P2|NOT COMPLETED|Period I||0
233510|NCT01128972|565731|P1|NOT COMPLETED|Period I||0
233511|NCT01128972|565727|P5|COMPLETED|Period I||8
233512|NCT01128972|565728|P4|COMPLETED|Period I||7
233513|NCT01128972|565729|P3|COMPLETED|Period I||7
233514|NCT01128972|565730|P2|COMPLETED|Period I||7
233515|NCT01128972|565731|P1|COMPLETED|Period I||7
233516|NCT01128972|565727|P5|STARTED|Period I||8
233517|NCT01128972|565728|P4|STARTED|Period I||7
233518|NCT01128972|565729|P3|STARTED|Period I||7
233519|NCT01128972|565730|P2|STARTED|Period I||7
233520|NCT01128972|565731|P1|STARTED|Period I||7
233521|NCT01128959|565760|P1|NOT COMPLETED|Treatment Period||4
233522|NCT01128959|565760|P1|COMPLETED|Treatment Period||101
233523|NCT01128959|565760|P1|STARTED|Treatment Period||105
233524|NCT01128959|565760|P1|NOT COMPLETED|Lead in Period||3
233525|NCT01128959|565760|P1|COMPLETED|Lead in Period||105
233526|NCT01128959|565760|P1|STARTED|Lead in Period||108
233527|NCT01128946|565766|P4|NOT COMPLETED|Period IV||0
233528|NCT01128946|565767|P3|NOT COMPLETED|Period IV||0
233529|NCT01128946|565768|P2|NOT COMPLETED|Period IV||0
233530|NCT01128946|565769|P1|NOT COMPLETED|Period IV||0
233531|NCT01128946|565766|P4|COMPLETED|Period IV||19
233532|NCT01128946|565767|P3|COMPLETED|Period IV||19
233533|NCT01128946|565768|P2|COMPLETED|Period IV||20
233534|NCT01128946|565769|P1|COMPLETED|Period IV||19
233535|NCT01128946|565766|P4|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
233536|NCT01128946|565767|P3|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
233537|NCT01128946|565768|P2|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|20
233538|NCT01128946|565769|P1|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
233539|NCT01128946|565766|P4|NOT COMPLETED|Period III||0
233540|NCT01128946|565767|P3|NOT COMPLETED|Period III||0
233541|NCT01128946|565768|P2|NOT COMPLETED|Period III||0
233542|NCT01128946|565769|P1|NOT COMPLETED|Period III||1
233543|NCT01128946|565766|P4|COMPLETED|Period III||19
233544|NCT01128946|565767|P3|COMPLETED|Period III||20
233545|NCT01128946|565768|P2|COMPLETED|Period III||19
233546|NCT01128946|565769|P1|COMPLETED|Period III||19
233547|NCT01128946|565766|P4|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
233548|NCT01128946|565767|P3|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
233549|NCT01128946|565768|P2|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
233550|NCT01128946|565769|P1|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
233551|NCT01128946|565766|P4|NOT COMPLETED|Period II||1
233552|NCT01128946|565767|P3|NOT COMPLETED|Period II||0
233553|NCT01128946|565768|P2|NOT COMPLETED|Period II||1
233554|NCT01128946|565769|P1|NOT COMPLETED|Period II||0
233555|NCT01128946|565766|P4|COMPLETED|Period II||19
233556|NCT01128946|565767|P3|COMPLETED|Period II||20
233557|NCT01128946|565768|P2|COMPLETED|Period II||19
233558|NCT01128946|565769|P1|COMPLETED|Period II||20
233559|NCT01128946|565766|P4|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
233560|NCT01128946|565767|P3|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
233561|NCT01128946|565768|P2|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
233562|NCT01128946|565769|P1|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
233563|NCT01128946|565766|P4|NOT COMPLETED|Period I||1
233564|NCT01128946|565767|P3|NOT COMPLETED|Period I||1
233565|NCT01128946|565768|P2|NOT COMPLETED|Period I||1
233566|NCT01128946|565769|P1|NOT COMPLETED|Period I||0
233567|NCT01128946|565766|P4|COMPLETED|Period I||20
233568|NCT01128946|565767|P3|COMPLETED|Period I||20
233569|NCT01128946|565768|P2|COMPLETED|Period I||20
233570|NCT01128946|565769|P1|COMPLETED|Period I||20
233571|NCT01128946|565766|P4|STARTED|Period I||21
233572|NCT01128946|565767|P3|STARTED|Period I||21
233573|NCT01128946|565768|P2|STARTED|Period I||21
233574|NCT01128946|565769|P1|STARTED|Period I||20
233575|NCT01128894|565787|P2|NOT COMPLETED|Overall Study||68
233576|NCT01128894|565788|P1|NOT COMPLETED|Overall Study||58
233577|NCT01128894|565787|P2|COMPLETED|Overall Study||340
233578|NCT01128894|565788|P1|COMPLETED|Overall Study||346
233579|NCT01128894|565787|P2|STARTED|Overall Study||408
233580|NCT01128894|565788|P1|STARTED|Overall Study||404
233581|NCT01128842|565806|P1|NOT COMPLETED|Overall Study||7
233582|NCT01128842|565806|P1|COMPLETED|Overall Study||0
233583|NCT01128842|565806|P1|STARTED|Overall Study||7
233584|NCT01128829|565816|P2|NOT COMPLETED|Overall Study||0
233585|NCT01128829|565817|P1|NOT COMPLETED|Overall Study||0
233586|NCT01128829|565816|P2|COMPLETED|Overall Study||11
233587|NCT01128829|565817|P1|COMPLETED|Overall Study||6
233588|NCT01128829|565816|P2|STARTED|Overall Study||11
233589|NCT01128829|565817|P1|STARTED|Overall Study||6
233590|NCT01128738|565823|P2|NOT COMPLETED|Second TP||3
233591|NCT01128738|565824|P1|NOT COMPLETED|Second TP||0
233592|NCT01128738|565823|P2|COMPLETED|Second TP||63
233593|NCT01128738|565824|P1|COMPLETED|Second TP||34
233594|NCT01128738|565823|P2|STARTED|Second TP|Only participants who received a second treatment entered this phase.|66
233595|NCT01128738|565824|P1|STARTED|Second TP|Only participants who received a second treatment entered this phase.|34
233596|NCT01128738|565823|P2|NOT COMPLETED|First Treatment Phase (TP)||1
233597|NCT01128738|565824|P1|NOT COMPLETED|First Treatment Phase (TP)||4
233598|NCT01128738|565823|P2|COMPLETED|First Treatment Phase (TP)||73
233599|NCT01128738|565824|P1|COMPLETED|First Treatment Phase (TP)||74
233600|NCT01128738|565823|P2|STARTED|First Treatment Phase (TP)||74
233601|NCT01128738|565824|P1|STARTED|First Treatment Phase (TP)||78
233602|NCT01128621|565949|P2|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||2
233603|NCT01128621|565950|P1|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
233604|NCT01128621|565949|P2|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||65
233605|NCT01128621|565950|P1|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
233606|NCT01128621|565949|P2|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||67
233607|NCT01128621|565950|P1|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
233608|NCT01128621|565949|P2|NOT COMPLETED|Part A: GSK1292263 300 mg||0
233609|NCT01128621|565950|P1|NOT COMPLETED|Part A: GSK1292263 300 mg||0
233610|NCT01128621|565949|P2|COMPLETED|Part A: GSK1292263 300 mg||0
233611|NCT01128621|565950|P1|COMPLETED|Part A: GSK1292263 300 mg||6
233612|NCT01128621|565949|P2|STARTED|Part A: GSK1292263 300 mg||0
233613|NCT01128621|565950|P1|STARTED|Part A: GSK1292263 300 mg||6
233614|NCT01128595|566071|P4|NOT COMPLETED|Treatment Period 4||0
233615|NCT01128595|566072|P3|NOT COMPLETED|Treatment Period 4||0
233616|NCT01128595|566073|P2|NOT COMPLETED|Treatment Period 4||0
233617|NCT01128595|566074|P1|NOT COMPLETED|Treatment Period 4||0
233618|NCT01128595|566071|P4|COMPLETED|Treatment Period 4||7
233619|NCT01128595|566072|P3|COMPLETED|Treatment Period 4||7
233620|NCT01128595|566073|P2|COMPLETED|Treatment Period 4||5
233621|NCT01128595|566074|P1|COMPLETED|Treatment Period 4||7
233622|NCT01128595|566071|P4|STARTED|Treatment Period 4||7
233623|NCT01128595|566072|P3|STARTED|Treatment Period 4||7
233624|NCT01128595|566073|P2|STARTED|Treatment Period 4||5
233625|NCT01128595|566074|P1|STARTED|Treatment Period 4||7
233626|NCT01128595|566071|P4|NOT COMPLETED|Washout Period 3||0
233627|NCT01128595|566072|P3|NOT COMPLETED|Washout Period 3||0
233628|NCT01128595|566073|P2|NOT COMPLETED|Washout Period 3||0
233629|NCT01128595|566074|P1|NOT COMPLETED|Washout Period 3||0
233630|NCT01128595|566071|P4|COMPLETED|Washout Period 3||7
233631|NCT01128595|566072|P3|COMPLETED|Washout Period 3||7
233632|NCT01128595|566073|P2|COMPLETED|Washout Period 3||5
233633|NCT01128595|566074|P1|COMPLETED|Washout Period 3||7
233634|NCT01128595|566071|P4|STARTED|Washout Period 3||7
233635|NCT01128595|566072|P3|STARTED|Washout Period 3||7
233636|NCT01128595|566073|P2|STARTED|Washout Period 3||5
233637|NCT01128595|566074|P1|STARTED|Washout Period 3||7
233638|NCT01128595|566071|P4|NOT COMPLETED|Treatment Period 3||0
233639|NCT01128595|566072|P3|NOT COMPLETED|Treatment Period 3||0
233640|NCT01128595|566073|P2|NOT COMPLETED|Treatment Period 3||1
233641|NCT01128595|566074|P1|NOT COMPLETED|Treatment Period 3||0
233642|NCT01128595|566071|P4|COMPLETED|Treatment Period 3||7
233643|NCT01128595|566072|P3|COMPLETED|Treatment Period 3||7
233644|NCT01128595|566073|P2|COMPLETED|Treatment Period 3||5
233645|NCT01128595|566074|P1|COMPLETED|Treatment Period 3||7
233646|NCT01128595|566071|P4|STARTED|Treatment Period 3||7
233647|NCT01128595|566072|P3|STARTED|Treatment Period 3||7
233648|NCT01128595|566073|P2|STARTED|Treatment Period 3||6
233649|NCT01128595|566074|P1|STARTED|Treatment Period 3||7
233650|NCT01128595|566071|P4|NOT COMPLETED|Washout Period 2||0
233651|NCT01128595|566072|P3|NOT COMPLETED|Washout Period 2||0
233652|NCT01128595|566073|P2|NOT COMPLETED|Washout Period 2||0
233653|NCT01128595|566074|P1|NOT COMPLETED|Washout Period 2||0
233654|NCT01128595|566071|P4|COMPLETED|Washout Period 2||7
233655|NCT01128595|566072|P3|COMPLETED|Washout Period 2||7
233656|NCT01128595|566073|P2|COMPLETED|Washout Period 2||6
233657|NCT01128595|566074|P1|COMPLETED|Washout Period 2||7
233658|NCT01128595|566071|P4|STARTED|Washout Period 2||7
233659|NCT01128595|566072|P3|STARTED|Washout Period 2||7
233660|NCT01128595|566073|P2|STARTED|Washout Period 2||6
233661|NCT01128595|566074|P1|STARTED|Washout Period 2||7
233662|NCT01128595|566071|P4|NOT COMPLETED|Treatment Period 2||0
233663|NCT01128595|566072|P3|NOT COMPLETED|Treatment Period 2||0
233664|NCT01128595|566073|P2|NOT COMPLETED|Treatment Period 2||0
233665|NCT01128595|566074|P1|NOT COMPLETED|Treatment Period 2||0
233666|NCT01128595|566071|P4|COMPLETED|Treatment Period 2||7
233667|NCT01128595|566072|P3|COMPLETED|Treatment Period 2||7
233668|NCT01128595|566073|P2|COMPLETED|Treatment Period 2||6
233669|NCT01128595|566074|P1|COMPLETED|Treatment Period 2||7
233670|NCT01128595|566071|P4|STARTED|Treatment Period 2||7
233671|NCT01128595|566072|P3|STARTED|Treatment Period 2||7
233672|NCT01128595|566073|P2|STARTED|Treatment Period 2||6
233673|NCT01128595|566074|P1|STARTED|Treatment Period 2||7
233674|NCT01128595|566071|P4|NOT COMPLETED|Washout Period 1||0
233675|NCT01128595|566072|P3|NOT COMPLETED|Washout Period 1||0
233676|NCT01128595|566073|P2|NOT COMPLETED|Washout Period 1||0
233677|NCT01128595|566074|P1|NOT COMPLETED|Washout Period 1||0
233678|NCT01128595|566071|P4|COMPLETED|Washout Period 1||7
233679|NCT01128595|566072|P3|COMPLETED|Washout Period 1||7
233680|NCT01128595|566073|P2|COMPLETED|Washout Period 1||6
233681|NCT01128595|566074|P1|COMPLETED|Washout Period 1||7
233682|NCT01128595|566071|P4|STARTED|Washout Period 1||7
233683|NCT01128595|566072|P3|STARTED|Washout Period 1||7
233684|NCT01128595|566073|P2|STARTED|Washout Period 1||6
233685|NCT01128595|566074|P1|STARTED|Washout Period 1||7
233686|NCT01128595|566071|P4|NOT COMPLETED|Treatment Period 1||0
233687|NCT01128595|566072|P3|NOT COMPLETED|Treatment Period 1||0
233688|NCT01128595|566073|P2|NOT COMPLETED|Treatment Period 1||0
233689|NCT01128595|566074|P1|NOT COMPLETED|Treatment Period 1||0
233690|NCT01128595|566071|P4|COMPLETED|Treatment Period 1||7
233691|NCT01128595|566072|P3|COMPLETED|Treatment Period 1||7
233692|NCT01128595|566073|P2|COMPLETED|Treatment Period 1||6
233693|NCT01128595|566074|P1|COMPLETED|Treatment Period 1||7
233694|NCT01128595|566071|P4|STARTED|Treatment Period 1||7
233695|NCT01128595|566072|P3|STARTED|Treatment Period 1||7
233696|NCT01128595|566073|P2|STARTED|Treatment Period 1||6
233697|NCT01128595|566074|P1|STARTED|Treatment Period 1||7
233698|NCT01128569|566104|P6|NOT COMPLETED|Treatment Period 3||0
233699|NCT01128569|566105|P5|NOT COMPLETED|Treatment Period 3||0
233700|NCT01128569|566106|P4|NOT COMPLETED|Treatment Period 3||0
233701|NCT01128569|566107|P3|NOT COMPLETED|Treatment Period 3||0
233702|NCT01128569|566108|P2|NOT COMPLETED|Treatment Period 3||0
233703|NCT01128569|566109|P1|NOT COMPLETED|Treatment Period 3||0
233704|NCT01128569|566104|P6|COMPLETED|Treatment Period 3||9
233705|NCT01128569|566105|P5|COMPLETED|Treatment Period 3||9
233706|NCT01128569|566106|P4|COMPLETED|Treatment Period 3||8
233707|NCT01128569|566107|P3|COMPLETED|Treatment Period 3||8
233708|NCT01128569|566108|P2|COMPLETED|Treatment Period 3||7
233709|NCT01128569|566109|P1|COMPLETED|Treatment Period 3||9
233710|NCT01128569|566104|P6|STARTED|Treatment Period 3||9
233711|NCT01128569|566105|P5|STARTED|Treatment Period 3||9
233712|NCT01128569|566106|P4|STARTED|Treatment Period 3||8
233713|NCT01128569|566107|P3|STARTED|Treatment Period 3||8
233714|NCT01128569|566108|P2|STARTED|Treatment Period 3||7
233715|NCT01128569|566109|P1|STARTED|Treatment Period 3||9
233716|NCT01128569|566104|P6|NOT COMPLETED|Washout Period 2||0
233717|NCT01128569|566105|P5|NOT COMPLETED|Washout Period 2||0
233718|NCT01128569|566106|P4|NOT COMPLETED|Washout Period 2||0
233719|NCT01128569|566107|P3|NOT COMPLETED|Washout Period 2||0
233720|NCT01128569|566108|P2|NOT COMPLETED|Washout Period 2||0
233721|NCT01128569|566109|P1|NOT COMPLETED|Washout Period 2||0
233722|NCT01128569|566104|P6|COMPLETED|Washout Period 2||9
233723|NCT01128569|566105|P5|COMPLETED|Washout Period 2||9
233724|NCT01128569|566106|P4|COMPLETED|Washout Period 2||8
233725|NCT01128569|566107|P3|COMPLETED|Washout Period 2||8
233726|NCT01128569|566108|P2|COMPLETED|Washout Period 2||7
233727|NCT01128569|566109|P1|COMPLETED|Washout Period 2||9
233728|NCT01128569|566104|P6|STARTED|Washout Period 2||9
233729|NCT01128569|566105|P5|STARTED|Washout Period 2||9
233730|NCT01128569|566106|P4|STARTED|Washout Period 2||8
233731|NCT01128569|566107|P3|STARTED|Washout Period 2||8
233732|NCT01128569|566108|P2|STARTED|Washout Period 2||7
233733|NCT01128569|566109|P1|STARTED|Washout Period 2||9
233734|NCT01128569|566104|P6|NOT COMPLETED|Treatment Period 2||0
233735|NCT01128569|566105|P5|NOT COMPLETED|Treatment Period 2||0
233736|NCT01128569|566106|P4|NOT COMPLETED|Treatment Period 2||0
233737|NCT01128569|566107|P3|NOT COMPLETED|Treatment Period 2||0
233738|NCT01128569|566108|P2|NOT COMPLETED|Treatment Period 2||1
233739|NCT01128569|566109|P1|NOT COMPLETED|Treatment Period 2||0
233740|NCT01128569|566104|P6|COMPLETED|Treatment Period 2||9
233741|NCT01128569|566105|P5|COMPLETED|Treatment Period 2||9
233742|NCT01128569|566106|P4|COMPLETED|Treatment Period 2||8
233743|NCT01128569|566107|P3|COMPLETED|Treatment Period 2||8
233744|NCT01128569|566108|P2|COMPLETED|Treatment Period 2||7
233745|NCT01128569|566109|P1|COMPLETED|Treatment Period 2||9
233746|NCT01128569|566104|P6|STARTED|Treatment Period 2||9
233747|NCT01128569|566105|P5|STARTED|Treatment Period 2||9
233748|NCT01128569|566106|P4|STARTED|Treatment Period 2||8
233749|NCT01128569|566107|P3|STARTED|Treatment Period 2||8
233750|NCT01128569|566108|P2|STARTED|Treatment Period 2||8
233751|NCT01128569|566109|P1|STARTED|Treatment Period 2||9
233752|NCT01128569|566104|P6|NOT COMPLETED|Washout Period 1||0
233753|NCT01128569|566105|P5|NOT COMPLETED|Washout Period 1||0
233754|NCT01128569|566106|P4|NOT COMPLETED|Washout Period 1||0
233755|NCT01128569|566107|P3|NOT COMPLETED|Washout Period 1||1
233756|NCT01128569|566108|P2|NOT COMPLETED|Washout Period 1||0
233757|NCT01128569|566109|P1|NOT COMPLETED|Washout Period 1||0
233758|NCT01128569|566104|P6|COMPLETED|Washout Period 1||9
233759|NCT01128569|566105|P5|COMPLETED|Washout Period 1||9
233760|NCT01128569|566106|P4|COMPLETED|Washout Period 1||8
233761|NCT01128569|566107|P3|COMPLETED|Washout Period 1||8
233762|NCT01128569|566108|P2|COMPLETED|Washout Period 1||8
233763|NCT01128569|566109|P1|COMPLETED|Washout Period 1||9
233764|NCT01128569|566104|P6|STARTED|Washout Period 1||9
233765|NCT01128569|566105|P5|STARTED|Washout Period 1||9
233766|NCT01128569|566106|P4|STARTED|Washout Period 1||8
233767|NCT01128569|566107|P3|STARTED|Washout Period 1||9
233768|NCT01128569|566108|P2|STARTED|Washout Period 1||8
233769|NCT01128569|566109|P1|STARTED|Washout Period 1||9
233770|NCT01128569|566104|P6|NOT COMPLETED|Treatment Period 1||0
233771|NCT01128569|566105|P5|NOT COMPLETED|Treatment Period 1||0
233772|NCT01128569|566106|P4|NOT COMPLETED|Treatment Period 1||0
233773|NCT01128569|566107|P3|NOT COMPLETED|Treatment Period 1||0
233774|NCT01128569|566108|P2|NOT COMPLETED|Treatment Period 1||0
233775|NCT01128569|566109|P1|NOT COMPLETED|Treatment Period 1||0
233776|NCT01128569|566104|P6|COMPLETED|Treatment Period 1||9
233777|NCT01128569|566105|P5|COMPLETED|Treatment Period 1||9
233778|NCT01128569|566106|P4|COMPLETED|Treatment Period 1||8
233779|NCT01128569|566107|P3|COMPLETED|Treatment Period 1||9
233780|NCT01128569|566108|P2|COMPLETED|Treatment Period 1||8
233781|NCT01128569|566109|P1|COMPLETED|Treatment Period 1||9
233782|NCT01128569|566104|P6|STARTED|Treatment Period 1||9
233783|NCT01128569|566105|P5|STARTED|Treatment Period 1||9
233784|NCT01128569|566106|P4|STARTED|Treatment Period 1||8
233785|NCT01128569|566107|P3|STARTED|Treatment Period 1||9
233786|NCT01128569|566108|P2|STARTED|Treatment Period 1||8
233787|NCT01128569|566109|P1|STARTED|Treatment Period 1||9
233788|NCT01128543|566126|P1|NOT COMPLETED|Overall Study||4
233789|NCT01128543|566126|P1|COMPLETED|Overall Study||25
233790|NCT01128543|566126|P1|STARTED|Overall Study||29
233791|NCT01128426|566132|P1|NOT COMPLETED|Overall Study||0
233792|NCT01128426|566132|P1|COMPLETED|Overall Study||53902
233793|NCT01128426|566132|P1|STARTED|Overall Study||53902
233794|NCT01128413|566152|P2|NOT COMPLETED|Overall Study||1
233795|NCT01128413|566153|P1|NOT COMPLETED|Overall Study||4
233796|NCT01128413|566152|P2|COMPLETED|Overall Study||10
233797|NCT01128413|566153|P1|COMPLETED|Overall Study||7
233798|NCT01128413|566152|P2|STARTED|Overall Study||11
233799|NCT01128413|566153|P1|STARTED|Overall Study||11
233800|NCT01128400|566162|P3|NOT COMPLETED|Overall Study||16
233801|NCT01128400|566163|P2|NOT COMPLETED|Overall Study||1
233802|NCT01128400|566164|P1|NOT COMPLETED|Overall Study||2
233803|NCT01128400|566162|P3|COMPLETED|Overall Study||7
233804|NCT01128400|566163|P2|COMPLETED|Overall Study||8
233805|NCT01128400|566164|P1|COMPLETED|Overall Study||6
233806|NCT01128400|566162|P3|STARTED|Overall Study||23
233807|NCT01128400|566163|P2|STARTED|Overall Study||9
233808|NCT01128400|566164|P1|STARTED|Overall Study||8
233809|NCT01128387|566177|P2|NOT COMPLETED|Overall Study||1
233810|NCT01128387|566178|P1|NOT COMPLETED|Overall Study||0
233811|NCT01128387|566177|P2|COMPLETED|Overall Study||5
233812|NCT01128387|566178|P1|COMPLETED|Overall Study||5
233813|NCT01128387|566177|P2|STARTED|Overall Study||6
233814|NCT01128387|566178|P1|STARTED|Overall Study||5
233815|NCT01128361|566188|P2|NOT COMPLETED|Overall Study||3
233816|NCT01128361|566189|P1|NOT COMPLETED|Overall Study||5
233817|NCT01128361|566188|P2|COMPLETED|Overall Study||34
233818|NCT01128361|566189|P1|COMPLETED|Overall Study||34
233819|NCT01128361|566188|P2|STARTED|Overall Study||37
233820|NCT01128361|566189|P1|STARTED|Overall Study||39
233821|NCT01128296|566201|P6|NOT COMPLETED|Overall Study||5
233822|NCT01128296|566202|P5|NOT COMPLETED|Overall Study||0
233823|NCT01128296|566203|P4|NOT COMPLETED|Overall Study||0
233824|NCT01128296|566204|P3|NOT COMPLETED|Overall Study||0
233825|NCT01128296|566205|P2|NOT COMPLETED|Overall Study||0
233826|NCT01128296|566206|P1|NOT COMPLETED|Overall Study||0
233827|NCT01128296|566201|P6|COMPLETED|Overall Study||21
233828|NCT01128296|566202|P5|COMPLETED|Overall Study||1
233829|NCT01128296|566203|P4|COMPLETED|Overall Study||1
233830|NCT01128296|566204|P3|COMPLETED|Overall Study||1
233831|NCT01128296|566205|P2|COMPLETED|Overall Study||1
233832|NCT01128296|566206|P1|COMPLETED|Overall Study||1
233833|NCT01128296|566201|P6|STARTED|Overall Study||26
233834|NCT01128296|566202|P5|STARTED|Overall Study||1
233835|NCT01128296|566203|P4|STARTED|Overall Study||1
233836|NCT01128296|566204|P3|STARTED|Overall Study||1
233837|NCT01128296|566205|P2|STARTED|Overall Study||1
233838|NCT01128296|566206|P1|STARTED|Overall Study||1
233839|NCT01128270|566224|P1|NOT COMPLETED|Therapeutic Chloral Hydrate (2B)||0
233840|NCT01128270|566224|P1|COMPLETED|Therapeutic Chloral Hydrate (2B)||8
233841|NCT01128270|566224|P1|STARTED|Therapeutic Chloral Hydrate (2B)||8
233842|NCT01128270|566224|P1|NOT COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||0
233843|NCT01128270|566224|P1|COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||8
233844|NCT01128270|566224|P1|STARTED|Therapeutic Chloral Hydrate and DCA (2A)||8
233845|NCT01128270|566224|P1|NOT COMPLETED|Environmental Chloral Hydrate (1B)||0
233846|NCT01128270|566224|P1|COMPLETED|Environmental Chloral Hydrate (1B)||8
233847|NCT01128270|566224|P1|STARTED|Environmental Chloral Hydrate (1B)|Per the suggestion from Heather, periods are not in chronological order, but defined by treatment.|8
233848|NCT01128270|566224|P1|NOT COMPLETED|Environment Chloral Hydrate and DCA (1A)||0
233849|NCT01128270|566224|P1|COMPLETED|Environment Chloral Hydrate and DCA (1A)||7
233850|NCT01128270|566224|P1|STARTED|Environment Chloral Hydrate and DCA (1A)||7
233851|NCT01128244|566237|P1|NOT COMPLETED|Overall Study||3
233852|NCT01128244|566237|P1|COMPLETED|Overall Study||10
233853|NCT01128244|566237|P1|STARTED|Overall Study||13
233854|NCT01128192|566247|P3|NOT COMPLETED|Overall Study||0
233855|NCT01128192|566248|P2|NOT COMPLETED|Overall Study||0
233856|NCT01128192|566249|P1|NOT COMPLETED|Overall Study||0
233857|NCT01128192|566247|P3|COMPLETED|Overall Study||7
233858|NCT01128192|566248|P2|COMPLETED|Overall Study||19
233859|NCT01128192|566249|P1|COMPLETED|Overall Study||19
233860|NCT01128192|566247|P3|STARTED|Overall Study||7
233861|NCT01128192|566248|P2|STARTED|Overall Study||19
233862|NCT01128192|566249|P1|STARTED|Overall Study||19
233863|NCT01128179|566278|P2|NOT COMPLETED|Overall Study||0
233864|NCT01128179|566279|P1|NOT COMPLETED|Overall Study||2
233865|NCT01128179|566278|P2|COMPLETED|Overall Study||12
233866|NCT01128179|566279|P1|COMPLETED|Overall Study||21
233867|NCT01128179|566278|P2|STARTED|Overall Study||12
233868|NCT01128179|566279|P1|STARTED|Overall Study||23
233869|NCT01128153|566299|P2|NOT COMPLETED|Overall Study||15
233870|NCT01128153|566300|P1|NOT COMPLETED|Overall Study||16
233871|NCT01128153|566299|P2|COMPLETED|Overall Study|Completed 24 weeks|113
233872|NCT01128153|566300|P1|COMPLETED|Overall Study|Completed 24 weeks|113
233873|NCT01128153|566299|P2|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|128
233874|NCT01128153|566300|P1|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|127
233875|NCT01128153|566299|P2|STARTED|Overall Study|Randomised|128
233876|NCT01128153|566300|P1|STARTED|Overall Study|Randomised|129
233877|NCT01128114|566316|P1|NOT COMPLETED|Overall Study||8
233878|NCT01128114|566316|P1|COMPLETED|Overall Study||24
233879|NCT01128114|566316|P1|STARTED|Overall Study||32
233880|NCT01128049|566323|P3|NOT COMPLETED|Overall Study||0
233881|NCT01128049|566324|P2|NOT COMPLETED|Overall Study||0
233882|NCT01128049|566325|P1|NOT COMPLETED|Overall Study||0
233883|NCT01128049|566323|P3|COMPLETED|Overall Study||5
233884|NCT01128049|566324|P2|COMPLETED|Overall Study||5
233885|NCT01128049|566325|P1|COMPLETED|Overall Study||5
233886|NCT01128049|566323|P3|STARTED|Overall Study||5
233887|NCT01128049|566324|P2|STARTED|Overall Study||5
233888|NCT01128049|566325|P1|STARTED|Overall Study||5
233889|NCT01127763|566333|P1|NOT COMPLETED|Overall Study||5
233890|NCT01127763|566333|P1|COMPLETED|Overall Study|Patients off study due to disease progression were considered to have completed the study.|20
233891|NCT01127763|566333|P1|STARTED|Overall Study||25
233892|NCT01127737|566344|P2|NOT COMPLETED|Overall Study||0
233893|NCT01127737|566345|P1|NOT COMPLETED|Overall Study||0
233894|NCT01127737|566344|P2|COMPLETED|Overall Study||38
233895|NCT01127737|566345|P1|COMPLETED|Overall Study||37
233896|NCT01127737|566344|P2|STARTED|Overall Study||38
233897|NCT01127737|566345|P1|STARTED|Overall Study||37
233898|NCT01127659|566357|P6|NOT COMPLETED|Overall Study||0
233899|NCT01127659|566358|P5|NOT COMPLETED|Overall Study||0
233900|NCT01127659|566359|P4|NOT COMPLETED|Overall Study||4
233901|NCT01127659|566360|P3|NOT COMPLETED|Overall Study||2
233902|NCT01127659|566361|P2|NOT COMPLETED|Overall Study||8
233903|NCT01127659|566362|P1|NOT COMPLETED|Overall Study||2
233904|NCT01127659|566357|P6|COMPLETED|Overall Study||21
233905|NCT01127659|566358|P5|COMPLETED|Overall Study||50
233906|NCT01127659|566359|P4|COMPLETED|Overall Study||6
233907|NCT01127659|566360|P3|COMPLETED|Overall Study||10
233908|NCT01127659|566361|P2|COMPLETED|Overall Study||14
233909|NCT01127659|566362|P1|COMPLETED|Overall Study||20
233910|NCT01127659|566357|P6|STARTED|Overall Study||21
233911|NCT01127659|566358|P5|STARTED|Overall Study||50
233912|NCT01127659|566359|P4|STARTED|Overall Study||10
233913|NCT01127659|566360|P3|STARTED|Overall Study||12
233914|NCT01127659|566361|P2|STARTED|Overall Study||22
233915|NCT01127659|566362|P1|STARTED|Overall Study||22
233916|NCT01127646|566378|P2|NOT COMPLETED|Overall Study||1
233917|NCT01127646|566379|P1|NOT COMPLETED|Overall Study||1
233918|NCT01127646|566378|P2|COMPLETED|Overall Study||7
233919|NCT01127646|566379|P1|COMPLETED|Overall Study||14
233920|NCT01127646|566378|P2|STARTED|Overall Study||8
233921|NCT01127646|566379|P1|STARTED|Overall Study||15
233922|NCT01127633|566413|P2|NOT COMPLETED|Overall Study||673
233923|NCT01127633|566414|P1|NOT COMPLETED|Overall Study||653
233924|NCT01127633|566413|P2|COMPLETED|Overall Study||61
233925|NCT01127633|566414|P1|COMPLETED|Overall Study||70
233926|NCT01127633|566413|P2|Received at Least 1 Dose of Study Drug|Overall Study||734
233927|NCT01127633|566414|P1|Received at Least 1 Dose of Study Drug|Overall Study||723
233928|NCT01127633|566413|P2|STARTED|Overall Study||734
233929|NCT01127633|566414|P1|STARTED|Overall Study||723
233930|NCT01127607|566446|P2|NOT COMPLETED|Phase II (Between Subjects)||2
233931|NCT01127607|566447|P1|NOT COMPLETED|Phase II (Between Subjects)||1
233932|NCT01127607|566446|P2|COMPLETED|Phase II (Between Subjects)||11
233933|NCT01127607|566447|P1|COMPLETED|Phase II (Between Subjects)||13
233934|NCT01127607|566446|P2|STARTED|Phase II (Between Subjects)||13
233935|NCT01127607|566447|P1|STARTED|Phase II (Between Subjects)||14
233936|NCT01127607|566446|P2|NOT COMPLETED|Phase I (Within Subjects)||0
233937|NCT01127607|566447|P1|NOT COMPLETED|Phase I (Within Subjects)||0
233938|NCT01127607|566446|P2|COMPLETED|Phase I (Within Subjects)||13
233939|NCT01127607|566447|P1|COMPLETED|Phase I (Within Subjects)||14
233940|NCT01127607|566446|P2|STARTED|Phase I (Within Subjects)||13
233941|NCT01127607|566447|P1|STARTED|Phase I (Within Subjects)||14
233942|NCT01127581|566520|P2|NOT COMPLETED|Overall Study||0
233943|NCT01127581|566521|P1|NOT COMPLETED|Overall Study||0
233944|NCT01127581|566520|P2|COMPLETED|Overall Study||680
233945|NCT01127581|566521|P1|COMPLETED|Overall Study||678
233946|NCT01127581|566520|P2|STARTED|Overall Study||680
233947|NCT01127581|566521|P1|STARTED|Overall Study||678
233948|NCT01127503|566549|P2|NOT COMPLETED|Overall Study||0
233949|NCT01127503|566550|P1|NOT COMPLETED|Overall Study||0
233950|NCT01127503|566549|P2|COMPLETED|Overall Study||1
233951|NCT01127503|566550|P1|COMPLETED|Overall Study||1
233952|NCT01127503|566549|P2|STARTED|Overall Study||1
233953|NCT01127503|566550|P1|STARTED|Overall Study||1
233954|NCT01127438|566564|P6|NOT COMPLETED|Overall Study||0
233955|NCT01127438|566565|P5|NOT COMPLETED|Overall Study||0
233956|NCT01127438|566566|P4|NOT COMPLETED|Overall Study||0
233957|NCT01127438|566567|P3|NOT COMPLETED|Overall Study||0
233958|NCT01127438|566568|P2|NOT COMPLETED|Overall Study||0
233959|NCT01127438|566569|P1|NOT COMPLETED|Overall Study||0
233960|NCT01127438|566564|P6|COMPLETED|Overall Study||25
233961|NCT01127438|566565|P5|COMPLETED|Overall Study||28
233962|NCT01127438|566566|P4|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|24
233963|NCT01127438|566567|P3|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|26
233964|NCT01127438|566568|P2|COMPLETED|Overall Study||25
233965|NCT01127438|566569|P1|COMPLETED|Overall Study||25
233966|NCT01127438|566564|P6|STARTED|Overall Study||25
233967|NCT01127438|566565|P5|STARTED|Overall Study||28
233968|NCT01127438|566566|P4|STARTED|Overall Study||24
233969|NCT01127438|566567|P3|STARTED|Overall Study||26
233970|NCT01127438|566568|P2|STARTED|Overall Study||25
233971|NCT01127438|566569|P1|STARTED|Overall Study||25
233972|NCT01127321|566596|P5|NOT COMPLETED|Overall Study||0
233973|NCT01127321|566597|P4|NOT COMPLETED|Overall Study||0
233974|NCT01127321|566598|P3|NOT COMPLETED|Overall Study||0
233975|NCT01127321|566599|P2|NOT COMPLETED|Overall Study||0
233976|NCT01127321|566600|P1|NOT COMPLETED|Overall Study||0
233977|NCT01127321|566596|P5|COMPLETED|Overall Study||5
233978|NCT01127321|566597|P4|COMPLETED|Overall Study||7
233979|NCT01127321|566598|P3|COMPLETED|Overall Study||1
233980|NCT01127321|566599|P2|COMPLETED|Overall Study||1
233981|NCT01127321|566600|P1|COMPLETED|Overall Study||3
233982|NCT01127321|566596|P5|STARTED|Overall Study||5
233983|NCT01127321|566597|P4|STARTED|Overall Study||7
233984|NCT01127321|566598|P3|STARTED|Overall Study||1
233985|NCT01127321|566599|P2|STARTED|Overall Study||1
233986|NCT01127321|566600|P1|STARTED|Overall Study||3
233987|NCT01127256|566624|P2|NOT COMPLETED|Overall Study||39
233988|NCT01127256|566625|P1|NOT COMPLETED|Overall Study||39
233989|NCT01127256|566624|P2|COMPLETED|Overall Study||65
233990|NCT01127256|566625|P1|COMPLETED|Overall Study||57
233991|NCT01127256|566624|P2|STARTED|Overall Study||104
233992|NCT01127256|566625|P1|STARTED|Overall Study||96
233993|NCT01127165|566637|P2|NOT COMPLETED|Overall Study||19
233994|NCT01127165|566638|P1|NOT COMPLETED|Overall Study||16
233995|NCT01127165|566637|P2|COMPLETED|Overall Study||41
233996|NCT01127165|566638|P1|COMPLETED|Overall Study||49
233997|NCT01127165|566637|P2|STARTED|Overall Study||60
233998|NCT01127165|566638|P1|STARTED|Overall Study||65
233999|NCT01127139|566650|P1|NOT COMPLETED|Overall Study||57
234000|NCT01127139|566650|P1|COMPLETED|Overall Study||3771
234001|NCT01127139|566650|P1|Number of Participants Analyzed|Overall Study||3828
234002|NCT01127139|566650|P1|STARTED|Overall Study||3828
234003|NCT01127087|566667|P2|NOT COMPLETED|Overall Study||0
234004|NCT01127087|566668|P1|NOT COMPLETED|Overall Study||0
234005|NCT01127087|566667|P2|COMPLETED|Overall Study||2
234006|NCT01127087|566668|P1|COMPLETED|Overall Study||8
234007|NCT01127087|566667|P2|STARTED|Overall Study||2
234008|NCT01127087|566668|P1|STARTED|Overall Study||8
234009|NCT01127061|566678|P2|NOT COMPLETED|Overall Study||13
234010|NCT01127061|566679|P1|NOT COMPLETED|Overall Study||10
234011|NCT01127061|566678|P2|COMPLETED|Overall Study||56
234012|NCT01127061|566679|P1|COMPLETED|Overall Study||57
234013|NCT01127061|566678|P2|STARTED|Overall Study||69
234014|NCT01127061|566679|P1|STARTED|Overall Study||67
234015|NCT01126957|566709|P1|NOT COMPLETED|Overall Study||0
234016|NCT01126957|566709|P1|COMPLETED|Overall Study||103
234017|NCT01126957|566709|P1|STARTED|Overall Study||103
234018|NCT01126879|566716|P2|NOT COMPLETED|Overall Study||2
234019|NCT01126879|566717|P1|NOT COMPLETED|Overall Study||5
234020|NCT01126879|566716|P2|COMPLETED|Overall Study||2
234021|NCT01126879|566717|P1|COMPLETED|Overall Study||3
234022|NCT01126879|566716|P2|Completed 3 Months Genistein/Placebo|Overall Study||2
234023|NCT01126879|566717|P1|Completed 3 Months Genistein/Placebo|Overall Study||4
234024|NCT01126879|566716|P2|Prostatectomy or Radiation|Overall Study||4
234025|NCT01126879|566717|P1|Prostatectomy or Radiation|Overall Study||8
234026|NCT01126879|566716|P2|Started 3 Months of Genistein/Placebo|Overall Study||4
234027|NCT01126879|566717|P1|Started 3 Months of Genistein/Placebo|Overall Study||8
234028|NCT01126879|566716|P2|STARTED|Overall Study||4
234029|NCT01126879|566717|P1|STARTED|Overall Study||8
234030|NCT01126801|566731|P2|NOT COMPLETED|Overall Study||0
234031|NCT01126801|566732|P1|NOT COMPLETED|Overall Study||0
234032|NCT01126801|566731|P2|COMPLETED|Overall Study||1
234033|NCT01126801|566732|P1|COMPLETED|Overall Study||1
234034|NCT01126801|566731|P2|STARTED|Overall Study||1
234035|NCT01126801|566732|P1|STARTED|Overall Study||1
234036|NCT01126723|566742|P2|NOT COMPLETED|Overall Study||3
234037|NCT01126723|566743|P1|NOT COMPLETED|Overall Study||6
234038|NCT01126723|566742|P2|COMPLETED|Overall Study||28
234039|NCT01126723|566743|P1|COMPLETED|Overall Study||29
234040|NCT01126723|566742|P2|STARTED|Overall Study||31
234041|NCT01126723|566743|P1|STARTED|Overall Study||35
234042|NCT01126671|566751|P2|NOT COMPLETED|Overall Study||1
234043|NCT01126671|566752|P1|NOT COMPLETED|Overall Study||2
234044|NCT01126671|566751|P2|COMPLETED|Overall Study||29
234045|NCT01126671|566752|P1|COMPLETED|Overall Study||24
234046|NCT01126671|566751|P2|STARTED|Overall Study||30
234047|NCT01126671|566752|P1|STARTED|Overall Study||26
234048|NCT01126619|566764|P1|NOT COMPLETED|Overall Study||17
234049|NCT01126619|566764|P1|COMPLETED|Overall Study|The completed population was used for all effectiveness analyses.|86
234050|NCT01126619|566764|P1|STARTED|Overall Study||103
234051|NCT01126593|566779|P3|NOT COMPLETED|Overall Study||2
234052|NCT01126593|566780|P2|NOT COMPLETED|Overall Study||2
234053|NCT01126593|566781|P1|NOT COMPLETED|Overall Study||4
234054|NCT01126593|566779|P3|COMPLETED|Overall Study||32
234055|NCT01126593|566780|P2|COMPLETED|Overall Study||27
234056|NCT01126593|566781|P1|COMPLETED|Overall Study||29
234057|NCT01126593|566779|P3|STARTED|Overall Study||34
234058|NCT01126593|566780|P2|STARTED|Overall Study||29
234059|NCT01126593|566781|P1|STARTED|Overall Study||33
234060|NCT01126580|566792|P3|NOT COMPLETED|Overall Study||55
234061|NCT01126580|566793|P2|NOT COMPLETED|Overall Study||52
234062|NCT01126580|566794|P1|NOT COMPLETED|Overall Study||49
234063|NCT01126580|566792|P3|COMPLETED|Overall Study||213
234064|NCT01126580|566793|P2|COMPLETED|Overall Study||218
234065|NCT01126580|566794|P1|COMPLETED|Overall Study||220
234066|NCT01126580|566792|P3|Completed 26 Weeks|Overall Study||226
234067|NCT01126580|566793|P2|Completed 26 Weeks|Overall Study||242
234068|NCT01126580|566794|P1|Completed 26 Weeks|Overall Study||233
234069|NCT01126580|566792|P3|Received at Least 1 Dose of Study Drug|Overall Study||268
234070|NCT01126580|566793|P2|Received at Least 1 Dose of Study Drug|Overall Study||270
234071|NCT01126580|566794|P1|Received at Least 1 Dose of Study Drug|Overall Study||269
234072|NCT01126580|566792|P3|STARTED|Overall Study||268
234073|NCT01126580|566793|P2|STARTED|Overall Study||270
234074|NCT01126580|566794|P1|STARTED|Overall Study||269
234075|NCT01126541|566889|P3|NOT COMPLETED|Overall Study||26
234076|NCT01126541|566890|P2|NOT COMPLETED|Overall Study||12
234077|NCT01126541|566891|P1|NOT COMPLETED|Overall Study||10
234078|NCT01126541|566889|P3|COMPLETED|Overall Study||55
234079|NCT01126541|566890|P2|COMPLETED|Overall Study||61
234080|NCT01126541|566891|P1|COMPLETED|Overall Study||60
234081|NCT01126541|566889|P3|STARTED|Overall Study||81
234082|NCT01126541|566890|P2|STARTED|Overall Study||73
234083|NCT01126541|566891|P1|STARTED|Overall Study||70
234084|NCT01126437|566975|P3|NOT COMPLETED|Overall Study||1313
234085|NCT01126437|566976|P2|NOT COMPLETED|Overall Study||1330
234086|NCT01126437|566977|P1|NOT COMPLETED|Overall Study||1341
234087|NCT01126437|566975|P3|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
234088|NCT01126437|566976|P2|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4399
234089|NCT01126437|566977|P1|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
234090|NCT01126437|566975|P3|STARTED|Overall Study||5713
234091|NCT01126437|566976|P2|STARTED|Overall Study||5729
234092|NCT01126437|566977|P1|STARTED|Overall Study||5741
234093|NCT01126424|567015|P6|NOT COMPLETED|Overall Study||0
234094|NCT01126424|567016|P5|NOT COMPLETED|Overall Study||2
234095|NCT01126424|567017|P4|NOT COMPLETED|Overall Study||3
234096|NCT01126424|567018|P3|NOT COMPLETED|Overall Study||1
234097|NCT01126424|567019|P2|NOT COMPLETED|Overall Study||0
234098|NCT01126424|567020|P1|NOT COMPLETED|Overall Study||0
234099|NCT01126424|567015|P6|COMPLETED|Overall Study||4
234100|NCT01126424|567016|P5|COMPLETED|Overall Study||2
234101|NCT01126424|567017|P4|COMPLETED|Overall Study||3
234102|NCT01126424|567018|P3|COMPLETED|Overall Study||4
234103|NCT01126424|567019|P2|COMPLETED|Overall Study||4
234104|NCT01126424|567020|P1|COMPLETED|Overall Study||3
234105|NCT01126424|567015|P6|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
234106|NCT01126424|567016|P5|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
234107|NCT01126424|567017|P4|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
234108|NCT01126424|567018|P3|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
234109|NCT01126424|567019|P2|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
234110|NCT01126424|567020|P1|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|3
234111|NCT01126424|567015|P6|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
234112|NCT01126424|567016|P5|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
234113|NCT01126424|567017|P4|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|6
234114|NCT01126424|567018|P3|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|5
234115|NCT01126424|567019|P2|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
234116|NCT01126424|567020|P1|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|3
234117|NCT01126359|567043|P2|NOT COMPLETED|Second Intervention (20-minutes)||0
234118|NCT01126359|567044|P1|NOT COMPLETED|Second Intervention (20-minutes)||0
234119|NCT01126359|567043|P2|COMPLETED|Second Intervention (20-minutes)||5
234120|NCT01126359|567044|P1|COMPLETED|Second Intervention (20-minutes)||5
234121|NCT01126359|567043|P2|STARTED|Second Intervention (20-minutes)||5
234122|NCT01126359|567044|P1|STARTED|Second Intervention (20-minutes)||5
234123|NCT01126359|567043|P2|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
234124|NCT01126359|567044|P1|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
234125|NCT01126359|567043|P2|COMPLETED|Dressing Replacement/Healing (48-hours)||5
234126|NCT01126359|567044|P1|COMPLETED|Dressing Replacement/Healing (48-hours)||5
234127|NCT01126359|567043|P2|STARTED|Dressing Replacement/Healing (48-hours)||5
234128|NCT01126359|567044|P1|STARTED|Dressing Replacement/Healing (48-hours)||5
234129|NCT01126359|567043|P2|NOT COMPLETED|First Intervention (20-minutes)||1
234130|NCT01126359|567044|P1|NOT COMPLETED|First Intervention (20-minutes)||0
234131|NCT01126359|567043|P2|COMPLETED|First Intervention (20-minutes)||5
234132|NCT01126359|567044|P1|COMPLETED|First Intervention (20-minutes)||5
234133|NCT01126359|567043|P2|STARTED|First Intervention (20-minutes)||6
234134|NCT01126359|567044|P1|STARTED|First Intervention (20-minutes)||5
234135|NCT01126268|567056|P1|NOT COMPLETED|Overall Study||1
234136|NCT01126268|567056|P1|COMPLETED|Overall Study||37
234137|NCT01126268|567056|P1|STARTED|Overall Study||38
234138|NCT01126099|567080|P2|NOT COMPLETED|Open-label Extension||1
234139|NCT01126099|567081|P1|NOT COMPLETED|Open-label Extension||1
234140|NCT01126099|567080|P2|COMPLETED|Open-label Extension||6
234141|NCT01126099|567081|P1|COMPLETED|Open-label Extension||4
234142|NCT01126099|567080|P2|STARTED|Open-label Extension||7
234143|NCT01126099|567081|P1|STARTED|Open-label Extension|2 in the Prazosin arm of the Double Blind Phase elected not to enter the Open-Label extension|5
234144|NCT01126099|567080|P2|NOT COMPLETED|Double Blind Phase||2
234145|NCT01126099|567081|P1|NOT COMPLETED|Double Blind Phase||4
234146|NCT01126099|567080|P2|COMPLETED|Double Blind Phase||7
234147|NCT01126099|567081|P1|COMPLETED|Double Blind Phase||7
234148|NCT01126099|567080|P2|STARTED|Double Blind Phase||9
234149|NCT01126099|567081|P1|STARTED|Double Blind Phase||11
234150|NCT01126060|567095|P2|NOT COMPLETED|Overall Study||2
234151|NCT01126060|567096|P1|NOT COMPLETED|Overall Study||0
234152|NCT01126060|567095|P2|COMPLETED|Overall Study||38
234153|NCT01126060|567096|P1|COMPLETED|Overall Study||40
234154|NCT01126060|567095|P2|STARTED|Overall Study||40
234155|NCT01126060|567096|P1|STARTED|Overall Study||40
234156|NCT01125930|567104|P2|NOT COMPLETED|Overall Study||10
234157|NCT01125930|567105|P1|NOT COMPLETED|Overall Study||1
234158|NCT01125930|567104|P2|COMPLETED|Overall Study||36
234159|NCT01125930|567105|P1|COMPLETED|Overall Study||21
234160|NCT01125930|567104|P2|STARTED|Overall Study||46
234161|NCT01125930|567105|P1|STARTED|Overall Study||22
234162|NCT01125917|567259|P1|NOT COMPLETED|Overall Study||339
234163|NCT01125917|567259|P1|COMPLETED|Overall Study||15
234164|NCT01125917|567259|P1|STARTED|Overall Study||354
234165|NCT01125813|567263|P1|NOT COMPLETED|Overall Study||6
234166|NCT01125813|567263|P1|COMPLETED|Overall Study||30
234167|NCT01125813|567263|P1|STARTED|Overall Study||36
234168|NCT01125800|567273|P5|NOT COMPLETED|Phase II||11
234169|NCT01125800|567274|P4|NOT COMPLETED|Phase II||1
234170|NCT01125800|567275|P3|NOT COMPLETED|Phase II||0
234171|NCT01125800|567276|P2|NOT COMPLETED|Phase II||0
234172|NCT01125800|567277|P1|NOT COMPLETED|Phase II||0
234173|NCT01125800|567273|P5|COMPLETED|Phase II||5
234174|NCT01125800|567274|P4|COMPLETED|Phase II||0
234175|NCT01125800|567275|P3|COMPLETED|Phase II||0
234176|NCT01125800|567276|P2|COMPLETED|Phase II||0
234177|NCT01125800|567277|P1|COMPLETED|Phase II||0
234178|NCT01125800|567273|P5|STARTED|Phase II|Additional participants were enrolled to this treatment in this period.|16
234179|NCT01125800|567274|P4|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|1
234180|NCT01125800|567275|P3|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
234181|NCT01125800|567276|P2|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
234182|NCT01125800|567277|P1|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
234183|NCT01125800|567273|P5|NOT COMPLETED|Phase I||0
234184|NCT01125800|567274|P4|NOT COMPLETED|Phase I||11
234185|NCT01125800|567275|P3|NOT COMPLETED|Phase I||4
234186|NCT01125800|567276|P2|NOT COMPLETED|Phase I||9
234187|NCT01125800|567277|P1|NOT COMPLETED|Phase I||8
234188|NCT01125800|567273|P5|COMPLETED|Phase I||0
234189|NCT01125800|567274|P4|COMPLETED|Phase I||10
234190|NCT01125800|567275|P3|COMPLETED|Phase I||7
234191|NCT01125800|567276|P2|COMPLETED|Phase I||7
234192|NCT01125800|567277|P1|COMPLETED|Phase I||3
234193|NCT01125800|567273|P5|STARTED|Phase I|None of participants were enrolled to this treatment in this period.|0
234194|NCT01125800|567274|P4|STARTED|Phase I||21
234195|NCT01125800|567275|P3|STARTED|Phase I||11
234196|NCT01125800|567276|P2|STARTED|Phase I||16
234197|NCT01125800|567277|P1|STARTED|Phase I||11
234198|NCT01125774|567316|P4|NOT COMPLETED|Overall Study||3
234199|NCT01125774|567317|P3|NOT COMPLETED|Overall Study||9
234200|NCT01125774|567318|P2|NOT COMPLETED|Overall Study||554
234201|NCT01125774|567319|P1|NOT COMPLETED|Overall Study||1125
234202|NCT01125774|567316|P4|COMPLETED|Overall Study|Completed study at least once|3
234203|NCT01125774|567317|P3|COMPLETED|Overall Study|"Completed study at least once while treated with telcagepant (otherwise counted Not Completed)"|13
234204|NCT01125774|567318|P2|COMPLETED|Overall Study||948
234205|NCT01125774|567319|P1|COMPLETED|Overall Study||1893
234206|NCT01125774|567316|P4|Treated|Overall Study||5
234207|NCT01125774|567317|P3|Treated|Overall Study|Received telcagepant|21
234208|NCT01125774|567318|P2|Treated|Overall Study|1 mistakenly took telcagepant and is included with telcagepant group for adverse event analysis|1322
234209|NCT01125774|567319|P1|Treated|Overall Study||2638
234210|NCT01125774|567316|P4|STARTED|Overall Study|Unique participants randomized|6
234211|NCT01125774|567317|P3|STARTED|Overall Study|Unique participants randomized|22
234212|NCT01125774|567318|P2|STARTED|Overall Study|Randomized|1502
234213|NCT01125774|567319|P1|STARTED|Overall Study|Randomized|3018
234214|NCT01125748|567343|P2|NOT COMPLETED|Overall Study||14
234215|NCT01125748|567344|P1|NOT COMPLETED|Overall Study||10
234216|NCT01125748|567343|P2|COMPLETED|Overall Study||74
234217|NCT01125748|567344|P1|COMPLETED|Overall Study||78
234218|NCT01125748|567343|P2|STARTED|Overall Study||88
234219|NCT01125748|567344|P1|STARTED|Overall Study||88
234220|NCT01125722|567354|P2|NOT COMPLETED|Overall Study||1
234221|NCT01125722|567355|P1|NOT COMPLETED|Overall Study||3
234222|NCT01125722|567354|P2|COMPLETED|Overall Study||36
234223|NCT01125722|567355|P1|COMPLETED|Overall Study||34
234224|NCT01125722|567354|P2|STARTED|Overall Study||37
234225|NCT01125722|567355|P1|STARTED|Overall Study||37
234226|NCT01125605|567369|P1|NOT COMPLETED|Overall Study||0
234227|NCT01125605|567369|P1|COMPLETED|Overall Study||325
234228|NCT01125605|567369|P1|Safety|Overall Study|1 patient was only analysed for safety|326
234229|NCT01125605|567369|P1|STARTED|Overall Study|started = had baseline values|325
234230|NCT01125566|567402|P3|NOT COMPLETED|Patients Who Switched From AV to TV||73
234231|NCT01125566|567403|P2|NOT COMPLETED|Patients Who Switched From AV to TV||0
234232|NCT01125566|567404|P1|NOT COMPLETED|Patients Who Switched From AV to TV||0
234233|NCT01125566|567402|P3|COMPLETED|Patients Who Switched From AV to TV||2
234234|NCT01125566|567403|P2|COMPLETED|Patients Who Switched From AV to TV||0
234235|NCT01125566|567404|P1|COMPLETED|Patients Who Switched From AV to TV||0
234236|NCT01125566|567402|P3|STARTED|Patients Who Switched From AV to TV||75
234237|NCT01125566|567403|P2|STARTED|Patients Who Switched From AV to TV||0
234238|NCT01125566|567404|P1|STARTED|Patients Who Switched From AV to TV||0
234239|NCT01125566|567402|P3|NOT COMPLETED|Patients Before the Switch (26Apr2013)||0
234240|NCT01125566|567403|P2|NOT COMPLETED|Patients Before the Switch (26Apr2013)||169
234241|NCT01125566|567404|P1|NOT COMPLETED|Patients Before the Switch (26Apr2013)||265
234242|NCT01125566|567402|P3|COMPLETED|Patients Before the Switch (26Apr2013)||0
234243|NCT01125566|567403|P2|COMPLETED|Patients Before the Switch (26Apr2013)||0
234244|NCT01125566|567404|P1|COMPLETED|Patients Before the Switch (26Apr2013)||74
234245|NCT01125566|567402|P3|Treated|Patients Before the Switch (26Apr2013)||0
234246|NCT01125566|567403|P2|Treated|Patients Before the Switch (26Apr2013)||169
234247|NCT01125566|567404|P1|Treated|Patients Before the Switch (26Apr2013)||337
234248|NCT01125566|567402|P3|STARTED|Patients Before the Switch (26Apr2013)||0
234249|NCT01125566|567403|P2|STARTED|Patients Before the Switch (26Apr2013)||169
234250|NCT01125566|567404|P1|STARTED|Patients Before the Switch (26Apr2013)||339
234251|NCT01125514|567417|P1|NOT COMPLETED|Treatment Period2(Day9-Day27) and Day 28||4
234252|NCT01125514|567417|P1|COMPLETED|Treatment Period2(Day9-Day27) and Day 28||28
234253|NCT01125514|567417|P1|STARTED|Treatment Period2(Day9-Day27) and Day 28||32
234254|NCT01125514|567417|P1|NOT COMPLETED|Treatment Period 2 (Day 8 - Day 17)||3
234255|NCT01125514|567417|P1|COMPLETED|Treatment Period 2 (Day 8 - Day 17)||32
234256|NCT01125514|567417|P1|Pharmacodynamics (PD) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
234257|NCT01125514|567417|P1|Pharmacokinetic (PK) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
234258|NCT01125514|567417|P1|STARTED|Treatment Period 2 (Day 8 - Day 17)||35
234259|NCT01125514|567417|P1|NOT COMPLETED|Treatment Period 1 (Day 1 - Day 7)||2
234260|NCT01125514|567417|P1|COMPLETED|Treatment Period 1 (Day 1 - Day 7)||35
234261|NCT01125514|567417|P1|STARTED|Treatment Period 1 (Day 1 - Day 7)|Randomized and safety population|37
234262|NCT01125202|567491|P2|NOT COMPLETED|Overall Study||7
234263|NCT01125202|567492|P1|NOT COMPLETED|Overall Study||12
234264|NCT01125202|567491|P2|COMPLETED|Overall Study||79
234265|NCT01125202|567492|P1|COMPLETED|Overall Study||81
234266|NCT01125202|567491|P2|STARTED|Overall Study||86
234267|NCT01125202|567492|P1|STARTED|Overall Study||93
234268|NCT01125189|567517|P3|NOT COMPLETED|Follow up Period||16
234269|NCT01125189|567518|P2|NOT COMPLETED|Follow up Period||15
234270|NCT01125189|567519|P1|NOT COMPLETED|Follow up Period||20
234271|NCT01125189|567517|P3|COMPLETED|Follow up Period||58
234272|NCT01125189|567518|P2|COMPLETED|Follow up Period||138
234273|NCT01125189|567519|P1|COMPLETED|Follow up Period||132
234274|NCT01125189|567517|P3|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|74
234275|NCT01125189|567518|P2|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|153
234276|NCT01125189|567519|P1|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|152
234277|NCT01125189|567517|P3|NOT COMPLETED|Treatment Period||41
234278|NCT01125189|567518|P2|NOT COMPLETED|Treatment Period||35
234279|NCT01125189|567519|P1|NOT COMPLETED|Treatment Period||31
234280|NCT01125189|567517|P3|COMPLETED|Treatment Period||37
234281|NCT01125189|567518|P2|COMPLETED|Treatment Period||123
234282|NCT01125189|567519|P1|COMPLETED|Treatment Period||128
234283|NCT01125189|567517|P3|STARTED|Treatment Period||78
234284|NCT01125189|567518|P2|STARTED|Treatment Period||158
234285|NCT01125189|567519|P1|STARTED|Treatment Period||159
234286|NCT01125176|567545|P1|NOT COMPLETED|Post-treatment Follow-up Phase||11
234287|NCT01125176|567545|P1|COMPLETED|Post-treatment Follow-up Phase||2
234288|NCT01125176|567545|P1|STARTED|Post-treatment Follow-up Phase||13
234289|NCT01125176|567545|P1|NOT COMPLETED|Treatment Phase||1
234290|NCT01125176|567545|P1|COMPLETED|Treatment Phase||13
234291|NCT01125176|567545|P1|STARTED|Treatment Phase||14
234292|NCT01125163|567551|P2|NOT COMPLETED|Overall Study||0
234293|NCT01125163|567552|P1|NOT COMPLETED|Overall Study||0
234294|NCT01125163|567551|P2|COMPLETED|Overall Study||74
234295|NCT01125163|567552|P1|COMPLETED|Overall Study||76
234296|NCT01125163|567551|P2|STARTED|Overall Study||74
234297|NCT01125163|567552|P1|STARTED|Overall Study||76
234298|NCT01125098|567562|P2|NOT COMPLETED|Overall Study||0
234299|NCT01125098|567563|P1|NOT COMPLETED|Overall Study||3
234300|NCT01125098|567562|P2|COMPLETED|Overall Study||90
234301|NCT01125098|567563|P1|COMPLETED|Overall Study||88
234302|NCT01125098|567562|P2|STARTED|Overall Study||90
234303|NCT01125098|567563|P1|STARTED|Overall Study||91
234304|NCT01124955|567571|P2|NOT COMPLETED|Overall Study||0
234305|NCT01124955|567572|P1|NOT COMPLETED|Overall Study||0
234306|NCT01124955|567571|P2|COMPLETED|Overall Study||40
234307|NCT01124955|567572|P1|COMPLETED|Overall Study||40
234308|NCT01124955|567571|P2|STARTED|Overall Study||40
234309|NCT01124955|567572|P1|STARTED|Overall Study||40
234310|NCT01124916|567588|P2|NOT COMPLETED|Overall Study||2
234311|NCT01124916|567589|P1|NOT COMPLETED|Overall Study||3
234312|NCT01124916|567588|P2|COMPLETED|Overall Study||38
234313|NCT01124916|567589|P1|COMPLETED|Overall Study||35
234314|NCT01124916|567588|P2|STARTED|Overall Study||40
234315|NCT01124916|567589|P1|STARTED|Overall Study||38
234316|NCT01124864|567603|P6|NOT COMPLETED|Overall Study||3
234317|NCT01124864|567604|P5|NOT COMPLETED|Overall Study||30
234318|NCT01124864|567605|P4|NOT COMPLETED|Overall Study||21
234319|NCT01124864|567606|P3|NOT COMPLETED|Overall Study||34
234320|NCT01124864|567607|P2|NOT COMPLETED|Overall Study||35
234321|NCT01124864|567608|P1|NOT COMPLETED|Overall Study||28
234322|NCT01124864|567603|P6|COMPLETED|Overall Study||0
234323|NCT01124864|567604|P5|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
234324|NCT01124864|567605|P4|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
234325|NCT01124864|567606|P3|COMPLETED|Overall Study||0
234326|NCT01124864|567607|P2|COMPLETED|Overall Study||0
234327|NCT01124864|567608|P1|COMPLETED|Overall Study||0
234328|NCT01124864|567603|P6|STARTED|Overall Study||3
234329|NCT01124864|567604|P5|STARTED|Overall Study||31
234330|NCT01124864|567605|P4|STARTED|Overall Study||22
234331|NCT01124864|567606|P3|STARTED|Overall Study||34
234332|NCT01124864|567607|P2|STARTED|Overall Study||35
234333|NCT01124864|567608|P1|STARTED|Overall Study||28
234334|NCT01124838|567642|P2|NOT COMPLETED|Overall Study||15
234335|NCT01124838|567643|P1|NOT COMPLETED|Overall Study||18
234336|NCT01124838|567642|P2|COMPLETED|Overall Study||116
234337|NCT01124838|567643|P1|COMPLETED|Overall Study||112
234338|NCT01124838|567642|P2|Enrolled in Japan Sub-study|Overall Study||16
234339|NCT01124838|567643|P1|Enrolled in Japan Sub-study|Overall Study||16
234340|NCT01124838|567642|P2|Enrolled in Main Study|Overall Study||115
234341|NCT01124838|567643|P1|Enrolled in Main Study|Overall Study||114
234342|NCT01124838|567642|P2|STARTED|Overall Study||131
234343|NCT01124838|567643|P1|STARTED|Overall Study||130
234344|NCT01124786|567689|P2|NOT COMPLETED|Overall Study||5
234345|NCT01124786|567690|P1|NOT COMPLETED|Overall Study||4
234346|NCT01124786|567689|P2|COMPLETED|Overall Study||180
234347|NCT01124786|567690|P1|COMPLETED|Overall Study||178
234348|NCT01124786|567689|P2|Tumor Evaluable Population|Overall Study||180
234349|NCT01124786|567690|P1|Tumor Evaluable Population|Overall Study|All pts with measurable/evaluable tumor at baseline per RECIST and have received ≥ one dose of drug|178
234350|NCT01124786|567689|P2|Safety Population|Overall Study||181
234351|NCT01124786|567690|P1|Safety Population|Overall Study|All pts who received at least one dose of study drug|179
234352|NCT01124786|567689|P2|Intent-to-Treat (ITT) Population|Overall Study||185
234353|NCT01124786|567690|P1|Intent-to-Treat (ITT) Population|Overall Study|All randomized patients (pts)|182
234354|NCT01124786|567689|P2|STARTED|Overall Study||185
234355|NCT01124786|567690|P1|STARTED|Overall Study||182
234356|NCT01124734|567710|P1|NOT COMPLETED|Overall Study||17
234357|NCT01124734|567710|P1|COMPLETED|Overall Study|Closed to accrual|0
234358|NCT01124734|567710|P1|Initiation of Course 1 Cycle 2|Overall Study||17
234359|NCT01124734|567710|P1|Completion of Course 1 Cycle 1|Overall Study|All 17 participants successfully completed Course 1 Cycle 1|17
234360|NCT01124734|567710|P1|STARTED|Overall Study||17
234361|NCT01124643|567721|P1|NOT COMPLETED|Overall Study||1
234362|NCT01124643|567721|P1|COMPLETED|Overall Study||34
234363|NCT01124643|567721|P1|STARTED|Overall Study||35
234364|NCT01124617|567735|P2|NOT COMPLETED|Overall Study||6
234365|NCT01124617|567736|P1|NOT COMPLETED|Overall Study||19
234366|NCT01124617|567735|P2|COMPLETED|Overall Study||25
234367|NCT01124617|567736|P1|COMPLETED|Overall Study||41
234368|NCT01124617|567735|P2|STARTED|Overall Study||31
234369|NCT01124617|567736|P1|STARTED|Overall Study||60
234370|NCT01124604|567768|P2|NOT COMPLETED|Overall Study||2
234371|NCT01124604|567769|P1|NOT COMPLETED|Overall Study||15
234372|NCT01124604|567768|P2|COMPLETED|Overall Study||29
234373|NCT01124604|567769|P1|COMPLETED|Overall Study||45
234374|NCT01124604|567768|P2|STARTED|Overall Study||31
234375|NCT01124604|567769|P1|STARTED|Overall Study||60
234376|NCT01124448|567808|P2|NOT COMPLETED|Overall Study||3
234377|NCT01124448|567809|P1|NOT COMPLETED|Overall Study||2
234378|NCT01124448|567808|P2|COMPLETED|Overall Study||12
234379|NCT01124448|567809|P1|COMPLETED|Overall Study||23
234380|NCT01124448|567808|P2|STARTED|Overall Study||15
234381|NCT01124448|567809|P1|STARTED|Overall Study||25
234382|NCT01124422|567817|P3|NOT COMPLETED|4-Week Double-blind Treatment Phase||9
234383|NCT01124422|567818|P2|NOT COMPLETED|4-Week Double-blind Treatment Phase||11
234384|NCT01124422|567819|P1|NOT COMPLETED|4-Week Double-blind Treatment Phase||0
234385|NCT01124422|567817|P3|COMPLETED|4-Week Double-blind Treatment Phase||115
234386|NCT01124422|567818|P2|COMPLETED|4-Week Double-blind Treatment Phase||120
234387|NCT01124422|567819|P1|COMPLETED|4-Week Double-blind Treatment Phase||0
234388|NCT01124422|567817|P3|STARTED|4-Week Double-blind Treatment Phase||124
234389|NCT01124422|567818|P2|STARTED|4-Week Double-blind Treatment Phase||131
234390|NCT01124422|567819|P1|STARTED|4-Week Double-blind Treatment Phase||0
234391|NCT01124422|567817|P3|NOT COMPLETED|4-Week Open-label Run-in Phase||0
234392|NCT01124422|567818|P2|NOT COMPLETED|4-Week Open-label Run-in Phase||0
234393|NCT01124422|567819|P1|NOT COMPLETED|4-Week Open-label Run-in Phase||83
234394|NCT01124422|567817|P3|COMPLETED|4-Week Open-label Run-in Phase||0
234395|NCT01124422|567818|P2|COMPLETED|4-Week Open-label Run-in Phase||0
234396|NCT01124422|567819|P1|COMPLETED|4-Week Open-label Run-in Phase||255
234397|NCT01124422|567817|P3|STARTED|4-Week Open-label Run-in Phase||0
234398|NCT01124422|567818|P2|STARTED|4-Week Open-label Run-in Phase||0
234399|NCT01124422|567819|P1|STARTED|4-Week Open-label Run-in Phase||338
234400|NCT01124370|567861|P1|NOT COMPLETED|Overall Study||20
234401|NCT01124370|567861|P1|COMPLETED|Overall Study|Completed 2 year post-implant follow-up|37
234402|NCT01124370|567861|P1|3 Month Visit|Overall Study|Defines evaluable population|47
234403|NCT01124370|567861|P1|Therapy Initiated|Overall Study||48
234404|NCT01124370|567861|P1|Successfully Implanted|Overall Study||50
234405|NCT01124370|567861|P1|STARTED|Overall Study|Underwent implant attempt|57
234406|NCT01124305|567873|P2|NOT COMPLETED|Overall Study||10
234407|NCT01124305|567874|P1|NOT COMPLETED|Overall Study||8
234408|NCT01124305|567873|P2|COMPLETED|Overall Study||26
234409|NCT01124305|567874|P1|COMPLETED|Overall Study||26
234410|NCT01124305|567873|P2|STARTED|Overall Study||36
234411|NCT01124305|567874|P1|STARTED|Overall Study||34
234412|NCT01124292|567889|P3|NOT COMPLETED|Overall Study||10
234413|NCT01124292|567890|P2|NOT COMPLETED|Overall Study||15
234414|NCT01124292|567891|P1|NOT COMPLETED|Overall Study||2
234415|NCT01124292|567889|P3|COMPLETED|Overall Study||11
234416|NCT01124292|567890|P2|COMPLETED|Overall Study||9
234417|NCT01124292|567891|P1|COMPLETED|Overall Study||14
234418|NCT01124292|567889|P3|STARTED|Overall Study||21
234419|NCT01124292|567890|P2|STARTED|Overall Study||24
234420|NCT01124292|567891|P1|STARTED|Overall Study||16
234421|NCT01124188|567949|P2|NOT COMPLETED|Overall Study||6
234422|NCT01124188|567950|P1|NOT COMPLETED|Overall Study||8
234423|NCT01124188|567949|P2|COMPLETED|Overall Study||65
234424|NCT01124188|567950|P1|COMPLETED|Overall Study||60
234425|NCT01124188|567949|P2|STARTED|Overall Study||71
234426|NCT01124188|567950|P1|STARTED|Overall Study||68
234427|NCT01124175|567962|P2|NOT COMPLETED|Second Intervention||0
234428|NCT01124175|567963|P1|NOT COMPLETED|Second Intervention||0
234429|NCT01124175|567962|P2|COMPLETED|Second Intervention||38
234430|NCT01124175|567963|P1|COMPLETED|Second Intervention||40
234431|NCT01124175|567962|P2|STARTED|Second Intervention||38
234432|NCT01124175|567963|P1|STARTED|Second Intervention||40
234433|NCT01124175|567962|P2|NOT COMPLETED|Washout of 7 Days||2
234434|NCT01124175|567963|P1|NOT COMPLETED|Washout of 7 Days||0
234435|NCT01124175|567962|P2|COMPLETED|Washout of 7 Days||38
234436|NCT01124175|567963|P1|COMPLETED|Washout of 7 Days||40
234437|NCT01124175|567962|P2|STARTED|Washout of 7 Days||40
234438|NCT01124175|567963|P1|STARTED|Washout of 7 Days||40
234439|NCT01124175|567962|P2|NOT COMPLETED|First Intervention||0
234440|NCT01124175|567963|P1|NOT COMPLETED|First Intervention||0
234441|NCT01124175|567962|P2|COMPLETED|First Intervention||40
234442|NCT01124175|567963|P1|COMPLETED|First Intervention||40
234443|NCT01124175|567962|P2|STARTED|First Intervention||40
234444|NCT01124175|567963|P1|STARTED|First Intervention||40
234445|NCT01124162|567981|P2|NOT COMPLETED|Second Intervention||0
234446|NCT01124162|567982|P1|NOT COMPLETED|Second Intervention||0
234447|NCT01124162|567981|P2|COMPLETED|Second Intervention||40
234448|NCT01124162|567982|P1|COMPLETED|Second Intervention||37
234449|NCT01124162|567981|P2|STARTED|Second Intervention||40
234450|NCT01124162|567982|P1|STARTED|Second Intervention||37
234451|NCT01124162|567981|P2|NOT COMPLETED|Washout of 7 Days||0
234452|NCT01124162|567982|P1|NOT COMPLETED|Washout of 7 Days||1
234453|NCT01124162|567981|P2|COMPLETED|Washout of 7 Days||40
234454|NCT01124162|567982|P1|COMPLETED|Washout of 7 Days||37
234455|NCT01124162|567981|P2|STARTED|Washout of 7 Days||40
234456|NCT01124162|567982|P1|STARTED|Washout of 7 Days||38
234457|NCT01124162|567981|P2|NOT COMPLETED|First Intervention||0
234458|NCT01124162|567982|P1|NOT COMPLETED|First Intervention||2
234459|NCT01124162|567981|P2|COMPLETED|First Intervention||40
234460|NCT01124162|567982|P1|COMPLETED|First Intervention||38
234461|NCT01124162|567981|P2|STARTED|First Intervention||40
234462|NCT01124162|567982|P1|STARTED|First Intervention||40
234463|NCT01124149|567998|P1|NOT COMPLETED|Maintenance Phase||96
234464|NCT01124149|567998|P1|COMPLETED|Maintenance Phase||373
234465|NCT01124149|567998|P1|STARTED|Maintenance Phase||469
234466|NCT01124149|567998|P1|NOT COMPLETED|Acute Phase||83
234467|NCT01124149|567998|P1|COMPLETED|Acute Phase||639
234468|NCT01124149|567998|P1|STARTED|Acute Phase||722
234469|NCT01124097|568018|P4|NOT COMPLETED|Overall Study||14
234470|NCT01124097|568019|P3|NOT COMPLETED|Overall Study||20
234471|NCT01124097|568020|P2|NOT COMPLETED|Overall Study||22
234472|NCT01124097|568021|P1|NOT COMPLETED|Overall Study||34
234473|NCT01124097|568018|P4|COMPLETED|Overall Study||46
234474|NCT01124097|568019|P3|COMPLETED|Overall Study||40
234475|NCT01124097|568020|P2|COMPLETED|Overall Study||38
234476|NCT01124097|568021|P1|COMPLETED|Overall Study||26
234477|NCT01124097|568018|P4|Efficacy Population|Overall Study||51
234478|NCT01124097|568019|P3|Efficacy Population|Overall Study||53
234479|NCT01124097|568020|P2|Efficacy Population|Overall Study||53
234480|NCT01124097|568021|P1|Efficacy Population|Overall Study||52
234481|NCT01124097|568018|P4|Safety Population|Overall Study||60
234482|NCT01124097|568019|P3|Safety Population|Overall Study||60
234483|NCT01124097|568020|P2|Safety Population|Overall Study||60
234484|NCT01124097|568021|P1|Safety Population|Overall Study||60
234485|NCT01124097|568018|P4|STARTED|Overall Study||60
234486|NCT01124097|568019|P3|STARTED|Overall Study||60
234487|NCT01124097|568020|P2|STARTED|Overall Study||60
234488|NCT01124097|568021|P1|STARTED|Overall Study||60
234489|NCT01124045|568033|P2|NOT COMPLETED|Overall Study||3
234490|NCT01124045|568034|P1|NOT COMPLETED|Overall Study||0
234491|NCT01124045|568033|P2|COMPLETED|Overall Study||37
234492|NCT01124045|568034|P1|COMPLETED|Overall Study||39
234493|NCT01124045|568033|P2|STARTED|Overall Study||40
234494|NCT01124045|568034|P1|STARTED|Overall Study||39
234495|NCT01124006|568067|P3|NOT COMPLETED|Overall Study||2
234496|NCT01124006|568068|P2|NOT COMPLETED|Overall Study||2
234497|NCT01124006|568069|P1|NOT COMPLETED|Overall Study||3
234498|NCT01124006|568067|P3|COMPLETED|Overall Study||2
234499|NCT01124006|568068|P2|COMPLETED|Overall Study||8
234500|NCT01124006|568069|P1|COMPLETED|Overall Study||7
234501|NCT01124006|568067|P3|STARTED|Overall Study||4
234502|NCT01124006|568068|P2|STARTED|Overall Study||10
234503|NCT01124006|568069|P1|STARTED|Overall Study||10
234504|NCT01123980|568097|P2|NOT COMPLETED|Overall Study||24
234505|NCT01123980|568098|P1|NOT COMPLETED|Overall Study||19
234506|NCT01123980|568097|P2|COMPLETED|Overall Study||236
234507|NCT01123980|568098|P1|COMPLETED|Overall Study||242
234508|NCT01123980|568097|P2|STARTED|Overall Study||260
234509|NCT01123980|568098|P1|STARTED|Overall Study||261
234510|NCT01123941|568118|P2|NOT COMPLETED|Overall Study||1
234511|NCT01123941|568119|P1|NOT COMPLETED|Overall Study||2
234512|NCT01123941|568118|P2|COMPLETED|Overall Study||24
234513|NCT01123941|568119|P1|COMPLETED|Overall Study||23
234514|NCT01123941|568118|P2|STARTED|Overall Study||25
234515|NCT01123941|568119|P1|STARTED|Overall Study||25
234516|NCT01123928|568133|P2|NOT COMPLETED|Overall Study||0
234517|NCT01123928|568134|P1|NOT COMPLETED|Overall Study||0
234518|NCT01123928|568133|P2|COMPLETED|Overall Study||222
234519|NCT01123928|568134|P1|COMPLETED|Overall Study||212
234520|NCT01123928|568133|P2|STARTED|Overall Study||222
234521|NCT01123928|568134|P1|STARTED|Overall Study||212
234522|NCT01123889|568154|P2|NOT COMPLETED|Overall Study||1
234523|NCT01123889|568155|P1|NOT COMPLETED|Overall Study||3
234524|NCT01123889|568154|P2|COMPLETED|Overall Study||6
234525|NCT01123889|568155|P1|COMPLETED|Overall Study||2
234526|NCT01123889|568154|P2|STARTED|Overall Study||7
234527|NCT01123889|568155|P1|STARTED|Overall Study||5
234528|NCT01123850|568165|P1|NOT COMPLETED|Overall Study||45
234529|NCT01123850|568165|P1|COMPLETED|Overall Study||0
234530|NCT01123850|568165|P1|STARTED|Overall Study||45
234531|NCT01123655|568172|P3|NOT COMPLETED|Overall Study||1
234532|NCT01123655|568173|P2|NOT COMPLETED|Overall Study||1
234533|NCT01123655|568174|P1|NOT COMPLETED|Overall Study||1
234534|NCT01123655|568172|P3|COMPLETED|Overall Study||7
234535|NCT01123655|568173|P2|COMPLETED|Overall Study||3
234536|NCT01123655|568174|P1|COMPLETED|Overall Study||9
234537|NCT01123655|568172|P3|STARTED|Overall Study||8
234538|NCT01123655|568173|P2|STARTED|Overall Study||4
234539|NCT01123655|568174|P1|STARTED|Overall Study||10
234540|NCT01123642|568246|P1|NOT COMPLETED|Overall Study||68
234541|NCT01123642|568246|P1|COMPLETED|Overall Study||277
234542|NCT01123642|568246|P1|STARTED|Overall Study||345
234543|NCT01123512|568255|P2|NOT COMPLETED|Overall Study||21
234544|NCT01123512|568256|P1|NOT COMPLETED|Overall Study||26
234545|NCT01123512|568255|P2|COMPLETED|Overall Study||126
234546|NCT01123512|568256|P1|COMPLETED|Overall Study||127
234547|NCT01123512|568255|P2|STARTED|Overall Study||147
234548|NCT01123512|568256|P1|STARTED|Overall Study||153
234549|NCT01123395|568262|P2|NOT COMPLETED|Period 2||0
234550|NCT01123395|568263|P1|NOT COMPLETED|Period 2||0
234551|NCT01123395|568262|P2|COMPLETED|Period 2||7
234552|NCT01123395|568263|P1|COMPLETED|Period 2||8
234553|NCT01123395|568262|P2|STARTED|Period 2||7
234554|NCT01123395|568263|P1|STARTED|Period 2||8
234555|NCT01123395|568262|P2|NOT COMPLETED|Washout Period of 14 Days||1
234556|NCT01123395|568263|P1|NOT COMPLETED|Washout Period of 14 Days||0
234557|NCT01123395|568262|P2|COMPLETED|Washout Period of 14 Days||7
234558|NCT01123395|568263|P1|COMPLETED|Washout Period of 14 Days||8
234559|NCT01123395|568262|P2|STARTED|Washout Period of 14 Days||8
234560|NCT01123395|568263|P1|STARTED|Washout Period of 14 Days||8
234561|NCT01123395|568262|P2|NOT COMPLETED|Period 1||0
234562|NCT01123395|568263|P1|NOT COMPLETED|Period 1||0
234563|NCT01123395|568262|P2|COMPLETED|Period 1||8
234564|NCT01123395|568263|P1|COMPLETED|Period 1||8
234565|NCT01123395|568262|P2|STARTED|Period 1||8
234566|NCT01123395|568263|P1|STARTED|Period 1||8
234567|NCT01123382|568275|P2|NOT COMPLETED|Overall Study||6
234568|NCT01123382|568276|P1|NOT COMPLETED|Overall Study||2
234569|NCT01123382|568275|P2|COMPLETED|Overall Study||6
234570|NCT01123382|568276|P1|COMPLETED|Overall Study||11
234571|NCT01123382|568275|P2|Received Intervention|Overall Study||10
234572|NCT01123382|568276|P1|Received Intervention|Overall Study||12
234573|NCT01123382|568275|P2|STARTED|Overall Study||12
234574|NCT01123382|568276|P1|STARTED|Overall Study||13
234575|NCT01123356|568298|P1|NOT COMPLETED|Overall Study||7
234576|NCT01123356|568298|P1|COMPLETED|Overall Study||14
234577|NCT01123356|568298|P1|STARTED|Overall Study||21
234578|NCT01123200|568306|P1|NOT COMPLETED|Overall Study||1
234579|NCT01123200|568306|P1|COMPLETED|Overall Study||0
234580|NCT01123200|568306|P1|STARTED|Overall Study||1
234581|NCT01123161|568313|P2|NOT COMPLETED|Overall Study||0
234582|NCT01123161|568314|P1|NOT COMPLETED|Overall Study||2
234583|NCT01123161|568313|P2|COMPLETED|Overall Study||63
234584|NCT01123161|568314|P1|COMPLETED|Overall Study||55
234585|NCT01123161|568313|P2|STARTED|Overall Study||63
234586|NCT01123161|568314|P1|STARTED|Overall Study||57
234587|NCT01123148|568332|P1|NOT COMPLETED|Overall Study||2
234588|NCT01123148|568332|P1|COMPLETED|Overall Study||12
234589|NCT01123148|568332|P1|BCI Calibration >50% Accuracy|Overall Study||13
234590|NCT01123148|568332|P1|STARTED|Overall Study||14
234591|NCT01123083|568338|P2|NOT COMPLETED|Overall Study||15
234592|NCT01123083|568339|P1|NOT COMPLETED|Overall Study||11
234593|NCT01123083|568338|P2|COMPLETED|Overall Study||103
234594|NCT01123083|568339|P1|COMPLETED|Overall Study||50
234595|NCT01123083|568338|P2|STARTED|Overall Study||118
234596|NCT01123083|568339|P1|STARTED|Overall Study||61
234597|NCT01122927|568363|P2|NOT COMPLETED|Period 2- Open-label Treatment Phase||312
234598|NCT01122927|568364|P1|NOT COMPLETED|Period 2- Open-label Treatment Phase||0
234599|NCT01122927|568363|P2|COMPLETED|Period 2- Open-label Treatment Phase|De novo participants who completed Month 24 visit or rolled over from study NCT01149655.|198
234600|NCT01122927|568364|P1|COMPLETED|Period 2- Open-label Treatment Phase||0
234601|NCT01122927|568363|P2|STARTED|Period 2- Open-label Treatment Phase|362 were de novo participants and 148 had rolled over from study NCT01149655.|510
234602|NCT01122927|568364|P1|STARTED|Period 2- Open-label Treatment Phase||0
234603|NCT01122927|568363|P2|NOT COMPLETED|Period 1 - Conversion Phase||0
234604|NCT01122927|568364|P1|NOT COMPLETED|Period 1 - Conversion Phase||14
234605|NCT01122927|568363|P2|COMPLETED|Period 1 - Conversion Phase||0
234606|NCT01122927|568364|P1|COMPLETED|Period 1 - Conversion Phase||283
234607|NCT01122927|568363|P2|STARTED|Period 1 - Conversion Phase||0
234608|NCT01122927|568364|P1|STARTED|Period 1 - Conversion Phase||297
234609|NCT01122901|568397|P2|NOT COMPLETED|Overall Study||0
234610|NCT01122901|568398|P1|NOT COMPLETED|Overall Study||0
234611|NCT01122901|568397|P2|COMPLETED|Overall Study||7
234612|NCT01122901|568398|P1|COMPLETED|Overall Study||40
234613|NCT01122901|568397|P2|STARTED|Overall Study||7
234614|NCT01122901|568398|P1|STARTED|Overall Study||40
234615|NCT01122862|568416|P3|NOT COMPLETED|Period 3||0
234616|NCT01122862|568417|P2|NOT COMPLETED|Period 3||0
234617|NCT01122862|568418|P1|NOT COMPLETED|Period 3||0
234618|NCT01122862|568416|P3|COMPLETED|Period 3||8
234619|NCT01122862|568417|P2|COMPLETED|Period 3||7
234620|NCT01122862|568418|P1|COMPLETED|Period 3||6
234621|NCT01122862|568416|P3|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|8
234622|NCT01122862|568417|P2|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|7
234623|NCT01122862|568418|P1|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|6
234624|NCT01122862|568416|P3|NOT COMPLETED|Period 2||1
234625|NCT01122862|568417|P2|NOT COMPLETED|Period 2||0
234626|NCT01122862|568418|P1|NOT COMPLETED|Period 2||0
234627|NCT01122862|568416|P3|COMPLETED|Period 2||6
234628|NCT01122862|568417|P2|COMPLETED|Period 2||7
234629|NCT01122862|568418|P1|COMPLETED|Period 2||8
234630|NCT01122862|568416|P3|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
234631|NCT01122862|568417|P2|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
234632|NCT01122862|568418|P1|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|8
234633|NCT01122862|568416|P3|NOT COMPLETED|Period 1||0
234634|NCT01122862|568417|P2|NOT COMPLETED|Period 1||1
234635|NCT01122862|568418|P1|NOT COMPLETED|Period 1||0
234636|NCT01122862|568416|P3|COMPLETED|Period 1||7
234637|NCT01122862|568417|P2|COMPLETED|Period 1||7
234638|NCT01122862|568418|P1|COMPLETED|Period 1||8
234639|NCT01122862|568416|P3|STARTED|Period 1||7
234640|NCT01122862|568417|P2|STARTED|Period 1||8
234641|NCT01122862|568418|P1|STARTED|Period 1||8
234642|NCT01122849|568439|P3|NOT COMPLETED|Overall Study||0
234643|NCT01122849|568440|P2|NOT COMPLETED|Overall Study||0
234644|NCT01122849|568441|P1|NOT COMPLETED|Overall Study||0
234645|NCT01122849|568439|P3|COMPLETED|Overall Study||20
234646|NCT01122849|568440|P2|COMPLETED|Overall Study||21
234647|NCT01122849|568441|P1|COMPLETED|Overall Study||20
234648|NCT01122849|568439|P3|STARTED|Overall Study||20
234649|NCT01122849|568440|P2|STARTED|Overall Study||21
234650|NCT01122849|568441|P1|STARTED|Overall Study||20
234651|NCT01122680|568524|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
234652|NCT01122680|568525|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
234653|NCT01122680|568526|P2|NOT COMPLETED|Period 3 (4 Weeks)||1
234654|NCT01122680|568527|P1|NOT COMPLETED|Period 3 (4 Weeks)||1
234655|NCT01122680|568524|P4|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|23
234656|NCT01122680|568525|P3|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|26
234657|NCT01122680|568526|P2|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
234658|NCT01122680|568527|P1|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
234659|NCT01122680|568524|P4|STARTED|Period 3 (4 Weeks)|Entered this study period.|23
234660|NCT01122680|568525|P3|STARTED|Period 3 (4 Weeks)|Entered this study period.|26
234661|NCT01122680|568526|P2|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
234662|NCT01122680|568527|P1|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
234663|NCT01122680|568524|P4|NOT COMPLETED|Period 2 (4 Weeks)||1
234664|NCT01122680|568525|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
234665|NCT01122680|568526|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
234666|NCT01122680|568527|P1|NOT COMPLETED|Period 2 (4 Weeks)||1
234667|NCT01122680|568524|P4|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|23
234668|NCT01122680|568525|P3|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|26
234669|NCT01122680|568526|P2|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
234670|NCT01122680|568527|P1|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
234671|NCT01122680|568524|P4|STARTED|Period 2 (4 Weeks)|Entered this study period.|24
234672|NCT01122680|568525|P3|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
234760|NCT01122238|568880|P13|COMPLETED|Overall Study||28
234673|NCT01122680|568526|P2|STARTED|Period 2 (4 Weeks)|Entered this study period.|25
234674|NCT01122680|568527|P1|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
234675|NCT01122680|568524|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
234676|NCT01122680|568525|P3|NOT COMPLETED|Period 1 (4 Weeks)||0
234677|NCT01122680|568526|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
234678|NCT01122680|568527|P1|NOT COMPLETED|Period 1 (4 Weeks)||3
234679|NCT01122680|568524|P4|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|24
234680|NCT01122680|568525|P3|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
234681|NCT01122680|568526|P2|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|25
234682|NCT01122680|568527|P1|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
234683|NCT01122680|568524|P4|STARTED|Period 1 (4 Weeks)|Entered this study period.|24
234684|NCT01122680|568525|P3|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
234685|NCT01122680|568526|P2|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
234686|NCT01122680|568527|P1|STARTED|Period 1 (4 Weeks)|Entered this study period.|29
234687|NCT01122576|568592|P3|NOT COMPLETED|Post-Cataract Surgery||2
234688|NCT01122576|568593|P2|NOT COMPLETED|Post-Cataract Surgery||0
234689|NCT01122576|568594|P1|NOT COMPLETED|Post-Cataract Surgery||0
234690|NCT01122576|568592|P3|COMPLETED|Post-Cataract Surgery||22
234691|NCT01122576|568593|P2|COMPLETED|Post-Cataract Surgery||25
234692|NCT01122576|568594|P1|COMPLETED|Post-Cataract Surgery||26
234693|NCT01122576|568592|P3|STARTED|Post-Cataract Surgery||24
234694|NCT01122576|568593|P2|STARTED|Post-Cataract Surgery||25
234695|NCT01122576|568594|P1|STARTED|Post-Cataract Surgery||26
234696|NCT01122576|568592|P3|NOT COMPLETED|Pre-Cataract Surgery||2
234697|NCT01122576|568593|P2|NOT COMPLETED|Pre-Cataract Surgery||1
234698|NCT01122576|568594|P1|NOT COMPLETED|Pre-Cataract Surgery||0
234699|NCT01122576|568592|P3|COMPLETED|Pre-Cataract Surgery||24
234700|NCT01122576|568593|P2|COMPLETED|Pre-Cataract Surgery||25
234701|NCT01122576|568594|P1|COMPLETED|Pre-Cataract Surgery||26
234702|NCT01122576|568592|P3|STARTED|Pre-Cataract Surgery||26
234703|NCT01122576|568593|P2|STARTED|Pre-Cataract Surgery||26
234704|NCT01122576|568594|P1|STARTED|Pre-Cataract Surgery||26
234705|NCT01122511|568733|P2|NOT COMPLETED|Overall Study||2
234706|NCT01122511|568734|P1|NOT COMPLETED|Overall Study||2
234707|NCT01122511|568733|P2|COMPLETED|Overall Study||0
234708|NCT01122511|568734|P1|COMPLETED|Overall Study||0
234709|NCT01122511|568733|P2|STARTED|Overall Study||2
234710|NCT01122511|568734|P1|STARTED|Overall Study||2
234711|NCT01122446|568748|P2|NOT COMPLETED|Overall Study||0
234712|NCT01122446|568749|P1|NOT COMPLETED|Overall Study||0
234713|NCT01122446|568748|P2|COMPLETED|Overall Study||25
234714|NCT01122446|568749|P1|COMPLETED|Overall Study||25
234715|NCT01122446|568748|P2|STARTED|Overall Study||25
234716|NCT01122446|568749|P1|STARTED|Overall Study||25
234717|NCT01122394|568775|P2|NOT COMPLETED|Overall Study||4
234718|NCT01122394|568776|P1|NOT COMPLETED|Overall Study||3
234719|NCT01122394|568775|P2|COMPLETED|Overall Study||70
234720|NCT01122394|568776|P1|COMPLETED|Overall Study||63
234721|NCT01122394|568775|P2|STARTED|Overall Study||74
234722|NCT01122394|568776|P1|STARTED|Overall Study||66
234723|NCT01122381|568792|P2|NOT COMPLETED|Overall Study||1
234724|NCT01122381|568793|P1|NOT COMPLETED|Overall Study||0
234725|NCT01122381|568792|P2|COMPLETED|Overall Study||0
234726|NCT01122381|568793|P1|COMPLETED|Overall Study|Subject never took the drug per review of ESX levels after unblinding|1
234727|NCT01122381|568792|P2|STARTED|Overall Study||1
234728|NCT01122381|568793|P1|STARTED|Overall Study||1
234729|NCT01122264|568802|P3|NOT COMPLETED|Overall Study||47
234730|NCT01122264|568803|P2|NOT COMPLETED|Overall Study||29
234731|NCT01122264|568804|P1|NOT COMPLETED|Overall Study||32
234732|NCT01122264|568802|P3|COMPLETED|Overall Study||214
234733|NCT01122264|568803|P2|COMPLETED|Overall Study||228
234734|NCT01122264|568804|P1|COMPLETED|Overall Study||220
234735|NCT01122264|568802|P3|Received at Least 1 Dose of Study Drug|Overall Study||260
234736|NCT01122264|568803|P2|Received at Least 1 Dose of Study Drug|Overall Study||257
234737|NCT01122264|568804|P1|Received at Least 1 Dose of Study Drug|Overall Study||250
234738|NCT01122264|568802|P3|STARTED|Overall Study||261
234739|NCT01122264|568803|P2|STARTED|Overall Study||257
234740|NCT01122264|568804|P1|STARTED|Overall Study||252
234741|NCT01122238|568877|P16|NOT COMPLETED|Overall Study||0
234742|NCT01122238|568878|P15|NOT COMPLETED|Overall Study||0
234743|NCT01122238|568879|P14|NOT COMPLETED|Overall Study||1
234744|NCT01122238|568880|P13|NOT COMPLETED|Overall Study||2
234745|NCT01122238|568881|P12|NOT COMPLETED|Overall Study||2
234746|NCT01122238|568882|P11|NOT COMPLETED|Overall Study||0
234747|NCT01122238|568883|P10|NOT COMPLETED|Overall Study||1
234748|NCT01122238|568884|P9|NOT COMPLETED|Overall Study||1
234749|NCT01122238|568885|P8|NOT COMPLETED|Overall Study||0
234750|NCT01122238|568886|P7|NOT COMPLETED|Overall Study||1
234751|NCT01122238|568887|P6|NOT COMPLETED|Overall Study||1
234752|NCT01122238|568888|P5|NOT COMPLETED|Overall Study||0
234753|NCT01122238|568889|P4|NOT COMPLETED|Overall Study||0
234754|NCT01122238|568890|P3|NOT COMPLETED|Overall Study||5
234755|NCT01122238|568891|P2|NOT COMPLETED|Overall Study||1
234756|NCT01122238|568892|P1|NOT COMPLETED|Overall Study||2
234757|NCT01122238|568877|P16|COMPLETED|Overall Study||31
234758|NCT01122238|568878|P15|COMPLETED|Overall Study||28
234759|NCT01122238|568879|P14|COMPLETED|Overall Study||31
234761|NCT01122238|568881|P12|COMPLETED|Overall Study||31
234762|NCT01122238|568882|P11|COMPLETED|Overall Study||32
234763|NCT01122238|568883|P10|COMPLETED|Overall Study||33
234764|NCT01122238|568884|P9|COMPLETED|Overall Study||31
234765|NCT01122238|568885|P8|COMPLETED|Overall Study||32
234766|NCT01122238|568886|P7|COMPLETED|Overall Study||34
234767|NCT01122238|568887|P6|COMPLETED|Overall Study||31
234768|NCT01122238|568888|P5|COMPLETED|Overall Study||33
234769|NCT01122238|568889|P4|COMPLETED|Overall Study||33
234770|NCT01122238|568890|P3|COMPLETED|Overall Study||28
234771|NCT01122238|568891|P2|COMPLETED|Overall Study||36
234772|NCT01122238|568892|P1|COMPLETED|Overall Study||28
234773|NCT01122238|568877|P16|STARTED|Overall Study||31
234774|NCT01122238|568878|P15|STARTED|Overall Study||28
234775|NCT01122238|568879|P14|STARTED|Overall Study||32
234776|NCT01122238|568880|P13|STARTED|Overall Study||30
234777|NCT01122238|568881|P12|STARTED|Overall Study||33
234778|NCT01122238|568882|P11|STARTED|Overall Study||32
234779|NCT01122238|568883|P10|STARTED|Overall Study||34
234780|NCT01122238|568884|P9|STARTED|Overall Study||32
234781|NCT01122238|568885|P8|STARTED|Overall Study||32
234782|NCT01122238|568886|P7|STARTED|Overall Study||35
234783|NCT01122238|568887|P6|STARTED|Overall Study||32
234784|NCT01122238|568888|P5|STARTED|Overall Study||33
234785|NCT01122238|568889|P4|STARTED|Overall Study||33
234786|NCT01122238|568890|P3|STARTED|Overall Study||33
234787|NCT01122238|568891|P2|STARTED|Overall Study||37
234788|NCT01122238|568892|P1|STARTED|Overall Study||30
234789|NCT01122173|568914|P1|NOT COMPLETED|Overall Study||9
234790|NCT01122173|568914|P1|COMPLETED|Overall Study||141
234791|NCT01122173|568914|P1|STARTED|Overall Study||150
234792|NCT01122160|568921|P2|NOT COMPLETED|Second Intervention (7 Days)||0
234793|NCT01122160|568922|P1|NOT COMPLETED|Second Intervention (7 Days)||0
234794|NCT01122160|568921|P2|COMPLETED|Second Intervention (7 Days)||5
234795|NCT01122160|568922|P1|COMPLETED|Second Intervention (7 Days)||6
234796|NCT01122160|568921|P2|STARTED|Second Intervention (7 Days)||5
234797|NCT01122160|568922|P1|STARTED|Second Intervention (7 Days)||6
234798|NCT01122160|568921|P2|NOT COMPLETED|Washout (7-14 Days)||0
234799|NCT01122160|568922|P1|NOT COMPLETED|Washout (7-14 Days)||0
234800|NCT01122160|568921|P2|COMPLETED|Washout (7-14 Days)||5
234801|NCT01122160|568922|P1|COMPLETED|Washout (7-14 Days)||6
234802|NCT01122160|568921|P2|STARTED|Washout (7-14 Days)||5
234803|NCT01122160|568922|P1|STARTED|Washout (7-14 Days)||6
234804|NCT01122160|568921|P2|NOT COMPLETED|First Intervention (7 Days)||0
234805|NCT01122160|568922|P1|NOT COMPLETED|First Intervention (7 Days)||0
234806|NCT01122160|568921|P2|COMPLETED|First Intervention (7 Days)||5
234807|NCT01122160|568922|P1|COMPLETED|First Intervention (7 Days)||6
234808|NCT01122160|568921|P2|STARTED|First Intervention (7 Days)||5
234809|NCT01122160|568922|P1|STARTED|First Intervention (7 Days)||6
234810|NCT01122108|568928|P2|NOT COMPLETED|Overall Study||0
234811|NCT01122108|568929|P1|NOT COMPLETED|Overall Study||0
234812|NCT01122108|568928|P2|COMPLETED|Overall Study||21
234813|NCT01122108|568929|P1|COMPLETED|Overall Study||21
234814|NCT01122108|568928|P2|STARTED|Overall Study||21
234815|NCT01122108|568929|P1|STARTED|Overall Study||21
234816|NCT01122030|568945|P7|NOT COMPLETED|Overall Study||0
234817|NCT01122030|568946|P6|NOT COMPLETED|Overall Study||0
234818|NCT01122030|568947|P5|NOT COMPLETED|Overall Study||0
234819|NCT01122030|568948|P4|NOT COMPLETED|Overall Study||0
234820|NCT01122030|568949|P3|NOT COMPLETED|Overall Study||0
234821|NCT01122030|568950|P2|NOT COMPLETED|Overall Study||0
234822|NCT01122030|568951|P1|NOT COMPLETED|Overall Study||0
234823|NCT01122030|568945|P7|COMPLETED|Overall Study||9
234824|NCT01122030|568946|P6|COMPLETED|Overall Study||9
234825|NCT01122030|568947|P5|COMPLETED|Overall Study||9
234826|NCT01122030|568948|P4|COMPLETED|Overall Study||9
234827|NCT01122030|568949|P3|COMPLETED|Overall Study||9
234828|NCT01122030|568950|P2|COMPLETED|Overall Study||9
234829|NCT01122030|568951|P1|COMPLETED|Overall Study||18
234830|NCT01122030|568945|P7|Received Treatment|Overall Study||9
234831|NCT01122030|568946|P6|Received Treatment|Overall Study||9
234832|NCT01122030|568947|P5|Received Treatment|Overall Study||9
234833|NCT01122030|568948|P4|Received Treatment|Overall Study||9
234834|NCT01122030|568949|P3|Received Treatment|Overall Study||9
234835|NCT01122030|568950|P2|Received Treatment|Overall Study||9
234836|NCT01122030|568951|P1|Received Treatment|Overall Study||18
234837|NCT01122030|568945|P7|STARTED|Overall Study||9
234838|NCT01122030|568946|P6|STARTED|Overall Study||9
234839|NCT01122030|568947|P5|STARTED|Overall Study||9
234840|NCT01122030|568948|P4|STARTED|Overall Study||9
234841|NCT01122030|568949|P3|STARTED|Overall Study||9
234842|NCT01122030|568950|P2|STARTED|Overall Study||9
234843|NCT01122030|568951|P1|STARTED|Overall Study||18
234844|NCT01121991|569137|P1|NOT COMPLETED|Overall Study||6
234845|NCT01121991|569137|P1|COMPLETED|Overall Study||46
234846|NCT01121991|569137|P1|STARTED|Overall Study|Number of participants treated|52
234847|NCT01121939|569148|P1|NOT COMPLETED|Overall Study||43
234848|NCT01121939|569148|P1|COMPLETED|Overall Study|Patients remained on-study until disease progression or unacceptable toxicity occurred.|0
234849|NCT01121939|569148|P1|STARTED|Overall Study||43
234850|NCT01121926|569162|P2|NOT COMPLETED|Second Intervention Period||0
234851|NCT01121926|569163|P1|NOT COMPLETED|Second Intervention Period||0
234852|NCT01121926|569162|P2|COMPLETED|Second Intervention Period||13
234853|NCT01121926|569163|P1|COMPLETED|Second Intervention Period||14
234854|NCT01121926|569162|P2|STARTED|Second Intervention Period||13
234855|NCT01121926|569163|P1|STARTED|Second Intervention Period||14
234856|NCT01121926|569162|P2|NOT COMPLETED|Washout Period||2
234857|NCT01121926|569163|P1|NOT COMPLETED|Washout Period||0
234858|NCT01121926|569162|P2|COMPLETED|Washout Period||13
234859|NCT01121926|569163|P1|COMPLETED|Washout Period||14
234860|NCT01121926|569162|P2|STARTED|Washout Period||15
234861|NCT01121926|569163|P1|STARTED|Washout Period||14
234862|NCT01121926|569162|P2|NOT COMPLETED|First Intervention Period||0
234863|NCT01121926|569163|P1|NOT COMPLETED|First Intervention Period||1
234864|NCT01121926|569162|P2|COMPLETED|First Intervention Period||15
234865|NCT01121926|569163|P1|COMPLETED|First Intervention Period||14
234866|NCT01121926|569162|P2|STARTED|First Intervention Period||15
234867|NCT01121926|569163|P1|STARTED|First Intervention Period||15
234868|NCT01121913|569181|P4|NOT COMPLETED|Fourth Intervention Period||0
234869|NCT01121913|569182|P3|NOT COMPLETED|Fourth Intervention Period||0
234870|NCT01121913|569183|P2|NOT COMPLETED|Fourth Intervention Period||0
234871|NCT01121913|569184|P1|NOT COMPLETED|Fourth Intervention Period||0
234872|NCT01121913|569181|P4|COMPLETED|Fourth Intervention Period||6
234873|NCT01121913|569182|P3|COMPLETED|Fourth Intervention Period||3
234874|NCT01121913|569183|P2|COMPLETED|Fourth Intervention Period||6
234875|NCT01121913|569184|P1|COMPLETED|Fourth Intervention Period||4
234876|NCT01121913|569181|P4|STARTED|Fourth Intervention Period||6
234877|NCT01121913|569182|P3|STARTED|Fourth Intervention Period||3
234878|NCT01121913|569183|P2|STARTED|Fourth Intervention Period||6
234879|NCT01121913|569184|P1|STARTED|Fourth Intervention Period||4
234880|NCT01121913|569181|P4|NOT COMPLETED|Third Washout Period||0
234881|NCT01121913|569182|P3|NOT COMPLETED|Third Washout Period||0
234882|NCT01121913|569183|P2|NOT COMPLETED|Third Washout Period||0
234883|NCT01121913|569184|P1|NOT COMPLETED|Third Washout Period||1
234884|NCT01121913|569181|P4|COMPLETED|Third Washout Period||6
234885|NCT01121913|569182|P3|COMPLETED|Third Washout Period||3
234886|NCT01121913|569183|P2|COMPLETED|Third Washout Period||6
234887|NCT01121913|569184|P1|COMPLETED|Third Washout Period||4
234888|NCT01121913|569181|P4|STARTED|Third Washout Period||6
234889|NCT01121913|569182|P3|STARTED|Third Washout Period||3
234890|NCT01121913|569183|P2|STARTED|Third Washout Period||6
234891|NCT01121913|569184|P1|STARTED|Third Washout Period||5
234892|NCT01121913|569181|P4|NOT COMPLETED|Third Intervention Period||0
234893|NCT01121913|569182|P3|NOT COMPLETED|Third Intervention Period||0
234894|NCT01121913|569183|P2|NOT COMPLETED|Third Intervention Period||0
234895|NCT01121913|569184|P1|NOT COMPLETED|Third Intervention Period||0
234896|NCT01121913|569181|P4|COMPLETED|Third Intervention Period||6
234897|NCT01121913|569182|P3|COMPLETED|Third Intervention Period||3
234898|NCT01121913|569183|P2|COMPLETED|Third Intervention Period||6
234899|NCT01121913|569184|P1|COMPLETED|Third Intervention Period||5
234900|NCT01121913|569181|P4|STARTED|Third Intervention Period||6
234901|NCT01121913|569182|P3|STARTED|Third Intervention Period||3
234902|NCT01121913|569183|P2|STARTED|Third Intervention Period||6
234903|NCT01121913|569184|P1|STARTED|Third Intervention Period||5
234904|NCT01121913|569181|P4|NOT COMPLETED|Second Washout Period||0
234905|NCT01121913|569182|P3|NOT COMPLETED|Second Washout Period||1
234906|NCT01121913|569183|P2|NOT COMPLETED|Second Washout Period||0
234907|NCT01121913|569184|P1|NOT COMPLETED|Second Washout Period||0
234908|NCT01121913|569181|P4|COMPLETED|Second Washout Period||6
234909|NCT01121913|569182|P3|COMPLETED|Second Washout Period||3
234910|NCT01121913|569183|P2|COMPLETED|Second Washout Period||6
234911|NCT01121913|569184|P1|COMPLETED|Second Washout Period||5
234912|NCT01121913|569181|P4|STARTED|Second Washout Period||6
234913|NCT01121913|569182|P3|STARTED|Second Washout Period||4
234914|NCT01121913|569183|P2|STARTED|Second Washout Period||6
234915|NCT01121913|569184|P1|STARTED|Second Washout Period||5
234916|NCT01121913|569181|P4|NOT COMPLETED|Second Intervention Period||0
234917|NCT01121913|569182|P3|NOT COMPLETED|Second Intervention Period||1
234918|NCT01121913|569183|P2|NOT COMPLETED|Second Intervention Period||0
234919|NCT01121913|569184|P1|NOT COMPLETED|Second Intervention Period||0
234920|NCT01121913|569181|P4|COMPLETED|Second Intervention Period||6
234921|NCT01121913|569182|P3|COMPLETED|Second Intervention Period||4
234922|NCT01121913|569183|P2|COMPLETED|Second Intervention Period||6
234923|NCT01121913|569184|P1|COMPLETED|Second Intervention Period||5
234924|NCT01121913|569181|P4|STARTED|Second Intervention Period||6
234925|NCT01121913|569182|P3|STARTED|Second Intervention Period||5
234926|NCT01121913|569183|P2|STARTED|Second Intervention Period||6
234927|NCT01121913|569184|P1|STARTED|Second Intervention Period||5
234928|NCT01121913|569181|P4|NOT COMPLETED|First Washout Period||0
234929|NCT01121913|569182|P3|NOT COMPLETED|First Washout Period||0
234930|NCT01121913|569183|P2|NOT COMPLETED|First Washout Period||0
234931|NCT01121913|569184|P1|NOT COMPLETED|First Washout Period||1
234932|NCT01121913|569181|P4|COMPLETED|First Washout Period||6
234933|NCT01121913|569182|P3|COMPLETED|First Washout Period||5
234934|NCT01121913|569183|P2|COMPLETED|First Washout Period||6
234935|NCT01121913|569184|P1|COMPLETED|First Washout Period||5
234936|NCT01121913|569181|P4|STARTED|First Washout Period||6
234937|NCT01121913|569182|P3|STARTED|First Washout Period||5
234938|NCT01121913|569183|P2|STARTED|First Washout Period||6
234939|NCT01121913|569184|P1|STARTED|First Washout Period||6
234940|NCT01121913|569181|P4|NOT COMPLETED|First Intervention Period||0
234941|NCT01121913|569182|P3|NOT COMPLETED|First Intervention Period||1
234942|NCT01121913|569183|P2|NOT COMPLETED|First Intervention Period||0
234943|NCT01121913|569184|P1|NOT COMPLETED|First Intervention Period||0
234944|NCT01121913|569181|P4|COMPLETED|First Intervention Period||6
234945|NCT01121913|569182|P3|COMPLETED|First Intervention Period||5
234946|NCT01121913|569183|P2|COMPLETED|First Intervention Period||6
234947|NCT01121913|569184|P1|COMPLETED|First Intervention Period||6
234948|NCT01121913|569181|P4|STARTED|First Intervention Period||6
234949|NCT01121913|569182|P3|STARTED|First Intervention Period||6
234950|NCT01121913|569183|P2|STARTED|First Intervention Period||6
234951|NCT01121913|569184|P1|STARTED|First Intervention Period||6
234952|NCT01121900|569214|P2|NOT COMPLETED|Second Intervention Period||0
234953|NCT01121900|569215|P1|NOT COMPLETED|Second Intervention Period||0
234954|NCT01121900|569214|P2|COMPLETED|Second Intervention Period||11
234955|NCT01121900|569215|P1|COMPLETED|Second Intervention Period||12
234956|NCT01121900|569214|P2|STARTED|Second Intervention Period||11
234957|NCT01121900|569215|P1|STARTED|Second Intervention Period||12
234958|NCT01121900|569214|P2|NOT COMPLETED|Washout Period of 7 Days||1
234959|NCT01121900|569215|P1|NOT COMPLETED|Washout Period of 7 Days||0
234960|NCT01121900|569214|P2|COMPLETED|Washout Period of 7 Days||11
234961|NCT01121900|569215|P1|COMPLETED|Washout Period of 7 Days||12
234962|NCT01121900|569214|P2|STARTED|Washout Period of 7 Days||12
234963|NCT01121900|569215|P1|STARTED|Washout Period of 7 Days||12
234964|NCT01121900|569214|P2|NOT COMPLETED|First Intervention Period||1
234965|NCT01121900|569215|P1|NOT COMPLETED|First Intervention Period||1
234966|NCT01121900|569214|P2|COMPLETED|First Intervention Period||12
234967|NCT01121900|569215|P1|COMPLETED|First Intervention Period||12
234968|NCT01121900|569214|P2|STARTED|First Intervention Period||13
234969|NCT01121900|569215|P1|STARTED|First Intervention Period||13
234970|NCT01121757|569235|P2|NOT COMPLETED|Combination||1
234971|NCT01121757|569236|P1|NOT COMPLETED|Combination||2
234972|NCT01121757|569235|P2|COMPLETED|Combination||0
234973|NCT01121757|569236|P1|COMPLETED|Combination||0
234974|NCT01121757|569235|P2|STARTED|Combination||1
234975|NCT01121757|569236|P1|STARTED|Combination|2 subjects did not start combination drug. 1 elected surgery 1 had a complete response after drug 2.|2
234976|NCT01121757|569235|P2|NOT COMPLETED|Second Drug||0
234977|NCT01121757|569236|P1|NOT COMPLETED|Second Drug||0
234978|NCT01121757|569235|P2|COMPLETED|Second Drug||1
234979|NCT01121757|569236|P1|COMPLETED|Second Drug||4
234980|NCT01121757|569235|P2|STARTED|Second Drug||1
234981|NCT01121757|569236|P1|STARTED|Second Drug|1 subject did not start drug 2 due to disease progression|4
234982|NCT01121757|569235|P2|NOT COMPLETED|First Drug||2
234983|NCT01121757|569236|P1|NOT COMPLETED|First Drug||1
234984|NCT01121757|569235|P2|COMPLETED|First Drug|Completed a minimum of 4 cycles of Lenalidomide|1
234985|NCT01121757|569236|P1|COMPLETED|First Drug|Completed a minimum of 4 cycles of Azacitidine.|5
234986|NCT01121757|569235|P2|STARTED|First Drug||3
234987|NCT01121757|569236|P1|STARTED|First Drug||6
234988|NCT01121666|569252|P2|NOT COMPLETED|Overall Study||10
234989|NCT01121666|569253|P1|NOT COMPLETED|Overall Study||29
234990|NCT01121666|569252|P2|COMPLETED|Overall Study||113
234991|NCT01121666|569253|P1|COMPLETED|Overall Study||220
234992|NCT01121666|569252|P2|STARTED|Overall Study||123
234993|NCT01121666|569253|P1|STARTED|Overall Study||249
234994|NCT01121575|569309|P6|NOT COMPLETED|Overall Study||12
234995|NCT01121575|569310|P5|NOT COMPLETED|Overall Study||25
234996|NCT01121575|569311|P4|NOT COMPLETED|Overall Study||6
234997|NCT01121575|569312|P3|NOT COMPLETED|Overall Study||7
234998|NCT01121575|569313|P2|NOT COMPLETED|Overall Study||6
234999|NCT01121575|569314|P1|NOT COMPLETED|Overall Study||14
235000|NCT01121575|569309|P6|COMPLETED|Overall Study||0
235001|NCT01121575|569310|P5|COMPLETED|Overall Study||0
235002|NCT01121575|569311|P4|COMPLETED|Overall Study||0
235003|NCT01121575|569312|P3|COMPLETED|Overall Study||0
235004|NCT01121575|569313|P2|COMPLETED|Overall Study||0
235005|NCT01121575|569314|P1|COMPLETED|Overall Study||0
235006|NCT01121575|569309|P6|Treated|Overall Study||12
235007|NCT01121575|569310|P5|Treated|Overall Study||25
235008|NCT01121575|569311|P4|Treated|Overall Study||6
235009|NCT01121575|569312|P3|Treated|Overall Study||7
235010|NCT01121575|569313|P2|Treated|Overall Study||6
235011|NCT01121575|569314|P1|Treated|Overall Study||14
235012|NCT01121575|569309|P6|STARTED|Overall Study||12
235013|NCT01121575|569310|P5|STARTED|Overall Study||25
235014|NCT01121575|569311|P4|STARTED|Overall Study||6
235015|NCT01121575|569312|P3|STARTED|Overall Study||7
235016|NCT01121575|569313|P2|STARTED|Overall Study||6
235017|NCT01121575|569314|P1|STARTED|Overall Study||14
235018|NCT01121562|569438|P1|NOT COMPLETED|Overall Study||12
235019|NCT01121562|569438|P1|COMPLETED|Overall Study||0
235020|NCT01121562|569438|P1|STARTED|Overall Study||12
235021|NCT01121549|569447|P1|NOT COMPLETED|Overall Study||347
235022|NCT01121549|569447|P1|COMPLETED|Overall Study||31
235023|NCT01121549|569447|P1|STARTED|Overall Study||378
235024|NCT01121536|569458|P1|NOT COMPLETED|Overall Study||361
235025|NCT01121536|569458|P1|COMPLETED|Overall Study|One participant 'completed' early due to study closeout.|506
235026|NCT01121536|569458|P1|Full Analysis Population|Overall Study|Treated participants who had at least 1 post-baseline efficacy assessment.|859
235027|NCT01121536|569458|P1|Safety Population|Overall Study|Participants treated|863
235028|NCT01121536|569458|P1|STARTED|Overall Study||867
235029|NCT01121484|569479|P2|NOT COMPLETED|Overall Study||43
235030|NCT01121484|569480|P1|NOT COMPLETED|Overall Study||33
235031|NCT01121484|569479|P2|COMPLETED|Overall Study||178
235032|NCT01121484|569480|P1|COMPLETED|Overall Study||185
235033|NCT01121484|569479|P2|Treated|Overall Study||217
235034|NCT01121484|569480|P1|Treated|Overall Study||217
235035|NCT01121484|569479|P2|STARTED|Overall Study||221
235036|NCT01121484|569480|P1|STARTED|Overall Study||218
235037|NCT01121406|569498|P2|NOT COMPLETED|Overall Study||55
235038|NCT01121406|569499|P1|NOT COMPLETED|Overall Study||55
235039|NCT01121406|569498|P2|COMPLETED|Overall Study||0
235040|NCT01121406|569499|P1|COMPLETED|Overall Study||0
235041|NCT01121406|569498|P2|STARTED|Overall Study|24 patients switched to Volasertib (BI 6727) due to disease progression or occurrence of toxicity|55
235042|NCT01121406|569499|P1|STARTED|Overall Study||55
235043|NCT01121393|569549|P2|NOT COMPLETED|Overall Study||84
235044|NCT01121393|569550|P1|NOT COMPLETED|Overall Study||242
235045|NCT01121393|569549|P2|COMPLETED|Overall Study|Completed 6 courses of chemotherapy|38
235046|NCT01121393|569550|P1|COMPLETED|Overall Study|At the time of data cut-off for last-patient out (07 December 2017)|0
235047|NCT01121393|569549|P2|Treated|Overall Study|Treated|113
235048|NCT01121393|569550|P1|Treated|Overall Study|Treated|239
235049|NCT01121393|569549|P2|STARTED|Overall Study|Randomised|122
235050|NCT01121393|569550|P1|STARTED|Overall Study|Randomised|242
235051|NCT01121263|569595|P2|NOT COMPLETED|Overall Study||15
235052|NCT01121263|569596|P1|NOT COMPLETED|Overall Study||25
235053|NCT01121263|569595|P2|COMPLETED|Overall Study||83
235054|NCT01121263|569596|P1|COMPLETED|Overall Study||175
235055|NCT01121263|569595|P2|STARTED|Overall Study||98
235056|NCT01121263|569596|P1|STARTED|Overall Study||200
235057|NCT01121250|569607|P3|NOT COMPLETED|Overall Study||1
235058|NCT01121250|569608|P2|NOT COMPLETED|Overall Study||0
235059|NCT01121250|569609|P1|NOT COMPLETED|Overall Study||0
235060|NCT01121250|569607|P3|COMPLETED|Overall Study||75
235061|NCT01121250|569608|P2|COMPLETED|Overall Study||76
235062|NCT01121250|569609|P1|COMPLETED|Overall Study||76
235063|NCT01121250|569607|P3|STARTED|Overall Study||76
235064|NCT01121250|569608|P2|STARTED|Overall Study||76
235065|NCT01121250|569609|P1|STARTED|Overall Study||76
235066|NCT01121224|569625|P2|NOT COMPLETED|Overall Study||17
235067|NCT01121224|569626|P1|NOT COMPLETED|Overall Study||25
235068|NCT01121224|569625|P2|COMPLETED|Overall Study||275
235069|NCT01121224|569626|P1|COMPLETED|Overall Study||280
235070|NCT01121224|569625|P2|STARTED|Overall Study||292
235071|NCT01121224|569626|P1|STARTED|Overall Study||305
235072|NCT01121211|569676|P2|NOT COMPLETED|Overall Study||12
235073|NCT01121211|569677|P1|NOT COMPLETED|Overall Study||11
235074|NCT01121211|569676|P2|COMPLETED|Overall Study||35
235075|NCT01121211|569677|P1|COMPLETED|Overall Study||32
235076|NCT01121211|569676|P2|STARTED|Overall Study||47
235077|NCT01121211|569677|P1|STARTED|Overall Study||43
235078|NCT01121185|569687|P2|NOT COMPLETED|Overall Study||1
235079|NCT01121185|569688|P1|NOT COMPLETED|Overall Study||1
235080|NCT01121185|569687|P2|COMPLETED|Overall Study||5
235081|NCT01121185|569688|P1|COMPLETED|Overall Study||6
235082|NCT01121185|569687|P2|Transplanted|Overall Study||5
235083|NCT01121185|569688|P1|Transplanted|Overall Study|One subject initiated the first study infusion, but transplant surgery was subsequently cancelled.|6
235084|NCT01121185|569687|P2|Infused|Overall Study|Excluded medical condition identified in one subject after randomization but before study infusion.|5
235085|NCT01121185|569688|P1|Infused|Overall Study||7
235086|NCT01121185|569687|P2|STARTED|Overall Study||6
235087|NCT01121185|569688|P1|STARTED|Overall Study||7
235088|NCT01121172|569712|P2|NOT COMPLETED|Overall Study||0
235089|NCT01121172|569713|P1|NOT COMPLETED|Overall Study||0
235090|NCT01121172|569712|P2|COMPLETED|Overall Study||90
235091|NCT01121172|569713|P1|COMPLETED|Overall Study||90
235092|NCT01121172|569712|P2|STARTED|Overall Study||90
235093|NCT01121172|569713|P1|STARTED|Overall Study||90
235094|NCT01121146|569722|P2|NOT COMPLETED|Overall Study||42
235095|NCT01121146|569723|P1|NOT COMPLETED|Overall Study||26
235096|NCT01121146|569722|P2|COMPLETED|Overall Study|The 72 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|72
235097|NCT01121146|569723|P1|COMPLETED|Overall Study|The 90 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|90
235098|NCT01121146|569722|P2|STARTED|Overall Study||114
235099|NCT01121146|569723|P1|STARTED|Overall Study||116
235100|NCT01120990|569737|P1|NOT COMPLETED|Overall Study||0
235101|NCT01120990|569737|P1|COMPLETED|Overall Study||51
235102|NCT01120990|569737|P1|STARTED|Overall Study||51
235103|NCT01120899|569744|P1|NOT COMPLETED|Overall Study||3
235104|NCT01120899|569744|P1|COMPLETED|Overall Study||3
235105|NCT01120899|569744|P1|Month 18|Overall Study||3
235106|NCT01120899|569744|P1|Month 12|Overall Study||3
235107|NCT01120899|569744|P1|Month 6|Overall Study||5
235108|NCT01120899|569744|P1|STARTED|Overall Study||6
235109|NCT01120834|569764|P1|NOT COMPLETED|Overall Study||0
235110|NCT01120834|569764|P1|COMPLETED|Overall Study||18
235111|NCT01120834|569764|P1|STARTED|Overall Study||18
235112|NCT01120808|569768|P1|NOT COMPLETED|Overall Study||46
235113|NCT01120808|569768|P1|COMPLETED|Overall Study||90
235114|NCT01120808|569768|P1|STARTED|Overall Study||136
235115|NCT01120782|569772|P1|NOT COMPLETED|Overall Study||11
235116|NCT01120782|569772|P1|COMPLETED|Overall Study||34
235117|NCT01120782|569772|P1|STARTED|Overall Study||45
235118|NCT01120756|569778|P2|NOT COMPLETED|Overall Study||1
235119|NCT01120756|569779|P1|NOT COMPLETED|Overall Study||1
235120|NCT01120756|569778|P2|COMPLETED|Overall Study||13
235121|NCT01120756|569779|P1|COMPLETED|Overall Study||20
235122|NCT01120756|569778|P2|STARTED|Overall Study||14
235123|NCT01120756|569779|P1|STARTED|Overall Study||21
235124|NCT01120717|569789|P2|NOT COMPLETED|Overall Study||24
235125|NCT01120717|569790|P1|NOT COMPLETED|Overall Study||32
235126|NCT01120717|569789|P2|COMPLETED|Overall Study||89
235127|NCT01120717|569790|P1|COMPLETED|Overall Study||194
235128|NCT01120717|569789|P2|Safety Population: Received Study Drug|Overall Study||113
235129|NCT01120717|569790|P1|Safety Population: Received Study Drug|Overall Study||225
235130|NCT01120717|569789|P2|STARTED|Overall Study||113
235131|NCT01120717|569790|P1|STARTED|Overall Study||226
235132|NCT01120704|569838|P32|NOT COMPLETED|Overall Study||1
235133|NCT01120704|569839|P31|NOT COMPLETED|Overall Study||2
235134|NCT01120704|569840|P30|NOT COMPLETED|Overall Study||3
235135|NCT01120704|569841|P29|NOT COMPLETED|Overall Study||5
235136|NCT01120704|569842|P28|NOT COMPLETED|Overall Study||2
235137|NCT01120704|569843|P27|NOT COMPLETED|Overall Study||3
235138|NCT01120704|569844|P26|NOT COMPLETED|Overall Study||0
235139|NCT01120704|569845|P25|NOT COMPLETED|Overall Study||2
235140|NCT01120704|569846|P24|NOT COMPLETED|Overall Study||3
235141|NCT01120704|569847|P23|NOT COMPLETED|Overall Study||4
235142|NCT01120704|569848|P22|NOT COMPLETED|Overall Study||0
235143|NCT01120704|569849|P21|NOT COMPLETED|Overall Study||3
235144|NCT01120704|569850|P20|NOT COMPLETED|Overall Study||3
235145|NCT01120704|569851|P19|NOT COMPLETED|Overall Study||2
235146|NCT01120704|569852|P18|NOT COMPLETED|Overall Study||0
235147|NCT01120704|569853|P17|NOT COMPLETED|Overall Study||1
235148|NCT01120704|569854|P16|NOT COMPLETED|Overall Study||2
235149|NCT01120704|569855|P15|NOT COMPLETED|Overall Study||1
235150|NCT01120704|569856|P14|NOT COMPLETED|Overall Study||4
235151|NCT01120704|569857|P13|NOT COMPLETED|Overall Study||3
235152|NCT01120704|569858|P12|NOT COMPLETED|Overall Study||2
235153|NCT01120704|569859|P11|NOT COMPLETED|Overall Study||1
235154|NCT01120704|569860|P10|NOT COMPLETED|Overall Study||1
235155|NCT01120704|569861|P9|NOT COMPLETED|Overall Study||3
235156|NCT01120704|569862|P8|NOT COMPLETED|Overall Study||2
235157|NCT01120704|569863|P7|NOT COMPLETED|Overall Study||3
235158|NCT01120704|569864|P6|NOT COMPLETED|Overall Study||1
235159|NCT01120704|569865|P5|NOT COMPLETED|Overall Study||2
235160|NCT01120704|569866|P4|NOT COMPLETED|Overall Study||4
235161|NCT01120704|569867|P3|NOT COMPLETED|Overall Study||1
235162|NCT01120704|569868|P2|NOT COMPLETED|Overall Study||4
235163|NCT01120704|569869|P1|NOT COMPLETED|Overall Study||3
235164|NCT01120704|569838|P32|COMPLETED|Overall Study||17
235165|NCT01120704|569839|P31|COMPLETED|Overall Study||12
235166|NCT01120704|569840|P30|COMPLETED|Overall Study||12
235167|NCT01120704|569841|P29|COMPLETED|Overall Study||14
235168|NCT01120704|569842|P28|COMPLETED|Overall Study||16
235169|NCT01120704|569843|P27|COMPLETED|Overall Study||15
235170|NCT01120704|569844|P26|COMPLETED|Overall Study||14
235171|NCT01120704|569845|P25|COMPLETED|Overall Study||16
235172|NCT01120704|569846|P24|COMPLETED|Overall Study||13
235173|NCT01120704|569847|P23|COMPLETED|Overall Study||17
235174|NCT01120704|569848|P22|COMPLETED|Overall Study||16
235175|NCT01120704|569849|P21|COMPLETED|Overall Study||14
235176|NCT01120704|569850|P20|COMPLETED|Overall Study||15
235177|NCT01120704|569851|P19|COMPLETED|Overall Study||15
235178|NCT01120704|569852|P18|COMPLETED|Overall Study||16
235179|NCT01120704|569853|P17|COMPLETED|Overall Study||13
235180|NCT01120704|569854|P16|COMPLETED|Overall Study||16
235181|NCT01120704|569855|P15|COMPLETED|Overall Study||17
235182|NCT01120704|569856|P14|COMPLETED|Overall Study||15
235183|NCT01120704|569857|P13|COMPLETED|Overall Study||14
235184|NCT01120704|569858|P12|COMPLETED|Overall Study||14
235185|NCT01120704|569859|P11|COMPLETED|Overall Study||16
235186|NCT01120704|569860|P10|COMPLETED|Overall Study||19
235187|NCT01120704|569861|P9|COMPLETED|Overall Study||19
235188|NCT01120704|569862|P8|COMPLETED|Overall Study||13
235189|NCT01120704|569863|P7|COMPLETED|Overall Study||12
235190|NCT01120704|569864|P6|COMPLETED|Overall Study||18
235191|NCT01120704|569865|P5|COMPLETED|Overall Study||14
235192|NCT01120704|569866|P4|COMPLETED|Overall Study||15
235193|NCT01120704|569867|P3|COMPLETED|Overall Study||13
235194|NCT01120704|569868|P2|COMPLETED|Overall Study||13
235195|NCT01120704|569869|P1|COMPLETED|Overall Study||10
235196|NCT01120704|569838|P32|STARTED|Overall Study||18
235197|NCT01120704|569839|P31|STARTED|Overall Study||14
235198|NCT01120704|569840|P30|STARTED|Overall Study||15
235199|NCT01120704|569841|P29|STARTED|Overall Study||19
235200|NCT01120704|569842|P28|STARTED|Overall Study||18
235201|NCT01120704|569843|P27|STARTED|Overall Study||18
235202|NCT01120704|569844|P26|STARTED|Overall Study||14
235203|NCT01120704|569845|P25|STARTED|Overall Study||18
235204|NCT01120704|569846|P24|STARTED|Overall Study||16
235205|NCT01120704|569847|P23|STARTED|Overall Study||21
235206|NCT01120704|569848|P22|STARTED|Overall Study||16
235207|NCT01120704|569849|P21|STARTED|Overall Study||17
235208|NCT01120704|569850|P20|STARTED|Overall Study||18
235209|NCT01120704|569851|P19|STARTED|Overall Study||17
235210|NCT01120704|569852|P18|STARTED|Overall Study||16
235211|NCT01120704|569853|P17|STARTED|Overall Study||14
235212|NCT01120704|569854|P16|STARTED|Overall Study||18
235213|NCT01120704|569855|P15|STARTED|Overall Study||18
235214|NCT01120704|569856|P14|STARTED|Overall Study||19
235215|NCT01120704|569857|P13|STARTED|Overall Study||17
235216|NCT01120704|569858|P12|STARTED|Overall Study||16
235217|NCT01120704|569859|P11|STARTED|Overall Study||17
235218|NCT01120704|569860|P10|STARTED|Overall Study||20
235219|NCT01120704|569861|P9|STARTED|Overall Study||22
235220|NCT01120704|569862|P8|STARTED|Overall Study||15
235221|NCT01120704|569863|P7|STARTED|Overall Study||15
235222|NCT01120704|569864|P6|STARTED|Overall Study||19
235223|NCT01120704|569865|P5|STARTED|Overall Study||16
235224|NCT01120704|569866|P4|STARTED|Overall Study||19
235225|NCT01120704|569867|P3|STARTED|Overall Study||14
235226|NCT01120704|569868|P2|STARTED|Overall Study||17
235227|NCT01120704|569869|P1|STARTED|Overall Study||13
235228|NCT01120691|569896|P3|NOT COMPLETED|Overall Study||183
235229|NCT01120691|569897|P2|NOT COMPLETED|Overall Study||203
235230|NCT01120691|569898|P1|NOT COMPLETED|Overall Study||171
235231|NCT01120691|569896|P3|COMPLETED|Overall Study||559
235232|NCT01120691|569897|P2|COMPLETED|Overall Study||538
235233|NCT01120691|569898|P1|COMPLETED|Overall Study||570
235234|NCT01120691|569896|P3|Modified Full Analysis Set (mFAS)|Overall Study||737
235235|NCT01120691|569897|P2|Modified Full Analysis Set (mFAS)|Overall Study||739
235236|NCT01120691|569898|P1|Modified Full Analysis Set (mFAS)|Overall Study||729
235237|NCT01120691|569896|P3|Modified Safety Set (mSAF)|Overall Study||737
235238|NCT01120691|569897|P2|Modified Safety Set (mSAF)|Overall Study||740
235239|NCT01120691|569898|P1|Modified Safety Set (mSAF)|Overall Study||729
235240|NCT01120691|569896|P3|Safety Set (SAF)|Overall Study||739
235241|NCT01120691|569897|P2|Safety Set (SAF)|Overall Study||740
235242|NCT01120691|569898|P1|Safety Set (SAF)|Overall Study||736
235243|NCT01120691|569896|P3|Full Analysis Set (FAS)|Overall Study||739
235244|NCT01120691|569897|P2|Full Analysis Set (FAS)|Overall Study||739
235245|NCT01120691|569898|P1|Full Analysis Set (FAS)|Overall Study||736
235246|NCT01120691|569896|P3|STARTED|Overall Study||742
235247|NCT01120691|569897|P2|STARTED|Overall Study||741
235248|NCT01120691|569898|P1|STARTED|Overall Study||741
235249|NCT01120639|569944|P4|NOT COMPLETED|Overall Study||0
235250|NCT01120639|569945|P3|NOT COMPLETED|Overall Study||0
235251|NCT01120639|569946|P2|NOT COMPLETED|Overall Study||0
235252|NCT01120639|569947|P1|NOT COMPLETED|Overall Study||0
235253|NCT01120639|569944|P4|COMPLETED|Overall Study||12
235254|NCT01120639|569945|P3|COMPLETED|Overall Study||6
235255|NCT01120639|569946|P2|COMPLETED|Overall Study||6
235256|NCT01120639|569947|P1|COMPLETED|Overall Study||6
235257|NCT01120639|569944|P4|STARTED|Overall Study||12
235258|NCT01120639|569945|P3|STARTED|Overall Study||6
235259|NCT01120639|569946|P2|STARTED|Overall Study||6
235260|NCT01120639|569947|P1|STARTED|Overall Study||6
235261|NCT01120626|569995|P2|NOT COMPLETED|Overall Study||0
235262|NCT01120626|569996|P1|NOT COMPLETED|Overall Study||1
235263|NCT01120626|569995|P2|COMPLETED|Overall Study||22
235264|NCT01120626|569996|P1|COMPLETED|Overall Study||19
235265|NCT01120626|569995|P2|STARTED|Overall Study||22
235266|NCT01120626|569996|P1|STARTED|Overall Study||20
235267|NCT01120600|570006|P2|NOT COMPLETED|Overall Study||32
235268|NCT01120600|570007|P1|NOT COMPLETED|Overall Study||19
235269|NCT01120600|570006|P2|COMPLETED|Overall Study||115
235270|NCT01120600|570007|P1|COMPLETED|Overall Study||128
235271|NCT01120600|570006|P2|Treated|Overall Study||146
235272|NCT01120600|570007|P1|Treated|Overall Study||146
235273|NCT01120600|570006|P2|STARTED|Overall Study||147
235274|NCT01120600|570007|P1|STARTED|Overall Study||147
235275|NCT01120405|570033|P2|NOT COMPLETED|Overall Study||33
235276|NCT01120405|570034|P1|NOT COMPLETED|Overall Study||27
235277|NCT01120405|570033|P2|COMPLETED|Overall Study||269
235278|NCT01120405|570034|P1|COMPLETED|Overall Study||271
235279|NCT01120405|570033|P2|STARTED|Overall Study||302
235280|NCT01120405|570034|P1|STARTED|Overall Study||298
235281|NCT01120379|570062|P1|NOT COMPLETED|Four Year Timepoint||368
235282|NCT01120379|570062|P1|COMPLETED|Four Year Timepoint||3923
235283|NCT01120379|570062|P1|STARTED|Four Year Timepoint||4291
235284|NCT01120379|570062|P1|NOT COMPLETED|Three Year Timepoint||214
235285|NCT01120379|570062|P1|COMPLETED|Three Year Timepoint||4291
235286|NCT01120379|570062|P1|STARTED|Three Year Timepoint||4505
235287|NCT01120379|570062|P1|NOT COMPLETED|Two Year Timepoint||237
235288|NCT01120379|570062|P1|COMPLETED|Two Year Timepoint||4505
235289|NCT01120379|570062|P1|STARTED|Two Year Timepoint||4742
235290|NCT01120379|570062|P1|NOT COMPLETED|One Year Timepoint||278
235291|NCT01120379|570062|P1|COMPLETED|One Year Timepoint||4742
235292|NCT01120379|570062|P1|STARTED|One Year Timepoint||5020
235293|NCT01120275|570098|P1|NOT COMPLETED|Overall Study||36
235294|NCT01120275|570098|P1|COMPLETED|Overall Study||0
235295|NCT01120275|570098|P1|Eligible and Treated|Overall Study||32
235296|NCT01120275|570098|P1|STARTED|Overall Study||36
235297|NCT01120236|570107|P2|NOT COMPLETED|Overall Study||1
235298|NCT01120236|570108|P1|NOT COMPLETED|Overall Study||0
235299|NCT01120236|570107|P2|COMPLETED|Overall Study||105
235300|NCT01120236|570108|P1|COMPLETED|Overall Study||105
235301|NCT01120236|570107|P2|Ineligble|Overall Study|Patient ineligible due to no demonstable radiographic metastasis and is excluded from all analyses.|1
235302|NCT01120236|570108|P1|Ineligble|Overall Study||0
235303|NCT01120236|570107|P2|STARTED|Overall Study||106
235304|NCT01120236|570108|P1|STARTED|Overall Study||105
235305|NCT01120223|570135|P1|NOT COMPLETED|Overall Study||4
235306|NCT01120223|570135|P1|COMPLETED|Overall Study||74
235307|NCT01120223|570135|P1|STARTED|Overall Study||78
235308|NCT01120210|570165|P2|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
235309|NCT01120210|570166|P1|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
235310|NCT01120210|570165|P2|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
235311|NCT01120210|570166|P1|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
235312|NCT01120210|570165|P2|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
235313|NCT01120210|570166|P1|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
235314|NCT01120210|570165|P2|NOT COMPLETED|MAIN INFUSION||1
235315|NCT01120210|570166|P1|NOT COMPLETED|MAIN INFUSION||1
235316|NCT01120210|570165|P2|COMPLETED|MAIN INFUSION||45
235317|NCT01120210|570166|P1|COMPLETED|MAIN INFUSION||15
235318|NCT01120210|570165|P2|STARTED|MAIN INFUSION||46
235319|NCT01120210|570166|P1|STARTED|MAIN INFUSION||16
235320|NCT01120197|570198|P2|NOT COMPLETED|Overall Study||10
235321|NCT01120197|570199|P1|NOT COMPLETED|Overall Study||9
235322|NCT01120197|570198|P2|COMPLETED|Overall Study||32
235323|NCT01120197|570199|P1|COMPLETED|Overall Study||38
235324|NCT01120197|570198|P2|STARTED|Overall Study||42
235325|NCT01120197|570199|P1|STARTED|Overall Study||47
235326|NCT01120184|570216|P3|NOT COMPLETED|Overall Study||363
235327|NCT01120184|570217|P2|NOT COMPLETED|Overall Study||367
235328|NCT01120184|570218|P1|NOT COMPLETED|Overall Study||365
235329|NCT01120184|570216|P3|COMPLETED|Overall Study||0
235330|NCT01120184|570217|P2|COMPLETED|Overall Study||0
235331|NCT01120184|570218|P1|COMPLETED|Overall Study||0
235332|NCT01120184|570216|P3|Treated|Overall Study||360
235333|NCT01120184|570217|P2|Treated|Overall Study||365
235334|NCT01120184|570218|P1|Treated|Overall Study||355
235335|NCT01120184|570216|P3|STARTED|Overall Study||363
235336|NCT01120184|570217|P2|STARTED|Overall Study||367
235337|NCT01120184|570218|P1|STARTED|Overall Study||365
235338|NCT01120093|570340|P5|NOT COMPLETED|Treatment Period 5||0
235339|NCT01120093|570341|P4|NOT COMPLETED|Treatment Period 5||1
235340|NCT01120093|570342|P3|NOT COMPLETED|Treatment Period 5||0
235341|NCT01120093|570343|P2|NOT COMPLETED|Treatment Period 5||1
235342|NCT01120093|570344|P1|NOT COMPLETED|Treatment Period 5||0
235343|NCT01120093|570340|P5|COMPLETED|Treatment Period 5||13
235344|NCT01120093|570341|P4|COMPLETED|Treatment Period 5||11
235345|NCT01120093|570342|P3|COMPLETED|Treatment Period 5||15
235346|NCT01120093|570343|P2|COMPLETED|Treatment Period 5||12
235347|NCT01120093|570344|P1|COMPLETED|Treatment Period 5||17
235348|NCT01120093|570340|P5|STARTED|Treatment Period 5||13
235349|NCT01120093|570341|P4|STARTED|Treatment Period 5||12
235350|NCT01120093|570342|P3|STARTED|Treatment Period 5||15
235351|NCT01120093|570343|P2|STARTED|Treatment Period 5||13
235352|NCT01120093|570344|P1|STARTED|Treatment Period 5||17
235353|NCT01120093|570340|P5|NOT COMPLETED|Treatment Period 4||0
235354|NCT01120093|570341|P4|NOT COMPLETED|Treatment Period 4||0
235355|NCT01120093|570342|P3|NOT COMPLETED|Treatment Period 4||0
235356|NCT01120093|570343|P2|NOT COMPLETED|Treatment Period 4||0
235357|NCT01120093|570344|P1|NOT COMPLETED|Treatment Period 4||1
235358|NCT01120093|570340|P5|COMPLETED|Treatment Period 4||13
235359|NCT01120093|570341|P4|COMPLETED|Treatment Period 4||12
235360|NCT01120093|570342|P3|COMPLETED|Treatment Period 4||15
235361|NCT01120093|570343|P2|COMPLETED|Treatment Period 4||13
235362|NCT01120093|570344|P1|COMPLETED|Treatment Period 4||17
235363|NCT01120093|570340|P5|STARTED|Treatment Period 4||13
235364|NCT01120093|570341|P4|STARTED|Treatment Period 4||12
235365|NCT01120093|570342|P3|STARTED|Treatment Period 4||15
235366|NCT01120093|570343|P2|STARTED|Treatment Period 4||13
235367|NCT01120093|570344|P1|STARTED|Treatment Period 4||18
235368|NCT01120093|570340|P5|NOT COMPLETED|Treatment Period 3||1
235369|NCT01120093|570341|P4|NOT COMPLETED|Treatment Period 3||1
235370|NCT01120093|570342|P3|NOT COMPLETED|Treatment Period 3||1
235371|NCT01120093|570343|P2|NOT COMPLETED|Treatment Period 3||0
235372|NCT01120093|570344|P1|NOT COMPLETED|Treatment Period 3||0
235373|NCT01120093|570340|P5|COMPLETED|Treatment Period 3||13
235374|NCT01120093|570341|P4|COMPLETED|Treatment Period 3||12
235375|NCT01120093|570342|P3|COMPLETED|Treatment Period 3||15
235376|NCT01120093|570343|P2|COMPLETED|Treatment Period 3||13
235377|NCT01120093|570344|P1|COMPLETED|Treatment Period 3||18
235378|NCT01120093|570340|P5|STARTED|Treatment Period 3||14
235379|NCT01120093|570341|P4|STARTED|Treatment Period 3||13
235380|NCT01120093|570342|P3|STARTED|Treatment Period 3||16
235381|NCT01120093|570343|P2|STARTED|Treatment Period 3||13
235382|NCT01120093|570344|P1|STARTED|Treatment Period 3||18
235383|NCT01120093|570340|P5|NOT COMPLETED|Treatment Period 2||1
235384|NCT01120093|570341|P4|NOT COMPLETED|Treatment Period 2||1
235385|NCT01120093|570342|P3|NOT COMPLETED|Treatment Period 2||0
235386|NCT01120093|570343|P2|NOT COMPLETED|Treatment Period 2||0
235387|NCT01120093|570344|P1|NOT COMPLETED|Treatment Period 2||0
235388|NCT01120093|570340|P5|COMPLETED|Treatment Period 2||14
235389|NCT01120093|570341|P4|COMPLETED|Treatment Period 2||13
235390|NCT01120093|570342|P3|COMPLETED|Treatment Period 2||16
235391|NCT01120093|570343|P2|COMPLETED|Treatment Period 2||13
235392|NCT01120093|570344|P1|COMPLETED|Treatment Period 2||18
235393|NCT01120093|570340|P5|STARTED|Treatment Period 2||15
235394|NCT01120093|570341|P4|STARTED|Treatment Period 2||14
235395|NCT01120093|570342|P3|STARTED|Treatment Period 2||16
235396|NCT01120093|570343|P2|STARTED|Treatment Period 2||13
235397|NCT01120093|570344|P1|STARTED|Treatment Period 2||18
235398|NCT01120093|570340|P5|NOT COMPLETED|Treatment Period 1||1
235399|NCT01120093|570341|P4|NOT COMPLETED|Treatment Period 1||0
235400|NCT01120093|570342|P3|NOT COMPLETED|Treatment Period 1||1
235401|NCT01120093|570343|P2|NOT COMPLETED|Treatment Period 1||1
235402|NCT01120093|570344|P1|NOT COMPLETED|Treatment Period 1||0
235403|NCT01120093|570340|P5|COMPLETED|Treatment Period 1||15
235404|NCT01120093|570341|P4|COMPLETED|Treatment Period 1||14
235405|NCT01120093|570342|P3|COMPLETED|Treatment Period 1||16
235406|NCT01120093|570343|P2|COMPLETED|Treatment Period 1||13
235407|NCT01120093|570344|P1|COMPLETED|Treatment Period 1||18
235408|NCT01120093|570340|P5|STARTED|Treatment Period 1||16
235409|NCT01120093|570341|P4|STARTED|Treatment Period 1||14
235410|NCT01120093|570342|P3|STARTED|Treatment Period 1||17
235411|NCT01120093|570343|P2|STARTED|Treatment Period 1||14
235412|NCT01120093|570344|P1|STARTED|Treatment Period 1||18
235413|NCT01120067|570373|P2|NOT COMPLETED|Overall Study||1
235414|NCT01120067|570374|P1|NOT COMPLETED|Overall Study||5
235415|NCT01120067|570373|P2|COMPLETED|Overall Study||10
235416|NCT01120067|570374|P1|COMPLETED|Overall Study||7
235417|NCT01120067|570373|P2|STARTED|Overall Study||11
235418|NCT01120067|570374|P1|STARTED|Overall Study||12
235419|NCT01120028|570384|P4|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
235420|NCT01120028|570385|P3|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
235421|NCT01120028|570386|P2|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
235422|NCT01120028|570387|P1|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
235423|NCT01120028|570384|P4|COMPLETED|Period 2: Tacrolimus or Sirolimus||197
235424|NCT01120028|570385|P3|COMPLETED|Period 2: Tacrolimus or Sirolimus||197
235425|NCT01120028|570386|P2|COMPLETED|Period 2: Tacrolimus or Sirolimus||0
235426|NCT01120028|570387|P1|COMPLETED|Period 2: Tacrolimus or Sirolimus||0
235427|NCT01120028|570384|P4|STARTED|Period 2: Tacrolimus or Sirolimus||197
235428|NCT01120028|570385|P3|STARTED|Period 2: Tacrolimus or Sirolimus||197
235429|NCT01120028|570386|P2|STARTED|Period 2: Tacrolimus or Sirolimus||0
235430|NCT01120028|570387|P1|STARTED|Period 2: Tacrolimus or Sirolimus||0
235431|NCT01120028|570384|P4|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
235432|NCT01120028|570385|P3|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
235433|NCT01120028|570386|P2|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||23
235434|NCT01120028|570387|P1|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||14
235435|NCT01120028|570384|P4|COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
235436|NCT01120028|570385|P3|COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
235437|NCT01120028|570386|P2|COMPLETED|Period 1: Alemtuzumab or Basiliximab||403
235438|NCT01120028|570387|P1|COMPLETED|Period 1: Alemtuzumab or Basiliximab||412
235439|NCT01120028|570384|P4|STARTED|Period 1: Alemtuzumab or Basiliximab||0
235440|NCT01120028|570385|P3|STARTED|Period 1: Alemtuzumab or Basiliximab||0
235441|NCT01120028|570386|P2|STARTED|Period 1: Alemtuzumab or Basiliximab||426
235442|NCT01120028|570387|P1|STARTED|Period 1: Alemtuzumab or Basiliximab||426
235443|NCT01119963|570411|P2|NOT COMPLETED|Overall Study||1
235444|NCT01119963|570412|P1|NOT COMPLETED|Overall Study||1
235445|NCT01119963|570411|P2|COMPLETED|Overall Study||77
235446|NCT01119963|570412|P1|COMPLETED|Overall Study||73
235447|NCT01119963|570411|P2|STARTED|Overall Study||78
235448|NCT01119963|570412|P1|STARTED|Overall Study||74
235449|NCT01119950|570422|P1|NOT COMPLETED|Overall Study||47
235450|NCT01119950|570422|P1|COMPLETED|Overall Study|These participants completed both periods 1 and 2|341
235451|NCT01119950|570422|P1|Placebo|Overall Study|3 randomized participants did not receive study drug, 82 completed treatment, 5 discontinued.|94
235452|NCT01119950|570422|P1|NVA237 50 ug b.i.d.|Overall Study|6 randomized and 1 misrandomized patients did not receive study drug, 82 completed, 5 discontinued.|94
235453|NCT01119950|570422|P1|NVA237 100 ug q.d.|Overall Study|2 randomized participants did not receive study drug, 92 completed treatment, 4 discontinued.|98
235454|NCT01119950|570422|P1|NVA237 25 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 7 discontinued.|100
235455|NCT01119950|570422|P1|NVA237 50 ug q.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 3 discontinued.|96
235456|NCT01119950|570422|P1|NVA237 12.5 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 93 completed treatment, 2 discontinued.|99
235457|NCT01119950|570422|P1|NVA237 25 ug q.d.|Overall Study|3 randomized participants did not receive study drug, 91 completed treatment, 5 discontinued.|99
235458|NCT01119950|570422|P1|NVA237 12.5 ug q.d.|Overall Study|5 randomized and 2 misrandomized patients did not receive study drug, 80 completed, 9 discontinued.|96
235459|NCT01119950|570422|P1|STARTED|Overall Study|These participants were randomized to 2 different treatment sequences during period 1 and 2.|388
235460|NCT01119937|570669|P2|NOT COMPLETED|Overall Study||7
235461|NCT01119937|570670|P1|NOT COMPLETED|Overall Study||19
235462|NCT01119937|570669|P2|COMPLETED|Overall Study||33
235463|NCT01119937|570670|P1|COMPLETED|Overall Study||104
235464|NCT01119937|570669|P2|STARTED|Overall Study||40
235465|NCT01119937|570670|P1|STARTED|Overall Study||123
235466|NCT01119898|570698|P2|NOT COMPLETED|Overall Study||12
235467|NCT01119898|570699|P1|NOT COMPLETED|Overall Study||8
235468|NCT01119898|570698|P2|COMPLETED|Overall Study||117
235469|NCT01119898|570699|P1|COMPLETED|Overall Study||123
235470|NCT01119898|570698|P2|Received Study Drug (mITT)|Overall Study||129
235471|NCT01119898|570699|P1|Received Study Drug (mITT)|Overall Study||130
235472|NCT01119898|570698|P2|STARTED|Overall Study||129
235473|NCT01119898|570699|P1|STARTED|Overall Study||131
235474|NCT01119859|570725|P2|NOT COMPLETED|Overall Study||30
235475|NCT01119859|570726|P1|NOT COMPLETED|Overall Study||24
235476|NCT01119859|570725|P2|COMPLETED|Overall Study||133
235477|NCT01119859|570726|P1|COMPLETED|Overall Study||139
235478|NCT01119859|570725|P2|STARTED|Overall Study||163
235479|NCT01119859|570726|P1|STARTED|Overall Study||163
235480|NCT01119846|570745|P3|NOT COMPLETED|Overall Study||11
235481|NCT01119846|570746|P2|NOT COMPLETED|Overall Study||0
235482|NCT01119846|570747|P1|NOT COMPLETED|Overall Study||2
235483|NCT01119846|570745|P3|COMPLETED|Overall Study||72
235484|NCT01119846|570746|P2|COMPLETED|Overall Study||4
235485|NCT01119846|570747|P1|COMPLETED|Overall Study||11
235486|NCT01119846|570745|P3|STARTED|Overall Study||83
235487|NCT01119846|570746|P2|STARTED|Overall Study||4
235488|NCT01119846|570747|P1|STARTED|Overall Study||13
235489|NCT01119794|570955|P1|NOT COMPLETED|Overall Study||0
235490|NCT01119794|570955|P1|COMPLETED|Overall Study||10
235491|NCT01119794|570955|P1|STARTED|Overall Study||10
235492|NCT01119768|570961|P2|NOT COMPLETED|Follow-up||2
235493|NCT01119768|570962|P1|NOT COMPLETED|Follow-up||1
235494|NCT01119768|570961|P2|COMPLETED|Follow-up||122
235495|NCT01119768|570962|P1|COMPLETED|Follow-up||135
235496|NCT01119768|570961|P2|STARTED|Follow-up||124
235497|NCT01119768|570962|P1|STARTED|Follow-up||136
235498|NCT01119768|570961|P2|NOT COMPLETED|Treatment Period||25
235499|NCT01119768|570962|P1|NOT COMPLETED|Treatment Period||18
235500|NCT01119768|570961|P2|COMPLETED|Treatment Period||126
235501|NCT01119768|570962|P1|COMPLETED|Treatment Period||136
235502|NCT01119768|570961|P2|STARTED|Treatment Period||151
235503|NCT01119768|570962|P1|STARTED|Treatment Period||154
235504|NCT01119755|570984|P1|NOT COMPLETED|Overall Study||0
235505|NCT01119755|570984|P1|COMPLETED|Overall Study||80
235506|NCT01119755|570984|P1|STARTED|Overall Study||80
235507|NCT01119716|570995|P1|NOT COMPLETED|Overall Study||0
235508|NCT01119716|570995|P1|COMPLETED|Overall Study||4658
235509|NCT01119716|570995|P1|STARTED|Overall Study||4658
235510|NCT01119703|571018|P2|NOT COMPLETED|Overall Study||1
235511|NCT01119703|571019|P1|NOT COMPLETED|Overall Study||0
235512|NCT01119703|571018|P2|COMPLETED|Overall Study||143
235513|NCT01119703|571019|P1|COMPLETED|Overall Study||30
235514|NCT01119703|571018|P2|STARTED|Overall Study||144
235515|NCT01119703|571019|P1|STARTED|Overall Study||30
235516|NCT01119625|571033|P2|NOT COMPLETED|Overall Study||4
235517|NCT01119625|571034|P1|NOT COMPLETED|Overall Study||3
235518|NCT01119625|571033|P2|COMPLETED|Overall Study||116
235519|NCT01119625|571034|P1|COMPLETED|Overall Study||115
235520|NCT01119625|571033|P2|STARTED|Overall Study||120
235521|NCT01119625|571034|P1|STARTED|Overall Study||118
235522|NCT01119456|571082|P8|NOT COMPLETED|Overall Study||0
235523|NCT01119456|571083|P7|NOT COMPLETED|Overall Study||0
235524|NCT01119456|571084|P6|NOT COMPLETED|Overall Study||0
235525|NCT01119456|571085|P5|NOT COMPLETED|Overall Study||0
235526|NCT01119456|571086|P4|NOT COMPLETED|Overall Study||0
235527|NCT01119456|571087|P3|NOT COMPLETED|Overall Study||0
235528|NCT01119456|571088|P2|NOT COMPLETED|Overall Study||0
235529|NCT01119456|571089|P1|NOT COMPLETED|Overall Study||0
235530|NCT01119456|571082|P8|COMPLETED|Overall Study||3
235531|NCT01119456|571083|P7|COMPLETED|Overall Study||3
235532|NCT01119456|571084|P6|COMPLETED|Overall Study||3
235533|NCT01119456|571085|P5|COMPLETED|Overall Study||4
235534|NCT01119456|571086|P4|COMPLETED|Overall Study||13
235535|NCT01119456|571087|P3|COMPLETED|Overall Study||3
235536|NCT01119456|571088|P2|COMPLETED|Overall Study||3
235537|NCT01119456|571089|P1|COMPLETED|Overall Study||7
235538|NCT01119456|571082|P8|Received at Least 1 Dose of Study Drug|Overall Study||3
235539|NCT01119456|571083|P7|Received at Least 1 Dose of Study Drug|Overall Study||3
235540|NCT01119456|571084|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
235541|NCT01119456|571085|P5|Received at Least 1 Dose of Study Drug|Overall Study||4
235542|NCT01119456|571086|P4|Received at Least 1 Dose of Study Drug|Overall Study||13
235543|NCT01119456|571087|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
235544|NCT01119456|571088|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
235545|NCT01119456|571089|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
235546|NCT01119456|571082|P8|STARTED|Overall Study||3
235547|NCT01119456|571083|P7|STARTED|Overall Study||3
235548|NCT01119456|571084|P6|STARTED|Overall Study||3
235549|NCT01119456|571085|P5|STARTED|Overall Study||4
235550|NCT01119456|571086|P4|STARTED|Overall Study||13
235551|NCT01119456|571087|P3|STARTED|Overall Study||3
235552|NCT01119456|571088|P2|STARTED|Overall Study||3
235553|NCT01119456|571089|P1|STARTED|Overall Study||7
235554|NCT01119443|571150|P2|NOT COMPLETED|End of Study (All Patients)||0
235555|NCT01119443|571151|P1|NOT COMPLETED|End of Study (All Patients)||0
235556|NCT01119443|571150|P2|COMPLETED|End of Study (All Patients)||14
235557|NCT01119443|571151|P1|COMPLETED|End of Study (All Patients)||14
235558|NCT01119443|571150|P2|STARTED|End of Study (All Patients)||14
235559|NCT01119443|571151|P1|STARTED|End of Study (All Patients)||14
235560|NCT01119443|571150|P2|NOT COMPLETED|Down-titration Period (1 Day)||0
235561|NCT01119443|571151|P1|NOT COMPLETED|Down-titration Period (1 Day)||0
235562|NCT01119443|571150|P2|COMPLETED|Down-titration Period (1 Day)||13
235563|NCT01119443|571151|P1|COMPLETED|Down-titration Period (1 Day)||14
235564|NCT01119443|571150|P2|STARTED|Down-titration Period (1 Day)||13
235565|NCT01119443|571151|P1|STARTED|Down-titration Period (1 Day)||14
235566|NCT01119443|571150|P2|NOT COMPLETED|Crossover Period 4 (5 Days)||0
235567|NCT01119443|571151|P1|NOT COMPLETED|Crossover Period 4 (5 Days)||0
235568|NCT01119443|571150|P2|COMPLETED|Crossover Period 4 (5 Days)||13
235569|NCT01119443|571151|P1|COMPLETED|Crossover Period 4 (5 Days)||14
235570|NCT01119443|571150|P2|STARTED|Crossover Period 4 (5 Days)||13
235571|NCT01119443|571151|P1|STARTED|Crossover Period 4 (5 Days)||14
235572|NCT01119443|571150|P2|NOT COMPLETED|Crossover Period 3 (5 Days)||0
235573|NCT01119443|571151|P1|NOT COMPLETED|Crossover Period 3 (5 Days)||0
235574|NCT01119443|571150|P2|COMPLETED|Crossover Period 3 (5 Days)||13
235575|NCT01119443|571151|P1|COMPLETED|Crossover Period 3 (5 Days)||14
235576|NCT01119443|571150|P2|STARTED|Crossover Period 3 (5 Days)||13
235577|NCT01119443|571151|P1|STARTED|Crossover Period 3 (5 Days)||14
235578|NCT01119443|571150|P2|NOT COMPLETED|Crossover Period 2 (5 Days)||0
235579|NCT01119443|571151|P1|NOT COMPLETED|Crossover Period 2 (5 Days)||0
235580|NCT01119443|571150|P2|COMPLETED|Crossover Period 2 (5 Days)||13
235581|NCT01119443|571151|P1|COMPLETED|Crossover Period 2 (5 Days)||14
235582|NCT01119443|571150|P2|STARTED|Crossover Period 2 (5 Days)||13
235583|NCT01119443|571151|P1|STARTED|Crossover Period 2 (5 Days)||14
235584|NCT01119443|571150|P2|NOT COMPLETED|Crossover Period 1 (5 Days)||1
235585|NCT01119443|571151|P1|NOT COMPLETED|Crossover Period 1 (5 Days)||0
235586|NCT01119443|571150|P2|COMPLETED|Crossover Period 1 (5 Days)||13
235587|NCT01119443|571151|P1|COMPLETED|Crossover Period 1 (5 Days)||14
235588|NCT01119443|571150|P2|STARTED|Crossover Period 1 (5 Days)||14
235589|NCT01119443|571151|P1|STARTED|Crossover Period 1 (5 Days)||14
235590|NCT01119443|571150|P2|NOT COMPLETED|Up-titration Period (10 Days)||0
235591|NCT01119443|571151|P1|NOT COMPLETED|Up-titration Period (10 Days)||0
235592|NCT01119443|571150|P2|COMPLETED|Up-titration Period (10 Days)||14
235593|NCT01119443|571151|P1|COMPLETED|Up-titration Period (10 Days)||14
235594|NCT01119443|571150|P2|STARTED|Up-titration Period (10 Days)||14
235595|NCT01119443|571151|P1|STARTED|Up-titration Period (10 Days)||14
235596|NCT01119287|571194|P6|NOT COMPLETED|Overall Study||0
235597|NCT01119287|571195|P5|NOT COMPLETED|Overall Study||1
235598|NCT01119287|571196|P4|NOT COMPLETED|Overall Study||2
235599|NCT01119287|571197|P3|NOT COMPLETED|Overall Study||2
235600|NCT01119287|571198|P2|NOT COMPLETED|Overall Study||0
235601|NCT01119287|571199|P1|NOT COMPLETED|Overall Study||0
235602|NCT01119287|571194|P6|COMPLETED|Overall Study||32
235603|NCT01119287|571195|P5|COMPLETED|Overall Study||30
235604|NCT01119287|571196|P4|COMPLETED|Overall Study||29
235605|NCT01119287|571197|P3|COMPLETED|Overall Study||24
235606|NCT01119287|571198|P2|COMPLETED|Overall Study||24
235607|NCT01119287|571199|P1|COMPLETED|Overall Study||26
235608|NCT01119287|571194|P6|STARTED|Overall Study||32
235609|NCT01119287|571195|P5|STARTED|Overall Study||31
235610|NCT01119287|571196|P4|STARTED|Overall Study||31
235611|NCT01119287|571197|P3|STARTED|Overall Study||26
235612|NCT01119287|571198|P2|STARTED|Overall Study||24
235613|NCT01119287|571199|P1|STARTED|Overall Study||26
235614|NCT01119248|571212|P1|NOT COMPLETED|Overall Study||5
235615|NCT01119248|571212|P1|COMPLETED|Overall Study||115
235616|NCT01119248|571212|P1|STARTED|Overall Study||120
235617|NCT01119222|571218|P4|NOT COMPLETED|Overall Study||0
235618|NCT01119222|571219|P3|NOT COMPLETED|Overall Study||0
235619|NCT01119222|571220|P2|NOT COMPLETED|Overall Study||0
235620|NCT01119222|571221|P1|NOT COMPLETED|Overall Study||0
235621|NCT01119222|571218|P4|COMPLETED|Overall Study||4
235622|NCT01119222|571219|P3|COMPLETED|Overall Study||5
235623|NCT01119222|571220|P2|COMPLETED|Overall Study||5
235624|NCT01119222|571221|P1|COMPLETED|Overall Study||5
235625|NCT01119222|571218|P4|STARTED|Overall Study||4
235626|NCT01119222|571219|P3|STARTED|Overall Study||5
235627|NCT01119222|571220|P2|STARTED|Overall Study||5
235628|NCT01119222|571221|P1|STARTED|Overall Study||5
235629|NCT01119131|571262|P3|NOT COMPLETED|Overall Study||6
235630|NCT01119131|571263|P2|NOT COMPLETED|Overall Study||1
235631|NCT01119131|571264|P1|NOT COMPLETED|Overall Study||2
235632|NCT01119131|571262|P3|COMPLETED|Overall Study||24
235633|NCT01119131|571263|P2|COMPLETED|Overall Study||27
235634|NCT01119131|571264|P1|COMPLETED|Overall Study||8
235635|NCT01119131|571262|P3|STARTED|Overall Study||30
235636|NCT01119131|571263|P2|STARTED|Overall Study||28
235637|NCT01119131|571264|P1|STARTED|Overall Study||10
235638|NCT01119118|571293|P1|NOT COMPLETED|Overall Study||1
235639|NCT01119118|571293|P1|COMPLETED|Overall Study||5
235640|NCT01119118|571293|P1|STARTED|Overall Study||6
235641|NCT01119040|571301|P1|NOT COMPLETED|Overall Study||1
235642|NCT01119040|571301|P1|COMPLETED|Overall Study||0
235643|NCT01119040|571301|P1|STARTED|Overall Study||1
235644|NCT01119001|571305|P1|NOT COMPLETED|Overall Study||2
235645|NCT01119001|571305|P1|COMPLETED|Overall Study||11
235646|NCT01119001|571305|P1|STARTED|Overall Study||13
235647|NCT01118988|571314|P3|NOT COMPLETED|Overall Study||4
235648|NCT01118988|571315|P2|NOT COMPLETED|Overall Study||1
235649|NCT01118988|571316|P1|NOT COMPLETED|Overall Study||5
235650|NCT01118988|571314|P3|COMPLETED|Overall Study||3
235651|NCT01118988|571315|P2|COMPLETED|Overall Study||3
235652|NCT01118988|571316|P1|COMPLETED|Overall Study||11
235653|NCT01118988|571314|P3|STARTED|Overall Study||7
235654|NCT01118988|571315|P2|STARTED|Overall Study||4
235655|NCT01118988|571316|P1|STARTED|Overall Study||16
235656|NCT01118975|571349|P2|NOT COMPLETED|Overall Study||1
235657|NCT01118975|571350|P1|NOT COMPLETED|Overall Study||0
235658|NCT01118975|571349|P2|COMPLETED|Overall Study||2
235659|NCT01118975|571350|P1|COMPLETED|Overall Study||9
235660|NCT01118975|571349|P2|STARTED|Overall Study||3
235661|NCT01118975|571350|P1|STARTED|Overall Study||9
235662|NCT01118962|571356|P1|NOT COMPLETED|Overall Study||10
235663|NCT01118962|571356|P1|COMPLETED|Overall Study||29
235664|NCT01118962|571356|P1|STARTED|Overall Study||39
235665|NCT01118949|571361|P1|NOT COMPLETED|Overall Study||9
235666|NCT01118949|571361|P1|COMPLETED|Overall Study||40
235667|NCT01118949|571361|P1|STARTED|Overall Study||49
235668|NCT01118845|571370|P1|NOT COMPLETED|Overall Study||42
235669|NCT01118845|571370|P1|COMPLETED|Overall Study||17
235670|NCT01118845|571370|P1|STARTED|Overall Study||59
235671|NCT01118780|571391|P2|NOT COMPLETED|Overall Study||35
235672|NCT01118780|571392|P1|NOT COMPLETED|Overall Study||36
235673|NCT01118780|571391|P2|COMPLETED|Overall Study||105
235674|NCT01118780|571392|P1|COMPLETED|Overall Study||115
235675|NCT01118780|571391|P2|STARTED|Overall Study||140
235676|NCT01118780|571392|P1|STARTED|Overall Study||151
235677|NCT01118741|571441|P2|NOT COMPLETED|Overall Study||0
235678|NCT01118741|571442|P1|NOT COMPLETED|Overall Study||0
235679|NCT01118741|571441|P2|COMPLETED|Overall Study||10
235680|NCT01118741|571442|P1|COMPLETED|Overall Study||9
235681|NCT01118741|571441|P2|STARTED|Overall Study||10
235682|NCT01118741|571442|P1|STARTED|Overall Study||9
235683|NCT01118728|571450|P1|NOT COMPLETED|Overall Study||223
235684|NCT01118728|571450|P1|COMPLETED|Overall Study||0
235685|NCT01118728|571450|P1|STARTED|Overall Study||223
235686|NCT01118663|571457|P2|NOT COMPLETED|Overall Study||2
235687|NCT01118663|571458|P1|NOT COMPLETED|Overall Study||2
235688|NCT01118663|571457|P2|COMPLETED|Overall Study||8
235689|NCT01118663|571458|P1|COMPLETED|Overall Study||5
235690|NCT01118663|571457|P2|STARTED|Overall Study||10
235691|NCT01118663|571458|P1|STARTED|Overall Study||7
235692|NCT01118624|571472|P1|NOT COMPLETED|Overall Study||22
235693|NCT01118624|571472|P1|COMPLETED|Overall Study||0
235694|NCT01118624|571472|P1|STARTED|Overall Study||22
235695|NCT01118455|571481|P2|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
235696|NCT01118455|571482|P1|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
235697|NCT01118455|571481|P2|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||69
235698|NCT01118455|571482|P1|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||65
235699|NCT01118455|571481|P2|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||69
235700|NCT01118455|571482|P1|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||65
235701|NCT01118455|571481|P2|NOT COMPLETED|Baseline [Visits 1 & 2]||0
235702|NCT01118455|571482|P1|NOT COMPLETED|Baseline [Visits 1 & 2]||1
235703|NCT01118455|571481|P2|COMPLETED|Baseline [Visits 1 & 2]||69
235704|NCT01118455|571482|P1|COMPLETED|Baseline [Visits 1 & 2]||65
235705|NCT01118455|571481|P2|Actual Patients Treated|Baseline [Visits 1 & 2]||69
235706|NCT01118455|571482|P1|Actual Patients Treated|Baseline [Visits 1 & 2]||65
235707|NCT01118455|571481|P2|STARTED|Baseline [Visits 1 & 2]||69
235708|NCT01118455|571482|P1|STARTED|Baseline [Visits 1 & 2]||66
235709|NCT01118377|571510|P1|NOT COMPLETED|Overall Study||42
235710|NCT01118377|571510|P1|COMPLETED|Overall Study||3
235711|NCT01118377|571510|P1|STARTED|Overall Study||45
235712|NCT01118351|571516|P1|NOT COMPLETED|Overall Study||4
235713|NCT01118351|571516|P1|COMPLETED|Overall Study||15
235714|NCT01118351|571516|P1|STARTED|Overall Study||19
235715|NCT01118325|571527|P3|NOT COMPLETED|Overall Study||1
235716|NCT01118325|571528|P2|NOT COMPLETED|Overall Study||0
235717|NCT01118325|571529|P1|NOT COMPLETED|Overall Study||1
235718|NCT01118325|571527|P3|COMPLETED|Overall Study||45
235719|NCT01118325|571528|P2|COMPLETED|Overall Study||43
235720|NCT01118325|571529|P1|COMPLETED|Overall Study||49
235721|NCT01118325|571527|P3|STARTED|Overall Study||46
235722|NCT01118325|571528|P2|STARTED|Overall Study||43
235723|NCT01118325|571529|P1|STARTED|Overall Study||50
235724|NCT01118312|571575|P2|NOT COMPLETED|Overall Study||35
235725|NCT01118312|571576|P1|NOT COMPLETED|Overall Study||34
235726|NCT01118312|571575|P2|COMPLETED|Overall Study||164
235727|NCT01118312|571576|P1|COMPLETED|Overall Study||155
235728|NCT01118312|571575|P2|STARTED|Overall Study||199
235729|NCT01118312|571576|P1|STARTED|Overall Study||189
235730|NCT01118273|571590|P6|NOT COMPLETED|Overall Study||0
235731|NCT01118273|571591|P5|NOT COMPLETED|Overall Study||0
235732|NCT01118273|571592|P4|NOT COMPLETED|Overall Study||0
235733|NCT01118273|571593|P3|NOT COMPLETED|Overall Study||0
235734|NCT01118273|571594|P2|NOT COMPLETED|Overall Study||0
235735|NCT01118273|571595|P1|NOT COMPLETED|Overall Study||0
235736|NCT01118273|571590|P6|COMPLETED|Overall Study||27
235737|NCT01118273|571591|P5|COMPLETED|Overall Study||27
235738|NCT01118273|571592|P4|COMPLETED|Overall Study||27
235739|NCT01118273|571593|P3|COMPLETED|Overall Study||27
235740|NCT01118273|571594|P2|COMPLETED|Overall Study||27
235741|NCT01118273|571595|P1|COMPLETED|Overall Study||27
235742|NCT01118273|571590|P6|STARTED|Overall Study||27
235743|NCT01118273|571591|P5|STARTED|Overall Study||27
235744|NCT01118273|571592|P4|STARTED|Overall Study||27
235745|NCT01118273|571593|P3|STARTED|Overall Study||27
235746|NCT01118273|571594|P2|STARTED|Overall Study||27
235747|NCT01118273|571595|P1|STARTED|Overall Study||27
235748|NCT01118221|571761|P2|NOT COMPLETED|Overall Study||1
235749|NCT01118221|571762|P1|NOT COMPLETED|Overall Study||3
235750|NCT01118221|571761|P2|COMPLETED|Overall Study||10
235751|NCT01118221|571762|P1|COMPLETED|Overall Study||11
235752|NCT01118221|571761|P2|STARTED|Overall Study||11
235753|NCT01118221|571762|P1|STARTED|Overall Study||14
235754|NCT01118143|571774|P2|NOT COMPLETED|Overall Study||5
235755|NCT01118143|571775|P1|NOT COMPLETED|Overall Study||2
235756|NCT01118143|571774|P2|COMPLETED|Overall Study||64
235757|NCT01118143|571775|P1|COMPLETED|Overall Study||62
235758|NCT01118143|571774|P2|STARTED|Overall Study||69
235759|NCT01118143|571775|P1|STARTED|Overall Study||64
235760|NCT01118117|571785|P2|NOT COMPLETED|Overall Study||0
235761|NCT01118117|571786|P1|NOT COMPLETED|Overall Study||21
235762|NCT01118117|571785|P2|COMPLETED|Overall Study||15
235763|NCT01118117|571786|P1|COMPLETED|Overall Study||240
235764|NCT01118117|571785|P2|STARTED|Overall Study||15
235765|NCT01118117|571786|P1|STARTED|Overall Study||261
235766|NCT01118091|571807|P2|NOT COMPLETED|Overall Study||0
235767|NCT01118091|571808|P1|NOT COMPLETED|Overall Study||0
235768|NCT01118091|571807|P2|COMPLETED|Overall Study||5
235769|NCT01118091|571808|P1|COMPLETED|Overall Study|Continued from above: These 2 pts are only represented in Arm 1 (and not Arm 2).|7
235770|NCT01118091|571807|P2|STARTED|Overall Study||5
235771|NCT01118091|571808|P1|STARTED|Overall Study|2pts were randomized to Arm 2, were not able to grow cell product, were treated with Arm 1 regimen.|7
235772|NCT01118052|571818|P1|NOT COMPLETED|Overall Study||2
235773|NCT01118052|571818|P1|COMPLETED|Overall Study||20
235774|NCT01118052|571818|P1|STARTED|Overall Study||22
235775|NCT01118013|571831|P1|NOT COMPLETED|Overall Study||0
235776|NCT01118013|571831|P1|COMPLETED|Overall Study||6
235777|NCT01118013|571831|P1|STARTED|Overall Study||6
235778|NCT01117987|571841|P2|NOT COMPLETED|Overall Study||74
235779|NCT01117987|571842|P1|NOT COMPLETED|Overall Study||61
235780|NCT01117987|571841|P2|COMPLETED|Overall Study||4
235781|NCT01117987|571842|P1|COMPLETED|Overall Study||5
235782|NCT01117987|571841|P2|STARTED|Overall Study||78
235783|NCT01117987|571842|P1|STARTED|Overall Study||66
235784|NCT01117948|571854|P2|NOT COMPLETED|Open Label||47
235785|NCT01117948|571855|P1|NOT COMPLETED|Open Label||52
235786|NCT01117948|571854|P2|COMPLETED|Open Label||51
235787|NCT01117948|571855|P1|COMPLETED|Open Label||41
235788|NCT01117948|571854|P2|STARTED|Open Label||98
235789|NCT01117948|571855|P1|STARTED|Open Label||93
235790|NCT01117948|571854|P2|NOT COMPLETED|Double Blind||10
235791|NCT01117948|571855|P1|NOT COMPLETED|Double Blind||18
235792|NCT01117948|571854|P2|COMPLETED|Double Blind||98
235793|NCT01117948|571855|P1|COMPLETED|Double Blind||93
235794|NCT01117948|571854|P2|STARTED|Double Blind||108
235795|NCT01117948|571855|P1|STARTED|Double Blind||111
235796|NCT01117870|571863|P2|NOT COMPLETED|Overall Study||0
235797|NCT01117870|571864|P1|NOT COMPLETED|Overall Study||1
235798|NCT01117870|571863|P2|COMPLETED|Overall Study||16
235799|NCT01117870|571864|P1|COMPLETED|Overall Study|One did not receive the allocated intervention; (degenerate spine/inability to place needle).|14
235800|NCT01117870|571863|P2|STARTED|Overall Study||16
235801|NCT01117870|571864|P1|STARTED|Overall Study||15
235802|NCT01117857|571878|P1|NOT COMPLETED|Overall Study||9
235803|NCT01117857|571878|P1|COMPLETED|Overall Study||13
235804|NCT01117857|571878|P1|STARTED|Overall Study||22
235805|NCT01117766|571886|P2|NOT COMPLETED|Second Intervention||5
235806|NCT01117766|571887|P1|NOT COMPLETED|Second Intervention||2
235807|NCT01117766|571886|P2|COMPLETED|Second Intervention||9
235808|NCT01117766|571887|P1|COMPLETED|Second Intervention||11
235809|NCT01117766|571886|P2|STARTED|Second Intervention||14
235810|NCT01117766|571887|P1|STARTED|Second Intervention||13
235811|NCT01117766|571886|P2|NOT COMPLETED|Washout Period||2
235812|NCT01117766|571887|P1|NOT COMPLETED|Washout Period||0
235813|NCT01117766|571886|P2|COMPLETED|Washout Period||14
235814|NCT01117766|571887|P1|COMPLETED|Washout Period||13
235815|NCT01117766|571886|P2|STARTED|Washout Period||16
235816|NCT01117766|571887|P1|STARTED|Washout Period||13
235817|NCT01117766|571886|P2|NOT COMPLETED|First Intervention||1
235818|NCT01117766|571887|P1|NOT COMPLETED|First Intervention||1
235819|NCT01117766|571886|P2|COMPLETED|First Intervention||16
235820|NCT01117766|571887|P1|COMPLETED|First Intervention||13
235821|NCT01117766|571886|P2|Received Treatment|First Intervention||17
235822|NCT01117766|571887|P1|Received Treatment|First Intervention||14
235823|NCT01117766|571886|P2|STARTED|First Intervention||17
235824|NCT01117766|571887|P1|STARTED|First Intervention||14
235825|NCT01117727|571911|P1|NOT COMPLETED|Overall Study||0
235826|NCT01117727|571911|P1|COMPLETED|Overall Study||1
235827|NCT01117727|571911|P1|STARTED|Overall Study||1
235828|NCT01117623|571924|P8|NOT COMPLETED|Overall Study||26
235829|NCT01117623|571925|P7|NOT COMPLETED|Overall Study||6
235830|NCT01117623|571926|P6|NOT COMPLETED|Overall Study||16
235831|NCT01117623|571927|P5|NOT COMPLETED|Overall Study||10
235832|NCT01117623|571928|P4|NOT COMPLETED|Overall Study||6
235833|NCT01117623|571929|P3|NOT COMPLETED|Overall Study||11
235834|NCT01117623|571930|P2|NOT COMPLETED|Overall Study||8
235835|NCT01117623|571931|P1|NOT COMPLETED|Overall Study||3
235836|NCT01117623|571924|P8|COMPLETED|Overall Study||0
235837|NCT01117623|571925|P7|COMPLETED|Overall Study||0
235838|NCT01117623|571926|P6|COMPLETED|Overall Study||0
235839|NCT01117623|571927|P5|COMPLETED|Overall Study||0
235840|NCT01117623|571928|P4|COMPLETED|Overall Study||0
235841|NCT01117623|571929|P3|COMPLETED|Overall Study||0
235842|NCT01117623|571930|P2|COMPLETED|Overall Study||0
235843|NCT01117623|571931|P1|COMPLETED|Overall Study||0
235844|NCT01117623|571924|P8|PK Population|Overall Study||24
235845|NCT01117623|571925|P7|PK Population|Overall Study||6
235846|NCT01117623|571926|P6|PK Population|Overall Study||14
235847|NCT01117623|571927|P5|PK Population|Overall Study||10
235848|NCT01117623|571928|P4|PK Population|Overall Study||6
235849|NCT01117623|571929|P3|PK Population|Overall Study||10
235850|NCT01117623|571930|P2|PK Population|Overall Study||8
235851|NCT01117623|571931|P1|PK Population|Overall Study||3
235852|NCT01117623|571924|P8|ITT Efficacy Analysis Population|Overall Study||22
235853|NCT01117623|571925|P7|ITT Efficacy Analysis Population|Overall Study||6
235854|NCT01117623|571926|P6|ITT Efficacy Analysis Population|Overall Study||16
235855|NCT01117623|571927|P5|ITT Efficacy Analysis Population|Overall Study||10
235856|NCT01117623|571928|P4|ITT Efficacy Analysis Population|Overall Study||5
235857|NCT01117623|571929|P3|ITT Efficacy Analysis Population|Overall Study||11
235858|NCT01117623|571930|P2|ITT Efficacy Analysis Population|Overall Study||8
235859|NCT01117623|571931|P1|ITT Efficacy Analysis Population|Overall Study||3
235860|NCT01117623|571924|P8|STARTED|Overall Study||26
235861|NCT01117623|571925|P7|STARTED|Overall Study||6
235862|NCT01117623|571926|P6|STARTED|Overall Study||16
235863|NCT01117623|571927|P5|STARTED|Overall Study||10
235864|NCT01117623|571928|P4|STARTED|Overall Study||6
235865|NCT01117623|571929|P3|STARTED|Overall Study||11
235866|NCT01117623|571930|P2|STARTED|Overall Study||8
235867|NCT01117623|571931|P1|STARTED|Overall Study||3
235868|NCT01117480|572083|P1|NOT COMPLETED|Overall Study||28
235869|NCT01117480|572083|P1|COMPLETED|Overall Study||985
235870|NCT01117480|572083|P1|STARTED|Overall Study||1013
235871|NCT01117454|572091|P2|NOT COMPLETED|Overall Study||1
235872|NCT01117454|572092|P1|NOT COMPLETED|Overall Study||0
235873|NCT01117454|572091|P2|COMPLETED|Overall Study||7
235874|NCT01117454|572092|P1|COMPLETED|Overall Study||6
235875|NCT01117454|572091|P2|STARTED|Overall Study||8
235876|NCT01117454|572092|P1|STARTED|Overall Study||6
235877|NCT01117428|572104|P6|NOT COMPLETED|Overall Study||20
235878|NCT01117428|572105|P5|NOT COMPLETED|Overall Study||17
235879|NCT01117428|572106|P4|NOT COMPLETED|Overall Study||12
235880|NCT01117428|572107|P3|NOT COMPLETED|Overall Study||13
235881|NCT01117428|572108|P2|NOT COMPLETED|Overall Study||29
235882|NCT01117428|572109|P1|NOT COMPLETED|Overall Study||20
235883|NCT01117428|572104|P6|COMPLETED|Overall Study||0
235884|NCT01117428|572105|P5|COMPLETED|Overall Study||0
235885|NCT01117428|572106|P4|COMPLETED|Overall Study||0
235886|NCT01117428|572107|P3|COMPLETED|Overall Study||0
235887|NCT01117428|572108|P2|COMPLETED|Overall Study||0
235888|NCT01117428|572109|P1|COMPLETED|Overall Study||0
235889|NCT01117428|572104|P6|STARTED|Overall Study||20
235890|NCT01117428|572105|P5|STARTED|Overall Study||17
235891|NCT01117428|572106|P4|STARTED|Overall Study||12
235892|NCT01117428|572107|P3|STARTED|Overall Study||13
235893|NCT01117428|572108|P2|STARTED|Overall Study||29
235894|NCT01117428|572109|P1|STARTED|Overall Study|"0.4 mg/kg=1~0.75 mg/kg=1~1.5 mg/kg=3~3 mg/kg=3~6 mg/kg=3~9 mg/kg=6~12 mg/kg=3"|20
235895|NCT01117350|572143|P2|NOT COMPLETED|Extension Period||63
235896|NCT01117350|572144|P1|NOT COMPLETED|Extension Period||0
235897|NCT01117350|572143|P2|COMPLETED|Extension Period||147
235898|NCT01117350|572144|P1|COMPLETED|Extension Period||0
235899|NCT01117350|572143|P2|mITT Population (Extension)|Extension Period|mITT (extension): treated patients with at least 1 efficacy value both at entry and during extension|154
235900|NCT01117350|572144|P1|mITT Population (Extension)|Extension Period||0
235901|NCT01117350|572143|P2|TREATED = Safety Population (Extension)|Extension Period|Safety population (extension): treated with insulin glargine during the extension period|160
235902|NCT01117350|572144|P1|TREATED = Safety Population (Extension)|Extension Period||0
235903|NCT01117350|572143|P2|STARTED|Extension Period|STARTED: patients having completed the comparative period and eligible for the extension period|210
235904|NCT01117350|572144|P1|STARTED|Extension Period||0
235905|NCT01117350|572143|P2|NOT COMPLETED|Comparative Period||75
235906|NCT01117350|572144|P1|NOT COMPLETED|Comparative Period||42
235907|NCT01117350|572143|P2|COMPLETED|Comparative Period||414
235908|NCT01117350|572144|P1|COMPLETED|Comparative Period||447
235909|NCT01117350|572143|P2|mITT Population|Comparative Period||470
235910|NCT01117350|572144|P1|mITT Population|Comparative Period|modified Intent-To-Treat population: treated patients with at least one efficacy post-baseline value|474
235911|NCT01117350|572143|P2|TREATED = Safety Population|Comparative Period||481
235912|NCT01117350|572144|P1|TREATED = Safety Population|Comparative Period|Safety population: all randomized and treated patients (received at least one dose)|484
235913|NCT01117350|572143|P2|STARTED|Comparative Period||489
235914|NCT01117350|572144|P1|STARTED|Comparative Period|STARTED: randomized|489
235915|NCT01117337|572176|P2|NOT COMPLETED|Overall Study||0
235916|NCT01117337|572177|P1|NOT COMPLETED|Overall Study||4
235917|NCT01117337|572176|P2|COMPLETED|Overall Study||52
235918|NCT01117337|572177|P1|COMPLETED|Overall Study|48 completed one year follow-up. 4 lost to follow-up.|48
235919|NCT01117337|572176|P2|Underwent Surgery|Overall Study||52
235920|NCT01117337|572177|P1|Underwent Surgery|Overall Study|52 patients underwent surgery|52
235921|NCT01117337|572176|P2|STARTED|Overall Study||52
235922|NCT01117337|572177|P1|STARTED|Overall Study|52 pateints on inguinal hernia were randomized to mesh fixation group|52
235923|NCT01117311|572187|P2|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
235924|NCT01117311|572188|P1|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
235925|NCT01117311|572187|P2|COMPLETED|Second Intervention - Mixed Meal 3||4
235926|NCT01117311|572188|P1|COMPLETED|Second Intervention - Mixed Meal 3||3
235927|NCT01117311|572187|P2|STARTED|Second Intervention - Mixed Meal 3||4
235928|NCT01117311|572188|P1|STARTED|Second Intervention - Mixed Meal 3||3
235929|NCT01117311|572187|P2|NOT COMPLETED|First Intervention - Mixed Meal 2||0
235930|NCT01117311|572188|P1|NOT COMPLETED|First Intervention - Mixed Meal 2||0
235931|NCT01117311|572187|P2|COMPLETED|First Intervention - Mixed Meal 2||4
235932|NCT01117311|572188|P1|COMPLETED|First Intervention - Mixed Meal 2||3
235933|NCT01117311|572187|P2|STARTED|First Intervention - Mixed Meal 2||4
235934|NCT01117311|572188|P1|STARTED|First Intervention - Mixed Meal 2||3
235935|NCT01117311|572187|P2|NOT COMPLETED|Lead-in Mixed Meal 1||0
235936|NCT01117311|572188|P1|NOT COMPLETED|Lead-in Mixed Meal 1||0
235937|NCT01117311|572187|P2|COMPLETED|Lead-in Mixed Meal 1||4
235938|NCT01117311|572188|P1|COMPLETED|Lead-in Mixed Meal 1||3
235939|NCT01117311|572187|P2|STARTED|Lead-in Mixed Meal 1||4
235940|NCT01117311|572188|P1|STARTED|Lead-in Mixed Meal 1||3
235941|NCT01117181|572198|P2|NOT COMPLETED|Overall Study||2
235942|NCT01117181|572199|P1|NOT COMPLETED|Overall Study||1
235943|NCT01117181|572198|P2|COMPLETED|Overall Study||29
235944|NCT01117181|572199|P1|COMPLETED|Overall Study||28
235945|NCT01117181|572198|P2|STARTED|Overall Study||31
235946|NCT01117181|572199|P1|STARTED|Overall Study||29
235947|NCT01117090|572219|P1|NOT COMPLETED|Overall Study||0
235948|NCT01117090|572219|P1|COMPLETED|Overall Study||47
235949|NCT01117090|572219|P1|STARTED|Overall Study||47
235950|NCT01117051|572232|P2|NOT COMPLETED|Overall Study||11
235951|NCT01117051|572233|P1|NOT COMPLETED|Overall Study||13
235952|NCT01117051|572232|P2|COMPLETED|Overall Study||77
235953|NCT01117051|572233|P1|COMPLETED|Overall Study||73
235954|NCT01117051|572232|P2|STARTED|Overall Study||88
235955|NCT01117051|572233|P1|STARTED|Overall Study||86
235956|NCT01117012|572243|P2|NOT COMPLETED|Overall Study||5
235957|NCT01117012|572244|P1|NOT COMPLETED|Overall Study||8
235958|NCT01117012|572243|P2|COMPLETED|Overall Study||98
235959|NCT01117012|572244|P1|COMPLETED|Overall Study||81
235960|NCT01117012|572243|P2|STARTED|Overall Study||103
235961|NCT01117012|572244|P1|STARTED|Overall Study||89
235962|NCT01116986|572292|P32|NOT COMPLETED|Overall Study||3
235963|NCT01116986|572293|P31|NOT COMPLETED|Overall Study||1
235964|NCT01116986|572294|P30|NOT COMPLETED|Overall Study||0
235965|NCT01116986|572295|P29|NOT COMPLETED|Overall Study||0
235966|NCT01116986|572296|P28|NOT COMPLETED|Overall Study||1
235967|NCT01116986|572297|P27|NOT COMPLETED|Overall Study||4
235968|NCT01116986|572298|P26|NOT COMPLETED|Overall Study||0
235969|NCT01116986|572299|P25|NOT COMPLETED|Overall Study||3
235970|NCT01116986|572300|P24|NOT COMPLETED|Overall Study||2
235971|NCT01116986|572301|P23|NOT COMPLETED|Overall Study||4
235972|NCT01116986|572302|P22|NOT COMPLETED|Overall Study||2
235973|NCT01116986|572303|P21|NOT COMPLETED|Overall Study||2
235974|NCT01116986|572304|P20|NOT COMPLETED|Overall Study||2
235975|NCT01116986|572305|P19|NOT COMPLETED|Overall Study||3
235976|NCT01116986|572306|P18|NOT COMPLETED|Overall Study||5
235977|NCT01116986|572307|P17|NOT COMPLETED|Overall Study||3
235978|NCT01116986|572308|P16|NOT COMPLETED|Overall Study||6
235979|NCT01116986|572309|P15|NOT COMPLETED|Overall Study||0
235980|NCT01116986|572310|P14|NOT COMPLETED|Overall Study||3
235981|NCT01116986|572311|P13|NOT COMPLETED|Overall Study||1
235982|NCT01116986|572312|P12|NOT COMPLETED|Overall Study||0
235983|NCT01116986|572313|P11|NOT COMPLETED|Overall Study||1
235984|NCT01116986|572314|P10|NOT COMPLETED|Overall Study||4
235985|NCT01116986|572315|P9|NOT COMPLETED|Overall Study||1
235986|NCT01116986|572316|P8|NOT COMPLETED|Overall Study||2
235987|NCT01116986|572317|P7|NOT COMPLETED|Overall Study||2
235988|NCT01116986|572318|P6|NOT COMPLETED|Overall Study||2
235989|NCT01116986|572319|P5|NOT COMPLETED|Overall Study||4
235990|NCT01116986|572320|P4|NOT COMPLETED|Overall Study||2
235991|NCT01116986|572321|P3|NOT COMPLETED|Overall Study||2
235992|NCT01116986|572322|P2|NOT COMPLETED|Overall Study||3
235993|NCT01116986|572323|P1|NOT COMPLETED|Overall Study||2
235994|NCT01116986|572292|P32|COMPLETED|Overall Study||14
235995|NCT01116986|572293|P31|COMPLETED|Overall Study||16
235996|NCT01116986|572294|P30|COMPLETED|Overall Study||17
235997|NCT01116986|572295|P29|COMPLETED|Overall Study||17
235998|NCT01116986|572296|P28|COMPLETED|Overall Study||18
235999|NCT01116986|572297|P27|COMPLETED|Overall Study||14
236000|NCT01116986|572298|P26|COMPLETED|Overall Study||19
236001|NCT01116986|572299|P25|COMPLETED|Overall Study||15
236002|NCT01116986|572300|P24|COMPLETED|Overall Study||19
236003|NCT01116986|572301|P23|COMPLETED|Overall Study||19
236004|NCT01116986|572302|P22|COMPLETED|Overall Study||18
236005|NCT01116986|572303|P21|COMPLETED|Overall Study||22
236006|NCT01116986|572304|P20|COMPLETED|Overall Study||13
236007|NCT01116986|572305|P19|COMPLETED|Overall Study||20
236008|NCT01116986|572306|P18|COMPLETED|Overall Study||19
236009|NCT01116986|572307|P17|COMPLETED|Overall Study||13
236010|NCT01116986|572308|P16|COMPLETED|Overall Study||15
236011|NCT01116986|572309|P15|COMPLETED|Overall Study||17
236012|NCT01116986|572310|P14|COMPLETED|Overall Study||16
236013|NCT01116986|572311|P13|COMPLETED|Overall Study||16
236014|NCT01116986|572312|P12|COMPLETED|Overall Study||20
236015|NCT01116986|572313|P11|COMPLETED|Overall Study||18
236016|NCT01116986|572314|P10|COMPLETED|Overall Study||19
236017|NCT01116986|572315|P9|COMPLETED|Overall Study||19
236018|NCT01116986|572316|P8|COMPLETED|Overall Study||20
236019|NCT01116986|572317|P7|COMPLETED|Overall Study||20
236020|NCT01116986|572318|P6|COMPLETED|Overall Study||20
236021|NCT01116986|572319|P5|COMPLETED|Overall Study||20
236022|NCT01116986|572320|P4|COMPLETED|Overall Study||20
236023|NCT01116986|572321|P3|COMPLETED|Overall Study||16
236024|NCT01116986|572322|P2|COMPLETED|Overall Study||16
236025|NCT01116986|572323|P1|COMPLETED|Overall Study||22
236026|NCT01116986|572292|P32|STARTED|Overall Study||17
236027|NCT01116986|572293|P31|STARTED|Overall Study||17
236028|NCT01116986|572294|P30|STARTED|Overall Study||17
236029|NCT01116986|572295|P29|STARTED|Overall Study||17
236030|NCT01116986|572296|P28|STARTED|Overall Study||19
236031|NCT01116986|572297|P27|STARTED|Overall Study||18
236032|NCT01116986|572298|P26|STARTED|Overall Study||19
236033|NCT01116986|572299|P25|STARTED|Overall Study||18
236034|NCT01116986|572300|P24|STARTED|Overall Study||21
236035|NCT01116986|572301|P23|STARTED|Overall Study||23
236036|NCT01116986|572302|P22|STARTED|Overall Study||20
236037|NCT01116986|572303|P21|STARTED|Overall Study||24
236038|NCT01116986|572304|P20|STARTED|Overall Study||15
236039|NCT01116986|572305|P19|STARTED|Overall Study||23
236040|NCT01116986|572306|P18|STARTED|Overall Study||24
236041|NCT01116986|572307|P17|STARTED|Overall Study||16
236042|NCT01116986|572308|P16|STARTED|Overall Study||21
236043|NCT01116986|572309|P15|STARTED|Overall Study||17
236044|NCT01116986|572310|P14|STARTED|Overall Study||19
236045|NCT01116986|572311|P13|STARTED|Overall Study||17
236046|NCT01116986|572312|P12|STARTED|Overall Study||20
236047|NCT01116986|572313|P11|STARTED|Overall Study||19
236048|NCT01116986|572314|P10|STARTED|Overall Study||23
236049|NCT01116986|572315|P9|STARTED|Overall Study||20
236050|NCT01116986|572316|P8|STARTED|Overall Study||22
236051|NCT01116986|572317|P7|STARTED|Overall Study||22
236052|NCT01116986|572318|P6|STARTED|Overall Study||22
236053|NCT01116986|572319|P5|STARTED|Overall Study||24
236054|NCT01116986|572320|P4|STARTED|Overall Study||22
236055|NCT01116986|572321|P3|STARTED|Overall Study||18
236056|NCT01116986|572322|P2|STARTED|Overall Study||19
236057|NCT01116986|572323|P1|STARTED|Overall Study||24
236058|NCT01116934|572357|P2|NOT COMPLETED|Overall Study||0
236059|NCT01116934|572358|P1|NOT COMPLETED|Overall Study||0
236060|NCT01116934|572357|P2|COMPLETED|Overall Study||9
236061|NCT01116934|572358|P1|COMPLETED|Overall Study||8
236062|NCT01116934|572357|P2|STARTED|Overall Study||9
236063|NCT01116934|572358|P1|STARTED|Overall Study||8
236064|NCT01116921|572366|P2|NOT COMPLETED|Overall Study||0
236065|NCT01116921|572367|P1|NOT COMPLETED|Overall Study||0
236066|NCT01116921|572366|P2|COMPLETED|Overall Study||50
236067|NCT01116921|572367|P1|COMPLETED|Overall Study||53
236068|NCT01116921|572366|P2|STARTED|Overall Study||50
236069|NCT01116921|572367|P1|STARTED|Overall Study||53
236070|NCT01116895|572387|P4|NOT COMPLETED|Overall Study||3
236071|NCT01116895|572388|P3|NOT COMPLETED|Overall Study||4
236072|NCT01116895|572389|P2|NOT COMPLETED|Overall Study||7
236073|NCT01116895|572390|P1|NOT COMPLETED|Overall Study||4
236074|NCT01116895|572387|P4|COMPLETED|Overall Study||11
236075|NCT01116895|572388|P3|COMPLETED|Overall Study||14
236076|NCT01116895|572389|P2|COMPLETED|Overall Study||8
236077|NCT01116895|572390|P1|COMPLETED|Overall Study||12
236078|NCT01116895|572387|P4|STARTED|Overall Study||14
236079|NCT01116895|572388|P3|STARTED|Overall Study||18
236080|NCT01116895|572389|P2|STARTED|Overall Study||15
236081|NCT01116895|572390|P1|STARTED|Overall Study||16
236082|NCT01116882|572418|P2|NOT COMPLETED|12-month||99
236083|NCT01116882|572419|P1|NOT COMPLETED|12-month||267
236084|NCT01116882|572418|P2|COMPLETED|12-month||787
236085|NCT01116882|572419|P1|COMPLETED|12-month||2439
236086|NCT01116882|572418|P2|STARTED|12-month||886
236087|NCT01116882|572419|P1|STARTED|12-month||2706
236088|NCT01116882|572418|P2|NOT COMPLETED|30-day||31
236089|NCT01116882|572419|P1|NOT COMPLETED|30-day||68
236090|NCT01116882|572418|P2|COMPLETED|30-day||886
236091|NCT01116882|572419|P1|COMPLETED|30-day||2706
236092|NCT01116882|572418|P2|STARTED|30-day||917
236093|NCT01116882|572419|P1|STARTED|30-day||2774
236094|NCT01116687|572457|P1|NOT COMPLETED|Overall Study||4
236095|NCT01116687|572457|P1|COMPLETED|Overall Study||33
236096|NCT01116687|572457|P1|STARTED|Overall Study||37
236097|NCT01116661|572464|P1|NOT COMPLETED|Overall Study||2
236098|NCT01116661|572464|P1|COMPLETED|Overall Study||197
236099|NCT01116661|572464|P1|STARTED|Overall Study||199
236100|NCT01116544|572471|P2|NOT COMPLETED|Overall Study||1
236101|NCT01116544|572472|P1|NOT COMPLETED|Overall Study||2
236102|NCT01116544|572471|P2|COMPLETED|Overall Study||22
236103|NCT01116544|572472|P1|COMPLETED|Overall Study||21
236104|NCT01116544|572471|P2|STARTED|Overall Study||23
236105|NCT01116544|572472|P1|STARTED|Overall Study||23
236106|NCT01116466|572488|P1|NOT COMPLETED|Overall Study||0
236107|NCT01116466|572488|P1|COMPLETED|Overall Study||5
236108|NCT01116466|572488|P1|STARTED|Overall Study||5
236109|NCT01116427|572498|P2|NOT COMPLETED|Extension Phase||2
236110|NCT01116427|572499|P1|NOT COMPLETED|Extension Phase||9
236111|NCT01116427|572498|P2|COMPLETED|Extension Phase||18
236112|NCT01116427|572499|P1|COMPLETED|Extension Phase||29
236113|NCT01116427|572498|P2|STARTED|Extension Phase||20
236114|NCT01116427|572499|P1|STARTED|Extension Phase|One participant that completed core phase did not meet eligibility for Extension Phase|38
236115|NCT01116427|572498|P2|NOT COMPLETED|Core Phase||1
236116|NCT01116427|572499|P1|NOT COMPLETED|Core Phase||5
236117|NCT01116427|572498|P2|COMPLETED|Core Phase||20
236118|NCT01116427|572499|P1|COMPLETED|Core Phase||39
236119|NCT01116427|572498|P2|STARTED|Core Phase||21
236120|NCT01116427|572499|P1|STARTED|Core Phase||44
236121|NCT01116401|572535|P1|NOT COMPLETED|Overall Study||0
236122|NCT01116401|572535|P1|COMPLETED|Overall Study||29
236123|NCT01116401|572535|P1|STARTED|Overall Study||29
236124|NCT01116232|572540|P1|NOT COMPLETED|Overall Study||4
236125|NCT01116232|572540|P1|COMPLETED|Overall Study||0
236126|NCT01116232|572540|P1|STARTED|Overall Study||4
236127|NCT01116102|572559|P8|NOT COMPLETED|Overall Study||0
236128|NCT01116102|572560|P7|NOT COMPLETED|Overall Study||0
236129|NCT01116102|572561|P6|NOT COMPLETED|Overall Study||0
236130|NCT01116102|572562|P5|NOT COMPLETED|Overall Study||0
236131|NCT01116102|572563|P4|NOT COMPLETED|Overall Study||0
236132|NCT01116102|572564|P3|NOT COMPLETED|Overall Study||0
236133|NCT01116102|572565|P2|NOT COMPLETED|Overall Study||0
236134|NCT01116102|572566|P1|NOT COMPLETED|Overall Study||0
236135|NCT01116102|572559|P8|COMPLETED|Overall Study||3
236136|NCT01116102|572560|P7|COMPLETED|Overall Study||2
236137|NCT01116102|572561|P6|COMPLETED|Overall Study||2
236138|NCT01116102|572562|P5|COMPLETED|Overall Study||2
236139|NCT01116102|572563|P4|COMPLETED|Overall Study||3
236140|NCT01116102|572564|P3|COMPLETED|Overall Study||3
236141|NCT01116102|572565|P2|COMPLETED|Overall Study||3
236142|NCT01116102|572566|P1|COMPLETED|Overall Study||2
236143|NCT01116102|572559|P8|STARTED|Overall Study||3
236144|NCT01116102|572560|P7|STARTED|Overall Study||2
236145|NCT01116102|572561|P6|STARTED|Overall Study||2
236146|NCT01116102|572562|P5|STARTED|Overall Study||2
236147|NCT01116102|572563|P4|STARTED|Overall Study||3
236148|NCT01116102|572564|P3|STARTED|Overall Study||3
236149|NCT01116102|572565|P2|STARTED|Overall Study||3
236150|NCT01116102|572566|P1|STARTED|Overall Study||2
236151|NCT01116037|572608|P1|NOT COMPLETED|Overall Study||25
236152|NCT01116037|572608|P1|COMPLETED|Overall Study||1
236153|NCT01116037|572608|P1|STARTED|Overall Study||26
236154|NCT01116024|572613|P1|NOT COMPLETED|Overall Study||52
236155|NCT01116024|572613|P1|COMPLETED|Overall Study|Patient Enrollment stop date|96
236156|NCT01116024|572613|P1|STARTED|Overall Study|148 subjects left operating room with the device implanted and were included in the analysis.|148
236157|NCT01115998|572654|P2|NOT COMPLETED|Overall Study||6
236158|NCT01115998|572655|P1|NOT COMPLETED|Overall Study||6
236159|NCT01115998|572654|P2|COMPLETED|Overall Study||11
236160|NCT01115998|572655|P1|COMPLETED|Overall Study||11
236161|NCT01115998|572654|P2|STARTED|Overall Study||17
236162|NCT01115998|572655|P1|STARTED|Overall Study||17
236163|NCT01115933|572665|P1|NOT COMPLETED|Overall Study||1
236164|NCT01115933|572665|P1|COMPLETED|Overall Study||64
236165|NCT01115933|572665|P1|STARTED|Overall Study||65
236166|NCT01115855|572762|P2|NOT COMPLETED|Overall Study||36
236167|NCT01115855|572763|P1|NOT COMPLETED|Overall Study||36
236168|NCT01115855|572762|P2|COMPLETED|Overall Study||74
236169|NCT01115855|572763|P1|COMPLETED|Overall Study||75
236170|NCT01115855|572762|P2|STARTED|Overall Study||110
236171|NCT01115855|572763|P1|STARTED|Overall Study||111
236172|NCT01115803|572818|P7|NOT COMPLETED|Overall Study||2
236173|NCT01115803|572819|P6|NOT COMPLETED|Overall Study||0
236174|NCT01115803|572820|P5|NOT COMPLETED|Overall Study||0
236175|NCT01115803|572821|P4|NOT COMPLETED|Overall Study||0
236176|NCT01115803|572822|P3|NOT COMPLETED|Overall Study||1
236177|NCT01115803|572823|P2|NOT COMPLETED|Overall Study||0
236178|NCT01115803|572824|P1|NOT COMPLETED|Overall Study||0
236179|NCT01115803|572818|P7|COMPLETED|Overall Study||4
236180|NCT01115803|572819|P6|COMPLETED|Overall Study||3
236181|NCT01115803|572820|P5|COMPLETED|Overall Study||3
236182|NCT01115803|572821|P4|COMPLETED|Overall Study||5
236183|NCT01115803|572822|P3|COMPLETED|Overall Study||2
236184|NCT01115803|572823|P2|COMPLETED|Overall Study||5
236185|NCT01115803|572824|P1|COMPLETED|Overall Study||4
236186|NCT01115803|572818|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
236187|NCT01115803|572819|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
236188|NCT01115803|572820|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
236189|NCT01115803|572821|P4|Received at Least 1 Dose of Study Drug|Overall Study||5
236190|NCT01115803|572822|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
236191|NCT01115803|572823|P2|Received at Least 1 Dose of Study Drug|Overall Study||5
236192|NCT01115803|572824|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
236193|NCT01115803|572818|P7|STARTED|Overall Study||6
236194|NCT01115803|572819|P6|STARTED|Overall Study||3
236195|NCT01115803|572820|P5|STARTED|Overall Study||3
236196|NCT01115803|572821|P4|STARTED|Overall Study||5
236197|NCT01115803|572822|P3|STARTED|Overall Study||3
236198|NCT01115803|572823|P2|STARTED|Overall Study||5
236199|NCT01115803|572824|P1|STARTED|Overall Study||4
236200|NCT01115738|572887|P3|NOT COMPLETED|Overall Study||27
236201|NCT01115738|572888|P2|NOT COMPLETED|Overall Study||21
236202|NCT01115738|572889|P1|NOT COMPLETED|Overall Study||25
236203|NCT01115738|572887|P3|COMPLETED|Overall Study||62
236204|NCT01115738|572888|P2|COMPLETED|Overall Study||62
236205|NCT01115738|572889|P1|COMPLETED|Overall Study||85
236206|NCT01115738|572887|P3|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|50
236207|NCT01115738|572888|P2|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|47
236208|NCT01115738|572889|P1|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|52
236209|NCT01115738|572887|P3|Received Any Treatment|Overall Study||88
236210|NCT01115738|572888|P2|Received Any Treatment|Overall Study||79
236211|NCT01115738|572889|P1|Received Any Treatment|Overall Study||109
236212|NCT01115738|572887|P3|STARTED|Overall Study||89
236213|NCT01115738|572888|P2|STARTED|Overall Study||83
236214|NCT01115738|572889|P1|STARTED|Overall Study||110
236215|NCT01115699|572923|P1|NOT COMPLETED|Overall Study||0
236216|NCT01115699|572923|P1|COMPLETED|Overall Study||2
236217|NCT01115699|572923|P1|STARTED|Overall Study||2
236218|NCT01115673|572931|P3|NOT COMPLETED|Overall Study||0
236219|NCT01115673|572932|P2|NOT COMPLETED|Overall Study||0
236220|NCT01115673|572933|P1|NOT COMPLETED|Overall Study||0
236221|NCT01115673|572931|P3|COMPLETED|Overall Study||60
236222|NCT01115673|572932|P2|COMPLETED|Overall Study||241
236223|NCT01115673|572933|P1|COMPLETED|Overall Study||239
236224|NCT01115673|572931|P3|STARTED|Overall Study||60
236225|NCT01115673|572932|P2|STARTED|Overall Study||241
236226|NCT01115673|572933|P1|STARTED|Overall Study||239
236227|NCT01115660|573069|P2|NOT COMPLETED|Overall Study||0
236228|NCT01115660|573070|P1|NOT COMPLETED|Overall Study||1
236229|NCT01115660|573069|P2|COMPLETED|Overall Study||10
236230|NCT01115660|573070|P1|COMPLETED|Overall Study||19
236231|NCT01115660|573069|P2|STARTED|Overall Study||10
236232|NCT01115660|573070|P1|STARTED|Overall Study||20
236233|NCT01115582|573078|P1|NOT COMPLETED|Overall Study||0
236234|NCT01115582|573078|P1|COMPLETED|Overall Study||16
236235|NCT01115582|573078|P1|STARTED|Overall Study||16
236236|NCT01115569|573087|P2|NOT COMPLETED|Maintenance Phase||139
236237|NCT01115569|573088|P1|NOT COMPLETED|Maintenance Phase||0
236238|NCT01115569|573087|P2|COMPLETED|Maintenance Phase||285
236239|NCT01115569|573088|P1|COMPLETED|Maintenance Phase||0
236240|NCT01115569|573087|P2|STARTED|Maintenance Phase||424
236241|NCT01115569|573088|P1|STARTED|Maintenance Phase||0
236242|NCT01115569|573087|P2|NOT COMPLETED|Conversion/Titration Phase||0
236243|NCT01115569|573088|P1|NOT COMPLETED|Conversion/Titration Phase||214
236244|NCT01115569|573087|P2|COMPLETED|Conversion/Titration Phase||0
236245|NCT01115569|573088|P1|COMPLETED|Conversion/Titration Phase||424
236246|NCT01115569|573087|P2|STARTED|Conversion/Titration Phase||0
236247|NCT01115569|573088|P1|STARTED|Conversion/Titration Phase||638
236248|NCT01115556|573095|P2|NOT COMPLETED|Overall Study||0
236249|NCT01115556|573096|P1|NOT COMPLETED|Overall Study||0
236250|NCT01115556|573095|P2|COMPLETED|Overall Study||2
236251|NCT01115556|573096|P1|COMPLETED|Overall Study||7
236252|NCT01115556|573095|P2|STARTED|Overall Study||2
236253|NCT01115556|573096|P1|STARTED|Overall Study||7
236254|NCT01115517|573106|P2|NOT COMPLETED|Overall Study||5
236255|NCT01115517|573107|P1|NOT COMPLETED|Overall Study||4
236256|NCT01115517|573106|P2|COMPLETED|Overall Study||16
236257|NCT01115517|573107|P1|COMPLETED|Overall Study||14
236258|NCT01115517|573106|P2|STARTED|Overall Study||21
236259|NCT01115517|573107|P1|STARTED|Overall Study||18
236260|NCT01115491|573117|P1|NOT COMPLETED|Overall Study||30
236261|NCT01115491|573117|P1|COMPLETED|Overall Study||2
236262|NCT01115491|573117|P1|STARTED|Overall Study||32
236263|NCT01115452|573126|P1|NOT COMPLETED|Overall Study||0
236264|NCT01115452|573126|P1|COMPLETED|Overall Study||32
236265|NCT01115452|573126|P1|STARTED|Overall Study||32
236266|NCT01115244|573178|P2|NOT COMPLETED|Overall Study||0
236267|NCT01115244|573179|P1|NOT COMPLETED|Overall Study||0
236268|NCT01115244|573178|P2|COMPLETED|Overall Study||0
236269|NCT01115244|573179|P1|COMPLETED|Overall Study||0
236270|NCT01115244|573178|P2|STARTED|Overall Study||0
236271|NCT01115244|573179|P1|STARTED|Overall Study||0
236272|NCT01115231|573191|P2|NOT COMPLETED|Overall Study||0
236273|NCT01115231|573192|P1|NOT COMPLETED|Overall Study||0
236274|NCT01115231|573191|P2|COMPLETED|Overall Study||90
236275|NCT01115231|573192|P1|COMPLETED|Overall Study||133
236276|NCT01115231|573191|P2|STARTED|Overall Study||90
236277|NCT01115231|573192|P1|STARTED|Overall Study||133
236278|NCT01115166|573204|P1|NOT COMPLETED|Overall Study||0
236279|NCT01115166|573204|P1|COMPLETED|Overall Study||10
236280|NCT01115166|573204|P1|STARTED|Overall Study||10
236281|NCT01115101|573212|P2|NOT COMPLETED|Overall Study||0
236282|NCT01115101|573213|P1|NOT COMPLETED|Overall Study||0
236283|NCT01115101|573212|P2|COMPLETED|Overall Study||126
236284|NCT01115101|573213|P1|COMPLETED|Overall Study||113
236285|NCT01115101|573212|P2|STARTED|Overall Study||126
236286|NCT01115101|573213|P1|STARTED|Overall Study||113
236287|NCT01114997|573222|P3|NOT COMPLETED|Overall Study||0
236288|NCT01114997|573223|P2|NOT COMPLETED|Overall Study||0
236289|NCT01114997|573224|P1|NOT COMPLETED|Overall Study||0
236290|NCT01114997|573222|P3|COMPLETED|Overall Study||11
236291|NCT01114997|573223|P2|COMPLETED|Overall Study||10
236292|NCT01114997|573224|P1|COMPLETED|Overall Study||11
236293|NCT01114997|573222|P3|STARTED|Overall Study||11
236294|NCT01114997|573223|P2|STARTED|Overall Study||10
236295|NCT01114997|573224|P1|STARTED|Overall Study||11
236296|NCT01114945|573254|P4|NOT COMPLETED|Overall Study||0
236297|NCT01114945|573255|P3|NOT COMPLETED|Overall Study||0
236298|NCT01114945|573256|P2|NOT COMPLETED|Overall Study||0
236299|NCT01114945|573257|P1|NOT COMPLETED|Overall Study||0
236300|NCT01114945|573254|P4|COMPLETED|Overall Study||31
236301|NCT01114945|573255|P3|COMPLETED|Overall Study||30
236302|NCT01114945|573256|P2|COMPLETED|Overall Study||30
236303|NCT01114945|573257|P1|COMPLETED|Overall Study||30
236304|NCT01114945|573254|P4|STARTED|Overall Study||31
236305|NCT01114945|573255|P3|STARTED|Overall Study||30
236306|NCT01114945|573256|P2|STARTED|Overall Study||30
236307|NCT01114945|573257|P1|STARTED|Overall Study||30
236308|NCT01114893|573284|P5|NOT COMPLETED|Overall Study||0
236309|NCT01114893|573285|P4|NOT COMPLETED|Overall Study||0
236310|NCT01114893|573286|P3|NOT COMPLETED|Overall Study||0
236311|NCT01114893|573287|P2|NOT COMPLETED|Overall Study||0
236312|NCT01114893|573288|P1|NOT COMPLETED|Overall Study||0
236313|NCT01114893|573284|P5|COMPLETED|Overall Study||12
236314|NCT01114893|573285|P4|COMPLETED|Overall Study||13
236315|NCT01114893|573286|P3|COMPLETED|Overall Study||14
236316|NCT01114893|573287|P2|COMPLETED|Overall Study||14
236317|NCT01114893|573288|P1|COMPLETED|Overall Study||14
236318|NCT01114893|573284|P5|STARTED|Overall Study||12
236319|NCT01114893|573285|P4|STARTED|Overall Study||13
236320|NCT01114893|573286|P3|STARTED|Overall Study||14
236321|NCT01114893|573287|P2|STARTED|Overall Study||14
236322|NCT01114893|573288|P1|STARTED|Overall Study||14
236323|NCT01114880|573307|P2|NOT COMPLETED|Period 2 (Week 12 to Week 24)||2
236324|NCT01114880|573308|P1|NOT COMPLETED|Period 2 (Week 12 to Week 24)||3
236325|NCT01114880|573307|P2|COMPLETED|Period 2 (Week 12 to Week 24)||111
236326|NCT01114880|573308|P1|COMPLETED|Period 2 (Week 12 to Week 24)||221
236327|NCT01114880|573307|P2|STARTED|Period 2 (Week 12 to Week 24)||113
236328|NCT01114880|573308|P1|STARTED|Period 2 (Week 12 to Week 24)||224
236329|NCT01114880|573307|P2|NOT COMPLETED|Period 1 (Week 0 to Week 12)||2
236330|NCT01114880|573308|P1|NOT COMPLETED|Period 1 (Week 0 to Week 12)||5
236331|NCT01114880|573307|P2|COMPLETED|Period 1 (Week 0 to Week 12)||113
236332|NCT01114880|573308|P1|COMPLETED|Period 1 (Week 0 to Week 12)||224
236333|NCT01114880|573307|P2|STARTED|Period 1 (Week 0 to Week 12)||115
236334|NCT01114880|573308|P1|STARTED|Period 1 (Week 0 to Week 12)||229
236335|NCT01114828|573360|P2|NOT COMPLETED|Overall Study||4
236336|NCT01114828|573361|P1|NOT COMPLETED|Overall Study||3
236337|NCT01114828|573360|P2|COMPLETED|Overall Study||17
236338|NCT01114828|573361|P1|COMPLETED|Overall Study||16
236339|NCT01114828|573360|P2|STARTED|Overall Study||21
236340|NCT01114828|573361|P1|STARTED|Overall Study||19
236341|NCT01114737|573371|P2|NOT COMPLETED|Open-Label Treatment Period||2
236342|NCT01114737|573372|P1|NOT COMPLETED|Open-Label Treatment Period||5
236343|NCT01114737|573371|P2|COMPLETED|Open-Label Treatment Period||95
236344|NCT01114737|573372|P1|COMPLETED|Open-Label Treatment Period||100
236345|NCT01114737|573371|P2|STARTED|Open-Label Treatment Period|Two subjects did not receive a single dose of the study drug|97
236346|NCT01114737|573372|P1|STARTED|Open-Label Treatment Period|One subject did not receive a single dose of the study drug|105
236347|NCT01114737|573371|P2|NOT COMPLETED|Randomized Treatment Period||1
236348|NCT01114737|573372|P1|NOT COMPLETED|Randomized Treatment Period||3
236349|NCT01114737|573371|P2|COMPLETED|Randomized Treatment Period||97
236350|NCT01114737|573372|P1|COMPLETED|Randomized Treatment Period||105
236351|NCT01114737|573371|P2|STARTED|Randomized Treatment Period||98
236352|NCT01114737|573372|P1|STARTED|Randomized Treatment Period||108
236353|NCT01114724|573420|P1|NOT COMPLETED|Overall Study||10
236354|NCT01114724|573420|P1|COMPLETED|Overall Study||40
236355|NCT01114724|573420|P1|STARTED|Overall Study||50
236356|NCT01114672|573440|P2|NOT COMPLETED|Overall Study||2
236357|NCT01114672|573441|P1|NOT COMPLETED|Overall Study||4
236358|NCT01114672|573440|P2|COMPLETED|Overall Study||23
236359|NCT01114672|573441|P1|COMPLETED|Overall Study||21
236360|NCT01114672|573440|P2|STARTED|Overall Study||25
236361|NCT01114672|573441|P1|STARTED|Overall Study||25
236362|NCT01114646|573449|P2|NOT COMPLETED|Overall Study||2
236363|NCT01114646|573450|P1|NOT COMPLETED|Overall Study||3
236364|NCT01114646|573449|P2|COMPLETED|Overall Study||62
236365|NCT01114646|573450|P1|COMPLETED|Overall Study||63
236366|NCT01114646|573449|P2|STARTED|Overall Study||64
236367|NCT01114646|573450|P1|STARTED|Overall Study||66
236368|NCT01114620|573456|P1|NOT COMPLETED|Overall Study||0
236369|NCT01114620|573456|P1|COMPLETED|Overall Study||50
236370|NCT01114620|573456|P1|STARTED|Overall Study||50
236371|NCT01114581|573489|P2|NOT COMPLETED|Overall Study||0
236372|NCT01114581|573490|P1|NOT COMPLETED|Overall Study||0
236373|NCT01114581|573489|P2|COMPLETED|Overall Study||19
236374|NCT01114581|573490|P1|COMPLETED|Overall Study||19
236375|NCT01114581|573489|P2|STARTED|Overall Study||19
236376|NCT01114581|573490|P1|STARTED|Overall Study||19
236377|NCT01114555|573500|P1|NOT COMPLETED|Overall Study||0
236378|NCT01114555|573500|P1|COMPLETED|Overall Study||34
236379|NCT01114555|573500|P1|STARTED|Overall Study||34
236380|NCT01114529|573510|P3|NOT COMPLETED|Completed Study Phase at Month 24||14
236381|NCT01114529|573511|P2|NOT COMPLETED|Completed Study Phase at Month 24||16
236382|NCT01114529|573512|P1|NOT COMPLETED|Completed Study Phase at Month 24||40
236383|NCT01114529|573510|P3|COMPLETED|Completed Study Phase at Month 24|at month 24|111
236465|NCT01113931|573714|P1|NOT COMPLETED|Overall Study||19
236384|NCT01114529|573511|P2|COMPLETED|Completed Study Phase at Month 24|at month 24|215
236385|NCT01114529|573512|P1|COMPLETED|Completed Study Phase at Month 24|at month 24|313
236386|NCT01114529|573510|P3|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|125
236387|NCT01114529|573511|P2|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|231
236388|NCT01114529|573512|P1|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|353
236389|NCT01114529|573510|P3|NOT COMPLETED|Completed Study Medication at Month 24||32
236390|NCT01114529|573511|P2|NOT COMPLETED|Completed Study Medication at Month 24||41
236391|NCT01114529|573512|P1|NOT COMPLETED|Completed Study Medication at Month 24||124
236392|NCT01114529|573510|P3|COMPLETED|Completed Study Medication at Month 24|completed at month 24|93
236393|NCT01114529|573511|P2|COMPLETED|Completed Study Medication at Month 24|completed at month 24|190
236394|NCT01114529|573512|P1|COMPLETED|Completed Study Medication at Month 24|completed at month 24|229
236395|NCT01114529|573510|P3|STARTED|Completed Study Medication at Month 24|Randomized set-125 Full analysis set -125 Safety analysis set -121***|125
236396|NCT01114529|573511|P2|STARTED|Completed Study Medication at Month 24|Randomized set -231 Full analysis set -231 Safety analysis set -238**|231
236397|NCT01114529|573512|P1|STARTED|Completed Study Medication at Month 24|Randomized set - 360 Full analysis set - 353 Safety analysis set -346*|353
236398|NCT01114516|573531|P2|NOT COMPLETED|Overall Study||1
236399|NCT01114516|573532|P1|NOT COMPLETED|Overall Study||2
236400|NCT01114516|573531|P2|COMPLETED|Overall Study||26
236401|NCT01114516|573532|P1|COMPLETED|Overall Study||24
236402|NCT01114516|573531|P2|STARTED|Overall Study||27
236403|NCT01114516|573532|P1|STARTED|Overall Study||26
236404|NCT01114503|573546|P1|NOT COMPLETED|Overall Study||0
236405|NCT01114503|573546|P1|COMPLETED|Overall Study||2
236406|NCT01114503|573546|P1|STARTED|Overall Study||2
236407|NCT01114438|573567|P1|NOT COMPLETED|Overall Study||14
236408|NCT01114438|573567|P1|COMPLETED|Overall Study||31
236409|NCT01114438|573567|P1|STARTED|Overall Study||45
236410|NCT01114373|573577|P2|NOT COMPLETED|Intervention 2 (4 Weeks)||1
236411|NCT01114373|573578|P1|NOT COMPLETED|Intervention 2 (4 Weeks)||0
236412|NCT01114373|573577|P2|COMPLETED|Intervention 2 (4 Weeks)||18
236413|NCT01114373|573578|P1|COMPLETED|Intervention 2 (4 Weeks)||18
236414|NCT01114373|573577|P2|STARTED|Intervention 2 (4 Weeks)||19
236415|NCT01114373|573578|P1|STARTED|Intervention 2 (4 Weeks)||18
236416|NCT01114373|573577|P2|NOT COMPLETED|Intervention 1 (4 Weeks)||0
236417|NCT01114373|573578|P1|NOT COMPLETED|Intervention 1 (4 Weeks)||3
236418|NCT01114373|573577|P2|COMPLETED|Intervention 1 (4 Weeks)||19
236419|NCT01114373|573578|P1|COMPLETED|Intervention 1 (4 Weeks)||18
236420|NCT01114373|573577|P2|STARTED|Intervention 1 (4 Weeks)||19
236421|NCT01114373|573578|P1|STARTED|Intervention 1 (4 Weeks)||21
236422|NCT01114360|573610|P2|NOT COMPLETED|Intervention 2 (4 Weeks)||0
236423|NCT01114360|573611|P1|NOT COMPLETED|Intervention 2 (4 Weeks)||0
236424|NCT01114360|573610|P2|COMPLETED|Intervention 2 (4 Weeks)||18
236425|NCT01114360|573611|P1|COMPLETED|Intervention 2 (4 Weeks)||18
236426|NCT01114360|573610|P2|STARTED|Intervention 2 (4 Weeks)||18
236427|NCT01114360|573611|P1|STARTED|Intervention 2 (4 Weeks)||18
236428|NCT01114360|573610|P2|NOT COMPLETED|Intervention 1 (4 Weeks)||1
236429|NCT01114360|573611|P1|NOT COMPLETED|Intervention 1 (4 Weeks)||0
236430|NCT01114360|573610|P2|COMPLETED|Intervention 1 (4 Weeks)||18
236431|NCT01114360|573611|P1|COMPLETED|Intervention 1 (4 Weeks)||18
236432|NCT01114360|573610|P2|STARTED|Intervention 1 (4 Weeks)||19
236433|NCT01114360|573611|P1|STARTED|Intervention 1 (4 Weeks)||18
236434|NCT01114334|573649|P2|NOT COMPLETED|Overall Study||22
236435|NCT01114334|573650|P1|NOT COMPLETED|Overall Study||21
236436|NCT01114334|573649|P2|COMPLETED|Overall Study||58
236437|NCT01114334|573650|P1|COMPLETED|Overall Study||67
236438|NCT01114334|573649|P2|STARTED|Overall Study||80
236439|NCT01114334|573650|P1|STARTED|Overall Study||88
236440|NCT01114217|573662|P2|NOT COMPLETED|Overall Study||98
236441|NCT01114217|573663|P1|NOT COMPLETED|Overall Study||75
236442|NCT01114217|573662|P2|COMPLETED|Overall Study||199
236443|NCT01114217|573663|P1|COMPLETED|Overall Study|Two participants lacked study completion data: one site stopped communicating during the study.|262
236444|NCT01114217|573662|P2|Received at Least 1 Dose of Ferumoxytol|Overall Study||0
236445|NCT01114217|573663|P1|Received at Least 1 Dose of Ferumoxytol|Overall Study||337
236446|NCT01114217|573662|P2|STARTED|Overall Study||297
236447|NCT01114217|573663|P1|STARTED|Overall Study||337
236448|NCT01114204|573675|P2|NOT COMPLETED|Overall Study||8
236449|NCT01114204|573676|P1|NOT COMPLETED|Overall Study||21
236450|NCT01114204|573675|P2|COMPLETED|Overall Study||191
236451|NCT01114204|573676|P1|COMPLETED|Overall Study||385
236452|NCT01114204|573675|P2|Received at Least 1 Dose of Study Drug|Overall Study||199
236453|NCT01114204|573676|P1|Received at Least 1 Dose of Study Drug|Overall Study||406
236454|NCT01114204|573675|P2|STARTED|Overall Study||199
236455|NCT01114204|573676|P1|STARTED|Overall Study||406
236456|NCT01114139|573694|P2|NOT COMPLETED|Overall Study||16
236457|NCT01114139|573695|P1|NOT COMPLETED|Overall Study||40
236458|NCT01114139|573694|P2|COMPLETED|Overall Study||187
236459|NCT01114139|573695|P1|COMPLETED|Overall Study||569
236460|NCT01114139|573694|P2|Received at Least 1 Dose of Study Drug|Overall Study||200
236461|NCT01114139|573695|P1|Received at Least 1 Dose of Study Drug|Overall Study||608
236462|NCT01114139|573694|P2|STARTED|Overall Study||203
236463|NCT01114139|573695|P1|STARTED|Overall Study||609
236464|NCT01113931|573713|P2|NOT COMPLETED|Overall Study||17
236466|NCT01113931|573713|P2|COMPLETED|Overall Study||231
236467|NCT01113931|573714|P1|COMPLETED|Overall Study||228
236468|NCT01113931|573713|P2|mITT Population|Overall Study||190
236469|NCT01113931|573714|P1|mITT Population|Overall Study||188
236470|NCT01113931|573713|P2|Safety Population|Overall Study||248
236471|NCT01113931|573714|P1|Safety Population|Overall Study|1 subject did not take any study medication|246
236472|NCT01113931|573713|P2|STARTED|Overall Study||248
236473|NCT01113931|573714|P1|STARTED|Overall Study||247
236474|NCT01113879|573728|P2|NOT COMPLETED|Period 2: Block 2||0
236475|NCT01113879|573729|P1|NOT COMPLETED|Period 2: Block 2||0
236476|NCT01113879|573728|P2|COMPLETED|Period 2: Block 2||2
236477|NCT01113879|573729|P1|COMPLETED|Period 2: Block 2||5
236478|NCT01113879|573728|P2|STARTED|Period 2: Block 2||2
236479|NCT01113879|573729|P1|STARTED|Period 2: Block 2||5
236480|NCT01113879|573728|P2|NOT COMPLETED|Period 1: Block 1||0
236481|NCT01113879|573729|P1|NOT COMPLETED|Period 1: Block 1||2
236482|NCT01113879|573728|P2|COMPLETED|Period 1: Block 1||2
236483|NCT01113879|573729|P1|COMPLETED|Period 1: Block 1||5
236484|NCT01113879|573728|P2|STARTED|Period 1: Block 1||2
236485|NCT01113879|573729|P1|STARTED|Period 1: Block 1||7
236486|NCT01113801|573741|P4|NOT COMPLETED|Overall Study||41
236487|NCT01113801|573742|P3|NOT COMPLETED|Overall Study||37
236488|NCT01113801|573743|P2|NOT COMPLETED|Overall Study||40
236489|NCT01113801|573744|P1|NOT COMPLETED|Overall Study||41
236490|NCT01113801|573741|P4|COMPLETED|Overall Study||65
236491|NCT01113801|573742|P3|COMPLETED|Overall Study||66
236492|NCT01113801|573743|P2|COMPLETED|Overall Study||65
236493|NCT01113801|573744|P1|COMPLETED|Overall Study||62
236494|NCT01113801|573741|P4|Received at Least One Dose of Drug|Overall Study||105
236495|NCT01113801|573742|P3|Received at Least One Dose of Drug|Overall Study||103
236496|NCT01113801|573743|P2|Received at Least One Dose of Drug|Overall Study||105
236497|NCT01113801|573744|P1|Received at Least One Dose of Drug|Overall Study||103
236498|NCT01113801|573741|P4|STARTED|Overall Study||106
236499|NCT01113801|573742|P3|STARTED|Overall Study||103
236500|NCT01113801|573743|P2|STARTED|Overall Study||105
236501|NCT01113801|573744|P1|STARTED|Overall Study||103
236502|NCT01113749|573772|P2|NOT COMPLETED|Overall Study||2
236503|NCT01113749|573773|P1|NOT COMPLETED|Overall Study||1
236504|NCT01113749|573772|P2|COMPLETED|Overall Study||127
236505|NCT01113749|573773|P1|COMPLETED|Overall Study||126
236506|NCT01113749|573772|P2|STARTED|Overall Study||129
236507|NCT01113749|573773|P1|STARTED|Overall Study||127
236508|NCT01113723|573785|P2|NOT COMPLETED|Overall Study||0
236509|NCT01113723|573786|P1|NOT COMPLETED|Overall Study||0
236510|NCT01113723|573785|P2|COMPLETED|Overall Study||70
236511|NCT01113723|573786|P1|COMPLETED|Overall Study||70
236512|NCT01113723|573785|P2|STARTED|Overall Study||70
236513|NCT01113723|573786|P1|STARTED|Overall Study||70
236514|NCT01113710|573796|P1|NOT COMPLETED|Overall Study||269
236515|NCT01113710|573796|P1|COMPLETED|Overall Study|"Discontinued reasons for Other are listed in the Participant Flow."|418
236516|NCT01113710|573796|P1|STARTED|Overall Study|See Additional Study Description for further information regarding withdrawal due to Adverse Event.|687
236517|NCT01113632|573807|P2|NOT COMPLETED|Overall Study||25
236518|NCT01113632|573808|P1|NOT COMPLETED|Overall Study||31
236519|NCT01113632|573807|P2|COMPLETED|Overall Study||19
236520|NCT01113632|573808|P1|COMPLETED|Overall Study||2
236521|NCT01113632|573807|P2|STARTED|Overall Study||44
236522|NCT01113632|573808|P1|STARTED|Overall Study||33
236523|NCT01113580|573824|P2|NOT COMPLETED|Overall Study||0
236524|NCT01113580|573825|P1|NOT COMPLETED|Overall Study||1
236525|NCT01113580|573824|P2|COMPLETED|Overall Study||60
236526|NCT01113580|573825|P1|COMPLETED|Overall Study||59
236527|NCT01113580|573824|P2|STARTED|Overall Study||60
236528|NCT01113580|573825|P1|STARTED|Overall Study||60
236529|NCT01113541|573839|P1|NOT COMPLETED|Overall Study||13
236530|NCT01113541|573839|P1|COMPLETED|Overall Study||0
236531|NCT01113541|573839|P1|STARTED|Overall Study||13
236532|NCT01113463|573872|P1|NOT COMPLETED|Overall Study||5
236533|NCT01113463|573872|P1|COMPLETED|Overall Study||12
236534|NCT01113463|573872|P1|STARTED|Overall Study||17
236535|NCT01113398|573877|P1|NOT COMPLETED|Overall Study||0
236536|NCT01113398|573877|P1|COMPLETED|Overall Study|Completed= Discontinued study drug due to disease progression, death, toxicity or any other reason|36
236537|NCT01113398|573877|P1|STARTED|Overall Study||36
236538|NCT01113385|573884|P1|NOT COMPLETED|Overall Study||0
236539|NCT01113385|573884|P1|COMPLETED|Overall Study||7
236540|NCT01113385|573884|P1|STARTED|Overall Study||7
236541|NCT01113008|573891|P2|NOT COMPLETED|Overall Study||0
236542|NCT01113008|573892|P1|NOT COMPLETED|Overall Study||0
236543|NCT01113008|573891|P2|COMPLETED|Overall Study||133
236544|NCT01113008|573892|P1|COMPLETED|Overall Study||133
236545|NCT01113008|573891|P2|STARTED|Overall Study||133
236546|NCT01113008|573892|P1|STARTED|Overall Study||133
236547|NCT01112982|573902|P1|NOT COMPLETED|Overall Study||2
236548|NCT01112982|573902|P1|COMPLETED|Overall Study||72
236549|NCT01112982|573902|P1|STARTED|Overall Study||74
236550|NCT01112917|573914|P2|NOT COMPLETED|Overall Study||15
236551|NCT01112917|573915|P1|NOT COMPLETED|Overall Study||7
236552|NCT01112917|573914|P2|COMPLETED|Overall Study||38
236553|NCT01112917|573915|P1|COMPLETED|Overall Study||89
236554|NCT01112917|573914|P2|STARTED|Overall Study||53
236555|NCT01112917|573915|P1|STARTED|Overall Study||96
236556|NCT01112865|573920|P2|NOT COMPLETED|Second Intervention||0
236557|NCT01112865|573921|P1|NOT COMPLETED|Second Intervention||0
236558|NCT01112865|573920|P2|COMPLETED|Second Intervention||61
236559|NCT01112865|573921|P1|COMPLETED|Second Intervention||59
236560|NCT01112865|573920|P2|STARTED|Second Intervention||61
236561|NCT01112865|573921|P1|STARTED|Second Intervention||59
236562|NCT01112865|573920|P2|NOT COMPLETED|First Intervention||0
236563|NCT01112865|573921|P1|NOT COMPLETED|First Intervention||0
236564|NCT01112865|573920|P2|COMPLETED|First Intervention||61
236565|NCT01112865|573921|P1|COMPLETED|First Intervention||59
236566|NCT01112865|573920|P2|STARTED|First Intervention||61
236567|NCT01112865|573921|P1|STARTED|First Intervention||59
236568|NCT01112735|573933|P2|NOT COMPLETED|Overall Study||0
236569|NCT01112735|573934|P1|NOT COMPLETED|Overall Study||0
236570|NCT01112735|573933|P2|COMPLETED|Overall Study||20
236571|NCT01112735|573934|P1|COMPLETED|Overall Study||20
236572|NCT01112735|573933|P2|STARTED|Overall Study||20
236573|NCT01112735|573934|P1|STARTED|Overall Study||20
236574|NCT01112696|573958|P1|NOT COMPLETED|Overall Study||2
236575|NCT01112696|573958|P1|COMPLETED|Overall Study||98
236576|NCT01112696|573958|P1|STARTED|Overall Study||100
236577|NCT01112683|573965|P2|NOT COMPLETED|Overall Study||1
236578|NCT01112683|573966|P1|NOT COMPLETED|Overall Study||1
236579|NCT01112683|573965|P2|COMPLETED|Overall Study||19
236580|NCT01112683|573966|P1|COMPLETED|Overall Study||18
236581|NCT01112683|573965|P2|STARTED|Overall Study||20
236582|NCT01112683|573966|P1|STARTED|Overall Study||19
236583|NCT01112670|573976|P6|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
236584|NCT01112670|573977|P5|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
236585|NCT01112670|573978|P4|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
236586|NCT01112670|573979|P3|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
236587|NCT01112670|573980|P2|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
236588|NCT01112670|573981|P1|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
236589|NCT01112670|573976|P6|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||5
236590|NCT01112670|573977|P5|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
236591|NCT01112670|573978|P4|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||4
236592|NCT01112670|573979|P3|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
236593|NCT01112670|573980|P2|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||3
236594|NCT01112670|573981|P1|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
236595|NCT01112670|573976|P6|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||5
236596|NCT01112670|573977|P5|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
236597|NCT01112670|573978|P4|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||4
236598|NCT01112670|573979|P3|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
236599|NCT01112670|573980|P2|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||3
236600|NCT01112670|573981|P1|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
236601|NCT01112670|573976|P6|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
236602|NCT01112670|573977|P5|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
236603|NCT01112670|573978|P4|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
236604|NCT01112670|573979|P3|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
236605|NCT01112670|573980|P2|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
236606|NCT01112670|573981|P1|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
236607|NCT01112670|573976|P6|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
236608|NCT01112670|573977|P5|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||5
236609|NCT01112670|573978|P4|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
236610|NCT01112670|573979|P3|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||6
236611|NCT01112670|573980|P2|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
236612|NCT01112670|573981|P1|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||7
236613|NCT01112670|573976|P6|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
236614|NCT01112670|573977|P5|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||6
236615|NCT01112670|573978|P4|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
236616|NCT01112670|573979|P3|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||7
236617|NCT01112670|573980|P2|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
236618|NCT01112670|573981|P1|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||8
236619|NCT01112579|574019|P2|NOT COMPLETED|Overall Study||3
236620|NCT01112579|574020|P1|NOT COMPLETED|Overall Study||1
236621|NCT01112579|574019|P2|COMPLETED|Overall Study||21
236622|NCT01112579|574020|P1|COMPLETED|Overall Study||41
236623|NCT01112579|574019|P2|STARTED|Overall Study||24
236624|NCT01112579|574020|P1|STARTED|Overall Study||42
236625|NCT01112514|574030|P1|NOT COMPLETED|Overall Study||1
236626|NCT01112514|574030|P1|COMPLETED|Overall Study||3
236627|NCT01112514|574030|P1|STARTED|Overall Study||4
236628|NCT01112358|574036|P2|NOT COMPLETED|Overall Study||0
236629|NCT01112358|574037|P1|NOT COMPLETED|Overall Study||0
236630|NCT01112358|574036|P2|COMPLETED|Overall Study||33
236631|NCT01112358|574037|P1|COMPLETED|Overall Study||25
236632|NCT01112358|574036|P2|STARTED|Overall Study||33
236633|NCT01112358|574037|P1|STARTED|Overall Study||25
236634|NCT01112267|574075|P2|NOT COMPLETED|Overall Study||18
236635|NCT01112267|574076|P1|NOT COMPLETED|Overall Study||34
236636|NCT01112267|574075|P2|COMPLETED|Overall Study||104
236637|NCT01112267|574076|P1|COMPLETED|Overall Study||92
236638|NCT01112267|574075|P2|Treated|Overall Study||120
236639|NCT01112267|574076|P1|Treated|Overall Study||125
236640|NCT01112267|574075|P2|STARTED|Overall Study||122
236641|NCT01112267|574076|P1|STARTED|Overall Study||126
236642|NCT01112241|574094|P1|NOT COMPLETED|Overall Study||0
236643|NCT01112241|574094|P1|COMPLETED|Overall Study||17
236644|NCT01112241|574094|P1|STARTED|Overall Study||17
236645|NCT01112059|574109|P2|NOT COMPLETED|Overall Study||0
236646|NCT01112059|574110|P1|NOT COMPLETED|Overall Study||1
236647|NCT01112059|574109|P2|COMPLETED|Overall Study||20
236648|NCT01112059|574110|P1|COMPLETED|Overall Study||19
236649|NCT01112059|574109|P2|STARTED|Overall Study||20
236650|NCT01112059|574110|P1|STARTED|Overall Study||20
236651|NCT01111851|574124|P2|NOT COMPLETED|Overall Study||0
236652|NCT01111851|574125|P1|NOT COMPLETED|Overall Study||2
236653|NCT01111851|574124|P2|COMPLETED|Overall Study||8
236654|NCT01111851|574125|P1|COMPLETED|Overall Study||6
236655|NCT01111851|574124|P2|STARTED|Overall Study||8
236656|NCT01111851|574125|P1|STARTED|Overall Study||8
236657|NCT01111838|574137|P1|NOT COMPLETED|Overall Study||7
236658|NCT01111838|574137|P1|COMPLETED|Overall Study||15
236659|NCT01111838|574137|P1|STARTED|Overall Study||22
236660|NCT01111825|574145|P4|NOT COMPLETED|Overall Study||21
236661|NCT01111825|574146|P3|NOT COMPLETED|Overall Study||8
236662|NCT01111825|574147|P2|NOT COMPLETED|Overall Study||1
236663|NCT01111825|574148|P1|NOT COMPLETED|Overall Study||3
236664|NCT01111825|574145|P4|COMPLETED|Overall Study||27
236665|NCT01111825|574146|P3|COMPLETED|Overall Study||29
236666|NCT01111825|574147|P2|COMPLETED|Overall Study||5
236667|NCT01111825|574148|P1|COMPLETED|Overall Study||5
236668|NCT01111825|574145|P4|STARTED|Overall Study||48
236669|NCT01111825|574146|P3|STARTED|Overall Study||37
236670|NCT01111825|574147|P2|STARTED|Overall Study||6
236671|NCT01111825|574148|P1|STARTED|Overall Study||8
236672|NCT01111604|574170|P3|NOT COMPLETED|Overall Study||3
236673|NCT01111604|574171|P2|NOT COMPLETED|Overall Study||0
236674|NCT01111604|574172|P1|NOT COMPLETED|Overall Study||8
236675|NCT01111604|574170|P3|COMPLETED|Overall Study||49
236676|NCT01111604|574171|P2|COMPLETED|Overall Study||52
236677|NCT01111604|574172|P1|COMPLETED|Overall Study||46
236678|NCT01111604|574170|P3|Received at Least One Dose of Study Drug|Overall Study||52
236679|NCT01111604|574171|P2|Received at Least One Dose of Study Drug|Overall Study||52
236680|NCT01111604|574172|P1|Received at Least One Dose of Study Drug|Overall Study||49
236681|NCT01111604|574170|P3|STARTED|Overall Study||52
236682|NCT01111604|574171|P2|STARTED|Overall Study||52
236683|NCT01111604|574172|P1|STARTED|Overall Study||54
236684|NCT01111526|574210|P3|NOT COMPLETED|Overall Study||2
236685|NCT01111526|574211|P2|NOT COMPLETED|Overall Study||1
236686|NCT01111526|574212|P1|NOT COMPLETED|Overall Study||0
236687|NCT01111526|574210|P3|COMPLETED|Overall Study||8
236688|NCT01111526|574211|P2|COMPLETED|Overall Study||7
236689|NCT01111526|574212|P1|COMPLETED|Overall Study||4
236690|NCT01111526|574210|P3|STARTED|Overall Study||10
236691|NCT01111526|574211|P2|STARTED|Overall Study||8
236692|NCT01111526|574212|P1|STARTED|Overall Study||4
236693|NCT01111461|574224|P1|NOT COMPLETED|Overall Study||51
236694|NCT01111461|574224|P1|COMPLETED|Overall Study|On treatment at data cut-off or on treatment until disease progression|82
236695|NCT01111461|574224|P1|STARTED|Overall Study||133
236696|NCT01111370|574237|P1|NOT COMPLETED|Overall Study||2
236697|NCT01111370|574237|P1|COMPLETED|Overall Study||58
236698|NCT01111370|574237|P1|STARTED|Overall Study||60
236699|NCT01111331|574241|P2|NOT COMPLETED|Overall Study||0
236700|NCT01111331|574242|P1|NOT COMPLETED|Overall Study||0
236701|NCT01111331|574241|P2|COMPLETED|Overall Study||9
236702|NCT01111331|574242|P1|COMPLETED|Overall Study||9
236703|NCT01111331|574241|P2|STARTED|Overall Study||9
236704|NCT01111331|574242|P1|STARTED|Overall Study||9
236705|NCT01111318|574324|P4|NOT COMPLETED|Overall Study||0
236706|NCT01111318|574325|P3|NOT COMPLETED|Overall Study||0
236707|NCT01111318|574326|P2|NOT COMPLETED|Overall Study||0
236708|NCT01111318|574327|P1|NOT COMPLETED|Overall Study||0
236709|NCT01111318|574324|P4|COMPLETED|Overall Study||8
236710|NCT01111318|574325|P3|COMPLETED|Overall Study||8
236711|NCT01111318|574326|P2|COMPLETED|Overall Study||8
236712|NCT01111318|574327|P1|COMPLETED|Overall Study||12
236713|NCT01111318|574324|P4|STARTED|Overall Study||8
236714|NCT01111318|574325|P3|STARTED|Overall Study||8
236715|NCT01111318|574326|P2|STARTED|Overall Study||8
236716|NCT01111318|574327|P1|STARTED|Overall Study||12
236717|NCT01111305|574391|P2|NOT COMPLETED|Overall Study||0
236718|NCT01111305|574392|P1|NOT COMPLETED|Overall Study||0
236719|NCT01111305|574391|P2|COMPLETED|Overall Study||4
236720|NCT01111305|574392|P1|COMPLETED|Overall Study||4
236721|NCT01111305|574391|P2|STARTED|Overall Study||4
236722|NCT01111305|574392|P1|STARTED|Overall Study||4
236723|NCT01111292|574404|P2|NOT COMPLETED|Follow-Up||0
236724|NCT01111292|574405|P1|NOT COMPLETED|Follow-Up||0
236725|NCT01111292|574404|P2|COMPLETED|Follow-Up||1
236726|NCT01111292|574405|P1|COMPLETED|Follow-Up||2
236727|NCT01111292|574404|P2|STARTED|Follow-Up||1
236728|NCT01111292|574405|P1|STARTED|Follow-Up||2
236729|NCT01111292|574404|P2|NOT COMPLETED|Post Treatment Biopsy||0
236730|NCT01111292|574405|P1|NOT COMPLETED|Post Treatment Biopsy||0
236731|NCT01111292|574404|P2|COMPLETED|Post Treatment Biopsy||1
236732|NCT01111292|574405|P1|COMPLETED|Post Treatment Biopsy||2
236733|NCT01111292|574404|P2|STARTED|Post Treatment Biopsy||1
236734|NCT01111292|574405|P1|STARTED|Post Treatment Biopsy||2
236735|NCT01111292|574404|P2|NOT COMPLETED|Treatment||1
236736|NCT01111292|574405|P1|NOT COMPLETED|Treatment||1
236737|NCT01111292|574404|P2|COMPLETED|Treatment||1
236738|NCT01111292|574405|P1|COMPLETED|Treatment||2
236739|NCT01111292|574404|P2|STARTED|Treatment||2
236740|NCT01111292|574405|P1|STARTED|Treatment||3
236741|NCT01111292|574404|P2|NOT COMPLETED|Randomization||0
236742|NCT01111292|574405|P1|NOT COMPLETED|Randomization||0
236743|NCT01111292|574404|P2|COMPLETED|Randomization||2
236744|NCT01111292|574405|P1|COMPLETED|Randomization||3
236745|NCT01111292|574404|P2|STARTED|Randomization||2
236746|NCT01111292|574405|P1|STARTED|Randomization||3
236747|NCT01111240|574411|P1|NOT COMPLETED|Overall Study||1066
236748|NCT01111240|574411|P1|COMPLETED|Overall Study||3569
236749|NCT01111240|574411|P1|STARTED|Overall Study||4635
236750|NCT01111162|574433|P1|NOT COMPLETED|Overall Study||0
236751|NCT01111162|574433|P1|COMPLETED|Overall Study||120
236752|NCT01111162|574433|P1|STARTED|Overall Study||120
236753|NCT01111149|574441|P3|NOT COMPLETED|Overall Study||4
236754|NCT01111149|574442|P2|NOT COMPLETED|Overall Study||1
236755|NCT01111149|574443|P1|NOT COMPLETED|Overall Study||2
236756|NCT01111149|574441|P3|COMPLETED|Overall Study||5
236757|NCT01111149|574442|P2|COMPLETED|Overall Study||5
236758|NCT01111149|574443|P1|COMPLETED|Overall Study||7
236759|NCT01111149|574441|P3|STARTED|Overall Study||9
236760|NCT01111149|574442|P2|STARTED|Overall Study||6
236761|NCT01111149|574443|P1|STARTED|Overall Study||9
236762|NCT01111123|574519|P2|NOT COMPLETED|Maintenance Phase||2
236763|NCT01111123|574520|P1|NOT COMPLETED|Maintenance Phase||0
236764|NCT01111123|574519|P2|COMPLETED|Maintenance Phase||18
236765|NCT01111123|574520|P1|COMPLETED|Maintenance Phase||21
236766|NCT01111123|574519|P2|STARTED|Maintenance Phase||20
236767|NCT01111123|574520|P1|STARTED|Maintenance Phase||21
236768|NCT01111123|574519|P2|NOT COMPLETED|Open- Label Phase||0
236769|NCT01111123|574520|P1|NOT COMPLETED|Open- Label Phase||14
236770|NCT01111123|574519|P2|COMPLETED|Open- Label Phase||0
236771|NCT01111123|574520|P1|COMPLETED|Open- Label Phase||41
236772|NCT01111123|574519|P2|STARTED|Open- Label Phase||0
236773|NCT01111123|574520|P1|STARTED|Open- Label Phase||55
236774|NCT01111110|574530|P2|NOT COMPLETED|Overall Study||0
236775|NCT01111110|574531|P1|NOT COMPLETED|Overall Study||0
236776|NCT01111110|574530|P2|COMPLETED|Overall Study||4
236777|NCT01111110|574531|P1|COMPLETED|Overall Study||3
236778|NCT01111110|574530|P2|STARTED|Overall Study||4
236779|NCT01111110|574531|P1|STARTED|Overall Study||3
236780|NCT01111019|574541|P1|NOT COMPLETED|Overall Study||3
236781|NCT01111019|574541|P1|COMPLETED|Overall Study||16
236782|NCT01111019|574541|P1|STARTED|Overall Study||19
236783|NCT01110967|574560|P1|NOT COMPLETED|Overall Study||9
236784|NCT01110967|574560|P1|COMPLETED|Overall Study||31
236785|NCT01110967|574560|P1|12 Months Follow up|Overall Study||31
236786|NCT01110967|574560|P1|6 Months Follow up|Overall Study||24
236787|NCT01110967|574560|P1|3 Months Follow up|Overall Study||28
236788|NCT01110967|574560|P1|1 Month Follow up|Overall Study||26
236789|NCT01110967|574560|P1|Surgery|Overall Study||40
236790|NCT01110967|574560|P1|STARTED|Overall Study||40
236791|NCT01110915|574573|P2|NOT COMPLETED|Overall Study||2
236792|NCT01110915|574574|P1|NOT COMPLETED|Overall Study||10
236793|NCT01110915|574573|P2|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|84
236794|NCT01110915|574574|P1|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|167
236795|NCT01110915|574573|P2|STARTED|Overall Study|Subjects being randomized to the Control group.|86
236796|NCT01110915|574574|P1|STARTED|Overall Study|Subjects being randomized to the MRI group.|177
236797|NCT01110707|574591|P2|NOT COMPLETED|Overall Study||3
236798|NCT01110707|574592|P1|NOT COMPLETED|Overall Study||0
236799|NCT01110707|574591|P2|COMPLETED|Overall Study||65
236800|NCT01110707|574592|P1|COMPLETED|Overall Study||63
236801|NCT01110707|574591|P2|STARTED|Overall Study||68
236802|NCT01110707|574592|P1|STARTED|Overall Study||63
236803|NCT01110681|574614|P1|NOT COMPLETED|Overall Study||32
236804|NCT01110681|574614|P1|COMPLETED|Overall Study||83
236805|NCT01110681|574614|P1|STARTED|Overall Study||115
236806|NCT01110499|574630|P8|NOT COMPLETED|Overall Study||0
236807|NCT01110499|574631|P7|NOT COMPLETED|Overall Study||0
236808|NCT01110499|574632|P6|NOT COMPLETED|Overall Study||0
236809|NCT01110499|574633|P5|NOT COMPLETED|Overall Study||0
236810|NCT01110499|574634|P4|NOT COMPLETED|Overall Study||0
236811|NCT01110499|574635|P3|NOT COMPLETED|Overall Study||0
236812|NCT01110499|574636|P2|NOT COMPLETED|Overall Study||0
236813|NCT01110499|574637|P1|NOT COMPLETED|Overall Study||0
236814|NCT01110499|574630|P8|COMPLETED|Overall Study||40
236815|NCT01110499|574631|P7|COMPLETED|Overall Study||39
236816|NCT01110499|574632|P6|COMPLETED|Overall Study||14
236817|NCT01110499|574633|P5|COMPLETED|Overall Study||14
236818|NCT01110499|574634|P4|COMPLETED|Overall Study||14
236819|NCT01110499|574635|P3|COMPLETED|Overall Study||14
236820|NCT01110499|574636|P2|COMPLETED|Overall Study||14
236821|NCT01110499|574637|P1|COMPLETED|Overall Study||14
236822|NCT01110499|574630|P8|STARTED|Overall Study||40
236823|NCT01110499|574631|P7|STARTED|Overall Study||39
236824|NCT01110499|574632|P6|STARTED|Overall Study||14
236825|NCT01110499|574633|P5|STARTED|Overall Study||14
236826|NCT01110499|574634|P4|STARTED|Overall Study||14
236827|NCT01110499|574635|P3|STARTED|Overall Study||14
236828|NCT01110499|574636|P2|STARTED|Overall Study||14
236829|NCT01110499|574637|P1|STARTED|Overall Study||14
236830|NCT01110421|574659|P2|NOT COMPLETED|Overall Study||0
236831|NCT01110421|574660|P1|NOT COMPLETED|Overall Study||0
236832|NCT01110421|574659|P2|COMPLETED|Overall Study||2
236833|NCT01110421|574660|P1|COMPLETED|Overall Study|Includes 1 participant who discontinued study drug due to an adverse event of empyema on Days 9-13.|5
236834|NCT01110421|574659|P2|STARTED|Overall Study||2
236835|NCT01110421|574660|P1|STARTED|Overall Study||5
236836|NCT01110408|574680|P2|NOT COMPLETED|Overall Study||0
236837|NCT01110408|574681|P1|NOT COMPLETED|Overall Study||1
236838|NCT01110408|574680|P2|COMPLETED|Overall Study||10
236839|NCT01110408|574681|P1|COMPLETED|Overall Study||30
236840|NCT01110408|574680|P2|STARTED|Overall Study||10
236841|NCT01110408|574681|P1|STARTED|Overall Study||31
236842|NCT01110382|574701|P2|NOT COMPLETED|Overall Study||2
236843|NCT01110382|574702|P1|NOT COMPLETED|Overall Study||0
236844|NCT01110382|574701|P2|COMPLETED|Overall Study||8
236845|NCT01110382|574702|P1|COMPLETED|Overall Study||31
236846|NCT01110382|574701|P2|STARTED|Overall Study||10
236847|NCT01110382|574702|P1|STARTED|Overall Study||31
236848|NCT01110330|574723|P3|NOT COMPLETED|Overall Study||26
236849|NCT01110330|574724|P2|NOT COMPLETED|Overall Study||23
236850|NCT01110330|574725|P1|NOT COMPLETED|Overall Study||15
236851|NCT01110330|574723|P3|COMPLETED|Overall Study||208
236852|NCT01110330|574724|P2|COMPLETED|Overall Study||207
236853|NCT01110330|574725|P1|COMPLETED|Overall Study||104
236854|NCT01110330|574723|P3|Positive Baseline Culture Set|Overall Study||114
236855|NCT01110330|574724|P2|Positive Baseline Culture Set|Overall Study||111
236856|NCT01110330|574725|P1|Positive Baseline Culture Set|Overall Study||56
236857|NCT01110330|574723|P3|STARTED|Overall Study||234
236858|NCT01110330|574724|P2|STARTED|Overall Study||230
236859|NCT01110330|574725|P1|STARTED|Overall Study||119
236860|NCT01110252|574736|P1|NOT COMPLETED|Post-procedure (Stem Cells Infusion)||0
236861|NCT01110252|574736|P1|COMPLETED|Post-procedure (Stem Cells Infusion)||4
236862|NCT01110252|574736|P1|STARTED|Post-procedure (Stem Cells Infusion)||4
236863|NCT01110252|574736|P1|NOT COMPLETED|Pre-procedure (Stem Cells Infusion)||0
236864|NCT01110252|574736|P1|COMPLETED|Pre-procedure (Stem Cells Infusion)||4
236865|NCT01110252|574736|P1|STARTED|Pre-procedure (Stem Cells Infusion)||4
236866|NCT01110239|574753|P4|NOT COMPLETED|10 Min Ischemia||0
236867|NCT01110239|574754|P3|NOT COMPLETED|10 Min Ischemia||0
236868|NCT01110239|574755|P2|NOT COMPLETED|10 Min Ischemia||0
236869|NCT01110239|574756|P1|NOT COMPLETED|10 Min Ischemia||0
236870|NCT01110239|574753|P4|COMPLETED|10 Min Ischemia||6
236871|NCT01110239|574754|P3|COMPLETED|10 Min Ischemia||0
236872|NCT01110239|574755|P2|COMPLETED|10 Min Ischemia||0
236873|NCT01110239|574756|P1|COMPLETED|10 Min Ischemia||0
236874|NCT01110239|574753|P4|STARTED|10 Min Ischemia||6
236875|NCT01110239|574754|P3|STARTED|10 Min Ischemia||0
236876|NCT01110239|574755|P2|STARTED|10 Min Ischemia||0
236877|NCT01110239|574756|P1|STARTED|10 Min Ischemia||0
236878|NCT01110239|574753|P4|NOT COMPLETED|7.5 Min Ischemia||0
236879|NCT01110239|574754|P3|NOT COMPLETED|7.5 Min Ischemia||1
236880|NCT01110239|574755|P2|NOT COMPLETED|7.5 Min Ischemia||0
236881|NCT01110239|574756|P1|NOT COMPLETED|7.5 Min Ischemia||0
236882|NCT01110239|574753|P4|COMPLETED|7.5 Min Ischemia||0
236883|NCT01110239|574754|P3|COMPLETED|7.5 Min Ischemia||6
236884|NCT01110239|574755|P2|COMPLETED|7.5 Min Ischemia||0
236885|NCT01110239|574756|P1|COMPLETED|7.5 Min Ischemia||0
236886|NCT01110239|574753|P4|STARTED|7.5 Min Ischemia||0
236887|NCT01110239|574754|P3|STARTED|7.5 Min Ischemia||7
236888|NCT01110239|574755|P2|STARTED|7.5 Min Ischemia||0
236889|NCT01110239|574756|P1|STARTED|7.5 Min Ischemia||0
236890|NCT01110239|574753|P4|NOT COMPLETED|5 Min Ischemia||0
236891|NCT01110239|574754|P3|NOT COMPLETED|5 Min Ischemia||0
236892|NCT01110239|574755|P2|NOT COMPLETED|5 Min Ischemia||14
236893|NCT01110239|574756|P1|NOT COMPLETED|5 Min Ischemia||0
236894|NCT01110239|574753|P4|COMPLETED|5 Min Ischemia||0
236895|NCT01110239|574754|P3|COMPLETED|5 Min Ischemia||0
236896|NCT01110239|574755|P2|COMPLETED|5 Min Ischemia||0
236897|NCT01110239|574756|P1|COMPLETED|5 Min Ischemia||0
236898|NCT01110239|574753|P4|STARTED|5 Min Ischemia||0
236899|NCT01110239|574754|P3|STARTED|5 Min Ischemia||0
236900|NCT01110239|574755|P2|STARTED|5 Min Ischemia||14
236901|NCT01110239|574756|P1|STARTED|5 Min Ischemia||0
236902|NCT01110239|574753|P4|NOT COMPLETED|Sham Preconditioning||0
236903|NCT01110239|574754|P3|NOT COMPLETED|Sham Preconditioning||1
236904|NCT01110239|574755|P2|NOT COMPLETED|Sham Preconditioning||0
236905|NCT01110239|574756|P1|NOT COMPLETED|Sham Preconditioning||0
236906|NCT01110239|574753|P4|COMPLETED|Sham Preconditioning||6
236907|NCT01110239|574754|P3|COMPLETED|Sham Preconditioning||6
236908|NCT01110239|574755|P2|COMPLETED|Sham Preconditioning||14
236909|NCT01110239|574756|P1|COMPLETED|Sham Preconditioning||7
236910|NCT01110239|574753|P4|STARTED|Sham Preconditioning||6
236911|NCT01110239|574754|P3|STARTED|Sham Preconditioning||7
236912|NCT01110239|574755|P2|STARTED|Sham Preconditioning||14
236913|NCT01110239|574756|P1|STARTED|Sham Preconditioning||7
236914|NCT01110200|574772|P2|NOT COMPLETED|Overall Study||121
236915|NCT01110200|574773|P1|NOT COMPLETED|Overall Study||106
236916|NCT01110200|574772|P2|COMPLETED|Overall Study||204
236917|NCT01110200|574773|P1|COMPLETED|Overall Study||208
236918|NCT01110200|574772|P2|STARTED|Overall Study||325
236919|NCT01110200|574773|P1|STARTED|Overall Study||314
236920|NCT01110187|574789|P2|NOT COMPLETED|Overall Study||0
236921|NCT01110187|574790|P1|NOT COMPLETED|Overall Study||0
236922|NCT01110187|574789|P2|COMPLETED|Overall Study|completed 7 day treatment|4
236923|NCT01110187|574790|P1|COMPLETED|Overall Study|completed 7 day treatment|7
236924|NCT01110187|574789|P2|STARTED|Overall Study||4
236925|NCT01110187|574790|P1|STARTED|Overall Study||7
236926|NCT01110174|574798|P1|NOT COMPLETED|Overall Study||0
236927|NCT01110174|574798|P1|COMPLETED|Overall Study||8
236928|NCT01110174|574798|P1|STARTED|Overall Study||8
236929|NCT01110135|574803|P1|NOT COMPLETED|Overall Study||9
236930|NCT01110135|574803|P1|COMPLETED|Overall Study||34
236931|NCT01110135|574803|P1|STARTED|Overall Study||43
236932|NCT01110005|574809|P2|NOT COMPLETED|Overall Study||5
236933|NCT01110005|574810|P1|NOT COMPLETED|Overall Study||4
236934|NCT01110005|574809|P2|COMPLETED|Overall Study||156
236935|NCT01110005|574810|P1|COMPLETED|Overall Study||153
236936|NCT01110005|574809|P2|STARTED|Overall Study||161
236937|NCT01110005|574810|P1|STARTED|Overall Study||157
236938|NCT01109992|574822|P2|NOT COMPLETED|Overall Study||2
236939|NCT01109992|574823|P1|NOT COMPLETED|Overall Study||0
236940|NCT01109992|574822|P2|COMPLETED|Overall Study||30
236941|NCT01109992|574823|P1|COMPLETED|Overall Study||11
236942|NCT01109992|574822|P2|Subjects Enrolled|Overall Study||32
236943|NCT01109992|574823|P1|Subjects Enrolled|Overall Study||11
236944|NCT01109992|574822|P2|STARTED|Overall Study||32
236945|NCT01109992|574823|P1|STARTED|Overall Study||11
236946|NCT01109979|574837|P2|NOT COMPLETED|Overall Study||1
236947|NCT01109979|574838|P1|NOT COMPLETED|Overall Study||2
236948|NCT01109979|574837|P2|COMPLETED|Overall Study||11
236949|NCT01109979|574838|P1|COMPLETED|Overall Study||10
236950|NCT01109979|574837|P2|STARTED|Overall Study||12
236951|NCT01109979|574838|P1|STARTED|Overall Study||12
236952|NCT01109849|574846|P5|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
236953|NCT01109849|574847|P4|NOT COMPLETED|Adaptive Randomization: Weight Recovery||3
236954|NCT01109849|574848|P3|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
236955|NCT01109849|574849|P2|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
236956|NCT01109849|574850|P1|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
236957|NCT01109849|574846|P5|COMPLETED|Adaptive Randomization: Weight Recovery||24
236958|NCT01109849|574847|P4|COMPLETED|Adaptive Randomization: Weight Recovery||20
236959|NCT01109849|574848|P3|COMPLETED|Adaptive Randomization: Weight Recovery||23
236960|NCT01109849|574849|P2|COMPLETED|Adaptive Randomization: Weight Recovery||0
236961|NCT01109849|574850|P1|COMPLETED|Adaptive Randomization: Weight Recovery||0
236962|NCT01109849|574846|P5|STARTED|Adaptive Randomization: Weight Recovery||25
236963|NCT01109849|574847|P4|STARTED|Adaptive Randomization: Weight Recovery||23
236964|NCT01109849|574848|P3|STARTED|Adaptive Randomization: Weight Recovery||24
236965|NCT01109849|574849|P2|STARTED|Adaptive Randomization: Weight Recovery||0
236966|NCT01109849|574850|P1|STARTED|Adaptive Randomization: Weight Recovery||0
236967|NCT01109849|574846|P5|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
236968|NCT01109849|574847|P4|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
236969|NCT01109849|574848|P3|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
236970|NCT01109849|574849|P2|NOT COMPLETED|Initial Randomization: ADHD Treatment||49
236971|NCT01109849|574850|P1|NOT COMPLETED|Initial Randomization: ADHD Treatment||18
236972|NCT01109849|574846|P5|COMPLETED|Initial Randomization: ADHD Treatment||0
236973|NCT01109849|574847|P4|COMPLETED|Initial Randomization: ADHD Treatment||0
236974|NCT01109849|574848|P3|COMPLETED|Initial Randomization: ADHD Treatment||0
236975|NCT01109849|574849|P2|COMPLETED|Initial Randomization: ADHD Treatment||131
236976|NCT01109849|574850|P1|COMPLETED|Initial Randomization: ADHD Treatment||32
236977|NCT01109849|574846|P5|STARTED|Initial Randomization: ADHD Treatment||0
236978|NCT01109849|574847|P4|STARTED|Initial Randomization: ADHD Treatment||0
236979|NCT01109849|574848|P3|STARTED|Initial Randomization: ADHD Treatment||0
236980|NCT01109849|574849|P2|STARTED|Initial Randomization: ADHD Treatment||180
236981|NCT01109849|574850|P1|STARTED|Initial Randomization: ADHD Treatment||50
236982|NCT01109602|574902|P3|NOT COMPLETED|Overall Study||1
236983|NCT01109602|574903|P2|NOT COMPLETED|Overall Study||2
236984|NCT01109602|574904|P1|NOT COMPLETED|Overall Study||1
236985|NCT01109602|574902|P3|COMPLETED|Overall Study||9
236986|NCT01109602|574903|P2|COMPLETED|Overall Study||21
236987|NCT01109602|574904|P1|COMPLETED|Overall Study||13
236988|NCT01109602|574902|P3|STARTED|Overall Study||10
236989|NCT01109602|574903|P2|STARTED|Overall Study||23
236990|NCT01109602|574904|P1|STARTED|Overall Study||14
236991|NCT01109576|574915|P1|NOT COMPLETED|Overall Study||1
236992|NCT01109576|574915|P1|COMPLETED|Overall Study||12
236993|NCT01109576|574915|P1|STARTED|Overall Study||13
236994|NCT01109524|574919|P1|NOT COMPLETED|Overall Study||57
236995|NCT01109524|574919|P1|COMPLETED|Overall Study||3
236996|NCT01109524|574919|P1|STARTED|Overall Study||60
236997|NCT01109381|574929|P1|NOT COMPLETED|Overall Study||2
236998|NCT01109381|574929|P1|COMPLETED|Overall Study||31
236999|NCT01109381|574929|P1|STARTED|Overall Study||33
237000|NCT01109316|574941|P6|NOT COMPLETED|Study Period 3||0
237001|NCT01109316|574942|P5|NOT COMPLETED|Study Period 3||2
237002|NCT01109316|574943|P4|NOT COMPLETED|Study Period 3||0
237003|NCT01109316|574944|P3|NOT COMPLETED|Study Period 3||0
237004|NCT01109316|574945|P2|NOT COMPLETED|Study Period 3||0
237005|NCT01109316|574946|P1|NOT COMPLETED|Study Period 3||1
237006|NCT01109316|574941|P6|COMPLETED|Study Period 3||19
237007|NCT01109316|574942|P5|COMPLETED|Study Period 3||18
237008|NCT01109316|574943|P4|COMPLETED|Study Period 3||20
237009|NCT01109316|574944|P3|COMPLETED|Study Period 3||18
237010|NCT01109316|574945|P2|COMPLETED|Study Period 3||21
237011|NCT01109316|574946|P1|COMPLETED|Study Period 3||20
237012|NCT01109316|574941|P6|STARTED|Study Period 3||19
237013|NCT01109316|574942|P5|STARTED|Study Period 3||20
237014|NCT01109316|574943|P4|STARTED|Study Period 3||20
237015|NCT01109316|574944|P3|STARTED|Study Period 3||18
237016|NCT01109316|574945|P2|STARTED|Study Period 3||21
237017|NCT01109316|574946|P1|STARTED|Study Period 3||21
237018|NCT01109316|574941|P6|NOT COMPLETED|Study Period 2||1
237019|NCT01109316|574942|P5|NOT COMPLETED|Study Period 2||0
237020|NCT01109316|574943|P4|NOT COMPLETED|Study Period 2||1
237021|NCT01109316|574944|P3|NOT COMPLETED|Study Period 2||1
237022|NCT01109316|574945|P2|NOT COMPLETED|Study Period 2||1
237023|NCT01109316|574946|P1|NOT COMPLETED|Study Period 2||1
237024|NCT01109316|574941|P6|COMPLETED|Study Period 2||19
237025|NCT01109316|574942|P5|COMPLETED|Study Period 2||20
237026|NCT01109316|574943|P4|COMPLETED|Study Period 2||20
237027|NCT01109316|574944|P3|COMPLETED|Study Period 2||18
237028|NCT01109316|574945|P2|COMPLETED|Study Period 2||21
237029|NCT01109316|574946|P1|COMPLETED|Study Period 2||21
237030|NCT01109316|574941|P6|STARTED|Study Period 2||20
237031|NCT01109316|574942|P5|STARTED|Study Period 2||20
237032|NCT01109316|574943|P4|STARTED|Study Period 2||21
237033|NCT01109316|574944|P3|STARTED|Study Period 2||19
237034|NCT01109316|574945|P2|STARTED|Study Period 2||22
237035|NCT01109316|574946|P1|STARTED|Study Period 2||22
237036|NCT01109316|574941|P6|NOT COMPLETED|Study Period 1||2
237037|NCT01109316|574942|P5|NOT COMPLETED|Study Period 1||2
237038|NCT01109316|574943|P4|NOT COMPLETED|Study Period 1||1
237039|NCT01109316|574944|P3|NOT COMPLETED|Study Period 1||3
237040|NCT01109316|574945|P2|NOT COMPLETED|Study Period 1||0
237041|NCT01109316|574946|P1|NOT COMPLETED|Study Period 1||0
237042|NCT01109316|574941|P6|COMPLETED|Study Period 1||20
237043|NCT01109316|574942|P5|COMPLETED|Study Period 1||20
237044|NCT01109316|574943|P4|COMPLETED|Study Period 1||21
237045|NCT01109316|574944|P3|COMPLETED|Study Period 1||19
237046|NCT01109316|574945|P2|COMPLETED|Study Period 1||22
237047|NCT01109316|574946|P1|COMPLETED|Study Period 1||22
237048|NCT01109316|574941|P6|Received at Least One Dose of Study Drug|Study Period 1||20
237049|NCT01109316|574942|P5|Received at Least One Dose of Study Drug|Study Period 1||22
237050|NCT01109316|574943|P4|Received at Least One Dose of Study Drug|Study Period 1||22
237051|NCT01109316|574944|P3|Received at Least One Dose of Study Drug|Study Period 1||22
237052|NCT01109316|574945|P2|Received at Least One Dose of Study Drug|Study Period 1||22
237053|NCT01109316|574946|P1|Received at Least One Dose of Study Drug|Study Period 1||22
237054|NCT01109316|574941|P6|STARTED|Study Period 1||22
237055|NCT01109316|574942|P5|STARTED|Study Period 1||22
237056|NCT01109316|574943|P4|STARTED|Study Period 1||22
237057|NCT01109316|574944|P3|STARTED|Study Period 1||22
237058|NCT01109316|574945|P2|STARTED|Study Period 1||22
237059|NCT01109316|574946|P1|STARTED|Study Period 1||22
237060|NCT01109173|574994|P4|NOT COMPLETED|Overall Study||93
237061|NCT01109173|574995|P3|NOT COMPLETED|Overall Study||101
237062|NCT01109173|574996|P2|NOT COMPLETED|Overall Study||86
237063|NCT01109173|574997|P1|NOT COMPLETED|Overall Study||88
237064|NCT01109173|574994|P4|COMPLETED|Overall Study||120
237065|NCT01109173|574995|P3|COMPLETED|Overall Study||110
237066|NCT01109173|574996|P2|COMPLETED|Overall Study||759
237067|NCT01109173|574997|P1|COMPLETED|Overall Study||763
237068|NCT01109173|574994|P4|STARTED|Overall Study||213
237069|NCT01109173|574995|P3|STARTED|Overall Study||211
237070|NCT01109173|574996|P2|STARTED|Overall Study||845
237071|NCT01109173|574997|P1|STARTED|Overall Study||851
237072|NCT01109147|575014|P3|NOT COMPLETED|Overall Study||10
237073|NCT01109147|575015|P2|NOT COMPLETED|Overall Study||3
237074|NCT01109147|575016|P1|NOT COMPLETED|Overall Study||2
237075|NCT01109147|575014|P3|COMPLETED|Overall Study|10 have been excluded of the results|26
237076|NCT01109147|575015|P2|COMPLETED|Overall Study|3 have been excluded of the results|11
237077|NCT01109147|575016|P1|COMPLETED|Overall Study|2 have been excluded of the results|15
237078|NCT01109147|575014|P3|STARTED|Overall Study||36
237079|NCT01109147|575015|P2|STARTED|Overall Study||14
237080|NCT01109147|575016|P1|STARTED|Overall Study||17
237081|NCT01109108|575026|P2|NOT COMPLETED|Overall Study||0
237082|NCT01109108|575027|P1|NOT COMPLETED|Overall Study||0
237083|NCT01109108|575026|P2|COMPLETED|Overall Study||4755
237084|NCT01109108|575027|P1|COMPLETED|Overall Study||4035
237085|NCT01109108|575026|P2|STARTED|Overall Study||4755
237086|NCT01109108|575027|P1|STARTED|Overall Study||4035
237087|NCT01109056|575035|P2|NOT COMPLETED|Overall Study||5
237088|NCT01109056|575036|P1|NOT COMPLETED|Overall Study||7
237089|NCT01109056|575035|P2|COMPLETED|Overall Study||53
237090|NCT01109056|575036|P1|COMPLETED|Overall Study||50
237091|NCT01109056|575035|P2|STARTED|Overall Study||58
237092|NCT01109056|575036|P1|STARTED|Overall Study||57
237093|NCT01109004|575049|P3|NOT COMPLETED|Overall Study||0
237094|NCT01109004|575050|P2|NOT COMPLETED|Overall Study||0
237095|NCT01109004|575051|P1|NOT COMPLETED|Overall Study||0
237096|NCT01109004|575049|P3|COMPLETED|Overall Study||257
237097|NCT01109004|575050|P2|COMPLETED|Overall Study||254
237098|NCT01109004|575051|P1|COMPLETED|Overall Study||247
237099|NCT01109004|575049|P3|STARTED|Overall Study||257
237100|NCT01109004|575050|P2|STARTED|Overall Study||254
237101|NCT01109004|575051|P1|STARTED|Overall Study||247
237102|NCT01108835|575088|P2|NOT COMPLETED|Overall Study||21
237103|NCT01108835|575089|P1|NOT COMPLETED|Overall Study||17
237104|NCT01108835|575088|P2|COMPLETED|Overall Study||69
237105|NCT01108835|575089|P1|COMPLETED|Overall Study||73
237106|NCT01108835|575088|P2|STARTED|Overall Study||90
237107|NCT01108835|575089|P1|STARTED|Overall Study||90
237108|NCT01108809|575103|P1|NOT COMPLETED|Overall Study||4
237109|NCT01108809|575103|P1|COMPLETED|Overall Study||291
237110|NCT01108809|575103|P1|STARTED|Overall Study||295
237111|NCT01108796|575120|P2|NOT COMPLETED|Overall Study||7
237112|NCT01108796|575121|P1|NOT COMPLETED|Overall Study||7
237113|NCT01108796|575120|P2|COMPLETED|Overall Study||1060
237114|NCT01108796|575121|P1|COMPLETED|Overall Study||767
237115|NCT01108796|575120|P2|STARTED|Overall Study||1067
237116|NCT01108796|575121|P1|STARTED|Overall Study||774
237117|NCT01108757|575155|P2|NOT COMPLETED|Overall Study||0
237118|NCT01108757|575156|P1|NOT COMPLETED|Overall Study||0
237119|NCT01108757|575155|P2|COMPLETED|Overall Study||26
237120|NCT01108757|575156|P1|COMPLETED|Overall Study||26
237121|NCT01108757|575155|P2|STARTED|Overall Study||26
237122|NCT01108757|575156|P1|STARTED|Overall Study||26
237123|NCT01108731|575164|P2|NOT COMPLETED|Overall Study||4
237124|NCT01108731|575165|P1|NOT COMPLETED|Overall Study||4
237125|NCT01108731|575164|P2|COMPLETED|Overall Study||13
237126|NCT01108731|575165|P1|COMPLETED|Overall Study||13
237127|NCT01108731|575164|P2|STARTED|Overall Study||17
237128|NCT01108731|575165|P1|STARTED|Overall Study||17
237129|NCT01108718|575177|P2|NOT COMPLETED|Received Second Intervention (2 Months)||0
237130|NCT01108718|575178|P1|NOT COMPLETED|Received Second Intervention (2 Months)||1
237131|NCT01108718|575177|P2|COMPLETED|Received Second Intervention (2 Months)||7
237132|NCT01108718|575178|P1|COMPLETED|Received Second Intervention (2 Months)||4
237133|NCT01108718|575177|P2|STARTED|Received Second Intervention (2 Months)||7
237134|NCT01108718|575178|P1|STARTED|Received Second Intervention (2 Months)|Used control mattress was delivered to participant at crossover causing her to withdraw.|5
237135|NCT01108718|575177|P2|NOT COMPLETED|Received First Intervention (2 Months)||0
237136|NCT01108718|575178|P1|NOT COMPLETED|Received First Intervention (2 Months)||0
237137|NCT01108718|575177|P2|COMPLETED|Received First Intervention (2 Months)||7
237138|NCT01108718|575178|P1|COMPLETED|Received First Intervention (2 Months)||5
237139|NCT01108718|575177|P2|STARTED|Received First Intervention (2 Months)||7
237140|NCT01108718|575178|P1|STARTED|Received First Intervention (2 Months)||5
237141|NCT01108523|575183|P1|NOT COMPLETED|Overall Study||4
237142|NCT01108523|575183|P1|COMPLETED|Overall Study||3
237143|NCT01108523|575183|P1|STARTED|Overall Study||7
237144|NCT01108510|575190|P2|NOT COMPLETED|Overall Study||268
237145|NCT01108510|575191|P1|NOT COMPLETED|Overall Study||279
237146|NCT01108510|575190|P2|COMPLETED|Overall Study||81
237147|NCT01108510|575191|P1|COMPLETED|Overall Study||70
237148|NCT01108510|575190|P2|STARTED|Overall Study||349
237149|NCT01108510|575191|P1|STARTED|Overall Study||349
237150|NCT01108458|575211|P1|NOT COMPLETED|Overall Study||1
237151|NCT01108458|575211|P1|COMPLETED|Overall Study||0
237152|NCT01108458|575211|P1|STARTED|Overall Study||1
237153|NCT01108445|575222|P2|NOT COMPLETED|Overall Study||49
237154|NCT01108445|575223|P1|NOT COMPLETED|Overall Study||56
237155|NCT01108445|575222|P2|COMPLETED|Overall Study||2
237156|NCT01108445|575223|P1|COMPLETED|Overall Study||1
237157|NCT01108445|575222|P2|STARTED|Overall Study||51
237158|NCT01108445|575223|P1|STARTED|Overall Study||57
237159|NCT01108406|575257|P1|NOT COMPLETED|Overall Study||0
237160|NCT01108406|575257|P1|COMPLETED|Overall Study||22
237161|NCT01108406|575257|P1|STARTED|Overall Study||22
237162|NCT01108341|575263|P1|NOT COMPLETED|Overall Study||5
237163|NCT01108341|575263|P1|COMPLETED|Overall Study||45
237164|NCT01108341|575263|P1|Safety Set (Enrolled and Treated)|Overall Study||49
237165|NCT01108341|575263|P1|STARTED|Overall Study||50
237166|NCT01108263|575270|P2|NOT COMPLETED|Overall Study||1
237167|NCT01108263|575271|P1|NOT COMPLETED|Overall Study||0
237168|NCT01108263|575270|P2|COMPLETED|Overall Study||2
237169|NCT01108263|575271|P1|COMPLETED|Overall Study||2
237170|NCT01108263|575270|P2|STARTED|Overall Study||3
237171|NCT01108263|575271|P1|STARTED|Overall Study||2
237172|NCT01108237|575281|P2|NOT COMPLETED|Overall Study||17
237173|NCT01108237|575282|P1|NOT COMPLETED|Overall Study||9
237174|NCT01108237|575281|P2|COMPLETED|Overall Study||84
237175|NCT01108237|575282|P1|COMPLETED|Overall Study|66 subjects underwent surgery per the protocol, however, only 64 met the primary end point.|64
237176|NCT01108237|575281|P2|STARTED|Overall Study||101
237177|NCT01108237|575282|P1|STARTED|Overall Study|78 subjects were consented with intent to treat, however, 73 had surgery.|73
237178|NCT01108185|575288|P1|NOT COMPLETED|Overall Study||27
237179|NCT01108185|575288|P1|COMPLETED|Overall Study||3154
237180|NCT01108185|575288|P1|Per Protocol Population|Overall Study||3181
237181|NCT01108185|575288|P1|STARTED|Overall Study||3181
237182|NCT01108094|575305|P4|NOT COMPLETED|Overall Study||0
237183|NCT01108094|575306|P3|NOT COMPLETED|Overall Study||0
237184|NCT01108094|575307|P2|NOT COMPLETED|Overall Study||0
237185|NCT01108094|575308|P1|NOT COMPLETED|Overall Study||3
237186|NCT01108094|575305|P4|COMPLETED|Overall Study||10
237187|NCT01108094|575306|P3|COMPLETED|Overall Study||4
237188|NCT01108094|575307|P2|COMPLETED|Overall Study||3
237189|NCT01108094|575308|P1|COMPLETED|Overall Study||9
237190|NCT01108094|575305|P4|STARTED|Overall Study||10
237191|NCT01108094|575306|P3|STARTED|Overall Study||4
237192|NCT01108094|575307|P2|STARTED|Overall Study||3
237193|NCT01108094|575308|P1|STARTED|Overall Study||12
237194|NCT01108081|575333|P4|NOT COMPLETED|Overall Study||4
237195|NCT01108081|575334|P3|NOT COMPLETED|Overall Study||0
237196|NCT01108081|575335|P2|NOT COMPLETED|Overall Study||2
237197|NCT01108081|575336|P1|NOT COMPLETED|Overall Study||2
237198|NCT01108081|575333|P4|COMPLETED|Overall Study||39
237199|NCT01108081|575334|P3|COMPLETED|Overall Study||38
237200|NCT01108081|575335|P2|COMPLETED|Overall Study||40
237201|NCT01108081|575336|P1|COMPLETED|Overall Study||44
237202|NCT01108081|575333|P4|STARTED|Overall Study||43
237203|NCT01108081|575334|P3|STARTED|Overall Study||38
237204|NCT01108081|575335|P2|STARTED|Overall Study||42
237205|NCT01108081|575336|P1|STARTED|Overall Study||46
237206|NCT01108068|575352|P2|NOT COMPLETED|Overall Study||0
237207|NCT01108068|575353|P1|NOT COMPLETED|Overall Study||6
237208|NCT01108068|575352|P2|COMPLETED|Overall Study||16
237209|NCT01108068|575353|P1|COMPLETED|Overall Study|Only 5 individuals were recruited into the Lithium treatment arm|4
237210|NCT01108068|575352|P2|STARTED|Overall Study||16
237211|NCT01108068|575353|P1|STARTED|Overall Study||10
237212|NCT01108055|575360|P1|NOT COMPLETED|Overall Study||15
237213|NCT01108055|575360|P1|COMPLETED|Overall Study||28
237214|NCT01108055|575360|P1|Eligible and Started Treatment|Overall Study||32
237215|NCT01108055|575360|P1|STARTED|Overall Study||43
237216|NCT01108003|575370|P2|NOT COMPLETED|Overall Study||0
237217|NCT01108003|575371|P1|NOT COMPLETED|Overall Study||0
237218|NCT01108003|575370|P2|COMPLETED|Overall Study||3
237219|NCT01108003|575371|P1|COMPLETED|Overall Study||4
237220|NCT01108003|575370|P2|STARTED|Overall Study||3
237221|NCT01108003|575371|P1|STARTED|Overall Study||4
237222|NCT01107964|575381|P2|NOT COMPLETED|Overall Study||1
237223|NCT01107964|575382|P1|NOT COMPLETED|Overall Study||1
237224|NCT01107964|575381|P2|COMPLETED|Overall Study||13
237225|NCT01107964|575382|P1|COMPLETED|Overall Study||12
237226|NCT01107964|575381|P2|STARTED|Overall Study||14
237227|NCT01107964|575382|P1|STARTED|Overall Study||13
237228|NCT01107925|575398|P6|NOT COMPLETED|Period 3||0
237229|NCT01107925|575399|P5|NOT COMPLETED|Period 3||0
237230|NCT01107925|575400|P4|NOT COMPLETED|Period 3||0
237231|NCT01107925|575401|P3|NOT COMPLETED|Period 3||0
237232|NCT01107925|575402|P2|NOT COMPLETED|Period 3||0
237233|NCT01107925|575403|P1|NOT COMPLETED|Period 3||0
237234|NCT01107925|575398|P6|COMPLETED|Period 3||20
237235|NCT01107925|575399|P5|COMPLETED|Period 3||0
237236|NCT01107925|575400|P4|COMPLETED|Period 3||16
237237|NCT01107925|575401|P3|COMPLETED|Period 3||15
237238|NCT01107925|575402|P2|COMPLETED|Period 3||17
237239|NCT01107925|575403|P1|COMPLETED|Period 3||0
237240|NCT01107925|575398|P6|Took at Least 1 Dose of Study Drug|Period 3||20
237241|NCT01107925|575399|P5|Took at Least 1 Dose of Study Drug|Period 3||0
237242|NCT01107925|575400|P4|Took at Least 1 Dose of Study Drug|Period 3||16
237243|NCT01107925|575401|P3|Took at Least 1 Dose of Study Drug|Period 3||15
237244|NCT01107925|575402|P2|Took at Least 1 Dose of Study Drug|Period 3||17
237245|NCT01107925|575403|P1|Took at Least 1 Dose of Study Drug|Period 3||0
237246|NCT01107925|575398|P6|STARTED|Period 3|5 mg prasugrel (Period 2, HBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|20
237247|NCT01107925|575399|P5|STARTED|Period 3||0
237248|NCT01107925|575400|P4|STARTED|Period 3|75 mg clopidogrel (Period 2, HBW treatment sequence) crossed over to 5 mg prasugrel (Period 3).|16
237249|NCT01107925|575401|P3|STARTED|Period 3|10 mg prasugrel (Period 2, LBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|15
237250|NCT01107925|575402|P2|STARTED|Period 3|75 mg clopidogrel (Period 2, LBW treatment sequence) crossed over to 10 mg prasugrel (Period 3).|17
237251|NCT01107925|575403|P1|STARTED|Period 3||0
237252|NCT01107925|575398|P6|NOT COMPLETED|Period 2||1
237253|NCT01107925|575399|P5|NOT COMPLETED|Period 2||0
237254|NCT01107925|575400|P4|NOT COMPLETED|Period 2||0
237255|NCT01107925|575401|P3|NOT COMPLETED|Period 2||0
237256|NCT01107925|575402|P2|NOT COMPLETED|Period 2||1
237257|NCT01107925|575403|P1|NOT COMPLETED|Period 2||0
237258|NCT01107925|575398|P6|COMPLETED|Period 2||16
237259|NCT01107925|575399|P5|COMPLETED|Period 2||0
237260|NCT01107925|575400|P4|COMPLETED|Period 2||20
237261|NCT01107925|575401|P3|COMPLETED|Period 2||17
237262|NCT01107925|575402|P2|COMPLETED|Period 2||15
237263|NCT01107925|575403|P1|COMPLETED|Period 2||0
237264|NCT01107925|575398|P6|Took at Least 1 Dose of Study Drug|Period 2||17
237265|NCT01107925|575399|P5|Took at Least 1 Dose of Study Drug|Period 2||0
237266|NCT01107925|575400|P4|Took at Least 1 Dose of Study Drug|Period 2||20
237267|NCT01107925|575401|P3|Took at Least 1 Dose of Study Drug|Period 2||17
237268|NCT01107925|575402|P2|Took at Least 1 Dose of Study Drug|Period 2||16
237269|NCT01107925|575403|P1|Took at Least 1 Dose of Study Drug|Period 2||0
237270|NCT01107925|575398|P6|STARTED|Period 2||17
237271|NCT01107925|575399|P5|STARTED|Period 2|10 mg prasugrel (Period 1, HBW treatment) switched to 5 mg prasugrel or 75 mg clopidogrel (Period 2)|0
237272|NCT01107925|575400|P4|STARTED|Period 2||20
237273|NCT01107925|575401|P3|STARTED|Period 2||17
237274|NCT01107925|575402|P2|STARTED|Period 2||16
237275|NCT01107925|575403|P1|STARTED|Period 2|5 mg prasugrel (Period 1, LBW treatment) switched to 10 mg prasugrel or 75 mg clopidogrel (Period 2)|0
237276|NCT01107925|575398|P6|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
237277|NCT01107925|575399|P5|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
237278|NCT01107925|575400|P4|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
237279|NCT01107925|575401|P3|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
237280|NCT01107925|575402|P2|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
237281|NCT01107925|575403|P1|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
237282|NCT01107925|575398|P6|COMPLETED|Period 1-Randomization up Through Day 12||0
237283|NCT01107925|575399|P5|COMPLETED|Period 1-Randomization up Through Day 12||37
237284|NCT01107925|575400|P4|COMPLETED|Period 1-Randomization up Through Day 12||0
237285|NCT01107925|575401|P3|COMPLETED|Period 1-Randomization up Through Day 12||0
237286|NCT01107925|575402|P2|COMPLETED|Period 1-Randomization up Through Day 12||0
237287|NCT01107925|575403|P1|COMPLETED|Period 1-Randomization up Through Day 12||33
237288|NCT01107925|575398|P6|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
237289|NCT01107925|575399|P5|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||38
237290|NCT01107925|575400|P4|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
237291|NCT01107925|575401|P3|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
237292|NCT01107925|575402|P2|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
237293|NCT01107925|575403|P1|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||34
237294|NCT01107925|575398|P6|STARTED|Period 1-Randomization up Through Day 12||0
237295|NCT01107925|575399|P5|STARTED|Period 1-Randomization up Through Day 12||38
237296|NCT01107925|575400|P4|STARTED|Period 1-Randomization up Through Day 12||0
237297|NCT01107925|575401|P3|STARTED|Period 1-Randomization up Through Day 12||0
237298|NCT01107925|575402|P2|STARTED|Period 1-Randomization up Through Day 12||0
237299|NCT01107925|575403|P1|STARTED|Period 1-Randomization up Through Day 12||34
237300|NCT01107912|575441|P6|NOT COMPLETED|Period 3||0
237301|NCT01107912|575442|P5|NOT COMPLETED|Period 3||0
237302|NCT01107912|575443|P4|NOT COMPLETED|Period 3||1
237303|NCT01107912|575444|P3|NOT COMPLETED|Period 3||1
237304|NCT01107912|575445|P2|NOT COMPLETED|Period 3||1
237305|NCT01107912|575446|P1|NOT COMPLETED|Period 3||0
237306|NCT01107912|575441|P6|COMPLETED|Period 3||41
237307|NCT01107912|575442|P5|COMPLETED|Period 3||0
237308|NCT01107912|575443|P4|COMPLETED|Period 3||37
237309|NCT01107912|575444|P3|COMPLETED|Period 3||35
237310|NCT01107912|575445|P2|COMPLETED|Period 3||34
237311|NCT01107912|575446|P1|COMPLETED|Period 3||0
237312|NCT01107912|575441|P6|STARTED|Period 3|Participants who received 5 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|41
237313|NCT01107912|575442|P5|STARTED|Period 3||0
237314|NCT01107912|575443|P4|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 5 mg prasugrel in Period 3|38
237315|NCT01107912|575444|P3|STARTED|Period 3|Participants who received 10 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|36
237316|NCT01107912|575445|P2|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 10 mg prasugrel in Period 3|35
237317|NCT01107912|575446|P1|STARTED|Period 3||0
237318|NCT01107912|575441|P6|NOT COMPLETED|Period 2||0
237319|NCT01107912|575442|P5|NOT COMPLETED|Period 2||0
237320|NCT01107912|575443|P4|NOT COMPLETED|Period 2||0
237321|NCT01107912|575444|P3|NOT COMPLETED|Period 2||1
237322|NCT01107912|575445|P2|NOT COMPLETED|Period 2||0
237323|NCT01107912|575446|P1|NOT COMPLETED|Period 2||0
237324|NCT01107912|575441|P6|COMPLETED|Period 2||38
237325|NCT01107912|575442|P5|COMPLETED|Period 2||0
237326|NCT01107912|575443|P4|COMPLETED|Period 2||41
237327|NCT01107912|575444|P3|COMPLETED|Period 2||35
237328|NCT01107912|575445|P2|COMPLETED|Period 2||36
237329|NCT01107912|575446|P1|COMPLETED|Period 2||0
237330|NCT01107912|575441|P6|STARTED|Period 2||38
237331|NCT01107912|575442|P5|STARTED|Period 2|Participants switched to either 5 mg prasugrel or 75 mg clopidogrel in Period 2.|0
237332|NCT01107912|575443|P4|STARTED|Period 2||41
237333|NCT01107912|575444|P3|STARTED|Period 2||36
237334|NCT01107912|575445|P2|STARTED|Period 2||36
237335|NCT01107912|575446|P1|STARTED|Period 2|Participants switched to either 10 mg prasugrel or 75 mg clopidogrel in Period 2.|0
237336|NCT01107912|575441|P6|NOT COMPLETED|Period 1||0
237337|NCT01107912|575442|P5|NOT COMPLETED|Period 1||3
237338|NCT01107912|575443|P4|NOT COMPLETED|Period 1||0
237339|NCT01107912|575444|P3|NOT COMPLETED|Period 1||0
237340|NCT01107912|575445|P2|NOT COMPLETED|Period 1||0
237341|NCT01107912|575446|P1|NOT COMPLETED|Period 1||1
237342|NCT01107912|575441|P6|COMPLETED|Period 1||0
237343|NCT01107912|575442|P5|COMPLETED|Period 1||79
237344|NCT01107912|575443|P4|COMPLETED|Period 1||0
237345|NCT01107912|575444|P3|COMPLETED|Period 1||0
237346|NCT01107912|575445|P2|COMPLETED|Period 1||0
237347|NCT01107912|575446|P1|COMPLETED|Period 1||72
237348|NCT01107912|575441|P6|Received at Least 1 Dose of Study Drug|Period 1||0
237349|NCT01107912|575442|P5|Received at Least 1 Dose of Study Drug|Period 1||82
237350|NCT01107912|575443|P4|Received at Least 1 Dose of Study Drug|Period 1||0
237351|NCT01107912|575444|P3|Received at Least 1 Dose of Study Drug|Period 1||0
237352|NCT01107912|575445|P2|Received at Least 1 Dose of Study Drug|Period 1||0
237353|NCT01107912|575446|P1|Received at Least 1 Dose of Study Drug|Period 1||73
237354|NCT01107912|575441|P6|STARTED|Period 1||0
237355|NCT01107912|575442|P5|STARTED|Period 1||82
237356|NCT01107912|575443|P4|STARTED|Period 1||0
237357|NCT01107912|575444|P3|STARTED|Period 1||0
237358|NCT01107912|575445|P2|STARTED|Period 1||0
237359|NCT01107912|575446|P1|STARTED|Period 1||73
237360|NCT01107899|575483|P3|NOT COMPLETED|Overall Study||4
237361|NCT01107899|575484|P2|NOT COMPLETED|Overall Study||0
237362|NCT01107899|575485|P1|NOT COMPLETED|Overall Study||5
237363|NCT01107899|575483|P3|COMPLETED|Overall Study||5
237364|NCT01107899|575484|P2|COMPLETED|Overall Study||10
237365|NCT01107899|575485|P1|COMPLETED|Overall Study||5
237366|NCT01107899|575483|P3|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|4
237367|NCT01107899|575484|P2|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|10
237368|NCT01107899|575485|P1|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|5
237369|NCT01107899|575483|P3|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|6
237370|NCT01107899|575484|P2|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|10
237371|NCT01107899|575485|P1|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|5
237372|NCT01107899|575483|P3|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|6
237373|NCT01107899|575484|P2|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|10
237374|NCT01107899|575485|P1|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|5
237375|NCT01107899|575483|P3|Received at Least One Dose of Study Drug|Overall Study||8
237376|NCT01107899|575484|P2|Received at Least One Dose of Study Drug|Overall Study||10
237377|NCT01107899|575485|P1|Received at Least One Dose of Study Drug|Overall Study||10
237378|NCT01107899|575483|P3|STARTED|Overall Study||9
237379|NCT01107899|575484|P2|STARTED|Overall Study||10
237380|NCT01107899|575485|P1|STARTED|Overall Study||10
237381|NCT01107886|575531|P2|NOT COMPLETED|Overall Study||214
237382|NCT01107886|575532|P1|NOT COMPLETED|Overall Study||202
237383|NCT01107886|575531|P2|COMPLETED|Overall Study|Completed subjects|7998
237384|NCT01107886|575532|P1|COMPLETED|Overall Study|Completed subjects|8078
237385|NCT01107886|575531|P2|STARTED|Overall Study|Randomized subjects|8212
237386|NCT01107886|575532|P1|STARTED|Overall Study|Randomized subjects|8280
237387|NCT01107834|575544|P2|NOT COMPLETED|Overall Study||0
237388|NCT01107834|575545|P1|NOT COMPLETED|Overall Study||0
237389|NCT01107834|575544|P2|COMPLETED|Overall Study||30
237390|NCT01107834|575545|P1|COMPLETED|Overall Study||30
237391|NCT01107834|575544|P2|STARTED|Overall Study||30
237392|NCT01107834|575545|P1|STARTED|Overall Study||30
237393|NCT01107743|575561|P1|NOT COMPLETED|Overall Study||46
237394|NCT01107743|575561|P1|COMPLETED|Overall Study||1245
237395|NCT01107743|575561|P1|STARTED|Overall Study||1291
237396|NCT01107730|575650|P3|NOT COMPLETED|Overall Study||0
237397|NCT01107730|575651|P2|NOT COMPLETED|Overall Study||0
237398|NCT01107730|575652|P1|NOT COMPLETED|Overall Study||0
237399|NCT01107730|575650|P3|COMPLETED|Overall Study||11
237400|NCT01107730|575651|P2|COMPLETED|Overall Study||11
237401|NCT01107730|575652|P1|COMPLETED|Overall Study||11
237402|NCT01107730|575650|P3|STARTED|Overall Study||11
237403|NCT01107730|575651|P2|STARTED|Overall Study||11
237404|NCT01107730|575652|P1|STARTED|Overall Study||11
237405|NCT01107665|575660|P1|NOT COMPLETED|Overall Study||49
237406|NCT01107665|575660|P1|COMPLETED|Overall Study||11
237407|NCT01107665|575660|P1|STARTED|Overall Study||60
237408|NCT01107535|575675|P1|NOT COMPLETED|Overall Study||5
237409|NCT01107535|575675|P1|COMPLETED|Overall Study||77
237410|NCT01107535|575675|P1|Number of Participants Analyzed|Overall Study||82
237411|NCT01107535|575675|P1|STARTED|Overall Study||82
237412|NCT01107457|575688|P6|NOT COMPLETED|Part B and C||120
237413|NCT01107457|575689|P5|NOT COMPLETED|Part B and C||0
237414|NCT01107457|575690|P4|NOT COMPLETED|Part B and C||0
237415|NCT01107457|575691|P3|NOT COMPLETED|Part B and C||0
237416|NCT01107457|575692|P2|NOT COMPLETED|Part B and C||0
237417|NCT01107457|575693|P1|NOT COMPLETED|Part B and C||0
237418|NCT01107457|575688|P6|COMPLETED|Part B and C|No participants completed the study as Part C was stopped.|0
237419|NCT01107457|575689|P5|COMPLETED|Part B and C||0
237420|NCT01107457|575690|P4|COMPLETED|Part B and C||0
237421|NCT01107457|575691|P3|COMPLETED|Part B and C||0
237422|NCT01107457|575692|P2|COMPLETED|Part B and C||0
237423|NCT01107457|575693|P1|COMPLETED|Part B and C||0
237424|NCT01107457|575688|P6|Post Treatment Safety Visits|Part B and C|Only participants with neutropenia entered the post treatment safety visits.|6
237425|NCT01107457|575689|P5|Post Treatment Safety Visits|Part B and C||0
237426|NCT01107457|575690|P4|Post Treatment Safety Visits|Part B and C||0
237427|NCT01107457|575691|P3|Post Treatment Safety Visits|Part B and C||0
237428|NCT01107457|575692|P2|Post Treatment Safety Visits|Part B and C||0
237429|NCT01107457|575693|P1|Post Treatment Safety Visits|Part B and C||0
237430|NCT01107457|575688|P6|Completed Part C|Part B and C|Part C was stopped once ixekizumab became available through marketing authorization.|0
237431|NCT01107457|575689|P5|Completed Part C|Part B and C||0
237432|NCT01107457|575690|P4|Completed Part C|Part B and C||0
237433|NCT01107457|575691|P3|Completed Part C|Part B and C||0
237434|NCT01107457|575692|P2|Completed Part C|Part B and C||0
237435|NCT01107457|575693|P1|Completed Part C|Part B and C||0
237436|NCT01107457|575688|P6|Completed Part B (Week 240)|Part B and C||74
237437|NCT01107457|575689|P5|Completed Part B (Week 240)|Part B and C||0
237438|NCT01107457|575690|P4|Completed Part B (Week 240)|Part B and C||0
237439|NCT01107457|575691|P3|Completed Part B (Week 240)|Part B and C||0
237440|NCT01107457|575692|P2|Completed Part B (Week 240)|Part B and C||0
237441|NCT01107457|575693|P1|Completed Part B (Week 240)|Part B and C||0
237442|NCT01107457|575688|P6|STARTED|Part B and C|80 and 120 mg ixekizumab were administered during Part B and C.|120
237443|NCT01107457|575689|P5|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
237444|NCT01107457|575690|P4|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
237445|NCT01107457|575691|P3|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
237446|NCT01107457|575692|P2|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
237447|NCT01107457|575693|P1|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
237448|NCT01107457|575688|P6|NOT COMPLETED|Part A||0
237449|NCT01107457|575689|P5|NOT COMPLETED|Part A||1
237450|NCT01107457|575690|P4|NOT COMPLETED|Part A||3
237451|NCT01107457|575691|P3|NOT COMPLETED|Part A||1
237452|NCT01107457|575692|P2|NOT COMPLETED|Part A||7
237453|NCT01107457|575693|P1|NOT COMPLETED|Part A||5
237454|NCT01107457|575688|P6|COMPLETED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
237455|NCT01107457|575689|P5|COMPLETED|Part A||27
237456|NCT01107457|575690|P4|COMPLETED|Part A||26
237457|NCT01107457|575691|P3|COMPLETED|Part A||29
237458|NCT01107457|575692|P2|COMPLETED|Part A||21
237459|NCT01107457|575693|P1|COMPLETED|Part A||22
237460|NCT01107457|575688|P6|Received at Least 1 Dose of Study Drug|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
237461|NCT01107457|575689|P5|Received at Least 1 Dose of Study Drug|Part A||28
237462|NCT01107457|575690|P4|Received at Least 1 Dose of Study Drug|Part A||29
237463|NCT01107457|575691|P3|Received at Least 1 Dose of Study Drug|Part A||30
237464|NCT01107457|575692|P2|Received at Least 1 Dose of Study Drug|Part A||28
237465|NCT01107457|575693|P1|Received at Least 1 Dose of Study Drug|Part A||27
237466|NCT01107457|575688|P6|STARTED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
237467|NCT01107457|575689|P5|STARTED|Part A||28
237468|NCT01107457|575690|P4|STARTED|Part A||29
237469|NCT01107457|575691|P3|STARTED|Part A||30
237470|NCT01107457|575692|P2|STARTED|Part A||28
237471|NCT01107457|575693|P1|STARTED|Part A||27
237472|NCT01107444|575821|P2|NOT COMPLETED|Overall Study||13
237473|NCT01107444|575822|P1|NOT COMPLETED|Overall Study||8
237474|NCT01107444|575821|P2|COMPLETED|Overall Study||47
237475|NCT01107444|575822|P1|COMPLETED|Overall Study||112
237476|NCT01107444|575821|P2|Received At Least 1 Dose of Study Drug|Overall Study||48
237477|NCT01107444|575822|P1|Received At Least 1 Dose of Study Drug|Overall Study||114
237478|NCT01107444|575821|P2|STARTED|Overall Study||60
237479|NCT01107444|575822|P1|STARTED|Overall Study||120
237480|NCT01107418|575856|P1|NOT COMPLETED|Overall Study||52
237481|NCT01107418|575856|P1|COMPLETED|Overall Study||0
237482|NCT01107418|575856|P1|STARTED|Overall Study||52
237483|NCT01107405|575929|P5|NOT COMPLETED|Overall Study||3
237484|NCT01107405|575930|P4|NOT COMPLETED|Overall Study||3
237485|NCT01107405|575931|P3|NOT COMPLETED|Overall Study||2
237486|NCT01107405|575932|P2|NOT COMPLETED|Overall Study||1
237487|NCT01107405|575933|P1|NOT COMPLETED|Overall Study||2
237488|NCT01107405|575929|P5|COMPLETED|Overall Study||17
237489|NCT01107405|575930|P4|COMPLETED|Overall Study||17
237490|NCT01107405|575931|P3|COMPLETED|Overall Study||18
237491|NCT01107405|575932|P2|COMPLETED|Overall Study||19
237492|NCT01107405|575933|P1|COMPLETED|Overall Study||19
237493|NCT01107405|575929|P5|STARTED|Overall Study||20
237494|NCT01107405|575930|P4|STARTED|Overall Study||20
237495|NCT01107405|575931|P3|STARTED|Overall Study||20
237496|NCT01107405|575932|P2|STARTED|Overall Study||20
237497|NCT01107405|575933|P1|STARTED|Overall Study||21
237498|NCT01107392|575972|P2|NOT COMPLETED|Overall Study||3
237499|NCT01107392|575973|P1|NOT COMPLETED|Overall Study||5
237500|NCT01107392|575972|P2|COMPLETED|Overall Study||154
237501|NCT01107392|575973|P1|COMPLETED|Overall Study||153
237502|NCT01107392|575972|P2|STARTED|Overall Study||157
237503|NCT01107392|575973|P1|STARTED|Overall Study||158
237504|NCT01107379|575985|P1|NOT COMPLETED|Overall Study||21
237505|NCT01107379|575985|P1|COMPLETED|Overall Study||182
237506|NCT01107379|575985|P1|STARTED|Overall Study||203
237507|NCT01107353|575996|P2|NOT COMPLETED|Overall Study||0
237508|NCT01107353|575997|P1|NOT COMPLETED|Overall Study||1
237509|NCT01107353|575996|P2|COMPLETED|Overall Study||20
237510|NCT01107353|575997|P1|COMPLETED|Overall Study||19
237511|NCT01107353|575996|P2|STARTED|Overall Study||20
237512|NCT01107353|575997|P1|STARTED|Overall Study||20
237513|NCT01107197|576005|P2|NOT COMPLETED|Overall Study||23
237514|NCT01107197|576006|P1|NOT COMPLETED|Overall Study||20
237515|NCT01107197|576005|P2|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 64 patients )|78
237516|NCT01107197|576006|P1|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 67 patients )|79
237517|NCT01107197|576005|P2|STARTED|Overall Study||101
237518|NCT01107197|576006|P1|STARTED|Overall Study||99
237519|NCT01107015|576028|P4|NOT COMPLETED|Overall Study||18
237520|NCT01107015|576029|P3|NOT COMPLETED|Overall Study||11
237521|NCT01107015|576030|P2|NOT COMPLETED|Overall Study||15
237522|NCT01107015|576031|P1|NOT COMPLETED|Overall Study||6
237523|NCT01107015|576028|P4|COMPLETED|Overall Study||62
237524|NCT01107015|576029|P3|COMPLETED|Overall Study||22
237525|NCT01107015|576030|P2|COMPLETED|Overall Study||23
237526|NCT01107015|576031|P1|COMPLETED|Overall Study||56
237527|NCT01107015|576028|P4|STARTED|Overall Study||80
237528|NCT01107015|576029|P3|STARTED|Overall Study||33
237529|NCT01107015|576030|P2|STARTED|Overall Study||38
237530|NCT01107015|576031|P1|STARTED|Overall Study||62
237531|NCT01106976|576041|P1|NOT COMPLETED|Overall Study||8
237532|NCT01106976|576041|P1|COMPLETED|Overall Study||59
237533|NCT01106976|576041|P1|STARTED|Overall Study||67
237534|NCT01106950|576045|P1|NOT COMPLETED|Overall Study||0
237535|NCT01106950|576045|P1|COMPLETED|Overall Study||15
237536|NCT01106950|576045|P1|STARTED|Overall Study||15
237537|NCT01106911|576055|P1|NOT COMPLETED|Overall Study||5
237538|NCT01106911|576055|P1|COMPLETED|Overall Study||1080
237539|NCT01106911|576055|P1|STARTED|Overall Study||1085
237540|NCT01106898|576059|P1|NOT COMPLETED|Overall Study||6
237541|NCT01106898|576059|P1|COMPLETED|Overall Study||94
237542|NCT01106898|576059|P1|STARTED|Overall Study||100
237543|NCT01106859|576063|P1|NOT COMPLETED|Overall Study||0
237544|NCT01106859|576063|P1|COMPLETED|Overall Study||40
237545|NCT01106859|576063|P1|STARTED|Overall Study|Intent to treat population and safety population are the same (40 participants)|40
237546|NCT01106846|576104|P2|NOT COMPLETED|Overall Study||1
237547|NCT01106846|576105|P1|NOT COMPLETED|Overall Study||0
237548|NCT01106846|576104|P2|COMPLETED|Overall Study||9
237549|NCT01106846|576105|P1|COMPLETED|Overall Study||12
237550|NCT01106846|576104|P2|STARTED|Overall Study||10
237551|NCT01106846|576105|P1|STARTED|Overall Study||12
237552|NCT01106833|576113|P2|NOT COMPLETED|Overall Study||0
237553|NCT01106833|576114|P1|NOT COMPLETED|Overall Study||0
237554|NCT01106833|576113|P2|COMPLETED|Overall Study||77
237555|NCT01106833|576114|P1|COMPLETED|Overall Study||74
237556|NCT01106833|576113|P2|STARTED|Overall Study||77
237557|NCT01106833|576114|P1|STARTED|Overall Study||74
237558|NCT01106690|576155|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
237559|NCT01106690|576156|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
237560|NCT01106690|576157|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
237561|NCT01106690|576155|P3|COMPLETED|Extension Period: Week 26 to Week 52||89
237562|NCT01106690|576156|P2|COMPLETED|Extension Period: Week 26 to Week 52||96
237563|NCT01106690|576157|P1|COMPLETED|Extension Period: Week 26 to Week 52||78
237564|NCT01106690|576155|P3|STARTED|Extension Period: Week 26 to Week 52|5 pts completed core but did not exter ext: lost to f/u(1), not spec(2), AE(1), eGFR criteria(1).|96
237565|NCT01106690|576156|P2|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|103
237566|NCT01106690|576157|P1|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|90
237567|NCT01106690|576155|P3|NOT COMPLETED|Core Period: Baseline to Week 26||13
237568|NCT01106690|576156|P2|NOT COMPLETED|Core Period: Baseline to Week 26||9
237569|NCT01106690|576157|P1|NOT COMPLETED|Core Period: Baseline to Week 26||24
237570|NCT01106690|576155|P3|COMPLETED|Core Period: Baseline to Week 26||101
237571|NCT01106690|576156|P2|COMPLETED|Core Period: Baseline to Week 26||104
237572|NCT01106690|576157|P1|COMPLETED|Core Period: Baseline to Week 26||91
237573|NCT01106690|576155|P3|STARTED|Core Period: Baseline to Week 26||114
237574|NCT01106690|576156|P2|STARTED|Core Period: Baseline to Week 26||113
237575|NCT01106690|576157|P1|STARTED|Core Period: Baseline to Week 26||115
237576|NCT01106677|576193|P4|NOT COMPLETED|Extension Period: Week 26 to Week 52||28
237577|NCT01106677|576194|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||22
237578|NCT01106677|576195|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
237579|NCT01106677|576196|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||15
237580|NCT01106677|576193|P4|COMPLETED|Extension Period: Week 26 to Week 52||285
237581|NCT01106677|576194|P3|COMPLETED|Extension Period: Week 26 to Week 52||299
237582|NCT01106677|576195|P2|COMPLETED|Extension Period: Week 26 to Week 52||298
237583|NCT01106677|576196|P1|COMPLETED|Extension Period: Week 26 to Week 52||138
237584|NCT01106677|576193|P4|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(3), physician decision(2), lost to f/u(1).|313
237585|NCT01106677|576194|P3|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: not specified(1), withdrawal by subject(1).|321
237586|NCT01106677|576195|P2|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(5), withdrawal by subject(1).|316
237587|NCT01106677|576196|P1|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: protcol violation(1), lost to f/u(1).|153
237588|NCT01106677|576193|P4|NOT COMPLETED|Core Period: Baseline to Week 26||47
237589|NCT01106677|576194|P3|NOT COMPLETED|Core Period: Baseline to Week 26||44
237590|NCT01106677|576195|P2|NOT COMPLETED|Core Period: Baseline to Week 26||46
237591|NCT01106677|576196|P1|NOT COMPLETED|Core Period: Baseline to Week 26||28
237592|NCT01106677|576193|P4|COMPLETED|Core Period: Baseline to Week 26||319
237593|NCT01106677|576194|P3|COMPLETED|Core Period: Baseline to Week 26||323
237594|NCT01106677|576195|P2|COMPLETED|Core Period: Baseline to Week 26||322
237595|NCT01106677|576196|P1|COMPLETED|Core Period: Baseline to Week 26||155
237596|NCT01106677|576193|P4|STARTED|Core Period: Baseline to Week 26||366
237597|NCT01106677|576194|P3|STARTED|Core Period: Baseline to Week 26||367
237598|NCT01106677|576195|P2|STARTED|Core Period: Baseline to Week 26||368
237599|NCT01106677|576196|P1|STARTED|Core Period: Baseline to Week 26||183
237600|NCT01106651|576259|P3|NOT COMPLETED|Overall Study||58
237601|NCT01106651|576260|P2|NOT COMPLETED|Overall Study||57
237602|NCT01106651|576261|P1|NOT COMPLETED|Overall Study||79
237603|NCT01106651|576259|P3|COMPLETED|Overall Study||178
237604|NCT01106651|576260|P2|COMPLETED|Overall Study||184
237605|NCT01106651|576261|P1|COMPLETED|Overall Study||158
237606|NCT01106651|576259|P3|STARTED|Overall Study||236
237607|NCT01106651|576260|P2|STARTED|Overall Study||241
237608|NCT01106651|576261|P1|STARTED|Overall Study||237
237609|NCT01106625|576314|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||17
237610|NCT01106625|576315|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
237611|NCT01106625|576316|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||29
237612|NCT01106625|576314|P3|COMPLETED|Extension Period: Week 26 to Week 52||111
237613|NCT01106625|576315|P2|COMPLETED|Extension Period: Week 26 to Week 52||109
237614|NCT01106625|576316|P1|COMPLETED|Extension Period: Week 26 to Week 52||90
237615|NCT01106625|576314|P3|STARTED|Extension Period: Week 26 to Week 52|1 pt discontinued last day of core: withdrawal by subject (1).|128
237616|NCT01106625|576315|P2|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued last day of core: adverse event (1), not specified (1).|127
237617|NCT01106625|576316|P1|STARTED|Extension Period: Week 26 to Week 52|4 pts discontinued last day of core: physician decision (1), noncompliance (1), not specified (2).|119
237618|NCT01106625|576314|P3|NOT COMPLETED|Core Period: Baseline to Week 26||27
237619|NCT01106625|576315|P2|NOT COMPLETED|Core Period: Baseline to Week 26||28
237620|NCT01106625|576316|P1|NOT COMPLETED|Core Period: Baseline to Week 26||33
237621|NCT01106625|576314|P3|COMPLETED|Core Period: Baseline to Week 26||129
237622|NCT01106625|576315|P2|COMPLETED|Core Period: Baseline to Week 26||129
237623|NCT01106625|576316|P1|COMPLETED|Core Period: Baseline to Week 26||123
237624|NCT01106625|576314|P3|STARTED|Core Period: Baseline to Week 26||156
237625|NCT01106625|576315|P2|STARTED|Core Period: Baseline to Week 26||157
237626|NCT01106625|576316|P1|STARTED|Core Period: Baseline to Week 26||156
237627|NCT01106586|576347|P2|NOT COMPLETED|Overall Study||285
237628|NCT01106586|576348|P1|NOT COMPLETED|Overall Study||285
237629|NCT01106586|576347|P2|COMPLETED|Overall Study||70
237630|NCT01106586|576348|P1|COMPLETED|Overall Study||68
237631|NCT01106586|576347|P2|STARTED|Overall Study||355
237632|NCT01106586|576348|P1|STARTED|Overall Study||353
237633|NCT01106534|576366|P1|NOT COMPLETED|Overall Study||37
237634|NCT01106534|576366|P1|COMPLETED|Overall Study||2960
237635|NCT01106534|576366|P1|STARTED|Overall Study||2997
237636|NCT01106456|576389|P2|NOT COMPLETED|Overall Study||124
237637|NCT01106456|576390|P1|NOT COMPLETED|Overall Study||103
237638|NCT01106456|576389|P2|COMPLETED|Overall Study||96
237639|NCT01106456|576390|P1|COMPLETED|Overall Study||140
237640|NCT01106456|576389|P2|STARTED|Overall Study||220
237641|NCT01106456|576390|P1|STARTED|Overall Study||243
237642|NCT01106430|576398|P2|NOT COMPLETED|Overall Study||33
237643|NCT01106430|576399|P1|NOT COMPLETED|Overall Study||33
237644|NCT01106430|576398|P2|COMPLETED|Overall Study||101
237645|NCT01106430|576399|P1|COMPLETED|Overall Study||100
237646|NCT01106430|576398|P2|STARTED|Overall Study||134
237647|NCT01106430|576399|P1|STARTED|Overall Study||133
237648|NCT01106404|576421|P2|NOT COMPLETED|Period II (Second 6 Weeks)||0
237649|NCT01106404|576422|P1|NOT COMPLETED|Period II (Second 6 Weeks)||0
237650|NCT01106404|576421|P2|COMPLETED|Period II (Second 6 Weeks)||38
237651|NCT01106404|576422|P1|COMPLETED|Period II (Second 6 Weeks)||33
237652|NCT01106404|576421|P2|STARTED|Period II (Second 6 Weeks)||38
237653|NCT01106404|576422|P1|STARTED|Period II (Second 6 Weeks)||33
237654|NCT01106404|576421|P2|NOT COMPLETED|Period I (First 6 Weeks)||2
237655|NCT01106404|576422|P1|NOT COMPLETED|Period I (First 6 Weeks)||3
237656|NCT01106404|576421|P2|COMPLETED|Period I (First 6 Weeks)||38
237657|NCT01106404|576422|P1|COMPLETED|Period I (First 6 Weeks)||33
237658|NCT01106404|576421|P2|STARTED|Period I (First 6 Weeks)||40
237659|NCT01106404|576422|P1|STARTED|Period I (First 6 Weeks)||36
237660|NCT01106391|576435|P1|NOT COMPLETED|Overall Study||0
237661|NCT01106391|576435|P1|COMPLETED|Overall Study||60
237662|NCT01106391|576435|P1|STARTED|Overall Study||60
237663|NCT01106352|576445|P5|NOT COMPLETED|Overall Study||8
237664|NCT01106352|576446|P4|NOT COMPLETED|Overall Study||13
237665|NCT01106352|576447|P3|NOT COMPLETED|Overall Study||2
237666|NCT01106352|576448|P2|NOT COMPLETED|Overall Study||0
237667|NCT01106352|576449|P1|NOT COMPLETED|Overall Study||1
237668|NCT01106352|576445|P5|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|9
237669|NCT01106352|576446|P4|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|23
237670|NCT01106352|576447|P3|COMPLETED|Overall Study||5
237671|NCT01106352|576448|P2|COMPLETED|Overall Study||3
237672|NCT01106352|576449|P1|COMPLETED|Overall Study||6
237673|NCT01106352|576445|P5|Completed Safety Cohort|Overall Study||9
237674|NCT01106352|576446|P4|Completed Safety Cohort|Overall Study||23
237675|NCT01106352|576447|P3|Completed Safety Cohort|Overall Study||0
237676|NCT01106352|576448|P2|Completed Safety Cohort|Overall Study||0
237677|NCT01106352|576449|P1|Completed Safety Cohort|Overall Study||0
237678|NCT01106352|576445|P5|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|13
237679|NCT01106352|576446|P4|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|33
237680|NCT01106352|576447|P3|Treated Safety Cohort|Overall Study||0
237681|NCT01106352|576448|P2|Treated Safety Cohort|Overall Study||0
237682|NCT01106352|576449|P1|Treated Safety Cohort|Overall Study||0
237683|NCT01106352|576445|P5|Started Safety Cohort|Overall Study||17
237684|NCT01106352|576446|P4|Started Safety Cohort|Overall Study||36
237685|NCT01106352|576447|P3|Started Safety Cohort|Overall Study||0
237686|NCT01106352|576448|P2|Started Safety Cohort|Overall Study||0
237687|NCT01106352|576449|P1|Started Safety Cohort|Overall Study||0
237688|NCT01106352|576445|P5|Completed Dose Escalation|Overall Study||0
237689|NCT01106352|576446|P4|Completed Dose Escalation|Overall Study||0
237690|NCT01106352|576447|P3|Completed Dose Escalation|Overall Study||5
237691|NCT01106352|576448|P2|Completed Dose Escalation|Overall Study||3
237692|NCT01106352|576449|P1|Completed Dose Escalation|Overall Study||6
237693|NCT01106352|576445|P5|Started Dose Escalation|Overall Study||0
237694|NCT01106352|576446|P4|Started Dose Escalation|Overall Study||0
237695|NCT01106352|576447|P3|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
237696|NCT01106352|576448|P2|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|3
237697|NCT01106352|576449|P1|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
237698|NCT01106352|576445|P5|STARTED|Overall Study||17
237699|NCT01106352|576446|P4|STARTED|Overall Study||36
237700|NCT01106352|576447|P3|STARTED|Overall Study||7
237701|NCT01106352|576448|P2|STARTED|Overall Study||3
237702|NCT01106352|576449|P1|STARTED|Overall Study||7
237703|NCT01106326|576535|P1|NOT COMPLETED|Overall Study||2
237704|NCT01106326|576535|P1|COMPLETED|Overall Study||28
237705|NCT01106326|576535|P1|STARTED|Overall Study||30
237706|NCT01106287|576545|P4|NOT COMPLETED|Overall Study||0
237707|NCT01106287|576546|P3|NOT COMPLETED|Overall Study||0
237708|NCT01106287|576547|P2|NOT COMPLETED|Overall Study||0
237709|NCT01106287|576548|P1|NOT COMPLETED|Overall Study||1
237710|NCT01106287|576545|P4|COMPLETED|Overall Study||3
237711|NCT01106287|576546|P3|COMPLETED|Overall Study||3
237712|NCT01106287|576547|P2|COMPLETED|Overall Study||3
237713|NCT01106287|576548|P1|COMPLETED|Overall Study||3
237714|NCT01106287|576545|P4|STARTED|Overall Study||3
237715|NCT01106287|576546|P3|STARTED|Overall Study||3
237716|NCT01106287|576547|P2|STARTED|Overall Study||3
237717|NCT01106287|576548|P1|STARTED|Overall Study|One participant that discontinued the study due to a pre-treatment adverse event was replaced.|4
237718|NCT01106248|576568|P1|NOT COMPLETED|Overall Study||3
237719|NCT01106248|576568|P1|COMPLETED|Overall Study||23
237720|NCT01106248|576568|P1|STARTED|Overall Study||26
237721|NCT01106157|576576|P2|NOT COMPLETED|Overall Study||0
237722|NCT01106157|576577|P1|NOT COMPLETED|Overall Study||1
237723|NCT01106157|576576|P2|COMPLETED|Overall Study||8
237724|NCT01106157|576577|P1|COMPLETED|Overall Study||16
237725|NCT01106157|576576|P2|STARTED|Overall Study||8
237726|NCT01106157|576577|P1|STARTED|Overall Study||17
237727|NCT01106092|576605|P4|NOT COMPLETED|Overall Study||1
237728|NCT01106092|576606|P3|NOT COMPLETED|Overall Study||0
237729|NCT01106092|576607|P2|NOT COMPLETED|Overall Study||0
237730|NCT01106092|576608|P1|NOT COMPLETED|Overall Study||0
237731|NCT01106092|576605|P4|COMPLETED|Overall Study||77
237732|NCT01106092|576606|P3|COMPLETED|Overall Study||78
237733|NCT01106092|576607|P2|COMPLETED|Overall Study||78
237734|NCT01106092|576608|P1|COMPLETED|Overall Study||78
237735|NCT01106092|576605|P4|STARTED|Overall Study||78
237736|NCT01106092|576606|P3|STARTED|Overall Study||78
237737|NCT01106092|576607|P2|STARTED|Overall Study||78
237738|NCT01106092|576608|P1|STARTED|Overall Study||78
237739|NCT01106040|576686|P1|NOT COMPLETED|Overall Study||11
237740|NCT01106040|576686|P1|COMPLETED|Overall Study||152
237741|NCT01106040|576686|P1|STARTED|Overall Study||163
237742|NCT01106027|576691|P1|NOT COMPLETED|Overall Study||1
237743|NCT01106027|576691|P1|COMPLETED|Overall Study||1
237744|NCT01106027|576691|P1|STARTED|Overall Study||2
237745|NCT01106014|576697|P2|NOT COMPLETED|Overall Study||330
237746|NCT01106014|576698|P1|NOT COMPLETED|Overall Study||285
237747|NCT01106014|576697|P2|COMPLETED|Overall Study||252
237748|NCT01106014|576698|P1|COMPLETED|Overall Study||289
237749|NCT01106014|576697|P2|STARTED|Overall Study||582
237750|NCT01106014|576698|P1|STARTED|Overall Study||574
237751|NCT01105975|576718|P10|NOT COMPLETED|Overall Study||9
237752|NCT01105975|576719|P9|NOT COMPLETED|Overall Study||6
237753|NCT01105975|576720|P8|NOT COMPLETED|Overall Study||7
237754|NCT01105975|576721|P7|NOT COMPLETED|Overall Study||8
237755|NCT01105975|576722|P6|NOT COMPLETED|Overall Study||5
237756|NCT01105975|576723|P5|NOT COMPLETED|Overall Study||6
237757|NCT01105975|576724|P4|NOT COMPLETED|Overall Study||2
237758|NCT01105975|576725|P3|NOT COMPLETED|Overall Study||10
237759|NCT01105975|576726|P2|NOT COMPLETED|Overall Study||5
237760|NCT01105975|576727|P1|NOT COMPLETED|Overall Study||5
237761|NCT01105975|576718|P10|COMPLETED|Overall Study||32
237762|NCT01105975|576719|P9|COMPLETED|Overall Study||34
237763|NCT01105975|576720|P8|COMPLETED|Overall Study||33
237764|NCT01105975|576721|P7|COMPLETED|Overall Study||34
237765|NCT01105975|576722|P6|COMPLETED|Overall Study||30
237766|NCT01105975|576723|P5|COMPLETED|Overall Study||35
237767|NCT01105975|576724|P4|COMPLETED|Overall Study||36
237768|NCT01105975|576725|P3|COMPLETED|Overall Study||32
237769|NCT01105975|576726|P2|COMPLETED|Overall Study||34
237770|NCT01105975|576727|P1|COMPLETED|Overall Study||35
237771|NCT01105975|576718|P10|Took at Least One Dose of Study Drug|Overall Study||41
237772|NCT01105975|576719|P9|Took at Least One Dose of Study Drug|Overall Study||39
237773|NCT01105975|576720|P8|Took at Least One Dose of Study Drug|Overall Study||40
237774|NCT01105975|576721|P7|Took at Least One Dose of Study Drug|Overall Study||41
237775|NCT01105975|576722|P6|Took at Least One Dose of Study Drug|Overall Study||35
237776|NCT01105975|576723|P5|Took at Least One Dose of Study Drug|Overall Study||41
237777|NCT01105975|576724|P4|Took at Least One Dose of Study Drug|Overall Study||38
237778|NCT01105975|576725|P3|Took at Least One Dose of Study Drug|Overall Study||40
237779|NCT01105975|576726|P2|Took at Least One Dose of Study Drug|Overall Study||38
237780|NCT01105975|576727|P1|Took at Least One Dose of Study Drug|Overall Study||40
237781|NCT01105975|576718|P10|STARTED|Overall Study||41
237782|NCT01105975|576719|P9|STARTED|Overall Study||40
237783|NCT01105975|576720|P8|STARTED|Overall Study||40
237784|NCT01105975|576721|P7|STARTED|Overall Study||42
237785|NCT01105975|576722|P6|STARTED|Overall Study||35
237786|NCT01105975|576723|P5|STARTED|Overall Study||41
237787|NCT01105975|576724|P4|STARTED|Overall Study||38
237788|NCT01105975|576725|P3|STARTED|Overall Study||42
237789|NCT01105975|576726|P2|STARTED|Overall Study||39
237790|NCT01105975|576727|P1|STARTED|Overall Study||40
237791|NCT01105936|576875|P4|NOT COMPLETED|Period 3||0
237792|NCT01105936|576876|P3|NOT COMPLETED|Period 3||0
237793|NCT01105936|576877|P2|NOT COMPLETED|Period 3||2
237794|NCT01105936|576878|P1|NOT COMPLETED|Period 3||0
237795|NCT01105936|576875|P4|COMPLETED|Period 3||7
237796|NCT01105936|576876|P3|COMPLETED|Period 3||7
237797|NCT01105936|576877|P2|COMPLETED|Period 3||6
237798|NCT01105936|576878|P1|COMPLETED|Period 3||7
237799|NCT01105936|576875|P4|STARTED|Period 3||7
237800|NCT01105936|576876|P3|STARTED|Period 3||7
237801|NCT01105936|576877|P2|STARTED|Period 3||8
237802|NCT01105936|576878|P1|STARTED|Period 3||7
237803|NCT01105936|576875|P4|NOT COMPLETED|Wash-out Period 2||0
237804|NCT01105936|576876|P3|NOT COMPLETED|Wash-out Period 2||0
237805|NCT01105936|576877|P2|NOT COMPLETED|Wash-out Period 2||0
237806|NCT01105936|576878|P1|NOT COMPLETED|Wash-out Period 2||0
237807|NCT01105936|576875|P4|COMPLETED|Wash-out Period 2||7
237808|NCT01105936|576876|P3|COMPLETED|Wash-out Period 2||7
237809|NCT01105936|576877|P2|COMPLETED|Wash-out Period 2||8
237810|NCT01105936|576878|P1|COMPLETED|Wash-out Period 2||7
237811|NCT01105936|576875|P4|STARTED|Wash-out Period 2||7
237812|NCT01105936|576876|P3|STARTED|Wash-out Period 2||7
237813|NCT01105936|576877|P2|STARTED|Wash-out Period 2||8
237814|NCT01105936|576878|P1|STARTED|Wash-out Period 2||7
237815|NCT01105936|576875|P4|NOT COMPLETED|Period 2||0
237816|NCT01105936|576876|P3|NOT COMPLETED|Period 2||0
237817|NCT01105936|576877|P2|NOT COMPLETED|Period 2||0
237818|NCT01105936|576878|P1|NOT COMPLETED|Period 2||1
237819|NCT01105936|576875|P4|COMPLETED|Period 2||7
237820|NCT01105936|576876|P3|COMPLETED|Period 2||7
237821|NCT01105936|576877|P2|COMPLETED|Period 2||8
237822|NCT01105936|576878|P1|COMPLETED|Period 2||7
237823|NCT01105936|576875|P4|STARTED|Period 2||7
237824|NCT01105936|576876|P3|STARTED|Period 2||7
237825|NCT01105936|576877|P2|STARTED|Period 2||8
237826|NCT01105936|576878|P1|STARTED|Period 2||8
237827|NCT01105936|576875|P4|NOT COMPLETED|Wash-out Period 1||0
237828|NCT01105936|576876|P3|NOT COMPLETED|Wash-out Period 1||0
237829|NCT01105936|576877|P2|NOT COMPLETED|Wash-out Period 1||0
237830|NCT01105936|576878|P1|NOT COMPLETED|Wash-out Period 1||0
237831|NCT01105936|576875|P4|COMPLETED|Wash-out Period 1||7
237832|NCT01105936|576876|P3|COMPLETED|Wash-out Period 1||7
237833|NCT01105936|576877|P2|COMPLETED|Wash-out Period 1||8
237834|NCT01105936|576878|P1|COMPLETED|Wash-out Period 1||8
237835|NCT01105936|576875|P4|STARTED|Wash-out Period 1||7
237836|NCT01105936|576876|P3|STARTED|Wash-out Period 1||7
237837|NCT01105936|576877|P2|STARTED|Wash-out Period 1||8
237838|NCT01105936|576878|P1|STARTED|Wash-out Period 1||8
237839|NCT01105936|576875|P4|NOT COMPLETED|Period 1||1
237840|NCT01105936|576876|P3|NOT COMPLETED|Period 1||0
237841|NCT01105936|576877|P2|NOT COMPLETED|Period 1||0
237842|NCT01105936|576878|P1|NOT COMPLETED|Period 1||0
237843|NCT01105936|576875|P4|COMPLETED|Period 1||7
237844|NCT01105936|576876|P3|COMPLETED|Period 1||7
237845|NCT01105936|576877|P2|COMPLETED|Period 1||8
237846|NCT01105936|576878|P1|COMPLETED|Period 1||8
237847|NCT01105936|576875|P4|STARTED|Period 1||8
237848|NCT01105936|576876|P3|STARTED|Period 1||7
237849|NCT01105936|576877|P2|STARTED|Period 1||8
237850|NCT01105936|576878|P1|STARTED|Period 1||8
237851|NCT01105767|576907|P3|NOT COMPLETED|Overall Study||1184
237852|NCT01105767|576908|P2|NOT COMPLETED|Overall Study||1614
237853|NCT01105767|576909|P1|NOT COMPLETED|Overall Study||1160
237854|NCT01105767|576907|P3|COMPLETED|Overall Study||8846
237855|NCT01105767|576908|P2|COMPLETED|Overall Study||9250
237856|NCT01105767|576909|P1|COMPLETED|Overall Study||8155
237857|NCT01105767|576907|P3|STARTED|Overall Study||10030
237858|NCT01105767|576908|P2|STARTED|Overall Study||10864
237859|NCT01105767|576909|P1|STARTED|Overall Study||9315
237860|NCT01105754|576922|P2|NOT COMPLETED|Overall Study||12
237861|NCT01105754|576923|P1|NOT COMPLETED|Overall Study||15
237862|NCT01105754|576922|P2|COMPLETED|Overall Study||307
237863|NCT01105754|576923|P1|COMPLETED|Overall Study||304
237864|NCT01105754|576922|P2|STARTED|Overall Study||319
237865|NCT01105754|576923|P1|STARTED|Overall Study||319
237866|NCT01105702|576931|P1|NOT COMPLETED|Overall Study||18
237867|NCT01105702|576931|P1|COMPLETED|Overall Study||10
237868|NCT01105702|576931|P1|STARTED|Overall Study||28
237869|NCT01105650|576941|P4|NOT COMPLETED|Overall Study||0
237870|NCT01105650|576942|P3|NOT COMPLETED|Overall Study||0
237871|NCT01105650|576943|P2|NOT COMPLETED|Overall Study||0
237872|NCT01105650|576944|P1|NOT COMPLETED|Overall Study||0
237873|NCT01105650|576941|P4|COMPLETED|Overall Study||0
237874|NCT01105650|576942|P3|COMPLETED|Overall Study||7
237875|NCT01105650|576943|P2|COMPLETED|Overall Study||3
237876|NCT01105650|576944|P1|COMPLETED|Overall Study||3
237877|NCT01105650|576941|P4|STARTED|Overall Study|Arm 3 was determined to be successful, thus eliminating the need to test Arm 4.|0
237878|NCT01105650|576942|P3|STARTED|Overall Study||7
237879|NCT01105650|576943|P2|STARTED|Overall Study||3
237880|NCT01105650|576944|P1|STARTED|Overall Study||3
237881|NCT01105533|576961|P9|NOT COMPLETED|Overall Study||12
237882|NCT01105533|576962|P8|NOT COMPLETED|Overall Study||4
237883|NCT01105533|576963|P7|NOT COMPLETED|Overall Study||8
237884|NCT01105533|576964|P6|NOT COMPLETED|Overall Study||7
237885|NCT01105533|576965|P5|NOT COMPLETED|Overall Study||7
237886|NCT01105533|576966|P4|NOT COMPLETED|Overall Study||3
237887|NCT01105533|576967|P3|NOT COMPLETED|Overall Study||3
237888|NCT01105533|576968|P2|NOT COMPLETED|Overall Study||1
237889|NCT01105533|576969|P1|NOT COMPLETED|Overall Study||1
237890|NCT01105533|576961|P9|COMPLETED|Overall Study||0
237891|NCT01105533|576962|P8|COMPLETED|Overall Study||0
237892|NCT01105533|576963|P7|COMPLETED|Overall Study||0
237893|NCT01105533|576964|P6|COMPLETED|Overall Study||0
237894|NCT01105533|576965|P5|COMPLETED|Overall Study||0
237895|NCT01105533|576966|P4|COMPLETED|Overall Study||0
237896|NCT01105533|576967|P3|COMPLETED|Overall Study||0
237897|NCT01105533|576968|P2|COMPLETED|Overall Study||0
237898|NCT01105533|576969|P1|COMPLETED|Overall Study||0
237899|NCT01105533|576961|P9|STARTED|Overall Study||12
237900|NCT01105533|576962|P8|STARTED|Overall Study||4
237901|NCT01105533|576963|P7|STARTED|Overall Study||8
237902|NCT01105533|576964|P6|STARTED|Overall Study||7
237903|NCT01105533|576965|P5|STARTED|Overall Study||7
237904|NCT01105533|576966|P4|STARTED|Overall Study||3
237905|NCT01105533|576967|P3|STARTED|Overall Study||3
237906|NCT01105533|576968|P2|STARTED|Overall Study||1
237907|NCT01105533|576969|P1|STARTED|Overall Study||1
237908|NCT01105377|577059|P2|NOT COMPLETED|Overall Study||1
237909|NCT01105377|577060|P1|NOT COMPLETED|Overall Study||0
237910|NCT01105377|577059|P2|COMPLETED|Overall Study||22
237911|NCT01105377|577060|P1|COMPLETED|Overall Study||24
237912|NCT01105377|577059|P2|STARTED|Overall Study||23
237913|NCT01105377|577060|P1|STARTED|Overall Study||24
237914|NCT01105312|577071|P3|NOT COMPLETED|Overall Study||0
237915|NCT01105312|577072|P2|NOT COMPLETED|Overall Study||0
237916|NCT01105312|577073|P1|NOT COMPLETED|Overall Study||3
237917|NCT01105312|577071|P3|COMPLETED|Overall Study||6
237918|NCT01105312|577072|P2|COMPLETED|Overall Study||6
237919|NCT01105312|577073|P1|COMPLETED|Overall Study||13
237920|NCT01105312|577071|P3|STARTED|Overall Study||6
237921|NCT01105312|577072|P2|STARTED|Overall Study||6
237922|NCT01105312|577073|P1|STARTED|Overall Study||16
237923|NCT01105247|577091|P2|NOT COMPLETED|Overall Study||0
237924|NCT01105247|577092|P1|NOT COMPLETED|Overall Study||37
237925|NCT01105247|577091|P2|COMPLETED|Overall Study||16
237926|NCT01105247|577092|P1|COMPLETED|Overall Study||79
237927|NCT01105247|577091|P2|STARTED|Overall Study||16
237928|NCT01105247|577092|P1|STARTED|Overall Study||116
237929|NCT01105130|577108|P3|NOT COMPLETED|Overall Study||10
237930|NCT01105130|577109|P2|NOT COMPLETED|Overall Study||11
237931|NCT01105130|577110|P1|NOT COMPLETED|Overall Study||10
237932|NCT01105130|577108|P3|COMPLETED|Overall Study||37
237933|NCT01105130|577109|P2|COMPLETED|Overall Study||34
237934|NCT01105130|577110|P1|COMPLETED|Overall Study||38
237935|NCT01105130|577108|P3|STARTED|Overall Study||47
237936|NCT01105130|577109|P2|STARTED|Overall Study||45
237937|NCT01105130|577110|P1|STARTED|Overall Study||48
237938|NCT01105117|577129|P2|NOT COMPLETED|Overall Study||0
237939|NCT01105117|577130|P1|NOT COMPLETED|Overall Study||0
237940|NCT01105117|577129|P2|COMPLETED|Overall Study||1
237941|NCT01105117|577130|P1|COMPLETED|Overall Study||1
237942|NCT01105117|577129|P2|STARTED|Overall Study||1
237943|NCT01105117|577130|P1|STARTED|Overall Study||1
237944|NCT01105091|577140|P2|NOT COMPLETED|Overall Study||0
237945|NCT01105091|577141|P1|NOT COMPLETED|Overall Study||2
237946|NCT01105091|577140|P2|COMPLETED|Overall Study||10
237947|NCT01105091|577141|P1|COMPLETED|Overall Study||18
237948|NCT01105091|577140|P2|STARTED|Overall Study||10
237949|NCT01105091|577141|P1|STARTED|Overall Study||20
237950|NCT01105065|577165|P1|NOT COMPLETED|Overall Study||6
237951|NCT01105065|577165|P1|COMPLETED|Overall Study||17
237952|NCT01105065|577165|P1|STARTED|Overall Study||23
237953|NCT01104870|577174|P3|NOT COMPLETED|Overall Study||2
237954|NCT01104870|577175|P2|NOT COMPLETED|Overall Study||1
237955|NCT01104870|577176|P1|NOT COMPLETED|Overall Study||1
237956|NCT01104870|577174|P3|COMPLETED|Overall Study||18
237957|NCT01104870|577175|P2|COMPLETED|Overall Study||18
237958|NCT01104870|577176|P1|COMPLETED|Overall Study||10
237959|NCT01104870|577174|P3|STARTED|Overall Study||20
237960|NCT01104870|577175|P2|STARTED|Overall Study||19
237961|NCT01104870|577176|P1|STARTED|Overall Study||11
237962|NCT01104792|577205|P1|NOT COMPLETED|Overall Study||526
237963|NCT01104792|577205|P1|COMPLETED|Overall Study||226
237964|NCT01104792|577205|P1|STARTED|Overall Study||752
237965|NCT01104779|577213|P3|NOT COMPLETED|Overall Study||62
237966|NCT01104779|577214|P2|NOT COMPLETED|Overall Study||55
237967|NCT01104779|577215|P1|NOT COMPLETED|Overall Study||59
237968|NCT01104779|577213|P3|COMPLETED|Overall Study||86
237969|NCT01104779|577214|P2|COMPLETED|Overall Study||96
237970|NCT01104779|577215|P1|COMPLETED|Overall Study||88
237971|NCT01104779|577213|P3|STARTED|Overall Study||148
237972|NCT01104779|577214|P2|STARTED|Overall Study||151
237973|NCT01104779|577215|P1|STARTED|Overall Study||147
237974|NCT01104766|577230|P4|NOT COMPLETED|Overall Study||38
237975|NCT01104766|577231|P3|NOT COMPLETED|Overall Study||60
237976|NCT01104766|577232|P2|NOT COMPLETED|Overall Study||51
237977|NCT01104766|577233|P1|NOT COMPLETED|Overall Study||58
237978|NCT01104766|577230|P4|COMPLETED|Overall Study||114
237979|NCT01104766|577231|P3|COMPLETED|Overall Study||97
237980|NCT01104766|577232|P2|COMPLETED|Overall Study||104
237981|NCT01104766|577233|P1|COMPLETED|Overall Study||95
237982|NCT01104766|577230|P4|STARTED|Overall Study||152
237983|NCT01104766|577231|P3|STARTED|Overall Study||157
237984|NCT01104766|577232|P2|STARTED|Overall Study||155
237985|NCT01104766|577233|P1|STARTED|Overall Study||153
237986|NCT01104701|577251|P4|NOT COMPLETED|Overall Study||2
237987|NCT01104701|577252|P3|NOT COMPLETED|Overall Study||2
237988|NCT01104701|577253|P2|NOT COMPLETED|Overall Study||3
237989|NCT01104701|577254|P1|NOT COMPLETED|Overall Study||0
237990|NCT01104701|577251|P4|COMPLETED|Overall Study||28
237991|NCT01104701|577252|P3|COMPLETED|Overall Study||29
237992|NCT01104701|577253|P2|COMPLETED|Overall Study||27
237993|NCT01104701|577254|P1|COMPLETED|Overall Study||30
237994|NCT01104701|577251|P4|STARTED|Overall Study||30
237995|NCT01104701|577252|P3|STARTED|Overall Study||31
237996|NCT01104701|577253|P2|STARTED|Overall Study||30
237997|NCT01104701|577254|P1|STARTED|Overall Study||30
237998|NCT01104662|577316|P8|NOT COMPLETED|Overall Study||0
237999|NCT01104662|577317|P7|NOT COMPLETED|Overall Study||0
238000|NCT01104662|577318|P6|NOT COMPLETED|Overall Study||4
238001|NCT01104662|577319|P5|NOT COMPLETED|Overall Study||1
238002|NCT01104662|577320|P4|NOT COMPLETED|Overall Study||1
238003|NCT01104662|577321|P3|NOT COMPLETED|Overall Study||1
238004|NCT01104662|577322|P2|NOT COMPLETED|Overall Study||10
238005|NCT01104662|577323|P1|NOT COMPLETED|Overall Study||10
238006|NCT01104662|577316|P8|COMPLETED|Overall Study||6
238007|NCT01104662|577317|P7|COMPLETED|Overall Study||5
238008|NCT01104662|577318|P6|COMPLETED|Overall Study||12
238009|NCT01104662|577319|P5|COMPLETED|Overall Study||14
238010|NCT01104662|577320|P4|COMPLETED|Overall Study||3
238011|NCT01104662|577321|P3|COMPLETED|Overall Study||4
238012|NCT01104662|577322|P2|COMPLETED|Overall Study||11
238013|NCT01104662|577323|P1|COMPLETED|Overall Study||10
238014|NCT01104662|577316|P8|Received at Least 1 Dose of Study Drug|Overall Study||6
238015|NCT01104662|577317|P7|Received at Least 1 Dose of Study Drug|Overall Study||5
238016|NCT01104662|577318|P6|Received at Least 1 Dose of Study Drug|Overall Study||15
238017|NCT01104662|577319|P5|Received at Least 1 Dose of Study Drug|Overall Study||15
238018|NCT01104662|577320|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
238019|NCT01104662|577321|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
238020|NCT01104662|577322|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
238021|NCT01104662|577323|P1|Received at Least 1 Dose of Study Drug|Overall Study||17
238022|NCT01104662|577316|P8|STARTED|Overall Study||6
238023|NCT01104662|577317|P7|STARTED|Overall Study||5
238024|NCT01104662|577318|P6|STARTED|Overall Study||16
238025|NCT01104662|577319|P5|STARTED|Overall Study||15
238026|NCT01104662|577320|P4|STARTED|Overall Study||4
238027|NCT01104662|577321|P3|STARTED|Overall Study||5
238028|NCT01104662|577322|P2|STARTED|Overall Study||21
238029|NCT01104662|577323|P1|STARTED|Overall Study||20
238030|NCT01104636|577349|P1|NOT COMPLETED|Overall Study||178
238031|NCT01104636|577349|P1|COMPLETED|Overall Study||999
238032|NCT01104636|577349|P1|STARTED|Overall Study||1177
238033|NCT01104584|577354|P1|NOT COMPLETED|Overall Study||23
238034|NCT01104584|577354|P1|COMPLETED|Overall Study|study course completed|437
238035|NCT01104584|577354|P1|Fulfilled Requirements of FAS Population|Overall Study||397
238036|NCT01104584|577354|P1|Received Treatment|Overall Study|treatment started|439
238037|NCT01104584|577354|P1|STARTED|Overall Study|screened and enrolled|460
238038|NCT01104558|577424|P1|NOT COMPLETED|Overall Study||17
238039|NCT01104558|577424|P1|COMPLETED|Overall Study||83
238040|NCT01104558|577424|P1|STARTED|Overall Study||100
238041|NCT01104545|577468|P3|NOT COMPLETED|Overall Study||2
238042|NCT01104545|577469|P2|NOT COMPLETED|Overall Study||1
238043|NCT01104545|577470|P1|NOT COMPLETED|Overall Study||0
238044|NCT01104545|577468|P3|COMPLETED|Overall Study|Participants discontinued after receiving MK-3614 0.75 mg (Period 1)and placebo (Period 2)|6
238045|NCT01104545|577469|P2|COMPLETED|Overall Study|Participant discontinued after receiving 0.75 mg MK-3614 in Period 1|7
238046|NCT01104545|577470|P1|COMPLETED|Overall Study||8
238047|NCT01104545|577468|P3|STARTED|Overall Study|1 participant received 0.50 mg of MK-3614 or placebo in Periods 3 and 4 instead of planned 0.75 mg|8
238048|NCT01104545|577469|P2|STARTED|Overall Study||8
238049|NCT01104545|577470|P1|STARTED|Overall Study||8
238050|NCT01104493|577627|P2|NOT COMPLETED|Overall Study||2
238051|NCT01104493|577628|P1|NOT COMPLETED|Overall Study||0
238052|NCT01104493|577627|P2|COMPLETED|Overall Study||58
238053|NCT01104493|577628|P1|COMPLETED|Overall Study||240
238054|NCT01104493|577627|P2|STARTED|Overall Study||60
238055|NCT01104493|577628|P1|STARTED|Overall Study||240
238056|NCT01104415|577646|P2|NOT COMPLETED|Extension Period||11
238057|NCT01104415|577647|P1|NOT COMPLETED|Extension Period||0
238058|NCT01104415|577646|P2|COMPLETED|Extension Period||0
238059|NCT01104415|577647|P1|COMPLETED|Extension Period||0
238060|NCT01104415|577646|P2|STARTED|Extension Period|Out of 14 participants who completed Core Phase, 3 were not eligible to enter the Extension Period.|11
238061|NCT01104415|577647|P1|STARTED|Extension Period||0
238062|NCT01104415|577646|P2|NOT COMPLETED|Core Phase||0
238063|NCT01104415|577647|P1|NOT COMPLETED|Core Phase||1
238064|NCT01104415|577646|P2|COMPLETED|Core Phase||0
238065|NCT01104415|577647|P1|COMPLETED|Core Phase||14
238066|NCT01104415|577646|P2|STARTED|Core Phase||0
238067|NCT01104415|577647|P1|STARTED|Core Phase||15
238068|NCT01104402|577672|P2|NOT COMPLETED|Overall Study||33
238069|NCT01104402|577673|P1|NOT COMPLETED|Overall Study||21
238070|NCT01104402|577672|P2|COMPLETED|Overall Study||102
238071|NCT01104402|577673|P1|COMPLETED|Overall Study||111
238072|NCT01104402|577672|P2|STARTED|Overall Study||135
238073|NCT01104402|577673|P1|STARTED|Overall Study||132
238074|NCT01104376|577691|P1|NOT COMPLETED|Overall Study||28
238075|NCT01104376|577691|P1|COMPLETED|Overall Study||61
238076|NCT01104376|577691|P1|STARTED|Overall Study||89
238077|NCT01104311|577697|P2|NOT COMPLETED|Overall Study||12
238078|NCT01104311|577698|P1|NOT COMPLETED|Overall Study||10
238079|NCT01104311|577697|P2|COMPLETED|Overall Study||54
238080|NCT01104311|577698|P1|COMPLETED|Overall Study||56
238081|NCT01104311|577697|P2|STARTED|Overall Study||66
238082|NCT01104311|577698|P1|STARTED|Overall Study||66
238083|NCT01104285|577718|P2|NOT COMPLETED|Overall Study||0
238084|NCT01104285|577719|P1|NOT COMPLETED|Overall Study||0
238085|NCT01104285|577718|P2|COMPLETED|Overall Study||86
238086|NCT01104285|577719|P1|COMPLETED|Overall Study||112
238087|NCT01104285|577718|P2|STARTED|Overall Study||86
238088|NCT01104285|577719|P1|STARTED|Overall Study||112
238089|NCT01104246|577725|P1|NOT COMPLETED|Overall Study||5
238090|NCT01104246|577725|P1|COMPLETED|Overall Study||35
238091|NCT01104246|577725|P1|Baseline Characteristics Measured|Overall Study||35
238092|NCT01104246|577725|P1|STARTED|Overall Study||40
238093|NCT01104207|577731|P2|NOT COMPLETED|Overall Study||3
238094|NCT01104207|577732|P1|NOT COMPLETED|Overall Study||3
238095|NCT01104207|577731|P2|COMPLETED|Overall Study||32
238096|NCT01104207|577732|P1|COMPLETED|Overall Study||32
238097|NCT01104207|577731|P2|STARTED|Overall Study||35
238098|NCT01104207|577732|P1|STARTED|Overall Study||35
238099|NCT01104155|577740|P2|NOT COMPLETED|Overall Study||18
238100|NCT01104155|577741|P1|NOT COMPLETED|Overall Study||25
238101|NCT01104155|577740|P2|COMPLETED|Overall Study||42
238102|NCT01104155|577741|P1|COMPLETED|Overall Study||38
238103|NCT01104155|577740|P2|STARTED|Overall Study||60
238104|NCT01104155|577741|P1|STARTED|Overall Study||63
238105|NCT01104116|577755|P1|NOT COMPLETED|Overall Study||0
238106|NCT01104116|577755|P1|COMPLETED|Overall Study||1
238107|NCT01104116|577755|P1|STARTED|Overall Study||1
238108|NCT01104103|577762|P2|NOT COMPLETED|Overall Study||0
238109|NCT01104103|577763|P1|NOT COMPLETED|Overall Study||0
238110|NCT01104103|577762|P2|COMPLETED|Overall Study||224
238111|NCT01104103|577763|P1|COMPLETED|Overall Study||243
238112|NCT01104103|577762|P2|STARTED|Overall Study||224
238113|NCT01104103|577763|P1|STARTED|Overall Study||243
238114|NCT01103973|577773|P2|NOT COMPLETED|Overall Study||0
238115|NCT01103973|577774|P1|NOT COMPLETED|Overall Study||0
238116|NCT01103973|577773|P2|COMPLETED|Overall Study||46
238117|NCT01103973|577774|P1|COMPLETED|Overall Study||51
238118|NCT01103973|577773|P2|STARTED|Overall Study||46
238119|NCT01103973|577774|P1|STARTED|Overall Study||51
238120|NCT01103960|577784|P2|NOT COMPLETED|Overall Study||2
238121|NCT01103960|577785|P1|NOT COMPLETED|Overall Study||5
238122|NCT01103960|577784|P2|COMPLETED|Overall Study|Completed study medication.|158
238123|NCT01103960|577785|P1|COMPLETED|Overall Study|Completed study medication.|159
238124|NCT01103960|577784|P2|STARTED|Overall Study|Randomised and treated.|160
238125|NCT01103960|577785|P1|STARTED|Overall Study|Randomised and treated.|164
238126|NCT01103934|577811|P2|NOT COMPLETED|Overall Study||0
238127|NCT01103934|577812|P1|NOT COMPLETED|Overall Study||0
238128|NCT01103934|577811|P2|COMPLETED|Overall Study||18
238129|NCT01103934|577812|P1|COMPLETED|Overall Study||17
238130|NCT01103934|577811|P2|STARTED|Overall Study||18
238131|NCT01103934|577812|P1|STARTED|Overall Study||17
238132|NCT01103778|577820|P1|NOT COMPLETED|Overall Study||3
238133|NCT01103778|577820|P1|COMPLETED|Overall Study||8
238134|NCT01103778|577820|P1|STARTED|Overall Study||11
238135|NCT01103713|577827|P1|NOT COMPLETED|Overall Study||13
238136|NCT01103713|577827|P1|COMPLETED|Overall Study||155
238137|NCT01103713|577827|P1|STARTED|Overall Study||168
238138|NCT01103505|577855|P2|NOT COMPLETED|Overall Study||20
238139|NCT01103505|577856|P1|NOT COMPLETED|Overall Study||24
238140|NCT01103505|577855|P2|COMPLETED|Overall Study||737
238141|NCT01103505|577856|P1|COMPLETED|Overall Study||739
238142|NCT01103505|577855|P2|STARTED|Overall Study||757
238143|NCT01103505|577856|P1|STARTED|Overall Study||763
238144|NCT01103492|577870|P1|NOT COMPLETED|Overall Study||0
238145|NCT01103492|577870|P1|COMPLETED|Overall Study||1
238146|NCT01103492|577870|P1|STARTED|Overall Study||1
238147|NCT01103479|577877|P3|NOT COMPLETED|Overall Study||14
238148|NCT01103479|577878|P2|NOT COMPLETED|Overall Study||9
238149|NCT01103479|577879|P1|NOT COMPLETED|Overall Study||5
238150|NCT01103479|577877|P3|COMPLETED|Overall Study||174
238151|NCT01103479|577878|P2|COMPLETED|Overall Study||201
238152|NCT01103479|577879|P1|COMPLETED|Overall Study||163
238153|NCT01103479|577877|P3|STARTED|Overall Study||188
238154|NCT01103479|577878|P2|STARTED|Overall Study||210
238155|NCT01103479|577879|P1|STARTED|Overall Study||168
238156|NCT01103466|577892|P3|NOT COMPLETED|Third Period (14 +/- 3 Days)||1
238157|NCT01103466|577893|P2|NOT COMPLETED|Third Period (14 +/- 3 Days)||0
238158|NCT01103466|577894|P1|NOT COMPLETED|Third Period (14 +/- 3 Days)||2
238159|NCT01103466|577892|P3|COMPLETED|Third Period (14 +/- 3 Days)||13
238160|NCT01103466|577893|P2|COMPLETED|Third Period (14 +/- 3 Days)||8
238161|NCT01103466|577894|P1|COMPLETED|Third Period (14 +/- 3 Days)||6
238162|NCT01103466|577892|P3|STARTED|Third Period (14 +/- 3 Days)||14
238163|NCT01103466|577893|P2|STARTED|Third Period (14 +/- 3 Days)||8
238164|NCT01103466|577894|P1|STARTED|Third Period (14 +/- 3 Days)||8
238165|NCT01103466|577892|P3|NOT COMPLETED|Second Period (14 +/- 3 Days)||1
238166|NCT01103466|577893|P2|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
238167|NCT01103466|577894|P1|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
238168|NCT01103466|577892|P3|COMPLETED|Second Period (14 +/- 3 Days)||6
238169|NCT01103466|577893|P2|COMPLETED|Second Period (14 +/- 3 Days)||11
238170|NCT01103466|577894|P1|COMPLETED|Second Period (14 +/- 3 Days)||13
238171|NCT01103466|577892|P3|STARTED|Second Period (14 +/- 3 Days)||7
238172|NCT01103466|577893|P2|STARTED|Second Period (14 +/- 3 Days)||13
238173|NCT01103466|577894|P1|STARTED|Second Period (14 +/- 3 Days)||15
238174|NCT01103466|577892|P3|NOT COMPLETED|First Period (14 +/- 3 Days)||0
238175|NCT01103466|577893|P2|NOT COMPLETED|First Period (14 +/- 3 Days)||0
238176|NCT01103466|577894|P1|NOT COMPLETED|First Period (14 +/- 3 Days)||2
238177|NCT01103466|577892|P3|COMPLETED|First Period (14 +/- 3 Days)||13
238178|NCT01103466|577893|P2|COMPLETED|First Period (14 +/- 3 Days)||12
238179|NCT01103466|577894|P1|COMPLETED|First Period (14 +/- 3 Days)||10
238180|NCT01103466|577892|P3|STARTED|First Period (14 +/- 3 Days)||13
238181|NCT01103466|577893|P2|STARTED|First Period (14 +/- 3 Days)||12
238182|NCT01103466|577894|P1|STARTED|First Period (14 +/- 3 Days)||12
238183|NCT01103440|577904|P2|NOT COMPLETED|Overall Study||0
238184|NCT01103440|577905|P1|NOT COMPLETED|Overall Study||0
238185|NCT01103440|577904|P2|COMPLETED|Overall Study||18
238186|NCT01103440|577905|P1|COMPLETED|Overall Study||18
238187|NCT01103440|577904|P2|STARTED|Overall Study||18
238188|NCT01103440|577905|P1|STARTED|Overall Study||18
238189|NCT01103414|577918|P5|NOT COMPLETED|Overall Study||15
238190|NCT01103414|577919|P4|NOT COMPLETED|Overall Study||7
238191|NCT01103414|577920|P3|NOT COMPLETED|Overall Study||15
238192|NCT01103414|577921|P2|NOT COMPLETED|Overall Study||9
238193|NCT01103414|577922|P1|NOT COMPLETED|Overall Study||13
238194|NCT01103414|577918|P5|COMPLETED|Overall Study||56
238195|NCT01103414|577919|P4|COMPLETED|Overall Study||64
238196|NCT01103414|577920|P3|COMPLETED|Overall Study||56
238197|NCT01103414|577921|P2|COMPLETED|Overall Study||62
238198|NCT01103414|577922|P1|COMPLETED|Overall Study||59
238199|NCT01103414|577918|P5|STARTED|Overall Study||71
238200|NCT01103414|577919|P4|STARTED|Overall Study||71
238201|NCT01103414|577920|P3|STARTED|Overall Study||71
238202|NCT01103414|577921|P2|STARTED|Overall Study||71
238203|NCT01103414|577922|P1|STARTED|Overall Study||72
238204|NCT01103362|577984|P1|NOT COMPLETED|Overall Study||596
238205|NCT01103362|577984|P1|COMPLETED|Overall Study||0
238206|NCT01103362|577984|P1|STARTED|Overall Study||596
238207|NCT01103323|577990|P2|NOT COMPLETED|Switched From Placebo to Regorafenib||1
238208|NCT01103323|577991|P1|NOT COMPLETED|Switched From Placebo to Regorafenib||0
238209|NCT01103323|577990|P2|COMPLETED|Switched From Placebo to Regorafenib||3
238210|NCT01103323|577991|P1|COMPLETED|Switched From Placebo to Regorafenib||0
238211|NCT01103323|577990|P2|STARTED|Switched From Placebo to Regorafenib|Participants in the placebo+BSC group switched to Regorafenib treatment after unblinding.|4
238212|NCT01103323|577991|P1|STARTED|Switched From Placebo to Regorafenib||0
238213|NCT01103323|577990|P2|NOT COMPLETED|Without/Before Drug Switch||18
238214|NCT01103323|577991|P1|NOT COMPLETED|Without/Before Drug Switch||76
238215|NCT01103323|577990|P2|COMPLETED|Without/Before Drug Switch||237
238216|NCT01103323|577991|P1|COMPLETED|Without/Before Drug Switch||429
238217|NCT01103323|577990|P2|Participants Received Treatment|Without/Before Drug Switch||253
238218|NCT01103323|577991|P1|Participants Received Treatment|Without/Before Drug Switch||500
238219|NCT01103323|577990|P2|STARTED|Without/Before Drug Switch||255
238220|NCT01103323|577991|P1|STARTED|Without/Before Drug Switch||505
238221|NCT01103284|578008|P2|NOT COMPLETED|Overall Study||44
238222|NCT01103284|578009|P1|NOT COMPLETED|Overall Study||42
238223|NCT01103284|578008|P2|COMPLETED|Overall Study||195
238224|NCT01103284|578009|P1|COMPLETED|Overall Study||194
238225|NCT01103284|578008|P2|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS)|235
238226|NCT01103284|578009|P1|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS) population|233
238227|NCT01103284|578008|P2|Treated|Overall Study||238
238228|NCT01103284|578009|P1|Treated|Overall Study||236
238229|NCT01103284|578008|P2|STARTED|Overall Study||239
238230|NCT01103284|578009|P1|STARTED|Overall Study||236
238231|NCT01103271|578025|P2|NOT COMPLETED|Overall Study||4
238232|NCT01103271|578026|P1|NOT COMPLETED|Overall Study||1
238233|NCT01103271|578025|P2|COMPLETED|Overall Study||5
238234|NCT01103271|578026|P1|COMPLETED|Overall Study||10
238235|NCT01103271|578025|P2|STARTED|Overall Study||9
238236|NCT01103271|578026|P1|STARTED|Overall Study||11
238237|NCT01103245|578037|P4|NOT COMPLETED|Overall Study||0
238238|NCT01103245|578038|P3|NOT COMPLETED|Overall Study||4
238239|NCT01103245|578039|P2|NOT COMPLETED|Overall Study||2
238240|NCT01103245|578040|P1|NOT COMPLETED|Overall Study||3
238241|NCT01103245|578037|P4|COMPLETED|Overall Study||6
238242|NCT01103245|578038|P3|COMPLETED|Overall Study||8
238243|NCT01103245|578039|P2|COMPLETED|Overall Study||5
238244|NCT01103245|578040|P1|COMPLETED|Overall Study||10
238245|NCT01103245|578037|P4|STARTED|Overall Study||6
238246|NCT01103245|578038|P3|STARTED|Overall Study||12
238247|NCT01103245|578039|P2|STARTED|Overall Study||7
238248|NCT01103245|578040|P1|STARTED|Overall Study||13
238249|NCT01103232|578056|P2|NOT COMPLETED|Overall Study||2
238250|NCT01103232|578057|P1|NOT COMPLETED|Overall Study||1
238251|NCT01103232|578056|P2|COMPLETED|Overall Study||11
238252|NCT01103232|578057|P1|COMPLETED|Overall Study||12
238253|NCT01103232|578056|P2|STARTED|Overall Study||13
238254|NCT01103232|578057|P1|STARTED|Overall Study||13
238255|NCT01103180|578065|P2|NOT COMPLETED|Overall Study||21
238256|NCT01103180|578066|P1|NOT COMPLETED|Overall Study||22
238257|NCT01103180|578065|P2|COMPLETED|Overall Study||14
238258|NCT01103180|578066|P1|COMPLETED|Overall Study||13
238259|NCT01103180|578065|P2|STARTED|Overall Study||35
238260|NCT01103180|578066|P1|STARTED|Overall Study||35
238261|NCT01103141|578076|P2|NOT COMPLETED|Overall Study||2
238262|NCT01103141|578077|P1|NOT COMPLETED|Overall Study||2
238263|NCT01103141|578076|P2|COMPLETED|Overall Study||74
238264|NCT01103141|578077|P1|COMPLETED|Overall Study||65
238265|NCT01103141|578076|P2|STARTED|Overall Study||76
238266|NCT01103141|578077|P1|STARTED|Overall Study||67
238267|NCT01103063|578085|P2|NOT COMPLETED|Overall Study||421
238268|NCT01103063|578086|P1|NOT COMPLETED|Overall Study||477
238269|NCT01103063|578085|P2|COMPLETED|Overall Study||1024
238270|NCT01103063|578086|P1|COMPLETED|Overall Study||969
238271|NCT01103063|578085|P2|STARTED|Overall Study||1445
238272|NCT01103063|578086|P1|STARTED|Overall Study||1446
238273|NCT01102972|578154|P2|NOT COMPLETED|Overall Study||14
238274|NCT01102972|578155|P1|NOT COMPLETED|Overall Study||29
238275|NCT01102972|578154|P2|COMPLETED|Overall Study|These participants completed Study Week 48.|83
238276|NCT01102972|578155|P1|COMPLETED|Overall Study|These participants completed Study Week 48.|170
238277|NCT01102972|578154|P2|Completed Week 24|Overall Study||88
238278|NCT01102972|578155|P1|Completed Week 24|Overall Study||180
238279|NCT01102972|578154|P2|STARTED|Overall Study|297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn’t “start” the study.|97
238280|NCT01102972|578155|P1|STARTED|Overall Study|297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn’t “start” the study.|199
238281|NCT01102894|578207|P1|NOT COMPLETED|Overall Study||0
238282|NCT01102894|578207|P1|COMPLETED|Overall Study||10
238283|NCT01102894|578207|P1|STARTED|Overall Study||10
238284|NCT01102803|578219|P2|NOT COMPLETED|Post to Follow-Up||3
238285|NCT01102803|578220|P1|NOT COMPLETED|Post to Follow-Up||1
238286|NCT01102803|578219|P2|COMPLETED|Post to Follow-Up||12
238287|NCT01102803|578220|P1|COMPLETED|Post to Follow-Up||10
238288|NCT01102803|578219|P2|STARTED|Post to Follow-Up||15
238289|NCT01102803|578220|P1|STARTED|Post to Follow-Up||11
238290|NCT01102803|578219|P2|NOT COMPLETED|Baseline to Post-Treatment||0
238291|NCT01102803|578220|P1|NOT COMPLETED|Baseline to Post-Treatment||3
238292|NCT01102803|578219|P2|COMPLETED|Baseline to Post-Treatment||15
238293|NCT01102803|578220|P1|COMPLETED|Baseline to Post-Treatment||11
238294|NCT01102803|578219|P2|STARTED|Baseline to Post-Treatment||15
238295|NCT01102803|578220|P1|STARTED|Baseline to Post-Treatment||14
238296|NCT01102777|578234|P2|NOT COMPLETED|Overall Study||16
238297|NCT01102777|578235|P1|NOT COMPLETED|Overall Study||9
238298|NCT01102777|578234|P2|COMPLETED|Overall Study||139
238299|NCT01102777|578235|P1|COMPLETED|Overall Study||75
238300|NCT01102777|578234|P2|STARTED|Overall Study||155
238301|NCT01102777|578235|P1|STARTED|Overall Study||84
238302|NCT01102764|578261|P2|NOT COMPLETED|Overall Study||13
238303|NCT01102764|578262|P1|NOT COMPLETED|Overall Study||21
238304|NCT01102764|578261|P2|COMPLETED|Overall Study||55
238305|NCT01102764|578262|P1|COMPLETED|Overall Study||43
238306|NCT01102764|578261|P2|STARTED|Overall Study||68
238307|NCT01102764|578262|P1|STARTED|Overall Study||64
238308|NCT01102491|578290|P2|NOT COMPLETED|Overall Study||12
238309|NCT01102491|578291|P1|NOT COMPLETED|Overall Study||11
238310|NCT01102491|578290|P2|COMPLETED|Overall Study|12 patients were excluded|59
238311|NCT01102491|578291|P1|COMPLETED|Overall Study|11 patient excluded|60
238312|NCT01102491|578290|P2|STARTED|Overall Study||71
238313|NCT01102491|578291|P1|STARTED|Overall Study||71
238314|NCT01102413|578299|P2|NOT COMPLETED|Overall Study||12
238315|NCT01102413|578300|P1|NOT COMPLETED|Overall Study||25
238316|NCT01102413|578299|P2|COMPLETED|Overall Study||106
238317|NCT01102413|578300|P1|COMPLETED|Overall Study||208
238318|NCT01102413|578299|P2|STARTED|Overall Study||118
238319|NCT01102413|578300|P1|STARTED|Overall Study||233
238320|NCT01102374|578310|P2|NOT COMPLETED|Overall Study||19
238321|NCT01102374|578311|P1|NOT COMPLETED|Overall Study||16
238322|NCT01102374|578310|P2|COMPLETED|Overall Study||33
238323|NCT01102374|578311|P1|COMPLETED|Overall Study||39
238324|NCT01102374|578310|P2|STARTED|Overall Study||52
238325|NCT01102374|578311|P1|STARTED|Overall Study||55
238326|NCT01102270|578345|P2|NOT COMPLETED|Overall Study||0
238327|NCT01102270|578346|P1|NOT COMPLETED|Overall Study||0
238328|NCT01102270|578345|P2|COMPLETED|Overall Study||9
238329|NCT01102270|578346|P1|COMPLETED|Overall Study||8
238330|NCT01102270|578345|P2|STARTED|Overall Study||9
238331|NCT01102270|578346|P1|STARTED|Overall Study||8
238332|NCT01102257|578360|P2|NOT COMPLETED|Overall Study||0
238333|NCT01102257|578361|P1|NOT COMPLETED|Overall Study||2
238334|NCT01102257|578360|P2|COMPLETED|Overall Study||9
238335|NCT01102257|578361|P1|COMPLETED|Overall Study|2 withdrew from the study d/t adverse events. 1 had shortness of breath and the other had chest pain|7
238336|NCT01102257|578360|P2|STARTED|Overall Study||9
238337|NCT01102257|578361|P1|STARTED|Overall Study||9
238338|NCT01102218|578369|P2|NOT COMPLETED|Overall Study||10
238339|NCT01102218|578370|P1|NOT COMPLETED|Overall Study||11
238340|NCT01102218|578369|P2|COMPLETED|Overall Study||14
238341|NCT01102218|578370|P1|COMPLETED|Overall Study||13
238342|NCT01102218|578369|P2|STARTED|Overall Study||24
238343|NCT01102218|578370|P1|STARTED|Overall Study||24
238344|NCT01102140|578378|P2|NOT COMPLETED|Overall Study||2
238345|NCT01102140|578379|P1|NOT COMPLETED|Overall Study||3
238346|NCT01102140|578378|P2|COMPLETED|Overall Study||5
238347|NCT01102140|578379|P1|COMPLETED|Overall Study||10
238348|NCT01102140|578378|P2|STARTED|Overall Study||7
238349|NCT01102140|578379|P1|STARTED|Overall Study||13
238350|NCT01101971|578391|P1|NOT COMPLETED|Overall Study||0
238351|NCT01101971|578391|P1|COMPLETED|Overall Study||45
238352|NCT01101971|578391|P1|STARTED|Overall Study||45
238353|NCT01101958|578397|P2|NOT COMPLETED|Overall Study||5
238354|NCT01101958|578398|P1|NOT COMPLETED|Overall Study||11
238355|NCT01101958|578397|P2|COMPLETED|Overall Study||29
238356|NCT01101958|578398|P1|COMPLETED|Overall Study||51
238357|NCT01101958|578397|P2|STARTED|Overall Study||34
238358|NCT01101958|578398|P1|STARTED|Overall Study||62
238359|NCT01101880|578404|P1|NOT COMPLETED|Overall Study||0
238360|NCT01101880|578404|P1|COMPLETED|Overall Study||50
238361|NCT01101880|578404|P1|STARTED|Overall Study||50
238362|NCT01101867|578415|P2|NOT COMPLETED|Overall Study||4
238363|NCT01101867|578416|P1|NOT COMPLETED|Overall Study||1
238364|NCT01101867|578415|P2|COMPLETED|Overall Study||59
238365|NCT01101867|578416|P1|COMPLETED|Overall Study||62
238366|NCT01101867|578415|P2|STARTED|Overall Study||63
238367|NCT01101867|578416|P1|STARTED|Overall Study||63
238368|NCT01101841|578434|P2|NOT COMPLETED|Overall Study||67
238369|NCT01101841|578435|P1|NOT COMPLETED|Overall Study||50
238370|NCT01101841|578434|P2|COMPLETED|Overall Study||218
238371|NCT01101841|578435|P1|COMPLETED|Overall Study||235
238372|NCT01101841|578434|P2|STARTED|Overall Study||285
238373|NCT01101841|578435|P1|STARTED|Overall Study||285
238374|NCT01101542|578473|P1|NOT COMPLETED|Year 6 Surveillance Period||991
238375|NCT01101542|578473|P1|COMPLETED|Year 6 Surveillance Period||2100
238376|NCT01101542|578473|P1|STARTED|Year 6 Surveillance Period||3091
238377|NCT01101542|578473|P1|NOT COMPLETED|Year 5 Surveillance Period||141
238378|NCT01101542|578473|P1|COMPLETED|Year 5 Surveillance Period||668
238379|NCT01101542|578473|P1|STARTED|Year 5 Surveillance Period||809
238380|NCT01101542|578473|P1|NOT COMPLETED|Year 4 Surveillance Period||287
238381|NCT01101542|578473|P1|COMPLETED|Year 4 Surveillance Period||282
238382|NCT01101542|578473|P1|STARTED|Year 4 Surveillance Period||569
238383|NCT01101542|578473|P1|NOT COMPLETED|Year 3 Surveillance Period||11
238384|NCT01101542|578473|P1|COMPLETED|Year 3 Surveillance Period||94
238385|NCT01101542|578473|P1|STARTED|Year 3 Surveillance Period||105
238386|NCT01101477|578489|P3|NOT COMPLETED|Overall Study||1
238387|NCT01101477|578490|P2|NOT COMPLETED|Overall Study||3
238388|NCT01101477|578491|P1|NOT COMPLETED|Overall Study||5
238389|NCT01101477|578489|P3|COMPLETED|Overall Study||45
238390|NCT01101477|578490|P2|COMPLETED|Overall Study||46
238391|NCT01101477|578491|P1|COMPLETED|Overall Study||44
238392|NCT01101477|578489|P3|STARTED|Overall Study||46
238393|NCT01101477|578490|P2|STARTED|Overall Study||49
238394|NCT01101477|578491|P1|STARTED|Overall Study||49
238395|NCT01101464|578501|P2|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
238396|NCT01101464|578502|P1|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
238397|NCT01101464|578501|P2|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
238398|NCT01101464|578502|P1|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
238399|NCT01101464|578501|P2|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
238400|NCT01101464|578502|P1|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
238401|NCT01101464|578501|P2|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
238402|NCT01101464|578502|P1|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
238403|NCT01101464|578501|P2|COMPLETED|Day 1 Through AM Dose of Day 5||4
238404|NCT01101464|578502|P1|COMPLETED|Day 1 Through AM Dose of Day 5||4
238405|NCT01101464|578501|P2|STARTED|Day 1 Through AM Dose of Day 5||4
238406|NCT01101464|578502|P1|STARTED|Day 1 Through AM Dose of Day 5||4
238407|NCT01101321|578512|P2|NOT COMPLETED|Period 2||0
238408|NCT01101321|578513|P1|NOT COMPLETED|Period 2||0
238409|NCT01101321|578512|P2|COMPLETED|Period 2||24
238410|NCT01101321|578513|P1|COMPLETED|Period 2||26
238411|NCT01101321|578512|P2|STARTED|Period 2||24
238412|NCT01101321|578513|P1|STARTED|Period 2||26
238413|NCT01101321|578512|P2|NOT COMPLETED|Period 1||4
238414|NCT01101321|578513|P1|NOT COMPLETED|Period 1||4
238415|NCT01101321|578512|P2|COMPLETED|Period 1||24
238416|NCT01101321|578513|P1|COMPLETED|Period 1||26
238417|NCT01101321|578512|P2|STARTED|Period 1||28
238418|NCT01101321|578513|P1|STARTED|Period 1||30
238419|NCT01101308|578523|P2|NOT COMPLETED|Period 2||0
238420|NCT01101308|578524|P1|NOT COMPLETED|Period 2||0
238421|NCT01101308|578523|P2|COMPLETED|Period 2||27
238422|NCT01101308|578524|P1|COMPLETED|Period 2||24
238423|NCT01101308|578523|P2|STARTED|Period 2||27
238424|NCT01101308|578524|P1|STARTED|Period 2||24
238425|NCT01101308|578523|P2|NOT COMPLETED|Period 1||1
238426|NCT01101308|578524|P1|NOT COMPLETED|Period 1||3
238427|NCT01101308|578523|P2|COMPLETED|Period 1||27
238428|NCT01101308|578524|P1|COMPLETED|Period 1||24
238429|NCT01101308|578523|P2|STARTED|Period 1||28
238430|NCT01101308|578524|P1|STARTED|Period 1||27
238431|NCT01101191|578535|P2|NOT COMPLETED|Period 2||0
238432|NCT01101191|578536|P1|NOT COMPLETED|Period 2||0
238433|NCT01101191|578535|P2|COMPLETED|Period 2||40
238434|NCT01101191|578536|P1|COMPLETED|Period 2||40
238435|NCT01101191|578535|P2|STARTED|Period 2||40
238436|NCT01101191|578536|P1|STARTED|Period 2||40
238437|NCT01101191|578535|P2|NOT COMPLETED|Period 1||2
238438|NCT01101191|578536|P1|NOT COMPLETED|Period 1||2
238439|NCT01101191|578535|P2|COMPLETED|Period 1||40
238440|NCT01101191|578536|P1|COMPLETED|Period 1||40
238441|NCT01101191|578535|P2|STARTED|Period 1||42
238442|NCT01101191|578536|P1|STARTED|Period 1||42
238443|NCT01101178|578547|P2|NOT COMPLETED|Period 2||1
238444|NCT01101178|578548|P1|NOT COMPLETED|Period 2||0
238445|NCT01101178|578547|P2|COMPLETED|Period 2||34
238446|NCT01101178|578548|P1|COMPLETED|Period 2||36
238447|NCT01101178|578547|P2|STARTED|Period 2||35
238448|NCT01101178|578548|P1|STARTED|Period 2||36
238449|NCT01101178|578547|P2|NOT COMPLETED|Period 1||4
238450|NCT01101178|578548|P1|NOT COMPLETED|Period 1||4
238451|NCT01101178|578547|P2|COMPLETED|Period 1||35
238452|NCT01101178|578548|P1|COMPLETED|Period 1||36
238453|NCT01101178|578547|P2|STARTED|Period 1||39
238454|NCT01101178|578548|P1|STARTED|Period 1||40
238455|NCT01101165|578559|P2|NOT COMPLETED|Period 2||1
238456|NCT01101165|578560|P1|NOT COMPLETED|Period 2||4
238457|NCT01101165|578559|P2|COMPLETED|Period 2||39
238458|NCT01101165|578560|P1|COMPLETED|Period 2||41
238459|NCT01101165|578559|P2|STARTED|Period 2||40
238460|NCT01101165|578560|P1|STARTED|Period 2||45
238461|NCT01101165|578559|P2|NOT COMPLETED|Period 1||5
238462|NCT01101165|578560|P1|NOT COMPLETED|Period 1||2
238463|NCT01101165|578559|P2|COMPLETED|Period 1||40
238464|NCT01101165|578560|P1|COMPLETED|Period 1||45
238465|NCT01101165|578559|P2|STARTED|Period 1||45
238466|NCT01101165|578560|P1|STARTED|Period 1||47
238467|NCT01101100|578570|P1|NOT COMPLETED|Overall Study||55
238468|NCT01101100|578570|P1|COMPLETED|Overall Study||126
238469|NCT01101100|578570|P1|STARTED|Overall Study||181
238470|NCT01101061|578581|P6|NOT COMPLETED|Overall Study||0
238471|NCT01101061|578582|P5|NOT COMPLETED|Overall Study||0
238472|NCT01101061|578583|P4|NOT COMPLETED|Overall Study||0
238473|NCT01101061|578584|P3|NOT COMPLETED|Overall Study||1
238474|NCT01101061|578585|P2|NOT COMPLETED|Overall Study||0
238475|NCT01101061|578586|P1|NOT COMPLETED|Overall Study||0
238476|NCT01101061|578581|P6|COMPLETED|Overall Study||4
238477|NCT01101061|578582|P5|COMPLETED|Overall Study||2
238478|NCT01101061|578583|P4|COMPLETED|Overall Study||6
238479|NCT01101061|578584|P3|COMPLETED|Overall Study||6
238480|NCT01101061|578585|P2|COMPLETED|Overall Study||6
238481|NCT01101061|578586|P1|COMPLETED|Overall Study||6
238482|NCT01101061|578581|P6|Received Study Drug|Overall Study||4
238483|NCT01101061|578582|P5|Received Study Drug|Overall Study||2
238484|NCT01101061|578583|P4|Received Study Drug|Overall Study||6
238485|NCT01101061|578584|P3|Received Study Drug|Overall Study||6
238486|NCT01101061|578585|P2|Received Study Drug|Overall Study||6
238487|NCT01101061|578586|P1|Received Study Drug|Overall Study||6
238488|NCT01101061|578581|P6|STARTED|Overall Study||4
238489|NCT01101061|578582|P5|STARTED|Overall Study||2
238490|NCT01101061|578583|P4|STARTED|Overall Study||6
238491|NCT01101061|578584|P3|STARTED|Overall Study||7
238492|NCT01101061|578585|P2|STARTED|Overall Study||6
238493|NCT01101061|578586|P1|STARTED|Overall Study||6
238494|NCT01101035|578666|P2|NOT COMPLETED|Overall Study||1391
238495|NCT01101035|578667|P1|NOT COMPLETED|Overall Study||1397
238496|NCT01101035|578666|P2|COMPLETED|Overall Study||1706
238497|NCT01101035|578667|P1|COMPLETED|Overall Study||1704
238498|NCT01101035|578666|P2|STARTED|Overall Study||3097
238499|NCT01101035|578667|P1|STARTED|Overall Study||3101
238500|NCT01101022|578687|P2|NOT COMPLETED|Overall Study||27
238501|NCT01101022|578688|P1|NOT COMPLETED|Overall Study||17
238502|NCT01101022|578687|P2|COMPLETED|Overall Study||53
238503|NCT01101022|578688|P1|COMPLETED|Overall Study||62
238504|NCT01101022|578687|P2|STARTED|Overall Study||80
238505|NCT01101022|578688|P1|STARTED|Overall Study||79
238506|NCT01100944|578722|P3|NOT COMPLETED|Expansion Phase - Phase 2||0
238507|NCT01100944|578723|P2|NOT COMPLETED|Expansion Phase - Phase 2||0
238508|NCT01100944|578724|P1|NOT COMPLETED|Expansion Phase - Phase 2||0
238509|NCT01100944|578722|P3|COMPLETED|Expansion Phase - Phase 2||18
238510|NCT01100944|578723|P2|COMPLETED|Expansion Phase - Phase 2||0
238511|NCT01100944|578724|P1|COMPLETED|Expansion Phase - Phase 2||0
238512|NCT01100944|578722|P3|STARTED|Expansion Phase - Phase 2||18
238513|NCT01100944|578723|P2|STARTED|Expansion Phase - Phase 2||0
238514|NCT01100944|578724|P1|STARTED|Expansion Phase - Phase 2||0
238515|NCT01100944|578722|P3|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
238516|NCT01100944|578723|P2|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||2
238517|NCT01100944|578724|P1|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
238518|NCT01100944|578722|P3|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
238519|NCT01100944|578723|P2|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
238520|NCT01100944|578724|P1|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
238521|NCT01100944|578722|P3|STARTED|Dose Escalation Phase 1 Dose Level 2||0
238522|NCT01100944|578723|P2|STARTED|Dose Escalation Phase 1 Dose Level 2||2
238523|NCT01100944|578724|P1|STARTED|Dose Escalation Phase 1 Dose Level 2||0
238524|NCT01100944|578722|P3|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
238525|NCT01100944|578723|P2|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
238526|NCT01100944|578724|P1|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||4
238527|NCT01100944|578722|P3|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
238528|NCT01100944|578723|P2|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
238529|NCT01100944|578724|P1|COMPLETED|Dose Escalation Phase 1 Dose Level 1||2
238530|NCT01100944|578722|P3|STARTED|Dose Escalation Phase 1 Dose Level 1||0
238531|NCT01100944|578723|P2|STARTED|Dose Escalation Phase 1 Dose Level 1||0
238532|NCT01100944|578724|P1|STARTED|Dose Escalation Phase 1 Dose Level 1||6
238533|NCT01100931|578771|P2|NOT COMPLETED|Phase II||0
238534|NCT01100931|578772|P1|NOT COMPLETED|Phase II||0
238535|NCT01100931|578771|P2|COMPLETED|Phase II||19
238536|NCT01100931|578772|P1|COMPLETED|Phase II||0
238537|NCT01100931|578771|P2|STARTED|Phase II||19
238538|NCT01100931|578772|P1|STARTED|Phase II||0
238539|NCT01100931|578771|P2|NOT COMPLETED|Phase I||0
238540|NCT01100931|578772|P1|NOT COMPLETED|Phase I||0
238541|NCT01100931|578771|P2|COMPLETED|Phase I||0
238542|NCT01100931|578772|P1|COMPLETED|Phase I||22
238543|NCT01100931|578771|P2|STARTED|Phase I||0
238544|NCT01100931|578772|P1|STARTED|Phase I||22
238545|NCT01100853|578782|P2|NOT COMPLETED|Overall Study||23
238546|NCT01100853|578783|P1|NOT COMPLETED|Overall Study||27
238547|NCT01100853|578782|P2|COMPLETED|Overall Study||26
238548|NCT01100853|578783|P1|COMPLETED|Overall Study||24
238549|NCT01100853|578782|P2|STARTED|Overall Study||49
238550|NCT01100853|578783|P1|STARTED|Overall Study||51
238551|NCT01100762|578799|P1|NOT COMPLETED|Overall Study||0
238552|NCT01100762|578799|P1|COMPLETED|Overall Study||10
238553|NCT01100762|578799|P1|STARTED|Overall Study||10
238554|NCT01100723|578820|P1|NOT COMPLETED|Overall Study||14
238555|NCT01100723|578820|P1|COMPLETED|Overall Study|78 subjects had laboratory data at the 12 month analysis and were compared to their baseline data.|78
238556|NCT01100723|578820|P1|6 Month Analysis|Overall Study|85 subjects had laboratory data at the 6 month analysis and were compared to their baseline data.|85
238557|NCT01100723|578820|P1|STARTED|Overall Study||92
238558|NCT01100658|578829|P1|NOT COMPLETED|Overall Study||1
238559|NCT01100658|578829|P1|COMPLETED|Overall Study||0
238560|NCT01100658|578829|P1|STARTED|Overall Study||1
238561|NCT01100606|578834|P2|NOT COMPLETED|Second Treatment Period||0
238562|NCT01100606|578835|P1|NOT COMPLETED|Second Treatment Period||0
238563|NCT01100606|578834|P2|COMPLETED|Second Treatment Period|Due to difficulty with syringe nurser, 1 participant completed study using apple sauce|7
238564|NCT01100606|578835|P1|COMPLETED|Second Treatment Period|Due to intolerance to apple sauce & apple juice,1 participant completed study with banana-based food|8
238565|NCT01100606|578834|P2|STARTED|Second Treatment Period||7
238566|NCT01100606|578835|P1|STARTED|Second Treatment Period||8
238567|NCT01100606|578834|P2|NOT COMPLETED|First Treatment Period||0
238568|NCT01100606|578835|P1|NOT COMPLETED|First Treatment Period||0
238569|NCT01100606|578834|P2|COMPLETED|First Treatment Period||7
238570|NCT01100606|578835|P1|COMPLETED|First Treatment Period|Due to difficulty with syringe nurser,1 participant completed study with apple sauce,not apple juice|8
238571|NCT01100606|578834|P2|STARTED|First Treatment Period||7
238572|NCT01100606|578835|P1|STARTED|First Treatment Period||8
238573|NCT01100567|578861|P2|NOT COMPLETED|Overall Study||16
238574|NCT01100567|578862|P1|NOT COMPLETED|Overall Study||12
238575|NCT01100567|578861|P2|COMPLETED|Overall Study||35
238576|NCT01100567|578862|P1|COMPLETED|Overall Study||38
238577|NCT01100567|578861|P2|STARTED|Overall Study||51
238578|NCT01100567|578862|P1|STARTED|Overall Study||50
238579|NCT01100528|578870|P1|NOT COMPLETED|Overall Study||3
238580|NCT01100528|578870|P1|COMPLETED|Overall Study||35
238581|NCT01100528|578870|P1|STARTED|Overall Study||38
238582|NCT01100502|578878|P2|NOT COMPLETED|Long-Term Follow-up||139
238583|NCT01100502|578879|P1|NOT COMPLETED|Long-Term Follow-up||137
238584|NCT01100502|578878|P2|COMPLETED|Long-Term Follow-up|Completed follow-up due to death|25
238585|NCT01100502|578879|P1|COMPLETED|Long-Term Follow-up|Completed follow-up due to death|28
238586|NCT01100502|578878|P2|STARTED|Long-Term Follow-up|All participants were to be followed after treatment|164
238587|NCT01100502|578879|P1|STARTED|Long-Term Follow-up|All participants were to be followed after treatment|165
238588|NCT01100502|578878|P2|NOT COMPLETED|Treatment Period||83
238589|NCT01100502|578879|P1|NOT COMPLETED|Treatment Period||87
238590|NCT01100502|578878|P2|COMPLETED|Treatment Period||81
238591|NCT01100502|578879|P1|COMPLETED|Treatment Period||78
238592|NCT01100502|578878|P2|STARTED|Treatment Period||164
238593|NCT01100502|578879|P1|STARTED|Treatment Period||165
238594|NCT01100437|578889|P3|NOT COMPLETED|Treatment 2||0
238595|NCT01100437|578890|P2|NOT COMPLETED|Treatment 2||0
238596|NCT01100437|578891|P1|NOT COMPLETED|Treatment 2||0
238597|NCT01100437|578889|P3|COMPLETED|Treatment 2||0
238598|NCT01100437|578890|P2|COMPLETED|Treatment 2||2
238599|NCT01100437|578891|P1|COMPLETED|Treatment 2||4
238600|NCT01100437|578889|P3|STARTED|Treatment 2||0
238601|NCT01100437|578890|P2|STARTED|Treatment 2||2
238602|NCT01100437|578891|P1|STARTED|Treatment 2||4
238603|NCT01100437|578889|P3|NOT COMPLETED|Washout (4 Days)||0
238604|NCT01100437|578890|P2|NOT COMPLETED|Washout (4 Days)||0
238605|NCT01100437|578891|P1|NOT COMPLETED|Washout (4 Days)||0
238606|NCT01100437|578889|P3|COMPLETED|Washout (4 Days)||0
238607|NCT01100437|578890|P2|COMPLETED|Washout (4 Days)||2
238608|NCT01100437|578891|P1|COMPLETED|Washout (4 Days)||4
238609|NCT01100437|578889|P3|STARTED|Washout (4 Days)||0
238610|NCT01100437|578890|P2|STARTED|Washout (4 Days)||2
238611|NCT01100437|578891|P1|STARTED|Washout (4 Days)||4
238612|NCT01100437|578889|P3|NOT COMPLETED|Treatment 1||0
238613|NCT01100437|578890|P2|NOT COMPLETED|Treatment 1||0
238614|NCT01100437|578891|P1|NOT COMPLETED|Treatment 1||0
238615|NCT01100437|578889|P3|COMPLETED|Treatment 1||0
238616|NCT01100437|578890|P2|COMPLETED|Treatment 1||2
238617|NCT01100437|578891|P1|COMPLETED|Treatment 1||4
238618|NCT01100437|578889|P3|STARTED|Treatment 1||0
238619|NCT01100437|578890|P2|STARTED|Treatment 1||2
238620|NCT01100437|578891|P1|STARTED|Treatment 1||4
238621|NCT01100437|578889|P3|NOT COMPLETED|Maintenance||2
238622|NCT01100437|578890|P2|NOT COMPLETED|Maintenance||0
238623|NCT01100437|578891|P1|NOT COMPLETED|Maintenance||0
238624|NCT01100437|578889|P3|COMPLETED|Maintenance||0
238625|NCT01100437|578890|P2|COMPLETED|Maintenance||2
238626|NCT01100437|578891|P1|COMPLETED|Maintenance||4
238627|NCT01100437|578889|P3|STARTED|Maintenance||2
238628|NCT01100437|578890|P2|STARTED|Maintenance||2
238629|NCT01100437|578891|P1|STARTED|Maintenance||4
238630|NCT01100437|578889|P3|NOT COMPLETED|Titration/Stabilization||6
238631|NCT01100437|578890|P2|NOT COMPLETED|Titration/Stabilization||0
238632|NCT01100437|578891|P1|NOT COMPLETED|Titration/Stabilization||0
238633|NCT01100437|578889|P3|COMPLETED|Titration/Stabilization||2
238634|NCT01100437|578890|P2|COMPLETED|Titration/Stabilization||2
238635|NCT01100437|578891|P1|COMPLETED|Titration/Stabilization||4
238636|NCT01100437|578889|P3|STARTED|Titration/Stabilization||8
238637|NCT01100437|578890|P2|STARTED|Titration/Stabilization||2
238638|NCT01100437|578891|P1|STARTED|Titration/Stabilization||4
238639|NCT01100437|578889|P3|NOT COMPLETED|Screening||0
238640|NCT01100437|578890|P2|NOT COMPLETED|Screening||0
238641|NCT01100437|578891|P1|NOT COMPLETED|Screening||0
238642|NCT01100437|578889|P3|COMPLETED|Screening||8
238643|NCT01100437|578890|P2|COMPLETED|Screening||2
238644|NCT01100437|578891|P1|COMPLETED|Screening||4
238645|NCT01100437|578889|P3|STARTED|Screening||8
238646|NCT01100437|578890|P2|STARTED|Screening||2
238647|NCT01100437|578891|P1|STARTED|Screening||4
238648|NCT01100320|578928|P2|NOT COMPLETED|Period 2||1
238649|NCT01100320|578929|P1|NOT COMPLETED|Period 2||1
238650|NCT01100320|578928|P2|COMPLETED|Period 2||37
238651|NCT01100320|578929|P1|COMPLETED|Period 2||37
238652|NCT01100320|578928|P2|STARTED|Period 2||38
238653|NCT01100320|578929|P1|STARTED|Period 2||38
238654|NCT01100320|578928|P2|NOT COMPLETED|Period 1||7
238655|NCT01100320|578929|P1|NOT COMPLETED|Period 1||5
238656|NCT01100320|578928|P2|COMPLETED|Period 1||38
238657|NCT01100320|578929|P1|COMPLETED|Period 1||38
238658|NCT01100320|578928|P2|STARTED|Period 1||45
238659|NCT01100320|578929|P1|STARTED|Period 1||43
238660|NCT01100307|578941|P2|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||13
238661|NCT01100307|578942|P1|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||6
238662|NCT01100307|578941|P2|COMPLETED|Open Phase (Week 24 up to Week 54)||99
238663|NCT01100307|578942|P1|COMPLETED|Open Phase (Week 24 up to Week 54)||110
238664|NCT01100307|578941|P2|STARTED|Open Phase (Week 24 up to Week 54)|Four participants did not enter to the open phase after completing the double masked phase.|112
238665|NCT01100307|578942|P1|STARTED|Open Phase (Week 24 up to Week 54)|One participant discontinued from the study due to adverse event before study drug administration.|116
238666|NCT01100307|578941|P2|NOT COMPLETED|Double Masked Phase (Up to Week 24)||4
238667|NCT01100307|578942|P1|NOT COMPLETED|Double Masked Phase (Up to Week 24)||6
238668|NCT01100307|578941|P2|COMPLETED|Double Masked Phase (Up to Week 24)||116
238669|NCT01100307|578942|P1|COMPLETED|Double Masked Phase (Up to Week 24)||117
238670|NCT01100307|578941|P2|STARTED|Double Masked Phase (Up to Week 24)||120
238671|NCT01100307|578942|P1|STARTED|Double Masked Phase (Up to Week 24)||123
238672|NCT01100268|578984|P1|NOT COMPLETED|Overall Study||0
238673|NCT01100268|578984|P1|COMPLETED|Overall Study||4
238674|NCT01100268|578984|P1|STARTED|Overall Study||4
238675|NCT01100255|578991|P2|NOT COMPLETED|Overall Study||0
238676|NCT01100255|578992|P1|NOT COMPLETED|Overall Study||0
238677|NCT01100255|578991|P2|COMPLETED|Overall Study||7
238678|NCT01100255|578992|P1|COMPLETED|Overall Study||8
238679|NCT01100255|578991|P2|STARTED|Overall Study||7
238680|NCT01100255|578992|P1|STARTED|Overall Study||8
238681|NCT01100242|578998|P1|NOT COMPLETED|Overall Study||0
238682|NCT01100242|578998|P1|COMPLETED|Overall Study||17
238683|NCT01100242|578998|P1|STARTED|Overall Study||17
238684|NCT01100112|579004|P1|NOT COMPLETED|Overall Study||8
238685|NCT01100112|579004|P1|COMPLETED|Overall Study||52
238686|NCT01100112|579004|P1|STARTED|Overall Study||60
238687|NCT01100086|579011|P2|NOT COMPLETED|Period 2||0
238688|NCT01100086|579012|P1|NOT COMPLETED|Period 2||0
238689|NCT01100086|579011|P2|COMPLETED|Period 2||41
238690|NCT01100086|579012|P1|COMPLETED|Period 2||42
238691|NCT01100086|579011|P2|STARTED|Period 2||41
238692|NCT01100086|579012|P1|STARTED|Period 2||42
238693|NCT01100086|579011|P2|NOT COMPLETED|Period 1||0
238694|NCT01100086|579012|P1|NOT COMPLETED|Period 1||1
238695|NCT01100086|579011|P2|COMPLETED|Period 1||41
238696|NCT01100086|579012|P1|COMPLETED|Period 1||42
238697|NCT01100086|579011|P2|STARTED|Period 1||41
238698|NCT01100086|579012|P1|STARTED|Period 1||43
238699|NCT01100073|579022|P1|NOT COMPLETED|Overall Study||100
238700|NCT01100073|579022|P1|COMPLETED|Overall Study|End of study (Visit 3)|1599
238701|NCT01100073|579022|P1|STARTED|Overall Study|Baseline (Visit 1)|1699
238702|NCT01100034|579037|P1|NOT COMPLETED|Overall Study||43
238703|NCT01100034|579037|P1|COMPLETED|Overall Study||29
238704|NCT01100034|579037|P1|STARTED|Overall Study||72
238705|NCT01099969|579050|P4|NOT COMPLETED|Overall Study||0
238706|NCT01099969|579051|P3|NOT COMPLETED|Overall Study||0
238707|NCT01099969|579052|P2|NOT COMPLETED|Overall Study||0
238708|NCT01099969|579053|P1|NOT COMPLETED|Overall Study||0
238709|NCT01099969|579050|P4|COMPLETED|Overall Study||15
238710|NCT01099969|579051|P3|COMPLETED|Overall Study||15
238711|NCT01099969|579052|P2|COMPLETED|Overall Study||15
238712|NCT01099969|579053|P1|COMPLETED|Overall Study||15
238713|NCT01099969|579050|P4|STARTED|Overall Study||15
238714|NCT01099969|579051|P3|STARTED|Overall Study||15
238715|NCT01099969|579052|P2|STARTED|Overall Study||15
238716|NCT01099969|579053|P1|STARTED|Overall Study||15
238717|NCT01099917|579075|P1|NOT COMPLETED|Overall Study||27
238718|NCT01099917|579075|P1|COMPLETED|Overall Study||18
238719|NCT01099917|579075|P1|STARTED|Overall Study||45
238720|NCT01099774|579081|P2|NOT COMPLETED|Overall Study||6
238721|NCT01099774|579082|P1|NOT COMPLETED|Overall Study||6
238722|NCT01099774|579081|P2|COMPLETED|Overall Study||289
238723|NCT01099774|579082|P1|COMPLETED|Overall Study||296
238724|NCT01099774|579081|P2|STARTED|Overall Study||295
238725|NCT01099774|579082|P1|STARTED|Overall Study||302
238726|NCT01099761|579098|P4|NOT COMPLETED|Overall Study||0
238727|NCT01099761|579099|P3|NOT COMPLETED|Overall Study||0
238728|NCT01099761|579100|P2|NOT COMPLETED|Overall Study||0
238729|NCT01099761|579101|P1|NOT COMPLETED|Overall Study||0
238730|NCT01099761|579098|P4|COMPLETED|Overall Study||6
238731|NCT01099761|579099|P3|COMPLETED|Overall Study||0
238732|NCT01099761|579100|P2|COMPLETED|Overall Study||9
238733|NCT01099761|579101|P1|COMPLETED|Overall Study||9
238734|NCT01099761|579098|P4|STARTED|Overall Study||6
238735|NCT01099761|579099|P3|STARTED|Overall Study|Study terminated prior to enrolling cohort 3|0
238736|NCT01099761|579100|P2|STARTED|Overall Study||9
238737|NCT01099761|579101|P1|STARTED|Overall Study||9
238738|NCT01099709|579137|P2|NOT COMPLETED|Period 2||0
238739|NCT01099709|579138|P1|NOT COMPLETED|Period 2||0
238740|NCT01099709|579137|P2|COMPLETED|Period 2||41
238741|NCT01099709|579138|P1|COMPLETED|Period 2||41
238742|NCT01099709|579137|P2|STARTED|Period 2||41
238743|NCT01099709|579138|P1|STARTED|Period 2||41
238744|NCT01099709|579137|P2|NOT COMPLETED|Period 1||2
238745|NCT01099709|579138|P1|NOT COMPLETED|Period 1||1
238746|NCT01099709|579137|P2|COMPLETED|Period 1||41
238747|NCT01099709|579138|P1|COMPLETED|Period 1||41
238748|NCT01099709|579137|P2|STARTED|Period 1||43
238749|NCT01099709|579138|P1|STARTED|Period 1||42
238750|NCT01099618|579151|P3|NOT COMPLETED|Overall Study||0
238751|NCT01099618|579152|P2|NOT COMPLETED|Overall Study||0
238752|NCT01099618|579153|P1|NOT COMPLETED|Overall Study||0
238753|NCT01099618|579151|P3|COMPLETED|Overall Study||15
238754|NCT01099618|579152|P2|COMPLETED|Overall Study||16
238755|NCT01099618|579153|P1|COMPLETED|Overall Study||17
238756|NCT01099618|579151|P3|STARTED|Overall Study||15
238757|NCT01099618|579152|P2|STARTED|Overall Study||16
238758|NCT01099618|579153|P1|STARTED|Overall Study||17
238759|NCT01099579|579164|P3|NOT COMPLETED|Stage 2 (ATV Capsule)||6
238760|NCT01099579|579165|P2|NOT COMPLETED|Stage 2 (ATV Capsule)||5
238761|NCT01099579|579166|P1|NOT COMPLETED|Stage 2 (ATV Capsule)||6
238762|NCT01099579|579164|P3|COMPLETED|Stage 2 (ATV Capsule)||9
238763|NCT01099579|579165|P2|COMPLETED|Stage 2 (ATV Capsule)||9
238764|NCT01099579|579166|P1|COMPLETED|Stage 2 (ATV Capsule)||10
238765|NCT01099579|579164|P3|STARTED|Stage 2 (ATV Capsule)||15
238766|NCT01099579|579165|P2|STARTED|Stage 2 (ATV Capsule)||14
238767|NCT01099579|579166|P1|STARTED|Stage 2 (ATV Capsule)||16
238768|NCT01099579|579164|P3|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||1
238769|NCT01099579|579165|P2|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||5
238770|NCT01099579|579166|P1|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||4
238771|NCT01099579|579164|P3|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|15
238772|NCT01099579|579165|P2|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|14
238773|NCT01099579|579166|P1|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|17
238774|NCT01099579|579164|P3|STARTED|Stage 1 (ATV Powder Formulation)||16
238775|NCT01099579|579165|P2|STARTED|Stage 1 (ATV Powder Formulation)||19
238776|NCT01099579|579166|P1|STARTED|Stage 1 (ATV Powder Formulation)||21
238777|NCT01099475|579222|P2|NOT COMPLETED|Overall Study||0
238778|NCT01099475|579223|P1|NOT COMPLETED|Overall Study||0
238779|NCT01099475|579222|P2|COMPLETED|Overall Study||10
238780|NCT01099475|579223|P1|COMPLETED|Overall Study||10
238781|NCT01099475|579222|P2|STARTED|Overall Study||10
238782|NCT01099475|579223|P1|STARTED|Overall Study||10
238783|NCT01099449|579238|P3|NOT COMPLETED|Overall Study||0
238784|NCT01099449|579239|P2|NOT COMPLETED|Overall Study||0
238785|NCT01099449|579240|P1|NOT COMPLETED|Overall Study||0
238786|NCT01099449|579238|P3|COMPLETED|Overall Study||116
238787|NCT01099449|579239|P2|COMPLETED|Overall Study||119
238788|NCT01099449|579240|P1|COMPLETED|Overall Study||118
238789|NCT01099449|579238|P3|STARTED|Overall Study||116
238790|NCT01099449|579239|P2|STARTED|Overall Study||119
238791|NCT01099449|579240|P1|STARTED|Overall Study||118
238792|NCT01099397|579275|P1|NOT COMPLETED|Overall Study||13
238793|NCT01099397|579275|P1|COMPLETED|Overall Study||26
238794|NCT01099397|579275|P1|STARTED|Overall Study||39
238795|NCT01099358|579280|P4|NOT COMPLETED|Overall Study||4
238796|NCT01099358|579281|P3|NOT COMPLETED|Overall Study||8
238797|NCT01099358|579282|P2|NOT COMPLETED|Overall Study||1
238798|NCT01099358|579283|P1|NOT COMPLETED|Overall Study||3
238799|NCT01099358|579280|P4|COMPLETED|Overall Study||12
238800|NCT01099358|579281|P3|COMPLETED|Overall Study||13
238801|NCT01099358|579282|P2|COMPLETED|Overall Study||5
238802|NCT01099358|579283|P1|COMPLETED|Overall Study||1
238803|NCT01099358|579280|P4|Received at Least One Dose of Study Drug|Overall Study||15
238804|NCT01099358|579281|P3|Received at Least One Dose of Study Drug|Overall Study||20
238805|NCT01099358|579282|P2|Received at Least One Dose of Study Drug|Overall Study||6
238806|NCT01099358|579283|P1|Received at Least One Dose of Study Drug|Overall Study||3
238807|NCT01099358|579280|P4|STARTED|Overall Study||16
238808|NCT01099358|579281|P3|STARTED|Overall Study||21
238809|NCT01099358|579282|P2|STARTED|Overall Study||6
238810|NCT01099358|579283|P1|STARTED|Overall Study||4
238811|NCT01099267|579302|P1|NOT COMPLETED|MDS-009 Extension Follow-up||0
238812|NCT01099267|579302|P1|COMPLETED|MDS-009 Extension Follow-up||54
238813|NCT01099267|579302|P1|Other Source of Follow-up Info Used|MDS-009 Extension Follow-up|Social Security Death Index, public records, verbal reports from health providers and next of kin.|21
238814|NCT01099267|579302|P1|Informed Consent Given|MDS-009 Extension Follow-up||33
238815|NCT01099267|579302|P1|STARTED|MDS-009 Extension Follow-up|Participants from MDS-003 (including some who did not complete) at sites participating in MDS-009.|54
238816|NCT01099267|579302|P1|NOT COMPLETED|MDS-003 Study||124
238817|NCT01099267|579302|P1|COMPLETED|MDS-003 Study||24
238818|NCT01099267|579302|P1|STARTED|MDS-003 Study|This information duplicates results in NCT00065156.|148
238819|NCT01099215|579312|P2|NOT COMPLETED|Overall Study||1
238820|NCT01099215|579313|P1|NOT COMPLETED|Overall Study||1
238821|NCT01099215|579312|P2|COMPLETED|Overall Study||9
238822|NCT01099215|579313|P1|COMPLETED|Overall Study||10
238823|NCT01099215|579312|P2|STARTED|Overall Study||10
238824|NCT01099215|579313|P1|STARTED|Overall Study||11
238825|NCT01099202|579351|P2|NOT COMPLETED|Overall Study||0
238826|NCT01099202|579352|P1|NOT COMPLETED|Overall Study||0
238827|NCT01099202|579351|P2|COMPLETED|Overall Study||54
238828|NCT01099202|579352|P1|COMPLETED|Overall Study||55
238829|NCT01099202|579351|P2|STARTED|Overall Study||54
238830|NCT01099202|579352|P1|STARTED|Overall Study||55
238831|NCT01099111|579365|P5|NOT COMPLETED|Overall Study||0
238832|NCT01099111|579366|P4|NOT COMPLETED|Overall Study||0
238833|NCT01099111|579367|P3|NOT COMPLETED|Overall Study||0
238834|NCT01099111|579368|P2|NOT COMPLETED|Overall Study||0
238835|NCT01099111|579369|P1|NOT COMPLETED|Overall Study||0
238836|NCT01099111|579365|P5|COMPLETED|Overall Study|6 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
238837|NCT01099111|579366|P4|COMPLETED|Overall Study||29
238838|NCT01099111|579367|P3|COMPLETED|Overall Study|2 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|46
238839|NCT01099111|579368|P2|COMPLETED|Overall Study|3 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
238840|NCT01099111|579369|P1|COMPLETED|Overall Study|5 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
238841|NCT01099111|579365|P5|STARTED|Overall Study||50
238842|NCT01099111|579366|P4|STARTED|Overall Study||29
238843|NCT01099111|579367|P3|STARTED|Overall Study||46
238844|NCT01099111|579368|P2|STARTED|Overall Study||50
238845|NCT01099111|579369|P1|STARTED|Overall Study||50
238846|NCT01098851|579383|P2|NOT COMPLETED|Overall Study||0
238847|NCT01098851|579384|P1|NOT COMPLETED|Overall Study||1
238848|NCT01098851|579383|P2|COMPLETED|Overall Study||10
238849|NCT01098851|579384|P1|COMPLETED|Overall Study||10
238850|NCT01098851|579383|P2|STARTED|Overall Study||10
238851|NCT01098851|579384|P1|STARTED|Overall Study||11
238852|NCT01098812|579395|P3|NOT COMPLETED|Overall Study||1
238853|NCT01098812|579396|P2|NOT COMPLETED|Overall Study||1
238854|NCT01098812|579397|P1|NOT COMPLETED|Overall Study||2
238855|NCT01098812|579395|P3|COMPLETED|Overall Study||71
238856|NCT01098812|579396|P2|COMPLETED|Overall Study||101
238857|NCT01098812|579397|P1|COMPLETED|Overall Study||93
238858|NCT01098812|579395|P3|STARTED|Overall Study||72
238859|NCT01098812|579396|P2|STARTED|Overall Study||102
238860|NCT01098812|579397|P1|STARTED|Overall Study||95
238861|NCT01098747|579411|P4|NOT COMPLETED|Overall Study||0
238862|NCT01098747|579412|P3|NOT COMPLETED|Overall Study||0
238863|NCT01098747|579413|P2|NOT COMPLETED|Overall Study||0
238864|NCT01098747|579414|P1|NOT COMPLETED|Overall Study||0
238865|NCT01098747|579411|P4|COMPLETED|Overall Study||87
238866|NCT01098747|579412|P3|COMPLETED|Overall Study||86
238867|NCT01098747|579413|P2|COMPLETED|Overall Study||95
238868|NCT01098747|579414|P1|COMPLETED|Overall Study||48
238869|NCT01098747|579411|P4|STARTED|Overall Study||87
238870|NCT01098747|579412|P3|STARTED|Overall Study||86
238871|NCT01098747|579413|P2|STARTED|Overall Study||95
238872|NCT01098747|579414|P1|STARTED|Overall Study||48
238873|NCT01098578|579464|P1|NOT COMPLETED|Overall Study||0
238874|NCT01098578|579464|P1|COMPLETED|Overall Study||20
238875|NCT01098578|579464|P1|STARTED|Overall Study||20
238876|NCT01098539|579473|P2|NOT COMPLETED|Overall Study||68
238877|NCT01098539|579474|P1|NOT COMPLETED|Overall Study||51
238878|NCT01098539|579473|P2|COMPLETED|Overall Study||178
238879|NCT01098539|579474|P1|COMPLETED|Overall Study||198
238880|NCT01098539|579473|P2|STARTED|Overall Study||246
238881|NCT01098539|579474|P1|STARTED|Overall Study||249
238882|NCT01098500|579510|P1|NOT COMPLETED|Overall Study||0
238883|NCT01098500|579510|P1|COMPLETED|Overall Study||3800
238884|NCT01098500|579510|P1|STARTED|Overall Study||3800
238885|NCT01098487|579525|P1|NOT COMPLETED|Overall Study||44
238886|NCT01098487|579525|P1|COMPLETED|Overall Study||118
238887|NCT01098487|579525|P1|STARTED|Overall Study||162
238888|NCT01098474|579543|P6|NOT COMPLETED|Follow Up Phase||5
238889|NCT01098474|579544|P5|NOT COMPLETED|Follow Up Phase||2
238890|NCT01098474|579545|P4|NOT COMPLETED|Follow Up Phase||2
238891|NCT01098474|579546|P3|NOT COMPLETED|Follow Up Phase||0
238892|NCT01098474|579547|P2|NOT COMPLETED|Follow Up Phase||0
238893|NCT01098474|579548|P1|NOT COMPLETED|Follow Up Phase||0
238894|NCT01098474|579543|P6|COMPLETED|Follow Up Phase||44
238895|NCT01098474|579544|P5|COMPLETED|Follow Up Phase||50
238896|NCT01098474|579545|P4|COMPLETED|Follow Up Phase||47
238897|NCT01098474|579546|P3|COMPLETED|Follow Up Phase||45
238898|NCT01098474|579547|P2|COMPLETED|Follow Up Phase||49
238899|NCT01098474|579548|P1|COMPLETED|Follow Up Phase||48
238900|NCT01098474|579543|P6|STARTED|Follow Up Phase||49
238901|NCT01098474|579544|P5|STARTED|Follow Up Phase||52
238902|NCT01098474|579545|P4|STARTED|Follow Up Phase||49
238903|NCT01098474|579546|P3|STARTED|Follow Up Phase||45
238904|NCT01098474|579547|P2|STARTED|Follow Up Phase||49
238905|NCT01098474|579548|P1|STARTED|Follow Up Phase||48
238906|NCT01098474|579543|P6|NOT COMPLETED|Active Phase||0
238907|NCT01098474|579544|P5|NOT COMPLETED|Active Phase||0
238908|NCT01098474|579545|P4|NOT COMPLETED|Active Phase||0
238909|NCT01098474|579546|P3|NOT COMPLETED|Active Phase||5
238910|NCT01098474|579547|P2|NOT COMPLETED|Active Phase||1
238911|NCT01098474|579548|P1|NOT COMPLETED|Active Phase||2
238912|NCT01098474|579543|P6|COMPLETED|Active Phase||49
238913|NCT01098474|579544|P5|COMPLETED|Active Phase||52
238914|NCT01098474|579545|P4|COMPLETED|Active Phase||49
238915|NCT01098474|579546|P3|COMPLETED|Active Phase||45
238916|NCT01098474|579547|P2|COMPLETED|Active Phase||49
238917|NCT01098474|579548|P1|COMPLETED|Active Phase||48
238918|NCT01098474|579543|P6|STARTED|Active Phase||49
238919|NCT01098474|579544|P5|STARTED|Active Phase||52
238920|NCT01098474|579545|P4|STARTED|Active Phase||49
238921|NCT01098474|579546|P3|STARTED|Active Phase||50
238922|NCT01098474|579547|P2|STARTED|Active Phase||50
238923|NCT01098474|579548|P1|STARTED|Active Phase||50
238924|NCT01098461|579782|P4|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
238925|NCT01098461|579783|P3|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||1
238926|NCT01098461|579784|P2|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||3
238927|NCT01098461|579785|P1|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
238928|NCT01098461|579782|P4|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
238929|NCT01098461|579783|P3|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
238930|NCT01098461|579784|P2|COMPLETED|Follow-up (FU) Period (8 Weeks)||49
238931|NCT01098461|579785|P1|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
238932|NCT01098461|579782|P4|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
238933|NCT01098461|579783|P3|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|53
238934|NCT01098461|579784|P2|STARTED|Follow-up (FU) Period (8 Weeks)||52
238935|NCT01098461|579785|P1|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
238936|NCT01098461|579782|P4|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||3
238937|NCT01098461|579783|P3|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||1
238938|NCT01098461|579784|P2|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||7
238939|NCT01098461|579785|P1|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||12
238940|NCT01098461|579782|P4|COMPLETED|Treatment Period (TP) (16 Weeks)||50
238941|NCT01098461|579783|P3|COMPLETED|Treatment Period (TP) (16 Weeks)||53
238942|NCT01098461|579784|P2|COMPLETED|Treatment Period (TP) (16 Weeks)||45
238943|NCT01098461|579785|P1|COMPLETED|Treatment Period (TP) (16 Weeks)||41
238944|NCT01098461|579782|P4|STARTED|Treatment Period (TP) (16 Weeks)||53
238945|NCT01098461|579783|P3|STARTED|Treatment Period (TP) (16 Weeks)||54
238946|NCT01098461|579784|P2|STARTED|Treatment Period (TP) (16 Weeks)||52
238947|NCT01098461|579785|P1|STARTED|Treatment Period (TP) (16 Weeks)||53
238948|NCT01098318|579818|P3|NOT COMPLETED|Overall Study||3
238949|NCT01098318|579819|P2|NOT COMPLETED|Overall Study||7
238950|NCT01098318|579820|P1|NOT COMPLETED|Overall Study||3
238951|NCT01098318|579818|P3|COMPLETED|Overall Study||15
238952|NCT01098318|579819|P2|COMPLETED|Overall Study||12
238953|NCT01098318|579820|P1|COMPLETED|Overall Study||17
238954|NCT01098318|579818|P3|STARTED|Overall Study||18
238955|NCT01098318|579819|P2|STARTED|Overall Study||19
238956|NCT01098318|579820|P1|STARTED|Overall Study||20
238957|NCT01098305|579845|P2|NOT COMPLETED|Overall Study||33
238958|NCT01098305|579846|P1|NOT COMPLETED|Overall Study||31
238959|NCT01098305|579845|P2|COMPLETED|Overall Study||85
238960|NCT01098305|579846|P1|COMPLETED|Overall Study||88
238961|NCT01098305|579845|P2|STARTED|Overall Study||118
238962|NCT01098305|579846|P1|STARTED|Overall Study||119
238963|NCT01098266|579856|P2|NOT COMPLETED|Overall Study||7
238964|NCT01098266|579857|P1|NOT COMPLETED|Overall Study||7
238965|NCT01098266|579856|P2|COMPLETED|Overall Study||193
238966|NCT01098266|579857|P1|COMPLETED|Overall Study||193
238967|NCT01098266|579856|P2|STARTED|Overall Study||200
238968|NCT01098266|579857|P1|STARTED|Overall Study||200
238969|NCT01098253|579877|P2|NOT COMPLETED|Overall Study||0
238970|NCT01098253|579878|P1|NOT COMPLETED|Overall Study||2
238971|NCT01098253|579877|P2|COMPLETED|Overall Study||88
238972|NCT01098253|579878|P1|COMPLETED|Overall Study||92
238973|NCT01098253|579877|P2|STARTED|Overall Study||88
238974|NCT01098253|579878|P1|STARTED|Overall Study||94
238975|NCT01098240|579886|P3|NOT COMPLETED|Double-Blind Phase||22
238976|NCT01098240|579887|P2|NOT COMPLETED|Double-Blind Phase||17
238977|NCT01098240|579888|P1|NOT COMPLETED|Double-Blind Phase||0
238978|NCT01098240|579886|P3|COMPLETED|Double-Blind Phase||63
238979|NCT01098240|579887|P2|COMPLETED|Double-Blind Phase||60
238980|NCT01098240|579888|P1|COMPLETED|Double-Blind Phase||0
238981|NCT01098240|579886|P3|STARTED|Double-Blind Phase||85
238982|NCT01098240|579887|P2|STARTED|Double-Blind Phase||77
238983|NCT01098240|579888|P1|STARTED|Double-Blind Phase||0
238984|NCT01098240|579886|P3|NOT COMPLETED|Open-Label Phase||0
238985|NCT01098240|579887|P2|NOT COMPLETED|Open-Label Phase||0
238986|NCT01098240|579888|P1|NOT COMPLETED|Open-Label Phase||135
238987|NCT01098240|579886|P3|COMPLETED|Open-Label Phase||0
238988|NCT01098240|579887|P2|COMPLETED|Open-Label Phase||0
238989|NCT01098240|579888|P1|COMPLETED|Open-Label Phase||162
238990|NCT01098240|579886|P3|STARTED|Open-Label Phase||0
238991|NCT01098240|579887|P2|STARTED|Open-Label Phase||0
238992|NCT01098240|579888|P1|STARTED|Open-Label Phase||297
238993|NCT01098162|579918|P1|NOT COMPLETED|Overall Study||112
238994|NCT01098162|579918|P1|COMPLETED|Overall Study||461
238995|NCT01098162|579918|P1|STARTED|Overall Study||573
238996|NCT01098110|579930|P3|NOT COMPLETED|Overall Study||94
238997|NCT01098110|579931|P2|NOT COMPLETED|Overall Study||73
238998|NCT01098110|579932|P1|NOT COMPLETED|Overall Study||62
238999|NCT01098110|579930|P3|COMPLETED|Overall Study||80
239000|NCT01098110|579931|P2|COMPLETED|Overall Study||109
239001|NCT01098110|579932|P1|COMPLETED|Overall Study||114
239002|NCT01098110|579930|P3|Treated|Overall Study|Received at least one dose of trial medication|174
239003|NCT01098110|579931|P2|Treated|Overall Study|Received at least one dose of trial medication|181
239004|NCT01098110|579932|P1|Treated|Overall Study|Received at least one dose of trial medication|175
239005|NCT01098110|579930|P3|STARTED|Overall Study|Randomized participants|174
239006|NCT01098110|579931|P2|STARTED|Overall Study|Randomized participants|182
239007|NCT01098110|579932|P1|STARTED|Overall Study|Randomized participants|176
239008|NCT01098097|579973|P1|NOT COMPLETED|Overall Study||82
239009|NCT01098097|579973|P1|COMPLETED|Overall Study|Participants completing the study received at least 12 weeks of treatment|881
239010|NCT01098097|579973|P1|STARTED|Overall Study||963
239011|NCT01098071|579982|P1|NOT COMPLETED|Overall Study||15
239012|NCT01098071|579982|P1|COMPLETED|Overall Study||19
239013|NCT01098071|579982|P1|STARTED|Overall Study||34
239014|NCT01098032|579995|P2|NOT COMPLETED|Overall Study||1
239015|NCT01098032|579996|P1|NOT COMPLETED|Overall Study||1
239016|NCT01098032|579995|P2|COMPLETED|Overall Study||146
239017|NCT01098032|579996|P1|COMPLETED|Overall Study||146
239018|NCT01098032|579995|P2|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
239019|NCT01098032|579996|P1|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
239020|NCT01098006|580006|P4|NOT COMPLETED|Overall Study||0
239021|NCT01098006|580007|P3|NOT COMPLETED|Overall Study||0
239022|NCT01098006|580008|P2|NOT COMPLETED|Overall Study||0
239023|NCT01098006|580009|P1|NOT COMPLETED|Overall Study||0
239024|NCT01098006|580006|P4|COMPLETED|Overall Study||21
239025|NCT01098006|580007|P3|COMPLETED|Overall Study||60
239026|NCT01098006|580008|P2|COMPLETED|Overall Study||11
239027|NCT01098006|580009|P1|COMPLETED|Overall Study||7
239028|NCT01098006|580006|P4|STARTED|Overall Study||21
239029|NCT01098006|580007|P3|STARTED|Overall Study||60
239030|NCT01098006|580008|P2|STARTED|Overall Study||11
239031|NCT01098006|580009|P1|STARTED|Overall Study||7
239032|NCT01097915|580086|P3|NOT COMPLETED|Overall Study||30
239033|NCT01097915|580087|P2|NOT COMPLETED|Overall Study||42
239034|NCT01097915|580088|P1|NOT COMPLETED|Overall Study||23
239035|NCT01097915|580086|P3|COMPLETED|Overall Study||20
239036|NCT01097915|580087|P2|COMPLETED|Overall Study||28
239037|NCT01097915|580088|P1|COMPLETED|Overall Study||27
239038|NCT01097915|580086|P3|STARTED|Overall Study||50
239039|NCT01097915|580087|P2|STARTED|Overall Study||70
239040|NCT01097915|580088|P1|STARTED|Overall Study||50
239041|NCT01097863|580113|P3|NOT COMPLETED|Overall Study||2
239042|NCT01097863|580114|P2|NOT COMPLETED|Overall Study||0
239043|NCT01097863|580115|P1|NOT COMPLETED|Overall Study||1
239044|NCT01097863|580113|P3|COMPLETED|Overall Study||89
239045|NCT01097863|580114|P2|COMPLETED|Overall Study||98
239046|NCT01097863|580115|P1|COMPLETED|Overall Study||89
239047|NCT01097863|580113|P3|STARTED|Overall Study||91
239048|NCT01097863|580114|P2|STARTED|Overall Study||98
239049|NCT01097863|580115|P1|STARTED|Overall Study||90
239050|NCT01097785|580125|P2|NOT COMPLETED|Cycle 3 (30 Days)||0
239051|NCT01097785|580126|P1|NOT COMPLETED|Cycle 3 (30 Days)||0
239052|NCT01097785|580125|P2|COMPLETED|Cycle 3 (30 Days)||6
239053|NCT01097785|580126|P1|COMPLETED|Cycle 3 (30 Days)||6
239054|NCT01097785|580125|P2|STARTED|Cycle 3 (30 Days)||6
239055|NCT01097785|580126|P1|STARTED|Cycle 3 (30 Days)||6
239056|NCT01097785|580125|P2|NOT COMPLETED|Washout (2 Weeks)||0
239057|NCT01097785|580126|P1|NOT COMPLETED|Washout (2 Weeks)||0
239058|NCT01097785|580125|P2|COMPLETED|Washout (2 Weeks)||6
239059|NCT01097785|580126|P1|COMPLETED|Washout (2 Weeks)||6
239060|NCT01097785|580125|P2|STARTED|Washout (2 Weeks)||6
239061|NCT01097785|580126|P1|STARTED|Washout (2 Weeks)||6
239062|NCT01097785|580125|P2|NOT COMPLETED|Cycle 1 (30 Days)||0
239063|NCT01097785|580126|P1|NOT COMPLETED|Cycle 1 (30 Days)||0
239064|NCT01097785|580125|P2|COMPLETED|Cycle 1 (30 Days)||6
239065|NCT01097785|580126|P1|COMPLETED|Cycle 1 (30 Days)||6
239066|NCT01097785|580125|P2|STARTED|Cycle 1 (30 Days)||6
239067|NCT01097785|580126|P1|STARTED|Cycle 1 (30 Days)||6
239068|NCT01097707|580139|P5|NOT COMPLETED|Overall Study||50
239069|NCT01097707|580140|P4|NOT COMPLETED|Overall Study||44
239070|NCT01097707|580141|P3|NOT COMPLETED|Overall Study||45
239071|NCT01097707|580142|P2|NOT COMPLETED|Overall Study||43
239072|NCT01097707|580143|P1|NOT COMPLETED|Overall Study||44
239073|NCT01097707|580139|P5|COMPLETED|Overall Study||35
239074|NCT01097707|580140|P4|COMPLETED|Overall Study||40
239075|NCT01097707|580141|P3|COMPLETED|Overall Study||37
239076|NCT01097707|580142|P2|COMPLETED|Overall Study||37
239077|NCT01097707|580143|P1|COMPLETED|Overall Study||39
239078|NCT01097707|580139|P5|STARTED|Overall Study||85
239079|NCT01097707|580140|P4|STARTED|Overall Study||84
239080|NCT01097707|580141|P3|STARTED|Overall Study||82
239081|NCT01097707|580142|P2|STARTED|Overall Study||80
239082|NCT01097707|580143|P1|STARTED|Overall Study||83
239083|NCT01097694|580192|P2|NOT COMPLETED|Overall Study||4
239084|NCT01097694|580193|P1|NOT COMPLETED|Overall Study||8
239085|NCT01097694|580192|P2|COMPLETED|Overall Study||26
239086|NCT01097694|580193|P1|COMPLETED|Overall Study||24
239087|NCT01097694|580192|P2|STARTED|Overall Study||30
239088|NCT01097694|580193|P1|STARTED|Overall Study||32
239089|NCT01097668|580255|P2|NOT COMPLETED|Overall Study||2
239090|NCT01097668|580256|P1|NOT COMPLETED|Overall Study||2
239091|NCT01097668|580255|P2|COMPLETED|Overall Study||20
239092|NCT01097668|580256|P1|COMPLETED|Overall Study||19
239093|NCT01097668|580255|P2|Week 48|Overall Study||20
239094|NCT01097668|580256|P1|Week 48|Overall Study||19
239095|NCT01097668|580255|P2|Week 20|Overall Study|Patient evaluability time point = week 20|22
239096|NCT01097668|580256|P1|Week 20|Overall Study|Patient evaluability time point = week 20|21
239097|NCT01097668|580255|P2|STARTED|Overall Study||22
239098|NCT01097668|580256|P1|STARTED|Overall Study||21
239099|NCT01097655|580266|P1|NOT COMPLETED|Overall Study||10
239100|NCT01097655|580266|P1|COMPLETED|Overall Study|participants included for analysis|3039
239101|NCT01097655|580266|P1|STARTED|Overall Study||3049
239102|NCT01097629|580276|P8|NOT COMPLETED|DB RO Phase||1
239103|NCT01097629|580277|P7|NOT COMPLETED|DB RO Phase||3
239104|NCT01097629|580278|P6|NOT COMPLETED|DB RO Phase||1
239105|NCT01097629|580279|P5|NOT COMPLETED|DB RO Phase||0
239106|NCT01097629|580280|P4|NOT COMPLETED|DB RO Phase||1
239107|NCT01097629|580281|P3|NOT COMPLETED|DB RO Phase||0
239108|NCT01097629|580282|P2|NOT COMPLETED|DB RO Phase||0
239109|NCT01097629|580283|P1|NOT COMPLETED|DB RO Phase||0
239110|NCT01097629|580276|P8|COMPLETED|DB RO Phase||326
239111|NCT01097629|580277|P7|COMPLETED|DB RO Phase||168
239112|NCT01097629|580278|P6|COMPLETED|DB RO Phase||172
239113|NCT01097629|580279|P5|COMPLETED|DB RO Phase||108
239114|NCT01097629|580280|P4|COMPLETED|DB RO Phase||96
239115|NCT01097629|580281|P3|COMPLETED|DB RO Phase||0
239116|NCT01097629|580282|P2|COMPLETED|DB RO Phase||0
239117|NCT01097629|580283|P1|COMPLETED|DB RO Phase||0
239118|NCT01097629|580276|P8|STARTED|DB RO Phase||327
239119|NCT01097629|580277|P7|STARTED|DB RO Phase||171
239120|NCT01097629|580278|P6|STARTED|DB RO Phase||173
239121|NCT01097629|580279|P5|STARTED|DB RO Phase||108
239122|NCT01097629|580280|P4|STARTED|DB RO Phase||97
239123|NCT01097629|580281|P3|STARTED|DB RO Phase||0
239124|NCT01097629|580282|P2|STARTED|DB RO Phase||0
239125|NCT01097629|580283|P1|STARTED|DB RO Phase||0
239126|NCT01097629|580276|P8|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
239127|NCT01097629|580277|P7|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
239128|NCT01097629|580278|P6|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
239129|NCT01097629|580279|P5|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
239130|NCT01097629|580280|P4|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
239131|NCT01097629|580281|P3|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||57
239132|NCT01097629|580282|P2|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||46
239133|NCT01097629|580283|P1|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||35
239134|NCT01097629|580276|P8|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
239135|NCT01097629|580277|P7|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
239136|NCT01097629|580278|P6|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
239137|NCT01097629|580279|P5|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
239138|NCT01097629|580280|P4|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
239139|NCT01097629|580281|P3|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|3 did not continue into RO|330
239140|NCT01097629|580282|P2|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|2 did not continue into RO|346
239141|NCT01097629|580283|P1|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||205
239142|NCT01097629|580276|P8|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
239143|NCT01097629|580277|P7|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
239144|NCT01097629|580278|P6|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
239145|NCT01097629|580279|P5|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
239146|NCT01097629|580280|P4|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
239147|NCT01097629|580281|P3|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
239148|NCT01097629|580282|P2|Treated|Double-Blind (DB) Treatment (TRT) Phase||387
239149|NCT01097629|580283|P1|Treated|Double-Blind (DB) Treatment (TRT) Phase||239
239150|NCT01097629|580276|P8|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
239151|NCT01097629|580277|P7|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
239152|NCT01097629|580278|P6|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
239153|NCT01097629|580279|P5|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
239154|NCT01097629|580280|P4|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
239155|NCT01097629|580281|P3|STARTED|Double-Blind (DB) Treatment (TRT) Phase||387
239156|NCT01097629|580282|P2|STARTED|Double-Blind (DB) Treatment (TRT) Phase||392
239157|NCT01097629|580283|P1|STARTED|Double-Blind (DB) Treatment (TRT) Phase||240
239158|NCT01097616|580334|P8|NOT COMPLETED|DB RO Phase||1
239159|NCT01097616|580335|P7|NOT COMPLETED|DB RO Phase||1
239160|NCT01097616|580336|P6|NOT COMPLETED|DB RO Phase||2
239161|NCT01097616|580337|P5|NOT COMPLETED|DB RO Phase||1
239162|NCT01097616|580338|P4|NOT COMPLETED|DB RO Phase||1
239163|NCT01097616|580339|P3|NOT COMPLETED|DB RO Phase||0
239164|NCT01097616|580340|P2|NOT COMPLETED|DB RO Phase||0
239165|NCT01097616|580341|P1|NOT COMPLETED|DB RO Phase||0
239166|NCT01097616|580334|P8|COMPLETED|DB RO Phase||326
239167|NCT01097616|580335|P7|COMPLETED|DB RO Phase||161
239168|NCT01097616|580336|P6|COMPLETED|DB RO Phase||159
239169|NCT01097616|580337|P5|COMPLETED|DB RO Phase||111
239170|NCT01097616|580338|P4|COMPLETED|DB RO Phase||100
239171|NCT01097616|580339|P3|COMPLETED|DB RO Phase||0
239172|NCT01097616|580340|P2|COMPLETED|DB RO Phase||0
239173|NCT01097616|580341|P1|COMPLETED|DB RO Phase||0
239174|NCT01097616|580334|P8|STARTED|DB RO Phase||327
239175|NCT01097616|580335|P7|STARTED|DB RO Phase||162
239176|NCT01097616|580336|P6|STARTED|DB RO Phase|1 entered RO but was not treated during RO|161
239177|NCT01097616|580337|P5|STARTED|DB RO Phase|1 was randomized to this group but actually received suvorexant LD during RO|112
239178|NCT01097616|580338|P4|STARTED|DB RO Phase||101
239179|NCT01097616|580339|P3|STARTED|DB RO Phase||0
239180|NCT01097616|580340|P2|STARTED|DB RO Phase||0
239181|NCT01097616|580341|P1|STARTED|DB RO Phase||0
239182|NCT01097616|580334|P8|NOT COMPLETED|Optional DB EXT Phase||0
239183|NCT01097616|580335|P7|NOT COMPLETED|Optional DB EXT Phase||0
239184|NCT01097616|580336|P6|NOT COMPLETED|Optional DB EXT Phase||0
239185|NCT01097616|580337|P5|NOT COMPLETED|Optional DB EXT Phase||0
239186|NCT01097616|580338|P4|NOT COMPLETED|Optional DB EXT Phase||0
239187|NCT01097616|580339|P3|NOT COMPLETED|Optional DB EXT Phase||10
239188|NCT01097616|580340|P2|NOT COMPLETED|Optional DB EXT Phase||21
239189|NCT01097616|580341|P1|NOT COMPLETED|Optional DB EXT Phase||15
239190|NCT01097616|580334|P8|COMPLETED|Optional DB EXT Phase||0
239191|NCT01097616|580335|P7|COMPLETED|Optional DB EXT Phase||0
239192|NCT01097616|580336|P6|COMPLETED|Optional DB EXT Phase||0
239193|NCT01097616|580337|P5|COMPLETED|Optional DB EXT Phase||0
239194|NCT01097616|580338|P4|COMPLETED|Optional DB EXT Phase||0
239195|NCT01097616|580339|P3|COMPLETED|Optional DB EXT Phase|All 141 continued into RO|141
239196|NCT01097616|580340|P2|COMPLETED|Optional DB EXT Phase|All 151 continued into RO|151
239197|NCT01097616|580341|P1|COMPLETED|Optional DB EXT Phase|All 85 continued into RO|85
239198|NCT01097616|580334|P8|STARTED|Optional DB EXT Phase||0
239199|NCT01097616|580335|P7|STARTED|Optional DB EXT Phase||0
239200|NCT01097616|580336|P6|STARTED|Optional DB EXT Phase||0
239201|NCT01097616|580337|P5|STARTED|Optional DB EXT Phase||0
239202|NCT01097616|580338|P4|STARTED|Optional DB EXT Phase||0
239203|NCT01097616|580339|P3|STARTED|Optional DB EXT Phase||151
239204|NCT01097616|580340|P2|STARTED|Optional DB EXT Phase||172
239205|NCT01097616|580341|P1|STARTED|Optional DB EXT Phase||100
239206|NCT01097616|580334|P8|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
239207|NCT01097616|580335|P7|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
239208|NCT01097616|580336|P6|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
239209|NCT01097616|580337|P5|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
239210|NCT01097616|580338|P4|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
239211|NCT01097616|580339|P3|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||44
239212|NCT01097616|580340|P2|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||38
239213|NCT01097616|580341|P1|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||24
239214|NCT01097616|580334|P8|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
239215|NCT01097616|580335|P7|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
239216|NCT01097616|580336|P6|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
239217|NCT01097616|580337|P5|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
239218|NCT01097616|580338|P4|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
239219|NCT01097616|580339|P3|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|151 continued into EXT, 186 continued directly into RO, 4 did not continue into either Phase|341
239303|NCT01096849|580515|P2|STARTED|Overall Study||76
239304|NCT01096849|580516|P1|STARTED|Overall Study||22
239220|NCT01097616|580340|P2|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|172 continued into EXT, 172 continued directly into RO, 1 did not continue into either Phase|345
239221|NCT01097616|580341|P1|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|100 continued into EXT, 128 continued directly into RO, 2 did not continue into either Phase|230
239222|NCT01097616|580334|P8|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
239223|NCT01097616|580335|P7|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
239224|NCT01097616|580336|P6|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
239225|NCT01097616|580337|P5|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
239226|NCT01097616|580338|P4|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
239227|NCT01097616|580339|P3|Treated|Double-Blind (DB) Treatment (TRT) Phase||384
239228|NCT01097616|580340|P2|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
239229|NCT01097616|580341|P1|Treated|Double-Blind (DB) Treatment (TRT) Phase||254
239230|NCT01097616|580334|P8|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
239231|NCT01097616|580335|P7|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
239232|NCT01097616|580336|P6|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
239233|NCT01097616|580337|P5|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
239234|NCT01097616|580338|P4|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
239235|NCT01097616|580339|P3|STARTED|Double-Blind (DB) Treatment (TRT) Phase||385
239236|NCT01097616|580340|P2|STARTED|Double-Blind (DB) Treatment (TRT) Phase||383
239237|NCT01097616|580341|P1|STARTED|Double-Blind (DB) Treatment (TRT) Phase||254
239238|NCT01097460|580412|P1|NOT COMPLETED|Overall Study||0
239239|NCT01097460|580412|P1|COMPLETED|Overall Study||16
239240|NCT01097460|580412|P1|STARTED|Overall Study||16
239241|NCT01097421|580416|P1|NOT COMPLETED|Overall Study||14
239242|NCT01097421|580416|P1|COMPLETED|Overall Study||314
239243|NCT01097421|580416|P1|STARTED|Overall Study||328
239244|NCT01097343|580426|P2|NOT COMPLETED|Second Intervention- 30 Days||0
239245|NCT01097343|580427|P1|NOT COMPLETED|Second Intervention- 30 Days||0
239246|NCT01097343|580426|P2|COMPLETED|Second Intervention- 30 Days||25
239247|NCT01097343|580427|P1|COMPLETED|Second Intervention- 30 Days||25
239248|NCT01097343|580426|P2|STARTED|Second Intervention- 30 Days||25
239249|NCT01097343|580427|P1|STARTED|Second Intervention- 30 Days||25
239250|NCT01097343|580426|P2|NOT COMPLETED|First Intervention- 30 Days||0
239251|NCT01097343|580427|P1|NOT COMPLETED|First Intervention- 30 Days||0
239252|NCT01097343|580426|P2|COMPLETED|First Intervention- 30 Days||25
239253|NCT01097343|580427|P1|COMPLETED|First Intervention- 30 Days||25
239254|NCT01097343|580426|P2|STARTED|First Intervention- 30 Days||25
239255|NCT01097343|580427|P1|STARTED|First Intervention- 30 Days||25
239256|NCT01097304|580433|P1|NOT COMPLETED|Overall Study||7
239257|NCT01097304|580433|P1|COMPLETED|Overall Study||29
239258|NCT01097304|580433|P1|STARTED|Overall Study||36
239259|NCT01097057|580440|P1|NOT COMPLETED|Overall Study||3
239260|NCT01097057|580440|P1|COMPLETED|Overall Study||17
239261|NCT01097057|580440|P1|STARTED|Overall Study||20
239262|NCT01097044|580449|P2|NOT COMPLETED|Overall Study||5
239263|NCT01097044|580450|P1|NOT COMPLETED|Overall Study||5
239264|NCT01097044|580449|P2|COMPLETED|Overall Study||33
239265|NCT01097044|580450|P1|COMPLETED|Overall Study||34
239266|NCT01097044|580449|P2|STARTED|Overall Study||38
239267|NCT01097044|580450|P1|STARTED|Overall Study||39
239268|NCT01097005|580468|P1|NOT COMPLETED|Overall Study||365
239269|NCT01097005|580468|P1|COMPLETED|Overall Study||101
239270|NCT01097005|580468|P1|Analysis of CGI|Overall Study|number of participants who were measured for Clinical Global Improvement (CGI)|249
239271|NCT01097005|580468|P1|Analysis of Bacilli Negative Conversion|Overall Study|number of participants who were analysed for bacilli negative conversion|285
239272|NCT01097005|580468|P1|Analysis of NTM Lung Disease|Overall Study|number of participants who contributed to the Baseline data|340
239273|NCT01097005|580468|P1|Analysis of Safety|Overall Study|number of participants who could be measured for Adverse Events|441
239274|NCT01097005|580468|P1|STARTED|Overall Study|number of participants who were enrolled for this study.|466
239275|NCT01096992|580479|P5|NOT COMPLETED|Overall Study||0
239276|NCT01096992|580480|P4|NOT COMPLETED|Overall Study||0
239277|NCT01096992|580481|P3|NOT COMPLETED|Overall Study||0
239278|NCT01096992|580482|P2|NOT COMPLETED|Overall Study||0
239279|NCT01096992|580483|P1|NOT COMPLETED|Overall Study||0
239280|NCT01096992|580479|P5|COMPLETED|Overall Study||30
239281|NCT01096992|580480|P4|COMPLETED|Overall Study||6
239282|NCT01096992|580481|P3|COMPLETED|Overall Study||6
239283|NCT01096992|580482|P2|COMPLETED|Overall Study||3
239284|NCT01096992|580483|P1|COMPLETED|Overall Study||6
239285|NCT01096992|580479|P5|STARTED|Overall Study||30
239286|NCT01096992|580480|P4|STARTED|Overall Study||6
239287|NCT01096992|580481|P3|STARTED|Overall Study||6
239288|NCT01096992|580482|P2|STARTED|Overall Study||3
239289|NCT01096992|580483|P1|STARTED|Overall Study||6
239290|NCT01096875|580498|P2|NOT COMPLETED|Overall Study||1
239291|NCT01096875|580499|P1|NOT COMPLETED|Overall Study||0
239292|NCT01096875|580498|P2|COMPLETED|Overall Study||29
239293|NCT01096875|580499|P1|COMPLETED|Overall Study||30
239294|NCT01096875|580498|P2|STARTED|Overall Study||30
239295|NCT01096875|580499|P1|STARTED|Overall Study||30
239296|NCT01096849|580514|P3|NOT COMPLETED|Overall Study||6
239297|NCT01096849|580515|P2|NOT COMPLETED|Overall Study||12
239298|NCT01096849|580516|P1|NOT COMPLETED|Overall Study||2
239299|NCT01096849|580514|P3|COMPLETED|Overall Study||41
239300|NCT01096849|580515|P2|COMPLETED|Overall Study||64
239301|NCT01096849|580516|P1|COMPLETED|Overall Study||20
239302|NCT01096849|580514|P3|STARTED|Overall Study||47
239305|NCT01096823|580571|P2|NOT COMPLETED|Overall Study||1
239306|NCT01096823|580572|P1|NOT COMPLETED|Overall Study||3
239307|NCT01096823|580571|P2|COMPLETED|Overall Study||15
239308|NCT01096823|580572|P1|COMPLETED|Overall Study||11
239309|NCT01096823|580571|P2|STARTED|Overall Study||16
239310|NCT01096823|580572|P1|STARTED|Overall Study||14
239311|NCT01096810|580584|P1|NOT COMPLETED|Overall Study||0
239312|NCT01096810|580584|P1|COMPLETED|Overall Study||20
239313|NCT01096810|580584|P1|STARTED|Overall Study||20
239314|NCT01096784|580592|P2|NOT COMPLETED|Overall Study||14
239315|NCT01096784|580593|P1|NOT COMPLETED|Overall Study||15
239316|NCT01096784|580592|P2|COMPLETED|Overall Study||46
239317|NCT01096784|580593|P1|COMPLETED|Overall Study||46
239318|NCT01096784|580592|P2|STARTED|Overall Study||60
239319|NCT01096784|580593|P1|STARTED|Overall Study||61
239320|NCT01096771|580627|P2|NOT COMPLETED|Overall Study||0
239321|NCT01096771|580628|P1|NOT COMPLETED|Overall Study||0
239322|NCT01096771|580627|P2|COMPLETED|Overall Study||7
239323|NCT01096771|580628|P1|COMPLETED|Overall Study||7
239324|NCT01096771|580627|P2|STARTED|Overall Study||7
239325|NCT01096771|580628|P1|STARTED|Overall Study||7
239326|NCT01096680|580657|P5|NOT COMPLETED|Overall Study||0
239327|NCT01096680|580658|P4|NOT COMPLETED|Overall Study||0
239328|NCT01096680|580659|P3|NOT COMPLETED|Overall Study||0
239329|NCT01096680|580660|P2|NOT COMPLETED|Overall Study||0
239330|NCT01096680|580661|P1|NOT COMPLETED|Overall Study||0
239331|NCT01096680|580657|P5|COMPLETED|Overall Study||27
239332|NCT01096680|580658|P4|COMPLETED|Overall Study||27
239333|NCT01096680|580659|P3|COMPLETED|Overall Study||27
239334|NCT01096680|580660|P2|COMPLETED|Overall Study||27
239335|NCT01096680|580661|P1|COMPLETED|Overall Study||27
239336|NCT01096680|580657|P5|STARTED|Overall Study||27
239337|NCT01096680|580658|P4|STARTED|Overall Study||27
239338|NCT01096680|580659|P3|STARTED|Overall Study||27
239339|NCT01096680|580660|P2|STARTED|Overall Study||27
239340|NCT01096680|580661|P1|STARTED|Overall Study||27
239341|NCT01096667|580698|P5|NOT COMPLETED|Overall Study||0
239342|NCT01096667|580699|P4|NOT COMPLETED|Overall Study||3
239343|NCT01096667|580700|P3|NOT COMPLETED|Overall Study||2
239344|NCT01096667|580701|P2|NOT COMPLETED|Overall Study||2
239345|NCT01096667|580702|P1|NOT COMPLETED|Overall Study||3
239346|NCT01096667|580698|P5|COMPLETED|Overall Study||39
239347|NCT01096667|580699|P4|COMPLETED|Overall Study||36
239348|NCT01096667|580700|P3|COMPLETED|Overall Study||36
239349|NCT01096667|580701|P2|COMPLETED|Overall Study||37
239350|NCT01096667|580702|P1|COMPLETED|Overall Study||36
239351|NCT01096667|580698|P5|Treated|Overall Study||39
239352|NCT01096667|580699|P4|Treated|Overall Study||39
239353|NCT01096667|580700|P3|Treated|Overall Study||38
239354|NCT01096667|580701|P2|Treated|Overall Study||39
239355|NCT01096667|580702|P1|Treated|Overall Study||38
239356|NCT01096667|580698|P5|STARTED|Overall Study||39
239357|NCT01096667|580699|P4|STARTED|Overall Study||39
239358|NCT01096667|580700|P3|STARTED|Overall Study||38
239359|NCT01096667|580701|P2|STARTED|Overall Study||39
239360|NCT01096667|580702|P1|STARTED|Overall Study||39
239361|NCT01096589|580844|P4|NOT COMPLETED|Overall Study||3
239362|NCT01096589|580845|P3|NOT COMPLETED|Overall Study||4
239363|NCT01096589|580846|P2|NOT COMPLETED|Overall Study||2
239364|NCT01096589|580847|P1|NOT COMPLETED|Overall Study||4
239365|NCT01096589|580844|P4|COMPLETED|Overall Study||15
239366|NCT01096589|580845|P3|COMPLETED|Overall Study||18
239367|NCT01096589|580846|P2|COMPLETED|Overall Study||18
239368|NCT01096589|580847|P1|COMPLETED|Overall Study||18
239369|NCT01096589|580844|P4|STARTED|Overall Study||18
239370|NCT01096589|580845|P3|STARTED|Overall Study||22
239371|NCT01096589|580846|P2|STARTED|Overall Study||20
239372|NCT01096589|580847|P1|STARTED|Overall Study||22
239373|NCT01096550|580863|P2|NOT COMPLETED|Overall Study||29
239374|NCT01096550|580864|P1|NOT COMPLETED|Overall Study||37
239375|NCT01096550|580863|P2|COMPLETED|Overall Study||146
239376|NCT01096550|580864|P1|COMPLETED|Overall Study||133
239377|NCT01096550|580863|P2|STARTED|Overall Study||175
239378|NCT01096550|580864|P1|STARTED|Overall Study||170
239379|NCT01096446|580872|P2|NOT COMPLETED|Overall Study||0
239380|NCT01096446|580873|P1|NOT COMPLETED|Overall Study||3
239381|NCT01096446|580872|P2|COMPLETED|Overall Study||10
239382|NCT01096446|580873|P1|COMPLETED|Overall Study|One infant was SGA; one infant had a congenital anomaly; and one discontinued medical management|9
239383|NCT01096446|580872|P2|STARTED|Overall Study||10
239384|NCT01096446|580873|P1|STARTED|Overall Study||12
239385|NCT01096342|580878|P1|NOT COMPLETED|Overall Study||1
239386|NCT01096342|580878|P1|COMPLETED|Overall Study||15
239387|NCT01096342|580878|P1|STARTED|Overall Study||16
239388|NCT01096316|580886|P2|NOT COMPLETED|Overall Study||9
239389|NCT01096316|580887|P1|NOT COMPLETED|Overall Study||15
239390|NCT01096316|580886|P2|COMPLETED|Overall Study||94
239391|NCT01096316|580887|P1|COMPLETED|Overall Study||87
239392|NCT01096316|580886|P2|STARTED|Overall Study||103
239393|NCT01096316|580887|P1|STARTED|Overall Study||102
239394|NCT01096186|580897|P1|NOT COMPLETED|Overall Study||50
239395|NCT01096186|580897|P1|COMPLETED|Overall Study||567
239396|NCT01096186|580897|P1|STARTED|Overall Study||617
239397|NCT01096160|580913|P10|NOT COMPLETED|Overall Study||1
239398|NCT01096160|580914|P9|NOT COMPLETED|Overall Study||2
239399|NCT01096160|580915|P8|NOT COMPLETED|Overall Study||0
239400|NCT01096160|580916|P7|NOT COMPLETED|Overall Study||2
239401|NCT01096160|580917|P6|NOT COMPLETED|Overall Study||0
239402|NCT01096160|580918|P5|NOT COMPLETED|Overall Study||1
239403|NCT01096160|580919|P4|NOT COMPLETED|Overall Study||0
239404|NCT01096160|580920|P3|NOT COMPLETED|Overall Study||1
239405|NCT01096160|580921|P2|NOT COMPLETED|Overall Study||0
239406|NCT01096160|580922|P1|NOT COMPLETED|Overall Study||0
239407|NCT01096160|580913|P10|COMPLETED|Overall Study||1
239408|NCT01096160|580914|P9|COMPLETED|Overall Study||4
239409|NCT01096160|580915|P8|COMPLETED|Overall Study||2
239410|NCT01096160|580916|P7|COMPLETED|Overall Study||4
239411|NCT01096160|580917|P6|COMPLETED|Overall Study||2
239412|NCT01096160|580918|P5|COMPLETED|Overall Study||5
239413|NCT01096160|580919|P4|COMPLETED|Overall Study||2
239414|NCT01096160|580920|P3|COMPLETED|Overall Study||5
239415|NCT01096160|580921|P2|COMPLETED|Overall Study||2
239416|NCT01096160|580922|P1|COMPLETED|Overall Study||6
239417|NCT01096160|580913|P10|STARTED|Overall Study||2
239418|NCT01096160|580914|P9|STARTED|Overall Study||6
239419|NCT01096160|580915|P8|STARTED|Overall Study||2
239420|NCT01096160|580916|P7|STARTED|Overall Study||6
239421|NCT01096160|580917|P6|STARTED|Overall Study||2
239422|NCT01096160|580918|P5|STARTED|Overall Study||6
239423|NCT01096160|580919|P4|STARTED|Overall Study||2
239424|NCT01096160|580920|P3|STARTED|Overall Study||6
239425|NCT01096160|580921|P2|STARTED|Overall Study||2
239426|NCT01096160|580922|P1|STARTED|Overall Study||6
239427|NCT01096056|580980|P2|NOT COMPLETED|Overall Study||1
239428|NCT01096056|580981|P1|NOT COMPLETED|Overall Study||0
239429|NCT01096056|580980|P2|COMPLETED|Overall Study||19
239430|NCT01096056|580981|P1|COMPLETED|Overall Study||20
239431|NCT01096056|580980|P2|Completed at Day 42|Overall Study||20
239432|NCT01096056|580981|P1|Completed at Day 42|Overall Study||20
239433|NCT01096056|580980|P2|STARTED|Overall Study||20
239434|NCT01096056|580981|P1|STARTED|Overall Study||20
239435|NCT01096017|581013|P2|NOT COMPLETED|Treatment Period 2||1
239436|NCT01096017|581014|P1|NOT COMPLETED|Treatment Period 2||1
239437|NCT01096017|581013|P2|COMPLETED|Treatment Period 2||11
239438|NCT01096017|581014|P1|COMPLETED|Treatment Period 2||11
239439|NCT01096017|581013|P2|STARTED|Treatment Period 2||12
239440|NCT01096017|581014|P1|STARTED|Treatment Period 2||12
239441|NCT01096017|581013|P2|NOT COMPLETED|Washout 1 - 14 Days||0
239442|NCT01096017|581014|P1|NOT COMPLETED|Washout 1 - 14 Days||0
239443|NCT01096017|581013|P2|COMPLETED|Washout 1 - 14 Days||12
239444|NCT01096017|581014|P1|COMPLETED|Washout 1 - 14 Days||12
239445|NCT01096017|581013|P2|STARTED|Washout 1 - 14 Days||12
239446|NCT01096017|581014|P1|STARTED|Washout 1 - 14 Days||12
239447|NCT01096017|581013|P2|NOT COMPLETED|Treatment Period 1||0
239448|NCT01096017|581014|P1|NOT COMPLETED|Treatment Period 1||0
239449|NCT01096017|581013|P2|COMPLETED|Treatment Period 1||12
239450|NCT01096017|581014|P1|COMPLETED|Treatment Period 1||12
239451|NCT01096017|581013|P2|STARTED|Treatment Period 1||12
239452|NCT01096017|581014|P1|STARTED|Treatment Period 1||12
239453|NCT01095978|581042|P1|NOT COMPLETED|Overall Study||3
239454|NCT01095978|581042|P1|COMPLETED|Overall Study||2819
239455|NCT01095978|581042|P1|STARTED|Overall Study||2822
239456|NCT01095887|581069|P1|NOT COMPLETED|Overall Study||0
239457|NCT01095887|581069|P1|COMPLETED|Overall Study||6
239458|NCT01095887|581069|P1|STARTED|Overall Study||6
239459|NCT01095835|581076|P3|NOT COMPLETED|Overall Study||8
239460|NCT01095835|581077|P2|NOT COMPLETED|Overall Study||12
239461|NCT01095835|581078|P1|NOT COMPLETED|Overall Study||10
239462|NCT01095835|581076|P3|COMPLETED|Overall Study||17
239463|NCT01095835|581077|P2|COMPLETED|Overall Study||40
239464|NCT01095835|581078|P1|COMPLETED|Overall Study||41
239465|NCT01095835|581076|P3|STARTED|Overall Study||25
239466|NCT01095835|581077|P2|STARTED|Overall Study||52
239467|NCT01095835|581078|P1|STARTED|Overall Study||51
239468|NCT01095796|581116|P2|NOT COMPLETED|Overall Study||289
239469|NCT01095796|581117|P1|NOT COMPLETED|Overall Study||295
239470|NCT01095796|581116|P2|COMPLETED|Overall Study||65
239471|NCT01095796|581117|P1|COMPLETED|Overall Study||58
239472|NCT01095796|581116|P2|STARTED|Overall Study||354
239473|NCT01095796|581117|P1|STARTED|Overall Study||353
239474|NCT01095757|581135|P1|NOT COMPLETED|Overall Study||0
239475|NCT01095757|581135|P1|COMPLETED|Overall Study||45
239476|NCT01095757|581135|P1|STARTED|Overall Study||45
239477|NCT01095666|581147|P3|NOT COMPLETED|Overall Study||7
239478|NCT01095666|581148|P2|NOT COMPLETED|Overall Study||11
239479|NCT01095666|581149|P1|NOT COMPLETED|Overall Study||17
239480|NCT01095666|581147|P3|COMPLETED|Overall Study||145
239481|NCT01095666|581148|P2|COMPLETED|Overall Study||136
239482|NCT01095666|581149|P1|COMPLETED|Overall Study||128
239483|NCT01095666|581147|P3|STARTED|Overall Study||152
239484|NCT01095666|581148|P2|STARTED|Overall Study||147
239485|NCT01095666|581149|P1|STARTED|Overall Study||145
239486|NCT01095653|581172|P3|NOT COMPLETED|Overall Study||16
239487|NCT01095653|581173|P2|NOT COMPLETED|Overall Study||15
239488|NCT01095653|581174|P1|NOT COMPLETED|Overall Study||19
239489|NCT01095653|581172|P3|COMPLETED|Overall Study||117
239490|NCT01095653|581173|P2|COMPLETED|Overall Study||113
239491|NCT01095653|581174|P1|COMPLETED|Overall Study||113
239492|NCT01095653|581172|P3|STARTED|Overall Study||133
239493|NCT01095653|581173|P2|STARTED|Overall Study||128
239494|NCT01095653|581174|P1|STARTED|Overall Study||132
239495|NCT01095510|581197|P4|NOT COMPLETED|Overall Study||0
239496|NCT01095510|581198|P3|NOT COMPLETED|Overall Study||0
239497|NCT01095510|581199|P2|NOT COMPLETED|Overall Study||0
239498|NCT01095510|581200|P1|NOT COMPLETED|Overall Study||0
239499|NCT01095510|581197|P4|COMPLETED|Overall Study||3
239500|NCT01095510|581198|P3|COMPLETED|Overall Study||3
239501|NCT01095510|581199|P2|COMPLETED|Overall Study||0
239502|NCT01095510|581200|P1|COMPLETED|Overall Study||3
239503|NCT01095510|581197|P4|STARTED|Overall Study||3
239504|NCT01095510|581198|P3|STARTED|Overall Study||3
239505|NCT01095510|581199|P2|STARTED|Overall Study||0
239506|NCT01095510|581200|P1|STARTED|Overall Study||3
239507|NCT01095497|581219|P2|NOT COMPLETED|Subcutaneous CINRYZE||0
239508|NCT01095497|581220|P1|NOT COMPLETED|Subcutaneous CINRYZE||1
239509|NCT01095497|581219|P2|COMPLETED|Subcutaneous CINRYZE||12
239510|NCT01095497|581220|P1|COMPLETED|Subcutaneous CINRYZE||12
239511|NCT01095497|581219|P2|STARTED|Subcutaneous CINRYZE||12
239512|NCT01095497|581220|P1|STARTED|Subcutaneous CINRYZE||13
239513|NCT01095497|581219|P2|NOT COMPLETED|Intravenous CINRYZE||0
239514|NCT01095497|581220|P1|NOT COMPLETED|Intravenous CINRYZE||1
239515|NCT01095497|581219|P2|COMPLETED|Intravenous CINRYZE||12
239516|NCT01095497|581220|P1|COMPLETED|Intravenous CINRYZE||13
239517|NCT01095497|581219|P2|STARTED|Intravenous CINRYZE||12
239518|NCT01095497|581220|P1|STARTED|Intravenous CINRYZE||14
239519|NCT01095250|581232|P4|NOT COMPLETED|Overall Study||5
239520|NCT01095250|581233|P3|NOT COMPLETED|Overall Study||8
239521|NCT01095250|581234|P2|NOT COMPLETED|Overall Study||10
239522|NCT01095250|581235|P1|NOT COMPLETED|Overall Study||8
239523|NCT01095250|581232|P4|COMPLETED|Overall Study||0
239524|NCT01095250|581233|P3|COMPLETED|Overall Study||0
239525|NCT01095250|581234|P2|COMPLETED|Overall Study||0
239526|NCT01095250|581235|P1|COMPLETED|Overall Study||0
239527|NCT01095250|581232|P4|STARTED|Overall Study||5
239528|NCT01095250|581233|P3|STARTED|Overall Study||8
239529|NCT01095250|581234|P2|STARTED|Overall Study||10
239530|NCT01095250|581235|P1|STARTED|Overall Study||8
239531|NCT01095094|581265|P1|NOT COMPLETED|Overall Study||3
239532|NCT01095094|581265|P1|COMPLETED|Overall Study||16
239533|NCT01095094|581265|P1|STARTED|Overall Study||19
239534|NCT01095003|581272|P2|NOT COMPLETED|Overall Study||386
239535|NCT01095003|581273|P1|NOT COMPLETED|Overall Study||384
239536|NCT01095003|581272|P2|COMPLETED|Overall Study||0
239537|NCT01095003|581273|P1|COMPLETED|Overall Study||0
239538|NCT01095003|581272|P2|STARTED|Overall Study||386
239539|NCT01095003|581273|P1|STARTED|Overall Study||384
239540|NCT01094886|581287|P1|NOT COMPLETED|Overall Study||7
239541|NCT01094886|581287|P1|COMPLETED|Overall Study||46
239542|NCT01094886|581287|P1|STARTED|Overall Study||53
239543|NCT01094808|581297|P3|NOT COMPLETED|Overall Study||0
239544|NCT01094808|581298|P2|NOT COMPLETED|Overall Study||1
239545|NCT01094808|581299|P1|NOT COMPLETED|Overall Study||1
239546|NCT01094808|581297|P3|COMPLETED|Overall Study||21
239547|NCT01094808|581298|P2|COMPLETED|Overall Study||19
239548|NCT01094808|581299|P1|COMPLETED|Overall Study||20
239549|NCT01094808|581297|P3|STARTED|Overall Study||21
239550|NCT01094808|581298|P2|STARTED|Overall Study||20
239551|NCT01094808|581299|P1|STARTED|Overall Study||21
239552|NCT01094782|581340|P6|NOT COMPLETED|Overall Study||8
239553|NCT01094782|581341|P5|NOT COMPLETED|Overall Study||11
239554|NCT01094782|581342|P4|NOT COMPLETED|Overall Study||11
239555|NCT01094782|581343|P3|NOT COMPLETED|Overall Study||3
239556|NCT01094782|581344|P2|NOT COMPLETED|Overall Study||10
239557|NCT01094782|581345|P1|NOT COMPLETED|Overall Study||8
239558|NCT01094782|581340|P6|COMPLETED|Overall Study||30
239559|NCT01094782|581341|P5|COMPLETED|Overall Study||31
239560|NCT01094782|581342|P4|COMPLETED|Overall Study||45
239561|NCT01094782|581343|P3|COMPLETED|Overall Study||31
239562|NCT01094782|581344|P2|COMPLETED|Overall Study||29
239563|NCT01094782|581345|P1|COMPLETED|Overall Study||31
239564|NCT01094782|581340|P6|STARTED|Overall Study||38
239565|NCT01094782|581341|P5|STARTED|Overall Study||42
239566|NCT01094782|581342|P4|STARTED|Overall Study||56
239567|NCT01094782|581343|P3|STARTED|Overall Study||34
239568|NCT01094782|581344|P2|STARTED|Overall Study||39
239569|NCT01094782|581345|P1|STARTED|Overall Study||39
239570|NCT01094743|581389|P1|NOT COMPLETED|Period 2||0
239571|NCT01094743|581389|P1|COMPLETED|Period 2||50
239572|NCT01094743|581389|P1|STARTED|Period 2||50
239573|NCT01094743|581389|P1|NOT COMPLETED|Period 1||2
239574|NCT01094743|581389|P1|COMPLETED|Period 1||50
239575|NCT01094743|581389|P1|STARTED|Period 1||52
239576|NCT01094730|581406|P2|NOT COMPLETED|Period 2 (14 Days)||2
239577|NCT01094730|581407|P1|NOT COMPLETED|Period 2 (14 Days)||3
239578|NCT01094730|581406|P2|COMPLETED|Period 2 (14 Days)||84
239579|NCT01094730|581407|P1|COMPLETED|Period 2 (14 Days)||87
239580|NCT01094730|581406|P2|STARTED|Period 2 (14 Days)||86
239581|NCT01094730|581407|P1|STARTED|Period 2 (14 Days)||90
239582|NCT01094730|581406|P2|NOT COMPLETED|Period 1 (14 Days)||2
239583|NCT01094730|581407|P1|NOT COMPLETED|Period 1 (14 Days)||2
239584|NCT01094730|581406|P2|COMPLETED|Period 1 (14 Days)||86
239585|NCT01094730|581407|P1|COMPLETED|Period 1 (14 Days)||90
239586|NCT01094730|581406|P2|STARTED|Period 1 (14 Days)||88
239587|NCT01094730|581407|P1|STARTED|Period 1 (14 Days)||92
239588|NCT01094717|581420|P2|NOT COMPLETED|Overall Study||0
239589|NCT01094717|581421|P1|NOT COMPLETED|Overall Study||0
239590|NCT01094717|581420|P2|COMPLETED|Overall Study||10
239591|NCT01094717|581421|P1|COMPLETED|Overall Study||3
239592|NCT01094717|581420|P2|STARTED|Overall Study||10
239593|NCT01094717|581421|P1|STARTED|Overall Study||3
239594|NCT01094704|581439|P2|NOT COMPLETED|Overall Study||0
239595|NCT01094704|581440|P1|NOT COMPLETED|Overall Study||0
239596|NCT01094704|581439|P2|COMPLETED|Overall Study||8
239597|NCT01094704|581440|P1|COMPLETED|Overall Study||8
239598|NCT01094704|581439|P2|STARTED|Overall Study||8
239599|NCT01094704|581440|P1|STARTED|Overall Study||8
239600|NCT01094574|581452|P6|NOT COMPLETED|Overall Study||0
239601|NCT01094574|581453|P5|NOT COMPLETED|Overall Study||0
239602|NCT01094574|581454|P4|NOT COMPLETED|Overall Study||0
239603|NCT01094574|581455|P3|NOT COMPLETED|Overall Study||0
239604|NCT01094574|581456|P2|NOT COMPLETED|Overall Study||0
239605|NCT01094574|581457|P1|NOT COMPLETED|Overall Study||0
239606|NCT01094574|581452|P6|COMPLETED|Overall Study||2
239607|NCT01094574|581453|P5|COMPLETED|Overall Study||2
239608|NCT01094574|581454|P4|COMPLETED|Overall Study||2
239609|NCT01094574|581455|P3|COMPLETED|Overall Study||2
239610|NCT01094574|581456|P2|COMPLETED|Overall Study||1
239611|NCT01094574|581457|P1|COMPLETED|Overall Study||1
239612|NCT01094574|581452|P6|STARTED|Overall Study||2
239613|NCT01094574|581453|P5|STARTED|Overall Study||2
239614|NCT01094574|581454|P4|STARTED|Overall Study||2
239615|NCT01094574|581455|P3|STARTED|Overall Study||2
239616|NCT01094574|581456|P2|STARTED|Overall Study||1
239617|NCT01094574|581457|P1|STARTED|Overall Study||1
239618|NCT01094561|581504|P1|NOT COMPLETED|Overall Study||6
239619|NCT01094561|581504|P1|COMPLETED|Overall Study||17
239620|NCT01094561|581504|P1|STARTED|Overall Study||23
239621|NCT01094548|581511|P2|NOT COMPLETED|Overall Study||0
239622|NCT01094548|581512|P1|NOT COMPLETED|Overall Study||0
239623|NCT01094548|581511|P2|COMPLETED|Overall Study||17
239624|NCT01094548|581512|P1|COMPLETED|Overall Study||17
239625|NCT01094548|581511|P2|STARTED|Overall Study||17
239626|NCT01094548|581512|P1|STARTED|Overall Study||17
239627|NCT01094522|581532|P2|NOT COMPLETED|Overall Study||0
239628|NCT01094522|581533|P1|NOT COMPLETED|Overall Study||0
239629|NCT01094522|581532|P2|COMPLETED|Overall Study||20
239630|NCT01094522|581533|P1|COMPLETED|Overall Study||20
239631|NCT01094522|581532|P2|STARTED|Overall Study||20
239632|NCT01094522|581533|P1|STARTED|Overall Study||20
239633|NCT01094301|581543|P1|NOT COMPLETED|Implant Stage||8
239634|NCT01094301|581543|P1|COMPLETED|Implant Stage||5
239635|NCT01094301|581543|P1|Subjects Who Received SPR IPG|Implant Stage||5
239636|NCT01094301|581543|P1|Met Criteria for Implant Stage|Implant Stage||7
239637|NCT01094301|581543|P1|STARTED|Implant Stage||13
239638|NCT01094301|581543|P1|NOT COMPLETED|Trial Stage||1
239639|NCT01094301|581543|P1|COMPLETED|Trial Stage||27
239640|NCT01094301|581543|P1|Subjects Who Received Smartpatch Lead|Trial Stage||28
239641|NCT01094301|581543|P1|STARTED|Trial Stage||28
239642|NCT01094288|581573|P8|NOT COMPLETED|Overall Study||2
239643|NCT01094288|581574|P7|NOT COMPLETED|Overall Study||0
239644|NCT01094288|581575|P6|NOT COMPLETED|Overall Study||0
239645|NCT01094288|581576|P5|NOT COMPLETED|Overall Study||0
239646|NCT01094288|581577|P4|NOT COMPLETED|Overall Study||2
239647|NCT01094288|581578|P3|NOT COMPLETED|Overall Study||4
239648|NCT01094288|581579|P2|NOT COMPLETED|Overall Study||10
239649|NCT01094288|581580|P1|NOT COMPLETED|Overall Study||2
239650|NCT01094288|581573|P8|COMPLETED|Overall Study||2
239651|NCT01094288|581574|P7|COMPLETED|Overall Study||2
239652|NCT01094288|581575|P6|COMPLETED|Overall Study||4
239653|NCT01094288|581576|P5|COMPLETED|Overall Study||2
239654|NCT01094288|581577|P4|COMPLETED|Overall Study||1
239655|NCT01094288|581578|P3|COMPLETED|Overall Study||1
239656|NCT01094288|581579|P2|COMPLETED|Overall Study||5
239657|NCT01094288|581580|P1|COMPLETED|Overall Study|Completed=Completed Treatment|4
239658|NCT01094288|581573|P8|STARTED|Overall Study||4
239659|NCT01094288|581574|P7|STARTED|Overall Study||2
239660|NCT01094288|581575|P6|STARTED|Overall Study||4
239661|NCT01094288|581576|P5|STARTED|Overall Study||2
239662|NCT01094288|581577|P4|STARTED|Overall Study||3
239663|NCT01094288|581578|P3|STARTED|Overall Study||5
239664|NCT01094288|581579|P2|STARTED|Overall Study||15
239665|NCT01094288|581580|P1|STARTED|Overall Study||6
239666|NCT01094184|581692|P2|NOT COMPLETED|Overall Study||11
239667|NCT01094184|581693|P1|NOT COMPLETED|Overall Study||35
239668|NCT01094184|581692|P2|COMPLETED|Overall Study||2
239669|NCT01094184|581693|P1|COMPLETED|Overall Study||1
239670|NCT01094184|581692|P2|STARTED|Overall Study||13
239671|NCT01094184|581693|P1|STARTED|Overall Study||36
239672|NCT01094171|581927|P1|NOT COMPLETED|Overall Study||10
239673|NCT01094171|581927|P1|COMPLETED|Overall Study||390
239674|NCT01094171|581927|P1|STARTED|Overall Study||400
239675|NCT01094119|581936|P2|NOT COMPLETED|Overall Study||4
239676|NCT01094119|581937|P1|NOT COMPLETED|Overall Study||2
239677|NCT01094119|581936|P2|COMPLETED|Overall Study||32
239678|NCT01094119|581937|P1|COMPLETED|Overall Study||32
239679|NCT01094119|581936|P2|STARTED|Overall Study||36
239680|NCT01094119|581937|P1|STARTED|Overall Study||34
239681|NCT01093976|581945|P1|NOT COMPLETED|Overall Study||0
239682|NCT01093976|581945|P1|COMPLETED|Overall Study||14
239683|NCT01093976|581945|P1|STARTED|Overall Study||14
239684|NCT01093885|581949|P1|NOT COMPLETED|Overall Study||5
239685|NCT01093885|581949|P1|COMPLETED|Overall Study||10
239686|NCT01093885|581949|P1|STARTED|Overall Study||15
239687|NCT01093846|581957|P3|NOT COMPLETED|Overall Study||21
239688|NCT01093846|581958|P2|NOT COMPLETED|Overall Study||18
239689|NCT01093846|581959|P1|NOT COMPLETED|Overall Study||19
239690|NCT01093846|581957|P3|COMPLETED|Overall Study||1
239691|NCT01093846|581958|P2|COMPLETED|Overall Study||0
239692|NCT01093846|581959|P1|COMPLETED|Overall Study||0
239693|NCT01093846|581957|P3|STARTED|Overall Study||22
239694|NCT01093846|581958|P2|STARTED|Overall Study||18
239695|NCT01093846|581959|P1|STARTED|Overall Study||19
239696|NCT01093794|581965|P4|NOT COMPLETED|Treatment Period 4||0
239697|NCT01093794|581966|P3|NOT COMPLETED|Treatment Period 4||0
239698|NCT01093794|581967|P2|NOT COMPLETED|Treatment Period 4||0
239699|NCT01093794|581968|P1|NOT COMPLETED|Treatment Period 4||0
239700|NCT01093794|581965|P4|COMPLETED|Treatment Period 4||7
239701|NCT01093794|581966|P3|COMPLETED|Treatment Period 4||6
239702|NCT01093794|581967|P2|COMPLETED|Treatment Period 4||7
239703|NCT01093794|581968|P1|COMPLETED|Treatment Period 4||7
239704|NCT01093794|581965|P4|STARTED|Treatment Period 4||7
239705|NCT01093794|581966|P3|STARTED|Treatment Period 4||6
239706|NCT01093794|581967|P2|STARTED|Treatment Period 4||7
239707|NCT01093794|581968|P1|STARTED|Treatment Period 4||7
239708|NCT01093794|581965|P4|NOT COMPLETED|Treatment Period 3||0
239709|NCT01093794|581966|P3|NOT COMPLETED|Treatment Period 3||0
239710|NCT01093794|581967|P2|NOT COMPLETED|Treatment Period 3||0
239711|NCT01093794|581968|P1|NOT COMPLETED|Treatment Period 3||0
239712|NCT01093794|581965|P4|COMPLETED|Treatment Period 3||7
239713|NCT01093794|581966|P3|COMPLETED|Treatment Period 3||6
239714|NCT01093794|581967|P2|COMPLETED|Treatment Period 3||7
239715|NCT01093794|581968|P1|COMPLETED|Treatment Period 3||7
239716|NCT01093794|581965|P4|STARTED|Treatment Period 3||7
239717|NCT01093794|581966|P3|STARTED|Treatment Period 3||6
239718|NCT01093794|581967|P2|STARTED|Treatment Period 3||7
239719|NCT01093794|581968|P1|STARTED|Treatment Period 3||7
239720|NCT01093794|581965|P4|NOT COMPLETED|Treatment Period 2||0
239721|NCT01093794|581966|P3|NOT COMPLETED|Treatment Period 2||0
239722|NCT01093794|581967|P2|NOT COMPLETED|Treatment Period 2||0
239723|NCT01093794|581968|P1|NOT COMPLETED|Treatment Period 2||0
239724|NCT01093794|581965|P4|COMPLETED|Treatment Period 2||7
239725|NCT01093794|581966|P3|COMPLETED|Treatment Period 2||6
239726|NCT01093794|581967|P2|COMPLETED|Treatment Period 2||7
239727|NCT01093794|581968|P1|COMPLETED|Treatment Period 2||7
239728|NCT01093794|581965|P4|STARTED|Treatment Period 2||7
239729|NCT01093794|581966|P3|STARTED|Treatment Period 2|After period 1, one participant was discontinued by the investigator due to a protocol deviation.|6
239730|NCT01093794|581967|P2|STARTED|Treatment Period 2||7
239731|NCT01093794|581968|P1|STARTED|Treatment Period 2||7
239732|NCT01093794|581965|P4|NOT COMPLETED|Treatment Period 1||0
239733|NCT01093794|581966|P3|NOT COMPLETED|Treatment Period 1||0
239734|NCT01093794|581967|P2|NOT COMPLETED|Treatment Period 1||0
239735|NCT01093794|581968|P1|NOT COMPLETED|Treatment Period 1||0
239736|NCT01093794|581965|P4|COMPLETED|Treatment Period 1||7
239737|NCT01093794|581966|P3|COMPLETED|Treatment Period 1||7
239738|NCT01093794|581967|P2|COMPLETED|Treatment Period 1||7
239739|NCT01093794|581968|P1|COMPLETED|Treatment Period 1||7
239740|NCT01093794|581965|P4|STARTED|Treatment Period 1||7
239741|NCT01093794|581966|P3|STARTED|Treatment Period 1||7
239742|NCT01093794|581967|P2|STARTED|Treatment Period 1||7
239743|NCT01093794|581968|P1|STARTED|Treatment Period 1||7
239744|NCT01093755|581984|P2|NOT COMPLETED|Overall Study||4
239745|NCT01093755|581985|P1|NOT COMPLETED|Overall Study||3
239746|NCT01093755|581984|P2|COMPLETED|Overall Study||10
239747|NCT01093755|581985|P1|COMPLETED|Overall Study||13
239748|NCT01093755|581984|P2|STARTED|Overall Study||14
239749|NCT01093755|581985|P1|STARTED|Overall Study||16
239750|NCT01093690|581995|P2|NOT COMPLETED|Overall Study||0
239751|NCT01093690|581996|P1|NOT COMPLETED|Overall Study||0
239752|NCT01093690|581995|P2|COMPLETED|Overall Study||79
239753|NCT01093690|581996|P1|COMPLETED|Overall Study||83
239754|NCT01093690|581995|P2|STARTED|Overall Study||79
239755|NCT01093690|581996|P1|STARTED|Overall Study||83
239756|NCT01093651|582004|P2|NOT COMPLETED|Overall Study||0
239757|NCT01093651|582005|P1|NOT COMPLETED|Overall Study||0
239758|NCT01093651|582004|P2|COMPLETED|Overall Study||10
239759|NCT01093651|582005|P1|COMPLETED|Overall Study||10
239760|NCT01093651|582004|P2|STARTED|Overall Study||10
239761|NCT01093651|582005|P1|STARTED|Overall Study||10
239762|NCT01093625|582025|P2|NOT COMPLETED|1-Year Visit||3
239763|NCT01093625|582026|P1|NOT COMPLETED|1-Year Visit||5
239764|NCT01093625|582025|P2|COMPLETED|1-Year Visit||37
239765|NCT01093625|582026|P1|COMPLETED|1-Year Visit||29
239766|NCT01093625|582025|P2|STARTED|1-Year Visit||40
239767|NCT01093625|582026|P1|STARTED|1-Year Visit||34
239768|NCT01093625|582025|P2|NOT COMPLETED|6-Month Visit||9
239769|NCT01093625|582026|P1|NOT COMPLETED|6-Month Visit||8
239770|NCT01093625|582025|P2|COMPLETED|6-Month Visit||40
239771|NCT01093625|582026|P1|COMPLETED|6-Month Visit||34
239772|NCT01093625|582025|P2|STARTED|6-Month Visit||49
239773|NCT01093625|582026|P1|STARTED|6-Month Visit||42
239774|NCT01093625|582025|P2|NOT COMPLETED|3-Month Visit||0
239775|NCT01093625|582026|P1|NOT COMPLETED|3-Month Visit||2
239776|NCT01093625|582025|P2|COMPLETED|3-Month Visit||49
239777|NCT01093625|582026|P1|COMPLETED|3-Month Visit||42
239778|NCT01093625|582025|P2|STARTED|3-Month Visit||49
239779|NCT01093625|582026|P1|STARTED|3-Month Visit||44
239780|NCT01093625|582025|P2|NOT COMPLETED|1-Month Visit||0
239781|NCT01093625|582026|P1|NOT COMPLETED|1-Month Visit||2
239782|NCT01093625|582025|P2|COMPLETED|1-Month Visit||49
239783|NCT01093625|582026|P1|COMPLETED|1-Month Visit||44
239784|NCT01093625|582025|P2|STARTED|1-Month Visit||49
239785|NCT01093625|582026|P1|STARTED|1-Month Visit||46
239786|NCT01093625|582025|P2|NOT COMPLETED|2-Week Visit||0
239787|NCT01093625|582026|P1|NOT COMPLETED|2-Week Visit||1
239788|NCT01093625|582025|P2|COMPLETED|2-Week Visit||49
239789|NCT01093625|582026|P1|COMPLETED|2-Week Visit||46
239790|NCT01093625|582025|P2|STARTED|2-Week Visit||49
239791|NCT01093625|582026|P1|STARTED|2-Week Visit||47
239792|NCT01093625|582025|P2|NOT COMPLETED|Baseline and Dispensed||0
239793|NCT01093625|582026|P1|NOT COMPLETED|Baseline and Dispensed||2
239794|NCT01093625|582025|P2|COMPLETED|Baseline and Dispensed||49
239795|NCT01093625|582026|P1|COMPLETED|Baseline and Dispensed||47
239796|NCT01093625|582025|P2|STARTED|Baseline and Dispensed||49
239797|NCT01093625|582026|P1|STARTED|Baseline and Dispensed||49
239798|NCT01093599|582046|P2|NOT COMPLETED|Overall Study||46
239799|NCT01093599|582047|P1|NOT COMPLETED|Overall Study||32
239800|NCT01093599|582046|P2|COMPLETED|Overall Study||59
239801|NCT01093599|582047|P1|COMPLETED|Overall Study||59
239802|NCT01093599|582046|P2|STARTED|Overall Study||105
239803|NCT01093599|582047|P1|STARTED|Overall Study||91
239804|NCT01093586|582053|P1|NOT COMPLETED|Overall Study||3
239805|NCT01093586|582053|P1|COMPLETED|Overall Study||11
239806|NCT01093586|582053|P1|STARTED|Overall Study||14
239807|NCT01093534|582074|P3|NOT COMPLETED|Overall Study||9
239808|NCT01093534|582075|P2|NOT COMPLETED|Overall Study||16
239809|NCT01093534|582076|P1|NOT COMPLETED|Overall Study||10
239810|NCT01093534|582074|P3|COMPLETED|Overall Study||169
239811|NCT01093534|582075|P2|COMPLETED|Overall Study||167
239812|NCT01093534|582076|P1|COMPLETED|Overall Study||176
239813|NCT01093534|582074|P3|Received Study Treatment|Overall Study||175
239814|NCT01093534|582075|P2|Received Study Treatment|Overall Study||182
239815|NCT01093534|582076|P1|Received Study Treatment|Overall Study||186
239816|NCT01093534|582074|P3|STARTED|Overall Study||178
239817|NCT01093534|582075|P2|STARTED|Overall Study||183
239818|NCT01093534|582076|P1|STARTED|Overall Study||186
239819|NCT01093521|582181|P1|NOT COMPLETED|Overall Study||0
239820|NCT01093521|582181|P1|COMPLETED|Overall Study||20
239821|NCT01093521|582181|P1|STARTED|Overall Study||20
239822|NCT01093482|582196|P1|NOT COMPLETED|Overall Study||0
239823|NCT01093482|582196|P1|COMPLETED|Overall Study||8151
239824|NCT01093482|582196|P1|STARTED|Overall Study||8151
239825|NCT01093469|582203|P3|NOT COMPLETED|Overall Study||1
239826|NCT01093469|582204|P2|NOT COMPLETED|Overall Study||0
239827|NCT01093469|582205|P1|NOT COMPLETED|Overall Study||0
239828|NCT01093469|582203|P3|COMPLETED|Overall Study||12
239829|NCT01093469|582204|P2|COMPLETED|Overall Study||13
239830|NCT01093469|582205|P1|COMPLETED|Overall Study||13
239831|NCT01093469|582203|P3|STARTED|Overall Study||13
239832|NCT01093469|582204|P2|STARTED|Overall Study||13
239833|NCT01093469|582205|P1|STARTED|Overall Study||13
239834|NCT01093417|582215|P2|NOT COMPLETED|Overall Study||1
239835|NCT01093417|582216|P1|NOT COMPLETED|Overall Study||0
239836|NCT01093417|582215|P2|COMPLETED|Overall Study||29
239837|NCT01093417|582216|P1|COMPLETED|Overall Study||15
239838|NCT01093417|582215|P2|STARTED|Overall Study||30
239839|NCT01093417|582216|P1|STARTED|Overall Study||15
239840|NCT01093222|582224|P1|NOT COMPLETED|Overall Study||40
239841|NCT01093222|582224|P1|COMPLETED|Overall Study||0
239842|NCT01093222|582224|P1|Eligible and Began Protocol Therapy|Overall Study||34
239843|NCT01093222|582224|P1|STARTED|Overall Study||40
239844|NCT01093183|582231|P2|NOT COMPLETED|Overall Study||2
239845|NCT01093183|582232|P1|NOT COMPLETED|Overall Study||1
239846|NCT01093183|582231|P2|COMPLETED|Overall Study||4
239847|NCT01093183|582232|P1|COMPLETED|Overall Study||18
239848|NCT01093183|582231|P2|STARTED|Overall Study||6
239849|NCT01093183|582232|P1|STARTED|Overall Study||19
239850|NCT01093027|582242|P2|NOT COMPLETED|Visit 2||0
239851|NCT01093027|582243|P1|NOT COMPLETED|Visit 2||0
239852|NCT01093027|582242|P2|COMPLETED|Visit 2||10
239853|NCT01093027|582243|P1|COMPLETED|Visit 2||10
239854|NCT01093027|582242|P2|STARTED|Visit 2||10
239855|NCT01093027|582243|P1|STARTED|Visit 2||10
239856|NCT01093027|582242|P2|NOT COMPLETED|Visit 1||0
239857|NCT01093027|582243|P1|NOT COMPLETED|Visit 1||0
239858|NCT01093027|582242|P2|COMPLETED|Visit 1||10
239859|NCT01093027|582243|P1|COMPLETED|Visit 1||10
239860|NCT01093027|582242|P2|STARTED|Visit 1||10
239861|NCT01093027|582243|P1|STARTED|Visit 1||10
239862|NCT01093014|582254|P3|NOT COMPLETED|Overall Study||0
239863|NCT01093014|582255|P2|NOT COMPLETED|Overall Study||0
239864|NCT01093014|582256|P1|NOT COMPLETED|Overall Study||0
239865|NCT01093014|582254|P3|COMPLETED|Overall Study||12
239866|NCT01093014|582255|P2|COMPLETED|Overall Study||9
239867|NCT01093014|582256|P1|COMPLETED|Overall Study||12
239868|NCT01093014|582254|P3|STARTED|Overall Study||12
239869|NCT01093014|582255|P2|STARTED|Overall Study||9
239870|NCT01093014|582256|P1|STARTED|Overall Study||12
239871|NCT01092923|582275|P2|NOT COMPLETED|Overall Study||0
239872|NCT01092923|582276|P1|NOT COMPLETED|Overall Study||0
239873|NCT01092923|582275|P2|COMPLETED|Overall Study||10
239874|NCT01092923|582276|P1|COMPLETED|Overall Study||10
239875|NCT01092923|582275|P2|STARTED|Overall Study||10
239876|NCT01092923|582276|P1|STARTED|Overall Study||10
239877|NCT01092910|582285|P1|NOT COMPLETED|Overall Study||5
239878|NCT01092910|582285|P1|COMPLETED|Overall Study||52
239879|NCT01092910|582285|P1|10 Month Follow-up|Overall Study||52
239880|NCT01092910|582285|P1|4 Month Follow-up|Overall Study||54
239881|NCT01092910|582285|P1|STARTED|Overall Study||57
239882|NCT01092832|582297|P2|NOT COMPLETED|Overall Study||0
239883|NCT01092832|582298|P1|NOT COMPLETED|Overall Study||1
239884|NCT01092832|582297|P2|COMPLETED|Overall Study||8
239885|NCT01092832|582298|P1|COMPLETED|Overall Study||13
239886|NCT01092832|582297|P2|STARTED|Overall Study||8
239887|NCT01092832|582298|P1|STARTED|Overall Study||14
239888|NCT01092780|582310|P4|NOT COMPLETED|Treatment Period 4||0
239889|NCT01092780|582311|P3|NOT COMPLETED|Treatment Period 4||0
239890|NCT01092780|582312|P2|NOT COMPLETED|Treatment Period 4||0
239891|NCT01092780|582313|P1|NOT COMPLETED|Treatment Period 4||0
239892|NCT01092780|582310|P4|COMPLETED|Treatment Period 4||13
239893|NCT01092780|582311|P3|COMPLETED|Treatment Period 4||13
239894|NCT01092780|582312|P2|COMPLETED|Treatment Period 4||13
239895|NCT01092780|582313|P1|COMPLETED|Treatment Period 4||13
239896|NCT01092780|582310|P4|STARTED|Treatment Period 4||13
239897|NCT01092780|582311|P3|STARTED|Treatment Period 4||13
239898|NCT01092780|582312|P2|STARTED|Treatment Period 4||13
239899|NCT01092780|582313|P1|STARTED|Treatment Period 4||13
239900|NCT01092780|582310|P4|NOT COMPLETED|Washout Period 3||0
239901|NCT01092780|582311|P3|NOT COMPLETED|Washout Period 3||0
239902|NCT01092780|582312|P2|NOT COMPLETED|Washout Period 3||0
239903|NCT01092780|582313|P1|NOT COMPLETED|Washout Period 3||0
239904|NCT01092780|582310|P4|COMPLETED|Washout Period 3||13
239905|NCT01092780|582311|P3|COMPLETED|Washout Period 3||13
239906|NCT01092780|582312|P2|COMPLETED|Washout Period 3||13
239907|NCT01092780|582313|P1|COMPLETED|Washout Period 3||13
239908|NCT01092780|582310|P4|STARTED|Washout Period 3||13
239909|NCT01092780|582311|P3|STARTED|Washout Period 3||13
239910|NCT01092780|582312|P2|STARTED|Washout Period 3||13
239911|NCT01092780|582313|P1|STARTED|Washout Period 3||13
239912|NCT01092780|582310|P4|NOT COMPLETED|Treatment Period 3||0
239913|NCT01092780|582311|P3|NOT COMPLETED|Treatment Period 3||0
239914|NCT01092780|582312|P2|NOT COMPLETED|Treatment Period 3||0
239915|NCT01092780|582313|P1|NOT COMPLETED|Treatment Period 3||0
239916|NCT01092780|582310|P4|COMPLETED|Treatment Period 3||13
239917|NCT01092780|582311|P3|COMPLETED|Treatment Period 3||13
239918|NCT01092780|582312|P2|COMPLETED|Treatment Period 3||13
239919|NCT01092780|582313|P1|COMPLETED|Treatment Period 3||13
239920|NCT01092780|582310|P4|STARTED|Treatment Period 3||13
239921|NCT01092780|582311|P3|STARTED|Treatment Period 3||13
239922|NCT01092780|582312|P2|STARTED|Treatment Period 3||13
239923|NCT01092780|582313|P1|STARTED|Treatment Period 3||13
239924|NCT01092780|582310|P4|NOT COMPLETED|Washout Period 2||0
239925|NCT01092780|582311|P3|NOT COMPLETED|Washout Period 2||1
239926|NCT01092780|582312|P2|NOT COMPLETED|Washout Period 2||1
239927|NCT01092780|582313|P1|NOT COMPLETED|Washout Period 2||0
239928|NCT01092780|582310|P4|COMPLETED|Washout Period 2||13
239929|NCT01092780|582311|P3|COMPLETED|Washout Period 2||13
239930|NCT01092780|582312|P2|COMPLETED|Washout Period 2||13
239931|NCT01092780|582313|P1|COMPLETED|Washout Period 2||13
239932|NCT01092780|582310|P4|STARTED|Washout Period 2||13
239933|NCT01092780|582311|P3|STARTED|Washout Period 2||14
239934|NCT01092780|582312|P2|STARTED|Washout Period 2||14
239935|NCT01092780|582313|P1|STARTED|Washout Period 2||13
239936|NCT01092780|582310|P4|NOT COMPLETED|Treatment Period 2||0
239937|NCT01092780|582311|P3|NOT COMPLETED|Treatment Period 2||0
239938|NCT01092780|582312|P2|NOT COMPLETED|Treatment Period 2||0
239939|NCT01092780|582313|P1|NOT COMPLETED|Treatment Period 2||0
239940|NCT01092780|582310|P4|COMPLETED|Treatment Period 2||13
239941|NCT01092780|582311|P3|COMPLETED|Treatment Period 2||14
239942|NCT01092780|582312|P2|COMPLETED|Treatment Period 2||14
239943|NCT01092780|582313|P1|COMPLETED|Treatment Period 2||13
239944|NCT01092780|582310|P4|STARTED|Treatment Period 2||13
239945|NCT01092780|582311|P3|STARTED|Treatment Period 2||14
239946|NCT01092780|582312|P2|STARTED|Treatment Period 2||14
239947|NCT01092780|582313|P1|STARTED|Treatment Period 2||13
239948|NCT01092780|582310|P4|NOT COMPLETED|Washout Period 1||0
239949|NCT01092780|582311|P3|NOT COMPLETED|Washout Period 1||0
239950|NCT01092780|582312|P2|NOT COMPLETED|Washout Period 1||1
239951|NCT01092780|582313|P1|NOT COMPLETED|Washout Period 1||1
239952|NCT01092780|582310|P4|COMPLETED|Washout Period 1||13
239953|NCT01092780|582311|P3|COMPLETED|Washout Period 1||14
239954|NCT01092780|582312|P2|COMPLETED|Washout Period 1||14
239955|NCT01092780|582313|P1|COMPLETED|Washout Period 1||13
239956|NCT01092780|582310|P4|STARTED|Washout Period 1||13
239957|NCT01092780|582311|P3|STARTED|Washout Period 1||14
239958|NCT01092780|582312|P2|STARTED|Washout Period 1||15
239959|NCT01092780|582313|P1|STARTED|Washout Period 1||14
239960|NCT01092780|582310|P4|NOT COMPLETED|Treatment Period 1||0
239961|NCT01092780|582311|P3|NOT COMPLETED|Treatment Period 1||0
239962|NCT01092780|582312|P2|NOT COMPLETED|Treatment Period 1||0
239963|NCT01092780|582313|P1|NOT COMPLETED|Treatment Period 1||0
239964|NCT01092780|582310|P4|COMPLETED|Treatment Period 1||13
239965|NCT01092780|582311|P3|COMPLETED|Treatment Period 1||14
239966|NCT01092780|582312|P2|COMPLETED|Treatment Period 1||15
239967|NCT01092780|582313|P1|COMPLETED|Treatment Period 1||14
239968|NCT01092780|582310|P4|STARTED|Treatment Period 1||13
239969|NCT01092780|582311|P3|STARTED|Treatment Period 1||14
239970|NCT01092780|582312|P2|STARTED|Treatment Period 1||15
239971|NCT01092780|582313|P1|STARTED|Treatment Period 1||14
239972|NCT01092767|582343|P1|NOT COMPLETED|Overall Study||5
239973|NCT01092767|582343|P1|COMPLETED|Overall Study||45
239974|NCT01092767|582343|P1|STARTED|Overall Study||50
239975|NCT01092728|582349|P2|NOT COMPLETED|Overall Study||14
239976|NCT01092728|582350|P1|NOT COMPLETED|Overall Study||4
239977|NCT01092728|582349|P2|COMPLETED|Overall Study||0
239978|NCT01092728|582350|P1|COMPLETED|Overall Study||0
239979|NCT01092728|582349|P2|STARTED|Overall Study||14
239980|NCT01092728|582350|P1|STARTED|Overall Study||4
239981|NCT01092702|582358|P1|NOT COMPLETED|Overall Study||9
239982|NCT01092702|582358|P1|COMPLETED|Overall Study||23
239983|NCT01092702|582358|P1|STARTED|Overall Study||32
239984|NCT01092676|582364|P2|NOT COMPLETED|Overall Study||0
239985|NCT01092676|582365|P1|NOT COMPLETED|Overall Study||0
239986|NCT01092676|582364|P2|COMPLETED|Overall Study||49
239987|NCT01092676|582365|P1|COMPLETED|Overall Study||50
239988|NCT01092676|582364|P2|STARTED|Overall Study||49
239989|NCT01092676|582365|P1|STARTED|Overall Study||50
239990|NCT01092663|582375|P2|NOT COMPLETED|Overall Study||4
239991|NCT01092663|582376|P1|NOT COMPLETED|Overall Study||7
239992|NCT01092663|582375|P2|COMPLETED|Overall Study||26
239993|NCT01092663|582376|P1|COMPLETED|Overall Study||24
239994|NCT01092663|582375|P2|STARTED|Overall Study||30
239995|NCT01092663|582376|P1|STARTED|Overall Study||31
239996|NCT01092637|582424|P2|NOT COMPLETED|Overall Study||49
239997|NCT01092637|582425|P1|NOT COMPLETED|Overall Study||47
239998|NCT01092637|582424|P2|COMPLETED|Overall Study||86
239999|NCT01092637|582425|P1|COMPLETED|Overall Study||98
240000|NCT01092637|582424|P2|STARTED|Overall Study||135
240001|NCT01092637|582425|P1|STARTED|Overall Study||145
240002|NCT01092559|582435|P1|NOT COMPLETED|Overall Study||0
240003|NCT01092559|582435|P1|COMPLETED|Overall Study||10
240004|NCT01092559|582435|P1|STARTED|Overall Study||10
240005|NCT01092546|582440|P1|NOT COMPLETED|Overall Study||4
240006|NCT01092546|582440|P1|COMPLETED|Overall Study||12
240007|NCT01092546|582440|P1|STARTED|Overall Study||16
240008|NCT01092507|582447|P2|NOT COMPLETED|Overall Study||0
240009|NCT01092507|582448|P1|NOT COMPLETED|Overall Study||2
240010|NCT01092507|582447|P2|COMPLETED|Overall Study||150
240011|NCT01092507|582448|P1|COMPLETED|Overall Study||147
240012|NCT01092507|582447|P2|STARTED|Overall Study||150
240013|NCT01092507|582448|P1|STARTED|Overall Study||149
240014|NCT01092442|582468|P2|NOT COMPLETED|Overall Study||0
240015|NCT01092442|582469|P1|NOT COMPLETED|Overall Study||0
240016|NCT01092442|582468|P2|COMPLETED|Overall Study||60
240017|NCT01092442|582469|P1|COMPLETED|Overall Study||80
240018|NCT01092442|582468|P2|STARTED|Overall Study||60
240019|NCT01092442|582469|P1|STARTED|Overall Study||80
240020|NCT01092416|582483|P1|NOT COMPLETED|12-Month Follow-up||25
240021|NCT01092416|582483|P1|COMPLETED|12-Month Follow-up||413
240022|NCT01092416|582483|P1|STARTED|12-Month Follow-up||438
240023|NCT01092416|582483|P1|NOT COMPLETED|30-Day Follow-up||10
240024|NCT01092416|582483|P1|COMPLETED|30-Day Follow-up||430
240025|NCT01092416|582483|P1|STARTED|30-Day Follow-up||440
240026|NCT01092416|582483|P1|NOT COMPLETED|Enrollment||3
240027|NCT01092416|582483|P1|COMPLETED|Enrollment||440
240028|NCT01092416|582483|P1|STARTED|Enrollment||443
240029|NCT01092364|582495|P3|NOT COMPLETED|Overall Study||18
240030|NCT01092364|582496|P2|NOT COMPLETED|Overall Study||16
240031|NCT01092364|582497|P1|NOT COMPLETED|Overall Study||18
240032|NCT01092364|582495|P3|COMPLETED|Overall Study||105
240033|NCT01092364|582496|P2|COMPLETED|Overall Study||104
240034|NCT01092364|582497|P1|COMPLETED|Overall Study||104
240035|NCT01092364|582495|P3|STARTED|Overall Study||123
240036|NCT01092364|582496|P2|STARTED|Overall Study||120
240037|NCT01092364|582497|P1|STARTED|Overall Study||122
240038|NCT01092338|582507|P2|NOT COMPLETED|Overall Study||1
240039|NCT01092338|582508|P1|NOT COMPLETED|Overall Study||1
240040|NCT01092338|582507|P2|COMPLETED|Overall Study||21
240041|NCT01092338|582508|P1|COMPLETED|Overall Study||21
240042|NCT01092338|582507|P2|STARTED|Overall Study||22
240043|NCT01092338|582508|P1|STARTED|Overall Study||22
240044|NCT01092195|582519|P3|NOT COMPLETED|Overall Study||0
240045|NCT01092195|582520|P2|NOT COMPLETED|Overall Study||0
240046|NCT01092195|582521|P1|NOT COMPLETED|Overall Study||0
240047|NCT01092195|582519|P3|COMPLETED|Overall Study||20
240048|NCT01092195|582520|P2|COMPLETED|Overall Study||21
240049|NCT01092195|582521|P1|COMPLETED|Overall Study||23
240050|NCT01092195|582519|P3|STARTED|Overall Study||20
240051|NCT01092195|582520|P2|STARTED|Overall Study||21
240052|NCT01092195|582521|P1|STARTED|Overall Study||23
240053|NCT01091974|582533|P4|NOT COMPLETED|Overall Study||7
240054|NCT01091974|582534|P3|NOT COMPLETED|Overall Study||6
240055|NCT01091974|582535|P2|NOT COMPLETED|Overall Study||5
240056|NCT01091974|582536|P1|NOT COMPLETED|Overall Study||5
240057|NCT01091974|582533|P4|COMPLETED|Overall Study||17
240058|NCT01091974|582534|P3|COMPLETED|Overall Study||19
240059|NCT01091974|582535|P2|COMPLETED|Overall Study||18
240060|NCT01091974|582536|P1|COMPLETED|Overall Study||19
240061|NCT01091974|582533|P4|STARTED|Overall Study||24
240062|NCT01091974|582534|P3|STARTED|Overall Study||25
240063|NCT01091974|582535|P2|STARTED|Overall Study||23
240064|NCT01091974|582536|P1|STARTED|Overall Study||24
240065|NCT01091948|582552|P2|NOT COMPLETED|Overall Study||0
240066|NCT01091948|582553|P1|NOT COMPLETED|Overall Study||0
240067|NCT01091948|582552|P2|COMPLETED|Overall Study||38
240068|NCT01091948|582553|P1|COMPLETED|Overall Study||37
240069|NCT01091948|582552|P2|STARTED|Overall Study||38
240070|NCT01091948|582553|P1|STARTED|Overall Study||37
240071|NCT01091675|582571|P1|NOT COMPLETED|Overall Study||34
240072|NCT01091675|582571|P1|COMPLETED|Overall Study||23
240073|NCT01091675|582571|P1|STARTED|Overall Study|7 patients leave the study due to hypertension, 27 patients withdrew due to lack of efficacy|57
240074|NCT01091662|582577|P2|NOT COMPLETED|Overall Study||34
240075|NCT01091662|582578|P1|NOT COMPLETED|Overall Study||17
240076|NCT01091662|582577|P2|COMPLETED|Overall Study||80
240077|NCT01091662|582578|P1|COMPLETED|Overall Study||41
240078|NCT01091662|582577|P2|STARTED|Overall Study||114
240079|NCT01091662|582578|P1|STARTED|Overall Study||58
240080|NCT01091519|582616|P2|NOT COMPLETED|Overall Study||73
240081|NCT01091519|582617|P1|NOT COMPLETED|Overall Study||55
240082|NCT01091519|582616|P2|COMPLETED|Overall Study||362
240083|NCT01091519|582617|P1|COMPLETED|Overall Study||291
240084|NCT01091519|582616|P2|Treated|Overall Study||431
240085|NCT01091519|582617|P1|Treated|Overall Study||342
240086|NCT01091519|582616|P2|STARTED|Overall Study||435
240087|NCT01091519|582617|P1|STARTED|Overall Study||346
240088|NCT01091454|582629|P1|NOT COMPLETED|Overall Study||1
240089|NCT01091454|582629|P1|COMPLETED|Overall Study||47
240090|NCT01091454|582629|P1|STARTED|Overall Study||48
240091|NCT01091428|582642|P4|NOT COMPLETED|Phase 2||69
240092|NCT01091428|582643|P3|NOT COMPLETED|Phase 2||73
240093|NCT01091428|582644|P2|NOT COMPLETED|Phase 2||0
240094|NCT01091428|582645|P1|NOT COMPLETED|Phase 2||0
240095|NCT01091428|582642|P4|COMPLETED|Phase 2||0
240096|NCT01091428|582643|P3|COMPLETED|Phase 2||0
240097|NCT01091428|582644|P2|COMPLETED|Phase 2||0
240098|NCT01091428|582645|P1|COMPLETED|Phase 2||0
240099|NCT01091428|582642|P4|STARTED|Phase 2||69
240100|NCT01091428|582643|P3|STARTED|Phase 2||73
240101|NCT01091428|582644|P2|STARTED|Phase 2||0
240102|NCT01091428|582645|P1|STARTED|Phase 2||0
240103|NCT01091428|582642|P4|NOT COMPLETED|Phase 1||0
240104|NCT01091428|582643|P3|NOT COMPLETED|Phase 1||0
240105|NCT01091428|582644|P2|NOT COMPLETED|Phase 1||11
240106|NCT01091428|582645|P1|NOT COMPLETED|Phase 1||38
240107|NCT01091428|582642|P4|COMPLETED|Phase 1||0
240108|NCT01091428|582643|P3|COMPLETED|Phase 1||0
240109|NCT01091428|582644|P2|COMPLETED|Phase 1||0
240110|NCT01091428|582645|P1|COMPLETED|Phase 1|Completed = participants who completed the treatment.|0
240111|NCT01091428|582642|P4|STARTED|Phase 1||0
240112|NCT01091428|582643|P3|STARTED|Phase 1||0
240113|NCT01091428|582644|P2|STARTED|Phase 1||11
240114|NCT01091428|582645|P1|STARTED|Phase 1||38
240115|NCT01091363|582748|P2|NOT COMPLETED|Overall Study||17
240116|NCT01091363|582749|P1|NOT COMPLETED|Overall Study||13
240117|NCT01091363|582748|P2|COMPLETED|Overall Study||37
240118|NCT01091363|582749|P1|COMPLETED|Overall Study||42
240119|NCT01091363|582748|P2|STARTED|Overall Study||54
240120|NCT01091363|582749|P1|STARTED|Overall Study||55
240121|NCT01091259|582759|P1|NOT COMPLETED|Overall Study||5
240122|NCT01091259|582759|P1|COMPLETED|Overall Study|Number of patients who had at least 2 cycles of treatments|24
240123|NCT01091259|582759|P1|STARTED|Overall Study||29
240124|NCT01091246|582770|P3|NOT COMPLETED|Overall Study||13
240125|NCT01091246|582771|P2|NOT COMPLETED|Overall Study||16
240126|NCT01091246|582772|P1|NOT COMPLETED|Overall Study||35
240127|NCT01091246|582770|P3|COMPLETED|Overall Study||450
240128|NCT01091246|582771|P2|COMPLETED|Overall Study||448
240129|NCT01091246|582772|P1|COMPLETED|Overall Study||1350
240130|NCT01091246|582770|P3|STARTED|Overall Study||463
240131|NCT01091246|582771|P2|STARTED|Overall Study||464
240132|NCT01091246|582772|P1|STARTED|Overall Study||1385
240133|NCT01091168|582848|P2|NOT COMPLETED|Overall Study||296
240134|NCT01091168|582849|P1|NOT COMPLETED|Overall Study||298
240135|NCT01091168|582848|P2|COMPLETED|Overall Study||0
240136|NCT01091168|582849|P1|COMPLETED|Overall Study||0
240137|NCT01091168|582848|P2|STARTED|Overall Study||296
240138|NCT01091168|582849|P1|STARTED|Overall Study||298
240139|NCT01091155|582859|P1|NOT COMPLETED|Overall Study||9
240140|NCT01091155|582859|P1|COMPLETED|Overall Study||279
240141|NCT01091155|582859|P1|STARTED|Overall Study||288
240142|NCT01091116|582868|P5|NOT COMPLETED|Overall Study||11
240143|NCT01091116|582869|P4|NOT COMPLETED|Overall Study||4
240144|NCT01091116|582870|P3|NOT COMPLETED|Overall Study||11
240145|NCT01091116|582871|P2|NOT COMPLETED|Overall Study||8
240146|NCT01091116|582872|P1|NOT COMPLETED|Overall Study||6
240147|NCT01091116|582868|P5|COMPLETED|Overall Study||73
240148|NCT01091116|582869|P4|COMPLETED|Overall Study||80
240149|NCT01091116|582870|P3|COMPLETED|Overall Study||73
240150|NCT01091116|582871|P2|COMPLETED|Overall Study||80
240151|NCT01091116|582872|P1|COMPLETED|Overall Study||77
240152|NCT01091116|582868|P5|STARTED|Overall Study||84
240153|NCT01091116|582869|P4|STARTED|Overall Study||84
240154|NCT01091116|582870|P3|STARTED|Overall Study||84
240155|NCT01091116|582871|P2|STARTED|Overall Study||88
240156|NCT01091116|582872|P1|STARTED|Overall Study||83
240157|NCT01091103|582924|P1|NOT COMPLETED|Overall Study||4
240158|NCT01091103|582924|P1|COMPLETED|Overall Study|Patients on study drug and completed Week 9 visit assessments.|56
240159|NCT01091103|582924|P1|STARTED|Overall Study||60
240160|NCT01090973|582944|P1|NOT COMPLETED|Overall Study||1
240161|NCT01090973|582944|P1|COMPLETED|Overall Study||0
240162|NCT01090973|582944|P1|STARTED|Overall Study||1
240163|NCT01090765|582960|P6|NOT COMPLETED|Overall Study||1
240164|NCT01090765|582961|P5|NOT COMPLETED|Overall Study||2
240165|NCT01090765|582962|P4|NOT COMPLETED|Overall Study||1
240166|NCT01090765|582963|P3|NOT COMPLETED|Overall Study||0
240167|NCT01090765|582964|P2|NOT COMPLETED|Overall Study||0
240168|NCT01090765|582965|P1|NOT COMPLETED|Overall Study||0
240169|NCT01090765|582960|P6|COMPLETED|Overall Study||3
240170|NCT01090765|582961|P5|COMPLETED|Overall Study||4
240171|NCT01090765|582962|P4|COMPLETED|Overall Study||1
240172|NCT01090765|582963|P3|COMPLETED|Overall Study||3
240173|NCT01090765|582964|P2|COMPLETED|Overall Study||3
240174|NCT01090765|582965|P1|COMPLETED|Overall Study||3
240175|NCT01090765|582960|P6|STARTED|Overall Study||4
240176|NCT01090765|582961|P5|STARTED|Overall Study||6
240177|NCT01090765|582962|P4|STARTED|Overall Study||2
240178|NCT01090765|582963|P3|STARTED|Overall Study||3
240179|NCT01090765|582964|P2|STARTED|Overall Study||3
240180|NCT01090765|582965|P1|STARTED|Overall Study||3
240181|NCT01090752|583000|P2|NOT COMPLETED|Overall Study||0
240182|NCT01090752|583001|P1|NOT COMPLETED|Overall Study||0
240183|NCT01090752|583000|P2|COMPLETED|Overall Study||8
240184|NCT01090752|583001|P1|COMPLETED|Overall Study||8
240185|NCT01090752|583000|P2|STARTED|Overall Study||8
240186|NCT01090752|583001|P1|STARTED|Overall Study||8
240187|NCT01090739|583011|P1|NOT COMPLETED|36 Month Follow-up||23
240188|NCT01090739|583011|P1|COMPLETED|36 Month Follow-up||115
240189|NCT01090739|583011|P1|STARTED|36 Month Follow-up||138
240190|NCT01090739|583011|P1|NOT COMPLETED|24 Month Follow-up||9
240191|NCT01090739|583011|P1|COMPLETED|24 Month Follow-up||138
240192|NCT01090739|583011|P1|STARTED|24 Month Follow-up||147
240193|NCT01090739|583011|P1|NOT COMPLETED|12 Month Follow-up||5
240194|NCT01090739|583011|P1|COMPLETED|12 Month Follow-up||147
240195|NCT01090739|583011|P1|STARTED|12 Month Follow-up||152
240196|NCT01090739|583011|P1|NOT COMPLETED|Enrollment||55
240197|NCT01090739|583011|P1|COMPLETED|Enrollment||152
240198|NCT01090739|583011|P1|STARTED|Enrollment|Subject enrollment = signed informed consent form|207
240199|NCT01090492|583036|P8|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
240200|NCT01090492|583037|P7|NOT COMPLETED|Second Intervention Period (4 Weeks)||9
240201|NCT01090492|583038|P6|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
240202|NCT01090492|583039|P5|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
240203|NCT01090492|583040|P4|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
240204|NCT01090492|583041|P3|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
240205|NCT01090492|583042|P2|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
240206|NCT01090492|583043|P1|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
240207|NCT01090492|583036|P8|COMPLETED|Second Intervention Period (4 Weeks)||25
240208|NCT01090492|583037|P7|COMPLETED|Second Intervention Period (4 Weeks)||22
240209|NCT01090492|583038|P6|COMPLETED|Second Intervention Period (4 Weeks)||29
240210|NCT01090492|583039|P5|COMPLETED|Second Intervention Period (4 Weeks)||27
240211|NCT01090492|583040|P4|COMPLETED|Second Intervention Period (4 Weeks)||22
240212|NCT01090492|583041|P3|COMPLETED|Second Intervention Period (4 Weeks)||24
240213|NCT01090492|583042|P2|COMPLETED|Second Intervention Period (4 Weeks)||22
240214|NCT01090492|583043|P1|COMPLETED|Second Intervention Period (4 Weeks)||25
240215|NCT01090492|583036|P8|STARTED|Second Intervention Period (4 Weeks)||27
240216|NCT01090492|583037|P7|STARTED|Second Intervention Period (4 Weeks)||31
240217|NCT01090492|583038|P6|STARTED|Second Intervention Period (4 Weeks)||30
240218|NCT01090492|583039|P5|STARTED|Second Intervention Period (4 Weeks)||29
240219|NCT01090492|583040|P4|STARTED|Second Intervention Period (4 Weeks)||22
240220|NCT01090492|583041|P3|STARTED|Second Intervention Period (4 Weeks)||26
240221|NCT01090492|583042|P2|STARTED|Second Intervention Period (4 Weeks)||24
240222|NCT01090492|583043|P1|STARTED|Second Intervention Period (4 Weeks)||26
240223|NCT01090492|583036|P8|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
240224|NCT01090492|583037|P7|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
240225|NCT01090492|583038|P6|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
240226|NCT01090492|583039|P5|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
240227|NCT01090492|583040|P4|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
240228|NCT01090492|583041|P3|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
240229|NCT01090492|583042|P2|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
240230|NCT01090492|583043|P1|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
240231|NCT01090492|583036|P8|COMPLETED|Placebo Washout Period ( 2 Weeks)||27
240232|NCT01090492|583037|P7|COMPLETED|Placebo Washout Period ( 2 Weeks)||31
240233|NCT01090492|583038|P6|COMPLETED|Placebo Washout Period ( 2 Weeks)||30
240234|NCT01090492|583039|P5|COMPLETED|Placebo Washout Period ( 2 Weeks)||29
240235|NCT01090492|583040|P4|COMPLETED|Placebo Washout Period ( 2 Weeks)||22
240236|NCT01090492|583041|P3|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
240237|NCT01090492|583042|P2|COMPLETED|Placebo Washout Period ( 2 Weeks)||24
240238|NCT01090492|583043|P1|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
240239|NCT01090492|583036|P8|STARTED|Placebo Washout Period ( 2 Weeks)||27
240240|NCT01090492|583037|P7|STARTED|Placebo Washout Period ( 2 Weeks)||31
240241|NCT01090492|583038|P6|STARTED|Placebo Washout Period ( 2 Weeks)||30
240242|NCT01090492|583039|P5|STARTED|Placebo Washout Period ( 2 Weeks)||29
240243|NCT01090492|583040|P4|STARTED|Placebo Washout Period ( 2 Weeks)||22
240244|NCT01090492|583041|P3|STARTED|Placebo Washout Period ( 2 Weeks)||26
240245|NCT01090492|583042|P2|STARTED|Placebo Washout Period ( 2 Weeks)||24
240246|NCT01090492|583043|P1|STARTED|Placebo Washout Period ( 2 Weeks)||26
240247|NCT01090492|583036|P8|NOT COMPLETED|First Intervention Period (4 Weeks)||6
240248|NCT01090492|583037|P7|NOT COMPLETED|First Intervention Period (4 Weeks)||1
240249|NCT01090492|583038|P6|NOT COMPLETED|First Intervention Period (4 Weeks)||2
240250|NCT01090492|583039|P5|NOT COMPLETED|First Intervention Period (4 Weeks)||4
240251|NCT01090492|583040|P4|NOT COMPLETED|First Intervention Period (4 Weeks)||6
240252|NCT01090492|583041|P3|NOT COMPLETED|First Intervention Period (4 Weeks)||3
240253|NCT01090492|583042|P2|NOT COMPLETED|First Intervention Period (4 Weeks)||5
240254|NCT01090492|583043|P1|NOT COMPLETED|First Intervention Period (4 Weeks)||1
240255|NCT01090492|583036|P8|COMPLETED|First Intervention Period (4 Weeks)||27
240256|NCT01090492|583037|P7|COMPLETED|First Intervention Period (4 Weeks)||31
240257|NCT01090492|583038|P6|COMPLETED|First Intervention Period (4 Weeks)||30
240258|NCT01090492|583039|P5|COMPLETED|First Intervention Period (4 Weeks)||29
240259|NCT01090492|583040|P4|COMPLETED|First Intervention Period (4 Weeks)||22
240260|NCT01090492|583041|P3|COMPLETED|First Intervention Period (4 Weeks)||26
240261|NCT01090492|583042|P2|COMPLETED|First Intervention Period (4 Weeks)||24
240262|NCT01090492|583043|P1|COMPLETED|First Intervention Period (4 Weeks)||26
240263|NCT01090492|583036|P8|STARTED|First Intervention Period (4 Weeks)||33
240264|NCT01090492|583037|P7|STARTED|First Intervention Period (4 Weeks)||32
240265|NCT01090492|583038|P6|STARTED|First Intervention Period (4 Weeks)||32
240266|NCT01090492|583039|P5|STARTED|First Intervention Period (4 Weeks)||33
240267|NCT01090492|583040|P4|STARTED|First Intervention Period (4 Weeks)||28
240268|NCT01090492|583041|P3|STARTED|First Intervention Period (4 Weeks)||29
240269|NCT01090492|583042|P2|STARTED|First Intervention Period (4 Weeks)||29
240270|NCT01090492|583043|P1|STARTED|First Intervention Period (4 Weeks)||27
240271|NCT01090479|583102|P2|NOT COMPLETED|Overall Study||0
240272|NCT01090479|583103|P1|NOT COMPLETED|Overall Study||0
240273|NCT01090479|583102|P2|COMPLETED|Overall Study||50
240274|NCT01090479|583103|P1|COMPLETED|Overall Study||50
240275|NCT01090479|583102|P2|STARTED|Overall Study||50
240276|NCT01090479|583103|P1|STARTED|Overall Study||50
240277|NCT01090453|583111|P2|NOT COMPLETED|Overall Study||14
240278|NCT01090453|583112|P1|NOT COMPLETED|Overall Study||13
240279|NCT01090453|583111|P2|COMPLETED|Overall Study||228
240280|NCT01090453|583112|P1|COMPLETED|Overall Study||225
240281|NCT01090453|583111|P2|STARTED|Overall Study||242
240282|NCT01090453|583112|P1|STARTED|Overall Study||238
240283|NCT01090427|583163|P7|NOT COMPLETED|After Controlled Period||2
240284|NCT01090427|583164|P6|NOT COMPLETED|After Controlled Period||5
240285|NCT01090427|583165|P5|NOT COMPLETED|After Controlled Period||0
240286|NCT01090427|583166|P4|NOT COMPLETED|After Controlled Period||2
240287|NCT01090427|583167|P3|NOT COMPLETED|After Controlled Period||0
240288|NCT01090427|583168|P2|NOT COMPLETED|After Controlled Period||0
240289|NCT01090427|583169|P1|NOT COMPLETED|After Controlled Period||0
240290|NCT01090427|583163|P7|COMPLETED|After Controlled Period||34
240291|NCT01090427|583164|P6|COMPLETED|After Controlled Period||32
240292|NCT01090427|583165|P5|COMPLETED|After Controlled Period||18
240293|NCT01090427|583166|P4|COMPLETED|After Controlled Period||17
240294|NCT01090427|583167|P3|COMPLETED|After Controlled Period||0
240295|NCT01090427|583168|P2|COMPLETED|After Controlled Period||0
240296|NCT01090427|583169|P1|COMPLETED|After Controlled Period||0
240297|NCT01090427|583163|P7|STARTED|After Controlled Period||36
240298|NCT01090427|583164|P6|STARTED|After Controlled Period||37
240299|NCT01090427|583165|P5|STARTED|After Controlled Period||18
240300|NCT01090427|583166|P4|STARTED|After Controlled Period||19
240301|NCT01090427|583167|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
240302|NCT01090427|583168|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
240303|NCT01090427|583169|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
240304|NCT01090427|583163|P7|NOT COMPLETED|Controlled Period||0
240305|NCT01090427|583164|P6|NOT COMPLETED|Controlled Period||0
240306|NCT01090427|583165|P5|NOT COMPLETED|Controlled Period||0
240307|NCT01090427|583166|P4|NOT COMPLETED|Controlled Period||0
240308|NCT01090427|583167|P3|NOT COMPLETED|Controlled Period||0
240309|NCT01090427|583168|P2|NOT COMPLETED|Controlled Period||0
240310|NCT01090427|583169|P1|NOT COMPLETED|Controlled Period||0
240311|NCT01090427|583163|P7|COMPLETED|Controlled Period||0
240312|NCT01090427|583164|P6|COMPLETED|Controlled Period||0
240313|NCT01090427|583165|P5|COMPLETED|Controlled Period||0
240314|NCT01090427|583166|P4|COMPLETED|Controlled Period||0
240315|NCT01090427|583167|P3|COMPLETED|Controlled Period||36
240316|NCT01090427|583168|P2|COMPLETED|Controlled Period||37
240317|NCT01090427|583169|P1|COMPLETED|Controlled Period||37
240318|NCT01090427|583163|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
240319|NCT01090427|583164|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
240320|NCT01090427|583165|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
240321|NCT01090427|583166|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
240322|NCT01090427|583167|P3|STARTED|Controlled Period||36
240323|NCT01090427|583168|P2|STARTED|Controlled Period||37
240324|NCT01090427|583169|P1|STARTED|Controlled Period||37
240325|NCT01090414|583206|P4|NOT COMPLETED|Study 101-99||5
240326|NCT01090414|583207|P3|NOT COMPLETED|Study 101-99||41
240327|NCT01090414|583208|P2|NOT COMPLETED|Study 101-99||108
240328|NCT01090414|583209|P1|NOT COMPLETED|Study 101-99||48
240329|NCT01090414|583206|P4|COMPLETED|Study 101-99||0
240330|NCT01090414|583207|P3|COMPLETED|Study 101-99||0
240331|NCT01090414|583208|P2|COMPLETED|Study 101-99||0
240332|NCT01090414|583209|P1|COMPLETED|Study 101-99||0
240333|NCT01090414|583206|P4|STARTED|Study 101-99||5
240334|NCT01090414|583207|P3|STARTED|Study 101-99|43 participants completed the parent study, but only 41 participants enrolled into Study 101-99.|41
240335|NCT01090414|583208|P2|STARTED|Study 101-99|114 participants completed the parent study, but only 108 participants enrolled into Study 101-99.|108
240336|NCT01090414|583209|P1|STARTED|Study 101-99|50 participants completed the parent study, but only 48 participants enrolled into Study 101-99.|48
240337|NCT01090414|583206|P4|NOT COMPLETED|Parent Studies||13
240338|NCT01090414|583207|P3|NOT COMPLETED|Parent Studies||21
240339|NCT01090414|583208|P2|NOT COMPLETED|Parent Studies||127
240340|NCT01090414|583209|P1|NOT COMPLETED|Parent Studies||141
240341|NCT01090414|583206|P4|COMPLETED|Parent Studies||5
240342|NCT01090414|583207|P3|COMPLETED|Parent Studies||43
240343|NCT01090414|583208|P2|COMPLETED|Parent Studies||114
240344|NCT01090414|583209|P1|COMPLETED|Parent Studies||50
240345|NCT01090414|583206|P4|STARTED|Parent Studies||18
240346|NCT01090414|583207|P3|STARTED|Parent Studies||64
240347|NCT01090414|583208|P2|STARTED|Parent Studies||241
240348|NCT01090414|583209|P1|STARTED|Parent Studies||191
240349|NCT01090323|583276|P2|NOT COMPLETED|Overall Study||34
240350|NCT01090323|583277|P1|NOT COMPLETED|Overall Study||89
240351|NCT01090323|583276|P2|COMPLETED|Overall Study||19
240352|NCT01090323|583277|P1|COMPLETED|Overall Study||43
240353|NCT01090323|583276|P2|STARTED|Overall Study||53
240354|NCT01090323|583277|P1|STARTED|Overall Study||132
240355|NCT01090310|583289|P4|NOT COMPLETED|Extension Study||20
240356|NCT01090310|583290|P3|NOT COMPLETED|Extension Study||15
240357|NCT01090310|583291|P2|NOT COMPLETED|Extension Study||16
240358|NCT01090310|583292|P1|NOT COMPLETED|Extension Study||14
240359|NCT01090310|583289|P4|COMPLETED|Extension Study||1
240360|NCT01090310|583290|P3|COMPLETED|Extension Study||1
240361|NCT01090310|583291|P2|COMPLETED|Extension Study||0
240362|NCT01090310|583292|P1|COMPLETED|Extension Study||3
240363|NCT01090310|583289|P4|STARTED|Extension Study||21
240364|NCT01090310|583290|P3|STARTED|Extension Study||16
240365|NCT01090310|583291|P2|STARTED|Extension Study||16
240366|NCT01090310|583292|P1|STARTED|Extension Study||17
240367|NCT01090310|583289|P4|NOT COMPLETED|Core Study||7
240368|NCT01090310|583290|P3|NOT COMPLETED|Core Study||7
240369|NCT01090310|583291|P2|NOT COMPLETED|Core Study||11
240370|NCT01090310|583292|P1|NOT COMPLETED|Core Study||8
240371|NCT01090310|583289|P4|COMPLETED|Core Study||27
240372|NCT01090310|583290|P3|COMPLETED|Core Study||24
240373|NCT01090310|583291|P2|COMPLETED|Core Study||20
240374|NCT01090310|583292|P1|COMPLETED|Core Study||21
240375|NCT01090310|583289|P4|STARTED|Core Study||34
240376|NCT01090310|583290|P3|STARTED|Core Study||31
240377|NCT01090310|583291|P2|STARTED|Core Study||31
240378|NCT01090310|583292|P1|STARTED|Core Study||29
240379|NCT01090180|583320|P2|NOT COMPLETED|Overall Study||8
240380|NCT01090180|583321|P1|NOT COMPLETED|Overall Study||11
240381|NCT01090180|583320|P2|COMPLETED|Overall Study||21
240382|NCT01090180|583321|P1|COMPLETED|Overall Study||22
240383|NCT01090180|583320|P2|STARTED|Overall Study||29
240384|NCT01090180|583321|P1|STARTED|Overall Study||33
240385|NCT01090102|583331|P2|NOT COMPLETED|Second 12 Weeks||1
240386|NCT01090102|583332|P1|NOT COMPLETED|Second 12 Weeks||0
240387|NCT01090102|583331|P2|COMPLETED|Second 12 Weeks||15
240388|NCT01090102|583332|P1|COMPLETED|Second 12 Weeks||11
240389|NCT01090102|583331|P2|STARTED|Second 12 Weeks||16
240390|NCT01090102|583332|P1|STARTED|Second 12 Weeks||11
240391|NCT01090102|583331|P2|NOT COMPLETED|First 12 Weeks||2
240392|NCT01090102|583332|P1|NOT COMPLETED|First 12 Weeks||4
240393|NCT01090102|583331|P2|COMPLETED|First 12 Weeks||16
240394|NCT01090102|583332|P1|COMPLETED|First 12 Weeks||11
240395|NCT01090102|583331|P2|STARTED|First 12 Weeks||18
240396|NCT01090102|583332|P1|STARTED|First 12 Weeks||15
240397|NCT01090076|583342|P2|NOT COMPLETED|Overall Study||2
240398|NCT01090076|583343|P1|NOT COMPLETED|Overall Study||1
240399|NCT01090076|583342|P2|COMPLETED|Overall Study||12
240400|NCT01090076|583343|P1|COMPLETED|Overall Study||11
240401|NCT01090076|583342|P2|STARTED|Overall Study||14
240402|NCT01090076|583343|P1|STARTED|Overall Study||12
240403|NCT01090063|583353|P1|NOT COMPLETED|Treatment||4
240404|NCT01090063|583353|P1|COMPLETED|Treatment||20
240405|NCT01090063|583353|P1|STARTED|Treatment||24
240406|NCT01090063|583353|P1|NOT COMPLETED|Screen||4
240407|NCT01090063|583353|P1|COMPLETED|Screen||24
240408|NCT01090063|583353|P1|STARTED|Screen||28
240409|NCT01090050|583369|P2|NOT COMPLETED|Overall Study||7
240410|NCT01090050|583370|P1|NOT COMPLETED|Overall Study||1
240411|NCT01090050|583369|P2|COMPLETED|Overall Study||5
240412|NCT01090050|583370|P1|COMPLETED|Overall Study||15
240413|NCT01090050|583369|P2|STARTED|Overall Study||12
240414|NCT01090050|583370|P1|STARTED|Overall Study||16
240415|NCT01090011|583390|P1|NOT COMPLETED|Overall Study||171
240416|NCT01090011|583390|P1|COMPLETED|Overall Study||0
240417|NCT01090011|583390|P1|STARTED|Overall Study||171
240418|NCT01089751|583460|P2|NOT COMPLETED|Overall Study||27
240419|NCT01089751|583461|P1|NOT COMPLETED|Overall Study||34
240420|NCT01089751|583460|P2|COMPLETED|Overall Study||132
240421|NCT01089751|583461|P1|COMPLETED|Overall Study||129
240422|NCT01089751|583460|P2|STARTED|Overall Study||159
240423|NCT01089751|583461|P1|STARTED|Overall Study||163
240424|NCT01089647|583483|P2|NOT COMPLETED|Overall Study||4
240425|NCT01089647|583484|P1|NOT COMPLETED|Overall Study||4
240426|NCT01089647|583483|P2|COMPLETED|Overall Study||13
240427|NCT01089647|583484|P1|COMPLETED|Overall Study||13
240428|NCT01089647|583483|P2|STARTED|Overall Study||17
240429|NCT01089647|583484|P1|STARTED|Overall Study||17
240430|NCT01089608|583492|P2|NOT COMPLETED|Overall Study||6
240431|NCT01089608|583493|P1|NOT COMPLETED|Overall Study||0
240432|NCT01089608|583492|P2|COMPLETED|Overall Study||44
240433|NCT01089608|583493|P1|COMPLETED|Overall Study||43
240434|NCT01089608|583492|P2|STARTED|Overall Study||50
240435|NCT01089608|583493|P1|STARTED|Overall Study||43
240436|NCT01089595|583501|P2|NOT COMPLETED|Overall Study||0
240437|NCT01089595|583502|P1|NOT COMPLETED|Overall Study||0
240438|NCT01089595|583501|P2|COMPLETED|Overall Study||3
240439|NCT01089595|583502|P1|COMPLETED|Overall Study||2
240440|NCT01089595|583501|P2|STARTED|Overall Study||3
240441|NCT01089595|583502|P1|STARTED|Overall Study||2
240442|NCT01089582|583510|P1|NOT COMPLETED|Overall Study||30
240443|NCT01089582|583510|P1|COMPLETED|Overall Study|1 subject died during the study; 1 subject died following permanent discontinuation from the study.|573
240444|NCT01089582|583510|P1|STARTED|Overall Study||603
240445|NCT01089569|583523|P3|NOT COMPLETED|Overall Study||4
240446|NCT01089569|583524|P2|NOT COMPLETED|Overall Study||3
240447|NCT01089569|583525|P1|NOT COMPLETED|Overall Study||4
240448|NCT01089569|583523|P3|COMPLETED|Overall Study||16
240449|NCT01089569|583524|P2|COMPLETED|Overall Study||17
240450|NCT01089569|583525|P1|COMPLETED|Overall Study||16
240451|NCT01089569|583523|P3|STARTED|Overall Study||20
240452|NCT01089569|583524|P2|STARTED|Overall Study||20
240453|NCT01089569|583525|P1|STARTED|Overall Study||20
240454|NCT01089556|583553|P6|NOT COMPLETED|Study Period III (Weeks 9-16)||7
240455|NCT01089556|583554|P5|NOT COMPLETED|Study Period III (Weeks 9-16)||12
240456|NCT01089556|583555|P4|NOT COMPLETED|Study Period III (Weeks 9-16)||9
240457|NCT01089556|583556|P3|NOT COMPLETED|Study Period III (Weeks 9-16)||14
240458|NCT01089556|583557|P2|NOT COMPLETED|Study Period III (Weeks 9-16)||0
240459|NCT01089556|583558|P1|NOT COMPLETED|Study Period III (Weeks 9-16)||0
240460|NCT01089556|583553|P6|COMPLETED|Study Period III (Weeks 9-16)||92
240461|NCT01089556|583554|P5|COMPLETED|Study Period III (Weeks 9-16)||83
240462|NCT01089556|583555|P4|COMPLETED|Study Period III (Weeks 9-16)||66
240463|NCT01089556|583556|P3|COMPLETED|Study Period III (Weeks 9-16)||60
240464|NCT01089556|583557|P2|COMPLETED|Study Period III (Weeks 9-16)||0
240465|NCT01089556|583558|P1|COMPLETED|Study Period III (Weeks 9-16)||0
240466|NCT01089556|583553|P6|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|97
240467|NCT01089556|583554|P5|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|94
240468|NCT01089556|583555|P4|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|75
240469|NCT01089556|583556|P3|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|73
240470|NCT01089556|583557|P2|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
240471|NCT01089556|583558|P1|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
240472|NCT01089556|583553|P6|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 1 responders entered SPIII|99
240473|NCT01089556|583554|P5|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|95
240474|NCT01089556|583555|P4|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 3 responders entered SPIII|75
240475|NCT01089556|583556|P3|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|74
240476|NCT01089556|583557|P2|STARTED|Study Period III (Weeks 9-16)||0
240477|NCT01089556|583558|P1|STARTED|Study Period III (Weeks 9-16)||0
240478|NCT01089556|583553|P6|NOT COMPLETED|Study Period II (Weeks 1-8)||0
240479|NCT01089556|583554|P5|NOT COMPLETED|Study Period II (Weeks 1-8)||0
240480|NCT01089556|583555|P4|NOT COMPLETED|Study Period II (Weeks 1-8)||0
240481|NCT01089556|583556|P3|NOT COMPLETED|Study Period II (Weeks 1-8)||0
240482|NCT01089556|583557|P2|NOT COMPLETED|Study Period II (Weeks 1-8)||74
240483|NCT01089556|583558|P1|NOT COMPLETED|Study Period II (Weeks 1-8)||71
240484|NCT01089556|583553|P6|COMPLETED|Study Period II (Weeks 1-8)||0
240485|NCT01089556|583554|P5|COMPLETED|Study Period II (Weeks 1-8)||0
240486|NCT01089556|583555|P4|COMPLETED|Study Period II (Weeks 1-8)||0
240487|NCT01089556|583556|P3|COMPLETED|Study Period II (Weeks 1-8)||0
240488|NCT01089556|583557|P2|COMPLETED|Study Period II (Weeks 1-8)||333
240489|NCT01089556|583558|P1|COMPLETED|Study Period II (Weeks 1-8)||333
240490|NCT01089556|583553|P6|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
240491|NCT01089556|583554|P5|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
240492|NCT01089556|583555|P4|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
240578|NCT01089127|583756|P3|STARTED|Overall Study||94
240493|NCT01089556|583556|P3|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
240494|NCT01089556|583557|P2|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||205
240495|NCT01089556|583558|P1|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||158
240496|NCT01089556|583553|P6|Safety Population|Study Period II (Weeks 1-8)||0
240497|NCT01089556|583554|P5|Safety Population|Study Period II (Weeks 1-8)||0
240498|NCT01089556|583555|P4|Safety Population|Study Period II (Weeks 1-8)||0
240499|NCT01089556|583556|P3|Safety Population|Study Period II (Weeks 1-8)||0
240500|NCT01089556|583557|P2|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|403
240501|NCT01089556|583558|P1|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|401
240502|NCT01089556|583553|P6|STARTED|Study Period II (Weeks 1-8)||0
240503|NCT01089556|583554|P5|STARTED|Study Period II (Weeks 1-8)||0
240504|NCT01089556|583555|P4|STARTED|Study Period II (Weeks 1-8)||0
240505|NCT01089556|583556|P3|STARTED|Study Period II (Weeks 1-8)||0
240506|NCT01089556|583557|P2|STARTED|Study Period II (Weeks 1-8)||407
240507|NCT01089556|583558|P1|STARTED|Study Period II (Weeks 1-8)||404
240508|NCT01089543|583632|P4|NOT COMPLETED|Overall Study||2
240509|NCT01089543|583633|P3|NOT COMPLETED|Overall Study||3
240510|NCT01089543|583634|P2|NOT COMPLETED|Overall Study||4
240511|NCT01089543|583635|P1|NOT COMPLETED|Overall Study||3
240512|NCT01089543|583632|P4|COMPLETED|Overall Study||83
240513|NCT01089543|583633|P3|COMPLETED|Overall Study||81
240514|NCT01089543|583634|P2|COMPLETED|Overall Study||81
240515|NCT01089543|583635|P1|COMPLETED|Overall Study||81
240516|NCT01089543|583632|P4|STARTED|Overall Study||85
240517|NCT01089543|583633|P3|STARTED|Overall Study||84
240518|NCT01089543|583634|P2|STARTED|Overall Study||85
240519|NCT01089543|583635|P1|STARTED|Overall Study||84
240520|NCT01089517|583652|P3|NOT COMPLETED|Overall Study||5
240521|NCT01089517|583653|P2|NOT COMPLETED|Overall Study||5
240522|NCT01089517|583654|P1|NOT COMPLETED|Overall Study||4
240523|NCT01089517|583652|P3|COMPLETED|Overall Study||147
240524|NCT01089517|583653|P2|COMPLETED|Overall Study||144
240525|NCT01089517|583654|P1|COMPLETED|Overall Study||144
240526|NCT01089517|583652|P3|STARTED|Overall Study||152
240527|NCT01089517|583653|P2|STARTED|Overall Study||149
240528|NCT01089517|583654|P1|STARTED|Overall Study||148
240529|NCT01089504|583670|P2|NOT COMPLETED|Overall Study||1
240530|NCT01089504|583671|P1|NOT COMPLETED|Overall Study||3
240531|NCT01089504|583670|P2|COMPLETED|Overall Study||4
240532|NCT01089504|583671|P1|COMPLETED|Overall Study||5
240533|NCT01089504|583670|P2|STARTED|Overall Study||5
240534|NCT01089504|583671|P1|STARTED|Overall Study||8
240535|NCT01089413|583684|P1|NOT COMPLETED|Overall Study||201
240536|NCT01089413|583684|P1|COMPLETED|Overall Study||0
240537|NCT01089413|583684|P1|Received Bevacizumab in First Line|Overall Study||199
240538|NCT01089413|583684|P1|STARTED|Overall Study||201
240539|NCT01089361|583703|P2|NOT COMPLETED|Overall Study||0
240540|NCT01089361|583704|P1|NOT COMPLETED|Overall Study||1
240541|NCT01089361|583703|P2|COMPLETED|Overall Study||10
240542|NCT01089361|583704|P1|COMPLETED|Overall Study||8
240543|NCT01089361|583703|P2|STARTED|Overall Study||10
240544|NCT01089361|583704|P1|STARTED|Overall Study||9
240545|NCT01089231|583726|P4|NOT COMPLETED|Overall Study||1
240546|NCT01089231|583727|P3|NOT COMPLETED|Overall Study||2
240547|NCT01089231|583728|P2|NOT COMPLETED|Overall Study||2
240548|NCT01089231|583729|P1|NOT COMPLETED|Overall Study||4
240549|NCT01089231|583726|P4|COMPLETED|Overall Study|1 subject excluded (low RNA yield)|9
240550|NCT01089231|583727|P3|COMPLETED|Overall Study|2 subject excluded (1 use of not allowed drugs; 1 low RNA yield)|8
240551|NCT01089231|583728|P2|COMPLETED|Overall Study|2 subjects excluded (1 highly elevated TG and TC data; 1 elevated inflammation (CRP level))|8
240552|NCT01089231|583729|P1|COMPLETED|Overall Study|4 subjects excluded (2 alcohol use / TG level changes; 1 use of not allowed drugs; 1 low RNA yield)|6
240553|NCT01089231|583726|P4|STARTED|Overall Study||10
240554|NCT01089231|583727|P3|STARTED|Overall Study||10
240555|NCT01089231|583728|P2|STARTED|Overall Study||10
240556|NCT01089231|583729|P1|STARTED|Overall Study||10
240557|NCT01089127|583753|P6|NOT COMPLETED|Overall Study||3
240558|NCT01089127|583754|P5|NOT COMPLETED|Overall Study||2
240559|NCT01089127|583755|P4|NOT COMPLETED|Overall Study||1
240560|NCT01089127|583756|P3|NOT COMPLETED|Overall Study||2
240561|NCT01089127|583757|P2|NOT COMPLETED|Overall Study||5
240562|NCT01089127|583758|P1|NOT COMPLETED|Overall Study||8
240563|NCT01089127|583753|P6|COMPLETED|Overall Study||88
240564|NCT01089127|583754|P5|COMPLETED|Overall Study||90
240565|NCT01089127|583755|P4|COMPLETED|Overall Study||91
240566|NCT01089127|583756|P3|COMPLETED|Overall Study||92
240567|NCT01089127|583757|P2|COMPLETED|Overall Study||86
240568|NCT01089127|583758|P1|COMPLETED|Overall Study||84
240569|NCT01089127|583753|P6|Exposed to Study Drug|Overall Study||91
240570|NCT01089127|583754|P5|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|91
240571|NCT01089127|583755|P4|Exposed to Study Drug|Overall Study||92
240572|NCT01089127|583756|P3|Exposed to Study Drug|Overall Study||94
240573|NCT01089127|583757|P2|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|90
240574|NCT01089127|583758|P1|Exposed to Study Drug|Overall Study|3 randomized patients in this group were not exposed to study treatment.|89
240575|NCT01089127|583753|P6|STARTED|Overall Study||91
240576|NCT01089127|583754|P5|STARTED|Overall Study||92
240577|NCT01089127|583755|P4|STARTED|Overall Study||92
240579|NCT01089127|583757|P2|STARTED|Overall Study||91
240580|NCT01089127|583758|P1|STARTED|Overall Study||92
240581|NCT01089062|583784|P6|NOT COMPLETED|Follow-up Visit (Final Visit)||0
240582|NCT01089062|583785|P5|NOT COMPLETED|Follow-up Visit (Final Visit)||0
240583|NCT01089062|583786|P4|NOT COMPLETED|Follow-up Visit (Final Visit)||0
240584|NCT01089062|583787|P3|NOT COMPLETED|Follow-up Visit (Final Visit)||0
240585|NCT01089062|583788|P2|NOT COMPLETED|Follow-up Visit (Final Visit)||0
240586|NCT01089062|583789|P1|NOT COMPLETED|Follow-up Visit (Final Visit)||0
240587|NCT01089062|583784|P6|COMPLETED|Follow-up Visit (Final Visit)||3
240588|NCT01089062|583785|P5|COMPLETED|Follow-up Visit (Final Visit)||3
240589|NCT01089062|583786|P4|COMPLETED|Follow-up Visit (Final Visit)||3
240590|NCT01089062|583787|P3|COMPLETED|Follow-up Visit (Final Visit)||3
240591|NCT01089062|583788|P2|COMPLETED|Follow-up Visit (Final Visit)||3
240592|NCT01089062|583789|P1|COMPLETED|Follow-up Visit (Final Visit)||3
240593|NCT01089062|583784|P6|STARTED|Follow-up Visit (Final Visit)||3
240594|NCT01089062|583785|P5|STARTED|Follow-up Visit (Final Visit)||3
240595|NCT01089062|583786|P4|STARTED|Follow-up Visit (Final Visit)||3
240596|NCT01089062|583787|P3|STARTED|Follow-up Visit (Final Visit)||3
240597|NCT01089062|583788|P2|STARTED|Follow-up Visit (Final Visit)||3
240598|NCT01089062|583789|P1|STARTED|Follow-up Visit (Final Visit)||3
240599|NCT01089062|583784|P6|NOT COMPLETED|Visit 4||0
240600|NCT01089062|583785|P5|NOT COMPLETED|Visit 4||0
240601|NCT01089062|583786|P4|NOT COMPLETED|Visit 4||0
240602|NCT01089062|583787|P3|NOT COMPLETED|Visit 4||0
240603|NCT01089062|583788|P2|NOT COMPLETED|Visit 4||0
240604|NCT01089062|583789|P1|NOT COMPLETED|Visit 4||0
240605|NCT01089062|583784|P6|COMPLETED|Visit 4||3
240606|NCT01089062|583785|P5|COMPLETED|Visit 4||3
240607|NCT01089062|583786|P4|COMPLETED|Visit 4||3
240608|NCT01089062|583787|P3|COMPLETED|Visit 4||3
240609|NCT01089062|583788|P2|COMPLETED|Visit 4||3
240610|NCT01089062|583789|P1|COMPLETED|Visit 4||3
240611|NCT01089062|583784|P6|STARTED|Visit 4||3
240612|NCT01089062|583785|P5|STARTED|Visit 4||3
240613|NCT01089062|583786|P4|STARTED|Visit 4||3
240614|NCT01089062|583787|P3|STARTED|Visit 4||3
240615|NCT01089062|583788|P2|STARTED|Visit 4||3
240616|NCT01089062|583789|P1|STARTED|Visit 4||3
240617|NCT01089062|583784|P6|NOT COMPLETED|Visit 3||0
240618|NCT01089062|583785|P5|NOT COMPLETED|Visit 3||0
240619|NCT01089062|583786|P4|NOT COMPLETED|Visit 3||1
240620|NCT01089062|583787|P3|NOT COMPLETED|Visit 3||0
240621|NCT01089062|583788|P2|NOT COMPLETED|Visit 3||0
240622|NCT01089062|583789|P1|NOT COMPLETED|Visit 3||0
240623|NCT01089062|583784|P6|COMPLETED|Visit 3||3
240624|NCT01089062|583785|P5|COMPLETED|Visit 3||3
240625|NCT01089062|583786|P4|COMPLETED|Visit 3||3
240626|NCT01089062|583787|P3|COMPLETED|Visit 3||3
240627|NCT01089062|583788|P2|COMPLETED|Visit 3||3
240628|NCT01089062|583789|P1|COMPLETED|Visit 3||3
240629|NCT01089062|583784|P6|STARTED|Visit 3||3
240630|NCT01089062|583785|P5|STARTED|Visit 3||3
240631|NCT01089062|583786|P4|STARTED|Visit 3||4
240632|NCT01089062|583787|P3|STARTED|Visit 3||3
240633|NCT01089062|583788|P2|STARTED|Visit 3||3
240634|NCT01089062|583789|P1|STARTED|Visit 3||3
240635|NCT01089062|583784|P6|NOT COMPLETED|Visit 2 (Randomization)||1
240636|NCT01089062|583785|P5|NOT COMPLETED|Visit 2 (Randomization)||1
240637|NCT01089062|583786|P4|NOT COMPLETED|Visit 2 (Randomization)||0
240638|NCT01089062|583787|P3|NOT COMPLETED|Visit 2 (Randomization)||1
240639|NCT01089062|583788|P2|NOT COMPLETED|Visit 2 (Randomization)||1
240640|NCT01089062|583789|P1|NOT COMPLETED|Visit 2 (Randomization)||1
240641|NCT01089062|583784|P6|COMPLETED|Visit 2 (Randomization)||3
240642|NCT01089062|583785|P5|COMPLETED|Visit 2 (Randomization)||3
240643|NCT01089062|583786|P4|COMPLETED|Visit 2 (Randomization)||4
240644|NCT01089062|583787|P3|COMPLETED|Visit 2 (Randomization)||3
240645|NCT01089062|583788|P2|COMPLETED|Visit 2 (Randomization)||3
240646|NCT01089062|583789|P1|COMPLETED|Visit 2 (Randomization)||3
240647|NCT01089062|583784|P6|STARTED|Visit 2 (Randomization)||4
240648|NCT01089062|583785|P5|STARTED|Visit 2 (Randomization)||4
240649|NCT01089062|583786|P4|STARTED|Visit 2 (Randomization)||4
240650|NCT01089062|583787|P3|STARTED|Visit 2 (Randomization)||4
240651|NCT01089062|583788|P2|STARTED|Visit 2 (Randomization)||4
240652|NCT01089062|583789|P1|STARTED|Visit 2 (Randomization)||4
240653|NCT01089023|583812|P1|NOT COMPLETED|Overall Study||7
240654|NCT01089023|583812|P1|COMPLETED|Overall Study||88
240655|NCT01089023|583812|P1|STARTED|Overall Study||95
240656|NCT01088997|583826|P2|NOT COMPLETED|Overall Study||3
240657|NCT01088997|583827|P1|NOT COMPLETED|Overall Study||3
240658|NCT01088997|583826|P2|COMPLETED|Overall Study||2
240659|NCT01088997|583827|P1|COMPLETED|Overall Study||4
240660|NCT01088997|583826|P2|STARTED|Overall Study||5
240661|NCT01088997|583827|P1|STARTED|Overall Study||7
240662|NCT01088984|583838|P2|NOT COMPLETED|Phase 2||32
240663|NCT01088984|583839|P1|NOT COMPLETED|Phase 2||0
240664|NCT01088984|583838|P2|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
240665|NCT01088984|583839|P1|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
240666|NCT01088984|583838|P2|STARTED|Phase 2||32
240667|NCT01088984|583839|P1|STARTED|Phase 2||0
240668|NCT01088984|583838|P2|NOT COMPLETED|Phase 1||6
240669|NCT01088984|583839|P1|NOT COMPLETED|Phase 1||5
240670|NCT01088984|583838|P2|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
240671|NCT01088984|583839|P1|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
240672|NCT01088984|583838|P2|STARTED|Phase 1||6
240673|NCT01088984|583839|P1|STARTED|Phase 1||5
240674|NCT01088815|583857|P1|NOT COMPLETED|Overall Study||0
240675|NCT01088815|583857|P1|COMPLETED|Overall Study||72
240676|NCT01088815|583857|P1|STARTED|Overall Study||72
240677|NCT01088711|583870|P4|NOT COMPLETED|Overall Study||0
240678|NCT01088711|583871|P3|NOT COMPLETED|Overall Study||0
240679|NCT01088711|583872|P2|NOT COMPLETED|Overall Study||0
240680|NCT01088711|583873|P1|NOT COMPLETED|Overall Study||0
240681|NCT01088711|583870|P4|COMPLETED|Overall Study||2
240682|NCT01088711|583871|P3|COMPLETED|Overall Study||6
240683|NCT01088711|583872|P2|COMPLETED|Overall Study||6
240684|NCT01088711|583873|P1|COMPLETED|Overall Study||18
240685|NCT01088711|583870|P4|STARTED|Overall Study||2
240686|NCT01088711|583871|P3|STARTED|Overall Study||6
240687|NCT01088711|583872|P2|STARTED|Overall Study||6
240688|NCT01088711|583873|P1|STARTED|Overall Study||18
240689|NCT01088672|583897|P1|NOT COMPLETED|Overall Study||0
240690|NCT01088672|583897|P1|COMPLETED|Overall Study||60
240691|NCT01088672|583897|P1|STARTED|Overall Study||60
240692|NCT01088646|583903|P1|NOT COMPLETED|Overall Study||0
240693|NCT01088646|583903|P1|COMPLETED|Overall Study||25
240694|NCT01088646|583903|P1|STARTED|Overall Study||25
240695|NCT01088529|583909|P2|NOT COMPLETED|Overall Study||1
240696|NCT01088529|583910|P1|NOT COMPLETED|Overall Study||0
240697|NCT01088529|583909|P2|COMPLETED|Overall Study||21
240698|NCT01088529|583910|P1|COMPLETED|Overall Study||44
240699|NCT01088529|583909|P2|Received Treatment|Overall Study||21
240700|NCT01088529|583910|P1|Received Treatment|Overall Study||44
240701|NCT01088529|583909|P2|STARTED|Overall Study||22
240702|NCT01088529|583910|P1|STARTED|Overall Study||44
240703|NCT01088503|583923|P3|NOT COMPLETED|Overall Study||17
240704|NCT01088503|583924|P2|NOT COMPLETED|Overall Study||685
240705|NCT01088503|583925|P1|NOT COMPLETED|Overall Study||182
240706|NCT01088503|583923|P3|COMPLETED|Overall Study||241
240707|NCT01088503|583924|P2|COMPLETED|Overall Study||8161
240708|NCT01088503|583925|P1|COMPLETED|Overall Study||2941
240709|NCT01088503|583923|P3|STARTED|Overall Study||258
240710|NCT01088503|583924|P2|STARTED|Overall Study||8846
240711|NCT01088503|583925|P1|STARTED|Overall Study||3123
240712|NCT01088464|583949|P3|NOT COMPLETED|Overall Study||0
240713|NCT01088464|583950|P2|NOT COMPLETED|Overall Study||0
240714|NCT01088464|583951|P1|NOT COMPLETED|Overall Study||0
240715|NCT01088464|583949|P3|COMPLETED|Overall Study||6
240716|NCT01088464|583950|P2|COMPLETED|Overall Study||6
240717|NCT01088464|583951|P1|COMPLETED|Overall Study||3
240718|NCT01088464|583949|P3|Received Any Quantity of Study Drug|Overall Study||6
240719|NCT01088464|583950|P2|Received Any Quantity of Study Drug|Overall Study||6
240720|NCT01088464|583951|P1|Received Any Quantity of Study Drug|Overall Study||3
240721|NCT01088464|583949|P3|STARTED|Overall Study||6
240722|NCT01088464|583950|P2|STARTED|Overall Study||6
240723|NCT01088464|583951|P1|STARTED|Overall Study||3
240724|NCT01088438|584003|P2|NOT COMPLETED|Overall Study||36
240725|NCT01088438|584004|P1|NOT COMPLETED|Overall Study||29
240726|NCT01088438|584003|P2|COMPLETED|Overall Study||59
240727|NCT01088438|584004|P1|COMPLETED|Overall Study||65
240728|NCT01088438|584003|P2|STARTED|Overall Study||95
240729|NCT01088438|584004|P1|STARTED|Overall Study||94
240730|NCT01088412|584017|P3|NOT COMPLETED|Overall Study||72
240731|NCT01088412|584018|P2|NOT COMPLETED|Overall Study||436
240732|NCT01088412|584019|P1|NOT COMPLETED|Overall Study||18017
240733|NCT01088412|584017|P3|COMPLETED|Overall Study||5
240734|NCT01088412|584018|P2|COMPLETED|Overall Study||21
240735|NCT01088412|584019|P1|COMPLETED|Overall Study||4294
240736|NCT01088412|584017|P3|SME+ >= 1 FU and Previous Cancer|Overall Study||0
240737|NCT01088412|584018|P2|SME+ >= 1 FU and Previous Cancer|Overall Study||114
240738|NCT01088412|584019|P1|SME+ >= 1 FU and Previous Cancer|Overall Study||622
240739|NCT01088412|584017|P3|SME+ >= 1 FU and No Previous Cancer|Overall Study||0
240740|NCT01088412|584018|P2|SME+ >= 1 FU and No Previous Cancer|Overall Study||192
240741|NCT01088412|584019|P1|SME+ >= 1 FU and No Previous Cancer|Overall Study||20556
240742|NCT01088412|584017|P3|SME+ >= 1 FU and Unknown Arm|Overall Study||40
240743|NCT01088412|584018|P2|SME+ >= 1 FU and Unknown Arm|Overall Study||306
240744|NCT01088412|584019|P1|SME+ >= 1 FU and Unknown Arm|Overall Study||21177
240745|NCT01088412|584017|P3|SME With at Least 1 Follow Up (FU)|Overall Study||0
240746|NCT01088412|584018|P2|SME With at Least 1 Follow Up (FU)|Overall Study||306
240747|NCT01088412|584019|P1|SME With at Least 1 Follow Up (FU)|Overall Study||21178
240748|NCT01088412|584017|P3|Safety Modified Evaluable (SME)|Overall Study||0
240749|NCT01088412|584018|P2|Safety Modified Evaluable (SME)|Overall Study||456
240750|NCT01088412|584019|P1|Safety Modified Evaluable (SME)|Overall Study||22294
240751|NCT01088412|584017|P3|STARTED|Overall Study||77
240752|NCT01088412|584018|P2|STARTED|Overall Study||457
240753|NCT01088412|584019|P1|STARTED|Overall Study||22311
240754|NCT01088399|584038|P3|NOT COMPLETED|Overall Study||281
240755|NCT01088399|584039|P2|NOT COMPLETED|Overall Study||1347
240756|NCT01088399|584040|P1|NOT COMPLETED|Overall Study||7121
240757|NCT01088399|584038|P3|COMPLETED|Overall Study||21
240758|NCT01088399|584039|P2|COMPLETED|Overall Study||308
240759|NCT01088399|584040|P1|COMPLETED|Overall Study||1595
240760|NCT01088399|584038|P3|STARTED|Overall Study||302
240761|NCT01088399|584039|P2|STARTED|Overall Study||1655
240762|NCT01088399|584040|P1|STARTED|Overall Study||8716
240763|NCT01088295|584063|P1|NOT COMPLETED|Overall Study||1
240764|NCT01088295|584063|P1|COMPLETED|Overall Study||35
240765|NCT01088295|584063|P1|STARTED|Overall Study||36
240766|NCT01088243|584069|P2|NOT COMPLETED|Overall Study||0
240767|NCT01088243|584070|P1|NOT COMPLETED|Overall Study||1
240768|NCT01088243|584069|P2|COMPLETED|Overall Study||5
240769|NCT01088243|584070|P1|COMPLETED|Overall Study||12
240770|NCT01088243|584069|P2|STARTED|Overall Study||5
240771|NCT01088243|584070|P1|STARTED|Overall Study||13
240772|NCT01087996|584088|P2|NOT COMPLETED|Overall Study||0
240773|NCT01087996|584089|P1|NOT COMPLETED|Overall Study||0
240774|NCT01087996|584088|P2|COMPLETED|Overall Study||15
240775|NCT01087996|584089|P1|COMPLETED|Overall Study||15
240776|NCT01087996|584088|P2|STARTED|Overall Study||15
240777|NCT01087996|584089|P1|STARTED|Overall Study||15
240778|NCT01087970|584111|P1|NOT COMPLETED|Overall Study||2
240779|NCT01087970|584111|P1|COMPLETED|Overall Study||67
240780|NCT01087970|584111|P1|Received Carboplatin|Overall Study||63
240781|NCT01087970|584111|P1|Efficacy Population|Overall Study|All treated participants excluding those from a noncompliant study site.|58
240782|NCT01087970|584111|P1|Completed 6 Cycles|Overall Study||69
240783|NCT01087970|584111|P1|Received ≥1 Dose of Any Study Drug|Overall Study||69
240784|NCT01087970|584111|P1|STARTED|Overall Study||69
240785|NCT01087957|584123|P2|NOT COMPLETED|Overall Study||55
240786|NCT01087957|584124|P1|NOT COMPLETED|Overall Study||41
240787|NCT01087957|584123|P2|COMPLETED|Overall Study||187
240788|NCT01087957|584124|P1|COMPLETED|Overall Study||212
240789|NCT01087957|584123|P2|STARTED|Overall Study||242
240790|NCT01087957|584124|P1|STARTED|Overall Study||253
240791|NCT01087944|584150|P2|NOT COMPLETED|Period 2 (Week 4-6)||2
240792|NCT01087944|584151|P1|NOT COMPLETED|Period 2 (Week 4-6)||0
240793|NCT01087944|584150|P2|COMPLETED|Period 2 (Week 4-6)||28
240794|NCT01087944|584151|P1|COMPLETED|Period 2 (Week 4-6)||29
240795|NCT01087944|584150|P2|STARTED|Period 2 (Week 4-6)||30
240796|NCT01087944|584151|P1|STARTED|Period 2 (Week 4-6)||29
240797|NCT01087944|584150|P2|NOT COMPLETED|Period 1 (Week 1-3)||0
240798|NCT01087944|584151|P1|NOT COMPLETED|Period 1 (Week 1-3)||1
240799|NCT01087944|584150|P2|COMPLETED|Period 1 (Week 1-3)||30
240800|NCT01087944|584151|P1|COMPLETED|Period 1 (Week 1-3)||29
240801|NCT01087944|584150|P2|STARTED|Period 1 (Week 1-3)||30
240802|NCT01087944|584151|P1|STARTED|Period 1 (Week 1-3)||30
240803|NCT01087931|584181|P2|NOT COMPLETED|Overall Study||0
240804|NCT01087931|584182|P1|NOT COMPLETED|Overall Study||0
240805|NCT01087931|584181|P2|COMPLETED|Overall Study||20
240806|NCT01087931|584182|P1|COMPLETED|Overall Study||20
240807|NCT01087931|584181|P2|Final Follow up|Overall Study||17
240808|NCT01087931|584182|P1|Final Follow up|Overall Study||19
240809|NCT01087931|584181|P2|1st Follow up|Overall Study||19
240810|NCT01087931|584182|P1|1st Follow up|Overall Study||20
240811|NCT01087931|584181|P2|STARTED|Overall Study||20
240812|NCT01087931|584182|P1|STARTED|Overall Study||20
240813|NCT01087918|584196|P2|NOT COMPLETED|Overall Study||0
240814|NCT01087918|584197|P1|NOT COMPLETED|Overall Study||0
240815|NCT01087918|584196|P2|COMPLETED|Overall Study||4
240816|NCT01087918|584197|P1|COMPLETED|Overall Study||5
240817|NCT01087918|584196|P2|STARTED|Overall Study||4
240818|NCT01087918|584197|P1|STARTED|Overall Study||5
240819|NCT01087905|584231|P8|NOT COMPLETED|Overall Study||29
240820|NCT01087905|584232|P7|NOT COMPLETED|Overall Study||23
240821|NCT01087905|584233|P6|NOT COMPLETED|Overall Study||28
240822|NCT01087905|584234|P5|NOT COMPLETED|Overall Study||31
240823|NCT01087905|584235|P4|NOT COMPLETED|Overall Study||36
240824|NCT01087905|584236|P3|NOT COMPLETED|Overall Study||22
240825|NCT01087905|584237|P2|NOT COMPLETED|Overall Study||32
240826|NCT01087905|584238|P1|NOT COMPLETED|Overall Study||29
240827|NCT01087905|584231|P8|COMPLETED|Overall Study||98
240828|NCT01087905|584232|P7|COMPLETED|Overall Study||98
240829|NCT01087905|584233|P6|COMPLETED|Overall Study||99
240830|NCT01087905|584234|P5|COMPLETED|Overall Study||91
240831|NCT01087905|584235|P4|COMPLETED|Overall Study||86
240832|NCT01087905|584236|P3|COMPLETED|Overall Study||101
240833|NCT01087905|584237|P2|COMPLETED|Overall Study||94
240834|NCT01087905|584238|P1|COMPLETED|Overall Study||90
240835|NCT01087905|584231|P8|STARTED|Overall Study||127
240836|NCT01087905|584232|P7|STARTED|Overall Study||121
240837|NCT01087905|584233|P6|STARTED|Overall Study||127
240838|NCT01087905|584234|P5|STARTED|Overall Study||122
240839|NCT01087905|584235|P4|STARTED|Overall Study||122
240840|NCT01087905|584236|P3|STARTED|Overall Study||123
240841|NCT01087905|584237|P2|STARTED|Overall Study||126
240842|NCT01087905|584238|P1|STARTED|Overall Study||119
240843|NCT01087814|584260|P2|NOT COMPLETED|Second Intervention (5 Days)||0
240844|NCT01087814|584261|P1|NOT COMPLETED|Second Intervention (5 Days)||1
240845|NCT01087814|584260|P2|COMPLETED|Second Intervention (5 Days)||6
240846|NCT01087814|584261|P1|COMPLETED|Second Intervention (5 Days)||4
240847|NCT01087814|584260|P2|STARTED|Second Intervention (5 Days)||6
240848|NCT01087814|584261|P1|STARTED|Second Intervention (5 Days)||5
240849|NCT01087814|584260|P2|NOT COMPLETED|First Intervention (5 Days)||1
240850|NCT01087814|584261|P1|NOT COMPLETED|First Intervention (5 Days)||3
240851|NCT01087814|584260|P2|COMPLETED|First Intervention (5 Days)||6
240852|NCT01087814|584261|P1|COMPLETED|First Intervention (5 Days)||5
240853|NCT01087814|584260|P2|STARTED|First Intervention (5 Days)||7
240854|NCT01087814|584261|P1|STARTED|First Intervention (5 Days)||8
240855|NCT01087801|584269|P2|NOT COMPLETED|Overall Study||5
240856|NCT01087801|584270|P1|NOT COMPLETED|Overall Study||4
240857|NCT01087801|584269|P2|COMPLETED|Overall Study||29
240858|NCT01087801|584270|P1|COMPLETED|Overall Study||26
240859|NCT01087801|584269|P2|STARTED|Overall Study||34
240860|NCT01087801|584270|P1|STARTED|Overall Study||30
240861|NCT01087788|584279|P3|NOT COMPLETED|Open-Label Period (OL-P)||28
240862|NCT01087788|584280|P2|NOT COMPLETED|Open-Label Period (OL-P)||24
240863|NCT01087788|584281|P1|NOT COMPLETED|Open-Label Period (OL-P)||30
240864|NCT01087788|584279|P3|COMPLETED|Open-Label Period (OL-P)||86
240865|NCT01087788|584280|P2|COMPLETED|Open-Label Period (OL-P)||97
240866|NCT01087788|584281|P1|COMPLETED|Open-Label Period (OL-P)||81
240867|NCT01087788|584279|P3|STARTED|Open-Label Period (OL-P)||114
240868|NCT01087788|584280|P2|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|121
240869|NCT01087788|584281|P1|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|111
240870|NCT01087788|584279|P3|NOT COMPLETED|24-weeks Dose-blind Period||6
240871|NCT01087788|584280|P2|NOT COMPLETED|24-weeks Dose-blind Period||5
240872|NCT01087788|584281|P1|NOT COMPLETED|24-weeks Dose-blind Period||7
240873|NCT01087788|584279|P3|COMPLETED|24-weeks Dose-blind Period||114
240874|NCT01087788|584280|P2|COMPLETED|24-weeks Dose-blind Period||123
240875|NCT01087788|584281|P1|COMPLETED|24-weeks Dose-blind Period||113
240876|NCT01087788|584279|P3|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
240877|NCT01087788|584280|P2|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
240878|NCT01087788|584281|P1|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 400mg Q2W at week 16 (29 subjects) and at week 24 (31 subjects)|60
240879|NCT01087788|584279|P3|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
240880|NCT01087788|584280|P2|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
240881|NCT01087788|584281|P1|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 200mg Q2W at week 16 (30 subjects) and at week 24 (30 subjects)|60
240882|NCT01087788|584279|P3|STARTED|24-weeks Dose-blind Period||120
240883|NCT01087788|584280|P2|STARTED|24-weeks Dose-blind Period||128
240884|NCT01087788|584281|P1|STARTED|24-weeks Dose-blind Period||120
240885|NCT01087788|584279|P3|NOT COMPLETED|24-weeks Double-blind Period||15
240886|NCT01087788|584280|P2|NOT COMPLETED|24-weeks Double-blind Period||10
240887|NCT01087788|584281|P1|NOT COMPLETED|24-weeks Double-blind Period||16
240888|NCT01087788|584279|P3|COMPLETED|24-weeks Double-blind Period||120
240889|NCT01087788|584280|P2|COMPLETED|24-weeks Double-blind Period||128
240890|NCT01087788|584281|P1|COMPLETED|24-weeks Double-blind Period||120
240891|NCT01087788|584279|P3|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
240892|NCT01087788|584280|P2|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
240893|NCT01087788|584281|P1|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|29 subjects left the Placebo group and were re-randomized to CZP 400 mg Q4W on Week 16.|29
240894|NCT01087788|584279|P3|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
240895|NCT01087788|584280|P2|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
240896|NCT01087788|584281|P1|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|30 subjects left the Placebo group and were re-randomized to CZP 200 mg Q2W on Week 16.|30
240897|NCT01087788|584279|P3|STARTED|24-weeks Double-blind Period||135
240898|NCT01087788|584280|P2|STARTED|24-weeks Double-blind Period||138
240899|NCT01087788|584281|P1|STARTED|24-weeks Double-blind Period||136
240900|NCT01087762|584311|P5|NOT COMPLETED|Open-Label Period (Weeks 48-204)||57
240901|NCT01087762|584312|P4|NOT COMPLETED|Open-Label Period (Weeks 48-204)||59
240902|NCT01087762|584313|P3|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
240903|NCT01087762|584314|P2|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
240904|NCT01087762|584315|P1|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
240905|NCT01087762|584311|P5|COMPLETED|Open-Label Period (Weeks 48-204)||100
240906|NCT01087762|584312|P4|COMPLETED|Open-Label Period (Weeks 48-204)||99
240907|NCT01087762|584313|P3|COMPLETED|Open-Label Period (Weeks 48-204)||0
240908|NCT01087762|584314|P2|COMPLETED|Open-Label Period (Weeks 48-204)||0
240909|NCT01087762|584315|P1|COMPLETED|Open-Label Period (Weeks 48-204)||0
240910|NCT01087762|584311|P5|STARTED|Open-Label Period (Weeks 48-204)||157
240911|NCT01087762|584312|P4|STARTED|Open-Label Period (Weeks 48-204)||158
240912|NCT01087762|584313|P3|STARTED|Open-Label Period (Weeks 48-204)||0
240913|NCT01087762|584314|P2|STARTED|Open-Label Period (Weeks 48-204)||0
240914|NCT01087762|584315|P1|STARTED|Open-Label Period (Weeks 48-204)||0
240915|NCT01087762|584311|P5|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
240916|NCT01087762|584312|P4|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
240917|NCT01087762|584313|P3|NOT COMPLETED|Double Blind Period (Weeks 0-24)||9
240918|NCT01087762|584314|P2|NOT COMPLETED|Double Blind Period (Weeks 0-24)||6
240919|NCT01087762|584315|P1|NOT COMPLETED|Double Blind Period (Weeks 0-24)||12
240920|NCT01087762|584311|P5|COMPLETED|Double Blind Period (Weeks 0-24)||0
240921|NCT01087762|584312|P4|COMPLETED|Double Blind Period (Weeks 0-24)||0
240922|NCT01087762|584313|P3|COMPLETED|Double Blind Period (Weeks 0-24)||98
240923|NCT01087762|584314|P2|COMPLETED|Double Blind Period (Weeks 0-24)||105
240924|NCT01087762|584315|P1|COMPLETED|Double Blind Period (Weeks 0-24)||95
240925|NCT01087762|584311|P5|STARTED|Double Blind Period (Weeks 0-24)||0
240926|NCT01087762|584312|P4|STARTED|Double Blind Period (Weeks 0-24)||0
240927|NCT01087762|584313|P3|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
240928|NCT01087762|584314|P2|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|111
240929|NCT01087762|584315|P1|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
240930|NCT01087736|584363|P2|NOT COMPLETED|Overall Study||2
240931|NCT01087736|584364|P1|NOT COMPLETED|Overall Study||1
240932|NCT01087736|584363|P2|COMPLETED|Overall Study||14
240933|NCT01087736|584364|P1|COMPLETED|Overall Study||13
240934|NCT01087736|584363|P2|STARTED|Overall Study||16
240935|NCT01087736|584364|P1|STARTED|Overall Study||14
240936|NCT01087723|584374|P2|NOT COMPLETED|Overall Study||20
240937|NCT01087723|584375|P1|NOT COMPLETED|Overall Study||14
240938|NCT01087723|584374|P2|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1089
240939|NCT01087723|584375|P1|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1075
240940|NCT01087723|584374|P2|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1094
240941|NCT01087723|584375|P1|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1099
240942|NCT01087723|584374|P2|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1109
240943|NCT01087723|584375|P1|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1089
240944|NCT01087541|584399|P2|NOT COMPLETED|Overall Study||0
240945|NCT01087541|584400|P1|NOT COMPLETED|Overall Study||0
240946|NCT01087541|584399|P2|COMPLETED|Overall Study||3523
240947|NCT01087541|584400|P1|COMPLETED|Overall Study||3307
240948|NCT01087541|584399|P2|STARTED|Overall Study||3523
240949|NCT01087541|584400|P1|STARTED|Overall Study||3307
240950|NCT01087528|584416|P1|NOT COMPLETED|Overall Study||7
240951|NCT01087528|584416|P1|COMPLETED|Overall Study|withdrawn from the study prior to any procedure|44
240952|NCT01087528|584416|P1|STARTED|Overall Study||51
240953|NCT01087502|584422|P2|NOT COMPLETED|Up to Final Analysis (Week 52)||23
240954|NCT01087502|584423|P1|NOT COMPLETED|Up to Final Analysis (Week 52)||33
240955|NCT01087502|584422|P2|COMPLETED|Up to Final Analysis (Week 52)||95
240956|NCT01087502|584423|P1|COMPLETED|Up to Final Analysis (Week 52)||90
240957|NCT01087502|584422|P2|STARTED|Up to Final Analysis (Week 52)||118
240958|NCT01087502|584423|P1|STARTED|Up to Final Analysis (Week 52)||123
240959|NCT01087502|584422|P2|NOT COMPLETED|Up to Interim Analysis (Week 12)||8
240960|NCT01087502|584423|P1|NOT COMPLETED|Up to Interim Analysis (Week 12)||9
240961|NCT01087502|584422|P2|COMPLETED|Up to Interim Analysis (Week 12)||110
240962|NCT01087502|584423|P1|COMPLETED|Up to Interim Analysis (Week 12)||114
240963|NCT01087502|584422|P2|STARTED|Up to Interim Analysis (Week 12)||118
240964|NCT01087502|584423|P1|STARTED|Up to Interim Analysis (Week 12)||123
240965|NCT01087489|584442|P2|NOT COMPLETED|Overall Study||3
240966|NCT01087489|584443|P1|NOT COMPLETED|Overall Study||0
240967|NCT01087489|584442|P2|COMPLETED|Overall Study||31
240968|NCT01087489|584443|P1|COMPLETED|Overall Study||19
240969|NCT01087489|584442|P2|STARTED|Overall Study||34
240970|NCT01087489|584443|P1|STARTED|Overall Study||19
240971|NCT01086969|584456|P3|NOT COMPLETED|Overall Study||0
240972|NCT01086969|584457|P2|NOT COMPLETED|Overall Study||2
240973|NCT01086969|584458|P1|NOT COMPLETED|Overall Study||1
240974|NCT01086969|584456|P3|COMPLETED|Overall Study||100
240975|NCT01086969|584457|P2|COMPLETED|Overall Study||98
240976|NCT01086969|584458|P1|COMPLETED|Overall Study||99
240977|NCT01086969|584456|P3|STARTED|Overall Study||100
240978|NCT01086969|584457|P2|STARTED|Overall Study||100
240979|NCT01086969|584458|P1|STARTED|Overall Study||100
240980|NCT01086852|584475|P1|NOT COMPLETED|Overall Study||0
240981|NCT01086852|584475|P1|COMPLETED|Overall Study||4
240982|NCT01086852|584475|P1|STARTED|Overall Study||4
240983|NCT01086761|584491|P6|NOT COMPLETED|Overall Study||0
240984|NCT01086761|584492|P5|NOT COMPLETED|Overall Study||0
240985|NCT01086761|584493|P4|NOT COMPLETED|Overall Study||0
240986|NCT01086761|584494|P3|NOT COMPLETED|Overall Study||0
240987|NCT01086761|584495|P2|NOT COMPLETED|Overall Study||0
240988|NCT01086761|584496|P1|NOT COMPLETED|Overall Study||0
240989|NCT01086761|584491|P6|COMPLETED|Overall Study||0
240990|NCT01086761|584492|P5|COMPLETED|Overall Study||4
240991|NCT01086761|584493|P4|COMPLETED|Overall Study||6
240992|NCT01086761|584494|P3|COMPLETED|Overall Study||6
240993|NCT01086761|584495|P2|COMPLETED|Overall Study||7
240994|NCT01086761|584496|P1|COMPLETED|Overall Study||9
240995|NCT01086761|584491|P6|STARTED|Overall Study||0
240996|NCT01086761|584492|P5|STARTED|Overall Study||4
240997|NCT01086761|584493|P4|STARTED|Overall Study||6
240998|NCT01086761|584494|P3|STARTED|Overall Study||6
240999|NCT01086761|584495|P2|STARTED|Overall Study||7
241000|NCT01086761|584496|P1|STARTED|Overall Study||9
241001|NCT01086605|584536|P2|NOT COMPLETED|Overall Study||0
241002|NCT01086605|584537|P1|NOT COMPLETED|Overall Study||0
241003|NCT01086605|584536|P2|COMPLETED|Overall Study||22
241004|NCT01086605|584537|P1|COMPLETED|Overall Study||24
241005|NCT01086605|584536|P2|STARTED|Overall Study||22
241006|NCT01086605|584537|P1|STARTED|Overall Study||24
241007|NCT01086475|584554|P2|NOT COMPLETED|Overall Study||0
241008|NCT01086475|584555|P1|NOT COMPLETED|Overall Study||0
241009|NCT01086475|584554|P2|COMPLETED|Overall Study||33
241010|NCT01086475|584555|P1|COMPLETED|Overall Study||34
241011|NCT01086475|584554|P2|STARTED|Overall Study||33
241012|NCT01086475|584555|P1|STARTED|Overall Study||34
241013|NCT01086423|584568|P3|NOT COMPLETED|Overall Study||9
241014|NCT01086423|584569|P2|NOT COMPLETED|Overall Study||3
241015|NCT01086423|584570|P1|NOT COMPLETED|Overall Study||10
241016|NCT01086423|584568|P3|COMPLETED|Overall Study||321
241017|NCT01086423|584569|P2|COMPLETED|Overall Study||321
241018|NCT01086423|584570|P1|COMPLETED|Overall Study||320
241019|NCT01086423|584568|P3|STARTED|Overall Study||330
241020|NCT01086423|584569|P2|STARTED|Overall Study||324
241021|NCT01086423|584570|P1|STARTED|Overall Study||330
241022|NCT01086410|584615|P4|NOT COMPLETED|Overall Study||2
241023|NCT01086410|584616|P3|NOT COMPLETED|Overall Study||1
241024|NCT01086410|584617|P2|NOT COMPLETED|Overall Study||2
241025|NCT01086410|584618|P1|NOT COMPLETED|Overall Study||3
241026|NCT01086410|584615|P4|COMPLETED|Overall Study||13
241027|NCT01086410|584616|P3|COMPLETED|Overall Study||55
241028|NCT01086410|584617|P2|COMPLETED|Overall Study||54
241029|NCT01086410|584618|P1|COMPLETED|Overall Study||55
241030|NCT01086410|584615|P4|STARTED|Overall Study||15
241031|NCT01086410|584616|P3|STARTED|Overall Study||56
241032|NCT01086410|584617|P2|STARTED|Overall Study||56
241033|NCT01086410|584618|P1|STARTED|Overall Study||58
241034|NCT01086384|584714|P3|NOT COMPLETED|Treatment Period||124
241035|NCT01086384|584715|P2|NOT COMPLETED|Treatment Period||148
241036|NCT01086384|584716|P1|NOT COMPLETED|Treatment Period||0
241037|NCT01086384|584714|P3|COMPLETED|Treatment Period||885
241038|NCT01086384|584715|P2|COMPLETED|Treatment Period||863
241039|NCT01086384|584716|P1|COMPLETED|Treatment Period||0
241040|NCT01086384|584714|P3|STARTED|Treatment Period||1009
241041|NCT01086384|584715|P2|STARTED|Treatment Period||1011
241042|NCT01086384|584716|P1|STARTED|Treatment Period||0
241043|NCT01086384|584714|P3|NOT COMPLETED|2-week Run-in Period||0
241044|NCT01086384|584715|P2|NOT COMPLETED|2-week Run-in Period||0
241045|NCT01086384|584716|P1|NOT COMPLETED|2-week Run-in Period||163
241046|NCT01086384|584714|P3|COMPLETED|2-week Run-in Period||0
241047|NCT01086384|584715|P2|COMPLETED|2-week Run-in Period||0
241048|NCT01086384|584716|P1|COMPLETED|2-week Run-in Period||2020
241049|NCT01086384|584714|P3|STARTED|2-week Run-in Period||0
241050|NCT01086384|584715|P2|STARTED|2-week Run-in Period||0
241051|NCT01086384|584716|P1|STARTED|2-week Run-in Period||2183
241052|NCT01086358|584726|P2|NOT COMPLETED|Second Intervention||4
241053|NCT01086358|584727|P1|NOT COMPLETED|Second Intervention||4
241054|NCT01086358|584726|P2|COMPLETED|Second Intervention||20
241055|NCT01086358|584727|P1|COMPLETED|Second Intervention||17
241056|NCT01086358|584726|P2|STARTED|Second Intervention||24
241057|NCT01086358|584727|P1|STARTED|Second Intervention||21
241058|NCT01086358|584726|P2|NOT COMPLETED|First Intervention||5
241059|NCT01086358|584727|P1|NOT COMPLETED|First Intervention||9
241060|NCT01086358|584726|P2|COMPLETED|First Intervention||24
241061|NCT01086358|584727|P1|COMPLETED|First Intervention||21
241062|NCT01086358|584726|P2|STARTED|First Intervention|30 subjects enrolled, 1 withdrew before randomization|29
241063|NCT01086358|584727|P1|STARTED|First Intervention|30 subjects enrolled.|30
241064|NCT01086228|584739|P1|NOT COMPLETED|5-year Follow-up||652
241065|NCT01086228|584739|P1|COMPLETED|5-year Follow-up||1012
241066|NCT01086228|584739|P1|STARTED|5-year Follow-up||1664
241067|NCT01086228|584739|P1|NOT COMPLETED|4-year Follow-up||103
241068|NCT01086228|584739|P1|COMPLETED|4-year Follow-up||1664
241069|NCT01086228|584739|P1|STARTED|4-year Follow-up||1767
241070|NCT01086228|584739|P1|NOT COMPLETED|3-year Follow-up||67
241071|NCT01086228|584739|P1|COMPLETED|3-year Follow-up||1767
241072|NCT01086228|584739|P1|STARTED|3-year Follow-up||1834
241073|NCT01086228|584739|P1|NOT COMPLETED|2-year Follow-up||60
241074|NCT01086228|584739|P1|COMPLETED|2-year Follow-up||1834
241075|NCT01086228|584739|P1|STARTED|2-year Follow-up||1894
241076|NCT01086228|584739|P1|NOT COMPLETED|1-year Follow-up||44
241077|NCT01086228|584739|P1|COMPLETED|1-year Follow-up||1894
241078|NCT01086228|584739|P1|STARTED|1-year Follow-up||1938
241079|NCT01086228|584739|P1|NOT COMPLETED|8 Month Follow-up||71
241080|NCT01086228|584739|P1|COMPLETED|8 Month Follow-up||1938
241081|NCT01086228|584739|P1|STARTED|8 Month Follow-up|Analysis population|2009
241082|NCT01086215|584797|P4|NOT COMPLETED|Overall Study||3
241083|NCT01086215|584798|P3|NOT COMPLETED|Overall Study||26
241084|NCT01086215|584799|P2|NOT COMPLETED|Overall Study||47
241085|NCT01086215|584800|P1|NOT COMPLETED|Overall Study||36
241086|NCT01086215|584797|P4|COMPLETED|Overall Study||11
241087|NCT01086215|584798|P3|COMPLETED|Overall Study||47
241088|NCT01086215|584799|P2|COMPLETED|Overall Study||154
241089|NCT01086215|584800|P1|COMPLETED|Overall Study||176
241090|NCT01086215|584797|P4|12 Month Follow Up|Overall Study|0 LTF; 1 Death|11
241091|NCT01086215|584798|P3|12 Month Follow Up|Overall Study|9 LTF; 4 Deaths|47
241092|NCT01086215|584799|P2|12 Month Follow Up|Overall Study|16 LTF; 2 Deaths|154
241093|NCT01086215|584800|P1|12 Month Follow Up|Overall Study|10 LTF; 6 Deaths|176
241094|NCT01086215|584797|P4|6 Month Follow Up|Overall Study|1 LTF; 0 Deaths|12
241095|NCT01086215|584798|P3|6 Month Follow Up|Overall Study|4 LTF; 0 Deaths|60
241096|NCT01086215|584799|P2|6 Month Follow Up|Overall Study|13 LTF; 2 Deaths|172
241097|NCT01086215|584800|P1|6 Month Follow Up|Overall Study|5 LTF; 4 Deaths|192
241098|NCT01086215|584797|P4|3 Month Follow Up|Overall Study|1 LTF; 0 Deaths|13
241099|NCT01086215|584798|P3|3 Month Follow Up|Overall Study|5 LTF; 4 Deaths|64
241100|NCT01086215|584799|P2|3 Month Follow Up|Overall Study|10 LTF; 4 Deaths|187
241101|NCT01086215|584800|P1|3 Month Follow Up|Overall Study|7 LTF; 4 Deaths|201
241102|NCT01086215|584797|P4|STARTED|Overall Study||14
241103|NCT01086215|584798|P3|STARTED|Overall Study||73
241104|NCT01086215|584799|P2|STARTED|Overall Study||201
241105|NCT01086215|584800|P1|STARTED|Overall Study||212
241106|NCT01086033|584818|P1|NOT COMPLETED|Overall Study||304
241107|NCT01086033|584818|P1|COMPLETED|Overall Study||262
241108|NCT01086033|584818|P1|STARTED|Overall Study||566
241109|NCT01085968|584832|P2|NOT COMPLETED|Overall Study||4
241110|NCT01085968|584833|P1|NOT COMPLETED|Overall Study||10
241111|NCT01085968|584832|P2|COMPLETED|Overall Study||21
241112|NCT01085968|584833|P1|COMPLETED|Overall Study||19
241113|NCT01085968|584832|P2|STARTED|Overall Study||25
241114|NCT01085968|584833|P1|STARTED|Overall Study||29
241115|NCT01085903|584849|P3|NOT COMPLETED|Overall Study||0
241116|NCT01085903|584850|P2|NOT COMPLETED|Overall Study||0
241117|NCT01085903|584851|P1|NOT COMPLETED|Overall Study||0
241118|NCT01085903|584849|P3|COMPLETED|Overall Study||3
241119|NCT01085903|584850|P2|COMPLETED|Overall Study||4
241120|NCT01085903|584851|P1|COMPLETED|Overall Study||21
241121|NCT01085903|584849|P3|STARTED|Overall Study||3
241122|NCT01085903|584850|P2|STARTED|Overall Study||4
241123|NCT01085903|584851|P1|STARTED|Overall Study||21
241124|NCT01085825|584877|P2|NOT COMPLETED|Overall Study||1
241125|NCT01085825|584878|P1|NOT COMPLETED|Overall Study||1
241126|NCT01085825|584877|P2|COMPLETED|Overall Study||247
241127|NCT01085825|584878|P1|COMPLETED|Overall Study||251
241128|NCT01085825|584877|P2|STARTED|Overall Study||248
241129|NCT01085825|584878|P1|STARTED|Overall Study|1st participant enrolled|252
241130|NCT01085786|584886|P2|NOT COMPLETED|Overall Study||0
241131|NCT01085786|584887|P1|NOT COMPLETED|Overall Study||0
241132|NCT01085786|584886|P2|COMPLETED|Overall Study||117
241133|NCT01085786|584887|P1|COMPLETED|Overall Study||123
241134|NCT01085786|584886|P2|STARTED|Overall Study||117
241135|NCT01085786|584887|P1|STARTED|Overall Study||123
241136|NCT01085760|584897|P4|NOT COMPLETED|Overall Study||3
241137|NCT01085760|584898|P3|NOT COMPLETED|Overall Study||2
241138|NCT01085760|584899|P2|NOT COMPLETED|Overall Study||1
241139|NCT01085760|584900|P1|NOT COMPLETED|Overall Study||1
241140|NCT01085760|584897|P4|COMPLETED|Overall Study||6
241141|NCT01085760|584898|P3|COMPLETED|Overall Study||7
241142|NCT01085760|584899|P2|COMPLETED|Overall Study||8
241143|NCT01085760|584900|P1|COMPLETED|Overall Study||7
241144|NCT01085760|584897|P4|STARTED|Overall Study||9
241145|NCT01085760|584898|P3|STARTED|Overall Study||9
241146|NCT01085760|584899|P2|STARTED|Overall Study||9
241147|NCT01085760|584900|P1|STARTED|Overall Study||8
241148|NCT01085734|584924|P2|NOT COMPLETED|Overall Study||4
241149|NCT01085734|584925|P1|NOT COMPLETED|Overall Study||1
241150|NCT01085734|584924|P2|COMPLETED|Overall Study||11
241151|NCT01085734|584925|P1|COMPLETED|Overall Study||14
241152|NCT01085734|584924|P2|STARTED|Overall Study||15
241153|NCT01085734|584925|P1|STARTED|Overall Study||15
241154|NCT01085682|584937|P2|NOT COMPLETED|Overall Study||25
241155|NCT01085682|584938|P1|NOT COMPLETED|Overall Study||25
241156|NCT01085682|584937|P2|COMPLETED|Overall Study||3
241157|NCT01085682|584938|P1|COMPLETED|Overall Study||6
241158|NCT01085682|584937|P2|STARTED|Overall Study||28
241159|NCT01085682|584938|P1|STARTED|Overall Study||31
241160|NCT01085643|584944|P1|NOT COMPLETED|Overall Study||0
241161|NCT01085643|584944|P1|COMPLETED|Overall Study||4
241162|NCT01085643|584944|P1|STARTED|Overall Study||4
241163|NCT01085630|584955|P2|NOT COMPLETED|Overall Study||0
241164|NCT01085630|584956|P1|NOT COMPLETED|Overall Study||4
241165|NCT01085630|584955|P2|COMPLETED|Overall Study||27
241166|NCT01085630|584956|P1|COMPLETED|Overall Study||22
241167|NCT01085630|584955|P2|STARTED|Overall Study||27
241168|NCT01085630|584956|P1|STARTED|Overall Study||26
241169|NCT01085591|584969|P3|NOT COMPLETED|Overall Study||7
241170|NCT01085591|584970|P2|NOT COMPLETED|Overall Study||6
241171|NCT01085591|584971|P1|NOT COMPLETED|Overall Study||3
241172|NCT01085591|584969|P3|COMPLETED|Overall Study||63
241173|NCT01085591|584970|P2|COMPLETED|Overall Study||65
241174|NCT01085591|584971|P1|COMPLETED|Overall Study||66
241175|NCT01085591|584969|P3|Received at Least 1 Dose of Study Drug|Overall Study||70
241176|NCT01085591|584970|P2|Received at Least 1 Dose of Study Drug|Overall Study||69
241177|NCT01085591|584971|P1|Received at Least 1 Dose of Study Drug|Overall Study||68
241178|NCT01085591|584969|P3|STARTED|Overall Study||70
241179|NCT01085591|584970|P2|STARTED|Overall Study||71
241180|NCT01085591|584971|P1|STARTED|Overall Study||69
241181|NCT01085539|584994|P1|NOT COMPLETED|100Sat Secs-100 Second Alarm Evaluation||0
241182|NCT01085539|584994|P1|COMPLETED|100Sat Secs-100 Second Alarm Evaluation||50
241183|NCT01085539|584994|P1|STARTED|100Sat Secs-100 Second Alarm Evaluation||50
241184|NCT01085539|584994|P1|NOT COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||0
241185|NCT01085539|584994|P1|COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||50
241186|NCT01085539|584994|P1|STARTED|50 Sat Secs--50 Second Alarm Evaluation||50
241187|NCT01085539|584994|P1|NOT COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||0
241188|NCT01085539|584994|P1|COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||50
241189|NCT01085539|584994|P1|STARTED|25 Sat Secs--25 Second Alarm Evaluation||50
241190|NCT01085539|584994|P1|NOT COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||0
241191|NCT01085539|584994|P1|COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||50
241192|NCT01085539|584994|P1|STARTED|10 Sat Secs--10 Second Alarm Evaluation||50
241193|NCT01085539|584994|P1|NOT COMPLETED|Sat Secs Off--No Alarm Evaluation||0
241194|NCT01085539|584994|P1|COMPLETED|Sat Secs Off--No Alarm Evaluation||50
241195|NCT01085539|584994|P1|STARTED|Sat Secs Off--No Alarm Evaluation||50
241196|NCT01085513|585000|P2|NOT COMPLETED|Overall Study||0
241197|NCT01085513|585001|P1|NOT COMPLETED|Overall Study||0
241198|NCT01085513|585000|P2|COMPLETED|Overall Study||68
241199|NCT01085513|585001|P1|COMPLETED|Overall Study|recruitment was premature terminated|75
241200|NCT01085513|585000|P2|STARTED|Overall Study||68
241201|NCT01085513|585001|P1|STARTED|Overall Study||75
241202|NCT01085500|585009|P2|NOT COMPLETED|Overall Study||0
241203|NCT01085500|585010|P1|NOT COMPLETED|Overall Study||0
241204|NCT01085500|585009|P2|COMPLETED|Overall Study||24
241205|NCT01085500|585010|P1|COMPLETED|Overall Study||26
241206|NCT01085500|585009|P2|STARTED|Overall Study||24
241207|NCT01085500|585010|P1|STARTED|Overall Study||26
241208|NCT01085357|585022|P2|NOT COMPLETED|Overall Study||6
241209|NCT01085357|585023|P1|NOT COMPLETED|Overall Study||19
241210|NCT01085357|585022|P2|COMPLETED|Overall Study||125
241211|NCT01085357|585023|P1|COMPLETED|Overall Study||355
241212|NCT01085357|585022|P2|STARTED|Overall Study||131
241213|NCT01085357|585023|P1|STARTED|Overall Study||374
241214|NCT01085331|585035|P2|NOT COMPLETED|Overall Study||0
241215|NCT01085331|585036|P1|NOT COMPLETED|Overall Study||0
241216|NCT01085331|585035|P2|COMPLETED|Overall Study||6
241217|NCT01085331|585036|P1|COMPLETED|Overall Study||10
241218|NCT01085331|585035|P2|STARTED|Overall Study||6
241219|NCT01085331|585036|P1|STARTED|Overall Study||10
241220|NCT01085318|585075|P2|NOT COMPLETED|Overall Study||0
241221|NCT01085318|585076|P1|NOT COMPLETED|Overall Study||2
241222|NCT01085318|585075|P2|COMPLETED|Overall Study||15
241223|NCT01085318|585076|P1|COMPLETED|Overall Study||21
241224|NCT01085318|585075|P2|STARTED|Overall Study||15
241225|NCT01085318|585076|P1|STARTED|Overall Study||23
241226|NCT01085214|585086|P1|NOT COMPLETED|Overall Study||1
241227|NCT01085214|585086|P1|COMPLETED|Overall Study||36
241228|NCT01085214|585086|P1|STARTED|Overall Study||37
241229|NCT01085201|585098|P5|NOT COMPLETED|Overall Study||0
241230|NCT01085201|585099|P4|NOT COMPLETED|Overall Study||0
241231|NCT01085201|585100|P3|NOT COMPLETED|Overall Study||2
241232|NCT01085201|585101|P2|NOT COMPLETED|Overall Study||1
241233|NCT01085201|585102|P1|NOT COMPLETED|Overall Study||3
241234|NCT01085201|585098|P5|COMPLETED|Overall Study||3
241235|NCT01085201|585099|P4|COMPLETED|Overall Study||6
241236|NCT01085201|585100|P3|COMPLETED|Overall Study||3
241237|NCT01085201|585101|P2|COMPLETED|Overall Study||6
241238|NCT01085201|585102|P1|COMPLETED|Overall Study||15
241239|NCT01085201|585098|P5|STARTED|Overall Study||3
241240|NCT01085201|585099|P4|STARTED|Overall Study||6
241241|NCT01085201|585100|P3|STARTED|Overall Study||5
241242|NCT01085201|585101|P2|STARTED|Overall Study||7
241243|NCT01085201|585102|P1|STARTED|Overall Study||18
241244|NCT01085136|585124|P3|NOT COMPLETED|Part B||26
241245|NCT01085136|585125|P2|NOT COMPLETED|Part B||51
241246|NCT01085136|585126|P1|NOT COMPLETED|Part B||0
241247|NCT01085136|585124|P3|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|42
241248|NCT01085136|585125|P2|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|87
241249|NCT01085136|585126|P1|COMPLETED|Part B|Afatinib monotherapy not administered in Part B|0
241250|NCT01085136|585124|P3|STARTED|Part B||68
241251|NCT01085136|585125|P2|STARTED|Part B||138
241252|NCT01085136|585126|P1|STARTED|Part B|Afatinib monotherapy not administered in Part B|0
241253|NCT01085136|585124|P3|NOT COMPLETED|Part A||0
241254|NCT01085136|585125|P2|NOT COMPLETED|Part A||0
241255|NCT01085136|585126|P1|NOT COMPLETED|Part A||323
241256|NCT01085136|585124|P3|COMPLETED|Part A||0
241257|NCT01085136|585125|P2|COMPLETED|Part A||0
241258|NCT01085136|585126|P1|COMPLETED|Part A|Randomized to Part B & completed trial as per protocol, had PD, clinical progression.|831
241259|NCT01085136|585124|P3|Randomized to Part B|Part A||0
241260|NCT01085136|585125|P2|Randomized to Part B|Part A||0
241261|NCT01085136|585126|P1|Randomized to Part B|Part A|Discontinued Part A -Randomized to Part B|206
241262|NCT01085136|585124|P3|STARTED|Part A||0
241263|NCT01085136|585125|P2|STARTED|Part A|Only Afatinib monotherapy administered in Part A|0
241264|NCT01085136|585126|P1|STARTED|Part A||1154
241265|NCT01085045|585142|P1|NOT COMPLETED|Part B||15
241266|NCT01085045|585142|P1|COMPLETED|Part B||89
241267|NCT01085045|585142|P1|GP MDI 36 µg (PT001)|Part B||0
241268|NCT01085045|585142|P1|Foradil 12 µg|Part B||41
241269|NCT01085045|585142|P1|Placebo MDI|Part B||47
241270|NCT01085045|585142|P1|FF MDI 7.2 µg (PT005)|Part B||43
241271|NCT01085045|585142|P1|FF MDI 9.6 µg (PT005)|Part B||43
241272|NCT01085045|585142|P1|Spiriva 18 µg|Part B||0
241273|NCT01085045|585142|P1|GFF MDI 36/9.6 µg|Part B||0
241274|NCT01085045|585142|P1|GFF MDI 72/9.6mcg (PT003)|Part B||0
241275|NCT01085045|585142|P1|STARTED|Part B||104
241276|NCT01085045|585142|P1|NOT COMPLETED|Part A||18
241277|NCT01085045|585142|P1|COMPLETED|Part A||104
241278|NCT01085045|585142|P1|Foradil 12 µg|Part A||14
241279|NCT01085045|585142|P1|Placebo MDI|Part A||5
241280|NCT01085045|585142|P1|FF MDI 7.2 µg (PT005)|Part A||21
241281|NCT01085045|585142|P1|FF MDI 9.6 µg (PT005)|Part A||20
241282|NCT01085045|585142|P1|Spiriva 18 µg|Part A||58
241283|NCT01085045|585142|P1|GP MDI 36 µg (PT001)|Part A||40
241284|NCT01085045|585142|P1|GFF MDI 36/9.6 µg (PT003)|Part A||42
241285|NCT01085045|585142|P1|GFF MDI 72/9.6mcg|Part A||40
241286|NCT01085045|585142|P1|STARTED|Part A||122
241287|NCT01085006|585244|P2|NOT COMPLETED|Overall Study||0
241288|NCT01085006|585245|P1|NOT COMPLETED|Overall Study||0
241289|NCT01085006|585244|P2|COMPLETED|Overall Study||50
241290|NCT01085006|585245|P1|COMPLETED|Overall Study||50
241291|NCT01085006|585244|P2|STARTED|Overall Study||50
241292|NCT01085006|585245|P1|STARTED|Overall Study||50
241293|NCT01084759|585251|P1|NOT COMPLETED|Overall Study||2
241294|NCT01084759|585251|P1|COMPLETED|Overall Study||14
241295|NCT01084759|585251|P1|STARTED|Overall Study||16
241296|NCT01084707|585257|P1|NOT COMPLETED|Overall Study||6
241297|NCT01084707|585257|P1|COMPLETED|Overall Study||34
241298|NCT01084707|585257|P1|STARTED|Overall Study||40
241299|NCT01084668|585291|P1|NOT COMPLETED|Overall Study||9
241300|NCT01084668|585291|P1|COMPLETED|Overall Study||33
241301|NCT01084668|585291|P1|STARTED|Overall Study|Three participants who took Humira prior to study entry have been excluded from the database.|42
241302|NCT01084655|585303|P3|NOT COMPLETED|Overall Study||19
241303|NCT01084655|585304|P2|NOT COMPLETED|Overall Study||6
241304|NCT01084655|585305|P1|NOT COMPLETED|Overall Study||6
241305|NCT01084655|585303|P3|COMPLETED|Overall Study||5
241306|NCT01084655|585304|P2|COMPLETED|Overall Study||2
241307|NCT01084655|585305|P1|COMPLETED|Overall Study||0
241308|NCT01084655|585303|P3|Treated|Overall Study||23
241309|NCT01084655|585304|P2|Treated|Overall Study||8
241310|NCT01084655|585305|P1|Treated|Overall Study||6
241311|NCT01084655|585303|P3|STARTED|Overall Study||24
241312|NCT01084655|585304|P2|STARTED|Overall Study||8
241313|NCT01084655|585305|P1|STARTED|Overall Study||6
241314|NCT01084603|585340|P1|NOT COMPLETED|Oral Nicotine 4||0
241315|NCT01084603|585340|P1|COMPLETED|Oral Nicotine 4||39
241316|NCT01084603|585340|P1|STARTED|Oral Nicotine 4||39
241317|NCT01084603|585340|P1|NOT COMPLETED|Washout Period 4||1
241318|NCT01084603|585340|P1|COMPLETED|Washout Period 4||39
241319|NCT01084603|585340|P1|STARTED|Washout Period 4||40
241320|NCT01084603|585340|P1|NOT COMPLETED|Oral Nicotine 2||0
241321|NCT01084603|585340|P1|COMPLETED|Oral Nicotine 2||40
241322|NCT01084603|585340|P1|STARTED|Oral Nicotine 2||40
241323|NCT01084603|585340|P1|NOT COMPLETED|Washout Period 3||0
241324|NCT01084603|585340|P1|COMPLETED|Washout Period 3||40
241325|NCT01084603|585340|P1|STARTED|Washout Period 3||40
241326|NCT01084603|585340|P1|NOT COMPLETED|Oral Nicotine 1||1
241327|NCT01084603|585340|P1|COMPLETED|Oral Nicotine 1||40
241328|NCT01084603|585340|P1|STARTED|Oral Nicotine 1||41
241329|NCT01084603|585340|P1|NOT COMPLETED|Washout Period 2||0
241330|NCT01084603|585340|P1|COMPLETED|Washout Period 2||41
241331|NCT01084603|585340|P1|STARTED|Washout Period 2||41
241332|NCT01084603|585340|P1|NOT COMPLETED|Nicorette® Gum||1
241333|NCT01084603|585340|P1|COMPLETED|Nicorette® Gum||41
241334|NCT01084603|585340|P1|STARTED|Nicorette® Gum||42
241335|NCT01084603|585340|P1|NOT COMPLETED|Washout Period 1||0
241336|NCT01084603|585340|P1|COMPLETED|Washout Period 1||42
241337|NCT01084603|585340|P1|STARTED|Washout Period 1||42
241338|NCT01084603|585340|P1|NOT COMPLETED|NiQuitinTM Lozenge||1
241339|NCT01084603|585340|P1|COMPLETED|NiQuitinTM Lozenge||42
241340|NCT01084603|585340|P1|STARTED|NiQuitinTM Lozenge||43
241341|NCT01084603|585340|P1|NOT COMPLETED|Baseline||2
241342|NCT01084603|585340|P1|COMPLETED|Baseline||43
241343|NCT01084603|585340|P1|STARTED|Baseline||45
241344|NCT01084551|585376|P3|NOT COMPLETED|Overall Study||8
241345|NCT01084551|585377|P2|NOT COMPLETED|Overall Study||14
241346|NCT01084551|585378|P1|NOT COMPLETED|Overall Study||9
241347|NCT01084551|585376|P3|COMPLETED|Overall Study||86
241348|NCT01084551|585377|P2|COMPLETED|Overall Study||81
241349|NCT01084551|585378|P1|COMPLETED|Overall Study||86
241350|NCT01084551|585376|P3|STARTED|Overall Study||94
241351|NCT01084551|585377|P2|STARTED|Overall Study||95
241352|NCT01084551|585378|P1|STARTED|Overall Study||95
241353|NCT01084538|585416|P1|NOT COMPLETED|Overall Study||68
241354|NCT01084538|585416|P1|COMPLETED|Overall Study||113
241355|NCT01084538|585416|P1|STARTED|Overall Study||181
241356|NCT01084499|585425|P2|NOT COMPLETED|Overall Study||0
241357|NCT01084499|585426|P1|NOT COMPLETED|Overall Study||0
241358|NCT01084499|585425|P2|COMPLETED|Overall Study|Second Intervention (Sequence 2) : Femara (1 Day)|13
241359|NCT01084499|585426|P1|COMPLETED|Overall Study|Second Intervention (Sequence 1) : Peratra (1 Day)|13
241360|NCT01084499|585425|P2|Washout (5 Weeks)|Overall Study||13
241361|NCT01084499|585426|P1|Washout (5 Weeks)|Overall Study||13
241362|NCT01084499|585425|P2|STARTED|Overall Study|First Intervention (Sequence 2) : Peratra (1 Day)|13
241363|NCT01084499|585426|P1|STARTED|Overall Study|First Intervention (Sequence 1) : Femara (1 Day)|13
241364|NCT01084278|585439|P5|NOT COMPLETED|Overall Study||0
241365|NCT01084278|585440|P4|NOT COMPLETED|Overall Study||0
241366|NCT01084278|585441|P3|NOT COMPLETED|Overall Study||0
241367|NCT01084278|585442|P2|NOT COMPLETED|Overall Study||0
241368|NCT01084278|585443|P1|NOT COMPLETED|Overall Study||0
241369|NCT01084278|585439|P5|COMPLETED|Overall Study||8
241370|NCT01084278|585440|P4|COMPLETED|Overall Study||8
241371|NCT01084278|585441|P3|COMPLETED|Overall Study||8
241372|NCT01084278|585442|P2|COMPLETED|Overall Study||8
241373|NCT01084278|585443|P1|COMPLETED|Overall Study||8
241374|NCT01084278|585439|P5|STARTED|Overall Study||8
241375|NCT01084278|585440|P4|STARTED|Overall Study||8
241376|NCT01084278|585441|P3|STARTED|Overall Study||8
241377|NCT01084278|585442|P2|STARTED|Overall Study||8
241378|NCT01084278|585443|P1|STARTED|Overall Study||8
241379|NCT01084265|585524|P1|NOT COMPLETED|Overall Study||0
241380|NCT01084265|585524|P1|COMPLETED|Overall Study||31
241381|NCT01084265|585524|P1|STARTED|Overall Study||31
241382|NCT01084239|585538|P2|NOT COMPLETED|28-Day Follow-up||9
241383|NCT01084239|585539|P1|NOT COMPLETED|28-Day Follow-up||4
241384|NCT01084239|585538|P2|COMPLETED|28-Day Follow-up||490
241385|NCT01084239|585539|P1|COMPLETED|28-Day Follow-up||497
241386|NCT01084239|585538|P2|STARTED|28-Day Follow-up||499
241387|NCT01084239|585539|P1|STARTED|28-Day Follow-up|All 501 patients enrolled were evaluated for follow-up at 28 days.|501
241388|NCT01084239|585538|P2|NOT COMPLETED|Randomization - Index Hospitalization||0
241389|NCT01084239|585539|P1|NOT COMPLETED|Randomization - Index Hospitalization||0
241390|NCT01084239|585538|P2|COMPLETED|Randomization - Index Hospitalization||499
241391|NCT01084239|585539|P1|COMPLETED|Randomization - Index Hospitalization||501
241392|NCT01084239|585538|P2|STARTED|Randomization - Index Hospitalization||499
241393|NCT01084239|585539|P1|STARTED|Randomization - Index Hospitalization||501
241394|NCT01084174|585557|P2|NOT COMPLETED|Overall Study||4
241395|NCT01084174|585558|P1|NOT COMPLETED|Overall Study||1
241396|NCT01084174|585557|P2|COMPLETED|Overall Study||7
241397|NCT01084174|585558|P1|COMPLETED|Overall Study||9
241398|NCT01084174|585557|P2|STARTED|Overall Study||11
241399|NCT01084174|585558|P1|STARTED|Overall Study||10
241400|NCT01084148|585578|P2|NOT COMPLETED|Overall Study||16
241401|NCT01084148|585579|P1|NOT COMPLETED|Overall Study||30
241402|NCT01084148|585578|P2|COMPLETED|Overall Study||102
241403|NCT01084148|585579|P1|COMPLETED|Overall Study||88
241404|NCT01084148|585578|P2|Treated Patients|Overall Study|Patients who received test product at least once|117
241405|NCT01084148|585579|P1|Treated Patients|Overall Study||118
241406|NCT01084148|585578|P2|STARTED|Overall Study|Among those 118 patients randomized into V0034 CR 01B vehicle arm, one patient not treated.|118
241407|NCT01084148|585579|P1|STARTED|Overall Study||118
241408|NCT01084135|585591|P2|NOT COMPLETED|20 Week||1
241409|NCT01084135|585592|P1|NOT COMPLETED|20 Week||0
241410|NCT01084135|585591|P2|COMPLETED|20 Week||10
241411|NCT01084135|585592|P1|COMPLETED|20 Week||12
241412|NCT01084135|585591|P2|STARTED|20 Week||11
241413|NCT01084135|585592|P1|STARTED|20 Week||12
241414|NCT01084135|585591|P2|NOT COMPLETED|12 Week||0
241415|NCT01084135|585592|P1|NOT COMPLETED|12 Week||0
241416|NCT01084135|585591|P2|COMPLETED|12 Week||4
241417|NCT01084135|585592|P1|COMPLETED|12 Week||4
241418|NCT01084135|585591|P2|STARTED|12 Week||4
241419|NCT01084135|585592|P1|STARTED|12 Week||4
241420|NCT01084083|585602|P1|NOT COMPLETED|Overall Study||12
241421|NCT01084083|585602|P1|COMPLETED|Overall Study||78
241422|NCT01084083|585602|P1|CR and Treated With 5400 cGy IMRT|Overall Study|This is the primary study population for the primary endpoint (24-month PFS).|44
241423|NCT01084083|585602|P1|CR to Induction Therapy|Overall Study||56
241424|NCT01084083|585602|P1|Eligible and Treated|Overall Study|This is the eligible and treated patients for secondary efficacy endpoints|80
241425|NCT01084083|585602|P1|Eligible|Overall Study||81
241426|NCT01084083|585602|P1|Treated|Overall Study|This is the all treated patients for toxicity analysis|89
241427|NCT01084083|585602|P1|STARTED|Overall Study||90
241428|NCT01084005|585610|P2|NOT COMPLETED|Overall Study||16
241429|NCT01084005|585611|P1|NOT COMPLETED|Overall Study||5
241430|NCT01084005|585610|P2|COMPLETED|Overall Study||146
241431|NCT01084005|585611|P1|COMPLETED|Overall Study||74
241432|NCT01084005|585610|P2|STARTED|Overall Study||162
241433|NCT01084005|585611|P1|STARTED|Overall Study||79
241434|NCT01083979|585639|P1|NOT COMPLETED|Overall Study||0
241435|NCT01083979|585639|P1|COMPLETED|Overall Study||1
241436|NCT01083979|585639|P1|STARTED|Overall Study||1
241437|NCT01083901|585647|P3|NOT COMPLETED|Overall Study||2
241438|NCT01083901|585648|P2|NOT COMPLETED|Overall Study||2
241439|NCT01083901|585649|P1|NOT COMPLETED|Overall Study||1
241440|NCT01083901|585647|P3|COMPLETED|Overall Study||11
241441|NCT01083901|585648|P2|COMPLETED|Overall Study||6
241442|NCT01083901|585649|P1|COMPLETED|Overall Study||12
241443|NCT01083901|585647|P3|STARTED|Overall Study||13
241444|NCT01083901|585648|P2|STARTED|Overall Study||8
241445|NCT01083901|585649|P1|STARTED|Overall Study||13
241446|NCT01083849|585668|P2|NOT COMPLETED|Overall Study||111
241447|NCT01083849|585669|P1|NOT COMPLETED|Overall Study||60
241448|NCT01083849|585668|P2|COMPLETED|Overall Study||527
241449|NCT01083849|585669|P1|COMPLETED|Overall Study||61
241450|NCT01083849|585668|P2|STARTED|Overall Study||638
241451|NCT01083849|585669|P1|STARTED|Overall Study||121
241452|NCT01083810|585692|P3|NOT COMPLETED|Overall Study||20
241453|NCT01083810|585693|P2|NOT COMPLETED|Overall Study||45
241454|NCT01083810|585694|P1|NOT COMPLETED|Overall Study||65
241455|NCT01083810|585692|P3|COMPLETED|Overall Study||35
241456|NCT01083810|585693|P2|COMPLETED|Overall Study||47
241457|NCT01083810|585694|P1|COMPLETED|Overall Study||72
241458|NCT01083810|585692|P3|STARTED|Overall Study||55
241459|NCT01083810|585693|P2|STARTED|Overall Study||92
241460|NCT01083810|585694|P1|STARTED|Overall Study||137
241461|NCT01083771|585715|P1|NOT COMPLETED|Overall Study||5
241462|NCT01083771|585715|P1|COMPLETED|Overall Study||16
241463|NCT01083771|585715|P1|STARTED|Overall Study||21
241464|NCT01083758|585720|P1|NOT COMPLETED|Overall Study||2
241465|NCT01083758|585720|P1|COMPLETED|Overall Study||29
241466|NCT01083758|585720|P1|STARTED|Overall Study||31
241467|NCT01083732|585754|P3|NOT COMPLETED|Overall Study||0
241468|NCT01083732|585755|P2|NOT COMPLETED|Overall Study||0
241469|NCT01083732|585756|P1|NOT COMPLETED|Overall Study||0
241470|NCT01083732|585754|P3|COMPLETED|Overall Study||3
241471|NCT01083732|585755|P2|COMPLETED|Overall Study||9
241472|NCT01083732|585756|P1|COMPLETED|Overall Study||6
241473|NCT01083732|585754|P3|STARTED|Overall Study||3
241474|NCT01083732|585755|P2|STARTED|Overall Study||9
241475|NCT01083732|585756|P1|STARTED|Overall Study||6
241476|NCT01083706|585807|P1|NOT COMPLETED|Overall Study||0
241477|NCT01083706|585807|P1|COMPLETED|Overall Study||39
241478|NCT01083706|585807|P1|STARTED|Overall Study||39
241479|NCT01083693|585816|P3|NOT COMPLETED|Overall Study||7
241480|NCT01083693|585817|P2|NOT COMPLETED|Overall Study||6
241481|NCT01083693|585818|P1|NOT COMPLETED|Overall Study||20
241482|NCT01083693|585816|P3|COMPLETED|Overall Study||33
241483|NCT01083693|585817|P2|COMPLETED|Overall Study||22
241484|NCT01083693|585818|P1|COMPLETED|Overall Study||73
241485|NCT01083693|585816|P3|STARTED|Overall Study||40
241486|NCT01083693|585817|P2|STARTED|Overall Study||28
241487|NCT01083693|585818|P1|STARTED|Overall Study||93
241488|NCT01083680|585853|P1|NOT COMPLETED|Overall Study||3844
241489|NCT01083680|585853|P1|COMPLETED|Overall Study||263
241490|NCT01083680|585853|P1|Full Analysis Set (FAS), Efficacy|Overall Study||1621
241491|NCT01083680|585853|P1|STARTED|Overall Study||4107
241492|NCT01083667|585862|P1|NOT COMPLETED|Overall Study||10
241493|NCT01083667|585862|P1|COMPLETED|Overall Study|22 completed to visit 9, the last visit on study.|22
241494|NCT01083667|585862|P1|STARTED|Overall Study|enrolled|32
241495|NCT01083654|585869|P2|NOT COMPLETED|Overall Study||0
241496|NCT01083654|585870|P1|NOT COMPLETED|Overall Study||0
241497|NCT01083654|585869|P2|COMPLETED|Overall Study||50
241498|NCT01083654|585870|P1|COMPLETED|Overall Study||53
241499|NCT01083654|585869|P2|STARTED|Overall Study||50
241500|NCT01083654|585870|P1|STARTED|Overall Study||53
241501|NCT01083641|585876|P1|NOT COMPLETED|Overall Study||2
241502|NCT01083641|585876|P1|COMPLETED|Overall Study||15
241503|NCT01083641|585876|P1|STARTED|Overall Study||17
241504|NCT01083628|585885|P2|NOT COMPLETED|Overall Study||0
241505|NCT01083628|585886|P1|NOT COMPLETED|Overall Study||0
241506|NCT01083628|585885|P2|COMPLETED|Overall Study||40
241507|NCT01083628|585886|P1|COMPLETED|Overall Study||45
241508|NCT01083628|585885|P2|STARTED|Overall Study||40
241509|NCT01083628|585886|P1|STARTED|Overall Study||45
241510|NCT01083602|585896|P1|NOT COMPLETED|Overall Study||55
241511|NCT01083602|585896|P1|COMPLETED|Overall Study||0
241512|NCT01083602|585896|P1|STARTED|Overall Study||55
241513|NCT01083576|585907|P2|NOT COMPLETED|Overall Study||1
241514|NCT01083576|585908|P1|NOT COMPLETED|Overall Study||6
241515|NCT01083576|585907|P2|COMPLETED|Overall Study||14
241516|NCT01083576|585908|P1|COMPLETED|Overall Study||9
241517|NCT01083576|585907|P2|STARTED|Overall Study||15
241518|NCT01083576|585908|P1|STARTED|Overall Study||15
241519|NCT01083485|585938|P2|NOT COMPLETED|Overall Study||3
241520|NCT01083485|585939|P1|NOT COMPLETED|Overall Study||7
241521|NCT01083485|585938|P2|COMPLETED|Overall Study||64
241522|NCT01083485|585939|P1|COMPLETED|Overall Study||63
241523|NCT01083485|585938|P2|STARTED|Overall Study||67
241524|NCT01083485|585939|P1|STARTED|Overall Study||70
241525|NCT01083472|585949|P2|NOT COMPLETED|Overall Study||0
241526|NCT01083472|585950|P1|NOT COMPLETED|Overall Study||0
241527|NCT01083472|585949|P2|COMPLETED|Overall Study||19
241528|NCT01083472|585950|P1|COMPLETED|Overall Study||18
241529|NCT01083472|585949|P2|STARTED|Overall Study||19
241530|NCT01083472|585950|P1|STARTED|Overall Study||18
241531|NCT01083368|585958|P4|NOT COMPLETED|Phase II - Efficacy/Safety||0
241532|NCT01083368|585959|P3|NOT COMPLETED|Phase II - Efficacy/Safety||0
241533|NCT01083368|585960|P2|NOT COMPLETED|Phase II - Efficacy/Safety||0
241534|NCT01083368|585961|P1|NOT COMPLETED|Phase II - Efficacy/Safety||0
241535|NCT01083368|585958|P4|COMPLETED|Phase II - Efficacy/Safety|14 plus 6 participants from previous period|20
241536|NCT01083368|585959|P3|COMPLETED|Phase II - Efficacy/Safety||0
241537|NCT01083368|585960|P2|COMPLETED|Phase II - Efficacy/Safety||0
241538|NCT01083368|585961|P1|COMPLETED|Phase II - Efficacy/Safety||0
241539|NCT01083368|585958|P4|STARTED|Phase II - Efficacy/Safety||20
241540|NCT01083368|585959|P3|STARTED|Phase II - Efficacy/Safety||0
241541|NCT01083368|585960|P2|STARTED|Phase II - Efficacy/Safety||0
241542|NCT01083368|585961|P1|STARTED|Phase II - Efficacy/Safety||0
241543|NCT01083368|585958|P4|NOT COMPLETED|Dose Escalation Weeks 5-9||0
241544|NCT01083368|585959|P3|NOT COMPLETED|Dose Escalation Weeks 5-9||0
241545|NCT01083368|585960|P2|NOT COMPLETED|Dose Escalation Weeks 5-9||0
241546|NCT01083368|585961|P1|NOT COMPLETED|Dose Escalation Weeks 5-9||0
241547|NCT01083368|585958|P4|COMPLETED|Dose Escalation Weeks 5-9|3 participants on dose level 1 moved to dose level 2, 3 more new participants joined.|6
241548|NCT01083368|585959|P3|COMPLETED|Dose Escalation Weeks 5-9||1
241549|NCT01083368|585960|P2|COMPLETED|Dose Escalation Weeks 5-9||0
241550|NCT01083368|585961|P1|COMPLETED|Dose Escalation Weeks 5-9||0
241551|NCT01083368|585958|P4|STARTED|Dose Escalation Weeks 5-9||6
241552|NCT01083368|585959|P3|STARTED|Dose Escalation Weeks 5-9|Participant on DL1 did not move to dose level 2 because of disease progression.|1
241553|NCT01083368|585960|P2|STARTED|Dose Escalation Weeks 5-9||0
241554|NCT01083368|585961|P1|STARTED|Dose Escalation Weeks 5-9||0
241555|NCT01083368|585958|P4|NOT COMPLETED|Dose Escalation Weeks 1-4||0
241556|NCT01083368|585959|P3|NOT COMPLETED|Dose Escalation Weeks 1-4||0
241557|NCT01083368|585960|P2|NOT COMPLETED|Dose Escalation Weeks 1-4||0
241558|NCT01083368|585961|P1|NOT COMPLETED|Dose Escalation Weeks 1-4||0
241559|NCT01083368|585958|P4|COMPLETED|Dose Escalation Weeks 1-4||0
241560|NCT01083368|585959|P3|COMPLETED|Dose Escalation Weeks 1-4||4
241561|NCT01083368|585960|P2|COMPLETED|Dose Escalation Weeks 1-4||0
241562|NCT01083368|585961|P1|COMPLETED|Dose Escalation Weeks 1-4||0
241563|NCT01083368|585958|P4|Disease Progression|Dose Escalation Weeks 1-4||0
241564|NCT01083368|585959|P3|Disease Progression|Dose Escalation Weeks 1-4||1
241565|NCT01083368|585960|P2|Disease Progression|Dose Escalation Weeks 1-4||0
241566|NCT01083368|585961|P1|Disease Progression|Dose Escalation Weeks 1-4||0
241567|NCT01083368|585958|P4|STARTED|Dose Escalation Weeks 1-4||0
241568|NCT01083368|585959|P3|STARTED|Dose Escalation Weeks 1-4||4
241569|NCT01083368|585960|P2|STARTED|Dose Escalation Weeks 1-4||0
241570|NCT01083368|585961|P1|STARTED|Dose Escalation Weeks 1-4||0
241571|NCT01083316|585971|P1|NOT COMPLETED|Overall Study||3
241572|NCT01083316|585971|P1|COMPLETED|Overall Study||32
241573|NCT01083316|585971|P1|STARTED|Overall Study||35
241574|NCT01083199|585978|P1|NOT COMPLETED|Overall Study||0
241575|NCT01083199|585978|P1|COMPLETED|Overall Study||10
241576|NCT01083199|585978|P1|STARTED|Overall Study||10
241577|NCT01083186|585983|P1|NOT COMPLETED|Overall Study||94
241578|NCT01083186|585983|P1|COMPLETED|Overall Study||406
241579|NCT01083186|585983|P1|STARTED|Overall Study||500
241580|NCT01083173|586024|P2|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||377
241581|NCT01083173|586025|P1|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||0
241582|NCT01083173|586024|P2|COMPLETED|Long-term Surveillance: Effectiveness Gr||102
241583|NCT01083173|586025|P1|COMPLETED|Long-term Surveillance: Effectiveness Gr||0
241584|NCT01083173|586024|P2|STARTED|Long-term Surveillance: Effectiveness Gr||479
241585|NCT01083173|586025|P1|STARTED|Long-term Surveillance: Effectiveness Gr||0
241586|NCT01083173|586024|P2|NOT COMPLETED|Long-term Surveillance: Safety Group||116
241587|NCT01083173|586025|P1|NOT COMPLETED|Long-term Surveillance: Safety Group||0
241588|NCT01083173|586024|P2|COMPLETED|Long-term Surveillance: Safety Group||479
241589|NCT01083173|586025|P1|COMPLETED|Long-term Surveillance: Safety Group||0
241590|NCT01083173|586024|P2|STARTED|Long-term Surveillance: Safety Group||595
241591|NCT01083173|586025|P1|STARTED|Long-term Surveillance: Safety Group||0
241592|NCT01083173|586024|P2|NOT COMPLETED|Main Surveillance: Effectiveness Group||0
241593|NCT01083173|586025|P1|NOT COMPLETED|Main Surveillance: Effectiveness Group||382
241594|NCT01083173|586024|P2|COMPLETED|Main Surveillance: Effectiveness Group||0
241595|NCT01083173|586025|P1|COMPLETED|Main Surveillance: Effectiveness Group||198
241596|NCT01083173|586024|P2|STARTED|Main Surveillance: Effectiveness Group||0
241597|NCT01083173|586025|P1|STARTED|Main Surveillance: Effectiveness Group||580
241598|NCT01083173|586024|P2|NOT COMPLETED|Main Surveillance: Safety Group||0
241599|NCT01083173|586025|P1|NOT COMPLETED|Main Surveillance: Safety Group||15
241600|NCT01083173|586024|P2|COMPLETED|Main Surveillance: Safety Group||0
241601|NCT01083173|586025|P1|COMPLETED|Main Surveillance: Safety Group||580
241602|NCT01083173|586024|P2|STARTED|Main Surveillance: Safety Group||0
241603|NCT01083173|586025|P1|STARTED|Main Surveillance: Safety Group||595
241604|NCT01083160|586043|P1|NOT COMPLETED|Overall Study||1
241605|NCT01083160|586043|P1|COMPLETED|Overall Study||81
241606|NCT01083160|586043|P1|Evaluable Population|Overall Study||71
241607|NCT01083160|586043|P1|STARTED|Overall Study||82
241608|NCT01083121|586050|P1|NOT COMPLETED|Overall Study||81
241609|NCT01083121|586050|P1|COMPLETED|Overall Study|Participants included in the analysis|1698
241610|NCT01083121|586050|P1|STARTED|Overall Study|Participants who were enrolled in the study|1779
241611|NCT01082965|586060|P2|NOT COMPLETED|Overall Study||2
241612|NCT01082965|586061|P1|NOT COMPLETED|Overall Study||1
241613|NCT01082965|586060|P2|COMPLETED|Overall Study||6
241614|NCT01082965|586061|P1|COMPLETED|Overall Study||9
241615|NCT01082965|586060|P2|STARTED|Overall Study||8
241616|NCT01082965|586061|P1|STARTED|Overall Study||10
241617|NCT01082952|586081|P2|NOT COMPLETED|Overall Study||0
241618|NCT01082952|586082|P1|NOT COMPLETED|Overall Study||0
241619|NCT01082952|586081|P2|COMPLETED|Overall Study||6
241620|NCT01082952|586082|P1|COMPLETED|Overall Study||6
241621|NCT01082952|586081|P2|STARTED|Overall Study||6
241622|NCT01082952|586082|P1|STARTED|Overall Study||6
241623|NCT01082939|586090|P1|NOT COMPLETED|Overall Study||0
241624|NCT01082939|586090|P1|COMPLETED|Overall Study||80
241625|NCT01082939|586090|P1|STARTED|Overall Study||80
241626|NCT01082874|586098|P4|NOT COMPLETED|Overall Study||13
241627|NCT01082874|586099|P3|NOT COMPLETED|Overall Study||11
241628|NCT01082874|586100|P2|NOT COMPLETED|Overall Study||12
241629|NCT01082874|586101|P1|NOT COMPLETED|Overall Study||11
241630|NCT01082874|586098|P4|COMPLETED|Overall Study||2489
241631|NCT01082874|586099|P3|COMPLETED|Overall Study||2488
241632|NCT01082874|586100|P2|COMPLETED|Overall Study||2498
241633|NCT01082874|586101|P1|COMPLETED|Overall Study||2488
241634|NCT01082874|586098|P4|STARTED|Overall Study||2502
241635|NCT01082874|586099|P3|STARTED|Overall Study||2499
241636|NCT01082874|586100|P2|STARTED|Overall Study||2510
241637|NCT01082874|586101|P1|STARTED|Overall Study||2499
241638|NCT01082640|586114|P3|NOT COMPLETED|Overall Study||8
241639|NCT01082640|586115|P2|NOT COMPLETED|Overall Study||15
241640|NCT01082640|586116|P1|NOT COMPLETED|Overall Study||17
241641|NCT01082640|586114|P3|COMPLETED|Overall Study||24
241642|NCT01082640|586115|P2|COMPLETED|Overall Study||17
241643|NCT01082640|586116|P1|COMPLETED|Overall Study||15
241644|NCT01082640|586114|P3|STARTED|Overall Study||32
241645|NCT01082640|586115|P2|STARTED|Overall Study||32
241646|NCT01082640|586116|P1|STARTED|Overall Study||32
241647|NCT01082614|586138|P2|NOT COMPLETED|Overall Study||5
241648|NCT01082614|586139|P1|NOT COMPLETED|Overall Study||3
241649|NCT01082614|586138|P2|COMPLETED|Overall Study||18
241650|NCT01082614|586139|P1|COMPLETED|Overall Study||20
241651|NCT01082614|586138|P2|STARTED|Overall Study||23
241652|NCT01082614|586139|P1|STARTED|Overall Study||23
241653|NCT01082588|586151|P2|NOT COMPLETED|Overall Study||5
241654|NCT01082588|586152|P1|NOT COMPLETED|Overall Study||6
241655|NCT01082588|586151|P2|COMPLETED|Overall Study||25
241656|NCT01082588|586152|P1|COMPLETED|Overall Study||24
241657|NCT01082588|586151|P2|STARTED|Overall Study||30
241658|NCT01082588|586152|P1|STARTED|Overall Study||30
241659|NCT01082575|586170|P1|NOT COMPLETED|Overall Study||0
241660|NCT01082575|586170|P1|COMPLETED|Overall Study||100
241661|NCT01082575|586170|P1|STARTED|Overall Study||100
241662|NCT01082380|586175|P1|NOT COMPLETED|Overall Study||0
241663|NCT01082380|586175|P1|COMPLETED|Overall Study||6
241664|NCT01082380|586175|P1|STARTED|Overall Study||6
241665|NCT01082367|586210|P2|NOT COMPLETED|Follow-up (F-U) Period||1
241666|NCT01082367|586211|P1|NOT COMPLETED|Follow-up (F-U) Period||2
241667|NCT01082367|586210|P2|COMPLETED|Follow-up (F-U) Period||9
241668|NCT01082367|586211|P1|COMPLETED|Follow-up (F-U) Period||17
241669|NCT01082367|586210|P2|Treated in F-U|Follow-up (F-U) Period||5
241670|NCT01082367|586211|P1|Treated in F-U|Follow-up (F-U) Period||5
241671|NCT01082367|586210|P2|STARTED|Follow-up (F-U) Period||10
241672|NCT01082367|586211|P1|STARTED|Follow-up (F-U) Period||19
241673|NCT01082367|586210|P2|NOT COMPLETED|Double-blind Period||13
241674|NCT01082367|586211|P1|NOT COMPLETED|Double-blind Period||5
241675|NCT01082367|586210|P2|COMPLETED|Double-blind Period||12
241676|NCT01082367|586211|P1|COMPLETED|Double-blind Period||21
241677|NCT01082367|586210|P2|Stage 4:no tx for Patients Not in co|Double-blind Period||0
241678|NCT01082367|586211|P1|Stage 4:no tx for Patients Not in co|Double-blind Period||0
241679|NCT01082367|586210|P2|Stage 3: Cross-over (co) tx|Double-blind Period||6
241680|NCT01082367|586211|P1|Stage 3: Cross-over (co) tx|Double-blind Period||13
241681|NCT01082367|586210|P2|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||0
241682|NCT01082367|586211|P1|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||9
241683|NCT01082367|586210|P2|Entered OL TOBI|Double-blind Period||18
241684|NCT01082367|586211|P1|Entered OL TOBI|Double-blind Period||4
241685|NCT01082367|586210|P2|Stage 2:no tx|Double-blind Period||0
241686|NCT01082367|586211|P1|Stage 2:no tx|Double-blind Period||0
241687|NCT01082367|586210|P2|Stage 1:1st Treatment (tx) Cycle|Double-blind Period|1 participant discontinued after cycle 1 due to an SAE|25
241688|NCT01082367|586211|P1|Stage 1:1st Treatment (tx) Cycle|Double-blind Period||26
241689|NCT01082367|586210|P2|STARTED|Double-blind Period||25
241690|NCT01082367|586211|P1|STARTED|Double-blind Period||26
241691|NCT01082328|586225|P1|NOT COMPLETED|Overall Study||1
241692|NCT01082328|586225|P1|COMPLETED|Overall Study||58
241693|NCT01082328|586225|P1|STARTED|Overall Study||59
241694|NCT01082211|586234|P1|NOT COMPLETED|Overall Study||7
241695|NCT01082211|586234|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
241696|NCT01082211|586234|P1|All Eligible Patients|Overall Study||58
241697|NCT01082211|586234|P1|Has Baseline/36-Month MD QOL Data|Overall Study||27
241698|NCT01082211|586234|P1|Has Baseline/36-month PT QOL Data|Overall Study||32
241699|NCT01082211|586234|P1|Has Baseline/12-Month MD QOL Data|Overall Study||35
241700|NCT01082211|586234|P1|Has Baseline/12-month PT QOL Data|Overall Study||36
241701|NCT01082211|586234|P1|Has Baseline MD QOL Data|Overall Study||44
241702|NCT01082211|586234|P1|Has Baseline PT QOL Data|Overall Study||46
241703|NCT01082211|586234|P1|STARTED|Overall Study||65
241704|NCT01082159|586252|P1|NOT COMPLETED|Overall Study||9
241705|NCT01082159|586252|P1|COMPLETED|Overall Study||46
241706|NCT01082159|586252|P1|STARTED|Overall Study||55
241707|NCT01082081|586261|P3|NOT COMPLETED|Overall Study||2
241708|NCT01082081|586262|P2|NOT COMPLETED|Overall Study||1
241709|NCT01082081|586263|P1|NOT COMPLETED|Overall Study||0
241710|NCT01082081|586261|P3|COMPLETED|Overall Study||58
241711|NCT01082081|586262|P2|COMPLETED|Overall Study||118
241712|NCT01082081|586263|P1|COMPLETED|Overall Study||121
241713|NCT01082081|586261|P3|STARTED|Overall Study||60
241714|NCT01082081|586262|P2|STARTED|Overall Study||119
241715|NCT01082081|586263|P1|STARTED|Overall Study||121
241716|NCT01081951|586315|P2|NOT COMPLETED|Overall Study||55
241717|NCT01081951|586316|P1|NOT COMPLETED|Overall Study||56
241718|NCT01081951|586315|P2|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off), either on-treatment or in survival follow-up|26
241719|NCT01081951|586316|P1|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off),either on-treatment or in survival follow-up|25
241720|NCT01081951|586315|P2|Ongoing Study Treatment at Data Cut-off|Overall Study||0
241721|NCT01081951|586316|P1|Ongoing Study Treatment at Data Cut-off|Overall Study||11
241722|NCT01081951|586315|P2|Entered Maintenance Phase|Overall Study||55
241723|NCT01081951|586316|P1|Entered Maintenance Phase|Overall Study||66
241724|NCT01081951|586315|P2|Received Study Treatment|Overall Study||75
241725|NCT01081951|586316|P1|Received Study Treatment|Overall Study||81
241726|NCT01081951|586315|P2|STARTED|Overall Study||81
241727|NCT01081951|586316|P1|STARTED|Overall Study||81
241728|NCT01081912|586326|P3|NOT COMPLETED|Maintenance Treatment||92
241729|NCT01081912|586327|P2|NOT COMPLETED|Maintenance Treatment||27
241730|NCT01081912|586328|P1|NOT COMPLETED|Maintenance Treatment||0
241731|NCT01081912|586326|P3|COMPLETED|Maintenance Treatment||59
241732|NCT01081912|586327|P2|COMPLETED|Maintenance Treatment||124
241733|NCT01081912|586328|P1|COMPLETED|Maintenance Treatment||0
241734|NCT01081912|586326|P3|STARTED|Maintenance Treatment||151
241735|NCT01081912|586327|P2|STARTED|Maintenance Treatment||151
241736|NCT01081912|586328|P1|STARTED|Maintenance Treatment||0
241737|NCT01081912|586326|P3|NOT COMPLETED|Conversion/Titration||0
241738|NCT01081912|586327|P2|NOT COMPLETED|Conversion/Titration||0
241739|NCT01081912|586328|P1|NOT COMPLETED|Conversion/Titration||208
241740|NCT01081912|586326|P3|COMPLETED|Conversion/Titration||0
241741|NCT01081912|586327|P2|COMPLETED|Conversion/Titration||0
241742|NCT01081912|586328|P1|COMPLETED|Conversion/Titration||302
241743|NCT01081912|586326|P3|STARTED|Conversion/Titration||0
241744|NCT01081912|586327|P2|STARTED|Conversion/Titration||0
241745|NCT01081912|586328|P1|STARTED|Conversion/Titration||510
241746|NCT01081886|586337|P2|NOT COMPLETED|Overall Study||13
241747|NCT01081886|586338|P1|NOT COMPLETED|Overall Study||11
241748|NCT01081886|586337|P2|COMPLETED|Overall Study||0
241749|NCT01081886|586338|P1|COMPLETED|Overall Study||0
241750|NCT01081886|586337|P2|STARTED|Overall Study||13
241751|NCT01081886|586338|P1|STARTED|Overall Study||11
241752|NCT01081873|586346|P1|NOT COMPLETED|Overall Study||298
241753|NCT01081873|586346|P1|COMPLETED|Overall Study||2416
241754|NCT01081873|586346|P1|STARTED|Overall Study|3 patients were excluded from this and all analyses due to no available data from Baseline.|2714
241755|NCT01081834|586418|P5|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
241756|NCT01081834|586419|P4|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
241757|NCT01081834|586420|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
241758|NCT01081834|586421|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
241759|NCT01081834|586422|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||20
241760|NCT01081834|586418|P5|COMPLETED|Extension Period: Week 26 to Week 52||0
241761|NCT01081834|586419|P4|COMPLETED|Extension Period: Week 26 to Week 52||0
241762|NCT01081834|586420|P3|COMPLETED|Extension Period: Week 26 to Week 52||165
241763|NCT01081834|586421|P2|COMPLETED|Extension Period: Week 26 to Week 52||152
241764|NCT01081834|586422|P1|COMPLETED|Extension Period: Week 26 to Week 52||135
241765|NCT01081834|586418|P5|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
241766|NCT01081834|586419|P4|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
241767|NCT01081834|586420|P3|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued last day of core: AE (1), lost f/u (1), PV (1), NS (1), physician decision (1).|170
241768|NCT01081834|586421|P2|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued on last day of core: adverse event (AE) (1), protocol violation (PV) (1).|170
241769|NCT01081834|586422|P1|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued on last day of core: lack of efficacy on rescue (2), not specified (NS) (3).|155
241770|NCT01081834|586418|P5|NOT COMPLETED|Core Period: Baseline to Week 26||4
241771|NCT01081834|586419|P4|NOT COMPLETED|Core Period: Baseline to Week 26||7
241772|NCT01081834|586420|P3|NOT COMPLETED|Core Period: Baseline to Week 26||22
241773|NCT01081834|586421|P2|NOT COMPLETED|Core Period: Baseline to Week 26||23
241774|NCT01081834|586422|P1|NOT COMPLETED|Core Period: Baseline to Week 26||32
241775|NCT01081834|586418|P5|COMPLETED|Core Period: Baseline to Week 26||40
241776|NCT01081834|586419|P4|COMPLETED|Core Period: Baseline to Week 26||40
241777|NCT01081834|586420|P3|COMPLETED|Core Period: Baseline to Week 26||175
241778|NCT01081834|586421|P2|COMPLETED|Core Period: Baseline to Week 26||172
241779|NCT01081834|586422|P1|COMPLETED|Core Period: Baseline to Week 26||160
241780|NCT01081834|586418|P5|STARTED|Core Period: Baseline to Week 26||44
241781|NCT01081834|586419|P4|STARTED|Core Period: Baseline to Week 26||47
241782|NCT01081834|586420|P3|STARTED|Core Period: Baseline to Week 26||197
241783|NCT01081834|586421|P2|STARTED|Core Period: Baseline to Week 26||195
241784|NCT01081834|586422|P1|STARTED|Core Period: Baseline to Week 26||192
241785|NCT01081795|586483|P3|NOT COMPLETED|Overall Study||30
241786|NCT01081795|586484|P2|NOT COMPLETED|Overall Study||35
241787|NCT01081795|586485|P1|NOT COMPLETED|Overall Study||33
241788|NCT01081795|586483|P3|COMPLETED|Overall Study||97
241789|NCT01081795|586484|P2|COMPLETED|Overall Study||95
241790|NCT01081795|586485|P1|COMPLETED|Overall Study||97
241791|NCT01081795|586483|P3|STARTED|Overall Study||127
241792|NCT01081795|586484|P2|STARTED|Overall Study||130
241793|NCT01081795|586485|P1|STARTED|Overall Study||130
241794|NCT01081769|586522|P2|NOT COMPLETED|CORE Intent-To-Treat||97
241795|NCT01081769|586523|P1|NOT COMPLETED|CORE Intent-To-Treat||80
241796|NCT01081769|586522|P2|COMPLETED|CORE Intent-To-Treat||266
241797|NCT01081769|586523|P1|COMPLETED|CORE Intent-To-Treat||272
241798|NCT01081769|586522|P2|STARTED|CORE Intent-To-Treat||363
241799|NCT01081769|586523|P1|STARTED|CORE Intent-To-Treat||352
241800|NCT01081769|586522|P2|NOT COMPLETED|Whole Intent-to-Treat||25
241801|NCT01081769|586523|P1|NOT COMPLETED|Whole Intent-to-Treat||24
241802|NCT01081769|586522|P2|COMPLETED|Whole Intent-to-Treat||363
241803|NCT01081769|586523|P1|COMPLETED|Whole Intent-to-Treat||352
241804|NCT01081769|586522|P2|STARTED|Whole Intent-to-Treat||388
241805|NCT01081769|586523|P1|STARTED|Whole Intent-to-Treat||376
241806|NCT01081678|586561|P4|NOT COMPLETED|Overall Study||29
241807|NCT01081678|586562|P3|NOT COMPLETED|Overall Study||31
241808|NCT01081678|586563|P2|NOT COMPLETED|Overall Study||16
241809|NCT01081678|586564|P1|NOT COMPLETED|Overall Study||27
241810|NCT01081678|586561|P4|COMPLETED|Overall Study||61
241811|NCT01081678|586562|P3|COMPLETED|Overall Study||62
241812|NCT01081678|586563|P2|COMPLETED|Overall Study||44
241813|NCT01081678|586564|P1|COMPLETED|Overall Study||62
241814|NCT01081678|586561|P4|Completed 24 Weeks of Study|Overall Study||68
241815|NCT01081678|586562|P3|Completed 24 Weeks of Study|Overall Study||72
241816|NCT01081678|586563|P2|Completed 24 Weeks of Study|Overall Study||50
241817|NCT01081678|586564|P1|Completed 24 Weeks of Study|Overall Study||73
241818|NCT01081678|586561|P4|Received Study Drug|Overall Study||89
241819|NCT01081678|586562|P3|Received Study Drug|Overall Study||89
241820|NCT01081678|586563|P2|Received Study Drug|Overall Study||60
241821|NCT01081678|586564|P1|Received Study Drug|Overall Study||87
241822|NCT01081678|586561|P4|STARTED|Overall Study||90
241823|NCT01081678|586562|P3|STARTED|Overall Study||93
241824|NCT01081678|586563|P2|STARTED|Overall Study||60
241825|NCT01081678|586564|P1|STARTED|Overall Study||89
241826|NCT01081665|586594|P1|NOT COMPLETED|Overall Study||95
241827|NCT01081665|586594|P1|COMPLETED|Overall Study||142
241828|NCT01081665|586594|P1|Evaluable Population|Overall Study|Participants with baseline and at least 2 post-baseline parathormone measurements at 24 months.|212
241829|NCT01081665|586594|P1|Full Analysis Set|Overall Study||237
241830|NCT01081665|586594|P1|STARTED|Overall Study||237
241831|NCT01081626|586606|P2|NOT COMPLETED|Overall Study||61
241832|NCT01081626|586607|P1|NOT COMPLETED|Overall Study||60
241833|NCT01081626|586606|P2|COMPLETED|Overall Study||94
241834|NCT01081626|586607|P1|COMPLETED|Overall Study||95
241835|NCT01081626|586606|P2|Assessed for Efficacy|Overall Study||125
241836|NCT01081626|586607|P1|Assessed for Efficacy|Overall Study||122
241837|NCT01081626|586606|P2|STARTED|Overall Study||155
241838|NCT01081626|586607|P1|STARTED|Overall Study||155
241839|NCT01081301|586633|P1|NOT COMPLETED|Overall Study||14
241840|NCT01081301|586633|P1|COMPLETED|Overall Study||22
241841|NCT01081301|586633|P1|STARTED|Overall Study||36
241842|NCT01081262|586675|P4|NOT COMPLETED|Overall Study||0
241843|NCT01081262|586676|P3|NOT COMPLETED|Overall Study||0
241844|NCT01081262|586677|P2|NOT COMPLETED|Overall Study||0
241845|NCT01081262|586678|P1|NOT COMPLETED|Overall Study||0
241846|NCT01081262|586675|P4|COMPLETED|Overall Study||11
241847|NCT01081262|586676|P3|COMPLETED|Overall Study||13
241848|NCT01081262|586677|P2|COMPLETED|Overall Study||13
241849|NCT01081262|586678|P1|COMPLETED|Overall Study||13
241850|NCT01081262|586675|P4|STARTED|Overall Study||11
241851|NCT01081262|586676|P3|STARTED|Overall Study||13
241852|NCT01081262|586677|P2|STARTED|Overall Study||13
241853|NCT01081262|586678|P1|STARTED|Overall Study||13
241854|NCT01081249|586708|P2|NOT COMPLETED|Overall Study||1
241855|NCT01081249|586709|P1|NOT COMPLETED|Overall Study||0
241856|NCT01081249|586708|P2|COMPLETED|Overall Study||6
241857|NCT01081249|586709|P1|COMPLETED|Overall Study||11
241858|NCT01081249|586708|P2|Second Psychotherapy Appointment (1 Day)|Overall Study||6
241859|NCT01081249|586709|P1|Second Psychotherapy Appointment (1 Day)|Overall Study||11
241860|NCT01081249|586708|P2|Washout (5-10 Days)|Overall Study||6
241861|NCT01081249|586709|P1|Washout (5-10 Days)|Overall Study||11
241862|NCT01081249|586708|P2|First Psychotherapy Appointment (1 Day)|Overall Study||6
241863|NCT01081249|586709|P1|First Psychotherapy Appointment (1 Day)|Overall Study||11
241864|NCT01081249|586708|P2|STARTED|Overall Study||7
241865|NCT01081249|586709|P1|STARTED|Overall Study||11
241866|NCT01081145|586715|P2|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||106
241867|NCT01081145|586716|P1|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||81
241868|NCT01081145|586715|P2|COMPLETED|Double-Blind Randomized-Withdrawal Phase||53
241869|NCT01081145|586716|P1|COMPLETED|Double-Blind Randomized-Withdrawal Phase||76
241870|NCT01081145|586715|P2|STARTED|Double-Blind Randomized-Withdrawal Phase||159
241871|NCT01081145|586716|P1|STARTED|Double-Blind Randomized-Withdrawal Phase||157
241872|NCT01081145|586715|P2|NOT COMPLETED|Open-Label Phase||0
241873|NCT01081145|586716|P1|NOT COMPLETED|Open-Label Phase||212
241874|NCT01081145|586715|P2|COMPLETED|Open-Label Phase||0
241875|NCT01081145|586716|P1|COMPLETED|Open-Label Phase||316
241876|NCT01081145|586715|P2|STARTED|Open-Label Phase||0
241877|NCT01081145|586716|P1|STARTED|Open-Label Phase||528
241878|NCT01081132|586744|P2|NOT COMPLETED|Overall Study||52
241879|NCT01081132|586745|P1|NOT COMPLETED|Overall Study||55
241880|NCT01081132|586744|P2|COMPLETED|Overall Study||105
241881|NCT01081132|586745|P1|COMPLETED|Overall Study||102
241882|NCT01081132|586744|P2|STARTED|Overall Study||157
241883|NCT01081132|586745|P1|STARTED|Overall Study||157
241884|NCT01081041|586786|P3|NOT COMPLETED|Overall Study||2
241885|NCT01081041|586787|P2|NOT COMPLETED|Overall Study||4
241886|NCT01081041|586788|P1|NOT COMPLETED|Overall Study||0
241887|NCT01081041|586786|P3|COMPLETED|Overall Study||71
241888|NCT01081041|586787|P2|COMPLETED|Overall Study||77
241889|NCT01081041|586788|P1|COMPLETED|Overall Study||33
241890|NCT01081041|586786|P3|Received at Least 1 Dose of Study Drug|Overall Study||71
241891|NCT01081041|586787|P2|Received at Least 1 Dose of Study Drug|Overall Study||77
241892|NCT01081041|586788|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
241893|NCT01081041|586786|P3|STARTED|Overall Study||73
241894|NCT01081041|586787|P2|STARTED|Overall Study||81
241895|NCT01081041|586788|P1|STARTED|Overall Study||33
241896|NCT01080976|586818|P2|NOT COMPLETED|Overall Study||0
241897|NCT01080976|586819|P1|NOT COMPLETED|Overall Study||0
241898|NCT01080976|586818|P2|COMPLETED|Overall Study||5
241899|NCT01080976|586819|P1|COMPLETED|Overall Study||5
241900|NCT01080976|586818|P2|STARTED|Overall Study||5
241901|NCT01080976|586819|P1|STARTED|Overall Study||5
241902|NCT01080807|586829|P2|NOT COMPLETED|Overall Study||23
241903|NCT01080807|586830|P1|NOT COMPLETED|Overall Study||35
241904|NCT01080807|586829|P2|COMPLETED|Overall Study||167
241905|NCT01080807|586830|P1|COMPLETED|Overall Study||158
241906|NCT01080807|586829|P2|STARTED|Overall Study|Three patients randomly assigned to the placebo treatment group did not receive study drug.|190
241907|NCT01080807|586830|P1|STARTED|Overall Study|Nine patients randomly assigned to the armodafinil treatment group did not receive study drug.|193
241908|NCT01080794|586888|P4|NOT COMPLETED|Overall Study||2
241909|NCT01080794|586889|P3|NOT COMPLETED|Overall Study||2
241910|NCT01080794|586890|P2|NOT COMPLETED|Overall Study||2
241911|NCT01080794|586891|P1|NOT COMPLETED|Overall Study||5
241912|NCT01080794|586888|P4|COMPLETED|Overall Study||13
241913|NCT01080794|586889|P3|COMPLETED|Overall Study||10
241914|NCT01080794|586890|P2|COMPLETED|Overall Study||12
241915|NCT01080794|586891|P1|COMPLETED|Overall Study||15
241916|NCT01080794|586888|P4|STARTED|Overall Study||15
241917|NCT01080794|586889|P3|STARTED|Overall Study||12
241918|NCT01080794|586890|P2|STARTED|Overall Study||14
241919|NCT01080794|586891|P1|STARTED|Overall Study||20
241920|NCT01080768|586939|P2|NOT COMPLETED|Overall Study||1
241921|NCT01080768|586940|P1|NOT COMPLETED|Overall Study||2
241922|NCT01080768|586939|P2|COMPLETED|Overall Study||16
241923|NCT01080768|586940|P1|COMPLETED|Overall Study||12
241924|NCT01080768|586939|P2|STARTED|Overall Study||17
241925|NCT01080768|586940|P1|STARTED|Overall Study||14
241926|NCT01080716|586950|P4|NOT COMPLETED|Part 2||0
241927|NCT01080716|586951|P3|NOT COMPLETED|Part 2||0
241928|NCT01080716|586952|P2|NOT COMPLETED|Part 2||0
241929|NCT01080716|586953|P1|NOT COMPLETED|Part 2||0
241930|NCT01080716|586950|P4|COMPLETED|Part 2||10
241931|NCT01080716|586951|P3|COMPLETED|Part 2||10
241932|NCT01080716|586952|P2|COMPLETED|Part 2||0
241933|NCT01080716|586953|P1|COMPLETED|Part 2||0
241934|NCT01080716|586950|P4|STARTED|Part 2||10
241935|NCT01080716|586951|P3|STARTED|Part 2||10
241936|NCT01080716|586952|P2|STARTED|Part 2||0
241937|NCT01080716|586953|P1|STARTED|Part 2||0
241938|NCT01080716|586950|P4|NOT COMPLETED|Part 1||0
241939|NCT01080716|586951|P3|NOT COMPLETED|Part 1||0
241940|NCT01080716|586952|P2|NOT COMPLETED|Part 1||0
241941|NCT01080716|586953|P1|NOT COMPLETED|Part 1||1
241942|NCT01080716|586950|P4|COMPLETED|Part 1||0
241943|NCT01080716|586951|P3|COMPLETED|Part 1||0
241944|NCT01080716|586952|P2|COMPLETED|Part 1||6
241945|NCT01080716|586953|P1|COMPLETED|Part 1||13
241946|NCT01080716|586950|P4|STARTED|Part 1||0
241947|NCT01080716|586951|P3|STARTED|Part 1||0
241948|NCT01080716|586952|P2|STARTED|Part 1||6
241949|NCT01080716|586953|P1|STARTED|Part 1||14
241950|NCT01080677|586970|P3|NOT COMPLETED|Overall Study||0
241951|NCT01080677|586971|P2|NOT COMPLETED|Overall Study||0
241952|NCT01080677|586972|P1|NOT COMPLETED|Overall Study||0
241953|NCT01080677|586970|P3|COMPLETED|Overall Study||20
241954|NCT01080677|586971|P2|COMPLETED|Overall Study||20
241955|NCT01080677|586972|P1|COMPLETED|Overall Study||20
241956|NCT01080677|586970|P3|STARTED|Overall Study||20
241957|NCT01080677|586971|P2|STARTED|Overall Study||20
241958|NCT01080677|586972|P1|STARTED|Overall Study||20
241959|NCT01080625|586992|P3|NOT COMPLETED|Overall Study||1
241960|NCT01080625|586993|P2|NOT COMPLETED|Overall Study||2
241961|NCT01080625|586994|P1|NOT COMPLETED|Overall Study||0
241962|NCT01080625|586992|P3|COMPLETED|Overall Study||31
241963|NCT01080625|586993|P2|COMPLETED|Overall Study||31
241964|NCT01080625|586994|P1|COMPLETED|Overall Study||31
241965|NCT01080625|586992|P3|STARTED|Overall Study||32
241966|NCT01080625|586993|P2|STARTED|Overall Study||33
241967|NCT01080625|586994|P1|STARTED|Overall Study||31
241968|NCT01080391|587004|P2|NOT COMPLETED|Overall Study||4
241969|NCT01080391|587005|P1|NOT COMPLETED|Overall Study||7
241970|NCT01080391|587004|P2|COMPLETED|Overall Study||392
241971|NCT01080391|587005|P1|COMPLETED|Overall Study||389
241972|NCT01080391|587004|P2|Treated|Overall Study||392
241973|NCT01080391|587005|P1|Treated|Overall Study||389
241974|NCT01080391|587004|P2|STARTED|Overall Study||396
241975|NCT01080391|587005|P1|STARTED|Overall Study||396
241976|NCT01080326|587023|P1|NOT COMPLETED|Overall Study||4
241977|NCT01080326|587023|P1|COMPLETED|Overall Study||3
241978|NCT01080326|587023|P1|STARTED|Overall Study||7
241979|NCT01080300|587029|P2|NOT COMPLETED|Overall Study||104
241980|NCT01080300|587030|P1|NOT COMPLETED|Overall Study||94
241981|NCT01080300|587029|P2|COMPLETED|Overall Study||191
241982|NCT01080300|587030|P1|COMPLETED|Overall Study||206
241983|NCT01080300|587029|P2|STARTED|Overall Study|298 subjects were randomized, but only 295 received study treatment.|295
241984|NCT01080300|587030|P1|STARTED|Overall Study|302 subjects were randomized, but only 300 received study treatment.|300
241985|NCT01080261|587038|P1|NOT COMPLETED|Overall Study||0
241986|NCT01080261|587038|P1|COMPLETED|Overall Study||60
241987|NCT01080261|587038|P1|STARTED|Overall Study||60
241988|NCT01080248|587053|P1|NOT COMPLETED|Overall Study||0
241989|NCT01080248|587053|P1|COMPLETED|Overall Study||2
241990|NCT01080248|587053|P1|STARTED|Overall Study||2
241991|NCT01080209|587067|P7|NOT COMPLETED|Overall Study||7
241992|NCT01080209|587068|P6|NOT COMPLETED|Overall Study||0
241993|NCT01080209|587069|P5|NOT COMPLETED|Overall Study||0
241994|NCT01080209|587070|P4|NOT COMPLETED|Overall Study||5
241995|NCT01080209|587071|P3|NOT COMPLETED|Overall Study||5
241996|NCT01080209|587072|P2|NOT COMPLETED|Overall Study||11
241997|NCT01080209|587073|P1|NOT COMPLETED|Overall Study||6
241998|NCT01080209|587067|P7|COMPLETED|Overall Study||44
241999|NCT01080209|587068|P6|COMPLETED|Overall Study||2
242000|NCT01080209|587069|P5|COMPLETED|Overall Study||6
242001|NCT01080209|587070|P4|COMPLETED|Overall Study||37
242002|NCT01080209|587071|P3|COMPLETED|Overall Study||28
242003|NCT01080209|587072|P2|COMPLETED|Overall Study||42
242004|NCT01080209|587073|P1|COMPLETED|Overall Study||22
242005|NCT01080209|587067|P7|STARTED|Overall Study||51
242006|NCT01080209|587068|P6|STARTED|Overall Study||2
242007|NCT01080209|587069|P5|STARTED|Overall Study||6
242008|NCT01080209|587070|P4|STARTED|Overall Study||42
242009|NCT01080209|587071|P3|STARTED|Overall Study||33
242010|NCT01080209|587072|P2|STARTED|Overall Study||53
242011|NCT01080209|587073|P1|STARTED|Overall Study||28
242012|NCT01080196|587098|P2|NOT COMPLETED|Overall Study||0
242013|NCT01080196|587099|P1|NOT COMPLETED|Overall Study||0
242014|NCT01080196|587098|P2|COMPLETED|Overall Study||66
242015|NCT01080196|587099|P1|COMPLETED|Overall Study||68
242016|NCT01080196|587098|P2|STARTED|Overall Study||66
242017|NCT01080196|587099|P1|STARTED|Overall Study||68
242018|NCT01080131|587115|P2|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||11
242019|NCT01080131|587116|P1|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||8
242020|NCT01080131|587115|P2|COMPLETED|Extension Study 2 (25-72 Weeks)||54
242021|NCT01080131|587116|P1|COMPLETED|Extension Study 2 (25-72 Weeks)||64
242022|NCT01080131|587115|P2|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|41
242023|NCT01080131|587116|P1|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab at any time during the 72 weeks|62
242024|NCT01080131|587115|P2|STARTED|Extension Study 2 (25-72 Weeks)||65
242025|NCT01080131|587116|P1|STARTED|Extension Study 2 (25-72 Weeks)||72
242026|NCT01080131|587115|P2|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||4
242027|NCT01080131|587116|P1|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||6
242028|NCT01080131|587115|P2|COMPLETED|Extension Study 1 (12 -24 Weeks)||72
242029|NCT01080131|587116|P1|COMPLETED|Extension Study 1 (12 -24 Weeks)||78
242030|NCT01080131|587115|P2|STARTED|Extension Study 1 (12 -24 Weeks)||76
242031|NCT01080131|587116|P1|STARTED|Extension Study 1 (12 -24 Weeks)||84
242032|NCT01080131|587115|P2|NOT COMPLETED|Core Study (0- 12 Weeks)||11
242033|NCT01080131|587116|P1|NOT COMPLETED|Core Study (0- 12 Weeks)||13
242034|NCT01080131|587115|P2|COMPLETED|Core Study (0- 12 Weeks)||103
242035|NCT01080131|587116|P1|COMPLETED|Core Study (0- 12 Weeks)||99
242036|NCT01080131|587115|P2|STARTED|Core Study (0- 12 Weeks)||114
242037|NCT01080131|587116|P1|STARTED|Core Study (0- 12 Weeks)||112
242038|NCT01080118|587195|P4|NOT COMPLETED|Overall Study||0
242039|NCT01080118|587196|P3|NOT COMPLETED|Overall Study||0
242040|NCT01080118|587197|P2|NOT COMPLETED|Overall Study||0
242041|NCT01080118|587198|P1|NOT COMPLETED|Overall Study||0
242042|NCT01080118|587195|P4|COMPLETED|Overall Study||30
242043|NCT01080118|587196|P3|COMPLETED|Overall Study||30
242044|NCT01080118|587197|P2|COMPLETED|Overall Study||15
242045|NCT01080118|587198|P1|COMPLETED|Overall Study||15
242046|NCT01080118|587195|P4|STARTED|Overall Study||30
242047|NCT01080118|587196|P3|STARTED|Overall Study||30
242048|NCT01080118|587197|P2|STARTED|Overall Study||15
242049|NCT01080118|587198|P1|STARTED|Overall Study||15
242050|NCT01079988|587211|P5|NOT COMPLETED|Overall Study||1
242051|NCT01079988|587212|P4|NOT COMPLETED|Overall Study||3
242052|NCT01079988|587213|P3|NOT COMPLETED|Overall Study||0
242053|NCT01079988|587214|P2|NOT COMPLETED|Overall Study||0
242054|NCT01079988|587215|P1|NOT COMPLETED|Overall Study||1
242055|NCT01079988|587211|P5|COMPLETED|Overall Study||1
242056|NCT01079988|587212|P4|COMPLETED|Overall Study||17
242057|NCT01079988|587213|P3|COMPLETED|Overall Study||8
242058|NCT01079988|587214|P2|COMPLETED|Overall Study||1
242059|NCT01079988|587215|P1|COMPLETED|Overall Study||9
242060|NCT01079988|587211|P5|STARTED|Overall Study||2
242061|NCT01079988|587212|P4|STARTED|Overall Study||20
242062|NCT01079988|587213|P3|STARTED|Overall Study||8
242063|NCT01079988|587214|P2|STARTED|Overall Study||1
242064|NCT01079988|587215|P1|STARTED|Overall Study||10
242065|NCT01079962|587234|P2|NOT COMPLETED|Overall Study||15
242066|NCT01079962|587235|P1|NOT COMPLETED|Overall Study||15
242067|NCT01079962|587234|P2|COMPLETED|Overall Study||89
242068|NCT01079962|587235|P1|COMPLETED|Overall Study||90
242069|NCT01079962|587234|P2|STARTED|Overall Study||104
242070|NCT01079962|587235|P1|STARTED|Overall Study||105
242071|NCT01079949|587263|P2|NOT COMPLETED|Overall Study||13
242072|NCT01079949|587264|P1|NOT COMPLETED|Overall Study||15
242073|NCT01079949|587263|P2|COMPLETED|Overall Study||34
242074|NCT01079949|587264|P1|COMPLETED|Overall Study||31
242075|NCT01079949|587263|P2|STARTED|Overall Study||47
242076|NCT01079949|587264|P1|STARTED|Overall Study||46
242077|NCT01079936|587310|P5|NOT COMPLETED|Phase II||1
242078|NCT01079936|587311|P4|NOT COMPLETED|Phase II||0
242079|NCT01079936|587312|P3|NOT COMPLETED|Phase II||1
242080|NCT01079936|587313|P2|NOT COMPLETED|Phase II||0
242081|NCT01079936|587314|P1|NOT COMPLETED|Phase II||0
242082|NCT01079936|587310|P5|COMPLETED|Phase II||25
242083|NCT01079936|587311|P4|COMPLETED|Phase II||24
242084|NCT01079936|587312|P3|COMPLETED|Phase II||5
242085|NCT01079936|587313|P2|COMPLETED|Phase II||3
242086|NCT01079936|587314|P1|COMPLETED|Phase II||0
242087|NCT01079936|587310|P5|STARTED|Phase II||26
242088|NCT01079936|587311|P4|STARTED|Phase II||24
242089|NCT01079936|587312|P3|STARTED|Phase II||6
242090|NCT01079936|587313|P2|STARTED|Phase II||3
242091|NCT01079936|587314|P1|STARTED|Phase II||0
242092|NCT01079936|587310|P5|NOT COMPLETED|Phase I: MTD||0
242093|NCT01079936|587311|P4|NOT COMPLETED|Phase I: MTD||0
242094|NCT01079936|587312|P3|NOT COMPLETED|Phase I: MTD||0
242095|NCT01079936|587313|P2|NOT COMPLETED|Phase I: MTD||0
242096|NCT01079936|587314|P1|NOT COMPLETED|Phase I: MTD||4
242097|NCT01079936|587310|P5|COMPLETED|Phase I: MTD||0
242098|NCT01079936|587311|P4|COMPLETED|Phase I: MTD||0
242099|NCT01079936|587312|P3|COMPLETED|Phase I: MTD||0
242100|NCT01079936|587313|P2|COMPLETED|Phase I: MTD||0
242101|NCT01079936|587314|P1|COMPLETED|Phase I: MTD|The 12 Phase I participants were randomized across 4 dose arms for Phase II.|12
242102|NCT01079936|587310|P5|STARTED|Phase I: MTD||0
242103|NCT01079936|587311|P4|STARTED|Phase I: MTD||0
242104|NCT01079936|587312|P3|STARTED|Phase I: MTD||0
242105|NCT01079936|587313|P2|STARTED|Phase I: MTD||0
242106|NCT01079936|587314|P1|STARTED|Phase I: MTD||16
242107|NCT01079832|587333|P1|NOT COMPLETED|Overall Study||1
242108|NCT01079832|587333|P1|COMPLETED|Overall Study||49
242109|NCT01079832|587333|P1|STARTED|Overall Study||50
242110|NCT01079806|587343|P2|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||15
242111|NCT01079806|587344|P1|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||19
242112|NCT01079806|587343|P2|COMPLETED|Long-term Follow-up: Day 1-End of Study||43
242113|NCT01079806|587344|P1|COMPLETED|Long-term Follow-up: Day 1-End of Study||92
242114|NCT01079806|587343|P2|STARTED|Long-term Follow-up: Day 1-End of Study||58
242115|NCT01079806|587344|P1|STARTED|Long-term Follow-up: Day 1-End of Study||111
242116|NCT01079806|587343|P2|NOT COMPLETED|Day 1 to Week 96||7
242117|NCT01079806|587344|P1|NOT COMPLETED|Day 1 to Week 96||7
242118|NCT01079806|587343|P2|COMPLETED|Day 1 to Week 96||53
242119|NCT01079806|587344|P1|COMPLETED|Day 1 to Week 96||113
242120|NCT01079806|587343|P2|Primary Endpoint Cohort|Day 1 to Week 96||41
242121|NCT01079806|587344|P1|Primary Endpoint Cohort|Day 1 to Week 96||82
242122|NCT01079806|587343|P2|Received Treatment|Day 1 to Week 96||60
242123|NCT01079806|587344|P1|Received Treatment|Day 1 to Week 96||120
242124|NCT01079806|587343|P2|STARTED|Day 1 to Week 96||60
242125|NCT01079806|587344|P1|STARTED|Day 1 to Week 96||120
242126|NCT01079741|587379|P5|NOT COMPLETED|Phase 2 (Weeks 37-48)||3
242127|NCT01079741|587380|P4|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
242128|NCT01079741|587381|P3|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
242129|NCT01079741|587382|P2|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
242130|NCT01079741|587383|P1|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
242131|NCT01079741|587379|P5|COMPLETED|Phase 2 (Weeks 37-48)||9
242132|NCT01079741|587380|P4|COMPLETED|Phase 2 (Weeks 37-48)||12
242133|NCT01079741|587381|P3|COMPLETED|Phase 2 (Weeks 37-48)||0
242134|NCT01079741|587382|P2|COMPLETED|Phase 2 (Weeks 37-48)||0
242135|NCT01079741|587383|P1|COMPLETED|Phase 2 (Weeks 37-48)||0
242136|NCT01079741|587379|P5|STARTED|Phase 2 (Weeks 37-48)||12
242137|NCT01079741|587380|P4|STARTED|Phase 2 (Weeks 37-48)||12
242138|NCT01079741|587381|P3|STARTED|Phase 2 (Weeks 37-48)||0
242139|NCT01079741|587382|P2|STARTED|Phase 2 (Weeks 37-48)||0
242140|NCT01079741|587383|P1|STARTED|Phase 2 (Weeks 37-48)||0
242141|NCT01079741|587379|P5|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
242142|NCT01079741|587380|P4|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
242143|NCT01079741|587381|P3|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
242144|NCT01079741|587382|P2|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
242145|NCT01079741|587383|P1|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
242146|NCT01079741|587379|P5|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
242147|NCT01079741|587380|P4|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
242148|NCT01079741|587381|P3|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
242149|NCT01079741|587382|P2|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
242150|NCT01079741|587383|P1|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
242151|NCT01079741|587379|P5|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
242152|NCT01079741|587380|P4|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
242153|NCT01079741|587381|P3|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
242154|NCT01079741|587382|P2|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
242155|NCT01079741|587383|P1|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
242156|NCT01079741|587379|P5|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
242157|NCT01079741|587380|P4|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
242158|NCT01079741|587381|P3|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
242159|NCT01079741|587382|P2|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||1
242160|NCT01079741|587383|P1|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
242161|NCT01079741|587379|P5|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
242162|NCT01079741|587380|P4|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
242163|NCT01079741|587381|P3|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
242164|NCT01079741|587382|P2|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||3
242165|NCT01079741|587383|P1|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
242166|NCT01079741|587379|P5|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
242167|NCT01079741|587380|P4|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
242168|NCT01079741|587381|P3|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
242169|NCT01079741|587382|P2|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||4
242170|NCT01079741|587383|P1|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
242171|NCT01079741|587379|P5|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
242172|NCT01079741|587380|P4|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
242173|NCT01079741|587381|P3|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
242174|NCT01079741|587382|P2|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
242175|NCT01079741|587383|P1|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
242176|NCT01079741|587379|P5|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
242177|NCT01079741|587380|P4|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
242178|NCT01079741|587381|P3|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
242179|NCT01079741|587382|P2|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
242180|NCT01079741|587383|P1|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
242181|NCT01079741|587379|P5|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
242182|NCT01079741|587380|P4|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
242183|NCT01079741|587381|P3|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
242184|NCT01079741|587382|P2|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
242185|NCT01079741|587383|P1|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
242186|NCT01079598|587397|P1|NOT COMPLETED|Overall Study||0
242187|NCT01079598|587397|P1|COMPLETED|Overall Study||8
242188|NCT01079598|587397|P1|STARTED|Overall Study||8
242189|NCT01079390|587407|P3|NOT COMPLETED|Overall Study||4
242190|NCT01079390|587408|P2|NOT COMPLETED|Overall Study||5
242191|NCT01079390|587409|P1|NOT COMPLETED|Overall Study||5
242192|NCT01079390|587407|P3|COMPLETED|Overall Study||10
242193|NCT01079390|587408|P2|COMPLETED|Overall Study||10
242194|NCT01079390|587409|P1|COMPLETED|Overall Study||10
242195|NCT01079390|587407|P3|STARTED|Overall Study||14
242196|NCT01079390|587408|P2|STARTED|Overall Study||15
242197|NCT01079390|587409|P1|STARTED|Overall Study||15
242198|NCT01079299|587421|P2|NOT COMPLETED|Overall Study||0
242199|NCT01079299|587422|P1|NOT COMPLETED|Overall Study||0
242200|NCT01079299|587421|P2|COMPLETED|Overall Study||25
242201|NCT01079299|587422|P1|COMPLETED|Overall Study||27
242202|NCT01079299|587421|P2|STARTED|Overall Study||25
242203|NCT01079299|587422|P1|STARTED|Overall Study||27
242204|NCT01079234|587431|P4|NOT COMPLETED|Extension: Week 27 to 52||16
242205|NCT01079234|587432|P3|NOT COMPLETED|Extension: Week 27 to 52||11
242206|NCT01079234|587433|P2|NOT COMPLETED|Extension: Week 27 to 52||0
242207|NCT01079234|587434|P1|NOT COMPLETED|Extension: Week 27 to 52||0
242208|NCT01079234|587431|P4|COMPLETED|Extension: Week 27 to 52||223
242209|NCT01079234|587432|P3|COMPLETED|Extension: Week 27 to 52||122
242210|NCT01079234|587433|P2|COMPLETED|Extension: Week 27 to 52||0
242211|NCT01079234|587434|P1|COMPLETED|Extension: Week 27 to 52||0
242212|NCT01079234|587431|P4|STARTED|Extension: Week 27 to 52|Thirty eight subjects did not continue into extension trial.|239
242213|NCT01079234|587432|P3|STARTED|Extension: Week 27 to 52|Nineteen subjects from main trial did not continue into extension trial|133
242214|NCT01079234|587433|P2|STARTED|Extension: Week 27 to 52||0
242215|NCT01079234|587434|P1|STARTED|Extension: Week 27 to 52||0
242216|NCT01079234|587431|P4|NOT COMPLETED|Main: Week 0 to 26||0
242217|NCT01079234|587432|P3|NOT COMPLETED|Main: Week 0 to 26||12
242218|NCT01079234|587433|P2|NOT COMPLETED|Main: Week 0 to 26||26
242219|NCT01079234|587434|P1|NOT COMPLETED|Main: Week 0 to 26||26
242220|NCT01079234|587431|P4|COMPLETED|Main: Week 0 to 26||0
242221|NCT01079234|587432|P3|COMPLETED|Main: Week 0 to 26||152
242222|NCT01079234|587433|P2|COMPLETED|Main: Week 0 to 26||139
242223|NCT01079234|587434|P1|COMPLETED|Main: Week 0 to 26||138
242224|NCT01079234|587431|P4|Exposed|Main: Week 0 to 26||0
242225|NCT01079234|587432|P3|Exposed|Main: Week 0 to 26|Three subjects withdrew prior to exposure to trial drug.|161
242226|NCT01079234|587433|P2|Exposed|Main: Week 0 to 26||165
242227|NCT01079234|587434|P1|Exposed|Main: Week 0 to 26||164
242228|NCT01079234|587431|P4|STARTED|Main: Week 0 to 26||0
242229|NCT01079234|587432|P3|STARTED|Main: Week 0 to 26||164
242230|NCT01079234|587433|P2|STARTED|Main: Week 0 to 26||165
242231|NCT01079234|587434|P1|STARTED|Main: Week 0 to 26||164
242232|NCT01079195|587452|P1|NOT COMPLETED|Overall Study||1431
242233|NCT01079195|587452|P1|COMPLETED|Overall Study||14442
242234|NCT01079195|587452|P1|STARTED|Overall Study||15873
242235|NCT01079182|587458|P1|NOT COMPLETED|Overall Study||2719
242236|NCT01079182|587458|P1|COMPLETED|Overall Study||1962
242237|NCT01079182|587458|P1|STARTED|Overall Study||4681
242238|NCT01079143|587489|P4|NOT COMPLETED|Overall Study||5
242239|NCT01079143|587490|P3|NOT COMPLETED|Overall Study||5
242240|NCT01079143|587491|P2|NOT COMPLETED|Overall Study||17
242241|NCT01079143|587492|P1|NOT COMPLETED|Overall Study||9
242242|NCT01079143|587489|P4|COMPLETED|Overall Study||54
242243|NCT01079143|587490|P3|COMPLETED|Overall Study||34
242244|NCT01079143|587491|P2|COMPLETED|Overall Study||43
242245|NCT01079143|587492|P1|COMPLETED|Overall Study||27
242246|NCT01079143|587489|P4|M3 and M12 Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
242247|NCT01079143|587490|P3|M3 and M12 Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
242248|NCT01079143|587491|P2|M3 and M12 Biopsies|Overall Study||43
242421|NCT01078623|587747|P3|STARTED|Treatment Period 4||6
242249|NCT01079143|587492|P1|M3 and M12 Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
242250|NCT01079143|587489|P4|Month 12 (M12) Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
242251|NCT01079143|587490|P3|Month 12 (M12) Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
242252|NCT01079143|587491|P2|Month 12 (M12) Biopsies|Overall Study||43
242253|NCT01079143|587492|P1|Month 12 (M12) Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
242254|NCT01079143|587489|P4|Month 3 (M3) Biopsies|Overall Study||59
242255|NCT01079143|587490|P3|Month 3 (M3) Biopsies|Overall Study||39
242256|NCT01079143|587491|P2|Month 3 (M3) Biopsies|Overall Study|1 patient was excluded due to an IF/TA Grade of III at the M3 Biopsy|59
242257|NCT01079143|587492|P1|Month 3 (M3) Biopsies|Overall Study||36
242258|NCT01079143|587489|P4|Exposed|Overall Study||59
242259|NCT01079143|587490|P3|Exposed|Overall Study||39
242260|NCT01079143|587491|P2|Exposed|Overall Study||60
242261|NCT01079143|587492|P1|Exposed|Overall Study||36
242262|NCT01079143|587489|P4|STARTED|Overall Study||59
242263|NCT01079143|587490|P3|STARTED|Overall Study||39
242264|NCT01079143|587491|P2|STARTED|Overall Study||60
242265|NCT01079143|587492|P1|STARTED|Overall Study||36
242266|NCT01079130|587566|P6|NOT COMPLETED|Overall Study||5
242267|NCT01079130|587567|P5|NOT COMPLETED|Overall Study||8
242268|NCT01079130|587568|P4|NOT COMPLETED|Overall Study||5
242269|NCT01079130|587569|P3|NOT COMPLETED|Overall Study||1
242270|NCT01079130|587570|P2|NOT COMPLETED|Overall Study||7
242271|NCT01079130|587571|P1|NOT COMPLETED|Overall Study||2
242272|NCT01079130|587566|P6|COMPLETED|Overall Study||80
242273|NCT01079130|587567|P5|COMPLETED|Overall Study||78
242274|NCT01079130|587568|P4|COMPLETED|Overall Study||81
242275|NCT01079130|587569|P3|COMPLETED|Overall Study||83
242276|NCT01079130|587570|P2|COMPLETED|Overall Study||78
242277|NCT01079130|587571|P1|COMPLETED|Overall Study||83
242278|NCT01079130|587566|P6|Full Analysis Set (FAS)|Overall Study||84
242279|NCT01079130|587567|P5|Full Analysis Set (FAS)|Overall Study||84
242280|NCT01079130|587568|P4|Full Analysis Set (FAS)|Overall Study||85
242281|NCT01079130|587569|P3|Full Analysis Set (FAS)|Overall Study||83
242282|NCT01079130|587570|P2|Full Analysis Set (FAS)|Overall Study|2 patients (1 in 37.5 µg;1 in 75 µg group) randomized more than once and were excluded from the FAS.|80
242283|NCT01079130|587571|P1|Full Analysis Set (FAS)|Overall Study||84
242284|NCT01079130|587566|P6|Safety Set: Received Study Drug|Overall Study||84
242285|NCT01079130|587567|P5|Safety Set: Received Study Drug|Overall Study||84
242286|NCT01079130|587568|P4|Safety Set: Received Study Drug|Overall Study||85
242287|NCT01079130|587569|P3|Safety Set: Received Study Drug|Overall Study||84
242288|NCT01079130|587570|P2|Safety Set: Received Study Drug|Overall Study||81
242289|NCT01079130|587571|P1|Safety Set: Received Study Drug|Overall Study||84
242290|NCT01079130|587566|P6|STARTED|Overall Study||85
242291|NCT01079130|587567|P5|STARTED|Overall Study||86
242292|NCT01079130|587568|P4|STARTED|Overall Study||86
242293|NCT01079130|587569|P3|STARTED|Overall Study||84
242294|NCT01079130|587570|P2|STARTED|Overall Study||85
242295|NCT01079130|587571|P1|STARTED|Overall Study||85
242296|NCT01078974|587591|P1|NOT COMPLETED|Overall Study||3
242297|NCT01078974|587591|P1|COMPLETED|Overall Study||4
242298|NCT01078974|587591|P1|STARTED|Overall Study||7
242299|NCT01078922|587596|P1|NOT COMPLETED|Overall Study||1
242300|NCT01078922|587596|P1|COMPLETED|Overall Study||10
242301|NCT01078922|587596|P1|STARTED|Overall Study||11
242302|NCT01078909|587606|P5|NOT COMPLETED|Overall Study||2
242303|NCT01078909|587607|P4|NOT COMPLETED|Overall Study||1
242304|NCT01078909|587608|P3|NOT COMPLETED|Overall Study||1
242305|NCT01078909|587609|P2|NOT COMPLETED|Overall Study||4
242306|NCT01078909|587610|P1|NOT COMPLETED|Overall Study||2
242307|NCT01078909|587606|P5|COMPLETED|Overall Study||23
242308|NCT01078909|587607|P4|COMPLETED|Overall Study||24
242309|NCT01078909|587608|P3|COMPLETED|Overall Study||24
242310|NCT01078909|587609|P2|COMPLETED|Overall Study||21
242311|NCT01078909|587610|P1|COMPLETED|Overall Study||23
242312|NCT01078909|587606|P5|STARTED|Overall Study||25
242313|NCT01078909|587607|P4|STARTED|Overall Study||25
242314|NCT01078909|587608|P3|STARTED|Overall Study||25
242315|NCT01078909|587609|P2|STARTED|Overall Study||25
242316|NCT01078909|587610|P1|STARTED|Overall Study||25
242317|NCT01078844|587632|P1|NOT COMPLETED|Overall Study||4
242318|NCT01078844|587632|P1|COMPLETED|Overall Study||0
242319|NCT01078844|587632|P1|STARTED|Overall Study||4
242320|NCT01078805|587637|P1|NOT COMPLETED|Overall Study||2050
242321|NCT01078805|587637|P1|COMPLETED|Overall Study||2117
242322|NCT01078805|587637|P1|Modified Intent-To-Treat|Overall Study|≥1 dose of study drug (SD) and didn't discontinue SD more than 3 consecutive months during treatment|3720
242323|NCT01078805|587637|P1|Took at Least 1 Dose of Study Drug|Overall Study||4085
242324|NCT01078805|587637|P1|STARTED|Overall Study||4167
242325|NCT01078753|587651|P2|NOT COMPLETED|Treatment Period II||0
242326|NCT01078753|587652|P1|NOT COMPLETED|Treatment Period II||0
242327|NCT01078753|587651|P2|COMPLETED|Treatment Period II||44
242328|NCT01078753|587652|P1|COMPLETED|Treatment Period II||45
242329|NCT01078753|587651|P2|Full Analysis Set|Treatment Period II||44
242330|NCT01078753|587652|P1|Full Analysis Set|Treatment Period II|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
242331|NCT01078753|587651|P2|STARTED|Treatment Period II||44
242332|NCT01078753|587652|P1|STARTED|Treatment Period II|Desmopressin 120 µg - 4 participants Desmopressin 240 µg - 41 participants|45
242333|NCT01078753|587651|P2|NOT COMPLETED|Treatment Period I||0
242334|NCT01078753|587652|P1|NOT COMPLETED|Treatment Period I||0
242335|NCT01078753|587651|P2|COMPLETED|Treatment Period I||44
242336|NCT01078753|587652|P1|COMPLETED|Treatment Period I||45
242337|NCT01078753|587651|P2|Full Analysis Set|Treatment Period I||44
242338|NCT01078753|587652|P1|Full Analysis Set|Treatment Period I|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
242339|NCT01078753|587651|P2|STARTED|Treatment Period I||44
242340|NCT01078753|587652|P1|STARTED|Treatment Period I||45
242341|NCT01078675|587664|P2|NOT COMPLETED|Overall Study||6
242342|NCT01078675|587665|P1|NOT COMPLETED|Overall Study||68
242343|NCT01078675|587664|P2|COMPLETED|Overall Study|Healthy siblings did not participate in investigational product administration.|59
242344|NCT01078675|587665|P1|COMPLETED|Overall Study||182
242345|NCT01078675|587664|P2|Patients Treated|Overall Study||0
242346|NCT01078675|587665|P1|Patients Treated|Overall Study||198
242347|NCT01078675|587664|P2|STARTED|Overall Study||65
242348|NCT01078675|587665|P1|STARTED|Overall Study||250
242349|NCT01078662|587687|P5|NOT COMPLETED|Overall Study||11
242350|NCT01078662|587688|P4|NOT COMPLETED|Overall Study||7
242351|NCT01078662|587689|P3|NOT COMPLETED|Overall Study||21
242352|NCT01078662|587690|P2|NOT COMPLETED|Overall Study||168
242353|NCT01078662|587691|P1|NOT COMPLETED|Overall Study||58
242354|NCT01078662|587687|P5|COMPLETED|Overall Study||1
242355|NCT01078662|587688|P4|COMPLETED|Overall Study||1
242356|NCT01078662|587689|P3|COMPLETED|Overall Study||2
242357|NCT01078662|587690|P2|COMPLETED|Overall Study||25
242358|NCT01078662|587691|P1|COMPLETED|Overall Study||4
242359|NCT01078662|587687|P5|STARTED|Overall Study||12
242360|NCT01078662|587688|P4|STARTED|Overall Study||8
242361|NCT01078662|587689|P3|STARTED|Overall Study||23
242362|NCT01078662|587690|P2|STARTED|Overall Study||193
242363|NCT01078662|587691|P1|STARTED|Overall Study||62
242364|NCT01078623|587730|P20|NOT COMPLETED|Treatment Period 4||0
242365|NCT01078623|587731|P19|NOT COMPLETED|Treatment Period 4||0
242366|NCT01078623|587732|P18|NOT COMPLETED|Treatment Period 4||0
242367|NCT01078623|587733|P17|NOT COMPLETED|Treatment Period 4||0
242368|NCT01078623|587734|P16|NOT COMPLETED|Treatment Period 4||1
242369|NCT01078623|587735|P15|NOT COMPLETED|Treatment Period 4||0
242370|NCT01078623|587736|P14|NOT COMPLETED|Treatment Period 4||0
242371|NCT01078623|587737|P13|NOT COMPLETED|Treatment Period 4||0
242372|NCT01078623|587738|P12|NOT COMPLETED|Treatment Period 4||0
242373|NCT01078623|587739|P11|NOT COMPLETED|Treatment Period 4||0
242374|NCT01078623|587740|P10|NOT COMPLETED|Treatment Period 4||0
242375|NCT01078623|587741|P9|NOT COMPLETED|Treatment Period 4||0
242376|NCT01078623|587742|P8|NOT COMPLETED|Treatment Period 4||0
242377|NCT01078623|587743|P7|NOT COMPLETED|Treatment Period 4||0
242378|NCT01078623|587744|P6|NOT COMPLETED|Treatment Period 4||0
242379|NCT01078623|587745|P5|NOT COMPLETED|Treatment Period 4||0
242380|NCT01078623|587746|P4|NOT COMPLETED|Treatment Period 4||0
242381|NCT01078623|587747|P3|NOT COMPLETED|Treatment Period 4||1
242382|NCT01078623|587748|P2|NOT COMPLETED|Treatment Period 4||0
242383|NCT01078623|587749|P1|NOT COMPLETED|Treatment Period 4||0
242384|NCT01078623|587730|P20|COMPLETED|Treatment Period 4||7
242385|NCT01078623|587731|P19|COMPLETED|Treatment Period 4||6
242386|NCT01078623|587732|P18|COMPLETED|Treatment Period 4||7
242387|NCT01078623|587733|P17|COMPLETED|Treatment Period 4||7
242388|NCT01078623|587734|P16|COMPLETED|Treatment Period 4||6
242389|NCT01078623|587735|P15|COMPLETED|Treatment Period 4||7
242390|NCT01078623|587736|P14|COMPLETED|Treatment Period 4||6
242391|NCT01078623|587737|P13|COMPLETED|Treatment Period 4||7
242392|NCT01078623|587738|P12|COMPLETED|Treatment Period 4||7
242393|NCT01078623|587739|P11|COMPLETED|Treatment Period 4||6
242394|NCT01078623|587740|P10|COMPLETED|Treatment Period 4||6
242395|NCT01078623|587741|P9|COMPLETED|Treatment Period 4||5
242396|NCT01078623|587742|P8|COMPLETED|Treatment Period 4||6
242397|NCT01078623|587743|P7|COMPLETED|Treatment Period 4||5
242398|NCT01078623|587744|P6|COMPLETED|Treatment Period 4||4
242399|NCT01078623|587745|P5|COMPLETED|Treatment Period 4||6
242400|NCT01078623|587746|P4|COMPLETED|Treatment Period 4||6
242401|NCT01078623|587747|P3|COMPLETED|Treatment Period 4||5
242402|NCT01078623|587748|P2|COMPLETED|Treatment Period 4||5
242403|NCT01078623|587749|P1|COMPLETED|Treatment Period 4||5
242404|NCT01078623|587730|P20|STARTED|Treatment Period 4||7
242405|NCT01078623|587731|P19|STARTED|Treatment Period 4||6
242406|NCT01078623|587732|P18|STARTED|Treatment Period 4||7
242407|NCT01078623|587733|P17|STARTED|Treatment Period 4||7
242408|NCT01078623|587734|P16|STARTED|Treatment Period 4||7
242409|NCT01078623|587735|P15|STARTED|Treatment Period 4||7
242410|NCT01078623|587736|P14|STARTED|Treatment Period 4||6
242411|NCT01078623|587737|P13|STARTED|Treatment Period 4||7
242412|NCT01078623|587738|P12|STARTED|Treatment Period 4||7
242413|NCT01078623|587739|P11|STARTED|Treatment Period 4||6
242414|NCT01078623|587740|P10|STARTED|Treatment Period 4||6
242415|NCT01078623|587741|P9|STARTED|Treatment Period 4||5
242416|NCT01078623|587742|P8|STARTED|Treatment Period 4||6
242417|NCT01078623|587743|P7|STARTED|Treatment Period 4||5
242418|NCT01078623|587744|P6|STARTED|Treatment Period 4||4
242419|NCT01078623|587745|P5|STARTED|Treatment Period 4||6
242420|NCT01078623|587746|P4|STARTED|Treatment Period 4||6
242422|NCT01078623|587748|P2|STARTED|Treatment Period 4||5
242423|NCT01078623|587749|P1|STARTED|Treatment Period 4||5
242424|NCT01078623|587730|P20|NOT COMPLETED|Treatment Period 3||0
242425|NCT01078623|587731|P19|NOT COMPLETED|Treatment Period 3||0
242426|NCT01078623|587732|P18|NOT COMPLETED|Treatment Period 3||0
242427|NCT01078623|587733|P17|NOT COMPLETED|Treatment Period 3||0
242428|NCT01078623|587734|P16|NOT COMPLETED|Treatment Period 3||0
242429|NCT01078623|587735|P15|NOT COMPLETED|Treatment Period 3||0
242430|NCT01078623|587736|P14|NOT COMPLETED|Treatment Period 3||1
242431|NCT01078623|587737|P13|NOT COMPLETED|Treatment Period 3||0
242432|NCT01078623|587738|P12|NOT COMPLETED|Treatment Period 3||0
242433|NCT01078623|587739|P11|NOT COMPLETED|Treatment Period 3||0
242434|NCT01078623|587740|P10|NOT COMPLETED|Treatment Period 3||0
242435|NCT01078623|587741|P9|NOT COMPLETED|Treatment Period 3||0
242436|NCT01078623|587742|P8|NOT COMPLETED|Treatment Period 3||0
242437|NCT01078623|587743|P7|NOT COMPLETED|Treatment Period 3||0
242438|NCT01078623|587744|P6|NOT COMPLETED|Treatment Period 3||0
242439|NCT01078623|587745|P5|NOT COMPLETED|Treatment Period 3||1
242440|NCT01078623|587746|P4|NOT COMPLETED|Treatment Period 3||0
242441|NCT01078623|587747|P3|NOT COMPLETED|Treatment Period 3||0
242442|NCT01078623|587748|P2|NOT COMPLETED|Treatment Period 3||0
242443|NCT01078623|587749|P1|NOT COMPLETED|Treatment Period 3||0
242444|NCT01078623|587730|P20|COMPLETED|Treatment Period 3||7
242445|NCT01078623|587731|P19|COMPLETED|Treatment Period 3||6
242446|NCT01078623|587732|P18|COMPLETED|Treatment Period 3||7
242447|NCT01078623|587733|P17|COMPLETED|Treatment Period 3||7
242448|NCT01078623|587734|P16|COMPLETED|Treatment Period 3||7
242449|NCT01078623|587735|P15|COMPLETED|Treatment Period 3||7
242450|NCT01078623|587736|P14|COMPLETED|Treatment Period 3||6
242451|NCT01078623|587737|P13|COMPLETED|Treatment Period 3||7
242452|NCT01078623|587738|P12|COMPLETED|Treatment Period 3||7
242453|NCT01078623|587739|P11|COMPLETED|Treatment Period 3||6
242454|NCT01078623|587740|P10|COMPLETED|Treatment Period 3||6
242455|NCT01078623|587741|P9|COMPLETED|Treatment Period 3||5
242456|NCT01078623|587742|P8|COMPLETED|Treatment Period 3||6
242457|NCT01078623|587743|P7|COMPLETED|Treatment Period 3||5
242458|NCT01078623|587744|P6|COMPLETED|Treatment Period 3||4
242459|NCT01078623|587745|P5|COMPLETED|Treatment Period 3||6
242460|NCT01078623|587746|P4|COMPLETED|Treatment Period 3||6
242461|NCT01078623|587747|P3|COMPLETED|Treatment Period 3||6
242462|NCT01078623|587748|P2|COMPLETED|Treatment Period 3||5
242463|NCT01078623|587749|P1|COMPLETED|Treatment Period 3||5
242464|NCT01078623|587730|P20|STARTED|Treatment Period 3||7
242465|NCT01078623|587731|P19|STARTED|Treatment Period 3||6
242466|NCT01078623|587732|P18|STARTED|Treatment Period 3||7
242467|NCT01078623|587733|P17|STARTED|Treatment Period 3||7
242468|NCT01078623|587734|P16|STARTED|Treatment Period 3||7
242469|NCT01078623|587735|P15|STARTED|Treatment Period 3||7
242470|NCT01078623|587736|P14|STARTED|Treatment Period 3||7
242471|NCT01078623|587737|P13|STARTED|Treatment Period 3||7
242472|NCT01078623|587738|P12|STARTED|Treatment Period 3||7
242473|NCT01078623|587739|P11|STARTED|Treatment Period 3||6
242474|NCT01078623|587740|P10|STARTED|Treatment Period 3||6
242475|NCT01078623|587741|P9|STARTED|Treatment Period 3||5
242476|NCT01078623|587742|P8|STARTED|Treatment Period 3||6
242477|NCT01078623|587743|P7|STARTED|Treatment Period 3||5
242478|NCT01078623|587744|P6|STARTED|Treatment Period 3||4
242479|NCT01078623|587745|P5|STARTED|Treatment Period 3||7
242480|NCT01078623|587746|P4|STARTED|Treatment Period 3||6
242481|NCT01078623|587747|P3|STARTED|Treatment Period 3||6
242482|NCT01078623|587748|P2|STARTED|Treatment Period 3||5
242483|NCT01078623|587749|P1|STARTED|Treatment Period 3||5
242484|NCT01078623|587730|P20|NOT COMPLETED|Treatment Period 2||0
242485|NCT01078623|587731|P19|NOT COMPLETED|Treatment Period 2||1
242486|NCT01078623|587732|P18|NOT COMPLETED|Treatment Period 2||0
242487|NCT01078623|587733|P17|NOT COMPLETED|Treatment Period 2||0
242488|NCT01078623|587734|P16|NOT COMPLETED|Treatment Period 2||0
242489|NCT01078623|587735|P15|NOT COMPLETED|Treatment Period 2||0
242490|NCT01078623|587736|P14|NOT COMPLETED|Treatment Period 2||0
242491|NCT01078623|587737|P13|NOT COMPLETED|Treatment Period 2||0
242492|NCT01078623|587738|P12|NOT COMPLETED|Treatment Period 2||0
242493|NCT01078623|587739|P11|NOT COMPLETED|Treatment Period 2||0
242494|NCT01078623|587740|P10|NOT COMPLETED|Treatment Period 2||0
242495|NCT01078623|587741|P9|NOT COMPLETED|Treatment Period 2||0
242496|NCT01078623|587742|P8|NOT COMPLETED|Treatment Period 2||0
242497|NCT01078623|587743|P7|NOT COMPLETED|Treatment Period 2||1
242498|NCT01078623|587744|P6|NOT COMPLETED|Treatment Period 2||1
242499|NCT01078623|587745|P5|NOT COMPLETED|Treatment Period 2||0
242500|NCT01078623|587746|P4|NOT COMPLETED|Treatment Period 2||0
242501|NCT01078623|587747|P3|NOT COMPLETED|Treatment Period 2||0
242502|NCT01078623|587748|P2|NOT COMPLETED|Treatment Period 2||0
242503|NCT01078623|587749|P1|NOT COMPLETED|Treatment Period 2||0
242504|NCT01078623|587730|P20|COMPLETED|Treatment Period 2||7
242505|NCT01078623|587731|P19|COMPLETED|Treatment Period 2||6
242506|NCT01078623|587732|P18|COMPLETED|Treatment Period 2||7
242507|NCT01078623|587733|P17|COMPLETED|Treatment Period 2||7
242508|NCT01078623|587734|P16|COMPLETED|Treatment Period 2||7
242509|NCT01078623|587735|P15|COMPLETED|Treatment Period 2||7
242510|NCT01078623|587736|P14|COMPLETED|Treatment Period 2||7
242511|NCT01078623|587737|P13|COMPLETED|Treatment Period 2||7
242512|NCT01078623|587738|P12|COMPLETED|Treatment Period 2||7
242513|NCT01078623|587739|P11|COMPLETED|Treatment Period 2||6
242514|NCT01078623|587740|P10|COMPLETED|Treatment Period 2||6
242515|NCT01078623|587741|P9|COMPLETED|Treatment Period 2||5
242516|NCT01078623|587742|P8|COMPLETED|Treatment Period 2||6
242517|NCT01078623|587743|P7|COMPLETED|Treatment Period 2||5
242518|NCT01078623|587744|P6|COMPLETED|Treatment Period 2||4
242519|NCT01078623|587745|P5|COMPLETED|Treatment Period 2||7
242520|NCT01078623|587746|P4|COMPLETED|Treatment Period 2||6
242521|NCT01078623|587747|P3|COMPLETED|Treatment Period 2||6
242522|NCT01078623|587748|P2|COMPLETED|Treatment Period 2||5
242523|NCT01078623|587749|P1|COMPLETED|Treatment Period 2||5
242524|NCT01078623|587730|P20|STARTED|Treatment Period 2||7
242525|NCT01078623|587731|P19|STARTED|Treatment Period 2||7
242526|NCT01078623|587732|P18|STARTED|Treatment Period 2||7
242527|NCT01078623|587733|P17|STARTED|Treatment Period 2||7
242528|NCT01078623|587734|P16|STARTED|Treatment Period 2||7
242529|NCT01078623|587735|P15|STARTED|Treatment Period 2||7
242530|NCT01078623|587736|P14|STARTED|Treatment Period 2||7
242531|NCT01078623|587737|P13|STARTED|Treatment Period 2||7
242532|NCT01078623|587738|P12|STARTED|Treatment Period 2||7
242533|NCT01078623|587739|P11|STARTED|Treatment Period 2||6
242534|NCT01078623|587740|P10|STARTED|Treatment Period 2||6
242535|NCT01078623|587741|P9|STARTED|Treatment Period 2||5
242536|NCT01078623|587742|P8|STARTED|Treatment Period 2||6
242537|NCT01078623|587743|P7|STARTED|Treatment Period 2||6
242538|NCT01078623|587744|P6|STARTED|Treatment Period 2||5
242539|NCT01078623|587745|P5|STARTED|Treatment Period 2||7
242540|NCT01078623|587746|P4|STARTED|Treatment Period 2||6
242541|NCT01078623|587747|P3|STARTED|Treatment Period 2||6
242542|NCT01078623|587748|P2|STARTED|Treatment Period 2||5
242543|NCT01078623|587749|P1|STARTED|Treatment Period 2||5
242544|NCT01078623|587730|P20|NOT COMPLETED|Treatment Period 1||0
242545|NCT01078623|587731|P19|NOT COMPLETED|Treatment Period 1||0
242546|NCT01078623|587732|P18|NOT COMPLETED|Treatment Period 1||0
242547|NCT01078623|587733|P17|NOT COMPLETED|Treatment Period 1||0
242548|NCT01078623|587734|P16|NOT COMPLETED|Treatment Period 1||0
242549|NCT01078623|587735|P15|NOT COMPLETED|Treatment Period 1||0
242550|NCT01078623|587736|P14|NOT COMPLETED|Treatment Period 1||0
242551|NCT01078623|587737|P13|NOT COMPLETED|Treatment Period 1||0
242552|NCT01078623|587738|P12|NOT COMPLETED|Treatment Period 1||0
242553|NCT01078623|587739|P11|NOT COMPLETED|Treatment Period 1||1
242554|NCT01078623|587740|P10|NOT COMPLETED|Treatment Period 1||1
242555|NCT01078623|587741|P9|NOT COMPLETED|Treatment Period 1||1
242556|NCT01078623|587742|P8|NOT COMPLETED|Treatment Period 1||1
242557|NCT01078623|587743|P7|NOT COMPLETED|Treatment Period 1||1
242558|NCT01078623|587744|P6|NOT COMPLETED|Treatment Period 1||1
242559|NCT01078623|587745|P5|NOT COMPLETED|Treatment Period 1||0
242560|NCT01078623|587746|P4|NOT COMPLETED|Treatment Period 1||0
242561|NCT01078623|587747|P3|NOT COMPLETED|Treatment Period 1||1
242562|NCT01078623|587748|P2|NOT COMPLETED|Treatment Period 1||1
242563|NCT01078623|587749|P1|NOT COMPLETED|Treatment Period 1||1
242564|NCT01078623|587730|P20|COMPLETED|Treatment Period 1||7
242565|NCT01078623|587731|P19|COMPLETED|Treatment Period 1||7
242566|NCT01078623|587732|P18|COMPLETED|Treatment Period 1||7
242567|NCT01078623|587733|P17|COMPLETED|Treatment Period 1||7
242568|NCT01078623|587734|P16|COMPLETED|Treatment Period 1||7
242569|NCT01078623|587735|P15|COMPLETED|Treatment Period 1||7
242570|NCT01078623|587736|P14|COMPLETED|Treatment Period 1||7
242571|NCT01078623|587737|P13|COMPLETED|Treatment Period 1||7
242572|NCT01078623|587738|P12|COMPLETED|Treatment Period 1||7
242573|NCT01078623|587739|P11|COMPLETED|Treatment Period 1||6
242574|NCT01078623|587740|P10|COMPLETED|Treatment Period 1||6
242575|NCT01078623|587741|P9|COMPLETED|Treatment Period 1||5
242576|NCT01078623|587742|P8|COMPLETED|Treatment Period 1||6
242577|NCT01078623|587743|P7|COMPLETED|Treatment Period 1||6
242578|NCT01078623|587744|P6|COMPLETED|Treatment Period 1||5
242579|NCT01078623|587745|P5|COMPLETED|Treatment Period 1||7
242580|NCT01078623|587746|P4|COMPLETED|Treatment Period 1||6
242581|NCT01078623|587747|P3|COMPLETED|Treatment Period 1||6
242582|NCT01078623|587748|P2|COMPLETED|Treatment Period 1||5
242583|NCT01078623|587749|P1|COMPLETED|Treatment Period 1||5
242584|NCT01078623|587730|P20|STARTED|Treatment Period 1||7
242585|NCT01078623|587731|P19|STARTED|Treatment Period 1||7
242586|NCT01078623|587732|P18|STARTED|Treatment Period 1||7
242587|NCT01078623|587733|P17|STARTED|Treatment Period 1||7
242588|NCT01078623|587734|P16|STARTED|Treatment Period 1||7
242589|NCT01078623|587735|P15|STARTED|Treatment Period 1||7
242590|NCT01078623|587736|P14|STARTED|Treatment Period 1||7
242591|NCT01078623|587737|P13|STARTED|Treatment Period 1||7
242592|NCT01078623|587738|P12|STARTED|Treatment Period 1||7
242593|NCT01078623|587739|P11|STARTED|Treatment Period 1||7
242594|NCT01078623|587740|P10|STARTED|Treatment Period 1||7
242595|NCT01078623|587741|P9|STARTED|Treatment Period 1||6
242596|NCT01078623|587742|P8|STARTED|Treatment Period 1||7
242597|NCT01078623|587743|P7|STARTED|Treatment Period 1||7
242598|NCT01078623|587744|P6|STARTED|Treatment Period 1||6
242599|NCT01078623|587745|P5|STARTED|Treatment Period 1||7
242600|NCT01078623|587746|P4|STARTED|Treatment Period 1||6
242601|NCT01078623|587747|P3|STARTED|Treatment Period 1||7
242602|NCT01078623|587748|P2|STARTED|Treatment Period 1||6
242603|NCT01078623|587749|P1|STARTED|Treatment Period 1||6
242604|NCT01078584|587771|P1|NOT COMPLETED|Overall Study||3010
242605|NCT01078584|587771|P1|COMPLETED|Overall Study||4983
242606|NCT01078584|587771|P1|Participants Conducted Visit 4(12-month)|Overall Study||4983
242607|NCT01078584|587771|P1|Participants Conducted Visit 3 (6-month)|Overall Study||5833
242608|NCT01078584|587771|P1|Participants Conducted Visit 2 (3-month)|Overall Study||7125
242609|NCT01078584|587771|P1|STARTED|Overall Study||7993
242610|NCT01078571|587852|P1|NOT COMPLETED|Overall Study||115
242611|NCT01078571|587852|P1|COMPLETED|Overall Study||590
242612|NCT01078571|587852|P1|Intent-to-treat (ITT) Population|Overall Study||591
242613|NCT01078571|587852|P1|Safety Population|Overall Study||675
242614|NCT01078571|587852|P1|STARTED|Overall Study||705
242615|NCT01078558|587871|P3|NOT COMPLETED|Overall Study||1361
242616|NCT01078558|587872|P2|NOT COMPLETED|Overall Study||755
242617|NCT01078558|587873|P1|NOT COMPLETED|Overall Study||2018
242618|NCT01078558|587871|P3|COMPLETED|Overall Study||596
242619|NCT01078558|587872|P2|COMPLETED|Overall Study||372
242620|NCT01078558|587873|P1|COMPLETED|Overall Study||818
242621|NCT01078558|587871|P3|Oligoarticular PsA|Overall Study||0
242622|NCT01078558|587872|P2|Oligoarticular PsA|Overall Study||197
242623|NCT01078558|587873|P1|Oligoarticular PsA|Overall Study||0
242624|NCT01078558|587871|P3|STARTED|Overall Study||1957
242625|NCT01078558|587872|P2|STARTED|Overall Study||1127
242626|NCT01078558|587873|P1|STARTED|Overall Study||2836
242627|NCT01078545|587903|P1|NOT COMPLETED|Overall Study||26
242628|NCT01078545|587903|P1|COMPLETED|Overall Study||703
242629|NCT01078545|587903|P1|Per Protocol Population|Overall Study||661
242630|NCT01078545|587903|P1|Intent-to-treat Population|Overall Study||729
242631|NCT01078545|587903|P1|STARTED|Overall Study||729
242632|NCT01078454|587913|P2|NOT COMPLETED|Overall Study||2
242633|NCT01078454|587914|P1|NOT COMPLETED|Overall Study||1
242634|NCT01078454|587913|P2|COMPLETED|Overall Study||3
242635|NCT01078454|587914|P1|COMPLETED|Overall Study||5
242636|NCT01078454|587913|P2|STARTED|Overall Study||5
242637|NCT01078454|587914|P1|STARTED|Overall Study||6
242638|NCT01078441|587920|P1|NOT COMPLETED|Overall Study||1
242639|NCT01078441|587920|P1|COMPLETED|Overall Study||1
242640|NCT01078441|587920|P1|STARTED|Overall Study||2
242641|NCT01078402|587927|P3|NOT COMPLETED|Overall Study||68
242642|NCT01078402|587928|P2|NOT COMPLETED|Overall Study||29
242643|NCT01078402|587929|P1|NOT COMPLETED|Overall Study||107
242644|NCT01078402|587927|P3|COMPLETED|Overall Study||166
242645|NCT01078402|587928|P2|COMPLETED|Overall Study||95
242646|NCT01078402|587929|P1|COMPLETED|Overall Study||324
242647|NCT01078402|587927|P3|STARTED|Overall Study||234
242648|NCT01078402|587928|P2|STARTED|Overall Study||124
242649|NCT01078402|587929|P1|STARTED|Overall Study||431
242650|NCT01078389|587960|P2|NOT COMPLETED|Overall Study||67
242651|NCT01078389|587961|P1|NOT COMPLETED|Overall Study||64
242652|NCT01078389|587960|P2|COMPLETED|Overall Study||90
242653|NCT01078389|587961|P1|COMPLETED|Overall Study||93
242654|NCT01078389|587960|P2|STARTED|Overall Study||157
242655|NCT01078389|587961|P1|STARTED|Overall Study||157
242656|NCT01078376|587979|P4|NOT COMPLETED|Overall Study||0
242657|NCT01078376|587980|P3|NOT COMPLETED|Overall Study||0
242658|NCT01078376|587981|P2|NOT COMPLETED|Overall Study||0
242659|NCT01078376|587982|P1|NOT COMPLETED|Overall Study||0
242660|NCT01078376|587979|P4|COMPLETED|Overall Study||3
242661|NCT01078376|587980|P3|COMPLETED|Overall Study||8
242662|NCT01078376|587981|P2|COMPLETED|Overall Study||9
242663|NCT01078376|587982|P1|COMPLETED|Overall Study||9
242664|NCT01078376|587979|P4|STARTED|Overall Study||3
242665|NCT01078376|587980|P3|STARTED|Overall Study||8
242666|NCT01078376|587981|P2|STARTED|Overall Study||9
242667|NCT01078376|587982|P1|STARTED|Overall Study||9
242668|NCT01078363|588103|P2|NOT COMPLETED|Overall Study||0
242669|NCT01078363|588104|P1|NOT COMPLETED|Overall Study||0
242670|NCT01078363|588103|P2|COMPLETED|Overall Study||49
242671|NCT01078363|588104|P1|COMPLETED|Overall Study||47
242672|NCT01078363|588103|P2|STARTED|Overall Study||49
242673|NCT01078363|588104|P1|STARTED|Overall Study||47
242674|NCT01078298|588122|P2|NOT COMPLETED|Overall Study||90
242675|NCT01078298|588123|P1|NOT COMPLETED|Overall Study||81
242676|NCT01078298|588122|P2|COMPLETED|Overall Study||179
242677|NCT01078298|588123|P1|COMPLETED|Overall Study||175
242678|NCT01078298|588122|P2|STARTED|Overall Study||269
242679|NCT01078298|588123|P1|STARTED|Overall Study||256
242680|NCT01078246|588156|P7|NOT COMPLETED|Overall Study||0
242681|NCT01078246|588157|P6|NOT COMPLETED|Overall Study||0
242682|NCT01078246|588158|P5|NOT COMPLETED|Overall Study||0
242683|NCT01078246|588159|P4|NOT COMPLETED|Overall Study||0
242684|NCT01078246|588160|P3|NOT COMPLETED|Overall Study||0
242685|NCT01078246|588161|P2|NOT COMPLETED|Overall Study||0
242686|NCT01078246|588162|P1|NOT COMPLETED|Overall Study||0
242687|NCT01078246|588156|P7|COMPLETED|Overall Study||22
242688|NCT01078246|588157|P6|COMPLETED|Overall Study||231
242689|NCT01078246|588158|P5|COMPLETED|Overall Study||3310
242690|NCT01078246|588159|P4|COMPLETED|Overall Study||152
242691|NCT01078246|588160|P3|COMPLETED|Overall Study||1963
242692|NCT01078246|588161|P2|COMPLETED|Overall Study||405
242693|NCT01078246|588162|P1|COMPLETED|Overall Study||1041
242694|NCT01078246|588156|P7|STARTED|Overall Study||22
242695|NCT01078246|588157|P6|STARTED|Overall Study||231
242696|NCT01078246|588158|P5|STARTED|Overall Study||3310
242697|NCT01078246|588159|P4|STARTED|Overall Study||152
242698|NCT01078246|588160|P3|STARTED|Overall Study||1963
242699|NCT01078246|588161|P2|STARTED|Overall Study||405
242700|NCT01078246|588162|P1|STARTED|Overall Study||1041
242701|NCT01078233|588194|P6|NOT COMPLETED|Overall Study||0
242702|NCT01078233|588195|P5|NOT COMPLETED|Overall Study||0
242703|NCT01078233|588196|P4|NOT COMPLETED|Overall Study||0
242704|NCT01078233|588197|P3|NOT COMPLETED|Overall Study||0
242705|NCT01078233|588198|P2|NOT COMPLETED|Overall Study||0
242706|NCT01078233|588199|P1|NOT COMPLETED|Overall Study||0
242707|NCT01078233|588194|P6|COMPLETED|Overall Study||154
242708|NCT01078233|588195|P5|COMPLETED|Overall Study||3199
242709|NCT01078233|588196|P4|COMPLETED|Overall Study||631
242710|NCT01078233|588197|P3|COMPLETED|Overall Study||1681
242711|NCT01078233|588198|P2|COMPLETED|Overall Study||296
242712|NCT01078233|588199|P1|COMPLETED|Overall Study||656
242713|NCT01078233|588194|P6|STARTED|Overall Study||154
242714|NCT01078233|588195|P5|STARTED|Overall Study||3199
242715|NCT01078233|588196|P4|STARTED|Overall Study||631
242716|NCT01078233|588197|P3|STARTED|Overall Study||1681
242717|NCT01078233|588198|P2|STARTED|Overall Study||296
242718|NCT01078233|588199|P1|STARTED|Overall Study||656
242719|NCT01078220|588216|P1|NOT COMPLETED|Overall Study||0
242720|NCT01078220|588216|P1|COMPLETED|Overall Study||189629
242721|NCT01078220|588216|P1|STARTED|Overall Study||189629
242722|NCT01078207|588226|P1|NOT COMPLETED|Overall Study||0
242723|NCT01078207|588226|P1|COMPLETED|Overall Study||100
242724|NCT01078207|588226|P1|STARTED|Overall Study||100
242725|NCT01078168|588233|P2|NOT COMPLETED|Overall Study||1
242726|NCT01078168|588234|P1|NOT COMPLETED|Overall Study||0
242727|NCT01078168|588233|P2|COMPLETED|Overall Study||10
242728|NCT01078168|588234|P1|COMPLETED|Overall Study||11
242729|NCT01078168|588233|P2|STARTED|Overall Study||11
242730|NCT01078168|588234|P1|STARTED|Overall Study||11
242731|NCT01078155|588240|P1|NOT COMPLETED|Overall Study||44
242732|NCT01078155|588240|P1|COMPLETED|Overall Study||87
242733|NCT01078155|588240|P1|STARTED|Overall Study||131
242734|NCT01078116|588256|P1|NOT COMPLETED|Overall Study||48
242735|NCT01078116|588256|P1|COMPLETED|Overall Study||76
242736|NCT01078116|588256|P1|STARTED|Overall Study|121 participants were included in analysis (3 were excluded due to missing case report form data).|124
242737|NCT01078090|588264|P1|NOT COMPLETED|Overall Study||4593
242738|NCT01078090|588264|P1|COMPLETED|Overall Study||1152
242739|NCT01078090|588264|P1|STARTED|Overall Study||5745
242740|NCT01077973|588308|P3|NOT COMPLETED|Overall Study||0
242741|NCT01077973|588309|P2|NOT COMPLETED|Overall Study||0
242742|NCT01077973|588310|P1|NOT COMPLETED|Overall Study||0
242743|NCT01077973|588308|P3|COMPLETED|Overall Study||80
242744|NCT01077973|588309|P2|COMPLETED|Overall Study||79
242745|NCT01077973|588310|P1|COMPLETED|Overall Study||41
242746|NCT01077973|588308|P3|STARTED|Overall Study||80
242747|NCT01077973|588309|P2|STARTED|Overall Study||79
242748|NCT01077973|588310|P1|STARTED|Overall Study||41
242749|NCT01077960|588358|P1|NOT COMPLETED|Overall Study||16
242750|NCT01077960|588358|P1|COMPLETED|Overall Study|Modified Intent To Treat (ITT) Population|110
242751|NCT01077960|588358|P1|STARTED|Overall Study|130 subjects consented to participate, 129 enrolled in the study, and 126 received study drug|126
242752|NCT01077921|588369|P2|NOT COMPLETED|Second Intervention||1
242753|NCT01077921|588370|P1|NOT COMPLETED|Second Intervention||0
242754|NCT01077921|588369|P2|COMPLETED|Second Intervention||9
242755|NCT01077921|588370|P1|COMPLETED|Second Intervention||13
242756|NCT01077921|588369|P2|STARTED|Second Intervention||10
242757|NCT01077921|588370|P1|STARTED|Second Intervention||13
242758|NCT01077921|588369|P2|NOT COMPLETED|Washout||2
242759|NCT01077921|588370|P1|NOT COMPLETED|Washout||0
242760|NCT01077921|588369|P2|COMPLETED|Washout||10
242761|NCT01077921|588370|P1|COMPLETED|Washout||13
242762|NCT01077921|588369|P2|STARTED|Washout||12
242763|NCT01077921|588370|P1|STARTED|Washout||13
242764|NCT01077921|588369|P2|NOT COMPLETED|First Intervention||1
242765|NCT01077921|588370|P1|NOT COMPLETED|First Intervention||1
242766|NCT01077921|588369|P2|COMPLETED|First Intervention||12
242767|NCT01077921|588370|P1|COMPLETED|First Intervention||13
242768|NCT01077921|588369|P2|STARTED|First Intervention||13
242769|NCT01077921|588370|P1|STARTED|First Intervention||14
242770|NCT01077856|588403|P3|NOT COMPLETED|Overall Study||0
242771|NCT01077856|588404|P2|NOT COMPLETED|Overall Study||0
242772|NCT01077856|588405|P1|NOT COMPLETED|Overall Study||0
242773|NCT01077856|588403|P3|COMPLETED|Overall Study||15713
242774|NCT01077856|588404|P2|COMPLETED|Overall Study||16604
242775|NCT01077856|588405|P1|COMPLETED|Overall Study||22199
242776|NCT01077856|588403|P3|STARTED|Overall Study||15713
242777|NCT01077856|588404|P2|STARTED|Overall Study||16604
242778|NCT01077856|588405|P1|STARTED|Overall Study||22199
242779|NCT01077830|588586|P2|NOT COMPLETED|Overall Study||0
242780|NCT01077830|588587|P1|NOT COMPLETED|Overall Study||0
242781|NCT01077830|588586|P2|COMPLETED|Overall Study||682
242782|NCT01077830|588587|P1|COMPLETED|Overall Study||677
242783|NCT01077830|588586|P2|STARTED|Overall Study||682
242784|NCT01077830|588587|P1|STARTED|Overall Study||677
242785|NCT01077817|588597|P1|NOT COMPLETED|Overall Study||0
242786|NCT01077817|588597|P1|COMPLETED|Overall Study||684815
242787|NCT01077817|588597|P1|STARTED|Overall Study|STARTED and COMPLETED is the number of participants meeting incl./excl. criteria in the GPRD.|684815
242788|NCT01077804|588608|P1|NOT COMPLETED|Overall Study||199
242789|NCT01077804|588608|P1|COMPLETED|Overall Study||7386
242790|NCT01077804|588608|P1|STARTED|Overall Study||7585
242791|NCT01077739|588617|P2|NOT COMPLETED|Overall Study||10
242792|NCT01077739|588618|P1|NOT COMPLETED|Overall Study||5
242793|NCT01077739|588617|P2|COMPLETED|Overall Study||40
242794|NCT01077739|588618|P1|COMPLETED|Overall Study||20
242795|NCT01077739|588617|P2|STARTED|Overall Study||50
242796|NCT01077739|588618|P1|STARTED|Overall Study||25
242797|NCT01077713|588632|P2|NOT COMPLETED|Overall Study||36
242798|NCT01077713|588633|P1|NOT COMPLETED|Overall Study||36
242799|NCT01077713|588632|P2|COMPLETED|Overall Study||6
242800|NCT01077713|588633|P1|COMPLETED|Overall Study||8
242801|NCT01077713|588632|P2|STARTED|Overall Study||42
242802|NCT01077713|588633|P1|STARTED|Overall Study||44
242803|NCT01077622|588657|P1|NOT COMPLETED|Overall Study||3
242804|NCT01077622|588657|P1|COMPLETED|Overall Study||7
242805|NCT01077622|588657|P1|STARTED|Overall Study||10
242806|NCT01077596|588715|P12|NOT COMPLETED|Overall Study||0
242807|NCT01077596|588716|P11|NOT COMPLETED|Overall Study||0
242808|NCT01077596|588717|P10|NOT COMPLETED|Overall Study||0
242809|NCT01077596|588718|P9|NOT COMPLETED|Overall Study||0
242810|NCT01077596|588719|P8|NOT COMPLETED|Overall Study||0
242811|NCT01077596|588720|P7|NOT COMPLETED|Overall Study||0
242812|NCT01077596|588721|P6|NOT COMPLETED|Overall Study||0
242813|NCT01077596|588722|P5|NOT COMPLETED|Overall Study||0
242814|NCT01077596|588723|P4|NOT COMPLETED|Overall Study||0
242815|NCT01077596|588724|P3|NOT COMPLETED|Overall Study||0
242816|NCT01077596|588725|P2|NOT COMPLETED|Overall Study||0
242817|NCT01077596|588726|P1|NOT COMPLETED|Overall Study||0
242818|NCT01077596|588715|P12|COMPLETED|Overall Study||22150
242819|NCT01077596|588716|P11|COMPLETED|Overall Study||2215
242820|NCT01077596|588717|P10|COMPLETED|Overall Study||28420
242821|NCT01077596|588718|P9|COMPLETED|Overall Study||2842
242822|NCT01077596|588719|P8|COMPLETED|Overall Study||837
242823|NCT01077596|588720|P7|COMPLETED|Overall Study||308
242824|NCT01077596|588721|P6|COMPLETED|Overall Study||882
242825|NCT01077596|588722|P5|COMPLETED|Overall Study||294
242826|NCT01077596|588723|P4|COMPLETED|Overall Study||1370
242827|NCT01077596|588724|P3|COMPLETED|Overall Study||457
242828|NCT01077596|588725|P2|COMPLETED|Overall Study||1050
242829|NCT01077596|588726|P1|COMPLETED|Overall Study||350
242830|NCT01077596|588715|P12|STARTED|Overall Study||22150
242831|NCT01077596|588716|P11|STARTED|Overall Study||2215
242832|NCT01077596|588717|P10|STARTED|Overall Study||28420
242833|NCT01077596|588718|P9|STARTED|Overall Study||2842
242834|NCT01077596|588719|P8|STARTED|Overall Study||837
242835|NCT01077596|588720|P7|STARTED|Overall Study||308
242836|NCT01077596|588721|P6|STARTED|Overall Study||882
242837|NCT01077596|588722|P5|STARTED|Overall Study||294
242838|NCT01077596|588723|P4|STARTED|Overall Study||1370
242839|NCT01077596|588724|P3|STARTED|Overall Study||457
242840|NCT01077596|588725|P2|STARTED|Overall Study||1050
242841|NCT01077596|588726|P1|STARTED|Overall Study||350
242842|NCT01077544|588777|P2|NOT COMPLETED|Overall Study||5
242843|NCT01077544|588778|P1|NOT COMPLETED|Overall Study||3
242844|NCT01077544|588777|P2|COMPLETED|Overall Study||2
242845|NCT01077544|588778|P1|COMPLETED|Overall Study||5
242846|NCT01077544|588777|P2|STARTED|Overall Study||7
242847|NCT01077544|588778|P1|STARTED|Overall Study||8
242848|NCT01077401|588806|P2|NOT COMPLETED|Overall Study||21
242849|NCT01077401|588807|P1|NOT COMPLETED|Overall Study||18
242850|NCT01077401|588806|P2|COMPLETED|Overall Study||54
242851|NCT01077401|588807|P1|COMPLETED|Overall Study||59
242852|NCT01077401|588806|P2|STARTED|Overall Study||75
242853|NCT01077401|588807|P1|STARTED|Overall Study||77
242854|NCT01077375|588819|P2|NOT COMPLETED|Overall Study||35
242855|NCT01077375|588820|P1|NOT COMPLETED|Overall Study||10
242856|NCT01077375|588819|P2|COMPLETED|Overall Study||51
242857|NCT01077375|588820|P1|COMPLETED|Overall Study||11
242858|NCT01077375|588819|P2|STARTED|Overall Study|One randomized patient not taking study drug was excluded from the Double-blind Safety Population.|86
242859|NCT01077375|588820|P1|STARTED|Overall Study||21
242860|NCT01077362|588831|P3|NOT COMPLETED|Overall Study||24
242861|NCT01077362|588832|P2|NOT COMPLETED|Overall Study||19
242862|NCT01077362|588833|P1|NOT COMPLETED|Overall Study||31
242863|NCT01077362|588831|P3|COMPLETED|Overall Study||81
242864|NCT01077362|588832|P2|COMPLETED|Overall Study||84
242865|NCT01077362|588833|P1|COMPLETED|Overall Study||73
242866|NCT01077362|588831|P3|STARTED|Overall Study||105
242867|NCT01077362|588832|P2|STARTED|Overall Study||103
242868|NCT01077362|588833|P1|STARTED|Overall Study||104
242869|NCT01077323|588869|P3|NOT COMPLETED|Overall Study||11912089
242870|NCT01077323|588870|P2|NOT COMPLETED|Overall Study||386263
242871|NCT01077323|588871|P1|NOT COMPLETED|Overall Study||11378
242872|NCT01077323|588869|P3|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|103511
242873|NCT01077323|588870|P2|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|234536
242874|NCT01077323|588871|P1|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|25719
242875|NCT01077323|588869|P3|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|12015600
242876|NCT01077323|588870|P2|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|620799
242877|NCT01077323|588871|P1|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|37097
242878|NCT01077310|588890|P2|NOT COMPLETED|Overall Study||0
242879|NCT01077310|588891|P1|NOT COMPLETED|Overall Study||0
242880|NCT01077310|588890|P2|COMPLETED|Overall Study||33
242881|NCT01077310|588891|P1|COMPLETED|Overall Study||67
242882|NCT01077310|588890|P2|STARTED|Overall Study||33
242883|NCT01077310|588891|P1|STARTED|Overall Study||67
242884|NCT01077284|588914|P3|NOT COMPLETED|Overall Study||3
242885|NCT01077284|588915|P2|NOT COMPLETED|Overall Study||5
242886|NCT01077284|588916|P1|NOT COMPLETED|Overall Study||5
242887|NCT01077284|588914|P3|COMPLETED|Overall Study||30
242888|NCT01077284|588915|P2|COMPLETED|Overall Study||28
242889|NCT01077284|588916|P1|COMPLETED|Overall Study||28
242890|NCT01077284|588914|P3|STARTED|Overall Study||33
242891|NCT01077284|588915|P2|STARTED|Overall Study||33
242892|NCT01077284|588916|P1|STARTED|Overall Study||33
242893|NCT01077271|588937|P1|NOT COMPLETED|Overall Study||22
242894|NCT01077271|588937|P1|COMPLETED|Overall Study||102
242895|NCT01077271|588937|P1|Number of Participants Analyzed|Overall Study||120
242896|NCT01077271|588937|P1|Participants Treated With Palivizumab|Overall Study||120
242897|NCT01077271|588937|P1|STARTED|Overall Study||124
242898|NCT01077258|588975|P1|NOT COMPLETED|Overall Study||2568
242899|NCT01077258|588975|P1|COMPLETED|Overall Study||1640
242900|NCT01077258|588975|P1|STARTED|Overall Study||4208
242901|NCT01077193|589011|P1|NOT COMPLETED|Overall Study||44
242902|NCT01077193|589011|P1|COMPLETED|Overall Study||0
242903|NCT01077193|589011|P1|STARTED|Overall Study||44
242904|NCT01077154|589017|P2|NOT COMPLETED|Overall Study||2228
242905|NCT01077154|589018|P1|NOT COMPLETED|Overall Study||2226
242906|NCT01077154|589017|P2|COMPLETED|Overall Study||28
242907|NCT01077154|589018|P1|COMPLETED|Overall Study||27
242908|NCT01077154|589017|P2|Received Study Drug|Overall Study||2230
242909|NCT01077154|589018|P1|Received Study Drug|Overall Study||2229
242910|NCT01077154|589017|P2|STARTED|Overall Study||2256
242911|NCT01077154|589018|P1|STARTED|Overall Study||2253
242912|NCT01077128|589032|P1|NOT COMPLETED|Overall Study||67
242913|NCT01077128|589032|P1|COMPLETED|Overall Study||433
242914|NCT01077128|589032|P1|STARTED|Overall Study||500
242915|NCT01077076|589090|P6|NOT COMPLETED|Third Intervention||1
242916|NCT01077076|589091|P5|NOT COMPLETED|Third Intervention||0
242917|NCT01077076|589092|P4|NOT COMPLETED|Third Intervention||0
242918|NCT01077076|589093|P3|NOT COMPLETED|Third Intervention||0
242919|NCT01077076|589094|P2|NOT COMPLETED|Third Intervention||0
242920|NCT01077076|589095|P1|NOT COMPLETED|Third Intervention||0
242921|NCT01077076|589090|P6|COMPLETED|Third Intervention||4
242922|NCT01077076|589091|P5|COMPLETED|Third Intervention||5
242923|NCT01077076|589092|P4|COMPLETED|Third Intervention||5
242924|NCT01077076|589093|P3|COMPLETED|Third Intervention||5
242925|NCT01077076|589094|P2|COMPLETED|Third Intervention||5
242926|NCT01077076|589095|P1|COMPLETED|Third Intervention||4
242927|NCT01077076|589090|P6|STARTED|Third Intervention||5
242928|NCT01077076|589091|P5|STARTED|Third Intervention||5
242929|NCT01077076|589092|P4|STARTED|Third Intervention||5
242930|NCT01077076|589093|P3|STARTED|Third Intervention||5
242931|NCT01077076|589094|P2|STARTED|Third Intervention||5
242932|NCT01077076|589095|P1|STARTED|Third Intervention||4
242933|NCT01077076|589090|P6|NOT COMPLETED|Washout Period of 2 Weeks||0
242934|NCT01077076|589091|P5|NOT COMPLETED|Washout Period of 2 Weeks||0
242935|NCT01077076|589092|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
242936|NCT01077076|589093|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
242937|NCT01077076|589094|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
242938|NCT01077076|589095|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
242939|NCT01077076|589090|P6|COMPLETED|Washout Period of 2 Weeks||5
242940|NCT01077076|589091|P5|COMPLETED|Washout Period of 2 Weeks||5
242941|NCT01077076|589092|P4|COMPLETED|Washout Period of 2 Weeks||5
242942|NCT01077076|589093|P3|COMPLETED|Washout Period of 2 Weeks||5
242943|NCT01077076|589094|P2|COMPLETED|Washout Period of 2 Weeks||5
242944|NCT01077076|589095|P1|COMPLETED|Washout Period of 2 Weeks||4
242945|NCT01077076|589090|P6|STARTED|Washout Period of 2 Weeks||5
242946|NCT01077076|589091|P5|STARTED|Washout Period of 2 Weeks||5
242947|NCT01077076|589092|P4|STARTED|Washout Period of 2 Weeks||5
242948|NCT01077076|589093|P3|STARTED|Washout Period of 2 Weeks||5
242949|NCT01077076|589094|P2|STARTED|Washout Period of 2 Weeks||5
242950|NCT01077076|589095|P1|STARTED|Washout Period of 2 Weeks||4
242951|NCT01077076|589090|P6|NOT COMPLETED|Second Intervention||0
242952|NCT01077076|589091|P5|NOT COMPLETED|Second Intervention||0
242953|NCT01077076|589092|P4|NOT COMPLETED|Second Intervention||0
242954|NCT01077076|589093|P3|NOT COMPLETED|Second Intervention||0
242955|NCT01077076|589094|P2|NOT COMPLETED|Second Intervention||0
242956|NCT01077076|589095|P1|NOT COMPLETED|Second Intervention||0
242957|NCT01077076|589090|P6|COMPLETED|Second Intervention||5
242958|NCT01077076|589091|P5|COMPLETED|Second Intervention||5
242959|NCT01077076|589092|P4|COMPLETED|Second Intervention||5
242960|NCT01077076|589093|P3|COMPLETED|Second Intervention||5
242961|NCT01077076|589094|P2|COMPLETED|Second Intervention||5
242962|NCT01077076|589095|P1|COMPLETED|Second Intervention||4
242963|NCT01077076|589090|P6|STARTED|Second Intervention||5
242964|NCT01077076|589091|P5|STARTED|Second Intervention||5
242965|NCT01077076|589092|P4|STARTED|Second Intervention||5
242966|NCT01077076|589093|P3|STARTED|Second Intervention||5
242967|NCT01077076|589094|P2|STARTED|Second Intervention||5
242968|NCT01077076|589095|P1|STARTED|Second Intervention||4
242969|NCT01077076|589090|P6|NOT COMPLETED|Washout Period of 2 Weeks||0
242970|NCT01077076|589091|P5|NOT COMPLETED|Washout Period of 2 Weeks||0
242971|NCT01077076|589092|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
242972|NCT01077076|589093|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
242973|NCT01077076|589094|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
242974|NCT01077076|589095|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
242975|NCT01077076|589090|P6|COMPLETED|Washout Period of 2 Weeks||5
242976|NCT01077076|589091|P5|COMPLETED|Washout Period of 2 Weeks||5
242977|NCT01077076|589092|P4|COMPLETED|Washout Period of 2 Weeks||5
242978|NCT01077076|589093|P3|COMPLETED|Washout Period of 2 Weeks||5
242979|NCT01077076|589094|P2|COMPLETED|Washout Period of 2 Weeks||5
242980|NCT01077076|589095|P1|COMPLETED|Washout Period of 2 Weeks||4
242981|NCT01077076|589090|P6|STARTED|Washout Period of 2 Weeks||5
242982|NCT01077076|589091|P5|STARTED|Washout Period of 2 Weeks||5
242983|NCT01077076|589092|P4|STARTED|Washout Period of 2 Weeks||5
242984|NCT01077076|589093|P3|STARTED|Washout Period of 2 Weeks||5
242985|NCT01077076|589094|P2|STARTED|Washout Period of 2 Weeks||5
242986|NCT01077076|589095|P1|STARTED|Washout Period of 2 Weeks||4
242987|NCT01077076|589090|P6|NOT COMPLETED|First Intervention||0
242988|NCT01077076|589091|P5|NOT COMPLETED|First Intervention||0
242989|NCT01077076|589092|P4|NOT COMPLETED|First Intervention||0
242990|NCT01077076|589093|P3|NOT COMPLETED|First Intervention||0
242991|NCT01077076|589094|P2|NOT COMPLETED|First Intervention||0
242992|NCT01077076|589095|P1|NOT COMPLETED|First Intervention||1
242993|NCT01077076|589090|P6|COMPLETED|First Intervention||5
242994|NCT01077076|589091|P5|COMPLETED|First Intervention||5
242995|NCT01077076|589092|P4|COMPLETED|First Intervention||5
242996|NCT01077076|589093|P3|COMPLETED|First Intervention||5
242997|NCT01077076|589094|P2|COMPLETED|First Intervention||5
242998|NCT01077076|589095|P1|COMPLETED|First Intervention||4
242999|NCT01077076|589090|P6|STARTED|First Intervention||5
243000|NCT01077076|589091|P5|STARTED|First Intervention||5
243001|NCT01077076|589092|P4|STARTED|First Intervention||5
243002|NCT01077076|589093|P3|STARTED|First Intervention||5
243003|NCT01077076|589094|P2|STARTED|First Intervention||5
243004|NCT01077076|589095|P1|STARTED|First Intervention||5
243005|NCT01077063|589105|P2|NOT COMPLETED|Overall Study||3
243006|NCT01077063|589106|P1|NOT COMPLETED|Overall Study||4
243007|NCT01077063|589105|P2|COMPLETED|Overall Study||0
243008|NCT01077063|589106|P1|COMPLETED|Overall Study||0
243009|NCT01077063|589105|P2|STARTED|Overall Study||3
243010|NCT01077063|589106|P1|STARTED|Overall Study||4
243011|NCT01077050|589112|P1|NOT COMPLETED|Overall Study||9
243012|NCT01077050|589112|P1|COMPLETED|Overall Study||1942
243013|NCT01077050|589112|P1|STARTED|Overall Study||1951
243014|NCT01077024|589118|P2|NOT COMPLETED|Overall Study||28
243015|NCT01077024|589119|P1|NOT COMPLETED|Overall Study||31
243016|NCT01077024|589118|P2|COMPLETED|Overall Study||243
243017|NCT01077024|589119|P1|COMPLETED|Overall Study||236
243018|NCT01077024|589118|P2|STARTED|Overall Study||271
243019|NCT01077024|589119|P1|STARTED|Overall Study||267
243020|NCT01076985|589137|P1|NOT COMPLETED|Overall Study||0
243021|NCT01076985|589137|P1|COMPLETED|Overall Study||24
243022|NCT01076985|589137|P1|STARTED|Overall Study||24
243023|NCT01076972|589143|P1|NOT COMPLETED|Overall Study||0
243024|NCT01076972|589143|P1|COMPLETED|Overall Study||1184
243025|NCT01076972|589143|P1|STARTED|Overall Study||1184
243026|NCT01076959|589158|P1|NOT COMPLETED|Overall Study||2250
243027|NCT01076959|589158|P1|COMPLETED|Overall Study||5490
243028|NCT01076959|589158|P1|STARTED|Overall Study||7740
243029|NCT01076686|589179|P4|NOT COMPLETED|Overall Study||0
243030|NCT01076686|589180|P3|NOT COMPLETED|Overall Study||0
243031|NCT01076686|589181|P2|NOT COMPLETED|Overall Study||0
243032|NCT01076686|589182|P1|NOT COMPLETED|Overall Study||0
243033|NCT01076686|589179|P4|COMPLETED|Overall Study||31
243034|NCT01076686|589180|P3|COMPLETED|Overall Study||32
243035|NCT01076686|589181|P2|COMPLETED|Overall Study||14
243036|NCT01076686|589182|P1|COMPLETED|Overall Study||17
243037|NCT01076686|589179|P4|STARTED|Overall Study||31
243038|NCT01076686|589180|P3|STARTED|Overall Study||32
243039|NCT01076686|589181|P2|STARTED|Overall Study||14
243040|NCT01076686|589182|P1|STARTED|Overall Study||17
243041|NCT01076647|589194|P2|NOT COMPLETED|Overall Study||25
243042|NCT01076647|589195|P1|NOT COMPLETED|Overall Study||25
243043|NCT01076647|589194|P2|COMPLETED|Overall Study||209
243044|NCT01076647|589195|P1|COMPLETED|Overall Study||208
243045|NCT01076647|589194|P2|STARTED|Overall Study||234
243046|NCT01076647|589195|P1|STARTED|Overall Study||233
243047|NCT01076543|589209|P6|NOT COMPLETED|Overall Study||0
243048|NCT01076543|589210|P5|NOT COMPLETED|Overall Study||0
243049|NCT01076543|589211|P4|NOT COMPLETED|Overall Study||0
243050|NCT01076543|589212|P3|NOT COMPLETED|Overall Study||0
243051|NCT01076543|589213|P2|NOT COMPLETED|Overall Study||0
243052|NCT01076543|589214|P1|NOT COMPLETED|Overall Study||2
243053|NCT01076543|589209|P6|COMPLETED|Overall Study||39
243054|NCT01076543|589210|P5|COMPLETED|Overall Study||15
243055|NCT01076543|589211|P4|COMPLETED|Overall Study||39
243056|NCT01076543|589212|P3|COMPLETED|Overall Study||6
243057|NCT01076543|589213|P2|COMPLETED|Overall Study||3
243058|NCT01076543|589214|P1|COMPLETED|Overall Study||6
243059|NCT01076543|589209|P6|STARTED|Overall Study||39
243060|NCT01076543|589210|P5|STARTED|Overall Study||15
243061|NCT01076543|589211|P4|STARTED|Overall Study||39
243062|NCT01076543|589212|P3|STARTED|Overall Study||6
243063|NCT01076543|589213|P2|STARTED|Overall Study||3
243064|NCT01076543|589214|P1|STARTED|Overall Study||8
243065|NCT01076504|589252|P1|NOT COMPLETED|Overall Study||80
243159|NCT01076088|589459|P2|STARTED|Overall Study||125
243066|NCT01076504|589252|P1|COMPLETED|Overall Study|Patients remained on study until disease progression or withdrawal for any other reason|0
243067|NCT01076504|589252|P1|STARTED|Overall Study||80
243068|NCT01076452|589262|P2|NOT COMPLETED|Overall Study||14
243069|NCT01076452|589263|P1|NOT COMPLETED|Overall Study||24
243070|NCT01076452|589262|P2|COMPLETED|Overall Study||138
243071|NCT01076452|589263|P1|COMPLETED|Overall Study||123
243072|NCT01076452|589262|P2|STARTED|Overall Study||152
243073|NCT01076452|589263|P1|STARTED|Overall Study||147
243074|NCT01076400|589275|P3|NOT COMPLETED|Overall Study||0
243075|NCT01076400|589276|P2|NOT COMPLETED|Overall Study||0
243076|NCT01076400|589277|P1|NOT COMPLETED|Overall Study||7
243077|NCT01076400|589275|P3|COMPLETED|Overall Study||0
243078|NCT01076400|589276|P2|COMPLETED|Overall Study||0
243079|NCT01076400|589277|P1|COMPLETED|Overall Study||0
243080|NCT01076400|589275|P3|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
243081|NCT01076400|589276|P2|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
243082|NCT01076400|589277|P1|STARTED|Overall Study||7
243083|NCT01076361|589283|P1|NOT COMPLETED|Overall Study||21
243084|NCT01076361|589283|P1|COMPLETED|Overall Study|Follow-up data was not available for 21 participants (22 leads)|349
243085|NCT01076361|589283|P1|STARTED|Overall Study|631 leads were implanted in 370 patients. 22 leads in 21 patients were excluded from analysis.|370
243086|NCT01076348|589287|P1|NOT COMPLETED|Overall Study||22
243087|NCT01076348|589287|P1|COMPLETED|Overall Study||51
243088|NCT01076348|589287|P1|STARTED|Overall Study||73
243089|NCT01076335|589291|P1|NOT COMPLETED|Overall Study||4
243090|NCT01076335|589291|P1|COMPLETED|Overall Study||36
243091|NCT01076335|589291|P1|STARTED|Overall Study||40
243092|NCT01076296|589295|P8|NOT COMPLETED|Overall Study||0
243093|NCT01076296|589296|P7|NOT COMPLETED|Overall Study||0
243094|NCT01076296|589297|P6|NOT COMPLETED|Overall Study||0
243095|NCT01076296|589298|P5|NOT COMPLETED|Overall Study||0
243096|NCT01076296|589299|P4|NOT COMPLETED|Overall Study||0
243097|NCT01076296|589300|P3|NOT COMPLETED|Overall Study||0
243098|NCT01076296|589301|P2|NOT COMPLETED|Overall Study||0
243099|NCT01076296|589302|P1|NOT COMPLETED|Overall Study||0
243100|NCT01076296|589295|P8|COMPLETED|Overall Study||199
243101|NCT01076296|589296|P7|COMPLETED|Overall Study||51
243102|NCT01076296|589297|P6|COMPLETED|Overall Study||191
243103|NCT01076296|589298|P5|COMPLETED|Overall Study||59
243104|NCT01076296|589299|P4|COMPLETED|Overall Study||199
243105|NCT01076296|589300|P3|COMPLETED|Overall Study||51
243106|NCT01076296|589301|P2|COMPLETED|Overall Study||196
243107|NCT01076296|589302|P1|COMPLETED|Overall Study||54
243108|NCT01076296|589295|P8|STARTED|Overall Study||199
243109|NCT01076296|589296|P7|STARTED|Overall Study||51
243110|NCT01076296|589297|P6|STARTED|Overall Study||191
243111|NCT01076296|589298|P5|STARTED|Overall Study||59
243112|NCT01076296|589299|P4|STARTED|Overall Study||199
243113|NCT01076296|589300|P3|STARTED|Overall Study||51
243114|NCT01076296|589301|P2|STARTED|Overall Study||196
243115|NCT01076296|589302|P1|STARTED|Overall Study||54
243116|NCT01076283|589322|P2|NOT COMPLETED|Overall Study||0
243117|NCT01076283|589323|P1|NOT COMPLETED|Overall Study||1
243118|NCT01076283|589322|P2|COMPLETED|Overall Study||7
243119|NCT01076283|589323|P1|COMPLETED|Overall Study||6
243120|NCT01076283|589322|P2|STARTED|Overall Study||7
243121|NCT01076283|589323|P1|STARTED|Overall Study||7
243122|NCT01076270|589331|P1|NOT COMPLETED|Overall Study||0
243123|NCT01076270|589331|P1|COMPLETED|Overall Study||1
243124|NCT01076270|589331|P1|STARTED|Overall Study||1
243125|NCT01076244|589336|P1|NOT COMPLETED|Overall Study||4
243126|NCT01076244|589336|P1|COMPLETED|Overall Study||42
243127|NCT01076244|589336|P1|STARTED|Overall Study||46
243128|NCT01076205|589343|P1|NOT COMPLETED|Overall Study||6019
243129|NCT01076205|589343|P1|COMPLETED|Overall Study||1210
243130|NCT01076205|589343|P1|STARTED|Overall Study||7229
243131|NCT01076192|589396|P1|NOT COMPLETED|Overall Study||197
243132|NCT01076192|589396|P1|COMPLETED|Overall Study||350
243133|NCT01076192|589396|P1|STARTED|Overall Study||547
243134|NCT01076179|589411|P1|NOT COMPLETED|Overall Study||1
243135|NCT01076179|589411|P1|COMPLETED|Overall Study||501
243136|NCT01076179|589411|P1|STARTED|Overall Study||502
243137|NCT01076166|589434|P1|NOT COMPLETED|Overall Study||9
243138|NCT01076166|589434|P1|COMPLETED|Overall Study||328
243139|NCT01076166|589434|P1|STARTED|Overall Study||337
243140|NCT01076153|589441|P1|NOT COMPLETED|Overall Study||11
243141|NCT01076153|589441|P1|COMPLETED|Overall Study||749
243142|NCT01076153|589441|P1|STARTED|Overall Study||760
243143|NCT01076088|589455|P6|NOT COMPLETED|Overall Study||23
243144|NCT01076088|589456|P5|NOT COMPLETED|Overall Study||16
243145|NCT01076088|589457|P4|NOT COMPLETED|Overall Study||15
243146|NCT01076088|589458|P3|NOT COMPLETED|Overall Study||17
243147|NCT01076088|589459|P2|NOT COMPLETED|Overall Study||18
243148|NCT01076088|589460|P1|NOT COMPLETED|Overall Study||11
243149|NCT01076088|589455|P6|COMPLETED|Overall Study||104
243150|NCT01076088|589456|P5|COMPLETED|Overall Study||104
243151|NCT01076088|589457|P4|COMPLETED|Overall Study||109
243152|NCT01076088|589458|P3|COMPLETED|Overall Study||109
243153|NCT01076088|589459|P2|COMPLETED|Overall Study||107
243154|NCT01076088|589460|P1|COMPLETED|Overall Study||111
243155|NCT01076088|589455|P6|STARTED|Overall Study||127
243156|NCT01076088|589456|P5|STARTED|Overall Study||120
243157|NCT01076088|589457|P4|STARTED|Overall Study||124
243158|NCT01076088|589458|P3|STARTED|Overall Study||126
243160|NCT01076088|589460|P1|STARTED|Overall Study||122
243161|NCT01076075|589488|P2|NOT COMPLETED|Overall Study||47
243162|NCT01076075|589489|P1|NOT COMPLETED|Overall Study||41
243163|NCT01076075|589488|P2|COMPLETED|Overall Study||167
243164|NCT01076075|589489|P1|COMPLETED|Overall Study||172
243165|NCT01076075|589488|P2|Completed Phase A|Overall Study||189
243166|NCT01076075|589489|P1|Completed Phase A|Overall Study||199
243167|NCT01076075|589488|P2|STARTED|Overall Study|2 participants were excluded from safety and efficacy analyses due to one site's non-compliance|214
243168|NCT01076075|589489|P1|STARTED|Overall Study|3 participants were excluded from safety and efficacy analyses due to one site's non-compliance|213
243169|NCT01076036|589503|P1|NOT COMPLETED|Overall Study||2
243170|NCT01076036|589503|P1|COMPLETED|Overall Study||8
243171|NCT01076036|589503|P1|Complete CorPath Procedures|Overall Study||8
243172|NCT01076036|589503|P1|# of Procedures|Overall Study||8
243173|NCT01076036|589503|P1|STARTED|Overall Study||10
243174|NCT01075984|589513|P5|NOT COMPLETED|Follow-up Phase||47
243175|NCT01075984|589514|P4|NOT COMPLETED|Follow-up Phase||2
243176|NCT01075984|589515|P3|NOT COMPLETED|Follow-up Phase||1
243177|NCT01075984|589516|P2|NOT COMPLETED|Follow-up Phase||0
243178|NCT01075984|589517|P1|NOT COMPLETED|Follow-up Phase||0
243179|NCT01075984|589513|P5|COMPLETED|Follow-up Phase||165
243180|NCT01075984|589514|P4|COMPLETED|Follow-up Phase||19
243181|NCT01075984|589515|P3|COMPLETED|Follow-up Phase||19
243182|NCT01075984|589516|P2|COMPLETED|Follow-up Phase||10
243183|NCT01075984|589517|P1|COMPLETED|Follow-up Phase||10
243184|NCT01075984|589513|P5|STARTED|Follow-up Phase|One participant withdrew consent before the start of the follow-up phase.|212
243185|NCT01075984|589514|P4|STARTED|Follow-up Phase|Three participants did not start the follow-up phase: one died and two were lost to follow-up.|21
243186|NCT01075984|589515|P3|STARTED|Follow-up Phase|One participant did not start the follow-up phase for reasons unrelated to study procedures.|20
243187|NCT01075984|589516|P2|STARTED|Follow-up Phase||10
243188|NCT01075984|589517|P1|STARTED|Follow-up Phase||10
243189|NCT01075984|589513|P5|NOT COMPLETED|Treatment Phase||60
243190|NCT01075984|589514|P4|NOT COMPLETED|Treatment Phase||7
243191|NCT01075984|589515|P3|NOT COMPLETED|Treatment Phase||7
243192|NCT01075984|589516|P2|NOT COMPLETED|Treatment Phase||1
243193|NCT01075984|589517|P1|NOT COMPLETED|Treatment Phase||0
243194|NCT01075984|589513|P5|COMPLETED|Treatment Phase||153
243195|NCT01075984|589514|P4|COMPLETED|Treatment Phase||17
243196|NCT01075984|589515|P3|COMPLETED|Treatment Phase||14
243197|NCT01075984|589516|P2|COMPLETED|Treatment Phase||10
243198|NCT01075984|589517|P1|COMPLETED|Treatment Phase||10
243199|NCT01075984|589513|P5|STARTED|Treatment Phase||213
243200|NCT01075984|589514|P4|STARTED|Treatment Phase||24
243201|NCT01075984|589515|P3|STARTED|Treatment Phase||21
243202|NCT01075984|589516|P2|STARTED|Treatment Phase||11
243203|NCT01075984|589517|P1|STARTED|Treatment Phase||10
243204|NCT01075971|589571|P1|NOT COMPLETED|Overall Study||0
243205|NCT01075971|589571|P1|COMPLETED|Overall Study||52
243206|NCT01075971|589571|P1|STARTED|Overall Study||52
243207|NCT01075958|589575|P1|NOT COMPLETED|Overall Study||44
243208|NCT01075958|589575|P1|COMPLETED|Overall Study||239
243209|NCT01075958|589575|P1|STARTED|Overall Study||283
243210|NCT01075815|589591|P2|NOT COMPLETED|Overall Study||4
243211|NCT01075815|589592|P1|NOT COMPLETED|Overall Study||10
243212|NCT01075815|589591|P2|COMPLETED|Overall Study||31
243213|NCT01075815|589592|P1|COMPLETED|Overall Study||30
243214|NCT01075815|589591|P2|STARTED|Overall Study|Number of participants treated.|35
243215|NCT01075815|589592|P1|STARTED|Overall Study|Number of participants treated.|40
243216|NCT01075763|589630|P2|NOT COMPLETED|Overall Study||4
243217|NCT01075763|589631|P1|NOT COMPLETED|Overall Study||4
243218|NCT01075763|589630|P2|COMPLETED|Overall Study||15
243219|NCT01075763|589631|P1|COMPLETED|Overall Study||19
243220|NCT01075763|589630|P2|STARTED|Overall Study||19
243221|NCT01075763|589631|P1|STARTED|Overall Study||23
243222|NCT01075685|589655|P2|NOT COMPLETED|Overall Study||226
243223|NCT01075685|589656|P1|NOT COMPLETED|Overall Study||592
243224|NCT01075685|589655|P2|COMPLETED|Overall Study||188
243225|NCT01075685|589656|P1|COMPLETED|Overall Study||151
243226|NCT01075685|589655|P2|Completed Baseline Measures|Overall Study||263
243227|NCT01075685|589656|P1|Completed Baseline Measures|Overall Study||225
243228|NCT01075685|589655|P2|Met Inclusion Criteria|Overall Study||413
243229|NCT01075685|589656|P1|Met Inclusion Criteria|Overall Study||734
243230|NCT01075685|589655|P2|STARTED|Overall Study||414
243231|NCT01075685|589656|P1|STARTED|Overall Study||743
243232|NCT01075646|589672|P4|NOT COMPLETED|Overall Study||2
243233|NCT01075646|589673|P3|NOT COMPLETED|Overall Study||1
243234|NCT01075646|589674|P2|NOT COMPLETED|Overall Study||3
243235|NCT01075646|589675|P1|NOT COMPLETED|Overall Study||4
243236|NCT01075646|589672|P4|COMPLETED|Overall Study||44
243237|NCT01075646|589673|P3|COMPLETED|Overall Study||52
243238|NCT01075646|589674|P2|COMPLETED|Overall Study||31
243239|NCT01075646|589675|P1|COMPLETED|Overall Study||29
243240|NCT01075646|589672|P4|STARTED|Overall Study||46
243241|NCT01075646|589673|P3|STARTED|Overall Study||53
243242|NCT01075646|589674|P2|STARTED|Overall Study||34
243243|NCT01075646|589675|P1|STARTED|Overall Study||33
243244|NCT01075412|589707|P2|NOT COMPLETED|Overall Study||1
243245|NCT01075412|589708|P1|NOT COMPLETED|Overall Study||0
243246|NCT01075412|589707|P2|COMPLETED|Overall Study||1
243247|NCT01075412|589708|P1|COMPLETED|Overall Study||4
243248|NCT01075412|589707|P2|STARTED|Overall Study||2
243249|NCT01075412|589708|P1|STARTED|Overall Study||4
243250|NCT01075399|589718|P1|NOT COMPLETED|Overall Study||8
243251|NCT01075399|589718|P1|COMPLETED|Overall Study|42 of 50 patients received at least one dose and 39 of 50 patients completed two pre-treatment scan|42
243252|NCT01075399|589718|P1|STARTED|Overall Study|A total of 50 patients were enrolled into the study.|50
243253|NCT01075347|589724|P2|NOT COMPLETED|Overall Study||0
243254|NCT01075347|589725|P1|NOT COMPLETED|Overall Study||0
243255|NCT01075347|589724|P2|COMPLETED|Overall Study||83
243256|NCT01075347|589725|P1|COMPLETED|Overall Study||82
243257|NCT01075347|589724|P2|STARTED|Overall Study||83
243258|NCT01075347|589725|P1|STARTED|Overall Study||82
243259|NCT01075282|589736|P3|NOT COMPLETED|Overall Study||27
243260|NCT01075282|589737|P2|NOT COMPLETED|Overall Study||29
243261|NCT01075282|589738|P1|NOT COMPLETED|Overall Study||31
243262|NCT01075282|589736|P3|COMPLETED|Overall Study||238
243263|NCT01075282|589737|P2|COMPLETED|Overall Study||243
243264|NCT01075282|589738|P1|COMPLETED|Overall Study||242
243265|NCT01075282|589736|P3|Received at Least One Dose of Study Drug|Overall Study||262
243266|NCT01075282|589737|P2|Received at Least One Dose of Study Drug|Overall Study||272
243267|NCT01075282|589738|P1|Received at Least One Dose of Study Drug|Overall Study||273
243268|NCT01075282|589736|P3|STARTED|Overall Study|Of 265 participants randomized to Insulin Glargine, 3 chose not to take study drug.|265
243269|NCT01075282|589737|P2|STARTED|Overall Study||272
243270|NCT01075282|589738|P1|STARTED|Overall Study||273
243271|NCT01075256|589821|P3|NOT COMPLETED|Overall Study||0
243272|NCT01075256|589822|P2|NOT COMPLETED|Overall Study||0
243273|NCT01075256|589823|P1|NOT COMPLETED|Overall Study||1
243274|NCT01075256|589821|P3|COMPLETED|Overall Study||65
243275|NCT01075256|589822|P2|COMPLETED|Overall Study||66
243276|NCT01075256|589823|P1|COMPLETED|Overall Study||63
243277|NCT01075256|589821|P3|STARTED|Overall Study||65
243278|NCT01075256|589822|P2|STARTED|Overall Study||66
243279|NCT01075256|589823|P1|STARTED|Overall Study||64
243280|NCT01075243|589855|P3|NOT COMPLETED|Overall Study||0
243281|NCT01075243|589856|P2|NOT COMPLETED|Overall Study||3
243282|NCT01075243|589857|P1|NOT COMPLETED|Overall Study||6
243283|NCT01075243|589855|P3|COMPLETED|Overall Study||80
243284|NCT01075243|589856|P2|COMPLETED|Overall Study||155
243285|NCT01075243|589857|P1|COMPLETED|Overall Study||157
243286|NCT01075243|589855|P3|STARTED|Overall Study||80
243287|NCT01075243|589856|P2|STARTED|Overall Study||158
243288|NCT01075243|589857|P1|STARTED|Overall Study||163
243289|NCT01075217|589909|P2|NOT COMPLETED|Overall Study||1
243290|NCT01075217|589910|P1|NOT COMPLETED|Overall Study||2
243291|NCT01075217|589909|P2|COMPLETED|Overall Study||84
243292|NCT01075217|589910|P1|COMPLETED|Overall Study||82
243293|NCT01075217|589909|P2|STARTED|Overall Study|86 patients randomized to receive Visipaque; 1 of the patients did not meet entry requirements|85
243294|NCT01075217|589910|P1|STARTED|Overall Study|88 patients randomized to receive Isovue; 4 of the patients did not meet entry requirements|84
243295|NCT01075204|589926|P1|NOT COMPLETED|Overall Study||0
243296|NCT01075204|589926|P1|COMPLETED|Overall Study||335
243297|NCT01075204|589926|P1|STARTED|Overall Study||335
243298|NCT01075191|589943|P1|NOT COMPLETED|Overall Study||18
243299|NCT01075191|589943|P1|COMPLETED|Overall Study||42
243300|NCT01075191|589943|P1|Discontinued Year 3|Overall Study||5
243301|NCT01075191|589943|P1|Discontinued Year 2|Overall Study||6
243302|NCT01075191|589943|P1|Discontinued Year 1|Overall Study||7
243303|NCT01075191|589943|P1|STARTED|Overall Study|65 participants were enrolled; 5 protocol violations were excluded from all analyses except safety.|60
243304|NCT01075178|589954|P2|NOT COMPLETED|Subject Chart Review||9
243305|NCT01075178|589955|P1|NOT COMPLETED|Subject Chart Review||9
243306|NCT01075178|589954|P2|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
243307|NCT01075178|589955|P1|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
243308|NCT01075178|589954|P2|STARTED|Subject Chart Review|subjects matched|1018
243309|NCT01075178|589955|P1|STARTED|Subject Chart Review|subjects matched|1018
243310|NCT01075178|589954|P2|NOT COMPLETED|Subject Matching||403
243311|NCT01075178|589955|P1|NOT COMPLETED|Subject Matching||130
243312|NCT01075178|589954|P2|COMPLETED|Subject Matching|subjects matched|1018
243313|NCT01075178|589955|P1|COMPLETED|Subject Matching|subjects matched|1018
243314|NCT01075178|589954|P2|STARTED|Subject Matching|eligible for matching|1421
243315|NCT01075178|589955|P1|STARTED|Subject Matching|eligible for matching|1148
243316|NCT01075152|589969|P2|NOT COMPLETED|Overall Study||0
243317|NCT01075152|589970|P1|NOT COMPLETED|Overall Study||1
243318|NCT01075152|589969|P2|COMPLETED|Overall Study||89
243319|NCT01075152|589970|P1|COMPLETED|Overall Study||87
243320|NCT01075152|589969|P2|STARTED|Overall Study|randomized|89
243321|NCT01075152|589970|P1|STARTED|Overall Study|randomized|88
243322|NCT01075100|589996|P2|NOT COMPLETED|Overall Study||53
243323|NCT01075100|589997|P1|NOT COMPLETED|Overall Study||49
243324|NCT01075100|589996|P2|COMPLETED|Overall Study||1
243325|NCT01075100|589997|P1|COMPLETED|Overall Study||0
243326|NCT01075100|589996|P2|STARTED|Overall Study||54
243327|NCT01075100|589997|P1|STARTED|Overall Study||49
243328|NCT01075087|590015|P2|NOT COMPLETED|Overall Study||0
243329|NCT01075087|590016|P1|NOT COMPLETED|Overall Study||0
243330|NCT01075087|590015|P2|COMPLETED|Overall Study||10
243331|NCT01075087|590016|P1|COMPLETED|Overall Study||9
243332|NCT01075087|590015|P2|STARTED|Overall Study||10
243333|NCT01075087|590016|P1|STARTED|Overall Study||9
243334|NCT01075074|590027|P3|NOT COMPLETED|Overall Study||2
243335|NCT01075074|590028|P2|NOT COMPLETED|Overall Study||2
243336|NCT01075074|590029|P1|NOT COMPLETED|Overall Study||1
243337|NCT01075074|590027|P3|COMPLETED|Overall Study||23
243338|NCT01075074|590028|P2|COMPLETED|Overall Study||23
243339|NCT01075074|590029|P1|COMPLETED|Overall Study||24
243340|NCT01075074|590027|P3|STARTED|Overall Study||25
243341|NCT01075074|590028|P2|STARTED|Overall Study||25
243342|NCT01075074|590029|P1|STARTED|Overall Study||25
243343|NCT01074944|590046|P5|NOT COMPLETED|Extended Treatment (up to 42 Months)||5
243344|NCT01074944|590047|P4|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
243345|NCT01074944|590048|P3|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
243346|NCT01074944|590049|P2|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
243347|NCT01074944|590050|P1|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
243348|NCT01074944|590046|P5|COMPLETED|Extended Treatment (up to 42 Months)||20
243349|NCT01074944|590047|P4|COMPLETED|Extended Treatment (up to 42 Months)||0
243350|NCT01074944|590048|P3|COMPLETED|Extended Treatment (up to 42 Months)||0
243351|NCT01074944|590049|P2|COMPLETED|Extended Treatment (up to 42 Months)||0
243352|NCT01074944|590050|P1|COMPLETED|Extended Treatment (up to 42 Months)||0
243353|NCT01074944|590046|P5|STARTED|Extended Treatment (up to 42 Months)|Participants who were failed to meet the randomization criteria during the lead-in period.|25
243354|NCT01074944|590047|P4|STARTED|Extended Treatment (up to 42 Months)||0
243355|NCT01074944|590048|P3|STARTED|Extended Treatment (up to 42 Months)||0
243356|NCT01074944|590049|P2|STARTED|Extended Treatment (up to 42 Months)||0
243357|NCT01074944|590050|P1|STARTED|Extended Treatment (up to 42 Months)||0
243358|NCT01074944|590046|P5|NOT COMPLETED|Long Term Treatment||0
243359|NCT01074944|590047|P4|NOT COMPLETED|Long Term Treatment||26
243360|NCT01074944|590048|P3|NOT COMPLETED|Long Term Treatment||0
243361|NCT01074944|590049|P2|NOT COMPLETED|Long Term Treatment||0
243362|NCT01074944|590050|P1|NOT COMPLETED|Long Term Treatment||0
243363|NCT01074944|590046|P5|COMPLETED|Long Term Treatment||0
243364|NCT01074944|590047|P4|COMPLETED|Long Term Treatment||95
243365|NCT01074944|590048|P3|COMPLETED|Long Term Treatment||0
243366|NCT01074944|590049|P2|COMPLETED|Long Term Treatment||0
243367|NCT01074944|590050|P1|COMPLETED|Long Term Treatment||0
243368|NCT01074944|590046|P5|STARTED|Long Term Treatment||0
243369|NCT01074944|590047|P4|STARTED|Long Term Treatment|Participants who completed PAP (114) including those who considered as treatment failure in PAP (7).|121
243370|NCT01074944|590048|P3|STARTED|Long Term Treatment||0
243371|NCT01074944|590049|P2|STARTED|Long Term Treatment||0
243372|NCT01074944|590050|P1|STARTED|Long Term Treatment||0
243373|NCT01074944|590046|P5|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
243374|NCT01074944|590047|P4|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
243375|NCT01074944|590048|P3|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||6
243376|NCT01074944|590049|P2|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||11
243377|NCT01074944|590050|P1|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
243378|NCT01074944|590046|P5|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
243379|NCT01074944|590047|P4|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
243380|NCT01074944|590048|P3|COMPLETED|Primary Analysis Period (up to 52 Weeks)||60
243381|NCT01074944|590049|P2|COMPLETED|Primary Analysis Period (up to 52 Weeks)||54
243382|NCT01074944|590050|P1|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
243383|NCT01074944|590046|P5|STARTED|Primary Analysis Period (up to 52 Weeks)||0
243384|NCT01074944|590047|P4|STARTED|Primary Analysis Period (up to 52 Weeks)||0
243385|NCT01074944|590048|P3|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|66
243386|NCT01074944|590049|P2|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|65
243387|NCT01074944|590050|P1|STARTED|Primary Analysis Period (up to 52 Weeks)||0
243388|NCT01074944|590046|P5|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
243389|NCT01074944|590047|P4|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
243390|NCT01074944|590048|P3|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
243391|NCT01074944|590049|P2|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
243392|NCT01074944|590050|P1|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||13
243393|NCT01074944|590046|P5|COMPLETED|Lead-in Period (up to 78 Weeks)||0
243394|NCT01074944|590047|P4|COMPLETED|Lead-in Period (up to 78 Weeks)||0
243395|NCT01074944|590048|P3|COMPLETED|Lead-in Period (up to 78 Weeks)||0
243396|NCT01074944|590049|P2|COMPLETED|Lead-in Period (up to 78 Weeks)||0
243397|NCT01074944|590050|P1|COMPLETED|Lead-in Period (up to 78 Weeks)||157
243398|NCT01074944|590046|P5|STARTED|Lead-in Period (up to 78 Weeks)||0
243399|NCT01074944|590047|P4|STARTED|Lead-in Period (up to 78 Weeks)||0
243400|NCT01074944|590048|P3|STARTED|Lead-in Period (up to 78 Weeks)||0
243401|NCT01074944|590049|P2|STARTED|Lead-in Period (up to 78 Weeks)||0
243402|NCT01074944|590050|P1|STARTED|Lead-in Period (up to 78 Weeks)|LIP conducted to assess randomization criteria of all participants in single reporting arm.|170
243403|NCT01074931|590104|P1|NOT COMPLETED|Overall Study||6
243404|NCT01074931|590104|P1|COMPLETED|Overall Study||92
243405|NCT01074931|590104|P1|STARTED|Overall Study||98
243406|NCT01074658|590116|P1|NOT COMPLETED|Overall Study||19
243407|NCT01074658|590116|P1|COMPLETED|Overall Study||996
243408|NCT01074658|590116|P1|Attempted Implant|Overall Study||996
243409|NCT01074658|590116|P1|STARTED|Overall Study||1015
243410|NCT01074554|590124|P2|NOT COMPLETED|Overall Study||4
243411|NCT01074554|590125|P1|NOT COMPLETED|Overall Study||3
243412|NCT01074554|590124|P2|COMPLETED|Overall Study||11
243413|NCT01074554|590125|P1|COMPLETED|Overall Study||11
243414|NCT01074554|590124|P2|STARTED|Overall Study||15
243415|NCT01074554|590125|P1|STARTED|Overall Study||14
243416|NCT01074502|590135|P1|NOT COMPLETED|Overall Study||1
243417|NCT01074502|590135|P1|COMPLETED|Overall Study||2
243418|NCT01074502|590135|P1|STARTED|Overall Study||3
243419|NCT01074463|590146|P2|NOT COMPLETED|Second Intervention||0
243420|NCT01074463|590147|P1|NOT COMPLETED|Second Intervention||0
243421|NCT01074463|590146|P2|COMPLETED|Second Intervention||12
243422|NCT01074463|590147|P1|COMPLETED|Second Intervention||12
243423|NCT01074463|590146|P2|STARTED|Second Intervention||12
243424|NCT01074463|590147|P1|STARTED|Second Intervention||12
243425|NCT01074463|590146|P2|NOT COMPLETED|Washout of 7 Days||0
243426|NCT01074463|590147|P1|NOT COMPLETED|Washout of 7 Days||0
243427|NCT01074463|590146|P2|COMPLETED|Washout of 7 Days||12
243428|NCT01074463|590147|P1|COMPLETED|Washout of 7 Days||12
243429|NCT01074463|590146|P2|STARTED|Washout of 7 Days||12
243430|NCT01074463|590147|P1|STARTED|Washout of 7 Days||12
243431|NCT01074463|590146|P2|NOT COMPLETED|First Intervention||0
243432|NCT01074463|590147|P1|NOT COMPLETED|First Intervention||0
243433|NCT01074463|590146|P2|COMPLETED|First Intervention||12
243434|NCT01074463|590147|P1|COMPLETED|First Intervention||12
243435|NCT01074463|590146|P2|STARTED|First Intervention||12
243436|NCT01074463|590147|P1|STARTED|First Intervention||12
243437|NCT01074450|590159|P2|NOT COMPLETED|Second Intervention||1
243438|NCT01074450|590160|P1|NOT COMPLETED|Second Intervention||1
243439|NCT01074450|590159|P2|COMPLETED|Second Intervention|Influenze Symptoms Present at Check in.|9
243440|NCT01074450|590160|P1|COMPLETED|Second Intervention|Positive Drug Screen at Check in.|11
243441|NCT01074450|590159|P2|STARTED|Second Intervention||10
243442|NCT01074450|590160|P1|STARTED|Second Intervention||12
243443|NCT01074450|590159|P2|NOT COMPLETED|Washout of 7 Days||0
243444|NCT01074450|590160|P1|NOT COMPLETED|Washout of 7 Days||0
243445|NCT01074450|590159|P2|COMPLETED|Washout of 7 Days||10
243446|NCT01074450|590160|P1|COMPLETED|Washout of 7 Days||12
243447|NCT01074450|590159|P2|STARTED|Washout of 7 Days||10
243448|NCT01074450|590160|P1|STARTED|Washout of 7 Days||12
243449|NCT01074450|590159|P2|NOT COMPLETED|First Intervention||2
243450|NCT01074450|590160|P1|NOT COMPLETED|First Intervention||0
243451|NCT01074450|590159|P2|COMPLETED|First Intervention||10
243452|NCT01074450|590160|P1|COMPLETED|First Intervention||12
243453|NCT01074450|590159|P2|STARTED|First Intervention||12
243454|NCT01074450|590160|P1|STARTED|First Intervention||12
243455|NCT01074437|590172|P2|NOT COMPLETED|Overall Study||0
243456|NCT01074437|590173|P1|NOT COMPLETED|Overall Study||0
243457|NCT01074437|590172|P2|COMPLETED|Overall Study||5
243458|NCT01074437|590173|P1|COMPLETED|Overall Study||4
243459|NCT01074437|590172|P2|STARTED|Overall Study||5
243460|NCT01074437|590173|P1|STARTED|Overall Study||4
243461|NCT01074307|590189|P2|NOT COMPLETED|Overall Study||12
243462|NCT01074307|590190|P1|NOT COMPLETED|Overall Study||22
243463|NCT01074307|590189|P2|COMPLETED|Overall Study||102
243464|NCT01074307|590190|P1|COMPLETED|Overall Study||44
243465|NCT01074307|590189|P2|STARTED|Overall Study||114
243466|NCT01074307|590190|P1|STARTED|Overall Study||66
243467|NCT01074268|590212|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||7
243468|NCT01074268|590213|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||6
243469|NCT01074268|590212|P2|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||115
243470|NCT01074268|590213|P1|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||242
243471|NCT01074268|590212|P2|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Sixteen subjects from main trial did not continue into the extension|122
243472|NCT01074268|590213|P1|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Thirty five subjects from main trial did not continue into the extension|248
243473|NCT01074268|590212|P2|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||15
243474|NCT01074268|590213|P1|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||20
243475|NCT01074268|590212|P2|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||138
243476|NCT01074268|590213|P1|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||283
243477|NCT01074268|590212|P2|Exposed|Main: Week 0 to 26 (NN1250-3585)|One subject withdrew prior to exposure to trial drugs|152
243478|NCT01074268|590213|P1|Exposed|Main: Week 0 to 26 (NN1250-3585)|Two subjects withdrew prior to exposure to trial drugs|301
243479|NCT01074268|590212|P2|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)||153
243480|NCT01074268|590213|P1|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)|One subject was withdrawn because the subject was randomised in error (screening failure)|302
243481|NCT01074268|590212|P2|STARTED|Main: Week 0 to 26 (NN1250-3585)||153
243482|NCT01074268|590213|P1|STARTED|Main: Week 0 to 26 (NN1250-3585)||303
243483|NCT01074255|590239|P1|NOT COMPLETED|Overall Study||2
243484|NCT01074255|590239|P1|COMPLETED|Overall Study||3139
243485|NCT01074255|590239|P1|Treated|Overall Study||3139
243486|NCT01074255|590239|P1|STARTED|Overall Study||3141
243487|NCT01074242|590243|P1|NOT COMPLETED|Overall Study||403
243488|NCT01074242|590243|P1|COMPLETED|Overall Study||3395
243489|NCT01074242|590243|P1|Received at Least 1 Dose of Vaccine|Overall Study||3395
243490|NCT01074242|590243|P1|STARTED|Overall Study||3798
243491|NCT01074229|590251|P3|NOT COMPLETED|Overall Study||4
243492|NCT01074229|590252|P2|NOT COMPLETED|Overall Study||3
243493|NCT01074229|590253|P1|NOT COMPLETED|Overall Study||2
243494|NCT01074229|590251|P3|COMPLETED|Overall Study||21
243495|NCT01074229|590252|P2|COMPLETED|Overall Study||22
243496|NCT01074229|590253|P1|COMPLETED|Overall Study||23
243497|NCT01074229|590251|P3|STARTED|Overall Study||25
243498|NCT01074229|590252|P2|STARTED|Overall Study||25
243499|NCT01074229|590253|P1|STARTED|Overall Study||25
243500|NCT01074216|590264|P1|NOT COMPLETED|Overall Study||13
243501|NCT01074216|590264|P1|COMPLETED|Overall Study||41
243502|NCT01074216|590264|P1|STARTED|Overall Study||54
243503|NCT01074177|590268|P1|NOT COMPLETED|Overall Study||0
243504|NCT01074177|590268|P1|COMPLETED|Overall Study||24
243505|NCT01074177|590268|P1|STARTED|Overall Study||24
243506|NCT01074164|590277|P2|NOT COMPLETED|Overall Study||1
243507|NCT01074164|590278|P1|NOT COMPLETED|Overall Study||3
243508|NCT01074164|590277|P2|COMPLETED|Overall Study||7
243509|NCT01074164|590278|P1|COMPLETED|Overall Study||4
243510|NCT01074164|590277|P2|STARTED|Overall Study||8
243511|NCT01074164|590278|P1|STARTED|Overall Study||7
243512|NCT01074125|590299|P3|NOT COMPLETED|Overall Study||12
243513|NCT01074125|590300|P2|NOT COMPLETED|Overall Study||5
243514|NCT01074125|590301|P1|NOT COMPLETED|Overall Study||12
243515|NCT01074125|590299|P3|COMPLETED|Overall Study||36
243516|NCT01074125|590300|P2|COMPLETED|Overall Study||47
243517|NCT01074125|590301|P1|COMPLETED|Overall Study||39
243518|NCT01074125|590299|P3|STARTED|Overall Study||48
243519|NCT01074125|590300|P2|STARTED|Overall Study||52
243520|NCT01074125|590301|P1|STARTED|Overall Study||51
243521|NCT01074099|590317|P2|NOT COMPLETED|Overall Study||0
243522|NCT01074099|590318|P1|NOT COMPLETED|Overall Study||0
243523|NCT01074099|590317|P2|COMPLETED|Overall Study||3
243524|NCT01074099|590318|P1|COMPLETED|Overall Study||2
243525|NCT01074099|590317|P2|STARTED|Overall Study||3
243526|NCT01074099|590318|P1|STARTED|Overall Study||2
243527|NCT01074047|590328|P2|NOT COMPLETED|Extension Phase||0
243528|NCT01074047|590329|P1|NOT COMPLETED|Extension Phase||22
243529|NCT01074047|590328|P2|COMPLETED|Extension Phase||0
243530|NCT01074047|590329|P1|COMPLETED|Extension Phase||0
243531|NCT01074047|590328|P2|Safety Population|Extension Phase||0
243532|NCT01074047|590329|P1|Safety Population|Extension Phase|Participants who enrolled in the extension phase|22
243533|NCT01074047|590328|P2|STARTED|Extension Phase||0
243534|NCT01074047|590329|P1|STARTED|Extension Phase|2 participants did not enroll in the extension period.|22
243535|NCT01074047|590328|P2|NOT COMPLETED|Survival Follow-Up Phase||136
243536|NCT01074047|590329|P1|NOT COMPLETED|Survival Follow-Up Phase||124
243537|NCT01074047|590328|P2|COMPLETED|Survival Follow-Up Phase||27
243538|NCT01074047|590329|P1|COMPLETED|Survival Follow-Up Phase||16
243539|NCT01074047|590328|P2|STARTED|Survival Follow-Up Phase||163
243540|NCT01074047|590329|P1|STARTED|Survival Follow-Up Phase||140
243541|NCT01074047|590328|P2|NOT COMPLETED|Treatment Phase||234
243542|NCT01074047|590329|P1|NOT COMPLETED|Treatment Phase||217
243543|NCT01074047|590328|P2|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|13
243544|NCT01074047|590329|P1|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|24
243545|NCT01074047|590328|P2|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|191
243546|NCT01074047|590329|P1|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|179
243547|NCT01074047|590328|P2|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|235
243548|NCT01074047|590329|P1|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|236
243549|NCT01074047|590328|P2|Treated Population|Treatment Phase|7 patients not treated with any drug regimen|240
243550|NCT01074047|590329|P1|Treated Population|Treatment Phase|5 patients not treated with any drug regimen|236
243551|NCT01074047|590328|P2|STARTED|Treatment Phase||247
243552|NCT01074047|590329|P1|STARTED|Treatment Phase||241
243553|NCT01074034|590403|P1|NOT COMPLETED|Overall Study||6
243554|NCT01074034|590403|P1|COMPLETED|Overall Study||205
243555|NCT01074034|590403|P1|STARTED|Overall Study||211
243556|NCT01074008|590417|P9|NOT COMPLETED|Overall Study||4
243557|NCT01074008|590418|P8|NOT COMPLETED|Overall Study||0
243558|NCT01074008|590419|P7|NOT COMPLETED|Overall Study||1
243559|NCT01074008|590420|P6|NOT COMPLETED|Overall Study||0
243560|NCT01074008|590421|P5|NOT COMPLETED|Overall Study||2
243561|NCT01074008|590422|P4|NOT COMPLETED|Overall Study||1
243562|NCT01074008|590423|P3|NOT COMPLETED|Overall Study||2
243563|NCT01074008|590424|P2|NOT COMPLETED|Overall Study||3
243564|NCT01074008|590425|P1|NOT COMPLETED|Overall Study||1
243565|NCT01074008|590417|P9|COMPLETED|Overall Study||7
243566|NCT01074008|590418|P8|COMPLETED|Overall Study||8
243567|NCT01074008|590419|P7|COMPLETED|Overall Study||7
243568|NCT01074008|590420|P6|COMPLETED|Overall Study||7
243569|NCT01074008|590421|P5|COMPLETED|Overall Study||6
243570|NCT01074008|590422|P4|COMPLETED|Overall Study||7
243571|NCT01074008|590423|P3|COMPLETED|Overall Study||6
243572|NCT01074008|590424|P2|COMPLETED|Overall Study||5
243573|NCT01074008|590425|P1|COMPLETED|Overall Study||7
243574|NCT01074008|590417|P9|Completed Direct-acting Antiviral Agent|Overall Study||5
243575|NCT01074008|590418|P8|Completed Direct-acting Antiviral Agent|Overall Study||7
243576|NCT01074008|590419|P7|Completed Direct-acting Antiviral Agent|Overall Study||8
243577|NCT01074008|590420|P6|Completed Direct-acting Antiviral Agent|Overall Study||5
243578|NCT01074008|590421|P5|Completed Direct-acting Antiviral Agent|Overall Study||8
243579|NCT01074008|590422|P4|Completed Direct-acting Antiviral Agent|Overall Study||8
243580|NCT01074008|590423|P3|Completed Direct-acting Antiviral Agent|Overall Study||7
243581|NCT01074008|590424|P2|Completed Direct-acting Antiviral Agent|Overall Study||7
243582|NCT01074008|590425|P1|Completed Direct-acting Antiviral Agent|Overall Study||8
243583|NCT01074008|590417|P9|STARTED|Overall Study||11
243584|NCT01074008|590418|P8|STARTED|Overall Study||8
243585|NCT01074008|590419|P7|STARTED|Overall Study||8
243586|NCT01074008|590420|P6|STARTED|Overall Study||7
243587|NCT01074008|590421|P5|STARTED|Overall Study||8
243588|NCT01074008|590422|P4|STARTED|Overall Study||8
243589|NCT01074008|590423|P3|STARTED|Overall Study||8
243590|NCT01074008|590424|P2|STARTED|Overall Study||8
243591|NCT01074008|590425|P1|STARTED|Overall Study||8
243592|NCT01073943|590535|P2|NOT COMPLETED|Overall Study||8
243593|NCT01073943|590536|P1|NOT COMPLETED|Overall Study||13
243594|NCT01073943|590535|P2|COMPLETED|Overall Study||295
243595|NCT01073943|590536|P1|COMPLETED|Overall Study||287
243596|NCT01073943|590535|P2|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|300
243597|NCT01073943|590536|P1|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|294
243598|NCT01073943|590535|P2|Safety Population (Treated)|Overall Study||302
243599|NCT01073943|590536|P1|Safety Population (Treated)|Overall Study||296
243600|NCT01073943|590535|P2|STARTED|Overall Study||303
243601|NCT01073943|590536|P1|STARTED|Overall Study||300
243602|NCT01073930|590562|P2|NOT COMPLETED|Overall Study||6
243603|NCT01073930|590563|P1|NOT COMPLETED|Overall Study||3
243604|NCT01073930|590562|P2|COMPLETED|Overall Study||295
243605|NCT01073930|590563|P1|COMPLETED|Overall Study||304
243606|NCT01073930|590562|P2|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|297
243607|NCT01073930|590563|P1|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|304
243608|NCT01073930|590562|P2|Safety Population (Treated)|Overall Study||298
243609|NCT01073930|590563|P1|Safety Population (Treated)|Overall Study||305
243610|NCT01073930|590562|P2|STARTED|Overall Study||301
243611|NCT01073930|590563|P1|STARTED|Overall Study||307
243612|NCT01073865|590587|P2|NOT COMPLETED|Overall Study||39
243613|NCT01073865|590588|P1|NOT COMPLETED|Overall Study||28
243614|NCT01073865|590587|P2|COMPLETED|Overall Study|Number of patients completed the study|74
243615|NCT01073865|590588|P1|COMPLETED|Overall Study|Number of patients completed the study|81
243616|NCT01073865|590587|P2|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|113
243617|NCT01073865|590588|P1|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|108
243618|NCT01073865|590587|P2|STARTED|Overall Study|Number of patients randomised|113
243619|NCT01073865|590588|P1|STARTED|Overall Study|Number of patients randomised|109
243620|NCT01073657|590600|P2|NOT COMPLETED|Overall Study||0
243621|NCT01073657|590601|P1|NOT COMPLETED|Overall Study||0
243622|NCT01073657|590600|P2|COMPLETED|Overall Study||16
243623|NCT01073657|590601|P1|COMPLETED|Overall Study||17
243624|NCT01073657|590600|P2|STARTED|Overall Study||16
243625|NCT01073657|590601|P1|STARTED|Overall Study||17
243626|NCT01073631|590607|P1|NOT COMPLETED|Overall Study||169
243627|NCT01073631|590607|P1|COMPLETED|Overall Study||374
243628|NCT01073631|590607|P1|STARTED|Overall Study||543
243629|NCT01073618|590612|P1|NOT COMPLETED|Overall Study||307
243630|NCT01073618|590612|P1|COMPLETED|Overall Study||385
243631|NCT01073618|590612|P1|STARTED|Overall Study||692
243632|NCT01073605|590620|P3|NOT COMPLETED|Overall Study||61
243633|NCT01073605|590621|P2|NOT COMPLETED|Overall Study||67
243634|NCT01073605|590622|P1|NOT COMPLETED|Overall Study||62
243635|NCT01073605|590620|P3|COMPLETED|Overall Study|Corresponds to follow-up until final height|8
243636|NCT01073605|590621|P2|COMPLETED|Overall Study|Corresponds to follow-up until final height|4
243637|NCT01073605|590622|P1|COMPLETED|Overall Study|Corresponds to follow-up until final height|6
243638|NCT01073605|590620|P3|Received Treatment|Overall Study||68
243639|NCT01073605|590621|P2|Received Treatment|Overall Study||70
243640|NCT01073605|590622|P1|Received Treatment|Overall Study||68
243641|NCT01073605|590620|P3|STARTED|Overall Study||69
243642|NCT01073605|590621|P2|STARTED|Overall Study||71
243643|NCT01073605|590622|P1|STARTED|Overall Study||68
243644|NCT01073566|590668|P2|NOT COMPLETED|Period 2 (6 Weeks)||0
243645|NCT01073566|590669|P1|NOT COMPLETED|Period 2 (6 Weeks)||1
243646|NCT01073566|590668|P2|COMPLETED|Period 2 (6 Weeks)||19
243647|NCT01073566|590669|P1|COMPLETED|Period 2 (6 Weeks)||18
243648|NCT01073566|590668|P2|STARTED|Period 2 (6 Weeks)||19
243649|NCT01073566|590669|P1|STARTED|Period 2 (6 Weeks)||19
243650|NCT01073566|590668|P2|NOT COMPLETED|Period 1 (6 Weeks)||0
243651|NCT01073566|590669|P1|NOT COMPLETED|Period 1 (6 Weeks)||0
243652|NCT01073566|590668|P2|COMPLETED|Period 1 (6 Weeks)||19
243653|NCT01073566|590669|P1|COMPLETED|Period 1 (6 Weeks)||19
243654|NCT01073566|590668|P2|STARTED|Period 1 (6 Weeks)||19
243655|NCT01073566|590669|P1|STARTED|Period 1 (6 Weeks)||19
243656|NCT01073462|590681|P1|NOT COMPLETED|Overall Study||41
243657|NCT01073462|590681|P1|COMPLETED|Overall Study||26
243658|NCT01073462|590681|P1|STARTED|Overall Study||67
243659|NCT01073449|590692|P1|NOT COMPLETED|Overall Study||0
243660|NCT01073449|590692|P1|COMPLETED|Overall Study||3362
243661|NCT01073449|590692|P1|STARTED|Overall Study||3362
243662|NCT01073293|590700|P2|NOT COMPLETED|Overall Study||11
243663|NCT01073293|590701|P1|NOT COMPLETED|Overall Study||5
243664|NCT01073293|590700|P2|COMPLETED|Overall Study||517
243665|NCT01073293|590701|P1|COMPLETED|Overall Study||521
243666|NCT01073293|590700|P2|STARTED|Overall Study||528
243667|NCT01073293|590701|P1|STARTED|Overall Study||526
243668|NCT01073267|590723|P1|NOT COMPLETED|Overall Study||3
243669|NCT01073267|590723|P1|COMPLETED|Overall Study||1
243670|NCT01073267|590723|P1|STARTED|Overall Study||4
243671|NCT01073163|590727|P1|NOT COMPLETED|Overall Study||3
243672|NCT01073163|590727|P1|COMPLETED|Overall Study|Patients completed study|51
243673|NCT01073163|590727|P1|Treated With >=6 Cycles|Overall Study||49
243674|NCT01073163|590727|P1|Treated With <6 Cycles|Overall Study||4
243675|NCT01073163|590727|P1|Enrolled But Not Treated|Overall Study||1
243676|NCT01073163|590727|P1|STARTED|Overall Study||54
243677|NCT01072929|590750|P3|NOT COMPLETED|Overall Study||9
243678|NCT01072929|590751|P2|NOT COMPLETED|Overall Study||51
243679|NCT01072929|590752|P1|NOT COMPLETED|Overall Study||44
243680|NCT01072929|590750|P3|COMPLETED|Overall Study||24
243681|NCT01072929|590751|P2|COMPLETED|Overall Study||150
243682|NCT01072929|590752|P1|COMPLETED|Overall Study||155
243683|NCT01072929|590750|P3|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|31
243684|NCT01072929|590751|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
243685|NCT01072929|590752|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
243686|NCT01072929|590750|P3|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|32
243687|NCT01072929|590751|P2|Safety Population|Overall Study|Treated participants. Three participants were randomized but not treated.|198
243688|NCT01072929|590752|P1|Safety Population|Overall Study|Treated participants|199
243689|NCT01072929|590750|P3|STARTED|Overall Study||33
243690|NCT01072929|590751|P2|STARTED|Overall Study||201
243691|NCT01072929|590752|P1|STARTED|Overall Study||199
243692|NCT01072877|590831|P5|NOT COMPLETED|Overall Study||0
243693|NCT01072877|590832|P4|NOT COMPLETED|Overall Study||2
243694|NCT01072877|590833|P3|NOT COMPLETED|Overall Study||0
243695|NCT01072877|590834|P2|NOT COMPLETED|Overall Study||1
243696|NCT01072877|590835|P1|NOT COMPLETED|Overall Study||1
243697|NCT01072877|590831|P5|COMPLETED|Overall Study||63
243698|NCT01072877|590832|P4|COMPLETED|Overall Study||50
243699|NCT01072877|590833|P3|COMPLETED|Overall Study||51
243700|NCT01072877|590834|P2|COMPLETED|Overall Study||56
243701|NCT01072877|590835|P1|COMPLETED|Overall Study||55
243702|NCT01072877|590831|P5|STARTED|Overall Study||63
243703|NCT01072877|590832|P4|STARTED|Overall Study||52
243704|NCT01072877|590833|P3|STARTED|Overall Study||51
243705|NCT01072877|590834|P2|STARTED|Overall Study||57
243706|NCT01072877|590835|P1|STARTED|Overall Study||56
243707|NCT01072773|590857|P1|NOT COMPLETED|Overall Study||0
243708|NCT01072773|590857|P1|COMPLETED|Overall Study||2
243709|NCT01072773|590857|P1|STARTED|Overall Study||2
243710|NCT01072669|590868|P2|NOT COMPLETED|Overall Study||0
243711|NCT01072669|590869|P1|NOT COMPLETED|Overall Study||0
243712|NCT01072669|590868|P2|COMPLETED|Overall Study||5
243713|NCT01072669|590869|P1|COMPLETED|Overall Study||15
243714|NCT01072669|590868|P2|STARTED|Overall Study||5
243715|NCT01072669|590869|P1|STARTED|Overall Study||15
243716|NCT01072656|590877|P2|NOT COMPLETED|Second Intervention||0
243717|NCT01072656|590878|P1|NOT COMPLETED|Second Intervention||0
243718|NCT01072656|590877|P2|COMPLETED|Second Intervention||4
243719|NCT01072656|590878|P1|COMPLETED|Second Intervention||5
243720|NCT01072656|590877|P2|STARTED|Second Intervention||4
243721|NCT01072656|590878|P1|STARTED|Second Intervention||5
243722|NCT01072656|590877|P2|NOT COMPLETED|First Intervention||0
243723|NCT01072656|590878|P1|NOT COMPLETED|First Intervention||0
243724|NCT01072656|590877|P2|COMPLETED|First Intervention||4
243725|NCT01072656|590878|P1|COMPLETED|First Intervention||5
243726|NCT01072656|590877|P2|STARTED|First Intervention||4
243727|NCT01072656|590878|P1|STARTED|First Intervention||5
243728|NCT01072643|590888|P1|NOT COMPLETED|Overall Study||0
243729|NCT01072643|590888|P1|COMPLETED|Overall Study||4
243730|NCT01072643|590888|P1|STARTED|Overall Study||4
243731|NCT01072630|590914|P3|NOT COMPLETED|Overall Study||13
243732|NCT01072630|590915|P2|NOT COMPLETED|Overall Study||60
243733|NCT01072630|590916|P1|NOT COMPLETED|Overall Study||55
243734|NCT01072630|590914|P3|COMPLETED|Overall Study||17
243735|NCT01072630|590915|P2|COMPLETED|Overall Study||172
243736|NCT01072630|590916|P1|COMPLETED|Overall Study||175
243737|NCT01072630|590914|P3|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|28
243738|NCT01072630|590915|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|230
243739|NCT01072630|590916|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|224
243740|NCT01072630|590914|P3|Safety Population|Overall Study|Treated participants.|30
243741|NCT01072630|590915|P2|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|231
243742|NCT01072630|590916|P1|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|229
243743|NCT01072630|590914|P3|STARTED|Overall Study||30
243744|NCT01072630|590915|P2|STARTED|Overall Study||232
243745|NCT01072630|590916|P1|STARTED|Overall Study||230
243746|NCT01072617|590990|P1|NOT COMPLETED|Overall Study||0
243747|NCT01072617|590990|P1|COMPLETED|Overall Study||8
243748|NCT01072617|590990|P1|STARTED|Overall Study||8
243749|NCT01072539|590997|P1|NOT COMPLETED|Overall Study||3
243750|NCT01072539|590997|P1|COMPLETED|Overall Study|Refer to the Safety Analysis Set. Data for completion were not collected.|3169
243751|NCT01072539|590997|P1|STARTED|Overall Study||3172
243752|NCT01072526|591005|P2|NOT COMPLETED|Overall Study||0
243753|NCT01072526|591006|P1|NOT COMPLETED|Overall Study||0
243754|NCT01072526|591005|P2|COMPLETED|Overall Study||0
243755|NCT01072526|591006|P1|COMPLETED|Overall Study|Study completed in September 2008(recruited 6 patients total of 20 anticipated)|6
243756|NCT01072526|591005|P2|STARTED|Overall Study||0
243757|NCT01072526|591006|P1|STARTED|Overall Study|Study started in December 2007 (recruited 6 patients total of 20 anticipated)|6
243758|NCT01072500|591021|P2|NOT COMPLETED|Overall Study||14
243759|NCT01072500|591022|P1|NOT COMPLETED|Overall Study||24
243760|NCT01072500|591021|P2|COMPLETED|Overall Study||803
243761|NCT01072500|591022|P1|COMPLETED|Overall Study||794
243762|NCT01072500|591021|P2|STARTED|Overall Study||817
243763|NCT01072500|591022|P1|STARTED|Overall Study||818
243764|NCT01072448|591032|P2|NOT COMPLETED|Overall Study||30
243765|NCT01072448|591033|P1|NOT COMPLETED|Overall Study||19
243766|NCT01072448|591032|P2|COMPLETED|Overall Study||130
243767|NCT01072448|591033|P1|COMPLETED|Overall Study||144
243768|NCT01072448|591032|P2|STARTED|Overall Study||160
243769|NCT01072448|591033|P1|STARTED|Overall Study||163
243770|NCT01072409|591041|P1|NOT COMPLETED|Overall Study||7
243771|NCT01072409|591041|P1|COMPLETED|Overall Study||38
243772|NCT01072409|591041|P1|STARTED|Overall Study||45
243773|NCT01072396|591047|P2|NOT COMPLETED|Period Two||3
243774|NCT01072396|591048|P1|NOT COMPLETED|Period Two||1
243775|NCT01072396|591047|P2|COMPLETED|Period Two||57
243776|NCT01072396|591048|P1|COMPLETED|Period Two||57
243777|NCT01072396|591047|P2|STARTED|Period Two||60
243778|NCT01072396|591048|P1|STARTED|Period Two||58
243779|NCT01072396|591047|P2|NOT COMPLETED|Washout Period||1
243780|NCT01072396|591048|P1|NOT COMPLETED|Washout Period||0
243781|NCT01072396|591047|P2|COMPLETED|Washout Period||60
243782|NCT01072396|591048|P1|COMPLETED|Washout Period||58
243783|NCT01072396|591047|P2|STARTED|Washout Period||61
243784|NCT01072396|591048|P1|STARTED|Washout Period||58
243785|NCT01072396|591047|P2|NOT COMPLETED|Period One||2
243786|NCT01072396|591048|P1|NOT COMPLETED|Period One||5
243787|NCT01072396|591047|P2|COMPLETED|Period One||61
243788|NCT01072396|591048|P1|COMPLETED|Period One||58
243789|NCT01072396|591047|P2|STARTED|Period One||63
243790|NCT01072396|591048|P1|STARTED|Period One||63
243791|NCT01072357|591060|P2|NOT COMPLETED|Overall Study||1
243792|NCT01072357|591061|P1|NOT COMPLETED|Overall Study||0
243793|NCT01072357|591060|P2|COMPLETED|Overall Study||14
243794|NCT01072357|591061|P1|COMPLETED|Overall Study||15
243795|NCT01072357|591060|P2|STARTED|Overall Study||15
243796|NCT01072357|591061|P1|STARTED|Overall Study||15
243797|NCT01072344|591071|P2|NOT COMPLETED|Overall Study||18
243798|NCT01072344|591072|P1|NOT COMPLETED|Overall Study||11
243799|NCT01072344|591071|P2|COMPLETED|Overall Study||29
243800|NCT01072344|591072|P1|COMPLETED|Overall Study||35
243801|NCT01072344|591071|P2|STARTED|Overall Study||47
243802|NCT01072344|591072|P1|STARTED|Overall Study||46
243803|NCT01072331|591089|P3|NOT COMPLETED|Overall Study||0
243804|NCT01072331|591090|P2|NOT COMPLETED|Overall Study||0
243805|NCT01072331|591091|P1|NOT COMPLETED|Overall Study||0
243806|NCT01072331|591089|P3|COMPLETED|Overall Study||32
243807|NCT01072331|591090|P2|COMPLETED|Overall Study||33
243808|NCT01072331|591091|P1|COMPLETED|Overall Study||34
243809|NCT01072331|591089|P3|STARTED|Overall Study||32
243810|NCT01072331|591090|P2|STARTED|Overall Study||33
243811|NCT01072331|591091|P1|STARTED|Overall Study||34
243812|NCT01072201|591110|P2|NOT COMPLETED|Overall Study||1
243813|NCT01072201|591111|P1|NOT COMPLETED|Overall Study||0
243814|NCT01072201|591110|P2|COMPLETED|Overall Study||29
243815|NCT01072201|591111|P1|COMPLETED|Overall Study||30
243816|NCT01072201|591110|P2|STARTED|Overall Study||30
243817|NCT01072201|591111|P1|STARTED|Overall Study||30
243818|NCT01072188|591123|P2|NOT COMPLETED|Overall Study||0
243819|NCT01072188|591124|P1|NOT COMPLETED|Overall Study||0
243820|NCT01072188|591123|P2|COMPLETED|Overall Study||23
243821|NCT01072188|591124|P1|COMPLETED|Overall Study||22
243822|NCT01072188|591123|P2|STARTED|Overall Study||23
243823|NCT01072188|591124|P1|STARTED|Overall Study||22
243824|NCT01072175|591144|P13|NOT COMPLETED|Part D (HPMC Capsules)||39
243825|NCT01072175|591145|P12|NOT COMPLETED|Part D (HPMC Capsules)||43
243826|NCT01072175|591146|P11|NOT COMPLETED|Part D (HPMC Capsules)||16
243827|NCT01072175|591147|P10|NOT COMPLETED|Part D (HPMC Capsules)||12
243828|NCT01072175|591148|P9|NOT COMPLETED|Part D (HPMC Capsules)||0
243829|NCT01072175|591149|P8|NOT COMPLETED|Part D (HPMC Capsules)||0
243830|NCT01072175|591150|P7|NOT COMPLETED|Part D (HPMC Capsules)||0
243831|NCT01072175|591151|P6|NOT COMPLETED|Part D (HPMC Capsules)||0
243832|NCT01072175|591152|P5|NOT COMPLETED|Part D (HPMC Capsules)||0
243833|NCT01072175|591153|P4|NOT COMPLETED|Part D (HPMC Capsules)||0
243834|NCT01072175|591154|P3|NOT COMPLETED|Part D (HPMC Capsules)||0
243835|NCT01072175|591155|P2|NOT COMPLETED|Part D (HPMC Capsules)||0
243836|NCT01072175|591156|P1|NOT COMPLETED|Part D (HPMC Capsules)||0
243837|NCT01072175|591144|P13|COMPLETED|Part D (HPMC Capsules)||0
243838|NCT01072175|591145|P12|COMPLETED|Part D (HPMC Capsules)||0
243839|NCT01072175|591146|P11|COMPLETED|Part D (HPMC Capsules)||0
243840|NCT01072175|591147|P10|COMPLETED|Part D (HPMC Capsules)||0
243841|NCT01072175|591148|P9|COMPLETED|Part D (HPMC Capsules)||0
243842|NCT01072175|591149|P8|COMPLETED|Part D (HPMC Capsules)||0
243843|NCT01072175|591150|P7|COMPLETED|Part D (HPMC Capsules)||0
243844|NCT01072175|591151|P6|COMPLETED|Part D (HPMC Capsules)||0
243845|NCT01072175|591152|P5|COMPLETED|Part D (HPMC Capsules)||0
243846|NCT01072175|591153|P4|COMPLETED|Part D (HPMC Capsules)||0
243847|NCT01072175|591154|P3|COMPLETED|Part D (HPMC Capsules)||0
243848|NCT01072175|591155|P2|COMPLETED|Part D (HPMC Capsules)||0
243849|NCT01072175|591156|P1|COMPLETED|Part D (HPMC Capsules)||0
243850|NCT01072175|591144|P13|STARTED|Part D (HPMC Capsules)||39
243851|NCT01072175|591145|P12|STARTED|Part D (HPMC Capsules)||43
243852|NCT01072175|591146|P11|STARTED|Part D (HPMC Capsules)||16
243853|NCT01072175|591147|P10|STARTED|Part D (HPMC Capsules)||12
243854|NCT01072175|591148|P9|STARTED|Part D (HPMC Capsules)||0
243855|NCT01072175|591149|P8|STARTED|Part D (HPMC Capsules)||0
243856|NCT01072175|591150|P7|STARTED|Part D (HPMC Capsules)||0
243857|NCT01072175|591151|P6|STARTED|Part D (HPMC Capsules)||0
243858|NCT01072175|591152|P5|STARTED|Part D (HPMC Capsules)||0
243859|NCT01072175|591153|P4|STARTED|Part D (HPMC Capsules)||0
243860|NCT01072175|591154|P3|STARTED|Part D (HPMC Capsules)||0
243861|NCT01072175|591155|P2|STARTED|Part D (HPMC Capsules)||0
243862|NCT01072175|591156|P1|STARTED|Part D (HPMC Capsules)||0
243863|NCT01072175|591144|P13|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
243864|NCT01072175|591145|P12|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
243865|NCT01072175|591146|P11|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
243866|NCT01072175|591147|P10|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
243867|NCT01072175|591148|P9|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||45
243868|NCT01072175|591149|P8|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
243869|NCT01072175|591150|P7|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
243870|NCT01072175|591151|P6|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
243871|NCT01072175|591152|P5|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
243872|NCT01072175|591153|P4|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
243873|NCT01072175|591154|P3|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
243874|NCT01072175|591155|P2|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
243875|NCT01072175|591156|P1|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
243876|NCT01072175|591144|P13|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
243877|NCT01072175|591145|P12|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
243878|NCT01072175|591146|P11|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
243879|NCT01072175|591147|P10|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
243880|NCT01072175|591148|P9|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
243881|NCT01072175|591149|P8|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
243882|NCT01072175|591150|P7|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
243883|NCT01072175|591151|P6|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
243884|NCT01072175|591152|P5|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
243885|NCT01072175|591153|P4|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
243886|NCT01072175|591154|P3|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
243887|NCT01072175|591155|P2|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
243888|NCT01072175|591156|P1|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
243889|NCT01072175|591144|P13|STARTED|Part C (Phase II: Crossover Phase [CP])||0
243890|NCT01072175|591145|P12|STARTED|Part C (Phase II: Crossover Phase [CP])||0
243891|NCT01072175|591146|P11|STARTED|Part C (Phase II: Crossover Phase [CP])||0
243892|NCT01072175|591147|P10|STARTED|Part C (Phase II: Crossover Phase [CP])||0
243893|NCT01072175|591148|P9|STARTED|Part C (Phase II: Crossover Phase [CP])||45
243894|NCT01072175|591149|P8|STARTED|Part C (Phase II: Crossover Phase [CP])||0
243895|NCT01072175|591150|P7|STARTED|Part C (Phase II: Crossover Phase [CP])||0
243896|NCT01072175|591151|P6|STARTED|Part C (Phase II: Crossover Phase [CP])||0
243897|NCT01072175|591152|P5|STARTED|Part C (Phase II: Crossover Phase [CP])||0
243898|NCT01072175|591153|P4|STARTED|Part C (Phase II: Crossover Phase [CP])||0
243899|NCT01072175|591154|P3|STARTED|Part C (Phase II: Crossover Phase [CP])||0
243900|NCT01072175|591155|P2|STARTED|Part C (Phase II: Crossover Phase [CP])||0
243901|NCT01072175|591156|P1|STARTED|Part C (Phase II: Crossover Phase [CP])||0
243902|NCT01072175|591144|P13|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
243903|NCT01072175|591145|P12|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
243904|NCT01072175|591146|P11|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
243905|NCT01072175|591147|P10|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
243906|NCT01072175|591148|P9|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
243907|NCT01072175|591149|P8|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
243908|NCT01072175|591150|P7|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
243909|NCT01072175|591151|P6|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
243910|NCT01072175|591152|P5|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
243911|NCT01072175|591153|P4|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
243912|NCT01072175|591154|P3|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
243913|NCT01072175|591155|P2|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
243914|NCT01072175|591156|P1|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
243915|NCT01072175|591144|P13|COMPLETED|Part C (Phase II: Randomized Phase)||0
243916|NCT01072175|591145|P12|COMPLETED|Part C (Phase II: Randomized Phase)||0
243917|NCT01072175|591146|P11|COMPLETED|Part C (Phase II: Randomized Phase)||0
243918|NCT01072175|591147|P10|COMPLETED|Part C (Phase II: Randomized Phase)||0
243919|NCT01072175|591148|P9|COMPLETED|Part C (Phase II: Randomized Phase)||0
243920|NCT01072175|591149|P8|COMPLETED|Part C (Phase II: Randomized Phase)||0
243921|NCT01072175|591150|P7|COMPLETED|Part C (Phase II: Randomized Phase)||0
243922|NCT01072175|591151|P6|COMPLETED|Part C (Phase II: Randomized Phase)||0
243923|NCT01072175|591152|P5|COMPLETED|Part C (Phase II: Randomized Phase)||0
243924|NCT01072175|591153|P4|COMPLETED|Part C (Phase II: Randomized Phase)||0
243925|NCT01072175|591154|P3|COMPLETED|Part C (Phase II: Randomized Phase)||0
243926|NCT01072175|591155|P2|COMPLETED|Part C (Phase II: Randomized Phase)||0
243927|NCT01072175|591156|P1|COMPLETED|Part C (Phase II: Randomized Phase)||0
243928|NCT01072175|591144|P13|STARTED|Part C (Phase II: Randomized Phase)||0
243929|NCT01072175|591145|P12|STARTED|Part C (Phase II: Randomized Phase)||0
243930|NCT01072175|591146|P11|STARTED|Part C (Phase II: Randomized Phase)||0
243931|NCT01072175|591147|P10|STARTED|Part C (Phase II: Randomized Phase)||0
243932|NCT01072175|591148|P9|STARTED|Part C (Phase II: Randomized Phase)||0
243933|NCT01072175|591149|P8|STARTED|Part C (Phase II: Randomized Phase)||54
243934|NCT01072175|591150|P7|STARTED|Part C (Phase II: Randomized Phase)||54
243935|NCT01072175|591151|P6|STARTED|Part C (Phase II: Randomized Phase)||54
243936|NCT01072175|591152|P5|STARTED|Part C (Phase II: Randomized Phase)||0
243937|NCT01072175|591153|P4|STARTED|Part C (Phase II: Randomized Phase)||0
243938|NCT01072175|591154|P3|STARTED|Part C (Phase II: Randomized Phase)||0
243939|NCT01072175|591155|P2|STARTED|Part C (Phase II: Randomized Phase)||0
243940|NCT01072175|591156|P1|STARTED|Part C (Phase II: Randomized Phase)||0
243941|NCT01072175|591144|P13|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
243942|NCT01072175|591145|P12|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
243943|NCT01072175|591146|P11|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
243944|NCT01072175|591147|P10|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
243945|NCT01072175|591148|P9|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
243946|NCT01072175|591149|P8|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
243947|NCT01072175|591150|P7|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
243948|NCT01072175|591151|P6|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
243949|NCT01072175|591152|P5|NOT COMPLETED|Part B (Dose Escalation and Expansion)||94
243950|NCT01072175|591153|P4|NOT COMPLETED|Part B (Dose Escalation and Expansion)||27
243951|NCT01072175|591154|P3|NOT COMPLETED|Part B (Dose Escalation and Expansion)||23
243952|NCT01072175|591155|P2|NOT COMPLETED|Part B (Dose Escalation and Expansion)||6
243953|NCT01072175|591156|P1|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
243954|NCT01072175|591144|P13|COMPLETED|Part B (Dose Escalation and Expansion)||0
243955|NCT01072175|591145|P12|COMPLETED|Part B (Dose Escalation and Expansion)||0
243956|NCT01072175|591146|P11|COMPLETED|Part B (Dose Escalation and Expansion)||0
243957|NCT01072175|591147|P10|COMPLETED|Part B (Dose Escalation and Expansion)||0
243958|NCT01072175|591148|P9|COMPLETED|Part B (Dose Escalation and Expansion)||0
243959|NCT01072175|591149|P8|COMPLETED|Part B (Dose Escalation and Expansion)||0
243960|NCT01072175|591150|P7|COMPLETED|Part B (Dose Escalation and Expansion)||0
243961|NCT01072175|591151|P6|COMPLETED|Part B (Dose Escalation and Expansion)||0
243962|NCT01072175|591152|P5|COMPLETED|Part B (Dose Escalation and Expansion)||0
243963|NCT01072175|591153|P4|COMPLETED|Part B (Dose Escalation and Expansion)||0
243964|NCT01072175|591154|P3|COMPLETED|Part B (Dose Escalation and Expansion)||0
243965|NCT01072175|591155|P2|COMPLETED|Part B (Dose Escalation and Expansion)||0
243966|NCT01072175|591156|P1|COMPLETED|Part B (Dose Escalation and Expansion)||0
243967|NCT01072175|591144|P13|STARTED|Part B (Dose Escalation and Expansion)||0
243968|NCT01072175|591145|P12|STARTED|Part B (Dose Escalation and Expansion)||0
243969|NCT01072175|591146|P11|STARTED|Part B (Dose Escalation and Expansion)||0
243970|NCT01072175|591147|P10|STARTED|Part B (Dose Escalation and Expansion)||0
243971|NCT01072175|591148|P9|STARTED|Part B (Dose Escalation and Expansion)||0
243972|NCT01072175|591149|P8|STARTED|Part B (Dose Escalation and Expansion)||0
243973|NCT01072175|591150|P7|STARTED|Part B (Dose Escalation and Expansion)||0
243974|NCT01072175|591151|P6|STARTED|Part B (Dose Escalation and Expansion)||0
243975|NCT01072175|591152|P5|STARTED|Part B (Dose Escalation and Expansion)||94
243976|NCT01072175|591153|P4|STARTED|Part B (Dose Escalation and Expansion)||27
243977|NCT01072175|591154|P3|STARTED|Part B (Dose Escalation and Expansion)||23
243978|NCT01072175|591155|P2|STARTED|Part B (Dose Escalation and Expansion)||6
243979|NCT01072175|591156|P1|STARTED|Part B (Dose Escalation and Expansion)||0
243980|NCT01072175|591144|P13|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
243981|NCT01072175|591145|P12|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
243982|NCT01072175|591146|P11|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
243983|NCT01072175|591147|P10|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
243984|NCT01072175|591148|P9|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
243985|NCT01072175|591149|P8|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
243986|NCT01072175|591150|P7|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
243987|NCT01072175|591151|P6|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
243988|NCT01072175|591152|P5|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
243989|NCT01072175|591153|P4|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
243990|NCT01072175|591154|P3|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
243991|NCT01072175|591155|P2|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
243992|NCT01072175|591156|P1|NOT COMPLETED|Part A (Drug-Drug Interaction)||8
243993|NCT01072175|591144|P13|COMPLETED|Part A (Drug-Drug Interaction)||0
243994|NCT01072175|591145|P12|COMPLETED|Part A (Drug-Drug Interaction)||0
243995|NCT01072175|591146|P11|COMPLETED|Part A (Drug-Drug Interaction)||0
243996|NCT01072175|591147|P10|COMPLETED|Part A (Drug-Drug Interaction)||0
243997|NCT01072175|591148|P9|COMPLETED|Part A (Drug-Drug Interaction)||0
243998|NCT01072175|591149|P8|COMPLETED|Part A (Drug-Drug Interaction)||0
243999|NCT01072175|591150|P7|COMPLETED|Part A (Drug-Drug Interaction)||0
244000|NCT01072175|591151|P6|COMPLETED|Part A (Drug-Drug Interaction)||0
244001|NCT01072175|591152|P5|COMPLETED|Part A (Drug-Drug Interaction)||0
244002|NCT01072175|591153|P4|COMPLETED|Part A (Drug-Drug Interaction)||0
244003|NCT01072175|591154|P3|COMPLETED|Part A (Drug-Drug Interaction)||0
244004|NCT01072175|591155|P2|COMPLETED|Part A (Drug-Drug Interaction)||0
244005|NCT01072175|591156|P1|COMPLETED|Part A (Drug-Drug Interaction)||0
244006|NCT01072175|591144|P13|STARTED|Part A (Drug-Drug Interaction)||0
244007|NCT01072175|591145|P12|STARTED|Part A (Drug-Drug Interaction)||0
244008|NCT01072175|591146|P11|STARTED|Part A (Drug-Drug Interaction)||0
244009|NCT01072175|591147|P10|STARTED|Part A (Drug-Drug Interaction)||0
244010|NCT01072175|591148|P9|STARTED|Part A (Drug-Drug Interaction)||0
244011|NCT01072175|591149|P8|STARTED|Part A (Drug-Drug Interaction)||0
244012|NCT01072175|591150|P7|STARTED|Part A (Drug-Drug Interaction)||0
244013|NCT01072175|591151|P6|STARTED|Part A (Drug-Drug Interaction)||0
244014|NCT01072175|591152|P5|STARTED|Part A (Drug-Drug Interaction)||0
244015|NCT01072175|591153|P4|STARTED|Part A (Drug-Drug Interaction)||0
244016|NCT01072175|591154|P3|STARTED|Part A (Drug-Drug Interaction)||0
244017|NCT01072175|591155|P2|STARTED|Part A (Drug-Drug Interaction)||0
244018|NCT01072175|591156|P1|STARTED|Part A (Drug-Drug Interaction)||8
244019|NCT01072149|591365|P18|NOT COMPLETED|Treatment Period 3 (28 Days)||0
244020|NCT01072149|591366|P17|NOT COMPLETED|Treatment Period 3 (28 Days)||0
244021|NCT01072149|591367|P16|NOT COMPLETED|Treatment Period 3 (28 Days)||0
244022|NCT01072149|591368|P15|NOT COMPLETED|Treatment Period 3 (28 Days)||0
244023|NCT01072149|591369|P14|NOT COMPLETED|Treatment Period 3 (28 Days)||1
244024|NCT01072149|591370|P13|NOT COMPLETED|Treatment Period 3 (28 Days)||0
244025|NCT01072149|591371|P12|NOT COMPLETED|Treatment Period 3 (28 Days)||0
244026|NCT01072149|591372|P11|NOT COMPLETED|Treatment Period 3 (28 Days)||0
244027|NCT01072149|591373|P10|NOT COMPLETED|Treatment Period 3 (28 Days)||0
244028|NCT01072149|591374|P9|NOT COMPLETED|Treatment Period 3 (28 Days)||0
244029|NCT01072149|591375|P8|NOT COMPLETED|Treatment Period 3 (28 Days)||0
244030|NCT01072149|591376|P7|NOT COMPLETED|Treatment Period 3 (28 Days)||0
244031|NCT01072149|591377|P6|NOT COMPLETED|Treatment Period 3 (28 Days)||0
244032|NCT01072149|591378|P5|NOT COMPLETED|Treatment Period 3 (28 Days)||0
244033|NCT01072149|591379|P4|NOT COMPLETED|Treatment Period 3 (28 Days)||0
244034|NCT01072149|591380|P3|NOT COMPLETED|Treatment Period 3 (28 Days)||1
244035|NCT01072149|591381|P2|NOT COMPLETED|Treatment Period 3 (28 Days)||0
244036|NCT01072149|591382|P1|NOT COMPLETED|Treatment Period 3 (28 Days)||0
244037|NCT01072149|591365|P18|COMPLETED|Treatment Period 3 (28 Days)||2
244038|NCT01072149|591366|P17|COMPLETED|Treatment Period 3 (28 Days)||3
244039|NCT01072149|591367|P16|COMPLETED|Treatment Period 3 (28 Days)||1
244040|NCT01072149|591368|P15|COMPLETED|Treatment Period 3 (28 Days)||3
244041|NCT01072149|591369|P14|COMPLETED|Treatment Period 3 (28 Days)||2
244042|NCT01072149|591370|P13|COMPLETED|Treatment Period 3 (28 Days)||2
244043|NCT01072149|591371|P12|COMPLETED|Treatment Period 3 (28 Days)||3
244044|NCT01072149|591372|P11|COMPLETED|Treatment Period 3 (28 Days)||2
244045|NCT01072149|591373|P10|COMPLETED|Treatment Period 3 (28 Days)||3
244046|NCT01072149|591374|P9|COMPLETED|Treatment Period 3 (28 Days)||3
244047|NCT01072149|591375|P8|COMPLETED|Treatment Period 3 (28 Days)||2
244048|NCT01072149|591376|P7|COMPLETED|Treatment Period 3 (28 Days)||3
244049|NCT01072149|591377|P6|COMPLETED|Treatment Period 3 (28 Days)||3
244050|NCT01072149|591378|P5|COMPLETED|Treatment Period 3 (28 Days)||3
244051|NCT01072149|591379|P4|COMPLETED|Treatment Period 3 (28 Days)||3
244052|NCT01072149|591380|P3|COMPLETED|Treatment Period 3 (28 Days)||0
244053|NCT01072149|591381|P2|COMPLETED|Treatment Period 3 (28 Days)||2
244054|NCT01072149|591382|P1|COMPLETED|Treatment Period 3 (28 Days)||2
244055|NCT01072149|591365|P18|STARTED|Treatment Period 3 (28 Days)||2
244056|NCT01072149|591366|P17|STARTED|Treatment Period 3 (28 Days)||3
244057|NCT01072149|591367|P16|STARTED|Treatment Period 3 (28 Days)||1
244058|NCT01072149|591368|P15|STARTED|Treatment Period 3 (28 Days)||3
244059|NCT01072149|591369|P14|STARTED|Treatment Period 3 (28 Days)||3
244060|NCT01072149|591370|P13|STARTED|Treatment Period 3 (28 Days)||2
244061|NCT01072149|591371|P12|STARTED|Treatment Period 3 (28 Days)||3
244062|NCT01072149|591372|P11|STARTED|Treatment Period 3 (28 Days)||2
244063|NCT01072149|591373|P10|STARTED|Treatment Period 3 (28 Days)||3
244064|NCT01072149|591374|P9|STARTED|Treatment Period 3 (28 Days)||3
244065|NCT01072149|591375|P8|STARTED|Treatment Period 3 (28 Days)||2
244066|NCT01072149|591376|P7|STARTED|Treatment Period 3 (28 Days)||3
244067|NCT01072149|591377|P6|STARTED|Treatment Period 3 (28 Days)||3
244068|NCT01072149|591378|P5|STARTED|Treatment Period 3 (28 Days)||3
244069|NCT01072149|591379|P4|STARTED|Treatment Period 3 (28 Days)||3
244070|NCT01072149|591380|P3|STARTED|Treatment Period 3 (28 Days)||1
244071|NCT01072149|591381|P2|STARTED|Treatment Period 3 (28 Days)||2
244072|NCT01072149|591382|P1|STARTED|Treatment Period 3 (28 Days)||2
244073|NCT01072149|591365|P18|NOT COMPLETED|Washout Period 2 (14 Days)||0
244074|NCT01072149|591366|P17|NOT COMPLETED|Washout Period 2 (14 Days)||0
244075|NCT01072149|591367|P16|NOT COMPLETED|Washout Period 2 (14 Days)||2
244076|NCT01072149|591368|P15|NOT COMPLETED|Washout Period 2 (14 Days)||0
244077|NCT01072149|591369|P14|NOT COMPLETED|Washout Period 2 (14 Days)||0
244078|NCT01072149|591370|P13|NOT COMPLETED|Washout Period 2 (14 Days)||1
244079|NCT01072149|591371|P12|NOT COMPLETED|Washout Period 2 (14 Days)||0
244080|NCT01072149|591372|P11|NOT COMPLETED|Washout Period 2 (14 Days)||0
244081|NCT01072149|591373|P10|NOT COMPLETED|Washout Period 2 (14 Days)||0
244082|NCT01072149|591374|P9|NOT COMPLETED|Washout Period 2 (14 Days)||0
244083|NCT01072149|591375|P8|NOT COMPLETED|Washout Period 2 (14 Days)||0
244084|NCT01072149|591376|P7|NOT COMPLETED|Washout Period 2 (14 Days)||0
244085|NCT01072149|591377|P6|NOT COMPLETED|Washout Period 2 (14 Days)||0
244086|NCT01072149|591378|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
244087|NCT01072149|591379|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
244088|NCT01072149|591380|P3|NOT COMPLETED|Washout Period 2 (14 Days)||0
244089|NCT01072149|591381|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
244090|NCT01072149|591382|P1|NOT COMPLETED|Washout Period 2 (14 Days)||1
244091|NCT01072149|591365|P18|COMPLETED|Washout Period 2 (14 Days)||2
244092|NCT01072149|591366|P17|COMPLETED|Washout Period 2 (14 Days)||3
244093|NCT01072149|591367|P16|COMPLETED|Washout Period 2 (14 Days)||1
244094|NCT01072149|591368|P15|COMPLETED|Washout Period 2 (14 Days)||3
244095|NCT01072149|591369|P14|COMPLETED|Washout Period 2 (14 Days)||3
244096|NCT01072149|591370|P13|COMPLETED|Washout Period 2 (14 Days)||2
244097|NCT01072149|591371|P12|COMPLETED|Washout Period 2 (14 Days)||3
244098|NCT01072149|591372|P11|COMPLETED|Washout Period 2 (14 Days)||2
244099|NCT01072149|591373|P10|COMPLETED|Washout Period 2 (14 Days)||3
244100|NCT01072149|591374|P9|COMPLETED|Washout Period 2 (14 Days)||3
244101|NCT01072149|591375|P8|COMPLETED|Washout Period 2 (14 Days)||2
244102|NCT01072149|591376|P7|COMPLETED|Washout Period 2 (14 Days)||3
244103|NCT01072149|591377|P6|COMPLETED|Washout Period 2 (14 Days)||3
244104|NCT01072149|591378|P5|COMPLETED|Washout Period 2 (14 Days)||3
244105|NCT01072149|591379|P4|COMPLETED|Washout Period 2 (14 Days)||3
244106|NCT01072149|591380|P3|COMPLETED|Washout Period 2 (14 Days)||1
244107|NCT01072149|591381|P2|COMPLETED|Washout Period 2 (14 Days)||2
244108|NCT01072149|591382|P1|COMPLETED|Washout Period 2 (14 Days)||2
244109|NCT01072149|591365|P18|STARTED|Washout Period 2 (14 Days)||2
244110|NCT01072149|591366|P17|STARTED|Washout Period 2 (14 Days)||3
244111|NCT01072149|591367|P16|STARTED|Washout Period 2 (14 Days)||3
244112|NCT01072149|591368|P15|STARTED|Washout Period 2 (14 Days)||3
244113|NCT01072149|591369|P14|STARTED|Washout Period 2 (14 Days)||3
244114|NCT01072149|591370|P13|STARTED|Washout Period 2 (14 Days)||3
244115|NCT01072149|591371|P12|STARTED|Washout Period 2 (14 Days)||3
244116|NCT01072149|591372|P11|STARTED|Washout Period 2 (14 Days)||2
244117|NCT01072149|591373|P10|STARTED|Washout Period 2 (14 Days)||3
244118|NCT01072149|591374|P9|STARTED|Washout Period 2 (14 Days)||3
244119|NCT01072149|591375|P8|STARTED|Washout Period 2 (14 Days)||2
244120|NCT01072149|591376|P7|STARTED|Washout Period 2 (14 Days)||3
244121|NCT01072149|591377|P6|STARTED|Washout Period 2 (14 Days)||3
244122|NCT01072149|591378|P5|STARTED|Washout Period 2 (14 Days)||3
244123|NCT01072149|591379|P4|STARTED|Washout Period 2 (14 Days)||3
244124|NCT01072149|591380|P3|STARTED|Washout Period 2 (14 Days)||1
244125|NCT01072149|591381|P2|STARTED|Washout Period 2 (14 Days)||2
244126|NCT01072149|591382|P1|STARTED|Washout Period 2 (14 Days)||3
244127|NCT01072149|591365|P18|NOT COMPLETED|Treatment Period 2 (28 Days)||0
244128|NCT01072149|591366|P17|NOT COMPLETED|Treatment Period 2 (28 Days)||0
244129|NCT01072149|591367|P16|NOT COMPLETED|Treatment Period 2 (28 Days)||0
244130|NCT01072149|591368|P15|NOT COMPLETED|Treatment Period 2 (28 Days)||0
244131|NCT01072149|591369|P14|NOT COMPLETED|Treatment Period 2 (28 Days)||0
244132|NCT01072149|591370|P13|NOT COMPLETED|Treatment Period 2 (28 Days)||0
244133|NCT01072149|591371|P12|NOT COMPLETED|Treatment Period 2 (28 Days)||0
244134|NCT01072149|591372|P11|NOT COMPLETED|Treatment Period 2 (28 Days)||0
244135|NCT01072149|591373|P10|NOT COMPLETED|Treatment Period 2 (28 Days)||0
244136|NCT01072149|591374|P9|NOT COMPLETED|Treatment Period 2 (28 Days)||0
244137|NCT01072149|591375|P8|NOT COMPLETED|Treatment Period 2 (28 Days)||1
244138|NCT01072149|591376|P7|NOT COMPLETED|Treatment Period 2 (28 Days)||0
244139|NCT01072149|591377|P6|NOT COMPLETED|Treatment Period 2 (28 Days)||0
244140|NCT01072149|591378|P5|NOT COMPLETED|Treatment Period 2 (28 Days)||0
244141|NCT01072149|591379|P4|NOT COMPLETED|Treatment Period 2 (28 Days)||0
244142|NCT01072149|591380|P3|NOT COMPLETED|Treatment Period 2 (28 Days)||1
244143|NCT01072149|591381|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||1
244144|NCT01072149|591382|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
244145|NCT01072149|591365|P18|COMPLETED|Treatment Period 2 (28 Days)||2
244146|NCT01072149|591366|P17|COMPLETED|Treatment Period 2 (28 Days)||3
244147|NCT01072149|591367|P16|COMPLETED|Treatment Period 2 (28 Days)||3
244148|NCT01072149|591368|P15|COMPLETED|Treatment Period 2 (28 Days)||3
244149|NCT01072149|591369|P14|COMPLETED|Treatment Period 2 (28 Days)||3
244150|NCT01072149|591370|P13|COMPLETED|Treatment Period 2 (28 Days)||3
244151|NCT01072149|591371|P12|COMPLETED|Treatment Period 2 (28 Days)||3
244152|NCT01072149|591372|P11|COMPLETED|Treatment Period 2 (28 Days)||2
244153|NCT01072149|591373|P10|COMPLETED|Treatment Period 2 (28 Days)||3
244154|NCT01072149|591374|P9|COMPLETED|Treatment Period 2 (28 Days)||3
244155|NCT01072149|591375|P8|COMPLETED|Treatment Period 2 (28 Days)||2
244156|NCT01072149|591376|P7|COMPLETED|Treatment Period 2 (28 Days)||3
244157|NCT01072149|591377|P6|COMPLETED|Treatment Period 2 (28 Days)||3
244158|NCT01072149|591378|P5|COMPLETED|Treatment Period 2 (28 Days)||3
244159|NCT01072149|591379|P4|COMPLETED|Treatment Period 2 (28 Days)||3
244160|NCT01072149|591380|P3|COMPLETED|Treatment Period 2 (28 Days)||1
244161|NCT01072149|591381|P2|COMPLETED|Treatment Period 2 (28 Days)||2
244162|NCT01072149|591382|P1|COMPLETED|Treatment Period 2 (28 Days)||3
244163|NCT01072149|591365|P18|STARTED|Treatment Period 2 (28 Days)||2
244164|NCT01072149|591366|P17|STARTED|Treatment Period 2 (28 Days)||3
244165|NCT01072149|591367|P16|STARTED|Treatment Period 2 (28 Days)||3
244166|NCT01072149|591368|P15|STARTED|Treatment Period 2 (28 Days)||3
244167|NCT01072149|591369|P14|STARTED|Treatment Period 2 (28 Days)||3
244168|NCT01072149|591370|P13|STARTED|Treatment Period 2 (28 Days)||3
244169|NCT01072149|591371|P12|STARTED|Treatment Period 2 (28 Days)||3
244170|NCT01072149|591372|P11|STARTED|Treatment Period 2 (28 Days)||2
244171|NCT01072149|591373|P10|STARTED|Treatment Period 2 (28 Days)||3
244172|NCT01072149|591374|P9|STARTED|Treatment Period 2 (28 Days)||3
244173|NCT01072149|591375|P8|STARTED|Treatment Period 2 (28 Days)||3
244174|NCT01072149|591376|P7|STARTED|Treatment Period 2 (28 Days)||3
244175|NCT01072149|591377|P6|STARTED|Treatment Period 2 (28 Days)||3
244176|NCT01072149|591378|P5|STARTED|Treatment Period 2 (28 Days)||3
244177|NCT01072149|591379|P4|STARTED|Treatment Period 2 (28 Days)||3
244178|NCT01072149|591380|P3|STARTED|Treatment Period 2 (28 Days)||2
244179|NCT01072149|591381|P2|STARTED|Treatment Period 2 (28 Days)||3
244180|NCT01072149|591382|P1|STARTED|Treatment Period 2 (28 Days)||3
244181|NCT01072149|591365|P18|NOT COMPLETED|Washout Period 1 (14 Days)||0
244182|NCT01072149|591366|P17|NOT COMPLETED|Washout Period 1 (14 Days)||0
244183|NCT01072149|591367|P16|NOT COMPLETED|Washout Period 1 (14 Days)||0
244184|NCT01072149|591368|P15|NOT COMPLETED|Washout Period 1 (14 Days)||0
244185|NCT01072149|591369|P14|NOT COMPLETED|Washout Period 1 (14 Days)||0
244186|NCT01072149|591370|P13|NOT COMPLETED|Washout Period 1 (14 Days)||0
244187|NCT01072149|591371|P12|NOT COMPLETED|Washout Period 1 (14 Days)||0
244188|NCT01072149|591372|P11|NOT COMPLETED|Washout Period 1 (14 Days)||0
244189|NCT01072149|591373|P10|NOT COMPLETED|Washout Period 1 (14 Days)||0
244190|NCT01072149|591374|P9|NOT COMPLETED|Washout Period 1 (14 Days)||0
244191|NCT01072149|591375|P8|NOT COMPLETED|Washout Period 1 (14 Days)||0
244192|NCT01072149|591376|P7|NOT COMPLETED|Washout Period 1 (14 Days)||0
244193|NCT01072149|591377|P6|NOT COMPLETED|Washout Period 1 (14 Days)||0
244194|NCT01072149|591378|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
244195|NCT01072149|591379|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
244196|NCT01072149|591380|P3|NOT COMPLETED|Washout Period 1 (14 Days)||0
244197|NCT01072149|591381|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
244198|NCT01072149|591382|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
244199|NCT01072149|591365|P18|COMPLETED|Washout Period 1 (14 Days)||2
244200|NCT01072149|591366|P17|COMPLETED|Washout Period 1 (14 Days)||3
244201|NCT01072149|591367|P16|COMPLETED|Washout Period 1 (14 Days)||3
244202|NCT01072149|591368|P15|COMPLETED|Washout Period 1 (14 Days)||3
244203|NCT01072149|591369|P14|COMPLETED|Washout Period 1 (14 Days)||3
244204|NCT01072149|591370|P13|COMPLETED|Washout Period 1 (14 Days)||3
244205|NCT01072149|591371|P12|COMPLETED|Washout Period 1 (14 Days)||3
244206|NCT01072149|591372|P11|COMPLETED|Washout Period 1 (14 Days)||2
244207|NCT01072149|591373|P10|COMPLETED|Washout Period 1 (14 Days)||3
244208|NCT01072149|591374|P9|COMPLETED|Washout Period 1 (14 Days)||3
244209|NCT01072149|591375|P8|COMPLETED|Washout Period 1 (14 Days)||3
244210|NCT01072149|591376|P7|COMPLETED|Washout Period 1 (14 Days)||3
244211|NCT01072149|591377|P6|COMPLETED|Washout Period 1 (14 Days)||3
244212|NCT01072149|591378|P5|COMPLETED|Washout Period 1 (14 Days)||3
244213|NCT01072149|591379|P4|COMPLETED|Washout Period 1 (14 Days)||3
244214|NCT01072149|591380|P3|COMPLETED|Washout Period 1 (14 Days)||2
244215|NCT01072149|591381|P2|COMPLETED|Washout Period 1 (14 Days)||3
244216|NCT01072149|591382|P1|COMPLETED|Washout Period 1 (14 Days)||3
244217|NCT01072149|591365|P18|STARTED|Washout Period 1 (14 Days)||2
244218|NCT01072149|591366|P17|STARTED|Washout Period 1 (14 Days)||3
244219|NCT01072149|591367|P16|STARTED|Washout Period 1 (14 Days)||3
244220|NCT01072149|591368|P15|STARTED|Washout Period 1 (14 Days)||3
244221|NCT01072149|591369|P14|STARTED|Washout Period 1 (14 Days)||3
244222|NCT01072149|591370|P13|STARTED|Washout Period 1 (14 Days)||3
244223|NCT01072149|591371|P12|STARTED|Washout Period 1 (14 Days)||3
244224|NCT01072149|591372|P11|STARTED|Washout Period 1 (14 Days)||2
244225|NCT01072149|591373|P10|STARTED|Washout Period 1 (14 Days)||3
244226|NCT01072149|591374|P9|STARTED|Washout Period 1 (14 Days)||3
244227|NCT01072149|591375|P8|STARTED|Washout Period 1 (14 Days)||3
244228|NCT01072149|591376|P7|STARTED|Washout Period 1 (14 Days)||3
244229|NCT01072149|591377|P6|STARTED|Washout Period 1 (14 Days)||3
244230|NCT01072149|591378|P5|STARTED|Washout Period 1 (14 Days)||3
244231|NCT01072149|591379|P4|STARTED|Washout Period 1 (14 Days)||3
244232|NCT01072149|591380|P3|STARTED|Washout Period 1 (14 Days)||2
244233|NCT01072149|591381|P2|STARTED|Washout Period 1 (14 Days)||3
244234|NCT01072149|591382|P1|STARTED|Washout Period 1 (14 Days)||3
244235|NCT01072149|591365|P18|NOT COMPLETED|Treatment Period 1 (28 Days)||1
244236|NCT01072149|591366|P17|NOT COMPLETED|Treatment Period 1 (28 Days)||0
244237|NCT01072149|591367|P16|NOT COMPLETED|Treatment Period 1 (28 Days)||0
244238|NCT01072149|591368|P15|NOT COMPLETED|Treatment Period 1 (28 Days)||0
244239|NCT01072149|591369|P14|NOT COMPLETED|Treatment Period 1 (28 Days)||0
244240|NCT01072149|591370|P13|NOT COMPLETED|Treatment Period 1 (28 Days)||0
244241|NCT01072149|591371|P12|NOT COMPLETED|Treatment Period 1 (28 Days)||0
244242|NCT01072149|591372|P11|NOT COMPLETED|Treatment Period 1 (28 Days)||1
244243|NCT01072149|591373|P10|NOT COMPLETED|Treatment Period 1 (28 Days)||0
244244|NCT01072149|591374|P9|NOT COMPLETED|Treatment Period 1 (28 Days)||0
244245|NCT01072149|591375|P8|NOT COMPLETED|Treatment Period 1 (28 Days)||0
244246|NCT01072149|591376|P7|NOT COMPLETED|Treatment Period 1 (28 Days)||0
244247|NCT01072149|591377|P6|NOT COMPLETED|Treatment Period 1 (28 Days)||0
244248|NCT01072149|591378|P5|NOT COMPLETED|Treatment Period 1 (28 Days)||0
244249|NCT01072149|591379|P4|NOT COMPLETED|Treatment Period 1 (28 Days)||0
244250|NCT01072149|591380|P3|NOT COMPLETED|Treatment Period 1 (28 Days)||1
244251|NCT01072149|591381|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||0
244252|NCT01072149|591382|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||0
244253|NCT01072149|591365|P18|COMPLETED|Treatment Period 1 (28 Days)||2
244254|NCT01072149|591366|P17|COMPLETED|Treatment Period 1 (28 Days)||3
244255|NCT01072149|591367|P16|COMPLETED|Treatment Period 1 (28 Days)||3
244256|NCT01072149|591368|P15|COMPLETED|Treatment Period 1 (28 Days)||3
244257|NCT01072149|591369|P14|COMPLETED|Treatment Period 1 (28 Days)||3
244258|NCT01072149|591370|P13|COMPLETED|Treatment Period 1 (28 Days)||3
244259|NCT01072149|591371|P12|COMPLETED|Treatment Period 1 (28 Days)||3
244260|NCT01072149|591372|P11|COMPLETED|Treatment Period 1 (28 Days)||2
244261|NCT01072149|591373|P10|COMPLETED|Treatment Period 1 (28 Days)||3
244262|NCT01072149|591374|P9|COMPLETED|Treatment Period 1 (28 Days)||3
244263|NCT01072149|591375|P8|COMPLETED|Treatment Period 1 (28 Days)||3
244264|NCT01072149|591376|P7|COMPLETED|Treatment Period 1 (28 Days)||3
244265|NCT01072149|591377|P6|COMPLETED|Treatment Period 1 (28 Days)||3
244266|NCT01072149|591378|P5|COMPLETED|Treatment Period 1 (28 Days)||3
244267|NCT01072149|591379|P4|COMPLETED|Treatment Period 1 (28 Days)||3
244268|NCT01072149|591380|P3|COMPLETED|Treatment Period 1 (28 Days)||2
244269|NCT01072149|591381|P2|COMPLETED|Treatment Period 1 (28 Days)||3
244270|NCT01072149|591382|P1|COMPLETED|Treatment Period 1 (28 Days)||3
244271|NCT01072149|591365|P18|STARTED|Treatment Period 1 (28 Days)||3
244272|NCT01072149|591366|P17|STARTED|Treatment Period 1 (28 Days)||3
244273|NCT01072149|591367|P16|STARTED|Treatment Period 1 (28 Days)||3
244274|NCT01072149|591368|P15|STARTED|Treatment Period 1 (28 Days)||3
244275|NCT01072149|591369|P14|STARTED|Treatment Period 1 (28 Days)||3
244276|NCT01072149|591370|P13|STARTED|Treatment Period 1 (28 Days)||3
244277|NCT01072149|591371|P12|STARTED|Treatment Period 1 (28 Days)||3
244278|NCT01072149|591372|P11|STARTED|Treatment Period 1 (28 Days)||3
244279|NCT01072149|591373|P10|STARTED|Treatment Period 1 (28 Days)||3
244280|NCT01072149|591374|P9|STARTED|Treatment Period 1 (28 Days)||3
244281|NCT01072149|591375|P8|STARTED|Treatment Period 1 (28 Days)||3
244282|NCT01072149|591376|P7|STARTED|Treatment Period 1 (28 Days)||3
244283|NCT01072149|591377|P6|STARTED|Treatment Period 1 (28 Days)||3
244284|NCT01072149|591378|P5|STARTED|Treatment Period 1 (28 Days)||3
244285|NCT01072149|591379|P4|STARTED|Treatment Period 1 (28 Days)||3
244286|NCT01072149|591380|P3|STARTED|Treatment Period 1 (28 Days)||3
244287|NCT01072149|591381|P2|STARTED|Treatment Period 1 (28 Days)||3
244288|NCT01072149|591382|P1|STARTED|Treatment Period 1 (28 Days)||3
244289|NCT01072136|591402|P2|NOT COMPLETED|Overall Study||31
244290|NCT01072136|591403|P1|NOT COMPLETED|Overall Study||23
244291|NCT01072136|591402|P2|COMPLETED|Overall Study||12
244292|NCT01072136|591403|P1|COMPLETED|Overall Study||21
244293|NCT01072136|591402|P2|Met All Enrollment Criteria|Overall Study||25
244294|NCT01072136|591403|P1|Met All Enrollment Criteria|Overall Study|Some eligibility test results were not available until after randomization.|30
244295|NCT01072136|591402|P2|STARTED|Overall Study||43
244296|NCT01072136|591403|P1|STARTED|Overall Study||44
244297|NCT01072032|591427|P2|NOT COMPLETED|Overall Study||9
244298|NCT01072032|591428|P1|NOT COMPLETED|Overall Study||8
244299|NCT01072032|591427|P2|COMPLETED|Overall Study||5
244300|NCT01072032|591428|P1|COMPLETED|Overall Study||5
244301|NCT01072032|591427|P2|STARTED|Overall Study||14
244302|NCT01072032|591428|P1|STARTED|Overall Study||13
244303|NCT01072006|591442|P4|NOT COMPLETED|Overall Study||0
244304|NCT01072006|591443|P3|NOT COMPLETED|Overall Study||0
244305|NCT01072006|591444|P2|NOT COMPLETED|Overall Study||0
244306|NCT01072006|591445|P1|NOT COMPLETED|Overall Study||0
244307|NCT01072006|591442|P4|COMPLETED|Overall Study||11
244308|NCT01072006|591443|P3|COMPLETED|Overall Study||0
244309|NCT01072006|591444|P2|COMPLETED|Overall Study||5
244310|NCT01072006|591445|P1|COMPLETED|Overall Study||14
244311|NCT01072006|591442|P4|STARTED|Overall Study||11
244312|NCT01072006|591443|P3|STARTED|Overall Study||0
244313|NCT01072006|591444|P2|STARTED|Overall Study||5
244314|NCT01072006|591445|P1|STARTED|Overall Study||14
244315|NCT01071993|591464|P2|NOT COMPLETED|Overall Study||0
244316|NCT01071993|591465|P1|NOT COMPLETED|Overall Study||0
244317|NCT01071993|591464|P2|COMPLETED|Overall Study||0
244318|NCT01071993|591465|P1|COMPLETED|Overall Study||0
244319|NCT01071993|591464|P2|STARTED|Overall Study||0
244320|NCT01071993|591465|P1|STARTED|Overall Study||0
244321|NCT01071954|591471|P1|NOT COMPLETED|Overall Study||27
244322|NCT01071954|591471|P1|COMPLETED|Overall Study||39
244323|NCT01071954|591471|P1|Received Treatment|Overall Study||65
244324|NCT01071954|591471|P1|STARTED|Overall Study||66
244325|NCT01071915|591480|P1|NOT COMPLETED|Overall Study||9
244326|NCT01071915|591480|P1|COMPLETED|Overall Study||148
244327|NCT01071915|591480|P1|Safety Analysis Set|Overall Study||156
244328|NCT01071915|591480|P1|Full Analysis Set (FAS)|Overall Study||155
244329|NCT01071915|591480|P1|STARTED|Overall Study|Intention to Treat Analysis Set|157
244330|NCT01071798|591490|P1|NOT COMPLETED|Subpopulation Who Received Two Cycles||15
244331|NCT01071798|591490|P1|COMPLETED|Subpopulation Who Received Two Cycles||805
244332|NCT01071798|591490|P1|Baseline and Safety Analysis Set|Subpopulation Who Received Two Cycles||820
244333|NCT01071798|591490|P1|STARTED|Subpopulation Who Received Two Cycles||820
244334|NCT01071798|591490|P1|NOT COMPLETED|Participants Who Received One Cycle||65
244335|NCT01071798|591490|P1|COMPLETED|Participants Who Received One Cycle||1588
244336|NCT01071798|591490|P1|Baseline and Safety Analysis Set|Participants Who Received One Cycle||1653
244337|NCT01071798|591490|P1|STARTED|Participants Who Received One Cycle||1653
244338|NCT01071538|591510|P1|NOT COMPLETED|Overall Study||2
244339|NCT01071538|591510|P1|COMPLETED|Overall Study||13
244340|NCT01071538|591510|P1|STARTED|Overall Study||15
244341|NCT01071512|591520|P1|NOT COMPLETED|Overall Study||5
244342|NCT01071512|591520|P1|COMPLETED|Overall Study||15
244343|NCT01071512|591520|P1|STARTED|Overall Study||20
244344|NCT01071395|591530|P2|NOT COMPLETED|Overall Study||2
244345|NCT01071395|591531|P1|NOT COMPLETED|Overall Study||5
244346|NCT01071395|591530|P2|COMPLETED|Overall Study||30
244347|NCT01071395|591531|P1|COMPLETED|Overall Study||31
244348|NCT01071395|591530|P2|STARTED|Overall Study||32
244349|NCT01071395|591531|P1|STARTED|Overall Study||36
244350|NCT01071356|591539|P2|NOT COMPLETED|Overall Study||9
244351|NCT01071356|591540|P1|NOT COMPLETED|Overall Study||7
244352|NCT01071356|591539|P2|COMPLETED|Overall Study||97
244353|NCT01071356|591540|P1|COMPLETED|Overall Study||104
244354|NCT01071356|591539|P2|STARTED|Overall Study||106
244355|NCT01071356|591540|P1|STARTED|Overall Study||111
244356|NCT01071317|591550|P2|NOT COMPLETED|Overall Study||2
244357|NCT01071317|591551|P1|NOT COMPLETED|Overall Study||2
244358|NCT01071317|591550|P2|COMPLETED|Overall Study||23
244359|NCT01071317|591551|P1|COMPLETED|Overall Study||23
244360|NCT01071317|591550|P2|STARTED|Overall Study||25
244361|NCT01071317|591551|P1|STARTED|Overall Study||25
244362|NCT01071278|591563|P1|NOT COMPLETED|Overall Study||713
244363|NCT01071278|591563|P1|COMPLETED|Overall Study||1677
244364|NCT01071278|591563|P1|STARTED|Overall Study||2390
244365|NCT01071252|591574|P5|NOT COMPLETED|Overall Study||11
244366|NCT01071252|591575|P4|NOT COMPLETED|Overall Study||7
244367|NCT01071252|591576|P3|NOT COMPLETED|Overall Study||4
244368|NCT01071252|591577|P2|NOT COMPLETED|Overall Study||10
244369|NCT01071252|591578|P1|NOT COMPLETED|Overall Study||15
244370|NCT01071252|591574|P5|COMPLETED|Overall Study||11
244371|NCT01071252|591575|P4|COMPLETED|Overall Study||20
244372|NCT01071252|591576|P3|COMPLETED|Overall Study||17
244373|NCT01071252|591577|P2|COMPLETED|Overall Study||16
244374|NCT01071252|591578|P1|COMPLETED|Overall Study||14
244375|NCT01071252|591574|P5|STARTED|Overall Study||22
244376|NCT01071252|591575|P4|STARTED|Overall Study||27
244377|NCT01071252|591576|P3|STARTED|Overall Study||21
244378|NCT01071252|591577|P2|STARTED|Overall Study||26
244379|NCT01071252|591578|P1|STARTED|Overall Study||29
244380|NCT01071200|591606|P2|NOT COMPLETED|Overall Study||3
244381|NCT01071200|591607|P1|NOT COMPLETED|Overall Study||7
244382|NCT01071200|591606|P2|COMPLETED|Overall Study||63
244383|NCT01071200|591607|P1|COMPLETED|Overall Study||60
244384|NCT01071200|591606|P2|STARTED|Overall Study||66
244385|NCT01071200|591607|P1|STARTED|Overall Study||67
244386|NCT01071096|591639|P2|NOT COMPLETED|Second Intervention (90 Days)||0
244387|NCT01071096|591640|P1|NOT COMPLETED|Second Intervention (90 Days)||0
244388|NCT01071096|591639|P2|COMPLETED|Second Intervention (90 Days)||10
244389|NCT01071096|591640|P1|COMPLETED|Second Intervention (90 Days)||9
244390|NCT01071096|591639|P2|STARTED|Second Intervention (90 Days)||10
244391|NCT01071096|591640|P1|STARTED|Second Intervention (90 Days)||9
244392|NCT01071096|591639|P2|NOT COMPLETED|Washout Period (30 Days)||0
244393|NCT01071096|591640|P1|NOT COMPLETED|Washout Period (30 Days)||0
244394|NCT01071096|591639|P2|COMPLETED|Washout Period (30 Days)||10
244395|NCT01071096|591640|P1|COMPLETED|Washout Period (30 Days)||9
244396|NCT01071096|591639|P2|STARTED|Washout Period (30 Days)||10
244397|NCT01071096|591640|P1|STARTED|Washout Period (30 Days)||9
244398|NCT01071096|591639|P2|NOT COMPLETED|First Intervention (90 Days)||0
244399|NCT01071096|591640|P1|NOT COMPLETED|First Intervention (90 Days)||1
244400|NCT01071096|591639|P2|COMPLETED|First Intervention (90 Days)||10
244401|NCT01071096|591640|P1|COMPLETED|First Intervention (90 Days)||9
244402|NCT01071096|591639|P2|STARTED|First Intervention (90 Days)||10
244403|NCT01071096|591640|P1|STARTED|First Intervention (90 Days)||10
244404|NCT01071083|591664|P5|NOT COMPLETED|Overall Study||8
244405|NCT01071083|591665|P4|NOT COMPLETED|Overall Study||2
244406|NCT01071083|591666|P3|NOT COMPLETED|Overall Study||5
244407|NCT01071083|591667|P2|NOT COMPLETED|Overall Study||2
244408|NCT01071083|591668|P1|NOT COMPLETED|Overall Study||7
244409|NCT01071083|591664|P5|COMPLETED|Overall Study||46
244410|NCT01071083|591665|P4|COMPLETED|Overall Study||15
244411|NCT01071083|591666|P3|COMPLETED|Overall Study||12
244412|NCT01071083|591667|P2|COMPLETED|Overall Study||43
244413|NCT01071083|591668|P1|COMPLETED|Overall Study||35
244414|NCT01071083|591664|P5|STARTED|Overall Study||54
244415|NCT01071083|591665|P4|STARTED|Overall Study||17
244416|NCT01071083|591666|P3|STARTED|Overall Study||17
244417|NCT01071083|591667|P2|STARTED|Overall Study||45
244418|NCT01071083|591668|P1|STARTED|Overall Study||42
244419|NCT01071070|591687|P2|NOT COMPLETED|Overall Study||3
244420|NCT01071070|591688|P1|NOT COMPLETED|Overall Study||4
244421|NCT01071070|591687|P2|COMPLETED|Overall Study||105
244422|NCT01071070|591688|P1|COMPLETED|Overall Study||104
244423|NCT01071070|591687|P2|STARTED|Overall Study||108
244424|NCT01071070|591688|P1|STARTED|Overall Study||108
244425|NCT01071044|591712|P2|NOT COMPLETED|Overall Study||0
244426|NCT01071044|591713|P1|NOT COMPLETED|Overall Study||2
244427|NCT01071044|591712|P2|COMPLETED|Overall Study||11
244428|NCT01071044|591713|P1|COMPLETED|Overall Study||13
244429|NCT01071044|591712|P2|STARTED|Overall Study||11
244430|NCT01071044|591713|P1|STARTED|Overall Study||15
244431|NCT01070979|591734|P3|NOT COMPLETED|Overall Study||13
244432|NCT01070979|591735|P2|NOT COMPLETED|Overall Study||12
244433|NCT01070979|591736|P1|NOT COMPLETED|Overall Study||11
244434|NCT01070979|591734|P3|COMPLETED|Overall Study||72
244435|NCT01070979|591735|P2|COMPLETED|Overall Study||73
244436|NCT01070979|591736|P1|COMPLETED|Overall Study||68
244437|NCT01070979|591734|P3|STARTED|Overall Study||85
244438|NCT01070979|591735|P2|STARTED|Overall Study||85
244439|NCT01070979|591736|P1|STARTED|Overall Study||79
244440|NCT01070966|591762|P1|NOT COMPLETED|Participants for Efficacy Evaluation||82
244441|NCT01070966|591762|P1|COMPLETED|Participants for Efficacy Evaluation||1929
244442|NCT01070966|591762|P1|STARTED|Participants for Efficacy Evaluation||2011
244443|NCT01070966|591762|P1|NOT COMPLETED|Participants for Safety Evaluation||78
244444|NCT01070966|591762|P1|COMPLETED|Participants for Safety Evaluation||2011
244445|NCT01070966|591762|P1|STARTED|Participants for Safety Evaluation||2089
244446|NCT01070953|591773|P1|NOT COMPLETED|Participants for Efficacy Evaluation||227
244447|NCT01070953|591773|P1|COMPLETED|Participants for Efficacy Evaluation||3309
244448|NCT01070953|591773|P1|STARTED|Participants for Efficacy Evaluation||3536
244449|NCT01070953|591773|P1|NOT COMPLETED|Participants for Safety Evaluation||931
244450|NCT01070953|591773|P1|COMPLETED|Participants for Safety Evaluation||3536
244451|NCT01070953|591773|P1|STARTED|Participants for Safety Evaluation||4467
244452|NCT01070888|591786|P2|NOT COMPLETED|Second Intervention (14 Days)||0
244453|NCT01070888|591787|P1|NOT COMPLETED|Second Intervention (14 Days)||0
244454|NCT01070888|591786|P2|COMPLETED|Second Intervention (14 Days)||2
244455|NCT01070888|591787|P1|COMPLETED|Second Intervention (14 Days)||1
244456|NCT01070888|591786|P2|STARTED|Second Intervention (14 Days)||2
244457|NCT01070888|591787|P1|STARTED|Second Intervention (14 Days)||1
244458|NCT01070888|591786|P2|NOT COMPLETED|Washout (14 Days)||0
244459|NCT01070888|591787|P1|NOT COMPLETED|Washout (14 Days)||1
244460|NCT01070888|591786|P2|COMPLETED|Washout (14 Days)||2
244461|NCT01070888|591787|P1|COMPLETED|Washout (14 Days)||1
244462|NCT01070888|591786|P2|STARTED|Washout (14 Days)||2
244463|NCT01070888|591787|P1|STARTED|Washout (14 Days)||2
244464|NCT01070888|591786|P2|NOT COMPLETED|First Intervention (14 Days)||2
244465|NCT01070888|591787|P1|NOT COMPLETED|First Intervention (14 Days)||0
244466|NCT01070888|591786|P2|COMPLETED|First Intervention (14 Days)||2
244467|NCT01070888|591787|P1|COMPLETED|First Intervention (14 Days)||2
244468|NCT01070888|591786|P2|STARTED|First Intervention (14 Days)||4
244469|NCT01070888|591787|P1|STARTED|First Intervention (14 Days)||2
244470|NCT01070810|591795|P2|NOT COMPLETED|Overall Study||0
244471|NCT01070810|591796|P1|NOT COMPLETED|Overall Study||0
244472|NCT01070810|591795|P2|COMPLETED|Overall Study||43
244473|NCT01070810|591796|P1|COMPLETED|Overall Study||45
244474|NCT01070810|591795|P2|STARTED|Overall Study||43
244475|NCT01070810|591796|P1|STARTED|Overall Study||45
244476|NCT01070784|591812|P2|NOT COMPLETED|Overall Study||18
244477|NCT01070784|591813|P1|NOT COMPLETED|Overall Study||20
244478|NCT01070784|591812|P2|COMPLETED|Overall Study||112
244479|NCT01070784|591813|P1|COMPLETED|Overall Study||110
244480|NCT01070784|591812|P2|STARTED|Overall Study||130
244481|NCT01070784|591813|P1|STARTED|Overall Study||130
244482|NCT01070771|591901|P1|NOT COMPLETED|Overall Study||3
244483|NCT01070771|591901|P1|COMPLETED|Overall Study|August 2012|200
244484|NCT01070771|591901|P1|STARTED|Overall Study|September 2008|203
244485|NCT01070693|591908|P2|NOT COMPLETED|Overall Study||39
244486|NCT01070693|591909|P1|NOT COMPLETED|Overall Study||28
244487|NCT01070693|591908|P2|COMPLETED|Overall Study||110
244488|NCT01070693|591909|P1|COMPLETED|Overall Study||122
244489|NCT01070693|591908|P2|STARTED|Overall Study||149
244490|NCT01070693|591909|P1|STARTED|Overall Study||150
244491|NCT01070550|591921|P6|NOT COMPLETED|Overall Study||7
244492|NCT01070550|591922|P5|NOT COMPLETED|Overall Study||1
244493|NCT01070550|591923|P4|NOT COMPLETED|Overall Study||77
244494|NCT01070550|591924|P3|NOT COMPLETED|Overall Study||216
244495|NCT01070550|591925|P2|NOT COMPLETED|Overall Study||62
244496|NCT01070550|591926|P1|NOT COMPLETED|Overall Study||1285
244497|NCT01070550|591921|P6|COMPLETED|Overall Study||35
244498|NCT01070550|591922|P5|COMPLETED|Overall Study||20
244499|NCT01070550|591923|P4|COMPLETED|Overall Study||124
244500|NCT01070550|591924|P3|COMPLETED|Overall Study||528
244501|NCT01070550|591925|P2|COMPLETED|Overall Study||254
244502|NCT01070550|591926|P1|COMPLETED|Overall Study||2071
244503|NCT01070550|591921|P6|STARTED|Overall Study||42
244504|NCT01070550|591922|P5|STARTED|Overall Study||21
244505|NCT01070550|591923|P4|STARTED|Overall Study||201
244506|NCT01070550|591924|P3|STARTED|Overall Study||744
244507|NCT01070550|591925|P2|STARTED|Overall Study||316
244508|NCT01070550|591926|P1|STARTED|Overall Study||3356
244509|NCT01070394|592066|P1|NOT COMPLETED|Overall Study||7
244510|NCT01070394|592066|P1|COMPLETED|Overall Study||33
244511|NCT01070394|592066|P1|STARTED|Overall Study||40
244512|NCT01070381|592077|P2|NOT COMPLETED|Period 2, 1 Week of Wear||1
244513|NCT01070381|592078|P1|NOT COMPLETED|Period 2, 1 Week of Wear||1
244514|NCT01070381|592077|P2|COMPLETED|Period 2, 1 Week of Wear||106
244515|NCT01070381|592078|P1|COMPLETED|Period 2, 1 Week of Wear||108
244516|NCT01070381|592077|P2|STARTED|Period 2, 1 Week of Wear||107
244517|NCT01070381|592078|P1|STARTED|Period 2, 1 Week of Wear||109
244518|NCT01070381|592077|P2|NOT COMPLETED|Period 1, 1 Week of Wear||0
244519|NCT01070381|592078|P1|NOT COMPLETED|Period 1, 1 Week of Wear||0
244520|NCT01070381|592077|P2|COMPLETED|Period 1, 1 Week of Wear||107
244521|NCT01070381|592078|P1|COMPLETED|Period 1, 1 Week of Wear|One subject could not continue into Period 2 due to product unavailability.|109
244522|NCT01070381|592077|P2|STARTED|Period 1, 1 Week of Wear||107
244523|NCT01070381|592078|P1|STARTED|Period 1, 1 Week of Wear|One subject could not be dispensed into Period 1 product. Subject started Period 2 wear.|109
244524|NCT01070329|592086|P2|NOT COMPLETED|Overall Study||49
244525|NCT01070329|592087|P1|NOT COMPLETED|Overall Study||52
244526|NCT01070329|592086|P2|COMPLETED|Overall Study||217
244527|NCT01070329|592087|P1|COMPLETED|Overall Study||209
244528|NCT01070329|592086|P2|STARTED|Overall Study||266
244529|NCT01070329|592087|P1|STARTED|Overall Study||261
244530|NCT01070316|592119|P1|NOT COMPLETED|Extension Phase||4
244531|NCT01070316|592119|P1|COMPLETED|Extension Phase||14
244532|NCT01070316|592119|P1|STARTED|Extension Phase|Two participants did not qualify for Extension Phase as defined by protocol|18
244533|NCT01070316|592119|P1|NOT COMPLETED|Main Phase||0
244534|NCT01070316|592119|P1|COMPLETED|Main Phase||20
244535|NCT01070316|592119|P1|STARTED|Main Phase||20
244536|NCT01070303|592126|P1|NOT COMPLETED|Overall Study||89
244537|NCT01070303|592126|P1|COMPLETED|Overall Study||88
244538|NCT01070303|592126|P1|STARTED|Overall Study||177
244539|NCT01070173|592185|P3|NOT COMPLETED|Overall Study||0
244540|NCT01070173|592186|P2|NOT COMPLETED|Overall Study||0
244541|NCT01070173|592187|P1|NOT COMPLETED|Overall Study||0
244542|NCT01070173|592185|P3|COMPLETED|Overall Study||11
244543|NCT01070173|592186|P2|COMPLETED|Overall Study||8
244544|NCT01070173|592187|P1|COMPLETED|Overall Study||33
244545|NCT01070173|592185|P3|STARTED|Overall Study||11
244546|NCT01070173|592186|P2|STARTED|Overall Study||8
244547|NCT01070173|592187|P1|STARTED|Overall Study||33
244548|NCT01070095|592198|P2|NOT COMPLETED|Intervention Period||0
244549|NCT01070095|592199|P1|NOT COMPLETED|Intervention Period||0
244550|NCT01070095|592198|P2|COMPLETED|Intervention Period||890
244551|NCT01070095|592199|P1|COMPLETED|Intervention Period||18
244552|NCT01070095|592198|P2|STARTED|Intervention Period||890
244553|NCT01070095|592199|P1|STARTED|Intervention Period||18
244554|NCT01070095|592198|P2|NOT COMPLETED|Baseline Period||0
244555|NCT01070095|592199|P1|NOT COMPLETED|Baseline Period||1
244556|NCT01070095|592198|P2|COMPLETED|Baseline Period||830
244557|NCT01070095|592199|P1|COMPLETED|Baseline Period||18
244558|NCT01070095|592198|P2|STARTED|Baseline Period||830
244559|NCT01070095|592199|P1|STARTED|Baseline Period||19
244560|NCT01070043|592221|P3|NOT COMPLETED|Double-Blind Treatment||2
244561|NCT01070043|592222|P2|NOT COMPLETED|Double-Blind Treatment||0
244562|NCT01070043|592223|P1|NOT COMPLETED|Double-Blind Treatment||0
244563|NCT01070043|592221|P3|COMPLETED|Double-Blind Treatment||19
244564|NCT01070043|592222|P2|COMPLETED|Double-Blind Treatment||21
244565|NCT01070043|592223|P1|COMPLETED|Double-Blind Treatment||0
244566|NCT01070043|592221|P3|STARTED|Double-Blind Treatment||21
244567|NCT01070043|592222|P2|STARTED|Double-Blind Treatment||21
244568|NCT01070043|592223|P1|STARTED|Double-Blind Treatment||0
244569|NCT01070043|592221|P3|NOT COMPLETED|Run-In Phase||0
244570|NCT01070043|592222|P2|NOT COMPLETED|Run-In Phase||0
244571|NCT01070043|592223|P1|NOT COMPLETED|Run-In Phase||18
244572|NCT01070043|592221|P3|COMPLETED|Run-In Phase||0
244573|NCT01070043|592222|P2|COMPLETED|Run-In Phase||0
244574|NCT01070043|592223|P1|COMPLETED|Run-In Phase||42
244575|NCT01070043|592221|P3|STARTED|Run-In Phase|This monotherapy (Valsartan 160 mg) treatment arm is used only for double-blind phase.|0
244576|NCT01070043|592222|P2|STARTED|Run-In Phase|This combination therapy arm is used only for double-blind phase.|0
244577|NCT01070043|592223|P1|STARTED|Run-In Phase||60
244578|NCT01069939|592239|P2|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||32
244579|NCT01069939|592240|P1|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||31
244580|NCT01069939|592239|P2|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
244581|NCT01069939|592240|P1|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
244582|NCT01069939|592239|P2|STARTED|At Data Cut Off Date (26 Feb 2011)||214
244583|NCT01069939|592240|P1|STARTED|At Data Cut Off Date (26 Feb 2011)||213
244584|NCT01069939|592239|P2|NOT COMPLETED|Randomised and Included in the Analyses||77
244585|NCT01069939|592240|P1|NOT COMPLETED|Randomised and Included in the Analyses||49
244586|NCT01069939|592239|P2|COMPLETED|Randomised and Included in the Analyses||137
244587|NCT01069939|592240|P1|COMPLETED|Randomised and Included in the Analyses||164
244588|NCT01069939|592239|P2|STARTED|Randomised and Included in the Analyses||214
244589|NCT01069939|592240|P1|STARTED|Randomised and Included in the Analyses||213
244590|NCT01069900|592266|P2|NOT COMPLETED|Overall Study||4
244591|NCT01069900|592267|P1|NOT COMPLETED|Overall Study||18
244592|NCT01069900|592266|P2|COMPLETED|Overall Study||149
244593|NCT01069900|592267|P1|COMPLETED|Overall Study||287
244594|NCT01069900|592266|P2|Treated|Overall Study||150
244595|NCT01069900|592267|P1|Treated|Overall Study||301
244596|NCT01069900|592266|P2|STARTED|Overall Study||153
244597|NCT01069900|592267|P1|STARTED|Overall Study||305
244598|NCT01069861|592311|P1|NOT COMPLETED|Overall Study||3
244599|NCT01069861|592311|P1|COMPLETED|Overall Study||1
244600|NCT01069861|592311|P1|STARTED|Overall Study||4
244601|NCT01069627|592324|P1|NOT COMPLETED|Overall Study||20
244602|NCT01069627|592324|P1|COMPLETED|Overall Study||0
244603|NCT01069627|592324|P1|STARTED|Overall Study||20
244604|NCT01069562|592347|P2|NOT COMPLETED|Overall Study||0
244605|NCT01069562|592348|P1|NOT COMPLETED|Overall Study||0
244606|NCT01069562|592347|P2|COMPLETED|Overall Study||20
244607|NCT01069562|592348|P1|COMPLETED|Overall Study||20
244608|NCT01069562|592347|P2|STARTED|Overall Study||20
244609|NCT01069562|592348|P1|STARTED|Overall Study||20
244610|NCT01069523|592374|P2|NOT COMPLETED|Overall Study||7
244611|NCT01069523|592375|P1|NOT COMPLETED|Overall Study||4
244612|NCT01069523|592374|P2|COMPLETED|Overall Study||9
244613|NCT01069523|592375|P1|COMPLETED|Overall Study||9
244614|NCT01069523|592374|P2|STARTED|Overall Study||16
244615|NCT01069523|592375|P1|STARTED|Overall Study||13
244616|NCT01069510|592385|P2|NOT COMPLETED|Overall Study||0
244617|NCT01069510|592386|P1|NOT COMPLETED|Overall Study||0
244618|NCT01069510|592385|P2|COMPLETED|Overall Study||7
244619|NCT01069510|592386|P1|COMPLETED|Overall Study||8
244620|NCT01069510|592385|P2|STARTED|Overall Study||7
244621|NCT01069510|592386|P1|STARTED|Overall Study||8
244622|NCT01069484|592398|P2|NOT COMPLETED|Overall Study||3
244623|NCT01069484|592399|P1|NOT COMPLETED|Overall Study||12
244624|NCT01069484|592398|P2|COMPLETED|Overall Study|27 in the stratum with major levator ani muscle defects and 58 in the stratum without such defects.|85
244625|NCT01069484|592399|P1|COMPLETED|Overall Study|24 in the stratum with major levator ani muscle defects and 51 in the stratum without such defects.|75
244626|NCT01069484|592398|P2|STARTED|Overall Study|28 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|88
244627|NCT01069484|592399|P1|STARTED|Overall Study|27 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|87
244628|NCT01069419|592407|P1|NOT COMPLETED|Overall Study||715
244629|NCT01069419|592407|P1|COMPLETED|Overall Study||402
244630|NCT01069419|592407|P1|Full Analysis Set|Overall Study||851
244631|NCT01069419|592407|P1|Safety Set|Overall Study||1111
244632|NCT01069419|592407|P1|STARTED|Overall Study||1117
244633|NCT01069354|592414|P1|NOT COMPLETED|Overall Study||1
244634|NCT01069354|592414|P1|COMPLETED|Overall Study|One subject's treatment fold not injected due to adverse event during control fold injection|101
244635|NCT01069354|592414|P1|STARTED|Overall Study||102
244636|NCT01069341|592436|P1|NOT COMPLETED|Overall Study||1
244637|NCT01069341|592436|P1|COMPLETED|Overall Study||3
244638|NCT01069341|592436|P1|STARTED|Overall Study||4
244639|NCT01069315|592451|P4|NOT COMPLETED|Overall Study||7
244640|NCT01069315|592452|P3|NOT COMPLETED|Overall Study||5
244641|NCT01069315|592453|P2|NOT COMPLETED|Overall Study||6
244642|NCT01069315|592454|P1|NOT COMPLETED|Overall Study||4
244643|NCT01069315|592451|P4|COMPLETED|Overall Study||19
244644|NCT01069315|592452|P3|COMPLETED|Overall Study||23
244645|NCT01069315|592453|P2|COMPLETED|Overall Study||24
244646|NCT01069315|592454|P1|COMPLETED|Overall Study||23
244647|NCT01069315|592451|P4|STARTED|Overall Study||26
244648|NCT01069315|592452|P3|STARTED|Overall Study||28
244649|NCT01069315|592453|P2|STARTED|Overall Study||30
244650|NCT01069315|592454|P1|STARTED|Overall Study||27
244651|NCT01069289|592478|P2|NOT COMPLETED|Overall Study||56
244652|NCT01069289|592479|P1|NOT COMPLETED|Overall Study||42
244653|NCT01069289|592478|P2|COMPLETED|Overall Study||601
244654|NCT01069289|592479|P1|COMPLETED|Overall Study||594
244655|NCT01069289|592478|P2|STARTED|Overall Study||657
244656|NCT01069289|592479|P1|STARTED|Overall Study||636
244657|NCT01069185|592519|P2|NOT COMPLETED|Overall Study||0
244658|NCT01069185|592520|P1|NOT COMPLETED|Overall Study||0
244659|NCT01069185|592519|P2|COMPLETED|Overall Study||45
244660|NCT01069185|592520|P1|COMPLETED|Overall Study||47
244661|NCT01069185|592519|P2|STARTED|Overall Study||45
244662|NCT01069185|592520|P1|STARTED|Overall Study||47
244663|NCT01069172|592528|P2|NOT COMPLETED|Overall Study||0
244664|NCT01069172|592529|P1|NOT COMPLETED|Overall Study||1
244665|NCT01069172|592528|P2|COMPLETED|Overall Study|30 eyes|30
244666|NCT01069172|592529|P1|COMPLETED|Overall Study|29 eyes|29
244667|NCT01069172|592528|P2|STARTED|Overall Study|30 eyes|30
244668|NCT01069172|592529|P1|STARTED|Overall Study|30 eyes|30
244669|NCT01069120|592539|P1|NOT COMPLETED|Overall Study||27
244670|NCT01069120|592539|P1|COMPLETED|Overall Study||0
244671|NCT01069120|592539|P1|STARTED|Overall Study||27
244672|NCT01069003|592548|P3|NOT COMPLETED|Overall Study||475
244673|NCT01069003|592549|P2|NOT COMPLETED|Overall Study||54
244674|NCT01069003|592550|P1|NOT COMPLETED|Overall Study||46
244675|NCT01069003|592548|P3|COMPLETED|Overall Study||976
244676|NCT01069003|592549|P2|COMPLETED|Overall Study||358
244677|NCT01069003|592550|P1|COMPLETED|Overall Study||353
244678|NCT01069003|592548|P3|STARTED|Overall Study||1451
244679|NCT01069003|592549|P2|STARTED|Overall Study||412
244680|NCT01069003|592550|P1|STARTED|Overall Study||399
244681|NCT01068964|592566|P2|NOT COMPLETED|Overall Study||10
244682|NCT01068964|592567|P1|NOT COMPLETED|Overall Study||8
244683|NCT01068964|592566|P2|COMPLETED|Overall Study||104
244684|NCT01068964|592567|P1|COMPLETED|Overall Study||113
244685|NCT01068964|592566|P2|STARTED|Overall Study||114
244686|NCT01068964|592567|P1|STARTED|Overall Study||121
244687|NCT01068912|592576|P3|NOT COMPLETED|Overall Study||15
244688|NCT01068912|592577|P2|NOT COMPLETED|Overall Study||22
244689|NCT01068912|592578|P1|NOT COMPLETED|Overall Study||11
244690|NCT01068912|592576|P3|COMPLETED|Overall Study||186
244691|NCT01068912|592577|P2|COMPLETED|Overall Study||173
244692|NCT01068912|592578|P1|COMPLETED|Overall Study||123
244693|NCT01068912|592576|P3|STARTED|Overall Study||201
244694|NCT01068912|592577|P2|STARTED|Overall Study||195
244695|NCT01068912|592578|P1|STARTED|Overall Study||134
244696|NCT01068860|592596|P10|NOT COMPLETED|Overall Study||4
244697|NCT01068860|592597|P9|NOT COMPLETED|Overall Study||0
244698|NCT01068860|592598|P8|NOT COMPLETED|Overall Study||0
244699|NCT01068860|592599|P7|NOT COMPLETED|Overall Study||0
244700|NCT01068860|592600|P6|NOT COMPLETED|Overall Study||2
244701|NCT01068860|592601|P5|NOT COMPLETED|Overall Study||0
244702|NCT01068860|592602|P4|NOT COMPLETED|Overall Study||1
244703|NCT01068860|592603|P3|NOT COMPLETED|Overall Study||0
244704|NCT01068860|592604|P2|NOT COMPLETED|Overall Study||1
244705|NCT01068860|592605|P1|NOT COMPLETED|Overall Study||0
244706|NCT01068860|592596|P10|COMPLETED|Overall Study||23
244707|NCT01068860|592597|P9|COMPLETED|Overall Study||28
244708|NCT01068860|592598|P8|COMPLETED|Overall Study||15
244709|NCT01068860|592599|P7|COMPLETED|Overall Study||28
244710|NCT01068860|592600|P6|COMPLETED|Overall Study||14
244711|NCT01068860|592601|P5|COMPLETED|Overall Study||32
244712|NCT01068860|592602|P4|COMPLETED|Overall Study||16
244713|NCT01068860|592603|P3|COMPLETED|Overall Study||33
244714|NCT01068860|592604|P2|COMPLETED|Overall Study||16
244715|NCT01068860|592605|P1|COMPLETED|Overall Study||33
244716|NCT01068860|592596|P10|STARTED|Overall Study||27
244717|NCT01068860|592597|P9|STARTED|Overall Study||28
244718|NCT01068860|592598|P8|STARTED|Overall Study||15
244719|NCT01068860|592599|P7|STARTED|Overall Study||28
244720|NCT01068860|592600|P6|STARTED|Overall Study||16
244721|NCT01068860|592601|P5|STARTED|Overall Study||32
244722|NCT01068860|592602|P4|STARTED|Overall Study||17
244723|NCT01068860|592603|P3|STARTED|Overall Study||33
244724|NCT01068860|592604|P2|STARTED|Overall Study||17
244725|NCT01068860|592605|P1|STARTED|Overall Study||33
244726|NCT01068821|592779|P2|NOT COMPLETED|Overall Study||0
244727|NCT01068821|592780|P1|NOT COMPLETED|Overall Study||1
244728|NCT01068821|592779|P2|COMPLETED|Overall Study||29
244729|NCT01068821|592780|P1|COMPLETED|Overall Study|1 patient had slide measured, but her patient ID not listed; couldn't do postoperative followup.|30
244730|NCT01068821|592779|P2|STARTED|Overall Study||29
244731|NCT01068821|592780|P1|STARTED|Overall Study||31
244732|NCT01068769|592788|P1|NOT COMPLETED|Overall Study||1
244733|NCT01068769|592788|P1|COMPLETED|Overall Study||33
244734|NCT01068769|592788|P1|STARTED|Overall Study||34
244735|NCT01068743|592793|P4|NOT COMPLETED|Period 4||0
244736|NCT01068743|592794|P3|NOT COMPLETED|Period 4||0
244737|NCT01068743|592795|P2|NOT COMPLETED|Period 4||0
244738|NCT01068743|592796|P1|NOT COMPLETED|Period 4||0
244739|NCT01068743|592793|P4|COMPLETED|Period 4||6
244740|NCT01068743|592794|P3|COMPLETED|Period 4||6
244741|NCT01068743|592795|P2|COMPLETED|Period 4||5
244742|NCT01068743|592796|P1|COMPLETED|Period 4||6
244743|NCT01068743|592793|P4|STARTED|Period 4||6
244744|NCT01068743|592794|P3|STARTED|Period 4||6
244745|NCT01068743|592795|P2|STARTED|Period 4||5
244746|NCT01068743|592796|P1|STARTED|Period 4||6
244747|NCT01068743|592793|P4|NOT COMPLETED|Period 3||0
244748|NCT01068743|592794|P3|NOT COMPLETED|Period 3||0
244749|NCT01068743|592795|P2|NOT COMPLETED|Period 3||1
244750|NCT01068743|592796|P1|NOT COMPLETED|Period 3||0
244751|NCT01068743|592793|P4|COMPLETED|Period 3||6
244752|NCT01068743|592794|P3|COMPLETED|Period 3||6
244753|NCT01068743|592795|P2|COMPLETED|Period 3||5
244754|NCT01068743|592796|P1|COMPLETED|Period 3||6
244755|NCT01068743|592793|P4|STARTED|Period 3||6
244756|NCT01068743|592794|P3|STARTED|Period 3||6
244757|NCT01068743|592795|P2|STARTED|Period 3||6
244758|NCT01068743|592796|P1|STARTED|Period 3||6
244759|NCT01068743|592793|P4|NOT COMPLETED|Period 2||0
244760|NCT01068743|592794|P3|NOT COMPLETED|Period 2||0
244761|NCT01068743|592795|P2|NOT COMPLETED|Period 2||0
244762|NCT01068743|592796|P1|NOT COMPLETED|Period 2||0
244763|NCT01068743|592793|P4|COMPLETED|Period 2||6
244764|NCT01068743|592794|P3|COMPLETED|Period 2||6
244765|NCT01068743|592795|P2|COMPLETED|Period 2||6
244766|NCT01068743|592796|P1|COMPLETED|Period 2||6
244767|NCT01068743|592793|P4|STARTED|Period 2||6
244768|NCT01068743|592794|P3|STARTED|Period 2||6
244769|NCT01068743|592795|P2|STARTED|Period 2||6
244770|NCT01068743|592796|P1|STARTED|Period 2||6
244771|NCT01068743|592793|P4|NOT COMPLETED|Period 1||0
244772|NCT01068743|592794|P3|NOT COMPLETED|Period 1||0
244773|NCT01068743|592795|P2|NOT COMPLETED|Period 1||0
244774|NCT01068743|592796|P1|NOT COMPLETED|Period 1||0
244775|NCT01068743|592793|P4|COMPLETED|Period 1||6
244776|NCT01068743|592794|P3|COMPLETED|Period 1||6
244777|NCT01068743|592795|P2|COMPLETED|Period 1||6
244778|NCT01068743|592796|P1|COMPLETED|Period 1||6
244779|NCT01068743|592793|P4|STARTED|Period 1||6
244780|NCT01068743|592794|P3|STARTED|Period 1||6
244781|NCT01068743|592795|P2|STARTED|Period 1||6
244782|NCT01068743|592796|P1|STARTED|Period 1||6
244783|NCT01068730|592870|P4|NOT COMPLETED|Period 4||0
244784|NCT01068730|592871|P3|NOT COMPLETED|Period 4||0
244785|NCT01068730|592872|P2|NOT COMPLETED|Period 4||1
244786|NCT01068730|592873|P1|NOT COMPLETED|Period 4||0
244787|NCT01068730|592870|P4|COMPLETED|Period 4||7
244788|NCT01068730|592871|P3|COMPLETED|Period 4||7
244789|NCT01068730|592872|P2|COMPLETED|Period 4||6
244790|NCT01068730|592873|P1|COMPLETED|Period 4||6
244791|NCT01068730|592870|P4|STARTED|Period 4||7
244792|NCT01068730|592871|P3|STARTED|Period 4||7
244793|NCT01068730|592872|P2|STARTED|Period 4||7
244794|NCT01068730|592873|P1|STARTED|Period 4||6
244795|NCT01068730|592870|P4|NOT COMPLETED|Period 3||0
244796|NCT01068730|592871|P3|NOT COMPLETED|Period 3||0
244797|NCT01068730|592872|P2|NOT COMPLETED|Period 3||0
244798|NCT01068730|592873|P1|NOT COMPLETED|Period 3||1
244799|NCT01068730|592870|P4|COMPLETED|Period 3||7
244800|NCT01068730|592871|P3|COMPLETED|Period 3||7
244801|NCT01068730|592872|P2|COMPLETED|Period 3||7
244802|NCT01068730|592873|P1|COMPLETED|Period 3||6
244803|NCT01068730|592870|P4|STARTED|Period 3||7
244804|NCT01068730|592871|P3|STARTED|Period 3||7
244805|NCT01068730|592872|P2|STARTED|Period 3||7
244806|NCT01068730|592873|P1|STARTED|Period 3||7
244807|NCT01068730|592870|P4|NOT COMPLETED|Period 2||0
244808|NCT01068730|592871|P3|NOT COMPLETED|Period 2||0
244809|NCT01068730|592872|P2|NOT COMPLETED|Period 2||0
244810|NCT01068730|592873|P1|NOT COMPLETED|Period 2||0
244811|NCT01068730|592870|P4|COMPLETED|Period 2||7
244812|NCT01068730|592871|P3|COMPLETED|Period 2||7
244813|NCT01068730|592872|P2|COMPLETED|Period 2||7
244814|NCT01068730|592873|P1|COMPLETED|Period 2||7
244815|NCT01068730|592870|P4|STARTED|Period 2||7
244816|NCT01068730|592871|P3|STARTED|Period 2||7
244817|NCT01068730|592872|P2|STARTED|Period 2||7
244818|NCT01068730|592873|P1|STARTED|Period 2||7
244819|NCT01068730|592870|P4|NOT COMPLETED|Period 1||0
244820|NCT01068730|592871|P3|NOT COMPLETED|Period 1||0
244821|NCT01068730|592872|P2|NOT COMPLETED|Period 1||0
244822|NCT01068730|592873|P1|NOT COMPLETED|Period 1||0
244823|NCT01068730|592870|P4|COMPLETED|Period 1||7
244824|NCT01068730|592871|P3|COMPLETED|Period 1||7
244825|NCT01068730|592872|P2|COMPLETED|Period 1||7
244826|NCT01068730|592873|P1|COMPLETED|Period 1||7
244827|NCT01068730|592870|P4|STARTED|Period 1||7
244828|NCT01068730|592871|P3|STARTED|Period 1||7
244829|NCT01068730|592872|P2|STARTED|Period 1||7
244830|NCT01068730|592873|P1|STARTED|Period 1||7
244831|NCT01068717|592927|P4|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
244832|NCT01068717|592928|P3|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
244833|NCT01068717|592929|P2|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
244834|NCT01068717|592930|P1|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
244835|NCT01068717|592927|P4|COMPLETED|Period 4: Treatment Schedule Phase 4||7
244836|NCT01068717|592928|P3|COMPLETED|Period 4: Treatment Schedule Phase 4||7
244837|NCT01068717|592929|P2|COMPLETED|Period 4: Treatment Schedule Phase 4||6
244838|NCT01068717|592930|P1|COMPLETED|Period 4: Treatment Schedule Phase 4||7
244839|NCT01068717|592927|P4|STARTED|Period 4: Treatment Schedule Phase 4||7
244840|NCT01068717|592928|P3|STARTED|Period 4: Treatment Schedule Phase 4||7
244841|NCT01068717|592929|P2|STARTED|Period 4: Treatment Schedule Phase 4||6
244842|NCT01068717|592930|P1|STARTED|Period 4: Treatment Schedule Phase 4|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
244843|NCT01068717|592927|P4|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
244844|NCT01068717|592928|P3|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
244845|NCT01068717|592929|P2|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
244846|NCT01068717|592930|P1|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
244847|NCT01068717|592927|P4|COMPLETED|Period 3: Treatment Schedule Phase 3||7
244848|NCT01068717|592928|P3|COMPLETED|Period 3: Treatment Schedule Phase 3||7
244849|NCT01068717|592929|P2|COMPLETED|Period 3: Treatment Schedule Phase 3||6
244850|NCT01068717|592930|P1|COMPLETED|Period 3: Treatment Schedule Phase 3||7
244851|NCT01068717|592927|P4|STARTED|Period 3: Treatment Schedule Phase 3||7
244852|NCT01068717|592928|P3|STARTED|Period 3: Treatment Schedule Phase 3||7
244853|NCT01068717|592929|P2|STARTED|Period 3: Treatment Schedule Phase 3||6
244854|NCT01068717|592930|P1|STARTED|Period 3: Treatment Schedule Phase 3|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
244855|NCT01068717|592927|P4|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
244856|NCT01068717|592928|P3|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
244857|NCT01068717|592929|P2|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
244858|NCT01068717|592930|P1|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
244859|NCT01068717|592927|P4|COMPLETED|Period 2: Treatment Schedule Phase 2||7
244860|NCT01068717|592928|P3|COMPLETED|Period 2: Treatment Schedule Phase 2||7
244861|NCT01068717|592929|P2|COMPLETED|Period 2: Treatment Schedule Phase 2||6
244862|NCT01068717|592930|P1|COMPLETED|Period 2: Treatment Schedule Phase 2||6
244863|NCT01068717|592927|P4|STARTED|Period 2: Treatment Schedule Phase 2||7
244864|NCT01068717|592928|P3|STARTED|Period 2: Treatment Schedule Phase 2||7
244865|NCT01068717|592929|P2|STARTED|Period 2: Treatment Schedule Phase 2||6
244866|NCT01068717|592930|P1|STARTED|Period 2: Treatment Schedule Phase 2||6
244867|NCT01068717|592927|P4|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
244868|NCT01068717|592928|P3|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
244869|NCT01068717|592929|P2|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
244870|NCT01068717|592930|P1|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||1
244871|NCT01068717|592927|P4|COMPLETED|Period 1: Treatment Schedule Phase 1||7
244872|NCT01068717|592928|P3|COMPLETED|Period 1: Treatment Schedule Phase 1||7
244873|NCT01068717|592929|P2|COMPLETED|Period 1: Treatment Schedule Phase 1||6
244874|NCT01068717|592930|P1|COMPLETED|Period 1: Treatment Schedule Phase 1|Patient who withdrew returned for Treatment Periods 3 and 4.|6
244875|NCT01068717|592927|P4|STARTED|Period 1: Treatment Schedule Phase 1||7
244876|NCT01068717|592928|P3|STARTED|Period 1: Treatment Schedule Phase 1||7
244877|NCT01068717|592929|P2|STARTED|Period 1: Treatment Schedule Phase 1||6
244878|NCT01068717|592930|P1|STARTED|Period 1: Treatment Schedule Phase 1||7
244879|NCT01068678|592986|P2|NOT COMPLETED|Overall Study||24
244880|NCT01068678|592987|P1|NOT COMPLETED|Overall Study||38
244881|NCT01068678|592986|P2|COMPLETED|Overall Study||206
244882|NCT01068678|592987|P1|COMPLETED|Overall Study||192
244883|NCT01068678|592986|P2|Exposed|Overall Study|one subject withdrew prior to exposure to trial product|229
244884|NCT01068678|592987|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial product.|227
244885|NCT01068678|592986|P2|STARTED|Overall Study||230
244886|NCT01068678|592987|P1|STARTED|Overall Study||230
244887|NCT01068665|592997|P2|NOT COMPLETED|Overall Study||29
244888|NCT01068665|592998|P1|NOT COMPLETED|Overall Study||30
244889|NCT01068665|592997|P2|COMPLETED|Overall Study||201
244890|NCT01068665|592998|P1|COMPLETED|Overall Study||200
244891|NCT01068665|592997|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|228
244892|NCT01068665|592998|P1|Exposed|Overall Study||228
244893|NCT01068665|592997|P2|Full Analysis Set|Overall Study|One subject was withdrawn because the subject was randomised in error.|229
244894|NCT01068665|592998|P1|Full Analysis Set|Overall Study|Two subjects were withdrawn because the subjects were randomised in error.|228
244895|NCT01068665|592997|P2|STARTED|Overall Study||230
244896|NCT01068665|592998|P1|STARTED|Overall Study||230
244897|NCT01068652|593008|P2|NOT COMPLETED|Overall Study||15
244898|NCT01068652|593009|P1|NOT COMPLETED|Overall Study||18
244899|NCT01068652|593008|P2|COMPLETED|Overall Study||188
244900|NCT01068652|593009|P1|COMPLETED|Overall Study||182
244901|NCT01068652|593008|P2|STARTED|Overall Study||203
244902|NCT01068652|593009|P1|STARTED|Overall Study||200
244903|NCT01068626|593049|P2|NOT COMPLETED|Overall Study||2
244904|NCT01068626|593050|P1|NOT COMPLETED|Overall Study||3
244905|NCT01068626|593049|P2|COMPLETED|Overall Study||27
244906|NCT01068626|593050|P1|COMPLETED|Overall Study||27
244907|NCT01068626|593049|P2|STARTED|Overall Study||29
244908|NCT01068626|593050|P1|STARTED|Overall Study||30
244909|NCT01068600|593068|P2|NOT COMPLETED|Overall Study||17
244910|NCT01068600|593069|P1|NOT COMPLETED|Overall Study||11
244911|NCT01068600|593068|P2|COMPLETED|Overall Study||142
244912|NCT01068600|593069|P1|COMPLETED|Overall Study||148
244913|NCT01068600|593068|P2|STARTED|Overall Study||159
244914|NCT01068600|593069|P1|STARTED|Overall Study||159
244915|NCT01068548|593079|P2|NOT COMPLETED|Overall Study||0
244916|NCT01068548|593080|P1|NOT COMPLETED|Overall Study||0
244917|NCT01068548|593079|P2|COMPLETED|Overall Study||63
244918|NCT01068548|593080|P1|COMPLETED|Overall Study||66
244919|NCT01068548|593079|P2|STARTED|Overall Study||63
244920|NCT01068548|593080|P1|STARTED|Overall Study||66
244921|NCT01068509|593091|P3|NOT COMPLETED|Overall Study||21
244922|NCT01068509|593092|P2|NOT COMPLETED|Overall Study||22
244923|NCT01068509|593093|P1|NOT COMPLETED|Overall Study||6
244924|NCT01068509|593091|P3|COMPLETED|Overall Study||6
244925|NCT01068509|593092|P2|COMPLETED|Overall Study||7
244926|NCT01068509|593093|P1|COMPLETED|Overall Study||1
244927|NCT01068509|593091|P3|STARTED|Overall Study||27
244928|NCT01068509|593092|P2|STARTED|Overall Study||29
244929|NCT01068509|593093|P1|STARTED|Overall Study||7
244930|NCT01068418|593106|P1|NOT COMPLETED|Overall Study||12
244931|NCT01068418|593106|P1|COMPLETED|Overall Study|14 participants completed all study procedures.|14
244932|NCT01068418|593106|P1|Medication Washout|Overall Study|9 participants were disempaneled during the medication washout phase due to noncompliance or high BP|17
244933|NCT01068418|593106|P1|STARTED|Overall Study|26 participants found to be eligible|26
244934|NCT01068262|593115|P4|NOT COMPLETED|Overall Study||0
244935|NCT01068262|593116|P3|NOT COMPLETED|Overall Study||1
244936|NCT01068262|593117|P2|NOT COMPLETED|Overall Study||1
244937|NCT01068262|593118|P1|NOT COMPLETED|Overall Study||3
244938|NCT01068262|593115|P4|COMPLETED|Overall Study||2
244939|NCT01068262|593116|P3|COMPLETED|Overall Study||9
244940|NCT01068262|593117|P2|COMPLETED|Overall Study||8
244941|NCT01068262|593118|P1|COMPLETED|Overall Study||20
244942|NCT01068262|593115|P4|STARTED|Overall Study||2
244943|NCT01068262|593116|P3|STARTED|Overall Study||10
244944|NCT01068262|593117|P2|STARTED|Overall Study||9
244945|NCT01068262|593118|P1|STARTED|Overall Study||23
244946|NCT01068158|593148|P2|NOT COMPLETED|Overall Study||4
244947|NCT01068158|593149|P1|NOT COMPLETED|Overall Study||8
244948|NCT01068158|593148|P2|COMPLETED|Overall Study||198
244949|NCT01068158|593149|P1|COMPLETED|Overall Study||161
244950|NCT01068158|593148|P2|STARTED|Overall Study||202
244951|NCT01068158|593149|P1|STARTED|Overall Study||169
244952|NCT01067976|593161|P1|NOT COMPLETED|Overall Study||22
244953|NCT01067976|593161|P1|COMPLETED|Overall Study|study course completed|424
244954|NCT01067976|593161|P1|Fulfilled Requirements of FAS Population|Overall Study||390
244955|NCT01067976|593161|P1|Received Treatment|Overall Study|treatment started|426
244956|NCT01067976|593161|P1|STARTED|Overall Study|screened and enrolled|446
244957|NCT01067846|593222|P2|NOT COMPLETED|Overall Study||19
244958|NCT01067846|593223|P1|NOT COMPLETED|Overall Study||19
244959|NCT01067846|593222|P2|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|11
244960|NCT01067846|593223|P1|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|10
244961|NCT01067846|593222|P2|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
244962|NCT01067846|593223|P1|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
244963|NCT01067846|593222|P2|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|30
244964|NCT01067846|593223|P1|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|29
244965|NCT01067781|593235|P4|NOT COMPLETED|180 to Day 720||89
244966|NCT01067781|593236|P3|NOT COMPLETED|180 to Day 720||89
244967|NCT01067781|593237|P2|NOT COMPLETED|180 to Day 720||164
244968|NCT01067781|593238|P1|NOT COMPLETED|180 to Day 720||170
244969|NCT01067781|593235|P4|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
244970|NCT01067781|593236|P3|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
244971|NCT01067781|593237|P2|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|4
244972|NCT01067781|593238|P1|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|3
244973|NCT01067781|593235|P4|STARTED|180 to Day 720||89
244974|NCT01067781|593236|P3|STARTED|180 to Day 720||89
244975|NCT01067781|593237|P2|STARTED|180 to Day 720||168
244976|NCT01067781|593238|P1|STARTED|180 to Day 720||173
244977|NCT01067781|593235|P4|NOT COMPLETED|Up to Day 180||12
244978|NCT01067781|593236|P3|NOT COMPLETED|Up to Day 180||8
244979|NCT01067781|593237|P2|NOT COMPLETED|Up to Day 180||31
244980|NCT01067781|593238|P1|NOT COMPLETED|Up to Day 180||30
244981|NCT01067781|593235|P4|COMPLETED|Up to Day 180||89
244982|NCT01067781|593236|P3|COMPLETED|Up to Day 180||89
244983|NCT01067781|593237|P2|COMPLETED|Up to Day 180||168
244984|NCT01067781|593238|P1|COMPLETED|Up to Day 180||173
244985|NCT01067781|593235|P4|STARTED|Up to Day 180||101
244986|NCT01067781|593236|P3|STARTED|Up to Day 180||97
244987|NCT01067781|593237|P2|STARTED|Up to Day 180||199
244988|NCT01067781|593238|P1|STARTED|Up to Day 180||203
244989|NCT01067768|593248|P2|NOT COMPLETED|Overall Study||0
244990|NCT01067768|593249|P1|NOT COMPLETED|Overall Study||0
244991|NCT01067768|593248|P2|COMPLETED|Overall Study||605
244992|NCT01067768|593249|P1|COMPLETED|Overall Study||604
244993|NCT01067768|593248|P2|STARTED|Overall Study||605
244994|NCT01067768|593249|P1|STARTED|Overall Study||604
244995|NCT01067716|593260|P3|NOT COMPLETED|Overall Study||0
244996|NCT01067716|593261|P2|NOT COMPLETED|Overall Study||0
244997|NCT01067716|593262|P1|NOT COMPLETED|Overall Study||0
244998|NCT01067716|593260|P3|COMPLETED|Overall Study|15 eyes|9
244999|NCT01067716|593261|P2|COMPLETED|Overall Study|25 eyes|13
245000|NCT01067716|593262|P1|COMPLETED|Overall Study|110 eyes|57
245001|NCT01067716|593260|P3|STARTED|Overall Study|15 eyes|9
245002|NCT01067716|593261|P2|STARTED|Overall Study|25 eyes|13
245003|NCT01067716|593262|P1|STARTED|Overall Study|110 eyes|57
245004|NCT01067521|593281|P2|NOT COMPLETED|Open-Label Period||158
245005|NCT01067521|593282|P1|NOT COMPLETED|Open-Label Period||254
245006|NCT01067521|593281|P2|COMPLETED|Open-Label Period||261
245007|NCT01067521|593282|P1|COMPLETED|Open-Label Period||580
245008|NCT01067521|593281|P2|STARTED|Open-Label Period|Some participants did not continue into the open-label period.|419
245009|NCT01067521|593282|P1|STARTED|Open-Label Period|Some participants did not continue into the open-label period.|834
245010|NCT01067521|593281|P2|NOT COMPLETED|Double-Blind Placebo-Controlled Period||31
245011|NCT01067521|593282|P1|NOT COMPLETED|Double-Blind Placebo-Controlled Period||84
245012|NCT01067521|593281|P2|COMPLETED|Double-Blind Placebo-Controlled Period||430
245013|NCT01067521|593282|P1|COMPLETED|Double-Blind Placebo-Controlled Period||859
245014|NCT01067521|593281|P2|STARTED|Double-Blind Placebo-Controlled Period||461
245015|NCT01067521|593282|P1|STARTED|Double-Blind Placebo-Controlled Period||943
245016|NCT01067508|593308|P2|NOT COMPLETED|Overall Study||2
245017|NCT01067508|593309|P1|NOT COMPLETED|Overall Study||0
245018|NCT01067508|593308|P2|COMPLETED|Overall Study||7
245019|NCT01067508|593309|P1|COMPLETED|Overall Study||10
245020|NCT01067508|593308|P2|STARTED|Overall Study||9
245021|NCT01067508|593309|P1|STARTED|Overall Study||10
245022|NCT01067456|593317|P2|NOT COMPLETED|Overall Study||0
245023|NCT01067456|593318|P1|NOT COMPLETED|Overall Study||0
245024|NCT01067456|593317|P2|COMPLETED|Overall Study||29
245025|NCT01067456|593318|P1|COMPLETED|Overall Study||30
245026|NCT01067456|593317|P2|STARTED|Overall Study||29
245027|NCT01067456|593318|P1|STARTED|Overall Study||30
245028|NCT01067352|593331|P3|NOT COMPLETED|Overall Study||1
245029|NCT01067352|593332|P2|NOT COMPLETED|Overall Study||3
245030|NCT01067352|593333|P1|NOT COMPLETED|Overall Study||1
245031|NCT01067352|593331|P3|COMPLETED|Overall Study||9
245032|NCT01067352|593332|P2|COMPLETED|Overall Study||3
245033|NCT01067352|593333|P1|COMPLETED|Overall Study||8
245034|NCT01067352|593331|P3|STARTED|Overall Study||10
245035|NCT01067352|593332|P2|STARTED|Overall Study||6
245036|NCT01067352|593333|P1|STARTED|Overall Study||9
245037|NCT01067339|593349|P2|NOT COMPLETED|Overall Study||5
245038|NCT01067339|593350|P1|NOT COMPLETED|Overall Study||6
245039|NCT01067339|593349|P2|COMPLETED|Overall Study||29
245040|NCT01067339|593350|P1|COMPLETED|Overall Study||25
245041|NCT01067339|593349|P2|STARTED|Overall Study||34
245042|NCT01067339|593350|P1|STARTED|Overall Study||31
245043|NCT01067326|593360|P2|NOT COMPLETED|Overall Study||3
245044|NCT01067326|593361|P1|NOT COMPLETED|Overall Study||2
245045|NCT01067326|593360|P2|COMPLETED|Overall Study||5
245046|NCT01067326|593361|P1|COMPLETED|Overall Study||12
245047|NCT01067326|593360|P2|STARTED|Overall Study||8
245048|NCT01067326|593361|P1|STARTED|Overall Study||14
245049|NCT01067144|593375|P2|NOT COMPLETED|Follow-up||56
245050|NCT01067144|593376|P1|NOT COMPLETED|Follow-up||59
245051|NCT01067144|593375|P2|COMPLETED|Follow-up||152
245052|NCT01067144|593376|P1|COMPLETED|Follow-up||144
245053|NCT01067144|593375|P2|Intention-to-Treat Analysis Set|Follow-up||208
245054|NCT01067144|593376|P1|Intention-to-Treat Analysis Set|Follow-up||202
245055|NCT01067144|593375|P2|STARTED|Follow-up||208
245056|NCT01067144|593376|P1|STARTED|Follow-up||203
245057|NCT01067144|593375|P2|NOT COMPLETED|Treatment||7
245058|NCT01067144|593376|P1|NOT COMPLETED|Treatment||4
245059|NCT01067144|593375|P2|COMPLETED|Treatment||208
245060|NCT01067144|593376|P1|COMPLETED|Treatment||203
245061|NCT01067144|593375|P2|STARTED|Treatment||215
245062|NCT01067144|593376|P1|STARTED|Treatment||207
245063|NCT01067105|593392|P1|NOT COMPLETED|Overall Study||141
245064|NCT01067105|593392|P1|COMPLETED|Overall Study||683
245065|NCT01067105|593392|P1|STARTED|Overall Study||824
245066|NCT01066923|593413|P4|NOT COMPLETED|Overall Study||8
245067|NCT01066923|593414|P3|NOT COMPLETED|Overall Study||8
245068|NCT01066923|593415|P2|NOT COMPLETED|Overall Study||3
245069|NCT01066923|593416|P1|NOT COMPLETED|Overall Study||3
245070|NCT01066923|593413|P4|COMPLETED|Overall Study||23
245071|NCT01066923|593414|P3|COMPLETED|Overall Study||25
245072|NCT01066923|593415|P2|COMPLETED|Overall Study||29
245073|NCT01066923|593416|P1|COMPLETED|Overall Study||25
245074|NCT01066923|593413|P4|Retinal Imaging|Overall Study||0
245075|NCT01066923|593414|P3|Retinal Imaging|Overall Study||0
245076|NCT01066923|593415|P2|Retinal Imaging|Overall Study||0
245077|NCT01066923|593416|P1|Retinal Imaging|Overall Study||0
245078|NCT01066923|593413|P4|Activation of Coagulation|Overall Study||0
245079|NCT01066923|593414|P3|Activation of Coagulation|Overall Study||0
245080|NCT01066923|593415|P2|Activation of Coagulation|Overall Study||0
245081|NCT01066923|593416|P1|Activation of Coagulation|Overall Study||0
245082|NCT01066923|593413|P4|Vascular Function|Overall Study||13
245083|NCT01066923|593414|P3|Vascular Function|Overall Study||12
245084|NCT01066923|593415|P2|Vascular Function|Overall Study||14
245085|NCT01066923|593416|P1|Vascular Function|Overall Study||13
245086|NCT01066923|593413|P4|Platelet Closure Time|Overall Study||23
245087|NCT01066923|593414|P3|Platelet Closure Time|Overall Study||25
245088|NCT01066923|593415|P2|Platelet Closure Time|Overall Study||29
245089|NCT01066923|593416|P1|Platelet Closure Time|Overall Study||25
245090|NCT01066923|593413|P4|STARTED|Overall Study||31
245091|NCT01066923|593414|P3|STARTED|Overall Study||33
245092|NCT01066923|593415|P2|STARTED|Overall Study||32
245093|NCT01066923|593416|P1|STARTED|Overall Study||28
245094|NCT01066897|593440|P2|NOT COMPLETED|Overall Study||0
245095|NCT01066897|593441|P1|NOT COMPLETED|Overall Study||2
245096|NCT01066897|593440|P2|COMPLETED|Overall Study||9
245097|NCT01066897|593441|P1|COMPLETED|Overall Study||5
245098|NCT01066897|593440|P2|STARTED|Overall Study||9
245099|NCT01066897|593441|P1|STARTED|Overall Study||7
245100|NCT01066871|593455|P4|NOT COMPLETED|Overall Study||5
245101|NCT01066871|593456|P3|NOT COMPLETED|Overall Study||6
245102|NCT01066871|593457|P2|NOT COMPLETED|Overall Study||5
245103|NCT01066871|593458|P1|NOT COMPLETED|Overall Study||4
245104|NCT01066871|593455|P4|COMPLETED|Overall Study||13
245105|NCT01066871|593456|P3|COMPLETED|Overall Study||12
245106|NCT01066871|593457|P2|COMPLETED|Overall Study||13
245107|NCT01066871|593458|P1|COMPLETED|Overall Study||16
245108|NCT01066871|593455|P4|STARTED|Overall Study||18
245109|NCT01066871|593456|P3|STARTED|Overall Study||18
245110|NCT01066871|593457|P2|STARTED|Overall Study||18
245111|NCT01066871|593458|P1|STARTED|Overall Study||20
245112|NCT01066819|593522|P6|NOT COMPLETED|Overall Study||6
245113|NCT01066819|593523|P5|NOT COMPLETED|Overall Study||4
245114|NCT01066819|593524|P4|NOT COMPLETED|Overall Study||17
245115|NCT01066819|593525|P3|NOT COMPLETED|Overall Study||146
245116|NCT01066819|593526|P2|NOT COMPLETED|Overall Study||171
245117|NCT01066819|593527|P1|NOT COMPLETED|Overall Study||689
245118|NCT01066819|593522|P6|COMPLETED|Overall Study||7
245119|NCT01066819|593523|P5|COMPLETED|Overall Study||3
245120|NCT01066819|593524|P4|COMPLETED|Overall Study||8
245121|NCT01066819|593525|P3|COMPLETED|Overall Study||111
245122|NCT01066819|593526|P2|COMPLETED|Overall Study||177
245123|NCT01066819|593527|P1|COMPLETED|Overall Study||317
245124|NCT01066819|593522|P6|STARTED|Overall Study||13
245125|NCT01066819|593523|P5|STARTED|Overall Study||7
245126|NCT01066819|593524|P4|STARTED|Overall Study||25
245127|NCT01066819|593525|P3|STARTED|Overall Study||257
245128|NCT01066819|593526|P2|STARTED|Overall Study||348
245129|NCT01066819|593527|P1|STARTED|Overall Study||1006
245130|NCT01066793|593668|P6|NOT COMPLETED|Overall Study||1
245131|NCT01066793|593669|P5|NOT COMPLETED|Overall Study||0
245132|NCT01066793|593670|P4|NOT COMPLETED|Overall Study||49
245133|NCT01066793|593671|P3|NOT COMPLETED|Overall Study||115
245134|NCT01066793|593672|P2|NOT COMPLETED|Overall Study||77
245135|NCT01066793|593673|P1|NOT COMPLETED|Overall Study||374
245136|NCT01066793|593668|P6|COMPLETED|Overall Study||4
245137|NCT01066793|593669|P5|COMPLETED|Overall Study||11
245138|NCT01066793|593670|P4|COMPLETED|Overall Study||94
245139|NCT01066793|593671|P3|COMPLETED|Overall Study||369
245140|NCT01066793|593672|P2|COMPLETED|Overall Study||495
245141|NCT01066793|593673|P1|COMPLETED|Overall Study||754
245142|NCT01066793|593668|P6|STARTED|Overall Study||5
245143|NCT01066793|593669|P5|STARTED|Overall Study||11
245144|NCT01066793|593670|P4|STARTED|Overall Study||143
245145|NCT01066793|593671|P3|STARTED|Overall Study||484
245146|NCT01066793|593672|P2|STARTED|Overall Study||572
245147|NCT01066793|593673|P1|STARTED|Overall Study||1128
245148|NCT01066780|593813|P2|NOT COMPLETED|Overall Study||1
245149|NCT01066780|593814|P1|NOT COMPLETED|Overall Study||1
245150|NCT01066780|593813|P2|COMPLETED|Overall Study||23
245151|NCT01066780|593814|P1|COMPLETED|Overall Study||23
245152|NCT01066780|593813|P2|STARTED|Overall Study||24
245153|NCT01066780|593814|P1|STARTED|Overall Study||24
245154|NCT01066624|593821|P3|NOT COMPLETED|Overall Study||0
245155|NCT01066624|593822|P2|NOT COMPLETED|Overall Study||0
245156|NCT01066624|593823|P1|NOT COMPLETED|Overall Study||0
245157|NCT01066624|593821|P3|COMPLETED|Overall Study||39
245158|NCT01066624|593822|P2|COMPLETED|Overall Study||40
245159|NCT01066624|593823|P1|COMPLETED|Overall Study||38
245160|NCT01066624|593821|P3|STARTED|Overall Study||39
245161|NCT01066624|593822|P2|STARTED|Overall Study||40
245162|NCT01066624|593823|P1|STARTED|Overall Study||38
245163|NCT01066585|593833|P2|NOT COMPLETED|Overall Study||3
245164|NCT01066585|593834|P1|NOT COMPLETED|Overall Study||1
245165|NCT01066585|593833|P2|COMPLETED|Overall Study||196
245166|NCT01066585|593834|P1|COMPLETED|Overall Study||210
245167|NCT01066585|593833|P2|STARTED|Overall Study||199
245168|NCT01066585|593834|P1|STARTED|Overall Study||211
245169|NCT01066546|593846|P1|NOT COMPLETED|Overall Study||5
245170|NCT01066546|593846|P1|COMPLETED|Overall Study||0
245171|NCT01066546|593846|P1|STARTED|Overall Study||5
245172|NCT01066520|593860|P3|NOT COMPLETED|Overall Study||0
245173|NCT01066520|593861|P2|NOT COMPLETED|Overall Study||0
245174|NCT01066520|593862|P1|NOT COMPLETED|Overall Study||0
245175|NCT01066520|593860|P3|COMPLETED|Overall Study||137
245176|NCT01066520|593861|P2|COMPLETED|Overall Study||140
245177|NCT01066520|593862|P1|COMPLETED|Overall Study||143
245178|NCT01066520|593860|P3|STARTED|Overall Study||137
245179|NCT01066520|593861|P2|STARTED|Overall Study||140
245180|NCT01066520|593862|P1|STARTED|Overall Study||143
245181|NCT01066156|593876|P1|NOT COMPLETED|Overall Study||10
245182|NCT01066156|593876|P1|COMPLETED|Overall Study||24
245183|NCT01066156|593876|P1|STARTED|Overall Study||34
245184|NCT01066143|593880|P1|NOT COMPLETED|Overall Study||8
245185|NCT01066143|593880|P1|COMPLETED|Overall Study||0
245186|NCT01066143|593880|P1|STARTED|Overall Study||8
245187|NCT01066104|593886|P2|NOT COMPLETED|Overall Study||1
245188|NCT01066104|593887|P1|NOT COMPLETED|Overall Study||2
245189|NCT01066104|593886|P2|COMPLETED|Overall Study||12
245190|NCT01066104|593887|P1|COMPLETED|Overall Study||12
245191|NCT01066104|593886|P2|STARTED|Overall Study||13
245192|NCT01066104|593887|P1|STARTED|Overall Study||14
245193|NCT01066052|593897|P2|NOT COMPLETED|Overall Study||0
245194|NCT01066052|593898|P1|NOT COMPLETED|Overall Study||3
245195|NCT01066052|593897|P2|COMPLETED|Overall Study||51
245196|NCT01066052|593898|P1|COMPLETED|Overall Study||61
245197|NCT01066052|593897|P2|Treated|Overall Study||0
245198|NCT01066052|593898|P1|Treated|Overall Study||61
245199|NCT01066052|593897|P2|STARTED|Overall Study||51
245200|NCT01066052|593898|P1|STARTED|Overall Study||64
245201|NCT01066039|593909|P1|NOT COMPLETED|Overall Study||44
245202|NCT01066039|593909|P1|COMPLETED|Overall Study||158
245203|NCT01066039|593909|P1|Treated|Overall Study||200
245204|NCT01066039|593909|P1|STARTED|Overall Study||202
245205|NCT01066000|593922|P1|NOT COMPLETED|Overall Study||9
245206|NCT01066000|593922|P1|COMPLETED|Overall Study||24
245207|NCT01066000|593922|P1|STARTED|Overall Study||33
245208|NCT01065844|593933|P1|NOT COMPLETED|Overall Study||5
245209|NCT01065844|593933|P1|COMPLETED|Overall Study||10
245210|NCT01065844|593933|P1|STARTED|Overall Study||15
245211|NCT01065818|593937|P1|NOT COMPLETED|Overall Study||2
245212|NCT01065818|593937|P1|COMPLETED|Overall Study||4
245213|NCT01065818|593937|P1|STARTED|Overall Study||6
245214|NCT01065779|593941|P1|NOT COMPLETED|Overall Study||82
245215|NCT01065779|593941|P1|COMPLETED|Overall Study||798
245216|NCT01065779|593941|P1|STARTED|Overall Study||880
245217|NCT01065766|593952|P1|NOT COMPLETED|Overall Study||32
245218|NCT01065766|593952|P1|COMPLETED|Overall Study||4033
245219|NCT01065766|593952|P1|STARTED|Overall Study||4065
245220|NCT01065714|593964|P1|NOT COMPLETED|Overall Study||0
245221|NCT01065714|593964|P1|COMPLETED|Overall Study||20
245222|NCT01065714|593964|P1|STARTED|Overall Study|"This was a split body Study. All participants used both Hydrogel and Eucerin"|20
245223|NCT01065597|593971|P1|NOT COMPLETED|Overall Study||1
245224|NCT01065597|593971|P1|COMPLETED|Overall Study||12
245225|NCT01065597|593971|P1|STARTED|Overall Study||13
245226|NCT01065571|593980|P2|NOT COMPLETED|Overall Study||0
245227|NCT01065571|593981|P1|NOT COMPLETED|Overall Study||3
245228|NCT01065571|593980|P2|COMPLETED|Overall Study||5
245229|NCT01065571|593981|P1|COMPLETED|Overall Study||7
245230|NCT01065571|593980|P2|STARTED|Overall Study||5
245231|NCT01065571|593981|P1|STARTED|Overall Study||10
245232|NCT01065558|593991|P1|NOT COMPLETED|Overall Study||0
245233|NCT01065558|593991|P1|COMPLETED|Overall Study||5
245234|NCT01065558|593991|P1|STARTED|Overall Study||5
245235|NCT01065506|593998|P2|NOT COMPLETED|Overall Study||38
245236|NCT01065506|593999|P1|NOT COMPLETED|Overall Study||32
245237|NCT01065506|593998|P2|COMPLETED|Overall Study||34
245238|NCT01065506|593999|P1|COMPLETED|Overall Study||32
245239|NCT01065506|593998|P2|4-Month Follow-Up|Overall Study||34
245240|NCT01065506|593999|P1|4-Month Follow-Up|Overall Study||35
245241|NCT01065506|593998|P2|End of Treatment|Overall Study||37
245242|NCT01065506|593999|P1|End of Treatment|Overall Study||44
245243|NCT01065506|593998|P2|STARTED|Overall Study||72
245244|NCT01065506|593999|P1|STARTED|Overall Study||64
245245|NCT01065480|594007|P2|NOT COMPLETED|Overall Study||0
245246|NCT01065480|594008|P1|NOT COMPLETED|Overall Study||0
245247|NCT01065480|594007|P2|COMPLETED|Overall Study||43
245248|NCT01065480|594008|P1|COMPLETED|Overall Study||48
245249|NCT01065480|594007|P2|STARTED|Overall Study||43
245250|NCT01065480|594008|P1|STARTED|Overall Study||48
245251|NCT01065454|594018|P4|NOT COMPLETED|Follow up||44
245252|NCT01065454|594019|P3|NOT COMPLETED|Follow up||17
245253|NCT01065454|594020|P2|NOT COMPLETED|Follow up||24
245254|NCT01065454|594021|P1|NOT COMPLETED|Follow up||39
245255|NCT01065454|594018|P4|COMPLETED|Follow up||13
245256|NCT01065454|594019|P3|COMPLETED|Follow up||6
245257|NCT01065454|594020|P2|COMPLETED|Follow up||4
245258|NCT01065454|594021|P1|COMPLETED|Follow up||15
245259|NCT01065454|594018|P4|Entering Follow-up|Follow up||51
245260|NCT01065454|594019|P3|Entering Follow-up|Follow up||23
245261|NCT01065454|594020|P2|Entering Follow-up|Follow up||27
245262|NCT01065454|594021|P1|Entering Follow-up|Follow up||49
245263|NCT01065454|594018|P4|STARTED|Follow up||57
245264|NCT01065454|594019|P3|STARTED|Follow up||23
245265|NCT01065454|594020|P2|STARTED|Follow up||28
245266|NCT01065454|594021|P1|STARTED|Follow up||54
245267|NCT01065454|594018|P4|NOT COMPLETED|Treatment||12
245268|NCT01065454|594019|P3|NOT COMPLETED|Treatment||9
245269|NCT01065454|594020|P2|NOT COMPLETED|Treatment||5
245270|NCT01065454|594021|P1|NOT COMPLETED|Treatment||13
245271|NCT01065454|594018|P4|COMPLETED|Treatment||57
245272|NCT01065454|594019|P3|COMPLETED|Treatment||23
245273|NCT01065454|594020|P2|COMPLETED|Treatment||28
245274|NCT01065454|594021|P1|COMPLETED|Treatment||54
245275|NCT01065454|594018|P4|STARTED|Treatment||69
245276|NCT01065454|594019|P3|STARTED|Treatment||32
245277|NCT01065454|594020|P2|STARTED|Treatment||33
245278|NCT01065454|594021|P1|STARTED|Treatment||67
245279|NCT01065428|594133|P2|NOT COMPLETED|Overall Study||0
245280|NCT01065428|594134|P1|NOT COMPLETED|Overall Study||0
245281|NCT01065428|594133|P2|COMPLETED|Overall Study||35
245282|NCT01065428|594134|P1|COMPLETED|Overall Study||17
245283|NCT01065428|594133|P2|STARTED|Overall Study||35
245284|NCT01065428|594134|P1|STARTED|Overall Study||17
245285|NCT01065350|594144|P2|NOT COMPLETED|Overall Study||1
245286|NCT01065350|594145|P1|NOT COMPLETED|Overall Study||0
245287|NCT01065350|594144|P2|COMPLETED|Overall Study||41
245288|NCT01065350|594145|P1|COMPLETED|Overall Study||43
245289|NCT01065350|594144|P2|STARTED|Overall Study||42
245290|NCT01065350|594145|P1|STARTED|Overall Study||43
245291|NCT01065051|594179|P2|NOT COMPLETED|Overall Study||0
245292|NCT01065051|594180|P1|NOT COMPLETED|Overall Study||0
245293|NCT01065051|594179|P2|COMPLETED|Overall Study||0
245294|NCT01065051|594180|P1|COMPLETED|Overall Study||1
245295|NCT01065051|594179|P2|STARTED|Overall Study||0
245296|NCT01065051|594180|P1|STARTED|Overall Study||1
245297|NCT01064947|594206|P1|NOT COMPLETED|Overall Study||41
245298|NCT01064947|594206|P1|COMPLETED|Overall Study||29
245299|NCT01064947|594206|P1|STARTED|Overall Study||70
245300|NCT01064882|594217|P3|NOT COMPLETED|Overall Study||2
245301|NCT01064882|594218|P2|NOT COMPLETED|Overall Study||2
245302|NCT01064882|594219|P1|NOT COMPLETED|Overall Study||2
245303|NCT01064882|594217|P3|COMPLETED|Overall Study||32
245304|NCT01064882|594218|P2|COMPLETED|Overall Study||32
245305|NCT01064882|594219|P1|COMPLETED|Overall Study||34
245306|NCT01064882|594217|P3|STARTED|Overall Study||34
245307|NCT01064882|594218|P2|STARTED|Overall Study||34
245308|NCT01064882|594219|P1|STARTED|Overall Study||36
245309|NCT01064856|594247|P4|NOT COMPLETED|Open-label (OL) Period||20
245310|NCT01064856|594248|P3|NOT COMPLETED|Open-label (OL) Period||26
245311|NCT01064856|594249|P2|NOT COMPLETED|Open-label (OL) Period||0
245312|NCT01064856|594250|P1|NOT COMPLETED|Open-label (OL) Period||0
245313|NCT01064856|594247|P4|COMPLETED|Open-label (OL) Period||61
245314|NCT01064856|594248|P3|COMPLETED|Open-label (OL) Period||56
245315|NCT01064856|594249|P2|COMPLETED|Open-label (OL) Period||0
245316|NCT01064856|594250|P1|COMPLETED|Open-label (OL) Period||0
245317|NCT01064856|594247|P4|STARTED|Open-label (OL) Period||81
245318|NCT01064856|594248|P3|STARTED|Open-label (OL) Period||82
245319|NCT01064856|594249|P2|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
245320|NCT01064856|594250|P1|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
245321|NCT01064856|594247|P4|NOT COMPLETED|Double-blind (DB) Period||0
245322|NCT01064856|594248|P3|NOT COMPLETED|Double-blind (DB) Period||0
245323|NCT01064856|594249|P2|NOT COMPLETED|Double-blind (DB) Period||0
245324|NCT01064856|594250|P1|NOT COMPLETED|Double-blind (DB) Period||2
245325|NCT01064856|594247|P4|COMPLETED|Double-blind (DB) Period||0
245326|NCT01064856|594248|P3|COMPLETED|Double-blind (DB) Period||0
245327|NCT01064856|594249|P2|COMPLETED|Double-blind (DB) Period||81
245328|NCT01064856|594250|P1|COMPLETED|Double-blind (DB) Period||82
245329|NCT01064856|594247|P4|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
245330|NCT01064856|594248|P3|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
245331|NCT01064856|594249|P2|STARTED|Double-blind (DB) Period||81
245332|NCT01064856|594250|P1|STARTED|Double-blind (DB) Period||84
245333|NCT01064830|594283|P2|NOT COMPLETED|Overall Study||4
245334|NCT01064830|594284|P1|NOT COMPLETED|Overall Study||2
245335|NCT01064830|594283|P2|COMPLETED|Overall Study||7
245336|NCT01064830|594284|P1|COMPLETED|Overall Study||8
245337|NCT01064830|594283|P2|STARTED|Overall Study||11
245338|NCT01064830|594284|P1|STARTED|Overall Study||10
245339|NCT01064817|594294|P2|NOT COMPLETED|Study Completion||0
245340|NCT01064817|594295|P1|NOT COMPLETED|Study Completion||2
245341|NCT01064817|594294|P2|COMPLETED|Study Completion||62
245342|NCT01064817|594295|P1|COMPLETED|Study Completion||60
245343|NCT01064817|594294|P2|STARTED|Study Completion||62
245344|NCT01064817|594295|P1|STARTED|Study Completion||62
245345|NCT01064817|594294|P2|NOT COMPLETED|All Study Treatment Days 1-9||0
245346|NCT01064817|594295|P1|NOT COMPLETED|All Study Treatment Days 1-9||0
245347|NCT01064817|594294|P2|COMPLETED|All Study Treatment Days 1-9||62
245348|NCT01064817|594295|P1|COMPLETED|All Study Treatment Days 1-9||62
245349|NCT01064817|594294|P2|STARTED|All Study Treatment Days 1-9||62
245350|NCT01064817|594295|P1|STARTED|All Study Treatment Days 1-9||62
245351|NCT01064739|594307|P1|NOT COMPLETED|Fixed Sodium Diet + Fava Beans||1
245352|NCT01064739|594307|P1|COMPLETED|Fixed Sodium Diet + Fava Beans|1 participant withdrew with blood in his urine on the fava bean study day.|13
245353|NCT01064739|594307|P1|STARTED|Fixed Sodium Diet + Fava Beans||14
245354|NCT01064739|594307|P1|NOT COMPLETED|Fixed Sodium Study Diet||0
245355|NCT01064739|594307|P1|COMPLETED|Fixed Sodium Study Diet||14
245356|NCT01064739|594307|P1|STARTED|Fixed Sodium Study Diet|14 participants consumed the fixed-sodium study diet prior to the fava bean supplement study day.|14
245357|NCT01064713|594365|P2|NOT COMPLETED|Overall Study||0
245358|NCT01064713|594366|P1|NOT COMPLETED|Overall Study||0
245359|NCT01064713|594365|P2|COMPLETED|Overall Study||4
245360|NCT01064713|594366|P1|COMPLETED|Overall Study||13
245361|NCT01064713|594365|P2|STARTED|Overall Study||4
245362|NCT01064713|594366|P1|STARTED|Overall Study||13
245363|NCT01064687|594378|P4|NOT COMPLETED|Overall Study||17
245364|NCT01064687|594379|P3|NOT COMPLETED|Overall Study||41
245365|NCT01064687|594380|P2|NOT COMPLETED|Overall Study||26
245366|NCT01064687|594381|P1|NOT COMPLETED|Overall Study||34
245367|NCT01064687|594378|P4|COMPLETED|Overall Study||124
245368|NCT01064687|594379|P3|COMPLETED|Overall Study||237
245369|NCT01064687|594380|P2|COMPLETED|Overall Study||254
245370|NCT01064687|594381|P1|COMPLETED|Overall Study||245
245371|NCT01064687|594378|P4|Completed 26 Weeks|Overall Study||124
245372|NCT01064687|594379|P3|Completed 26 Weeks|Overall Study||252
245373|NCT01064687|594380|P2|Completed 26 Weeks|Overall Study||263
245374|NCT01064687|594381|P1|Completed 26 Weeks|Overall Study||260
245375|NCT01064687|594378|P4|Received at Least 1 Dose of Study Drug|Overall Study||141
245376|NCT01064687|594379|P3|Received at Least 1 Dose of Study Drug|Overall Study||276
245377|NCT01064687|594380|P2|Received at Least 1 Dose of Study Drug|Overall Study||280
245378|NCT01064687|594381|P1|Received at Least 1 Dose of Study Drug|Overall Study||279
245379|NCT01064687|594378|P4|STARTED|Overall Study||141
245380|NCT01064687|594379|P3|STARTED|Overall Study|Of 278 participants randomized to Exenatide, 2 chose not to take study drug.|278
245381|NCT01064687|594380|P2|STARTED|Overall Study||280
245382|NCT01064687|594381|P1|STARTED|Overall Study||279
245383|NCT01064622|594561|P2|NOT COMPLETED|Crossover of Arm I||0
245384|NCT01064622|594562|P1|NOT COMPLETED|Crossover of Arm I||0
245385|NCT01064622|594561|P2|COMPLETED|Crossover of Arm I||0
245386|NCT01064622|594562|P1|COMPLETED|Crossover of Arm I||22
245387|NCT01064622|594561|P2|STARTED|Crossover of Arm I||0
245388|NCT01064622|594562|P1|STARTED|Crossover of Arm I|Among 53 patients, 45 had disease progression; however 23 elected not to crossover to vismodegib.|22
245389|NCT01064622|594561|P2|NOT COMPLETED|Randomized Phase II||3
245390|NCT01064622|594562|P1|NOT COMPLETED|Randomized Phase II||2
245391|NCT01064622|594561|P2|COMPLETED|Randomized Phase II||53
245392|NCT01064622|594562|P1|COMPLETED|Randomized Phase II||53
245393|NCT01064622|594561|P2|STARTED|Randomized Phase II||56
245394|NCT01064622|594562|P1|STARTED|Randomized Phase II||55
245395|NCT01064622|594561|P2|NOT COMPLETED|Lead-in Phase I||0
245396|NCT01064622|594562|P1|NOT COMPLETED|Lead-in Phase I||0
245397|NCT01064622|594561|P2|COMPLETED|Lead-in Phase I||7
245398|NCT01064622|594562|P1|COMPLETED|Lead-in Phase I||0
245399|NCT01064622|594561|P2|STARTED|Lead-in Phase I||7
245400|NCT01064622|594562|P1|STARTED|Lead-in Phase I||0
245401|NCT01064414|594586|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
245402|NCT01064414|594587|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
245403|NCT01064414|594588|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
245404|NCT01064414|594586|P3|COMPLETED|Extension Period: Week 26 to Week 52||76
245405|NCT01064414|594587|P2|COMPLETED|Extension Period: Week 26 to Week 52||67
245406|NCT01064414|594588|P1|COMPLETED|Extension Period: Week 26 to Week 52||64
245407|NCT01064414|594586|P3|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|81
245408|NCT01064414|594587|P2|STARTED|Extension Period: Week 26 to Week 52|3 pts completed core but did not enter ext. Reason: other (not specified) (3).|72
245409|NCT01064414|594588|P1|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|76
245410|NCT01064414|594586|P3|NOT COMPLETED|Core Period: Baseline to Week 26||7
245411|NCT01064414|594587|P2|NOT COMPLETED|Core Period: Baseline to Week 26||15
245412|NCT01064414|594588|P1|NOT COMPLETED|Core Period: Baseline to Week 26||13
245413|NCT01064414|594586|P3|COMPLETED|Core Period: Baseline to Week 26||82
245414|NCT01064414|594587|P2|COMPLETED|Core Period: Baseline to Week 26||75
245415|NCT01064414|594588|P1|COMPLETED|Core Period: Baseline to Week 26||77
245416|NCT01064414|594586|P3|STARTED|Core Period: Baseline to Week 26||89
245417|NCT01064414|594587|P2|STARTED|Core Period: Baseline to Week 26||90
245418|NCT01064414|594588|P1|STARTED|Core Period: Baseline to Week 26||90
245419|NCT01064401|594607|P2|NOT COMPLETED|Overall Study||195
245420|NCT01064401|594608|P1|NOT COMPLETED|Overall Study||228
245421|NCT01064401|594607|P2|COMPLETED|Overall Study||724
245422|NCT01064401|594608|P1|COMPLETED|Overall Study||694
245423|NCT01064401|594607|P2|STARTED|Overall Study||919
245424|NCT01064401|594608|P1|STARTED|Overall Study||922
245425|NCT01064362|594624|P2|NOT COMPLETED|Overall Study||0
245426|NCT01064362|594625|P1|NOT COMPLETED|Overall Study||0
245427|NCT01064362|594624|P2|COMPLETED|Overall Study||11883
245428|NCT01064362|594625|P1|COMPLETED|Overall Study||1559
245429|NCT01064362|594624|P2|STARTED|Overall Study||11883
245430|NCT01064362|594625|P1|STARTED|Overall Study||1559
245431|NCT01064323|594633|P1|NOT COMPLETED|Overall Study||0
245432|NCT01064323|594633|P1|COMPLETED|Overall Study||10
245433|NCT01064323|594633|P1|STARTED|Overall Study||10
245434|NCT01064310|594657|P3|NOT COMPLETED|Open Label Pazopinib||84
245435|NCT01064310|594658|P2|NOT COMPLETED|Open Label Pazopinib||0
245436|NCT01064310|594659|P1|NOT COMPLETED|Open Label Pazopinib||0
245437|NCT01064310|594657|P3|COMPLETED|Open Label Pazopinib||0
245438|NCT01064310|594658|P2|COMPLETED|Open Label Pazopinib||0
245439|NCT01064310|594659|P1|COMPLETED|Open Label Pazopinib||0
245440|NCT01064310|594657|P3|STARTED|Open Label Pazopinib||84
245441|NCT01064310|594658|P2|STARTED|Open Label Pazopinib||0
245442|NCT01064310|594659|P1|STARTED|Open Label Pazopinib||0
245443|NCT01064310|594657|P3|NOT COMPLETED|Period 2||0
245444|NCT01064310|594658|P2|NOT COMPLETED|Period 2||6
245445|NCT01064310|594659|P1|NOT COMPLETED|Period 2||4
245446|NCT01064310|594657|P3|COMPLETED|Period 2||0
245447|NCT01064310|594658|P2|COMPLETED|Period 2||62
245448|NCT01064310|594659|P1|COMPLETED|Period 2||64
245449|NCT01064310|594657|P3|STARTED|Period 2||0
245450|NCT01064310|594658|P2|STARTED|Period 2||68
245451|NCT01064310|594659|P1|STARTED|Period 2||68
245452|NCT01064310|594657|P3|NOT COMPLETED|Period 1||0
245453|NCT01064310|594658|P2|NOT COMPLETED|Period 1||18
245454|NCT01064310|594659|P1|NOT COMPLETED|Period 1||14
245455|NCT01064310|594657|P3|COMPLETED|Period 1||0
245456|NCT01064310|594658|P2|COMPLETED|Period 1||68
245457|NCT01064310|594659|P1|COMPLETED|Period 1||68
245458|NCT01064310|594657|P3|STARTED|Period 1||0
245459|NCT01064310|594658|P2|STARTED|Period 1||86
245460|NCT01064310|594659|P1|STARTED|Period 1||82
245461|NCT01064297|594689|P3|NOT COMPLETED|Overall Study||133
245462|NCT01064297|594690|P2|NOT COMPLETED|Overall Study||48
245463|NCT01064297|594691|P1|NOT COMPLETED|Overall Study||791
245464|NCT01064297|594689|P3|COMPLETED|Overall Study||497
245465|NCT01064297|594690|P2|COMPLETED|Overall Study||171
245466|NCT01064297|594691|P1|COMPLETED|Overall Study||1776
245467|NCT01064297|594689|P3|STARTED|Overall Study||630
245468|NCT01064297|594690|P2|STARTED|Overall Study||219
245469|NCT01064297|594691|P1|STARTED|Overall Study||2567
245470|NCT01064284|594737|P2|NOT COMPLETED|Overall Study||17
245471|NCT01064284|594738|P1|NOT COMPLETED|Overall Study||18
245472|NCT01064284|594737|P2|COMPLETED|Overall Study||109
245473|NCT01064284|594738|P1|COMPLETED|Overall Study||107
245474|NCT01064284|594737|P2|STARTED|Overall Study|Taking into account the analyzed patients only|126
245475|NCT01064284|594738|P1|STARTED|Overall Study|Taking into account the analyzed patients only|125
245476|NCT01064167|594760|P2|NOT COMPLETED|Overall Study||15
245477|NCT01064167|594761|P1|NOT COMPLETED|Overall Study||14
245478|NCT01064167|594760|P2|COMPLETED|Overall Study||115
245479|NCT01064167|594761|P1|COMPLETED|Overall Study||116
245480|NCT01064167|594760|P2|STARTED|Overall Study||130
245481|NCT01064167|594761|P1|STARTED|Overall Study||130
245482|NCT01064076|594769|P1|NOT COMPLETED|Overall Study||18
245483|NCT01064076|594769|P1|COMPLETED|Overall Study|303 subjects completed a minimum of 180 days of follow up|303
245484|NCT01064076|594769|P1|STARTED|Overall Study|321 subjects underwent an implant procedure for the S-ICD System|321
245485|NCT01063972|594776|P2|NOT COMPLETED|Overall Study||12
245486|NCT01063972|594777|P1|NOT COMPLETED|Overall Study||14
245487|NCT01063972|594776|P2|COMPLETED|Overall Study|Participants who were deceased or incarcerated were excluded.|284
245488|NCT01063972|594777|P1|COMPLETED|Overall Study|Participants who were deceased or incarcerated were excluded.|296
245489|NCT01063972|594776|P2|STARTED|Overall Study||296
245490|NCT01063972|594777|P1|STARTED|Overall Study||310
245491|NCT01063907|594793|P2|NOT COMPLETED|Overall Study||0
245492|NCT01063907|594794|P1|NOT COMPLETED|Overall Study||0
245493|NCT01063907|594793|P2|COMPLETED|Overall Study||80
245494|NCT01063907|594794|P1|COMPLETED|Overall Study||15
245495|NCT01063907|594793|P2|STARTED|Overall Study||80
245496|NCT01063907|594794|P1|STARTED|Overall Study||15
245497|NCT01063881|594827|P3|NOT COMPLETED|Overall Study||1
245498|NCT01063881|594828|P2|NOT COMPLETED|Overall Study||11
245499|NCT01063881|594829|P1|NOT COMPLETED|Overall Study||55
245500|NCT01063881|594827|P3|COMPLETED|Overall Study||12
245501|NCT01063881|594828|P2|COMPLETED|Overall Study||114
245502|NCT01063881|594829|P1|COMPLETED|Overall Study||92
245503|NCT01063881|594827|P3|STARTED|Overall Study||13
245504|NCT01063881|594828|P2|STARTED|Overall Study||125
245505|NCT01063881|594829|P1|STARTED|Overall Study||147
245506|NCT01063868|594853|P2|NOT COMPLETED|Overall Study||12
245507|NCT01063868|594854|P1|NOT COMPLETED|Overall Study||35
245508|NCT01063868|594853|P2|COMPLETED|Overall Study||0
245509|NCT01063868|594854|P1|COMPLETED|Overall Study||0
245510|NCT01063868|594853|P2|STARTED|Overall Study||12
245511|NCT01063868|594854|P1|STARTED|Overall Study||35
245512|NCT01063855|594862|P2|NOT COMPLETED|Overall Study||29
245513|NCT01063855|594863|P1|NOT COMPLETED|Overall Study||37
245514|NCT01063855|594862|P2|COMPLETED|Overall Study||221
245515|NCT01063855|594863|P1|COMPLETED|Overall Study||208
245516|NCT01063855|594862|P2|STARTED|Overall Study||250
245517|NCT01063855|594863|P1|STARTED|Overall Study||245
245518|NCT01063829|594889|P4|NOT COMPLETED|Overall Study||21
245519|NCT01063829|594890|P3|NOT COMPLETED|Overall Study||10
245520|NCT01063829|594891|P2|NOT COMPLETED|Overall Study||10
245521|NCT01063829|594892|P1|NOT COMPLETED|Overall Study||16
245522|NCT01063829|594889|P4|COMPLETED|Overall Study|Non-completers considered as failure; FAS|12
245523|NCT01063829|594890|P3|COMPLETED|Overall Study|Non-completers considered as failure; FAS|24
245524|NCT01063829|594891|P2|COMPLETED|Overall Study|Non-completers considered as failure; FAS|21
245525|NCT01063829|594892|P1|COMPLETED|Overall Study|Non-completers considered as failure; FAS|17
245526|NCT01063829|594889|P4|STARTED|Overall Study||33
245527|NCT01063829|594890|P3|STARTED|Overall Study||34
245528|NCT01063829|594891|P2|STARTED|Overall Study||31
245529|NCT01063829|594892|P1|STARTED|Overall Study||33
245530|NCT01063764|594910|P1|NOT COMPLETED|2nd Period (Week 22 to the End of Study)||20
245531|NCT01063764|594910|P1|COMPLETED|2nd Period (Week 22 to the End of Study)||35
245532|NCT01063764|594910|P1|STARTED|2nd Period (Week 22 to the End of Study)|7 subjects who completed Period 1 did not enter the Second Period.|55
245533|NCT01063764|594910|P1|NOT COMPLETED|1st Period (From Week 8 to Week 22)||11
245534|NCT01063764|594910|P1|COMPLETED|1st Period (From Week 8 to Week 22)|62 subjects completed the First Period, but 7 of these subjects did not enter the Second Period.|62
245535|NCT01063764|594910|P1|STARTED|1st Period (From Week 8 to Week 22)||73
245536|NCT01063712|594924|P1|NOT COMPLETED|Overall Study||0
245537|NCT01063712|594924|P1|COMPLETED|Overall Study||29
245538|NCT01063712|594924|P1|STARTED|Overall Study||29
245539|NCT01063595|594929|P2|NOT COMPLETED|Second Intervention||0
245540|NCT01063595|594930|P1|NOT COMPLETED|Second Intervention||0
245541|NCT01063595|594929|P2|COMPLETED|Second Intervention||24
245542|NCT01063595|594930|P1|COMPLETED|Second Intervention||29
245543|NCT01063595|594929|P2|STARTED|Second Intervention||24
245544|NCT01063595|594930|P1|STARTED|Second Intervention||29
245545|NCT01063595|594929|P2|NOT COMPLETED|First Intervention||5
245546|NCT01063595|594930|P1|NOT COMPLETED|First Intervention||2
245547|NCT01063595|594929|P2|COMPLETED|First Intervention||24
245548|NCT01063595|594930|P1|COMPLETED|First Intervention||29
245549|NCT01063595|594929|P2|STARTED|First Intervention||29
245550|NCT01063595|594930|P1|STARTED|First Intervention||31
245551|NCT01063595|594929|P2|NOT COMPLETED|Enrolled in Study and Randomized||2
245552|NCT01063595|594930|P1|NOT COMPLETED|Enrolled in Study and Randomized||1
245553|NCT01063595|594929|P2|COMPLETED|Enrolled in Study and Randomized||29
245554|NCT01063595|594930|P1|COMPLETED|Enrolled in Study and Randomized||31
245555|NCT01063595|594929|P2|Received Treatment|Enrolled in Study and Randomized||29
245556|NCT01063595|594930|P1|Received Treatment|Enrolled in Study and Randomized||31
245557|NCT01063595|594929|P2|STARTED|Enrolled in Study and Randomized||31
245558|NCT01063595|594930|P1|STARTED|Enrolled in Study and Randomized||32
245559|NCT01063517|594942|P2|NOT COMPLETED|Overall Study||60
245560|NCT01063517|594943|P1|NOT COMPLETED|Overall Study||58
245561|NCT01063517|594942|P2|COMPLETED|Overall Study||2
245562|NCT01063517|594943|P1|COMPLETED|Overall Study||4
245563|NCT01063517|594942|P2|Received Randomised Treatment|Overall Study||62
245564|NCT01063517|594943|P1|Received Randomised Treatment|Overall Study||61
245565|NCT01063517|594942|P2|STARTED|Overall Study||62
245566|NCT01063517|594943|P1|STARTED|Overall Study||62
245567|NCT01063348|594983|P2|NOT COMPLETED|Overall Study||10
245568|NCT01063348|594984|P1|NOT COMPLETED|Overall Study||3
245569|NCT01063348|594983|P2|COMPLETED|Overall Study||21
245570|NCT01063348|594984|P1|COMPLETED|Overall Study||32
245571|NCT01063348|594983|P2|STARTED|Overall Study||31
245572|NCT01063348|594984|P1|STARTED|Overall Study||35
245573|NCT01063283|594994|P3|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
245574|NCT01063283|594995|P2|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
245575|NCT01063283|594996|P1|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
245576|NCT01063283|594994|P3|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||11
245577|NCT01063283|594995|P2|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||6
245578|NCT01063283|594996|P1|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
245579|NCT01063283|594994|P3|STARTED|Randomized Phase (Cycle 2 and Beyond)||11
245580|NCT01063283|594995|P2|STARTED|Randomized Phase (Cycle 2 and Beyond)||6
245581|NCT01063283|594996|P1|STARTED|Randomized Phase (Cycle 2 and Beyond)||0
245582|NCT01063283|594994|P3|NOT COMPLETED|Cycle 1||0
245583|NCT01063283|594995|P2|NOT COMPLETED|Cycle 1||0
245584|NCT01063283|594996|P1|NOT COMPLETED|Cycle 1||3
245585|NCT01063283|594994|P3|COMPLETED|Cycle 1||0
245586|NCT01063283|594995|P2|COMPLETED|Cycle 1||0
245587|NCT01063283|594996|P1|COMPLETED|Cycle 1||17
245588|NCT01063283|594994|P3|STARTED|Cycle 1||0
245589|NCT01063283|594995|P2|STARTED|Cycle 1||0
245590|NCT01063283|594996|P1|STARTED|Cycle 1||20
245591|NCT01063153|595010|P2|NOT COMPLETED|Overall Study||12
245592|NCT01063153|595011|P1|NOT COMPLETED|Overall Study||2
245593|NCT01063153|595010|P2|COMPLETED|Overall Study||26
245594|NCT01063153|595011|P1|COMPLETED|Overall Study||31
245595|NCT01063153|595010|P2|STARTED|Overall Study||38
245596|NCT01063153|595011|P1|STARTED|Overall Study||33
245597|NCT01063075|595021|P4|NOT COMPLETED|Overall Study||1
245598|NCT01063075|595022|P3|NOT COMPLETED|Overall Study||5
245599|NCT01063075|595023|P2|NOT COMPLETED|Overall Study||2
245600|NCT01063075|595024|P1|NOT COMPLETED|Overall Study||1
245601|NCT01063075|595021|P4|COMPLETED|Overall Study||14
245602|NCT01063075|595022|P3|COMPLETED|Overall Study||9
245603|NCT01063075|595023|P2|COMPLETED|Overall Study||1
245604|NCT01063075|595024|P1|COMPLETED|Overall Study||1
245605|NCT01063075|595021|P4|STARTED|Overall Study||15
245606|NCT01063075|595022|P3|STARTED|Overall Study||14
245607|NCT01063075|595023|P2|STARTED|Overall Study||3
245608|NCT01063075|595024|P1|STARTED|Overall Study||2
245609|NCT01063062|595042|P2|NOT COMPLETED|Overall Study||12
245610|NCT01063062|595043|P1|NOT COMPLETED|Overall Study||8
245611|NCT01063062|595042|P2|COMPLETED|Overall Study||65
245612|NCT01063062|595043|P1|COMPLETED|Overall Study||22
245613|NCT01063062|595042|P2|Received Study Drug|Overall Study||76
245614|NCT01063062|595043|P1|Received Study Drug|Overall Study||29
245615|NCT01063062|595042|P2|STARTED|Overall Study||77
245616|NCT01063062|595043|P1|STARTED|Overall Study||30
245617|NCT01063049|595084|P3|NOT COMPLETED|Overall Study||0
245618|NCT01063049|595085|P2|NOT COMPLETED|Overall Study||0
245619|NCT01063049|595086|P1|NOT COMPLETED|Overall Study||0
245620|NCT01063049|595084|P3|COMPLETED|Overall Study||200
245621|NCT01063049|595085|P2|COMPLETED|Overall Study||200
245622|NCT01063049|595086|P1|COMPLETED|Overall Study||200
245623|NCT01063049|595084|P3|STARTED|Overall Study||200
245624|NCT01063049|595085|P2|STARTED|Overall Study||200
245625|NCT01063049|595086|P1|STARTED|Overall Study||200
245626|NCT01063036|595097|P1|NOT COMPLETED|Post Dosing Follow-up Through 24 Weeks||39
245627|NCT01063036|595097|P1|COMPLETED|Post Dosing Follow-up Through 24 Weeks||46
245628|NCT01063036|595097|P1|STARTED|Post Dosing Follow-up Through 24 Weeks|2 included did not complete treatment; 3 completed treatment but not included (lost to follow-up).|85
245629|NCT01063036|595097|P1|NOT COMPLETED|Participants Treated With Study Drug||6
245630|NCT01063036|595097|P1|COMPLETED|Participants Treated With Study Drug||86
245631|NCT01063036|595097|P1|STARTED|Participants Treated With Study Drug||92
245632|NCT01062971|595113|P2|NOT COMPLETED|Overall Study||7
245633|NCT01062971|595114|P1|NOT COMPLETED|Overall Study||4
245634|NCT01062971|595113|P2|COMPLETED|Overall Study||56
245635|NCT01062971|595114|P1|COMPLETED|Overall Study||56
245636|NCT01062971|595113|P2|STARTED|Overall Study||63
245637|NCT01062971|595114|P1|STARTED|Overall Study||60
245638|NCT01062893|595124|P2|NOT COMPLETED|Overall Study||13
245639|NCT01062893|595125|P1|NOT COMPLETED|Overall Study||14
245640|NCT01062893|595124|P2|COMPLETED|Overall Study||28
245641|NCT01062893|595125|P1|COMPLETED|Overall Study||27
245642|NCT01062893|595124|P2|STARTED|Overall Study||41
245643|NCT01062893|595125|P1|STARTED|Overall Study||41
245644|NCT01062841|595153|P2|NOT COMPLETED|Overall Study||53
245645|NCT01062841|595154|P1|NOT COMPLETED|Overall Study||49
245646|NCT01062841|595153|P2|COMPLETED|Overall Study||162
245647|NCT01062841|595154|P1|COMPLETED|Overall Study||154
245648|NCT01062841|595153|P2|STARTED|Overall Study||215
245649|NCT01062841|595154|P1|STARTED|Overall Study||203
245650|NCT01062763|595184|P2|NOT COMPLETED|Overall Study||4
245651|NCT01062763|595185|P1|NOT COMPLETED|Overall Study||3
245652|NCT01062763|595184|P2|COMPLETED|Overall Study||57
245653|NCT01062763|595185|P1|COMPLETED|Overall Study||55
245654|NCT01062763|595184|P2|STARTED|Overall Study||61
245655|NCT01062763|595185|P1|STARTED|Overall Study|119 randomized.|58
245656|NCT01062568|595197|P2|NOT COMPLETED|Overall Study||0
245657|NCT01062568|595198|P1|NOT COMPLETED|Overall Study||0
245658|NCT01062568|595197|P2|COMPLETED|Overall Study||40
245659|NCT01062568|595198|P1|COMPLETED|Overall Study||10
245660|NCT01062568|595197|P2|STARTED|Overall Study||40
245661|NCT01062568|595198|P1|STARTED|Overall Study||10
245662|NCT01062425|595211|P2|NOT COMPLETED|Overall Study||6
245663|NCT01062425|595212|P1|NOT COMPLETED|Overall Study||3
245664|NCT01062425|595211|P2|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|97
245665|NCT01062425|595212|P1|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|52
245666|NCT01062425|595211|P2|STARTED|Overall Study||103
245667|NCT01062425|595212|P1|STARTED|Overall Study||55
245668|NCT01062399|595229|P5|NOT COMPLETED|Overall Study||4
245669|NCT01062399|595230|P4|NOT COMPLETED|Overall Study||6
245670|NCT01062399|595231|P3|NOT COMPLETED|Overall Study||0
245671|NCT01062399|595232|P2|NOT COMPLETED|Overall Study||1
245672|NCT01062399|595233|P1|NOT COMPLETED|Overall Study||0
245673|NCT01062399|595229|P5|COMPLETED|Overall Study||88
245674|NCT01062399|595230|P4|COMPLETED|Overall Study||83
245675|NCT01062399|595231|P3|COMPLETED|Overall Study||8
245676|NCT01062399|595232|P2|COMPLETED|Overall Study||9
245677|NCT01062399|595233|P1|COMPLETED|Overall Study|Subjects with data available for the primary analyses are considered to have completed the study.|8
245678|NCT01062399|595229|P5|STARTED|Overall Study||92
245679|NCT01062399|595230|P4|STARTED|Overall Study||89
245680|NCT01062399|595231|P3|STARTED|Overall Study||8
245681|NCT01062399|595232|P2|STARTED|Overall Study||10
245682|NCT01062399|595233|P1|STARTED|Overall Study||8
245683|NCT01062308|595254|P2|NOT COMPLETED|Overall Study||10
245684|NCT01062308|595255|P1|NOT COMPLETED|Overall Study||16
245685|NCT01062308|595254|P2|COMPLETED|Overall Study||72
245686|NCT01062308|595255|P1|COMPLETED|Overall Study||64
245687|NCT01062308|595254|P2|STARTED|Overall Study||82
245688|NCT01062308|595255|P1|STARTED|Overall Study||80
245689|NCT01062269|595263|P1|NOT COMPLETED|Overall Study||0
245690|NCT01062269|595263|P1|COMPLETED|Overall Study||42
245691|NCT01062269|595263|P1|STARTED|Overall Study||42
245692|NCT01062256|595277|P3|NOT COMPLETED|Overall Study||4
245693|NCT01062256|595278|P2|NOT COMPLETED|Overall Study||7
245694|NCT01062256|595279|P1|NOT COMPLETED|Overall Study||3
245695|NCT01062256|595277|P3|COMPLETED|Overall Study||103
245696|NCT01062256|595278|P2|COMPLETED|Overall Study||96
245697|NCT01062256|595279|P1|COMPLETED|Overall Study||52
245698|NCT01062256|595277|P3|STARTED|Overall Study||107
245699|NCT01062256|595278|P2|STARTED|Overall Study||103
245700|NCT01062256|595279|P1|STARTED|Overall Study||55
245701|NCT01062230|595302|P1|NOT COMPLETED|Overall Study||0
245702|NCT01062230|595302|P1|COMPLETED|Overall Study||6
245703|NCT01062230|595302|P1|STARTED|Overall Study||6
245704|NCT01062165|595306|P1|NOT COMPLETED|Overall Study||0
245705|NCT01062165|595306|P1|COMPLETED|Overall Study||18
245706|NCT01062165|595306|P1|STARTED|Overall Study||18
245707|NCT01062113|595313|P3|NOT COMPLETED|Overall Study||31
245708|NCT01062113|595314|P2|NOT COMPLETED|Overall Study||22
245709|NCT01062113|595315|P1|NOT COMPLETED|Overall Study||40
245710|NCT01062113|595313|P3|COMPLETED|Overall Study||27
245711|NCT01062113|595314|P2|COMPLETED|Overall Study||42
245712|NCT01062113|595315|P1|COMPLETED|Overall Study||93
245713|NCT01062113|595313|P3|STARTED|Overall Study||58
245714|NCT01062113|595314|P2|STARTED|Overall Study||64
245715|NCT01062113|595315|P1|STARTED|Overall Study||133
245716|NCT01062074|595328|P1|NOT COMPLETED|Overall Study||0
245717|NCT01062074|595328|P1|COMPLETED|Overall Study||3605
245718|NCT01062074|595328|P1|STARTED|Overall Study||3605
245719|NCT01062061|595333|P1|NOT COMPLETED|Overall Study||27
245720|NCT01062061|595333|P1|COMPLETED|Overall Study||727
245721|NCT01062061|595333|P1|STARTED|Overall Study||754
245722|NCT01062009|595351|P4|NOT COMPLETED|Overall Study||0
245723|NCT01062009|595352|P3|NOT COMPLETED|Overall Study||0
245724|NCT01062009|595353|P2|NOT COMPLETED|Overall Study||0
245725|NCT01062009|595354|P1|NOT COMPLETED|Overall Study||1
245726|NCT01062009|595351|P4|COMPLETED|Overall Study||6
245727|NCT01062009|595352|P3|COMPLETED|Overall Study||6
245728|NCT01062009|595353|P2|COMPLETED|Overall Study||6
245729|NCT01062009|595354|P1|COMPLETED|Overall Study||6
245730|NCT01062009|595351|P4|STARTED|Overall Study||6
245731|NCT01062009|595352|P3|STARTED|Overall Study||6
245732|NCT01062009|595353|P2|STARTED|Overall Study||6
245733|NCT01062009|595354|P1|STARTED|Overall Study||7
245734|NCT01061866|595372|P1|NOT COMPLETED|Overall Study||2
245735|NCT01061866|595372|P1|COMPLETED|Overall Study||5
245736|NCT01061866|595372|P1|STARTED|Overall Study||7
245737|NCT01061775|595376|P1|NOT COMPLETED|Overall Study||3
245738|NCT01061775|595376|P1|COMPLETED|Overall Study||16
245739|NCT01061775|595376|P1|STARTED|Overall Study||19
245740|NCT01061736|595393|P10|NOT COMPLETED|Overall Study||74
245741|NCT01061736|595394|P9|NOT COMPLETED|Overall Study||97
245742|NCT01061736|595395|P8|NOT COMPLETED|Overall Study||94
245743|NCT01061736|595396|P7|NOT COMPLETED|Overall Study||84
245744|NCT01061736|595397|P6|NOT COMPLETED|Overall Study||3
245745|NCT01061736|595398|P5|NOT COMPLETED|Overall Study||7
245746|NCT01061736|595399|P4|NOT COMPLETED|Overall Study||3
245747|NCT01061736|595400|P3|NOT COMPLETED|Overall Study||6
245748|NCT01061736|595401|P2|NOT COMPLETED|Overall Study||4
245749|NCT01061736|595402|P1|NOT COMPLETED|Overall Study||13
245750|NCT01061736|595393|P10|COMPLETED|Overall Study||354
245751|NCT01061736|595394|P9|COMPLETED|Overall Study||330
245752|NCT01061736|595395|P8|COMPLETED|Overall Study||336
245753|NCT01061736|595396|P7|COMPLETED|Overall Study||0
245754|NCT01061736|595397|P6|COMPLETED|Overall Study||49
245755|NCT01061736|595398|P5|COMPLETED|Overall Study||45
245756|NCT01061736|595399|P4|COMPLETED|Overall Study||48
245757|NCT01061736|595400|P3|COMPLETED|Overall Study||45
245758|NCT01061736|595401|P2|COMPLETED|Overall Study||46
245759|NCT01061736|595402|P1|COMPLETED|Overall Study||37
245760|NCT01061736|595393|P10|Rescued|Overall Study|Included both participants who completed and did not complete the study.|168
245761|NCT01061736|595394|P9|Rescued|Overall Study|Included both participants who completed and did not complete the study.|55
245762|NCT01061736|595395|P8|Rescued|Overall Study|Included both participants who completed and did not complete the study.|61
245763|NCT01061736|595396|P7|Rescued|Overall Study||0
245764|NCT01061736|595397|P6|Rescued|Overall Study||0
245765|NCT01061736|595398|P5|Rescued|Overall Study||0
245766|NCT01061736|595399|P4|Rescued|Overall Study||0
245767|NCT01061736|595400|P3|Rescued|Overall Study||0
245768|NCT01061736|595401|P2|Rescued|Overall Study||0
245769|NCT01061736|595402|P1|Rescued|Overall Study||0
245770|NCT01061736|595393|P10|Treated|Overall Study||428
245771|NCT01061736|595394|P9|Treated|Overall Study||426
245772|NCT01061736|595395|P8|Treated|Overall Study||428
245773|NCT01061736|595396|P7|Treated|Overall Study||84
245774|NCT01061736|595397|P6|Treated|Overall Study||52
245775|NCT01061736|595398|P5|Treated|Overall Study||51
245776|NCT01061736|595399|P4|Treated|Overall Study||51
245777|NCT01061736|595400|P3|Treated|Overall Study||51
245778|NCT01061736|595401|P2|Treated|Overall Study||50
245779|NCT01061736|595402|P1|Treated|Overall Study||50
245780|NCT01061736|595393|P10|STARTED|Overall Study||428
245781|NCT01061736|595394|P9|STARTED|Overall Study||427
245782|NCT01061736|595395|P8|STARTED|Overall Study||430
245783|NCT01061736|595396|P7|STARTED|Overall Study||84
245784|NCT01061736|595397|P6|STARTED|Overall Study||52
245785|NCT01061736|595398|P5|STARTED|Overall Study||52
245786|NCT01061736|595399|P4|STARTED|Overall Study||51
245787|NCT01061736|595400|P3|STARTED|Overall Study||51
245788|NCT01061736|595401|P2|STARTED|Overall Study||50
245789|NCT01061736|595402|P1|STARTED|Overall Study||50
245790|NCT01061723|595441|P6|NOT COMPLETED|Overall Study||9
245791|NCT01061723|595442|P5|NOT COMPLETED|Overall Study||3
245792|NCT01061723|595443|P4|NOT COMPLETED|Overall Study||8
245793|NCT01061723|595444|P3|NOT COMPLETED|Overall Study||10
245794|NCT01061723|595445|P2|NOT COMPLETED|Overall Study||6
245795|NCT01061723|595446|P1|NOT COMPLETED|Overall Study||4
245796|NCT01061723|595441|P6|COMPLETED|Overall Study||41
245797|NCT01061723|595442|P5|COMPLETED|Overall Study||47
245798|NCT01061723|595443|P4|COMPLETED|Overall Study||44
245799|NCT01061723|595444|P3|COMPLETED|Overall Study||40
245800|NCT01061723|595445|P2|COMPLETED|Overall Study||43
245801|NCT01061723|595446|P1|COMPLETED|Overall Study||46
245802|NCT01061723|595441|P6|Treated|Overall Study||49
245803|NCT01061723|595442|P5|Treated|Overall Study||50
245804|NCT01061723|595443|P4|Treated|Overall Study||52
245805|NCT01061723|595444|P3|Treated|Overall Study||50
245806|NCT01061723|595445|P2|Treated|Overall Study||49
245807|NCT01061723|595446|P1|Treated|Overall Study||50
245808|NCT01061723|595441|P6|STARTED|Overall Study||50
245809|NCT01061723|595442|P5|STARTED|Overall Study||50
245810|NCT01061723|595443|P4|STARTED|Overall Study||52
245811|NCT01061723|595444|P3|STARTED|Overall Study||50
245812|NCT01061723|595445|P2|STARTED|Overall Study||49
245813|NCT01061723|595446|P1|STARTED|Overall Study||50
245814|NCT01061710|595526|P1|NOT COMPLETED|Overall Study||14
245815|NCT01061710|595526|P1|COMPLETED|Overall Study||6
245816|NCT01061710|595526|P1|STARTED|Overall Study||20
245817|NCT01061671|595536|P2|NOT COMPLETED|Overall Study||55
245818|NCT01061671|595537|P1|NOT COMPLETED|Overall Study||47
245819|NCT01061671|595536|P2|COMPLETED|Overall Study||397
245820|NCT01061671|595537|P1|COMPLETED|Overall Study||386
245821|NCT01061671|595536|P2|STARTED|Overall Study||452
245822|NCT01061671|595537|P1|STARTED|Overall Study||433
245823|NCT01061606|595549|P1|NOT COMPLETED|Overall Study||8
245824|NCT01061606|595549|P1|COMPLETED|Overall Study||0
245825|NCT01061606|595549|P1|STARTED|Overall Study||8
245826|NCT01061567|595558|P1|NOT COMPLETED|Overall Study||76
245827|NCT01061567|595558|P1|COMPLETED|Overall Study||1738
245828|NCT01061567|595558|P1|STARTED|Overall Study||1814
245829|NCT01061528|595569|P2|NOT COMPLETED|Overall Study||2
245830|NCT01061528|595570|P1|NOT COMPLETED|Overall Study||3
245831|NCT01061528|595569|P2|COMPLETED|Overall Study||52
245832|NCT01061528|595570|P1|COMPLETED|Overall Study||59
245833|NCT01061528|595569|P2|STARTED|Overall Study||54
245834|NCT01061528|595570|P1|STARTED|Overall Study||62
245835|NCT01061476|595576|P1|NOT COMPLETED|Overall Study||0
245836|NCT01061476|595576|P1|COMPLETED|Overall Study||12
245837|NCT01061476|595576|P1|STARTED|Overall Study||12
245838|NCT01061385|595582|P2|NOT COMPLETED|Overall Study||1
245839|NCT01061385|595583|P1|NOT COMPLETED|Overall Study||1
245840|NCT01061385|595582|P2|COMPLETED|Overall Study||8
245841|NCT01061385|595583|P1|COMPLETED|Overall Study||20
245842|NCT01061385|595582|P2|STARTED|Overall Study||9
245843|NCT01061385|595583|P1|STARTED|Overall Study||21
245844|NCT01061359|595591|P1|NOT COMPLETED|Overall Study||1302
245845|NCT01061359|595591|P1|COMPLETED|Overall Study|Completed 5 years of follow-up: 668 Disease free and 2 Relapsed|670
245846|NCT01061359|595591|P1|STARTED|Overall Study||1972
245847|NCT01061333|595597|P2|NOT COMPLETED|Period 7: Mometasone||0
245848|NCT01061333|595598|P1|NOT COMPLETED|Period 7: Mometasone||0
245849|NCT01061333|595597|P2|COMPLETED|Period 7: Mometasone||7
245850|NCT01061333|595598|P1|COMPLETED|Period 7: Mometasone||8
245851|NCT01061333|595597|P2|STARTED|Period 7: Mometasone||7
245852|NCT01061333|595598|P1|STARTED|Period 7: Mometasone||8
245853|NCT01061333|595597|P2|NOT COMPLETED|Period 6: 20-day Washout||0
245854|NCT01061333|595598|P1|NOT COMPLETED|Period 6: 20-day Washout||0
245855|NCT01061333|595597|P2|COMPLETED|Period 6: 20-day Washout||7
245856|NCT01061333|595598|P1|COMPLETED|Period 6: 20-day Washout||8
245857|NCT01061333|595597|P2|STARTED|Period 6: 20-day Washout||7
245858|NCT01061333|595598|P1|STARTED|Period 6: 20-day Washout||8
245859|NCT01061333|595597|P2|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
245860|NCT01061333|595598|P1|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
245861|NCT01061333|595597|P2|COMPLETED|Period 5: Nedocromil-Montelukast X-over||7
245862|NCT01061333|595598|P1|COMPLETED|Period 5: Nedocromil-Montelukast X-over||8
245863|NCT01061333|595597|P2|STARTED|Period 5: Nedocromil-Montelukast X-over||7
245864|NCT01061333|595598|P1|STARTED|Period 5: Nedocromil-Montelukast X-over||8
245865|NCT01061333|595597|P2|NOT COMPLETED|Period 4: 20-day Washout||1
245866|NCT01061333|595598|P1|NOT COMPLETED|Period 4: 20-day Washout||0
245867|NCT01061333|595597|P2|COMPLETED|Period 4: 20-day Washout||7
245868|NCT01061333|595598|P1|COMPLETED|Period 4: 20-day Washout||8
245869|NCT01061333|595597|P2|STARTED|Period 4: 20-day Washout||8
245870|NCT01061333|595598|P1|STARTED|Period 4: 20-day Washout||8
245871|NCT01061333|595597|P2|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
245872|NCT01061333|595598|P1|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
245873|NCT01061333|595597|P2|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
245874|NCT01061333|595598|P1|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
245875|NCT01061333|595597|P2|STARTED|Period 3: Nedocromil-Montelukast X-over||8
245876|NCT01061333|595598|P1|STARTED|Period 3: Nedocromil-Montelukast X-over||8
245877|NCT01061333|595597|P2|NOT COMPLETED|Period 2: 20-day Washout||0
245878|NCT01061333|595598|P1|NOT COMPLETED|Period 2: 20-day Washout||0
245879|NCT01061333|595597|P2|COMPLETED|Period 2: 20-day Washout||8
245880|NCT01061333|595598|P1|COMPLETED|Period 2: 20-day Washout||8
245881|NCT01061333|595597|P2|STARTED|Period 2: 20-day Washout||8
245882|NCT01061333|595598|P1|STARTED|Period 2: 20-day Washout||8
245883|NCT01061333|595597|P2|NOT COMPLETED|Period 1: Placebo Run-in||0
245884|NCT01061333|595598|P1|NOT COMPLETED|Period 1: Placebo Run-in||0
245885|NCT01061333|595597|P2|COMPLETED|Period 1: Placebo Run-in||8
245886|NCT01061333|595598|P1|COMPLETED|Period 1: Placebo Run-in||8
245887|NCT01061333|595597|P2|STARTED|Period 1: Placebo Run-in||8
245888|NCT01061333|595598|P1|STARTED|Period 1: Placebo Run-in||8
245889|NCT01061177|595636|P1|NOT COMPLETED|Overall Study||208
245890|NCT01061177|595636|P1|COMPLETED|Overall Study||881
245891|NCT01061177|595636|P1|ITT_CyR (Ph+ Patients Only)|Overall Study||983
245892|NCT01061177|595636|P1|ITT_MR (b2a2 &/or b3a2 +ve Pts Only)|Overall Study||1056
245893|NCT01061177|595636|P1|STARTED|Overall Study||1089
245894|NCT01061151|595659|P4|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||20
245895|NCT01061151|595660|P3|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||77
245896|NCT01061151|595661|P2|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||138
245897|NCT01061151|595662|P1|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||152
245898|NCT01061151|595659|P4|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||55
245899|NCT01061151|595660|P3|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||345
245900|NCT01061151|595661|P2|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||548
245901|NCT01061151|595662|P1|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||542
245902|NCT01061151|595659|P4|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||75
245903|NCT01061151|595660|P3|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||421
245904|NCT01061151|595661|P2|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||684
245905|NCT01061151|595662|P1|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||694
245906|NCT01061151|595659|P4|STARTED|Protocol Version 3.0: 10/2012-10/2014||75
245907|NCT01061151|595660|P3|STARTED|Protocol Version 3.0: 10/2012-10/2014||422
245908|NCT01061151|595661|P2|STARTED|Protocol Version 3.0: 10/2012-10/2014||686
245909|NCT01061151|595662|P1|STARTED|Protocol Version 3.0: 10/2012-10/2014||694
245910|NCT01061151|595659|P4|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||28
245911|NCT01061151|595660|P3|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||9
245912|NCT01061151|595661|P2|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||241
245913|NCT01061151|595662|P1|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||232
245914|NCT01061151|595659|P4|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||101
245915|NCT01061151|595660|P3|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||16
245916|NCT01061151|595661|P2|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||620
245917|NCT01061151|595662|P1|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||623
245918|NCT01061151|595659|P4|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||129
245919|NCT01061151|595660|P3|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||24
245920|NCT01061151|595661|P2|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||861
245921|NCT01061151|595662|P1|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||853
245922|NCT01061151|595659|P4|STARTED|Protocol Version 2.0: 04/2011-09/2012||129
245923|NCT01061151|595660|P3|STARTED|Protocol Version 2.0: 04/2011-09/2012||25
245924|NCT01061151|595661|P2|STARTED|Protocol Version 2.0: 04/2011-09/2012||861
245925|NCT01061151|595662|P1|STARTED|Protocol Version 2.0: 04/2011-09/2012||855
245926|NCT01061034|595714|P1|NOT COMPLETED|Aspirin Plus Omeprazole||0
245927|NCT01061034|595714|P1|COMPLETED|Aspirin Plus Omeprazole||9
245928|NCT01061034|595714|P1|STARTED|Aspirin Plus Omeprazole||9
245929|NCT01061034|595714|P1|NOT COMPLETED|Aspirin||0
245930|NCT01061034|595714|P1|COMPLETED|Aspirin||9
245931|NCT01061034|595714|P1|STARTED|Aspirin||9
245932|NCT01061008|595721|P2|NOT COMPLETED|Overall Study||6
245933|NCT01061008|595722|P1|NOT COMPLETED|Overall Study||6
245934|NCT01061008|595721|P2|COMPLETED|Overall Study||9
245935|NCT01061008|595722|P1|COMPLETED|Overall Study||10
245936|NCT01061008|595721|P2|STARTED|Overall Study||15
245937|NCT01061008|595722|P1|STARTED|Overall Study||16
245938|NCT01060670|595730|P2|NOT COMPLETED|Follow up Phase||35
245939|NCT01060670|595731|P1|NOT COMPLETED|Follow up Phase||22
245940|NCT01060670|595730|P2|COMPLETED|Follow up Phase||82
245941|NCT01060670|595731|P1|COMPLETED|Follow up Phase||106
245942|NCT01060670|595730|P2|Withdrew From Follow up Phase|Follow up Phase||35
245943|NCT01060670|595731|P1|Withdrew From Follow up Phase|Follow up Phase||22
245944|NCT01060670|595730|P2|Recurrence|Follow up Phase||9
245945|NCT01060670|595731|P1|Recurrence|Follow up Phase||14
245946|NCT01060670|595730|P2|STARTED|Follow up Phase||117
245947|NCT01060670|595731|P1|STARTED|Follow up Phase||128
245948|NCT01060670|595730|P2|NOT COMPLETED|Treatment Phase||36
245949|NCT01060670|595731|P1|NOT COMPLETED|Treatment Phase||26
245950|NCT01060670|595730|P2|COMPLETED|Treatment Phase||117
245951|NCT01060670|595731|P1|COMPLETED|Treatment Phase||128
245952|NCT01060670|595730|P2|Withdrew From Treatment|Treatment Phase||36
245953|NCT01060670|595731|P1|Withdrew From Treatment|Treatment Phase||26
245954|NCT01060670|595730|P2|Did Not Heal by Treatment Visit 17|Treatment Phase||68
245955|NCT01060670|595731|P1|Did Not Heal by Treatment Visit 17|Treatment Phase||49
245956|NCT01060670|595730|P2|Healed at End of Treatment Phase|Treatment Phase||49
245957|NCT01060670|595731|P1|Healed at End of Treatment Phase|Treatment Phase||79
245958|NCT01060670|595730|P2|STARTED|Treatment Phase||153
245959|NCT01060670|595731|P1|STARTED|Treatment Phase||154
245960|NCT01060670|595730|P2|NOT COMPLETED|Run In||238
245961|NCT01060670|595731|P1|NOT COMPLETED|Run In||0
245962|NCT01060670|595730|P2|COMPLETED|Run In||307
245963|NCT01060670|595731|P1|COMPLETED|Run In||0
245964|NCT01060670|595730|P2|STARTED|Run In||545
245965|NCT01060670|595731|P1|STARTED|Run In||0
245966|NCT01060592|595751|P2|NOT COMPLETED|12m||18
245967|NCT01060592|595752|P1|NOT COMPLETED|12m||0
245968|NCT01060592|595751|P2|COMPLETED|12m|Historic data was not available at 12m for 18 of the historic controls|31
245969|NCT01060592|595752|P1|COMPLETED|12m||35
245970|NCT01060592|595751|P2|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|49
245971|NCT01060592|595752|P1|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|35
245972|NCT01060592|595751|P2|NOT COMPLETED|4-6w||10
245973|NCT01060592|595752|P1|NOT COMPLETED|4-6w||12
245974|NCT01060592|595751|P2|COMPLETED|4-6w||39
245975|NCT01060592|595752|P1|COMPLETED|4-6w||23
245976|NCT01060592|595751|P2|STARTED|4-6w||49
245977|NCT01060592|595752|P1|STARTED|4-6w||35
245978|NCT01060553|595766|P2|NOT COMPLETED|Overall Study||10
245979|NCT01060553|595767|P1|NOT COMPLETED|Overall Study||9
245980|NCT01060553|595766|P2|COMPLETED|Overall Study||5
245981|NCT01060553|595767|P1|COMPLETED|Overall Study|5 subjects completed more than half the sessions and midpoint outcome measures were obtained|6
245982|NCT01060553|595766|P2|STARTED|Overall Study||15
245983|NCT01060553|595767|P1|STARTED|Overall Study||15
245984|NCT01060540|595774|P2|NOT COMPLETED|Overall Study||65
245985|NCT01060540|595775|P1|NOT COMPLETED|Overall Study||64
245986|NCT01060540|595774|P2|COMPLETED|Overall Study||233
245987|NCT01060540|595775|P1|COMPLETED|Overall Study||239
245988|NCT01060540|595774|P2|STARTED|Overall Study||298
245989|NCT01060540|595775|P1|STARTED|Overall Study||303
245990|NCT01060384|595789|P5|NOT COMPLETED|Overall Study||2
245991|NCT01060384|595790|P4|NOT COMPLETED|Overall Study||0
245992|NCT01060384|595791|P3|NOT COMPLETED|Overall Study||0
245993|NCT01060384|595792|P2|NOT COMPLETED|Overall Study||1
245994|NCT01060384|595793|P1|NOT COMPLETED|Overall Study||0
245995|NCT01060384|595789|P5|COMPLETED|Overall Study||34
245996|NCT01060384|595790|P4|COMPLETED|Overall Study||0
245997|NCT01060384|595791|P3|COMPLETED|Overall Study||0
245998|NCT01060384|595792|P2|COMPLETED|Overall Study||3
245999|NCT01060384|595793|P1|COMPLETED|Overall Study||6
246000|NCT01060384|595789|P5|STARTED|Overall Study||36
246001|NCT01060384|595790|P4|STARTED|Overall Study||0
246002|NCT01060384|595791|P3|STARTED|Overall Study||0
246003|NCT01060384|595792|P2|STARTED|Overall Study||4
246004|NCT01060384|595793|P1|STARTED|Overall Study||6
246005|NCT01060150|595802|P1|NOT COMPLETED|Overall Study||23
246006|NCT01060150|595802|P1|COMPLETED|Overall Study||92
246007|NCT01060150|595802|P1|Treated|Overall Study||113
246008|NCT01060150|595802|P1|STARTED|Overall Study||115
246009|NCT01060124|595817|P1|NOT COMPLETED|Overall Study||37
246010|NCT01060124|595817|P1|COMPLETED|Overall Study||66
246011|NCT01060124|595817|P1|STARTED|Overall Study||103
246012|NCT01060111|595828|P3|NOT COMPLETED|Overall Study||35
246013|NCT01060111|595829|P2|NOT COMPLETED|Overall Study||23
246014|NCT01060111|595830|P1|NOT COMPLETED|Overall Study||27
246015|NCT01060111|595828|P3|COMPLETED|Overall Study||45
246016|NCT01060111|595829|P2|COMPLETED|Overall Study||61
246017|NCT01060111|595830|P1|COMPLETED|Overall Study||54
246018|NCT01060111|595828|P3|Treated|Overall Study||79
246019|NCT01060111|595829|P2|Treated|Overall Study||83
246020|NCT01060111|595830|P1|Treated|Overall Study||81
246021|NCT01060111|595828|P3|STARTED|Overall Study||80
246022|NCT01060111|595829|P2|STARTED|Overall Study||84
246023|NCT01060111|595830|P1|STARTED|Overall Study||81
246024|NCT01060072|595849|P2|NOT COMPLETED|Overall Study||5
246025|NCT01060072|595850|P1|NOT COMPLETED|Overall Study||2
246026|NCT01060072|595849|P2|COMPLETED|Overall Study||196
246027|NCT01060072|595850|P1|COMPLETED|Overall Study||204
246028|NCT01060072|595849|P2|STARTED|Overall Study||201
246029|NCT01060072|595850|P1|STARTED|Overall Study||206
246030|NCT01060059|595866|P2|NOT COMPLETED|Overall Study||67
246031|NCT01060059|595867|P1|NOT COMPLETED|Overall Study||67
246032|NCT01060059|595866|P2|COMPLETED|Overall Study||371
246033|NCT01060059|595867|P1|COMPLETED|Overall Study||377
246034|NCT01060059|595866|P2|STARTED|Overall Study||438
246035|NCT01060059|595867|P1|STARTED|Overall Study||444
246036|NCT01060020|595917|P1|NOT COMPLETED|Overall Study||0
246037|NCT01060020|595917|P1|COMPLETED|Overall Study||20
246038|NCT01060020|595917|P1|STARTED|Overall Study||20
246039|NCT01060007|595925|P1|NOT COMPLETED|Overall Study||4
246040|NCT01060007|595925|P1|COMPLETED|Overall Study||76
246041|NCT01060007|595925|P1|STARTED|Overall Study||80
246042|NCT01059994|595943|P4|NOT COMPLETED|Overall Study||1
246043|NCT01059994|595944|P3|NOT COMPLETED|Overall Study||0
246044|NCT01059994|595945|P2|NOT COMPLETED|Overall Study||0
246045|NCT01059994|595946|P1|NOT COMPLETED|Overall Study||0
246046|NCT01059994|595943|P4|COMPLETED|Overall Study||3
246047|NCT01059994|595944|P3|COMPLETED|Overall Study||3
246048|NCT01059994|595945|P2|COMPLETED|Overall Study||2
246049|NCT01059994|595946|P1|COMPLETED|Overall Study||3
246050|NCT01059994|595943|P4|STARTED|Overall Study||4
246051|NCT01059994|595944|P3|STARTED|Overall Study||3
246052|NCT01059994|595945|P2|STARTED|Overall Study||2
246053|NCT01059994|595946|P1|STARTED|Overall Study||3
246054|NCT01059929|595962|P2|NOT COMPLETED|Overall Study||0
246055|NCT01059929|595963|P1|NOT COMPLETED|Overall Study||0
246056|NCT01059929|595962|P2|COMPLETED|Overall Study||21
246057|NCT01059929|595963|P1|COMPLETED|Overall Study||20
246058|NCT01059929|595962|P2|STARTED|Overall Study||21
246059|NCT01059929|595963|P1|STARTED|Overall Study||20
246060|NCT01059903|595993|P2|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
246061|NCT01059903|595994|P1|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
246062|NCT01059903|595993|P2|COMPLETED|Period 3: Second Intervention- 24 Hours||24
246063|NCT01059903|595994|P1|COMPLETED|Period 3: Second Intervention- 24 Hours||24
246064|NCT01059903|595993|P2|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Two subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|22
246065|NCT01059903|595994|P1|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Six subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|18
246066|NCT01059903|595993|P2|STARTED|Period 3: Second Intervention- 24 Hours||24
246067|NCT01059903|595994|P1|STARTED|Period 3: Second Intervention- 24 Hours||24
246068|NCT01059903|595993|P2|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
246069|NCT01059903|595994|P1|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
246070|NCT01059903|595993|P2|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
246071|NCT01059903|595994|P1|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
246072|NCT01059903|595993|P2|STARTED|Period 2: Washout Period (>= 5 Days)||24
246073|NCT01059903|595994|P1|STARTED|Period 2: Washout Period (>= 5 Days)||24
246074|NCT01059903|595993|P2|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
246075|NCT01059903|595994|P1|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
246076|NCT01059903|595993|P2|COMPLETED|Period 1: First Intervention- 24 Hours||24
246077|NCT01059903|595994|P1|COMPLETED|Period 1: First Intervention- 24 Hours||24
246078|NCT01059903|595993|P2|STARTED|Period 1: First Intervention- 24 Hours||25
246079|NCT01059903|595994|P1|STARTED|Period 1: First Intervention- 24 Hours||25
246080|NCT01059877|596030|P2|NOT COMPLETED|Overall Study||2
246081|NCT01059877|596031|P1|NOT COMPLETED|Overall Study||0
246082|NCT01059877|596030|P2|COMPLETED|Overall Study||3
246083|NCT01059877|596031|P1|COMPLETED|Overall Study||6
246084|NCT01059877|596030|P2|STARTED|Overall Study||5
246085|NCT01059877|596031|P1|STARTED|Overall Study||6
246086|NCT01059864|596037|P3|NOT COMPLETED|Double-Blind Treatment Phase||3
246087|NCT01059864|596038|P2|NOT COMPLETED|Double-Blind Treatment Phase||3
246088|NCT01059864|596039|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
246089|NCT01059864|596037|P3|COMPLETED|Double-Blind Treatment Phase||45
246090|NCT01059864|596038|P2|COMPLETED|Double-Blind Treatment Phase||47
246091|NCT01059864|596039|P1|COMPLETED|Double-Blind Treatment Phase||0
246092|NCT01059864|596037|P3|Treated|Double-Blind Treatment Phase||47
246093|NCT01059864|596038|P2|Treated|Double-Blind Treatment Phase||50
246094|NCT01059864|596039|P1|Treated|Double-Blind Treatment Phase||0
246095|NCT01059864|596037|P3|STARTED|Double-Blind Treatment Phase||48
246096|NCT01059864|596038|P2|STARTED|Double-Blind Treatment Phase||50
246097|NCT01059864|596039|P1|STARTED|Double-Blind Treatment Phase||0
246098|NCT01059864|596037|P3|NOT COMPLETED|Open-Label Run-In Phase||0
246099|NCT01059864|596038|P2|NOT COMPLETED|Open-Label Run-In Phase||0
246100|NCT01059864|596039|P1|NOT COMPLETED|Open-Label Run-In Phase||13
246101|NCT01059864|596037|P3|COMPLETED|Open-Label Run-In Phase||0
246102|NCT01059864|596038|P2|COMPLETED|Open-Label Run-In Phase||0
246103|NCT01059864|596039|P1|COMPLETED|Open-Label Run-In Phase||98
246104|NCT01059864|596037|P3|STARTED|Open-Label Run-In Phase||0
246105|NCT01059864|596038|P2|STARTED|Open-Label Run-In Phase||0
246106|NCT01059864|596039|P1|STARTED|Open-Label Run-In Phase||111
246107|NCT01059851|596088|P6|NOT COMPLETED|Overall Study||0
246108|NCT01059851|596089|P5|NOT COMPLETED|Overall Study||0
246109|NCT01059851|596090|P4|NOT COMPLETED|Overall Study||0
246110|NCT01059851|596091|P3|NOT COMPLETED|Overall Study||0
246111|NCT01059851|596092|P2|NOT COMPLETED|Overall Study||0
246112|NCT01059851|596093|P1|NOT COMPLETED|Overall Study||0
246113|NCT01059851|596088|P6|COMPLETED|Overall Study||0
246114|NCT01059851|596089|P5|COMPLETED|Overall Study||0
246115|NCT01059851|596090|P4|COMPLETED|Overall Study||0
246116|NCT01059851|596091|P3|COMPLETED|Overall Study||0
246117|NCT01059851|596092|P2|COMPLETED|Overall Study||8
246118|NCT01059851|596093|P1|COMPLETED|Overall Study||8
246119|NCT01059851|596088|P6|STARTED|Overall Study||0
246120|NCT01059851|596089|P5|STARTED|Overall Study||0
246121|NCT01059851|596090|P4|STARTED|Overall Study||0
246122|NCT01059851|596091|P3|STARTED|Overall Study||0
246123|NCT01059851|596092|P2|STARTED|Overall Study||8
246124|NCT01059851|596093|P1|STARTED|Overall Study||8
246125|NCT01059825|596113|P7|NOT COMPLETED|Treatment Period||0
246126|NCT01059825|596114|P6|NOT COMPLETED|Treatment Period||3
246127|NCT01059825|596115|P5|NOT COMPLETED|Treatment Period||8
246128|NCT01059825|596116|P4|NOT COMPLETED|Treatment Period||11
246129|NCT01059825|596117|P3|NOT COMPLETED|Treatment Period||6
246130|NCT01059825|596118|P2|NOT COMPLETED|Treatment Period||4
246131|NCT01059825|596119|P1|NOT COMPLETED|Treatment Period||10
246132|NCT01059825|596113|P7|COMPLETED|Treatment Period||0
246133|NCT01059825|596114|P6|COMPLETED|Treatment Period||52
246134|NCT01059825|596115|P5|COMPLETED|Treatment Period||47
246135|NCT01059825|596116|P4|COMPLETED|Treatment Period||44
246136|NCT01059825|596117|P3|COMPLETED|Treatment Period||49
246137|NCT01059825|596118|P2|COMPLETED|Treatment Period||50
246138|NCT01059825|596119|P1|COMPLETED|Treatment Period||44
246139|NCT01059825|596113|P7|STARTED|Treatment Period|Participants who completed run-in were randomized to 1 of 6 treatment groups.|0
246140|NCT01059825|596114|P6|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
246141|NCT01059825|596115|P5|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
246142|NCT01059825|596116|P4|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
246143|NCT01059825|596117|P3|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
246144|NCT01059825|596118|P2|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
246145|NCT01059825|596119|P1|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
246146|NCT01059825|596113|P7|NOT COMPLETED|Enrolled, Run-in Period||47
246147|NCT01059825|596114|P6|NOT COMPLETED|Enrolled, Run-in Period||0
246148|NCT01059825|596115|P5|NOT COMPLETED|Enrolled, Run-in Period||0
246149|NCT01059825|596116|P4|NOT COMPLETED|Enrolled, Run-in Period||0
246150|NCT01059825|596117|P3|NOT COMPLETED|Enrolled, Run-in Period||0
246151|NCT01059825|596118|P2|NOT COMPLETED|Enrolled, Run-in Period||0
246152|NCT01059825|596119|P1|NOT COMPLETED|Enrolled, Run-in Period||0
246153|NCT01059825|596113|P7|COMPLETED|Enrolled, Run-in Period||328
246154|NCT01059825|596114|P6|COMPLETED|Enrolled, Run-in Period||0
246155|NCT01059825|596115|P5|COMPLETED|Enrolled, Run-in Period||0
246156|NCT01059825|596116|P4|COMPLETED|Enrolled, Run-in Period||0
246157|NCT01059825|596117|P3|COMPLETED|Enrolled, Run-in Period||0
246158|NCT01059825|596118|P2|COMPLETED|Enrolled, Run-in Period||0
246159|NCT01059825|596119|P1|COMPLETED|Enrolled, Run-in Period||0
246160|NCT01059825|596113|P7|STARTED|Enrolled, Run-in Period||375
246161|NCT01059825|596114|P6|STARTED|Enrolled, Run-in Period||0
246162|NCT01059825|596115|P5|STARTED|Enrolled, Run-in Period||0
246163|NCT01059825|596116|P4|STARTED|Enrolled, Run-in Period||0
246164|NCT01059825|596117|P3|STARTED|Enrolled, Run-in Period||0
246165|NCT01059825|596118|P2|STARTED|Enrolled, Run-in Period||0
246166|NCT01059825|596119|P1|STARTED|Enrolled, Run-in Period||0
246167|NCT01059812|596306|P2|NOT COMPLETED|Overall Study||16
246168|NCT01059812|596307|P1|NOT COMPLETED|Overall Study||37
246169|NCT01059812|596306|P2|COMPLETED|Overall Study||126
246170|NCT01059812|596307|P1|COMPLETED|Overall Study||245
246171|NCT01059812|596306|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|141
246172|NCT01059812|596307|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|279
246173|NCT01059812|596306|P2|STARTED|Overall Study||142
246174|NCT01059812|596307|P1|STARTED|Overall Study||282
246175|NCT01059799|596323|P2|NOT COMPLETED|Overall Study||10
246176|NCT01059799|596324|P1|NOT COMPLETED|Overall Study||31
246177|NCT01059799|596323|P2|COMPLETED|Overall Study||136
246178|NCT01059799|596324|P1|COMPLETED|Overall Study||258
246179|NCT01059799|596323|P2|Exposed|Overall Study||146
246180|NCT01059799|596324|P1|Exposed|Overall Study|Five subjects withdrew before exposure to trial drug|284
246181|NCT01059799|596323|P2|STARTED|Overall Study||146
246182|NCT01059799|596324|P1|STARTED|Overall Study||289
246183|NCT01059773|596338|P2|NOT COMPLETED|Overall Study||24
246184|NCT01059773|596339|P1|NOT COMPLETED|Overall Study||20
246185|NCT01059773|596338|P2|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|221
246186|NCT01059773|596339|P1|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|224
246187|NCT01059773|596338|P2|STARTED|Overall Study||245
246188|NCT01059773|596339|P1|STARTED|Overall Study||244
246189|NCT01059760|596371|P2|NOT COMPLETED|Overall Study||0
246190|NCT01059760|596372|P1|NOT COMPLETED|Overall Study||0
246191|NCT01059760|596371|P2|COMPLETED|Overall Study||14
246192|NCT01059760|596372|P1|COMPLETED|Overall Study||16
246193|NCT01059760|596371|P2|STARTED|Overall Study||14
246194|NCT01059760|596372|P1|STARTED|Overall Study||16
246195|NCT01059643|596478|P1|NOT COMPLETED|Overall Study||6
246196|NCT01059643|596478|P1|COMPLETED|Overall Study||97
246197|NCT01059643|596478|P1|Received at Least 1 Dose of Study Drug|Overall Study||103
246198|NCT01059643|596478|P1|STARTED|Overall Study||103
246199|NCT01059630|596493|P2|NOT COMPLETED|Maintenance Period (up to 2 Years)||108
246200|NCT01059630|596494|P1|NOT COMPLETED|Maintenance Period (up to 2 Years)||0
246201|NCT01059630|596493|P2|COMPLETED|Maintenance Period (up to 2 Years)||35
246202|NCT01059630|596494|P1|COMPLETED|Maintenance Period (up to 2 Years)||0
246203|NCT01059630|596493|P2|STARTED|Maintenance Period (up to 2 Years)|Of all participants who completed induction, 13 participants did not start maintenance.|143
246204|NCT01059630|596494|P1|STARTED|Maintenance Period (up to 2 Years)|Maintenance was not planned for this arm.|0
246205|NCT01059630|596493|P2|NOT COMPLETED|Induction Period (6 Months)||38
246206|NCT01059630|596494|P1|NOT COMPLETED|Induction Period (6 Months)||73
246207|NCT01059630|596493|P2|COMPLETED|Induction Period (6 Months)||156
246208|NCT01059630|596494|P1|COMPLETED|Induction Period (6 Months)||129
246209|NCT01059630|596493|P2|Treated|Induction Period (6 Months)||194
246210|NCT01059630|596494|P1|Treated|Induction Period (6 Months)||198
246211|NCT01059630|596493|P2|STARTED|Induction Period (6 Months)||194
246212|NCT01059630|596494|P1|STARTED|Induction Period (6 Months)||202
246213|NCT01059617|596554|P4|NOT COMPLETED|Overall Study||6
246214|NCT01059617|596555|P3|NOT COMPLETED|Overall Study||8
246215|NCT01059617|596556|P2|NOT COMPLETED|Overall Study||1
246216|NCT01059617|596557|P1|NOT COMPLETED|Overall Study||7
246217|NCT01059617|596554|P4|COMPLETED|Overall Study||27
246218|NCT01059617|596555|P3|COMPLETED|Overall Study||25
246219|NCT01059617|596556|P2|COMPLETED|Overall Study||33
246220|NCT01059617|596557|P1|COMPLETED|Overall Study||26
246221|NCT01059617|596554|P4|STARTED|Overall Study||33
246222|NCT01059617|596555|P3|STARTED|Overall Study||33
246223|NCT01059617|596556|P2|STARTED|Overall Study||34
246224|NCT01059617|596557|P1|STARTED|Overall Study||33
246225|NCT01059565|596727|P2|NOT COMPLETED|24-Week Open-Label Phase||3
246226|NCT01059565|596728|P1|NOT COMPLETED|24-Week Open-Label Phase||5
246227|NCT01059565|596727|P2|COMPLETED|24-Week Open-Label Phase||42
246228|NCT01059565|596728|P1|COMPLETED|24-Week Open-Label Phase||34
246229|NCT01059565|596727|P2|STARTED|24-Week Open-Label Phase||45
246230|NCT01059565|596728|P1|STARTED|24-Week Open-Label Phase||39
246231|NCT01059565|596727|P2|NOT COMPLETED|24-Week Randomized Phase||7
246232|NCT01059565|596728|P1|NOT COMPLETED|24-Week Randomized Phase||10
246233|NCT01059565|596727|P2|COMPLETED|24-Week Randomized Phase||45
246234|NCT01059565|596728|P1|COMPLETED|24-Week Randomized Phase||39
246235|NCT01059565|596727|P2|Randomized and Treated|24-Week Randomized Phase||52
246236|NCT01059565|596728|P1|Randomized and Treated|24-Week Randomized Phase||48
246237|NCT01059565|596727|P2|STARTED|24-Week Randomized Phase||52
246238|NCT01059565|596728|P1|STARTED|24-Week Randomized Phase||49
246239|NCT01059539|596762|P1|NOT COMPLETED|Overall Study||271
246240|NCT01059539|596762|P1|COMPLETED|Overall Study||132
246241|NCT01059539|596762|P1|STARTED|Overall Study||403
246242|NCT01059526|596769|P2|NOT COMPLETED|Overall Study||22
246243|NCT01059526|596770|P1|NOT COMPLETED|Overall Study||30
246244|NCT01059526|596769|P2|COMPLETED|Overall Study||18
246245|NCT01059526|596770|P1|COMPLETED|Overall Study||11
246246|NCT01059526|596769|P2|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|23
246247|NCT01059526|596770|P1|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|21
246248|NCT01059526|596769|P2|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|40
246249|NCT01059526|596770|P1|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|41
246250|NCT01059435|596788|P10|NOT COMPLETED|Overall Study||0
246251|NCT01059435|596789|P9|NOT COMPLETED|Overall Study||0
246252|NCT01059435|596790|P8|NOT COMPLETED|Overall Study||0
246253|NCT01059435|596791|P7|NOT COMPLETED|Overall Study||0
246254|NCT01059435|596792|P6|NOT COMPLETED|Overall Study||0
246255|NCT01059435|596793|P5|NOT COMPLETED|Overall Study||0
246256|NCT01059435|596794|P4|NOT COMPLETED|Overall Study||0
246257|NCT01059435|596795|P3|NOT COMPLETED|Overall Study||2
246258|NCT01059435|596796|P2|NOT COMPLETED|Overall Study||0
246259|NCT01059435|596797|P1|NOT COMPLETED|Overall Study||0
246260|NCT01059435|596788|P10|COMPLETED|Overall Study||6
246261|NCT01059435|596789|P9|COMPLETED|Overall Study||6
246262|NCT01059435|596790|P8|COMPLETED|Overall Study||4
246263|NCT01059435|596791|P7|COMPLETED|Overall Study||6
246264|NCT01059435|596792|P6|COMPLETED|Overall Study||9
246265|NCT01059435|596793|P5|COMPLETED|Overall Study||6
246266|NCT01059435|596794|P4|COMPLETED|Overall Study||9
246267|NCT01059435|596795|P3|COMPLETED|Overall Study||6
246268|NCT01059435|596796|P2|COMPLETED|Overall Study||6
246269|NCT01059435|596797|P1|COMPLETED|Overall Study||14
246270|NCT01059435|596788|P10|Received Study Drug|Overall Study||6
246271|NCT01059435|596789|P9|Received Study Drug|Overall Study||6
246272|NCT01059435|596790|P8|Received Study Drug|Overall Study||4
246273|NCT01059435|596791|P7|Received Study Drug|Overall Study||6
246274|NCT01059435|596792|P6|Received Study Drug|Overall Study||9
246275|NCT01059435|596793|P5|Received Study Drug|Overall Study||6
246276|NCT01059435|596794|P4|Received Study Drug|Overall Study||9
246277|NCT01059435|596795|P3|Received Study Drug|Overall Study||6
246278|NCT01059435|596796|P2|Received Study Drug|Overall Study||6
246279|NCT01059435|596797|P1|Received Study Drug|Overall Study||14
246280|NCT01059435|596788|P10|STARTED|Overall Study||6
246281|NCT01059435|596789|P9|STARTED|Overall Study||6
246282|NCT01059435|596790|P8|STARTED|Overall Study||4
246283|NCT01059435|596791|P7|STARTED|Overall Study||6
246284|NCT01059435|596792|P6|STARTED|Overall Study||9
246285|NCT01059435|596793|P5|STARTED|Overall Study||6
246286|NCT01059435|596794|P4|STARTED|Overall Study||9
246287|NCT01059435|596795|P3|STARTED|Overall Study||8
246288|NCT01059435|596796|P2|STARTED|Overall Study||6
246289|NCT01059435|596797|P1|STARTED|Overall Study||14
246290|NCT01059357|597105|P1|NOT COMPLETED|Overall Study||4
246291|NCT01059357|597105|P1|COMPLETED|Overall Study||54
246292|NCT01059357|597105|P1|STARTED|Overall Study||58
246293|NCT01059344|597116|P2|NOT COMPLETED|Overall Study||46
246294|NCT01059344|597117|P1|NOT COMPLETED|Overall Study||22
246295|NCT01059344|597116|P2|COMPLETED|Overall Study||95
246296|NCT01059344|597117|P1|COMPLETED|Overall Study||118
246297|NCT01059344|597116|P2|STARTED|Overall Study||141
246298|NCT01059344|597117|P1|STARTED|Overall Study||140
246299|NCT01059305|597135|P1|NOT COMPLETED|Overall Study||0
246300|NCT01059305|597135|P1|COMPLETED|Overall Study||10
246301|NCT01059305|597135|P1|STARTED|Overall Study||10
246302|NCT01059175|597141|P2|NOT COMPLETED|Overall Study||20
246303|NCT01059175|597142|P1|NOT COMPLETED|Overall Study||21
246304|NCT01059175|597141|P2|COMPLETED|Overall Study|17 patients deceased 3 patients were prematurely exited|21
246305|NCT01059175|597142|P1|COMPLETED|Overall Study|17 patients deceased 4 additional patients were prematurely exited|22
246306|NCT01059175|597141|P2|STARTED|Overall Study||41
246307|NCT01059175|597142|P1|STARTED|Overall Study||43
246308|NCT01059071|597164|P4|NOT COMPLETED|Overall Study||6
246309|NCT01059071|597165|P3|NOT COMPLETED|Overall Study||2
246310|NCT01059071|597166|P2|NOT COMPLETED|Overall Study||4
246311|NCT01059071|597167|P1|NOT COMPLETED|Overall Study||2
246312|NCT01059071|597164|P4|COMPLETED|Overall Study||3
246313|NCT01059071|597165|P3|COMPLETED|Overall Study||1
246314|NCT01059071|597166|P2|COMPLETED|Overall Study||1
246315|NCT01059071|597167|P1|COMPLETED|Overall Study||2
246316|NCT01059071|597164|P4|STARTED|Overall Study||9
246317|NCT01059071|597165|P3|STARTED|Overall Study||3
246318|NCT01059071|597166|P2|STARTED|Overall Study||5
246319|NCT01059071|597167|P1|STARTED|Overall Study||4
246320|NCT01058993|597179|P1|NOT COMPLETED|Overall Study||0
246321|NCT01058993|597179|P1|COMPLETED|Overall Study||6
246322|NCT01058993|597179|P1|STARTED|Overall Study||6
246323|NCT01058941|597185|P2|NOT COMPLETED|Overall Study||11
246324|NCT01058941|597186|P1|NOT COMPLETED|Overall Study||9
246325|NCT01058941|597185|P2|COMPLETED|Overall Study||22
246326|NCT01058941|597186|P1|COMPLETED|Overall Study||25
246327|NCT01058941|597185|P2|STARTED|Overall Study||33
246328|NCT01058941|597186|P1|STARTED|Overall Study||34
246329|NCT01058863|597194|P1|NOT COMPLETED|Overall Study||4
246330|NCT01058863|597194|P1|COMPLETED|Overall Study||68
246331|NCT01058863|597194|P1|Treated With Placebo Inhaler|Overall Study||69
246332|NCT01058863|597194|P1|Treated With ProAir® HFA 180 mcg|Overall Study||68
246333|NCT01058863|597194|P1|Treated With ProAir® HFA 90 mcg|Overall Study||70
246334|NCT01058863|597194|P1|Treated With Albuterol Spiromax® 180 mcg|Overall Study||68
246335|NCT01058863|597194|P1|Treated With Albuterol Spiromax® 90 mcg|Overall Study||68
246336|NCT01058863|597194|P1|Safety and ITT Populations|Overall Study|One patient was randomized in error and never received the study drug.|71
246337|NCT01058863|597194|P1|STARTED|Overall Study||72
246338|NCT01058668|597215|P3|NOT COMPLETED|Safety Follow-up||7
246339|NCT01058668|597216|P2|NOT COMPLETED|Safety Follow-up||0
246340|NCT01058668|597217|P1|NOT COMPLETED|Safety Follow-up||5
246341|NCT01058668|597215|P3|COMPLETED|Safety Follow-up||141
246342|NCT01058668|597216|P2|COMPLETED|Safety Follow-up||146
246343|NCT01058668|597217|P1|COMPLETED|Safety Follow-up||139
246344|NCT01058668|597215|P3|STARTED|Safety Follow-up||148
246345|NCT01058668|597216|P2|STARTED|Safety Follow-up||146
246346|NCT01058668|597217|P1|STARTED|Safety Follow-up|Not all participants entered the Safety-Follow-up|144
246347|NCT01058668|597215|P3|NOT COMPLETED|Double-blind Treatment Phase||50
246348|NCT01058668|597216|P2|NOT COMPLETED|Double-blind Treatment Phase||38
246349|NCT01058668|597217|P1|NOT COMPLETED|Double-blind Treatment Phase||39
246350|NCT01058668|597215|P3|COMPLETED|Double-blind Treatment Phase||119
246351|NCT01058668|597216|P2|COMPLETED|Double-blind Treatment Phase||129
246352|NCT01058668|597217|P1|COMPLETED|Double-blind Treatment Phase||122
246353|NCT01058668|597215|P3|STARTED|Double-blind Treatment Phase||169
246354|NCT01058668|597216|P2|STARTED|Double-blind Treatment Phase||167
246355|NCT01058668|597217|P1|STARTED|Double-blind Treatment Phase||161
246356|NCT01058655|597232|P4|NOT COMPLETED|Overall Study||42
246357|NCT01058655|597233|P3|NOT COMPLETED|Overall Study||8
246358|NCT01058655|597234|P2|NOT COMPLETED|Overall Study||3
246359|NCT01058655|597235|P1|NOT COMPLETED|Overall Study||3
246360|NCT01058655|597232|P4|COMPLETED|Overall Study||0
246361|NCT01058655|597233|P3|COMPLETED|Overall Study||0
246362|NCT01058655|597234|P2|COMPLETED|Overall Study||0
246363|NCT01058655|597235|P1|COMPLETED|Overall Study||0
246364|NCT01058655|597232|P4|Evaluable|Overall Study||40
246365|NCT01058655|597233|P3|Evaluable|Overall Study||6
246366|NCT01058655|597234|P2|Evaluable|Overall Study||3
246367|NCT01058655|597235|P1|Evaluable|Overall Study||3
246368|NCT01058655|597232|P4|STARTED|Overall Study||42
246369|NCT01058655|597233|P3|STARTED|Overall Study||8
246370|NCT01058655|597234|P2|STARTED|Overall Study||3
246371|NCT01058655|597235|P1|STARTED|Overall Study||3
246372|NCT01058642|597253|P4|NOT COMPLETED|Treatment Period 2||0
246373|NCT01058642|597254|P3|NOT COMPLETED|Treatment Period 2||0
246374|NCT01058642|597255|P2|NOT COMPLETED|Treatment Period 2||0
246375|NCT01058642|597256|P1|NOT COMPLETED|Treatment Period 2||0
246376|NCT01058642|597253|P4|COMPLETED|Treatment Period 2||7
246377|NCT01058642|597254|P3|COMPLETED|Treatment Period 2||9
246378|NCT01058642|597255|P2|COMPLETED|Treatment Period 2||11
246379|NCT01058642|597256|P1|COMPLETED|Treatment Period 2||7
246380|NCT01058642|597253|P4|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
246381|NCT01058642|597254|P3|Received at Least 1 Dose of Study Drug|Treatment Period 2||9
246382|NCT01058642|597255|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||11
246383|NCT01058642|597256|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
246384|NCT01058642|597253|P4|STARTED|Treatment Period 2||7
246385|NCT01058642|597254|P3|STARTED|Treatment Period 2||9
246386|NCT01058642|597255|P2|STARTED|Treatment Period 2||11
246387|NCT01058642|597256|P1|STARTED|Treatment Period 2||7
246388|NCT01058642|597253|P4|NOT COMPLETED|Washout Period||0
246389|NCT01058642|597254|P3|NOT COMPLETED|Washout Period||0
246390|NCT01058642|597255|P2|NOT COMPLETED|Washout Period||0
246391|NCT01058642|597256|P1|NOT COMPLETED|Washout Period||0
246392|NCT01058642|597253|P4|COMPLETED|Washout Period||7
246393|NCT01058642|597254|P3|COMPLETED|Washout Period||9
246394|NCT01058642|597255|P2|COMPLETED|Washout Period||11
246395|NCT01058642|597256|P1|COMPLETED|Washout Period||7
246396|NCT01058642|597253|P4|STARTED|Washout Period||7
246397|NCT01058642|597254|P3|STARTED|Washout Period||9
246398|NCT01058642|597255|P2|STARTED|Washout Period||11
246399|NCT01058642|597256|P1|STARTED|Washout Period||7
246400|NCT01058642|597253|P4|NOT COMPLETED|Treatment Period 1||2
246401|NCT01058642|597254|P3|NOT COMPLETED|Treatment Period 1||2
246402|NCT01058642|597255|P2|NOT COMPLETED|Treatment Period 1||1
246403|NCT01058642|597256|P1|NOT COMPLETED|Treatment Period 1||2
246404|NCT01058642|597253|P4|COMPLETED|Treatment Period 1||7
246405|NCT01058642|597254|P3|COMPLETED|Treatment Period 1||9
246406|NCT01058642|597255|P2|COMPLETED|Treatment Period 1||11
246407|NCT01058642|597256|P1|COMPLETED|Treatment Period 1||7
246408|NCT01058642|597253|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
246409|NCT01058642|597254|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1||11
246410|NCT01058642|597255|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||12
246411|NCT01058642|597256|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
246412|NCT01058642|597253|P4|STARTED|Treatment Period 1||9
246413|NCT01058642|597254|P3|STARTED|Treatment Period 1||11
246414|NCT01058642|597255|P2|STARTED|Treatment Period 1||12
246415|NCT01058642|597256|P1|STARTED|Treatment Period 1||9
246416|NCT01058421|597266|P2|NOT COMPLETED|6 Month Outcomes||26
246417|NCT01058421|597267|P1|NOT COMPLETED|6 Month Outcomes||19
246418|NCT01058421|597266|P2|COMPLETED|6 Month Outcomes||24
246419|NCT01058421|597267|P1|COMPLETED|6 Month Outcomes||27
246420|NCT01058421|597266|P2|STARTED|6 Month Outcomes|61 (subjects started Period 1) minus 11 (deceased subjects in Periods 1 & 2) = 50 started Period 3.|50
246421|NCT01058421|597267|P1|STARTED|6 Month Outcomes|55 (subjects started Period 1) minus 13 (deceased subjects in Periods 1 & 2) = 46 started Period 3.|46
246422|NCT01058421|597266|P2|NOT COMPLETED|3 Month Outcomes||26
246423|NCT01058421|597267|P1|NOT COMPLETED|3 Month Outcomes||20
246424|NCT01058421|597266|P2|COMPLETED|3 Month Outcomes||29
246425|NCT01058421|597267|P1|COMPLETED|3 Month Outcomes||29
246426|NCT01058421|597266|P2|STARTED|3 Month Outcomes|61 (Subjects started Period 1) minus 6 (deceased subjects during Period 1) = 55 started Period 2.|55
246427|NCT01058421|597267|P1|STARTED|3 Month Outcomes|59 (Subjects started Period 1) minus 10 (deceased subjects during Period 1) = 49 started Period 2.|49
246428|NCT01058421|597266|P2|NOT COMPLETED|1 Month Outcomes||42
246429|NCT01058421|597267|P1|NOT COMPLETED|1 Month Outcomes||39
246430|NCT01058421|597266|P2|COMPLETED|1 Month Outcomes||19
246431|NCT01058421|597267|P1|COMPLETED|1 Month Outcomes||20
246432|NCT01058421|597266|P2|STARTED|1 Month Outcomes||61
246433|NCT01058421|597267|P1|STARTED|1 Month Outcomes||59
246434|NCT01058395|597291|P2|NOT COMPLETED|Overall Study||1
246435|NCT01058395|597292|P1|NOT COMPLETED|Overall Study||3
246436|NCT01058395|597291|P2|COMPLETED|Overall Study|One died after enrollment. The patient died in the first 48 hours.|7
246437|NCT01058395|597292|P1|COMPLETED|Overall Study|Two died, and one was lost to followup.|4
246438|NCT01058395|597291|P2|STARTED|Overall Study||8
246439|NCT01058395|597292|P1|STARTED|Overall Study||7
246440|NCT01058356|597301|P1|NOT COMPLETED|Overall Study||42
246441|NCT01058356|597301|P1|COMPLETED|Overall Study||172
246442|NCT01058356|597301|P1|STARTED|Overall Study||214
246443|NCT01058304|597308|P2|NOT COMPLETED|Overall Study||33
246444|NCT01058304|597309|P1|NOT COMPLETED|Overall Study||27
246445|NCT01058304|597308|P2|COMPLETED|Overall Study||128
246446|NCT01058304|597309|P1|COMPLETED|Overall Study||132
246447|NCT01058304|597308|P2|STARTED|Overall Study||161
246448|NCT01058304|597309|P1|STARTED|Overall Study||159
246449|NCT01058265|597319|P2|NOT COMPLETED|Overall Study||12
246450|NCT01058265|597320|P1|NOT COMPLETED|Overall Study||11
246451|NCT01058265|597319|P2|COMPLETED|Overall Study||13
246452|NCT01058265|597320|P1|COMPLETED|Overall Study||11
246453|NCT01058265|597319|P2|STARTED|Overall Study||25
246454|NCT01058265|597320|P1|STARTED|Overall Study||22
246455|NCT01058239|597328|P1|NOT COMPLETED|Overall Study||0
246456|NCT01058239|597328|P1|COMPLETED|Overall Study||7
246457|NCT01058239|597328|P1|STARTED|Overall Study||7
246458|NCT01058096|597339|P2|NOT COMPLETED|Safety Follow-up||4
246459|NCT01058096|597340|P1|NOT COMPLETED|Safety Follow-up||4
246460|NCT01058096|597339|P2|COMPLETED|Safety Follow-up||130
246461|NCT01058096|597340|P1|COMPLETED|Safety Follow-up||129
246462|NCT01058096|597339|P2|STARTED|Safety Follow-up||134
246463|NCT01058096|597340|P1|STARTED|Safety Follow-up|Not all participants continued to Safety Follow-up.|133
246464|NCT01058096|597339|P2|NOT COMPLETED|Double-blind Treatment Phase||50
246465|NCT01058096|597340|P1|NOT COMPLETED|Double-blind Treatment Phase||48
246466|NCT01058096|597339|P2|COMPLETED|Double-blind Treatment Phase||108
246467|NCT01058096|597340|P1|COMPLETED|Double-blind Treatment Phase||106
246468|NCT01058096|597339|P2|STARTED|Double-blind Treatment Phase||158
246469|NCT01058096|597340|P1|STARTED|Double-blind Treatment Phase||154
246470|NCT01058070|597348|P1|NOT COMPLETED|Overall Study||11
246471|NCT01058070|597348|P1|COMPLETED|Overall Study||33
246472|NCT01058070|597348|P1|STARTED|Overall Study||44
246473|NCT01058005|597356|P3|NOT COMPLETED|Overall Study||20
246474|NCT01058005|597357|P2|NOT COMPLETED|Overall Study||25
246475|NCT01058005|597358|P1|NOT COMPLETED|Overall Study||38
246476|NCT01058005|597356|P3|COMPLETED|Overall Study||1
246477|NCT01058005|597357|P2|COMPLETED|Overall Study||0
246478|NCT01058005|597358|P1|COMPLETED|Overall Study||0
246479|NCT01058005|597356|P3|Dosed With Study Treatment|Overall Study||17
246480|NCT01058005|597357|P2|Dosed With Study Treatment|Overall Study||22
246481|NCT01058005|597358|P1|Dosed With Study Treatment|Overall Study||36
246482|NCT01058005|597356|P3|STARTED|Overall Study||21
246483|NCT01058005|597357|P2|STARTED|Overall Study||25
246484|NCT01058005|597358|P1|STARTED|Overall Study||38
246485|NCT01057901|597368|P2|NOT COMPLETED|Overall Study||246
246486|NCT01057901|597369|P1|NOT COMPLETED|Overall Study||260
246487|NCT01057901|597368|P2|COMPLETED|Overall Study||126
246488|NCT01057901|597369|P1|COMPLETED|Overall Study||116
246489|NCT01057901|597368|P2|STARTED|Overall Study||372
246490|NCT01057901|597369|P1|STARTED|Overall Study||376
246491|NCT01057888|597380|P3|NOT COMPLETED|Overall Study||0
246492|NCT01057888|597381|P2|NOT COMPLETED|Overall Study||0
246493|NCT01057888|597382|P1|NOT COMPLETED|Overall Study||0
246494|NCT01057888|597380|P3|COMPLETED|Overall Study||2494
246495|NCT01057888|597381|P2|COMPLETED|Overall Study||2406
246496|NCT01057888|597382|P1|COMPLETED|Overall Study||2504
246497|NCT01057888|597380|P3|STARTED|Overall Study||2494
246498|NCT01057888|597381|P2|STARTED|Overall Study||2406
246499|NCT01057888|597382|P1|STARTED|Overall Study||2504
246500|NCT01057862|597393|P2|NOT COMPLETED|Overall Study||2
246501|NCT01057862|597394|P1|NOT COMPLETED|Overall Study||1
246502|NCT01057862|597393|P2|COMPLETED|Overall Study||2
246503|NCT01057862|597394|P1|COMPLETED|Overall Study||4
246504|NCT01057862|597393|P2|STARTED|Overall Study||4
246505|NCT01057862|597394|P1|STARTED|Overall Study||5
246506|NCT01057810|597404|P2|NOT COMPLETED|Overall Study||398
246507|NCT01057810|597405|P1|NOT COMPLETED|Overall Study||198
246508|NCT01057810|597404|P2|COMPLETED|Overall Study||1
246509|NCT01057810|597405|P1|COMPLETED|Overall Study||1
246510|NCT01057810|597404|P2|STARTED|Overall Study||399
246511|NCT01057810|597405|P1|STARTED|Overall Study||199
246512|NCT01057693|597421|P3|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||36
246513|NCT01057693|597422|P2|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||22
246514|NCT01057693|597423|P1|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
246515|NCT01057693|597421|P3|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||113
246516|NCT01057693|597422|P2|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||125
246517|NCT01057693|597423|P1|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
246518|NCT01057693|597421|P3|Treated|Double-Blind Phase (Week 7 to Week 19)||147
246519|NCT01057693|597422|P2|Treated|Double-Blind Phase (Week 7 to Week 19)||147
246520|NCT01057693|597423|P1|Treated|Double-Blind Phase (Week 7 to Week 19)||0
246521|NCT01057693|597421|P3|STARTED|Double-Blind Phase (Week 7 to Week 19)||149
246522|NCT01057693|597422|P2|STARTED|Double-Blind Phase (Week 7 to Week 19)||147
246523|NCT01057693|597423|P1|STARTED|Double-Blind Phase (Week 7 to Week 19)||0
246524|NCT01057693|597421|P3|NOT COMPLETED|Between Single-Blind and Double-Blind||0
246525|NCT01057693|597422|P2|NOT COMPLETED|Between Single-Blind and Double-Blind||0
246526|NCT01057693|597423|P1|NOT COMPLETED|Between Single-Blind and Double-Blind||270
246527|NCT01057693|597421|P3|COMPLETED|Between Single-Blind and Double-Blind||0
246528|NCT01057693|597422|P2|COMPLETED|Between Single-Blind and Double-Blind||0
246529|NCT01057693|597423|P1|COMPLETED|Between Single-Blind and Double-Blind||296
246530|NCT01057693|597421|P3|STARTED|Between Single-Blind and Double-Blind||0
246531|NCT01057693|597422|P2|STARTED|Between Single-Blind and Double-Blind||0
246532|NCT01057693|597423|P1|STARTED|Between Single-Blind and Double-Blind||566
246533|NCT01057693|597421|P3|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
246534|NCT01057693|597422|P2|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
246535|NCT01057693|597423|P1|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||99
246536|NCT01057693|597421|P3|COMPLETED|Single-Blind Phase (Up to Week 6)||0
246537|NCT01057693|597422|P2|COMPLETED|Single-Blind Phase (Up to Week 6)||0
246538|NCT01057693|597423|P1|COMPLETED|Single-Blind Phase (Up to Week 6)||566
246539|NCT01057693|597421|P3|STARTED|Single-Blind Phase (Up to Week 6)||0
246540|NCT01057693|597422|P2|STARTED|Single-Blind Phase (Up to Week 6)||0
246541|NCT01057693|597423|P1|STARTED|Single-Blind Phase (Up to Week 6)||665
246542|NCT01057589|597469|P1|NOT COMPLETED|Overall Study||66
246543|NCT01057589|597469|P1|COMPLETED|Overall Study||0
246544|NCT01057589|597469|P1|STARTED|Overall Study||66
246545|NCT01057433|597478|P1|NOT COMPLETED|Overall Study||1
246546|NCT01057433|597478|P1|COMPLETED|Overall Study||23
246547|NCT01057433|597478|P1|STARTED|Overall Study||24
246548|NCT01057394|597482|P2|NOT COMPLETED|Overall Study||2
246549|NCT01057394|597483|P1|NOT COMPLETED|Overall Study||0
246550|NCT01057394|597482|P2|COMPLETED|Overall Study|19 treated participants|19
246551|NCT01057394|597483|P1|COMPLETED|Overall Study||0
246552|NCT01057394|597482|P2|STARTED|Overall Study|21 enrolled participants|21
246553|NCT01057394|597483|P1|STARTED|Overall Study||0
246554|NCT01057277|597487|P1|NOT COMPLETED|Overall Study||0
246555|NCT01057277|597487|P1|COMPLETED|Overall Study||3
246556|NCT01057277|597487|P1|STARTED|Overall Study||3
246557|NCT01057251|597493|P2|NOT COMPLETED|Overall Study||29
246558|NCT01057251|597494|P1|NOT COMPLETED|Overall Study||28
246559|NCT01057251|597493|P2|COMPLETED|Overall Study||114
246560|NCT01057251|597494|P1|COMPLETED|Overall Study||262
246561|NCT01057251|597493|P2|STARTED|Overall Study|The safety population is 142, as one patient was randomized, but never received study drug.|143
246562|NCT01057251|597494|P1|STARTED|Overall Study||290
246563|NCT01057225|597502|P6|NOT COMPLETED|Overall Study||0
246564|NCT01057225|597503|P5|NOT COMPLETED|Overall Study||0
246565|NCT01057225|597504|P4|NOT COMPLETED|Overall Study||0
246566|NCT01057225|597505|P3|NOT COMPLETED|Overall Study||0
246567|NCT01057225|597506|P2|NOT COMPLETED|Overall Study||0
246568|NCT01057225|597507|P1|NOT COMPLETED|Overall Study||0
246569|NCT01057225|597502|P6|COMPLETED|Overall Study||23
246570|NCT01057225|597503|P5|COMPLETED|Overall Study||22
246571|NCT01057225|597504|P4|COMPLETED|Overall Study||7
246572|NCT01057225|597505|P3|COMPLETED|Overall Study||6
246573|NCT01057225|597506|P2|COMPLETED|Overall Study||3
246574|NCT01057225|597507|P1|COMPLETED|Overall Study||3
246575|NCT01057225|597502|P6|STARTED|Overall Study||23
246576|NCT01057225|597503|P5|STARTED|Overall Study||22
246577|NCT01057225|597504|P4|STARTED|Overall Study||7
246578|NCT01057225|597505|P3|STARTED|Overall Study||6
246579|NCT01057225|597506|P2|STARTED|Overall Study||3
246580|NCT01057225|597507|P1|STARTED|Overall Study||3
246581|NCT01057121|597529|P5|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
246582|NCT01057121|597530|P4|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
246583|NCT01057121|597531|P3|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
246584|NCT01057121|597532|P2|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
246585|NCT01057121|597533|P1|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
246586|NCT01057121|597529|P5|COMPLETED|Phase II: 25 mg/Day Lenalidomide||23
246587|NCT01057121|597530|P4|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
246588|NCT01057121|597531|P3|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
246589|NCT01057121|597532|P2|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
246590|NCT01057121|597533|P1|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
246591|NCT01057121|597529|P5|STARTED|Phase II: 25 mg/Day Lenalidomide||23
246592|NCT01057121|597530|P4|STARTED|Phase II: 25 mg/Day Lenalidomide||0
246593|NCT01057121|597531|P3|STARTED|Phase II: 25 mg/Day Lenalidomide||0
246594|NCT01057121|597532|P2|STARTED|Phase II: 25 mg/Day Lenalidomide||0
246595|NCT01057121|597533|P1|STARTED|Phase II: 25 mg/Day Lenalidomide||0
246596|NCT01057121|597529|P5|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
246597|NCT01057121|597530|P4|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
246598|NCT01057121|597531|P3|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
246599|NCT01057121|597532|P2|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
246600|NCT01057121|597533|P1|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
246601|NCT01057121|597529|P5|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
246602|NCT01057121|597530|P4|COMPLETED|Phase I: 25 mg/Day Lenalidomide||6
246603|NCT01057121|597531|P3|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
246604|NCT01057121|597532|P2|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
246605|NCT01057121|597533|P1|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
246606|NCT01057121|597529|P5|STARTED|Phase I: 25 mg/Day Lenalidomide||0
246607|NCT01057121|597530|P4|STARTED|Phase I: 25 mg/Day Lenalidomide||6
246608|NCT01057121|597531|P3|STARTED|Phase I: 25 mg/Day Lenalidomide||0
246609|NCT01057121|597532|P2|STARTED|Phase I: 25 mg/Day Lenalidomide||0
246610|NCT01057121|597533|P1|STARTED|Phase I: 25 mg/Day Lenalidomide||0
246611|NCT01057121|597529|P5|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
246612|NCT01057121|597530|P4|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
246613|NCT01057121|597531|P3|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
246614|NCT01057121|597532|P2|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
246615|NCT01057121|597533|P1|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
246616|NCT01057121|597529|P5|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
246617|NCT01057121|597530|P4|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
246618|NCT01057121|597531|P3|COMPLETED|Phase I: 20 mg/Day Lenalidomide||3
246619|NCT01057121|597532|P2|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
246620|NCT01057121|597533|P1|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
246621|NCT01057121|597529|P5|STARTED|Phase I: 20 mg/Day Lenalidomide||0
246622|NCT01057121|597530|P4|STARTED|Phase I: 20 mg/Day Lenalidomide||0
246623|NCT01057121|597531|P3|STARTED|Phase I: 20 mg/Day Lenalidomide||3
246624|NCT01057121|597532|P2|STARTED|Phase I: 20 mg/Day Lenalidomide||0
246625|NCT01057121|597533|P1|STARTED|Phase I: 20 mg/Day Lenalidomide||0
246626|NCT01057121|597529|P5|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
246627|NCT01057121|597530|P4|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
246628|NCT01057121|597531|P3|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
246629|NCT01057121|597532|P2|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
246630|NCT01057121|597533|P1|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
246631|NCT01057121|597529|P5|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
246632|NCT01057121|597530|P4|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
246633|NCT01057121|597531|P3|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
246634|NCT01057121|597532|P2|COMPLETED|Phase I: 15 mg/Day Lenolidomide||3
246635|NCT01057121|597533|P1|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
246636|NCT01057121|597529|P5|STARTED|Phase I: 15 mg/Day Lenolidomide||0
246637|NCT01057121|597530|P4|STARTED|Phase I: 15 mg/Day Lenolidomide||0
246638|NCT01057121|597531|P3|STARTED|Phase I: 15 mg/Day Lenolidomide||0
246639|NCT01057121|597532|P2|STARTED|Phase I: 15 mg/Day Lenolidomide||3
246640|NCT01057121|597533|P1|STARTED|Phase I: 15 mg/Day Lenolidomide||0
246641|NCT01057121|597529|P5|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
246642|NCT01057121|597530|P4|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
246643|NCT01057121|597531|P3|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
246644|NCT01057121|597532|P2|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
246645|NCT01057121|597533|P1|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
246646|NCT01057121|597529|P5|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
246647|NCT01057121|597530|P4|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
246648|NCT01057121|597531|P3|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
246649|NCT01057121|597532|P2|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
246650|NCT01057121|597533|P1|COMPLETED|Phase I: 10 mg/Day Lenalidomide||3
246651|NCT01057121|597529|P5|STARTED|Phase I: 10 mg/Day Lenalidomide||0
246652|NCT01057121|597530|P4|STARTED|Phase I: 10 mg/Day Lenalidomide||0
246653|NCT01057121|597531|P3|STARTED|Phase I: 10 mg/Day Lenalidomide||0
246654|NCT01057121|597532|P2|STARTED|Phase I: 10 mg/Day Lenalidomide||0
246655|NCT01057121|597533|P1|STARTED|Phase I: 10 mg/Day Lenalidomide||3
246656|NCT01057017|597562|P1|NOT COMPLETED|Overall Study||0
246657|NCT01057017|597562|P1|COMPLETED|Overall Study||5
246658|NCT01057017|597562|P1|STARTED|Overall Study||5
246659|NCT01056913|597566|P1|NOT COMPLETED|Overall Study||0
246660|NCT01056913|597566|P1|COMPLETED|Overall Study||62
246661|NCT01056913|597566|P1|STARTED|Overall Study||62
246662|NCT01056822|597572|P2|NOT COMPLETED|Overall Study||7
246663|NCT01056822|597573|P1|NOT COMPLETED|Overall Study||8
246664|NCT01056822|597572|P2|COMPLETED|Overall Study||35
246665|NCT01056822|597573|P1|COMPLETED|Overall Study||39
246666|NCT01056822|597572|P2|Safety (SAF) Population: NO|Overall Study||2
246667|NCT01056822|597573|P1|Safety (SAF) Population: NO|Overall Study||1
246668|NCT01056822|597572|P2|Safety (SAF) Population: YES|Overall Study||40
246669|NCT01056822|597573|P1|Safety (SAF) Population: YES|Overall Study||46
246670|NCT01056822|597572|P2|Per-protocol (PP) Population: NO|Overall Study||17
246671|NCT01056822|597573|P1|Per-protocol (PP) Population: NO|Overall Study||18
246672|NCT01056822|597572|P2|Per-protocol (PP) Population: YES|Overall Study||25
246673|NCT01056822|597573|P1|Per-protocol (PP) Population: YES|Overall Study||29
246674|NCT01056822|597572|P2|Intention-to-treat (ITT) Population: NO|Overall Study||4
246675|NCT01056822|597573|P1|Intention-to-treat (ITT) Population: NO|Overall Study||4
246676|NCT01056822|597572|P2|Intention-to-treat (ITT) Population: YES|Overall Study||38
246677|NCT01056822|597573|P1|Intention-to-treat (ITT) Population: YES|Overall Study||43
246678|NCT01056822|597572|P2|STARTED|Overall Study||42
246679|NCT01056822|597573|P1|STARTED|Overall Study||47
246680|NCT01056718|597622|P1|NOT COMPLETED|Overall Study||3
246681|NCT01056718|597622|P1|COMPLETED|Overall Study||50
246682|NCT01056718|597622|P1|STARTED|Overall Study||53
246683|NCT01056653|597655|P3|NOT COMPLETED|Overall Study||2
246684|NCT01056653|597656|P2|NOT COMPLETED|Overall Study||0
246685|NCT01056653|597657|P1|NOT COMPLETED|Overall Study||0
246686|NCT01056653|597655|P3|COMPLETED|Overall Study|2 were lost to follow-up because one mother left the country and one father was too busy.|42
246687|NCT01056653|597656|P2|COMPLETED|Overall Study||23
246688|NCT01056653|597657|P1|COMPLETED|Overall Study||46
246689|NCT01056653|597655|P3|STARTED|Overall Study||44
246690|NCT01056653|597656|P2|STARTED|Overall Study||23
246691|NCT01056653|597657|P1|STARTED|Overall Study||46
246692|NCT01056640|597673|P2|NOT COMPLETED|Overall Study||12
246693|NCT01056640|597674|P1|NOT COMPLETED|Overall Study||26
246694|NCT01056640|597673|P2|COMPLETED|Overall Study||91
246695|NCT01056640|597674|P1|COMPLETED|Overall Study||76
246696|NCT01056640|597673|P2|STARTED|Overall Study||103
246697|NCT01056640|597674|P1|STARTED|Overall Study||102
246698|NCT01056601|597680|P1|NOT COMPLETED|Overall Study||0
246699|NCT01056601|597680|P1|COMPLETED|Overall Study||7
246700|NCT01056601|597680|P1|STARTED|Overall Study||7
246701|NCT01056523|597686|P7|NOT COMPLETED|Overall Study||1
246702|NCT01056523|597687|P6|NOT COMPLETED|Overall Study||0
246703|NCT01056523|597688|P5|NOT COMPLETED|Overall Study||0
246704|NCT01056523|597689|P4|NOT COMPLETED|Overall Study||3
246705|NCT01056523|597690|P3|NOT COMPLETED|Overall Study||2
246706|NCT01056523|597691|P2|NOT COMPLETED|Overall Study||0
246707|NCT01056523|597692|P1|NOT COMPLETED|Overall Study||1
246708|NCT01056523|597686|P7|COMPLETED|Overall Study||4
246709|NCT01056523|597687|P6|COMPLETED|Overall Study||3
246710|NCT01056523|597688|P5|COMPLETED|Overall Study||3
246711|NCT01056523|597689|P4|COMPLETED|Overall Study||3
246712|NCT01056523|597690|P3|COMPLETED|Overall Study||3
246713|NCT01056523|597691|P2|COMPLETED|Overall Study||3
246714|NCT01056523|597692|P1|COMPLETED|Overall Study||3
246715|NCT01056523|597686|P7|STARTED|Overall Study||5
246716|NCT01056523|597687|P6|STARTED|Overall Study||3
246717|NCT01056523|597688|P5|STARTED|Overall Study||3
246718|NCT01056523|597689|P4|STARTED|Overall Study||6
246719|NCT01056523|597690|P3|STARTED|Overall Study||5
246720|NCT01056523|597691|P2|STARTED|Overall Study||3
246721|NCT01056523|597692|P1|STARTED|Overall Study||4
246722|NCT01056510|597702|P2|NOT COMPLETED|Overall Study||64
246723|NCT01056510|597703|P1|NOT COMPLETED|Overall Study||54
246724|NCT01056510|597702|P2|COMPLETED|Overall Study||115
246725|NCT01056510|597703|P1|COMPLETED|Overall Study||124
246726|NCT01056510|597702|P2|STARTED|Overall Study||179
246727|NCT01056510|597703|P1|STARTED|Overall Study||178
246728|NCT01056484|597749|P2|NOT COMPLETED|Follow up - Non-randomized||2
246729|NCT01056484|597750|P1|NOT COMPLETED|Follow up - Non-randomized||0
246730|NCT01056484|597749|P2|COMPLETED|Follow up - Non-randomized||56
246731|NCT01056484|597750|P1|COMPLETED|Follow up - Non-randomized||57
246732|NCT01056484|597749|P2|STARTED|Follow up - Non-randomized|Out of the enrolled control subjects (N=59), 58 completed Period 1 and entered into Period 2.|58
246733|NCT01056484|597750|P1|STARTED|Follow up - Non-randomized|Out of the enrolled experimental subjects (N=64), 57 completed Period 1 and entered into Period 2.|57
246734|NCT01056484|597749|P2|NOT COMPLETED|Randomized Controlled Trial||1
246735|NCT01056484|597750|P1|NOT COMPLETED|Randomized Controlled Trial||7
246736|NCT01056484|597749|P2|COMPLETED|Randomized Controlled Trial||58
246737|NCT01056484|597750|P1|COMPLETED|Randomized Controlled Trial||57
246738|NCT01056484|597749|P2|STARTED|Randomized Controlled Trial||59
246739|NCT01056484|597750|P1|STARTED|Randomized Controlled Trial||64
246740|NCT01056380|597766|P2|NOT COMPLETED|Overall Study||3
246741|NCT01056380|597767|P1|NOT COMPLETED|Overall Study||2
246742|NCT01056380|597766|P2|COMPLETED|Overall Study||39
246743|NCT01056380|597767|P1|COMPLETED|Overall Study||35
246744|NCT01056380|597766|P2|STARTED|Overall Study||42
246745|NCT01056380|597767|P1|STARTED|Overall Study||37
246746|NCT01056341|597794|P5|NOT COMPLETED|Overall Study||14
246747|NCT01056341|597795|P4|NOT COMPLETED|Overall Study||36
246748|NCT01056341|597796|P3|NOT COMPLETED|Overall Study||15
246749|NCT01056341|597797|P2|NOT COMPLETED|Overall Study||36
246750|NCT01056341|597798|P1|NOT COMPLETED|Overall Study||36
246751|NCT01056341|597794|P5|COMPLETED|Overall Study||88
246752|NCT01056341|597795|P4|COMPLETED|Overall Study||65
246753|NCT01056341|597796|P3|COMPLETED|Overall Study||88
246754|NCT01056341|597797|P2|COMPLETED|Overall Study||63
246755|NCT01056341|597798|P1|COMPLETED|Overall Study||19
246756|NCT01056341|597794|P5|Interim Analysis|Overall Study||43
246757|NCT01056341|597795|P4|Interim Analysis|Overall Study||40
246758|NCT01056341|597796|P3|Interim Analysis|Overall Study||41
246759|NCT01056341|597797|P2|Interim Analysis|Overall Study||41
246760|NCT01056341|597798|P1|Interim Analysis|Overall Study||25
246761|NCT01056341|597794|P5|STARTED|Overall Study||102
246762|NCT01056341|597795|P4|STARTED|Overall Study||101
246763|NCT01056341|597796|P3|STARTED|Overall Study||103
246764|NCT01056341|597797|P2|STARTED|Overall Study||99
246765|NCT01056341|597798|P1|STARTED|Overall Study||55
246766|NCT01056328|597819|P2|NOT COMPLETED|Overall Study||16
246767|NCT01056328|597820|P1|NOT COMPLETED|Overall Study||17
246768|NCT01056328|597819|P2|COMPLETED|Overall Study||144
246769|NCT01056328|597820|P1|COMPLETED|Overall Study||147
246770|NCT01056328|597819|P2|STARTED|Overall Study||160
246771|NCT01056328|597820|P1|STARTED|Overall Study||164
246772|NCT01056315|597836|P2|NOT COMPLETED|Overall Study||11
246773|NCT01056315|597837|P1|NOT COMPLETED|Overall Study||14
246774|NCT01056315|597836|P2|COMPLETED|Overall Study||12
246775|NCT01056315|597837|P1|COMPLETED|Overall Study||13
246776|NCT01056315|597836|P2|STARTED|Overall Study||23
246777|NCT01056315|597837|P1|STARTED|Overall Study||27
246778|NCT01056289|597871|P4|NOT COMPLETED|Double-blind Phase||10
246779|NCT01056289|597872|P3|NOT COMPLETED|Double-blind Phase||13
246780|NCT01056289|597873|P2|NOT COMPLETED|Double-blind Phase||4
246781|NCT01056289|597874|P1|NOT COMPLETED|Double-blind Phase||0
246782|NCT01056289|597871|P4|COMPLETED|Double-blind Phase||138
246783|NCT01056289|597872|P3|COMPLETED|Double-blind Phase||127
246784|NCT01056289|597873|P2|COMPLETED|Double-blind Phase||69
246785|NCT01056289|597874|P1|COMPLETED|Double-blind Phase||0
246786|NCT01056289|597871|P4|STARTED|Double-blind Phase||148
246787|NCT01056289|597872|P3|STARTED|Double-blind Phase||140
246788|NCT01056289|597873|P2|STARTED|Double-blind Phase||73
246789|NCT01056289|597874|P1|STARTED|Double-blind Phase||0
246790|NCT01056289|597871|P4|NOT COMPLETED|Open-label Phase||0
246791|NCT01056289|597872|P3|NOT COMPLETED|Open-label Phase||0
246792|NCT01056289|597873|P2|NOT COMPLETED|Open-label Phase||0
246793|NCT01056289|597874|P1|NOT COMPLETED|Open-label Phase||119
246794|NCT01056289|597871|P4|COMPLETED|Open-label Phase||0
246795|NCT01056289|597872|P3|COMPLETED|Open-label Phase||0
246796|NCT01056289|597873|P2|COMPLETED|Open-label Phase||0
246797|NCT01056289|597874|P1|COMPLETED|Open-label Phase|Participants transitioned to Double-blind phase|361
246798|NCT01056289|597871|P4|STARTED|Open-label Phase||0
246799|NCT01056289|597872|P3|STARTED|Open-label Phase||0
246800|NCT01056289|597873|P2|STARTED|Open-label Phase||0
246801|NCT01056289|597874|P1|STARTED|Open-label Phase||480
246802|NCT01056276|597891|P2|NOT COMPLETED|Maintenance Therapy||28
246803|NCT01056276|597892|P1|NOT COMPLETED|Maintenance Therapy||0
246804|NCT01056276|597891|P2|COMPLETED|Maintenance Therapy|14 patients are continuing maintenance therapy.|0
246805|NCT01056276|597892|P1|COMPLETED|Maintenance Therapy||0
246890|NCT01055769|598027|P1|STARTED|First Intervention||10
246806|NCT01056276|597891|P2|STARTED|Maintenance Therapy|5 patients completed 8 cycles but did not have maintenance therapy.|28
246807|NCT01056276|597892|P1|STARTED|Maintenance Therapy|Original regimen did not include maintenance therapy.|0
246808|NCT01056276|597891|P2|NOT COMPLETED|Treatment Period-Cycles 1-8||8
246809|NCT01056276|597892|P1|NOT COMPLETED|Treatment Period-Cycles 1-8||13
246810|NCT01056276|597891|P2|COMPLETED|Treatment Period-Cycles 1-8||33
246811|NCT01056276|597892|P1|COMPLETED|Treatment Period-Cycles 1-8||5
246812|NCT01056276|597891|P2|STARTED|Treatment Period-Cycles 1-8||41
246813|NCT01056276|597892|P1|STARTED|Treatment Period-Cycles 1-8||18
246814|NCT01056263|597906|P1|NOT COMPLETED|Overall Study||52
246815|NCT01056263|597906|P1|COMPLETED|Overall Study||0
246816|NCT01056263|597906|P1|STARTED|Overall Study||52
246817|NCT01056198|597912|P2|NOT COMPLETED|Overall Study||0
246818|NCT01056198|597913|P1|NOT COMPLETED|Overall Study||0
246819|NCT01056198|597912|P2|COMPLETED|Overall Study||24
246820|NCT01056198|597913|P1|COMPLETED|Overall Study||24
246821|NCT01056198|597912|P2|STARTED|Overall Study||24
246822|NCT01056198|597913|P1|STARTED|Overall Study||24
246823|NCT01056107|597929|P4|NOT COMPLETED|Overall Study||0
246824|NCT01056107|597930|P3|NOT COMPLETED|Overall Study||3
246825|NCT01056107|597931|P2|NOT COMPLETED|Overall Study||1
246826|NCT01056107|597932|P1|NOT COMPLETED|Overall Study||0
246827|NCT01056107|597929|P4|COMPLETED|Overall Study||12
246828|NCT01056107|597930|P3|COMPLETED|Overall Study||9
246829|NCT01056107|597931|P2|COMPLETED|Overall Study||10
246830|NCT01056107|597932|P1|COMPLETED|Overall Study||11
246831|NCT01056107|597929|P4|STARTED|Overall Study||12
246832|NCT01056107|597930|P3|STARTED|Overall Study||12
246833|NCT01056107|597931|P2|STARTED|Overall Study||11
246834|NCT01056107|597932|P1|STARTED|Overall Study||11
246835|NCT01056016|597980|P2|NOT COMPLETED|Overall Study||1
246836|NCT01056016|597981|P1|NOT COMPLETED|Overall Study||2
246837|NCT01056016|597980|P2|COMPLETED|Overall Study||26
246838|NCT01056016|597981|P1|COMPLETED|Overall Study||20
246839|NCT01056016|597980|P2|STARTED|Overall Study|27 pediatricians were at 4 practices; practices were unit of randomization|27
246840|NCT01056016|597981|P1|STARTED|Overall Study|22 pediatricians were at 4 practices; practices were unit of randomization|22
246841|NCT01055886|597989|P2|NOT COMPLETED|Overall Study||11
246842|NCT01055886|597990|P1|NOT COMPLETED|Overall Study||5
246843|NCT01055886|597989|P2|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|21
246844|NCT01055886|597990|P1|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|28
246845|NCT01055886|597989|P2|Reached Pre-quit Period|Overall Study|1 lost to contact|31
246846|NCT01055886|597990|P1|Reached Pre-quit Period|Overall Study|2 withdrawals, 1 lost to contact|30
246847|NCT01055886|597989|P2|STARTED|Overall Study||32
246848|NCT01055886|597990|P1|STARTED|Overall Study||33
246849|NCT01055834|598002|P2|NOT COMPLETED|Treatment Period III||0
246850|NCT01055834|598003|P1|NOT COMPLETED|Treatment Period III||0
246851|NCT01055834|598002|P2|COMPLETED|Treatment Period III||14
246852|NCT01055834|598003|P1|COMPLETED|Treatment Period III||0
246853|NCT01055834|598002|P2|STARTED|Treatment Period III|14 of 21 participants in Group B who were treated in Period II participated in Period III.|14
246854|NCT01055834|598003|P1|STARTED|Treatment Period III|Participants from Group A did not continue into Period III.|0
246855|NCT01055834|598002|P2|NOT COMPLETED|Treatment Period II||0
246856|NCT01055834|598003|P1|NOT COMPLETED|Treatment Period II||0
246857|NCT01055834|598002|P2|COMPLETED|Treatment Period II||21
246858|NCT01055834|598003|P1|COMPLETED|Treatment Period II||20
246859|NCT01055834|598002|P2|STARTED|Treatment Period II||21
246860|NCT01055834|598003|P1|STARTED|Treatment Period II||20
246861|NCT01055834|598002|P2|NOT COMPLETED|Treatment Period I||0
246862|NCT01055834|598003|P1|NOT COMPLETED|Treatment Period I||1
246863|NCT01055834|598002|P2|COMPLETED|Treatment Period I||21
246864|NCT01055834|598003|P1|COMPLETED|Treatment Period I||20
246865|NCT01055834|598002|P2|STARTED|Treatment Period I||21
246866|NCT01055834|598003|P1|STARTED|Treatment Period I||21
246867|NCT01055782|598017|P2|NOT COMPLETED|Overall Study||0
246868|NCT01055782|598018|P1|NOT COMPLETED|Overall Study||0
246869|NCT01055782|598017|P2|COMPLETED|Overall Study||449
246870|NCT01055782|598018|P1|COMPLETED|Overall Study||555
246871|NCT01055782|598017|P2|STARTED|Overall Study||449
246872|NCT01055782|598018|P1|STARTED|Overall Study||555
246873|NCT01055769|598026|P2|NOT COMPLETED|Second Intervention||0
246874|NCT01055769|598027|P1|NOT COMPLETED|Second Intervention||0
246875|NCT01055769|598026|P2|COMPLETED|Second Intervention||10
246876|NCT01055769|598027|P1|COMPLETED|Second Intervention||10
246877|NCT01055769|598026|P2|STARTED|Second Intervention||10
246878|NCT01055769|598027|P1|STARTED|Second Intervention||10
246879|NCT01055769|598026|P2|NOT COMPLETED|Washout Period of Atleast 4 Days||0
246880|NCT01055769|598027|P1|NOT COMPLETED|Washout Period of Atleast 4 Days||0
246881|NCT01055769|598026|P2|COMPLETED|Washout Period of Atleast 4 Days||10
246882|NCT01055769|598027|P1|COMPLETED|Washout Period of Atleast 4 Days||10
246883|NCT01055769|598026|P2|STARTED|Washout Period of Atleast 4 Days||10
246884|NCT01055769|598027|P1|STARTED|Washout Period of Atleast 4 Days||10
246885|NCT01055769|598026|P2|NOT COMPLETED|First Intervention||0
246886|NCT01055769|598027|P1|NOT COMPLETED|First Intervention||0
246887|NCT01055769|598026|P2|COMPLETED|First Intervention||10
246888|NCT01055769|598027|P1|COMPLETED|First Intervention||10
246889|NCT01055769|598026|P2|STARTED|First Intervention||10
246891|NCT01055704|598045|P4|NOT COMPLETED|Overall Study||0
246892|NCT01055704|598046|P3|NOT COMPLETED|Overall Study||0
246893|NCT01055704|598047|P2|NOT COMPLETED|Overall Study||0
246894|NCT01055704|598048|P1|NOT COMPLETED|Overall Study||0
246895|NCT01055704|598045|P4|COMPLETED|Overall Study||8
246896|NCT01055704|598046|P3|COMPLETED|Overall Study||16
246897|NCT01055704|598047|P2|COMPLETED|Overall Study||8
246898|NCT01055704|598048|P1|COMPLETED|Overall Study||16
246899|NCT01055704|598045|P4|STARTED|Overall Study||8
246900|NCT01055704|598046|P3|STARTED|Overall Study||16
246901|NCT01055704|598047|P2|STARTED|Overall Study||8
246902|NCT01055704|598048|P1|STARTED|Overall Study||16
246903|NCT01055639|598088|P2|NOT COMPLETED|Overall Study||29
246904|NCT01055639|598089|P1|NOT COMPLETED|Overall Study||21
246905|NCT01055639|598088|P2|COMPLETED|Overall Study||31
246906|NCT01055639|598089|P1|COMPLETED|Overall Study||45
246907|NCT01055639|598088|P2|STARTED|Overall Study||60
246908|NCT01055639|598089|P1|STARTED|Overall Study||66
246909|NCT01055613|598113|P2|NOT COMPLETED|Overall Study||4
246910|NCT01055613|598114|P1|NOT COMPLETED|Overall Study||9
246911|NCT01055613|598113|P2|COMPLETED|Overall Study||96
246912|NCT01055613|598114|P1|COMPLETED|Overall Study||191
246913|NCT01055613|598113|P2|STARTED|Overall Study||100
246914|NCT01055613|598114|P1|STARTED|Overall Study||200
246915|NCT01055496|598124|P2|NOT COMPLETED|Overall Study||30
246916|NCT01055496|598125|P1|NOT COMPLETED|Overall Study||15
246917|NCT01055496|598124|P2|COMPLETED|Overall Study||25
246918|NCT01055496|598125|P1|COMPLETED|Overall Study||33
246919|NCT01055496|598124|P2|STARTED|Overall Study||55
246920|NCT01055496|598125|P1|STARTED|Overall Study||48
246921|NCT01055457|598182|P10|NOT COMPLETED|Overall Study||1
246922|NCT01055457|598183|P9|NOT COMPLETED|Overall Study||0
246923|NCT01055457|598184|P8|NOT COMPLETED|Overall Study||1
246924|NCT01055457|598185|P7|NOT COMPLETED|Overall Study||1
246925|NCT01055457|598186|P6|NOT COMPLETED|Overall Study||3
246926|NCT01055457|598187|P5|NOT COMPLETED|Overall Study||3
246927|NCT01055457|598188|P4|NOT COMPLETED|Overall Study||3
246928|NCT01055457|598189|P3|NOT COMPLETED|Overall Study||2
246929|NCT01055457|598190|P2|NOT COMPLETED|Overall Study||1
246930|NCT01055457|598191|P1|NOT COMPLETED|Overall Study||1
246931|NCT01055457|598182|P10|COMPLETED|Overall Study||19
246932|NCT01055457|598183|P9|COMPLETED|Overall Study||20
246933|NCT01055457|598184|P8|COMPLETED|Overall Study||18
246934|NCT01055457|598185|P7|COMPLETED|Overall Study||18
246935|NCT01055457|598186|P6|COMPLETED|Overall Study||15
246936|NCT01055457|598187|P5|COMPLETED|Overall Study||38
246937|NCT01055457|598188|P4|COMPLETED|Overall Study||37
246938|NCT01055457|598189|P3|COMPLETED|Overall Study||36
246939|NCT01055457|598190|P2|COMPLETED|Overall Study||39
246940|NCT01055457|598191|P1|COMPLETED|Overall Study||39
246941|NCT01055457|598182|P10|STARTED|Overall Study||20
246942|NCT01055457|598183|P9|STARTED|Overall Study||20
246943|NCT01055457|598184|P8|STARTED|Overall Study||19
246944|NCT01055457|598185|P7|STARTED|Overall Study||19
246945|NCT01055457|598186|P6|STARTED|Overall Study||18
246946|NCT01055457|598187|P5|STARTED|Overall Study||41
246947|NCT01055457|598188|P4|STARTED|Overall Study||40
246948|NCT01055457|598189|P3|STARTED|Overall Study||38
246949|NCT01055457|598190|P2|STARTED|Overall Study||40
246950|NCT01055457|598191|P1|STARTED|Overall Study||40
246951|NCT01055314|598225|P2|NOT COMPLETED|Overall Study||38
246952|NCT01055314|598226|P1|NOT COMPLETED|Overall Study||45
246953|NCT01055314|598225|P2|COMPLETED|Overall Study||37
246954|NCT01055314|598226|P1|COMPLETED|Overall Study||55
246955|NCT01055314|598225|P2|STARTED|Overall Study||75
246956|NCT01055314|598226|P1|STARTED|Overall Study||100
246957|NCT01055262|598238|P1|NOT COMPLETED|Overall Study||9
246958|NCT01055262|598238|P1|COMPLETED|Overall Study||160
246959|NCT01055262|598238|P1|STARTED|Overall Study||169
246960|NCT01055223|598249|P1|NOT COMPLETED|Overall Study||0
246961|NCT01055223|598249|P1|COMPLETED|Overall Study||98483
246962|NCT01055223|598249|P1|STARTED|Overall Study||98483
246963|NCT01055197|598279|P2|NOT COMPLETED|Overall Study||2
246964|NCT01055197|598280|P1|NOT COMPLETED|Overall Study||9
246965|NCT01055197|598279|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
246966|NCT01055197|598280|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|42
246967|NCT01055197|598279|P2|STARTED|Overall Study||46
246968|NCT01055197|598280|P1|STARTED|Overall Study||51
246969|NCT01055184|598294|P1|NOT COMPLETED|Overall Study||0
246970|NCT01055184|598294|P1|COMPLETED|Overall Study||34
246971|NCT01055184|598294|P1|STARTED|Overall Study||34
246972|NCT01055171|598300|P2|NOT COMPLETED|Overall Study||7
246973|NCT01055171|598301|P1|NOT COMPLETED|Overall Study||11
246974|NCT01055171|598300|P2|COMPLETED|Overall Study|Received the sugar pill and completed all visits including the one-week follow-up.|21
246975|NCT01055171|598301|P1|COMPLETED|Overall Study|Received the medication and completed all visits including the one-week follow-up.|18
246976|NCT01055171|598300|P2|Test Procedure Completion|Overall Study|Received the placebo and completed the first test session.|23
246977|NCT01055171|598301|P1|Test Procedure Completion|Overall Study|Received the medication and completed the first test session.|21
246978|NCT01055171|598300|P2|Retrieval Completion|Overall Study|Received the sugar pill and completed the retrieval session.|24
246979|NCT01055171|598301|P1|Retrieval Completion|Overall Study|Received the medication and completed the retrieval session.|25
246980|NCT01055171|598300|P2|STARTED|Overall Study|Randomized to receive placebo.|28
246981|NCT01055171|598301|P1|STARTED|Overall Study|Randomized to receive medication.|29
246982|NCT01055132|598315|P2|NOT COMPLETED|Period 2 (5-9 Days)||1
246983|NCT01055132|598316|P1|NOT COMPLETED|Period 2 (5-9 Days)||0
246984|NCT01055132|598315|P2|COMPLETED|Period 2 (5-9 Days)||32
246985|NCT01055132|598316|P1|COMPLETED|Period 2 (5-9 Days)||35
246986|NCT01055132|598315|P2|STARTED|Period 2 (5-9 Days)||33
246987|NCT01055132|598316|P1|STARTED|Period 2 (5-9 Days)||35
246988|NCT01055132|598315|P2|NOT COMPLETED|Period 1 (5-9 Days)||0
246989|NCT01055132|598316|P1|NOT COMPLETED|Period 1 (5-9 Days)||1
246990|NCT01055132|598315|P2|COMPLETED|Period 1 (5-9 Days)||33
246991|NCT01055132|598316|P1|COMPLETED|Period 1 (5-9 Days)||35
246992|NCT01055132|598315|P2|STARTED|Period 1 (5-9 Days)||33
246993|NCT01055132|598316|P1|STARTED|Period 1 (5-9 Days)||36
246994|NCT01055028|598329|P2|NOT COMPLETED|Treatment Cycles 4 to 6||0
246995|NCT01055028|598330|P1|NOT COMPLETED|Treatment Cycles 4 to 6||0
246996|NCT01055028|598329|P2|COMPLETED|Treatment Cycles 4 to 6||2
246997|NCT01055028|598330|P1|COMPLETED|Treatment Cycles 4 to 6||6
246998|NCT01055028|598329|P2|STARTED|Treatment Cycles 4 to 6||2
246999|NCT01055028|598330|P1|STARTED|Treatment Cycles 4 to 6||6
247000|NCT01055028|598329|P2|NOT COMPLETED|Inter-treatment Period||3
247001|NCT01055028|598330|P1|NOT COMPLETED|Inter-treatment Period||0
247002|NCT01055028|598329|P2|COMPLETED|Inter-treatment Period||2
247003|NCT01055028|598330|P1|COMPLETED|Inter-treatment Period||6
247004|NCT01055028|598329|P2|STARTED|Inter-treatment Period||5
247005|NCT01055028|598330|P1|STARTED|Inter-treatment Period||6
247006|NCT01055028|598329|P2|NOT COMPLETED|Treatment Cycles 1 to 3||3
247007|NCT01055028|598330|P1|NOT COMPLETED|Treatment Cycles 1 to 3||2
247008|NCT01055028|598329|P2|COMPLETED|Treatment Cycles 1 to 3||5
247009|NCT01055028|598330|P1|COMPLETED|Treatment Cycles 1 to 3||6
247010|NCT01055028|598329|P2|STARTED|Treatment Cycles 1 to 3||8
247011|NCT01055028|598330|P1|STARTED|Treatment Cycles 1 to 3||8
247012|NCT01055028|598329|P2|NOT COMPLETED|Screening||1
247013|NCT01055028|598330|P1|NOT COMPLETED|Screening||1
247014|NCT01055028|598329|P2|COMPLETED|Screening||8
247015|NCT01055028|598330|P1|COMPLETED|Screening||8
247016|NCT01055028|598329|P2|STARTED|Screening||9
247017|NCT01055028|598330|P1|STARTED|Screening||9
247018|NCT01054976|598344|P1|NOT COMPLETED|Overall Study||35
247019|NCT01054976|598344|P1|COMPLETED|Overall Study||57
247020|NCT01054976|598344|P1|STARTED|Overall Study||92
247021|NCT01054911|598352|P1|NOT COMPLETED|Overall Study||0
247022|NCT01054911|598352|P1|COMPLETED|Overall Study||5
247023|NCT01054911|598352|P1|STARTED|Overall Study||5
247024|NCT01054885|598365|P7|NOT COMPLETED|24-week, Double-blind Treatment Period||47
247025|NCT01054885|598366|P6|NOT COMPLETED|24-week, Double-blind Treatment Period||60
247026|NCT01054885|598367|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||42
247027|NCT01054885|598368|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||43
247028|NCT01054885|598369|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||49
247029|NCT01054885|598370|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||59
247030|NCT01054885|598371|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
247031|NCT01054885|598365|P7|COMPLETED|24-week, Double-blind Treatment Period||158
247032|NCT01054885|598366|P6|COMPLETED|24-week, Double-blind Treatment Period||144
247033|NCT01054885|598367|P5|COMPLETED|24-week, Double-blind Treatment Period||161
247034|NCT01054885|598368|P4|COMPLETED|24-week, Double-blind Treatment Period||160
247035|NCT01054885|598369|P3|COMPLETED|24-week, Double-blind Treatment Period||155
247036|NCT01054885|598370|P2|COMPLETED|24-week, Double-blind Treatment Period||146
247037|NCT01054885|598371|P1|COMPLETED|24-week, Double-blind Treatment Period||0
247038|NCT01054885|598365|P7|STARTED|24-week, Double-blind Treatment Period||205
247039|NCT01054885|598366|P6|STARTED|24-week, Double-blind Treatment Period||204
247040|NCT01054885|598367|P5|STARTED|24-week, Double-blind Treatment Period||203
247041|NCT01054885|598368|P4|STARTED|24-week, Double-blind Treatment Period||203
247042|NCT01054885|598369|P3|STARTED|24-week, Double-blind Treatment Period||204
247043|NCT01054885|598370|P2|STARTED|24-week, Double-blind Treatment Period||205
247044|NCT01054885|598371|P1|STARTED|24-week, Double-blind Treatment Period||0
247045|NCT01054885|598365|P7|NOT COMPLETED|2-week, Single-blind Run-In Period||0
247046|NCT01054885|598366|P6|NOT COMPLETED|2-week, Single-blind Run-In Period||0
247047|NCT01054885|598367|P5|NOT COMPLETED|2-week, Single-blind Run-In Period||0
247048|NCT01054885|598368|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
247049|NCT01054885|598369|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
247050|NCT01054885|598370|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
247051|NCT01054885|598371|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||351
247052|NCT01054885|598365|P7|COMPLETED|2-week, Single-blind Run-In Period||0
247053|NCT01054885|598366|P6|COMPLETED|2-week, Single-blind Run-In Period||0
247054|NCT01054885|598367|P5|COMPLETED|2-week, Single-blind Run-In Period||0
247055|NCT01054885|598368|P4|COMPLETED|2-week, Single-blind Run-In Period||0
247056|NCT01054885|598369|P3|COMPLETED|2-week, Single-blind Run-In Period||0
247057|NCT01054885|598370|P2|COMPLETED|2-week, Single-blind Run-In Period||0
247058|NCT01054885|598371|P1|COMPLETED|2-week, Single-blind Run-In Period||1226
247059|NCT01054885|598365|P7|STARTED|2-week, Single-blind Run-In Period||0
247060|NCT01054885|598366|P6|STARTED|2-week, Single-blind Run-In Period||0
247061|NCT01054885|598367|P5|STARTED|2-week, Single-blind Run-In Period||0
247062|NCT01054885|598368|P4|STARTED|2-week, Single-blind Run-In Period||0
247063|NCT01054885|598369|P3|STARTED|2-week, Single-blind Run-In Period||0
247064|NCT01054885|598370|P2|STARTED|2-week, Single-blind Run-In Period||0
247065|NCT01054885|598371|P1|STARTED|2-week, Single-blind Run-In Period||1577
247066|NCT01054846|598411|P2|NOT COMPLETED|Overall Study||17
247067|NCT01054846|598412|P1|NOT COMPLETED|Overall Study||76
247068|NCT01054846|598411|P2|COMPLETED|Overall Study||51
247069|NCT01054846|598412|P1|COMPLETED|Overall Study||246
247070|NCT01054846|598411|P2|STARTED|Overall Study||68
247071|NCT01054846|598412|P1|STARTED|Overall Study||322
247072|NCT01054820|598419|P1|NOT COMPLETED|Overall Study||2
247073|NCT01054820|598419|P1|COMPLETED|Overall Study||121
247074|NCT01054820|598419|P1|STARTED|Overall Study||123
247075|NCT01054742|598433|P1|NOT COMPLETED|Overall Study||0
247076|NCT01054742|598433|P1|COMPLETED|Overall Study||2
247077|NCT01054742|598433|P1|STARTED|Overall Study||2
247078|NCT01054729|598441|P4|NOT COMPLETED|Overall Study||3
247079|NCT01054729|598442|P3|NOT COMPLETED|Overall Study||6
247080|NCT01054729|598443|P2|NOT COMPLETED|Overall Study||5
247081|NCT01054729|598444|P1|NOT COMPLETED|Overall Study||4
247082|NCT01054729|598441|P4|COMPLETED|Overall Study||11
247083|NCT01054729|598442|P3|COMPLETED|Overall Study||9
247084|NCT01054729|598443|P2|COMPLETED|Overall Study||14
247085|NCT01054729|598444|P1|COMPLETED|Overall Study||12
247086|NCT01054729|598441|P4|Randomized and Treated|Overall Study||14
247087|NCT01054729|598442|P3|Randomized and Treated|Overall Study||15
247088|NCT01054729|598443|P2|Randomized and Treated|Overall Study||18
247089|NCT01054729|598444|P1|Randomized and Treated|Overall Study||16
247090|NCT01054729|598441|P4|STARTED|Overall Study||14
247091|NCT01054729|598442|P3|STARTED|Overall Study||15
247092|NCT01054729|598443|P2|STARTED|Overall Study||19
247093|NCT01054729|598444|P1|STARTED|Overall Study||16
247094|NCT01054703|598505|P1|NOT COMPLETED|Overall Study||0
247095|NCT01054703|598505|P1|COMPLETED|Overall Study||14
247096|NCT01054703|598505|P1|STARTED|Overall Study||14
247097|NCT01054625|598512|P3|NOT COMPLETED|Overall Study||1
247098|NCT01054625|598513|P2|NOT COMPLETED|Overall Study||3
247099|NCT01054625|598514|P1|NOT COMPLETED|Overall Study||2
247100|NCT01054625|598512|P3|COMPLETED|Overall Study||9
247101|NCT01054625|598513|P2|COMPLETED|Overall Study||9
247102|NCT01054625|598514|P1|COMPLETED|Overall Study||6
247103|NCT01054625|598512|P3|STARTED|Overall Study||10
247104|NCT01054625|598513|P2|STARTED|Overall Study||12
247105|NCT01054625|598514|P1|STARTED|Overall Study|A total of 31 patients were enrolled, 1 patient died before receiving any zalutumumab|8
247106|NCT01054599|598542|P2|NOT COMPLETED|Overall Study||7
247107|NCT01054599|598543|P1|NOT COMPLETED|Overall Study||4
247108|NCT01054599|598542|P2|COMPLETED|Overall Study||9
247109|NCT01054599|598543|P1|COMPLETED|Overall Study||9
247110|NCT01054599|598542|P2|STARTED|Overall Study||16
247111|NCT01054599|598543|P1|STARTED|Overall Study||13
247112|NCT01054586|598555|P4|NOT COMPLETED|Overall Study||0
247113|NCT01054586|598556|P3|NOT COMPLETED|Overall Study||0
247114|NCT01054586|598557|P2|NOT COMPLETED|Overall Study||0
247115|NCT01054586|598558|P1|NOT COMPLETED|Overall Study||0
247116|NCT01054586|598555|P4|COMPLETED|Overall Study||101
247117|NCT01054586|598556|P3|COMPLETED|Overall Study||8
247118|NCT01054586|598557|P2|COMPLETED|Overall Study||15
247119|NCT01054586|598558|P1|COMPLETED|Overall Study||43
247120|NCT01054586|598555|P4|STARTED|Overall Study||101
247121|NCT01054586|598556|P3|STARTED|Overall Study||8
247122|NCT01054586|598557|P2|STARTED|Overall Study||15
247123|NCT01054586|598558|P1|STARTED|Overall Study||43
247124|NCT01054573|598650|P4|NOT COMPLETED|Overall Study||2
247125|NCT01054573|598651|P3|NOT COMPLETED|Overall Study||3
247126|NCT01054573|598652|P2|NOT COMPLETED|Overall Study||4
247127|NCT01054573|598653|P1|NOT COMPLETED|Overall Study||1
247128|NCT01054573|598650|P4|COMPLETED|Overall Study||25
247129|NCT01054573|598651|P3|COMPLETED|Overall Study||19
247130|NCT01054573|598652|P2|COMPLETED|Overall Study||28
247131|NCT01054573|598653|P1|COMPLETED|Overall Study||8
247132|NCT01054573|598650|P4|STARTED|Overall Study||27
247133|NCT01054573|598651|P3|STARTED|Overall Study||22
247134|NCT01054573|598652|P2|STARTED|Overall Study||32
247135|NCT01054573|598653|P1|STARTED|Overall Study||9
247136|NCT01054560|598699|P2|NOT COMPLETED|Overall Study||28
247137|NCT01054560|598700|P1|NOT COMPLETED|Overall Study||13
247138|NCT01054560|598699|P2|COMPLETED|Overall Study||27
247139|NCT01054560|598700|P1|COMPLETED|Overall Study||45
247140|NCT01054560|598699|P2|STARTED|Overall Study||55
247141|NCT01054560|598700|P1|STARTED|Overall Study||58
247142|NCT01054404|598724|P2|NOT COMPLETED|Overall Study||0
247143|NCT01054404|598725|P1|NOT COMPLETED|Overall Study||0
247144|NCT01054404|598724|P2|COMPLETED|Overall Study||13
247145|NCT01054404|598725|P1|COMPLETED|Overall Study||10
247146|NCT01054404|598724|P2|STARTED|Overall Study||13
247147|NCT01054404|598725|P1|STARTED|Overall Study||10
247148|NCT01054339|598734|P3|NOT COMPLETED|Overall Study||0
247149|NCT01054339|598735|P2|NOT COMPLETED|Overall Study||0
247150|NCT01054339|598736|P1|NOT COMPLETED|Overall Study||0
247151|NCT01054339|598734|P3|COMPLETED|Overall Study||3
247152|NCT01054339|598735|P2|COMPLETED|Overall Study||3
247153|NCT01054339|598736|P1|COMPLETED|Overall Study||3
247154|NCT01054339|598734|P3|STARTED|Overall Study||3
247155|NCT01054339|598735|P2|STARTED|Overall Study||3
247156|NCT01054339|598736|P1|STARTED|Overall Study||3
247157|NCT01054300|598752|P4|NOT COMPLETED|Period 2||0
247158|NCT01054300|598753|P3|NOT COMPLETED|Period 2||1
247159|NCT01054300|598754|P2|NOT COMPLETED|Period 2||0
247160|NCT01054300|598755|P1|NOT COMPLETED|Period 2||0
247161|NCT01054300|598752|P4|COMPLETED|Period 2||13
247162|NCT01054300|598753|P3|COMPLETED|Period 2||12
247163|NCT01054300|598754|P2|COMPLETED|Period 2||13
247164|NCT01054300|598755|P1|COMPLETED|Period 2||12
247165|NCT01054300|598752|P4|STARTED|Period 2||13
247166|NCT01054300|598753|P3|STARTED|Period 2||13
247167|NCT01054300|598754|P2|STARTED|Period 2||13
247168|NCT01054300|598755|P1|STARTED|Period 2||12
247169|NCT01054300|598752|P4|NOT COMPLETED|Period 1||0
247170|NCT01054300|598753|P3|NOT COMPLETED|Period 1||0
247171|NCT01054300|598754|P2|NOT COMPLETED|Period 1||0
247172|NCT01054300|598755|P1|NOT COMPLETED|Period 1||1
247173|NCT01054300|598752|P4|COMPLETED|Period 1||13
247174|NCT01054300|598753|P3|COMPLETED|Period 1||13
247175|NCT01054300|598754|P2|COMPLETED|Period 1||13
247176|NCT01054300|598755|P1|COMPLETED|Period 1|Discontinuation occurred prior to Period 2 dose.|12
247177|NCT01054300|598752|P4|STARTED|Period 1||13
247178|NCT01054300|598753|P3|STARTED|Period 1||13
247179|NCT01054300|598754|P2|STARTED|Period 1||13
247180|NCT01054300|598755|P1|STARTED|Period 1||13
247181|NCT01054222|598805|P1|NOT COMPLETED|Overall Study||11
247182|NCT01054222|598805|P1|COMPLETED|Overall Study||20
247183|NCT01054222|598805|P1|STARTED|Overall Study||31
247184|NCT01054209|598826|P2|NOT COMPLETED|Overall Study||0
247185|NCT01054209|598827|P1|NOT COMPLETED|Overall Study||0
247186|NCT01054209|598826|P2|COMPLETED|Overall Study||58
247187|NCT01054209|598827|P1|COMPLETED|Overall Study||58
247188|NCT01054209|598826|P2|STARTED|Overall Study||58
247189|NCT01054209|598827|P1|STARTED|Overall Study||58
247190|NCT01054183|598835|P2|NOT COMPLETED|Overall Study||0
247191|NCT01054183|598836|P1|NOT COMPLETED|Overall Study||0
247192|NCT01054183|598835|P2|COMPLETED|Overall Study||12
247193|NCT01054183|598836|P1|COMPLETED|Overall Study||10
247194|NCT01054183|598835|P2|STARTED|Overall Study||12
247195|NCT01054183|598836|P1|STARTED|Overall Study||10
247196|NCT01054170|598846|P2|NOT COMPLETED|Overall Study||6
247197|NCT01054170|598847|P1|NOT COMPLETED|Overall Study||4
247198|NCT01054170|598846|P2|COMPLETED|Overall Study||21
247199|NCT01054170|598847|P1|COMPLETED|Overall Study||21
247200|NCT01054170|598846|P2|STARTED|Overall Study||27
247201|NCT01054170|598847|P1|STARTED|Overall Study||25
247202|NCT01054079|598899|P1|NOT COMPLETED|Overall Study||0
247203|NCT01054079|598899|P1|COMPLETED|Overall Study|while all 20 patients received at least some of the intervention, some did not get proper PSA tests.|20
247204|NCT01054079|598899|P1|# Recieved Proper PSA Testing|Overall Study||10
247205|NCT01054079|598899|P1|STARTED|Overall Study||20
247206|NCT01053988|598912|P6|NOT COMPLETED|24-week, Double-blind Treatment Period||55
247207|NCT01053988|598913|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||59
247208|NCT01053988|598914|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||63
247209|NCT01053988|598915|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||61
247210|NCT01053988|598916|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||69
247211|NCT01053988|598917|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
247212|NCT01053988|598912|P6|COMPLETED|24-week, Double-blind Treatment Period||151
247213|NCT01053988|598913|P5|COMPLETED|24-week, Double-blind Treatment Period||147
247214|NCT01053988|598914|P4|COMPLETED|24-week, Double-blind Treatment Period||142
247215|NCT01053988|598915|P3|COMPLETED|24-week, Double-blind Treatment Period||145
247216|NCT01053988|598916|P2|COMPLETED|24-week, Double-blind Treatment Period||138
247217|NCT01053988|598917|P1|COMPLETED|24-week, Double-blind Treatment Period||0
247218|NCT01053988|598912|P6|STARTED|24-week, Double-blind Treatment Period||206
247219|NCT01053988|598913|P5|STARTED|24-week, Double-blind Treatment Period||206
247220|NCT01053988|598914|P4|STARTED|24-week, Double-blind Treatment Period||205
247221|NCT01053988|598915|P3|STARTED|24-week, Double-blind Treatment Period||206
247222|NCT01053988|598916|P2|STARTED|24-week, Double-blind Treatment Period||207
247223|NCT01053988|598917|P1|STARTED|24-week, Double-blind Treatment Period||0
247224|NCT01053988|598912|P6|NOT COMPLETED|2-week, Single-blind Run-In Period||0
247225|NCT01053988|598913|P5|NOT COMPLETED|2-week, Single-blind Run-In Period||0
247226|NCT01053988|598914|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
247227|NCT01053988|598915|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
247228|NCT01053988|598916|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
247229|NCT01053988|598917|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||360
247230|NCT01053988|598912|P6|COMPLETED|2-week, Single-blind Run-In Period||0
247231|NCT01053988|598913|P5|COMPLETED|2-week, Single-blind Run-In Period||0
247232|NCT01053988|598914|P4|COMPLETED|2-week, Single-blind Run-In Period||0
247233|NCT01053988|598915|P3|COMPLETED|2-week, Single-blind Run-In Period||0
247234|NCT01053988|598916|P2|COMPLETED|2-week, Single-blind Run-In Period||0
247235|NCT01053988|598917|P1|COMPLETED|2-week, Single-blind Run-In Period||1030
247236|NCT01053988|598912|P6|STARTED|2-week, Single-blind Run-In Period||0
247237|NCT01053988|598913|P5|STARTED|2-week, Single-blind Run-In Period||0
247238|NCT01053988|598914|P4|STARTED|2-week, Single-blind Run-In Period||0
247239|NCT01053988|598915|P3|STARTED|2-week, Single-blind Run-In Period||0
247240|NCT01053988|598916|P2|STARTED|2-week, Single-blind Run-In Period||0
247241|NCT01053988|598917|P1|STARTED|2-week, Single-blind Run-In Period||1390
247242|NCT01053897|598949|P1|NOT COMPLETED|Overall Study||0
247243|NCT01053897|598949|P1|COMPLETED|Overall Study||5
247244|NCT01053897|598949|P1|STARTED|Overall Study||5
247245|NCT01053819|598961|P1|NOT COMPLETED|Overall Study||0
247246|NCT01053819|598961|P1|COMPLETED|Overall Study||6
247247|NCT01053819|598961|P1|STARTED|Overall Study||6
247248|NCT01053741|598968|P2|NOT COMPLETED|2nd Study Intervention||1
247249|NCT01053741|598969|P1|NOT COMPLETED|2nd Study Intervention||0
247250|NCT01053741|598968|P2|COMPLETED|2nd Study Intervention||5
247251|NCT01053741|598969|P1|COMPLETED|2nd Study Intervention||5
247252|NCT01053741|598968|P2|STARTED|2nd Study Intervention||6
247253|NCT01053741|598969|P1|STARTED|2nd Study Intervention||5
247254|NCT01053741|598968|P2|NOT COMPLETED|14 Day Washout||0
247255|NCT01053741|598969|P1|NOT COMPLETED|14 Day Washout||0
247256|NCT01053741|598968|P2|COMPLETED|14 Day Washout||6
247257|NCT01053741|598969|P1|COMPLETED|14 Day Washout||5
247258|NCT01053741|598968|P2|STARTED|14 Day Washout||6
247259|NCT01053741|598969|P1|STARTED|14 Day Washout||5
247260|NCT01053741|598968|P2|NOT COMPLETED|1st Intervention||0
247261|NCT01053741|598969|P1|NOT COMPLETED|1st Intervention||0
247262|NCT01053741|598968|P2|COMPLETED|1st Intervention||6
247263|NCT01053741|598969|P1|COMPLETED|1st Intervention||5
247264|NCT01053741|598968|P2|STARTED|1st Intervention||6
247265|NCT01053741|598969|P1|STARTED|1st Intervention||5
247266|NCT01053663|598978|P1|NOT COMPLETED|Overall Study||6
247267|NCT01053663|598978|P1|COMPLETED|Overall Study||3
247268|NCT01053663|598978|P1|STARTED|Overall Study||9
247269|NCT01053507|599021|P2|NOT COMPLETED|Overall Study||1
247270|NCT01053507|599022|P1|NOT COMPLETED|Overall Study||3
247271|NCT01053507|599021|P2|COMPLETED|Overall Study||11
247272|NCT01053507|599022|P1|COMPLETED|Overall Study||8
247273|NCT01053507|599021|P2|STARTED|Overall Study||12
247274|NCT01053507|599022|P1|STARTED|Overall Study||11
247275|NCT01053429|599036|P1|NOT COMPLETED|Overall Study||373
247276|NCT01053429|599036|P1|COMPLETED|Overall Study||3018
247277|NCT01053429|599036|P1|STARTED|Overall Study||3391
247278|NCT01053312|599045|P1|NOT COMPLETED|Overall Study||0
247279|NCT01053312|599045|P1|COMPLETED|Overall Study||7
247280|NCT01053312|599045|P1|STARTED|Overall Study||7
247281|NCT01053247|599066|P3|NOT COMPLETED|Overall Study||28
247282|NCT01053247|599067|P2|NOT COMPLETED|Overall Study||19
247283|NCT01053247|599068|P1|NOT COMPLETED|Overall Study||20
247284|NCT01053247|599066|P3|COMPLETED|Overall Study||236
247285|NCT01053247|599067|P2|COMPLETED|Overall Study||241
247286|NCT01053247|599068|P1|COMPLETED|Overall Study||249
247287|NCT01053247|599066|P3|STARTED|Overall Study||264
247288|NCT01053247|599067|P2|STARTED|Overall Study||260
247289|NCT01053247|599068|P1|STARTED|Overall Study||269
247290|NCT01053221|599078|P2|NOT COMPLETED|Overall Study||9
247291|NCT01053221|599079|P1|NOT COMPLETED|Overall Study||5
247292|NCT01053221|599078|P2|COMPLETED|Overall Study||0
247293|NCT01053221|599079|P1|COMPLETED|Overall Study||0
247294|NCT01053221|599078|P2|STARTED|Overall Study||9
247295|NCT01053221|599079|P1|STARTED|Overall Study||5
247296|NCT01053156|599095|P2|NOT COMPLETED|Second Intervention (Week 13-24)||5
247297|NCT01053156|599096|P1|NOT COMPLETED|Second Intervention (Week 13-24)||2
247298|NCT01053156|599095|P2|COMPLETED|Second Intervention (Week 13-24)||22
247299|NCT01053156|599096|P1|COMPLETED|Second Intervention (Week 13-24)||26
247300|NCT01053156|599095|P2|STARTED|Second Intervention (Week 13-24)||27
247301|NCT01053156|599096|P1|STARTED|Second Intervention (Week 13-24)||28
247302|NCT01053156|599095|P2|NOT COMPLETED|First Intervention (Week 1-12)||6
247303|NCT01053156|599096|P1|NOT COMPLETED|First Intervention (Week 1-12)||5
247304|NCT01053156|599095|P2|COMPLETED|First Intervention (Week 1-12)||27
247305|NCT01053156|599096|P1|COMPLETED|First Intervention (Week 1-12)||28
247306|NCT01053156|599095|P2|STARTED|First Intervention (Week 1-12)||33
247307|NCT01053156|599096|P1|STARTED|First Intervention (Week 1-12)||33
247308|NCT01053078|599134|P2|NOT COMPLETED|Overall Study||3
247309|NCT01053078|599135|P1|NOT COMPLETED|Overall Study||4
247310|NCT01053078|599134|P2|COMPLETED|Overall Study||12
247311|NCT01053078|599135|P1|COMPLETED|Overall Study||10
247312|NCT01053078|599134|P2|STARTED|Overall Study||15
247313|NCT01053078|599135|P1|STARTED|Overall Study||14
247314|NCT01053000|599141|P2|NOT COMPLETED|Overall Study||0
247315|NCT01053000|599142|P1|NOT COMPLETED|Overall Study||0
247316|NCT01053000|599141|P2|COMPLETED|Overall Study||5
247317|NCT01053000|599142|P1|COMPLETED|Overall Study||5
247318|NCT01053000|599141|P2|STARTED|Overall Study||5
247319|NCT01053000|599142|P1|STARTED|Overall Study||5
247320|NCT01052948|599152|P4|NOT COMPLETED|Overall Study||0
247321|NCT01052948|599153|P3|NOT COMPLETED|Overall Study||0
247322|NCT01052948|599154|P2|NOT COMPLETED|Overall Study||0
247323|NCT01052948|599155|P1|NOT COMPLETED|Overall Study||0
247324|NCT01052948|599152|P4|COMPLETED|Overall Study||29311
247325|NCT01052948|599153|P3|COMPLETED|Overall Study||15147
247326|NCT01052948|599154|P2|COMPLETED|Overall Study||14669
247327|NCT01052948|599155|P1|COMPLETED|Overall Study||27812
247328|NCT01052948|599152|P4|STARTED|Overall Study||29311
247329|NCT01052948|599153|P3|STARTED|Overall Study||15147
247330|NCT01052948|599154|P2|STARTED|Overall Study||14669
247331|NCT01052948|599155|P1|STARTED|Overall Study||27812
247332|NCT01052844|599179|P2|NOT COMPLETED|Overall Study||1
247333|NCT01052844|599180|P1|NOT COMPLETED|Overall Study||0
247334|NCT01052844|599179|P2|COMPLETED|Overall Study||39
247335|NCT01052844|599180|P1|COMPLETED|Overall Study||40
247336|NCT01052844|599179|P2|STARTED|Overall Study||40
247337|NCT01052844|599180|P1|STARTED|Overall Study||40
247338|NCT01052831|599190|P2|NOT COMPLETED|Overall Study||1
247339|NCT01052831|599191|P1|NOT COMPLETED|Overall Study||4
247340|NCT01052831|599190|P2|COMPLETED|Overall Study||23
247341|NCT01052831|599191|P1|COMPLETED|Overall Study||22
247342|NCT01052831|599190|P2|STARTED|Overall Study||24
247343|NCT01052831|599191|P1|STARTED|Overall Study||26
247344|NCT01052779|599201|P2|NOT COMPLETED|Overall Study||9
247345|NCT01052779|599202|P1|NOT COMPLETED|Overall Study||5
247346|NCT01052779|599201|P2|COMPLETED|Overall Study||73
247347|NCT01052779|599202|P1|COMPLETED|Overall Study||75
247348|NCT01052779|599201|P2|Received at Least 1 Dose of Study Drug|Overall Study||81
247349|NCT01052779|599202|P1|Received at Least 1 Dose of Study Drug|Overall Study||80
247350|NCT01052779|599201|P2|STARTED|Overall Study||82
247351|NCT01052779|599202|P1|STARTED|Overall Study||80
247352|NCT01052714|599212|P3|NOT COMPLETED|Overall Study||2
247353|NCT01052714|599213|P2|NOT COMPLETED|Overall Study||29
247354|NCT01052714|599214|P1|NOT COMPLETED|Overall Study||25
247355|NCT01052714|599212|P3|COMPLETED|Overall Study||15
247356|NCT01052714|599213|P2|COMPLETED|Overall Study||33
247357|NCT01052714|599214|P1|COMPLETED|Overall Study||17
247358|NCT01052714|599212|P3|STARTED|Overall Study||17
247359|NCT01052714|599213|P2|STARTED|Overall Study||62
247360|NCT01052714|599214|P1|STARTED|Overall Study||42
247361|NCT01052701|599256|P2|NOT COMPLETED|Overall Study||0
247362|NCT01052701|599257|P1|NOT COMPLETED|Overall Study||0
247363|NCT01052701|599256|P2|COMPLETED|Overall Study||12
247364|NCT01052701|599257|P1|COMPLETED|Overall Study||14
247365|NCT01052701|599256|P2|STARTED|Overall Study||12
247366|NCT01052701|599257|P1|STARTED|Overall Study||14
247367|NCT01052662|599268|P3|NOT COMPLETED|Overall Study||22
247368|NCT01052662|599269|P2|NOT COMPLETED|Overall Study||22
247369|NCT01052662|599270|P1|NOT COMPLETED|Overall Study||22
247370|NCT01052662|599268|P3|COMPLETED|Overall Study||10
247371|NCT01052662|599269|P2|COMPLETED|Overall Study||5
247372|NCT01052662|599270|P1|COMPLETED|Overall Study||6
247373|NCT01052662|599268|P3|Discontinuation Phase|Overall Study||10
247374|NCT01052662|599269|P2|Discontinuation Phase|Overall Study||5
247375|NCT01052662|599270|P1|Discontinuation Phase|Overall Study||6
247376|NCT01052662|599268|P3|Stabilization Phase|Overall Study||26
247377|NCT01052662|599269|P2|Stabilization Phase|Overall Study||21
247378|NCT01052662|599270|P1|Stabilization Phase|Overall Study||21
247379|NCT01052662|599268|P3|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|32
247380|NCT01052662|599269|P2|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|27
247381|NCT01052662|599270|P1|STARTED|Overall Study|1 subject excluded from Intent-to-treat sample for final analysis due to pharmacy issue.|28
247382|NCT01052545|599286|P2|NOT COMPLETED|Overall Study||0
247383|NCT01052545|599287|P1|NOT COMPLETED|Overall Study||0
247384|NCT01052545|599286|P2|COMPLETED|Overall Study||731
247385|NCT01052545|599287|P1|COMPLETED|Overall Study||867
247386|NCT01052545|599286|P2|STARTED|Overall Study||731
247387|NCT01052545|599287|P1|STARTED|Overall Study||867
247388|NCT01052480|599311|P2|NOT COMPLETED|Overall Study||17
247389|NCT01052480|599312|P1|NOT COMPLETED|Overall Study||8
247390|NCT01052480|599311|P2|COMPLETED|Overall Study||32
247391|NCT01052480|599312|P1|COMPLETED|Overall Study||41
247392|NCT01052480|599311|P2|STARTED|Overall Study||49
247393|NCT01052480|599312|P1|STARTED|Overall Study||49
247394|NCT01052428|599362|P2|NOT COMPLETED|Overall Study||1
247395|NCT01052428|599363|P1|NOT COMPLETED|Overall Study||1
247396|NCT01052428|599362|P2|COMPLETED|Overall Study||18
247397|NCT01052428|599363|P1|COMPLETED|Overall Study||18
247398|NCT01052428|599362|P2|STARTED|Overall Study||19
247399|NCT01052428|599363|P1|STARTED|Overall Study||19
247400|NCT01052272|599385|P4|NOT COMPLETED|Overall Study||7
247401|NCT01052272|599386|P3|NOT COMPLETED|Overall Study||8
247402|NCT01052272|599387|P2|NOT COMPLETED|Overall Study||7
247403|NCT01052272|599388|P1|NOT COMPLETED|Overall Study||5
247404|NCT01052272|599385|P4|COMPLETED|Overall Study||11
247405|NCT01052272|599386|P3|COMPLETED|Overall Study||10
247406|NCT01052272|599387|P2|COMPLETED|Overall Study||11
247407|NCT01052272|599388|P1|COMPLETED|Overall Study||13
247408|NCT01052272|599385|P4|STARTED|Overall Study||18
247409|NCT01052272|599386|P3|STARTED|Overall Study||18
247410|NCT01052272|599387|P2|STARTED|Overall Study||18
247411|NCT01052272|599388|P1|STARTED|Overall Study||18
247412|NCT01052207|599424|P2|NOT COMPLETED|Overall Study||0
247413|NCT01052207|599425|P1|NOT COMPLETED|Overall Study||0
247414|NCT01052207|599424|P2|COMPLETED|Overall Study||42
247415|NCT01052207|599425|P1|COMPLETED|Overall Study||60
247416|NCT01052207|599424|P2|STARTED|Overall Study||42
247417|NCT01052207|599425|P1|STARTED|Overall Study||60
247418|NCT01052116|599433|P2|NOT COMPLETED|Overall Study||27
247419|NCT01052116|599434|P1|NOT COMPLETED|Overall Study||14
247420|NCT01052116|599433|P2|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|166
247421|NCT01052116|599434|P1|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|179
247422|NCT01052116|599433|P2|STARTED|Overall Study||193
247423|NCT01052116|599434|P1|STARTED|Overall Study||193
247424|NCT01052077|599442|P4|NOT COMPLETED|Phase A+||21
247425|NCT01052077|599443|P3|NOT COMPLETED|Phase A+||0
247426|NCT01052077|599444|P2|NOT COMPLETED|Phase A+||0
247427|NCT01052077|599445|P1|NOT COMPLETED|Phase A+||0
247428|NCT01052077|599442|P4|COMPLETED|Phase A+||230
247429|NCT01052077|599443|P3|COMPLETED|Phase A+||0
247430|NCT01052077|599444|P2|COMPLETED|Phase A+||0
247431|NCT01052077|599445|P1|COMPLETED|Phase A+||0
247432|NCT01052077|599442|P4|STARTED|Phase A+||251
247433|NCT01052077|599443|P3|STARTED|Phase A+||0
247434|NCT01052077|599444|P2|STARTED|Phase A+||0
247435|NCT01052077|599445|P1|STARTED|Phase A+||0
247436|NCT01052077|599442|P4|NOT COMPLETED|Phase B||0
247437|NCT01052077|599443|P3|NOT COMPLETED|Phase B||16
247438|NCT01052077|599444|P2|NOT COMPLETED|Phase B||18
247439|NCT01052077|599445|P1|NOT COMPLETED|Phase B||0
247440|NCT01052077|599442|P4|COMPLETED|Phase B||0
247441|NCT01052077|599443|P3|COMPLETED|Phase B||171
247442|NCT01052077|599444|P2|COMPLETED|Phase B||167
247443|NCT01052077|599445|P1|COMPLETED|Phase B||0
247444|NCT01052077|599442|P4|STARTED|Phase B||0
247445|NCT01052077|599443|P3|STARTED|Phase B||187
247446|NCT01052077|599444|P2|STARTED|Phase B||185
247447|NCT01052077|599445|P1|STARTED|Phase B||0
247448|NCT01052077|599442|P4|NOT COMPLETED|Phase A||0
247449|NCT01052077|599443|P3|NOT COMPLETED|Phase A||0
247450|NCT01052077|599444|P2|NOT COMPLETED|Phase A||0
247451|NCT01052077|599445|P1|NOT COMPLETED|Phase A||146
247452|NCT01052077|599442|P4|COMPLETED|Phase A||0
247453|NCT01052077|599443|P3|COMPLETED|Phase A||0
247454|NCT01052077|599444|P2|COMPLETED|Phase A||0
247455|NCT01052077|599445|P1|COMPLETED|Phase A||623
247456|NCT01052077|599442|P4|STARTED|Phase A||0
247457|NCT01052077|599443|P3|STARTED|Phase A||0
247458|NCT01052077|599444|P2|STARTED|Phase A||0
247459|NCT01052077|599445|P1|STARTED|Phase A||769
247460|NCT01052038|599472|P3|NOT COMPLETED|Overall Study||4
247461|NCT01052038|599473|P2|NOT COMPLETED|Overall Study||6
247462|NCT01052038|599474|P1|NOT COMPLETED|Overall Study||4
247463|NCT01052038|599472|P3|COMPLETED|Overall Study||36
247464|NCT01052038|599473|P2|COMPLETED|Overall Study||34
247465|NCT01052038|599474|P1|COMPLETED|Overall Study||36
247466|NCT01052038|599472|P3|STARTED|Overall Study||40
247467|NCT01052038|599473|P2|STARTED|Overall Study||40
247468|NCT01052038|599474|P1|STARTED|Overall Study||40
247469|NCT01051986|599496|P2|NOT COMPLETED|Overall Study||4
247470|NCT01051986|599497|P1|NOT COMPLETED|Overall Study||5
247471|NCT01051986|599496|P2|COMPLETED|Overall Study||108
247472|NCT01051986|599497|P1|COMPLETED|Overall Study||107
247473|NCT01051986|599496|P2|STARTED|Overall Study||112
247474|NCT01051986|599497|P1|STARTED|Overall Study||112
247475|NCT01051921|599511|P1|NOT COMPLETED|Overall Study||30
247476|NCT01051921|599511|P1|COMPLETED|Overall Study||37
247477|NCT01051921|599511|P1|STARTED|Overall Study||67
247478|NCT01051856|599518|P2|NOT COMPLETED|Overall Study||0
247479|NCT01051856|599519|P1|NOT COMPLETED|Overall Study||1
247480|NCT01051856|599518|P2|COMPLETED|Overall Study||35
247481|NCT01051856|599519|P1|COMPLETED|Overall Study||32
247482|NCT01051856|599518|P2|STARTED|Overall Study||35
247483|NCT01051856|599519|P1|STARTED|Overall Study||33
247484|NCT01051817|599529|P2|NOT COMPLETED|Overall Study||9
247485|NCT01051817|599530|P1|NOT COMPLETED|Overall Study||3
247486|NCT01051817|599529|P2|COMPLETED|Overall Study||26
247487|NCT01051817|599530|P1|COMPLETED|Overall Study||35
247488|NCT01051817|599529|P2|STARTED|Overall Study||35
247489|NCT01051817|599530|P1|STARTED|Overall Study||38
247490|NCT01051791|599540|P1|NOT COMPLETED|Overall Study||4
247491|NCT01051791|599540|P1|COMPLETED|Overall Study||9
247492|NCT01051791|599540|P1|STARTED|Overall Study||13
247493|NCT01051778|599549|P2|NOT COMPLETED|Overall Study||0
247494|NCT01051778|599550|P1|NOT COMPLETED|Overall Study||0
247495|NCT01051778|599549|P2|COMPLETED|Overall Study|November 2009|30
247496|NCT01051778|599550|P1|COMPLETED|Overall Study|November 2009|30
247497|NCT01051778|599549|P2|STARTED|Overall Study|June 2006|30
247498|NCT01051778|599550|P1|STARTED|Overall Study|June 2006|30
247499|NCT01051739|599558|P2|NOT COMPLETED|Overall Study||13
247500|NCT01051739|599559|P1|NOT COMPLETED|Overall Study||28
247501|NCT01051739|599558|P2|COMPLETED|Overall Study||47
247502|NCT01051739|599559|P1|COMPLETED|Overall Study||92
247503|NCT01051739|599558|P2|STARTED|Overall Study||60
247504|NCT01051739|599559|P1|STARTED|Overall Study||120
247505|NCT01051596|599565|P1|NOT COMPLETED|Overall Study||0
247506|NCT01051596|599565|P1|COMPLETED|Overall Study||75
247507|NCT01051596|599565|P1|STARTED|Overall Study||75
247508|NCT01051570|599572|P1|NOT COMPLETED|Overall Study||0
247509|NCT01051570|599572|P1|COMPLETED|Overall Study||26
247510|NCT01051570|599572|P1|STARTED|Overall Study||26
247511|NCT01051557|599583|P7|NOT COMPLETED|Overall Study||6
247512|NCT01051557|599584|P6|NOT COMPLETED|Overall Study||6
247513|NCT01051557|599585|P5|NOT COMPLETED|Overall Study||7
247514|NCT01051557|599586|P4|NOT COMPLETED|Overall Study||3
247515|NCT01051557|599587|P3|NOT COMPLETED|Overall Study||6
247516|NCT01051557|599588|P2|NOT COMPLETED|Overall Study||3
247517|NCT01051557|599589|P1|NOT COMPLETED|Overall Study||4
247518|NCT01051557|599583|P7|COMPLETED|Overall Study||0
247519|NCT01051557|599584|P6|COMPLETED|Overall Study||0
247520|NCT01051557|599585|P5|COMPLETED|Overall Study||1
247521|NCT01051557|599586|P4|COMPLETED|Overall Study||0
247522|NCT01051557|599587|P3|COMPLETED|Overall Study||0
247523|NCT01051557|599588|P2|COMPLETED|Overall Study||0
247524|NCT01051557|599589|P1|COMPLETED|Overall Study||0
247525|NCT01051557|599583|P7|STARTED|Overall Study||6
247526|NCT01051557|599584|P6|STARTED|Overall Study||6
247527|NCT01051557|599585|P5|STARTED|Overall Study||8
247528|NCT01051557|599586|P4|STARTED|Overall Study||3
247529|NCT01051557|599587|P3|STARTED|Overall Study||6
247530|NCT01051557|599588|P2|STARTED|Overall Study||3
247531|NCT01051557|599589|P1|STARTED|Overall Study||4
247532|NCT01051518|599608|P1|NOT COMPLETED|Overall Study||73
247533|NCT01051518|599608|P1|COMPLETED|Overall Study||53
247534|NCT01051518|599608|P1|STARTED|Overall Study||126
247535|NCT01051466|599620|P2|NOT COMPLETED|Overall Study||5
247536|NCT01051466|599621|P1|NOT COMPLETED|Overall Study||8
247537|NCT01051466|599620|P2|COMPLETED|Overall Study||23
247538|NCT01051466|599621|P1|COMPLETED|Overall Study||24
247539|NCT01051466|599620|P2|STARTED|Overall Study||28
247540|NCT01051466|599621|P1|STARTED|Overall Study||32
247541|NCT01051440|599655|P2|NOT COMPLETED|Overall Study||0
247542|NCT01051440|599656|P1|NOT COMPLETED|Overall Study||0
247543|NCT01051440|599655|P2|COMPLETED|Overall Study||1
247544|NCT01051440|599656|P1|COMPLETED|Overall Study||1
247545|NCT01051440|599655|P2|STARTED|Overall Study||1
247546|NCT01051440|599656|P1|STARTED|Overall Study||1
247547|NCT01051349|599666|P1|NOT COMPLETED|Overall Study||173
247548|NCT01051349|599666|P1|COMPLETED|Overall Study||237
247549|NCT01051349|599666|P1|STARTED|Overall Study||410
247550|NCT01051323|599695|P1|NOT COMPLETED|Overall Study||539
247551|NCT01051323|599695|P1|COMPLETED|Overall Study||1041
247552|NCT01051323|599695|P1|Received at Least One Dose|Overall Study||1547
247553|NCT01051323|599695|P1|STARTED|Overall Study||1580
247554|NCT01051310|599717|P1|NOT COMPLETED|Overall Study||5
247555|NCT01051310|599717|P1|COMPLETED|Overall Study||13
247556|NCT01051310|599717|P1|STARTED|Overall Study||18
247557|NCT01051063|599724|P2|NOT COMPLETED|Overall Study||4
247558|NCT01051063|599725|P1|NOT COMPLETED|Overall Study||10
247559|NCT01051063|599724|P2|COMPLETED|Overall Study||1
247560|NCT01051063|599725|P1|COMPLETED|Overall Study||2
247561|NCT01051063|599724|P2|STARTED|Overall Study||5
247562|NCT01051063|599725|P1|STARTED|Overall Study||12
247563|NCT01050998|599745|P5|NOT COMPLETED|Overall Study||14
247564|NCT01050998|599746|P4|NOT COMPLETED|Overall Study||3
247565|NCT01050998|599747|P3|NOT COMPLETED|Overall Study||3
247566|NCT01050998|599748|P2|NOT COMPLETED|Overall Study||2
247567|NCT01050998|599749|P1|NOT COMPLETED|Overall Study||4
247568|NCT01050998|599745|P5|COMPLETED|Overall Study||82
247569|NCT01050998|599746|P4|COMPLETED|Overall Study||45
247570|NCT01050998|599747|P3|COMPLETED|Overall Study||46
247571|NCT01050998|599748|P2|COMPLETED|Overall Study||47
247572|NCT01050998|599749|P1|COMPLETED|Overall Study||44
247573|NCT01050998|599745|P5|STARTED|Overall Study||96
247574|NCT01050998|599746|P4|STARTED|Overall Study||48
247575|NCT01050998|599747|P3|STARTED|Overall Study||49
247576|NCT01050998|599748|P2|STARTED|Overall Study||49
247577|NCT01050998|599749|P1|STARTED|Overall Study||48
247578|NCT01050946|600073|P1|NOT COMPLETED|Overall Study||0
247579|NCT01050946|600073|P1|COMPLETED|Overall Study|Patient signed consent 2/3/2011. Patient had their transplant 2/15/2011. Patient died 9/2/2011|1
247580|NCT01050946|600073|P1|STARTED|Overall Study||1
247581|NCT01050816|600083|P1|NOT COMPLETED|Overall Study||4
247582|NCT01050816|600083|P1|COMPLETED|Overall Study||26
247583|NCT01050816|600083|P1|STARTED|Overall Study||30
247584|NCT01050790|600089|P1|NOT COMPLETED|Overall Study||1
247585|NCT01050790|600089|P1|COMPLETED|Overall Study||16
247586|NCT01050790|600089|P1|STARTED|Overall Study||17
247587|NCT01050764|600099|P1|NOT COMPLETED|Overall Study||3
247588|NCT01050764|600099|P1|COMPLETED|Overall Study||7
247589|NCT01050764|600099|P1|Received Infusion of T-con Cells|Overall Study||7
247590|NCT01050764|600099|P1|Received Infusion of T-reg Cells|Overall Study||7
247591|NCT01050764|600099|P1|Received HSCT Graft|Overall Study||8
247592|NCT01050764|600099|P1|STARTED|Overall Study||10
247593|NCT01050673|600110|P2|NOT COMPLETED|Overall Study||5
247594|NCT01050673|600111|P1|NOT COMPLETED|Overall Study||4
247595|NCT01050673|600110|P2|COMPLETED|Overall Study||14
247596|NCT01050673|600111|P1|COMPLETED|Overall Study||17
247597|NCT01050673|600110|P2|STARTED|Overall Study||19
247598|NCT01050673|600111|P1|STARTED|Overall Study||21
247599|NCT01050660|600135|P2|NOT COMPLETED|Overall Study||0
247600|NCT01050660|600136|P1|NOT COMPLETED|Overall Study||0
247601|NCT01050660|600135|P2|COMPLETED|Overall Study||69
247602|NCT01050660|600136|P1|COMPLETED|Overall Study||67
247603|NCT01050660|600135|P2|STARTED|Overall Study||69
247604|NCT01050660|600136|P1|STARTED|Overall Study||67
247605|NCT01050647|600162|P2|NOT COMPLETED|Overall Study||0
247606|NCT01050647|600163|P1|NOT COMPLETED|Overall Study||0
247607|NCT01050647|600162|P2|COMPLETED|Overall Study||11
247608|NCT01050647|600163|P1|COMPLETED|Overall Study||10
247609|NCT01050647|600162|P2|STARTED|Overall Study||11
247610|NCT01050647|600163|P1|STARTED|Overall Study||10
247611|NCT01050634|600179|P1|NOT COMPLETED|Overall Study||128
247612|NCT01050634|600179|P1|COMPLETED|Overall Study||852
247613|NCT01050634|600179|P1|Received Treatment|Overall Study||924
247614|NCT01050634|600179|P1|STARTED|Overall Study||980
247615|NCT01050582|600189|P2|NOT COMPLETED|Overall Study||0
247616|NCT01050582|600190|P1|NOT COMPLETED|Overall Study||0
247617|NCT01050582|600189|P2|COMPLETED|Overall Study||51
247618|NCT01050582|600190|P1|COMPLETED|Overall Study||133
247619|NCT01050582|600189|P2|STARTED|Overall Study||51
247620|NCT01050582|600190|P1|STARTED|Overall Study||133
247621|NCT01050569|600203|P3|NOT COMPLETED|Overall Study||33
247622|NCT01050569|600204|P2|NOT COMPLETED|Overall Study||24
247623|NCT01050569|600205|P1|NOT COMPLETED|Overall Study||38
247624|NCT01050569|600203|P3|COMPLETED|Overall Study||47
247625|NCT01050569|600204|P2|COMPLETED|Overall Study||52
247626|NCT01050569|600205|P1|COMPLETED|Overall Study||41
247627|NCT01050569|600203|P3|STARTED|Overall Study||80
247628|NCT01050569|600204|P2|STARTED|Overall Study||76
247629|NCT01050569|600205|P1|STARTED|Overall Study||79
247630|NCT01050543|600224|P2|NOT COMPLETED|Overall Study||4
247631|NCT01050543|600225|P1|NOT COMPLETED|Overall Study||4
247632|NCT01050543|600224|P2|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
247633|NCT01050543|600225|P1|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
247634|NCT01050543|600224|P2|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
247635|NCT01050543|600225|P1|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
247636|NCT01050530|600233|P2|NOT COMPLETED|Overall Study||10
247637|NCT01050530|600234|P1|NOT COMPLETED|Overall Study||8
247638|NCT01050530|600233|P2|COMPLETED|Overall Study||70
247639|NCT01050530|600234|P1|COMPLETED|Overall Study||74
247640|NCT01050530|600233|P2|STARTED|Overall Study||80
247641|NCT01050530|600234|P1|STARTED|Overall Study||82
247642|NCT01050257|600245|P3|NOT COMPLETED|Overall Study||7
247643|NCT01050257|600246|P2|NOT COMPLETED|Overall Study||13
247644|NCT01050257|600247|P1|NOT COMPLETED|Overall Study||11
247645|NCT01050257|600245|P3|COMPLETED|Overall Study||8
247646|NCT01050257|600246|P2|COMPLETED|Overall Study||40
247647|NCT01050257|600247|P1|COMPLETED|Overall Study|Completed 5 days of treatment either IV or Oral|39
247648|NCT01050257|600245|P3|Switched to Oral Treatment|Overall Study||3
247649|NCT01050257|600246|P2|Switched to Oral Treatment|Overall Study||31
247650|NCT01050257|600247|P1|Switched to Oral Treatment|Overall Study||28
247651|NCT01050257|600245|P3|Intent-to-treat Infected Confirmed|Overall Study||10
247652|NCT01050257|600246|P2|Intent-to-treat Infected Confirmed|Overall Study||32
247653|NCT01050257|600247|P1|Intent-to-treat Infected Confirmed|Overall Study||30
247654|NCT01050257|600245|P3|Safety Population: Actual Dose Received|Overall Study||14
247655|NCT01050257|600246|P2|Safety Population: Actual Dose Received|Overall Study|One participant randomized to 100 mg actually received the 200 mg doses.|51
247656|NCT01050257|600247|P1|Safety Population: Actual Dose Received|Overall Study||48
247657|NCT01050257|600245|P3|Received Treatment|Overall Study||14
247658|NCT01050257|600246|P2|Received Treatment|Overall Study||50
247659|NCT01050257|600247|P1|Received Treatment|Overall Study||49
247660|NCT01050257|600245|P3|STARTED|Overall Study||15
247661|NCT01050257|600246|P2|STARTED|Overall Study||53
247662|NCT01050257|600247|P1|STARTED|Overall Study||50
247663|NCT01050218|600282|P1|NOT COMPLETED|Overall Study||95
247664|NCT01050218|600282|P1|COMPLETED|Overall Study||142
247665|NCT01050218|600282|P1|STARTED|Overall Study||237
247666|NCT01050205|600288|P2|NOT COMPLETED|Overall Study||4
247667|NCT01050205|600289|P1|NOT COMPLETED|Overall Study||11
247668|NCT01050205|600288|P2|COMPLETED|Overall Study||71
247669|NCT01050205|600289|P1|COMPLETED|Overall Study||137
247670|NCT01050205|600288|P2|STARTED|Overall Study||75
247671|NCT01050205|600289|P1|STARTED|Overall Study||148
247672|NCT01050153|600319|P2|NOT COMPLETED|Overall Study||0
247673|NCT01050153|600320|P1|NOT COMPLETED|Overall Study||0
247674|NCT01050153|600319|P2|COMPLETED|Overall Study||25
247675|NCT01050153|600320|P1|COMPLETED|Overall Study||25
247676|NCT01050153|600319|P2|STARTED|Overall Study||25
247677|NCT01050153|600320|P1|STARTED|Overall Study||25
247678|NCT01050062|600346|P2|NOT COMPLETED|Overall Study||112
247679|NCT01050062|600347|P1|NOT COMPLETED|Overall Study||271
247680|NCT01050062|600346|P2|COMPLETED|Overall Study||243
247681|NCT01050062|600347|P1|COMPLETED|Overall Study||799
247682|NCT01050062|600346|P2|STARTED|Overall Study||355
247683|NCT01050062|600347|P1|STARTED|Overall Study||1070
247684|NCT01049984|600369|P2|NOT COMPLETED|Overall Study||19
247685|NCT01049984|600370|P1|NOT COMPLETED|Overall Study||19
247686|NCT01049984|600369|P2|COMPLETED|Overall Study||146
247687|NCT01049984|600370|P1|COMPLETED|Overall Study||144
247688|NCT01049984|600369|P2|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|162
247689|NCT01049984|600370|P1|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|159
247690|NCT01049984|600369|P2|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|164
247691|NCT01049984|600370|P1|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|162
247692|NCT01049984|600369|P2|STARTED|Overall Study||165
247693|NCT01049984|600370|P1|STARTED|Overall Study||163
247694|NCT01049945|600388|P6|NOT COMPLETED|Overall Study||0
247695|NCT01049945|600389|P5|NOT COMPLETED|Overall Study||0
247696|NCT01049945|600390|P4|NOT COMPLETED|Overall Study||0
247697|NCT01049945|600391|P3|NOT COMPLETED|Overall Study||0
247698|NCT01049945|600392|P2|NOT COMPLETED|Overall Study||0
247699|NCT01049945|600393|P1|NOT COMPLETED|Overall Study||0
247700|NCT01049945|600388|P6|COMPLETED|Overall Study||49
247701|NCT01049945|600389|P5|COMPLETED|Overall Study||3
247702|NCT01049945|600390|P4|COMPLETED|Overall Study||6
247703|NCT01049945|600391|P3|COMPLETED|Overall Study||3
247704|NCT01049945|600392|P2|COMPLETED|Overall Study||6
247705|NCT01049945|600393|P1|COMPLETED|Overall Study||3
247706|NCT01049945|600388|P6|STARTED|Overall Study||49
247707|NCT01049945|600389|P5|STARTED|Overall Study||3
247708|NCT01049945|600390|P4|STARTED|Overall Study||6
247709|NCT01049945|600391|P3|STARTED|Overall Study||3
247710|NCT01049945|600392|P2|STARTED|Overall Study||6
247711|NCT01049945|600393|P1|STARTED|Overall Study||3
247712|NCT01049802|600409|P2|NOT COMPLETED|Overall Study||0
247713|NCT01049802|600410|P1|NOT COMPLETED|Overall Study||0
247714|NCT01049802|600409|P2|COMPLETED|Overall Study||10
247715|NCT01049802|600410|P1|COMPLETED|Overall Study||20
247716|NCT01049802|600409|P2|STARTED|Overall Study||10
247717|NCT01049802|600410|P1|STARTED|Overall Study||20
247718|NCT01049776|600424|P1|NOT COMPLETED|Overall Study||20
247719|NCT01049776|600424|P1|COMPLETED|Overall Study||12
247720|NCT01049776|600424|P1|STARTED|Overall Study||32
247721|NCT01049581|600430|P2|NOT COMPLETED|Overall Study||1
247722|NCT01049581|600431|P1|NOT COMPLETED|Overall Study||2
247723|NCT01049581|600430|P2|COMPLETED|Overall Study||13
247724|NCT01049581|600431|P1|COMPLETED|Overall Study||11
247725|NCT01049581|600430|P2|STARTED|Overall Study||14
247726|NCT01049581|600431|P1|STARTED|Overall Study||13
247727|NCT01049503|600446|P6|NOT COMPLETED|Overall Study||8
247728|NCT01049503|600447|P5|NOT COMPLETED|Overall Study||27
247729|NCT01049503|600448|P4|NOT COMPLETED|Overall Study||26
247730|NCT01049503|600449|P3|NOT COMPLETED|Overall Study||24
247731|NCT01049503|600450|P2|NOT COMPLETED|Overall Study||12
247732|NCT01049503|600451|P1|NOT COMPLETED|Overall Study||11
247733|NCT01049503|600446|P6|COMPLETED|Overall Study||40
247734|NCT01049503|600447|P5|COMPLETED|Overall Study||29
247735|NCT01049503|600448|P4|COMPLETED|Overall Study||29
247736|NCT01049503|600449|P3|COMPLETED|Overall Study||32
247737|NCT01049503|600450|P2|COMPLETED|Overall Study||36
247738|NCT01049503|600451|P1|COMPLETED|Overall Study||41
247739|NCT01049503|600446|P6|STARTED|Overall Study||48
247740|NCT01049503|600447|P5|STARTED|Overall Study||56
247741|NCT01049503|600448|P4|STARTED|Overall Study||55
247742|NCT01049503|600449|P3|STARTED|Overall Study||56
247743|NCT01049503|600450|P2|STARTED|Overall Study||48
247744|NCT01049503|600451|P1|STARTED|Overall Study||52
247745|NCT01049412|600482|P2|NOT COMPLETED|Period II||3
247746|NCT01049412|600483|P1|NOT COMPLETED|Period II||4
247747|NCT01049412|600482|P2|COMPLETED|Period II||52
247748|NCT01049412|600483|P1|COMPLETED|Period II||58
247749|NCT01049412|600482|P2|STARTED|Period II||55
247750|NCT01049412|600483|P1|STARTED|Period II||62
247751|NCT01049412|600482|P2|NOT COMPLETED|Period I||13
247752|NCT01049412|600483|P1|NOT COMPLETED|Period I||8
247753|NCT01049412|600482|P2|COMPLETED|Period I||55
247754|NCT01049412|600483|P1|COMPLETED|Period I||62
247755|NCT01049412|600482|P2|Took at Least One Dose of Study Drug|Period I||68
247756|NCT01049412|600483|P1|Took at Least One Dose of Study Drug|Period I||69
247757|NCT01049412|600482|P2|STARTED|Period I||68
247758|NCT01049412|600483|P1|STARTED|Period I||70
247759|NCT01049373|600512|P2|NOT COMPLETED|Overall Study||44
247760|NCT01049373|600513|P1|NOT COMPLETED|Overall Study||39
247761|NCT01049373|600512|P2|COMPLETED|Overall Study||65
247762|NCT01049373|600513|P1|COMPLETED|Overall Study||73
247763|NCT01049373|600512|P2|STARTED|Overall Study||109
247764|NCT01049373|600513|P1|STARTED|Overall Study||112
247765|NCT01049360|600527|P20|NOT COMPLETED|Period 4||0
247766|NCT01049360|600528|P19|NOT COMPLETED|Period 4||0
247767|NCT01049360|600529|P18|NOT COMPLETED|Period 4||1
247768|NCT01049360|600530|P17|NOT COMPLETED|Period 4||0
247769|NCT01049360|600531|P16|NOT COMPLETED|Period 4||0
247770|NCT01049360|600532|P15|NOT COMPLETED|Period 4||0
247771|NCT01049360|600533|P14|NOT COMPLETED|Period 4||0
247772|NCT01049360|600534|P13|NOT COMPLETED|Period 4||0
247773|NCT01049360|600535|P12|NOT COMPLETED|Period 4||0
247774|NCT01049360|600536|P11|NOT COMPLETED|Period 4||0
247775|NCT01049360|600537|P10|NOT COMPLETED|Period 4||0
247776|NCT01049360|600538|P9|NOT COMPLETED|Period 4||0
247777|NCT01049360|600539|P8|NOT COMPLETED|Period 4||0
247778|NCT01049360|600540|P7|NOT COMPLETED|Period 4||0
247779|NCT01049360|600541|P6|NOT COMPLETED|Period 4||0
247780|NCT01049360|600542|P5|NOT COMPLETED|Period 4||0
247781|NCT01049360|600543|P4|NOT COMPLETED|Period 4||1
247782|NCT01049360|600544|P3|NOT COMPLETED|Period 4||0
247783|NCT01049360|600545|P2|NOT COMPLETED|Period 4||0
247784|NCT01049360|600546|P1|NOT COMPLETED|Period 4||0
247785|NCT01049360|600527|P20|COMPLETED|Period 4||5
247786|NCT01049360|600528|P19|COMPLETED|Period 4||5
247787|NCT01049360|600529|P18|COMPLETED|Period 4||5
247788|NCT01049360|600530|P17|COMPLETED|Period 4||5
247789|NCT01049360|600531|P16|COMPLETED|Period 4||6
247790|NCT01049360|600532|P15|COMPLETED|Period 4||5
247791|NCT01049360|600533|P14|COMPLETED|Period 4||6
247792|NCT01049360|600534|P13|COMPLETED|Period 4||4
247793|NCT01049360|600535|P12|COMPLETED|Period 4||6
247794|NCT01049360|600536|P11|COMPLETED|Period 4||5
247795|NCT01049360|600537|P10|COMPLETED|Period 4||6
247796|NCT01049360|600538|P9|COMPLETED|Period 4||4
247797|NCT01049360|600539|P8|COMPLETED|Period 4||4
247798|NCT01049360|600540|P7|COMPLETED|Period 4||6
247799|NCT01049360|600541|P6|COMPLETED|Period 4||5
247800|NCT01049360|600542|P5|COMPLETED|Period 4||7
247801|NCT01049360|600543|P4|COMPLETED|Period 4||3
247802|NCT01049360|600544|P3|COMPLETED|Period 4||7
247803|NCT01049360|600545|P2|COMPLETED|Period 4||4
247804|NCT01049360|600546|P1|COMPLETED|Period 4||6
247805|NCT01049360|600527|P20|STARTED|Period 4||5
247806|NCT01049360|600528|P19|STARTED|Period 4||5
247807|NCT01049360|600529|P18|STARTED|Period 4||6
247808|NCT01049360|600530|P17|STARTED|Period 4||5
247809|NCT01049360|600531|P16|STARTED|Period 4||6
247810|NCT01049360|600532|P15|STARTED|Period 4||5
247811|NCT01049360|600533|P14|STARTED|Period 4||6
247812|NCT01049360|600534|P13|STARTED|Period 4||4
247813|NCT01049360|600535|P12|STARTED|Period 4||6
247814|NCT01049360|600536|P11|STARTED|Period 4||5
247815|NCT01049360|600537|P10|STARTED|Period 4||6
247816|NCT01049360|600538|P9|STARTED|Period 4||4
247817|NCT01049360|600539|P8|STARTED|Period 4||4
247818|NCT01049360|600540|P7|STARTED|Period 4||6
247819|NCT01049360|600541|P6|STARTED|Period 4||5
247820|NCT01049360|600542|P5|STARTED|Period 4||7
247821|NCT01049360|600543|P4|STARTED|Period 4||4
247822|NCT01049360|600544|P3|STARTED|Period 4||7
247823|NCT01049360|600545|P2|STARTED|Period 4||4
247824|NCT01049360|600546|P1|STARTED|Period 4||6
247825|NCT01049360|600527|P20|NOT COMPLETED|Period 3||0
247826|NCT01049360|600528|P19|NOT COMPLETED|Period 3||0
247827|NCT01049360|600529|P18|NOT COMPLETED|Period 3||0
247828|NCT01049360|600530|P17|NOT COMPLETED|Period 3||0
247829|NCT01049360|600531|P16|NOT COMPLETED|Period 3||0
247830|NCT01049360|600532|P15|NOT COMPLETED|Period 3||0
247831|NCT01049360|600533|P14|NOT COMPLETED|Period 3||0
247832|NCT01049360|600534|P13|NOT COMPLETED|Period 3||0
247833|NCT01049360|600535|P12|NOT COMPLETED|Period 3||0
247834|NCT01049360|600536|P11|NOT COMPLETED|Period 3||0
247835|NCT01049360|600537|P10|NOT COMPLETED|Period 3||0
247836|NCT01049360|600538|P9|NOT COMPLETED|Period 3||0
247837|NCT01049360|600539|P8|NOT COMPLETED|Period 3||0
247838|NCT01049360|600540|P7|NOT COMPLETED|Period 3||0
247839|NCT01049360|600541|P6|NOT COMPLETED|Period 3||0
247840|NCT01049360|600542|P5|NOT COMPLETED|Period 3||0
247841|NCT01049360|600543|P4|NOT COMPLETED|Period 3||0
247842|NCT01049360|600544|P3|NOT COMPLETED|Period 3||0
247843|NCT01049360|600545|P2|NOT COMPLETED|Period 3||0
247844|NCT01049360|600546|P1|NOT COMPLETED|Period 3||0
247845|NCT01049360|600527|P20|COMPLETED|Period 3||5
247846|NCT01049360|600528|P19|COMPLETED|Period 3||5
247847|NCT01049360|600529|P18|COMPLETED|Period 3||6
247848|NCT01049360|600530|P17|COMPLETED|Period 3||5
247849|NCT01049360|600531|P16|COMPLETED|Period 3||6
247850|NCT01049360|600532|P15|COMPLETED|Period 3||5
247851|NCT01049360|600533|P14|COMPLETED|Period 3||6
247852|NCT01049360|600534|P13|COMPLETED|Period 3||4
247853|NCT01049360|600535|P12|COMPLETED|Period 3||6
247854|NCT01049360|600536|P11|COMPLETED|Period 3||5
247855|NCT01049360|600537|P10|COMPLETED|Period 3||6
247856|NCT01049360|600538|P9|COMPLETED|Period 3||4
247857|NCT01049360|600539|P8|COMPLETED|Period 3||4
247858|NCT01049360|600540|P7|COMPLETED|Period 3||6
247859|NCT01049360|600541|P6|COMPLETED|Period 3||5
247860|NCT01049360|600542|P5|COMPLETED|Period 3||7
247861|NCT01049360|600543|P4|COMPLETED|Period 3||4
247862|NCT01049360|600544|P3|COMPLETED|Period 3||7
247863|NCT01049360|600545|P2|COMPLETED|Period 3||4
247864|NCT01049360|600546|P1|COMPLETED|Period 3||6
247865|NCT01049360|600527|P20|STARTED|Period 3||5
247866|NCT01049360|600528|P19|STARTED|Period 3||5
247867|NCT01049360|600529|P18|STARTED|Period 3||6
247868|NCT01049360|600530|P17|STARTED|Period 3||5
247869|NCT01049360|600531|P16|STARTED|Period 3||6
247870|NCT01049360|600532|P15|STARTED|Period 3||5
247871|NCT01049360|600533|P14|STARTED|Period 3||6
247872|NCT01049360|600534|P13|STARTED|Period 3||4
247873|NCT01049360|600535|P12|STARTED|Period 3||6
247874|NCT01049360|600536|P11|STARTED|Period 3||5
247875|NCT01049360|600537|P10|STARTED|Period 3||6
247876|NCT01049360|600538|P9|STARTED|Period 3||4
247877|NCT01049360|600539|P8|STARTED|Period 3||4
247878|NCT01049360|600540|P7|STARTED|Period 3||6
247879|NCT01049360|600541|P6|STARTED|Period 3||5
247880|NCT01049360|600542|P5|STARTED|Period 3||7
247881|NCT01049360|600543|P4|STARTED|Period 3||4
247882|NCT01049360|600544|P3|STARTED|Period 3||7
247883|NCT01049360|600545|P2|STARTED|Period 3||4
247884|NCT01049360|600546|P1|STARTED|Period 3||6
247885|NCT01049360|600527|P20|NOT COMPLETED|Period 2||2
247886|NCT01049360|600528|P19|NOT COMPLETED|Period 2||0
247887|NCT01049360|600529|P18|NOT COMPLETED|Period 2||0
247888|NCT01049360|600530|P17|NOT COMPLETED|Period 2||0
247889|NCT01049360|600531|P16|NOT COMPLETED|Period 2||1
247890|NCT01049360|600532|P15|NOT COMPLETED|Period 2||2
247891|NCT01049360|600533|P14|NOT COMPLETED|Period 2||0
247892|NCT01049360|600534|P13|NOT COMPLETED|Period 2||0
247893|NCT01049360|600535|P12|NOT COMPLETED|Period 2||0
247894|NCT01049360|600536|P11|NOT COMPLETED|Period 2||0
247895|NCT01049360|600537|P10|NOT COMPLETED|Period 2||0
247896|NCT01049360|600538|P9|NOT COMPLETED|Period 2||1
247897|NCT01049360|600539|P8|NOT COMPLETED|Period 2||0
247898|NCT01049360|600540|P7|NOT COMPLETED|Period 2||0
247899|NCT01049360|600541|P6|NOT COMPLETED|Period 2||1
247900|NCT01049360|600542|P5|NOT COMPLETED|Period 2||0
247901|NCT01049360|600543|P4|NOT COMPLETED|Period 2||2
247902|NCT01049360|600544|P3|NOT COMPLETED|Period 2||0
247903|NCT01049360|600545|P2|NOT COMPLETED|Period 2||1
247904|NCT01049360|600546|P1|NOT COMPLETED|Period 2||0
247905|NCT01049360|600527|P20|COMPLETED|Period 2||5
247906|NCT01049360|600528|P19|COMPLETED|Period 2||5
247907|NCT01049360|600529|P18|COMPLETED|Period 2||6
247908|NCT01049360|600530|P17|COMPLETED|Period 2||5
247909|NCT01049360|600531|P16|COMPLETED|Period 2||6
247910|NCT01049360|600532|P15|COMPLETED|Period 2||5
247911|NCT01049360|600533|P14|COMPLETED|Period 2||6
247912|NCT01049360|600534|P13|COMPLETED|Period 2||4
247913|NCT01049360|600535|P12|COMPLETED|Period 2||6
247914|NCT01049360|600536|P11|COMPLETED|Period 2||5
247915|NCT01049360|600537|P10|COMPLETED|Period 2||6
247916|NCT01049360|600538|P9|COMPLETED|Period 2||4
247917|NCT01049360|600539|P8|COMPLETED|Period 2||4
247918|NCT01049360|600540|P7|COMPLETED|Period 2||6
247919|NCT01049360|600541|P6|COMPLETED|Period 2||5
247920|NCT01049360|600542|P5|COMPLETED|Period 2||7
247921|NCT01049360|600543|P4|COMPLETED|Period 2||4
247922|NCT01049360|600544|P3|COMPLETED|Period 2||7
247923|NCT01049360|600545|P2|COMPLETED|Period 2||4
247924|NCT01049360|600546|P1|COMPLETED|Period 2||6
247925|NCT01049360|600527|P20|STARTED|Period 2||7
247926|NCT01049360|600528|P19|STARTED|Period 2||5
247927|NCT01049360|600529|P18|STARTED|Period 2||6
247928|NCT01049360|600530|P17|STARTED|Period 2||5
247929|NCT01049360|600531|P16|STARTED|Period 2||7
247930|NCT01049360|600532|P15|STARTED|Period 2||7
247931|NCT01049360|600533|P14|STARTED|Period 2||6
247932|NCT01049360|600534|P13|STARTED|Period 2||4
247933|NCT01049360|600535|P12|STARTED|Period 2||6
247934|NCT01049360|600536|P11|STARTED|Period 2||5
247935|NCT01049360|600537|P10|STARTED|Period 2||6
247936|NCT01049360|600538|P9|STARTED|Period 2||5
247937|NCT01049360|600539|P8|STARTED|Period 2||4
247938|NCT01049360|600540|P7|STARTED|Period 2||6
247939|NCT01049360|600541|P6|STARTED|Period 2||6
247940|NCT01049360|600542|P5|STARTED|Period 2||7
247941|NCT01049360|600543|P4|STARTED|Period 2||6
247942|NCT01049360|600544|P3|STARTED|Period 2||7
247943|NCT01049360|600545|P2|STARTED|Period 2||5
247944|NCT01049360|600546|P1|STARTED|Period 2||6
247945|NCT01049360|600527|P20|NOT COMPLETED|Period 1||0
247946|NCT01049360|600528|P19|NOT COMPLETED|Period 1||1
247947|NCT01049360|600529|P18|NOT COMPLETED|Period 1||0
247948|NCT01049360|600530|P17|NOT COMPLETED|Period 1||1
247949|NCT01049360|600531|P16|NOT COMPLETED|Period 1||0
247950|NCT01049360|600532|P15|NOT COMPLETED|Period 1||0
247951|NCT01049360|600533|P14|NOT COMPLETED|Period 1||1
247952|NCT01049360|600534|P13|NOT COMPLETED|Period 1||2
247953|NCT01049360|600535|P12|NOT COMPLETED|Period 1||0
247954|NCT01049360|600536|P11|NOT COMPLETED|Period 1||1
247955|NCT01049360|600537|P10|NOT COMPLETED|Period 1||0
247956|NCT01049360|600538|P9|NOT COMPLETED|Period 1||2
247957|NCT01049360|600539|P8|NOT COMPLETED|Period 1||2
247958|NCT01049360|600540|P7|NOT COMPLETED|Period 1||0
247959|NCT01049360|600541|P6|NOT COMPLETED|Period 1||0
247960|NCT01049360|600542|P5|NOT COMPLETED|Period 1||0
247961|NCT01049360|600543|P4|NOT COMPLETED|Period 1||1
247962|NCT01049360|600544|P3|NOT COMPLETED|Period 1||0
247963|NCT01049360|600545|P2|NOT COMPLETED|Period 1||1
247964|NCT01049360|600546|P1|NOT COMPLETED|Period 1||0
247965|NCT01049360|600527|P20|COMPLETED|Period 1||7
247966|NCT01049360|600528|P19|COMPLETED|Period 1||5
247967|NCT01049360|600529|P18|COMPLETED|Period 1||6
247968|NCT01049360|600530|P17|COMPLETED|Period 1||5
247969|NCT01049360|600531|P16|COMPLETED|Period 1||7
247970|NCT01049360|600532|P15|COMPLETED|Period 1||7
247971|NCT01049360|600533|P14|COMPLETED|Period 1||6
247972|NCT01049360|600534|P13|COMPLETED|Period 1||4
247973|NCT01049360|600535|P12|COMPLETED|Period 1||6
247974|NCT01049360|600536|P11|COMPLETED|Period 1||5
247975|NCT01049360|600537|P10|COMPLETED|Period 1||6
247976|NCT01049360|600538|P9|COMPLETED|Period 1||5
247977|NCT01049360|600539|P8|COMPLETED|Period 1||4
247978|NCT01049360|600540|P7|COMPLETED|Period 1||6
247979|NCT01049360|600541|P6|COMPLETED|Period 1||6
247980|NCT01049360|600542|P5|COMPLETED|Period 1||7
247981|NCT01049360|600543|P4|COMPLETED|Period 1||6
247982|NCT01049360|600544|P3|COMPLETED|Period 1||7
247983|NCT01049360|600545|P2|COMPLETED|Period 1||5
247984|NCT01049360|600546|P1|COMPLETED|Period 1||6
247985|NCT01049360|600527|P20|STARTED|Period 1||7
247986|NCT01049360|600528|P19|STARTED|Period 1||6
247987|NCT01049360|600529|P18|STARTED|Period 1||6
247988|NCT01049360|600530|P17|STARTED|Period 1||6
247989|NCT01049360|600531|P16|STARTED|Period 1||7
247990|NCT01049360|600532|P15|STARTED|Period 1||7
247991|NCT01049360|600533|P14|STARTED|Period 1||7
247992|NCT01049360|600534|P13|STARTED|Period 1||6
247993|NCT01049360|600535|P12|STARTED|Period 1||6
247994|NCT01049360|600536|P11|STARTED|Period 1||6
247995|NCT01049360|600537|P10|STARTED|Period 1||6
247996|NCT01049360|600538|P9|STARTED|Period 1||7
247997|NCT01049360|600539|P8|STARTED|Period 1||6
247998|NCT01049360|600540|P7|STARTED|Period 1||6
247999|NCT01049360|600541|P6|STARTED|Period 1||6
248000|NCT01049360|600542|P5|STARTED|Period 1||7
248001|NCT01049360|600543|P4|STARTED|Period 1||7
248002|NCT01049360|600544|P3|STARTED|Period 1||7
248003|NCT01049360|600545|P2|STARTED|Period 1||6
248004|NCT01049360|600546|P1|STARTED|Period 1||6
248005|NCT01049334|600570|P2|NOT COMPLETED|Overall Study||7
248006|NCT01049334|600571|P1|NOT COMPLETED|Overall Study||9
248007|NCT01049334|600570|P2|COMPLETED|Overall Study||95
248008|NCT01049334|600571|P1|COMPLETED|Overall Study||93
248009|NCT01049334|600570|P2|STARTED|Overall Study||102
248010|NCT01049334|600571|P1|STARTED|Overall Study||102
248011|NCT01049308|600607|P1|NOT COMPLETED|Pill Counts||83
248012|NCT01049308|600607|P1|COMPLETED|Pill Counts||168
248013|NCT01049308|600607|P1|STARTED|Pill Counts||251
248014|NCT01049308|600607|P1|NOT COMPLETED|Evaluation of Cognitive Impairment||0
248015|NCT01049308|600607|P1|COMPLETED|Evaluation of Cognitive Impairment||251
248016|NCT01049308|600607|P1|STARTED|Evaluation of Cognitive Impairment||251
248017|NCT01049243|600614|P1|NOT COMPLETED|Overall Study||2
248018|NCT01049243|600614|P1|COMPLETED|Overall Study||18
248019|NCT01049243|600614|P1|STARTED|Overall Study||20
248020|NCT01049217|600621|P2|NOT COMPLETED|Overall Study||63
248021|NCT01049217|600622|P1|NOT COMPLETED|Overall Study||56
248022|NCT01049217|600621|P2|COMPLETED|Overall Study||131
248023|NCT01049217|600622|P1|COMPLETED|Overall Study||127
248024|NCT01049217|600621|P2|Treated|Overall Study||192
248025|NCT01049217|600622|P1|Treated|Overall Study||183
248026|NCT01049217|600621|P2|STARTED|Overall Study||194
248027|NCT01049217|600622|P1|STARTED|Overall Study||183
248028|NCT01049009|600694|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
248029|NCT01049009|600695|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
248030|NCT01049009|600694|P2|COMPLETED|Treatment Period 2 (12 Weeks)||8
248031|NCT01049009|600695|P1|COMPLETED|Treatment Period 2 (12 Weeks)||11
248032|NCT01049009|600694|P2|STARTED|Treatment Period 2 (12 Weeks)||18
248033|NCT01049009|600695|P1|STARTED|Treatment Period 2 (12 Weeks)||21
248034|NCT01049009|600694|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
248035|NCT01049009|600695|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
248036|NCT01049009|600694|P2|COMPLETED|Treatment Period 1 (12 Weeks)||18
248037|NCT01049009|600695|P1|COMPLETED|Treatment Period 1 (12 Weeks)||21
248038|NCT01049009|600694|P2|STARTED|Treatment Period 1 (12 Weeks)||21
248039|NCT01049009|600695|P1|STARTED|Treatment Period 1 (12 Weeks)||23
248040|NCT01048944|600707|P4|NOT COMPLETED|Overall Study||2
248041|NCT01048944|600708|P3|NOT COMPLETED|Overall Study||10
248042|NCT01048944|600709|P2|NOT COMPLETED|Overall Study||10
248043|NCT01048944|600710|P1|NOT COMPLETED|Overall Study||8
248044|NCT01048944|600707|P4|COMPLETED|Overall Study||19
248045|NCT01048944|600708|P3|COMPLETED|Overall Study||25
248046|NCT01048944|600709|P2|COMPLETED|Overall Study||28
248047|NCT01048944|600710|P1|COMPLETED|Overall Study||24
248048|NCT01048944|600707|P4|STARTED|Overall Study||21
248049|NCT01048944|600708|P3|STARTED|Overall Study||35
248050|NCT01048944|600709|P2|STARTED|Overall Study||38
248051|NCT01048944|600710|P1|STARTED|Overall Study||32
248052|NCT01048879|600727|P3|NOT COMPLETED|Overall Study||0
248053|NCT01048879|600728|P2|NOT COMPLETED|Overall Study||0
248054|NCT01048879|600729|P1|NOT COMPLETED|Overall Study||0
248055|NCT01048879|600727|P3|COMPLETED|Overall Study||5
248056|NCT01048879|600728|P2|COMPLETED|Overall Study||9
248057|NCT01048879|600729|P1|COMPLETED|Overall Study||1
248058|NCT01048879|600727|P3|STARTED|Overall Study||5
248059|NCT01048879|600728|P2|STARTED|Overall Study||9
248060|NCT01048879|600729|P1|STARTED|Overall Study||1
248061|NCT01048866|600742|P2|NOT COMPLETED|Overall Study||5
248062|NCT01048866|600743|P1|NOT COMPLETED|Overall Study||4
248063|NCT01048866|600742|P2|COMPLETED|Overall Study||92
248064|NCT01048866|600743|P1|COMPLETED|Overall Study||97
248065|NCT01048866|600742|P2|STARTED|Overall Study||97
248066|NCT01048866|600743|P1|STARTED|Overall Study||101
248067|NCT01048788|600788|P3|NOT COMPLETED|Overall Study||2
248068|NCT01048788|600789|P2|NOT COMPLETED|Overall Study||2
248069|NCT01048788|600790|P1|NOT COMPLETED|Overall Study||5
248070|NCT01048788|600788|P3|COMPLETED|Overall Study||11
248071|NCT01048788|600789|P2|COMPLETED|Overall Study||28
248072|NCT01048788|600790|P1|COMPLETED|Overall Study||3
248073|NCT01048788|600788|P3|STARTED|Overall Study||13
248074|NCT01048788|600789|P2|STARTED|Overall Study||30
248075|NCT01048788|600790|P1|STARTED|Overall Study||8
248076|NCT01048723|600798|P1|NOT COMPLETED|Overall Study||0
248077|NCT01048723|600798|P1|COMPLETED|Overall Study||2
248078|NCT01048723|600798|P1|STARTED|Overall Study||2
248079|NCT01048697|600805|P1|NOT COMPLETED|Overall Study||0
248080|NCT01048697|600805|P1|COMPLETED|Overall Study||18
248081|NCT01048697|600805|P1|STARTED|Overall Study||18
248082|NCT01048671|600812|P3|NOT COMPLETED|Overall Study||1
248083|NCT01048671|600813|P2|NOT COMPLETED|Overall Study||1
248084|NCT01048671|600814|P1|NOT COMPLETED|Overall Study||0
248085|NCT01048671|600812|P3|COMPLETED|Overall Study||151
248086|NCT01048671|600813|P2|COMPLETED|Overall Study||263
248087|NCT01048671|600814|P1|COMPLETED|Overall Study||66
248088|NCT01048671|600812|P3|STARTED|Overall Study||152
248089|NCT01048671|600813|P2|STARTED|Overall Study||264
248090|NCT01048671|600814|P1|STARTED|Overall Study||66
248091|NCT01048658|600837|P2|NOT COMPLETED|Overall Study||0
248092|NCT01048658|600838|P1|NOT COMPLETED|Overall Study||0
248093|NCT01048658|600837|P2|COMPLETED|Overall Study||80
248094|NCT01048658|600838|P1|COMPLETED|Overall Study||80
248095|NCT01048658|600837|P2|STARTED|Overall Study||80
248096|NCT01048658|600838|P1|STARTED|Overall Study||80
248097|NCT01048606|600856|P4|NOT COMPLETED|Overall Study||5
248098|NCT01048606|600857|P3|NOT COMPLETED|Overall Study||10
248099|NCT01048606|600858|P2|NOT COMPLETED|Overall Study||7
248100|NCT01048606|600859|P1|NOT COMPLETED|Overall Study||12
248101|NCT01048606|600856|P4|COMPLETED|Overall Study||5
248102|NCT01048606|600857|P3|COMPLETED|Overall Study||16
248103|NCT01048606|600858|P2|COMPLETED|Overall Study||8
248104|NCT01048606|600859|P1|COMPLETED|Overall Study||16
248105|NCT01048606|600856|P4|STARTED|Overall Study||10
248106|NCT01048606|600857|P3|STARTED|Overall Study||26
248107|NCT01048606|600858|P2|STARTED|Overall Study||15
248108|NCT01048606|600859|P1|STARTED|Overall Study||28
248109|NCT01048593|600872|P3|NOT COMPLETED|Overall Study||0
248110|NCT01048593|600873|P2|NOT COMPLETED|Overall Study||0
248111|NCT01048593|600874|P1|NOT COMPLETED|Overall Study||0
248112|NCT01048593|600872|P3|COMPLETED|Overall Study||1
248113|NCT01048593|600873|P2|COMPLETED|Overall Study||2
248114|NCT01048593|600874|P1|COMPLETED|Overall Study||3
248115|NCT01048593|600872|P3|STARTED|Overall Study||1
248116|NCT01048593|600873|P2|STARTED|Overall Study||2
248117|NCT01048593|600874|P1|STARTED|Overall Study||3
248118|NCT01048541|600894|P2|NOT COMPLETED|Overall Study||0
248119|NCT01048541|600895|P1|NOT COMPLETED|Overall Study||1
248120|NCT01048541|600894|P2|COMPLETED|Overall Study||19
248121|NCT01048541|600895|P1|COMPLETED|Overall Study||17
248122|NCT01048541|600894|P2|STARTED|Overall Study||19
248123|NCT01048541|600895|P1|STARTED|Overall Study||18
248124|NCT01048502|600905|P4|NOT COMPLETED|Overall Study||4
248125|NCT01048502|600906|P3|NOT COMPLETED|Overall Study||5
248126|NCT01048502|600907|P2|NOT COMPLETED|Overall Study||7
248127|NCT01048502|600908|P1|NOT COMPLETED|Overall Study||4
248128|NCT01048502|600905|P4|COMPLETED|Overall Study||21
248129|NCT01048502|600906|P3|COMPLETED|Overall Study||23
248130|NCT01048502|600907|P2|COMPLETED|Overall Study||16
248131|NCT01048502|600908|P1|COMPLETED|Overall Study||20
248132|NCT01048502|600905|P4|STARTED|Overall Study||25
248133|NCT01048502|600906|P3|STARTED|Overall Study||28
248134|NCT01048502|600907|P2|STARTED|Overall Study||23
248135|NCT01048502|600908|P1|STARTED|Overall Study||24
248136|NCT01048424|600921|P2|NOT COMPLETED|Overall Study||0
248137|NCT01048424|600922|P1|NOT COMPLETED|Overall Study||2
248138|NCT01048424|600921|P2|COMPLETED|Overall Study||10
248139|NCT01048424|600922|P1|COMPLETED|Overall Study||8
248140|NCT01048424|600921|P2|STARTED|Overall Study||10
248141|NCT01048424|600922|P1|STARTED|Overall Study||10
248142|NCT01048333|600944|P6|NOT COMPLETED|Treatment Period 3||0
248143|NCT01048333|600945|P5|NOT COMPLETED|Treatment Period 3||0
248144|NCT01048333|600946|P4|NOT COMPLETED|Treatment Period 3||0
248145|NCT01048333|600947|P3|NOT COMPLETED|Treatment Period 3||0
248146|NCT01048333|600948|P2|NOT COMPLETED|Treatment Period 3||0
248147|NCT01048333|600949|P1|NOT COMPLETED|Treatment Period 3||0
248148|NCT01048333|600944|P6|COMPLETED|Treatment Period 3||18
248149|NCT01048333|600945|P5|COMPLETED|Treatment Period 3||17
248150|NCT01048333|600946|P4|COMPLETED|Treatment Period 3||18
248151|NCT01048333|600947|P3|COMPLETED|Treatment Period 3||16
248152|NCT01048333|600948|P2|COMPLETED|Treatment Period 3||18
248153|NCT01048333|600949|P1|COMPLETED|Treatment Period 3||21
248154|NCT01048333|600944|P6|STARTED|Treatment Period 3||18
248155|NCT01048333|600945|P5|STARTED|Treatment Period 3||17
248156|NCT01048333|600946|P4|STARTED|Treatment Period 3||18
248157|NCT01048333|600947|P3|STARTED|Treatment Period 3||16
248158|NCT01048333|600948|P2|STARTED|Treatment Period 3||18
248159|NCT01048333|600949|P1|STARTED|Treatment Period 3||21
248160|NCT01048333|600944|P6|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
248161|NCT01048333|600945|P5|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
248162|NCT01048333|600946|P4|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
248163|NCT01048333|600947|P3|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
248164|NCT01048333|600948|P2|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||1
248165|NCT01048333|600949|P1|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
248166|NCT01048333|600944|P6|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
248167|NCT01048333|600945|P5|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||17
248168|NCT01048333|600946|P4|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
248169|NCT01048333|600947|P3|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||16
248170|NCT01048333|600948|P2|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
248171|NCT01048333|600949|P1|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||21
248172|NCT01048333|600944|P6|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
248173|NCT01048333|600945|P5|STARTED|Wash-Out Period 2 of 2 - 7 Days||17
248174|NCT01048333|600946|P4|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
248175|NCT01048333|600947|P3|STARTED|Wash-Out Period 2 of 2 - 7 Days||16
248176|NCT01048333|600948|P2|STARTED|Wash-Out Period 2 of 2 - 7 Days||19
248177|NCT01048333|600949|P1|STARTED|Wash-Out Period 2 of 2 - 7 Days||21
248178|NCT01048333|600944|P6|NOT COMPLETED|Treatment Period 2||0
248179|NCT01048333|600945|P5|NOT COMPLETED|Treatment Period 2||0
248180|NCT01048333|600946|P4|NOT COMPLETED|Treatment Period 2||0
248181|NCT01048333|600947|P3|NOT COMPLETED|Treatment Period 2||0
248182|NCT01048333|600948|P2|NOT COMPLETED|Treatment Period 2||0
248183|NCT01048333|600949|P1|NOT COMPLETED|Treatment Period 2||0
248184|NCT01048333|600944|P6|COMPLETED|Treatment Period 2||18
248185|NCT01048333|600945|P5|COMPLETED|Treatment Period 2||17
248186|NCT01048333|600946|P4|COMPLETED|Treatment Period 2||18
248187|NCT01048333|600947|P3|COMPLETED|Treatment Period 2||16
248188|NCT01048333|600948|P2|COMPLETED|Treatment Period 2||19
248189|NCT01048333|600949|P1|COMPLETED|Treatment Period 2||21
248190|NCT01048333|600944|P6|STARTED|Treatment Period 2||18
248191|NCT01048333|600945|P5|STARTED|Treatment Period 2||17
248192|NCT01048333|600946|P4|STARTED|Treatment Period 2||18
248193|NCT01048333|600947|P3|STARTED|Treatment Period 2||16
248194|NCT01048333|600948|P2|STARTED|Treatment Period 2||19
248195|NCT01048333|600949|P1|STARTED|Treatment Period 2||21
248196|NCT01048333|600944|P6|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
248197|NCT01048333|600945|P5|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
248198|NCT01048333|600946|P4|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
248199|NCT01048333|600947|P3|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
248200|NCT01048333|600948|P2|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
248201|NCT01048333|600949|P1|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
248202|NCT01048333|600944|P6|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
248203|NCT01048333|600945|P5|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||17
248204|NCT01048333|600946|P4|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
248205|NCT01048333|600947|P3|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||16
248206|NCT01048333|600948|P2|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||19
248207|NCT01048333|600949|P1|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||21
248208|NCT01048333|600944|P6|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
248209|NCT01048333|600945|P5|STARTED|Wash-Out Period 1 of 2 - 7 Days||17
248210|NCT01048333|600946|P4|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
248211|NCT01048333|600947|P3|STARTED|Wash-Out Period 1 of 2 - 7 Days||16
248212|NCT01048333|600948|P2|STARTED|Wash-Out Period 1 of 2 - 7 Days||19
248213|NCT01048333|600949|P1|STARTED|Wash-Out Period 1 of 2 - 7 Days||21
248214|NCT01048333|600944|P6|NOT COMPLETED|Treatment Period 1||0
248215|NCT01048333|600945|P5|NOT COMPLETED|Treatment Period 1||0
248216|NCT01048333|600946|P4|NOT COMPLETED|Treatment Period 1||0
248217|NCT01048333|600947|P3|NOT COMPLETED|Treatment Period 1||0
248218|NCT01048333|600948|P2|NOT COMPLETED|Treatment Period 1||0
248219|NCT01048333|600949|P1|NOT COMPLETED|Treatment Period 1||0
248220|NCT01048333|600944|P6|COMPLETED|Treatment Period 1||18
248221|NCT01048333|600945|P5|COMPLETED|Treatment Period 1||17
248222|NCT01048333|600946|P4|COMPLETED|Treatment Period 1||18
248223|NCT01048333|600947|P3|COMPLETED|Treatment Period 1||16
248224|NCT01048333|600948|P2|COMPLETED|Treatment Period 1||19
248225|NCT01048333|600949|P1|COMPLETED|Treatment Period 1||21
248226|NCT01048333|600944|P6|STARTED|Treatment Period 1||18
248227|NCT01048333|600945|P5|STARTED|Treatment Period 1||17
248228|NCT01048333|600946|P4|STARTED|Treatment Period 1||18
248229|NCT01048333|600947|P3|STARTED|Treatment Period 1||16
248230|NCT01048333|600948|P2|STARTED|Treatment Period 1||19
248231|NCT01048333|600949|P1|STARTED|Treatment Period 1||21
248232|NCT01048242|600971|P2|NOT COMPLETED|Overall Study||2
248233|NCT01048242|600972|P1|NOT COMPLETED|Overall Study||4
248234|NCT01048242|600971|P2|COMPLETED|Overall Study||13
248235|NCT01048242|600972|P1|COMPLETED|Overall Study||8
248236|NCT01048242|600971|P2|STARTED|Overall Study||15
248237|NCT01048242|600972|P1|STARTED|Overall Study||12
248238|NCT01048125|600980|P2|NOT COMPLETED|Overall Study||0
248239|NCT01048125|600981|P1|NOT COMPLETED|Overall Study||0
248240|NCT01048125|600980|P2|COMPLETED|Overall Study||0
248241|NCT01048125|600981|P1|COMPLETED|Overall Study||0
248242|NCT01048125|600980|P2|STARTED|Overall Study||0
248243|NCT01048125|600981|P1|STARTED|Overall Study||0
248244|NCT01048099|600987|P1|NOT COMPLETED|Treatment Per Protocol||14
248245|NCT01048099|600987|P1|COMPLETED|Treatment Per Protocol|Patients continued treatment until disease progression or coming off-study for any other reason|0
248246|NCT01048099|600987|P1|STARTED|Treatment Per Protocol||14
248247|NCT01048099|600987|P1|NOT COMPLETED|Pts w/ HER2 Overexpression/Activation||10
248248|NCT01048099|600987|P1|COMPLETED|Pts w/ HER2 Overexpression/Activation|Patients who proceeded to treatment|14
248249|NCT01048099|600987|P1|STARTED|Pts w/ HER2 Overexpression/Activation|Patients with detected HER2 activation and/or overexpression|24
248250|NCT01048099|600987|P1|NOT COMPLETED|Patients Evaluated by PRO Onc Assay||202
248251|NCT01048099|600987|P1|COMPLETED|Patients Evaluated by PRO Onc Assay|Patients evaluated by PRO Onc Assay with HER2 overexpression/activation detected|24
248252|NCT01048099|600987|P1|STARTED|Patients Evaluated by PRO Onc Assay|Patients with CTCs who were evaluated by PRO Onc Assay|226
248253|NCT01048099|600987|P1|NOT COMPLETED|Patients Enrolled and Blood Collected||57
248254|NCT01048099|600987|P1|COMPLETED|Patients Enrolled and Blood Collected|Patients with circulating tumor cells (CTCs)|226
248255|NCT01048099|600987|P1|STARTED|Patients Enrolled and Blood Collected|Patients enrolled|283
248256|NCT01047839|600998|P3|NOT COMPLETED|Overall Study||6
248257|NCT01047839|600999|P2|NOT COMPLETED|Overall Study||0
248258|NCT01047839|601000|P1|NOT COMPLETED|Overall Study||2
248259|NCT01047839|600998|P3|COMPLETED|Overall Study||53
248260|NCT01047839|600999|P2|COMPLETED|Overall Study||29
248261|NCT01047839|601000|P1|COMPLETED|Overall Study||10
248262|NCT01047839|600998|P3|STARTED|Overall Study||59
248263|NCT01047839|600999|P2|STARTED|Overall Study||29
248264|NCT01047839|601000|P1|STARTED|Overall Study||12
248265|NCT01047709|601008|P2|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
248266|NCT01047709|601009|P1|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
248267|NCT01047709|601008|P2|COMPLETED|Control/Positioning ad Lib (1 Night)||9
248268|NCT01047709|601009|P1|COMPLETED|Control/Positioning ad Lib (1 Night)||9
248269|NCT01047709|601008|P2|STARTED|Control/Positioning ad Lib (1 Night)||9
248270|NCT01047709|601009|P1|STARTED|Control/Positioning ad Lib (1 Night)||9
248271|NCT01047709|601008|P2|NOT COMPLETED|Positional Therapy (1 Night)||0
248272|NCT01047709|601009|P1|NOT COMPLETED|Positional Therapy (1 Night)||0
248273|NCT01047709|601008|P2|COMPLETED|Positional Therapy (1 Night)||9
248274|NCT01047709|601009|P1|COMPLETED|Positional Therapy (1 Night)||9
248275|NCT01047709|601008|P2|STARTED|Positional Therapy (1 Night)||9
248276|NCT01047709|601009|P1|STARTED|Positional Therapy (1 Night)||9
248277|NCT01047553|601017|P2|NOT COMPLETED|Overall Study||9
248278|NCT01047553|601018|P1|NOT COMPLETED|Overall Study||17
248279|NCT01047553|601017|P2|COMPLETED|Overall Study||117
248280|NCT01047553|601018|P1|COMPLETED|Overall Study||108
248281|NCT01047553|601017|P2|STARTED|Overall Study||126
248282|NCT01047553|601018|P1|STARTED|Overall Study||125
248283|NCT01047527|601103|P3|NOT COMPLETED|Overall Study||65
248284|NCT01047527|601104|P2|NOT COMPLETED|Overall Study||61
248285|NCT01047527|601105|P1|NOT COMPLETED|Overall Study||85
248286|NCT01047527|601103|P3|COMPLETED|Overall Study||107
248287|NCT01047527|601104|P2|COMPLETED|Overall Study||112
248288|NCT01047527|601105|P1|COMPLETED|Overall Study||95
248289|NCT01047527|601103|P3|24 Weeks|Overall Study||119
248290|NCT01047527|601104|P2|24 Weeks|Overall Study||123
248291|NCT01047527|601105|P1|24 Weeks|Overall Study||111
248292|NCT01047527|601103|P3|8 Weeks|Overall Study||138
248293|NCT01047527|601104|P2|8 Weeks|Overall Study||142
248294|NCT01047527|601105|P1|8 Weeks|Overall Study||148
248295|NCT01047527|601103|P3|STARTED|Overall Study||172
248296|NCT01047527|601104|P2|STARTED|Overall Study||173
248297|NCT01047527|601105|P1|STARTED|Overall Study||180
248298|NCT01047475|601116|P2|NOT COMPLETED|Overall Study||7
248299|NCT01047475|601117|P1|NOT COMPLETED|Overall Study||5
248300|NCT01047475|601116|P2|COMPLETED|Overall Study||31
248301|NCT01047475|601117|P1|COMPLETED|Overall Study||29
248302|NCT01047475|601116|P2|STARTED|Overall Study||38
248303|NCT01047475|601117|P1|STARTED|Overall Study||34
248304|NCT01047436|601125|P2|NOT COMPLETED|Overall Study||0
248305|NCT01047436|601126|P1|NOT COMPLETED|Overall Study||1
248306|NCT01047436|601125|P2|COMPLETED|Overall Study||15
248307|NCT01047436|601126|P1|COMPLETED|Overall Study||15
248308|NCT01047436|601125|P2|STARTED|Overall Study||15
248309|NCT01047436|601126|P1|STARTED|Overall Study||16
248310|NCT01047358|601142|P1|NOT COMPLETED|Overall Study||0
248311|NCT01047358|601142|P1|COMPLETED|Overall Study|At least one safety assessment (Safety Population)|206
248312|NCT01047358|601142|P1|STARTED|Overall Study||206
248313|NCT01047345|601151|P3|NOT COMPLETED|Extension||6
248314|NCT01047345|601152|P2|NOT COMPLETED|Extension||0
248315|NCT01047345|601153|P1|NOT COMPLETED|Extension||0
248316|NCT01047345|601151|P3|COMPLETED|Extension||96
248317|NCT01047345|601152|P2|COMPLETED|Extension||0
248318|NCT01047345|601153|P1|COMPLETED|Extension||0
248319|NCT01047345|601151|P3|Vaccination 6|Extension|1 participant received 6th vaccination outside the context of study but completed the study.|95
248320|NCT01047345|601152|P2|Vaccination 6|Extension||0
248321|NCT01047345|601153|P1|Vaccination 6|Extension||0
248322|NCT01047345|601151|P3|Vaccination 5|Extension||99
248323|NCT01047345|601152|P2|Vaccination 5|Extension||0
248324|NCT01047345|601153|P1|Vaccination 5|Extension||0
248325|NCT01047345|601151|P3|Vaccination 4|Extension||102
248326|NCT01047345|601152|P2|Vaccination 4|Extension||0
248327|NCT01047345|601153|P1|Vaccination 4|Extension||0
248328|NCT01047345|601151|P3|STARTED|Extension|Not all eligible participants elected to participate in extension|102
248329|NCT01047345|601152|P2|STARTED|Extension||0
248330|NCT01047345|601153|P1|STARTED|Extension||0
248331|NCT01047345|601151|P3|NOT COMPLETED|Base Study||0
248332|NCT01047345|601152|P2|NOT COMPLETED|Base Study||6
248333|NCT01047345|601153|P1|NOT COMPLETED|Base Study||22
248334|NCT01047345|601151|P3|COMPLETED|Base Study||0
248335|NCT01047345|601152|P2|COMPLETED|Base Study||300
248336|NCT01047345|601153|P1|COMPLETED|Base Study|Includes 1 participant for whom completion status is unknown|596
248337|NCT01047345|601151|P3|Vaccination 3|Base Study||0
248338|NCT01047345|601152|P2|Vaccination 3|Base Study||300
248339|NCT01047345|601153|P1|Vaccination 3|Base Study||597
248340|NCT01047345|601151|P3|Vaccination 2|Base Study||0
248341|NCT01047345|601152|P2|Vaccination 2|Base Study||304
248342|NCT01047345|601153|P1|Vaccination 2|Base Study||604
248343|NCT01047345|601151|P3|Vaccination 1|Base Study||0
248344|NCT01047345|601152|P2|Vaccination 1|Base Study||306
248345|NCT01047345|601153|P1|Vaccination 1|Base Study||615
248346|NCT01047345|601151|P3|STARTED|Base Study||0
248347|NCT01047345|601152|P2|STARTED|Base Study||306
248348|NCT01047345|601153|P1|STARTED|Base Study||618
248349|NCT01047332|601175|P2|NOT COMPLETED|Overall Study||64
248350|NCT01047332|601176|P1|NOT COMPLETED|Overall Study||57
248351|NCT01047332|601175|P2|COMPLETED|Overall Study|Alive at final follow-up|4
248352|NCT01047332|601176|P1|COMPLETED|Overall Study|Alive at final follow-up|4
248353|NCT01047332|601175|P2|STARTED|Overall Study||68
248354|NCT01047332|601176|P1|STARTED|Overall Study||61
248355|NCT01047319|601191|P3|NOT COMPLETED|Overall Study||352
248356|NCT01047319|601192|P2|NOT COMPLETED|Overall Study||350
248357|NCT01047319|601193|P1|NOT COMPLETED|Overall Study||345
248358|NCT01047319|601191|P3|COMPLETED|Overall Study||0
248359|NCT01047319|601192|P2|COMPLETED|Overall Study||0
248360|NCT01047319|601193|P1|COMPLETED|Overall Study||0
248361|NCT01047319|601191|P3|STARTED|Overall Study||352
248362|NCT01047319|601192|P2|STARTED|Overall Study||350
248363|NCT01047319|601193|P1|STARTED|Overall Study||345
248364|NCT01047306|601215|P2|NOT COMPLETED|Overall Study||0
248365|NCT01047306|601216|P1|NOT COMPLETED|Overall Study||3
248366|NCT01047306|601215|P2|COMPLETED|Overall Study||6
248367|NCT01047306|601216|P1|COMPLETED|Overall Study||16
248368|NCT01047306|601215|P2|Discontinued From the Study|Overall Study||0
248369|NCT01047306|601216|P1|Discontinued From the Study|Overall Study||3
248370|NCT01047306|601215|P2|STARTED|Overall Study||6
248371|NCT01047306|601216|P1|STARTED|Overall Study||19
248372|NCT01047293|601290|P4|NOT COMPLETED|Overall Study||0
248373|NCT01047293|601291|P3|NOT COMPLETED|Overall Study||0
248374|NCT01047293|601292|P2|NOT COMPLETED|Overall Study||1
248375|NCT01047293|601293|P1|NOT COMPLETED|Overall Study||1
248376|NCT01047293|601290|P4|COMPLETED|Overall Study||26
248377|NCT01047293|601291|P3|COMPLETED|Overall Study||9
248378|NCT01047293|601292|P2|COMPLETED|Overall Study||7
248379|NCT01047293|601293|P1|COMPLETED|Overall Study||3
248380|NCT01047293|601290|P4|STARTED|Overall Study||26
248381|NCT01047293|601291|P3|STARTED|Overall Study||9
248382|NCT01047293|601292|P2|STARTED|Overall Study||8
248383|NCT01047293|601293|P1|STARTED|Overall Study||4
248384|NCT01047241|601300|P1|NOT COMPLETED|Overall Study||0
248385|NCT01047241|601300|P1|COMPLETED|Overall Study||50
248386|NCT01047241|601300|P1|STARTED|Overall Study||50
248387|NCT01047189|601311|P2|NOT COMPLETED|Overall Study||0
248388|NCT01047189|601312|P1|NOT COMPLETED|Overall Study||4
248389|NCT01047189|601311|P2|COMPLETED|Overall Study||13
248390|NCT01047189|601312|P1|COMPLETED|Overall Study||9
248391|NCT01047189|601311|P2|STARTED|Overall Study||13
248392|NCT01047189|601312|P1|STARTED|Overall Study||13
248393|NCT01047007|601324|P4|NOT COMPLETED|Overall Study||0
248394|NCT01047007|601325|P3|NOT COMPLETED|Overall Study||2
248395|NCT01047007|601326|P2|NOT COMPLETED|Overall Study||6
248396|NCT01047007|601327|P1|NOT COMPLETED|Overall Study||2
248397|NCT01047007|601324|P4|COMPLETED|Overall Study||0
248398|NCT01047007|601325|P3|COMPLETED|Overall Study||0
248399|NCT01047007|601326|P2|COMPLETED|Overall Study||0
248400|NCT01047007|601327|P1|COMPLETED|Overall Study||1
248401|NCT01047007|601324|P4|Treated|Overall Study||0
248402|NCT01047007|601325|P3|Treated|Overall Study||2
248403|NCT01047007|601326|P2|Treated|Overall Study||6
248404|NCT01047007|601327|P1|Treated|Overall Study||3
248405|NCT01047007|601324|P4|STARTED|Overall Study||0
248406|NCT01047007|601325|P3|STARTED|Overall Study||2
248407|NCT01047007|601326|P2|STARTED|Overall Study||6
248408|NCT01047007|601327|P1|STARTED|Overall Study||3
248409|NCT01046903|601338|P1|NOT COMPLETED|Overall Study||28
248410|NCT01046903|601338|P1|COMPLETED|Overall Study||475
248411|NCT01046903|601338|P1|STARTED|Overall Study||503
248412|NCT01046877|601351|P1|NOT COMPLETED|Overall Study||18
248413|NCT01046877|601351|P1|COMPLETED|Overall Study||7
248414|NCT01046877|601351|P1|Completed Study Late|Overall Study|One completed (evidencing extrusions) at 23.5 mos. Missed 9 mo visit. Exam not possible at 12 mo.|1
248415|NCT01046877|601351|P1|Completed on Schedule|Overall Study|Final visit = the earlier of 24 months post-procedure or 12 months after extrusion.|6
248416|NCT01046877|601351|P1|STARTED|Overall Study||25
248417|NCT01046695|601367|P2|NOT COMPLETED|Overall Study||2
248418|NCT01046695|601368|P1|NOT COMPLETED|Overall Study||0
248419|NCT01046695|601367|P2|COMPLETED|Overall Study||20
248420|NCT01046695|601368|P1|COMPLETED|Overall Study||20
248421|NCT01046695|601367|P2|STARTED|Overall Study||22
248422|NCT01046695|601368|P1|STARTED|Overall Study||20
248423|NCT01046682|601380|P2|NOT COMPLETED|Overall Study||0
248424|NCT01046682|601381|P1|NOT COMPLETED|Overall Study||2
248425|NCT01046682|601380|P2|COMPLETED|Overall Study||20
248426|NCT01046682|601381|P1|COMPLETED|Overall Study||18
248427|NCT01046682|601380|P2|STARTED|Overall Study||20
248428|NCT01046682|601381|P1|STARTED|Overall Study||20
248429|NCT01046669|601389|P2|NOT COMPLETED|Overall Study||1
248430|NCT01046669|601390|P1|NOT COMPLETED|Overall Study||0
248431|NCT01046669|601389|P2|COMPLETED|Overall Study||223
248432|NCT01046669|601390|P1|COMPLETED|Overall Study||226
248433|NCT01046669|601389|P2|STARTED|Overall Study||224
248434|NCT01046669|601390|P1|STARTED|Overall Study||226
248435|NCT01046643|601398|P4|NOT COMPLETED|Second Period Treatment or Placebo||0
248436|NCT01046643|601399|P3|NOT COMPLETED|Second Period Treatment or Placebo||0
248437|NCT01046643|601400|P2|NOT COMPLETED|Second Period Treatment or Placebo||0
248438|NCT01046643|601401|P1|NOT COMPLETED|Second Period Treatment or Placebo||0
248439|NCT01046643|601398|P4|COMPLETED|Second Period Treatment or Placebo||7
248440|NCT01046643|601399|P3|COMPLETED|Second Period Treatment or Placebo||7
248441|NCT01046643|601400|P2|COMPLETED|Second Period Treatment or Placebo||6
248442|NCT01046643|601401|P1|COMPLETED|Second Period Treatment or Placebo||9
248443|NCT01046643|601398|P4|STARTED|Second Period Treatment or Placebo||7
248444|NCT01046643|601399|P3|STARTED|Second Period Treatment or Placebo||7
248445|NCT01046643|601400|P2|STARTED|Second Period Treatment or Placebo||6
248446|NCT01046643|601401|P1|STARTED|Second Period Treatment or Placebo||9
248447|NCT01046643|601398|P4|NOT COMPLETED|Washout Period||0
248448|NCT01046643|601399|P3|NOT COMPLETED|Washout Period||0
248449|NCT01046643|601400|P2|NOT COMPLETED|Washout Period||0
248450|NCT01046643|601401|P1|NOT COMPLETED|Washout Period||0
248451|NCT01046643|601398|P4|COMPLETED|Washout Period||7
248452|NCT01046643|601399|P3|COMPLETED|Washout Period||7
248453|NCT01046643|601400|P2|COMPLETED|Washout Period||6
248454|NCT01046643|601401|P1|COMPLETED|Washout Period||9
248455|NCT01046643|601398|P4|STARTED|Washout Period||7
248456|NCT01046643|601399|P3|STARTED|Washout Period||7
248457|NCT01046643|601400|P2|STARTED|Washout Period||6
248458|NCT01046643|601401|P1|STARTED|Washout Period||9
248459|NCT01046643|601398|P4|NOT COMPLETED|First Period Treatment or Placebo||0
248460|NCT01046643|601399|P3|NOT COMPLETED|First Period Treatment or Placebo||0
248461|NCT01046643|601400|P2|NOT COMPLETED|First Period Treatment or Placebo||1
248462|NCT01046643|601401|P1|NOT COMPLETED|First Period Treatment or Placebo||0
248463|NCT01046643|601398|P4|COMPLETED|First Period Treatment or Placebo||7
248464|NCT01046643|601399|P3|COMPLETED|First Period Treatment or Placebo||7
248465|NCT01046643|601400|P2|COMPLETED|First Period Treatment or Placebo||6
248466|NCT01046643|601401|P1|COMPLETED|First Period Treatment or Placebo||9
248467|NCT01046643|601398|P4|STARTED|First Period Treatment or Placebo||7
248468|NCT01046643|601399|P3|STARTED|First Period Treatment or Placebo||7
248469|NCT01046643|601400|P2|STARTED|First Period Treatment or Placebo||7
248470|NCT01046643|601401|P1|STARTED|First Period Treatment or Placebo||9
248471|NCT01046565|601423|P1|NOT COMPLETED|Overall Study||9
248472|NCT01046565|601423|P1|COMPLETED|Overall Study||66
248473|NCT01046565|601423|P1|STARTED|Overall Study||75
248474|NCT01046396|601432|P1|NOT COMPLETED|Overall Study||5
248475|NCT01046396|601432|P1|COMPLETED|Overall Study||64
248476|NCT01046396|601432|P1|STARTED|Overall Study||69
248477|NCT01046253|601443|P2|NOT COMPLETED|Fourth Intervention||0
248478|NCT01046253|601444|P1|NOT COMPLETED|Fourth Intervention||0
248479|NCT01046253|601443|P2|COMPLETED|Fourth Intervention||23
248480|NCT01046253|601444|P1|COMPLETED|Fourth Intervention||25
248481|NCT01046253|601443|P2|STARTED|Fourth Intervention||23
248482|NCT01046253|601444|P1|STARTED|Fourth Intervention||25
248483|NCT01046253|601443|P2|NOT COMPLETED|Third Washout of 7 Days||0
248484|NCT01046253|601444|P1|NOT COMPLETED|Third Washout of 7 Days||0
248485|NCT01046253|601443|P2|COMPLETED|Third Washout of 7 Days||23
248486|NCT01046253|601444|P1|COMPLETED|Third Washout of 7 Days||25
248487|NCT01046253|601443|P2|STARTED|Third Washout of 7 Days||23
248488|NCT01046253|601444|P1|STARTED|Third Washout of 7 Days||25
248489|NCT01046253|601443|P2|NOT COMPLETED|Third Intervention||0
248490|NCT01046253|601444|P1|NOT COMPLETED|Third Intervention||0
248491|NCT01046253|601443|P2|COMPLETED|Third Intervention||23
248492|NCT01046253|601444|P1|COMPLETED|Third Intervention||25
248493|NCT01046253|601443|P2|STARTED|Third Intervention||23
248494|NCT01046253|601444|P1|STARTED|Third Intervention||25
248495|NCT01046253|601443|P2|NOT COMPLETED|Second Washout of 7 Days||0
248496|NCT01046253|601444|P1|NOT COMPLETED|Second Washout of 7 Days||0
248497|NCT01046253|601443|P2|COMPLETED|Second Washout of 7 Days||23
248498|NCT01046253|601444|P1|COMPLETED|Second Washout of 7 Days||25
248499|NCT01046253|601443|P2|STARTED|Second Washout of 7 Days||23
248500|NCT01046253|601444|P1|STARTED|Second Washout of 7 Days||25
248501|NCT01046253|601443|P2|NOT COMPLETED|Second Intervention||2
248502|NCT01046253|601444|P1|NOT COMPLETED|Second Intervention||0
248503|NCT01046253|601443|P2|COMPLETED|Second Intervention||23
248504|NCT01046253|601444|P1|COMPLETED|Second Intervention||25
248505|NCT01046253|601443|P2|STARTED|Second Intervention||25
248506|NCT01046253|601444|P1|STARTED|Second Intervention||25
248507|NCT01046253|601443|P2|NOT COMPLETED|First Washout of 7 Days||0
248508|NCT01046253|601444|P1|NOT COMPLETED|First Washout of 7 Days||0
248509|NCT01046253|601443|P2|COMPLETED|First Washout of 7 Days||25
248510|NCT01046253|601444|P1|COMPLETED|First Washout of 7 Days||25
248511|NCT01046253|601443|P2|STARTED|First Washout of 7 Days||25
248512|NCT01046253|601444|P1|STARTED|First Washout of 7 Days||25
248513|NCT01046253|601443|P2|NOT COMPLETED|First Intervention||0
248514|NCT01046253|601444|P1|NOT COMPLETED|First Intervention||0
248515|NCT01046253|601443|P2|COMPLETED|First Intervention||25
248516|NCT01046253|601444|P1|COMPLETED|First Intervention||25
248517|NCT01046253|601443|P2|STARTED|First Intervention||25
248518|NCT01046253|601444|P1|STARTED|First Intervention||25
248519|NCT01046136|601456|P2|NOT COMPLETED|Overall Study||8
248520|NCT01046136|601457|P1|NOT COMPLETED|Overall Study||4
248521|NCT01046136|601456|P2|COMPLETED|Overall Study||182
248522|NCT01046136|601457|P1|COMPLETED|Overall Study||184
248523|NCT01046136|601456|P2|STARTED|Overall Study||190
248524|NCT01046136|601457|P1|STARTED|Overall Study||188
248525|NCT01046110|601469|P2|NOT COMPLETED|Overall Study||55
248526|NCT01046110|601470|P1|NOT COMPLETED|Overall Study||55
248527|NCT01046110|601469|P2|COMPLETED|Overall Study||174
248528|NCT01046110|601470|P1|COMPLETED|Overall Study||174
248529|NCT01046110|601469|P2|Exposed|Overall Study|1 subject was randomised in error|228
248530|NCT01046110|601470|P1|Exposed|Overall Study|2 subjects were randomised in error and 1 subject did not want to take insulin|226
248531|NCT01046110|601469|P2|STARTED|Overall Study||229
248532|NCT01046110|601470|P1|STARTED|Overall Study||229
248533|NCT01046084|601480|P2|NOT COMPLETED|Fourth Intervention||0
248534|NCT01046084|601481|P1|NOT COMPLETED|Fourth Intervention||0
248535|NCT01046084|601480|P2|COMPLETED|Fourth Intervention||25
248536|NCT01046084|601481|P1|COMPLETED|Fourth Intervention||23
248537|NCT01046084|601480|P2|STARTED|Fourth Intervention||25
248538|NCT01046084|601481|P1|STARTED|Fourth Intervention||23
248539|NCT01046084|601480|P2|NOT COMPLETED|Third Washout of 7 Days||0
248540|NCT01046084|601481|P1|NOT COMPLETED|Third Washout of 7 Days||2
248541|NCT01046084|601480|P2|COMPLETED|Third Washout of 7 Days||25
248542|NCT01046084|601481|P1|COMPLETED|Third Washout of 7 Days||23
248543|NCT01046084|601480|P2|STARTED|Third Washout of 7 Days||25
248544|NCT01046084|601481|P1|STARTED|Third Washout of 7 Days||25
248545|NCT01046084|601480|P2|NOT COMPLETED|Third Intervention||0
248546|NCT01046084|601481|P1|NOT COMPLETED|Third Intervention||0
248547|NCT01046084|601480|P2|COMPLETED|Third Intervention||25
248548|NCT01046084|601481|P1|COMPLETED|Third Intervention||25
248549|NCT01046084|601480|P2|STARTED|Third Intervention||25
248550|NCT01046084|601481|P1|STARTED|Third Intervention||25
248551|NCT01046084|601480|P2|NOT COMPLETED|Second Washout of 7 Days||0
248552|NCT01046084|601481|P1|NOT COMPLETED|Second Washout of 7 Days||0
248553|NCT01046084|601480|P2|COMPLETED|Second Washout of 7 Days||25
248554|NCT01046084|601481|P1|COMPLETED|Second Washout of 7 Days||25
248555|NCT01046084|601480|P2|STARTED|Second Washout of 7 Days||25
248556|NCT01046084|601481|P1|STARTED|Second Washout of 7 Days||25
248557|NCT01046084|601480|P2|NOT COMPLETED|Second Intervention||0
248558|NCT01046084|601481|P1|NOT COMPLETED|Second Intervention||0
248559|NCT01046084|601480|P2|COMPLETED|Second Intervention||25
248560|NCT01046084|601481|P1|COMPLETED|Second Intervention||25
248561|NCT01046084|601480|P2|STARTED|Second Intervention||25
248562|NCT01046084|601481|P1|STARTED|Second Intervention||25
248563|NCT01046084|601480|P2|NOT COMPLETED|First Washout of 7 Days||0
248564|NCT01046084|601481|P1|NOT COMPLETED|First Washout of 7 Days||0
248565|NCT01046084|601480|P2|COMPLETED|First Washout of 7 Days||25
248566|NCT01046084|601481|P1|COMPLETED|First Washout of 7 Days||25
248567|NCT01046084|601480|P2|STARTED|First Washout of 7 Days||25
248568|NCT01046084|601481|P1|STARTED|First Washout of 7 Days||25
248569|NCT01046084|601480|P2|NOT COMPLETED|First Intervention||0
248570|NCT01046084|601481|P1|NOT COMPLETED|First Intervention||0
248571|NCT01046084|601480|P2|COMPLETED|First Intervention||25
248572|NCT01046084|601481|P1|COMPLETED|First Intervention||25
248573|NCT01046084|601480|P2|STARTED|First Intervention||25
248574|NCT01046084|601481|P1|STARTED|First Intervention||25
248575|NCT01045993|601495|P4|NOT COMPLETED|Overall Study||0
248576|NCT01045993|601496|P3|NOT COMPLETED|Overall Study||0
248577|NCT01045993|601497|P2|NOT COMPLETED|Overall Study||1
248578|NCT01045993|601498|P1|NOT COMPLETED|Overall Study||0
248579|NCT01045993|601495|P4|COMPLETED|Overall Study||25
248580|NCT01045993|601496|P3|COMPLETED|Overall Study||5
248581|NCT01045993|601497|P2|COMPLETED|Overall Study||4
248582|NCT01045993|601498|P1|COMPLETED|Overall Study||26
248583|NCT01045993|601495|P4|STARTED|Overall Study||25
248584|NCT01045993|601496|P3|STARTED|Overall Study||5
248585|NCT01045993|601497|P2|STARTED|Overall Study||5
248586|NCT01045993|601498|P1|STARTED|Overall Study||26
248587|NCT01045967|601574|P2|NOT COMPLETED|Second Intervention||1
248588|NCT01045967|601575|P1|NOT COMPLETED|Second Intervention||0
248589|NCT01045967|601574|P2|COMPLETED|Second Intervention||27
248590|NCT01045967|601575|P1|COMPLETED|Second Intervention||28
248591|NCT01045967|601574|P2|STARTED|Second Intervention|Subject was dropped prior to dosing in Period II due to positive drug screen.|28
248592|NCT01045967|601575|P1|STARTED|Second Intervention||28
248593|NCT01045967|601574|P2|NOT COMPLETED|Washout of 7 Days||0
248594|NCT01045967|601575|P1|NOT COMPLETED|Washout of 7 Days||0
248595|NCT01045967|601574|P2|COMPLETED|Washout of 7 Days||28
248596|NCT01045967|601575|P1|COMPLETED|Washout of 7 Days||28
248597|NCT01045967|601574|P2|STARTED|Washout of 7 Days||28
248598|NCT01045967|601575|P1|STARTED|Washout of 7 Days||28
248599|NCT01045967|601574|P2|NOT COMPLETED|First Intervention||0
248600|NCT01045967|601575|P1|NOT COMPLETED|First Intervention||0
248601|NCT01045967|601574|P2|COMPLETED|First Intervention||28
248602|NCT01045967|601575|P1|COMPLETED|First Intervention||28
248603|NCT01045967|601574|P2|STARTED|First Intervention||28
248604|NCT01045967|601575|P1|STARTED|First Intervention||28
248605|NCT01045798|601587|P2|NOT COMPLETED|Overall Study||4
248606|NCT01045798|601588|P1|NOT COMPLETED|Overall Study||2
248607|NCT01045798|601587|P2|COMPLETED|Overall Study||5
248608|NCT01045798|601588|P1|COMPLETED|Overall Study||4
248609|NCT01045798|601587|P2|STARTED|Overall Study||9
248610|NCT01045798|601588|P1|STARTED|Overall Study||6
248611|NCT01045707|601596|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||12
248612|NCT01045707|601597|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||13
248613|NCT01045707|601596|P2|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||209
248614|NCT01045707|601597|P1|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||179
248615|NCT01045707|601596|P2|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Eleven subjects from main trial did not continue into the extension|221
248616|NCT01045707|601597|P1|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Twenty seven subjects from main trial did not continue into the extension|192
248617|NCT01045707|601596|P2|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||32
248618|NCT01045707|601597|P1|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||47
248619|NCT01045707|601596|P2|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||232
248620|NCT01045707|601597|P1|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||219
248621|NCT01045707|601596|P2|Exposed|Main: Week 0 to 26 (NN5401-3590)|Three subjects withdrew prior to exposure to trial drug|261
248622|NCT01045707|601597|P1|Exposed|Main: Week 0 to 26 (NN5401-3590)|One subject withdrew prior to exposure to trial drug|265
248623|NCT01045707|601596|P2|STARTED|Main: Week 0 to 26 (NN5401-3590)||264
248624|NCT01045707|601597|P1|STARTED|Main: Week 0 to 26 (NN5401-3590)||266
248625|NCT01045694|601613|P1|NOT COMPLETED|Overall Study||2
248626|NCT01045694|601613|P1|COMPLETED|Overall Study||6
248627|NCT01045694|601613|P1|STARTED|Overall Study||8
248628|NCT01045551|601619|P1|NOT COMPLETED|Overall Study||0
248629|NCT01045551|601619|P1|COMPLETED|Overall Study||10
248630|NCT01045551|601619|P1|STARTED|Overall Study||10
248631|NCT01045460|601629|P2|NOT COMPLETED|Overall Study||3
248632|NCT01045460|601630|P1|NOT COMPLETED|Overall Study||6
248633|NCT01045460|601629|P2|COMPLETED|Overall Study||15
248634|NCT01045460|601630|P1|COMPLETED|Overall Study||11
248635|NCT01045460|601629|P2|STARTED|Overall Study||18
248636|NCT01045460|601630|P1|STARTED|Overall Study||17
248637|NCT01045447|601642|P2|NOT COMPLETED|Overall Study||28
248638|NCT01045447|601643|P1|NOT COMPLETED|Overall Study||36
248639|NCT01045447|601642|P2|COMPLETED|Overall Study||205
248640|NCT01045447|601643|P1|COMPLETED|Overall Study||196
248641|NCT01045447|601642|P2|Exposed|Overall Study||233
248642|NCT01045447|601643|P1|Exposed|Overall Study|Two subjects withdrew prior to exposure to trial drug|230
248643|NCT01045447|601642|P2|STARTED|Overall Study||233
248644|NCT01045447|601643|P1|STARTED|Overall Study||232
248645|NCT01045421|601657|P11|NOT COMPLETED|Phase 2||2
248646|NCT01045421|601658|P10|NOT COMPLETED|Phase 2||3
248647|NCT01045421|601659|P9|NOT COMPLETED|Phase 2||2
248648|NCT01045421|601660|P8|NOT COMPLETED|Phase 2||5
248649|NCT01045421|601661|P7|NOT COMPLETED|Phase 2||0
248650|NCT01045421|601662|P6|NOT COMPLETED|Phase 2||0
248651|NCT01045421|601663|P5|NOT COMPLETED|Phase 2||0
248652|NCT01045421|601664|P4|NOT COMPLETED|Phase 2||0
248653|NCT01045421|601665|P3|NOT COMPLETED|Phase 2||0
248654|NCT01045421|601666|P2|NOT COMPLETED|Phase 2||0
248655|NCT01045421|601667|P1|NOT COMPLETED|Phase 2||0
248656|NCT01045421|601657|P11|COMPLETED|Phase 2||58
248657|NCT01045421|601658|P10|COMPLETED|Phase 2||23
248658|NCT01045421|601659|P9|COMPLETED|Phase 2||53
248659|NCT01045421|601660|P8|COMPLETED|Phase 2||50
248660|NCT01045421|601661|P7|COMPLETED|Phase 2||53
248661|NCT01045421|601662|P6|COMPLETED|Phase 2||0
248662|NCT01045421|601663|P5|COMPLETED|Phase 2||0
248663|NCT01045421|601664|P4|COMPLETED|Phase 2||0
248664|NCT01045421|601665|P3|COMPLETED|Phase 2||0
248665|NCT01045421|601666|P2|COMPLETED|Phase 2||0
248666|NCT01045421|601667|P1|COMPLETED|Phase 2||0
248667|NCT01045421|601657|P11|STARTED|Phase 2||60
248668|NCT01045421|601658|P10|STARTED|Phase 2||26
248669|NCT01045421|601659|P9|STARTED|Phase 2||55
248670|NCT01045421|601660|P8|STARTED|Phase 2||55
248671|NCT01045421|601661|P7|STARTED|Phase 2||53
248672|NCT01045421|601662|P6|STARTED|Phase 2||0
248673|NCT01045421|601663|P5|STARTED|Phase 2||0
248674|NCT01045421|601664|P4|STARTED|Phase 2||0
248675|NCT01045421|601665|P3|STARTED|Phase 2||0
248676|NCT01045421|601666|P2|STARTED|Phase 2||0
248677|NCT01045421|601667|P1|STARTED|Phase 2||0
248678|NCT01045421|601657|P11|NOT COMPLETED|Phase 1||0
248679|NCT01045421|601658|P10|NOT COMPLETED|Phase 1||0
248680|NCT01045421|601659|P9|NOT COMPLETED|Phase 1||0
248681|NCT01045421|601660|P8|NOT COMPLETED|Phase 1||0
248682|NCT01045421|601661|P7|NOT COMPLETED|Phase 1||0
248683|NCT01045421|601662|P6|NOT COMPLETED|Phase 1||0
248684|NCT01045421|601663|P5|NOT COMPLETED|Phase 1||1
248685|NCT01045421|601664|P4|NOT COMPLETED|Phase 1||1
248686|NCT01045421|601665|P3|NOT COMPLETED|Phase 1||0
248687|NCT01045421|601666|P2|NOT COMPLETED|Phase 1||0
248688|NCT01045421|601667|P1|NOT COMPLETED|Phase 1||0
248689|NCT01045421|601657|P11|COMPLETED|Phase 1||0
248690|NCT01045421|601658|P10|COMPLETED|Phase 1||0
248691|NCT01045421|601659|P9|COMPLETED|Phase 1||0
248692|NCT01045421|601660|P8|COMPLETED|Phase 1||0
248693|NCT01045421|601661|P7|COMPLETED|Phase 1||0
248694|NCT01045421|601662|P6|COMPLETED|Phase 1||1
248695|NCT01045421|601663|P5|COMPLETED|Phase 1||2
248696|NCT01045421|601664|P4|COMPLETED|Phase 1||11
248697|NCT01045421|601665|P3|COMPLETED|Phase 1||4
248698|NCT01045421|601666|P2|COMPLETED|Phase 1||3
248699|NCT01045421|601667|P1|COMPLETED|Phase 1||1
248700|NCT01045421|601657|P11|STARTED|Phase 1||0
248701|NCT01045421|601658|P10|STARTED|Phase 1||0
248702|NCT01045421|601659|P9|STARTED|Phase 1||0
248703|NCT01045421|601660|P8|STARTED|Phase 1||0
248704|NCT01045421|601661|P7|STARTED|Phase 1||0
248705|NCT01045421|601662|P6|STARTED|Phase 1||1
248706|NCT01045421|601663|P5|STARTED|Phase 1||3
248707|NCT01045421|601664|P4|STARTED|Phase 1||12
248708|NCT01045421|601665|P3|STARTED|Phase 1||4
248709|NCT01045421|601666|P2|STARTED|Phase 1||3
248710|NCT01045421|601667|P1|STARTED|Phase 1||1
248711|NCT01045265|601747|P1|NOT COMPLETED|Overall Study||0
248712|NCT01045265|601747|P1|COMPLETED|Overall Study||16
248713|NCT01045265|601747|P1|STARTED|Overall Study||16
248714|NCT01045187|601754|P1|NOT COMPLETED|Overall Study||0
248715|NCT01045187|601754|P1|COMPLETED|Overall Study||15
248716|NCT01045187|601754|P1|STARTED|Overall Study||15
248717|NCT01045161|601761|P3|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||32
248718|NCT01045161|601762|P2|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
248719|NCT01045161|601763|P1|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
248720|NCT01045161|601761|P3|COMPLETED|Part B - 40 Additional Weeks Open Label||115
248721|NCT01045161|601762|P2|COMPLETED|Part B - 40 Additional Weeks Open Label||118
248722|NCT01045161|601763|P1|COMPLETED|Part B - 40 Additional Weeks Open Label||111
248723|NCT01045161|601761|P3|STARTED|Part B - 40 Additional Weeks Open Label||147
248724|NCT01045161|601762|P2|STARTED|Part B - 40 Additional Weeks Open Label||154
248725|NCT01045161|601763|P1|STARTED|Part B - 40 Additional Weeks Open Label||147
248726|NCT01045161|601761|P3|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||30
248727|NCT01045161|601762|P2|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||29
248728|NCT01045161|601763|P1|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||31
248729|NCT01045161|601761|P3|COMPLETED|Part A - 12 Weeks Double Blind Treatment||148
248730|NCT01045161|601762|P2|COMPLETED|Part A - 12 Weeks Double Blind Treatment||155
248731|NCT01045161|601763|P1|COMPLETED|Part A - 12 Weeks Double Blind Treatment||151
248732|NCT01045161|601761|P3|STARTED|Part A - 12 Weeks Double Blind Treatment||178
248733|NCT01045161|601762|P2|STARTED|Part A - 12 Weeks Double Blind Treatment||184
248734|NCT01045161|601763|P1|STARTED|Part A - 12 Weeks Double Blind Treatment||182
248735|NCT01045135|601783|P1|NOT COMPLETED|Overall Study||26
248736|NCT01045135|601783|P1|COMPLETED|Overall Study||274
248737|NCT01045135|601783|P1|STARTED|Overall Study||300
248738|NCT01045122|601790|P2|NOT COMPLETED|Propofol Then Dexmedetomidine||0
248739|NCT01045122|601791|P1|NOT COMPLETED|Propofol Then Dexmedetomidine||0
248740|NCT01045122|601790|P2|COMPLETED|Propofol Then Dexmedetomidine||6
248741|NCT01045122|601791|P1|COMPLETED|Propofol Then Dexmedetomidine||5
248742|NCT01045122|601790|P2|STARTED|Propofol Then Dexmedetomidine||6
248743|NCT01045122|601791|P1|STARTED|Propofol Then Dexmedetomidine||5
248744|NCT01045122|601790|P2|NOT COMPLETED|Dexmedetomidine Then Propofol||0
248745|NCT01045122|601791|P1|NOT COMPLETED|Dexmedetomidine Then Propofol||0
248746|NCT01045122|601790|P2|COMPLETED|Dexmedetomidine Then Propofol||6
248747|NCT01045122|601791|P1|COMPLETED|Dexmedetomidine Then Propofol||5
248748|NCT01045122|601790|P2|STARTED|Dexmedetomidine Then Propofol||6
248749|NCT01045122|601791|P1|STARTED|Dexmedetomidine Then Propofol||5
248750|NCT01045096|601800|P3|NOT COMPLETED|Overall Study||0
248751|NCT01045096|601801|P2|NOT COMPLETED|Overall Study||0
248752|NCT01045096|601802|P1|NOT COMPLETED|Overall Study||3
248753|NCT01045096|601800|P3|COMPLETED|Overall Study||12
248754|NCT01045096|601801|P2|COMPLETED|Overall Study||12
248755|NCT01045096|601802|P1|COMPLETED|Overall Study||9
248756|NCT01045096|601800|P3|Pharmacokinetic Set|Overall Study||11
248757|NCT01045096|601801|P2|Pharmacokinetic Set|Overall Study||11
248758|NCT01045096|601802|P1|Pharmacokinetic Set|Overall Study|All patients with at least one estimable PK parameter for dexlansoprazole on Day 7.|9
248759|NCT01045096|601800|P3|STARTED|Overall Study||12
248760|NCT01045096|601801|P2|STARTED|Overall Study||12
248761|NCT01045096|601802|P1|STARTED|Overall Study||12
248762|NCT01045057|601828|P1|NOT COMPLETED|Overall Study||0
248763|NCT01045057|601828|P1|COMPLETED|Overall Study||27
248764|NCT01045057|601828|P1|STARTED|Overall Study||27
248765|NCT01045031|601837|P2|NOT COMPLETED|Overall Study||6
248766|NCT01045031|601838|P1|NOT COMPLETED|Overall Study||9
248767|NCT01045031|601837|P2|COMPLETED|Overall Study||50
248768|NCT01045031|601838|P1|COMPLETED|Overall Study||49
248769|NCT01045031|601837|P2|STARTED|Overall Study||56
248770|NCT01045031|601838|P1|STARTED|Overall Study||58
248771|NCT01044966|601848|P1|NOT COMPLETED|Consolidation Phase||10
248772|NCT01044966|601848|P1|COMPLETED|Consolidation Phase||2
248773|NCT01044966|601848|P1|STARTED|Consolidation Phase||12
248774|NCT01044966|601848|P1|NOT COMPLETED|Induction Phase||0
248775|NCT01044966|601848|P1|COMPLETED|Induction Phase||12
248776|NCT01044966|601848|P1|STARTED|Induction Phase||12
248777|NCT01044862|601859|P3|NOT COMPLETED|Overall Study||52
248778|NCT01044862|601860|P2|NOT COMPLETED|Overall Study||49
248779|NCT01044862|601861|P1|NOT COMPLETED|Overall Study||53
248780|NCT01044862|601859|P3|COMPLETED|Overall Study||249
248781|NCT01044862|601860|P2|COMPLETED|Overall Study||251
248782|NCT01044862|601861|P1|COMPLETED|Overall Study||246
248783|NCT01044862|601859|P3|STARTED|Overall Study||301
248784|NCT01044862|601860|P2|STARTED|Overall Study||300
248785|NCT01044862|601861|P1|STARTED|Overall Study||299
248786|NCT01044771|601878|P1|NOT COMPLETED|Overall Study||0
248787|NCT01044771|601878|P1|COMPLETED|Overall Study||20
248788|NCT01044771|601878|P1|STARTED|Overall Study||20
248789|NCT01044758|601890|P7|NOT COMPLETED|Overall Study||10
248790|NCT01044758|601891|P6|NOT COMPLETED|Overall Study||3
248791|NCT01044758|601892|P5|NOT COMPLETED|Overall Study||2
248792|NCT01044758|601893|P4|NOT COMPLETED|Overall Study||2
248793|NCT01044758|601894|P3|NOT COMPLETED|Overall Study||4
248794|NCT01044758|601895|P2|NOT COMPLETED|Overall Study||0
248795|NCT01044758|601896|P1|NOT COMPLETED|Overall Study||4
248796|NCT01044758|601890|P7|COMPLETED|Overall Study||17
248797|NCT01044758|601891|P6|COMPLETED|Overall Study||8
248798|NCT01044758|601892|P5|COMPLETED|Overall Study||9
248799|NCT01044758|601893|P4|COMPLETED|Overall Study||10
248800|NCT01044758|601894|P3|COMPLETED|Overall Study||7
248801|NCT01044758|601895|P2|COMPLETED|Overall Study||12
248802|NCT01044758|601896|P1|COMPLETED|Overall Study||8
248803|NCT01044758|601890|P7|STARTED|Overall Study||27
248804|NCT01044758|601891|P6|STARTED|Overall Study||11
248805|NCT01044758|601892|P5|STARTED|Overall Study||11
248806|NCT01044758|601893|P4|STARTED|Overall Study||12
248807|NCT01044758|601894|P3|STARTED|Overall Study||11
248808|NCT01044758|601895|P2|STARTED|Overall Study||12
248809|NCT01044758|601896|P1|STARTED|Overall Study||12
248810|NCT01044745|601919|P1|NOT COMPLETED|Overall Study||2
248811|NCT01044745|601919|P1|COMPLETED|Overall Study||18
248812|NCT01044745|601919|P1|STARTED|Overall Study||20
248813|NCT01044732|601928|P2|NOT COMPLETED|Overall Study||50
248814|NCT01044732|601929|P1|NOT COMPLETED|Overall Study||49
248815|NCT01044732|601928|P2|COMPLETED|Overall Study||176
248816|NCT01044732|601929|P1|COMPLETED|Overall Study||173
248817|NCT01044732|601928|P2|STARTED|Overall Study||226
248818|NCT01044732|601929|P1|STARTED|Overall Study||222
248819|NCT01044706|601939|P2|NOT COMPLETED|Overall Study||0
248820|NCT01044706|601940|P1|NOT COMPLETED|Overall Study||0
248821|NCT01044706|601939|P2|COMPLETED|Overall Study||30
248822|NCT01044706|601940|P1|COMPLETED|Overall Study||30
248823|NCT01044706|601939|P2|STARTED|Overall Study||30
248824|NCT01044706|601940|P1|STARTED|Overall Study||30
248825|NCT01044693|601948|P16|NOT COMPLETED|Overall Study||0
248826|NCT01044693|601949|P15|NOT COMPLETED|Overall Study||0
248827|NCT01044693|601950|P14|NOT COMPLETED|Overall Study||0
248828|NCT01044693|601951|P13|NOT COMPLETED|Overall Study||0
248829|NCT01044693|601952|P12|NOT COMPLETED|Overall Study||0
248830|NCT01044693|601953|P11|NOT COMPLETED|Overall Study||0
248831|NCT01044693|601954|P10|NOT COMPLETED|Overall Study||0
248832|NCT01044693|601955|P9|NOT COMPLETED|Overall Study||0
248833|NCT01044693|601956|P8|NOT COMPLETED|Overall Study||0
248834|NCT01044693|601957|P7|NOT COMPLETED|Overall Study||0
248835|NCT01044693|601958|P6|NOT COMPLETED|Overall Study||0
248836|NCT01044693|601959|P5|NOT COMPLETED|Overall Study||0
248837|NCT01044693|601960|P4|NOT COMPLETED|Overall Study||0
248838|NCT01044693|601961|P3|NOT COMPLETED|Overall Study||0
248839|NCT01044693|601962|P2|NOT COMPLETED|Overall Study||0
248840|NCT01044693|601963|P1|NOT COMPLETED|Overall Study||0
248841|NCT01044693|601948|P16|COMPLETED|Overall Study||1
248842|NCT01044693|601949|P15|COMPLETED|Overall Study||1
248843|NCT01044693|601950|P14|COMPLETED|Overall Study||1
248844|NCT01044693|601951|P13|COMPLETED|Overall Study||2
248845|NCT01044693|601952|P12|COMPLETED|Overall Study||1
248846|NCT01044693|601953|P11|COMPLETED|Overall Study||1
248847|NCT01044693|601954|P10|COMPLETED|Overall Study||1
248848|NCT01044693|601955|P9|COMPLETED|Overall Study||1
248849|NCT01044693|601956|P8|COMPLETED|Overall Study||1
248850|NCT01044693|601957|P7|COMPLETED|Overall Study||1
248851|NCT01044693|601958|P6|COMPLETED|Overall Study||2
248852|NCT01044693|601959|P5|COMPLETED|Overall Study||1
248853|NCT01044693|601960|P4|COMPLETED|Overall Study||1
248854|NCT01044693|601961|P3|COMPLETED|Overall Study||1
248855|NCT01044693|601962|P2|COMPLETED|Overall Study||1
248856|NCT01044693|601963|P1|COMPLETED|Overall Study||3
248857|NCT01044693|601948|P16|STARTED|Overall Study||1
248858|NCT01044693|601949|P15|STARTED|Overall Study||1
248859|NCT01044693|601950|P14|STARTED|Overall Study||1
248860|NCT01044693|601951|P13|STARTED|Overall Study||2
248861|NCT01044693|601952|P12|STARTED|Overall Study||1
248862|NCT01044693|601953|P11|STARTED|Overall Study||1
248863|NCT01044693|601954|P10|STARTED|Overall Study||1
248864|NCT01044693|601955|P9|STARTED|Overall Study||1
248865|NCT01044693|601956|P8|STARTED|Overall Study||1
248866|NCT01044693|601957|P7|STARTED|Overall Study||1
248867|NCT01044693|601958|P6|STARTED|Overall Study||2
248868|NCT01044693|601959|P5|STARTED|Overall Study||1
248869|NCT01044693|601960|P4|STARTED|Overall Study||1
248870|NCT01044693|601961|P3|STARTED|Overall Study||1
248871|NCT01044693|601962|P2|STARTED|Overall Study||1
248872|NCT01044693|601963|P1|STARTED|Overall Study||3
248873|NCT01044589|601987|P2|NOT COMPLETED|Overall Study||5
248874|NCT01044589|601988|P1|NOT COMPLETED|Overall Study||3
248875|NCT01044589|601987|P2|COMPLETED|Overall Study||2
248876|NCT01044589|601988|P1|COMPLETED|Overall Study||3
248877|NCT01044589|601987|P2|STARTED|Overall Study||7
248878|NCT01044589|601988|P1|STARTED|Overall Study||6
248879|NCT01044537|602003|P7|NOT COMPLETED|Overall Study||0
248880|NCT01044537|602004|P6|NOT COMPLETED|Overall Study||0
248881|NCT01044537|602005|P5|NOT COMPLETED|Overall Study||0
248882|NCT01044537|602006|P4|NOT COMPLETED|Overall Study||0
248883|NCT01044537|602007|P3|NOT COMPLETED|Overall Study||0
248884|NCT01044537|602008|P2|NOT COMPLETED|Overall Study||0
248885|NCT01044537|602009|P1|NOT COMPLETED|Overall Study||0
248886|NCT01044537|602003|P7|COMPLETED|Overall Study||16
248887|NCT01044537|602004|P6|COMPLETED|Overall Study||5
248888|NCT01044537|602005|P5|COMPLETED|Overall Study||5
248889|NCT01044537|602006|P4|COMPLETED|Overall Study||6
248890|NCT01044537|602007|P3|COMPLETED|Overall Study||6
248891|NCT01044537|602008|P2|COMPLETED|Overall Study||6
248892|NCT01044537|602009|P1|COMPLETED|Overall Study||6
248893|NCT01044537|602003|P7|STARTED|Overall Study||16
248894|NCT01044537|602004|P6|STARTED|Overall Study||5
248895|NCT01044537|602005|P5|STARTED|Overall Study||5
248896|NCT01044537|602006|P4|STARTED|Overall Study||6
248897|NCT01044537|602007|P3|STARTED|Overall Study||6
248898|NCT01044537|602008|P2|STARTED|Overall Study||6
248899|NCT01044537|602009|P1|STARTED|Overall Study||6
248900|NCT01044498|602118|P2|NOT COMPLETED|Overall Study||2
248901|NCT01044498|602119|P1|NOT COMPLETED|Overall Study||3
248902|NCT01044498|602118|P2|COMPLETED|Overall Study||21
248903|NCT01044498|602119|P1|COMPLETED|Overall Study||20
248904|NCT01044498|602118|P2|STARTED|Overall Study||23
248905|NCT01044498|602119|P1|STARTED|Overall Study||23
248906|NCT01044459|602145|P2|NOT COMPLETED|Overall Study||131
248907|NCT01044459|602146|P1|NOT COMPLETED|Overall Study||133
248908|NCT01044459|602145|P2|COMPLETED|Overall Study||162
248909|NCT01044459|602146|P1|COMPLETED|Overall Study||179
248910|NCT01044459|602145|P2|STARTED|Overall Study||293
248911|NCT01044459|602146|P1|STARTED|Overall Study||312
248912|NCT01044303|602154|P1|NOT COMPLETED|Overall Study||2
248913|NCT01044303|602154|P1|COMPLETED|Overall Study||30
248914|NCT01044303|602154|P1|STARTED|Overall Study||32
248915|NCT01044290|602164|P3|NOT COMPLETED|Follow-Up 2||2
248916|NCT01044290|602165|P2|NOT COMPLETED|Follow-Up 2||2
248917|NCT01044290|602166|P1|NOT COMPLETED|Follow-Up 2||0
248918|NCT01044290|602164|P3|COMPLETED|Follow-Up 2||69
248919|NCT01044290|602165|P2|COMPLETED|Follow-Up 2||67
248920|NCT01044290|602166|P1|COMPLETED|Follow-Up 2||70
248921|NCT01044290|602164|P3|Completed F2 Interview|Follow-Up 2||64
248922|NCT01044290|602165|P2|Completed F2 Interview|Follow-Up 2||57
248923|NCT01044290|602166|P1|Completed F2 Interview|Follow-Up 2||64
248924|NCT01044290|602164|P3|STARTED|Follow-Up 2||71
248925|NCT01044290|602165|P2|STARTED|Follow-Up 2||69
248926|NCT01044290|602166|P1|STARTED|Follow-Up 2||70
248927|NCT01044290|602164|P3|NOT COMPLETED|Follow-up 1||1
248928|NCT01044290|602165|P2|NOT COMPLETED|Follow-up 1||5
248929|NCT01044290|602166|P1|NOT COMPLETED|Follow-up 1||5
248930|NCT01044290|602164|P3|COMPLETED|Follow-up 1||71
248931|NCT01044290|602165|P2|COMPLETED|Follow-up 1||69
248932|NCT01044290|602166|P1|COMPLETED|Follow-up 1||70
248933|NCT01044290|602164|P3|Completed F1 Interview|Follow-up 1||61
248934|NCT01044290|602165|P2|Completed F1 Interview|Follow-up 1||60
248935|NCT01044290|602166|P1|Completed F1 Interview|Follow-up 1||61
248936|NCT01044290|602164|P3|STARTED|Follow-up 1||72
248937|NCT01044290|602165|P2|STARTED|Follow-up 1||74
248938|NCT01044290|602166|P1|STARTED|Follow-up 1||75
248939|NCT01044290|602164|P3|NOT COMPLETED|Randomization||0
248940|NCT01044290|602165|P2|NOT COMPLETED|Randomization||0
248941|NCT01044290|602166|P1|NOT COMPLETED|Randomization||0
248942|NCT01044290|602164|P3|COMPLETED|Randomization||72
248943|NCT01044290|602165|P2|COMPLETED|Randomization||74
248944|NCT01044290|602166|P1|COMPLETED|Randomization||75
248945|NCT01044290|602164|P3|Randomized|Randomization||72
248946|NCT01044290|602165|P2|Randomized|Randomization||74
248947|NCT01044290|602166|P1|Randomized|Randomization||75
248948|NCT01044290|602164|P3|STARTED|Randomization||72
248949|NCT01044290|602165|P2|STARTED|Randomization||74
248950|NCT01044290|602166|P1|STARTED|Randomization||75
248951|NCT01044264|602192|P3|NOT COMPLETED|Overall Study||92
248952|NCT01044264|602193|P2|NOT COMPLETED|Overall Study||94
248953|NCT01044264|602194|P1|NOT COMPLETED|Overall Study||90
248954|NCT01044264|602192|P3|COMPLETED|Overall Study||108
248955|NCT01044264|602193|P2|COMPLETED|Overall Study||108
248956|NCT01044264|602194|P1|COMPLETED|Overall Study||110
248957|NCT01044264|602192|P3|STARTED|Overall Study||200
248958|NCT01044264|602193|P2|STARTED|Overall Study||202
248959|NCT01044264|602194|P1|STARTED|Overall Study||200
248960|NCT01044212|602204|P2|NOT COMPLETED|Overall Study||7
248961|NCT01044212|602205|P1|NOT COMPLETED|Overall Study||5
248962|NCT01044212|602204|P2|COMPLETED|Overall Study||30
248963|NCT01044212|602205|P1|COMPLETED|Overall Study||30
248964|NCT01044212|602204|P2|STARTED|Overall Study||37
248965|NCT01044212|602205|P1|STARTED|Overall Study||35
248966|NCT01044056|602218|P3|NOT COMPLETED|Overall Study||0
248967|NCT01044056|602219|P2|NOT COMPLETED|Overall Study||0
248968|NCT01044056|602220|P1|NOT COMPLETED|Overall Study||0
248969|NCT01044056|602218|P3|COMPLETED|Overall Study||8
248970|NCT01044056|602219|P2|COMPLETED|Overall Study||8
248971|NCT01044056|602220|P1|COMPLETED|Overall Study||8
248972|NCT01044056|602218|P3|STARTED|Overall Study||8
248973|NCT01044056|602219|P2|STARTED|Overall Study||8
248974|NCT01044056|602220|P1|STARTED|Overall Study||8
248975|NCT01044030|602239|P2|NOT COMPLETED|Overall Study||20
248976|NCT01044030|602240|P1|NOT COMPLETED|Overall Study||19
248977|NCT01044030|602239|P2|COMPLETED|Overall Study||146
248978|NCT01044030|602240|P1|COMPLETED|Overall Study||141
248979|NCT01044030|602239|P2|STARTED|Overall Study||166
248980|NCT01044030|602240|P1|STARTED|Overall Study||160
248981|NCT01043939|602254|P2|NOT COMPLETED|Second Intervention||0
248982|NCT01043939|602255|P1|NOT COMPLETED|Second Intervention||0
248983|NCT01043939|602254|P2|COMPLETED|Second Intervention||12
248984|NCT01043939|602255|P1|COMPLETED|Second Intervention||12
248985|NCT01043939|602254|P2|STARTED|Second Intervention||12
248986|NCT01043939|602255|P1|STARTED|Second Intervention||12
248987|NCT01043939|602254|P2|NOT COMPLETED|Washout Period||0
248988|NCT01043939|602255|P1|NOT COMPLETED|Washout Period||0
248989|NCT01043939|602254|P2|COMPLETED|Washout Period||12
248990|NCT01043939|602255|P1|COMPLETED|Washout Period||12
248991|NCT01043939|602254|P2|STARTED|Washout Period||12
248992|NCT01043939|602255|P1|STARTED|Washout Period||12
248993|NCT01043939|602254|P2|NOT COMPLETED|First Intervention||0
248994|NCT01043939|602255|P1|NOT COMPLETED|First Intervention||0
248995|NCT01043939|602254|P2|COMPLETED|First Intervention||12
248996|NCT01043939|602255|P1|COMPLETED|First Intervention||12
248997|NCT01043939|602254|P2|STARTED|First Intervention||12
248998|NCT01043939|602255|P1|STARTED|First Intervention||12
248999|NCT01043926|602269|P4|NOT COMPLETED|Overall Study||0
249000|NCT01043926|602270|P3|NOT COMPLETED|Overall Study||0
249001|NCT01043926|602271|P2|NOT COMPLETED|Overall Study||0
249002|NCT01043926|602272|P1|NOT COMPLETED|Overall Study||0
249003|NCT01043926|602269|P4|COMPLETED|Overall Study||0
249004|NCT01043926|602270|P3|COMPLETED|Overall Study||0
249005|NCT01043926|602271|P2|COMPLETED|Overall Study||8
249006|NCT01043926|602272|P1|COMPLETED|Overall Study||8
249007|NCT01043926|602269|P4|STARTED|Overall Study||0
249008|NCT01043926|602270|P3|STARTED|Overall Study||0
249009|NCT01043926|602271|P2|STARTED|Overall Study||8
249010|NCT01043926|602272|P1|STARTED|Overall Study||8
249011|NCT01043874|602286|P1|NOT COMPLETED|Overall Study||6
249012|NCT01043874|602286|P1|COMPLETED|Overall Study||39
249013|NCT01043874|602286|P1|STARTED|Overall Study||45
249014|NCT01043705|602296|P3|NOT COMPLETED|Overall Study||80
249015|NCT01043705|602297|P2|NOT COMPLETED|Overall Study||131
249016|NCT01043705|602298|P1|NOT COMPLETED|Overall Study||107
249017|NCT01043705|602296|P3|COMPLETED|Overall Study||498
249018|NCT01043705|602297|P2|COMPLETED|Overall Study||447
249019|NCT01043705|602298|P1|COMPLETED|Overall Study||352
249020|NCT01043705|602296|P3|STARTED|Overall Study||578
249021|NCT01043705|602297|P2|STARTED|Overall Study||578
249022|NCT01043705|602298|P1|STARTED|Overall Study||459
249023|NCT01043653|602308|P1|NOT COMPLETED|Overall Study||64
249024|NCT01043653|602308|P1|COMPLETED|Overall Study||186
249025|NCT01043653|602308|P1|STARTED|Overall Study||250
249026|NCT01043640|602313|P1|NOT COMPLETED|Overall Study||0
249027|NCT01043640|602313|P1|COMPLETED|Overall Study||46
249028|NCT01043640|602313|P1|STARTED|Overall Study||46
249029|NCT01043562|602328|P1|NOT COMPLETED|Overall Study||0
249030|NCT01043562|602328|P1|COMPLETED|Overall Study||20
249031|NCT01043562|602328|P1|STARTED|Overall Study||20
249032|NCT01043523|602335|P1|NOT COMPLETED|Overall Study||0
249033|NCT01043523|602335|P1|COMPLETED|Overall Study||52
249034|NCT01043523|602335|P1|Participants With Unenhanced Images|Overall Study||51
249035|NCT01043523|602335|P1|STARTED|Overall Study||52
249036|NCT01043432|602364|P4|NOT COMPLETED|Overall Study||0
249037|NCT01043432|602365|P3|NOT COMPLETED|Overall Study||0
249038|NCT01043432|602366|P2|NOT COMPLETED|Overall Study||0
249039|NCT01043432|602367|P1|NOT COMPLETED|Overall Study||0
249040|NCT01043432|602364|P4|COMPLETED|Overall Study||48
249041|NCT01043432|602365|P3|COMPLETED|Overall Study||12
249042|NCT01043432|602366|P2|COMPLETED|Overall Study||51
249043|NCT01043432|602367|P1|COMPLETED|Overall Study||22
249044|NCT01043432|602364|P4|STARTED|Overall Study||48
249045|NCT01043432|602365|P3|STARTED|Overall Study||12
249046|NCT01043432|602366|P2|STARTED|Overall Study||51
249047|NCT01043432|602367|P1|STARTED|Overall Study||22
249048|NCT01043393|602376|P2|NOT COMPLETED|Overall Study||0
249049|NCT01043393|602377|P1|NOT COMPLETED|Overall Study||0
249050|NCT01043393|602376|P2|COMPLETED|Overall Study||12
249051|NCT01043393|602377|P1|COMPLETED|Overall Study||12
249052|NCT01043393|602376|P2|STARTED|Overall Study||12
249053|NCT01043393|602377|P1|STARTED|Overall Study||12
249054|NCT01043185|602387|P10|NOT COMPLETED|Period 7 - Fourth Intervention||0
249055|NCT01043185|602388|P9|NOT COMPLETED|Period 7 - Fourth Intervention||0
249056|NCT01043185|602389|P8|NOT COMPLETED|Period 7 - Fourth Intervention||0
249057|NCT01043185|602390|P7|NOT COMPLETED|Period 7 - Fourth Intervention||0
249058|NCT01043185|602391|P6|NOT COMPLETED|Period 7 - Fourth Intervention||0
249059|NCT01043185|602392|P5|NOT COMPLETED|Period 7 - Fourth Intervention||0
249060|NCT01043185|602393|P4|NOT COMPLETED|Period 7 - Fourth Intervention||0
249061|NCT01043185|602394|P3|NOT COMPLETED|Period 7 - Fourth Intervention||0
249062|NCT01043185|602395|P2|NOT COMPLETED|Period 7 - Fourth Intervention||0
249063|NCT01043185|602396|P1|NOT COMPLETED|Period 7 - Fourth Intervention||0
249064|NCT01043185|602387|P10|COMPLETED|Period 7 - Fourth Intervention||3
249065|NCT01043185|602388|P9|COMPLETED|Period 7 - Fourth Intervention||2
249066|NCT01043185|602389|P8|COMPLETED|Period 7 - Fourth Intervention||3
249067|NCT01043185|602390|P7|COMPLETED|Period 7 - Fourth Intervention||3
249068|NCT01043185|602391|P6|COMPLETED|Period 7 - Fourth Intervention||3
249069|NCT01043185|602392|P5|COMPLETED|Period 7 - Fourth Intervention||2
249070|NCT01043185|602393|P4|COMPLETED|Period 7 - Fourth Intervention||2
249071|NCT01043185|602394|P3|COMPLETED|Period 7 - Fourth Intervention||3
249072|NCT01043185|602395|P2|COMPLETED|Period 7 - Fourth Intervention||2
249073|NCT01043185|602396|P1|COMPLETED|Period 7 - Fourth Intervention||3
249074|NCT01043185|602387|P10|STARTED|Period 7 - Fourth Intervention||3
249075|NCT01043185|602388|P9|STARTED|Period 7 - Fourth Intervention||2
249076|NCT01043185|602389|P8|STARTED|Period 7 - Fourth Intervention||3
249077|NCT01043185|602390|P7|STARTED|Period 7 - Fourth Intervention||3
249078|NCT01043185|602391|P6|STARTED|Period 7 - Fourth Intervention||3
249079|NCT01043185|602392|P5|STARTED|Period 7 - Fourth Intervention||2
249080|NCT01043185|602393|P4|STARTED|Period 7 - Fourth Intervention||2
249081|NCT01043185|602394|P3|STARTED|Period 7 - Fourth Intervention||3
249082|NCT01043185|602395|P2|STARTED|Period 7 - Fourth Intervention||2
249083|NCT01043185|602396|P1|STARTED|Period 7 - Fourth Intervention||3
249084|NCT01043185|602387|P10|NOT COMPLETED|Period 6 - Third Washout Period||0
249085|NCT01043185|602388|P9|NOT COMPLETED|Period 6 - Third Washout Period||1
249086|NCT01043185|602389|P8|NOT COMPLETED|Period 6 - Third Washout Period||0
249087|NCT01043185|602390|P7|NOT COMPLETED|Period 6 - Third Washout Period||0
249088|NCT01043185|602391|P6|NOT COMPLETED|Period 6 - Third Washout Period||0
249089|NCT01043185|602392|P5|NOT COMPLETED|Period 6 - Third Washout Period||0
249090|NCT01043185|602393|P4|NOT COMPLETED|Period 6 - Third Washout Period||0
249091|NCT01043185|602394|P3|NOT COMPLETED|Period 6 - Third Washout Period||0
249092|NCT01043185|602395|P2|NOT COMPLETED|Period 6 - Third Washout Period||0
249093|NCT01043185|602396|P1|NOT COMPLETED|Period 6 - Third Washout Period||0
249094|NCT01043185|602387|P10|COMPLETED|Period 6 - Third Washout Period||3
249095|NCT01043185|602388|P9|COMPLETED|Period 6 - Third Washout Period||2
249096|NCT01043185|602389|P8|COMPLETED|Period 6 - Third Washout Period||3
249097|NCT01043185|602390|P7|COMPLETED|Period 6 - Third Washout Period||3
249098|NCT01043185|602391|P6|COMPLETED|Period 6 - Third Washout Period||3
249099|NCT01043185|602392|P5|COMPLETED|Period 6 - Third Washout Period||2
249100|NCT01043185|602393|P4|COMPLETED|Period 6 - Third Washout Period||2
249101|NCT01043185|602394|P3|COMPLETED|Period 6 - Third Washout Period||3
249102|NCT01043185|602395|P2|COMPLETED|Period 6 - Third Washout Period||2
249103|NCT01043185|602396|P1|COMPLETED|Period 6 - Third Washout Period||3
249104|NCT01043185|602387|P10|STARTED|Period 6 - Third Washout Period||3
249105|NCT01043185|602388|P9|STARTED|Period 6 - Third Washout Period||3
249106|NCT01043185|602389|P8|STARTED|Period 6 - Third Washout Period||3
249107|NCT01043185|602390|P7|STARTED|Period 6 - Third Washout Period||3
249108|NCT01043185|602391|P6|STARTED|Period 6 - Third Washout Period||3
249109|NCT01043185|602392|P5|STARTED|Period 6 - Third Washout Period||2
249110|NCT01043185|602393|P4|STARTED|Period 6 - Third Washout Period||2
249111|NCT01043185|602394|P3|STARTED|Period 6 - Third Washout Period||3
249112|NCT01043185|602395|P2|STARTED|Period 6 - Third Washout Period||2
249113|NCT01043185|602396|P1|STARTED|Period 6 - Third Washout Period||3
249114|NCT01043185|602387|P10|NOT COMPLETED|Period 5 - Third Intervention||0
249115|NCT01043185|602388|P9|NOT COMPLETED|Period 5 - Third Intervention||0
249116|NCT01043185|602389|P8|NOT COMPLETED|Period 5 - Third Intervention||0
249117|NCT01043185|602390|P7|NOT COMPLETED|Period 5 - Third Intervention||0
249118|NCT01043185|602391|P6|NOT COMPLETED|Period 5 - Third Intervention||0
249119|NCT01043185|602392|P5|NOT COMPLETED|Period 5 - Third Intervention||0
249120|NCT01043185|602393|P4|NOT COMPLETED|Period 5 - Third Intervention||0
249121|NCT01043185|602394|P3|NOT COMPLETED|Period 5 - Third Intervention||0
249122|NCT01043185|602395|P2|NOT COMPLETED|Period 5 - Third Intervention||0
249123|NCT01043185|602396|P1|NOT COMPLETED|Period 5 - Third Intervention||0
249124|NCT01043185|602387|P10|COMPLETED|Period 5 - Third Intervention||3
249125|NCT01043185|602388|P9|COMPLETED|Period 5 - Third Intervention||3
249126|NCT01043185|602389|P8|COMPLETED|Period 5 - Third Intervention||3
249127|NCT01043185|602390|P7|COMPLETED|Period 5 - Third Intervention||3
249128|NCT01043185|602391|P6|COMPLETED|Period 5 - Third Intervention||3
249129|NCT01043185|602392|P5|COMPLETED|Period 5 - Third Intervention||2
249130|NCT01043185|602393|P4|COMPLETED|Period 5 - Third Intervention||2
249131|NCT01043185|602394|P3|COMPLETED|Period 5 - Third Intervention||3
249132|NCT01043185|602395|P2|COMPLETED|Period 5 - Third Intervention||2
249133|NCT01043185|602396|P1|COMPLETED|Period 5 - Third Intervention||3
249134|NCT01043185|602387|P10|STARTED|Period 5 - Third Intervention||3
249135|NCT01043185|602388|P9|STARTED|Period 5 - Third Intervention||3
249136|NCT01043185|602389|P8|STARTED|Period 5 - Third Intervention||3
249137|NCT01043185|602390|P7|STARTED|Period 5 - Third Intervention||3
249138|NCT01043185|602391|P6|STARTED|Period 5 - Third Intervention||3
249139|NCT01043185|602392|P5|STARTED|Period 5 - Third Intervention||2
249140|NCT01043185|602393|P4|STARTED|Period 5 - Third Intervention||2
249141|NCT01043185|602394|P3|STARTED|Period 5 - Third Intervention||3
249142|NCT01043185|602395|P2|STARTED|Period 5 - Third Intervention||2
249143|NCT01043185|602396|P1|STARTED|Period 5 - Third Intervention||3
249144|NCT01043185|602387|P10|NOT COMPLETED|Period 4 - Second Washout Period||0
249145|NCT01043185|602388|P9|NOT COMPLETED|Period 4 - Second Washout Period||0
249146|NCT01043185|602389|P8|NOT COMPLETED|Period 4 - Second Washout Period||0
249147|NCT01043185|602390|P7|NOT COMPLETED|Period 4 - Second Washout Period||0
249148|NCT01043185|602391|P6|NOT COMPLETED|Period 4 - Second Washout Period||0
249149|NCT01043185|602392|P5|NOT COMPLETED|Period 4 - Second Washout Period||0
249150|NCT01043185|602393|P4|NOT COMPLETED|Period 4 - Second Washout Period||0
249151|NCT01043185|602394|P3|NOT COMPLETED|Period 4 - Second Washout Period||0
249152|NCT01043185|602395|P2|NOT COMPLETED|Period 4 - Second Washout Period||0
249153|NCT01043185|602396|P1|NOT COMPLETED|Period 4 - Second Washout Period||0
249154|NCT01043185|602387|P10|COMPLETED|Period 4 - Second Washout Period||3
249155|NCT01043185|602388|P9|COMPLETED|Period 4 - Second Washout Period||3
249156|NCT01043185|602389|P8|COMPLETED|Period 4 - Second Washout Period||3
249157|NCT01043185|602390|P7|COMPLETED|Period 4 - Second Washout Period||3
249158|NCT01043185|602391|P6|COMPLETED|Period 4 - Second Washout Period||3
249159|NCT01043185|602392|P5|COMPLETED|Period 4 - Second Washout Period||2
249160|NCT01043185|602393|P4|COMPLETED|Period 4 - Second Washout Period||2
249161|NCT01043185|602394|P3|COMPLETED|Period 4 - Second Washout Period||3
249162|NCT01043185|602395|P2|COMPLETED|Period 4 - Second Washout Period||2
249163|NCT01043185|602396|P1|COMPLETED|Period 4 - Second Washout Period||3
249164|NCT01043185|602387|P10|STARTED|Period 4 - Second Washout Period||3
249165|NCT01043185|602388|P9|STARTED|Period 4 - Second Washout Period||3
249166|NCT01043185|602389|P8|STARTED|Period 4 - Second Washout Period||3
249167|NCT01043185|602390|P7|STARTED|Period 4 - Second Washout Period||3
249168|NCT01043185|602391|P6|STARTED|Period 4 - Second Washout Period||3
249169|NCT01043185|602392|P5|STARTED|Period 4 - Second Washout Period||2
249170|NCT01043185|602393|P4|STARTED|Period 4 - Second Washout Period||2
249171|NCT01043185|602394|P3|STARTED|Period 4 - Second Washout Period||3
249172|NCT01043185|602395|P2|STARTED|Period 4 - Second Washout Period||2
249173|NCT01043185|602396|P1|STARTED|Period 4 - Second Washout Period||3
249174|NCT01043185|602387|P10|NOT COMPLETED|Period 3 - Second Intervention||0
249175|NCT01043185|602388|P9|NOT COMPLETED|Period 3 - Second Intervention||0
249176|NCT01043185|602389|P8|NOT COMPLETED|Period 3 - Second Intervention||0
249177|NCT01043185|602390|P7|NOT COMPLETED|Period 3 - Second Intervention||0
249178|NCT01043185|602391|P6|NOT COMPLETED|Period 3 - Second Intervention||0
249179|NCT01043185|602392|P5|NOT COMPLETED|Period 3 - Second Intervention||0
249180|NCT01043185|602393|P4|NOT COMPLETED|Period 3 - Second Intervention||0
249181|NCT01043185|602394|P3|NOT COMPLETED|Period 3 - Second Intervention||0
249182|NCT01043185|602395|P2|NOT COMPLETED|Period 3 - Second Intervention||0
249183|NCT01043185|602396|P1|NOT COMPLETED|Period 3 - Second Intervention||0
249184|NCT01043185|602387|P10|COMPLETED|Period 3 - Second Intervention||3
249185|NCT01043185|602388|P9|COMPLETED|Period 3 - Second Intervention||3
249186|NCT01043185|602389|P8|COMPLETED|Period 3 - Second Intervention||3
249187|NCT01043185|602390|P7|COMPLETED|Period 3 - Second Intervention||3
249188|NCT01043185|602391|P6|COMPLETED|Period 3 - Second Intervention||3
249189|NCT01043185|602392|P5|COMPLETED|Period 3 - Second Intervention||2
249190|NCT01043185|602393|P4|COMPLETED|Period 3 - Second Intervention||2
249191|NCT01043185|602394|P3|COMPLETED|Period 3 - Second Intervention||3
249192|NCT01043185|602395|P2|COMPLETED|Period 3 - Second Intervention||2
249193|NCT01043185|602396|P1|COMPLETED|Period 3 - Second Intervention||3
249194|NCT01043185|602387|P10|STARTED|Period 3 - Second Intervention||3
249195|NCT01043185|602388|P9|STARTED|Period 3 - Second Intervention||3
249196|NCT01043185|602389|P8|STARTED|Period 3 - Second Intervention||3
249197|NCT01043185|602390|P7|STARTED|Period 3 - Second Intervention||3
249198|NCT01043185|602391|P6|STARTED|Period 3 - Second Intervention||3
249199|NCT01043185|602392|P5|STARTED|Period 3 - Second Intervention||2
249200|NCT01043185|602393|P4|STARTED|Period 3 - Second Intervention||2
249201|NCT01043185|602394|P3|STARTED|Period 3 - Second Intervention||3
249202|NCT01043185|602395|P2|STARTED|Period 3 - Second Intervention||2
249203|NCT01043185|602396|P1|STARTED|Period 3 - Second Intervention||3
249204|NCT01043185|602387|P10|NOT COMPLETED|Period 2 - First Washout Period||0
249205|NCT01043185|602388|P9|NOT COMPLETED|Period 2 - First Washout Period||0
249206|NCT01043185|602389|P8|NOT COMPLETED|Period 2 - First Washout Period||0
249207|NCT01043185|602390|P7|NOT COMPLETED|Period 2 - First Washout Period||0
249208|NCT01043185|602391|P6|NOT COMPLETED|Period 2 - First Washout Period||0
249209|NCT01043185|602392|P5|NOT COMPLETED|Period 2 - First Washout Period||0
249210|NCT01043185|602393|P4|NOT COMPLETED|Period 2 - First Washout Period||0
249211|NCT01043185|602394|P3|NOT COMPLETED|Period 2 - First Washout Period||0
249212|NCT01043185|602395|P2|NOT COMPLETED|Period 2 - First Washout Period||0
249213|NCT01043185|602396|P1|NOT COMPLETED|Period 2 - First Washout Period||0
249214|NCT01043185|602387|P10|COMPLETED|Period 2 - First Washout Period||3
249215|NCT01043185|602388|P9|COMPLETED|Period 2 - First Washout Period||3
249216|NCT01043185|602389|P8|COMPLETED|Period 2 - First Washout Period||3
249217|NCT01043185|602390|P7|COMPLETED|Period 2 - First Washout Period||3
249218|NCT01043185|602391|P6|COMPLETED|Period 2 - First Washout Period||3
249219|NCT01043185|602392|P5|COMPLETED|Period 2 - First Washout Period||2
249220|NCT01043185|602393|P4|COMPLETED|Period 2 - First Washout Period||2
249221|NCT01043185|602394|P3|COMPLETED|Period 2 - First Washout Period||3
249222|NCT01043185|602395|P2|COMPLETED|Period 2 - First Washout Period||2
249223|NCT01043185|602396|P1|COMPLETED|Period 2 - First Washout Period||3
249224|NCT01043185|602387|P10|STARTED|Period 2 - First Washout Period||3
249225|NCT01043185|602388|P9|STARTED|Period 2 - First Washout Period||3
249226|NCT01043185|602389|P8|STARTED|Period 2 - First Washout Period||3
249227|NCT01043185|602390|P7|STARTED|Period 2 - First Washout Period||3
249228|NCT01043185|602391|P6|STARTED|Period 2 - First Washout Period||3
249229|NCT01043185|602392|P5|STARTED|Period 2 - First Washout Period||2
249230|NCT01043185|602393|P4|STARTED|Period 2 - First Washout Period||2
249231|NCT01043185|602394|P3|STARTED|Period 2 - First Washout Period||3
249232|NCT01043185|602395|P2|STARTED|Period 2 - First Washout Period||2
249233|NCT01043185|602396|P1|STARTED|Period 2 - First Washout Period||3
249234|NCT01043185|602387|P10|NOT COMPLETED|Period 1 - First Intervention||0
249235|NCT01043185|602388|P9|NOT COMPLETED|Period 1 - First Intervention||0
249236|NCT01043185|602389|P8|NOT COMPLETED|Period 1 - First Intervention||0
249237|NCT01043185|602390|P7|NOT COMPLETED|Period 1 - First Intervention||0
249238|NCT01043185|602391|P6|NOT COMPLETED|Period 1 - First Intervention||0
249239|NCT01043185|602392|P5|NOT COMPLETED|Period 1 - First Intervention||0
249240|NCT01043185|602393|P4|NOT COMPLETED|Period 1 - First Intervention||0
249241|NCT01043185|602394|P3|NOT COMPLETED|Period 1 - First Intervention||0
249242|NCT01043185|602395|P2|NOT COMPLETED|Period 1 - First Intervention||0
249243|NCT01043185|602396|P1|NOT COMPLETED|Period 1 - First Intervention||0
249244|NCT01043185|602387|P10|COMPLETED|Period 1 - First Intervention||3
249245|NCT01043185|602388|P9|COMPLETED|Period 1 - First Intervention||3
249246|NCT01043185|602389|P8|COMPLETED|Period 1 - First Intervention||3
249247|NCT01043185|602390|P7|COMPLETED|Period 1 - First Intervention||3
249248|NCT01043185|602391|P6|COMPLETED|Period 1 - First Intervention||3
249249|NCT01043185|602392|P5|COMPLETED|Period 1 - First Intervention||2
249250|NCT01043185|602393|P4|COMPLETED|Period 1 - First Intervention||2
249251|NCT01043185|602394|P3|COMPLETED|Period 1 - First Intervention||3
249252|NCT01043185|602395|P2|COMPLETED|Period 1 - First Intervention||2
249253|NCT01043185|602396|P1|COMPLETED|Period 1 - First Intervention||3
249254|NCT01043185|602387|P10|STARTED|Period 1 - First Intervention||3
249255|NCT01043185|602388|P9|STARTED|Period 1 - First Intervention||3
249256|NCT01043185|602389|P8|STARTED|Period 1 - First Intervention||3
249257|NCT01043185|602390|P7|STARTED|Period 1 - First Intervention||3
249258|NCT01043185|602391|P6|STARTED|Period 1 - First Intervention||3
249259|NCT01043185|602392|P5|STARTED|Period 1 - First Intervention||2
249260|NCT01043185|602393|P4|STARTED|Period 1 - First Intervention||2
249261|NCT01043185|602394|P3|STARTED|Period 1 - First Intervention||3
249262|NCT01043185|602395|P2|STARTED|Period 1 - First Intervention||2
249263|NCT01043185|602396|P1|STARTED|Period 1 - First Intervention||3
249264|NCT01043146|602429|P6|NOT COMPLETED|Overall Study||0
249265|NCT01043146|602430|P5|NOT COMPLETED|Overall Study||0
249266|NCT01043146|602431|P4|NOT COMPLETED|Overall Study||0
249267|NCT01043146|602432|P3|NOT COMPLETED|Overall Study||0
249268|NCT01043146|602433|P2|NOT COMPLETED|Overall Study||0
249269|NCT01043146|602434|P1|NOT COMPLETED|Overall Study||0
249270|NCT01043146|602429|P6|COMPLETED|Overall Study||8
249271|NCT01043146|602430|P5|COMPLETED|Overall Study||8
249272|NCT01043146|602431|P4|COMPLETED|Overall Study||8
249273|NCT01043146|602432|P3|COMPLETED|Overall Study||8
249274|NCT01043146|602433|P2|COMPLETED|Overall Study||8
249275|NCT01043146|602434|P1|COMPLETED|Overall Study||10
249276|NCT01043146|602429|P6|STARTED|Overall Study||8
249277|NCT01043146|602430|P5|STARTED|Overall Study||8
249278|NCT01043146|602431|P4|STARTED|Overall Study||8
249279|NCT01043146|602432|P3|STARTED|Overall Study||8
249280|NCT01043146|602433|P2|STARTED|Overall Study||8
249281|NCT01043146|602434|P1|STARTED|Overall Study||10
249282|NCT01043133|602450|P2|NOT COMPLETED|Overall Study||2
249283|NCT01043133|602451|P1|NOT COMPLETED|Overall Study||1
249284|NCT01043133|602450|P2|COMPLETED|Overall Study||78
249285|NCT01043133|602451|P1|COMPLETED|Overall Study||74
249286|NCT01043133|602450|P2|STARTED|Overall Study||80
249287|NCT01043133|602451|P1|STARTED|Overall Study||75
249288|NCT01043094|602461|P2|NOT COMPLETED|Overall Study||0
249289|NCT01043094|602462|P1|NOT COMPLETED|Overall Study||0
249290|NCT01043094|602461|P2|COMPLETED|Overall Study||8
249291|NCT01043094|602462|P1|COMPLETED|Overall Study||8
249292|NCT01043094|602461|P2|STARTED|Overall Study||8
249293|NCT01043094|602462|P1|STARTED|Overall Study||8
249294|NCT01042977|602472|P2|NOT COMPLETED|Overall Study||55
249295|NCT01042977|602473|P1|NOT COMPLETED|Overall Study||41
249296|NCT01042977|602472|P2|COMPLETED|Overall Study||428
249297|NCT01042977|602473|P1|COMPLETED|Overall Study||441
249298|NCT01042977|602472|P2|STARTED|Overall Study|Of the 483 participants only 482 were included in the full analysis set.|483
249299|NCT01042977|602473|P1|STARTED|Overall Study|Of 482 part. 480 were included in full analysis set. Thereof, 1 part. treated but not randomized.|482
249300|NCT01042938|602493|P2|NOT COMPLETED|Overall Study||2
249301|NCT01042938|602494|P1|NOT COMPLETED|Overall Study||3
249302|NCT01042938|602493|P2|COMPLETED|Overall Study||16
249303|NCT01042938|602494|P1|COMPLETED|Overall Study||14
249304|NCT01042938|602493|P2|STARTED|Overall Study|1 withdrew before radiation; 1 non-compliance.|18
249305|NCT01042938|602494|P1|STARTED|Overall Study|1 withdrew before radiation; 1 ineligible due to other clinical trial; 1 non-compliance.|17
249306|NCT01042795|602506|P1|NOT COMPLETED|Follow up - 22 Months After Drug Start||2
249307|NCT01042795|602506|P1|COMPLETED|Follow up - 22 Months After Drug Start||0
249308|NCT01042795|602506|P1|STARTED|Follow up - 22 Months After Drug Start||2
249309|NCT01042795|602506|P1|NOT COMPLETED|Dosing Period - 16 Weeks of Daily Doses||5
249310|NCT01042795|602506|P1|COMPLETED|Dosing Period - 16 Weeks of Daily Doses||2
249311|NCT01042795|602506|P1|STARTED|Dosing Period - 16 Weeks of Daily Doses||7
249312|NCT01042678|602513|P6|NOT COMPLETED|Overall Study||0
249313|NCT01042678|602514|P5|NOT COMPLETED|Overall Study||0
249314|NCT01042678|602515|P4|NOT COMPLETED|Overall Study||0
249315|NCT01042678|602516|P3|NOT COMPLETED|Overall Study||0
249316|NCT01042678|602517|P2|NOT COMPLETED|Overall Study||0
249317|NCT01042678|602518|P1|NOT COMPLETED|Overall Study||1
249318|NCT01042678|602513|P6|COMPLETED|Overall Study||0
249319|NCT01042678|602514|P5|COMPLETED|Overall Study||0
249320|NCT01042678|602515|P4|COMPLETED|Overall Study||0
249321|NCT01042678|602516|P3|COMPLETED|Overall Study||6
249322|NCT01042678|602517|P2|COMPLETED|Overall Study||6
249323|NCT01042678|602518|P1|COMPLETED|Overall Study||5
249324|NCT01042678|602513|P6|STARTED|Overall Study||0
249325|NCT01042678|602514|P5|STARTED|Overall Study||0
249326|NCT01042678|602515|P4|STARTED|Overall Study||0
249327|NCT01042678|602516|P3|STARTED|Overall Study||6
249328|NCT01042678|602517|P2|STARTED|Overall Study||6
249329|NCT01042678|602518|P1|STARTED|Overall Study||6
249330|NCT01042613|602543|P2|NOT COMPLETED|Overall Study||0
249331|NCT01042613|602544|P1|NOT COMPLETED|Overall Study||0
249332|NCT01042613|602543|P2|COMPLETED|Overall Study||74
249333|NCT01042613|602544|P1|COMPLETED|Overall Study||72
249334|NCT01042613|602543|P2|STARTED|Overall Study||74
249335|NCT01042613|602544|P1|STARTED|Overall Study||72
249336|NCT01042600|602556|P2|NOT COMPLETED|Overall Study||0
249337|NCT01042600|602557|P1|NOT COMPLETED|Overall Study||1
249338|NCT01042600|602556|P2|COMPLETED|Overall Study||30
249339|NCT01042600|602557|P1|COMPLETED|Overall Study||30
249340|NCT01042600|602556|P2|STARTED|Overall Study||30
249341|NCT01042600|602557|P1|STARTED|Overall Study||31
249342|NCT01042535|602577|P1|NOT COMPLETED|Overall Study||8
249343|NCT01042535|602577|P1|COMPLETED|Overall Study||36
249344|NCT01042535|602577|P1|STARTED|Overall Study||44
249345|NCT01042509|602585|P1|NOT COMPLETED|Overall Study||0
249346|NCT01042509|602585|P1|COMPLETED|Overall Study||15
249347|NCT01042509|602585|P1|STARTED|Overall Study||15
249348|NCT01042496|602592|P2|NOT COMPLETED|Overall Study||0
249349|NCT01042496|602593|P1|NOT COMPLETED|Overall Study||0
249350|NCT01042496|602592|P2|COMPLETED|Overall Study||33
249351|NCT01042496|602593|P1|COMPLETED|Overall Study||29
249352|NCT01042496|602592|P2|STARTED|Overall Study||33
249353|NCT01042496|602593|P1|STARTED|Overall Study||29
249354|NCT01042392|602611|P4|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
249355|NCT01042392|602612|P3|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||4
249356|NCT01042392|602613|P2|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
249357|NCT01042392|602614|P1|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||2
249358|NCT01042392|602611|P4|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||121
249359|NCT01042392|602612|P3|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||115
249360|NCT01042392|602613|P2|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||117
249361|NCT01042392|602614|P1|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||127
249362|NCT01042392|602611|P4|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||82
249363|NCT01042392|602612|P3|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||93
249364|NCT01042392|602613|P2|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||73
249365|NCT01042392|602614|P1|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)|PPMD excluded patients violated protocol instructions for period 3 (duration and treatment intake)|98
249366|NCT01042392|602611|P4|STARTED|Period III (Unblinded,Controlled, 1 Day)||122
249367|NCT01042392|602612|P3|STARTED|Period III (Unblinded,Controlled, 1 Day)||119
249368|NCT01042392|602613|P2|STARTED|Period III (Unblinded,Controlled, 1 Day)||118
249369|NCT01042392|602614|P1|STARTED|Period III (Unblinded,Controlled, 1 Day)||129
249370|NCT01042392|602611|P4|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
249371|NCT01042392|602612|P3|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||8
249372|NCT01042392|602613|P2|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
249373|NCT01042392|602614|P1|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||10
249374|NCT01042392|602611|P4|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
249375|NCT01042392|602612|P3|COMPLETED|Period II(Randomized,Double Blinded,8wk)||241
249376|NCT01042392|602613|P2|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
249377|NCT01042392|602614|P1|COMPLETED|Period II(Randomized,Double Blinded,8wk)||247
249378|NCT01042392|602611|P4|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
249379|NCT01042392|602612|P3|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||222
249380|NCT01042392|602613|P2|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
249381|NCT01042392|602614|P1|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)|ITT excluded patients from centers where 90% of BP measurements were rounded to 5 or 0|222
249382|NCT01042392|602611|P4|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
249383|NCT01042392|602612|P3|STARTED|Period II(Randomized,Double Blinded,8wk)||249
249384|NCT01042392|602613|P2|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
249385|NCT01042392|602614|P1|STARTED|Period II(Randomized,Double Blinded,8wk)||257
249386|NCT01042366|602643|P3|NOT COMPLETED|Overall Study||0
249387|NCT01042366|602644|P2|NOT COMPLETED|Overall Study||0
249388|NCT01042366|602645|P1|NOT COMPLETED|Overall Study||0
249389|NCT01042366|602643|P3|COMPLETED|Overall Study||4
249390|NCT01042366|602644|P2|COMPLETED|Overall Study||6
249391|NCT01042366|602645|P1|COMPLETED|Overall Study||5
249392|NCT01042366|602643|P3|STARTED|Overall Study||4
249393|NCT01042366|602644|P2|STARTED|Overall Study||6
249394|NCT01042366|602645|P1|STARTED|Overall Study||5
249395|NCT01042288|602654|P1|NOT COMPLETED|Overall Study||69
249396|NCT01042288|602654|P1|COMPLETED|Overall Study|Patients remained on maintenance until disease progression, toxicity or other reason to come off|0
249397|NCT01042288|602654|P1|Maintenance|Overall Study||27
249398|NCT01042288|602654|P1|STARTED|Overall Study||69
249399|NCT01042236|602662|P6|NOT COMPLETED|Treatment Period 3||0
249400|NCT01042236|602663|P5|NOT COMPLETED|Treatment Period 3||0
249401|NCT01042236|602664|P4|NOT COMPLETED|Treatment Period 3||2
249402|NCT01042236|602665|P3|NOT COMPLETED|Treatment Period 3||0
249403|NCT01042236|602666|P2|NOT COMPLETED|Treatment Period 3||0
249404|NCT01042236|602667|P1|NOT COMPLETED|Treatment Period 3||0
249405|NCT01042236|602662|P6|COMPLETED|Treatment Period 3||3
249406|NCT01042236|602663|P5|COMPLETED|Treatment Period 3||3
249407|NCT01042236|602664|P4|COMPLETED|Treatment Period 3||3
249408|NCT01042236|602665|P3|COMPLETED|Treatment Period 3||3
249409|NCT01042236|602666|P2|COMPLETED|Treatment Period 3||3
249410|NCT01042236|602667|P1|COMPLETED|Treatment Period 3||3
249411|NCT01042236|602662|P6|STARTED|Treatment Period 3||3
249412|NCT01042236|602663|P5|STARTED|Treatment Period 3||3
249413|NCT01042236|602664|P4|STARTED|Treatment Period 3||5
249414|NCT01042236|602665|P3|STARTED|Treatment Period 3||3
249415|NCT01042236|602666|P2|STARTED|Treatment Period 3||3
249416|NCT01042236|602667|P1|STARTED|Treatment Period 3||3
249417|NCT01042236|602662|P6|NOT COMPLETED|Treatment Period 2||0
249418|NCT01042236|602663|P5|NOT COMPLETED|Treatment Period 2||0
249419|NCT01042236|602664|P4|NOT COMPLETED|Treatment Period 2||0
249420|NCT01042236|602665|P3|NOT COMPLETED|Treatment Period 2||0
249421|NCT01042236|602666|P2|NOT COMPLETED|Treatment Period 2||0
249422|NCT01042236|602667|P1|NOT COMPLETED|Treatment Period 2||0
249423|NCT01042236|602662|P6|COMPLETED|Treatment Period 2||3
249424|NCT01042236|602663|P5|COMPLETED|Treatment Period 2||3
249425|NCT01042236|602664|P4|COMPLETED|Treatment Period 2||5
249426|NCT01042236|602665|P3|COMPLETED|Treatment Period 2||3
249427|NCT01042236|602666|P2|COMPLETED|Treatment Period 2||3
249428|NCT01042236|602667|P1|COMPLETED|Treatment Period 2||3
249429|NCT01042236|602662|P6|STARTED|Treatment Period 2||3
249430|NCT01042236|602663|P5|STARTED|Treatment Period 2||3
249431|NCT01042236|602664|P4|STARTED|Treatment Period 2||5
249432|NCT01042236|602665|P3|STARTED|Treatment Period 2||3
249433|NCT01042236|602666|P2|STARTED|Treatment Period 2||3
249434|NCT01042236|602667|P1|STARTED|Treatment Period 2||3
249435|NCT01042236|602662|P6|NOT COMPLETED|Treatment Period 1||0
249436|NCT01042236|602663|P5|NOT COMPLETED|Treatment Period 1||1
249437|NCT01042236|602664|P4|NOT COMPLETED|Treatment Period 1||0
249438|NCT01042236|602665|P3|NOT COMPLETED|Treatment Period 1||0
249439|NCT01042236|602666|P2|NOT COMPLETED|Treatment Period 1||1
249440|NCT01042236|602667|P1|NOT COMPLETED|Treatment Period 1||0
249441|NCT01042236|602662|P6|COMPLETED|Treatment Period 1||3
249442|NCT01042236|602663|P5|COMPLETED|Treatment Period 1||3
249443|NCT01042236|602664|P4|COMPLETED|Treatment Period 1||5
249444|NCT01042236|602665|P3|COMPLETED|Treatment Period 1||3
249445|NCT01042236|602666|P2|COMPLETED|Treatment Period 1||3
249446|NCT01042236|602667|P1|COMPLETED|Treatment Period 1||3
249447|NCT01042236|602662|P6|STARTED|Treatment Period 1||3
249448|NCT01042236|602663|P5|STARTED|Treatment Period 1||4
249449|NCT01042236|602664|P4|STARTED|Treatment Period 1||5
249450|NCT01042236|602665|P3|STARTED|Treatment Period 1||3
249451|NCT01042236|602666|P2|STARTED|Treatment Period 1||4
249452|NCT01042236|602667|P1|STARTED|Treatment Period 1||3
249453|NCT01042158|602704|P1|NOT COMPLETED|Overall Study||1
249454|NCT01042158|602704|P1|COMPLETED|Overall Study||24
249455|NCT01042158|602704|P1|STARTED|Overall Study||25
249456|NCT01042145|602713|P2|NOT COMPLETED|Overall Study||1
249457|NCT01042145|602714|P1|NOT COMPLETED|Overall Study||1
249458|NCT01042145|602713|P2|COMPLETED|Overall Study||45
249459|NCT01042145|602714|P1|COMPLETED|Overall Study||40
249460|NCT01042145|602713|P2|STARTED|Overall Study||46
249461|NCT01042145|602714|P1|STARTED|Overall Study||41
249462|NCT01042093|602734|P4|NOT COMPLETED|Overall Study||4
249463|NCT01042093|602735|P3|NOT COMPLETED|Overall Study||2
249464|NCT01042093|602736|P2|NOT COMPLETED|Overall Study||2
249465|NCT01042093|602737|P1|NOT COMPLETED|Overall Study||2
249466|NCT01042093|602734|P4|COMPLETED|Overall Study||36
249467|NCT01042093|602735|P3|COMPLETED|Overall Study||38
249468|NCT01042093|602736|P2|COMPLETED|Overall Study||38
249469|NCT01042093|602737|P1|COMPLETED|Overall Study||38
249470|NCT01042093|602734|P4|STARTED|Overall Study||40
249471|NCT01042093|602735|P3|STARTED|Overall Study||40
249472|NCT01042093|602736|P2|STARTED|Overall Study||40
249473|NCT01042093|602737|P1|STARTED|Overall Study||40
249474|NCT01041976|602757|P2|NOT COMPLETED|Overall Study||4
249475|NCT01041976|602758|P1|NOT COMPLETED|Overall Study||5
249476|NCT01041976|602757|P2|COMPLETED|Overall Study||38
249477|NCT01041976|602758|P1|COMPLETED|Overall Study||37
249478|NCT01041976|602757|P2|18 Month Follow-up|Overall Study||38
249479|NCT01041976|602758|P1|18 Month Follow-up|Overall Study||37
249480|NCT01041976|602757|P2|12 Month Follow-up|Overall Study||38
249481|NCT01041976|602758|P1|12 Month Follow-up|Overall Study||37
249482|NCT01041976|602757|P2|6 Month Follow-up|Overall Study||41
249483|NCT01041976|602758|P1|6 Month Follow-up|Overall Study||39
249484|NCT01041976|602757|P2|STARTED|Overall Study||42
249485|NCT01041976|602758|P1|STARTED|Overall Study||42
249486|NCT01041859|602768|P3|NOT COMPLETED|Double-Blind Maintenance||45
249487|NCT01041859|602769|P2|NOT COMPLETED|Double-Blind Maintenance||46
249488|NCT01041859|602770|P1|NOT COMPLETED|Double-Blind Maintenance||0
249489|NCT01041859|602768|P3|COMPLETED|Double-Blind Maintenance||107
249490|NCT01041859|602769|P2|COMPLETED|Double-Blind Maintenance||120
249491|NCT01041859|602770|P1|COMPLETED|Double-Blind Maintenance||0
249492|NCT01041859|602768|P3|STARTED|Double-Blind Maintenance|152 randomized, all were treated.|152
249493|NCT01041859|602769|P2|STARTED|Double-Blind Maintenance|168 were randomized, 2 were not treated (1 randomized in error, 1 withdrew consent).|166
249494|NCT01041859|602770|P1|STARTED|Double-Blind Maintenance||0
249495|NCT01041859|602768|P3|NOT COMPLETED|Open-Label Titration||0
249496|NCT01041859|602769|P2|NOT COMPLETED|Open-Label Titration||0
249497|NCT01041859|602770|P1|NOT COMPLETED|Open-Label Titration||101
249498|NCT01041859|602768|P3|COMPLETED|Open-Label Titration||0
249499|NCT01041859|602769|P2|COMPLETED|Open-Label Titration||0
249500|NCT01041859|602770|P1|COMPLETED|Open-Label Titration|Of 358 completed subjects, 320 were randomized to the Double-Blind Maintenance Period.|358
249501|NCT01041859|602768|P3|STARTED|Open-Label Titration||0
249502|NCT01041859|602769|P2|STARTED|Open-Label Titration||0
249503|NCT01041859|602770|P1|STARTED|Open-Label Titration|Of 460 total enrollment, one subject enrolled twice; this subject's second enrollment is excluded.|459
249504|NCT01041781|602787|P2|NOT COMPLETED|Overall Study||0
249505|NCT01041781|602788|P1|NOT COMPLETED|Overall Study||0
249506|NCT01041781|602787|P2|COMPLETED|Overall Study||158
249507|NCT01041781|602788|P1|COMPLETED|Overall Study||154
249508|NCT01041781|602787|P2|STARTED|Overall Study||158
249509|NCT01041781|602788|P1|STARTED|Overall Study||154
249510|NCT01041638|602806|P1|NOT COMPLETED|Overall Study||27
249511|NCT01041638|602806|P1|COMPLETED|Overall Study||78
249512|NCT01041638|602806|P1|STARTED|Overall Study||105
249513|NCT01041573|602816|P4|NOT COMPLETED|Overall Study||2
249514|NCT01041573|602817|P3|NOT COMPLETED|Overall Study||7
249515|NCT01041573|602818|P2|NOT COMPLETED|Overall Study||13
249516|NCT01041573|602819|P1|NOT COMPLETED|Overall Study||5
249517|NCT01041573|602816|P4|COMPLETED|Overall Study||62
249518|NCT01041573|602817|P3|COMPLETED|Overall Study||387
249519|NCT01041573|602818|P2|COMPLETED|Overall Study||858
249520|NCT01041573|602819|P1|COMPLETED|Overall Study||535
249521|NCT01041573|602816|P4|STARTED|Overall Study||64
249522|NCT01041573|602817|P3|STARTED|Overall Study||394
249523|NCT01041573|602818|P2|STARTED|Overall Study||871
249524|NCT01041573|602819|P1|STARTED|Overall Study||540
249525|NCT01041417|602831|P2|NOT COMPLETED|Overall Study||3
249526|NCT01041417|602832|P1|NOT COMPLETED|Overall Study||7
249527|NCT01041417|602831|P2|COMPLETED|Overall Study||76
249528|NCT01041417|602832|P1|COMPLETED|Overall Study||73
249529|NCT01041417|602831|P2|STARTED|Overall Study||79
249530|NCT01041417|602832|P1|STARTED|Overall Study||80
249531|NCT01041404|602870|P2|NOT COMPLETED|Overall Study||294
249532|NCT01041404|602871|P1|NOT COMPLETED|Overall Study||290
249533|NCT01041404|602870|P2|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
249534|NCT01041404|602871|P1|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
249535|NCT01041404|602870|P2|Alive in Follow-up|Overall Study||41
249536|NCT01041404|602871|P1|Alive in Follow-up|Overall Study||40
249537|NCT01041404|602870|P2|Lost to Follow-up|Overall Study||10
249538|NCT01041404|602871|P1|Lost to Follow-up|Overall Study||12
249539|NCT01041404|602870|P2|Died in Follow-up|Overall Study||200
249540|NCT01041404|602871|P1|Died in Follow-up|Overall Study||199
249541|NCT01041404|602870|P2|Entered Follow-Up|Overall Study||251
249542|NCT01041404|602871|P1|Entered Follow-Up|Overall Study||251
249543|NCT01041404|602870|P2|STARTED|Overall Study||294
249544|NCT01041404|602871|P1|STARTED|Overall Study||290
249545|NCT01041287|602912|P2|NOT COMPLETED|Treatment Period 2 (3 Months)||5
249546|NCT01041287|602913|P1|NOT COMPLETED|Treatment Period 2 (3 Months)||3
249547|NCT01041287|602912|P2|COMPLETED|Treatment Period 2 (3 Months)||14
249548|NCT01041287|602913|P1|COMPLETED|Treatment Period 2 (3 Months)||16
249549|NCT01041287|602912|P2|STARTED|Treatment Period 2 (3 Months)||19
249550|NCT01041287|602913|P1|STARTED|Treatment Period 2 (3 Months)||19
249551|NCT01041287|602912|P2|NOT COMPLETED|Treatment Period 1 (3 Months)||0
249552|NCT01041287|602913|P1|NOT COMPLETED|Treatment Period 1 (3 Months)||0
249553|NCT01041287|602912|P2|COMPLETED|Treatment Period 1 (3 Months)||19
249554|NCT01041287|602913|P1|COMPLETED|Treatment Period 1 (3 Months)||19
249555|NCT01041287|602912|P2|STARTED|Treatment Period 1 (3 Months)||19
249556|NCT01041287|602913|P1|STARTED|Treatment Period 1 (3 Months)||19
249557|NCT01041274|602925|P2|NOT COMPLETED|Overall Study||21
249558|NCT01041274|602926|P1|NOT COMPLETED|Overall Study||23
249559|NCT01041274|602925|P2|COMPLETED|Overall Study||25
249560|NCT01041274|602926|P1|COMPLETED|Overall Study||26
249561|NCT01041274|602925|P2|STARTED|Overall Study||46
249562|NCT01041274|602926|P1|STARTED|Overall Study||49
249563|NCT01041209|602940|P2|NOT COMPLETED|Overall Study||0
249564|NCT01041209|602941|P1|NOT COMPLETED|Overall Study||0
249565|NCT01041209|602940|P2|COMPLETED|Overall Study||60
249566|NCT01041209|602941|P1|COMPLETED|Overall Study||60
249567|NCT01041209|602940|P2|STARTED|Overall Study||60
249568|NCT01041209|602941|P1|STARTED|Overall Study||60
249569|NCT01040871|602951|P2|NOT COMPLETED|Overall Study||7
249570|NCT01040871|602952|P1|NOT COMPLETED|Overall Study||13
249571|NCT01040871|602951|P2|COMPLETED|Overall Study||73
249572|NCT01040871|602952|P1|COMPLETED|Overall Study||71
249573|NCT01040871|602951|P2|STARTED|Overall Study|Intent to Treat, Randomized|80
249574|NCT01040871|602952|P1|STARTED|Overall Study|Intent to Treat, Randomized|84
249575|NCT01040858|602972|P2|NOT COMPLETED|Overall Study||0
249576|NCT01040858|602973|P1|NOT COMPLETED|Overall Study||9
249577|NCT01040858|602972|P2|COMPLETED|Overall Study||69
249578|NCT01040858|602973|P1|COMPLETED|Overall Study||50
249579|NCT01040858|602972|P2|STARTED|Overall Study||69
249580|NCT01040858|602973|P1|STARTED|Overall Study||59
249581|NCT01040845|603003|P2|NOT COMPLETED|Overall Study||1
249582|NCT01040845|603004|P1|NOT COMPLETED|Overall Study||2
249583|NCT01040845|603003|P2|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1)|14
249584|NCT01040845|603004|P1|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1); dropped by physician due to positive drug screen (1)|13
249585|NCT01040845|603003|P2|STARTED|Overall Study||15
249586|NCT01040845|603004|P1|STARTED|Overall Study||15
249587|NCT01040832|603019|P2|NOT COMPLETED|Overall Study||37
249588|NCT01040832|603020|P1|NOT COMPLETED|Overall Study||46
249589|NCT01040832|603019|P2|COMPLETED|Overall Study||16
249590|NCT01040832|603020|P1|COMPLETED|Overall Study||8
249591|NCT01040832|603019|P2|STARTED|Overall Study||53
249592|NCT01040832|603020|P1|STARTED|Overall Study|One participant was treated with study drug 'Cetuximab Plus EMD 1201081' but was not randomized|54
249593|NCT01040819|603036|P2|NOT COMPLETED|Overall Study||0
249594|NCT01040819|603037|P1|NOT COMPLETED|Overall Study||0
249595|NCT01040819|603036|P2|COMPLETED|Overall Study||12
249596|NCT01040819|603037|P1|COMPLETED|Overall Study||13
249597|NCT01040819|603036|P2|STARTED|Overall Study||12
249598|NCT01040819|603037|P1|STARTED|Overall Study||13
249599|NCT01040793|603043|P6|NOT COMPLETED|Overall Study||1
249600|NCT01040793|603044|P5|NOT COMPLETED|Overall Study||4
249601|NCT01040793|603045|P4|NOT COMPLETED|Overall Study||4
249602|NCT01040793|603046|P3|NOT COMPLETED|Overall Study||3
249603|NCT01040793|603047|P2|NOT COMPLETED|Overall Study||5
249604|NCT01040793|603048|P1|NOT COMPLETED|Overall Study||6
249605|NCT01040793|603043|P6|COMPLETED|Overall Study||26
249606|NCT01040793|603044|P5|COMPLETED|Overall Study||22
249607|NCT01040793|603045|P4|COMPLETED|Overall Study||22
249608|NCT01040793|603046|P3|COMPLETED|Overall Study||23
249609|NCT01040793|603047|P2|COMPLETED|Overall Study||21
249610|NCT01040793|603048|P1|COMPLETED|Overall Study||20
249611|NCT01040793|603043|P6|STARTED|Overall Study||27
249612|NCT01040793|603044|P5|STARTED|Overall Study||26
249613|NCT01040793|603045|P4|STARTED|Overall Study||26
249614|NCT01040793|603046|P3|STARTED|Overall Study||26
249615|NCT01040793|603047|P2|STARTED|Overall Study||26
249616|NCT01040793|603048|P1|STARTED|Overall Study|Entered and treated|26
249617|NCT01040780|603127|P2|NOT COMPLETED|Overall Study||3
249618|NCT01040780|603128|P1|NOT COMPLETED|Overall Study||1
249619|NCT01040780|603127|P2|COMPLETED|Overall Study||196
249620|NCT01040780|603128|P1|COMPLETED|Overall Study||199
249621|NCT01040780|603127|P2|STARTED|Overall Study||199
249622|NCT01040780|603128|P1|STARTED|Overall Study||200
249623|NCT01040728|603142|P4|NOT COMPLETED|Overall Study||6
249624|NCT01040728|603143|P3|NOT COMPLETED|Overall Study||1
249625|NCT01040728|603144|P2|NOT COMPLETED|Overall Study||11
249626|NCT01040728|603145|P1|NOT COMPLETED|Overall Study||4
249627|NCT01040728|603142|P4|COMPLETED|Overall Study||24
249628|NCT01040728|603143|P3|COMPLETED|Overall Study||30
249629|NCT01040728|603144|P2|COMPLETED|Overall Study||19
249630|NCT01040728|603145|P1|COMPLETED|Overall Study||27
249631|NCT01040728|603142|P4|STARTED|Overall Study||30
249632|NCT01040728|603143|P3|STARTED|Overall Study||31
249633|NCT01040728|603144|P2|STARTED|Overall Study||30
249634|NCT01040728|603145|P1|STARTED|Overall Study||31
249635|NCT01040689|603215|P4|NOT COMPLETED|Overall Study||4
249636|NCT01040689|603216|P3|NOT COMPLETED|Overall Study||4
249637|NCT01040689|603217|P2|NOT COMPLETED|Overall Study||2
249638|NCT01040689|603218|P1|NOT COMPLETED|Overall Study||3
249639|NCT01040689|603215|P4|COMPLETED|Overall Study||23
249640|NCT01040689|603216|P3|COMPLETED|Overall Study||23
249641|NCT01040689|603217|P2|COMPLETED|Overall Study||25
249642|NCT01040689|603218|P1|COMPLETED|Overall Study||24
249643|NCT01040689|603215|P4|STARTED|Overall Study||27
249644|NCT01040689|603216|P3|STARTED|Overall Study||27
249645|NCT01040689|603217|P2|STARTED|Overall Study||27
249646|NCT01040689|603218|P1|STARTED|Overall Study||27
249647|NCT01040624|603290|P2|NOT COMPLETED|Overall Study||0
249648|NCT01040624|603291|P1|NOT COMPLETED|Overall Study||0
249649|NCT01040624|603290|P2|COMPLETED|Overall Study||19
249650|NCT01040624|603291|P1|COMPLETED|Overall Study||58
249651|NCT01040624|603290|P2|STARTED|Overall Study||19
249652|NCT01040624|603291|P1|STARTED|Overall Study||58
249653|NCT01040403|603297|P1|NOT COMPLETED|Overall Study||20
249654|NCT01040403|603297|P1|COMPLETED|Overall Study|All treatment periods|213
249655|NCT01040403|603297|P1|Completed T+O 5/10|Overall Study||107
249656|NCT01040403|603297|P1|Completed T+O 2.5/10|Overall Study||110
249657|NCT01040403|603297|P1|Completed T+O 1.25/10|Overall Study||106
249658|NCT01040403|603297|P1|Completed Olo 10|Overall Study||109
249659|NCT01040403|603297|P1|Completed T+O 5/5|Overall Study||106
249660|NCT01040403|603297|P1|Completed T+O 2.5/5|Overall Study||111
249661|NCT01040403|603297|P1|Completed T+O 1.25/5|Overall Study||105
249662|NCT01040403|603297|P1|Completed Olo 5|Overall Study||106
249663|NCT01040403|603297|P1|STARTED|Overall Study||233
249664|NCT01040351|603485|P2|NOT COMPLETED|Overall Study||2
249665|NCT01040351|603486|P1|NOT COMPLETED|Overall Study||1
249666|NCT01040351|603485|P2|COMPLETED|Overall Study|May 2010|53
249667|NCT01040351|603486|P1|COMPLETED|Overall Study|May 2010|54
249668|NCT01040351|603485|P2|STARTED|Overall Study|October 2006|55
249669|NCT01040351|603486|P1|STARTED|Overall Study|October 2006|55
249670|NCT01040260|603496|P2|NOT COMPLETED|Overall Study||11
249671|NCT01040260|603497|P1|NOT COMPLETED|Overall Study||15
249672|NCT01040260|603496|P2|COMPLETED|Overall Study||39
249673|NCT01040260|603497|P1|COMPLETED|Overall Study||38
249674|NCT01040260|603496|P2|STARTED|Overall Study||50
249675|NCT01040260|603497|P1|STARTED|Overall Study||53
249676|NCT01040208|603506|P3|NOT COMPLETED|Overall Study||3
249677|NCT01040208|603507|P2|NOT COMPLETED|Overall Study||13
249678|NCT01040208|603508|P1|NOT COMPLETED|Overall Study||6
249679|NCT01040208|603506|P3|COMPLETED|Overall Study||35
249680|NCT01040208|603507|P2|COMPLETED|Overall Study||15
249681|NCT01040208|603508|P1|COMPLETED|Overall Study||39
249682|NCT01040208|603506|P3|STARTED|Overall Study||38
249683|NCT01040208|603507|P2|STARTED|Overall Study||28
249684|NCT01040208|603508|P1|STARTED|Overall Study||45
249685|NCT01040169|603524|P2|NOT COMPLETED|Overall Study||8
249686|NCT01040169|603525|P1|NOT COMPLETED|Overall Study||3
249687|NCT01040169|603524|P2|COMPLETED|Overall Study||36
249688|NCT01040169|603525|P1|COMPLETED|Overall Study||32
249689|NCT01040169|603524|P2|STARTED|Overall Study||44
249690|NCT01040169|603525|P1|STARTED|Overall Study||35
249691|NCT01040130|603533|P6|NOT COMPLETED|Overall Study||4
249692|NCT01040130|603534|P5|NOT COMPLETED|Overall Study||0
249693|NCT01040130|603535|P4|NOT COMPLETED|Overall Study||5
249694|NCT01040130|603536|P3|NOT COMPLETED|Overall Study||2
249695|NCT01040130|603537|P2|NOT COMPLETED|Overall Study||3
249696|NCT01040130|603538|P1|NOT COMPLETED|Overall Study||3
249697|NCT01040130|603533|P6|COMPLETED|Overall Study||22
249698|NCT01040130|603534|P5|COMPLETED|Overall Study||25
249699|NCT01040130|603535|P4|COMPLETED|Overall Study||20
249700|NCT01040130|603536|P3|COMPLETED|Overall Study||23
249701|NCT01040130|603537|P2|COMPLETED|Overall Study||22
249702|NCT01040130|603538|P1|COMPLETED|Overall Study|Number of patients who did not discontinue from the trial.|22
249703|NCT01040130|603533|P6|STARTED|Overall Study||26
249704|NCT01040130|603534|P5|STARTED|Overall Study||25
249705|NCT01040130|603535|P4|STARTED|Overall Study||25
249706|NCT01040130|603536|P3|STARTED|Overall Study||25
249707|NCT01040130|603537|P2|STARTED|Overall Study||25
249708|NCT01040130|603538|P1|STARTED|Overall Study|Number of patients entered and treated|25
249709|NCT01040052|603615|P1|NOT COMPLETED|Overall Study||0
249710|NCT01040052|603615|P1|COMPLETED|Overall Study||30
249711|NCT01040052|603615|P1|STARTED|Overall Study||30
249712|NCT01039792|603621|P2|NOT COMPLETED|Overall Study||1
249713|NCT01039792|603622|P1|NOT COMPLETED|Overall Study||6
249714|NCT01039792|603621|P2|COMPLETED|Overall Study||27
249715|NCT01039792|603622|P1|COMPLETED|Overall Study||23
249716|NCT01039792|603621|P2|STARTED|Overall Study||28
249717|NCT01039792|603622|P1|STARTED|Overall Study||29
249718|NCT01039688|603631|P3|NOT COMPLETED|Overall Study||80
249719|NCT01039688|603632|P2|NOT COMPLETED|Overall Study||111
249720|NCT01039688|603633|P1|NOT COMPLETED|Overall Study||107
249721|NCT01039688|603631|P3|COMPLETED|Overall Study||106
249722|NCT01039688|603632|P2|COMPLETED|Overall Study||286
249723|NCT01039688|603633|P1|COMPLETED|Overall Study||266
249724|NCT01039688|603631|P3|STARTED|Overall Study||186
249725|NCT01039688|603632|P2|STARTED|Overall Study||397
249726|NCT01039688|603633|P1|STARTED|Overall Study||373
249727|NCT01039675|603904|P2|NOT COMPLETED|Overall Study||7
249728|NCT01039675|603905|P1|NOT COMPLETED|Overall Study||0
249729|NCT01039675|603904|P2|COMPLETED|Overall Study||35
249730|NCT01039675|603905|P1|COMPLETED|Overall Study||9
249731|NCT01039675|603904|P2|STARTED|Overall Study||42
249732|NCT01039675|603905|P1|STARTED|Overall Study||9
249733|NCT01039584|603918|P3|NOT COMPLETED|Overall Study||57
249734|NCT01039584|603919|P2|NOT COMPLETED|Overall Study||97
249735|NCT01039584|603920|P1|NOT COMPLETED|Overall Study||103
249736|NCT01039584|603918|P3|COMPLETED|Overall Study||65
249737|NCT01039584|603919|P2|COMPLETED|Overall Study||146
249738|NCT01039584|603920|P1|COMPLETED|Overall Study||143
249739|NCT01039584|603918|P3|STARTED|Overall Study||122
249740|NCT01039584|603919|P2|STARTED|Overall Study||243
249741|NCT01039584|603920|P1|STARTED|Overall Study||246
249742|NCT01039519|603934|P1|NOT COMPLETED|Survival Follow-up||27
249743|NCT01039519|603934|P1|COMPLETED|Survival Follow-up||0
249744|NCT01039519|603934|P1|STARTED|Survival Follow-up||27
249745|NCT01039519|603934|P1|NOT COMPLETED|Treatment||27
249746|NCT01039519|603934|P1|COMPLETED|Treatment|Reason not completed represents reason for terminating treatment.|0
249747|NCT01039519|603934|P1|STARTED|Treatment||27
249748|NCT01039428|603945|P2|NOT COMPLETED|Overall Study||0
249749|NCT01039428|603946|P1|NOT COMPLETED|Overall Study||2
249750|NCT01039428|603945|P2|COMPLETED|Overall Study||28
249751|NCT01039428|603946|P1|COMPLETED|Overall Study||33
249752|NCT01039428|603945|P2|STARTED|Overall Study||28
249753|NCT01039428|603946|P1|STARTED|Overall Study||35
249754|NCT01039376|603970|P2|NOT COMPLETED|Overall Study||126
249755|NCT01039376|603971|P1|NOT COMPLETED|Overall Study||130
249756|NCT01039376|603970|P2|COMPLETED|Overall Study||114
249757|NCT01039376|603971|P1|COMPLETED|Overall Study||110
249758|NCT01039376|603970|P2|STARTED|Overall Study||240
249759|NCT01039376|603971|P1|STARTED|Overall Study||240
249760|NCT01039207|604030|P1|NOT COMPLETED|Overall Study||0
249761|NCT01039207|604030|P1|COMPLETED|Overall Study||31
249762|NCT01039207|604030|P1|STARTED|Overall Study||31
249763|NCT01038921|604040|P2|NOT COMPLETED|Overall Study||0
249764|NCT01038921|604041|P1|NOT COMPLETED|Overall Study||2
249765|NCT01038921|604040|P2|COMPLETED|Overall Study||20
249766|NCT01038921|604041|P1|COMPLETED|Overall Study|2 subjects withdrew|17
249767|NCT01038921|604040|P2|STARTED|Overall Study|20 subjects received placebo first (10 weeks), washout (6 weeks), melatonin second ( 10 weeks)|20
249768|NCT01038921|604041|P1|STARTED|Overall Study|19 subjects received melatonin first(10 weeks), washout (6 weeks), placebo second (10 weeks)|19
249769|NCT01038869|604047|P1|NOT COMPLETED|Overall Study||7
249770|NCT01038869|604047|P1|COMPLETED|Overall Study||13
249771|NCT01038869|604047|P1|STARTED|Overall Study||20
249772|NCT01038856|604055|P1|NOT COMPLETED|Overall Study||2
249773|NCT01038856|604055|P1|COMPLETED|Overall Study||3
249774|NCT01038856|604055|P1|STARTED|Overall Study||5
249775|NCT01038752|604064|P2|NOT COMPLETED|Overall Study||5
249776|NCT01038752|604065|P1|NOT COMPLETED|Overall Study||5
249777|NCT01038752|604064|P2|COMPLETED|Overall Study||1
249778|NCT01038752|604065|P1|COMPLETED|Overall Study||3
249779|NCT01038752|604064|P2|STARTED|Overall Study||6
249780|NCT01038752|604065|P1|STARTED|Overall Study||8
249781|NCT01038713|604088|P3|NOT COMPLETED|Overall Study||1
249782|NCT01038713|604089|P2|NOT COMPLETED|Overall Study||3
249783|NCT01038713|604090|P1|NOT COMPLETED|Overall Study||5
249784|NCT01038713|604088|P3|COMPLETED|Overall Study||16
249785|NCT01038713|604089|P2|COMPLETED|Overall Study||17
249786|NCT01038713|604090|P1|COMPLETED|Overall Study||21
249787|NCT01038713|604088|P3|STARTED|Overall Study||17
249788|NCT01038713|604089|P2|STARTED|Overall Study||20
249789|NCT01038713|604090|P1|STARTED|Overall Study||26
249790|NCT01038635|604119|P9|NOT COMPLETED|Overall Study||2
249791|NCT01038635|604120|P8|NOT COMPLETED|Overall Study||5
249792|NCT01038635|604121|P7|NOT COMPLETED|Overall Study||2
249793|NCT01038635|604122|P6|NOT COMPLETED|Overall Study||0
249794|NCT01038635|604123|P5|NOT COMPLETED|Overall Study||1
249795|NCT01038635|604124|P4|NOT COMPLETED|Overall Study||0
249796|NCT01038635|604125|P3|NOT COMPLETED|Overall Study||0
249797|NCT01038635|604126|P2|NOT COMPLETED|Overall Study||0
249798|NCT01038635|604127|P1|NOT COMPLETED|Overall Study||2
249799|NCT01038635|604119|P9|COMPLETED|Overall Study||38
249800|NCT01038635|604120|P8|COMPLETED|Overall Study||15
249801|NCT01038635|604121|P7|COMPLETED|Overall Study||5
249802|NCT01038635|604122|P6|COMPLETED|Overall Study||3
249803|NCT01038635|604123|P5|COMPLETED|Overall Study||3
249804|NCT01038635|604124|P4|COMPLETED|Overall Study||3
249805|NCT01038635|604125|P3|COMPLETED|Overall Study||3
249806|NCT01038635|604126|P2|COMPLETED|Overall Study||3
249807|NCT01038635|604127|P1|COMPLETED|Overall Study||3
249808|NCT01038635|604119|P9|STARTED|Overall Study||40
249809|NCT01038635|604120|P8|STARTED|Overall Study||20
249810|NCT01038635|604121|P7|STARTED|Overall Study||7
249811|NCT01038635|604122|P6|STARTED|Overall Study||3
249812|NCT01038635|604123|P5|STARTED|Overall Study||4
249813|NCT01038635|604124|P4|STARTED|Overall Study||3
249814|NCT01038635|604125|P3|STARTED|Overall Study||3
249815|NCT01038635|604126|P2|STARTED|Overall Study||3
249816|NCT01038635|604127|P1|STARTED|Overall Study||5
249817|NCT01038609|604153|P5|NOT COMPLETED|Overall Study||1
249818|NCT01038609|604154|P4|NOT COMPLETED|Overall Study||1
249819|NCT01038609|604155|P3|NOT COMPLETED|Overall Study||1
249820|NCT01038609|604156|P2|NOT COMPLETED|Overall Study||1
249821|NCT01038609|604157|P1|NOT COMPLETED|Overall Study||1
249822|NCT01038609|604153|P5|COMPLETED|Overall Study||50
249823|NCT01038609|604154|P4|COMPLETED|Overall Study||47
249824|NCT01038609|604155|P3|COMPLETED|Overall Study||48
249825|NCT01038609|604156|P2|COMPLETED|Overall Study||51
249826|NCT01038609|604157|P1|COMPLETED|Overall Study||49
249827|NCT01038609|604153|P5|STARTED|Overall Study||51
249828|NCT01038609|604154|P4|STARTED|Overall Study||48
249829|NCT01038609|604155|P3|STARTED|Overall Study||49
249830|NCT01038609|604156|P2|STARTED|Overall Study||52
249831|NCT01038609|604157|P1|STARTED|Overall Study||50
249832|NCT01038336|604202|P3|NOT COMPLETED|Overall Study||0
249833|NCT01038336|604203|P2|NOT COMPLETED|Overall Study||0
249834|NCT01038336|604204|P1|NOT COMPLETED|Overall Study||0
249835|NCT01038336|604202|P3|COMPLETED|Overall Study||44
249836|NCT01038336|604203|P2|COMPLETED|Overall Study||42
249837|NCT01038336|604204|P1|COMPLETED|Overall Study||43
249838|NCT01038336|604202|P3|STARTED|Overall Study||44
249839|NCT01038336|604203|P2|STARTED|Overall Study||42
249840|NCT01038336|604204|P1|STARTED|Overall Study||43
249841|NCT01038323|604236|P3|NOT COMPLETED|Overall Study||4
249842|NCT01038323|604237|P2|NOT COMPLETED|Overall Study||2
249843|NCT01038323|604238|P1|NOT COMPLETED|Overall Study||3
249844|NCT01038323|604236|P3|COMPLETED|Overall Study||15
249845|NCT01038323|604237|P2|COMPLETED|Overall Study||17
249846|NCT01038323|604238|P1|COMPLETED|Overall Study||17
249847|NCT01038323|604236|P3|STARTED|Overall Study||19
249848|NCT01038323|604237|P2|STARTED|Overall Study||19
249849|NCT01038323|604238|P1|STARTED|Overall Study||20
249850|NCT01038128|604252|P1|NOT COMPLETED|Overall Study||4
249851|NCT01038128|604252|P1|COMPLETED|Overall Study||1
249852|NCT01038128|604252|P1|Baseline Visit|Overall Study||3
249853|NCT01038128|604252|P1|STARTED|Overall Study||5
249854|NCT01037881|604267|P7|NOT COMPLETED|Overall Study||2
249855|NCT01037881|604268|P6|NOT COMPLETED|Overall Study||3
249856|NCT01037881|604269|P5|NOT COMPLETED|Overall Study||3
249857|NCT01037881|604270|P4|NOT COMPLETED|Overall Study||1
249858|NCT01037881|604271|P3|NOT COMPLETED|Overall Study||3
249859|NCT01037881|604272|P2|NOT COMPLETED|Overall Study||2
249860|NCT01037881|604273|P1|NOT COMPLETED|Overall Study||6
249861|NCT01037881|604267|P7|COMPLETED|Overall Study||23
249862|NCT01037881|604268|P6|COMPLETED|Overall Study||27
249863|NCT01037881|604269|P5|COMPLETED|Overall Study||26
249864|NCT01037881|604270|P4|COMPLETED|Overall Study||24
249865|NCT01037881|604271|P3|COMPLETED|Overall Study||22
249866|NCT01037881|604272|P2|COMPLETED|Overall Study||22
249867|NCT01037881|604273|P1|COMPLETED|Overall Study||19
249868|NCT01037881|604267|P7|STARTED|Overall Study||25
249869|NCT01037881|604268|P6|STARTED|Overall Study||30
249870|NCT01037881|604269|P5|STARTED|Overall Study||29
249871|NCT01037881|604270|P4|STARTED|Overall Study||25
249872|NCT01037881|604271|P3|STARTED|Overall Study||25
249873|NCT01037881|604272|P2|STARTED|Overall Study||24
249874|NCT01037881|604273|P1|STARTED|Overall Study||25
249875|NCT01037452|604335|P4|NOT COMPLETED|Overall Study||0
249876|NCT01037452|604336|P3|NOT COMPLETED|Overall Study||0
249877|NCT01037452|604337|P2|NOT COMPLETED|Overall Study||0
249878|NCT01037452|604338|P1|NOT COMPLETED|Overall Study||0
249879|NCT01037452|604335|P4|COMPLETED|Overall Study||30
249880|NCT01037452|604336|P3|COMPLETED|Overall Study||30
249881|NCT01037452|604337|P2|COMPLETED|Overall Study||30
249882|NCT01037452|604338|P1|COMPLETED|Overall Study||30
249883|NCT01037452|604335|P4|STARTED|Overall Study||30
249884|NCT01037452|604336|P3|STARTED|Overall Study||30
249885|NCT01037452|604337|P2|STARTED|Overall Study||30
249886|NCT01037452|604338|P1|STARTED|Overall Study||30
249887|NCT01037309|604366|P9|NOT COMPLETED|Intravenous Period 7 - 9||0
249888|NCT01037309|604367|P8|NOT COMPLETED|Intravenous Period 7 - 9||0
249889|NCT01037309|604368|P7|NOT COMPLETED|Intravenous Period 7 - 9||0
249890|NCT01037309|604369|P6|NOT COMPLETED|Intravenous Period 7 - 9||0
249891|NCT01037309|604370|P5|NOT COMPLETED|Intravenous Period 7 - 9||0
249892|NCT01037309|604371|P4|NOT COMPLETED|Intravenous Period 7 - 9||0
249893|NCT01037309|604372|P3|NOT COMPLETED|Intravenous Period 7 - 9||0
249894|NCT01037309|604373|P2|NOT COMPLETED|Intravenous Period 7 - 9||0
249895|NCT01037309|604374|P1|NOT COMPLETED|Intravenous Period 7 - 9||0
249896|NCT01037309|604366|P9|COMPLETED|Intravenous Period 7 - 9||3
249897|NCT01037309|604367|P8|COMPLETED|Intravenous Period 7 - 9||3
249898|NCT01037309|604368|P7|COMPLETED|Intravenous Period 7 - 9||3
249899|NCT01037309|604369|P6|COMPLETED|Intravenous Period 7 - 9||0
249900|NCT01037309|604370|P5|COMPLETED|Intravenous Period 7 - 9||0
249901|NCT01037309|604371|P4|COMPLETED|Intravenous Period 7 - 9||0
249902|NCT01037309|604372|P3|COMPLETED|Intravenous Period 7 - 9||0
249903|NCT01037309|604373|P2|COMPLETED|Intravenous Period 7 - 9||0
249904|NCT01037309|604374|P1|COMPLETED|Intravenous Period 7 - 9||0
249905|NCT01037309|604366|P9|STARTED|Intravenous Period 7 - 9||3
249906|NCT01037309|604367|P8|STARTED|Intravenous Period 7 - 9||3
249907|NCT01037309|604368|P7|STARTED|Intravenous Period 7 - 9||3
249908|NCT01037309|604369|P6|STARTED|Intravenous Period 7 - 9||0
249909|NCT01037309|604370|P5|STARTED|Intravenous Period 7 - 9||0
249910|NCT01037309|604371|P4|STARTED|Intravenous Period 7 - 9||0
249911|NCT01037309|604372|P3|STARTED|Intravenous Period 7 - 9||0
249912|NCT01037309|604373|P2|STARTED|Intravenous Period 7 - 9||0
249913|NCT01037309|604374|P1|STARTED|Intravenous Period 7 - 9||0
249914|NCT01037309|604366|P9|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
249915|NCT01037309|604367|P8|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
249916|NCT01037309|604368|P7|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
249917|NCT01037309|604369|P6|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
249918|NCT01037309|604370|P5|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
249919|NCT01037309|604371|P4|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
249920|NCT01037309|604372|P3|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
249921|NCT01037309|604373|P2|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
249922|NCT01037309|604374|P1|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
249923|NCT01037309|604366|P9|COMPLETED|Subcutaneous Cohort 1 - 6||0
249924|NCT01037309|604367|P8|COMPLETED|Subcutaneous Cohort 1 - 6||0
249925|NCT01037309|604368|P7|COMPLETED|Subcutaneous Cohort 1 - 6||0
249926|NCT01037309|604369|P6|COMPLETED|Subcutaneous Cohort 1 - 6||3
249927|NCT01037309|604370|P5|COMPLETED|Subcutaneous Cohort 1 - 6||3
249928|NCT01037309|604371|P4|COMPLETED|Subcutaneous Cohort 1 - 6||3
249929|NCT01037309|604372|P3|COMPLETED|Subcutaneous Cohort 1 - 6||3
249930|NCT01037309|604373|P2|COMPLETED|Subcutaneous Cohort 1 - 6||3
249931|NCT01037309|604374|P1|COMPLETED|Subcutaneous Cohort 1 - 6||3
249932|NCT01037309|604366|P9|STARTED|Subcutaneous Cohort 1 - 6||0
249933|NCT01037309|604367|P8|STARTED|Subcutaneous Cohort 1 - 6||0
249934|NCT01037309|604368|P7|STARTED|Subcutaneous Cohort 1 - 6||0
249935|NCT01037309|604369|P6|STARTED|Subcutaneous Cohort 1 - 6||3
249936|NCT01037309|604370|P5|STARTED|Subcutaneous Cohort 1 - 6||3
249937|NCT01037309|604371|P4|STARTED|Subcutaneous Cohort 1 - 6||3
249938|NCT01037309|604372|P3|STARTED|Subcutaneous Cohort 1 - 6||3
249939|NCT01037309|604373|P2|STARTED|Subcutaneous Cohort 1 - 6||3
249940|NCT01037309|604374|P1|STARTED|Subcutaneous Cohort 1 - 6||3
249941|NCT01037244|604416|P4|NOT COMPLETED|Overall Study||14
249942|NCT01037244|604417|P3|NOT COMPLETED|Overall Study||14
249943|NCT01037244|604418|P2|NOT COMPLETED|Overall Study||14
249944|NCT01037244|604419|P1|NOT COMPLETED|Overall Study||13
249945|NCT01037244|604416|P4|COMPLETED|Overall Study||140
249946|NCT01037244|604417|P3|COMPLETED|Overall Study||144
249947|NCT01037244|604418|P2|COMPLETED|Overall Study||138
249948|NCT01037244|604419|P1|COMPLETED|Overall Study||141
249949|NCT01037244|604416|P4|Safety Population|Overall Study||152
249950|NCT01037244|604417|P3|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|159
249951|NCT01037244|604418|P2|Safety Population|Overall Study||150
249952|NCT01037244|604419|P1|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|155
249953|NCT01037244|604416|P4|mITT (Modified Intent-to-Treat)|Overall Study||153
249954|NCT01037244|604417|P3|mITT (Modified Intent-to-Treat)|Overall Study||154
249955|NCT01037244|604418|P2|mITT (Modified Intent-to-Treat)|Overall Study||148
249956|NCT01037244|604419|P1|mITT (Modified Intent-to-Treat)|Overall Study||150
249957|NCT01037244|604416|P4|STARTED|Overall Study||154
249958|NCT01037244|604417|P3|STARTED|Overall Study||158
249959|NCT01037244|604418|P2|STARTED|Overall Study||152
249960|NCT01037244|604419|P1|STARTED|Overall Study||154
249961|NCT01037218|604481|P4|NOT COMPLETED|Overall Study||16
249962|NCT01037218|604482|P3|NOT COMPLETED|Overall Study||21
249963|NCT01037218|604483|P2|NOT COMPLETED|Overall Study||21
249964|NCT01037218|604484|P1|NOT COMPLETED|Overall Study||16
249965|NCT01037218|604481|P4|COMPLETED|Overall Study||134
249966|NCT01037218|604482|P3|COMPLETED|Overall Study||134
249967|NCT01037218|604483|P2|COMPLETED|Overall Study||128
249968|NCT01037218|604484|P1|COMPLETED|Overall Study||131
249969|NCT01037218|604481|P4|mITT Population|Overall Study||141
249970|NCT01037218|604482|P3|mITT Population|Overall Study||147
249971|NCT01037218|604483|P2|mITT Population|Overall Study||140
249972|NCT01037218|604484|P1|mITT Population|Overall Study||141
249973|NCT01037218|604481|P4|Safety Population|Overall Study||150
249974|NCT01037218|604482|P3|Safety Population|Overall Study||154
249975|NCT01037218|604483|P2|Safety Population|Overall Study||148
249976|NCT01037218|604484|P1|Safety Population|Overall Study||147
249977|NCT01037218|604481|P4|STARTED|Overall Study||150
249978|NCT01037218|604482|P3|STARTED|Overall Study||155
249979|NCT01037218|604483|P2|STARTED|Overall Study||149
249980|NCT01037218|604484|P1|STARTED|Overall Study||147
249981|NCT01037192|604544|P2|NOT COMPLETED|Overall Study||0
249982|NCT01037192|604545|P1|NOT COMPLETED|Overall Study||0
249983|NCT01037192|604544|P2|COMPLETED|Overall Study||1
249984|NCT01037192|604545|P1|COMPLETED|Overall Study||3
249985|NCT01037192|604544|P2|STARTED|Overall Study||1
249986|NCT01037192|604545|P1|STARTED|Overall Study||3
249987|NCT01037127|604555|P2|NOT COMPLETED|Overall Study||21
249988|NCT01037127|604556|P1|NOT COMPLETED|Overall Study||5
249989|NCT01037127|604555|P2|COMPLETED|Overall Study||36
249990|NCT01037127|604556|P1|COMPLETED|Overall Study||35
249991|NCT01037127|604555|P2|STARTED|Overall Study||57
249992|NCT01037127|604556|P1|STARTED|Overall Study||40
249993|NCT01037114|604588|P1|NOT COMPLETED|Year 20||1
249994|NCT01037114|604588|P1|COMPLETED|Year 20|One subject returned at Y20 but did not do lab test because subject met a study exclusion criteria.|44
249995|NCT01037114|604588|P1|STARTED|Year 20||45
249996|NCT01037114|604588|P1|NOT COMPLETED|Year 19||0
249997|NCT01037114|604588|P1|COMPLETED|Year 19||45
249998|NCT01037114|604588|P1|STARTED|Year 19||45
249999|NCT01037114|604588|P1|NOT COMPLETED|Year 18||0
250000|NCT01037114|604588|P1|COMPLETED|Year 18||44
250001|NCT01037114|604588|P1|STARTED|Year 18||44
250002|NCT01037114|604588|P1|NOT COMPLETED|Year 17||0
250003|NCT01037114|604588|P1|COMPLETED|Year 17||48
250004|NCT01037114|604588|P1|STARTED|Year 17||48
250005|NCT01037114|604588|P1|NOT COMPLETED|Year 16||0
250006|NCT01037114|604588|P1|COMPLETED|Year 16||49
250007|NCT01037114|604588|P1|STARTED|Year 16||49
250008|NCT01037088|604601|P1|NOT COMPLETED|Overall Study||3
250009|NCT01037088|604601|P1|COMPLETED|Overall Study||36
250010|NCT01037088|604601|P1|Received Placebo|Overall Study||38
250011|NCT01037088|604601|P1|Received 1.29% THC|Overall Study||37
250012|NCT01037088|604601|P1|Received 3.53% THC|Overall Study||36
250013|NCT01037088|604601|P1|STARTED|Overall Study||39
250014|NCT01036802|604614|P2|NOT COMPLETED|Overall Study||0
250015|NCT01036802|604615|P1|NOT COMPLETED|Overall Study||0
250016|NCT01036802|604614|P2|COMPLETED|Overall Study|Patient was taken off study after 7 months as she required hip replacement surgery.|1
250017|NCT01036802|604615|P1|COMPLETED|Overall Study||2
250018|NCT01036802|604614|P2|STARTED|Overall Study||1
250019|NCT01036802|604615|P1|STARTED|Overall Study||2
250020|NCT01036763|604633|P1|NOT COMPLETED|Overall Study||93
250021|NCT01036763|604633|P1|COMPLETED|Overall Study||1171
250022|NCT01036763|604633|P1|STARTED|Overall Study||1264
250023|NCT01036724|604645|P2|NOT COMPLETED|Overall Study||8
250024|NCT01036724|604646|P1|NOT COMPLETED|Overall Study||6
250025|NCT01036724|604645|P2|COMPLETED|Overall Study||47
250026|NCT01036724|604646|P1|COMPLETED|Overall Study||46
250027|NCT01036724|604645|P2|STARTED|Overall Study||55
250028|NCT01036724|604646|P1|STARTED|Overall Study||52
250029|NCT01036529|604656|P2|NOT COMPLETED|Overall Study||15
250030|NCT01036529|604657|P1|NOT COMPLETED|Overall Study||13
250031|NCT01036529|604656|P2|COMPLETED|Overall Study||0
250032|NCT01036529|604657|P1|COMPLETED|Overall Study||0
250033|NCT01036529|604656|P2|Crossover to Other Group|Overall Study||1
250034|NCT01036529|604657|P1|Crossover to Other Group|Overall Study||1
250035|NCT01036529|604656|P2|Requested Crossover|Overall Study||2
250036|NCT01036529|604657|P1|Requested Crossover|Overall Study||1
250037|NCT01036529|604656|P2|12 Month Follow-up|Overall Study||3
250038|NCT01036529|604657|P1|12 Month Follow-up|Overall Study||4
250039|NCT01036529|604656|P2|6 Month Follow-up|Overall Study||7
250040|NCT01036529|604657|P1|6 Month Follow-up|Overall Study||6
250041|NCT01036529|604656|P2|3 Month Follow-up|Overall Study||9
250042|NCT01036529|604657|P1|3 Month Follow-up|Overall Study||7
250043|NCT01036529|604656|P2|Index Procedure|Overall Study|Index Procedure: Surgery|11
250044|NCT01036529|604657|P1|Index Procedure|Overall Study|Index Procedure: Trial Stimulation|10
250045|NCT01036529|604656|P2|Baseline Visit|Overall Study||13
250046|NCT01036529|604657|P1|Baseline Visit|Overall Study||10
250047|NCT01036529|604656|P2|STARTED|Overall Study||15
250048|NCT01036529|604657|P1|STARTED|Overall Study||13
250049|NCT01036490|604665|P2|NOT COMPLETED|Overall Study||0
250050|NCT01036490|604666|P1|NOT COMPLETED|Overall Study||4
250051|NCT01036490|604665|P2|COMPLETED|Overall Study||18
250052|NCT01036490|604666|P1|COMPLETED|Overall Study||14
250053|NCT01036490|604665|P2|STARTED|Overall Study||18
250054|NCT01036490|604666|P1|STARTED|Overall Study||18
250055|NCT01036438|604684|P2|NOT COMPLETED|Overall Study||10
250056|NCT01036438|604685|P1|NOT COMPLETED|Overall Study||10
250057|NCT01036438|604684|P2|COMPLETED|Overall Study||90
250058|NCT01036438|604685|P1|COMPLETED|Overall Study||91
250059|NCT01036438|604684|P2|STARTED|Overall Study||100
250060|NCT01036438|604685|P1|STARTED|Overall Study||101
250061|NCT01036321|604693|P2|NOT COMPLETED|Overall Study||4
250062|NCT01036321|604694|P1|NOT COMPLETED|Overall Study||5
250063|NCT01036321|604693|P2|COMPLETED|Overall Study||31
250064|NCT01036321|604694|P1|COMPLETED|Overall Study||31
250065|NCT01036321|604693|P2|STARTED|Overall Study||35
250066|NCT01036321|604694|P1|STARTED|Overall Study||36
250067|NCT01036165|604718|P1|NOT COMPLETED|Overall Study||15
250068|NCT01036165|604718|P1|COMPLETED|Overall Study||88
250069|NCT01036165|604718|P1|STARTED|Overall Study||103
250070|NCT01036022|604729|P6|NOT COMPLETED|Overall Study||3
250071|NCT01036022|604730|P5|NOT COMPLETED|Overall Study||3
250072|NCT01036022|604731|P4|NOT COMPLETED|Overall Study||2
250073|NCT01036022|604732|P3|NOT COMPLETED|Overall Study||4
250074|NCT01036022|604733|P2|NOT COMPLETED|Overall Study||4
250075|NCT01036022|604734|P1|NOT COMPLETED|Overall Study||2
250076|NCT01036022|604729|P6|COMPLETED|Overall Study||13
250077|NCT01036022|604730|P5|COMPLETED|Overall Study||9
250078|NCT01036022|604731|P4|COMPLETED|Overall Study||10
250079|NCT01036022|604732|P3|COMPLETED|Overall Study||8
250080|NCT01036022|604733|P2|COMPLETED|Overall Study||7
250081|NCT01036022|604734|P1|COMPLETED|Overall Study||13
250082|NCT01036022|604729|P6|STARTED|Overall Study||16
250083|NCT01036022|604730|P5|STARTED|Overall Study||12
250084|NCT01036022|604731|P4|STARTED|Overall Study||12
250085|NCT01036022|604732|P3|STARTED|Overall Study||12
250086|NCT01036022|604733|P2|STARTED|Overall Study||11
250087|NCT01036022|604734|P1|STARTED|Overall Study||15
250088|NCT01036009|604836|P2|NOT COMPLETED|Overall Study||0
250089|NCT01036009|604837|P1|NOT COMPLETED|Overall Study||0
250090|NCT01036009|604836|P2|COMPLETED|Overall Study||26
250091|NCT01036009|604837|P1|COMPLETED|Overall Study||17
250092|NCT01036009|604836|P2|STARTED|Overall Study||26
250093|NCT01036009|604837|P1|STARTED|Overall Study||17
250094|NCT01035944|604855|P4|NOT COMPLETED|Overall Study||0
250095|NCT01035944|604856|P3|NOT COMPLETED|Overall Study||1
250096|NCT01035944|604857|P2|NOT COMPLETED|Overall Study||1
250097|NCT01035944|604858|P1|NOT COMPLETED|Overall Study||3
250098|NCT01035944|604855|P4|COMPLETED|Overall Study||4
250099|NCT01035944|604856|P3|COMPLETED|Overall Study||4
250100|NCT01035944|604857|P2|COMPLETED|Overall Study||13
250101|NCT01035944|604858|P1|COMPLETED|Overall Study||11
250102|NCT01035944|604855|P4|STARTED|Overall Study||4
250103|NCT01035944|604856|P3|STARTED|Overall Study||5
250104|NCT01035944|604857|P2|STARTED|Overall Study||14
250105|NCT01035944|604858|P1|STARTED|Overall Study||14
250106|NCT01035905|604870|P2|NOT COMPLETED|Overall Study||1
250107|NCT01035905|604871|P1|NOT COMPLETED|Overall Study||1
250108|NCT01035905|604870|P2|COMPLETED|Overall Study||30
250109|NCT01035905|604871|P1|COMPLETED|Overall Study||31
250110|NCT01035905|604870|P2|STARTED|Overall Study||31
250111|NCT01035905|604871|P1|STARTED|Overall Study||32
250112|NCT01035788|604879|P2|NOT COMPLETED|Overall Study||14
250113|NCT01035788|604880|P1|NOT COMPLETED|Overall Study||6
250114|NCT01035788|604879|P2|COMPLETED|Overall Study||9
250115|NCT01035788|604880|P1|COMPLETED|Overall Study||17
250116|NCT01035788|604879|P2|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
250117|NCT01035788|604880|P1|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
250118|NCT01035749|604890|P4|NOT COMPLETED|Overall Study||0
250119|NCT01035749|604891|P3|NOT COMPLETED|Overall Study||0
250120|NCT01035749|604892|P2|NOT COMPLETED|Overall Study||0
250121|NCT01035749|604893|P1|NOT COMPLETED|Overall Study||0
250122|NCT01035749|604890|P4|COMPLETED|Overall Study||110
250123|NCT01035749|604891|P3|COMPLETED|Overall Study||68
250124|NCT01035749|604892|P2|COMPLETED|Overall Study||66
250125|NCT01035749|604893|P1|COMPLETED|Overall Study||66
250126|NCT01035749|604890|P4|STARTED|Overall Study||110
250127|NCT01035749|604891|P3|STARTED|Overall Study||68
250128|NCT01035749|604892|P2|STARTED|Overall Study||66
250129|NCT01035749|604893|P1|STARTED|Overall Study||66
250130|NCT01035658|605015|P4|NOT COMPLETED|Overall Study||0
250131|NCT01035658|605016|P3|NOT COMPLETED|Overall Study||0
250132|NCT01035658|605017|P2|NOT COMPLETED|Overall Study||0
250133|NCT01035658|605018|P1|NOT COMPLETED|Overall Study||0
250134|NCT01035658|605015|P4|COMPLETED|Overall Study||6
250135|NCT01035658|605016|P3|COMPLETED|Overall Study||3
250136|NCT01035658|605017|P2|COMPLETED|Overall Study||8
250137|NCT01035658|605018|P1|COMPLETED|Overall Study||5
250138|NCT01035658|605015|P4|STARTED|Overall Study||6
250139|NCT01035658|605016|P3|STARTED|Overall Study||3
250140|NCT01035658|605017|P2|STARTED|Overall Study||8
250141|NCT01035658|605018|P1|STARTED|Overall Study||5
250142|NCT01035606|605044|P3|NOT COMPLETED|Overall Study||4
250143|NCT01035606|605045|P2|NOT COMPLETED|Overall Study||3
250144|NCT01035606|605046|P1|NOT COMPLETED|Overall Study||3
250145|NCT01035606|605044|P3|COMPLETED|Overall Study||7
250146|NCT01035606|605045|P2|COMPLETED|Overall Study||16
250147|NCT01035606|605046|P1|COMPLETED|Overall Study||16
250148|NCT01035606|605044|P3|STARTED|Overall Study||11
250149|NCT01035606|605045|P2|STARTED|Overall Study||19
250150|NCT01035606|605046|P1|STARTED|Overall Study||19
250151|NCT01035463|605062|P6|NOT COMPLETED|Overall Study||18
250152|NCT01035463|605063|P5|NOT COMPLETED|Overall Study||6
250153|NCT01035463|605064|P4|NOT COMPLETED|Overall Study||2
250154|NCT01035463|605065|P3|NOT COMPLETED|Overall Study||5
250155|NCT01035463|605066|P2|NOT COMPLETED|Overall Study||2
250156|NCT01035463|605067|P1|NOT COMPLETED|Overall Study||0
250157|NCT01035463|605062|P6|COMPLETED|Overall Study||15
250158|NCT01035463|605063|P5|COMPLETED|Overall Study||1
250159|NCT01035463|605064|P4|COMPLETED|Overall Study||2
250160|NCT01035463|605065|P3|COMPLETED|Overall Study||1
250161|NCT01035463|605066|P2|COMPLETED|Overall Study||1
250162|NCT01035463|605067|P1|COMPLETED|Overall Study||6
250163|NCT01035463|605062|P6|STARTED|Overall Study||33
250164|NCT01035463|605063|P5|STARTED|Overall Study||7
250165|NCT01035463|605064|P4|STARTED|Overall Study||4
250166|NCT01035463|605065|P3|STARTED|Overall Study||6
250167|NCT01035463|605066|P2|STARTED|Overall Study||3
250168|NCT01035463|605067|P1|STARTED|Overall Study||6
250169|NCT01035346|605078|P2|NOT COMPLETED|Overall Study||0
250170|NCT01035346|605079|P1|NOT COMPLETED|Overall Study||0
250171|NCT01035346|605078|P2|COMPLETED|Overall Study||9
250172|NCT01035346|605079|P1|COMPLETED|Overall Study||7
250173|NCT01035346|605078|P2|STARTED|Overall Study||9
250174|NCT01035346|605079|P1|STARTED|Overall Study||7
250175|NCT01035333|605097|P1|NOT COMPLETED|Overall Study||10
250176|NCT01035333|605097|P1|COMPLETED|Overall Study||9
250177|NCT01035333|605097|P1|STARTED|Overall Study||19
250178|NCT01035255|605104|P2|NOT COMPLETED|Overall Study||862
250179|NCT01035255|605105|P1|NOT COMPLETED|Overall Study||741
250180|NCT01035255|605104|P2|COMPLETED|Overall Study||3371
250181|NCT01035255|605105|P1|COMPLETED|Overall Study||3468
250182|NCT01035255|605104|P2|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4212
250183|NCT01035255|605105|P1|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4187
250184|NCT01035255|605104|P2|Mis-randomized|Overall Study||2
250185|NCT01035255|605105|P1|Mis-randomized|Overall Study||4
250186|NCT01035255|605104|P2|GCP Violations|Overall Study||19
250187|NCT01035255|605105|P1|GCP Violations|Overall Study||18
250188|NCT01035255|605104|P2|STARTED|Overall Study||4233
250189|NCT01035255|605105|P1|STARTED|Overall Study||4209
250190|NCT01035229|605123|P2|NOT COMPLETED|Overall Study||184
250191|NCT01035229|605124|P1|NOT COMPLETED|Overall Study||362
250192|NCT01035229|605123|P2|COMPLETED|Overall Study||0
250193|NCT01035229|605124|P1|COMPLETED|Overall Study||0
250194|NCT01035229|605123|P2|STARTED|Overall Study||184
250195|NCT01035229|605124|P1|STARTED|Overall Study||362
250196|NCT01035151|605144|P2|NOT COMPLETED|Overall Study||15
250197|NCT01035151|605145|P1|NOT COMPLETED|Overall Study||21
250198|NCT01035151|605144|P2|COMPLETED|Overall Study||185
250199|NCT01035151|605145|P1|COMPLETED|Overall Study||188
250200|NCT01035151|605144|P2|STARTED|Overall Study||200
250201|NCT01035151|605145|P1|STARTED|Overall Study||209
250202|NCT01035138|605154|P3|NOT COMPLETED|Overall Study||47
250203|NCT01035138|605155|P2|NOT COMPLETED|Overall Study||60
250204|NCT01035138|605156|P1|NOT COMPLETED|Overall Study||73
250205|NCT01035138|605154|P3|COMPLETED|Overall Study||0
250206|NCT01035138|605155|P2|COMPLETED|Overall Study||0
250207|NCT01035138|605156|P1|COMPLETED|Overall Study||0
250208|NCT01035138|605154|P3|STARTED|Overall Study||47
250209|NCT01035138|605155|P2|STARTED|Overall Study||60
250210|NCT01035138|605156|P1|STARTED|Overall Study||73
250211|NCT01035060|605212|P2|NOT COMPLETED|Overall Study||14
250212|NCT01035060|605213|P1|NOT COMPLETED|Overall Study||24
250213|NCT01035060|605212|P2|COMPLETED|Overall Study||15
250214|NCT01035060|605213|P1|COMPLETED|Overall Study||15
250215|NCT01035060|605212|P2|STARTED|Overall Study||29
250216|NCT01035060|605213|P1|STARTED|Overall Study||39
250217|NCT01035047|605221|P2|NOT COMPLETED|Overall Study||0
250218|NCT01035047|605222|P1|NOT COMPLETED|Overall Study||0
250219|NCT01035047|605221|P2|COMPLETED|Overall Study||53
250220|NCT01035047|605222|P1|COMPLETED|Overall Study||52
250221|NCT01035047|605221|P2|STARTED|Overall Study||53
250222|NCT01035047|605222|P1|STARTED|Overall Study||52
250223|NCT01034709|605238|P2|NOT COMPLETED|Overall Study||16
250224|NCT01034709|605239|P1|NOT COMPLETED|Overall Study||9
250225|NCT01034709|605238|P2|COMPLETED|Overall Study||42
250226|NCT01034709|605239|P1|COMPLETED|Overall Study||44
250227|NCT01034709|605238|P2|STARTED|Overall Study||58
250228|NCT01034709|605239|P1|STARTED|Overall Study||53
250229|NCT01034657|605245|P3|NOT COMPLETED|Randomized Phase||1
250230|NCT01034657|605246|P2|NOT COMPLETED|Randomized Phase||6
250231|NCT01034657|605247|P1|NOT COMPLETED|Randomized Phase||5
250232|NCT01034657|605245|P3|COMPLETED|Randomized Phase||0
250233|NCT01034657|605246|P2|COMPLETED|Randomized Phase||0
250234|NCT01034657|605247|P1|COMPLETED|Randomized Phase||1
250235|NCT01034657|605245|P3|STARTED|Randomized Phase||1
250236|NCT01034657|605246|P2|STARTED|Randomized Phase||6
250237|NCT01034657|605247|P1|STARTED|Randomized Phase||6
250238|NCT01034657|605245|P3|NOT COMPLETED|Core Phase||0
250239|NCT01034657|605246|P2|NOT COMPLETED|Core Phase||0
250240|NCT01034657|605247|P1|NOT COMPLETED|Core Phase||14
250241|NCT01034657|605245|P3|COMPLETED|Core Phase||0
250242|NCT01034657|605246|P2|COMPLETED|Core Phase||0
250243|NCT01034657|605247|P1|COMPLETED|Core Phase||20
250244|NCT01034657|605245|P3|STARTED|Core Phase||0
250245|NCT01034657|605246|P2|STARTED|Core Phase||0
250246|NCT01034657|605247|P1|STARTED|Core Phase||34
250247|NCT01034631|605288|P3|NOT COMPLETED|Phase II||2
250248|NCT01034631|605289|P2|NOT COMPLETED|Phase II||1
250249|NCT01034631|605290|P1|NOT COMPLETED|Phase II||0
250250|NCT01034631|605288|P3|COMPLETED|Phase II||67
250251|NCT01034631|605289|P2|COMPLETED|Phase II||69
250252|NCT01034631|605290|P1|COMPLETED|Phase II||0
250253|NCT01034631|605288|P3|STARTED|Phase II||69
250254|NCT01034631|605289|P2|STARTED|Phase II||70
250347|NCT01034137|605576|P1|NOT COMPLETED|Overall Study||28
250255|NCT01034631|605290|P1|STARTED|Phase II|No Phase I Participants were enrolled during this time period.|0
250256|NCT01034631|605288|P3|NOT COMPLETED|Phase I||0
250257|NCT01034631|605289|P2|NOT COMPLETED|Phase I||0
250258|NCT01034631|605290|P1|NOT COMPLETED|Phase I||3
250259|NCT01034631|605288|P3|COMPLETED|Phase I||0
250260|NCT01034631|605289|P2|COMPLETED|Phase I||0
250261|NCT01034631|605290|P1|COMPLETED|Phase I||12
250262|NCT01034631|605288|P3|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
250263|NCT01034631|605289|P2|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
250264|NCT01034631|605290|P1|STARTED|Phase I||15
250265|NCT01034592|605309|P1|NOT COMPLETED|Overall Study||0
250266|NCT01034592|605309|P1|COMPLETED|Overall Study||2
250267|NCT01034592|605309|P1|STARTED|Overall Study||2
250268|NCT01034579|605321|P2|NOT COMPLETED|Overall Study||0
250269|NCT01034579|605322|P1|NOT COMPLETED|Overall Study||0
250270|NCT01034579|605321|P2|COMPLETED|Overall Study||166
250271|NCT01034579|605322|P1|COMPLETED|Overall Study||158
250272|NCT01034579|605321|P2|STARTED|Overall Study||166
250273|NCT01034579|605322|P1|STARTED|Overall Study||158
250274|NCT01034553|605336|P6|NOT COMPLETED|Overall Study||0
250275|NCT01034553|605337|P5|NOT COMPLETED|Overall Study||0
250276|NCT01034553|605338|P4|NOT COMPLETED|Overall Study||0
250277|NCT01034553|605339|P3|NOT COMPLETED|Overall Study||0
250278|NCT01034553|605340|P2|NOT COMPLETED|Overall Study||0
250279|NCT01034553|605341|P1|NOT COMPLETED|Overall Study||0
250280|NCT01034553|605336|P6|COMPLETED|Overall Study||7
250281|NCT01034553|605337|P5|COMPLETED|Overall Study||6
250282|NCT01034553|605338|P4|COMPLETED|Overall Study||3
250283|NCT01034553|605339|P3|COMPLETED|Overall Study||3
250284|NCT01034553|605340|P2|COMPLETED|Overall Study||4
250285|NCT01034553|605341|P1|COMPLETED|Overall Study||3
250286|NCT01034553|605336|P6|STARTED|Overall Study||7
250287|NCT01034553|605337|P5|STARTED|Overall Study||6
250288|NCT01034553|605338|P4|STARTED|Overall Study||3
250289|NCT01034553|605339|P3|STARTED|Overall Study||3
250290|NCT01034553|605340|P2|STARTED|Overall Study||4
250291|NCT01034553|605341|P1|STARTED|Overall Study||3
250292|NCT01034540|605357|P2|NOT COMPLETED|Overall Study||1
250293|NCT01034540|605358|P1|NOT COMPLETED|Overall Study||0
250294|NCT01034540|605357|P2|COMPLETED|Overall Study||11
250295|NCT01034540|605358|P1|COMPLETED|Overall Study||11
250296|NCT01034540|605357|P2|Completed 1st Treatment Intervention|Overall Study||11
250297|NCT01034540|605358|P1|Completed 1st Treatment Intervention|Overall Study||11
250298|NCT01034540|605357|P2|STARTED|Overall Study||12
250299|NCT01034540|605358|P1|STARTED|Overall Study||11
250300|NCT01034527|605368|P2|NOT COMPLETED|Overall Study||0
250301|NCT01034527|605369|P1|NOT COMPLETED|Overall Study||0
250302|NCT01034527|605368|P2|COMPLETED|Overall Study||216
250303|NCT01034527|605369|P1|COMPLETED|Overall Study||307
250304|NCT01034527|605368|P2|STARTED|Overall Study||216
250305|NCT01034527|605369|P1|STARTED|Overall Study||307
250306|NCT01034462|605377|P2|NOT COMPLETED|Overall Study||54
250307|NCT01034462|605378|P1|NOT COMPLETED|Overall Study||45
250308|NCT01034462|605377|P2|COMPLETED|Overall Study||163
250309|NCT01034462|605378|P1|COMPLETED|Overall Study||172
250310|NCT01034462|605377|P2|STARTED|Overall Study||217
250311|NCT01034462|605378|P1|STARTED|Overall Study||217
250312|NCT01034397|605388|P2|NOT COMPLETED|Overall Study||2
250313|NCT01034397|605389|P1|NOT COMPLETED|Overall Study||7
250314|NCT01034397|605388|P2|COMPLETED|Overall Study||17
250315|NCT01034397|605389|P1|COMPLETED|Overall Study||28
250316|NCT01034397|605388|P2|STARTED|Overall Study||19
250317|NCT01034397|605389|P1|STARTED|Overall Study||35
250318|NCT01034358|605538|P1|NOT COMPLETED|Overall Study||2
250319|NCT01034358|605538|P1|COMPLETED|Overall Study|One patient was found after enrollment to have already received one prior dose of the HPV vaccine.|13
250320|NCT01034358|605538|P1|STARTED|Overall Study||15
250321|NCT01034306|605544|P2|NOT COMPLETED|Overall Study||3
250322|NCT01034306|605545|P1|NOT COMPLETED|Overall Study||5
250323|NCT01034306|605544|P2|COMPLETED|Overall Study||34
250324|NCT01034306|605545|P1|COMPLETED|Overall Study||37
250325|NCT01034306|605544|P2|STARTED|Overall Study||37
250326|NCT01034306|605545|P1|STARTED|Overall Study||42
250327|NCT01034176|605553|P2|NOT COMPLETED|Overall Study||2
250328|NCT01034176|605554|P1|NOT COMPLETED|Overall Study||2
250329|NCT01034176|605553|P2|COMPLETED|Overall Study||19
250330|NCT01034176|605554|P1|COMPLETED|Overall Study||20
250331|NCT01034176|605553|P2|STARTED|Overall Study||21
250332|NCT01034176|605554|P1|STARTED|Overall Study||22
250333|NCT01034163|605564|P2|NOT COMPLETED|Overall Study||14
250334|NCT01034163|605565|P1|NOT COMPLETED|Overall Study||27
250335|NCT01034163|605564|P2|COMPLETED|Overall Study||0
250336|NCT01034163|605565|P1|COMPLETED|Overall Study||0
250337|NCT01034163|605564|P2|In Open Label Phase After Unblinding|Overall Study||0
250338|NCT01034163|605565|P1|In Open Label Phase After Unblinding|Overall Study||5
250339|NCT01034163|605564|P2|Safety Set|Overall Study||12
250340|NCT01034163|605565|P1|Safety Set|Overall Study||26
250341|NCT01034163|605564|P2|Untreated (Not in Safety Set)|Overall Study||2
250342|NCT01034163|605565|P1|Untreated (Not in Safety Set)|Overall Study||1
250343|NCT01034163|605564|P2|STARTED|Overall Study||14
250344|NCT01034163|605565|P1|STARTED|Overall Study||27
250345|NCT01034137|605574|P3|NOT COMPLETED|Overall Study||30
250346|NCT01034137|605575|P2|NOT COMPLETED|Overall Study||22
250348|NCT01034137|605574|P3|COMPLETED|Overall Study||78
250349|NCT01034137|605575|P2|COMPLETED|Overall Study||81
250350|NCT01034137|605576|P1|COMPLETED|Overall Study||78
250351|NCT01034137|605574|P3|STARTED|Overall Study||108
250352|NCT01034137|605575|P2|STARTED|Overall Study||103
250353|NCT01034137|605576|P1|STARTED|Overall Study||106
250354|NCT01034111|605707|P1|NOT COMPLETED|Overall Study||0
250355|NCT01034111|605707|P1|COMPLETED|Overall Study||30
250356|NCT01034111|605707|P1|STARTED|Overall Study||30
250357|NCT01033942|605715|P3|NOT COMPLETED|Overall Study||1
250358|NCT01033942|605716|P2|NOT COMPLETED|Overall Study||4
250359|NCT01033942|605717|P1|NOT COMPLETED|Overall Study||2
250360|NCT01033942|605715|P3|COMPLETED|Overall Study||18
250361|NCT01033942|605716|P2|COMPLETED|Overall Study||15
250362|NCT01033942|605717|P1|COMPLETED|Overall Study||18
250363|NCT01033942|605715|P3|STARTED|Overall Study||19
250364|NCT01033942|605716|P2|STARTED|Overall Study||19
250365|NCT01033942|605717|P1|STARTED|Overall Study||20
250366|NCT01033864|605989|P2|NOT COMPLETED|Overall Study||0
250367|NCT01033864|605990|P1|NOT COMPLETED|Overall Study||0
250368|NCT01033864|605989|P2|COMPLETED|Overall Study||11
250369|NCT01033864|605990|P1|COMPLETED|Overall Study||12
250370|NCT01033864|605989|P2|STARTED|Overall Study||11
250371|NCT01033864|605990|P1|STARTED|Overall Study||12
250372|NCT01033851|606015|P2|NOT COMPLETED|Overall Study||7
250373|NCT01033851|606016|P1|NOT COMPLETED|Overall Study||3
250374|NCT01033851|606015|P2|COMPLETED|Overall Study||34
250375|NCT01033851|606016|P1|COMPLETED|Overall Study||45
250376|NCT01033851|606015|P2|STARTED|Overall Study||41
250377|NCT01033851|606016|P1|STARTED|Overall Study||48
250378|NCT01033825|606031|P7|NOT COMPLETED|Overall Study||0
250379|NCT01033825|606032|P6|NOT COMPLETED|Overall Study||0
250380|NCT01033825|606033|P5|NOT COMPLETED|Overall Study||2
250381|NCT01033825|606034|P4|NOT COMPLETED|Overall Study||2
250382|NCT01033825|606035|P3|NOT COMPLETED|Overall Study||2
250383|NCT01033825|606036|P2|NOT COMPLETED|Overall Study||3
250384|NCT01033825|606037|P1|NOT COMPLETED|Overall Study||3
250385|NCT01033825|606031|P7|COMPLETED|Overall Study||18
250386|NCT01033825|606032|P6|COMPLETED|Overall Study||18
250387|NCT01033825|606033|P5|COMPLETED|Overall Study||56
250388|NCT01033825|606034|P4|COMPLETED|Overall Study||46
250389|NCT01033825|606035|P3|COMPLETED|Overall Study||55
250390|NCT01033825|606036|P2|COMPLETED|Overall Study||57
250391|NCT01033825|606037|P1|COMPLETED|Overall Study||48
250392|NCT01033825|606031|P7|STARTED|Overall Study||18
250393|NCT01033825|606032|P6|STARTED|Overall Study||18
250394|NCT01033825|606033|P5|STARTED|Overall Study||58
250395|NCT01033825|606034|P4|STARTED|Overall Study||48
250396|NCT01033825|606035|P3|STARTED|Overall Study||57
250397|NCT01033825|606036|P2|STARTED|Overall Study||60
250398|NCT01033825|606037|P1|STARTED|Overall Study||51
250399|NCT01033747|606258|P2|NOT COMPLETED|Overall Study||15
250400|NCT01033747|606259|P1|NOT COMPLETED|Overall Study||37
250401|NCT01033747|606258|P2|COMPLETED|Overall Study||4
250402|NCT01033747|606259|P1|COMPLETED|Overall Study||14
250403|NCT01033747|606258|P2|STARTED|Overall Study||19
250404|NCT01033747|606259|P1|STARTED|Overall Study||51
250405|NCT01033734|606267|P1|NOT COMPLETED|Overall Study||1
250406|NCT01033734|606267|P1|COMPLETED|Overall Study||7
250407|NCT01033734|606267|P1|STARTED|Overall Study||8
250408|NCT01033565|606319|P1|NOT COMPLETED|Overall Study||0
250409|NCT01033565|606319|P1|COMPLETED|Overall Study||1
250410|NCT01033565|606319|P1|STARTED|Overall Study||1
250411|NCT01033487|606323|P10|NOT COMPLETED|Fifth Intervention Period||0
250412|NCT01033487|606324|P9|NOT COMPLETED|Fifth Intervention Period||0
250413|NCT01033487|606325|P8|NOT COMPLETED|Fifth Intervention Period||0
250414|NCT01033487|606326|P7|NOT COMPLETED|Fifth Intervention Period||0
250415|NCT01033487|606327|P6|NOT COMPLETED|Fifth Intervention Period||0
250416|NCT01033487|606328|P5|NOT COMPLETED|Fifth Intervention Period||0
250417|NCT01033487|606329|P4|NOT COMPLETED|Fifth Intervention Period||0
250418|NCT01033487|606330|P3|NOT COMPLETED|Fifth Intervention Period||0
250419|NCT01033487|606331|P2|NOT COMPLETED|Fifth Intervention Period||0
250420|NCT01033487|606332|P1|NOT COMPLETED|Fifth Intervention Period||0
250421|NCT01033487|606323|P10|COMPLETED|Fifth Intervention Period||2
250422|NCT01033487|606324|P9|COMPLETED|Fifth Intervention Period||1
250423|NCT01033487|606325|P8|COMPLETED|Fifth Intervention Period||3
250424|NCT01033487|606326|P7|COMPLETED|Fifth Intervention Period||2
250425|NCT01033487|606327|P6|COMPLETED|Fifth Intervention Period||2
250426|NCT01033487|606328|P5|COMPLETED|Fifth Intervention Period||2
250427|NCT01033487|606329|P4|COMPLETED|Fifth Intervention Period||2
250428|NCT01033487|606330|P3|COMPLETED|Fifth Intervention Period||2
250429|NCT01033487|606331|P2|COMPLETED|Fifth Intervention Period||3
250430|NCT01033487|606332|P1|COMPLETED|Fifth Intervention Period||2
250431|NCT01033487|606323|P10|STARTED|Fifth Intervention Period||2
250432|NCT01033487|606324|P9|STARTED|Fifth Intervention Period||1
250433|NCT01033487|606325|P8|STARTED|Fifth Intervention Period||3
250434|NCT01033487|606326|P7|STARTED|Fifth Intervention Period||2
250435|NCT01033487|606327|P6|STARTED|Fifth Intervention Period||2
250436|NCT01033487|606328|P5|STARTED|Fifth Intervention Period||2
250437|NCT01033487|606329|P4|STARTED|Fifth Intervention Period||2
250438|NCT01033487|606330|P3|STARTED|Fifth Intervention Period||2
250439|NCT01033487|606331|P2|STARTED|Fifth Intervention Period||3
250440|NCT01033487|606332|P1|STARTED|Fifth Intervention Period||2
250441|NCT01033487|606323|P10|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
250442|NCT01033487|606324|P9|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
250443|NCT01033487|606325|P8|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
250444|NCT01033487|606326|P7|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
250445|NCT01033487|606327|P6|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
250446|NCT01033487|606328|P5|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
250447|NCT01033487|606329|P4|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
250448|NCT01033487|606330|P3|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
250449|NCT01033487|606331|P2|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
250450|NCT01033487|606332|P1|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
250451|NCT01033487|606323|P10|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
250452|NCT01033487|606324|P9|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||1
250453|NCT01033487|606325|P8|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
250454|NCT01033487|606326|P7|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
250455|NCT01033487|606327|P6|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
250456|NCT01033487|606328|P5|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
250457|NCT01033487|606329|P4|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
250458|NCT01033487|606330|P3|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
250459|NCT01033487|606331|P2|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
250460|NCT01033487|606332|P1|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
250461|NCT01033487|606323|P10|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
250462|NCT01033487|606324|P9|STARTED|Between Period 4 and 5 (At Least 7 Days)||1
250463|NCT01033487|606325|P8|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
250464|NCT01033487|606326|P7|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
250465|NCT01033487|606327|P6|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
250466|NCT01033487|606328|P5|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
250467|NCT01033487|606329|P4|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
250468|NCT01033487|606330|P3|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
250469|NCT01033487|606331|P2|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
250470|NCT01033487|606332|P1|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
250471|NCT01033487|606323|P10|NOT COMPLETED|Fourth Intervention Period||0
250472|NCT01033487|606324|P9|NOT COMPLETED|Fourth Intervention Period||1
250473|NCT01033487|606325|P8|NOT COMPLETED|Fourth Intervention Period||0
250474|NCT01033487|606326|P7|NOT COMPLETED|Fourth Intervention Period||0
250475|NCT01033487|606327|P6|NOT COMPLETED|Fourth Intervention Period||0
250476|NCT01033487|606328|P5|NOT COMPLETED|Fourth Intervention Period||0
250477|NCT01033487|606329|P4|NOT COMPLETED|Fourth Intervention Period||0
250478|NCT01033487|606330|P3|NOT COMPLETED|Fourth Intervention Period||0
250479|NCT01033487|606331|P2|NOT COMPLETED|Fourth Intervention Period||0
250480|NCT01033487|606332|P1|NOT COMPLETED|Fourth Intervention Period||0
250481|NCT01033487|606323|P10|COMPLETED|Fourth Intervention Period||2
250482|NCT01033487|606324|P9|COMPLETED|Fourth Intervention Period||1
250483|NCT01033487|606325|P8|COMPLETED|Fourth Intervention Period||3
250484|NCT01033487|606326|P7|COMPLETED|Fourth Intervention Period||2
250485|NCT01033487|606327|P6|COMPLETED|Fourth Intervention Period||2
250486|NCT01033487|606328|P5|COMPLETED|Fourth Intervention Period||2
250487|NCT01033487|606329|P4|COMPLETED|Fourth Intervention Period||2
250488|NCT01033487|606330|P3|COMPLETED|Fourth Intervention Period||2
250489|NCT01033487|606331|P2|COMPLETED|Fourth Intervention Period||3
250490|NCT01033487|606332|P1|COMPLETED|Fourth Intervention Period||2
250491|NCT01033487|606323|P10|STARTED|Fourth Intervention Period||2
250492|NCT01033487|606324|P9|STARTED|Fourth Intervention Period||2
250493|NCT01033487|606325|P8|STARTED|Fourth Intervention Period||3
250494|NCT01033487|606326|P7|STARTED|Fourth Intervention Period||2
250495|NCT01033487|606327|P6|STARTED|Fourth Intervention Period||2
250496|NCT01033487|606328|P5|STARTED|Fourth Intervention Period||2
250497|NCT01033487|606329|P4|STARTED|Fourth Intervention Period||2
250498|NCT01033487|606330|P3|STARTED|Fourth Intervention Period||2
250499|NCT01033487|606331|P2|STARTED|Fourth Intervention Period||3
250500|NCT01033487|606332|P1|STARTED|Fourth Intervention Period||2
250501|NCT01033487|606323|P10|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
250502|NCT01033487|606324|P9|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
250503|NCT01033487|606325|P8|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
250504|NCT01033487|606326|P7|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
250505|NCT01033487|606327|P6|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
250506|NCT01033487|606328|P5|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
250507|NCT01033487|606329|P4|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
250508|NCT01033487|606330|P3|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
250509|NCT01033487|606331|P2|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
250510|NCT01033487|606332|P1|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
250511|NCT01033487|606323|P10|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
250512|NCT01033487|606324|P9|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
250513|NCT01033487|606325|P8|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
250514|NCT01033487|606326|P7|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
250515|NCT01033487|606327|P6|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
250516|NCT01033487|606328|P5|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
250517|NCT01033487|606329|P4|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
250518|NCT01033487|606330|P3|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
250519|NCT01033487|606331|P2|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
250520|NCT01033487|606332|P1|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
250521|NCT01033487|606323|P10|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
250522|NCT01033487|606324|P9|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
250523|NCT01033487|606325|P8|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
250524|NCT01033487|606326|P7|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
250525|NCT01033487|606327|P6|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
250526|NCT01033487|606328|P5|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
250527|NCT01033487|606329|P4|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
250528|NCT01033487|606330|P3|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
250529|NCT01033487|606331|P2|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
250530|NCT01033487|606332|P1|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
250531|NCT01033487|606323|P10|NOT COMPLETED|Third Intervention Period||0
250532|NCT01033487|606324|P9|NOT COMPLETED|Third Intervention Period||0
250533|NCT01033487|606325|P8|NOT COMPLETED|Third Intervention Period||0
250534|NCT01033487|606326|P7|NOT COMPLETED|Third Intervention Period||0
250535|NCT01033487|606327|P6|NOT COMPLETED|Third Intervention Period||0
250536|NCT01033487|606328|P5|NOT COMPLETED|Third Intervention Period||0
250537|NCT01033487|606329|P4|NOT COMPLETED|Third Intervention Period||0
250538|NCT01033487|606330|P3|NOT COMPLETED|Third Intervention Period||0
250539|NCT01033487|606331|P2|NOT COMPLETED|Third Intervention Period||0
250540|NCT01033487|606332|P1|NOT COMPLETED|Third Intervention Period||0
250541|NCT01033487|606323|P10|COMPLETED|Third Intervention Period||2
250542|NCT01033487|606324|P9|COMPLETED|Third Intervention Period||2
250543|NCT01033487|606325|P8|COMPLETED|Third Intervention Period||3
250544|NCT01033487|606326|P7|COMPLETED|Third Intervention Period||2
250545|NCT01033487|606327|P6|COMPLETED|Third Intervention Period||2
250546|NCT01033487|606328|P5|COMPLETED|Third Intervention Period||2
250547|NCT01033487|606329|P4|COMPLETED|Third Intervention Period||2
250548|NCT01033487|606330|P3|COMPLETED|Third Intervention Period||2
250549|NCT01033487|606331|P2|COMPLETED|Third Intervention Period||3
250550|NCT01033487|606332|P1|COMPLETED|Third Intervention Period||2
250551|NCT01033487|606323|P10|STARTED|Third Intervention Period||2
250552|NCT01033487|606324|P9|STARTED|Third Intervention Period||2
250553|NCT01033487|606325|P8|STARTED|Third Intervention Period||3
250554|NCT01033487|606326|P7|STARTED|Third Intervention Period||2
250555|NCT01033487|606327|P6|STARTED|Third Intervention Period||2
250556|NCT01033487|606328|P5|STARTED|Third Intervention Period||2
250557|NCT01033487|606329|P4|STARTED|Third Intervention Period||2
250558|NCT01033487|606330|P3|STARTED|Third Intervention Period||2
250559|NCT01033487|606331|P2|STARTED|Third Intervention Period||3
250560|NCT01033487|606332|P1|STARTED|Third Intervention Period||2
250561|NCT01033487|606323|P10|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
250562|NCT01033487|606324|P9|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
250563|NCT01033487|606325|P8|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
250564|NCT01033487|606326|P7|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
250565|NCT01033487|606327|P6|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
250566|NCT01033487|606328|P5|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
250567|NCT01033487|606329|P4|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
250568|NCT01033487|606330|P3|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
250569|NCT01033487|606331|P2|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
250570|NCT01033487|606332|P1|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
250571|NCT01033487|606323|P10|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
250572|NCT01033487|606324|P9|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
250573|NCT01033487|606325|P8|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
250574|NCT01033487|606326|P7|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
250575|NCT01033487|606327|P6|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
250576|NCT01033487|606328|P5|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
250577|NCT01033487|606329|P4|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
250578|NCT01033487|606330|P3|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
250579|NCT01033487|606331|P2|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
250580|NCT01033487|606332|P1|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
250581|NCT01033487|606323|P10|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
250582|NCT01033487|606324|P9|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
250583|NCT01033487|606325|P8|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
250584|NCT01033487|606326|P7|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
250585|NCT01033487|606327|P6|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
250586|NCT01033487|606328|P5|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
250587|NCT01033487|606329|P4|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
250588|NCT01033487|606330|P3|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
250589|NCT01033487|606331|P2|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
250590|NCT01033487|606332|P1|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
250591|NCT01033487|606323|P10|NOT COMPLETED|Second Intervention Period||0
250592|NCT01033487|606324|P9|NOT COMPLETED|Second Intervention Period||0
250593|NCT01033487|606325|P8|NOT COMPLETED|Second Intervention Period||0
250594|NCT01033487|606326|P7|NOT COMPLETED|Second Intervention Period||0
250595|NCT01033487|606327|P6|NOT COMPLETED|Second Intervention Period||0
250596|NCT01033487|606328|P5|NOT COMPLETED|Second Intervention Period||0
250597|NCT01033487|606329|P4|NOT COMPLETED|Second Intervention Period||0
250598|NCT01033487|606330|P3|NOT COMPLETED|Second Intervention Period||0
250599|NCT01033487|606331|P2|NOT COMPLETED|Second Intervention Period||0
250600|NCT01033487|606332|P1|NOT COMPLETED|Second Intervention Period||0
250601|NCT01033487|606323|P10|COMPLETED|Second Intervention Period||2
250602|NCT01033487|606324|P9|COMPLETED|Second Intervention Period||2
250603|NCT01033487|606325|P8|COMPLETED|Second Intervention Period||3
250604|NCT01033487|606326|P7|COMPLETED|Second Intervention Period||2
250605|NCT01033487|606327|P6|COMPLETED|Second Intervention Period||2
250606|NCT01033487|606328|P5|COMPLETED|Second Intervention Period||2
250607|NCT01033487|606329|P4|COMPLETED|Second Intervention Period||2
250608|NCT01033487|606330|P3|COMPLETED|Second Intervention Period||2
250609|NCT01033487|606331|P2|COMPLETED|Second Intervention Period||3
250610|NCT01033487|606332|P1|COMPLETED|Second Intervention Period||2
250611|NCT01033487|606323|P10|STARTED|Second Intervention Period||2
250612|NCT01033487|606324|P9|STARTED|Second Intervention Period||2
250613|NCT01033487|606325|P8|STARTED|Second Intervention Period||3
250614|NCT01033487|606326|P7|STARTED|Second Intervention Period||2
250615|NCT01033487|606327|P6|STARTED|Second Intervention Period||2
250616|NCT01033487|606328|P5|STARTED|Second Intervention Period||2
250617|NCT01033487|606329|P4|STARTED|Second Intervention Period||2
250618|NCT01033487|606330|P3|STARTED|Second Intervention Period||2
250619|NCT01033487|606331|P2|STARTED|Second Intervention Period||3
250620|NCT01033487|606332|P1|STARTED|Second Intervention Period||2
250621|NCT01033487|606323|P10|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
250622|NCT01033487|606324|P9|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
250623|NCT01033487|606325|P8|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
250624|NCT01033487|606326|P7|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
250625|NCT01033487|606327|P6|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
250626|NCT01033487|606328|P5|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
250627|NCT01033487|606329|P4|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
250628|NCT01033487|606330|P3|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
250629|NCT01033487|606331|P2|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
250630|NCT01033487|606332|P1|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
250631|NCT01033487|606323|P10|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
250632|NCT01033487|606324|P9|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
250633|NCT01033487|606325|P8|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
250634|NCT01033487|606326|P7|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
250635|NCT01033487|606327|P6|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
250636|NCT01033487|606328|P5|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
250637|NCT01033487|606329|P4|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
250638|NCT01033487|606330|P3|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
250639|NCT01033487|606331|P2|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
250640|NCT01033487|606332|P1|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
250641|NCT01033487|606323|P10|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
250642|NCT01033487|606324|P9|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
250643|NCT01033487|606325|P8|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
250644|NCT01033487|606326|P7|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
250645|NCT01033487|606327|P6|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
250646|NCT01033487|606328|P5|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
250647|NCT01033487|606329|P4|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
250648|NCT01033487|606330|P3|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
250649|NCT01033487|606331|P2|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
250650|NCT01033487|606332|P1|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
250651|NCT01033487|606323|P10|NOT COMPLETED|First Intervention Period||0
250652|NCT01033487|606324|P9|NOT COMPLETED|First Intervention Period||0
250653|NCT01033487|606325|P8|NOT COMPLETED|First Intervention Period||0
250654|NCT01033487|606326|P7|NOT COMPLETED|First Intervention Period||0
250655|NCT01033487|606327|P6|NOT COMPLETED|First Intervention Period||0
250656|NCT01033487|606328|P5|NOT COMPLETED|First Intervention Period||0
250657|NCT01033487|606329|P4|NOT COMPLETED|First Intervention Period||0
250658|NCT01033487|606330|P3|NOT COMPLETED|First Intervention Period||0
250659|NCT01033487|606331|P2|NOT COMPLETED|First Intervention Period||0
250660|NCT01033487|606332|P1|NOT COMPLETED|First Intervention Period||0
250661|NCT01033487|606323|P10|COMPLETED|First Intervention Period||2
250662|NCT01033487|606324|P9|COMPLETED|First Intervention Period||2
250663|NCT01033487|606325|P8|COMPLETED|First Intervention Period||3
250664|NCT01033487|606326|P7|COMPLETED|First Intervention Period||2
250665|NCT01033487|606327|P6|COMPLETED|First Intervention Period||2
250666|NCT01033487|606328|P5|COMPLETED|First Intervention Period||2
250667|NCT01033487|606329|P4|COMPLETED|First Intervention Period||2
250668|NCT01033487|606330|P3|COMPLETED|First Intervention Period||2
250669|NCT01033487|606331|P2|COMPLETED|First Intervention Period||3
250670|NCT01033487|606332|P1|COMPLETED|First Intervention Period||2
250671|NCT01033487|606323|P10|STARTED|First Intervention Period||2
250672|NCT01033487|606324|P9|STARTED|First Intervention Period||2
250673|NCT01033487|606325|P8|STARTED|First Intervention Period||3
250674|NCT01033487|606326|P7|STARTED|First Intervention Period||2
250675|NCT01033487|606327|P6|STARTED|First Intervention Period||2
250676|NCT01033487|606328|P5|STARTED|First Intervention Period||2
250677|NCT01033487|606329|P4|STARTED|First Intervention Period||2
250678|NCT01033487|606330|P3|STARTED|First Intervention Period||2
250679|NCT01033487|606331|P2|STARTED|First Intervention Period||3
250680|NCT01033487|606332|P1|STARTED|First Intervention Period||2
250681|NCT01033448|606386|P1|NOT COMPLETED|Overall Study||12
250682|NCT01033448|606386|P1|COMPLETED|Overall Study||47
250683|NCT01033448|606386|P1|STARTED|Overall Study||59
250684|NCT01033422|606397|P3|NOT COMPLETED|Overall Study||1
250685|NCT01033422|606398|P2|NOT COMPLETED|Overall Study||4
250686|NCT01033422|606399|P1|NOT COMPLETED|Overall Study||1
250687|NCT01033422|606397|P3|COMPLETED|Overall Study||22
250688|NCT01033422|606398|P2|COMPLETED|Overall Study||28
250689|NCT01033422|606399|P1|COMPLETED|Overall Study||33
250690|NCT01033422|606397|P3|STARTED|Overall Study||23
250691|NCT01033422|606398|P2|STARTED|Overall Study||32
250692|NCT01033422|606399|P1|STARTED|Overall Study||34
250693|NCT01033383|606411|P4|NOT COMPLETED|Overall Study||0
250694|NCT01033383|606412|P3|NOT COMPLETED|Overall Study||0
250695|NCT01033383|606413|P2|NOT COMPLETED|Overall Study||0
250696|NCT01033383|606414|P1|NOT COMPLETED|Overall Study||0
250697|NCT01033383|606411|P4|COMPLETED|Overall Study||20
250698|NCT01033383|606412|P3|COMPLETED|Overall Study||20
250699|NCT01033383|606413|P2|COMPLETED|Overall Study||20
250700|NCT01033383|606414|P1|COMPLETED|Overall Study||20
250701|NCT01033383|606411|P4|STARTED|Overall Study||20
250702|NCT01033383|606412|P3|STARTED|Overall Study||20
250703|NCT01033383|606413|P2|STARTED|Overall Study||20
250704|NCT01033383|606414|P1|STARTED|Overall Study||20
250705|NCT01033227|606434|P2|NOT COMPLETED|Overall Study||0
250706|NCT01033227|606435|P1|NOT COMPLETED|Overall Study||0
250707|NCT01033227|606434|P2|COMPLETED|Overall Study||2
250708|NCT01033227|606435|P1|COMPLETED|Overall Study||3
250709|NCT01033227|606434|P2|STARTED|Overall Study||2
250710|NCT01033227|606435|P1|STARTED|Overall Study||3
250711|NCT01033136|606445|P2|NOT COMPLETED|Follow-Up (3 Month)||2
250712|NCT01033136|606446|P1|NOT COMPLETED|Follow-Up (3 Month)||2
250713|NCT01033136|606445|P2|COMPLETED|Follow-Up (3 Month)||13
250714|NCT01033136|606446|P1|COMPLETED|Follow-Up (3 Month)||14
250715|NCT01033136|606445|P2|STARTED|Follow-Up (3 Month)||15
250716|NCT01033136|606446|P1|STARTED|Follow-Up (3 Month)||16
250717|NCT01033136|606445|P2|NOT COMPLETED|Post-Treatment (1 Week)||11
250718|NCT01033136|606446|P1|NOT COMPLETED|Post-Treatment (1 Week)||14
250719|NCT01033136|606445|P2|COMPLETED|Post-Treatment (1 Week)||15
250720|NCT01033136|606446|P1|COMPLETED|Post-Treatment (1 Week)||16
250721|NCT01033136|606445|P2|STARTED|Post-Treatment (1 Week)||26
250722|NCT01033136|606446|P1|STARTED|Post-Treatment (1 Week)||30
250723|NCT01033136|606445|P2|NOT COMPLETED|Baseline Assessment||6
250724|NCT01033136|606446|P1|NOT COMPLETED|Baseline Assessment||6
250725|NCT01033136|606445|P2|COMPLETED|Baseline Assessment||26
250726|NCT01033136|606446|P1|COMPLETED|Baseline Assessment||30
250727|NCT01033136|606445|P2|STARTED|Baseline Assessment||32
250728|NCT01033136|606446|P1|STARTED|Baseline Assessment||36
250729|NCT01033071|606457|P3|NOT COMPLETED|Overall Study||47
250730|NCT01033071|606458|P2|NOT COMPLETED|Overall Study||77
250731|NCT01033071|606459|P1|NOT COMPLETED|Overall Study||55
250732|NCT01033071|606457|P3|COMPLETED|Overall Study||317
250733|NCT01033071|606458|P2|COMPLETED|Overall Study||275
250734|NCT01033071|606459|P1|COMPLETED|Overall Study||300
250735|NCT01033071|606457|P3|STARTED|Overall Study||364
250736|NCT01033071|606458|P2|STARTED|Overall Study||352
250737|NCT01033071|606459|P1|STARTED|Overall Study||355
250738|NCT01033032|606518|P4|NOT COMPLETED|Phase II||0
250739|NCT01033032|606519|P3|NOT COMPLETED|Phase II||66
250740|NCT01033032|606520|P2|NOT COMPLETED|Phase II||0
250741|NCT01033032|606521|P1|NOT COMPLETED|Phase II||0
250742|NCT01033032|606518|P4|COMPLETED|Phase II||0
250743|NCT01033032|606519|P3|COMPLETED|Phase II|Patients continued recieving treatment until disease progression or unacceptable toxicity|0
250744|NCT01033032|606520|P2|COMPLETED|Phase II||0
250745|NCT01033032|606521|P1|COMPLETED|Phase II||0
250746|NCT01033032|606518|P4|STARTED|Phase II||0
250747|NCT01033032|606519|P3|STARTED|Phase II|Includes patients treated at MTD during Phase I (3 patients); 63 additional patients enrolled|66
250748|NCT01033032|606520|P2|STARTED|Phase II||0
250749|NCT01033032|606521|P1|STARTED|Phase II||0
250750|NCT01033032|606518|P4|NOT COMPLETED|Phase I||6
250751|NCT01033032|606519|P3|NOT COMPLETED|Phase I||0
250752|NCT01033032|606520|P2|NOT COMPLETED|Phase I||3
250753|NCT01033032|606521|P1|NOT COMPLETED|Phase I||3
250754|NCT01033032|606518|P4|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
250755|NCT01033032|606519|P3|COMPLETED|Phase I||3
250756|NCT01033032|606520|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
250757|NCT01033032|606521|P1|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
250758|NCT01033032|606518|P4|STARTED|Phase I||6
250759|NCT01033032|606519|P3|STARTED|Phase I||3
250760|NCT01033032|606520|P2|STARTED|Phase I||3
250761|NCT01033032|606521|P1|STARTED|Phase I||3
250762|NCT01033019|606530|P2|NOT COMPLETED|Overall Study||0
250763|NCT01033019|606531|P1|NOT COMPLETED|Overall Study||1
250764|NCT01033019|606530|P2|COMPLETED|Overall Study||8
250765|NCT01033019|606531|P1|COMPLETED|Overall Study||15
250766|NCT01033019|606530|P2|STARTED|Overall Study||8
250767|NCT01033019|606531|P1|STARTED|Overall Study||16
250768|NCT01032993|606540|P2|NOT COMPLETED|Overall Study||0
250769|NCT01032993|606541|P1|NOT COMPLETED|Overall Study||0
250770|NCT01032993|606540|P2|COMPLETED|Overall Study||20
250771|NCT01032993|606541|P1|COMPLETED|Overall Study||19
250772|NCT01032993|606540|P2|STARTED|Overall Study||20
250773|NCT01032993|606541|P1|STARTED|Overall Study||19
250774|NCT01032928|606553|P1|NOT COMPLETED|Overall Study||0
250775|NCT01032928|606553|P1|COMPLETED|Overall Study||30
250776|NCT01032928|606553|P1|STARTED|Overall Study||30
250777|NCT01032915|606569|P4|NOT COMPLETED|Overall Study||7
250778|NCT01032915|606570|P3|NOT COMPLETED|Overall Study||7
250779|NCT01032915|606571|P2|NOT COMPLETED|Overall Study||11
250780|NCT01032915|606572|P1|NOT COMPLETED|Overall Study||8
250781|NCT01032915|606569|P4|COMPLETED|Overall Study||27
250782|NCT01032915|606570|P3|COMPLETED|Overall Study||24
250783|NCT01032915|606571|P2|COMPLETED|Overall Study||20
250784|NCT01032915|606572|P1|COMPLETED|Overall Study||21
250785|NCT01032915|606569|P4|STARTED|Overall Study||34
250786|NCT01032915|606570|P3|STARTED|Overall Study||31
250787|NCT01032915|606571|P2|STARTED|Overall Study||31
250788|NCT01032915|606572|P1|STARTED|Overall Study||29
250789|NCT01032889|606597|P3|NOT COMPLETED|Overall Study||3
250790|NCT01032889|606598|P2|NOT COMPLETED|Overall Study||15
250791|NCT01032889|606599|P1|NOT COMPLETED|Overall Study||8
250792|NCT01032889|606597|P3|COMPLETED|Overall Study||42
250793|NCT01032889|606598|P2|COMPLETED|Overall Study||28
250794|NCT01032889|606599|P1|COMPLETED|Overall Study||33
250795|NCT01032889|606597|P3|Received Treatment|Overall Study||45
250796|NCT01032889|606598|P2|Received Treatment|Overall Study||43
250797|NCT01032889|606599|P1|Received Treatment|Overall Study||41
250798|NCT01032889|606597|P3|STARTED|Overall Study||45
250799|NCT01032889|606598|P2|STARTED|Overall Study||43
250800|NCT01032889|606599|P1|STARTED|Overall Study||41
250801|NCT01032850|606619|P1|NOT COMPLETED|Overall Study||2
250802|NCT01032850|606619|P1|COMPLETED|Overall Study||13
250803|NCT01032850|606619|P1|STARTED|Overall Study||15
250804|NCT01032837|606630|P4|NOT COMPLETED|Overall Study||3
250805|NCT01032837|606631|P3|NOT COMPLETED|Overall Study||1
250806|NCT01032837|606632|P2|NOT COMPLETED|Overall Study||3
250807|NCT01032837|606633|P1|NOT COMPLETED|Overall Study||0
250808|NCT01032837|606630|P4|COMPLETED|Overall Study|Represents patients who completed treatment.|22
250809|NCT01032837|606631|P3|COMPLETED|Overall Study|Represents patients who completed treatment.|24
250810|NCT01032837|606632|P2|COMPLETED|Overall Study|Represents patients who completed treatment.|23
250811|NCT01032837|606633|P1|COMPLETED|Overall Study|Represents patients who completed treatment.|26
250812|NCT01032837|606630|P4|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|24
250813|NCT01032837|606631|P3|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|25
250814|NCT01032837|606632|P2|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
250815|NCT01032837|606633|P1|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
250816|NCT01032837|606630|P4|STARTED|Overall Study||25
250817|NCT01032837|606631|P3|STARTED|Overall Study||25
250818|NCT01032837|606632|P2|STARTED|Overall Study||26
250819|NCT01032837|606633|P1|STARTED|Overall Study||26
250820|NCT01032759|606681|P2|NOT COMPLETED|Overall Study||3
250821|NCT01032759|606682|P1|NOT COMPLETED|Overall Study||1
250822|NCT01032759|606681|P2|COMPLETED|Overall Study||28
250823|NCT01032759|606682|P1|COMPLETED|Overall Study||31
250824|NCT01032759|606681|P2|Completed 48 Hour Assessment|Overall Study||28
250825|NCT01032759|606682|P1|Completed 48 Hour Assessment|Overall Study||31
250826|NCT01032759|606681|P2|Completed 24 Hour Assessment|Overall Study||30
250827|NCT01032759|606682|P1|Completed 24 Hour Assessment|Overall Study||32
250828|NCT01032759|606681|P2|STARTED|Overall Study||31
250829|NCT01032759|606682|P1|STARTED|Overall Study||32
250830|NCT01032733|606702|P2|NOT COMPLETED|Overall Study||1
250831|NCT01032733|606703|P1|NOT COMPLETED|Overall Study||1
250832|NCT01032733|606702|P2|COMPLETED|Overall Study||16
250833|NCT01032733|606703|P1|COMPLETED|Overall Study||16
250834|NCT01032733|606702|P2|STARTED|Overall Study||17
250835|NCT01032733|606703|P1|STARTED|Overall Study||17
250836|NCT01032694|606719|P2|NOT COMPLETED|Overall Study||0
250837|NCT01032694|606720|P1|NOT COMPLETED|Overall Study||0
250838|NCT01032694|606719|P2|COMPLETED|Overall Study||10
250839|NCT01032694|606720|P1|COMPLETED|Overall Study||20
250840|NCT01032694|606719|P2|STARTED|Overall Study||10
250841|NCT01032694|606720|P1|STARTED|Overall Study||20
250842|NCT01032629|606733|P3|NOT COMPLETED|Overall Study||88
250843|NCT01032629|606734|P2|NOT COMPLETED|Overall Study||101
250844|NCT01032629|606735|P1|NOT COMPLETED|Overall Study||145
250845|NCT01032629|606733|P3|COMPLETED|Overall Study|Participants who died on trial were considered completed|1355
250846|NCT01032629|606734|P2|COMPLETED|Overall Study|Participants who died on trial were considered completed|1344
250847|NCT01032629|606735|P1|COMPLETED|Overall Study|Participants who died on trial were considered completed|1297
250848|NCT01032629|606733|P3|Treated|Overall Study||1441
250849|NCT01032629|606734|P2|Treated|Overall Study||1445
250850|NCT01032629|606735|P1|Treated|Overall Study||1441
250851|NCT01032629|606733|P3|STARTED|Overall Study||1443
250852|NCT01032629|606734|P2|STARTED|Overall Study||1445
250853|NCT01032629|606735|P1|STARTED|Overall Study||1442
250854|NCT01032603|606782|P2|NOT COMPLETED|Overall Study||19
250855|NCT01032603|606783|P1|NOT COMPLETED|Overall Study||15
250856|NCT01032603|606782|P2|COMPLETED|Overall Study||77
250857|NCT01032603|606783|P1|COMPLETED|Overall Study||86
250858|NCT01032603|606782|P2|STARTED|Overall Study||96
250859|NCT01032603|606783|P1|STARTED|Overall Study||101
250860|NCT01032538|606839|P1|NOT COMPLETED|Overall Study||0
250861|NCT01032538|606839|P1|COMPLETED|Overall Study|Knees|99
250862|NCT01032538|606839|P1|STARTED|Overall Study|Knees|99
250863|NCT01032382|606847|P2|NOT COMPLETED|Overall Study||5
250864|NCT01032382|606848|P1|NOT COMPLETED|Overall Study||5
250865|NCT01032382|606847|P2|COMPLETED|Overall Study||9
250866|NCT01032382|606848|P1|COMPLETED|Overall Study||11
250867|NCT01032382|606847|P2|STARTED|Overall Study||14
250868|NCT01032382|606848|P1|STARTED|Overall Study||16
250869|NCT01032330|606878|P4|NOT COMPLETED|Overall Study||14
250870|NCT01032330|606879|P3|NOT COMPLETED|Overall Study||10
250871|NCT01032330|606880|P2|NOT COMPLETED|Overall Study||24
250872|NCT01032330|606881|P1|NOT COMPLETED|Overall Study||18
250873|NCT01032330|606878|P4|COMPLETED|Overall Study||90
250874|NCT01032330|606879|P3|COMPLETED|Overall Study||87
250875|NCT01032330|606880|P2|COMPLETED|Overall Study||151
250876|NCT01032330|606881|P1|COMPLETED|Overall Study||165
250877|NCT01032330|606878|P4|STARTED|Overall Study||104
250878|NCT01032330|606879|P3|STARTED|Overall Study||97
250879|NCT01032330|606880|P2|STARTED|Overall Study||175
250880|NCT01032330|606881|P1|STARTED|Overall Study||183
250881|NCT01032291|606936|P3|NOT COMPLETED|Proof of Concept||3
250882|NCT01032291|606937|P2|NOT COMPLETED|Proof of Concept||8
250883|NCT01032291|606938|P1|NOT COMPLETED|Proof of Concept||0
250884|NCT01032291|606936|P3|COMPLETED|Proof of Concept|Participants with disease progression|18
250885|NCT01032291|606937|P2|COMPLETED|Proof of Concept|Participants with disease progression|14
250886|NCT01032291|606938|P1|COMPLETED|Proof of Concept||0
250887|NCT01032291|606936|P3|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
250888|NCT01032291|606937|P2|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
250889|NCT01032291|606938|P1|Intent to Treat and Safety Populations|Proof of Concept||0
250890|NCT01032291|606936|P3|STARTED|Proof of Concept||21
250891|NCT01032291|606937|P2|STARTED|Proof of Concept||22
250892|NCT01032291|606938|P1|STARTED|Proof of Concept||0
250893|NCT01032291|606936|P3|NOT COMPLETED|Safety Lead-in||0
250894|NCT01032291|606937|P2|NOT COMPLETED|Safety Lead-in||0
250895|NCT01032291|606938|P1|NOT COMPLETED|Safety Lead-in||2
250896|NCT01032291|606936|P3|COMPLETED|Safety Lead-in||0
250897|NCT01032291|606937|P2|COMPLETED|Safety Lead-in||0
250898|NCT01032291|606938|P1|COMPLETED|Safety Lead-in|Participants with disease progression|6
250899|NCT01032291|606936|P3|STARTED|Safety Lead-in||0
250900|NCT01032291|606937|P2|STARTED|Safety Lead-in||0
250901|NCT01032291|606938|P1|STARTED|Safety Lead-in||8
250902|NCT01032265|606964|P2|NOT COMPLETED|Overall Study||17
250903|NCT01032265|606965|P1|NOT COMPLETED|Overall Study||13
250904|NCT01032265|606964|P2|COMPLETED|Overall Study||107
250905|NCT01032265|606965|P1|COMPLETED|Overall Study||113
250906|NCT01032265|606964|P2|STARTED|Overall Study||124
250907|NCT01032265|606965|P1|STARTED|Overall Study||126
250908|NCT01032239|606985|P2|NOT COMPLETED|Overall Study||5
250909|NCT01032239|606986|P1|NOT COMPLETED|Overall Study||7
250910|NCT01032239|606985|P2|COMPLETED|Overall Study||24
250911|NCT01032239|606986|P1|COMPLETED|Overall Study||24
250912|NCT01032239|606985|P2|Implant|Overall Study||0
250913|NCT01032239|606986|P1|Implant|Overall Study|implanted|25
250914|NCT01032239|606985|P2|STARTED|Overall Study|randomized to BMT arm|29
250915|NCT01032239|606986|P1|STARTED|Overall Study|randomized to ITB arm|31
250916|NCT01032200|607016|P2|NOT COMPLETED|Overall Study||7
250917|NCT01032200|607017|P1|NOT COMPLETED|Overall Study||4
250918|NCT01032200|607016|P2|COMPLETED|Overall Study||21
250919|NCT01032200|607017|P1|COMPLETED|Overall Study||22
250920|NCT01032200|607016|P2|STARTED|Overall Study||28
250921|NCT01032200|607017|P1|STARTED|Overall Study||26
250922|NCT01032174|607033|P2|NOT COMPLETED|Overall Study||1
250923|NCT01032174|607034|P1|NOT COMPLETED|Overall Study||0
250924|NCT01032174|607033|P2|COMPLETED|Overall Study||59
250925|NCT01032174|607034|P1|COMPLETED|Overall Study||63
250926|NCT01032174|607033|P2|STARTED|Overall Study||60
250927|NCT01032174|607034|P1|STARTED|Overall Study||63
250928|NCT01032135|607049|P7|NOT COMPLETED|8 Week Randomization||18
250929|NCT01032135|607050|P6|NOT COMPLETED|8 Week Randomization||17
250930|NCT01032135|607051|P5|NOT COMPLETED|8 Week Randomization||9
250931|NCT01032135|607052|P4|NOT COMPLETED|8 Week Randomization||11
250932|NCT01032135|607053|P3|NOT COMPLETED|8 Week Randomization||0
250933|NCT01032135|607054|P2|NOT COMPLETED|8 Week Randomization||0
250934|NCT01032135|607055|P1|NOT COMPLETED|8 Week Randomization||26
250935|NCT01032135|607049|P7|COMPLETED|8 Week Randomization||36
250936|NCT01032135|607050|P6|COMPLETED|8 Week Randomization||31
250937|NCT01032135|607051|P5|COMPLETED|8 Week Randomization||34
250938|NCT01032135|607052|P4|COMPLETED|8 Week Randomization||30
250939|NCT01032135|607053|P3|COMPLETED|8 Week Randomization||0
250940|NCT01032135|607054|P2|COMPLETED|8 Week Randomization||0
250941|NCT01032135|607055|P1|COMPLETED|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|201
250942|NCT01032135|607049|P7|12 Week Follow up|8 Week Randomization||41
250943|NCT01032135|607050|P6|12 Week Follow up|8 Week Randomization||36
250944|NCT01032135|607051|P5|12 Week Follow up|8 Week Randomization||38
250945|NCT01032135|607052|P4|12 Week Follow up|8 Week Randomization||34
250946|NCT01032135|607053|P3|12 Week Follow up|8 Week Randomization||0
250947|NCT01032135|607054|P2|12 Week Follow up|8 Week Randomization||0
250948|NCT01032135|607055|P1|12 Week Follow up|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|217
250949|NCT01032135|607049|P7|STARTED|8 Week Randomization||54
250950|NCT01032135|607050|P6|STARTED|8 Week Randomization||48
250951|NCT01032135|607051|P5|STARTED|8 Week Randomization||43
250952|NCT01032135|607052|P4|STARTED|8 Week Randomization||41
250953|NCT01032135|607053|P3|STARTED|8 Week Randomization||0
250954|NCT01032135|607054|P2|STARTED|8 Week Randomization||0
250955|NCT01032135|607055|P1|STARTED|8 Week Randomization||227
250956|NCT01032135|607049|P7|NOT COMPLETED|2 Week Randomization||0
250957|NCT01032135|607050|P6|NOT COMPLETED|2 Week Randomization||0
250958|NCT01032135|607051|P5|NOT COMPLETED|2 Week Randomization||0
250959|NCT01032135|607052|P4|NOT COMPLETED|2 Week Randomization||0
250960|NCT01032135|607053|P3|NOT COMPLETED|2 Week Randomization||0
250961|NCT01032135|607054|P2|NOT COMPLETED|2 Week Randomization||0
250962|NCT01032135|607055|P1|NOT COMPLETED|2 Week Randomization||0
250963|NCT01032135|607049|P7|COMPLETED|2 Week Randomization||0
250964|NCT01032135|607050|P6|COMPLETED|2 Week Randomization||0
250965|NCT01032135|607051|P5|COMPLETED|2 Week Randomization||0
250966|NCT01032135|607052|P4|COMPLETED|2 Week Randomization||0
250967|NCT01032135|607053|P3|COMPLETED|2 Week Randomization||96
250968|NCT01032135|607054|P2|COMPLETED|2 Week Randomization||93
250969|NCT01032135|607055|P1|COMPLETED|2 Week Randomization||311
250970|NCT01032135|607049|P7|STARTED|2 Week Randomization||0
250971|NCT01032135|607050|P6|STARTED|2 Week Randomization||0
250972|NCT01032135|607051|P5|STARTED|2 Week Randomization||0
250973|NCT01032135|607052|P4|STARTED|2 Week Randomization||0
250974|NCT01032135|607053|P3|STARTED|2 Week Randomization||96
250975|NCT01032135|607054|P2|STARTED|2 Week Randomization||93
250976|NCT01032135|607055|P1|STARTED|2 Week Randomization||311
250977|NCT01032070|607274|P2|NOT COMPLETED|Overall Study||12
250978|NCT01032070|607275|P1|NOT COMPLETED|Overall Study||13
250979|NCT01032070|607274|P2|COMPLETED|Overall Study||0
250980|NCT01032070|607275|P1|COMPLETED|Overall Study||0
250981|NCT01032070|607274|P2|STARTED|Overall Study||12
250982|NCT01032070|607275|P1|STARTED|Overall Study||13
250983|NCT01032044|607304|P2|NOT COMPLETED|Overall Study||20
250984|NCT01032044|607305|P1|NOT COMPLETED|Overall Study||25
250985|NCT01032044|607304|P2|COMPLETED|Overall Study||62
250986|NCT01032044|607305|P1|COMPLETED|Overall Study||57
250987|NCT01032044|607304|P2|Procedure|Overall Study||75
250988|NCT01032044|607305|P1|Procedure|Overall Study||74
250989|NCT01032044|607304|P2|STARTED|Overall Study||82
250990|NCT01032044|607305|P1|STARTED|Overall Study||82
250991|NCT01032018|607313|P2|NOT COMPLETED|Overall Study||6
250992|NCT01032018|607314|P1|NOT COMPLETED|Overall Study||6
250993|NCT01032018|607313|P2|COMPLETED|Overall Study||67
250994|NCT01032018|607314|P1|COMPLETED|Overall Study||71
250995|NCT01032018|607313|P2|STARTED|Overall Study||73
250996|NCT01032018|607314|P1|STARTED|Overall Study||77
250997|NCT01031979|607324|P2|NOT COMPLETED|Overall Study||4
250998|NCT01031979|607325|P1|NOT COMPLETED|Overall Study||5
250999|NCT01031979|607324|P2|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|8
251000|NCT01031979|607325|P1|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|9
251001|NCT01031979|607324|P2|Completed Primary Outcome Measure|Overall Study||12
251002|NCT01031979|607325|P1|Completed Primary Outcome Measure|Overall Study||12
251003|NCT01031979|607324|P2|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|12
251004|NCT01031979|607325|P1|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|14
251005|NCT01031953|607337|P1|NOT COMPLETED|Overall Study||0
251006|NCT01031953|607337|P1|COMPLETED|Overall Study||11
251007|NCT01031953|607337|P1|STARTED|Overall Study||11
251008|NCT01031914|607348|P1|NOT COMPLETED|Overall Study||0
251009|NCT01031914|607348|P1|COMPLETED|Overall Study||36
251010|NCT01031914|607348|P1|STARTED|Overall Study||36
251011|NCT01031836|607358|P6|NOT COMPLETED|Stage II||1
251012|NCT01031836|607359|P5|NOT COMPLETED|Stage II||2
251013|NCT01031836|607360|P4|NOT COMPLETED|Stage II||3
251014|NCT01031836|607361|P3|NOT COMPLETED|Stage II||2
251015|NCT01031836|607362|P2|NOT COMPLETED|Stage II||0
251016|NCT01031836|607363|P1|NOT COMPLETED|Stage II||2
251017|NCT01031836|607358|P6|COMPLETED|Stage II||3
251018|NCT01031836|607359|P5|COMPLETED|Stage II||3
251019|NCT01031836|607360|P4|COMPLETED|Stage II||1
251020|NCT01031836|607361|P3|COMPLETED|Stage II||2
251021|NCT01031836|607362|P2|COMPLETED|Stage II||1
251022|NCT01031836|607363|P1|COMPLETED|Stage II||1
251023|NCT01031836|607358|P6|STARTED|Stage II||4
251024|NCT01031836|607359|P5|STARTED|Stage II||5
251025|NCT01031836|607360|P4|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|4
251026|NCT01031836|607361|P3|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|4
251027|NCT01031836|607362|P2|STARTED|Stage II|2 patient who completed the study treatment in Stage I did not register in Stage II.|1
251028|NCT01031836|607363|P1|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|3
251029|NCT01031836|607358|P6|NOT COMPLETED|Stage I||1
251030|NCT01031836|607359|P5|NOT COMPLETED|Stage I||0
251031|NCT01031836|607360|P4|NOT COMPLETED|Stage I||0
251032|NCT01031836|607361|P3|NOT COMPLETED|Stage I||0
251033|NCT01031836|607362|P2|NOT COMPLETED|Stage I||2
251034|NCT01031836|607363|P1|NOT COMPLETED|Stage I||1
251035|NCT01031836|607358|P6|COMPLETED|Stage I||4
251036|NCT01031836|607359|P5|COMPLETED|Stage I||5
251037|NCT01031836|607360|P4|COMPLETED|Stage I||5
251038|NCT01031836|607361|P3|COMPLETED|Stage I||5
251039|NCT01031836|607362|P2|COMPLETED|Stage I||3
251040|NCT01031836|607363|P1|COMPLETED|Stage I||4
251041|NCT01031836|607358|P6|STARTED|Stage I||5
251042|NCT01031836|607359|P5|STARTED|Stage I||5
251043|NCT01031836|607360|P4|STARTED|Stage I||5
251044|NCT01031836|607361|P3|STARTED|Stage I||5
251045|NCT01031836|607362|P2|STARTED|Stage I||5
251046|NCT01031836|607363|P1|STARTED|Stage I||5
251047|NCT01031810|607413|P1|NOT COMPLETED|Overall Study||4
251048|NCT01031810|607413|P1|COMPLETED|Overall Study||9
251049|NCT01031810|607413|P1|STARTED|Overall Study||13
251050|NCT01031706|607424|P2|NOT COMPLETED|Overall Study||1
251051|NCT01031706|607425|P1|NOT COMPLETED|Overall Study||2
251052|NCT01031706|607424|P2|COMPLETED|Overall Study||8
251053|NCT01031706|607425|P1|COMPLETED|Overall Study||12
251054|NCT01031706|607424|P2|STARTED|Overall Study||9
251055|NCT01031706|607425|P1|STARTED|Overall Study||14
251056|NCT01031680|607435|P2|NOT COMPLETED|Overall Study||58
251057|NCT01031680|607436|P1|NOT COMPLETED|Overall Study||57
251058|NCT01031680|607435|P2|COMPLETED|Overall Study||404
251059|NCT01031680|607436|P1|COMPLETED|Overall Study||403
251060|NCT01031680|607435|P2|STARTED|Overall Study|Of the 462 randomized participants only 459 were included in the full analysis set.|462
251061|NCT01031680|607436|P1|STARTED|Overall Study|Of the 460 randomized participants only 455 were included in the full analysis set.|460
251062|NCT01031628|607456|P4|NOT COMPLETED|Overall Study||0
251063|NCT01031628|607457|P3|NOT COMPLETED|Overall Study||3
251064|NCT01031628|607458|P2|NOT COMPLETED|Overall Study||1
251065|NCT01031628|607459|P1|NOT COMPLETED|Overall Study||0
251066|NCT01031628|607456|P4|COMPLETED|Overall Study||0
251067|NCT01031628|607457|P3|COMPLETED|Overall Study||0
251068|NCT01031628|607458|P2|COMPLETED|Overall Study||0
251069|NCT01031628|607459|P1|COMPLETED|Overall Study||0
251070|NCT01031628|607456|P4|STARTED|Overall Study||0
251071|NCT01031628|607457|P3|STARTED|Overall Study||3
251072|NCT01031628|607458|P2|STARTED|Overall Study||1
251073|NCT01031628|607459|P1|STARTED|Overall Study||0
251074|NCT01031550|607471|P2|NOT COMPLETED|Overall Study||0
251075|NCT01031550|607472|P1|NOT COMPLETED|Overall Study||0
251076|NCT01031550|607471|P2|COMPLETED|Overall Study||3
251077|NCT01031550|607472|P1|COMPLETED|Overall Study||5
251078|NCT01031550|607471|P2|STARTED|Overall Study||3
251079|NCT01031550|607472|P1|STARTED|Overall Study||5
251080|NCT01031537|607484|P1|NOT COMPLETED|Overall Study||32
251081|NCT01031537|607484|P1|COMPLETED|Overall Study||34
251082|NCT01031537|607484|P1|STARTED|Overall Study||66
251083|NCT01031498|607492|P3|NOT COMPLETED|Overall Study||2
251084|NCT01031498|607493|P2|NOT COMPLETED|Overall Study||3
251085|NCT01031498|607494|P1|NOT COMPLETED|Overall Study||2
251086|NCT01031498|607492|P3|COMPLETED|Overall Study||48
251087|NCT01031498|607493|P2|COMPLETED|Overall Study||48
251088|NCT01031498|607494|P1|COMPLETED|Overall Study||47
251089|NCT01031498|607492|P3|STARTED|Overall Study|2 patients were not evaluable in arm 3.|50
251090|NCT01031498|607493|P2|STARTED|Overall Study|3 patients were not evaluable in arm 2|51
251091|NCT01031498|607494|P1|STARTED|Overall Study|2 patients were not evaluable in arm 1.|49
251092|NCT01031446|607502|P1|NOT COMPLETED|Overall Study||55
251093|NCT01031446|607502|P1|COMPLETED|Overall Study||0
251094|NCT01031446|607502|P1|STARTED|Overall Study||55
251095|NCT01031420|607511|P1|NOT COMPLETED|Overall Study||10
251096|NCT01031420|607511|P1|COMPLETED|Overall Study||44
251097|NCT01031420|607511|P1|STARTED|Overall Study||54
251098|NCT01031381|607516|P1|NOT COMPLETED|Overall Study||9
251099|NCT01031381|607516|P1|COMPLETED|Overall Study||50
251100|NCT01031381|607516|P1|STARTED|Overall Study||59
251101|NCT01031134|607523|P2|NOT COMPLETED|Overall Study||10
251102|NCT01031134|607524|P1|NOT COMPLETED|Overall Study||11
251103|NCT01031134|607523|P2|COMPLETED|Overall Study||78
251104|NCT01031134|607524|P1|COMPLETED|Overall Study||103
251105|NCT01031134|607523|P2|STARTED|Overall Study||88
251106|NCT01031134|607524|P1|STARTED|Overall Study||114
251107|NCT01031095|607534|P2|NOT COMPLETED|Overall Study||0
251108|NCT01031095|607535|P1|NOT COMPLETED|Overall Study||0
251109|NCT01031095|607534|P2|COMPLETED|Overall Study||100
251110|NCT01031095|607535|P1|COMPLETED|Overall Study||100
251111|NCT01031095|607534|P2|STARTED|Overall Study||100
251112|NCT01031095|607535|P1|STARTED|Overall Study||100
251113|NCT01031069|607545|P4|NOT COMPLETED|Overall Study||34
251114|NCT01031069|607546|P3|NOT COMPLETED|Overall Study||41
251115|NCT01031069|607547|P2|NOT COMPLETED|Overall Study||11
251116|NCT01031069|607548|P1|NOT COMPLETED|Overall Study||12
251117|NCT01031069|607545|P4|COMPLETED|Overall Study||111
251118|NCT01031069|607546|P3|COMPLETED|Overall Study||103
251119|NCT01031069|607547|P2|COMPLETED|Overall Study||117
251120|NCT01031069|607548|P1|COMPLETED|Overall Study||117
251121|NCT01031069|607545|P4|STARTED|Overall Study||145
251122|NCT01031069|607546|P3|STARTED|Overall Study||144
251123|NCT01031069|607547|P2|STARTED|Overall Study||128
251124|NCT01031069|607548|P1|STARTED|Overall Study||129
251125|NCT01031043|607644|P1|NOT COMPLETED|Overall Study||1
251126|NCT01031043|607644|P1|COMPLETED|Overall Study||4
251127|NCT01031043|607644|P1|STARTED|Overall Study||5
251128|NCT01031004|607650|P2|NOT COMPLETED|Overall Study||1
251129|NCT01031004|607651|P1|NOT COMPLETED|Overall Study||1
251130|NCT01031004|607650|P2|COMPLETED|Overall Study||24
251131|NCT01031004|607651|P1|COMPLETED|Overall Study||24
251132|NCT01031004|607650|P2|STARTED|Overall Study||25
251133|NCT01031004|607651|P1|STARTED|Overall Study||25
251134|NCT01030965|607695|P4|NOT COMPLETED|Overall Study||7
251135|NCT01030965|607696|P3|NOT COMPLETED|Overall Study||4
251136|NCT01030965|607697|P2|NOT COMPLETED|Overall Study||6
251137|NCT01030965|607698|P1|NOT COMPLETED|Overall Study||4
251138|NCT01030965|607695|P4|COMPLETED|Overall Study||64
251139|NCT01030965|607696|P3|COMPLETED|Overall Study||68
251140|NCT01030965|607697|P2|COMPLETED|Overall Study||65
251141|NCT01030965|607698|P1|COMPLETED|Overall Study||67
251142|NCT01030965|607695|P4|STARTED|Overall Study||71
251143|NCT01030965|607696|P3|STARTED|Overall Study||72
251144|NCT01030965|607697|P2|STARTED|Overall Study||71
251145|NCT01030965|607698|P1|STARTED|Overall Study||71
251146|NCT01030952|607718|P2|NOT COMPLETED|Overall Study||3
251147|NCT01030952|607719|P1|NOT COMPLETED|Overall Study||2
251148|NCT01030952|607718|P2|COMPLETED|Overall Study||49
251149|NCT01030952|607719|P1|COMPLETED|Overall Study||49
251150|NCT01030952|607718|P2|STARTED|Overall Study||52
251151|NCT01030952|607719|P1|STARTED|Overall Study||51
251152|NCT01030822|607756|P3|NOT COMPLETED|Overall Study||26
251153|NCT01030822|607757|P2|NOT COMPLETED|Overall Study||24
251154|NCT01030822|607758|P1|NOT COMPLETED|Overall Study||31
251155|NCT01030822|607756|P3|COMPLETED|Overall Study||61
251156|NCT01030822|607757|P2|COMPLETED|Overall Study||71
251157|NCT01030822|607758|P1|COMPLETED|Overall Study||69
251158|NCT01030822|607756|P3|STARTED|Overall Study||87
251159|NCT01030822|607757|P2|STARTED|Overall Study||95
251160|NCT01030822|607758|P1|STARTED|Overall Study||100
251161|NCT01030783|607807|P2|NOT COMPLETED|Overall Study||26
251162|NCT01030783|607808|P1|NOT COMPLETED|Overall Study||49
251163|NCT01030783|607807|P2|COMPLETED|Overall Study||231
251164|NCT01030783|607808|P1|COMPLETED|Overall Study||211
251165|NCT01030783|607807|P2|STARTED|Overall Study||257
251166|NCT01030783|607808|P1|STARTED|Overall Study||260
251167|NCT01030757|607825|P1|NOT COMPLETED|Overall Study||0
251168|NCT01030757|607825|P1|COMPLETED|Overall Study||2
251169|NCT01030757|607825|P1|STARTED|Overall Study||2
251170|NCT01030718|607833|P3|NOT COMPLETED|Study CA180-036 Only||5
251171|NCT01030718|607834|P2|NOT COMPLETED|Study CA180-036 Only||7
251172|NCT01030718|607835|P1|NOT COMPLETED|Study CA180-036 Only||3
251173|NCT01030718|607833|P3|COMPLETED|Study CA180-036 Only||1
251174|NCT01030718|607834|P2|COMPLETED|Study CA180-036 Only||2
251175|NCT01030718|607835|P1|COMPLETED|Study CA180-036 Only||26
251176|NCT01030718|607833|P3|STARTED|Study CA180-036 Only||6
251177|NCT01030718|607834|P2|STARTED|Study CA180-036 Only||9
251178|NCT01030718|607835|P1|STARTED|Study CA180-036 Only||29
251179|NCT01030718|607833|P3|NOT COMPLETED|Studies CA180-031 and -036 Combined||12
251180|NCT01030718|607834|P2|NOT COMPLETED|Studies CA180-031 and -036 Combined||9
251181|NCT01030718|607835|P1|NOT COMPLETED|Studies CA180-031 and -036 Combined||4
251182|NCT01030718|607833|P3|COMPLETED|Studies CA180-031 and -036 Combined||1
251183|NCT01030718|607834|P2|COMPLETED|Studies CA180-031 and -036 Combined||2
251184|NCT01030718|607835|P1|COMPLETED|Studies CA180-031 and -036 Combined||26
251185|NCT01030718|607833|P3|STARTED|Studies CA180-031 and -036 Combined||13
251186|NCT01030718|607834|P2|STARTED|Studies CA180-031 and -036 Combined||11
251187|NCT01030718|607835|P1|STARTED|Studies CA180-031 and -036 Combined||30
251188|NCT01030666|607896|P2|NOT COMPLETED|Overall Study||2
251189|NCT01030666|607897|P1|NOT COMPLETED|Overall Study||3
251190|NCT01030666|607896|P2|COMPLETED|Overall Study||31
251191|NCT01030666|607897|P1|COMPLETED|Overall Study||25
251192|NCT01030666|607896|P2|STARTED|Overall Study||33
251193|NCT01030666|607897|P1|STARTED|Overall Study||28
251194|NCT01030653|607907|P2|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
251195|NCT01030653|607908|P1|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
251196|NCT01030653|607907|P2|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
251197|NCT01030653|607908|P1|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
251198|NCT01030653|607907|P2|STARTED|Loading Dose & 2nd Maintenance Regimen||4
251199|NCT01030653|607908|P1|STARTED|Loading Dose & 2nd Maintenance Regimen||4
251200|NCT01030653|607907|P2|NOT COMPLETED|7-Day Washout Period||0
251201|NCT01030653|607908|P1|NOT COMPLETED|7-Day Washout Period||0
251202|NCT01030653|607907|P2|COMPLETED|7-Day Washout Period||4
251203|NCT01030653|607908|P1|COMPLETED|7-Day Washout Period||4
251204|NCT01030653|607907|P2|STARTED|7-Day Washout Period||4
251205|NCT01030653|607908|P1|STARTED|7-Day Washout Period||4
251206|NCT01030653|607907|P2|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
251207|NCT01030653|607908|P1|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
251208|NCT01030653|607907|P2|COMPLETED|Loading Dose & First Maintenance Regimen||4
251209|NCT01030653|607908|P1|COMPLETED|Loading Dose & First Maintenance Regimen||4
251210|NCT01030653|607907|P2|STARTED|Loading Dose & First Maintenance Regimen||4
251211|NCT01030653|607908|P1|STARTED|Loading Dose & First Maintenance Regimen||4
251212|NCT01030536|607922|P5|NOT COMPLETED|Overall Study||1
251213|NCT01030536|607923|P4|NOT COMPLETED|Overall Study||3
251214|NCT01030536|607924|P3|NOT COMPLETED|Overall Study||6
251215|NCT01030536|607925|P2|NOT COMPLETED|Overall Study||6
251216|NCT01030536|607926|P1|NOT COMPLETED|Overall Study||7
251217|NCT01030536|607922|P5|COMPLETED|Overall Study||0
251218|NCT01030536|607923|P4|COMPLETED|Overall Study||0
251219|NCT01030536|607924|P3|COMPLETED|Overall Study||0
251220|NCT01030536|607925|P2|COMPLETED|Overall Study||0
251221|NCT01030536|607926|P1|COMPLETED|Overall Study||0
251222|NCT01030536|607922|P5|STARTED|Overall Study||1
251223|NCT01030536|607923|P4|STARTED|Overall Study||3
251224|NCT01030536|607924|P3|STARTED|Overall Study||6
251225|NCT01030536|607925|P2|STARTED|Overall Study||6
251226|NCT01030536|607926|P1|STARTED|Overall Study||7
251227|NCT01030458|608031|P2|NOT COMPLETED|Overall Study||32
251228|NCT01030458|608032|P1|NOT COMPLETED|Overall Study||27
251229|NCT01030458|608031|P2|COMPLETED|Overall Study||57
251230|NCT01030458|608032|P1|COMPLETED|Overall Study||67
251231|NCT01030458|608031|P2|STARTED|Overall Study||89
251232|NCT01030458|608032|P1|STARTED|Overall Study||94
251233|NCT01030406|608049|P5|NOT COMPLETED|Overall Study||0
251234|NCT01030406|608050|P4|NOT COMPLETED|Overall Study||1
251235|NCT01030406|608051|P3|NOT COMPLETED|Overall Study||1
251236|NCT01030406|608052|P2|NOT COMPLETED|Overall Study||0
251237|NCT01030406|608053|P1|NOT COMPLETED|Overall Study||0
251238|NCT01030406|608049|P5|COMPLETED|Overall Study||9
251239|NCT01030406|608050|P4|COMPLETED|Overall Study||9
251240|NCT01030406|608051|P3|COMPLETED|Overall Study||9
251241|NCT01030406|608052|P2|COMPLETED|Overall Study||10
251242|NCT01030406|608053|P1|COMPLETED|Overall Study||10
251243|NCT01030406|608049|P5|STARTED|Overall Study||9
251244|NCT01030406|608050|P4|STARTED|Overall Study||10
251245|NCT01030406|608051|P3|STARTED|Overall Study||10
251246|NCT01030406|608052|P2|STARTED|Overall Study||10
251247|NCT01030406|608053|P1|STARTED|Overall Study||10
251248|NCT01030341|608065|P1|NOT COMPLETED|Overall Study||3
251249|NCT01030341|608065|P1|COMPLETED|Overall Study|42 participants completed the study|42
251250|NCT01030341|608065|P1|STARTED|Overall Study|45 participants met all enrollment criteria by completing the screening and run-in phases|45
251251|NCT01030289|608070|P2|NOT COMPLETED|Overall Study||0
251252|NCT01030289|608071|P1|NOT COMPLETED|Overall Study||0
251253|NCT01030289|608070|P2|COMPLETED|Overall Study||10
251254|NCT01030289|608071|P1|COMPLETED|Overall Study||9
251255|NCT01030289|608070|P2|STARTED|Overall Study||10
251256|NCT01030289|608071|P1|STARTED|Overall Study||9
251257|NCT01030133|608088|P2|NOT COMPLETED|Overall Study||2
251258|NCT01030133|608089|P1|NOT COMPLETED|Overall Study||2
251259|NCT01030133|608088|P2|COMPLETED|Overall Study||12
251260|NCT01030133|608089|P1|COMPLETED|Overall Study||12
251261|NCT01030133|608088|P2|STARTED|Overall Study||14
251262|NCT01030133|608089|P1|STARTED|Overall Study||14
251263|NCT01029925|608101|P1|NOT COMPLETED|Completion of Cycle 2 (56 Days)||1
251264|NCT01029925|608101|P1|COMPLETED|Completion of Cycle 2 (56 Days)||2
251265|NCT01029925|608101|P1|STARTED|Completion of Cycle 2 (56 Days)||3
251266|NCT01029925|608101|P1|NOT COMPLETED|Completion of Cycle 1 (28 Days)||4
251267|NCT01029925|608101|P1|COMPLETED|Completion of Cycle 1 (28 Days)||3
251268|NCT01029925|608101|P1|STARTED|Completion of Cycle 1 (28 Days)||7
251269|NCT01029912|608107|P2|NOT COMPLETED|Overall Study||0
251270|NCT01029912|608108|P1|NOT COMPLETED|Overall Study||2
251271|NCT01029912|608107|P2|COMPLETED|Overall Study||12
251272|NCT01029912|608108|P1|COMPLETED|Overall Study||12
251273|NCT01029912|608107|P2|STARTED|Overall Study||12
251274|NCT01029912|608108|P1|STARTED|Overall Study||14
251275|NCT01029886|608120|P2|NOT COMPLETED|Overall Study||60
251276|NCT01029886|608121|P1|NOT COMPLETED|Overall Study||61
251277|NCT01029886|608120|P2|COMPLETED|Overall Study||391
251278|NCT01029886|608121|P1|COMPLETED|Overall Study||400
251279|NCT01029886|608120|P2|Intent to Treat (ITT)|Overall Study||450
251280|NCT01029886|608121|P1|Intent to Treat (ITT)|Overall Study||461
251281|NCT01029886|608120|P2|STARTED|Overall Study||451
251282|NCT01029886|608121|P1|STARTED|Overall Study||461
251283|NCT01029795|608149|P2|NOT COMPLETED|Overall Study||22
251284|NCT01029795|608150|P1|NOT COMPLETED|Overall Study||16
251285|NCT01029795|608149|P2|COMPLETED|Overall Study||0
251286|NCT01029795|608150|P1|COMPLETED|Overall Study||0
251287|NCT01029795|608149|P2|STARTED|Overall Study||22
251288|NCT01029795|608150|P1|STARTED|Overall Study||16
251289|NCT01029782|608204|P2|NOT COMPLETED|Overall Study||8
251290|NCT01029782|608205|P1|NOT COMPLETED|Overall Study||3
251291|NCT01029782|608204|P2|COMPLETED|Overall Study||96
251292|NCT01029782|608205|P1|COMPLETED|Overall Study||99
251293|NCT01029782|608204|P2|STARTED|Overall Study||104
251294|NCT01029782|608205|P1|STARTED|Overall Study||102
251295|NCT01029730|608211|P1|NOT COMPLETED|Maintenance Therapy||23
251296|NCT01029730|608211|P1|COMPLETED|Maintenance Therapy||14
251297|NCT01029730|608211|P1|STARTED|Maintenance Therapy|Two patients complete study treatment but declined subsequent maintenance therapy|37
251298|NCT01029730|608211|P1|NOT COMPLETED|Combination Therapy||16
251299|NCT01029730|608211|P1|COMPLETED|Combination Therapy|Patients remained on-study until completing 6 cycles or coming off-treatment for any other reason|39
251300|NCT01029730|608211|P1|STARTED|Combination Therapy||55
251301|NCT01029704|608223|P5|NOT COMPLETED|Overall Study||0
251302|NCT01029704|608224|P4|NOT COMPLETED|Overall Study||0
251303|NCT01029704|608225|P3|NOT COMPLETED|Overall Study||0
251304|NCT01029704|608226|P2|NOT COMPLETED|Overall Study||0
251305|NCT01029704|608227|P1|NOT COMPLETED|Overall Study||0
251306|NCT01029704|608223|P5|COMPLETED|Overall Study||26
251307|NCT01029704|608224|P4|COMPLETED|Overall Study||28
251308|NCT01029704|608225|P3|COMPLETED|Overall Study||23
251309|NCT01029704|608226|P2|COMPLETED|Overall Study||24
251310|NCT01029704|608227|P1|COMPLETED|Overall Study||28
251311|NCT01029704|608223|P5|STARTED|Overall Study||26
251312|NCT01029704|608224|P4|STARTED|Overall Study||28
251313|NCT01029704|608225|P3|STARTED|Overall Study||23
251314|NCT01029704|608226|P2|STARTED|Overall Study||24
251315|NCT01029704|608227|P1|STARTED|Overall Study||28
251316|NCT01029691|608257|P3|NOT COMPLETED|Continued APAP to Delivery||1
251317|NCT01029691|608258|P2|NOT COMPLETED|Continued APAP to Delivery||0
251318|NCT01029691|608259|P1|NOT COMPLETED|Continued APAP to Delivery||0
251319|NCT01029691|608257|P3|COMPLETED|Continued APAP to Delivery||76
251320|NCT01029691|608258|P2|COMPLETED|Continued APAP to Delivery||16
251321|NCT01029691|608259|P1|COMPLETED|Continued APAP to Delivery||20
251322|NCT01029691|608257|P3|STARTED|Continued APAP to Delivery||77
251323|NCT01029691|608258|P2|STARTED|Continued APAP to Delivery||16
251324|NCT01029691|608259|P1|STARTED|Continued APAP to Delivery||20
251325|NCT01029691|608257|P3|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
251326|NCT01029691|608258|P2|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||11
251327|NCT01029691|608259|P1|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
251328|NCT01029691|608257|P3|COMPLETED|APAP Initiation to Week 1 or Delivery||77
251329|NCT01029691|608258|P2|COMPLETED|APAP Initiation to Week 1 or Delivery||16
251330|NCT01029691|608259|P1|COMPLETED|APAP Initiation to Week 1 or Delivery||20
251331|NCT01029691|608257|P3|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||77
251332|NCT01029691|608258|P2|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||16
251333|NCT01029691|608259|P1|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||20
251334|NCT01029691|608257|P3|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||77
251335|NCT01029691|608258|P2|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||23
251336|NCT01029691|608259|P1|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||20
251337|NCT01029691|608257|P3|STARTED|APAP Initiation to Week 1 or Delivery||77
251338|NCT01029691|608258|P2|STARTED|APAP Initiation to Week 1 or Delivery|4 delivered before APAP initiation 7 elected not to have APAP following baseline study|27
251339|NCT01029691|608259|P1|STARTED|APAP Initiation to Week 1 or Delivery||20
251340|NCT01029652|608284|P2|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||3
251341|NCT01029652|608285|P1|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||1
251342|NCT01029652|608284|P2|COMPLETED|Extension Study 2 (25-72 Weeks)||63
251343|NCT01029652|608285|P1|COMPLETED|Extension Study 2 (25-72 Weeks)||68
251344|NCT01029652|608284|P2|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|39
251345|NCT01029652|608285|P1|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab over 72 weeks study duration overall|69
251346|NCT01029652|608284|P2|STARTED|Extension Study 2 (25-72 Weeks)||66
251347|NCT01029652|608285|P1|STARTED|Extension Study 2 (25-72 Weeks)||69
251348|NCT01029652|608284|P2|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||5
251349|NCT01029652|608285|P1|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||3
251350|NCT01029652|608284|P2|COMPLETED|Extension Study 1 (12-24 Weeks)||80
251351|NCT01029652|608285|P1|COMPLETED|Extension Study 1 (12-24 Weeks)||87
251352|NCT01029652|608284|P2|STARTED|Extension Study 1 (12-24 Weeks)||85
251353|NCT01029652|608285|P1|STARTED|Extension Study 1 (12-24 Weeks)||90
251354|NCT01029652|608284|P2|NOT COMPLETED|Core Study (0-12 Weeks)||10
251355|NCT01029652|608285|P1|NOT COMPLETED|Core Study (0-12 Weeks)||6
251356|NCT01029652|608284|P2|COMPLETED|Core Study (0-12 Weeks)||105
251357|NCT01029652|608285|P1|COMPLETED|Core Study (0-12 Weeks)||109
251358|NCT01029652|608284|P2|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||115
251359|NCT01029652|608285|P1|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||113
251360|NCT01029652|608284|P2|STARTED|Core Study (0-12 Weeks)||115
251361|NCT01029652|608285|P1|STARTED|Core Study (0-12 Weeks)||115
251362|NCT01029535|608363|P1|NOT COMPLETED|Overall Study||31
251363|NCT01029535|608363|P1|COMPLETED|Overall Study||72
251364|NCT01029535|608363|P1|STARTED|Overall Study||103
251365|NCT01029405|608392|P4|NOT COMPLETED|Overall Study||5
251366|NCT01029405|608393|P3|NOT COMPLETED|Overall Study||4
251367|NCT01029405|608394|P2|NOT COMPLETED|Overall Study||3
251368|NCT01029405|608395|P1|NOT COMPLETED|Overall Study||2
251369|NCT01029405|608392|P4|COMPLETED|Overall Study||32
251370|NCT01029405|608393|P3|COMPLETED|Overall Study||31
251371|NCT01029405|608394|P2|COMPLETED|Overall Study||34
251372|NCT01029405|608395|P1|COMPLETED|Overall Study||34
251373|NCT01029405|608392|P4|STARTED|Overall Study||37
251374|NCT01029405|608393|P3|STARTED|Overall Study||35
251375|NCT01029405|608394|P2|STARTED|Overall Study||37
251376|NCT01029405|608395|P1|STARTED|Overall Study||36
251377|NCT01029392|608407|P2|NOT COMPLETED|Overall Study||11
251378|NCT01029392|608408|P1|NOT COMPLETED|Overall Study||20
251379|NCT01029392|608407|P2|COMPLETED|Overall Study||27
251380|NCT01029392|608408|P1|COMPLETED|Overall Study||17
251381|NCT01029392|608407|P2|STARTED|Overall Study||38
251382|NCT01029392|608408|P1|STARTED|Overall Study||37
251383|NCT01029366|608418|P2|NOT COMPLETED|Overall Study||2
251384|NCT01029366|608419|P1|NOT COMPLETED|Overall Study||4
251385|NCT01029366|608418|P2|COMPLETED|Overall Study||6
251386|NCT01029366|608419|P1|COMPLETED|Overall Study||14
251387|NCT01029366|608418|P2|STARTED|Overall Study||8
251388|NCT01029366|608419|P1|STARTED|Overall Study||18
251389|NCT01029340|608431|P6|NOT COMPLETED|Part C Follow up Period||0
251390|NCT01029340|608432|P5|NOT COMPLETED|Part C Follow up Period||0
251391|NCT01029340|608433|P4|NOT COMPLETED|Part C Follow up Period||0
251392|NCT01029340|608434|P3|NOT COMPLETED|Part C Follow up Period||0
251393|NCT01029340|608435|P2|NOT COMPLETED|Part C Follow up Period||0
251394|NCT01029340|608436|P1|NOT COMPLETED|Part C Follow up Period||0
251395|NCT01029340|608431|P6|COMPLETED|Part C Follow up Period||0
251396|NCT01029340|608432|P5|COMPLETED|Part C Follow up Period||5
251397|NCT01029340|608433|P4|COMPLETED|Part C Follow up Period||0
251398|NCT01029340|608434|P3|COMPLETED|Part C Follow up Period||0
251399|NCT01029340|608435|P2|COMPLETED|Part C Follow up Period||0
251400|NCT01029340|608436|P1|COMPLETED|Part C Follow up Period||0
251401|NCT01029340|608431|P6|STARTED|Part C Follow up Period||0
251402|NCT01029340|608432|P5|STARTED|Part C Follow up Period||5
251403|NCT01029340|608433|P4|STARTED|Part C Follow up Period||0
251404|NCT01029340|608434|P3|STARTED|Part C Follow up Period||0
251405|NCT01029340|608435|P2|STARTED|Part C Follow up Period||0
251406|NCT01029340|608436|P1|STARTED|Part C Follow up Period||0
251407|NCT01029340|608431|P6|NOT COMPLETED|Part C Treatment Period||0
251408|NCT01029340|608432|P5|NOT COMPLETED|Part C Treatment Period||0
251409|NCT01029340|608433|P4|NOT COMPLETED|Part C Treatment Period||0
251410|NCT01029340|608434|P3|NOT COMPLETED|Part C Treatment Period||0
251411|NCT01029340|608435|P2|NOT COMPLETED|Part C Treatment Period||0
251412|NCT01029340|608436|P1|NOT COMPLETED|Part C Treatment Period||0
251413|NCT01029340|608431|P6|COMPLETED|Part C Treatment Period||0
251414|NCT01029340|608432|P5|COMPLETED|Part C Treatment Period||5
251415|NCT01029340|608433|P4|COMPLETED|Part C Treatment Period||0
251416|NCT01029340|608434|P3|COMPLETED|Part C Treatment Period||0
251417|NCT01029340|608435|P2|COMPLETED|Part C Treatment Period||0
251418|NCT01029340|608436|P1|COMPLETED|Part C Treatment Period||0
251419|NCT01029340|608431|P6|Participants Received Treatment|Part C Treatment Period||0
251420|NCT01029340|608432|P5|Participants Received Treatment|Part C Treatment Period||5
251421|NCT01029340|608433|P4|Participants Received Treatment|Part C Treatment Period||0
251422|NCT01029340|608434|P3|Participants Received Treatment|Part C Treatment Period||0
251423|NCT01029340|608435|P2|Participants Received Treatment|Part C Treatment Period||0
251424|NCT01029340|608436|P1|Participants Received Treatment|Part C Treatment Period||0
251425|NCT01029340|608431|P6|STARTED|Part C Treatment Period||0
251426|NCT01029340|608432|P5|STARTED|Part C Treatment Period||5
251427|NCT01029340|608433|P4|STARTED|Part C Treatment Period||0
251428|NCT01029340|608434|P3|STARTED|Part C Treatment Period||0
251429|NCT01029340|608435|P2|STARTED|Part C Treatment Period||0
251430|NCT01029340|608436|P1|STARTED|Part C Treatment Period||0
251431|NCT01029340|608431|P6|NOT COMPLETED|Extension Period||12
251432|NCT01029340|608432|P5|NOT COMPLETED|Extension Period||0
251433|NCT01029340|608433|P4|NOT COMPLETED|Extension Period||0
251434|NCT01029340|608434|P3|NOT COMPLETED|Extension Period||0
251435|NCT01029340|608435|P2|NOT COMPLETED|Extension Period||0
251436|NCT01029340|608436|P1|NOT COMPLETED|Extension Period||0
251437|NCT01029340|608431|P6|COMPLETED|Extension Period||43
251438|NCT01029340|608432|P5|COMPLETED|Extension Period||0
251439|NCT01029340|608433|P4|COMPLETED|Extension Period||0
251440|NCT01029340|608434|P3|COMPLETED|Extension Period||0
251441|NCT01029340|608435|P2|COMPLETED|Extension Period||0
251442|NCT01029340|608436|P1|COMPLETED|Extension Period||0
251443|NCT01029340|608431|P6|STARTED|Extension Period||55
251444|NCT01029340|608432|P5|STARTED|Extension Period||0
251445|NCT01029340|608433|P4|STARTED|Extension Period||0
251446|NCT01029340|608434|P3|STARTED|Extension Period||0
251447|NCT01029340|608435|P2|STARTED|Extension Period||0
251448|NCT01029340|608436|P1|STARTED|Extension Period||0
251449|NCT01029340|608431|P6|NOT COMPLETED|Part B Follow up Period||0
251450|NCT01029340|608432|P5|NOT COMPLETED|Part B Follow up Period||0
251451|NCT01029340|608433|P4|NOT COMPLETED|Part B Follow up Period||0
251452|NCT01029340|608434|P3|NOT COMPLETED|Part B Follow up Period||0
251453|NCT01029340|608435|P2|NOT COMPLETED|Part B Follow up Period||0
251454|NCT01029340|608436|P1|NOT COMPLETED|Part B Follow up Period||0
251455|NCT01029340|608431|P6|COMPLETED|Part B Follow up Period||0
251456|NCT01029340|608432|P5|COMPLETED|Part B Follow up Period||0
251457|NCT01029340|608433|P4|COMPLETED|Part B Follow up Period||32
251458|NCT01029340|608434|P3|COMPLETED|Part B Follow up Period||29
251459|NCT01029340|608435|P2|COMPLETED|Part B Follow up Period||0
251460|NCT01029340|608436|P1|COMPLETED|Part B Follow up Period||0
251461|NCT01029340|608431|P6|STARTED|Part B Follow up Period||0
251462|NCT01029340|608432|P5|STARTED|Part B Follow up Period||0
251463|NCT01029340|608433|P4|STARTED|Part B Follow up Period||32
251464|NCT01029340|608434|P3|STARTED|Part B Follow up Period||29
251465|NCT01029340|608435|P2|STARTED|Part B Follow up Period||0
251466|NCT01029340|608436|P1|STARTED|Part B Follow up Period||0
251467|NCT01029340|608431|P6|NOT COMPLETED|Part B Treatment Period||0
251468|NCT01029340|608432|P5|NOT COMPLETED|Part B Treatment Period||0
251469|NCT01029340|608433|P4|NOT COMPLETED|Part B Treatment Period||0
251470|NCT01029340|608434|P3|NOT COMPLETED|Part B Treatment Period||2
251471|NCT01029340|608435|P2|NOT COMPLETED|Part B Treatment Period||0
251472|NCT01029340|608436|P1|NOT COMPLETED|Part B Treatment Period||0
251473|NCT01029340|608431|P6|COMPLETED|Part B Treatment Period||0
251474|NCT01029340|608432|P5|COMPLETED|Part B Treatment Period||0
251475|NCT01029340|608433|P4|COMPLETED|Part B Treatment Period||32
251476|NCT01029340|608434|P3|COMPLETED|Part B Treatment Period||29
251477|NCT01029340|608435|P2|COMPLETED|Part B Treatment Period||0
251478|NCT01029340|608436|P1|COMPLETED|Part B Treatment Period||0
251479|NCT01029340|608431|P6|Participants Received Treatment|Part B Treatment Period||0
251480|NCT01029340|608432|P5|Participants Received Treatment|Part B Treatment Period||0
251481|NCT01029340|608433|P4|Participants Received Treatment|Part B Treatment Period||32
251482|NCT01029340|608434|P3|Participants Received Treatment|Part B Treatment Period||30
251483|NCT01029340|608435|P2|Participants Received Treatment|Part B Treatment Period||0
251484|NCT01029340|608436|P1|Participants Received Treatment|Part B Treatment Period||0
251485|NCT01029340|608431|P6|STARTED|Part B Treatment Period||0
251486|NCT01029340|608432|P5|STARTED|Part B Treatment Period||0
251487|NCT01029340|608433|P4|STARTED|Part B Treatment Period|Enrolled 7 participants from Arm 1 and 4 participants from Arm 2|32
251488|NCT01029340|608434|P3|STARTED|Part B Treatment Period|Enrolled 4 participants from Arm 1 and 7 participants from Arm 2|31
251489|NCT01029340|608435|P2|STARTED|Part B Treatment Period||0
251490|NCT01029340|608436|P1|STARTED|Part B Treatment Period||0
251491|NCT01029340|608431|P6|NOT COMPLETED|Part A Follow up Period||0
251492|NCT01029340|608432|P5|NOT COMPLETED|Part A Follow up Period||0
251493|NCT01029340|608433|P4|NOT COMPLETED|Part A Follow up Period||0
251494|NCT01029340|608434|P3|NOT COMPLETED|Part A Follow up Period||0
251495|NCT01029340|608435|P2|NOT COMPLETED|Part A Follow up Period||0
251496|NCT01029340|608436|P1|NOT COMPLETED|Part A Follow up Period||0
251497|NCT01029340|608431|P6|COMPLETED|Part A Follow up Period||0
251498|NCT01029340|608432|P5|COMPLETED|Part A Follow up Period||0
251499|NCT01029340|608433|P4|COMPLETED|Part A Follow up Period||0
251500|NCT01029340|608434|P3|COMPLETED|Part A Follow up Period||0
251501|NCT01029340|608435|P2|COMPLETED|Part A Follow up Period||14
251502|NCT01029340|608436|P1|COMPLETED|Part A Follow up Period||14
251503|NCT01029340|608431|P6|STARTED|Part A Follow up Period||0
251504|NCT01029340|608432|P5|STARTED|Part A Follow up Period||0
251505|NCT01029340|608433|P4|STARTED|Part A Follow up Period||0
251506|NCT01029340|608434|P3|STARTED|Part A Follow up Period||0
251507|NCT01029340|608435|P2|STARTED|Part A Follow up Period||14
251508|NCT01029340|608436|P1|STARTED|Part A Follow up Period||14
251509|NCT01029340|608431|P6|NOT COMPLETED|Part A Treatment Period||0
251510|NCT01029340|608432|P5|NOT COMPLETED|Part A Treatment Period||0
251511|NCT01029340|608433|P4|NOT COMPLETED|Part A Treatment Period||0
251512|NCT01029340|608434|P3|NOT COMPLETED|Part A Treatment Period||0
251513|NCT01029340|608435|P2|NOT COMPLETED|Part A Treatment Period||0
251514|NCT01029340|608436|P1|NOT COMPLETED|Part A Treatment Period||0
251515|NCT01029340|608431|P6|COMPLETED|Part A Treatment Period||0
251516|NCT01029340|608432|P5|COMPLETED|Part A Treatment Period||0
251517|NCT01029340|608433|P4|COMPLETED|Part A Treatment Period||0
251518|NCT01029340|608434|P3|COMPLETED|Part A Treatment Period||0
251519|NCT01029340|608435|P2|COMPLETED|Part A Treatment Period||14
251520|NCT01029340|608436|P1|COMPLETED|Part A Treatment Period||14
251521|NCT01029340|608431|P6|Safety Population|Part A Treatment Period||0
251522|NCT01029340|608432|P5|Safety Population|Part A Treatment Period||0
251523|NCT01029340|608433|P4|Safety Population|Part A Treatment Period||0
251524|NCT01029340|608434|P3|Safety Population|Part A Treatment Period||0
251525|NCT01029340|608435|P2|Safety Population|Part A Treatment Period||14
251526|NCT01029340|608436|P1|Safety Population|Part A Treatment Period|One excluded because receiving Kogenate FS twice.|13
251527|NCT01029340|608431|P6|Participants Received Treatment|Part A Treatment Period||0
251528|NCT01029340|608432|P5|Participants Received Treatment|Part A Treatment Period||0
251529|NCT01029340|608433|P4|Participants Received Treatment|Part A Treatment Period||0
251530|NCT01029340|608434|P3|Participants Received Treatment|Part A Treatment Period||0
251531|NCT01029340|608435|P2|Participants Received Treatment|Part A Treatment Period||14
251532|NCT01029340|608436|P1|Participants Received Treatment|Part A Treatment Period||14
251533|NCT01029340|608431|P6|STARTED|Part A Treatment Period||0
251534|NCT01029340|608432|P5|STARTED|Part A Treatment Period||0
251535|NCT01029340|608433|P4|STARTED|Part A Treatment Period||0
251536|NCT01029340|608434|P3|STARTED|Part A Treatment Period||0
251537|NCT01029340|608435|P2|STARTED|Part A Treatment Period||14
251538|NCT01029340|608436|P1|STARTED|Part A Treatment Period||14
251539|NCT01029262|608467|P2|NOT COMPLETED|Overall Study||160
251540|NCT01029262|608468|P1|NOT COMPLETED|Overall Study||79
251541|NCT01029262|608467|P2|COMPLETED|Overall Study||0
251542|NCT01029262|608468|P1|COMPLETED|Overall Study||0
251543|NCT01029262|608467|P2|STARTED|Overall Study||160
251544|NCT01029262|608468|P1|STARTED|Overall Study||79
251545|NCT01029054|608530|P3|NOT COMPLETED|Phase II||0
251546|NCT01029054|608531|P2|NOT COMPLETED|Phase II||0
251547|NCT01029054|608532|P1|NOT COMPLETED|Phase II||0
251548|NCT01029054|608530|P3|COMPLETED|Phase II||18
251549|NCT01029054|608531|P2|COMPLETED|Phase II||0
251550|NCT01029054|608532|P1|COMPLETED|Phase II||0
251551|NCT01029054|608530|P3|STARTED|Phase II|35 participants were enrolled in Ph I. 18 additional participants were enrolled in Ph II at the MTD.|18
251552|NCT01029054|608531|P2|STARTED|Phase II||0
251553|NCT01029054|608532|P1|STARTED|Phase II||0
251554|NCT01029054|608530|P3|NOT COMPLETED|Phase I||0
251555|NCT01029054|608531|P2|NOT COMPLETED|Phase I||0
251556|NCT01029054|608532|P1|NOT COMPLETED|Phase I||0
251557|NCT01029054|608530|P3|COMPLETED|Phase I||18
251558|NCT01029054|608531|P2|COMPLETED|Phase I||13
251559|NCT01029054|608532|P1|COMPLETED|Phase I||4
251560|NCT01029054|608530|P3|STARTED|Phase I||18
251561|NCT01029054|608531|P2|STARTED|Phase I||13
251562|NCT01029054|608532|P1|STARTED|Phase I||4
251563|NCT01028937|608538|P1|NOT COMPLETED|Overall Study||0
251564|NCT01028937|608538|P1|COMPLETED|Overall Study||6
251565|NCT01028937|608538|P1|STARTED|Overall Study||6
251566|NCT01028911|608545|P2|NOT COMPLETED|Overall Study||0
251567|NCT01028911|608546|P1|NOT COMPLETED|Overall Study||0
251568|NCT01028911|608545|P2|COMPLETED|Overall Study||2
251569|NCT01028911|608546|P1|COMPLETED|Overall Study||7
251570|NCT01028911|608545|P2|STARTED|Overall Study||2
251571|NCT01028911|608546|P1|STARTED|Overall Study||7
251572|NCT01028820|608611|P1|NOT COMPLETED|Overall Study||1
251573|NCT01028820|608611|P1|COMPLETED|Overall Study||12
251574|NCT01028820|608611|P1|STARTED|Overall Study||13
251575|NCT01028677|608620|P2|NOT COMPLETED|Overall Study||1
251576|NCT01028677|608621|P1|NOT COMPLETED|Overall Study||2
251577|NCT01028677|608620|P2|COMPLETED|Overall Study||6
251578|NCT01028677|608621|P1|COMPLETED|Overall Study||8
251579|NCT01028677|608620|P2|STARTED|Overall Study||7
251580|NCT01028677|608621|P1|STARTED|Overall Study||10
251581|NCT01028651|608637|P1|NOT COMPLETED|Overall Study||3
251582|NCT01028651|608637|P1|COMPLETED|Overall Study||10
251583|NCT01028651|608637|P1|STARTED|Overall Study||13
251584|NCT01028560|608660|P2|NOT COMPLETED|Overall Study||18
251585|NCT01028560|608661|P1|NOT COMPLETED|Overall Study||10
251586|NCT01028560|608660|P2|COMPLETED|Overall Study||13
251587|NCT01028560|608661|P1|COMPLETED|Overall Study||17
251588|NCT01028560|608660|P2|Started Study Protocol|Overall Study||27
251589|NCT01028560|608661|P1|Started Study Protocol|Overall Study||23
251590|NCT01028560|608660|P2|STARTED|Overall Study|4 of 31 withdrew consent immediately after randomization and are excluded from outcome analysis|31
251591|NCT01028560|608661|P1|STARTED|Overall Study|4 of 27 withdrew consent immediately after randomization and are excluded from outcome analysis|27
251592|NCT01028391|608675|P2|NOT COMPLETED|Overall Study||11
251593|NCT01028391|608676|P1|NOT COMPLETED|Overall Study||14
251594|NCT01028391|608675|P2|COMPLETED|Overall Study||142
251595|NCT01028391|608676|P1|COMPLETED|Overall Study||150
251596|NCT01028391|608675|P2|STARTED|Overall Study||153
251597|NCT01028391|608676|P1|STARTED|Overall Study||164
251598|NCT01028378|608684|P1|NOT COMPLETED|Overall Study||17
251599|NCT01028378|608684|P1|COMPLETED|Overall Study|195 participants (230 eyes) with myopia|195
251600|NCT01028378|608684|P1|STARTED|Overall Study|212 participants (249 eyes) with myopia|212
251601|NCT01028352|608696|P1|NOT COMPLETED|Overall Study||6
251602|NCT01028352|608696|P1|COMPLETED|Overall Study||29
251603|NCT01028352|608696|P1|STARTED|Overall Study||35
251604|NCT01028300|608701|P1|NOT COMPLETED|Overall Study||4
251605|NCT01028300|608701|P1|COMPLETED|Overall Study||0
251606|NCT01028300|608701|P1|STARTED|Overall Study||4
251607|NCT01028222|608710|P2|NOT COMPLETED|Overall Study||13
251608|NCT01028222|608711|P1|NOT COMPLETED|Overall Study||38
251609|NCT01028222|608710|P2|COMPLETED|Overall Study||0
251610|NCT01028222|608711|P1|COMPLETED|Overall Study||4
251611|NCT01028222|608710|P2|Cross Over From DTIC to Nilotinib|Overall Study||10
251612|NCT01028222|608711|P1|Cross Over From DTIC to Nilotinib|Overall Study||0
251613|NCT01028222|608710|P2|STARTED|Overall Study||13
251614|NCT01028222|608711|P1|STARTED|Overall Study||42
251615|NCT01028131|608736|P4|NOT COMPLETED|Overall Study||4
251616|NCT01028131|608737|P3|NOT COMPLETED|Overall Study||6
251617|NCT01028131|608738|P2|NOT COMPLETED|Overall Study||3
251618|NCT01028131|608739|P1|NOT COMPLETED|Overall Study||3
251619|NCT01028131|608736|P4|COMPLETED|Overall Study||26
251620|NCT01028131|608737|P3|COMPLETED|Overall Study||22
251621|NCT01028131|608738|P2|COMPLETED|Overall Study||23
251622|NCT01028131|608739|P1|COMPLETED|Overall Study||23
251623|NCT01028131|608736|P4|Completed Intervention/Control Session|Overall Study||30
251624|NCT01028131|608737|P3|Completed Intervention/Control Session|Overall Study||28
251625|NCT01028131|608738|P2|Completed Intervention/Control Session|Overall Study||26
251626|NCT01028131|608739|P1|Completed Intervention/Control Session|Overall Study||26
251627|NCT01028131|608736|P4|STARTED|Overall Study||30
251628|NCT01028131|608737|P3|STARTED|Overall Study||28
251629|NCT01028131|608738|P2|STARTED|Overall Study||26
251630|NCT01028131|608739|P1|STARTED|Overall Study||26
251631|NCT01028053|608753|P1|NOT COMPLETED|Overall Study||133
251632|NCT01028053|608753|P1|COMPLETED|Overall Study||232
251633|NCT01028053|608753|P1|STARTED|Overall Study||365
251634|NCT01028027|608761|P2|NOT COMPLETED|Overall Study||13
251635|NCT01028027|608762|P1|NOT COMPLETED|Overall Study||16
251636|NCT01028027|608761|P2|COMPLETED|Overall Study||164
251637|NCT01028027|608762|P1|COMPLETED|Overall Study||164
251638|NCT01028027|608761|P2|STARTED|Overall Study||177
251639|NCT01028027|608762|P1|STARTED|Overall Study||180
251640|NCT01028014|608784|P6|NOT COMPLETED|Overall Study||2
251641|NCT01028014|608785|P5|NOT COMPLETED|Overall Study||1
251642|NCT01028014|608786|P4|NOT COMPLETED|Overall Study||1
251643|NCT01028014|608787|P3|NOT COMPLETED|Overall Study||0
251644|NCT01028014|608788|P2|NOT COMPLETED|Overall Study||2
251645|NCT01028014|608789|P1|NOT COMPLETED|Overall Study||1
251646|NCT01028014|608784|P6|COMPLETED|Overall Study||4
251647|NCT01028014|608785|P5|COMPLETED|Overall Study||9
251648|NCT01028014|608786|P4|COMPLETED|Overall Study||9
251649|NCT01028014|608787|P3|COMPLETED|Overall Study||10
251650|NCT01028014|608788|P2|COMPLETED|Overall Study||8
251651|NCT01028014|608789|P1|COMPLETED|Overall Study||9
251652|NCT01028014|608784|P6|STARTED|Overall Study||6
251653|NCT01028014|608785|P5|STARTED|Overall Study||10
251654|NCT01028014|608786|P4|STARTED|Overall Study||10
251655|NCT01028014|608787|P3|STARTED|Overall Study||10
251656|NCT01028014|608788|P2|STARTED|Overall Study||10
251657|NCT01028014|608789|P1|STARTED|Overall Study||10
251658|NCT01027910|608817|P2|NOT COMPLETED|Overall Study||0
251659|NCT01027910|608818|P1|NOT COMPLETED|Overall Study||0
251660|NCT01027910|608817|P2|COMPLETED|Overall Study||14
251661|NCT01027910|608818|P1|COMPLETED|Overall Study||6
251662|NCT01027910|608817|P2|STARTED|Overall Study||14
251663|NCT01027910|608818|P1|STARTED|Overall Study||6
251664|NCT01027897|608830|P1|NOT COMPLETED|Overall Study||2
251665|NCT01027897|608830|P1|COMPLETED|Overall Study||28
251666|NCT01027897|608830|P1|STARTED|Overall Study||30
251667|NCT01027884|608838|P2|NOT COMPLETED|Overall Study||7
251668|NCT01027884|608839|P1|NOT COMPLETED|Overall Study||4
251669|NCT01027884|608838|P2|COMPLETED|Overall Study||25
251670|NCT01027884|608839|P1|COMPLETED|Overall Study||30
251671|NCT01027884|608838|P2|STARTED|Overall Study||32
251672|NCT01027884|608839|P1|STARTED|Overall Study||34
251673|NCT01027871|608856|P3|NOT COMPLETED|Overall Study||7
251674|NCT01027871|608857|P2|NOT COMPLETED|Overall Study||13
251675|NCT01027871|608858|P1|NOT COMPLETED|Overall Study||2
251676|NCT01027871|608856|P3|COMPLETED|Overall Study||91
251677|NCT01027871|608857|P2|COMPLETED|Overall Study||85
251678|NCT01027871|608858|P1|COMPLETED|Overall Study||91
251679|NCT01027871|608856|P3|Received at Least One Dose of Study Drug|Overall Study||97
251680|NCT01027871|608857|P2|Received at Least One Dose of Study Drug|Overall Study||98
251681|NCT01027871|608858|P1|Received at Least One Dose of Study Drug|Overall Study||93
251682|NCT01027871|608856|P3|STARTED|Overall Study||98
251683|NCT01027871|608857|P2|STARTED|Overall Study||98
251684|NCT01027871|608858|P1|STARTED|Overall Study||93
251685|NCT01027845|608917|P4|NOT COMPLETED|Booster Vaccination Phase||0
251686|NCT01027845|608918|P3|NOT COMPLETED|Booster Vaccination Phase||0
251687|NCT01027845|608919|P2|NOT COMPLETED|Booster Vaccination Phase||0
251688|NCT01027845|608920|P1|NOT COMPLETED|Booster Vaccination Phase||2
251689|NCT01027845|608917|P4|COMPLETED|Booster Vaccination Phase||1
251690|NCT01027845|608918|P3|COMPLETED|Booster Vaccination Phase||119
251691|NCT01027845|608919|P2|COMPLETED|Booster Vaccination Phase||0
251692|NCT01027845|608920|P1|COMPLETED|Booster Vaccination Phase||226
251693|NCT01027845|608917|P4|STARTED|Booster Vaccination Phase||1
251694|NCT01027845|608918|P3|STARTED|Booster Vaccination Phase||119
251695|NCT01027845|608919|P2|STARTED|Booster Vaccination Phase|Subjects from this group were assigned to DTPa+Prevenar&DTPa-No Prevenar Groups in the booster phase|0
251696|NCT01027845|608920|P1|STARTED|Booster Vaccination Phase||228
251697|NCT01027845|608917|P4|NOT COMPLETED|Primary Vaccination Phase||0
251698|NCT01027845|608918|P3|NOT COMPLETED|Primary Vaccination Phase||0
251699|NCT01027845|608919|P2|NOT COMPLETED|Primary Vaccination Phase||1
251700|NCT01027845|608920|P1|NOT COMPLETED|Primary Vaccination Phase||4
251701|NCT01027845|608917|P4|COMPLETED|Primary Vaccination Phase||0
251702|NCT01027845|608918|P3|COMPLETED|Primary Vaccination Phase||0
251703|NCT01027845|608919|P2|COMPLETED|Primary Vaccination Phase||122
251704|NCT01027845|608920|P1|COMPLETED|Primary Vaccination Phase||233
251705|NCT01027845|608917|P4|STARTED|Primary Vaccination Phase|Subjects were not yet assigned to this group at the time of the primary vaccination|0
251706|NCT01027845|608918|P3|STARTED|Primary Vaccination Phase|Subjects were not yet assigned to this group at the time of the primary vaccination|0
251707|NCT01027845|608919|P2|STARTED|Primary Vaccination Phase||123
251708|NCT01027845|608920|P1|STARTED|Primary Vaccination Phase||237
251709|NCT01027819|608972|P2|NOT COMPLETED|Overall Study||0
251710|NCT01027819|608973|P1|NOT COMPLETED|Overall Study||0
251711|NCT01027819|608972|P2|COMPLETED|Overall Study||40
251712|NCT01027819|608973|P1|COMPLETED|Overall Study||40
251713|NCT01027819|608972|P2|STARTED|Overall Study||40
251714|NCT01027819|608973|P1|STARTED|Overall Study||40
251715|NCT01027806|608981|P2|NOT COMPLETED|Overall Study||3
251716|NCT01027806|608982|P1|NOT COMPLETED|Overall Study||4
251717|NCT01027806|608981|P2|COMPLETED|Overall Study||29
251718|NCT01027806|608982|P1|COMPLETED|Overall Study||28
251719|NCT01027806|608981|P2|STARTED|Overall Study||32
251720|NCT01027806|608982|P1|STARTED|Overall Study||32
251721|NCT01027780|608990|P2|NOT COMPLETED|Overall Study||1
251722|NCT01027780|608991|P1|NOT COMPLETED|Overall Study||0
251723|NCT01027780|608990|P2|COMPLETED|Overall Study||102
251724|NCT01027780|608991|P1|COMPLETED|Overall Study||105
251725|NCT01027780|608990|P2|STARTED|Overall Study||103
251726|NCT01027780|608991|P1|STARTED|Overall Study||105
251727|NCT01027702|609001|P7|NOT COMPLETED|Overall Study||1
251728|NCT01027702|609002|P6|NOT COMPLETED|Overall Study||0
251729|NCT01027702|609003|P5|NOT COMPLETED|Overall Study||1
251730|NCT01027702|609004|P4|NOT COMPLETED|Overall Study||4
251731|NCT01027702|609005|P3|NOT COMPLETED|Overall Study||1
251732|NCT01027702|609006|P2|NOT COMPLETED|Overall Study||2
251733|NCT01027702|609007|P1|NOT COMPLETED|Overall Study||1
251734|NCT01027702|609001|P7|COMPLETED|Overall Study||1
251735|NCT01027702|609002|P6|COMPLETED|Overall Study||1
251736|NCT01027702|609003|P5|COMPLETED|Overall Study||9
251737|NCT01027702|609004|P4|COMPLETED|Overall Study||10
251738|NCT01027702|609005|P3|COMPLETED|Overall Study||2
251739|NCT01027702|609006|P2|COMPLETED|Overall Study||2
251740|NCT01027702|609007|P1|COMPLETED|Overall Study||3
251741|NCT01027702|609001|P7|STARTED|Overall Study||2
251742|NCT01027702|609002|P6|STARTED|Overall Study||1
251743|NCT01027702|609003|P5|STARTED|Overall Study||10
251744|NCT01027702|609004|P4|STARTED|Overall Study||14
251745|NCT01027702|609005|P3|STARTED|Overall Study||3
251746|NCT01027702|609006|P2|STARTED|Overall Study||4
251747|NCT01027702|609007|P1|STARTED|Overall Study||4
251748|NCT01027650|609033|P8|NOT COMPLETED|Overall Study||0
251749|NCT01027650|609034|P7|NOT COMPLETED|Overall Study||1
251750|NCT01027650|609035|P6|NOT COMPLETED|Overall Study||2
251751|NCT01027650|609036|P5|NOT COMPLETED|Overall Study||2
251752|NCT01027650|609037|P4|NOT COMPLETED|Overall Study||0
251753|NCT01027650|609038|P3|NOT COMPLETED|Overall Study||0
251754|NCT01027650|609039|P2|NOT COMPLETED|Overall Study||0
251755|NCT01027650|609040|P1|NOT COMPLETED|Overall Study||0
251756|NCT01027650|609033|P8|COMPLETED|Overall Study||24
251757|NCT01027650|609034|P7|COMPLETED|Overall Study||24
251758|NCT01027650|609035|P6|COMPLETED|Overall Study||24
251759|NCT01027650|609036|P5|COMPLETED|Overall Study||23
251760|NCT01027650|609037|P4|COMPLETED|Overall Study||3
251761|NCT01027650|609038|P3|COMPLETED|Overall Study||6
251762|NCT01027650|609039|P2|COMPLETED|Overall Study||6
251763|NCT01027650|609040|P1|COMPLETED|Overall Study||6
251764|NCT01027650|609033|P8|STARTED|Overall Study||24
251765|NCT01027650|609034|P7|STARTED|Overall Study||25
251766|NCT01027650|609035|P6|STARTED|Overall Study||26
251767|NCT01027650|609036|P5|STARTED|Overall Study||25
251768|NCT01027650|609037|P4|STARTED|Overall Study||3
251769|NCT01027650|609038|P3|STARTED|Overall Study||6
251770|NCT01027650|609039|P2|STARTED|Overall Study||6
251771|NCT01027650|609040|P1|STARTED|Overall Study||6
251772|NCT01027598|609084|P2|NOT COMPLETED|Overall Study||67
251773|NCT01027598|609085|P1|NOT COMPLETED|Overall Study||134
251774|NCT01027598|609084|P2|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
251775|NCT01027598|609085|P1|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
251776|NCT01027598|609084|P2|STARTED|Overall Study||67
251777|NCT01027598|609085|P1|STARTED|Overall Study|One patient was enrolled but not treated|134
251778|NCT01027559|609098|P3|NOT COMPLETED|Overall Study||9
251779|NCT01027559|609099|P2|NOT COMPLETED|Overall Study||8
251780|NCT01027559|609100|P1|NOT COMPLETED|Overall Study||6
251781|NCT01027559|609098|P3|COMPLETED|Overall Study||22
251782|NCT01027559|609099|P2|COMPLETED|Overall Study||26
251783|NCT01027559|609100|P1|COMPLETED|Overall Study||20
251784|NCT01027559|609098|P3|STARTED|Overall Study||31
251785|NCT01027559|609099|P2|STARTED|Overall Study||34
251786|NCT01027559|609100|P1|STARTED|Overall Study||26
251787|NCT01027468|609110|P1|NOT COMPLETED|Overall Study||0
251788|NCT01027468|609110|P1|COMPLETED|Overall Study||160
251789|NCT01027468|609110|P1|STARTED|Overall Study||160
251790|NCT01027416|609118|P2|NOT COMPLETED|Overall Study||5
251791|NCT01027416|609119|P1|NOT COMPLETED|Overall Study||1
251792|NCT01027416|609118|P2|COMPLETED|Overall Study||23
251793|NCT01027416|609119|P1|COMPLETED|Overall Study||30
251794|NCT01027416|609118|P2|STARTED|Overall Study||28
251795|NCT01027416|609119|P1|STARTED|Overall Study||31
251796|NCT01027364|609131|P4|NOT COMPLETED|Overall Study||1
251797|NCT01027364|609132|P3|NOT COMPLETED|Overall Study||1
251798|NCT01027364|609133|P2|NOT COMPLETED|Overall Study||2
251799|NCT01027364|609134|P1|NOT COMPLETED|Overall Study||4
251800|NCT01027364|609131|P4|COMPLETED|Overall Study|11 participants total completed Arm 4 (3: compl. Arm 4 only; 7: cont. to Arm 1; 1: cont. to Arm 3)|3
251801|NCT01027364|609132|P3|COMPLETED|Overall Study||26
251802|NCT01027364|609133|P2|COMPLETED|Overall Study||27
251803|NCT01027364|609134|P1|COMPLETED|Overall Study||59
251804|NCT01027364|609131|P4|Started Arm 4 Then Joined Another Arm|Overall Study||0
251805|NCT01027364|609132|P3|Started Arm 4 Then Joined Another Arm|Overall Study||0
251806|NCT01027364|609133|P2|Started Arm 4 Then Joined Another Arm|Overall Study||0
251807|NCT01027364|609134|P1|Started Arm 4 Then Joined Another Arm|Overall Study||2
251808|NCT01027364|609131|P4|Joined Arm 4 for Surgery Then Returned|Overall Study||0
251809|NCT01027364|609132|P3|Joined Arm 4 for Surgery Then Returned|Overall Study||1
251810|NCT01027364|609133|P2|Joined Arm 4 for Surgery Then Returned|Overall Study||0
251811|NCT01027364|609134|P1|Joined Arm 4 for Surgery Then Returned|Overall Study||5
251812|NCT01027364|609131|P4|Enrolled in Sequential PK Subgroup|Overall Study||0
251813|NCT01027364|609132|P3|Enrolled in Sequential PK Subgroup|Overall Study||0
251814|NCT01027364|609133|P2|Enrolled in Sequential PK Subgroup|Overall Study||0
251815|NCT01027364|609134|P1|Enrolled in Sequential PK Subgroup|Overall Study||22
251816|NCT01027364|609131|P4|STARTED|Overall Study|12 total participants in Arm 4 (6 started in Arm 4; 5 joined from Arm 1; 1 joined from Arm 3)|4
251817|NCT01027364|609132|P3|STARTED|Overall Study||27
251818|NCT01027364|609133|P2|STARTED|Overall Study||29
251819|NCT01027364|609134|P1|STARTED|Overall Study||63
251820|NCT01027351|609229|P6|NOT COMPLETED|Overall Study||5
251821|NCT01027351|609230|P5|NOT COMPLETED|Overall Study||11
251822|NCT01027351|609231|P4|NOT COMPLETED|Overall Study||2
251823|NCT01027351|609232|P3|NOT COMPLETED|Overall Study||1
251824|NCT01027351|609233|P2|NOT COMPLETED|Overall Study||1
251825|NCT01027351|609234|P1|NOT COMPLETED|Overall Study||3
251826|NCT01027351|609229|P6|COMPLETED|Overall Study||45
251827|NCT01027351|609230|P5|COMPLETED|Overall Study||32
251828|NCT01027351|609231|P4|COMPLETED|Overall Study||6
251829|NCT01027351|609232|P3|COMPLETED|Overall Study||13
251830|NCT01027351|609233|P2|COMPLETED|Overall Study||18
251831|NCT01027351|609234|P1|COMPLETED|Overall Study||26
251832|NCT01027351|609229|P6|STARTED|Overall Study||50
251833|NCT01027351|609230|P5|STARTED|Overall Study||43
251834|NCT01027351|609231|P4|STARTED|Overall Study||8
251835|NCT01027351|609232|P3|STARTED|Overall Study||14
251836|NCT01027351|609233|P2|STARTED|Overall Study||19
251837|NCT01027351|609234|P1|STARTED|Overall Study||29
251838|NCT01027286|609318|P2|NOT COMPLETED|Overall Study||1
251839|NCT01027286|609319|P1|NOT COMPLETED|Overall Study||1
251840|NCT01027286|609318|P2|COMPLETED|Overall Study||49
251841|NCT01027286|609319|P1|COMPLETED|Overall Study||49
251842|NCT01027286|609318|P2|12 Week Postoperative|Overall Study||49
251843|NCT01027286|609319|P1|12 Week Postoperative|Overall Study||49
251844|NCT01027286|609318|P2|4 Week Postoperative|Overall Study||50
251845|NCT01027286|609319|P1|4 Week Postoperative|Overall Study||49
251846|NCT01027286|609318|P2|Day of Surgery|Overall Study||50
251847|NCT01027286|609319|P1|Day of Surgery|Overall Study||50
251848|NCT01027286|609318|P2|Preoperative|Overall Study||50
251849|NCT01027286|609319|P1|Preoperative|Overall Study||50
251850|NCT01027286|609318|P2|STARTED|Overall Study||50
251851|NCT01027286|609319|P1|STARTED|Overall Study||50
251852|NCT01027273|609339|P2|NOT COMPLETED|Overall Study||33
251853|NCT01027273|609340|P1|NOT COMPLETED|Overall Study||59
251854|NCT01027273|609339|P2|COMPLETED|Overall Study||266
251855|NCT01027273|609340|P1|COMPLETED|Overall Study||242
251856|NCT01027273|609339|P2|STARTED|Overall Study||299
251857|NCT01027273|609340|P1|STARTED|Overall Study||301
251858|NCT01027195|609358|P2|NOT COMPLETED|Overall Study||0
251859|NCT01027195|609359|P1|NOT COMPLETED|Overall Study||0
251860|NCT01027195|609358|P2|COMPLETED|Overall Study||69
251861|NCT01027195|609359|P1|COMPLETED|Overall Study||71
251862|NCT01027195|609358|P2|STARTED|Overall Study||69
251863|NCT01027195|609359|P1|STARTED|Overall Study||71
251864|NCT01027000|609379|P1|NOT COMPLETED|Overall Study||0
251865|NCT01027000|609379|P1|COMPLETED|Overall Study||68
251866|NCT01027000|609379|P1|STARTED|Overall Study||68
251867|NCT01026974|609387|P4|NOT COMPLETED|Overall Study||3
251868|NCT01026974|609388|P3|NOT COMPLETED|Overall Study||12
251869|NCT01026974|609389|P2|NOT COMPLETED|Overall Study||2
251870|NCT01026974|609390|P1|NOT COMPLETED|Overall Study||1
251871|NCT01026974|609387|P4|COMPLETED|Overall Study||46
251872|NCT01026974|609388|P3|COMPLETED|Overall Study||29
251873|NCT01026974|609389|P2|COMPLETED|Overall Study||12
251874|NCT01026974|609390|P1|COMPLETED|Overall Study||15
251875|NCT01026974|609387|P4|STARTED|Overall Study||49
251876|NCT01026974|609388|P3|STARTED|Overall Study||41
251877|NCT01026974|609389|P2|STARTED|Overall Study||14
251878|NCT01026974|609390|P1|STARTED|Overall Study||16
251879|NCT01026948|609447|P1|NOT COMPLETED|Overall Study||8
251880|NCT01026948|609447|P1|COMPLETED|Overall Study|8 Women were recalled because of signal loss|62
251881|NCT01026948|609447|P1|STARTED|Overall Study||70
251882|NCT01026909|609454|P2|NOT COMPLETED|Overall Study||0
251883|NCT01026909|609455|P1|NOT COMPLETED|Overall Study||0
251884|NCT01026909|609454|P2|COMPLETED|Overall Study||2
251885|NCT01026909|609455|P1|COMPLETED|Overall Study||1
251886|NCT01026909|609454|P2|STARTED|Overall Study||2
251887|NCT01026909|609455|P1|STARTED|Overall Study||1
251888|NCT01026844|609465|P2|NOT COMPLETED|Overall Study||0
251889|NCT01026844|609466|P1|NOT COMPLETED|Overall Study||0
251890|NCT01026844|609465|P2|COMPLETED|Overall Study||8
251891|NCT01026844|609466|P1|COMPLETED|Overall Study||19
251892|NCT01026844|609465|P2|STARTED|Overall Study||8
251893|NCT01026844|609466|P1|STARTED|Overall Study||19
251894|NCT01026831|609480|P2|NOT COMPLETED|Overall Study||11
251895|NCT01026831|609481|P1|NOT COMPLETED|Overall Study||14
251896|NCT01026831|609480|P2|COMPLETED|Overall Study||312
251897|NCT01026831|609481|P1|COMPLETED|Overall Study||306
251898|NCT01026831|609480|P2|STARTED|Overall Study|randomized|323
251899|NCT01026831|609481|P1|STARTED|Overall Study|randomized|320
251900|NCT01026818|609492|P4|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||3
251901|NCT01026818|609493|P3|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||5
251902|NCT01026818|609494|P2|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||7
251903|NCT01026818|609495|P1|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||0
251904|NCT01026818|609492|P4|COMPLETED|OL Period (Month 10.5 - 13.5)||105
251905|NCT01026818|609493|P3|COMPLETED|OL Period (Month 10.5 - 13.5)||112
251906|NCT01026818|609494|P2|COMPLETED|OL Period (Month 10.5 - 13.5)||98
251907|NCT01026818|609495|P1|COMPLETED|OL Period (Month 10.5 - 13.5)||0
251908|NCT01026818|609492|P4|STARTED|OL Period (Month 10.5 - 13.5)||108
251909|NCT01026818|609493|P3|STARTED|OL Period (Month 10.5 - 13.5)||117
251910|NCT01026818|609494|P2|STARTED|OL Period (Month 10.5 - 13.5)||105
251911|NCT01026818|609495|P1|STARTED|OL Period (Month 10.5 - 13.5)||0
251912|NCT01026818|609492|P4|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||7
251913|NCT01026818|609493|P3|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||5
251914|NCT01026818|609494|P2|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||9
251915|NCT01026818|609495|P1|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
251916|NCT01026818|609492|P4|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||108
251917|NCT01026818|609493|P3|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||117
251918|NCT01026818|609494|P2|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||105
251919|NCT01026818|609495|P1|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
251920|NCT01026818|609492|P4|STARTED|Drug-Free Washout Period (Month 9-10.5)||115
251921|NCT01026818|609493|P3|STARTED|Drug-Free Washout Period (Month 9-10.5)||122
251922|NCT01026818|609494|P2|STARTED|Drug-Free Washout Period (Month 9-10.5)||114
251923|NCT01026818|609495|P1|STARTED|Drug-Free Washout Period (Month 9-10.5)||0
251924|NCT01026818|609492|P4|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||26
251925|NCT01026818|609493|P3|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||21
251926|NCT01026818|609494|P2|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||25
251927|NCT01026818|609495|P1|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||0
251928|NCT01026818|609492|P4|COMPLETED|DB Treatment Period (Month 0 - 9)||115
251929|NCT01026818|609493|P3|COMPLETED|DB Treatment Period (Month 0 - 9)||122
251930|NCT01026818|609494|P2|COMPLETED|DB Treatment Period (Month 0 - 9)||114
251931|NCT01026818|609495|P1|COMPLETED|DB Treatment Period (Month 0 - 9)||0
251932|NCT01026818|609492|P4|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||141
251933|NCT01026818|609493|P3|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||143
251934|NCT01026818|609494|P2|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||139
251935|NCT01026818|609495|P1|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||0
251936|NCT01026818|609492|P4|STARTED|DB Treatment Period (Month 0 - 9)||141
251937|NCT01026818|609493|P3|STARTED|DB Treatment Period (Month 0 - 9)||143
251938|NCT01026818|609494|P2|STARTED|DB Treatment Period (Month 0 - 9)||139
251939|NCT01026818|609495|P1|STARTED|DB Treatment Period (Month 0 - 9)||0
251940|NCT01026818|609492|P4|NOT COMPLETED|Screening Period||0
251941|NCT01026818|609493|P3|NOT COMPLETED|Screening Period||0
251942|NCT01026818|609494|P2|NOT COMPLETED|Screening Period||0
251943|NCT01026818|609495|P1|NOT COMPLETED|Screening Period||160
251944|NCT01026818|609492|P4|COMPLETED|Screening Period||0
251945|NCT01026818|609493|P3|COMPLETED|Screening Period||0
251946|NCT01026818|609494|P2|COMPLETED|Screening Period||0
251947|NCT01026818|609495|P1|COMPLETED|Screening Period||423
251948|NCT01026818|609492|P4|STARTED|Screening Period||0
251949|NCT01026818|609493|P3|STARTED|Screening Period||0
251950|NCT01026818|609494|P2|STARTED|Screening Period||0
251951|NCT01026818|609495|P1|STARTED|Screening Period||583
251952|NCT01026805|609573|P1|NOT COMPLETED|Overall Study||0
251953|NCT01026805|609573|P1|COMPLETED|Overall Study||11
251954|NCT01026805|609573|P1|STARTED|Overall Study||11
251955|NCT01026792|609583|P1|NOT COMPLETED|Overall Study||1
251956|NCT01026792|609583|P1|COMPLETED|Overall Study||37
251957|NCT01026792|609583|P1|STARTED|Overall Study||38
251958|NCT01026623|609590|P3|NOT COMPLETED|Overall Study||0
251959|NCT01026623|609591|P2|NOT COMPLETED|Overall Study||0
251960|NCT01026623|609592|P1|NOT COMPLETED|Overall Study||0
251961|NCT01026623|609590|P3|COMPLETED|Overall Study||5
251962|NCT01026623|609591|P2|COMPLETED|Overall Study||5
251963|NCT01026623|609592|P1|COMPLETED|Overall Study||6
251964|NCT01026623|609590|P3|STARTED|Overall Study||5
251965|NCT01026623|609591|P2|STARTED|Overall Study||5
251966|NCT01026623|609592|P1|STARTED|Overall Study||6
251967|NCT01026493|609626|P8|NOT COMPLETED|Overall Study||1
251968|NCT01026493|609627|P7|NOT COMPLETED|Overall Study||4
251969|NCT01026493|609628|P6|NOT COMPLETED|Overall Study||3
251970|NCT01026493|609629|P5|NOT COMPLETED|Overall Study||2
251971|NCT01026493|609630|P4|NOT COMPLETED|Overall Study||0
251972|NCT01026493|609631|P3|NOT COMPLETED|Overall Study||0
251973|NCT01026493|609632|P2|NOT COMPLETED|Overall Study||1
251974|NCT01026493|609633|P1|NOT COMPLETED|Overall Study||0
251975|NCT01026493|609626|P8|COMPLETED|Overall Study||37
251976|NCT01026493|609627|P7|COMPLETED|Overall Study||32
251977|NCT01026493|609628|P6|COMPLETED|Overall Study||73
251978|NCT01026493|609629|P5|COMPLETED|Overall Study||73
251979|NCT01026493|609630|P4|COMPLETED|Overall Study||8
251980|NCT01026493|609631|P3|COMPLETED|Overall Study||9
251981|NCT01026493|609632|P2|COMPLETED|Overall Study||6
251982|NCT01026493|609633|P1|COMPLETED|Overall Study||8
251983|NCT01026493|609626|P8|STARTED|Overall Study||38
251984|NCT01026493|609627|P7|STARTED|Overall Study||36
251985|NCT01026493|609628|P6|STARTED|Overall Study||76
251986|NCT01026493|609629|P5|STARTED|Overall Study||75
251987|NCT01026493|609630|P4|STARTED|Overall Study||8
251988|NCT01026493|609631|P3|STARTED|Overall Study||9
251989|NCT01026493|609632|P2|STARTED|Overall Study||7
251990|NCT01026493|609633|P1|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|8
251991|NCT01026454|609661|P2|NOT COMPLETED|Second Intervention||1
251992|NCT01026454|609662|P1|NOT COMPLETED|Second Intervention||1
251993|NCT01026454|609661|P2|COMPLETED|Second Intervention||13
251994|NCT01026454|609662|P1|COMPLETED|Second Intervention||16
251995|NCT01026454|609661|P2|STARTED|Second Intervention||14
251996|NCT01026454|609662|P1|STARTED|Second Intervention||17
251997|NCT01026454|609661|P2|NOT COMPLETED|Washout||0
251998|NCT01026454|609662|P1|NOT COMPLETED|Washout||0
251999|NCT01026454|609661|P2|COMPLETED|Washout||14
252000|NCT01026454|609662|P1|COMPLETED|Washout||18
252001|NCT01026454|609661|P2|STARTED|Washout||14
252002|NCT01026454|609662|P1|STARTED|Washout||18
252003|NCT01026454|609661|P2|NOT COMPLETED|First Intervention||0
252004|NCT01026454|609662|P1|NOT COMPLETED|First Intervention||0
252005|NCT01026454|609661|P2|COMPLETED|First Intervention||14
252006|NCT01026454|609662|P1|COMPLETED|First Intervention||18
252007|NCT01026454|609661|P2|STARTED|First Intervention||14
252008|NCT01026454|609662|P1|STARTED|First Intervention||18
252009|NCT01026402|609685|P17|NOT COMPLETED|Overall Study||0
252010|NCT01026402|609686|P16|NOT COMPLETED|Overall Study||0
252011|NCT01026402|609687|P15|NOT COMPLETED|Overall Study||0
252012|NCT01026402|609688|P14|NOT COMPLETED|Overall Study||0
252013|NCT01026402|609689|P13|NOT COMPLETED|Overall Study||0
252014|NCT01026402|609690|P12|NOT COMPLETED|Overall Study||0
252015|NCT01026402|609691|P11|NOT COMPLETED|Overall Study||0
252016|NCT01026402|609692|P10|NOT COMPLETED|Overall Study||0
252017|NCT01026402|609693|P9|NOT COMPLETED|Overall Study||0
252018|NCT01026402|609694|P8|NOT COMPLETED|Overall Study||0
252019|NCT01026402|609695|P7|NOT COMPLETED|Overall Study||0
252020|NCT01026402|609696|P6|NOT COMPLETED|Overall Study||0
252021|NCT01026402|609697|P5|NOT COMPLETED|Overall Study||0
252022|NCT01026402|609698|P4|NOT COMPLETED|Overall Study||0
252023|NCT01026402|609699|P3|NOT COMPLETED|Overall Study||0
252024|NCT01026402|609700|P2|NOT COMPLETED|Overall Study||0
252025|NCT01026402|609701|P1|NOT COMPLETED|Overall Study||0
252026|NCT01026402|609685|P17|COMPLETED|Overall Study||4
252027|NCT01026402|609686|P16|COMPLETED|Overall Study||5
252028|NCT01026402|609687|P15|COMPLETED|Overall Study||3
252029|NCT01026402|609688|P14|COMPLETED|Overall Study||6
252030|NCT01026402|609689|P13|COMPLETED|Overall Study||8
252031|NCT01026402|609690|P12|COMPLETED|Overall Study||8
252032|NCT01026402|609691|P11|COMPLETED|Overall Study||7
252033|NCT01026402|609692|P10|COMPLETED|Overall Study||3
252034|NCT01026402|609693|P9|COMPLETED|Overall Study||7
252035|NCT01026402|609694|P8|COMPLETED|Overall Study||3
252036|NCT01026402|609695|P7|COMPLETED|Overall Study||8
252037|NCT01026402|609696|P6|COMPLETED|Overall Study||5
252038|NCT01026402|609697|P5|COMPLETED|Overall Study||3
252039|NCT01026402|609698|P4|COMPLETED|Overall Study||18
252040|NCT01026402|609699|P3|COMPLETED|Overall Study||33
252041|NCT01026402|609700|P2|COMPLETED|Overall Study||8
252042|NCT01026402|609701|P1|COMPLETED|Overall Study||6
252043|NCT01026402|609685|P17|STARTED|Overall Study||4
252044|NCT01026402|609686|P16|STARTED|Overall Study||5
252045|NCT01026402|609687|P15|STARTED|Overall Study||3
252046|NCT01026402|609688|P14|STARTED|Overall Study||6
252047|NCT01026402|609689|P13|STARTED|Overall Study||8
252048|NCT01026402|609690|P12|STARTED|Overall Study||8
252049|NCT01026402|609691|P11|STARTED|Overall Study||7
252050|NCT01026402|609692|P10|STARTED|Overall Study||3
252051|NCT01026402|609693|P9|STARTED|Overall Study||7
252052|NCT01026402|609694|P8|STARTED|Overall Study||3
252053|NCT01026402|609695|P7|STARTED|Overall Study||8
252054|NCT01026402|609696|P6|STARTED|Overall Study||5
252055|NCT01026402|609697|P5|STARTED|Overall Study||3
252056|NCT01026402|609698|P4|STARTED|Overall Study||18
252057|NCT01026402|609699|P3|STARTED|Overall Study||33
252058|NCT01026402|609700|P2|STARTED|Overall Study||8
252059|NCT01026402|609701|P1|STARTED|Overall Study||6
252060|NCT01026389|610011|P2|NOT COMPLETED|Overall Study||5
252061|NCT01026389|610012|P1|NOT COMPLETED|Overall Study||5
252062|NCT01026389|610011|P2|COMPLETED|Overall Study||88
252063|NCT01026389|610012|P1|COMPLETED|Overall Study||88
252064|NCT01026389|610011|P2|STARTED|Overall Study||93
252065|NCT01026389|610012|P1|STARTED|Overall Study||93
252066|NCT01026324|610027|P3|NOT COMPLETED|Follow up/Survival||0
252067|NCT01026324|610028|P2|NOT COMPLETED|Follow up/Survival||0
252068|NCT01026324|610029|P1|NOT COMPLETED|Follow up/Survival||1
252069|NCT01026324|610027|P3|COMPLETED|Follow up/Survival||4
252070|NCT01026324|610028|P2|COMPLETED|Follow up/Survival||3
252071|NCT01026324|610029|P1|COMPLETED|Follow up/Survival||4
252072|NCT01026324|610027|P3|Follow up Discontinuation (Death)|Follow up/Survival||4
252073|NCT01026324|610028|P2|Follow up Discontinuation (Death)|Follow up/Survival||3
252074|NCT01026324|610029|P1|Follow up Discontinuation (Death)|Follow up/Survival||4
252075|NCT01026324|610027|P3|STARTED|Follow up/Survival||4
252076|NCT01026324|610028|P2|STARTED|Follow up/Survival||3
252077|NCT01026324|610029|P1|STARTED|Follow up/Survival||5
252078|NCT01026324|610027|P3|NOT COMPLETED|Treatment Allocation||0
252079|NCT01026324|610028|P2|NOT COMPLETED|Treatment Allocation||0
252080|NCT01026324|610029|P1|NOT COMPLETED|Treatment Allocation||0
252081|NCT01026324|610027|P3|COMPLETED|Treatment Allocation||4
252082|NCT01026324|610028|P2|COMPLETED|Treatment Allocation||3
252083|NCT01026324|610029|P1|COMPLETED|Treatment Allocation||5
252084|NCT01026324|610027|P3|Discontinued Intervention (Withdrew)|Treatment Allocation||0
252085|NCT01026324|610028|P2|Discontinued Intervention (Withdrew)|Treatment Allocation||0
252086|NCT01026324|610029|P1|Discontinued Intervention (Withdrew)|Treatment Allocation||1
252087|NCT01026324|610027|P3|Discontinuted Intervention (Progression)|Treatment Allocation||4
252088|NCT01026324|610028|P2|Discontinuted Intervention (Progression)|Treatment Allocation||3
252089|NCT01026324|610029|P1|Discontinuted Intervention (Progression)|Treatment Allocation||3
252090|NCT01026324|610027|P3|Discontinued Intervention (Toxicity)|Treatment Allocation||0
252091|NCT01026324|610028|P2|Discontinued Intervention (Toxicity)|Treatment Allocation||0
252092|NCT01026324|610029|P1|Discontinued Intervention (Toxicity)|Treatment Allocation||1
252093|NCT01026324|610027|P3|STARTED|Treatment Allocation||4
252094|NCT01026324|610028|P2|STARTED|Treatment Allocation||3
252095|NCT01026324|610029|P1|STARTED|Treatment Allocation||5
252096|NCT01026220|610039|P3|NOT COMPLETED|Consolidation Maintenance||14
252097|NCT01026220|610040|P2|NOT COMPLETED|Consolidation Maintenance||6
252098|NCT01026220|610041|P1|NOT COMPLETED|Consolidation Maintenance||0
252099|NCT01026220|610039|P3|COMPLETED|Consolidation Maintenance||66
252100|NCT01026220|610040|P2|COMPLETED|Consolidation Maintenance||75
252101|NCT01026220|610041|P1|COMPLETED|Consolidation Maintenance||0
252102|NCT01026220|610039|P3|STARTED|Consolidation Maintenance||80
252103|NCT01026220|610040|P2|STARTED|Consolidation Maintenance||81
252104|NCT01026220|610041|P1|STARTED|Consolidation Maintenance||0
252105|NCT01026220|610039|P3|NOT COMPLETED|Induction||0
252106|NCT01026220|610040|P2|NOT COMPLETED|Induction||0
252107|NCT01026220|610041|P1|NOT COMPLETED|Induction||25
252108|NCT01026220|610039|P3|COMPLETED|Induction||0
252109|NCT01026220|610040|P2|COMPLETED|Induction||0
252110|NCT01026220|610041|P1|COMPLETED|Induction||141
252111|NCT01026220|610039|P3|STARTED|Induction||0
252112|NCT01026220|610040|P2|STARTED|Induction||0
252113|NCT01026220|610041|P1|STARTED|Induction||166
252114|NCT01026194|610065|P2|NOT COMPLETED|Period 2：Open-label Period||10
252115|NCT01026194|610066|P1|NOT COMPLETED|Period 2：Open-label Period||7
252116|NCT01026194|610065|P2|COMPLETED|Period 2：Open-label Period||88
252117|NCT01026194|610066|P1|COMPLETED|Period 2：Open-label Period||91
252118|NCT01026194|610065|P2|STARTED|Period 2：Open-label Period||98
252119|NCT01026194|610066|P1|STARTED|Period 2：Open-label Period||98
252120|NCT01026194|610065|P2|NOT COMPLETED|Period 1：Double Blind Period||5
252121|NCT01026194|610066|P1|NOT COMPLETED|Period 1：Double Blind Period||3
252122|NCT01026194|610065|P2|COMPLETED|Period 1：Double Blind Period||98
252123|NCT01026194|610066|P1|COMPLETED|Period 1：Double Blind Period||98
252124|NCT01026194|610065|P2|STARTED|Period 1：Double Blind Period||103
252125|NCT01026194|610066|P1|STARTED|Period 1：Double Blind Period||101
252126|NCT01026181|610083|P3|NOT COMPLETED|Overall Study||0
252127|NCT01026181|610084|P2|NOT COMPLETED|Overall Study||0
252128|NCT01026181|610085|P1|NOT COMPLETED|Overall Study||0
252129|NCT01026181|610083|P3|COMPLETED|Overall Study||48
252130|NCT01026181|610084|P2|COMPLETED|Overall Study||51
252131|NCT01026181|610085|P1|COMPLETED|Overall Study||51
252132|NCT01026181|610083|P3|STARTED|Overall Study||48
252133|NCT01026181|610084|P2|STARTED|Overall Study||51
252134|NCT01026181|610085|P1|STARTED|Overall Study||51
252135|NCT01026142|610098|P2|NOT COMPLETED|Overall Study||163
252136|NCT01026142|610099|P1|NOT COMPLETED|Overall Study||172
252137|NCT01026142|610098|P2|COMPLETED|Overall Study||65
252138|NCT01026142|610099|P1|COMPLETED|Overall Study||52
252139|NCT01026142|610098|P2|STARTED|Overall Study||228
252140|NCT01026142|610099|P1|STARTED|Overall Study||224
252141|NCT01026103|610121|P1|NOT COMPLETED|Overall Study||2
252142|NCT01026103|610121|P1|COMPLETED|Overall Study||28
252143|NCT01026103|610121|P1|Consented|Overall Study||30
252144|NCT01026103|610121|P1|STARTED|Overall Study||30
252145|NCT01026038|610131|P3|NOT COMPLETED|Overall Study||0
252146|NCT01026038|610132|P2|NOT COMPLETED|Overall Study||1
252147|NCT01026038|610133|P1|NOT COMPLETED|Overall Study||1
252148|NCT01026038|610131|P3|COMPLETED|Overall Study||67
252149|NCT01026038|610132|P2|COMPLETED|Overall Study||64
252150|NCT01026038|610133|P1|COMPLETED|Overall Study||129
252151|NCT01026038|610131|P3|STARTED|Overall Study||67
252152|NCT01026038|610132|P2|STARTED|Overall Study||65
252153|NCT01026038|610133|P1|STARTED|Overall Study||130
252154|NCT01026012|610168|P1|NOT COMPLETED|Overall Study||0
252155|NCT01026012|610168|P1|COMPLETED|Overall Study||40
252156|NCT01026012|610168|P1|STARTED|Overall Study||40
252157|NCT01025843|610182|P10|NOT COMPLETED|Period 5||0
252158|NCT01025843|610183|P9|NOT COMPLETED|Period 5||0
252159|NCT01025843|610184|P8|NOT COMPLETED|Period 5||0
252160|NCT01025843|610185|P7|NOT COMPLETED|Period 5||0
252161|NCT01025843|610186|P6|NOT COMPLETED|Period 5||0
252162|NCT01025843|610187|P5|NOT COMPLETED|Period 5||0
252163|NCT01025843|610188|P4|NOT COMPLETED|Period 5||0
252164|NCT01025843|610189|P3|NOT COMPLETED|Period 5||0
252165|NCT01025843|610190|P2|NOT COMPLETED|Period 5||0
252166|NCT01025843|610191|P1|NOT COMPLETED|Period 5||0
252167|NCT01025843|610182|P10|COMPLETED|Period 5||2
252168|NCT01025843|610183|P9|COMPLETED|Period 5||2
252169|NCT01025843|610184|P8|COMPLETED|Period 5||2
252170|NCT01025843|610185|P7|COMPLETED|Period 5||2
252171|NCT01025843|610186|P6|COMPLETED|Period 5||2
252172|NCT01025843|610187|P5|COMPLETED|Period 5||2
252173|NCT01025843|610188|P4|COMPLETED|Period 5||1
252174|NCT01025843|610189|P3|COMPLETED|Period 5||1
252175|NCT01025843|610190|P2|COMPLETED|Period 5||2
252176|NCT01025843|610191|P1|COMPLETED|Period 5||2
252177|NCT01025843|610182|P10|STARTED|Period 5||2
252178|NCT01025843|610183|P9|STARTED|Period 5||2
252179|NCT01025843|610184|P8|STARTED|Period 5||2
252180|NCT01025843|610185|P7|STARTED|Period 5||2
252181|NCT01025843|610186|P6|STARTED|Period 5||2
252182|NCT01025843|610187|P5|STARTED|Period 5||2
252183|NCT01025843|610188|P4|STARTED|Period 5||1
252184|NCT01025843|610189|P3|STARTED|Period 5||1
252185|NCT01025843|610190|P2|STARTED|Period 5||2
252186|NCT01025843|610191|P1|STARTED|Period 5||2
252187|NCT01025843|610182|P10|NOT COMPLETED|Washout 4||0
252188|NCT01025843|610183|P9|NOT COMPLETED|Washout 4||0
252189|NCT01025843|610184|P8|NOT COMPLETED|Washout 4||0
252190|NCT01025843|610185|P7|NOT COMPLETED|Washout 4||0
252191|NCT01025843|610186|P6|NOT COMPLETED|Washout 4||0
252192|NCT01025843|610187|P5|NOT COMPLETED|Washout 4||0
252193|NCT01025843|610188|P4|NOT COMPLETED|Washout 4||1
252194|NCT01025843|610189|P3|NOT COMPLETED|Washout 4||1
252195|NCT01025843|610190|P2|NOT COMPLETED|Washout 4||0
252196|NCT01025843|610191|P1|NOT COMPLETED|Washout 4||0
252197|NCT01025843|610182|P10|COMPLETED|Washout 4||2
252198|NCT01025843|610183|P9|COMPLETED|Washout 4||2
252199|NCT01025843|610184|P8|COMPLETED|Washout 4||2
252200|NCT01025843|610185|P7|COMPLETED|Washout 4||2
252201|NCT01025843|610186|P6|COMPLETED|Washout 4||2
252202|NCT01025843|610187|P5|COMPLETED|Washout 4||2
252203|NCT01025843|610188|P4|COMPLETED|Washout 4||1
252204|NCT01025843|610189|P3|COMPLETED|Washout 4||1
252205|NCT01025843|610190|P2|COMPLETED|Washout 4||2
252206|NCT01025843|610191|P1|COMPLETED|Washout 4||2
252207|NCT01025843|610182|P10|STARTED|Washout 4||2
252208|NCT01025843|610183|P9|STARTED|Washout 4||2
252209|NCT01025843|610184|P8|STARTED|Washout 4||2
252210|NCT01025843|610185|P7|STARTED|Washout 4||2
252211|NCT01025843|610186|P6|STARTED|Washout 4||2
252212|NCT01025843|610187|P5|STARTED|Washout 4||2
252213|NCT01025843|610188|P4|STARTED|Washout 4||2
252214|NCT01025843|610189|P3|STARTED|Washout 4||2
252215|NCT01025843|610190|P2|STARTED|Washout 4||2
252216|NCT01025843|610191|P1|STARTED|Washout 4||2
252217|NCT01025843|610182|P10|NOT COMPLETED|Period 4||0
252218|NCT01025843|610183|P9|NOT COMPLETED|Period 4||0
252219|NCT01025843|610184|P8|NOT COMPLETED|Period 4||0
252220|NCT01025843|610185|P7|NOT COMPLETED|Period 4||0
252221|NCT01025843|610186|P6|NOT COMPLETED|Period 4||0
252222|NCT01025843|610187|P5|NOT COMPLETED|Period 4||0
252223|NCT01025843|610188|P4|NOT COMPLETED|Period 4||0
252224|NCT01025843|610189|P3|NOT COMPLETED|Period 4||0
252225|NCT01025843|610190|P2|NOT COMPLETED|Period 4||0
252226|NCT01025843|610191|P1|NOT COMPLETED|Period 4||0
252227|NCT01025843|610182|P10|COMPLETED|Period 4||2
252228|NCT01025843|610183|P9|COMPLETED|Period 4||2
252229|NCT01025843|610184|P8|COMPLETED|Period 4||2
252230|NCT01025843|610185|P7|COMPLETED|Period 4||2
252231|NCT01025843|610186|P6|COMPLETED|Period 4||2
252232|NCT01025843|610187|P5|COMPLETED|Period 4||2
252233|NCT01025843|610188|P4|COMPLETED|Period 4||2
252234|NCT01025843|610189|P3|COMPLETED|Period 4||2
252235|NCT01025843|610190|P2|COMPLETED|Period 4||2
252236|NCT01025843|610191|P1|COMPLETED|Period 4||2
252237|NCT01025843|610182|P10|STARTED|Period 4||2
252238|NCT01025843|610183|P9|STARTED|Period 4||2
252239|NCT01025843|610184|P8|STARTED|Period 4||2
252240|NCT01025843|610185|P7|STARTED|Period 4||2
252241|NCT01025843|610186|P6|STARTED|Period 4||2
252242|NCT01025843|610187|P5|STARTED|Period 4||2
252243|NCT01025843|610188|P4|STARTED|Period 4||2
252244|NCT01025843|610189|P3|STARTED|Period 4||2
252245|NCT01025843|610190|P2|STARTED|Period 4||2
252246|NCT01025843|610191|P1|STARTED|Period 4||2
252247|NCT01025843|610182|P10|NOT COMPLETED|Washout 3||0
252248|NCT01025843|610183|P9|NOT COMPLETED|Washout 3||0
252249|NCT01025843|610184|P8|NOT COMPLETED|Washout 3||0
252250|NCT01025843|610185|P7|NOT COMPLETED|Washout 3||0
252251|NCT01025843|610186|P6|NOT COMPLETED|Washout 3||0
252252|NCT01025843|610187|P5|NOT COMPLETED|Washout 3||0
252253|NCT01025843|610188|P4|NOT COMPLETED|Washout 3||0
252254|NCT01025843|610189|P3|NOT COMPLETED|Washout 3||0
252255|NCT01025843|610190|P2|NOT COMPLETED|Washout 3||0
252256|NCT01025843|610191|P1|NOT COMPLETED|Washout 3||0
252257|NCT01025843|610182|P10|COMPLETED|Washout 3||2
252258|NCT01025843|610183|P9|COMPLETED|Washout 3||2
252259|NCT01025843|610184|P8|COMPLETED|Washout 3||2
252260|NCT01025843|610185|P7|COMPLETED|Washout 3||2
252261|NCT01025843|610186|P6|COMPLETED|Washout 3||2
252262|NCT01025843|610187|P5|COMPLETED|Washout 3||2
252263|NCT01025843|610188|P4|COMPLETED|Washout 3||2
252264|NCT01025843|610189|P3|COMPLETED|Washout 3||2
252265|NCT01025843|610190|P2|COMPLETED|Washout 3||2
252266|NCT01025843|610191|P1|COMPLETED|Washout 3||2
252267|NCT01025843|610182|P10|STARTED|Washout 3||2
252268|NCT01025843|610183|P9|STARTED|Washout 3||2
252269|NCT01025843|610184|P8|STARTED|Washout 3||2
252270|NCT01025843|610185|P7|STARTED|Washout 3||2
252271|NCT01025843|610186|P6|STARTED|Washout 3||2
252272|NCT01025843|610187|P5|STARTED|Washout 3||2
252273|NCT01025843|610188|P4|STARTED|Washout 3||2
252274|NCT01025843|610189|P3|STARTED|Washout 3||2
252275|NCT01025843|610190|P2|STARTED|Washout 3||2
252276|NCT01025843|610191|P1|STARTED|Washout 3||2
252277|NCT01025843|610182|P10|NOT COMPLETED|Period 3||0
252278|NCT01025843|610183|P9|NOT COMPLETED|Period 3||0
252279|NCT01025843|610184|P8|NOT COMPLETED|Period 3||0
252280|NCT01025843|610185|P7|NOT COMPLETED|Period 3||0
252281|NCT01025843|610186|P6|NOT COMPLETED|Period 3||0
252282|NCT01025843|610187|P5|NOT COMPLETED|Period 3||0
252283|NCT01025843|610188|P4|NOT COMPLETED|Period 3||0
252284|NCT01025843|610189|P3|NOT COMPLETED|Period 3||0
252285|NCT01025843|610190|P2|NOT COMPLETED|Period 3||0
252286|NCT01025843|610191|P1|NOT COMPLETED|Period 3||0
252287|NCT01025843|610182|P10|COMPLETED|Period 3||2
252288|NCT01025843|610183|P9|COMPLETED|Period 3||2
252289|NCT01025843|610184|P8|COMPLETED|Period 3||2
252290|NCT01025843|610185|P7|COMPLETED|Period 3||2
252291|NCT01025843|610186|P6|COMPLETED|Period 3||2
252292|NCT01025843|610187|P5|COMPLETED|Period 3||2
252293|NCT01025843|610188|P4|COMPLETED|Period 3||2
252294|NCT01025843|610189|P3|COMPLETED|Period 3||2
252295|NCT01025843|610190|P2|COMPLETED|Period 3||2
252296|NCT01025843|610191|P1|COMPLETED|Period 3||2
252297|NCT01025843|610182|P10|STARTED|Period 3||2
252298|NCT01025843|610183|P9|STARTED|Period 3||2
252299|NCT01025843|610184|P8|STARTED|Period 3||2
252300|NCT01025843|610185|P7|STARTED|Period 3||2
252301|NCT01025843|610186|P6|STARTED|Period 3||2
252302|NCT01025843|610187|P5|STARTED|Period 3||2
252303|NCT01025843|610188|P4|STARTED|Period 3||2
252304|NCT01025843|610189|P3|STARTED|Period 3||2
252305|NCT01025843|610190|P2|STARTED|Period 3||2
252306|NCT01025843|610191|P1|STARTED|Period 3||2
252307|NCT01025843|610182|P10|NOT COMPLETED|Washout 2||0
252308|NCT01025843|610183|P9|NOT COMPLETED|Washout 2||0
252309|NCT01025843|610184|P8|NOT COMPLETED|Washout 2||0
252310|NCT01025843|610185|P7|NOT COMPLETED|Washout 2||0
252311|NCT01025843|610186|P6|NOT COMPLETED|Washout 2||0
252312|NCT01025843|610187|P5|NOT COMPLETED|Washout 2||0
252313|NCT01025843|610188|P4|NOT COMPLETED|Washout 2||0
252314|NCT01025843|610189|P3|NOT COMPLETED|Washout 2||0
252315|NCT01025843|610190|P2|NOT COMPLETED|Washout 2||0
252316|NCT01025843|610191|P1|NOT COMPLETED|Washout 2||0
252317|NCT01025843|610182|P10|COMPLETED|Washout 2||2
252318|NCT01025843|610183|P9|COMPLETED|Washout 2||2
252319|NCT01025843|610184|P8|COMPLETED|Washout 2||2
252320|NCT01025843|610185|P7|COMPLETED|Washout 2||2
252321|NCT01025843|610186|P6|COMPLETED|Washout 2||2
252322|NCT01025843|610187|P5|COMPLETED|Washout 2||2
252323|NCT01025843|610188|P4|COMPLETED|Washout 2||2
252324|NCT01025843|610189|P3|COMPLETED|Washout 2||2
252325|NCT01025843|610190|P2|COMPLETED|Washout 2||2
252326|NCT01025843|610191|P1|COMPLETED|Washout 2||2
252327|NCT01025843|610182|P10|STARTED|Washout 2||2
252328|NCT01025843|610183|P9|STARTED|Washout 2||2
252329|NCT01025843|610184|P8|STARTED|Washout 2||2
252330|NCT01025843|610185|P7|STARTED|Washout 2||2
252331|NCT01025843|610186|P6|STARTED|Washout 2||2
252332|NCT01025843|610187|P5|STARTED|Washout 2||2
252333|NCT01025843|610188|P4|STARTED|Washout 2||2
252334|NCT01025843|610189|P3|STARTED|Washout 2||2
252335|NCT01025843|610190|P2|STARTED|Washout 2||2
252336|NCT01025843|610191|P1|STARTED|Washout 2||2
252337|NCT01025843|610182|P10|NOT COMPLETED|Period 2||0
252338|NCT01025843|610183|P9|NOT COMPLETED|Period 2||0
252339|NCT01025843|610184|P8|NOT COMPLETED|Period 2||0
252340|NCT01025843|610185|P7|NOT COMPLETED|Period 2||0
252341|NCT01025843|610186|P6|NOT COMPLETED|Period 2||0
252342|NCT01025843|610187|P5|NOT COMPLETED|Period 2||0
252343|NCT01025843|610188|P4|NOT COMPLETED|Period 2||0
252344|NCT01025843|610189|P3|NOT COMPLETED|Period 2||0
252345|NCT01025843|610190|P2|NOT COMPLETED|Period 2||0
252346|NCT01025843|610191|P1|NOT COMPLETED|Period 2||0
252347|NCT01025843|610182|P10|COMPLETED|Period 2||2
252348|NCT01025843|610183|P9|COMPLETED|Period 2||2
252349|NCT01025843|610184|P8|COMPLETED|Period 2||2
252350|NCT01025843|610185|P7|COMPLETED|Period 2||2
252351|NCT01025843|610186|P6|COMPLETED|Period 2||2
252352|NCT01025843|610187|P5|COMPLETED|Period 2||2
252353|NCT01025843|610188|P4|COMPLETED|Period 2||2
252354|NCT01025843|610189|P3|COMPLETED|Period 2||2
252355|NCT01025843|610190|P2|COMPLETED|Period 2||2
252356|NCT01025843|610191|P1|COMPLETED|Period 2||2
252357|NCT01025843|610182|P10|STARTED|Period 2||2
252358|NCT01025843|610183|P9|STARTED|Period 2||2
252359|NCT01025843|610184|P8|STARTED|Period 2||2
252360|NCT01025843|610185|P7|STARTED|Period 2||2
252361|NCT01025843|610186|P6|STARTED|Period 2||2
252362|NCT01025843|610187|P5|STARTED|Period 2||2
252363|NCT01025843|610188|P4|STARTED|Period 2||2
252364|NCT01025843|610189|P3|STARTED|Period 2||2
252365|NCT01025843|610190|P2|STARTED|Period 2||2
252366|NCT01025843|610191|P1|STARTED|Period 2||2
252367|NCT01025843|610182|P10|NOT COMPLETED|Washout 1||0
252368|NCT01025843|610183|P9|NOT COMPLETED|Washout 1||0
252369|NCT01025843|610184|P8|NOT COMPLETED|Washout 1||0
252370|NCT01025843|610185|P7|NOT COMPLETED|Washout 1||0
252371|NCT01025843|610186|P6|NOT COMPLETED|Washout 1||0
252372|NCT01025843|610187|P5|NOT COMPLETED|Washout 1||0
252373|NCT01025843|610188|P4|NOT COMPLETED|Washout 1||0
252374|NCT01025843|610189|P3|NOT COMPLETED|Washout 1||0
252375|NCT01025843|610190|P2|NOT COMPLETED|Washout 1||0
252376|NCT01025843|610191|P1|NOT COMPLETED|Washout 1||0
252377|NCT01025843|610182|P10|COMPLETED|Washout 1||2
252378|NCT01025843|610183|P9|COMPLETED|Washout 1||2
252379|NCT01025843|610184|P8|COMPLETED|Washout 1||2
252380|NCT01025843|610185|P7|COMPLETED|Washout 1||2
252381|NCT01025843|610186|P6|COMPLETED|Washout 1||2
252382|NCT01025843|610187|P5|COMPLETED|Washout 1||2
252383|NCT01025843|610188|P4|COMPLETED|Washout 1||2
252384|NCT01025843|610189|P3|COMPLETED|Washout 1||2
252385|NCT01025843|610190|P2|COMPLETED|Washout 1||2
252386|NCT01025843|610191|P1|COMPLETED|Washout 1||2
252387|NCT01025843|610182|P10|STARTED|Washout 1||2
252388|NCT01025843|610183|P9|STARTED|Washout 1||2
252389|NCT01025843|610184|P8|STARTED|Washout 1||2
252390|NCT01025843|610185|P7|STARTED|Washout 1||2
252391|NCT01025843|610186|P6|STARTED|Washout 1||2
252392|NCT01025843|610187|P5|STARTED|Washout 1||2
252393|NCT01025843|610188|P4|STARTED|Washout 1||2
252394|NCT01025843|610189|P3|STARTED|Washout 1||2
252395|NCT01025843|610190|P2|STARTED|Washout 1||2
252396|NCT01025843|610191|P1|STARTED|Washout 1||2
252397|NCT01025843|610182|P10|NOT COMPLETED|Period 1||0
252398|NCT01025843|610183|P9|NOT COMPLETED|Period 1||0
252399|NCT01025843|610184|P8|NOT COMPLETED|Period 1||0
252400|NCT01025843|610185|P7|NOT COMPLETED|Period 1||0
252401|NCT01025843|610186|P6|NOT COMPLETED|Period 1||0
252402|NCT01025843|610187|P5|NOT COMPLETED|Period 1||0
252403|NCT01025843|610188|P4|NOT COMPLETED|Period 1||0
252404|NCT01025843|610189|P3|NOT COMPLETED|Period 1||0
252405|NCT01025843|610190|P2|NOT COMPLETED|Period 1||0
252406|NCT01025843|610191|P1|NOT COMPLETED|Period 1||0
252407|NCT01025843|610182|P10|COMPLETED|Period 1||2
252408|NCT01025843|610183|P9|COMPLETED|Period 1||2
252409|NCT01025843|610184|P8|COMPLETED|Period 1||2
252410|NCT01025843|610185|P7|COMPLETED|Period 1||2
252411|NCT01025843|610186|P6|COMPLETED|Period 1||2
252412|NCT01025843|610187|P5|COMPLETED|Period 1||2
252413|NCT01025843|610188|P4|COMPLETED|Period 1||2
252414|NCT01025843|610189|P3|COMPLETED|Period 1||2
252415|NCT01025843|610190|P2|COMPLETED|Period 1||2
252416|NCT01025843|610191|P1|COMPLETED|Period 1||2
252417|NCT01025843|610182|P10|STARTED|Period 1||2
252418|NCT01025843|610183|P9|STARTED|Period 1||2
252419|NCT01025843|610184|P8|STARTED|Period 1||2
252420|NCT01025843|610185|P7|STARTED|Period 1||2
252421|NCT01025843|610186|P6|STARTED|Period 1||2
252422|NCT01025843|610187|P5|STARTED|Period 1||2
252423|NCT01025843|610188|P4|STARTED|Period 1||2
252424|NCT01025843|610189|P3|STARTED|Period 1||2
252425|NCT01025843|610190|P2|STARTED|Period 1||2
252426|NCT01025843|610191|P1|STARTED|Period 1||2
252427|NCT01025830|610265|P2|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
252428|NCT01025830|610266|P1|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
252429|NCT01025830|610265|P2|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
252430|NCT01025830|610266|P1|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
252431|NCT01025830|610265|P2|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
252432|NCT01025830|610266|P1|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
252433|NCT01025830|610265|P2|NOT COMPLETED|Washout Period of 30 Days||0
252434|NCT01025830|610266|P1|NOT COMPLETED|Washout Period of 30 Days||0
252435|NCT01025830|610265|P2|COMPLETED|Washout Period of 30 Days||12
252436|NCT01025830|610266|P1|COMPLETED|Washout Period of 30 Days||8
252437|NCT01025830|610265|P2|STARTED|Washout Period of 30 Days||12
252438|NCT01025830|610266|P1|STARTED|Washout Period of 30 Days||8
252439|NCT01025830|610265|P2|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
252440|NCT01025830|610266|P1|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
252441|NCT01025830|610265|P2|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
252442|NCT01025830|610266|P1|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
252443|NCT01025830|610265|P2|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
252444|NCT01025830|610266|P1|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
252445|NCT01025817|610285|P2|NOT COMPLETED|Completed Study||22
252446|NCT01025817|610286|P1|NOT COMPLETED|Completed Study||16
252447|NCT01025817|610285|P2|COMPLETED|Completed Study|Completed study phase|282
252448|NCT01025817|610286|P1|COMPLETED|Completed Study|Completed study phase|293
252449|NCT01025817|610285|P2|STARTED|Completed Study||304
252450|NCT01025817|610286|P1|STARTED|Completed Study||309
252451|NCT01025817|610285|P2|NOT COMPLETED|Completed Study Medication||72
252452|NCT01025817|610286|P1|NOT COMPLETED|Completed Study Medication||105
252453|NCT01025817|610285|P2|COMPLETED|Completed Study Medication||232
252454|NCT01025817|610286|P1|COMPLETED|Completed Study Medication||204
252455|NCT01025817|610285|P2|STARTED|Completed Study Medication||304
252456|NCT01025817|610286|P1|STARTED|Completed Study Medication||309
252457|NCT01025791|610307|P14|NOT COMPLETED|Period 5||0
252458|NCT01025791|610308|P13|NOT COMPLETED|Period 5||0
252459|NCT01025791|610309|P12|NOT COMPLETED|Period 5||0
252460|NCT01025791|610310|P11|NOT COMPLETED|Period 5||0
252461|NCT01025791|610311|P10|NOT COMPLETED|Period 5||0
252462|NCT01025791|610312|P9|NOT COMPLETED|Period 5||0
252463|NCT01025791|610313|P8|NOT COMPLETED|Period 5||0
252464|NCT01025791|610314|P7|NOT COMPLETED|Period 5||0
252465|NCT01025791|610315|P6|NOT COMPLETED|Period 5||0
252466|NCT01025791|610316|P5|NOT COMPLETED|Period 5||0
252467|NCT01025791|610317|P4|NOT COMPLETED|Period 5||0
252468|NCT01025791|610318|P3|NOT COMPLETED|Period 5||0
252469|NCT01025791|610319|P2|NOT COMPLETED|Period 5||0
252470|NCT01025791|610320|P1|NOT COMPLETED|Period 5||0
252471|NCT01025791|610307|P14|COMPLETED|Period 5||0
252472|NCT01025791|610308|P13|COMPLETED|Period 5||0
252473|NCT01025791|610309|P12|COMPLETED|Period 5||0
252474|NCT01025791|610310|P11|COMPLETED|Period 5||0
252475|NCT01025791|610311|P10|COMPLETED|Period 5||0
252476|NCT01025791|610312|P9|COMPLETED|Period 5||0
252477|NCT01025791|610313|P8|COMPLETED|Period 5||0
252478|NCT01025791|610314|P7|COMPLETED|Period 5||0
252479|NCT01025791|610315|P6|COMPLETED|Period 5||0
252480|NCT01025791|610316|P5|COMPLETED|Period 5||0
252481|NCT01025791|610317|P4|COMPLETED|Period 5||2
252482|NCT01025791|610318|P3|COMPLETED|Period 5||2
252483|NCT01025791|610319|P2|COMPLETED|Period 5||2
252484|NCT01025791|610320|P1|COMPLETED|Period 5||2
252485|NCT01025791|610307|P14|STARTED|Period 5||0
252486|NCT01025791|610308|P13|STARTED|Period 5||0
252487|NCT01025791|610309|P12|STARTED|Period 5||0
252488|NCT01025791|610310|P11|STARTED|Period 5||0
252489|NCT01025791|610311|P10|STARTED|Period 5||0
252490|NCT01025791|610312|P9|STARTED|Period 5||0
252491|NCT01025791|610313|P8|STARTED|Period 5||0
252492|NCT01025791|610314|P7|STARTED|Period 5||0
252493|NCT01025791|610315|P6|STARTED|Period 5||0
252494|NCT01025791|610316|P5|STARTED|Period 5||0
252495|NCT01025791|610317|P4|STARTED|Period 5||2
252496|NCT01025791|610318|P3|STARTED|Period 5||2
252497|NCT01025791|610319|P2|STARTED|Period 5||2
252498|NCT01025791|610320|P1|STARTED|Period 5||2
252499|NCT01025791|610307|P14|NOT COMPLETED|Period 4||0
252500|NCT01025791|610308|P13|NOT COMPLETED|Period 4||0
252501|NCT01025791|610309|P12|NOT COMPLETED|Period 4||0
252502|NCT01025791|610310|P11|NOT COMPLETED|Period 4||0
252503|NCT01025791|610311|P10|NOT COMPLETED|Period 4||0
252504|NCT01025791|610312|P9|NOT COMPLETED|Period 4||0
252505|NCT01025791|610313|P8|NOT COMPLETED|Period 4||0
252506|NCT01025791|610314|P7|NOT COMPLETED|Period 4||0
252507|NCT01025791|610315|P6|NOT COMPLETED|Period 4||0
252508|NCT01025791|610316|P5|NOT COMPLETED|Period 4||0
252509|NCT01025791|610317|P4|NOT COMPLETED|Period 4||0
252510|NCT01025791|610318|P3|NOT COMPLETED|Period 4||0
252511|NCT01025791|610319|P2|NOT COMPLETED|Period 4||0
252512|NCT01025791|610320|P1|NOT COMPLETED|Period 4||0
252513|NCT01025791|610307|P14|COMPLETED|Period 4||1
252514|NCT01025791|610308|P13|COMPLETED|Period 4||2
252515|NCT01025791|610309|P12|COMPLETED|Period 4||1
252516|NCT01025791|610310|P11|COMPLETED|Period 4||2
252517|NCT01025791|610311|P10|COMPLETED|Period 4||1
252518|NCT01025791|610312|P9|COMPLETED|Period 4||2
252519|NCT01025791|610313|P8|COMPLETED|Period 4||2
252520|NCT01025791|610314|P7|COMPLETED|Period 4||2
252521|NCT01025791|610315|P6|COMPLETED|Period 4||2
252522|NCT01025791|610316|P5|COMPLETED|Period 4||2
252523|NCT01025791|610317|P4|COMPLETED|Period 4||2
252524|NCT01025791|610318|P3|COMPLETED|Period 4||2
252525|NCT01025791|610319|P2|COMPLETED|Period 4||2
252526|NCT01025791|610320|P1|COMPLETED|Period 4||2
252527|NCT01025791|610307|P14|STARTED|Period 4||1
252528|NCT01025791|610308|P13|STARTED|Period 4||2
252529|NCT01025791|610309|P12|STARTED|Period 4||1
252530|NCT01025791|610310|P11|STARTED|Period 4||2
252531|NCT01025791|610311|P10|STARTED|Period 4||1
252532|NCT01025791|610312|P9|STARTED|Period 4||2
252533|NCT01025791|610313|P8|STARTED|Period 4||2
252534|NCT01025791|610314|P7|STARTED|Period 4||2
252535|NCT01025791|610315|P6|STARTED|Period 4||2
252536|NCT01025791|610316|P5|STARTED|Period 4||2
252537|NCT01025791|610317|P4|STARTED|Period 4||2
252538|NCT01025791|610318|P3|STARTED|Period 4||2
252539|NCT01025791|610319|P2|STARTED|Period 4||2
252540|NCT01025791|610320|P1|STARTED|Period 4||2
252541|NCT01025791|610307|P14|NOT COMPLETED|Period 3||0
252542|NCT01025791|610308|P13|NOT COMPLETED|Period 3||0
252543|NCT01025791|610309|P12|NOT COMPLETED|Period 3||0
252544|NCT01025791|610310|P11|NOT COMPLETED|Period 3||0
252545|NCT01025791|610311|P10|NOT COMPLETED|Period 3||0
252546|NCT01025791|610312|P9|NOT COMPLETED|Period 3||0
252547|NCT01025791|610313|P8|NOT COMPLETED|Period 3||0
252548|NCT01025791|610314|P7|NOT COMPLETED|Period 3||0
252549|NCT01025791|610315|P6|NOT COMPLETED|Period 3||0
252550|NCT01025791|610316|P5|NOT COMPLETED|Period 3||0
252551|NCT01025791|610317|P4|NOT COMPLETED|Period 3||0
252552|NCT01025791|610318|P3|NOT COMPLETED|Period 3||0
252553|NCT01025791|610319|P2|NOT COMPLETED|Period 3||0
252554|NCT01025791|610320|P1|NOT COMPLETED|Period 3||0
252555|NCT01025791|610307|P14|COMPLETED|Period 3||1
252556|NCT01025791|610308|P13|COMPLETED|Period 3||2
252557|NCT01025791|610309|P12|COMPLETED|Period 3||1
252558|NCT01025791|610310|P11|COMPLETED|Period 3||2
252559|NCT01025791|610311|P10|COMPLETED|Period 3||1
252560|NCT01025791|610312|P9|COMPLETED|Period 3||2
252561|NCT01025791|610313|P8|COMPLETED|Period 3||2
252562|NCT01025791|610314|P7|COMPLETED|Period 3||2
252563|NCT01025791|610315|P6|COMPLETED|Period 3||2
252564|NCT01025791|610316|P5|COMPLETED|Period 3||2
252565|NCT01025791|610317|P4|COMPLETED|Period 3||2
252566|NCT01025791|610318|P3|COMPLETED|Period 3||2
252567|NCT01025791|610319|P2|COMPLETED|Period 3||2
252568|NCT01025791|610320|P1|COMPLETED|Period 3||2
252569|NCT01025791|610307|P14|STARTED|Period 3||1
252570|NCT01025791|610308|P13|STARTED|Period 3||2
252571|NCT01025791|610309|P12|STARTED|Period 3||1
252572|NCT01025791|610310|P11|STARTED|Period 3||2
252573|NCT01025791|610311|P10|STARTED|Period 3||1
252574|NCT01025791|610312|P9|STARTED|Period 3||2
252575|NCT01025791|610313|P8|STARTED|Period 3||2
252576|NCT01025791|610314|P7|STARTED|Period 3||2
252577|NCT01025791|610315|P6|STARTED|Period 3||2
252578|NCT01025791|610316|P5|STARTED|Period 3||2
252579|NCT01025791|610317|P4|STARTED|Period 3||2
252580|NCT01025791|610318|P3|STARTED|Period 3||2
252581|NCT01025791|610319|P2|STARTED|Period 3||2
252582|NCT01025791|610320|P1|STARTED|Period 3||2
252583|NCT01025791|610307|P14|NOT COMPLETED|Period 2||0
252584|NCT01025791|610308|P13|NOT COMPLETED|Period 2||0
252585|NCT01025791|610309|P12|NOT COMPLETED|Period 2||0
252586|NCT01025791|610310|P11|NOT COMPLETED|Period 2||0
252587|NCT01025791|610311|P10|NOT COMPLETED|Period 2||0
252588|NCT01025791|610312|P9|NOT COMPLETED|Period 2||0
252589|NCT01025791|610313|P8|NOT COMPLETED|Period 2||0
252590|NCT01025791|610314|P7|NOT COMPLETED|Period 2||0
252591|NCT01025791|610315|P6|NOT COMPLETED|Period 2||0
252592|NCT01025791|610316|P5|NOT COMPLETED|Period 2||0
252593|NCT01025791|610317|P4|NOT COMPLETED|Period 2||0
252594|NCT01025791|610318|P3|NOT COMPLETED|Period 2||0
252595|NCT01025791|610319|P2|NOT COMPLETED|Period 2||0
252596|NCT01025791|610320|P1|NOT COMPLETED|Period 2||0
252597|NCT01025791|610307|P14|COMPLETED|Period 2||1
252598|NCT01025791|610308|P13|COMPLETED|Period 2||2
252599|NCT01025791|610309|P12|COMPLETED|Period 2||1
252600|NCT01025791|610310|P11|COMPLETED|Period 2||2
252601|NCT01025791|610311|P10|COMPLETED|Period 2||1
252602|NCT01025791|610312|P9|COMPLETED|Period 2||2
252603|NCT01025791|610313|P8|COMPLETED|Period 2||2
252604|NCT01025791|610314|P7|COMPLETED|Period 2||2
252605|NCT01025791|610315|P6|COMPLETED|Period 2||2
252606|NCT01025791|610316|P5|COMPLETED|Period 2||2
252607|NCT01025791|610317|P4|COMPLETED|Period 2||2
252608|NCT01025791|610318|P3|COMPLETED|Period 2||2
252609|NCT01025791|610319|P2|COMPLETED|Period 2||2
252610|NCT01025791|610320|P1|COMPLETED|Period 2||2
252611|NCT01025791|610307|P14|STARTED|Period 2||1
252612|NCT01025791|610308|P13|STARTED|Period 2||2
252613|NCT01025791|610309|P12|STARTED|Period 2||1
252614|NCT01025791|610310|P11|STARTED|Period 2||2
252615|NCT01025791|610311|P10|STARTED|Period 2||1
252616|NCT01025791|610312|P9|STARTED|Period 2||2
252617|NCT01025791|610313|P8|STARTED|Period 2||2
252618|NCT01025791|610314|P7|STARTED|Period 2||2
252619|NCT01025791|610315|P6|STARTED|Period 2||2
252620|NCT01025791|610316|P5|STARTED|Period 2||2
252621|NCT01025791|610317|P4|STARTED|Period 2||2
252622|NCT01025791|610318|P3|STARTED|Period 2||2
252623|NCT01025791|610319|P2|STARTED|Period 2||2
252624|NCT01025791|610320|P1|STARTED|Period 2||2
252625|NCT01025791|610307|P14|NOT COMPLETED|Period 1||0
252626|NCT01025791|610308|P13|NOT COMPLETED|Period 1||0
252627|NCT01025791|610309|P12|NOT COMPLETED|Period 1||0
252628|NCT01025791|610310|P11|NOT COMPLETED|Period 1||0
252629|NCT01025791|610311|P10|NOT COMPLETED|Period 1||0
252630|NCT01025791|610312|P9|NOT COMPLETED|Period 1||0
252631|NCT01025791|610313|P8|NOT COMPLETED|Period 1||0
252632|NCT01025791|610314|P7|NOT COMPLETED|Period 1||0
252633|NCT01025791|610315|P6|NOT COMPLETED|Period 1||0
252634|NCT01025791|610316|P5|NOT COMPLETED|Period 1||0
252635|NCT01025791|610317|P4|NOT COMPLETED|Period 1||0
252636|NCT01025791|610318|P3|NOT COMPLETED|Period 1||0
252637|NCT01025791|610319|P2|NOT COMPLETED|Period 1||0
252638|NCT01025791|610320|P1|NOT COMPLETED|Period 1||0
252639|NCT01025791|610307|P14|COMPLETED|Period 1||1
252640|NCT01025791|610308|P13|COMPLETED|Period 1||2
252641|NCT01025791|610309|P12|COMPLETED|Period 1||1
252642|NCT01025791|610310|P11|COMPLETED|Period 1||2
252643|NCT01025791|610311|P10|COMPLETED|Period 1||1
252644|NCT01025791|610312|P9|COMPLETED|Period 1||2
252645|NCT01025791|610313|P8|COMPLETED|Period 1||2
252646|NCT01025791|610314|P7|COMPLETED|Period 1||2
252647|NCT01025791|610315|P6|COMPLETED|Period 1||2
252648|NCT01025791|610316|P5|COMPLETED|Period 1||2
252649|NCT01025791|610317|P4|COMPLETED|Period 1||2
252650|NCT01025791|610318|P3|COMPLETED|Period 1||2
252651|NCT01025791|610319|P2|COMPLETED|Period 1||2
252652|NCT01025791|610320|P1|COMPLETED|Period 1||2
252653|NCT01025791|610307|P14|STARTED|Period 1||1
252654|NCT01025791|610308|P13|STARTED|Period 1||2
252655|NCT01025791|610309|P12|STARTED|Period 1||1
252656|NCT01025791|610310|P11|STARTED|Period 1||2
252657|NCT01025791|610311|P10|STARTED|Period 1||1
252658|NCT01025791|610312|P9|STARTED|Period 1||2
252659|NCT01025791|610313|P8|STARTED|Period 1||2
252660|NCT01025791|610314|P7|STARTED|Period 1||2
252661|NCT01025791|610315|P6|STARTED|Period 1||2
252662|NCT01025791|610316|P5|STARTED|Period 1||2
252663|NCT01025791|610317|P4|STARTED|Period 1||2
252664|NCT01025791|610318|P3|STARTED|Period 1||2
252665|NCT01025791|610319|P2|STARTED|Period 1||2
252666|NCT01025791|610320|P1|STARTED|Period 1||2
252667|NCT01025752|610452|P2|NOT COMPLETED|Overall Study||13
252668|NCT01025752|610453|P1|NOT COMPLETED|Overall Study||8
252669|NCT01025752|610452|P2|COMPLETED|Overall Study||50
252670|NCT01025752|610453|P1|COMPLETED|Overall Study||54
252671|NCT01025752|610452|P2|STARTED|Overall Study||63
252672|NCT01025752|610453|P1|STARTED|Overall Study||62
252673|NCT01025635|610473|P2|NOT COMPLETED|Overall Study||25
252674|NCT01025635|610474|P1|NOT COMPLETED|Overall Study||23
252675|NCT01025635|610473|P2|COMPLETED|Overall Study||178
252676|NCT01025635|610474|P1|COMPLETED|Overall Study||175
252677|NCT01025635|610473|P2|STARTED|Overall Study||203
252678|NCT01025635|610474|P1|STARTED|Overall Study||198
252679|NCT01025492|610486|P1|NOT COMPLETED|Overall Study||0
252680|NCT01025492|610486|P1|COMPLETED|Overall Study||24
252681|NCT01025492|610486|P1|STARTED|Overall Study||24
252682|NCT01025453|610490|P1|NOT COMPLETED|Overall Study||0
252683|NCT01025453|610490|P1|COMPLETED|Overall Study||37
252684|NCT01025453|610490|P1|STARTED|Overall Study||37
252685|NCT01025336|610502|P5|NOT COMPLETED|Overall Study||0
252686|NCT01025336|610503|P4|NOT COMPLETED|Overall Study||2
252687|NCT01025336|610504|P3|NOT COMPLETED|Overall Study||0
252688|NCT01025336|610505|P2|NOT COMPLETED|Overall Study||0
252689|NCT01025336|610506|P1|NOT COMPLETED|Overall Study||0
252690|NCT01025336|610502|P5|COMPLETED|Overall Study||222
252691|NCT01025336|610503|P4|COMPLETED|Overall Study||219
252692|NCT01025336|610504|P3|COMPLETED|Overall Study||179
252693|NCT01025336|610505|P2|COMPLETED|Overall Study||210
252694|NCT01025336|610506|P1|COMPLETED|Overall Study||130
252695|NCT01025336|610502|P5|STARTED|Overall Study||222
252696|NCT01025336|610503|P4|STARTED|Overall Study||221
252697|NCT01025336|610504|P3|STARTED|Overall Study||179
252698|NCT01025336|610505|P2|STARTED|Overall Study||210
252699|NCT01025336|610506|P1|STARTED|Overall Study||130
252700|NCT01025284|610561|P3|NOT COMPLETED|Overall Study||0
252701|NCT01025284|610562|P2|NOT COMPLETED|Overall Study||2
252702|NCT01025284|610563|P1|NOT COMPLETED|Overall Study||0
252703|NCT01025284|610561|P3|COMPLETED|Overall Study||8
252704|NCT01025284|610562|P2|COMPLETED|Overall Study||16
252705|NCT01025284|610563|P1|COMPLETED|Overall Study||38
252706|NCT01025284|610561|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
252707|NCT01025284|610562|P2|Received at Least 1 Dose of Study Drug|Overall Study||18
252708|NCT01025284|610563|P1|Received at Least 1 Dose of Study Drug|Overall Study||38
252709|NCT01025284|610561|P3|STARTED|Overall Study||8
252710|NCT01025284|610562|P2|STARTED|Overall Study||18
252711|NCT01025284|610563|P1|STARTED|Overall Study||38
252712|NCT01025271|610581|P1|NOT COMPLETED|Overall Study||0
252713|NCT01025271|610581|P1|COMPLETED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
252714|NCT01025271|610581|P1|STARTED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
252715|NCT01025232|610588|P2|NOT COMPLETED|Overall Study||6
252716|NCT01025232|610589|P1|NOT COMPLETED|Overall Study||3
252717|NCT01025232|610588|P2|COMPLETED|Overall Study||36
252718|NCT01025232|610589|P1|COMPLETED|Overall Study||43
252719|NCT01025232|610588|P2|STARTED|Overall Study||42
252720|NCT01025232|610589|P1|STARTED|Overall Study||46
252721|NCT01025193|610607|P1|NOT COMPLETED|Overall Study||4
252722|NCT01025193|610607|P1|COMPLETED|Overall Study|one patient was transplanted 2 weeks after 8 month belimumab dose and did not receive further doses.|4
252723|NCT01025193|610607|P1|STARTED|Overall Study||8
252724|NCT01025154|610617|P1|NOT COMPLETED|Overall Study||2
252725|NCT01025154|610617|P1|COMPLETED|Overall Study||57
252726|NCT01025154|610617|P1|STARTED|Overall Study||59
252727|NCT01025076|610622|P1|NOT COMPLETED|Overall Study||0
252728|NCT01025076|610622|P1|COMPLETED|Overall Study||14
252729|NCT01025076|610622|P1|STARTED|Overall Study||14
252730|NCT01025037|610626|P1|NOT COMPLETED|Overall Study||11
252731|NCT01025037|610626|P1|COMPLETED|Overall Study||50
252732|NCT01025037|610626|P1|STARTED|Overall Study||61
252733|NCT01024972|610637|P2|NOT COMPLETED|Overall Study||0
252734|NCT01024972|610638|P1|NOT COMPLETED|Overall Study||0
252735|NCT01024972|610637|P2|COMPLETED|Overall Study||15
252736|NCT01024972|610638|P1|COMPLETED|Overall Study||16
252737|NCT01024972|610637|P2|STARTED|Overall Study||15
252738|NCT01024972|610638|P1|STARTED|Overall Study||16
252739|NCT01024959|610648|P1|NOT COMPLETED|Overall Study||41
252740|NCT01024959|610648|P1|COMPLETED|Overall Study||466
252741|NCT01024959|610648|P1|STARTED|Overall Study||507
252742|NCT01024946|610657|P1|NOT COMPLETED|Overall Study||5
252743|NCT01024946|610657|P1|COMPLETED|Overall Study||6
252744|NCT01024946|610657|P1|STARTED|Overall Study||11
252745|NCT01024855|610661|P1|NOT COMPLETED|Overall Study||1
252746|NCT01024855|610661|P1|COMPLETED|Overall Study|One subject of the 30 seen for baseline did not meet the inclusion/exclusion criteria|29
252747|NCT01024855|610661|P1|STARTED|Overall Study|30 subjects enrolled in a paired/split-eye evaluation; each subject used both study treatments|30
252748|NCT01024751|610668|P2|NOT COMPLETED|Eligible Participants||3
252749|NCT01024751|610669|P1|NOT COMPLETED|Eligible Participants||0
252750|NCT01024751|610668|P2|COMPLETED|Eligible Participants||149
252751|NCT01024751|610669|P1|COMPLETED|Eligible Participants||153
252752|NCT01024751|610668|P2|STARTED|Eligible Participants||152
252753|NCT01024751|610669|P1|STARTED|Eligible Participants||153
252754|NCT01024751|610668|P2|NOT COMPLETED|Enrolled Participants||4
252755|NCT01024751|610669|P1|NOT COMPLETED|Enrolled Participants||3
252756|NCT01024751|610668|P2|COMPLETED|Enrolled Participants||152
252757|NCT01024751|610669|P1|COMPLETED|Enrolled Participants||153
252758|NCT01024751|610668|P2|STARTED|Enrolled Participants||156
252759|NCT01024751|610669|P1|STARTED|Enrolled Participants||156
252760|NCT01024738|610680|P3|NOT COMPLETED|Third Intervention:||0
252761|NCT01024738|610681|P2|NOT COMPLETED|Third Intervention:||0
252762|NCT01024738|610682|P1|NOT COMPLETED|Third Intervention:||0
252763|NCT01024738|610680|P3|COMPLETED|Third Intervention:||8
252764|NCT01024738|610681|P2|COMPLETED|Third Intervention:||7
252765|NCT01024738|610682|P1|COMPLETED|Third Intervention:||7
252766|NCT01024738|610680|P3|STARTED|Third Intervention:||8
252767|NCT01024738|610681|P2|STARTED|Third Intervention:||7
252768|NCT01024738|610682|P1|STARTED|Third Intervention:||7
252769|NCT01024738|610680|P3|NOT COMPLETED|Washout After 2nd Intervention||0
252770|NCT01024738|610681|P2|NOT COMPLETED|Washout After 2nd Intervention||0
252771|NCT01024738|610682|P1|NOT COMPLETED|Washout After 2nd Intervention||0
252772|NCT01024738|610680|P3|COMPLETED|Washout After 2nd Intervention||8
252773|NCT01024738|610681|P2|COMPLETED|Washout After 2nd Intervention||7
252774|NCT01024738|610682|P1|COMPLETED|Washout After 2nd Intervention||7
252775|NCT01024738|610680|P3|STARTED|Washout After 2nd Intervention||8
252776|NCT01024738|610681|P2|STARTED|Washout After 2nd Intervention||7
252777|NCT01024738|610682|P1|STARTED|Washout After 2nd Intervention||7
252778|NCT01024738|610680|P3|NOT COMPLETED|Second Intervention:||0
252779|NCT01024738|610681|P2|NOT COMPLETED|Second Intervention:||0
252780|NCT01024738|610682|P1|NOT COMPLETED|Second Intervention:||0
252781|NCT01024738|610680|P3|COMPLETED|Second Intervention:||8
252782|NCT01024738|610681|P2|COMPLETED|Second Intervention:||7
252783|NCT01024738|610682|P1|COMPLETED|Second Intervention:||7
252784|NCT01024738|610680|P3|STARTED|Second Intervention:||8
252785|NCT01024738|610681|P2|STARTED|Second Intervention:||7
252786|NCT01024738|610682|P1|STARTED|Second Intervention:||7
252787|NCT01024738|610680|P3|NOT COMPLETED|Washout After 1st Intervention||0
252788|NCT01024738|610681|P2|NOT COMPLETED|Washout After 1st Intervention||0
252789|NCT01024738|610682|P1|NOT COMPLETED|Washout After 1st Intervention||0
252790|NCT01024738|610680|P3|COMPLETED|Washout After 1st Intervention||8
252791|NCT01024738|610681|P2|COMPLETED|Washout After 1st Intervention||7
252792|NCT01024738|610682|P1|COMPLETED|Washout After 1st Intervention||7
252793|NCT01024738|610680|P3|STARTED|Washout After 1st Intervention||8
252794|NCT01024738|610681|P2|STARTED|Washout After 1st Intervention||7
252795|NCT01024738|610682|P1|STARTED|Washout After 1st Intervention||7
252796|NCT01024738|610680|P3|NOT COMPLETED|First Intervention:||0
252797|NCT01024738|610681|P2|NOT COMPLETED|First Intervention:||0
252798|NCT01024738|610682|P1|NOT COMPLETED|First Intervention:||0
252799|NCT01024738|610680|P3|COMPLETED|First Intervention:||8
252800|NCT01024738|610681|P2|COMPLETED|First Intervention:||7
252801|NCT01024738|610682|P1|COMPLETED|First Intervention:||7
252802|NCT01024738|610680|P3|STARTED|First Intervention:||8
252803|NCT01024738|610681|P2|STARTED|First Intervention:||7
252804|NCT01024738|610682|P1|STARTED|First Intervention:||7
252805|NCT01024686|610693|P3|NOT COMPLETED|Overall Study||0
252806|NCT01024686|610694|P2|NOT COMPLETED|Overall Study||0
252807|NCT01024686|610695|P1|NOT COMPLETED|Overall Study||0
252808|NCT01024686|610693|P3|COMPLETED|Overall Study|(0) participants because the clinical trial was terminated prior to enrollment.|0
252809|NCT01024686|610694|P2|COMPLETED|Overall Study|(0) participants because the clinical trial was terminated prior to enrollment.|0
252810|NCT01024686|610695|P1|COMPLETED|Overall Study||6
252811|NCT01024686|610693|P3|STARTED|Overall Study||0
252812|NCT01024686|610694|P2|STARTED|Overall Study||0
252813|NCT01024686|610695|P1|STARTED|Overall Study|July 11, 2010: unexpected adverse event, (1) participant|6
252814|NCT01024608|610726|P2|NOT COMPLETED|Overall Study||4
252815|NCT01024608|610727|P1|NOT COMPLETED|Overall Study||4
252816|NCT01024608|610726|P2|COMPLETED|Overall Study||167
252817|NCT01024608|610727|P1|COMPLETED|Overall Study||165
252818|NCT01024608|610726|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|171
252819|NCT01024608|610727|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|167
252820|NCT01024608|610726|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|171
252821|NCT01024608|610727|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|167
252822|NCT01024608|610726|P2|STARTED|Overall Study||171
252823|NCT01024608|610727|P1|STARTED|Overall Study||169
252824|NCT01024465|610739|P1|NOT COMPLETED|Overall Study||3
252825|NCT01024465|610739|P1|COMPLETED|Overall Study||23
252826|NCT01024465|610739|P1|STARTED|Overall Study||26
252827|NCT01024387|610743|P1|NOT COMPLETED|Overall Study||60
252828|NCT01024387|610743|P1|COMPLETED|Overall Study||0
252829|NCT01024387|610743|P1|Evaluable for Response|Overall Study||53
252830|NCT01024387|610743|P1|Evaluable for PFS|Overall Study||54
252831|NCT01024387|610743|P1|STARTED|Overall Study||60
252832|NCT01024335|610753|P2|NOT COMPLETED|Overall Study||26
252833|NCT01024335|610754|P1|NOT COMPLETED|Overall Study||13
252834|NCT01024335|610753|P2|COMPLETED|Overall Study||14
252835|NCT01024335|610754|P1|COMPLETED|Overall Study||7
252836|NCT01024335|610753|P2|STARTED|Overall Study||40
252837|NCT01024335|610754|P1|STARTED|Overall Study||20
252838|NCT01024309|610764|P2|NOT COMPLETED|Overall Study||4
252839|NCT01024309|610765|P1|NOT COMPLETED|Overall Study||8
252840|NCT01024309|610764|P2|COMPLETED|Overall Study||27
252841|NCT01024309|610765|P1|COMPLETED|Overall Study||27
252842|NCT01024309|610764|P2|STARTED|Overall Study||31
252843|NCT01024309|610765|P1|STARTED|Overall Study||35
252844|NCT01024296|610787|P1|NOT COMPLETED|Overall Study||0
252845|NCT01024296|610787|P1|COMPLETED|Overall Study||4
252846|NCT01024296|610787|P1|STARTED|Overall Study||4
252847|NCT01024244|610797|P5|NOT COMPLETED|Overall Study||14
252848|NCT01024244|610798|P4|NOT COMPLETED|Overall Study||13
252849|NCT01024244|610799|P3|NOT COMPLETED|Overall Study||14
252850|NCT01024244|610800|P2|NOT COMPLETED|Overall Study||11
252851|NCT01024244|610801|P1|NOT COMPLETED|Overall Study||17
252852|NCT01024244|610797|P5|COMPLETED|Overall Study||1
252853|NCT01024244|610798|P4|COMPLETED|Overall Study||1
252854|NCT01024244|610799|P3|COMPLETED|Overall Study||1
252855|NCT01024244|610800|P2|COMPLETED|Overall Study||1
252856|NCT01024244|610801|P1|COMPLETED|Overall Study||5
252857|NCT01024244|610797|P5|STARTED|Overall Study||15
252858|NCT01024244|610798|P4|STARTED|Overall Study||14
252859|NCT01024244|610799|P3|STARTED|Overall Study||15
252860|NCT01024244|610800|P2|STARTED|Overall Study||12
252861|NCT01024244|610801|P1|STARTED|Overall Study||22
252862|NCT01024036|610915|P2|NOT COMPLETED|Follow-Up Period||3
252863|NCT01024036|610916|P1|NOT COMPLETED|Follow-Up Period||5
252864|NCT01024036|610915|P2|COMPLETED|Follow-Up Period||3
252865|NCT01024036|610916|P1|COMPLETED|Follow-Up Period||9
252866|NCT01024036|610915|P2|STARTED|Follow-Up Period||6
252867|NCT01024036|610916|P1|STARTED|Follow-Up Period||14
252868|NCT01024036|610915|P2|NOT COMPLETED|Unblinded Treatment||3
252869|NCT01024036|610916|P1|NOT COMPLETED|Unblinded Treatment||0
252870|NCT01024036|610915|P2|COMPLETED|Unblinded Treatment||10
252871|NCT01024036|610916|P1|COMPLETED|Unblinded Treatment||0
252872|NCT01024036|610915|P2|STARTED|Unblinded Treatment|Placebo participants had an option to receive siltuximab in unblinded treatment period|13
252873|NCT01024036|610916|P1|STARTED|Unblinded Treatment|No participants in this group received treatment during unblinded treatment period|0
252874|NCT01024036|610915|P2|NOT COMPLETED|Blinded Treatment||20
252875|NCT01024036|610916|P1|NOT COMPLETED|Blinded Treatment||22
252876|NCT01024036|610915|P2|COMPLETED|Blinded Treatment||6
252877|NCT01024036|610916|P1|COMPLETED|Blinded Treatment||31
252878|NCT01024036|610915|P2|STARTED|Blinded Treatment||26
252879|NCT01024036|610916|P1|STARTED|Blinded Treatment||53
252880|NCT01024010|610949|P2|NOT COMPLETED|Overall Study||0
252881|NCT01024010|610950|P1|NOT COMPLETED|Overall Study||0
252882|NCT01024010|610949|P2|COMPLETED|Overall Study||34
252883|NCT01024010|610950|P1|COMPLETED|Overall Study||48
252884|NCT01024010|610949|P2|STARTED|Overall Study||34
252885|NCT01024010|610950|P1|STARTED|Overall Study||48
252886|NCT01023958|610963|P1|NOT COMPLETED|Overall Study||50
252887|NCT01023958|610963|P1|COMPLETED|Overall Study||0
252888|NCT01023958|610963|P1|STARTED|Overall Study||50
252889|NCT01023841|610992|P2|NOT COMPLETED|Overall Study||0
252890|NCT01023841|610993|P1|NOT COMPLETED|Overall Study||1
252891|NCT01023841|610992|P2|COMPLETED|Overall Study||23
252892|NCT01023841|610993|P1|COMPLETED|Overall Study||47
252893|NCT01023841|610992|P2|STARTED|Overall Study||23
252894|NCT01023841|610993|P1|STARTED|Overall Study||48
252895|NCT01023815|611011|P4|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
252896|NCT01023815|611012|P3|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||8
252897|NCT01023815|611013|P2|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
252898|NCT01023815|611014|P1|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||0
252899|NCT01023815|611011|P4|COMPLETED|Randomized Period (Day 90 to Month 12)||68
252900|NCT01023815|611012|P3|COMPLETED|Randomized Period (Day 90 to Month 12)||60
252901|NCT01023815|611013|P2|COMPLETED|Randomized Period (Day 90 to Month 12)||42
252902|NCT01023815|611014|P1|COMPLETED|Randomized Period (Day 90 to Month 12)||0
252903|NCT01023815|611011|P4|STARTED|Randomized Period (Day 90 to Month 12)||71
252904|NCT01023815|611012|P3|STARTED|Randomized Period (Day 90 to Month 12)||68
252905|NCT01023815|611013|P2|STARTED|Randomized Period (Day 90 to Month 12)|Randomized patients to Group A, B and C are also intent to treat population.|45
252906|NCT01023815|611014|P1|STARTED|Randomized Period (Day 90 to Month 12)||0
252907|NCT01023815|611011|P4|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
252908|NCT01023815|611012|P3|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
252909|NCT01023815|611013|P2|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
252910|NCT01023815|611014|P1|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||144
252911|NCT01023815|611011|P4|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
252912|NCT01023815|611012|P3|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
252913|NCT01023815|611013|P2|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
252914|NCT01023815|611014|P1|COMPLETED|Pre-randomization Period (Day 1 to 90)||184
252915|NCT01023815|611011|P4|STARTED|Pre-randomization Period (Day 1 to 90)||0
252916|NCT01023815|611012|P3|STARTED|Pre-randomization Period (Day 1 to 90)||0
252917|NCT01023815|611013|P2|STARTED|Pre-randomization Period (Day 1 to 90)||0
252918|NCT01023815|611014|P1|STARTED|Pre-randomization Period (Day 1 to 90)|Out of 330 enrolled, 2 patients never received everolimus.|328
252919|NCT01023789|611033|P1|NOT COMPLETED|3 - Year Visit||43
252920|NCT01023789|611033|P1|COMPLETED|3 - Year Visit||769
252921|NCT01023789|611033|P1|STARTED|3 - Year Visit||812
252922|NCT01023789|611033|P1|NOT COMPLETED|2 - Year Visit||0
252923|NCT01023789|611033|P1|COMPLETED|2 - Year Visit||812
252924|NCT01023789|611033|P1|STARTED|2 - Year Visit||812
252925|NCT01023789|611033|P1|NOT COMPLETED|1 - Year Visit||0
252926|NCT01023789|611033|P1|COMPLETED|1 - Year Visit||812
252927|NCT01023789|611033|P1|STARTED|1 - Year Visit||812
252928|NCT01023789|611033|P1|NOT COMPLETED|180-day Clinical Follow-up||0
252929|NCT01023789|611033|P1|COMPLETED|180-day Clinical Follow-up||812
252930|NCT01023789|611033|P1|STARTED|180-day Clinical Follow-up||812
252931|NCT01023789|611033|P1|NOT COMPLETED|30-day Follow-up Visit||0
252932|NCT01023789|611033|P1|COMPLETED|30-day Follow-up Visit||812
252933|NCT01023789|611033|P1|STARTED|30-day Follow-up Visit|Intent-to-treat population (ITT).|812
252934|NCT01023776|611100|P1|NOT COMPLETED|Overall Study||0
252935|NCT01023776|611100|P1|COMPLETED|Overall Study||20
252936|NCT01023776|611100|P1|STARTED|Overall Study|Subjects received 2 dose of vaccine 0.1 ml in each nostril intra nasally 28 days apart|20
252937|NCT01023724|611107|P2|NOT COMPLETED|Overall Study||3
252938|NCT01023724|611108|P1|NOT COMPLETED|Overall Study||4
252939|NCT01023724|611107|P2|COMPLETED|Overall Study||22
252940|NCT01023724|611108|P1|COMPLETED|Overall Study||21
252941|NCT01023724|611107|P2|STARTED|Overall Study||25
252942|NCT01023724|611108|P1|STARTED|Overall Study||25
252943|NCT01023711|611114|P1|NOT COMPLETED|Overall Study||0
252944|NCT01023711|611114|P1|COMPLETED|Overall Study||107
252945|NCT01023711|611114|P1|STARTED|Overall Study||107
252946|NCT01023672|611119|P1|NOT COMPLETED|Overall Study||3
252947|NCT01023672|611119|P1|COMPLETED|Overall Study||17
252948|NCT01023672|611119|P1|STARTED|Overall Study||20
252949|NCT01023659|611126|P3|NOT COMPLETED|Overall Study||99
252950|NCT01023659|611127|P2|NOT COMPLETED|Overall Study||228
252951|NCT01023659|611128|P1|NOT COMPLETED|Overall Study||73
252952|NCT01023659|611126|P3|COMPLETED|Overall Study||165
252953|NCT01023659|611127|P2|COMPLETED|Overall Study||137
252954|NCT01023659|611128|P1|COMPLETED|Overall Study||185
252955|NCT01023659|611126|P3|STARTED|Overall Study||264
252956|NCT01023659|611127|P2|STARTED|Overall Study||365
252957|NCT01023659|611128|P1|STARTED|Overall Study||258
252958|NCT01023620|611139|P2|NOT COMPLETED|Overall Study||0
252959|NCT01023620|611140|P1|NOT COMPLETED|Overall Study||0
252960|NCT01023620|611139|P2|COMPLETED|Overall Study||0
252961|NCT01023620|611140|P1|COMPLETED|Overall Study||0
252962|NCT01023620|611139|P2|STARTED|Overall Study||0
252963|NCT01023620|611140|P1|STARTED|Overall Study||0
252964|NCT01023581|611155|P7|NOT COMPLETED|Overall Study||20
252965|NCT01023581|611156|P6|NOT COMPLETED|Overall Study||19
252966|NCT01023581|611157|P5|NOT COMPLETED|Overall Study||16
252967|NCT01023581|611158|P4|NOT COMPLETED|Overall Study||20
252968|NCT01023581|611159|P3|NOT COMPLETED|Overall Study||42
252969|NCT01023581|611160|P2|NOT COMPLETED|Overall Study||23
252970|NCT01023581|611161|P1|NOT COMPLETED|Overall Study||35
252971|NCT01023581|611155|P7|COMPLETED|Overall Study||94
252972|NCT01023581|611156|P6|COMPLETED|Overall Study||92
252973|NCT01023581|611157|P5|COMPLETED|Overall Study||95
252974|NCT01023581|611158|P4|COMPLETED|Overall Study||94
252975|NCT01023581|611159|P3|COMPLETED|Overall Study||71
252976|NCT01023581|611160|P2|COMPLETED|Overall Study||89
252977|NCT01023581|611161|P1|COMPLETED|Overall Study|The number of completed patients represents those who completed study drug.|74
252978|NCT01023581|611155|P7|Received Study Treatment|Overall Study||114
252979|NCT01023581|611156|P6|Received Study Treatment|Overall Study||106
252980|NCT01023581|611157|P5|Received Study Treatment|Overall Study||111
252981|NCT01023581|611158|P4|Received Study Treatment|Overall Study||109
252982|NCT01023581|611159|P3|Received Study Treatment|Overall Study||110
252983|NCT01023581|611160|P2|Received Study Treatment|Overall Study||112
252984|NCT01023581|611161|P1|Received Study Treatment|Overall Study||106
252985|NCT01023581|611155|P7|STARTED|Overall Study||114
252986|NCT01023581|611156|P6|STARTED|Overall Study||111
252987|NCT01023581|611157|P5|STARTED|Overall Study||111
252988|NCT01023581|611158|P4|STARTED|Overall Study||114
252989|NCT01023581|611159|P3|STARTED|Overall Study||113
252990|NCT01023581|611160|P2|STARTED|Overall Study||112
252991|NCT01023581|611161|P1|STARTED|Overall Study||109
252992|NCT01023568|611194|P3|NOT COMPLETED|Overall Study||0
252993|NCT01023568|611195|P2|NOT COMPLETED|Overall Study||0
252994|NCT01023568|611196|P1|NOT COMPLETED|Overall Study||0
252995|NCT01023568|611194|P3|COMPLETED|Overall Study||45
252996|NCT01023568|611195|P2|COMPLETED|Overall Study||44
252997|NCT01023568|611196|P1|COMPLETED|Overall Study||45
252998|NCT01023568|611194|P3|STARTED|Overall Study||45
252999|NCT01023568|611195|P2|STARTED|Overall Study||44
253000|NCT01023568|611196|P1|STARTED|Overall Study||45
253001|NCT01023516|611218|P2|NOT COMPLETED|Overall Study||18
253002|NCT01023516|611219|P1|NOT COMPLETED|Overall Study||24
253003|NCT01023516|611218|P2|COMPLETED|Overall Study||284
253004|NCT01023516|611219|P1|COMPLETED|Overall Study||289
253005|NCT01023516|611218|P2|STARTED|Overall Study||302
253006|NCT01023516|611219|P1|STARTED|Overall Study||313
253007|NCT01023308|611301|P2|NOT COMPLETED|Overall Study||279
253008|NCT01023308|611302|P1|NOT COMPLETED|Overall Study||285
253009|NCT01023308|611301|P2|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
253010|NCT01023308|611302|P1|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
253011|NCT01023308|611301|P2|STARTED|Overall Study||381
253012|NCT01023308|611302|P1|STARTED|Overall Study||387
253013|NCT01023269|611328|P2|NOT COMPLETED|Overall Study||0
253014|NCT01023269|611329|P1|NOT COMPLETED|Overall Study||2
253015|NCT01023269|611328|P2|COMPLETED|Overall Study||2
253016|NCT01023269|611329|P1|COMPLETED|Overall Study||1
253017|NCT01023269|611328|P2|STARTED|Overall Study||2
253018|NCT01023269|611329|P1|STARTED|Overall Study||3
253019|NCT01023256|611337|P4|NOT COMPLETED|Overall Study||5
253020|NCT01023256|611338|P3|NOT COMPLETED|Overall Study||1
253021|NCT01023256|611339|P2|NOT COMPLETED|Overall Study||3
253022|NCT01023256|611340|P1|NOT COMPLETED|Overall Study||4
253023|NCT01023256|611337|P4|COMPLETED|Overall Study||22
253024|NCT01023256|611338|P3|COMPLETED|Overall Study||23
253025|NCT01023256|611339|P2|COMPLETED|Overall Study||19
253026|NCT01023256|611340|P1|COMPLETED|Overall Study||21
253027|NCT01023256|611337|P4|STARTED|Overall Study||27
253028|NCT01023256|611338|P3|STARTED|Overall Study||24
253029|NCT01023256|611339|P2|STARTED|Overall Study||22
253030|NCT01023256|611340|P1|STARTED|Overall Study||25
253031|NCT01023217|611382|P2|NOT COMPLETED|Overall Study||0
253032|NCT01023217|611383|P1|NOT COMPLETED|Overall Study||1
253033|NCT01023217|611382|P2|COMPLETED|Overall Study||45
253034|NCT01023217|611383|P1|COMPLETED|Overall Study||44
253035|NCT01023217|611382|P2|STARTED|Overall Study||45
253036|NCT01023217|611383|P1|STARTED|Overall Study||45
253037|NCT01023178|611392|P3|NOT COMPLETED|Overall Study||3
253038|NCT01023178|611393|P2|NOT COMPLETED|Overall Study||2
253039|NCT01023178|611394|P1|NOT COMPLETED|Overall Study||2
253040|NCT01023178|611392|P3|COMPLETED|Overall Study||4
253041|NCT01023178|611393|P2|COMPLETED|Overall Study||6
253042|NCT01023178|611394|P1|COMPLETED|Overall Study||3
253043|NCT01023178|611392|P3|STARTED|Overall Study||7
253044|NCT01023178|611393|P2|STARTED|Overall Study||8
253045|NCT01023178|611394|P1|STARTED|Overall Study||5
253046|NCT01023074|611405|P3|NOT COMPLETED|Overall Study||0
253047|NCT01023074|611406|P2|NOT COMPLETED|Overall Study||0
253048|NCT01023074|611407|P1|NOT COMPLETED|Overall Study||0
253049|NCT01023074|611405|P3|COMPLETED|Overall Study||13
253050|NCT01023074|611406|P2|COMPLETED|Overall Study||13
253051|NCT01023074|611407|P1|COMPLETED|Overall Study||26
253052|NCT01023074|611405|P3|STARTED|Overall Study||13
253053|NCT01023074|611406|P2|STARTED|Overall Study||13
253054|NCT01023074|611407|P1|STARTED|Overall Study||26
253055|NCT01023061|611421|P1|NOT COMPLETED|Overall Study||2
253056|NCT01023061|611421|P1|COMPLETED|Overall Study||22
253057|NCT01023061|611421|P1|STARTED|Overall Study||24
253058|NCT01023035|611430|P3|NOT COMPLETED|Follow-up Period (up to Week 72)||39
253059|NCT01023035|611431|P2|NOT COMPLETED|Follow-up Period (up to Week 72)||28
253060|NCT01023035|611432|P1|NOT COMPLETED|Follow-up Period (up to Week 72)||28
253061|NCT01023035|611430|P3|COMPLETED|Follow-up Period (up to Week 72)||108
253062|NCT01023035|611431|P2|COMPLETED|Follow-up Period (up to Week 72)||207
253063|NCT01023035|611432|P1|COMPLETED|Follow-up Period (up to Week 72)||210
253064|NCT01023035|611430|P3|STARTED|Follow-up Period (up to Week 72)||147
253065|NCT01023035|611431|P2|STARTED|Follow-up Period (up to Week 72)||235
253066|NCT01023035|611432|P1|STARTED|Follow-up Period (up to Week 72)||238
253067|NCT01023035|611430|P3|NOT COMPLETED|Treatment Period||118
253068|NCT01023035|611431|P2|NOT COMPLETED|Treatment Period||85
253069|NCT01023035|611432|P1|NOT COMPLETED|Treatment Period||72
253070|NCT01023035|611430|P3|COMPLETED|Treatment Period||69
253071|NCT01023035|611431|P2|COMPLETED|Treatment Period||166
253072|NCT01023035|611432|P1|COMPLETED|Treatment Period||177
253073|NCT01023035|611430|P3|STARTED|Treatment Period||187
253074|NCT01023035|611431|P2|STARTED|Treatment Period||251
253075|NCT01023035|611432|P1|STARTED|Treatment Period||249
253076|NCT01023022|611442|P1|NOT COMPLETED|Overall Study||14
253077|NCT01023022|611442|P1|COMPLETED|Overall Study||162
253078|NCT01023022|611442|P1|STARTED|Overall Study|Previous No.: 178 subjects incl. 2 pts who withdraw their approval for processing personal data|176
253079|NCT01022996|611448|P1|NOT COMPLETED|Overall Study||57
253080|NCT01022996|611448|P1|COMPLETED|Overall Study||0
253081|NCT01022996|611448|P1|STARTED|Overall Study||57
253082|NCT01022853|611462|P5|NOT COMPLETED|Overall Study||2
253083|NCT01022853|611463|P4|NOT COMPLETED|Overall Study||8
253084|NCT01022853|611464|P3|NOT COMPLETED|Overall Study||13
253085|NCT01022853|611465|P2|NOT COMPLETED|Overall Study||4
253086|NCT01022853|611466|P1|NOT COMPLETED|Overall Study||3
253087|NCT01022853|611462|P5|COMPLETED|Overall Study||0
253088|NCT01022853|611463|P4|COMPLETED|Overall Study||0
253089|NCT01022853|611464|P3|COMPLETED|Overall Study||0
253090|NCT01022853|611465|P2|COMPLETED|Overall Study||0
253091|NCT01022853|611466|P1|COMPLETED|Overall Study||0
253092|NCT01022853|611462|P5|STARTED|Overall Study|entered and treated|2
253093|NCT01022853|611463|P4|STARTED|Overall Study|entered and treated|8
253094|NCT01022853|611464|P3|STARTED|Overall Study|entered and treated|13
253095|NCT01022853|611465|P2|STARTED|Overall Study|entered and treated|4
253096|NCT01022853|611466|P1|STARTED|Overall Study|entered and treated|3
253097|NCT01022762|611545|P2|NOT COMPLETED|Overall Study||28
253098|NCT01022762|611546|P1|NOT COMPLETED|Overall Study||22
253099|NCT01022762|611545|P2|COMPLETED|Overall Study||194
253100|NCT01022762|611546|P1|COMPLETED|Overall Study||196
253101|NCT01022762|611545|P2|Exposed to Trial Drug|Overall Study|Four participants were not exposed to the treatment due to non-compliance or lost to follow-up|218
253102|NCT01022762|611546|P1|Exposed to Trial Drug|Overall Study|One participant was not exposed to the treatment due to fulfillment of exclusion criteria|217
253103|NCT01022762|611545|P2|STARTED|Overall Study||222
253104|NCT01022762|611546|P1|STARTED|Overall Study||218
253105|NCT01022567|611574|P2|NOT COMPLETED|Overall Study||15
253106|NCT01022567|611575|P1|NOT COMPLETED|Overall Study||1
253107|NCT01022567|611574|P2|COMPLETED|Overall Study||242
253108|NCT01022567|611575|P1|COMPLETED|Overall Study||272
253109|NCT01022567|611574|P2|STARTED|Overall Study||257
253110|NCT01022567|611575|P1|STARTED|Overall Study||273
253111|NCT01022502|611581|P1|NOT COMPLETED|Overall Study||3
253112|NCT01022502|611581|P1|COMPLETED|Overall Study|3 participants withdrew at week 4,5,6,respectively.|35
253113|NCT01022502|611581|P1|STARTED|Overall Study|19 used the refined ointment on the right site, 19 used the crude ointment on the left site.|38
253114|NCT01022424|611595|P1|NOT COMPLETED|Overall Study||4
253115|NCT01022424|611595|P1|COMPLETED|Overall Study||9
253116|NCT01022424|611595|P1|STARTED|Overall Study||13
253117|NCT01022398|611610|P2|NOT COMPLETED|Overall Study||2
253118|NCT01022398|611611|P1|NOT COMPLETED|Overall Study||2
253119|NCT01022398|611610|P2|COMPLETED|Overall Study||0
253120|NCT01022398|611611|P1|COMPLETED|Overall Study||0
253121|NCT01022398|611610|P2|STARTED|Overall Study||2
253122|NCT01022398|611611|P1|STARTED|Overall Study||2
253123|NCT01022307|611618|P2|NOT COMPLETED|Overall Study||4
253124|NCT01022307|611619|P1|NOT COMPLETED|Overall Study||0
253125|NCT01022307|611618|P2|COMPLETED|Overall Study|Some TBI patients could not undergo MR scanning due to contraindications.|24
253126|NCT01022307|611619|P1|COMPLETED|Overall Study||184
253127|NCT01022307|611618|P2|STARTED|Overall Study||28
253128|NCT01022307|611619|P1|STARTED|Overall Study||184
253129|NCT01022242|611627|P2|NOT COMPLETED|Overall Study||19
253130|NCT01022242|611628|P1|NOT COMPLETED|Overall Study||21
253131|NCT01022242|611627|P2|COMPLETED|Overall Study||46
253132|NCT01022242|611628|P1|COMPLETED|Overall Study||49
253133|NCT01022242|611627|P2|STARTED|Overall Study|67 pat rand to PXL01. 2 got incorrect mix of PXL01. 65 patients treated with the correct PXL01 mix.|65
253134|NCT01022242|611628|P1|STARTED|Overall Study|71 pat rand to placebo. 1 got incorrect mix of placebo. 70 patients treated with the correct mix.|70
253135|NCT01022203|611636|P2|NOT COMPLETED|Follow-Up Assessment||2
253136|NCT01022203|611637|P1|NOT COMPLETED|Follow-Up Assessment||2
253137|NCT01022203|611636|P2|COMPLETED|Follow-Up Assessment||40
253138|NCT01022203|611637|P1|COMPLETED|Follow-Up Assessment||42
253139|NCT01022203|611636|P2|STARTED|Follow-Up Assessment||42
253140|NCT01022203|611637|P1|STARTED|Follow-Up Assessment||44
253141|NCT01022203|611636|P2|NOT COMPLETED|Post Treatment Assessment||14
253142|NCT01022203|611637|P1|NOT COMPLETED|Post Treatment Assessment||14
253143|NCT01022203|611636|P2|COMPLETED|Post Treatment Assessment||42
253144|NCT01022203|611637|P1|COMPLETED|Post Treatment Assessment||44
253145|NCT01022203|611636|P2|STARTED|Post Treatment Assessment||56
253146|NCT01022203|611637|P1|STARTED|Post Treatment Assessment||58
253147|NCT01022203|611636|P2|NOT COMPLETED|PreTreatment Assessment||0
253148|NCT01022203|611637|P1|NOT COMPLETED|PreTreatment Assessment||0
253149|NCT01022203|611636|P2|COMPLETED|PreTreatment Assessment||56
253150|NCT01022203|611637|P1|COMPLETED|PreTreatment Assessment||58
253151|NCT01022203|611636|P2|STARTED|PreTreatment Assessment||56
253152|NCT01022203|611637|P1|STARTED|PreTreatment Assessment||58
253153|NCT01022190|611647|P1|NOT COMPLETED|Overall Study||0
253154|NCT01022190|611647|P1|COMPLETED|Overall Study||42
253155|NCT01022190|611647|P1|STARTED|Overall Study||42
253156|NCT01022112|611656|P5|NOT COMPLETED|Overall Study||10
253157|NCT01022112|611657|P4|NOT COMPLETED|Overall Study||3
253158|NCT01022112|611658|P3|NOT COMPLETED|Overall Study||3
253159|NCT01022112|611659|P2|NOT COMPLETED|Overall Study||3
253160|NCT01022112|611660|P1|NOT COMPLETED|Overall Study||3
253161|NCT01022112|611656|P5|COMPLETED|Overall Study||65
253162|NCT01022112|611657|P4|COMPLETED|Overall Study||72
253163|NCT01022112|611658|P3|COMPLETED|Overall Study||74
253164|NCT01022112|611659|P2|COMPLETED|Overall Study||71
253165|NCT01022112|611660|P1|COMPLETED|Overall Study||79
253166|NCT01022112|611656|P5|STARTED|Overall Study||75
253167|NCT01022112|611657|P4|STARTED|Overall Study||75
253168|NCT01022112|611658|P3|STARTED|Overall Study||77
253169|NCT01022112|611659|P2|STARTED|Overall Study||74
253170|NCT01022112|611660|P1|STARTED|Overall Study||82
253171|NCT01022073|611674|P2|NOT COMPLETED|Overall Study||18
253172|NCT01022073|611675|P1|NOT COMPLETED|Overall Study||19
253173|NCT01022073|611674|P2|COMPLETED|Overall Study||52
253174|NCT01022073|611675|P1|COMPLETED|Overall Study||67
253175|NCT01022073|611674|P2|STARTED|Overall Study||70
253176|NCT01022073|611675|P1|STARTED|Overall Study||86
253177|NCT01021956|611685|P4|NOT COMPLETED|Overall Study||0
253178|NCT01021956|611686|P3|NOT COMPLETED|Overall Study||0
253179|NCT01021956|611687|P2|NOT COMPLETED|Overall Study||0
253180|NCT01021956|611688|P1|NOT COMPLETED|Overall Study||0
253181|NCT01021956|611685|P4|COMPLETED|Overall Study||1
253182|NCT01021956|611686|P3|COMPLETED|Overall Study||3
253183|NCT01021956|611687|P2|COMPLETED|Overall Study||3
253184|NCT01021956|611688|P1|COMPLETED|Overall Study||3
253185|NCT01021956|611685|P4|STARTED|Overall Study||1
253186|NCT01021956|611686|P3|STARTED|Overall Study||3
253187|NCT01021956|611687|P2|STARTED|Overall Study||3
253188|NCT01021956|611688|P1|STARTED|Overall Study||3
253189|NCT01021878|611709|P2|NOT COMPLETED|Overall Study||10
253190|NCT01021878|611710|P1|NOT COMPLETED|Overall Study||16
253191|NCT01021878|611709|P2|COMPLETED|Overall Study||17
253192|NCT01021878|611710|P1|COMPLETED|Overall Study||17
253193|NCT01021878|611709|P2|Completed Follow-up|Overall Study||17
253194|NCT01021878|611710|P1|Completed Follow-up|Overall Study||17
253195|NCT01021878|611709|P2|STARTED|Overall Study||27
253196|NCT01021878|611710|P1|STARTED|Overall Study||33
253197|NCT01021852|611732|P8|NOT COMPLETED|Treatment Period 2||2
253198|NCT01021852|611733|P7|NOT COMPLETED|Treatment Period 2||3
253199|NCT01021852|611734|P6|NOT COMPLETED|Treatment Period 2||1
253200|NCT01021852|611735|P5|NOT COMPLETED|Treatment Period 2||2
253201|NCT01021852|611736|P4|NOT COMPLETED|Treatment Period 2||0
253202|NCT01021852|611737|P3|NOT COMPLETED|Treatment Period 2||1
253203|NCT01021852|611738|P2|NOT COMPLETED|Treatment Period 2||1
253204|NCT01021852|611739|P1|NOT COMPLETED|Treatment Period 2||0
253205|NCT01021852|611732|P8|COMPLETED|Treatment Period 2||38
253206|NCT01021852|611733|P7|COMPLETED|Treatment Period 2||37
253207|NCT01021852|611734|P6|COMPLETED|Treatment Period 2||37
253208|NCT01021852|611735|P5|COMPLETED|Treatment Period 2||37
253209|NCT01021852|611736|P4|COMPLETED|Treatment Period 2||37
253210|NCT01021852|611737|P3|COMPLETED|Treatment Period 2||38
253211|NCT01021852|611738|P2|COMPLETED|Treatment Period 2||38
253212|NCT01021852|611739|P1|COMPLETED|Treatment Period 2||37
253213|NCT01021852|611732|P8|STARTED|Treatment Period 2||40
253214|NCT01021852|611733|P7|STARTED|Treatment Period 2||40
253215|NCT01021852|611734|P6|STARTED|Treatment Period 2||38
253216|NCT01021852|611735|P5|STARTED|Treatment Period 2||39
253217|NCT01021852|611736|P4|STARTED|Treatment Period 2||37
253218|NCT01021852|611737|P3|STARTED|Treatment Period 2||39
253219|NCT01021852|611738|P2|STARTED|Treatment Period 2||39
253220|NCT01021852|611739|P1|STARTED|Treatment Period 2||37
253221|NCT01021852|611732|P8|NOT COMPLETED|Washout Period-No Drug||0
253222|NCT01021852|611733|P7|NOT COMPLETED|Washout Period-No Drug||0
253223|NCT01021852|611734|P6|NOT COMPLETED|Washout Period-No Drug||1
253224|NCT01021852|611735|P5|NOT COMPLETED|Washout Period-No Drug||0
253225|NCT01021852|611736|P4|NOT COMPLETED|Washout Period-No Drug||0
253226|NCT01021852|611737|P3|NOT COMPLETED|Washout Period-No Drug||0
253227|NCT01021852|611738|P2|NOT COMPLETED|Washout Period-No Drug||0
253228|NCT01021852|611739|P1|NOT COMPLETED|Washout Period-No Drug||1
253229|NCT01021852|611732|P8|COMPLETED|Washout Period-No Drug||40
253230|NCT01021852|611733|P7|COMPLETED|Washout Period-No Drug||40
253231|NCT01021852|611734|P6|COMPLETED|Washout Period-No Drug||38
253232|NCT01021852|611735|P5|COMPLETED|Washout Period-No Drug||39
253233|NCT01021852|611736|P4|COMPLETED|Washout Period-No Drug||37
253234|NCT01021852|611737|P3|COMPLETED|Washout Period-No Drug||39
253235|NCT01021852|611738|P2|COMPLETED|Washout Period-No Drug||39
253236|NCT01021852|611739|P1|COMPLETED|Washout Period-No Drug||37
253237|NCT01021852|611732|P8|STARTED|Washout Period-No Drug||40
253238|NCT01021852|611733|P7|STARTED|Washout Period-No Drug||40
253239|NCT01021852|611734|P6|STARTED|Washout Period-No Drug|Includes 1 participant who completed Treatment Period 1 but missed Placebo Washout.|39
253240|NCT01021852|611735|P5|STARTED|Washout Period-No Drug||39
253241|NCT01021852|611736|P4|STARTED|Washout Period-No Drug||37
253242|NCT01021852|611737|P3|STARTED|Washout Period-No Drug||39
253243|NCT01021852|611738|P2|STARTED|Washout Period-No Drug||39
253244|NCT01021852|611739|P1|STARTED|Washout Period-No Drug|Includes 1 participant who discontinued Treatment Period 1 (AE) and missed Placebo Washout.|38
253245|NCT01021852|611732|P8|NOT COMPLETED|Washout Period-Placebo||0
253246|NCT01021852|611733|P7|NOT COMPLETED|Washout Period-Placebo||1
253247|NCT01021852|611734|P6|NOT COMPLETED|Washout Period-Placebo||1
253248|NCT01021852|611735|P5|NOT COMPLETED|Washout Period-Placebo||1
253249|NCT01021852|611736|P4|NOT COMPLETED|Washout Period-Placebo||1
253250|NCT01021852|611737|P3|NOT COMPLETED|Washout Period-Placebo||0
253251|NCT01021852|611738|P2|NOT COMPLETED|Washout Period-Placebo||0
253252|NCT01021852|611739|P1|NOT COMPLETED|Washout Period-Placebo||0
253253|NCT01021852|611732|P8|COMPLETED|Washout Period-Placebo||40
253254|NCT01021852|611733|P7|COMPLETED|Washout Period-Placebo||40
253255|NCT01021852|611734|P6|COMPLETED|Washout Period-Placebo||38
253256|NCT01021852|611735|P5|COMPLETED|Washout Period-Placebo||39
253257|NCT01021852|611736|P4|COMPLETED|Washout Period-Placebo||37
253258|NCT01021852|611737|P3|COMPLETED|Washout Period-Placebo||39
253259|NCT01021852|611738|P2|COMPLETED|Washout Period-Placebo||39
253260|NCT01021852|611739|P1|COMPLETED|Washout Period-Placebo||37
253261|NCT01021852|611732|P8|STARTED|Washout Period-Placebo||40
253262|NCT01021852|611733|P7|STARTED|Washout Period-Placebo||41
253263|NCT01021852|611734|P6|STARTED|Washout Period-Placebo|Excludes 1 participant who completed Treatment Period 1 but missed Placebo Washout|39
253264|NCT01021852|611735|P5|STARTED|Washout Period-Placebo|Includes 1 participant that discontinued Treatment Period 1 (AE).|40
253265|NCT01021852|611736|P4|STARTED|Washout Period-Placebo||38
253266|NCT01021852|611737|P3|STARTED|Washout Period-Placebo||39
253267|NCT01021852|611738|P2|STARTED|Washout Period-Placebo||39
253268|NCT01021852|611739|P1|STARTED|Washout Period-Placebo||37
253269|NCT01021852|611732|P8|NOT COMPLETED|Treatment Period 1||1
253270|NCT01021852|611733|P7|NOT COMPLETED|Treatment Period 1||0
253271|NCT01021852|611734|P6|NOT COMPLETED|Treatment Period 1||2
253272|NCT01021852|611735|P5|NOT COMPLETED|Treatment Period 1||3
253273|NCT01021852|611736|P4|NOT COMPLETED|Treatment Period 1||2
253274|NCT01021852|611737|P3|NOT COMPLETED|Treatment Period 1||2
253275|NCT01021852|611738|P2|NOT COMPLETED|Treatment Period 1||1
253276|NCT01021852|611739|P1|NOT COMPLETED|Treatment Period 1||3
253277|NCT01021852|611732|P8|COMPLETED|Treatment Period 1||40
253278|NCT01021852|611733|P7|COMPLETED|Treatment Period 1||41
253279|NCT01021852|611734|P6|COMPLETED|Treatment Period 1||39
253280|NCT01021852|611735|P5|COMPLETED|Treatment Period 1||39
253281|NCT01021852|611736|P4|COMPLETED|Treatment Period 1||38
253282|NCT01021852|611737|P3|COMPLETED|Treatment Period 1||39
253283|NCT01021852|611738|P2|COMPLETED|Treatment Period 1||39
253284|NCT01021852|611739|P1|COMPLETED|Treatment Period 1||37
253285|NCT01021852|611732|P8|Treated|Treatment Period 1||41
253286|NCT01021852|611733|P7|Treated|Treatment Period 1||41
253287|NCT01021852|611734|P6|Treated|Treatment Period 1|1 participant discontinued Treatment Period 1 (AE) but continued in Placebo Washout|41
253288|NCT01021852|611735|P5|Treated|Treatment Period 1||42
253289|NCT01021852|611736|P4|Treated|Treatment Period 1||38
253290|NCT01021852|611737|P3|Treated|Treatment Period 1||41
253291|NCT01021852|611738|P2|Treated|Treatment Period 1||40
253292|NCT01021852|611739|P1|Treated|Treatment Period 1||40
253293|NCT01021852|611732|P8|STARTED|Treatment Period 1||41
253294|NCT01021852|611733|P7|STARTED|Treatment Period 1||41
253295|NCT01021852|611734|P6|STARTED|Treatment Period 1||41
253296|NCT01021852|611735|P5|STARTED|Treatment Period 1||42
253297|NCT01021852|611736|P4|STARTED|Treatment Period 1||40
253298|NCT01021852|611737|P3|STARTED|Treatment Period 1||41
253299|NCT01021852|611738|P2|STARTED|Treatment Period 1||40
253300|NCT01021852|611739|P1|STARTED|Treatment Period 1||40
253301|NCT01021813|611775|P5|NOT COMPLETED|DB Randomized Discontinuation Phase||5
253302|NCT01021813|611776|P4|NOT COMPLETED|DB Randomized Discontinuation Phase||5
253303|NCT01021813|611777|P3|NOT COMPLETED|DB Randomized Discontinuation Phase||4
253304|NCT01021813|611778|P2|NOT COMPLETED|DB Randomized Discontinuation Phase||0
253305|NCT01021813|611779|P1|NOT COMPLETED|DB Randomized Discontinuation Phase||0
253306|NCT01021813|611775|P5|COMPLETED|DB Randomized Discontinuation Phase||157
253307|NCT01021813|611776|P4|COMPLETED|DB Randomized Discontinuation Phase||161
253308|NCT01021813|611777|P3|COMPLETED|DB Randomized Discontinuation Phase||152
253309|NCT01021813|611778|P2|COMPLETED|DB Randomized Discontinuation Phase||0
253310|NCT01021813|611779|P1|COMPLETED|DB Randomized Discontinuation Phase||0
253311|NCT01021813|611775|P5|STARTED|DB Randomized Discontinuation Phase||162
253312|NCT01021813|611776|P4|STARTED|DB Randomized Discontinuation Phase||166
253313|NCT01021813|611777|P3|STARTED|DB Randomized Discontinuation Phase||156
253314|NCT01021813|611778|P2|STARTED|DB Randomized Discontinuation Phase||0
253315|NCT01021813|611779|P1|STARTED|DB Randomized Discontinuation Phase||0
253316|NCT01021813|611775|P5|NOT COMPLETED|DB Treatment Phase||0
253317|NCT01021813|611776|P4|NOT COMPLETED|DB Treatment Phase||0
253318|NCT01021813|611777|P3|NOT COMPLETED|DB Treatment Phase||0
253319|NCT01021813|611778|P2|NOT COMPLETED|DB Treatment Phase||97
253320|NCT01021813|611779|P1|NOT COMPLETED|DB Treatment Phase||200
253321|NCT01021813|611775|P5|COMPLETED|DB Treatment Phase||0
253322|NCT01021813|611776|P4|COMPLETED|DB Treatment Phase||0
253323|NCT01021813|611777|P3|COMPLETED|DB Treatment Phase||0
253324|NCT01021813|611778|P2|COMPLETED|DB Treatment Phase||162
253325|NCT01021813|611779|P1|COMPLETED|DB Treatment Phase||322
253326|NCT01021813|611775|P5|Treated|DB Treatment Phase||0
253327|NCT01021813|611776|P4|Treated|DB Treatment Phase||0
253328|NCT01021813|611777|P3|Treated|DB Treatment Phase||0
253329|NCT01021813|611778|P2|Treated|DB Treatment Phase||258
253330|NCT01021813|611779|P1|Treated|DB Treatment Phase||521
253331|NCT01021813|611775|P5|STARTED|DB Treatment Phase||0
253332|NCT01021813|611776|P4|STARTED|DB Treatment Phase||0
253333|NCT01021813|611777|P3|STARTED|DB Treatment Phase||0
253334|NCT01021813|611778|P2|STARTED|DB Treatment Phase||259
253335|NCT01021813|611779|P1|STARTED|DB Treatment Phase||522
253336|NCT01021761|611821|P3|NOT COMPLETED|Overall Study||0
253337|NCT01021761|611822|P2|NOT COMPLETED|Overall Study||4
253338|NCT01021761|611823|P1|NOT COMPLETED|Overall Study||1
253339|NCT01021761|611821|P3|COMPLETED|Overall Study||42
253340|NCT01021761|611822|P2|COMPLETED|Overall Study||38
253341|NCT01021761|611823|P1|COMPLETED|Overall Study||41
253342|NCT01021761|611821|P3|STARTED|Overall Study||42
253343|NCT01021761|611822|P2|STARTED|Overall Study||42
253344|NCT01021761|611823|P1|STARTED|Overall Study||42
253345|NCT01021748|611840|P9|NOT COMPLETED|Overall Study||16
253346|NCT01021748|611841|P8|NOT COMPLETED|Overall Study||6
253347|NCT01021748|611842|P7|NOT COMPLETED|Overall Study||3
253348|NCT01021748|611843|P6|NOT COMPLETED|Overall Study||3
253349|NCT01021748|611844|P5|NOT COMPLETED|Overall Study||9
253350|NCT01021748|611845|P4|NOT COMPLETED|Overall Study||7
253351|NCT01021748|611846|P3|NOT COMPLETED|Overall Study||7
253352|NCT01021748|611847|P2|NOT COMPLETED|Overall Study||5
253353|NCT01021748|611848|P1|NOT COMPLETED|Overall Study||6
253354|NCT01021748|611840|P9|COMPLETED|Overall Study||1
253355|NCT01021748|611841|P8|COMPLETED|Overall Study||0
253356|NCT01021748|611842|P7|COMPLETED|Overall Study||0
253357|NCT01021748|611843|P6|COMPLETED|Overall Study||0
253358|NCT01021748|611844|P5|COMPLETED|Overall Study||0
253359|NCT01021748|611845|P4|COMPLETED|Overall Study||0
253360|NCT01021748|611846|P3|COMPLETED|Overall Study||0
253361|NCT01021748|611847|P2|COMPLETED|Overall Study||0
253362|NCT01021748|611848|P1|COMPLETED|Overall Study||0
253363|NCT01021748|611840|P9|Treated|Overall Study||17
253364|NCT01021748|611841|P8|Treated|Overall Study||6
253365|NCT01021748|611842|P7|Treated|Overall Study||3
253366|NCT01021748|611843|P6|Treated|Overall Study||3
253367|NCT01021748|611844|P5|Treated|Overall Study||9
253368|NCT01021748|611845|P4|Treated|Overall Study||7
253369|NCT01021748|611846|P3|Treated|Overall Study||7
253370|NCT01021748|611847|P2|Treated|Overall Study|One participant was allocated, but not treated.|4
253371|NCT01021748|611848|P1|Treated|Overall Study||6
253372|NCT01021748|611840|P9|STARTED|Overall Study||17
253373|NCT01021748|611841|P8|STARTED|Overall Study||6
253374|NCT01021748|611842|P7|STARTED|Overall Study||3
253375|NCT01021748|611843|P6|STARTED|Overall Study||3
253376|NCT01021748|611844|P5|STARTED|Overall Study||9
253377|NCT01021748|611845|P4|STARTED|Overall Study||7
253378|NCT01021748|611846|P3|STARTED|Overall Study||7
253379|NCT01021748|611847|P2|STARTED|Overall Study||5
253380|NCT01021748|611848|P1|STARTED|Overall Study||6
253381|NCT01021683|611895|P1|NOT COMPLETED|Overall Study||71
253382|NCT01021683|611895|P1|COMPLETED|Overall Study||132
253383|NCT01021683|611895|P1|STARTED|Overall Study||203
253384|NCT01021618|611909|P2|NOT COMPLETED|Overall Study||0
253385|NCT01021618|611910|P1|NOT COMPLETED|Overall Study||0
253386|NCT01021618|611909|P2|COMPLETED|Overall Study||96
253387|NCT01021618|611910|P1|COMPLETED|Overall Study||44
253388|NCT01021618|611909|P2|STARTED|Overall Study||96
253389|NCT01021618|611910|P1|STARTED|Overall Study||44
253390|NCT01021553|611921|P3|NOT COMPLETED|Overall Study||3
253391|NCT01021553|611922|P2|NOT COMPLETED|Overall Study||5
253392|NCT01021553|611923|P1|NOT COMPLETED|Overall Study||4
253393|NCT01021553|611921|P3|COMPLETED|Overall Study||25
253394|NCT01021553|611922|P2|COMPLETED|Overall Study||17
253395|NCT01021553|611923|P1|COMPLETED|Overall Study||23
253396|NCT01021553|611921|P3|STARTED|Overall Study||28
253397|NCT01021553|611922|P2|STARTED|Overall Study||22
253398|NCT01021553|611923|P1|STARTED|Overall Study||27
253399|NCT01021423|611977|P2|NOT COMPLETED|Overall Study||5
253400|NCT01021423|611978|P1|NOT COMPLETED|Overall Study||4
253401|NCT01021423|611977|P2|COMPLETED|Overall Study||0
253402|NCT01021423|611978|P1|COMPLETED|Overall Study||0
253403|NCT01021423|611977|P2|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to disease progression|5
253404|NCT01021423|611978|P1|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to an AE|4
253405|NCT01021332|611994|P1|NOT COMPLETED|Overall Study||106
253406|NCT01021332|611994|P1|COMPLETED|Overall Study||960
253407|NCT01021332|611994|P1|Full Analysis Set (FAS)|Overall Study||1009
253408|NCT01021332|611994|P1|Safety Analysis Set (SAF)|Overall Study||1066
253409|NCT01021332|611994|P1|STARTED|Overall Study|Took ≥ 1 dose of FDC open-label study drug|1066
253410|NCT01021306|612032|P4|NOT COMPLETED|6 Month (Follow-up)||3
253411|NCT01021306|612033|P3|NOT COMPLETED|6 Month (Follow-up)||0
253412|NCT01021306|612034|P2|NOT COMPLETED|6 Month (Follow-up)||1
253413|NCT01021306|612035|P1|NOT COMPLETED|6 Month (Follow-up)||3
253414|NCT01021306|612032|P4|COMPLETED|6 Month (Follow-up)||14
253415|NCT01021306|612033|P3|COMPLETED|6 Month (Follow-up)||14
253416|NCT01021306|612034|P2|COMPLETED|6 Month (Follow-up)||13
253417|NCT01021306|612035|P1|COMPLETED|6 Month (Follow-up)||11
253418|NCT01021306|612032|P4|STARTED|6 Month (Follow-up)||17
253419|NCT01021306|612033|P3|STARTED|6 Month (Follow-up)||14
253420|NCT01021306|612034|P2|STARTED|6 Month (Follow-up)||14
253421|NCT01021306|612035|P1|STARTED|6 Month (Follow-up)||14
253422|NCT01021306|612032|P4|NOT COMPLETED|2 Month (Primary Outcome)||4
253423|NCT01021306|612033|P3|NOT COMPLETED|2 Month (Primary Outcome)||5
253424|NCT01021306|612034|P2|NOT COMPLETED|2 Month (Primary Outcome)||6
253425|NCT01021306|612035|P1|NOT COMPLETED|2 Month (Primary Outcome)||6
253426|NCT01021306|612032|P4|COMPLETED|2 Month (Primary Outcome)||17
253427|NCT01021306|612033|P3|COMPLETED|2 Month (Primary Outcome)||14
253428|NCT01021306|612034|P2|COMPLETED|2 Month (Primary Outcome)||14
253429|NCT01021306|612035|P1|COMPLETED|2 Month (Primary Outcome)||14
253430|NCT01021306|612032|P4|STARTED|2 Month (Primary Outcome)||21
253431|NCT01021306|612033|P3|STARTED|2 Month (Primary Outcome)||19
253432|NCT01021306|612034|P2|STARTED|2 Month (Primary Outcome)||20
253433|NCT01021306|612035|P1|STARTED|2 Month (Primary Outcome)||20
253434|NCT01021293|612055|P2|NOT COMPLETED|Overall Study||24
253435|NCT01021293|612056|P1|NOT COMPLETED|Overall Study||12
253436|NCT01021293|612055|P2|COMPLETED|Overall Study||526
253437|NCT01021293|612056|P1|COMPLETED|Overall Study||538
253438|NCT01021293|612055|P2|STARTED|Overall Study||550
253439|NCT01021293|612056|P1|STARTED|Overall Study||550
253440|NCT01021215|612075|P2|NOT COMPLETED|Overall Study||0
253441|NCT01021215|612076|P1|NOT COMPLETED|Overall Study||3
253442|NCT01021215|612075|P2|COMPLETED|Overall Study||20
253443|NCT01021215|612076|P1|COMPLETED|Overall Study||57
253444|NCT01021215|612075|P2|Received Allocated Intervention|Overall Study||20
253445|NCT01021215|612076|P1|Received Allocated Intervention|Overall Study||60
253446|NCT01021215|612075|P2|STARTED|Overall Study||20
253447|NCT01021215|612076|P1|STARTED|Overall Study||60
253448|NCT01021137|612090|P4|NOT COMPLETED|Overall Study||9
253449|NCT01021137|612091|P3|NOT COMPLETED|Overall Study||2
253450|NCT01021137|612092|P2|NOT COMPLETED|Overall Study||4
253451|NCT01021137|612093|P1|NOT COMPLETED|Overall Study||10
253452|NCT01021137|612090|P4|COMPLETED|Overall Study||32
253453|NCT01021137|612091|P3|COMPLETED|Overall Study||9
253454|NCT01021137|612092|P2|COMPLETED|Overall Study||16
253455|NCT01021137|612093|P1|COMPLETED|Overall Study||52
253456|NCT01021137|612090|P4|STARTED|Overall Study||41
253457|NCT01021137|612091|P3|STARTED|Overall Study||11
253458|NCT01021137|612092|P2|STARTED|Overall Study||20
253459|NCT01021137|612093|P1|STARTED|Overall Study||62
253460|NCT01021111|612131|P1|NOT COMPLETED|Overall Study||0
253461|NCT01021111|612131|P1|COMPLETED|Overall Study||17
253462|NCT01021111|612131|P1|STARTED|Overall Study||17
253463|NCT01021020|612136|P1|NOT COMPLETED|Period III||0
253464|NCT01021020|612136|P1|COMPLETED|Period III||25
253465|NCT01021020|612136|P1|STARTED|Period III||25
253466|NCT01021020|612136|P1|NOT COMPLETED|14 Day Washout Period B||0
253467|NCT01021020|612136|P1|COMPLETED|14 Day Washout Period B||25
253468|NCT01021020|612136|P1|STARTED|14 Day Washout Period B||25
253469|NCT01021020|612136|P1|NOT COMPLETED|Period II||0
253470|NCT01021020|612136|P1|COMPLETED|Period II||25
253471|NCT01021020|612136|P1|STARTED|Period II||25
253472|NCT01021020|612136|P1|NOT COMPLETED|14 Day Washout Period A||1
253473|NCT01021020|612136|P1|COMPLETED|14 Day Washout Period A|Colchicine/Probenecid-medical investigator dropped due to abnormal check-in lab results.|25
253474|NCT01021020|612136|P1|STARTED|14 Day Washout Period A||26
253475|NCT01021020|612136|P1|NOT COMPLETED|Period I||2
253476|NCT01021020|612136|P1|COMPLETED|Period I|Colchicine(fasted)-subject took Claritin-D 12hour.Colchicine(fed)arm-subject had schedule conflict.|26
253477|NCT01021020|612136|P1|STARTED|Period I||28
253478|NCT01021007|612152|P2|NOT COMPLETED|Overall Study||4
253479|NCT01021007|612153|P1|NOT COMPLETED|Overall Study||2
253480|NCT01021007|612152|P2|COMPLETED|Overall Study||33
253481|NCT01021007|612153|P1|COMPLETED|Overall Study||34
253482|NCT01021007|612152|P2|STARTED|Overall Study||37
253483|NCT01021007|612153|P1|STARTED|Overall Study||36
253484|NCT01020981|612165|P2|NOT COMPLETED|Overall Study||90
253485|NCT01020981|612166|P1|NOT COMPLETED|Overall Study||84
253486|NCT01020981|612165|P2|COMPLETED|Overall Study||60
253487|NCT01020981|612166|P1|COMPLETED|Overall Study||66
253488|NCT01020981|612165|P2|STARTED|Overall Study||150
253489|NCT01020981|612166|P1|STARTED|Overall Study||150
253490|NCT01020903|612178|P2|NOT COMPLETED|Overall Study||0
253491|NCT01020903|612179|P1|NOT COMPLETED|Overall Study||0
253492|NCT01020903|612178|P2|COMPLETED|Overall Study|Please be advised that the investigator of the study entitled left the institution in 2011.|100
253493|NCT01020903|612179|P1|COMPLETED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
253494|NCT01020903|612178|P2|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
253495|NCT01020903|612179|P1|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
253496|NCT01020877|612187|P2|NOT COMPLETED|Second Intervention||0
253497|NCT01020877|612188|P1|NOT COMPLETED|Second Intervention||1
253498|NCT01020877|612187|P2|COMPLETED|Second Intervention||19
253499|NCT01020877|612188|P1|COMPLETED|Second Intervention||18
253500|NCT01020877|612187|P2|STARTED|Second Intervention||19
253501|NCT01020877|612188|P1|STARTED|Second Intervention||19
253502|NCT01020877|612187|P2|NOT COMPLETED|Washout of 7 Days||0
253503|NCT01020877|612188|P1|NOT COMPLETED|Washout of 7 Days||0
253504|NCT01020877|612187|P2|COMPLETED|Washout of 7 Days||19
253505|NCT01020877|612188|P1|COMPLETED|Washout of 7 Days||19
253506|NCT01020877|612187|P2|STARTED|Washout of 7 Days||19
253507|NCT01020877|612188|P1|STARTED|Washout of 7 Days||19
253508|NCT01020877|612187|P2|NOT COMPLETED|First Intervention||0
253509|NCT01020877|612188|P1|NOT COMPLETED|First Intervention||0
253510|NCT01020877|612187|P2|COMPLETED|First Intervention||19
253511|NCT01020877|612188|P1|COMPLETED|First Intervention||19
253512|NCT01020877|612187|P2|STARTED|First Intervention||19
253513|NCT01020877|612188|P1|STARTED|First Intervention||19
253514|NCT01020838|612198|P1|NOT COMPLETED|Overall Study||183
253515|NCT01020838|612198|P1|COMPLETED|Overall Study||35
253516|NCT01020838|612198|P1|Second Annual Repeat Injection|Overall Study|Patients returning for second follow-up administration and PET-scan.|34
253517|NCT01020838|612198|P1|First Annual Repeat Injection|Overall Study|Patients returning for first follow-up administration and PET-scan.|91
253518|NCT01020838|612198|P1|Final Analysis Set (Whole Brain)|Overall Study|Final analysis set comparing PET scans with different histopathological evaluations.|97
253519|NCT01020838|612198|P1|Interim Analysis Set (Primary Efficacy)|Overall Study|Primary efficacy analysis of initial study period (tissue-scan matched regional analysis)|41
253520|NCT01020838|612198|P1|Safety Analysis Set|Overall Study|Two patients were excluded from this population because injection of florbetaben was not done.|216
253521|NCT01020838|612198|P1|STARTED|Overall Study||218
253522|NCT01020812|612213|P1|NOT COMPLETED|Overall Study||3
253523|NCT01020812|612213|P1|COMPLETED|Overall Study||8
253524|NCT01020812|612213|P1|STARTED|Overall Study||11
253525|NCT01020799|612223|P3|NOT COMPLETED|Overall Study||7
253526|NCT01020799|612224|P2|NOT COMPLETED|Overall Study||14
253527|NCT01020799|612225|P1|NOT COMPLETED|Overall Study||19
253528|NCT01020799|612223|P3|COMPLETED|Overall Study||43
253529|NCT01020799|612224|P2|COMPLETED|Overall Study||85
253530|NCT01020799|612225|P1|COMPLETED|Overall Study||79
253531|NCT01020799|612223|P3|Full Analysis Set|Overall Study||49
253532|NCT01020799|612224|P2|Full Analysis Set|Overall Study||94
253533|NCT01020799|612225|P1|Full Analysis Set|Overall Study||91
253534|NCT01020799|612223|P3|Patients Received Treatment|Overall Study||50
253535|NCT01020799|612224|P2|Patients Received Treatment|Overall Study||99
253536|NCT01020799|612225|P1|Patients Received Treatment|Overall Study||96
253537|NCT01020799|612223|P3|STARTED|Overall Study||50
253538|NCT01020799|612224|P2|STARTED|Overall Study||99
253539|NCT01020799|612225|P1|STARTED|Overall Study||98
253540|NCT01020786|612248|P1|NOT COMPLETED|Maintenance Period||60
253541|NCT01020786|612248|P1|COMPLETED|Maintenance Period||0
253542|NCT01020786|612248|P1|STARTED|Maintenance Period||60
253543|NCT01020786|612248|P1|NOT COMPLETED|Induction Period||49
253544|NCT01020786|612248|P1|COMPLETED|Induction Period|Completed induction therapy. Completed=starting the maintenance therapy.|60
253545|NCT01020786|612248|P1|STARTED|Induction Period||109
253546|NCT01020773|612262|P2|NOT COMPLETED|Overall Study||3
253547|NCT01020773|612263|P1|NOT COMPLETED|Overall Study||4
253548|NCT01020773|612262|P2|COMPLETED|Overall Study||29
253549|NCT01020773|612263|P1|COMPLETED|Overall Study||31
253550|NCT01020773|612262|P2|STARTED|Overall Study||32
253551|NCT01020773|612263|P1|STARTED|Overall Study||35
253552|NCT01020747|612269|P1|NOT COMPLETED|Overall Study||1
253553|NCT01020747|612269|P1|COMPLETED|Overall Study||19
253554|NCT01020747|612269|P1|STARTED|Overall Study||20
253555|NCT01020591|612276|P2|NOT COMPLETED|Overall Study||0
253556|NCT01020591|612277|P1|NOT COMPLETED|Overall Study||0
253557|NCT01020591|612276|P2|COMPLETED|Overall Study||15
253558|NCT01020591|612277|P1|COMPLETED|Overall Study||15
253559|NCT01020591|612276|P2|STARTED|Overall Study||15
253560|NCT01020591|612277|P1|STARTED|Overall Study||15
253561|NCT01020526|612285|P1|NOT COMPLETED|Overall Study||14
253562|NCT01020526|612285|P1|COMPLETED|Overall Study||49
253563|NCT01020526|612285|P1|STARTED|Overall Study||63
253564|NCT01020474|612291|P2|NOT COMPLETED|Overall Study||17
253565|NCT01020474|612292|P1|NOT COMPLETED|Overall Study||10
253566|NCT01020474|612291|P2|COMPLETED|Overall Study||36
253567|NCT01020474|612292|P1|COMPLETED|Overall Study||44
253568|NCT01020474|612291|P2|STARTED|Overall Study||53
253569|NCT01020474|612292|P1|STARTED|Overall Study||54
253570|NCT01020448|612312|P1|NOT COMPLETED|Treatment||26
253571|NCT01020448|612312|P1|COMPLETED|Treatment||299
253572|NCT01020448|612312|P1|STARTED|Treatment|One patient was excluded from the safety population as no post-baseline assessment was available|325
253573|NCT01020448|612312|P1|NOT COMPLETED|Pre-assignment||13
253574|NCT01020448|612312|P1|COMPLETED|Pre-assignment||326
253575|NCT01020448|612312|P1|STARTED|Pre-assignment||339
253576|NCT01020435|612323|P2|NOT COMPLETED|Overall Study||1
253577|NCT01020435|612324|P1|NOT COMPLETED|Overall Study||0
253578|NCT01020435|612323|P2|COMPLETED|Overall Study||26
253579|NCT01020435|612324|P1|COMPLETED|Overall Study||24
253580|NCT01020435|612323|P2|STARTED|Overall Study||27
253581|NCT01020435|612324|P1|STARTED|Overall Study||24
253582|NCT01020305|612332|P1|NOT COMPLETED|Overall Study||2
253583|NCT01020305|612332|P1|COMPLETED|Overall Study||3
253584|NCT01020305|612332|P1|STARTED|Overall Study||5
253585|NCT01020123|612343|P7|NOT COMPLETED|Extention Period||1
253586|NCT01020123|612344|P6|NOT COMPLETED|Extention Period||2
253587|NCT01020123|612345|P5|NOT COMPLETED|Extention Period||0
253588|NCT01020123|612346|P4|NOT COMPLETED|Extention Period||1
253589|NCT01020123|612347|P3|NOT COMPLETED|Extention Period||2
253590|NCT01020123|612348|P2|NOT COMPLETED|Extention Period||2
253591|NCT01020123|612349|P1|NOT COMPLETED|Extention Period||3
253592|NCT01020123|612343|P7|COMPLETED|Extention Period||18
253593|NCT01020123|612344|P6|COMPLETED|Extention Period||36
253594|NCT01020123|612345|P5|COMPLETED|Extention Period||31
253595|NCT01020123|612346|P4|COMPLETED|Extention Period||12
253596|NCT01020123|612347|P3|COMPLETED|Extention Period||17
253597|NCT01020123|612348|P2|COMPLETED|Extention Period||33
253598|NCT01020123|612349|P1|COMPLETED|Extention Period||37
253599|NCT01020123|612343|P7|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
253600|NCT01020123|612344|P6|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|38
253601|NCT01020123|612345|P5|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|31
253602|NCT01020123|612346|P4|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|13
253603|NCT01020123|612347|P3|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
253604|NCT01020123|612348|P2|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|35
253605|NCT01020123|612349|P1|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|40
253606|NCT01020123|612343|P7|NOT COMPLETED|Main Period||11
253607|NCT01020123|612344|P6|NOT COMPLETED|Main Period||11
253608|NCT01020123|612345|P5|NOT COMPLETED|Main Period||11
253609|NCT01020123|612346|P4|NOT COMPLETED|Main Period||7
253610|NCT01020123|612347|P3|NOT COMPLETED|Main Period||8
253611|NCT01020123|612348|P2|NOT COMPLETED|Main Period||14
253612|NCT01020123|612349|P1|NOT COMPLETED|Main Period||17
253613|NCT01020123|612343|P7|COMPLETED|Main Period||61
253614|NCT01020123|612344|P6|COMPLETED|Main Period||83
253615|NCT01020123|612345|P5|COMPLETED|Main Period||77
253616|NCT01020123|612346|P4|COMPLETED|Main Period||33
253617|NCT01020123|612347|P3|COMPLETED|Main Period||44
253618|NCT01020123|612348|P2|COMPLETED|Main Period||77
253619|NCT01020123|612349|P1|COMPLETED|Main Period||76
253620|NCT01020123|612343|P7|STARTED|Main Period||72
253621|NCT01020123|612344|P6|STARTED|Main Period||94
253622|NCT01020123|612345|P5|STARTED|Main Period||88
253623|NCT01020123|612346|P4|STARTED|Main Period||40
253624|NCT01020123|612347|P3|STARTED|Main Period||52
253625|NCT01020123|612348|P2|STARTED|Main Period||91
253626|NCT01020123|612349|P1|STARTED|Main Period||93
253627|NCT01020019|612544|P2|NOT COMPLETED|Overall Study||29
253628|NCT01020019|612545|P1|NOT COMPLETED|Overall Study||26
253629|NCT01020019|612544|P2|COMPLETED|Overall Study||32
253630|NCT01020019|612545|P1|COMPLETED|Overall Study||35
253631|NCT01020019|612544|P2|STARTED|Overall Study||61
253632|NCT01020019|612545|P1|STARTED|Overall Study||61
253633|NCT01020006|612554|P3|NOT COMPLETED|Overall Study||16
253634|NCT01020006|612555|P2|NOT COMPLETED|Overall Study||18
253635|NCT01020006|612556|P1|NOT COMPLETED|Overall Study||8
253636|NCT01020006|612554|P3|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
253637|NCT01020006|612555|P2|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
253638|NCT01020006|612556|P1|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
253639|NCT01020006|612554|P3|STARTED|Overall Study||16
253640|NCT01020006|612555|P2|STARTED|Overall Study||18
253641|NCT01020006|612556|P1|STARTED|Overall Study||8
253642|NCT01019980|612566|P2|NOT COMPLETED|Overall Study||0
253643|NCT01019980|612567|P1|NOT COMPLETED|Overall Study||2
253644|NCT01019980|612566|P2|COMPLETED|Overall Study||0
253645|NCT01019980|612567|P1|COMPLETED|Overall Study||0
253646|NCT01019980|612566|P2|Discontinued|Overall Study||0
253647|NCT01019980|612567|P1|Discontinued|Overall Study||2
253648|NCT01019980|612566|P2|STARTED|Overall Study||0
253649|NCT01019980|612567|P1|STARTED|Overall Study|2 patients entered study but did not receive any drug since it was not available in the region.|2
253650|NCT01019928|612575|P2|NOT COMPLETED|Period 3||0
253651|NCT01019928|612576|P1|NOT COMPLETED|Period 3||0
253652|NCT01019928|612575|P2|COMPLETED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
253653|NCT01019928|612576|P1|COMPLETED|Period 3||7
253654|NCT01019928|612575|P2|STARTED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
253655|NCT01019928|612576|P1|STARTED|Period 3||7
253656|NCT01019928|612575|P2|NOT COMPLETED|Period 2||1
253657|NCT01019928|612576|P1|NOT COMPLETED|Period 2||0
253658|NCT01019928|612575|P2|COMPLETED|Period 2|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
253659|NCT01019928|612576|P1|COMPLETED|Period 2||7
253660|NCT01019928|612575|P2|STARTED|Period 2||7
253661|NCT01019928|612576|P1|STARTED|Period 2||7
253662|NCT01019928|612575|P2|NOT COMPLETED|Period 1||0
253663|NCT01019928|612576|P1|NOT COMPLETED|Period 1||0
253664|NCT01019928|612575|P2|COMPLETED|Period 1||7
253665|NCT01019928|612576|P1|COMPLETED|Period 1||7
253666|NCT01019928|612575|P2|STARTED|Period 1||7
253667|NCT01019928|612576|P1|STARTED|Period 1||7
253668|NCT01019707|612616|P2|NOT COMPLETED|Second Phase||0
253669|NCT01019707|612617|P1|NOT COMPLETED|Second Phase||0
253670|NCT01019707|612616|P2|COMPLETED|Second Phase||1
253671|NCT01019707|612617|P1|COMPLETED|Second Phase||3
253672|NCT01019707|612616|P2|STARTED|Second Phase||1
253673|NCT01019707|612617|P1|STARTED|Second Phase||3
253674|NCT01019707|612616|P2|NOT COMPLETED|Washout||2
253675|NCT01019707|612617|P1|NOT COMPLETED|Washout||0
253676|NCT01019707|612616|P2|COMPLETED|Washout||1
253677|NCT01019707|612617|P1|COMPLETED|Washout||3
253678|NCT01019707|612616|P2|STARTED|Washout||3
253679|NCT01019707|612617|P1|STARTED|Washout||3
253680|NCT01019707|612616|P2|NOT COMPLETED|First Phase||0
253681|NCT01019707|612617|P1|NOT COMPLETED|First Phase||0
253682|NCT01019707|612616|P2|COMPLETED|First Phase||3
253683|NCT01019707|612617|P1|COMPLETED|First Phase||3
253684|NCT01019707|612616|P2|STARTED|First Phase||3
253685|NCT01019707|612617|P1|STARTED|First Phase||3
253686|NCT01019694|612630|P3|NOT COMPLETED|Overall Study||47
253687|NCT01019694|612631|P2|NOT COMPLETED|Overall Study||38
253688|NCT01019694|612632|P1|NOT COMPLETED|Overall Study||24
253689|NCT01019694|612630|P3|COMPLETED|Overall Study||110
253690|NCT01019694|612631|P2|COMPLETED|Overall Study||118
253691|NCT01019694|612632|P1|COMPLETED|Overall Study||133
253692|NCT01019694|612630|P3|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
253693|NCT01019694|612631|P2|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|156
253694|NCT01019694|612632|P1|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
253695|NCT01019486|612757|P3|NOT COMPLETED|Overall Study||1
253696|NCT01019486|612758|P2|NOT COMPLETED|Overall Study||1
253697|NCT01019486|612759|P1|NOT COMPLETED|Overall Study||1
253698|NCT01019486|612757|P3|COMPLETED|Overall Study||15
253699|NCT01019486|612758|P2|COMPLETED|Overall Study||4
253700|NCT01019486|612759|P1|COMPLETED|Overall Study||4
253701|NCT01019486|612757|P3|STARTED|Overall Study||16
253702|NCT01019486|612758|P2|STARTED|Overall Study||5
253703|NCT01019486|612759|P1|STARTED|Overall Study||5
253704|NCT01019369|612773|P2|NOT COMPLETED|Overall Study||7
253705|NCT01019369|612774|P1|NOT COMPLETED|Overall Study||10
253706|NCT01019369|612773|P2|COMPLETED|Overall Study||39
253707|NCT01019369|612774|P1|COMPLETED|Overall Study||76
253708|NCT01019369|612773|P2|STARTED|Overall Study||46
253709|NCT01019369|612774|P1|STARTED|Overall Study||86
253710|NCT01019317|612790|P1|NOT COMPLETED|Overall Study||4
253711|NCT01019317|612790|P1|COMPLETED|Overall Study||147
253712|NCT01019317|612790|P1|STARTED|Overall Study||151
253713|NCT01019252|612796|P2|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||7
253714|NCT01019252|612797|P1|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||0
253715|NCT01019252|612796|P2|COMPLETED|Wait List Cross-over to CBT for ADHD||15
253716|NCT01019252|612797|P1|COMPLETED|Wait List Cross-over to CBT for ADHD||21
253717|NCT01019252|612796|P2|STARTED|Wait List Cross-over to CBT for ADHD||22
253718|NCT01019252|612797|P1|STARTED|Wait List Cross-over to CBT for ADHD|Lost to follow up, did not start treatment following wait list completion (n=3)|21
253719|NCT01019252|612796|P2|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||0
253720|NCT01019252|612797|P1|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||3
253721|NCT01019252|612796|P2|COMPLETED|Initial CBT for ADHD vs. Wait List||22
253722|NCT01019252|612797|P1|COMPLETED|Initial CBT for ADHD vs. Wait List||21
253723|NCT01019252|612796|P2|STARTED|Initial CBT for ADHD vs. Wait List|Stratified based on biological sex and clinician-rated severity (CGI score)|22
253724|NCT01019252|612797|P1|STARTED|Initial CBT for ADHD vs. Wait List|Stratified based on biological sex and clinician-rated severity (CGI score)|24
253725|NCT01019135|612810|P3|NOT COMPLETED|Overall Study||31
253726|NCT01019135|612811|P2|NOT COMPLETED|Overall Study||19
253727|NCT01019135|612812|P1|NOT COMPLETED|Overall Study||20
253728|NCT01019135|612810|P3|COMPLETED|Overall Study||24
253729|NCT01019135|612811|P2|COMPLETED|Overall Study||40
253730|NCT01019135|612812|P1|COMPLETED|Overall Study||35
253731|NCT01019135|612810|P3|STARTED|Overall Study||55
253732|NCT01019135|612811|P2|STARTED|Overall Study||59
253733|NCT01019135|612812|P1|STARTED|Overall Study||55
253734|NCT01018992|612840|P2|NOT COMPLETED|Overall Study||16
253735|NCT01018992|612841|P1|NOT COMPLETED|Overall Study||16
253736|NCT01018992|612840|P2|COMPLETED|Overall Study||49
253737|NCT01018992|612841|P1|COMPLETED|Overall Study||47
253738|NCT01018992|612840|P2|STARTED|Overall Study||65
253739|NCT01018992|612841|P1|STARTED|Overall Study||63
253740|NCT01018979|612855|P2|NOT COMPLETED|Overall Study||10
253741|NCT01018979|612856|P1|NOT COMPLETED|Overall Study||3
253742|NCT01018979|612855|P2|COMPLETED|Overall Study||3
253743|NCT01018979|612856|P1|COMPLETED|Overall Study||4
253744|NCT01018979|612855|P2|Received at Least One Dose|Overall Study||12
253745|NCT01018979|612856|P1|Received at Least One Dose|Overall Study||7
253746|NCT01018979|612855|P2|STARTED|Overall Study|A total of 20 subjects were randomized.|13
253747|NCT01018979|612856|P1|STARTED|Overall Study||7
253748|NCT01018953|612886|P1|NOT COMPLETED|Overall Study||8
253749|NCT01018953|612886|P1|COMPLETED|Overall Study||0
253750|NCT01018953|612886|P1|BIM 23A760 4 mg|Overall Study||3
253751|NCT01018953|612886|P1|BIM 23A760 2 mg|Overall Study||2
253752|NCT01018953|612886|P1|BIM 23A760 1 mg|Overall Study||3
253753|NCT01018953|612886|P1|STARTED|Overall Study||8
253754|NCT01018862|612899|P3|NOT COMPLETED|Overall Study||16
253755|NCT01018862|612900|P2|NOT COMPLETED|Overall Study||10
253756|NCT01018862|612901|P1|NOT COMPLETED|Overall Study||13
253757|NCT01018862|612899|P3|COMPLETED|Overall Study||146
253758|NCT01018862|612900|P2|COMPLETED|Overall Study||156
253759|NCT01018862|612901|P1|COMPLETED|Overall Study||148
253760|NCT01018862|612899|P3|STARTED|Overall Study||162
253761|NCT01018862|612900|P2|STARTED|Overall Study||166
253762|NCT01018862|612901|P1|STARTED|Overall Study||161
253763|NCT01018810|612923|P5|NOT COMPLETED|Overall Study||1
253764|NCT01018810|612924|P4|NOT COMPLETED|Overall Study||1
253765|NCT01018810|612925|P3|NOT COMPLETED|Overall Study||1
253766|NCT01018810|612926|P2|NOT COMPLETED|Overall Study||1
253767|NCT01018810|612927|P1|NOT COMPLETED|Overall Study||2
253768|NCT01018810|612923|P5|COMPLETED|Overall Study||0
253769|NCT01018810|612924|P4|COMPLETED|Overall Study||0
253770|NCT01018810|612925|P3|COMPLETED|Overall Study||0
253771|NCT01018810|612926|P2|COMPLETED|Overall Study||0
253772|NCT01018810|612927|P1|COMPLETED|Overall Study||2
253773|NCT01018810|612923|P5|STARTED|Overall Study||1
253774|NCT01018810|612924|P4|STARTED|Overall Study||1
253775|NCT01018810|612925|P3|STARTED|Overall Study||1
253776|NCT01018810|612926|P2|STARTED|Overall Study||1
253777|NCT01018810|612927|P1|STARTED|Overall Study||4
253778|NCT01018732|612987|P3|NOT COMPLETED|Overall Study||4
253779|NCT01018732|612988|P2|NOT COMPLETED|Overall Study||2
253780|NCT01018732|612989|P1|NOT COMPLETED|Overall Study||1
253781|NCT01018732|612987|P3|COMPLETED|Overall Study||50
253782|NCT01018732|612988|P2|COMPLETED|Overall Study||49
253783|NCT01018732|612989|P1|COMPLETED|Overall Study||49
253784|NCT01018732|612987|P3|STARTED|Overall Study||54
253785|NCT01018732|612988|P2|STARTED|Overall Study||51
253786|NCT01018732|612989|P1|STARTED|Overall Study||50
253787|NCT01018680|613023|P2|NOT COMPLETED|Overall Study||75
253788|NCT01018680|613024|P1|NOT COMPLETED|Overall Study||61
253789|NCT01018680|613023|P2|COMPLETED|Overall Study||189
253790|NCT01018680|613024|P1|COMPLETED|Overall Study||199
253791|NCT01018680|613023|P2|STARTED|Overall Study||264
253792|NCT01018680|613024|P1|STARTED|Overall Study||260
253793|NCT01020487|613067|P3|NOT COMPLETED|Part 2 Open-label Period||1
253794|NCT01020487|613068|P2|NOT COMPLETED|Part 2 Open-label Period||4
253795|NCT01020487|613069|P1|NOT COMPLETED|Part 2 Open-label Period||0
253796|NCT01020487|613067|P3|COMPLETED|Part 2 Open-label Period||12
253797|NCT01020487|613068|P2|COMPLETED|Part 2 Open-label Period||12
253798|NCT01020487|613069|P1|COMPLETED|Part 2 Open-label Period||0
253799|NCT01020487|613067|P3|STARTED|Part 2 Open-label Period||13
253800|NCT01020487|613068|P2|STARTED|Part 2 Open-label Period||16
253801|NCT01020487|613069|P1|STARTED|Part 2 Open-label Period||0
253802|NCT01020487|613067|P3|NOT COMPLETED|Part 2 Double-blind Treatment Period||6
253803|NCT01020487|613068|P2|NOT COMPLETED|Part 2 Double-blind Treatment Period||2
253804|NCT01020487|613069|P1|NOT COMPLETED|Part 2 Double-blind Treatment Period||0
253805|NCT01020487|613067|P3|COMPLETED|Part 2 Double-blind Treatment Period||13
253806|NCT01020487|613068|P2|COMPLETED|Part 2 Double-blind Treatment Period||16
253807|NCT01020487|613069|P1|COMPLETED|Part 2 Double-blind Treatment Period||0
253808|NCT01020487|613067|P3|Received Treatment|Part 2 Double-blind Treatment Period||18
253809|NCT01020487|613068|P2|Received Treatment|Part 2 Double-blind Treatment Period||18
253810|NCT01020487|613069|P1|Received Treatment|Part 2 Double-blind Treatment Period||0
253811|NCT01020487|613067|P3|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|19
253812|NCT01020487|613068|P2|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|18
253813|NCT01020487|613069|P1|STARTED|Part 2 Double-blind Treatment Period||0
253814|NCT01020487|613067|P3|NOT COMPLETED|Part 1||0
253815|NCT01020487|613068|P2|NOT COMPLETED|Part 1||0
253816|NCT01020487|613069|P1|NOT COMPLETED|Part 1||0
253817|NCT01020487|613067|P3|COMPLETED|Part 1||0
253818|NCT01020487|613068|P2|COMPLETED|Part 1||0
253819|NCT01020487|613069|P1|COMPLETED|Part 1||12
253820|NCT01020487|613067|P3|STARTED|Part 1||0
253821|NCT01020487|613068|P2|STARTED|Part 1||0
253822|NCT01020487|613069|P1|STARTED|Part 1||12
253823|NCT01018511|613094|P4|NOT COMPLETED|Overall Study||33
253824|NCT01018511|613095|P3|NOT COMPLETED|Overall Study||40
253825|NCT01018511|613096|P2|NOT COMPLETED|Overall Study||32
253826|NCT01018511|613097|P1|NOT COMPLETED|Overall Study||26
253827|NCT01018511|613094|P4|COMPLETED|Overall Study||294
253828|NCT01018511|613095|P3|COMPLETED|Overall Study||299
253829|NCT01018511|613096|P2|COMPLETED|Overall Study||295
253830|NCT01018511|613097|P1|COMPLETED|Overall Study||315
253831|NCT01018511|613094|P4|Randomized and Treated|Overall Study||324
253832|NCT01018511|613095|P3|Randomized and Treated|Overall Study||338
253833|NCT01018511|613096|P2|Randomized and Treated|Overall Study||326
253834|NCT01018511|613097|P1|Randomized and Treated|Overall Study||341
253835|NCT01018511|613094|P4|STARTED|Overall Study||327
253836|NCT01018511|613095|P3|STARTED|Overall Study||339
253837|NCT01018511|613096|P2|STARTED|Overall Study||327
253838|NCT01018511|613097|P1|STARTED|Overall Study||341
253839|NCT01018420|613266|P2|NOT COMPLETED|Overall Study||0
253840|NCT01018420|613267|P1|NOT COMPLETED|Overall Study||0
253841|NCT01018420|613266|P2|COMPLETED|Overall Study||3
253842|NCT01018420|613267|P1|COMPLETED|Overall Study||15
253843|NCT01018420|613266|P2|STARTED|Overall Study||3
253844|NCT01018420|613267|P1|STARTED|Overall Study||15
253845|NCT01018394|613294|P2|NOT COMPLETED|Overall Study||8
253846|NCT01018394|613295|P1|NOT COMPLETED|Overall Study||9
253847|NCT01018394|613294|P2|COMPLETED|Overall Study||33
253848|NCT01018394|613295|P1|COMPLETED|Overall Study||31
253849|NCT01018394|613294|P2|STARTED|Overall Study||41
253850|NCT01018394|613295|P1|STARTED|Overall Study||40
253851|NCT01018264|613305|P2|NOT COMPLETED|Overall Study||1
253852|NCT01018264|613306|P1|NOT COMPLETED|Overall Study||1
253853|NCT01018264|613305|P2|COMPLETED|Overall Study||12
253854|NCT01018264|613306|P1|COMPLETED|Overall Study||9
253855|NCT01018264|613305|P2|STARTED|Overall Study||13
253856|NCT01018264|613306|P1|STARTED|Overall Study||10
253857|NCT01018186|613323|P4|NOT COMPLETED|52-week Double-blind Treatment Period||29
253858|NCT01018186|613324|P3|NOT COMPLETED|52-week Double-blind Treatment Period||41
253859|NCT01018186|613325|P2|NOT COMPLETED|52-week Double-blind Treatment Period||40
253860|NCT01018186|613326|P1|NOT COMPLETED|52-week Double-blind Treatment Period||0
253861|NCT01018186|613323|P4|COMPLETED|52-week Double-blind Treatment Period||71
253862|NCT01018186|613324|P3|COMPLETED|52-week Double-blind Treatment Period||161
253863|NCT01018186|613325|P2|COMPLETED|52-week Double-blind Treatment Period||161
253864|NCT01018186|613326|P1|COMPLETED|52-week Double-blind Treatment Period||0
253865|NCT01018186|613323|P4|STARTED|52-week Double-blind Treatment Period||100
253866|NCT01018186|613324|P3|STARTED|52-week Double-blind Treatment Period||202
253867|NCT01018186|613325|P2|STARTED|52-week Double-blind Treatment Period||201
253868|NCT01018186|613326|P1|STARTED|52-week Double-blind Treatment Period||0
253869|NCT01018186|613323|P4|NOT COMPLETED|2-week Run-in Period||0
253870|NCT01018186|613324|P3|NOT COMPLETED|2-week Run-in Period||0
253871|NCT01018186|613325|P2|NOT COMPLETED|2-week Run-in Period||0
253872|NCT01018186|613326|P1|NOT COMPLETED|2-week Run-in Period||114
253873|NCT01018186|613323|P4|COMPLETED|2-week Run-in Period||0
253874|NCT01018186|613324|P3|COMPLETED|2-week Run-in Period||0
253875|NCT01018186|613325|P2|COMPLETED|2-week Run-in Period||0
253876|NCT01018186|613326|P1|COMPLETED|2-week Run-in Period||503
253877|NCT01018186|613323|P4|STARTED|2-week Run-in Period||0
253878|NCT01018186|613324|P3|STARTED|2-week Run-in Period||0
253879|NCT01018186|613325|P2|STARTED|2-week Run-in Period||0
253880|NCT01018186|613326|P1|STARTED|2-week Run-in Period||617
253881|NCT01018134|613418|P6|NOT COMPLETED|Overall Study||0
253882|NCT01018134|613419|P5|NOT COMPLETED|Overall Study||0
253883|NCT01018134|613420|P4|NOT COMPLETED|Overall Study||0
253884|NCT01018134|613421|P3|NOT COMPLETED|Overall Study||1
253885|NCT01018134|613422|P2|NOT COMPLETED|Overall Study||1
253886|NCT01018134|613423|P1|NOT COMPLETED|Overall Study||0
253887|NCT01018134|613418|P6|COMPLETED|Overall Study||15
253888|NCT01018134|613419|P5|COMPLETED|Overall Study||15
253889|NCT01018134|613420|P4|COMPLETED|Overall Study||29
253890|NCT01018134|613421|P3|COMPLETED|Overall Study||29
253891|NCT01018134|613422|P2|COMPLETED|Overall Study||30
253892|NCT01018134|613423|P1|COMPLETED|Overall Study||30
253893|NCT01018134|613418|P6|STARTED|Overall Study||15
253894|NCT01018134|613419|P5|STARTED|Overall Study||15
253895|NCT01018134|613420|P4|STARTED|Overall Study|30 enrolled patients, one who did not use the study medication was excluded from all analyses|29
253896|NCT01018134|613421|P3|STARTED|Overall Study||30
253897|NCT01018134|613422|P2|STARTED|Overall Study||31
253898|NCT01018134|613423|P1|STARTED|Overall Study||30
253899|NCT01018095|613463|P2|NOT COMPLETED|Overall Study||62
253900|NCT01018095|613464|P1|NOT COMPLETED|Overall Study||56
253901|NCT01018095|613463|P2|COMPLETED|Overall Study||73
253902|NCT01018095|613464|P1|COMPLETED|Overall Study||79
253903|NCT01018095|613463|P2|STARTED|Overall Study||135
253904|NCT01018095|613464|P1|STARTED|Overall Study||135
253905|NCT01018056|613475|P3|NOT COMPLETED|Overall Study||1
253906|NCT01018056|613476|P2|NOT COMPLETED|Overall Study||2
253907|NCT01018056|613477|P1|NOT COMPLETED|Overall Study||3
253908|NCT01018056|613475|P3|COMPLETED|Overall Study||5
253909|NCT01018056|613476|P2|COMPLETED|Overall Study||10
253910|NCT01018056|613477|P1|COMPLETED|Overall Study||9
253911|NCT01018056|613475|P3|STARTED|Overall Study||6
253912|NCT01018056|613476|P2|STARTED|Overall Study||12
253913|NCT01018056|613477|P1|STARTED|Overall Study||12
253914|NCT01018030|613527|P3|NOT COMPLETED|Overall Study||13
253915|NCT01018030|613528|P2|NOT COMPLETED|Overall Study||11
253916|NCT01018030|613529|P1|NOT COMPLETED|Overall Study||19
253917|NCT01018030|613527|P3|COMPLETED|Overall Study||239
253918|NCT01018030|613528|P2|COMPLETED|Overall Study||232
253919|NCT01018030|613529|P1|COMPLETED|Overall Study||227
253920|NCT01018030|613527|P3|STARTED|Overall Study||252
253921|NCT01018030|613528|P2|STARTED|Overall Study||243
253922|NCT01018030|613529|P1|STARTED|Overall Study||246
253923|NCT01017952|613580|P5|NOT COMPLETED|52-week, Double-blind Treatment Period||103
253924|NCT01017952|613581|P4|NOT COMPLETED|52-week, Double-blind Treatment Period||112
253925|NCT01017952|613582|P3|NOT COMPLETED|52-week, Double-blind Treatment Period||109
253926|NCT01017952|613583|P2|NOT COMPLETED|52-week, Double-blind Treatment Period||125
253927|NCT01017952|613584|P1|NOT COMPLETED|52-week, Double-blind Treatment Period||0
253928|NCT01017952|613580|P5|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|306
253929|NCT01017952|613581|P4|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|291
253930|NCT01017952|613582|P3|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|303
253931|NCT01017952|613583|P2|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|284
253932|NCT01017952|613584|P1|COMPLETED|52-week, Double-blind Treatment Period||0
253933|NCT01017952|613580|P5|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|307
253934|NCT01017952|613581|P4|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|293
253935|NCT01017952|613582|P3|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|305
253936|NCT01017952|613583|P2|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|285
253937|NCT01017952|613584|P1|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
253938|NCT01017952|613580|P5|STARTED|52-week, Double-blind Treatment Period||409
253939|NCT01017952|613581|P4|STARTED|52-week, Double-blind Treatment Period||403
253940|NCT01017952|613582|P3|STARTED|52-week, Double-blind Treatment Period||412
253941|NCT01017952|613583|P2|STARTED|52-week, Double-blind Treatment Period||409
253942|NCT01017952|613584|P1|STARTED|52-week, Double-blind Treatment Period||0
253943|NCT01017952|613580|P5|NOT COMPLETED|4-week, Open-label Run-In Period||0
253944|NCT01017952|613581|P4|NOT COMPLETED|4-week, Open-label Run-In Period||0
253945|NCT01017952|613582|P3|NOT COMPLETED|4-week, Open-label Run-In Period||0
253946|NCT01017952|613583|P2|NOT COMPLETED|4-week, Open-label Run-In Period||0
253947|NCT01017952|613584|P1|NOT COMPLETED|4-week, Open-label Run-In Period||459
253948|NCT01017952|613580|P5|COMPLETED|4-week, Open-label Run-In Period||0
253949|NCT01017952|613581|P4|COMPLETED|4-week, Open-label Run-In Period||0
253950|NCT01017952|613582|P3|COMPLETED|4-week, Open-label Run-In Period||0
253951|NCT01017952|613583|P2|COMPLETED|4-week, Open-label Run-In Period||0
253952|NCT01017952|613584|P1|COMPLETED|4-week, Open-label Run-In Period||1633
253953|NCT01017952|613580|P5|STARTED|4-week, Open-label Run-In Period||0
253954|NCT01017952|613581|P4|STARTED|4-week, Open-label Run-In Period||0
253955|NCT01017952|613582|P3|STARTED|4-week, Open-label Run-In Period||0
253956|NCT01017952|613583|P2|STARTED|4-week, Open-label Run-In Period||0
253957|NCT01017952|613584|P1|STARTED|4-week, Open-label Run-In Period||2092
253958|NCT01017874|613608|P2|NOT COMPLETED|Overall Study||26
253959|NCT01017874|613609|P1|NOT COMPLETED|Overall Study||30
253960|NCT01017874|613608|P2|COMPLETED|Overall Study||92
253961|NCT01017874|613609|P1|COMPLETED|Overall Study||88
253962|NCT01017874|613608|P2|Received at Least 1 Dose of Study Drug|Overall Study||118
253963|NCT01017874|613609|P1|Received at Least 1 Dose of Study Drug|Overall Study||114
253964|NCT01017874|613608|P2|STARTED|Overall Study||118
253965|NCT01017874|613609|P1|STARTED|Overall Study||118
253966|NCT01017731|613627|P1|NOT COMPLETED|Overall Study||8
253967|NCT01017731|613627|P1|COMPLETED|Overall Study||60
253968|NCT01017731|613627|P1|Received at Least 1 Dose of Study Drug|Overall Study||66
253969|NCT01017731|613627|P1|STARTED|Overall Study||68
253970|NCT01017653|613644|P1|NOT COMPLETED|Overall Study||0
253971|NCT01017653|613644|P1|COMPLETED|Overall Study||16
253972|NCT01017653|613644|P1|STARTED|Overall Study||16
253973|NCT01017601|613656|P2|NOT COMPLETED|Overall Study||13
253974|NCT01017601|613657|P1|NOT COMPLETED|Overall Study||12
253975|NCT01017601|613656|P2|COMPLETED|Overall Study||11
253976|NCT01017601|613657|P1|COMPLETED|Overall Study||14
253977|NCT01017601|613656|P2|STARTED|Overall Study||24
253978|NCT01017601|613657|P1|STARTED|Overall Study||26
253979|NCT01017575|613684|P5|NOT COMPLETED|Overall Study||3
253980|NCT01017575|613685|P4|NOT COMPLETED|Overall Study||1
253981|NCT01017575|613686|P3|NOT COMPLETED|Overall Study||0
253982|NCT01017575|613687|P2|NOT COMPLETED|Overall Study||2
253983|NCT01017575|613688|P1|NOT COMPLETED|Overall Study||1
253984|NCT01017575|613684|P5|COMPLETED|Overall Study||6
253985|NCT01017575|613685|P4|COMPLETED|Overall Study||7
253986|NCT01017575|613686|P3|COMPLETED|Overall Study||8
253987|NCT01017575|613687|P2|COMPLETED|Overall Study||7
253988|NCT01017575|613688|P1|COMPLETED|Overall Study||7
253989|NCT01017575|613684|P5|STARTED|Overall Study||9
253990|NCT01017575|613685|P4|STARTED|Overall Study||8
253991|NCT01017575|613686|P3|STARTED|Overall Study||8
253992|NCT01017575|613687|P2|STARTED|Overall Study||9
253993|NCT01017575|613688|P1|STARTED|Overall Study||8
253994|NCT01017549|613725|P1|NOT COMPLETED|One-year Follow-up||7
253995|NCT01017549|613725|P1|COMPLETED|One-year Follow-up||36
253996|NCT01017549|613725|P1|STARTED|One-year Follow-up||43
253997|NCT01017549|613725|P1|NOT COMPLETED|Eligibility Through 6 Month Follow-up||1
253998|NCT01017549|613725|P1|COMPLETED|Eligibility Through 6 Month Follow-up|6 month follow-up complete Oct 2008; data through 6 months and 1 year are published.|43
253999|NCT01017549|613725|P1|STARTED|Eligibility Through 6 Month Follow-up||44
254000|NCT01017536|613732|P2|NOT COMPLETED|Overall Study||0
254001|NCT01017536|613733|P1|NOT COMPLETED|Overall Study||0
254002|NCT01017536|613732|P2|COMPLETED|Overall Study||13
254003|NCT01017536|613733|P1|COMPLETED|Overall Study||13
254004|NCT01017536|613732|P2|STARTED|Overall Study||13
254005|NCT01017536|613733|P1|STARTED|Overall Study||13
254006|NCT01017497|613743|P1|NOT COMPLETED|Overall Study||0
254007|NCT01017497|613743|P1|COMPLETED|Overall Study||49
254008|NCT01017497|613743|P1|STARTED|Overall Study||49
254009|NCT01017263|613756|P1|NOT COMPLETED|Overall Study||12
254010|NCT01017263|613756|P1|COMPLETED|Overall Study|A total of 14 participants screened: 2 qualified and received drug the remaining 12 failed screen|2
254011|NCT01017263|613756|P1|STARTED|Overall Study||14
254012|NCT01017250|613760|P1|NOT COMPLETED|Overall Study||0
254013|NCT01017250|613760|P1|COMPLETED|Overall Study||15
254014|NCT01017250|613760|P1|2-month MRI|Overall Study|1 participant did not return for the 2 month MRI at treating facility. Resides out of state.|14
254015|NCT01017250|613760|P1|STARTED|Overall Study||15
254016|NCT01017237|613782|P2|NOT COMPLETED|Overall Study||2
254017|NCT01017237|613783|P1|NOT COMPLETED|Overall Study||5
254018|NCT01017237|613782|P2|COMPLETED|Overall Study||6
254019|NCT01017237|613783|P1|COMPLETED|Overall Study||5
254020|NCT01017237|613782|P2|STARTED|Overall Study||8
254021|NCT01017237|613783|P1|STARTED|Overall Study||10
254022|NCT01017146|613837|P2|NOT COMPLETED|Overall Study||39
254023|NCT01017146|613838|P1|NOT COMPLETED|Overall Study||66
254024|NCT01017146|613837|P2|COMPLETED|Overall Study||333
254025|NCT01017146|613838|P1|COMPLETED|Overall Study||306
254026|NCT01017146|613837|P2|STARTED|Overall Study||372
254027|NCT01017146|613838|P1|STARTED|Overall Study||372
254028|NCT01017120|613876|P2|NOT COMPLETED|Overall Study||35
254029|NCT01017120|613877|P1|NOT COMPLETED|Overall Study||66
254030|NCT01017120|613876|P2|COMPLETED|Overall Study||334
254031|NCT01017120|613877|P1|COMPLETED|Overall Study||307
254032|NCT01017120|613876|P2|STARTED|Overall Study||369
254033|NCT01017120|613877|P1|STARTED|Overall Study||373
254034|NCT01017042|613925|P1|NOT COMPLETED|Overall Study||0
254035|NCT01017042|613925|P1|COMPLETED|Overall Study||13
254036|NCT01017042|613925|P1|STARTED|Overall Study||13
254037|NCT01017029|613938|P2|NOT COMPLETED|Overall Study||2
254038|NCT01017029|613939|P1|NOT COMPLETED|Overall Study||4
254039|NCT01017029|613938|P2|COMPLETED|Overall Study||90
254040|NCT01017029|613939|P1|COMPLETED|Overall Study||85
254041|NCT01017029|613938|P2|STARTED|Overall Study||92
254042|NCT01017029|613939|P1|STARTED|Overall Study||89
254043|NCT01017003|613955|P1|NOT COMPLETED|Colchicine 0.6 mg Final Dose||0
254044|NCT01017003|613955|P1|COMPLETED|Colchicine 0.6 mg Final Dose||13
254045|NCT01017003|613955|P1|STARTED|Colchicine 0.6 mg Final Dose||13
254046|NCT01017003|613955|P1|NOT COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||0
254047|NCT01017003|613955|P1|COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||13
254048|NCT01017003|613955|P1|STARTED|Colchicine 0.6 mg Twice Daily x 10 Days||13
254049|NCT01017003|613955|P1|NOT COMPLETED|14 Day Washout Period||0
254050|NCT01017003|613955|P1|COMPLETED|14 Day Washout Period||13
254051|NCT01017003|613955|P1|STARTED|14 Day Washout Period||13
254052|NCT01017003|613955|P1|NOT COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||0
254053|NCT01017003|613955|P1|COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||13
254054|NCT01017003|613955|P1|STARTED|Single Dose Colchicine 0.6 mg, Day 1||13
254055|NCT01016977|613967|P2|NOT COMPLETED|Overall Study||2
254056|NCT01016977|613968|P1|NOT COMPLETED|Overall Study||3
254057|NCT01016977|613967|P2|COMPLETED|Overall Study||18
254058|NCT01016977|613968|P1|COMPLETED|Overall Study||17
254059|NCT01016977|613967|P2|STARTED|Overall Study||20
254060|NCT01016977|613968|P1|STARTED|Overall Study||20
254061|NCT01016964|614004|P2|NOT COMPLETED|Overall Study||3
254062|NCT01016964|614005|P1|NOT COMPLETED|Overall Study||3
254063|NCT01016964|614004|P2|COMPLETED|Overall Study||39
254064|NCT01016964|614005|P1|COMPLETED|Overall Study||18
254065|NCT01016964|614004|P2|STARTED|Overall Study||42
254066|NCT01016964|614005|P1|STARTED|Overall Study||21
254067|NCT01016938|614011|P1|NOT COMPLETED|Overall Study||9
254068|NCT01016938|614011|P1|COMPLETED|Overall Study||7
254069|NCT01016938|614011|P1|STARTED|Overall Study||16
254070|NCT01016912|614021|P5|NOT COMPLETED|Follow-up Period||0
254071|NCT01016912|614022|P4|NOT COMPLETED|Follow-up Period||1
254072|NCT01016912|614023|P3|NOT COMPLETED|Follow-up Period||1
254073|NCT01016912|614024|P2|NOT COMPLETED|Follow-up Period||0
254074|NCT01016912|614025|P1|NOT COMPLETED|Follow-up Period||0
254075|NCT01016912|614021|P5|COMPLETED|Follow-up Period||9
254076|NCT01016912|614022|P4|COMPLETED|Follow-up Period||8
254077|NCT01016912|614023|P3|COMPLETED|Follow-up Period||9
254078|NCT01016912|614024|P2|COMPLETED|Follow-up Period||9
254079|NCT01016912|614025|P1|COMPLETED|Follow-up Period||8
254080|NCT01016912|614021|P5|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
254081|NCT01016912|614022|P4|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
254175|NCT01016678|614160|P2|STARTED|Overall Study||17
254082|NCT01016912|614023|P3|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|10
254083|NCT01016912|614024|P2|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
254084|NCT01016912|614025|P1|STARTED|Follow-up Period||8
254085|NCT01016912|614021|P5|NOT COMPLETED|End of Treatment Period||4
254086|NCT01016912|614022|P4|NOT COMPLETED|End of Treatment Period||4
254087|NCT01016912|614023|P3|NOT COMPLETED|End of Treatment Period||1
254088|NCT01016912|614024|P2|NOT COMPLETED|End of Treatment Period||3
254089|NCT01016912|614025|P1|NOT COMPLETED|End of Treatment Period||0
254090|NCT01016912|614021|P5|COMPLETED|End of Treatment Period||5
254091|NCT01016912|614022|P4|COMPLETED|End of Treatment Period||5
254092|NCT01016912|614023|P3|COMPLETED|End of Treatment Period||9
254093|NCT01016912|614024|P2|COMPLETED|End of Treatment Period||6
254094|NCT01016912|614025|P1|COMPLETED|End of Treatment Period||8
254095|NCT01016912|614021|P5|Received Treatment|End of Treatment Period||9
254096|NCT01016912|614022|P4|Received Treatment|End of Treatment Period||9
254097|NCT01016912|614023|P3|Received Treatment|End of Treatment Period||10
254098|NCT01016912|614024|P2|Received Treatment|End of Treatment Period||9
254099|NCT01016912|614025|P1|Received Treatment|End of Treatment Period||8
254100|NCT01016912|614021|P5|STARTED|End of Treatment Period||9
254101|NCT01016912|614022|P4|STARTED|End of Treatment Period||9
254102|NCT01016912|614023|P3|STARTED|End of Treatment Period||10
254103|NCT01016912|614024|P2|STARTED|End of Treatment Period||9
254104|NCT01016912|614025|P1|STARTED|End of Treatment Period||8
254105|NCT01016873|614070|P3|NOT COMPLETED|36 Months||6
254106|NCT01016873|614071|P2|NOT COMPLETED|36 Months||4
254107|NCT01016873|614072|P1|NOT COMPLETED|36 Months||11
254108|NCT01016873|614070|P3|COMPLETED|36 Months||67
254109|NCT01016873|614071|P2|COMPLETED|36 Months||64
254110|NCT01016873|614072|P1|COMPLETED|36 Months||58
254111|NCT01016873|614070|P3|STARTED|36 Months||73
254112|NCT01016873|614071|P2|STARTED|36 Months||68
254113|NCT01016873|614072|P1|STARTED|36 Months||69
254114|NCT01016873|614070|P3|NOT COMPLETED|24 Months||6
254115|NCT01016873|614071|P2|NOT COMPLETED|24 Months||4
254116|NCT01016873|614072|P1|NOT COMPLETED|24 Months||5
254117|NCT01016873|614070|P3|COMPLETED|24 Months||73
254118|NCT01016873|614071|P2|COMPLETED|24 Months||68
254119|NCT01016873|614072|P1|COMPLETED|24 Months||69
254120|NCT01016873|614070|P3|STARTED|24 Months||79
254121|NCT01016873|614071|P2|STARTED|24 Months||72
254122|NCT01016873|614072|P1|STARTED|24 Months||74
254123|NCT01016873|614070|P3|NOT COMPLETED|12 Months||1
254124|NCT01016873|614071|P2|NOT COMPLETED|12 Months||3
254125|NCT01016873|614072|P1|NOT COMPLETED|12 Months||1
254126|NCT01016873|614070|P3|COMPLETED|12 Months||79
254127|NCT01016873|614071|P2|COMPLETED|12 Months||72
254128|NCT01016873|614072|P1|COMPLETED|12 Months||74
254129|NCT01016873|614070|P3|STARTED|12 Months||80
254130|NCT01016873|614071|P2|STARTED|12 Months||75
254131|NCT01016873|614072|P1|STARTED|12 Months||75
254132|NCT01016847|614103|P2|NOT COMPLETED|Overall Study||0
254133|NCT01016847|614104|P1|NOT COMPLETED|Overall Study||0
254134|NCT01016847|614103|P2|COMPLETED|Overall Study||2
254135|NCT01016847|614104|P1|COMPLETED|Overall Study||1
254136|NCT01016847|614103|P2|STARTED|Overall Study||2
254137|NCT01016847|614104|P1|STARTED|Overall Study||1
254138|NCT01016834|614120|P1|NOT COMPLETED|Overall Study||22
254139|NCT01016834|614120|P1|COMPLETED|Overall Study||220
254140|NCT01016834|614120|P1|STARTED|Overall Study||242
254141|NCT01016769|614130|P4|NOT COMPLETED|Overall Study||0
254142|NCT01016769|614131|P3|NOT COMPLETED|Overall Study||1
254143|NCT01016769|614132|P2|NOT COMPLETED|Overall Study||1
254144|NCT01016769|614133|P1|NOT COMPLETED|Overall Study||1
254145|NCT01016769|614130|P4|COMPLETED|Overall Study||30
254146|NCT01016769|614131|P3|COMPLETED|Overall Study||6
254147|NCT01016769|614132|P2|COMPLETED|Overall Study||6
254148|NCT01016769|614133|P1|COMPLETED|Overall Study||3
254149|NCT01016769|614130|P4|STARTED|Overall Study||30
254150|NCT01016769|614131|P3|STARTED|Overall Study||7
254151|NCT01016769|614132|P2|STARTED|Overall Study||7
254152|NCT01016769|614133|P1|STARTED|Overall Study||4
254153|NCT01016691|614147|P3|NOT COMPLETED|Overall Study||0
254154|NCT01016691|614148|P2|NOT COMPLETED|Overall Study||0
254155|NCT01016691|614149|P1|NOT COMPLETED|Overall Study||0
254156|NCT01016691|614147|P3|COMPLETED|Overall Study||18
254157|NCT01016691|614148|P2|COMPLETED|Overall Study||12
254158|NCT01016691|614149|P1|COMPLETED|Overall Study||17
254159|NCT01016691|614147|P3|STARTED|Overall Study||18
254160|NCT01016691|614148|P2|STARTED|Overall Study||12
254161|NCT01016691|614149|P1|STARTED|Overall Study||17
254162|NCT01016678|614157|P5|NOT COMPLETED|Overall Study||6
254163|NCT01016678|614158|P4|NOT COMPLETED|Overall Study||0
254164|NCT01016678|614159|P3|NOT COMPLETED|Overall Study||4
254165|NCT01016678|614160|P2|NOT COMPLETED|Overall Study||3
254166|NCT01016678|614161|P1|NOT COMPLETED|Overall Study||2
254167|NCT01016678|614157|P5|COMPLETED|Overall Study||13
254168|NCT01016678|614158|P4|COMPLETED|Overall Study||19
254169|NCT01016678|614159|P3|COMPLETED|Overall Study||15
254170|NCT01016678|614160|P2|COMPLETED|Overall Study||14
254171|NCT01016678|614161|P1|COMPLETED|Overall Study||18
254172|NCT01016678|614157|P5|STARTED|Overall Study||19
254173|NCT01016678|614158|P4|STARTED|Overall Study||19
254174|NCT01016678|614159|P3|STARTED|Overall Study||19
254176|NCT01016678|614161|P1|STARTED|Overall Study||20
254177|NCT01016652|614183|P2|NOT COMPLETED|Period 2||0
254178|NCT01016652|614184|P1|NOT COMPLETED|Period 2||0
254179|NCT01016652|614183|P2|COMPLETED|Period 2||24
254180|NCT01016652|614184|P1|COMPLETED|Period 2||25
254181|NCT01016652|614183|P2|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|24
254182|NCT01016652|614184|P1|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|25
254183|NCT01016652|614183|P2|NOT COMPLETED|Period 1||0
254184|NCT01016652|614184|P1|NOT COMPLETED|Period 1||0
254185|NCT01016652|614183|P2|COMPLETED|Period 1||24
254186|NCT01016652|614184|P1|COMPLETED|Period 1||25
254187|NCT01016652|614183|P2|STARTED|Period 1||24
254188|NCT01016652|614184|P1|STARTED|Period 1||25
254189|NCT01016600|614204|P4|NOT COMPLETED|Overall Study||0
254190|NCT01016600|614205|P3|NOT COMPLETED|Overall Study||0
254191|NCT01016600|614206|P2|NOT COMPLETED|Overall Study||0
254192|NCT01016600|614207|P1|NOT COMPLETED|Overall Study||1
254193|NCT01016600|614204|P4|COMPLETED|Overall Study||12
254194|NCT01016600|614205|P3|COMPLETED|Overall Study||6
254195|NCT01016600|614206|P2|COMPLETED|Overall Study||4
254196|NCT01016600|614207|P1|COMPLETED|Overall Study||8
254197|NCT01016600|614204|P4|STARTED|Overall Study||12
254198|NCT01016600|614205|P3|STARTED|Overall Study||6
254199|NCT01016600|614206|P2|STARTED|Overall Study||4
254200|NCT01016600|614207|P1|STARTED|Overall Study||9
254201|NCT01016483|614274|P4|NOT COMPLETED|Phase II||0
254202|NCT01016483|614275|P3|NOT COMPLETED|Phase II||0
254203|NCT01016483|614276|P2|NOT COMPLETED|Phase II||0
254204|NCT01016483|614277|P1|NOT COMPLETED|Phase II||0
254205|NCT01016483|614274|P4|COMPLETED|Phase II||44
254206|NCT01016483|614275|P3|COMPLETED|Phase II||44
254207|NCT01016483|614276|P2|COMPLETED|Phase II||0
254208|NCT01016483|614277|P1|COMPLETED|Phase II||0
254209|NCT01016483|614274|P4|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|45
254210|NCT01016483|614275|P3|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|42
254211|NCT01016483|614276|P2|Treated (Safety Analysis Set [SAF])|Phase II||0
254212|NCT01016483|614277|P1|Treated (Safety Analysis Set [SAF])|Phase II||0
254213|NCT01016483|614274|P4|STARTED|Phase II|Subjects presented as randomized (ITT Analysis Set).|44
254214|NCT01016483|614275|P3|STARTED|Phase II|Subjects presented as randomized (Intention-to-Treat [ITT] Analysis Set).|44
254215|NCT01016483|614276|P2|STARTED|Phase II||0
254216|NCT01016483|614277|P1|STARTED|Phase II||0
254217|NCT01016483|614274|P4|NOT COMPLETED|Safety Run-in Part||0
254218|NCT01016483|614275|P3|NOT COMPLETED|Safety Run-in Part||0
254219|NCT01016483|614276|P2|NOT COMPLETED|Safety Run-in Part||0
254220|NCT01016483|614277|P1|NOT COMPLETED|Safety Run-in Part||0
254221|NCT01016483|614274|P4|COMPLETED|Safety Run-in Part||0
254222|NCT01016483|614275|P3|COMPLETED|Safety Run-in Part||0
254223|NCT01016483|614276|P2|COMPLETED|Safety Run-in Part||26
254224|NCT01016483|614277|P1|COMPLETED|Safety Run-in Part||27
254225|NCT01016483|614274|P4|STARTED|Safety Run-in Part||0
254226|NCT01016483|614275|P3|STARTED|Safety Run-in Part||0
254227|NCT01016483|614276|P2|STARTED|Safety Run-in Part||26
254228|NCT01016483|614277|P1|STARTED|Safety Run-in Part||27
254229|NCT01016353|614385|P2|NOT COMPLETED|Overall Study||1
254230|NCT01016353|614386|P1|NOT COMPLETED|Overall Study||2
254231|NCT01016353|614385|P2|COMPLETED|Overall Study||102
254232|NCT01016353|614386|P1|COMPLETED|Overall Study||178
254233|NCT01016353|614385|P2|STARTED|Overall Study||103
254234|NCT01016353|614386|P1|STARTED|Overall Study||180
254235|NCT01016262|614395|P6|NOT COMPLETED|Open-Label Phase||0
254236|NCT01016262|614396|P5|NOT COMPLETED|Open-Label Phase||2
254237|NCT01016262|614397|P4|NOT COMPLETED|Open-Label Phase||2
254238|NCT01016262|614398|P3|NOT COMPLETED|Open-Label Phase||0
254239|NCT01016262|614399|P2|NOT COMPLETED|Open-Label Phase||0
254240|NCT01016262|614400|P1|NOT COMPLETED|Open-Label Phase||0
254241|NCT01016262|614395|P6|COMPLETED|Open-Label Phase||20
254242|NCT01016262|614396|P5|COMPLETED|Open-Label Phase||50
254243|NCT01016262|614397|P4|COMPLETED|Open-Label Phase||42
254244|NCT01016262|614398|P3|COMPLETED|Open-Label Phase||0
254245|NCT01016262|614399|P2|COMPLETED|Open-Label Phase||0
254246|NCT01016262|614400|P1|COMPLETED|Open-Label Phase||0
254247|NCT01016262|614395|P6|STARTED|Open-Label Phase||20
254248|NCT01016262|614396|P5|STARTED|Open-Label Phase||52
254249|NCT01016262|614397|P4|STARTED|Open-Label Phase||44
254250|NCT01016262|614398|P3|STARTED|Open-Label Phase||0
254251|NCT01016262|614399|P2|STARTED|Open-Label Phase||0
254252|NCT01016262|614400|P1|STARTED|Open-Label Phase||0
254253|NCT01016262|614395|P6|NOT COMPLETED|Double-blind Phase||0
254254|NCT01016262|614396|P5|NOT COMPLETED|Double-blind Phase||0
254255|NCT01016262|614397|P4|NOT COMPLETED|Double-blind Phase||0
254256|NCT01016262|614398|P3|NOT COMPLETED|Double-blind Phase||9
254257|NCT01016262|614399|P2|NOT COMPLETED|Double-blind Phase||1
254258|NCT01016262|614400|P1|NOT COMPLETED|Double-blind Phase||1
254259|NCT01016262|614395|P6|COMPLETED|Double-blind Phase||0
254260|NCT01016262|614396|P5|COMPLETED|Double-blind Phase||0
254261|NCT01016262|614397|P4|COMPLETED|Double-blind Phase||0
254262|NCT01016262|614398|P3|COMPLETED|Double-blind Phase||30
254263|NCT01016262|614399|P2|COMPLETED|Double-blind Phase||38
254264|NCT01016262|614400|P1|COMPLETED|Double-blind Phase||40
254265|NCT01016262|614395|P6|STARTED|Double-blind Phase||0
254266|NCT01016262|614396|P5|STARTED|Double-blind Phase||0
254267|NCT01016262|614397|P4|STARTED|Double-blind Phase||0
254268|NCT01016262|614398|P3|STARTED|Double-blind Phase||39
254269|NCT01016262|614399|P2|STARTED|Double-blind Phase||39
254270|NCT01016262|614400|P1|STARTED|Double-blind Phase||41
254271|NCT01016132|614423|P1|NOT COMPLETED|Overall Study||1
254272|NCT01016132|614423|P1|COMPLETED|Overall Study||151
254273|NCT01016132|614423|P1|STARTED|Overall Study||152
254274|NCT01016106|614429|P2|NOT COMPLETED|Overall Study||0
254275|NCT01016106|614430|P1|NOT COMPLETED|Overall Study||0
254276|NCT01016106|614429|P2|COMPLETED|Overall Study||18
254277|NCT01016106|614430|P1|COMPLETED|Overall Study||17
254278|NCT01016106|614429|P2|STARTED|Overall Study||18
254279|NCT01016106|614430|P1|STARTED|Overall Study||17
254280|NCT01016067|614438|P2|NOT COMPLETED|Overall Study||4
254281|NCT01016067|614439|P1|NOT COMPLETED|Overall Study||2
254282|NCT01016067|614438|P2|COMPLETED|Overall Study||8
254283|NCT01016067|614439|P1|COMPLETED|Overall Study||9
254284|NCT01016067|614438|P2|STARTED|Overall Study||12
254285|NCT01016067|614439|P1|STARTED|Overall Study||11
254286|NCT01016015|614457|P1|NOT COMPLETED|Overall Study||19
254287|NCT01016015|614457|P1|COMPLETED|Overall Study||159
254288|NCT01016015|614457|P1|STARTED|Overall Study||178
254289|NCT01015976|614461|P2|NOT COMPLETED|Overall Study||0
254290|NCT01015976|614462|P1|NOT COMPLETED|Overall Study||0
254291|NCT01015976|614461|P2|COMPLETED|Overall Study||5
254292|NCT01015976|614462|P1|COMPLETED|Overall Study||5
254293|NCT01015976|614461|P2|STARTED|Overall Study||5
254294|NCT01015976|614462|P1|STARTED|Overall Study||5
254295|NCT01015833|614468|P2|NOT COMPLETED|Overall Study||5
254296|NCT01015833|614469|P1|NOT COMPLETED|Overall Study||13
254297|NCT01015833|614468|P2|COMPLETED|Overall Study||171
254298|NCT01015833|614469|P1|COMPLETED|Overall Study||167
254299|NCT01015833|614468|P2|STARTED|Overall Study||176
254300|NCT01015833|614469|P1|STARTED|Overall Study||180
254301|NCT01015820|614485|P2|NOT COMPLETED|Overall Study||0
254302|NCT01015820|614486|P1|NOT COMPLETED|Overall Study||1
254303|NCT01015820|614485|P2|COMPLETED|Overall Study||15
254304|NCT01015820|614486|P1|COMPLETED|Overall Study||14
254305|NCT01015820|614485|P2|STARTED|Overall Study||15
254306|NCT01015820|614486|P1|STARTED|Overall Study||15
254307|NCT01015807|614497|P3|NOT COMPLETED|Overall Study||0
254308|NCT01015807|614498|P2|NOT COMPLETED|Overall Study||0
254309|NCT01015807|614499|P1|NOT COMPLETED|Overall Study||0
254310|NCT01015807|614497|P3|COMPLETED|Overall Study||30
254311|NCT01015807|614498|P2|COMPLETED|Overall Study||30
254312|NCT01015807|614499|P1|COMPLETED|Overall Study||30
254313|NCT01015807|614497|P3|STARTED|Overall Study||30
254314|NCT01015807|614498|P2|STARTED|Overall Study||30
254315|NCT01015807|614499|P1|STARTED|Overall Study||30
254316|NCT01015781|614509|P2|NOT COMPLETED|Overall Study||29
254317|NCT01015781|614510|P1|NOT COMPLETED|Overall Study||37
254318|NCT01015781|614509|P2|COMPLETED|Overall Study||121
254319|NCT01015781|614510|P1|COMPLETED|Overall Study||113
254320|NCT01015781|614509|P2|STARTED|Overall Study||150
254321|NCT01015781|614510|P1|STARTED|Overall Study||150
254322|NCT01015703|614521|P5|NOT COMPLETED|Overall Study||0
254323|NCT01015703|614522|P4|NOT COMPLETED|Overall Study||0
254324|NCT01015703|614523|P3|NOT COMPLETED|Overall Study||0
254325|NCT01015703|614524|P2|NOT COMPLETED|Overall Study||1
254326|NCT01015703|614525|P1|NOT COMPLETED|Overall Study||2
254327|NCT01015703|614521|P5|COMPLETED|Overall Study||10
254328|NCT01015703|614522|P4|COMPLETED|Overall Study||10
254329|NCT01015703|614523|P3|COMPLETED|Overall Study||10
254330|NCT01015703|614524|P2|COMPLETED|Overall Study||9
254331|NCT01015703|614525|P1|COMPLETED|Overall Study||8
254332|NCT01015703|614521|P5|STARTED|Overall Study||10
254333|NCT01015703|614522|P4|STARTED|Overall Study||10
254334|NCT01015703|614523|P3|STARTED|Overall Study||10
254335|NCT01015703|614524|P2|STARTED|Overall Study||10
254336|NCT01015703|614525|P1|STARTED|Overall Study||10
254337|NCT01015677|614540|P3|NOT COMPLETED|Overall Study||0
254338|NCT01015677|614541|P2|NOT COMPLETED|Overall Study||4
254339|NCT01015677|614542|P1|NOT COMPLETED|Overall Study||1
254340|NCT01015677|614540|P3|COMPLETED|Overall Study||33
254341|NCT01015677|614541|P2|COMPLETED|Overall Study||28
254342|NCT01015677|614542|P1|COMPLETED|Overall Study||33
254343|NCT01015677|614540|P3|STARTED|Overall Study||33
254344|NCT01015677|614541|P2|STARTED|Overall Study||32
254345|NCT01015677|614542|P1|STARTED|Overall Study||34
254346|NCT01015638|614564|P2|NOT COMPLETED|Overall Study||0
254347|NCT01015638|614565|P1|NOT COMPLETED|Overall Study||1
254348|NCT01015638|614564|P2|COMPLETED|Overall Study||19
254349|NCT01015638|614565|P1|COMPLETED|Overall Study||16
254350|NCT01015638|614564|P2|STARTED|Overall Study||19
254351|NCT01015638|614565|P1|STARTED|Overall Study||17
254352|NCT01015612|614593|P1|NOT COMPLETED|Overall Study||153
254353|NCT01015612|614593|P1|COMPLETED|Overall Study||481
254354|NCT01015612|614593|P1|STARTED|Overall Study||634
254355|NCT01015586|614605|P2|NOT COMPLETED|Overall Study||11
254356|NCT01015586|614606|P1|NOT COMPLETED|Overall Study||7
254357|NCT01015586|614605|P2|COMPLETED|Overall Study||11
254358|NCT01015586|614606|P1|COMPLETED|Overall Study||14
254359|NCT01015586|614605|P2|STARTED|Overall Study||22
254360|NCT01015586|614606|P1|STARTED|Overall Study||21
254361|NCT01015560|614624|P1|NOT COMPLETED|Overall Study||3
254362|NCT01015560|614624|P1|COMPLETED|Overall Study||41
254363|NCT01015560|614624|P1|Eligible and Analyzable|Overall Study||43
254364|NCT01015560|614624|P1|STARTED|Overall Study||44
254365|NCT01015534|614630|P2|NOT COMPLETED|Overall Study||0
254366|NCT01015534|614631|P1|NOT COMPLETED|Overall Study||1
254367|NCT01015534|614630|P2|COMPLETED|Overall Study||27
254368|NCT01015534|614631|P1|COMPLETED|Overall Study||27
254369|NCT01015534|614630|P2|STARTED|Overall Study||27
254370|NCT01015534|614631|P1|STARTED|Overall Study||28
254371|NCT01015443|614645|P2|NOT COMPLETED|Overall Study||0
254372|NCT01015443|614646|P1|NOT COMPLETED|Overall Study||0
254373|NCT01015443|614645|P2|COMPLETED|Overall Study||94
254374|NCT01015443|614646|P1|COMPLETED|Overall Study||191
254375|NCT01015443|614645|P2|Treated|Overall Study||93
254376|NCT01015443|614646|P1|Treated|Overall Study||191
254377|NCT01015443|614645|P2|STARTED|Overall Study||94
254378|NCT01015443|614646|P1|STARTED|Overall Study||191
254379|NCT01015326|614664|P2|NOT COMPLETED|Overall Study||2
254380|NCT01015326|614665|P1|NOT COMPLETED|Overall Study||1
254381|NCT01015326|614664|P2|COMPLETED|Overall Study||18
254382|NCT01015326|614665|P1|COMPLETED|Overall Study||11
254383|NCT01015326|614664|P2|STARTED|Overall Study||20
254384|NCT01015326|614665|P1|STARTED|Overall Study||12
254385|NCT01015287|614673|P2|NOT COMPLETED|Overall Study||79
254386|NCT01015287|614674|P1|NOT COMPLETED|Overall Study||72
254387|NCT01015287|614673|P2|COMPLETED|Overall Study||1958
254388|NCT01015287|614674|P1|COMPLETED|Overall Study||1924
254389|NCT01015287|614673|P2|Received at Least 1 Dose of Study Drug|Overall Study||2037
254390|NCT01015287|614674|P1|Received at Least 1 Dose of Study Drug|Overall Study||1996
254391|NCT01015287|614673|P2|STARTED|Overall Study||2037
254392|NCT01015287|614674|P1|STARTED|Overall Study||1996
254393|NCT01015170|614700|P1|NOT COMPLETED|Overall Study||239
254394|NCT01015170|614700|P1|COMPLETED|Overall Study||215
254395|NCT01015170|614700|P1|STARTED|Overall Study||454
254396|NCT01015131|614706|P1|NOT COMPLETED|Overall Study||8
254397|NCT01015131|614706|P1|COMPLETED|Overall Study||36
254398|NCT01015131|614706|P1|STARTED|Overall Study||44
254399|NCT01015118|614722|P2|NOT COMPLETED|Overall Study||327
254400|NCT01015118|614723|P1|NOT COMPLETED|Overall Study||669
254401|NCT01015118|614722|P2|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|128
254402|NCT01015118|614723|P1|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|242
254403|NCT01015118|614722|P2|STARTED|Overall Study||455
254404|NCT01015118|614723|P1|STARTED|Overall Study||911
254405|NCT01014988|614751|P6|NOT COMPLETED|Overall Study||3
254406|NCT01014988|614752|P5|NOT COMPLETED|Overall Study||1
254407|NCT01014988|614753|P4|NOT COMPLETED|Overall Study||0
254408|NCT01014988|614754|P3|NOT COMPLETED|Overall Study||2
254409|NCT01014988|614755|P2|NOT COMPLETED|Overall Study||0
254410|NCT01014988|614756|P1|NOT COMPLETED|Overall Study||23
254411|NCT01014988|614751|P6|COMPLETED|Overall Study||11
254412|NCT01014988|614752|P5|COMPLETED|Overall Study||26
254413|NCT01014988|614753|P4|COMPLETED|Overall Study||12
254414|NCT01014988|614754|P3|COMPLETED|Overall Study||9
254415|NCT01014988|614755|P2|COMPLETED|Overall Study||7
254416|NCT01014988|614756|P1|COMPLETED|Overall Study||107
254417|NCT01014988|614751|P6|STARTED|Overall Study||14
254418|NCT01014988|614752|P5|STARTED|Overall Study||27
254419|NCT01014988|614753|P4|STARTED|Overall Study||12
254420|NCT01014988|614754|P3|STARTED|Overall Study||11
254421|NCT01014988|614755|P2|STARTED|Overall Study||7
254422|NCT01014988|614756|P1|STARTED|Overall Study||130
254423|NCT01014975|614928|P3|NOT COMPLETED|Overall Study||6
254424|NCT01014975|614929|P2|NOT COMPLETED|Overall Study||3
254425|NCT01014975|614930|P1|NOT COMPLETED|Overall Study||4
254426|NCT01014975|614928|P3|COMPLETED|Overall Study||10
254427|NCT01014975|614929|P2|COMPLETED|Overall Study||13
254428|NCT01014975|614930|P1|COMPLETED|Overall Study||4
254429|NCT01014975|614928|P3|STARTED|Overall Study||16
254430|NCT01014975|614929|P2|STARTED|Overall Study||16
254431|NCT01014975|614930|P1|STARTED|Overall Study||8
254432|NCT01014936|614941|P3|NOT COMPLETED|Overall Study||0
254433|NCT01014936|614942|P2|NOT COMPLETED|Overall Study||0
254434|NCT01014936|614943|P1|NOT COMPLETED|Overall Study||0
254435|NCT01014936|614941|P3|COMPLETED|Overall Study||62
254436|NCT01014936|614942|P2|COMPLETED|Overall Study||45
254437|NCT01014936|614943|P1|COMPLETED|Overall Study||42
254438|NCT01014936|614941|P3|STARTED|Overall Study||62
254439|NCT01014936|614942|P2|STARTED|Overall Study||45
254440|NCT01014936|614943|P1|STARTED|Overall Study||42
254441|NCT01014910|615435|P2|NOT COMPLETED|Overall Study||2
254442|NCT01014910|615436|P1|NOT COMPLETED|Overall Study||0
254443|NCT01014910|615435|P2|COMPLETED|Overall Study||79
254444|NCT01014910|615436|P1|COMPLETED|Overall Study||80
254445|NCT01014910|615435|P2|STARTED|Overall Study||81
254446|NCT01014910|615436|P1|STARTED|Overall Study||80
254447|NCT01014871|615444|P1|NOT COMPLETED|Overall Study||0
254448|NCT01014871|615444|P1|COMPLETED|Overall Study||30
254449|NCT01014871|615444|P1|STARTED|Overall Study||30
254450|NCT01014767|615454|P4|NOT COMPLETED|Overall Study||1
254451|NCT01014767|615455|P3|NOT COMPLETED|Overall Study||4
254452|NCT01014767|615456|P2|NOT COMPLETED|Overall Study||1
254453|NCT01014767|615457|P1|NOT COMPLETED|Overall Study||12
254454|NCT01014767|615454|P4|COMPLETED|Overall Study||0
254455|NCT01014767|615455|P3|COMPLETED|Overall Study||0
254456|NCT01014767|615456|P2|COMPLETED|Overall Study||0
254457|NCT01014767|615457|P1|COMPLETED|Overall Study||0
254458|NCT01014767|615454|P4|STARTED|Overall Study||1
254459|NCT01014767|615455|P3|STARTED|Overall Study||4
254460|NCT01014767|615456|P2|STARTED|Overall Study||1
254461|NCT01014767|615457|P1|STARTED|Overall Study||12
254462|NCT01014741|615473|P2|NOT COMPLETED|Overall Study||5
254463|NCT01014741|615474|P1|NOT COMPLETED|Overall Study||11
254464|NCT01014741|615473|P2|COMPLETED|Overall Study||90
254465|NCT01014741|615474|P1|COMPLETED|Overall Study||94
254466|NCT01014741|615473|P2|STARTED|Overall Study||95
254467|NCT01014741|615474|P1|STARTED|Overall Study||105
254468|NCT01014728|615488|P2|NOT COMPLETED|Overall Study||0
254469|NCT01014728|615489|P1|NOT COMPLETED|Overall Study||0
254470|NCT01014728|615488|P2|COMPLETED|Overall Study||15
254471|NCT01014728|615489|P1|COMPLETED|Overall Study||18
254472|NCT01014728|615488|P2|STARTED|Overall Study||15
254473|NCT01014728|615489|P1|STARTED|Overall Study||18
254474|NCT01014689|615501|P2|NOT COMPLETED|Overall Study||13
254475|NCT01014689|615502|P1|NOT COMPLETED|Overall Study||13
254476|NCT01014689|615501|P2|COMPLETED|Overall Study||174
254477|NCT01014689|615502|P1|COMPLETED|Overall Study||178
254478|NCT01014689|615501|P2|STARTED|Overall Study||187
254479|NCT01014689|615502|P1|STARTED|Overall Study||191
254480|NCT01014624|615512|P2|NOT COMPLETED|Overall Study||1
254481|NCT01014624|615513|P1|NOT COMPLETED|Overall Study||2
254482|NCT01014624|615512|P2|COMPLETED|Overall Study||26
254483|NCT01014624|615513|P1|COMPLETED|Overall Study||27
254484|NCT01014624|615512|P2|STARTED|Overall Study||27
254485|NCT01014624|615513|P1|STARTED|Overall Study||29
254486|NCT01014585|615537|P4|NOT COMPLETED|Overall Study||30
254487|NCT01014585|615538|P3|NOT COMPLETED|Overall Study||23
254488|NCT01014585|615539|P2|NOT COMPLETED|Overall Study||25
254489|NCT01014585|615540|P1|NOT COMPLETED|Overall Study||20
254490|NCT01014585|615537|P4|COMPLETED|Overall Study||99
254491|NCT01014585|615538|P3|COMPLETED|Overall Study||37
254492|NCT01014585|615539|P2|COMPLETED|Overall Study||75
254493|NCT01014585|615540|P1|COMPLETED|Overall Study||31
254494|NCT01014585|615537|P4|STARTED|Overall Study||129
254495|NCT01014585|615538|P3|STARTED|Overall Study||60
254496|NCT01014585|615539|P2|STARTED|Overall Study||100
254497|NCT01014585|615540|P1|STARTED|Overall Study||51
254498|NCT01014533|615560|P2|NOT COMPLETED|Overall Study||5
254499|NCT01014533|615561|P1|NOT COMPLETED|Overall Study||5
254500|NCT01014533|615560|P2|COMPLETED|Overall Study||25
254501|NCT01014533|615561|P1|COMPLETED|Overall Study||24
254502|NCT01014533|615560|P2|STARTED|Overall Study||30
254503|NCT01014533|615561|P1|STARTED|Overall Study||29
254504|NCT01014455|615573|P2|NOT COMPLETED|Overall Study||0
254505|NCT01014455|615574|P1|NOT COMPLETED|Overall Study||0
254506|NCT01014455|615573|P2|COMPLETED|Overall Study||87
254507|NCT01014455|615574|P1|COMPLETED|Overall Study||82
254508|NCT01014455|615573|P2|STARTED|Overall Study||87
254509|NCT01014455|615574|P1|STARTED|Overall Study||82
254510|NCT01014442|615582|P2|NOT COMPLETED|Overall Study||19
254511|NCT01014442|615583|P1|NOT COMPLETED|Overall Study||7
254512|NCT01014442|615582|P2|COMPLETED|Overall Study||16
254513|NCT01014442|615583|P1|COMPLETED|Overall Study||26
254514|NCT01014442|615582|P2|STARTED|Overall Study||35
254515|NCT01014442|615583|P1|STARTED|Overall Study||33
254516|NCT01014351|615695|P1|NOT COMPLETED|Overall Study||37
254517|NCT01014351|615695|P1|COMPLETED|Overall Study||33
254518|NCT01014351|615695|P1|STARTED|Overall Study||70
254519|NCT01014208|615703|P2|NOT COMPLETED|Overall Study||100
254520|NCT01014208|615704|P1|NOT COMPLETED|Overall Study||94
254521|NCT01014208|615703|P2|COMPLETED|Overall Study||122
254522|NCT01014208|615704|P1|COMPLETED|Overall Study||131
254523|NCT01014208|615703|P2|Intent-to-Treat Population|Overall Study||222
254524|NCT01014208|615704|P1|Intent-to-Treat Population|Overall Study||223
254525|NCT01014208|615703|P2|STARTED|Overall Study||222
254526|NCT01014208|615704|P1|STARTED|Overall Study||225
254527|NCT01014169|615732|P2|NOT COMPLETED|Overall Study||13
254528|NCT01014169|615733|P1|NOT COMPLETED|Overall Study||7
254529|NCT01014169|615732|P2|COMPLETED|Overall Study||48
254530|NCT01014169|615733|P1|COMPLETED|Overall Study||58
254531|NCT01014169|615732|P2|STARTED|Overall Study||61
254532|NCT01014169|615733|P1|STARTED|Overall Study||65
254533|NCT01014143|615746|P3|NOT COMPLETED|Third Intervention||0
254534|NCT01014143|615747|P2|NOT COMPLETED|Third Intervention||0
254535|NCT01014143|615748|P1|NOT COMPLETED|Third Intervention||0
254536|NCT01014143|615746|P3|COMPLETED|Third Intervention||9
254537|NCT01014143|615747|P2|COMPLETED|Third Intervention||9
254538|NCT01014143|615748|P1|COMPLETED|Third Intervention||8
254539|NCT01014143|615746|P3|STARTED|Third Intervention||9
254540|NCT01014143|615747|P2|STARTED|Third Intervention||9
254541|NCT01014143|615748|P1|STARTED|Third Intervention||8
254542|NCT01014143|615746|P3|NOT COMPLETED|Washout After 2nd Intervention||0
254543|NCT01014143|615747|P2|NOT COMPLETED|Washout After 2nd Intervention||0
254544|NCT01014143|615748|P1|NOT COMPLETED|Washout After 2nd Intervention||0
254545|NCT01014143|615746|P3|COMPLETED|Washout After 2nd Intervention||9
254546|NCT01014143|615747|P2|COMPLETED|Washout After 2nd Intervention||9
254547|NCT01014143|615748|P1|COMPLETED|Washout After 2nd Intervention||8
254548|NCT01014143|615746|P3|STARTED|Washout After 2nd Intervention||9
254549|NCT01014143|615747|P2|STARTED|Washout After 2nd Intervention||9
254550|NCT01014143|615748|P1|STARTED|Washout After 2nd Intervention||8
254551|NCT01014143|615746|P3|NOT COMPLETED|Second Intervention||0
254552|NCT01014143|615747|P2|NOT COMPLETED|Second Intervention||0
254553|NCT01014143|615748|P1|NOT COMPLETED|Second Intervention||2
254554|NCT01014143|615746|P3|COMPLETED|Second Intervention||9
254555|NCT01014143|615747|P2|COMPLETED|Second Intervention||9
254556|NCT01014143|615748|P1|COMPLETED|Second Intervention||8
254557|NCT01014143|615746|P3|STARTED|Second Intervention||9
254558|NCT01014143|615747|P2|STARTED|Second Intervention||9
254559|NCT01014143|615748|P1|STARTED|Second Intervention||10
254560|NCT01014143|615746|P3|NOT COMPLETED|Washout Period After 1st Intervention||0
254561|NCT01014143|615747|P2|NOT COMPLETED|Washout Period After 1st Intervention||0
254562|NCT01014143|615748|P1|NOT COMPLETED|Washout Period After 1st Intervention||0
254563|NCT01014143|615746|P3|COMPLETED|Washout Period After 1st Intervention||9
254564|NCT01014143|615747|P2|COMPLETED|Washout Period After 1st Intervention||9
254565|NCT01014143|615748|P1|COMPLETED|Washout Period After 1st Intervention||10
254566|NCT01014143|615746|P3|STARTED|Washout Period After 1st Intervention||9
254567|NCT01014143|615747|P2|STARTED|Washout Period After 1st Intervention||9
254568|NCT01014143|615748|P1|STARTED|Washout Period After 1st Intervention||10
254569|NCT01014143|615746|P3|NOT COMPLETED|First Intervention||0
254570|NCT01014143|615747|P2|NOT COMPLETED|First Intervention||0
254571|NCT01014143|615748|P1|NOT COMPLETED|First Intervention||0
254572|NCT01014143|615746|P3|COMPLETED|First Intervention||9
254573|NCT01014143|615747|P2|COMPLETED|First Intervention||9
254574|NCT01014143|615748|P1|COMPLETED|First Intervention||10
254575|NCT01014143|615746|P3|STARTED|First Intervention||9
254576|NCT01014143|615747|P2|STARTED|First Intervention||9
254577|NCT01014143|615748|P1|STARTED|First Intervention||10
254578|NCT01014091|615762|P6|NOT COMPLETED|Overall Study||0
254579|NCT01014091|615763|P5|NOT COMPLETED|Overall Study||0
254580|NCT01014091|615764|P4|NOT COMPLETED|Overall Study||0
254581|NCT01014091|615765|P3|NOT COMPLETED|Overall Study||0
254582|NCT01014091|615766|P2|NOT COMPLETED|Overall Study||0
254583|NCT01014091|615767|P1|NOT COMPLETED|Overall Study||0
254584|NCT01014091|615762|P6|COMPLETED|Overall Study||12
254585|NCT01014091|615763|P5|COMPLETED|Overall Study||6
254586|NCT01014091|615764|P4|COMPLETED|Overall Study||15
254587|NCT01014091|615765|P3|COMPLETED|Overall Study||5
254588|NCT01014091|615766|P2|COMPLETED|Overall Study||13
254589|NCT01014091|615767|P1|COMPLETED|Overall Study||7
254590|NCT01014091|615762|P6|STARTED|Overall Study||12
254591|NCT01014091|615763|P5|STARTED|Overall Study||6
254592|NCT01014091|615764|P4|STARTED|Overall Study||15
254593|NCT01014091|615765|P3|STARTED|Overall Study||5
254594|NCT01014091|615766|P2|STARTED|Overall Study||13
254595|NCT01014091|615767|P1|STARTED|Overall Study||7
254596|NCT01014013|615843|P2|NOT COMPLETED|Overall Study||56
254597|NCT01014013|615844|P1|NOT COMPLETED|Overall Study||51
254598|NCT01014013|615843|P2|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of Ceftriaxone parentheral therapy|80
254599|NCT01014013|615844|P1|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of MK0826 parentheral therapy|84
254600|NCT01014013|615843|P2|Completed Parenteral Therapy|Overall Study|Patients completing Ceftriaxone as a single daily dose of 2.0g intravenous infusion at least 3 days|88
254601|NCT01014013|615844|P1|Completed Parenteral Therapy|Overall Study|"Patients completing MK0826 as a single daily dose of 1.0g intravenous~infusion at least 3 days"|87
254602|NCT01014013|615843|P2|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of Ceftriaxone parenteral therapy|135
254603|NCT01014013|615844|P1|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of MK0826 parenteral therapy|132
254604|NCT01014013|615843|P2|STARTED|Overall Study||136
254605|NCT01014013|615844|P1|STARTED|Overall Study||135
254606|NCT01013961|615856|P2|NOT COMPLETED|Overall Study||3
254607|NCT01013961|615857|P1|NOT COMPLETED|Overall Study||3
254608|NCT01013961|615856|P2|COMPLETED|Overall Study||12
254609|NCT01013961|615857|P1|COMPLETED|Overall Study||13
254610|NCT01013961|615856|P2|STARTED|Overall Study||15
254611|NCT01013961|615857|P1|STARTED|Overall Study||16
254612|NCT01013883|615875|P2|NOT COMPLETED|Overall Study||2
254613|NCT01013883|615876|P1|NOT COMPLETED|Overall Study||2
254614|NCT01013883|615875|P2|COMPLETED|Overall Study||241
254615|NCT01013883|615876|P1|COMPLETED|Overall Study||268
254616|NCT01013883|615875|P2|STARTED|Overall Study||243
254617|NCT01013883|615876|P1|STARTED|Overall Study||270
254618|NCT01013870|615888|P2|NOT COMPLETED|Overall Study||3
254619|NCT01013870|615889|P1|NOT COMPLETED|Overall Study||1
254620|NCT01013870|615888|P2|COMPLETED|Overall Study||21
254621|NCT01013870|615889|P1|COMPLETED|Overall Study||27
254622|NCT01013870|615888|P2|STARTED|Overall Study||24
254623|NCT01013870|615889|P1|STARTED|Overall Study||28
254624|NCT01013844|615913|P2|NOT COMPLETED|Overall Study||0
254625|NCT01013844|615914|P1|NOT COMPLETED|Overall Study||0
254626|NCT01013844|615913|P2|COMPLETED|Overall Study||65
254627|NCT01013844|615914|P1|COMPLETED|Overall Study||65
254628|NCT01013844|615913|P2|STARTED|Overall Study||65
254629|NCT01013844|615914|P1|STARTED|Overall Study||65
254630|NCT01013792|615938|P2|NOT COMPLETED|Overall Study||5
254631|NCT01013792|615939|P1|NOT COMPLETED|Overall Study||2
254632|NCT01013792|615938|P2|COMPLETED|Overall Study||11
254633|NCT01013792|615939|P1|COMPLETED|Overall Study||12
254634|NCT01013792|615938|P2|STARTED|Overall Study||16
254635|NCT01013792|615939|P1|STARTED|Overall Study||14
254636|NCT01013753|615945|P1|NOT COMPLETED|Overall Study||16
254637|NCT01013753|615945|P1|COMPLETED|Overall Study||182
254638|NCT01013753|615945|P1|Received Form 12 mcg Bid|Overall Study||125
254639|NCT01013753|615945|P1|Received Olo 20 mcg qd|Overall Study||124
254640|NCT01013753|615945|P1|Received Olo 10 mcg qd|Overall Study||127
254641|NCT01013753|615945|P1|Received Olo 5 mcg qd|Overall Study||130
254642|NCT01013753|615945|P1|Received Olo 2 mcg qd|Overall Study||121
254643|NCT01013753|615945|P1|Received Placebo|Overall Study||125
254644|NCT01013753|615945|P1|STARTED|Overall Study|Entered and treated|198
254645|NCT01013740|616141|P2|NOT COMPLETED|Overall Study||19
254646|NCT01013740|616142|P1|NOT COMPLETED|Overall Study||11
254647|NCT01013740|616141|P2|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|56
254648|NCT01013740|616142|P1|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|26
254649|NCT01013740|616141|P2|Ongoing|Overall Study||0
254650|NCT01013740|616142|P1|Ongoing|Overall Study||0
254651|NCT01013740|616141|P2|STARTED|Overall Study|29 participants experiencing PD in the RP elected to enroll in the optional CP.|75
254652|NCT01013740|616142|P1|STARTED|Overall Study|13 participants (par.) experiencing PD in the RP elected to enroll in the optional CP.|37
254653|NCT01013701|616166|P1|NOT COMPLETED|Overall Study||7
254654|NCT01013701|616166|P1|COMPLETED|Overall Study||0
254655|NCT01013701|616166|P1|STARTED|Overall Study||7
254656|NCT01013597|616173|P1|NOT COMPLETED|Overall Study||1
254657|NCT01013597|616173|P1|COMPLETED|Overall Study||12
254658|NCT01013597|616173|P1|STARTED|Overall Study||13
254659|NCT01013350|616185|P2|NOT COMPLETED|Overall Study||192
254660|NCT01013350|616186|P1|NOT COMPLETED|Overall Study||38
254661|NCT01013350|616185|P2|COMPLETED|Overall Study||771
254662|NCT01013350|616186|P1|COMPLETED|Overall Study||160
254663|NCT01013350|616185|P2|Safety Analysis Set|Overall Study||950
254664|NCT01013350|616186|P1|Safety Analysis Set|Overall Study||198
254665|NCT01013350|616185|P2|STARTED|Overall Study||963
254666|NCT01013350|616186|P1|STARTED|Overall Study||198
254667|NCT01013207|616197|P1|NOT COMPLETED|CPAP Post Nexus (S9)||6
254668|NCT01013207|616197|P1|COMPLETED|CPAP Post Nexus (S9)||44
254669|NCT01013207|616197|P1|STARTED|CPAP Post Nexus (S9)||50
254670|NCT01013207|616197|P1|NOT COMPLETED|Nexus (S9)||0
254671|NCT01013207|616197|P1|COMPLETED|Nexus (S9)||50
254672|NCT01013207|616197|P1|STARTED|Nexus (S9)||50
254673|NCT01013207|616197|P1|NOT COMPLETED|CPAP Pre Nexus (S9)||0
254674|NCT01013207|616197|P1|COMPLETED|CPAP Pre Nexus (S9)||50
254675|NCT01013207|616197|P1|STARTED|CPAP Pre Nexus (S9)||50
254676|NCT01013194|616204|P2|NOT COMPLETED|Overall Study||0
254677|NCT01013194|616205|P1|NOT COMPLETED|Overall Study||0
254678|NCT01013194|616204|P2|COMPLETED|Overall Study|Retrospectively contemporary matched-pair group|16
254679|NCT01013194|616205|P1|COMPLETED|Overall Study|Consecutive patients|9
254680|NCT01013194|616204|P2|STARTED|Overall Study||16
254681|NCT01013194|616205|P1|STARTED|Overall Study||9
254682|NCT01012999|616215|P1|NOT COMPLETED|Overall Study||1
254683|NCT01012999|616215|P1|COMPLETED|Overall Study||15
254684|NCT01012999|616215|P1|STARTED|Overall Study||16
254685|NCT01012973|616221|P2|NOT COMPLETED|Overall Study||19
254686|NCT01012973|616222|P1|NOT COMPLETED|Overall Study||16
254687|NCT01012973|616221|P2|COMPLETED|Overall Study||52
254688|NCT01012973|616222|P1|COMPLETED|Overall Study||90
254689|NCT01012973|616221|P2|Completed Week 52, From FAS|Overall Study||52
254690|NCT01012973|616222|P1|Completed Week 52, From FAS|Overall Study||91
254691|NCT01012973|616221|P2|Completed Week 24, From FAS|Overall Study||57
254692|NCT01012973|616222|P1|Completed Week 24, From FAS|Overall Study||97
254693|NCT01012973|616221|P2|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|68
254694|NCT01012973|616222|P1|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|103
254695|NCT01012973|616221|P2|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|68
254696|NCT01012973|616222|P1|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|104
254697|NCT01012973|616221|P2|STARTED|Overall Study||71
254698|NCT01012973|616222|P1|STARTED|Overall Study||106
254699|NCT01012947|616247|P5|NOT COMPLETED|Overall Study||142
254700|NCT01012947|616248|P4|NOT COMPLETED|Overall Study||118
254701|NCT01012947|616249|P3|NOT COMPLETED|Overall Study||130
254702|NCT01012947|616250|P2|NOT COMPLETED|Overall Study||135
254703|NCT01012947|616251|P1|NOT COMPLETED|Overall Study||131
254704|NCT01012947|616247|P5|COMPLETED|Overall Study||94
254705|NCT01012947|616248|P4|COMPLETED|Overall Study||93
254706|NCT01012947|616249|P3|COMPLETED|Overall Study||111
254707|NCT01012947|616250|P2|COMPLETED|Overall Study||80
254708|NCT01012947|616251|P1|COMPLETED|Overall Study||81
254709|NCT01012947|616247|P5|STARTED|Overall Study||236
254710|NCT01012947|616248|P4|STARTED|Overall Study||211
254711|NCT01012947|616249|P3|STARTED|Overall Study||241
254712|NCT01012947|616250|P2|STARTED|Overall Study||215
254713|NCT01012947|616251|P1|STARTED|Overall Study||212
254714|NCT01012921|616265|P2|NOT COMPLETED|Overall Study||13
254715|NCT01012921|616266|P1|NOT COMPLETED|Overall Study||10
254716|NCT01012921|616265|P2|COMPLETED|Overall Study||47
254717|NCT01012921|616266|P1|COMPLETED|Overall Study||47
254718|NCT01012921|616265|P2|STARTED|Overall Study||60
254719|NCT01012921|616266|P1|STARTED|Overall Study||57
254720|NCT01012765|616272|P6|NOT COMPLETED|Treatment Period 3||0
254721|NCT01012765|616273|P5|NOT COMPLETED|Treatment Period 3||0
254722|NCT01012765|616274|P4|NOT COMPLETED|Treatment Period 3||0
254723|NCT01012765|616275|P3|NOT COMPLETED|Treatment Period 3||0
254724|NCT01012765|616276|P2|NOT COMPLETED|Treatment Period 3||0
254725|NCT01012765|616277|P1|NOT COMPLETED|Treatment Period 3||0
254726|NCT01012765|616272|P6|COMPLETED|Treatment Period 3||24
254727|NCT01012765|616273|P5|COMPLETED|Treatment Period 3||18
254728|NCT01012765|616274|P4|COMPLETED|Treatment Period 3||15
254729|NCT01012765|616275|P3|COMPLETED|Treatment Period 3||18
254730|NCT01012765|616276|P2|COMPLETED|Treatment Period 3||19
254731|NCT01012765|616277|P1|COMPLETED|Treatment Period 3||16
254732|NCT01012765|616272|P6|STARTED|Treatment Period 3||24
254733|NCT01012765|616273|P5|STARTED|Treatment Period 3||18
254734|NCT01012765|616274|P4|STARTED|Treatment Period 3||15
254735|NCT01012765|616275|P3|STARTED|Treatment Period 3||18
254736|NCT01012765|616276|P2|STARTED|Treatment Period 3||19
254737|NCT01012765|616277|P1|STARTED|Treatment Period 3||16
254738|NCT01012765|616272|P6|NOT COMPLETED|Treatment Period 2||1
254739|NCT01012765|616273|P5|NOT COMPLETED|Treatment Period 2||1
254740|NCT01012765|616274|P4|NOT COMPLETED|Treatment Period 2||0
254741|NCT01012765|616275|P3|NOT COMPLETED|Treatment Period 2||3
254742|NCT01012765|616276|P2|NOT COMPLETED|Treatment Period 2||2
254743|NCT01012765|616277|P1|NOT COMPLETED|Treatment Period 2||1
254744|NCT01012765|616272|P6|COMPLETED|Treatment Period 2||24
254745|NCT01012765|616273|P5|COMPLETED|Treatment Period 2||18
254746|NCT01012765|616274|P4|COMPLETED|Treatment Period 2||15
254747|NCT01012765|616275|P3|COMPLETED|Treatment Period 2||18
254748|NCT01012765|616276|P2|COMPLETED|Treatment Period 2||19
254749|NCT01012765|616277|P1|COMPLETED|Treatment Period 2||16
254750|NCT01012765|616272|P6|STARTED|Treatment Period 2||25
254751|NCT01012765|616273|P5|STARTED|Treatment Period 2||19
254752|NCT01012765|616274|P4|STARTED|Treatment Period 2||15
254753|NCT01012765|616275|P3|STARTED|Treatment Period 2||21
254754|NCT01012765|616276|P2|STARTED|Treatment Period 2||21
254755|NCT01012765|616277|P1|STARTED|Treatment Period 2||17
254756|NCT01012765|616272|P6|NOT COMPLETED|Treatment Period 1||0
254757|NCT01012765|616273|P5|NOT COMPLETED|Treatment Period 1||3
254758|NCT01012765|616274|P4|NOT COMPLETED|Treatment Period 1||3
254759|NCT01012765|616275|P3|NOT COMPLETED|Treatment Period 1||2
254760|NCT01012765|616276|P2|NOT COMPLETED|Treatment Period 1||0
254761|NCT01012765|616277|P1|NOT COMPLETED|Treatment Period 1||3
254762|NCT01012765|616272|P6|COMPLETED|Treatment Period 1||25
254763|NCT01012765|616273|P5|COMPLETED|Treatment Period 1||19
254764|NCT01012765|616274|P4|COMPLETED|Treatment Period 1||15
254765|NCT01012765|616275|P3|COMPLETED|Treatment Period 1||21
254766|NCT01012765|616276|P2|COMPLETED|Treatment Period 1||21
254767|NCT01012765|616277|P1|COMPLETED|Treatment Period 1||17
254768|NCT01012765|616272|P6|STARTED|Treatment Period 1||25
254769|NCT01012765|616273|P5|STARTED|Treatment Period 1||22
254770|NCT01012765|616274|P4|STARTED|Treatment Period 1||18
254771|NCT01012765|616275|P3|STARTED|Treatment Period 1||23
254772|NCT01012765|616276|P2|STARTED|Treatment Period 1||21
254773|NCT01012765|616277|P1|STARTED|Treatment Period 1||20
254774|NCT01012739|616306|P4|NOT COMPLETED|Treatment Period 4||0
254775|NCT01012739|616307|P3|NOT COMPLETED|Treatment Period 4||0
254776|NCT01012739|616308|P2|NOT COMPLETED|Treatment Period 4||0
254777|NCT01012739|616309|P1|NOT COMPLETED|Treatment Period 4||0
254778|NCT01012739|616306|P4|COMPLETED|Treatment Period 4||7
254779|NCT01012739|616307|P3|COMPLETED|Treatment Period 4||9
254780|NCT01012739|616308|P2|COMPLETED|Treatment Period 4||8
254781|NCT01012739|616309|P1|COMPLETED|Treatment Period 4||9
254782|NCT01012739|616306|P4|STARTED|Treatment Period 4||7
254783|NCT01012739|616307|P3|STARTED|Treatment Period 4||9
254784|NCT01012739|616308|P2|STARTED|Treatment Period 4||8
254785|NCT01012739|616309|P1|STARTED|Treatment Period 4||9
254786|NCT01012739|616306|P4|NOT COMPLETED|Treatment Period 3||0
254787|NCT01012739|616307|P3|NOT COMPLETED|Treatment Period 3||0
254788|NCT01012739|616308|P2|NOT COMPLETED|Treatment Period 3||0
254789|NCT01012739|616309|P1|NOT COMPLETED|Treatment Period 3||0
254790|NCT01012739|616306|P4|COMPLETED|Treatment Period 3||7
254791|NCT01012739|616307|P3|COMPLETED|Treatment Period 3||9
254792|NCT01012739|616308|P2|COMPLETED|Treatment Period 3||8
254793|NCT01012739|616309|P1|COMPLETED|Treatment Period 3||9
254794|NCT01012739|616306|P4|STARTED|Treatment Period 3||7
254795|NCT01012739|616307|P3|STARTED|Treatment Period 3||9
254796|NCT01012739|616308|P2|STARTED|Treatment Period 3||8
254797|NCT01012739|616309|P1|STARTED|Treatment Period 3||9
254798|NCT01012739|616306|P4|NOT COMPLETED|Treatment Period 2||1
254799|NCT01012739|616307|P3|NOT COMPLETED|Treatment Period 2||0
254800|NCT01012739|616308|P2|NOT COMPLETED|Treatment Period 2||0
254801|NCT01012739|616309|P1|NOT COMPLETED|Treatment Period 2||0
254802|NCT01012739|616306|P4|COMPLETED|Treatment Period 2||7
254803|NCT01012739|616307|P3|COMPLETED|Treatment Period 2||9
254804|NCT01012739|616308|P2|COMPLETED|Treatment Period 2||8
254805|NCT01012739|616309|P1|COMPLETED|Treatment Period 2||9
254806|NCT01012739|616306|P4|STARTED|Treatment Period 2||8
254807|NCT01012739|616307|P3|STARTED|Treatment Period 2||9
254808|NCT01012739|616308|P2|STARTED|Treatment Period 2||8
254809|NCT01012739|616309|P1|STARTED|Treatment Period 2||9
254810|NCT01012739|616306|P4|NOT COMPLETED|Treatment Period 1||1
254811|NCT01012739|616307|P3|NOT COMPLETED|Treatment Period 1||0
254812|NCT01012739|616308|P2|NOT COMPLETED|Treatment Period 1||0
254813|NCT01012739|616309|P1|NOT COMPLETED|Treatment Period 1||0
254814|NCT01012739|616306|P4|COMPLETED|Treatment Period 1||8
254815|NCT01012739|616307|P3|COMPLETED|Treatment Period 1||9
254816|NCT01012739|616308|P2|COMPLETED|Treatment Period 1||8
254817|NCT01012739|616309|P1|COMPLETED|Treatment Period 1||9
254818|NCT01012739|616306|P4|STARTED|Treatment Period 1||9
254819|NCT01012739|616307|P3|STARTED|Treatment Period 1||9
254820|NCT01012739|616308|P2|STARTED|Treatment Period 1||8
254821|NCT01012739|616309|P1|STARTED|Treatment Period 1||9
254822|NCT01012713|616337|P1|NOT COMPLETED|Overall Study||3
254823|NCT01012713|616337|P1|COMPLETED|Overall Study||27
254824|NCT01012713|616337|P1|STARTED|Overall Study||30
254825|NCT01012674|616343|P1|NOT COMPLETED|Overall Study||24
254826|NCT01012674|616343|P1|COMPLETED|Overall Study||187
254827|NCT01012674|616343|P1|STARTED|Overall Study||211
254828|NCT01012661|616355|P1|NOT COMPLETED|Overall Study||0
254829|NCT01012661|616355|P1|COMPLETED|Overall Study||50
254830|NCT01012661|616355|P1|STARTED|Overall Study||50
254831|NCT01012622|616363|P1|NOT COMPLETED|Overall Study||31
254832|NCT01012622|616363|P1|COMPLETED|Overall Study||111
254833|NCT01012622|616363|P1|STARTED|Overall Study||142
254834|NCT01012492|616382|P1|NOT COMPLETED|Overall Study||0
254835|NCT01012492|616382|P1|COMPLETED|Overall Study||10
254836|NCT01012492|616382|P1|STARTED|Overall Study||10
254837|NCT01012440|616389|P1|NOT COMPLETED|Overall Study||2
254838|NCT01012440|616389|P1|COMPLETED|Overall Study||3
254839|NCT01012440|616389|P1|STARTED|Overall Study||5
254840|NCT01012414|616393|P1|NOT COMPLETED|Overall Study||10
254841|NCT01012414|616393|P1|COMPLETED|Overall Study|No subjects completed the study.|0
254842|NCT01012414|616393|P1|STARTED|Overall Study||10
254843|NCT01012388|616400|P1|NOT COMPLETED|Overall Study||0
254844|NCT01012388|616400|P1|COMPLETED|Overall Study||100
254845|NCT01012388|616400|P1|STARTED|Overall Study||100
254846|NCT01012362|616410|P5|NOT COMPLETED|Overall Study||0
254847|NCT01012362|616411|P4|NOT COMPLETED|Overall Study||0
254848|NCT01012362|616412|P3|NOT COMPLETED|Overall Study||0
254849|NCT01012362|616413|P2|NOT COMPLETED|Overall Study||0
254850|NCT01012362|616414|P1|NOT COMPLETED|Overall Study||0
254851|NCT01012362|616410|P5|COMPLETED|Overall Study||9
254852|NCT01012362|616411|P4|COMPLETED|Overall Study||4
254853|NCT01012362|616412|P3|COMPLETED|Overall Study||3
254854|NCT01012362|616413|P2|COMPLETED|Overall Study||6
254855|NCT01012362|616414|P1|COMPLETED|Overall Study||9
254856|NCT01012362|616410|P5|STARTED|Overall Study||9
254857|NCT01012362|616411|P4|STARTED|Overall Study||4
254858|NCT01012362|616412|P3|STARTED|Overall Study||3
254859|NCT01012362|616413|P2|STARTED|Overall Study||6
254860|NCT01012362|616414|P1|STARTED|Overall Study||9
254861|NCT01012336|616430|P1|NOT COMPLETED|Overall Study||0
254862|NCT01012336|616430|P1|COMPLETED|Overall Study||85
254863|NCT01012336|616430|P1|STARTED|Overall Study||85
254864|NCT01012323|616434|P1|NOT COMPLETED|Overall Study||1
254865|NCT01012323|616434|P1|COMPLETED|Overall Study||50
254866|NCT01012323|616434|P1|STARTED|Overall Study||51
254867|NCT01012297|616458|P2|NOT COMPLETED|Overall Study||0
254868|NCT01012297|616459|P1|NOT COMPLETED|Overall Study||0
254869|NCT01012297|616458|P2|COMPLETED|Overall Study||53
254870|NCT01012297|616459|P1|COMPLETED|Overall Study||54
254871|NCT01012297|616458|P2|STARTED|Overall Study||53
254872|NCT01012297|616459|P1|STARTED|Overall Study||54
254873|NCT01012258|616471|P1|NOT COMPLETED|Overall Study||66
254874|NCT01012258|616471|P1|COMPLETED|Overall Study||0
254875|NCT01012258|616471|P1|STARTED|Overall Study||66
254876|NCT01012245|616481|P1|NOT COMPLETED|Overall Study||2427
254877|NCT01012245|616481|P1|COMPLETED|Overall Study|More than 1 discontinuation (DC) reason possible per subject. See outcome measure Reasons for DC.|26385
254878|NCT01012245|616481|P1|STARTED|Overall Study||28812
254879|NCT01012219|616518|P1|NOT COMPLETED|Period 3||0
254880|NCT01012219|616518|P1|COMPLETED|Period 3||20
254881|NCT01012219|616518|P1|STARTED|Period 3|of the 36 who started Period 1|20
254882|NCT01012219|616518|P1|NOT COMPLETED|Period 2||1
254883|NCT01012219|616518|P1|COMPLETED|Period 2||34
254884|NCT01012219|616518|P1|STARTED|Period 2|Number who completed Period 1|35
254885|NCT01012219|616518|P1|NOT COMPLETED|Period 1||1
254886|NCT01012219|616518|P1|COMPLETED|Period 1||35
254887|NCT01012219|616518|P1|STARTED|Period 1|Number randomized|36
254888|NCT01012167|616528|P3|NOT COMPLETED|Overall Study||4
254889|NCT01012167|616529|P2|NOT COMPLETED|Overall Study||2
254890|NCT01012167|616530|P1|NOT COMPLETED|Overall Study||2
254891|NCT01012167|616528|P3|COMPLETED|Overall Study||17
254892|NCT01012167|616529|P2|COMPLETED|Overall Study||18
254893|NCT01012167|616530|P1|COMPLETED|Overall Study||15
254894|NCT01012167|616528|P3|Exposed to Study Drug|Overall Study||20
254895|NCT01012167|616529|P2|Exposed to Study Drug|Overall Study||20
254896|NCT01012167|616530|P1|Exposed to Study Drug|Overall Study||16
254897|NCT01012167|616528|P3|Withdrawn Prior to Study Drug Exposure|Overall Study||1
254898|NCT01012167|616529|P2|Withdrawn Prior to Study Drug Exposure|Overall Study||0
254899|NCT01012167|616530|P1|Withdrawn Prior to Study Drug Exposure|Overall Study||1
254900|NCT01012167|616528|P3|STARTED|Overall Study||21
254901|NCT01012167|616529|P2|STARTED|Overall Study||20
254902|NCT01012167|616530|P1|STARTED|Overall Study||17
254903|NCT01012089|616786|P1|NOT COMPLETED|Overall Study||0
254904|NCT01012089|616786|P1|COMPLETED|Overall Study||6
254905|NCT01012089|616786|P1|STARTED|Overall Study||6
254906|NCT01012037|616809|P3|NOT COMPLETED|Overall Study||10
254907|NCT01012037|616810|P2|NOT COMPLETED|Overall Study||16
254908|NCT01012037|616811|P1|NOT COMPLETED|Overall Study||1
254909|NCT01012037|616809|P3|COMPLETED|Overall Study||214
254910|NCT01012037|616810|P2|COMPLETED|Overall Study||207
254911|NCT01012037|616811|P1|COMPLETED|Overall Study||43
254912|NCT01012037|616809|P3|STARTED|Overall Study||224
254913|NCT01012037|616810|P2|STARTED|Overall Study||223
254914|NCT01012037|616811|P1|STARTED|Overall Study||44
254915|NCT01011946|616846|P1|NOT COMPLETED|Overall Study||3
254916|NCT01011946|616846|P1|COMPLETED|Overall Study||33
254917|NCT01011946|616846|P1|STARTED|Overall Study||36
254918|NCT01011933|616850|P1|NOT COMPLETED|Overall Study||4
254919|NCT01011933|616850|P1|COMPLETED|Overall Study|total eligible and evaluable|50
254920|NCT01011933|616850|P1|STARTED|Overall Study|total enrolled|54
254921|NCT01011907|616867|P2|NOT COMPLETED|Overall Study||15
254922|NCT01011907|616868|P1|NOT COMPLETED|Overall Study||14
254923|NCT01011907|616867|P2|COMPLETED|Overall Study||18
254924|NCT01011907|616868|P1|COMPLETED|Overall Study||17
254925|NCT01011907|616867|P2|STARTED|Overall Study||33
254926|NCT01011907|616868|P1|STARTED|Overall Study||31
254927|NCT01011894|616878|P1|NOT COMPLETED|Overall Study||0
254928|NCT01011894|616878|P1|COMPLETED|Overall Study||26
254929|NCT01011894|616878|P1|STARTED|Overall Study||26
254930|NCT01011868|616885|P3|NOT COMPLETED|After Week 78 Follow-up||44
254931|NCT01011868|616886|P2|NOT COMPLETED|After Week 78 Follow-up||38
254932|NCT01011868|616887|P1|NOT COMPLETED|After Week 78 Follow-up||52
254933|NCT01011868|616885|P3|COMPLETED|After Week 78 Follow-up||111
254934|NCT01011868|616886|P2|COMPLETED|After Week 78 Follow-up||131
254935|NCT01011868|616887|P1|COMPLETED|After Week 78 Follow-up||118
254936|NCT01011868|616885|P3|STARTED|After Week 78 Follow-up||155
254937|NCT01011868|616886|P2|STARTED|After Week 78 Follow-up||169
254938|NCT01011868|616887|P1|STARTED|After Week 78 Follow-up||170
254939|NCT01011868|616885|P3|NOT COMPLETED|After Week 18 Follow-up||26
254940|NCT01011868|616886|P2|NOT COMPLETED|After Week 18 Follow-up||16
254941|NCT01011868|616887|P1|NOT COMPLETED|After Week 18 Follow-up||23
254942|NCT01011868|616885|P3|COMPLETED|After Week 18 Follow-up||129
254943|NCT01011868|616886|P2|COMPLETED|After Week 18 Follow-up||153
254944|NCT01011868|616887|P1|COMPLETED|After Week 18 Follow-up||147
254945|NCT01011868|616885|P3|STARTED|After Week 18 Follow-up||155
254946|NCT01011868|616886|P2|STARTED|After Week 18 Follow-up||169
254947|NCT01011868|616887|P1|STARTED|After Week 18 Follow-up||170
254948|NCT01011829|616924|P2|NOT COMPLETED|Overall Study||9
254949|NCT01011829|616925|P1|NOT COMPLETED|Overall Study||4
254950|NCT01011829|616924|P2|COMPLETED|Overall Study||1
254951|NCT01011829|616925|P1|COMPLETED|Overall Study||6
254952|NCT01011829|616924|P2|STARTED|Overall Study||10
254953|NCT01011829|616925|P1|STARTED|Overall Study||10
254954|NCT01011816|616935|P2|NOT COMPLETED|78-Week Extended Follow-up||28
254955|NCT01011816|616936|P1|NOT COMPLETED|78-Week Extended Follow-up||72
254956|NCT01011816|616935|P2|COMPLETED|78-Week Extended Follow-up||26
254957|NCT01011816|616936|P1|COMPLETED|78-Week Extended Follow-up||85
254958|NCT01011816|616935|P2|STARTED|78-Week Extended Follow-up||54
254959|NCT01011816|616936|P1|STARTED|78-Week Extended Follow-up||157
254960|NCT01011816|616935|P2|NOT COMPLETED|26-Week Primary Endpoint||2
254961|NCT01011816|616936|P1|NOT COMPLETED|26-Week Primary Endpoint||7
254962|NCT01011816|616935|P2|COMPLETED|26-Week Primary Endpoint||54
254963|NCT01011816|616936|P1|COMPLETED|26-Week Primary Endpoint||157
254964|NCT01011816|616935|P2|STARTED|26-Week Primary Endpoint||56
254965|NCT01011816|616936|P1|STARTED|26-Week Primary Endpoint||164
254966|NCT01011738|616949|P3|NOT COMPLETED|Overall Study||17
254967|NCT01011738|616950|P2|NOT COMPLETED|Overall Study||294
254968|NCT01011738|616951|P1|NOT COMPLETED|Overall Study||324
254969|NCT01011738|616949|P3|COMPLETED|Overall Study||36
254970|NCT01011738|616950|P2|COMPLETED|Overall Study||618
254971|NCT01011738|616951|P1|COMPLETED|Overall Study||553
254972|NCT01011738|616949|P3|STARTED|Overall Study||53
254973|NCT01011738|616950|P2|STARTED|Overall Study||912
254974|NCT01011738|616951|P1|STARTED|Overall Study||877
254975|NCT01011673|616991|P2|NOT COMPLETED|24 Hour Follow-up||3
254976|NCT01011673|616992|P1|NOT COMPLETED|24 Hour Follow-up||3
254977|NCT01011673|616991|P2|COMPLETED|24 Hour Follow-up||57
254978|NCT01011673|616992|P1|COMPLETED|24 Hour Follow-up||57
254979|NCT01011673|616991|P2|STARTED|24 Hour Follow-up||60
254980|NCT01011673|616992|P1|STARTED|24 Hour Follow-up||60
254981|NCT01011673|616991|P2|NOT COMPLETED|Emergency Department Portion||0
254982|NCT01011673|616992|P1|NOT COMPLETED|Emergency Department Portion||0
254983|NCT01011673|616991|P2|COMPLETED|Emergency Department Portion||60
254984|NCT01011673|616992|P1|COMPLETED|Emergency Department Portion||60
254985|NCT01011673|616991|P2|STARTED|Emergency Department Portion||60
254986|NCT01011673|616992|P1|STARTED|Emergency Department Portion||60
254987|NCT01011673|616991|P2|NOT COMPLETED|Randomized||1
254988|NCT01011673|616992|P1|NOT COMPLETED|Randomized||2
254989|NCT01011673|616991|P2|COMPLETED|Randomized|1 patient was randomized but not included in analyses bc they did not truly meet study criteria.|60
254990|NCT01011673|616992|P1|COMPLETED|Randomized|2 patients were randomized but not included in analyses bc they did not truly meet study criteria.|60
254991|NCT01011673|616991|P2|STARTED|Randomized||61
254992|NCT01011673|616992|P1|STARTED|Randomized||62
254993|NCT01011634|617002|P2|NOT COMPLETED|Overall Study||1
254994|NCT01011634|617003|P1|NOT COMPLETED|Overall Study||0
254995|NCT01011634|617002|P2|COMPLETED|Overall Study||8
254996|NCT01011634|617003|P1|COMPLETED|Overall Study||9
254997|NCT01011634|617002|P2|STARTED|Overall Study||9
254998|NCT01011634|617003|P1|STARTED|Overall Study||9
254999|NCT01011556|617015|P4|NOT COMPLETED|Overall Study||13
255000|NCT01011556|617016|P3|NOT COMPLETED|Overall Study||10
255001|NCT01011556|617017|P2|NOT COMPLETED|Overall Study||8
255002|NCT01011556|617018|P1|NOT COMPLETED|Overall Study||6
255003|NCT01011556|617015|P4|COMPLETED|Overall Study||51
255004|NCT01011556|617016|P3|COMPLETED|Overall Study||45
255005|NCT01011556|617017|P2|COMPLETED|Overall Study||48
255006|NCT01011556|617018|P1|COMPLETED|Overall Study||52
255007|NCT01011556|617015|P4|Received at Least 1 Dose of Study Drug|Overall Study||64
255008|NCT01011556|617016|P3|Received at Least 1 Dose of Study Drug|Overall Study||54
255009|NCT01011556|617017|P2|Received at Least 1 Dose of Study Drug|Overall Study||56
255010|NCT01011556|617018|P1|Received at Least 1 Dose of Study Drug|Overall Study||57
255011|NCT01011556|617015|P4|STARTED|Overall Study||64
255012|NCT01011556|617016|P3|STARTED|Overall Study||55
255013|NCT01011556|617017|P2|STARTED|Overall Study||56
255014|NCT01011556|617018|P1|STARTED|Overall Study||58
255015|NCT01011465|617096|P8|NOT COMPLETED|Overall Study||0
255016|NCT01011465|617097|P7|NOT COMPLETED|Overall Study||1
255017|NCT01011465|617098|P6|NOT COMPLETED|Overall Study||0
255018|NCT01011465|617099|P5|NOT COMPLETED|Overall Study||1
255019|NCT01011465|617100|P4|NOT COMPLETED|Overall Study||0
255020|NCT01011465|617101|P3|NOT COMPLETED|Overall Study||0
255021|NCT01011465|617102|P2|NOT COMPLETED|Overall Study||1
255022|NCT01011465|617103|P1|NOT COMPLETED|Overall Study||2
255023|NCT01011465|617096|P8|COMPLETED|Overall Study||32
255024|NCT01011465|617097|P7|COMPLETED|Overall Study||51
255025|NCT01011465|617098|P6|COMPLETED|Overall Study||29
255026|NCT01011465|617099|P5|COMPLETED|Overall Study||46
255027|NCT01011465|617100|P4|COMPLETED|Overall Study||18
255028|NCT01011465|617101|P3|COMPLETED|Overall Study||36
255029|NCT01011465|617102|P2|COMPLETED|Overall Study||19
255030|NCT01011465|617103|P1|COMPLETED|Overall Study||34
255031|NCT01011465|617096|P8|STARTED|Overall Study||32
255032|NCT01011465|617097|P7|STARTED|Overall Study||52
255033|NCT01011465|617098|P6|STARTED|Overall Study||29
255034|NCT01011465|617099|P5|STARTED|Overall Study||47
255035|NCT01011465|617100|P4|STARTED|Overall Study||18
255036|NCT01011465|617101|P3|STARTED|Overall Study||36
255037|NCT01011465|617102|P2|STARTED|Overall Study||20
255038|NCT01011465|617103|P1|STARTED|Overall Study||36
255039|NCT01011439|617131|P1|NOT COMPLETED|Overall Study||57
255040|NCT01011439|617131|P1|COMPLETED|Overall Study||15
255041|NCT01011439|617131|P1|STARTED|Overall Study||72
255042|NCT01011387|617141|P1|NOT COMPLETED|Overall Study||6
255043|NCT01011387|617141|P1|COMPLETED|Overall Study||10
255044|NCT01011387|617141|P1|STARTED|Overall Study||16
255045|NCT01011335|617149|P13|NOT COMPLETED|Overall Study||3
255046|NCT01011335|617150|P12|NOT COMPLETED|Overall Study||1
255047|NCT01011335|617151|P11|NOT COMPLETED|Overall Study||6
255048|NCT01011335|617152|P10|NOT COMPLETED|Overall Study||0
255049|NCT01011335|617153|P9|NOT COMPLETED|Overall Study||2
255050|NCT01011335|617154|P8|NOT COMPLETED|Overall Study||2
255051|NCT01011335|617155|P7|NOT COMPLETED|Overall Study||3
255052|NCT01011335|617156|P6|NOT COMPLETED|Overall Study||1
255053|NCT01011335|617157|P5|NOT COMPLETED|Overall Study||1
255054|NCT01011335|617158|P4|NOT COMPLETED|Overall Study||2
255055|NCT01011335|617159|P3|NOT COMPLETED|Overall Study||1
255056|NCT01011335|617160|P2|NOT COMPLETED|Overall Study||1
255057|NCT01011335|617161|P1|NOT COMPLETED|Overall Study||1
255058|NCT01011335|617149|P13|COMPLETED|Overall Study||19
255059|NCT01011335|617150|P12|COMPLETED|Overall Study||21
255060|NCT01011335|617151|P11|COMPLETED|Overall Study||6
255061|NCT01011335|617152|P10|COMPLETED|Overall Study||12
255062|NCT01011335|617153|P9|COMPLETED|Overall Study||10
255063|NCT01011335|617154|P8|COMPLETED|Overall Study||10
255064|NCT01011335|617155|P7|COMPLETED|Overall Study||9
255065|NCT01011335|617156|P6|COMPLETED|Overall Study||11
255066|NCT01011335|617157|P5|COMPLETED|Overall Study||12
255067|NCT01011335|617158|P4|COMPLETED|Overall Study||10
255068|NCT01011335|617159|P3|COMPLETED|Overall Study||11
255069|NCT01011335|617160|P2|COMPLETED|Overall Study||11
255070|NCT01011335|617161|P1|COMPLETED|Overall Study||10
255071|NCT01011335|617149|P13|STARTED|Overall Study||22
255072|NCT01011335|617150|P12|STARTED|Overall Study||22
255073|NCT01011335|617151|P11|STARTED|Overall Study||12
255074|NCT01011335|617152|P10|STARTED|Overall Study||12
255075|NCT01011335|617153|P9|STARTED|Overall Study||12
255076|NCT01011335|617154|P8|STARTED|Overall Study||12
255077|NCT01011335|617155|P7|STARTED|Overall Study||12
255078|NCT01011335|617156|P6|STARTED|Overall Study||12
255079|NCT01011335|617157|P5|STARTED|Overall Study||13
255080|NCT01011335|617158|P4|STARTED|Overall Study||12
255081|NCT01011335|617159|P3|STARTED|Overall Study||12
255082|NCT01011335|617160|P2|STARTED|Overall Study||12
255083|NCT01011335|617161|P1|STARTED|Overall Study||11
255084|NCT01011309|617201|P3|NOT COMPLETED|Overall Study||5
255085|NCT01011309|617202|P2|NOT COMPLETED|Overall Study||3
255086|NCT01011309|617203|P1|NOT COMPLETED|Overall Study||2
255087|NCT01011309|617201|P3|COMPLETED|Overall Study||16
255088|NCT01011309|617202|P2|COMPLETED|Overall Study||7
255089|NCT01011309|617203|P1|COMPLETED|Overall Study||12
255090|NCT01011309|617201|P3|STARTED|Overall Study||21
255091|NCT01011309|617202|P2|STARTED|Overall Study||10
255092|NCT01011309|617203|P1|STARTED|Overall Study||14
255093|NCT01011283|617219|P2|NOT COMPLETED|Overall Study||11
255094|NCT01011283|617220|P1|NOT COMPLETED|Overall Study||11
255095|NCT01011283|617219|P2|COMPLETED|Overall Study||2
255096|NCT01011283|617220|P1|COMPLETED|Overall Study||2
255097|NCT01011283|617219|P2|STARTED|Overall Study||13
255098|NCT01011283|617220|P1|STARTED|Overall Study||13
255099|NCT01011218|617232|P4|NOT COMPLETED|Overall Study||0
255100|NCT01011218|617233|P3|NOT COMPLETED|Overall Study||0
255101|NCT01011218|617234|P2|NOT COMPLETED|Overall Study||0
255102|NCT01011218|617235|P1|NOT COMPLETED|Overall Study||0
255103|NCT01011218|617232|P4|COMPLETED|Overall Study||26
255104|NCT01011218|617233|P3|COMPLETED|Overall Study||26
255105|NCT01011218|617234|P2|COMPLETED|Overall Study||9
255106|NCT01011218|617235|P1|COMPLETED|Overall Study||9
255107|NCT01011218|617232|P4|STARTED|Overall Study||26
255108|NCT01011218|617233|P3|STARTED|Overall Study||26
255109|NCT01011218|617234|P2|STARTED|Overall Study||9
255110|NCT01011218|617235|P1|STARTED|Overall Study||9
255111|NCT01011179|617259|P2|NOT COMPLETED|Overall Study||2
255112|NCT01011179|617260|P1|NOT COMPLETED|Overall Study||4
255113|NCT01011179|617259|P2|COMPLETED|Overall Study||20
255114|NCT01011179|617260|P1|COMPLETED|Overall Study||20
255115|NCT01011179|617259|P2|STARTED|Overall Study||22
255116|NCT01011179|617260|P1|STARTED|Overall Study||24
255117|NCT01011153|617269|P3|NOT COMPLETED|Overall Study||9
255118|NCT01011153|617270|P2|NOT COMPLETED|Overall Study||11
255119|NCT01011153|617271|P1|NOT COMPLETED|Overall Study||8
255120|NCT01011153|617269|P3|COMPLETED|Overall Study||45
255121|NCT01011153|617270|P2|COMPLETED|Overall Study||64
255122|NCT01011153|617271|P1|COMPLETED|Overall Study||46
255123|NCT01011153|617269|P3|STARTED|Overall Study||54
255124|NCT01011153|617270|P2|STARTED|Overall Study||75
255125|NCT01011153|617271|P1|STARTED|Overall Study||54
255126|NCT01011075|617289|P1|NOT COMPLETED|Overall Study||0
255127|NCT01011075|617289|P1|COMPLETED|Overall Study||34
255128|NCT01011075|617289|P1|STARTED|Overall Study||34
255129|NCT01011049|617300|P4|NOT COMPLETED|Overall Study||0
255130|NCT01011049|617301|P3|NOT COMPLETED|Overall Study||4
255131|NCT01011049|617302|P2|NOT COMPLETED|Overall Study||2
255132|NCT01011049|617303|P1|NOT COMPLETED|Overall Study||1
255133|NCT01011049|617300|P4|COMPLETED|Overall Study||246
255134|NCT01011049|617301|P3|COMPLETED|Overall Study||239
255135|NCT01011049|617302|P2|COMPLETED|Overall Study||250
255136|NCT01011049|617303|P1|COMPLETED|Overall Study||506
255137|NCT01011049|617300|P4|STARTED|Overall Study||246
255138|NCT01011049|617301|P3|STARTED|Overall Study||243
255139|NCT01011049|617302|P2|STARTED|Overall Study||252
255140|NCT01011049|617303|P1|STARTED|Overall Study||507
255141|NCT01010984|617325|P1|NOT COMPLETED|Overall Study||0
255142|NCT01010984|617325|P1|COMPLETED|Overall Study||20
255143|NCT01010984|617325|P1|STARTED|Overall Study||20
255144|NCT01010971|617333|P3|NOT COMPLETED|Overall Study||13
255145|NCT01010971|617334|P2|NOT COMPLETED|Overall Study||8
255146|NCT01010971|617335|P1|NOT COMPLETED|Overall Study||3
255147|NCT01010971|617333|P3|COMPLETED|Overall Study||207
255148|NCT01010971|617334|P2|COMPLETED|Overall Study||218
255149|NCT01010971|617335|P1|COMPLETED|Overall Study||222
255150|NCT01010971|617333|P3|STARTED|Overall Study||220
255151|NCT01010971|617334|P2|STARTED|Overall Study||226
255152|NCT01010971|617335|P1|STARTED|Overall Study||225
255153|NCT01010932|617420|P1|NOT COMPLETED|Overall Study||22
255154|NCT01010932|617420|P1|COMPLETED|Overall Study||200
255155|NCT01010932|617420|P1|STARTED|Overall Study||222
255156|NCT01010906|617438|P6|NOT COMPLETED|Overall Study||0
255157|NCT01010906|617439|P5|NOT COMPLETED|Overall Study||0
255158|NCT01010906|617440|P4|NOT COMPLETED|Overall Study||0
255159|NCT01010906|617441|P3|NOT COMPLETED|Overall Study||0
255160|NCT01010906|617442|P2|NOT COMPLETED|Overall Study||0
255161|NCT01010906|617443|P1|NOT COMPLETED|Overall Study||0
255162|NCT01010906|617438|P6|COMPLETED|Overall Study||10
255163|NCT01010906|617439|P5|COMPLETED|Overall Study||10
255164|NCT01010906|617440|P4|COMPLETED|Overall Study||10
255165|NCT01010906|617441|P3|COMPLETED|Overall Study||10
255166|NCT01010906|617442|P2|COMPLETED|Overall Study||10
255167|NCT01010906|617443|P1|COMPLETED|Overall Study||10
255168|NCT01010906|617438|P6|STARTED|Overall Study||10
255169|NCT01010906|617439|P5|STARTED|Overall Study||10
255170|NCT01010906|617440|P4|STARTED|Overall Study||10
255171|NCT01010906|617441|P3|STARTED|Overall Study||10
255172|NCT01010906|617442|P2|STARTED|Overall Study||10
255173|NCT01010906|617443|P1|STARTED|Overall Study||10
255174|NCT01010867|617463|P1|NOT COMPLETED|Overall Study||1
255175|NCT01010867|617463|P1|COMPLETED|Overall Study||30
255176|NCT01010867|617463|P1|STARTED|Overall Study||31
255177|NCT01010854|617470|P1|NOT COMPLETED|Overall Study||0
255178|NCT01010854|617470|P1|COMPLETED|Overall Study||6
255179|NCT01010854|617470|P1|STARTED|Overall Study||6
255180|NCT01010776|617475|P1|NOT COMPLETED|Extension Phase||3
255181|NCT01010776|617475|P1|COMPLETED|Extension Phase||156
255182|NCT01010776|617475|P1|STARTED|Extension Phase||159
255183|NCT01010776|617475|P1|NOT COMPLETED|In-Between Main Phase & Extension Phase||15
255184|NCT01010776|617475|P1|COMPLETED|In-Between Main Phase & Extension Phase||159
255185|NCT01010776|617475|P1|STARTED|In-Between Main Phase & Extension Phase||174
255186|NCT01010776|617475|P1|NOT COMPLETED|Main Phase||49
255187|NCT01010776|617475|P1|COMPLETED|Main Phase||174
255188|NCT01010776|617475|P1|Treated|Main Phase||218
255189|NCT01010776|617475|P1|STARTED|Main Phase||223
255190|NCT01010763|617499|P2|NOT COMPLETED|Overall Study||30
255191|NCT01010763|617500|P1|NOT COMPLETED|Overall Study||35
255192|NCT01010763|617499|P2|COMPLETED|Overall Study||54
255193|NCT01010763|617500|P1|COMPLETED|Overall Study||61
255194|NCT01010763|617499|P2|STARTED|Overall Study||84
255195|NCT01010763|617500|P1|STARTED|Overall Study||96
255196|NCT01010750|617532|P6|NOT COMPLETED|Third Intervention||0
255197|NCT01010750|617533|P5|NOT COMPLETED|Third Intervention||0
255198|NCT01010750|617534|P4|NOT COMPLETED|Third Intervention||0
255199|NCT01010750|617535|P3|NOT COMPLETED|Third Intervention||0
255200|NCT01010750|617536|P2|NOT COMPLETED|Third Intervention||0
255201|NCT01010750|617537|P1|NOT COMPLETED|Third Intervention||0
255202|NCT01010750|617532|P6|COMPLETED|Third Intervention||3
255203|NCT01010750|617533|P5|COMPLETED|Third Intervention||2
255204|NCT01010750|617534|P4|COMPLETED|Third Intervention||3
255205|NCT01010750|617535|P3|COMPLETED|Third Intervention||3
255206|NCT01010750|617536|P2|COMPLETED|Third Intervention||3
255207|NCT01010750|617537|P1|COMPLETED|Third Intervention||3
255208|NCT01010750|617532|P6|STARTED|Third Intervention||3
255209|NCT01010750|617533|P5|STARTED|Third Intervention||2
255210|NCT01010750|617534|P4|STARTED|Third Intervention||3
255211|NCT01010750|617535|P3|STARTED|Third Intervention||3
255212|NCT01010750|617536|P2|STARTED|Third Intervention||3
255213|NCT01010750|617537|P1|STARTED|Third Intervention||3
255214|NCT01010750|617532|P6|NOT COMPLETED|Second Intervention||0
255215|NCT01010750|617533|P5|NOT COMPLETED|Second Intervention||0
255216|NCT01010750|617534|P4|NOT COMPLETED|Second Intervention||0
255217|NCT01010750|617535|P3|NOT COMPLETED|Second Intervention||0
255218|NCT01010750|617536|P2|NOT COMPLETED|Second Intervention||1
255219|NCT01010750|617537|P1|NOT COMPLETED|Second Intervention||0
255220|NCT01010750|617532|P6|COMPLETED|Second Intervention||3
255221|NCT01010750|617533|P5|COMPLETED|Second Intervention||2
255222|NCT01010750|617534|P4|COMPLETED|Second Intervention||3
255223|NCT01010750|617535|P3|COMPLETED|Second Intervention||3
255224|NCT01010750|617536|P2|COMPLETED|Second Intervention||3
255225|NCT01010750|617537|P1|COMPLETED|Second Intervention||3
255226|NCT01010750|617532|P6|STARTED|Second Intervention||3
255227|NCT01010750|617533|P5|STARTED|Second Intervention||2
255228|NCT01010750|617534|P4|STARTED|Second Intervention||3
255229|NCT01010750|617535|P3|STARTED|Second Intervention||3
255230|NCT01010750|617536|P2|STARTED|Second Intervention||4
255231|NCT01010750|617537|P1|STARTED|Second Intervention||3
255232|NCT01010750|617532|P6|NOT COMPLETED|First Intervention||0
255233|NCT01010750|617533|P5|NOT COMPLETED|First Intervention||0
255234|NCT01010750|617534|P4|NOT COMPLETED|First Intervention||0
255235|NCT01010750|617535|P3|NOT COMPLETED|First Intervention||0
255236|NCT01010750|617536|P2|NOT COMPLETED|First Intervention||0
255237|NCT01010750|617537|P1|NOT COMPLETED|First Intervention||0
255238|NCT01010750|617532|P6|COMPLETED|First Intervention||3
255239|NCT01010750|617533|P5|COMPLETED|First Intervention||2
255240|NCT01010750|617534|P4|COMPLETED|First Intervention||3
255241|NCT01010750|617535|P3|COMPLETED|First Intervention||3
255242|NCT01010750|617536|P2|COMPLETED|First Intervention||4
255243|NCT01010750|617537|P1|COMPLETED|First Intervention||3
255244|NCT01010750|617532|P6|STARTED|First Intervention||3
255245|NCT01010750|617533|P5|STARTED|First Intervention||2
255246|NCT01010750|617534|P4|STARTED|First Intervention||3
255247|NCT01010750|617535|P3|STARTED|First Intervention||3
255248|NCT01010750|617536|P2|STARTED|First Intervention||4
255249|NCT01010750|617537|P1|STARTED|First Intervention||3
255250|NCT01010633|617562|P2|NOT COMPLETED|Overall Study||5
255251|NCT01010633|617563|P1|NOT COMPLETED|Overall Study||4
255252|NCT01010633|617562|P2|COMPLETED|Overall Study||198
255253|NCT01010633|617563|P1|COMPLETED|Overall Study||199
255254|NCT01010633|617562|P2|STARTED|Overall Study||203
255255|NCT01010633|617563|P1|STARTED|Overall Study||203
255256|NCT01010568|617573|P1|NOT COMPLETED|Overall Study||5
255257|NCT01010568|617573|P1|COMPLETED|Overall Study||5
255258|NCT01010568|617573|P1|STARTED|Overall Study||10
255259|NCT01010555|617579|P2|NOT COMPLETED|Second Four Weeks of Wear||0
255260|NCT01010555|617580|P1|NOT COMPLETED|Second Four Weeks of Wear||0
255261|NCT01010555|617579|P2|COMPLETED|Second Four Weeks of Wear||9
255262|NCT01010555|617580|P1|COMPLETED|Second Four Weeks of Wear||10
255263|NCT01010555|617579|P2|STARTED|Second Four Weeks of Wear||9
255264|NCT01010555|617580|P1|STARTED|Second Four Weeks of Wear||10
255265|NCT01010555|617579|P2|NOT COMPLETED|First Four Weeks of Wear||0
255266|NCT01010555|617580|P1|NOT COMPLETED|First Four Weeks of Wear||0
255267|NCT01010555|617579|P2|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Non-compliance with visit schedule.|10
255268|NCT01010555|617580|P1|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Relocation.|11
255269|NCT01010555|617579|P2|STARTED|First Four Weeks of Wear||10
255270|NCT01010555|617580|P1|STARTED|First Four Weeks of Wear||11
255271|NCT01010503|617590|P1|NOT COMPLETED|Overall Study||2
255272|NCT01010503|617590|P1|COMPLETED|Overall Study||30
255273|NCT01010503|617590|P1|STARTED|Overall Study||32
255274|NCT01010477|617610|P2|NOT COMPLETED|Overall Study||3
255275|NCT01010477|617611|P1|NOT COMPLETED|Overall Study||6
255276|NCT01010477|617610|P2|COMPLETED|Overall Study||22
255277|NCT01010477|617611|P1|COMPLETED|Overall Study||21
255278|NCT01010477|617610|P2|STARTED|Overall Study||25
255279|NCT01010477|617611|P1|STARTED|Overall Study||27
255280|NCT01010399|617617|P1|NOT COMPLETED|Overall Study||5
255281|NCT01010399|617617|P1|COMPLETED|Overall Study||31
255282|NCT01010399|617617|P1|STARTED|Overall Study||36
255283|NCT01010282|617625|P3|NOT COMPLETED|Overall Study||19
255284|NCT01010282|617626|P2|NOT COMPLETED|Overall Study||7
255285|NCT01010282|617627|P1|NOT COMPLETED|Overall Study||6
255286|NCT01010282|617625|P3|COMPLETED|Overall Study||77
255287|NCT01010282|617626|P2|COMPLETED|Overall Study||88
255288|NCT01010282|617627|P1|COMPLETED|Overall Study||91
255289|NCT01010282|617625|P3|STARTED|Overall Study||96
255290|NCT01010282|617626|P2|STARTED|Overall Study||95
255291|NCT01010282|617627|P1|STARTED|Overall Study||97
255292|NCT01010230|617649|P2|NOT COMPLETED|Overall Study||7
255293|NCT01010230|617650|P1|NOT COMPLETED|Overall Study||10
255294|NCT01010230|617649|P2|COMPLETED|Overall Study||26
255295|NCT01010230|617650|P1|COMPLETED|Overall Study||22
255296|NCT01010230|617649|P2|STARTED|Overall Study||33
255297|NCT01010230|617650|P1|STARTED|Overall Study||32
255298|NCT01010204|617682|P2|NOT COMPLETED|Overall Study||9
255299|NCT01010204|617683|P1|NOT COMPLETED|Overall Study||7
255300|NCT01010204|617682|P2|COMPLETED|Overall Study||20
255301|NCT01010204|617683|P1|COMPLETED|Overall Study||24
255302|NCT01010204|617682|P2|STARTED|Overall Study||29
255303|NCT01010204|617683|P1|STARTED|Overall Study||31
255304|NCT01010126|617699|P6|NOT COMPLETED|Overall Study||0
255305|NCT01010126|617700|P5|NOT COMPLETED|Overall Study||3
255306|NCT01010126|617701|P4|NOT COMPLETED|Overall Study||0
255307|NCT01010126|617702|P3|NOT COMPLETED|Overall Study||1
255308|NCT01010126|617703|P2|NOT COMPLETED|Overall Study||0
255309|NCT01010126|617704|P1|NOT COMPLETED|Overall Study||1
255310|NCT01010126|617699|P6|COMPLETED|Overall Study||24
255311|NCT01010126|617700|P5|COMPLETED|Overall Study||55
255312|NCT01010126|617701|P4|COMPLETED|Overall Study||57
255313|NCT01010126|617702|P3|COMPLETED|Overall Study||27
255314|NCT01010126|617703|P2|COMPLETED|Overall Study||58
255315|NCT01010126|617704|P1|COMPLETED|Overall Study||26
255316|NCT01010126|617699|P6|STARTED|Overall Study||24
255317|NCT01010126|617700|P5|STARTED|Overall Study||58
255318|NCT01010126|617701|P4|STARTED|Overall Study||57
255319|NCT01010126|617702|P3|STARTED|Overall Study||28
255320|NCT01010126|617703|P2|STARTED|Overall Study||58
255321|NCT01010126|617704|P1|STARTED|Overall Study||27
255322|NCT01010061|617756|P2|NOT COMPLETED|Overall Study||40
255323|NCT01010061|617757|P1|NOT COMPLETED|Overall Study||48
255324|NCT01010061|617756|P2|COMPLETED|Overall Study||78
255325|NCT01010061|617757|P1|COMPLETED|Overall Study|Completed=Completed treatment.|190
255326|NCT01010061|617756|P2|Received Study Drug|Overall Study||116
255327|NCT01010061|617757|P1|Received Study Drug|Overall Study||236
255328|NCT01010061|617756|P2|STARTED|Overall Study||118
255329|NCT01010061|617757|P1|STARTED|Overall Study||238
255330|NCT01010009|617792|P3|NOT COMPLETED|Overall Study||0
255331|NCT01010009|617793|P2|NOT COMPLETED|Overall Study||0
255332|NCT01010009|617794|P1|NOT COMPLETED|Overall Study||0
255333|NCT01010009|617792|P3|COMPLETED|Overall Study||8
255334|NCT01010009|617793|P2|COMPLETED|Overall Study||8
255335|NCT01010009|617794|P1|COMPLETED|Overall Study||8
255336|NCT01010009|617792|P3|STARTED|Overall Study||8
255337|NCT01010009|617793|P2|STARTED|Overall Study||8
255338|NCT01010009|617794|P1|STARTED|Overall Study||8
255339|NCT01009983|617808|P1|NOT COMPLETED|Overall Study||1
255340|NCT01009983|617808|P1|COMPLETED|Overall Study||13
255341|NCT01009983|617808|P1|STARTED|Overall Study||14
255342|NCT01009931|617815|P1|NOT COMPLETED|Overall Study||1
255343|NCT01009931|617815|P1|COMPLETED|Overall Study||0
255344|NCT01009931|617815|P1|STARTED|Overall Study||1
255345|NCT01009840|617821|P1|NOT COMPLETED|Overall Study||14
255346|NCT01009840|617821|P1|COMPLETED|Overall Study||16
255347|NCT01009840|617821|P1|STARTED|Overall Study||30
255348|NCT01009762|617836|P2|NOT COMPLETED|Overall Study||0
255349|NCT01009762|617837|P1|NOT COMPLETED|Overall Study||0
255350|NCT01009762|617836|P2|COMPLETED|Overall Study|10 participants received vaccine|10
255351|NCT01009762|617837|P1|COMPLETED|Overall Study|according to randomization this one participant received placebo|1
255352|NCT01009762|617836|P2|Primary Outcome|Overall Study|no SAE, no treatment related side effects DLT grade 3 or more|0
255353|NCT01009762|617837|P1|Primary Outcome|Overall Study|no Serious Adverse Events (SAE), no treatment related side effects DLT grade 3 or more|0
255354|NCT01009762|617836|P2|STARTED|Overall Study||10
255355|NCT01009762|617837|P1|STARTED|Overall Study||1
255356|NCT01009645|617851|P4|NOT COMPLETED|Overall Study||5
255357|NCT01009645|617852|P3|NOT COMPLETED|Overall Study||4
255358|NCT01009645|617853|P2|NOT COMPLETED|Overall Study||8
255359|NCT01009645|617854|P1|NOT COMPLETED|Overall Study||2
255360|NCT01009645|617851|P4|COMPLETED|Overall Study||26
255361|NCT01009645|617852|P3|COMPLETED|Overall Study||28
255362|NCT01009645|617853|P2|COMPLETED|Overall Study||23
255363|NCT01009645|617854|P1|COMPLETED|Overall Study||29
255364|NCT01009645|617851|P4|STARTED|Overall Study||31
255365|NCT01009645|617852|P3|STARTED|Overall Study||32
255366|NCT01009645|617853|P2|STARTED|Overall Study||31
255367|NCT01009645|617854|P1|STARTED|Overall Study||31
255368|NCT01009619|617870|P2|NOT COMPLETED|Overall Study||0
255369|NCT01009619|617871|P1|NOT COMPLETED|Overall Study||0
255370|NCT01009619|617870|P2|COMPLETED|Overall Study||43
255371|NCT01009619|617871|P1|COMPLETED|Overall Study||40
255372|NCT01009619|617870|P2|STARTED|Overall Study||43
255373|NCT01009619|617871|P1|STARTED|Overall Study||40
255374|NCT01009580|617891|P2|NOT COMPLETED|Overall Study||35
255375|NCT01009580|617892|P1|NOT COMPLETED|Overall Study||27
255376|NCT01009580|617891|P2|COMPLETED|Overall Study||188
255377|NCT01009580|617892|P1|COMPLETED|Overall Study||197
255378|NCT01009580|617891|P2|Exposed|Overall Study|One subject was randomised in error and withdrew prior to exposure to drug|222
255379|NCT01009580|617892|P1|Exposed|Overall Study||224
255380|NCT01009580|617891|P2|STARTED|Overall Study||223
255381|NCT01009580|617892|P1|STARTED|Overall Study||224
255382|NCT01009554|617906|P2|NOT COMPLETED|Overall Study||7
255383|NCT01009554|617907|P1|NOT COMPLETED|Overall Study||2
255384|NCT01009554|617906|P2|COMPLETED|Overall Study||41
255385|NCT01009554|617907|P1|COMPLETED|Overall Study||46
255386|NCT01009554|617906|P2|STARTED|Overall Study||48
255387|NCT01009554|617907|P1|STARTED|Overall Study||48
255388|NCT01009515|618039|P1|NOT COMPLETED|Overall Study||3
255389|NCT01009515|618039|P1|COMPLETED|Overall Study||16
255390|NCT01009515|618039|P1|STARTED|Overall Study||19
255391|NCT01009463|618050|P5|NOT COMPLETED|52-week, Double-blind Treatment Period||101
255392|NCT01009463|618051|P4|NOT COMPLETED|52-week, Double-blind Treatment Period||91
255393|NCT01009463|618052|P3|NOT COMPLETED|52-week, Double-blind Treatment Period||93
255394|NCT01009463|618053|P2|NOT COMPLETED|52-week, Double-blind Treatment Period||115
255395|NCT01009463|618054|P1|NOT COMPLETED|52-week, Double-blind Treatment Period||0
255396|NCT01009463|618050|P5|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|301
255397|NCT01009463|618051|P4|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|312
255398|NCT01009463|618052|P3|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|315
255399|NCT01009463|618053|P2|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|294
255400|NCT01009463|618054|P1|COMPLETED|52-week, Double-blind Treatment Period||0
255401|NCT01009463|618050|P5|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|303
255402|NCT01009463|618051|P4|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|314
255403|NCT01009463|618052|P3|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|318
255404|NCT01009463|618053|P2|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|295
255405|NCT01009463|618054|P1|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
255406|NCT01009463|618050|P5|STARTED|52-week, Double-blind Treatment Period||402
255407|NCT01009463|618051|P4|STARTED|52-week, Double-blind Treatment Period||403
255408|NCT01009463|618052|P3|STARTED|52-week, Double-blind Treatment Period||408
255409|NCT01009463|618053|P2|STARTED|52-week, Double-blind Treatment Period||409
255410|NCT01009463|618054|P1|STARTED|52-week, Double-blind Treatment Period||0
255411|NCT01009463|618050|P5|NOT COMPLETED|4-week, Open-label Run-In Period||0
255412|NCT01009463|618051|P4|NOT COMPLETED|4-week, Open-label Run-In Period||0
255413|NCT01009463|618052|P3|NOT COMPLETED|4-week, Open-label Run-In Period||0
255414|NCT01009463|618053|P2|NOT COMPLETED|4-week, Open-label Run-In Period||0
255415|NCT01009463|618054|P1|NOT COMPLETED|4-week, Open-label Run-In Period||449
255416|NCT01009463|618050|P5|COMPLETED|4-week, Open-label Run-In Period||0
255417|NCT01009463|618051|P4|COMPLETED|4-week, Open-label Run-In Period||0
255418|NCT01009463|618052|P3|COMPLETED|4-week, Open-label Run-In Period||0
255419|NCT01009463|618053|P2|COMPLETED|4-week, Open-label Run-In Period||0
255420|NCT01009463|618054|P1|COMPLETED|4-week, Open-label Run-In Period||1622
255421|NCT01009463|618050|P5|STARTED|4-week, Open-label Run-In Period||0
255422|NCT01009463|618051|P4|STARTED|4-week, Open-label Run-In Period||0
255423|NCT01009463|618052|P3|STARTED|4-week, Open-label Run-In Period||0
255424|NCT01009463|618053|P2|STARTED|4-week, Open-label Run-In Period||0
255425|NCT01009463|618054|P1|STARTED|4-week, Open-label Run-In Period||2071
255426|NCT01009346|618076|P1|NOT COMPLETED|Overall Study||4
255427|NCT01009346|618076|P1|COMPLETED|Overall Study||5
255428|NCT01009346|618076|P1|STARTED|Overall Study||9
255429|NCT01009333|618081|P6|NOT COMPLETED|Week 3||0
255430|NCT01009333|618082|P5|NOT COMPLETED|Week 3||0
255431|NCT01009333|618083|P4|NOT COMPLETED|Week 3||0
255432|NCT01009333|618084|P3|NOT COMPLETED|Week 3||0
255433|NCT01009333|618085|P2|NOT COMPLETED|Week 3||0
255434|NCT01009333|618086|P1|NOT COMPLETED|Week 3||0
255435|NCT01009333|618081|P6|COMPLETED|Week 3||2
255436|NCT01009333|618082|P5|COMPLETED|Week 3||2
255437|NCT01009333|618083|P4|COMPLETED|Week 3||2
255438|NCT01009333|618084|P3|COMPLETED|Week 3||2
255439|NCT01009333|618085|P2|COMPLETED|Week 3||2
255440|NCT01009333|618086|P1|COMPLETED|Week 3||2
255441|NCT01009333|618081|P6|STARTED|Week 3||2
255442|NCT01009333|618082|P5|STARTED|Week 3||2
255443|NCT01009333|618083|P4|STARTED|Week 3||2
255444|NCT01009333|618084|P3|STARTED|Week 3||2
255445|NCT01009333|618085|P2|STARTED|Week 3||2
255446|NCT01009333|618086|P1|STARTED|Week 3||2
255447|NCT01009333|618081|P6|NOT COMPLETED|Week 2||0
255448|NCT01009333|618082|P5|NOT COMPLETED|Week 2||0
255449|NCT01009333|618083|P4|NOT COMPLETED|Week 2||0
255450|NCT01009333|618084|P3|NOT COMPLETED|Week 2||0
255451|NCT01009333|618085|P2|NOT COMPLETED|Week 2||0
255452|NCT01009333|618086|P1|NOT COMPLETED|Week 2||0
255453|NCT01009333|618081|P6|COMPLETED|Week 2||2
255454|NCT01009333|618082|P5|COMPLETED|Week 2||2
255455|NCT01009333|618083|P4|COMPLETED|Week 2||2
255456|NCT01009333|618084|P3|COMPLETED|Week 2||2
255457|NCT01009333|618085|P2|COMPLETED|Week 2||2
255458|NCT01009333|618086|P1|COMPLETED|Week 2||2
255459|NCT01009333|618081|P6|STARTED|Week 2||2
255460|NCT01009333|618082|P5|STARTED|Week 2||2
255461|NCT01009333|618083|P4|STARTED|Week 2||2
255462|NCT01009333|618084|P3|STARTED|Week 2||2
255463|NCT01009333|618085|P2|STARTED|Week 2||2
255464|NCT01009333|618086|P1|STARTED|Week 2||2
255465|NCT01009333|618081|P6|NOT COMPLETED|Week 1||0
255466|NCT01009333|618082|P5|NOT COMPLETED|Week 1||0
255467|NCT01009333|618083|P4|NOT COMPLETED|Week 1||0
255468|NCT01009333|618084|P3|NOT COMPLETED|Week 1||0
255469|NCT01009333|618085|P2|NOT COMPLETED|Week 1||0
255470|NCT01009333|618086|P1|NOT COMPLETED|Week 1||0
255471|NCT01009333|618081|P6|COMPLETED|Week 1||2
255472|NCT01009333|618082|P5|COMPLETED|Week 1||2
255473|NCT01009333|618083|P4|COMPLETED|Week 1||2
255474|NCT01009333|618084|P3|COMPLETED|Week 1||2
255475|NCT01009333|618085|P2|COMPLETED|Week 1|1 participant did not progress to the second period due to a protocol violation.|3
255476|NCT01009333|618086|P1|COMPLETED|Week 1||2
255477|NCT01009333|618081|P6|STARTED|Week 1||2
255478|NCT01009333|618082|P5|STARTED|Week 1||2
255479|NCT01009333|618083|P4|STARTED|Week 1||2
255480|NCT01009333|618084|P3|STARTED|Week 1||2
255481|NCT01009333|618085|P2|STARTED|Week 1||3
255482|NCT01009333|618086|P1|STARTED|Week 1||2
255483|NCT01009203|618100|P1|NOT COMPLETED|Overall Study||7
255484|NCT01009203|618100|P1|COMPLETED|Overall Study||6
255485|NCT01009203|618100|P1|Received Treatment|Overall Study|One patient withdrew consent before treatment started.|12
255486|NCT01009203|618100|P1|STARTED|Overall Study||13
255487|NCT01009138|618109|P2|NOT COMPLETED|Overall Study||20
255488|NCT01009138|618110|P1|NOT COMPLETED|Overall Study||13
255489|NCT01009138|618109|P2|COMPLETED|Overall Study||88
255490|NCT01009138|618110|P1|COMPLETED|Overall Study||93
255491|NCT01009138|618109|P2|STARTED|Overall Study||108
255492|NCT01009138|618110|P1|STARTED|Overall Study||106
255493|NCT01009099|618140|P2|NOT COMPLETED|Overall Study||4
255494|NCT01009099|618141|P1|NOT COMPLETED|Overall Study||5
255495|NCT01009099|618140|P2|COMPLETED|Overall Study||57
255496|NCT01009099|618141|P1|COMPLETED|Overall Study||53
255497|NCT01009099|618140|P2|STARTED|Overall Study||61
255498|NCT01009099|618141|P1|STARTED|Overall Study||58
255499|NCT01009086|618150|P3|NOT COMPLETED|Overall Study||34
255500|NCT01009086|618151|P2|NOT COMPLETED|Overall Study||47
255501|NCT01009086|618152|P1|NOT COMPLETED|Overall Study||44
255502|NCT01009086|618150|P3|COMPLETED|Overall Study||170
255503|NCT01009086|618151|P2|COMPLETED|Overall Study||158
255504|NCT01009086|618152|P1|COMPLETED|Overall Study||162
255505|NCT01009086|618150|P3|STARTED|Overall Study||204
255506|NCT01009086|618151|P2|STARTED|Overall Study||205
255507|NCT01009086|618152|P1|STARTED|Overall Study||206
255508|NCT01009060|618187|P2|NOT COMPLETED|Overall Study||5
255509|NCT01009060|618188|P1|NOT COMPLETED|Overall Study||4
255510|NCT01009060|618187|P2|COMPLETED|Overall Study||20
255511|NCT01009060|618188|P1|COMPLETED|Overall Study||21
255512|NCT01009060|618187|P2|STARTED|Overall Study||25
255513|NCT01009060|618188|P1|STARTED|Overall Study||25
255514|NCT01009047|618226|P2|NOT COMPLETED|Overall Study||26
255515|NCT01009047|618227|P1|NOT COMPLETED|Overall Study||28
255516|NCT01009047|618226|P2|COMPLETED|Overall Study||89
255517|NCT01009047|618227|P1|COMPLETED|Overall Study||85
255518|NCT01009047|618226|P2|STARTED|Overall Study||115
255519|NCT01009047|618227|P1|STARTED|Overall Study||113
255520|NCT01009034|618249|P1|NOT COMPLETED|Overall Study||4
255521|NCT01009034|618249|P1|COMPLETED|Overall Study||10
255522|NCT01009034|618249|P1|STARTED|Overall Study||14
255523|NCT01008995|618257|P4|NOT COMPLETED|After Controlled Period||1
255524|NCT01008995|618258|P3|NOT COMPLETED|After Controlled Period||2
255525|NCT01008995|618259|P2|NOT COMPLETED|After Controlled Period||0
255526|NCT01008995|618260|P1|NOT COMPLETED|After Controlled Period||0
255527|NCT01008995|618257|P4|COMPLETED|After Controlled Period||156
255528|NCT01008995|618258|P3|COMPLETED|After Controlled Period||156
255529|NCT01008995|618259|P2|COMPLETED|After Controlled Period||0
255530|NCT01008995|618260|P1|COMPLETED|After Controlled Period||0
255531|NCT01008995|618257|P4|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|157
255532|NCT01008995|618258|P3|STARTED|After Controlled Period|1 placebo participant discontinued after completing the CP and did not receive ustekinumab 45 mg.|158
255533|NCT01008995|618259|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
255534|NCT01008995|618260|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
255535|NCT01008995|618257|P4|NOT COMPLETED|Controlled Period||0
255536|NCT01008995|618258|P3|NOT COMPLETED|Controlled Period||0
255537|NCT01008995|618259|P2|NOT COMPLETED|Controlled Period||3
255538|NCT01008995|618260|P1|NOT COMPLETED|Controlled Period||3
255539|NCT01008995|618257|P4|COMPLETED|Controlled Period||0
255540|NCT01008995|618258|P3|COMPLETED|Controlled Period||0
255541|NCT01008995|618259|P2|COMPLETED|Controlled Period||157
255542|NCT01008995|618260|P1|COMPLETED|Controlled Period||159
255543|NCT01008995|618257|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
255544|NCT01008995|618258|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
255545|NCT01008995|618259|P2|STARTED|Controlled Period||160
255546|NCT01008995|618260|P1|STARTED|Controlled Period||162
255547|NCT01008969|618272|P1|NOT COMPLETED|Overall Study||0
255548|NCT01008969|618272|P1|COMPLETED|Overall Study||10
255549|NCT01008969|618272|P1|STARTED|Overall Study||10
255550|NCT01008943|618277|P1|NOT COMPLETED|Overall Study||1
255551|NCT01008943|618277|P1|COMPLETED|Overall Study||15
255552|NCT01008943|618277|P1|STARTED|Overall Study||16
255553|NCT01008904|618284|P1|NOT COMPLETED|Overall Study||4
255554|NCT01008904|618284|P1|COMPLETED|Overall Study||25
255555|NCT01008904|618284|P1|STARTED|Overall Study||29
255556|NCT01008722|618291|P2|NOT COMPLETED|Overall Study||0
255557|NCT01008722|618292|P1|NOT COMPLETED|Overall Study||0
255558|NCT01008722|618291|P2|COMPLETED|Overall Study||71
255559|NCT01008722|618292|P1|COMPLETED|Overall Study||36
255560|NCT01008722|618291|P2|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|71
255561|NCT01008722|618292|P1|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|36
255562|NCT01008696|618302|P2|NOT COMPLETED|Overall Study||17
255563|NCT01008696|618303|P1|NOT COMPLETED|Overall Study||17
255564|NCT01008696|618302|P2|COMPLETED|Overall Study||92
255565|NCT01008696|618303|P1|COMPLETED|Overall Study||91
255566|NCT01008696|618302|P2|STARTED|Overall Study||109
255567|NCT01008696|618303|P1|STARTED|Overall Study||108
255568|NCT01008618|618313|P3|NOT COMPLETED|Period 2 (Double-Blind Period)||38
255569|NCT01008618|618314|P2|NOT COMPLETED|Period 2 (Double-Blind Period)||36
255570|NCT01008618|618315|P1|NOT COMPLETED|Period 2 (Double-Blind Period)||0
255571|NCT01008618|618313|P3|COMPLETED|Period 2 (Double-Blind Period)||39
255572|NCT01008618|618314|P2|COMPLETED|Period 2 (Double-Blind Period)||37
255573|NCT01008618|618315|P1|COMPLETED|Period 2 (Double-Blind Period)||0
255574|NCT01008618|618313|P3|STARTED|Period 2 (Double-Blind Period)||77
255575|NCT01008618|618314|P2|STARTED|Period 2 (Double-Blind Period)||73
255576|NCT01008618|618315|P1|STARTED|Period 2 (Double-Blind Period)||0
255577|NCT01008618|618313|P3|NOT COMPLETED|Period 1 (Titration Period)||0
255578|NCT01008618|618314|P2|NOT COMPLETED|Period 1 (Titration Period)||0
255579|NCT01008618|618315|P1|NOT COMPLETED|Period 1 (Titration Period)||68
255580|NCT01008618|618313|P3|COMPLETED|Period 1 (Titration Period)||0
255581|NCT01008618|618314|P2|COMPLETED|Period 1 (Titration Period)||0
255582|NCT01008618|618315|P1|COMPLETED|Period 1 (Titration Period)||150
255583|NCT01008618|618313|P3|STARTED|Period 1 (Titration Period)||0
255584|NCT01008618|618314|P2|STARTED|Period 1 (Titration Period)||0
255585|NCT01008618|618315|P1|STARTED|Period 1 (Titration Period)||218
255586|NCT01008605|618340|P1|NOT COMPLETED|Overall Study||0
255587|NCT01008605|618340|P1|COMPLETED|Overall Study||48
255588|NCT01008605|618340|P1|STARTED|Overall Study||48
255589|NCT01008553|618364|P3|NOT COMPLETED|Period 2 (Double-Blind Period)||51
255590|NCT01008553|618365|P2|NOT COMPLETED|Period 2 (Double-Blind Period)||37
255591|NCT01008553|618366|P1|NOT COMPLETED|Period 2 (Double-Blind Period)||0
255592|NCT01008553|618364|P3|COMPLETED|Period 2 (Double-Blind Period)||28
255593|NCT01008553|618365|P2|COMPLETED|Period 2 (Double-Blind Period)||47
255594|NCT01008553|618366|P1|COMPLETED|Period 2 (Double-Blind Period)||0
255595|NCT01008553|618364|P3|STARTED|Period 2 (Double-Blind Period)||79
255596|NCT01008553|618365|P2|STARTED|Period 2 (Double-Blind Period)||84
255597|NCT01008553|618366|P1|STARTED|Period 2 (Double-Blind Period)||0
255598|NCT01008553|618364|P3|NOT COMPLETED|Period 1 (Titration Period)||0
255599|NCT01008553|618365|P2|NOT COMPLETED|Period 1 (Titration Period)||0
255600|NCT01008553|618366|P1|NOT COMPLETED|Period 1 (Titration Period)||95
255601|NCT01008553|618364|P3|COMPLETED|Period 1 (Titration Period)||0
255602|NCT01008553|618365|P2|COMPLETED|Period 1 (Titration Period)||0
255603|NCT01008553|618366|P1|COMPLETED|Period 1 (Titration Period)||163
255604|NCT01008553|618364|P3|STARTED|Period 1 (Titration Period)||0
255605|NCT01008553|618365|P2|STARTED|Period 1 (Titration Period)||0
255606|NCT01008553|618366|P1|STARTED|Period 1 (Titration Period)||258
255607|NCT01008475|618398|P7|NOT COMPLETED|Overall Study||4
255608|NCT01008475|618399|P6|NOT COMPLETED|Overall Study||6
255609|NCT01008475|618400|P5|NOT COMPLETED|Overall Study||5
255610|NCT01008475|618401|P4|NOT COMPLETED|Overall Study||0
255611|NCT01008475|618402|P3|NOT COMPLETED|Overall Study||0
255612|NCT01008475|618403|P2|NOT COMPLETED|Overall Study||0
255613|NCT01008475|618404|P1|NOT COMPLETED|Overall Study||0
255614|NCT01008475|618398|P7|COMPLETED|Overall Study||67
255615|NCT01008475|618399|P6|COMPLETED|Overall Study||67
255616|NCT01008475|618400|P5|COMPLETED|Overall Study||67
255617|NCT01008475|618401|P4|COMPLETED|Overall Study||3
255618|NCT01008475|618402|P3|COMPLETED|Overall Study||7
255619|NCT01008475|618403|P2|COMPLETED|Overall Study||3
255620|NCT01008475|618404|P1|COMPLETED|Overall Study||3
255621|NCT01008475|618398|P7|Safety Analysis Set|Overall Study||69
255622|NCT01008475|618399|P6|Safety Analysis Set|Overall Study||72
255623|NCT01008475|618400|P5|Safety Analysis Set|Overall Study|1 subject randomized to EMD525797 1000 mg group received only SoC. Hence, reported under SOC group.|73
255624|NCT01008475|618401|P4|Safety Analysis Set|Overall Study||3
255625|NCT01008475|618402|P3|Safety Analysis Set|Overall Study||7
255626|NCT01008475|618403|P2|Safety Analysis Set|Overall Study||3
255627|NCT01008475|618404|P1|Safety Analysis Set|Overall Study||3
255628|NCT01008475|618398|P7|STARTED|Overall Study||71
255629|NCT01008475|618399|P6|STARTED|Overall Study||73
255630|NCT01008475|618400|P5|STARTED|Overall Study||72
255631|NCT01008475|618401|P4|STARTED|Overall Study||3
255632|NCT01008475|618402|P3|STARTED|Overall Study||7
255633|NCT01008475|618403|P2|STARTED|Overall Study||3
255634|NCT01008475|618404|P1|STARTED|Overall Study||3
255635|NCT01008462|618432|P1|NOT COMPLETED|Overall Study||0
255636|NCT01008462|618432|P1|COMPLETED|Overall Study||16
255637|NCT01008462|618432|P1|STARTED|Overall Study||16
255638|NCT01008449|618444|P2|NOT COMPLETED|Overall Study||19
255639|NCT01008449|618445|P1|NOT COMPLETED|Overall Study||29
255640|NCT01008449|618444|P2|COMPLETED|Overall Study||179
255641|NCT01008449|618445|P1|COMPLETED|Overall Study||171
255642|NCT01008449|618444|P2|STARTED|Overall Study||198
255643|NCT01008449|618445|P1|STARTED|Overall Study||200
255644|NCT01008423|618467|P2|NOT COMPLETED|Overall Study||22
255645|NCT01008423|618468|P1|NOT COMPLETED|Overall Study||19
255646|NCT01008423|618467|P2|COMPLETED|Overall Study||125
255647|NCT01008423|618468|P1|COMPLETED|Overall Study||115
255648|NCT01008423|618467|P2|Received at Least 1 Dose of Study Drug|Overall Study||147
255649|NCT01008423|618468|P1|Received at Least 1 Dose of Study Drug|Overall Study||134
255650|NCT01008423|618467|P2|STARTED|Overall Study||147
255651|NCT01008423|618468|P1|STARTED|Overall Study||134
255652|NCT01008410|618494|P2|NOT COMPLETED|Overall Study||16
255653|NCT01008410|618495|P1|NOT COMPLETED|Overall Study||25
255654|NCT01008410|618494|P2|COMPLETED|Overall Study||116
255655|NCT01008410|618495|P1|COMPLETED|Overall Study||108
255656|NCT01008410|618494|P2|Received at Least 1 Dose of Study Drug|Overall Study||132
255657|NCT01008410|618495|P1|Received at Least 1 Dose of Study Drug|Overall Study||133
255658|NCT01008410|618494|P2|STARTED|Overall Study||132
255659|NCT01008410|618495|P1|STARTED|Overall Study||133
255660|NCT01008319|618521|P2|NOT COMPLETED|Overall Study||0
255661|NCT01008319|618522|P1|NOT COMPLETED|Overall Study||0
255662|NCT01008319|618521|P2|COMPLETED|Overall Study||60
255663|NCT01008319|618522|P1|COMPLETED|Overall Study||60
255664|NCT01008319|618521|P2|STARTED|Overall Study||60
255665|NCT01008319|618522|P1|STARTED|Overall Study||60
255666|NCT01008280|618534|P2|NOT COMPLETED|Overall Study||19
255667|NCT01008280|618535|P1|NOT COMPLETED|Overall Study||21
255668|NCT01008280|618534|P2|COMPLETED|Overall Study||73
255669|NCT01008280|618535|P1|COMPLETED|Overall Study||67
255670|NCT01008280|618534|P2|STARTED|Overall Study||92
255671|NCT01008280|618535|P1|STARTED|Overall Study||88
255672|NCT01008150|618549|P4|NOT COMPLETED|Overall Study||0
255673|NCT01008150|618550|P3|NOT COMPLETED|Overall Study||1
255674|NCT01008150|618551|P2|NOT COMPLETED|Overall Study||1
255675|NCT01008150|618552|P1|NOT COMPLETED|Overall Study||1
255676|NCT01008150|618549|P4|COMPLETED|Overall Study||12
255677|NCT01008150|618550|P3|COMPLETED|Overall Study||42
255678|NCT01008150|618551|P2|COMPLETED|Overall Study||42
255679|NCT01008150|618552|P1|COMPLETED|Overall Study||42
255680|NCT01008150|618549|P4|STARTED|Overall Study||12
255681|NCT01008150|618550|P3|STARTED|Overall Study||43
255682|NCT01008150|618551|P2|STARTED|Overall Study||43
255683|NCT01008150|618552|P1|STARTED|Overall Study||43
255684|NCT01008059|618582|P8|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
255685|NCT01008059|618583|P7|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
255686|NCT01008059|618584|P6|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
255687|NCT01008059|618585|P5|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
255688|NCT01008059|618586|P4|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
255689|NCT01008059|618587|P3|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
255690|NCT01008059|618588|P2|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
255691|NCT01008059|618589|P1|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
255692|NCT01008059|618582|P8|COMPLETED|Ketoconazole Simultaneous Alfentanil||6
255693|NCT01008059|618583|P7|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
255694|NCT01008059|618584|P6|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
255695|NCT01008059|618585|P5|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
255696|NCT01008059|618586|P4|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
255697|NCT01008059|618587|P3|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
255698|NCT01008059|618588|P2|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
255699|NCT01008059|618589|P1|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
255700|NCT01008059|618582|P8|STARTED|Ketoconazole Simultaneous Alfentanil||6
255701|NCT01008059|618583|P7|STARTED|Ketoconazole Simultaneous Alfentanil||0
255702|NCT01008059|618584|P6|STARTED|Ketoconazole Simultaneous Alfentanil||0
255703|NCT01008059|618585|P5|STARTED|Ketoconazole Simultaneous Alfentanil||0
255704|NCT01008059|618586|P4|STARTED|Ketoconazole Simultaneous Alfentanil||0
255705|NCT01008059|618587|P3|STARTED|Ketoconazole Simultaneous Alfentanil||0
255706|NCT01008059|618588|P2|STARTED|Ketoconazole Simultaneous Alfentanil||0
255707|NCT01008059|618589|P1|STARTED|Ketoconazole Simultaneous Alfentanil||0
255708|NCT01008059|618582|P8|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
255709|NCT01008059|618583|P7|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
255710|NCT01008059|618584|P6|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
255711|NCT01008059|618585|P5|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
255712|NCT01008059|618586|P4|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
255713|NCT01008059|618587|P3|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
255714|NCT01008059|618588|P2|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
255715|NCT01008059|618589|P1|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
255716|NCT01008059|618582|P8|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
255717|NCT01008059|618583|P7|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||6
255718|NCT01008059|618584|P6|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
255719|NCT01008059|618585|P5|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
255720|NCT01008059|618586|P4|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
255721|NCT01008059|618587|P3|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
255722|NCT01008059|618588|P2|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
255723|NCT01008059|618589|P1|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
255724|NCT01008059|618582|P8|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
255725|NCT01008059|618583|P7|STARTED|Grapefruit Juice Simultaneous Alfentanil||6
255726|NCT01008059|618584|P6|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
255727|NCT01008059|618585|P5|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
255728|NCT01008059|618586|P4|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
255729|NCT01008059|618587|P3|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
255730|NCT01008059|618588|P2|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
255731|NCT01008059|618589|P1|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
255732|NCT01008059|618582|P8|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
255733|NCT01008059|618583|P7|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
255734|NCT01008059|618584|P6|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
255735|NCT01008059|618585|P5|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
255736|NCT01008059|618586|P4|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
255737|NCT01008059|618587|P3|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
255738|NCT01008059|618588|P2|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
255739|NCT01008059|618589|P1|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
255740|NCT01008059|618582|P8|COMPLETED|Rifampin Simultaneous Alfentanil||0
255741|NCT01008059|618583|P7|COMPLETED|Rifampin Simultaneous Alfentanil||0
255742|NCT01008059|618584|P6|COMPLETED|Rifampin Simultaneous Alfentanil||6
255743|NCT01008059|618585|P5|COMPLETED|Rifampin Simultaneous Alfentanil||0
255744|NCT01008059|618586|P4|COMPLETED|Rifampin Simultaneous Alfentanil||0
255745|NCT01008059|618587|P3|COMPLETED|Rifampin Simultaneous Alfentanil||0
255746|NCT01008059|618588|P2|COMPLETED|Rifampin Simultaneous Alfentanil||0
255747|NCT01008059|618589|P1|COMPLETED|Rifampin Simultaneous Alfentanil||0
255748|NCT01008059|618582|P8|STARTED|Rifampin Simultaneous Alfentanil||0
255749|NCT01008059|618583|P7|STARTED|Rifampin Simultaneous Alfentanil||0
255750|NCT01008059|618584|P6|STARTED|Rifampin Simultaneous Alfentanil||6
255751|NCT01008059|618585|P5|STARTED|Rifampin Simultaneous Alfentanil||0
255752|NCT01008059|618586|P4|STARTED|Rifampin Simultaneous Alfentanil||0
255753|NCT01008059|618587|P3|STARTED|Rifampin Simultaneous Alfentanil||0
255754|NCT01008059|618588|P2|STARTED|Rifampin Simultaneous Alfentanil||0
255755|NCT01008059|618589|P1|STARTED|Rifampin Simultaneous Alfentanil||0
255756|NCT01008059|618582|P8|NOT COMPLETED|Control Simultaneous Alfentanil||0
255757|NCT01008059|618583|P7|NOT COMPLETED|Control Simultaneous Alfentanil||0
255758|NCT01008059|618584|P6|NOT COMPLETED|Control Simultaneous Alfentanil||0
255759|NCT01008059|618585|P5|NOT COMPLETED|Control Simultaneous Alfentanil||0
255760|NCT01008059|618586|P4|NOT COMPLETED|Control Simultaneous Alfentanil||0
255761|NCT01008059|618587|P3|NOT COMPLETED|Control Simultaneous Alfentanil||0
255762|NCT01008059|618588|P2|NOT COMPLETED|Control Simultaneous Alfentanil||0
255763|NCT01008059|618589|P1|NOT COMPLETED|Control Simultaneous Alfentanil||0
255764|NCT01008059|618582|P8|COMPLETED|Control Simultaneous Alfentanil||0
255765|NCT01008059|618583|P7|COMPLETED|Control Simultaneous Alfentanil||0
255766|NCT01008059|618584|P6|COMPLETED|Control Simultaneous Alfentanil||0
255767|NCT01008059|618585|P5|COMPLETED|Control Simultaneous Alfentanil||6
255768|NCT01008059|618586|P4|COMPLETED|Control Simultaneous Alfentanil||0
255769|NCT01008059|618587|P3|COMPLETED|Control Simultaneous Alfentanil||0
255770|NCT01008059|618588|P2|COMPLETED|Control Simultaneous Alfentanil||0
255771|NCT01008059|618589|P1|COMPLETED|Control Simultaneous Alfentanil||0
255772|NCT01008059|618582|P8|STARTED|Control Simultaneous Alfentanil||0
255773|NCT01008059|618583|P7|STARTED|Control Simultaneous Alfentanil||0
255774|NCT01008059|618584|P6|STARTED|Control Simultaneous Alfentanil||0
255775|NCT01008059|618585|P5|STARTED|Control Simultaneous Alfentanil||6
255776|NCT01008059|618586|P4|STARTED|Control Simultaneous Alfentanil||0
255777|NCT01008059|618587|P3|STARTED|Control Simultaneous Alfentanil||0
255778|NCT01008059|618588|P2|STARTED|Control Simultaneous Alfentanil||0
255779|NCT01008059|618589|P1|STARTED|Control Simultaneous Alfentanil||0
255780|NCT01008059|618582|P8|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
255781|NCT01008059|618583|P7|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
255782|NCT01008059|618584|P6|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
255783|NCT01008059|618585|P5|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
255784|NCT01008059|618586|P4|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
255785|NCT01008059|618587|P3|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
255786|NCT01008059|618588|P2|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
255787|NCT01008059|618589|P1|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
255788|NCT01008059|618582|P8|COMPLETED|Ketoconazole Sequential Alfentanil||0
255789|NCT01008059|618583|P7|COMPLETED|Ketoconazole Sequential Alfentanil||0
255790|NCT01008059|618584|P6|COMPLETED|Ketoconazole Sequential Alfentanil||0
255791|NCT01008059|618585|P5|COMPLETED|Ketoconazole Sequential Alfentanil||0
255792|NCT01008059|618586|P4|COMPLETED|Ketoconazole Sequential Alfentanil||6
255793|NCT01008059|618587|P3|COMPLETED|Ketoconazole Sequential Alfentanil||0
255794|NCT01008059|618588|P2|COMPLETED|Ketoconazole Sequential Alfentanil||0
255795|NCT01008059|618589|P1|COMPLETED|Ketoconazole Sequential Alfentanil||0
255796|NCT01008059|618582|P8|STARTED|Ketoconazole Sequential Alfentanil||0
255797|NCT01008059|618583|P7|STARTED|Ketoconazole Sequential Alfentanil||0
255798|NCT01008059|618584|P6|STARTED|Ketoconazole Sequential Alfentanil||0
255799|NCT01008059|618585|P5|STARTED|Ketoconazole Sequential Alfentanil||0
255800|NCT01008059|618586|P4|STARTED|Ketoconazole Sequential Alfentanil||6
255801|NCT01008059|618587|P3|STARTED|Ketoconazole Sequential Alfentanil||0
255802|NCT01008059|618588|P2|STARTED|Ketoconazole Sequential Alfentanil||0
255803|NCT01008059|618589|P1|STARTED|Ketoconazole Sequential Alfentanil||0
255804|NCT01008059|618582|P8|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
255805|NCT01008059|618583|P7|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
255806|NCT01008059|618584|P6|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
255807|NCT01008059|618585|P5|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
255808|NCT01008059|618586|P4|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
255809|NCT01008059|618587|P3|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
255810|NCT01008059|618588|P2|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
255811|NCT01008059|618589|P1|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
255812|NCT01008059|618582|P8|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
255813|NCT01008059|618583|P7|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
255814|NCT01008059|618584|P6|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
255815|NCT01008059|618585|P5|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
255816|NCT01008059|618586|P4|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
255817|NCT01008059|618587|P3|COMPLETED|Grapefruit Juice Sequential Alfentanil||6
255818|NCT01008059|618588|P2|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
255819|NCT01008059|618589|P1|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
255820|NCT01008059|618582|P8|STARTED|Grapefruit Juice Sequential Alfentanil||0
255821|NCT01008059|618583|P7|STARTED|Grapefruit Juice Sequential Alfentanil||0
255822|NCT01008059|618584|P6|STARTED|Grapefruit Juice Sequential Alfentanil||0
255823|NCT01008059|618585|P5|STARTED|Grapefruit Juice Sequential Alfentanil||0
255824|NCT01008059|618586|P4|STARTED|Grapefruit Juice Sequential Alfentanil||0
255825|NCT01008059|618587|P3|STARTED|Grapefruit Juice Sequential Alfentanil||6
255826|NCT01008059|618588|P2|STARTED|Grapefruit Juice Sequential Alfentanil||0
255827|NCT01008059|618589|P1|STARTED|Grapefruit Juice Sequential Alfentanil||0
255828|NCT01008059|618582|P8|NOT COMPLETED|Rifampin Sequential Alfentanil||0
255829|NCT01008059|618583|P7|NOT COMPLETED|Rifampin Sequential Alfentanil||0
255830|NCT01008059|618584|P6|NOT COMPLETED|Rifampin Sequential Alfentanil||0
255831|NCT01008059|618585|P5|NOT COMPLETED|Rifampin Sequential Alfentanil||0
255832|NCT01008059|618586|P4|NOT COMPLETED|Rifampin Sequential Alfentanil||0
255833|NCT01008059|618587|P3|NOT COMPLETED|Rifampin Sequential Alfentanil||0
255834|NCT01008059|618588|P2|NOT COMPLETED|Rifampin Sequential Alfentanil||0
255835|NCT01008059|618589|P1|NOT COMPLETED|Rifampin Sequential Alfentanil||0
255836|NCT01008059|618582|P8|COMPLETED|Rifampin Sequential Alfentanil||0
255837|NCT01008059|618583|P7|COMPLETED|Rifampin Sequential Alfentanil||0
255838|NCT01008059|618584|P6|COMPLETED|Rifampin Sequential Alfentanil||0
255839|NCT01008059|618585|P5|COMPLETED|Rifampin Sequential Alfentanil||0
255840|NCT01008059|618586|P4|COMPLETED|Rifampin Sequential Alfentanil||0
255841|NCT01008059|618587|P3|COMPLETED|Rifampin Sequential Alfentanil||0
255842|NCT01008059|618588|P2|COMPLETED|Rifampin Sequential Alfentanil||6
255843|NCT01008059|618589|P1|COMPLETED|Rifampin Sequential Alfentanil||0
255844|NCT01008059|618582|P8|STARTED|Rifampin Sequential Alfentanil||0
255845|NCT01008059|618583|P7|STARTED|Rifampin Sequential Alfentanil||0
255846|NCT01008059|618584|P6|STARTED|Rifampin Sequential Alfentanil||0
255847|NCT01008059|618585|P5|STARTED|Rifampin Sequential Alfentanil||0
255848|NCT01008059|618586|P4|STARTED|Rifampin Sequential Alfentanil||0
255849|NCT01008059|618587|P3|STARTED|Rifampin Sequential Alfentanil||0
255850|NCT01008059|618588|P2|STARTED|Rifampin Sequential Alfentanil||6
255851|NCT01008059|618589|P1|STARTED|Rifampin Sequential Alfentanil||0
255852|NCT01008059|618582|P8|NOT COMPLETED|Control Sequential Alfentanil||0
255853|NCT01008059|618583|P7|NOT COMPLETED|Control Sequential Alfentanil||0
255854|NCT01008059|618584|P6|NOT COMPLETED|Control Sequential Alfentanil||0
255855|NCT01008059|618585|P5|NOT COMPLETED|Control Sequential Alfentanil||0
255856|NCT01008059|618586|P4|NOT COMPLETED|Control Sequential Alfentanil||0
255857|NCT01008059|618587|P3|NOT COMPLETED|Control Sequential Alfentanil||0
255858|NCT01008059|618588|P2|NOT COMPLETED|Control Sequential Alfentanil||0
255859|NCT01008059|618589|P1|NOT COMPLETED|Control Sequential Alfentanil||0
255860|NCT01008059|618582|P8|COMPLETED|Control Sequential Alfentanil||0
255861|NCT01008059|618583|P7|COMPLETED|Control Sequential Alfentanil||0
255862|NCT01008059|618584|P6|COMPLETED|Control Sequential Alfentanil||0
255863|NCT01008059|618585|P5|COMPLETED|Control Sequential Alfentanil||0
255864|NCT01008059|618586|P4|COMPLETED|Control Sequential Alfentanil||0
255865|NCT01008059|618587|P3|COMPLETED|Control Sequential Alfentanil||0
255866|NCT01008059|618588|P2|COMPLETED|Control Sequential Alfentanil||0
255867|NCT01008059|618589|P1|COMPLETED|Control Sequential Alfentanil||6
255868|NCT01008059|618582|P8|STARTED|Control Sequential Alfentanil||0
255869|NCT01008059|618583|P7|STARTED|Control Sequential Alfentanil||0
255870|NCT01008059|618584|P6|STARTED|Control Sequential Alfentanil||0
255871|NCT01008059|618585|P5|STARTED|Control Sequential Alfentanil||0
255872|NCT01008059|618586|P4|STARTED|Control Sequential Alfentanil||0
255873|NCT01008059|618587|P3|STARTED|Control Sequential Alfentanil||0
255874|NCT01008059|618588|P2|STARTED|Control Sequential Alfentanil||0
255875|NCT01008059|618589|P1|STARTED|Control Sequential Alfentanil||6
255876|NCT01007916|618600|P2|NOT COMPLETED|Period 2, 4 Weeks of Wear||0
255877|NCT01007916|618601|P1|NOT COMPLETED|Period 2, 4 Weeks of Wear||1
255878|NCT01007916|618600|P2|COMPLETED|Period 2, 4 Weeks of Wear||25
255879|NCT01007916|618601|P1|COMPLETED|Period 2, 4 Weeks of Wear||21
255880|NCT01007916|618600|P2|STARTED|Period 2, 4 Weeks of Wear|One participant completed Period 1 but did not start Period 2 due to failing inclusion criteria.|25
255881|NCT01007916|618601|P1|STARTED|Period 2, 4 Weeks of Wear||22
255882|NCT01007916|618600|P2|NOT COMPLETED|Period 1, 4 Weeks of Wear||0
255883|NCT01007916|618601|P1|NOT COMPLETED|Period 1, 4 Weeks of Wear||1
255884|NCT01007916|618600|P2|COMPLETED|Period 1, 4 Weeks of Wear||26
255885|NCT01007916|618601|P1|COMPLETED|Period 1, 4 Weeks of Wear||22
255886|NCT01007916|618600|P2|STARTED|Period 1, 4 Weeks of Wear||26
255887|NCT01007916|618601|P1|STARTED|Period 1, 4 Weeks of Wear||23
255888|NCT01007942|618609|P2|NOT COMPLETED|Overall Study||278
255889|NCT01007942|618610|P1|NOT COMPLETED|Overall Study||281
255890|NCT01007942|618609|P2|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|7
255891|NCT01007942|618610|P1|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|3
255892|NCT01007942|618609|P2|STARTED|Overall Study||285
255893|NCT01007942|618610|P1|STARTED|Overall Study||284
255894|NCT01007838|618636|P4|NOT COMPLETED|Overall Study||0
255895|NCT01007838|618637|P3|NOT COMPLETED|Overall Study||0
255896|NCT01007838|618638|P2|NOT COMPLETED|Overall Study||0
255897|NCT01007838|618639|P1|NOT COMPLETED|Overall Study||3
255898|NCT01007838|618636|P4|COMPLETED|Overall Study||4
255899|NCT01007838|618637|P3|COMPLETED|Overall Study||5
255900|NCT01007838|618638|P2|COMPLETED|Overall Study||11
255901|NCT01007838|618639|P1|COMPLETED|Overall Study||9
255902|NCT01007838|618636|P4|STARTED|Overall Study||4
255903|NCT01007838|618637|P3|STARTED|Overall Study||5
255904|NCT01007838|618638|P2|STARTED|Overall Study||11
255905|NCT01007838|618639|P1|STARTED|Overall Study||12
255906|NCT01007812|618649|P2|NOT COMPLETED|Period 2, One Week||0
255907|NCT01007812|618650|P1|NOT COMPLETED|Period 2, One Week||0
255908|NCT01007812|618649|P2|COMPLETED|Period 2, One Week||24
255909|NCT01007812|618650|P1|COMPLETED|Period 2, One Week||24
255910|NCT01007812|618649|P2|STARTED|Period 2, One Week||24
255911|NCT01007812|618650|P1|STARTED|Period 2, One Week||24
255912|NCT01007812|618649|P2|NOT COMPLETED|Period 1, One Week||1
255913|NCT01007812|618650|P1|NOT COMPLETED|Period 1, One Week||1
255914|NCT01007812|618649|P2|COMPLETED|Period 1, One Week||24
255915|NCT01007812|618650|P1|COMPLETED|Period 1, One Week||24
255916|NCT01007812|618649|P2|STARTED|Period 1, One Week||25
255917|NCT01007812|618650|P1|STARTED|Period 1, One Week||25
255918|NCT01007656|618656|P1|NOT COMPLETED|Overall Study||0
255919|NCT01007656|618656|P1|COMPLETED|Overall Study||31
255920|NCT01007656|618656|P1|STARTED|Overall Study||31
255921|NCT01007643|618676|P2|NOT COMPLETED|Overall Study||0
255922|NCT01007643|618677|P1|NOT COMPLETED|Overall Study||0
255923|NCT01007643|618676|P2|COMPLETED|Overall Study||14
255924|NCT01007643|618677|P1|COMPLETED|Overall Study||8
255925|NCT01007643|618676|P2|STARTED|Overall Study||14
255926|NCT01007643|618677|P1|STARTED|Overall Study||8
255927|NCT01007591|618685|P2|NOT COMPLETED|Overall Study||1
255928|NCT01007591|618686|P1|NOT COMPLETED|Overall Study||1
255929|NCT01007591|618685|P2|COMPLETED|Overall Study||12
255930|NCT01007591|618686|P1|COMPLETED|Overall Study||26
255931|NCT01007591|618685|P2|STARTED|Overall Study||13
255932|NCT01007591|618686|P1|STARTED|Overall Study||27
255933|NCT01007552|618700|P1|NOT COMPLETED|Overall Study||1
255934|NCT01007552|618700|P1|COMPLETED|Overall Study||49
255935|NCT01007552|618700|P1|STARTED|Overall Study||50
255936|NCT01007526|618710|P1|NOT COMPLETED|Overall Study||0
255937|NCT01007526|618710|P1|COMPLETED|Overall Study||31
255938|NCT01007526|618710|P1|STARTED|Overall Study||31
255939|NCT01007448|618716|P2|NOT COMPLETED|Overall Study||9
255940|NCT01007448|618717|P1|NOT COMPLETED|Overall Study||10
255941|NCT01007448|618716|P2|COMPLETED|Overall Study||20
255942|NCT01007448|618717|P1|COMPLETED|Overall Study||20
255943|NCT01007448|618716|P2|Safety Population|Overall Study||29
255944|NCT01007448|618717|P1|Safety Population|Overall Study||30
255945|NCT01007448|618716|P2|Full Analysis Population|Overall Study||29
255946|NCT01007448|618717|P1|Full Analysis Population|Overall Study||30
255947|NCT01007448|618716|P2|STARTED|Overall Study||29
255948|NCT01007448|618717|P1|STARTED|Overall Study||30
255949|NCT01007435|618749|P4|NOT COMPLETED|Overall Study||56
255950|NCT01007435|618750|P3|NOT COMPLETED|Overall Study||64
255951|NCT01007435|618751|P2|NOT COMPLETED|Overall Study||59
255952|NCT01007435|618752|P1|NOT COMPLETED|Overall Study||63
255953|NCT01007435|618749|P4|COMPLETED|Overall Study||236
255954|NCT01007435|618750|P3|COMPLETED|Overall Study||227
255955|NCT01007435|618751|P2|COMPLETED|Overall Study||231
255956|NCT01007435|618752|P1|COMPLETED|Overall Study||226
255957|NCT01007435|618749|P4|STARTED|Overall Study||292
255958|NCT01007435|618750|P3|STARTED|Overall Study||291
255959|NCT01007435|618751|P2|STARTED|Overall Study||290
255960|NCT01007435|618752|P1|STARTED|Overall Study||289
255961|NCT01007396|618794|P1|NOT COMPLETED|Overall Study||47
255962|NCT01007396|618794|P1|COMPLETED|Overall Study||275
255963|NCT01007396|618794|P1|STARTED|Overall Study||322
255964|NCT01007253|618799|P4|NOT COMPLETED|Fourth Intervention||0
255965|NCT01007253|618800|P3|NOT COMPLETED|Fourth Intervention||0
255966|NCT01007253|618801|P2|NOT COMPLETED|Fourth Intervention||0
255967|NCT01007253|618802|P1|NOT COMPLETED|Fourth Intervention||0
255968|NCT01007253|618799|P4|COMPLETED|Fourth Intervention||5
255969|NCT01007253|618800|P3|COMPLETED|Fourth Intervention||5
255970|NCT01007253|618801|P2|COMPLETED|Fourth Intervention||5
255971|NCT01007253|618802|P1|COMPLETED|Fourth Intervention||5
255972|NCT01007253|618799|P4|STARTED|Fourth Intervention||5
255973|NCT01007253|618800|P3|STARTED|Fourth Intervention||5
255974|NCT01007253|618801|P2|STARTED|Fourth Intervention||5
255975|NCT01007253|618802|P1|STARTED|Fourth Intervention||5
255976|NCT01007253|618799|P4|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
255977|NCT01007253|618800|P3|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
255978|NCT01007253|618801|P2|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
255979|NCT01007253|618802|P1|NOT COMPLETED|Washout Period (2 Weeks) # 3||1
255980|NCT01007253|618799|P4|COMPLETED|Washout Period (2 Weeks) # 3||5
255981|NCT01007253|618800|P3|COMPLETED|Washout Period (2 Weeks) # 3||5
255982|NCT01007253|618801|P2|COMPLETED|Washout Period (2 Weeks) # 3||5
255983|NCT01007253|618802|P1|COMPLETED|Washout Period (2 Weeks) # 3||5
255984|NCT01007253|618799|P4|STARTED|Washout Period (2 Weeks) # 3||5
255985|NCT01007253|618800|P3|STARTED|Washout Period (2 Weeks) # 3||5
255986|NCT01007253|618801|P2|STARTED|Washout Period (2 Weeks) # 3||5
255987|NCT01007253|618802|P1|STARTED|Washout Period (2 Weeks) # 3||6
255988|NCT01007253|618799|P4|NOT COMPLETED|Third Intervention||0
255989|NCT01007253|618800|P3|NOT COMPLETED|Third Intervention||0
255990|NCT01007253|618801|P2|NOT COMPLETED|Third Intervention||0
255991|NCT01007253|618802|P1|NOT COMPLETED|Third Intervention||0
255992|NCT01007253|618799|P4|COMPLETED|Third Intervention||5
255993|NCT01007253|618800|P3|COMPLETED|Third Intervention||5
255994|NCT01007253|618801|P2|COMPLETED|Third Intervention||5
255995|NCT01007253|618802|P1|COMPLETED|Third Intervention||6
255996|NCT01007253|618799|P4|STARTED|Third Intervention||5
255997|NCT01007253|618800|P3|STARTED|Third Intervention||5
255998|NCT01007253|618801|P2|STARTED|Third Intervention||5
255999|NCT01007253|618802|P1|STARTED|Third Intervention||6
256000|NCT01007253|618799|P4|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
256001|NCT01007253|618800|P3|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
256002|NCT01007253|618801|P2|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
256003|NCT01007253|618802|P1|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
256004|NCT01007253|618799|P4|COMPLETED|Washout Period (2 Weeks) # 2||5
256005|NCT01007253|618800|P3|COMPLETED|Washout Period (2 Weeks) # 2||5
256006|NCT01007253|618801|P2|COMPLETED|Washout Period (2 Weeks) # 2||5
256007|NCT01007253|618802|P1|COMPLETED|Washout Period (2 Weeks) # 2||6
256008|NCT01007253|618799|P4|STARTED|Washout Period (2 Weeks) # 2||5
256009|NCT01007253|618800|P3|STARTED|Washout Period (2 Weeks) # 2||5
256010|NCT01007253|618801|P2|STARTED|Washout Period (2 Weeks) # 2||5
256011|NCT01007253|618802|P1|STARTED|Washout Period (2 Weeks) # 2||6
256012|NCT01007253|618799|P4|NOT COMPLETED|Second Intervention||0
256013|NCT01007253|618800|P3|NOT COMPLETED|Second Intervention||0
256014|NCT01007253|618801|P2|NOT COMPLETED|Second Intervention||0
256015|NCT01007253|618802|P1|NOT COMPLETED|Second Intervention||0
256016|NCT01007253|618799|P4|COMPLETED|Second Intervention||5
256017|NCT01007253|618800|P3|COMPLETED|Second Intervention||5
256018|NCT01007253|618801|P2|COMPLETED|Second Intervention||5
256019|NCT01007253|618802|P1|COMPLETED|Second Intervention||6
256020|NCT01007253|618799|P4|STARTED|Second Intervention||5
256021|NCT01007253|618800|P3|STARTED|Second Intervention||5
256022|NCT01007253|618801|P2|STARTED|Second Intervention||5
256023|NCT01007253|618802|P1|STARTED|Second Intervention||6
256024|NCT01007253|618799|P4|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
256025|NCT01007253|618800|P3|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
256026|NCT01007253|618801|P2|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
256027|NCT01007253|618802|P1|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
256028|NCT01007253|618799|P4|COMPLETED|Washout Period (2 Weeks) # 1||5
256029|NCT01007253|618800|P3|COMPLETED|Washout Period (2 Weeks) # 1||5
256030|NCT01007253|618801|P2|COMPLETED|Washout Period (2 Weeks) # 1||5
256031|NCT01007253|618802|P1|COMPLETED|Washout Period (2 Weeks) # 1||6
256032|NCT01007253|618799|P4|STARTED|Washout Period (2 Weeks) # 1||5
256033|NCT01007253|618800|P3|STARTED|Washout Period (2 Weeks) # 1||5
256034|NCT01007253|618801|P2|STARTED|Washout Period (2 Weeks) # 1||5
256035|NCT01007253|618802|P1|STARTED|Washout Period (2 Weeks) # 1||6
256036|NCT01007253|618799|P4|NOT COMPLETED|First Intervention||0
256037|NCT01007253|618800|P3|NOT COMPLETED|First Intervention||0
256038|NCT01007253|618801|P2|NOT COMPLETED|First Intervention||0
256039|NCT01007253|618802|P1|NOT COMPLETED|First Intervention||0
256040|NCT01007253|618799|P4|COMPLETED|First Intervention||5
256041|NCT01007253|618800|P3|COMPLETED|First Intervention||5
256042|NCT01007253|618801|P2|COMPLETED|First Intervention||5
256043|NCT01007253|618802|P1|COMPLETED|First Intervention||6
256044|NCT01007253|618799|P4|STARTED|First Intervention||5
256045|NCT01007253|618800|P3|STARTED|First Intervention||5
256046|NCT01007253|618801|P2|STARTED|First Intervention||5
256047|NCT01007253|618802|P1|STARTED|First Intervention||6
256048|NCT01007149|618834|P2|NOT COMPLETED|Overall Study||1
256049|NCT01007149|618835|P1|NOT COMPLETED|Overall Study||0
256050|NCT01007149|618834|P2|COMPLETED|Overall Study||20
256051|NCT01007149|618835|P1|COMPLETED|Overall Study||20
256052|NCT01007149|618834|P2|STARTED|Overall Study||21
256053|NCT01007149|618835|P1|STARTED|Overall Study||20
256054|NCT01007123|618861|P4|NOT COMPLETED|Overall Study||6
256055|NCT01007123|618862|P3|NOT COMPLETED|Overall Study||11
256056|NCT01007123|618863|P2|NOT COMPLETED|Overall Study||6
256057|NCT01007123|618864|P1|NOT COMPLETED|Overall Study||6
256058|NCT01007123|618861|P4|COMPLETED|Overall Study||41
256059|NCT01007123|618862|P3|COMPLETED|Overall Study||37
256060|NCT01007123|618863|P2|COMPLETED|Overall Study||41
256061|NCT01007123|618864|P1|COMPLETED|Overall Study||42
256062|NCT01007123|618861|P4|STARTED|Overall Study||47
256063|NCT01007123|618862|P3|STARTED|Overall Study||48
256064|NCT01007123|618863|P2|STARTED|Overall Study||47
256065|NCT01007123|618864|P1|STARTED|Overall Study||48
256066|NCT01007110|618895|P2|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||5
256067|NCT01007110|618896|P1|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
256068|NCT01007110|618895|P2|COMPLETED|Neonatal Behavioral Assessment Scale (NB||15
256069|NCT01007110|618896|P1|COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
256070|NCT01007110|618895|P2|STARTED|Neonatal Behavioral Assessment Scale (NB||20
256071|NCT01007110|618896|P1|STARTED|Neonatal Behavioral Assessment Scale (NB||24
256072|NCT01007110|618895|P2|NOT COMPLETED|Follow-Up at 36 Weeks||2
256073|NCT01007110|618896|P1|NOT COMPLETED|Follow-Up at 36 Weeks||0
256074|NCT01007110|618895|P2|COMPLETED|Follow-Up at 36 Weeks||20
256075|NCT01007110|618896|P1|COMPLETED|Follow-Up at 36 Weeks||24
256076|NCT01007110|618895|P2|STARTED|Follow-Up at 36 Weeks||22
256077|NCT01007110|618896|P1|STARTED|Follow-Up at 36 Weeks||24
256078|NCT01007110|618895|P2|NOT COMPLETED|Follow-Up at 32 Weeks||1
256079|NCT01007110|618896|P1|NOT COMPLETED|Follow-Up at 32 Weeks||1
256080|NCT01007110|618895|P2|COMPLETED|Follow-Up at 32 Weeks||22
256081|NCT01007110|618896|P1|COMPLETED|Follow-Up at 32 Weeks||24
256082|NCT01007110|618895|P2|STARTED|Follow-Up at 32 Weeks||23
256083|NCT01007110|618896|P1|STARTED|Follow-Up at 32 Weeks||25
256084|NCT01007110|618895|P2|NOT COMPLETED|Follow-Up at 24 Weeks||4
256085|NCT01007110|618896|P1|NOT COMPLETED|Follow-Up at 24 Weeks||0
256086|NCT01007110|618895|P2|COMPLETED|Follow-Up at 24 Weeks||23
256087|NCT01007110|618896|P1|COMPLETED|Follow-Up at 24 Weeks||25
256088|NCT01007110|618895|P2|STARTED|Follow-Up at 24 Weeks||27
256089|NCT01007110|618896|P1|STARTED|Follow-Up at 24 Weeks||25
256090|NCT01007110|618895|P2|NOT COMPLETED|Allocation||8
256091|NCT01007110|618896|P1|NOT COMPLETED|Allocation||7
256092|NCT01007110|618895|P2|COMPLETED|Allocation||27
256093|NCT01007110|618896|P1|COMPLETED|Allocation||25
256094|NCT01007110|618895|P2|STARTED|Allocation||35
256095|NCT01007110|618896|P1|STARTED|Allocation||32
256096|NCT01007071|618912|P2|NOT COMPLETED|Overall Study||0
256097|NCT01007071|618913|P1|NOT COMPLETED|Overall Study||0
256098|NCT01007071|618912|P2|COMPLETED|Overall Study||5
256099|NCT01007071|618913|P1|COMPLETED|Overall Study||6
256100|NCT01007071|618912|P2|STARTED|Overall Study||5
256101|NCT01007071|618913|P1|STARTED|Overall Study||6
256102|NCT01007032|618925|P4|NOT COMPLETED|Overall Study||1
256103|NCT01007032|618926|P3|NOT COMPLETED|Overall Study||1
256104|NCT01007032|618927|P2|NOT COMPLETED|Overall Study||1
256105|NCT01007032|618928|P1|NOT COMPLETED|Overall Study||0
256106|NCT01007032|618925|P4|COMPLETED|Overall Study||6
256107|NCT01007032|618926|P3|COMPLETED|Overall Study||2
256108|NCT01007032|618927|P2|COMPLETED|Overall Study||6
256109|NCT01007032|618928|P1|COMPLETED|Overall Study||4
256110|NCT01007032|618925|P4|Received at Least 1 Dose of Study Drug|Overall Study||7
256111|NCT01007032|618926|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
256112|NCT01007032|618927|P2|Received at Least 1 Dose of Study Drug|Overall Study||7
256113|NCT01007032|618928|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
256114|NCT01007032|618925|P4|STARTED|Overall Study||7
256115|NCT01007032|618926|P3|STARTED|Overall Study||3
256116|NCT01007032|618927|P2|STARTED|Overall Study||7
256117|NCT01007032|618928|P1|STARTED|Overall Study||4
256118|NCT01006980|618972|P2|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||84
256119|NCT01006980|618973|P1|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
256120|NCT01006980|618972|P2|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
256121|NCT01006980|618973|P1|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
256122|NCT01006980|618972|P2|STARTED|Crossover: Dacarbazine to Vemurafenib|Participants who crossed over from dacarbazine to vemurafenib treatment.|84
256123|NCT01006980|618973|P1|STARTED|Crossover: Dacarbazine to Vemurafenib||0
256124|NCT01006980|618972|P2|NOT COMPLETED|Vemurafenib and Dacarbazine||338
256125|NCT01006980|618973|P1|NOT COMPLETED|Vemurafenib and Dacarbazine||337
256126|NCT01006980|618972|P2|COMPLETED|Vemurafenib and Dacarbazine||0
256127|NCT01006980|618973|P1|COMPLETED|Vemurafenib and Dacarbazine||0
256128|NCT01006980|618972|P2|Treated|Vemurafenib and Dacarbazine||293
256129|NCT01006980|618973|P1|Treated|Vemurafenib and Dacarbazine||336
256130|NCT01006980|618972|P2|STARTED|Vemurafenib and Dacarbazine||338
256131|NCT01006980|618973|P1|STARTED|Vemurafenib and Dacarbazine||337
256132|NCT01006967|618995|P2|NOT COMPLETED|Overall Study||63
256133|NCT01006967|618996|P1|NOT COMPLETED|Overall Study||66
256134|NCT01006967|618995|P2|COMPLETED|Overall Study||190
256135|NCT01006967|618996|P1|COMPLETED|Overall Study||187
256136|NCT01006967|618995|P2|3 Month Follow-up|Overall Study||210
256137|NCT01006967|618996|P1|3 Month Follow-up|Overall Study||212
256138|NCT01006967|618995|P2|Received Treatment|Overall Study||245
256139|NCT01006967|618996|P1|Received Treatment|Overall Study||245
256140|NCT01006967|618995|P2|STARTED|Overall Study||253
256141|NCT01006967|618996|P1|STARTED|Overall Study||253
256142|NCT01006889|619012|P1|NOT COMPLETED|Overall Study||3
256143|NCT01006889|619012|P1|COMPLETED|Overall Study||17
256144|NCT01006889|619012|P1|STARTED|Overall Study||20
256145|NCT01006707|619023|P3|NOT COMPLETED|Study Session 3||0
256146|NCT01006707|619024|P2|NOT COMPLETED|Study Session 3||0
256147|NCT01006707|619025|P1|NOT COMPLETED|Study Session 3||0
256148|NCT01006707|619023|P3|COMPLETED|Study Session 3||6
256149|NCT01006707|619024|P2|COMPLETED|Study Session 3||4
256150|NCT01006707|619025|P1|COMPLETED|Study Session 3||0
256151|NCT01006707|619023|P3|STARTED|Study Session 3||6
256152|NCT01006707|619024|P2|STARTED|Study Session 3||4
256153|NCT01006707|619025|P1|STARTED|Study Session 3||0
256154|NCT01006707|619023|P3|NOT COMPLETED|Study Session 2||0
256155|NCT01006707|619024|P2|NOT COMPLETED|Study Session 2||0
256156|NCT01006707|619025|P1|NOT COMPLETED|Study Session 2||0
256157|NCT01006707|619023|P3|COMPLETED|Study Session 2||6
256158|NCT01006707|619024|P2|COMPLETED|Study Session 2||4
256159|NCT01006707|619025|P1|COMPLETED|Study Session 2||0
256160|NCT01006707|619023|P3|STARTED|Study Session 2||6
256161|NCT01006707|619024|P2|STARTED|Study Session 2||4
256162|NCT01006707|619025|P1|STARTED|Study Session 2||0
256163|NCT01006707|619023|P3|NOT COMPLETED|Study Session 1||0
256164|NCT01006707|619024|P2|NOT COMPLETED|Study Session 1||0
256165|NCT01006707|619025|P1|NOT COMPLETED|Study Session 1||5
256166|NCT01006707|619023|P3|COMPLETED|Study Session 1||0
256167|NCT01006707|619024|P2|COMPLETED|Study Session 1||0
256168|NCT01006707|619025|P1|COMPLETED|Study Session 1||10
256169|NCT01006707|619023|P3|STARTED|Study Session 1||0
256170|NCT01006707|619024|P2|STARTED|Study Session 1||0
256171|NCT01006707|619025|P1|STARTED|Study Session 1||15
256172|NCT01006655|619038|P2|NOT COMPLETED|Second Intervention||0
256173|NCT01006655|619039|P1|NOT COMPLETED|Second Intervention||0
256174|NCT01006655|619038|P2|COMPLETED|Second Intervention||10
256175|NCT01006655|619039|P1|COMPLETED|Second Intervention||11
256176|NCT01006655|619038|P2|STARTED|Second Intervention||10
256177|NCT01006655|619039|P1|STARTED|Second Intervention||11
256178|NCT01006655|619038|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
256179|NCT01006655|619039|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
256180|NCT01006655|619038|P2|COMPLETED|Washout Period of 2 Weeks||10
256181|NCT01006655|619039|P1|COMPLETED|Washout Period of 2 Weeks||11
256182|NCT01006655|619038|P2|STARTED|Washout Period of 2 Weeks||10
256183|NCT01006655|619039|P1|STARTED|Washout Period of 2 Weeks||11
256184|NCT01006655|619038|P2|NOT COMPLETED|First Intervention||0
256185|NCT01006655|619039|P1|NOT COMPLETED|First Intervention||0
256186|NCT01006655|619038|P2|COMPLETED|First Intervention||10
256187|NCT01006655|619039|P1|COMPLETED|First Intervention||11
256188|NCT01006655|619038|P2|STARTED|First Intervention||10
256189|NCT01006655|619039|P1|STARTED|First Intervention||11
256190|NCT01006629|619045|P1|NOT COMPLETED|Overall Study||6
256191|NCT01006629|619045|P1|COMPLETED|Overall Study||94
256192|NCT01006629|619045|P1|STARTED|Overall Study||100
256193|NCT01006616|619060|P4|NOT COMPLETED|Period 2 (18 Months)||82
256194|NCT01006616|619061|P3|NOT COMPLETED|Period 2 (18 Months)||55
256195|NCT01006616|619062|P2|NOT COMPLETED|Period 2 (18 Months)||63
256196|NCT01006616|619063|P1|NOT COMPLETED|Period 2 (18 Months)||75
256197|NCT01006616|619060|P4|COMPLETED|Period 2 (18 Months)||0
256198|NCT01006616|619061|P3|COMPLETED|Period 2 (18 Months)||0
256199|NCT01006616|619062|P2|COMPLETED|Period 2 (18 Months)||0
256200|NCT01006616|619063|P1|COMPLETED|Period 2 (18 Months)||0
256201|NCT01006616|619060|P4|Treated|Period 2 (18 Months)||82
256202|NCT01006616|619061|P3|Treated|Period 2 (18 Months)||55
256203|NCT01006616|619062|P2|Treated|Period 2 (18 Months)||63
256204|NCT01006616|619063|P1|Treated|Period 2 (18 Months)||75
256205|NCT01006616|619060|P4|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|82
256206|NCT01006616|619061|P3|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|55
256207|NCT01006616|619062|P2|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|63
256208|NCT01006616|619063|P1|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|75
256209|NCT01006616|619060|P4|NOT COMPLETED|Period 1 (6 Months)||27
256210|NCT01006616|619061|P3|NOT COMPLETED|Period 1 (6 Months)||51
256211|NCT01006616|619062|P2|NOT COMPLETED|Period 1 (6 Months)||54
256212|NCT01006616|619063|P1|NOT COMPLETED|Period 1 (6 Months)||26
256213|NCT01006616|619060|P4|COMPLETED|Period 1 (6 Months)||128
256214|NCT01006616|619061|P3|COMPLETED|Period 1 (6 Months)||102
256215|NCT01006616|619062|P2|COMPLETED|Period 1 (6 Months)||102
256216|NCT01006616|619063|P1|COMPLETED|Period 1 (6 Months)||126
256217|NCT01006616|619060|P4|Treated|Period 1 (6 Months)||154
256218|NCT01006616|619061|P3|Treated|Period 1 (6 Months)||152
256219|NCT01006616|619062|P2|Treated|Period 1 (6 Months)||156
256220|NCT01006616|619063|P1|Treated|Period 1 (6 Months)||152
256221|NCT01006616|619060|P4|STARTED|Period 1 (6 Months)||155
256222|NCT01006616|619061|P3|STARTED|Period 1 (6 Months)||153
256223|NCT01006616|619062|P2|STARTED|Period 1 (6 Months)||156
256224|NCT01006616|619063|P1|STARTED|Period 1 (6 Months)||152
256225|NCT01006603|619199|P2|NOT COMPLETED|Overall Study||75
256226|NCT01006603|619200|P1|NOT COMPLETED|Overall Study||71
256227|NCT01006603|619199|P2|COMPLETED|Overall Study||285
256228|NCT01006603|619200|P1|COMPLETED|Overall Study||289
256229|NCT01006603|619199|P2|STARTED|Overall Study|Completed lead-in period and were randomised|360
256230|NCT01006603|619200|P1|STARTED|Overall Study|Completed lead-in period and were randomised|360
256231|NCT01006590|619220|P2|NOT COMPLETED|Overall Study||32
256232|NCT01006590|619221|P1|NOT COMPLETED|Overall Study||28
256233|NCT01006590|619220|P2|COMPLETED|Overall Study|Completed 24 weeks of treatment|107
256234|NCT01006590|619221|P1|COMPLETED|Overall Study|Completed 24 weeks of treatment|119
256235|NCT01006590|619220|P2|STARTED|Overall Study|Randomised and treated|139
256236|NCT01006590|619221|P1|STARTED|Overall Study|Randomised and treated|147
256237|NCT01006538|619239|P2|NOT COMPLETED|Overall Study||4
256238|NCT01006538|619240|P1|NOT COMPLETED|Overall Study||11
256239|NCT01006538|619239|P2|COMPLETED|Overall Study||115
256240|NCT01006538|619240|P1|COMPLETED|Overall Study||233
256241|NCT01006538|619239|P2|STARTED|Overall Study||119
256242|NCT01006538|619240|P1|STARTED|Overall Study||244
256243|NCT01006356|619260|P1|NOT COMPLETED|Overall Study||42
256244|NCT01006356|619260|P1|COMPLETED|Overall Study||99
256245|NCT01006356|619260|P1|STARTED|Overall Study||141
256246|NCT01006291|619275|P3|NOT COMPLETED|Overall Study||27
256247|NCT01006291|619276|P2|NOT COMPLETED|Overall Study||24
256248|NCT01006291|619277|P1|NOT COMPLETED|Overall Study||26
256249|NCT01006291|619275|P3|COMPLETED|Overall Study||203
256250|NCT01006291|619276|P2|COMPLETED|Overall Study||204
256251|NCT01006291|619277|P1|COMPLETED|Overall Study||203
256252|NCT01006291|619275|P3|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|229
256253|NCT01006291|619276|P2|Exposed|Overall Study|2 subjects received IDeg OD FF|226
256254|NCT01006291|619277|P1|Exposed|Overall Study|1 subject withdrew before exposure to drug. 2 subjects randomised to IDeg OD received IDeg OD FF|230
256255|NCT01006291|619275|P3|STARTED|Overall Study||230
256256|NCT01006291|619276|P2|STARTED|Overall Study||228
256257|NCT01006291|619277|P1|STARTED|Overall Study||229
256258|NCT01006252|619296|P2|NOT COMPLETED|Overall Study||0
256259|NCT01006252|619297|P1|NOT COMPLETED|Overall Study||0
256260|NCT01006252|619296|P2|COMPLETED|Overall Study||168
256261|NCT01006252|619297|P1|COMPLETED|Overall Study||168
256262|NCT01006252|619296|P2|Received Treatment|Overall Study||161
256263|NCT01006252|619297|P1|Received Treatment|Overall Study||164
256264|NCT01006252|619296|P2|STARTED|Overall Study||168
256265|NCT01006252|619297|P1|STARTED|Overall Study||168
256266|NCT01006135|619327|P1|NOT COMPLETED|Overall Study||140
256267|NCT01006135|619327|P1|COMPLETED|Overall Study||4712
256268|NCT01006135|619327|P1|STARTED|Overall Study||4852
256269|NCT01006122|619334|P2|NOT COMPLETED|Second Double-blind Intervention Period||7
256270|NCT01006122|619335|P1|NOT COMPLETED|Second Double-blind Intervention Period||2
256271|NCT01006122|619334|P2|COMPLETED|Second Double-blind Intervention Period||24
256272|NCT01006122|619335|P1|COMPLETED|Second Double-blind Intervention Period||29
256273|NCT01006122|619334|P2|STARTED|Second Double-blind Intervention Period||31
256274|NCT01006122|619335|P1|STARTED|Second Double-blind Intervention Period||31
256275|NCT01006122|619334|P2|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
256276|NCT01006122|619335|P1|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
256277|NCT01006122|619334|P2|COMPLETED|Wash-out Period (at Least 7 Days)||31
256278|NCT01006122|619335|P1|COMPLETED|Wash-out Period (at Least 7 Days)||31
256279|NCT01006122|619334|P2|STARTED|Wash-out Period (at Least 7 Days)||31
256280|NCT01006122|619335|P1|STARTED|Wash-out Period (at Least 7 Days)||31
256281|NCT01006122|619334|P2|NOT COMPLETED|First Double-blind Intervention Period||17
256282|NCT01006122|619335|P1|NOT COMPLETED|First Double-blind Intervention Period||16
256283|NCT01006122|619334|P2|COMPLETED|First Double-blind Intervention Period||31
256284|NCT01006122|619335|P1|COMPLETED|First Double-blind Intervention Period||31
256285|NCT01006122|619334|P2|STARTED|First Double-blind Intervention Period||48
256286|NCT01006122|619335|P1|STARTED|First Double-blind Intervention Period||47
256287|NCT01006018|619376|P3|NOT COMPLETED|Overall Study||0
256288|NCT01006018|619377|P2|NOT COMPLETED|Overall Study||0
256289|NCT01006018|619378|P1|NOT COMPLETED|Overall Study||0
256290|NCT01006018|619376|P3|COMPLETED|Overall Study||0
256291|NCT01006018|619377|P2|COMPLETED|Overall Study||0
256292|NCT01006018|619378|P1|COMPLETED|Overall Study||0
256293|NCT01006018|619376|P3|STARTED|Overall Study||0
256294|NCT01006018|619377|P2|STARTED|Overall Study||0
256295|NCT01006018|619378|P1|STARTED|Overall Study||0
256296|NCT01005966|619386|P5|NOT COMPLETED|Treatment Period 5 (14 Days)||0
256297|NCT01005966|619387|P4|NOT COMPLETED|Treatment Period 5 (14 Days)||0
256298|NCT01005966|619388|P3|NOT COMPLETED|Treatment Period 5 (14 Days)||0
256299|NCT01005966|619389|P2|NOT COMPLETED|Treatment Period 5 (14 Days)||0
256300|NCT01005966|619390|P1|NOT COMPLETED|Treatment Period 5 (14 Days)||0
256301|NCT01005966|619386|P5|COMPLETED|Treatment Period 5 (14 Days)||10
256302|NCT01005966|619387|P4|COMPLETED|Treatment Period 5 (14 Days)||11
256303|NCT01005966|619388|P3|COMPLETED|Treatment Period 5 (14 Days)||11
256304|NCT01005966|619389|P2|COMPLETED|Treatment Period 5 (14 Days)||12
256305|NCT01005966|619390|P1|COMPLETED|Treatment Period 5 (14 Days)||9
256306|NCT01005966|619386|P5|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|10
256307|NCT01005966|619387|P4|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
256308|NCT01005966|619388|P3|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
256309|NCT01005966|619389|P2|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|12
256310|NCT01005966|619390|P1|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|9
256311|NCT01005966|619386|P5|NOT COMPLETED|Washout Period 4 (4 Days)||0
256312|NCT01005966|619387|P4|NOT COMPLETED|Washout Period 4 (4 Days)||0
256313|NCT01005966|619388|P3|NOT COMPLETED|Washout Period 4 (4 Days)||0
256314|NCT01005966|619389|P2|NOT COMPLETED|Washout Period 4 (4 Days)||0
256315|NCT01005966|619390|P1|NOT COMPLETED|Washout Period 4 (4 Days)||0
256316|NCT01005966|619386|P5|COMPLETED|Washout Period 4 (4 Days)||12
256317|NCT01005966|619387|P4|COMPLETED|Washout Period 4 (4 Days)||10
256318|NCT01005966|619388|P3|COMPLETED|Washout Period 4 (4 Days)||11
256319|NCT01005966|619389|P2|COMPLETED|Washout Period 4 (4 Days)||10
256320|NCT01005966|619390|P1|COMPLETED|Washout Period 4 (4 Days)||10
256321|NCT01005966|619386|P5|STARTED|Washout Period 4 (4 Days)||12
256322|NCT01005966|619387|P4|STARTED|Washout Period 4 (4 Days)||10
256323|NCT01005966|619388|P3|STARTED|Washout Period 4 (4 Days)||11
256324|NCT01005966|619389|P2|STARTED|Washout Period 4 (4 Days)||10
256325|NCT01005966|619390|P1|STARTED|Washout Period 4 (4 Days)||10
256326|NCT01005966|619386|P5|NOT COMPLETED|Treatment Period 4 (14 Days)||1
256327|NCT01005966|619387|P4|NOT COMPLETED|Treatment Period 4 (14 Days)||0
256328|NCT01005966|619388|P3|NOT COMPLETED|Treatment Period 4 (14 Days)||0
256329|NCT01005966|619389|P2|NOT COMPLETED|Treatment Period 4 (14 Days)||1
256330|NCT01005966|619390|P1|NOT COMPLETED|Treatment Period 4 (14 Days)||0
256331|NCT01005966|619386|P5|COMPLETED|Treatment Period 4 (14 Days)||12
256332|NCT01005966|619387|P4|COMPLETED|Treatment Period 4 (14 Days)||10
256333|NCT01005966|619388|P3|COMPLETED|Treatment Period 4 (14 Days)||11
256334|NCT01005966|619389|P2|COMPLETED|Treatment Period 4 (14 Days)||10
256335|NCT01005966|619390|P1|COMPLETED|Treatment Period 4 (14 Days)||10
256336|NCT01005966|619386|P5|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|13
256337|NCT01005966|619387|P4|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
256338|NCT01005966|619388|P3|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
256339|NCT01005966|619389|P2|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
256340|NCT01005966|619390|P1|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
256341|NCT01005966|619386|P5|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
256342|NCT01005966|619387|P4|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
256343|NCT01005966|619388|P3|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
256344|NCT01005966|619389|P2|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
256345|NCT01005966|619390|P1|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
256346|NCT01005966|619386|P5|COMPLETED|Washout Period 3 ( 4 Days)||11
256347|NCT01005966|619387|P4|COMPLETED|Washout Period 3 ( 4 Days)||13
256348|NCT01005966|619388|P3|COMPLETED|Washout Period 3 ( 4 Days)||12
256349|NCT01005966|619389|P2|COMPLETED|Washout Period 3 ( 4 Days)||7
256350|NCT01005966|619390|P1|COMPLETED|Washout Period 3 ( 4 Days)||12
256351|NCT01005966|619386|P5|STARTED|Washout Period 3 ( 4 Days)||11
256352|NCT01005966|619387|P4|STARTED|Washout Period 3 ( 4 Days)||13
256353|NCT01005966|619388|P3|STARTED|Washout Period 3 ( 4 Days)||12
256354|NCT01005966|619389|P2|STARTED|Washout Period 3 ( 4 Days)||7
256355|NCT01005966|619390|P1|STARTED|Washout Period 3 ( 4 Days)||12
256356|NCT01005966|619386|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||1
256357|NCT01005966|619387|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
256358|NCT01005966|619388|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||0
256359|NCT01005966|619389|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||1
256360|NCT01005966|619390|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
256361|NCT01005966|619386|P5|COMPLETED|Treatment Period 3 (14 Days)||11
256362|NCT01005966|619387|P4|COMPLETED|Treatment Period 3 (14 Days)||13
256363|NCT01005966|619388|P3|COMPLETED|Treatment Period 3 (14 Days)||12
256364|NCT01005966|619389|P2|COMPLETED|Treatment Period 3 (14 Days)||7
256365|NCT01005966|619390|P1|COMPLETED|Treatment Period 3 (14 Days)||12
256366|NCT01005966|619386|P5|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
256367|NCT01005966|619387|P4|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|13
256368|NCT01005966|619388|P3|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
256369|NCT01005966|619389|P2|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|8
256370|NCT01005966|619390|P1|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
256371|NCT01005966|619386|P5|NOT COMPLETED|Washout Period 2 (4 Days)||0
256372|NCT01005966|619387|P4|NOT COMPLETED|Washout Period 2 (4 Days)||0
256373|NCT01005966|619388|P3|NOT COMPLETED|Washout Period 2 (4 Days)||0
256374|NCT01005966|619389|P2|NOT COMPLETED|Washout Period 2 (4 Days)||0
256375|NCT01005966|619390|P1|NOT COMPLETED|Washout Period 2 (4 Days)||0
256376|NCT01005966|619386|P5|COMPLETED|Washout Period 2 (4 Days)||11
256377|NCT01005966|619387|P4|COMPLETED|Washout Period 2 (4 Days)||11
256378|NCT01005966|619388|P3|COMPLETED|Washout Period 2 (4 Days)||10
256379|NCT01005966|619389|P2|COMPLETED|Washout Period 2 (4 Days)||12
256380|NCT01005966|619390|P1|COMPLETED|Washout Period 2 (4 Days)||13
256381|NCT01005966|619386|P5|STARTED|Washout Period 2 (4 Days)||11
256382|NCT01005966|619387|P4|STARTED|Washout Period 2 (4 Days)||11
256383|NCT01005966|619388|P3|STARTED|Washout Period 2 (4 Days)||10
256384|NCT01005966|619389|P2|STARTED|Washout Period 2 (4 Days)||12
256385|NCT01005966|619390|P1|STARTED|Washout Period 2 (4 Days)||13
256386|NCT01005966|619386|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
256387|NCT01005966|619387|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
256388|NCT01005966|619388|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||2
256389|NCT01005966|619389|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
256390|NCT01005966|619390|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
256391|NCT01005966|619386|P5|COMPLETED|Treatment Period 2 (14 Days)||11
256392|NCT01005966|619387|P4|COMPLETED|Treatment Period 2 (14 Days)||11
256393|NCT01005966|619388|P3|COMPLETED|Treatment Period 2 (14 Days)||10
256394|NCT01005966|619389|P2|COMPLETED|Treatment Period 2 (14 Days)||12
256395|NCT01005966|619390|P1|COMPLETED|Treatment Period 2 (14 Days)||13
256396|NCT01005966|619386|P5|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
256397|NCT01005966|619387|P4|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
256398|NCT01005966|619388|P3|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
256399|NCT01005966|619389|P2|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
256400|NCT01005966|619390|P1|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
256401|NCT01005966|619386|P5|NOT COMPLETED|Washout Period 1 (4 Days)||0
256402|NCT01005966|619387|P4|NOT COMPLETED|Washout Period 1 (4 Days)||1
256403|NCT01005966|619388|P3|NOT COMPLETED|Washout Period 1 (4 Days)||0
256404|NCT01005966|619389|P2|NOT COMPLETED|Washout Period 1 (4 Days)||0
256405|NCT01005966|619390|P1|NOT COMPLETED|Washout Period 1 (4 Days)||0
256406|NCT01005966|619386|P5|COMPLETED|Washout Period 1 (4 Days)||13
256407|NCT01005966|619387|P4|COMPLETED|Washout Period 1 (4 Days)||12
256408|NCT01005966|619388|P3|COMPLETED|Washout Period 1 (4 Days)||12
256409|NCT01005966|619389|P2|COMPLETED|Washout Period 1 (4 Days)||13
256410|NCT01005966|619390|P1|COMPLETED|Washout Period 1 (4 Days)||11
256411|NCT01005966|619386|P5|STARTED|Washout Period 1 (4 Days)||13
256412|NCT01005966|619387|P4|STARTED|Washout Period 1 (4 Days)||13
256413|NCT01005966|619388|P3|STARTED|Washout Period 1 (4 Days)||12
256414|NCT01005966|619389|P2|STARTED|Washout Period 1 (4 Days)||13
256415|NCT01005966|619390|P1|STARTED|Washout Period 1 (4 Days)||11
256416|NCT01005966|619386|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||0
256417|NCT01005966|619387|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||0
256418|NCT01005966|619388|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||1
256419|NCT01005966|619389|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||0
256420|NCT01005966|619390|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
256421|NCT01005966|619386|P5|COMPLETED|Treatment Period 1 (14 Days)||13
256422|NCT01005966|619387|P4|COMPLETED|Treatment Period 1 (14 Days)||13
256423|NCT01005966|619388|P3|COMPLETED|Treatment Period 1 (14 Days)||12
256424|NCT01005966|619389|P2|COMPLETED|Treatment Period 1 (14 Days)||13
256425|NCT01005966|619390|P1|COMPLETED|Treatment Period 1 (14 Days)||11
256426|NCT01005966|619386|P5|STARTED|Treatment Period 1 (14 Days)||13
256427|NCT01005966|619387|P4|STARTED|Treatment Period 1 (14 Days)||13
256428|NCT01005966|619388|P3|STARTED|Treatment Period 1 (14 Days)||13
256429|NCT01005966|619389|P2|STARTED|Treatment Period 1 (14 Days)||13
256430|NCT01005966|619390|P1|STARTED|Treatment Period 1 (14 Days)||13
256431|NCT01005914|619410|P1|NOT COMPLETED|Overall Study||10
256432|NCT01005914|619410|P1|COMPLETED|Overall Study||1
256433|NCT01005914|619410|P1|STARTED|Overall Study||11
256434|NCT01005901|619416|P2|NOT COMPLETED|Overall Study||58
256435|NCT01005901|619417|P1|NOT COMPLETED|Overall Study||102
256436|NCT01005901|619416|P2|COMPLETED|Overall Study||212
256437|NCT01005901|619417|P1|COMPLETED|Overall Study||450
256438|NCT01005901|619416|P2|Full Analysis Set|Overall Study||260
256439|NCT01005901|619417|P1|Full Analysis Set|Overall Study||534
256440|NCT01005901|619416|P2|Safety Population|Overall Study||267
256441|NCT01005901|619417|P1|Safety Population|Overall Study||550
256442|NCT01005901|619416|P2|STARTED|Overall Study||270
256443|NCT01005901|619417|P1|STARTED|Overall Study||552
256444|NCT01005888|619459|P2|NOT COMPLETED|Second Intervention||1
256445|NCT01005888|619460|P1|NOT COMPLETED|Second Intervention||1
256446|NCT01005888|619459|P2|COMPLETED|Second Intervention||10
256447|NCT01005888|619460|P1|COMPLETED|Second Intervention||10
256448|NCT01005888|619459|P2|STARTED|Second Intervention||11
256449|NCT01005888|619460|P1|STARTED|Second Intervention||11
256450|NCT01005888|619459|P2|NOT COMPLETED|First Intervention||1
256451|NCT01005888|619460|P1|NOT COMPLETED|First Intervention||1
256452|NCT01005888|619459|P2|COMPLETED|First Intervention||11
256453|NCT01005888|619460|P1|COMPLETED|First Intervention||11
256454|NCT01005888|619459|P2|STARTED|First Intervention||12
256455|NCT01005888|619460|P1|STARTED|First Intervention||12
256456|NCT01005875|619480|P1|NOT COMPLETED|Overall Study||3
256457|NCT01005875|619480|P1|COMPLETED|Overall Study||2
256458|NCT01005875|619480|P1|STARTED|Overall Study||5
256459|NCT01005810|619490|P2|NOT COMPLETED|Overall Study||25
256460|NCT01005810|619491|P1|NOT COMPLETED|Overall Study||21
256461|NCT01005810|619490|P2|COMPLETED|Overall Study||33
256462|NCT01005810|619491|P1|COMPLETED|Overall Study||37
256463|NCT01005810|619490|P2|STARTED|Overall Study||58
256464|NCT01005810|619491|P1|STARTED|Overall Study||58
256465|NCT01005745|619497|P1|NOT COMPLETED|Overall Study||6
256466|NCT01005745|619497|P1|COMPLETED|Overall Study||13
256467|NCT01005745|619497|P1|STARTED|Overall Study||19
256468|NCT01005732|619502|P1|NOT COMPLETED|Overall Study||11
256469|NCT01005732|619502|P1|COMPLETED|Overall Study||43
256470|NCT01005732|619502|P1|STARTED|Overall Study||54
256471|NCT01005719|619518|P6|NOT COMPLETED|Period 3||0
256472|NCT01005719|619519|P5|NOT COMPLETED|Period 3||0
256473|NCT01005719|619520|P4|NOT COMPLETED|Period 3||0
256474|NCT01005719|619521|P3|NOT COMPLETED|Period 3||0
256475|NCT01005719|619522|P2|NOT COMPLETED|Period 3||0
256476|NCT01005719|619523|P1|NOT COMPLETED|Period 3||0
256477|NCT01005719|619518|P6|COMPLETED|Period 3||9
256478|NCT01005719|619519|P5|COMPLETED|Period 3||10
256479|NCT01005719|619520|P4|COMPLETED|Period 3||10
256480|NCT01005719|619521|P3|COMPLETED|Period 3||10
256481|NCT01005719|619522|P2|COMPLETED|Period 3||10
256482|NCT01005719|619523|P1|COMPLETED|Period 3||10
256483|NCT01005719|619518|P6|STARTED|Period 3||9
256484|NCT01005719|619519|P5|STARTED|Period 3||10
256485|NCT01005719|619520|P4|STARTED|Period 3||10
256486|NCT01005719|619521|P3|STARTED|Period 3||10
256487|NCT01005719|619522|P2|STARTED|Period 3||10
256488|NCT01005719|619523|P1|STARTED|Period 3||10
256489|NCT01005719|619518|P6|NOT COMPLETED|Period 2||1
256490|NCT01005719|619519|P5|NOT COMPLETED|Period 2||1
256491|NCT01005719|619520|P4|NOT COMPLETED|Period 2||0
256492|NCT01005719|619521|P3|NOT COMPLETED|Period 2||0
256493|NCT01005719|619522|P2|NOT COMPLETED|Period 2||0
256494|NCT01005719|619523|P1|NOT COMPLETED|Period 2||0
256495|NCT01005719|619518|P6|COMPLETED|Period 2||9
256496|NCT01005719|619519|P5|COMPLETED|Period 2||10
256497|NCT01005719|619520|P4|COMPLETED|Period 2||10
256498|NCT01005719|619521|P3|COMPLETED|Period 2||10
256499|NCT01005719|619522|P2|COMPLETED|Period 2||10
256500|NCT01005719|619523|P1|COMPLETED|Period 2||10
256501|NCT01005719|619518|P6|STARTED|Period 2||10
256502|NCT01005719|619519|P5|STARTED|Period 2||11
256503|NCT01005719|619520|P4|STARTED|Period 2||10
256504|NCT01005719|619521|P3|STARTED|Period 2||10
256505|NCT01005719|619522|P2|STARTED|Period 2||10
256506|NCT01005719|619523|P1|STARTED|Period 2||10
256507|NCT01005719|619518|P6|NOT COMPLETED|Period 1||1
256508|NCT01005719|619519|P5|NOT COMPLETED|Period 1||0
256509|NCT01005719|619520|P4|NOT COMPLETED|Period 1||1
256510|NCT01005719|619521|P3|NOT COMPLETED|Period 1||0
256511|NCT01005719|619522|P2|NOT COMPLETED|Period 1||0
256512|NCT01005719|619523|P1|NOT COMPLETED|Period 1||0
256513|NCT01005719|619518|P6|COMPLETED|Period 1||10
256514|NCT01005719|619519|P5|COMPLETED|Period 1||11
256515|NCT01005719|619520|P4|COMPLETED|Period 1||10
256516|NCT01005719|619521|P3|COMPLETED|Period 1||10
256517|NCT01005719|619522|P2|COMPLETED|Period 1||10
256518|NCT01005719|619523|P1|COMPLETED|Period 1||10
256519|NCT01005719|619518|P6|STARTED|Period 1||11
256520|NCT01005719|619519|P5|STARTED|Period 1||11
256521|NCT01005719|619520|P4|STARTED|Period 1||11
256522|NCT01005719|619521|P3|STARTED|Period 1||10
256523|NCT01005719|619522|P2|STARTED|Period 1||10
256524|NCT01005719|619523|P1|STARTED|Period 1||10
256525|NCT01005706|619581|P2|NOT COMPLETED|Overall Study||0
256526|NCT01005706|619582|P1|NOT COMPLETED|Overall Study||0
256527|NCT01005706|619581|P2|COMPLETED|Overall Study||17
256528|NCT01005706|619582|P1|COMPLETED|Overall Study||23
256529|NCT01005706|619581|P2|STARTED|Overall Study||17
256530|NCT01005706|619582|P1|STARTED|Overall Study||23
256531|NCT01005680|619590|P2|NOT COMPLETED|Overall Study||11
256532|NCT01005680|619591|P1|NOT COMPLETED|Overall Study||6
256533|NCT01005680|619590|P2|COMPLETED|Overall Study||119
256534|NCT01005680|619591|P1|COMPLETED|Overall Study||120
256535|NCT01005680|619590|P2|Received at Least 1 Dose of Study Drug|Overall Study||127
256536|NCT01005680|619591|P1|Received at Least 1 Dose of Study Drug|Overall Study||125
256537|NCT01005680|619590|P2|STARTED|Overall Study||130
256538|NCT01005680|619591|P1|STARTED|Overall Study||126
256539|NCT01005602|619615|P2|NOT COMPLETED|Overall Study||0
256540|NCT01005602|619616|P1|NOT COMPLETED|Overall Study||1
256541|NCT01005602|619615|P2|COMPLETED|Overall Study||66
256542|NCT01005602|619616|P1|COMPLETED|Overall Study|One patient completed the trial but was excluded from data analyses due to unreliable clinical data.|65
256543|NCT01005602|619615|P2|STARTED|Overall Study||66
256544|NCT01005602|619616|P1|STARTED|Overall Study||66
256545|NCT01005576|619636|P1|NOT COMPLETED|Overall Study||0
256546|NCT01005576|619636|P1|COMPLETED|Overall Study|All participants completed the conditioning regimen and received their stem cell transplant|21
256547|NCT01005576|619636|P1|STARTED|Overall Study||21
256548|NCT01005459|619646|P2|NOT COMPLETED|Overall Study||0
256549|NCT01005459|619647|P1|NOT COMPLETED|Overall Study||0
256550|NCT01005459|619646|P2|COMPLETED|Overall Study||23
256551|NCT01005459|619647|P1|COMPLETED|Overall Study||23
256552|NCT01005459|619646|P2|STARTED|Overall Study||23
256553|NCT01005459|619647|P1|STARTED|Overall Study||23
256554|NCT01005407|619655|P2|NOT COMPLETED|Overall Study||32
256555|NCT01005407|619656|P1|NOT COMPLETED|Overall Study||151
256556|NCT01005407|619655|P2|COMPLETED|Overall Study||451
256557|NCT01005407|619656|P1|COMPLETED|Overall Study||1818
256558|NCT01005407|619655|P2|STARTED|Overall Study||483
256559|NCT01005407|619656|P1|STARTED|Overall Study||1969
256560|NCT01005355|619667|P3|NOT COMPLETED|Overall Study||0
256561|NCT01005355|619668|P2|NOT COMPLETED|Overall Study||0
256562|NCT01005355|619669|P1|NOT COMPLETED|Overall Study||0
256563|NCT01005355|619667|P3|COMPLETED|Overall Study||6
256564|NCT01005355|619668|P2|COMPLETED|Overall Study||6
256565|NCT01005355|619669|P1|COMPLETED|Overall Study||3
256566|NCT01005355|619667|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
256567|NCT01005355|619668|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
256568|NCT01005355|619669|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
256569|NCT01005355|619667|P3|STARTED|Overall Study||6
256570|NCT01005355|619668|P2|STARTED|Overall Study||6
256571|NCT01005355|619669|P1|STARTED|Overall Study||3
256572|NCT01005329|619704|P1|NOT COMPLETED|Overall Study||4
256573|NCT01005329|619704|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|30
256574|NCT01005329|619704|P1|STARTED|Overall Study||34
256575|NCT01005316|619717|P4|NOT COMPLETED|Overall Study||108
256576|NCT01005316|619718|P3|NOT COMPLETED|Overall Study||11
256577|NCT01005316|619719|P2|NOT COMPLETED|Overall Study||76
256578|NCT01005316|619720|P1|NOT COMPLETED|Overall Study||50
256579|NCT01005316|619717|P4|COMPLETED|Overall Study||19
256580|NCT01005316|619718|P3|COMPLETED|Overall Study||5
256581|NCT01005316|619719|P2|COMPLETED|Overall Study||21
256582|NCT01005316|619720|P1|COMPLETED|Overall Study||0
256583|NCT01005316|619717|P4|STARTED|Overall Study||127
256584|NCT01005316|619718|P3|STARTED|Overall Study||16
256585|NCT01005316|619719|P2|STARTED|Overall Study||97
256586|NCT01005316|619720|P1|STARTED|Overall Study||50
256587|NCT01005290|619772|P3|NOT COMPLETED|Period 2 (5 Weeks)||2
256588|NCT01005290|619773|P2|NOT COMPLETED|Period 2 (5 Weeks)||0
256589|NCT01005290|619774|P1|NOT COMPLETED|Period 2 (5 Weeks)||0
256590|NCT01005290|619772|P3|COMPLETED|Period 2 (5 Weeks)||7
256591|NCT01005290|619773|P2|COMPLETED|Period 2 (5 Weeks)||13
256592|NCT01005290|619774|P1|COMPLETED|Period 2 (5 Weeks)||0
256593|NCT01005290|619772|P3|STARTED|Period 2 (5 Weeks)||9
256594|NCT01005290|619773|P2|STARTED|Period 2 (5 Weeks)||13
256595|NCT01005290|619774|P1|STARTED|Period 2 (5 Weeks)||0
256596|NCT01005290|619772|P3|NOT COMPLETED|Washout Period (2 Weeks)||0
256597|NCT01005290|619773|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
256598|NCT01005290|619774|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
256599|NCT01005290|619772|P3|COMPLETED|Washout Period (2 Weeks)||9
256600|NCT01005290|619773|P2|COMPLETED|Washout Period (2 Weeks)||13
256601|NCT01005290|619774|P1|COMPLETED|Washout Period (2 Weeks)||0
256602|NCT01005290|619772|P3|STARTED|Washout Period (2 Weeks)||9
256603|NCT01005290|619773|P2|STARTED|Washout Period (2 Weeks)||13
256604|NCT01005290|619774|P1|STARTED|Washout Period (2 Weeks)||0
256605|NCT01005290|619772|P3|NOT COMPLETED|Period 1 (5 Weeks)||9
256606|NCT01005290|619773|P2|NOT COMPLETED|Period 1 (5 Weeks)||7
256607|NCT01005290|619774|P1|NOT COMPLETED|Period 1 (5 Weeks)||0
256608|NCT01005290|619772|P3|COMPLETED|Period 1 (5 Weeks)||9
256609|NCT01005290|619773|P2|COMPLETED|Period 1 (5 Weeks)||13
256610|NCT01005290|619774|P1|COMPLETED|Period 1 (5 Weeks)||0
256611|NCT01005290|619772|P3|STARTED|Period 1 (5 Weeks)||18
256612|NCT01005290|619773|P2|STARTED|Period 1 (5 Weeks)||20
256613|NCT01005290|619774|P1|STARTED|Period 1 (5 Weeks)||0
256614|NCT01005290|619772|P3|NOT COMPLETED|Run-In||0
256615|NCT01005290|619773|P2|NOT COMPLETED|Run-In||0
256616|NCT01005290|619774|P1|NOT COMPLETED|Run-In||14
256617|NCT01005290|619772|P3|COMPLETED|Run-In||0
256618|NCT01005290|619773|P2|COMPLETED|Run-In||0
256619|NCT01005290|619774|P1|COMPLETED|Run-In||38
256620|NCT01005290|619772|P3|STARTED|Run-In||0
256621|NCT01005290|619773|P2|STARTED|Run-In||0
256622|NCT01005290|619774|P1|STARTED|Run-In||52
256623|NCT01005251|619787|P5|NOT COMPLETED|Overall Study||18
256624|NCT01005251|619788|P4|NOT COMPLETED|Overall Study||12
256625|NCT01005251|619789|P3|NOT COMPLETED|Overall Study||22
256626|NCT01005251|619790|P2|NOT COMPLETED|Overall Study||16
256627|NCT01005251|619791|P1|NOT COMPLETED|Overall Study||13
256628|NCT01005251|619787|P5|COMPLETED|Overall Study||122
256629|NCT01005251|619788|P4|COMPLETED|Overall Study||114
256630|NCT01005251|619789|P3|COMPLETED|Overall Study||114
256631|NCT01005251|619790|P2|COMPLETED|Overall Study||109
256632|NCT01005251|619791|P1|COMPLETED|Overall Study||121
256633|NCT01005251|619787|P5|STARTED|Overall Study||140
256634|NCT01005251|619788|P4|STARTED|Overall Study||126
256635|NCT01005251|619789|P3|STARTED|Overall Study||136
256636|NCT01005251|619790|P2|STARTED|Overall Study||125
256637|NCT01005251|619791|P1|STARTED|Overall Study||134
256638|NCT01004991|619808|P1|NOT COMPLETED|Overall Study||0
256639|NCT01004991|619808|P1|COMPLETED|Overall Study||12
256640|NCT01004991|619808|P1|STARTED|Overall Study||12
256641|NCT01004939|619812|P1|NOT COMPLETED|Overall Study||0
256642|NCT01004939|619812|P1|COMPLETED|Overall Study||120
256643|NCT01004939|619812|P1|STARTED|Overall Study||120
256644|NCT01004874|619853|P1|NOT COMPLETED|Overall Study||0
256645|NCT01004874|619853|P1|COMPLETED|Overall Study||80
256646|NCT01004874|619853|P1|STARTED|Overall Study||80
256647|NCT01004848|619864|P2|NOT COMPLETED|Overall Study||45
256648|NCT01004848|619865|P1|NOT COMPLETED|Overall Study||55
256649|NCT01004848|619864|P2|COMPLETED|Overall Study||147
256650|NCT01004848|619865|P1|COMPLETED|Overall Study||155
256651|NCT01004848|619864|P2|STARTED|Overall Study||192
256652|NCT01004848|619865|P1|STARTED|Overall Study||210
256653|NCT01004822|619903|P8|NOT COMPLETED|Overall Study||5
256654|NCT01004822|619904|P7|NOT COMPLETED|Overall Study||4
256655|NCT01004822|619905|P6|NOT COMPLETED|Overall Study||4
256656|NCT01004822|619906|P5|NOT COMPLETED|Overall Study||4
256657|NCT01004822|619907|P4|NOT COMPLETED|Overall Study||4
256658|NCT01004822|619908|P3|NOT COMPLETED|Overall Study||4
256659|NCT01004822|619909|P2|NOT COMPLETED|Overall Study||3
256660|NCT01004822|619910|P1|NOT COMPLETED|Overall Study||3
256661|NCT01004822|619903|P8|COMPLETED|Overall Study||0
256662|NCT01004822|619904|P7|COMPLETED|Overall Study||0
256663|NCT01004822|619905|P6|COMPLETED|Overall Study||0
256664|NCT01004822|619906|P5|COMPLETED|Overall Study||0
256665|NCT01004822|619907|P4|COMPLETED|Overall Study||0
256666|NCT01004822|619908|P3|COMPLETED|Overall Study||0
256667|NCT01004822|619909|P2|COMPLETED|Overall Study||0
256668|NCT01004822|619910|P1|COMPLETED|Overall Study||0
256669|NCT01004822|619903|P8|Treated|Overall Study||5
256670|NCT01004822|619904|P7|Treated|Overall Study||4
256671|NCT01004822|619905|P6|Treated|Overall Study||4
256672|NCT01004822|619906|P5|Treated|Overall Study||4
256673|NCT01004822|619907|P4|Treated|Overall Study||4
256674|NCT01004822|619908|P3|Treated|Overall Study||3
256675|NCT01004822|619909|P2|Treated|Overall Study||3
256676|NCT01004822|619910|P1|Treated|Overall Study||3
256677|NCT01004822|619903|P8|STARTED|Overall Study||5
256678|NCT01004822|619904|P7|STARTED|Overall Study||4
256679|NCT01004822|619905|P6|STARTED|Overall Study||4
256680|NCT01004822|619906|P5|STARTED|Overall Study||4
256681|NCT01004822|619907|P4|STARTED|Overall Study||4
256682|NCT01004822|619908|P3|STARTED|Overall Study||4
256683|NCT01004822|619909|P2|STARTED|Overall Study||3
256684|NCT01004822|619910|P1|STARTED|Overall Study||3
256685|NCT01004770|620024|P5|NOT COMPLETED|Overall Study||0
256686|NCT01004770|620025|P4|NOT COMPLETED|Overall Study||0
256687|NCT01004770|620026|P3|NOT COMPLETED|Overall Study||0
256688|NCT01004770|620027|P2|NOT COMPLETED|Overall Study||0
256689|NCT01004770|620028|P1|NOT COMPLETED|Overall Study||0
256690|NCT01004770|620024|P5|COMPLETED|Overall Study||10
256691|NCT01004770|620025|P4|COMPLETED|Overall Study||10
256692|NCT01004770|620026|P3|COMPLETED|Overall Study||10
256693|NCT01004770|620027|P2|COMPLETED|Overall Study||10
256694|NCT01004770|620028|P1|COMPLETED|Overall Study||10
256695|NCT01004770|620024|P5|STARTED|Overall Study||10
256696|NCT01004770|620025|P4|STARTED|Overall Study||10
256697|NCT01004770|620026|P3|STARTED|Overall Study||10
256698|NCT01004770|620027|P2|STARTED|Overall Study||10
256699|NCT01004770|620028|P1|STARTED|Overall Study||10
256700|NCT01004705|620060|P3|NOT COMPLETED|Period 2 (12 Weeks)||4
256701|NCT01004705|620061|P2|NOT COMPLETED|Period 2 (12 Weeks)||0
256702|NCT01004705|620062|P1|NOT COMPLETED|Period 2 (12 Weeks)||0
256703|NCT01004705|620060|P3|COMPLETED|Period 2 (12 Weeks)||9
256704|NCT01004705|620061|P2|COMPLETED|Period 2 (12 Weeks)||13
256705|NCT01004705|620062|P1|COMPLETED|Period 2 (12 Weeks)||0
256706|NCT01004705|620060|P3|STARTED|Period 2 (12 Weeks)||13
256707|NCT01004705|620061|P2|STARTED|Period 2 (12 Weeks)||13
256708|NCT01004705|620062|P1|STARTED|Period 2 (12 Weeks)||0
256709|NCT01004705|620060|P3|NOT COMPLETED|Washout Period (6 Weeks)||0
256710|NCT01004705|620061|P2|NOT COMPLETED|Washout Period (6 Weeks)||0
256711|NCT01004705|620062|P1|NOT COMPLETED|Washout Period (6 Weeks)||0
256712|NCT01004705|620060|P3|COMPLETED|Washout Period (6 Weeks)||13
256713|NCT01004705|620061|P2|COMPLETED|Washout Period (6 Weeks)||13
256714|NCT01004705|620062|P1|COMPLETED|Washout Period (6 Weeks)||0
256715|NCT01004705|620060|P3|STARTED|Washout Period (6 Weeks)||13
256716|NCT01004705|620061|P2|STARTED|Washout Period (6 Weeks)||13
256717|NCT01004705|620062|P1|STARTED|Washout Period (6 Weeks)||0
256718|NCT01004705|620060|P3|NOT COMPLETED|Period 1 (12 Weeks)||5
256719|NCT01004705|620061|P2|NOT COMPLETED|Period 1 (12 Weeks)||5
256720|NCT01004705|620062|P1|NOT COMPLETED|Period 1 (12 Weeks)||0
256721|NCT01004705|620060|P3|COMPLETED|Period 1 (12 Weeks)||13
256722|NCT01004705|620061|P2|COMPLETED|Period 1 (12 Weeks)||13
256723|NCT01004705|620062|P1|COMPLETED|Period 1 (12 Weeks)||0
256724|NCT01004705|620060|P3|STARTED|Period 1 (12 Weeks)||18
256725|NCT01004705|620061|P2|STARTED|Period 1 (12 Weeks)||18
256726|NCT01004705|620062|P1|STARTED|Period 1 (12 Weeks)||0
256727|NCT01004705|620060|P3|NOT COMPLETED|Run-In||0
256728|NCT01004705|620061|P2|NOT COMPLETED|Run-In||0
256729|NCT01004705|620062|P1|NOT COMPLETED|Run-In||8
256730|NCT01004705|620060|P3|COMPLETED|Run-In||0
256731|NCT01004705|620061|P2|COMPLETED|Run-In||0
256732|NCT01004705|620062|P1|COMPLETED|Run-In||36
256733|NCT01004705|620060|P3|STARTED|Run-In||0
256734|NCT01004705|620061|P2|STARTED|Run-In||0
256735|NCT01004705|620062|P1|STARTED|Run-In||44
256736|NCT01004614|620075|P4|NOT COMPLETED|Second Intervention||0
256737|NCT01004614|620076|P3|NOT COMPLETED|Second Intervention||0
256738|NCT01004614|620077|P2|NOT COMPLETED|Second Intervention||0
256739|NCT01004614|620078|P1|NOT COMPLETED|Second Intervention||0
256740|NCT01004614|620075|P4|COMPLETED|Second Intervention||12
256741|NCT01004614|620076|P3|COMPLETED|Second Intervention||12
256742|NCT01004614|620077|P2|COMPLETED|Second Intervention||11
256743|NCT01004614|620078|P1|COMPLETED|Second Intervention||12
256744|NCT01004614|620075|P4|STARTED|Second Intervention||12
256745|NCT01004614|620076|P3|STARTED|Second Intervention||12
256746|NCT01004614|620077|P2|STARTED|Second Intervention||11
256747|NCT01004614|620078|P1|STARTED|Second Intervention||12
256748|NCT01004614|620075|P4|NOT COMPLETED|Washout||0
256749|NCT01004614|620076|P3|NOT COMPLETED|Washout||0
256750|NCT01004614|620077|P2|NOT COMPLETED|Washout||1
256751|NCT01004614|620078|P1|NOT COMPLETED|Washout||0
256752|NCT01004614|620075|P4|COMPLETED|Washout||12
256753|NCT01004614|620076|P3|COMPLETED|Washout||12
256754|NCT01004614|620077|P2|COMPLETED|Washout||11
256755|NCT01004614|620078|P1|COMPLETED|Washout||12
256756|NCT01004614|620075|P4|STARTED|Washout||12
256757|NCT01004614|620076|P3|STARTED|Washout||12
256758|NCT01004614|620077|P2|STARTED|Washout||12
256759|NCT01004614|620078|P1|STARTED|Washout||12
256760|NCT01004614|620075|P4|NOT COMPLETED|First Intervention||0
256761|NCT01004614|620076|P3|NOT COMPLETED|First Intervention||0
256762|NCT01004614|620077|P2|NOT COMPLETED|First Intervention||0
256763|NCT01004614|620078|P1|NOT COMPLETED|First Intervention||0
256764|NCT01004614|620075|P4|COMPLETED|First Intervention||12
256765|NCT01004614|620076|P3|COMPLETED|First Intervention||12
256766|NCT01004614|620077|P2|COMPLETED|First Intervention||12
256767|NCT01004614|620078|P1|COMPLETED|First Intervention||12
256768|NCT01004614|620075|P4|STARTED|First Intervention||12
256769|NCT01004614|620076|P3|STARTED|First Intervention||12
256770|NCT01004614|620077|P2|STARTED|First Intervention||12
256771|NCT01004614|620078|P1|STARTED|First Intervention||12
256772|NCT01004510|620112|P1|NOT COMPLETED|Overall Study||1
256773|NCT01004510|620112|P1|COMPLETED|Overall Study||2
256774|NCT01004510|620112|P1|STARTED|Overall Study||3
256775|NCT01004432|620116|P5|NOT COMPLETED|OL Study Extension (Week 52 - 76)||18
256776|NCT01004432|620117|P4|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
256777|NCT01004432|620118|P3|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
256778|NCT01004432|620119|P2|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
256779|NCT01004432|620120|P1|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
256780|NCT01004432|620116|P5|COMPLETED|OL Study Extension (Week 52 - 76)||194
256781|NCT01004432|620117|P4|COMPLETED|OL Study Extension (Week 52 - 76)||0
256782|NCT01004432|620118|P3|COMPLETED|OL Study Extension (Week 52 - 76)||0
256783|NCT01004432|620119|P2|COMPLETED|OL Study Extension (Week 52 - 76)||0
256784|NCT01004432|620120|P1|COMPLETED|OL Study Extension (Week 52 - 76)||0
256785|NCT01004432|620116|P5|STARTED|OL Study Extension (Week 52 - 76)||212
256786|NCT01004432|620117|P4|STARTED|OL Study Extension (Week 52 - 76)||0
256787|NCT01004432|620118|P3|STARTED|OL Study Extension (Week 52 - 76)||0
256788|NCT01004432|620119|P2|STARTED|OL Study Extension (Week 52 - 76)||0
256789|NCT01004432|620120|P1|STARTED|OL Study Extension (Week 52 - 76)||0
256790|NCT01004432|620116|P5|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
256791|NCT01004432|620117|P4|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||58
256792|NCT01004432|620118|P3|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||37
256793|NCT01004432|620119|P2|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||10
256794|NCT01004432|620120|P1|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
256795|NCT01004432|620116|P5|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
256796|NCT01004432|620117|P4|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||126
256797|NCT01004432|620118|P3|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||54
256798|NCT01004432|620119|P2|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||65
256799|NCT01004432|620120|P1|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
256800|NCT01004432|620116|P5|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
256801|NCT01004432|620117|P4|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||184
256802|NCT01004432|620118|P3|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||91
256803|NCT01004432|620119|P2|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||75
256804|NCT01004432|620120|P1|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
256805|NCT01004432|620116|P5|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
256806|NCT01004432|620117|P4|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
256807|NCT01004432|620118|P3|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
256808|NCT01004432|620119|P2|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
256809|NCT01004432|620120|P1|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||83
256810|NCT01004432|620116|P5|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
256811|NCT01004432|620117|P4|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
256812|NCT01004432|620118|P3|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
256813|NCT01004432|620119|P2|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
256814|NCT01004432|620120|P1|COMPLETED|Open-label (OL) Period (Week 0 – 16)|1 Participant died after completing open-label period. Discontinuation was noted as adverse event.|350
256815|NCT01004432|620116|P5|STARTED|Open-label (OL) Period (Week 0 – 16)||0
256816|NCT01004432|620117|P4|STARTED|Open-label (OL) Period (Week 0 – 16)||0
256817|NCT01004432|620118|P3|STARTED|Open-label (OL) Period (Week 0 – 16)||0
256818|NCT01004432|620119|P2|STARTED|Open-label (OL) Period (Week 0 – 16)||0
256819|NCT01004432|620120|P1|STARTED|Open-label (OL) Period (Week 0 – 16)||433
256820|NCT01004406|620142|P2|NOT COMPLETED|Overall Study||0
256821|NCT01004406|620143|P1|NOT COMPLETED|Overall Study||3
256822|NCT01004406|620142|P2|COMPLETED|Overall Study||10
256823|NCT01004406|620143|P1|COMPLETED|Overall Study||18
256824|NCT01004406|620142|P2|STARTED|Overall Study||10
256825|NCT01004406|620143|P1|STARTED|Overall Study||21
256826|NCT01004393|620155|P1|NOT COMPLETED|Overall Study||0
256827|NCT01004393|620155|P1|COMPLETED|Overall Study||12
256828|NCT01004393|620155|P1|STARTED|Overall Study||12
256829|NCT01004354|620166|P1|NOT COMPLETED|Overall Study||0
256830|NCT01004354|620166|P1|COMPLETED|Overall Study||12
256831|NCT01004354|620166|P1|STARTED|Overall Study||12
256832|NCT01004263|620178|P1|NOT COMPLETED|Overall Study||179
256833|NCT01004263|620178|P1|COMPLETED|Overall Study||427
256834|NCT01004263|620178|P1|STARTED|Overall Study|Participants who took study drug|606
256835|NCT01004250|620186|P1|NOT COMPLETED|Follow-Up (FU) Period||1
256836|NCT01004250|620186|P1|COMPLETED|Follow-Up (FU) Period||100
256837|NCT01004250|620186|P1|STARTED|Follow-Up (FU) Period|Did not enter FU:Death-4pts Ind,1pts Maint; Pt Withdrew-1 pts Ind,1pts Maint; Lost to FU-1 pts Maint|101
256838|NCT01004250|620186|P1|NOT COMPLETED|Maintenance Therapy Period||26
256839|NCT01004250|620186|P1|COMPLETED|Maintenance Therapy Period||46
256840|NCT01004250|620186|P1|Death (Any Cause) or Disease Progression|Maintenance Therapy Period|Pts with death or disease progression considered to have completed phase.|46
256841|NCT01004250|620186|P1|STARTED|Maintenance Therapy Period|Did not enter Maint: 21 pts due to death or disease progression; 1 pts had performance status 2.|72
256842|NCT01004250|620186|P1|NOT COMPLETED|Induction Therapy Period||15
256843|NCT01004250|620186|P1|COMPLETED|Induction Therapy Period||94
256844|NCT01004250|620186|P1|Death (Any Cause) or Disease Progression|Induction Therapy Period|Participants (pts) with death or disease progression considered to have completed phase.|21
256845|NCT01004250|620186|P1|Received at Least One Dose of Study Drug|Induction Therapy Period||109
256846|NCT01004250|620186|P1|STARTED|Induction Therapy Period||109
256847|NCT01004185|620198|P2|NOT COMPLETED|Overall Study||9
256848|NCT01004185|620199|P1|NOT COMPLETED|Overall Study||9
256849|NCT01004185|620198|P2|COMPLETED|Overall Study||11
256850|NCT01004185|620199|P1|COMPLETED|Overall Study||10
256851|NCT01004185|620198|P2|STARTED|Overall Study||20
256852|NCT01004185|620199|P1|STARTED|Overall Study||19
256853|NCT01004172|620207|P1|NOT COMPLETED|Overall Study||38
256854|NCT01004172|620207|P1|COMPLETED|Overall Study||0
256855|NCT01004172|620207|P1|STARTED|Overall Study||38
256856|NCT01004159|620215|P1|NOT COMPLETED|Overall Study||20
256857|NCT01004159|620215|P1|COMPLETED|Overall Study||0
256858|NCT01004159|620215|P1|STARTED|Overall Study||20
256859|NCT01004146|620222|P2|NOT COMPLETED|Overall Study||5
256860|NCT01004146|620223|P1|NOT COMPLETED|Overall Study||4
256861|NCT01004146|620222|P2|COMPLETED|Overall Study||20
256862|NCT01004146|620223|P1|COMPLETED|Overall Study||21
256863|NCT01004146|620222|P2|Have Incentive Spirometry Data|Overall Study||20
256864|NCT01004146|620223|P1|Have Incentive Spirometry Data|Overall Study||21
256865|NCT01004146|620222|P2|STARTED|Overall Study||25
256866|NCT01004146|620223|P1|STARTED|Overall Study||25
256867|NCT01004107|620231|P2|NOT COMPLETED|Overall Study||2
256868|NCT01004107|620232|P1|NOT COMPLETED|Overall Study||1
256869|NCT01004107|620231|P2|COMPLETED|Overall Study||23
256870|NCT01004107|620232|P1|COMPLETED|Overall Study||75
256871|NCT01004107|620231|P2|STARTED|Overall Study||25
256872|NCT01004107|620232|P1|STARTED|Overall Study||76
256873|NCT01004003|620317|P9|NOT COMPLETED|Overall Study||30
256874|NCT01004003|620318|P8|NOT COMPLETED|Overall Study||60
256875|NCT01004003|620319|P7|NOT COMPLETED|Overall Study||8
256876|NCT01004003|620320|P6|NOT COMPLETED|Overall Study||4
256877|NCT01004003|620321|P5|NOT COMPLETED|Overall Study||4
256878|NCT01004003|620322|P4|NOT COMPLETED|Overall Study||3
256879|NCT01004003|620323|P3|NOT COMPLETED|Overall Study||4
256880|NCT01004003|620324|P2|NOT COMPLETED|Overall Study||3
256881|NCT01004003|620325|P1|NOT COMPLETED|Overall Study||6
256882|NCT01004003|620317|P9|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|1
256883|NCT01004003|620318|P8|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|2
256884|NCT01004003|620319|P7|COMPLETED|Overall Study||0
256885|NCT01004003|620320|P6|COMPLETED|Overall Study||0
256886|NCT01004003|620321|P5|COMPLETED|Overall Study||0
256887|NCT01004003|620322|P4|COMPLETED|Overall Study||0
256888|NCT01004003|620323|P3|COMPLETED|Overall Study||0
256889|NCT01004003|620324|P2|COMPLETED|Overall Study||0
256890|NCT01004003|620325|P1|COMPLETED|Overall Study||0
256891|NCT01004003|620317|P9|STARTED|Overall Study||31
256892|NCT01004003|620318|P8|STARTED|Overall Study||62
256893|NCT01004003|620319|P7|STARTED|Overall Study||8
256894|NCT01004003|620320|P6|STARTED|Overall Study||4
256895|NCT01004003|620321|P5|STARTED|Overall Study||4
256896|NCT01004003|620322|P4|STARTED|Overall Study||3
256897|NCT01004003|620323|P3|STARTED|Overall Study||4
256898|NCT01004003|620324|P2|STARTED|Overall Study||3
256899|NCT01004003|620325|P1|STARTED|Overall Study||6
256900|NCT01003990|620356|P3|NOT COMPLETED|Overall Study||43
256901|NCT01003990|620357|P2|NOT COMPLETED|Overall Study||51
256902|NCT01003990|620358|P1|NOT COMPLETED|Overall Study||92
256903|NCT01003990|620356|P3|COMPLETED|Overall Study||53
256904|NCT01003990|620357|P2|COMPLETED|Overall Study||103
256905|NCT01003990|620358|P1|COMPLETED|Overall Study||367
256906|NCT01003990|620356|P3|STARTED|Overall Study||96
256907|NCT01003990|620357|P2|STARTED|Overall Study||154
256908|NCT01003990|620358|P1|STARTED|Overall Study||459
256909|NCT01003938|620366|P1|NOT COMPLETED|Overall Study||0
256910|NCT01003938|620366|P1|COMPLETED|Overall Study||6
256911|NCT01003938|620366|P1|STARTED|Overall Study||6
256912|NCT01003899|620375|P1|NOT COMPLETED|Overall Study||47
256913|NCT01003899|620375|P1|COMPLETED|Overall Study||0
256914|NCT01003899|620375|P1|STARTED|Overall Study|enrolled|47
256915|NCT01003886|620384|P1|NOT COMPLETED|Overall Study||230
256916|NCT01003886|620384|P1|COMPLETED|Overall Study||759
256917|NCT01003886|620384|P1|STARTED|Overall Study||989
256918|NCT01003639|620395|P2|NOT COMPLETED|Overall Study||22
256919|NCT01003639|620396|P1|NOT COMPLETED|Overall Study||17
256920|NCT01003639|620395|P2|COMPLETED|Overall Study||57
256921|NCT01003639|620396|P1|COMPLETED|Overall Study||69
256922|NCT01003639|620395|P2|STARTED|Overall Study||79
256923|NCT01003639|620396|P1|STARTED|Overall Study||86
256924|NCT01003418|620410|P2|NOT COMPLETED|Overall Study||0
256925|NCT01003418|620411|P1|NOT COMPLETED|Overall Study||0
256926|NCT01003418|620410|P2|COMPLETED|Overall Study||3
256927|NCT01003418|620411|P1|COMPLETED|Overall Study||5
256928|NCT01003418|620410|P2|STARTED|Overall Study||3
256929|NCT01003418|620411|P1|STARTED|Overall Study||5
256930|NCT01003301|620429|P2|NOT COMPLETED|Overall Study||0
256931|NCT01003301|620430|P1|NOT COMPLETED|Overall Study||0
256932|NCT01003301|620429|P2|COMPLETED|Overall Study||9
256933|NCT01003301|620430|P1|COMPLETED|Overall Study||10
256934|NCT01003301|620429|P2|STARTED|Overall Study||9
256935|NCT01003301|620430|P1|STARTED|Overall Study||10
256936|NCT01003288|620438|P1|NOT COMPLETED|Overall Study||0
256937|NCT01003288|620438|P1|COMPLETED|Overall Study||255
256938|NCT01003288|620438|P1|STARTED|Overall Study||255
256939|NCT01003275|620445|P2|NOT COMPLETED|Overall Study||0
256940|NCT01003275|620446|P1|NOT COMPLETED|Overall Study||1
256941|NCT01003275|620445|P2|COMPLETED|Overall Study||11
256942|NCT01003275|620446|P1|COMPLETED|Overall Study||10
256943|NCT01003275|620445|P2|STARTED|Overall Study||11
256944|NCT01003275|620446|P1|STARTED|Overall Study||11
256945|NCT01003249|620452|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
256946|NCT01003249|620453|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
256947|NCT01003249|620452|P2|COMPLETED|Second Intervention (4 Weeks)||2
256948|NCT01003249|620453|P1|COMPLETED|Second Intervention (4 Weeks)||3
256949|NCT01003249|620452|P2|STARTED|Second Intervention (4 Weeks)||3
256950|NCT01003249|620453|P1|STARTED|Second Intervention (4 Weeks)||4
256951|NCT01003249|620452|P2|NOT COMPLETED|Washout (3 Weeks)||0
256952|NCT01003249|620453|P1|NOT COMPLETED|Washout (3 Weeks)||0
256953|NCT01003249|620452|P2|COMPLETED|Washout (3 Weeks)||3
256954|NCT01003249|620453|P1|COMPLETED|Washout (3 Weeks)||4
256955|NCT01003249|620452|P2|STARTED|Washout (3 Weeks)||3
256956|NCT01003249|620453|P1|STARTED|Washout (3 Weeks)||4
256957|NCT01003249|620452|P2|NOT COMPLETED|First Intervention (4 Weeks)||2
256958|NCT01003249|620453|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
256959|NCT01003249|620452|P2|COMPLETED|First Intervention (4 Weeks)||3
256960|NCT01003249|620453|P1|COMPLETED|First Intervention (4 Weeks)||5
256961|NCT01003249|620452|P2|Received Intervention|First Intervention (4 Weeks)||5
256962|NCT01003249|620453|P1|Received Intervention|First Intervention (4 Weeks)||7
256963|NCT01003249|620452|P2|STARTED|First Intervention (4 Weeks)||5
256964|NCT01003249|620453|P1|STARTED|First Intervention (4 Weeks)||7
256965|NCT01003210|620471|P2|NOT COMPLETED|Overall Study||3
256966|NCT01003210|620472|P1|NOT COMPLETED|Overall Study||1
256967|NCT01003210|620471|P2|COMPLETED|Overall Study||102
256968|NCT01003210|620472|P1|COMPLETED|Overall Study||104
256969|NCT01003210|620471|P2|STARTED|Overall Study||105
256970|NCT01003210|620472|P1|STARTED|Overall Study||105
256971|NCT01003184|620484|P2|NOT COMPLETED|Overall Study||12
256972|NCT01003184|620485|P1|NOT COMPLETED|Overall Study||19
256973|NCT01003184|620484|P2|COMPLETED|Overall Study||99
256974|NCT01003184|620485|P1|COMPLETED|Overall Study||92
256975|NCT01003184|620484|P2|Full Analysis Set (FAS)|Overall Study||105
256976|NCT01003184|620485|P1|Full Analysis Set (FAS)|Overall Study||111
256977|NCT01003184|620484|P2|STARTED|Overall Study||111
256978|NCT01003184|620485|P1|STARTED|Overall Study||111
256979|NCT01003106|620521|P8|NOT COMPLETED|Month 6-Month 36||0
256980|NCT01003106|620522|P7|NOT COMPLETED|Month 6-Month 36||1
256981|NCT01003106|620523|P6|NOT COMPLETED|Month 6-Month 36||0
256982|NCT01003106|620524|P5|NOT COMPLETED|Month 6-Month 36||0
256983|NCT01003106|620525|P4|NOT COMPLETED|Month 6-Month 36||0
256984|NCT01003106|620526|P3|NOT COMPLETED|Month 6-Month 36||1
256985|NCT01003106|620527|P2|NOT COMPLETED|Month 6-Month 36||0
256986|NCT01003106|620528|P1|NOT COMPLETED|Month 6-Month 36||0
256987|NCT01003106|620521|P8|COMPLETED|Month 6-Month 36||18
256988|NCT01003106|620522|P7|COMPLETED|Month 6-Month 36||19
256989|NCT01003106|620523|P6|COMPLETED|Month 6-Month 36||0
256990|NCT01003106|620524|P5|COMPLETED|Month 6-Month 36||0
256991|NCT01003106|620525|P4|COMPLETED|Month 6-Month 36||20
256992|NCT01003106|620526|P3|COMPLETED|Month 6-Month 36||18
256993|NCT01003106|620527|P2|COMPLETED|Month 6-Month 36||0
256994|NCT01003106|620528|P1|COMPLETED|Month 6-Month 36||0
256995|NCT01003106|620521|P8|STARTED|Month 6-Month 36||18
256996|NCT01003106|620522|P7|STARTED|Month 6-Month 36||20
256997|NCT01003106|620523|P6|STARTED|Month 6-Month 36||0
256998|NCT01003106|620524|P5|STARTED|Month 6-Month 36||0
256999|NCT01003106|620525|P4|STARTED|Month 6-Month 36||20
257000|NCT01003106|620526|P3|STARTED|Month 6-Month 36||19
257001|NCT01003106|620527|P2|STARTED|Month 6-Month 36||0
257002|NCT01003106|620528|P1|STARTED|Month 6-Month 36||0
257003|NCT01003106|620521|P8|NOT COMPLETED|Baseline to Month 6||0
257004|NCT01003106|620522|P7|NOT COMPLETED|Baseline to Month 6||0
257005|NCT01003106|620523|P6|NOT COMPLETED|Baseline to Month 6||0
257006|NCT01003106|620524|P5|NOT COMPLETED|Baseline to Month 6||0
257007|NCT01003106|620525|P4|NOT COMPLETED|Baseline to Month 6||0
257008|NCT01003106|620526|P3|NOT COMPLETED|Baseline to Month 6||0
257009|NCT01003106|620527|P2|NOT COMPLETED|Baseline to Month 6||0
257010|NCT01003106|620528|P1|NOT COMPLETED|Baseline to Month 6||0
257011|NCT01003106|620521|P8|COMPLETED|Baseline to Month 6||0
257012|NCT01003106|620522|P7|COMPLETED|Baseline to Month 6||0
257013|NCT01003106|620523|P6|COMPLETED|Baseline to Month 6||20
257014|NCT01003106|620524|P5|COMPLETED|Baseline to Month 6||19
257015|NCT01003106|620525|P4|COMPLETED|Baseline to Month 6||0
257016|NCT01003106|620526|P3|COMPLETED|Baseline to Month 6||0
257017|NCT01003106|620527|P2|COMPLETED|Baseline to Month 6||20
257018|NCT01003106|620528|P1|COMPLETED|Baseline to Month 6||22
257019|NCT01003106|620521|P8|STARTED|Baseline to Month 6||0
257020|NCT01003106|620522|P7|STARTED|Baseline to Month 6||0
257021|NCT01003106|620523|P6|STARTED|Baseline to Month 6||20
257022|NCT01003106|620524|P5|STARTED|Baseline to Month 6||19
257023|NCT01003106|620525|P4|STARTED|Baseline to Month 6||0
257024|NCT01003106|620526|P3|STARTED|Baseline to Month 6||0
257025|NCT01003106|620527|P2|STARTED|Baseline to Month 6||20
257026|NCT01003106|620528|P1|STARTED|Baseline to Month 6||22
257027|NCT01003080|620552|P2|NOT COMPLETED|Overall Study||0
257028|NCT01003080|620553|P1|NOT COMPLETED|Overall Study||0
257029|NCT01003080|620552|P2|COMPLETED|Overall Study||61
257030|NCT01003080|620553|P1|COMPLETED|Overall Study||50
257031|NCT01003080|620552|P2|STARTED|Overall Study||61
257032|NCT01003080|620553|P1|STARTED|Overall Study||50
257033|NCT01003067|620561|P2|NOT COMPLETED|Overall Study||24
257034|NCT01003067|620562|P1|NOT COMPLETED|Overall Study||33
257035|NCT01003067|620561|P2|COMPLETED|Overall Study||107
257036|NCT01003067|620562|P1|COMPLETED|Overall Study||103
257037|NCT01003067|620561|P2|STARTED|Overall Study||131
257038|NCT01003067|620562|P1|STARTED|Overall Study||136
257039|NCT01002989|620568|P1|NOT COMPLETED|Overall Study||5
257040|NCT01002989|620568|P1|COMPLETED|Overall Study||93
257041|NCT01002989|620568|P1|STARTED|Overall Study||98
257042|NCT01002755|620575|P1|NOT COMPLETED|Overall Study||0
257043|NCT01002755|620575|P1|COMPLETED|Overall Study||36
257044|NCT01002755|620575|P1|STARTED|Overall Study||36
257045|NCT01002742|620583|P2|NOT COMPLETED|Overall Study||1
257046|NCT01002742|620584|P1|NOT COMPLETED|Overall Study||0
257047|NCT01002742|620583|P2|COMPLETED|Overall Study||116
257048|NCT01002742|620584|P1|COMPLETED|Overall Study||119
257049|NCT01002742|620583|P2|STARTED|Overall Study||117
257050|NCT01002742|620584|P1|STARTED|Overall Study||119
257051|NCT01002573|620620|P2|NOT COMPLETED|Overall Study||7
257052|NCT01002573|620621|P1|NOT COMPLETED|Overall Study||11
257053|NCT01002573|620620|P2|COMPLETED|Overall Study||53
257054|NCT01002573|620621|P1|COMPLETED|Overall Study||47
257055|NCT01002573|620620|P2|STARTED|Overall Study||60
257056|NCT01002573|620621|P1|STARTED|Overall Study||58
257057|NCT01002547|620642|P3|NOT COMPLETED|Overall Study||8
257058|NCT01002547|620643|P2|NOT COMPLETED|Overall Study||3
257059|NCT01002547|620644|P1|NOT COMPLETED|Overall Study||8
257060|NCT01002547|620642|P3|COMPLETED|Overall Study||29
257061|NCT01002547|620643|P2|COMPLETED|Overall Study||33
257062|NCT01002547|620644|P1|COMPLETED|Overall Study||24
257063|NCT01002547|620642|P3|STARTED|Overall Study||37
257064|NCT01002547|620643|P2|STARTED|Overall Study||36
257065|NCT01002547|620644|P1|STARTED|Overall Study||32
257066|NCT01002482|620702|P2|NOT COMPLETED|Overall Study||21
257067|NCT01002482|620703|P1|NOT COMPLETED|Overall Study||15
257068|NCT01002482|620702|P2|COMPLETED|Overall Study||1312
257069|NCT01002482|620703|P1|COMPLETED|Overall Study||1336
257070|NCT01002482|620702|P2|STARTED|Overall Study||1333
257071|NCT01002482|620703|P1|STARTED|Overall Study||1351
257072|NCT01002456|620725|P2|NOT COMPLETED|Overall Study||0
257073|NCT01002456|620726|P1|NOT COMPLETED|Overall Study||0
257074|NCT01002456|620725|P2|COMPLETED|Overall Study||122
257075|NCT01002456|620726|P1|COMPLETED|Overall Study||98
257076|NCT01002456|620725|P2|STARTED|Overall Study||122
257077|NCT01002456|620726|P1|STARTED|Overall Study||98
257078|NCT01002339|620737|P3|NOT COMPLETED|Overall Study||5
257079|NCT01002339|620738|P2|NOT COMPLETED|Overall Study||1
257080|NCT01002339|620739|P1|NOT COMPLETED|Overall Study||0
257081|NCT01002339|620737|P3|COMPLETED|Overall Study||42
257082|NCT01002339|620738|P2|COMPLETED|Overall Study||42
257083|NCT01002339|620739|P1|COMPLETED|Overall Study||44
257084|NCT01002339|620737|P3|STARTED|Overall Study||47
257085|NCT01002339|620738|P2|STARTED|Overall Study||43
257086|NCT01002339|620739|P1|STARTED|Overall Study||44
257087|NCT01002287|620794|P2|NOT COMPLETED|Overall Study||0
257088|NCT01002287|620795|P1|NOT COMPLETED|Overall Study||0
257089|NCT01002287|620794|P2|COMPLETED|Overall Study||3
257090|NCT01002287|620795|P1|COMPLETED|Overall Study||8
257091|NCT01002287|620794|P2|STARTED|Overall Study||3
257092|NCT01002287|620795|P1|STARTED|Overall Study||8
257093|NCT01002118|620807|P1|NOT COMPLETED|Overall Study||0
257094|NCT01002118|620807|P1|COMPLETED|Overall Study||1
257095|NCT01002118|620807|P1|Randomized Only Patient|Overall Study||1
257096|NCT01002118|620807|P1|STARTED|Overall Study||1
257097|NCT01002105|620815|P2|NOT COMPLETED|Overall Study||21
257098|NCT01002105|620816|P1|NOT COMPLETED|Overall Study||19
257099|NCT01002105|620815|P2|COMPLETED|Overall Study||11
257100|NCT01002105|620816|P1|COMPLETED|Overall Study||13
257101|NCT01002105|620815|P2|STARTED|Overall Study||32
257102|NCT01002105|620816|P1|STARTED|Overall Study||32
257103|NCT01001988|620832|P1|NOT COMPLETED|Overall Study||117
257104|NCT01001988|620832|P1|COMPLETED|Overall Study||479
257105|NCT01001988|620832|P1|STARTED|Overall Study||596
257106|NCT01001975|620839|P2|NOT COMPLETED|Overall Study||0
257107|NCT01001975|620840|P1|NOT COMPLETED|Overall Study||0
257108|NCT01001975|620839|P2|COMPLETED|Overall Study||5
257109|NCT01001975|620840|P1|COMPLETED|Overall Study||5
257110|NCT01001975|620839|P2|STARTED|Overall Study||5
257111|NCT01001975|620840|P1|STARTED|Overall Study||5
257112|NCT01001832|620850|P2|NOT COMPLETED|Follow-up Period||21
257113|NCT01001832|620851|P1|NOT COMPLETED|Follow-up Period||18
257114|NCT01001832|620850|P2|COMPLETED|Follow-up Period||30
257115|NCT01001832|620851|P1|COMPLETED|Follow-up Period||34
257116|NCT01001832|620850|P2|STARTED|Follow-up Period||51
257117|NCT01001832|620851|P1|STARTED|Follow-up Period||52
257118|NCT01001832|620850|P2|NOT COMPLETED|Long-term Period||5
257119|NCT01001832|620851|P1|NOT COMPLETED|Long-term Period||4
257120|NCT01001832|620850|P2|COMPLETED|Long-term Period||51
257121|NCT01001832|620851|P1|COMPLETED|Long-term Period||52
257122|NCT01001832|620850|P2|STARTED|Long-term Period||56
257123|NCT01001832|620851|P1|STARTED|Long-term Period|1 participant completed the short term period but discontinued before start of the Long-term Period.|56
257124|NCT01001832|620850|P2|NOT COMPLETED|Short-term Period||3
257125|NCT01001832|620851|P1|NOT COMPLETED|Short-term Period||2
257126|NCT01001832|620850|P2|COMPLETED|Short-term Period||56
257127|NCT01001832|620851|P1|COMPLETED|Short-term Period||57
257128|NCT01001832|620850|P2|STARTED|Short-term Period||59
257129|NCT01001832|620851|P1|STARTED|Short-term Period||59
257130|NCT01001806|620897|P3|NOT COMPLETED|Overall Study||4
257131|NCT01001806|620898|P2|NOT COMPLETED|Overall Study||1
257132|NCT01001806|620899|P1|NOT COMPLETED|Overall Study||0
257133|NCT01001806|620897|P3|COMPLETED|Overall Study||38
257134|NCT01001806|620898|P2|COMPLETED|Overall Study||41
257135|NCT01001806|620899|P1|COMPLETED|Overall Study||42
257136|NCT01001806|620897|P3|STARTED|Overall Study||42
257137|NCT01001806|620898|P2|STARTED|Overall Study||42
257138|NCT01001806|620899|P1|STARTED|Overall Study||42
257139|NCT01001767|620909|P2|NOT COMPLETED|Overall Study||0
257140|NCT01001767|620910|P1|NOT COMPLETED|Overall Study||4
257141|NCT01001767|620909|P2|COMPLETED|Overall Study||17
257142|NCT01001767|620910|P1|COMPLETED|Overall Study||14
257143|NCT01001767|620909|P2|STARTED|Overall Study||17
257144|NCT01001767|620910|P1|STARTED|Overall Study||18
257145|NCT01001702|620916|P1|NOT COMPLETED|Overall Study||72
257146|NCT01001702|620916|P1|COMPLETED|Overall Study||13
257147|NCT01001702|620916|P1|STARTED|Overall Study||85
257148|NCT01001598|620927|P1|NOT COMPLETED|Overall Study||2
257149|NCT01001598|620927|P1|COMPLETED|Overall Study|3 completed study (2 FA and 1 DC) in 2011|3
257150|NCT01001598|620927|P1|STARTED|Overall Study||5
257151|NCT01001572|620935|P3|NOT COMPLETED|Double-Blind Treatment Phase||19
257152|NCT01001572|620936|P2|NOT COMPLETED|Double-Blind Treatment Phase||10
257153|NCT01001572|620937|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
257154|NCT01001572|620935|P3|COMPLETED|Double-Blind Treatment Phase||306
257155|NCT01001572|620936|P2|COMPLETED|Double-Blind Treatment Phase||319
257156|NCT01001572|620937|P1|COMPLETED|Double-Blind Treatment Phase||0
257157|NCT01001572|620935|P3|Full Analysis Set (FAS)|Double-Blind Treatment Phase|Two patients were excluded from full analysis set for having no post-baseline efficacy assessment.|323
257158|NCT01001572|620936|P2|Full Analysis Set (FAS)|Double-Blind Treatment Phase|One patient was excluded from full analysis set for having no post-baseline efficacy assessment.|328
257159|NCT01001572|620937|P1|Full Analysis Set (FAS)|Double-Blind Treatment Phase||0
257160|NCT01001572|620935|P3|STARTED|Double-Blind Treatment Phase||325
257161|NCT01001572|620936|P2|STARTED|Double-Blind Treatment Phase||329
257162|NCT01001572|620937|P1|STARTED|Double-Blind Treatment Phase|This arm is only used for single blind period. So, no enrollment during double blind period.|0
257163|NCT01001572|620935|P3|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
257164|NCT01001572|620936|P2|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
257165|NCT01001572|620937|P1|NOT COMPLETED|Single-Blind Valsartan 160 mg||278
257166|NCT01001572|620935|P3|COMPLETED|Single-Blind Valsartan 160 mg||0
257167|NCT01001572|620936|P2|COMPLETED|Single-Blind Valsartan 160 mg||0
257168|NCT01001572|620937|P1|COMPLETED|Single-Blind Valsartan 160 mg||654
257169|NCT01001572|620935|P3|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
257170|NCT01001572|620936|P2|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
257171|NCT01001572|620937|P1|STARTED|Single-Blind Valsartan 160 mg||932
257172|NCT01001559|620953|P2|NOT COMPLETED|Overall Study||0
257173|NCT01001559|620954|P1|NOT COMPLETED|Overall Study||0
257174|NCT01001559|620953|P2|COMPLETED|Overall Study||147
257175|NCT01001559|620954|P1|COMPLETED|Overall Study||95
257176|NCT01001559|620953|P2|STARTED|Overall Study||147
257177|NCT01001559|620954|P1|STARTED|Overall Study||95
257178|NCT01001546|620968|P2|NOT COMPLETED|Overall Study||0
257179|NCT01001546|620969|P1|NOT COMPLETED|Overall Study||0
257180|NCT01001546|620968|P2|COMPLETED|Overall Study||207
257181|NCT01001546|620969|P1|COMPLETED|Overall Study||206
257182|NCT01001546|620968|P2|STARTED|Overall Study||207
257183|NCT01001546|620969|P1|STARTED|Overall Study||206
257184|NCT01001520|620975|P2|NOT COMPLETED|Medication Period 2||3
257185|NCT01001520|620976|P1|NOT COMPLETED|Medication Period 2||0
257186|NCT01001520|620975|P2|COMPLETED|Medication Period 2||13
257187|NCT01001520|620976|P1|COMPLETED|Medication Period 2||16
257188|NCT01001520|620975|P2|STARTED|Medication Period 2||16
257189|NCT01001520|620976|P1|STARTED|Medication Period 2||16
257190|NCT01001520|620975|P2|NOT COMPLETED|Washout Period||1
257191|NCT01001520|620976|P1|NOT COMPLETED|Washout Period||2
257192|NCT01001520|620975|P2|COMPLETED|Washout Period||16
257193|NCT01001520|620976|P1|COMPLETED|Washout Period||16
257194|NCT01001520|620975|P2|STARTED|Washout Period||17
257195|NCT01001520|620976|P1|STARTED|Washout Period||18
257196|NCT01001520|620975|P2|NOT COMPLETED|Medication Period 1||7
257197|NCT01001520|620976|P1|NOT COMPLETED|Medication Period 1||4
257198|NCT01001520|620975|P2|COMPLETED|Medication Period 1||17
257199|NCT01001520|620976|P1|COMPLETED|Medication Period 1||18
257200|NCT01001520|620975|P2|STARTED|Medication Period 1||24
257201|NCT01001520|620976|P1|STARTED|Medication Period 1||22
257202|NCT01001494|621003|P3|NOT COMPLETED|Overall Study||41
257203|NCT01001494|621004|P2|NOT COMPLETED|Overall Study||17
257204|NCT01001494|621005|P1|NOT COMPLETED|Overall Study||24
257205|NCT01001494|621003|P3|COMPLETED|Overall Study||232
257206|NCT01001494|621004|P2|COMPLETED|Overall Study||252
257207|NCT01001494|621005|P1|COMPLETED|Overall Study||253
257208|NCT01001494|621003|P3|STARTED|Overall Study|276 patients were randomized, but baseline data was missing from 3 patients in one center|273
257209|NCT01001494|621004|P2|STARTED|Overall Study|272 patients were randomized, but baseline data was missing from 3 patients in one center|269
257210|NCT01001494|621005|P1|STARTED|Overall Study|280 patients were randomized, but baseline data was missing from 3 patients in one center|277
257211|NCT01001442|621033|P8|NOT COMPLETED|Overall Study||2
257212|NCT01001442|621034|P7|NOT COMPLETED|Overall Study||4
257213|NCT01001442|621035|P6|NOT COMPLETED|Overall Study||0
257214|NCT01001442|621036|P5|NOT COMPLETED|Overall Study||2
257215|NCT01001442|621037|P4|NOT COMPLETED|Overall Study||0
257216|NCT01001442|621038|P3|NOT COMPLETED|Overall Study||0
257217|NCT01001442|621039|P2|NOT COMPLETED|Overall Study||0
257218|NCT01001442|621040|P1|NOT COMPLETED|Overall Study||0
257219|NCT01001442|621033|P8|COMPLETED|Overall Study||2
257220|NCT01001442|621034|P7|COMPLETED|Overall Study||6
257221|NCT01001442|621035|P6|COMPLETED|Overall Study||3
257222|NCT01001442|621036|P5|COMPLETED|Overall Study||2
257223|NCT01001442|621037|P4|COMPLETED|Overall Study||3
257224|NCT01001442|621038|P3|COMPLETED|Overall Study||4
257225|NCT01001442|621039|P2|COMPLETED|Overall Study||3
257226|NCT01001442|621040|P1|COMPLETED|Overall Study||4
257227|NCT01001442|621033|P8|STARTED|Overall Study||4
257228|NCT01001442|621034|P7|STARTED|Overall Study||10
257229|NCT01001442|621035|P6|STARTED|Overall Study||3
257230|NCT01001442|621036|P5|STARTED|Overall Study||4
257231|NCT01001442|621037|P4|STARTED|Overall Study||3
257232|NCT01001442|621038|P3|STARTED|Overall Study||4
257233|NCT01001442|621039|P2|STARTED|Overall Study||3
257234|NCT01001442|621040|P1|STARTED|Overall Study||4
257235|NCT01001429|621090|P2|NOT COMPLETED|Overall Study||1
257236|NCT01001429|621091|P1|NOT COMPLETED|Overall Study||0
257237|NCT01001429|621090|P2|COMPLETED|Overall Study||37
257238|NCT01001429|621091|P1|COMPLETED|Overall Study||39
257239|NCT01001429|621090|P2|STARTED|Overall Study||38
257240|NCT01001429|621091|P1|STARTED|Overall Study||39
257241|NCT01001403|621123|P2|NOT COMPLETED|Overall Study||0
257242|NCT01001403|621124|P1|NOT COMPLETED|Overall Study||0
257243|NCT01001403|621123|P2|COMPLETED|Overall Study||31
257244|NCT01001403|621124|P1|COMPLETED|Overall Study||31
257245|NCT01001403|621123|P2|STARTED|Overall Study||31
257246|NCT01001403|621124|P1|STARTED|Overall Study||31
257247|NCT01001390|621130|P2|NOT COMPLETED|Overall Study||0
257248|NCT01001390|621131|P1|NOT COMPLETED|Overall Study||2
257249|NCT01001390|621130|P2|COMPLETED|Overall Study||0
257250|NCT01001390|621131|P1|COMPLETED|Overall Study||0
257251|NCT01001390|621130|P2|STARTED|Overall Study||0
257252|NCT01001390|621131|P1|STARTED|Overall Study||2
257253|NCT01001377|621139|P2|NOT COMPLETED|Overall Study||421
257254|NCT01001377|621140|P1|NOT COMPLETED|Overall Study||426
257255|NCT01001377|621139|P2|COMPLETED|Overall Study|Indicates participants continuing in study|85
257256|NCT01001377|621140|P1|COMPLETED|Overall Study|Indicates participants continuing in study|78
257257|NCT01001377|621139|P2|Received Treatment|Overall Study||499
257258|NCT01001377|621140|P1|Received Treatment|Overall Study||500
257259|NCT01001377|621139|P2|STARTED|Overall Study||506
257260|NCT01001377|621140|P1|STARTED|Overall Study||504
257261|NCT01001325|621170|P2|NOT COMPLETED|Overall Study||10
257262|NCT01001325|621171|P1|NOT COMPLETED|Overall Study||18
257263|NCT01001325|621170|P2|COMPLETED|Overall Study||224
257264|NCT01001325|621171|P1|COMPLETED|Overall Study||216
257265|NCT01001325|621170|P2|STARTED|Overall Study||234
257266|NCT01001325|621171|P1|STARTED|Overall Study||234
257267|NCT01001299|621177|P1|NOT COMPLETED|Overall Study||25
257268|NCT01001299|621177|P1|COMPLETED|Overall Study||0
257269|NCT01001299|621177|P1|STARTED|Overall Study||25
257270|NCT01001234|621206|P5|NOT COMPLETED|Overall Study||0
257271|NCT01001234|621207|P4|NOT COMPLETED|Overall Study||25
257272|NCT01001234|621208|P3|NOT COMPLETED|Overall Study||32
257273|NCT01001234|621209|P2|NOT COMPLETED|Overall Study||26
257274|NCT01001234|621210|P1|NOT COMPLETED|Overall Study||405
257275|NCT01001234|621206|P5|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|40
257276|NCT01001234|621207|P4|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|385
257277|NCT01001234|621208|P3|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|377
257278|NCT01001234|621209|P2|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|5
257279|NCT01001234|621210|P1|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|87
257280|NCT01001234|621206|P5|Participants Not Treated|Overall Study|Participants who did not take study drug|0
257281|NCT01001234|621207|P4|Participants Not Treated|Overall Study|Participants who did not take study drug|5
257282|NCT01001234|621208|P3|Participants Not Treated|Overall Study|Participants who did not take study drug|9
257283|NCT01001234|621209|P2|Participants Not Treated|Overall Study|Participants who did not take study drug|23
257284|NCT01001234|621210|P1|Participants Not Treated|Overall Study|Participants who did not take study drug|368
257285|NCT01001234|621206|P5|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|40
257286|NCT01001234|621207|P4|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|405
257287|NCT01001234|621208|P3|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|400
257288|NCT01001234|621209|P2|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|8
257289|NCT01001234|621210|P1|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|124
257290|NCT01001234|621206|P5|STARTED|Overall Study|Participants who were randomized to study drug|40
257291|NCT01001234|621207|P4|STARTED|Overall Study|Participants who were randomized to study drug|410
257292|NCT01001234|621208|P3|STARTED|Overall Study|Participants who were randomized to study drug|409
257293|NCT01001234|621209|P2|STARTED|Overall Study|Participants who were randomized to study drug|31
257294|NCT01001234|621210|P1|STARTED|Overall Study|Participants who were randomized to study drug|492
257295|NCT01001221|621226|P5|NOT COMPLETED|Overall Study||0
257296|NCT01001221|621227|P4|NOT COMPLETED|Overall Study||6
257297|NCT01001221|621228|P3|NOT COMPLETED|Overall Study||3
257298|NCT01001221|621229|P2|NOT COMPLETED|Overall Study||5
257299|NCT01001221|621230|P1|NOT COMPLETED|Overall Study||5
257300|NCT01001221|621226|P5|COMPLETED|Overall Study||0
257301|NCT01001221|621227|P4|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
257302|NCT01001221|621228|P3|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
257303|NCT01001221|621229|P2|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
257304|NCT01001221|621230|P1|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
257305|NCT01001221|621226|P5|Completed 1st Treatment Cycle|Overall Study||0
257306|NCT01001221|621227|P4|Completed 1st Treatment Cycle|Overall Study||6
257307|NCT01001221|621228|P3|Completed 1st Treatment Cycle|Overall Study||2
257308|NCT01001221|621229|P2|Completed 1st Treatment Cycle|Overall Study||5
257309|NCT01001221|621230|P1|Completed 1st Treatment Cycle|Overall Study||5
257310|NCT01001221|621226|P5|Treated|Overall Study||0
257311|NCT01001221|621227|P4|Treated|Overall Study||6
257312|NCT01001221|621228|P3|Treated|Overall Study||2
257313|NCT01001221|621229|P2|Treated|Overall Study||5
257314|NCT01001221|621230|P1|Treated|Overall Study||5
257315|NCT01001221|621226|P5|STARTED|Overall Study|Inability to determine the MTD during study part 1|0
257316|NCT01001221|621227|P4|STARTED|Overall Study||6
257317|NCT01001221|621228|P3|STARTED|Overall Study||3
257318|NCT01001221|621229|P2|STARTED|Overall Study||5
257319|NCT01001221|621230|P1|STARTED|Overall Study||5
257320|NCT01001208|621405|P2|NOT COMPLETED|Overall Study||33
257321|NCT01001208|621406|P1|NOT COMPLETED|Overall Study||28
257322|NCT01001208|621405|P2|COMPLETED|Overall Study||206
257323|NCT01001208|621406|P1|COMPLETED|Overall Study||211
257324|NCT01001208|621405|P2|STARTED|Overall Study||239
257325|NCT01001208|621406|P1|STARTED|Overall Study||239
257326|NCT01001195|621434|P4|NOT COMPLETED|Overall Study||0
257327|NCT01001195|621435|P3|NOT COMPLETED|Overall Study||0
257328|NCT01001195|621436|P2|NOT COMPLETED|Overall Study||2
257329|NCT01001195|621437|P1|NOT COMPLETED|Overall Study||2
257330|NCT01001195|621434|P4|COMPLETED|Overall Study||41
257331|NCT01001195|621435|P3|COMPLETED|Overall Study||44
257332|NCT01001195|621436|P2|COMPLETED|Overall Study||39
257333|NCT01001195|621437|P1|COMPLETED|Overall Study||37
257334|NCT01001195|621434|P4|STARTED|Overall Study||41
257335|NCT01001195|621435|P3|STARTED|Overall Study||44
257336|NCT01001195|621436|P2|STARTED|Overall Study||41
257337|NCT01001195|621437|P1|STARTED|Overall Study||39
257338|NCT01001169|621449|P2|NOT COMPLETED|Overall Study||1
257339|NCT01001169|621450|P1|NOT COMPLETED|Overall Study||2
257340|NCT01001169|621449|P2|COMPLETED|Overall Study||29
257341|NCT01001169|621450|P1|COMPLETED|Overall Study||28
257342|NCT01001169|621449|P2|STARTED|Overall Study||30
257343|NCT01001169|621450|P1|STARTED|Overall Study||30
257344|NCT01001104|621558|P4|NOT COMPLETED|Overall Study||3
257345|NCT01001104|621559|P3|NOT COMPLETED|Overall Study||1
257346|NCT01001104|621560|P2|NOT COMPLETED|Overall Study||1
257347|NCT01001104|621561|P1|NOT COMPLETED|Overall Study||2
257348|NCT01001104|621558|P4|COMPLETED|Overall Study||34
257349|NCT01001104|621559|P3|COMPLETED|Overall Study||35
257350|NCT01001104|621560|P2|COMPLETED|Overall Study||36
257351|NCT01001104|621561|P1|COMPLETED|Overall Study||33
257352|NCT01001104|621558|P4|STARTED|Overall Study||37
257353|NCT01001104|621559|P3|STARTED|Overall Study||36
257354|NCT01001104|621560|P2|STARTED|Overall Study||37
257355|NCT01001104|621561|P1|STARTED|Overall Study||35
257356|NCT01001078|621608|P2|NOT COMPLETED|Overall Study||0
257357|NCT01001078|621609|P1|NOT COMPLETED|Overall Study||0
257358|NCT01001078|621608|P2|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 2|50
257359|NCT01001078|621609|P1|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 5|50
257360|NCT01001078|621608|P2|Lost to Followup Interview|Overall Study|Could not be interviewed.|2
257361|NCT01001078|621609|P1|Lost to Followup Interview|Overall Study|Could not be interviewed.|5
257362|NCT01001078|621608|P2|Intubated|Overall Study||1
257363|NCT01001078|621609|P1|Intubated|Overall Study||2
257364|NCT01001078|621608|P2|Received Crossover|Overall Study||3
257365|NCT01001078|621609|P1|Received Crossover|Overall Study||2
257366|NCT01001078|621608|P2|Received Allocated Intervention|Overall Study||46
257367|NCT01001078|621609|P1|Received Allocated Intervention|Overall Study||46
257368|NCT01001078|621608|P2|STARTED|Overall Study||50
257369|NCT01001078|621609|P1|STARTED|Overall Study||50
257370|NCT01001052|621625|P2|NOT COMPLETED|Overall Study||0
257371|NCT01001052|621626|P1|NOT COMPLETED|Overall Study||0
257372|NCT01001052|621625|P2|COMPLETED|Overall Study||18
257373|NCT01001052|621626|P1|COMPLETED|Overall Study||20
257374|NCT01001052|621625|P2|STARTED|Overall Study||18
257375|NCT01001052|621626|P1|STARTED|Overall Study||20
257376|NCT01000987|621639|P3|NOT COMPLETED|Overall Study||0
257377|NCT01000987|621640|P2|NOT COMPLETED|Overall Study||0
257378|NCT01000987|621641|P1|NOT COMPLETED|Overall Study||0
257379|NCT01000987|621639|P3|COMPLETED|Overall Study||17
257380|NCT01000987|621640|P2|COMPLETED|Overall Study||15
257381|NCT01000987|621641|P1|COMPLETED|Overall Study||12
257382|NCT01000987|621639|P3|STARTED|Overall Study||17
257383|NCT01000987|621640|P2|STARTED|Overall Study||15
257384|NCT01000987|621641|P1|STARTED|Overall Study||12
257385|NCT01000974|621652|P3|NOT COMPLETED|Booster Vaccination Phase||14
257386|NCT01000974|621653|P2|NOT COMPLETED|Booster Vaccination Phase||12
257387|NCT01000974|621654|P1|NOT COMPLETED|Booster Vaccination Phase||67
257388|NCT01000974|621652|P3|COMPLETED|Booster Vaccination Phase||386
257389|NCT01000974|621653|P2|COMPLETED|Booster Vaccination Phase||423
257390|NCT01000974|621654|P1|COMPLETED|Booster Vaccination Phase||2270
257391|NCT01000974|621652|P3|STARTED|Booster Vaccination Phase||400
257392|NCT01000974|621653|P2|STARTED|Booster Vaccination Phase||435
257393|NCT01000974|621654|P1|STARTED|Booster Vaccination Phase||2337
257394|NCT01000974|621652|P3|NOT COMPLETED|Primary Vaccination Phase||63
257395|NCT01000974|621653|P2|NOT COMPLETED|Primary Vaccination Phase||50
257396|NCT01000974|621654|P1|NOT COMPLETED|Primary Vaccination Phase||338
257397|NCT01000974|621652|P3|COMPLETED|Primary Vaccination Phase||457
257398|NCT01000974|621653|P2|COMPLETED|Primary Vaccination Phase||470
257399|NCT01000974|621654|P1|COMPLETED|Primary Vaccination Phase||2625
257400|NCT01000974|621652|P3|STARTED|Primary Vaccination Phase||520
257401|NCT01000974|621653|P2|STARTED|Primary Vaccination Phase||520
257402|NCT01000974|621654|P1|STARTED|Primary Vaccination Phase||2963
257403|NCT01000961|621761|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
257404|NCT01000961|621762|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
257405|NCT01000961|621761|P2|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|20
257406|NCT01000961|621762|P1|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|21
257407|NCT01000961|621761|P2|STARTED|Second Intervention (3 Weeks)||20
257408|NCT01000961|621762|P1|STARTED|Second Intervention (3 Weeks)||21
257409|NCT01000961|621761|P2|NOT COMPLETED|First Intervention (3 Weeks)||2
257410|NCT01000961|621762|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
257411|NCT01000961|621761|P2|COMPLETED|First Intervention (3 Weeks)||20
257412|NCT01000961|621762|P1|COMPLETED|First Intervention (3 Weeks)||21
257413|NCT01000961|621761|P2|STARTED|First Intervention (3 Weeks)||22
257414|NCT01000961|621762|P1|STARTED|First Intervention (3 Weeks)||21
257415|NCT01000961|621761|P2|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
257416|NCT01000961|621762|P1|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
257417|NCT01000961|621761|P2|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||22
257418|NCT01000961|621762|P1|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||21
257419|NCT01000961|621761|P2|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|22
257420|NCT01000961|621762|P1|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|21
257421|NCT01000818|621774|P1|NOT COMPLETED|Omeprazole + Raltegravir||0
257422|NCT01000818|621774|P1|COMPLETED|Omeprazole + Raltegravir||18
257423|NCT01000818|621774|P1|STARTED|Omeprazole + Raltegravir||18
257424|NCT01000818|621774|P1|NOT COMPLETED|Famotidine + Raltegravir||0
257425|NCT01000818|621774|P1|COMPLETED|Famotidine + Raltegravir||18
257426|NCT01000818|621774|P1|STARTED|Famotidine + Raltegravir||18
257427|NCT01000818|621774|P1|NOT COMPLETED|Raltegravir||0
257428|NCT01000818|621774|P1|COMPLETED|Raltegravir||18
257429|NCT01000818|621774|P1|STARTED|Raltegravir||18
257430|NCT01000805|621785|P2|NOT COMPLETED|Overall Study||62
257431|NCT01000805|621786|P1|NOT COMPLETED|Overall Study||70
257432|NCT01000805|621785|P2|COMPLETED|Overall Study||204
257433|NCT01000805|621786|P1|COMPLETED|Overall Study||192
257434|NCT01000805|621785|P2|STARTED|Overall Study||266
257435|NCT01000805|621786|P1|STARTED|Overall Study||262
257436|NCT01000727|621820|P2|NOT COMPLETED|Overall Study||176
257437|NCT01000727|621821|P1|NOT COMPLETED|Overall Study||175
257438|NCT01000727|621820|P2|COMPLETED|Overall Study||6328
257439|NCT01000727|621821|P1|COMPLETED|Overall Study||6347
257440|NCT01000727|621820|P2|STARTED|Overall Study||6504
257441|NCT01000727|621821|P1|STARTED|Overall Study||6522
257442|NCT01000662|621851|P2|NOT COMPLETED|Overall Study||8
257443|NCT01000662|621852|P1|NOT COMPLETED|Overall Study||4
257444|NCT01000662|621851|P2|COMPLETED|Overall Study||198
257445|NCT01000662|621852|P1|COMPLETED|Overall Study||202
257446|NCT01000662|621851|P2|STARTED|Overall Study||206
257447|NCT01000662|621852|P1|STARTED|Overall Study||206
257448|NCT01000649|621862|P4|NOT COMPLETED|Overall Study||6
257449|NCT01000649|621863|P3|NOT COMPLETED|Overall Study||2
257450|NCT01000649|621864|P2|NOT COMPLETED|Overall Study||3
257451|NCT01000649|621865|P1|NOT COMPLETED|Overall Study||5
257452|NCT01000649|621862|P4|COMPLETED|Overall Study||15
257453|NCT01000649|621863|P3|COMPLETED|Overall Study||0
257454|NCT01000649|621864|P2|COMPLETED|Overall Study||16
257455|NCT01000649|621865|P1|COMPLETED|Overall Study||5
257456|NCT01000649|621862|P4|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|21
257457|NCT01000649|621863|P3|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|2
257458|NCT01000649|621864|P2|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|20
257459|NCT01000649|621865|P1|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|10
257460|NCT01000649|621862|P4|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|21
257461|NCT01000649|621863|P3|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|2
257462|NCT01000649|621864|P2|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|19
257463|NCT01000649|621865|P1|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|10
257464|NCT01000610|621946|P1|NOT COMPLETED|Overall Study||6
257465|NCT01000610|621946|P1|COMPLETED|Overall Study||12
257466|NCT01000610|621946|P1|STARTED|Overall Study||18
257467|NCT01000506|621957|P4|NOT COMPLETED|Overall Study||23
257468|NCT01000506|621958|P3|NOT COMPLETED|Overall Study||21
257469|NCT01000506|621959|P2|NOT COMPLETED|Overall Study||24
257470|NCT01000506|621960|P1|NOT COMPLETED|Overall Study||28
257471|NCT01000506|621957|P4|COMPLETED|Overall Study||133
257472|NCT01000506|621958|P3|COMPLETED|Overall Study||131
257473|NCT01000506|621959|P2|COMPLETED|Overall Study||129
257474|NCT01000506|621960|P1|COMPLETED|Overall Study||127
257475|NCT01000506|621957|P4|STARTED|Overall Study||156
257476|NCT01000506|621958|P3|STARTED|Overall Study||152
257477|NCT01000506|621959|P2|STARTED|Overall Study||153
257478|NCT01000506|621960|P1|STARTED|Overall Study||155
257479|NCT01000493|622004|P2|NOT COMPLETED|Overall Study||55
257480|NCT01000493|622005|P1|NOT COMPLETED|Overall Study||39
257481|NCT01000493|622004|P2|COMPLETED|Overall Study||14
257482|NCT01000493|622005|P1|COMPLETED|Overall Study||21
257483|NCT01000493|622004|P2|STARTED|Overall Study||69
257484|NCT01000493|622005|P1|STARTED|Overall Study||60
257485|NCT01000480|622055|P1|NOT COMPLETED|Follow-Up Period||0
257486|NCT01000480|622055|P1|COMPLETED|Follow-Up Period||88
257487|NCT01000480|622055|P1|STARTED|Follow-Up Period|One pt lost to follow-up during induction, 1 pt died in concurrent therapy, both not enter follow-up|88
257488|NCT01000480|622055|P1|NOT COMPLETED|Concurrent Therapy Phase||10
257489|NCT01000480|622055|P1|COMPLETED|Concurrent Therapy Phase||65
257490|NCT01000480|622055|P1|Death (Any Cause) or Disease Progression|Concurrent Therapy Phase|Pts who died (any cause) or had disease progression considered to have completed the phase.|1
257491|NCT01000480|622055|P1|STARTED|Concurrent Therapy Phase|Eight participants (pts) who completed Induction Phase, not eligible for Concurrent Therapy Phase.|75
257492|NCT01000480|622055|P1|NOT COMPLETED|Induction Phase||7
257493|NCT01000480|622055|P1|COMPLETED|Induction Phase||83
257494|NCT01000480|622055|P1|Death (Any Cause) or Disease Progression|Induction Phase|Participants who died (any cause) or had disease progression considered to have completed phase.|8
257495|NCT01000480|622055|P1|Received at Least 1 Dose of Either Drug|Induction Phase||90
257496|NCT01000480|622055|P1|STARTED|Induction Phase||90
257497|NCT01000376|622063|P2|NOT COMPLETED|Cycle 1 Day 15||0
257498|NCT01000376|622064|P1|NOT COMPLETED|Cycle 1 Day 15||0
257499|NCT01000376|622063|P2|COMPLETED|Cycle 1 Day 15||6
257500|NCT01000376|622064|P1|COMPLETED|Cycle 1 Day 15||4
257501|NCT01000376|622063|P2|STARTED|Cycle 1 Day 15||6
257502|NCT01000376|622064|P1|STARTED|Cycle 1 Day 15||4
257503|NCT01000376|622063|P2|NOT COMPLETED|Cycle 1 Day 1||0
257504|NCT01000376|622064|P1|NOT COMPLETED|Cycle 1 Day 1||2
257505|NCT01000376|622063|P2|COMPLETED|Cycle 1 Day 1||6
257506|NCT01000376|622064|P1|COMPLETED|Cycle 1 Day 1||4
257507|NCT01000376|622063|P2|STARTED|Cycle 1 Day 1||6
257508|NCT01000376|622064|P1|STARTED|Cycle 1 Day 1||6
257509|NCT01000337|622074|P2|NOT COMPLETED|Overall Study||3
257510|NCT01000337|622075|P1|NOT COMPLETED|Overall Study||4
257511|NCT01000337|622074|P2|COMPLETED|Overall Study||30
257512|NCT01000337|622075|P1|COMPLETED|Overall Study||30
257513|NCT01000337|622074|P2|STARTED|Overall Study||33
257514|NCT01000337|622075|P1|STARTED|Overall Study||34
257515|NCT01000324|622081|P1|NOT COMPLETED|Year 20||0
257516|NCT01000324|622081|P1|COMPLETED|Year 20||28
257517|NCT01000324|622081|P1|STARTED|Year 20||28
257518|NCT01000324|622081|P1|NOT COMPLETED|Year 19||0
257519|NCT01000324|622081|P1|COMPLETED|Year 19||28
257520|NCT01000324|622081|P1|STARTED|Year 19||28
257521|NCT01000324|622081|P1|NOT COMPLETED|Year 18||0
257522|NCT01000324|622081|P1|COMPLETED|Year 18||29
257523|NCT01000324|622081|P1|STARTED|Year 18||29
257524|NCT01000324|622081|P1|NOT COMPLETED|Year 17||0
257525|NCT01000324|622081|P1|COMPLETED|Year 17||32
257526|NCT01000324|622081|P1|STARTED|Year 17||32
257527|NCT01000324|622081|P1|NOT COMPLETED|Year 16||0
257528|NCT01000324|622081|P1|COMPLETED|Year 16||40
257529|NCT01000324|622081|P1|STARTED|Year 16||40
257530|NCT01000311|622093|P2|NOT COMPLETED|Overall Study||70
257531|NCT01000311|622094|P1|NOT COMPLETED|Overall Study||45
257532|NCT01000311|622093|P2|COMPLETED|Overall Study||201
257533|NCT01000311|622094|P1|COMPLETED|Overall Study||213
257534|NCT01000311|622093|P2|STARTED|Overall Study||271
257535|NCT01000311|622094|P1|STARTED|Overall Study||258
257536|NCT01000285|622124|P1|NOT COMPLETED|Overall Study||0
257537|NCT01000285|622124|P1|COMPLETED|Overall Study||18
257538|NCT01000285|622124|P1|STARTED|Overall Study||18
257539|NCT01000155|622144|P1|NOT COMPLETED|Overall Study||2
257540|NCT01000155|622144|P1|COMPLETED|Overall Study||3
257541|NCT01000155|622144|P1|STARTED|Overall Study||5
257542|NCT01000064|622150|P2|NOT COMPLETED|Overall Study||1
257543|NCT01000064|622151|P1|NOT COMPLETED|Overall Study||1
257544|NCT01000064|622150|P2|COMPLETED|Overall Study||5
257545|NCT01000064|622151|P1|COMPLETED|Overall Study||6
257546|NCT01000064|622150|P2|STARTED|Overall Study||6
257547|NCT01000064|622151|P1|STARTED|Overall Study||7
257548|NCT01000051|622174|P2|NOT COMPLETED|Overall Study||1
257549|NCT01000051|622175|P1|NOT COMPLETED|Overall Study||3
257550|NCT01000051|622174|P2|COMPLETED|Overall Study||17
257551|NCT01000051|622175|P1|COMPLETED|Overall Study||39
257552|NCT01000051|622174|P2|STARTED|Overall Study||18
257553|NCT01000051|622175|P1|STARTED|Overall Study||42
257554|NCT01000025|622183|P2|NOT COMPLETED|Overall Study||238
257555|NCT01000025|622184|P1|NOT COMPLETED|Overall Study||468
257556|NCT01000025|622183|P2|COMPLETED|Overall Study||2
257557|NCT01000025|622184|P1|COMPLETED|Overall Study||12
257558|NCT01000025|622183|P2|STARTED|Overall Study||240
257559|NCT01000025|622184|P1|STARTED|Overall Study||480
257560|NCT00999921|622202|P2|NOT COMPLETED|Overall Study||19
257561|NCT00999921|622203|P1|NOT COMPLETED|Overall Study||10
257562|NCT00999921|622202|P2|COMPLETED|Overall Study||110
257563|NCT00999921|622203|P1|COMPLETED|Overall Study||117
257564|NCT00999921|622202|P2|STARTED|Overall Study||129
257565|NCT00999921|622203|P1|STARTED|Overall Study||127
257566|NCT00999908|622213|P3|NOT COMPLETED|Treatment Period 3||0
257567|NCT00999908|622214|P2|NOT COMPLETED|Treatment Period 3||0
257568|NCT00999908|622215|P1|NOT COMPLETED|Treatment Period 3||0
257569|NCT00999908|622213|P3|COMPLETED|Treatment Period 3||19
257570|NCT00999908|622214|P2|COMPLETED|Treatment Period 3||16
257571|NCT00999908|622215|P1|COMPLETED|Treatment Period 3||16
257572|NCT00999908|622213|P3|STARTED|Treatment Period 3||19
257573|NCT00999908|622214|P2|STARTED|Treatment Period 3||16
257574|NCT00999908|622215|P1|STARTED|Treatment Period 3||16
257575|NCT00999908|622213|P3|NOT COMPLETED|Treatment Period 2||0
257576|NCT00999908|622214|P2|NOT COMPLETED|Treatment Period 2||0
257577|NCT00999908|622215|P1|NOT COMPLETED|Treatment Period 2||1
257578|NCT00999908|622213|P3|COMPLETED|Treatment Period 2||19
257579|NCT00999908|622214|P2|COMPLETED|Treatment Period 2||16
257580|NCT00999908|622215|P1|COMPLETED|Treatment Period 2||16
257581|NCT00999908|622213|P3|STARTED|Treatment Period 2||19
257582|NCT00999908|622214|P2|STARTED|Treatment Period 2||16
257583|NCT00999908|622215|P1|STARTED|Treatment Period 2||17
257584|NCT00999908|622213|P3|NOT COMPLETED|Treatment Period 1||0
257585|NCT00999908|622214|P2|NOT COMPLETED|Treatment Period 1||0
257586|NCT00999908|622215|P1|NOT COMPLETED|Treatment Period 1||2
257587|NCT00999908|622213|P3|COMPLETED|Treatment Period 1||19
257588|NCT00999908|622214|P2|COMPLETED|Treatment Period 1||16
257589|NCT00999908|622215|P1|COMPLETED|Treatment Period 1||17
257590|NCT00999908|622213|P3|STARTED|Treatment Period 1||19
257591|NCT00999908|622214|P2|STARTED|Treatment Period 1||16
257592|NCT00999908|622215|P1|STARTED|Treatment Period 1||19
257593|NCT00999830|622231|P2|NOT COMPLETED|Overall Study||0
257594|NCT00999830|622232|P1|NOT COMPLETED|Overall Study||0
257595|NCT00999830|622231|P2|COMPLETED|Overall Study||13
257596|NCT00999830|622232|P1|COMPLETED|Overall Study||14
257597|NCT00999830|622231|P2|STARTED|Overall Study||13
257598|NCT00999830|622232|P1|STARTED|Overall Study||14
257599|NCT00999804|622244|P2|NOT COMPLETED|Overall Study||5
257600|NCT00999804|622245|P1|NOT COMPLETED|Overall Study||21
257601|NCT00999804|622244|P2|COMPLETED|Overall Study||38
257602|NCT00999804|622245|P1|COMPLETED|Overall Study||64
257603|NCT00999804|622244|P2|STARTED|Overall Study||43
257604|NCT00999804|622245|P1|STARTED|Overall Study||85
257605|NCT00999713|622259|P2|NOT COMPLETED|Overall Study||0
257606|NCT00999713|622260|P1|NOT COMPLETED|Overall Study||2
257607|NCT00999713|622259|P2|COMPLETED|Overall Study||17
257608|NCT00999713|622260|P1|COMPLETED|Overall Study||24
257609|NCT00999713|622259|P2|STARTED|Overall Study||17
257610|NCT00999713|622260|P1|STARTED|Overall Study||26
257611|NCT00999687|622274|P1|NOT COMPLETED|Second Intervention||3
257612|NCT00999687|622274|P1|COMPLETED|Second Intervention||27
257613|NCT00999687|622274|P1|STARTED|Second Intervention|From week 13 to 24, all participants applied INOE to both hands twice daily.|30
257614|NCT00999687|622274|P1|NOT COMPLETED|First Intervention||1
257615|NCT00999687|622274|P1|COMPLETED|First Intervention||30
257616|NCT00999687|622274|P1|STARTED|First Intervention|16 used the INOE on the right hand,15 used the INOE on the left hand.|31
257617|NCT00999661|622281|P1|NOT COMPLETED|Overall Study||70
257618|NCT00999661|622281|P1|COMPLETED|Overall Study||161
257619|NCT00999661|622281|P1|STARTED|Overall Study||231
257620|NCT00999609|622289|P2|NOT COMPLETED|Overall Study||1
257621|NCT00999609|622290|P1|NOT COMPLETED|Overall Study||1
257622|NCT00999609|622289|P2|COMPLETED|Overall Study|1 year post intervention|9
257623|NCT00999609|622290|P1|COMPLETED|Overall Study|1 year post intervention|20
257624|NCT00999609|622289|P2|STARTED|Overall Study||10
257625|NCT00999609|622290|P1|STARTED|Overall Study|Before intervention|21
257626|NCT00999596|622302|P1|NOT COMPLETED|Overall Study||101
257627|NCT00999596|622302|P1|COMPLETED|Overall Study|Not all patient images were used for the reader evaluation based on new FDA Guidelines|6
257628|NCT00999596|622302|P1|New FDA Guideline Released|Overall Study|FDA Guidance: Class II Special Controls Guidance Document: Full-Field Digital Mammography System|6
257629|NCT00999596|622302|P1|STARTED|Overall Study||107
257630|NCT00999544|622307|P1|NOT COMPLETED|Overall Study||1
257631|NCT00999544|622307|P1|COMPLETED|Overall Study||8
257632|NCT00999544|622307|P1|STARTED|Overall Study||9
257633|NCT00999466|622343|P3|NOT COMPLETED|Main Part||4
257634|NCT00999466|622344|P2|NOT COMPLETED|Main Part||4
257635|NCT00999466|622345|P1|NOT COMPLETED|Main Part||0
257636|NCT00999466|622343|P3|COMPLETED|Main Part||21
257637|NCT00999466|622344|P2|COMPLETED|Main Part||22
257638|NCT00999466|622345|P1|COMPLETED|Main Part||0
257639|NCT00999466|622343|P3|STARTED|Main Part||25
257640|NCT00999466|622344|P2|STARTED|Main Part||26
257641|NCT00999466|622345|P1|STARTED|Main Part|AZD8848 nasal spray 30 μg group was not participated in the Main part|0
257642|NCT00999466|622343|P3|NOT COMPLETED|Pilot Part||0
257643|NCT00999466|622344|P2|NOT COMPLETED|Pilot Part||0
257644|NCT00999466|622345|P1|NOT COMPLETED|Pilot Part||0
257645|NCT00999466|622343|P3|COMPLETED|Pilot Part||3
257646|NCT00999466|622344|P2|COMPLETED|Pilot Part||0
257647|NCT00999466|622345|P1|COMPLETED|Pilot Part||6
257648|NCT00999466|622343|P3|STARTED|Pilot Part||3
257649|NCT00999466|622344|P2|STARTED|Pilot Part|AZD8848 nasal spray 60 μg group was not participated in the Pilot part|0
257650|NCT00999466|622345|P1|STARTED|Pilot Part||6
257651|NCT00999167|622622|P3|NOT COMPLETED|Part B: Randomized, Placebo Controlled||21
257652|NCT00999167|622623|P2|NOT COMPLETED|Part B: Randomized, Placebo Controlled||35
257653|NCT00999167|622624|P1|NOT COMPLETED|Part B: Randomized, Placebo Controlled||0
257654|NCT00999167|622622|P3|COMPLETED|Part B: Randomized, Placebo Controlled||67
257655|NCT00999167|622623|P2|COMPLETED|Part B: Randomized, Placebo Controlled||55
257656|NCT00999167|622624|P1|COMPLETED|Part B: Randomized, Placebo Controlled||0
257657|NCT00999167|622622|P3|STARTED|Part B: Randomized, Placebo Controlled||88
257658|NCT00999167|622623|P2|STARTED|Part B: Randomized, Placebo Controlled|4 subjects who participated in Part A enrolled in Part B and remainder were newly enrolled|90
257659|NCT00999167|622624|P1|STARTED|Part B: Randomized, Placebo Controlled||0
257660|NCT00999167|622622|P3|NOT COMPLETED|Part A: Open Label Safety run-in||0
257661|NCT00999167|622623|P2|NOT COMPLETED|Part A: Open Label Safety run-in||0
257662|NCT00999167|622624|P1|NOT COMPLETED|Part A: Open Label Safety run-in||7
257663|NCT00999167|622622|P3|COMPLETED|Part A: Open Label Safety run-in||0
257664|NCT00999167|622623|P2|COMPLETED|Part A: Open Label Safety run-in||0
257665|NCT00999167|622624|P1|COMPLETED|Part A: Open Label Safety run-in||8
257666|NCT00999167|622622|P3|Received 9 mL BID|Part A: Open Label Safety run-in||0
257667|NCT00999167|622623|P2|Received 9 mL BID|Part A: Open Label Safety run-in||0
257668|NCT00999167|622624|P1|Received 9 mL BID|Part A: Open Label Safety run-in||15
257669|NCT00999167|622622|P3|STARTED|Part A: Open Label Safety run-in||0
257670|NCT00999167|622623|P2|STARTED|Part A: Open Label Safety run-in||0
257671|NCT00999167|622624|P1|STARTED|Part A: Open Label Safety run-in||15
257672|NCT00999141|622638|P1|NOT COMPLETED|Overall Study||0
257673|NCT00999141|622638|P1|COMPLETED|Overall Study||75
257674|NCT00999141|622638|P1|STARTED|Overall Study|Randomized and treated|75
257675|NCT00999102|622720|P2|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0
257676|NCT00999102|622721|P1|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0
257677|NCT00999102|622720|P2|COMPLETED|4 Weeks at Higher Dose of Second Drug||16
257678|NCT00999102|622721|P1|COMPLETED|4 Weeks at Higher Dose of Second Drug||15
257679|NCT00999102|622720|P2|STARTED|4 Weeks at Higher Dose of Second Drug||16
257680|NCT00999102|622721|P1|STARTED|4 Weeks at Higher Dose of Second Drug||15
257681|NCT00999102|622720|P2|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0
257682|NCT00999102|622721|P1|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0
257683|NCT00999102|622720|P2|COMPLETED|4 Weeks at Lower Dose of Second Drug||16
257684|NCT00999102|622721|P1|COMPLETED|4 Weeks at Lower Dose of Second Drug||15
257685|NCT00999102|622720|P2|STARTED|4 Weeks at Lower Dose of Second Drug||16
257686|NCT00999102|622721|P1|STARTED|4 Weeks at Lower Dose of Second Drug||15
257687|NCT00999102|622720|P2|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0
257688|NCT00999102|622721|P1|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0
257689|NCT00999102|622720|P2|COMPLETED|4 Weeks at Higher Dose of First Drug||16
257690|NCT00999102|622721|P1|COMPLETED|4 Weeks at Higher Dose of First Drug||15
257691|NCT00999102|622720|P2|STARTED|4 Weeks at Higher Dose of First Drug||16
257692|NCT00999102|622721|P1|STARTED|4 Weeks at Higher Dose of First Drug||15
257693|NCT00999102|622720|P2|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1
257694|NCT00999102|622721|P1|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1
257695|NCT00999102|622720|P2|COMPLETED|4 Weeks at Lower Dose of First Drug||16
257696|NCT00999102|622721|P1|COMPLETED|4 Weeks at Lower Dose of First Drug||15
257697|NCT00999102|622720|P2|STARTED|4 Weeks at Lower Dose of First Drug||17
257698|NCT00999102|622721|P1|STARTED|4 Weeks at Lower Dose of First Drug||16
257699|NCT00999037|622737|P2|NOT COMPLETED|Overall Study||0
257700|NCT00999037|622738|P1|NOT COMPLETED|Overall Study||0
257701|NCT00999037|622737|P2|COMPLETED|Overall Study||9
257702|NCT00999037|622738|P1|COMPLETED|Overall Study||9
257703|NCT00999037|622737|P2|STARTED|Overall Study|20|9
257704|NCT00999037|622738|P1|STARTED|Overall Study||9
257705|NCT00998985|622762|P14|NOT COMPLETED|Overall Study||0
257706|NCT00998985|622763|P13|NOT COMPLETED|Overall Study||0
257707|NCT00998985|622764|P12|NOT COMPLETED|Overall Study||0
257708|NCT00998985|622765|P11|NOT COMPLETED|Overall Study||0
257709|NCT00998985|622766|P10|NOT COMPLETED|Overall Study||0
257710|NCT00998985|622767|P9|NOT COMPLETED|Overall Study||1
257711|NCT00998985|622768|P8|NOT COMPLETED|Overall Study||0
257712|NCT00998985|622769|P7|NOT COMPLETED|Overall Study||0
257713|NCT00998985|622770|P6|NOT COMPLETED|Overall Study||1
257714|NCT00998985|622771|P5|NOT COMPLETED|Overall Study||0
257715|NCT00998985|622772|P4|NOT COMPLETED|Overall Study||0
257716|NCT00998985|622773|P3|NOT COMPLETED|Overall Study||0
257717|NCT00998985|622774|P2|NOT COMPLETED|Overall Study||0
257718|NCT00998985|622775|P1|NOT COMPLETED|Overall Study||0
257719|NCT00998985|622762|P14|COMPLETED|Overall Study||15
257720|NCT00998985|622763|P13|COMPLETED|Overall Study||5
257721|NCT00998985|622764|P12|COMPLETED|Overall Study||5
257722|NCT00998985|622765|P11|COMPLETED|Overall Study||5
257723|NCT00998985|622766|P10|COMPLETED|Overall Study||5
257724|NCT00998985|622767|P9|COMPLETED|Overall Study||5
257725|NCT00998985|622768|P8|COMPLETED|Overall Study||5
257726|NCT00998985|622769|P7|COMPLETED|Overall Study||5
257727|NCT00998985|622770|P6|COMPLETED|Overall Study||4
257728|NCT00998985|622771|P5|COMPLETED|Overall Study||5
257729|NCT00998985|622772|P4|COMPLETED|Overall Study||5
257730|NCT00998985|622773|P3|COMPLETED|Overall Study||15
257731|NCT00998985|622774|P2|COMPLETED|Overall Study||5
257732|NCT00998985|622775|P1|COMPLETED|Overall Study||5
257733|NCT00998985|622762|P14|STARTED|Overall Study||15
257734|NCT00998985|622763|P13|STARTED|Overall Study||5
257735|NCT00998985|622764|P12|STARTED|Overall Study||5
257736|NCT00998985|622765|P11|STARTED|Overall Study||5
257737|NCT00998985|622766|P10|STARTED|Overall Study||5
257738|NCT00998985|622767|P9|STARTED|Overall Study||6
257739|NCT00998985|622768|P8|STARTED|Overall Study||5
257740|NCT00998985|622769|P7|STARTED|Overall Study||5
257741|NCT00998985|622770|P6|STARTED|Overall Study||5
257742|NCT00998985|622771|P5|STARTED|Overall Study||5
257743|NCT00998985|622772|P4|STARTED|Overall Study||5
257744|NCT00998985|622773|P3|STARTED|Overall Study||15
257745|NCT00998985|622774|P2|STARTED|Overall Study||5
257746|NCT00998985|622775|P1|STARTED|Overall Study||5
257747|NCT00998881|622843|P2|NOT COMPLETED|Overall Study||2
257748|NCT00998881|622844|P1|NOT COMPLETED|Overall Study||8
257749|NCT00998881|622843|P2|COMPLETED|Overall Study||97
257750|NCT00998881|622844|P1|COMPLETED|Overall Study||96
257751|NCT00998881|622843|P2|STARTED|Overall Study||99
257752|NCT00998881|622844|P1|STARTED|Overall Study||104
257753|NCT00998868|622856|P1|NOT COMPLETED|Overall Study||0
257754|NCT00998868|622856|P1|COMPLETED|Overall Study||51
257755|NCT00998868|622856|P1|STARTED|Overall Study|>=10 for each muscle strength per MRC scale, after excluding the cases following exclusion criteria|51
257756|NCT00998790|622863|P1|NOT COMPLETED|Overall Study||21
257757|NCT00998790|622863|P1|COMPLETED|Overall Study||93
257758|NCT00998790|622863|P1|Participants Who Were Treated|Overall Study||113
257759|NCT00998790|622863|P1|STARTED|Overall Study||114
257760|NCT00998764|622873|P2|NOT COMPLETED|Overall Study||274
257761|NCT00998764|622874|P1|NOT COMPLETED|Overall Study||216
257762|NCT00998764|622873|P2|COMPLETED|Overall Study||2
257763|NCT00998764|622874|P1|COMPLETED|Overall Study||0
257764|NCT00998764|622873|P2|Treated|Overall Study||275
257765|NCT00998764|622874|P1|Treated|Overall Study||215
257766|NCT00998764|622873|P2|STARTED|Overall Study||276
257767|NCT00998764|622874|P1|STARTED|Overall Study||216
257768|NCT00998738|622896|P1|NOT COMPLETED|Overall Study||1
257769|NCT00998738|622896|P1|COMPLETED|Overall Study||0
257770|NCT00998738|622896|P1|STARTED|Overall Study||1
257771|NCT00998660|622911|P1|NOT COMPLETED|Overall Study||13
257772|NCT00998660|622911|P1|COMPLETED|Overall Study|87 subjects reached the final study visit at Month 6.|87
257773|NCT00998660|622911|P1|Month 3 Visit|Overall Study||87
257774|NCT00998660|622911|P1|Implanted|Overall Study||93
257775|NCT00998660|622911|P1|STARTED|Overall Study||100
257776|NCT00998582|622917|P2|NOT COMPLETED|Overall Study||0
257777|NCT00998582|622918|P1|NOT COMPLETED|Overall Study||0
257778|NCT00998582|622917|P2|COMPLETED|Overall Study||14
257779|NCT00998582|622918|P1|COMPLETED|Overall Study||13
257780|NCT00998582|622917|P2|STARTED|Overall Study||14
257781|NCT00998582|622918|P1|STARTED|Overall Study||13
257782|NCT00998517|622929|P3|NOT COMPLETED|Overall Study||0
257783|NCT00998517|622930|P2|NOT COMPLETED|Overall Study||0
257784|NCT00998517|622931|P1|NOT COMPLETED|Overall Study||0
257785|NCT00998517|622929|P3|COMPLETED|Overall Study||918
257786|NCT00998517|622930|P2|COMPLETED|Overall Study||906
257787|NCT00998517|622931|P1|COMPLETED|Overall Study||888
257788|NCT00998517|622929|P3|STARTED|Overall Study||918
257789|NCT00998517|622930|P2|STARTED|Overall Study||906
257790|NCT00998517|622931|P1|STARTED|Overall Study||888
257791|NCT00998426|622957|P1|NOT COMPLETED|Overall Study||0
257792|NCT00998426|622957|P1|COMPLETED|Overall Study||5
257793|NCT00998426|622957|P1|Blood Glucose Monitoring|Overall Study||5
257794|NCT00998426|622957|P1|STARTED|Overall Study||5
257795|NCT00998374|622964|P2|NOT COMPLETED|Overall Study||11
257796|NCT00998374|622965|P1|NOT COMPLETED|Overall Study||12
257797|NCT00998374|622964|P2|COMPLETED|Overall Study||12
257798|NCT00998374|622965|P1|COMPLETED|Overall Study||27
257799|NCT00998374|622964|P2|STARTED|Overall Study||23
257800|NCT00998374|622965|P1|STARTED|Overall Study||39
257801|NCT00998335|622979|P2|NOT COMPLETED|Randomized Period (Months 3 to 6)||2
257802|NCT00998335|622980|P1|NOT COMPLETED|Randomized Period (Months 3 to 6)||0
257803|NCT00998335|622979|P2|COMPLETED|Randomized Period (Months 3 to 6)||20
257804|NCT00998335|622980|P1|COMPLETED|Randomized Period (Months 3 to 6)||8
257805|NCT00998335|622979|P2|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|22
257806|NCT00998335|622980|P1|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|8
257807|NCT00998335|622979|P2|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
257808|NCT00998335|622980|P1|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
257809|NCT00998335|622979|P2|COMPLETED|Initial Treatment (Months 0 - 3)||0
257810|NCT00998335|622980|P1|COMPLETED|Initial Treatment (Months 0 - 3)||30
257811|NCT00998335|622979|P2|STARTED|Initial Treatment (Months 0 - 3)||0
257812|NCT00998335|622980|P1|STARTED|Initial Treatment (Months 0 - 3)||30
257813|NCT00998309|623008|P1|NOT COMPLETED|Overall Study||4
257814|NCT00998309|623008|P1|COMPLETED|Overall Study||498
257815|NCT00998309|623008|P1|STARTED|Overall Study||502
257816|NCT00998296|623075|P11|NOT COMPLETED|Overall Study||7
257817|NCT00998296|623076|P10|NOT COMPLETED|Overall Study||18
257818|NCT00998296|623077|P9|NOT COMPLETED|Overall Study||2
257819|NCT00998296|623078|P8|NOT COMPLETED|Overall Study||2
257820|NCT00998296|623079|P7|NOT COMPLETED|Overall Study||1
257821|NCT00998296|623080|P6|NOT COMPLETED|Overall Study||0
257822|NCT00998296|623081|P5|NOT COMPLETED|Overall Study||2
257823|NCT00998296|623082|P4|NOT COMPLETED|Overall Study||0
257824|NCT00998296|623083|P3|NOT COMPLETED|Overall Study||0
257825|NCT00998296|623084|P2|NOT COMPLETED|Overall Study||1
257826|NCT00998296|623085|P1|NOT COMPLETED|Overall Study||0
257827|NCT00998296|623075|P11|COMPLETED|Overall Study||0
257828|NCT00998296|623076|P10|COMPLETED|Overall Study||0
257829|NCT00998296|623077|P9|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
257830|NCT00998296|623078|P8|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
257831|NCT00998296|623079|P7|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
257832|NCT00998296|623080|P6|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
257833|NCT00998296|623081|P5|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
257834|NCT00998296|623082|P4|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
257835|NCT00998296|623083|P3|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
257836|NCT00998296|623084|P2|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|2
257837|NCT00998296|623085|P1|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
257838|NCT00998296|623075|P11|STARTED|Overall Study||7
257839|NCT00998296|623076|P10|STARTED|Overall Study||18
257840|NCT00998296|623077|P9|STARTED|Overall Study||6
257841|NCT00998296|623078|P8|STARTED|Overall Study||6
257842|NCT00998296|623079|P7|STARTED|Overall Study||7
257843|NCT00998296|623080|P6|STARTED|Overall Study||3
257844|NCT00998296|623081|P5|STARTED|Overall Study||8
257845|NCT00998296|623082|P4|STARTED|Overall Study||3
257846|NCT00998296|623083|P3|STARTED|Overall Study||3
257847|NCT00998296|623084|P2|STARTED|Overall Study||3
257848|NCT00998296|623085|P1|STARTED|Overall Study||6
257849|NCT00998205|623152|P1|NOT COMPLETED|Overall Study||0
257850|NCT00998205|623152|P1|COMPLETED|Overall Study||16
257851|NCT00998205|623152|P1|STARTED|Overall Study||16
257852|NCT00998049|623157|P1|NOT COMPLETED|Overall Study||0
257853|NCT00998049|623157|P1|COMPLETED|Overall Study||39
257854|NCT00998049|623157|P1|STARTED|Overall Study||39
257855|NCT00998023|623168|P2|NOT COMPLETED|Overall Study||0
257856|NCT00998023|623169|P1|NOT COMPLETED|Overall Study||0
257857|NCT00998023|623168|P2|COMPLETED|Overall Study||32
257858|NCT00998023|623169|P1|COMPLETED|Overall Study||32
257859|NCT00998023|623168|P2|STARTED|Overall Study||32
257860|NCT00998023|623169|P1|STARTED|Overall Study||32
257861|NCT00997984|623180|P3|NOT COMPLETED|Overall Study||26
257862|NCT00997984|623181|P2|NOT COMPLETED|Overall Study||34
257863|NCT00997984|623182|P1|NOT COMPLETED|Overall Study||37
257864|NCT00997984|623180|P3|COMPLETED|Overall Study||88
257865|NCT00997984|623181|P2|COMPLETED|Overall Study||79
257866|NCT00997984|623182|P1|COMPLETED|Overall Study||76
257867|NCT00997984|623180|P3|STARTED|Overall Study||114
257868|NCT00997984|623181|P2|STARTED|Overall Study||113
257869|NCT00997984|623182|P1|STARTED|Overall Study||113
257870|NCT00997932|623248|P1|NOT COMPLETED|Overall Study||2
257871|NCT00997932|623248|P1|COMPLETED|Overall Study||27
257872|NCT00997932|623248|P1|STARTED|Overall Study||29
257873|NCT00997672|623255|P2|NOT COMPLETED|Overall Study||4
257874|NCT00997672|623256|P1|NOT COMPLETED|Overall Study||4
257875|NCT00997672|623255|P2|COMPLETED|Overall Study||1
257876|NCT00997672|623256|P1|COMPLETED|Overall Study||0
257877|NCT00997672|623255|P2|STARTED|Overall Study||5
257878|NCT00997672|623256|P1|STARTED|Overall Study||4
257879|NCT00997620|623264|P2|NOT COMPLETED|Overall Study||0
257880|NCT00997620|623265|P1|NOT COMPLETED|Overall Study||0
257881|NCT00997620|623264|P2|COMPLETED|Overall Study||21
257882|NCT00997620|623265|P1|COMPLETED|Overall Study||19
257883|NCT00997620|623264|P2|STARTED|Overall Study||21
257884|NCT00997620|623265|P1|STARTED|Overall Study||19
257885|NCT00997594|623283|P2|NOT COMPLETED|Overall Study||0
257886|NCT00997594|623284|P1|NOT COMPLETED|Overall Study||0
257887|NCT00997594|623283|P2|COMPLETED|Overall Study||9
257888|NCT00997594|623284|P1|COMPLETED|Overall Study||9
257889|NCT00997594|623283|P2|Completion of Ablation Procedure|Overall Study||9
257890|NCT00997594|623284|P1|Completion of Ablation Procedure|Overall Study||9
257891|NCT00997594|623283|P2|STARTED|Overall Study||9
257892|NCT00997594|623284|P1|STARTED|Overall Study||9
257893|NCT00997555|623292|P2|NOT COMPLETED|Overall Study||0
257894|NCT00997555|623293|P1|NOT COMPLETED|Overall Study||0
257895|NCT00997555|623292|P2|COMPLETED|Overall Study||15
257896|NCT00997555|623293|P1|COMPLETED|Overall Study||13
257897|NCT00997555|623292|P2|STARTED|Overall Study||15
257898|NCT00997555|623293|P1|STARTED|Overall Study||13
257899|NCT00997516|623311|P2|NOT COMPLETED|Long-term Follow-up (After 6 Months)||2
257900|NCT00997516|623312|P1|NOT COMPLETED|Long-term Follow-up (After 6 Months)||6
257901|NCT00997516|623311|P2|COMPLETED|Long-term Follow-up (After 6 Months)||36
257902|NCT00997516|623312|P1|COMPLETED|Long-term Follow-up (After 6 Months)||31
257903|NCT00997516|623311|P2|STARTED|Long-term Follow-up (After 6 Months)||38
257904|NCT00997516|623312|P1|STARTED|Long-term Follow-up (After 6 Months)||37
257905|NCT00997516|623311|P2|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
257906|NCT00997516|623312|P1|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
257907|NCT00997516|623311|P2|COMPLETED|Short-term Follow-up (Post Operative)||38
257908|NCT00997516|623312|P1|COMPLETED|Short-term Follow-up (Post Operative)||37
257909|NCT00997516|623311|P2|STARTED|Short-term Follow-up (Post Operative)||38
257910|NCT00997516|623312|P1|STARTED|Short-term Follow-up (Post Operative)||37
257911|NCT00997503|623340|P1|NOT COMPLETED|Overall Study||273
257912|NCT00997503|623340|P1|COMPLETED|Overall Study||3926
257913|NCT00997503|623340|P1|12 Months|Overall Study|4059 subjects evaluable at 12-months (cardiac death/MI within 365 days or completed follow-up)|4059
257914|NCT00997503|623340|P1|STARTED|Overall Study||4199
257915|NCT00997438|623383|P3|NOT COMPLETED|Overall Study||4
257916|NCT00997438|623384|P2|NOT COMPLETED|Overall Study||3
257917|NCT00997438|623385|P1|NOT COMPLETED|Overall Study||5
257918|NCT00997438|623383|P3|COMPLETED|Overall Study||20
257919|NCT00997438|623384|P2|COMPLETED|Overall Study||21
257920|NCT00997438|623385|P1|COMPLETED|Overall Study||16
257921|NCT00997438|623383|P3|STARTED|Overall Study||24
257922|NCT00997438|623384|P2|STARTED|Overall Study||24
257923|NCT00997438|623385|P1|STARTED|Overall Study||21
257924|NCT00997425|623420|P1|NOT COMPLETED|Overall Study||0
257925|NCT00997425|623420|P1|COMPLETED|Overall Study||19
257926|NCT00997425|623420|P1|STARTED|Overall Study||19
257927|NCT00997386|623425|P1|NOT COMPLETED|Overall Study||7
257928|NCT00997386|623425|P1|COMPLETED|Overall Study||9
257929|NCT00997386|623425|P1|STARTED|Overall Study||16
257930|NCT00997373|623434|P2|NOT COMPLETED|Overall Study||0
257931|NCT00997373|623435|P1|NOT COMPLETED|Overall Study||15
257932|NCT00997373|623434|P2|COMPLETED|Overall Study||15
257933|NCT00997373|623435|P1|COMPLETED|Overall Study||13
257934|NCT00997373|623434|P2|Completed Hysterectomy|Overall Study||15
257935|NCT00997373|623435|P1|Completed Hysterectomy|Overall Study||17
257936|NCT00997373|623434|P2|Received Letrozole|Overall Study||0
257937|NCT00997373|623435|P1|Received Letrozole|Overall Study||23
257938|NCT00997373|623434|P2|STARTED|Overall Study||15
257939|NCT00997373|623435|P1|STARTED|Overall Study||28
257940|NCT00997334|623441|P1|NOT COMPLETED|Overall Study||25
257941|NCT00997334|623441|P1|COMPLETED|Overall Study||35
257942|NCT00997334|623441|P1|Evaluable|Overall Study|Patients with tissue available for re-biopsy at time of progression|35
257943|NCT00997334|623441|P1|Eligible for Repeat Biopsy|Overall Study|Patients who experience disease progression on treatment were eligible for repeat biopsy|44
257944|NCT00997334|623441|P1|STARTED|Overall Study||60
257945|NCT00997321|623450|P2|NOT COMPLETED|Overall Study||3
257946|NCT00997321|623451|P1|NOT COMPLETED|Overall Study||0
257947|NCT00997321|623450|P2|COMPLETED|Overall Study||47
257948|NCT00997321|623451|P1|COMPLETED|Overall Study||50
257949|NCT00997321|623450|P2|STARTED|Overall Study||50
257950|NCT00997321|623451|P1|STARTED|Overall Study||50
257951|NCT00997243|623463|P1|NOT COMPLETED|Overall Study||7
257952|NCT00997243|623463|P1|COMPLETED|Overall Study||0
257953|NCT00997243|623463|P1|STARTED|Overall Study||7
257954|NCT00997204|623475|P2|NOT COMPLETED|Self-administration Phase||1
257955|NCT00997204|623476|P1|NOT COMPLETED|Self-administration Phase||0
257956|NCT00997204|623475|P2|COMPLETED|Self-administration Phase||77
257957|NCT00997204|623476|P1|COMPLETED|Self-administration Phase||19
257958|NCT00997204|623475|P2|STARTED|Self-administration Phase|1 subject did not self-administered icatibant but had a HCP to perform. the data were not included.|78
257959|NCT00997204|623476|P1|STARTED|Self-administration Phase||19
257960|NCT00997204|623475|P2|NOT COMPLETED|Naive Treatment Phase||79
257961|NCT00997204|623476|P1|NOT COMPLETED|Naive Treatment Phase||6
257962|NCT00997204|623475|P2|COMPLETED|Naive Treatment Phase||0
257963|NCT00997204|623476|P1|COMPLETED|Naive Treatment Phase||19
257964|NCT00997204|623475|P2|STARTED|Naive Treatment Phase|Non-naive patients participated in the study but they were not treated in the naive treatment phase|79
257965|NCT00997204|623476|P1|STARTED|Naive Treatment Phase||25
257966|NCT00997139|623487|P1|NOT COMPLETED|Overall Study||186
257967|NCT00997139|623487|P1|COMPLETED|Overall Study||30
257968|NCT00997139|623487|P1|Treated for Positive Baseline Culture|Overall Study||30
257969|NCT00997139|623487|P1|STARTED|Overall Study||216
257970|NCT00997126|623495|P2|NOT COMPLETED|Overall Study||11
257971|NCT00997126|623496|P1|NOT COMPLETED|Overall Study||7
257972|NCT00997126|623495|P2|COMPLETED|Overall Study||52
257973|NCT00997126|623496|P1|COMPLETED|Overall Study||56
257974|NCT00997126|623495|P2|STARTED|Overall Study||63
257975|NCT00997126|623496|P1|STARTED|Overall Study||63
257976|NCT00997113|623512|P2|NOT COMPLETED|Overall Study||0
257977|NCT00997113|623513|P1|NOT COMPLETED|Overall Study||0
257978|NCT00997113|623512|P2|COMPLETED|Overall Study||10
257979|NCT00997113|623513|P1|COMPLETED|Overall Study||10
257980|NCT00997113|623512|P2|STARTED|Overall Study||10
257981|NCT00997113|623513|P1|STARTED|Overall Study||10
257982|NCT00997035|623525|P2|NOT COMPLETED|3-month Follow-up Visit||6
257983|NCT00997035|623526|P1|NOT COMPLETED|3-month Follow-up Visit||12
257984|NCT00997035|623525|P2|COMPLETED|3-month Follow-up Visit||107
257985|NCT00997035|623526|P1|COMPLETED|3-month Follow-up Visit||100
257986|NCT00997035|623525|P2|STARTED|3-month Follow-up Visit||113
257987|NCT00997035|623526|P1|STARTED|3-month Follow-up Visit||112
257988|NCT00997035|623525|P2|NOT COMPLETED|3-week Followup Visit||6
257989|NCT00997035|623526|P1|NOT COMPLETED|3-week Followup Visit||9
257990|NCT00997035|623525|P2|COMPLETED|3-week Followup Visit||113
257991|NCT00997035|623526|P1|COMPLETED|3-week Followup Visit||112
257992|NCT00997035|623525|P2|STARTED|3-week Followup Visit||119
257993|NCT00997035|623526|P1|STARTED|3-week Followup Visit||121
257994|NCT00996996|623550|P1|NOT COMPLETED|Overall Study||33
257995|NCT00996996|623550|P1|COMPLETED|Overall Study|These participants completed 12 years of follow-up.|44
257996|NCT00996996|623550|P1|STARTED|Overall Study||77
257997|NCT00996944|623584|P2|NOT COMPLETED|Long-term Treatment Period||5
257998|NCT00996944|623585|P1|NOT COMPLETED|Long-term Treatment Period||12
257999|NCT00996944|623584|P2|COMPLETED|Long-term Treatment Period||0
258000|NCT00996944|623585|P1|COMPLETED|Long-term Treatment Period||0
258001|NCT00996944|623584|P2|STARTED|Long-term Treatment Period||5
258002|NCT00996944|623585|P1|STARTED|Long-term Treatment Period||12
258003|NCT00996944|623584|P2|NOT COMPLETED|Double-blind Treatment Period||7
258004|NCT00996944|623585|P1|NOT COMPLETED|Double-blind Treatment Period||10
258005|NCT00996944|623584|P2|COMPLETED|Double-blind Treatment Period||5
258006|NCT00996944|623585|P1|COMPLETED|Double-blind Treatment Period||12
258007|NCT00996944|623584|P2|STARTED|Double-blind Treatment Period||12
258008|NCT00996944|623585|P1|STARTED|Double-blind Treatment Period||22
258009|NCT00996931|623627|P1|NOT COMPLETED|Overall Study||0
258010|NCT00996931|623627|P1|COMPLETED|Overall Study||6
258011|NCT00996931|623627|P1|STARTED|Overall Study||6
258012|NCT00996918|623637|P5|NOT COMPLETED|Overall Study||4
258013|NCT00996918|623638|P4|NOT COMPLETED|Overall Study||56
258014|NCT00996918|623639|P3|NOT COMPLETED|Overall Study||37
258015|NCT00996918|623640|P2|NOT COMPLETED|Overall Study||66
258016|NCT00996918|623641|P1|NOT COMPLETED|Overall Study||39
258017|NCT00996918|623637|P5|COMPLETED|Overall Study||0
258018|NCT00996918|623638|P4|COMPLETED|Overall Study||0
258019|NCT00996918|623639|P3|COMPLETED|Overall Study||0
258020|NCT00996918|623640|P2|COMPLETED|Overall Study||0
258021|NCT00996918|623641|P1|COMPLETED|Overall Study||0
258022|NCT00996918|623637|P5|Treated|Overall Study||4
258023|NCT00996918|623638|P4|Treated|Overall Study||56
258024|NCT00996918|623639|P3|Treated|Overall Study||37
258025|NCT00996918|623640|P2|Treated|Overall Study||66
258026|NCT00996918|623641|P1|Treated|Overall Study||39
258027|NCT00996918|623637|P5|STARTED|Overall Study||4
258028|NCT00996918|623638|P4|STARTED|Overall Study||56
258029|NCT00996918|623639|P3|STARTED|Overall Study||37
258030|NCT00996918|623640|P2|STARTED|Overall Study||66
258031|NCT00996918|623641|P1|STARTED|Overall Study||39
258032|NCT00996892|623685|P20|NOT COMPLETED|Expansion Stage 2A||45
258033|NCT00996892|623686|P19|NOT COMPLETED|Expansion Stage 2A||0
258034|NCT00996892|623687|P18|NOT COMPLETED|Expansion Stage 2A||0
258035|NCT00996892|623688|P17|NOT COMPLETED|Expansion Stage 2A||0
258036|NCT00996892|623689|P16|NOT COMPLETED|Expansion Stage 2A||0
258037|NCT00996892|623690|P15|NOT COMPLETED|Expansion Stage 2A||0
258038|NCT00996892|623691|P14|NOT COMPLETED|Expansion Stage 2A||0
258039|NCT00996892|623692|P13|NOT COMPLETED|Expansion Stage 2A||0
258040|NCT00996892|623693|P12|NOT COMPLETED|Expansion Stage 2A||0
258041|NCT00996892|623694|P11|NOT COMPLETED|Expansion Stage 2A||0
258042|NCT00996892|623695|P10|NOT COMPLETED|Expansion Stage 2A||0
258043|NCT00996892|623696|P9|NOT COMPLETED|Expansion Stage 2A||0
258044|NCT00996892|623697|P8|NOT COMPLETED|Expansion Stage 2A||0
258045|NCT00996892|623698|P7|NOT COMPLETED|Expansion Stage 2A||0
258046|NCT00996892|623699|P6|NOT COMPLETED|Expansion Stage 2A||0
258047|NCT00996892|623700|P5|NOT COMPLETED|Expansion Stage 2A||0
258048|NCT00996892|623701|P4|NOT COMPLETED|Expansion Stage 2A||0
258049|NCT00996892|623702|P3|NOT COMPLETED|Expansion Stage 2A||0
258050|NCT00996892|623703|P2|NOT COMPLETED|Expansion Stage 2A||0
258051|NCT00996892|623704|P1|NOT COMPLETED|Expansion Stage 2A||0
258052|NCT00996892|623685|P20|COMPLETED|Expansion Stage 2A||0
258053|NCT00996892|623686|P19|COMPLETED|Expansion Stage 2A||0
258054|NCT00996892|623687|P18|COMPLETED|Expansion Stage 2A||0
258055|NCT00996892|623688|P17|COMPLETED|Expansion Stage 2A||0
258056|NCT00996892|623689|P16|COMPLETED|Expansion Stage 2A||0
258057|NCT00996892|623690|P15|COMPLETED|Expansion Stage 2A||0
258058|NCT00996892|623691|P14|COMPLETED|Expansion Stage 2A||0
258059|NCT00996892|623692|P13|COMPLETED|Expansion Stage 2A||0
258060|NCT00996892|623693|P12|COMPLETED|Expansion Stage 2A||0
258061|NCT00996892|623694|P11|COMPLETED|Expansion Stage 2A||0
258062|NCT00996892|623695|P10|COMPLETED|Expansion Stage 2A||0
258063|NCT00996892|623696|P9|COMPLETED|Expansion Stage 2A||0
258064|NCT00996892|623697|P8|COMPLETED|Expansion Stage 2A||0
258065|NCT00996892|623698|P7|COMPLETED|Expansion Stage 2A||0
258066|NCT00996892|623699|P6|COMPLETED|Expansion Stage 2A||0
258067|NCT00996892|623700|P5|COMPLETED|Expansion Stage 2A||0
258068|NCT00996892|623701|P4|COMPLETED|Expansion Stage 2A||0
258069|NCT00996892|623702|P3|COMPLETED|Expansion Stage 2A||0
258070|NCT00996892|623703|P2|COMPLETED|Expansion Stage 2A||0
258071|NCT00996892|623704|P1|COMPLETED|Expansion Stage 2A||0
258072|NCT00996892|623685|P20|STARTED|Expansion Stage 2A||45
258073|NCT00996892|623686|P19|STARTED|Expansion Stage 2A||0
258074|NCT00996892|623687|P18|STARTED|Expansion Stage 2A||0
258075|NCT00996892|623688|P17|STARTED|Expansion Stage 2A||0
258076|NCT00996892|623689|P16|STARTED|Expansion Stage 2A||0
258077|NCT00996892|623690|P15|STARTED|Expansion Stage 2A||0
258078|NCT00996892|623691|P14|STARTED|Expansion Stage 2A||0
258079|NCT00996892|623692|P13|STARTED|Expansion Stage 2A||0
258080|NCT00996892|623693|P12|STARTED|Expansion Stage 2A||0
258081|NCT00996892|623694|P11|STARTED|Expansion Stage 2A||0
258082|NCT00996892|623695|P10|STARTED|Expansion Stage 2A||0
258083|NCT00996892|623696|P9|STARTED|Expansion Stage 2A||0
258084|NCT00996892|623697|P8|STARTED|Expansion Stage 2A||0
258085|NCT00996892|623698|P7|STARTED|Expansion Stage 2A||0
258086|NCT00996892|623699|P6|STARTED|Expansion Stage 2A||0
258087|NCT00996892|623700|P5|STARTED|Expansion Stage 2A||0
258088|NCT00996892|623701|P4|STARTED|Expansion Stage 2A||0
258089|NCT00996892|623702|P3|STARTED|Expansion Stage 2A||0
258090|NCT00996892|623703|P2|STARTED|Expansion Stage 2A||0
258091|NCT00996892|623704|P1|STARTED|Expansion Stage 2A||0
258092|NCT00996892|623685|P20|NOT COMPLETED|Expansion Stage 2||0
258093|NCT00996892|623686|P19|NOT COMPLETED|Expansion Stage 2||35
258094|NCT00996892|623687|P18|NOT COMPLETED|Expansion Stage 2||0
258095|NCT00996892|623688|P17|NOT COMPLETED|Expansion Stage 2||0
258096|NCT00996892|623689|P16|NOT COMPLETED|Expansion Stage 2||0
258097|NCT00996892|623690|P15|NOT COMPLETED|Expansion Stage 2||0
258098|NCT00996892|623691|P14|NOT COMPLETED|Expansion Stage 2||0
258099|NCT00996892|623692|P13|NOT COMPLETED|Expansion Stage 2||0
258100|NCT00996892|623693|P12|NOT COMPLETED|Expansion Stage 2||0
258101|NCT00996892|623694|P11|NOT COMPLETED|Expansion Stage 2||0
258102|NCT00996892|623695|P10|NOT COMPLETED|Expansion Stage 2||0
258103|NCT00996892|623696|P9|NOT COMPLETED|Expansion Stage 2||0
258104|NCT00996892|623697|P8|NOT COMPLETED|Expansion Stage 2||0
258105|NCT00996892|623698|P7|NOT COMPLETED|Expansion Stage 2||0
258106|NCT00996892|623699|P6|NOT COMPLETED|Expansion Stage 2||0
258107|NCT00996892|623700|P5|NOT COMPLETED|Expansion Stage 2||0
258108|NCT00996892|623701|P4|NOT COMPLETED|Expansion Stage 2||0
258109|NCT00996892|623702|P3|NOT COMPLETED|Expansion Stage 2||0
258110|NCT00996892|623703|P2|NOT COMPLETED|Expansion Stage 2||0
258111|NCT00996892|623704|P1|NOT COMPLETED|Expansion Stage 2||0
258112|NCT00996892|623685|P20|COMPLETED|Expansion Stage 2||0
258113|NCT00996892|623686|P19|COMPLETED|Expansion Stage 2||0
258114|NCT00996892|623687|P18|COMPLETED|Expansion Stage 2||0
258115|NCT00996892|623688|P17|COMPLETED|Expansion Stage 2||0
258116|NCT00996892|623689|P16|COMPLETED|Expansion Stage 2||0
258117|NCT00996892|623690|P15|COMPLETED|Expansion Stage 2||0
258118|NCT00996892|623691|P14|COMPLETED|Expansion Stage 2||0
258119|NCT00996892|623692|P13|COMPLETED|Expansion Stage 2||0
258120|NCT00996892|623693|P12|COMPLETED|Expansion Stage 2||0
258121|NCT00996892|623694|P11|COMPLETED|Expansion Stage 2||0
258122|NCT00996892|623695|P10|COMPLETED|Expansion Stage 2||0
258123|NCT00996892|623696|P9|COMPLETED|Expansion Stage 2||0
258124|NCT00996892|623697|P8|COMPLETED|Expansion Stage 2||0
258125|NCT00996892|623698|P7|COMPLETED|Expansion Stage 2||0
258126|NCT00996892|623699|P6|COMPLETED|Expansion Stage 2||0
258127|NCT00996892|623700|P5|COMPLETED|Expansion Stage 2||0
258128|NCT00996892|623701|P4|COMPLETED|Expansion Stage 2||0
258129|NCT00996892|623702|P3|COMPLETED|Expansion Stage 2||0
258130|NCT00996892|623703|P2|COMPLETED|Expansion Stage 2||0
258131|NCT00996892|623704|P1|COMPLETED|Expansion Stage 2||0
258132|NCT00996892|623685|P20|STARTED|Expansion Stage 2||0
258133|NCT00996892|623686|P19|STARTED|Expansion Stage 2||35
258134|NCT00996892|623687|P18|STARTED|Expansion Stage 2||0
258135|NCT00996892|623688|P17|STARTED|Expansion Stage 2||0
258136|NCT00996892|623689|P16|STARTED|Expansion Stage 2||0
258137|NCT00996892|623690|P15|STARTED|Expansion Stage 2||0
258138|NCT00996892|623691|P14|STARTED|Expansion Stage 2||0
258139|NCT00996892|623692|P13|STARTED|Expansion Stage 2||0
258140|NCT00996892|623693|P12|STARTED|Expansion Stage 2||0
258141|NCT00996892|623694|P11|STARTED|Expansion Stage 2||0
258142|NCT00996892|623695|P10|STARTED|Expansion Stage 2||0
258143|NCT00996892|623696|P9|STARTED|Expansion Stage 2||0
258144|NCT00996892|623697|P8|STARTED|Expansion Stage 2||0
258145|NCT00996892|623698|P7|STARTED|Expansion Stage 2||0
258146|NCT00996892|623699|P6|STARTED|Expansion Stage 2||0
258147|NCT00996892|623700|P5|STARTED|Expansion Stage 2||0
258148|NCT00996892|623701|P4|STARTED|Expansion Stage 2||0
258149|NCT00996892|623702|P3|STARTED|Expansion Stage 2||0
258150|NCT00996892|623703|P2|STARTED|Expansion Stage 2||0
258151|NCT00996892|623704|P1|STARTED|Expansion Stage 2||0
258152|NCT00996892|623685|P20|NOT COMPLETED|Dose-Escalation Stage 1B||0
258153|NCT00996892|623686|P19|NOT COMPLETED|Dose-Escalation Stage 1B||0
258154|NCT00996892|623687|P18|NOT COMPLETED|Dose-Escalation Stage 1B||5
258155|NCT00996892|623688|P17|NOT COMPLETED|Dose-Escalation Stage 1B||3
258156|NCT00996892|623689|P16|NOT COMPLETED|Dose-Escalation Stage 1B||3
258157|NCT00996892|623690|P15|NOT COMPLETED|Dose-Escalation Stage 1B||4
258158|NCT00996892|623691|P14|NOT COMPLETED|Dose-Escalation Stage 1B||0
258159|NCT00996892|623692|P13|NOT COMPLETED|Dose-Escalation Stage 1B||0
258160|NCT00996892|623693|P12|NOT COMPLETED|Dose-Escalation Stage 1B||0
258161|NCT00996892|623694|P11|NOT COMPLETED|Dose-Escalation Stage 1B||0
258162|NCT00996892|623695|P10|NOT COMPLETED|Dose-Escalation Stage 1B||0
258163|NCT00996892|623696|P9|NOT COMPLETED|Dose-Escalation Stage 1B||0
258164|NCT00996892|623697|P8|NOT COMPLETED|Dose-Escalation Stage 1B||0
258165|NCT00996892|623698|P7|NOT COMPLETED|Dose-Escalation Stage 1B||0
258166|NCT00996892|623699|P6|NOT COMPLETED|Dose-Escalation Stage 1B||0
258167|NCT00996892|623700|P5|NOT COMPLETED|Dose-Escalation Stage 1B||0
258168|NCT00996892|623701|P4|NOT COMPLETED|Dose-Escalation Stage 1B||0
258169|NCT00996892|623702|P3|NOT COMPLETED|Dose-Escalation Stage 1B||0
258170|NCT00996892|623703|P2|NOT COMPLETED|Dose-Escalation Stage 1B||0
258171|NCT00996892|623704|P1|NOT COMPLETED|Dose-Escalation Stage 1B||0
258172|NCT00996892|623685|P20|COMPLETED|Dose-Escalation Stage 1B||0
258173|NCT00996892|623686|P19|COMPLETED|Dose-Escalation Stage 1B||0
258174|NCT00996892|623687|P18|COMPLETED|Dose-Escalation Stage 1B||0
258175|NCT00996892|623688|P17|COMPLETED|Dose-Escalation Stage 1B||0
258176|NCT00996892|623689|P16|COMPLETED|Dose-Escalation Stage 1B||0
258177|NCT00996892|623690|P15|COMPLETED|Dose-Escalation Stage 1B||0
258178|NCT00996892|623691|P14|COMPLETED|Dose-Escalation Stage 1B||0
258179|NCT00996892|623692|P13|COMPLETED|Dose-Escalation Stage 1B||0
258180|NCT00996892|623693|P12|COMPLETED|Dose-Escalation Stage 1B||0
258181|NCT00996892|623694|P11|COMPLETED|Dose-Escalation Stage 1B||0
258182|NCT00996892|623695|P10|COMPLETED|Dose-Escalation Stage 1B||0
258183|NCT00996892|623696|P9|COMPLETED|Dose-Escalation Stage 1B||0
258184|NCT00996892|623697|P8|COMPLETED|Dose-Escalation Stage 1B||0
258185|NCT00996892|623698|P7|COMPLETED|Dose-Escalation Stage 1B||0
258186|NCT00996892|623699|P6|COMPLETED|Dose-Escalation Stage 1B||0
258187|NCT00996892|623700|P5|COMPLETED|Dose-Escalation Stage 1B||0
258188|NCT00996892|623701|P4|COMPLETED|Dose-Escalation Stage 1B||0
258189|NCT00996892|623702|P3|COMPLETED|Dose-Escalation Stage 1B||0
258190|NCT00996892|623703|P2|COMPLETED|Dose-Escalation Stage 1B||0
258191|NCT00996892|623704|P1|COMPLETED|Dose-Escalation Stage 1B||0
258192|NCT00996892|623685|P20|STARTED|Dose-Escalation Stage 1B||0
258193|NCT00996892|623686|P19|STARTED|Dose-Escalation Stage 1B||0
258194|NCT00996892|623687|P18|STARTED|Dose-Escalation Stage 1B||5
258195|NCT00996892|623688|P17|STARTED|Dose-Escalation Stage 1B||3
258196|NCT00996892|623689|P16|STARTED|Dose-Escalation Stage 1B||3
258197|NCT00996892|623690|P15|STARTED|Dose-Escalation Stage 1B||4
258198|NCT00996892|623691|P14|STARTED|Dose-Escalation Stage 1B||0
258199|NCT00996892|623692|P13|STARTED|Dose-Escalation Stage 1B||0
258200|NCT00996892|623693|P12|STARTED|Dose-Escalation Stage 1B||0
258201|NCT00996892|623694|P11|STARTED|Dose-Escalation Stage 1B||0
258202|NCT00996892|623695|P10|STARTED|Dose-Escalation Stage 1B||0
258203|NCT00996892|623696|P9|STARTED|Dose-Escalation Stage 1B||0
258204|NCT00996892|623697|P8|STARTED|Dose-Escalation Stage 1B||0
258205|NCT00996892|623698|P7|STARTED|Dose-Escalation Stage 1B||0
258206|NCT00996892|623699|P6|STARTED|Dose-Escalation Stage 1B||0
258207|NCT00996892|623700|P5|STARTED|Dose-Escalation Stage 1B||0
258208|NCT00996892|623701|P4|STARTED|Dose-Escalation Stage 1B||0
258209|NCT00996892|623702|P3|STARTED|Dose-Escalation Stage 1B||0
258210|NCT00996892|623703|P2|STARTED|Dose-Escalation Stage 1B||0
258211|NCT00996892|623704|P1|STARTED|Dose-Escalation Stage 1B||0
258212|NCT00996892|623685|P20|NOT COMPLETED|Dose-Escalation Stage 1A||0
258213|NCT00996892|623686|P19|NOT COMPLETED|Dose-Escalation Stage 1A||0
258214|NCT00996892|623687|P18|NOT COMPLETED|Dose-Escalation Stage 1A||0
258215|NCT00996892|623688|P17|NOT COMPLETED|Dose-Escalation Stage 1A||0
258216|NCT00996892|623689|P16|NOT COMPLETED|Dose-Escalation Stage 1A||0
258217|NCT00996892|623690|P15|NOT COMPLETED|Dose-Escalation Stage 1A||0
258218|NCT00996892|623691|P14|NOT COMPLETED|Dose-Escalation Stage 1A||5
258219|NCT00996892|623692|P13|NOT COMPLETED|Dose-Escalation Stage 1A||8
258220|NCT00996892|623693|P12|NOT COMPLETED|Dose-Escalation Stage 1A||9
258221|NCT00996892|623694|P11|NOT COMPLETED|Dose-Escalation Stage 1A||7
258222|NCT00996892|623695|P10|NOT COMPLETED|Dose-Escalation Stage 1A||4
258223|NCT00996892|623696|P9|NOT COMPLETED|Dose-Escalation Stage 1A||3
258224|NCT00996892|623697|P8|NOT COMPLETED|Dose-Escalation Stage 1A||3
258225|NCT00996892|623698|P7|NOT COMPLETED|Dose-Escalation Stage 1A||0
258226|NCT00996892|623699|P6|NOT COMPLETED|Dose-Escalation Stage 1A||0
258227|NCT00996892|623700|P5|NOT COMPLETED|Dose-Escalation Stage 1A||0
258228|NCT00996892|623701|P4|NOT COMPLETED|Dose-Escalation Stage 1A||0
258229|NCT00996892|623702|P3|NOT COMPLETED|Dose-Escalation Stage 1A||0
258230|NCT00996892|623703|P2|NOT COMPLETED|Dose-Escalation Stage 1A||0
258231|NCT00996892|623704|P1|NOT COMPLETED|Dose-Escalation Stage 1A||0
258232|NCT00996892|623685|P20|COMPLETED|Dose-Escalation Stage 1A||0
258233|NCT00996892|623686|P19|COMPLETED|Dose-Escalation Stage 1A||0
258234|NCT00996892|623687|P18|COMPLETED|Dose-Escalation Stage 1A||0
258235|NCT00996892|623688|P17|COMPLETED|Dose-Escalation Stage 1A||0
258236|NCT00996892|623689|P16|COMPLETED|Dose-Escalation Stage 1A||0
258237|NCT00996892|623690|P15|COMPLETED|Dose-Escalation Stage 1A||0
258238|NCT00996892|623691|P14|COMPLETED|Dose-Escalation Stage 1A||0
258239|NCT00996892|623692|P13|COMPLETED|Dose-Escalation Stage 1A||0
258240|NCT00996892|623693|P12|COMPLETED|Dose-Escalation Stage 1A||0
258241|NCT00996892|623694|P11|COMPLETED|Dose-Escalation Stage 1A||0
258242|NCT00996892|623695|P10|COMPLETED|Dose-Escalation Stage 1A||0
258243|NCT00996892|623696|P9|COMPLETED|Dose-Escalation Stage 1A||0
258244|NCT00996892|623697|P8|COMPLETED|Dose-Escalation Stage 1A||0
258245|NCT00996892|623698|P7|COMPLETED|Dose-Escalation Stage 1A||0
258246|NCT00996892|623699|P6|COMPLETED|Dose-Escalation Stage 1A||0
258247|NCT00996892|623700|P5|COMPLETED|Dose-Escalation Stage 1A||0
258248|NCT00996892|623701|P4|COMPLETED|Dose-Escalation Stage 1A||0
258249|NCT00996892|623702|P3|COMPLETED|Dose-Escalation Stage 1A||0
258250|NCT00996892|623703|P2|COMPLETED|Dose-Escalation Stage 1A||0
258251|NCT00996892|623704|P1|COMPLETED|Dose-Escalation Stage 1A||0
258252|NCT00996892|623685|P20|STARTED|Dose-Escalation Stage 1A||0
258253|NCT00996892|623686|P19|STARTED|Dose-Escalation Stage 1A||0
258254|NCT00996892|623687|P18|STARTED|Dose-Escalation Stage 1A||0
258255|NCT00996892|623688|P17|STARTED|Dose-Escalation Stage 1A||0
258256|NCT00996892|623689|P16|STARTED|Dose-Escalation Stage 1A||0
258257|NCT00996892|623690|P15|STARTED|Dose-Escalation Stage 1A||0
258258|NCT00996892|623691|P14|STARTED|Dose-Escalation Stage 1A||5
258259|NCT00996892|623692|P13|STARTED|Dose-Escalation Stage 1A||8
258260|NCT00996892|623693|P12|STARTED|Dose-Escalation Stage 1A||9
258261|NCT00996892|623694|P11|STARTED|Dose-Escalation Stage 1A||7
258262|NCT00996892|623695|P10|STARTED|Dose-Escalation Stage 1A||4
258263|NCT00996892|623696|P9|STARTED|Dose-Escalation Stage 1A||3
258264|NCT00996892|623697|P8|STARTED|Dose-Escalation Stage 1A||3
258265|NCT00996892|623698|P7|STARTED|Dose-Escalation Stage 1A||0
258266|NCT00996892|623699|P6|STARTED|Dose-Escalation Stage 1A||0
258267|NCT00996892|623700|P5|STARTED|Dose-Escalation Stage 1A||0
258268|NCT00996892|623701|P4|STARTED|Dose-Escalation Stage 1A||0
258269|NCT00996892|623702|P3|STARTED|Dose-Escalation Stage 1A||0
258270|NCT00996892|623703|P2|STARTED|Dose-Escalation Stage 1A||0
258271|NCT00996892|623704|P1|STARTED|Dose-Escalation Stage 1A||0
258272|NCT00996892|623685|P20|NOT COMPLETED|Dose-Escalation Stage 1||0
258273|NCT00996892|623686|P19|NOT COMPLETED|Dose-Escalation Stage 1||0
258274|NCT00996892|623687|P18|NOT COMPLETED|Dose-Escalation Stage 1||0
258275|NCT00996892|623688|P17|NOT COMPLETED|Dose-Escalation Stage 1||0
258276|NCT00996892|623689|P16|NOT COMPLETED|Dose-Escalation Stage 1||0
258277|NCT00996892|623690|P15|NOT COMPLETED|Dose-Escalation Stage 1||0
258278|NCT00996892|623691|P14|NOT COMPLETED|Dose-Escalation Stage 1||0
258279|NCT00996892|623692|P13|NOT COMPLETED|Dose-Escalation Stage 1||0
258280|NCT00996892|623693|P12|NOT COMPLETED|Dose-Escalation Stage 1||0
258281|NCT00996892|623694|P11|NOT COMPLETED|Dose-Escalation Stage 1||0
258282|NCT00996892|623695|P10|NOT COMPLETED|Dose-Escalation Stage 1||0
258283|NCT00996892|623696|P9|NOT COMPLETED|Dose-Escalation Stage 1||0
258284|NCT00996892|623697|P8|NOT COMPLETED|Dose-Escalation Stage 1||0
258285|NCT00996892|623698|P7|NOT COMPLETED|Dose-Escalation Stage 1||4
258286|NCT00996892|623699|P6|NOT COMPLETED|Dose-Escalation Stage 1||10
258287|NCT00996892|623700|P5|NOT COMPLETED|Dose-Escalation Stage 1||11
258288|NCT00996892|623701|P4|NOT COMPLETED|Dose-Escalation Stage 1||9
258289|NCT00996892|623702|P3|NOT COMPLETED|Dose-Escalation Stage 1||3
258290|NCT00996892|623703|P2|NOT COMPLETED|Dose-Escalation Stage 1||3
258291|NCT00996892|623704|P1|NOT COMPLETED|Dose-Escalation Stage 1||4
258292|NCT00996892|623685|P20|COMPLETED|Dose-Escalation Stage 1||0
258293|NCT00996892|623686|P19|COMPLETED|Dose-Escalation Stage 1||0
258294|NCT00996892|623687|P18|COMPLETED|Dose-Escalation Stage 1||0
258295|NCT00996892|623688|P17|COMPLETED|Dose-Escalation Stage 1||0
258296|NCT00996892|623689|P16|COMPLETED|Dose-Escalation Stage 1||0
258297|NCT00996892|623690|P15|COMPLETED|Dose-Escalation Stage 1||0
258298|NCT00996892|623691|P14|COMPLETED|Dose-Escalation Stage 1||0
258299|NCT00996892|623692|P13|COMPLETED|Dose-Escalation Stage 1||0
258300|NCT00996892|623693|P12|COMPLETED|Dose-Escalation Stage 1||0
258301|NCT00996892|623694|P11|COMPLETED|Dose-Escalation Stage 1||0
258302|NCT00996892|623695|P10|COMPLETED|Dose-Escalation Stage 1||0
258303|NCT00996892|623696|P9|COMPLETED|Dose-Escalation Stage 1||0
258304|NCT00996892|623697|P8|COMPLETED|Dose-Escalation Stage 1||0
258305|NCT00996892|623698|P7|COMPLETED|Dose-Escalation Stage 1||0
258306|NCT00996892|623699|P6|COMPLETED|Dose-Escalation Stage 1||0
258307|NCT00996892|623700|P5|COMPLETED|Dose-Escalation Stage 1||0
258308|NCT00996892|623701|P4|COMPLETED|Dose-Escalation Stage 1||0
258309|NCT00996892|623702|P3|COMPLETED|Dose-Escalation Stage 1||0
258310|NCT00996892|623703|P2|COMPLETED|Dose-Escalation Stage 1||0
258311|NCT00996892|623704|P1|COMPLETED|Dose-Escalation Stage 1||0
258312|NCT00996892|623685|P20|STARTED|Dose-Escalation Stage 1||0
258313|NCT00996892|623686|P19|STARTED|Dose-Escalation Stage 1||0
258314|NCT00996892|623687|P18|STARTED|Dose-Escalation Stage 1||0
258315|NCT00996892|623688|P17|STARTED|Dose-Escalation Stage 1||0
258316|NCT00996892|623689|P16|STARTED|Dose-Escalation Stage 1||0
258317|NCT00996892|623690|P15|STARTED|Dose-Escalation Stage 1||0
258318|NCT00996892|623691|P14|STARTED|Dose-Escalation Stage 1||0
258319|NCT00996892|623692|P13|STARTED|Dose-Escalation Stage 1||0
258320|NCT00996892|623693|P12|STARTED|Dose-Escalation Stage 1||0
258321|NCT00996892|623694|P11|STARTED|Dose-Escalation Stage 1||0
258322|NCT00996892|623695|P10|STARTED|Dose-Escalation Stage 1||0
258323|NCT00996892|623696|P9|STARTED|Dose-Escalation Stage 1||0
258324|NCT00996892|623697|P8|STARTED|Dose-Escalation Stage 1||0
258325|NCT00996892|623698|P7|STARTED|Dose-Escalation Stage 1||4
258326|NCT00996892|623699|P6|STARTED|Dose-Escalation Stage 1||10
258327|NCT00996892|623700|P5|STARTED|Dose-Escalation Stage 1||11
258328|NCT00996892|623701|P4|STARTED|Dose-Escalation Stage 1||9
258329|NCT00996892|623702|P3|STARTED|Dose-Escalation Stage 1||3
258330|NCT00996892|623703|P2|STARTED|Dose-Escalation Stage 1||3
258331|NCT00996892|623704|P1|STARTED|Dose-Escalation Stage 1||4
258332|NCT00996840|624298|P5|NOT COMPLETED|Overall Study||2
258333|NCT00996840|624299|P4|NOT COMPLETED|Overall Study||1
258334|NCT00996840|624300|P3|NOT COMPLETED|Overall Study||1
258335|NCT00996840|624301|P2|NOT COMPLETED|Overall Study||2
258336|NCT00996840|624302|P1|NOT COMPLETED|Overall Study||1
258337|NCT00996840|624298|P5|COMPLETED|Overall Study||16
258338|NCT00996840|624299|P4|COMPLETED|Overall Study||17
258339|NCT00996840|624300|P3|COMPLETED|Overall Study||11
258340|NCT00996840|624301|P2|COMPLETED|Overall Study||7
258341|NCT00996840|624302|P1|COMPLETED|Overall Study||19
258342|NCT00996840|624298|P5|STARTED|Overall Study||18
258343|NCT00996840|624299|P4|STARTED|Overall Study||18
258344|NCT00996840|624300|P3|STARTED|Overall Study||12
258345|NCT00996840|624301|P2|STARTED|Overall Study||9
258346|NCT00996840|624302|P1|STARTED|Overall Study||20
258347|NCT00996801|624452|P6|NOT COMPLETED|Overall Study||19
258348|NCT00996801|624453|P5|NOT COMPLETED|Overall Study||88
258349|NCT00996801|624454|P4|NOT COMPLETED|Overall Study||31
258350|NCT00996801|624455|P3|NOT COMPLETED|Overall Study||23
258351|NCT00996801|624456|P2|NOT COMPLETED|Overall Study||16
258352|NCT00996801|624457|P1|NOT COMPLETED|Overall Study||20
258353|NCT00996801|624452|P6|COMPLETED|Overall Study||68
258354|NCT00996801|624453|P5|COMPLETED|Overall Study||0
258355|NCT00996801|624454|P4|COMPLETED|Overall Study||56
258356|NCT00996801|624455|P3|COMPLETED|Overall Study||65
258357|NCT00996801|624456|P2|COMPLETED|Overall Study||72
258358|NCT00996801|624457|P1|COMPLETED|Overall Study||68
258359|NCT00996801|624452|P6|STARTED|Overall Study||87
258360|NCT00996801|624453|P5|STARTED|Overall Study|15-mg arm was discontinued as a result of Protocol Amendment 1.|88
258361|NCT00996801|624454|P4|STARTED|Overall Study||87
258362|NCT00996801|624455|P3|STARTED|Overall Study||88
258363|NCT00996801|624456|P2|STARTED|Overall Study||88
258364|NCT00996801|624457|P1|STARTED|Overall Study||88
258365|NCT00996775|624560|P2|NOT COMPLETED|Overall Study||14
258366|NCT00996775|624561|P1|NOT COMPLETED|Overall Study||11
258367|NCT00996775|624560|P2|COMPLETED|Overall Study||75
258368|NCT00996775|624561|P1|COMPLETED|Overall Study||67
258369|NCT00996775|624560|P2|STARTED|Overall Study||89
258370|NCT00996775|624561|P1|STARTED|Overall Study||78
258371|NCT00996736|624569|P2|NOT COMPLETED|Overall Study||18
258372|NCT00996736|624570|P1|NOT COMPLETED|Overall Study||21
258373|NCT00996736|624569|P2|COMPLETED|Overall Study||143
258374|NCT00996736|624570|P1|COMPLETED|Overall Study||141
258375|NCT00996736|624569|P2|3-month Visit|Overall Study||146
258376|NCT00996736|624570|P1|3-month Visit|Overall Study||146
258377|NCT00996736|624569|P2|3-week Visit|Overall Study|144 visited within pre-specified 3-week window (2.5-5 weeks); 7 had a second visit not within window|151
258378|NCT00996736|624570|P1|3-week Visit|Overall Study|149 visited within pre-specified 3-week window (2.5-5 weeks); 6 had a second visit not within window|155
258379|NCT00996736|624569|P2|STARTED|Overall Study||161
258380|NCT00996736|624570|P1|STARTED|Overall Study||162
258381|NCT00996658|624590|P2|NOT COMPLETED|Overall Study||21
258382|NCT00996658|624591|P1|NOT COMPLETED|Overall Study||16
258383|NCT00996658|624590|P2|COMPLETED|Overall Study||165
258384|NCT00996658|624591|P1|COMPLETED|Overall Study||76
258385|NCT00996658|624590|P2|STARTED|Overall Study||186
258386|NCT00996658|624591|P1|STARTED|Overall Study||92
258387|NCT00996632|624619|P2|NOT COMPLETED|Overall Study||0
258388|NCT00996632|624620|P1|NOT COMPLETED|Overall Study||0
258389|NCT00996632|624619|P2|COMPLETED|Overall Study||56
258390|NCT00996632|624620|P1|COMPLETED|Overall Study||38
258391|NCT00996632|624619|P2|STARTED|Overall Study||56
258392|NCT00996632|624620|P1|STARTED|Overall Study||38
258393|NCT00996606|624628|P1|NOT COMPLETED|Overall Study||8
258394|NCT00996606|624628|P1|COMPLETED|Overall Study||50
258395|NCT00996606|624628|P1|STARTED|Overall Study||58
258396|NCT00996593|624722|P1|NOT COMPLETED|Long-Term Follow-Up||3
258397|NCT00996593|624722|P1|COMPLETED|Long-Term Follow-Up||6
258398|NCT00996593|624722|P1|STARTED|Long-Term Follow-Up|9 of the 40 participants withdrawing from Study BEX104507 enrolled in long-term follow-up study.|9
258399|NCT00996593|624722|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||43
258400|NCT00996593|624722|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
258401|NCT00996593|624722|P1|STARTED|Dosimetric and Therapeutic Treatment||43
258402|NCT00996580|624750|P1|NOT COMPLETED|Overall Study||1453
258403|NCT00996580|624750|P1|COMPLETED|Overall Study||2144
258404|NCT00996580|624750|P1|Pregnancy Intent-to-Treat Population|Overall Study||3019
258405|NCT00996580|624750|P1|STARTED|Overall Study||3597
258406|NCT00996502|624778|P1|NOT COMPLETED|Overall Study||0
258407|NCT00996502|624778|P1|COMPLETED|Overall Study||4
258408|NCT00996502|624778|P1|STARTED|Overall Study||4
258409|NCT00996489|624785|P1|NOT COMPLETED|Overall Study||161
258410|NCT00996489|624785|P1|COMPLETED|Overall Study||298
258411|NCT00996489|624785|P1|STARTED|Overall Study||459
258412|NCT00996476|624805|P5|NOT COMPLETED|Overall Study||2
258413|NCT00996476|624806|P4|NOT COMPLETED|Overall Study||0
258414|NCT00996476|624807|P3|NOT COMPLETED|Overall Study||1
258415|NCT00996476|624808|P2|NOT COMPLETED|Overall Study||3
258416|NCT00996476|624809|P1|NOT COMPLETED|Overall Study||1
258417|NCT00996476|624805|P5|COMPLETED|Overall Study||11
258418|NCT00996476|624806|P4|COMPLETED|Overall Study||13
258419|NCT00996476|624807|P3|COMPLETED|Overall Study||12
258420|NCT00996476|624808|P2|COMPLETED|Overall Study||23
258421|NCT00996476|624809|P1|COMPLETED|Overall Study||26
258422|NCT00996476|624805|P5|STARTED|Overall Study||13
258423|NCT00996476|624806|P4|STARTED|Overall Study||13
258424|NCT00996476|624807|P3|STARTED|Overall Study||13
258425|NCT00996476|624808|P2|STARTED|Overall Study||26
258426|NCT00996476|624809|P1|STARTED|Overall Study||27
258427|NCT00996437|624877|P2|NOT COMPLETED|Overall Study||7
258428|NCT00996437|624878|P1|NOT COMPLETED|Overall Study||5
258429|NCT00996437|624877|P2|COMPLETED|Overall Study||129
258430|NCT00996437|624878|P1|COMPLETED|Overall Study||120
258431|NCT00996437|624877|P2|STARTED|Overall Study||136
258432|NCT00996437|624878|P1|STARTED|Overall Study||125
258433|NCT00996372|624900|P2|NOT COMPLETED|Overall Study||84
258434|NCT00996372|624901|P1|NOT COMPLETED|Overall Study||103
258435|NCT00996372|624900|P2|COMPLETED|Overall Study||397
258436|NCT00996372|624901|P1|COMPLETED|Overall Study||365
258437|NCT00996372|624900|P2|STARTED|Overall Study||481
258438|NCT00996372|624901|P1|STARTED|Overall Study||468
258439|NCT00996346|624914|P3|NOT COMPLETED|Overall Study||0
258440|NCT00996346|624915|P2|NOT COMPLETED|Overall Study||0
258441|NCT00996346|624916|P1|NOT COMPLETED|Overall Study||0
258442|NCT00996346|624914|P3|COMPLETED|Overall Study||3
258443|NCT00996346|624915|P2|COMPLETED|Overall Study||8
258444|NCT00996346|624916|P1|COMPLETED|Overall Study||6
258445|NCT00996346|624914|P3|STARTED|Overall Study||3
258446|NCT00996346|624915|P2|STARTED|Overall Study||8
258447|NCT00996346|624916|P1|STARTED|Overall Study||6
258448|NCT00996333|624923|P1|NOT COMPLETED|Overall Study||13
258449|NCT00996333|624923|P1|COMPLETED|Overall Study||33
258450|NCT00996333|624923|P1|STARTED|Overall Study||46
258451|NCT00996307|624933|P4|NOT COMPLETED|Overall Study||21
258452|NCT00996307|624934|P3|NOT COMPLETED|Overall Study||14
258453|NCT00996307|624935|P2|NOT COMPLETED|Overall Study||17
258454|NCT00996307|624936|P1|NOT COMPLETED|Overall Study||20
258455|NCT00996307|624933|P4|COMPLETED|Overall Study||144
258456|NCT00996307|624934|P3|COMPLETED|Overall Study||146
258457|NCT00996307|624935|P2|COMPLETED|Overall Study||148
258458|NCT00996307|624936|P1|COMPLETED|Overall Study||144
258459|NCT00996307|624933|P4|STARTED|Overall Study||165
258460|NCT00996307|624934|P3|STARTED|Overall Study||160
258461|NCT00996307|624935|P2|STARTED|Overall Study||165
258462|NCT00996307|624936|P1|STARTED|Overall Study||164
258463|NCT00996281|624996|P2|NOT COMPLETED|Overall Study||89
258464|NCT00996281|624997|P1|NOT COMPLETED|Overall Study||131
258465|NCT00996281|624996|P2|COMPLETED|Overall Study||330
258466|NCT00996281|624997|P1|COMPLETED|Overall Study||287
258467|NCT00996281|624996|P2|STARTED|Overall Study||419
258468|NCT00996281|624997|P1|STARTED|Overall Study||418
258469|NCT00996216|625005|P1|NOT COMPLETED|Part 2 (Antiviral Treatment Phase)||4
258470|NCT00996216|625005|P1|COMPLETED|Part 2 (Antiviral Treatment Phase)||21
258471|NCT00996216|625005|P1|STARTED|Part 2 (Antiviral Treatment Phase)|One participant who completed Part 1 didn’t qualify to begin antiviral treatment in Part 2.|25
258472|NCT00996216|625005|P1|NOT COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||1
258473|NCT00996216|625005|P1|COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||26
258474|NCT00996216|625005|P1|STARTED|Part 1 (Pre-Antiviral Treatment Phase)||27
258475|NCT00996203|625021|P1|NOT COMPLETED|Overall Study||7
258476|NCT00996203|625021|P1|COMPLETED|Overall Study||194
258477|NCT00996203|625021|P1|STARTED|Overall Study||201
258478|NCT00996164|625042|P2|NOT COMPLETED|Overall Study||101
258479|NCT00996164|625043|P1|NOT COMPLETED|Overall Study||135
258480|NCT00996164|625042|P2|COMPLETED|Overall Study||446
258481|NCT00996164|625043|P1|COMPLETED|Overall Study||408
258482|NCT00996164|625042|P2|STARTED|Overall Study||547
258483|NCT00996164|625043|P1|STARTED|Overall Study||543
258484|NCT00996125|625053|P2|NOT COMPLETED|Overall Study||11
258485|NCT00996125|625054|P1|NOT COMPLETED|Overall Study||5
258486|NCT00996125|625053|P2|COMPLETED|Overall Study||365
258487|NCT00996125|625054|P1|COMPLETED|Overall Study||369
258488|NCT00996125|625053|P2|STARTED|Overall Study||376
258489|NCT00996125|625054|P1|STARTED|Overall Study||374
258490|NCT00996034|625074|P1|NOT COMPLETED|Overall Study||3
258491|NCT00996034|625074|P1|COMPLETED|Overall Study||11
258492|NCT00996034|625074|P1|STARTED|Overall Study||14
258493|NCT00995930|625080|P2|NOT COMPLETED|Overall Study||28
258494|NCT00995930|625081|P1|NOT COMPLETED|Overall Study||21
258495|NCT00995930|625080|P2|COMPLETED|Overall Study||67
258496|NCT00995930|625081|P1|COMPLETED|Overall Study||73
258497|NCT00995930|625080|P2|Imaging Analysis Set|Overall Study||92
258498|NCT00995930|625081|P1|Imaging Analysis Set|Overall Study||92
258499|NCT00995930|625080|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||92
258500|NCT00995930|625081|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||92
258501|NCT00995930|625080|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||95
258502|NCT00995930|625081|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||0
258503|NCT00995930|625080|P2|Safety Analysis Set|Overall Study||95
258504|NCT00995930|625081|P1|Safety Analysis Set|Overall Study||94
258505|NCT00995930|625080|P2|STARTED|Overall Study||95
258506|NCT00995930|625081|P1|STARTED|Overall Study||94
258507|NCT00995904|625110|P6|NOT COMPLETED|Follow-up Visit (Final Visit)||0
258508|NCT00995904|625111|P5|NOT COMPLETED|Follow-up Visit (Final Visit)||0
258509|NCT00995904|625112|P4|NOT COMPLETED|Follow-up Visit (Final Visit)||0
258510|NCT00995904|625113|P3|NOT COMPLETED|Follow-up Visit (Final Visit)||0
258511|NCT00995904|625114|P2|NOT COMPLETED|Follow-up Visit (Final Visit)||0
258512|NCT00995904|625115|P1|NOT COMPLETED|Follow-up Visit (Final Visit)||0
258513|NCT00995904|625110|P6|COMPLETED|Follow-up Visit (Final Visit)||3
258514|NCT00995904|625111|P5|COMPLETED|Follow-up Visit (Final Visit)||5
258515|NCT00995904|625112|P4|COMPLETED|Follow-up Visit (Final Visit)||5
258516|NCT00995904|625113|P3|COMPLETED|Follow-up Visit (Final Visit)||4
258517|NCT00995904|625114|P2|COMPLETED|Follow-up Visit (Final Visit)||3
258518|NCT00995904|625115|P1|COMPLETED|Follow-up Visit (Final Visit)||4
258519|NCT00995904|625110|P6|STARTED|Follow-up Visit (Final Visit)||3
258520|NCT00995904|625111|P5|STARTED|Follow-up Visit (Final Visit)||5
258521|NCT00995904|625112|P4|STARTED|Follow-up Visit (Final Visit)||5
258522|NCT00995904|625113|P3|STARTED|Follow-up Visit (Final Visit)||4
258523|NCT00995904|625114|P2|STARTED|Follow-up Visit (Final Visit)||3
258524|NCT00995904|625115|P1|STARTED|Follow-up Visit (Final Visit)||4
258525|NCT00995904|625110|P6|NOT COMPLETED|Visit 4||0
258526|NCT00995904|625111|P5|NOT COMPLETED|Visit 4||0
258527|NCT00995904|625112|P4|NOT COMPLETED|Visit 4||0
258528|NCT00995904|625113|P3|NOT COMPLETED|Visit 4||0
258529|NCT00995904|625114|P2|NOT COMPLETED|Visit 4||0
258530|NCT00995904|625115|P1|NOT COMPLETED|Visit 4||0
258531|NCT00995904|625110|P6|COMPLETED|Visit 4||3
258532|NCT00995904|625111|P5|COMPLETED|Visit 4||5
258533|NCT00995904|625112|P4|COMPLETED|Visit 4||5
258534|NCT00995904|625113|P3|COMPLETED|Visit 4||4
258535|NCT00995904|625114|P2|COMPLETED|Visit 4||3
258536|NCT00995904|625115|P1|COMPLETED|Visit 4||4
258537|NCT00995904|625110|P6|STARTED|Visit 4||3
258538|NCT00995904|625111|P5|STARTED|Visit 4||5
258539|NCT00995904|625112|P4|STARTED|Visit 4||5
258540|NCT00995904|625113|P3|STARTED|Visit 4||4
258541|NCT00995904|625114|P2|STARTED|Visit 4||3
258542|NCT00995904|625115|P1|STARTED|Visit 4||4
258543|NCT00995904|625110|P6|NOT COMPLETED|Visit 3||0
258544|NCT00995904|625111|P5|NOT COMPLETED|Visit 3||0
258545|NCT00995904|625112|P4|NOT COMPLETED|Visit 3||0
258546|NCT00995904|625113|P3|NOT COMPLETED|Visit 3||0
258547|NCT00995904|625114|P2|NOT COMPLETED|Visit 3||0
258548|NCT00995904|625115|P1|NOT COMPLETED|Visit 3||0
258549|NCT00995904|625110|P6|COMPLETED|Visit 3||3
258550|NCT00995904|625111|P5|COMPLETED|Visit 3||5
258551|NCT00995904|625112|P4|COMPLETED|Visit 3||5
258552|NCT00995904|625113|P3|COMPLETED|Visit 3||4
258553|NCT00995904|625114|P2|COMPLETED|Visit 3||3
258554|NCT00995904|625115|P1|COMPLETED|Visit 3||4
258555|NCT00995904|625110|P6|STARTED|Visit 3|One subject was withdrawn from the study after completion of Visit 2 but prior to Visit 3.|3
258556|NCT00995904|625111|P5|STARTED|Visit 3||5
258557|NCT00995904|625112|P4|STARTED|Visit 3||5
258558|NCT00995904|625113|P3|STARTED|Visit 3||4
258559|NCT00995904|625114|P2|STARTED|Visit 3||3
258560|NCT00995904|625115|P1|STARTED|Visit 3||4
258561|NCT00995904|625110|P6|NOT COMPLETED|Visit 2 (Randomization)||0
258562|NCT00995904|625111|P5|NOT COMPLETED|Visit 2 (Randomization)||0
258563|NCT00995904|625112|P4|NOT COMPLETED|Visit 2 (Randomization)||0
258564|NCT00995904|625113|P3|NOT COMPLETED|Visit 2 (Randomization)||0
258565|NCT00995904|625114|P2|NOT COMPLETED|Visit 2 (Randomization)||0
258566|NCT00995904|625115|P1|NOT COMPLETED|Visit 2 (Randomization)||0
258567|NCT00995904|625110|P6|COMPLETED|Visit 2 (Randomization)||4
258568|NCT00995904|625111|P5|COMPLETED|Visit 2 (Randomization)||5
258569|NCT00995904|625112|P4|COMPLETED|Visit 2 (Randomization)||5
258570|NCT00995904|625113|P3|COMPLETED|Visit 2 (Randomization)||4
258571|NCT00995904|625114|P2|COMPLETED|Visit 2 (Randomization)||3
258572|NCT00995904|625115|P1|COMPLETED|Visit 2 (Randomization)||4
258573|NCT00995904|625110|P6|STARTED|Visit 2 (Randomization)||4
258574|NCT00995904|625111|P5|STARTED|Visit 2 (Randomization)||5
258575|NCT00995904|625112|P4|STARTED|Visit 2 (Randomization)||5
258576|NCT00995904|625113|P3|STARTED|Visit 2 (Randomization)||4
258577|NCT00995904|625114|P2|STARTED|Visit 2 (Randomization)||3
258578|NCT00995904|625115|P1|STARTED|Visit 2 (Randomization)||4
258579|NCT00995865|625132|P3|NOT COMPLETED|Overall Study||1
258580|NCT00995865|625133|P2|NOT COMPLETED|Overall Study||0
258581|NCT00995865|625134|P1|NOT COMPLETED|Overall Study||2
258582|NCT00995865|625132|P3|COMPLETED|Overall Study||11
258583|NCT00995865|625133|P2|COMPLETED|Overall Study||24
258584|NCT00995865|625134|P1|COMPLETED|Overall Study||22
258585|NCT00995865|625132|P3|STARTED|Overall Study||12
258586|NCT00995865|625133|P2|STARTED|Overall Study||24
258587|NCT00995865|625134|P1|STARTED|Overall Study||24
258588|NCT00995774|625156|P2|NOT COMPLETED|Training Period 2||0
258589|NCT00995774|625157|P1|NOT COMPLETED|Training Period 2||2
258590|NCT00995774|625156|P2|COMPLETED|Training Period 2||5
258591|NCT00995774|625157|P1|COMPLETED|Training Period 2||5
258592|NCT00995774|625156|P2|STARTED|Training Period 2||5
258593|NCT00995774|625157|P1|STARTED|Training Period 2||7
258594|NCT00995774|625156|P2|NOT COMPLETED|Washout Period||0
258595|NCT00995774|625157|P1|NOT COMPLETED|Washout Period||0
258596|NCT00995774|625156|P2|COMPLETED|Washout Period||5
258597|NCT00995774|625157|P1|COMPLETED|Washout Period||7
258598|NCT00995774|625156|P2|STARTED|Washout Period||5
258599|NCT00995774|625157|P1|STARTED|Washout Period||7
258600|NCT00995774|625156|P2|NOT COMPLETED|Training Period 1||0
258601|NCT00995774|625157|P1|NOT COMPLETED|Training Period 1||0
258602|NCT00995774|625156|P2|COMPLETED|Training Period 1||5
258603|NCT00995774|625157|P1|COMPLETED|Training Period 1||7
258604|NCT00995774|625156|P2|STARTED|Training Period 1||5
258605|NCT00995774|625157|P1|STARTED|Training Period 1||7
258606|NCT00995761|625167|P1|NOT COMPLETED|Overall Study||0
258607|NCT00995761|625167|P1|COMPLETED|Overall Study||48
258608|NCT00995761|625167|P1|STARTED|Overall Study||48
258609|NCT00995722|625173|P2|NOT COMPLETED|Overall Study: 36 Weeks||2
258610|NCT00995722|625174|P1|NOT COMPLETED|Overall Study: 36 Weeks||2
258611|NCT00995722|625173|P2|COMPLETED|Overall Study: 36 Weeks||2
258612|NCT00995722|625174|P1|COMPLETED|Overall Study: 36 Weeks||3
258613|NCT00995722|625173|P2|STARTED|Overall Study: 36 Weeks||4
258614|NCT00995722|625174|P1|STARTED|Overall Study: 36 Weeks||5
258615|NCT00995722|625173|P2|NOT COMPLETED|Double Blinded: 16 Weeks||1
258616|NCT00995722|625174|P1|NOT COMPLETED|Double Blinded: 16 Weeks||1
258617|NCT00995722|625173|P2|COMPLETED|Double Blinded: 16 Weeks||4
258618|NCT00995722|625174|P1|COMPLETED|Double Blinded: 16 Weeks||5
258619|NCT00995722|625173|P2|STARTED|Double Blinded: 16 Weeks||5
258620|NCT00995722|625174|P1|STARTED|Double Blinded: 16 Weeks||6
258621|NCT00995709|625191|P3|NOT COMPLETED|Overall Study||5
258622|NCT00995709|625192|P2|NOT COMPLETED|Overall Study||9
258623|NCT00995709|625193|P1|NOT COMPLETED|Overall Study||7
258624|NCT00995709|625191|P3|COMPLETED|Overall Study||34
258625|NCT00995709|625192|P2|COMPLETED|Overall Study|patient in the 300 mg monthly group was randomized,was not eligible,never received study medication|31
258626|NCT00995709|625193|P1|COMPLETED|Overall Study||32
258627|NCT00995709|625191|P3|STARTED|Overall Study||39
258628|NCT00995709|625192|P2|STARTED|Overall Study||40
258629|NCT00995709|625193|P1|STARTED|Overall Study||39
258630|NCT00995670|625219|P3|NOT COMPLETED|Overall Study||3
258631|NCT00995670|625220|P2|NOT COMPLETED|Overall Study||0
258632|NCT00995670|625221|P1|NOT COMPLETED|Overall Study||1
258633|NCT00995670|625219|P3|COMPLETED|Overall Study|These 17 volunteers underwent 33 studies on the effect of statins, glucose, and glucose & statins.|14
258634|NCT00995670|625220|P2|COMPLETED|Overall Study|These 16 subjects underwent a total of 25 studies on the effect of Vitamin C.|16
258635|NCT00995670|625221|P1|COMPLETED|Overall Study|These 26 subjects underwent a total of 58 studies to determine the effect of dose of glucose on I/R.|25
258636|NCT00995670|625219|P3|STARTED|Overall Study||17
258637|NCT00995670|625220|P2|STARTED|Overall Study||16
258638|NCT00995670|625221|P1|STARTED|Overall Study||26
258639|NCT00995566|625229|P1|NOT COMPLETED|Overall Study||54
258640|NCT00995566|625229|P1|COMPLETED|Overall Study||0
258641|NCT00995566|625229|P1|STARTED|Overall Study||54
258642|NCT00995553|625243|P2|NOT COMPLETED|Overall Study||6
258643|NCT00995553|625244|P1|NOT COMPLETED|Overall Study||2
258644|NCT00995553|625243|P2|COMPLETED|Overall Study||35
258645|NCT00995553|625244|P1|COMPLETED|Overall Study||38
258646|NCT00995553|625243|P2|STARTED|Overall Study||41
258647|NCT00995553|625244|P1|STARTED|Overall Study||40
258648|NCT00995501|625260|P8|NOT COMPLETED|Overall Study||0
258649|NCT00995501|625261|P7|NOT COMPLETED|Overall Study||0
258650|NCT00995501|625262|P6|NOT COMPLETED|Overall Study||0
258651|NCT00995501|625263|P5|NOT COMPLETED|Overall Study||0
258652|NCT00995501|625264|P4|NOT COMPLETED|Overall Study||0
258653|NCT00995501|625265|P3|NOT COMPLETED|Overall Study||0
258654|NCT00995501|625266|P2|NOT COMPLETED|Overall Study||0
258655|NCT00995501|625267|P1|NOT COMPLETED|Overall Study||0
258656|NCT00995501|625260|P8|COMPLETED|Overall Study||46
258657|NCT00995501|625261|P7|COMPLETED|Overall Study||49
258658|NCT00995501|625262|P6|COMPLETED|Overall Study||44
258659|NCT00995501|625263|P5|COMPLETED|Overall Study||46
258660|NCT00995501|625264|P4|COMPLETED|Overall Study||46
258661|NCT00995501|625265|P3|COMPLETED|Overall Study||47
258662|NCT00995501|625266|P2|COMPLETED|Overall Study||51
258663|NCT00995501|625267|P1|COMPLETED|Overall Study||52
258664|NCT00995501|625260|P8|STARTED|Overall Study||46
258665|NCT00995501|625261|P7|STARTED|Overall Study||49
258666|NCT00995501|625262|P6|STARTED|Overall Study||44
258667|NCT00995501|625263|P5|STARTED|Overall Study||46
258668|NCT00995501|625264|P4|STARTED|Overall Study||46
258669|NCT00995501|625265|P3|STARTED|Overall Study||47
258670|NCT00995501|625266|P2|STARTED|Overall Study||51
258671|NCT00995501|625267|P1|STARTED|Overall Study||52
258672|NCT00995488|625293|P1|NOT COMPLETED|Overall Study||1
258673|NCT00995488|625293|P1|COMPLETED|Overall Study||15
258674|NCT00995488|625293|P1|STARTED|Overall Study||16
258675|NCT00995475|625298|P2|NOT COMPLETED|Second Intervention||0
258676|NCT00995475|625299|P1|NOT COMPLETED|Second Intervention||0
258677|NCT00995475|625298|P2|COMPLETED|Second Intervention||9
258678|NCT00995475|625299|P1|COMPLETED|Second Intervention||9
258679|NCT00995475|625298|P2|STARTED|Second Intervention||9
258680|NCT00995475|625299|P1|STARTED|Second Intervention||9
258681|NCT00995475|625298|P2|NOT COMPLETED|Wash-out Two Week||0
258682|NCT00995475|625299|P1|NOT COMPLETED|Wash-out Two Week||0
258683|NCT00995475|625298|P2|COMPLETED|Wash-out Two Week||9
258684|NCT00995475|625299|P1|COMPLETED|Wash-out Two Week||9
258685|NCT00995475|625298|P2|STARTED|Wash-out Two Week||9
258686|NCT00995475|625299|P1|STARTED|Wash-out Two Week||9
258687|NCT00995475|625298|P2|NOT COMPLETED|First Intervention||0
258688|NCT00995475|625299|P1|NOT COMPLETED|First Intervention||0
258689|NCT00995475|625298|P2|COMPLETED|First Intervention||9
258690|NCT00995475|625299|P1|COMPLETED|First Intervention||9
258691|NCT00995475|625298|P2|STARTED|First Intervention||9
258692|NCT00995475|625299|P1|STARTED|First Intervention||9
258693|NCT00995449|625313|P4|NOT COMPLETED|Overall Study||0
258694|NCT00995449|625314|P3|NOT COMPLETED|Overall Study||2
258695|NCT00995449|625315|P2|NOT COMPLETED|Overall Study||0
258696|NCT00995449|625316|P1|NOT COMPLETED|Overall Study||0
258697|NCT00995449|625313|P4|COMPLETED|Overall Study||2
258698|NCT00995449|625314|P3|COMPLETED|Overall Study||5
258699|NCT00995449|625315|P2|COMPLETED|Overall Study||0
258700|NCT00995449|625316|P1|COMPLETED|Overall Study||0
258701|NCT00995449|625313|P4|STARTED|Overall Study||2
258702|NCT00995449|625314|P3|STARTED|Overall Study||7
258703|NCT00995449|625315|P2|STARTED|Overall Study||0
258704|NCT00995449|625316|P1|STARTED|Overall Study||0
258705|NCT00995436|625327|P3|NOT COMPLETED|Overall Study||0
258706|NCT00995436|625328|P2|NOT COMPLETED|Overall Study||5
258707|NCT00995436|625329|P1|NOT COMPLETED|Overall Study||2
258708|NCT00995436|625327|P3|COMPLETED|Overall Study||26
258709|NCT00995436|625328|P2|COMPLETED|Overall Study||22
258710|NCT00995436|625329|P1|COMPLETED|Overall Study||23
258711|NCT00995436|625327|P3|STARTED|Overall Study||26
258712|NCT00995436|625328|P2|STARTED|Overall Study||27
258713|NCT00995436|625329|P1|STARTED|Overall Study|25|25
258714|NCT00995410|625337|P1|NOT COMPLETED|Overall Study||88
258715|NCT00995410|625337|P1|COMPLETED|Overall Study||292
258716|NCT00995410|625337|P1|Treated|Overall Study||379
258717|NCT00995410|625337|P1|STARTED|Overall Study||380
258718|NCT00995371|625344|P2|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
258719|NCT00995371|625345|P1|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
258720|NCT00995371|625344|P2|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 17 completed Wk 6 Intent to Treat analysis prior to x-over. After x-over 12 reported Wk 26|12
258721|NCT00995371|625345|P1|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 21 completed Wk 6 Intent to Treat analysis. Sixteen reported Week 26 outcomes.|16
258722|NCT00995371|625344|P2|STARTED|After ESI Cross-over to Mild, 26 Weeks||17
258723|NCT00995371|625345|P1|STARTED|After ESI Cross-over to Mild, 26 Weeks||21
258724|NCT00995371|625344|P2|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
258725|NCT00995371|625345|P1|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
258726|NCT00995371|625344|P2|COMPLETED|Prior to ESI Cross-over, 6 Weeks||17
258727|NCT00995371|625345|P1|COMPLETED|Prior to ESI Cross-over, 6 Weeks||21
258728|NCT00995371|625344|P2|STARTED|Prior to ESI Cross-over, 6 Weeks||17
258729|NCT00995371|625345|P1|STARTED|Prior to ESI Cross-over, 6 Weeks||21
258730|NCT00995345|625363|P5|NOT COMPLETED|Overall Study||5
258731|NCT00995345|625364|P4|NOT COMPLETED|Overall Study||5
258732|NCT00995345|625365|P3|NOT COMPLETED|Overall Study||7
258733|NCT00995345|625366|P2|NOT COMPLETED|Overall Study||7
258734|NCT00995345|625367|P1|NOT COMPLETED|Overall Study||11
258735|NCT00995345|625363|P5|COMPLETED|Overall Study||75
258736|NCT00995345|625364|P4|COMPLETED|Overall Study||76
258737|NCT00995345|625365|P3|COMPLETED|Overall Study||73
258738|NCT00995345|625366|P2|COMPLETED|Overall Study||74
258739|NCT00995345|625367|P1|COMPLETED|Overall Study||70
258740|NCT00995345|625363|P5|STARTED|Overall Study||80
258741|NCT00995345|625364|P4|STARTED|Overall Study||81
258742|NCT00995345|625365|P3|STARTED|Overall Study||80
258743|NCT00995345|625366|P2|STARTED|Overall Study||81
258744|NCT00995345|625367|P1|STARTED|Overall Study||81
258745|NCT00995085|625394|P1|NOT COMPLETED|Overall Study||5
258746|NCT00995085|625394|P1|COMPLETED|Overall Study||38
258747|NCT00995085|625394|P1|STARTED|Overall Study||43
258748|NCT00995072|625400|P2|NOT COMPLETED|Overall Study||3
258749|NCT00995072|625401|P1|NOT COMPLETED|Overall Study||1
258750|NCT00995072|625400|P2|COMPLETED|Overall Study||12
258751|NCT00995072|625401|P1|COMPLETED|Overall Study||9
258752|NCT00995072|625400|P2|STARTED|Overall Study||15
258753|NCT00995072|625401|P1|STARTED|Overall Study||10
258754|NCT00995020|625411|P2|NOT COMPLETED|Overall Study||7
258755|NCT00995020|625412|P1|NOT COMPLETED|Overall Study||3
258756|NCT00995020|625411|P2|COMPLETED|Overall Study|"Reasons for not completed:~margin analysis not performed specimen fragmentation thermal damage"|45
258757|NCT00995020|625412|P1|COMPLETED|Overall Study|"Reasons for not completed:~margin analysis not performed specimen fragmentation thermal damage"|48
258758|NCT00995020|625411|P2|STARTED|Overall Study||52
258759|NCT00995020|625412|P1|STARTED|Overall Study||51
258760|NCT00995007|625422|P2|NOT COMPLETED|Overall Study||2
258761|NCT00995007|625423|P1|NOT COMPLETED|Overall Study||17
258762|NCT00995007|625422|P2|COMPLETED|Overall Study||54
258763|NCT00995007|625423|P1|COMPLETED|Overall Study||39
258764|NCT00995007|625422|P2|Crossover to Vandetanib|Overall Study||0
258765|NCT00995007|625423|P1|Crossover to Vandetanib|Overall Study||42
258766|NCT00995007|625422|P2|STARTED|Overall Study||56
258767|NCT00995007|625423|P1|STARTED|Overall Study||56
258768|NCT00994929|625439|P1|NOT COMPLETED|Overall Study||0
258769|NCT00994929|625439|P1|COMPLETED|Overall Study||9
258770|NCT00994929|625439|P1|STARTED|Overall Study||9
258771|NCT00994760|625445|P1|NOT COMPLETED|Overall Study||24
258772|NCT00994760|625445|P1|COMPLETED|Overall Study||107
258773|NCT00994760|625445|P1|STARTED|Overall Study||131
258774|NCT00994682|625486|P2|NOT COMPLETED|Pioglitazone Open Label||7
258775|NCT00994682|625487|P1|NOT COMPLETED|Pioglitazone Open Label||13
258776|NCT00994682|625486|P2|COMPLETED|Pioglitazone Open Label||34
258777|NCT00994682|625487|P1|COMPLETED|Pioglitazone Open Label||29
258778|NCT00994682|625486|P2|STARTED|Pioglitazone Open Label||41
258779|NCT00994682|625487|P1|STARTED|Pioglitazone Open Label||42
258780|NCT00994682|625486|P2|NOT COMPLETED|Double Bilnd||9
258781|NCT00994682|625487|P1|NOT COMPLETED|Double Bilnd||9
258782|NCT00994682|625486|P2|COMPLETED|Double Bilnd||41
258783|NCT00994682|625487|P1|COMPLETED|Double Bilnd||42
258784|NCT00994682|625486|P2|STARTED|Double Bilnd||50
258785|NCT00994682|625487|P1|STARTED|Double Bilnd||51
258786|NCT00994643|625531|P1|NOT COMPLETED|Overall Study||1
258787|NCT00994643|625531|P1|COMPLETED|Overall Study||10
258788|NCT00994643|625531|P1|STARTED|Overall Study||11
258789|NCT00994604|625535|P1|NOT COMPLETED|Overall Study||6
258790|NCT00994604|625535|P1|COMPLETED|Overall Study||45
258791|NCT00994604|625535|P1|STARTED|Overall Study||51
258792|NCT00994461|625545|P3|NOT COMPLETED|Overall Study||0
258793|NCT00994461|625546|P2|NOT COMPLETED|Overall Study||1
258794|NCT00994461|625547|P1|NOT COMPLETED|Overall Study||2
258795|NCT00994461|625545|P3|COMPLETED|Overall Study||37
258796|NCT00994461|625546|P2|COMPLETED|Overall Study||75
258797|NCT00994461|625547|P1|COMPLETED|Overall Study||74
258798|NCT00994461|625545|P3|STARTED|Overall Study|One subject was randomized but did not receive study drug.|37
258799|NCT00994461|625546|P2|STARTED|Overall Study||76
258800|NCT00994461|625547|P1|STARTED|Overall Study||76
258801|NCT00994448|625575|P2|NOT COMPLETED|Overall Study||2
258802|NCT00994448|625576|P1|NOT COMPLETED|Overall Study||8
258803|NCT00994448|625575|P2|COMPLETED|Overall Study||5
258804|NCT00994448|625576|P1|COMPLETED|Overall Study||4
258805|NCT00994448|625575|P2|STARTED|Overall Study||7
258806|NCT00994448|625576|P1|STARTED|Overall Study||12
258807|NCT00994422|625584|P2|NOT COMPLETED|Overall Study||1
258808|NCT00994422|625585|P1|NOT COMPLETED|Overall Study||7
258809|NCT00994422|625584|P2|COMPLETED|Overall Study||54
258810|NCT00994422|625585|P1|COMPLETED|Overall Study||185
258811|NCT00994422|625584|P2|STARTED|Overall Study||55
258812|NCT00994422|625585|P1|STARTED|Overall Study||192
258813|NCT00994318|625598|P3|NOT COMPLETED|Overall Study||67
258814|NCT00994318|625599|P2|NOT COMPLETED|Overall Study||18
258815|NCT00994318|625600|P1|NOT COMPLETED|Overall Study||22
258816|NCT00994318|625598|P3|COMPLETED|Overall Study||250
258817|NCT00994318|625599|P2|COMPLETED|Overall Study||136
258818|NCT00994318|625600|P1|COMPLETED|Overall Study||133
258819|NCT00994318|625598|P3|STARTED|Overall Study||317
258820|NCT00994318|625599|P2|STARTED|Overall Study||154
258821|NCT00994318|625600|P1|STARTED|Overall Study||155
258822|NCT00994279|625610|P2|NOT COMPLETED|Overall Study||5
258823|NCT00994279|625611|P1|NOT COMPLETED|Overall Study||4
258824|NCT00994279|625610|P2|COMPLETED|Overall Study||13
258825|NCT00994279|625611|P1|COMPLETED|Overall Study||18
258826|NCT00994279|625610|P2|STARTED|Overall Study||18
258827|NCT00994279|625611|P1|STARTED|Overall Study||22
258828|NCT00994240|625621|P2|NOT COMPLETED|Overall Study||5
258829|NCT00994240|625622|P1|NOT COMPLETED|Overall Study||6
258830|NCT00994240|625621|P2|COMPLETED|Overall Study||39
258831|NCT00994240|625622|P1|COMPLETED|Overall Study||35
258832|NCT00994240|625621|P2|STARTED|Overall Study||44
258833|NCT00994240|625622|P1|STARTED|Overall Study||41
258834|NCT00994214|625632|P4|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
258835|NCT00994214|625633|P3|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||2
258836|NCT00994214|625634|P2|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
258837|NCT00994214|625635|P1|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||4
258838|NCT00994214|625632|P4|COMPLETED|ITT (Intention-to-Treat) - Part B||0
258839|NCT00994214|625633|P3|COMPLETED|ITT (Intention-to-Treat) - Part B||0
258840|NCT00994214|625634|P2|COMPLETED|ITT (Intention-to-Treat) - Part B||0
258841|NCT00994214|625635|P1|COMPLETED|ITT (Intention-to-Treat) - Part B||0
258842|NCT00994214|625632|P4|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||3
258843|NCT00994214|625633|P3|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||2
258844|NCT00994214|625634|P2|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
258845|NCT00994214|625635|P1|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
258846|NCT00994214|625632|P4|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
258847|NCT00994214|625633|P3|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
258848|NCT00994214|625634|P2|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||3
258849|NCT00994214|625635|P1|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||1
258850|NCT00994214|625632|P4|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
258851|NCT00994214|625633|P3|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
258852|NCT00994214|625634|P2|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
258853|NCT00994214|625635|P1|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||3
258854|NCT00994214|625632|P4|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
258855|NCT00994214|625633|P3|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
258856|NCT00994214|625634|P2|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
258857|NCT00994214|625635|P1|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
258858|NCT00994214|625632|P4|STARTED|ITT (Intention-to-Treat) - Part B|2 subjects did not enter Part B Arm D|3
258859|NCT00994214|625633|P3|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm C|2
258860|NCT00994214|625634|P2|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm B|3
258861|NCT00994214|625635|P1|STARTED|ITT (Intention-to-Treat) - Part B|1 subject did not enter Part B Arm A|4
258862|NCT00994214|625632|P4|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||15
258863|NCT00994214|625633|P3|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
258864|NCT00994214|625634|P2|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
258865|NCT00994214|625635|P1|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||14
258866|NCT00994214|625632|P4|COMPLETED|ITT (Intention-to-Treat) - Part A||5
258867|NCT00994214|625633|P3|COMPLETED|ITT (Intention-to-Treat) - Part A||5
258868|NCT00994214|625634|P2|COMPLETED|ITT (Intention-to-Treat) - Part A||6
258869|NCT00994214|625635|P1|COMPLETED|ITT (Intention-to-Treat) - Part A||5
258870|NCT00994214|625632|P4|STARTED|ITT (Intention-to-Treat) - Part A||20
258871|NCT00994214|625633|P3|STARTED|ITT (Intention-to-Treat) - Part A||18
258872|NCT00994214|625634|P2|STARTED|ITT (Intention-to-Treat) - Part A||19
258873|NCT00994214|625635|P1|STARTED|ITT (Intention-to-Treat) - Part A||19
258874|NCT00994175|625679|P2|NOT COMPLETED|Second Intervention||0
258875|NCT00994175|625680|P1|NOT COMPLETED|Second Intervention||0
258876|NCT00994175|625679|P2|COMPLETED|Second Intervention||8
258877|NCT00994175|625680|P1|COMPLETED|Second Intervention||4
258878|NCT00994175|625679|P2|STARTED|Second Intervention||8
258879|NCT00994175|625680|P1|STARTED|Second Intervention||4
258880|NCT00994175|625679|P2|NOT COMPLETED|First Intervention||1
258881|NCT00994175|625680|P1|NOT COMPLETED|First Intervention||2
258882|NCT00994175|625679|P2|COMPLETED|First Intervention||8
258883|NCT00994175|625680|P1|COMPLETED|First Intervention||4
258884|NCT00994175|625679|P2|STARTED|First Intervention||9
258885|NCT00994175|625680|P1|STARTED|First Intervention||6
258886|NCT00994123|625691|P3|NOT COMPLETED|Overall Study||0
258887|NCT00994123|625692|P2|NOT COMPLETED|Overall Study||0
258888|NCT00994123|625693|P1|NOT COMPLETED|Overall Study||0
258889|NCT00994123|625691|P3|COMPLETED|Overall Study||44
258890|NCT00994123|625692|P2|COMPLETED|Overall Study||85
258891|NCT00994123|625693|P1|COMPLETED|Overall Study||33
258892|NCT00994123|625691|P3|STARTED|Overall Study||44
258893|NCT00994123|625692|P2|STARTED|Overall Study||85
258894|NCT00994123|625693|P1|STARTED|Overall Study||33
258895|NCT00994110|625714|P2|NOT COMPLETED|Overall Study||74
258896|NCT00994110|625715|P1|NOT COMPLETED|Overall Study||65
258897|NCT00994110|625714|P2|COMPLETED|Overall Study||148
258898|NCT00994110|625715|P1|COMPLETED|Overall Study||152
258899|NCT00994110|625714|P2|STARTED|Overall Study||222
258900|NCT00994110|625715|P1|STARTED|Overall Study||217
258901|NCT00993967|625721|P1|NOT COMPLETED|Overall Study||61
258902|NCT00993967|625721|P1|COMPLETED|Overall Study||139
258903|NCT00993967|625721|P1|STARTED|Overall Study||200
258904|NCT00993954|625728|P2|NOT COMPLETED|Overall Study||2
258905|NCT00993954|625729|P1|NOT COMPLETED|Overall Study||21
258906|NCT00993954|625728|P2|COMPLETED|Overall Study||121
258907|NCT00993954|625729|P1|COMPLETED|Overall Study||124
258908|NCT00993954|625728|P2|STARTED|Overall Study||123
258909|NCT00993954|625729|P1|STARTED|Overall Study||145
258910|NCT00993928|625742|P2|NOT COMPLETED|Overall Study||7
258911|NCT00993928|625743|P1|NOT COMPLETED|Overall Study||5
258912|NCT00993928|625742|P2|COMPLETED|Overall Study||38
258913|NCT00993928|625743|P1|COMPLETED|Overall Study||43
258914|NCT00993928|625742|P2|STARTED|Overall Study||45
258915|NCT00993928|625743|P1|STARTED|Overall Study||48
258916|NCT00993915|625757|P1|NOT COMPLETED|Overall Study||9
258917|NCT00993915|625757|P1|COMPLETED|Overall Study||678
258918|NCT00993915|625757|P1|STARTED|Overall Study||687
258919|NCT00993824|625768|P2|NOT COMPLETED|Overall Study||0
258920|NCT00993824|625769|P1|NOT COMPLETED|Overall Study||0
258921|NCT00993824|625768|P2|COMPLETED|Overall Study||10
258922|NCT00993824|625769|P1|COMPLETED|Overall Study||11
258923|NCT00993824|625768|P2|STARTED|Overall Study||10
258924|NCT00993824|625769|P1|STARTED|Overall Study||11
258925|NCT00993668|625783|P2|NOT COMPLETED|Open-Label Period||15
258926|NCT00993668|625784|P1|NOT COMPLETED|Open-Label Period||23
258927|NCT00993668|625783|P2|COMPLETED|Open-Label Period||91
258928|NCT00993668|625784|P1|COMPLETED|Open-Label Period||86
258929|NCT00993668|625783|P2|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|106
258930|NCT00993668|625784|P1|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|109
258931|NCT00993668|625783|P2|NOT COMPLETED|Single-Blind Period||3
258932|NCT00993668|625784|P1|NOT COMPLETED|Single-Blind Period||4
258933|NCT00993668|625783|P2|COMPLETED|Single-Blind Period||107
258934|NCT00993668|625784|P1|COMPLETED|Single-Blind Period||110
258935|NCT00993668|625783|P2|STARTED|Single-Blind Period||110
258936|NCT00993668|625784|P1|STARTED|Single-Blind Period||114
258937|NCT00993655|625812|P3|NOT COMPLETED|Overall Study||0
258938|NCT00993655|625813|P2|NOT COMPLETED|Overall Study||0
258939|NCT00993655|625814|P1|NOT COMPLETED|Overall Study||0
258940|NCT00993655|625812|P3|COMPLETED|Overall Study||102
258941|NCT00993655|625813|P2|COMPLETED|Overall Study||72
258942|NCT00993655|625814|P1|COMPLETED|Overall Study||101
258943|NCT00993655|625812|P3|STARTED|Overall Study||102
258944|NCT00993655|625813|P2|STARTED|Overall Study||72
258945|NCT00993655|625814|P1|STARTED|Overall Study||101
258946|NCT00993616|625828|P1|NOT COMPLETED|Overall Study||2
258947|NCT00993616|625828|P1|COMPLETED|Overall Study|Number of eligible and evaluable participants|27
258948|NCT00993616|625828|P1|STARTED|Overall Study||29
258949|NCT00993499|625846|P6|NOT COMPLETED|Discontinued After Starting Course 3||3
258950|NCT00993499|625847|P5|NOT COMPLETED|Discontinued After Starting Course 3||3
258951|NCT00993499|625848|P4|NOT COMPLETED|Discontinued After Starting Course 3||2
258952|NCT00993499|625849|P3|NOT COMPLETED|Discontinued After Starting Course 3||6
258953|NCT00993499|625850|P2|NOT COMPLETED|Discontinued After Starting Course 3||5
258954|NCT00993499|625851|P1|NOT COMPLETED|Discontinued After Starting Course 3||8
258955|NCT00993499|625846|P6|COMPLETED|Discontinued After Starting Course 3||0
258956|NCT00993499|625847|P5|COMPLETED|Discontinued After Starting Course 3||0
258957|NCT00993499|625848|P4|COMPLETED|Discontinued After Starting Course 3||1
258958|NCT00993499|625849|P3|COMPLETED|Discontinued After Starting Course 3||3
258959|NCT00993499|625850|P2|COMPLETED|Discontinued After Starting Course 3||4
258960|NCT00993499|625851|P1|COMPLETED|Discontinued After Starting Course 3||4
258961|NCT00993499|625846|P6|STARTED|Discontinued After Starting Course 3||3
258962|NCT00993499|625847|P5|STARTED|Discontinued After Starting Course 3||3
258963|NCT00993499|625848|P4|STARTED|Discontinued After Starting Course 3||3
258964|NCT00993499|625849|P3|STARTED|Discontinued After Starting Course 3||9
258965|NCT00993499|625850|P2|STARTED|Discontinued After Starting Course 3||9
258966|NCT00993499|625851|P1|STARTED|Discontinued After Starting Course 3||12
258967|NCT00993499|625846|P6|NOT COMPLETED|Discontinued Before Starting Course 3||0
258968|NCT00993499|625847|P5|NOT COMPLETED|Discontinued Before Starting Course 3||0
258969|NCT00993499|625848|P4|NOT COMPLETED|Discontinued Before Starting Course 3||1
258970|NCT00993499|625849|P3|NOT COMPLETED|Discontinued Before Starting Course 3||3
258971|NCT00993499|625850|P2|NOT COMPLETED|Discontinued Before Starting Course 3||4
258972|NCT00993499|625851|P1|NOT COMPLETED|Discontinued Before Starting Course 3||4
258973|NCT00993499|625846|P6|COMPLETED|Discontinued Before Starting Course 3||3
258974|NCT00993499|625847|P5|COMPLETED|Discontinued Before Starting Course 3||3
258975|NCT00993499|625848|P4|COMPLETED|Discontinued Before Starting Course 3||2
258976|NCT00993499|625849|P3|COMPLETED|Discontinued Before Starting Course 3||6
258977|NCT00993499|625850|P2|COMPLETED|Discontinued Before Starting Course 3||5
258978|NCT00993499|625851|P1|COMPLETED|Discontinued Before Starting Course 3||8
258979|NCT00993499|625846|P6|STARTED|Discontinued Before Starting Course 3||3
258980|NCT00993499|625847|P5|STARTED|Discontinued Before Starting Course 3||3
258981|NCT00993499|625848|P4|STARTED|Discontinued Before Starting Course 3||3
258982|NCT00993499|625849|P3|STARTED|Discontinued Before Starting Course 3||9
258983|NCT00993499|625850|P2|STARTED|Discontinued Before Starting Course 3||9
258984|NCT00993499|625851|P1|STARTED|Discontinued Before Starting Course 3||12
258985|NCT00993499|625846|P6|NOT COMPLETED|Run-in Period (8 Days)||0
258986|NCT00993499|625847|P5|NOT COMPLETED|Run-in Period (8 Days)||0
258987|NCT00993499|625848|P4|NOT COMPLETED|Run-in Period (8 Days)||0
258988|NCT00993499|625849|P3|NOT COMPLETED|Run-in Period (8 Days)||1
258989|NCT00993499|625850|P2|NOT COMPLETED|Run-in Period (8 Days)||3
258990|NCT00993499|625851|P1|NOT COMPLETED|Run-in Period (8 Days)||1
258991|NCT00993499|625846|P6|COMPLETED|Run-in Period (8 Days)||3
258992|NCT00993499|625847|P5|COMPLETED|Run-in Period (8 Days)||3
258993|NCT00993499|625848|P4|COMPLETED|Run-in Period (8 Days)||3
258994|NCT00993499|625849|P3|COMPLETED|Run-in Period (8 Days)||9
258995|NCT00993499|625850|P2|COMPLETED|Run-in Period (8 Days)||9
258996|NCT00993499|625851|P1|COMPLETED|Run-in Period (8 Days)||12
258997|NCT00993499|625846|P6|STARTED|Run-in Period (8 Days)||3
258998|NCT00993499|625847|P5|STARTED|Run-in Period (8 Days)||3
258999|NCT00993499|625848|P4|STARTED|Run-in Period (8 Days)||3
259000|NCT00993499|625849|P3|STARTED|Run-in Period (8 Days)||10
259001|NCT00993499|625850|P2|STARTED|Run-in Period (8 Days)||12
259002|NCT00993499|625851|P1|STARTED|Run-in Period (8 Days)||13
259003|NCT00993473|625933|P2|NOT COMPLETED|Overall Study||10
259004|NCT00993473|625934|P1|NOT COMPLETED|Overall Study||4
259005|NCT00993473|625933|P2|COMPLETED|Overall Study||54
259006|NCT00993473|625934|P1|COMPLETED|Overall Study||57
259007|NCT00993473|625933|P2|STARTED|Overall Study|64 patients randomized to NPH but only 63 patients treated with NPH due to a dispensation's error|64
259008|NCT00993473|625934|P1|STARTED|Overall Study|61 patients randomized to Lantus but 62 patients treated with Lantus due to a dispensation's error|61
259009|NCT00993447|625972|P2|NOT COMPLETED|Overall Study||19
259010|NCT00993447|625973|P1|NOT COMPLETED|Overall Study||37
259011|NCT00993447|625972|P2|COMPLETED|Overall Study||180
259012|NCT00993447|625973|P1|COMPLETED|Overall Study||364
259013|NCT00993447|625972|P2|STARTED|Overall Study||199
259014|NCT00993447|625973|P1|STARTED|Overall Study||401
259015|NCT00993421|626010|P7|NOT COMPLETED|Overall Study||42
259016|NCT00993421|626011|P6|NOT COMPLETED|Overall Study||46
259017|NCT00993421|626012|P5|NOT COMPLETED|Overall Study||46
259018|NCT00993421|626013|P4|NOT COMPLETED|Overall Study||45
259019|NCT00993421|626014|P3|NOT COMPLETED|Overall Study||43
259020|NCT00993421|626015|P2|NOT COMPLETED|Overall Study||45
259021|NCT00993421|626016|P1|NOT COMPLETED|Overall Study||44
259022|NCT00993421|626010|P7|COMPLETED|Overall Study||4
259023|NCT00993421|626011|P6|COMPLETED|Overall Study||4
259024|NCT00993421|626012|P5|COMPLETED|Overall Study||6
259025|NCT00993421|626013|P4|COMPLETED|Overall Study||4
259026|NCT00993421|626014|P3|COMPLETED|Overall Study||5
259027|NCT00993421|626015|P2|COMPLETED|Overall Study||4
259028|NCT00993421|626016|P1|COMPLETED|Overall Study||5
259029|NCT00993421|626010|P7|STARTED|Overall Study||46
259030|NCT00993421|626011|P6|STARTED|Overall Study||50
259031|NCT00993421|626012|P5|STARTED|Overall Study||52
259032|NCT00993421|626013|P4|STARTED|Overall Study||49
259033|NCT00993421|626014|P3|STARTED|Overall Study||48
259034|NCT00993421|626015|P2|STARTED|Overall Study||49
259035|NCT00993421|626016|P1|STARTED|Overall Study||49
259036|NCT00993317|626167|P2|NOT COMPLETED|Overall Study||25
259037|NCT00993317|626168|P1|NOT COMPLETED|Overall Study||21
259038|NCT00993317|626167|P2|COMPLETED|Overall Study||60
259039|NCT00993317|626168|P1|COMPLETED|Overall Study||21
259040|NCT00993317|626167|P2|STARTED|Overall Study||85
259041|NCT00993317|626168|P1|STARTED|Overall Study||42
259042|NCT00993291|626186|P1|NOT COMPLETED|Overall Study||1
259043|NCT00993291|626186|P1|COMPLETED|Overall Study||19
259044|NCT00993291|626186|P1|STARTED|Overall Study||20
259045|NCT00993265|626192|P2|NOT COMPLETED|Overall Study||0
259046|NCT00993265|626193|P1|NOT COMPLETED|Overall Study||4
259047|NCT00993265|626192|P2|COMPLETED|Overall Study||19
259048|NCT00993265|626193|P1|COMPLETED|Overall Study||16
259049|NCT00993265|626192|P2|STARTED|Overall Study||19
259050|NCT00993265|626193|P1|STARTED|Overall Study||20
259051|NCT00993200|626213|P2|NOT COMPLETED|Overall Study||0
259052|NCT00993200|626214|P1|NOT COMPLETED|Overall Study||0
259053|NCT00993200|626213|P2|COMPLETED|Overall Study||13
259054|NCT00993200|626214|P1|COMPLETED|Overall Study||13
259055|NCT00993200|626213|P2|STARTED|Overall Study||13
259056|NCT00993200|626214|P1|STARTED|Overall Study||13
259057|NCT00993187|626226|P2|NOT COMPLETED|Overall Study||37
259058|NCT00993187|626227|P1|NOT COMPLETED|Overall Study||26
259059|NCT00993187|626226|P2|COMPLETED|Overall Study||108
259060|NCT00993187|626227|P1|COMPLETED|Overall Study||121
259061|NCT00993187|626226|P2|Received at Least 1 Dose of Study Drug|Overall Study||144
259062|NCT00993187|626227|P1|Received at Least 1 Dose of Study Drug|Overall Study||146
259063|NCT00993187|626226|P2|STARTED|Overall Study||145
259064|NCT00993187|626227|P1|STARTED|Overall Study||147
259065|NCT00993148|626245|P1|NOT COMPLETED|Overall Study||3
259066|NCT00993148|626245|P1|COMPLETED|Overall Study||22
259067|NCT00993148|626245|P1|STARTED|Overall Study||25
259068|NCT00993044|626257|P1|NOT COMPLETED|Irinotecan 50 mg||1
259069|NCT00993044|626257|P1|COMPLETED|Irinotecan 50 mg||6
259070|NCT00993044|626257|P1|STARTED|Irinotecan 50 mg||7
259071|NCT00993044|626257|P1|NOT COMPLETED|Irinotecan 30 mg||0
259072|NCT00993044|626257|P1|COMPLETED|Irinotecan 30 mg||6
259073|NCT00993044|626257|P1|STARTED|Irinotecan 30 mg||6
259074|NCT00993031|626264|P2|NOT COMPLETED|Overall Study||19
259075|NCT00993031|626265|P1|NOT COMPLETED|Overall Study||22
259076|NCT00993031|626264|P2|COMPLETED|Overall Study||175
259077|NCT00993031|626265|P1|COMPLETED|Overall Study||173
259078|NCT00993031|626264|P2|Delivered|Overall Study||190
259079|NCT00993031|626265|P1|Delivered|Overall Study||187
259080|NCT00993031|626264|P2|STARTED|Overall Study||194
259081|NCT00993031|626265|P1|STARTED|Overall Study||195
259082|NCT00992992|626297|P1|NOT COMPLETED|Overall Study||25
259083|NCT00992992|626297|P1|COMPLETED|Overall Study||0
259084|NCT00992992|626297|P1|STARTED|Overall Study||25
259085|NCT00992927|626319|P2|NOT COMPLETED|Overall Study||0
259086|NCT00992927|626320|P1|NOT COMPLETED|Overall Study||0
259087|NCT00992927|626319|P2|COMPLETED|Overall Study||22
259088|NCT00992927|626320|P1|COMPLETED|Overall Study||32
259089|NCT00992927|626319|P2|STARTED|Overall Study||22
259090|NCT00992927|626320|P1|STARTED|Overall Study||32
259091|NCT00992836|626328|P1|NOT COMPLETED|Overall Study||5
259092|NCT00992836|626328|P1|COMPLETED|Overall Study||150
259093|NCT00992836|626328|P1|Received Both Study Vaccinations|Overall Study||150
259094|NCT00992836|626328|P1|STARTED|Overall Study||155
259095|NCT00992784|626343|P3|NOT COMPLETED|Overall Study||1
259096|NCT00992784|626344|P2|NOT COMPLETED|Overall Study||2
259097|NCT00992784|626345|P1|NOT COMPLETED|Overall Study||3
259098|NCT00992784|626343|P3|COMPLETED|Overall Study||85
259099|NCT00992784|626344|P2|COMPLETED|Overall Study||102
259100|NCT00992784|626345|P1|COMPLETED|Overall Study||177
259101|NCT00992784|626343|P3|STARTED|Overall Study||86
259102|NCT00992784|626344|P2|STARTED|Overall Study||104
259103|NCT00992784|626345|P1|STARTED|Overall Study||180
259104|NCT00992719|626416|P3|NOT COMPLETED|Overall Study||0
259105|NCT00992719|626417|P2|NOT COMPLETED|Overall Study||1
259106|NCT00992719|626418|P1|NOT COMPLETED|Overall Study||1
259107|NCT00992719|626416|P3|COMPLETED|Overall Study||28
259108|NCT00992719|626417|P2|COMPLETED|Overall Study||27
259109|NCT00992719|626418|P1|COMPLETED|Overall Study||27
259110|NCT00992719|626416|P3|STARTED|Overall Study||28
259111|NCT00992719|626417|P2|STARTED|Overall Study||28
259112|NCT00992719|626418|P1|STARTED|Overall Study||28
259113|NCT00992602|626452|P1|NOT COMPLETED|Overall Study||3
259114|NCT00992602|626452|P1|COMPLETED|Overall Study||0
259115|NCT00992602|626452|P1|STARTED|Overall Study||3
259116|NCT00992589|626457|P4|NOT COMPLETED|Double-Blind Phase||10
259117|NCT00992589|626458|P3|NOT COMPLETED|Double-Blind Phase||13
259118|NCT00992589|626459|P2|NOT COMPLETED|Double-Blind Phase||13
259119|NCT00992589|626460|P1|NOT COMPLETED|Double-Blind Phase||0
259120|NCT00992589|626457|P4|COMPLETED|Double-Blind Phase||78
259121|NCT00992589|626458|P3|COMPLETED|Double-Blind Phase||77
259122|NCT00992589|626459|P2|COMPLETED|Double-Blind Phase||76
259123|NCT00992589|626460|P1|COMPLETED|Double-Blind Phase||0
259124|NCT00992589|626457|P4|STARTED|Double-Blind Phase||88
259125|NCT00992589|626458|P3|STARTED|Double-Blind Phase||90
259126|NCT00992589|626459|P2|STARTED|Double-Blind Phase||89
259127|NCT00992589|626460|P1|STARTED|Double-Blind Phase||0
259128|NCT00992589|626457|P4|NOT COMPLETED|Open-Label Phase||0
259129|NCT00992589|626458|P3|NOT COMPLETED|Open-Label Phase||0
259130|NCT00992589|626459|P2|NOT COMPLETED|Open-Label Phase||0
259131|NCT00992589|626460|P1|NOT COMPLETED|Open-Label Phase||77
259132|NCT00992589|626457|P4|COMPLETED|Open-Label Phase||0
259133|NCT00992589|626458|P3|COMPLETED|Open-Label Phase||0
259134|NCT00992589|626459|P2|COMPLETED|Open-Label Phase||0
259135|NCT00992589|626460|P1|COMPLETED|Open-Label Phase||267
259136|NCT00992589|626457|P4|STARTED|Open-Label Phase||0
259137|NCT00992589|626458|P3|STARTED|Open-Label Phase||0
259138|NCT00992589|626459|P2|STARTED|Open-Label Phase||0
259139|NCT00992589|626460|P1|STARTED|Open-Label Phase||344
259140|NCT00992511|626506|P4|NOT COMPLETED|Overall Study||5
259141|NCT00992511|626507|P3|NOT COMPLETED|Overall Study||2
259142|NCT00992511|626508|P2|NOT COMPLETED|Overall Study||0
259143|NCT00992511|626509|P1|NOT COMPLETED|Overall Study||2
259144|NCT00992511|626506|P4|COMPLETED|Overall Study||70
259145|NCT00992511|626507|P3|COMPLETED|Overall Study||74
259146|NCT00992511|626508|P2|COMPLETED|Overall Study||73
259147|NCT00992511|626509|P1|COMPLETED|Overall Study||74
259148|NCT00992511|626506|P4|STARTED|Overall Study||75
259149|NCT00992511|626507|P3|STARTED|Overall Study||76
259150|NCT00992511|626508|P2|STARTED|Overall Study||73
259151|NCT00992511|626509|P1|STARTED|Overall Study||76
259152|NCT00992459|626593|P2|NOT COMPLETED|Overall Study||1
259153|NCT00992459|626594|P1|NOT COMPLETED|Overall Study||1
259154|NCT00992459|626593|P2|COMPLETED|Overall Study|Totals enrolled and completed in Arm B HPN 100 treatment + NaPBA Placebo are not mutually exclusive.|23
259155|NCT00992459|626594|P1|COMPLETED|Overall Study|Totals enrolled and completed in Arm A NaPBA treatment + HPN 100 Placebo are not mutually exclusive.|21
259156|NCT00992459|626593|P2|STARTED|Overall Study|All patients received NaPBA placebo in Arm B (+ concomitant active HPN 100)|24
259157|NCT00992459|626594|P1|STARTED|Overall Study|All patients received HPN 100 placebo in Arm A (+ concomitant active NaPBA)|22
259158|NCT00992446|626618|P1|NOT COMPLETED|Overall Study||8
259159|NCT00992446|626618|P1|COMPLETED|Overall Study||19
259160|NCT00992446|626618|P1|STARTED|Overall Study||27
259161|NCT00992433|626625|P2|NOT COMPLETED|Overall Study||7
259162|NCT00992433|626626|P1|NOT COMPLETED|Overall Study||4
259163|NCT00992433|626625|P2|COMPLETED|Overall Study||90
259164|NCT00992433|626626|P1|COMPLETED|Overall Study||91
259165|NCT00992433|626625|P2|STARTED|Overall Study||97
259166|NCT00992433|626626|P1|STARTED|Overall Study||95
259167|NCT00992407|626690|P2|NOT COMPLETED|Overall Study||24
259168|NCT00992407|626691|P1|NOT COMPLETED|Overall Study||31
259169|NCT00992407|626690|P2|COMPLETED|Overall Study||14
259170|NCT00992407|626691|P1|COMPLETED|Overall Study||6
259171|NCT00992407|626690|P2|Treated|Overall Study||25
259172|NCT00992407|626691|P1|Treated|Overall Study||20
259173|NCT00992407|626690|P2|STARTED|Overall Study||38
259174|NCT00992407|626691|P1|STARTED|Overall Study||37
259175|NCT00992394|626741|P2|NOT COMPLETED|Overall Study||14
259176|NCT00992394|626742|P1|NOT COMPLETED|Overall Study||24
259177|NCT00992394|626741|P2|COMPLETED|Overall Study||72
259178|NCT00992394|626742|P1|COMPLETED|Overall Study||64
259179|NCT00992394|626741|P2|mITT Population|Overall Study||84
259180|NCT00992394|626742|P1|mITT Population|Overall Study||86
259181|NCT00992394|626741|P2|Safety Population|Overall Study||84
259182|NCT00992394|626742|P1|Safety Population|Overall Study||87
259183|NCT00992394|626741|P2|STARTED|Overall Study||86
259184|NCT00992394|626742|P1|STARTED|Overall Study||88
259185|NCT00992264|626800|P16|NOT COMPLETED|Overall Study||0
259186|NCT00992264|626801|P15|NOT COMPLETED|Overall Study||0
259187|NCT00992264|626802|P14|NOT COMPLETED|Overall Study||0
259188|NCT00992264|626803|P13|NOT COMPLETED|Overall Study||0
259189|NCT00992264|626804|P12|NOT COMPLETED|Overall Study||0
259190|NCT00992264|626805|P11|NOT COMPLETED|Overall Study||0
259191|NCT00992264|626806|P10|NOT COMPLETED|Overall Study||0
259192|NCT00992264|626807|P9|NOT COMPLETED|Overall Study||0
259193|NCT00992264|626808|P8|NOT COMPLETED|Overall Study||0
259194|NCT00992264|626809|P7|NOT COMPLETED|Overall Study||0
259195|NCT00992264|626810|P6|NOT COMPLETED|Overall Study||0
259196|NCT00992264|626811|P5|NOT COMPLETED|Overall Study||0
259197|NCT00992264|626812|P4|NOT COMPLETED|Overall Study||0
259198|NCT00992264|626813|P3|NOT COMPLETED|Overall Study||0
259199|NCT00992264|626814|P2|NOT COMPLETED|Overall Study||0
259200|NCT00992264|626815|P1|NOT COMPLETED|Overall Study||0
259201|NCT00992264|626800|P16|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
259202|NCT00992264|626801|P15|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
259203|NCT00992264|626802|P14|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
259204|NCT00992264|626803|P13|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
259205|NCT00992264|626804|P12|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
259206|NCT00992264|626805|P11|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
259207|NCT00992264|626806|P10|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
259208|NCT00992264|626807|P9|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
259209|NCT00992264|626808|P8|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
259210|NCT00992264|626809|P7|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
259211|NCT00992264|626810|P6|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
259212|NCT00992264|626811|P5|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
259213|NCT00992264|626812|P4|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
259214|NCT00992264|626813|P3|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
259215|NCT00992264|626814|P2|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
259216|NCT00992264|626815|P1|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
259217|NCT00992264|626800|P16|STARTED|Overall Study||116
259218|NCT00992264|626801|P15|STARTED|Overall Study||117
259219|NCT00992264|626802|P14|STARTED|Overall Study||117
259220|NCT00992264|626803|P13|STARTED|Overall Study||116
259221|NCT00992264|626804|P12|STARTED|Overall Study||117
259222|NCT00992264|626805|P11|STARTED|Overall Study||117
259223|NCT00992264|626806|P10|STARTED|Overall Study||116
259224|NCT00992264|626807|P9|STARTED|Overall Study||116
259225|NCT00992264|626808|P8|STARTED|Overall Study||117
259226|NCT00992264|626809|P7|STARTED|Overall Study||116
259227|NCT00992264|626810|P6|STARTED|Overall Study||117
259228|NCT00992264|626811|P5|STARTED|Overall Study||117
259229|NCT00992264|626812|P4|STARTED|Overall Study||117
259230|NCT00992264|626813|P3|STARTED|Overall Study||117
259231|NCT00992264|626814|P2|STARTED|Overall Study||116
259232|NCT00992264|626815|P1|STARTED|Overall Study||116
259233|NCT00992225|626829|P1|NOT COMPLETED|Overall Study||10
259234|NCT00992225|626829|P1|COMPLETED|Overall Study||33
259235|NCT00992225|626829|P1|Received at Least One Dose of Study Drug|Overall Study||33
259236|NCT00992225|626829|P1|STARTED|Overall Study||43
259237|NCT00992186|626839|P1|NOT COMPLETED|Overall Study||46
259238|NCT00992186|626839|P1|COMPLETED|Overall Study||0
259239|NCT00992186|626839|P1|STARTED|Overall Study||46
259240|NCT00992108|626858|P2|NOT COMPLETED|Overall Study||1
259241|NCT00992108|626859|P1|NOT COMPLETED|Overall Study||0
259242|NCT00992108|626858|P2|COMPLETED|Overall Study||9
259243|NCT00992108|626859|P1|COMPLETED|Overall Study||7
259244|NCT00992108|626858|P2|STARTED|Overall Study||10
259245|NCT00992108|626859|P1|STARTED|Overall Study||7
259246|NCT00992056|626873|P2|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
259247|NCT00992056|626874|P1|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
259248|NCT00992056|626873|P2|COMPLETED|Treatment Period 2 (6 Weeks)||10
259249|NCT00992056|626874|P1|COMPLETED|Treatment Period 2 (6 Weeks)||10
259250|NCT00992056|626873|P2|STARTED|Treatment Period 2 (6 Weeks)||10
259251|NCT00992056|626874|P1|STARTED|Treatment Period 2 (6 Weeks)||10
259252|NCT00992056|626873|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
259253|NCT00992056|626874|P1|NOT COMPLETED|Washout Period (2 Weeks)||1
259254|NCT00992056|626873|P2|COMPLETED|Washout Period (2 Weeks)||10
259255|NCT00992056|626874|P1|COMPLETED|Washout Period (2 Weeks)||10
259256|NCT00992056|626873|P2|STARTED|Washout Period (2 Weeks)||10
259257|NCT00992056|626874|P1|STARTED|Washout Period (2 Weeks)||11
259258|NCT00992056|626873|P2|NOT COMPLETED|Treatment Period 1 (6 Weeks)||2
259259|NCT00992056|626874|P1|NOT COMPLETED|Treatment Period 1 (6 Weeks)||1
259260|NCT00992056|626873|P2|COMPLETED|Treatment Period 1 (6 Weeks)||10
259261|NCT00992056|626874|P1|COMPLETED|Treatment Period 1 (6 Weeks)|February 2012|11
259262|NCT00992056|626873|P2|STARTED|Treatment Period 1 (6 Weeks)||12
259263|NCT00992056|626874|P1|STARTED|Treatment Period 1 (6 Weeks)||12
259264|NCT00992017|626880|P1|NOT COMPLETED|Overall Study||10
259265|NCT00992017|626880|P1|COMPLETED|Overall Study||118
259266|NCT00992017|626880|P1|Received Only One Study Vaccination|Overall Study|Reasons: delivered and LFU; moved; no transportation; ineligible - blood transfusion at delivery|4
259267|NCT00992017|626880|P1|Received Both Study Vaccinations|Overall Study||124
259268|NCT00992017|626880|P1|STARTED|Overall Study|Two additional women were enrolled but left the clinic before vaccine was administered.|128
259269|NCT00991952|626895|P2|NOT COMPLETED|Overall Study||1
259270|NCT00991952|626896|P1|NOT COMPLETED|Overall Study||0
259271|NCT00991952|626895|P2|COMPLETED|Overall Study||5
259272|NCT00991952|626896|P1|COMPLETED|Overall Study||13
259273|NCT00991952|626895|P2|STARTED|Overall Study||6
259274|NCT00991952|626896|P1|STARTED|Overall Study||13
259275|NCT00991939|626904|P2|NOT COMPLETED|Overall Study||2
259276|NCT00991939|626905|P1|NOT COMPLETED|Overall Study||5
259277|NCT00991939|626904|P2|COMPLETED|Overall Study||1
259278|NCT00991939|626905|P1|COMPLETED|Overall Study||0
259279|NCT00991939|626904|P2|STARTED|Overall Study||3
259280|NCT00991939|626905|P1|STARTED|Overall Study||5
259281|NCT00991887|626939|P2|NOT COMPLETED|Overall Study||1
259282|NCT00991887|626940|P1|NOT COMPLETED|Overall Study||2
259283|NCT00991887|626939|P2|COMPLETED|Overall Study||21
259284|NCT00991887|626940|P1|COMPLETED|Overall Study||24
259285|NCT00991887|626939|P2|STARTED|Overall Study||22
259286|NCT00991887|626940|P1|STARTED|Overall Study||26
259287|NCT00991809|626948|P2|NOT COMPLETED|Overall Study||6
259288|NCT00991809|626949|P1|NOT COMPLETED|Overall Study||4
259289|NCT00991809|626948|P2|COMPLETED|Overall Study||4
259290|NCT00991809|626949|P1|COMPLETED|Overall Study||8
259291|NCT00991809|626948|P2|STARTED|Overall Study||10
259292|NCT00991809|626949|P1|STARTED|Overall Study||12
259293|NCT00991510|626959|P2|NOT COMPLETED|Period III (Days 29-112)||1
259294|NCT00991510|626960|P1|NOT COMPLETED|Period III (Days 29-112)||1
259295|NCT00991510|626959|P2|COMPLETED|Period III (Days 29-112)||20
259296|NCT00991510|626960|P1|COMPLETED|Period III (Days 29-112)||20
259297|NCT00991510|626959|P2|STARTED|Period III (Days 29-112)||21
259298|NCT00991510|626960|P1|STARTED|Period III (Days 29-112)||21
259299|NCT00991510|626959|P2|NOT COMPLETED|Period II (Days 15-28)||0
259300|NCT00991510|626960|P1|NOT COMPLETED|Period II (Days 15-28)||0
259301|NCT00991510|626959|P2|COMPLETED|Period II (Days 15-28)||21
259302|NCT00991510|626960|P1|COMPLETED|Period II (Days 15-28)||21
259303|NCT00991510|626959|P2|STARTED|Period II (Days 15-28)||21
259304|NCT00991510|626960|P1|STARTED|Period II (Days 15-28)||21
259305|NCT00991510|626959|P2|NOT COMPLETED|Period I (Days 1-14)||0
259306|NCT00991510|626960|P1|NOT COMPLETED|Period I (Days 1-14)||1
259307|NCT00991510|626959|P2|COMPLETED|Period I (Days 1-14)||21
259308|NCT00991510|626960|P1|COMPLETED|Period I (Days 1-14)||21
259309|NCT00991510|626959|P2|STARTED|Period I (Days 1-14)||21
259310|NCT00991510|626960|P1|STARTED|Period I (Days 1-14)||22
259311|NCT00991458|626985|P3|NOT COMPLETED|Overall Study||25
259312|NCT00991458|626986|P2|NOT COMPLETED|Overall Study||28
259313|NCT00991458|626987|P1|NOT COMPLETED|Overall Study||20
259314|NCT00991458|626985|P3|COMPLETED|Overall Study||180
259315|NCT00991458|626986|P2|COMPLETED|Overall Study||181
259316|NCT00991458|626987|P1|COMPLETED|Overall Study||187
259317|NCT00991458|626985|P3|STARTED|Overall Study||205
259318|NCT00991458|626986|P2|STARTED|Overall Study||209
259319|NCT00991458|626987|P1|STARTED|Overall Study||207
259320|NCT00991406|627004|P1|NOT COMPLETED|Overall Study||1
259321|NCT00991406|627004|P1|COMPLETED|Overall Study|One participant did not respond to FES due to tone.|8
259322|NCT00991406|627004|P1|STARTED|Overall Study||9
259323|NCT00991341|627013|P2|NOT COMPLETED|Overall Study||179
259324|NCT00991341|627014|P1|NOT COMPLETED|Overall Study||204
259325|NCT00991341|627013|P2|COMPLETED|Overall Study||560
259326|NCT00991341|627014|P1|COMPLETED|Overall Study||538
259327|NCT00991341|627013|P2|STARTED|Overall Study||739
259328|NCT00991341|627014|P1|STARTED|Overall Study||742
259329|NCT00991302|627052|P2|NOT COMPLETED|Overall Study||13
259330|NCT00991302|627053|P1|NOT COMPLETED|Overall Study||14
259331|NCT00991302|627052|P2|COMPLETED|Overall Study||73
259332|NCT00991302|627053|P1|COMPLETED|Overall Study||72
259333|NCT00991302|627052|P2|STARTED|Overall Study||86
259334|NCT00991302|627053|P1|STARTED|Overall Study||86
259335|NCT00991289|627069|P1|NOT COMPLETED|Overall Study||12
259336|NCT00991289|627069|P1|COMPLETED|Overall Study|Completed study.|55
259337|NCT00991289|627069|P1|COMPLETED Week 16|Overall Study|Completed 16 weeks of the study (the primary endpoint time point). The study continued to Week 76.|61
259338|NCT00991289|627069|P1|STARTED|Overall Study|68 participants enrolled, one was found to have been ineligible and was excluded.|67
259339|NCT00991276|627089|P6|NOT COMPLETED|Third Intervention Period||1
259340|NCT00991276|627090|P5|NOT COMPLETED|Third Intervention Period||0
259341|NCT00991276|627091|P4|NOT COMPLETED|Third Intervention Period||1
259342|NCT00991276|627092|P3|NOT COMPLETED|Third Intervention Period||1
259343|NCT00991276|627093|P2|NOT COMPLETED|Third Intervention Period||0
259344|NCT00991276|627094|P1|NOT COMPLETED|Third Intervention Period||1
259345|NCT00991276|627089|P6|COMPLETED|Third Intervention Period||10
259346|NCT00991276|627090|P5|COMPLETED|Third Intervention Period||10
259347|NCT00991276|627091|P4|COMPLETED|Third Intervention Period||8
259348|NCT00991276|627092|P3|COMPLETED|Third Intervention Period||13
259349|NCT00991276|627093|P2|COMPLETED|Third Intervention Period||8
259350|NCT00991276|627094|P1|COMPLETED|Third Intervention Period||13
259351|NCT00991276|627089|P6|STARTED|Third Intervention Period||11
259352|NCT00991276|627090|P5|STARTED|Third Intervention Period||10
259353|NCT00991276|627091|P4|STARTED|Third Intervention Period||9
259354|NCT00991276|627092|P3|STARTED|Third Intervention Period||14
259355|NCT00991276|627093|P2|STARTED|Third Intervention Period||8
259356|NCT00991276|627094|P1|STARTED|Third Intervention Period||14
259357|NCT00991276|627089|P6|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
259358|NCT00991276|627090|P5|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
259359|NCT00991276|627091|P4|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
259360|NCT00991276|627092|P3|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
259361|NCT00991276|627093|P2|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
259362|NCT00991276|627094|P1|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
259363|NCT00991276|627089|P6|COMPLETED|Placebo Wash-out Period (7 Days)||11
259364|NCT00991276|627090|P5|COMPLETED|Placebo Wash-out Period (7 Days)||10
259365|NCT00991276|627091|P4|COMPLETED|Placebo Wash-out Period (7 Days)||9
259366|NCT00991276|627092|P3|COMPLETED|Placebo Wash-out Period (7 Days)||14
259367|NCT00991276|627093|P2|COMPLETED|Placebo Wash-out Period (7 Days)||8
259368|NCT00991276|627094|P1|COMPLETED|Placebo Wash-out Period (7 Days)||14
259369|NCT00991276|627089|P6|STARTED|Placebo Wash-out Period (7 Days)||11
259370|NCT00991276|627090|P5|STARTED|Placebo Wash-out Period (7 Days)||10
259371|NCT00991276|627091|P4|STARTED|Placebo Wash-out Period (7 Days)||9
259372|NCT00991276|627092|P3|STARTED|Placebo Wash-out Period (7 Days)||14
259373|NCT00991276|627093|P2|STARTED|Placebo Wash-out Period (7 Days)||8
259374|NCT00991276|627094|P1|STARTED|Placebo Wash-out Period (7 Days)||14
259375|NCT00991276|627089|P6|NOT COMPLETED|Second Intervention Period||1
259376|NCT00991276|627090|P5|NOT COMPLETED|Second Intervention Period||1
259377|NCT00991276|627091|P4|NOT COMPLETED|Second Intervention Period||2
259378|NCT00991276|627092|P3|NOT COMPLETED|Second Intervention Period||0
259379|NCT00991276|627093|P2|NOT COMPLETED|Second Intervention Period||2
259380|NCT00991276|627094|P1|NOT COMPLETED|Second Intervention Period||1
259381|NCT00991276|627089|P6|COMPLETED|Second Intervention Period||11
259382|NCT00991276|627090|P5|COMPLETED|Second Intervention Period||10
259383|NCT00991276|627091|P4|COMPLETED|Second Intervention Period||9
259384|NCT00991276|627092|P3|COMPLETED|Second Intervention Period||14
259385|NCT00991276|627093|P2|COMPLETED|Second Intervention Period||8
259386|NCT00991276|627094|P1|COMPLETED|Second Intervention Period||14
259387|NCT00991276|627089|P6|STARTED|Second Intervention Period||12
259388|NCT00991276|627090|P5|STARTED|Second Intervention Period||11
259389|NCT00991276|627091|P4|STARTED|Second Intervention Period||11
259390|NCT00991276|627092|P3|STARTED|Second Intervention Period||14
259391|NCT00991276|627093|P2|STARTED|Second Intervention Period||10
259392|NCT00991276|627094|P1|STARTED|Second Intervention Period||15
259393|NCT00991276|627089|P6|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
259394|NCT00991276|627090|P5|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
259395|NCT00991276|627091|P4|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
259396|NCT00991276|627092|P3|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
259397|NCT00991276|627093|P2|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
259398|NCT00991276|627094|P1|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
259399|NCT00991276|627089|P6|COMPLETED|Placebo Wash-out Period (7 Days)||12
259400|NCT00991276|627090|P5|COMPLETED|Placebo Wash-out Period (7 Days)||11
259401|NCT00991276|627091|P4|COMPLETED|Placebo Wash-out Period (7 Days)||11
259402|NCT00991276|627092|P3|COMPLETED|Placebo Wash-out Period (7 Days)||14
259403|NCT00991276|627093|P2|COMPLETED|Placebo Wash-out Period (7 Days)||10
259404|NCT00991276|627094|P1|COMPLETED|Placebo Wash-out Period (7 Days)||15
259405|NCT00991276|627089|P6|STARTED|Placebo Wash-out Period (7 Days)||12
259406|NCT00991276|627090|P5|STARTED|Placebo Wash-out Period (7 Days)||11
259407|NCT00991276|627091|P4|STARTED|Placebo Wash-out Period (7 Days)||11
259408|NCT00991276|627092|P3|STARTED|Placebo Wash-out Period (7 Days)||14
259409|NCT00991276|627093|P2|STARTED|Placebo Wash-out Period (7 Days)||10
259410|NCT00991276|627094|P1|STARTED|Placebo Wash-out Period (7 Days)||15
259411|NCT00991276|627089|P6|NOT COMPLETED|First Intervention Period||1
259412|NCT00991276|627090|P5|NOT COMPLETED|First Intervention Period||4
259413|NCT00991276|627091|P4|NOT COMPLETED|First Intervention Period||4
259414|NCT00991276|627092|P3|NOT COMPLETED|First Intervention Period||0
259415|NCT00991276|627093|P2|NOT COMPLETED|First Intervention Period||3
259416|NCT00991276|627094|P1|NOT COMPLETED|First Intervention Period||0
259417|NCT00991276|627089|P6|COMPLETED|First Intervention Period||12
259418|NCT00991276|627090|P5|COMPLETED|First Intervention Period||11
259419|NCT00991276|627091|P4|COMPLETED|First Intervention Period||11
259420|NCT00991276|627092|P3|COMPLETED|First Intervention Period||14
259421|NCT00991276|627093|P2|COMPLETED|First Intervention Period||10
259422|NCT00991276|627094|P1|COMPLETED|First Intervention Period||15
259423|NCT00991276|627089|P6|STARTED|First Intervention Period||13
259424|NCT00991276|627090|P5|STARTED|First Intervention Period||15
259425|NCT00991276|627091|P4|STARTED|First Intervention Period||15
259426|NCT00991276|627092|P3|STARTED|First Intervention Period||14
259427|NCT00991276|627093|P2|STARTED|First Intervention Period||13
259428|NCT00991276|627094|P1|STARTED|First Intervention Period||15
259429|NCT00991185|627192|P1|NOT COMPLETED|Overall Study||0
259430|NCT00991185|627192|P1|COMPLETED|Overall Study||8
259431|NCT00991185|627192|P1|STARTED|Overall Study||8
259432|NCT00991081|627198|P3|NOT COMPLETED|Phase II, Randomized Control Trial||4
259433|NCT00991081|627199|P2|NOT COMPLETED|Phase II, Randomized Control Trial||2
259434|NCT00991081|627200|P1|NOT COMPLETED|Phase II, Randomized Control Trial||0
259435|NCT00991081|627198|P3|COMPLETED|Phase II, Randomized Control Trial||15
259436|NCT00991081|627199|P2|COMPLETED|Phase II, Randomized Control Trial||15
259437|NCT00991081|627200|P1|COMPLETED|Phase II, Randomized Control Trial||0
259438|NCT00991081|627198|P3|Received First Clinical Call|Phase II, Randomized Control Trial||17
259439|NCT00991081|627199|P2|Received First Clinical Call|Phase II, Randomized Control Trial||16
259440|NCT00991081|627200|P1|Received First Clinical Call|Phase II, Randomized Control Trial||0
259441|NCT00991081|627198|P3|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|19
259624|NCT00990093|627502|P1|STARTED|Test Period 1 (1-14 Days)||19
259442|NCT00991081|627199|P2|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|17
259443|NCT00991081|627200|P1|STARTED|Phase II, Randomized Control Trial||0
259444|NCT00991081|627198|P3|NOT COMPLETED|Phase I, Formative Research||0
259445|NCT00991081|627199|P2|NOT COMPLETED|Phase I, Formative Research||0
259446|NCT00991081|627200|P1|NOT COMPLETED|Phase I, Formative Research||0
259447|NCT00991081|627198|P3|COMPLETED|Phase I, Formative Research||0
259448|NCT00991081|627199|P2|COMPLETED|Phase I, Formative Research||0
259449|NCT00991081|627200|P1|COMPLETED|Phase I, Formative Research|The 10 smokers interviewed were not enrolled in the Phase II RCT.|20
259450|NCT00991081|627198|P3|STARTED|Phase I, Formative Research||0
259451|NCT00991081|627199|P2|STARTED|Phase I, Formative Research||0
259452|NCT00991081|627200|P1|STARTED|Phase I, Formative Research||20
259453|NCT00991029|627234|P2|NOT COMPLETED|Overall Study||168
259454|NCT00991029|627235|P1|NOT COMPLETED|Overall Study||156
259455|NCT00991029|627234|P2|COMPLETED|Overall Study||2281
259456|NCT00991029|627235|P1|COMPLETED|Overall Study||2276
259457|NCT00991029|627234|P2|STARTED|Overall Study||2449
259458|NCT00991029|627235|P1|STARTED|Overall Study||2432
259459|NCT00990964|627265|P1|NOT COMPLETED|Overall Study||212
259460|NCT00990964|627265|P1|COMPLETED|Overall Study|Total number of subjects with successful Attain Family lead using Attain Family catheter|1802
259461|NCT00990964|627265|P1|Attain Family Study System Attempt|Overall Study|Total number of subjects with an Attain Family lead attempt after an Attain Family catheter attempt|1917
259462|NCT00990964|627265|P1|STARTED|Overall Study|Total number of subjects enrolled|2014
259463|NCT00990938|627276|P6|NOT COMPLETED|Overall Study||0
259464|NCT00990938|627277|P5|NOT COMPLETED|Overall Study||0
259465|NCT00990938|627278|P4|NOT COMPLETED|Overall Study||0
259466|NCT00990938|627279|P3|NOT COMPLETED|Overall Study||0
259467|NCT00990938|627280|P2|NOT COMPLETED|Overall Study||0
259468|NCT00990938|627281|P1|NOT COMPLETED|Overall Study||0
259469|NCT00990938|627276|P6|COMPLETED|Overall Study||12
259470|NCT00990938|627277|P5|COMPLETED|Overall Study||12
259471|NCT00990938|627278|P4|COMPLETED|Overall Study||12
259472|NCT00990938|627279|P3|COMPLETED|Overall Study||12
259473|NCT00990938|627280|P2|COMPLETED|Overall Study||12
259474|NCT00990938|627281|P1|COMPLETED|Overall Study||3
259475|NCT00990938|627276|P6|STARTED|Overall Study||12
259476|NCT00990938|627277|P5|STARTED|Overall Study||12
259477|NCT00990938|627278|P4|STARTED|Overall Study||12
259478|NCT00990938|627279|P3|STARTED|Overall Study||12
259479|NCT00990938|627280|P2|STARTED|Overall Study||12
259480|NCT00990938|627281|P1|STARTED|Overall Study||3
259481|NCT00990821|627309|P14|NOT COMPLETED|Overall Study||1
259482|NCT00990821|627310|P13|NOT COMPLETED|Overall Study||2
259483|NCT00990821|627311|P12|NOT COMPLETED|Overall Study||5
259484|NCT00990821|627312|P11|NOT COMPLETED|Overall Study||3
259485|NCT00990821|627313|P10|NOT COMPLETED|Overall Study||1
259486|NCT00990821|627314|P9|NOT COMPLETED|Overall Study||0
259487|NCT00990821|627315|P8|NOT COMPLETED|Overall Study||0
259488|NCT00990821|627316|P7|NOT COMPLETED|Overall Study||1
259489|NCT00990821|627317|P6|NOT COMPLETED|Overall Study||3
259490|NCT00990821|627318|P5|NOT COMPLETED|Overall Study||3
259491|NCT00990821|627319|P4|NOT COMPLETED|Overall Study||0
259492|NCT00990821|627320|P3|NOT COMPLETED|Overall Study||0
259493|NCT00990821|627321|P2|NOT COMPLETED|Overall Study||2
259494|NCT00990821|627322|P1|NOT COMPLETED|Overall Study||0
259495|NCT00990821|627309|P14|COMPLETED|Overall Study||11
259496|NCT00990821|627310|P13|COMPLETED|Overall Study||10
259497|NCT00990821|627311|P12|COMPLETED|Overall Study||9
259498|NCT00990821|627312|P11|COMPLETED|Overall Study||9
259499|NCT00990821|627313|P10|COMPLETED|Overall Study||13
259500|NCT00990821|627314|P9|COMPLETED|Overall Study||12
259501|NCT00990821|627315|P8|COMPLETED|Overall Study||14
259502|NCT00990821|627316|P7|COMPLETED|Overall Study||11
259503|NCT00990821|627317|P6|COMPLETED|Overall Study||14
259504|NCT00990821|627318|P5|COMPLETED|Overall Study||14
259505|NCT00990821|627319|P4|COMPLETED|Overall Study||8
259506|NCT00990821|627320|P3|COMPLETED|Overall Study||14
259507|NCT00990821|627321|P2|COMPLETED|Overall Study||14
259508|NCT00990821|627322|P1|COMPLETED|Overall Study||14
259509|NCT00990821|627309|P14|STARTED|Overall Study||12
259510|NCT00990821|627310|P13|STARTED|Overall Study||12
259511|NCT00990821|627311|P12|STARTED|Overall Study||14
259512|NCT00990821|627312|P11|STARTED|Overall Study||12
259513|NCT00990821|627313|P10|STARTED|Overall Study||14
259514|NCT00990821|627314|P9|STARTED|Overall Study||12
259515|NCT00990821|627315|P8|STARTED|Overall Study||14
259516|NCT00990821|627316|P7|STARTED|Overall Study||12
259517|NCT00990821|627317|P6|STARTED|Overall Study||17
259518|NCT00990821|627318|P5|STARTED|Overall Study||17
259519|NCT00990821|627319|P4|STARTED|Overall Study||8
259520|NCT00990821|627320|P3|STARTED|Overall Study||14
259521|NCT00990821|627321|P2|STARTED|Overall Study||16
259522|NCT00990821|627322|P1|STARTED|Overall Study||14
259523|NCT00990782|627339|P1|NOT COMPLETED|Overall Study||5
259524|NCT00990782|627339|P1|COMPLETED|Overall Study||88
259525|NCT00990782|627339|P1|STARTED|Overall Study||93
259526|NCT00990769|627346|P2|NOT COMPLETED|Overall Study||0
259527|NCT00990769|627347|P1|NOT COMPLETED|Overall Study||0
259528|NCT00990769|627346|P2|COMPLETED|Overall Study||18
259529|NCT00990769|627347|P1|COMPLETED|Overall Study||22
259530|NCT00990769|627346|P2|STARTED|Overall Study|Signed consent and assigned to Low-normal BIS|18
259531|NCT00990769|627347|P1|STARTED|Overall Study|Signed consent and assigned to High-normal BIS|22
259532|NCT00990704|627359|P2|NOT COMPLETED|Overall Study||2
259533|NCT00990704|627360|P1|NOT COMPLETED|Overall Study||1
259534|NCT00990704|627359|P2|COMPLETED|Overall Study||31
259535|NCT00990704|627360|P1|COMPLETED|Overall Study||13
259536|NCT00990704|627359|P2|STARTED|Overall Study||33
259537|NCT00990704|627360|P1|STARTED|Overall Study||14
259538|NCT00990665|627380|P1|NOT COMPLETED|Overall Study||48
259539|NCT00990665|627380|P1|COMPLETED|Overall Study||130
259540|NCT00990665|627380|P1|STARTED|Overall Study||178
259541|NCT00990652|627387|P1|NOT COMPLETED|Post-sugery Bortezomib + Temozolomide||1
259542|NCT00990652|627387|P1|COMPLETED|Post-sugery Bortezomib + Temozolomide||8
259543|NCT00990652|627387|P1|STARTED|Post-sugery Bortezomib + Temozolomide||9
259544|NCT00990652|627387|P1|NOT COMPLETED|Surgical Resection||0
259545|NCT00990652|627387|P1|COMPLETED|Surgical Resection||9
259546|NCT00990652|627387|P1|STARTED|Surgical Resection||9
259547|NCT00990652|627387|P1|NOT COMPLETED|Pre-surgical Bortezomib||1
259548|NCT00990652|627387|P1|COMPLETED|Pre-surgical Bortezomib||9
259549|NCT00990652|627387|P1|STARTED|Pre-surgical Bortezomib||10
259550|NCT00990561|627397|P4|NOT COMPLETED|Period 2||2
259551|NCT00990561|627398|P3|NOT COMPLETED|Period 2||0
259552|NCT00990561|627399|P2|NOT COMPLETED|Period 2||0
259553|NCT00990561|627400|P1|NOT COMPLETED|Period 2||0
259554|NCT00990561|627397|P4|COMPLETED|Period 2||17
259555|NCT00990561|627398|P3|COMPLETED|Period 2||20
259556|NCT00990561|627399|P2|COMPLETED|Period 2||0
259557|NCT00990561|627400|P1|COMPLETED|Period 2||0
259558|NCT00990561|627397|P4|STARTED|Period 2||19
259559|NCT00990561|627398|P3|STARTED|Period 2||20
259560|NCT00990561|627399|P2|STARTED|Period 2||0
259561|NCT00990561|627400|P1|STARTED|Period 2||0
259562|NCT00990561|627397|P4|NOT COMPLETED|Period 1||0
259563|NCT00990561|627398|P3|NOT COMPLETED|Period 1||0
259564|NCT00990561|627399|P2|NOT COMPLETED|Period 1||1
259565|NCT00990561|627400|P1|NOT COMPLETED|Period 1||0
259566|NCT00990561|627397|P4|COMPLETED|Period 1||0
259567|NCT00990561|627398|P3|COMPLETED|Period 1||0
259568|NCT00990561|627399|P2|COMPLETED|Period 1||19
259569|NCT00990561|627400|P1|COMPLETED|Period 1||20
259570|NCT00990561|627397|P4|STARTED|Period 1||0
259571|NCT00990561|627398|P3|STARTED|Period 1||0
259572|NCT00990561|627399|P2|STARTED|Period 1||20
259573|NCT00990561|627400|P1|STARTED|Period 1||20
259574|NCT00990509|627408|P2|NOT COMPLETED|Overall Study||1
259575|NCT00990509|627409|P1|NOT COMPLETED|Overall Study||0
259576|NCT00990509|627408|P2|COMPLETED|Overall Study||8
259577|NCT00990509|627409|P1|COMPLETED|Overall Study||5
259578|NCT00990509|627408|P2|STARTED|Overall Study||9
259579|NCT00990509|627409|P1|STARTED|Overall Study||5
259580|NCT00990340|627421|P2|NOT COMPLETED|Second 14-day Treatment||0
259581|NCT00990340|627422|P1|NOT COMPLETED|Second 14-day Treatment||0
259582|NCT00990340|627421|P2|COMPLETED|Second 14-day Treatment||21
259583|NCT00990340|627422|P1|COMPLETED|Second 14-day Treatment||21
259584|NCT00990340|627421|P2|STARTED|Second 14-day Treatment||21
259585|NCT00990340|627422|P1|STARTED|Second 14-day Treatment||21
259586|NCT00990340|627421|P2|NOT COMPLETED|First 14-day Treatment||4
259587|NCT00990340|627422|P1|NOT COMPLETED|First 14-day Treatment||6
259588|NCT00990340|627421|P2|COMPLETED|First 14-day Treatment||21
259589|NCT00990340|627422|P1|COMPLETED|First 14-day Treatment||21
259590|NCT00990340|627421|P2|STARTED|First 14-day Treatment||25
259591|NCT00990340|627422|P1|STARTED|First 14-day Treatment||27
259592|NCT00990314|627436|P1|NOT COMPLETED|Overall Study||12
259593|NCT00990314|627436|P1|COMPLETED|Overall Study||19
259594|NCT00990314|627436|P1|STARTED|Overall Study||31
259595|NCT00990288|627447|P2|NOT COMPLETED|Overall Study||0
259596|NCT00990288|627448|P1|NOT COMPLETED|Overall Study||0
259597|NCT00990288|627447|P2|COMPLETED|Overall Study||99
259598|NCT00990288|627448|P1|COMPLETED|Overall Study||97
259599|NCT00990288|627447|P2|STARTED|Overall Study||99
259600|NCT00990288|627448|P1|STARTED|Overall Study||97
259601|NCT00990249|627478|P1|NOT COMPLETED|Overall Study||13
259602|NCT00990249|627478|P1|COMPLETED|Overall Study||107
259603|NCT00990249|627478|P1|STARTED|Overall Study||120
259604|NCT00990184|627482|P1|NOT COMPLETED|Overall Study||1
259605|NCT00990184|627482|P1|COMPLETED|Overall Study||20
259606|NCT00990184|627482|P1|STARTED|Overall Study||21
259607|NCT00990106|627490|P2|NOT COMPLETED|Overall Study||12
259608|NCT00990106|627491|P1|NOT COMPLETED|Overall Study||9
259609|NCT00990106|627490|P2|COMPLETED|Overall Study||23
259610|NCT00990106|627491|P1|COMPLETED|Overall Study||23
259611|NCT00990106|627490|P2|STARTED|Overall Study||35
259612|NCT00990106|627491|P1|STARTED|Overall Study||32
259613|NCT00990093|627501|P2|NOT COMPLETED|Test Period 2 (15-28 Days)||1
259614|NCT00990093|627502|P1|NOT COMPLETED|Test Period 2 (15-28 Days)||2
259615|NCT00990093|627501|P2|COMPLETED|Test Period 2 (15-28 Days)||14
259616|NCT00990093|627502|P1|COMPLETED|Test Period 2 (15-28 Days)||13
259617|NCT00990093|627501|P2|STARTED|Test Period 2 (15-28 Days)||15
259618|NCT00990093|627502|P1|STARTED|Test Period 2 (15-28 Days)||15
259619|NCT00990093|627501|P2|NOT COMPLETED|Test Period 1 (1-14 Days)||2
259620|NCT00990093|627502|P1|NOT COMPLETED|Test Period 1 (1-14 Days)||4
259621|NCT00990093|627501|P2|COMPLETED|Test Period 1 (1-14 Days)||15
259622|NCT00990093|627502|P1|COMPLETED|Test Period 1 (1-14 Days)||15
259623|NCT00990093|627501|P2|STARTED|Test Period 1 (1-14 Days)||17
259625|NCT00989989|627511|P3|NOT COMPLETED|Overall Study||23
259626|NCT00989989|627512|P2|NOT COMPLETED|Overall Study||10
259627|NCT00989989|627513|P1|NOT COMPLETED|Overall Study||18
259628|NCT00989989|627511|P3|COMPLETED|Overall Study||108
259629|NCT00989989|627512|P2|COMPLETED|Overall Study||123
259630|NCT00989989|627513|P1|COMPLETED|Overall Study||114
259631|NCT00989989|627511|P3|STARTED|Overall Study||131
259632|NCT00989989|627512|P2|STARTED|Overall Study||133
259633|NCT00989989|627513|P1|STARTED|Overall Study||132
259634|NCT00989950|627555|P4|NOT COMPLETED|Randomized Phase||0
259635|NCT00989950|627556|P3|NOT COMPLETED|Randomized Phase||0
259636|NCT00989950|627557|P2|NOT COMPLETED|Randomized Phase||1
259637|NCT00989950|627558|P1|NOT COMPLETED|Randomized Phase||1
259638|NCT00989950|627555|P4|COMPLETED|Randomized Phase||7
259639|NCT00989950|627556|P3|COMPLETED|Randomized Phase||4
259640|NCT00989950|627557|P2|COMPLETED|Randomized Phase||8
259641|NCT00989950|627558|P1|COMPLETED|Randomized Phase||5
259642|NCT00989950|627555|P4|STARTED|Randomized Phase||7
259643|NCT00989950|627556|P3|STARTED|Randomized Phase||4
259644|NCT00989950|627557|P2|STARTED|Randomized Phase||9
259645|NCT00989950|627558|P1|STARTED|Randomized Phase||6
259646|NCT00989950|627555|P4|NOT COMPLETED|Open Label Dose Optimization||0
259647|NCT00989950|627556|P3|NOT COMPLETED|Open Label Dose Optimization||0
259648|NCT00989950|627557|P2|NOT COMPLETED|Open Label Dose Optimization||0
259649|NCT00989950|627558|P1|NOT COMPLETED|Open Label Dose Optimization||0
259650|NCT00989950|627555|P4|COMPLETED|Open Label Dose Optimization||7
259651|NCT00989950|627556|P3|COMPLETED|Open Label Dose Optimization||4
259652|NCT00989950|627557|P2|COMPLETED|Open Label Dose Optimization||9
259653|NCT00989950|627558|P1|COMPLETED|Open Label Dose Optimization||6
259654|NCT00989950|627555|P4|STARTED|Open Label Dose Optimization||7
259655|NCT00989950|627556|P3|STARTED|Open Label Dose Optimization||4
259656|NCT00989950|627557|P2|STARTED|Open Label Dose Optimization||9
259657|NCT00989950|627558|P1|STARTED|Open Label Dose Optimization||6
259658|NCT00989937|627568|P1|NOT COMPLETED|Overall Study||0
259659|NCT00989937|627568|P1|COMPLETED|Overall Study||0
259660|NCT00989937|627568|P1|STARTED|Overall Study||0
259661|NCT00989911|627583|P1|NOT COMPLETED|Overall Study||3
259662|NCT00989911|627583|P1|COMPLETED|Overall Study||7
259663|NCT00989911|627583|P1|STARTED|Overall Study||10
259664|NCT00989833|627590|P3|NOT COMPLETED|Overall Study||2
259665|NCT00989833|627591|P2|NOT COMPLETED|Overall Study||3
259666|NCT00989833|627592|P1|NOT COMPLETED|Overall Study||2
259667|NCT00989833|627590|P3|COMPLETED|Overall Study||21
259668|NCT00989833|627591|P2|COMPLETED|Overall Study||19
259669|NCT00989833|627592|P1|COMPLETED|Overall Study||19
259670|NCT00989833|627590|P3|STARTED|Overall Study||23
259671|NCT00989833|627591|P2|STARTED|Overall Study||22
259672|NCT00989833|627592|P1|STARTED|Overall Study||21
259673|NCT00989781|627623|P2|NOT COMPLETED|Adrenal Response ot ACTH||3
259674|NCT00989781|627624|P1|NOT COMPLETED|Adrenal Response ot ACTH||5
259675|NCT00989781|627623|P2|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented and completed study|15
259676|NCT00989781|627624|P1|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented. 2 dropped out and 13 completed study|13
259677|NCT00989781|627623|P2|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
259678|NCT00989781|627624|P1|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
259679|NCT00989781|627623|P2|NOT COMPLETED|Ovarian Response to hCG||2
259680|NCT00989781|627624|P1|NOT COMPLETED|Ovarian Response to hCG||3
259681|NCT00989781|627623|P2|COMPLETED|Ovarian Response to hCG||18
259682|NCT00989781|627624|P1|COMPLETED|Ovarian Response to hCG||18
259683|NCT00989781|627623|P2|STARTED|Ovarian Response to hCG||20
259684|NCT00989781|627624|P1|STARTED|Ovarian Response to hCG||21
259685|NCT00989768|627643|P1|NOT COMPLETED|Overall Study||1
259686|NCT00989768|627643|P1|COMPLETED|Overall Study||28
259687|NCT00989768|627643|P1|STARTED|Overall Study|All patients received both treatments. They are their own controls|29
259688|NCT00989664|627654|P1|NOT COMPLETED|Long-Term Follow-Up||3
259689|NCT00989664|627654|P1|COMPLETED|Long-Term Follow-Up||11
259690|NCT00989664|627654|P1|STARTED|Long-Term Follow-Up|14 of the 61 participants withdrawing from Study BEX104504 enrolled in the LTFU study.|14
259691|NCT00989664|627654|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||61
259692|NCT00989664|627654|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
259693|NCT00989664|627654|P1|STARTED|Dosimetric and Therapeutic Treatment||61
259694|NCT00989612|627682|P1|NOT COMPLETED|Overall Study||0
259695|NCT00989612|627682|P1|COMPLETED|Overall Study||100
259696|NCT00989612|627682|P1|STARTED|Overall Study||100
259697|NCT00989586|627723|P2|NOT COMPLETED|Overall Study||0
259698|NCT00989586|627724|P1|NOT COMPLETED|Overall Study||0
259699|NCT00989586|627723|P2|COMPLETED|Overall Study||17
259700|NCT00989586|627724|P1|COMPLETED|Overall Study||18
259701|NCT00989586|627723|P2|STARTED|Overall Study||17
259702|NCT00989586|627724|P1|STARTED|Overall Study||18
259703|NCT00989287|627739|P2|NOT COMPLETED|Overall Study||1
259704|NCT00989287|627740|P1|NOT COMPLETED|Overall Study||1
259705|NCT00989287|627739|P2|COMPLETED|Overall Study||65
259706|NCT00989287|627740|P1|COMPLETED|Overall Study||64
259707|NCT00989287|627739|P2|STARTED|Overall Study||66
259708|NCT00989287|627740|P1|STARTED|Overall Study||65
259709|NCT00989261|627842|P2|NOT COMPLETED|Overall Study||22
259710|NCT00989261|627843|P1|NOT COMPLETED|Overall Study||15
259711|NCT00989261|627842|P2|COMPLETED|Overall Study||154
259712|NCT00989261|627843|P1|COMPLETED|Overall Study||142
259713|NCT00989261|627842|P2|STARTED|Overall Study||176
259714|NCT00989261|627843|P1|STARTED|Overall Study||157
259715|NCT00989235|627873|P2|NOT COMPLETED|Overall Study||6
259716|NCT00989235|627874|P1|NOT COMPLETED|Overall Study||3
259717|NCT00989235|627873|P2|COMPLETED|Overall Study||44
259718|NCT00989235|627874|P1|COMPLETED|Overall Study||55
259719|NCT00989235|627873|P2|Number Completing Double-Blind Treatment|Overall Study||41
259720|NCT00989235|627874|P1|Number Completing Double-Blind Treatment|Overall Study||51
259721|NCT00989235|627873|P2|Number Rescued to Open-Label Treatment|Overall Study|Of these, 1 was discontinued from open-label treatment (lost to follow-up).|4
259722|NCT00989235|627874|P1|Number Rescued to Open-Label Treatment|Overall Study||4
259723|NCT00989235|627873|P2|STARTED|Overall Study||50
259724|NCT00989235|627874|P1|STARTED|Overall Study||58
259725|NCT00989196|627919|P2|NOT COMPLETED|Treatment Period||0
259726|NCT00989196|627920|P1|NOT COMPLETED|Treatment Period||1
259727|NCT00989196|627919|P2|COMPLETED|Treatment Period||12
259728|NCT00989196|627920|P1|COMPLETED|Treatment Period||9
259729|NCT00989196|627919|P2|STARTED|Treatment Period||12
259730|NCT00989196|627920|P1|STARTED|Treatment Period||10
259731|NCT00989196|627919|P2|NOT COMPLETED|PK Crossover Period||0
259732|NCT00989196|627920|P1|NOT COMPLETED|PK Crossover Period||0
259733|NCT00989196|627919|P2|COMPLETED|PK Crossover Period||12
259734|NCT00989196|627920|P1|COMPLETED|PK Crossover Period||10
259735|NCT00989196|627919|P2|STARTED|PK Crossover Period||12
259736|NCT00989196|627920|P1|STARTED|PK Crossover Period||10
259737|NCT00989157|627941|P2|NOT COMPLETED|Overall Study||0
259738|NCT00989157|627942|P1|NOT COMPLETED|Overall Study||0
259739|NCT00989157|627941|P2|COMPLETED|Overall Study||10
259740|NCT00989157|627942|P1|COMPLETED|Overall Study||10
259741|NCT00989157|627941|P2|STARTED|Overall Study||10
259742|NCT00989157|627942|P1|STARTED|Overall Study||10
259743|NCT00989092|627958|P2|NOT COMPLETED|Overall Study||28
259744|NCT00989092|627959|P1|NOT COMPLETED|Overall Study||90
259745|NCT00989092|627958|P2|COMPLETED|Overall Study||31
259746|NCT00989092|627959|P1|COMPLETED|Overall Study||138
259747|NCT00989092|627958|P2|Treated With Darbepoetin Alfa|Overall Study||33
259748|NCT00989092|627959|P1|Treated With Darbepoetin Alfa|Overall Study||226
259749|NCT00989092|627958|P2|STARTED|Overall Study||59
259750|NCT00989092|627959|P1|STARTED|Overall Study||228
259751|NCT00989014|627996|P4|NOT COMPLETED|Overall Study||0
259752|NCT00989014|627997|P3|NOT COMPLETED|Overall Study||0
259753|NCT00989014|627998|P2|NOT COMPLETED|Overall Study||0
259754|NCT00989014|627999|P1|NOT COMPLETED|Overall Study||0
259755|NCT00989014|627996|P4|COMPLETED|Overall Study||32
259756|NCT00989014|627997|P3|COMPLETED|Overall Study||28
259757|NCT00989014|627998|P2|COMPLETED|Overall Study||31
259758|NCT00989014|627999|P1|COMPLETED|Overall Study||31
259759|NCT00989014|627996|P4|STARTED|Overall Study||32
259760|NCT00989014|627997|P3|STARTED|Overall Study||28
259761|NCT00989014|627998|P2|STARTED|Overall Study||31
259762|NCT00989014|627999|P1|STARTED|Overall Study||31
259763|NCT00988884|628011|P2|NOT COMPLETED|Overall Study||36
259764|NCT00988884|628012|P1|NOT COMPLETED|Overall Study||35
259765|NCT00988884|628011|P2|COMPLETED|Overall Study||584
259766|NCT00988884|628012|P1|COMPLETED|Overall Study||586
259767|NCT00988884|628011|P2|STARTED|Overall Study||620
259768|NCT00988884|628012|P1|STARTED|Overall Study||621
259769|NCT00988858|628034|P1|NOT COMPLETED|Overall Study||10
259770|NCT00988858|628034|P1|COMPLETED|Overall Study||45
259771|NCT00988858|628034|P1|STARTED|Overall Study||55
259772|NCT00988832|628046|P1|NOT COMPLETED|Overall Study||0
259773|NCT00988832|628046|P1|COMPLETED|Overall Study||380
259774|NCT00988832|628046|P1|STARTED|Overall Study||380
259775|NCT00988637|628083|P2|NOT COMPLETED|Overall Study||3
259776|NCT00988637|628084|P1|NOT COMPLETED|Overall Study||3
259777|NCT00988637|628083|P2|COMPLETED|Overall Study||65
259778|NCT00988637|628084|P1|COMPLETED|Overall Study||67
259779|NCT00988637|628083|P2|STARTED|Overall Study||68
259780|NCT00988637|628084|P1|STARTED|Overall Study||70
259781|NCT00988559|628118|P4|NOT COMPLETED|Overall Study||1
259782|NCT00988559|628119|P3|NOT COMPLETED|Overall Study||2
259783|NCT00988559|628120|P2|NOT COMPLETED|Overall Study||2
259784|NCT00988559|628121|P1|NOT COMPLETED|Overall Study||1
259785|NCT00988559|628118|P4|COMPLETED|Overall Study||6
259786|NCT00988559|628119|P3|COMPLETED|Overall Study||9
259787|NCT00988559|628120|P2|COMPLETED|Overall Study||9
259788|NCT00988559|628121|P1|COMPLETED|Overall Study||9
259789|NCT00988559|628118|P4|STARTED|Overall Study||7
259790|NCT00988559|628119|P3|STARTED|Overall Study||11
259791|NCT00988559|628120|P2|STARTED|Overall Study||11
259792|NCT00988559|628121|P1|STARTED|Overall Study||10
259793|NCT00988533|628135|P1|NOT COMPLETED|Overall Study||3
259794|NCT00988533|628135|P1|COMPLETED|Overall Study||27
259795|NCT00988533|628135|P1|STARTED|Overall Study||30
259796|NCT00988442|628149|P2|NOT COMPLETED|Overall Study||28
259797|NCT00988442|628150|P1|NOT COMPLETED|Overall Study||30
259798|NCT00988442|628149|P2|COMPLETED|Overall Study||1
259799|NCT00988442|628150|P1|COMPLETED|Overall Study||0
259800|NCT00988442|628149|P2|STARTED|Overall Study||29
259801|NCT00988442|628150|P1|STARTED|Overall Study||30
259802|NCT00988429|628213|P3|NOT COMPLETED|Overall Study||69
259803|NCT00988429|628214|P2|NOT COMPLETED|Overall Study||43
259804|NCT00988429|628215|P1|NOT COMPLETED|Overall Study||37
259805|NCT00988429|628213|P3|COMPLETED|Overall Study||142
259806|NCT00988429|628214|P2|COMPLETED|Overall Study||173
259807|NCT00988429|628215|P1|COMPLETED|Overall Study||189
259808|NCT00988429|628213|P3|Intention-to-treat (ITT) Population|Overall Study||205
259809|NCT00988429|628214|P2|Intention-to-treat (ITT) Population|Overall Study||215
259810|NCT00988429|628215|P1|Intention-to-treat (ITT) Population|Overall Study||220
259811|NCT00988429|628213|P3|Safety Population|Overall Study||210
259812|NCT00988429|628214|P2|Safety Population|Overall Study||216
259813|NCT00988429|628215|P1|Safety Population|Overall Study||224
259814|NCT00988429|628213|P3|STARTED|Overall Study||211
259815|NCT00988429|628214|P2|STARTED|Overall Study||216
259816|NCT00988429|628215|P1|STARTED|Overall Study||226
259817|NCT00988351|628228|P2|NOT COMPLETED|Overall Study||12
259818|NCT00988351|628229|P1|NOT COMPLETED|Overall Study||19
259819|NCT00988351|628228|P2|COMPLETED|Overall Study||66
259820|NCT00988351|628229|P1|COMPLETED|Overall Study||59
259821|NCT00988351|628228|P2|Using CPAP or APAP|Overall Study|3 not using APAP (less than 1/2 hour per night)|66
259822|NCT00988351|628229|P1|Using CPAP or APAP|Overall Study|5 not using CPAP (use < 1/2 hour per night)|59
259823|NCT00988351|628228|P2|Clinic Visit|Overall Study|9 lost to follow-up or no show for clinic|69
259824|NCT00988351|628229|P1|Clinic Visit|Overall Study|6 lost to follow-up or no show for clinic|64
259825|NCT00988351|628228|P2|PAP Setup|Overall Study|APAP treatment started|78
259826|NCT00988351|628229|P1|PAP Setup|Overall Study|CPAP treatment started|70
259827|NCT00988351|628228|P2|CPAP Titration|Overall Study|no titration needed|78
259828|NCT00988351|628229|P1|CPAP Titration|Overall Study|8 declined CPAP treatment|78
259829|NCT00988351|628228|P2|STARTED|Overall Study||78
259830|NCT00988351|628229|P1|STARTED|Overall Study||78
259831|NCT00988325|628246|P3|NOT COMPLETED|Overall Study||0
259832|NCT00988325|628247|P2|NOT COMPLETED|Overall Study||0
259833|NCT00988325|628248|P1|NOT COMPLETED|Overall Study||0
259834|NCT00988325|628246|P3|COMPLETED|Overall Study||5
259835|NCT00988325|628247|P2|COMPLETED|Overall Study||20
259836|NCT00988325|628248|P1|COMPLETED|Overall Study||40
259837|NCT00988325|628246|P3|STARTED|Overall Study||5
259838|NCT00988325|628247|P2|STARTED|Overall Study||20
259839|NCT00988325|628248|P1|STARTED|Overall Study||40
259840|NCT00988247|628306|P2|NOT COMPLETED|Overall Study||26
259841|NCT00988247|628307|P1|NOT COMPLETED|Overall Study||83
259842|NCT00988247|628306|P2|COMPLETED|Overall Study||85
259843|NCT00988247|628307|P1|COMPLETED|Overall Study||335
259844|NCT00988247|628306|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|110
259845|NCT00988247|628307|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|414
259846|NCT00988247|628306|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|111
259847|NCT00988247|628307|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|415
259848|NCT00988247|628306|P2|STARTED|Overall Study||111
259849|NCT00988247|628307|P1|STARTED|Overall Study||418
259850|NCT00988221|628326|P4|NOT COMPLETED|Part III||0
259851|NCT00988221|628327|P3|NOT COMPLETED|Part III||3
259852|NCT00988221|628328|P2|NOT COMPLETED|Part III||1
259853|NCT00988221|628329|P1|NOT COMPLETED|Part III||1
259854|NCT00988221|628326|P4|COMPLETED|Part III||0
259855|NCT00988221|628327|P3|COMPLETED|Part III||103
259856|NCT00988221|628328|P2|COMPLETED|Part III||23
259857|NCT00988221|628329|P1|COMPLETED|Part III||29
259858|NCT00988221|628326|P4|STARTED|Part III|No patients received placebo in Part III of this study.|0
259859|NCT00988221|628327|P3|STARTED|Part III||106
259860|NCT00988221|628328|P2|STARTED|Part III||24
259861|NCT00988221|628329|P1|STARTED|Part III||30
259862|NCT00988221|628326|P4|NOT COMPLETED|Part II||3
259863|NCT00988221|628327|P3|NOT COMPLETED|Part II||3
259864|NCT00988221|628328|P2|NOT COMPLETED|Part II||0
259865|NCT00988221|628329|P1|NOT COMPLETED|Part II||1
259866|NCT00988221|628326|P4|COMPLETED|Part II||81
259867|NCT00988221|628327|P3|COMPLETED|Part II|One participant who did not complete Part II was available to continue in the study and did.|52
259868|NCT00988221|628328|P2|COMPLETED|Part II||11
259869|NCT00988221|628329|P1|COMPLETED|Part II||15
259870|NCT00988221|628326|P4|STARTED|Part II||84
259871|NCT00988221|628327|P3|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|55
259872|NCT00988221|628328|P2|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|11
259873|NCT00988221|628329|P1|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|16
259874|NCT00988221|628326|P4|NOT COMPLETED|Part I||0
259875|NCT00988221|628327|P3|NOT COMPLETED|Part I||8
259876|NCT00988221|628328|P2|NOT COMPLETED|Part I||10
259877|NCT00988221|628329|P1|NOT COMPLETED|Part I||4
259878|NCT00988221|628326|P4|COMPLETED|Part I||0
259879|NCT00988221|628327|P3|COMPLETED|Part I||111
259880|NCT00988221|628328|P2|COMPLETED|Part I||24
259881|NCT00988221|628329|P1|COMPLETED|Part I||31
259882|NCT00988221|628326|P4|STARTED|Part I|No patients received placebo in Part I of this study.|0
259883|NCT00988221|628327|P3|STARTED|Part I||119
259884|NCT00988221|628328|P2|STARTED|Part I||34
259885|NCT00988221|628329|P1|STARTED|Part I||35
259886|NCT00988208|628502|P2|NOT COMPLETED|Overall Study||438
259887|NCT00988208|628503|P1|NOT COMPLETED|Overall Study||431
259888|NCT00988208|628502|P2|COMPLETED|Overall Study|DPL Completed = kept on treatment with docetaxel/prednisone; Lenalidomide discontinued in DPL arm|95
259889|NCT00988208|628503|P1|COMPLETED|Overall Study|DP Completed = kept on treatment with docetaxel/prednisone; Placebo was discontinued in DP arm|95
259890|NCT00988208|628502|P2|Treated|Overall Study||525
259891|NCT00988208|628503|P1|Treated|Overall Study||521
259892|NCT00988208|628502|P2|STARTED|Overall Study||533
259893|NCT00988208|628503|P1|STARTED|Overall Study||526
259894|NCT00988169|628521|P1|NOT COMPLETED|Overall Study||1
259895|NCT00988169|628521|P1|COMPLETED|Overall Study||5
259896|NCT00988169|628521|P1|STARTED|Overall Study||6
259897|NCT00988156|628527|P2|NOT COMPLETED|Overall Study||20
259898|NCT00988156|628528|P1|NOT COMPLETED|Overall Study||17
259899|NCT00988156|628527|P2|COMPLETED|Overall Study||135
259900|NCT00988156|628528|P1|COMPLETED|Overall Study||132
259901|NCT00988156|628527|P2|Safety Set|Overall Study||134
259902|NCT00988156|628528|P1|Safety Set|Overall Study||129
259903|NCT00988156|628527|P2|Per Protocol Set (PP)|Overall Study||97
259904|NCT00988156|628528|P1|Per Protocol Set (PP)|Overall Study||101
259905|NCT00988156|628527|P2|Intention-to-Treat Set (ITT)|Overall Study||134
259906|NCT00988156|628528|P1|Intention-to-Treat Set (ITT)|Overall Study||129
259907|NCT00988156|628527|P2|STARTED|Overall Study||155
259908|NCT00988156|628528|P1|STARTED|Overall Study||149
259909|NCT00988143|628539|P3|NOT COMPLETED|Overall Study||0
259910|NCT00988143|628540|P2|NOT COMPLETED|Overall Study||0
259911|NCT00988143|628541|P1|NOT COMPLETED|Overall Study||0
259912|NCT00988143|628539|P3|COMPLETED|Overall Study||190
259913|NCT00988143|628540|P2|COMPLETED|Overall Study||190
259914|NCT00988143|628541|P1|COMPLETED|Overall Study||220
259915|NCT00988143|628539|P3|STARTED|Overall Study||190
259916|NCT00988143|628540|P2|STARTED|Overall Study||190
259917|NCT00988143|628541|P1|STARTED|Overall Study||220
259918|NCT00988117|628573|P1|NOT COMPLETED|9.5 mg/24 Hours From Week 4 to 12||2
259919|NCT00988117|628573|P1|COMPLETED|9.5 mg/24 Hours From Week 4 to 12||12
259920|NCT00988117|628573|P1|STARTED|9.5 mg/24 Hours From Week 4 to 12||14
259921|NCT00988117|628573|P1|NOT COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||1
259922|NCT00988117|628573|P1|COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||14
259923|NCT00988117|628573|P1|STARTED|4.6 mg/24 Hours From Baseline to Week 4||15
259924|NCT00988091|628582|P2|NOT COMPLETED|Open-label Period||33
259925|NCT00988091|628583|P1|NOT COMPLETED|Open-label Period||21
259926|NCT00988091|628582|P2|COMPLETED|Open-label Period||192
259927|NCT00988091|628583|P1|COMPLETED|Open-label Period||208
259928|NCT00988091|628582|P2|STARTED|Open-label Period|Participation in the Open-label period was optional.|225
259929|NCT00988091|628583|P1|STARTED|Open-label Period|Participation in the Open-label period was optional.|229
259930|NCT00988091|628582|P2|NOT COMPLETED|Double-blind Period||47
259931|NCT00988091|628583|P1|NOT COMPLETED|Double-blind Period||43
259932|NCT00988091|628582|P2|COMPLETED|Double-blind Period||251
259933|NCT00988091|628583|P1|COMPLETED|Double-blind Period||255
259934|NCT00988091|628582|P2|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|295
259935|NCT00988091|628583|P1|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|294
259936|NCT00988091|628582|P2|STARTED|Double-blind Period||298
259937|NCT00988091|628583|P1|STARTED|Double-blind Period||298
259938|NCT00988065|628605|P3|NOT COMPLETED|Overall Study||15
259939|NCT00988065|628606|P2|NOT COMPLETED|Overall Study||23
259940|NCT00988065|628607|P1|NOT COMPLETED|Overall Study||13
259941|NCT00988065|628605|P3|COMPLETED|Overall Study||135
259942|NCT00988065|628606|P2|COMPLETED|Overall Study||127
259943|NCT00988065|628607|P1|COMPLETED|Overall Study||135
259944|NCT00988065|628605|P3|Received Third Randomized Dose|Overall Study||135
259945|NCT00988065|628606|P2|Received Third Randomized Dose|Overall Study||127
259946|NCT00988065|628607|P1|Received Third Randomized Dose|Overall Study||135
259947|NCT00988065|628605|P3|Received Second Randomized Dose|Overall Study||145
259948|NCT00988065|628606|P2|Received Second Randomized Dose|Overall Study||135
259949|NCT00988065|628607|P1|Received Second Randomized Dose|Overall Study||139
259950|NCT00988065|628605|P3|Received First Randomized Dose|Overall Study||150
259951|NCT00988065|628606|P2|Received First Randomized Dose|Overall Study||150
259952|NCT00988065|628607|P1|Received First Randomized Dose|Overall Study||148
259953|NCT00988065|628605|P3|STARTED|Overall Study|Randomized to double-blind treatment|150
259954|NCT00988065|628606|P2|STARTED|Overall Study|Randomized to double-blind treatment|150
259955|NCT00988065|628607|P1|STARTED|Overall Study|Randomized to double-blind treatment|148
259956|NCT00988052|628629|P2|NOT COMPLETED|Overall Study||416
259957|NCT00988052|628630|P1|NOT COMPLETED|Overall Study||423
259958|NCT00988052|628629|P2|COMPLETED|Overall Study||0
259959|NCT00988052|628630|P1|COMPLETED|Overall Study||0
259960|NCT00988052|628629|P2|STARTED|Overall Study||416
259961|NCT00988052|628630|P1|STARTED|Overall Study||423
259962|NCT00988000|628647|P3|NOT COMPLETED|Overall Study||0
259963|NCT00988000|628648|P2|NOT COMPLETED|Overall Study||0
259964|NCT00988000|628649|P1|NOT COMPLETED|Overall Study||0
259965|NCT00988000|628647|P3|COMPLETED|Overall Study||57
259966|NCT00988000|628648|P2|COMPLETED|Overall Study||51
259967|NCT00988000|628649|P1|COMPLETED|Overall Study||49
259968|NCT00988000|628647|P3|STARTED|Overall Study||57
259969|NCT00988000|628648|P2|STARTED|Overall Study||51
259970|NCT00988000|628649|P1|STARTED|Overall Study||49
259971|NCT00987948|628660|P1|NOT COMPLETED|Overall Study||3
259972|NCT00987948|628660|P1|COMPLETED|Overall Study||12
259973|NCT00987948|628660|P1|STARTED|Overall Study||15
259974|NCT00987935|628674|P9|NOT COMPLETED|Overall Study||32
259975|NCT00987935|628675|P8|NOT COMPLETED|Overall Study||62
259976|NCT00987935|628676|P7|NOT COMPLETED|Overall Study||15
259977|NCT00987935|628677|P6|NOT COMPLETED|Overall Study||3
259978|NCT00987935|628678|P5|NOT COMPLETED|Overall Study||7
259979|NCT00987935|628679|P4|NOT COMPLETED|Overall Study||3
259980|NCT00987935|628680|P3|NOT COMPLETED|Overall Study||3
259981|NCT00987935|628681|P2|NOT COMPLETED|Overall Study||3
259982|NCT00987935|628682|P1|NOT COMPLETED|Overall Study||4
259983|NCT00987935|628674|P9|COMPLETED|Overall Study||0
259984|NCT00987935|628675|P8|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
259985|NCT00987935|628676|P7|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
259986|NCT00987935|628677|P6|COMPLETED|Overall Study||0
259987|NCT00987935|628678|P5|COMPLETED|Overall Study||0
259988|NCT00987935|628679|P4|COMPLETED|Overall Study||0
259989|NCT00987935|628680|P3|COMPLETED|Overall Study||0
259990|NCT00987935|628681|P2|COMPLETED|Overall Study||0
259991|NCT00987935|628682|P1|COMPLETED|Overall Study||0
259992|NCT00987935|628674|P9|STARTED|Overall Study||32
259993|NCT00987935|628675|P8|STARTED|Overall Study||63
259994|NCT00987935|628676|P7|STARTED|Overall Study||16
259995|NCT00987935|628677|P6|STARTED|Overall Study||3
259996|NCT00987935|628678|P5|STARTED|Overall Study||7
259997|NCT00987935|628679|P4|STARTED|Overall Study||3
259998|NCT00987935|628680|P3|STARTED|Overall Study||3
259999|NCT00987935|628681|P2|STARTED|Overall Study||3
260000|NCT00987935|628682|P1|STARTED|Overall Study||4
260001|NCT00987831|628738|P3|NOT COMPLETED|Overall Study||0
260002|NCT00987831|628739|P2|NOT COMPLETED|Overall Study||3
260003|NCT00987831|628740|P1|NOT COMPLETED|Overall Study||1
260004|NCT00987831|628738|P3|COMPLETED|Overall Study|Anyone who entered this arm completed it the same day|62
260005|NCT00987831|628739|P2|COMPLETED|Overall Study|all controls returned for two visits|52
260006|NCT00987831|628740|P1|COMPLETED|Overall Study|40 patients completed in 6 months. 1 patient did not meet completion definition in 12 months.|40
260007|NCT00987831|628738|P3|STARTED|Overall Study|Anyone who entered this arm completed it the same day|62
260008|NCT00987831|628739|P2|STARTED|Overall Study|52 healthy controls donated biomarkers on two occasions in order to verify biomarkers ranges|55
260009|NCT00987831|628740|P1|STARTED|Overall Study|41 patients improved after depomedrol, if not improved, treated and moved to Group B|41
260010|NCT00987727|628751|P2|NOT COMPLETED|Overall Study||7
260011|NCT00987727|628752|P1|NOT COMPLETED|Overall Study||5
260012|NCT00987727|628751|P2|COMPLETED|Overall Study||34
260013|NCT00987727|628752|P1|COMPLETED|Overall Study||36
260014|NCT00987727|628751|P2|STARTED|Overall Study||41
260015|NCT00987727|628752|P1|STARTED|Overall Study||41
260016|NCT00987623|628762|P2|NOT COMPLETED|Overall Study||3
260017|NCT00987623|628763|P1|NOT COMPLETED|Overall Study||5
260018|NCT00987623|628762|P2|COMPLETED|Overall Study||151
260019|NCT00987623|628763|P1|COMPLETED|Overall Study||140
260020|NCT00987623|628762|P2|STARTED|Overall Study||154
260021|NCT00987623|628763|P1|STARTED|Overall Study||145
260022|NCT00987558|628769|P2|NOT COMPLETED|Overall Study||5
260023|NCT00987558|628770|P1|NOT COMPLETED|Overall Study||1
260024|NCT00987558|628769|P2|COMPLETED|Overall Study||12
260025|NCT00987558|628770|P1|COMPLETED|Overall Study||12
260026|NCT00987558|628769|P2|Eslicarbazepine Acetate + Simvastatin|Overall Study||17
260027|NCT00987558|628770|P1|Eslicarbazepine Acetate + Simvastatin|Overall Study||13
260028|NCT00987558|628769|P2|Washout|Overall Study||12
260029|NCT00987558|628770|P1|Washout|Overall Study||13
260030|NCT00987558|628769|P2|Simvastatin|Overall Study||12
260031|NCT00987558|628770|P1|Simvastatin|Overall Study||13
260032|NCT00987558|628769|P2|STARTED|Overall Study||17
260033|NCT00987558|628770|P1|STARTED|Overall Study||13
260034|NCT00987480|628783|P1|NOT COMPLETED|Overall Study||0
260035|NCT00987480|628783|P1|COMPLETED|Overall Study||45
260036|NCT00987480|628783|P1|STARTED|Overall Study||45
260037|NCT00987467|628792|P1|NOT COMPLETED|Overall Study||2
260038|NCT00987467|628792|P1|COMPLETED|Overall Study||10
260039|NCT00987467|628792|P1|STARTED|Overall Study||12
260040|NCT00987415|628799|P2|NOT COMPLETED|Overall Study||9
260041|NCT00987415|628800|P1|NOT COMPLETED|Overall Study||9
260042|NCT00987415|628799|P2|COMPLETED|Overall Study||116
260043|NCT00987415|628800|P1|COMPLETED|Overall Study||119
260044|NCT00987415|628799|P2|STARTED|Overall Study||125
260045|NCT00987415|628800|P1|STARTED|Overall Study||128
260046|NCT00987402|628816|P2|NOT COMPLETED|Overall Study||98
260047|NCT00987402|628817|P1|NOT COMPLETED|Overall Study||86
260048|NCT00987402|628816|P2|COMPLETED|Overall Study|98 patients did not have sufficient data|1537
260049|NCT00987402|628817|P1|COMPLETED|Overall Study|86 patients did not have some data, and could not be evaluated|1596
260050|NCT00987402|628816|P2|STARTED|Overall Study|January 2007 with crossover every 2 months|1635
260051|NCT00987402|628817|P1|STARTED|Overall Study|January 2007, with crossover every 2 months|1682
260052|NCT00987337|628826|P3|NOT COMPLETED|Overall Study||51
260053|NCT00987337|628827|P2|NOT COMPLETED|Overall Study||55
260054|NCT00987337|628828|P1|NOT COMPLETED|Overall Study||57
260055|NCT00987337|628826|P3|COMPLETED|Overall Study||45
260056|NCT00987337|628827|P2|COMPLETED|Overall Study||41
260057|NCT00987337|628828|P1|COMPLETED|Overall Study||39
260058|NCT00987337|628826|P3|STARTED|Overall Study||96
260059|NCT00987337|628827|P2|STARTED|Overall Study||96
260060|NCT00987337|628828|P1|STARTED|Overall Study||96
260061|NCT00986999|628872|P1|NOT COMPLETED|Overall Study||1
260062|NCT00986999|628872|P1|COMPLETED|Overall Study||6
260063|NCT00986999|628872|P1|STARTED|Overall Study||7
260064|NCT00986986|628883|P2|NOT COMPLETED|Overall Study||1
260065|NCT00986986|628884|P1|NOT COMPLETED|Overall Study||0
260066|NCT00986986|628883|P2|COMPLETED|Overall Study||9
260067|NCT00986986|628884|P1|COMPLETED|Overall Study||10
260068|NCT00986986|628883|P2|STARTED|Overall Study||10
260069|NCT00986986|628884|P1|STARTED|Overall Study||10
260070|NCT00986973|628894|P1|NOT COMPLETED|Overall Study||1
260071|NCT00986973|628894|P1|COMPLETED|Overall Study|One subject was withdrawn from the study due to poor compliance with KUVAN therapy.|5
260072|NCT00986973|628894|P1|STARTED|Overall Study||6
260073|NCT00986960|628906|P2|NOT COMPLETED|Overall Study||0
260074|NCT00986960|628907|P1|NOT COMPLETED|Overall Study||0
260075|NCT00986960|628906|P2|COMPLETED|Overall Study||0
260076|NCT00986960|628907|P1|COMPLETED|Overall Study||0
260077|NCT00986960|628906|P2|STARTED|Overall Study||0
260078|NCT00986960|628907|P1|STARTED|Overall Study||0
260079|NCT00986947|628913|P1|NOT COMPLETED|Overall Study||20
260080|NCT00986947|628913|P1|COMPLETED|Overall Study||0
260081|NCT00986947|628913|P1|STARTED|Overall Study||20
260082|NCT00986921|628920|P2|NOT COMPLETED|Overall Study||0
260083|NCT00986921|628921|P1|NOT COMPLETED|Overall Study||1
260084|NCT00986921|628920|P2|COMPLETED|Overall Study||25
260085|NCT00986921|628921|P1|COMPLETED|Overall Study||24
260086|NCT00986921|628920|P2|STARTED|Overall Study||25
260087|NCT00986921|628921|P1|STARTED|Overall Study||25
260088|NCT00986856|628933|P2|NOT COMPLETED|Overall Study||0
260089|NCT00986856|628934|P1|NOT COMPLETED|Overall Study||0
260090|NCT00986856|628933|P2|COMPLETED|Overall Study||16
260091|NCT00986856|628934|P1|COMPLETED|Overall Study||42
260092|NCT00986856|628933|P2|STARTED|Overall Study||16
260093|NCT00986856|628934|P1|STARTED|Overall Study||42
260094|NCT00986674|628957|P3|NOT COMPLETED|Overall Study||48
260095|NCT00986674|628958|P2|NOT COMPLETED|Overall Study||45
260096|NCT00986674|628959|P1|NOT COMPLETED|Overall Study||47
260097|NCT00986674|628957|P3|COMPLETED|Overall Study||0
260098|NCT00986674|628958|P2|COMPLETED|Overall Study||0
260099|NCT00986674|628959|P1|COMPLETED|Overall Study||0
260100|NCT00986674|628957|P3|Eligible and Treated|Overall Study||47
260101|NCT00986674|628958|P2|Eligible and Treated|Overall Study||41
260102|NCT00986674|628959|P1|Eligible and Treated|Overall Study||39
260103|NCT00986674|628957|P3|Treated|Overall Study||47
260104|NCT00986674|628958|P2|Treated|Overall Study||42
260105|NCT00986674|628959|P1|Treated|Overall Study||43
260106|NCT00986674|628957|P3|STARTED|Overall Study||48
260107|NCT00986674|628958|P2|STARTED|Overall Study||45
260108|NCT00986674|628959|P1|STARTED|Overall Study||47
260109|NCT00986583|628975|P2|NOT COMPLETED|Overall Study||0
260110|NCT00986583|628976|P1|NOT COMPLETED|Overall Study||0
260111|NCT00986583|628975|P2|COMPLETED|Overall Study||32
260112|NCT00986583|628976|P1|COMPLETED|Overall Study||38
260113|NCT00986583|628975|P2|STARTED|Overall Study||32
260114|NCT00986583|628976|P1|STARTED|Overall Study||38
260115|NCT00986570|628992|P1|NOT COMPLETED|Overall Study||7
260116|NCT00986570|628992|P1|COMPLETED|Overall Study||114
260117|NCT00986570|628992|P1|STARTED|Overall Study||121
260118|NCT00986544|628998|P2|NOT COMPLETED|Overall Study||0
260119|NCT00986544|628999|P1|NOT COMPLETED|Overall Study||0
260120|NCT00986544|628998|P2|COMPLETED|Overall Study||53
260121|NCT00986544|628999|P1|COMPLETED|Overall Study||53
260122|NCT00986544|628998|P2|STARTED|Overall Study||53
260123|NCT00986544|628999|P1|STARTED|Overall Study||53
260124|NCT00986479|629009|P2|NOT COMPLETED|Period 2||0
260125|NCT00986479|629010|P1|NOT COMPLETED|Period 2||0
260126|NCT00986479|629009|P2|COMPLETED|Period 2||10
260127|NCT00986479|629010|P1|COMPLETED|Period 2||10
260128|NCT00986479|629009|P2|STARTED|Period 2||10
260129|NCT00986479|629010|P1|STARTED|Period 2||10
260130|NCT00986479|629009|P2|NOT COMPLETED|Period 1||0
260131|NCT00986479|629010|P1|NOT COMPLETED|Period 1||2
260132|NCT00986479|629009|P2|COMPLETED|Period 1||10
260133|NCT00986479|629010|P1|COMPLETED|Period 1||10
260134|NCT00986479|629009|P2|STARTED|Period 1||10
260135|NCT00986479|629010|P1|STARTED|Period 1||12
260136|NCT00986453|629040|P1|NOT COMPLETED|Overall Study||2
260137|NCT00986453|629040|P1|COMPLETED|Overall Study||43
260138|NCT00986453|629040|P1|STARTED|Overall Study||45
260139|NCT00986427|629056|P2|NOT COMPLETED|Overall Study||0
260140|NCT00986427|629057|P1|NOT COMPLETED|Overall Study||4
260141|NCT00986427|629056|P2|COMPLETED|Overall Study||12
260142|NCT00986427|629057|P1|COMPLETED|Overall Study||8
260143|NCT00986427|629056|P2|STARTED|Overall Study||12
260144|NCT00986427|629057|P1|STARTED|Overall Study||12
260145|NCT00986401|629073|P2|NOT COMPLETED|Period 2||0
260146|NCT00986401|629074|P1|NOT COMPLETED|Period 2||0
260147|NCT00986401|629073|P2|COMPLETED|Period 2||21
260148|NCT00986401|629074|P1|COMPLETED|Period 2||22
260149|NCT00986401|629073|P2|STARTED|Period 2||21
260150|NCT00986401|629074|P1|STARTED|Period 2||22
260151|NCT00986401|629073|P2|NOT COMPLETED|Period 1||1
260152|NCT00986401|629074|P1|NOT COMPLETED|Period 1||0
260153|NCT00986401|629073|P2|COMPLETED|Period 1||21
260154|NCT00986401|629074|P1|COMPLETED|Period 1||22
260155|NCT00986401|629073|P2|STARTED|Period 1||22
260156|NCT00986401|629074|P1|STARTED|Period 1||22
260157|NCT00986362|629085|P2|NOT COMPLETED|Overall Study||1
260158|NCT00986362|629086|P1|NOT COMPLETED|Overall Study||2
260159|NCT00986362|629085|P2|COMPLETED|Overall Study|7 eyes completed the study (in 7 subjects).|7
260160|NCT00986362|629086|P1|COMPLETED|Overall Study|14 eyes completed the study (in 14 subjects).|14
260161|NCT00986362|629085|P2|STARTED|Overall Study|8 eyes randomized and treated (in 8 subjects).|8
260162|NCT00986362|629086|P1|STARTED|Overall Study|16 eyes randomized and treated (in 15 subjects).|16
260163|NCT00986349|629092|P1|NOT COMPLETED|Overall Study||7
260164|NCT00986349|629092|P1|COMPLETED|Overall Study||16
260165|NCT00986349|629092|P1|Early Explant|Overall Study||4
260166|NCT00986349|629092|P1|Successful Implant Procedure|Overall Study|successful device implant procedure|20
260167|NCT00986349|629092|P1|STARTED|Overall Study|attempted implant procedures|23
260168|NCT00986310|629107|P2|NOT COMPLETED|Overall Study||0
260169|NCT00986310|629108|P1|NOT COMPLETED|Overall Study||0
260170|NCT00986310|629107|P2|COMPLETED|Overall Study||0
260171|NCT00986310|629108|P1|COMPLETED|Overall Study||0
260172|NCT00986310|629107|P2|STARTED|Overall Study||0
260173|NCT00986310|629108|P1|STARTED|Overall Study||0
260174|NCT00986258|629116|P1|NOT COMPLETED|Maintenance Period||9
260175|NCT00986258|629116|P1|COMPLETED|Maintenance Period||93
260176|NCT00986258|629116|P1|STARTED|Maintenance Period||102
260177|NCT00986258|629116|P1|NOT COMPLETED|Titration and Optimal Dose Period||23
260178|NCT00986258|629116|P1|COMPLETED|Titration and Optimal Dose Period||102
260179|NCT00986258|629116|P1|STARTED|Titration and Optimal Dose Period||125
260180|NCT00986258|629116|P1|NOT COMPLETED|Observation Period||11
260181|NCT00986258|629116|P1|COMPLETED|Observation Period||125
260182|NCT00986258|629116|P1|STARTED|Observation Period||136
260183|NCT00986245|629144|P2|NOT COMPLETED|Second Intervention||1
260184|NCT00986245|629145|P1|NOT COMPLETED|Second Intervention||2
260185|NCT00986245|629144|P2|COMPLETED|Second Intervention||32
260186|NCT00986245|629145|P1|COMPLETED|Second Intervention||29
260187|NCT00986245|629144|P2|STARTED|Second Intervention||33
260188|NCT00986245|629145|P1|STARTED|Second Intervention||31
260189|NCT00986245|629144|P2|NOT COMPLETED|First Intervention||8
260190|NCT00986245|629145|P1|NOT COMPLETED|First Intervention||10
260191|NCT00986245|629144|P2|COMPLETED|First Intervention||33
260192|NCT00986245|629145|P1|COMPLETED|First Intervention||31
260193|NCT00986245|629144|P2|STARTED|First Intervention||41
260194|NCT00986245|629145|P1|STARTED|First Intervention||41
260195|NCT00986232|629182|P4|NOT COMPLETED|Overall Study||20
260196|NCT00986232|629183|P3|NOT COMPLETED|Overall Study||35
260197|NCT00986232|629184|P2|NOT COMPLETED|Overall Study||50
260198|NCT00986232|629185|P1|NOT COMPLETED|Overall Study||51
260199|NCT00986232|629182|P4|COMPLETED|Overall Study||370
260200|NCT00986232|629183|P3|COMPLETED|Overall Study||346
260201|NCT00986232|629184|P2|COMPLETED|Overall Study||343
260202|NCT00986232|629185|P1|COMPLETED|Overall Study||336
260203|NCT00986232|629182|P4|Vaccination Visit 2|Overall Study||0
260204|NCT00986232|629183|P3|Vaccination Visit 2|Overall Study||360
260205|NCT00986232|629184|P2|Vaccination Visit 2|Overall Study||365
260206|NCT00986232|629185|P1|Vaccination Visit 2|Overall Study||360
260207|NCT00986232|629182|P4|Vaccination Visit 1|Overall Study||390
260208|NCT00986232|629183|P3|Vaccination Visit 1|Overall Study||381
260209|NCT00986232|629184|P2|Vaccination Visit 1|Overall Study||393
260210|NCT00986232|629185|P1|Vaccination Visit 1|Overall Study||387
260211|NCT00986232|629182|P4|STARTED|Overall Study|Excludes 1 patient who was randomized to receive M-M-R™ II + PUVV, but was not vaccinated.|390
260212|NCT00986232|629183|P3|STARTED|Overall Study||381
260213|NCT00986232|629184|P2|STARTED|Overall Study|Excludes 1 patient who was randomized to receive ProQuad (Middle Dose), but was not vaccinated.|393
260214|NCT00986232|629185|P1|STARTED|Overall Study||387
260215|NCT00986180|629259|P2|NOT COMPLETED|Overall Study||56
260216|NCT00986180|629260|P1|NOT COMPLETED|Overall Study||44
260217|NCT00986180|629259|P2|COMPLETED|Overall Study||268
260218|NCT00986180|629260|P1|COMPLETED|Overall Study||277
260219|NCT00986180|629259|P2|STARTED|Overall Study||324
260220|NCT00986180|629260|P1|STARTED|Overall Study||321
260221|NCT00986154|629338|P2|NOT COMPLETED|Overall Study||194
260222|NCT00986154|629339|P1|NOT COMPLETED|Overall Study||206
260223|NCT00986154|629338|P2|COMPLETED|Overall Study||3955
260224|NCT00986154|629339|P1|COMPLETED|Overall Study||3937
260225|NCT00986154|629338|P2|Safety Analysis Set (Received Drug)|Overall Study||4122
260226|NCT00986154|629339|P1|Safety Analysis Set (Received Drug)|Overall Study||4118
260227|NCT00986154|629338|P2|STARTED|Overall Study||4149
260228|NCT00986154|629339|P1|STARTED|Overall Study||4143
260229|NCT00986102|629353|P4|NOT COMPLETED|Overall Study||1
260230|NCT00986102|629354|P3|NOT COMPLETED|Overall Study||0
260231|NCT00986102|629355|P2|NOT COMPLETED|Overall Study||2
260232|NCT00986102|629356|P1|NOT COMPLETED|Overall Study||1
260233|NCT00986102|629353|P4|COMPLETED|Overall Study||66
260234|NCT00986102|629354|P3|COMPLETED|Overall Study||19
260235|NCT00986102|629355|P2|COMPLETED|Overall Study||75
260236|NCT00986102|629356|P1|COMPLETED|Overall Study||52
260237|NCT00986102|629353|P4|STARTED|Overall Study|Number of participants who received study medication|67
260238|NCT00986102|629354|P3|STARTED|Overall Study|Number of participants who received study medication|19
260239|NCT00986102|629355|P2|STARTED|Overall Study|Number of participants who received study medication|77
260240|NCT00986102|629356|P1|STARTED|Overall Study|Number of participants who received study medication|53
260241|NCT00985985|629406|P4|NOT COMPLETED|Overall Study||13
260242|NCT00985985|629407|P3|NOT COMPLETED|Overall Study||11
260243|NCT00985985|629408|P2|NOT COMPLETED|Overall Study||24
260244|NCT00985985|629409|P1|NOT COMPLETED|Overall Study||24
260245|NCT00985985|629406|P4|COMPLETED|Overall Study||107
260246|NCT00985985|629407|P3|COMPLETED|Overall Study||109
260247|NCT00985985|629408|P2|COMPLETED|Overall Study||218
260248|NCT00985985|629409|P1|COMPLETED|Overall Study||217
260249|NCT00985985|629406|P4|Full Analysis Set (FAS) Population|Overall Study|One participant withdrew consent and was not included as the FAS population.|119
260250|NCT00985985|629407|P3|Full Analysis Set (FAS) Population|Overall Study||120
260251|NCT00985985|629408|P2|Full Analysis Set (FAS) Population|Overall Study||242
260252|NCT00985985|629409|P1|Full Analysis Set (FAS) Population|Overall Study||241
260253|NCT00985985|629406|P4|Safety Population|Overall Study||118
260254|NCT00985985|629407|P3|Safety Population|Overall Study||119
260255|NCT00985985|629408|P2|Safety Population|Overall Study||242
260256|NCT00985985|629409|P1|Safety Population|Overall Study||241
260257|NCT00985985|629406|P4|STARTED|Overall Study||120
260258|NCT00985985|629407|P3|STARTED|Overall Study||120
260259|NCT00985985|629408|P2|STARTED|Overall Study||242
260260|NCT00985985|629409|P1|STARTED|Overall Study||241
260261|NCT00985959|629450|P3|NOT COMPLETED|Overall Study||59
260262|NCT00985959|629451|P2|NOT COMPLETED|Overall Study||3
260263|NCT00985959|629452|P1|NOT COMPLETED|Overall Study||3
260264|NCT00985959|629450|P3|COMPLETED|Overall Study||28
260265|NCT00985959|629451|P2|COMPLETED|Overall Study|Completed all 9 cycles|3
260266|NCT00985959|629452|P1|COMPLETED|Overall Study|Completed all 9 cycles|3
260267|NCT00985959|629450|P3|STARTED|Overall Study|Number of participants treated|87
260268|NCT00985959|629451|P2|STARTED|Overall Study|Number of participants treated|6
260269|NCT00985959|629452|P1|STARTED|Overall Study|Number of participants treated|6
260270|NCT00985946|629475|P1|NOT COMPLETED|Overall Study||7
260271|NCT00985946|629475|P1|COMPLETED|Overall Study||8
260272|NCT00985946|629475|P1|STARTED|Overall Study|Eighty-seven percent (n=13) were evaluable for response.|15
260273|NCT00985829|629483|P1|NOT COMPLETED|Overall Study||0
260274|NCT00985829|629483|P1|COMPLETED|Overall Study||28
260275|NCT00985829|629483|P1|STARTED|Overall Study||28
260276|NCT00985790|629494|P2|NOT COMPLETED|Overall Study||8
260277|NCT00985790|629495|P1|NOT COMPLETED|Overall Study||7
260278|NCT00985790|629494|P2|COMPLETED|Overall Study||293
260279|NCT00985790|629495|P1|COMPLETED|Overall Study||291
260280|NCT00985790|629494|P2|STARTED|Overall Study|97 were primed and 204 were unprimed subjects.|301
260281|NCT00985790|629495|P1|STARTED|Overall Study|95 were primed and 203 were unprimed subjects.|298
260282|NCT00985751|629536|P5|NOT COMPLETED|Overall Study||1
260283|NCT00985751|629537|P4|NOT COMPLETED|Overall Study||0
260284|NCT00985751|629538|P3|NOT COMPLETED|Overall Study||0
260285|NCT00985751|629539|P2|NOT COMPLETED|Overall Study||0
260286|NCT00985751|629540|P1|NOT COMPLETED|Overall Study||0
260287|NCT00985751|629536|P5|COMPLETED|Overall Study||50
260288|NCT00985751|629537|P4|COMPLETED|Overall Study||51
260289|NCT00985751|629538|P3|COMPLETED|Overall Study||52
260290|NCT00985751|629539|P2|COMPLETED|Overall Study||52
260291|NCT00985751|629540|P1|COMPLETED|Overall Study||51
260292|NCT00985751|629536|P5|STARTED|Overall Study||51
260293|NCT00985751|629537|P4|STARTED|Overall Study||51
260294|NCT00985751|629538|P3|STARTED|Overall Study||52
260295|NCT00985751|629539|P2|STARTED|Overall Study||52
260296|NCT00985751|629540|P1|STARTED|Overall Study||51
260297|NCT00985738|629603|P2|NOT COMPLETED|Overall Study||8
260298|NCT00985738|629604|P1|NOT COMPLETED|Overall Study||8
260299|NCT00985738|629603|P2|COMPLETED|Overall Study||0
260300|NCT00985738|629604|P1|COMPLETED|Overall Study||0
260301|NCT00985738|629603|P2|STARTED|Overall Study||8
260302|NCT00985738|629604|P1|STARTED|Overall Study||8
260303|NCT00985725|629612|P2|NOT COMPLETED|Overall Study||13
260304|NCT00985725|629613|P1|NOT COMPLETED|Overall Study||11
260305|NCT00985725|629612|P2|COMPLETED|Overall Study||59
260306|NCT00985725|629613|P1|COMPLETED|Overall Study||60
260307|NCT00985725|629612|P2|STARTED|Overall Study||72
260308|NCT00985725|629613|P1|STARTED|Overall Study||71
260309|NCT00985712|629649|P2|NOT COMPLETED|Overall Study||7
260310|NCT00985712|629650|P1|NOT COMPLETED|Overall Study||6
260311|NCT00985712|629649|P2|COMPLETED|Overall Study||123
260312|NCT00985712|629650|P1|COMPLETED|Overall Study||127
260313|NCT00985712|629649|P2|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|129
260314|NCT00985712|629650|P1|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|128
260315|NCT00985712|629649|P2|Received at Least One Dose of Study Drug|Overall Study||130
260316|NCT00985712|629650|P1|Received at Least One Dose of Study Drug|Overall Study||131
260317|NCT00985712|629649|P2|STARTED|Overall Study||130
260318|NCT00985712|629650|P1|STARTED|Overall Study||133
260319|NCT00985686|629668|P4|NOT COMPLETED|Overall Study||2
260320|NCT00985686|629669|P3|NOT COMPLETED|Overall Study||0
260321|NCT00985686|629670|P2|NOT COMPLETED|Overall Study||1
260322|NCT00985686|629671|P1|NOT COMPLETED|Overall Study||1
260323|NCT00985686|629668|P4|COMPLETED|Overall Study||14
260324|NCT00985686|629669|P3|COMPLETED|Overall Study||13
260325|NCT00985686|629670|P2|COMPLETED|Overall Study||15
260326|NCT00985686|629671|P1|COMPLETED|Overall Study||17
260327|NCT00985686|629668|P4|Visit 4: Data Collection at 24 Weeks|Overall Study||14
260328|NCT00985686|629669|P3|Visit 4: Data Collection at 24 Weeks|Overall Study||13
260329|NCT00985686|629670|P2|Visit 4: Data Collection at 24 Weeks|Overall Study||15
260330|NCT00985686|629671|P1|Visit 4: Data Collection at 24 Weeks|Overall Study||17
260331|NCT00985686|629668|P4|Visit 3: Data Collection at 16 Weeks|Overall Study||16
260332|NCT00985686|629669|P3|Visit 3: Data Collection at 16 Weeks|Overall Study||13
260333|NCT00985686|629670|P2|Visit 3: Data Collection at 16 Weeks|Overall Study||15
260334|NCT00985686|629671|P1|Visit 3: Data Collection at 16 Weeks|Overall Study||17
260335|NCT00985686|629668|P4|Visit 2: Data Collection at 8 Weeks|Overall Study||16
260336|NCT00985686|629669|P3|Visit 2: Data Collection at 8 Weeks|Overall Study||13
260337|NCT00985686|629670|P2|Visit 2: Data Collection at 8 Weeks|Overall Study||15
260338|NCT00985686|629671|P1|Visit 2: Data Collection at 8 Weeks|Overall Study||18
260339|NCT00985686|629668|P4|Visit 1: Baseline Data Collection|Overall Study||16
260340|NCT00985686|629669|P3|Visit 1: Baseline Data Collection|Overall Study||13
260341|NCT00985686|629670|P2|Visit 1: Baseline Data Collection|Overall Study||15
260342|NCT00985686|629671|P1|Visit 1: Baseline Data Collection|Overall Study||18
260343|NCT00985686|629668|P4|STARTED|Overall Study||16
260344|NCT00985686|629669|P3|STARTED|Overall Study||13
260345|NCT00985686|629670|P2|STARTED|Overall Study||16
260346|NCT00985686|629671|P1|STARTED|Overall Study||18
260347|NCT00985673|629685|P6|NOT COMPLETED|Overall Study||6
260348|NCT00985673|629686|P5|NOT COMPLETED|Overall Study||8
260349|NCT00985673|629687|P4|NOT COMPLETED|Overall Study||12
260350|NCT00985673|629688|P3|NOT COMPLETED|Overall Study||12
260351|NCT00985673|629689|P2|NOT COMPLETED|Overall Study||11
260352|NCT00985673|629690|P1|NOT COMPLETED|Overall Study||7
260353|NCT00985673|629685|P6|COMPLETED|Overall Study||96
260354|NCT00985673|629686|P5|COMPLETED|Overall Study||93
260355|NCT00985673|629687|P4|COMPLETED|Overall Study||88
260356|NCT00985673|629688|P3|COMPLETED|Overall Study||90
260357|NCT00985673|629689|P2|COMPLETED|Overall Study||93
260358|NCT00985673|629690|P1|COMPLETED|Overall Study||95
260359|NCT00985673|629685|P6|STARTED|Overall Study||102
260360|NCT00985673|629686|P5|STARTED|Overall Study||101
260361|NCT00985673|629687|P4|STARTED|Overall Study||100
260362|NCT00985673|629688|P3|STARTED|Overall Study||102
260363|NCT00985673|629689|P2|STARTED|Overall Study||104
260364|NCT00985673|629690|P1|STARTED|Overall Study||102
260365|NCT00985543|629941|P1|NOT COMPLETED|Overall Study||0
260366|NCT00985543|629941|P1|COMPLETED|Overall Study||22
260367|NCT00985543|629941|P1|STARTED|Overall Study||22
260368|NCT00985504|629952|P2|NOT COMPLETED|Optimization Period||23
260369|NCT00985504|629953|P1|NOT COMPLETED|Optimization Period||26
260370|NCT00985504|629952|P2|COMPLETED|Optimization Period||204
260371|NCT00985504|629953|P1|COMPLETED|Optimization Period||203
260372|NCT00985504|629952|P2|STARTED|Optimization Period||227
260373|NCT00985504|629953|P1|STARTED|Optimization Period||229
260374|NCT00985504|629952|P2|NOT COMPLETED|Acute Treatment Period||12
260375|NCT00985504|629953|P1|NOT COMPLETED|Acute Treatment Period||15
260376|NCT00985504|629952|P2|COMPLETED|Acute Treatment Period||227
260377|NCT00985504|629953|P1|COMPLETED|Acute Treatment Period||229
260378|NCT00985504|629952|P2|STARTED|Acute Treatment Period||239
260379|NCT00985504|629953|P1|STARTED|Acute Treatment Period||244
260380|NCT00985491|629979|P1|NOT COMPLETED|Overall Study||19
260381|NCT00985491|629979|P1|COMPLETED|Overall Study|43 subjects received a device, 27 subjects completed 12 month implant period|27
260382|NCT00985491|629979|P1|Received Device|Overall Study||43
260383|NCT00985491|629979|P1|STARTED|Overall Study|46 subjects underwent an attempted implantation procedure|46
260384|NCT00985465|629986|P2|NOT COMPLETED|Overall Study||3
260385|NCT00985465|629987|P1|NOT COMPLETED|Overall Study||1
260386|NCT00985465|629986|P2|COMPLETED|Overall Study||66
260387|NCT00985465|629987|P1|COMPLETED|Overall Study||140
260388|NCT00985465|629986|P2|STARTED|Overall Study||69
260389|NCT00985465|629987|P1|STARTED|Overall Study||141
260390|NCT00985439|630014|P4|NOT COMPLETED|Overall Study||0
260391|NCT00985439|630015|P3|NOT COMPLETED|Overall Study||1
260392|NCT00985439|630016|P2|NOT COMPLETED|Overall Study||0
260393|NCT00985439|630017|P1|NOT COMPLETED|Overall Study||0
260394|NCT00985439|630014|P4|COMPLETED|Overall Study||51
260395|NCT00985439|630015|P3|COMPLETED|Overall Study||50
260396|NCT00985439|630016|P2|COMPLETED|Overall Study||51
260397|NCT00985439|630017|P1|COMPLETED|Overall Study||49
260398|NCT00985439|630014|P4|STARTED|Overall Study||51
260399|NCT00985439|630015|P3|STARTED|Overall Study||51
260400|NCT00985439|630016|P2|STARTED|Overall Study||51
260401|NCT00985439|630017|P1|STARTED|Overall Study||49
260402|NCT00985257|630027|P1|NOT COMPLETED|Overall Study||0
260403|NCT00985257|630027|P1|COMPLETED|Overall Study||123
260404|NCT00985257|630027|P1|STARTED|Overall Study||123
260405|NCT00985231|630033|P2|NOT COMPLETED|Overall Study||3
260406|NCT00985231|630034|P1|NOT COMPLETED|Overall Study||3
260407|NCT00985231|630033|P2|COMPLETED|Overall Study||129
260408|NCT00985231|630034|P1|COMPLETED|Overall Study||130
260409|NCT00985231|630033|P2|STARTED|Overall Study||132
260410|NCT00985231|630034|P1|STARTED|Overall Study||133
260411|NCT00985192|630042|P1|NOT COMPLETED|Overall Study||4
260412|NCT00985192|630042|P1|COMPLETED|Overall Study||45
260413|NCT00985192|630042|P1|STARTED|Overall Study||49
260414|NCT00985166|630054|P3|NOT COMPLETED|Overall Study||7
260415|NCT00985166|630055|P2|NOT COMPLETED|Overall Study||4
260416|NCT00985166|630056|P1|NOT COMPLETED|Overall Study||9
260417|NCT00985166|630054|P3|COMPLETED|Overall Study||188
260418|NCT00985166|630055|P2|COMPLETED|Overall Study||201
260419|NCT00985166|630056|P1|COMPLETED|Overall Study||392
260420|NCT00985166|630054|P3|Vaccinated at Visit 1|Overall Study||195
260421|NCT00985166|630055|P2|Vaccinated at Visit 1|Overall Study||205
260422|NCT00985166|630056|P1|Vaccinated at Visit 1|Overall Study||399
260423|NCT00985166|630054|P3|STARTED|Overall Study||195
260424|NCT00985166|630055|P2|STARTED|Overall Study||205
260425|NCT00985166|630056|P1|STARTED|Overall Study|Two randomized subjects withdrew consent before vaccination: no demographic information available.|401
260426|NCT00985153|630076|P4|NOT COMPLETED|Overall Study||47
260427|NCT00985153|630077|P3|NOT COMPLETED|Overall Study||44
260428|NCT00985153|630078|P2|NOT COMPLETED|Overall Study||44
260429|NCT00985153|630079|P1|NOT COMPLETED|Overall Study||35
260430|NCT00985153|630076|P4|COMPLETED|Overall Study||965
260431|NCT00985153|630077|P3|COMPLETED|Overall Study||918
260432|NCT00985153|630078|P2|COMPLETED|Overall Study||924
260433|NCT00985153|630079|P1|COMPLETED|Overall Study||950
260434|NCT00985153|630076|P4|Vaccinated at Visit 1|Overall Study||1012
260435|NCT00985153|630077|P3|Vaccinated at Visit 1|Overall Study||962
260436|NCT00985153|630078|P2|Vaccinated at Visit 1|Overall Study||968
260437|NCT00985153|630079|P1|Vaccinated at Visit 1|Overall Study||985
260438|NCT00985153|630076|P4|STARTED|Overall Study||1012
260439|NCT00985153|630077|P3|STARTED|Overall Study||962
260440|NCT00985153|630078|P2|STARTED|Overall Study||968
260441|NCT00985153|630079|P1|STARTED|Overall Study||985
260442|NCT00985140|630121|P1|NOT COMPLETED|Overall Study||0
260443|NCT00985140|630121|P1|COMPLETED|Overall Study||15
260444|NCT00985140|630121|P1|STARTED|Overall Study||15
260445|NCT00985114|630127|P2|NOT COMPLETED|Overall Study||2
260446|NCT00985114|630128|P1|NOT COMPLETED|Overall Study||1
260447|NCT00985114|630127|P2|COMPLETED|Overall Study||37
260448|NCT00985114|630128|P1|COMPLETED|Overall Study||33
260449|NCT00985114|630127|P2|Diet + Lifestyle Counseling Cross-over|Overall Study|Received device for intended period of 12 months with 6 months follow up|28
260450|NCT00985114|630128|P1|Diet + Lifestyle Counseling Cross-over|Overall Study||0
260451|NCT00985114|630127|P2|STARTED|Overall Study||39
260452|NCT00985114|630128|P1|STARTED|Overall Study|38 randomized, 34 received the device|34
260453|NCT00985088|630142|P8|NOT COMPLETED|Overall Study||6
260454|NCT00985088|630143|P7|NOT COMPLETED|Overall Study||4
260455|NCT00985088|630144|P6|NOT COMPLETED|Overall Study||7
260456|NCT00985088|630145|P5|NOT COMPLETED|Overall Study||9
260457|NCT00985088|630146|P4|NOT COMPLETED|Overall Study||7
260458|NCT00985088|630147|P3|NOT COMPLETED|Overall Study||4
260459|NCT00985088|630148|P2|NOT COMPLETED|Overall Study||2
260460|NCT00985088|630149|P1|NOT COMPLETED|Overall Study||11
260461|NCT00985088|630142|P8|COMPLETED|Overall Study||216
260462|NCT00985088|630143|P7|COMPLETED|Overall Study||107
260463|NCT00985088|630144|P6|COMPLETED|Overall Study||108
260464|NCT00985088|630145|P5|COMPLETED|Overall Study||214
260465|NCT00985088|630146|P4|COMPLETED|Overall Study||214
260466|NCT00985088|630147|P3|COMPLETED|Overall Study||108
260467|NCT00985088|630148|P2|COMPLETED|Overall Study||112
260468|NCT00985088|630149|P1|COMPLETED|Overall Study||211
260469|NCT00985088|630142|P8|STARTED|Overall Study||222
260470|NCT00985088|630143|P7|STARTED|Overall Study||111
260471|NCT00985088|630144|P6|STARTED|Overall Study||115
260472|NCT00985088|630145|P5|STARTED|Overall Study||223
260473|NCT00985088|630146|P4|STARTED|Overall Study||221
260474|NCT00985088|630147|P3|STARTED|Overall Study||112
260475|NCT00985088|630148|P2|STARTED|Overall Study||114
260476|NCT00985088|630149|P1|STARTED|Overall Study||222
260477|NCT00985010|630407|P2|NOT COMPLETED|Overall Study||0
260478|NCT00985010|630408|P1|NOT COMPLETED|Overall Study||0
260479|NCT00985010|630407|P2|COMPLETED|Overall Study||5
260480|NCT00985010|630408|P1|COMPLETED|Overall Study||4
260481|NCT00985010|630407|P2|STARTED|Overall Study||5
260482|NCT00985010|630408|P1|STARTED|Overall Study||4
260483|NCT00984867|630418|P2|NOT COMPLETED|Overall Study||17
260484|NCT00984867|630419|P1|NOT COMPLETED|Overall Study||23
260485|NCT00984867|630418|P2|COMPLETED|Overall Study||208
260486|NCT00984867|630419|P1|COMPLETED|Overall Study||203
260487|NCT00984867|630418|P2|STARTED|Overall Study|Of the 225 randomized and treated participants only 223 were included in the full analysis set.|225
260488|NCT00984867|630419|P1|STARTED|Overall Study|Of the 226 randomized and treated participants only 224 were included in the full analysis set.|226
260489|NCT00984815|630437|P1|NOT COMPLETED|Overall Study||30
260490|NCT00984815|630437|P1|COMPLETED|Overall Study||56
260491|NCT00984815|630437|P1|STARTED|Overall Study||86
260492|NCT00984698|630446|P2|NOT COMPLETED|Overall Study||8
260493|NCT00984698|630447|P1|NOT COMPLETED|Overall Study||3
260494|NCT00984698|630446|P2|COMPLETED|Overall Study||14
260495|NCT00984698|630447|P1|COMPLETED|Overall Study||18
260496|NCT00984698|630446|P2|STARTED|Overall Study||22
260497|NCT00984698|630447|P1|STARTED|Overall Study||21
260498|NCT00984659|630459|P4|NOT COMPLETED|6-week Double-blind Treatment Period||13
260499|NCT00984659|630460|P3|NOT COMPLETED|6-week Double-blind Treatment Period||11
260500|NCT00984659|630461|P2|NOT COMPLETED|6-week Double-blind Treatment Period||6
260501|NCT00984659|630462|P1|NOT COMPLETED|6-week Double-blind Treatment Period||0
260502|NCT00984659|630459|P4|COMPLETED|6-week Double-blind Treatment Period||126
260503|NCT00984659|630460|P3|COMPLETED|6-week Double-blind Treatment Period||141
260504|NCT00984659|630461|P2|COMPLETED|6-week Double-blind Treatment Period||69
260505|NCT00984659|630462|P1|COMPLETED|6-week Double-blind Treatment Period||0
260506|NCT00984659|630459|P4|STARTED|6-week Double-blind Treatment Period||139
260507|NCT00984659|630460|P3|STARTED|6-week Double-blind Treatment Period||152
260508|NCT00984659|630461|P2|STARTED|6-week Double-blind Treatment Period||75
260509|NCT00984659|630462|P1|STARTED|6-week Double-blind Treatment Period||0
260510|NCT00984659|630459|P4|NOT COMPLETED|2-week Run-in Period||0
260511|NCT00984659|630460|P3|NOT COMPLETED|2-week Run-in Period||0
260512|NCT00984659|630461|P2|NOT COMPLETED|2-week Run-in Period||0
260513|NCT00984659|630462|P1|NOT COMPLETED|2-week Run-in Period||52
260514|NCT00984659|630459|P4|COMPLETED|2-week Run-in Period||0
260515|NCT00984659|630460|P3|COMPLETED|2-week Run-in Period||0
260516|NCT00984659|630461|P2|COMPLETED|2-week Run-in Period||0
260517|NCT00984659|630462|P1|COMPLETED|2-week Run-in Period||366
260518|NCT00984659|630459|P4|STARTED|2-week Run-in Period||0
260519|NCT00984659|630460|P3|STARTED|2-week Run-in Period||0
260520|NCT00984659|630461|P2|STARTED|2-week Run-in Period||0
260521|NCT00984659|630462|P1|STARTED|2-week Run-in Period||418
260522|NCT00984620|630489|P2|NOT COMPLETED|Overall Study||12
260523|NCT00984620|630490|P1|NOT COMPLETED|Overall Study||6
260524|NCT00984620|630489|P2|COMPLETED|Overall Study||67
260525|NCT00984620|630490|P1|COMPLETED|Overall Study||75
260526|NCT00984620|630489|P2|STARTED|Overall Study||79
260527|NCT00984620|630490|P1|STARTED|Overall Study||81
260528|NCT00984594|630528|P2|NOT COMPLETED|Overall Study||1
260529|NCT00984594|630529|P1|NOT COMPLETED|Overall Study||1
260530|NCT00984594|630528|P2|COMPLETED|Overall Study||1
260531|NCT00984594|630529|P1|COMPLETED|Overall Study||1
260532|NCT00984594|630528|P2|STARTED|Overall Study|One patient withdrew consent and left the study before treatment.|2
260533|NCT00984594|630529|P1|STARTED|Overall Study||2
260534|NCT00984568|630545|P2|NOT COMPLETED|Overall Study||6
260535|NCT00984568|630546|P1|NOT COMPLETED|Overall Study||8
260536|NCT00984568|630545|P2|COMPLETED|Overall Study||7
260537|NCT00984568|630546|P1|COMPLETED|Overall Study||7
260538|NCT00984568|630545|P2|STARTED|Overall Study||13
260539|NCT00984568|630546|P1|STARTED|Overall Study||15
260540|NCT00984542|630554|P1|NOT COMPLETED|Overall Study||41
260541|NCT00984542|630554|P1|COMPLETED|Overall Study||9
260542|NCT00984542|630554|P1|STARTED|Overall Study||50
260543|NCT00984490|630562|P1|NOT COMPLETED|Overall Study||0
260544|NCT00984490|630562|P1|COMPLETED|Overall Study||5
260545|NCT00984490|630562|P1|STARTED|Overall Study||5
260546|NCT00984334|630572|P5|NOT COMPLETED|Overall Study||1
260547|NCT00984334|630573|P4|NOT COMPLETED|Overall Study||1
260548|NCT00984334|630574|P3|NOT COMPLETED|Overall Study||0
260549|NCT00984334|630575|P2|NOT COMPLETED|Overall Study||1
260550|NCT00984334|630576|P1|NOT COMPLETED|Overall Study||1
260551|NCT00984334|630572|P5|COMPLETED|Overall Study||7
260552|NCT00984334|630573|P4|COMPLETED|Overall Study||7
260553|NCT00984334|630574|P3|COMPLETED|Overall Study||8
260554|NCT00984334|630575|P2|COMPLETED|Overall Study||7
260555|NCT00984334|630576|P1|COMPLETED|Overall Study||7
260556|NCT00984334|630572|P5|STARTED|Overall Study||8
260557|NCT00984334|630573|P4|STARTED|Overall Study||8
260558|NCT00984334|630574|P3|STARTED|Overall Study||8
260559|NCT00984334|630575|P2|STARTED|Overall Study||8
260560|NCT00984334|630576|P1|STARTED|Overall Study||8
260561|NCT00984308|630590|P2|NOT COMPLETED|Overall Study||6
260562|NCT00984308|630591|P1|NOT COMPLETED|Overall Study||18
260563|NCT00984308|630590|P2|COMPLETED|Overall Study||109
260564|NCT00984308|630591|P1|COMPLETED|Overall Study||92
260565|NCT00984308|630590|P2|STARTED|Overall Study||115
260566|NCT00984308|630591|P1|STARTED|Overall Study||110
260567|NCT00984295|630604|P3|NOT COMPLETED|Overall Study||37
260568|NCT00984295|630605|P2|NOT COMPLETED|Overall Study||32
260569|NCT00984295|630606|P1|NOT COMPLETED|Overall Study||65
260570|NCT00984295|630604|P3|COMPLETED|Overall Study||442
260571|NCT00984295|630605|P2|COMPLETED|Overall Study||453
260572|NCT00984295|630606|P1|COMPLETED|Overall Study||884
260573|NCT00984295|630604|P3|Visit 2|Overall Study||453
260574|NCT00984295|630605|P2|Visit 2|Overall Study||468
260575|NCT00984295|630606|P1|Visit 2|Overall Study||909
260576|NCT00984295|630604|P3|Visit 1|Overall Study||479
260577|NCT00984295|630605|P2|Visit 1|Overall Study||485
260578|NCT00984295|630606|P1|Visit 1|Overall Study||949
260579|NCT00984295|630604|P3|STARTED|Overall Study||479
260580|NCT00984295|630605|P2|STARTED|Overall Study||485
260581|NCT00984295|630606|P1|STARTED|Overall Study|2 patients were incorrectly vaccinated and are excluded from this table.|949
260582|NCT00984282|630673|P2|NOT COMPLETED|Long Term Follow-up||120
260583|NCT00984282|630674|P1|NOT COMPLETED|Long Term Follow-up||69
260584|NCT00984282|630673|P2|COMPLETED|Long Term Follow-up||4
260585|NCT00984282|630674|P1|COMPLETED|Long Term Follow-up||3
260586|NCT00984282|630673|P2|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|124
260587|NCT00984282|630674|P1|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|72
260588|NCT00984282|630673|P2|NOT COMPLETED|Open-label Treatment||161
260589|NCT00984282|630674|P1|NOT COMPLETED|Open-label Treatment||86
260590|NCT00984282|630673|P2|COMPLETED|Open-label Treatment||0
260591|NCT00984282|630674|P1|COMPLETED|Open-label Treatment||0
260592|NCT00984282|630673|P2|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG4 (RG= Reporting Group for Safety Data)|161
260593|NCT00984282|630674|P1|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG3 (RG= Reporting Group for Safety Data)|86
260594|NCT00984282|630673|P2|STARTED|Open-label Treatment||161
260595|NCT00984282|630674|P1|STARTED|Open-label Treatment||86
260596|NCT00984282|630673|P2|NOT COMPLETED|Double Blind Treatment||38
260597|NCT00984282|630674|P1|NOT COMPLETED|Double Blind Treatment||104
260598|NCT00984282|630673|P2|COMPLETED|Double Blind Treatment||172
260599|NCT00984282|630674|P1|COMPLETED|Double Blind Treatment||103
260600|NCT00984282|630673|P2|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG2 (RG= Reporting Group for Safety Data)|209
260601|NCT00984282|630674|P1|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG1 (RG= Reporting Group for Safety Data)|207
260602|NCT00984282|630673|P2|STARTED|Double Blind Treatment||210
260603|NCT00984282|630674|P1|STARTED|Double Blind Treatment||207
260604|NCT00984256|630697|P2|NOT COMPLETED|Overall Study||1
260605|NCT00984256|630698|P1|NOT COMPLETED|Overall Study||0
260606|NCT00984256|630697|P2|COMPLETED|Overall Study||29
260607|NCT00984256|630698|P1|COMPLETED|Overall Study||6
260608|NCT00984256|630697|P2|STARTED|Overall Study||30
260609|NCT00984256|630698|P1|STARTED|Overall Study||6
260610|NCT00984204|630718|P1|NOT COMPLETED|Overall Study||15
260611|NCT00984204|630718|P1|COMPLETED|Overall Study|"Seven subjects of the ten Lack of efficacy were acute failures that had no block after 30 min"|173
260612|NCT00984204|630718|P1|STARTED|Overall Study||188
260613|NCT00984165|630728|P4|NOT COMPLETED|Overall Study||4
260614|NCT00984165|630729|P3|NOT COMPLETED|Overall Study||0
260615|NCT00984165|630730|P2|NOT COMPLETED|Overall Study||1
260616|NCT00984165|630731|P1|NOT COMPLETED|Overall Study||7
260617|NCT00984165|630728|P4|COMPLETED|Overall Study||0
260618|NCT00984165|630729|P3|COMPLETED|Overall Study||4
260619|NCT00984165|630730|P2|COMPLETED|Overall Study||0
260620|NCT00984165|630731|P1|COMPLETED|Overall Study||2
260621|NCT00984165|630728|P4|STARTED|Overall Study||4
260622|NCT00984165|630729|P3|STARTED|Overall Study||4
260623|NCT00984165|630730|P2|STARTED|Overall Study||1
260624|NCT00984165|630731|P1|STARTED|Overall Study||9
260625|NCT00984139|630744|P1|NOT COMPLETED|Overall Study||0
260626|NCT00984139|630744|P1|COMPLETED|Overall Study||306
260627|NCT00984139|630744|P1|STARTED|Overall Study||306
260628|NCT00984126|630760|P4|NOT COMPLETED|Overall Study||59
260629|NCT00984126|630761|P3|NOT COMPLETED|Overall Study||7
260630|NCT00984126|630762|P2|NOT COMPLETED|Overall Study||8
260631|NCT00984126|630763|P1|NOT COMPLETED|Overall Study||7
260632|NCT00984126|630760|P4|COMPLETED|Overall Study||76
260633|NCT00984126|630761|P3|COMPLETED|Overall Study||16
260634|NCT00984126|630762|P2|COMPLETED|Overall Study||20
260635|NCT00984126|630763|P1|COMPLETED|Overall Study||20
260636|NCT00984126|630760|P4|STARTED|Overall Study||135
260637|NCT00984126|630761|P3|STARTED|Overall Study||23
260638|NCT00984126|630762|P2|STARTED|Overall Study||28
260639|NCT00984126|630763|P1|STARTED|Overall Study||27
260640|NCT00984061|630788|P1|NOT COMPLETED|Colchicine With Clarithromycin||0
260641|NCT00984061|630788|P1|COMPLETED|Colchicine With Clarithromycin||23
260642|NCT00984061|630788|P1|STARTED|Colchicine With Clarithromycin||23
260643|NCT00984061|630788|P1|NOT COMPLETED|Clarithromycin Alone||1
260644|NCT00984061|630788|P1|COMPLETED|Clarithromycin Alone|One subject was dropped due to noncompliance with outpatient clarithromycin regimen.|23
260645|NCT00984061|630788|P1|STARTED|Clarithromycin Alone||24
260646|NCT00984061|630788|P1|NOT COMPLETED|21 Day Washout Period||0
260647|NCT00984061|630788|P1|COMPLETED|21 Day Washout Period||24
260648|NCT00984061|630788|P1|STARTED|21 Day Washout Period||24
260649|NCT00984061|630788|P1|NOT COMPLETED|Colchicine Alone||0
260650|NCT00984061|630788|P1|COMPLETED|Colchicine Alone||24
260651|NCT00984061|630788|P1|STARTED|Colchicine Alone||24
260652|NCT00984022|630801|P2|NOT COMPLETED|Overall Study||14
260653|NCT00984022|630802|P1|NOT COMPLETED|Overall Study||10
260654|NCT00984022|630801|P2|COMPLETED|Overall Study||35
260655|NCT00984022|630802|P1|COMPLETED|Overall Study||33
260656|NCT00984022|630801|P2|STARTED|Overall Study||49
260657|NCT00984022|630802|P1|STARTED|Overall Study||43
260658|NCT00984009|630812|P1|NOT COMPLETED|Colchicine With Grapefruit Juice||0
260659|NCT00984009|630812|P1|COMPLETED|Colchicine With Grapefruit Juice||21
260660|NCT00984009|630812|P1|STARTED|Colchicine With Grapefruit Juice||21
260661|NCT00984009|630812|P1|NOT COMPLETED|Grapefruit Juice Alone||1
260662|NCT00984009|630812|P1|COMPLETED|Grapefruit Juice Alone|one subject dropped due to missed a.m. serving of grapefruit juice on Day 16|21
260663|NCT00984009|630812|P1|STARTED|Grapefruit Juice Alone||22
260664|NCT00984009|630812|P1|NOT COMPLETED|14 Day Washout Period||0
260665|NCT00984009|630812|P1|COMPLETED|14 Day Washout Period||22
260666|NCT00984009|630812|P1|STARTED|14 Day Washout Period||22
260667|NCT00984009|630812|P1|NOT COMPLETED|Colchicine Alone||0
260668|NCT00984009|630812|P1|COMPLETED|Colchicine Alone||22
260669|NCT00984009|630812|P1|STARTED|Colchicine Alone||22
260670|NCT00983983|630826|P3|NOT COMPLETED|Overall Study||1
260671|NCT00983983|630827|P2|NOT COMPLETED|Overall Study||1
260672|NCT00983983|630828|P1|NOT COMPLETED|Overall Study||2
260673|NCT00983983|630826|P3|COMPLETED|Overall Study||6
260674|NCT00983983|630827|P2|COMPLETED|Overall Study||8
260675|NCT00983983|630828|P1|COMPLETED|Overall Study||6
260676|NCT00983983|630826|P3|STARTED|Overall Study||7
260677|NCT00983983|630827|P2|STARTED|Overall Study||9
260678|NCT00983983|630828|P1|STARTED|Overall Study||8
260679|NCT00983957|630845|P1|NOT COMPLETED|Overall Study||2
260680|NCT00983957|630845|P1|COMPLETED|Overall Study||18
260681|NCT00983957|630845|P1|Treatment C|Overall Study||18
260682|NCT00983957|630845|P1|Treatment B|Overall Study||20
260683|NCT00983957|630845|P1|Treatment A|Overall Study||20
260684|NCT00983957|630845|P1|STARTED|Overall Study||20
260685|NCT00983931|630879|P1|NOT COMPLETED|Colchicine With Cyclosporine||0
260686|NCT00983931|630879|P1|COMPLETED|Colchicine With Cyclosporine||23
260687|NCT00983931|630879|P1|STARTED|Colchicine With Cyclosporine||23
260688|NCT00983931|630879|P1|NOT COMPLETED|14 Day Washout Period||1
260689|NCT00983931|630879|P1|COMPLETED|14 Day Washout Period|one subject withdrawn due to creatine kinase out of range|23
260690|NCT00983931|630879|P1|STARTED|14 Day Washout Period||24
260691|NCT00983931|630879|P1|NOT COMPLETED|Colchicine Alone||0
260692|NCT00983931|630879|P1|COMPLETED|Colchicine Alone||24
260693|NCT00983931|630879|P1|STARTED|Colchicine Alone||24
260694|NCT00983918|630893|P4|NOT COMPLETED|Overall Study||2
260695|NCT00983918|630894|P3|NOT COMPLETED|Overall Study||2
260696|NCT00983918|630895|P2|NOT COMPLETED|Overall Study||2
260697|NCT00983918|630896|P1|NOT COMPLETED|Overall Study||0
260698|NCT00983918|630893|P4|COMPLETED|Overall Study||18
260699|NCT00983918|630894|P3|COMPLETED|Overall Study||18
260700|NCT00983918|630895|P2|COMPLETED|Overall Study||18
260701|NCT00983918|630896|P1|COMPLETED|Overall Study||20
260702|NCT00983918|630893|P4|STARTED|Overall Study||20
260703|NCT00983918|630894|P3|STARTED|Overall Study||20
260704|NCT00983918|630895|P2|STARTED|Overall Study||20
260705|NCT00983918|630896|P1|STARTED|Overall Study||20
260706|NCT00983905|630906|P1|NOT COMPLETED|Theophylline With Colchicine||0
260707|NCT00983905|630906|P1|COMPLETED|Theophylline With Colchicine||27
260708|NCT00983905|630906|P1|STARTED|Theophylline With Colchicine||27
260709|NCT00983905|630906|P1|NOT COMPLETED|Colchicine Alone||2
260710|NCT00983905|630906|P1|COMPLETED|Colchicine Alone|withdrawn by sponsor due to: diarrhea(1); vomiting and diarrhea(1)|27
260711|NCT00983905|630906|P1|STARTED|Colchicine Alone||29
260712|NCT00983905|630906|P1|NOT COMPLETED|4 Day Washout Period||0
260713|NCT00983905|630906|P1|COMPLETED|4 Day Washout Period||29
260714|NCT00983905|630906|P1|STARTED|4 Day Washout Period||29
260715|NCT00983905|630906|P1|NOT COMPLETED|Theophylline Alone||1
260716|NCT00983905|630906|P1|COMPLETED|Theophylline Alone|withdrawn by sponsor due to vomiting(1)|29
260717|NCT00983905|630906|P1|STARTED|Theophylline Alone||30
260718|NCT00983892|630919|P2|NOT COMPLETED|Overall Study||12
260719|NCT00983892|630920|P1|NOT COMPLETED|Overall Study||10
260720|NCT00983892|630919|P2|COMPLETED|Overall Study||56
260721|NCT00983892|630920|P1|COMPLETED|Overall Study||56
260722|NCT00983892|630919|P2|STARTED|Overall Study||68
260723|NCT00983892|630920|P1|STARTED|Overall Study||66
260724|NCT00983853|630932|P6|NOT COMPLETED|Overall Study||1
260725|NCT00983853|630933|P5|NOT COMPLETED|Overall Study||3
260726|NCT00983853|630934|P4|NOT COMPLETED|Overall Study||2
260727|NCT00983853|630935|P3|NOT COMPLETED|Overall Study||3
260728|NCT00983853|630936|P2|NOT COMPLETED|Overall Study||2
260729|NCT00983853|630937|P1|NOT COMPLETED|Overall Study||1
260730|NCT00983853|630932|P6|COMPLETED|Overall Study||7
260731|NCT00983853|630933|P5|COMPLETED|Overall Study||12
260732|NCT00983853|630934|P4|COMPLETED|Overall Study||6
260733|NCT00983853|630935|P3|COMPLETED|Overall Study||14
260734|NCT00983853|630936|P2|COMPLETED|Overall Study||5
260735|NCT00983853|630937|P1|COMPLETED|Overall Study||6
260736|NCT00983853|630932|P6|STARTED|Overall Study||8
260737|NCT00983853|630933|P5|STARTED|Overall Study||15
260738|NCT00983853|630934|P4|STARTED|Overall Study||8
260739|NCT00983853|630935|P3|STARTED|Overall Study|1 subject was randomized but not dosed|17
260740|NCT00983853|630936|P2|STARTED|Overall Study|1 subject was randomized but not dosed|7
260741|NCT00983853|630937|P1|STARTED|Overall Study||7
260742|NCT00983827|630965|P1|NOT COMPLETED|Overall Study||1
260743|NCT00983827|630965|P1|COMPLETED|Overall Study||7
260744|NCT00983827|630965|P1|STARTED|Overall Study||8
260745|NCT00983801|630969|P1|NOT COMPLETED|Overall Study||0
260746|NCT00983801|630969|P1|COMPLETED|Overall Study|Participants who were taken off treatment.|52
260747|NCT00983801|630969|P1|STARTED|Overall Study|Participants who received treatment.|52
260748|NCT00983749|630983|P2|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||3
260749|NCT00983749|630984|P1|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||1
260750|NCT00983749|630983|P2|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||7
260751|NCT00983749|630984|P1|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||12
260752|NCT00983749|630983|P2|STARTED|Follow-up Phase (Hospital DC to 30 Days)||10
260753|NCT00983749|630984|P1|STARTED|Follow-up Phase (Hospital DC to 30 Days)||13
260754|NCT00983749|630983|P2|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
260755|NCT00983749|630984|P1|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
260756|NCT00983749|630983|P2|COMPLETED|Acute Phase (Enrollment to Hospital DC)||10
260757|NCT00983749|630984|P1|COMPLETED|Acute Phase (Enrollment to Hospital DC)||13
260758|NCT00983749|630983|P2|STARTED|Acute Phase (Enrollment to Hospital DC)||10
260759|NCT00983749|630984|P1|STARTED|Acute Phase (Enrollment to Hospital DC)||13
260760|NCT00983645|630994|P2|NOT COMPLETED|Overall Study||0
260761|NCT00983645|630995|P1|NOT COMPLETED|Overall Study||0
260762|NCT00983645|630994|P2|COMPLETED|Overall Study||7
260763|NCT00983645|630995|P1|COMPLETED|Overall Study||8
260764|NCT00983645|630994|P2|STARTED|Overall Study||7
260765|NCT00983645|630995|P1|STARTED|Overall Study||8
260766|NCT00983580|631009|P2|NOT COMPLETED|Overall Study||4
260767|NCT00983580|631010|P1|NOT COMPLETED|Overall Study||5
260768|NCT00983580|631009|P2|COMPLETED|Overall Study||49
260769|NCT00983580|631010|P1|COMPLETED|Overall Study||49
260770|NCT00983580|631009|P2|STARTED|Overall Study||53
260771|NCT00983580|631010|P1|STARTED|Overall Study||54
260772|NCT00983541|631026|P1|NOT COMPLETED|Overall Study||0
260773|NCT00983541|631026|P1|COMPLETED|Overall Study||1
260774|NCT00983541|631026|P1|STARTED|Overall Study||1
260775|NCT00983515|631036|P1|NOT COMPLETED|Colchicine With Ritonavir||1
260776|NCT00983515|631036|P1|COMPLETED|Colchicine With Ritonavir|pharmacokinetic data included since parameters could be estimated for both dosing conditions|17
260777|NCT00983515|631036|P1|STARTED|Colchicine With Ritonavir||18
260778|NCT00983515|631036|P1|NOT COMPLETED|Ritonavir Alone||6
260779|NCT00983515|631036|P1|COMPLETED|Ritonavir Alone||18
260780|NCT00983515|631036|P1|STARTED|Ritonavir Alone||24
260781|NCT00983515|631036|P1|NOT COMPLETED|14 Day Washout Period||0
260782|NCT00983515|631036|P1|COMPLETED|14 Day Washout Period||24
260783|NCT00983515|631036|P1|STARTED|14 Day Washout Period||24
260784|NCT00983515|631036|P1|NOT COMPLETED|Colchicine Alone||0
260785|NCT00983515|631036|P1|COMPLETED|Colchicine Alone||24
260786|NCT00983515|631036|P1|STARTED|Colchicine Alone||24
260787|NCT00983489|631050|P3|NOT COMPLETED|Overall Study||312
260788|NCT00983489|631051|P2|NOT COMPLETED|Overall Study||285
260789|NCT00983489|631052|P1|NOT COMPLETED|Overall Study||185
260790|NCT00983489|631050|P3|COMPLETED|Overall Study||135
260791|NCT00983489|631051|P2|COMPLETED|Overall Study||168
260792|NCT00983489|631052|P1|COMPLETED|Overall Study||326
260793|NCT00983489|631050|P3|STARTED|Overall Study||447
260794|NCT00983489|631051|P2|STARTED|Overall Study||453
260795|NCT00983489|631052|P1|STARTED|Overall Study||511
260796|NCT00983476|631063|P3|NOT COMPLETED|Overall Study||0
260797|NCT00983476|631064|P2|NOT COMPLETED|Overall Study||22
260798|NCT00983476|631065|P1|NOT COMPLETED|Overall Study||17
260799|NCT00983476|631063|P3|COMPLETED|Overall Study||88
260800|NCT00983476|631064|P2|COMPLETED|Overall Study||71
260801|NCT00983476|631065|P1|COMPLETED|Overall Study||78
260802|NCT00983476|631063|P3|6 Month Follow up Assessment|Overall Study||74
260803|NCT00983476|631064|P2|6 Month Follow up Assessment|Overall Study||62
260804|NCT00983476|631065|P1|6 Month Follow up Assessment|Overall Study||71
260805|NCT00983476|631063|P3|STARTED|Overall Study||88
260806|NCT00983476|631064|P2|STARTED|Overall Study||93
260807|NCT00983476|631065|P1|STARTED|Overall Study||95
260808|NCT00983437|631097|P1|NOT COMPLETED|Overall Study||47
260809|NCT00983437|631097|P1|COMPLETED|Overall Study|Completed 12 months of treatment with armodafinil.|0
260810|NCT00983437|631097|P1|Full Analysis Set (FAS)|Overall Study|Participants had to have at least 1 postbaseline efficacy assessment to be evaluable for efficacy.|45
260811|NCT00983437|631097|P1|Safety Analysis Set (SAS)|Overall Study|Participants who received at least 1 dose of study drug were evaluable for safety.|47
260812|NCT00983437|631097|P1|STARTED|Overall Study||47
260813|NCT00983385|631116|P1|NOT COMPLETED|Maintenance Period||23
260814|NCT00983385|631116|P1|COMPLETED|Maintenance Period||117
260815|NCT00983385|631116|P1|STARTED|Maintenance Period||140
260816|NCT00983385|631116|P1|NOT COMPLETED|Titration and Optimal Dose Period||36
260817|NCT00983385|631116|P1|COMPLETED|Titration and Optimal Dose Period||140
260818|NCT00983385|631116|P1|STARTED|Titration and Optimal Dose Period||176
260819|NCT00983385|631116|P1|NOT COMPLETED|Observation Period||32
260820|NCT00983385|631116|P1|COMPLETED|Observation Period||176
260821|NCT00983385|631116|P1|STARTED|Observation Period||208
260822|NCT00983372|631161|P1|NOT COMPLETED|Colchicine With Diltiazem ER||0
260823|NCT00983372|631161|P1|COMPLETED|Colchicine With Diltiazem ER||20
260824|NCT00983372|631161|P1|STARTED|Colchicine With Diltiazem ER||20
260825|NCT00983372|631161|P1|NOT COMPLETED|Diltiazem ER Alone||3
260826|NCT00983372|631161|P1|COMPLETED|Diltiazem ER Alone|two subjects dropped due to missed diltiazem ER dose; one subject dropped due to vomitting|20
260827|NCT00983372|631161|P1|STARTED|Diltiazem ER Alone||23
260828|NCT00983372|631161|P1|NOT COMPLETED|14 Day Washout Period||1
260829|NCT00983372|631161|P1|COMPLETED|14 Day Washout Period|subject withdrew consent due to schedule conflict - during washout period or diltiazem alone|23
260830|NCT00983372|631161|P1|STARTED|14 Day Washout Period||24
260831|NCT00983372|631161|P1|NOT COMPLETED|Colchicine Alone||0
260832|NCT00983372|631161|P1|COMPLETED|Colchicine Alone||24
260833|NCT00983372|631161|P1|STARTED|Colchicine Alone||24
260834|NCT00983359|631172|P1|NOT COMPLETED|Overall Study||1
260835|NCT00983359|631172|P1|COMPLETED|Overall Study||39
260836|NCT00983359|631172|P1|Not Eligible for Analysis|Overall Study||1
260837|NCT00983359|631172|P1|STARTED|Overall Study||40
260838|NCT00983346|631180|P1|NOT COMPLETED|Overall Study||0
260839|NCT00983346|631180|P1|COMPLETED|Overall Study||17
260840|NCT00983346|631180|P1|STARTED|Overall Study||17
260841|NCT00983307|631184|P1|NOT COMPLETED|Overall Study||0
260842|NCT00983307|631184|P1|COMPLETED|Overall Study||17
260843|NCT00983307|631184|P1|STARTED|Overall Study||17
260844|NCT00983294|631188|P1|NOT COMPLETED|Colchicine With Azithromycin||1
260845|NCT00983294|631188|P1|COMPLETED|Colchicine With Azithromycin|withdrawn by sponsor on Day 21 due to vomiting on Day 15, prior to azithromycin dosing(1)|21
260846|NCT00983294|631188|P1|STARTED|Colchicine With Azithromycin||22
260847|NCT00983294|631188|P1|NOT COMPLETED|Azithromycin Alone||0
260848|NCT00983294|631188|P1|COMPLETED|Azithromycin Alone||22
260849|NCT00983294|631188|P1|STARTED|Azithromycin Alone||22
260850|NCT00983294|631188|P1|NOT COMPLETED|14 Day Washout Period||2
260851|NCT00983294|631188|P1|COMPLETED|14 Day Washout Period|two subjects withdrew consent due to personal reasons|22
260852|NCT00983294|631188|P1|STARTED|14 Day Washout Period||24
260853|NCT00983294|631188|P1|NOT COMPLETED|Colchicine Alone||0
260854|NCT00983294|631188|P1|COMPLETED|Colchicine Alone||24
260855|NCT00983294|631188|P1|STARTED|Colchicine Alone||24
260856|NCT00983281|631201|P2|NOT COMPLETED|Overall Study||0
260857|NCT00983281|631202|P1|NOT COMPLETED|Overall Study||0
260858|NCT00983281|631201|P2|COMPLETED|Overall Study||909
260859|NCT00983281|631202|P1|COMPLETED|Overall Study||805
260860|NCT00983281|631201|P2|STARTED|Overall Study||909
260861|NCT00983281|631202|P1|STARTED|Overall Study||805
260862|NCT00983242|631208|P1|NOT COMPLETED|Colchicine With Verapamil HCl ER||0
260863|NCT00983242|631208|P1|COMPLETED|Colchicine With Verapamil HCl ER||24
260864|NCT00983242|631208|P1|STARTED|Colchicine With Verapamil HCl ER||24
260865|NCT00983242|631208|P1|NOT COMPLETED|Verapamil HCl ER Alone||0
260866|NCT00983242|631208|P1|COMPLETED|Verapamil HCl ER Alone||24
260867|NCT00983242|631208|P1|STARTED|Verapamil HCl ER Alone||24
260868|NCT00983242|631208|P1|NOT COMPLETED|14 Day Washout Period||0
260869|NCT00983242|631208|P1|COMPLETED|14 Day Washout Period||24
260870|NCT00983242|631208|P1|STARTED|14 Day Washout Period||24
260871|NCT00983242|631208|P1|NOT COMPLETED|Colchicine Alone||0
260872|NCT00983242|631208|P1|COMPLETED|Colchicine Alone||24
260873|NCT00983242|631208|P1|STARTED|Colchicine Alone||24
260874|NCT00983216|631219|P1|NOT COMPLETED|Colchicine With Ketoconazole||0
260875|NCT00983216|631219|P1|COMPLETED|Colchicine With Ketoconazole||24
260876|NCT00983216|631219|P1|STARTED|Colchicine With Ketoconazole||24
260877|NCT00983216|631219|P1|NOT COMPLETED|Ketoconazole Alone||0
260878|NCT00983216|631219|P1|COMPLETED|Ketoconazole Alone||24
260879|NCT00983216|631219|P1|STARTED|Ketoconazole Alone||24
260880|NCT00983216|631219|P1|NOT COMPLETED|14 Day Washout Period||0
260881|NCT00983216|631219|P1|COMPLETED|14 Day Washout Period||24
260882|NCT00983216|631219|P1|STARTED|14 Day Washout Period||24
260883|NCT00983216|631219|P1|NOT COMPLETED|Colchicine Alone||0
260884|NCT00983216|631219|P1|COMPLETED|Colchicine Alone||24
260885|NCT00983216|631219|P1|STARTED|Colchicine Alone||24
260886|NCT00983073|631230|P1|NOT COMPLETED|Maintenance Period||16
260887|NCT00983073|631230|P1|COMPLETED|Maintenance Period||144
260888|NCT00983073|631230|P1|STARTED|Maintenance Period||160
260889|NCT00983073|631230|P1|NOT COMPLETED|Titration and Optimal Dose Period||40
260890|NCT00983073|631230|P1|COMPLETED|Titration and Optimal Dose Period||160
260891|NCT00983073|631230|P1|STARTED|Titration and Optimal Dose Period||200
260892|NCT00983073|631230|P1|NOT COMPLETED|Observation Period||24
260893|NCT00983073|631230|P1|COMPLETED|Observation Period|24 participants not eligible to be dosed.|200
260894|NCT00983073|631230|P1|STARTED|Observation Period||224
260895|NCT00982995|631251|P1|NOT COMPLETED|Overall Study||0
260896|NCT00982995|631251|P1|COMPLETED|Overall Study||3
260897|NCT00982995|631251|P1|STARTED|Overall Study||3
260898|NCT00982878|631256|P1|NOT COMPLETED|Overall Study||1
260899|NCT00982878|631256|P1|COMPLETED|Overall Study||12
260900|NCT00982878|631256|P1|STARTED|Overall Study||13
260901|NCT00982865|631265|P4|NOT COMPLETED|Overall Study||0
260902|NCT00982865|631266|P3|NOT COMPLETED|Overall Study||0
260903|NCT00982865|631267|P2|NOT COMPLETED|Overall Study||0
260904|NCT00982865|631268|P1|NOT COMPLETED|Overall Study||0
260905|NCT00982865|631265|P4|COMPLETED|Overall Study||34
260906|NCT00982865|631266|P3|COMPLETED|Overall Study||15
260907|NCT00982865|631267|P2|COMPLETED|Overall Study||82
260908|NCT00982865|631268|P1|COMPLETED|Overall Study||49
260909|NCT00982865|631265|P4|STARTED|Overall Study||34
260910|NCT00982865|631266|P3|STARTED|Overall Study||15
260911|NCT00982865|631267|P2|STARTED|Overall Study||82
260912|NCT00982865|631268|P1|STARTED|Overall Study||49
260913|NCT00982735|631554|P1|NOT COMPLETED|Overall Study||230
260914|NCT00982735|631554|P1|COMPLETED|Overall Study||757
260915|NCT00982735|631554|P1|STARTED|Overall Study||987
260916|NCT00982657|631564|P4|NOT COMPLETED|Overall Study||9
260917|NCT00982657|631565|P3|NOT COMPLETED|Overall Study||2
260918|NCT00982657|631566|P2|NOT COMPLETED|Overall Study||0
260919|NCT00982657|631567|P1|NOT COMPLETED|Overall Study||1
260920|NCT00982657|631564|P4|COMPLETED|Overall Study||7
260921|NCT00982657|631565|P3|COMPLETED|Overall Study||1
260922|NCT00982657|631566|P2|COMPLETED|Overall Study||3
260923|NCT00982657|631567|P1|COMPLETED|Overall Study||11
260924|NCT00982657|631564|P4|STARTED|Overall Study||16
260925|NCT00982657|631565|P3|STARTED|Overall Study||3
260926|NCT00982657|631566|P2|STARTED|Overall Study||3
260927|NCT00982657|631567|P1|STARTED|Overall Study||12
260928|NCT00982644|631608|P2|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||20
260929|NCT00982644|631609|P1|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||46
260930|NCT00982644|631608|P2|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||154
260931|NCT00982644|631609|P1|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||505
260932|NCT00982644|631608|P2|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Twenty-three subjects did not continue into extension trial|174
260933|NCT00982644|631609|P1|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Fifty-six subjects did not continue into extension trial|551
260934|NCT00982644|631608|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||60
260935|NCT00982644|631609|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||166
260936|NCT00982644|631608|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||197
260937|NCT00982644|631609|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||607
260938|NCT00982644|631608|P2|Exposed|Main: Week 0 to 52 (NN1250-3579)||257
260939|NCT00982644|631609|P1|Exposed|Main: Week 0 to 52 (NN1250-3579)|7 subjects were withdrawn prior to exposure to trial products|766
260940|NCT00982644|631608|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||257
260941|NCT00982644|631609|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||773
260942|NCT00982644|631608|P2|STARTED|Main: Week 0 to 52 (NN1250-3579)||257
260943|NCT00982644|631609|P1|STARTED|Main: Week 0 to 52 (NN1250-3579)||773
260944|NCT00982592|631633|P2|NOT COMPLETED|Overall Study||33
260945|NCT00982592|631634|P1|NOT COMPLETED|Overall Study||31
260946|NCT00982592|631633|P2|COMPLETED|Overall Study|patients who were off treatment due to disease progression|27
260947|NCT00982592|631634|P1|COMPLETED|Overall Study|patients who were off treatment due to disease progression|33
260948|NCT00982592|631633|P2|Treatment Received|Overall Study||52
260949|NCT00982592|631634|P1|Treatment Received|Overall Study||63
260950|NCT00982592|631633|P2|STARTED|Overall Study||60
260951|NCT00982592|631634|P1|STARTED|Overall Study||64
260952|NCT00982553|631648|P1|NOT COMPLETED|Phase3||0
260953|NCT00982553|631648|P1|COMPLETED|Phase3||14
260954|NCT00982553|631648|P1|STARTED|Phase3||14
260955|NCT00982553|631648|P1|NOT COMPLETED|Phase2||0
260956|NCT00982553|631648|P1|COMPLETED|Phase2||14
260957|NCT00982553|631648|P1|STARTED|Phase2||14
260958|NCT00982553|631648|P1|NOT COMPLETED|Phase1||0
260959|NCT00982553|631648|P1|COMPLETED|Phase1||14
260960|NCT00982553|631648|P1|STARTED|Phase1||14
260961|NCT00982488|631664|P5|NOT COMPLETED|Overall Study||1
260962|NCT00982488|631665|P4|NOT COMPLETED|Overall Study||3
260963|NCT00982488|631666|P3|NOT COMPLETED|Overall Study||34
260964|NCT00982488|631667|P2|NOT COMPLETED|Overall Study||14
260965|NCT00982488|631668|P1|NOT COMPLETED|Overall Study||185
260966|NCT00982488|631664|P5|COMPLETED|Overall Study|Still receiving treatment|0
260967|NCT00982488|631665|P4|COMPLETED|Overall Study|Still receiving treatment|0
260968|NCT00982488|631666|P3|COMPLETED|Overall Study|Still receiving treatment|0
260969|NCT00982488|631667|P2|COMPLETED|Overall Study|Still receiving treatment|0
260970|NCT00982488|631668|P1|COMPLETED|Overall Study|Still receiving treatment|0
260971|NCT00982488|631664|P5|STARTED|Overall Study|Received treatment|1
260972|NCT00982488|631665|P4|STARTED|Overall Study|Received treatment|3
260973|NCT00982488|631666|P3|STARTED|Overall Study|Received treatment|34
260974|NCT00982488|631667|P2|STARTED|Overall Study|Received treatment|14
260975|NCT00982488|631668|P1|STARTED|Overall Study|Received treatment|185
260976|NCT00982423|631682|P2|NOT COMPLETED|Overall Study||0
260977|NCT00982423|631683|P1|NOT COMPLETED|Overall Study||0
260978|NCT00982423|631682|P2|COMPLETED|Overall Study||19
260979|NCT00982423|631683|P1|COMPLETED|Overall Study||13
260980|NCT00982423|631682|P2|STARTED|Overall Study||19
260981|NCT00982423|631683|P1|STARTED|Overall Study||13
260982|NCT00982410|631701|P2|NOT COMPLETED|12-month Follow-up Assessment||9
260983|NCT00982410|631702|P1|NOT COMPLETED|12-month Follow-up Assessment||9
260984|NCT00982410|631701|P2|COMPLETED|12-month Follow-up Assessment||55
260985|NCT00982410|631702|P1|COMPLETED|12-month Follow-up Assessment||56
260986|NCT00982410|631701|P2|STARTED|12-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
260987|NCT00982410|631702|P1|STARTED|12-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
260988|NCT00982410|631701|P2|NOT COMPLETED|6-month Follow-up Assessment||11
260989|NCT00982410|631702|P1|NOT COMPLETED|6-month Follow-up Assessment||6
260990|NCT00982410|631701|P2|COMPLETED|6-month Follow-up Assessment||53
260991|NCT00982410|631702|P1|COMPLETED|6-month Follow-up Assessment||59
260992|NCT00982410|631701|P2|STARTED|6-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
260993|NCT00982410|631702|P1|STARTED|6-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
260994|NCT00982410|631701|P2|NOT COMPLETED|3-month Follow-up Assessment||13
260995|NCT00982410|631702|P1|NOT COMPLETED|3-month Follow-up Assessment||9
260996|NCT00982410|631701|P2|COMPLETED|3-month Follow-up Assessment||53
260997|NCT00982410|631702|P1|COMPLETED|3-month Follow-up Assessment||56
260998|NCT00982410|631701|P2|STARTED|3-month Follow-up Assessment||66
260999|NCT00982410|631702|P1|STARTED|3-month Follow-up Assessment||65
261000|NCT00982397|631726|P2|NOT COMPLETED|Phase II/Overall Study||0
261001|NCT00982397|631727|P1|NOT COMPLETED|Phase II/Overall Study||0
261002|NCT00982397|631726|P2|COMPLETED|Phase II/Overall Study||751
261003|NCT00982397|631727|P1|COMPLETED|Phase II/Overall Study||2019
261004|NCT00982397|631726|P2|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||131
261005|NCT00982397|631727|P1|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||221
261006|NCT00982397|631726|P2|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||122
261007|NCT00982397|631727|P1|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||231
261008|NCT00982397|631726|P2|STARTED|Phase II/Overall Study||751
261009|NCT00982397|631727|P1|STARTED|Phase II/Overall Study||2019
261010|NCT00982397|631726|P2|NOT COMPLETED|Phase I||0
261011|NCT00982397|631727|P1|NOT COMPLETED|Phase I||0
261012|NCT00982397|631726|P2|COMPLETED|Phase I||0
261013|NCT00982397|631727|P1|COMPLETED|Phase I||236
261014|NCT00982397|631726|P2|STARTED|Phase I||0
261015|NCT00982397|631727|P1|STARTED|Phase I||236
261016|NCT00982345|631737|P1|NOT COMPLETED|Overall Study||2
261017|NCT00982345|631737|P1|COMPLETED|Overall Study||18
261018|NCT00982345|631737|P1|STARTED|Overall Study||20
261019|NCT00982319|631743|P2|NOT COMPLETED|Overall Study||2
261020|NCT00982319|631744|P1|NOT COMPLETED|Overall Study||2
261021|NCT00982319|631743|P2|COMPLETED|Overall Study||15
261022|NCT00982319|631744|P1|COMPLETED|Overall Study||15
261023|NCT00982319|631743|P2|STARTED|Overall Study||17
261024|NCT00982319|631744|P1|STARTED|Overall Study||17
261025|NCT00982280|631752|P1|NOT COMPLETED|Maintenance Period||1
261026|NCT00982280|631752|P1|COMPLETED|Maintenance Period||54
261027|NCT00982280|631752|P1|STARTED|Maintenance Period||55
261028|NCT00982280|631752|P1|NOT COMPLETED|Titration and Optimal Dose Period||8
261029|NCT00982280|631752|P1|COMPLETED|Titration and Optimal Dose Period||55
261030|NCT00982280|631752|P1|STARTED|Titration and Optimal Dose Period||63
261031|NCT00982280|631752|P1|NOT COMPLETED|Observation Period||19
261032|NCT00982280|631752|P1|COMPLETED|Observation Period||63
261033|NCT00982280|631752|P1|STARTED|Observation Period||82
261034|NCT00982228|631777|P2|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||5
261035|NCT00982228|631778|P1|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||21
261036|NCT00982228|631777|P2|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||113
261037|NCT00982228|631778|P1|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||330
261038|NCT00982228|631777|P2|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Nineteen subjects from the main trial did not continue into the extension|118
261039|NCT00982228|631778|P1|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Fifty-three subjects from the main trial did not continue into the extension|351
261040|NCT00982228|631777|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||20
261041|NCT00982228|631778|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||68
261042|NCT00982228|631777|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||137
261043|NCT00982228|631778|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||404
261044|NCT00982228|631777|P2|Exposed|Main: Week 0 to 52 (NN1250-3583)|Three subjects withdrew prior to exposure to trial drug|154
261045|NCT00982228|631778|P1|Exposed|Main: Week 0 to 52 (NN1250-3583)||472
261046|NCT00982228|631777|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||157
261047|NCT00982228|631778|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||472
261048|NCT00982228|631777|P2|STARTED|Main: Week 0 to 52 (NN1250-3583)||157
261049|NCT00982228|631778|P1|STARTED|Main: Week 0 to 52 (NN1250-3583)||472
261050|NCT00982189|631806|P4|NOT COMPLETED|Overall Study||0
261051|NCT00982189|631807|P3|NOT COMPLETED|Overall Study||0
261052|NCT00982189|631808|P2|NOT COMPLETED|Overall Study||0
261053|NCT00982189|631809|P1|NOT COMPLETED|Overall Study||0
261054|NCT00982189|631806|P4|COMPLETED|Overall Study||9
261055|NCT00982189|631807|P3|COMPLETED|Overall Study||9
261056|NCT00982189|631808|P2|COMPLETED|Overall Study||9
261057|NCT00982189|631809|P1|COMPLETED|Overall Study||10
261058|NCT00982189|631806|P4|STARTED|Overall Study||9
261059|NCT00982189|631807|P3|STARTED|Overall Study||9
261060|NCT00982189|631808|P2|STARTED|Overall Study||9
261061|NCT00982189|631809|P1|STARTED|Overall Study||10
261062|NCT00982137|631837|P4|NOT COMPLETED|Overall Study||1
261063|NCT00982137|631838|P3|NOT COMPLETED|Overall Study||0
261064|NCT00982137|631839|P2|NOT COMPLETED|Overall Study||1
261065|NCT00982137|631840|P1|NOT COMPLETED|Overall Study||0
261066|NCT00982137|631837|P4|COMPLETED|Overall Study||17
261067|NCT00982137|631838|P3|COMPLETED|Overall Study||18
261068|NCT00982137|631839|P2|COMPLETED|Overall Study||35
261069|NCT00982137|631840|P1|COMPLETED|Overall Study||36
261070|NCT00982137|631837|P4|STARTED|Overall Study||18
261071|NCT00982137|631838|P3|STARTED|Overall Study||18
261072|NCT00982137|631839|P2|STARTED|Overall Study||36
261073|NCT00982137|631840|P1|STARTED|Overall Study||36
261074|NCT00982111|631872|P2|NOT COMPLETED|Overall Study||66
261075|NCT00982111|631873|P1|NOT COMPLETED|Overall Study||75
261076|NCT00982111|631872|P2|COMPLETED|Overall Study||252
261077|NCT00982111|631873|P1|COMPLETED|Overall Study||240
261078|NCT00982111|631872|P2|On Study at Conclusion, Off Treatment|Overall Study||6
261079|NCT00982111|631873|P1|On Study at Conclusion, Off Treatment|Overall Study||4
261080|NCT00982111|631872|P2|Death Due to Any Cause|Overall Study||246
261081|NCT00982111|631873|P1|Death Due to Any Cause|Overall Study||236
261082|NCT00982111|631872|P2|Received at Least 1 Dose of Study Drug|Overall Study||312
261083|NCT00982111|631873|P1|Received at Least 1 Dose of Study Drug|Overall Study||304
261084|NCT00982111|631872|P2|STARTED|Overall Study||318
261085|NCT00982111|631873|P1|STARTED|Overall Study||315
261086|NCT00982033|631897|P2|NOT COMPLETED|Overall Study||0
261087|NCT00982033|631898|P1|NOT COMPLETED|Overall Study||0
261088|NCT00982033|631897|P2|COMPLETED|Overall Study||27
261089|NCT00982033|631898|P1|COMPLETED|Overall Study||25
261090|NCT00982033|631897|P2|STARTED|Overall Study||27
261091|NCT00982033|631898|P1|STARTED|Overall Study||25
261092|NCT00982020|631906|P2|NOT COMPLETED|Overall Study||64
261093|NCT00982020|631907|P1|NOT COMPLETED|Overall Study||57
261094|NCT00982020|631906|P2|COMPLETED|Overall Study||37
261095|NCT00982020|631907|P1|COMPLETED|Overall Study||45
261096|NCT00982020|631906|P2|Received at Least 1 Dose of Study Drug|Overall Study||101
261097|NCT00982020|631907|P1|Received at Least 1 Dose of Study Drug|Overall Study||102
261098|NCT00982020|631906|P2|STARTED|Overall Study||101
261099|NCT00982020|631907|P1|STARTED|Overall Study||102
261100|NCT00982007|631931|P4|NOT COMPLETED|Overall Study||6
261101|NCT00982007|631932|P3|NOT COMPLETED|Overall Study||0
261102|NCT00982007|631933|P2|NOT COMPLETED|Overall Study||4
261103|NCT00982007|631934|P1|NOT COMPLETED|Overall Study||4
261104|NCT00982007|631931|P4|COMPLETED|Overall Study||245
261105|NCT00982007|631932|P3|COMPLETED|Overall Study||253
261106|NCT00982007|631933|P2|COMPLETED|Overall Study||253
261107|NCT00982007|631934|P1|COMPLETED|Overall Study||246
261108|NCT00982007|631931|P4|STARTED|Overall Study||251
261109|NCT00982007|631932|P3|STARTED|Overall Study||253
261110|NCT00982007|631933|P2|STARTED|Overall Study||257
261111|NCT00982007|631934|P1|STARTED|Overall Study||250
261112|NCT00981825|631946|P2|NOT COMPLETED|Second Intervention||0
261113|NCT00981825|631947|P1|NOT COMPLETED|Second Intervention||0
261114|NCT00981825|631946|P2|COMPLETED|Second Intervention||11
261115|NCT00981825|631947|P1|COMPLETED|Second Intervention||11
261116|NCT00981825|631946|P2|STARTED|Second Intervention||11
261117|NCT00981825|631947|P1|STARTED|Second Intervention||11
261118|NCT00981825|631946|P2|NOT COMPLETED|Washout After 1st Intervention||0
261119|NCT00981825|631947|P1|NOT COMPLETED|Washout After 1st Intervention||0
261120|NCT00981825|631946|P2|COMPLETED|Washout After 1st Intervention||11
261121|NCT00981825|631947|P1|COMPLETED|Washout After 1st Intervention||11
261122|NCT00981825|631946|P2|STARTED|Washout After 1st Intervention||11
261123|NCT00981825|631947|P1|STARTED|Washout After 1st Intervention||11
261124|NCT00981825|631946|P2|NOT COMPLETED|First Intervention||0
261125|NCT00981825|631947|P1|NOT COMPLETED|First Intervention||0
261126|NCT00981825|631946|P2|COMPLETED|First Intervention||11
261127|NCT00981825|631947|P1|COMPLETED|First Intervention||11
261128|NCT00981825|631946|P2|STARTED|First Intervention||11
261129|NCT00981825|631947|P1|STARTED|First Intervention||11
261130|NCT00981812|631953|P1|NOT COMPLETED|Overall Study||0
261131|NCT00981812|631953|P1|COMPLETED|Overall Study||20
261132|NCT00981812|631953|P1|STARTED|Overall Study||20
261133|NCT00981747|631957|P1|NOT COMPLETED|Sildenafil and Losartan||0
261134|NCT00981747|631957|P1|COMPLETED|Sildenafil and Losartan||9
261135|NCT00981747|631957|P1|Completed Sildenafil and Losartan|Sildenafil and Losartan||9
261136|NCT00981747|631957|P1|Started Sildenafil and Losartan|Sildenafil and Losartan||9
261137|NCT00981747|631957|P1|STARTED|Sildenafil and Losartan||9
261138|NCT00981747|631957|P1|NOT COMPLETED|Sildenafil||0
261139|NCT00981747|631957|P1|COMPLETED|Sildenafil||9
261140|NCT00981747|631957|P1|Completed Sildenafil|Sildenafil||9
261141|NCT00981747|631957|P1|Started Sildenafil|Sildenafil||9
261142|NCT00981747|631957|P1|STARTED|Sildenafil||9
261143|NCT00981747|631957|P1|NOT COMPLETED|Placebo Oral Tablet||1
261144|NCT00981747|631957|P1|COMPLETED|Placebo Oral Tablet||9
261145|NCT00981747|631957|P1|Completed Placebo Oral Tablet|Placebo Oral Tablet||9
261146|NCT00981747|631957|P1|Started Placebo Oral Tablet|Placebo Oral Tablet||10
261147|NCT00981747|631957|P1|STARTED|Placebo Oral Tablet||10
261148|NCT00981747|631957|P1|NOT COMPLETED|Losartan||2
261149|NCT00981747|631957|P1|COMPLETED|Losartan|Only 9 were analyzed because only 9 completed all four interventions.|10
261150|NCT00981747|631957|P1|Completed Losartan|Losartan|Only 9 were analyzed because only 9 completed all four interventions.|10
261151|NCT00981747|631957|P1|Started Losartan|Losartan||12
261152|NCT00981747|631957|P1|STARTED|Losartan||12
261153|NCT00981669|631977|P2|NOT COMPLETED|Overall Study||0
261154|NCT00981669|631978|P1|NOT COMPLETED|Overall Study||1
261155|NCT00981669|631977|P2|COMPLETED|Overall Study||40
261156|NCT00981669|631978|P1|COMPLETED|Overall Study||39
261157|NCT00981669|631977|P2|STARTED|Overall Study||40
261158|NCT00981669|631978|P1|STARTED|Overall Study||40
261159|NCT00981630|631990|P4|NOT COMPLETED|Overall Study||0
261160|NCT00981630|631991|P3|NOT COMPLETED|Overall Study||0
261161|NCT00981630|631992|P2|NOT COMPLETED|Overall Study||0
261162|NCT00981630|631993|P1|NOT COMPLETED|Overall Study||0
261163|NCT00981630|631990|P4|COMPLETED|Overall Study||32
261164|NCT00981630|631991|P3|COMPLETED|Overall Study||32
261165|NCT00981630|631992|P2|COMPLETED|Overall Study||32
261166|NCT00981630|631993|P1|COMPLETED|Overall Study||32
261167|NCT00981630|631990|P4|STARTED|Overall Study||32
261168|NCT00981630|631991|P3|STARTED|Overall Study||32
261169|NCT00981630|631992|P2|STARTED|Overall Study||32
261170|NCT00981630|631993|P1|STARTED|Overall Study||32
261171|NCT00981526|632025|P2|NOT COMPLETED|Overall Study||6
261172|NCT00981526|632026|P1|NOT COMPLETED|Overall Study||4
261173|NCT00981526|632025|P2|COMPLETED|Overall Study||22
261174|NCT00981526|632026|P1|COMPLETED|Overall Study||22
261175|NCT00981526|632025|P2|STARTED|Overall Study||28
261176|NCT00981526|632026|P1|STARTED|Overall Study||26
261177|NCT00981461|632044|P2|NOT COMPLETED|Overall Study||2
261178|NCT00981461|632045|P1|NOT COMPLETED|Overall Study||5
261179|NCT00981461|632044|P2|COMPLETED|Overall Study||22
261180|NCT00981461|632045|P1|COMPLETED|Overall Study||43
261181|NCT00981461|632044|P2|STARTED|Overall Study||24
261182|NCT00981461|632045|P1|STARTED|Overall Study||48
261183|NCT00981435|632054|P3|NOT COMPLETED|Overall Study||0
261184|NCT00981435|632055|P2|NOT COMPLETED|Overall Study||0
261185|NCT00981435|632056|P1|NOT COMPLETED|Overall Study||0
261186|NCT00981435|632054|P3|COMPLETED|Overall Study||37
261187|NCT00981435|632055|P2|COMPLETED|Overall Study||29
261188|NCT00981435|632056|P1|COMPLETED|Overall Study||31
261189|NCT00981435|632054|P3|STARTED|Overall Study||37
261190|NCT00981435|632055|P2|STARTED|Overall Study||29
261191|NCT00981435|632056|P1|STARTED|Overall Study||31
261192|NCT00981409|632069|P2|NOT COMPLETED|Overall Study||1
261193|NCT00981409|632070|P1|NOT COMPLETED|Overall Study||6
261194|NCT00981409|632069|P2|COMPLETED|Overall Study||10
261195|NCT00981409|632070|P1|COMPLETED|Overall Study||24
261196|NCT00981409|632069|P2|STARTED|Overall Study||11
261197|NCT00981409|632070|P1|STARTED|Overall Study||30
261198|NCT00981370|632084|P1|NOT COMPLETED|Overall Study||0
261199|NCT00981370|632084|P1|COMPLETED|Overall Study||0
261200|NCT00981370|632084|P1|STARTED|Overall Study||0
261201|NCT00981305|632090|P2|NOT COMPLETED|Overall Study||10
261202|NCT00981305|632091|P1|NOT COMPLETED|Overall Study||19
261203|NCT00981305|632090|P2|COMPLETED|Overall Study||57
261204|NCT00981305|632091|P1|COMPLETED|Overall Study||50
261205|NCT00981305|632090|P2|STARTED|Overall Study||67
261206|NCT00981305|632091|P1|STARTED|Overall Study||69
261207|NCT00981292|632109|P6|NOT COMPLETED|Day 3||1
261208|NCT00981292|632110|P5|NOT COMPLETED|Day 3||0
261209|NCT00981292|632111|P4|NOT COMPLETED|Day 3||0
261210|NCT00981292|632112|P3|NOT COMPLETED|Day 3||0
261211|NCT00981292|632113|P2|NOT COMPLETED|Day 3||0
261212|NCT00981292|632114|P1|NOT COMPLETED|Day 3||0
261213|NCT00981292|632109|P6|COMPLETED|Day 3||4
261214|NCT00981292|632110|P5|COMPLETED|Day 3||4
261215|NCT00981292|632111|P4|COMPLETED|Day 3||4
261216|NCT00981292|632112|P3|COMPLETED|Day 3||6
261217|NCT00981292|632113|P2|COMPLETED|Day 3||4
261218|NCT00981292|632114|P1|COMPLETED|Day 3||4
261219|NCT00981292|632109|P6|STARTED|Day 3||5
261220|NCT00981292|632110|P5|STARTED|Day 3||4
261221|NCT00981292|632111|P4|STARTED|Day 3||4
261222|NCT00981292|632112|P3|STARTED|Day 3||6
261223|NCT00981292|632113|P2|STARTED|Day 3||4
261224|NCT00981292|632114|P1|STARTED|Day 3||4
261225|NCT00981292|632109|P6|NOT COMPLETED|Day 2||0
261226|NCT00981292|632110|P5|NOT COMPLETED|Day 2||0
261227|NCT00981292|632111|P4|NOT COMPLETED|Day 2||0
261228|NCT00981292|632112|P3|NOT COMPLETED|Day 2||0
261229|NCT00981292|632113|P2|NOT COMPLETED|Day 2||0
261230|NCT00981292|632114|P1|NOT COMPLETED|Day 2||2
261231|NCT00981292|632109|P6|COMPLETED|Day 2||5
261232|NCT00981292|632110|P5|COMPLETED|Day 2||4
261233|NCT00981292|632111|P4|COMPLETED|Day 2||4
261234|NCT00981292|632112|P3|COMPLETED|Day 2||6
261235|NCT00981292|632113|P2|COMPLETED|Day 2||4
261236|NCT00981292|632114|P1|COMPLETED|Day 2||4
261237|NCT00981292|632109|P6|STARTED|Day 2||5
261238|NCT00981292|632110|P5|STARTED|Day 2||4
261239|NCT00981292|632111|P4|STARTED|Day 2||4
261240|NCT00981292|632112|P3|STARTED|Day 2||6
261241|NCT00981292|632113|P2|STARTED|Day 2||4
261242|NCT00981292|632114|P1|STARTED|Day 2||6
261243|NCT00981292|632109|P6|NOT COMPLETED|Day 1||2
261244|NCT00981292|632110|P5|NOT COMPLETED|Day 1||0
261245|NCT00981292|632111|P4|NOT COMPLETED|Day 1||0
261246|NCT00981292|632112|P3|NOT COMPLETED|Day 1||0
261247|NCT00981292|632113|P2|NOT COMPLETED|Day 1||0
261248|NCT00981292|632114|P1|NOT COMPLETED|Day 1||1
261249|NCT00981292|632109|P6|COMPLETED|Day 1||5
261250|NCT00981292|632110|P5|COMPLETED|Day 1||4
261251|NCT00981292|632111|P4|COMPLETED|Day 1||4
261252|NCT00981292|632112|P3|COMPLETED|Day 1||6
261253|NCT00981292|632113|P2|COMPLETED|Day 1||4
261254|NCT00981292|632114|P1|COMPLETED|Day 1||6
261255|NCT00981292|632109|P6|STARTED|Day 1||7
261256|NCT00981292|632110|P5|STARTED|Day 1||4
261257|NCT00981292|632111|P4|STARTED|Day 1||4
261258|NCT00981292|632112|P3|STARTED|Day 1||6
261259|NCT00981292|632113|P2|STARTED|Day 1||4
261260|NCT00981292|632114|P1|STARTED|Day 1||7
261261|NCT00981253|632133|P2|NOT COMPLETED|Overall Study||3
261262|NCT00981253|632134|P1|NOT COMPLETED|Overall Study||3
261263|NCT00981253|632133|P2|COMPLETED|Overall Study||72
261264|NCT00981253|632134|P1|COMPLETED|Overall Study||73
261265|NCT00981253|632133|P2|STARTED|Overall Study||75
261266|NCT00981253|632134|P1|STARTED|Overall Study||76
261267|NCT00981227|632158|P6|NOT COMPLETED|Overall Study||18
261268|NCT00981227|632159|P5|NOT COMPLETED|Overall Study||30
261269|NCT00981227|632160|P4|NOT COMPLETED|Overall Study||21
261270|NCT00981227|632161|P3|NOT COMPLETED|Overall Study||21
261271|NCT00981227|632162|P2|NOT COMPLETED|Overall Study||19
261272|NCT00981227|632163|P1|NOT COMPLETED|Overall Study||22
261273|NCT00981227|632158|P6|COMPLETED|Overall Study||75
261274|NCT00981227|632159|P5|COMPLETED|Overall Study||60
261275|NCT00981227|632160|P4|COMPLETED|Overall Study||73
261276|NCT00981227|632161|P3|COMPLETED|Overall Study||73
261277|NCT00981227|632162|P2|COMPLETED|Overall Study||75
261278|NCT00981227|632163|P1|COMPLETED|Overall Study||80
261279|NCT00981227|632158|P6|Per–Protocol|Overall Study||70
261280|NCT00981227|632159|P5|Per–Protocol|Overall Study||50
261281|NCT00981227|632160|P4|Per–Protocol|Overall Study||68
261282|NCT00981227|632161|P3|Per–Protocol|Overall Study||67
261283|NCT00981227|632162|P2|Per–Protocol|Overall Study||72
261284|NCT00981227|632163|P1|Per–Protocol|Overall Study||69
261285|NCT00981227|632158|P6|Safety Population|Overall Study||93
261286|NCT00981227|632159|P5|Safety Population|Overall Study||90
261287|NCT00981227|632160|P4|Safety Population|Overall Study||94
261288|NCT00981227|632161|P3|Safety Population|Overall Study||94
261289|NCT00981227|632162|P2|Safety Population|Overall Study||94
261290|NCT00981227|632163|P1|Safety Population|Overall Study||102
261291|NCT00981227|632158|P6|Randomized|Overall Study||93
261292|NCT00981227|632159|P5|Randomized|Overall Study||90
261293|NCT00981227|632160|P4|Randomized|Overall Study||94
261294|NCT00981227|632161|P3|Randomized|Overall Study||94
261295|NCT00981227|632162|P2|Randomized|Overall Study||94
261296|NCT00981227|632163|P1|Randomized|Overall Study||102
261297|NCT00981227|632158|P6|STARTED|Overall Study||93
261298|NCT00981227|632159|P5|STARTED|Overall Study||90
261299|NCT00981227|632160|P4|STARTED|Overall Study||94
261300|NCT00981227|632161|P3|STARTED|Overall Study||94
261301|NCT00981227|632162|P2|STARTED|Overall Study||94
261302|NCT00981227|632163|P1|STARTED|Overall Study||102
261303|NCT00981214|632181|P1|NOT COMPLETED|Overall Study||0
261304|NCT00981214|632181|P1|COMPLETED|Overall Study||19
261305|NCT00981214|632181|P1|STARTED|Overall Study||19
261306|NCT00981175|632198|P2|NOT COMPLETED|Booster Dose Vaccination||3
261307|NCT00981175|632199|P1|NOT COMPLETED|Booster Dose Vaccination||2
261308|NCT00981175|632198|P2|COMPLETED|Booster Dose Vaccination||40
261309|NCT00981175|632199|P1|COMPLETED|Booster Dose Vaccination||53
261310|NCT00981175|632198|P2|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|43
261311|NCT00981175|632199|P1|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|55
261312|NCT00981175|632198|P2|NOT COMPLETED|Primary Dose Vaccination||2
261313|NCT00981175|632199|P1|NOT COMPLETED|Primary Dose Vaccination||3
261314|NCT00981175|632198|P2|COMPLETED|Primary Dose Vaccination||99
261315|NCT00981175|632199|P1|COMPLETED|Primary Dose Vaccination||98
261316|NCT00981175|632198|P2|STARTED|Primary Dose Vaccination||101
261317|NCT00981175|632199|P1|STARTED|Primary Dose Vaccination||101
261318|NCT00981149|632224|P2|NOT COMPLETED|Overall Study||3
261319|NCT00981149|632225|P1|NOT COMPLETED|Overall Study||2
261320|NCT00981149|632224|P2|COMPLETED|Overall Study||9
261321|NCT00981149|632225|P1|COMPLETED|Overall Study||10
261322|NCT00981149|632224|P2|STARTED|Overall Study||12
261323|NCT00981149|632225|P1|STARTED|Overall Study||12
261324|NCT00981084|632235|P2|NOT COMPLETED|Post Intervention (Data Analysis)||1
261325|NCT00981084|632236|P1|NOT COMPLETED|Post Intervention (Data Analysis)||2
261326|NCT00981084|632235|P2|COMPLETED|Post Intervention (Data Analysis)||16
261327|NCT00981084|632236|P1|COMPLETED|Post Intervention (Data Analysis)||14
261328|NCT00981084|632235|P2|STARTED|Post Intervention (Data Analysis)||17
261329|NCT00981084|632236|P1|STARTED|Post Intervention (Data Analysis)||16
261330|NCT00981084|632235|P2|NOT COMPLETED|Second Intervention (One Day)||0
261331|NCT00981084|632236|P1|NOT COMPLETED|Second Intervention (One Day)||0
261332|NCT00981084|632235|P2|COMPLETED|Second Intervention (One Day)||17
261333|NCT00981084|632236|P1|COMPLETED|Second Intervention (One Day)||16
261334|NCT00981084|632235|P2|STARTED|Second Intervention (One Day)||17
261335|NCT00981084|632236|P1|STARTED|Second Intervention (One Day)||16
261336|NCT00981084|632235|P2|NOT COMPLETED|Washout Period (7 Days)||0
261337|NCT00981084|632236|P1|NOT COMPLETED|Washout Period (7 Days)||0
261338|NCT00981084|632235|P2|COMPLETED|Washout Period (7 Days)||17
261339|NCT00981084|632236|P1|COMPLETED|Washout Period (7 Days)||16
261340|NCT00981084|632235|P2|STARTED|Washout Period (7 Days)||17
261341|NCT00981084|632236|P1|STARTED|Washout Period (7 Days)||16
261342|NCT00981084|632235|P2|NOT COMPLETED|First Intervention (One Day)||0
261343|NCT00981084|632236|P1|NOT COMPLETED|First Intervention (One Day)||0
261344|NCT00981084|632235|P2|COMPLETED|First Intervention (One Day)||17
261345|NCT00981084|632236|P1|COMPLETED|First Intervention (One Day)||16
261346|NCT00981084|632235|P2|STARTED|First Intervention (One Day)||17
261347|NCT00981084|632236|P1|STARTED|First Intervention (One Day)||16
261348|NCT00981058|632252|P2|NOT COMPLETED|Overall Study||97
261349|NCT00981058|632253|P1|NOT COMPLETED|Overall Study||120
261350|NCT00981058|632252|P2|COMPLETED|Overall Study||451
261351|NCT00981058|632253|P1|COMPLETED|Overall Study||425
261352|NCT00981058|632252|P2|Death Due to Any Cause|Overall Study||442
261353|NCT00981058|632253|P1|Death Due to Any Cause|Overall Study||418
261354|NCT00981058|632252|P2|Received at Least 1 Dose of Study Drug|Overall Study||541
261355|NCT00981058|632253|P1|Received at Least 1 Dose of Study Drug|Overall Study||538
261356|NCT00981058|632252|P2|STARTED|Overall Study||548
261357|NCT00981058|632253|P1|STARTED|Overall Study||545
261358|NCT00981045|632275|P2|NOT COMPLETED|Overall Study||9
261359|NCT00981045|632276|P1|NOT COMPLETED|Overall Study||14
261360|NCT00981045|632275|P2|COMPLETED|Overall Study||1285
261361|NCT00981045|632276|P1|COMPLETED|Overall Study||1276
261362|NCT00981045|632275|P2|STARTED|Overall Study||1294
261363|NCT00981045|632276|P1|STARTED|Overall Study||1290
261364|NCT00981019|632284|P1|NOT COMPLETED|Overall Study||477
261365|NCT00981019|632284|P1|COMPLETED|Overall Study||301
261366|NCT00981019|632284|P1|STARTED|Overall Study||778
261367|NCT00980980|632291|P3|NOT COMPLETED|Overall Study||0
261368|NCT00980980|632292|P2|NOT COMPLETED|Overall Study||1
261369|NCT00980980|632293|P1|NOT COMPLETED|Overall Study||0
261370|NCT00980980|632291|P3|COMPLETED|Overall Study||13
261371|NCT00980980|632292|P2|COMPLETED|Overall Study||13
261372|NCT00980980|632293|P1|COMPLETED|Overall Study||16
261373|NCT00980980|632291|P3|STARTED|Overall Study||13
261374|NCT00980980|632292|P2|STARTED|Overall Study||14
261375|NCT00980980|632293|P1|STARTED|Overall Study||16
261376|NCT00980798|632324|P2|NOT COMPLETED|Overall Study||55
261377|NCT00980798|632325|P1|NOT COMPLETED|Overall Study||33
261378|NCT00980798|632324|P2|COMPLETED|Overall Study||84
261379|NCT00980798|632325|P1|COMPLETED|Overall Study||116
261380|NCT00980798|632324|P2|STARTED|Overall Study||139
261381|NCT00980798|632325|P1|STARTED|Overall Study||149
261382|NCT00980746|632339|P6|NOT COMPLETED|Overall Study||18
261383|NCT00980746|632340|P5|NOT COMPLETED|Overall Study||17
261384|NCT00980746|632341|P4|NOT COMPLETED|Overall Study||36
261385|NCT00980746|632342|P3|NOT COMPLETED|Overall Study||20
261386|NCT00980746|632343|P2|NOT COMPLETED|Overall Study||22
261387|NCT00980746|632344|P1|NOT COMPLETED|Overall Study||27
261388|NCT00980746|632339|P6|COMPLETED|Overall Study||78
261389|NCT00980746|632340|P5|COMPLETED|Overall Study||75
261390|NCT00980746|632341|P4|COMPLETED|Overall Study||64
261391|NCT00980746|632342|P3|COMPLETED|Overall Study||75
261392|NCT00980746|632343|P2|COMPLETED|Overall Study||67
261393|NCT00980746|632344|P1|COMPLETED|Overall Study||58
261394|NCT00980746|632339|P6|Per-protocol|Overall Study||74
261395|NCT00980746|632340|P5|Per-protocol|Overall Study||73
261396|NCT00980746|632341|P4|Per-protocol|Overall Study||62
261397|NCT00980746|632342|P3|Per-protocol|Overall Study||73
261398|NCT00980746|632343|P2|Per-protocol|Overall Study||66
261399|NCT00980746|632344|P1|Per-protocol|Overall Study||55
261400|NCT00980746|632339|P6|Safety Population|Overall Study||96
261401|NCT00980746|632340|P5|Safety Population|Overall Study||92
261402|NCT00980746|632341|P4|Safety Population|Overall Study||100
261403|NCT00980746|632342|P3|Safety Population|Overall Study||95
261404|NCT00980746|632343|P2|Safety Population|Overall Study||89
261405|NCT00980746|632344|P1|Safety Population|Overall Study||85
261406|NCT00980746|632339|P6|Randomized|Overall Study||96
261407|NCT00980746|632340|P5|Randomized|Overall Study||92
261408|NCT00980746|632341|P4|Randomized|Overall Study||100
261409|NCT00980746|632342|P3|Randomized|Overall Study||95
261410|NCT00980746|632343|P2|Randomized|Overall Study||89
261411|NCT00980746|632344|P1|Randomized|Overall Study||85
261412|NCT00980746|632339|P6|STARTED|Overall Study||96
261413|NCT00980746|632340|P5|STARTED|Overall Study||92
261414|NCT00980746|632341|P4|STARTED|Overall Study||100
261415|NCT00980746|632342|P3|STARTED|Overall Study||95
261416|NCT00980746|632343|P2|STARTED|Overall Study||89
261417|NCT00980746|632344|P1|STARTED|Overall Study||85
261418|NCT00980681|632358|P1|NOT COMPLETED|Dotarem MRA||0
261419|NCT00980681|632358|P1|COMPLETED|Dotarem MRA||10
261420|NCT00980681|632358|P1|STARTED|Dotarem MRA|Out of the 13 enrolled patients, three did not receive treatment|10
261421|NCT00980681|632358|P1|NOT COMPLETED|TOF MRA||0
261422|NCT00980681|632358|P1|COMPLETED|TOF MRA||10
261423|NCT00980681|632358|P1|STARTED|TOF MRA|Out of the 13 enrolled patients, three did not receive treatment|10
261424|NCT00980655|632366|P2|NOT COMPLETED|Overall Study||51
261425|NCT00980655|632367|P1|NOT COMPLETED|Overall Study||16
261426|NCT00980655|632366|P2|COMPLETED|Overall Study||139
261427|NCT00980655|632367|P1|COMPLETED|Overall Study||45
261428|NCT00980655|632366|P2|Vaccinated 23vPS Dose|Overall Study||140
261429|NCT00980655|632367|P1|Vaccinated 23vPS Dose|Overall Study||45
261430|NCT00980655|632366|P2|Vaccinated 13vPnC Dose 4|Overall Study||146
261431|NCT00980655|632367|P1|Vaccinated 13vPnC Dose 4|Overall Study||46
261432|NCT00980655|632366|P2|Vaccinated 13vPnC Dose 3|Overall Study||167
261433|NCT00980655|632367|P1|Vaccinated 13vPnC Dose 3|Overall Study||54
261434|NCT00980655|632366|P2|Vaccinated 13vPnC Dose 2|Overall Study||176
261435|NCT00980655|632367|P1|Vaccinated 13vPnC Dose 2|Overall Study||55
261436|NCT00980655|632366|P2|Vaccinated 13vPnC Dose 1|Overall Study||188
261437|NCT00980655|632367|P1|Vaccinated 13vPnC Dose 1|Overall Study||59
261438|NCT00980655|632366|P2|STARTED|Overall Study||190
261439|NCT00980655|632367|P1|STARTED|Overall Study||61
261440|NCT00980642|632415|P2|NOT COMPLETED|Overall Study||0
261441|NCT00980642|632416|P1|NOT COMPLETED|Overall Study||0
261442|NCT00980642|632415|P2|COMPLETED|Overall Study||20
261443|NCT00980642|632416|P1|COMPLETED|Overall Study||36
261444|NCT00980642|632415|P2|STARTED|Overall Study||20
261445|NCT00980642|632416|P1|STARTED|Overall Study||36
261446|NCT00980590|632428|P2|NOT COMPLETED|Overall Study||0
261447|NCT00980590|632429|P1|NOT COMPLETED|Overall Study||0
261448|NCT00980590|632428|P2|COMPLETED|Overall Study||50
261449|NCT00980590|632429|P1|COMPLETED|Overall Study||50
261450|NCT00980590|632428|P2|STARTED|Overall Study||50
261451|NCT00980590|632429|P1|STARTED|Overall Study||50
261452|NCT00980395|632441|P1|NOT COMPLETED|Overall Study||0
261453|NCT00980395|632441|P1|COMPLETED|Overall Study||24
261454|NCT00980395|632441|P1|STARTED|Overall Study||24
261455|NCT00980343|632450|P2|NOT COMPLETED|Overall Study||3
261456|NCT00980343|632451|P1|NOT COMPLETED|Overall Study||1
261457|NCT00980343|632450|P2|COMPLETED|Overall Study||20
261458|NCT00980343|632451|P1|COMPLETED|Overall Study||20
261459|NCT00980343|632450|P2|STARTED|Overall Study||23
261460|NCT00980343|632451|P1|STARTED|Overall Study||21
261461|NCT00980330|632475|P7|NOT COMPLETED|Overall Study||7
261462|NCT00980330|632476|P6|NOT COMPLETED|Overall Study||4
261463|NCT00980330|632477|P5|NOT COMPLETED|Overall Study||5
261464|NCT00980330|632478|P4|NOT COMPLETED|Overall Study||5
261465|NCT00980330|632479|P3|NOT COMPLETED|Overall Study||8
261466|NCT00980330|632480|P2|NOT COMPLETED|Overall Study||5
261467|NCT00980330|632481|P1|NOT COMPLETED|Overall Study||5
261468|NCT00980330|632475|P7|COMPLETED|Overall Study||59
261469|NCT00980330|632476|P6|COMPLETED|Overall Study||61
261470|NCT00980330|632477|P5|COMPLETED|Overall Study||63
261471|NCT00980330|632478|P4|COMPLETED|Overall Study||61
261472|NCT00980330|632479|P3|COMPLETED|Overall Study||58
261473|NCT00980330|632480|P2|COMPLETED|Overall Study||60
261474|NCT00980330|632481|P1|COMPLETED|Overall Study||61
261475|NCT00980330|632475|P7|STARTED|Overall Study||66
261476|NCT00980330|632476|P6|STARTED|Overall Study||65
261477|NCT00980330|632477|P5|STARTED|Overall Study||68
261478|NCT00980330|632478|P4|STARTED|Overall Study||66
261479|NCT00980330|632479|P3|STARTED|Overall Study||66
261480|NCT00980330|632480|P2|STARTED|Overall Study||65
261481|NCT00980330|632481|P1|STARTED|Overall Study||66
261482|NCT00980278|632581|P2|NOT COMPLETED|Overall Study||0
261483|NCT00980278|632582|P1|NOT COMPLETED|Overall Study||2
261484|NCT00980278|632581|P2|COMPLETED|Overall Study||13
261485|NCT00980278|632582|P1|COMPLETED|Overall Study||11
261486|NCT00980278|632581|P2|STARTED|Overall Study||13
261487|NCT00980278|632582|P1|STARTED|Overall Study||13
261488|NCT00980200|632596|P5|NOT COMPLETED|7-day Treatment Period 5||0
261489|NCT00980200|632597|P4|NOT COMPLETED|7-day Treatment Period 5||0
261490|NCT00980200|632598|P3|NOT COMPLETED|7-day Treatment Period 5||0
261491|NCT00980200|632599|P2|NOT COMPLETED|7-day Treatment Period 5||0
261492|NCT00980200|632600|P1|NOT COMPLETED|7-day Treatment Period 5||0
261493|NCT00980200|632596|P5|COMPLETED|7-day Treatment Period 5||14
261494|NCT00980200|632597|P4|COMPLETED|7-day Treatment Period 5||16
261495|NCT00980200|632598|P3|COMPLETED|7-day Treatment Period 5||15
261496|NCT00980200|632599|P2|COMPLETED|7-day Treatment Period 5||12
261497|NCT00980200|632600|P1|COMPLETED|7-day Treatment Period 5||15
261498|NCT00980200|632596|P5|STARTED|7-day Treatment Period 5||14
261499|NCT00980200|632597|P4|STARTED|7-day Treatment Period 5||16
261500|NCT00980200|632598|P3|STARTED|7-day Treatment Period 5||15
261501|NCT00980200|632599|P2|STARTED|7-day Treatment Period 5||12
261502|NCT00980200|632600|P1|STARTED|7-day Treatment Period 5||15
261503|NCT00980200|632596|P5|NOT COMPLETED|7-day Washout Period 4||0
261504|NCT00980200|632597|P4|NOT COMPLETED|7-day Washout Period 4||0
261505|NCT00980200|632598|P3|NOT COMPLETED|7-day Washout Period 4||0
261506|NCT00980200|632599|P2|NOT COMPLETED|7-day Washout Period 4||0
261507|NCT00980200|632600|P1|NOT COMPLETED|7-day Washout Period 4||0
261508|NCT00980200|632596|P5|COMPLETED|7-day Washout Period 4||14
261509|NCT00980200|632597|P4|COMPLETED|7-day Washout Period 4||16
261510|NCT00980200|632598|P3|COMPLETED|7-day Washout Period 4||15
261511|NCT00980200|632599|P2|COMPLETED|7-day Washout Period 4||12
261512|NCT00980200|632600|P1|COMPLETED|7-day Washout Period 4||15
261513|NCT00980200|632596|P5|STARTED|7-day Washout Period 4||14
261514|NCT00980200|632597|P4|STARTED|7-day Washout Period 4||16
261515|NCT00980200|632598|P3|STARTED|7-day Washout Period 4||15
261516|NCT00980200|632599|P2|STARTED|7-day Washout Period 4||12
261517|NCT00980200|632600|P1|STARTED|7-day Washout Period 4||15
261518|NCT00980200|632596|P5|NOT COMPLETED|7-day Treatment Period 4||0
261519|NCT00980200|632597|P4|NOT COMPLETED|7-day Treatment Period 4||0
261520|NCT00980200|632598|P3|NOT COMPLETED|7-day Treatment Period 4||0
261521|NCT00980200|632599|P2|NOT COMPLETED|7-day Treatment Period 4||0
261522|NCT00980200|632600|P1|NOT COMPLETED|7-day Treatment Period 4||0
261523|NCT00980200|632596|P5|COMPLETED|7-day Treatment Period 4||14
261524|NCT00980200|632597|P4|COMPLETED|7-day Treatment Period 4||16
261525|NCT00980200|632598|P3|COMPLETED|7-day Treatment Period 4||15
261526|NCT00980200|632599|P2|COMPLETED|7-day Treatment Period 4||12
261527|NCT00980200|632600|P1|COMPLETED|7-day Treatment Period 4||15
261528|NCT00980200|632596|P5|STARTED|7-day Treatment Period 4||14
261529|NCT00980200|632597|P4|STARTED|7-day Treatment Period 4||16
261530|NCT00980200|632598|P3|STARTED|7-day Treatment Period 4||15
261531|NCT00980200|632599|P2|STARTED|7-day Treatment Period 4||12
261532|NCT00980200|632600|P1|STARTED|7-day Treatment Period 4||15
261533|NCT00980200|632596|P5|NOT COMPLETED|7-day Washout Period 3||0
261534|NCT00980200|632597|P4|NOT COMPLETED|7-day Washout Period 3||0
261535|NCT00980200|632598|P3|NOT COMPLETED|7-day Washout Period 3||0
261536|NCT00980200|632599|P2|NOT COMPLETED|7-day Washout Period 3||0
261537|NCT00980200|632600|P1|NOT COMPLETED|7-day Washout Period 3||0
261538|NCT00980200|632596|P5|COMPLETED|7-day Washout Period 3||14
261539|NCT00980200|632597|P4|COMPLETED|7-day Washout Period 3||16
261540|NCT00980200|632598|P3|COMPLETED|7-day Washout Period 3||15
261541|NCT00980200|632599|P2|COMPLETED|7-day Washout Period 3||12
261542|NCT00980200|632600|P1|COMPLETED|7-day Washout Period 3||15
261543|NCT00980200|632596|P5|STARTED|7-day Washout Period 3||14
261544|NCT00980200|632597|P4|STARTED|7-day Washout Period 3||16
261545|NCT00980200|632598|P3|STARTED|7-day Washout Period 3||15
261546|NCT00980200|632599|P2|STARTED|7-day Washout Period 3||12
261547|NCT00980200|632600|P1|STARTED|7-day Washout Period 3||15
261548|NCT00980200|632596|P5|NOT COMPLETED|7-day Treatment Period 3||1
261549|NCT00980200|632597|P4|NOT COMPLETED|7-day Treatment Period 3||0
261550|NCT00980200|632598|P3|NOT COMPLETED|7-day Treatment Period 3||0
261551|NCT00980200|632599|P2|NOT COMPLETED|7-day Treatment Period 3||1
261552|NCT00980200|632600|P1|NOT COMPLETED|7-day Treatment Period 3||0
261553|NCT00980200|632596|P5|COMPLETED|7-day Treatment Period 3||14
261554|NCT00980200|632597|P4|COMPLETED|7-day Treatment Period 3||16
261555|NCT00980200|632598|P3|COMPLETED|7-day Treatment Period 3||15
261556|NCT00980200|632599|P2|COMPLETED|7-day Treatment Period 3||12
261557|NCT00980200|632600|P1|COMPLETED|7-day Treatment Period 3||15
261558|NCT00980200|632596|P5|STARTED|7-day Treatment Period 3||15
261559|NCT00980200|632597|P4|STARTED|7-day Treatment Period 3||16
261560|NCT00980200|632598|P3|STARTED|7-day Treatment Period 3||15
261561|NCT00980200|632599|P2|STARTED|7-day Treatment Period 3||13
261562|NCT00980200|632600|P1|STARTED|7-day Treatment Period 3||15
261563|NCT00980200|632596|P5|NOT COMPLETED|7-day Washout Period 2||0
261564|NCT00980200|632597|P4|NOT COMPLETED|7-day Washout Period 2||0
261565|NCT00980200|632598|P3|NOT COMPLETED|7-day Washout Period 2||0
261566|NCT00980200|632599|P2|NOT COMPLETED|7-day Washout Period 2||0
261567|NCT00980200|632600|P1|NOT COMPLETED|7-day Washout Period 2||0
261568|NCT00980200|632596|P5|COMPLETED|7-day Washout Period 2||15
261569|NCT00980200|632597|P4|COMPLETED|7-day Washout Period 2||16
261570|NCT00980200|632598|P3|COMPLETED|7-day Washout Period 2||15
261571|NCT00980200|632599|P2|COMPLETED|7-day Washout Period 2||13
261572|NCT00980200|632600|P1|COMPLETED|7-day Washout Period 2||15
261573|NCT00980200|632596|P5|STARTED|7-day Washout Period 2||15
261574|NCT00980200|632597|P4|STARTED|7-day Washout Period 2||16
261575|NCT00980200|632598|P3|STARTED|7-day Washout Period 2||15
261576|NCT00980200|632599|P2|STARTED|7-day Washout Period 2||13
261577|NCT00980200|632600|P1|STARTED|7-day Washout Period 2||15
261578|NCT00980200|632596|P5|NOT COMPLETED|7-day Treatment Period 2||0
261579|NCT00980200|632597|P4|NOT COMPLETED|7-day Treatment Period 2||0
261580|NCT00980200|632598|P3|NOT COMPLETED|7-day Treatment Period 2||0
261581|NCT00980200|632599|P2|NOT COMPLETED|7-day Treatment Period 2||0
261582|NCT00980200|632600|P1|NOT COMPLETED|7-day Treatment Period 2||0
261583|NCT00980200|632596|P5|COMPLETED|7-day Treatment Period 2||15
261584|NCT00980200|632597|P4|COMPLETED|7-day Treatment Period 2||16
261585|NCT00980200|632598|P3|COMPLETED|7-day Treatment Period 2||15
261586|NCT00980200|632599|P2|COMPLETED|7-day Treatment Period 2||13
261587|NCT00980200|632600|P1|COMPLETED|7-day Treatment Period 2||15
261588|NCT00980200|632596|P5|STARTED|7-day Treatment Period 2||15
261589|NCT00980200|632597|P4|STARTED|7-day Treatment Period 2||16
261590|NCT00980200|632598|P3|STARTED|7-day Treatment Period 2||15
261591|NCT00980200|632599|P2|STARTED|7-day Treatment Period 2||13
261592|NCT00980200|632600|P1|STARTED|7-day Treatment Period 2||15
261593|NCT00980200|632596|P5|NOT COMPLETED|7-day Washout Period 1||0
261594|NCT00980200|632597|P4|NOT COMPLETED|7-day Washout Period 1||0
261595|NCT00980200|632598|P3|NOT COMPLETED|7-day Washout Period 1||0
261596|NCT00980200|632599|P2|NOT COMPLETED|7-day Washout Period 1||0
261597|NCT00980200|632600|P1|NOT COMPLETED|7-day Washout Period 1||0
261598|NCT00980200|632596|P5|COMPLETED|7-day Washout Period 1||15
261599|NCT00980200|632597|P4|COMPLETED|7-day Washout Period 1||16
261600|NCT00980200|632598|P3|COMPLETED|7-day Washout Period 1||15
261601|NCT00980200|632599|P2|COMPLETED|7-day Washout Period 1||13
261602|NCT00980200|632600|P1|COMPLETED|7-day Washout Period 1||15
261603|NCT00980200|632596|P5|STARTED|7-day Washout Period 1||15
261604|NCT00980200|632597|P4|STARTED|7-day Washout Period 1||16
261605|NCT00980200|632598|P3|STARTED|7-day Washout Period 1||15
261606|NCT00980200|632599|P2|STARTED|7-day Washout Period 1||13
261607|NCT00980200|632600|P1|STARTED|7-day Washout Period 1||15
261608|NCT00980200|632596|P5|NOT COMPLETED|7-day Treatment Period 1||0
261609|NCT00980200|632597|P4|NOT COMPLETED|7-day Treatment Period 1||0
261610|NCT00980200|632598|P3|NOT COMPLETED|7-day Treatment Period 1||0
261611|NCT00980200|632599|P2|NOT COMPLETED|7-day Treatment Period 1||1
261612|NCT00980200|632600|P1|NOT COMPLETED|7-day Treatment Period 1||0
261613|NCT00980200|632596|P5|COMPLETED|7-day Treatment Period 1||15
261614|NCT00980200|632597|P4|COMPLETED|7-day Treatment Period 1||16
261615|NCT00980200|632598|P3|COMPLETED|7-day Treatment Period 1||15
261616|NCT00980200|632599|P2|COMPLETED|7-day Treatment Period 1||13
261617|NCT00980200|632600|P1|COMPLETED|7-day Treatment Period 1||15
261618|NCT00980200|632596|P5|STARTED|7-day Treatment Period 1||15
261619|NCT00980200|632597|P4|STARTED|7-day Treatment Period 1||16
261620|NCT00980200|632598|P3|STARTED|7-day Treatment Period 1||15
261621|NCT00980200|632599|P2|STARTED|7-day Treatment Period 1||14
261622|NCT00980200|632600|P1|STARTED|7-day Treatment Period 1||15
261623|NCT00980174|632619|P2|NOT COMPLETED|Overall Study||10
261624|NCT00980174|632620|P1|NOT COMPLETED|Overall Study||4
261625|NCT00980174|632619|P2|COMPLETED|Overall Study||111
261626|NCT00980174|632620|P1|COMPLETED|Overall Study||117
261627|NCT00980174|632619|P2|STARTED|Overall Study||121
261628|NCT00980174|632620|P1|STARTED|Overall Study||121
261629|NCT00980148|632638|P2|NOT COMPLETED|Overall Study||128
261630|NCT00980148|632639|P1|NOT COMPLETED|Overall Study||129
261631|NCT00980148|632638|P2|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
261632|NCT00980148|632639|P1|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
261633|NCT00980148|632638|P2|STARTED|Overall Study||283
261634|NCT00980148|632639|P1|STARTED|Overall Study||284
261635|NCT00980057|632647|P2|NOT COMPLETED|Overall Study||5
261636|NCT00980057|632648|P1|NOT COMPLETED|Overall Study||19
261637|NCT00980057|632647|P2|COMPLETED|Overall Study||155
261638|NCT00980057|632648|P1|COMPLETED|Overall Study||299
261639|NCT00980057|632647|P2|STARTED|Overall Study||160
261640|NCT00980057|632648|P1|STARTED|Overall Study||318
261641|NCT00980044|632671|P3|NOT COMPLETED|Overall Study||5
261642|NCT00980044|632672|P2|NOT COMPLETED|Overall Study||7
261643|NCT00980044|632673|P1|NOT COMPLETED|Overall Study||5
261644|NCT00980044|632671|P3|COMPLETED|Overall Study||12
261645|NCT00980044|632672|P2|COMPLETED|Overall Study||12
261646|NCT00980044|632673|P1|COMPLETED|Overall Study||12
261647|NCT00980044|632671|P3|STARTED|Overall Study||17
261648|NCT00980044|632672|P2|STARTED|Overall Study||19
261649|NCT00980044|632673|P1|STARTED|Overall Study||17
261650|NCT00980005|632692|P2|NOT COMPLETED|Overall Study||63
261651|NCT00980005|632693|P1|NOT COMPLETED|Overall Study||47
261652|NCT00980005|632692|P2|COMPLETED|Overall Study||998
261653|NCT00980005|632693|P1|COMPLETED|Overall Study||1008
261654|NCT00980005|632692|P2|STARTED|Overall Study||1061
261655|NCT00980005|632693|P1|STARTED|Overall Study||1055
261656|NCT00979992|632733|P1|NOT COMPLETED|Overall Study||5
261657|NCT00979992|632733|P1|COMPLETED|Overall Study||30
261658|NCT00979992|632733|P1|STARTED|Overall Study||35
261659|NCT00979953|632745|P4|NOT COMPLETED|Overall Study||7
261660|NCT00979953|632746|P3|NOT COMPLETED|Overall Study||22
261661|NCT00979953|632747|P2|NOT COMPLETED|Overall Study||5
261662|NCT00979953|632748|P1|NOT COMPLETED|Overall Study||8
261663|NCT00979953|632745|P4|COMPLETED|Overall Study||97
261664|NCT00979953|632746|P3|COMPLETED|Overall Study||82
261665|NCT00979953|632747|P2|COMPLETED|Overall Study||94
261666|NCT00979953|632748|P1|COMPLETED|Overall Study||93
261667|NCT00979953|632745|P4|Received at Least 1 Dose of Study Drug|Overall Study||104
261668|NCT00979953|632746|P3|Received at Least 1 Dose of Study Drug|Overall Study||104
261669|NCT00979953|632747|P2|Received at Least 1 Dose of Study Drug|Overall Study||99
261670|NCT00979953|632748|P1|Received at Least 1 Dose of Study Drug|Overall Study||101
261671|NCT00979953|632745|P4|STARTED|Overall Study||104
261672|NCT00979953|632746|P3|STARTED|Overall Study||104
261673|NCT00979953|632747|P2|STARTED|Overall Study||99
261674|NCT00979953|632748|P1|STARTED|Overall Study||101
261675|NCT00979940|632760|P2|NOT COMPLETED|Overall Study||0
261676|NCT00979940|632761|P1|NOT COMPLETED|Overall Study||0
261677|NCT00979940|632760|P2|COMPLETED|Overall Study||28
261678|NCT00979940|632761|P1|COMPLETED|Overall Study||32
261679|NCT00979940|632760|P2|STARTED|Overall Study||28
261680|NCT00979940|632761|P1|STARTED|Overall Study||32
261681|NCT00979901|632771|P4|NOT COMPLETED|Overall Study||116
261682|NCT00979901|632772|P3|NOT COMPLETED|Overall Study||29
261683|NCT00979901|632773|P2|NOT COMPLETED|Overall Study||12
261684|NCT00979901|632774|P1|NOT COMPLETED|Overall Study||18
261685|NCT00979901|632771|P4|COMPLETED|Overall Study||159
261686|NCT00979901|632772|P3|COMPLETED|Overall Study||573
261687|NCT00979901|632773|P2|COMPLETED|Overall Study||336
261688|NCT00979901|632774|P1|COMPLETED|Overall Study||334
261689|NCT00979901|632771|P4|STARTED|Overall Study||275
261690|NCT00979901|632772|P3|STARTED|Overall Study||602
261691|NCT00979901|632773|P2|STARTED|Overall Study||348
261692|NCT00979901|632774|P1|STARTED|Overall Study||352
261693|NCT00979875|632798|P6|NOT COMPLETED|Intervention 3||0
261694|NCT00979875|632799|P5|NOT COMPLETED|Intervention 3||0
261695|NCT00979875|632800|P4|NOT COMPLETED|Intervention 3||0
261696|NCT00979875|632801|P3|NOT COMPLETED|Intervention 3||0
261697|NCT00979875|632802|P2|NOT COMPLETED|Intervention 3||0
261698|NCT00979875|632803|P1|NOT COMPLETED|Intervention 3||0
261699|NCT00979875|632798|P6|COMPLETED|Intervention 3||2
261700|NCT00979875|632799|P5|COMPLETED|Intervention 3||3
261701|NCT00979875|632800|P4|COMPLETED|Intervention 3||2
261702|NCT00979875|632801|P3|COMPLETED|Intervention 3||3
261703|NCT00979875|632802|P2|COMPLETED|Intervention 3||2
261704|NCT00979875|632803|P1|COMPLETED|Intervention 3||2
261705|NCT00979875|632798|P6|STARTED|Intervention 3||2
261706|NCT00979875|632799|P5|STARTED|Intervention 3||3
261707|NCT00979875|632800|P4|STARTED|Intervention 3||2
261708|NCT00979875|632801|P3|STARTED|Intervention 3||3
261709|NCT00979875|632802|P2|STARTED|Intervention 3||2
261710|NCT00979875|632803|P1|STARTED|Intervention 3||2
261711|NCT00979875|632798|P6|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
261712|NCT00979875|632799|P5|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
261713|NCT00979875|632800|P4|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
261714|NCT00979875|632801|P3|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
261715|NCT00979875|632802|P2|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
261716|NCT00979875|632803|P1|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
261717|NCT00979875|632798|P6|COMPLETED|Washout 2 (3 to 14 Days)||2
261718|NCT00979875|632799|P5|COMPLETED|Washout 2 (3 to 14 Days)||3
261719|NCT00979875|632800|P4|COMPLETED|Washout 2 (3 to 14 Days)||2
261720|NCT00979875|632801|P3|COMPLETED|Washout 2 (3 to 14 Days)||3
261721|NCT00979875|632802|P2|COMPLETED|Washout 2 (3 to 14 Days)||2
261722|NCT00979875|632803|P1|COMPLETED|Washout 2 (3 to 14 Days)||2
261723|NCT00979875|632798|P6|STARTED|Washout 2 (3 to 14 Days)||2
261724|NCT00979875|632799|P5|STARTED|Washout 2 (3 to 14 Days)||3
261725|NCT00979875|632800|P4|STARTED|Washout 2 (3 to 14 Days)||2
261726|NCT00979875|632801|P3|STARTED|Washout 2 (3 to 14 Days)||3
261727|NCT00979875|632802|P2|STARTED|Washout 2 (3 to 14 Days)||2
261728|NCT00979875|632803|P1|STARTED|Washout 2 (3 to 14 Days)||2
261729|NCT00979875|632798|P6|NOT COMPLETED|Intervention 2||0
261730|NCT00979875|632799|P5|NOT COMPLETED|Intervention 2||0
261731|NCT00979875|632800|P4|NOT COMPLETED|Intervention 2||0
261732|NCT00979875|632801|P3|NOT COMPLETED|Intervention 2||0
261733|NCT00979875|632802|P2|NOT COMPLETED|Intervention 2||0
261734|NCT00979875|632803|P1|NOT COMPLETED|Intervention 2||0
261735|NCT00979875|632798|P6|COMPLETED|Intervention 2||2
261736|NCT00979875|632799|P5|COMPLETED|Intervention 2||3
261737|NCT00979875|632800|P4|COMPLETED|Intervention 2||2
261738|NCT00979875|632801|P3|COMPLETED|Intervention 2||3
261739|NCT00979875|632802|P2|COMPLETED|Intervention 2||2
261740|NCT00979875|632803|P1|COMPLETED|Intervention 2||2
261741|NCT00979875|632798|P6|STARTED|Intervention 2||2
261742|NCT00979875|632799|P5|STARTED|Intervention 2||3
261743|NCT00979875|632800|P4|STARTED|Intervention 2||2
261744|NCT00979875|632801|P3|STARTED|Intervention 2||3
261745|NCT00979875|632802|P2|STARTED|Intervention 2||2
261746|NCT00979875|632803|P1|STARTED|Intervention 2||2
261747|NCT00979875|632798|P6|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
261748|NCT00979875|632799|P5|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
261749|NCT00979875|632800|P4|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
261750|NCT00979875|632801|P3|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
261751|NCT00979875|632802|P2|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
261752|NCT00979875|632803|P1|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
261753|NCT00979875|632798|P6|COMPLETED|Washout 1 (3 to 14 Days)||2
261754|NCT00979875|632799|P5|COMPLETED|Washout 1 (3 to 14 Days)||3
261755|NCT00979875|632800|P4|COMPLETED|Washout 1 (3 to 14 Days)||2
261756|NCT00979875|632801|P3|COMPLETED|Washout 1 (3 to 14 Days)||3
261757|NCT00979875|632802|P2|COMPLETED|Washout 1 (3 to 14 Days)||2
261758|NCT00979875|632803|P1|COMPLETED|Washout 1 (3 to 14 Days)||2
261759|NCT00979875|632798|P6|STARTED|Washout 1 (3 to 14 Days)||2
261760|NCT00979875|632799|P5|STARTED|Washout 1 (3 to 14 Days)||3
261761|NCT00979875|632800|P4|STARTED|Washout 1 (3 to 14 Days)||2
261762|NCT00979875|632801|P3|STARTED|Washout 1 (3 to 14 Days)||3
261763|NCT00979875|632802|P2|STARTED|Washout 1 (3 to 14 Days)||2
261764|NCT00979875|632803|P1|STARTED|Washout 1 (3 to 14 Days)||2
261765|NCT00979875|632798|P6|NOT COMPLETED|Intervention 1||0
261766|NCT00979875|632799|P5|NOT COMPLETED|Intervention 1||0
261767|NCT00979875|632800|P4|NOT COMPLETED|Intervention 1||0
261768|NCT00979875|632801|P3|NOT COMPLETED|Intervention 1||0
261769|NCT00979875|632802|P2|NOT COMPLETED|Intervention 1||0
261770|NCT00979875|632803|P1|NOT COMPLETED|Intervention 1||0
261771|NCT00979875|632798|P6|COMPLETED|Intervention 1||2
261772|NCT00979875|632799|P5|COMPLETED|Intervention 1||3
261773|NCT00979875|632800|P4|COMPLETED|Intervention 1||2
261774|NCT00979875|632801|P3|COMPLETED|Intervention 1||3
261775|NCT00979875|632802|P2|COMPLETED|Intervention 1||2
261776|NCT00979875|632803|P1|COMPLETED|Intervention 1||2
261777|NCT00979875|632798|P6|Received at Least 1 Dose of Study Drug|Intervention 1||2
261778|NCT00979875|632799|P5|Received at Least 1 Dose of Study Drug|Intervention 1||3
261779|NCT00979875|632800|P4|Received at Least 1 Dose of Study Drug|Intervention 1||2
261780|NCT00979875|632801|P3|Received at Least 1 Dose of Study Drug|Intervention 1||3
261781|NCT00979875|632802|P2|Received at Least 1 Dose of Study Drug|Intervention 1||2
261782|NCT00979875|632803|P1|Received at Least 1 Dose of Study Drug|Intervention 1||2
261783|NCT00979875|632798|P6|STARTED|Intervention 1||2
261784|NCT00979875|632799|P5|STARTED|Intervention 1||3
261785|NCT00979875|632800|P4|STARTED|Intervention 1||2
261786|NCT00979875|632801|P3|STARTED|Intervention 1||3
261787|NCT00979875|632802|P2|STARTED|Intervention 1||2
261788|NCT00979875|632803|P1|STARTED|Intervention 1||2
261789|NCT00979654|632847|P1|NOT COMPLETED|Overall Study||36
261790|NCT00979654|632847|P1|COMPLETED|Overall Study||67
261791|NCT00979654|632847|P1|STARTED|Overall Study||103
261792|NCT00979628|632862|P3|NOT COMPLETED|Overall Study||6
261793|NCT00979628|632863|P2|NOT COMPLETED|Overall Study||9
261794|NCT00979628|632864|P1|NOT COMPLETED|Overall Study||9
261795|NCT00979628|632862|P3|COMPLETED|Overall Study||74
261796|NCT00979628|632863|P2|COMPLETED|Overall Study||133
261797|NCT00979628|632864|P1|COMPLETED|Overall Study||144
261798|NCT00979628|632862|P3|STARTED|Overall Study||80
261799|NCT00979628|632863|P2|STARTED|Overall Study||142
261800|NCT00979628|632864|P1|STARTED|Overall Study||153
261801|NCT00979615|632877|P2|NOT COMPLETED|Overall Study||8
261802|NCT00979615|632878|P1|NOT COMPLETED|Overall Study||6
261803|NCT00979615|632877|P2|COMPLETED|Overall Study||58
261804|NCT00979615|632878|P1|COMPLETED|Overall Study||57
261805|NCT00979615|632877|P2|STARTED|Overall Study||66
261806|NCT00979615|632878|P1|STARTED|Overall Study||63
261807|NCT00979602|632894|P2|NOT COMPLETED|Overall Study||133
261808|NCT00979602|632895|P1|NOT COMPLETED|Overall Study||145
261809|NCT00979602|632894|P2|COMPLETED|Overall Study||1890
261810|NCT00979602|632895|P1|COMPLETED|Overall Study||1880
261811|NCT00979602|632894|P2|STARTED|Overall Study||2023
261812|NCT00979602|632895|P1|STARTED|Overall Study||2025
261813|NCT00979576|633066|P3|NOT COMPLETED|Combination Followed by Monotherapy||1
261814|NCT00979576|633067|P2|NOT COMPLETED|Combination Followed by Monotherapy||2
261815|NCT00979576|633068|P1|NOT COMPLETED|Combination Followed by Monotherapy||0
261816|NCT00979576|633066|P3|COMPLETED|Combination Followed by Monotherapy||0
261817|NCT00979576|633067|P2|COMPLETED|Combination Followed by Monotherapy||0
261818|NCT00979576|633068|P1|COMPLETED|Combination Followed by Monotherapy||0
261819|NCT00979576|633066|P3|STARTED|Combination Followed by Monotherapy||1
261820|NCT00979576|633067|P2|STARTED|Combination Followed by Monotherapy||2
261821|NCT00979576|633068|P1|STARTED|Combination Followed by Monotherapy||0
261822|NCT00979576|633066|P3|NOT COMPLETED|Combination Treatment Phase||9
261823|NCT00979576|633067|P2|NOT COMPLETED|Combination Treatment Phase||6
261824|NCT00979576|633068|P1|NOT COMPLETED|Combination Treatment Phase||3
261825|NCT00979576|633066|P3|COMPLETED|Combination Treatment Phase||0
261826|NCT00979576|633067|P2|COMPLETED|Combination Treatment Phase||0
261827|NCT00979576|633068|P1|COMPLETED|Combination Treatment Phase||0
261828|NCT00979576|633066|P3|STARTED|Combination Treatment Phase||9
261829|NCT00979576|633067|P2|STARTED|Combination Treatment Phase||6
261830|NCT00979576|633068|P1|STARTED|Combination Treatment Phase||3
261831|NCT00979550|633101|P2|NOT COMPLETED|Overall Study||0
261832|NCT00979550|633102|P1|NOT COMPLETED|Overall Study||0
261833|NCT00979550|633101|P2|COMPLETED|Overall Study||3
261834|NCT00979550|633102|P1|COMPLETED|Overall Study||4
261835|NCT00979550|633101|P2|STARTED|Overall Study||3
261836|NCT00979550|633102|P1|STARTED|Overall Study||4
261837|NCT00979459|633108|P2|NOT COMPLETED|Second Intervention||0
261838|NCT00979459|633109|P1|NOT COMPLETED|Second Intervention||0
261839|NCT00979459|633108|P2|COMPLETED|Second Intervention||6
261840|NCT00979459|633109|P1|COMPLETED|Second Intervention||6
261841|NCT00979459|633108|P2|STARTED|Second Intervention||6
261842|NCT00979459|633109|P1|STARTED|Second Intervention||6
261843|NCT00979459|633108|P2|NOT COMPLETED|7-day Washout Period||0
261844|NCT00979459|633109|P1|NOT COMPLETED|7-day Washout Period||0
261845|NCT00979459|633108|P2|COMPLETED|7-day Washout Period||6
261846|NCT00979459|633109|P1|COMPLETED|7-day Washout Period||6
261847|NCT00979459|633108|P2|STARTED|7-day Washout Period||6
261848|NCT00979459|633109|P1|STARTED|7-day Washout Period||6
261849|NCT00979459|633108|P2|NOT COMPLETED|First Intervention||0
261850|NCT00979459|633109|P1|NOT COMPLETED|First Intervention||0
261851|NCT00979459|633108|P2|COMPLETED|First Intervention||6
261852|NCT00979459|633109|P1|COMPLETED|First Intervention||6
261853|NCT00979459|633108|P2|STARTED|First Intervention||6
261854|NCT00979459|633109|P1|STARTED|First Intervention||6
261855|NCT00979420|633125|P4|NOT COMPLETED|Overall Study||2
261856|NCT00979420|633126|P3|NOT COMPLETED|Overall Study||1
261857|NCT00979420|633127|P2|NOT COMPLETED|Overall Study||0
261858|NCT00979420|633128|P1|NOT COMPLETED|Overall Study||7
261859|NCT00979420|633125|P4|COMPLETED|Overall Study||59
261860|NCT00979420|633126|P3|COMPLETED|Overall Study||59
261861|NCT00979420|633127|P2|COMPLETED|Overall Study||57
261862|NCT00979420|633128|P1|COMPLETED|Overall Study||171
261863|NCT00979420|633125|P4|STARTED|Overall Study||61
261864|NCT00979420|633126|P3|STARTED|Overall Study||60
261865|NCT00979420|633127|P2|STARTED|Overall Study||57
261866|NCT00979420|633128|P1|STARTED|Overall Study||178
261867|NCT00979407|633198|P2|NOT COMPLETED|Overall Study||7
261868|NCT00979407|633199|P1|NOT COMPLETED|Overall Study||6
261869|NCT00979407|633198|P2|COMPLETED|Overall Study||160
261870|NCT00979407|633199|P1|COMPLETED|Overall Study||161
261871|NCT00979407|633198|P2|STARTED|Overall Study||167
261872|NCT00979407|633199|P1|STARTED|Overall Study||167
261873|NCT00979303|633241|P2|NOT COMPLETED|Overall Study||0
261874|NCT00979303|633242|P1|NOT COMPLETED|Overall Study||0
261875|NCT00979303|633241|P2|COMPLETED|Overall Study||37
261876|NCT00979303|633242|P1|COMPLETED|Overall Study||37
261877|NCT00979303|633241|P2|STARTED|Overall Study||37
261878|NCT00979303|633242|P1|STARTED|Overall Study||37
261879|NCT00979212|633252|P2|NOT COMPLETED|Overall Study||8
261880|NCT00979212|633253|P1|NOT COMPLETED|Overall Study||2
261881|NCT00979212|633252|P2|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|39
261882|NCT00979212|633253|P1|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|22
261883|NCT00979212|633252|P2|STARTED|Overall Study||47
261884|NCT00979212|633253|P1|STARTED|Overall Study||24
261885|NCT00979199|633271|P1|NOT COMPLETED|Overall Study||222
261886|NCT00979199|633271|P1|COMPLETED|Overall Study||475
261887|NCT00979199|633271|P1|STARTED|Overall Study||697
261888|NCT00979134|633279|P3|NOT COMPLETED|Overall Study||40
261889|NCT00979134|633280|P2|NOT COMPLETED|Overall Study||6
261890|NCT00979134|633281|P1|NOT COMPLETED|Overall Study||33
261891|NCT00979134|633279|P3|COMPLETED|Overall Study|At DCO|5
261892|NCT00979134|633280|P2|COMPLETED|Overall Study|At DCO|0
261893|NCT00979134|633281|P1|COMPLETED|Overall Study|At DCO|10
261894|NCT00979134|633279|P3|STARTED|Overall Study||45
261895|NCT00979134|633280|P2|STARTED|Overall Study||6
261896|NCT00979134|633281|P1|STARTED|Overall Study||43
261897|NCT00979121|633333|P2|NOT COMPLETED|Overall Study||0
261898|NCT00979121|633334|P1|NOT COMPLETED|Overall Study||0
261899|NCT00979121|633333|P2|COMPLETED|Overall Study||366
261900|NCT00979121|633334|P1|COMPLETED|Overall Study||379
261901|NCT00979121|633333|P2|STARTED|Overall Study||366
261902|NCT00979121|633334|P1|STARTED|Overall Study||379
261903|NCT00979069|633352|P2|NOT COMPLETED|Overall Study||2
261904|NCT00979069|633353|P1|NOT COMPLETED|Overall Study||0
261905|NCT00979069|633352|P2|COMPLETED|Overall Study||8
261906|NCT00979069|633353|P1|COMPLETED|Overall Study||10
261907|NCT00979069|633352|P2|STARTED|Overall Study||10
261908|NCT00979069|633353|P1|STARTED|Overall Study||10
261909|NCT00979017|633359|P1|NOT COMPLETED|Overall Study||0
261910|NCT00979017|633359|P1|COMPLETED|Overall Study||41
261911|NCT00979017|633359|P1|STARTED|Overall Study||41
261912|NCT00978757|633369|P2|NOT COMPLETED|Overall Study||3
261913|NCT00978757|633370|P1|NOT COMPLETED|Overall Study||1
261914|NCT00978757|633369|P2|COMPLETED|Overall Study|June 2008|17
261915|NCT00978757|633370|P1|COMPLETED|Overall Study|June 2008|21
261916|NCT00978757|633369|P2|STARTED|Overall Study|June 2001|20
261917|NCT00978757|633370|P1|STARTED|Overall Study|June 2001|22
261918|NCT00978731|633380|P4|NOT COMPLETED|Overall Study||4
261919|NCT00978731|633381|P3|NOT COMPLETED|Overall Study||5
261920|NCT00978731|633382|P2|NOT COMPLETED|Overall Study||15
261921|NCT00978731|633383|P1|NOT COMPLETED|Overall Study||22
261922|NCT00978731|633380|P4|COMPLETED|Overall Study||0
261923|NCT00978731|633381|P3|COMPLETED|Overall Study||0
261924|NCT00978731|633382|P2|COMPLETED|Overall Study||0
261925|NCT00978731|633383|P1|COMPLETED|Overall Study||0
261926|NCT00978731|633380|P4|STARTED|Overall Study||4
261927|NCT00978731|633381|P3|STARTED|Overall Study||5
261928|NCT00978731|633382|P2|STARTED|Overall Study||15
261929|NCT00978731|633383|P1|STARTED|Overall Study||22
261930|NCT00978627|633423|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||9
261931|NCT00978627|633424|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||21
261932|NCT00978627|633423|P2|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||113
261933|NCT00978627|633424|P1|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||233
261934|NCT00978627|633423|P2|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Thirty four subjects from main trial did not continue into extension trial|122
261935|NCT00978627|633424|P1|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Sixty six subjects from main trial did not continue into extension trial|254
261936|NCT00978627|633423|P2|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||26
261937|NCT00978627|633424|P1|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||46
261938|NCT00978627|633423|P2|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||156
261939|NCT00978627|633424|P1|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||320
261940|NCT00978627|633423|P2|Exposed|Main: Week 0 to 26 (NN5401-3594)|Two subjects withdrew prior to exposure to trial products|180
261941|NCT00978627|633424|P1|Exposed|Main: Week 0 to 26 (NN5401-3594)|Four subjects withdrew prior to exposure to trial products|362
261942|NCT00978627|633423|P2|STARTED|Main: Week 0 to 26 (NN5401-3594)||182
261943|NCT00978627|633424|P1|STARTED|Main: Week 0 to 26 (NN5401-3594)||366
261944|NCT00978562|633446|P1|NOT COMPLETED|Overall Study||0
261945|NCT00978562|633446|P1|COMPLETED|Overall Study||7
261946|NCT00978562|633446|P1|STARTED|Overall Study||7
261947|NCT00978445|633451|P2|NOT COMPLETED|Overall Study||1
261948|NCT00978445|633452|P1|NOT COMPLETED|Overall Study||2
261949|NCT00978445|633451|P2|COMPLETED|Overall Study||12
261950|NCT00978445|633452|P1|COMPLETED|Overall Study||10
261951|NCT00978445|633451|P2|STARTED|Overall Study||13
261952|NCT00978445|633452|P1|STARTED|Overall Study||12
261953|NCT00978432|633462|P3|NOT COMPLETED|Overall Study||5
261954|NCT00978432|633463|P2|NOT COMPLETED|Overall Study||1
261955|NCT00978432|633464|P1|NOT COMPLETED|Overall Study||3
261956|NCT00978432|633462|P3|COMPLETED|Overall Study||13
261957|NCT00978432|633463|P2|COMPLETED|Overall Study||4
261958|NCT00978432|633464|P1|COMPLETED|Overall Study||7
261959|NCT00978432|633462|P3|STARTED|Overall Study||18
261960|NCT00978432|633463|P2|STARTED|Overall Study||5
261961|NCT00978432|633464|P1|STARTED|Overall Study||10
261962|NCT00978419|633486|P2|NOT COMPLETED|Overall Study||0
261963|NCT00978419|633487|P1|NOT COMPLETED|Overall Study||0
261964|NCT00978419|633486|P2|COMPLETED|Overall Study||0
261965|NCT00978419|633487|P1|COMPLETED|Overall Study||0
261966|NCT00978419|633486|P2|STARTED|Overall Study||0
261967|NCT00978419|633487|P1|STARTED|Overall Study||0
261968|NCT00978380|633515|P1|NOT COMPLETED|Overall Study||19
261969|NCT00978380|633515|P1|COMPLETED|Overall Study||44
261970|NCT00978380|633515|P1|STARTED|Overall Study||63
261971|NCT00978341|633521|P2|NOT COMPLETED|Second Intervention||0
261972|NCT00978341|633522|P1|NOT COMPLETED|Second Intervention||0
261973|NCT00978341|633521|P2|COMPLETED|Second Intervention||7
261974|NCT00978341|633522|P1|COMPLETED|Second Intervention||7
261975|NCT00978341|633521|P2|STARTED|Second Intervention||7
261976|NCT00978341|633522|P1|STARTED|Second Intervention||7
261977|NCT00978341|633521|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
261978|NCT00978341|633522|P1|NOT COMPLETED|Washout Period of 2 Weeks||1
261979|NCT00978341|633521|P2|COMPLETED|Washout Period of 2 Weeks||7
261980|NCT00978341|633522|P1|COMPLETED|Washout Period of 2 Weeks||7
261981|NCT00978341|633521|P2|STARTED|Washout Period of 2 Weeks||7
261982|NCT00978341|633522|P1|STARTED|Washout Period of 2 Weeks||8
261983|NCT00978341|633521|P2|NOT COMPLETED|First Intervention||0
261984|NCT00978341|633522|P1|NOT COMPLETED|First Intervention||0
261985|NCT00978341|633521|P2|COMPLETED|First Intervention||7
261986|NCT00978341|633522|P1|COMPLETED|First Intervention||8
261987|NCT00978341|633521|P2|STARTED|First Intervention||7
261988|NCT00978341|633522|P1|STARTED|First Intervention||8
261989|NCT00978120|633544|P4|NOT COMPLETED|Overall Study||2
261990|NCT00978120|633545|P3|NOT COMPLETED|Overall Study||3
261991|NCT00978120|633546|P2|NOT COMPLETED|Overall Study||0
261992|NCT00978120|633547|P1|NOT COMPLETED|Overall Study||2
261993|NCT00978120|633544|P4|COMPLETED|Overall Study||84
261994|NCT00978120|633545|P3|COMPLETED|Overall Study||84
261995|NCT00978120|633546|P2|COMPLETED|Overall Study||107
261996|NCT00978120|633547|P1|COMPLETED|Overall Study||108
261997|NCT00978120|633544|P4|STARTED|Overall Study||86
261998|NCT00978120|633545|P3|STARTED|Overall Study||87
261999|NCT00978120|633546|P2|STARTED|Overall Study||107
262000|NCT00978120|633547|P1|STARTED|Overall Study||110
262001|NCT00978068|633599|P2|NOT COMPLETED|Overall Study||9
262002|NCT00978068|633600|P1|NOT COMPLETED|Overall Study||4
262003|NCT00978068|633599|P2|COMPLETED|Overall Study||80
262004|NCT00978068|633600|P1|COMPLETED|Overall Study||83
262005|NCT00978068|633599|P2|Initiated Study Drugs|Overall Study||86
262006|NCT00978068|633600|P1|Initiated Study Drugs|Overall Study||84
262007|NCT00978068|633599|P2|STARTED|Overall Study||89
262008|NCT00978068|633600|P1|STARTED|Overall Study||87
262009|NCT00978042|633618|P2|NOT COMPLETED|Received Repeat Treatment||3
262010|NCT00978042|633619|P1|NOT COMPLETED|Received Repeat Treatment||43
262011|NCT00978042|633618|P2|COMPLETED|Received Repeat Treatment||23
262012|NCT00978042|633619|P1|COMPLETED|Received Repeat Treatment|Completed=Completed Repeat Treatment Follow-up|98
262013|NCT00978042|633618|P2|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|26
262014|NCT00978042|633619|P1|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|141
262015|NCT00978042|633618|P2|NOT COMPLETED|Initial Treatment Period||15
262016|NCT00978042|633619|P1|NOT COMPLETED|Initial Treatment Period||61
262017|NCT00978042|633618|P2|COMPLETED|Initial Treatment Period||32
262018|NCT00978042|633619|P1|COMPLETED|Initial Treatment Period|Completed 24-month Follow-Up|174
262019|NCT00978042|633618|P2|MITT_treated With VOLUMA XC|Initial Treatment Period||35
262020|NCT00978042|633619|P1|MITT_treated With VOLUMA XC|Initial Treatment Period||235
262021|NCT00978042|633618|P2|STARTED|Initial Treatment Period||47
262022|NCT00978042|633619|P1|STARTED|Initial Treatment Period||235
262023|NCT00978029|633632|P3|NOT COMPLETED|Overall Study||6
262024|NCT00978029|633633|P2|NOT COMPLETED|Overall Study||3
262025|NCT00978029|633634|P1|NOT COMPLETED|Overall Study||1
262026|NCT00978029|633632|P3|COMPLETED|Overall Study||59
262027|NCT00978029|633633|P2|COMPLETED|Overall Study||63
262028|NCT00978029|633634|P1|COMPLETED|Overall Study||64
262029|NCT00978029|633632|P3|STARTED|Overall Study||65
262030|NCT00978029|633633|P2|STARTED|Overall Study||66
262031|NCT00978029|633634|P1|STARTED|Overall Study||65
262032|NCT00977938|633661|P4|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||3
262033|NCT00977938|633662|P3|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||12
262034|NCT00977938|633663|P2|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||58
262035|NCT00977938|633664|P1|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||51
262036|NCT00977938|633661|P4|COMPLETED|Observation (30-33 mo. Post Procedure)||781
262037|NCT00977938|633662|P3|COMPLETED|Observation (30-33 mo. Post Procedure)||784
262038|NCT00977938|633663|P2|COMPLETED|Observation (30-33 mo. Post Procedure)||4658
262039|NCT00977938|633664|P1|COMPLETED|Observation (30-33 mo. Post Procedure)||4732
262040|NCT00977938|633661|P4|STARTED|Observation (30-33 mo. Post Procedure)||784
262041|NCT00977938|633662|P3|STARTED|Observation (30-33 mo. Post Procedure)||796
262042|NCT00977938|633663|P2|STARTED|Observation (30-33 mo. Post Procedure)||4716
262043|NCT00977938|633664|P1|STARTED|Observation (30-33 mo. Post Procedure)||4783
262044|NCT00977938|633661|P4|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||61
262045|NCT00977938|633662|P3|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||46
262046|NCT00977938|633663|P2|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||225
262047|NCT00977938|633664|P1|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||237
262048|NCT00977938|633661|P4|COMPLETED|Treatment (12-30 mo. Post Procedure)||784
262049|NCT00977938|633662|P3|COMPLETED|Treatment (12-30 mo. Post Procedure)||796
262050|NCT00977938|633663|P2|COMPLETED|Treatment (12-30 mo. Post Procedure)||4716
262051|NCT00977938|633664|P1|COMPLETED|Treatment (12-30 mo. Post Procedure)||4783
262052|NCT00977938|633661|P4|STARTED|Treatment (12-30 mo. Post Procedure)||845
262053|NCT00977938|633662|P3|STARTED|Treatment (12-30 mo. Post Procedure)||842
262054|NCT00977938|633663|P2|STARTED|Treatment (12-30 mo. Post Procedure)||4941
262055|NCT00977938|633664|P1|STARTED|Treatment (12-30 mo. Post Procedure)||5020
262056|NCT00977808|633698|P1|NOT COMPLETED|Overall Study||1
262057|NCT00977808|633698|P1|COMPLETED|Overall Study||11
262058|NCT00977808|633698|P1|Completion of Closed-Loop Admission|Overall Study||11
262059|NCT00977808|633698|P1|Completion of Open-Loop Admission|Overall Study||12
262060|NCT00977808|633698|P1|STARTED|Overall Study||12
262061|NCT00977769|633706|P3|NOT COMPLETED|Overall Study||0
262062|NCT00977769|633707|P2|NOT COMPLETED|Overall Study||0
262063|NCT00977769|633708|P1|NOT COMPLETED|Overall Study||0
262064|NCT00977769|633706|P3|COMPLETED|Overall Study||25
262065|NCT00977769|633707|P2|COMPLETED|Overall Study||26
262066|NCT00977769|633708|P1|COMPLETED|Overall Study||25
262067|NCT00977769|633706|P3|STARTED|Overall Study||25
262068|NCT00977769|633707|P2|STARTED|Overall Study||26
262069|NCT00977769|633708|P1|STARTED|Overall Study||25
262070|NCT00977704|633722|P1|NOT COMPLETED|Overall Study||0
262071|NCT00977704|633722|P1|COMPLETED|Overall Study||20
262072|NCT00977704|633722|P1|STARTED|Overall Study||20
262073|NCT00977691|633729|P3|NOT COMPLETED|Overall Study||0
262074|NCT00977691|633730|P2|NOT COMPLETED|Overall Study||1
262075|NCT00977691|633731|P1|NOT COMPLETED|Overall Study||0
262076|NCT00977691|633729|P3|COMPLETED|Overall Study||12
262077|NCT00977691|633730|P2|COMPLETED|Overall Study||7
262078|NCT00977691|633731|P1|COMPLETED|Overall Study||3
262079|NCT00977691|633729|P3|STARTED|Overall Study||12
262080|NCT00977691|633730|P2|STARTED|Overall Study||8
262081|NCT00977691|633731|P1|STARTED|Overall Study||3
262082|NCT00977665|633741|P2|NOT COMPLETED|Overall Study||15
262083|NCT00977665|633742|P1|NOT COMPLETED|Overall Study||21
262084|NCT00977665|633741|P2|COMPLETED|Overall Study||75
262085|NCT00977665|633742|P1|COMPLETED|Overall Study||63
262086|NCT00977665|633741|P2|STARTED|Overall Study||90
262087|NCT00977665|633742|P1|STARTED|Overall Study||84
262088|NCT00977613|633774|P1|NOT COMPLETED|Overall Study||16
262089|NCT00977613|633774|P1|COMPLETED|Overall Study||34
262090|NCT00977613|633774|P1|STARTED|Overall Study||50
262091|NCT00977574|633781|P3|NOT COMPLETED|Overall Study||4
262092|NCT00977574|633782|P2|NOT COMPLETED|Overall Study||2
262093|NCT00977574|633783|P1|NOT COMPLETED|Overall Study||4
262094|NCT00977574|633781|P3|COMPLETED|Overall Study||114
262095|NCT00977574|633782|P2|COMPLETED|Overall Study||113
262096|NCT00977574|633783|P1|COMPLETED|Overall Study||112
262097|NCT00977574|633781|P3|STARTED|Overall Study||118
262098|NCT00977574|633782|P2|STARTED|Overall Study||115
262099|NCT00977574|633783|P1|STARTED|Overall Study||116
262100|NCT00977561|633802|P2|NOT COMPLETED|Overall Study||4
262101|NCT00977561|633803|P1|NOT COMPLETED|Overall Study||5
262102|NCT00977561|633802|P2|COMPLETED|Overall Study||0
262103|NCT00977561|633803|P1|COMPLETED|Overall Study||0
262104|NCT00977561|633802|P2|STARTED|Overall Study||4
262105|NCT00977561|633803|P1|STARTED|Overall Study||5
262106|NCT00977548|633830|P1|NOT COMPLETED|Overall Study||13
262107|NCT00977548|633830|P1|COMPLETED|Overall Study||26
262108|NCT00977548|633830|P1|STARTED|Overall Study||39
262109|NCT00977470|633839|P2|NOT COMPLETED|Overall Study||38
262110|NCT00977470|633840|P1|NOT COMPLETED|Overall Study||38
262111|NCT00977470|633839|P2|COMPLETED|Overall Study||0
262112|NCT00977470|633840|P1|COMPLETED|Overall Study||0
262113|NCT00977470|633839|P2|STARTED|Overall Study||38
262114|NCT00977470|633840|P1|STARTED|Overall Study||38
262115|NCT00977431|633863|P5|NOT COMPLETED|Overall Study||13
262116|NCT00977431|633864|P4|NOT COMPLETED|Overall Study||3
262117|NCT00977431|633865|P3|NOT COMPLETED|Overall Study||7
262118|NCT00977431|633866|P2|NOT COMPLETED|Overall Study||6
262119|NCT00977431|633867|P1|NOT COMPLETED|Overall Study||7
262120|NCT00977431|633863|P5|COMPLETED|Overall Study||0
262121|NCT00977431|633864|P4|COMPLETED|Overall Study||0
262122|NCT00977431|633865|P3|COMPLETED|Overall Study||0
262123|NCT00977431|633866|P2|COMPLETED|Overall Study||0
262124|NCT00977431|633867|P1|COMPLETED|Overall Study||0
262125|NCT00977431|633863|P5|Discontinued Afatinib Before/on Day 42|Overall Study||3
262126|NCT00977431|633864|P4|Discontinued Afatinib Before/on Day 42|Overall Study||0
262127|NCT00977431|633865|P3|Discontinued Afatinib Before/on Day 42|Overall Study||4
262128|NCT00977431|633866|P2|Discontinued Afatinib Before/on Day 42|Overall Study||0
262129|NCT00977431|633867|P1|Discontinued Afatinib Before/on Day 42|Overall Study||1
262130|NCT00977431|633863|P5|STARTED|Overall Study||13
262131|NCT00977431|633864|P4|STARTED|Overall Study||3
262132|NCT00977431|633865|P3|STARTED|Overall Study||7
262133|NCT00977431|633866|P2|STARTED|Overall Study||6
262134|NCT00977431|633867|P1|STARTED|Overall Study||7
262135|NCT00977379|633900|P2|NOT COMPLETED|Overall Study||12
262136|NCT00977379|633901|P1|NOT COMPLETED|Overall Study||12
262137|NCT00977379|633900|P2|COMPLETED|Overall Study||0
262138|NCT00977379|633901|P1|COMPLETED|Overall Study||0
262139|NCT00977379|633900|P2|Treated|Overall Study||11
262140|NCT00977379|633901|P1|Treated|Overall Study||12
262141|NCT00977379|633900|P2|STARTED|Overall Study|Randomized|12
262142|NCT00977379|633901|P1|STARTED|Overall Study|Randomized|12
262143|NCT00977314|633937|P2|NOT COMPLETED|Overall Study||0
262144|NCT00977314|633938|P1|NOT COMPLETED|Overall Study||2
262145|NCT00977314|633937|P2|COMPLETED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
262146|NCT00977314|633938|P1|COMPLETED|Overall Study||28
262147|NCT00977314|633937|P2|STARTED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
262148|NCT00977314|633938|P1|STARTED|Overall Study||30
262149|NCT00977197|633946|P2|NOT COMPLETED|Overall Study||9
262150|NCT00977197|633947|P1|NOT COMPLETED|Overall Study||9
262151|NCT00977197|633946|P2|COMPLETED|Overall Study||35
262152|NCT00977197|633947|P1|COMPLETED|Overall Study||32
262153|NCT00977197|633946|P2|STARTED|Overall Study||44
262154|NCT00977197|633947|P1|STARTED|Overall Study||41
262155|NCT00977184|633977|P2|NOT COMPLETED|Overall Study||0
262156|NCT00977184|633978|P1|NOT COMPLETED|Overall Study||0
262157|NCT00977184|633977|P2|COMPLETED|Overall Study||13
262158|NCT00977184|633978|P1|COMPLETED|Overall Study||13
262159|NCT00977184|633977|P2|STARTED|Overall Study||13
262160|NCT00977184|633978|P1|STARTED|Overall Study||13
262161|NCT00977171|634004|P1|NOT COMPLETED|Overall Study||0
262162|NCT00977171|634004|P1|COMPLETED|Overall Study||3
262163|NCT00977171|634004|P1|STARTED|Overall Study||3
262164|NCT00977106|634010|P2|NOT COMPLETED|Overall Study||11
262165|NCT00977106|634011|P1|NOT COMPLETED|Overall Study||10
262166|NCT00977106|634010|P2|COMPLETED|Overall Study||45
262167|NCT00977106|634011|P1|COMPLETED|Overall Study||37
262168|NCT00977106|634010|P2|STARTED|Overall Study|Includes 3 participants who were randomized to placebo, but received tocilizumab.|56
262169|NCT00977106|634011|P1|STARTED|Overall Study||47
262170|NCT00977080|634103|P4|NOT COMPLETED|Overall Study||17
262171|NCT00977080|634104|P3|NOT COMPLETED|Overall Study||16
262172|NCT00977080|634105|P2|NOT COMPLETED|Overall Study||20
262173|NCT00977080|634106|P1|NOT COMPLETED|Overall Study||12
262174|NCT00977080|634103|P4|COMPLETED|Overall Study||53
262175|NCT00977080|634104|P3|COMPLETED|Overall Study||56
262176|NCT00977080|634105|P2|COMPLETED|Overall Study||44
262177|NCT00977080|634106|P1|COMPLETED|Overall Study||50
262178|NCT00977080|634103|P4|STARTED|Overall Study||70
262179|NCT00977080|634104|P3|STARTED|Overall Study||72
262180|NCT00977080|634105|P2|STARTED|Overall Study||64
262181|NCT00977080|634106|P1|STARTED|Overall Study||62
262182|NCT00976989|634139|P3|NOT COMPLETED|Overall Study||17
262183|NCT00976989|634140|P2|NOT COMPLETED|Overall Study||12
262184|NCT00976989|634141|P1|NOT COMPLETED|Overall Study||13
262185|NCT00976989|634139|P3|COMPLETED|Overall Study||60
262186|NCT00976989|634140|P2|COMPLETED|Overall Study||63
262187|NCT00976989|634141|P1|COMPLETED|Overall Study||60
262188|NCT00976989|634139|P3|STARTED|Overall Study||77
262189|NCT00976989|634140|P2|STARTED|Overall Study||75
262190|NCT00976989|634141|P1|STARTED|Overall Study||73
262191|NCT00976950|634182|P1|NOT COMPLETED|Overall Study||6
262192|NCT00976950|634182|P1|COMPLETED|Overall Study||36
262193|NCT00976950|634182|P1|STARTED|Overall Study||42
262194|NCT00976937|634190|P2|NOT COMPLETED|Overall Study||11
262195|NCT00976937|634191|P1|NOT COMPLETED|Overall Study||16
262196|NCT00976937|634190|P2|COMPLETED|Overall Study||150
262197|NCT00976937|634191|P1|COMPLETED|Overall Study||142
262198|NCT00976937|634190|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||161
262199|NCT00976937|634191|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All randomized patients who received at least 1 dose of study drug.|158
262200|NCT00976937|634190|P2|Treated/Safety Population|Overall Study||161
262201|NCT00976937|634191|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|158
262202|NCT00976937|634190|P2|STARTED|Overall Study||161
262203|NCT00976937|634191|P1|STARTED|Overall Study|Randomized|158
262204|NCT00976911|634233|P2|NOT COMPLETED|Overall Study||179
262205|NCT00976911|634234|P1|NOT COMPLETED|Overall Study||182
262206|NCT00976911|634233|P2|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
262207|NCT00976911|634234|P1|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
262208|NCT00976911|634233|P2|STARTED|Overall Study||179
262209|NCT00976911|634234|P1|STARTED|Overall Study||182
262210|NCT00976898|634252|P1|NOT COMPLETED|Overall Study||5
262211|NCT00976898|634252|P1|COMPLETED|Overall Study||78
262212|NCT00976898|634252|P1|STARTED|Overall Study||83
262213|NCT00976820|634263|P4|NOT COMPLETED|Overall Study||7
262214|NCT00976820|634264|P3|NOT COMPLETED|Overall Study||4
262215|NCT00976820|634265|P2|NOT COMPLETED|Overall Study||20
262216|NCT00976820|634266|P1|NOT COMPLETED|Overall Study||8
262217|NCT00976820|634263|P4|COMPLETED|Overall Study||56
262218|NCT00976820|634264|P3|COMPLETED|Overall Study||60
262219|NCT00976820|634265|P2|COMPLETED|Overall Study||108
262220|NCT00976820|634266|P1|COMPLETED|Overall Study||59
262221|NCT00976820|634263|P4|STARTED|Overall Study||63
262222|NCT00976820|634264|P3|STARTED|Overall Study||64
262223|NCT00976820|634265|P2|STARTED|Overall Study||128
262224|NCT00976820|634266|P1|STARTED|Overall Study||67
262225|NCT00976716|634602|P1|NOT COMPLETED|Overall Study||1
262226|NCT00976716|634602|P1|COMPLETED|Overall Study||79
262227|NCT00976716|634602|P1|STARTED|Overall Study||80
262228|NCT00976703|634620|P2|NOT COMPLETED|Overall Study||3
262229|NCT00976703|634621|P1|NOT COMPLETED|Overall Study||3
262230|NCT00976703|634620|P2|COMPLETED|Overall Study||95
262231|NCT00976703|634621|P1|COMPLETED|Overall Study||96
262232|NCT00976703|634620|P2|STARTED|Overall Study||98
262233|NCT00976703|634621|P1|STARTED|Overall Study||99
262234|NCT00976677|634635|P2|NOT COMPLETED|Overall Study||5
262235|NCT00976677|634636|P1|NOT COMPLETED|Overall Study||5
262236|NCT00976677|634635|P2|COMPLETED|Overall Study||0
262237|NCT00976677|634636|P1|COMPLETED|Overall Study||0
262238|NCT00976677|634635|P2|STARTED|Overall Study||5
262239|NCT00976677|634636|P1|STARTED|Overall Study||5
262240|NCT00976664|634644|P2|NOT COMPLETED|Overall Study||1
262241|NCT00976664|634645|P1|NOT COMPLETED|Overall Study||3
262242|NCT00976664|634644|P2|COMPLETED|Overall Study||24
262243|NCT00976664|634645|P1|COMPLETED|Overall Study||22
262244|NCT00976664|634644|P2|STARTED|Overall Study||25
262245|NCT00976664|634645|P1|STARTED|Overall Study||25
262246|NCT00976599|634655|P2|NOT COMPLETED|Overall Study||0
262247|NCT00976599|634656|P1|NOT COMPLETED|Overall Study||0
262248|NCT00976599|634655|P2|COMPLETED|Overall Study||14
262249|NCT00976599|634656|P1|COMPLETED|Overall Study||15
262250|NCT00976599|634655|P2|STARTED|Overall Study||14
262251|NCT00976599|634656|P1|STARTED|Overall Study||15
262252|NCT00976573|634844|P2|NOT COMPLETED|Overall Study||3
262253|NCT00976573|634845|P1|NOT COMPLETED|Overall Study||4
262254|NCT00976573|634844|P2|COMPLETED|Overall Study||71
262255|NCT00976573|634845|P1|COMPLETED|Overall Study||71
262256|NCT00976573|634844|P2|STARTED|Overall Study||74
262257|NCT00976573|634845|P1|STARTED|Overall Study||75
262258|NCT00976560|634859|P2|NOT COMPLETED|Overall Study||13
262259|NCT00976560|634860|P1|NOT COMPLETED|Overall Study||14
262260|NCT00976560|634859|P2|COMPLETED|Overall Study||51
262261|NCT00976560|634860|P1|COMPLETED|Overall Study||50
262262|NCT00976560|634859|P2|STARTED|Overall Study||64
262263|NCT00976560|634860|P1|STARTED|Overall Study||64
262264|NCT00976521|634912|P4|NOT COMPLETED|Overall Study||19
262265|NCT00976521|634913|P3|NOT COMPLETED|Overall Study||9
262266|NCT00976521|634914|P2|NOT COMPLETED|Overall Study||12
262267|NCT00976521|634915|P1|NOT COMPLETED|Overall Study||9
262268|NCT00976521|634912|P4|COMPLETED|Overall Study||93
262269|NCT00976521|634913|P3|COMPLETED|Overall Study||102
262270|NCT00976521|634914|P2|COMPLETED|Overall Study||99
262271|NCT00976521|634915|P1|COMPLETED|Overall Study||109
262272|NCT00976521|634912|P4|STARTED|Overall Study||112
262273|NCT00976521|634913|P3|STARTED|Overall Study||111
262274|NCT00976521|634914|P2|STARTED|Overall Study||111
262275|NCT00976521|634915|P1|STARTED|Overall Study||118
262276|NCT00976508|634929|P2|NOT COMPLETED|Overall Study||6
262277|NCT00976508|634930|P1|NOT COMPLETED|Overall Study||14
262278|NCT00976508|634929|P2|COMPLETED|Overall Study||0
262279|NCT00976508|634930|P1|COMPLETED|Overall Study|These subjects withdrew from last study treatment due to progressive disease.|3
262280|NCT00976508|634929|P2|STARTED|Overall Study||6
262281|NCT00976508|634930|P1|STARTED|Overall Study|18 subjects were enrolled; 17 subjects were treated; 1 subject was not eligible.|17
262282|NCT00976495|634963|P3|NOT COMPLETED|Overall Study||0
262283|NCT00976495|634964|P2|NOT COMPLETED|Overall Study||1
262284|NCT00976495|634965|P1|NOT COMPLETED|Overall Study||0
262285|NCT00976495|634963|P3|COMPLETED|Overall Study||26
262286|NCT00976495|634964|P2|COMPLETED|Overall Study||23
262287|NCT00976495|634965|P1|COMPLETED|Overall Study||25
262288|NCT00976495|634963|P3|STARTED|Overall Study||26
262289|NCT00976495|634964|P2|STARTED|Overall Study||24
262290|NCT00976495|634965|P1|STARTED|Overall Study||25
262291|NCT00976482|634982|P1|NOT COMPLETED|Overall Study||259
262292|NCT00976482|634982|P1|COMPLETED|Overall Study||1486
262293|NCT00976482|634982|P1|Eligible for Last Follow up|Overall Study||1487
262294|NCT00976482|634982|P1|STARTED|Overall Study||1745
262295|NCT00976456|634988|P2|NOT COMPLETED|Overall Study||38
262296|NCT00976456|634989|P1|NOT COMPLETED|Overall Study||43
262297|NCT00976456|634988|P2|COMPLETED|Overall Study||98
262298|NCT00976456|634989|P1|COMPLETED|Overall Study||92
262299|NCT00976456|634988|P2|STARTED|Overall Study||136
262300|NCT00976456|634989|P1|STARTED|Overall Study||135
262301|NCT00976404|634999|P2|NOT COMPLETED|Overall Study||0
262302|NCT00976404|635000|P1|NOT COMPLETED|Overall Study||0
262303|NCT00976404|634999|P2|COMPLETED|Overall Study||14
262304|NCT00976404|635000|P1|COMPLETED|Overall Study||14
262305|NCT00976404|634999|P2|STARTED|Overall Study||14
262306|NCT00976404|635000|P1|STARTED|Overall Study||14
262307|NCT00976391|635016|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||34
262308|NCT00976391|635017|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||29
262309|NCT00976391|635016|P2|COMPLETED|Follow-up Period (8 Weeks)||247
262310|NCT00976391|635017|P1|COMPLETED|Follow-up Period (8 Weeks)||256
262311|NCT00976391|635016|P2|STARTED|Follow-up Period (8 Weeks)||281
262312|NCT00976391|635017|P1|STARTED|Follow-up Period (8 Weeks)||285
262313|NCT00976391|635016|P2|NOT COMPLETED|Treatment Period (52 Weeks)||39
262314|NCT00976391|635017|P1|NOT COMPLETED|Treatment Period (52 Weeks)||42
262315|NCT00976391|635016|P2|COMPLETED|Treatment Period (52 Weeks)||242
262316|NCT00976391|635017|P1|COMPLETED|Treatment Period (52 Weeks)||243
262317|NCT00976391|635016|P2|STARTED|Treatment Period (52 Weeks)||281
262318|NCT00976391|635017|P1|STARTED|Treatment Period (52 Weeks)||285
262319|NCT00976352|635039|P2|NOT COMPLETED|Overall Study||4
262320|NCT00976352|635040|P1|NOT COMPLETED|Overall Study||0
262321|NCT00976352|635039|P2|COMPLETED|Overall Study|Last evaluation of last subject in cohort.|6
262322|NCT00976352|635040|P1|COMPLETED|Overall Study||3
262323|NCT00976352|635039|P2|STARTED|Overall Study||10
262324|NCT00976352|635040|P1|STARTED|Overall Study||3
262325|NCT00976339|635054|P2|NOT COMPLETED|Overall Study||0
262326|NCT00976339|635055|P1|NOT COMPLETED|Overall Study||0
262327|NCT00976339|635054|P2|COMPLETED|Overall Study||10
262328|NCT00976339|635055|P1|COMPLETED|Overall Study||10
262329|NCT00976339|635054|P2|STARTED|Overall Study||10
262330|NCT00976339|635055|P1|STARTED|Overall Study||10
262331|NCT00976274|635065|P2|NOT COMPLETED|Overall Study||8
262332|NCT00976274|635066|P1|NOT COMPLETED|Overall Study||7
262333|NCT00976274|635065|P2|COMPLETED|Overall Study||21
262334|NCT00976274|635066|P1|COMPLETED|Overall Study||24
262335|NCT00976274|635065|P2|STARTED|Overall Study||29
262336|NCT00976274|635066|P1|STARTED|Overall Study||31
262337|NCT00976248|635074|P1|NOT COMPLETED|Overall Study||0
262338|NCT00976248|635074|P1|COMPLETED|Overall Study||33
262339|NCT00976248|635074|P1|STARTED|Overall Study||33
262340|NCT00976209|635082|P2|NOT COMPLETED|Treatment Period 2||2
262341|NCT00976209|635083|P1|NOT COMPLETED|Treatment Period 2||0
262342|NCT00976209|635082|P2|COMPLETED|Treatment Period 2||161
262343|NCT00976209|635083|P1|COMPLETED|Treatment Period 2||158
262344|NCT00976209|635082|P2|STARTED|Treatment Period 2||163
262345|NCT00976209|635083|P1|STARTED|Treatment Period 2||158
262346|NCT00976209|635082|P2|NOT COMPLETED|Wash-out Period||2
262347|NCT00976209|635083|P1|NOT COMPLETED|Wash-out Period||4
262348|NCT00976209|635082|P2|COMPLETED|Wash-out Period||163
262349|NCT00976209|635083|P1|COMPLETED|Wash-out Period||158
262350|NCT00976209|635082|P2|STARTED|Wash-out Period||165
262351|NCT00976209|635083|P1|STARTED|Wash-out Period||162
262352|NCT00976209|635082|P2|NOT COMPLETED|Treatment Period 1||1
262353|NCT00976209|635083|P1|NOT COMPLETED|Treatment Period 1||3
262354|NCT00976209|635082|P2|COMPLETED|Treatment Period 1||165
262355|NCT00976209|635083|P1|COMPLETED|Treatment Period 1||162
262356|NCT00976209|635082|P2|STARTED|Treatment Period 1||166
262357|NCT00976209|635083|P1|STARTED|Treatment Period 1||165
262358|NCT00976183|635089|P1|NOT COMPLETED|Overall Study||0
262359|NCT00976183|635089|P1|COMPLETED|Overall Study|The study was closed on 05/30/12 due to adverse events. We did not complete enrollment|18
262360|NCT00976183|635089|P1|STARTED|Overall Study||18
262361|NCT00976027|635096|P2|NOT COMPLETED|Overall Study||215
262362|NCT00976027|635097|P1|NOT COMPLETED|Overall Study||411
262363|NCT00976027|635096|P2|COMPLETED|Overall Study||2835
262364|NCT00976027|635097|P1|COMPLETED|Overall Study||5697
262365|NCT00976027|635096|P2|STARTED|Overall Study||3050
262366|NCT00976027|635097|P1|STARTED|Overall Study||6108
262367|NCT00975975|635109|P1|NOT COMPLETED|Overall Study||6
262368|NCT00975975|635109|P1|COMPLETED|Overall Study||11
262369|NCT00975975|635109|P1|STARTED|Overall Study||17
262370|NCT00975923|635117|P2|NOT COMPLETED|Overall Study||1
262371|NCT00975923|635118|P1|NOT COMPLETED|Overall Study||0
262372|NCT00975923|635117|P2|COMPLETED|Overall Study|1 hospital was sold, yielding 29 hospitals in the Tool Kit Group|29
262373|NCT00975923|635118|P1|COMPLETED|Overall Study||30
262374|NCT00975923|635117|P2|STARTED|Overall Study||30
262375|NCT00975923|635118|P1|STARTED|Overall Study||30
262376|NCT00975884|635128|P2|NOT COMPLETED|Overall Study||15
262377|NCT00975884|635129|P1|NOT COMPLETED|Overall Study||16
262378|NCT00975884|635128|P2|COMPLETED|Overall Study||107
262379|NCT00975884|635129|P1|COMPLETED|Overall Study||168
262380|NCT00975884|635128|P2|STARTED|Overall Study||122
262381|NCT00975884|635129|P1|STARTED|Overall Study||184
262382|NCT00975806|635286|P3|NOT COMPLETED|Overall Study||4
262383|NCT00975806|635287|P2|NOT COMPLETED|Overall Study||7
262384|NCT00975806|635288|P1|NOT COMPLETED|Overall Study||5
262385|NCT00975806|635286|P3|COMPLETED|Overall Study|Participants were prematurely discontinued|0
262386|NCT00975806|635287|P2|COMPLETED|Overall Study|Participants were prematurely discontinued|0
262387|NCT00975806|635288|P1|COMPLETED|Overall Study|Participants were prematurely discontinued|0
262388|NCT00975806|635286|P3|STARTED|Overall Study||4
262389|NCT00975806|635287|P2|STARTED|Overall Study||7
262390|NCT00975806|635288|P1|STARTED|Overall Study||5
262391|NCT00975780|635312|P2|NOT COMPLETED|Follow Up||157
262392|NCT00975780|635313|P1|NOT COMPLETED|Follow Up||102
262393|NCT00975780|635312|P2|COMPLETED|Follow Up||277
262394|NCT00975780|635313|P1|COMPLETED|Follow Up||298
262395|NCT00975780|635312|P2|STARTED|Follow Up||434
262396|NCT00975780|635313|P1|STARTED|Follow Up||400
262397|NCT00975780|635312|P2|NOT COMPLETED|Allocation||0
262398|NCT00975780|635313|P1|NOT COMPLETED|Allocation||0
262399|NCT00975780|635312|P2|COMPLETED|Allocation||434
262400|NCT00975780|635313|P1|COMPLETED|Allocation||400
262401|NCT00975780|635312|P2|STARTED|Allocation||434
262402|NCT00975780|635313|P1|STARTED|Allocation||400
262403|NCT00975715|635323|P2|NOT COMPLETED|Maintenance Period||1
262404|NCT00975715|635324|P1|NOT COMPLETED|Maintenance Period||2
262405|NCT00975715|635323|P2|COMPLETED|Maintenance Period||50
262406|NCT00975715|635324|P1|COMPLETED|Maintenance Period||39
262407|NCT00975715|635323|P2|STARTED|Maintenance Period||51
262408|NCT00975715|635324|P1|STARTED|Maintenance Period||41
262409|NCT00975715|635323|P2|NOT COMPLETED|Titration Period||0
262410|NCT00975715|635324|P1|NOT COMPLETED|Titration Period||7
262411|NCT00975715|635323|P2|COMPLETED|Titration Period||51
262412|NCT00975715|635324|P1|COMPLETED|Titration Period||41
262413|NCT00975715|635323|P2|STARTED|Titration Period||51
262414|NCT00975715|635324|P1|STARTED|Titration Period||48
262415|NCT00975689|635340|P2|NOT COMPLETED|Overall Study||3
262416|NCT00975689|635341|P1|NOT COMPLETED|Overall Study||2
262417|NCT00975689|635340|P2|COMPLETED|Overall Study||15
262418|NCT00975689|635341|P1|COMPLETED|Overall Study||15
262419|NCT00975689|635340|P2|STARTED|Overall Study||18
262420|NCT00975689|635341|P1|STARTED|Overall Study||17
262421|NCT00975650|635347|P4|NOT COMPLETED|Period 4||0
262422|NCT00975650|635348|P3|NOT COMPLETED|Period 4||0
262423|NCT00975650|635349|P2|NOT COMPLETED|Period 4||0
262424|NCT00975650|635350|P1|NOT COMPLETED|Period 4||0
262425|NCT00975650|635347|P4|COMPLETED|Period 4||14
262426|NCT00975650|635348|P3|COMPLETED|Period 4||14
262427|NCT00975650|635349|P2|COMPLETED|Period 4||14
262428|NCT00975650|635350|P1|COMPLETED|Period 4||12
262429|NCT00975650|635347|P4|STARTED|Period 4||14
262430|NCT00975650|635348|P3|STARTED|Period 4||14
262431|NCT00975650|635349|P2|STARTED|Period 4||14
262432|NCT00975650|635350|P1|STARTED|Period 4||12
262433|NCT00975650|635347|P4|NOT COMPLETED|Period 3||0
262434|NCT00975650|635348|P3|NOT COMPLETED|Period 3||0
262435|NCT00975650|635349|P2|NOT COMPLETED|Period 3||0
262436|NCT00975650|635350|P1|NOT COMPLETED|Period 3||0
262437|NCT00975650|635347|P4|COMPLETED|Period 3||14
262438|NCT00975650|635348|P3|COMPLETED|Period 3||14
262439|NCT00975650|635349|P2|COMPLETED|Period 3||14
262440|NCT00975650|635350|P1|COMPLETED|Period 3||12
262441|NCT00975650|635347|P4|STARTED|Period 3||14
262442|NCT00975650|635348|P3|STARTED|Period 3||14
262443|NCT00975650|635349|P2|STARTED|Period 3||14
262444|NCT00975650|635350|P1|STARTED|Period 3||12
262445|NCT00975650|635347|P4|NOT COMPLETED|Period 2||0
262446|NCT00975650|635348|P3|NOT COMPLETED|Period 2||0
262447|NCT00975650|635349|P2|NOT COMPLETED|Period 2||2
262448|NCT00975650|635350|P1|NOT COMPLETED|Period 2||1
262449|NCT00975650|635347|P4|COMPLETED|Period 2||14
262450|NCT00975650|635348|P3|COMPLETED|Period 2||14
262451|NCT00975650|635349|P2|COMPLETED|Period 2||14
262452|NCT00975650|635350|P1|COMPLETED|Period 2||12
262453|NCT00975650|635347|P4|STARTED|Period 2||14
262454|NCT00975650|635348|P3|STARTED|Period 2||14
262455|NCT00975650|635349|P2|STARTED|Period 2||16
262456|NCT00975650|635350|P1|STARTED|Period 2||13
262457|NCT00975650|635347|P4|NOT COMPLETED|Period 1||0
262458|NCT00975650|635348|P3|NOT COMPLETED|Period 1||0
262459|NCT00975650|635349|P2|NOT COMPLETED|Period 1||0
262460|NCT00975650|635350|P1|NOT COMPLETED|Period 1||0
262461|NCT00975650|635347|P4|COMPLETED|Period 1||14
262462|NCT00975650|635348|P3|COMPLETED|Period 1||14
262463|NCT00975650|635349|P2|COMPLETED|Period 1||16
262464|NCT00975650|635350|P1|COMPLETED|Period 1||13
262465|NCT00975650|635347|P4|STARTED|Period 1||14
262466|NCT00975650|635348|P3|STARTED|Period 1||14
262467|NCT00975650|635349|P2|STARTED|Period 1||16
262468|NCT00975650|635350|P1|STARTED|Period 1||13
262469|NCT00975637|635389|P5|NOT COMPLETED|Overall Study||2
262470|NCT00975637|635390|P4|NOT COMPLETED|Overall Study||6
262471|NCT00975637|635391|P3|NOT COMPLETED|Overall Study||2
262472|NCT00975637|635392|P2|NOT COMPLETED|Overall Study||1
262473|NCT00975637|635393|P1|NOT COMPLETED|Overall Study||3
262474|NCT00975637|635389|P5|COMPLETED|Overall Study||37
262475|NCT00975637|635390|P4|COMPLETED|Overall Study||32
262476|NCT00975637|635391|P3|COMPLETED|Overall Study||40
262477|NCT00975637|635392|P2|COMPLETED|Overall Study||38
262478|NCT00975637|635393|P1|COMPLETED|Overall Study||37
262479|NCT00975637|635389|P5|STARTED|Overall Study||39
262480|NCT00975637|635390|P4|STARTED|Overall Study||38
262481|NCT00975637|635391|P3|STARTED|Overall Study||42
262482|NCT00975637|635392|P2|STARTED|Overall Study||39
262483|NCT00975637|635393|P1|STARTED|Overall Study||40
262484|NCT00975611|635410|P1|NOT COMPLETED|Overall Study||17
262485|NCT00975611|635410|P1|COMPLETED|Overall Study||5
262486|NCT00975611|635410|P1|STARTED|Overall Study||22
262487|NCT00975585|635416|P2|NOT COMPLETED|Overall Study||12
262488|NCT00975585|635417|P1|NOT COMPLETED|Overall Study||7
262489|NCT00975585|635416|P2|COMPLETED|Overall Study||183
262490|NCT00975585|635417|P1|COMPLETED|Overall Study||177
262491|NCT00975585|635416|P2|STARTED|Overall Study||195
262492|NCT00975585|635417|P1|STARTED|Overall Study||184
262493|NCT00975507|635437|P2|NOT COMPLETED|Overall Study||4
262494|NCT00975507|635438|P1|NOT COMPLETED|Overall Study||20
262495|NCT00975507|635437|P2|COMPLETED|Overall Study||153
262496|NCT00975507|635438|P1|COMPLETED|Overall Study||303
262497|NCT00975507|635437|P2|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects receiving M-M-R™ II + VARIVAX™ at Visit 1 were not vaccinated at Visit 2|0
262498|NCT00975507|635438|P1|Vaccinated at Visit 2|Overall Study||310
262499|NCT00975507|635437|P2|Vaccinated at Visit 1|Overall Study||157
262500|NCT00975507|635438|P1|Vaccinated at Visit 1|Overall Study||323
262501|NCT00975507|635437|P2|STARTED|Overall Study||157
262502|NCT00975507|635438|P1|STARTED|Overall Study||323
262503|NCT00975481|635458|P6|NOT COMPLETED|Sixth Intervention Period||0
262504|NCT00975481|635459|P5|NOT COMPLETED|Sixth Intervention Period||0
262505|NCT00975481|635460|P4|NOT COMPLETED|Sixth Intervention Period||0
262506|NCT00975481|635461|P3|NOT COMPLETED|Sixth Intervention Period||0
262507|NCT00975481|635462|P2|NOT COMPLETED|Sixth Intervention Period||0
262508|NCT00975481|635463|P1|NOT COMPLETED|Sixth Intervention Period||0
262509|NCT00975481|635458|P6|COMPLETED|Sixth Intervention Period||6
262510|NCT00975481|635459|P5|COMPLETED|Sixth Intervention Period||5
262511|NCT00975481|635460|P4|COMPLETED|Sixth Intervention Period||5
262512|NCT00975481|635461|P3|COMPLETED|Sixth Intervention Period||4
262513|NCT00975481|635462|P2|COMPLETED|Sixth Intervention Period||5
262514|NCT00975481|635463|P1|COMPLETED|Sixth Intervention Period||4
262515|NCT00975481|635458|P6|STARTED|Sixth Intervention Period||6
262516|NCT00975481|635459|P5|STARTED|Sixth Intervention Period||5
262517|NCT00975481|635460|P4|STARTED|Sixth Intervention Period||5
262518|NCT00975481|635461|P3|STARTED|Sixth Intervention Period||4
262519|NCT00975481|635462|P2|STARTED|Sixth Intervention Period||5
262520|NCT00975481|635463|P1|STARTED|Sixth Intervention Period||4
262521|NCT00975481|635458|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
262522|NCT00975481|635459|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
262523|NCT00975481|635460|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
262524|NCT00975481|635461|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
262525|NCT00975481|635462|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
262526|NCT00975481|635463|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
262527|NCT00975481|635458|P6|COMPLETED|Washout Period (at Least 7 Days)||6
262528|NCT00975481|635459|P5|COMPLETED|Washout Period (at Least 7 Days)||5
262529|NCT00975481|635460|P4|COMPLETED|Washout Period (at Least 7 Days)||5
262530|NCT00975481|635461|P3|COMPLETED|Washout Period (at Least 7 Days)||4
262531|NCT00975481|635462|P2|COMPLETED|Washout Period (at Least 7 Days)||5
262532|NCT00975481|635463|P1|COMPLETED|Washout Period (at Least 7 Days)||4
262533|NCT00975481|635458|P6|STARTED|Washout Period (at Least 7 Days)||6
262534|NCT00975481|635459|P5|STARTED|Washout Period (at Least 7 Days)||5
262535|NCT00975481|635460|P4|STARTED|Washout Period (at Least 7 Days)||5
262536|NCT00975481|635461|P3|STARTED|Washout Period (at Least 7 Days)||4
262537|NCT00975481|635462|P2|STARTED|Washout Period (at Least 7 Days)||5
262538|NCT00975481|635463|P1|STARTED|Washout Period (at Least 7 Days)||4
262539|NCT00975481|635458|P6|NOT COMPLETED|Fifth Intervention Period||0
262540|NCT00975481|635459|P5|NOT COMPLETED|Fifth Intervention Period||1
262541|NCT00975481|635460|P4|NOT COMPLETED|Fifth Intervention Period||0
262542|NCT00975481|635461|P3|NOT COMPLETED|Fifth Intervention Period||0
262543|NCT00975481|635462|P2|NOT COMPLETED|Fifth Intervention Period||0
262544|NCT00975481|635463|P1|NOT COMPLETED|Fifth Intervention Period||0
262545|NCT00975481|635458|P6|COMPLETED|Fifth Intervention Period||6
262546|NCT00975481|635459|P5|COMPLETED|Fifth Intervention Period||5
262547|NCT00975481|635460|P4|COMPLETED|Fifth Intervention Period||5
262548|NCT00975481|635461|P3|COMPLETED|Fifth Intervention Period||4
262549|NCT00975481|635462|P2|COMPLETED|Fifth Intervention Period||5
262550|NCT00975481|635463|P1|COMPLETED|Fifth Intervention Period||4
262551|NCT00975481|635458|P6|STARTED|Fifth Intervention Period||6
262552|NCT00975481|635459|P5|STARTED|Fifth Intervention Period||6
262553|NCT00975481|635460|P4|STARTED|Fifth Intervention Period||5
262554|NCT00975481|635461|P3|STARTED|Fifth Intervention Period||4
262555|NCT00975481|635462|P2|STARTED|Fifth Intervention Period||5
262556|NCT00975481|635463|P1|STARTED|Fifth Intervention Period||4
262557|NCT00975481|635458|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
262558|NCT00975481|635459|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
262559|NCT00975481|635460|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
262560|NCT00975481|635461|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
262561|NCT00975481|635462|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
262562|NCT00975481|635463|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
262563|NCT00975481|635458|P6|COMPLETED|Washout Period (at Least 7 Days)||6
262564|NCT00975481|635459|P5|COMPLETED|Washout Period (at Least 7 Days)||6
262565|NCT00975481|635460|P4|COMPLETED|Washout Period (at Least 7 Days)||5
262566|NCT00975481|635461|P3|COMPLETED|Washout Period (at Least 7 Days)||4
262567|NCT00975481|635462|P2|COMPLETED|Washout Period (at Least 7 Days)||5
262568|NCT00975481|635463|P1|COMPLETED|Washout Period (at Least 7 Days)||4
262569|NCT00975481|635458|P6|STARTED|Washout Period (at Least 7 Days)||6
262570|NCT00975481|635459|P5|STARTED|Washout Period (at Least 7 Days)||6
262571|NCT00975481|635460|P4|STARTED|Washout Period (at Least 7 Days)||5
262572|NCT00975481|635461|P3|STARTED|Washout Period (at Least 7 Days)||4
262573|NCT00975481|635462|P2|STARTED|Washout Period (at Least 7 Days)||5
262574|NCT00975481|635463|P1|STARTED|Washout Period (at Least 7 Days)||4
262575|NCT00975481|635458|P6|NOT COMPLETED|Fourth Intervention Period||0
262576|NCT00975481|635459|P5|NOT COMPLETED|Fourth Intervention Period||0
262577|NCT00975481|635460|P4|NOT COMPLETED|Fourth Intervention Period||1
262578|NCT00975481|635461|P3|NOT COMPLETED|Fourth Intervention Period||1
262579|NCT00975481|635462|P2|NOT COMPLETED|Fourth Intervention Period||0
262580|NCT00975481|635463|P1|NOT COMPLETED|Fourth Intervention Period||0
262581|NCT00975481|635458|P6|COMPLETED|Fourth Intervention Period||6
262582|NCT00975481|635459|P5|COMPLETED|Fourth Intervention Period||6
262583|NCT00975481|635460|P4|COMPLETED|Fourth Intervention Period||5
262584|NCT00975481|635461|P3|COMPLETED|Fourth Intervention Period||4
262585|NCT00975481|635462|P2|COMPLETED|Fourth Intervention Period||5
262586|NCT00975481|635463|P1|COMPLETED|Fourth Intervention Period||4
262587|NCT00975481|635458|P6|STARTED|Fourth Intervention Period||6
262588|NCT00975481|635459|P5|STARTED|Fourth Intervention Period||6
262589|NCT00975481|635460|P4|STARTED|Fourth Intervention Period||6
262590|NCT00975481|635461|P3|STARTED|Fourth Intervention Period||5
262591|NCT00975481|635462|P2|STARTED|Fourth Intervention Period||5
262592|NCT00975481|635463|P1|STARTED|Fourth Intervention Period||4
262593|NCT00975481|635458|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
262594|NCT00975481|635459|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
262595|NCT00975481|635460|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
262596|NCT00975481|635461|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
262597|NCT00975481|635462|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
262598|NCT00975481|635463|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
262599|NCT00975481|635458|P6|COMPLETED|Washout Period (at Least 7 Days)||6
262600|NCT00975481|635459|P5|COMPLETED|Washout Period (at Least 7 Days)||6
262601|NCT00975481|635460|P4|COMPLETED|Washout Period (at Least 7 Days)||6
262602|NCT00975481|635461|P3|COMPLETED|Washout Period (at Least 7 Days)||5
262603|NCT00975481|635462|P2|COMPLETED|Washout Period (at Least 7 Days)||5
262604|NCT00975481|635463|P1|COMPLETED|Washout Period (at Least 7 Days)||4
262605|NCT00975481|635458|P6|STARTED|Washout Period (at Least 7 Days)||6
262606|NCT00975481|635459|P5|STARTED|Washout Period (at Least 7 Days)||6
262607|NCT00975481|635460|P4|STARTED|Washout Period (at Least 7 Days)||6
262608|NCT00975481|635461|P3|STARTED|Washout Period (at Least 7 Days)||5
262609|NCT00975481|635462|P2|STARTED|Washout Period (at Least 7 Days)||5
262610|NCT00975481|635463|P1|STARTED|Washout Period (at Least 7 Days)||4
262611|NCT00975481|635458|P6|NOT COMPLETED|Third Intervention Period||0
262612|NCT00975481|635459|P5|NOT COMPLETED|Third Intervention Period||0
262613|NCT00975481|635460|P4|NOT COMPLETED|Third Intervention Period||0
262614|NCT00975481|635461|P3|NOT COMPLETED|Third Intervention Period||0
262615|NCT00975481|635462|P2|NOT COMPLETED|Third Intervention Period||0
262616|NCT00975481|635463|P1|NOT COMPLETED|Third Intervention Period||0
262617|NCT00975481|635458|P6|COMPLETED|Third Intervention Period||6
262618|NCT00975481|635459|P5|COMPLETED|Third Intervention Period||6
262619|NCT00975481|635460|P4|COMPLETED|Third Intervention Period||6
262620|NCT00975481|635461|P3|COMPLETED|Third Intervention Period||5
262621|NCT00975481|635462|P2|COMPLETED|Third Intervention Period||5
262622|NCT00975481|635463|P1|COMPLETED|Third Intervention Period||4
262623|NCT00975481|635458|P6|STARTED|Third Intervention Period||6
262624|NCT00975481|635459|P5|STARTED|Third Intervention Period||6
262625|NCT00975481|635460|P4|STARTED|Third Intervention Period||6
262626|NCT00975481|635461|P3|STARTED|Third Intervention Period||5
262627|NCT00975481|635462|P2|STARTED|Third Intervention Period||5
262628|NCT00975481|635463|P1|STARTED|Third Intervention Period||4
262629|NCT00975481|635458|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
262630|NCT00975481|635459|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
262631|NCT00975481|635460|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
262632|NCT00975481|635461|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
262633|NCT00975481|635462|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
262634|NCT00975481|635463|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
262635|NCT00975481|635458|P6|COMPLETED|Washout Period (at Least 7 Days)||6
262636|NCT00975481|635459|P5|COMPLETED|Washout Period (at Least 7 Days)||6
262637|NCT00975481|635460|P4|COMPLETED|Washout Period (at Least 7 Days)||6
262638|NCT00975481|635461|P3|COMPLETED|Washout Period (at Least 7 Days)||5
262639|NCT00975481|635462|P2|COMPLETED|Washout Period (at Least 7 Days)||5
262640|NCT00975481|635463|P1|COMPLETED|Washout Period (at Least 7 Days)||4
262641|NCT00975481|635458|P6|STARTED|Washout Period (at Least 7 Days)||6
262642|NCT00975481|635459|P5|STARTED|Washout Period (at Least 7 Days)||6
262643|NCT00975481|635460|P4|STARTED|Washout Period (at Least 7 Days)||6
262644|NCT00975481|635461|P3|STARTED|Washout Period (at Least 7 Days)||5
262645|NCT00975481|635462|P2|STARTED|Washout Period (at Least 7 Days)||5
262646|NCT00975481|635463|P1|STARTED|Washout Period (at Least 7 Days)||4
262647|NCT00975481|635458|P6|NOT COMPLETED|Second Intervention Period||0
262648|NCT00975481|635459|P5|NOT COMPLETED|Second Intervention Period||0
262649|NCT00975481|635460|P4|NOT COMPLETED|Second Intervention Period||0
262650|NCT00975481|635461|P3|NOT COMPLETED|Second Intervention Period||1
262651|NCT00975481|635462|P2|NOT COMPLETED|Second Intervention Period||1
262652|NCT00975481|635463|P1|NOT COMPLETED|Second Intervention Period||2
262653|NCT00975481|635458|P6|COMPLETED|Second Intervention Period||6
262654|NCT00975481|635459|P5|COMPLETED|Second Intervention Period||6
262655|NCT00975481|635460|P4|COMPLETED|Second Intervention Period||6
262656|NCT00975481|635461|P3|COMPLETED|Second Intervention Period||5
262657|NCT00975481|635462|P2|COMPLETED|Second Intervention Period||5
262658|NCT00975481|635463|P1|COMPLETED|Second Intervention Period||4
262659|NCT00975481|635458|P6|STARTED|Second Intervention Period||6
262660|NCT00975481|635459|P5|STARTED|Second Intervention Period||6
262661|NCT00975481|635460|P4|STARTED|Second Intervention Period||6
262662|NCT00975481|635461|P3|STARTED|Second Intervention Period||6
262663|NCT00975481|635462|P2|STARTED|Second Intervention Period||6
262664|NCT00975481|635463|P1|STARTED|Second Intervention Period||6
262665|NCT00975481|635458|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
262666|NCT00975481|635459|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
262667|NCT00975481|635460|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
262668|NCT00975481|635461|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
262669|NCT00975481|635462|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
262670|NCT00975481|635463|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
262671|NCT00975481|635458|P6|COMPLETED|Washout Period (at Least 7 Days)||6
262672|NCT00975481|635459|P5|COMPLETED|Washout Period (at Least 7 Days)||6
262673|NCT00975481|635460|P4|COMPLETED|Washout Period (at Least 7 Days)||6
262674|NCT00975481|635461|P3|COMPLETED|Washout Period (at Least 7 Days)||6
262675|NCT00975481|635462|P2|COMPLETED|Washout Period (at Least 7 Days)||6
262676|NCT00975481|635463|P1|COMPLETED|Washout Period (at Least 7 Days)||6
262677|NCT00975481|635458|P6|STARTED|Washout Period (at Least 7 Days)||6
262678|NCT00975481|635459|P5|STARTED|Washout Period (at Least 7 Days)||6
262679|NCT00975481|635460|P4|STARTED|Washout Period (at Least 7 Days)||6
262680|NCT00975481|635461|P3|STARTED|Washout Period (at Least 7 Days)||6
262681|NCT00975481|635462|P2|STARTED|Washout Period (at Least 7 Days)||6
262682|NCT00975481|635463|P1|STARTED|Washout Period (at Least 7 Days)||6
262683|NCT00975481|635458|P6|NOT COMPLETED|First Intervention Period||0
262684|NCT00975481|635459|P5|NOT COMPLETED|First Intervention Period||0
262685|NCT00975481|635460|P4|NOT COMPLETED|First Intervention Period||0
262686|NCT00975481|635461|P3|NOT COMPLETED|First Intervention Period||0
262687|NCT00975481|635462|P2|NOT COMPLETED|First Intervention Period||0
262688|NCT00975481|635463|P1|NOT COMPLETED|First Intervention Period||0
262689|NCT00975481|635458|P6|COMPLETED|First Intervention Period||6
262690|NCT00975481|635459|P5|COMPLETED|First Intervention Period||6
262691|NCT00975481|635460|P4|COMPLETED|First Intervention Period||6
262692|NCT00975481|635461|P3|COMPLETED|First Intervention Period||6
262693|NCT00975481|635462|P2|COMPLETED|First Intervention Period||6
262694|NCT00975481|635463|P1|COMPLETED|First Intervention Period||6
262695|NCT00975481|635458|P6|STARTED|First Intervention Period||6
262696|NCT00975481|635459|P5|STARTED|First Intervention Period||6
262697|NCT00975481|635460|P4|STARTED|First Intervention Period||6
262698|NCT00975481|635461|P3|STARTED|First Intervention Period||6
262699|NCT00975481|635462|P2|STARTED|First Intervention Period||6
262700|NCT00975481|635463|P1|STARTED|First Intervention Period||6
262701|NCT00975416|635563|P2|NOT COMPLETED|Overall Study||5
262702|NCT00975416|635564|P1|NOT COMPLETED|Overall Study||3
262703|NCT00975416|635563|P2|COMPLETED|Overall Study||11
262704|NCT00975416|635564|P1|COMPLETED|Overall Study||11
262705|NCT00975416|635563|P2|STARTED|Overall Study||16
262706|NCT00975416|635564|P1|STARTED|Overall Study||14
262707|NCT00975286|635573|P2|NOT COMPLETED|Overall Study||29
262708|NCT00975286|635574|P1|NOT COMPLETED|Overall Study||12
262709|NCT00975286|635573|P2|COMPLETED|Overall Study||194
262710|NCT00975286|635574|P1|COMPLETED|Overall Study||211
262711|NCT00975286|635573|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||223
262712|NCT00975286|635574|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|223
262713|NCT00975286|635573|P2|Safety Population|Overall Study||223
262714|NCT00975286|635574|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|223
262715|NCT00975286|635573|P2|STARTED|Overall Study||223
262716|NCT00975286|635574|P1|STARTED|Overall Study|Randomized.|223
262717|NCT00975221|635606|P2|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||1
262718|NCT00975221|635607|P1|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||2
262719|NCT00975221|635606|P2|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
262720|NCT00975221|635607|P1|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
262721|NCT00975221|635606|P2|STARTED|Open-label Extension Phase (Weeks 29-52)||28
262722|NCT00975221|635607|P1|STARTED|Open-label Extension Phase (Weeks 29-52)|1 participant who completed the EAP did not enter the open-label phase|29
262723|NCT00975221|635606|P2|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||1
262724|NCT00975221|635607|P1|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||0
262725|NCT00975221|635606|P2|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||28
262726|NCT00975221|635607|P1|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||30
262727|NCT00975221|635606|P2|STARTED|Efficacy Assessment Phase (Weeks 13-28)||29
262728|NCT00975221|635607|P1|STARTED|Efficacy Assessment Phase (Weeks 13-28)|1 participant who completed the Titration Phase did not enter the EAP|30
262729|NCT00975221|635606|P2|NOT COMPLETED|Titration Phase (Weeks 1-12)||4
262730|NCT00975221|635607|P1|NOT COMPLETED|Titration Phase (Weeks 1-12)||3
262731|NCT00975221|635606|P2|COMPLETED|Titration Phase (Weeks 1-12)||29
262732|NCT00975221|635607|P1|COMPLETED|Titration Phase (Weeks 1-12)||31
262733|NCT00975221|635606|P2|Received Study Drug|Titration Phase (Weeks 1-12)||33
262734|NCT00975221|635607|P1|Received Study Drug|Titration Phase (Weeks 1-12)||34
262735|NCT00975221|635606|P2|STARTED|Titration Phase (Weeks 1-12)||33
262736|NCT00975221|635607|P1|STARTED|Titration Phase (Weeks 1-12)||34
262737|NCT00975195|635623|P2|NOT COMPLETED|Overall Study||233
262738|NCT00975195|635624|P1|NOT COMPLETED|Overall Study||228
262739|NCT00975195|635623|P2|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1011
262740|NCT00975195|635624|P1|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1016
262741|NCT00975195|635623|P2|STARTED|Overall Study||1244
262742|NCT00975195|635624|P1|STARTED|Overall Study||1244
262743|NCT00975156|635684|P2|NOT COMPLETED|Overall Study||1
262744|NCT00975156|635685|P1|NOT COMPLETED|Overall Study||0
262745|NCT00975156|635684|P2|COMPLETED|Overall Study||9
262746|NCT00975156|635685|P1|COMPLETED|Overall Study||11
262747|NCT00975156|635684|P2|STARTED|Overall Study||10
262748|NCT00975156|635685|P1|STARTED|Overall Study||11
262749|NCT00975143|635697|P2|NOT COMPLETED|Overall Study||60
262750|NCT00975143|635698|P1|NOT COMPLETED|Overall Study||70
262751|NCT00975143|635697|P2|COMPLETED|Overall Study||401
262752|NCT00975143|635698|P1|COMPLETED|Overall Study||394
262753|NCT00975143|635697|P2|Completed Treatment (Week 20)|Overall Study||410
262754|NCT00975143|635698|P1|Completed Treatment (Week 20)|Overall Study||403
262755|NCT00975143|635697|P2|STARTED|Overall Study||461
262756|NCT00975143|635698|P1|STARTED|Overall Study||464
262757|NCT00975130|635708|P3|NOT COMPLETED|Study Part 2||17
262758|NCT00975130|635709|P2|NOT COMPLETED|Study Part 2||38
262759|NCT00975130|635710|P1|NOT COMPLETED|Study Part 2||0
262760|NCT00975130|635708|P3|COMPLETED|Study Part 2||238
262761|NCT00975130|635709|P2|COMPLETED|Study Part 2||212
262762|NCT00975130|635710|P1|COMPLETED|Study Part 2||0
262763|NCT00975130|635708|P3|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|255
262764|NCT00975130|635709|P2|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|250
262765|NCT00975130|635710|P1|STARTED|Study Part 2||0
262766|NCT00975130|635708|P3|NOT COMPLETED|Study Part 1||0
262767|NCT00975130|635709|P2|NOT COMPLETED|Study Part 1||0
262768|NCT00975130|635710|P1|NOT COMPLETED|Study Part 1||280
262769|NCT00975130|635708|P3|COMPLETED|Study Part 1||0
262770|NCT00975130|635709|P2|COMPLETED|Study Part 1||0
262771|NCT00975130|635710|P1|COMPLETED|Study Part 1||3086
262772|NCT00975130|635708|P3|STARTED|Study Part 1||0
262773|NCT00975130|635709|P2|STARTED|Study Part 1||0
262774|NCT00975130|635710|P1|STARTED|Study Part 1||3366
262775|NCT00975000|635894|P2|NOT COMPLETED|Overall Study||5
262776|NCT00975000|635895|P1|NOT COMPLETED|Overall Study||5
262777|NCT00975000|635894|P2|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
262778|NCT00975000|635895|P1|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
262779|NCT00975000|635894|P2|Completed Maintenance Phase|Overall Study||52
262780|NCT00975000|635895|P1|Completed Maintenance Phase|Overall Study||52
262781|NCT00975000|635894|P2|Completed Efficacy Assessment Phase|Overall Study||54
262782|NCT00975000|635895|P1|Completed Efficacy Assessment Phase|Overall Study||54
262783|NCT00975000|635894|P2|Completed Titration Phase|Overall Study||55
262784|NCT00975000|635895|P1|Completed Titration Phase|Overall Study||54
262785|NCT00975000|635894|P2|STARTED|Overall Study||57
262786|NCT00975000|635895|P1|STARTED|Overall Study||57
262787|NCT00974974|635919|P2|NOT COMPLETED|Maintenance - Double Blind Treatment||10
262788|NCT00974974|635920|P1|NOT COMPLETED|Maintenance - Double Blind Treatment||15
262789|NCT00974974|635919|P2|COMPLETED|Maintenance - Double Blind Treatment||182
262790|NCT00974974|635920|P1|COMPLETED|Maintenance - Double Blind Treatment||186
262791|NCT00974974|635919|P2|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|192
262792|NCT00974974|635920|P1|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|201
262793|NCT00974974|635919|P2|NOT COMPLETED|IPX066 Dose Conversion||0
262794|NCT00974974|635920|P1|NOT COMPLETED|IPX066 Dose Conversion||57
262795|NCT00974974|635919|P2|COMPLETED|IPX066 Dose Conversion||0
262796|NCT00974974|635920|P1|COMPLETED|IPX066 Dose Conversion||393
262797|NCT00974974|635919|P2|STARTED|IPX066 Dose Conversion|IR is not applicable in IPX066 dose conversion.|0
262798|NCT00974974|635920|P1|STARTED|IPX066 Dose Conversion|All subjects who completed IR Dose adjustment entered into IPX066 dose conversion.|450
262799|NCT00974974|635919|P2|NOT COMPLETED|IR CD-LD Dose Adjustment||21
262800|NCT00974974|635920|P1|NOT COMPLETED|IR CD-LD Dose Adjustment||0
262801|NCT00974974|635919|P2|COMPLETED|IR CD-LD Dose Adjustment||450
262802|NCT00974974|635920|P1|COMPLETED|IR CD-LD Dose Adjustment||0
262803|NCT00974974|635919|P2|STARTED|IR CD-LD Dose Adjustment||471
262804|NCT00974974|635920|P1|STARTED|IR CD-LD Dose Adjustment||0
262805|NCT00974922|635930|P1|NOT COMPLETED|Overall Study||24
262806|NCT00974922|635930|P1|COMPLETED|Overall Study||16
262807|NCT00974922|635930|P1|STARTED|Overall Study||40
262808|NCT00974818|635937|P2|NOT COMPLETED|Overall Study||0
262809|NCT00974818|635938|P1|NOT COMPLETED|Overall Study||0
262810|NCT00974818|635937|P2|COMPLETED|Overall Study||25
262811|NCT00974818|635938|P1|COMPLETED|Overall Study||25
262812|NCT00974818|635937|P2|STARTED|Overall Study||25
262813|NCT00974818|635938|P1|STARTED|Overall Study||25
262814|NCT00974675|635948|P4|NOT COMPLETED|Overall Study||2
262815|NCT00974675|635949|P3|NOT COMPLETED|Overall Study||2
262816|NCT00974675|635950|P2|NOT COMPLETED|Overall Study||1
262817|NCT00974675|635951|P1|NOT COMPLETED|Overall Study||2
262818|NCT00974675|635948|P4|COMPLETED|Overall Study||2
262819|NCT00974675|635949|P3|COMPLETED|Overall Study||1
262820|NCT00974675|635950|P2|COMPLETED|Overall Study||7
262821|NCT00974675|635951|P1|COMPLETED|Overall Study||6
262822|NCT00974675|635948|P4|STARTED|Overall Study||4
262823|NCT00974675|635949|P3|STARTED|Overall Study||3
262824|NCT00974675|635950|P2|STARTED|Overall Study||8
262825|NCT00974675|635951|P1|STARTED|Overall Study||8
262826|NCT00974571|636000|P3|NOT COMPLETED|Overall Study||83
262827|NCT00974571|636001|P2|NOT COMPLETED|Overall Study||16
262828|NCT00974571|636002|P1|NOT COMPLETED|Overall Study||68
262829|NCT00974571|636000|P3|COMPLETED|Overall Study||530
262830|NCT00974571|636001|P2|COMPLETED|Overall Study||106
262831|NCT00974571|636002|P1|COMPLETED|Overall Study||562
262832|NCT00974571|636000|P3|STARTED|Overall Study||613
262833|NCT00974571|636001|P2|STARTED|Overall Study||122
262834|NCT00974571|636002|P1|STARTED|Overall Study||630
262835|NCT00974480|636025|P3|NOT COMPLETED|Overall Study||10
262836|NCT00974480|636026|P2|NOT COMPLETED|Overall Study||7
262837|NCT00974480|636027|P1|NOT COMPLETED|Overall Study||11
262838|NCT00974480|636025|P3|COMPLETED|Overall Study||30
262839|NCT00974480|636026|P2|COMPLETED|Overall Study||33
262840|NCT00974480|636027|P1|COMPLETED|Overall Study||29
262841|NCT00974480|636025|P3|STARTED|Overall Study||40
262842|NCT00974480|636026|P2|STARTED|Overall Study||40
262843|NCT00974480|636027|P1|STARTED|Overall Study||40
262844|NCT00974376|636067|P2|NOT COMPLETED|Overall Study||33
262845|NCT00974376|636068|P1|NOT COMPLETED|Overall Study||34
262846|NCT00974376|636067|P2|COMPLETED|Overall Study||42
262847|NCT00974376|636068|P1|COMPLETED|Overall Study||41
262848|NCT00974376|636067|P2|STARTED|Overall Study||75
262849|NCT00974376|636068|P1|STARTED|Overall Study||75
262850|NCT00974363|636076|P2|NOT COMPLETED|Overall Study||0
262851|NCT00974363|636077|P1|NOT COMPLETED|Overall Study||0
262852|NCT00974363|636076|P2|COMPLETED|Overall Study||168
262853|NCT00974363|636077|P1|COMPLETED|Overall Study||521
262854|NCT00974363|636076|P2|STARTED|Overall Study||168
262855|NCT00974363|636077|P1|STARTED|Overall Study||521
262856|NCT00974311|636099|P2|NOT COMPLETED|OLE Phase (up to 77 Months)||50
262857|NCT00974311|636100|P1|NOT COMPLETED|OLE Phase (up to 77 Months)||109
262858|NCT00974311|636099|P2|COMPLETED|OLE Phase (up to 77 Months)||0
262859|NCT00974311|636100|P1|COMPLETED|OLE Phase (up to 77 Months)||0
262860|NCT00974311|636099|P2|STARTED|OLE Phase (up to 77 Months)||50
262861|NCT00974311|636100|P1|STARTED|OLE Phase (up to 77 Months)||109
262862|NCT00974311|636099|P2|NOT COMPLETED|DB Phase (up to 24 Months)||349
262863|NCT00974311|636100|P1|NOT COMPLETED|DB Phase (up to 24 Months)||691
262864|NCT00974311|636099|P2|COMPLETED|DB Phase (up to 24 Months)||50
262865|NCT00974311|636100|P1|COMPLETED|DB Phase (up to 24 Months)||109
262866|NCT00974311|636099|P2|STARTED|DB Phase (up to 24 Months)||399
262867|NCT00974311|636100|P1|STARTED|DB Phase (up to 24 Months)||800
262868|NCT00974259|636138|P2|NOT COMPLETED|Overall Study||1
262869|NCT00974259|636139|P1|NOT COMPLETED|Overall Study||2
262870|NCT00974259|636138|P2|COMPLETED|Overall Study||62
262871|NCT00974259|636139|P1|COMPLETED|Overall Study||57
262872|NCT00974259|636138|P2|STARTED|Overall Study||63
262873|NCT00974259|636139|P1|STARTED|Overall Study||59
262874|NCT00974246|636151|P1|NOT COMPLETED|Overall Study||0
262875|NCT00974246|636151|P1|COMPLETED|Overall Study||27
262876|NCT00974246|636151|P1|STARTED|Overall Study||27
262877|NCT00974233|636157|P1|NOT COMPLETED|Maintenance Lenalidomide||13
262878|NCT00974233|636157|P1|COMPLETED|Maintenance Lenalidomide||6
262879|NCT00974233|636157|P1|STARTED|Maintenance Lenalidomide||19
262880|NCT00974233|636157|P1|NOT COMPLETED|Induction Chemoimmunotherapy||15
262881|NCT00974233|636157|P1|COMPLETED|Induction Chemoimmunotherapy||19
262882|NCT00974233|636157|P1|STARTED|Induction Chemoimmunotherapy||34
262883|NCT00974220|636172|P2|NOT COMPLETED|Treatment Period 2||0
262884|NCT00974220|636173|P1|NOT COMPLETED|Treatment Period 2||0
262885|NCT00974220|636172|P2|COMPLETED|Treatment Period 2||5
262886|NCT00974220|636173|P1|COMPLETED|Treatment Period 2||7
262887|NCT00974220|636172|P2|STARTED|Treatment Period 2||5
262888|NCT00974220|636173|P1|STARTED|Treatment Period 2||7
262889|NCT00974220|636172|P2|NOT COMPLETED|Treatment Period 1||2
262890|NCT00974220|636173|P1|NOT COMPLETED|Treatment Period 1||2
262891|NCT00974220|636172|P2|COMPLETED|Treatment Period 1||5
262892|NCT00974220|636173|P1|COMPLETED|Treatment Period 1||7
262893|NCT00974220|636172|P2|STARTED|Treatment Period 1||7
262894|NCT00974220|636173|P1|STARTED|Treatment Period 1||9
262895|NCT00974142|636183|P2|NOT COMPLETED|Overall Study||0
262896|NCT00974142|636184|P1|NOT COMPLETED|Overall Study||0
262897|NCT00974142|636183|P2|COMPLETED|Overall Study||9
262898|NCT00974142|636184|P1|COMPLETED|Overall Study||8
262899|NCT00974142|636183|P2|STARTED|Overall Study||9
262900|NCT00974142|636184|P1|STARTED|Overall Study||8
262901|NCT00974090|636218|P2|NOT COMPLETED|Period 2: Open-label Period||10
262902|NCT00974090|636219|P1|NOT COMPLETED|Period 2: Open-label Period||8
262903|NCT00974090|636218|P2|COMPLETED|Period 2: Open-label Period||85
262904|NCT00974090|636219|P1|COMPLETED|Period 2: Open-label Period||87
262905|NCT00974090|636218|P2|STARTED|Period 2: Open-label Period||95
262906|NCT00974090|636219|P1|STARTED|Period 2: Open-label Period||95
262907|NCT00974090|636218|P2|NOT COMPLETED|Period 1: Double Blind Period||1
262908|NCT00974090|636219|P1|NOT COMPLETED|Period 1: Double Blind Period||3
262909|NCT00974090|636218|P2|COMPLETED|Period 1: Double Blind Period||95
262910|NCT00974090|636219|P1|COMPLETED|Period 1: Double Blind Period||95
262911|NCT00974090|636218|P2|STARTED|Period 1: Double Blind Period||96
262912|NCT00974090|636219|P1|STARTED|Period 1: Double Blind Period||98
262913|NCT00974051|636233|P3|NOT COMPLETED|Overall Study||0
262914|NCT00974051|636234|P2|NOT COMPLETED|Overall Study||0
262915|NCT00974051|636235|P1|NOT COMPLETED|Overall Study||0
262916|NCT00974051|636233|P3|COMPLETED|Overall Study||6
262917|NCT00974051|636234|P2|COMPLETED|Overall Study||4
262918|NCT00974051|636235|P1|COMPLETED|Overall Study||6
262919|NCT00974051|636233|P3|STARTED|Overall Study||6
262920|NCT00974051|636234|P2|STARTED|Overall Study||4
262921|NCT00974051|636235|P1|STARTED|Overall Study||6
262922|NCT00973973|636255|P2|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||5
262923|NCT00973973|636256|P1|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||6
262924|NCT00973973|636255|P2|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||55
262925|NCT00973973|636256|P1|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||57
262926|NCT00973973|636255|P2|STARTED|Open-label Treatment Phase (Weeks 8-24)||60
262927|NCT00973973|636256|P1|STARTED|Open-label Treatment Phase (Weeks 8-24)||63
262928|NCT00973973|636255|P2|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||8
262929|NCT00973973|636256|P1|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||6
262930|NCT00973973|636255|P2|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||60
262931|NCT00973973|636256|P1|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||63
262932|NCT00973973|636255|P2|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||68
262933|NCT00973973|636256|P1|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||69
262934|NCT00973973|636255|P2|STARTED|Double-blind Treatment Phase (Weeks 1-8)||68
262935|NCT00973973|636256|P1|STARTED|Double-blind Treatment Phase (Weeks 1-8)||69
262936|NCT00973921|636316|P1|NOT COMPLETED|Overall Study||9
262937|NCT00973921|636316|P1|COMPLETED|Overall Study||31
262938|NCT00973921|636316|P1|STARTED|Overall Study||40
262939|NCT00973856|636325|P2|NOT COMPLETED|Overall Study||0
262940|NCT00973856|636326|P1|NOT COMPLETED|Overall Study||0
262941|NCT00973856|636325|P2|COMPLETED|Overall Study||2
262942|NCT00973856|636326|P1|COMPLETED|Overall Study||3
262943|NCT00973856|636325|P2|STARTED|Overall Study||2
262944|NCT00973856|636326|P1|STARTED|Overall Study||3
262945|NCT00973765|636333|P2|NOT COMPLETED|Overall Study||14
262946|NCT00973765|636334|P1|NOT COMPLETED|Overall Study||8
262947|NCT00973765|636333|P2|COMPLETED|Overall Study|102|102
262948|NCT00973765|636334|P1|COMPLETED|Overall Study|88|88
262949|NCT00973765|636333|P2|STARTED|Overall Study|116|116
262950|NCT00973765|636334|P1|STARTED|Overall Study|96|96
262951|NCT00973752|636340|P1|NOT COMPLETED|Overall Study||0
262952|NCT00973752|636340|P1|COMPLETED|Overall Study||30
262953|NCT00973752|636340|P1|STARTED|Overall Study||30
262954|NCT00973739|636344|P1|NOT COMPLETED|Overall Study||4
262955|NCT00973739|636344|P1|COMPLETED|Overall Study||17
262956|NCT00973739|636344|P1|STARTED|Overall Study||21
262957|NCT00973700|636356|P5|NOT COMPLETED|Overall Study||10
262958|NCT00973700|636357|P4|NOT COMPLETED|Overall Study||18
262959|NCT00973700|636358|P3|NOT COMPLETED|Overall Study||10
262960|NCT00973700|636359|P2|NOT COMPLETED|Overall Study||2
262961|NCT00973700|636360|P1|NOT COMPLETED|Overall Study||7
262962|NCT00973700|636356|P5|COMPLETED|Overall Study||158
262963|NCT00973700|636357|P4|COMPLETED|Overall Study||318
262964|NCT00973700|636358|P3|COMPLETED|Overall Study||158
262965|NCT00973700|636359|P2|COMPLETED|Overall Study||54
262966|NCT00973700|636360|P1|COMPLETED|Overall Study||49
262967|NCT00973700|636356|P5|STARTED|Overall Study||168
262968|NCT00973700|636357|P4|STARTED|Overall Study||336
262969|NCT00973700|636358|P3|STARTED|Overall Study||168
262970|NCT00973700|636359|P2|STARTED|Overall Study||56
262971|NCT00973700|636360|P1|STARTED|Overall Study||56
262972|NCT00973674|636409|P2|NOT COMPLETED|Overall Study||0
262973|NCT00973674|636410|P1|NOT COMPLETED|Overall Study||2
262974|NCT00973674|636409|P2|COMPLETED|Overall Study||26
262975|NCT00973674|636410|P1|COMPLETED|Overall Study||22
262976|NCT00973674|636409|P2|STARTED|Overall Study||26
262977|NCT00973674|636410|P1|STARTED|Overall Study||24
262978|NCT00973622|636424|P2|NOT COMPLETED|Overall Study||5
262979|NCT00973622|636425|P1|NOT COMPLETED|Overall Study||31
262980|NCT00973622|636424|P2|COMPLETED|Overall Study|Completed three sessions of rTMS|14
262981|NCT00973622|636425|P1|COMPLETED|Overall Study|Completed three sessions of rTMS|16
262982|NCT00973622|636424|P2|STARTED|Overall Study|21 passed telephone interview; 19 passed the in-person interview, were enrolled, and sent for MRI.|19
262983|NCT00973622|636425|P1|STARTED|Overall Study|75 passed telephone interview; 28 passed in-person interview, were enrolled, and sent for MRI.|47
262984|NCT00973479|636433|P2|NOT COMPLETED|Overall Study||69
262985|NCT00973479|636434|P1|NOT COMPLETED|Overall Study||37
262986|NCT00973479|636433|P2|COMPLETED|Overall Study||326
262987|NCT00973479|636434|P1|COMPLETED|Overall Study||160
262988|NCT00973479|636433|P2|STARTED|Overall Study||395
262989|NCT00973479|636434|P1|STARTED|Overall Study||197
262990|NCT00973362|636452|P2|NOT COMPLETED|3-Year Follow-up||0
262991|NCT00973362|636453|P1|NOT COMPLETED|3-Year Follow-up||17
262992|NCT00973362|636452|P2|COMPLETED|3-Year Follow-up||0
262993|NCT00973362|636453|P1|COMPLETED|3-Year Follow-up||10854
262994|NCT00973362|636452|P2|STARTED|3-Year Follow-up|ASC-US study arm did not have a follow-up period|0
262995|NCT00973362|636453|P1|STARTED|3-Year Follow-up||10871
262996|NCT00973362|636452|P2|NOT COMPLETED|Baseline Evaluation||223
262997|NCT00973362|636453|P1|NOT COMPLETED|Baseline Evaluation||773
262998|NCT00973362|636452|P2|COMPLETED|Baseline Evaluation||1029
262999|NCT00973362|636453|P1|COMPLETED|Baseline Evaluation||10871
263000|NCT00973362|636452|P2|Conclusive Disease Status|Baseline Evaluation||939
263001|NCT00973362|636453|P1|Conclusive Disease Status|Baseline Evaluation||819
263002|NCT00973362|636452|P2|Evaluable for Analysis|Baseline Evaluation||958
263003|NCT00973362|636453|P1|Evaluable for Analysis|Baseline Evaluation||10871
263004|NCT00973362|636452|P2|STARTED|Baseline Evaluation||1252
263005|NCT00973362|636453|P1|STARTED|Baseline Evaluation||11644
263006|NCT00973349|636478|P16|NOT COMPLETED|Overall Study||2
263007|NCT00973349|636479|P15|NOT COMPLETED|Overall Study||2
263008|NCT00973349|636480|P14|NOT COMPLETED|Overall Study||0
263009|NCT00973349|636481|P13|NOT COMPLETED|Overall Study||1
263010|NCT00973349|636482|P12|NOT COMPLETED|Overall Study||2
263011|NCT00973349|636483|P11|NOT COMPLETED|Overall Study||0
263012|NCT00973349|636484|P10|NOT COMPLETED|Overall Study||6
263013|NCT00973349|636485|P9|NOT COMPLETED|Overall Study||4
263014|NCT00973349|636486|P8|NOT COMPLETED|Overall Study||3
263015|NCT00973349|636487|P7|NOT COMPLETED|Overall Study||2
263016|NCT00973349|636488|P6|NOT COMPLETED|Overall Study||4
263017|NCT00973349|636489|P5|NOT COMPLETED|Overall Study||5
263018|NCT00973349|636490|P4|NOT COMPLETED|Overall Study||5
263019|NCT00973349|636491|P3|NOT COMPLETED|Overall Study||5
263020|NCT00973349|636492|P2|NOT COMPLETED|Overall Study||3
263021|NCT00973349|636493|P1|NOT COMPLETED|Overall Study||4
263022|NCT00973349|636478|P16|COMPLETED|Overall Study||165
263023|NCT00973349|636479|P15|COMPLETED|Overall Study||168
263024|NCT00973349|636480|P14|COMPLETED|Overall Study||171
263025|NCT00973349|636481|P13|COMPLETED|Overall Study||168
263026|NCT00973349|636482|P12|COMPLETED|Overall Study||167
263027|NCT00973349|636483|P11|COMPLETED|Overall Study||174
263028|NCT00973349|636484|P10|COMPLETED|Overall Study||163
263029|NCT00973349|636485|P9|COMPLETED|Overall Study||167
263030|NCT00973349|636486|P8|COMPLETED|Overall Study||166
263031|NCT00973349|636487|P7|COMPLETED|Overall Study||172
263032|NCT00973349|636488|P6|COMPLETED|Overall Study||165
263033|NCT00973349|636489|P5|COMPLETED|Overall Study||165
263034|NCT00973349|636490|P4|COMPLETED|Overall Study||163
263035|NCT00973349|636491|P3|COMPLETED|Overall Study||166
263036|NCT00973349|636492|P2|COMPLETED|Overall Study||165
263037|NCT00973349|636493|P1|COMPLETED|Overall Study||166
263038|NCT00973349|636478|P16|STARTED|Overall Study||167
263039|NCT00973349|636479|P15|STARTED|Overall Study||170
263040|NCT00973349|636480|P14|STARTED|Overall Study||171
263041|NCT00973349|636481|P13|STARTED|Overall Study||169
263042|NCT00973349|636482|P12|STARTED|Overall Study||169
263043|NCT00973349|636483|P11|STARTED|Overall Study||174
263044|NCT00973349|636484|P10|STARTED|Overall Study||169
263045|NCT00973349|636485|P9|STARTED|Overall Study||171
263046|NCT00973349|636486|P8|STARTED|Overall Study||169
263047|NCT00973349|636487|P7|STARTED|Overall Study||174
263048|NCT00973349|636488|P6|STARTED|Overall Study||169
263049|NCT00973349|636489|P5|STARTED|Overall Study||170
263050|NCT00973349|636490|P4|STARTED|Overall Study||168
263051|NCT00973349|636491|P3|STARTED|Overall Study||171
263052|NCT00973349|636492|P2|STARTED|Overall Study||168
263053|NCT00973349|636493|P1|STARTED|Overall Study||170
263054|NCT00972959|636591|P1|NOT COMPLETED|Overall Study||0
263055|NCT00972959|636591|P1|COMPLETED|Overall Study||17
263056|NCT00972959|636591|P1|STARTED|Overall Study||17
263057|NCT00972816|636614|P8|NOT COMPLETED|Overall Study||9
263058|NCT00972816|636615|P7|NOT COMPLETED|Overall Study||10
263059|NCT00972816|636616|P6|NOT COMPLETED|Overall Study||11
263060|NCT00972816|636617|P5|NOT COMPLETED|Overall Study||12
263061|NCT00972816|636618|P4|NOT COMPLETED|Overall Study||8
263062|NCT00972816|636619|P3|NOT COMPLETED|Overall Study||9
263063|NCT00972816|636620|P2|NOT COMPLETED|Overall Study||11
263064|NCT00972816|636621|P1|NOT COMPLETED|Overall Study||17
263065|NCT00972816|636614|P8|COMPLETED|Overall Study||161
263066|NCT00972816|636615|P7|COMPLETED|Overall Study||159
263067|NCT00972816|636616|P6|COMPLETED|Overall Study||158
263068|NCT00972816|636617|P5|COMPLETED|Overall Study||157
263069|NCT00972816|636618|P4|COMPLETED|Overall Study||161
263070|NCT00972816|636619|P3|COMPLETED|Overall Study||160
263071|NCT00972816|636620|P2|COMPLETED|Overall Study||158
263072|NCT00972816|636621|P1|COMPLETED|Overall Study||156
263073|NCT00972816|636614|P8|STARTED|Overall Study||170
263074|NCT00972816|636615|P7|STARTED|Overall Study||169
263075|NCT00972816|636616|P6|STARTED|Overall Study||169
263076|NCT00972816|636617|P5|STARTED|Overall Study||169
263077|NCT00972816|636618|P4|STARTED|Overall Study||169
263078|NCT00972816|636619|P3|STARTED|Overall Study||169
263079|NCT00972816|636620|P2|STARTED|Overall Study||169
263080|NCT00972816|636621|P1|STARTED|Overall Study||173
263081|NCT00972777|636705|P2|NOT COMPLETED|Overall Study||14
263082|NCT00972777|636706|P1|NOT COMPLETED|Overall Study||14
263083|NCT00972777|636705|P2|COMPLETED|Overall Study||229
263084|NCT00972777|636706|P1|COMPLETED|Overall Study||217
263085|NCT00972777|636705|P2|STARTED|Overall Study||243
263086|NCT00972777|636706|P1|STARTED|Overall Study||231
263087|NCT00972738|636721|P3|NOT COMPLETED|Overall Study||29
263088|NCT00972738|636722|P2|NOT COMPLETED|Overall Study||6
263089|NCT00972738|636723|P1|NOT COMPLETED|Overall Study||21
263090|NCT00972738|636721|P3|COMPLETED|Overall Study||492
263091|NCT00972738|636722|P2|COMPLETED|Overall Study||165
263092|NCT00972738|636723|P1|COMPLETED|Overall Study||501
263093|NCT00972738|636721|P3|STARTED|Overall Study||521
263094|NCT00972738|636722|P2|STARTED|Overall Study||171
263095|NCT00972738|636723|P1|STARTED|Overall Study||522
263096|NCT00972725|636748|P2|NOT COMPLETED|Overall Study||0
263097|NCT00972725|636749|P1|NOT COMPLETED|Overall Study||0
263098|NCT00972725|636748|P2|COMPLETED|Overall Study||15
263099|NCT00972725|636749|P1|COMPLETED|Overall Study||13
263100|NCT00972725|636748|P2|STARTED|Overall Study||15
263101|NCT00972725|636749|P1|STARTED|Overall Study||13
263102|NCT00972621|636831|P2|NOT COMPLETED|Overall Study||1
263103|NCT00972621|636832|P1|NOT COMPLETED|Overall Study||0
263104|NCT00972621|636831|P2|COMPLETED|Overall Study|One subject discontinued due to lens exchange.|199
263105|NCT00972621|636832|P1|COMPLETED|Overall Study||200
263106|NCT00972621|636831|P2|STARTED|Overall Study||200
263107|NCT00972621|636832|P1|STARTED|Overall Study||200
263108|NCT00972595|636840|P2|NOT COMPLETED|Period 2||0
263109|NCT00972595|636841|P1|NOT COMPLETED|Period 2||0
263110|NCT00972595|636840|P2|COMPLETED|Period 2||22
263111|NCT00972595|636841|P1|COMPLETED|Period 2||22
263112|NCT00972595|636840|P2|STARTED|Period 2||22
263113|NCT00972595|636841|P1|STARTED|Period 2||22
263114|NCT00972595|636840|P2|NOT COMPLETED|Period 1||0
263115|NCT00972595|636841|P1|NOT COMPLETED|Period 1||1
263116|NCT00972595|636840|P2|COMPLETED|Period 1||22
263117|NCT00972595|636841|P1|COMPLETED|Period 1||22
263118|NCT00972595|636840|P2|STARTED|Period 1||22
263119|NCT00972595|636841|P1|STARTED|Period 1||23
263120|NCT00972543|636851|P2|NOT COMPLETED|Overall Study||1
263121|NCT00972543|636852|P1|NOT COMPLETED|Overall Study||5
263122|NCT00972543|636851|P2|COMPLETED|Overall Study||0
263123|NCT00972543|636852|P1|COMPLETED|Overall Study||0
263124|NCT00972543|636851|P2|STARTED|Overall Study||1
263125|NCT00972543|636852|P1|STARTED|Overall Study||5
263126|NCT00972530|636928|P2|NOT COMPLETED|Overall Study||0
263127|NCT00972530|636929|P1|NOT COMPLETED|Overall Study||0
263128|NCT00972530|636928|P2|COMPLETED|Overall Study||46
263129|NCT00972530|636929|P1|COMPLETED|Overall Study||44
263130|NCT00972530|636928|P2|STARTED|Overall Study||46
263131|NCT00972530|636929|P1|STARTED|Overall Study||44
263132|NCT00972517|636935|P6|NOT COMPLETED|Overall Study||0
263133|NCT00972517|636936|P5|NOT COMPLETED|Overall Study||1
263134|NCT00972517|636937|P4|NOT COMPLETED|Overall Study||3
263135|NCT00972517|636938|P3|NOT COMPLETED|Overall Study||0
263136|NCT00972517|636939|P2|NOT COMPLETED|Overall Study||1
263137|NCT00972517|636940|P1|NOT COMPLETED|Overall Study||0
263138|NCT00972517|636935|P6|COMPLETED|Overall Study||58
263139|NCT00972517|636936|P5|COMPLETED|Overall Study||33
263140|NCT00972517|636937|P4|COMPLETED|Overall Study||27
263141|NCT00972517|636938|P3|COMPLETED|Overall Study||60
263142|NCT00972517|636939|P2|COMPLETED|Overall Study||30
263143|NCT00972517|636940|P1|COMPLETED|Overall Study||31
263144|NCT00972517|636935|P6|STARTED|Overall Study||58
263145|NCT00972517|636936|P5|STARTED|Overall Study||34
263146|NCT00972517|636937|P4|STARTED|Overall Study||30
263147|NCT00972517|636938|P3|STARTED|Overall Study||60
263148|NCT00972517|636939|P2|STARTED|Overall Study||31
263149|NCT00972517|636940|P1|STARTED|Overall Study||31
263150|NCT00972504|637035|P1|NOT COMPLETED|Overall Study||3
263151|NCT00972504|637035|P1|COMPLETED|Overall Study||51
263152|NCT00972504|637035|P1|STARTED|Overall Study||54
263153|NCT00972478|637067|P2|NOT COMPLETED|Overall Study||38
263154|NCT00972478|637068|P1|NOT COMPLETED|Overall Study||7
263155|NCT00972478|637067|P2|COMPLETED|Overall Study||34
263156|NCT00972478|637068|P1|COMPLETED|Overall Study||4
263157|NCT00972478|637067|P2|Eligible and Began Protocol Therapy|Overall Study||63
263158|NCT00972478|637068|P1|Eligible and Began Protocol Therapy|Overall Study||9
263159|NCT00972478|637067|P2|STARTED|Overall Study||72
263160|NCT00972478|637068|P1|STARTED|Overall Study||11
263161|NCT00972439|637080|P2|NOT COMPLETED|Overall Study||0
263162|NCT00972439|637081|P1|NOT COMPLETED|Overall Study||0
263163|NCT00972439|637080|P2|COMPLETED|Overall Study||16
263164|NCT00972439|637081|P1|COMPLETED|Overall Study||17
263165|NCT00972439|637080|P2|STARTED|Overall Study||16
263166|NCT00972439|637081|P1|STARTED|Overall Study||17
263167|NCT00972374|637090|P3|NOT COMPLETED|Overall Study||1
263168|NCT00972374|637091|P2|NOT COMPLETED|Overall Study||0
263169|NCT00972374|637092|P1|NOT COMPLETED|Overall Study||2
263170|NCT00972374|637090|P3|COMPLETED|Overall Study||13
263171|NCT00972374|637091|P2|COMPLETED|Overall Study||15
263172|NCT00972374|637092|P1|COMPLETED|Overall Study||13
263173|NCT00972374|637090|P3|STARTED|Overall Study||14
263174|NCT00972374|637091|P2|STARTED|Overall Study||15
263175|NCT00972374|637092|P1|STARTED|Overall Study||15
263176|NCT00972335|637106|P1|NOT COMPLETED|Overall Study||17
263177|NCT00972335|637106|P1|COMPLETED|Overall Study|Patients were on study until an event or condition occured which required them to come off study|0
263178|NCT00972335|637106|P1|STARTED|Overall Study|One patient was enrolled but showed no evidence of disease at study entry and was not treated|17
263179|NCT00972322|637113|P2|NOT COMPLETED|Overall Study||3
263180|NCT00972322|637114|P1|NOT COMPLETED|Overall Study||3
263181|NCT00972322|637113|P2|COMPLETED|Overall Study||25
263182|NCT00972322|637114|P1|COMPLETED|Overall Study||25
263183|NCT00972322|637113|P2|STARTED|Overall Study||28
263184|NCT00972322|637114|P1|STARTED|Overall Study||28
263185|NCT00972283|637126|P2|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||8
263186|NCT00972283|637127|P1|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||27
263187|NCT00972283|637126|P2|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||183
263188|NCT00972283|637127|P1|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||539
263189|NCT00972283|637126|P2|STARTED|Extension: Week 53 to 78 (NN1250-3667)|20 subjects did not continue into the extension from main trial|191
263190|NCT00972283|637127|P1|STARTED|Extension: Week 53 to 78 (NN1250-3667)|52 subjects did not continue into the extension from main trial|566
263191|NCT00972283|637126|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||40
263192|NCT00972283|637127|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||137
263193|NCT00972283|637126|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||211
263194|NCT00972283|637127|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||618
263195|NCT00972283|637126|P2|Exposed|Main: Week 0 to 52 (NN1250-3582)||251
263196|NCT00972283|637127|P1|Exposed|Main: Week 0 to 52 (NN1250-3582)|2 subjects were withdrawn prior to exposure to trial products|753
263197|NCT00972283|637126|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|3 subjects were excluded due to closure of a site|248
263198|NCT00972283|637127|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|11 subjects were excluded due to closure of a site|744
263199|NCT00972283|637126|P2|STARTED|Main: Week 0 to 52 (NN1250-3582)||251
263200|NCT00972283|637127|P1|STARTED|Main: Week 0 to 52 (NN1250-3582)||755
263201|NCT00972244|637154|P5|NOT COMPLETED|Overall Study||9
263202|NCT00972244|637155|P4|NOT COMPLETED|Overall Study||0
263203|NCT00972244|637156|P3|NOT COMPLETED|Overall Study||2
263204|NCT00972244|637157|P2|NOT COMPLETED|Overall Study||5
263205|NCT00972244|637158|P1|NOT COMPLETED|Overall Study||5
263206|NCT00972244|637154|P5|COMPLETED|Overall Study||45
263207|NCT00972244|637155|P4|COMPLETED|Overall Study||52
263208|NCT00972244|637156|P3|COMPLETED|Overall Study||56
263209|NCT00972244|637157|P2|COMPLETED|Overall Study||51
263210|NCT00972244|637158|P1|COMPLETED|Overall Study||54
263211|NCT00972244|637154|P5|STARTED|Overall Study||54
263212|NCT00972244|637155|P4|STARTED|Overall Study||52
263213|NCT00972244|637156|P3|STARTED|Overall Study||58
263214|NCT00972244|637157|P2|STARTED|Overall Study||56
263215|NCT00972244|637158|P1|STARTED|Overall Study||59
263216|NCT00972205|637180|P1|NOT COMPLETED|Overall Study||0
263217|NCT00972205|637180|P1|COMPLETED|Overall Study||12
263218|NCT00972205|637180|P1|STARTED|Overall Study||12
263219|NCT00972153|637190|P3|NOT COMPLETED|Overall Study||0
263220|NCT00972153|637191|P2|NOT COMPLETED|Overall Study||1
263221|NCT00972153|637192|P1|NOT COMPLETED|Overall Study||0
263222|NCT00972153|637190|P3|COMPLETED|Overall Study||12
263223|NCT00972153|637191|P2|COMPLETED|Overall Study|One case excluded due to technical problem with measuring equipment.|11
263224|NCT00972153|637192|P1|COMPLETED|Overall Study||12
263225|NCT00972153|637190|P3|STARTED|Overall Study||12
263226|NCT00972153|637191|P2|STARTED|Overall Study||12
263227|NCT00972153|637192|P1|STARTED|Overall Study||12
263228|NCT00972088|637203|P1|NOT COMPLETED|Overall Study||0
263229|NCT00972088|637203|P1|COMPLETED|Overall Study||26
263230|NCT00972088|637203|P1|STARTED|Overall Study||26
263231|NCT00972023|637207|P1|NOT COMPLETED|Overall Study||1
263232|NCT00972023|637207|P1|COMPLETED|Overall Study||0
263233|NCT00972023|637207|P1|STARTED|Overall Study||1
263234|NCT00971997|637214|P1|NOT COMPLETED|Overall Study||19
263235|NCT00971997|637214|P1|COMPLETED|Overall Study||116
263236|NCT00971997|637214|P1|STARTED|Overall Study||135
263237|NCT00971932|637232|P1|NOT COMPLETED|Overall Study||7
263238|NCT00971932|637232|P1|COMPLETED|Overall Study||26
263239|NCT00971932|637232|P1|STARTED|Overall Study|Number of participants treated.|33
263240|NCT00971841|637242|P1|NOT COMPLETED|Overall Study||0
263241|NCT00971841|637242|P1|COMPLETED|Overall Study||1
263242|NCT00971841|637242|P1|STARTED|Overall Study||1
263243|NCT00971789|637247|P1|NOT COMPLETED|Overall Study||0
263244|NCT00971789|637247|P1|COMPLETED|Overall Study||18
263245|NCT00971789|637247|P1|STARTED|Overall Study||18
263246|NCT00971750|637252|P1|NOT COMPLETED|Overall Study||0
263247|NCT00971750|637252|P1|COMPLETED|Overall Study||253
263248|NCT00971750|637252|P1|STARTED|Overall Study||253
263249|NCT00971737|637263|P2|NOT COMPLETED|Overall Study||0
263250|NCT00971737|637264|P1|NOT COMPLETED|Overall Study||0
263251|NCT00971737|637263|P2|COMPLETED|Overall Study||30
263252|NCT00971737|637264|P1|COMPLETED|Overall Study||30
263253|NCT00971737|637263|P2|STARTED|Overall Study||30
263254|NCT00971737|637264|P1|STARTED|Overall Study||30
263255|NCT00971633|637282|P6|NOT COMPLETED|Period 3||0
263256|NCT00971633|637283|P5|NOT COMPLETED|Period 3||0
263257|NCT00971633|637284|P4|NOT COMPLETED|Period 3||0
263258|NCT00971633|637285|P3|NOT COMPLETED|Period 3||0
263259|NCT00971633|637286|P2|NOT COMPLETED|Period 3||0
263260|NCT00971633|637287|P1|NOT COMPLETED|Period 3||0
263261|NCT00971633|637282|P6|COMPLETED|Period 3||2
263262|NCT00971633|637283|P5|COMPLETED|Period 3||2
263263|NCT00971633|637284|P4|COMPLETED|Period 3||2
263264|NCT00971633|637285|P3|COMPLETED|Period 3||2
263265|NCT00971633|637286|P2|COMPLETED|Period 3||2
263266|NCT00971633|637287|P1|COMPLETED|Period 3||2
263267|NCT00971633|637282|P6|STARTED|Period 3||2
263268|NCT00971633|637283|P5|STARTED|Period 3||2
263269|NCT00971633|637284|P4|STARTED|Period 3||2
263270|NCT00971633|637285|P3|STARTED|Period 3||2
263271|NCT00971633|637286|P2|STARTED|Period 3||2
263272|NCT00971633|637287|P1|STARTED|Period 3||2
263273|NCT00971633|637282|P6|NOT COMPLETED|Period 2||0
263274|NCT00971633|637283|P5|NOT COMPLETED|Period 2||0
263275|NCT00971633|637284|P4|NOT COMPLETED|Period 2||0
263276|NCT00971633|637285|P3|NOT COMPLETED|Period 2||0
263277|NCT00971633|637286|P2|NOT COMPLETED|Period 2||0
263278|NCT00971633|637287|P1|NOT COMPLETED|Period 2||0
263279|NCT00971633|637282|P6|COMPLETED|Period 2||2
263280|NCT00971633|637283|P5|COMPLETED|Period 2||2
263281|NCT00971633|637284|P4|COMPLETED|Period 2||2
263282|NCT00971633|637285|P3|COMPLETED|Period 2||2
263283|NCT00971633|637286|P2|COMPLETED|Period 2||2
263284|NCT00971633|637287|P1|COMPLETED|Period 2||2
263285|NCT00971633|637282|P6|STARTED|Period 2||2
263286|NCT00971633|637283|P5|STARTED|Period 2||2
263287|NCT00971633|637284|P4|STARTED|Period 2||2
263288|NCT00971633|637285|P3|STARTED|Period 2||2
263289|NCT00971633|637286|P2|STARTED|Period 2||2
263290|NCT00971633|637287|P1|STARTED|Period 2||2
263291|NCT00971633|637282|P6|NOT COMPLETED|Period 1||0
263292|NCT00971633|637283|P5|NOT COMPLETED|Period 1||0
263293|NCT00971633|637284|P4|NOT COMPLETED|Period 1||0
263294|NCT00971633|637285|P3|NOT COMPLETED|Period 1||0
263295|NCT00971633|637286|P2|NOT COMPLETED|Period 1||0
263296|NCT00971633|637287|P1|NOT COMPLETED|Period 1||0
263297|NCT00971633|637282|P6|COMPLETED|Period 1||2
263298|NCT00971633|637283|P5|COMPLETED|Period 1||2
263299|NCT00971633|637284|P4|COMPLETED|Period 1||2
263300|NCT00971633|637285|P3|COMPLETED|Period 1||2
263301|NCT00971633|637286|P2|COMPLETED|Period 1||2
263302|NCT00971633|637287|P1|COMPLETED|Period 1||2
263303|NCT00971633|637282|P6|STARTED|Period 1||2
263304|NCT00971633|637283|P5|STARTED|Period 1||2
263305|NCT00971633|637284|P4|STARTED|Period 1||2
263306|NCT00971633|637285|P3|STARTED|Period 1||2
263307|NCT00971633|637286|P2|STARTED|Period 1||2
263308|NCT00971633|637287|P1|STARTED|Period 1||2
263309|NCT00971620|637300|P2|NOT COMPLETED|Overall Study||0
263310|NCT00971620|637301|P1|NOT COMPLETED|Overall Study||0
263311|NCT00971620|637300|P2|COMPLETED|Overall Study||9
263312|NCT00971620|637301|P1|COMPLETED|Overall Study||9
263313|NCT00971620|637300|P2|STARTED|Overall Study||9
263314|NCT00971620|637301|P1|STARTED|Overall Study||9
263315|NCT00971425|637333|P2|NOT COMPLETED|Overall Study||2
263316|NCT00971425|637334|P1|NOT COMPLETED|Overall Study||1
263317|NCT00971425|637333|P2|COMPLETED|Overall Study||71
263318|NCT00971425|637334|P1|COMPLETED|Overall Study||71
263319|NCT00971425|637333|P2|STARTED|Overall Study||73
263320|NCT00971425|637334|P1|STARTED|Overall Study||72
263321|NCT00971321|637370|P2|NOT COMPLETED|Up to Month 11-12||3
263322|NCT00971321|637371|P1|NOT COMPLETED|Up to Month 11-12||5
263323|NCT00971321|637370|P2|COMPLETED|Up to Month 11-12||50
263324|NCT00971321|637371|P1|COMPLETED|Up to Month 11-12||99
263325|NCT00971321|637370|P2|STARTED|Up to Month 11-12||53
263326|NCT00971321|637371|P1|STARTED|Up to Month 11-12||104
263327|NCT00971321|637370|P2|NOT COMPLETED|Up to Month 7||2
263328|NCT00971321|637371|P1|NOT COMPLETED|Up to Month 7||4
263329|NCT00971321|637370|P2|COMPLETED|Up to Month 7||51
263330|NCT00971321|637371|P1|COMPLETED|Up to Month 7||100
263331|NCT00971321|637370|P2|STARTED|Up to Month 7||53
263332|NCT00971321|637371|P1|STARTED|Up to Month 7||104
263333|NCT00971321|637370|P2|NOT COMPLETED|Up to Day 42||0
263334|NCT00971321|637371|P1|NOT COMPLETED|Up to Day 42||0
263335|NCT00971321|637370|P2|COMPLETED|Up to Day 42||53
263336|NCT00971321|637371|P1|COMPLETED|Up to Day 42||104
263337|NCT00971321|637370|P2|STARTED|Up to Day 42||53
263338|NCT00971321|637371|P1|STARTED|Up to Day 42||104
263339|NCT00971295|637421|P2|NOT COMPLETED|Overall Study||1
263340|NCT00971295|637422|P1|NOT COMPLETED|Overall Study||0
263341|NCT00971295|637421|P2|COMPLETED|Overall Study||9
263342|NCT00971295|637422|P1|COMPLETED|Overall Study||10
263343|NCT00971295|637421|P2|STARTED|Overall Study||10
263344|NCT00971295|637422|P1|STARTED|Overall Study||10
263345|NCT00971282|637432|P1|NOT COMPLETED|Overall Study||0
263346|NCT00971282|637432|P1|COMPLETED|Overall Study||30
263347|NCT00971282|637432|P1|STARTED|Overall Study||30
263348|NCT00971243|637451|P5|NOT COMPLETED|Open-label Period||6
263349|NCT00971243|637452|P4|NOT COMPLETED|Open-label Period||10
263350|NCT00971243|637453|P3|NOT COMPLETED|Open-label Period||5
263351|NCT00971243|637454|P2|NOT COMPLETED|Open-label Period||10
263352|NCT00971243|637455|P1|NOT COMPLETED|Open-label Period||8
263353|NCT00971243|637451|P5|COMPLETED|Open-label Period||64
263354|NCT00971243|637452|P4|COMPLETED|Open-label Period||64
263355|NCT00971243|637453|P3|COMPLETED|Open-label Period||66
263356|NCT00971243|637454|P2|COMPLETED|Open-label Period||71
263357|NCT00971243|637455|P1|COMPLETED|Open-label Period||60
263358|NCT00971243|637451|P5|STARTED|Open-label Period||70
263359|NCT00971243|637452|P4|STARTED|Open-label Period||74
263360|NCT00971243|637453|P3|STARTED|Open-label Period|One Subject did not entered the Open-label Period because of the withdrawal of consent.|71
263361|NCT00971243|637454|P2|STARTED|Open-label Period|One Subject did not entered because of the failure of inclusion/exclusion criteria.|81
263362|NCT00971243|637455|P1|STARTED|Open-label Period||68
263363|NCT00971243|637451|P5|NOT COMPLETED|Double Blind Period||18
263364|NCT00971243|637452|P4|NOT COMPLETED|Double Blind Period||14
263365|NCT00971243|637453|P3|NOT COMPLETED|Double Blind Period||19
263366|NCT00971243|637454|P2|NOT COMPLETED|Double Blind Period||11
263367|NCT00971243|637455|P1|NOT COMPLETED|Double Blind Period||19
263368|NCT00971243|637451|P5|COMPLETED|Double Blind Period||70
263369|NCT00971243|637452|P4|COMPLETED|Double Blind Period||74
263370|NCT00971243|637453|P3|COMPLETED|Double Blind Period||72
263371|NCT00971243|637454|P2|COMPLETED|Double Blind Period||82
263372|NCT00971243|637455|P1|COMPLETED|Double Blind Period||68
263373|NCT00971243|637451|P5|STARTED|Double Blind Period||88
263374|NCT00971243|637452|P4|STARTED|Double Blind Period|One subject who did not receive any study drug was excluded from the ITT|88
263375|NCT00971243|637453|P3|STARTED|Double Blind Period||91
263376|NCT00971243|637454|P2|STARTED|Double Blind Period||93
263377|NCT00971243|637455|P1|STARTED|Double Blind Period||87
263378|NCT00971204|637472|P1|NOT COMPLETED|Overall Study||24
263379|NCT00971204|637472|P1|COMPLETED|Overall Study|86 participants were treated and of these 86, 76 completed the study.|76
263380|NCT00971204|637472|P1|Treated|Overall Study||86
263381|NCT00971204|637472|P1|STARTED|Overall Study|100 enrolled participants|100
263382|NCT00971048|637480|P4|NOT COMPLETED|Overall Study||2
263383|NCT00971048|637481|P3|NOT COMPLETED|Overall Study||1
263384|NCT00971048|637482|P2|NOT COMPLETED|Overall Study||2
263385|NCT00971048|637483|P1|NOT COMPLETED|Overall Study||1
263386|NCT00971048|637480|P4|COMPLETED|Overall Study||11
263387|NCT00971048|637481|P3|COMPLETED|Overall Study||11
263388|NCT00971048|637482|P2|COMPLETED|Overall Study||31
263389|NCT00971048|637483|P1|COMPLETED|Overall Study||29
263390|NCT00971048|637480|P4|STARTED|Overall Study||13
263391|NCT00971048|637481|P3|STARTED|Overall Study||12
263392|NCT00971048|637482|P2|STARTED|Overall Study||33
263393|NCT00971048|637483|P1|STARTED|Overall Study||30
263394|NCT00970944|637507|P2|NOT COMPLETED|Overall Study||2
263395|NCT00970944|637508|P1|NOT COMPLETED|Overall Study||1
263396|NCT00970944|637507|P2|COMPLETED|Overall Study||95
263397|NCT00970944|637508|P1|COMPLETED|Overall Study||86
263398|NCT00970944|637507|P2|STARTED|Overall Study||97
263399|NCT00970944|637508|P1|STARTED|Overall Study||87
263400|NCT00970853|637518|P2|NOT COMPLETED|Overall Study||0
263401|NCT00970853|637519|P1|NOT COMPLETED|Overall Study||0
263402|NCT00970853|637518|P2|COMPLETED|Overall Study||98
263403|NCT00970853|637519|P1|COMPLETED|Overall Study||89
263404|NCT00970853|637518|P2|STARTED|Overall Study||98
263405|NCT00970853|637519|P1|STARTED|Overall Study||89
263406|NCT00970814|637543|P2|NOT COMPLETED|Overall Study||14
263407|NCT00970814|637544|P1|NOT COMPLETED|Overall Study||8
263408|NCT00970814|637543|P2|COMPLETED|Overall Study||50
263409|NCT00970814|637544|P1|COMPLETED|Overall Study||58
263410|NCT00970814|637543|P2|STARTED|Overall Study||64
263411|NCT00970814|637544|P1|STARTED|Overall Study||66
263412|NCT00970736|637554|P1|NOT COMPLETED|Overall Study||2
263413|NCT00970736|637554|P1|COMPLETED|Overall Study||18
263414|NCT00970736|637554|P1|STARTED|Overall Study||20
263415|NCT00970684|637560|P1|NOT COMPLETED|Overall Study||10
263416|NCT00970684|637560|P1|COMPLETED|Overall Study||3
263417|NCT00970684|637560|P1|STARTED|Overall Study||13
263418|NCT00970632|637569|P3|NOT COMPLETED|Overall Study||18
263419|NCT00970632|637570|P2|NOT COMPLETED|Overall Study||15
263420|NCT00970632|637571|P1|NOT COMPLETED|Overall Study||24
263421|NCT00970632|637569|P3|COMPLETED|Overall Study||150
263422|NCT00970632|637570|P2|COMPLETED|Overall Study||156
263423|NCT00970632|637571|P1|COMPLETED|Overall Study||148
263424|NCT00970632|637569|P3|STARTED|Overall Study||168
263425|NCT00970632|637570|P2|STARTED|Overall Study||171
263426|NCT00970632|637571|P1|STARTED|Overall Study||172
263427|NCT00970606|637629|P2|NOT COMPLETED|Overall Study||0
263428|NCT00970606|637630|P1|NOT COMPLETED|Overall Study||0
263429|NCT00970606|637629|P2|COMPLETED|Overall Study||3
263430|NCT00970606|637630|P1|COMPLETED|Overall Study||4
263431|NCT00970606|637629|P2|STARTED|Overall Study||3
263432|NCT00970606|637630|P1|STARTED|Overall Study||4
263433|NCT00970502|637636|P1|NOT COMPLETED|Overall Study||1
263434|NCT00970502|637636|P1|COMPLETED|Overall Study||14
263435|NCT00970502|637636|P1|STARTED|Overall Study||15
263436|NCT00970489|637647|P2|NOT COMPLETED|Overall Study||41
263437|NCT00970489|637648|P1|NOT COMPLETED|Overall Study||54
263438|NCT00970489|637647|P2|COMPLETED|Overall Study||717
263439|NCT00970489|637648|P1|COMPLETED|Overall Study||704
263440|NCT00970489|637647|P2|STARTED|Overall Study||758
263441|NCT00970489|637648|P1|STARTED|Overall Study||758
263442|NCT00970359|637660|P1|NOT COMPLETED|Overall Study||4
263443|NCT00970359|637660|P1|COMPLETED|Overall Study||20
263444|NCT00970359|637660|P1|STARTED|Overall Study||24
263445|NCT00970320|637671|P5|NOT COMPLETED|Overall Study||540
263446|NCT00970320|637672|P4|NOT COMPLETED|Overall Study||14
263447|NCT00970320|637673|P3|NOT COMPLETED|Overall Study||13
263448|NCT00970320|637674|P2|NOT COMPLETED|Overall Study||11
263449|NCT00970320|637675|P1|NOT COMPLETED|Overall Study||0
263450|NCT00970320|637671|P5|COMPLETED|Overall Study||1031
263451|NCT00970320|637672|P4|COMPLETED|Overall Study||36
263452|NCT00970320|637673|P3|COMPLETED|Overall Study||35
263453|NCT00970320|637674|P2|COMPLETED|Overall Study||13
263454|NCT00970320|637675|P1|COMPLETED|Overall Study||25
263455|NCT00970320|637671|P5|STARTED|Overall Study||1571
263456|NCT00970320|637672|P4|STARTED|Overall Study||50
263457|NCT00970320|637673|P3|STARTED|Overall Study||48
263458|NCT00970320|637674|P2|STARTED|Overall Study||24
263459|NCT00970320|637675|P1|STARTED|Overall Study||25
263460|NCT00970307|637690|P3|NOT COMPLETED|Overall Study||2
263461|NCT00970307|637691|P2|NOT COMPLETED|Overall Study||3
263462|NCT00970307|637692|P1|NOT COMPLETED|Overall Study||3
263463|NCT00970307|637690|P3|COMPLETED|Overall Study||139
263464|NCT00970307|637691|P2|COMPLETED|Overall Study||136
263465|NCT00970307|637692|P1|COMPLETED|Overall Study||138
263466|NCT00970307|637690|P3|STARTED|Overall Study||141
263467|NCT00970307|637691|P2|STARTED|Overall Study||139
263468|NCT00970307|637692|P1|STARTED|Overall Study||141
263469|NCT00970294|637766|P1|NOT COMPLETED|Overall Study||5
263470|NCT00970294|637766|P1|COMPLETED|Overall Study||6
263471|NCT00970294|637766|P1|STARTED|Overall Study||11
263472|NCT00970281|637774|P2|NOT COMPLETED|Overall Study||16
263473|NCT00970281|637775|P1|NOT COMPLETED|Overall Study||2
263474|NCT00970281|637774|P2|COMPLETED|Overall Study||29
263475|NCT00970281|637775|P1|COMPLETED|Overall Study||44
263476|NCT00970281|637774|P2|Full Analysis Set|Overall Study||45
263477|NCT00970281|637775|P1|Full Analysis Set|Overall Study|1 participant in the olanzapine arm discontinued before the first intramuscular (IM) injection.|45
263478|NCT00970281|637774|P2|STARTED|Overall Study||45
263479|NCT00970281|637775|P1|STARTED|Overall Study||46
263480|NCT00970268|637793|P2|NOT COMPLETED|Overall Study||49
263481|NCT00970268|637794|P1|NOT COMPLETED|Overall Study||43
263482|NCT00970268|637793|P2|COMPLETED|Overall Study||103
263483|NCT00970268|637794|P1|COMPLETED|Overall Study||96
263484|NCT00970268|637793|P2|STARTED|Overall Study||152
263485|NCT00970268|637794|P1|STARTED|Overall Study||139
263486|NCT00970216|637808|P1|NOT COMPLETED|Overall Study||80
263487|NCT00970216|637808|P1|COMPLETED|Overall Study||80
263488|NCT00970216|637808|P1|STARTED|Overall Study||160
263489|NCT00970073|637815|P3|NOT COMPLETED|Overall Study||0
263490|NCT00970073|637816|P2|NOT COMPLETED|Overall Study||0
263491|NCT00970073|637817|P1|NOT COMPLETED|Overall Study||0
263492|NCT00970073|637815|P3|COMPLETED|Overall Study||10
263493|NCT00970073|637816|P2|COMPLETED|Overall Study||10
263494|NCT00970073|637817|P1|COMPLETED|Overall Study||10
263495|NCT00970073|637815|P3|STARTED|Overall Study||10
263496|NCT00970073|637816|P2|STARTED|Overall Study||10
263497|NCT00970073|637817|P1|STARTED|Overall Study||10
263498|NCT00969878|637836|P2|NOT COMPLETED|Overall Study||26
263499|NCT00969878|637837|P1|NOT COMPLETED|Overall Study||30
263500|NCT00969878|637836|P2|COMPLETED|Overall Study||126
263501|NCT00969878|637837|P1|COMPLETED|Overall Study||118
263502|NCT00969878|637836|P2|STARTED|Overall Study||152
263503|NCT00969878|637837|P1|STARTED|Overall Study||148
263504|NCT00969761|637857|P12|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
263505|NCT00969761|637858|P11|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
263506|NCT00969761|637859|P10|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||2
263507|NCT00969761|637860|P9|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||11
263508|NCT00969761|637861|P8|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||6
263509|NCT00969761|637862|P7|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
263510|NCT00969761|637863|P6|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
263511|NCT00969761|637864|P5|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
263512|NCT00969761|637865|P4|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||5
263513|NCT00969761|637866|P3|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||10
263514|NCT00969761|637867|P2|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
263515|NCT00969761|637868|P1|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||2
263516|NCT00969761|637857|P12|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
263517|NCT00969761|637858|P11|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
263518|NCT00969761|637859|P10|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
263519|NCT00969761|637860|P9|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
263520|NCT00969761|637861|P8|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
263521|NCT00969761|637862|P7|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
263522|NCT00969761|637863|P6|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
263523|NCT00969761|637864|P5|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
263524|NCT00969761|637865|P4|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
263525|NCT00969761|637866|P3|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
263526|NCT00969761|637867|P2|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
263527|NCT00969761|637868|P1|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
263528|NCT00969761|637857|P12|STARTED|Treated in and Beyond Treat. Cycle 2||3
263529|NCT00969761|637858|P11|STARTED|Treated in and Beyond Treat. Cycle 2||3
263530|NCT00969761|637859|P10|STARTED|Treated in and Beyond Treat. Cycle 2||2
263531|NCT00969761|637860|P9|STARTED|Treated in and Beyond Treat. Cycle 2||11
263532|NCT00969761|637861|P8|STARTED|Treated in and Beyond Treat. Cycle 2||6
263533|NCT00969761|637862|P7|STARTED|Treated in and Beyond Treat. Cycle 2||3
263534|NCT00969761|637863|P6|STARTED|Treated in and Beyond Treat. Cycle 2||3
263535|NCT00969761|637864|P5|STARTED|Treated in and Beyond Treat. Cycle 2||3
263536|NCT00969761|637865|P4|STARTED|Treated in and Beyond Treat. Cycle 2||5
263537|NCT00969761|637866|P3|STARTED|Treated in and Beyond Treat. Cycle 2||10
263538|NCT00969761|637867|P2|STARTED|Treated in and Beyond Treat. Cycle 2||3
263539|NCT00969761|637868|P1|STARTED|Treated in and Beyond Treat. Cycle 2||2
263540|NCT00969761|637857|P12|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
263541|NCT00969761|637858|P11|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
263542|NCT00969761|637859|P10|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
263543|NCT00969761|637860|P9|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||2
263544|NCT00969761|637861|P8|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
263545|NCT00969761|637862|P7|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
263546|NCT00969761|637863|P6|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
263547|NCT00969761|637864|P5|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
263548|NCT00969761|637865|P4|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
263549|NCT00969761|637866|P3|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||2
263550|NCT00969761|637867|P2|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
263551|NCT00969761|637868|P1|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
263552|NCT00969761|637857|P12|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
263553|NCT00969761|637858|P11|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
263554|NCT00969761|637859|P10|COMPLETED|Discont. Before Start of Treat. Cycle 2||2
263555|NCT00969761|637860|P9|COMPLETED|Discont. Before Start of Treat. Cycle 2||11
263556|NCT00969761|637861|P8|COMPLETED|Discont. Before Start of Treat. Cycle 2||6
263557|NCT00969761|637862|P7|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
263558|NCT00969761|637863|P6|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
263559|NCT00969761|637864|P5|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
263560|NCT00969761|637865|P4|COMPLETED|Discont. Before Start of Treat. Cycle 2||5
263561|NCT00969761|637866|P3|COMPLETED|Discont. Before Start of Treat. Cycle 2||10
263562|NCT00969761|637867|P2|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
263563|NCT00969761|637868|P1|COMPLETED|Discont. Before Start of Treat. Cycle 2||2
263564|NCT00969761|637857|P12|STARTED|Discont. Before Start of Treat. Cycle 2||3
263565|NCT00969761|637858|P11|STARTED|Discont. Before Start of Treat. Cycle 2||3
263566|NCT00969761|637859|P10|STARTED|Discont. Before Start of Treat. Cycle 2||3
263567|NCT00969761|637860|P9|STARTED|Discont. Before Start of Treat. Cycle 2||13
263568|NCT00969761|637861|P8|STARTED|Discont. Before Start of Treat. Cycle 2||6
263569|NCT00969761|637862|P7|STARTED|Discont. Before Start of Treat. Cycle 2||3
263570|NCT00969761|637863|P6|STARTED|Discont. Before Start of Treat. Cycle 2||3
263571|NCT00969761|637864|P5|STARTED|Discont. Before Start of Treat. Cycle 2||3
263572|NCT00969761|637865|P4|STARTED|Discont. Before Start of Treat. Cycle 2||6
263573|NCT00969761|637866|P3|STARTED|Discont. Before Start of Treat. Cycle 2||12
263574|NCT00969761|637867|P2|STARTED|Discont. Before Start of Treat. Cycle 2||3
263575|NCT00969761|637868|P1|STARTED|Discont. Before Start of Treat. Cycle 2||3
263576|NCT00969709|638174|P4|NOT COMPLETED|Overall Study||63
263577|NCT00969709|638175|P3|NOT COMPLETED|Overall Study||58
263578|NCT00969709|638176|P2|NOT COMPLETED|Overall Study||48
263579|NCT00969709|638177|P1|NOT COMPLETED|Overall Study||38
263580|NCT00969709|638174|P4|COMPLETED|Overall Study||117
263581|NCT00969709|638175|P3|COMPLETED|Overall Study||121
263582|NCT00969709|638176|P2|COMPLETED|Overall Study||130
263583|NCT00969709|638177|P1|COMPLETED|Overall Study||138
263584|NCT00969709|638174|P4|STARTED|Overall Study||180
263585|NCT00969709|638175|P3|STARTED|Overall Study||179
263586|NCT00969709|638176|P2|STARTED|Overall Study||178
263587|NCT00969709|638177|P1|STARTED|Overall Study||176
263588|NCT00969618|638191|P1|NOT COMPLETED|Overall Study||78
263589|NCT00969618|638191|P1|COMPLETED|Overall Study||133
263590|NCT00969618|638191|P1|STARTED|Overall Study||211
263591|NCT00969553|638211|P9|NOT COMPLETED|Overall Study||3
263592|NCT00969553|638212|P8|NOT COMPLETED|Overall Study||14
263593|NCT00969553|638213|P7|NOT COMPLETED|Overall Study||4
263594|NCT00969553|638214|P6|NOT COMPLETED|Overall Study||4
263595|NCT00969553|638215|P5|NOT COMPLETED|Overall Study||3
263596|NCT00969553|638216|P4|NOT COMPLETED|Overall Study||16
263597|NCT00969553|638217|P3|NOT COMPLETED|Overall Study||6
263598|NCT00969553|638218|P2|NOT COMPLETED|Overall Study||3
263599|NCT00969553|638219|P1|NOT COMPLETED|Overall Study||3
263600|NCT00969553|638211|P9|COMPLETED|Overall Study||0
263601|NCT00969553|638212|P8|COMPLETED|Overall Study|on-treatment at analysis data base lock date (27-Oct-2011)|2
263602|NCT00969553|638213|P7|COMPLETED|Overall Study||0
263603|NCT00969553|638214|P6|COMPLETED|Overall Study||0
263604|NCT00969553|638215|P5|COMPLETED|Overall Study||0
263605|NCT00969553|638216|P4|COMPLETED|Overall Study|on-treatment at analysis data base lock date (27-Oct-2011)|1
263606|NCT00969553|638217|P3|COMPLETED|Overall Study||0
263607|NCT00969553|638218|P2|COMPLETED|Overall Study||0
263608|NCT00969553|638219|P1|COMPLETED|Overall Study||0
263609|NCT00969553|638211|P9|STARTED|Overall Study||3
263610|NCT00969553|638212|P8|STARTED|Overall Study||16
263611|NCT00969553|638213|P7|STARTED|Overall Study||4
263612|NCT00969553|638214|P6|STARTED|Overall Study||4
263613|NCT00969553|638215|P5|STARTED|Overall Study||3
263614|NCT00969553|638216|P4|STARTED|Overall Study||17
263615|NCT00969553|638217|P3|STARTED|Overall Study||6
263616|NCT00969553|638218|P2|STARTED|Overall Study||3
263617|NCT00969553|638219|P1|STARTED|Overall Study||3
263618|NCT00969540|638362|P2|NOT COMPLETED|Overall Study||1
263619|NCT00969540|638363|P1|NOT COMPLETED|Overall Study||1
263620|NCT00969540|638362|P2|COMPLETED|Overall Study||3
263621|NCT00969540|638363|P1|COMPLETED|Overall Study||3
263622|NCT00969540|638362|P2|STARTED|Overall Study||4
263623|NCT00969540|638363|P1|STARTED|Overall Study||4
263624|NCT00969501|638381|P1|NOT COMPLETED|Overall Study||5
263625|NCT00969501|638381|P1|COMPLETED|Overall Study||27
263626|NCT00969501|638381|P1|STARTED|Overall Study||32
263627|NCT00969436|638388|P3|NOT COMPLETED|Overall Study||11
263628|NCT00969436|638389|P2|NOT COMPLETED|Overall Study||21
263629|NCT00969436|638390|P1|NOT COMPLETED|Overall Study||25
263630|NCT00969436|638388|P3|COMPLETED|Overall Study||79
263631|NCT00969436|638389|P2|COMPLETED|Overall Study||159
263632|NCT00969436|638390|P1|COMPLETED|Overall Study||155
263633|NCT00969436|638388|P3|STARTED|Overall Study||90
263634|NCT00969436|638389|P2|STARTED|Overall Study||180
263635|NCT00969436|638390|P1|STARTED|Overall Study||180
263636|NCT00969280|638424|P2|NOT COMPLETED|Overall Study||3
263637|NCT00969280|638425|P1|NOT COMPLETED|Overall Study||2
263638|NCT00969280|638424|P2|COMPLETED|Overall Study||18
263639|NCT00969280|638425|P1|COMPLETED|Overall Study||19
263640|NCT00969280|638424|P2|STARTED|Overall Study||21
263641|NCT00969280|638425|P1|STARTED|Overall Study||21
263642|NCT00969228|638433|P2|NOT COMPLETED|Overall Study||14
263643|NCT00969228|638434|P1|NOT COMPLETED|Overall Study||43
263644|NCT00969228|638433|P2|COMPLETED|Overall Study||162
263645|NCT00969228|638434|P1|COMPLETED|Overall Study||465
263646|NCT00969228|638433|P2|STARTED|Overall Study||176
263647|NCT00969228|638434|P1|STARTED|Overall Study||508
263648|NCT00969150|638452|P2|NOT COMPLETED|Overall Study||40
263649|NCT00969150|638453|P1|NOT COMPLETED|Overall Study||33
263650|NCT00969150|638452|P2|COMPLETED|Overall Study||135
263651|NCT00969150|638453|P1|COMPLETED|Overall Study||149
263652|NCT00969150|638452|P2|STARTED|Overall Study||175
263653|NCT00969150|638453|P1|STARTED|Overall Study||182
263654|NCT00969124|638461|P1|NOT COMPLETED|Overall Study||30
263655|NCT00969124|638461|P1|COMPLETED|Overall Study||298
263656|NCT00969124|638461|P1|STARTED|Overall Study||328
263657|NCT00968981|638470|P3|NOT COMPLETED|Overall Study||22
263658|NCT00968981|638471|P2|NOT COMPLETED|Overall Study||22
263659|NCT00968981|638472|P1|NOT COMPLETED|Overall Study||22
263660|NCT00968981|638470|P3|COMPLETED|Overall Study||0
263661|NCT00968981|638471|P2|COMPLETED|Overall Study||0
263662|NCT00968981|638472|P1|COMPLETED|Overall Study||1
263663|NCT00968981|638470|P3|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|22
263664|NCT00968981|638471|P2|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|21
263665|NCT00968981|638472|P1|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|20
263666|NCT00968981|638470|P3|STARTED|Overall Study||22
263667|NCT00968981|638471|P2|STARTED|Overall Study||22
263668|NCT00968981|638472|P1|STARTED|Overall Study||23
263669|NCT00968968|638510|P2|NOT COMPLETED|Overall Study||14
263670|NCT00968968|638511|P1|NOT COMPLETED|Overall Study||16
263671|NCT00968968|638510|P2|COMPLETED|Overall Study||3
263672|NCT00968968|638511|P1|COMPLETED|Overall Study||4
263673|NCT00968968|638510|P2|STARTED|Overall Study||17
263674|NCT00968968|638511|P1|STARTED|Overall Study||20
263675|NCT00968890|638528|P2|NOT COMPLETED|Overall Study||0
263676|NCT00968890|638529|P1|NOT COMPLETED|Overall Study||0
263677|NCT00968890|638528|P2|COMPLETED|Overall Study||84
263678|NCT00968890|638529|P1|COMPLETED|Overall Study||84
263679|NCT00968890|638528|P2|STARTED|Overall Study||84
263680|NCT00968890|638529|P1|STARTED|Overall Study||84
263681|NCT00968864|638557|P1|NOT COMPLETED|Overall Study||1
263682|NCT00968864|638557|P1|COMPLETED|Overall Study||52
263683|NCT00968864|638557|P1|STARTED|Overall Study|One patient, FDA and IRB approved to enroll as an exception, was not evaluable for study endpoints.|53
263684|NCT00968838|638575|P2|NOT COMPLETED|Overall Study||0
263685|NCT00968838|638576|P1|NOT COMPLETED|Overall Study||0
263686|NCT00968838|638575|P2|COMPLETED|Overall Study||58
263687|NCT00968838|638576|P1|COMPLETED|Overall Study||50
263688|NCT00968838|638575|P2|STARTED|Overall Study||58
263689|NCT00968838|638576|P1|STARTED|Overall Study||50
263690|NCT00968812|638585|P3|NOT COMPLETED|Overall Study||168
263691|NCT00968812|638586|P2|NOT COMPLETED|Overall Study||162
263692|NCT00968812|638587|P1|NOT COMPLETED|Overall Study||140
263693|NCT00968812|638585|P3|COMPLETED|Overall Study||314
263694|NCT00968812|638586|P2|COMPLETED|Overall Study||323
263695|NCT00968812|638587|P1|COMPLETED|Overall Study||343
263696|NCT00968812|638585|P3|STARTED|Overall Study||482
263697|NCT00968812|638586|P2|STARTED|Overall Study||485
263698|NCT00968812|638587|P1|STARTED|Overall Study||483
263699|NCT00968799|638607|P1|NOT COMPLETED|Overall Study||2
263700|NCT00968799|638607|P1|COMPLETED|Overall Study||4
263701|NCT00968799|638607|P1|STARTED|Overall Study||6
263702|NCT00968708|638617|P2|NOT COMPLETED|Overall Study||298
263703|NCT00968708|638618|P1|NOT COMPLETED|Overall Study||318
263704|NCT00968708|638617|P2|COMPLETED|Overall Study||2403
263705|NCT00968708|638618|P1|COMPLETED|Overall Study||2361
263706|NCT00968708|638617|P2|Treated|Overall Study||2698
263707|NCT00968708|638618|P1|Treated|Overall Study||2676
263708|NCT00968708|638617|P2|STARTED|Overall Study||2701
263709|NCT00968708|638618|P1|STARTED|Overall Study||2679
263710|NCT00968669|638630|P4|NOT COMPLETED|Overall Study||9
263711|NCT00968669|638631|P3|NOT COMPLETED|Overall Study||11
263712|NCT00968669|638632|P2|NOT COMPLETED|Overall Study||18
263713|NCT00968669|638633|P1|NOT COMPLETED|Overall Study||18
263714|NCT00968669|638630|P4|COMPLETED|Overall Study||72
263715|NCT00968669|638631|P3|COMPLETED|Overall Study||72
263716|NCT00968669|638632|P2|COMPLETED|Overall Study||63
263717|NCT00968669|638633|P1|COMPLETED|Overall Study||64
263718|NCT00968669|638630|P4|STARTED|Overall Study||81
263719|NCT00968669|638631|P3|STARTED|Overall Study||83
263720|NCT00968669|638632|P2|STARTED|Overall Study||81
263721|NCT00968669|638633|P1|STARTED|Overall Study||82
263722|NCT00968617|638723|P1|NOT COMPLETED|Overall Study||6
263723|NCT00968617|638723|P1|COMPLETED|Overall Study||1
263724|NCT00968617|638723|P1|STARTED|Overall Study||7
263725|NCT00968539|638737|P2|NOT COMPLETED|Overall Study||0
263726|NCT00968539|638738|P1|NOT COMPLETED|Overall Study||1
263727|NCT00968539|638737|P2|COMPLETED|Overall Study||66
263728|NCT00968539|638738|P1|COMPLETED|Overall Study||63
263729|NCT00968539|638737|P2|STARTED|Overall Study||66
263730|NCT00968539|638738|P1|STARTED|Overall Study||64
263731|NCT00968526|638798|P2|NOT COMPLETED|Overall Study||0
263732|NCT00968526|638799|P1|NOT COMPLETED|Overall Study||3
263733|NCT00968526|638798|P2|COMPLETED|Overall Study||102
263734|NCT00968526|638799|P1|COMPLETED|Overall Study||135
263735|NCT00968526|638798|P2|STARTED|Overall Study||102
263736|NCT00968526|638799|P1|STARTED|Overall Study||138
263737|NCT00968344|638891|P2|NOT COMPLETED|Overall Study||11
263738|NCT00968344|638892|P1|NOT COMPLETED|Overall Study||10
263739|NCT00968344|638891|P2|COMPLETED|Overall Study||9
263740|NCT00968344|638892|P1|COMPLETED|Overall Study||10
263741|NCT00968344|638891|P2|STARTED|Overall Study|Includes screen fails|20
263742|NCT00968344|638892|P1|STARTED|Overall Study|Includes screen fails|20
263743|NCT00968253|638901|P3|NOT COMPLETED|Overall Study||7
263744|NCT00968253|638902|P2|NOT COMPLETED|Overall Study||3
263745|NCT00968253|638903|P1|NOT COMPLETED|Overall Study||0
263746|NCT00968253|638901|P3|COMPLETED|Overall Study||5
263747|NCT00968253|638902|P2|COMPLETED|Overall Study||6
263748|NCT00968253|638903|P1|COMPLETED|Overall Study||3
263749|NCT00968253|638901|P3|STARTED|Overall Study||12
263750|NCT00968253|638902|P2|STARTED|Overall Study||9
263751|NCT00968253|638903|P1|STARTED|Overall Study||3
263752|NCT00968227|638917|P1|NOT COMPLETED|Overall Study||0
263753|NCT00968227|638917|P1|COMPLETED|Overall Study||56
263754|NCT00968227|638917|P1|STARTED|Overall Study||56
263755|NCT00968201|638924|P3|NOT COMPLETED|Extension Study - (Period III)||280
263756|NCT00968201|638925|P2|NOT COMPLETED|Extension Study - (Period III)||124
263757|NCT00968201|638926|P1|NOT COMPLETED|Extension Study - (Period III)||0
263758|NCT00968201|638924|P3|COMPLETED|Extension Study - (Period III)||84
263759|NCT00968201|638925|P2|COMPLETED|Extension Study - (Period III)||33
263760|NCT00968201|638926|P1|COMPLETED|Extension Study - (Period III)||0
263761|NCT00968201|638924|P3|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|364
263762|NCT00968201|638925|P2|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|157
263763|NCT00968201|638926|P1|STARTED|Extension Study - (Period III)||0
263764|NCT00968201|638924|P3|NOT COMPLETED|Base Study - (Period II)||45
263765|NCT00968201|638925|P2|NOT COMPLETED|Base Study - (Period II)||0
263766|NCT00968201|638926|P1|NOT COMPLETED|Base Study - (Period II)||26
263767|NCT00968201|638924|P3|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|416
263768|NCT00968201|638925|P2|COMPLETED|Base Study - (Period II)||0
263769|NCT00968201|638926|P1|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|202
263770|NCT00968201|638924|P3|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to montelukast.|461
263771|NCT00968201|638925|P2|STARTED|Base Study - (Period II)||0
263772|NCT00968201|638926|P1|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to placebo.|228
263773|NCT00968149|638987|P2|NOT COMPLETED|Overall Study||6
263774|NCT00968149|638988|P1|NOT COMPLETED|Overall Study||11
263775|NCT00968149|638987|P2|COMPLETED|Overall Study||127
263776|NCT00968149|638988|P1|COMPLETED|Overall Study||269
263777|NCT00968149|638987|P2|STARTED|Overall Study||133
263778|NCT00968149|638988|P1|STARTED|Overall Study||280
263779|NCT00968071|639008|P1|NOT COMPLETED|Overall Study||0
263780|NCT00968071|639008|P1|COMPLETED|Overall Study||71
263781|NCT00968071|639008|P1|STARTED|Overall Study||71
263782|NCT00968032|639012|P1|NOT COMPLETED|Overall Study||2
263783|NCT00968032|639012|P1|COMPLETED|Overall Study|"1 patient not receiving investigational device due to failure in usage~1 patient denied latest FU"|61
263784|NCT00968032|639012|P1|STARTED|Overall Study||63
263785|NCT00968019|639016|P1|NOT COMPLETED|Overall Study||15
263786|NCT00968019|639016|P1|COMPLETED|Overall Study||303
263787|NCT00968019|639016|P1|STARTED|Overall Study||318
263788|NCT00967993|639037|P1|NOT COMPLETED|Overall Study||4
263789|NCT00967993|639037|P1|COMPLETED|Overall Study||18
263790|NCT00967993|639037|P1|STARTED|Overall Study||22
263791|NCT00967798|639043|P2|NOT COMPLETED|Overall Study||3
263792|NCT00967798|639044|P1|NOT COMPLETED|Overall Study||9
263793|NCT00967798|639043|P2|COMPLETED|Overall Study||13
263794|NCT00967798|639044|P1|COMPLETED|Overall Study||8
263795|NCT00967798|639043|P2|STARTED|Overall Study||16
263796|NCT00967798|639044|P1|STARTED|Overall Study||17
263797|NCT00967694|639058|P1|NOT COMPLETED|Overall Study||6
263798|NCT00967694|639058|P1|COMPLETED|Overall Study|5 discontinued during N2O administration due to agitation ⁄ dysphoria, one due to nausea⁄vomiting.|20
263799|NCT00967694|639058|P1|STARTED|Overall Study||26
263800|NCT00967668|639065|P3|NOT COMPLETED|Overall Study||69
263801|NCT00967668|639066|P2|NOT COMPLETED|Overall Study||56
263802|NCT00967668|639067|P1|NOT COMPLETED|Overall Study||71
263803|NCT00967668|639065|P3|COMPLETED|Overall Study||90
263804|NCT00967668|639066|P2|COMPLETED|Overall Study||104
263805|NCT00967668|639067|P1|COMPLETED|Overall Study||91
263806|NCT00967668|639065|P3|18-mo Assessment|Overall Study||92
263807|NCT00967668|639066|P2|18-mo Assessment|Overall Study||102
263808|NCT00967668|639067|P1|18-mo Assessment|Overall Study||95
263809|NCT00967668|639065|P3|Completed Year 1 - 12-mo Assessment|Overall Study||119
263810|NCT00967668|639066|P2|Completed Year 1 - 12-mo Assessment|Overall Study||122
263811|NCT00967668|639067|P1|Completed Year 1 - 12-mo Assessment|Overall Study||120
263812|NCT00967668|639065|P3|3-mo Assessment|Overall Study||115
263813|NCT00967668|639066|P2|3-mo Assessment|Overall Study||127
263814|NCT00967668|639067|P1|3-mo Assessment|Overall Study||131
263815|NCT00967668|639065|P3|STARTED|Overall Study||159
263816|NCT00967668|639066|P2|STARTED|Overall Study||160
263817|NCT00967668|639067|P1|STARTED|Overall Study||162
263818|NCT00967551|639080|P2|NOT COMPLETED|Overall Study||0
263819|NCT00967551|639081|P1|NOT COMPLETED|Overall Study||0
263820|NCT00967551|639080|P2|COMPLETED|Overall Study||75
263821|NCT00967551|639081|P1|COMPLETED|Overall Study||68
263822|NCT00967551|639080|P2|STARTED|Overall Study||75
263823|NCT00967551|639081|P1|STARTED|Overall Study||68
263824|NCT00967486|639091|P2|NOT COMPLETED|Overall Study||0
263825|NCT00967486|639092|P1|NOT COMPLETED|Overall Study||0
263826|NCT00967486|639091|P2|COMPLETED|Overall Study||102
263827|NCT00967486|639092|P1|COMPLETED|Overall Study||98
263828|NCT00967486|639091|P2|STARTED|Overall Study||102
263829|NCT00967486|639092|P1|STARTED|Overall Study||98
263830|NCT00967473|639098|P1|NOT COMPLETED|Overall Study||0
263831|NCT00967473|639098|P1|COMPLETED|Overall Study||15
263832|NCT00967473|639098|P1|STARTED|Overall Study||15
263833|NCT00967447|639104|P1|NOT COMPLETED|Overall Study||0
263834|NCT00967447|639104|P1|COMPLETED|Overall Study|there are no collected data in CRF|2
263835|NCT00967447|639104|P1|STARTED|Overall Study|there are no collected data in CRF|2
263836|NCT00967330|639113|P2|NOT COMPLETED|Overall Study||60
263837|NCT00967330|639114|P1|NOT COMPLETED|Overall Study||122
263838|NCT00967330|639113|P2|COMPLETED|Overall Study||0
263839|NCT00967330|639114|P1|COMPLETED|Overall Study||0
263840|NCT00967330|639113|P2|STARTED|Overall Study||60
263841|NCT00967330|639114|P1|STARTED|Overall Study||122
263842|NCT00967226|639144|P2|NOT COMPLETED|Overall Study||6
263843|NCT00967226|639145|P1|NOT COMPLETED|Overall Study||2
263844|NCT00967226|639144|P2|COMPLETED|Overall Study||2
263845|NCT00967226|639145|P1|COMPLETED|Overall Study||9
263846|NCT00967226|639144|P2|STARTED|Overall Study||8
263847|NCT00967226|639145|P1|STARTED|Overall Study||11
263848|NCT00967044|639175|P1|NOT COMPLETED|Overall Study||0
263849|NCT00967044|639175|P1|COMPLETED|Overall Study||30
263850|NCT00967044|639175|P1|STARTED|Overall Study||30
263851|NCT00967018|639179|P1|NOT COMPLETED|Overall Study||21
263852|NCT00967018|639179|P1|COMPLETED|Overall Study||56
263853|NCT00967018|639179|P1|STARTED|Overall Study||77
263854|NCT00967005|639188|P2|NOT COMPLETED|Overall Study||10
263855|NCT00967005|639189|P1|NOT COMPLETED|Overall Study||7
263856|NCT00967005|639188|P2|COMPLETED|Overall Study||5
263857|NCT00967005|639189|P1|COMPLETED|Overall Study||6
263858|NCT00967005|639188|P2|Treatment Completion|Overall Study||10
263859|NCT00967005|639189|P1|Treatment Completion|Overall Study||10
263860|NCT00967005|639188|P2|STARTED|Overall Study||15
263861|NCT00967005|639189|P1|STARTED|Overall Study||13
263862|NCT00966992|639243|P2|NOT COMPLETED|Overall Study||0
263863|NCT00966992|639244|P1|NOT COMPLETED|Overall Study||0
263864|NCT00966992|639243|P2|COMPLETED|Overall Study||0
263865|NCT00966992|639244|P1|COMPLETED|Overall Study||3
263866|NCT00966992|639243|P2|STARTED|Overall Study||0
263867|NCT00966992|639244|P1|STARTED|Overall Study||3
263868|NCT00966953|639264|P4|NOT COMPLETED|4th Intervention Order||0
263869|NCT00966953|639265|P3|NOT COMPLETED|4th Intervention Order||0
263870|NCT00966953|639266|P2|NOT COMPLETED|4th Intervention Order||0
263871|NCT00966953|639267|P1|NOT COMPLETED|4th Intervention Order||0
263872|NCT00966953|639264|P4|COMPLETED|4th Intervention Order||7
263873|NCT00966953|639265|P3|COMPLETED|4th Intervention Order||6
263874|NCT00966953|639266|P2|COMPLETED|4th Intervention Order||6
263875|NCT00966953|639267|P1|COMPLETED|4th Intervention Order||6
263876|NCT00966953|639264|P4|STARTED|4th Intervention Order||7
263877|NCT00966953|639265|P3|STARTED|4th Intervention Order||6
263878|NCT00966953|639266|P2|STARTED|4th Intervention Order||6
263879|NCT00966953|639267|P1|STARTED|4th Intervention Order||6
263880|NCT00966953|639264|P4|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
263881|NCT00966953|639265|P3|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
263882|NCT00966953|639266|P2|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
263883|NCT00966953|639267|P1|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
263884|NCT00966953|639264|P4|COMPLETED|1 Week Washout After 3rd Intervention||7
263885|NCT00966953|639265|P3|COMPLETED|1 Week Washout After 3rd Intervention||6
263886|NCT00966953|639266|P2|COMPLETED|1 Week Washout After 3rd Intervention||6
263887|NCT00966953|639267|P1|COMPLETED|1 Week Washout After 3rd Intervention||6
263888|NCT00966953|639264|P4|STARTED|1 Week Washout After 3rd Intervention||7
263889|NCT00966953|639265|P3|STARTED|1 Week Washout After 3rd Intervention||6
263890|NCT00966953|639266|P2|STARTED|1 Week Washout After 3rd Intervention||6
263891|NCT00966953|639267|P1|STARTED|1 Week Washout After 3rd Intervention||6
263892|NCT00966953|639264|P4|NOT COMPLETED|3rd Intervention Order||0
263893|NCT00966953|639265|P3|NOT COMPLETED|3rd Intervention Order||0
263894|NCT00966953|639266|P2|NOT COMPLETED|3rd Intervention Order||0
263895|NCT00966953|639267|P1|NOT COMPLETED|3rd Intervention Order||0
263896|NCT00966953|639264|P4|COMPLETED|3rd Intervention Order||7
263897|NCT00966953|639265|P3|COMPLETED|3rd Intervention Order||6
263898|NCT00966953|639266|P2|COMPLETED|3rd Intervention Order||6
263899|NCT00966953|639267|P1|COMPLETED|3rd Intervention Order||6
263900|NCT00966953|639264|P4|STARTED|3rd Intervention Order||7
263901|NCT00966953|639265|P3|STARTED|3rd Intervention Order||6
263902|NCT00966953|639266|P2|STARTED|3rd Intervention Order||6
263903|NCT00966953|639267|P1|STARTED|3rd Intervention Order||6
263904|NCT00966953|639264|P4|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
263905|NCT00966953|639265|P3|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
263906|NCT00966953|639266|P2|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
263907|NCT00966953|639267|P1|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
263908|NCT00966953|639264|P4|COMPLETED|1 Week Washout After 2nd Intervention||7
263909|NCT00966953|639265|P3|COMPLETED|1 Week Washout After 2nd Intervention||6
263910|NCT00966953|639266|P2|COMPLETED|1 Week Washout After 2nd Intervention||6
263911|NCT00966953|639267|P1|COMPLETED|1 Week Washout After 2nd Intervention||6
263912|NCT00966953|639264|P4|STARTED|1 Week Washout After 2nd Intervention||7
263913|NCT00966953|639265|P3|STARTED|1 Week Washout After 2nd Intervention||6
263914|NCT00966953|639266|P2|STARTED|1 Week Washout After 2nd Intervention||6
263915|NCT00966953|639267|P1|STARTED|1 Week Washout After 2nd Intervention||6
263916|NCT00966953|639264|P4|NOT COMPLETED|2nd Intervention||0
263917|NCT00966953|639265|P3|NOT COMPLETED|2nd Intervention||0
263918|NCT00966953|639266|P2|NOT COMPLETED|2nd Intervention||0
263919|NCT00966953|639267|P1|NOT COMPLETED|2nd Intervention||0
263920|NCT00966953|639264|P4|COMPLETED|2nd Intervention||7
263921|NCT00966953|639265|P3|COMPLETED|2nd Intervention||6
263922|NCT00966953|639266|P2|COMPLETED|2nd Intervention||6
263923|NCT00966953|639267|P1|COMPLETED|2nd Intervention||6
263924|NCT00966953|639264|P4|STARTED|2nd Intervention||7
263925|NCT00966953|639265|P3|STARTED|2nd Intervention||6
263926|NCT00966953|639266|P2|STARTED|2nd Intervention||6
263927|NCT00966953|639267|P1|STARTED|2nd Intervention||6
263928|NCT00966953|639264|P4|NOT COMPLETED|1 Week Washout After 1st Intervention||0
263929|NCT00966953|639265|P3|NOT COMPLETED|1 Week Washout After 1st Intervention||0
263930|NCT00966953|639266|P2|NOT COMPLETED|1 Week Washout After 1st Intervention||0
263931|NCT00966953|639267|P1|NOT COMPLETED|1 Week Washout After 1st Intervention||0
263932|NCT00966953|639264|P4|COMPLETED|1 Week Washout After 1st Intervention||7
263933|NCT00966953|639265|P3|COMPLETED|1 Week Washout After 1st Intervention||6
263934|NCT00966953|639266|P2|COMPLETED|1 Week Washout After 1st Intervention||6
263935|NCT00966953|639267|P1|COMPLETED|1 Week Washout After 1st Intervention||6
263936|NCT00966953|639264|P4|STARTED|1 Week Washout After 1st Intervention||7
263937|NCT00966953|639265|P3|STARTED|1 Week Washout After 1st Intervention||6
263938|NCT00966953|639266|P2|STARTED|1 Week Washout After 1st Intervention||6
263939|NCT00966953|639267|P1|STARTED|1 Week Washout After 1st Intervention||6
263940|NCT00966953|639264|P4|NOT COMPLETED|1st Intervention||0
263941|NCT00966953|639265|P3|NOT COMPLETED|1st Intervention||0
263942|NCT00966953|639266|P2|NOT COMPLETED|1st Intervention||0
263943|NCT00966953|639267|P1|NOT COMPLETED|1st Intervention||0
263944|NCT00966953|639264|P4|COMPLETED|1st Intervention||7
263945|NCT00966953|639265|P3|COMPLETED|1st Intervention||6
263946|NCT00966953|639266|P2|COMPLETED|1st Intervention||6
263947|NCT00966953|639267|P1|COMPLETED|1st Intervention||6
263948|NCT00966953|639264|P4|STARTED|1st Intervention||7
263949|NCT00966953|639265|P3|STARTED|1st Intervention||6
263950|NCT00966953|639266|P2|STARTED|1st Intervention||6
263951|NCT00966953|639267|P1|STARTED|1st Intervention||6
263952|NCT00966940|639275|P2|NOT COMPLETED|Period 2, Second 6 Weeks||0
263953|NCT00966940|639276|P1|NOT COMPLETED|Period 2, Second 6 Weeks||0
263954|NCT00966940|639275|P2|COMPLETED|Period 2, Second 6 Weeks||23
263955|NCT00966940|639276|P1|COMPLETED|Period 2, Second 6 Weeks||25
263956|NCT00966940|639275|P2|STARTED|Period 2, Second 6 Weeks||23
263957|NCT00966940|639276|P1|STARTED|Period 2, Second 6 Weeks||25
263958|NCT00966940|639275|P2|NOT COMPLETED|Period 1, First 6 Weeks||0
263959|NCT00966940|639276|P1|NOT COMPLETED|Period 1, First 6 Weeks||3
263960|NCT00966940|639275|P2|COMPLETED|Period 1, First 6 Weeks||23
263961|NCT00966940|639276|P1|COMPLETED|Period 1, First 6 Weeks||25
263962|NCT00966940|639275|P2|STARTED|Period 1, First 6 Weeks||23
263963|NCT00966940|639276|P1|STARTED|Period 1, First 6 Weeks||28
263964|NCT00966875|639303|P9|NOT COMPLETED|Part B||18
263965|NCT00966875|639304|P8|NOT COMPLETED|Part B||19
263966|NCT00966875|639305|P7|NOT COMPLETED|Part B||22
263967|NCT00966875|639306|P6|NOT COMPLETED|Part B||6
263968|NCT00966875|639307|P5|NOT COMPLETED|Part B||7
263969|NCT00966875|639308|P4|NOT COMPLETED|Part B||3
263970|NCT00966875|639309|P3|NOT COMPLETED|Part B||6
263971|NCT00966875|639310|P2|NOT COMPLETED|Part B||3
263972|NCT00966875|639311|P1|NOT COMPLETED|Part B||5
263973|NCT00966875|639303|P9|COMPLETED|Part B||32
263974|NCT00966875|639304|P8|COMPLETED|Part B||38
263975|NCT00966875|639305|P7|COMPLETED|Part B||29
263976|NCT00966875|639306|P6|COMPLETED|Part B||26
263977|NCT00966875|639307|P5|COMPLETED|Part B||44
263978|NCT00966875|639308|P4|COMPLETED|Part B||31
263979|NCT00966875|639309|P3|COMPLETED|Part B||27
263980|NCT00966875|639310|P2|COMPLETED|Part B||33
263981|NCT00966875|639311|P1|COMPLETED|Part B||41
263982|NCT00966875|639303|P9|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|50
263983|NCT00966875|639304|P8|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|57
263984|NCT00966875|639305|P7|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
263985|NCT00966875|639306|P6|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|32
263986|NCT00966875|639307|P5|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
263987|NCT00966875|639308|P4|STARTED|Part B||34
263988|NCT00966875|639309|P3|STARTED|Part B||33
263989|NCT00966875|639310|P2|STARTED|Part B||36
263990|NCT00966875|639311|P1|STARTED|Part B|Two (2) participants who completed Part A did not enter Part B.|46
263991|NCT00966875|639303|P9|NOT COMPLETED|Part A||8
263992|NCT00966875|639304|P8|NOT COMPLETED|Part A||7
263993|NCT00966875|639305|P7|NOT COMPLETED|Part A||12
263994|NCT00966875|639306|P6|NOT COMPLETED|Part A||4
263995|NCT00966875|639307|P5|NOT COMPLETED|Part A||5
263996|NCT00966875|639308|P4|NOT COMPLETED|Part A||3
263997|NCT00966875|639309|P3|NOT COMPLETED|Part A||2
263998|NCT00966875|639310|P2|NOT COMPLETED|Part A||4
263999|NCT00966875|639311|P1|NOT COMPLETED|Part A||6
264000|NCT00966875|639303|P9|COMPLETED|Part A||51
264001|NCT00966875|639304|P8|COMPLETED|Part A||58
264002|NCT00966875|639305|P7|COMPLETED|Part A||52
264003|NCT00966875|639306|P6|COMPLETED|Part A||33
264004|NCT00966875|639307|P5|COMPLETED|Part A||52
264005|NCT00966875|639308|P4|COMPLETED|Part A||34
264006|NCT00966875|639309|P3|COMPLETED|Part A||33
264007|NCT00966875|639310|P2|COMPLETED|Part A||36
264008|NCT00966875|639311|P1|COMPLETED|Part A||48
264009|NCT00966875|639303|P9|Received ≥1 Doses of Study Drug|Part A||59
264010|NCT00966875|639304|P8|Received ≥1 Doses of Study Drug|Part A||65
264011|NCT00966875|639305|P7|Received ≥1 Doses of Study Drug|Part A||64
264012|NCT00966875|639306|P6|Received ≥1 Doses of Study Drug|Part A||37
264013|NCT00966875|639307|P5|Received ≥1 Doses of Study Drug|Part A||57
264014|NCT00966875|639308|P4|Received ≥1 Doses of Study Drug|Part A||37
264015|NCT00966875|639309|P3|Received ≥1 Doses of Study Drug|Part A||35
264016|NCT00966875|639310|P2|Received ≥1 Doses of Study Drug|Part A||40
264017|NCT00966875|639311|P1|Received ≥1 Doses of Study Drug|Part A||54
264018|NCT00966875|639303|P9|STARTED|Part A||59
264019|NCT00966875|639304|P8|STARTED|Part A||65
264020|NCT00966875|639305|P7|STARTED|Part A||64
264021|NCT00966875|639306|P6|STARTED|Part A||37
264022|NCT00966875|639307|P5|STARTED|Part A||57
264023|NCT00966875|639308|P4|STARTED|Part A||37
264024|NCT00966875|639309|P3|STARTED|Part A||35
264025|NCT00966875|639310|P2|STARTED|Part A||40
264026|NCT00966875|639311|P1|STARTED|Part A||54
264027|NCT00966849|639633|P3|NOT COMPLETED|Overall Study||1293
264028|NCT00966849|639634|P2|NOT COMPLETED|Overall Study||1478
264029|NCT00966849|639635|P1|NOT COMPLETED|Overall Study||1541
264030|NCT00966849|639633|P3|COMPLETED|Overall Study||1876
264031|NCT00966849|639634|P2|COMPLETED|Overall Study||2498
264032|NCT00966849|639635|P1|COMPLETED|Overall Study||2119
264033|NCT00966849|639633|P3|STARTED|Overall Study||3169
264034|NCT00966849|639634|P2|STARTED|Overall Study||3976
264035|NCT00966849|639635|P1|STARTED|Overall Study||3660
264036|NCT00966823|639652|P1|NOT COMPLETED|Overall Study||1
264037|NCT00966823|639652|P1|COMPLETED|Overall Study||2
264038|NCT00966823|639652|P1|STARTED|Overall Study||3
264039|NCT00966719|639662|P2|NOT COMPLETED|Overall Study||11
264040|NCT00966719|639663|P1|NOT COMPLETED|Overall Study||6
264041|NCT00966719|639662|P2|COMPLETED|Overall Study||38
264042|NCT00966719|639663|P1|COMPLETED|Overall Study||44
264043|NCT00966719|639662|P2|STARTED|Overall Study||49
264044|NCT00966719|639663|P1|STARTED|Overall Study||50
264045|NCT00966654|639683|P1|NOT COMPLETED|Overall Study||12
264046|NCT00966654|639683|P1|COMPLETED|Overall Study||0
264047|NCT00966654|639683|P1|STARTED|Overall Study||12
264048|NCT00966641|639691|P2|NOT COMPLETED|Second Intervention||0
264049|NCT00966641|639692|P1|NOT COMPLETED|Second Intervention||0
264050|NCT00966641|639691|P2|COMPLETED|Second Intervention||17
264051|NCT00966641|639692|P1|COMPLETED|Second Intervention||17
264052|NCT00966641|639691|P2|STARTED|Second Intervention||17
264053|NCT00966641|639692|P1|STARTED|Second Intervention||17
264054|NCT00966641|639691|P2|NOT COMPLETED|First Intervention||0
264055|NCT00966641|639692|P1|NOT COMPLETED|First Intervention||0
264056|NCT00966641|639691|P2|COMPLETED|First Intervention||17
264057|NCT00966641|639692|P1|COMPLETED|First Intervention||17
264058|NCT00966641|639691|P2|STARTED|First Intervention||17
264059|NCT00966641|639692|P1|STARTED|First Intervention||17
264060|NCT00966550|639700|P2|NOT COMPLETED|Overall Study||0
264061|NCT00966550|639701|P1|NOT COMPLETED|Overall Study||0
264062|NCT00966550|639700|P2|COMPLETED|Overall Study||12
264063|NCT00966550|639701|P1|COMPLETED|Overall Study||13
264064|NCT00966550|639700|P2|STARTED|Overall Study||12
264065|NCT00966550|639701|P1|STARTED|Overall Study||13
264066|NCT00966446|639710|P3|NOT COMPLETED|Overall Study||21
264067|NCT00966446|639711|P2|NOT COMPLETED|Overall Study||25
264068|NCT00966446|639712|P1|NOT COMPLETED|Overall Study||28
264069|NCT00966446|639710|P3|COMPLETED|Overall Study||52
264070|NCT00966446|639711|P2|COMPLETED|Overall Study||49
264071|NCT00966446|639712|P1|COMPLETED|Overall Study||48
264072|NCT00966446|639710|P3|STARTED|Overall Study||73
264073|NCT00966446|639711|P2|STARTED|Overall Study||74
264074|NCT00966446|639712|P1|STARTED|Overall Study||76
264075|NCT00966433|639729|P3|NOT COMPLETED|Overall Study||0
264076|NCT00966433|639730|P2|NOT COMPLETED|Overall Study||1
264077|NCT00966433|639731|P1|NOT COMPLETED|Overall Study||1
264078|NCT00966433|639729|P3|COMPLETED|Overall Study||11
264079|NCT00966433|639730|P2|COMPLETED|Overall Study||10
264080|NCT00966433|639731|P1|COMPLETED|Overall Study||10
264081|NCT00966433|639729|P3|STARTED|Overall Study||11
264082|NCT00966433|639730|P2|STARTED|Overall Study||11
264083|NCT00966433|639731|P1|STARTED|Overall Study||11
264084|NCT00966355|639757|P3|NOT COMPLETED|Overall Study||84
264085|NCT00966355|639758|P2|NOT COMPLETED|Overall Study||86
264086|NCT00966355|639759|P1|NOT COMPLETED|Overall Study||84
264087|NCT00966355|639757|P3|COMPLETED|Overall Study||261
264088|NCT00966355|639758|P2|COMPLETED|Overall Study||259
264089|NCT00966355|639759|P1|COMPLETED|Overall Study||260
264090|NCT00966355|639757|P3|STARTED|Overall Study||345
264091|NCT00966355|639758|P2|STARTED|Overall Study||345
264092|NCT00966355|639759|P1|STARTED|Overall Study||344
264093|NCT00966277|639772|P2|NOT COMPLETED|Overall Study||4
264094|NCT00966277|639773|P1|NOT COMPLETED|Overall Study||4
264095|NCT00966277|639772|P2|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|33
264096|NCT00966277|639773|P1|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|34
264097|NCT00966277|639772|P2|STARTED|Overall Study||37
264098|NCT00966277|639773|P1|STARTED|Overall Study||38
264099|NCT00966264|639781|P2|NOT COMPLETED|Overall Study||3
264100|NCT00966264|639782|P1|NOT COMPLETED|Overall Study||4
264101|NCT00966264|639781|P2|COMPLETED|Overall Study|5 years results|114
264102|NCT00966264|639782|P1|COMPLETED|Overall Study|5 years results|115
264103|NCT00966264|639781|P2|STARTED|Overall Study||117
264104|NCT00966264|639782|P1|STARTED|Overall Study||119
264105|NCT00966238|639794|P6|NOT COMPLETED|Overall Study||0
264106|NCT00966238|639795|P5|NOT COMPLETED|Overall Study||0
264107|NCT00966238|639796|P4|NOT COMPLETED|Overall Study||0
264108|NCT00966238|639797|P3|NOT COMPLETED|Overall Study||0
264109|NCT00966238|639798|P2|NOT COMPLETED|Overall Study||0
264110|NCT00966238|639799|P1|NOT COMPLETED|Overall Study||0
264111|NCT00966238|639794|P6|COMPLETED|Overall Study||20
264112|NCT00966238|639795|P5|COMPLETED|Overall Study||20
264113|NCT00966238|639796|P4|COMPLETED|Overall Study||20
264114|NCT00966238|639797|P3|COMPLETED|Overall Study||20
264115|NCT00966238|639798|P2|COMPLETED|Overall Study||20
264116|NCT00966238|639799|P1|COMPLETED|Overall Study||20
264117|NCT00966238|639794|P6|STARTED|Overall Study||20
264118|NCT00966238|639795|P5|STARTED|Overall Study||20
264119|NCT00966238|639796|P4|STARTED|Overall Study||20
264120|NCT00966238|639797|P3|STARTED|Overall Study||20
264121|NCT00966238|639798|P2|STARTED|Overall Study||20
264122|NCT00966238|639799|P1|STARTED|Overall Study||20
264123|NCT00966186|639821|P2|NOT COMPLETED|Overall Study||0
264124|NCT00966186|639822|P1|NOT COMPLETED|Overall Study||0
264125|NCT00966186|639821|P2|COMPLETED|Overall Study||60
264126|NCT00966186|639822|P1|COMPLETED|Overall Study||60
264127|NCT00966186|639821|P2|STARTED|Overall Study||60
264128|NCT00966186|639822|P1|STARTED|Overall Study||60
264129|NCT00965848|639828|P3|NOT COMPLETED|Overall Study||10
264130|NCT00965848|639829|P2|NOT COMPLETED|Overall Study||2
264131|NCT00965848|639830|P1|NOT COMPLETED|Overall Study||29
264132|NCT00965848|639828|P3|COMPLETED|Overall Study||117
264133|NCT00965848|639829|P2|COMPLETED|Overall Study||32
264134|NCT00965848|639830|P1|COMPLETED|Overall Study||78
264135|NCT00965848|639828|P3|STARTED|Overall Study||127
264136|NCT00965848|639829|P2|STARTED|Overall Study||34
264137|NCT00965848|639830|P1|STARTED|Overall Study||107
264138|NCT00965757|639849|P4|NOT COMPLETED|Extension Phase||24
264139|NCT00965757|639850|P3|NOT COMPLETED|Extension Phase||33
264140|NCT00965757|639851|P2|NOT COMPLETED|Extension Phase||0
264141|NCT00965757|639852|P1|NOT COMPLETED|Extension Phase||0
264142|NCT00965757|639849|P4|COMPLETED|Extension Phase||64
264143|NCT00965757|639850|P3|COMPLETED|Extension Phase||132
264144|NCT00965757|639851|P2|COMPLETED|Extension Phase||0
264145|NCT00965757|639852|P1|COMPLETED|Extension Phase||0
264146|NCT00965757|639849|P4|STARTED|Extension Phase||88
264147|NCT00965757|639850|P3|STARTED|Extension Phase||165
264148|NCT00965757|639851|P2|STARTED|Extension Phase||0
264149|NCT00965757|639852|P1|STARTED|Extension Phase||0
264150|NCT00965757|639849|P4|NOT COMPLETED|Double-blind Phase||0
264151|NCT00965757|639850|P3|NOT COMPLETED|Double-blind Phase||0
264152|NCT00965757|639851|P2|NOT COMPLETED|Double-blind Phase||18
264153|NCT00965757|639852|P1|NOT COMPLETED|Double-blind Phase||17
264154|NCT00965757|639849|P4|COMPLETED|Double-blind Phase||0
264155|NCT00965757|639850|P3|COMPLETED|Double-blind Phase||0
264156|NCT00965757|639851|P2|COMPLETED|Double-blind Phase||70
264157|NCT00965757|639852|P1|COMPLETED|Double-blind Phase||148
264158|NCT00965757|639849|P4|STARTED|Double-blind Phase||0
264159|NCT00965757|639850|P3|STARTED|Double-blind Phase||0
264160|NCT00965757|639851|P2|STARTED|Double-blind Phase||88
264161|NCT00965757|639852|P1|STARTED|Double-blind Phase||165
264162|NCT00965731|639886|P2|NOT COMPLETED|Overall Study||20
264163|NCT00965731|639887|P1|NOT COMPLETED|Overall Study||7
264164|NCT00965731|639886|P2|COMPLETED|Overall Study||0
264165|NCT00965731|639887|P1|COMPLETED|Overall Study||0
264166|NCT00965731|639886|P2|STARTED|Overall Study|Dose level given only after lower dose was successfully administered|20
264167|NCT00965731|639887|P1|STARTED|Overall Study||7
264168|NCT00965718|639951|P1|NOT COMPLETED|Overall Study||4
264169|NCT00965718|639951|P1|COMPLETED|Overall Study||16
264170|NCT00965718|639951|P1|STARTED|Overall Study||20
264171|NCT00965562|639964|P3|NOT COMPLETED|Overall Study||3
264172|NCT00965562|639965|P2|NOT COMPLETED|Overall Study||4
264173|NCT00965562|639966|P1|NOT COMPLETED|Overall Study||3
264174|NCT00965562|639964|P3|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
264175|NCT00965562|639965|P2|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
264176|NCT00965562|639966|P1|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
264177|NCT00965562|639964|P3|Women Who Participated Full Follow up|Overall Study|2 patients discontinued intervention: 2 patient requests|11
264178|NCT00965562|639965|P2|Women Who Participated Full Follow up|Overall Study|3 patients discontinued intervention: 1 out of contact, 2 patient requests|10
264179|NCT00965562|639966|P1|Women Who Participated Full Follow up|Overall Study|7 patients discontinued intervention: 2 out of contact, 4 patient requests, 1 suspended by IRB|6
264180|NCT00965562|639964|P3|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 3 out of contact|13
264181|NCT00965562|639965|P2|Women With at Least 2 Follow up Visits|Overall Study|4 patients with no follow up visits: 2 out of contact, 2 patient requests|13
264182|NCT00965562|639966|P1|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 1 out of contact, 2 patient requests|13
264183|NCT00965562|639964|P3|STARTED|Overall Study||16
264184|NCT00965562|639965|P2|STARTED|Overall Study||17
264185|NCT00965562|639966|P1|STARTED|Overall Study||16
264186|NCT00965523|640004|P1|NOT COMPLETED|Study 224||6
264187|NCT00965523|640004|P1|COMPLETED|Study 224||0
264188|NCT00965523|640004|P1|STARTED|Study 224|Six subjects continued into Study 224 from Study 221.|6
264189|NCT00965523|640004|P1|NOT COMPLETED|Study 221||7
264190|NCT00965523|640004|P1|COMPLETED|Study 221||74
264191|NCT00965523|640004|P1|STARTED|Study 221|Study 221 (Safety Analysis Set).|81
264192|NCT00965497|640009|P1|NOT COMPLETED|Overall Study||1
264193|NCT00965497|640009|P1|COMPLETED|Overall Study||13
264194|NCT00965497|640009|P1|STARTED|Overall Study||14
264195|NCT00965484|640014|P1|NOT COMPLETED|Overall Study||2
264196|NCT00965484|640014|P1|COMPLETED|Overall Study||134
264197|NCT00965484|640014|P1|STARTED|Overall Study||136
264198|NCT00965458|640023|P2|NOT COMPLETED|Overall Study||4
264199|NCT00965458|640024|P1|NOT COMPLETED|Overall Study||2
264200|NCT00965458|640023|P2|COMPLETED|Overall Study||12
264201|NCT00965458|640024|P1|COMPLETED|Overall Study||31
264202|NCT00965458|640023|P2|STARTED|Overall Study||16
264203|NCT00965458|640024|P1|STARTED|Overall Study||33
264204|NCT00965419|640040|P1|NOT COMPLETED|Follow-up Phase||62
264205|NCT00965419|640040|P1|COMPLETED|Follow-up Phase||18
264206|NCT00965419|640040|P1|STARTED|Follow-up Phase||80
264207|NCT00965419|640040|P1|NOT COMPLETED|Open Label Treatment for Responders||247
264208|NCT00965419|640040|P1|COMPLETED|Open Label Treatment for Responders||20
264209|NCT00965419|640040|P1|Not Lost to f/u at First Post-baseline|Open Label Treatment for Responders||264
264210|NCT00965419|640040|P1|STARTED|Open Label Treatment for Responders||267
264211|NCT00965341|640086|P2|NOT COMPLETED|Overall Study||8
264212|NCT00965341|640087|P1|NOT COMPLETED|Overall Study||6
264213|NCT00965341|640086|P2|COMPLETED|Overall Study||16
264214|NCT00965341|640087|P1|COMPLETED|Overall Study||13
264215|NCT00965341|640086|P2|STARTED|Overall Study||24
264216|NCT00965341|640087|P1|STARTED|Overall Study||19
264217|NCT00965263|640097|P2|NOT COMPLETED|Overall Study||3
264218|NCT00965263|640098|P1|NOT COMPLETED|Overall Study||2
264219|NCT00965263|640097|P2|COMPLETED|Overall Study||6
264220|NCT00965263|640098|P1|COMPLETED|Overall Study||4
264221|NCT00965263|640097|P2|STARTED|Overall Study||9
264222|NCT00965263|640098|P1|STARTED|Overall Study||6
264223|NCT00965250|640130|P2|NOT COMPLETED|Overall Study||0
264224|NCT00965250|640131|P1|NOT COMPLETED|Overall Study||0
264225|NCT00965250|640130|P2|COMPLETED|Overall Study||12
264226|NCT00965250|640131|P1|COMPLETED|Overall Study||37
264227|NCT00965250|640130|P2|STARTED|Overall Study||12
264228|NCT00965250|640131|P1|STARTED|Overall Study||37
264229|NCT00965237|640149|P2|NOT COMPLETED|Period 2, One Week of Wear||0
264230|NCT00965237|640150|P1|NOT COMPLETED|Period 2, One Week of Wear||0
264231|NCT00965237|640149|P2|COMPLETED|Period 2, One Week of Wear||8
264232|NCT00965237|640150|P1|COMPLETED|Period 2, One Week of Wear||8
264233|NCT00965237|640149|P2|STARTED|Period 2, One Week of Wear||8
264234|NCT00965237|640150|P1|STARTED|Period 2, One Week of Wear||8
264235|NCT00965237|640149|P2|NOT COMPLETED|Period 1, One Week of Wear||0
264236|NCT00965237|640150|P1|NOT COMPLETED|Period 1, One Week of Wear||0
264237|NCT00965237|640149|P2|COMPLETED|Period 1, One Week of Wear||8
264238|NCT00965237|640150|P1|COMPLETED|Period 1, One Week of Wear||8
264239|NCT00965237|640149|P2|STARTED|Period 1, One Week of Wear||8
264240|NCT00965237|640150|P1|STARTED|Period 1, One Week of Wear||8
264241|NCT00965185|640158|P2|NOT COMPLETED|Overall Study||1
264242|NCT00965185|640159|P1|NOT COMPLETED|Overall Study||2
264243|NCT00965185|640158|P2|COMPLETED|Overall Study||20
264244|NCT00965185|640159|P1|COMPLETED|Overall Study||17
264245|NCT00965185|640158|P2|9 Month Visit|Overall Study||21
264246|NCT00965185|640159|P1|9 Month Visit|Overall Study||18
264247|NCT00965185|640158|P2|6 Month Visit|Overall Study||21
264248|NCT00965185|640159|P1|6 Month Visit|Overall Study||18
264249|NCT00965185|640158|P2|3 Month Visit|Overall Study||21
264250|NCT00965185|640159|P1|3 Month Visit|Overall Study||18
264251|NCT00965185|640158|P2|1 Month Visit|Overall Study||21
264252|NCT00965185|640159|P1|1 Month Visit|Overall Study||18
264253|NCT00965185|640158|P2|STARTED|Overall Study||21
264254|NCT00965185|640159|P1|STARTED|Overall Study||19
264255|NCT00965146|640179|P1|NOT COMPLETED|Overall Study||210
264256|NCT00965146|640179|P1|COMPLETED|Overall Study|Study was terminated prior to reaching 15 year endpoint.|0
264257|NCT00965146|640179|P1|STARTED|Overall Study||210
264258|NCT00965094|640186|P2|NOT COMPLETED|Overall Study||1
264259|NCT00965094|640187|P1|NOT COMPLETED|Overall Study||5
264260|NCT00965094|640186|P2|COMPLETED|Overall Study||16
264261|NCT00965094|640187|P1|COMPLETED|Overall Study||14
264262|NCT00965094|640186|P2|STARTED|Overall Study||17
264263|NCT00965094|640187|P1|STARTED|Overall Study||19
264264|NCT00965081|640203|P2|NOT COMPLETED|Overall Study||43
264265|NCT00965081|640204|P1|NOT COMPLETED|Overall Study||34
264266|NCT00965081|640203|P2|COMPLETED|Overall Study||110
264267|NCT00965081|640204|P1|COMPLETED|Overall Study|In addition, 16/17 rescue participants completed study on protocol-specified study medication.|121
264268|NCT00965081|640203|P2|STARTED|Overall Study||153
264269|NCT00965081|640204|P1|STARTED|Overall Study|2 randomized participants had no post-baseline measures and are not included in outcome measures.|155
264270|NCT00965055|640227|P1|NOT COMPLETED|Overall Study||0
264271|NCT00965055|640227|P1|COMPLETED|Overall Study||2
264272|NCT00965055|640227|P1|STARTED|Overall Study||2
264273|NCT00964886|640236|P4|NOT COMPLETED|Overall Study||9
264274|NCT00964886|640237|P3|NOT COMPLETED|Overall Study||16
264275|NCT00964886|640238|P2|NOT COMPLETED|Overall Study||7
264276|NCT00964886|640239|P1|NOT COMPLETED|Overall Study||11
264277|NCT00964886|640236|P4|COMPLETED|Overall Study||24
264278|NCT00964886|640237|P3|COMPLETED|Overall Study||21
264279|NCT00964886|640238|P2|COMPLETED|Overall Study||27
264280|NCT00964886|640239|P1|COMPLETED|Overall Study||27
264281|NCT00964886|640236|P4|STARTED|Overall Study||33
264282|NCT00964886|640237|P3|STARTED|Overall Study||37
264283|NCT00964886|640238|P2|STARTED|Overall Study||34
264284|NCT00964886|640239|P1|STARTED|Overall Study||38
264285|NCT00964860|640255|P2|NOT COMPLETED|Overall Study||1
264286|NCT00964860|640256|P1|NOT COMPLETED|Overall Study||0
264287|NCT00964860|640255|P2|COMPLETED|Overall Study||29
264288|NCT00964860|640256|P1|COMPLETED|Overall Study||30
264289|NCT00964860|640255|P2|STARTED|Overall Study||30
264290|NCT00964860|640256|P1|STARTED|Overall Study||30
264291|NCT00964795|640264|P1|NOT COMPLETED|Overall Study||307
264292|NCT00964795|640264|P1|COMPLETED|Overall Study|Prior to amendment 4, 16 participants completed up to Week 120. No participants completed Week 180.|16
264293|NCT00964795|640264|P1|Number of Participants Treated|Overall Study||320
264294|NCT00964795|640264|P1|STARTED|Overall Study|randomized|323
264295|NCT00964782|640273|P2|NOT COMPLETED|Overall Study||0
264296|NCT00964782|640274|P1|NOT COMPLETED|Overall Study||1
264297|NCT00964782|640273|P2|COMPLETED|Overall Study||8
264298|NCT00964782|640274|P1|COMPLETED|Overall Study||7
264299|NCT00964782|640273|P2|STARTED|Overall Study||8
264300|NCT00964782|640274|P1|STARTED|Overall Study||8
264301|NCT00964743|640288|P1|NOT COMPLETED|Overall Study||2
264302|NCT00964743|640288|P1|COMPLETED|Overall Study||0
264303|NCT00964743|640288|P1|STARTED|Overall Study||2
264304|NCT00964678|640296|P1|NOT COMPLETED|Overall Study||4
264305|NCT00964678|640296|P1|COMPLETED|Overall Study||6
264306|NCT00964678|640296|P1|STARTED|Overall Study||10
264307|NCT00964548|640305|P2|NOT COMPLETED|Overall Study||0
264308|NCT00964548|640306|P1|NOT COMPLETED|Overall Study||0
264309|NCT00964548|640305|P2|COMPLETED|Overall Study||5
264310|NCT00964548|640306|P1|COMPLETED|Overall Study||5
264311|NCT00964548|640305|P2|STARTED|Overall Study||5
264312|NCT00964548|640306|P1|STARTED|Overall Study||5
264313|NCT00964496|640318|P2|NOT COMPLETED|Overall Study||1
264314|NCT00964496|640319|P1|NOT COMPLETED|Overall Study||2
264315|NCT00964496|640318|P2|COMPLETED|Overall Study||26
264316|NCT00964496|640319|P1|COMPLETED|Overall Study||26
264317|NCT00964496|640318|P2|STARTED|Overall Study||27
264318|NCT00964496|640319|P1|STARTED|Overall Study||28
264319|NCT00964444|640337|P1|NOT COMPLETED|Overall Study||0
264320|NCT00964444|640337|P1|COMPLETED|Overall Study||10
264321|NCT00964444|640337|P1|STARTED|Overall Study||10
264322|NCT00964431|640345|P4|NOT COMPLETED|Overall Study||0
264323|NCT00964431|640346|P3|NOT COMPLETED|Overall Study||0
264324|NCT00964431|640347|P2|NOT COMPLETED|Overall Study||0
264325|NCT00964431|640348|P1|NOT COMPLETED|Overall Study||0
264326|NCT00964431|640345|P4|COMPLETED|Overall Study||51
264327|NCT00964431|640346|P3|COMPLETED|Overall Study||51
264328|NCT00964431|640347|P2|COMPLETED|Overall Study||51
264329|NCT00964431|640348|P1|COMPLETED|Overall Study||50
264330|NCT00964431|640345|P4|STARTED|Overall Study||51
264331|NCT00964431|640346|P3|STARTED|Overall Study||51
264332|NCT00964431|640347|P2|STARTED|Overall Study||51
264333|NCT00964431|640348|P1|STARTED|Overall Study||50
264334|NCT00964392|640360|P2|NOT COMPLETED|Overall Study||190
264335|NCT00964392|640361|P1|NOT COMPLETED|Overall Study||53
264336|NCT00964392|640360|P2|COMPLETED|Overall Study||92
264337|NCT00964392|640361|P1|COMPLETED|Overall Study||72
264338|NCT00964392|640360|P2|STARTED|Overall Study|Both safety and efficacy cohort: Total 292 (10 LEP Excluded)|282
264339|NCT00964392|640361|P1|STARTED|Overall Study|Both safety and efficacy cohort: Total 128 (3 MEP Excluded)|125
264340|NCT00964366|640371|P2|NOT COMPLETED|Overall Study||1
264341|NCT00964366|640372|P1|NOT COMPLETED|Overall Study||1
264342|NCT00964366|640371|P2|COMPLETED|Overall Study||24
264343|NCT00964366|640372|P1|COMPLETED|Overall Study||27
264344|NCT00964366|640371|P2|STARTED|Overall Study||25
264345|NCT00964366|640372|P1|STARTED|Overall Study|27 of the 28 enrolled were eligible after screening.|28
264346|NCT00964353|640388|P2|NOT COMPLETED|Overall Study||0
264347|NCT00964353|640389|P1|NOT COMPLETED|Overall Study||0
264348|NCT00964353|640388|P2|COMPLETED|Overall Study||178
264349|NCT00964353|640389|P1|COMPLETED|Overall Study||181
264350|NCT00964353|640388|P2|STARTED|Overall Study||178
264351|NCT00964353|640389|P1|STARTED|Overall Study||181
264352|NCT00964223|640397|P1|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||1
264353|NCT00964223|640397|P1|COMPLETED|Full Face Treatment (Weeks 5 and 8)||27
264354|NCT00964223|640397|P1|STARTED|Full Face Treatment (Weeks 5 and 8)||28
264355|NCT00964223|640397|P1|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
264356|NCT00964223|640397|P1|COMPLETED|Split Face Treatment (Weeks 1 and 2)||28
264357|NCT00964223|640397|P1|STARTED|Split Face Treatment (Weeks 1 and 2)||28
264358|NCT00964158|640465|P3|NOT COMPLETED|Overall Study||8
264359|NCT00964158|640466|P2|NOT COMPLETED|Overall Study||1
264360|NCT00964158|640467|P1|NOT COMPLETED|Overall Study||0
264361|NCT00964158|640465|P3|COMPLETED|Overall Study||92
264362|NCT00964158|640466|P2|COMPLETED|Overall Study||56
264363|NCT00964158|640467|P1|COMPLETED|Overall Study||53
264364|NCT00964158|640465|P3|STARTED|Overall Study||100
264365|NCT00964158|640466|P2|STARTED|Overall Study||57
264366|NCT00964158|640467|P1|STARTED|Overall Study||53
264367|NCT00964119|640536|P1|NOT COMPLETED|Overall Study||0
264368|NCT00964119|640536|P1|COMPLETED|Overall Study||15
264369|NCT00964119|640536|P1|STARTED|Overall Study||15
264370|NCT00964028|640542|P2|NOT COMPLETED|Overall Study||1
264371|NCT00964028|640543|P1|NOT COMPLETED|Overall Study||0
264372|NCT00964028|640542|P2|COMPLETED|Overall Study||24
264373|NCT00964028|640543|P1|COMPLETED|Overall Study||25
264374|NCT00964028|640542|P2|STARTED|Overall Study||25
264375|NCT00964028|640543|P1|STARTED|Overall Study||25
264376|NCT00963937|640558|P3|NOT COMPLETED|Overall Study||4
264377|NCT00963937|640559|P2|NOT COMPLETED|Overall Study||11
264378|NCT00963937|640560|P1|NOT COMPLETED|Overall Study||19
264379|NCT00963937|640558|P3|COMPLETED|Overall Study||41
264380|NCT00963937|640559|P2|COMPLETED|Overall Study||33
264381|NCT00963937|640560|P1|COMPLETED|Overall Study||70
264382|NCT00963937|640558|P3|STARTED|Overall Study||45
264383|NCT00963937|640559|P2|STARTED|Overall Study||44
264384|NCT00963937|640560|P1|STARTED|Overall Study||89
264385|NCT00963924|640598|P2|NOT COMPLETED|Overall Study||3
264386|NCT00963924|640599|P1|NOT COMPLETED|Overall Study||1
264387|NCT00963924|640598|P2|COMPLETED|Overall Study||15
264388|NCT00963924|640599|P1|COMPLETED|Overall Study||17
264389|NCT00963924|640598|P2|STARTED|Overall Study||18
264390|NCT00963924|640599|P1|STARTED|Overall Study||18
264391|NCT00963872|640623|P2|NOT COMPLETED|Overall Study||1
264392|NCT00963872|640624|P1|NOT COMPLETED|Overall Study||1
264393|NCT00963872|640623|P2|COMPLETED|Overall Study||5
264394|NCT00963872|640624|P1|COMPLETED|Overall Study||24
264395|NCT00963872|640623|P2|STARTED|Overall Study||6
264396|NCT00963872|640624|P1|STARTED|Overall Study||25
264397|NCT00963859|640668|P1|NOT COMPLETED|Overall Study||0
264398|NCT00963859|640668|P1|COMPLETED|Overall Study||11
264399|NCT00963859|640668|P1|STARTED|Overall Study||11
264400|NCT00963820|640673|P12|NOT COMPLETED|Expansion Phase||4
264401|NCT00963820|640674|P11|NOT COMPLETED|Expansion Phase||5
264402|NCT00963820|640675|P10|NOT COMPLETED|Expansion Phase||9
264403|NCT00963820|640676|P9|NOT COMPLETED|Expansion Phase||10
264404|NCT00963820|640677|P8|NOT COMPLETED|Expansion Phase||0
264405|NCT00963820|640678|P7|NOT COMPLETED|Expansion Phase||0
264406|NCT00963820|640679|P6|NOT COMPLETED|Expansion Phase||0
264407|NCT00963820|640680|P5|NOT COMPLETED|Expansion Phase||0
264408|NCT00963820|640681|P4|NOT COMPLETED|Expansion Phase||0
264409|NCT00963820|640682|P3|NOT COMPLETED|Expansion Phase||0
264410|NCT00963820|640683|P2|NOT COMPLETED|Expansion Phase||0
264411|NCT00963820|640684|P1|NOT COMPLETED|Expansion Phase||0
264412|NCT00963820|640673|P12|COMPLETED|Expansion Phase||0
264413|NCT00963820|640674|P11|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
264414|NCT00963820|640675|P10|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
264415|NCT00963820|640676|P9|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
264416|NCT00963820|640677|P8|COMPLETED|Expansion Phase||0
264417|NCT00963820|640678|P7|COMPLETED|Expansion Phase||0
264418|NCT00963820|640679|P6|COMPLETED|Expansion Phase||0
264419|NCT00963820|640680|P5|COMPLETED|Expansion Phase||0
264420|NCT00963820|640681|P4|COMPLETED|Expansion Phase||0
264421|NCT00963820|640682|P3|COMPLETED|Expansion Phase||0
264422|NCT00963820|640683|P2|COMPLETED|Expansion Phase||0
264423|NCT00963820|640684|P1|COMPLETED|Expansion Phase||0
264424|NCT00963820|640673|P12|STARTED|Expansion Phase|Includes participants with last dose of carfilzomib 21 to 60 days before 1st ixazomib citrate dose.|4
264425|NCT00963820|640674|P11|STARTED|Expansion Phase|Includes only participants who are proteasome inhibitor (PI)-naïve.|6
264426|NCT00963820|640675|P10|STARTED|Expansion Phase|Includes 1 participant from the dose escalation cohort 2.97 mg/m^2.|10
264427|NCT00963820|640676|P9|STARTED|Expansion Phase|Includes 2 participants from the dose escalation cohort 2.97 mg/m^2.|11
264428|NCT00963820|640677|P8|STARTED|Expansion Phase||0
264429|NCT00963820|640678|P7|STARTED|Expansion Phase||0
264430|NCT00963820|640679|P6|STARTED|Expansion Phase||0
264431|NCT00963820|640680|P5|STARTED|Expansion Phase||0
264432|NCT00963820|640681|P4|STARTED|Expansion Phase||0
264433|NCT00963820|640682|P3|STARTED|Expansion Phase||0
264434|NCT00963820|640683|P2|STARTED|Expansion Phase||0
264435|NCT00963820|640684|P1|STARTED|Expansion Phase|Dose escalation cohorts were not part of the Expansion Phase except as noted in comments.|0
264436|NCT00963820|640673|P12|NOT COMPLETED|Dose Escalation Phase||0
264437|NCT00963820|640674|P11|NOT COMPLETED|Dose Escalation Phase||0
264438|NCT00963820|640675|P10|NOT COMPLETED|Dose Escalation Phase||0
264439|NCT00963820|640676|P9|NOT COMPLETED|Dose Escalation Phase||0
264440|NCT00963820|640677|P8|NOT COMPLETED|Dose Escalation Phase||5
264441|NCT00963820|640678|P7|NOT COMPLETED|Dose Escalation Phase||8
264442|NCT00963820|640679|P6|NOT COMPLETED|Dose Escalation Phase||3
264443|NCT00963820|640680|P5|NOT COMPLETED|Dose Escalation Phase||4
264444|NCT00963820|640681|P4|NOT COMPLETED|Dose Escalation Phase||3
264445|NCT00963820|640682|P3|NOT COMPLETED|Dose Escalation Phase||3
264446|NCT00963820|640683|P2|NOT COMPLETED|Dose Escalation Phase||3
264447|NCT00963820|640684|P1|NOT COMPLETED|Dose Escalation Phase||3
264448|NCT00963820|640673|P12|COMPLETED|Dose Escalation Phase||0
264449|NCT00963820|640674|P11|COMPLETED|Dose Escalation Phase||0
264450|NCT00963820|640675|P10|COMPLETED|Dose Escalation Phase||0
264451|NCT00963820|640676|P9|COMPLETED|Dose Escalation Phase||0
264452|NCT00963820|640677|P8|COMPLETED|Dose Escalation Phase||0
264453|NCT00963820|640678|P7|COMPLETED|Dose Escalation Phase||0
264454|NCT00963820|640679|P6|COMPLETED|Dose Escalation Phase||0
264455|NCT00963820|640680|P5|COMPLETED|Dose Escalation Phase||0
264456|NCT00963820|640681|P4|COMPLETED|Dose Escalation Phase||0
264457|NCT00963820|640682|P3|COMPLETED|Dose Escalation Phase||0
264458|NCT00963820|640683|P2|COMPLETED|Dose Escalation Phase||0
264459|NCT00963820|640684|P1|COMPLETED|Dose Escalation Phase||0
264460|NCT00963820|640673|P12|STARTED|Dose Escalation Phase||0
264461|NCT00963820|640674|P11|STARTED|Dose Escalation Phase||0
264462|NCT00963820|640675|P10|STARTED|Dose Escalation Phase||0
264463|NCT00963820|640676|P9|STARTED|Dose Escalation Phase|Expansion cohorts were not part of Dose Escalation except as noted in comments.|0
264464|NCT00963820|640677|P8|STARTED|Dose Escalation Phase||5
264465|NCT00963820|640678|P7|STARTED|Dose Escalation Phase||8
264466|NCT00963820|640679|P6|STARTED|Dose Escalation Phase||3
264467|NCT00963820|640680|P5|STARTED|Dose Escalation Phase||4
264468|NCT00963820|640681|P4|STARTED|Dose Escalation Phase||3
264469|NCT00963820|640682|P3|STARTED|Dose Escalation Phase||3
264470|NCT00963820|640683|P2|STARTED|Dose Escalation Phase||3
264471|NCT00963820|640684|P1|STARTED|Dose Escalation Phase||3
264472|NCT00963807|640820|P1|NOT COMPLETED|Overall Study||18
264473|NCT00963807|640820|P1|COMPLETED|Overall Study||8
264474|NCT00963807|640820|P1|Completed Post-Cycle 2 FDG Imaging|Overall Study||8
264475|NCT00963807|640820|P1|Completed Post-Cycle 2 FLT Imaging|Overall Study||9
264476|NCT00963807|640820|P1|Completed Post-Cycle 1 Imaging|Overall Study||9
264477|NCT00963807|640820|P1|Completed Baseline Imaging|Overall Study||11
264478|NCT00963807|640820|P1|STARTED|Overall Study||26
264479|NCT00963677|640831|P2|NOT COMPLETED|Overall Study||2
264480|NCT00963677|640832|P1|NOT COMPLETED|Overall Study||0
264481|NCT00963677|640831|P2|COMPLETED|Overall Study|Two patients were excluded from the study due to the difficult ventilation with facemask ventilation|18
264482|NCT00963677|640832|P1|COMPLETED|Overall Study||35
264483|NCT00963677|640831|P2|STARTED|Overall Study|Patients with predicted difficult intubation but not ventilation|20
264484|NCT00963677|640832|P1|STARTED|Overall Study|Patients without predicted difficult intubation|35
264485|NCT00963638|640842|P2|NOT COMPLETED|Overall Study||0
264486|NCT00963638|640843|P1|NOT COMPLETED|Overall Study||0
264487|NCT00963638|640842|P2|COMPLETED|Overall Study||20
264488|NCT00963638|640843|P1|COMPLETED|Overall Study||20
264489|NCT00963638|640842|P2|STARTED|Overall Study||20
264490|NCT00963638|640843|P1|STARTED|Overall Study||20
264491|NCT00963599|640853|P4|NOT COMPLETED|Overall Study||14
264492|NCT00963599|640854|P3|NOT COMPLETED|Overall Study||9
264493|NCT00963599|640855|P2|NOT COMPLETED|Overall Study||6
264494|NCT00963599|640856|P1|NOT COMPLETED|Overall Study||6
264495|NCT00963599|640853|P4|COMPLETED|Overall Study||288
264496|NCT00963599|640854|P3|COMPLETED|Overall Study||292
264497|NCT00963599|640855|P2|COMPLETED|Overall Study||149
264498|NCT00963599|640856|P1|COMPLETED|Overall Study||143
264499|NCT00963599|640853|P4|STARTED|Overall Study||302
264500|NCT00963599|640854|P3|STARTED|Overall Study||301
264501|NCT00963599|640855|P2|STARTED|Overall Study||155
264502|NCT00963599|640856|P1|STARTED|Overall Study||149
264503|NCT00963560|640913|P3|NOT COMPLETED|Overall Study||0
264504|NCT00963560|640914|P2|NOT COMPLETED|Overall Study||3
264505|NCT00963560|640915|P1|NOT COMPLETED|Overall Study||3
264506|NCT00963560|640913|P3|COMPLETED|Overall Study||41
264507|NCT00963560|640914|P2|COMPLETED|Overall Study||41
264508|NCT00963560|640915|P1|COMPLETED|Overall Study||44
264509|NCT00963560|640913|P3|STARTED|Overall Study||41
264510|NCT00963560|640914|P2|STARTED|Overall Study||44
264511|NCT00963560|640915|P1|STARTED|Overall Study||47
264512|NCT00963547|640927|P7|NOT COMPLETED|Overall Study||0
264513|NCT00963547|640928|P6|NOT COMPLETED|Overall Study||0
264514|NCT00963547|640929|P5|NOT COMPLETED|Overall Study||0
264515|NCT00963547|640930|P4|NOT COMPLETED|Overall Study||6
264516|NCT00963547|640931|P3|NOT COMPLETED|Overall Study||12
264517|NCT00963547|640932|P2|NOT COMPLETED|Overall Study||11
264518|NCT00963547|640933|P1|NOT COMPLETED|Overall Study||4
264519|NCT00963547|640927|P7|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
264520|NCT00963547|640928|P6|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
264521|NCT00963547|640929|P5|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
264522|NCT00963547|640930|P4|COMPLETED|Overall Study||0
264523|NCT00963547|640931|P3|COMPLETED|Overall Study||0
264524|NCT00963547|640932|P2|COMPLETED|Overall Study||0
264525|NCT00963547|640933|P1|COMPLETED|Overall Study||0
264526|NCT00963547|640927|P7|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
264527|NCT00963547|640928|P6|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
264528|NCT00963547|640929|P5|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
264529|NCT00963547|640930|P4|Treated|Overall Study||6
264530|NCT00963547|640931|P3|Treated|Overall Study||11
264531|NCT00963547|640932|P2|Treated|Overall Study||11
264532|NCT00963547|640933|P1|Treated|Overall Study||3
264533|NCT00963547|640927|P7|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
264534|NCT00963547|640928|P6|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
264535|NCT00963547|640929|P5|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
264536|NCT00963547|640930|P4|STARTED|Overall Study||6
264537|NCT00963547|640931|P3|STARTED|Overall Study||12
264538|NCT00963547|640932|P2|STARTED|Overall Study||11
264539|NCT00963547|640933|P1|STARTED|Overall Study||4
264540|NCT00963508|640959|P2|NOT COMPLETED|Overall Study||28
264541|NCT00963508|640960|P1|NOT COMPLETED|Overall Study||10
264542|NCT00963508|640959|P2|COMPLETED|Overall Study||169
264543|NCT00963508|640960|P1|COMPLETED|Overall Study||196
264544|NCT00963508|640959|P2|STARTED|Overall Study||197
264545|NCT00963508|640960|P1|STARTED|Overall Study||206
264546|NCT00963482|640970|P2|NOT COMPLETED|Overall Study||17
264547|NCT00963482|640971|P1|NOT COMPLETED|Overall Study||28
264548|NCT00963482|640970|P2|COMPLETED|Overall Study||33
264549|NCT00963482|640971|P1|COMPLETED|Overall Study||25
264550|NCT00963482|640970|P2|STARTED|Overall Study||50
264551|NCT00963482|640971|P1|STARTED|Overall Study||53
264552|NCT00963469|640980|P3|NOT COMPLETED|Overall Study||10
264553|NCT00963469|640981|P2|NOT COMPLETED|Overall Study||28
264554|NCT00963469|640982|P1|NOT COMPLETED|Overall Study||41
264555|NCT00963469|640980|P3|COMPLETED|Overall Study||170
264556|NCT00963469|640981|P2|COMPLETED|Overall Study||420
264557|NCT00963469|640982|P1|COMPLETED|Overall Study||410
264558|NCT00963469|640980|P3|STARTED|Overall Study||180
264559|NCT00963469|640981|P2|STARTED|Overall Study||448
264560|NCT00963469|640982|P1|STARTED|Overall Study||451
264561|NCT00963430|641010|P2|NOT COMPLETED|Overall Study||3
264562|NCT00963430|641011|P1|NOT COMPLETED|Overall Study||1
264563|NCT00963430|641010|P2|COMPLETED|Overall Study||57
264564|NCT00963430|641011|P1|COMPLETED|Overall Study||59
264565|NCT00963430|641010|P2|STARTED|Overall Study||60
264566|NCT00963430|641011|P1|STARTED|Overall Study||60
264567|NCT00963235|641049|P1|NOT COMPLETED|Overall Study||60
264568|NCT00963235|641049|P1|COMPLETED|Overall Study||271
264569|NCT00963235|641049|P1|Completed Dose 3 1-month Blood Draw|Overall Study||277
264570|NCT00963235|641049|P1|Vaccinated Dose 3|Overall Study||279
264571|NCT00963235|641049|P1|Vaccinated Dose 2|Overall Study||300
264572|NCT00963235|641049|P1|Vaccinated Dose 1|Overall Study||329
264573|NCT00963235|641049|P1|STARTED|Overall Study||331
264574|NCT00963157|641073|P5|NOT COMPLETED|Overall Study||2
264575|NCT00963157|641074|P4|NOT COMPLETED|Overall Study||7
264576|NCT00963157|641075|P3|NOT COMPLETED|Overall Study||5
264577|NCT00963157|641076|P2|NOT COMPLETED|Overall Study||4
264578|NCT00963157|641077|P1|NOT COMPLETED|Overall Study||5
264579|NCT00963157|641073|P5|COMPLETED|Overall Study||151
264580|NCT00963157|641074|P4|COMPLETED|Overall Study||150
264581|NCT00963157|641075|P3|COMPLETED|Overall Study||155
264582|NCT00963157|641076|P2|COMPLETED|Overall Study||159
264583|NCT00963157|641077|P1|COMPLETED|Overall Study||151
264584|NCT00963157|641073|P5|STARTED|Overall Study||153
264585|NCT00963157|641074|P4|STARTED|Overall Study||157
264586|NCT00963157|641075|P3|STARTED|Overall Study||160
264587|NCT00963157|641076|P2|STARTED|Overall Study||163
264588|NCT00963157|641077|P1|STARTED|Overall Study||156
264589|NCT00963105|641272|P3|NOT COMPLETED|Overall Study||0
264590|NCT00963105|641273|P2|NOT COMPLETED|Overall Study||0
264591|NCT00963105|641274|P1|NOT COMPLETED|Overall Study||0
264592|NCT00963105|641272|P3|COMPLETED|Overall Study||35
264593|NCT00963105|641273|P2|COMPLETED|Overall Study||35
264594|NCT00963105|641274|P1|COMPLETED|Overall Study||34
264595|NCT00963105|641272|P3|Received Treatment|Overall Study||35
264596|NCT00963105|641273|P2|Received Treatment|Overall Study||34
264597|NCT00963105|641274|P1|Received Treatment|Overall Study||34
264598|NCT00963105|641272|P3|STARTED|Overall Study||35
264599|NCT00963105|641273|P2|STARTED|Overall Study||35
264600|NCT00963105|641274|P1|STARTED|Overall Study||34
264601|NCT00962949|641305|P2|NOT COMPLETED|Overall Study||0
264602|NCT00962949|641306|P1|NOT COMPLETED|Overall Study||0
264603|NCT00962949|641305|P2|COMPLETED|Overall Study||15
264604|NCT00962949|641306|P1|COMPLETED|Overall Study||13
264605|NCT00962949|641305|P2|STARTED|Overall Study||15
264606|NCT00962949|641306|P1|STARTED|Overall Study||13
264607|NCT00962871|641322|P4|NOT COMPLETED|Overall Study||0
264608|NCT00962871|641323|P3|NOT COMPLETED|Overall Study||0
264609|NCT00962871|641324|P2|NOT COMPLETED|Overall Study||0
264610|NCT00962871|641325|P1|NOT COMPLETED|Overall Study||0
264611|NCT00962871|641322|P4|COMPLETED|Overall Study||6
264612|NCT00962871|641323|P3|COMPLETED|Overall Study||12
264613|NCT00962871|641324|P2|COMPLETED|Overall Study||6
264614|NCT00962871|641325|P1|COMPLETED|Overall Study||6
264615|NCT00962871|641322|P4|STARTED|Overall Study||6
264616|NCT00962871|641323|P3|STARTED|Overall Study||12
264617|NCT00962871|641324|P2|STARTED|Overall Study||6
264618|NCT00962871|641325|P1|STARTED|Overall Study||6
264619|NCT00962780|641341|P2|NOT COMPLETED|Overall Study||14
264620|NCT00962780|641342|P1|NOT COMPLETED|Overall Study||10
264621|NCT00962780|641341|P2|COMPLETED|Overall Study||138
264622|NCT00962780|641342|P1|COMPLETED|Overall Study||141
264623|NCT00962780|641341|P2|Vaccinated 23vPS Dose|Overall Study||139
264624|NCT00962780|641342|P1|Vaccinated 23vPS Dose|Overall Study||143
264625|NCT00962780|641341|P2|Vaccinated 13vPnC Dose 3|Overall Study||142
264626|NCT00962780|641342|P1|Vaccinated 13vPnC Dose 3|Overall Study||144
264627|NCT00962780|641341|P2|Vaccinated 13vPnC Dose 2|Overall Study||145
264628|NCT00962780|641342|P1|Vaccinated 13vPnC Dose 2|Overall Study||145
264629|NCT00962780|641341|P2|Vaccinated 13vPnC Dose 1|Overall Study||151
264630|NCT00962780|641342|P1|Vaccinated 13vPnC Dose 1|Overall Study||150
264631|NCT00962780|641341|P2|STARTED|Overall Study||152
264632|NCT00962780|641342|P1|STARTED|Overall Study||151
264633|NCT00962754|641406|P2|NOT COMPLETED|Overall Study||0
264634|NCT00962754|641407|P1|NOT COMPLETED|Overall Study||0
264635|NCT00962754|641406|P2|COMPLETED|Overall Study||84
264636|NCT00962754|641407|P1|COMPLETED|Overall Study||86
264637|NCT00962754|641406|P2|STARTED|Overall Study||84
264638|NCT00962754|641407|P1|STARTED|Overall Study||86
264639|NCT00962741|641417|P1|NOT COMPLETED|Overall Study||8
264640|NCT00962741|641417|P1|COMPLETED|Overall Study||119
264641|NCT00962741|641417|P1|STARTED|Overall Study||127
264642|NCT00962650|641508|P1|NOT COMPLETED|Overall Study||2
264643|NCT00962650|641508|P1|COMPLETED|Overall Study||8
264644|NCT00962650|641508|P1|STARTED|Overall Study||10
264645|NCT00962598|641514|P2|NOT COMPLETED|Overall Study||0
264646|NCT00962598|641515|P1|NOT COMPLETED|Overall Study||0
264647|NCT00962598|641514|P2|COMPLETED|Overall Study||9
264648|NCT00962598|641515|P1|COMPLETED|Overall Study||7
264649|NCT00962598|641514|P2|STARTED|Overall Study||9
264650|NCT00962598|641515|P1|STARTED|Overall Study||7
264651|NCT00962585|641527|P4|NOT COMPLETED|Overall Study||0
264652|NCT00962585|641528|P3|NOT COMPLETED|Overall Study||3
264653|NCT00962585|641529|P2|NOT COMPLETED|Overall Study||2
264654|NCT00962585|641530|P1|NOT COMPLETED|Overall Study||6
264655|NCT00962585|641527|P4|COMPLETED|Overall Study||42
264656|NCT00962585|641528|P3|COMPLETED|Overall Study||39
264657|NCT00962585|641529|P2|COMPLETED|Overall Study||40
264658|NCT00962585|641530|P1|COMPLETED|Overall Study||37
264659|NCT00962585|641527|P4|STARTED|Overall Study||42
264660|NCT00962585|641528|P3|STARTED|Overall Study||42
264661|NCT00962585|641529|P2|STARTED|Overall Study||42
264662|NCT00962585|641530|P1|STARTED|Overall Study||43
264663|NCT00962390|641592|P4|NOT COMPLETED|Overall Study||1
264664|NCT00962390|641593|P3|NOT COMPLETED|Overall Study||4
264665|NCT00962390|641594|P2|NOT COMPLETED|Overall Study||3
264666|NCT00962390|641595|P1|NOT COMPLETED|Overall Study||4
264667|NCT00962390|641592|P4|COMPLETED|Overall Study||28
264668|NCT00962390|641593|P3|COMPLETED|Overall Study||25
264669|NCT00962390|641594|P2|COMPLETED|Overall Study||26
264670|NCT00962390|641595|P1|COMPLETED|Overall Study||25
264671|NCT00962390|641592|P4|STARTED|Overall Study||29
264672|NCT00962390|641593|P3|STARTED|Overall Study||29
264673|NCT00962390|641594|P2|STARTED|Overall Study||29
264674|NCT00962390|641595|P1|STARTED|Overall Study||29
264675|NCT00962247|641657|P1|NOT COMPLETED|50% Reduction of Sedentary Activity||0
264676|NCT00962247|641657|P1|COMPLETED|50% Reduction of Sedentary Activity||56
264677|NCT00962247|641657|P1|STARTED|50% Reduction of Sedentary Activity||56
264678|NCT00962247|641657|P1|NOT COMPLETED|25% Reduction of Sedentary Activity||5
264679|NCT00962247|641657|P1|COMPLETED|25% Reduction of Sedentary Activity||56
264680|NCT00962247|641657|P1|STARTED|25% Reduction of Sedentary Activity||61
264681|NCT00962247|641657|P1|NOT COMPLETED|Usual Sedentary||0
264682|NCT00962247|641657|P1|COMPLETED|Usual Sedentary||61
264683|NCT00962247|641657|P1|STARTED|Usual Sedentary||61
264684|NCT00962208|641668|P2|NOT COMPLETED|Overall Study||10
264685|NCT00962208|641669|P1|NOT COMPLETED|Overall Study||14
264686|NCT00962208|641668|P2|COMPLETED|Overall Study||41
264687|NCT00962208|641669|P1|COMPLETED|Overall Study||37
264688|NCT00962208|641668|P2|STARTED|Overall Study||51
264689|NCT00962208|641669|P1|STARTED|Overall Study||51
264690|NCT00962104|641677|P2|NOT COMPLETED|Overall Study||25
264691|NCT00962104|641678|P1|NOT COMPLETED|Overall Study||40
264692|NCT00962104|641677|P2|COMPLETED|Overall Study||171
264693|NCT00962104|641678|P1|COMPLETED|Overall Study||155
264694|NCT00962104|641677|P2|Full Analysis Set|Overall Study|1 participant was excluded because that participant failed to take the assigned study medication.|195
264695|NCT00962104|641678|P1|Full Analysis Set|Overall Study|2 participants were excluded because they failed to take the assigned study medication.|193
264696|NCT00962104|641677|P2|STARTED|Overall Study||196
264697|NCT00962104|641678|P1|STARTED|Overall Study||195
264698|NCT00962091|641711|P7|NOT COMPLETED|Overall Study||1
264699|NCT00962091|641712|P6|NOT COMPLETED|Overall Study||1
264700|NCT00962091|641713|P5|NOT COMPLETED|Overall Study||0
264701|NCT00962091|641714|P4|NOT COMPLETED|Overall Study||1
264702|NCT00962091|641715|P3|NOT COMPLETED|Overall Study||1
264703|NCT00962091|641716|P2|NOT COMPLETED|Overall Study||2
264704|NCT00962091|641717|P1|NOT COMPLETED|Overall Study||1
264705|NCT00962091|641711|P7|COMPLETED|Overall Study||11
264706|NCT00962091|641712|P6|COMPLETED|Overall Study||11
264707|NCT00962091|641713|P5|COMPLETED|Overall Study||3
264708|NCT00962091|641714|P4|COMPLETED|Overall Study||2
264709|NCT00962091|641715|P3|COMPLETED|Overall Study||9
264710|NCT00962091|641716|P2|COMPLETED|Overall Study||7
264711|NCT00962091|641717|P1|COMPLETED|Overall Study||3
264712|NCT00962091|641711|P7|STARTED|Overall Study||12
264713|NCT00962091|641712|P6|STARTED|Overall Study||12
264714|NCT00962091|641713|P5|STARTED|Overall Study||3
264715|NCT00962091|641714|P4|STARTED|Overall Study||3
264716|NCT00962091|641715|P3|STARTED|Overall Study||10
264717|NCT00962091|641716|P2|STARTED|Overall Study||9
264718|NCT00962091|641717|P1|STARTED|Overall Study||4
264719|NCT00962078|641764|P2|NOT COMPLETED|Overall Study||6
264720|NCT00962078|641765|P1|NOT COMPLETED|Overall Study||5
264721|NCT00962078|641764|P2|COMPLETED|Overall Study||30
264722|NCT00962078|641765|P1|COMPLETED|Overall Study||30
264723|NCT00962078|641764|P2|STARTED|Overall Study||36
264724|NCT00962078|641765|P1|STARTED|Overall Study||35
264725|NCT00962065|641776|P3|NOT COMPLETED|Overall Study||0
264726|NCT00962065|641777|P2|NOT COMPLETED|Overall Study||0
264727|NCT00962065|641778|P1|NOT COMPLETED|Overall Study||0
264728|NCT00962065|641776|P3|COMPLETED|Overall Study||12
264729|NCT00962065|641777|P2|COMPLETED|Overall Study||12
264730|NCT00962065|641778|P1|COMPLETED|Overall Study||12
264731|NCT00962065|641776|P3|STARTED|Overall Study||12
264732|NCT00962065|641777|P2|STARTED|Overall Study||12
264733|NCT00962065|641778|P1|STARTED|Overall Study||12
264734|NCT00962013|641801|P1|NOT COMPLETED|Overall Study||68
264735|NCT00962013|641801|P1|COMPLETED|Overall Study|Number of participants with 5 year primary endpoint data|52
264736|NCT00962013|641801|P1|STARTED|Overall Study||120
264737|NCT00962000|641810|P2|NOT COMPLETED|Period 4 - 1 Week||0
264738|NCT00962000|641811|P1|NOT COMPLETED|Period 4 - 1 Week||0
264739|NCT00962000|641810|P2|COMPLETED|Period 4 - 1 Week||21
264740|NCT00962000|641811|P1|COMPLETED|Period 4 - 1 Week||21
264741|NCT00962000|641810|P2|STARTED|Period 4 - 1 Week||21
264742|NCT00962000|641811|P1|STARTED|Period 4 - 1 Week||21
264743|NCT00962000|641810|P2|NOT COMPLETED|Period 3 - 1 Week||0
264744|NCT00962000|641811|P1|NOT COMPLETED|Period 3 - 1 Week||0
264745|NCT00962000|641810|P2|COMPLETED|Period 3 - 1 Week||21
264746|NCT00962000|641811|P1|COMPLETED|Period 3 - 1 Week||21
264747|NCT00962000|641810|P2|STARTED|Period 3 - 1 Week||21
264748|NCT00962000|641811|P1|STARTED|Period 3 - 1 Week||21
264749|NCT00962000|641810|P2|NOT COMPLETED|Period 2 - 1 Week||0
264750|NCT00962000|641811|P1|NOT COMPLETED|Period 2 - 1 Week||0
264751|NCT00962000|641810|P2|COMPLETED|Period 2 - 1 Week||21
264752|NCT00962000|641811|P1|COMPLETED|Period 2 - 1 Week||21
264753|NCT00962000|641810|P2|STARTED|Period 2 - 1 Week||21
264754|NCT00962000|641811|P1|STARTED|Period 2 - 1 Week||21
264755|NCT00962000|641810|P2|NOT COMPLETED|Period 1 - 1 Week||0
264756|NCT00962000|641811|P1|NOT COMPLETED|Period 1 - 1 Week||0
264757|NCT00962000|641810|P2|COMPLETED|Period 1 - 1 Week||21
264758|NCT00962000|641811|P1|COMPLETED|Period 1 - 1 Week||21
264759|NCT00962000|641810|P2|STARTED|Period 1 - 1 Week||21
264760|NCT00962000|641811|P1|STARTED|Period 1 - 1 Week||21
264761|NCT00961896|641824|P3|NOT COMPLETED|Overall Study||1
264762|NCT00961896|641825|P2|NOT COMPLETED|Overall Study||0
264763|NCT00961896|641826|P1|NOT COMPLETED|Overall Study||0
264764|NCT00961896|641824|P3|COMPLETED|Overall Study||6
264765|NCT00961896|641825|P2|COMPLETED|Overall Study||3
264766|NCT00961896|641826|P1|COMPLETED|Overall Study||8
264767|NCT00961896|641824|P3|STARTED|Overall Study||7
264768|NCT00961896|641825|P2|STARTED|Overall Study||3
264769|NCT00961896|641826|P1|STARTED|Overall Study||8
264770|NCT00961805|641847|P2|NOT COMPLETED|Overall Study||0
264771|NCT00961805|641848|P1|NOT COMPLETED|Overall Study||0
264772|NCT00961805|641847|P2|COMPLETED|Overall Study||40
264773|NCT00961805|641848|P1|COMPLETED|Overall Study||40
264774|NCT00961805|641847|P2|STARTED|Overall Study||40
264775|NCT00961805|641848|P1|STARTED|Overall Study||40
264776|NCT00961662|641879|P3|NOT COMPLETED|Overall Study||19
264777|NCT00961662|641880|P2|NOT COMPLETED|Overall Study||19
264778|NCT00961662|641881|P1|NOT COMPLETED|Overall Study||22
264779|NCT00961662|641879|P3|COMPLETED|Overall Study||34
264780|NCT00961662|641880|P2|COMPLETED|Overall Study||32
264781|NCT00961662|641881|P1|COMPLETED|Overall Study||35
264782|NCT00961662|641879|P3|STARTED|Overall Study||53
264783|NCT00961662|641880|P2|STARTED|Overall Study||51
264784|NCT00961662|641881|P1|STARTED|Overall Study||57
264785|NCT00961649|641893|P4|NOT COMPLETED|Overall Study||4
264786|NCT00961649|641894|P3|NOT COMPLETED|Overall Study||5
264787|NCT00961649|641895|P2|NOT COMPLETED|Overall Study||4
264788|NCT00961649|641896|P1|NOT COMPLETED|Overall Study||9
264789|NCT00961649|641893|P4|COMPLETED|Overall Study||37
264790|NCT00961649|641894|P3|COMPLETED|Overall Study||39
264791|NCT00961649|641895|P2|COMPLETED|Overall Study||40
264792|NCT00961649|641896|P1|COMPLETED|Overall Study||32
264793|NCT00961649|641893|P4|STARTED|Overall Study||41
264794|NCT00961649|641894|P3|STARTED|Overall Study||44
264795|NCT00961649|641895|P2|STARTED|Overall Study||44
264796|NCT00961649|641896|P1|STARTED|Overall Study||41
264797|NCT00961636|641910|P3|NOT COMPLETED|Overall Study||32
264798|NCT00961636|641911|P2|NOT COMPLETED|Overall Study||131
264799|NCT00961636|641912|P1|NOT COMPLETED|Overall Study||107
264800|NCT00961636|641910|P3|COMPLETED|Overall Study||201
264801|NCT00961636|641911|P2|COMPLETED|Overall Study||325
264802|NCT00961636|641912|P1|COMPLETED|Overall Study||356
264803|NCT00961636|641910|P3|STARTED|Overall Study||233
264804|NCT00961636|641911|P2|STARTED|Overall Study||456
264805|NCT00961636|641912|P1|STARTED|Overall Study||463
264806|NCT00961571|641923|P1|NOT COMPLETED|Overall Study||39
264807|NCT00961571|641923|P1|COMPLETED|Overall Study|high percentage of patient drop-off study prior cancer progression|11
264808|NCT00961571|641923|P1|STARTED|Overall Study||50
264809|NCT00961532|641927|P1|NOT COMPLETED|Overall Study||0
264810|NCT00961532|641927|P1|COMPLETED|Overall Study||14
264811|NCT00961532|641927|P1|STARTED|Overall Study||14
264812|NCT00961441|641934|P2|NOT COMPLETED|Overall Study||0
264813|NCT00961441|641935|P1|NOT COMPLETED|Overall Study||0
264814|NCT00961441|641934|P2|COMPLETED|Overall Study||13
264815|NCT00961441|641935|P1|COMPLETED|Overall Study||12
264816|NCT00961441|641934|P2|Pharmacokinetic (PK-PP) Population|Overall Study|Two subjects were excluded due to study medication noncompliance, one due to wrong dosing regimen.|10
264817|NCT00961441|641935|P1|Pharmacokinetic (PK-PP) Population|Overall Study||12
264818|NCT00961441|641934|P2|STARTED|Overall Study||13
264819|NCT00961441|641935|P1|STARTED|Overall Study||12
264820|NCT00961415|641951|P3|NOT COMPLETED|Maintenance Treatment Phase||45
264821|NCT00961415|641952|P2|NOT COMPLETED|Maintenance Treatment Phase||48
264822|NCT00961415|641953|P1|NOT COMPLETED|Maintenance Treatment Phase||0
264823|NCT00961415|641951|P3|COMPLETED|Maintenance Treatment Phase||83
264824|NCT00961415|641952|P2|COMPLETED|Maintenance Treatment Phase||77
264825|NCT00961415|641953|P1|COMPLETED|Maintenance Treatment Phase||0
264826|NCT00961415|641951|P3|STARTED|Maintenance Treatment Phase||128
264827|NCT00961415|641952|P2|STARTED|Maintenance Treatment Phase||125
264828|NCT00961415|641953|P1|STARTED|Maintenance Treatment Phase||0
264829|NCT00961415|641951|P3|NOT COMPLETED|Induction Treatment Phase||0
264830|NCT00961415|641952|P2|NOT COMPLETED|Induction Treatment Phase||0
264831|NCT00961415|641953|P1|NOT COMPLETED|Induction Treatment Phase||123
264832|NCT00961415|641951|P3|COMPLETED|Induction Treatment Phase||0
264833|NCT00961415|641952|P2|COMPLETED|Induction Treatment Phase||0
264834|NCT00961415|641953|P1|COMPLETED|Induction Treatment Phase||253
264835|NCT00961415|641951|P3|STARTED|Induction Treatment Phase||0
264836|NCT00961415|641952|P2|STARTED|Induction Treatment Phase||0
264837|NCT00961415|641953|P1|STARTED|Induction Treatment Phase||376
264838|NCT00961402|641978|P2|NOT COMPLETED|Overall Study||5
264839|NCT00961402|641979|P1|NOT COMPLETED|Overall Study||1
264840|NCT00961402|641978|P2|COMPLETED|Overall Study||61
264841|NCT00961402|641979|P1|COMPLETED|Overall Study||63
264842|NCT00961402|641978|P2|Randomized|Overall Study||66
264843|NCT00961402|641979|P1|Randomized|Overall Study||64
264844|NCT00961402|641978|P2|STARTED|Overall Study||66
264845|NCT00961402|641979|P1|STARTED|Overall Study||64
264846|NCT00961350|641993|P2|NOT COMPLETED|Overall Study||67
264847|NCT00961350|641994|P1|NOT COMPLETED|Overall Study||47
264848|NCT00961350|641993|P2|COMPLETED|Overall Study||198
264849|NCT00961350|641994|P1|COMPLETED|Overall Study||218
264850|NCT00961350|641993|P2|Safety Population|Overall Study||265
264851|NCT00961350|641994|P1|Safety Population|Overall Study|1. One sub rand to PA32540 took EC-Aspirin|264
264852|NCT00961350|641993|P2|Intent-to-Treat Population (ITT)|Overall Study||265
264853|NCT00961350|641994|P1|Intent-to-Treat Population (ITT)|Overall Study||265
264854|NCT00961350|641993|P2|STARTED|Overall Study||265
264855|NCT00961350|641994|P1|STARTED|Overall Study||265
264856|NCT00961311|642008|P1|NOT COMPLETED|Overall Study||0
264857|NCT00961311|642008|P1|COMPLETED|Overall Study||51
264858|NCT00961311|642008|P1|STARTED|Overall Study||51
264859|NCT00961298|642015|P1|NOT COMPLETED|12 Weeks Duloxetine Treatment Phase||3
264860|NCT00961298|642015|P1|COMPLETED|12 Weeks Duloxetine Treatment Phase||11
264861|NCT00961298|642015|P1|STARTED|12 Weeks Duloxetine Treatment Phase||14
264862|NCT00961298|642015|P1|NOT COMPLETED|Two Week Placebo Run in||1
264863|NCT00961298|642015|P1|COMPLETED|Two Week Placebo Run in||14
264864|NCT00961298|642015|P1|STARTED|Two Week Placebo Run in||15
264865|NCT00961259|642022|P3|NOT COMPLETED|Third Intervention||0
264866|NCT00961259|642023|P2|NOT COMPLETED|Third Intervention||0
264867|NCT00961259|642024|P1|NOT COMPLETED|Third Intervention||0
264868|NCT00961259|642022|P3|COMPLETED|Third Intervention||18
264869|NCT00961259|642023|P2|COMPLETED|Third Intervention||17
264870|NCT00961259|642024|P1|COMPLETED|Third Intervention||18
264871|NCT00961259|642022|P3|STARTED|Third Intervention||18
264872|NCT00961259|642023|P2|STARTED|Third Intervention||17
264873|NCT00961259|642024|P1|STARTED|Third Intervention||18
264874|NCT00961259|642022|P3|NOT COMPLETED|Washout Period of 7 Days||0
264875|NCT00961259|642023|P2|NOT COMPLETED|Washout Period of 7 Days||0
264876|NCT00961259|642024|P1|NOT COMPLETED|Washout Period of 7 Days||0
264877|NCT00961259|642022|P3|COMPLETED|Washout Period of 7 Days||18
264878|NCT00961259|642023|P2|COMPLETED|Washout Period of 7 Days||17
264879|NCT00961259|642024|P1|COMPLETED|Washout Period of 7 Days||18
264880|NCT00961259|642022|P3|STARTED|Washout Period of 7 Days||18
264881|NCT00961259|642023|P2|STARTED|Washout Period of 7 Days||17
264882|NCT00961259|642024|P1|STARTED|Washout Period of 7 Days||18
264883|NCT00961259|642022|P3|NOT COMPLETED|Second Intervention||0
264884|NCT00961259|642023|P2|NOT COMPLETED|Second Intervention||0
264885|NCT00961259|642024|P1|NOT COMPLETED|Second Intervention||0
264886|NCT00961259|642022|P3|COMPLETED|Second Intervention||18
264887|NCT00961259|642023|P2|COMPLETED|Second Intervention||17
264888|NCT00961259|642024|P1|COMPLETED|Second Intervention||18
264889|NCT00961259|642022|P3|STARTED|Second Intervention||18
264890|NCT00961259|642023|P2|STARTED|Second Intervention||17
264891|NCT00961259|642024|P1|STARTED|Second Intervention||18
264892|NCT00961259|642022|P3|NOT COMPLETED|Washout Period of 7 Days||0
264893|NCT00961259|642023|P2|NOT COMPLETED|Washout Period of 7 Days||1
264894|NCT00961259|642024|P1|NOT COMPLETED|Washout Period of 7 Days||0
264895|NCT00961259|642022|P3|COMPLETED|Washout Period of 7 Days||18
264896|NCT00961259|642023|P2|COMPLETED|Washout Period of 7 Days|dropped due to concomitant medication used prior to admission.|17
264897|NCT00961259|642024|P1|COMPLETED|Washout Period of 7 Days||18
264898|NCT00961259|642022|P3|STARTED|Washout Period of 7 Days||18
264899|NCT00961259|642023|P2|STARTED|Washout Period of 7 Days||18
264900|NCT00961259|642024|P1|STARTED|Washout Period of 7 Days||18
264901|NCT00961259|642022|P3|NOT COMPLETED|First Intervention||0
264902|NCT00961259|642023|P2|NOT COMPLETED|First Intervention||0
264903|NCT00961259|642024|P1|NOT COMPLETED|First Intervention||0
264904|NCT00961259|642022|P3|COMPLETED|First Intervention||18
264905|NCT00961259|642023|P2|COMPLETED|First Intervention||18
264906|NCT00961259|642024|P1|COMPLETED|First Intervention||18
264907|NCT00961259|642022|P3|STARTED|First Intervention||18
264908|NCT00961259|642023|P2|STARTED|First Intervention||18
264909|NCT00961259|642024|P1|STARTED|First Intervention||18
264910|NCT00961233|642043|P2|NOT COMPLETED|Overall Study||1
264911|NCT00961233|642044|P1|NOT COMPLETED|Overall Study||2
264912|NCT00961233|642043|P2|COMPLETED|Overall Study||11
264913|NCT00961233|642044|P1|COMPLETED|Overall Study||11
264914|NCT00961233|642043|P2|STARTED|Overall Study||12
264915|NCT00961233|642044|P1|STARTED|Overall Study||13
264916|NCT00961220|642052|P1|NOT COMPLETED|Overall Study||7
264917|NCT00961220|642052|P1|COMPLETED|Overall Study||10
264918|NCT00961220|642052|P1|STARTED|Overall Study||17
264919|NCT00961181|642068|P1|NOT COMPLETED|Overall Study||5
264920|NCT00961181|642068|P1|COMPLETED|Overall Study||76
264921|NCT00961181|642068|P1|STARTED|Overall Study||81
264922|NCT00961116|642081|P2|NOT COMPLETED|Second Intervention||0
264923|NCT00961116|642082|P1|NOT COMPLETED|Second Intervention||0
264924|NCT00961116|642081|P2|COMPLETED|Second Intervention||24
264925|NCT00961116|642082|P1|COMPLETED|Second Intervention||25
264926|NCT00961116|642081|P2|STARTED|Second Intervention||24
264927|NCT00961116|642082|P1|STARTED|Second Intervention||25
264928|NCT00961116|642081|P2|NOT COMPLETED|Washout Period of 7 Days||3
264929|NCT00961116|642082|P1|NOT COMPLETED|Washout Period of 7 Days||2
264930|NCT00961116|642081|P2|COMPLETED|Washout Period of 7 Days||24
264931|NCT00961116|642082|P1|COMPLETED|Washout Period of 7 Days||25
264932|NCT00961116|642081|P2|STARTED|Washout Period of 7 Days||27
264933|NCT00961116|642082|P1|STARTED|Washout Period of 7 Days||27
264934|NCT00961116|642081|P2|NOT COMPLETED|First Intervention||0
264935|NCT00961116|642082|P1|NOT COMPLETED|First Intervention||0
264936|NCT00961116|642081|P2|COMPLETED|First Intervention||27
264937|NCT00961116|642082|P1|COMPLETED|First Intervention||27
264938|NCT00961116|642081|P2|STARTED|First Intervention||27
264939|NCT00961116|642082|P1|STARTED|First Intervention||27
264940|NCT00961064|642092|P1|NOT COMPLETED|Overall Study||0
264941|NCT00961064|642092|P1|COMPLETED|Overall Study||30
264942|NCT00961064|642092|P1|STARTED|Overall Study||30
264943|NCT00961051|642098|P2|NOT COMPLETED|Overall Study||14
264944|NCT00961051|642099|P1|NOT COMPLETED|Overall Study||12
264945|NCT00961051|642098|P2|COMPLETED|Overall Study||79
264946|NCT00961051|642099|P1|COMPLETED|Overall Study||165
264947|NCT00961051|642098|P2|STARTED|Overall Study||93
264948|NCT00961051|642099|P1|STARTED|Overall Study||177
264949|NCT00960999|642109|P2|NOT COMPLETED|Overall Study||2
264950|NCT00960999|642110|P1|NOT COMPLETED|Overall Study||8
264951|NCT00960999|642109|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|45
264952|NCT00960999|642110|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|39
264953|NCT00960999|642109|P2|STARTED|Overall Study||47
264954|NCT00960999|642110|P1|STARTED|Overall Study||47
264955|NCT00960986|642120|P4|NOT COMPLETED|Period 3 (7-week Therapy Period)||25
264956|NCT00960986|642121|P3|NOT COMPLETED|Period 3 (7-week Therapy Period)||20
264957|NCT00960986|642122|P2|NOT COMPLETED|Period 3 (7-week Therapy Period)||23
264958|NCT00960986|642123|P1|NOT COMPLETED|Period 3 (7-week Therapy Period)||30
264959|NCT00960986|642120|P4|COMPLETED|Period 3 (7-week Therapy Period)||36
264960|NCT00960986|642121|P3|COMPLETED|Period 3 (7-week Therapy Period)||39
264961|NCT00960986|642122|P2|COMPLETED|Period 3 (7-week Therapy Period)||36
264962|NCT00960986|642123|P1|COMPLETED|Period 3 (7-week Therapy Period)||26
264963|NCT00960986|642120|P4|STARTED|Period 3 (7-week Therapy Period)||61
264964|NCT00960986|642121|P3|STARTED|Period 3 (7-week Therapy Period)||59
264965|NCT00960986|642122|P2|STARTED|Period 3 (7-week Therapy Period)||59
264966|NCT00960986|642123|P1|STARTED|Period 3 (7-week Therapy Period)||56
264967|NCT00960986|642120|P4|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
264968|NCT00960986|642121|P3|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
264969|NCT00960986|642122|P2|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
264970|NCT00960986|642123|P1|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
264971|NCT00960986|642120|P4|COMPLETED|Period 2 (1-week Initial Dosing Period)||61
264972|NCT00960986|642121|P3|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
264973|NCT00960986|642122|P2|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
264974|NCT00960986|642123|P1|COMPLETED|Period 2 (1-week Initial Dosing Period)||56
264975|NCT00960986|642120|P4|STARTED|Period 2 (1-week Initial Dosing Period)||61
264976|NCT00960986|642121|P3|STARTED|Period 2 (1-week Initial Dosing Period)||59
264977|NCT00960986|642122|P2|STARTED|Period 2 (1-week Initial Dosing Period)||59
264978|NCT00960986|642123|P1|STARTED|Period 2 (1-week Initial Dosing Period)||56
264979|NCT00960986|642120|P4|NOT COMPLETED|Period 1 (Screening and Washout)||3
264980|NCT00960986|642121|P3|NOT COMPLETED|Period 1 (Screening and Washout)||4
264981|NCT00960986|642122|P2|NOT COMPLETED|Period 1 (Screening and Washout)||4
264982|NCT00960986|642123|P1|NOT COMPLETED|Period 1 (Screening and Washout)||3
264983|NCT00960986|642120|P4|COMPLETED|Period 1 (Screening and Washout)||61
264984|NCT00960986|642121|P3|COMPLETED|Period 1 (Screening and Washout)||59
264985|NCT00960986|642122|P2|COMPLETED|Period 1 (Screening and Washout)||59
264986|NCT00960986|642123|P1|COMPLETED|Period 1 (Screening and Washout)||56
264987|NCT00960986|642120|P4|STARTED|Period 1 (Screening and Washout)||64
264988|NCT00960986|642121|P3|STARTED|Period 1 (Screening and Washout)||63
264989|NCT00960986|642122|P2|STARTED|Period 1 (Screening and Washout)||63
264990|NCT00960986|642123|P1|STARTED|Period 1 (Screening and Washout)||59
264991|NCT00960934|642199|P6|NOT COMPLETED|Overall Study||64
264992|NCT00960934|642200|P5|NOT COMPLETED|Overall Study||64
264993|NCT00960934|642201|P4|NOT COMPLETED|Overall Study||64
264994|NCT00960934|642202|P3|NOT COMPLETED|Overall Study||64
264995|NCT00960934|642203|P2|NOT COMPLETED|Overall Study||63
264996|NCT00960934|642204|P1|NOT COMPLETED|Overall Study||64
264997|NCT00960934|642199|P6|COMPLETED|Overall Study||0
264998|NCT00960934|642200|P5|COMPLETED|Overall Study||0
264999|NCT00960934|642201|P4|COMPLETED|Overall Study||0
265000|NCT00960934|642202|P3|COMPLETED|Overall Study||0
265001|NCT00960934|642203|P2|COMPLETED|Overall Study||0
265002|NCT00960934|642204|P1|COMPLETED|Overall Study||0
265003|NCT00960934|642199|P6|Number Treated|Overall Study|1 participant was randomized but not treated|63
265004|NCT00960934|642200|P5|Number Treated|Overall Study|1 participant was randomized but not treated|63
265005|NCT00960934|642201|P4|Number Treated|Overall Study||64
265006|NCT00960934|642202|P3|Number Treated|Overall Study||64
265007|NCT00960934|642203|P2|Number Treated|Overall Study|1 participant was randomized but not treated|62
265008|NCT00960934|642204|P1|Number Treated|Overall Study||64
265009|NCT00960934|642199|P6|STARTED|Overall Study||64
265010|NCT00960934|642200|P5|STARTED|Overall Study||64
265011|NCT00960934|642201|P4|STARTED|Overall Study||64
265012|NCT00960934|642202|P3|STARTED|Overall Study||64
265013|NCT00960934|642203|P2|STARTED|Overall Study||63
265014|NCT00960934|642204|P1|STARTED|Overall Study||64
265015|NCT00960869|642316|P2|NOT COMPLETED|Overall Study||62
265016|NCT00960869|642317|P1|NOT COMPLETED|Overall Study||53
265017|NCT00960869|642316|P2|COMPLETED|Overall Study||198
265018|NCT00960869|642317|P1|COMPLETED|Overall Study||206
265019|NCT00960869|642316|P2|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|259
265020|NCT00960869|642317|P1|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|257
265021|NCT00960869|642316|P2|Intent-to-Treat Population (ITT)|Overall Study||260
265022|NCT00960869|642317|P1|Intent-to-Treat Population (ITT)|Overall Study||259
265023|NCT00960869|642316|P2|STARTED|Overall Study||260
265024|NCT00960869|642317|P1|STARTED|Overall Study||259
265025|NCT00960856|642331|P4|NOT COMPLETED|Period IV||0
265026|NCT00960856|642332|P3|NOT COMPLETED|Period IV||0
265027|NCT00960856|642333|P2|NOT COMPLETED|Period IV||0
265028|NCT00960856|642334|P1|NOT COMPLETED|Period IV||0
265029|NCT00960856|642331|P4|COMPLETED|Period IV||9
265030|NCT00960856|642332|P3|COMPLETED|Period IV||8
265031|NCT00960856|642333|P2|COMPLETED|Period IV||7
265032|NCT00960856|642334|P1|COMPLETED|Period IV||10
265033|NCT00960856|642331|P4|STARTED|Period IV||9
265034|NCT00960856|642332|P3|STARTED|Period IV||8
265035|NCT00960856|642333|P2|STARTED|Period IV||7
265036|NCT00960856|642334|P1|STARTED|Period IV||10
265037|NCT00960856|642331|P4|NOT COMPLETED|Washout Period of 7 Days||0
265038|NCT00960856|642332|P3|NOT COMPLETED|Washout Period of 7 Days||1
265039|NCT00960856|642333|P2|NOT COMPLETED|Washout Period of 7 Days||0
265040|NCT00960856|642334|P1|NOT COMPLETED|Washout Period of 7 Days||0
265041|NCT00960856|642331|P4|COMPLETED|Washout Period of 7 Days||9
265042|NCT00960856|642332|P3|COMPLETED|Washout Period of 7 Days||8
265043|NCT00960856|642333|P2|COMPLETED|Washout Period of 7 Days||7
265044|NCT00960856|642334|P1|COMPLETED|Washout Period of 7 Days||10
265045|NCT00960856|642331|P4|STARTED|Washout Period of 7 Days||9
265046|NCT00960856|642332|P3|STARTED|Washout Period of 7 Days||9
265047|NCT00960856|642333|P2|STARTED|Washout Period of 7 Days||7
265048|NCT00960856|642334|P1|STARTED|Washout Period of 7 Days||10
265049|NCT00960856|642331|P4|NOT COMPLETED|Period III||0
265050|NCT00960856|642332|P3|NOT COMPLETED|Period III||0
265051|NCT00960856|642333|P2|NOT COMPLETED|Period III||0
265052|NCT00960856|642334|P1|NOT COMPLETED|Period III||0
265053|NCT00960856|642331|P4|COMPLETED|Period III||9
265054|NCT00960856|642332|P3|COMPLETED|Period III||9
265055|NCT00960856|642333|P2|COMPLETED|Period III||7
265056|NCT00960856|642334|P1|COMPLETED|Period III||10
265057|NCT00960856|642331|P4|STARTED|Period III||9
265058|NCT00960856|642332|P3|STARTED|Period III||9
265059|NCT00960856|642333|P2|STARTED|Period III||7
265060|NCT00960856|642334|P1|STARTED|Period III||10
265061|NCT00960856|642331|P4|NOT COMPLETED|Washout Period of 7 Days||0
265062|NCT00960856|642332|P3|NOT COMPLETED|Washout Period of 7 Days||0
265063|NCT00960856|642333|P2|NOT COMPLETED|Washout Period of 7 Days||0
265064|NCT00960856|642334|P1|NOT COMPLETED|Washout Period of 7 Days||0
265065|NCT00960856|642331|P4|COMPLETED|Washout Period of 7 Days||9
265066|NCT00960856|642332|P3|COMPLETED|Washout Period of 7 Days||9
265067|NCT00960856|642333|P2|COMPLETED|Washout Period of 7 Days||7
265068|NCT00960856|642334|P1|COMPLETED|Washout Period of 7 Days||10
265069|NCT00960856|642331|P4|STARTED|Washout Period of 7 Days||9
265070|NCT00960856|642332|P3|STARTED|Washout Period of 7 Days||9
265071|NCT00960856|642333|P2|STARTED|Washout Period of 7 Days||7
265072|NCT00960856|642334|P1|STARTED|Washout Period of 7 Days||10
265073|NCT00960856|642331|P4|NOT COMPLETED|Period II||0
265074|NCT00960856|642332|P3|NOT COMPLETED|Period II||0
265075|NCT00960856|642333|P2|NOT COMPLETED|Period II||0
265076|NCT00960856|642334|P1|NOT COMPLETED|Period II||0
265077|NCT00960856|642331|P4|COMPLETED|Period II||9
265078|NCT00960856|642332|P3|COMPLETED|Period II||9
265079|NCT00960856|642333|P2|COMPLETED|Period II||7
265080|NCT00960856|642334|P1|COMPLETED|Period II||10
265081|NCT00960856|642331|P4|STARTED|Period II||9
265082|NCT00960856|642332|P3|STARTED|Period II||9
265083|NCT00960856|642333|P2|STARTED|Period II||7
265084|NCT00960856|642334|P1|STARTED|Period II||10
265085|NCT00960856|642331|P4|NOT COMPLETED|Washout Period of 7 Days||0
265086|NCT00960856|642332|P3|NOT COMPLETED|Washout Period of 7 Days||0
265087|NCT00960856|642333|P2|NOT COMPLETED|Washout Period of 7 Days||2
265088|NCT00960856|642334|P1|NOT COMPLETED|Washout Period of 7 Days||0
265089|NCT00960856|642331|P4|COMPLETED|Washout Period of 7 Days||9
265090|NCT00960856|642332|P3|COMPLETED|Washout Period of 7 Days||9
265091|NCT00960856|642333|P2|COMPLETED|Washout Period of 7 Days|personal reasons|7
265092|NCT00960856|642334|P1|COMPLETED|Washout Period of 7 Days||10
265093|NCT00960856|642331|P4|STARTED|Washout Period of 7 Days||9
265094|NCT00960856|642332|P3|STARTED|Washout Period of 7 Days||9
265095|NCT00960856|642333|P2|STARTED|Washout Period of 7 Days||9
265096|NCT00960856|642334|P1|STARTED|Washout Period of 7 Days||10
265097|NCT00960856|642331|P4|NOT COMPLETED|Period I||0
265098|NCT00960856|642332|P3|NOT COMPLETED|Period I||0
265099|NCT00960856|642333|P2|NOT COMPLETED|Period I||0
265100|NCT00960856|642334|P1|NOT COMPLETED|Period I||0
265101|NCT00960856|642331|P4|COMPLETED|Period I||9
265102|NCT00960856|642332|P3|COMPLETED|Period I||9
265103|NCT00960856|642333|P2|COMPLETED|Period I||9
265104|NCT00960856|642334|P1|COMPLETED|Period I||10
265105|NCT00960856|642331|P4|STARTED|Period I||9
265106|NCT00960856|642332|P3|STARTED|Period I||9
265107|NCT00960856|642333|P2|STARTED|Period I||9
265108|NCT00960856|642334|P1|STARTED|Period I||10
265109|NCT00960843|642354|P2|NOT COMPLETED|Overall Study||5
265110|NCT00960843|642355|P1|NOT COMPLETED|Overall Study||2
265111|NCT00960843|642354|P2|COMPLETED|Overall Study||21
265112|NCT00960843|642355|P1|COMPLETED|Overall Study||23
265113|NCT00960843|642354|P2|STARTED|Overall Study||26
265114|NCT00960843|642355|P1|STARTED|Overall Study||25
265115|NCT00960778|642367|P2|NOT COMPLETED|Overall Study||3
265116|NCT00960778|642368|P1|NOT COMPLETED|Overall Study||9
265117|NCT00960778|642367|P2|COMPLETED|Overall Study||13
265118|NCT00960778|642368|P1|COMPLETED|Overall Study||8
265119|NCT00960778|642367|P2|STARTED|Overall Study||16
265120|NCT00960778|642368|P1|STARTED|Overall Study||17
265121|NCT00960687|642376|P2|NOT COMPLETED|Second Intervention||0
265122|NCT00960687|642377|P1|NOT COMPLETED|Second Intervention||0
265123|NCT00960687|642376|P2|COMPLETED|Second Intervention||24
265124|NCT00960687|642377|P1|COMPLETED|Second Intervention||23
265125|NCT00960687|642376|P2|STARTED|Second Intervention||24
265126|NCT00960687|642377|P1|STARTED|Second Intervention||23
265127|NCT00960687|642376|P2|NOT COMPLETED|Washout Period of 7 Days||3
265128|NCT00960687|642377|P1|NOT COMPLETED|Washout Period of 7 Days||4
265129|NCT00960687|642376|P2|COMPLETED|Washout Period of 7 Days|two subjects withdrew due to adverse events and one subject withdrew for personal reasons.|24
265130|NCT00960687|642377|P1|COMPLETED|Washout Period of 7 Days|three subjects withdrew due to adverse events and one subject withdrew for personal reasons.|23
265131|NCT00960687|642376|P2|STARTED|Washout Period of 7 Days||27
265132|NCT00960687|642377|P1|STARTED|Washout Period of 7 Days||27
265133|NCT00960687|642376|P2|NOT COMPLETED|First Intervention||0
265134|NCT00960687|642377|P1|NOT COMPLETED|First Intervention||0
265135|NCT00960687|642376|P2|COMPLETED|First Intervention||27
265136|NCT00960687|642377|P1|COMPLETED|First Intervention||27
265137|NCT00960687|642376|P2|STARTED|First Intervention||27
265138|NCT00960687|642377|P1|STARTED|First Intervention||27
265139|NCT00960661|642389|P3|NOT COMPLETED|Interventional Phase||46
265140|NCT00960661|642390|P2|NOT COMPLETED|Interventional Phase||52
265141|NCT00960661|642391|P1|NOT COMPLETED|Interventional Phase||0
265142|NCT00960661|642389|P3|COMPLETED|Interventional Phase||275
265143|NCT00960661|642390|P2|COMPLETED|Interventional Phase||264
265144|NCT00960661|642391|P1|COMPLETED|Interventional Phase||0
265145|NCT00960661|642389|P3|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|263
265146|NCT00960661|642390|P2|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|247
265147|NCT00960661|642391|P1|Per Protocol Population|Interventional Phase||0
265148|NCT00960661|642389|P3|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|312
265149|NCT00960661|642390|P2|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|315
265150|NCT00960661|642391|P1|Intent to Treat Population|Interventional Phase||0
265151|NCT00960661|642389|P3|STARTED|Interventional Phase||321
265152|NCT00960661|642390|P2|STARTED|Interventional Phase||316
265153|NCT00960661|642391|P1|STARTED|Interventional Phase||0
265154|NCT00960661|642389|P3|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
265155|NCT00960661|642390|P2|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
265156|NCT00960661|642391|P1|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||399
265157|NCT00960661|642389|P3|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
265158|NCT00960661|642390|P2|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
265159|NCT00960661|642391|P1|COMPLETED|Basal Insulin Optimization Phase (BIO)||637
265160|NCT00960661|642389|P3|STARTED|Basal Insulin Optimization Phase (BIO)||0
265161|NCT00960661|642390|P2|STARTED|Basal Insulin Optimization Phase (BIO)||0
265162|NCT00960661|642391|P1|STARTED|Basal Insulin Optimization Phase (BIO)||1036
265163|NCT00960622|642423|P2|NOT COMPLETED|Overall Study||3
265164|NCT00960622|642424|P1|NOT COMPLETED|Overall Study||0
265165|NCT00960622|642423|P2|COMPLETED|Overall Study||7
265166|NCT00960622|642424|P1|COMPLETED|Overall Study||10
265167|NCT00960622|642423|P2|STARTED|Overall Study||10
265168|NCT00960622|642424|P1|STARTED|Overall Study||10
265169|NCT00960570|642430|P1|NOT COMPLETED|Efavirenz and Fenofibric Acid||0
265170|NCT00960570|642430|P1|COMPLETED|Efavirenz and Fenofibric Acid||25
265171|NCT00960570|642430|P1|STARTED|Efavirenz and Fenofibric Acid||25
265172|NCT00960570|642430|P1|NOT COMPLETED|1 Day Period Between Dosing||3
265173|NCT00960570|642430|P1|COMPLETED|1 Day Period Between Dosing||25
265174|NCT00960570|642430|P1|STARTED|1 Day Period Between Dosing||28
265175|NCT00960570|642430|P1|NOT COMPLETED|Fenofibric Acid Alone||0
265176|NCT00960570|642430|P1|COMPLETED|Fenofibric Acid Alone||28
265177|NCT00960570|642430|P1|STARTED|Fenofibric Acid Alone||28
265178|NCT00960570|642430|P1|NOT COMPLETED|21 Day Washout Period||2
265179|NCT00960570|642430|P1|COMPLETED|21 Day Washout Period||28
265180|NCT00960570|642430|P1|STARTED|21 Day Washout Period||30
265181|NCT00960570|642430|P1|NOT COMPLETED|Efavirenz Alone||0
265182|NCT00960570|642430|P1|COMPLETED|Efavirenz Alone||30
265183|NCT00960570|642430|P1|STARTED|Efavirenz Alone||30
265184|NCT00960531|642451|P10|NOT COMPLETED|Overall Study||1
265185|NCT00960531|642452|P9|NOT COMPLETED|Overall Study||14
265186|NCT00960531|642453|P8|NOT COMPLETED|Overall Study||4
265187|NCT00960531|642454|P7|NOT COMPLETED|Overall Study||24
265188|NCT00960531|642455|P6|NOT COMPLETED|Overall Study||3
265189|NCT00960531|642456|P5|NOT COMPLETED|Overall Study||2
265190|NCT00960531|642457|P4|NOT COMPLETED|Overall Study||8
265191|NCT00960531|642458|P3|NOT COMPLETED|Overall Study||26
265192|NCT00960531|642459|P2|NOT COMPLETED|Overall Study||1
265193|NCT00960531|642460|P1|NOT COMPLETED|Overall Study||10
265194|NCT00960531|642451|P10|COMPLETED|Overall Study|Completed study|3
265195|NCT00960531|642452|P9|COMPLETED|Overall Study|Completed study|2
265196|NCT00960531|642453|P8|COMPLETED|Overall Study|Completed study|2
265197|NCT00960531|642454|P7|COMPLETED|Overall Study|Completed study|3
265198|NCT00960531|642455|P6|COMPLETED|Overall Study|Completed study|6
265199|NCT00960531|642456|P5|COMPLETED|Overall Study|Completed study|3
265200|NCT00960531|642457|P4|COMPLETED|Overall Study|Completed study|17
265201|NCT00960531|642458|P3|COMPLETED|Overall Study|Completed study|15
265202|NCT00960531|642459|P2|COMPLETED|Overall Study|Completed study|5
265203|NCT00960531|642460|P1|COMPLETED|Overall Study|Completed study|11
265204|NCT00960531|642451|P10|Completed Treatment|Overall Study||4
265205|NCT00960531|642452|P9|Completed Treatment|Overall Study||2
265206|NCT00960531|642453|P8|Completed Treatment|Overall Study||3
265207|NCT00960531|642454|P7|Completed Treatment|Overall Study||4
265208|NCT00960531|642455|P6|Completed Treatment|Overall Study||7
265209|NCT00960531|642456|P5|Completed Treatment|Overall Study||3
265210|NCT00960531|642457|P4|Completed Treatment|Overall Study||17
265211|NCT00960531|642458|P3|Completed Treatment|Overall Study||15
265212|NCT00960531|642459|P2|Completed Treatment|Overall Study||5
265213|NCT00960531|642460|P1|Completed Treatment|Overall Study||12
265214|NCT00960531|642451|P10|Treated|Overall Study||4
265215|NCT00960531|642452|P9|Treated|Overall Study||16
265216|NCT00960531|642453|P8|Treated|Overall Study||6
265217|NCT00960531|642454|P7|Treated|Overall Study||27
265218|NCT00960531|642455|P6|Treated|Overall Study||9
265219|NCT00960531|642456|P5|Treated|Overall Study||5
265220|NCT00960531|642457|P4|Treated|Overall Study||24
265221|NCT00960531|642458|P3|Treated|Overall Study||41
265222|NCT00960531|642459|P2|Treated|Overall Study||6
265223|NCT00960531|642460|P1|Treated|Overall Study||21
265224|NCT00960531|642451|P10|STARTED|Overall Study|Started=Randomized|4
265225|NCT00960531|642452|P9|STARTED|Overall Study|Started=Randomized|16
265226|NCT00960531|642453|P8|STARTED|Overall Study|Started=Randomized|6
265227|NCT00960531|642454|P7|STARTED|Overall Study|Started=Randomized|27
265228|NCT00960531|642455|P6|STARTED|Overall Study|Started=Randomized|9
265229|NCT00960531|642456|P5|STARTED|Overall Study|Started=Randomized|5
265230|NCT00960531|642457|P4|STARTED|Overall Study|Started=Randomized.|25
265231|NCT00960531|642458|P3|STARTED|Overall Study|Started=Randomized|41
265232|NCT00960531|642459|P2|STARTED|Overall Study|Started=Randomized|6
265233|NCT00960531|642460|P1|STARTED|Overall Study|Started=Randomized|21
265234|NCT00960440|642508|P4|NOT COMPLETED|Overall Study||18
265235|NCT00960440|642509|P3|NOT COMPLETED|Overall Study||13
265236|NCT00960440|642510|P2|NOT COMPLETED|Overall Study||31
265237|NCT00960440|642511|P1|NOT COMPLETED|Overall Study||26
265238|NCT00960440|642508|P4|COMPLETED|Overall Study||48
265239|NCT00960440|642509|P3|COMPLETED|Overall Study||53
265240|NCT00960440|642510|P2|COMPLETED|Overall Study||103
265241|NCT00960440|642511|P1|COMPLETED|Overall Study||107
265242|NCT00960440|642508|P4|STARTED|Overall Study||66
265243|NCT00960440|642509|P3|STARTED|Overall Study||66
265244|NCT00960440|642510|P2|STARTED|Overall Study||134
265245|NCT00960440|642511|P1|STARTED|Overall Study||133
265246|NCT00960375|642683|P2|NOT COMPLETED|Overall Study||22
265247|NCT00960375|642684|P1|NOT COMPLETED|Overall Study||20
265248|NCT00960375|642683|P2|COMPLETED|Overall Study||65
265249|NCT00960375|642684|P1|COMPLETED|Overall Study||72
265250|NCT00960375|642683|P2|STARTED|Overall Study||87
265251|NCT00960375|642684|P1|STARTED|Overall Study||92
265252|NCT00960323|642692|P1|NOT COMPLETED|Colchicine and Atorvastatin||0
265253|NCT00960323|642692|P1|COMPLETED|Colchicine and Atorvastatin||23
265254|NCT00960323|642692|P1|STARTED|Colchicine and Atorvastatin||23
265255|NCT00960323|642692|P1|NOT COMPLETED|Atorvastatin Alone||1
265256|NCT00960323|642692|P1|COMPLETED|Atorvastatin Alone||23
265257|NCT00960323|642692|P1|STARTED|Atorvastatin Alone||24
265258|NCT00960323|642692|P1|NOT COMPLETED|14 Day Washout Period||0
265259|NCT00960323|642692|P1|COMPLETED|14 Day Washout Period||24
265260|NCT00960323|642692|P1|STARTED|14 Day Washout Period||24
265261|NCT00960323|642692|P1|NOT COMPLETED|Colchicine Alone||0
265262|NCT00960323|642692|P1|COMPLETED|Colchicine Alone||24
265263|NCT00960323|642692|P1|STARTED|Colchicine Alone||24
265264|NCT00960297|642703|P1|NOT COMPLETED|Overall Study||3
265265|NCT00960297|642703|P1|COMPLETED|Overall Study||1
265266|NCT00960297|642703|P1|STARTED|Overall Study||4
265267|NCT00960206|642710|P3|NOT COMPLETED|Overall Study||12
265268|NCT00960206|642711|P2|NOT COMPLETED|Overall Study||27
265269|NCT00960206|642712|P1|NOT COMPLETED|Overall Study||40
265270|NCT00960206|642710|P3|COMPLETED|Overall Study||77
265271|NCT00960206|642711|P2|COMPLETED|Overall Study||158
265272|NCT00960206|642712|P1|COMPLETED|Overall Study||150
265273|NCT00960206|642710|P3|STARTED|Overall Study||89
265274|NCT00960206|642711|P2|STARTED|Overall Study||185
265275|NCT00960206|642712|P1|STARTED|Overall Study||190
265276|NCT00960193|642730|P1|NOT COMPLETED|Colchicine With Seville Orange Juice||0
265277|NCT00960193|642730|P1|COMPLETED|Colchicine With Seville Orange Juice||23
265278|NCT00960193|642730|P1|STARTED|Colchicine With Seville Orange Juice||23
265279|NCT00960193|642730|P1|NOT COMPLETED|Seville Orange Juice Alone||0
265280|NCT00960193|642730|P1|COMPLETED|Seville Orange Juice Alone||23
265281|NCT00960193|642730|P1|STARTED|Seville Orange Juice Alone||23
265282|NCT00960193|642730|P1|NOT COMPLETED|14 Day Washout Period||1
265283|NCT00960193|642730|P1|COMPLETED|14 Day Washout Period||23
265284|NCT00960193|642730|P1|STARTED|14 Day Washout Period||24
265285|NCT00960193|642730|P1|NOT COMPLETED|Colchicine Alone||0
265286|NCT00960193|642730|P1|COMPLETED|Colchicine Alone||24
265287|NCT00960193|642730|P1|STARTED|Colchicine Alone||24
265288|NCT00960154|642743|P2|NOT COMPLETED|Overall Study||25
265289|NCT00960154|642744|P1|NOT COMPLETED|Overall Study||25
265290|NCT00960154|642743|P2|COMPLETED|Overall Study||0
265291|NCT00960154|642744|P1|COMPLETED|Overall Study||0
265292|NCT00960154|642743|P2|STARTED|Overall Study||25
265293|NCT00960154|642744|P1|STARTED|Overall Study||25
265294|NCT00960141|642755|P3|NOT COMPLETED|Overall Study||7
265295|NCT00960141|642756|P2|NOT COMPLETED|Overall Study||17
265296|NCT00960141|642757|P1|NOT COMPLETED|Overall Study||10
265297|NCT00960141|642755|P3|COMPLETED|Overall Study||163
265298|NCT00960141|642756|P2|COMPLETED|Overall Study||309
265299|NCT00960141|642757|P1|COMPLETED|Overall Study||323
265300|NCT00960141|642755|P3|STARTED|Overall Study||170
265301|NCT00960141|642756|P2|STARTED|Overall Study||326
265302|NCT00960141|642757|P1|STARTED|Overall Study||333
265303|NCT00960115|642782|P2|NOT COMPLETED|Overall Study||15
265304|NCT00960115|642783|P1|NOT COMPLETED|Overall Study||19
265305|NCT00960115|642782|P2|COMPLETED|Overall Study||43
265306|NCT00960115|642783|P1|COMPLETED|Overall Study||95
265307|NCT00960115|642782|P2|STARTED|Overall Study||58
265308|NCT00960115|642783|P1|STARTED|Overall Study||114
265309|NCT00960076|642797|P2|NOT COMPLETED|Overall Study||25
265310|NCT00960076|642798|P1|NOT COMPLETED|Overall Study||8
265311|NCT00960076|642797|P2|COMPLETED|Overall Study|Completing 18 weeks of treatment|119
265403|NCT00959699|643061|P1|STARTED|Treatment Period||34
265312|NCT00960076|642798|P1|COMPLETED|Overall Study|Completing 18 weeks of treatment|130
265313|NCT00960076|642797|P2|STARTED|Overall Study|Randomized and treated|144
265314|NCT00960076|642798|P1|STARTED|Overall Study|Randomized and treated|138
265315|NCT00960063|642813|P3|NOT COMPLETED|Overall Study||3
265316|NCT00960063|642814|P2|NOT COMPLETED|Overall Study||0
265317|NCT00960063|642815|P1|NOT COMPLETED|Overall Study||1
265318|NCT00960063|642813|P3|COMPLETED|Overall Study||0
265319|NCT00960063|642814|P2|COMPLETED|Overall Study||0
265320|NCT00960063|642815|P1|COMPLETED|Overall Study||0
265321|NCT00960063|642813|P3|STARTED|Overall Study||3
265322|NCT00960063|642814|P2|STARTED|Overall Study||0
265323|NCT00960063|642815|P1|STARTED|Overall Study||1
265324|NCT00959985|642857|P4|NOT COMPLETED|Overall Study||0
265325|NCT00959985|642858|P3|NOT COMPLETED|Overall Study||0
265326|NCT00959985|642859|P2|NOT COMPLETED|Overall Study||0
265327|NCT00959985|642860|P1|NOT COMPLETED|Overall Study||0
265328|NCT00959985|642857|P4|COMPLETED|Overall Study||4
265329|NCT00959985|642858|P3|COMPLETED|Overall Study||4
265330|NCT00959985|642859|P2|COMPLETED|Overall Study||7
265331|NCT00959985|642860|P1|COMPLETED|Overall Study||8
265332|NCT00959985|642857|P4|STARTED|Overall Study||4
265333|NCT00959985|642858|P3|STARTED|Overall Study||4
265334|NCT00959985|642859|P2|STARTED|Overall Study||7
265335|NCT00959985|642860|P1|STARTED|Overall Study||8
265336|NCT00959946|642906|P8|NOT COMPLETED|Overall Study||2
265337|NCT00959946|642907|P7|NOT COMPLETED|Overall Study||2
265338|NCT00959946|642908|P6|NOT COMPLETED|Overall Study||9
265339|NCT00959946|642909|P5|NOT COMPLETED|Overall Study||4
265340|NCT00959946|642910|P4|NOT COMPLETED|Overall Study||5
265341|NCT00959946|642911|P3|NOT COMPLETED|Overall Study||4
265342|NCT00959946|642912|P2|NOT COMPLETED|Overall Study||4
265343|NCT00959946|642913|P1|NOT COMPLETED|Overall Study||2
265344|NCT00959946|642906|P8|COMPLETED|Overall Study||0
265345|NCT00959946|642907|P7|COMPLETED|Overall Study||0
265346|NCT00959946|642908|P6|COMPLETED|Overall Study||0
265347|NCT00959946|642909|P5|COMPLETED|Overall Study||0
265348|NCT00959946|642910|P4|COMPLETED|Overall Study||0
265349|NCT00959946|642911|P3|COMPLETED|Overall Study||0
265350|NCT00959946|642912|P2|COMPLETED|Overall Study||0
265351|NCT00959946|642913|P1|COMPLETED|Overall Study||0
265352|NCT00959946|642906|P8|STARTED|Overall Study||2
265353|NCT00959946|642907|P7|STARTED|Overall Study||2
265354|NCT00959946|642908|P6|STARTED|Overall Study||9
265355|NCT00959946|642909|P5|STARTED|Overall Study||4
265356|NCT00959946|642910|P4|STARTED|Overall Study||5
265357|NCT00959946|642911|P3|STARTED|Overall Study||4
265358|NCT00959946|642912|P2|STARTED|Overall Study||4
265359|NCT00959946|642913|P1|STARTED|Overall Study||2
265360|NCT00959920|642966|P2|NOT COMPLETED|Overall Study||1
265361|NCT00959920|642967|P1|NOT COMPLETED|Overall Study||0
265362|NCT00959920|642966|P2|COMPLETED|Overall Study||66
265363|NCT00959920|642967|P1|COMPLETED|Overall Study||72
265364|NCT00959920|642966|P2|STARTED|Overall Study||67
265365|NCT00959920|642967|P1|STARTED|Overall Study||72
265366|NCT00959907|642977|P2|NOT COMPLETED|Overall Study||1
265367|NCT00959907|642978|P1|NOT COMPLETED|Overall Study||3
265368|NCT00959907|642977|P2|COMPLETED|Overall Study||28
265369|NCT00959907|642978|P1|COMPLETED|Overall Study||27
265370|NCT00959907|642977|P2|STARTED|Overall Study||29
265371|NCT00959907|642978|P1|STARTED|Overall Study||30
265372|NCT00959894|642988|P1|NOT COMPLETED|Overall Study||16
265373|NCT00959894|642988|P1|COMPLETED|Overall Study||63
265374|NCT00959894|642988|P1|STARTED|Overall Study|One (1) additional subject became ineligible on the day of entry and never started study medication.|79
265375|NCT00959764|643019|P3|NOT COMPLETED|Overall Study||36
265376|NCT00959764|643020|P2|NOT COMPLETED|Overall Study||57
265377|NCT00959764|643021|P1|NOT COMPLETED|Overall Study||95
265378|NCT00959764|643019|P3|COMPLETED|Overall Study||73
265379|NCT00959764|643020|P2|COMPLETED|Overall Study||128
265380|NCT00959764|643021|P1|COMPLETED|Overall Study||176
265381|NCT00959764|643019|P3|STARTED|Overall Study||109
265382|NCT00959764|643020|P2|STARTED|Overall Study||185
265383|NCT00959764|643021|P1|STARTED|Overall Study||271
265384|NCT00959751|643037|P2|NOT COMPLETED|Overall Study||12
265385|NCT00959751|643038|P1|NOT COMPLETED|Overall Study||9
265386|NCT00959751|643037|P2|COMPLETED|Overall Study||86
265387|NCT00959751|643038|P1|COMPLETED|Overall Study||88
265388|NCT00959751|643037|P2|STARTED|Overall Study||98
265389|NCT00959751|643038|P1|STARTED|Overall Study||97
265390|NCT00959699|643060|P2|NOT COMPLETED|Follow-up Period||6
265391|NCT00959699|643061|P1|NOT COMPLETED|Follow-up Period||6
265392|NCT00959699|643060|P2|COMPLETED|Follow-up Period||56
265393|NCT00959699|643061|P1|COMPLETED|Follow-up Period||27
265394|NCT00959699|643060|P2|STARTED|Follow-up Period|2 participants didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|62
265395|NCT00959699|643061|P1|STARTED|Follow-up Period|1 participant didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|33
265396|NCT00959699|643060|P2|NOT COMPLETED|Treatment Period||25
265397|NCT00959699|643061|P1|NOT COMPLETED|Treatment Period||23
265398|NCT00959699|643060|P2|COMPLETED|Treatment Period||40
265399|NCT00959699|643061|P1|COMPLETED|Treatment Period|At TW24, 4 participants not achieving undetectable HCV-RNA crossed-over and received boceprevir.|11
265400|NCT00959699|643060|P2|Treated|Treatment Period||64
265401|NCT00959699|643061|P1|Treated|Treatment Period||34
265402|NCT00959699|643060|P2|STARTED|Treatment Period||65
265404|NCT00959660|643082|P4|NOT COMPLETED|Overall Study||3
265405|NCT00959660|643083|P3|NOT COMPLETED|Overall Study||3
265406|NCT00959660|643084|P2|NOT COMPLETED|Overall Study||0
265407|NCT00959660|643085|P1|NOT COMPLETED|Overall Study||2
265408|NCT00959660|643082|P4|COMPLETED|Overall Study||22
265409|NCT00959660|643083|P3|COMPLETED|Overall Study||22
265410|NCT00959660|643084|P2|COMPLETED|Overall Study||24
265411|NCT00959660|643085|P1|COMPLETED|Overall Study||24
265412|NCT00959660|643082|P4|STARTED|Overall Study||25
265413|NCT00959660|643083|P3|STARTED|Overall Study||25
265414|NCT00959660|643084|P2|STARTED|Overall Study||24
265415|NCT00959660|643085|P1|STARTED|Overall Study||26
265416|NCT00959647|643107|P1|NOT COMPLETED|Overall Study||19
265417|NCT00959647|643107|P1|COMPLETED|Overall Study||0
265418|NCT00959647|643107|P1|STARTED|Overall Study||19
265419|NCT00959374|643112|P1|NOT COMPLETED|Overall Study||23
265420|NCT00959374|643112|P1|COMPLETED|Overall Study||218
265421|NCT00959374|643112|P1|STARTED|Overall Study|Of the 241 enrolled subjects, 229 were randomized and treated|241
265422|NCT00959192|643126|P4|NOT COMPLETED|Overall Study||1
265423|NCT00959192|643127|P3|NOT COMPLETED|Overall Study||3
265424|NCT00959192|643128|P2|NOT COMPLETED|Overall Study||1
265425|NCT00959192|643129|P1|NOT COMPLETED|Overall Study||2
265426|NCT00959192|643126|P4|COMPLETED|Overall Study||7
265427|NCT00959192|643127|P3|COMPLETED|Overall Study||6
265428|NCT00959192|643128|P2|COMPLETED|Overall Study||8
265429|NCT00959192|643129|P1|COMPLETED|Overall Study||4
265430|NCT00959192|643126|P4|STARTED|Overall Study||8
265431|NCT00959192|643127|P3|STARTED|Overall Study||9
265432|NCT00959192|643128|P2|STARTED|Overall Study||9
265433|NCT00959192|643129|P1|STARTED|Overall Study||6
265434|NCT00959166|643173|P2|NOT COMPLETED|Overall Study||0
265435|NCT00959166|643174|P1|NOT COMPLETED|Overall Study||0
265436|NCT00959166|643173|P2|COMPLETED|Overall Study||57
265437|NCT00959166|643174|P1|COMPLETED|Overall Study||24
265438|NCT00959166|643173|P2|STARTED|Overall Study||57
265439|NCT00959166|643174|P1|STARTED|Overall Study||24
265440|NCT00959049|643188|P6|NOT COMPLETED|Overall Study||1
265441|NCT00959049|643189|P5|NOT COMPLETED|Overall Study||9
265442|NCT00959049|643190|P4|NOT COMPLETED|Overall Study||11
265443|NCT00959049|643191|P3|NOT COMPLETED|Overall Study||1
265444|NCT00959049|643192|P2|NOT COMPLETED|Overall Study||7
265445|NCT00959049|643193|P1|NOT COMPLETED|Overall Study||18
265446|NCT00959049|643188|P6|COMPLETED|Overall Study||249
265447|NCT00959049|643189|P5|COMPLETED|Overall Study||248
265448|NCT00959049|643190|P4|COMPLETED|Overall Study||217
265449|NCT00959049|643191|P3|COMPLETED|Overall Study||253
265450|NCT00959049|643192|P2|COMPLETED|Overall Study||247
265451|NCT00959049|643193|P1|COMPLETED|Overall Study||213
265452|NCT00959049|643188|P6|STARTED|Overall Study||250
265453|NCT00959049|643189|P5|STARTED|Overall Study||257
265454|NCT00959049|643190|P4|STARTED|Overall Study||228
265455|NCT00959049|643191|P3|STARTED|Overall Study||254
265456|NCT00959049|643192|P2|STARTED|Overall Study||254
265457|NCT00959049|643193|P1|STARTED|Overall Study||231
265458|NCT00958919|643243|P2|NOT COMPLETED|Second Intervention||0
265459|NCT00958919|643244|P1|NOT COMPLETED|Second Intervention||0
265460|NCT00958919|643243|P2|COMPLETED|Second Intervention||7
265461|NCT00958919|643244|P1|COMPLETED|Second Intervention||7
265462|NCT00958919|643243|P2|STARTED|Second Intervention||7
265463|NCT00958919|643244|P1|STARTED|Second Intervention||7
265464|NCT00958919|643243|P2|NOT COMPLETED|First Intervention||0
265465|NCT00958919|643244|P1|NOT COMPLETED|First Intervention||0
265466|NCT00958919|643243|P2|COMPLETED|First Intervention||7
265467|NCT00958919|643244|P1|COMPLETED|First Intervention||7
265468|NCT00958919|643243|P2|STARTED|First Intervention||7
265469|NCT00958919|643244|P1|STARTED|First Intervention||7
265470|NCT00958893|643258|P1|NOT COMPLETED|Overall Study||4
265471|NCT00958893|643258|P1|COMPLETED|Overall Study||0
265472|NCT00958893|643258|P1|STARTED|Overall Study||4
265473|NCT00958880|643264|P2|NOT COMPLETED|Overall Study||2
265474|NCT00958880|643265|P1|NOT COMPLETED|Overall Study||2
265475|NCT00958880|643264|P2|COMPLETED|Overall Study||18
265476|NCT00958880|643265|P1|COMPLETED|Overall Study||18
265477|NCT00958880|643264|P2|STARTED|Overall Study||20
265478|NCT00958880|643265|P1|STARTED|Overall Study||20
265479|NCT00958841|643273|P1|NOT COMPLETED|Overall Study||96
265480|NCT00958841|643273|P1|COMPLETED|Overall Study|Completed = Completed extension|22
265481|NCT00958841|643273|P1|Entered in Extension|Overall Study||63
265482|NCT00958841|643273|P1|Completed Month 6 (M6)|Overall Study||90
265483|NCT00958841|643273|P1|STARTED|Overall Study||118
265484|NCT00958828|643291|P2|NOT COMPLETED|Period 2, 1 Week of Wear||1
265485|NCT00958828|643292|P1|NOT COMPLETED|Period 2, 1 Week of Wear||0
265486|NCT00958828|643291|P2|COMPLETED|Period 2, 1 Week of Wear||87
265487|NCT00958828|643292|P1|COMPLETED|Period 2, 1 Week of Wear||89
265488|NCT00958828|643291|P2|STARTED|Period 2, 1 Week of Wear||88
265489|NCT00958828|643292|P1|STARTED|Period 2, 1 Week of Wear||89
265490|NCT00958828|643291|P2|NOT COMPLETED|Period 1, 1 Week of Wear||1
265491|NCT00958828|643292|P1|NOT COMPLETED|Period 1, 1 Week of Wear||0
265492|NCT00958828|643291|P2|COMPLETED|Period 1, 1 Week of Wear||88
265493|NCT00958828|643292|P1|COMPLETED|Period 1, 1 Week of Wear||89
265494|NCT00958828|643291|P2|STARTED|Period 1, 1 Week of Wear||89
265495|NCT00958828|643292|P1|STARTED|Period 1, 1 Week of Wear||89
265496|NCT00958789|643298|P1|NOT COMPLETED|Overall Study||50
265497|NCT00958789|643298|P1|COMPLETED|Overall Study|Participant status at the 2 year primary outcome interval determined Completed/Not Completed counts.|130
265498|NCT00958789|643298|P1|STARTED|Overall Study||180
265499|NCT00958776|643305|P2|NOT COMPLETED|Overall Study||29
265500|NCT00958776|643306|P1|NOT COMPLETED|Overall Study||16
265501|NCT00958776|643305|P2|COMPLETED|Overall Study||239
265502|NCT00958776|643306|P1|COMPLETED|Overall Study||121
265503|NCT00958776|643305|P2|STARTED|Overall Study||268
265504|NCT00958776|643306|P1|STARTED|Overall Study||137
265505|NCT00958724|643336|P1|NOT COMPLETED|Overall Study||6
265506|NCT00958724|643336|P1|COMPLETED|Overall Study||0
265507|NCT00958724|643336|P1|STARTED|Overall Study||6
265508|NCT00958581|643349|P3|NOT COMPLETED|Overall Study||0
265509|NCT00958581|643350|P2|NOT COMPLETED|Overall Study||0
265510|NCT00958581|643351|P1|NOT COMPLETED|Overall Study||0
265511|NCT00958581|643349|P3|COMPLETED|Overall Study||55
265512|NCT00958581|643350|P2|COMPLETED|Overall Study||61
265513|NCT00958581|643351|P1|COMPLETED|Overall Study||61
265514|NCT00958581|643349|P3|STARTED|Overall Study||55
265515|NCT00958581|643350|P2|STARTED|Overall Study||61
265516|NCT00958581|643351|P1|STARTED|Overall Study||61
265517|NCT00958568|643365|P4|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||106
265518|NCT00958568|643366|P3|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||82
265519|NCT00958568|643367|P2|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
265520|NCT00958568|643368|P1|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
265521|NCT00958568|643365|P4|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||117
265522|NCT00958568|643366|P3|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||139
265523|NCT00958568|643367|P2|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
265524|NCT00958568|643368|P1|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
265525|NCT00958568|643365|P4|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||223
265526|NCT00958568|643366|P3|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||221
265527|NCT00958568|643367|P2|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
265528|NCT00958568|643368|P1|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
265529|NCT00958568|643365|P4|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
265530|NCT00958568|643366|P3|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
265531|NCT00958568|643367|P2|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||211
265532|NCT00958568|643368|P1|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
265533|NCT00958568|643365|P4|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
265534|NCT00958568|643366|P3|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
265535|NCT00958568|643367|P2|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||444
265536|NCT00958568|643368|P1|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
265537|NCT00958568|643365|P4|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
265538|NCT00958568|643366|P3|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
265539|NCT00958568|643367|P2|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||655
265540|NCT00958568|643368|P1|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
265541|NCT00958568|643365|P4|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
265542|NCT00958568|643366|P3|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
265543|NCT00958568|643367|P2|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
265544|NCT00958568|643368|P1|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||237
265545|NCT00958568|643365|P4|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
265546|NCT00958568|643366|P3|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
265547|NCT00958568|643367|P2|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
265548|NCT00958568|643368|P1|COMPLETED|SPII (Wk 0-8, Acute Open-label)||655
265549|NCT00958568|643365|P4|STARTED|SPII (Wk 0-8, Acute Open-label)||0
265550|NCT00958568|643366|P3|STARTED|SPII (Wk 0-8, Acute Open-label)||0
265551|NCT00958568|643367|P2|STARTED|SPII (Wk 0-8, Acute Open-label)||0
265552|NCT00958568|643368|P1|STARTED|SPII (Wk 0-8, Acute Open-label)||892
265553|NCT00958477|643453|P4|NOT COMPLETED|Overall Study||0
265554|NCT00958477|643454|P3|NOT COMPLETED|Overall Study||0
265555|NCT00958477|643455|P2|NOT COMPLETED|Overall Study||0
265556|NCT00958477|643456|P1|NOT COMPLETED|Overall Study||0
265557|NCT00958477|643453|P4|COMPLETED|Overall Study||6
265558|NCT00958477|643454|P3|COMPLETED|Overall Study||6
265559|NCT00958477|643455|P2|COMPLETED|Overall Study||6
265560|NCT00958477|643456|P1|COMPLETED|Overall Study||8
265561|NCT00958477|643453|P4|STARTED|Overall Study||6
265562|NCT00958477|643454|P3|STARTED|Overall Study||6
265563|NCT00958477|643455|P2|STARTED|Overall Study||6
265564|NCT00958477|643456|P1|STARTED|Overall Study||8
265565|NCT00958438|643605|P3|NOT COMPLETED|Overall Study||6
265566|NCT00958438|643606|P2|NOT COMPLETED|Overall Study||10
265567|NCT00958438|643607|P1|NOT COMPLETED|Overall Study||10
265568|NCT00958438|643605|P3|COMPLETED|Overall Study||78
265569|NCT00958438|643606|P2|COMPLETED|Overall Study||72
265570|NCT00958438|643607|P1|COMPLETED|Overall Study||72
265571|NCT00958438|643605|P3|STARTED|Overall Study||84
265572|NCT00958438|643606|P2|STARTED|Overall Study||82
265573|NCT00958438|643607|P1|STARTED|Overall Study||82
265574|NCT00958412|643630|P1|NOT COMPLETED|Overall Study||18
265575|NCT00958412|643630|P1|COMPLETED|Overall Study||0
265576|NCT00958412|643630|P1|STARTED|Overall Study||18
265577|NCT00958360|643636|P2|NOT COMPLETED|Overall Study||10
265578|NCT00958360|643637|P1|NOT COMPLETED|Overall Study||11
265579|NCT00958360|643636|P2|COMPLETED|Overall Study||150
265580|NCT00958360|643637|P1|COMPLETED|Overall Study||152
265581|NCT00958360|643636|P2|STARTED|Overall Study||160
265582|NCT00958360|643637|P1|STARTED|Overall Study||163
265583|NCT00958347|643651|P1|NOT COMPLETED|Overall Study||226
265584|NCT00958347|643651|P1|COMPLETED|Overall Study|11 revisions total, one was a bilateral participant with the other hip counted as not completed.|0
265585|NCT00958347|643651|P1|STARTED|Overall Study||226
265586|NCT00958334|643658|P3|NOT COMPLETED|Overall Study||13
265587|NCT00958334|643659|P2|NOT COMPLETED|Overall Study||17
265588|NCT00958334|643660|P1|NOT COMPLETED|Overall Study||14
265589|NCT00958334|643658|P3|COMPLETED|Overall Study||8
265590|NCT00958334|643659|P2|COMPLETED|Overall Study||5
265591|NCT00958334|643660|P1|COMPLETED|Overall Study||8
265592|NCT00958334|643658|P3|STARTED|Overall Study||21
265593|NCT00958334|643659|P2|STARTED|Overall Study||22
265594|NCT00958334|643660|P1|STARTED|Overall Study||22
265595|NCT00958308|643674|P3|NOT COMPLETED|Overall Study||0
265596|NCT00958308|643675|P2|NOT COMPLETED|Overall Study||0
265597|NCT00958308|643676|P1|NOT COMPLETED|Overall Study||0
265598|NCT00958308|643674|P3|COMPLETED|Overall Study||86
265599|NCT00958308|643675|P2|COMPLETED|Overall Study||85
265600|NCT00958308|643676|P1|COMPLETED|Overall Study||84
265601|NCT00958308|643674|P3|STARTED|Overall Study||86
265602|NCT00958308|643675|P2|STARTED|Overall Study||85
265603|NCT00958308|643676|P1|STARTED|Overall Study||84
265604|NCT00958282|643686|P2|NOT COMPLETED|Overall Study||6
265605|NCT00958282|643687|P1|NOT COMPLETED|Overall Study||10
265606|NCT00958282|643686|P2|COMPLETED|Overall Study||15
265607|NCT00958282|643687|P1|COMPLETED|Overall Study||12
265608|NCT00958282|643686|P2|STARTED|Overall Study||21
265609|NCT00958282|643687|P1|STARTED|Overall Study||22
265610|NCT00958256|643695|P1|NOT COMPLETED|Overall Study||3
265611|NCT00958256|643695|P1|COMPLETED|Overall Study||18
265612|NCT00958256|643695|P1|STARTED|Overall Study||21
265613|NCT00958243|643705|P6|NOT COMPLETED|Overall Study||10
265614|NCT00958243|643706|P5|NOT COMPLETED|Overall Study||9
265615|NCT00958243|643707|P4|NOT COMPLETED|Overall Study||3
265616|NCT00958243|643708|P3|NOT COMPLETED|Overall Study||14
265617|NCT00958243|643709|P2|NOT COMPLETED|Overall Study||6
265618|NCT00958243|643710|P1|NOT COMPLETED|Overall Study||2
265619|NCT00958243|643705|P6|COMPLETED|Overall Study||99
265620|NCT00958243|643706|P5|COMPLETED|Overall Study||100
265621|NCT00958243|643707|P4|COMPLETED|Overall Study||25
265622|NCT00958243|643708|P3|COMPLETED|Overall Study||82
265623|NCT00958243|643709|P2|COMPLETED|Overall Study||99
265624|NCT00958243|643710|P1|COMPLETED|Overall Study||24
265625|NCT00958243|643705|P6|STARTED|Overall Study||109
265626|NCT00958243|643706|P5|STARTED|Overall Study||109
265627|NCT00958243|643707|P4|STARTED|Overall Study||28
265628|NCT00958243|643708|P3|STARTED|Overall Study||96
265629|NCT00958243|643709|P2|STARTED|Overall Study||105
265630|NCT00958243|643710|P1|STARTED|Overall Study||26
265631|NCT00958217|643768|P2|NOT COMPLETED|Overall Study||25
265632|NCT00958217|643769|P1|NOT COMPLETED|Overall Study||24
265633|NCT00958217|643768|P2|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
265634|NCT00958217|643769|P1|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
265635|NCT00958217|643768|P2|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|57
265636|NCT00958217|643769|P1|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|56
265637|NCT00958217|643768|P2|STARTED|Overall Study||62
265638|NCT00958217|643769|P1|STARTED|Overall Study||61
265639|NCT00958191|643780|P1|NOT COMPLETED|Overall Study||111
265640|NCT00958191|643780|P1|COMPLETED|Overall Study||110
265641|NCT00958191|643780|P1|STARTED|Overall Study||221
265642|NCT00958165|643795|P1|NOT COMPLETED|Overall Study||14
265643|NCT00958165|643795|P1|COMPLETED|Overall Study|Of the 72 treated participants, 67 completed follow-up and were evaluable for effectiveness.|67
265644|NCT00958165|643795|P1|Treated|Overall Study||72
265645|NCT00958165|643795|P1|STARTED|Overall Study|81 enrolled participants resulted in 72 eligible participants that were treated.|81
265646|NCT00958126|643807|P8|NOT COMPLETED|Overall Study||0
265647|NCT00958126|643808|P7|NOT COMPLETED|Overall Study||1
265648|NCT00958126|643809|P6|NOT COMPLETED|Overall Study||1
265649|NCT00958126|643810|P5|NOT COMPLETED|Overall Study||0
265650|NCT00958126|643811|P4|NOT COMPLETED|Overall Study||11
265651|NCT00958126|643812|P3|NOT COMPLETED|Overall Study||10
265652|NCT00958126|643813|P2|NOT COMPLETED|Overall Study||9
265653|NCT00958126|643814|P1|NOT COMPLETED|Overall Study||1
265654|NCT00958126|643807|P8|COMPLETED|Overall Study||202
265655|NCT00958126|643808|P7|COMPLETED|Overall Study||199
265656|NCT00958126|643809|P6|COMPLETED|Overall Study||202
265657|NCT00958126|643810|P5|COMPLETED|Overall Study||50
265658|NCT00958126|643811|P4|COMPLETED|Overall Study||192
265659|NCT00958126|643812|P3|COMPLETED|Overall Study||191
265660|NCT00958126|643813|P2|COMPLETED|Overall Study||196
265661|NCT00958126|643814|P1|COMPLETED|Overall Study||48
265662|NCT00958126|643807|P8|STARTED|Overall Study||202
265663|NCT00958126|643808|P7|STARTED|Overall Study||200
265664|NCT00958126|643809|P6|STARTED|Overall Study||203
265665|NCT00958126|643810|P5|STARTED|Overall Study||50
265666|NCT00958126|643811|P4|STARTED|Overall Study||203
265667|NCT00958126|643812|P3|STARTED|Overall Study||201
265668|NCT00958126|643813|P2|STARTED|Overall Study||205
265669|NCT00958126|643814|P1|STARTED|Overall Study||49
265670|NCT00958074|643886|P2|NOT COMPLETED|Overall Study||1
265671|NCT00958074|643887|P1|NOT COMPLETED|Overall Study||0
265672|NCT00958074|643886|P2|COMPLETED|Overall Study||6
265673|NCT00958074|643887|P1|COMPLETED|Overall Study||4
265674|NCT00958074|643886|P2|STARTED|Overall Study||7
265675|NCT00958074|643887|P1|STARTED|Overall Study||4
265676|NCT00958035|643903|P2|NOT COMPLETED|Overall Study||4
265677|NCT00958035|643904|P1|NOT COMPLETED|Overall Study||3
265678|NCT00958035|643903|P2|COMPLETED|Overall Study||39
265679|NCT00958035|643904|P1|COMPLETED|Overall Study||43
265680|NCT00958035|643903|P2|STARTED|Overall Study||43
265681|NCT00958035|643904|P1|STARTED|Overall Study||46
265682|NCT00958009|643910|P1|NOT COMPLETED|Overall Study||2
265683|NCT00958009|643910|P1|COMPLETED|Overall Study||107
265684|NCT00958009|643910|P1|STARTED|Overall Study||109
265685|NCT00957996|643917|P2|NOT COMPLETED|Overall Study||28
265686|NCT00957996|643918|P1|NOT COMPLETED|Overall Study||26
265687|NCT00957996|643917|P2|COMPLETED|Overall Study||89
265688|NCT00957996|643918|P1|COMPLETED|Overall Study||91
265689|NCT00957996|643917|P2|STARTED|Overall Study||117
265690|NCT00957996|643918|P1|STARTED|Overall Study||117
265691|NCT00957944|643950|P2|NOT COMPLETED|Second Intervention- 24 Hours||0
265692|NCT00957944|643951|P1|NOT COMPLETED|Second Intervention- 24 Hours||0
265693|NCT00957944|643950|P2|COMPLETED|Second Intervention- 24 Hours||19
265694|NCT00957944|643951|P1|COMPLETED|Second Intervention- 24 Hours||20
265695|NCT00957944|643950|P2|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours|One subject that fullfilled predefined criteria for patch adhesiveness was excluded from the PKS|18
265696|NCT00957944|643951|P1|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours||20
265697|NCT00957944|643950|P2|STARTED|Second Intervention- 24 Hours||19
265698|NCT00957944|643951|P1|STARTED|Second Intervention- 24 Hours||20
265699|NCT00957944|643950|P2|NOT COMPLETED|Washout Period of at Least 5 Days||0
265700|NCT00957944|643951|P1|NOT COMPLETED|Washout Period of at Least 5 Days||0
265701|NCT00957944|643950|P2|COMPLETED|Washout Period of at Least 5 Days||19
265702|NCT00957944|643951|P1|COMPLETED|Washout Period of at Least 5 Days||20
265703|NCT00957944|643950|P2|STARTED|Washout Period of at Least 5 Days||19
265704|NCT00957944|643951|P1|STARTED|Washout Period of at Least 5 Days||20
265705|NCT00957944|643950|P2|NOT COMPLETED|First Intervention- 24 Hours||1
265706|NCT00957944|643951|P1|NOT COMPLETED|First Intervention- 24 Hours||0
265707|NCT00957944|643950|P2|COMPLETED|First Intervention- 24 Hours||19
265708|NCT00957944|643951|P1|COMPLETED|First Intervention- 24 Hours||20
265709|NCT00957944|643950|P2|STARTED|First Intervention- 24 Hours||20
265710|NCT00957944|643951|P1|STARTED|First Intervention- 24 Hours||20
265711|NCT00957931|643985|P1|NOT COMPLETED|Overall Study||4
265712|NCT00957931|643985|P1|COMPLETED|Overall Study||2
265713|NCT00957931|643985|P1|STARTED|Overall Study||6
265714|NCT00957905|643995|P2|NOT COMPLETED|Part B||4
265715|NCT00957905|643996|P1|NOT COMPLETED|Part B||0
265716|NCT00957905|643995|P2|COMPLETED|Part B||25
265717|NCT00957905|643996|P1|COMPLETED|Part B||0
265718|NCT00957905|643995|P2|STARTED|Part B||29
265719|NCT00957905|643996|P1|STARTED|Part B||0
265720|NCT00957905|643995|P2|NOT COMPLETED|Part A||0
265721|NCT00957905|643996|P1|NOT COMPLETED|Part A||0
265722|NCT00957905|643995|P2|COMPLETED|Part A||0
265723|NCT00957905|643996|P1|COMPLETED|Part A||7
265724|NCT00957905|643995|P2|STARTED|Part A||0
265725|NCT00957905|643996|P1|STARTED|Part A||7
265726|NCT00957827|644004|P2|NOT COMPLETED|Overall Study||0
265727|NCT00957827|644005|P1|NOT COMPLETED|Overall Study||0
265728|NCT00957827|644004|P2|COMPLETED|Overall Study||2
265729|NCT00957827|644005|P1|COMPLETED|Overall Study||2
265730|NCT00957827|644004|P2|STARTED|Overall Study||2
265731|NCT00957827|644005|P1|STARTED|Overall Study||2
265732|NCT00957801|644015|P4|NOT COMPLETED|Overall Study||1
265733|NCT00957801|644016|P3|NOT COMPLETED|Overall Study||0
265734|NCT00957801|644017|P2|NOT COMPLETED|Overall Study||0
265735|NCT00957801|644018|P1|NOT COMPLETED|Overall Study||0
265736|NCT00957801|644015|P4|COMPLETED|Overall Study||7
265737|NCT00957801|644016|P3|COMPLETED|Overall Study||7
265738|NCT00957801|644017|P2|COMPLETED|Overall Study||7
265739|NCT00957801|644018|P1|COMPLETED|Overall Study||7
265740|NCT00957801|644015|P4|STARTED|Overall Study||8
265741|NCT00957801|644016|P3|STARTED|Overall Study||7
265742|NCT00957801|644017|P2|STARTED|Overall Study||7
265743|NCT00957801|644018|P1|STARTED|Overall Study||7
265744|NCT00957723|644184|P1|NOT COMPLETED|Overall Study||113
265745|NCT00957723|644184|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|298
265746|NCT00957723|644184|P1|STARTED|Overall Study||411
265747|NCT00957684|644202|P5|NOT COMPLETED|PART II||75
265748|NCT00957684|644203|P4|NOT COMPLETED|PART II||0
265749|NCT00957684|644204|P3|NOT COMPLETED|PART II||0
265750|NCT00957684|644205|P2|NOT COMPLETED|PART II||0
265751|NCT00957684|644206|P1|NOT COMPLETED|PART II||0
265752|NCT00957684|644202|P5|COMPLETED|PART II||239
265753|NCT00957684|644203|P4|COMPLETED|PART II||0
265754|NCT00957684|644204|P3|COMPLETED|PART II||0
265755|NCT00957684|644205|P2|COMPLETED|PART II||0
265756|NCT00957684|644206|P1|COMPLETED|PART II||0
265757|NCT00957684|644202|P5|Patients Entered Part II|PART II||314
265758|NCT00957684|644203|P4|Patients Entered Part II|PART II||0
265759|NCT00957684|644204|P3|Patients Entered Part II|PART II||0
265760|NCT00957684|644205|P2|Patients Entered Part II|PART II||0
265761|NCT00957684|644206|P1|Patients Entered Part II|PART II||0
265762|NCT00957684|644202|P5|STARTED|PART II||314
265763|NCT00957684|644203|P4|STARTED|PART II||0
265764|NCT00957684|644204|P3|STARTED|PART II||0
265765|NCT00957684|644205|P2|STARTED|PART II||0
265766|NCT00957684|644206|P1|STARTED|PART II||0
265767|NCT00957684|644202|P5|NOT COMPLETED|PART I||0
265768|NCT00957684|644203|P4|NOT COMPLETED|PART I||18
265769|NCT00957684|644204|P3|NOT COMPLETED|PART I||10
265770|NCT00957684|644205|P2|NOT COMPLETED|PART I||13
265771|NCT00957684|644206|P1|NOT COMPLETED|PART I||31
265772|NCT00957684|644202|P5|COMPLETED|PART I||0
265773|NCT00957684|644203|P4|COMPLETED|PART I||84
265774|NCT00957684|644204|P3|COMPLETED|PART I||90
265775|NCT00957684|644205|P2|COMPLETED|PART I||85
265776|NCT00957684|644206|P1|COMPLETED|PART I||71
265777|NCT00957684|644202|P5|Per-protocol (PP)Population|PART I||0
265778|NCT00957684|644203|P4|Per-protocol (PP)Population|PART I||91
265779|NCT00957684|644204|P3|Per-protocol (PP)Population|PART I||94
265780|NCT00957684|644205|P2|Per-protocol (PP)Population|PART I||86
265781|NCT00957684|644206|P1|Per-protocol (PP)Population|PART I||72
265782|NCT00957684|644202|P5|Intention-to-treat (ITT) Population|PART I||0
265783|NCT00957684|644203|P4|Intention-to-treat (ITT) Population|PART I||102
265784|NCT00957684|644204|P3|Intention-to-treat (ITT) Population|PART I||99
265785|NCT00957684|644205|P2|Intention-to-treat (ITT) Population|PART I||98
265786|NCT00957684|644206|P1|Intention-to-treat (ITT) Population|PART I||98
265787|NCT00957684|644202|P5|Randomised (Safety Population)|PART I||0
265788|NCT00957684|644203|P4|Randomised (Safety Population)|PART I||102
265789|NCT00957684|644204|P3|Randomised (Safety Population)|PART I||100
265790|NCT00957684|644205|P2|Randomised (Safety Population)|PART I||98
265791|NCT00957684|644206|P1|Randomised (Safety Population)|PART I||102
265792|NCT00957684|644202|P5|STARTED|PART I||0
265793|NCT00957684|644203|P4|STARTED|PART I||102
265794|NCT00957684|644204|P3|STARTED|PART I||100
265795|NCT00957684|644205|P2|STARTED|PART I||98
265796|NCT00957684|644206|P1|STARTED|PART I||102
265797|NCT00957671|644216|P1|NOT COMPLETED|Overall Study||0
265798|NCT00957671|644216|P1|COMPLETED|Overall Study|15 subjects completed the treatment phase of the study.|15
265799|NCT00957671|644216|P1|STARTED|Overall Study|15 subjects began the treatment phase.|15
265800|NCT00957658|644273|P1|NOT COMPLETED|Overall Study||65
265801|NCT00957658|644273|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|169
265802|NCT00957658|644273|P1|STARTED|Overall Study||234
265803|NCT00957593|644288|P2|NOT COMPLETED|Overall Study||0
265804|NCT00957593|644289|P1|NOT COMPLETED|Overall Study||0
265805|NCT00957593|644288|P2|COMPLETED|Overall Study||125
265806|NCT00957593|644289|P1|COMPLETED|Overall Study||127
265807|NCT00957593|644288|P2|STARTED|Overall Study||125
265808|NCT00957593|644289|P1|STARTED|Overall Study||127
265809|NCT00957580|644300|P3|NOT COMPLETED|Overall Study||0
265810|NCT00957580|644301|P2|NOT COMPLETED|Overall Study||2
265811|NCT00957580|644302|P1|NOT COMPLETED|Overall Study||0
265812|NCT00957580|644300|P3|COMPLETED|Overall Study||15
265813|NCT00957580|644301|P2|COMPLETED|Overall Study||31
265814|NCT00957580|644302|P1|COMPLETED|Overall Study||33
265815|NCT00957580|644300|P3|Treated|Overall Study||15
265816|NCT00957580|644301|P2|Treated|Overall Study||32
265817|NCT00957580|644302|P1|Treated|Overall Study||33
265818|NCT00957580|644300|P3|STARTED|Overall Study||15
265819|NCT00957580|644301|P2|STARTED|Overall Study||33
265820|NCT00957580|644302|P1|STARTED|Overall Study||33
265821|NCT00957528|644449|P3|NOT COMPLETED|Overall Study||1
265822|NCT00957528|644450|P2|NOT COMPLETED|Overall Study||1
265823|NCT00957528|644451|P1|NOT COMPLETED|Overall Study||0
265824|NCT00957528|644449|P3|COMPLETED|Overall Study||8
265825|NCT00957528|644450|P2|COMPLETED|Overall Study||8
265826|NCT00957528|644451|P1|COMPLETED|Overall Study||8
265827|NCT00957528|644449|P3|STARTED|Overall Study||9
265828|NCT00957528|644450|P2|STARTED|Overall Study||9
265829|NCT00957528|644451|P1|STARTED|Overall Study||8
265830|NCT00957424|644474|P1|NOT COMPLETED|Overall Study||23
265831|NCT00957424|644474|P1|COMPLETED|Overall Study||44
265832|NCT00957424|644474|P1|Follow-up #2|Overall Study||50
265833|NCT00957424|644474|P1|Follow-up #1|Overall Study||59
265834|NCT00957424|644474|P1|STARTED|Overall Study||67
265835|NCT00957372|644484|P4|NOT COMPLETED|PART II||44
265836|NCT00957372|644485|P3|NOT COMPLETED|PART II||0
265837|NCT00957372|644486|P2|NOT COMPLETED|PART II||0
265838|NCT00957372|644487|P1|NOT COMPLETED|PART II||0
265839|NCT00957372|644484|P4|COMPLETED|PART II||150
265840|NCT00957372|644485|P3|COMPLETED|PART II||0
265841|NCT00957372|644486|P2|COMPLETED|PART II||0
265842|NCT00957372|644487|P1|COMPLETED|PART II||0
265843|NCT00957372|644484|P4|Per-Protocol Population|PART II||108
265844|NCT00957372|644485|P3|Per-Protocol Population|PART II||0
265845|NCT00957372|644486|P2|Per-Protocol Population|PART II||0
265846|NCT00957372|644487|P1|Per-Protocol Population|PART II||0
265847|NCT00957372|644484|P4|Intention-to-treat (ITT) Population|PART II||191
265848|NCT00957372|644485|P3|Intention-to-treat (ITT) Population|PART II||0
265849|NCT00957372|644486|P2|Intention-to-treat (ITT) Population|PART II||0
265850|NCT00957372|644487|P1|Intention-to-treat (ITT) Population|PART II||0
265851|NCT00957372|644484|P4|Safety Population|PART II||194
265852|NCT00957372|644485|P3|Safety Population|PART II||0
265853|NCT00957372|644486|P2|Safety Population|PART II||0
265854|NCT00957372|644487|P1|Safety Population|PART II||0
265855|NCT00957372|644484|P4|STARTED|PART II||194
265856|NCT00957372|644485|P3|STARTED|PART II||0
265857|NCT00957372|644486|P2|STARTED|PART II||0
265858|NCT00957372|644487|P1|STARTED|PART II||0
265859|NCT00957372|644484|P4|NOT COMPLETED|PART I||0
265860|NCT00957372|644485|P3|NOT COMPLETED|PART I||1
265861|NCT00957372|644486|P2|NOT COMPLETED|PART I||0
265862|NCT00957372|644487|P1|NOT COMPLETED|PART I||0
265863|NCT00957372|644484|P4|COMPLETED|PART I||0
265864|NCT00957372|644485|P3|COMPLETED|PART I||87
265865|NCT00957372|644486|P2|COMPLETED|PART I||85
265866|NCT00957372|644487|P1|COMPLETED|PART I||80
265867|NCT00957372|644484|P4|Randomized But Not Treated|PART I||0
265868|NCT00957372|644485|P3|Randomized But Not Treated|PART I||1
265869|NCT00957372|644486|P2|Randomized But Not Treated|PART I||0
265870|NCT00957372|644487|P1|Randomized But Not Treated|PART I||0
265871|NCT00957372|644484|P4|Per-Protocol Population|PART I||0
265872|NCT00957372|644485|P3|Per-Protocol Population|PART I||51
265873|NCT00957372|644486|P2|Per-Protocol Population|PART I||47
265874|NCT00957372|644487|P1|Per-Protocol Population|PART I||35
265875|NCT00957372|644484|P4|Intention-to-Treat Population|PART I||0
265876|NCT00957372|644485|P3|Intention-to-Treat Population|PART I||84
265877|NCT00957372|644486|P2|Intention-to-Treat Population|PART I||84
265878|NCT00957372|644487|P1|Intention-to-Treat Population|PART I||77
265879|NCT00957372|644484|P4|Safety Population|PART I||0
265880|NCT00957372|644485|P3|Safety Population|PART I||87
265881|NCT00957372|644486|P2|Safety Population|PART I||85
265882|NCT00957372|644487|P1|Safety Population|PART I||80
265883|NCT00957372|644484|P4|STARTED|PART I||0
265884|NCT00957372|644485|P3|STARTED|PART I||88
265885|NCT00957372|644486|P2|STARTED|PART I||85
265886|NCT00957372|644487|P1|STARTED|PART I||80
265887|NCT00957359|644505|P2|NOT COMPLETED|Overall Study||0
265888|NCT00957359|644506|P1|NOT COMPLETED|Overall Study||0
265889|NCT00957359|644505|P2|COMPLETED|Overall Study||15
265890|NCT00957359|644506|P1|COMPLETED|Overall Study||14
265891|NCT00957359|644505|P2|STARTED|Overall Study||15
265892|NCT00957359|644506|P1|STARTED|Overall Study||14
265893|NCT00957333|644618|P1|NOT COMPLETED|Overall Study||0
265894|NCT00957333|644618|P1|COMPLETED|Overall Study||44
265895|NCT00957333|644618|P1|STARTED|Overall Study||44
265896|NCT00957268|644627|P5|NOT COMPLETED|Overall Study||0
265897|NCT00957268|644628|P4|NOT COMPLETED|Overall Study||0
265898|NCT00957268|644629|P3|NOT COMPLETED|Overall Study||1
265899|NCT00957268|644630|P2|NOT COMPLETED|Overall Study||0
265900|NCT00957268|644631|P1|NOT COMPLETED|Overall Study||0
265901|NCT00957268|644627|P5|COMPLETED|Overall Study||22
265902|NCT00957268|644628|P4|COMPLETED|Overall Study||7
265903|NCT00957268|644629|P3|COMPLETED|Overall Study||7
265904|NCT00957268|644630|P2|COMPLETED|Overall Study||4
265905|NCT00957268|644631|P1|COMPLETED|Overall Study||5
265906|NCT00957268|644627|P5|STARTED|Overall Study||22
265907|NCT00957268|644628|P4|STARTED|Overall Study||7
265908|NCT00957268|644629|P3|STARTED|Overall Study||8
265909|NCT00957268|644630|P2|STARTED|Overall Study||4
265910|NCT00957268|644631|P1|STARTED|Overall Study||5
265911|NCT00957242|644695|P2|NOT COMPLETED|Overall Study||0
265912|NCT00957242|644696|P1|NOT COMPLETED|Overall Study||0
265913|NCT00957242|644695|P2|COMPLETED|Overall Study||72
265914|NCT00957242|644696|P1|COMPLETED|Overall Study||73
265915|NCT00957242|644695|P2|STARTED|Overall Study||72
265916|NCT00957242|644696|P1|STARTED|Overall Study||73
265917|NCT00957047|644728|P5|NOT COMPLETED|PART II||102
265918|NCT00957047|644729|P4|NOT COMPLETED|PART II||0
265919|NCT00957047|644730|P3|NOT COMPLETED|PART II||0
265920|NCT00957047|644731|P2|NOT COMPLETED|PART II||0
265921|NCT00957047|644732|P1|NOT COMPLETED|PART II||0
265922|NCT00957047|644728|P5|COMPLETED|PART II||223
265923|NCT00957047|644729|P4|COMPLETED|PART II||0
265924|NCT00957047|644730|P3|COMPLETED|PART II||0
265925|NCT00957047|644731|P2|COMPLETED|PART II||0
265926|NCT00957047|644732|P1|COMPLETED|PART II||0
265927|NCT00957047|644728|P5|Terminated Prematurely|PART II|Terminated Prematurely during 1-year Open-Label Period|102
265928|NCT00957047|644729|P4|Terminated Prematurely|PART II||0
265929|NCT00957047|644730|P3|Terminated Prematurely|PART II||0
265930|NCT00957047|644731|P2|Terminated Prematurely|PART II||0
265931|NCT00957047|644732|P1|Terminated Prematurely|PART II||0
265932|NCT00957047|644728|P5|STARTED|PART II|325 patients who completed Part I were enrolled in Part II.|325
265933|NCT00957047|644729|P4|STARTED|PART II||0
265934|NCT00957047|644730|P3|STARTED|PART II||0
265935|NCT00957047|644731|P2|STARTED|PART II||0
265936|NCT00957047|644732|P1|STARTED|PART II||0
265937|NCT00957047|644728|P5|NOT COMPLETED|PART I||0
265938|NCT00957047|644729|P4|NOT COMPLETED|PART I||30
265939|NCT00957047|644730|P3|NOT COMPLETED|PART I||21
265940|NCT00957047|644731|P2|NOT COMPLETED|PART I||13
265941|NCT00957047|644732|P1|NOT COMPLETED|PART I||6
265942|NCT00957047|644728|P5|COMPLETED|PART I||0
265943|NCT00957047|644729|P4|COMPLETED|PART I||68
265944|NCT00957047|644730|P3|COMPLETED|PART I||80
265945|NCT00957047|644731|P2|COMPLETED|PART I||83
265946|NCT00957047|644732|P1|COMPLETED|PART I||94
265947|NCT00957047|644728|P5|Per-Protocol Population|PART I||0
265948|NCT00957047|644729|P4|Per-Protocol Population|PART I||54
265949|NCT00957047|644730|P3|Per-Protocol Population|PART I||75
265950|NCT00957047|644731|P2|Per-Protocol Population|PART I||70
265951|NCT00957047|644732|P1|Per-Protocol Population|PART I||81
265952|NCT00957047|644728|P5|Intention-to-treat (ITT) Population|PART I||0
265953|NCT00957047|644729|P4|Intention-to-treat (ITT) Population|PART I||97
265954|NCT00957047|644730|P3|Intention-to-treat (ITT) Population|PART I||100
265955|NCT00957047|644731|P2|Intention-to-treat (ITT) Population|PART I||96
265956|NCT00957047|644732|P1|Intention-to-treat (ITT) Population|PART I||100
265957|NCT00957047|644728|P5|Randomized/Safety Population|PART I||0
265958|NCT00957047|644729|P4|Randomized/Safety Population|PART I||98
265959|NCT00957047|644730|P3|Randomized/Safety Population|PART I||101
265960|NCT00957047|644731|P2|Randomized/Safety Population|PART I||96
265961|NCT00957047|644732|P1|Randomized/Safety Population|PART I||100
265962|NCT00957047|644728|P5|STARTED|PART I||0
265963|NCT00957047|644729|P4|STARTED|PART I||98
265964|NCT00957047|644730|P3|STARTED|PART I||101
265965|NCT00957047|644731|P2|STARTED|PART I||96
265966|NCT00957047|644732|P1|STARTED|PART I||100
265967|NCT00957034|644753|P3|NOT COMPLETED|Overall Study||6
265968|NCT00957034|644754|P2|NOT COMPLETED|Overall Study||4
265969|NCT00957034|644755|P1|NOT COMPLETED|Overall Study||6
265970|NCT00957034|644753|P3|COMPLETED|Overall Study||1
265971|NCT00957034|644754|P2|COMPLETED|Overall Study||0
265972|NCT00957034|644755|P1|COMPLETED|Overall Study||0
265973|NCT00957034|644753|P3|STARTED|Overall Study||7
265974|NCT00957034|644754|P2|STARTED|Overall Study||4
265975|NCT00957034|644755|P1|STARTED|Overall Study||6
265976|NCT00957021|644778|P1|NOT COMPLETED|Overall Study||117
265977|NCT00957021|644778|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2 yr primary outcome interval.|237
265978|NCT00957021|644778|P1|STARTED|Overall Study||354
265979|NCT00957008|644791|P4|NOT COMPLETED|Overall Study||24
265980|NCT00957008|644792|P3|NOT COMPLETED|Overall Study||17
265981|NCT00957008|644793|P2|NOT COMPLETED|Overall Study||12
265982|NCT00957008|644794|P1|NOT COMPLETED|Overall Study||21
265983|NCT00957008|644791|P4|COMPLETED|Overall Study||26
265984|NCT00957008|644792|P3|COMPLETED|Overall Study||32
265985|NCT00957008|644793|P2|COMPLETED|Overall Study||37
265986|NCT00957008|644794|P1|COMPLETED|Overall Study||28
265987|NCT00957008|644791|P4|STARTED|Overall Study||50
265988|NCT00957008|644792|P3|STARTED|Overall Study||49
265989|NCT00957008|644793|P2|STARTED|Overall Study||49
265990|NCT00957008|644794|P1|STARTED|Overall Study||49
265991|NCT00956943|644822|P2|NOT COMPLETED|Overall Study||10
265992|NCT00956943|644823|P1|NOT COMPLETED|Overall Study||9
265993|NCT00956943|644822|P2|COMPLETED|Overall Study||34
265994|NCT00956943|644823|P1|COMPLETED|Overall Study||34
265995|NCT00956943|644822|P2|Baseline|Overall Study||44
265996|NCT00956943|644823|P1|Baseline|Overall Study||43
265997|NCT00956943|644822|P2|STARTED|Overall Study||44
265998|NCT00956943|644823|P1|STARTED|Overall Study||43
265999|NCT00956930|644833|P2|NOT COMPLETED|Overall Study||0
266000|NCT00956930|644834|P1|NOT COMPLETED|Overall Study||0
266001|NCT00956930|644833|P2|COMPLETED|Overall Study||21
266002|NCT00956930|644834|P1|COMPLETED|Overall Study||24
266003|NCT00956930|644833|P2|STARTED|Overall Study||21
266004|NCT00956930|644834|P1|STARTED|Overall Study||24
266005|NCT00956839|644847|P3|NOT COMPLETED|Overall Study||3
266006|NCT00956839|644848|P2|NOT COMPLETED|Overall Study||0
266007|NCT00956839|644849|P1|NOT COMPLETED|Overall Study||3
266008|NCT00956839|644847|P3|COMPLETED|Overall Study||10
266009|NCT00956839|644848|P2|COMPLETED|Overall Study||13
266010|NCT00956839|644849|P1|COMPLETED|Overall Study||11
266011|NCT00956839|644847|P3|STARTED|Overall Study||13
266012|NCT00956839|644848|P2|STARTED|Overall Study||13
266013|NCT00956839|644849|P1|STARTED|Overall Study||14
266014|NCT00956813|644862|P2|NOT COMPLETED|Continuation Phase||0
266015|NCT00956813|644863|P1|NOT COMPLETED|Continuation Phase||0
266016|NCT00956813|644862|P2|COMPLETED|Continuation Phase||0
266017|NCT00956813|644863|P1|COMPLETED|Continuation Phase||80
266018|NCT00956813|644862|P2|STARTED|Continuation Phase||0
266019|NCT00956813|644863|P1|STARTED|Continuation Phase||80
266020|NCT00956813|644862|P2|NOT COMPLETED|Flaxseed and Placebo||5
266021|NCT00956813|644863|P1|NOT COMPLETED|Flaxseed and Placebo||8
266022|NCT00956813|644862|P2|COMPLETED|Flaxseed and Placebo||100
266023|NCT00956813|644863|P1|COMPLETED|Flaxseed and Placebo||97
266024|NCT00956813|644862|P2|STARTED|Flaxseed and Placebo||105
266025|NCT00956813|644863|P1|STARTED|Flaxseed and Placebo||105
266026|NCT00956761|644878|P1|NOT COMPLETED|Overall Study||0
266027|NCT00956761|644878|P1|COMPLETED|Overall Study||63
266028|NCT00956761|644878|P1|STARTED|Overall Study||63
266029|NCT00956709|644887|P2|NOT COMPLETED|Overall Study||0
266030|NCT00956709|644888|P1|NOT COMPLETED|Overall Study||0
266031|NCT00956709|644887|P2|COMPLETED|Overall Study||19
266032|NCT00956709|644888|P1|COMPLETED|Overall Study||16
266033|NCT00956709|644887|P2|STARTED|Overall Study||19
266034|NCT00956709|644888|P1|STARTED|Overall Study||16
266035|NCT00956657|644900|P2|NOT COMPLETED|Overall Study||0
266036|NCT00956657|644901|P1|NOT COMPLETED|Overall Study||0
266037|NCT00956657|644900|P2|COMPLETED|Overall Study||13
266038|NCT00956657|644901|P1|COMPLETED|Overall Study||18
266039|NCT00956657|644900|P2|STARTED|Overall Study||13
266040|NCT00956657|644901|P1|STARTED|Overall Study||18
266041|NCT00956631|644907|P1|NOT COMPLETED|Overall Study||16
266042|NCT00956631|644907|P1|COMPLETED|Overall Study||62
266043|NCT00956631|644907|P1|STARTED|Overall Study||78
266044|NCT00956592|644915|P2|NOT COMPLETED|Overall Study||3
266045|NCT00956592|644916|P1|NOT COMPLETED|Overall Study||1
266046|NCT00956592|644915|P2|COMPLETED|Overall Study||147
266047|NCT00956592|644916|P1|COMPLETED|Overall Study||149
266048|NCT00956592|644915|P2|STARTED|Overall Study||150
266049|NCT00956592|644916|P1|STARTED|Overall Study||150
266050|NCT00956540|644936|P4|NOT COMPLETED|Overall Study||4
266051|NCT00956540|644937|P3|NOT COMPLETED|Overall Study||3
266052|NCT00956540|644938|P2|NOT COMPLETED|Overall Study||4
266053|NCT00956540|644939|P1|NOT COMPLETED|Overall Study||3
266054|NCT00956540|644936|P4|COMPLETED|Overall Study||41
266055|NCT00956540|644937|P3|COMPLETED|Overall Study||43
266056|NCT00956540|644938|P2|COMPLETED|Overall Study||46
266057|NCT00956540|644939|P1|COMPLETED|Overall Study||51
266058|NCT00956540|644936|P4|STARTED|Overall Study||45
266059|NCT00956540|644937|P3|STARTED|Overall Study||46
266060|NCT00956540|644938|P2|STARTED|Overall Study||50
266061|NCT00956540|644939|P1|STARTED|Overall Study||54
266062|NCT00956293|644951|P3|NOT COMPLETED|Follow-up Period||0
266063|NCT00956293|644952|P2|NOT COMPLETED|Follow-up Period||32
266064|NCT00956293|644953|P1|NOT COMPLETED|Follow-up Period||20
266065|NCT00956293|644951|P3|COMPLETED|Follow-up Period||0
266066|NCT00956293|644952|P2|COMPLETED|Follow-up Period||0
266067|NCT00956293|644953|P1|COMPLETED|Follow-up Period||0
266068|NCT00956293|644951|P3|STARTED|Follow-up Period||0
266069|NCT00956293|644952|P2|STARTED|Follow-up Period||32
266070|NCT00956293|644953|P1|STARTED|Follow-up Period||20
266071|NCT00956293|644951|P3|NOT COMPLETED|Main Period (Randomization)||0
266072|NCT00956293|644952|P2|NOT COMPLETED|Main Period (Randomization)||27
266073|NCT00956293|644953|P1|NOT COMPLETED|Main Period (Randomization)||1
266074|NCT00956293|644951|P3|COMPLETED|Main Period (Randomization)||0
266075|NCT00956293|644952|P2|COMPLETED|Main Period (Randomization)||26
266076|NCT00956293|644953|P1|COMPLETED|Main Period (Randomization)||23
266077|NCT00956293|644951|P3|Randomized Safety Set|Main Period (Randomization)||0
266078|NCT00956293|644952|P2|Randomized Safety Set|Main Period (Randomization)||51
266079|NCT00956293|644953|P1|Randomized Safety Set|Main Period (Randomization)||24
266080|NCT00956293|644951|P3|Full Analysis Set|Main Period (Randomization)||0
266081|NCT00956293|644952|P2|Full Analysis Set|Main Period (Randomization)|Two participants, randomized to this arm, did not receive everolimus.|51
266082|NCT00956293|644953|P1|Full Analysis Set|Main Period (Randomization)||24
266083|NCT00956293|644951|P3|STARTED|Main Period (Randomization)||0
266084|NCT00956293|644952|P2|STARTED|Main Period (Randomization)||53
266085|NCT00956293|644953|P1|STARTED|Main Period (Randomization)||24
266086|NCT00956293|644951|P3|NOT COMPLETED|Main Period (Pre-randomization)||130
266087|NCT00956293|644952|P2|NOT COMPLETED|Main Period (Pre-randomization)||0
266088|NCT00956293|644953|P1|NOT COMPLETED|Main Period (Pre-randomization)||0
266089|NCT00956293|644951|P3|COMPLETED|Main Period (Pre-randomization)||77
266090|NCT00956293|644952|P2|COMPLETED|Main Period (Pre-randomization)||0
266091|NCT00956293|644953|P1|COMPLETED|Main Period (Pre-randomization)||0
266092|NCT00956293|644951|P3|Enrolled Safety Set|Main Period (Pre-randomization)||203
266093|NCT00956293|644952|P2|Enrolled Safety Set|Main Period (Pre-randomization)||0
266094|NCT00956293|644953|P1|Enrolled Safety Set|Main Period (Pre-randomization)||0
266095|NCT00956293|644951|P3|STARTED|Main Period (Pre-randomization)||207
266096|NCT00956293|644952|P2|STARTED|Main Period (Pre-randomization)||0
266097|NCT00956293|644953|P1|STARTED|Main Period (Pre-randomization)||0
266098|NCT00956254|644977|P1|NOT COMPLETED|Overall Study||0
266099|NCT00956254|644977|P1|COMPLETED|Overall Study||18
266100|NCT00956254|644977|P1|STARTED|Overall Study||18
266101|NCT00956085|644987|P1|NOT COMPLETED|Overall Study||0
266102|NCT00956085|644987|P1|COMPLETED|Overall Study||12
266103|NCT00956085|644987|P1|STARTED|Overall Study||12
266104|NCT00956020|644991|P1|NOT COMPLETED|Overall Study||0
266105|NCT00956020|644991|P1|COMPLETED|Overall Study||4
266106|NCT00956020|644991|P1|STARTED|Overall Study||4
266107|NCT00955968|645008|P2|NOT COMPLETED|Overall Study||126
266108|NCT00955968|645009|P1|NOT COMPLETED|Overall Study||137
266109|NCT00955968|645008|P2|COMPLETED|Overall Study||699
266110|NCT00955968|645009|P1|COMPLETED|Overall Study||691
266111|NCT00955968|645008|P2|STARTED|Overall Study||825
266112|NCT00955968|645009|P1|STARTED|Overall Study||828
266113|NCT00955955|645047|P3|NOT COMPLETED|Overall Study||0
266114|NCT00955955|645048|P2|NOT COMPLETED|Overall Study||0
266115|NCT00955955|645049|P1|NOT COMPLETED|Overall Study||2
266116|NCT00955955|645047|P3|COMPLETED|Overall Study||28
266117|NCT00955955|645048|P2|COMPLETED|Overall Study||28
266118|NCT00955955|645049|P1|COMPLETED|Overall Study||17
266119|NCT00955955|645047|P3|STARTED|Overall Study||28
266120|NCT00955955|645048|P2|STARTED|Overall Study||28
266121|NCT00955955|645049|P1|STARTED|Overall Study||19
266122|NCT00955916|645063|P1|NOT COMPLETED|Overall Study||0
266123|NCT00955916|645063|P1|COMPLETED|Overall Study||38
266124|NCT00955916|645063|P1|STARTED|Overall Study||38
266125|NCT00955903|645072|P3|NOT COMPLETED|Overall Study||7
266126|NCT00955903|645073|P2|NOT COMPLETED|Overall Study||3
266127|NCT00955903|645074|P1|NOT COMPLETED|Overall Study||6
266128|NCT00955903|645072|P3|COMPLETED|Overall Study||48
266129|NCT00955903|645073|P2|COMPLETED|Overall Study||51
266130|NCT00955903|645074|P1|COMPLETED|Overall Study||49
266131|NCT00955903|645072|P3|STARTED|Overall Study||55
266132|NCT00955903|645073|P2|STARTED|Overall Study||54
266133|NCT00955903|645074|P1|STARTED|Overall Study||55
266134|NCT00955877|645091|P3|NOT COMPLETED|Overall Study||0
266135|NCT00955877|645092|P2|NOT COMPLETED|Overall Study||0
266136|NCT00955877|645093|P1|NOT COMPLETED|Overall Study||0
266137|NCT00955877|645091|P3|COMPLETED|Overall Study||7
266138|NCT00955877|645092|P2|COMPLETED|Overall Study||0
266139|NCT00955877|645093|P1|COMPLETED|Overall Study||6
266140|NCT00955877|645091|P3|STARTED|Overall Study||7
266141|NCT00955877|645092|P2|STARTED|Overall Study|No patients were enrolled because analysis of previous arm wasn't completed.|0
266142|NCT00955877|645093|P1|STARTED|Overall Study|Drug manufacturer ceased producing the drug prior to completion of 10 enrolled in this arm.|6
266143|NCT00955825|645133|P2|NOT COMPLETED|Overall Study||17
266144|NCT00955825|645134|P1|NOT COMPLETED|Overall Study||26
266145|NCT00955825|645133|P2|COMPLETED|Overall Study||223
266146|NCT00955825|645134|P1|COMPLETED|Overall Study||207
266147|NCT00955825|645133|P2|STARTED|Overall Study||240
266148|NCT00955825|645134|P1|STARTED|Overall Study||233
266149|NCT00955747|645142|P2|NOT COMPLETED|Overall Study||69
266150|NCT00955747|645143|P1|NOT COMPLETED|Overall Study||69
266151|NCT00955747|645142|P2|COMPLETED|Overall Study||172
266152|NCT00955747|645143|P1|COMPLETED|Overall Study||184
266153|NCT00955747|645142|P2|STARTED|Overall Study||241
266154|NCT00955747|645143|P1|STARTED|Overall Study||253
266155|NCT00955721|645151|P2|NOT COMPLETED|Overall Study||0
266156|NCT00955721|645152|P1|NOT COMPLETED|Overall Study||3
266157|NCT00955721|645151|P2|COMPLETED|Overall Study||0
266158|NCT00955721|645152|P1|COMPLETED|Overall Study||6
266159|NCT00955721|645151|P2|STARTED|Overall Study||0
266160|NCT00955721|645152|P1|STARTED|Overall Study||9
266161|NCT00955708|645162|P1|NOT COMPLETED|Overall Study||1058
266162|NCT00955708|645162|P1|COMPLETED|Overall Study||250
266163|NCT00955708|645162|P1|STARTED|Overall Study||1308
266164|NCT00955682|645168|P2|NOT COMPLETED|Year 5 Period||0
266165|NCT00955682|645169|P1|NOT COMPLETED|Year 5 Period||0
266166|NCT00955682|645168|P2|COMPLETED|Year 5 Period||47
266167|NCT00955682|645169|P1|COMPLETED|Year 5 Period||239
266168|NCT00955682|645168|P2|STARTED|Year 5 Period||47
266169|NCT00955682|645169|P1|STARTED|Year 5 Period||239
266170|NCT00955682|645168|P2|NOT COMPLETED|Booster Period (Month 49)||1
266171|NCT00955682|645169|P1|NOT COMPLETED|Booster Period (Month 49)||1
266172|NCT00955682|645168|P2|COMPLETED|Booster Period (Month 49)||47
266173|NCT00955682|645169|P1|COMPLETED|Booster Period (Month 49)||244
266174|NCT00955682|645168|P2|STARTED|Booster Period (Month 49)||48
266175|NCT00955682|645169|P1|STARTED|Booster Period (Month 49)||245
266176|NCT00955682|645168|P2|NOT COMPLETED|Year 4 Period||0
266177|NCT00955682|645169|P1|NOT COMPLETED|Year 4 Period||0
266178|NCT00955682|645168|P2|COMPLETED|Year 4 Period||48
266179|NCT00955682|645169|P1|COMPLETED|Year 4 Period||246
266180|NCT00955682|645168|P2|STARTED|Year 4 Period||48
266181|NCT00955682|645169|P1|STARTED|Year 4 Period||246
266182|NCT00955682|645168|P2|NOT COMPLETED|Year 3 Period||0
266183|NCT00955682|645169|P1|NOT COMPLETED|Year 3 Period||0
266184|NCT00955682|645168|P2|COMPLETED|Year 3 Period||47
266185|NCT00955682|645169|P1|COMPLETED|Year 3 Period||273
266186|NCT00955682|645168|P2|STARTED|Year 3 Period||47
266187|NCT00955682|645169|P1|STARTED|Year 3 Period||273
266188|NCT00955682|645168|P2|NOT COMPLETED|Year 2 Period||0
266189|NCT00955682|645169|P1|NOT COMPLETED|Year 2 Period||0
266190|NCT00955682|645168|P2|COMPLETED|Year 2 Period||42
266191|NCT00955682|645169|P1|COMPLETED|Year 2 Period||253
266192|NCT00955682|645168|P2|STARTED|Year 2 Period||42
266193|NCT00955682|645169|P1|STARTED|Year 2 Period||253
266194|NCT00955617|645279|P2|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
266195|NCT00955617|645280|P1|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
266196|NCT00955617|645279|P2|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
266197|NCT00955617|645280|P1|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
266198|NCT00955617|645279|P2|STARTED|Second MRA (Between Day 1 and Day 51)||10
266199|NCT00955617|645280|P1|STARTED|Second MRA (Between Day 1 and Day 51)||10
266200|NCT00955617|645279|P2|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
266201|NCT00955617|645280|P1|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
266202|NCT00955617|645279|P2|COMPLETED|First MRA (Between Day0 and Day21)||10
266203|NCT00955617|645280|P1|COMPLETED|First MRA (Between Day0 and Day21)||10
266204|NCT00955617|645279|P2|STARTED|First MRA (Between Day0 and Day21)||10
266205|NCT00955617|645280|P1|STARTED|First MRA (Between Day0 and Day21)||10
266206|NCT00955513|645293|P3|NOT COMPLETED|Overall Study||3
266207|NCT00955513|645294|P2|NOT COMPLETED|Overall Study||2
266208|NCT00955513|645295|P1|NOT COMPLETED|Overall Study||1
266209|NCT00955513|645293|P3|COMPLETED|Overall Study||79
266210|NCT00955513|645294|P2|COMPLETED|Overall Study||78
266211|NCT00955513|645295|P1|COMPLETED|Overall Study||79
266212|NCT00955513|645293|P3|STARTED|Overall Study||82
266213|NCT00955513|645294|P2|STARTED|Overall Study||80
266214|NCT00955513|645295|P1|STARTED|Overall Study||80
266215|NCT00955487|645305|P6|NOT COMPLETED|Overall Study||0
266216|NCT00955487|645306|P5|NOT COMPLETED|Overall Study||0
266217|NCT00955487|645307|P4|NOT COMPLETED|Overall Study||0
266218|NCT00955487|645308|P3|NOT COMPLETED|Overall Study||0
266219|NCT00955487|645309|P2|NOT COMPLETED|Overall Study||0
266220|NCT00955487|645310|P1|NOT COMPLETED|Overall Study||0
266221|NCT00955487|645305|P6|COMPLETED|Overall Study||35
266222|NCT00955487|645306|P5|COMPLETED|Overall Study||32
266223|NCT00955487|645307|P4|COMPLETED|Overall Study||21
266224|NCT00955487|645308|P3|COMPLETED|Overall Study||17
266225|NCT00955487|645309|P2|COMPLETED|Overall Study||9
266226|NCT00955487|645310|P1|COMPLETED|Overall Study||10
266227|NCT00955487|645305|P6|STARTED|Overall Study||35
266228|NCT00955487|645306|P5|STARTED|Overall Study||32
266229|NCT00955487|645307|P4|STARTED|Overall Study||21
266230|NCT00955487|645308|P3|STARTED|Overall Study||17
266231|NCT00955487|645309|P2|STARTED|Overall Study||9
266232|NCT00955487|645310|P1|STARTED|Overall Study||10
266233|NCT00955474|645344|P2|NOT COMPLETED|Overall Study||5
266234|NCT00955474|645345|P1|NOT COMPLETED|Overall Study||7
266235|NCT00955474|645344|P2|COMPLETED|Overall Study||8
266236|NCT00955474|645345|P1|COMPLETED|Overall Study||5
266237|NCT00955474|645344|P2|STARTED|Overall Study||13
266238|NCT00955474|645345|P1|STARTED|Overall Study||12
266239|NCT00955357|645381|P2|NOT COMPLETED|Maintenance Phase||45
266240|NCT00955357|645382|P1|NOT COMPLETED|Maintenance Phase||12
266241|NCT00955357|645381|P2|COMPLETED|Maintenance Phase||249
266242|NCT00955357|645382|P1|COMPLETED|Maintenance Phase||68
266243|NCT00955357|645381|P2|STARTED|Maintenance Phase||294
266244|NCT00955357|645382|P1|STARTED|Maintenance Phase||80
266245|NCT00955357|645381|P2|NOT COMPLETED|Titration Phase||66
266246|NCT00955357|645382|P1|NOT COMPLETED|Titration Phase||16
266247|NCT00955357|645381|P2|COMPLETED|Titration Phase||294
266248|NCT00955357|645382|P1|COMPLETED|Titration Phase||80
266249|NCT00955357|645381|P2|STARTED|Titration Phase||360
266250|NCT00955357|645382|P1|STARTED|Titration Phase||96
266251|NCT00955305|645390|P2|NOT COMPLETED|Overall Study||87
266252|NCT00955305|645391|P1|NOT COMPLETED|Overall Study||88
266253|NCT00955305|645390|P2|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
266254|NCT00955305|645391|P1|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
266255|NCT00955305|645390|P2|Eligible and Treated|Overall Study||75
266256|NCT00955305|645391|P1|Eligible and Treated|Overall Study||78
266257|NCT00955305|645390|P2|Treated|Overall Study||82
266258|NCT00955305|645391|P1|Treated|Overall Study||83
266259|NCT00955305|645390|P2|STARTED|Overall Study||87
266260|NCT00955305|645391|P1|STARTED|Overall Study||88
266261|NCT00955279|645404|P3|NOT COMPLETED|Overall Study||8
266262|NCT00955279|645405|P2|NOT COMPLETED|Overall Study||4
266263|NCT00955279|645406|P1|NOT COMPLETED|Overall Study||3
266264|NCT00955279|645404|P3|COMPLETED|Overall Study||52
266265|NCT00955279|645405|P2|COMPLETED|Overall Study||51
266266|NCT00955279|645406|P1|COMPLETED|Overall Study||55
266267|NCT00955279|645404|P3|STARTED|Overall Study||60
266268|NCT00955279|645405|P2|STARTED|Overall Study||55
266269|NCT00955279|645406|P1|STARTED|Overall Study||58
266270|NCT00955266|645428|P2|NOT COMPLETED|Overall Study||0
266271|NCT00955266|645429|P1|NOT COMPLETED|Overall Study||0
266272|NCT00955266|645428|P2|COMPLETED|Overall Study||4
266273|NCT00955266|645429|P1|COMPLETED|Overall Study||4
266274|NCT00955266|645428|P2|STARTED|Overall Study||4
266275|NCT00955266|645429|P1|STARTED|Overall Study||4
266276|NCT00955253|645443|P2|NOT COMPLETED|Overall Study||0
266277|NCT00955253|645444|P1|NOT COMPLETED|Overall Study||0
266278|NCT00955253|645443|P2|COMPLETED|Overall Study||6
266279|NCT00955253|645444|P1|COMPLETED|Overall Study||7
266280|NCT00955253|645443|P2|STARTED|Overall Study||6
266281|NCT00955253|645444|P1|STARTED|Overall Study||7
266282|NCT00955201|645453|P4|NOT COMPLETED|Overall Study||4
266283|NCT00955201|645454|P3|NOT COMPLETED|Overall Study||1
266284|NCT00955201|645455|P2|NOT COMPLETED|Overall Study||0
266285|NCT00955201|645456|P1|NOT COMPLETED|Overall Study||4
266286|NCT00955201|645453|P4|COMPLETED|Overall Study||7
266287|NCT00955201|645454|P3|COMPLETED|Overall Study||10
266288|NCT00955201|645455|P2|COMPLETED|Overall Study||11
266289|NCT00955201|645456|P1|COMPLETED|Overall Study||8
266290|NCT00955201|645453|P4|STARTED|Overall Study||11
266291|NCT00955201|645454|P3|STARTED|Overall Study||11
266292|NCT00955201|645455|P2|STARTED|Overall Study||11
266293|NCT00955201|645456|P1|STARTED|Overall Study||12
266294|NCT00955110|645614|P1|NOT COMPLETED|Treatment Phase||6
266295|NCT00955110|645614|P1|COMPLETED|Treatment Phase||35
266296|NCT00955110|645614|P1|Oxycodone CR 60 mg|Treatment Phase||40
266297|NCT00955110|645614|P1|Oxycodone CR 30 mg|Treatment Phase||40
266298|NCT00955110|645614|P1|Oxymorphone ER 30 mg|Treatment Phase||38
266299|NCT00955110|645614|P1|Oxymorphone ER 15 mg|Treatment Phase||37
266300|NCT00955110|645614|P1|Placebo|Treatment Phase||38
266301|NCT00955110|645614|P1|STARTED|Treatment Phase||41
266302|NCT00955110|645614|P1|NOT COMPLETED|Qualification Phase||24
266303|NCT00955110|645614|P1|COMPLETED|Qualification Phase||54
266304|NCT00955110|645614|P1|STARTED|Qualification Phase||78
266305|NCT00955032|645628|P2|NOT COMPLETED|Overall Study||0
266306|NCT00955032|645629|P1|NOT COMPLETED|Overall Study||0
266307|NCT00955032|645628|P2|COMPLETED|Overall Study||8
266308|NCT00955032|645629|P1|COMPLETED|Overall Study||16
266309|NCT00955032|645628|P2|STARTED|Overall Study||8
266310|NCT00955032|645629|P1|STARTED|Overall Study||16
266311|NCT00954993|645649|P1|NOT COMPLETED|Period 2||0
266312|NCT00954993|645649|P1|COMPLETED|Period 2||3
266313|NCT00954993|645649|P1|STARTED|Period 2||3
266314|NCT00954993|645649|P1|NOT COMPLETED|Washout||0
266315|NCT00954993|645649|P1|COMPLETED|Washout||3
266316|NCT00954993|645649|P1|STARTED|Washout||3
266317|NCT00954993|645649|P1|NOT COMPLETED|Period 1||0
266318|NCT00954993|645649|P1|COMPLETED|Period 1||3
266319|NCT00954993|645649|P1|STARTED|Period 1||3
266320|NCT00954941|645661|P2|NOT COMPLETED|Overall Study||7
266321|NCT00954941|645662|P1|NOT COMPLETED|Overall Study||8
266322|NCT00954941|645661|P2|COMPLETED|Overall Study||41
266323|NCT00954941|645662|P1|COMPLETED|Overall Study||42
266324|NCT00954941|645661|P2|STARTED|Overall Study||48
266325|NCT00954941|645662|P1|STARTED|Overall Study||50
266326|NCT00954915|645670|P1|NOT COMPLETED|Overall Study||0
266327|NCT00954915|645670|P1|COMPLETED|Overall Study||1
266328|NCT00954915|645670|P1|STARTED|Overall Study||1
266329|NCT00954824|645674|P1|NOT COMPLETED|Overall Study||50
266330|NCT00954824|645674|P1|COMPLETED|Overall Study||50
266331|NCT00954824|645674|P1|STARTED|Overall Study||100
266332|NCT00954733|645678|P1|NOT COMPLETED|Overall Study||1
266333|NCT00954733|645678|P1|COMPLETED|Overall Study||39
266334|NCT00954733|645678|P1|STARTED|Overall Study||40
266335|NCT00954707|645682|P1|NOT COMPLETED|Overall Study||167
266336|NCT00954707|645682|P1|COMPLETED|Overall Study|2342 Subjects completed 12-month Phase 1 follow-up; 167 subjects didn't complete the Phase 1.|2342
266337|NCT00954707|645682|P1|STARTED|Overall Study||2509
266338|NCT00954681|645698|P1|NOT COMPLETED|Overall Study||5
266339|NCT00954681|645698|P1|COMPLETED|Overall Study||10
266340|NCT00954681|645698|P1|STARTED|Overall Study||15
266341|NCT00954538|645704|P6|NOT COMPLETED|Part III||0
266342|NCT00954538|645705|P5|NOT COMPLETED|Part III||1
266343|NCT00954538|645706|P4|NOT COMPLETED|Part III||0
266344|NCT00954538|645707|P3|NOT COMPLETED|Part III||0
266345|NCT00954538|645708|P2|NOT COMPLETED|Part III||0
266346|NCT00954538|645709|P1|NOT COMPLETED|Part III||0
266347|NCT00954538|645704|P6|COMPLETED|Part III||2
266348|NCT00954538|645705|P5|COMPLETED|Part III|The subject who did not complete received 1 dose of study drug|5
266349|NCT00954538|645706|P4|COMPLETED|Part III||4
266350|NCT00954538|645707|P3|COMPLETED|Part III||0
266351|NCT00954538|645708|P2|COMPLETED|Part III||0
266352|NCT00954538|645709|P1|COMPLETED|Part III||0
266353|NCT00954538|645704|P6|STARTED|Part III|These subjects did not participate in Part I and did participate in Part II and III|2
266354|NCT00954538|645705|P5|STARTED|Part III|These subjects did not participate in Part I or II|6
266355|NCT00954538|645706|P4|STARTED|Part III|These subjects did not participate in Part I or II|4
266356|NCT00954538|645707|P3|STARTED|Part III||0
266357|NCT00954538|645708|P2|STARTED|Part III||0
266358|NCT00954538|645709|P1|STARTED|Part III||0
266359|NCT00954538|645704|P6|NOT COMPLETED|Part II||0
266360|NCT00954538|645705|P5|NOT COMPLETED|Part II||0
266361|NCT00954538|645706|P4|NOT COMPLETED|Part II||0
266362|NCT00954538|645707|P3|NOT COMPLETED|Part II||0
266363|NCT00954538|645708|P2|NOT COMPLETED|Part II||0
266364|NCT00954538|645709|P1|NOT COMPLETED|Part II||0
266365|NCT00954538|645704|P6|COMPLETED|Part II||2
266366|NCT00954538|645705|P5|COMPLETED|Part II||0
266367|NCT00954538|645706|P4|COMPLETED|Part II||0
266368|NCT00954538|645707|P3|COMPLETED|Part II||3
266369|NCT00954538|645708|P2|COMPLETED|Part II||1
266370|NCT00954538|645709|P1|COMPLETED|Part II||0
266371|NCT00954538|645704|P6|STARTED|Part II|These subjects did not participate in Part I and did participate in Part II and III|2
266372|NCT00954538|645705|P5|STARTED|Part II||0
266373|NCT00954538|645706|P4|STARTED|Part II||0
266374|NCT00954538|645707|P3|STARTED|Part II|These subjects did not participate in Part I or III|3
266375|NCT00954538|645708|P2|STARTED|Part II|This subject did not participate in Part I or III|1
266376|NCT00954538|645709|P1|STARTED|Part II||0
266377|NCT00954538|645704|P6|NOT COMPLETED|Part I||0
266378|NCT00954538|645705|P5|NOT COMPLETED|Part I||0
266379|NCT00954538|645706|P4|NOT COMPLETED|Part I||0
266380|NCT00954538|645707|P3|NOT COMPLETED|Part I||0
266381|NCT00954538|645708|P2|NOT COMPLETED|Part I||0
266382|NCT00954538|645709|P1|NOT COMPLETED|Part I||0
266383|NCT00954538|645704|P6|COMPLETED|Part I||0
266384|NCT00954538|645705|P5|COMPLETED|Part I||0
266385|NCT00954538|645706|P4|COMPLETED|Part I||0
266386|NCT00954538|645707|P3|COMPLETED|Part I||0
266387|NCT00954538|645708|P2|COMPLETED|Part I||0
266388|NCT00954538|645709|P1|COMPLETED|Part I||3
266389|NCT00954538|645704|P6|STARTED|Part I||0
266390|NCT00954538|645705|P5|STARTED|Part I||0
266391|NCT00954538|645706|P4|STARTED|Part I||0
266392|NCT00954538|645707|P3|STARTED|Part I||0
266393|NCT00954538|645708|P2|STARTED|Part I||0
266394|NCT00954538|645709|P1|STARTED|Part I|These subjects did not participate in Part II or III|3
266395|NCT00954512|645726|P6|NOT COMPLETED|Overall Study||4
266396|NCT00954512|645727|P5|NOT COMPLETED|Overall Study||4
266397|NCT00954512|645728|P4|NOT COMPLETED|Overall Study||2
266398|NCT00954512|645729|P3|NOT COMPLETED|Overall Study||0
266399|NCT00954512|645730|P2|NOT COMPLETED|Overall Study||3
266400|NCT00954512|645731|P1|NOT COMPLETED|Overall Study||2
266401|NCT00954512|645726|P6|COMPLETED|Overall Study||0
266402|NCT00954512|645727|P5|COMPLETED|Overall Study||0
266403|NCT00954512|645728|P4|COMPLETED|Overall Study||0
266404|NCT00954512|645729|P3|COMPLETED|Overall Study||0
266405|NCT00954512|645730|P2|COMPLETED|Overall Study||0
266406|NCT00954512|645731|P1|COMPLETED|Overall Study||0
266407|NCT00954512|645726|P6|STARTED|Overall Study||4
266408|NCT00954512|645727|P5|STARTED|Overall Study||4
266409|NCT00954512|645728|P4|STARTED|Overall Study||2
266410|NCT00954512|645729|P3|STARTED|Overall Study||0
266411|NCT00954512|645730|P2|STARTED|Overall Study||3
266412|NCT00954512|645731|P1|STARTED|Overall Study||2
266413|NCT00954447|645752|P2|NOT COMPLETED|Overall Study||88
266414|NCT00954447|645753|P1|NOT COMPLETED|Overall Study||110
266415|NCT00954447|645752|P2|COMPLETED|Overall Study||543
266416|NCT00954447|645753|P1|COMPLETED|Overall Study||520
266417|NCT00954447|645752|P2|STARTED|Overall Study||631
266418|NCT00954447|645753|P1|STARTED|Overall Study||630
266419|NCT00954421|645789|P1|NOT COMPLETED|VIM=ON VO=OFF at 6 Months||1
266420|NCT00954421|645789|P1|COMPLETED|VIM=ON VO=OFF at 6 Months||11
266421|NCT00954421|645789|P1|STARTED|VIM=ON VO=OFF at 6 Months||12
266422|NCT00954421|645789|P1|NOT COMPLETED|VIM=OFF VO=ON at 6 Months||0
266423|NCT00954421|645789|P1|COMPLETED|VIM=OFF VO=ON at 6 Months||12
266424|NCT00954421|645789|P1|STARTED|VIM=OFF VO=ON at 6 Months||12
266425|NCT00954421|645789|P1|NOT COMPLETED|VIM=OFF VO=OFF at 6 Months||0
266426|NCT00954421|645789|P1|COMPLETED|VIM=OFF VO=OFF at 6 Months||12
266427|NCT00954421|645789|P1|STARTED|VIM=OFF VO=OFF at 6 Months||12
266428|NCT00954421|645789|P1|NOT COMPLETED|VIM=ON VO=ON at 6 Months||0
266429|NCT00954421|645789|P1|COMPLETED|VIM=ON VO=ON at 6 Months||12
266430|NCT00954421|645789|P1|STARTED|VIM=ON VO=ON at 6 Months|This is the point of evaluation: Order of assessment was random for periods 4-7|12
266431|NCT00954421|645789|P1|NOT COMPLETED|6 Months of DBS||1
266432|NCT00954421|645789|P1|COMPLETED|6 Months of DBS||12
266433|NCT00954421|645789|P1|STARTED|6 Months of DBS||13
266434|NCT00954421|645789|P1|NOT COMPLETED|Baseline||0
266435|NCT00954421|645789|P1|COMPLETED|Baseline||13
266436|NCT00954421|645789|P1|STARTED|Baseline||13
266437|NCT00954421|645789|P1|NOT COMPLETED|Screening||3
266438|NCT00954421|645789|P1|COMPLETED|Screening||13
266439|NCT00954421|645789|P1|STARTED|Screening||16
266440|NCT00954356|645797|P2|NOT COMPLETED|Overall Study||0
266441|NCT00954356|645798|P1|NOT COMPLETED|Overall Study||0
266442|NCT00954356|645797|P2|COMPLETED|Overall Study||20
266443|NCT00954356|645798|P1|COMPLETED|Overall Study||41
266444|NCT00954356|645797|P2|STARTED|Overall Study||20
266445|NCT00954356|645798|P1|STARTED|Overall Study||41
266446|NCT00954187|645828|P2|NOT COMPLETED|Overall Study||0
266447|NCT00954187|645829|P1|NOT COMPLETED|Overall Study||0
266448|NCT00954187|645828|P2|COMPLETED|Overall Study||0
266449|NCT00954187|645829|P1|COMPLETED|Overall Study||0
266450|NCT00954187|645828|P2|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
266451|NCT00954187|645829|P1|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
266452|NCT00954122|645835|P1|NOT COMPLETED|Overall Study||7
266453|NCT00954122|645835|P1|COMPLETED|Overall Study||28
266454|NCT00954122|645835|P1|STARTED|Overall Study||35
266455|NCT00954109|645845|P1|NOT COMPLETED|Overall Study||0
266456|NCT00954109|645845|P1|COMPLETED|Overall Study||11
266457|NCT00954109|645845|P1|STARTED|Overall Study||11
266458|NCT00953927|645852|P2|NOT COMPLETED|Overall Study||95
266459|NCT00953927|645853|P1|NOT COMPLETED|Overall Study||105
266460|NCT00953927|645852|P2|COMPLETED|Overall Study||1303
266461|NCT00953927|645853|P1|COMPLETED|Overall Study||1294
266462|NCT00953927|645852|P2|STARTED|Overall Study||1398
266463|NCT00953927|645853|P1|STARTED|Overall Study||1399
266464|NCT00953862|645871|P1|NOT COMPLETED|Overall Study||6
266465|NCT00953862|645871|P1|COMPLETED|Overall Study||12
266466|NCT00953862|645871|P1|STARTED|Overall Study||18
266467|NCT00953849|645881|P4|NOT COMPLETED|Overall Study||0
266468|NCT00953849|645882|P3|NOT COMPLETED|Overall Study||0
266469|NCT00953849|645883|P2|NOT COMPLETED|Overall Study||0
266470|NCT00953849|645884|P1|NOT COMPLETED|Overall Study||0
266471|NCT00953849|645881|P4|COMPLETED|Overall Study||5
266472|NCT00953849|645882|P3|COMPLETED|Overall Study||4
266473|NCT00953849|645883|P2|COMPLETED|Overall Study||6
266474|NCT00953849|645884|P1|COMPLETED|Overall Study||6
266475|NCT00953849|645881|P4|STARTED|Overall Study||5
266476|NCT00953849|645882|P3|STARTED|Overall Study||4
266477|NCT00953849|645883|P2|STARTED|Overall Study||6
266478|NCT00953849|645884|P1|STARTED|Overall Study||6
266479|NCT00953745|645908|P2|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
266480|NCT00953745|645909|P1|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
266481|NCT00953745|645908|P2|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
266482|NCT00953745|645909|P1|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||17
266483|NCT00953745|645908|P2|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||0
266484|NCT00953745|645909|P1|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||17
266485|NCT00953745|645908|P2|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
266486|NCT00953745|645909|P1|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||1
266487|NCT00953745|645908|P2|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
266488|NCT00953745|645909|P1|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||17
266489|NCT00953745|645908|P2|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||0
266490|NCT00953745|645909|P1|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||18
266491|NCT00953745|645908|P2|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||0
266492|NCT00953745|645909|P1|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||13
266493|NCT00953745|645908|P2|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||6
266494|NCT00953745|645909|P1|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||24
266495|NCT00953745|645908|P2|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||6
266496|NCT00953745|645909|P1|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||37
266497|NCT00953719|645919|P2|NOT COMPLETED|Overall Study||5
266498|NCT00953719|645920|P1|NOT COMPLETED|Overall Study||19
266499|NCT00953719|645919|P2|COMPLETED|Overall Study||69
266500|NCT00953719|645920|P1|COMPLETED|Overall Study||150
266501|NCT00953719|645919|P2|STARTED|Overall Study||74
266502|NCT00953719|645920|P1|STARTED|Overall Study||169
266503|NCT00953706|645942|P4|NOT COMPLETED|Part B (96-Week Open-Label Extension)||33
266504|NCT00953706|645943|P3|NOT COMPLETED|Part B (96-Week Open-Label Extension)||5
266505|NCT00953706|645944|P2|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
266506|NCT00953706|645945|P1|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
266507|NCT00953706|645942|P4|COMPLETED|Part B (96-Week Open-Label Extension)||0
266508|NCT00953706|645943|P3|COMPLETED|Part B (96-Week Open-Label Extension)||0
266509|NCT00953706|645944|P2|COMPLETED|Part B (96-Week Open-Label Extension)||0
266510|NCT00953706|645945|P1|COMPLETED|Part B (96-Week Open-Label Extension)||0
266511|NCT00953706|645942|P4|STARTED|Part B (96-Week Open-Label Extension)||33
266512|NCT00953706|645943|P3|STARTED|Part B (96-Week Open-Label Extension)||5
266513|NCT00953706|645944|P2|STARTED|Part B (96-Week Open-Label Extension)||0
266514|NCT00953706|645945|P1|STARTED|Part B (96-Week Open-Label Extension)||0
266515|NCT00953706|645942|P4|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
266516|NCT00953706|645943|P3|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
266517|NCT00953706|645944|P2|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||8
266518|NCT00953706|645945|P1|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||2
266519|NCT00953706|645942|P4|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
266520|NCT00953706|645943|P3|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
266521|NCT00953706|645944|P2|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 33 participants continued in Part B.|104
266522|NCT00953706|645945|P1|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 5 participants continued in Part B.|26
266523|NCT00953706|645942|P4|STARTED|Part A (16-Week Double-Blind Treatment)||0
266524|NCT00953706|645943|P3|STARTED|Part A (16-Week Double-Blind Treatment)||0
266525|NCT00953706|645944|P2|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (ivacaftor)|112
266526|NCT00953706|645945|P1|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (placebo)|28
266527|NCT00953680|645977|P2|NOT COMPLETED|Period 2||0
266528|NCT00953680|645978|P1|NOT COMPLETED|Period 2||0
266529|NCT00953680|645977|P2|COMPLETED|Period 2||38
266530|NCT00953680|645978|P1|COMPLETED|Period 2||38
266531|NCT00953680|645977|P2|STARTED|Period 2||38
266532|NCT00953680|645978|P1|STARTED|Period 2||38
266533|NCT00953680|645977|P2|NOT COMPLETED|Period 1||1
266534|NCT00953680|645978|P1|NOT COMPLETED|Period 1||0
266535|NCT00953680|645977|P2|COMPLETED|Period 1||38
266536|NCT00953680|645978|P1|COMPLETED|Period 1||38
266537|NCT00953680|645977|P2|STARTED|Period 1||39
266538|NCT00953680|645978|P1|STARTED|Period 1||38
266539|NCT00953667|645990|P1|NOT COMPLETED|Overall Study||123
266540|NCT00953667|645990|P1|COMPLETED|Overall Study||277
266541|NCT00953667|645990|P1|STARTED|Overall Study||400
266542|NCT00953654|645998|P3|NOT COMPLETED|Overall Study||0
266543|NCT00953654|645999|P2|NOT COMPLETED|Overall Study||0
266544|NCT00953654|646000|P1|NOT COMPLETED|Overall Study||0
266545|NCT00953654|645998|P3|COMPLETED|Overall Study||10
266546|NCT00953654|645999|P2|COMPLETED|Overall Study||10
266547|NCT00953654|646000|P1|COMPLETED|Overall Study||10
266548|NCT00953654|645998|P3|STARTED|Overall Study||10
266549|NCT00953654|645999|P2|STARTED|Overall Study||10
266550|NCT00953654|646000|P1|STARTED|Overall Study||10
266551|NCT00953615|646011|P1|NOT COMPLETED|Overall Study||1
266552|NCT00953615|646011|P1|COMPLETED|Overall Study||0
266553|NCT00953615|646011|P1|STARTED|Overall Study||1
266554|NCT00953576|646020|P2|NOT COMPLETED|Overall Study||1
266555|NCT00953576|646021|P1|NOT COMPLETED|Overall Study||2
266556|NCT00953576|646020|P2|COMPLETED|Overall Study||4
266557|NCT00953576|646021|P1|COMPLETED|Overall Study|One participant enrolled on dose level 1 did not receive full dose ketoconazole and was replaced.|4
266558|NCT00953576|646020|P2|Pharmacokinetic (PK) Evaluable|Overall Study||3
266559|NCT00953576|646021|P1|Pharmacokinetic (PK) Evaluable|Overall Study||4
266560|NCT00953576|646020|P2|Treated|Overall Study||5
266561|NCT00953576|646021|P1|Treated|Overall Study||4
266562|NCT00953576|646020|P2|DLT Evaluable|Overall Study||5
266563|NCT00953576|646021|P1|DLT Evaluable|Overall Study||3
266564|NCT00953576|646020|P2|STARTED|Overall Study||5
266565|NCT00953576|646021|P1|STARTED|Overall Study||6
266566|NCT00953524|646036|P4|NOT COMPLETED|Overall Study||8
266567|NCT00953524|646037|P3|NOT COMPLETED|Overall Study||14
266568|NCT00953524|646038|P2|NOT COMPLETED|Overall Study||15
266569|NCT00953524|646039|P1|NOT COMPLETED|Overall Study||22
266570|NCT00953524|646036|P4|COMPLETED|Overall Study||91
266571|NCT00953524|646037|P3|COMPLETED|Overall Study||233
266572|NCT00953524|646038|P2|COMPLETED|Overall Study||239
266573|NCT00953524|646039|P1|COMPLETED|Overall Study||227
266574|NCT00953524|646036|P4|STARTED|Overall Study||99
266575|NCT00953524|646037|P3|STARTED|Overall Study||247
266576|NCT00953524|646038|P2|STARTED|Overall Study||254
266577|NCT00953524|646039|P1|STARTED|Overall Study||249
266578|NCT00953407|646082|P5|NOT COMPLETED|Overall Study||1
266579|NCT00953407|646083|P4|NOT COMPLETED|Overall Study||2
266580|NCT00953407|646084|P3|NOT COMPLETED|Overall Study||1
266581|NCT00953407|646085|P2|NOT COMPLETED|Overall Study||1
266582|NCT00953407|646086|P1|NOT COMPLETED|Overall Study||1
266583|NCT00953407|646082|P5|COMPLETED|Overall Study||23
266584|NCT00953407|646083|P4|COMPLETED|Overall Study||23
266585|NCT00953407|646084|P3|COMPLETED|Overall Study||25
266586|NCT00953407|646085|P2|COMPLETED|Overall Study||24
266587|NCT00953407|646086|P1|COMPLETED|Overall Study||25
266588|NCT00953407|646082|P5|STARTED|Overall Study||24
266589|NCT00953407|646083|P4|STARTED|Overall Study||25
266590|NCT00953407|646084|P3|STARTED|Overall Study||26
266591|NCT00953407|646085|P2|STARTED|Overall Study||25
266592|NCT00953407|646086|P1|STARTED|Overall Study||26
266593|NCT00953329|646098|P1|NOT COMPLETED|Overall Study||1
266594|NCT00953329|646098|P1|COMPLETED|Overall Study||0
266595|NCT00953329|646098|P1|STARTED|Overall Study||1
266596|NCT00953290|646102|P1|NOT COMPLETED|Overall Study||0
266597|NCT00953290|646102|P1|COMPLETED|Overall Study||4
266598|NCT00953290|646102|P1|STARTED|Overall Study||4
266599|NCT00953225|646111|P2|NOT COMPLETED|Overall Study||0
266600|NCT00953225|646112|P1|NOT COMPLETED|Overall Study||2
266601|NCT00953225|646111|P2|COMPLETED|Overall Study||37
266602|NCT00953225|646112|P1|COMPLETED|Overall Study||44
266603|NCT00953225|646111|P2|STARTED|Overall Study||37
266604|NCT00953225|646112|P1|STARTED|Overall Study||46
266605|NCT00953212|646124|P4|NOT COMPLETED|Overall Study||0
266606|NCT00953212|646125|P3|NOT COMPLETED|Overall Study||0
266607|NCT00953212|646126|P2|NOT COMPLETED|Overall Study||0
266608|NCT00953212|646127|P1|NOT COMPLETED|Overall Study||0
266609|NCT00953212|646124|P4|COMPLETED|Overall Study||76
266610|NCT00953212|646125|P3|COMPLETED|Overall Study||78
266611|NCT00953212|646126|P2|COMPLETED|Overall Study||74
266612|NCT00953212|646127|P1|COMPLETED|Overall Study||76
266613|NCT00953212|646124|P4|STARTED|Overall Study||76
266614|NCT00953212|646125|P3|STARTED|Overall Study||78
266615|NCT00953212|646126|P2|STARTED|Overall Study||74
266616|NCT00953212|646127|P1|STARTED|Overall Study||76
266617|NCT00953199|646183|P2|NOT COMPLETED|Overall Study||0
266618|NCT00953199|646184|P1|NOT COMPLETED|Overall Study||0
266619|NCT00953199|646183|P2|COMPLETED|Overall Study||252
266620|NCT00953199|646184|P1|COMPLETED|Overall Study||254
266621|NCT00953199|646183|P2|STARTED|Overall Study||252
266622|NCT00953199|646184|P1|STARTED|Overall Study||254
266623|NCT00953173|646192|P1|NOT COMPLETED|Overall Study||282
266624|NCT00953173|646192|P1|COMPLETED|Overall Study||389
266625|NCT00953173|646192|P1|STARTED|Overall Study||671
266626|NCT00953160|646196|P1|NOT COMPLETED|Overall Study||27
266627|NCT00953160|646196|P1|COMPLETED|Overall Study||49
266628|NCT00953160|646196|P1|STARTED|Overall Study||76
266629|NCT00953147|646205|P3|NOT COMPLETED|Overall Study||42
266630|NCT00953147|646206|P2|NOT COMPLETED|Overall Study||66
266631|NCT00953147|646207|P1|NOT COMPLETED|Overall Study||37
266632|NCT00953147|646205|P3|COMPLETED|Overall Study||265
266633|NCT00953147|646206|P2|COMPLETED|Overall Study||439
266634|NCT00953147|646207|P1|COMPLETED|Overall Study||261
266635|NCT00953147|646205|P3|STARTED|Overall Study||307
266636|NCT00953147|646206|P2|STARTED|Overall Study||505
266637|NCT00953147|646207|P1|STARTED|Overall Study||298
266638|NCT00953121|646257|P3|NOT COMPLETED|Overall Study||0
266639|NCT00953121|646258|P2|NOT COMPLETED|Overall Study||0
266640|NCT00953121|646259|P1|NOT COMPLETED|Overall Study||0
266641|NCT00953121|646257|P3|COMPLETED|Overall Study||25
266642|NCT00953121|646258|P2|COMPLETED|Overall Study||39
266643|NCT00953121|646259|P1|COMPLETED|Overall Study||40
266644|NCT00953121|646257|P3|STARTED|Overall Study||25
266645|NCT00953121|646258|P2|STARTED|Overall Study||39
266646|NCT00953121|646259|P1|STARTED|Overall Study||40
266647|NCT00953056|646285|P6|NOT COMPLETED|Overall Study||4
266648|NCT00953056|646286|P5|NOT COMPLETED|Overall Study||2
266649|NCT00953056|646287|P4|NOT COMPLETED|Overall Study||0
266650|NCT00953056|646288|P3|NOT COMPLETED|Overall Study||0
266651|NCT00953056|646289|P2|NOT COMPLETED|Overall Study||0
266652|NCT00953056|646290|P1|NOT COMPLETED|Overall Study||0
266653|NCT00953056|646285|P6|COMPLETED|Overall Study||20
266654|NCT00953056|646286|P5|COMPLETED|Overall Study|One participant received placebo at the second dose in error, but completed the study.|22
266655|NCT00953056|646287|P4|COMPLETED|Overall Study||24
266656|NCT00953056|646288|P3|COMPLETED|Overall Study||24
266657|NCT00953056|646289|P2|COMPLETED|Overall Study||24
266658|NCT00953056|646290|P1|COMPLETED|Overall Study||24
266659|NCT00953056|646285|P6|STARTED|Overall Study||24
266660|NCT00953056|646286|P5|STARTED|Overall Study||24
266661|NCT00953056|646287|P4|STARTED|Overall Study||24
266662|NCT00953056|646288|P3|STARTED|Overall Study||24
266663|NCT00953056|646289|P2|STARTED|Overall Study||24
266664|NCT00953056|646290|P1|STARTED|Overall Study||24
266665|NCT00953043|646314|P2|NOT COMPLETED|Overall Study||2
266666|NCT00953043|646315|P1|NOT COMPLETED|Overall Study||4
266667|NCT00953043|646314|P2|COMPLETED|Overall Study||28
266668|NCT00953043|646315|P1|COMPLETED|Overall Study||26
266669|NCT00953043|646314|P2|STARTED|Overall Study||30
266670|NCT00953043|646315|P1|STARTED|Overall Study||30
266671|NCT00953017|646339|P4|NOT COMPLETED|Overall Study||5
266672|NCT00953017|646340|P3|NOT COMPLETED|Overall Study||6
266673|NCT00953017|646341|P2|NOT COMPLETED|Overall Study||6
266674|NCT00953017|646342|P1|NOT COMPLETED|Overall Study||5
266675|NCT00953017|646339|P4|COMPLETED|Overall Study||101
266676|NCT00953017|646340|P3|COMPLETED|Overall Study||100
266677|NCT00953017|646341|P2|COMPLETED|Overall Study||101
266678|NCT00953017|646342|P1|COMPLETED|Overall Study||101
266679|NCT00953017|646339|P4|STARTED|Overall Study||106
266680|NCT00953017|646340|P3|STARTED|Overall Study||106
266681|NCT00953017|646341|P2|STARTED|Overall Study||107
266682|NCT00953017|646342|P1|STARTED|Overall Study||106
266683|NCT00952848|646364|P1|NOT COMPLETED|Overall Study||4
266684|NCT00952848|646364|P1|COMPLETED|Overall Study||14
266685|NCT00952848|646364|P1|STARTED|Overall Study||18
266686|NCT00952822|646371|P4|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
266687|NCT00952822|646372|P3|NOT COMPLETED|2nd Pharmacokinetic Evaluation||1
266688|NCT00952822|646373|P2|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
266689|NCT00952822|646374|P1|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
266690|NCT00952822|646371|P4|COMPLETED|2nd Pharmacokinetic Evaluation||4
266691|NCT00952822|646372|P3|COMPLETED|2nd Pharmacokinetic Evaluation||10
266692|NCT00952822|646373|P2|COMPLETED|2nd Pharmacokinetic Evaluation||17
266693|NCT00952822|646374|P1|COMPLETED|2nd Pharmacokinetic Evaluation||9
266694|NCT00952822|646371|P4|STARTED|2nd Pharmacokinetic Evaluation||4
266695|NCT00952822|646372|P3|STARTED|2nd Pharmacokinetic Evaluation||11
266696|NCT00952822|646373|P2|STARTED|2nd Pharmacokinetic Evaluation||17
266697|NCT00952822|646374|P1|STARTED|2nd Pharmacokinetic Evaluation||9
266698|NCT00952822|646371|P4|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
266699|NCT00952822|646372|P3|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
266700|NCT00952822|646373|P2|NOT COMPLETED|1st Pharmacokinetic Evaluation||1
266701|NCT00952822|646374|P1|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
266702|NCT00952822|646371|P4|COMPLETED|1st Pharmacokinetic Evaluation||4
266703|NCT00952822|646372|P3|COMPLETED|1st Pharmacokinetic Evaluation||11
266704|NCT00952822|646373|P2|COMPLETED|1st Pharmacokinetic Evaluation||17
266705|NCT00952822|646374|P1|COMPLETED|1st Pharmacokinetic Evaluation||9
266706|NCT00952822|646371|P4|STARTED|1st Pharmacokinetic Evaluation||4
266707|NCT00952822|646372|P3|STARTED|1st Pharmacokinetic Evaluation||11
266708|NCT00952822|646373|P2|STARTED|1st Pharmacokinetic Evaluation||18
266709|NCT00952822|646374|P1|STARTED|1st Pharmacokinetic Evaluation||9
266710|NCT00952731|646406|P2|NOT COMPLETED|Overall Study||0
266711|NCT00952731|646407|P1|NOT COMPLETED|Overall Study||1
266712|NCT00952731|646406|P2|COMPLETED|Overall Study||14
266713|NCT00952731|646407|P1|COMPLETED|Overall Study||12
266714|NCT00952731|646406|P2|Follow-up|Overall Study||14
266715|NCT00952731|646407|P1|Follow-up|Overall Study||12
266716|NCT00952731|646406|P2|Surgery|Overall Study||14
266717|NCT00952731|646407|P1|Surgery|Overall Study||12
266718|NCT00952731|646406|P2|Treatment & Pre-Surgery|Overall Study||14
266719|NCT00952731|646407|P1|Treatment & Pre-Surgery|Overall Study||12
266720|NCT00952731|646406|P2|Randomization|Overall Study||14
266721|NCT00952731|646407|P1|Randomization|Overall Study||13
266722|NCT00952731|646406|P2|STARTED|Overall Study||14
266723|NCT00952731|646407|P1|STARTED|Overall Study||13
266724|NCT00952718|646425|P2|NOT COMPLETED|Overall Study||6
266725|NCT00952718|646426|P1|NOT COMPLETED|Overall Study||6
266726|NCT00952718|646425|P2|COMPLETED|Overall Study||13
266727|NCT00952718|646426|P1|COMPLETED|Overall Study||13
266728|NCT00952718|646425|P2|STARTED|Overall Study||19
266729|NCT00952718|646426|P1|STARTED|Overall Study||19
266730|NCT00952705|646439|P3|NOT COMPLETED|Overall Study||10
266731|NCT00952705|646440|P2|NOT COMPLETED|Overall Study||10
266732|NCT00952705|646441|P1|NOT COMPLETED|Overall Study||33
266733|NCT00952705|646439|P3|COMPLETED|Overall Study||288
266734|NCT00952705|646440|P2|COMPLETED|Overall Study||290
266735|NCT00952705|646441|P1|COMPLETED|Overall Study||1169
266736|NCT00952705|646439|P3|STARTED|Overall Study||298
266737|NCT00952705|646440|P2|STARTED|Overall Study||300
266738|NCT00952705|646441|P1|STARTED|Overall Study|Three not treated with Q/LAIV-BFS (1 treated with FluMist/B/Yamagata; 2 withdrew prior to dosing).|1202
266739|NCT00952653|646503|P1|NOT COMPLETED|Period 2: Coadministration DVS SR, MDZ||0
266740|NCT00952653|646503|P1|COMPLETED|Period 2: Coadministration DVS SR, MDZ||28
266741|NCT00952653|646503|P1|STARTED|Period 2: Coadministration DVS SR, MDZ||28
266742|NCT00952653|646503|P1|NOT COMPLETED|Period 1: MDZ Alone||0
266743|NCT00952653|646503|P1|COMPLETED|Period 1: MDZ Alone||28
266744|NCT00952653|646503|P1|STARTED|Period 1: MDZ Alone||28
266745|NCT00952614|646528|P1|NOT COMPLETED|Overall Study||7
266746|NCT00952614|646528|P1|COMPLETED|Overall Study|3 subjects died from unrelated causes, 3 were lost to follow-up & 1 had both eyes included in study.|23
266747|NCT00952614|646528|P1|Participants Started Treatment|Overall Study|29 subjects signed consent; 1 agreed for both eyes to enroll. 30 eyes rec'd drug delivery implant|30
266748|NCT00952614|646528|P1|STARTED|Overall Study||30
266749|NCT00952588|646535|P2|NOT COMPLETED|Overall Study||24
266750|NCT00952588|646536|P1|NOT COMPLETED|Overall Study||36
266751|NCT00952588|646535|P2|COMPLETED|Overall Study||2
266752|NCT00952588|646536|P1|COMPLETED|Overall Study||12
266753|NCT00952588|646535|P2|STARTED|Overall Study||26
266754|NCT00952588|646536|P1|STARTED|Overall Study||48
266755|NCT00952523|646554|P1|NOT COMPLETED|Overall Study||7
266756|NCT00952523|646554|P1|COMPLETED|Overall Study||155
266757|NCT00952523|646554|P1|STARTED|Overall Study||162
266758|NCT00952484|646563|P3|NOT COMPLETED|Overall Study||0
266759|NCT00952484|646564|P2|NOT COMPLETED|Overall Study||1
266760|NCT00952484|646565|P1|NOT COMPLETED|Overall Study||0
266761|NCT00952484|646563|P3|COMPLETED|Overall Study||16
266762|NCT00952484|646564|P2|COMPLETED|Overall Study||6
266763|NCT00952484|646565|P1|COMPLETED|Overall Study||6
266764|NCT00952484|646563|P3|STARTED|Overall Study||16
266765|NCT00952484|646564|P2|STARTED|Overall Study||7
266766|NCT00952484|646565|P1|STARTED|Overall Study||6
266767|NCT00952419|646592|P3|NOT COMPLETED|Overall Study||0
266768|NCT00952419|646593|P2|NOT COMPLETED|Overall Study||10
266769|NCT00952419|646594|P1|NOT COMPLETED|Overall Study||6
266770|NCT00952419|646592|P3|COMPLETED|Overall Study||51
266771|NCT00952419|646593|P2|COMPLETED|Overall Study||198
266772|NCT00952419|646594|P1|COMPLETED|Overall Study||209
266773|NCT00952419|646592|P3|STARTED|Overall Study||51
266774|NCT00952419|646593|P2|STARTED|Overall Study||208
266775|NCT00952419|646594|P1|STARTED|Overall Study||215
266776|NCT00952393|646626|P1|NOT COMPLETED|Overall Study||0
266777|NCT00952393|646626|P1|COMPLETED|Overall Study||10
266778|NCT00952393|646626|P1|STARTED|Overall Study|10|10
266779|NCT00952380|646635|P5|NOT COMPLETED|Overall Study||6
266780|NCT00952380|646636|P4|NOT COMPLETED|Overall Study||3
266781|NCT00952380|646637|P3|NOT COMPLETED|Overall Study||2
266782|NCT00952380|646638|P2|NOT COMPLETED|Overall Study||1
266783|NCT00952380|646639|P1|NOT COMPLETED|Overall Study||0
266784|NCT00952380|646635|P5|COMPLETED|Overall Study||14
266785|NCT00952380|646636|P4|COMPLETED|Overall Study||4
266786|NCT00952380|646637|P3|COMPLETED|Overall Study||6
266787|NCT00952380|646638|P2|COMPLETED|Overall Study||1
266788|NCT00952380|646639|P1|COMPLETED|Overall Study||1
266789|NCT00952380|646635|P5|STARTED|Overall Study||20
266790|NCT00952380|646636|P4|STARTED|Overall Study||7
266791|NCT00952380|646637|P3|STARTED|Overall Study||8
266792|NCT00952380|646638|P2|STARTED|Overall Study||2
266793|NCT00952380|646639|P1|STARTED|Overall Study||1
266794|NCT00952367|646740|P1|NOT COMPLETED|Overall Study||6
266795|NCT00952367|646740|P1|COMPLETED|Overall Study||3635
266796|NCT00952367|646740|P1|STARTED|Overall Study||3641
266797|NCT00952341|646755|P2|NOT COMPLETED|Cycle 2||12
266798|NCT00952341|646756|P1|NOT COMPLETED|Cycle 2||9
266799|NCT00952341|646755|P2|COMPLETED|Cycle 2||118
266800|NCT00952341|646756|P1|COMPLETED|Cycle 2||101
266801|NCT00952341|646755|P2|STARTED|Cycle 2||130
266802|NCT00952341|646756|P1|STARTED|Cycle 2||110
266803|NCT00952341|646755|P2|NOT COMPLETED|Cycle 1||13
266804|NCT00952341|646756|P1|NOT COMPLETED|Cycle 1||20
266805|NCT00952341|646755|P2|COMPLETED|Cycle 1||199
266806|NCT00952341|646756|P1|COMPLETED|Cycle 1||189
266807|NCT00952341|646755|P2|STARTED|Cycle 1||212
266808|NCT00952341|646756|P1|STARTED|Cycle 1||209
266809|NCT00952315|646779|P3|NOT COMPLETED|Overall Study||19
266810|NCT00952315|646780|P2|NOT COMPLETED|Overall Study||24
266811|NCT00952315|646781|P1|NOT COMPLETED|Overall Study||26
266812|NCT00952315|646779|P3|COMPLETED|Overall Study||71
266813|NCT00952315|646780|P2|COMPLETED|Overall Study||66
266814|NCT00952315|646781|P1|COMPLETED|Overall Study||64
266815|NCT00952315|646779|P3|STARTED|Overall Study||90
266816|NCT00952315|646780|P2|STARTED|Overall Study||90
266817|NCT00952315|646781|P1|STARTED|Overall Study||90
266818|NCT00952289|646818|P2|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||54
266819|NCT00952289|646819|P1|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
266820|NCT00952289|646818|P2|COMPLETED|Patients Who Crossed Over to Ruxolitinib|Number of cross over subjects who were still in the study as of 25 JAN 2013|57
266821|NCT00952289|646819|P1|COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
266822|NCT00952289|646818|P2|STARTED|Patients Who Crossed Over to Ruxolitinib||111
266823|NCT00952289|646819|P1|STARTED|Patients Who Crossed Over to Ruxolitinib||0
266824|NCT00952289|646818|P2|NOT COMPLETED|All Participants||40
266825|NCT00952289|646819|P1|NOT COMPLETED|All Participants||21
266826|NCT00952289|646818|P2|COMPLETED|All Participants|Includes patients in the study as of 2 November 2010 (78) + those who crossed over to Ruxolitinib.|114
266827|NCT00952289|646819|P1|COMPLETED|All Participants|Represents the number of patients who were still in the study as of 02 November 2010|134
266828|NCT00952289|646818|P2|Safety Population|All Participants|Randomized patients who are documented to have received at least 1 dose of study medication.|151
266829|NCT00952289|646819|P1|Safety Population|All Participants||155
266830|NCT00952289|646818|P2|STARTED|All Participants||154
266831|NCT00952289|646819|P1|STARTED|All Participants||155
266832|NCT00952276|646848|P5|NOT COMPLETED|Overall Study||0
266833|NCT00952276|646849|P4|NOT COMPLETED|Overall Study||1
266834|NCT00952276|646850|P3|NOT COMPLETED|Overall Study||0
266835|NCT00952276|646851|P2|NOT COMPLETED|Overall Study||0
266836|NCT00952276|646852|P1|NOT COMPLETED|Overall Study||1
266837|NCT00952276|646848|P5|COMPLETED|Overall Study||63
266838|NCT00952276|646849|P4|COMPLETED|Overall Study||120
266839|NCT00952276|646850|P3|COMPLETED|Overall Study||122
266840|NCT00952276|646851|P2|COMPLETED|Overall Study||115
266841|NCT00952276|646852|P1|COMPLETED|Overall Study||126
266842|NCT00952276|646848|P5|STARTED|Overall Study||63
266843|NCT00952276|646849|P4|STARTED|Overall Study||121
266844|NCT00952276|646850|P3|STARTED|Overall Study||122
266845|NCT00952276|646851|P2|STARTED|Overall Study||115
266846|NCT00952276|646852|P1|STARTED|Overall Study||127
266847|NCT00952211|646901|P2|NOT COMPLETED|Overall Study||0
266848|NCT00952211|646902|P1|NOT COMPLETED|Overall Study||0
266849|NCT00952211|646901|P2|COMPLETED|Overall Study||0
266850|NCT00952211|646902|P1|COMPLETED|Overall Study||3
266851|NCT00952211|646901|P2|STARTED|Overall Study||0
266852|NCT00952211|646902|P1|STARTED|Overall Study||3
266853|NCT00952133|646912|P2|NOT COMPLETED|Overall Study||0
266854|NCT00952133|646913|P1|NOT COMPLETED|Overall Study||0
266855|NCT00952133|646912|P2|COMPLETED|Overall Study||59
266856|NCT00952133|646913|P1|COMPLETED|Overall Study||59
266857|NCT00952133|646912|P2|STARTED|Overall Study||59
266858|NCT00952133|646913|P1|STARTED|Overall Study||59
266859|NCT00952120|646924|P3|NOT COMPLETED|Overall Study||0
266860|NCT00952120|646925|P2|NOT COMPLETED|Overall Study||0
266861|NCT00952120|646926|P1|NOT COMPLETED|Overall Study||0
266862|NCT00952120|646924|P3|COMPLETED|Overall Study||5
266863|NCT00952120|646925|P2|COMPLETED|Overall Study||47
266864|NCT00952120|646926|P1|COMPLETED|Overall Study||52
266865|NCT00952120|646924|P3|STARTED|Overall Study||5
266866|NCT00952120|646925|P2|STARTED|Overall Study||47
266867|NCT00952120|646926|P1|STARTED|Overall Study||52
266868|NCT00952081|646934|P1|NOT COMPLETED|Overall Study||0
266869|NCT00952081|646934|P1|COMPLETED|Overall Study||22
266870|NCT00952081|646934|P1|STARTED|Overall Study||22
266871|NCT00952068|646938|P1|NOT COMPLETED|Overall Study||7
266872|NCT00952068|646938|P1|COMPLETED|Overall Study||40
266873|NCT00952068|646938|P1|STARTED|Overall Study||47
266874|NCT00951912|646949|P3|NOT COMPLETED|Overall Study||2
266875|NCT00951912|646950|P2|NOT COMPLETED|Overall Study||5
266876|NCT00951912|646951|P1|NOT COMPLETED|Overall Study||7
266877|NCT00951912|646949|P3|COMPLETED|Overall Study||54
266878|NCT00951912|646950|P2|COMPLETED|Overall Study||50
266879|NCT00951912|646951|P1|COMPLETED|Overall Study||47
266880|NCT00951912|646949|P3|STARTED|Overall Study||56
266881|NCT00951912|646950|P2|STARTED|Overall Study||55
266882|NCT00951912|646951|P1|STARTED|Overall Study||54
266883|NCT00951899|647003|P2|NOT COMPLETED|Overall Study||0
266884|NCT00951899|647004|P1|NOT COMPLETED|Overall Study||0
266885|NCT00951899|647003|P2|COMPLETED|Overall Study||19
266886|NCT00951899|647004|P1|COMPLETED|Overall Study||19
266887|NCT00951899|647003|P2|STARTED|Overall Study||19
266888|NCT00951899|647004|P1|STARTED|Overall Study||19
266889|NCT00951821|647028|P2|NOT COMPLETED|Overall Study||0
266890|NCT00951821|647029|P1|NOT COMPLETED|Overall Study||0
266891|NCT00951821|647028|P2|COMPLETED|Overall Study||8
266892|NCT00951821|647029|P1|COMPLETED|Overall Study||16
266893|NCT00951821|647028|P2|STARTED|Overall Study||8
266894|NCT00951821|647029|P1|STARTED|Overall Study||16
266895|NCT00951808|647037|P3|NOT COMPLETED|Overall Study||4
266896|NCT00951808|647038|P2|NOT COMPLETED|Overall Study||0
266897|NCT00951808|647039|P1|NOT COMPLETED|Overall Study||0
266898|NCT00951808|647037|P3|COMPLETED|Overall Study|Four subjects withdrew from the study.|223
266899|NCT00951808|647038|P2|COMPLETED|Overall Study||6
266900|NCT00951808|647039|P1|COMPLETED|Overall Study||4
266901|NCT00951808|647037|P3|STARTED|Overall Study||227
266902|NCT00951808|647038|P2|STARTED|Overall Study||6
266903|NCT00951808|647039|P1|STARTED|Overall Study||4
266904|NCT00951665|647051|P6|NOT COMPLETED|Phase 2a||7
266905|NCT00951665|647052|P5|NOT COMPLETED|Phase 2a||12
266906|NCT00951665|647053|P4|NOT COMPLETED|Phase 2a||0
266907|NCT00951665|647054|P3|NOT COMPLETED|Phase 2a||0
266908|NCT00951665|647055|P2|NOT COMPLETED|Phase 2a||0
266909|NCT00951665|647056|P1|NOT COMPLETED|Phase 2a||0
266910|NCT00951665|647051|P6|COMPLETED|Phase 2a||15
266911|NCT00951665|647052|P5|COMPLETED|Phase 2a||10
266912|NCT00951665|647053|P4|COMPLETED|Phase 2a||0
266913|NCT00951665|647054|P3|COMPLETED|Phase 2a||0
266914|NCT00951665|647055|P2|COMPLETED|Phase 2a||0
266915|NCT00951665|647056|P1|COMPLETED|Phase 2a||0
266916|NCT00951665|647051|P6|STARTED|Phase 2a||22
266917|NCT00951665|647052|P5|STARTED|Phase 2a||22
266918|NCT00951665|647053|P4|STARTED|Phase 2a||0
266919|NCT00951665|647054|P3|STARTED|Phase 2a||0
266920|NCT00951665|647055|P2|STARTED|Phase 2a||0
266921|NCT00951665|647056|P1|STARTED|Phase 2a||0
266922|NCT00951665|647051|P6|NOT COMPLETED|Phase 1b||0
266923|NCT00951665|647052|P5|NOT COMPLETED|Phase 1b||0
266924|NCT00951665|647053|P4|NOT COMPLETED|Phase 1b||1
266925|NCT00951665|647054|P3|NOT COMPLETED|Phase 1b||17
266926|NCT00951665|647055|P2|NOT COMPLETED|Phase 1b||4
266927|NCT00951665|647056|P1|NOT COMPLETED|Phase 1b||22
266928|NCT00951665|647051|P6|COMPLETED|Phase 1b||0
266929|NCT00951665|647052|P5|COMPLETED|Phase 1b||0
266930|NCT00951665|647053|P4|COMPLETED|Phase 1b||2
266931|NCT00951665|647054|P3|COMPLETED|Phase 1b||4
266932|NCT00951665|647055|P2|COMPLETED|Phase 1b||6
266933|NCT00951665|647056|P1|COMPLETED|Phase 1b||7
266934|NCT00951665|647051|P6|Started Treatment|Phase 1b||0
266935|NCT00951665|647052|P5|Started Treatment|Phase 1b||0
266936|NCT00951665|647053|P4|Started Treatment|Phase 1b||3
266937|NCT00951665|647054|P3|Started Treatment|Phase 1b||21
266938|NCT00951665|647055|P2|Started Treatment|Phase 1b||10
266939|NCT00951665|647056|P1|Started Treatment|Phase 1b||26
266940|NCT00951665|647051|P6|STARTED|Phase 1b||0
266941|NCT00951665|647052|P5|STARTED|Phase 1b||0
266942|NCT00951665|647053|P4|STARTED|Phase 1b||3
266943|NCT00951665|647054|P3|STARTED|Phase 1b||21
266944|NCT00951665|647055|P2|STARTED|Phase 1b||10
266945|NCT00951665|647056|P1|STARTED|Phase 1b||29
266946|NCT00951561|647157|P4|NOT COMPLETED|Overall Study||1
266947|NCT00951561|647158|P3|NOT COMPLETED|Overall Study||3
266948|NCT00951561|647159|P2|NOT COMPLETED|Overall Study||0
266949|NCT00951561|647160|P1|NOT COMPLETED|Overall Study||0
266950|NCT00951561|647157|P4|COMPLETED|Overall Study|1 subject dropped after period 2|26
266951|NCT00951561|647158|P3|COMPLETED|Overall Study|3 subjects dropped after period 2|18
266952|NCT00951561|647159|P2|COMPLETED|Overall Study||29
266953|NCT00951561|647160|P1|COMPLETED|Overall Study||25
266954|NCT00951561|647157|P4|STARTED|Overall Study||27
266955|NCT00951561|647158|P3|STARTED|Overall Study|1 subject used Vipon periods 1 & 2 instead of Ibuprofen period 2.|21
266956|NCT00951561|647159|P2|STARTED|Overall Study||29
266957|NCT00951561|647160|P1|STARTED|Overall Study|Randomized Vipon or Ibuprofen period 1, crossover period 2, randomized period 3, crossover period 4|25
266958|NCT00951509|647165|P1|NOT COMPLETED|Overall Study||2
266959|NCT00951509|647165|P1|COMPLETED|Overall Study||29
266960|NCT00951509|647165|P1|Driving Condition 5|Overall Study||30
266961|NCT00951509|647165|P1|Driving Condition 4|Overall Study||28
266962|NCT00951509|647165|P1|Driving Condition 3|Overall Study||25
266963|NCT00951509|647165|P1|Driving Condition 2|Overall Study||29
266964|NCT00951509|647165|P1|Driving Condition 1|Overall Study||29
266965|NCT00951509|647165|P1|STARTED|Overall Study||31
266966|NCT00951496|647176|P3|NOT COMPLETED|Overall Study||13
266967|NCT00951496|647177|P2|NOT COMPLETED|Overall Study||8
266968|NCT00951496|647178|P1|NOT COMPLETED|Overall Study||10
266969|NCT00951496|647176|P3|COMPLETED|Overall Study||508
266970|NCT00951496|647177|P2|COMPLETED|Overall Study||510
266971|NCT00951496|647178|P1|COMPLETED|Overall Study||511
266972|NCT00951496|647176|P3|STARTED|Overall Study||521
266973|NCT00951496|647177|P2|STARTED|Overall Study||518
266974|NCT00951496|647178|P1|STARTED|Overall Study||521
266975|NCT00951483|647206|P2|NOT COMPLETED|Overall Study||0
266976|NCT00951483|647207|P1|NOT COMPLETED|Overall Study||19
266977|NCT00951483|647206|P2|COMPLETED|Overall Study||44
266978|NCT00951483|647207|P1|COMPLETED|Overall Study||28
266979|NCT00951483|647206|P2|STARTED|Overall Study||44
266980|NCT00951483|647207|P1|STARTED|Overall Study||47
266981|NCT00951379|647227|P2|NOT COMPLETED|Overall Study||2
266982|NCT00951379|647228|P1|NOT COMPLETED|Overall Study||6
266983|NCT00951379|647227|P2|COMPLETED|Overall Study||23
266984|NCT00951379|647228|P1|COMPLETED|Overall Study||21
266985|NCT00951379|647227|P2|STARTED|Overall Study||25
266986|NCT00951379|647228|P1|STARTED|Overall Study||27
266987|NCT00951275|647270|P1|NOT COMPLETED|Overall Study||13
266988|NCT00951275|647270|P1|COMPLETED|Overall Study||92
266989|NCT00951275|647270|P1|STARTED|Overall Study||105
266990|NCT00951171|647302|P2|NOT COMPLETED|Overall Study||0
266991|NCT00951171|647303|P1|NOT COMPLETED|Overall Study||2
266992|NCT00951171|647302|P2|COMPLETED|Overall Study|2 of the cervical occlusion group transferred to standard group because of pain during attempted IUI|55
266993|NCT00951171|647303|P1|COMPLETED|Overall Study||38
266994|NCT00951171|647302|P2|Pregnancy|Overall Study||7
266995|NCT00951171|647303|P1|Pregnancy|Overall Study||1
266996|NCT00951171|647302|P2|STARTED|Overall Study||55
266997|NCT00951171|647303|P1|STARTED|Overall Study||40
266998|NCT00951093|647309|P1|NOT COMPLETED|6 Months After GBP||0
266999|NCT00951093|647309|P1|COMPLETED|6 Months After GBP||53
267000|NCT00951093|647309|P1|STARTED|6 Months After GBP||53
267001|NCT00951093|647309|P1|NOT COMPLETED|Before GBP||0
267002|NCT00951093|647309|P1|COMPLETED|Before GBP||53
267003|NCT00951093|647309|P1|STARTED|Before GBP||53
267004|NCT00951041|647335|P2|NOT COMPLETED|Overall Study||1
267005|NCT00951041|647336|P1|NOT COMPLETED|Overall Study||5
267006|NCT00951041|647335|P2|COMPLETED|Overall Study||65
267007|NCT00951041|647336|P1|COMPLETED|Overall Study||59
267008|NCT00951041|647335|P2|STARTED|Overall Study||66
267009|NCT00951041|647336|P1|STARTED|Overall Study||64
267010|NCT00951015|647391|P5|NOT COMPLETED|Open-label Phase||50
267011|NCT00951015|647392|P4|NOT COMPLETED|Open-label Phase||0
267012|NCT00951015|647393|P3|NOT COMPLETED|Open-label Phase||0
267013|NCT00951015|647394|P2|NOT COMPLETED|Open-label Phase||0
267014|NCT00951015|647395|P1|NOT COMPLETED|Open-label Phase||0
267015|NCT00951015|647391|P5|COMPLETED|Open-label Phase||88
267016|NCT00951015|647392|P4|COMPLETED|Open-label Phase||0
267017|NCT00951015|647393|P3|COMPLETED|Open-label Phase||0
267018|NCT00951015|647394|P2|COMPLETED|Open-label Phase||0
267019|NCT00951015|647395|P1|COMPLETED|Open-label Phase||0
267020|NCT00951015|647391|P5|STARTED|Open-label Phase||138
267021|NCT00951015|647392|P4|STARTED|Open-label Phase||0
267022|NCT00951015|647393|P3|STARTED|Open-label Phase||0
267023|NCT00951015|647394|P2|STARTED|Open-label Phase||0
267024|NCT00951015|647395|P1|STARTED|Open-label Phase||0
267025|NCT00951015|647391|P5|NOT COMPLETED|Randomization Phase 96 Week||0
267026|NCT00951015|647392|P4|NOT COMPLETED|Randomization Phase 96 Week||10
267027|NCT00951015|647393|P3|NOT COMPLETED|Randomization Phase 96 Week||5
267028|NCT00951015|647394|P2|NOT COMPLETED|Randomization Phase 96 Week||7
267029|NCT00951015|647395|P1|NOT COMPLETED|Randomization Phase 96 Week||5
267030|NCT00951015|647391|P5|COMPLETED|Randomization Phase 96 Week||0
267031|NCT00951015|647392|P4|COMPLETED|Randomization Phase 96 Week||40
267032|NCT00951015|647393|P3|COMPLETED|Randomization Phase 96 Week||46
267033|NCT00951015|647394|P2|COMPLETED|Randomization Phase 96 Week||44
267034|NCT00951015|647395|P1|COMPLETED|Randomization Phase 96 Week||48
267035|NCT00951015|647391|P5|STARTED|Randomization Phase 96 Week||0
267036|NCT00951015|647392|P4|STARTED|Randomization Phase 96 Week||50
267037|NCT00951015|647393|P3|STARTED|Randomization Phase 96 Week||51
267038|NCT00951015|647394|P2|STARTED|Randomization Phase 96 Week||51
267039|NCT00951015|647395|P1|STARTED|Randomization Phase 96 Week||53
267040|NCT00950963|647492|P2|NOT COMPLETED|Overall Study||24
267041|NCT00950963|647493|P1|NOT COMPLETED|Overall Study||29
267042|NCT00950963|647492|P2|COMPLETED|Overall Study||357
267043|NCT00950963|647493|P1|COMPLETED|Overall Study||352
267044|NCT00950963|647492|P2|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
267045|NCT00950963|647493|P1|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
267046|NCT00950950|647509|P2|NOT COMPLETED|Overall Study||1
267047|NCT00950950|647510|P1|NOT COMPLETED|Overall Study||1
267048|NCT00950950|647509|P2|COMPLETED|Overall Study||11
267049|NCT00950950|647510|P1|COMPLETED|Overall Study||11
267050|NCT00950950|647509|P2|STARTED|Overall Study||12
267051|NCT00950950|647510|P1|STARTED|Overall Study||12
267052|NCT00950937|647573|P2|NOT COMPLETED|Overall Study||0
267053|NCT00950937|647574|P1|NOT COMPLETED|Overall Study||0
267054|NCT00950937|647573|P2|COMPLETED|Overall Study||14
267055|NCT00950937|647574|P1|COMPLETED|Overall Study||14
267056|NCT00950937|647573|P2|STARTED|Overall Study||14
267057|NCT00950937|647574|P1|STARTED|Overall Study||14
267058|NCT00950911|647592|P2|NOT COMPLETED|Overall Study||15
267059|NCT00950911|647593|P1|NOT COMPLETED|Overall Study||12
267060|NCT00950911|647592|P2|COMPLETED|Overall Study||3
267061|NCT00950911|647593|P1|COMPLETED|Overall Study||5
267062|NCT00950911|647592|P2|STARTED|Overall Study||18
267063|NCT00950911|647593|P1|STARTED|Overall Study||17
267064|NCT00950872|647599|P1|NOT COMPLETED|Overall Study||3
267065|NCT00950872|647599|P1|COMPLETED|Overall Study||26
267066|NCT00950872|647599|P1|STARTED|Overall Study||29
267067|NCT00950859|647608|P2|NOT COMPLETED|Overall Study||10
267068|NCT00950859|647609|P1|NOT COMPLETED|Overall Study||16
267069|NCT00950859|647608|P2|COMPLETED|Overall Study||14
267070|NCT00950859|647609|P1|COMPLETED|Overall Study||11
267071|NCT00950859|647608|P2|STARTED|Overall Study||24
267072|NCT00950859|647609|P1|STARTED|Overall Study||27
267073|NCT00950833|647652|P3|NOT COMPLETED|Overall Study||0
267074|NCT00950833|647653|P2|NOT COMPLETED|Overall Study||0
267075|NCT00950833|647654|P1|NOT COMPLETED|Overall Study||0
267076|NCT00950833|647652|P3|COMPLETED|Overall Study||223
267077|NCT00950833|647653|P2|COMPLETED|Overall Study||108
267078|NCT00950833|647654|P1|COMPLETED|Overall Study||112
267079|NCT00950833|647652|P3|STARTED|Overall Study||223
267080|NCT00950833|647653|P2|STARTED|Overall Study||108
267081|NCT00950833|647654|P1|STARTED|Overall Study||112
267082|NCT00950807|647708|P10|NOT COMPLETED|Treatment Period 3||1
267083|NCT00950807|647709|P9|NOT COMPLETED|Treatment Period 3||0
267084|NCT00950807|647710|P8|NOT COMPLETED|Treatment Period 3||1
267085|NCT00950807|647711|P7|NOT COMPLETED|Treatment Period 3||1
267086|NCT00950807|647712|P6|NOT COMPLETED|Treatment Period 3||0
267087|NCT00950807|647713|P5|NOT COMPLETED|Treatment Period 3||0
267088|NCT00950807|647714|P4|NOT COMPLETED|Treatment Period 3||0
267089|NCT00950807|647715|P3|NOT COMPLETED|Treatment Period 3||0
267090|NCT00950807|647716|P2|NOT COMPLETED|Treatment Period 3||0
267091|NCT00950807|647717|P1|NOT COMPLETED|Treatment Period 3||1
267092|NCT00950807|647708|P10|COMPLETED|Treatment Period 3||10
267093|NCT00950807|647709|P9|COMPLETED|Treatment Period 3||9
267094|NCT00950807|647710|P8|COMPLETED|Treatment Period 3||9
267095|NCT00950807|647711|P7|COMPLETED|Treatment Period 3||11
267096|NCT00950807|647712|P6|COMPLETED|Treatment Period 3||9
267097|NCT00950807|647713|P5|COMPLETED|Treatment Period 3||12
267098|NCT00950807|647714|P4|COMPLETED|Treatment Period 3||11
267099|NCT00950807|647715|P3|COMPLETED|Treatment Period 3||10
267100|NCT00950807|647716|P2|COMPLETED|Treatment Period 3||9
267101|NCT00950807|647717|P1|COMPLETED|Treatment Period 3||45
267102|NCT00950807|647708|P10|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
267103|NCT00950807|647709|P9|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
267104|NCT00950807|647710|P8|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
267105|NCT00950807|647711|P7|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
267106|NCT00950807|647712|P6|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
267107|NCT00950807|647713|P5|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
267108|NCT00950807|647714|P4|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
267109|NCT00950807|647715|P3|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
267110|NCT00950807|647716|P2|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
267111|NCT00950807|647717|P1|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|46
267112|NCT00950807|647708|P10|NOT COMPLETED|Washout Period 2||0
267113|NCT00950807|647709|P9|NOT COMPLETED|Washout Period 2||0
267114|NCT00950807|647710|P8|NOT COMPLETED|Washout Period 2||1
267115|NCT00950807|647711|P7|NOT COMPLETED|Washout Period 2||1
267116|NCT00950807|647712|P6|NOT COMPLETED|Washout Period 2||0
267117|NCT00950807|647713|P5|NOT COMPLETED|Washout Period 2||1
267118|NCT00950807|647714|P4|NOT COMPLETED|Washout Period 2||1
267119|NCT00950807|647715|P3|NOT COMPLETED|Washout Period 2||0
267120|NCT00950807|647716|P2|NOT COMPLETED|Washout Period 2||1
267121|NCT00950807|647717|P1|NOT COMPLETED|Washout Period 2||4
267122|NCT00950807|647708|P10|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
267123|NCT00950807|647709|P9|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
267124|NCT00950807|647710|P8|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
267125|NCT00950807|647711|P7|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|8
267126|NCT00950807|647712|P6|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
267127|NCT00950807|647713|P5|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|12
267128|NCT00950807|647714|P4|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
267129|NCT00950807|647715|P3|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|10
267130|NCT00950807|647716|P2|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
267131|NCT00950807|647717|P1|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|47
267132|NCT00950807|647708|P10|STARTED|Washout Period 2||11
267133|NCT00950807|647709|P9|STARTED|Washout Period 2||11
267134|NCT00950807|647710|P8|STARTED|Washout Period 2||10
267135|NCT00950807|647711|P7|STARTED|Washout Period 2||9
267136|NCT00950807|647712|P6|STARTED|Washout Period 2||9
267137|NCT00950807|647713|P5|STARTED|Washout Period 2||13
267138|NCT00950807|647714|P4|STARTED|Washout Period 2||12
267139|NCT00950807|647715|P3|STARTED|Washout Period 2||10
267140|NCT00950807|647716|P2|STARTED|Washout Period 2||12
267141|NCT00950807|647717|P1|STARTED|Washout Period 2||51
267142|NCT00950807|647708|P10|NOT COMPLETED|Treatment Period 2||0
267143|NCT00950807|647709|P9|NOT COMPLETED|Treatment Period 2||0
267144|NCT00950807|647710|P8|NOT COMPLETED|Treatment Period 2||3
267145|NCT00950807|647711|P7|NOT COMPLETED|Treatment Period 2||1
267146|NCT00950807|647712|P6|NOT COMPLETED|Treatment Period 2||1
267147|NCT00950807|647713|P5|NOT COMPLETED|Treatment Period 2||0
267148|NCT00950807|647714|P4|NOT COMPLETED|Treatment Period 2||1
267149|NCT00950807|647715|P3|NOT COMPLETED|Treatment Period 2||0
267150|NCT00950807|647716|P2|NOT COMPLETED|Treatment Period 2||1
267151|NCT00950807|647717|P1|NOT COMPLETED|Treatment Period 2||2
267152|NCT00950807|647708|P10|COMPLETED|Treatment Period 2||11
267153|NCT00950807|647709|P9|COMPLETED|Treatment Period 2||11
267154|NCT00950807|647710|P8|COMPLETED|Treatment Period 2||10
267155|NCT00950807|647711|P7|COMPLETED|Treatment Period 2||9
267156|NCT00950807|647712|P6|COMPLETED|Treatment Period 2||9
267157|NCT00950807|647713|P5|COMPLETED|Treatment Period 2||13
267158|NCT00950807|647714|P4|COMPLETED|Treatment Period 2||12
267159|NCT00950807|647715|P3|COMPLETED|Treatment Period 2||10
267160|NCT00950807|647716|P2|COMPLETED|Treatment Period 2||12
267161|NCT00950807|647717|P1|COMPLETED|Treatment Period 2||51
267162|NCT00950807|647708|P10|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
267163|NCT00950807|647709|P9|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
267164|NCT00950807|647710|P8|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
267165|NCT00950807|647711|P7|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
267166|NCT00950807|647712|P6|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
267167|NCT00950807|647713|P5|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
267168|NCT00950807|647714|P4|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
267169|NCT00950807|647715|P3|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
267170|NCT00950807|647716|P2|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
267171|NCT00950807|647717|P1|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|53
267172|NCT00950807|647708|P10|NOT COMPLETED|Washout Period 1||0
267173|NCT00950807|647709|P9|NOT COMPLETED|Washout Period 1||1
267174|NCT00950807|647710|P8|NOT COMPLETED|Washout Period 1||1
267175|NCT00950807|647711|P7|NOT COMPLETED|Washout Period 1||2
267176|NCT00950807|647712|P6|NOT COMPLETED|Washout Period 1||0
267177|NCT00950807|647713|P5|NOT COMPLETED|Washout Period 1||1
267178|NCT00950807|647714|P4|NOT COMPLETED|Washout Period 1||1
267179|NCT00950807|647715|P3|NOT COMPLETED|Washout Period 1||0
267180|NCT00950807|647716|P2|NOT COMPLETED|Washout Period 1||0
267181|NCT00950807|647717|P1|NOT COMPLETED|Washout Period 1||5
267182|NCT00950807|647708|P10|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
267183|NCT00950807|647709|P9|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
267184|NCT00950807|647710|P8|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
267185|NCT00950807|647711|P7|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|10
267186|NCT00950807|647712|P6|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
267187|NCT00950807|647713|P5|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
267188|NCT00950807|647714|P4|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
267189|NCT00950807|647715|P3|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
267190|NCT00950807|647716|P2|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
267191|NCT00950807|647717|P1|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|51
267192|NCT00950807|647708|P10|STARTED|Washout Period 1||13
267193|NCT00950807|647709|P9|STARTED|Washout Period 1||12
267194|NCT00950807|647710|P8|STARTED|Washout Period 1||14
267195|NCT00950807|647711|P7|STARTED|Washout Period 1||12
267196|NCT00950807|647712|P6|STARTED|Washout Period 1||11
267197|NCT00950807|647713|P5|STARTED|Washout Period 1||12
267198|NCT00950807|647714|P4|STARTED|Washout Period 1||12
267199|NCT00950807|647715|P3|STARTED|Washout Period 1||13
267200|NCT00950807|647716|P2|STARTED|Washout Period 1||13
267201|NCT00950807|647717|P1|STARTED|Washout Period 1||56
267202|NCT00950807|647708|P10|NOT COMPLETED|Treatment Period 1||0
267203|NCT00950807|647709|P9|NOT COMPLETED|Treatment Period 1||1
267204|NCT00950807|647710|P8|NOT COMPLETED|Treatment Period 1||0
267205|NCT00950807|647711|P7|NOT COMPLETED|Treatment Period 1||0
267206|NCT00950807|647712|P6|NOT COMPLETED|Treatment Period 1||2
267207|NCT00950807|647713|P5|NOT COMPLETED|Treatment Period 1||1
267208|NCT00950807|647714|P4|NOT COMPLETED|Treatment Period 1||0
267209|NCT00950807|647715|P3|NOT COMPLETED|Treatment Period 1||1
267210|NCT00950807|647716|P2|NOT COMPLETED|Treatment Period 1||0
267211|NCT00950807|647717|P1|NOT COMPLETED|Treatment Period 1||3
267212|NCT00950807|647708|P10|COMPLETED|Treatment Period 1||13
267213|NCT00950807|647709|P9|COMPLETED|Treatment Period 1||12
267214|NCT00950807|647710|P8|COMPLETED|Treatment Period 1||14
267215|NCT00950807|647711|P7|COMPLETED|Treatment Period 1||12
267216|NCT00950807|647712|P6|COMPLETED|Treatment Period 1||11
267217|NCT00950807|647713|P5|COMPLETED|Treatment Period 1||12
267218|NCT00950807|647714|P4|COMPLETED|Treatment Period 1||12
267219|NCT00950807|647715|P3|COMPLETED|Treatment Period 1||13
267220|NCT00950807|647716|P2|COMPLETED|Treatment Period 1||13
267221|NCT00950807|647717|P1|COMPLETED|Treatment Period 1||56
267222|NCT00950807|647708|P10|STARTED|Treatment Period 1||13
267223|NCT00950807|647709|P9|STARTED|Treatment Period 1||13
267224|NCT00950807|647710|P8|STARTED|Treatment Period 1||14
267225|NCT00950807|647711|P7|STARTED|Treatment Period 1||12
267226|NCT00950807|647712|P6|STARTED|Treatment Period 1||13
267227|NCT00950807|647713|P5|STARTED|Treatment Period 1||13
267228|NCT00950807|647714|P4|STARTED|Treatment Period 1||12
267229|NCT00950807|647715|P3|STARTED|Treatment Period 1||14
267230|NCT00950807|647716|P2|STARTED|Treatment Period 1||13
267231|NCT00950807|647717|P1|STARTED|Treatment Period 1||59
267232|NCT00950755|647759|P1|NOT COMPLETED|Long-Term Follow-Up||9
267233|NCT00950755|647759|P1|COMPLETED|Long-Term Follow-Up||9
267234|NCT00950755|647759|P1|STARTED|Long-Term Follow-Up|18 of the 41 participants withdrawing from Study BEX104505 enrolled in the LTFU study.|18
267235|NCT00950755|647759|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||41
267236|NCT00950755|647759|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
267237|NCT00950755|647759|P1|STARTED|Dosimetric and Therapeutic Treatment||41
267238|NCT00950742|647785|P2|NOT COMPLETED|Overall Study||2
267239|NCT00950742|647786|P1|NOT COMPLETED|Overall Study||16
267240|NCT00950742|647785|P2|COMPLETED|Overall Study||0
267241|NCT00950742|647786|P1|COMPLETED|Overall Study||0
267242|NCT00950742|647785|P2|STARTED|Overall Study|entered and treated|2
267243|NCT00950742|647786|P1|STARTED|Overall Study|entered and treated|16
267244|NCT00950729|647802|P1|NOT COMPLETED|Driving With Aircast||0
267245|NCT00950729|647802|P1|COMPLETED|Driving With Aircast||48
267246|NCT00950729|647802|P1|STARTED|Driving With Aircast||48
267247|NCT00950729|647802|P1|NOT COMPLETED|Driving With Plaster Cast||0
267248|NCT00950729|647802|P1|COMPLETED|Driving With Plaster Cast||48
267249|NCT00950729|647802|P1|STARTED|Driving With Plaster Cast||48
267250|NCT00950729|647802|P1|NOT COMPLETED|Driving With Running Shoes||0
267251|NCT00950729|647802|P1|COMPLETED|Driving With Running Shoes|June 2007|48
267252|NCT00950729|647802|P1|STARTED|Driving With Running Shoes|March 2007|48
267253|NCT00950690|647807|P1|NOT COMPLETED|Overall Study||244
267254|NCT00950690|647807|P1|COMPLETED|Overall Study||1105
267255|NCT00950690|647807|P1|STARTED|Overall Study||1349
267256|NCT00950664|647814|P2|NOT COMPLETED|Second Intervention||48
267257|NCT00950664|647815|P1|NOT COMPLETED|Second Intervention||46
267258|NCT00950664|647814|P2|COMPLETED|Second Intervention||0
267259|NCT00950664|647815|P1|COMPLETED|Second Intervention||0
267260|NCT00950664|647814|P2|STARTED|Second Intervention||48
267261|NCT00950664|647815|P1|STARTED|Second Intervention||46
267262|NCT00950664|647814|P2|NOT COMPLETED|Washout Period of 4 Weeks||0
267263|NCT00950664|647815|P1|NOT COMPLETED|Washout Period of 4 Weeks||0
267264|NCT00950664|647814|P2|COMPLETED|Washout Period of 4 Weeks||48
267265|NCT00950664|647815|P1|COMPLETED|Washout Period of 4 Weeks||46
267266|NCT00950664|647814|P2|STARTED|Washout Period of 4 Weeks||48
267267|NCT00950664|647815|P1|STARTED|Washout Period of 4 Weeks||46
267268|NCT00950664|647814|P2|NOT COMPLETED|First Intervention||5
267269|NCT00950664|647815|P1|NOT COMPLETED|First Intervention||3
267270|NCT00950664|647814|P2|COMPLETED|First Intervention||48
267271|NCT00950664|647815|P1|COMPLETED|First Intervention||46
267272|NCT00950664|647814|P2|STARTED|First Intervention||53
267273|NCT00950664|647815|P1|STARTED|First Intervention||49
267274|NCT00950651|647835|P2|NOT COMPLETED|Overall Study||35
267275|NCT00950651|647836|P1|NOT COMPLETED|Overall Study||31
267276|NCT00950651|647835|P2|COMPLETED|Overall Study||181
267277|NCT00950651|647836|P1|COMPLETED|Overall Study||184
267278|NCT00950651|647835|P2|STARTED|Overall Study|216 patients randomized but one never took study medication|216
267279|NCT00950651|647836|P1|STARTED|Overall Study||215
267280|NCT00950612|647884|P2|NOT COMPLETED|Overall Study||0
267281|NCT00950612|647885|P1|NOT COMPLETED|Overall Study||0
267282|NCT00950612|647884|P2|COMPLETED|Overall Study||20
267283|NCT00950612|647885|P1|COMPLETED|Overall Study||40
267284|NCT00950612|647884|P2|STARTED|Overall Study||20
267285|NCT00950612|647885|P1|STARTED|Overall Study||40
267286|NCT00950599|647929|P10|NOT COMPLETED|Follow-Up Period||2
267287|NCT00950599|647930|P9|NOT COMPLETED|Follow-Up Period||13
267288|NCT00950599|647931|P8|NOT COMPLETED|Follow-Up Period||0
267289|NCT00950599|647932|P7|NOT COMPLETED|Follow-Up Period||0
267290|NCT00950599|647933|P6|NOT COMPLETED|Follow-Up Period||0
267291|NCT00950599|647934|P5|NOT COMPLETED|Follow-Up Period||0
267292|NCT00950599|647935|P4|NOT COMPLETED|Follow-Up Period||0
267293|NCT00950599|647936|P3|NOT COMPLETED|Follow-Up Period||0
267294|NCT00950599|647937|P2|NOT COMPLETED|Follow-Up Period||0
267295|NCT00950599|647938|P1|NOT COMPLETED|Follow-Up Period||0
267296|NCT00950599|647929|P10|COMPLETED|Follow-Up Period||78
267297|NCT00950599|647930|P9|COMPLETED|Follow-Up Period||296
267298|NCT00950599|647931|P8|COMPLETED|Follow-Up Period||0
267299|NCT00950599|647932|P7|COMPLETED|Follow-Up Period||0
267300|NCT00950599|647933|P6|COMPLETED|Follow-Up Period||0
267301|NCT00950599|647934|P5|COMPLETED|Follow-Up Period||0
267302|NCT00950599|647935|P4|COMPLETED|Follow-Up Period||0
267303|NCT00950599|647936|P3|COMPLETED|Follow-Up Period||0
267304|NCT00950599|647937|P2|COMPLETED|Follow-Up Period||0
267305|NCT00950599|647938|P1|COMPLETED|Follow-Up Period||0
267306|NCT00950599|647929|P10|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|80
267307|NCT00950599|647930|P9|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|309
267308|NCT00950599|647931|P8|STARTED|Follow-Up Period||0
267309|NCT00950599|647932|P7|STARTED|Follow-Up Period||0
267310|NCT00950599|647933|P6|STARTED|Follow-Up Period||0
267311|NCT00950599|647934|P5|STARTED|Follow-Up Period||0
267312|NCT00950599|647935|P4|STARTED|Follow-Up Period||0
267313|NCT00950599|647936|P3|STARTED|Follow-Up Period||0
267314|NCT00950599|647937|P2|STARTED|Follow-Up Period||0
267315|NCT00950599|647938|P1|STARTED|Follow-Up Period||0
267316|NCT00950599|647929|P10|NOT COMPLETED|Double-Blind Treatment Period||0
267317|NCT00950599|647930|P9|NOT COMPLETED|Double-Blind Treatment Period||0
267318|NCT00950599|647931|P8|NOT COMPLETED|Double-Blind Treatment Period||6
267319|NCT00950599|647932|P7|NOT COMPLETED|Double-Blind Treatment Period||0
267320|NCT00950599|647933|P6|NOT COMPLETED|Double-Blind Treatment Period||12
267321|NCT00950599|647934|P5|NOT COMPLETED|Double-Blind Treatment Period||7
267322|NCT00950599|647935|P4|NOT COMPLETED|Double-Blind Treatment Period||11
267323|NCT00950599|647936|P3|NOT COMPLETED|Double-Blind Treatment Period||9
267324|NCT00950599|647937|P2|NOT COMPLETED|Double-Blind Treatment Period||10
267325|NCT00950599|647938|P1|NOT COMPLETED|Double-Blind Treatment Period||7
267326|NCT00950599|647929|P10|COMPLETED|Double-Blind Treatment Period||0
267327|NCT00950599|647930|P9|COMPLETED|Double-Blind Treatment Period||0
267328|NCT00950599|647931|P8|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|35
267329|NCT00950599|647932|P7|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|44
267330|NCT00950599|647933|P6|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|55
267331|NCT00950599|647934|P5|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|45
267332|NCT00950599|647935|P4|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|43
267333|NCT00950599|647936|P3|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|54
267334|NCT00950599|647937|P2|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|37
267335|NCT00950599|647938|P1|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|48
267336|NCT00950599|647929|P10|STARTED|Double-Blind Treatment Period||0
267337|NCT00950599|647930|P9|STARTED|Double-Blind Treatment Period||0
267338|NCT00950599|647931|P8|STARTED|Double-Blind Treatment Period||41
267339|NCT00950599|647932|P7|STARTED|Double-Blind Treatment Period||44
267340|NCT00950599|647933|P6|STARTED|Double-Blind Treatment Period||67
267341|NCT00950599|647934|P5|STARTED|Double-Blind Treatment Period||52
267342|NCT00950599|647935|P4|STARTED|Double-Blind Treatment Period||54
267343|NCT00950599|647936|P3|STARTED|Double-Blind Treatment Period||63
267344|NCT00950599|647937|P2|STARTED|Double-Blind Treatment Period||47
267345|NCT00950599|647938|P1|STARTED|Double-Blind Treatment Period||55
267346|NCT00950352|648502|P2|NOT COMPLETED|Overall Study||11
267347|NCT00950352|648503|P1|NOT COMPLETED|Overall Study||42
267348|NCT00950352|648502|P2|COMPLETED|Overall Study||21
267349|NCT00950352|648503|P1|COMPLETED|Overall Study||30
267350|NCT00950352|648502|P2|STARTED|Overall Study||32
267351|NCT00950352|648503|P1|STARTED|Overall Study||72
267352|NCT00950300|648511|P2|NOT COMPLETED|SFU Period||78
267353|NCT00950300|648512|P1|NOT COMPLETED|SFU Period||78
267354|NCT00950300|648511|P2|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|45
267355|NCT00950300|648512|P1|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|40
267356|NCT00950300|648511|P2|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|123
267357|NCT00950300|648512|P1|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|118
267358|NCT00950300|648511|P2|NOT COMPLETED|TFFU Period||107
267359|NCT00950300|648512|P1|NOT COMPLETED|TFFU Period||100
267360|NCT00950300|648511|P2|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|161
267361|NCT00950300|648512|P1|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|165
267362|NCT00950300|648511|P2|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|268
267363|NCT00950300|648512|P1|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|265
267364|NCT00950300|648511|P2|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
267365|NCT00950300|648512|P1|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
267366|NCT00950300|648511|P2|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||255
267367|NCT00950300|648512|P1|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||257
267368|NCT00950300|648511|P2|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||274
267369|NCT00950300|648512|P1|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||277
267370|NCT00950300|648511|P2|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||273
267371|NCT00950300|648512|P1|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||277
267372|NCT00950300|648511|P2|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||297
267373|NCT00950300|648512|P1|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||298
267374|NCT00950300|648511|P2|STARTED|Neoadjuvant/Adjuvant Treatment Periods||297
267375|NCT00950300|648512|P1|STARTED|Neoadjuvant/Adjuvant Treatment Periods||299
267376|NCT00950248|648561|P3|NOT COMPLETED|Year 2&3 Treatment Randomization||5
267377|NCT00950248|648562|P2|NOT COMPLETED|Year 2&3 Treatment Randomization||6
267378|NCT00950248|648563|P1|NOT COMPLETED|Year 2&3 Treatment Randomization||0
267379|NCT00950248|648561|P3|COMPLETED|Year 2&3 Treatment Randomization||33
267380|NCT00950248|648562|P2|COMPLETED|Year 2&3 Treatment Randomization||33
267381|NCT00950248|648563|P1|COMPLETED|Year 2&3 Treatment Randomization||0
267382|NCT00950248|648561|P3|STARTED|Year 2&3 Treatment Randomization||38
267383|NCT00950248|648562|P2|STARTED|Year 2&3 Treatment Randomization||39
267384|NCT00950248|648563|P1|STARTED|Year 2&3 Treatment Randomization||0
267385|NCT00950248|648561|P3|NOT COMPLETED|Year 1: Baseline||0
267386|NCT00950248|648562|P2|NOT COMPLETED|Year 1: Baseline||0
267387|NCT00950248|648563|P1|NOT COMPLETED|Year 1: Baseline||8
267388|NCT00950248|648561|P3|COMPLETED|Year 1: Baseline||0
267389|NCT00950248|648562|P2|COMPLETED|Year 1: Baseline||0
267390|NCT00950248|648563|P1|COMPLETED|Year 1: Baseline||77
267391|NCT00950248|648561|P3|STARTED|Year 1: Baseline||0
267392|NCT00950248|648562|P2|STARTED|Year 1: Baseline||0
267393|NCT00950248|648563|P1|STARTED|Year 1: Baseline||85
267394|NCT00950235|648584|P2|NOT COMPLETED|Overall Study||4
267395|NCT00950235|648585|P1|NOT COMPLETED|Overall Study||2
267396|NCT00950235|648584|P2|COMPLETED|Overall Study||54
267397|NCT00950235|648585|P1|COMPLETED|Overall Study||58
267398|NCT00950235|648584|P2|STARTED|Overall Study||58
267399|NCT00950235|648585|P1|STARTED|Overall Study||60
267400|NCT00950183|648595|P1|NOT COMPLETED|Overall Study||36
267401|NCT00950183|648595|P1|COMPLETED|Overall Study||0
267402|NCT00950183|648595|P1|STARTED|Overall Study||36
267403|NCT00950170|648603|P1|NOT COMPLETED|Overall Study||4
267404|NCT00950170|648603|P1|COMPLETED|Overall Study||19
267405|NCT00950170|648603|P1|STARTED|Overall Study||23
267406|NCT00949988|648654|P1|NOT COMPLETED|Overall Study||3
267407|NCT00949988|648654|P1|COMPLETED|Overall Study||0
267408|NCT00949988|648654|P1|STARTED|Overall Study||3
267409|NCT00949975|648669|P4|NOT COMPLETED|Overall Study||28
267410|NCT00949975|648670|P3|NOT COMPLETED|Overall Study||19
267411|NCT00949975|648671|P2|NOT COMPLETED|Overall Study||29
267412|NCT00949975|648672|P1|NOT COMPLETED|Overall Study||27
267413|NCT00949975|648669|P4|COMPLETED|Overall Study||190
267414|NCT00949975|648670|P3|COMPLETED|Overall Study||183
267415|NCT00949975|648671|P2|COMPLETED|Overall Study||177
267416|NCT00949975|648672|P1|COMPLETED|Overall Study||185
267417|NCT00949975|648669|P4|STARTED|Overall Study||218
267418|NCT00949975|648670|P3|STARTED|Overall Study||202
267419|NCT00949975|648671|P2|STARTED|Overall Study||206
267420|NCT00949975|648672|P1|STARTED|Overall Study||212
267421|NCT00949910|648790|P1|NOT COMPLETED|Overall Study||6576
267422|NCT00949910|648790|P1|COMPLETED|Overall Study||10
267423|NCT00949910|648790|P1|STARTED|Overall Study||6586
267424|NCT00949884|648803|P3|NOT COMPLETED|Overall Study||58
267425|NCT00949884|648804|P2|NOT COMPLETED|Overall Study||15
267426|NCT00949884|648805|P1|NOT COMPLETED|Overall Study||50
267427|NCT00949884|648803|P3|COMPLETED|Overall Study||411
267428|NCT00949884|648804|P2|COMPLETED|Overall Study||37
267429|NCT00949884|648805|P1|COMPLETED|Overall Study||370
267430|NCT00949884|648803|P3|STARTED|Overall Study||469
267431|NCT00949884|648804|P2|STARTED|Overall Study||52
267432|NCT00949884|648805|P1|STARTED|Overall Study||420
267433|NCT00949715|648860|P2|NOT COMPLETED|Overall Study||0
267434|NCT00949715|648861|P1|NOT COMPLETED|Overall Study||4
267435|NCT00949715|648860|P2|COMPLETED|Overall Study||33
267436|NCT00949715|648861|P1|COMPLETED|Overall Study||28
267437|NCT00949715|648860|P2|STARTED|Overall Study||33
267438|NCT00949715|648861|P1|STARTED|Overall Study||32
267439|NCT00949702|648872|P1|NOT COMPLETED|Overall Study||48
267440|NCT00949702|648872|P1|COMPLETED|Overall Study||84
267441|NCT00949702|648872|P1|STARTED|Overall Study||132
267442|NCT00949650|648889|P2|NOT COMPLETED|Overall Study||115
267443|NCT00949650|648890|P1|NOT COMPLETED|Overall Study||230
267444|NCT00949650|648889|P2|COMPLETED|Overall Study||0
267445|NCT00949650|648890|P1|COMPLETED|Overall Study|On treatment at the cut-off date 17MAR2017.|0
267446|NCT00949650|648889|P2|STARTED|Overall Study|Treated patients.|115
267447|NCT00949650|648890|P1|STARTED|Overall Study|Treated patients.|230
267448|NCT00949533|648928|P2|NOT COMPLETED|Overall Study||1
267449|NCT00949533|648929|P1|NOT COMPLETED|Overall Study||0
267450|NCT00949533|648928|P2|COMPLETED|Overall Study||17
267451|NCT00949533|648929|P1|COMPLETED|Overall Study||19
267452|NCT00949533|648928|P2|STARTED|Overall Study||18
267453|NCT00949533|648929|P1|STARTED|Overall Study||19
267454|NCT00949325|648941|P3|NOT COMPLETED|Overall Study||0
267455|NCT00949325|648942|P2|NOT COMPLETED|Overall Study||2
267456|NCT00949325|648943|P1|NOT COMPLETED|Overall Study||0
267457|NCT00949325|648941|P3|COMPLETED|Overall Study||3
267458|NCT00949325|648942|P2|COMPLETED|Overall Study||16
267459|NCT00949325|648943|P1|COMPLETED|Overall Study||3
267460|NCT00949325|648941|P3|STARTED|Overall Study||3
267461|NCT00949325|648942|P2|STARTED|Overall Study||18
267462|NCT00949325|648943|P1|STARTED|Overall Study||3
267463|NCT00949234|648961|P1|NOT COMPLETED|Overall Study||42
267464|NCT00949234|648961|P1|COMPLETED|Overall Study||225
267465|NCT00949234|648961|P1|STARTED|Overall Study||267
267466|NCT00949117|648967|P2|NOT COMPLETED|Overall Study||5
267467|NCT00949117|648968|P1|NOT COMPLETED|Overall Study||3
267468|NCT00949117|648967|P2|COMPLETED|Overall Study||0
267469|NCT00949117|648968|P1|COMPLETED|Overall Study||1
267470|NCT00949117|648967|P2|STARTED|Overall Study||5
267471|NCT00949117|648968|P1|STARTED|Overall Study||4
267472|NCT00949078|648984|P2|NOT COMPLETED|Overall Study||0
267473|NCT00949078|648985|P1|NOT COMPLETED|Overall Study||0
267474|NCT00949078|648984|P2|COMPLETED|Overall Study||9
267475|NCT00949078|648985|P1|COMPLETED|Overall Study||5
267476|NCT00949078|648984|P2|STARTED|Overall Study||9
267477|NCT00949078|648985|P1|STARTED|Overall Study||5
267478|NCT00948974|649009|P2|NOT COMPLETED|Overall Study||20
267479|NCT00948974|649010|P1|NOT COMPLETED|Overall Study||23
267480|NCT00948974|649009|P2|COMPLETED|Overall Study||28
267481|NCT00948974|649010|P1|COMPLETED|Overall Study||17
267482|NCT00948974|649009|P2|STARTED|Overall Study||48
267483|NCT00948974|649010|P1|STARTED|Overall Study||40
267484|NCT00948935|649020|P1|NOT COMPLETED|Overall Study||0
267485|NCT00948935|649020|P1|COMPLETED|Overall Study||35
267486|NCT00948935|649020|P1|STARTED|Overall Study||35
267487|NCT00948922|649028|P3|NOT COMPLETED|Overall Study||1
267488|NCT00948922|649029|P2|NOT COMPLETED|Overall Study||14
267489|NCT00948922|649030|P1|NOT COMPLETED|Overall Study||8
267490|NCT00948922|649028|P3|COMPLETED|Overall Study||38
267491|NCT00948922|649029|P2|COMPLETED|Overall Study||37
267492|NCT00948922|649030|P1|COMPLETED|Overall Study||26
267493|NCT00948922|649028|P3|STARTED|Overall Study||39
267494|NCT00948922|649029|P2|STARTED|Overall Study||51
267495|NCT00948922|649030|P1|STARTED|Overall Study||34
267496|NCT00948896|649053|P8|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
267497|NCT00948896|649054|P7|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
267498|NCT00948896|649055|P6|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
267499|NCT00948896|649056|P5|NOT COMPLETED|24 Months of Age to 36 Months of Age||1
267500|NCT00948896|649057|P4|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
267501|NCT00948896|649058|P3|NOT COMPLETED|24 Months of Age to 36 Months of Age||5
267502|NCT00948896|649059|P2|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
267503|NCT00948896|649060|P1|NOT COMPLETED|24 Months of Age to 36 Months of Age||3
267504|NCT00948896|649053|P8|COMPLETED|24 Months of Age to 36 Months of Age||45
267505|NCT00948896|649054|P7|COMPLETED|24 Months of Age to 36 Months of Age||43
267506|NCT00948896|649055|P6|COMPLETED|24 Months of Age to 36 Months of Age||40
267507|NCT00948896|649056|P5|COMPLETED|24 Months of Age to 36 Months of Age||43
267508|NCT00948896|649057|P4|COMPLETED|24 Months of Age to 36 Months of Age||85
267509|NCT00948896|649058|P3|COMPLETED|24 Months of Age to 36 Months of Age||85
267510|NCT00948896|649059|P2|COMPLETED|24 Months of Age to 36 Months of Age||83
267511|NCT00948896|649060|P1|COMPLETED|24 Months of Age to 36 Months of Age||87
267512|NCT00948896|649053|P8|STARTED|24 Months of Age to 36 Months of Age||45
267513|NCT00948896|649054|P7|STARTED|24 Months of Age to 36 Months of Age||43
267514|NCT00948896|649055|P6|STARTED|24 Months of Age to 36 Months of Age||42
267515|NCT00948896|649056|P5|STARTED|24 Months of Age to 36 Months of Age||44
267516|NCT00948896|649057|P4|STARTED|24 Months of Age to 36 Months of Age||87
267517|NCT00948896|649058|P3|STARTED|24 Months of Age to 36 Months of Age||90
267518|NCT00948896|649059|P2|STARTED|24 Months of Age to 36 Months of Age||85
267519|NCT00948896|649060|P1|STARTED|24 Months of Age to 36 Months of Age||90
267520|NCT00948896|649053|P8|NOT COMPLETED|Randomization to 24 Months of Age||2
267521|NCT00948896|649054|P7|NOT COMPLETED|Randomization to 24 Months of Age||4
267522|NCT00948896|649055|P6|NOT COMPLETED|Randomization to 24 Months of Age||4
267523|NCT00948896|649056|P5|NOT COMPLETED|Randomization to 24 Months of Age||2
267524|NCT00948896|649057|P4|NOT COMPLETED|Randomization to 24 Months of Age||11
267525|NCT00948896|649058|P3|NOT COMPLETED|Randomization to 24 Months of Age||9
267526|NCT00948896|649059|P2|NOT COMPLETED|Randomization to 24 Months of Age||13
267527|NCT00948896|649060|P1|NOT COMPLETED|Randomization to 24 Months of Age||8
267528|NCT00948896|649053|P8|COMPLETED|Randomization to 24 Months of Age||45
267529|NCT00948896|649054|P7|COMPLETED|Randomization to 24 Months of Age||43
267530|NCT00948896|649055|P6|COMPLETED|Randomization to 24 Months of Age||42
267531|NCT00948896|649056|P5|COMPLETED|Randomization to 24 Months of Age||44
267532|NCT00948896|649057|P4|COMPLETED|Randomization to 24 Months of Age||87
267533|NCT00948896|649058|P3|COMPLETED|Randomization to 24 Months of Age||90
267534|NCT00948896|649059|P2|COMPLETED|Randomization to 24 Months of Age||85
267535|NCT00948896|649060|P1|COMPLETED|Randomization to 24 Months of Age||90
267536|NCT00948896|649053|P8|STARTED|Randomization to 24 Months of Age||47
267537|NCT00948896|649054|P7|STARTED|Randomization to 24 Months of Age||47
267538|NCT00948896|649055|P6|STARTED|Randomization to 24 Months of Age||46
267539|NCT00948896|649056|P5|STARTED|Randomization to 24 Months of Age||46
267540|NCT00948896|649057|P4|STARTED|Randomization to 24 Months of Age||98
267541|NCT00948896|649058|P3|STARTED|Randomization to 24 Months of Age||99
267542|NCT00948896|649059|P2|STARTED|Randomization to 24 Months of Age||98
267543|NCT00948896|649060|P1|STARTED|Randomization to 24 Months of Age||98
267544|NCT00948857|649096|P2|NOT COMPLETED|Overall Study||0
267545|NCT00948857|649097|P1|NOT COMPLETED|Overall Study||1
267546|NCT00948857|649096|P2|COMPLETED|Overall Study||2
267547|NCT00948857|649097|P1|COMPLETED|Overall Study|3 completed and 1 dropped out.|2
267548|NCT00948857|649096|P2|STARTED|Overall Study||2
267549|NCT00948857|649097|P1|STARTED|Overall Study||3
267550|NCT00948818|649105|P2|NOT COMPLETED|Overall Study||94
267551|NCT00948818|649106|P1|NOT COMPLETED|Overall Study||62
267552|NCT00948818|649105|P2|COMPLETED|Overall Study||312
267553|NCT00948818|649106|P1|COMPLETED|Overall Study||335
267554|NCT00948818|649105|P2|STARTED|Overall Study||406
267555|NCT00948818|649106|P1|STARTED|Overall Study||397
267556|NCT00948792|649141|P1|NOT COMPLETED|Overall Study||0
267557|NCT00948792|649141|P1|COMPLETED|Overall Study||21
267558|NCT00948792|649141|P1|STARTED|Overall Study||21
267559|NCT00948766|649153|P2|NOT COMPLETED|Extension Study||0
267560|NCT00948766|649154|P1|NOT COMPLETED|Extension Study||91
267561|NCT00948766|649153|P2|COMPLETED|Extension Study||0
267562|NCT00948766|649154|P1|COMPLETED|Extension Study||306
267563|NCT00948766|649153|P2|Exposed to Study Medication|Extension Study||0
267564|NCT00948766|649154|P1|Exposed to Study Medication|Extension Study||396
267565|NCT00948766|649153|P2|STARTED|Extension Study|No patients received this treatment in the extension study.|0
267566|NCT00948766|649154|P1|STARTED|Extension Study|397 of the 463 patients who completed the core study entered the extension study.|397
267567|NCT00948766|649153|P2|NOT COMPLETED|Core Study||126
267568|NCT00948766|649154|P1|NOT COMPLETED|Core Study||127
267569|NCT00948766|649153|P2|COMPLETED|Core Study||234
267570|NCT00948766|649154|P1|COMPLETED|Core Study||229
267571|NCT00948766|649153|P2|Exposed to Study Medication|Core Study||359
267572|NCT00948766|649154|P1|Exposed to Study Medication|Core Study||355
267573|NCT00948766|649153|P2|STARTED|Core Study||360
267574|NCT00948766|649154|P1|STARTED|Core Study||356
267575|NCT00948688|649170|P2|NOT COMPLETED|Period 2: 100 mg Vorinostat||1
267576|NCT00948688|649171|P1|NOT COMPLETED|Period 2: 100 mg Vorinostat||0
267577|NCT00948688|649170|P2|COMPLETED|Period 2: 100 mg Vorinostat||5
267578|NCT00948688|649171|P1|COMPLETED|Period 2: 100 mg Vorinostat||0
267579|NCT00948688|649170|P2|STARTED|Period 2: 100 mg Vorinostat||6
267580|NCT00948688|649171|P1|STARTED|Period 2: 100 mg Vorinostat||0
267581|NCT00948688|649170|P2|NOT COMPLETED|Period 1: 200 mg Vorinostat||0
267582|NCT00948688|649171|P1|NOT COMPLETED|Period 1: 200 mg Vorinostat||2
267583|NCT00948688|649170|P2|COMPLETED|Period 1: 200 mg Vorinostat||0
267584|NCT00948688|649171|P1|COMPLETED|Period 1: 200 mg Vorinostat||2
267585|NCT00948688|649170|P2|STARTED|Period 1: 200 mg Vorinostat||0
267586|NCT00948688|649171|P1|STARTED|Period 1: 200 mg Vorinostat||4
267587|NCT00948675|649185|P2|NOT COMPLETED|Overall Study||4
267588|NCT00948675|649186|P1|NOT COMPLETED|Overall Study||7
267589|NCT00948675|649185|P2|COMPLETED|Overall Study||175
267590|NCT00948675|649186|P1|COMPLETED|Overall Study||175
267591|NCT00948675|649185|P2|STARTED|Overall Study||179
267592|NCT00948675|649186|P1|STARTED|Overall Study||182
267593|NCT00948610|649202|P2|NOT COMPLETED|Overall Study||1
267594|NCT00948610|649203|P1|NOT COMPLETED|Overall Study||1
267595|NCT00948610|649202|P2|COMPLETED|Overall Study||9
267596|NCT00948610|649203|P1|COMPLETED|Overall Study||9
267597|NCT00948610|649202|P2|STARTED|Overall Study||10
267598|NCT00948610|649203|P1|STARTED|Overall Study||10
267599|NCT00948506|649213|P2|NOT COMPLETED|Overall Study||1
267600|NCT00948506|649214|P1|NOT COMPLETED|Overall Study||3
267601|NCT00948506|649213|P2|COMPLETED|Overall Study||8
267602|NCT00948506|649214|P1|COMPLETED|Overall Study||8
267603|NCT00948506|649213|P2|STARTED|Overall Study||9
267604|NCT00948506|649214|P1|STARTED|Overall Study||11
267605|NCT00948441|649225|P2|NOT COMPLETED|Overall Study||4
267606|NCT00948441|649226|P1|NOT COMPLETED|Overall Study||1
267607|NCT00948441|649225|P2|COMPLETED|Overall Study||4
267608|NCT00948441|649226|P1|COMPLETED|Overall Study||7
267609|NCT00948441|649225|P2|STARTED|Overall Study||8
267610|NCT00948441|649226|P1|STARTED|Overall Study||8
267611|NCT00948389|649239|P5|NOT COMPLETED|Overall Study||1
267612|NCT00948389|649240|P4|NOT COMPLETED|Overall Study||9
267613|NCT00948389|649241|P3|NOT COMPLETED|Overall Study||7
267614|NCT00948389|649242|P2|NOT COMPLETED|Overall Study||3
267615|NCT00948389|649243|P1|NOT COMPLETED|Overall Study||6
267616|NCT00948389|649239|P5|COMPLETED|Overall Study||0
267617|NCT00948389|649240|P4|COMPLETED|Overall Study||0
267618|NCT00948389|649241|P3|COMPLETED|Overall Study||0
267619|NCT00948389|649242|P2|COMPLETED|Overall Study||0
267620|NCT00948389|649243|P1|COMPLETED|Overall Study||0
267621|NCT00948389|649239|P5|STARTED|Overall Study||1
267622|NCT00948389|649240|P4|STARTED|Overall Study||9
267623|NCT00948389|649241|P3|STARTED|Overall Study||7
267624|NCT00948389|649242|P2|STARTED|Overall Study||3
267625|NCT00948389|649243|P1|STARTED|Overall Study||6
267626|NCT00948298|649282|P2|NOT COMPLETED|Overall Study||5
267627|NCT00948298|649283|P1|NOT COMPLETED|Overall Study||10
267628|NCT00948298|649282|P2|COMPLETED|Overall Study||60
267629|NCT00948298|649283|P1|COMPLETED|Overall Study||55
267630|NCT00948298|649282|P2|STARTED|Overall Study||65
267631|NCT00948298|649283|P1|STARTED|Overall Study||65
267632|NCT00948246|649291|P1|NOT COMPLETED|Overall Study||24
267633|NCT00948246|649291|P1|COMPLETED|Overall Study||86
267634|NCT00948246|649291|P1|STARTED|Overall Study||110
267635|NCT00948155|649300|P2|NOT COMPLETED|Second Intervention 21 Days||3
267636|NCT00948155|649301|P1|NOT COMPLETED|Second Intervention 21 Days||2
267637|NCT00948155|649300|P2|COMPLETED|Second Intervention 21 Days||8
267638|NCT00948155|649301|P1|COMPLETED|Second Intervention 21 Days||9
267639|NCT00948155|649300|P2|STARTED|Second Intervention 21 Days||11
267640|NCT00948155|649301|P1|STARTED|Second Intervention 21 Days||11
267641|NCT00948155|649300|P2|NOT COMPLETED|Washout 14 Days||2
267642|NCT00948155|649301|P1|NOT COMPLETED|Washout 14 Days||1
267643|NCT00948155|649300|P2|COMPLETED|Washout 14 Days||11
267644|NCT00948155|649301|P1|COMPLETED|Washout 14 Days||11
267645|NCT00948155|649300|P2|STARTED|Washout 14 Days||13
267646|NCT00948155|649301|P1|STARTED|Washout 14 Days||12
267647|NCT00948155|649300|P2|NOT COMPLETED|First Intervention 21 Days||2
267648|NCT00948155|649301|P1|NOT COMPLETED|First Intervention 21 Days||2
267649|NCT00948155|649300|P2|COMPLETED|First Intervention 21 Days||13
267650|NCT00948155|649301|P1|COMPLETED|First Intervention 21 Days||12
267651|NCT00948155|649300|P2|STARTED|First Intervention 21 Days||15
267652|NCT00948155|649301|P1|STARTED|First Intervention 21 Days||14
267653|NCT00948090|649323|P4|NOT COMPLETED|Overall Study||11
267654|NCT00948090|649324|P3|NOT COMPLETED|Overall Study||56
267655|NCT00948090|649325|P2|NOT COMPLETED|Overall Study||1
267656|NCT00948090|649326|P1|NOT COMPLETED|Overall Study||43
267657|NCT00948090|649323|P4|COMPLETED|Overall Study||7
267658|NCT00948090|649324|P3|COMPLETED|Overall Study||67
267659|NCT00948090|649325|P2|COMPLETED|Overall Study||0
267660|NCT00948090|649326|P1|COMPLETED|Overall Study||22
267661|NCT00948090|649323|P4|STARTED|Overall Study||18
267662|NCT00948090|649324|P3|STARTED|Overall Study||123
267663|NCT00948090|649325|P2|STARTED|Overall Study||1
267664|NCT00948090|649326|P1|STARTED|Overall Study||65
267665|NCT00948064|649348|P3|NOT COMPLETED|Phase II||1
267666|NCT00948064|649349|P2|NOT COMPLETED|Phase II||1
267667|NCT00948064|649350|P1|NOT COMPLETED|Phase II||0
267668|NCT00948064|649348|P3|COMPLETED|Phase II||26
267669|NCT00948064|649349|P2|COMPLETED|Phase II||51
267670|NCT00948064|649350|P1|COMPLETED|Phase II||0
267671|NCT00948064|649348|P3|STARTED|Phase II||27
267672|NCT00948064|649349|P2|STARTED|Phase II||52
267673|NCT00948064|649350|P1|STARTED|Phase II||0
267674|NCT00948064|649348|P3|NOT COMPLETED|Phase I||0
267675|NCT00948064|649349|P2|NOT COMPLETED|Phase I||0
267676|NCT00948064|649350|P1|NOT COMPLETED|Phase I||1
267677|NCT00948064|649348|P3|COMPLETED|Phase I||0
267678|NCT00948064|649349|P2|COMPLETED|Phase I||0
267679|NCT00948064|649350|P1|COMPLETED|Phase I||30
267680|NCT00948064|649348|P3|STARTED|Phase I||0
267681|NCT00948064|649349|P2|STARTED|Phase I||0
267682|NCT00948064|649350|P1|STARTED|Phase I||31
267683|NCT00947882|649365|P4|NOT COMPLETED|Overall Study||82
267684|NCT00947882|649366|P3|NOT COMPLETED|Overall Study||79
267685|NCT00947882|649367|P2|NOT COMPLETED|Overall Study||77
267686|NCT00947882|649368|P1|NOT COMPLETED|Overall Study||74
267687|NCT00947882|649365|P4|COMPLETED|Overall Study||20
267688|NCT00947882|649366|P3|COMPLETED|Overall Study||22
267689|NCT00947882|649367|P2|COMPLETED|Overall Study||24
267690|NCT00947882|649368|P1|COMPLETED|Overall Study|End of Trial, Month 12: Patients who had completed the 12-month period when the trial was stopped.|26
267691|NCT00947882|649365|P4|Visit 12, Month 6|Overall Study||95
267692|NCT00947882|649366|P3|Visit 12, Month 6|Overall Study||90
267693|NCT00947882|649367|P2|Visit 12, Month 6|Overall Study||91
267694|NCT00947882|649368|P1|Visit 12, Month 6|Overall Study|The trial was stopped when all patients had completed Visit 12, scheduled 6 months after the dosing.|93
267695|NCT00947882|649365|P4|Safety Analysis Set|Overall Study||105
267696|NCT00947882|649366|P3|Safety Analysis Set|Overall Study||100
267697|NCT00947882|649367|P2|Safety Analysis Set|Overall Study||101
267698|NCT00947882|649368|P1|Safety Analysis Set|Overall Study|Safety Analysis Set: Received a dose of Investigational Medicinal Product (IMP).|98
267699|NCT00947882|649365|P4|Actual Treatment|Overall Study||105
267700|NCT00947882|649366|P3|Actual Treatment|Overall Study|1 patient randomised to 20 mg degarelix received 30 mg degarelix|100
267701|NCT00947882|649367|P2|Actual Treatment|Overall Study||101
267702|NCT00947882|649368|P1|Actual Treatment|Overall Study|2 placebo patients received 30 mg degarelix|98
267703|NCT00947882|649365|P4|Full Analysis Set (FAS)|Overall Study||102
267704|NCT00947882|649366|P3|Full Analysis Set (FAS)|Overall Study|1 patient received 20 mg degarelix but had no post-baseline IPSS value and was excluded from the FAS|100
267705|NCT00947882|649367|P2|Full Analysis Set (FAS)|Overall Study||101
267789|NCT00947505|649542|P1|COMPLETED|Overall Study||24
267706|NCT00947882|649368|P1|Full Analysis Set (FAS)|Overall Study|FAS: Received a dose of IMP and completed at least one post-baseline IPSS questionnaire.|100
267707|NCT00947882|649365|P4|STARTED|Overall Study||102
267708|NCT00947882|649366|P3|STARTED|Overall Study||101
267709|NCT00947882|649367|P2|STARTED|Overall Study||101
267710|NCT00947882|649368|P1|STARTED|Overall Study|Started: Randomised.|100
267711|NCT00947856|649396|P2|NOT COMPLETED|Follow-up Period||23
267712|NCT00947856|649397|P1|NOT COMPLETED|Follow-up Period||51
267713|NCT00947856|649396|P2|COMPLETED|Follow-up Period|Completed survival follow-up due to death|9
267714|NCT00947856|649397|P1|COMPLETED|Follow-up Period||27
267715|NCT00947856|649396|P2|STARTED|Follow-up Period|All participants were followed after treatment; thus, number started will not match number completed|32
267716|NCT00947856|649397|P1|STARTED|Follow-up Period||78
267717|NCT00947856|649396|P2|NOT COMPLETED|Treatment Period||32
267718|NCT00947856|649397|P1|NOT COMPLETED|Treatment Period||78
267719|NCT00947856|649396|P2|COMPLETED|Treatment Period|Patients treated until disease progression, unacceptable toxicity or study closure|0
267720|NCT00947856|649397|P1|COMPLETED|Treatment Period||0
267721|NCT00947856|649396|P2|STARTED|Treatment Period|Two patients in extension arm re-enrolled in retreatment arm and are represented in both arms|32
267722|NCT00947856|649397|P1|STARTED|Treatment Period||78
267723|NCT00947791|649426|P2|NOT COMPLETED|Overall Study||0
267724|NCT00947791|649427|P1|NOT COMPLETED|Overall Study||0
267725|NCT00947791|649426|P2|COMPLETED|Overall Study||1
267726|NCT00947791|649427|P1|COMPLETED|Overall Study||0
267727|NCT00947791|649426|P2|STARTED|Overall Study||1
267728|NCT00947791|649427|P1|STARTED|Overall Study||0
267729|NCT00947765|649445|P2|NOT COMPLETED|Overall Study||0
267730|NCT00947765|649446|P1|NOT COMPLETED|Overall Study||0
267731|NCT00947765|649445|P2|COMPLETED|Overall Study||30
267732|NCT00947765|649446|P1|COMPLETED|Overall Study||30
267733|NCT00947765|649445|P2|STARTED|Overall Study||30
267734|NCT00947765|649446|P1|STARTED|Overall Study||30
267735|NCT00947752|649468|P2|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
267736|NCT00947752|649469|P1|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
267737|NCT00947752|649468|P2|COMPLETED|Crossover to 2nd 14-day Treatment Period||76
267738|NCT00947752|649469|P1|COMPLETED|Crossover to 2nd 14-day Treatment Period||71
267739|NCT00947752|649468|P2|STARTED|Crossover to 2nd 14-day Treatment Period||76
267740|NCT00947752|649469|P1|STARTED|Crossover to 2nd 14-day Treatment Period||71
267741|NCT00947752|649468|P2|NOT COMPLETED|1st 14-day Treatment Period||0
267742|NCT00947752|649469|P1|NOT COMPLETED|1st 14-day Treatment Period||0
267743|NCT00947752|649468|P2|COMPLETED|1st 14-day Treatment Period||71
267744|NCT00947752|649469|P1|COMPLETED|1st 14-day Treatment Period||76
267745|NCT00947752|649468|P2|STARTED|1st 14-day Treatment Period||71
267746|NCT00947752|649469|P1|STARTED|1st 14-day Treatment Period||76
267747|NCT00947752|649468|P2|NOT COMPLETED|7-Day Run-in Treatment Period||0
267748|NCT00947752|649469|P1|NOT COMPLETED|7-Day Run-in Treatment Period||0
267749|NCT00947752|649468|P2|COMPLETED|7-Day Run-in Treatment Period||0
267750|NCT00947752|649469|P1|COMPLETED|7-Day Run-in Treatment Period||147
267751|NCT00947752|649468|P2|STARTED|7-Day Run-in Treatment Period||0
267752|NCT00947752|649469|P1|STARTED|7-Day Run-in Treatment Period|All subjects started with a daily does of F1 for 7 days|147
267753|NCT00947661|649479|P2|NOT COMPLETED|Overall Study||15
267754|NCT00947661|649480|P1|NOT COMPLETED|Overall Study||13
267755|NCT00947661|649479|P2|COMPLETED|Overall Study||274
267756|NCT00947661|649480|P1|COMPLETED|Overall Study||276
267757|NCT00947661|649479|P2|STARTED|Overall Study||289
267758|NCT00947661|649480|P1|STARTED|Overall Study||289
267759|NCT00947544|649486|P2|NOT COMPLETED|Safety-Extension Period (12 Months)||0
267760|NCT00947544|649487|P1|NOT COMPLETED|Safety-Extension Period (12 Months)||1
267761|NCT00947544|649486|P2|COMPLETED|Safety-Extension Period (12 Months)||6
267762|NCT00947544|649487|P1|COMPLETED|Safety-Extension Period (12 Months)||10
267763|NCT00947544|649486|P2|STARTED|Safety-Extension Period (12 Months)|New participants were enrolled due to DSMB approval.|6
267764|NCT00947544|649487|P1|STARTED|Safety-Extension Period (12 Months)||11
267765|NCT00947544|649486|P2|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
267766|NCT00947544|649487|P1|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
267767|NCT00947544|649486|P2|COMPLETED|Switch-Over Period (2 Weeks)||0
267768|NCT00947544|649487|P1|COMPLETED|Switch-Over Period (2 Weeks)||11
267769|NCT00947544|649486|P2|STARTED|Switch-Over Period (2 Weeks)||0
267770|NCT00947544|649487|P1|STARTED|Switch-Over Period (2 Weeks)||11
267771|NCT00947531|649513|P2|NOT COMPLETED|Overall Study||11
267772|NCT00947531|649514|P1|NOT COMPLETED|Overall Study||14
267773|NCT00947531|649513|P2|COMPLETED|Overall Study||110
267774|NCT00947531|649514|P1|COMPLETED|Overall Study||107
267775|NCT00947531|649513|P2|STARTED|Overall Study||121
267776|NCT00947531|649514|P1|STARTED|Overall Study||121
267777|NCT00947518|649523|P3|NOT COMPLETED|Overall Study||0
267778|NCT00947518|649524|P2|NOT COMPLETED|Overall Study||0
267779|NCT00947518|649525|P1|NOT COMPLETED|Overall Study||0
267780|NCT00947518|649523|P3|COMPLETED|Overall Study||20
267781|NCT00947518|649524|P2|COMPLETED|Overall Study||20
267782|NCT00947518|649525|P1|COMPLETED|Overall Study||20
267783|NCT00947518|649523|P3|STARTED|Overall Study||20
267784|NCT00947518|649524|P2|STARTED|Overall Study||20
267785|NCT00947518|649525|P1|STARTED|Overall Study||20
267786|NCT00947505|649541|P2|NOT COMPLETED|Overall Study||2
267787|NCT00947505|649542|P1|NOT COMPLETED|Overall Study||9
267788|NCT00947505|649541|P2|COMPLETED|Overall Study||14
267790|NCT00947505|649541|P2|STARTED|Overall Study||16
267791|NCT00947505|649542|P1|STARTED|Overall Study||33
267792|NCT00947427|649550|P2|NOT COMPLETED|Overall Study||4
267793|NCT00947427|649551|P1|NOT COMPLETED|Overall Study||1
267794|NCT00947427|649550|P2|COMPLETED|Overall Study||45
267795|NCT00947427|649551|P1|COMPLETED|Overall Study||21
267796|NCT00947427|649550|P2|STARTED|Overall Study|2 participants discontinued prior to any study drug administration|49
267797|NCT00947427|649551|P1|STARTED|Overall Study||22
267798|NCT00947349|649561|P4|NOT COMPLETED|Overall Study Standard of Care||2
267799|NCT00947349|649562|P3|NOT COMPLETED|Overall Study Standard of Care||2
267800|NCT00947349|649563|P2|NOT COMPLETED|Overall Study Standard of Care||0
267801|NCT00947349|649564|P1|NOT COMPLETED|Overall Study Standard of Care||0
267802|NCT00947349|649561|P4|COMPLETED|Overall Study Standard of Care||4
267803|NCT00947349|649562|P3|COMPLETED|Overall Study Standard of Care||4
267804|NCT00947349|649563|P2|COMPLETED|Overall Study Standard of Care||5
267805|NCT00947349|649564|P1|COMPLETED|Overall Study Standard of Care||4
267806|NCT00947349|649561|P4|STARTED|Overall Study Standard of Care||6
267807|NCT00947349|649562|P3|STARTED|Overall Study Standard of Care||6
267808|NCT00947349|649563|P2|STARTED|Overall Study Standard of Care||5
267809|NCT00947349|649564|P1|STARTED|Overall Study Standard of Care||4
267810|NCT00947349|649561|P4|NOT COMPLETED|Triple Treatment Combination Period||0
267811|NCT00947349|649562|P3|NOT COMPLETED|Triple Treatment Combination Period||0
267812|NCT00947349|649563|P2|NOT COMPLETED|Triple Treatment Combination Period||1
267813|NCT00947349|649564|P1|NOT COMPLETED|Triple Treatment Combination Period||0
267814|NCT00947349|649561|P4|COMPLETED|Triple Treatment Combination Period||6
267815|NCT00947349|649562|P3|COMPLETED|Triple Treatment Combination Period||6
267816|NCT00947349|649563|P2|COMPLETED|Triple Treatment Combination Period||5
267817|NCT00947349|649564|P1|COMPLETED|Triple Treatment Combination Period||4
267818|NCT00947349|649561|P4|STARTED|Triple Treatment Combination Period||6
267819|NCT00947349|649562|P3|STARTED|Triple Treatment Combination Period||6
267820|NCT00947349|649563|P2|STARTED|Triple Treatment Combination Period||6
267821|NCT00947349|649564|P1|STARTED|Triple Treatment Combination Period||4
267822|NCT00947310|649699|P3|NOT COMPLETED|Overall Study||0
267823|NCT00947310|649700|P2|NOT COMPLETED|Overall Study||0
267824|NCT00947310|649701|P1|NOT COMPLETED|Overall Study||0
267825|NCT00947310|649699|P3|COMPLETED|Overall Study||486
267826|NCT00947310|649700|P2|COMPLETED|Overall Study||500
267827|NCT00947310|649701|P1|COMPLETED|Overall Study||514
267828|NCT00947310|649699|P3|STARTED|Overall Study||486
267829|NCT00947310|649700|P2|STARTED|Overall Study||500
267830|NCT00947310|649701|P1|STARTED|Overall Study||514
267831|NCT00947297|649715|P1|NOT COMPLETED|Overall Study||7
267832|NCT00947297|649715|P1|COMPLETED|Overall Study||53
267833|NCT00947297|649715|P1|STARTED|Overall Study||60
267834|NCT00947284|649722|P2|NOT COMPLETED|Overall Study||3
267835|NCT00947284|649723|P1|NOT COMPLETED|Overall Study||0
267836|NCT00947284|649722|P2|COMPLETED|Overall Study||0
267837|NCT00947284|649723|P1|COMPLETED|Overall Study||0
267838|NCT00947284|649722|P2|STARTED|Overall Study||3
267839|NCT00947284|649723|P1|STARTED|Overall Study||0
267840|NCT00947271|649731|P4|NOT COMPLETED|12 Months Post Intervention||62
267841|NCT00947271|649732|P3|NOT COMPLETED|12 Months Post Intervention||59
267842|NCT00947271|649733|P2|NOT COMPLETED|12 Months Post Intervention||60
267843|NCT00947271|649734|P1|NOT COMPLETED|12 Months Post Intervention||71
267844|NCT00947271|649731|P4|COMPLETED|12 Months Post Intervention||188
267845|NCT00947271|649732|P3|COMPLETED|12 Months Post Intervention||195
267846|NCT00947271|649733|P2|COMPLETED|12 Months Post Intervention||192
267847|NCT00947271|649734|P1|COMPLETED|12 Months Post Intervention||183
267848|NCT00947271|649731|P4|STARTED|12 Months Post Intervention||250
267849|NCT00947271|649732|P3|STARTED|12 Months Post Intervention||254
267850|NCT00947271|649733|P2|STARTED|12 Months Post Intervention||252
267851|NCT00947271|649734|P1|STARTED|12 Months Post Intervention||254
267852|NCT00947271|649731|P4|NOT COMPLETED|9 Months Post Intervention||59
267853|NCT00947271|649732|P3|NOT COMPLETED|9 Months Post Intervention||61
267854|NCT00947271|649733|P2|NOT COMPLETED|9 Months Post Intervention||60
267855|NCT00947271|649734|P1|NOT COMPLETED|9 Months Post Intervention||70
267856|NCT00947271|649731|P4|COMPLETED|9 Months Post Intervention||191
267857|NCT00947271|649732|P3|COMPLETED|9 Months Post Intervention||193
267858|NCT00947271|649733|P2|COMPLETED|9 Months Post Intervention||192
267859|NCT00947271|649734|P1|COMPLETED|9 Months Post Intervention||184
267860|NCT00947271|649731|P4|STARTED|9 Months Post Intervention||250
267861|NCT00947271|649732|P3|STARTED|9 Months Post Intervention||254
267862|NCT00947271|649733|P2|STARTED|9 Months Post Intervention||252
267863|NCT00947271|649734|P1|STARTED|9 Months Post Intervention||254
267864|NCT00947271|649731|P4|NOT COMPLETED|6 Months Post Intervention||54
267865|NCT00947271|649732|P3|NOT COMPLETED|6 Months Post Intervention||58
267866|NCT00947271|649733|P2|NOT COMPLETED|6 Months Post Intervention||53
267867|NCT00947271|649734|P1|NOT COMPLETED|6 Months Post Intervention||55
267868|NCT00947271|649731|P4|COMPLETED|6 Months Post Intervention||196
267869|NCT00947271|649732|P3|COMPLETED|6 Months Post Intervention||196
267870|NCT00947271|649733|P2|COMPLETED|6 Months Post Intervention||199
267871|NCT00947271|649734|P1|COMPLETED|6 Months Post Intervention||199
267872|NCT00947271|649731|P4|STARTED|6 Months Post Intervention||250
267873|NCT00947271|649732|P3|STARTED|6 Months Post Intervention||254
267874|NCT00947271|649733|P2|STARTED|6 Months Post Intervention||252
267875|NCT00947271|649734|P1|STARTED|6 Months Post Intervention||254
267876|NCT00947271|649731|P4|NOT COMPLETED|3 Months Post Intervention||44
267877|NCT00947271|649732|P3|NOT COMPLETED|3 Months Post Intervention||36
267878|NCT00947271|649733|P2|NOT COMPLETED|3 Months Post Intervention||48
267879|NCT00947271|649734|P1|NOT COMPLETED|3 Months Post Intervention||52
267880|NCT00947271|649731|P4|COMPLETED|3 Months Post Intervention||206
267881|NCT00947271|649732|P3|COMPLETED|3 Months Post Intervention||218
267882|NCT00947271|649733|P2|COMPLETED|3 Months Post Intervention||204
267883|NCT00947271|649734|P1|COMPLETED|3 Months Post Intervention||202
267884|NCT00947271|649731|P4|STARTED|3 Months Post Intervention||250
267885|NCT00947271|649732|P3|STARTED|3 Months Post Intervention||254
267886|NCT00947271|649733|P2|STARTED|3 Months Post Intervention||252
267887|NCT00947271|649734|P1|STARTED|3 Months Post Intervention||254
267888|NCT00947219|649763|P3|NOT COMPLETED|Overall Study||4
267889|NCT00947219|649764|P2|NOT COMPLETED|Overall Study||4
267890|NCT00947219|649765|P1|NOT COMPLETED|Overall Study||6
267891|NCT00947219|649763|P3|COMPLETED|Overall Study||22
267892|NCT00947219|649764|P2|COMPLETED|Overall Study||21
267893|NCT00947219|649765|P1|COMPLETED|Overall Study||22
267894|NCT00947219|649763|P3|STARTED|Overall Study||26
267895|NCT00947219|649764|P2|STARTED|Overall Study||25
267896|NCT00947219|649765|P1|STARTED|Overall Study||28
267897|NCT00947167|649773|P1|NOT COMPLETED|Erlotinib Added to Pertuzumab||0
267898|NCT00947167|649773|P1|COMPLETED|Erlotinib Added to Pertuzumab||3
267899|NCT00947167|649773|P1|STARTED|Erlotinib Added to Pertuzumab||3
267900|NCT00947167|649773|P1|NOT COMPLETED|Pertuzumab Alone||0
267901|NCT00947167|649773|P1|COMPLETED|Pertuzumab Alone||4
267902|NCT00947167|649773|P1|STARTED|Pertuzumab Alone||4
267903|NCT00947154|649778|P1|NOT COMPLETED|Overall Study||1
267904|NCT00947154|649778|P1|COMPLETED|Overall Study||11
267905|NCT00947154|649778|P1|STARTED|Overall Study||12
267906|NCT00947115|649788|P3|NOT COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||15
267907|NCT00947115|649789|P2|NOT COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||22
267908|NCT00947115|649790|P1|NOT COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||17
267909|NCT00947115|649788|P3|COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||156
267910|NCT00947115|649789|P2|COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||172
267911|NCT00947115|649790|P1|COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||142
267912|NCT00947115|649788|P3|STARTED|Year 0 (Month 0) - Year 10 (Month 120)||171
267913|NCT00947115|649789|P2|STARTED|Year 0 (Month 0) - Year 10 (Month 120)||194
267914|NCT00947115|649790|P1|STARTED|Year 0 (Month 0) - Year 10 (Month 120)||159
267915|NCT00947115|649788|P3|NOT COMPLETED|Year 10 (Month 120)||0
267916|NCT00947115|649789|P2|NOT COMPLETED|Year 10 (Month 120)||0
267917|NCT00947115|649790|P1|NOT COMPLETED|Year 10 (Month 120)||0
267918|NCT00947115|649788|P3|COMPLETED|Year 10 (Month 120)||156
267919|NCT00947115|649789|P2|COMPLETED|Year 10 (Month 120)||172
267920|NCT00947115|649790|P1|COMPLETED|Year 10 (Month 120)||142
267921|NCT00947115|649788|P3|STARTED|Year 10 (Month 120)||156
267922|NCT00947115|649789|P2|STARTED|Year 10 (Month 120)||172
267923|NCT00947115|649790|P1|STARTED|Year 10 (Month 120)||142
267924|NCT00947115|649788|P3|NOT COMPLETED|Year 9 (Month 108)||0
267925|NCT00947115|649789|P2|NOT COMPLETED|Year 9 (Month 108)||0
267926|NCT00947115|649790|P1|NOT COMPLETED|Year 9 (Month 108)||0
267927|NCT00947115|649788|P3|COMPLETED|Year 9 (Month 108)||157
267928|NCT00947115|649789|P2|COMPLETED|Year 9 (Month 108)||180
267929|NCT00947115|649790|P1|COMPLETED|Year 9 (Month 108)||146
267930|NCT00947115|649788|P3|STARTED|Year 9 (Month 108)||157
267931|NCT00947115|649789|P2|STARTED|Year 9 (Month 108)||180
267932|NCT00947115|649790|P1|STARTED|Year 9 (Month 108)||146
267933|NCT00947115|649788|P3|NOT COMPLETED|Year 8 (Month 96)||0
267934|NCT00947115|649789|P2|NOT COMPLETED|Year 8 (Month 96)||0
267935|NCT00947115|649790|P1|NOT COMPLETED|Year 8 (Month 96)||0
267936|NCT00947115|649788|P3|COMPLETED|Year 8 (Month 96)||141
267937|NCT00947115|649789|P2|COMPLETED|Year 8 (Month 96)||152
267938|NCT00947115|649790|P1|COMPLETED|Year 8 (Month 96)||137
267939|NCT00947115|649788|P3|STARTED|Year 8 (Month 96)||141
267940|NCT00947115|649789|P2|STARTED|Year 8 (Month 96)||152
267941|NCT00947115|649790|P1|STARTED|Year 8 (Month 96)||137
267942|NCT00947115|649788|P3|NOT COMPLETED|Year 7 (Month 84)||0
267943|NCT00947115|649789|P2|NOT COMPLETED|Year 7 (Month 84)||0
267944|NCT00947115|649790|P1|NOT COMPLETED|Year 7 (Month 84)||0
267945|NCT00947115|649788|P3|COMPLETED|Year 7 (Month 84)||160
267946|NCT00947115|649789|P2|COMPLETED|Year 7 (Month 84)||165
267947|NCT00947115|649790|P1|COMPLETED|Year 7 (Month 84)||149
267948|NCT00947115|649788|P3|STARTED|Year 7 (Month 84)||160
267949|NCT00947115|649789|P2|STARTED|Year 7 (Month 84)||165
267950|NCT00947115|649790|P1|STARTED|Year 7 (Month 84)||149
267951|NCT00947115|649788|P3|NOT COMPLETED|Year 6 (Month 72)||0
267952|NCT00947115|649789|P2|NOT COMPLETED|Year 6 (Month 72)||0
267953|NCT00947115|649790|P1|NOT COMPLETED|Year 6 (Month 72)||0
267954|NCT00947115|649788|P3|COMPLETED|Year 6 (Month 72)||164
267955|NCT00947115|649789|P2|COMPLETED|Year 6 (Month 72)||177
267956|NCT00947115|649790|P1|COMPLETED|Year 6 (Month 72)||147
267957|NCT00947115|649788|P3|STARTED|Year 6 (Month 72)||164
267958|NCT00947115|649789|P2|STARTED|Year 6 (Month 72)||177
267959|NCT00947115|649790|P1|STARTED|Year 6 (Month 72)||147
267960|NCT00947115|649788|P3|NOT COMPLETED|Year 5 (Month 60)||0
267961|NCT00947115|649789|P2|NOT COMPLETED|Year 5 (Month 60)||0
267962|NCT00947115|649790|P1|NOT COMPLETED|Year 5 (Month 60)||0
267963|NCT00947115|649788|P3|COMPLETED|Year 5 (Month 60)||170
267964|NCT00947115|649789|P2|COMPLETED|Year 5 (Month 60)||184
267965|NCT00947115|649790|P1|COMPLETED|Year 5 (Month 60)||153
267966|NCT00947115|649788|P3|STARTED|Year 5 (Month 60)||170
267967|NCT00947115|649789|P2|STARTED|Year 5 (Month 60)||184
267968|NCT00947115|649790|P1|STARTED|Year 5 (Month 60)||153
267969|NCT00947011|649852|P1|NOT COMPLETED|Overall Study||12
267970|NCT00947011|649852|P1|COMPLETED|Overall Study||0
267971|NCT00947011|649852|P1|STARTED|Overall Study||12
267972|NCT00946998|649862|P2|NOT COMPLETED|Overall Study||3
267973|NCT00946998|649863|P1|NOT COMPLETED|Overall Study||5
267974|NCT00946998|649862|P2|COMPLETED|Overall Study||96
267975|NCT00946998|649863|P1|COMPLETED|Overall Study||97
267976|NCT00946998|649862|P2|Received Treatment as Randomized|Overall Study||99
267977|NCT00946998|649863|P1|Received Treatment as Randomized|Overall Study||102
267978|NCT00946998|649862|P2|STARTED|Overall Study||99
267979|NCT00946998|649863|P1|STARTED|Overall Study||102
267980|NCT00946985|649877|P1|NOT COMPLETED|Relapse Prevention Phase (24 Months)||2
267981|NCT00946985|649877|P1|COMPLETED|Relapse Prevention Phase (24 Months)||0
267982|NCT00946985|649877|P1|STARTED|Relapse Prevention Phase (24 Months)|Both randomized patients were discontinued when the sponsor terminated the trial early.|2
267983|NCT00946985|649877|P1|NOT COMPLETED|Stabilization Phase (25 Weeks)||160
267984|NCT00946985|649877|P1|COMPLETED|Stabilization Phase (25 Weeks)||2
267985|NCT00946985|649877|P1|STARTED|Stabilization Phase (25 Weeks)||162
267986|NCT00946920|649883|P2|NOT COMPLETED|Overall Study||44
267987|NCT00946920|649884|P1|NOT COMPLETED|Overall Study||110
267988|NCT00946920|649883|P2|COMPLETED|Overall Study||239
267989|NCT00946920|649884|P1|COMPLETED|Overall Study||455
267990|NCT00946920|649883|P2|Full Analysis Set (FAS)|Overall Study|Received at least one dose of goserelin and had at least one post-dosing efficacy assessment.|282
267991|NCT00946920|649884|P1|Full Analysis Set (FAS)|Overall Study|Received at least one dose of degarelix and had at least one post-dosing efficacy assessment.|565
267992|NCT00946920|649883|P2|STARTED|Overall Study|Received at least one dose of goserelin acetate.|283
267993|NCT00946920|649884|P1|STARTED|Overall Study|Received at least one dose of degarelix.|565
267994|NCT00946881|649899|P1|NOT COMPLETED|Retreatment||1
267995|NCT00946881|649899|P1|COMPLETED|Retreatment||7
267996|NCT00946881|649899|P1|STARTED|Retreatment||8
267997|NCT00946881|649899|P1|NOT COMPLETED|First Treatment||2
267998|NCT00946881|649899|P1|COMPLETED|First Treatment||28
267999|NCT00946881|649899|P1|STARTED|First Treatment||30
268000|NCT00946712|649930|P2|NOT COMPLETED|Overall Study||662
268001|NCT00946712|649931|P1|NOT COMPLETED|Overall Study||547
268002|NCT00946712|649930|P2|COMPLETED|Overall Study||0
268003|NCT00946712|649931|P1|COMPLETED|Overall Study||124
268004|NCT00946712|649930|P2|STARTED|Overall Study||662
268005|NCT00946712|649931|P1|STARTED|Overall Study||671
268006|NCT00946530|649955|P4|NOT COMPLETED|Overall Study||4
268007|NCT00946530|649956|P3|NOT COMPLETED|Overall Study||1
268008|NCT00946530|649957|P2|NOT COMPLETED|Overall Study||4
268009|NCT00946530|649958|P1|NOT COMPLETED|Overall Study||1
268010|NCT00946530|649955|P4|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|23
268011|NCT00946530|649956|P3|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
268012|NCT00946530|649957|P2|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver completed to the Dim Light (Control) arm|23
268013|NCT00946530|649958|P1|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
268014|NCT00946530|649955|P4|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
268015|NCT00946530|649956|P3|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
268016|NCT00946530|649957|P2|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
268017|NCT00946530|649958|P1|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
268018|NCT00946478|649974|P2|NOT COMPLETED|Overall Study||0
268019|NCT00946478|649975|P1|NOT COMPLETED|Overall Study||0
268020|NCT00946478|649974|P2|COMPLETED|Overall Study||20
268021|NCT00946478|649975|P1|COMPLETED|Overall Study||20
268022|NCT00946478|649974|P2|STARTED|Overall Study||20
268023|NCT00946478|649975|P1|STARTED|Overall Study||20
268024|NCT00946348|649983|P2|NOT COMPLETED|Overall Study||0
268025|NCT00946348|649984|P1|NOT COMPLETED|Overall Study||0
268026|NCT00946348|649983|P2|COMPLETED|Overall Study||6
268027|NCT00946348|649984|P1|COMPLETED|Overall Study||6
268028|NCT00946348|649983|P2|STARTED|Overall Study||6
268029|NCT00946348|649984|P1|STARTED|Overall Study||6
268030|NCT00946322|649990|P1|NOT COMPLETED|Post-treatment||2
268031|NCT00946322|649990|P1|COMPLETED|Post-treatment||9
268032|NCT00946322|649990|P1|STARTED|Post-treatment||11
268033|NCT00946322|649990|P1|NOT COMPLETED|Pre-treatment||1
268034|NCT00946322|649990|P1|COMPLETED|Pre-treatment||11
268035|NCT00946322|649990|P1|STARTED|Pre-treatment||12
268036|NCT00946309|650003|P2|NOT COMPLETED|Overall Study||4
268037|NCT00946309|650004|P1|NOT COMPLETED|Overall Study||1
268038|NCT00946309|650003|P2|COMPLETED|Overall Study||19
268039|NCT00946309|650004|P1|COMPLETED|Overall Study||21
268040|NCT00946309|650003|P2|STARTED|Overall Study||23
268041|NCT00946309|650004|P1|STARTED|Overall Study||22
268042|NCT00946296|650022|P2|NOT COMPLETED|Overall Study||0
268043|NCT00946296|650023|P1|NOT COMPLETED|Overall Study||3
268044|NCT00946296|650022|P2|COMPLETED|Overall Study||15
268045|NCT00946296|650023|P1|COMPLETED|Overall Study||18
268046|NCT00946296|650022|P2|STARTED|Overall Study||15
268047|NCT00946296|650023|P1|STARTED|Overall Study||21
268048|NCT00946270|650032|P3|NOT COMPLETED|Overall Study||0
268049|NCT00946270|650033|P2|NOT COMPLETED|Overall Study||0
268050|NCT00946270|650034|P1|NOT COMPLETED|Overall Study||0
268051|NCT00946270|650032|P3|COMPLETED|Overall Study||29
268052|NCT00946270|650033|P2|COMPLETED|Overall Study||20
268053|NCT00946270|650034|P1|COMPLETED|Overall Study||21
268054|NCT00946270|650032|P3|STARTED|Overall Study||29
268055|NCT00946270|650033|P2|STARTED|Overall Study||20
268056|NCT00946270|650034|P1|STARTED|Overall Study||21
268057|NCT00946153|650047|P5|NOT COMPLETED|Phase 2||13
268058|NCT00946153|650048|P4|NOT COMPLETED|Phase 2||0
268059|NCT00946153|650049|P3|NOT COMPLETED|Phase 2||0
268060|NCT00946153|650050|P2|NOT COMPLETED|Phase 2||0
268061|NCT00946153|650051|P1|NOT COMPLETED|Phase 2||0
268062|NCT00946153|650047|P5|COMPLETED|Phase 2||33
268063|NCT00946153|650048|P4|COMPLETED|Phase 2||0
268064|NCT00946153|650049|P3|COMPLETED|Phase 2||0
268065|NCT00946153|650050|P2|COMPLETED|Phase 2||0
268066|NCT00946153|650051|P1|COMPLETED|Phase 2||0
268067|NCT00946153|650047|P5|STARTED|Phase 2||46
268068|NCT00946153|650048|P4|STARTED|Phase 2||0
268069|NCT00946153|650049|P3|STARTED|Phase 2||0
268070|NCT00946153|650050|P2|STARTED|Phase 2||0
268071|NCT00946153|650051|P1|STARTED|Phase 2||0
268072|NCT00946153|650047|P5|NOT COMPLETED|Phase 1||0
268073|NCT00946153|650048|P4|NOT COMPLETED|Phase 1||0
268074|NCT00946153|650049|P3|NOT COMPLETED|Phase 1||0
268075|NCT00946153|650050|P2|NOT COMPLETED|Phase 1||0
268076|NCT00946153|650051|P1|NOT COMPLETED|Phase 1||0
268077|NCT00946153|650047|P5|COMPLETED|Phase 1||0
268078|NCT00946153|650048|P4|COMPLETED|Phase 1||5
268079|NCT00946153|650049|P3|COMPLETED|Phase 1||6
268080|NCT00946153|650050|P2|COMPLETED|Phase 1||3
268081|NCT00946153|650051|P1|COMPLETED|Phase 1||6
268082|NCT00946153|650047|P5|STARTED|Phase 1||0
268083|NCT00946153|650048|P4|STARTED|Phase 1||5
268084|NCT00946153|650049|P3|STARTED|Phase 1||6
268085|NCT00946153|650050|P2|STARTED|Phase 1||3
268086|NCT00946153|650051|P1|STARTED|Phase 1||6
268087|NCT00946114|650079|P2|NOT COMPLETED|Overall Study||2
268088|NCT00946114|650080|P1|NOT COMPLETED|Overall Study||8
268089|NCT00946114|650079|P2|COMPLETED|Overall Study||10
268090|NCT00946114|650080|P1|COMPLETED|Overall Study||12
268091|NCT00946114|650079|P2|STARTED|Overall Study||12
268092|NCT00946114|650080|P1|STARTED|Overall Study||20
268093|NCT00946101|650088|P2|NOT COMPLETED|Overall Study||2
268094|NCT00946101|650089|P1|NOT COMPLETED|Overall Study||4
268095|NCT00946101|650088|P2|COMPLETED|Overall Study||63
268096|NCT00946101|650089|P1|COMPLETED|Overall Study||257
268097|NCT00946101|650088|P2|Day 15 Post Dose 2|Overall Study||63
268098|NCT00946101|650089|P1|Day 15 Post Dose 2|Overall Study||254
268099|NCT00946101|650088|P2|Day 15 Post Dose 1|Overall Study||64
268100|NCT00946101|650089|P1|Day 15 Post Dose 1|Overall Study||260
268101|NCT00946101|650088|P2|STARTED|Overall Study||65
268102|NCT00946101|650089|P1|STARTED|Overall Study|Intent to Treat population, enrolled and randomized|261
268103|NCT00946088|650155|P2|NOT COMPLETED|Overall Study||1
268104|NCT00946088|650156|P1|NOT COMPLETED|Overall Study||0
268105|NCT00946088|650155|P2|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|2
268106|NCT00946088|650156|P1|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|4
268107|NCT00946088|650155|P2|STARTED|Overall Study||3
268108|NCT00946088|650156|P1|STARTED|Overall Study||4
268109|NCT00946023|650178|P1|NOT COMPLETED|Overall Study||0
268110|NCT00946023|650178|P1|COMPLETED|Overall Study||83
268111|NCT00946023|650178|P1|STARTED|Overall Study||83
268112|NCT00945958|650193|P1|NOT COMPLETED|Overall Study||12
268113|NCT00945958|650193|P1|COMPLETED|Overall Study||149
268114|NCT00945958|650193|P1|STARTED|Overall Study||161
268115|NCT00945945|650200|P2|NOT COMPLETED|Overall Study||55
268116|NCT00945945|650201|P1|NOT COMPLETED|Overall Study||36
268117|NCT00945945|650200|P2|COMPLETED|Overall Study||162
268118|NCT00945945|650201|P1|COMPLETED|Overall Study||171
268119|NCT00945945|650200|P2|STARTED|Overall Study||217
268120|NCT00945945|650201|P1|STARTED|Overall Study||207
268121|NCT00945906|650227|P1|NOT COMPLETED|Overall Study||7
268122|NCT00945906|650227|P1|COMPLETED|Overall Study||54
268123|NCT00945906|650227|P1|STARTED|Overall Study||61
268124|NCT00945893|650238|P2|NOT COMPLETED|Overall Study||10
268125|NCT00945893|650239|P1|NOT COMPLETED|Overall Study||3
268126|NCT00945893|650238|P2|COMPLETED|Overall Study||230
268127|NCT00945893|650239|P1|COMPLETED|Overall Study||57
268128|NCT00945893|650238|P2|Day 15 Post Dose 2|Overall Study||226
268129|NCT00945893|650239|P1|Day 15 Post Dose 2|Overall Study||54
268130|NCT00945893|650238|P2|Day 15 Post Dose 1|Overall Study||238
268131|NCT00945893|650239|P1|Day 15 Post Dose 1|Overall Study||60
268132|NCT00945893|650238|P2|STARTED|Overall Study||240
268133|NCT00945893|650239|P1|STARTED|Overall Study||60
268134|NCT00945854|650305|P2|NOT COMPLETED|Overall Study||4
268135|NCT00945854|650306|P1|NOT COMPLETED|Overall Study||2
268136|NCT00945854|650305|P2|COMPLETED|Overall Study||26
268137|NCT00945854|650306|P1|COMPLETED|Overall Study||28
268138|NCT00945854|650305|P2|STARTED|Overall Study||30
268139|NCT00945854|650306|P1|STARTED|Overall Study||30
268140|NCT00945815|650316|P1|NOT COMPLETED|Overall Study||8
268141|NCT00945815|650316|P1|COMPLETED|Overall Study||27
268142|NCT00945815|650316|P1|Eligible and Began Protocol Therapy|Overall Study||31
268143|NCT00945815|650316|P1|Eligible|Overall Study||32
268144|NCT00945815|650316|P1|STARTED|Overall Study||35
268145|NCT00945750|650327|P6|NOT COMPLETED|Period III||0
268146|NCT00945750|650328|P5|NOT COMPLETED|Period III||0
268147|NCT00945750|650329|P4|NOT COMPLETED|Period III||0
268148|NCT00945750|650330|P3|NOT COMPLETED|Period III||0
268149|NCT00945750|650331|P2|NOT COMPLETED|Period III||0
268150|NCT00945750|650332|P1|NOT COMPLETED|Period III||0
268151|NCT00945750|650327|P6|COMPLETED|Period III||5
268152|NCT00945750|650328|P5|COMPLETED|Period III||5
268153|NCT00945750|650329|P4|COMPLETED|Period III||5
268154|NCT00945750|650330|P3|COMPLETED|Period III||5
268155|NCT00945750|650331|P2|COMPLETED|Period III||5
268156|NCT00945750|650332|P1|COMPLETED|Period III||5
268157|NCT00945750|650327|P6|STARTED|Period III||5
268158|NCT00945750|650328|P5|STARTED|Period III||5
268159|NCT00945750|650329|P4|STARTED|Period III||5
268160|NCT00945750|650330|P3|STARTED|Period III||5
268161|NCT00945750|650331|P2|STARTED|Period III||5
268162|NCT00945750|650332|P1|STARTED|Period III||5
268163|NCT00945750|650327|P6|NOT COMPLETED|Period II||0
268164|NCT00945750|650328|P5|NOT COMPLETED|Period II||0
268165|NCT00945750|650329|P4|NOT COMPLETED|Period II||0
268166|NCT00945750|650330|P3|NOT COMPLETED|Period II||0
268167|NCT00945750|650331|P2|NOT COMPLETED|Period II||0
268168|NCT00945750|650332|P1|NOT COMPLETED|Period II||0
268169|NCT00945750|650327|P6|COMPLETED|Period II||5
268170|NCT00945750|650328|P5|COMPLETED|Period II||5
268171|NCT00945750|650329|P4|COMPLETED|Period II||5
268172|NCT00945750|650330|P3|COMPLETED|Period II||5
268173|NCT00945750|650331|P2|COMPLETED|Period II||5
268174|NCT00945750|650332|P1|COMPLETED|Period II||5
268175|NCT00945750|650327|P6|STARTED|Period II||5
268176|NCT00945750|650328|P5|STARTED|Period II||5
268177|NCT00945750|650329|P4|STARTED|Period II||5
268178|NCT00945750|650330|P3|STARTED|Period II||5
268179|NCT00945750|650331|P2|STARTED|Period II||5
268180|NCT00945750|650332|P1|STARTED|Period II||5
268181|NCT00945750|650327|P6|NOT COMPLETED|Period I||0
268182|NCT00945750|650328|P5|NOT COMPLETED|Period I||0
268183|NCT00945750|650329|P4|NOT COMPLETED|Period I||0
268184|NCT00945750|650330|P3|NOT COMPLETED|Period I||0
268185|NCT00945750|650331|P2|NOT COMPLETED|Period I||0
268186|NCT00945750|650332|P1|NOT COMPLETED|Period I||0
268187|NCT00945750|650327|P6|COMPLETED|Period I||5
268188|NCT00945750|650328|P5|COMPLETED|Period I||5
268189|NCT00945750|650329|P4|COMPLETED|Period I||5
268190|NCT00945750|650330|P3|COMPLETED|Period I||5
268191|NCT00945750|650331|P2|COMPLETED|Period I||5
268192|NCT00945750|650332|P1|COMPLETED|Period I||5
268193|NCT00945750|650327|P6|STARTED|Period I||5
268194|NCT00945750|650328|P5|STARTED|Period I||5
268195|NCT00945750|650329|P4|STARTED|Period I||5
268196|NCT00945750|650330|P3|STARTED|Period I||5
268197|NCT00945750|650331|P2|STARTED|Period I||5
268198|NCT00945750|650332|P1|STARTED|Period I||5
268199|NCT00945659|650348|P3|NOT COMPLETED|Overall Study||17
268200|NCT00945659|650349|P2|NOT COMPLETED|Overall Study||20
268201|NCT00945659|650350|P1|NOT COMPLETED|Overall Study||7
268202|NCT00945659|650348|P3|COMPLETED|Overall Study||20
268203|NCT00945659|650349|P2|COMPLETED|Overall Study||20
268204|NCT00945659|650350|P1|COMPLETED|Overall Study||32
268205|NCT00945659|650348|P3|12-Months|Overall Study||20
268206|NCT00945659|650349|P2|12-Months|Overall Study||20
268207|NCT00945659|650350|P1|12-Months|Overall Study||32
268208|NCT00945659|650348|P3|9-Months|Overall Study||20
268209|NCT00945659|650349|P2|9-Months|Overall Study||20
268210|NCT00945659|650350|P1|9-Months|Overall Study||32
268211|NCT00945659|650348|P3|6-Months|Overall Study||25
268212|NCT00945659|650349|P2|6-Months|Overall Study||29
268213|NCT00945659|650350|P1|6-Months|Overall Study||31
268214|NCT00945659|650348|P3|3-Months|Overall Study||35
268215|NCT00945659|650349|P2|3-Months|Overall Study||39
268216|NCT00945659|650350|P1|3-Months|Overall Study||38
268217|NCT00945659|650348|P3|Baseline|Overall Study||37
268218|NCT00945659|650349|P2|Baseline|Overall Study||40
268219|NCT00945659|650350|P1|Baseline|Overall Study||39
268220|NCT00945659|650348|P3|STARTED|Overall Study||37
268221|NCT00945659|650349|P2|STARTED|Overall Study||40
268222|NCT00945659|650350|P1|STARTED|Overall Study||39
268223|NCT00945594|650396|P2|NOT COMPLETED|Overall Study||0
268224|NCT00945594|650397|P1|NOT COMPLETED|Overall Study||0
268225|NCT00945594|650396|P2|COMPLETED|Overall Study||50
268226|NCT00945594|650397|P1|COMPLETED|Overall Study||50
268227|NCT00945594|650396|P2|STARTED|Overall Study||50
268228|NCT00945594|650397|P1|STARTED|Overall Study||50
268229|NCT00945555|650407|P1|NOT COMPLETED|Overall Study||28
268230|NCT00945555|650407|P1|COMPLETED|Overall Study||236
268231|NCT00945555|650407|P1|STARTED|Overall Study||264
268232|NCT00945477|650418|P1|NOT COMPLETED|Overall Study||6
268233|NCT00945477|650418|P1|COMPLETED|Overall Study||5
268234|NCT00945477|650418|P1|STARTED|Overall Study||11
268235|NCT00945334|650425|P2|NOT COMPLETED|Overall Study||3
268236|NCT00945334|650426|P1|NOT COMPLETED|Overall Study||3
268237|NCT00945334|650425|P2|COMPLETED|Overall Study||15
268238|NCT00945334|650426|P1|COMPLETED|Overall Study||16
268239|NCT00945334|650425|P2|STARTED|Overall Study||18
268240|NCT00945334|650426|P1|STARTED|Overall Study||19
268241|NCT00945321|650434|P6|NOT COMPLETED|Period 4||1
268242|NCT00945321|650435|P5|NOT COMPLETED|Period 4||0
268243|NCT00945321|650436|P4|NOT COMPLETED|Period 4||0
268244|NCT00945321|650437|P3|NOT COMPLETED|Period 4||0
268245|NCT00945321|650438|P2|NOT COMPLETED|Period 4||0
268246|NCT00945321|650439|P1|NOT COMPLETED|Period 4||0
268247|NCT00945321|650434|P6|COMPLETED|Period 4||6
268248|NCT00945321|650435|P5|COMPLETED|Period 4||6
268249|NCT00945321|650436|P4|COMPLETED|Period 4||7
268250|NCT00945321|650437|P3|COMPLETED|Period 4||7
268251|NCT00945321|650438|P2|COMPLETED|Period 4||7
268252|NCT00945321|650439|P1|COMPLETED|Period 4||7
268253|NCT00945321|650434|P6|STARTED|Period 4||7
268254|NCT00945321|650435|P5|STARTED|Period 4||6
268255|NCT00945321|650436|P4|STARTED|Period 4||7
268256|NCT00945321|650437|P3|STARTED|Period 4||7
268257|NCT00945321|650438|P2|STARTED|Period 4||7
268258|NCT00945321|650439|P1|STARTED|Period 4||7
268259|NCT00945321|650434|P6|NOT COMPLETED|Period 3||0
268260|NCT00945321|650435|P5|NOT COMPLETED|Period 3||0
268261|NCT00945321|650436|P4|NOT COMPLETED|Period 3||0
268262|NCT00945321|650437|P3|NOT COMPLETED|Period 3||0
268263|NCT00945321|650438|P2|NOT COMPLETED|Period 3||0
268264|NCT00945321|650439|P1|NOT COMPLETED|Period 3||0
268265|NCT00945321|650434|P6|COMPLETED|Period 3||7
268266|NCT00945321|650435|P5|COMPLETED|Period 3||6
268267|NCT00945321|650436|P4|COMPLETED|Period 3||7
268268|NCT00945321|650437|P3|COMPLETED|Period 3||7
268269|NCT00945321|650438|P2|COMPLETED|Period 3||7
268270|NCT00945321|650439|P1|COMPLETED|Period 3||7
268271|NCT00945321|650434|P6|STARTED|Period 3||7
268272|NCT00945321|650435|P5|STARTED|Period 3||6
268273|NCT00945321|650436|P4|STARTED|Period 3||7
268274|NCT00945321|650437|P3|STARTED|Period 3||7
268275|NCT00945321|650438|P2|STARTED|Period 3||7
268276|NCT00945321|650439|P1|STARTED|Period 3||7
268277|NCT00945321|650434|P6|NOT COMPLETED|Period 2||0
268278|NCT00945321|650435|P5|NOT COMPLETED|Period 2||0
268279|NCT00945321|650436|P4|NOT COMPLETED|Period 2||0
268280|NCT00945321|650437|P3|NOT COMPLETED|Period 2||0
268281|NCT00945321|650438|P2|NOT COMPLETED|Period 2||0
268282|NCT00945321|650439|P1|NOT COMPLETED|Period 2||0
268283|NCT00945321|650434|P6|COMPLETED|Period 2||7
268284|NCT00945321|650435|P5|COMPLETED|Period 2||6
268285|NCT00945321|650436|P4|COMPLETED|Period 2||7
268286|NCT00945321|650437|P3|COMPLETED|Period 2||7
268287|NCT00945321|650438|P2|COMPLETED|Period 2||7
268288|NCT00945321|650439|P1|COMPLETED|Period 2||7
268289|NCT00945321|650434|P6|STARTED|Period 2||7
268290|NCT00945321|650435|P5|STARTED|Period 2||6
268291|NCT00945321|650436|P4|STARTED|Period 2||7
268292|NCT00945321|650437|P3|STARTED|Period 2||7
268293|NCT00945321|650438|P2|STARTED|Period 2||7
268294|NCT00945321|650439|P1|STARTED|Period 2||7
268295|NCT00945321|650434|P6|NOT COMPLETED|Period 1||0
268296|NCT00945321|650435|P5|NOT COMPLETED|Period 1||1
268297|NCT00945321|650436|P4|NOT COMPLETED|Period 1||0
268298|NCT00945321|650437|P3|NOT COMPLETED|Period 1||0
268299|NCT00945321|650438|P2|NOT COMPLETED|Period 1||0
268300|NCT00945321|650439|P1|NOT COMPLETED|Period 1||0
268301|NCT00945321|650434|P6|COMPLETED|Period 1||7
268302|NCT00945321|650435|P5|COMPLETED|Period 1||6
268303|NCT00945321|650436|P4|COMPLETED|Period 1||7
268304|NCT00945321|650437|P3|COMPLETED|Period 1||7
268305|NCT00945321|650438|P2|COMPLETED|Period 1||7
268306|NCT00945321|650439|P1|COMPLETED|Period 1||7
268307|NCT00945321|650434|P6|STARTED|Period 1||7
268308|NCT00945321|650435|P5|STARTED|Period 1||7
268309|NCT00945321|650436|P4|STARTED|Period 1||7
268310|NCT00945321|650437|P3|STARTED|Period 1||7
268311|NCT00945321|650438|P2|STARTED|Period 1||7
268312|NCT00945321|650439|P1|STARTED|Period 1||7
268313|NCT00945295|650461|P2|NOT COMPLETED|Overall Study||2
268314|NCT00945295|650462|P1|NOT COMPLETED|Overall Study||0
268315|NCT00945295|650461|P2|COMPLETED|Overall Study||14
268316|NCT00945295|650462|P1|COMPLETED|Overall Study||15
268317|NCT00945295|650461|P2|STARTED|Overall Study||16
268318|NCT00945295|650462|P1|STARTED|Overall Study||15
268319|NCT00945282|650472|P2|NOT COMPLETED|Overall Study||0
268320|NCT00945282|650473|P1|NOT COMPLETED|Overall Study||0
268321|NCT00945282|650472|P2|COMPLETED|Overall Study||2
268322|NCT00945282|650473|P1|COMPLETED|Overall Study||6
268323|NCT00945282|650472|P2|STARTED|Overall Study||2
268324|NCT00945282|650473|P1|STARTED|Overall Study||6
268325|NCT00945256|650556|P5|NOT COMPLETED|Overall Study||1
268326|NCT00945256|650557|P4|NOT COMPLETED|Overall Study||9
268327|NCT00945256|650558|P3|NOT COMPLETED|Overall Study||8
268328|NCT00945256|650559|P2|NOT COMPLETED|Overall Study||2
268329|NCT00945256|650560|P1|NOT COMPLETED|Overall Study||4
268330|NCT00945256|650556|P5|COMPLETED|Overall Study||7
268331|NCT00945256|650557|P4|COMPLETED|Overall Study||7
268332|NCT00945256|650558|P3|COMPLETED|Overall Study||7
268333|NCT00945256|650559|P2|COMPLETED|Overall Study||8
268334|NCT00945256|650560|P1|COMPLETED|Overall Study||9
268335|NCT00945256|650556|P5|STARTED|Overall Study||8
268336|NCT00945256|650557|P4|STARTED|Overall Study||16
268337|NCT00945256|650558|P3|STARTED|Overall Study||15
268338|NCT00945256|650559|P2|STARTED|Overall Study||10
268339|NCT00945256|650560|P1|STARTED|Overall Study||13
268340|NCT00945243|650572|P1|NOT COMPLETED|Overall Study||3
268341|NCT00945243|650572|P1|COMPLETED|Overall Study||8
268342|NCT00945243|650572|P1|STARTED|Overall Study|Enrolled and Treated Per Protocol|11
268343|NCT00945139|650578|P1|NOT COMPLETED|Overall Study||0
268344|NCT00945139|650578|P1|COMPLETED|Overall Study||46
268345|NCT00945139|650578|P1|STARTED|Overall Study||46
268346|NCT00945100|650589|P2|NOT COMPLETED|Post-10 Week Primary Outcome||7
268347|NCT00945100|650590|P1|NOT COMPLETED|Post-10 Week Primary Outcome||4
268348|NCT00945100|650589|P2|COMPLETED|Post-10 Week Primary Outcome||56
268349|NCT00945100|650590|P1|COMPLETED|Post-10 Week Primary Outcome||51
268350|NCT00945100|650589|P2|STARTED|Post-10 Week Primary Outcome|20 participants were not eligible for Post 10 week Primary Outcome phase|63
268351|NCT00945100|650590|P1|STARTED|Post-10 Week Primary Outcome|27 participants were not eligible for Post 10 week Primary Outcome phase|55
268352|NCT00945100|650589|P2|NOT COMPLETED|10-week Primary Outcome||3
268353|NCT00945100|650590|P1|NOT COMPLETED|10-week Primary Outcome||1
268354|NCT00945100|650589|P2|COMPLETED|10-week Primary Outcome||83
268355|NCT00945100|650590|P1|COMPLETED|10-week Primary Outcome||82
268356|NCT00945100|650589|P2|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|20
268357|NCT00945100|650590|P1|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|27
268358|NCT00945100|650589|P2|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|63
268359|NCT00945100|650590|P1|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|55
268360|NCT00945100|650589|P2|STARTED|10-week Primary Outcome||86
268361|NCT00945100|650590|P1|STARTED|10-week Primary Outcome||83
268362|NCT00945035|650654|P2|NOT COMPLETED|Period 2||0
268363|NCT00945035|650655|P1|NOT COMPLETED|Period 2||0
268364|NCT00945035|650654|P2|COMPLETED|Period 2||18
268365|NCT00945035|650655|P1|COMPLETED|Period 2||18
268366|NCT00945035|650654|P2|STARTED|Period 2||18
268367|NCT00945035|650655|P1|STARTED|Period 2||18
268368|NCT00945035|650654|P2|NOT COMPLETED|Period 1||0
268369|NCT00945035|650655|P1|NOT COMPLETED|Period 1||0
268370|NCT00945035|650654|P2|COMPLETED|Period 1||18
268371|NCT00945035|650655|P1|COMPLETED|Period 1||18
268372|NCT00945035|650654|P2|STARTED|Period 1||18
268373|NCT00945035|650655|P1|STARTED|Period 1||18
268374|NCT00945009|650666|P3|NOT COMPLETED|Overall Study||3
268375|NCT00945009|650667|P2|NOT COMPLETED|Overall Study||7
268376|NCT00945009|650668|P1|NOT COMPLETED|Overall Study||45
268377|NCT00945009|650666|P3|COMPLETED|Overall Study||6
268378|NCT00945009|650667|P2|COMPLETED|Overall Study||32
268379|NCT00945009|650668|P1|COMPLETED|Overall Study||156
268380|NCT00945009|650666|P3|STARTED|Overall Study||9
268381|NCT00945009|650667|P2|STARTED|Overall Study||39
268382|NCT00945009|650668|P1|STARTED|Overall Study||201
268383|NCT00944749|650678|P1|NOT COMPLETED|Overall Study||1
268384|NCT00944749|650678|P1|COMPLETED|Overall Study||22
268385|NCT00944749|650678|P1|STARTED|Overall Study||23
268386|NCT00944710|650685|P2|NOT COMPLETED|Additional Post 10-week Primary Outcome||11
268387|NCT00944710|650686|P1|NOT COMPLETED|Additional Post 10-week Primary Outcome||17
268388|NCT00944710|650685|P2|COMPLETED|Additional Post 10-week Primary Outcome||22
268389|NCT00944710|650686|P1|COMPLETED|Additional Post 10-week Primary Outcome||23
268390|NCT00944710|650685|P2|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||26
268391|NCT00944710|650686|P1|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||24
268392|NCT00944710|650685|P2|STARTED|Additional Post 10-week Primary Outcome||33
268393|NCT00944710|650686|P1|STARTED|Additional Post 10-week Primary Outcome||40
268394|NCT00944710|650685|P2|NOT COMPLETED|12-week Visit (Off-treatment)||0
268395|NCT00944710|650686|P1|NOT COMPLETED|12-week Visit (Off-treatment)||0
268396|NCT00944710|650685|P2|COMPLETED|12-week Visit (Off-treatment)||33
268397|NCT00944710|650686|P1|COMPLETED|12-week Visit (Off-treatment)||40
268398|NCT00944710|650685|P2|STARTED|12-week Visit (Off-treatment)||33
268399|NCT00944710|650686|P1|STARTED|12-week Visit (Off-treatment)||40
268400|NCT00944710|650685|P2|NOT COMPLETED|10-week Primary Outcome||0
268401|NCT00944710|650686|P1|NOT COMPLETED|10-week Primary Outcome||0
268402|NCT00944710|650685|P2|COMPLETED|10-week Primary Outcome||33
268403|NCT00944710|650686|P1|COMPLETED|10-week Primary Outcome||40
268404|NCT00944710|650685|P2|STARTED|10-week Primary Outcome||33
268405|NCT00944710|650686|P1|STARTED|10-week Primary Outcome||40
268406|NCT00944697|650744|P2|NOT COMPLETED|Overall Study||5
268407|NCT00944697|650745|P1|NOT COMPLETED|Overall Study||2
268408|NCT00944697|650744|P2|COMPLETED|Overall Study||43
268409|NCT00944697|650745|P1|COMPLETED|Overall Study||48
268410|NCT00944697|650744|P2|STARTED|Overall Study||48
268411|NCT00944697|650745|P1|STARTED|Overall Study||50
268412|NCT00944671|650757|P6|NOT COMPLETED|Period III||0
268413|NCT00944671|650758|P5|NOT COMPLETED|Period III||0
268414|NCT00944671|650759|P4|NOT COMPLETED|Period III||0
268415|NCT00944671|650760|P3|NOT COMPLETED|Period III||0
268416|NCT00944671|650761|P2|NOT COMPLETED|Period III||0
268417|NCT00944671|650762|P1|NOT COMPLETED|Period III||0
268418|NCT00944671|650757|P6|COMPLETED|Period III||4
268419|NCT00944671|650758|P5|COMPLETED|Period III||4
268420|NCT00944671|650759|P4|COMPLETED|Period III||4
268421|NCT00944671|650760|P3|COMPLETED|Period III||4
268422|NCT00944671|650761|P2|COMPLETED|Period III||4
268423|NCT00944671|650762|P1|COMPLETED|Period III||4
268424|NCT00944671|650757|P6|STARTED|Period III||4
268425|NCT00944671|650758|P5|STARTED|Period III||4
268426|NCT00944671|650759|P4|STARTED|Period III||4
268427|NCT00944671|650760|P3|STARTED|Period III||4
268428|NCT00944671|650761|P2|STARTED|Period III||4
268429|NCT00944671|650762|P1|STARTED|Period III||4
268430|NCT00944671|650757|P6|NOT COMPLETED|Period II||0
268431|NCT00944671|650758|P5|NOT COMPLETED|Period II||0
268432|NCT00944671|650759|P4|NOT COMPLETED|Period II||0
268433|NCT00944671|650760|P3|NOT COMPLETED|Period II||0
268434|NCT00944671|650761|P2|NOT COMPLETED|Period II||0
268435|NCT00944671|650762|P1|NOT COMPLETED|Period II||0
268436|NCT00944671|650757|P6|COMPLETED|Period II||4
268437|NCT00944671|650758|P5|COMPLETED|Period II||4
268438|NCT00944671|650759|P4|COMPLETED|Period II||4
268439|NCT00944671|650760|P3|COMPLETED|Period II||4
268440|NCT00944671|650761|P2|COMPLETED|Period II||4
268441|NCT00944671|650762|P1|COMPLETED|Period II||4
268442|NCT00944671|650757|P6|STARTED|Period II||4
268443|NCT00944671|650758|P5|STARTED|Period II||4
268444|NCT00944671|650759|P4|STARTED|Period II||4
268445|NCT00944671|650760|P3|STARTED|Period II||4
268446|NCT00944671|650761|P2|STARTED|Period II||4
268447|NCT00944671|650762|P1|STARTED|Period II||4
268448|NCT00944671|650757|P6|NOT COMPLETED|Period I||0
268449|NCT00944671|650758|P5|NOT COMPLETED|Period I||0
268450|NCT00944671|650759|P4|NOT COMPLETED|Period I||0
268451|NCT00944671|650760|P3|NOT COMPLETED|Period I||0
268452|NCT00944671|650761|P2|NOT COMPLETED|Period I||0
268453|NCT00944671|650762|P1|NOT COMPLETED|Period I||0
268454|NCT00944671|650757|P6|COMPLETED|Period I||4
268455|NCT00944671|650758|P5|COMPLETED|Period I||4
268456|NCT00944671|650759|P4|COMPLETED|Period I||4
268457|NCT00944671|650760|P3|COMPLETED|Period I||4
268458|NCT00944671|650761|P2|COMPLETED|Period I||4
268459|NCT00944671|650762|P1|COMPLETED|Period I||4
268460|NCT00944671|650757|P6|STARTED|Period I||4
268461|NCT00944671|650758|P5|STARTED|Period I||4
268462|NCT00944671|650759|P4|STARTED|Period I||4
268463|NCT00944671|650760|P3|STARTED|Period I||4
268464|NCT00944671|650761|P2|STARTED|Period I||4
268465|NCT00944671|650762|P1|STARTED|Period I||4
268466|NCT00944645|650775|P2|NOT COMPLETED|Period 2||9
268467|NCT00944645|650776|P1|NOT COMPLETED|Period 2||8
268468|NCT00944645|650775|P2|COMPLETED|Period 2||85
268469|NCT00944645|650776|P1|COMPLETED|Period 2||86
268470|NCT00944645|650775|P2|STARTED|Period 2||94
268471|NCT00944645|650776|P1|STARTED|Period 2||94
268472|NCT00944645|650775|P2|NOT COMPLETED|Period 1||0
268473|NCT00944645|650776|P1|NOT COMPLETED|Period 1||0
268474|NCT00944645|650775|P2|COMPLETED|Period 1||94
268475|NCT00944645|650776|P1|COMPLETED|Period 1||94
268476|NCT00944645|650775|P2|STARTED|Period 1||94
268477|NCT00944645|650776|P1|STARTED|Period 1||94
268478|NCT00944554|650790|P2|NOT COMPLETED|Overall Study||29
268479|NCT00944554|650791|P1|NOT COMPLETED|Overall Study||28
268480|NCT00944554|650790|P2|COMPLETED|Overall Study||25
268481|NCT00944554|650791|P1|COMPLETED|Overall Study||22
268482|NCT00944554|650790|P2|STARTED|Overall Study||54
268483|NCT00944554|650791|P1|STARTED|Overall Study||50
268484|NCT00944450|650797|P2|NOT COMPLETED|Period 2||0
268485|NCT00944450|650798|P1|NOT COMPLETED|Period 2||0
268486|NCT00944450|650797|P2|COMPLETED|Period 2||6
268487|NCT00944450|650798|P1|COMPLETED|Period 2||6
268488|NCT00944450|650797|P2|STARTED|Period 2||6
268489|NCT00944450|650798|P1|STARTED|Period 2||6
268490|NCT00944450|650797|P2|NOT COMPLETED|Period 1||0
268491|NCT00944450|650798|P1|NOT COMPLETED|Period 1||0
268492|NCT00944450|650797|P2|COMPLETED|Period 1||6
268493|NCT00944450|650798|P1|COMPLETED|Period 1||6
268494|NCT00944450|650797|P2|STARTED|Period 1||6
268495|NCT00944450|650798|P1|STARTED|Period 1||6
268496|NCT00944229|650806|P1|NOT COMPLETED|Overall Study||25
268497|NCT00944229|650806|P1|COMPLETED|Overall Study||33
268498|NCT00944229|650806|P1|STARTED|Overall Study||58
268499|NCT00944125|650812|P2|NOT COMPLETED|6 Months to Study Completion||2
268500|NCT00944125|650813|P1|NOT COMPLETED|6 Months to Study Completion||0
268501|NCT00944125|650812|P2|COMPLETED|6 Months to Study Completion||18
268502|NCT00944125|650813|P1|COMPLETED|6 Months to Study Completion||19
268503|NCT00944125|650812|P2|STARTED|6 Months to Study Completion||20
268504|NCT00944125|650813|P1|STARTED|6 Months to Study Completion||19
268505|NCT00944125|650812|P2|NOT COMPLETED|3 to 6 Months||2
268506|NCT00944125|650813|P1|NOT COMPLETED|3 to 6 Months||0
268507|NCT00944125|650812|P2|COMPLETED|3 to 6 Months||20
268508|NCT00944125|650813|P1|COMPLETED|3 to 6 Months||19
268509|NCT00944125|650812|P2|STARTED|3 to 6 Months||22
268510|NCT00944125|650813|P1|STARTED|3 to 6 Months||19
268511|NCT00944125|650812|P2|NOT COMPLETED|Baseline to 3 Months||0
268512|NCT00944125|650813|P1|NOT COMPLETED|Baseline to 3 Months||0
268513|NCT00944125|650812|P2|COMPLETED|Baseline to 3 Months||22
268514|NCT00944125|650813|P1|COMPLETED|Baseline to 3 Months||19
268515|NCT00944125|650812|P2|STARTED|Baseline to 3 Months||22
268516|NCT00944125|650813|P1|STARTED|Baseline to 3 Months||19
268517|NCT00944073|650821|P2|NOT COMPLETED|Overall Study||4
268518|NCT00944073|650822|P1|NOT COMPLETED|Overall Study||5
268519|NCT00944073|650821|P2|COMPLETED|Overall Study||287
268520|NCT00944073|650822|P1|COMPLETED|Overall Study||287
268521|NCT00944073|650821|P2|STARTED|Overall Study||291
268522|NCT00944073|650822|P1|STARTED|Overall Study||292
268523|NCT00944047|650900|P1|NOT COMPLETED|Overall Study||5
268524|NCT00944047|650900|P1|COMPLETED|Overall Study||27
268525|NCT00944047|650900|P1|STARTED|Overall Study||32
268526|NCT00944034|650916|P12|NOT COMPLETED|Overall Study||4
268527|NCT00944034|650917|P11|NOT COMPLETED|Overall Study||1
268528|NCT00944034|650918|P10|NOT COMPLETED|Overall Study||10
268529|NCT00944034|650919|P9|NOT COMPLETED|Overall Study||10
268530|NCT00944034|650920|P8|NOT COMPLETED|Overall Study||5
268531|NCT00944034|650921|P7|NOT COMPLETED|Overall Study||4
268532|NCT00944034|650922|P6|NOT COMPLETED|Overall Study||20
268533|NCT00944034|650923|P5|NOT COMPLETED|Overall Study||14
268534|NCT00944034|650924|P4|NOT COMPLETED|Overall Study||4
268535|NCT00944034|650925|P3|NOT COMPLETED|Overall Study||9
268536|NCT00944034|650926|P2|NOT COMPLETED|Overall Study||7
268537|NCT00944034|650927|P1|NOT COMPLETED|Overall Study||5
268538|NCT00944034|650916|P12|COMPLETED|Overall Study||52
268539|NCT00944034|650917|P11|COMPLETED|Overall Study||50
268540|NCT00944034|650918|P10|COMPLETED|Overall Study||236
268541|NCT00944034|650919|P9|COMPLETED|Overall Study||63
268542|NCT00944034|650920|P8|COMPLETED|Overall Study||73
268543|NCT00944034|650921|P7|COMPLETED|Overall Study||102
268544|NCT00944034|650922|P6|COMPLETED|Overall Study||123
268545|NCT00944034|650923|P5|COMPLETED|Overall Study||150
268546|NCT00944034|650924|P4|COMPLETED|Overall Study||170
268547|NCT00944034|650925|P3|COMPLETED|Overall Study||143
268548|NCT00944034|650926|P2|COMPLETED|Overall Study||150
268549|NCT00944034|650927|P1|COMPLETED|Overall Study||183
268550|NCT00944034|650916|P12|STARTED|Overall Study||56
268551|NCT00944034|650917|P11|STARTED|Overall Study||51
268552|NCT00944034|650918|P10|STARTED|Overall Study||246
268553|NCT00944034|650919|P9|STARTED|Overall Study||73
268554|NCT00944034|650920|P8|STARTED|Overall Study||78
268555|NCT00944034|650921|P7|STARTED|Overall Study||106
268556|NCT00944034|650922|P6|STARTED|Overall Study||143
268557|NCT00944034|650923|P5|STARTED|Overall Study||164
268558|NCT00944034|650924|P4|STARTED|Overall Study||174
268559|NCT00944034|650925|P3|STARTED|Overall Study||152
268560|NCT00944034|650926|P2|STARTED|Overall Study||157
268561|NCT00944034|650927|P1|STARTED|Overall Study||188
268562|NCT00944021|650997|P5|NOT COMPLETED|Overall Study||0
268563|NCT00944021|650998|P4|NOT COMPLETED|Overall Study||0
268564|NCT00944021|650999|P3|NOT COMPLETED|Overall Study||0
268565|NCT00944021|651000|P2|NOT COMPLETED|Overall Study||0
268566|NCT00944021|651001|P1|NOT COMPLETED|Overall Study||1
268567|NCT00944021|650997|P5|COMPLETED|Overall Study||8
268568|NCT00944021|650998|P4|COMPLETED|Overall Study||16
268569|NCT00944021|650999|P3|COMPLETED|Overall Study||15
268570|NCT00944021|651000|P2|COMPLETED|Overall Study||15
268571|NCT00944021|651001|P1|COMPLETED|Overall Study||14
268572|NCT00944021|650997|P5|STARTED|Overall Study||8
268573|NCT00944021|650998|P4|STARTED|Overall Study||16
268574|NCT00944021|650999|P3|STARTED|Overall Study||15
268575|NCT00944021|651000|P2|STARTED|Overall Study||15
268576|NCT00944021|651001|P1|STARTED|Overall Study||15
268577|NCT00943917|651073|P15|NOT COMPLETED|Stage II Continuation||4
268578|NCT00943917|651074|P14|NOT COMPLETED|Stage II Continuation||3
268579|NCT00943917|651075|P13|NOT COMPLETED|Stage II Continuation||3
268580|NCT00943917|651076|P12|NOT COMPLETED|Stage II Continuation||2
268581|NCT00943917|651077|P11|NOT COMPLETED|Stage II Continuation||0
268582|NCT00943917|651078|P10|NOT COMPLETED|Stage II Continuation||1
268583|NCT00943917|651079|P9|NOT COMPLETED|Stage II Continuation||0
268584|NCT00943917|651080|P8|NOT COMPLETED|Stage II Continuation||0
268585|NCT00943917|651081|P7|NOT COMPLETED|Stage II Continuation||0
268586|NCT00943917|651082|P6|NOT COMPLETED|Stage II Continuation||0
268587|NCT00943917|651083|P5|NOT COMPLETED|Stage II Continuation||0
268588|NCT00943917|651084|P4|NOT COMPLETED|Stage II Continuation||0
268589|NCT00943917|651085|P3|NOT COMPLETED|Stage II Continuation||0
268590|NCT00943917|651086|P2|NOT COMPLETED|Stage II Continuation||0
268591|NCT00943917|651087|P1|NOT COMPLETED|Stage II Continuation||0
268592|NCT00943917|651073|P15|COMPLETED|Stage II Continuation||8
268593|NCT00943917|651074|P14|COMPLETED|Stage II Continuation||12
268594|NCT00943917|651075|P13|COMPLETED|Stage II Continuation||13
268595|NCT00943917|651076|P12|COMPLETED|Stage II Continuation||11
268596|NCT00943917|651077|P11|COMPLETED|Stage II Continuation||15
268597|NCT00943917|651078|P10|COMPLETED|Stage II Continuation||14
268598|NCT00943917|651079|P9|COMPLETED|Stage II Continuation||0
268599|NCT00943917|651080|P8|COMPLETED|Stage II Continuation||0
268600|NCT00943917|651081|P7|COMPLETED|Stage II Continuation||0
268601|NCT00943917|651082|P6|COMPLETED|Stage II Continuation||0
268602|NCT00943917|651083|P5|COMPLETED|Stage II Continuation||0
268603|NCT00943917|651084|P4|COMPLETED|Stage II Continuation||0
268604|NCT00943917|651085|P3|COMPLETED|Stage II Continuation||0
268605|NCT00943917|651086|P2|COMPLETED|Stage II Continuation||0
268606|NCT00943917|651087|P1|COMPLETED|Stage II Continuation||0
268607|NCT00943917|651073|P15|STARTED|Stage II Continuation||12
268608|NCT00943917|651074|P14|STARTED|Stage II Continuation||15
268609|NCT00943917|651075|P13|STARTED|Stage II Continuation||16
268610|NCT00943917|651076|P12|STARTED|Stage II Continuation||13
268611|NCT00943917|651077|P11|STARTED|Stage II Continuation||15
268612|NCT00943917|651078|P10|STARTED|Stage II Continuation||15
268613|NCT00943917|651079|P9|STARTED|Stage II Continuation||0
268614|NCT00943917|651080|P8|STARTED|Stage II Continuation||0
268615|NCT00943917|651081|P7|STARTED|Stage II Continuation||0
268616|NCT00943917|651082|P6|STARTED|Stage II Continuation||0
268617|NCT00943917|651083|P5|STARTED|Stage II Continuation||0
268618|NCT00943917|651084|P4|STARTED|Stage II Continuation||0
268619|NCT00943917|651085|P3|STARTED|Stage II Continuation||0
268620|NCT00943917|651086|P2|STARTED|Stage II Continuation||0
268621|NCT00943917|651087|P1|STARTED|Stage II Continuation||0
268622|NCT00943917|651073|P15|NOT COMPLETED|Stage II||0
268623|NCT00943917|651074|P14|NOT COMPLETED|Stage II||0
268624|NCT00943917|651075|P13|NOT COMPLETED|Stage II||0
268625|NCT00943917|651076|P12|NOT COMPLETED|Stage II||0
268626|NCT00943917|651077|P11|NOT COMPLETED|Stage II||0
268627|NCT00943917|651078|P10|NOT COMPLETED|Stage II||0
268628|NCT00943917|651079|P9|NOT COMPLETED|Stage II||1
268629|NCT00943917|651080|P8|NOT COMPLETED|Stage II||0
268630|NCT00943917|651081|P7|NOT COMPLETED|Stage II||3
268631|NCT00943917|651082|P6|NOT COMPLETED|Stage II||3
268632|NCT00943917|651083|P5|NOT COMPLETED|Stage II||0
268633|NCT00943917|651084|P4|NOT COMPLETED|Stage II||0
268634|NCT00943917|651085|P3|NOT COMPLETED|Stage II||0
268635|NCT00943917|651086|P2|NOT COMPLETED|Stage II||0
268636|NCT00943917|651087|P1|NOT COMPLETED|Stage II||0
268637|NCT00943917|651073|P15|COMPLETED|Stage II||0
268638|NCT00943917|651074|P14|COMPLETED|Stage II||0
268639|NCT00943917|651075|P13|COMPLETED|Stage II||0
268640|NCT00943917|651076|P12|COMPLETED|Stage II||0
268641|NCT00943917|651077|P11|COMPLETED|Stage II||0
268642|NCT00943917|651078|P10|COMPLETED|Stage II||0
268643|NCT00943917|651079|P9|COMPLETED|Stage II||20
268644|NCT00943917|651080|P8|COMPLETED|Stage II||23
268645|NCT00943917|651081|P7|COMPLETED|Stage II||20
268646|NCT00943917|651082|P6|COMPLETED|Stage II||20
268647|NCT00943917|651083|P5|COMPLETED|Stage II||21
268648|NCT00943917|651084|P4|COMPLETED|Stage II||20
268649|NCT00943917|651085|P3|COMPLETED|Stage II||0
268650|NCT00943917|651086|P2|COMPLETED|Stage II||0
268651|NCT00943917|651087|P1|COMPLETED|Stage II||0
268652|NCT00943917|651073|P15|STARTED|Stage II||0
268653|NCT00943917|651074|P14|STARTED|Stage II||0
268654|NCT00943917|651075|P13|STARTED|Stage II||0
268655|NCT00943917|651076|P12|STARTED|Stage II||0
268656|NCT00943917|651077|P11|STARTED|Stage II||0
268657|NCT00943917|651078|P10|STARTED|Stage II||0
268658|NCT00943917|651079|P9|STARTED|Stage II||21
268659|NCT00943917|651080|P8|STARTED|Stage II||23
268660|NCT00943917|651081|P7|STARTED|Stage II||23
268661|NCT00943917|651082|P6|STARTED|Stage II||23
268662|NCT00943917|651083|P5|STARTED|Stage II||21
268663|NCT00943917|651084|P4|STARTED|Stage II||20
268664|NCT00943917|651085|P3|STARTED|Stage II||0
268665|NCT00943917|651086|P2|STARTED|Stage II||0
268666|NCT00943917|651087|P1|STARTED|Stage II||0
268667|NCT00943917|651073|P15|NOT COMPLETED|Stage I||0
268668|NCT00943917|651074|P14|NOT COMPLETED|Stage I||0
268669|NCT00943917|651075|P13|NOT COMPLETED|Stage I||0
268670|NCT00943917|651076|P12|NOT COMPLETED|Stage I||0
268671|NCT00943917|651077|P11|NOT COMPLETED|Stage I||0
268672|NCT00943917|651078|P10|NOT COMPLETED|Stage I||0
268673|NCT00943917|651079|P9|NOT COMPLETED|Stage I||0
268674|NCT00943917|651080|P8|NOT COMPLETED|Stage I||0
268675|NCT00943917|651081|P7|NOT COMPLETED|Stage I||0
268676|NCT00943917|651082|P6|NOT COMPLETED|Stage I||0
268677|NCT00943917|651083|P5|NOT COMPLETED|Stage I||0
268678|NCT00943917|651084|P4|NOT COMPLETED|Stage I||0
268679|NCT00943917|651085|P3|NOT COMPLETED|Stage I||6
268680|NCT00943917|651086|P2|NOT COMPLETED|Stage I||3
268681|NCT00943917|651087|P1|NOT COMPLETED|Stage I||4
268682|NCT00943917|651073|P15|COMPLETED|Stage I||0
268683|NCT00943917|651074|P14|COMPLETED|Stage I||0
268684|NCT00943917|651075|P13|COMPLETED|Stage I||0
268685|NCT00943917|651076|P12|COMPLETED|Stage I||0
268686|NCT00943917|651077|P11|COMPLETED|Stage I||0
268687|NCT00943917|651078|P10|COMPLETED|Stage I||0
268688|NCT00943917|651079|P9|COMPLETED|Stage I||0
268689|NCT00943917|651080|P8|COMPLETED|Stage I||0
268690|NCT00943917|651081|P7|COMPLETED|Stage I||0
268691|NCT00943917|651082|P6|COMPLETED|Stage I||0
268692|NCT00943917|651083|P5|COMPLETED|Stage I||0
268693|NCT00943917|651084|P4|COMPLETED|Stage I||0
268694|NCT00943917|651085|P3|COMPLETED|Stage I||47
268695|NCT00943917|651086|P2|COMPLETED|Stage I||48
268696|NCT00943917|651087|P1|COMPLETED|Stage I||47
268697|NCT00943917|651073|P15|STARTED|Stage I||0
268698|NCT00943917|651074|P14|STARTED|Stage I||0
268699|NCT00943917|651075|P13|STARTED|Stage I||0
268700|NCT00943917|651076|P12|STARTED|Stage I||0
268701|NCT00943917|651077|P11|STARTED|Stage I||0
268702|NCT00943917|651078|P10|STARTED|Stage I||0
268703|NCT00943917|651079|P9|STARTED|Stage I||0
268704|NCT00943917|651080|P8|STARTED|Stage I||0
268705|NCT00943917|651081|P7|STARTED|Stage I||0
268706|NCT00943917|651082|P6|STARTED|Stage I||0
268707|NCT00943917|651083|P5|STARTED|Stage I||0
268708|NCT00943917|651084|P4|STARTED|Stage I||0
268709|NCT00943917|651085|P3|STARTED|Stage I||53
268710|NCT00943917|651086|P2|STARTED|Stage I||51
268711|NCT00943917|651087|P1|STARTED|Stage I||51
268712|NCT00943878|651138|P4|NOT COMPLETED|Overall Study||2
268713|NCT00943878|651139|P3|NOT COMPLETED|Overall Study||6
268714|NCT00943878|651140|P2|NOT COMPLETED|Overall Study||2
268715|NCT00943878|651141|P1|NOT COMPLETED|Overall Study||2
268716|NCT00943878|651138|P4|COMPLETED|Overall Study||198
268717|NCT00943878|651139|P3|COMPLETED|Overall Study||197
268718|NCT00943878|651140|P2|COMPLETED|Overall Study||198
268719|NCT00943878|651141|P1|COMPLETED|Overall Study||200
268720|NCT00943878|651138|P4|STARTED|Overall Study||200
268721|NCT00943878|651139|P3|STARTED|Overall Study||203
268722|NCT00943878|651140|P2|STARTED|Overall Study||200
268723|NCT00943878|651141|P1|STARTED|Overall Study||202
268724|NCT00943852|651263|P10|NOT COMPLETED|Fifth Period of Treatment Intervention||0
268725|NCT00943852|651264|P9|NOT COMPLETED|Fifth Period of Treatment Intervention||0
268726|NCT00943852|651265|P8|NOT COMPLETED|Fifth Period of Treatment Intervention||0
268727|NCT00943852|651266|P7|NOT COMPLETED|Fifth Period of Treatment Intervention||0
268728|NCT00943852|651267|P6|NOT COMPLETED|Fifth Period of Treatment Intervention||0
268729|NCT00943852|651268|P5|NOT COMPLETED|Fifth Period of Treatment Intervention||0
268730|NCT00943852|651269|P4|NOT COMPLETED|Fifth Period of Treatment Intervention||0
268731|NCT00943852|651270|P3|NOT COMPLETED|Fifth Period of Treatment Intervention||0
268732|NCT00943852|651271|P2|NOT COMPLETED|Fifth Period of Treatment Intervention||0
268733|NCT00943852|651272|P1|NOT COMPLETED|Fifth Period of Treatment Intervention||0
268734|NCT00943852|651263|P10|COMPLETED|Fifth Period of Treatment Intervention||1
268735|NCT00943852|651264|P9|COMPLETED|Fifth Period of Treatment Intervention||1
268736|NCT00943852|651265|P8|COMPLETED|Fifth Period of Treatment Intervention||0
268737|NCT00943852|651266|P7|COMPLETED|Fifth Period of Treatment Intervention||0
268738|NCT00943852|651267|P6|COMPLETED|Fifth Period of Treatment Intervention||0
268739|NCT00943852|651268|P5|COMPLETED|Fifth Period of Treatment Intervention||1
268740|NCT00943852|651269|P4|COMPLETED|Fifth Period of Treatment Intervention||0
268741|NCT00943852|651270|P3|COMPLETED|Fifth Period of Treatment Intervention||0
268742|NCT00943852|651271|P2|COMPLETED|Fifth Period of Treatment Intervention||1
268743|NCT00943852|651272|P1|COMPLETED|Fifth Period of Treatment Intervention||1
268744|NCT00943852|651263|P10|STARTED|Fifth Period of Treatment Intervention||1
268745|NCT00943852|651264|P9|STARTED|Fifth Period of Treatment Intervention||1
268746|NCT00943852|651265|P8|STARTED|Fifth Period of Treatment Intervention||0
268747|NCT00943852|651266|P7|STARTED|Fifth Period of Treatment Intervention||0
268748|NCT00943852|651267|P6|STARTED|Fifth Period of Treatment Intervention||0
268749|NCT00943852|651268|P5|STARTED|Fifth Period of Treatment Intervention||1
268750|NCT00943852|651269|P4|STARTED|Fifth Period of Treatment Intervention||0
268751|NCT00943852|651270|P3|STARTED|Fifth Period of Treatment Intervention||0
268752|NCT00943852|651271|P2|STARTED|Fifth Period of Treatment Intervention||1
268753|NCT00943852|651272|P1|STARTED|Fifth Period of Treatment Intervention||1
268754|NCT00943852|651263|P10|NOT COMPLETED|Washout Period After Period 4 Treatment||0
268755|NCT00943852|651264|P9|NOT COMPLETED|Washout Period After Period 4 Treatment||0
268756|NCT00943852|651265|P8|NOT COMPLETED|Washout Period After Period 4 Treatment||1
268757|NCT00943852|651266|P7|NOT COMPLETED|Washout Period After Period 4 Treatment||1
268758|NCT00943852|651267|P6|NOT COMPLETED|Washout Period After Period 4 Treatment||0
268759|NCT00943852|651268|P5|NOT COMPLETED|Washout Period After Period 4 Treatment||0
268760|NCT00943852|651269|P4|NOT COMPLETED|Washout Period After Period 4 Treatment||1
268761|NCT00943852|651270|P3|NOT COMPLETED|Washout Period After Period 4 Treatment||1
268762|NCT00943852|651271|P2|NOT COMPLETED|Washout Period After Period 4 Treatment||0
268763|NCT00943852|651272|P1|NOT COMPLETED|Washout Period After Period 4 Treatment||1
268764|NCT00943852|651263|P10|COMPLETED|Washout Period After Period 4 Treatment||1
268765|NCT00943852|651264|P9|COMPLETED|Washout Period After Period 4 Treatment||1
268766|NCT00943852|651265|P8|COMPLETED|Washout Period After Period 4 Treatment||0
268767|NCT00943852|651266|P7|COMPLETED|Washout Period After Period 4 Treatment||0
268768|NCT00943852|651267|P6|COMPLETED|Washout Period After Period 4 Treatment||0
268769|NCT00943852|651268|P5|COMPLETED|Washout Period After Period 4 Treatment||1
268770|NCT00943852|651269|P4|COMPLETED|Washout Period After Period 4 Treatment||0
268771|NCT00943852|651270|P3|COMPLETED|Washout Period After Period 4 Treatment||0
268772|NCT00943852|651271|P2|COMPLETED|Washout Period After Period 4 Treatment||1
268773|NCT00943852|651272|P1|COMPLETED|Washout Period After Period 4 Treatment||1
268774|NCT00943852|651263|P10|STARTED|Washout Period After Period 4 Treatment||1
268775|NCT00943852|651264|P9|STARTED|Washout Period After Period 4 Treatment||1
268776|NCT00943852|651265|P8|STARTED|Washout Period After Period 4 Treatment||1
268777|NCT00943852|651266|P7|STARTED|Washout Period After Period 4 Treatment||1
268778|NCT00943852|651267|P6|STARTED|Washout Period After Period 4 Treatment||0
268779|NCT00943852|651268|P5|STARTED|Washout Period After Period 4 Treatment||1
268780|NCT00943852|651269|P4|STARTED|Washout Period After Period 4 Treatment||1
268781|NCT00943852|651270|P3|STARTED|Washout Period After Period 4 Treatment||1
268782|NCT00943852|651271|P2|STARTED|Washout Period After Period 4 Treatment||1
268783|NCT00943852|651272|P1|STARTED|Washout Period After Period 4 Treatment||2
268784|NCT00943852|651263|P10|NOT COMPLETED|Fourth Period of Treatment Intervention||0
268785|NCT00943852|651264|P9|NOT COMPLETED|Fourth Period of Treatment Intervention||0
268786|NCT00943852|651265|P8|NOT COMPLETED|Fourth Period of Treatment Intervention||0
268787|NCT00943852|651266|P7|NOT COMPLETED|Fourth Period of Treatment Intervention||0
268788|NCT00943852|651267|P6|NOT COMPLETED|Fourth Period of Treatment Intervention||0
268789|NCT00943852|651268|P5|NOT COMPLETED|Fourth Period of Treatment Intervention||0
268790|NCT00943852|651269|P4|NOT COMPLETED|Fourth Period of Treatment Intervention||0
268791|NCT00943852|651270|P3|NOT COMPLETED|Fourth Period of Treatment Intervention||0
268792|NCT00943852|651271|P2|NOT COMPLETED|Fourth Period of Treatment Intervention||0
268793|NCT00943852|651272|P1|NOT COMPLETED|Fourth Period of Treatment Intervention||0
268794|NCT00943852|651263|P10|COMPLETED|Fourth Period of Treatment Intervention||1
268795|NCT00943852|651264|P9|COMPLETED|Fourth Period of Treatment Intervention||1
268796|NCT00943852|651265|P8|COMPLETED|Fourth Period of Treatment Intervention||1
268797|NCT00943852|651266|P7|COMPLETED|Fourth Period of Treatment Intervention||1
268798|NCT00943852|651267|P6|COMPLETED|Fourth Period of Treatment Intervention||0
268799|NCT00943852|651268|P5|COMPLETED|Fourth Period of Treatment Intervention||1
268800|NCT00943852|651269|P4|COMPLETED|Fourth Period of Treatment Intervention||1
268801|NCT00943852|651270|P3|COMPLETED|Fourth Period of Treatment Intervention||1
268802|NCT00943852|651271|P2|COMPLETED|Fourth Period of Treatment Intervention||1
268803|NCT00943852|651272|P1|COMPLETED|Fourth Period of Treatment Intervention||2
268804|NCT00943852|651263|P10|STARTED|Fourth Period of Treatment Intervention||1
268805|NCT00943852|651264|P9|STARTED|Fourth Period of Treatment Intervention||1
268806|NCT00943852|651265|P8|STARTED|Fourth Period of Treatment Intervention||1
268807|NCT00943852|651266|P7|STARTED|Fourth Period of Treatment Intervention||1
268808|NCT00943852|651267|P6|STARTED|Fourth Period of Treatment Intervention||0
268809|NCT00943852|651268|P5|STARTED|Fourth Period of Treatment Intervention||1
268810|NCT00943852|651269|P4|STARTED|Fourth Period of Treatment Intervention||1
268811|NCT00943852|651270|P3|STARTED|Fourth Period of Treatment Intervention||1
268812|NCT00943852|651271|P2|STARTED|Fourth Period of Treatment Intervention||1
268813|NCT00943852|651272|P1|STARTED|Fourth Period of Treatment Intervention||2
268814|NCT00943852|651263|P10|NOT COMPLETED|Washout Period After Period 3 Treatment||0
268815|NCT00943852|651264|P9|NOT COMPLETED|Washout Period After Period 3 Treatment||0
268816|NCT00943852|651265|P8|NOT COMPLETED|Washout Period After Period 3 Treatment||0
268817|NCT00943852|651266|P7|NOT COMPLETED|Washout Period After Period 3 Treatment||1
268818|NCT00943852|651267|P6|NOT COMPLETED|Washout Period After Period 3 Treatment||0
268819|NCT00943852|651268|P5|NOT COMPLETED|Washout Period After Period 3 Treatment||0
268820|NCT00943852|651269|P4|NOT COMPLETED|Washout Period After Period 3 Treatment||0
268821|NCT00943852|651270|P3|NOT COMPLETED|Washout Period After Period 3 Treatment||0
268822|NCT00943852|651271|P2|NOT COMPLETED|Washout Period After Period 3 Treatment||0
268823|NCT00943852|651272|P1|NOT COMPLETED|Washout Period After Period 3 Treatment||0
268824|NCT00943852|651263|P10|COMPLETED|Washout Period After Period 3 Treatment||1
268825|NCT00943852|651264|P9|COMPLETED|Washout Period After Period 3 Treatment||1
268826|NCT00943852|651265|P8|COMPLETED|Washout Period After Period 3 Treatment||1
268827|NCT00943852|651266|P7|COMPLETED|Washout Period After Period 3 Treatment||1
268828|NCT00943852|651267|P6|COMPLETED|Washout Period After Period 3 Treatment||0
268829|NCT00943852|651268|P5|COMPLETED|Washout Period After Period 3 Treatment||1
268830|NCT00943852|651269|P4|COMPLETED|Washout Period After Period 3 Treatment||1
268831|NCT00943852|651270|P3|COMPLETED|Washout Period After Period 3 Treatment||1
268832|NCT00943852|651271|P2|COMPLETED|Washout Period After Period 3 Treatment||1
268833|NCT00943852|651272|P1|COMPLETED|Washout Period After Period 3 Treatment||2
268834|NCT00943852|651263|P10|STARTED|Washout Period After Period 3 Treatment||1
268835|NCT00943852|651264|P9|STARTED|Washout Period After Period 3 Treatment||1
268836|NCT00943852|651265|P8|STARTED|Washout Period After Period 3 Treatment||1
268837|NCT00943852|651266|P7|STARTED|Washout Period After Period 3 Treatment||2
268838|NCT00943852|651267|P6|STARTED|Washout Period After Period 3 Treatment||0
268839|NCT00943852|651268|P5|STARTED|Washout Period After Period 3 Treatment||1
268840|NCT00943852|651269|P4|STARTED|Washout Period After Period 3 Treatment||1
268841|NCT00943852|651270|P3|STARTED|Washout Period After Period 3 Treatment||1
268842|NCT00943852|651271|P2|STARTED|Washout Period After Period 3 Treatment||1
268843|NCT00943852|651272|P1|STARTED|Washout Period After Period 3 Treatment||2
268844|NCT00943852|651263|P10|NOT COMPLETED|Third Period of Treatment Intervention||0
268845|NCT00943852|651264|P9|NOT COMPLETED|Third Period of Treatment Intervention||0
268846|NCT00943852|651265|P8|NOT COMPLETED|Third Period of Treatment Intervention||0
268847|NCT00943852|651266|P7|NOT COMPLETED|Third Period of Treatment Intervention||0
268848|NCT00943852|651267|P6|NOT COMPLETED|Third Period of Treatment Intervention||0
268849|NCT00943852|651268|P5|NOT COMPLETED|Third Period of Treatment Intervention||0
268850|NCT00943852|651269|P4|NOT COMPLETED|Third Period of Treatment Intervention||0
268851|NCT00943852|651270|P3|NOT COMPLETED|Third Period of Treatment Intervention||0
268852|NCT00943852|651271|P2|NOT COMPLETED|Third Period of Treatment Intervention||0
268853|NCT00943852|651272|P1|NOT COMPLETED|Third Period of Treatment Intervention||0
268854|NCT00943852|651263|P10|COMPLETED|Third Period of Treatment Intervention||1
268855|NCT00943852|651264|P9|COMPLETED|Third Period of Treatment Intervention||1
268856|NCT00943852|651265|P8|COMPLETED|Third Period of Treatment Intervention||1
268857|NCT00943852|651266|P7|COMPLETED|Third Period of Treatment Intervention||2
268858|NCT00943852|651267|P6|COMPLETED|Third Period of Treatment Intervention||0
268859|NCT00943852|651268|P5|COMPLETED|Third Period of Treatment Intervention||1
268860|NCT00943852|651269|P4|COMPLETED|Third Period of Treatment Intervention||1
268861|NCT00943852|651270|P3|COMPLETED|Third Period of Treatment Intervention||1
268862|NCT00943852|651271|P2|COMPLETED|Third Period of Treatment Intervention||1
268863|NCT00943852|651272|P1|COMPLETED|Third Period of Treatment Intervention||2
268864|NCT00943852|651263|P10|STARTED|Third Period of Treatment Intervention||1
268865|NCT00943852|651264|P9|STARTED|Third Period of Treatment Intervention||1
268866|NCT00943852|651265|P8|STARTED|Third Period of Treatment Intervention||1
268867|NCT00943852|651266|P7|STARTED|Third Period of Treatment Intervention||2
268868|NCT00943852|651267|P6|STARTED|Third Period of Treatment Intervention||0
268869|NCT00943852|651268|P5|STARTED|Third Period of Treatment Intervention||1
268870|NCT00943852|651269|P4|STARTED|Third Period of Treatment Intervention||1
268871|NCT00943852|651270|P3|STARTED|Third Period of Treatment Intervention||1
268872|NCT00943852|651271|P2|STARTED|Third Period of Treatment Intervention||1
268873|NCT00943852|651272|P1|STARTED|Third Period of Treatment Intervention||2
268874|NCT00943852|651263|P10|NOT COMPLETED|Washout Period After Period 2 Treatment||0
268875|NCT00943852|651264|P9|NOT COMPLETED|Washout Period After Period 2 Treatment||0
268876|NCT00943852|651265|P8|NOT COMPLETED|Washout Period After Period 2 Treatment||0
268877|NCT00943852|651266|P7|NOT COMPLETED|Washout Period After Period 2 Treatment||0
268878|NCT00943852|651267|P6|NOT COMPLETED|Washout Period After Period 2 Treatment||1
268879|NCT00943852|651268|P5|NOT COMPLETED|Washout Period After Period 2 Treatment||0
268880|NCT00943852|651269|P4|NOT COMPLETED|Washout Period After Period 2 Treatment||0
268881|NCT00943852|651270|P3|NOT COMPLETED|Washout Period After Period 2 Treatment||0
268882|NCT00943852|651271|P2|NOT COMPLETED|Washout Period After Period 2 Treatment||0
268883|NCT00943852|651272|P1|NOT COMPLETED|Washout Period After Period 2 Treatment||0
268884|NCT00943852|651263|P10|COMPLETED|Washout Period After Period 2 Treatment||1
268885|NCT00943852|651264|P9|COMPLETED|Washout Period After Period 2 Treatment||1
268886|NCT00943852|651265|P8|COMPLETED|Washout Period After Period 2 Treatment||1
268887|NCT00943852|651266|P7|COMPLETED|Washout Period After Period 2 Treatment||2
268888|NCT00943852|651267|P6|COMPLETED|Washout Period After Period 2 Treatment||0
268889|NCT00943852|651268|P5|COMPLETED|Washout Period After Period 2 Treatment||1
268890|NCT00943852|651269|P4|COMPLETED|Washout Period After Period 2 Treatment||1
268891|NCT00943852|651270|P3|COMPLETED|Washout Period After Period 2 Treatment||1
268892|NCT00943852|651271|P2|COMPLETED|Washout Period After Period 2 Treatment||1
268893|NCT00943852|651272|P1|COMPLETED|Washout Period After Period 2 Treatment||2
268894|NCT00943852|651263|P10|STARTED|Washout Period After Period 2 Treatment||1
268895|NCT00943852|651264|P9|STARTED|Washout Period After Period 2 Treatment||1
268896|NCT00943852|651265|P8|STARTED|Washout Period After Period 2 Treatment||1
268897|NCT00943852|651266|P7|STARTED|Washout Period After Period 2 Treatment||2
268898|NCT00943852|651267|P6|STARTED|Washout Period After Period 2 Treatment||1
268899|NCT00943852|651268|P5|STARTED|Washout Period After Period 2 Treatment||1
268900|NCT00943852|651269|P4|STARTED|Washout Period After Period 2 Treatment||1
268901|NCT00943852|651270|P3|STARTED|Washout Period After Period 2 Treatment||1
268902|NCT00943852|651271|P2|STARTED|Washout Period After Period 2 Treatment||1
268903|NCT00943852|651272|P1|STARTED|Washout Period After Period 2 Treatment||2
268904|NCT00943852|651263|P10|NOT COMPLETED|Second Period of Treatment Intervention||0
268905|NCT00943852|651264|P9|NOT COMPLETED|Second Period of Treatment Intervention||0
268906|NCT00943852|651265|P8|NOT COMPLETED|Second Period of Treatment Intervention||0
268907|NCT00943852|651266|P7|NOT COMPLETED|Second Period of Treatment Intervention||0
268908|NCT00943852|651267|P6|NOT COMPLETED|Second Period of Treatment Intervention||0
268909|NCT00943852|651268|P5|NOT COMPLETED|Second Period of Treatment Intervention||0
268910|NCT00943852|651269|P4|NOT COMPLETED|Second Period of Treatment Intervention||0
268911|NCT00943852|651270|P3|NOT COMPLETED|Second Period of Treatment Intervention||0
268912|NCT00943852|651271|P2|NOT COMPLETED|Second Period of Treatment Intervention||0
268913|NCT00943852|651272|P1|NOT COMPLETED|Second Period of Treatment Intervention||0
268914|NCT00943852|651263|P10|COMPLETED|Second Period of Treatment Intervention||1
268915|NCT00943852|651264|P9|COMPLETED|Second Period of Treatment Intervention||1
268916|NCT00943852|651265|P8|COMPLETED|Second Period of Treatment Intervention||1
268917|NCT00943852|651266|P7|COMPLETED|Second Period of Treatment Intervention||2
268918|NCT00943852|651267|P6|COMPLETED|Second Period of Treatment Intervention||1
268919|NCT00943852|651268|P5|COMPLETED|Second Period of Treatment Intervention||1
268920|NCT00943852|651269|P4|COMPLETED|Second Period of Treatment Intervention||1
268921|NCT00943852|651270|P3|COMPLETED|Second Period of Treatment Intervention||1
268922|NCT00943852|651271|P2|COMPLETED|Second Period of Treatment Intervention||1
268923|NCT00943852|651272|P1|COMPLETED|Second Period of Treatment Intervention||2
268924|NCT00943852|651263|P10|STARTED|Second Period of Treatment Intervention||1
268925|NCT00943852|651264|P9|STARTED|Second Period of Treatment Intervention||1
268926|NCT00943852|651265|P8|STARTED|Second Period of Treatment Intervention||1
268927|NCT00943852|651266|P7|STARTED|Second Period of Treatment Intervention||2
268928|NCT00943852|651267|P6|STARTED|Second Period of Treatment Intervention||1
268929|NCT00943852|651268|P5|STARTED|Second Period of Treatment Intervention||1
268930|NCT00943852|651269|P4|STARTED|Second Period of Treatment Intervention||1
268931|NCT00943852|651270|P3|STARTED|Second Period of Treatment Intervention||1
268932|NCT00943852|651271|P2|STARTED|Second Period of Treatment Intervention||1
268933|NCT00943852|651272|P1|STARTED|Second Period of Treatment Intervention||2
268934|NCT00943852|651263|P10|NOT COMPLETED|Washout Period After Period 1 Treatment||0
268935|NCT00943852|651264|P9|NOT COMPLETED|Washout Period After Period 1 Treatment||0
268936|NCT00943852|651265|P8|NOT COMPLETED|Washout Period After Period 1 Treatment||0
268937|NCT00943852|651266|P7|NOT COMPLETED|Washout Period After Period 1 Treatment||0
268938|NCT00943852|651267|P6|NOT COMPLETED|Washout Period After Period 1 Treatment||0
268939|NCT00943852|651268|P5|NOT COMPLETED|Washout Period After Period 1 Treatment||0
268940|NCT00943852|651269|P4|NOT COMPLETED|Washout Period After Period 1 Treatment||1
268941|NCT00943852|651270|P3|NOT COMPLETED|Washout Period After Period 1 Treatment||0
268942|NCT00943852|651271|P2|NOT COMPLETED|Washout Period After Period 1 Treatment||0
268943|NCT00943852|651272|P1|NOT COMPLETED|Washout Period After Period 1 Treatment||0
268944|NCT00943852|651263|P10|COMPLETED|Washout Period After Period 1 Treatment||1
268945|NCT00943852|651264|P9|COMPLETED|Washout Period After Period 1 Treatment||1
268946|NCT00943852|651265|P8|COMPLETED|Washout Period After Period 1 Treatment||1
268947|NCT00943852|651266|P7|COMPLETED|Washout Period After Period 1 Treatment||2
268948|NCT00943852|651267|P6|COMPLETED|Washout Period After Period 1 Treatment||1
268949|NCT00943852|651268|P5|COMPLETED|Washout Period After Period 1 Treatment||1
268950|NCT00943852|651269|P4|COMPLETED|Washout Period After Period 1 Treatment||1
268951|NCT00943852|651270|P3|COMPLETED|Washout Period After Period 1 Treatment||1
268952|NCT00943852|651271|P2|COMPLETED|Washout Period After Period 1 Treatment||1
268953|NCT00943852|651272|P1|COMPLETED|Washout Period After Period 1 Treatment||2
268954|NCT00943852|651263|P10|STARTED|Washout Period After Period 1 Treatment||1
268955|NCT00943852|651264|P9|STARTED|Washout Period After Period 1 Treatment||1
268956|NCT00943852|651265|P8|STARTED|Washout Period After Period 1 Treatment||1
268957|NCT00943852|651266|P7|STARTED|Washout Period After Period 1 Treatment||2
268958|NCT00943852|651267|P6|STARTED|Washout Period After Period 1 Treatment||1
268959|NCT00943852|651268|P5|STARTED|Washout Period After Period 1 Treatment||1
268960|NCT00943852|651269|P4|STARTED|Washout Period After Period 1 Treatment||2
268961|NCT00943852|651270|P3|STARTED|Washout Period After Period 1 Treatment||1
268962|NCT00943852|651271|P2|STARTED|Washout Period After Period 1 Treatment||1
268963|NCT00943852|651272|P1|STARTED|Washout Period After Period 1 Treatment||2
268964|NCT00943852|651263|P10|NOT COMPLETED|First Period of Treatment Intervention||0
268965|NCT00943852|651264|P9|NOT COMPLETED|First Period of Treatment Intervention||0
268966|NCT00943852|651265|P8|NOT COMPLETED|First Period of Treatment Intervention||0
268967|NCT00943852|651266|P7|NOT COMPLETED|First Period of Treatment Intervention||0
268968|NCT00943852|651267|P6|NOT COMPLETED|First Period of Treatment Intervention||0
268969|NCT00943852|651268|P5|NOT COMPLETED|First Period of Treatment Intervention||0
268970|NCT00943852|651269|P4|NOT COMPLETED|First Period of Treatment Intervention||0
268971|NCT00943852|651270|P3|NOT COMPLETED|First Period of Treatment Intervention||0
268972|NCT00943852|651271|P2|NOT COMPLETED|First Period of Treatment Intervention||0
268973|NCT00943852|651272|P1|NOT COMPLETED|First Period of Treatment Intervention||0
268974|NCT00943852|651263|P10|COMPLETED|First Period of Treatment Intervention||1
268975|NCT00943852|651264|P9|COMPLETED|First Period of Treatment Intervention||1
268976|NCT00943852|651265|P8|COMPLETED|First Period of Treatment Intervention||1
268977|NCT00943852|651266|P7|COMPLETED|First Period of Treatment Intervention||2
268978|NCT00943852|651267|P6|COMPLETED|First Period of Treatment Intervention||1
268979|NCT00943852|651268|P5|COMPLETED|First Period of Treatment Intervention||1
268980|NCT00943852|651269|P4|COMPLETED|First Period of Treatment Intervention||2
268981|NCT00943852|651270|P3|COMPLETED|First Period of Treatment Intervention||1
268982|NCT00943852|651271|P2|COMPLETED|First Period of Treatment Intervention||1
268983|NCT00943852|651272|P1|COMPLETED|First Period of Treatment Intervention||2
268984|NCT00943852|651263|P10|STARTED|First Period of Treatment Intervention||1
268985|NCT00943852|651264|P9|STARTED|First Period of Treatment Intervention||1
268986|NCT00943852|651265|P8|STARTED|First Period of Treatment Intervention||1
268987|NCT00943852|651266|P7|STARTED|First Period of Treatment Intervention||2
268988|NCT00943852|651267|P6|STARTED|First Period of Treatment Intervention||1
268989|NCT00943852|651268|P5|STARTED|First Period of Treatment Intervention||1
268990|NCT00943852|651269|P4|STARTED|First Period of Treatment Intervention||2
268991|NCT00943852|651270|P3|STARTED|First Period of Treatment Intervention||1
268992|NCT00943852|651271|P2|STARTED|First Period of Treatment Intervention||1
268993|NCT00943852|651272|P1|STARTED|First Period of Treatment Intervention||2
268994|NCT00943826|651285|P2|NOT COMPLETED|After Primary Overall Survival Analysis||20
268995|NCT00943826|651286|P1|NOT COMPLETED|After Primary Overall Survival Analysis||27
268996|NCT00943826|651285|P2|COMPLETED|After Primary Overall Survival Analysis||0
268997|NCT00943826|651286|P1|COMPLETED|After Primary Overall Survival Analysis||0
268998|NCT00943826|651285|P2|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|20
268999|NCT00943826|651286|P1|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|27
269000|NCT00943826|651285|P2|NOT COMPLETED|Monotherapy Phase||16
269001|NCT00943826|651286|P1|NOT COMPLETED|Monotherapy Phase||65
269002|NCT00943826|651285|P2|COMPLETED|Monotherapy Phase||143
269003|NCT00943826|651286|P1|COMPLETED|Monotherapy Phase||204
269004|NCT00943826|651285|P2|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|159
269005|NCT00943826|651286|P1|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|269
269006|NCT00943826|651285|P2|NOT COMPLETED|Maintenance Phase||39
269007|NCT00943826|651286|P1|NOT COMPLETED|Maintenance Phase||43
269008|NCT00943826|651285|P2|COMPLETED|Maintenance Phase||331
269009|NCT00943826|651286|P1|COMPLETED|Maintenance Phase||353
269010|NCT00943826|651285|P2|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|370
269011|NCT00943826|651286|P1|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|396
269012|NCT00943826|651285|P2|NOT COMPLETED|Concurrent Phase||42
269013|NCT00943826|651286|P1|NOT COMPLETED|Concurrent Phase||61
269014|NCT00943826|651285|P2|COMPLETED|Concurrent Phase||421
269015|NCT00943826|651286|P1|COMPLETED|Concurrent Phase||397
269016|NCT00943826|651285|P2|Treated|Concurrent Phase||459
269017|NCT00943826|651286|P1|Treated|Concurrent Phase||452
269018|NCT00943826|651285|P2|STARTED|Concurrent Phase||463
269019|NCT00943826|651286|P1|STARTED|Concurrent Phase||458
269020|NCT00943787|651304|P1|NOT COMPLETED|Overall Study||7
269021|NCT00943787|651304|P1|COMPLETED|Overall Study||34
269022|NCT00943787|651304|P1|STARTED|Overall Study||41
269023|NCT00943761|651311|P2|NOT COMPLETED|Overall Study||1
269024|NCT00943761|651312|P1|NOT COMPLETED|Overall Study||4
269025|NCT00943761|651311|P2|COMPLETED|Overall Study||23
269026|NCT00943761|651312|P1|COMPLETED|Overall Study||17
269027|NCT00943761|651311|P2|STARTED|Overall Study||24
269028|NCT00943761|651312|P1|STARTED|Overall Study||21
269029|NCT00943735|651324|P1|NOT COMPLETED|Overall Study||32
269030|NCT00943735|651324|P1|COMPLETED|Overall Study||742
269031|NCT00943735|651324|P1|Per Protocol Population|Overall Study||500
269032|NCT00943735|651324|P1|STARTED|Overall Study||774
269033|NCT00943722|651362|P5|NOT COMPLETED|Overall Study||22
269034|NCT00943722|651363|P4|NOT COMPLETED|Overall Study||22
269035|NCT00943722|651364|P3|NOT COMPLETED|Overall Study||13
269036|NCT00943722|651365|P2|NOT COMPLETED|Overall Study||22
269037|NCT00943722|651366|P1|NOT COMPLETED|Overall Study||25
269038|NCT00943722|651362|P5|COMPLETED|Overall Study|Includes 4 participants for whom completion status is unknown|448
269039|NCT00943722|651363|P4|COMPLETED|Overall Study||647
269040|NCT00943722|651364|P3|COMPLETED|Overall Study||631
269041|NCT00943722|651365|P2|COMPLETED|Overall Study||621
269042|NCT00943722|651366|P1|COMPLETED|Overall Study||623
269043|NCT00943722|651362|P5|Vaccination 3|Overall Study||455
269044|NCT00943722|651363|P4|Vaccination 3|Overall Study||653
269045|NCT00943722|651364|P3|Vaccination 3|Overall Study||637
269046|NCT00943722|651365|P2|Vaccination 3|Overall Study||627
269047|NCT00943722|651366|P1|Vaccination 3|Overall Study||635
269048|NCT00943722|651362|P5|Vaccination 2|Overall Study||462
269049|NCT00943722|651363|P4|Vaccination 2|Overall Study||658
269050|NCT00943722|651364|P3|Vaccination 2|Overall Study||638
269051|NCT00943722|651365|P2|Vaccination 2|Overall Study||633
269052|NCT00943722|651366|P1|Vaccination 2|Overall Study||637
269053|NCT00943722|651362|P5|Vaccination 1|Overall Study||468
269054|NCT00943722|651363|P4|Vaccination 1|Overall Study||666
269055|NCT00943722|651364|P3|Vaccination 1|Overall Study||644
269056|NCT00943722|651365|P2|Vaccination 1|Overall Study||642
269057|NCT00943722|651366|P1|Vaccination 1|Overall Study||646
269058|NCT00943722|651362|P5|STARTED|Overall Study||470
269059|NCT00943722|651363|P4|STARTED|Overall Study||669
269060|NCT00943722|651364|P3|STARTED|Overall Study||644
269061|NCT00943722|651365|P2|STARTED|Overall Study||643
269062|NCT00943722|651366|P1|STARTED|Overall Study||648
269063|NCT00943683|651396|P2|NOT COMPLETED|Overall Study||6
269064|NCT00943683|651397|P1|NOT COMPLETED|Overall Study||7
269065|NCT00943683|651396|P2|COMPLETED|Overall Study||169
269066|NCT00943683|651397|P1|COMPLETED|Overall Study||74
269067|NCT00943683|651396|P2|STARTED|Overall Study||175
269068|NCT00943683|651397|P1|STARTED|Overall Study||81
269069|NCT00943670|651403|P1|NOT COMPLETED|Trastuzumab Emtansine + Pertuzumab||18
269070|NCT00943670|651403|P1|COMPLETED|Trastuzumab Emtansine + Pertuzumab|Completed treatment defined as receiving a total of 17 cycles of therapy in both treatment periods.|2
269071|NCT00943670|651403|P1|STARTED|Trastuzumab Emtansine + Pertuzumab|Patients with early progressive disease who elected to receive T-DM1 and pertuzumab.|20
269072|NCT00943670|651403|P1|NOT COMPLETED|Single-agent Trastuzumab Emtansine||42
269073|NCT00943670|651403|P1|COMPLETED|Single-agent Trastuzumab Emtansine|Completed single-agent treatment defined as receiving 17 cycles of trastuzumab emtansine therapy.|9
269074|NCT00943670|651403|P1|Treated|Single-agent Trastuzumab Emtansine||51
269075|NCT00943670|651403|P1|STARTED|Single-agent Trastuzumab Emtansine||51
269076|NCT00943631|651439|P2|NOT COMPLETED|Overall Study||2
269077|NCT00943631|651440|P1|NOT COMPLETED|Overall Study||4
269078|NCT00943631|651439|P2|COMPLETED|Overall Study||202
269079|NCT00943631|651440|P1|COMPLETED|Overall Study||198
269080|NCT00943631|651439|P2|STARTED|Overall Study||204
269081|NCT00943631|651440|P1|STARTED|Overall Study||202
269082|NCT00943605|651492|P2|NOT COMPLETED|Overall Study||30
269083|NCT00943605|651493|P1|NOT COMPLETED|Overall Study||30
269084|NCT00943605|651492|P2|COMPLETED|Overall Study||0
269085|NCT00943605|651493|P1|COMPLETED|Overall Study||0
269086|NCT00943605|651492|P2|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
269087|NCT00943605|651493|P1|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
269088|NCT00943592|651503|P1|NOT COMPLETED|Overall Study||3
269089|NCT00943592|651503|P1|COMPLETED|Overall Study|None of the three deaths were attributed to the conditioning regimen|79
269090|NCT00943592|651503|P1|Maximum Tolerated Dose|Overall Study|74 patients received the Maximum Tolerated Dose|74
269091|NCT00943592|651503|P1|STARTED|Overall Study||82
269092|NCT00943579|651516|P2|NOT COMPLETED|Overall Study||5
269093|NCT00943579|651517|P1|NOT COMPLETED|Overall Study||6
269094|NCT00943579|651516|P2|COMPLETED|Overall Study||15
269095|NCT00943579|651517|P1|COMPLETED|Overall Study||15
269096|NCT00943579|651516|P2|STARTED|Overall Study||20
269097|NCT00943579|651517|P1|STARTED|Overall Study||21
269098|NCT00943488|651538|P2|NOT COMPLETED|Overall Study||2
269099|NCT00943488|651539|P1|NOT COMPLETED|Overall Study||1
269100|NCT00943488|651538|P2|COMPLETED|Overall Study||202
269101|NCT00943488|651539|P1|COMPLETED|Overall Study||203
269102|NCT00943488|651538|P2|STARTED|Overall Study||204
269103|NCT00943488|651539|P1|STARTED|Overall Study||204
269104|NCT00943436|651595|P2|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
269105|NCT00943436|651596|P1|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
269106|NCT00943436|651595|P2|COMPLETED|Rest Session: 45 Minutes of Reading||10
269107|NCT00943436|651596|P1|COMPLETED|Rest Session: 45 Minutes of Reading||10
269108|NCT00943436|651595|P2|STARTED|Rest Session: 45 Minutes of Reading||10
269109|NCT00943436|651596|P1|STARTED|Rest Session: 45 Minutes of Reading||10
269110|NCT00943436|651595|P2|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
269111|NCT00943436|651596|P1|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
269112|NCT00943436|651595|P2|COMPLETED|Exercise Session: 45 Minutes of Activity||10
269113|NCT00943436|651596|P1|COMPLETED|Exercise Session: 45 Minutes of Activity||10
269114|NCT00943436|651595|P2|STARTED|Exercise Session: 45 Minutes of Activity||10
269115|NCT00943436|651596|P1|STARTED|Exercise Session: 45 Minutes of Activity||10
269116|NCT00943397|651618|P2|NOT COMPLETED|Overall Study||72
269117|NCT00943397|651619|P1|NOT COMPLETED|Overall Study||15
269118|NCT00943397|651618|P2|COMPLETED|Overall Study|Site terminated - Merck administrative decision (52); Patient moved (1); Discontinued for other (3)|86
269119|NCT00943397|651619|P1|COMPLETED|Overall Study|Site terminated - Merck administrative decision (11); Discontinued for other (1)|17
269120|NCT00943397|651618|P2|STARTED|Overall Study||158
269121|NCT00943397|651619|P1|STARTED|Overall Study||32
269122|NCT00943384|651625|P1|NOT COMPLETED|Overall Study||49
269123|NCT00943384|651625|P1|COMPLETED|Overall Study|evaluated at the Month 24 visit with complete or partial data|55
269124|NCT00943384|651625|P1|Treated on Protocol|Overall Study|5 subjects were treated off protocol due to intraoperative decisions made by the surgeon|76
269125|NCT00943384|651625|P1|Treated|Overall Study|81 subjects were eligible and willing to participate in the study and were treated|81
269126|NCT00943384|651625|P1|STARTED|Overall Study|104 subjects consented and underwent additional screening to determine eligibility to participate|104
269127|NCT00943319|651639|P1|NOT COMPLETED|Overall Study||1
269128|NCT00943319|651639|P1|COMPLETED|Overall Study||49
269129|NCT00943319|651639|P1|STARTED|Overall Study||50
269130|NCT00943306|651645|P1|NOT COMPLETED|Overall Study||3
269131|NCT00943306|651645|P1|COMPLETED|Overall Study||16
269132|NCT00943306|651645|P1|STARTED|Overall Study||19
269133|NCT00943202|651706|P4|NOT COMPLETED|Overall Study||1
269134|NCT00943202|651707|P3|NOT COMPLETED|Overall Study||0
269135|NCT00943202|651708|P2|NOT COMPLETED|Overall Study||2
269136|NCT00943202|651709|P1|NOT COMPLETED|Overall Study||1
269137|NCT00943202|651706|P4|COMPLETED|Overall Study||131
269138|NCT00943202|651707|P3|COMPLETED|Overall Study||133
269139|NCT00943202|651708|P2|COMPLETED|Overall Study||131
269140|NCT00943202|651709|P1|COMPLETED|Overall Study||132
269141|NCT00943202|651706|P4|STARTED|Overall Study||132
269142|NCT00943202|651707|P3|STARTED|Overall Study||133
269143|NCT00943202|651708|P2|STARTED|Overall Study||133
269144|NCT00943202|651709|P1|STARTED|Overall Study||133
269145|NCT00943150|651925|P2|NOT COMPLETED|Overall Study||0
269146|NCT00943150|651926|P1|NOT COMPLETED|Overall Study||0
269147|NCT00943150|651925|P2|COMPLETED|Overall Study||10
269148|NCT00943150|651926|P1|COMPLETED|Overall Study||10
269149|NCT00943150|651925|P2|STARTED|Overall Study||10
269150|NCT00943150|651926|P1|STARTED|Overall Study||10
269151|NCT00943124|651947|P2|NOT COMPLETED|Period 2||0
269152|NCT00943124|651948|P1|NOT COMPLETED|Period 2||0
269153|NCT00943124|651947|P2|COMPLETED|Period 2||108
269154|NCT00943124|651948|P1|COMPLETED|Period 2||108
269155|NCT00943124|651947|P2|STARTED|Period 2||108
269156|NCT00943124|651948|P1|STARTED|Period 2||108
269157|NCT00943124|651947|P2|NOT COMPLETED|Period 1||2
269158|NCT00943124|651948|P1|NOT COMPLETED|Period 1||2
269159|NCT00943124|651947|P2|COMPLETED|Period 1||108
269160|NCT00943124|651948|P1|COMPLETED|Period 1||108
269161|NCT00943124|651947|P2|STARTED|Period 1||110
269162|NCT00943124|651948|P1|STARTED|Period 1||110
269163|NCT00943111|651970|P3|NOT COMPLETED|5 Years Long-term Treatment Period||75
269164|NCT00943111|651971|P2|NOT COMPLETED|5 Years Long-term Treatment Period||0
269165|NCT00943111|651972|P1|NOT COMPLETED|5 Years Long-term Treatment Period||0
269166|NCT00943111|651970|P3|COMPLETED|5 Years Long-term Treatment Period||77
269167|NCT00943111|651971|P2|COMPLETED|5 Years Long-term Treatment Period||0
269168|NCT00943111|651972|P1|COMPLETED|5 Years Long-term Treatment Period||0
269169|NCT00943111|651970|P3|STARTED|5 Years Long-term Treatment Period|Participants from both the arms of PAP who completed PAP and remained on-study|152
269170|NCT00943111|651971|P2|STARTED|5 Years Long-term Treatment Period||0
269171|NCT00943111|651972|P1|STARTED|5 Years Long-term Treatment Period||0
269172|NCT00943111|651970|P3|NOT COMPLETED|52-Weeks Primary Analysis Period||0
269173|NCT00943111|651971|P2|NOT COMPLETED|52-Weeks Primary Analysis Period||2
269174|NCT00943111|651972|P1|NOT COMPLETED|52-Weeks Primary Analysis Period||2
269175|NCT00943111|651970|P3|COMPLETED|52-Weeks Primary Analysis Period||0
269176|NCT00943111|651971|P2|COMPLETED|52-Weeks Primary Analysis Period||52
269177|NCT00943111|651972|P1|COMPLETED|52-Weeks Primary Analysis Period||104
269178|NCT00943111|651970|P3|Treated|52-Weeks Primary Analysis Period||0
269179|NCT00943111|651971|P2|Treated|52-Weeks Primary Analysis Period||53
269180|NCT00943111|651972|P1|Treated|52-Weeks Primary Analysis Period||106
269181|NCT00943111|651970|P3|STARTED|52-Weeks Primary Analysis Period||0
269182|NCT00943111|651971|P2|STARTED|52-Weeks Primary Analysis Period||54
269183|NCT00943111|651972|P1|STARTED|52-Weeks Primary Analysis Period||106
269184|NCT00943098|652005|P2|NOT COMPLETED|Overall Study||0
269185|NCT00943098|652006|P1|NOT COMPLETED|Overall Study||0
269186|NCT00943098|652005|P2|COMPLETED|Overall Study||72
269187|NCT00943098|652006|P1|COMPLETED|Overall Study||70
269188|NCT00943098|652005|P2|STARTED|Overall Study|1 patient was excluded from the ITT and therefore the baseline population is 71|72
269189|NCT00943098|652006|P1|STARTED|Overall Study||70
269190|NCT00943072|652040|P2|NOT COMPLETED|Overall Study||14
269191|NCT00943072|652041|P1|NOT COMPLETED|Overall Study||5
269192|NCT00943072|652040|P2|COMPLETED|Overall Study|60 Participants completed Week 24, From FAS; 50 Participants completed up to Week 100, From SAF|60
269193|NCT00943072|652041|P1|COMPLETED|Overall Study|110 Participants completed Week 24, From FAS; 102 Participants completed up to Week 100, From SAF|110
269194|NCT00943072|652040|P2|Full Analysis Set (FAS) Population|Overall Study||73
269195|NCT00943072|652041|P1|Full Analysis Set (FAS) Population|Overall Study|FAS population used for analysis of Primary and Secondary Outcome Measures|114
269196|NCT00943072|652040|P2|Participants Received Treatment|Overall Study||74
269197|NCT00943072|652041|P1|Participants Received Treatment|Overall Study|Safety population (SAF)|114
269198|NCT00943072|652040|P2|STARTED|Overall Study||74
269199|NCT00943072|652041|P1|STARTED|Overall Study||115
269200|NCT00942994|652059|P2|NOT COMPLETED|Overall Study||19
269201|NCT00942994|652060|P1|NOT COMPLETED|Overall Study||16
269202|NCT00942994|652059|P2|COMPLETED|Overall Study||190
269203|NCT00942994|652060|P1|COMPLETED|Overall Study||187
269204|NCT00942994|652059|P2|STARTED|Overall Study||209
269205|NCT00942994|652060|P1|STARTED|Overall Study||203
269206|NCT00942968|652076|P1|NOT COMPLETED|Overall Study||229
269207|NCT00942968|652076|P1|COMPLETED|Overall Study||109
269208|NCT00942968|652076|P1|Treated|Overall Study||334
269209|NCT00942968|652076|P1|STARTED|Overall Study||338
269210|NCT00942903|652097|P1|NOT COMPLETED|Overall Study||0
269211|NCT00942903|652097|P1|COMPLETED|Overall Study||20
269212|NCT00942903|652097|P1|STARTED|Overall Study||20
269213|NCT00942890|652104|P2|NOT COMPLETED|Overall Study||0
269214|NCT00942890|652105|P1|NOT COMPLETED|Overall Study||0
269215|NCT00942890|652104|P2|COMPLETED|Overall Study||23
269216|NCT00942890|652105|P1|COMPLETED|Overall Study||21
269217|NCT00942890|652104|P2|STARTED|Overall Study||23
269218|NCT00942890|652105|P1|STARTED|Overall Study||21
269219|NCT00942851|652127|P2|NOT COMPLETED|Overall Study||1
269220|NCT00942851|652128|P1|NOT COMPLETED|Overall Study||0
269221|NCT00942851|652127|P2|COMPLETED|Overall Study||11
269222|NCT00942851|652128|P1|COMPLETED|Overall Study||12
269223|NCT00942851|652127|P2|STARTED|Overall Study||12
269224|NCT00942851|652128|P1|STARTED|Overall Study||12
269225|NCT00942825|652140|P2|NOT COMPLETED|Overall Study||0
269226|NCT00942825|652141|P1|NOT COMPLETED|Overall Study||0
269227|NCT00942825|652140|P2|COMPLETED|Overall Study||98
269228|NCT00942825|652141|P1|COMPLETED|Overall Study||97
269229|NCT00942825|652140|P2|STARTED|Overall Study||98
269230|NCT00942825|652141|P1|STARTED|Overall Study||97
269231|NCT00942786|652147|P1|NOT COMPLETED|Overall Study||0
269232|NCT00942786|652147|P1|COMPLETED|Overall Study|date of last follow-up|297
269233|NCT00942786|652147|P1|STARTED|Overall Study||297
269234|NCT00942734|652154|P1|NOT COMPLETED|Overall Study||8
269235|NCT00942734|652154|P1|COMPLETED|Overall Study||35
269236|NCT00942734|652154|P1|STARTED|Overall Study||43
269237|NCT00942708|652158|P1|NOT COMPLETED|Overall Study||1
269238|NCT00942708|652158|P1|COMPLETED|Overall Study||5
269239|NCT00942708|652158|P1|STARTED|Overall Study||6
269240|NCT00942604|652166|P2|NOT COMPLETED|Overall Study||4
269241|NCT00942604|652167|P1|NOT COMPLETED|Overall Study||2
269242|NCT00942604|652166|P2|COMPLETED|Overall Study||99
269243|NCT00942604|652167|P1|COMPLETED|Overall Study||98
269244|NCT00942604|652166|P2|STARTED|Overall Study||103
269245|NCT00942604|652167|P1|STARTED|Overall Study||100
269246|NCT00942578|652178|P3|NOT COMPLETED|Expansion Phase||0
269247|NCT00942578|652179|P2|NOT COMPLETED|Expansion Phase||0
269248|NCT00942578|652180|P1|NOT COMPLETED|Expansion Phase||0
269249|NCT00942578|652178|P3|COMPLETED|Expansion Phase||43
269250|NCT00942578|652179|P2|COMPLETED|Expansion Phase||0
269251|NCT00942578|652180|P1|COMPLETED|Expansion Phase||11
269252|NCT00942578|652178|P3|STARTED|Expansion Phase||43
269253|NCT00942578|652179|P2|STARTED|Expansion Phase||0
269254|NCT00942578|652180|P1|STARTED|Expansion Phase||11
269255|NCT00942578|652178|P3|NOT COMPLETED|Dose Escalation Phase||0
269256|NCT00942578|652179|P2|NOT COMPLETED|Dose Escalation Phase||0
269257|NCT00942578|652180|P1|NOT COMPLETED|Dose Escalation Phase||0
269258|NCT00942578|652178|P3|COMPLETED|Dose Escalation Phase||3
269259|NCT00942578|652179|P2|COMPLETED|Dose Escalation Phase||3
269260|NCT00942578|652180|P1|COMPLETED|Dose Escalation Phase||3
269261|NCT00942578|652178|P3|STARTED|Dose Escalation Phase||3
269262|NCT00942578|652179|P2|STARTED|Dose Escalation Phase||3
269263|NCT00942578|652180|P1|STARTED|Dose Escalation Phase||3
269264|NCT00942448|652210|P4|NOT COMPLETED|Overall Study||0
269265|NCT00942448|652211|P3|NOT COMPLETED|Overall Study||0
269266|NCT00942448|652212|P2|NOT COMPLETED|Overall Study||0
269267|NCT00942448|652213|P1|NOT COMPLETED|Overall Study||0
269268|NCT00942448|652210|P4|COMPLETED|Overall Study||75
269269|NCT00942448|652211|P3|COMPLETED|Overall Study||78
269270|NCT00942448|652212|P2|COMPLETED|Overall Study||76
269271|NCT00942448|652213|P1|COMPLETED|Overall Study||77
269272|NCT00942448|652210|P4|STARTED|Overall Study||75
269273|NCT00942448|652211|P3|STARTED|Overall Study||78
269274|NCT00942448|652212|P2|STARTED|Overall Study||76
269275|NCT00942448|652213|P1|STARTED|Overall Study||77
269276|NCT00942422|652275|P1|NOT COMPLETED|Overall Study||3
269277|NCT00942422|652275|P1|COMPLETED|Overall Study||5
269278|NCT00942422|652275|P1|STARTED|Overall Study||8
269279|NCT00942409|652279|P1|NOT COMPLETED|Overall Study||3
269280|NCT00942409|652279|P1|COMPLETED|Overall Study||2
269281|NCT00942409|652279|P1|STARTED|Overall Study||5
269282|NCT00942357|652285|P2|NOT COMPLETED|Overall Study||40
269283|NCT00942357|652286|P1|NOT COMPLETED|Overall Study||37
269284|NCT00942357|652285|P2|COMPLETED|Overall Study||366
269285|NCT00942357|652286|P1|COMPLETED|Overall Study||370
269286|NCT00942357|652285|P2|STARTED|Overall Study||406
269287|NCT00942357|652286|P1|STARTED|Overall Study||407
269288|NCT00942266|652302|P2|NOT COMPLETED|Overall Study||15
269289|NCT00942266|652303|P1|NOT COMPLETED|Overall Study||43
269290|NCT00942266|652302|P2|COMPLETED|Overall Study||0
269291|NCT00942266|652303|P1|COMPLETED|Overall Study||0
269292|NCT00942266|652302|P2|STARTED|Overall Study||15
269293|NCT00942266|652303|P1|STARTED|Overall Study||43
269294|NCT00942188|652325|P4|NOT COMPLETED|Overall Study||4
269295|NCT00942188|652326|P3|NOT COMPLETED|Overall Study||9
269296|NCT00942188|652327|P2|NOT COMPLETED|Overall Study||10
269297|NCT00942188|652328|P1|NOT COMPLETED|Overall Study||4
269298|NCT00942188|652325|P4|COMPLETED|Overall Study||23
269299|NCT00942188|652326|P3|COMPLETED|Overall Study||18
269300|NCT00942188|652327|P2|COMPLETED|Overall Study||16
269301|NCT00942188|652328|P1|COMPLETED|Overall Study||22
269302|NCT00942188|652325|P4|STARTED|Overall Study||27
269303|NCT00942188|652326|P3|STARTED|Overall Study||27
269304|NCT00942188|652327|P2|STARTED|Overall Study||26
269305|NCT00942188|652328|P1|STARTED|Overall Study||26
269306|NCT00942175|652367|P4|NOT COMPLETED|Overall Study||2
269307|NCT00942175|652368|P3|NOT COMPLETED|Overall Study||2
269308|NCT00942175|652369|P2|NOT COMPLETED|Overall Study||4
269309|NCT00942175|652370|P1|NOT COMPLETED|Overall Study||2
269310|NCT00942175|652367|P4|COMPLETED|Overall Study||38
269311|NCT00942175|652368|P3|COMPLETED|Overall Study||38
269312|NCT00942175|652369|P2|COMPLETED|Overall Study||36
269313|NCT00942175|652370|P1|COMPLETED|Overall Study||38
269314|NCT00942175|652367|P4|STARTED|Overall Study||40
269315|NCT00942175|652368|P3|STARTED|Overall Study||40
269316|NCT00942175|652369|P2|STARTED|Overall Study||40
269317|NCT00942175|652370|P1|STARTED|Overall Study||40
269318|NCT00942162|652423|P3|NOT COMPLETED|Overall Study||1
269319|NCT00942162|652424|P2|NOT COMPLETED|Overall Study||47
269320|NCT00942162|652425|P1|NOT COMPLETED|Overall Study||68
269321|NCT00942162|652423|P3|COMPLETED|Overall Study||1
269322|NCT00942162|652424|P2|COMPLETED|Overall Study||3
269323|NCT00942162|652425|P1|COMPLETED|Overall Study||3
269324|NCT00942162|652423|P3|STARTED|Overall Study||2
269325|NCT00942162|652424|P2|STARTED|Overall Study||50
269326|NCT00942162|652425|P1|STARTED|Overall Study||71
269327|NCT00942149|652490|P1|NOT COMPLETED|Overall Study||0
269328|NCT00942149|652490|P1|COMPLETED|Overall Study||20
269329|NCT00942149|652490|P1|STARTED|Overall Study||20
269330|NCT00942084|652494|P1|NOT COMPLETED|Overall Study||2
269331|NCT00942084|652494|P1|COMPLETED|Overall Study|There were 2 infant deaths. None determined to be related to study drug.|30
269332|NCT00942084|652494|P1|STARTED|Overall Study||32
269333|NCT00941993|652503|P1|NOT COMPLETED|Overall Study||0
269334|NCT00941993|652503|P1|COMPLETED|Overall Study||109
269335|NCT00941993|652503|P1|STARTED|Overall Study||109
269336|NCT00941928|652511|P1|NOT COMPLETED|Overall Study||2
269337|NCT00941928|652511|P1|COMPLETED|Overall Study||0
269338|NCT00941928|652511|P1|STARTED|Overall Study||2
269339|NCT00941889|652517|P2|NOT COMPLETED|Overall Study||12
269340|NCT00941889|652518|P1|NOT COMPLETED|Overall Study||12
269341|NCT00941889|652517|P2|COMPLETED|Overall Study||3
269342|NCT00941889|652518|P1|COMPLETED|Overall Study||5
269343|NCT00941889|652517|P2|STARTED|Overall Study||15
269344|NCT00941889|652518|P1|STARTED|Overall Study||17
269345|NCT00941863|652529|P5|NOT COMPLETED|Continued After PCD||19
269346|NCT00941863|652530|P4|NOT COMPLETED|Continued After PCD||0
269347|NCT00941863|652531|P3|NOT COMPLETED|Continued After PCD||0
269348|NCT00941863|652532|P2|NOT COMPLETED|Continued After PCD||0
269349|NCT00941863|652533|P1|NOT COMPLETED|Continued After PCD||0
269350|NCT00941863|652529|P5|COMPLETED|Continued After PCD||6
269351|NCT00941863|652530|P4|COMPLETED|Continued After PCD||0
269352|NCT00941863|652531|P3|COMPLETED|Continued After PCD||0
269353|NCT00941863|652532|P2|COMPLETED|Continued After PCD||0
269354|NCT00941863|652533|P1|COMPLETED|Continued After PCD||0
269355|NCT00941863|652529|P5|STARTED|Continued After PCD|25 of 119 participants from the Expansion Phase, were still on the treatment as of 31 May 2005.|25
269356|NCT00941863|652530|P4|STARTED|Continued After PCD||0
269357|NCT00941863|652531|P3|STARTED|Continued After PCD||0
269358|NCT00941863|652532|P2|STARTED|Continued After PCD||0
269359|NCT00941863|652533|P1|STARTED|Continued After PCD||0
269360|NCT00941863|652529|P5|NOT COMPLETED|Until Primary Completion Date (PCD)||94
269361|NCT00941863|652530|P4|NOT COMPLETED|Until Primary Completion Date (PCD)||17
269362|NCT00941863|652531|P3|NOT COMPLETED|Until Primary Completion Date (PCD)||12
269363|NCT00941863|652532|P2|NOT COMPLETED|Until Primary Completion Date (PCD)||3
269364|NCT00941863|652533|P1|NOT COMPLETED|Until Primary Completion Date (PCD)||7
269365|NCT00941863|652529|P5|COMPLETED|Until Primary Completion Date (PCD)||25
269366|NCT00941863|652530|P4|COMPLETED|Until Primary Completion Date (PCD)||0
269367|NCT00941863|652531|P3|COMPLETED|Until Primary Completion Date (PCD)||0
269368|NCT00941863|652532|P2|COMPLETED|Until Primary Completion Date (PCD)||0
269369|NCT00941863|652533|P1|COMPLETED|Until Primary Completion Date (PCD)||0
269370|NCT00941863|652529|P5|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||94
269371|NCT00941863|652530|P4|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||17
269372|NCT00941863|652531|P3|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||12
269373|NCT00941863|652532|P2|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||3
269374|NCT00941863|652533|P1|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||7
269375|NCT00941863|652529|P5|STARTED|Until Primary Completion Date (PCD)||119
269376|NCT00941863|652530|P4|STARTED|Until Primary Completion Date (PCD)||17
269377|NCT00941863|652531|P3|STARTED|Until Primary Completion Date (PCD)||12
269378|NCT00941863|652532|P2|STARTED|Until Primary Completion Date (PCD)||3
269379|NCT00941863|652533|P1|STARTED|Until Primary Completion Date (PCD)||7
269380|NCT00941798|652560|P2|NOT COMPLETED|Overall Study||185
269381|NCT00941798|652561|P1|NOT COMPLETED|Overall Study||194
269382|NCT00941798|652560|P2|COMPLETED|Overall Study||578
269383|NCT00941798|652561|P1|COMPLETED|Overall Study||561
269384|NCT00941798|652560|P2|Full Analysis Set|Overall Study||759
269385|NCT00941798|652561|P1|Full Analysis Set|Overall Study||749
269386|NCT00941798|652560|P2|STARTED|Overall Study||763
269387|NCT00941798|652561|P1|STARTED|Overall Study||755
269388|NCT00941733|652591|P2|NOT COMPLETED|Overall Study||28
269389|NCT00941733|652592|P1|NOT COMPLETED|Overall Study||74
269390|NCT00941733|652591|P2|COMPLETED|Overall Study|1 year follow-up|91
269391|NCT00941733|652592|P1|COMPLETED|Overall Study|1 year follow-up|165
269392|NCT00941733|652591|P2|STARTED|Overall Study||119
269393|NCT00941733|652592|P1|STARTED|Overall Study||239
269394|NCT00941720|652632|P1|NOT COMPLETED|Overall Study||14
269395|NCT00941720|652632|P1|COMPLETED|Overall Study||57
269396|NCT00941720|652632|P1|STARTED|Overall Study||71
269397|NCT00941681|652641|P3|NOT COMPLETED|Overall Study||0
269398|NCT00941681|652642|P2|NOT COMPLETED|Overall Study||1
269399|NCT00941681|652643|P1|NOT COMPLETED|Overall Study||0
269400|NCT00941681|652641|P3|COMPLETED|Overall Study||12
269401|NCT00941681|652642|P2|COMPLETED|Overall Study||10
269402|NCT00941681|652643|P1|COMPLETED|Overall Study||12
269403|NCT00941681|652641|P3|STARTED|Overall Study||12
269404|NCT00941681|652642|P2|STARTED|Overall Study||11
269405|NCT00941681|652643|P1|STARTED|Overall Study||12
269406|NCT00941668|652668|P2|NOT COMPLETED|Overall Study||25
269407|NCT00941668|652669|P1|NOT COMPLETED|Overall Study||24
269408|NCT00941668|652668|P2|COMPLETED|Overall Study||0
269409|NCT00941668|652669|P1|COMPLETED|Overall Study||0
269410|NCT00941668|652668|P2|STARTED|Overall Study||25
269411|NCT00941668|652669|P1|STARTED|Overall Study||24
269412|NCT00941655|652679|P2|NOT COMPLETED|Overall Study||5
269413|NCT00941655|652680|P1|NOT COMPLETED|Overall Study||5
269414|NCT00941655|652679|P2|COMPLETED|Overall Study||2
269415|NCT00941655|652680|P1|COMPLETED|Overall Study||3
269416|NCT00941655|652679|P2|STARTED|Overall Study||7
269417|NCT00941655|652680|P1|STARTED|Overall Study||8
269418|NCT00941603|652705|P6|NOT COMPLETED|Overall Study||3
269419|NCT00941603|652706|P5|NOT COMPLETED|Overall Study||4
269420|NCT00941603|652707|P4|NOT COMPLETED|Overall Study||4
269421|NCT00941603|652708|P3|NOT COMPLETED|Overall Study||5
269422|NCT00941603|652709|P2|NOT COMPLETED|Overall Study||16
269423|NCT00941603|652710|P1|NOT COMPLETED|Overall Study||11
269424|NCT00941603|652705|P6|COMPLETED|Overall Study||94
269425|NCT00941603|652706|P5|COMPLETED|Overall Study||101
269426|NCT00941603|652707|P4|COMPLETED|Overall Study||100
269427|NCT00941603|652708|P3|COMPLETED|Overall Study||99
269428|NCT00941603|652709|P2|COMPLETED|Overall Study||89
269429|NCT00941603|652710|P1|COMPLETED|Overall Study||93
269430|NCT00941603|652705|P6|STARTED|Overall Study||97
269431|NCT00941603|652706|P5|STARTED|Overall Study||105
269432|NCT00941603|652707|P4|STARTED|Overall Study||104
269433|NCT00941603|652708|P3|STARTED|Overall Study||104
269434|NCT00941603|652709|P2|STARTED|Overall Study||105
269435|NCT00941603|652710|P1|STARTED|Overall Study||104
269436|NCT00941330|652732|P2|NOT COMPLETED|Overall Study||2
269437|NCT00941330|652733|P1|NOT COMPLETED|Overall Study||1
269438|NCT00941330|652732|P2|COMPLETED|Overall Study||9
269439|NCT00941330|652733|P1|COMPLETED|Overall Study||14
269440|NCT00941330|652732|P2|STARTED|Overall Study||11
269441|NCT00941330|652733|P1|STARTED|Overall Study||15
269442|NCT00941304|652746|P5|NOT COMPLETED|Overall Study||0
269443|NCT00941304|652747|P4|NOT COMPLETED|Overall Study||0
269444|NCT00941304|652748|P3|NOT COMPLETED|Overall Study||0
269445|NCT00941304|652749|P2|NOT COMPLETED|Overall Study||0
269446|NCT00941304|652750|P1|NOT COMPLETED|Overall Study||1
269447|NCT00941304|652746|P5|COMPLETED|Overall Study||31
269448|NCT00941304|652747|P4|COMPLETED|Overall Study||30
269449|NCT00941304|652748|P3|COMPLETED|Overall Study||31
269450|NCT00941304|652749|P2|COMPLETED|Overall Study||30
269451|NCT00941304|652750|P1|COMPLETED|Overall Study||30
269452|NCT00941304|652746|P5|STARTED|Overall Study||31
269453|NCT00941304|652747|P4|STARTED|Overall Study||30
269454|NCT00941304|652748|P3|STARTED|Overall Study||31
269455|NCT00941304|652749|P2|STARTED|Overall Study||30
269456|NCT00941304|652750|P1|STARTED|Overall Study||31
269457|NCT00941070|652812|P1|NOT COMPLETED|Overall Study||1
269458|NCT00941070|652812|P1|COMPLETED|Overall Study||25
269459|NCT00941070|652812|P1|STARTED|Overall Study||26
269460|NCT00941031|652832|P7|NOT COMPLETED|Maintenance Period||43
269461|NCT00941031|652833|P6|NOT COMPLETED|Maintenance Period||6
269462|NCT00941031|652834|P5|NOT COMPLETED|Maintenance Period||9
269463|NCT00941031|652835|P4|NOT COMPLETED|Maintenance Period||0
269464|NCT00941031|652836|P3|NOT COMPLETED|Maintenance Period||0
269465|NCT00941031|652837|P2|NOT COMPLETED|Maintenance Period||0
269466|NCT00941031|652838|P1|NOT COMPLETED|Maintenance Period||0
269467|NCT00941031|652832|P7|COMPLETED|Maintenance Period||204
269468|NCT00941031|652833|P6|COMPLETED|Maintenance Period||61
269469|NCT00941031|652834|P5|COMPLETED|Maintenance Period||56
269470|NCT00941031|652835|P4|COMPLETED|Maintenance Period|Non Responders treated with an open label regimen.|0
269471|NCT00941031|652836|P3|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
269472|NCT00941031|652837|P2|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
269473|NCT00941031|652838|P1|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
269474|NCT00941031|652832|P7|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|247
269475|NCT00941031|652833|P6|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|67
269476|NCT00941031|652834|P5|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|65
269477|NCT00941031|652835|P4|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|0
269478|NCT00941031|652836|P3|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
269479|NCT00941031|652837|P2|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
269480|NCT00941031|652838|P1|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
269481|NCT00941031|652832|P7|NOT COMPLETED|Induction Period||0
269482|NCT00941031|652833|P6|NOT COMPLETED|Induction Period||0
269483|NCT00941031|652834|P5|NOT COMPLETED|Induction Period||0
269484|NCT00941031|652835|P4|NOT COMPLETED|Induction Period||9
269485|NCT00941031|652836|P3|NOT COMPLETED|Induction Period||6
269486|NCT00941031|652837|P2|NOT COMPLETED|Induction Period||4
269487|NCT00941031|652838|P1|NOT COMPLETED|Induction Period||5
269488|NCT00941031|652832|P7|COMPLETED|Induction Period||0
269489|NCT00941031|652833|P6|COMPLETED|Induction Period||0
269490|NCT00941031|652834|P5|COMPLETED|Induction Period||0
269491|NCT00941031|652835|P4|COMPLETED|Induction Period||58
269492|NCT00941031|652836|P3|COMPLETED|Induction Period||127
269493|NCT00941031|652837|P2|COMPLETED|Induction Period||134
269494|NCT00941031|652838|P1|COMPLETED|Induction Period||61
269495|NCT00941031|652832|P7|STARTED|Induction Period||0
269496|NCT00941031|652833|P6|STARTED|Induction Period||0
269497|NCT00941031|652834|P5|STARTED|Induction Period||0
269498|NCT00941031|652835|P4|STARTED|Induction Period||67
269499|NCT00941031|652836|P3|STARTED|Induction Period||133
269500|NCT00941031|652837|P2|STARTED|Induction Period||138
269501|NCT00941031|652838|P1|STARTED|Induction Period||66
269502|NCT00940992|652864|P3|NOT COMPLETED|Overall Study||2
269503|NCT00940992|652865|P2|NOT COMPLETED|Overall Study||2
269504|NCT00940992|652866|P1|NOT COMPLETED|Overall Study||4
269505|NCT00940992|652864|P3|COMPLETED|Overall Study||28
269506|NCT00940992|652865|P2|COMPLETED|Overall Study||28
269507|NCT00940992|652866|P1|COMPLETED|Overall Study||28
269508|NCT00940992|652864|P3|STARTED|Overall Study||30
269509|NCT00940992|652865|P2|STARTED|Overall Study||30
269510|NCT00940992|652866|P1|STARTED|Overall Study||32
269511|NCT00940927|652877|P1|NOT COMPLETED|Overall Study||0
269512|NCT00940927|652877|P1|COMPLETED|Overall Study||81
269513|NCT00940927|652877|P1|STARTED|Overall Study||81
269514|NCT00940901|652884|P2|NOT COMPLETED|Week 9-16 (Phase 2)||3
269515|NCT00940901|652885|P1|NOT COMPLETED|Week 9-16 (Phase 2)||2
269516|NCT00940901|652884|P2|COMPLETED|Week 9-16 (Phase 2)||4
269517|NCT00940901|652885|P1|COMPLETED|Week 9-16 (Phase 2)||4
269518|NCT00940901|652884|P2|STARTED|Week 9-16 (Phase 2)||7
269519|NCT00940901|652885|P1|STARTED|Week 9-16 (Phase 2)||6
269520|NCT00940901|652884|P2|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
269521|NCT00940901|652885|P1|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
269522|NCT00940901|652884|P2|COMPLETED|Weeks 1-8 (Phase 1)||7
269523|NCT00940901|652885|P1|COMPLETED|Weeks 1-8 (Phase 1)||6
269524|NCT00940901|652884|P2|STARTED|Weeks 1-8 (Phase 1)||7
269525|NCT00940901|652885|P1|STARTED|Weeks 1-8 (Phase 1)||6
269526|NCT00940888|652895|P1|NOT COMPLETED|Overall Study||835
269527|NCT00940888|652895|P1|COMPLETED|Overall Study|Subjects that completed the 60 month follow up visit|866
269528|NCT00940888|652895|P1|STARTED|Overall Study|Total number of subjects consented|1701
269529|NCT00940875|652902|P2|NOT COMPLETED|Post-Study Treatment||3
269530|NCT00940875|652903|P1|NOT COMPLETED|Post-Study Treatment||0
269531|NCT00940875|652902|P2|COMPLETED|Post-Study Treatment||1
269532|NCT00940875|652903|P1|COMPLETED|Post-Study Treatment||0
269533|NCT00940875|652902|P2|STARTED|Post-Study Treatment||4
269534|NCT00940875|652903|P1|STARTED|Post-Study Treatment||0
269535|NCT00940875|652902|P2|NOT COMPLETED|Treatment Phase||19
269536|NCT00940875|652903|P1|NOT COMPLETED|Treatment Phase||26
269537|NCT00940875|652902|P2|COMPLETED|Treatment Phase||4
269538|NCT00940875|652903|P1|COMPLETED|Treatment Phase||5
269539|NCT00940875|652902|P2|STARTED|Treatment Phase|3 participants randomized to G+E arm received only gemcitabine and were analyzed in Gemcitabine arm|23
269540|NCT00940875|652903|P1|STARTED|Treatment Phase|Disposition analysis includes 3 participants randomized to G+E but received only gemcitabine|31
269541|NCT00940823|652923|P2|NOT COMPLETED|Overall Study||32
269542|NCT00940823|652924|P1|NOT COMPLETED|Overall Study||35
269543|NCT00940823|652923|P2|COMPLETED|Overall Study||82
269544|NCT00940823|652924|P1|COMPLETED|Overall Study||89
269545|NCT00940823|652923|P2|STARTED|Overall Study||114
269546|NCT00940823|652924|P1|STARTED|Overall Study||124
269547|NCT00940589|652942|P2|NOT COMPLETED|Overall Study||5
269548|NCT00940589|652943|P1|NOT COMPLETED|Overall Study||8
269549|NCT00940589|652942|P2|COMPLETED|Overall Study||29
269550|NCT00940589|652943|P1|COMPLETED|Overall Study||31
269551|NCT00940589|652942|P2|STARTED|Overall Study||34
269552|NCT00940589|652943|P1|STARTED|Overall Study||39
269553|NCT00940576|652953|P2|NOT COMPLETED|Overall Study||0
269554|NCT00940576|652954|P1|NOT COMPLETED|Overall Study||0
269555|NCT00940576|652953|P2|COMPLETED|Overall Study||9
269556|NCT00940576|652954|P1|COMPLETED|Overall Study||8
269557|NCT00940576|652953|P2|STARTED|Overall Study||9
269558|NCT00940576|652954|P1|STARTED|Overall Study||8
269559|NCT00940537|652963|P2|NOT COMPLETED|Overall Study||0
269560|NCT00940537|652964|P1|NOT COMPLETED|Overall Study||0
269561|NCT00940537|652963|P2|COMPLETED|Overall Study||9
269562|NCT00940537|652964|P1|COMPLETED|Overall Study||5
269563|NCT00940537|652963|P2|STARTED|Overall Study||9
269564|NCT00940537|652964|P1|STARTED|Overall Study||5
269565|NCT00940498|652981|P8|NOT COMPLETED|Overall Study||1
269566|NCT00940498|652982|P7|NOT COMPLETED|Overall Study||1
269567|NCT00940498|652983|P6|NOT COMPLETED|Overall Study||1
269568|NCT00940498|652984|P5|NOT COMPLETED|Overall Study||9
269569|NCT00940498|652985|P4|NOT COMPLETED|Overall Study||2
269570|NCT00940498|652986|P3|NOT COMPLETED|Overall Study||3
269571|NCT00940498|652987|P2|NOT COMPLETED|Overall Study||1
269572|NCT00940498|652988|P1|NOT COMPLETED|Overall Study||3
269573|NCT00940498|652981|P8|COMPLETED|Overall Study||3
269574|NCT00940498|652982|P7|COMPLETED|Overall Study||7
269575|NCT00940498|652983|P6|COMPLETED|Overall Study||6
269576|NCT00940498|652984|P5|COMPLETED|Overall Study||34
269577|NCT00940498|652985|P4|COMPLETED|Overall Study||2
269578|NCT00940498|652986|P3|COMPLETED|Overall Study||1
269579|NCT00940498|652987|P2|COMPLETED|Overall Study||3
269580|NCT00940498|652988|P1|COMPLETED|Overall Study||1
269581|NCT00940498|652981|P8|STARTED|Overall Study||4
269582|NCT00940498|652982|P7|STARTED|Overall Study||8
269583|NCT00940498|652983|P6|STARTED|Overall Study||7
269584|NCT00940498|652984|P5|STARTED|Overall Study||43
269585|NCT00940498|652985|P4|STARTED|Overall Study||4
269586|NCT00940498|652986|P3|STARTED|Overall Study||4
269587|NCT00940498|652987|P2|STARTED|Overall Study||4
269588|NCT00940498|652988|P1|STARTED|Overall Study||4
269589|NCT00940485|653106|P2|NOT COMPLETED|Overall Study||7
269590|NCT00940485|653107|P1|NOT COMPLETED|Overall Study||15
269591|NCT00940485|653106|P2|COMPLETED|Overall Study||93
269592|NCT00940485|653107|P1|COMPLETED|Overall Study||82
269593|NCT00940485|653106|P2|STARTED|Overall Study||100
269594|NCT00940485|653107|P1|STARTED|Overall Study||97
269595|NCT00940446|653133|P2|NOT COMPLETED|Overall Study||0
269596|NCT00940446|653134|P1|NOT COMPLETED|Overall Study||0
269597|NCT00940446|653133|P2|COMPLETED|Overall Study||30
269598|NCT00940446|653134|P1|COMPLETED|Overall Study||30
269599|NCT00940446|653133|P2|STARTED|Overall Study||30
269600|NCT00940446|653134|P1|STARTED|Overall Study||30
269601|NCT00940342|653145|P3|NOT COMPLETED|Overall Study||1
269602|NCT00940342|653146|P2|NOT COMPLETED|Overall Study||2
269603|NCT00940342|653147|P1|NOT COMPLETED|Overall Study||0
269604|NCT00940342|653145|P3|COMPLETED|Overall Study||39
269605|NCT00940342|653146|P2|COMPLETED|Overall Study||38
269606|NCT00940342|653147|P1|COMPLETED|Overall Study||50
269607|NCT00940342|653145|P3|STARTED|Overall Study||40
269608|NCT00940342|653146|P2|STARTED|Overall Study||40
269609|NCT00940342|653147|P1|STARTED|Overall Study||50
269610|NCT00940316|653158|P3|NOT COMPLETED|Follow up Every 3 Months||0
269611|NCT00940316|653159|P2|NOT COMPLETED|Follow up Every 3 Months||0
269612|NCT00940316|653160|P1|NOT COMPLETED|Follow up Every 3 Months||0
269613|NCT00940316|653158|P3|COMPLETED|Follow up Every 3 Months||2
269614|NCT00940316|653159|P2|COMPLETED|Follow up Every 3 Months||13
269615|NCT00940316|653160|P1|COMPLETED|Follow up Every 3 Months||13
269616|NCT00940316|653158|P3|STARTED|Follow up Every 3 Months||2
269617|NCT00940316|653159|P2|STARTED|Follow up Every 3 Months||13
269618|NCT00940316|653160|P1|STARTED|Follow up Every 3 Months||13
269619|NCT00940316|653158|P3|NOT COMPLETED|Crossed Over to Arm A After Progression||0
269620|NCT00940316|653159|P2|NOT COMPLETED|Crossed Over to Arm A After Progression||0
269621|NCT00940316|653160|P1|NOT COMPLETED|Crossed Over to Arm A After Progression||0
269622|NCT00940316|653158|P3|COMPLETED|Crossed Over to Arm A After Progression||0
269623|NCT00940316|653159|P2|COMPLETED|Crossed Over to Arm A After Progression||3
269624|NCT00940316|653160|P1|COMPLETED|Crossed Over to Arm A After Progression||0
269625|NCT00940316|653158|P3|Treated for Cycle One|Crossed Over to Arm A After Progression||0
269626|NCT00940316|653159|P2|Treated for Cycle One|Crossed Over to Arm A After Progression||3
269627|NCT00940316|653160|P1|Treated for Cycle One|Crossed Over to Arm A After Progression||0
269628|NCT00940316|653158|P3|STARTED|Crossed Over to Arm A After Progression||0
269629|NCT00940316|653159|P2|STARTED|Crossed Over to Arm A After Progression||3
269630|NCT00940316|653160|P1|STARTED|Crossed Over to Arm A After Progression||0
269631|NCT00940316|653158|P3|NOT COMPLETED|Treated After Cycle 5||1
269632|NCT00940316|653159|P2|NOT COMPLETED|Treated After Cycle 5||1
269633|NCT00940316|653160|P1|NOT COMPLETED|Treated After Cycle 5||0
269634|NCT00940316|653158|P3|COMPLETED|Treated After Cycle 5||1
269635|NCT00940316|653159|P2|COMPLETED|Treated After Cycle 5||8
269636|NCT00940316|653160|P1|COMPLETED|Treated After Cycle 5||8
269637|NCT00940316|653158|P3|STARTED|Treated After Cycle 5||2
269638|NCT00940316|653159|P2|STARTED|Treated After Cycle 5||9
269639|NCT00940316|653160|P1|STARTED|Treated After Cycle 5||8
269640|NCT00940316|653158|P3|NOT COMPLETED|Moved on to be Treated Cycle 5||0
269641|NCT00940316|653159|P2|NOT COMPLETED|Moved on to be Treated Cycle 5||0
269642|NCT00940316|653160|P1|NOT COMPLETED|Moved on to be Treated Cycle 5||2
269643|NCT00940316|653158|P3|COMPLETED|Moved on to be Treated Cycle 5||2
269644|NCT00940316|653159|P2|COMPLETED|Moved on to be Treated Cycle 5||9
269645|NCT00940316|653160|P1|COMPLETED|Moved on to be Treated Cycle 5||8
269646|NCT00940316|653158|P3|STARTED|Moved on to be Treated Cycle 5||2
269647|NCT00940316|653159|P2|STARTED|Moved on to be Treated Cycle 5||9
269648|NCT00940316|653160|P1|STARTED|Moved on to be Treated Cycle 5||10
269649|NCT00940316|653158|P3|NOT COMPLETED|Reached First Response at 8 Weeks||0
269650|NCT00940316|653159|P2|NOT COMPLETED|Reached First Response at 8 Weeks||4
269651|NCT00940316|653160|P1|NOT COMPLETED|Reached First Response at 8 Weeks||3
269652|NCT00940316|653158|P3|COMPLETED|Reached First Response at 8 Weeks||2
269653|NCT00940316|653159|P2|COMPLETED|Reached First Response at 8 Weeks||9
269654|NCT00940316|653160|P1|COMPLETED|Reached First Response at 8 Weeks||10
269655|NCT00940316|653158|P3|STARTED|Reached First Response at 8 Weeks||2
269656|NCT00940316|653159|P2|STARTED|Reached First Response at 8 Weeks||13
269657|NCT00940316|653160|P1|STARTED|Reached First Response at 8 Weeks||13
269658|NCT00940290|653186|P4|NOT COMPLETED|Overall Study||0
269659|NCT00940290|653187|P3|NOT COMPLETED|Overall Study||0
269660|NCT00940290|653188|P2|NOT COMPLETED|Overall Study||0
269661|NCT00940290|653189|P1|NOT COMPLETED|Overall Study||0
269662|NCT00940290|653186|P4|COMPLETED|Overall Study||54
269663|NCT00940290|653187|P3|COMPLETED|Overall Study||55
269664|NCT00940290|653188|P2|COMPLETED|Overall Study||53
269665|NCT00940290|653189|P1|COMPLETED|Overall Study||54
269666|NCT00940290|653186|P4|STARTED|Overall Study||54
269667|NCT00940290|653187|P3|STARTED|Overall Study||55
269668|NCT00940290|653188|P2|STARTED|Overall Study||53
269669|NCT00940290|653189|P1|STARTED|Overall Study||54
269670|NCT00940108|653203|P4|NOT COMPLETED|Overall Study||5
269671|NCT00940108|653204|P3|NOT COMPLETED|Overall Study||3
269672|NCT00940108|653205|P2|NOT COMPLETED|Overall Study||9
269673|NCT00940108|653206|P1|NOT COMPLETED|Overall Study||5
269674|NCT00940108|653203|P4|COMPLETED|Overall Study||99
269675|NCT00940108|653204|P3|COMPLETED|Overall Study||100
269676|NCT00940108|653205|P2|COMPLETED|Overall Study||71
269677|NCT00940108|653206|P1|COMPLETED|Overall Study||77
269678|NCT00940108|653203|P4|STARTED|Overall Study||104
269679|NCT00940108|653204|P3|STARTED|Overall Study||103
269680|NCT00940108|653205|P2|STARTED|Overall Study||80
269681|NCT00940108|653206|P1|STARTED|Overall Study||82
269682|NCT00940017|653256|P1|NOT COMPLETED|Overall Study||4
269683|NCT00940017|653256|P1|COMPLETED|Overall Study||20
269684|NCT00940017|653256|P1|Subjects Treated|Overall Study||21
269685|NCT00940017|653256|P1|STARTED|Overall Study||24
269686|NCT00939991|653277|P2|NOT COMPLETED|Overall Study||0
269687|NCT00939991|653278|P1|NOT COMPLETED|Overall Study||0
269688|NCT00939991|653277|P2|COMPLETED|Overall Study||39
269689|NCT00939991|653278|P1|COMPLETED|Overall Study||9
269690|NCT00939991|653277|P2|STARTED|Overall Study||39
269691|NCT00939991|653278|P1|STARTED|Overall Study||9
269692|NCT00939952|653288|P1|NOT COMPLETED|Overall Study||0
269693|NCT00939952|653288|P1|COMPLETED|Overall Study||7
269694|NCT00939952|653288|P1|STARTED|Overall Study||7
269695|NCT00939900|653300|P2|NOT COMPLETED|Overall Study||7
269696|NCT00939900|653301|P1|NOT COMPLETED|Overall Study||2
269697|NCT00939900|653300|P2|COMPLETED|Overall Study||48
269698|NCT00939900|653301|P1|COMPLETED|Overall Study||53
269699|NCT00939900|653300|P2|STARTED|Overall Study||55
269700|NCT00939900|653301|P1|STARTED|Overall Study||55
269701|NCT00939874|653307|P1|NOT COMPLETED|Overall Study||20
269702|NCT00939874|653307|P1|COMPLETED|Overall Study||32
269703|NCT00939874|653307|P1|Completed Week 48|Overall Study||37
269704|NCT00939874|653307|P1|STARTED|Overall Study||52
269705|NCT00939822|653314|P2|NOT COMPLETED|Overall Study||3
269706|NCT00939822|653315|P1|NOT COMPLETED|Overall Study||2
269707|NCT00939822|653314|P2|COMPLETED|Overall Study||41
269708|NCT00939822|653315|P1|COMPLETED|Overall Study||42
269709|NCT00939822|653314|P2|STARTED|Overall Study||44
269710|NCT00939822|653315|P1|STARTED|Overall Study||44
269711|NCT00939809|653327|P1|NOT COMPLETED|Overall Study||3
269712|NCT00939809|653327|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|28
269713|NCT00939809|653327|P1|STARTED|Overall Study||31
269714|NCT00939796|653336|P1|NOT COMPLETED|Overall Study||0
269715|NCT00939796|653336|P1|COMPLETED|Overall Study||16
269716|NCT00939796|653336|P1|STARTED|Overall Study||16
269717|NCT00939783|653342|P1|NOT COMPLETED|Overall Study||649
269718|NCT00939783|653342|P1|COMPLETED|Overall Study||0
269719|NCT00939783|653342|P1|Treated|Overall Study||648
269720|NCT00939783|653342|P1|STARTED|Overall Study||649
269721|NCT00939731|653349|P2|NOT COMPLETED|Second Intervention Period||0
269722|NCT00939731|653350|P1|NOT COMPLETED|Second Intervention Period||0
269723|NCT00939731|653349|P2|COMPLETED|Second Intervention Period||12
269724|NCT00939731|653350|P1|COMPLETED|Second Intervention Period||12
269725|NCT00939731|653349|P2|STARTED|Second Intervention Period||12
269726|NCT00939731|653350|P1|STARTED|Second Intervention Period||12
269727|NCT00939731|653349|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
269728|NCT00939731|653350|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
269729|NCT00939731|653349|P2|COMPLETED|Washout Period (at Least 14 Days)||12
269730|NCT00939731|653350|P1|COMPLETED|Washout Period (at Least 14 Days)||12
269731|NCT00939731|653349|P2|STARTED|Washout Period (at Least 14 Days)||12
269732|NCT00939731|653350|P1|STARTED|Washout Period (at Least 14 Days)||12
269733|NCT00939731|653349|P2|NOT COMPLETED|First Intervention Period||0
269734|NCT00939731|653350|P1|NOT COMPLETED|First Intervention Period||0
269735|NCT00939731|653349|P2|COMPLETED|First Intervention Period||12
269736|NCT00939731|653350|P1|COMPLETED|First Intervention Period||12
269737|NCT00939731|653349|P2|STARTED|First Intervention Period||12
269738|NCT00939731|653350|P1|STARTED|First Intervention Period||12
269739|NCT00939705|653370|P2|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
269740|NCT00939705|653371|P1|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
269741|NCT00939705|653370|P2|COMPLETED|Period 3 - Second Intervent - 5 Days||9
269742|NCT00939705|653371|P1|COMPLETED|Period 3 - Second Intervent - 5 Days||9
269743|NCT00939705|653370|P2|STARTED|Period 3 - Second Intervent - 5 Days||9
269744|NCT00939705|653371|P1|STARTED|Period 3 - Second Intervent - 5 Days||9
269745|NCT00939705|653370|P2|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
269746|NCT00939705|653371|P1|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
269747|NCT00939705|653370|P2|COMPLETED|Period 2 - Washout Period - 21 Days||9
269748|NCT00939705|653371|P1|COMPLETED|Period 2 - Washout Period - 21 Days||9
269749|NCT00939705|653370|P2|STARTED|Period 2 - Washout Period - 21 Days||9
269750|NCT00939705|653371|P1|STARTED|Period 2 - Washout Period - 21 Days||9
269751|NCT00939705|653370|P2|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
269752|NCT00939705|653371|P1|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
269753|NCT00939705|653370|P2|COMPLETED|Period 1 - First Intervention - 5 Days||9
269754|NCT00939705|653371|P1|COMPLETED|Period 1 - First Intervention - 5 Days||9
269755|NCT00939705|653370|P2|STARTED|Period 1 - First Intervention - 5 Days||9
269756|NCT00939705|653371|P1|STARTED|Period 1 - First Intervention - 5 Days||9
269757|NCT00939692|653383|P2|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||1
269758|NCT00939692|653384|P1|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||0
269759|NCT00939692|653383|P2|COMPLETED|Period 2 - Second Intervent - 5 Days||12
269760|NCT00939692|653384|P1|COMPLETED|Period 2 - Second Intervent - 5 Days||12
269761|NCT00939692|653383|P2|STARTED|Period 2 - Second Intervent - 5 Days||13
269762|NCT00939692|653384|P1|STARTED|Period 2 - Second Intervent - 5 Days||12
269763|NCT00939692|653383|P2|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
269764|NCT00939692|653384|P1|NOT COMPLETED|Period 1 - First Intervention - 5 Days||1
269765|NCT00939692|653383|P2|COMPLETED|Period 1 - First Intervention - 5 Days||13
269766|NCT00939692|653384|P1|COMPLETED|Period 1 - First Intervention - 5 Days||12
269767|NCT00939692|653383|P2|STARTED|Period 1 - First Intervention - 5 Days||13
269768|NCT00939692|653384|P1|STARTED|Period 1 - First Intervention - 5 Days||13
269769|NCT00939640|653394|P1|NOT COMPLETED|Overall Study||1
269770|NCT00939640|653394|P1|COMPLETED|Overall Study||13
269771|NCT00939640|653394|P1|STARTED|Overall Study||14
269772|NCT00939627|653415|P3|NOT COMPLETED|Overall Study||0
269773|NCT00939627|653416|P2|NOT COMPLETED|Overall Study||28
269774|NCT00939627|653417|P1|NOT COMPLETED|Overall Study||27
269775|NCT00939627|653415|P3|COMPLETED|Overall Study||0
269776|NCT00939627|653416|P2|COMPLETED|Overall Study||0
269777|NCT00939627|653417|P1|COMPLETED|Overall Study||0
269778|NCT00939627|653415|P3|STARTED|Overall Study||0
269779|NCT00939627|653416|P2|STARTED|Overall Study||28
269780|NCT00939627|653417|P1|STARTED|Overall Study||27
269781|NCT00939562|653435|P2|NOT COMPLETED|Period 2||0
269782|NCT00939562|653436|P1|NOT COMPLETED|Period 2||0
269783|NCT00939562|653435|P2|COMPLETED|Period 2||12
269784|NCT00939562|653436|P1|COMPLETED|Period 2||12
269785|NCT00939562|653435|P2|STARTED|Period 2||12
269786|NCT00939562|653436|P1|STARTED|Period 2||12
269787|NCT00939562|653435|P2|NOT COMPLETED|Period 1||0
269788|NCT00939562|653436|P1|NOT COMPLETED|Period 1||0
269789|NCT00939562|653435|P2|COMPLETED|Period 1||12
269790|NCT00939562|653436|P1|COMPLETED|Period 1||12
269791|NCT00939562|653435|P2|STARTED|Period 1||12
269792|NCT00939562|653436|P1|STARTED|Period 1||12
269793|NCT00939536|653446|P2|NOT COMPLETED|Second Intervention||0
269794|NCT00939536|653447|P1|NOT COMPLETED|Second Intervention||0
269795|NCT00939536|653446|P2|COMPLETED|Second Intervention||12
269796|NCT00939536|653447|P1|COMPLETED|Second Intervention||12
269797|NCT00939536|653446|P2|STARTED|Second Intervention||12
269798|NCT00939536|653447|P1|STARTED|Second Intervention||12
269799|NCT00939536|653446|P2|NOT COMPLETED|First Intervention||0
269800|NCT00939536|653447|P1|NOT COMPLETED|First Intervention||0
269801|NCT00939536|653446|P2|COMPLETED|First Intervention||12
269802|NCT00939536|653447|P1|COMPLETED|First Intervention||12
269803|NCT00939536|653446|P2|STARTED|First Intervention||12
269804|NCT00939536|653447|P1|STARTED|First Intervention||12
269805|NCT00939510|653457|P1|NOT COMPLETED|Overall Study||1
269806|NCT00939510|653457|P1|COMPLETED|Overall Study||31
269807|NCT00939510|653457|P1|STARTED|Overall Study||32
269808|NCT00939484|653466|P3|NOT COMPLETED|Overall Study||3
269809|NCT00939484|653467|P2|NOT COMPLETED|Overall Study||20
269810|NCT00939484|653468|P1|NOT COMPLETED|Overall Study||8
269811|NCT00939484|653466|P3|COMPLETED|Overall Study||0
269812|NCT00939484|653467|P2|COMPLETED|Overall Study||0
269813|NCT00939484|653468|P1|COMPLETED|Overall Study||0
269814|NCT00939484|653466|P3|STARTED|Overall Study||3
269815|NCT00939484|653467|P2|STARTED|Overall Study||20
269816|NCT00939484|653468|P1|STARTED|Overall Study||8
269817|NCT00939471|653481|P1|NOT COMPLETED|Overall Study||11
269818|NCT00939471|653481|P1|COMPLETED|Overall Study||33
269819|NCT00939471|653481|P1|STARTED|Overall Study||44
269820|NCT00939393|653494|P2|NOT COMPLETED|Overall Study||0
269821|NCT00939393|653495|P1|NOT COMPLETED|Overall Study||4
269822|NCT00939393|653494|P2|COMPLETED|Overall Study||35
269823|NCT00939393|653495|P1|COMPLETED|Overall Study||33
269824|NCT00939393|653494|P2|STARTED|Overall Study||35
269825|NCT00939393|653495|P1|STARTED|Overall Study||37
269826|NCT00939367|653515|P2|NOT COMPLETED|Second Intervention||0
269827|NCT00939367|653516|P1|NOT COMPLETED|Second Intervention||0
269828|NCT00939367|653515|P2|COMPLETED|Second Intervention||15
269829|NCT00939367|653516|P1|COMPLETED|Second Intervention||15
269830|NCT00939367|653515|P2|STARTED|Second Intervention||15
269831|NCT00939367|653516|P1|STARTED|Second Intervention||15
269832|NCT00939367|653515|P2|NOT COMPLETED|First Intervention||0
269833|NCT00939367|653516|P1|NOT COMPLETED|First Intervention||0
269834|NCT00939367|653515|P2|COMPLETED|First Intervention||15
269835|NCT00939367|653516|P1|COMPLETED|First Intervention||15
269836|NCT00939367|653515|P2|STARTED|First Intervention||15
269837|NCT00939367|653516|P1|STARTED|First Intervention||15
269838|NCT00939341|653526|P1|NOT COMPLETED|Overall Study||66
269839|NCT00939341|653526|P1|COMPLETED|Overall Study|862 participants entered into the 12-week treatment,66 discontinued, 796 completed the treatment.|796
269840|NCT00939341|653526|P1|STARTED|Overall Study|1022 participants were enrolled. There were 160 screen failures, 862 proceeded to treatment period.|862
269841|NCT00939211|653546|P1|NOT COMPLETED|Placebo||0
269842|NCT00939211|653546|P1|COMPLETED|Placebo||28
269843|NCT00939211|653546|P1|STARTED|Placebo||28
269844|NCT00939211|653546|P1|NOT COMPLETED|Spiriva 18 Mcg First, Then Placebo||0
269845|NCT00939211|653546|P1|COMPLETED|Spiriva 18 Mcg First, Then Placebo||28
269846|NCT00939211|653546|P1|STARTED|Spiriva 18 Mcg First, Then Placebo||28
269847|NCT00939211|653546|P1|NOT COMPLETED|AZD9164 1200 Mcg First, Then Placebo||0
269848|NCT00939211|653546|P1|COMPLETED|AZD9164 1200 Mcg First, Then Placebo||28
269849|NCT00939211|653546|P1|STARTED|AZD9164 1200 Mcg First, Then Placebo||28
269850|NCT00939211|653546|P1|NOT COMPLETED|AZD9164 400 Mcg First, Then Placebo||0
269851|NCT00939211|653546|P1|COMPLETED|AZD9164 400 Mcg First, Then Placebo||28
269852|NCT00939211|653546|P1|STARTED|AZD9164 400 Mcg First, Then Placebo||28
269853|NCT00939211|653546|P1|NOT COMPLETED|AZD9164 100 Mcg First, Then Placebo||0
269854|NCT00939211|653546|P1|COMPLETED|AZD9164 100 Mcg First, Then Placebo||28
269855|NCT00939211|653546|P1|STARTED|AZD9164 100 Mcg First, Then Placebo|Cross-over study|28
269856|NCT00939198|653608|P1|NOT COMPLETED|Overall Study||0
269857|NCT00939198|653608|P1|COMPLETED|Overall Study||87
269858|NCT00939198|653608|P1|STARTED|Overall Study||87
269859|NCT00939185|653613|P1|NOT COMPLETED|Overall Study||25
269860|NCT00939185|653613|P1|COMPLETED|Overall Study||375
269861|NCT00939185|653613|P1|Received Treatment|Overall Study||390
269862|NCT00939185|653613|P1|STARTED|Overall Study||400
269863|NCT00939159|653620|P1|NOT COMPLETED|Overall Study||0
269864|NCT00939159|653620|P1|COMPLETED|Overall Study||13
269865|NCT00939159|653620|P1|STARTED|Overall Study||13
269866|NCT00939120|653626|P2|NOT COMPLETED|Overall Study||5
269867|NCT00939120|653627|P1|NOT COMPLETED|Overall Study||8
269868|NCT00939120|653626|P2|COMPLETED|Overall Study||18
269869|NCT00939120|653627|P1|COMPLETED|Overall Study||15
269870|NCT00939120|653626|P2|STARTED|Overall Study||23
269871|NCT00939120|653627|P1|STARTED|Overall Study||23
269872|NCT00939107|653651|P2|NOT COMPLETED|Overall Study||12
269873|NCT00939107|653652|P1|NOT COMPLETED|Overall Study||14
269874|NCT00939107|653651|P2|COMPLETED|Overall Study||163
269875|NCT00939107|653652|P1|COMPLETED|Overall Study||161
269876|NCT00939107|653651|P2|12 Months Follow-up|Overall Study||163
269877|NCT00939107|653652|P1|12 Months Follow-up|Overall Study||161
269878|NCT00939107|653651|P2|STARTED|Overall Study||175
269879|NCT00939107|653652|P1|STARTED|Overall Study||175
269880|NCT00939094|653666|P2|NOT COMPLETED|Overall Study||10
269881|NCT00939094|653667|P1|NOT COMPLETED|Overall Study||14
269882|NCT00939094|653666|P2|COMPLETED|Overall Study||35
269883|NCT00939094|653667|P1|COMPLETED|Overall Study||28
269884|NCT00939094|653666|P2|STARTED|Overall Study||45
269885|NCT00939094|653667|P1|STARTED|Overall Study||42
269886|NCT00939055|653689|P2|NOT COMPLETED|Overall Study||0
269887|NCT00939055|653690|P1|NOT COMPLETED|Overall Study||4
269888|NCT00939055|653689|P2|COMPLETED|Overall Study||39
269889|NCT00939055|653690|P1|COMPLETED|Overall Study||69
269890|NCT00939055|653689|P2|STARTED|Overall Study||39
269891|NCT00939055|653690|P1|STARTED|Overall Study||73
269892|NCT00939029|653700|P2|NOT COMPLETED|Overall Study||12
269893|NCT00939029|653701|P1|NOT COMPLETED|Overall Study||6
269894|NCT00939029|653700|P2|COMPLETED|Overall Study||15
269895|NCT00939029|653701|P1|COMPLETED|Overall Study||19
269896|NCT00939029|653700|P2|STARTED|Overall Study||27
269897|NCT00939029|653701|P1|STARTED|Overall Study||25
269898|NCT00939003|653713|P2|NOT COMPLETED|Open-label Treatment Period||29
269899|NCT00939003|653714|P1|NOT COMPLETED|Open-label Treatment Period||29
269900|NCT00939003|653713|P2|COMPLETED|Open-label Treatment Period||62
269901|NCT00939003|653714|P1|COMPLETED|Open-label Treatment Period||66
269902|NCT00939003|653713|P2|STARTED|Open-label Treatment Period||91
269903|NCT00939003|653714|P1|STARTED|Open-label Treatment Period||95
269904|NCT00939003|653713|P2|NOT COMPLETED|Double-blind Treatment Period||4
269905|NCT00939003|653714|P1|NOT COMPLETED|Double-blind Treatment Period||2
269906|NCT00939003|653713|P2|COMPLETED|Double-blind Treatment Period||91
269907|NCT00939003|653714|P1|COMPLETED|Double-blind Treatment Period||95
269908|NCT00939003|653713|P2|STARTED|Double-blind Treatment Period||95
269909|NCT00939003|653714|P1|STARTED|Double-blind Treatment Period||97
269910|NCT00938964|653751|P2|NOT COMPLETED|Overall Study||28
269911|NCT00938964|653752|P1|NOT COMPLETED|Overall Study||30
269912|NCT00938964|653751|P2|COMPLETED|Overall Study||209
269913|NCT00938964|653752|P1|COMPLETED|Overall Study||211
269914|NCT00938964|653751|P2|STARTED|Overall Study||237
269915|NCT00938964|653752|P1|STARTED|Overall Study||241
269916|NCT00938886|653816|P2|NOT COMPLETED|Overall Study||10
269917|NCT00938886|653817|P1|NOT COMPLETED|Overall Study||7
269918|NCT00938886|653816|P2|COMPLETED|Overall Study||65
269919|NCT00938886|653817|P1|COMPLETED|Overall Study||68
269920|NCT00938886|653816|P2|Attended 1 Counseling Session|Overall Study||70
269921|NCT00938886|653817|P1|Attended 1 Counseling Session|Overall Study||70
269922|NCT00938886|653816|P2|STARTED|Overall Study||75
269923|NCT00938886|653817|P1|STARTED|Overall Study||75
269924|NCT00938860|653827|P2|NOT COMPLETED|Overall Study||17
269925|NCT00938860|653828|P1|NOT COMPLETED|Overall Study||25
269926|NCT00938860|653827|P2|COMPLETED|Overall Study||25
269927|NCT00938860|653828|P1|COMPLETED|Overall Study||25
269928|NCT00938860|653827|P2|Efficacy Population|Overall Study||41
269929|NCT00938860|653828|P1|Efficacy Population|Overall Study||40
269930|NCT00938860|653827|P2|STARTED|Overall Study||42
269931|NCT00938860|653828|P1|STARTED|Overall Study|Intent-to-Treat (ITT) population. ITT population consisted of all randomized patients|50
269932|NCT00938782|653852|P2|NOT COMPLETED|Overall Study||0
269933|NCT00938782|653853|P1|NOT COMPLETED|Overall Study||0
269934|NCT00938782|653852|P2|COMPLETED|Overall Study|Upon discharge from PACU|35
269935|NCT00938782|653853|P1|COMPLETED|Overall Study|Upon discharge from PACU|32
269936|NCT00938782|653852|P2|STARTED|Overall Study|Monitoring started pre-induction of anesthesia|35
269937|NCT00938782|653853|P1|STARTED|Overall Study|Pre-induction of anesthesia|32
269938|NCT00938717|653861|P2|NOT COMPLETED|Overall Study||108
269939|NCT00938717|653862|P1|NOT COMPLETED|Overall Study||98
269940|NCT00938717|653861|P2|COMPLETED|Overall Study||294
269941|NCT00938717|653862|P1|COMPLETED|Overall Study||305
269942|NCT00938717|653861|P2|STARTED|Overall Study||402
269943|NCT00938717|653862|P1|STARTED|Overall Study||403
269944|NCT00938704|653896|P2|NOT COMPLETED|Overall Study||0
269945|NCT00938704|653897|P1|NOT COMPLETED|Overall Study||0
269946|NCT00938704|653896|P2|COMPLETED|Overall Study||37
269947|NCT00938704|653897|P1|COMPLETED|Overall Study||33
269948|NCT00938704|653896|P2|STARTED|Overall Study||37
269949|NCT00938704|653897|P1|STARTED|Overall Study||33
269950|NCT00938639|653913|P2|NOT COMPLETED|Overall Study||4
269951|NCT00938639|653914|P1|NOT COMPLETED|Overall Study||3
269952|NCT00938639|653913|P2|COMPLETED|Overall Study||116
269953|NCT00938639|653914|P1|COMPLETED|Overall Study||117
269954|NCT00938639|653913|P2|STARTED|Overall Study||120
269955|NCT00938639|653914|P1|STARTED|Overall Study||120
269956|NCT00938548|653984|P2|NOT COMPLETED|Overall Study||0
269957|NCT00938548|653985|P1|NOT COMPLETED|Overall Study||0
269958|NCT00938548|653984|P2|COMPLETED|Overall Study||35
269959|NCT00938548|653985|P1|COMPLETED|Overall Study||35
269960|NCT00938548|653984|P2|STARTED|Overall Study||35
269961|NCT00938548|653985|P1|STARTED|Overall Study||35
269962|NCT00938470|653997|P2|NOT COMPLETED|Overall Study||3
269963|NCT00938470|653998|P1|NOT COMPLETED|Overall Study||7
269964|NCT00938470|653997|P2|COMPLETED|Overall Study||25
269965|NCT00938470|653998|P1|COMPLETED|Overall Study||27
269966|NCT00938470|653997|P2|STARTED|Overall Study||28
269967|NCT00938470|653998|P1|STARTED|Overall Study||34
269968|NCT00938457|654012|P1|NOT COMPLETED|Overall Study||0
269969|NCT00938457|654012|P1|COMPLETED|Overall Study||3
269970|NCT00938457|654012|P1|STARTED|Overall Study||3
269971|NCT00938431|654028|P3|NOT COMPLETED|Overall Study||8
269972|NCT00938431|654029|P2|NOT COMPLETED|Overall Study||9
269973|NCT00938431|654030|P1|NOT COMPLETED|Overall Study||6
269974|NCT00938431|654028|P3|COMPLETED|Overall Study||1
269975|NCT00938431|654029|P2|COMPLETED|Overall Study||14
269976|NCT00938431|654030|P1|COMPLETED|Overall Study||9
269977|NCT00938431|654028|P3|STARTED|Overall Study||9
269978|NCT00938431|654029|P2|STARTED|Overall Study||23
269979|NCT00938431|654030|P1|STARTED|Overall Study||15
269980|NCT00938392|654057|P2|NOT COMPLETED|Overall Study||4
269981|NCT00938392|654058|P1|NOT COMPLETED|Overall Study||2
269982|NCT00938392|654057|P2|COMPLETED|Overall Study||358
269983|NCT00938392|654058|P1|COMPLETED|Overall Study||360
269984|NCT00938392|654057|P2|STARTED|Overall Study||362
269985|NCT00938392|654058|P1|STARTED|Overall Study||362
269986|NCT00938366|654084|P2|NOT COMPLETED|Overall Study||0
269987|NCT00938366|654085|P1|NOT COMPLETED|Overall Study||1
269988|NCT00938366|654084|P2|COMPLETED|Overall Study||9
269989|NCT00938366|654085|P1|COMPLETED|Overall Study||8
269990|NCT00938366|654084|P2|STARTED|Overall Study||9
269991|NCT00938366|654085|P1|STARTED|Overall Study||9
269992|NCT00938340|654105|P1|NOT COMPLETED|Overall Study||5
269993|NCT00938340|654105|P1|COMPLETED|Overall Study||15
269994|NCT00938340|654105|P1|Received Walnut Oil Intervention|Overall Study||15
269995|NCT00938340|654105|P1|Received Walnut Skins Intervention|Overall Study||15
269996|NCT00938340|654105|P1|Received Walnut Nutmeat Intervention|Overall Study||19
269997|NCT00938340|654105|P1|Received Whole Walnut Intervention|Overall Study||16
269998|NCT00938340|654105|P1|STARTED|Overall Study||20
269999|NCT00938327|654235|P1|NOT COMPLETED|Overall Study||60
270000|NCT00938327|654235|P1|COMPLETED|Overall Study||272
270001|NCT00938327|654235|P1|STARTED|Overall Study||332
270002|NCT00938314|654246|P4|NOT COMPLETED|Cohort 3||1
270003|NCT00938314|654247|P3|NOT COMPLETED|Cohort 3||4
270004|NCT00938314|654248|P2|NOT COMPLETED|Cohort 3||0
270005|NCT00938314|654249|P1|NOT COMPLETED|Cohort 3||0
270006|NCT00938314|654246|P4|COMPLETED|Cohort 3||7
270007|NCT00938314|654247|P3|COMPLETED|Cohort 3||20
270008|NCT00938314|654248|P2|COMPLETED|Cohort 3||0
270009|NCT00938314|654249|P1|COMPLETED|Cohort 3||0
270010|NCT00938314|654246|P4|STARTED|Cohort 3||8
270011|NCT00938314|654247|P3|STARTED|Cohort 3||24
270012|NCT00938314|654248|P2|STARTED|Cohort 3||0
270013|NCT00938314|654249|P1|STARTED|Cohort 3||0
270014|NCT00938314|654246|P4|NOT COMPLETED|Cohort 2||2
270015|NCT00938314|654247|P3|NOT COMPLETED|Cohort 2||0
270016|NCT00938314|654248|P2|NOT COMPLETED|Cohort 2||6
270017|NCT00938314|654249|P1|NOT COMPLETED|Cohort 2||0
270018|NCT00938314|654246|P4|COMPLETED|Cohort 2||6
270019|NCT00938314|654247|P3|COMPLETED|Cohort 2||0
270020|NCT00938314|654248|P2|COMPLETED|Cohort 2||18
270021|NCT00938314|654249|P1|COMPLETED|Cohort 2||0
270022|NCT00938314|654246|P4|STARTED|Cohort 2||8
270023|NCT00938314|654247|P3|STARTED|Cohort 2||0
270024|NCT00938314|654248|P2|STARTED|Cohort 2||24
270025|NCT00938314|654249|P1|STARTED|Cohort 2||0
270026|NCT00938314|654246|P4|NOT COMPLETED|Cohort 1||2
270027|NCT00938314|654247|P3|NOT COMPLETED|Cohort 1||0
270028|NCT00938314|654248|P2|NOT COMPLETED|Cohort 1||0
270029|NCT00938314|654249|P1|NOT COMPLETED|Cohort 1||2
270030|NCT00938314|654246|P4|COMPLETED|Cohort 1||6
270031|NCT00938314|654247|P3|COMPLETED|Cohort 1||0
270032|NCT00938314|654248|P2|COMPLETED|Cohort 1||0
270033|NCT00938314|654249|P1|COMPLETED|Cohort 1||22
270034|NCT00938314|654246|P4|STARTED|Cohort 1||8
270035|NCT00938314|654247|P3|STARTED|Cohort 1||0
270036|NCT00938314|654248|P2|STARTED|Cohort 1||0
270037|NCT00938314|654249|P1|STARTED|Cohort 1||24
270038|NCT00938041|654303|P1|NOT COMPLETED|Overall Study||27
270039|NCT00938041|654303|P1|COMPLETED|Overall Study||5
270040|NCT00938041|654303|P1|STARTED|Overall Study||32
270041|NCT00938015|654312|P1|NOT COMPLETED|Overall Study||147
270042|NCT00938015|654312|P1|COMPLETED|Overall Study||156
270043|NCT00938015|654312|P1|STARTED|Overall Study||303
270044|NCT00937950|654328|P1|NOT COMPLETED|Overall Study||216
270045|NCT00937950|654328|P1|COMPLETED|Overall Study||1787
270046|NCT00937950|654328|P1|STARTED|Overall Study||2003
270047|NCT00937937|654344|P1|NOT COMPLETED|Overall Study||72
270048|NCT00937937|654344|P1|COMPLETED|Overall Study||0
270049|NCT00937937|654344|P1|STARTED|Overall Study||72
270050|NCT00937833|654353|P2|NOT COMPLETED|Overall Study||17
270051|NCT00937833|654354|P1|NOT COMPLETED|Overall Study||15
270052|NCT00937833|654353|P2|COMPLETED|Overall Study||60
270053|NCT00937833|654354|P1|COMPLETED|Overall Study||58
270054|NCT00937833|654353|P2|STARTED|Overall Study||77
270055|NCT00937833|654354|P1|STARTED|Overall Study||73
270056|NCT00937794|654360|P1|NOT COMPLETED|Overall Study||0
270057|NCT00937794|654360|P1|COMPLETED|Overall Study||33
270058|NCT00937794|654360|P1|STARTED|Overall Study||33
270059|NCT00937768|654367|P2|NOT COMPLETED|Overall Study||8
270060|NCT00937768|654368|P1|NOT COMPLETED|Overall Study||8
270061|NCT00937768|654367|P2|COMPLETED|Overall Study||0
270062|NCT00937768|654368|P1|COMPLETED|Overall Study||0
270063|NCT00937768|654367|P2|STARTED|Overall Study||8
270064|NCT00937768|654368|P1|STARTED|Overall Study||8
270065|NCT00937560|654374|P1|NOT COMPLETED|Maintenance Treatment||18
270066|NCT00937560|654374|P1|COMPLETED|Maintenance Treatment||150
270067|NCT00937560|654374|P1|STARTED|Maintenance Treatment||168
270068|NCT00937560|654374|P1|NOT COMPLETED|Initial Treatment||21
270069|NCT00937560|654374|P1|COMPLETED|Initial Treatment||168
270070|NCT00937560|654374|P1|Received Treatment|Initial Treatment||189
270071|NCT00937560|654374|P1|STARTED|Initial Treatment||189
270072|NCT00937547|654385|P3|NOT COMPLETED|Overall Study||7
270073|NCT00937547|654386|P2|NOT COMPLETED|Overall Study||6
270074|NCT00937547|654387|P1|NOT COMPLETED|Overall Study||1
270075|NCT00937547|654385|P3|COMPLETED|Overall Study||142
270076|NCT00937547|654386|P2|COMPLETED|Overall Study||78
270077|NCT00937547|654387|P1|COMPLETED|Overall Study||95
270078|NCT00937547|654385|P3|Histological Samples|Overall Study||142
270079|NCT00937547|654386|P2|Histological Samples|Overall Study||78
270080|NCT00937547|654387|P1|Histological Samples|Overall Study||95
270081|NCT00937547|654385|P3|STARTED|Overall Study||149
270082|NCT00937547|654386|P2|STARTED|Overall Study||84
270083|NCT00937547|654387|P1|STARTED|Overall Study||96
270084|NCT00937521|654424|P8|NOT COMPLETED|Booster Phase||2
270085|NCT00937521|654425|P7|NOT COMPLETED|Booster Phase||5
270086|NCT00937521|654426|P6|NOT COMPLETED|Booster Phase||5
270087|NCT00937521|654427|P5|NOT COMPLETED|Booster Phase||5
270088|NCT00937521|654428|P4|NOT COMPLETED|Booster Phase||3
270089|NCT00937521|654429|P3|NOT COMPLETED|Booster Phase||5
270090|NCT00937521|654430|P2|NOT COMPLETED|Booster Phase||2
270091|NCT00937521|654431|P1|NOT COMPLETED|Booster Phase||3
270092|NCT00937521|654424|P8|COMPLETED|Booster Phase||159
270093|NCT00937521|654425|P7|COMPLETED|Booster Phase||160
270094|NCT00937521|654426|P6|COMPLETED|Booster Phase||160
270095|NCT00937521|654427|P5|COMPLETED|Booster Phase||163
270096|NCT00937521|654428|P4|COMPLETED|Booster Phase||167
270097|NCT00937521|654429|P3|COMPLETED|Booster Phase||164
270098|NCT00937521|654430|P2|COMPLETED|Booster Phase||161
270099|NCT00937521|654431|P1|COMPLETED|Booster Phase||152
270100|NCT00937521|654424|P8|Premature Withdrawal|Booster Phase||2
270101|NCT00937521|654425|P7|Premature Withdrawal|Booster Phase||5
270102|NCT00937521|654426|P6|Premature Withdrawal|Booster Phase||5
270103|NCT00937521|654427|P5|Premature Withdrawal|Booster Phase||5
270104|NCT00937521|654428|P4|Premature Withdrawal|Booster Phase||3
270105|NCT00937521|654429|P3|Premature Withdrawal|Booster Phase||5
270106|NCT00937521|654430|P2|Premature Withdrawal|Booster Phase||2
270107|NCT00937521|654431|P1|Premature Withdrawal|Booster Phase||3
270108|NCT00937521|654424|P8|STARTED|Booster Phase||161
270109|NCT00937521|654425|P7|STARTED|Booster Phase||165
270110|NCT00937521|654426|P6|STARTED|Booster Phase||165
270111|NCT00937521|654427|P5|STARTED|Booster Phase||168
270112|NCT00937521|654428|P4|STARTED|Booster Phase||170
270113|NCT00937521|654429|P3|STARTED|Booster Phase||169
270114|NCT00937521|654430|P2|STARTED|Booster Phase||163
270115|NCT00937521|654431|P1|STARTED|Booster Phase||155
270116|NCT00937521|654424|P8|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
270117|NCT00937521|654425|P7|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
270118|NCT00937521|654426|P6|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
270119|NCT00937521|654427|P5|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
270120|NCT00937521|654428|P4|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
270121|NCT00937521|654429|P3|NOT COMPLETED|Overall Study - Prior to Booster Dose||6
270122|NCT00937521|654430|P2|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
270123|NCT00937521|654431|P1|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
270124|NCT00937521|654424|P8|COMPLETED|Overall Study - Prior to Booster Dose||183
270125|NCT00937521|654425|P7|COMPLETED|Overall Study - Prior to Booster Dose||181
270126|NCT00937521|654426|P6|COMPLETED|Overall Study - Prior to Booster Dose||187
270127|NCT00937521|654427|P5|COMPLETED|Overall Study - Prior to Booster Dose||188
270128|NCT00937521|654428|P4|COMPLETED|Overall Study - Prior to Booster Dose||187
270129|NCT00937521|654429|P3|COMPLETED|Overall Study - Prior to Booster Dose||186
270130|NCT00937521|654430|P2|COMPLETED|Overall Study - Prior to Booster Dose||185
270131|NCT00937521|654431|P1|COMPLETED|Overall Study - Prior to Booster Dose||185
270132|NCT00937521|654424|P8|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
270133|NCT00937521|654425|P7|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
270134|NCT00937521|654426|P6|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
270135|NCT00937521|654427|P5|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
270136|NCT00937521|654428|P4|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
270137|NCT00937521|654429|P3|Premature Withdrawal|Overall Study - Prior to Booster Dose||6
270138|NCT00937521|654430|P2|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
270139|NCT00937521|654431|P1|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
270140|NCT00937521|654424|P8|STARTED|Overall Study - Prior to Booster Dose||184
270141|NCT00937521|654425|P7|STARTED|Overall Study - Prior to Booster Dose||186
270142|NCT00937521|654426|P6|STARTED|Overall Study - Prior to Booster Dose||188
270143|NCT00937521|654427|P5|STARTED|Overall Study - Prior to Booster Dose||191
270144|NCT00937521|654428|P4|STARTED|Overall Study - Prior to Booster Dose||188
270145|NCT00937521|654429|P3|STARTED|Overall Study - Prior to Booster Dose||192
270146|NCT00937521|654430|P2|STARTED|Overall Study - Prior to Booster Dose||190
270147|NCT00937521|654431|P1|STARTED|Overall Study - Prior to Booster Dose||188
270148|NCT00937495|654537|P1|NOT COMPLETED|Overall Study||2
270149|NCT00937495|654537|P1|COMPLETED|Overall Study||14
270150|NCT00937495|654537|P1|STARTED|Overall Study||16
270151|NCT00937404|654543|P1|NOT COMPLETED|Overall Study||2
270152|NCT00937404|654543|P1|COMPLETED|Overall Study||23
270153|NCT00937404|654543|P1|STARTED|Overall Study||25
270154|NCT00937391|654552|P1|NOT COMPLETED|Stage 2||1
270155|NCT00937391|654552|P1|COMPLETED|Stage 2|The number completed includes participants within the FAS and Per Protocol Set (PPS)|33
270156|NCT00937391|654552|P1|Treated|Stage 2|Valid for Full Analysis Set; participants administered correct Magnevist dose based on body weight|34
270157|NCT00937391|654552|P1|STARTED|Stage 2|Stage 1 and Stage 2 are independent each enrolling a different set of participants|34
270158|NCT00937391|654552|P1|NOT COMPLETED|Stage 1||0
270159|NCT00937391|654552|P1|COMPLETED|Stage 1||20
270160|NCT00937391|654552|P1|Treated|Stage 1|Valid for Full Analysis Set (FAS); includes all participants administered Magnevist Injection|20
270161|NCT00937391|654552|P1|STARTED|Stage 1||20
270162|NCT00937326|654608|P5|NOT COMPLETED|Overall Study||5
270163|NCT00937326|654609|P4|NOT COMPLETED|Overall Study||5
270164|NCT00937326|654610|P3|NOT COMPLETED|Overall Study||4
270165|NCT00937326|654611|P2|NOT COMPLETED|Overall Study||7
270166|NCT00937326|654612|P1|NOT COMPLETED|Overall Study||3
270167|NCT00937326|654608|P5|COMPLETED|Overall Study||40
270168|NCT00937326|654609|P4|COMPLETED|Overall Study||40
270169|NCT00937326|654610|P3|COMPLETED|Overall Study||42
270170|NCT00937326|654611|P2|COMPLETED|Overall Study||38
270171|NCT00937326|654612|P1|COMPLETED|Overall Study||43
270172|NCT00937326|654608|P5|STARTED|Overall Study||45
270173|NCT00937326|654609|P4|STARTED|Overall Study||45
270174|NCT00937326|654610|P3|STARTED|Overall Study||46
270175|NCT00937326|654611|P2|STARTED|Overall Study||45
270176|NCT00937326|654612|P1|STARTED|Overall Study||46
270177|NCT00937235|654840|P2|NOT COMPLETED|Overall Study||0
270178|NCT00937235|654841|P1|NOT COMPLETED|Overall Study||0
270179|NCT00937235|654840|P2|COMPLETED|Overall Study||70
270180|NCT00937235|654841|P1|COMPLETED|Overall Study||72
270181|NCT00937235|654840|P2|STARTED|Overall Study||70
270182|NCT00937235|654841|P1|STARTED|Overall Study||72
270183|NCT00937157|654861|P1|NOT COMPLETED|Overall Study||4
270184|NCT00937157|654861|P1|COMPLETED|Overall Study||8
270185|NCT00937157|654861|P1|STARTED|Overall Study||12
270186|NCT00937118|654865|P1|NOT COMPLETED|Overall Study||0
270187|NCT00937118|654865|P1|COMPLETED|Overall Study||41
270188|NCT00937118|654865|P1|STARTED|Overall Study||41
270189|NCT00937105|654874|P2|NOT COMPLETED|Overall Study||39
270190|NCT00937105|654875|P1|NOT COMPLETED|Overall Study||40
270191|NCT00937105|654874|P2|COMPLETED|Overall Study||70
270192|NCT00937105|654875|P1|COMPLETED|Overall Study||69
270193|NCT00937105|654874|P2|STARTED|Overall Study||109
270194|NCT00937105|654875|P1|STARTED|Overall Study||109
270195|NCT00937040|654892|P2|NOT COMPLETED|Overall Study||37
270196|NCT00937040|654893|P1|NOT COMPLETED|Overall Study||41
270197|NCT00937040|654892|P2|COMPLETED|Overall Study||141
270198|NCT00937040|654893|P1|COMPLETED|Overall Study||138
270199|NCT00937040|654892|P2|STARTED|Overall Study||178
270200|NCT00937040|654893|P1|STARTED|Overall Study||179
270201|NCT00936975|654935|P1|NOT COMPLETED|Overall Study||6
270202|NCT00936975|654935|P1|COMPLETED|Overall Study||12
270203|NCT00936975|654935|P1|STARTED|Overall Study||18
270204|NCT00936910|654944|P1|NOT COMPLETED|Overall Study||3
270205|NCT00936910|654944|P1|COMPLETED|Overall Study|The primary endpt. of 2 (-) cultures within 5 d of lock therapy was met for 10 patients|10
270206|NCT00936910|654944|P1|STARTED|Overall Study||13
270207|NCT00936897|654953|P2|NOT COMPLETED|Overall Study||60
270208|NCT00936897|654954|P1|NOT COMPLETED|Overall Study||19
270209|NCT00936897|654953|P2|COMPLETED|Overall Study||356
270210|NCT00936897|654954|P1|COMPLETED|Overall Study||398
270211|NCT00936897|654953|P2|STARTED|Overall Study|Randomized|416
270212|NCT00936897|654954|P1|STARTED|Overall Study|Randomized|417
270213|NCT00936741|654966|P1|NOT COMPLETED|Overall Study||9
270214|NCT00936741|654966|P1|COMPLETED|Overall Study||21
270215|NCT00936741|654966|P1|STARTED|Overall Study||30
270216|NCT00936715|654971|P1|NOT COMPLETED|Overall Study||6
270217|NCT00936715|654971|P1|COMPLETED|Overall Study||18
270218|NCT00936715|654971|P1|STARTED|Overall Study||24
270219|NCT00936702|654975|P1|NOT COMPLETED|Overall Study||46
270220|NCT00936702|654975|P1|COMPLETED|Overall Study||0
270221|NCT00936702|654975|P1|STARTED|Overall Study||46
270222|NCT00936663|654985|P2|NOT COMPLETED|Overall Study||0
270223|NCT00936663|654986|P1|NOT COMPLETED|Overall Study||0
270224|NCT00936663|654985|P2|COMPLETED|Overall Study||2
270225|NCT00936663|654986|P1|COMPLETED|Overall Study||1
270226|NCT00936663|654985|P2|STARTED|Overall Study||2
270227|NCT00936663|654986|P1|STARTED|Overall Study||1
270228|NCT00936598|655008|P2|NOT COMPLETED|Overall Study||0
270229|NCT00936598|655009|P1|NOT COMPLETED|Overall Study||2
270230|NCT00936598|655008|P2|COMPLETED|Overall Study||1
270231|NCT00936598|655009|P1|COMPLETED|Overall Study||2
270232|NCT00936598|655008|P2|STARTED|Overall Study||1
270233|NCT00936598|655009|P1|STARTED|Overall Study||4
270234|NCT00936585|655019|P1|NOT COMPLETED|Overall Study||0
270235|NCT00936585|655019|P1|COMPLETED|Overall Study||2
270236|NCT00936585|655019|P1|STARTED|Overall Study||2
270237|NCT00936481|655025|P2|NOT COMPLETED|Overall Study||0
270238|NCT00936481|655026|P1|NOT COMPLETED|Overall Study||0
270239|NCT00936481|655025|P2|COMPLETED|Overall Study||17
270240|NCT00936481|655026|P1|COMPLETED|Overall Study||17
270241|NCT00936481|655025|P2|STARTED|Overall Study||17
270242|NCT00936481|655026|P1|STARTED|Overall Study||17
270243|NCT00936455|655036|P2|NOT COMPLETED|Overall Study||0
270244|NCT00936455|655037|P1|NOT COMPLETED|Overall Study||0
270245|NCT00936455|655036|P2|COMPLETED|Overall Study||38
270246|NCT00936455|655037|P1|COMPLETED|Overall Study||37
270247|NCT00936455|655036|P2|STARTED|Overall Study||38
270248|NCT00936455|655037|P1|STARTED|Overall Study||37
270249|NCT00936377|655052|P3|NOT COMPLETED|Overall Study||0
270250|NCT00936377|655053|P2|NOT COMPLETED|Overall Study||0
270251|NCT00936377|655054|P1|NOT COMPLETED|Overall Study||0
270252|NCT00936377|655052|P3|COMPLETED|Overall Study||8
270253|NCT00936377|655053|P2|COMPLETED|Overall Study||8
270254|NCT00936377|655054|P1|COMPLETED|Overall Study||8
270255|NCT00936377|655052|P3|STARTED|Overall Study||8
270256|NCT00936377|655053|P2|STARTED|Overall Study||8
270257|NCT00936377|655054|P1|STARTED|Overall Study||8
270258|NCT00936351|655085|P2|NOT COMPLETED|Overall Study||2
270259|NCT00936351|655086|P1|NOT COMPLETED|Overall Study||3
270260|NCT00936351|655085|P2|COMPLETED|Overall Study||14
270261|NCT00936351|655086|P1|COMPLETED|Overall Study||15
270262|NCT00936351|655085|P2|STARTED|Overall Study||16
270263|NCT00936351|655086|P1|STARTED|Overall Study||18
270264|NCT00936221|655098|P2|NOT COMPLETED|Overall Study||1
270265|NCT00936221|655099|P1|NOT COMPLETED|Overall Study||1
270266|NCT00936221|655098|P2|COMPLETED|Overall Study|10 patients ongoing at data cutoff + 35 patients who had died.|45
270267|NCT00936221|655099|P1|COMPLETED|Overall Study|13 patients ongoing cutoff + 31 patients who had died.|44
270268|NCT00936221|655098|P2|Received Treatment|Overall Study||45
270269|NCT00936221|655099|P1|Received Treatment|Overall Study||44
270270|NCT00936221|655098|P2|STARTED|Overall Study||46
270271|NCT00936221|655099|P1|STARTED|Overall Study||45
270272|NCT00936208|655113|P2|NOT COMPLETED|Overall Study||22
270273|NCT00936208|655114|P1|NOT COMPLETED|Overall Study||37
270274|NCT00936208|655113|P2|COMPLETED|Overall Study||1574
270275|NCT00936208|655114|P1|COMPLETED|Overall Study||1462
270276|NCT00936208|655113|P2|STARTED|Overall Study||1596
270277|NCT00936208|655114|P1|STARTED|Overall Study||1499
270278|NCT00936117|655132|P1|NOT COMPLETED|Overall Study||10
270279|NCT00936117|655132|P1|COMPLETED|Overall Study|Completed 42 days on study drug|10
270280|NCT00936117|655132|P1|STARTED|Overall Study||20
270281|NCT00936065|655140|P3|NOT COMPLETED|Overall Study||7
270282|NCT00936065|655141|P2|NOT COMPLETED|Overall Study||4
270283|NCT00936065|655142|P1|NOT COMPLETED|Overall Study||4
270284|NCT00936065|655140|P3|COMPLETED|Overall Study||12
270285|NCT00936065|655141|P2|COMPLETED|Overall Study||16
270286|NCT00936065|655142|P1|COMPLETED|Overall Study||17
270287|NCT00936065|655140|P3|Study Assessments Performed|Overall Study||18
270288|NCT00936065|655141|P2|Study Assessments Performed|Overall Study||19
270289|NCT00936065|655142|P1|Study Assessments Performed|Overall Study||21
270290|NCT00936065|655140|P3|Received Treatment|Overall Study||18
270291|NCT00936065|655141|P2|Received Treatment|Overall Study||20
270292|NCT00936065|655142|P1|Received Treatment|Overall Study||21
270293|NCT00936065|655140|P3|STARTED|Overall Study||19
270294|NCT00936065|655141|P2|STARTED|Overall Study||20
270295|NCT00936065|655142|P1|STARTED|Overall Study||21
270296|NCT00935883|655248|P2|NOT COMPLETED|Follow-Up Period||0
270297|NCT00935883|655249|P1|NOT COMPLETED|Follow-Up Period||0
270298|NCT00935883|655248|P2|COMPLETED|Follow-Up Period||38
270299|NCT00935883|655249|P1|COMPLETED|Follow-Up Period||19
270300|NCT00935883|655248|P2|STARTED|Follow-Up Period||38
270301|NCT00935883|655249|P1|STARTED|Follow-Up Period||19
270302|NCT00935883|655248|P2|NOT COMPLETED|Treatment Period||2
270303|NCT00935883|655249|P1|NOT COMPLETED|Treatment Period||1
270304|NCT00935883|655248|P2|COMPLETED|Treatment Period||38
270305|NCT00935883|655249|P1|COMPLETED|Treatment Period||19
270306|NCT00935883|655248|P2|STARTED|Treatment Period||40
270307|NCT00935883|655249|P1|STARTED|Treatment Period||20
270308|NCT00935857|655263|P2|NOT COMPLETED|Overall Study||0
270309|NCT00935857|655264|P1|NOT COMPLETED|Overall Study||0
270310|NCT00935857|655263|P2|COMPLETED|Overall Study||16
270311|NCT00935857|655264|P1|COMPLETED|Overall Study||14
270312|NCT00935857|655263|P2|STARTED|Overall Study||16
270313|NCT00935857|655264|P1|STARTED|Overall Study||14
270314|NCT00935818|655276|P2|NOT COMPLETED|Overall Study||100
270315|NCT00935818|655277|P1|NOT COMPLETED|Overall Study||91
270316|NCT00935818|655276|P2|COMPLETED|Overall Study||157
270317|NCT00935818|655277|P1|COMPLETED|Overall Study||158
270318|NCT00935818|655276|P2|End of Medication Phase|Overall Study||184
270319|NCT00935818|655277|P1|End of Medication Phase|Overall Study||182
270320|NCT00935818|655276|P2|STARTED|Overall Study||257
270321|NCT00935818|655277|P1|STARTED|Overall Study||249
270322|NCT00935792|655298|P3|NOT COMPLETED|Overall Study||0
270323|NCT00935792|655299|P2|NOT COMPLETED|Overall Study||3
270324|NCT00935792|655300|P1|NOT COMPLETED|Overall Study||1
270325|NCT00935792|655298|P3|COMPLETED|Overall Study||12
270326|NCT00935792|655299|P2|COMPLETED|Overall Study||6
270327|NCT00935792|655300|P1|COMPLETED|Overall Study||6
270328|NCT00935792|655298|P3|STARTED|Overall Study||12
270329|NCT00935792|655299|P2|STARTED|Overall Study||9
270330|NCT00935792|655300|P1|STARTED|Overall Study||7
270331|NCT00935766|655317|P2|NOT COMPLETED|Overall Study||7
270332|NCT00935766|655318|P1|NOT COMPLETED|Overall Study||7
270333|NCT00935766|655317|P2|COMPLETED|Overall Study||27
270334|NCT00935766|655318|P1|COMPLETED|Overall Study||35
270335|NCT00935766|655317|P2|STARTED|Overall Study||34
270336|NCT00935766|655318|P1|STARTED|Overall Study||42
270337|NCT00935701|655328|P1|NOT COMPLETED|Overall Study||1
270338|NCT00935701|655328|P1|COMPLETED|Overall Study||9
270339|NCT00935701|655328|P1|Transition Acupressure to Acupuncture|Overall Study||9
270340|NCT00935701|655328|P1|STARTED|Overall Study||10
270341|NCT00935649|655335|P1|NOT COMPLETED|Overall Study||5
270342|NCT00935649|655335|P1|COMPLETED|Overall Study||134
270343|NCT00935649|655335|P1|STARTED|Overall Study||139
270344|NCT00935584|655345|P2|NOT COMPLETED|Overall Study||4
270345|NCT00935584|655346|P1|NOT COMPLETED|Overall Study||49
270346|NCT00935584|655345|P2|COMPLETED|Overall Study||19
270347|NCT00935584|655346|P1|COMPLETED|Overall Study||77
270348|NCT00935584|655345|P2|STARTED|Overall Study||23
270349|NCT00935584|655346|P1|STARTED|Overall Study|Out of 128 participants consented, 2 patients had no data collected, as the clinic was cancelled.|126
270350|NCT00935532|655358|P2|NOT COMPLETED|Overall Study||11
270351|NCT00935532|655359|P1|NOT COMPLETED|Overall Study||22
270352|NCT00935532|655358|P2|COMPLETED|Overall Study||201
270353|NCT00935532|655359|P1|COMPLETED|Overall Study||193
270354|NCT00935532|655358|P2|STARTED|Overall Study||212
270355|NCT00935532|655359|P1|STARTED|Overall Study||215
270356|NCT00935493|655388|P3|NOT COMPLETED|Overall Study||1
270357|NCT00935493|655389|P2|NOT COMPLETED|Overall Study||2
270358|NCT00935493|655390|P1|NOT COMPLETED|Overall Study||1
270359|NCT00935493|655388|P3|COMPLETED|Overall Study||40
270360|NCT00935493|655389|P2|COMPLETED|Overall Study||39
270361|NCT00935493|655390|P1|COMPLETED|Overall Study||40
270362|NCT00935493|655388|P3|STARTED|Overall Study||41
270363|NCT00935493|655389|P2|STARTED|Overall Study||41
270364|NCT00935493|655390|P1|STARTED|Overall Study||41
270365|NCT00935311|655407|P3|NOT COMPLETED|Overall Study||0
270366|NCT00935311|655408|P2|NOT COMPLETED|Overall Study||0
270367|NCT00935311|655409|P1|NOT COMPLETED|Overall Study||0
270368|NCT00935311|655407|P3|COMPLETED|Overall Study||40
270369|NCT00935311|655408|P2|COMPLETED|Overall Study||39
270370|NCT00935311|655409|P1|COMPLETED|Overall Study||43
270371|NCT00935311|655407|P3|STARTED|Overall Study||40
270372|NCT00935311|655408|P2|STARTED|Overall Study||39
270373|NCT00935311|655409|P1|STARTED|Overall Study||43
270374|NCT00935272|655428|P2|NOT COMPLETED|Overall Study||6
270375|NCT00935272|655429|P1|NOT COMPLETED|Overall Study||19
270376|NCT00935272|655428|P2|COMPLETED|Overall Study||39
270377|NCT00935272|655429|P1|COMPLETED|Overall Study||116
270378|NCT00935272|655428|P2|STARTED|Overall Study||45
270379|NCT00935272|655429|P1|STARTED|Overall Study||135
270380|NCT00935259|655438|P2|NOT COMPLETED|Period 2||0
270381|NCT00935259|655439|P1|NOT COMPLETED|Period 2||0
270382|NCT00935259|655438|P2|COMPLETED|Period 2||14
270383|NCT00935259|655439|P1|COMPLETED|Period 2||15
270384|NCT00935259|655438|P2|STARTED|Period 2||14
270385|NCT00935259|655439|P1|STARTED|Period 2||15
270386|NCT00935259|655438|P2|NOT COMPLETED|Period 1||1
270387|NCT00935259|655439|P1|NOT COMPLETED|Period 1||1
270388|NCT00935259|655438|P2|COMPLETED|Period 1||14
270389|NCT00935259|655439|P1|COMPLETED|Period 1||15
270390|NCT00935259|655438|P2|STARTED|Period 1||15
270391|NCT00935259|655439|P1|STARTED|Period 1||16
270392|NCT00935220|655453|P1|NOT COMPLETED|Overall Study||2
270393|NCT00935220|655453|P1|COMPLETED|Overall Study||39
270394|NCT00935220|655453|P1|STARTED|Overall Study||41
270395|NCT00935064|655467|P2|NOT COMPLETED|Overall Study||0
270396|NCT00935064|655468|P1|NOT COMPLETED|Overall Study||0
270397|NCT00935064|655467|P2|COMPLETED|Overall Study||30
270398|NCT00935064|655468|P1|COMPLETED|Overall Study||30
270399|NCT00935064|655467|P2|STARTED|Overall Study||30
270400|NCT00935064|655468|P1|STARTED|Overall Study||30
270401|NCT00934947|655484|P2|NOT COMPLETED|Overall Study||2
270402|NCT00934947|655485|P1|NOT COMPLETED|Overall Study||0
270403|NCT00934947|655484|P2|COMPLETED|Overall Study||20
270404|NCT00934947|655485|P1|COMPLETED|Overall Study||23
270405|NCT00934947|655484|P2|STARTED|Overall Study||22
270406|NCT00934947|655485|P1|STARTED|Overall Study||23
270407|NCT00934921|655499|P2|NOT COMPLETED|Second Intervention||0
270408|NCT00934921|655500|P1|NOT COMPLETED|Second Intervention||0
270409|NCT00934921|655499|P2|COMPLETED|Second Intervention||12
270410|NCT00934921|655500|P1|COMPLETED|Second Intervention||12
270411|NCT00934921|655499|P2|STARTED|Second Intervention||12
270412|NCT00934921|655500|P1|STARTED|Second Intervention||12
270413|NCT00934921|655499|P2|NOT COMPLETED|First Intervention||0
270414|NCT00934921|655500|P1|NOT COMPLETED|First Intervention||0
270415|NCT00934921|655499|P2|COMPLETED|First Intervention||12
270416|NCT00934921|655500|P1|COMPLETED|First Intervention||12
270417|NCT00934921|655499|P2|STARTED|First Intervention||12
270418|NCT00934921|655500|P1|STARTED|First Intervention||12
270419|NCT00934856|655514|P6|NOT COMPLETED|Extension Part||5
270420|NCT00934856|655515|P5|NOT COMPLETED|Extension Part||4
270421|NCT00934856|655516|P4|NOT COMPLETED|Extension Part||2
270422|NCT00934856|655517|P3|NOT COMPLETED|Extension Part||0
270423|NCT00934856|655518|P2|NOT COMPLETED|Extension Part||0
270424|NCT00934856|655519|P1|NOT COMPLETED|Extension Part||0
270425|NCT00934856|655514|P6|COMPLETED|Extension Part||19
270426|NCT00934856|655515|P5|COMPLETED|Extension Part||24
270427|NCT00934856|655516|P4|COMPLETED|Extension Part||2
270428|NCT00934856|655517|P3|COMPLETED|Extension Part||0
270429|NCT00934856|655518|P2|COMPLETED|Extension Part||0
270430|NCT00934856|655519|P1|COMPLETED|Extension Part||0
270431|NCT00934856|655514|P6|STARTED|Extension Part|New participants were enrolled in the extension part.|24
270432|NCT00934856|655515|P5|STARTED|Extension Part|New participants were enrolled in the extension part.|28
270433|NCT00934856|655516|P4|STARTED|Extension Part|New participants were enrolled in the extension part.|4
270434|NCT00934856|655517|P3|STARTED|Extension Part||0
270435|NCT00934856|655518|P2|STARTED|Extension Part||0
270436|NCT00934856|655519|P1|STARTED|Extension Part||0
270437|NCT00934856|655514|P6|NOT COMPLETED|Feasibility Part||3
270438|NCT00934856|655515|P5|NOT COMPLETED|Feasibility Part||0
270439|NCT00934856|655516|P4|NOT COMPLETED|Feasibility Part||5
270440|NCT00934856|655517|P3|NOT COMPLETED|Feasibility Part||3
270441|NCT00934856|655518|P2|NOT COMPLETED|Feasibility Part||5
270442|NCT00934856|655519|P1|NOT COMPLETED|Feasibility Part||5
270443|NCT00934856|655514|P6|COMPLETED|Feasibility Part||6
270444|NCT00934856|655515|P5|COMPLETED|Feasibility Part||12
270445|NCT00934856|655516|P4|COMPLETED|Feasibility Part||1
270446|NCT00934856|655517|P3|COMPLETED|Feasibility Part||0
270447|NCT00934856|655518|P2|COMPLETED|Feasibility Part||1
270448|NCT00934856|655519|P1|COMPLETED|Feasibility Part||1
270449|NCT00934856|655514|P6|STARTED|Feasibility Part||9
270450|NCT00934856|655515|P5|STARTED|Feasibility Part||12
270451|NCT00934856|655516|P4|STARTED|Feasibility Part||6
270452|NCT00934856|655517|P3|STARTED|Feasibility Part||3
270453|NCT00934856|655518|P2|STARTED|Feasibility Part||6
270454|NCT00934856|655519|P1|STARTED|Feasibility Part||6
270455|NCT00934843|655617|P2|NOT COMPLETED|Overall Study||1
270456|NCT00934843|655618|P1|NOT COMPLETED|Overall Study||0
270457|NCT00934843|655617|P2|COMPLETED|Overall Study|1 subject discontinued intervention, surgery plan changed and did not require CPB|39
270458|NCT00934843|655618|P1|COMPLETED|Overall Study||37
270459|NCT00934843|655617|P2|STARTED|Overall Study||40
270460|NCT00934843|655618|P1|STARTED|Overall Study||37
270461|NCT00934791|655634|P2|NOT COMPLETED|Overall Study||0
270462|NCT00934791|655635|P1|NOT COMPLETED|Overall Study||1
270463|NCT00934791|655634|P2|COMPLETED|Overall Study||0
270464|NCT00934791|655635|P1|COMPLETED|Overall Study||0
270465|NCT00934791|655634|P2|STARTED|Overall Study||0
270466|NCT00934791|655635|P1|STARTED|Overall Study||1
270467|NCT00934661|655643|P2|NOT COMPLETED|Overall Study||0
270468|NCT00934661|655644|P1|NOT COMPLETED|Overall Study||1
270469|NCT00934661|655643|P2|COMPLETED|Overall Study||20
270470|NCT00934661|655644|P1|COMPLETED|Overall Study||19
270471|NCT00934661|655643|P2|STARTED|Overall Study||20
270472|NCT00934661|655644|P1|STARTED|Overall Study||20
270473|NCT00934648|655664|P1|NOT COMPLETED|Overall Study||9
270474|NCT00934648|655664|P1|COMPLETED|Overall Study||6
270475|NCT00934648|655664|P1|STARTED|Overall Study||15
270476|NCT00934635|655680|P9|NOT COMPLETED|Overall Study||0
270477|NCT00934635|655681|P8|NOT COMPLETED|Overall Study||0
270478|NCT00934635|655682|P7|NOT COMPLETED|Overall Study||0
270479|NCT00934635|655683|P6|NOT COMPLETED|Overall Study||0
270480|NCT00934635|655684|P5|NOT COMPLETED|Overall Study||0
270481|NCT00934635|655685|P4|NOT COMPLETED|Overall Study||0
270482|NCT00934635|655686|P3|NOT COMPLETED|Overall Study||0
270483|NCT00934635|655687|P2|NOT COMPLETED|Overall Study||0
270484|NCT00934635|655688|P1|NOT COMPLETED|Overall Study||0
270485|NCT00934635|655680|P9|COMPLETED|Overall Study||1
270486|NCT00934635|655681|P8|COMPLETED|Overall Study||0
270487|NCT00934635|655682|P7|COMPLETED|Overall Study||0
270488|NCT00934635|655683|P6|COMPLETED|Overall Study||0
270489|NCT00934635|655684|P5|COMPLETED|Overall Study||0
270490|NCT00934635|655685|P4|COMPLETED|Overall Study||0
270491|NCT00934635|655686|P3|COMPLETED|Overall Study||0
270492|NCT00934635|655687|P2|COMPLETED|Overall Study||1
270493|NCT00934635|655688|P1|COMPLETED|Overall Study||0
270494|NCT00934635|655680|P9|STARTED|Overall Study||1
270495|NCT00934635|655681|P8|STARTED|Overall Study||0
270496|NCT00934635|655682|P7|STARTED|Overall Study||0
270497|NCT00934635|655683|P6|STARTED|Overall Study||0
270498|NCT00934635|655684|P5|STARTED|Overall Study||0
270499|NCT00934635|655685|P4|STARTED|Overall Study||0
270500|NCT00934635|655686|P3|STARTED|Overall Study||0
270501|NCT00934635|655687|P2|STARTED|Overall Study||1
270502|NCT00934635|655688|P1|STARTED|Overall Study||0
270503|NCT00934622|655708|P1|NOT COMPLETED|Overall Study||8
270504|NCT00934622|655708|P1|COMPLETED|Overall Study||68
270505|NCT00934622|655708|P1|STARTED|Overall Study||76
270506|NCT00934596|655715|P2|NOT COMPLETED|Overall Study||0
270507|NCT00934596|655716|P1|NOT COMPLETED|Overall Study||0
270508|NCT00934596|655715|P2|COMPLETED|Overall Study||10
270509|NCT00934596|655716|P1|COMPLETED|Overall Study||10
270510|NCT00934596|655715|P2|STARTED|Overall Study||10
270511|NCT00934596|655716|P1|STARTED|Overall Study|Twenty patients were prospectively randomly assigned to the two arms|10
270512|NCT00934544|655746|P3|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||34
270513|NCT00934544|655747|P2|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||28
270514|NCT00934544|655748|P1|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||107
270515|NCT00934544|655746|P3|COMPLETED|Overall Disposition at 5 Year Follow-up||11
270516|NCT00934544|655747|P2|COMPLETED|Overall Disposition at 5 Year Follow-up||0
270517|NCT00934544|655748|P1|COMPLETED|Overall Disposition at 5 Year Follow-up||39
270518|NCT00934544|655746|P3|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||6
270519|NCT00934544|655747|P2|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||0
270520|NCT00934544|655748|P1|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||0
270521|NCT00934544|655746|P3|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||12
270522|NCT00934544|655747|P2|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||0
270523|NCT00934544|655748|P1|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||0
270524|NCT00934544|655746|P3|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||27
270525|NCT00934544|655747|P2|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||0
270526|NCT00934544|655748|P1|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||0
270527|NCT00934544|655746|P3|STARTED|Overall Disposition at 5 Year Follow-up||45
270528|NCT00934544|655747|P2|STARTED|Overall Disposition at 5 Year Follow-up||28
270529|NCT00934544|655748|P1|STARTED|Overall Disposition at 5 Year Follow-up||146
270530|NCT00934544|655746|P3|NOT COMPLETED|Primary Endpoint Analysis (Interim)||0
270531|NCT00934544|655747|P2|NOT COMPLETED|Primary Endpoint Analysis (Interim)||42
270532|NCT00934544|655748|P1|NOT COMPLETED|Primary Endpoint Analysis (Interim)||55
270533|NCT00934544|655746|P3|COMPLETED|Primary Endpoint Analysis (Interim)||0
270534|NCT00934544|655747|P2|COMPLETED|Primary Endpoint Analysis (Interim)||31
270535|NCT00934544|655748|P1|COMPLETED|Primary Endpoint Analysis (Interim)||91
270536|NCT00934544|655746|P3|STARTED|Primary Endpoint Analysis (Interim)||0
270537|NCT00934544|655747|P2|STARTED|Primary Endpoint Analysis (Interim)||73
270538|NCT00934544|655748|P1|STARTED|Primary Endpoint Analysis (Interim)||146
270539|NCT00934440|655784|P1|NOT COMPLETED|Overall Study||1
270540|NCT00934440|655784|P1|COMPLETED|Overall Study||10
270541|NCT00934440|655784|P1|STARTED|Overall Study||11
270542|NCT00934375|655791|P2|NOT COMPLETED|Overall Study||22
270543|NCT00934375|655792|P1|NOT COMPLETED|Overall Study||13
270544|NCT00934375|655791|P2|COMPLETED|Overall Study||55
270545|NCT00934375|655792|P1|COMPLETED|Overall Study||55
270546|NCT00934375|655791|P2|STARTED|Overall Study||77
270547|NCT00934375|655792|P1|STARTED|Overall Study||68
270548|NCT00934362|655800|P2|NOT COMPLETED|Overall Study||0
270549|NCT00934362|655801|P1|NOT COMPLETED|Overall Study||1
270550|NCT00934362|655800|P2|COMPLETED|Overall Study||8
270551|NCT00934362|655801|P1|COMPLETED|Overall Study||7
270552|NCT00934362|655800|P2|STARTED|Overall Study||8
270553|NCT00934362|655801|P1|STARTED|Overall Study||8
270554|NCT00934180|655811|P2|NOT COMPLETED|Second Intervention||0
270555|NCT00934180|655812|P1|NOT COMPLETED|Second Intervention||0
270556|NCT00934180|655811|P2|COMPLETED|Second Intervention||12
270557|NCT00934180|655812|P1|COMPLETED|Second Intervention||12
270558|NCT00934180|655811|P2|STARTED|Second Intervention||12
270559|NCT00934180|655812|P1|STARTED|Second Intervention||12
270560|NCT00934180|655811|P2|NOT COMPLETED|First Intervention||0
270561|NCT00934180|655812|P1|NOT COMPLETED|First Intervention||0
270562|NCT00934180|655811|P2|COMPLETED|First Intervention||12
270563|NCT00934180|655812|P1|COMPLETED|First Intervention||12
270564|NCT00934180|655811|P2|STARTED|First Intervention||12
270565|NCT00934180|655812|P1|STARTED|First Intervention||12
270566|NCT00934141|655824|P4|NOT COMPLETED|Overall Study||3
270567|NCT00934141|655825|P3|NOT COMPLETED|Overall Study||0
270568|NCT00934141|655826|P2|NOT COMPLETED|Overall Study||3
270569|NCT00934141|655827|P1|NOT COMPLETED|Overall Study||4
270570|NCT00934141|655824|P4|COMPLETED|Overall Study||51
270571|NCT00934141|655825|P3|COMPLETED|Overall Study||48
270572|NCT00934141|655826|P2|COMPLETED|Overall Study||47
270573|NCT00934141|655827|P1|COMPLETED|Overall Study||45
270574|NCT00934141|655824|P4|STARTED|Overall Study||54
270575|NCT00934141|655825|P3|STARTED|Overall Study||48
270576|NCT00934141|655826|P2|STARTED|Overall Study||50
270577|NCT00934141|655827|P1|STARTED|Overall Study||49
270578|NCT00934128|655851|P2|NOT COMPLETED|Second Intervention (2 Hours)||3
270579|NCT00934128|655852|P1|NOT COMPLETED|Second Intervention (2 Hours)||0
270580|NCT00934128|655851|P2|COMPLETED|Second Intervention (2 Hours)||5
270581|NCT00934128|655852|P1|COMPLETED|Second Intervention (2 Hours)||3
270582|NCT00934128|655851|P2|STARTED|Second Intervention (2 Hours)||8
270583|NCT00934128|655852|P1|STARTED|Second Intervention (2 Hours)||3
270584|NCT00934128|655851|P2|NOT COMPLETED|Washout Period (1 Hour)||5
270585|NCT00934128|655852|P1|NOT COMPLETED|Washout Period (1 Hour)||7
270586|NCT00934128|655851|P2|COMPLETED|Washout Period (1 Hour)||8
270587|NCT00934128|655852|P1|COMPLETED|Washout Period (1 Hour)||3
270588|NCT00934128|655851|P2|STARTED|Washout Period (1 Hour)||13
270589|NCT00934128|655852|P1|STARTED|Washout Period (1 Hour)||10
270590|NCT00934128|655851|P2|NOT COMPLETED|First Intervention (2 Hours)||2
270591|NCT00934128|655852|P1|NOT COMPLETED|First Intervention (2 Hours)||5
270592|NCT00934128|655851|P2|COMPLETED|First Intervention (2 Hours)||13
270593|NCT00934128|655852|P1|COMPLETED|First Intervention (2 Hours)||10
270594|NCT00934128|655851|P2|STARTED|First Intervention (2 Hours)||15
270595|NCT00934128|655852|P1|STARTED|First Intervention (2 Hours)||15
270596|NCT00934102|655860|P3|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
270597|NCT00934102|655861|P2|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
270598|NCT00934102|655862|P1|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
270599|NCT00934102|655860|P3|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
270600|NCT00934102|655861|P2|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
270601|NCT00934102|655862|P1|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
270602|NCT00934102|655860|P3|STARTED|Period 2, 7 Days/6 Nights of Wear||15
270603|NCT00934102|655861|P2|STARTED|Period 2, 7 Days/6 Nights of Wear||15
270604|NCT00934102|655862|P1|STARTED|Period 2, 7 Days/6 Nights of Wear||15
270605|NCT00934102|655860|P3|NOT COMPLETED|Period 1, One Night of Wear||0
270606|NCT00934102|655861|P2|NOT COMPLETED|Period 1, One Night of Wear||0
270607|NCT00934102|655862|P1|NOT COMPLETED|Period 1, One Night of Wear||1
270608|NCT00934102|655860|P3|COMPLETED|Period 1, One Night of Wear||15
270609|NCT00934102|655861|P2|COMPLETED|Period 1, One Night of Wear||15
270610|NCT00934102|655862|P1|COMPLETED|Period 1, One Night of Wear||15
270611|NCT00934102|655860|P3|STARTED|Period 1, One Night of Wear||15
270612|NCT00934102|655861|P2|STARTED|Period 1, One Night of Wear||15
270613|NCT00934102|655862|P1|STARTED|Period 1, One Night of Wear||16
270614|NCT00934050|655876|P6|NOT COMPLETED|Enrolled After 15 Dec 2009||4
270615|NCT00934050|655877|P5|NOT COMPLETED|Enrolled After 15 Dec 2009||7
270616|NCT00934050|655878|P4|NOT COMPLETED|Enrolled After 15 Dec 2009||0
270617|NCT00934050|655879|P3|NOT COMPLETED|Enrolled After 15 Dec 2009||0
270618|NCT00934050|655880|P2|NOT COMPLETED|Enrolled After 15 Dec 2009||0
270619|NCT00934050|655881|P1|NOT COMPLETED|Enrolled After 15 Dec 2009||0
270620|NCT00934050|655876|P6|COMPLETED|Enrolled After 15 Dec 2009||23
270621|NCT00934050|655877|P5|COMPLETED|Enrolled After 15 Dec 2009||19
270622|NCT00934050|655878|P4|COMPLETED|Enrolled After 15 Dec 2009||0
270623|NCT00934050|655879|P3|COMPLETED|Enrolled After 15 Dec 2009||0
270624|NCT00934050|655880|P2|COMPLETED|Enrolled After 15 Dec 2009||0
270625|NCT00934050|655881|P1|COMPLETED|Enrolled After 15 Dec 2009||0
270626|NCT00934050|655876|P6|STARTED|Enrolled After 15 Dec 2009||27
270627|NCT00934050|655877|P5|STARTED|Enrolled After 15 Dec 2009||26
270628|NCT00934050|655878|P4|STARTED|Enrolled After 15 Dec 2009||0
270629|NCT00934050|655879|P3|STARTED|Enrolled After 15 Dec 2009||0
270630|NCT00934050|655880|P2|STARTED|Enrolled After 15 Dec 2009||0
270631|NCT00934050|655881|P1|STARTED|Enrolled After 15 Dec 2009||0
270632|NCT00934050|655876|P6|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
270633|NCT00934050|655877|P5|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
270634|NCT00934050|655878|P4|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||14
270635|NCT00934050|655879|P3|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
270636|NCT00934050|655880|P2|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
270637|NCT00934050|655881|P1|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
270638|NCT00934050|655876|P6|COMPLETED|Enrolled Prior to 15 Dec 2009||0
270639|NCT00934050|655877|P5|COMPLETED|Enrolled Prior to 15 Dec 2009||0
270640|NCT00934050|655878|P4|COMPLETED|Enrolled Prior to 15 Dec 2009||0
270641|NCT00934050|655879|P3|COMPLETED|Enrolled Prior to 15 Dec 2009||0
270642|NCT00934050|655880|P2|COMPLETED|Enrolled Prior to 15 Dec 2009||0
270643|NCT00934050|655881|P1|COMPLETED|Enrolled Prior to 15 Dec 2009||0
270644|NCT00934050|655876|P6|STARTED|Enrolled Prior to 15 Dec 2009||0
270645|NCT00934050|655877|P5|STARTED|Enrolled Prior to 15 Dec 2009||0
270646|NCT00934050|655878|P4|STARTED|Enrolled Prior to 15 Dec 2009||14
270647|NCT00934050|655879|P3|STARTED|Enrolled Prior to 15 Dec 2009||12
270648|NCT00934050|655880|P2|STARTED|Enrolled Prior to 15 Dec 2009||12
270649|NCT00934050|655881|P1|STARTED|Enrolled Prior to 15 Dec 2009||12
270650|NCT00934024|655893|P2|NOT COMPLETED|Overall Study||5
270651|NCT00934024|655894|P1|NOT COMPLETED|Overall Study||0
270652|NCT00934024|655893|P2|COMPLETED|Overall Study||6
270653|NCT00934024|655894|P1|COMPLETED|Overall Study||10
270654|NCT00934024|655893|P2|STARTED|Overall Study||11
270655|NCT00934024|655894|P1|STARTED|Overall Study||10
270656|NCT00933933|655904|P3|NOT COMPLETED|Pediatric From 2 to 21 Years||0
270657|NCT00933933|655905|P2|NOT COMPLETED|Pediatric From 2 to 21 Years||0
270658|NCT00933933|655906|P1|NOT COMPLETED|Pediatric From 2 to 21 Years||0
270659|NCT00933933|655904|P3|COMPLETED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women|0
270660|NCT00933933|655905|P2|COMPLETED|Pediatric From 2 to 21 Years||64
270661|NCT00933933|655906|P1|COMPLETED|Pediatric From 2 to 21 Years||588
270662|NCT00933933|655904|P3|STARTED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women.|0
270663|NCT00933933|655905|P2|STARTED|Pediatric From 2 to 21 Years||64
270664|NCT00933933|655906|P1|STARTED|Pediatric From 2 to 21 Years||588
270665|NCT00933933|655904|P3|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
270666|NCT00933933|655905|P2|NOT COMPLETED|Pregnant Females Between 16-44 Years||2
270667|NCT00933933|655906|P1|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
270668|NCT00933933|655904|P3|COMPLETED|Pregnant Females Between 16-44 Years||203
270669|NCT00933933|655905|P2|COMPLETED|Pregnant Females Between 16-44 Years||65
270670|NCT00933933|655906|P1|COMPLETED|Pregnant Females Between 16-44 Years||448
270671|NCT00933933|655904|P3|STARTED|Pregnant Females Between 16-44 Years||203
270672|NCT00933933|655905|P2|STARTED|Pregnant Females Between 16-44 Years||67
270673|NCT00933933|655906|P1|STARTED|Pregnant Females Between 16-44 Years||448
270674|NCT00933933|655904|P3|NOT COMPLETED|General Population From 16 to 89 Years||0
270675|NCT00933933|655905|P2|NOT COMPLETED|General Population From 16 to 89 Years||20
270676|NCT00933933|655906|P1|NOT COMPLETED|General Population From 16 to 89 Years||0
270677|NCT00933933|655904|P3|COMPLETED|General Population From 16 to 89 Years||1206
270678|NCT00933933|655905|P2|COMPLETED|General Population From 16 to 89 Years||1267
270679|NCT00933933|655906|P1|COMPLETED|General Population From 16 to 89 Years||6164
270680|NCT00933933|655904|P3|STARTED|General Population From 16 to 89 Years||1206
270681|NCT00933933|655905|P2|STARTED|General Population From 16 to 89 Years||1287
270682|NCT00933933|655906|P1|STARTED|General Population From 16 to 89 Years||6164
270683|NCT00933686|655924|P2|NOT COMPLETED|Overall Study||11
270684|NCT00933686|655925|P1|NOT COMPLETED|Overall Study||10
270685|NCT00933686|655924|P2|COMPLETED|Overall Study||47
270686|NCT00933686|655925|P1|COMPLETED|Overall Study||45
270687|NCT00933686|655924|P2|STARTED|Overall Study||58
270688|NCT00933686|655925|P1|STARTED|Overall Study||55
270689|NCT00933608|655945|P2|NOT COMPLETED|Overall Study||2
270690|NCT00933608|655946|P1|NOT COMPLETED|Overall Study||5
270691|NCT00933608|655945|P2|COMPLETED|Overall Study||8
270692|NCT00933608|655946|P1|COMPLETED|Overall Study||2
270693|NCT00933608|655945|P2|STARTED|Overall Study||10
270694|NCT00933608|655946|P1|STARTED|Overall Study||7
270695|NCT00933543|655954|P2|NOT COMPLETED|Overall Study||7
270696|NCT00933543|655955|P1|NOT COMPLETED|Overall Study||3
270697|NCT00933543|655954|P2|COMPLETED|Overall Study||46
270698|NCT00933543|655955|P1|COMPLETED|Overall Study||51
270699|NCT00933543|655954|P2|STARTED|Overall Study||53
270700|NCT00933543|655955|P1|STARTED|Overall Study||54
270701|NCT00933491|656013|P2|NOT COMPLETED|Overall Study||0
270702|NCT00933491|656014|P1|NOT COMPLETED|Overall Study||0
270703|NCT00933491|656013|P2|COMPLETED|Overall Study||18
270704|NCT00933491|656014|P1|COMPLETED|Overall Study||14
270705|NCT00933491|656013|P2|STARTED|Overall Study||18
270706|NCT00933491|656014|P1|STARTED|Overall Study||14
270707|NCT00933335|656024|P2|NOT COMPLETED|Overall Study||16
270708|NCT00933335|656025|P1|NOT COMPLETED|Overall Study||2
270709|NCT00933335|656024|P2|COMPLETED|Overall Study||20
270710|NCT00933335|656025|P1|COMPLETED|Overall Study||0
270711|NCT00933335|656024|P2|STARTED|Overall Study|35/36 participants who received 3 cycles of fludarabine later received a DD and TD of TST/I 131 TST.|36
270712|NCT00933335|656025|P1|STARTED|Overall Study||2
270713|NCT00933270|656095|P1|NOT COMPLETED|Overall Study||87
270714|NCT00933270|656095|P1|COMPLETED|Overall Study||177
270715|NCT00933270|656095|P1|STARTED|Overall Study|ITT population|264
270716|NCT00933244|656189|P3|NOT COMPLETED|Overall Study||3
270717|NCT00933244|656190|P2|NOT COMPLETED|Overall Study||1
270718|NCT00933244|656191|P1|NOT COMPLETED|Overall Study||5
270719|NCT00933244|656189|P3|COMPLETED|Overall Study||73
270720|NCT00933244|656190|P2|COMPLETED|Overall Study||74
270721|NCT00933244|656191|P1|COMPLETED|Overall Study||74
270722|NCT00933244|656189|P3|STARTED|Overall Study||76
270723|NCT00933244|656190|P2|STARTED|Overall Study||75
270724|NCT00933244|656191|P1|STARTED|Overall Study||79
270725|NCT00933166|656208|P1|NOT COMPLETED|Overall Study||18
270726|NCT00933166|656208|P1|COMPLETED|Overall Study||151
270727|NCT00933166|656208|P1|STARTED|Overall Study||169
270728|NCT00932893|656214|P2|NOT COMPLETED|Overall Study||170
270729|NCT00932893|656215|P1|NOT COMPLETED|Overall Study||133
270730|NCT00932893|656214|P2|COMPLETED|Overall Study||4
270731|NCT00932893|656215|P1|COMPLETED|Overall Study||40
270732|NCT00932893|656214|P2|Treated|Overall Study||171
270733|NCT00932893|656215|P1|Treated|Overall Study||172
270734|NCT00932893|656214|P2|STARTED|Overall Study||174
270735|NCT00932893|656215|P1|STARTED|Overall Study||173
270736|NCT00932828|656246|P1|NOT COMPLETED|Overall Study||5
270737|NCT00932828|656246|P1|COMPLETED|Overall Study|5 subjects who did not complete the protocol were considered in an ITT analysis.|32
270738|NCT00932828|656246|P1|STARTED|Overall Study||37
270739|NCT00932698|656263|P11|NOT COMPLETED|Part 2 (Dose Expansion)||2
270740|NCT00932698|656264|P10|NOT COMPLETED|Part 2 (Dose Expansion)||6
270741|NCT00932698|656265|P9|NOT COMPLETED|Part 2 (Dose Expansion)||12
270742|NCT00932698|656266|P8|NOT COMPLETED|Part 2 (Dose Expansion)||20
270743|NCT00932698|656267|P7|NOT COMPLETED|Part 2 (Dose Expansion)||0
270744|NCT00932698|656268|P6|NOT COMPLETED|Part 2 (Dose Expansion)||0
270745|NCT00932698|656269|P5|NOT COMPLETED|Part 2 (Dose Expansion)||0
270746|NCT00932698|656270|P4|NOT COMPLETED|Part 2 (Dose Expansion)||0
270747|NCT00932698|656271|P3|NOT COMPLETED|Part 2 (Dose Expansion)||0
270748|NCT00932698|656272|P2|NOT COMPLETED|Part 2 (Dose Expansion)||0
270749|NCT00932698|656273|P1|NOT COMPLETED|Part 2 (Dose Expansion)||0
270750|NCT00932698|656263|P11|COMPLETED|Part 2 (Dose Expansion)||0
270751|NCT00932698|656264|P10|COMPLETED|Part 2 (Dose Expansion)||0
270752|NCT00932698|656265|P9|COMPLETED|Part 2 (Dose Expansion)||0
270753|NCT00932698|656266|P8|COMPLETED|Part 2 (Dose Expansion)||0
270754|NCT00932698|656267|P7|COMPLETED|Part 2 (Dose Expansion)||0
270755|NCT00932698|656268|P6|COMPLETED|Part 2 (Dose Expansion)||0
270756|NCT00932698|656269|P5|COMPLETED|Part 2 (Dose Expansion)||0
270757|NCT00932698|656270|P4|COMPLETED|Part 2 (Dose Expansion)||0
270758|NCT00932698|656271|P3|COMPLETED|Part 2 (Dose Expansion)||0
270759|NCT00932698|656272|P2|COMPLETED|Part 2 (Dose Expansion)||0
270760|NCT00932698|656273|P1|COMPLETED|Part 2 (Dose Expansion)||0
270761|NCT00932698|656263|P11|STARTED|Part 2 (Dose Expansion)||2
270762|NCT00932698|656264|P10|STARTED|Part 2 (Dose Expansion)||6
270763|NCT00932698|656265|P9|STARTED|Part 2 (Dose Expansion)||12
270764|NCT00932698|656266|P8|STARTED|Part 2 (Dose Expansion)||20
270765|NCT00932698|656267|P7|STARTED|Part 2 (Dose Expansion)||0
270766|NCT00932698|656268|P6|STARTED|Part 2 (Dose Expansion)||0
270767|NCT00932698|656269|P5|STARTED|Part 2 (Dose Expansion)||0
270768|NCT00932698|656270|P4|STARTED|Part 2 (Dose Expansion)||0
270769|NCT00932698|656271|P3|STARTED|Part 2 (Dose Expansion)||0
270770|NCT00932698|656272|P2|STARTED|Part 2 (Dose Expansion)||0
270771|NCT00932698|656273|P1|STARTED|Part 2 (Dose Expansion)||0
270772|NCT00932698|656263|P11|NOT COMPLETED|Part 1 (Dose Escalation)||0
270773|NCT00932698|656264|P10|NOT COMPLETED|Part 1 (Dose Escalation)||0
270774|NCT00932698|656265|P9|NOT COMPLETED|Part 1 (Dose Escalation)||0
270775|NCT00932698|656266|P8|NOT COMPLETED|Part 1 (Dose Escalation)||0
270776|NCT00932698|656267|P7|NOT COMPLETED|Part 1 (Dose Escalation)||4
270777|NCT00932698|656268|P6|NOT COMPLETED|Part 1 (Dose Escalation)||7
270778|NCT00932698|656269|P5|NOT COMPLETED|Part 1 (Dose Escalation)||3
270779|NCT00932698|656270|P4|NOT COMPLETED|Part 1 (Dose Escalation)||3
270780|NCT00932698|656271|P3|NOT COMPLETED|Part 1 (Dose Escalation)||3
270781|NCT00932698|656272|P2|NOT COMPLETED|Part 1 (Dose Escalation)||3
270782|NCT00932698|656273|P1|NOT COMPLETED|Part 1 (Dose Escalation)||3
270783|NCT00932698|656263|P11|COMPLETED|Part 1 (Dose Escalation)||0
270784|NCT00932698|656264|P10|COMPLETED|Part 1 (Dose Escalation)||0
270785|NCT00932698|656265|P9|COMPLETED|Part 1 (Dose Escalation)||0
270786|NCT00932698|656266|P8|COMPLETED|Part 1 (Dose Escalation)||0
270787|NCT00932698|656267|P7|COMPLETED|Part 1 (Dose Escalation)||0
270788|NCT00932698|656268|P6|COMPLETED|Part 1 (Dose Escalation)|6 participants from 2.0 mg/m^2 dose cohort transitioned to dose expansion cohort: 5 in RR, 1 in VR.|0
270789|NCT00932698|656269|P5|COMPLETED|Part 1 (Dose Escalation)||0
270790|NCT00932698|656270|P4|COMPLETED|Part 1 (Dose Escalation)||0
270791|NCT00932698|656271|P3|COMPLETED|Part 1 (Dose Escalation)||0
270792|NCT00932698|656272|P2|COMPLETED|Part 1 (Dose Escalation)||0
270793|NCT00932698|656273|P1|COMPLETED|Part 1 (Dose Escalation)||0
270794|NCT00932698|656263|P11|STARTED|Part 1 (Dose Escalation)||0
270795|NCT00932698|656264|P10|STARTED|Part 1 (Dose Escalation)||0
270796|NCT00932698|656265|P9|STARTED|Part 1 (Dose Escalation)||0
270797|NCT00932698|656266|P8|STARTED|Part 1 (Dose Escalation)||0
270798|NCT00932698|656267|P7|STARTED|Part 1 (Dose Escalation)||4
270799|NCT00932698|656268|P6|STARTED|Part 1 (Dose Escalation)||7
270800|NCT00932698|656269|P5|STARTED|Part 1 (Dose Escalation)||3
270801|NCT00932698|656270|P4|STARTED|Part 1 (Dose Escalation)||3
270802|NCT00932698|656271|P3|STARTED|Part 1 (Dose Escalation)||3
270803|NCT00932698|656272|P2|STARTED|Part 1 (Dose Escalation)||3
270804|NCT00932698|656273|P1|STARTED|Part 1 (Dose Escalation)||3
270805|NCT00932659|656442|P1|NOT COMPLETED|Overall Study||0
270806|NCT00932659|656442|P1|COMPLETED|Overall Study||8
270807|NCT00932659|656442|P1|STARTED|Overall Study||8
270808|NCT00932646|656447|P4|NOT COMPLETED|Overall Study||1
270809|NCT00932646|656448|P3|NOT COMPLETED|Overall Study||4
270810|NCT00932646|656449|P2|NOT COMPLETED|Overall Study||3
270811|NCT00932646|656450|P1|NOT COMPLETED|Overall Study||5
270812|NCT00932646|656447|P4|COMPLETED|Overall Study||24
270813|NCT00932646|656448|P3|COMPLETED|Overall Study||21
270814|NCT00932646|656449|P2|COMPLETED|Overall Study||22
270815|NCT00932646|656450|P1|COMPLETED|Overall Study||20
270816|NCT00932646|656447|P4|STARTED|Overall Study||25
270817|NCT00932646|656448|P3|STARTED|Overall Study||25
270818|NCT00932646|656449|P2|STARTED|Overall Study||25
270819|NCT00932646|656450|P1|STARTED|Overall Study||25
270820|NCT00932620|656506|P2|NOT COMPLETED|Overall Study||0
270821|NCT00932620|656507|P1|NOT COMPLETED|Overall Study||0
270822|NCT00932620|656506|P2|COMPLETED|Overall Study||50
270823|NCT00932620|656507|P1|COMPLETED|Overall Study||50
270824|NCT00932620|656506|P2|STARTED|Overall Study||50
270825|NCT00932620|656507|P1|STARTED|Overall Study||50
270826|NCT00932477|656515|P6|NOT COMPLETED|Treatment 3||0
270827|NCT00932477|656516|P5|NOT COMPLETED|Treatment 3||0
270828|NCT00932477|656517|P4|NOT COMPLETED|Treatment 3||0
270829|NCT00932477|656518|P3|NOT COMPLETED|Treatment 3||0
270830|NCT00932477|656519|P2|NOT COMPLETED|Treatment 3||0
270831|NCT00932477|656520|P1|NOT COMPLETED|Treatment 3||0
270832|NCT00932477|656515|P6|COMPLETED|Treatment 3||8
270833|NCT00932477|656516|P5|COMPLETED|Treatment 3||8
270834|NCT00932477|656517|P4|COMPLETED|Treatment 3||7
270835|NCT00932477|656518|P3|COMPLETED|Treatment 3||9
270836|NCT00932477|656519|P2|COMPLETED|Treatment 3||8
270837|NCT00932477|656520|P1|COMPLETED|Treatment 3||7
270838|NCT00932477|656515|P6|STARTED|Treatment 3||8
270839|NCT00932477|656516|P5|STARTED|Treatment 3||8
270840|NCT00932477|656517|P4|STARTED|Treatment 3||7
270841|NCT00932477|656518|P3|STARTED|Treatment 3||9
270842|NCT00932477|656519|P2|STARTED|Treatment 3||8
270843|NCT00932477|656520|P1|STARTED|Treatment 3||7
270844|NCT00932477|656515|P6|NOT COMPLETED|Treatment 2||0
270845|NCT00932477|656516|P5|NOT COMPLETED|Treatment 2||0
270846|NCT00932477|656517|P4|NOT COMPLETED|Treatment 2||0
270847|NCT00932477|656518|P3|NOT COMPLETED|Treatment 2||0
270848|NCT00932477|656519|P2|NOT COMPLETED|Treatment 2||0
270849|NCT00932477|656520|P1|NOT COMPLETED|Treatment 2||0
270850|NCT00932477|656515|P6|COMPLETED|Treatment 2||8
270851|NCT00932477|656516|P5|COMPLETED|Treatment 2||8
270852|NCT00932477|656517|P4|COMPLETED|Treatment 2||7
270853|NCT00932477|656518|P3|COMPLETED|Treatment 2||9
270854|NCT00932477|656519|P2|COMPLETED|Treatment 2||8
270855|NCT00932477|656520|P1|COMPLETED|Treatment 2||7
270856|NCT00932477|656515|P6|STARTED|Treatment 2||8
270857|NCT00932477|656516|P5|STARTED|Treatment 2||8
270858|NCT00932477|656517|P4|STARTED|Treatment 2||7
270859|NCT00932477|656518|P3|STARTED|Treatment 2||9
270860|NCT00932477|656519|P2|STARTED|Treatment 2||8
270861|NCT00932477|656520|P1|STARTED|Treatment 2||7
270862|NCT00932477|656515|P6|NOT COMPLETED|Treatment 1||0
270863|NCT00932477|656516|P5|NOT COMPLETED|Treatment 1||0
270864|NCT00932477|656517|P4|NOT COMPLETED|Treatment 1||0
270865|NCT00932477|656518|P3|NOT COMPLETED|Treatment 1||0
270866|NCT00932477|656519|P2|NOT COMPLETED|Treatment 1||0
270867|NCT00932477|656520|P1|NOT COMPLETED|Treatment 1||0
270868|NCT00932477|656515|P6|COMPLETED|Treatment 1||8
270869|NCT00932477|656516|P5|COMPLETED|Treatment 1||8
270870|NCT00932477|656517|P4|COMPLETED|Treatment 1||7
270871|NCT00932477|656518|P3|COMPLETED|Treatment 1||9
270872|NCT00932477|656519|P2|COMPLETED|Treatment 1||8
270873|NCT00932477|656520|P1|COMPLETED|Treatment 1||7
270874|NCT00932477|656515|P6|STARTED|Treatment 1||8
270875|NCT00932477|656516|P5|STARTED|Treatment 1||8
270876|NCT00932477|656517|P4|STARTED|Treatment 1||7
270877|NCT00932477|656518|P3|STARTED|Treatment 1||9
270878|NCT00932477|656519|P2|STARTED|Treatment 1||8
270879|NCT00932477|656520|P1|STARTED|Treatment 1||7
270880|NCT00932451|656537|P1|NOT COMPLETED|Overall Study||822
270881|NCT00932451|656537|P1|COMPLETED|Overall Study||244
270882|NCT00932451|656537|P1|STARTED|Overall Study||1066
270883|NCT00932425|656561|P2|NOT COMPLETED|Overall Study||2
270884|NCT00932425|656562|P1|NOT COMPLETED|Overall Study||0
270885|NCT00932425|656561|P2|COMPLETED|Overall Study||18
270886|NCT00932425|656562|P1|COMPLETED|Overall Study||20
270887|NCT00932425|656561|P2|STARTED|Overall Study||20
270888|NCT00932425|656562|P1|STARTED|Overall Study||20
270889|NCT00932399|656577|P2|NOT COMPLETED|Overall Study||0
270890|NCT00932399|656578|P1|NOT COMPLETED|Overall Study||0
270891|NCT00932399|656577|P2|COMPLETED|Overall Study||3790
270892|NCT00932399|656578|P1|COMPLETED|Overall Study||759
270893|NCT00932399|656577|P2|STARTED|Overall Study||3790
270894|NCT00932399|656578|P1|STARTED|Overall Study||759
270895|NCT00932373|656595|P11|NOT COMPLETED|Overall Study||3
270896|NCT00932373|656596|P10|NOT COMPLETED|Overall Study||13
270897|NCT00932373|656597|P9|NOT COMPLETED|Overall Study||2
270898|NCT00932373|656598|P8|NOT COMPLETED|Overall Study||3
270899|NCT00932373|656599|P7|NOT COMPLETED|Overall Study||1
270900|NCT00932373|656600|P6|NOT COMPLETED|Overall Study||3
270901|NCT00932373|656601|P5|NOT COMPLETED|Overall Study||14
270902|NCT00932373|656602|P4|NOT COMPLETED|Overall Study||0
270903|NCT00932373|656603|P3|NOT COMPLETED|Overall Study||1
270904|NCT00932373|656604|P2|NOT COMPLETED|Overall Study||1
270905|NCT00932373|656605|P1|NOT COMPLETED|Overall Study||3
270906|NCT00932373|656595|P11|COMPLETED|Overall Study||0
270907|NCT00932373|656596|P10|COMPLETED|Overall Study||3
270908|NCT00932373|656597|P9|COMPLETED|Overall Study||1
270909|NCT00932373|656598|P8|COMPLETED|Overall Study||0
270910|NCT00932373|656599|P7|COMPLETED|Overall Study||2
270911|NCT00932373|656600|P6|COMPLETED|Overall Study||0
270912|NCT00932373|656601|P5|COMPLETED|Overall Study||1
270913|NCT00932373|656602|P4|COMPLETED|Overall Study||1
270914|NCT00932373|656603|P3|COMPLETED|Overall Study||0
270915|NCT00932373|656604|P2|COMPLETED|Overall Study||0
270916|NCT00932373|656605|P1|COMPLETED|Overall Study||0
270917|NCT00932373|656595|P11|STARTED|Overall Study||3
270918|NCT00932373|656596|P10|STARTED|Overall Study||16
270919|NCT00932373|656597|P9|STARTED|Overall Study||3
270920|NCT00932373|656598|P8|STARTED|Overall Study||3
270921|NCT00932373|656599|P7|STARTED|Overall Study||3
270922|NCT00932373|656600|P6|STARTED|Overall Study||3
270923|NCT00932373|656601|P5|STARTED|Overall Study||15
270924|NCT00932373|656602|P4|STARTED|Overall Study||1
270925|NCT00932373|656603|P3|STARTED|Overall Study||1
270926|NCT00932373|656604|P2|STARTED|Overall Study||1
270927|NCT00932373|656605|P1|STARTED|Overall Study||3
270928|NCT00932360|656705|P6|NOT COMPLETED|Visit 3/Week 3||0
270929|NCT00932360|656706|P5|NOT COMPLETED|Visit 3/Week 3||0
270930|NCT00932360|656707|P4|NOT COMPLETED|Visit 3/Week 3||0
270931|NCT00932360|656708|P3|NOT COMPLETED|Visit 3/Week 3||0
270932|NCT00932360|656709|P2|NOT COMPLETED|Visit 3/Week 3||0
270933|NCT00932360|656710|P1|NOT COMPLETED|Visit 3/Week 3||0
270934|NCT00932360|656705|P6|COMPLETED|Visit 3/Week 3||7
270935|NCT00932360|656706|P5|COMPLETED|Visit 3/Week 3||2
270936|NCT00932360|656707|P4|COMPLETED|Visit 3/Week 3||13
270937|NCT00932360|656708|P3|COMPLETED|Visit 3/Week 3||3
270938|NCT00932360|656709|P2|COMPLETED|Visit 3/Week 3||6
270939|NCT00932360|656710|P1|COMPLETED|Visit 3/Week 3||10
270940|NCT00932360|656705|P6|STARTED|Visit 3/Week 3||7
270941|NCT00932360|656706|P5|STARTED|Visit 3/Week 3||2
270942|NCT00932360|656707|P4|STARTED|Visit 3/Week 3||13
270943|NCT00932360|656708|P3|STARTED|Visit 3/Week 3||3
270944|NCT00932360|656709|P2|STARTED|Visit 3/Week 3||6
270945|NCT00932360|656710|P1|STARTED|Visit 3/Week 3||10
270946|NCT00932360|656705|P6|NOT COMPLETED|Washout (One Week)||0
270947|NCT00932360|656706|P5|NOT COMPLETED|Washout (One Week)||0
270948|NCT00932360|656707|P4|NOT COMPLETED|Washout (One Week)||0
270949|NCT00932360|656708|P3|NOT COMPLETED|Washout (One Week)||0
270950|NCT00932360|656709|P2|NOT COMPLETED|Washout (One Week)||0
270951|NCT00932360|656710|P1|NOT COMPLETED|Washout (One Week)||0
270952|NCT00932360|656705|P6|COMPLETED|Washout (One Week)||7
270953|NCT00932360|656706|P5|COMPLETED|Washout (One Week)||2
270954|NCT00932360|656707|P4|COMPLETED|Washout (One Week)||13
270955|NCT00932360|656708|P3|COMPLETED|Washout (One Week)||3
270956|NCT00932360|656709|P2|COMPLETED|Washout (One Week)||6
270957|NCT00932360|656710|P1|COMPLETED|Washout (One Week)||10
270958|NCT00932360|656705|P6|STARTED|Washout (One Week)||7
270959|NCT00932360|656706|P5|STARTED|Washout (One Week)||2
270960|NCT00932360|656707|P4|STARTED|Washout (One Week)||13
270961|NCT00932360|656708|P3|STARTED|Washout (One Week)||3
270962|NCT00932360|656709|P2|STARTED|Washout (One Week)||6
270963|NCT00932360|656710|P1|STARTED|Washout (One Week)||10
270964|NCT00932360|656705|P6|NOT COMPLETED|Visit 2/Week 2||0
270965|NCT00932360|656706|P5|NOT COMPLETED|Visit 2/Week 2||0
270966|NCT00932360|656707|P4|NOT COMPLETED|Visit 2/Week 2||0
270967|NCT00932360|656708|P3|NOT COMPLETED|Visit 2/Week 2||0
270968|NCT00932360|656709|P2|NOT COMPLETED|Visit 2/Week 2||0
270969|NCT00932360|656710|P1|NOT COMPLETED|Visit 2/Week 2||0
270970|NCT00932360|656705|P6|COMPLETED|Visit 2/Week 2||7
270971|NCT00932360|656706|P5|COMPLETED|Visit 2/Week 2||2
270972|NCT00932360|656707|P4|COMPLETED|Visit 2/Week 2||13
270973|NCT00932360|656708|P3|COMPLETED|Visit 2/Week 2||3
270974|NCT00932360|656709|P2|COMPLETED|Visit 2/Week 2||6
270975|NCT00932360|656710|P1|COMPLETED|Visit 2/Week 2||10
270976|NCT00932360|656705|P6|STARTED|Visit 2/Week 2||7
270977|NCT00932360|656706|P5|STARTED|Visit 2/Week 2||2
270978|NCT00932360|656707|P4|STARTED|Visit 2/Week 2||13
270979|NCT00932360|656708|P3|STARTED|Visit 2/Week 2||3
270980|NCT00932360|656709|P2|STARTED|Visit 2/Week 2||6
270981|NCT00932360|656710|P1|STARTED|Visit 2/Week 2||10
270982|NCT00932360|656705|P6|NOT COMPLETED|Washout (One Week)||0
270983|NCT00932360|656706|P5|NOT COMPLETED|Washout (One Week)||2
270984|NCT00932360|656707|P4|NOT COMPLETED|Washout (One Week)||0
270985|NCT00932360|656708|P3|NOT COMPLETED|Washout (One Week)||0
270986|NCT00932360|656709|P2|NOT COMPLETED|Washout (One Week)||0
270987|NCT00932360|656710|P1|NOT COMPLETED|Washout (One Week)||0
270988|NCT00932360|656705|P6|COMPLETED|Washout (One Week)||7
270989|NCT00932360|656706|P5|COMPLETED|Washout (One Week)||2
270990|NCT00932360|656707|P4|COMPLETED|Washout (One Week)||13
270991|NCT00932360|656708|P3|COMPLETED|Washout (One Week)||3
270992|NCT00932360|656709|P2|COMPLETED|Washout (One Week)||6
270993|NCT00932360|656710|P1|COMPLETED|Washout (One Week)||10
270994|NCT00932360|656705|P6|STARTED|Washout (One Week)||7
270995|NCT00932360|656706|P5|STARTED|Washout (One Week)||4
270996|NCT00932360|656707|P4|STARTED|Washout (One Week)||13
270997|NCT00932360|656708|P3|STARTED|Washout (One Week)||3
270998|NCT00932360|656709|P2|STARTED|Washout (One Week)||6
270999|NCT00932360|656710|P1|STARTED|Washout (One Week)||10
271000|NCT00932360|656705|P6|NOT COMPLETED|1: Visit 1/Week1||0
271001|NCT00932360|656706|P5|NOT COMPLETED|1: Visit 1/Week1||0
271002|NCT00932360|656707|P4|NOT COMPLETED|1: Visit 1/Week1||0
271003|NCT00932360|656708|P3|NOT COMPLETED|1: Visit 1/Week1||0
271004|NCT00932360|656709|P2|NOT COMPLETED|1: Visit 1/Week1||0
271005|NCT00932360|656710|P1|NOT COMPLETED|1: Visit 1/Week1||0
271006|NCT00932360|656705|P6|COMPLETED|1: Visit 1/Week1||7
271007|NCT00932360|656706|P5|COMPLETED|1: Visit 1/Week1||4
271008|NCT00932360|656707|P4|COMPLETED|1: Visit 1/Week1||13
271009|NCT00932360|656708|P3|COMPLETED|1: Visit 1/Week1||3
271010|NCT00932360|656709|P2|COMPLETED|1: Visit 1/Week1||6
271011|NCT00932360|656710|P1|COMPLETED|1: Visit 1/Week1||10
271012|NCT00932360|656705|P6|STARTED|1: Visit 1/Week1||7
271013|NCT00932360|656706|P5|STARTED|1: Visit 1/Week1||4
271014|NCT00932360|656707|P4|STARTED|1: Visit 1/Week1||13
271015|NCT00932360|656708|P3|STARTED|1: Visit 1/Week1||3
271016|NCT00932360|656709|P2|STARTED|1: Visit 1/Week1||6
271017|NCT00932360|656710|P1|STARTED|1: Visit 1/Week1||10
271018|NCT00932321|656741|P2|NOT COMPLETED|Overall Study||46
271019|NCT00932321|656742|P1|NOT COMPLETED|Overall Study||171
271020|NCT00932321|656741|P2|COMPLETED|Overall Study||141
271021|NCT00932321|656742|P1|COMPLETED|Overall Study||580
271022|NCT00932321|656741|P2|MITT Population|Overall Study||181
271023|NCT00932321|656742|P1|MITT Population|Overall Study||705
271024|NCT00932321|656741|P2|STARTED|Overall Study||187
271025|NCT00932321|656742|P1|STARTED|Overall Study||751
271026|NCT00932282|656752|P2|NOT COMPLETED|OIT Maintenance Phase||2
271027|NCT00932282|656753|P1|NOT COMPLETED|OIT Maintenance Phase||1
271028|NCT00932282|656752|P2|COMPLETED|OIT Maintenance Phase||2
271029|NCT00932282|656753|P1|COMPLETED|OIT Maintenance Phase||4
271030|NCT00932282|656752|P2|STARTED|OIT Maintenance Phase||4
271031|NCT00932282|656753|P1|STARTED|OIT Maintenance Phase||5
271032|NCT00932282|656752|P2|NOT COMPLETED|Biweekly OIT Buildup Phase||1
271033|NCT00932282|656753|P1|NOT COMPLETED|Biweekly OIT Buildup Phase||1
271034|NCT00932282|656752|P2|COMPLETED|Biweekly OIT Buildup Phase||4
271035|NCT00932282|656753|P1|COMPLETED|Biweekly OIT Buildup Phase||5
271036|NCT00932282|656752|P2|STARTED|Biweekly OIT Buildup Phase||5
271037|NCT00932282|656753|P1|STARTED|Biweekly OIT Buildup Phase||6
271038|NCT00932282|656752|P2|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
271039|NCT00932282|656753|P1|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
271040|NCT00932282|656752|P2|COMPLETED|Modified OIT Rush Desensitization Phase||5
271041|NCT00932282|656753|P1|COMPLETED|Modified OIT Rush Desensitization Phase||6
271042|NCT00932282|656752|P2|STARTED|Modified OIT Rush Desensitization Phase||5
271043|NCT00932282|656753|P1|STARTED|Modified OIT Rush Desensitization Phase||6
271044|NCT00932282|656752|P2|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
271045|NCT00932282|656753|P1|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
271046|NCT00932282|656752|P2|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||5
271047|NCT00932282|656753|P1|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||6
271048|NCT00932282|656752|P2|STARTED|Pre-OIT Anti-IgE Therapy Phase||6
271049|NCT00932282|656753|P1|STARTED|Pre-OIT Anti-IgE Therapy Phase||7
271050|NCT00932165|656767|P1|NOT COMPLETED|Overall Study||1
271051|NCT00932165|656767|P1|COMPLETED|Overall Study||450
271052|NCT00932165|656767|P1|STARTED|Overall Study||451
271053|NCT00932152|656780|P2|NOT COMPLETED|Overall Study||2
271054|NCT00932152|656781|P1|NOT COMPLETED|Overall Study||1
271055|NCT00932152|656780|P2|COMPLETED|Overall Study||0
271056|NCT00932152|656781|P1|COMPLETED|Overall Study||0
271057|NCT00932152|656780|P2|STARTED|Overall Study||2
271058|NCT00932152|656781|P1|STARTED|Overall Study||1
271059|NCT00932126|656791|P8|NOT COMPLETED|Overall Study||10
271060|NCT00932126|656792|P7|NOT COMPLETED|Overall Study||5
271061|NCT00932126|656793|P6|NOT COMPLETED|Overall Study||3
271062|NCT00932126|656794|P5|NOT COMPLETED|Overall Study||5
271063|NCT00932126|656795|P4|NOT COMPLETED|Overall Study||3
271064|NCT00932126|656796|P3|NOT COMPLETED|Overall Study||3
271065|NCT00932126|656797|P2|NOT COMPLETED|Overall Study||3
271066|NCT00932126|656798|P1|NOT COMPLETED|Overall Study||3
271067|NCT00932126|656791|P8|COMPLETED|Overall Study||0
271068|NCT00932126|656792|P7|COMPLETED|Overall Study||0
271069|NCT00932126|656793|P6|COMPLETED|Overall Study||0
271070|NCT00932126|656794|P5|COMPLETED|Overall Study||0
271071|NCT00932126|656795|P4|COMPLETED|Overall Study||0
271072|NCT00932126|656796|P3|COMPLETED|Overall Study||0
271073|NCT00932126|656797|P2|COMPLETED|Overall Study||0
271074|NCT00932126|656798|P1|COMPLETED|Overall Study||0
271075|NCT00932126|656791|P8|STARTED|Overall Study||10
271076|NCT00932126|656792|P7|STARTED|Overall Study||5
271077|NCT00932126|656793|P6|STARTED|Overall Study||3
271078|NCT00932126|656794|P5|STARTED|Overall Study||5
271079|NCT00932126|656795|P4|STARTED|Overall Study||3
271080|NCT00932126|656796|P3|STARTED|Overall Study||3
271081|NCT00932126|656797|P2|STARTED|Overall Study||3
271082|NCT00932126|656798|P1|STARTED|Overall Study||3
271083|NCT00932113|656836|P2|NOT COMPLETED|Overall Study||0
271084|NCT00932113|656837|P1|NOT COMPLETED|Overall Study||1
271085|NCT00932113|656836|P2|COMPLETED|Overall Study||15
271086|NCT00932113|656837|P1|COMPLETED|Overall Study||14
271087|NCT00932113|656836|P2|STARTED|Overall Study||15
271088|NCT00932113|656837|P1|STARTED|Overall Study||15
271089|NCT00932035|656855|P2|NOT COMPLETED|Overall Study||0
271090|NCT00932035|656856|P1|NOT COMPLETED|Overall Study||0
271091|NCT00932035|656855|P2|COMPLETED|Overall Study||21
271092|NCT00932035|656856|P1|COMPLETED|Overall Study||18
271093|NCT00932035|656855|P2|STARTED|Overall Study||21
271094|NCT00932035|656856|P1|STARTED|Overall Study||18
271095|NCT00932022|656868|P2|NOT COMPLETED|Overall Study||4
271096|NCT00932022|656869|P1|NOT COMPLETED|Overall Study||5
271097|NCT00932022|656868|P2|COMPLETED|Overall Study||59
271098|NCT00932022|656869|P1|COMPLETED|Overall Study||59
271099|NCT00932022|656868|P2|STARTED|Overall Study||63
271100|NCT00932022|656869|P1|STARTED|Overall Study||64
271101|NCT00931996|656883|P1|NOT COMPLETED|Overall Study||7
271102|NCT00931996|656883|P1|COMPLETED|Overall Study||5
271103|NCT00931996|656883|P1|STARTED|Overall Study||12
271104|NCT00931918|656889|P2|NOT COMPLETED|Overall Study||17
271105|NCT00931918|656890|P1|NOT COMPLETED|Overall Study||17
271106|NCT00931918|656889|P2|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
271107|NCT00931918|656890|P1|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
271108|NCT00931918|656889|P2|Safety Population: Received Study Drug|Overall Study||101
271109|NCT00931918|656890|P1|Safety Population: Received Study Drug|Overall Study||100
271110|NCT00931918|656889|P2|STARTED|Overall Study||103
271111|NCT00931918|656890|P1|STARTED|Overall Study||103
271112|NCT00931879|656916|P2|NOT COMPLETED|Overall Study||3
271113|NCT00931879|656917|P1|NOT COMPLETED|Overall Study||3
271114|NCT00931879|656916|P2|COMPLETED|Overall Study||19
271115|NCT00931879|656917|P1|COMPLETED|Overall Study||19
271116|NCT00931879|656916|P2|STARTED|Overall Study||22
271117|NCT00931879|656917|P1|STARTED|Overall Study||22
271118|NCT00931801|656942|P3|NOT COMPLETED|Overall Study||4
271119|NCT00931801|656943|P2|NOT COMPLETED|Overall Study||1
271120|NCT00931801|656944|P1|NOT COMPLETED|Overall Study||1
271121|NCT00931801|656942|P3|COMPLETED|Overall Study||10
271122|NCT00931801|656943|P2|COMPLETED|Overall Study||14
271123|NCT00931801|656944|P1|COMPLETED|Overall Study||13
271124|NCT00931801|656942|P3|STARTED|Overall Study||14
271125|NCT00931801|656943|P2|STARTED|Overall Study||15
271126|NCT00931801|656944|P1|STARTED|Overall Study||14
271127|NCT00931723|656967|P2|NOT COMPLETED|Overall Study||39
271128|NCT00931723|656968|P1|NOT COMPLETED|Overall Study||26
271129|NCT00931723|656967|P2|COMPLETED|Overall Study||144
271130|NCT00931723|656968|P1|COMPLETED|Overall Study||147
271131|NCT00931723|656967|P2|STARTED|Overall Study||183
271132|NCT00931723|656968|P1|STARTED|Overall Study||173
271133|NCT00931710|657016|P2|NOT COMPLETED|Overall Study||38
271134|NCT00931710|657017|P1|NOT COMPLETED|Overall Study||34
271135|NCT00931710|657016|P2|COMPLETED|Overall Study||209
271136|NCT00931710|657017|P1|COMPLETED|Overall Study||207
271137|NCT00931710|657016|P2|STARTED|Overall Study||247
271138|NCT00931710|657017|P1|STARTED|Overall Study||241
271139|NCT00931632|657035|P2|NOT COMPLETED|Overall Study||18
271140|NCT00931632|657036|P1|NOT COMPLETED|Overall Study||21
271141|NCT00931632|657035|P2|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|204
271142|NCT00931632|657036|P1|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|208
271143|NCT00931632|657035|P2|STARTED|Overall Study|Randomized|222
271144|NCT00931632|657036|P1|STARTED|Overall Study|Randomized|229
271145|NCT00931528|657058|P2|NOT COMPLETED|Overall Study||60
271146|NCT00931528|657059|P1|NOT COMPLETED|Overall Study||41
271147|NCT00931528|657058|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|61
271148|NCT00931528|657059|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|80
271149|NCT00931528|657058|P2|STARTED|Overall Study||121
271150|NCT00931528|657059|P1|STARTED|Overall Study||121
271151|NCT00931515|657079|P2|NOT COMPLETED|Overall Study||5
271152|NCT00931515|657080|P1|NOT COMPLETED|Overall Study||2
271153|NCT00931515|657079|P2|COMPLETED|Overall Study||10
271154|NCT00931515|657080|P1|COMPLETED|Overall Study||13
271155|NCT00931515|657079|P2|STARTED|Overall Study||15
271156|NCT00931515|657080|P1|STARTED|Overall Study||15
271157|NCT00931489|657091|P5|NOT COMPLETED|Overall Study||0
271158|NCT00931489|657092|P4|NOT COMPLETED|Overall Study||0
271159|NCT00931489|657093|P3|NOT COMPLETED|Overall Study||0
271160|NCT00931489|657094|P2|NOT COMPLETED|Overall Study||0
271161|NCT00931489|657095|P1|NOT COMPLETED|Overall Study||0
271162|NCT00931489|657091|P5|COMPLETED|Overall Study||7
271163|NCT00931489|657092|P4|COMPLETED|Overall Study||39
271164|NCT00931489|657093|P3|COMPLETED|Overall Study|3 subjects enrolled in Group 1 (responders) were moved to Group 3 (non-responders)|5
271165|NCT00931489|657094|P2|COMPLETED|Overall Study||40
271166|NCT00931489|657095|P1|COMPLETED|Overall Study||40
271167|NCT00931489|657091|P5|STARTED|Overall Study||7
271168|NCT00931489|657092|P4|STARTED|Overall Study||39
271169|NCT00931489|657093|P3|STARTED|Overall Study||5
271170|NCT00931489|657094|P2|STARTED|Overall Study||40
271171|NCT00931489|657095|P1|STARTED|Overall Study||40
271172|NCT00931463|657110|P2|NOT COMPLETED|Overall Study||5
271173|NCT00931463|657111|P1|NOT COMPLETED|Overall Study||17
271174|NCT00931463|657110|P2|COMPLETED|Overall Study||265
271175|NCT00931463|657111|P1|COMPLETED|Overall Study||254
271176|NCT00931463|657110|P2|STARTED|Overall Study||270
271177|NCT00931463|657111|P1|STARTED|Overall Study||271
271178|NCT00931411|657127|P2|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||1
271179|NCT00931411|657128|P1|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||0
271180|NCT00931411|657127|P2|COMPLETED|After Crossover - 14 Days (up to Day 56)||34
271181|NCT00931411|657128|P1|COMPLETED|After Crossover - 14 Days (up to Day 56)||31
271182|NCT00931411|657127|P2|STARTED|After Crossover - 14 Days (up to Day 56)||35
271183|NCT00931411|657128|P1|STARTED|After Crossover - 14 Days (up to Day 56)||31
271184|NCT00931411|657127|P2|NOT COMPLETED|First Intervention - 42 Days||3
271185|NCT00931411|657128|P1|NOT COMPLETED|First Intervention - 42 Days||4
271186|NCT00931411|657127|P2|COMPLETED|First Intervention - 42 Days||35
271187|NCT00931411|657128|P1|COMPLETED|First Intervention - 42 Days||31
271188|NCT00931411|657127|P2|STARTED|First Intervention - 42 Days||38
271189|NCT00931411|657128|P1|STARTED|First Intervention - 42 Days||35
271190|NCT00931385|657149|P4|NOT COMPLETED|Overall Study||5
271191|NCT00931385|657150|P3|NOT COMPLETED|Overall Study||1
271192|NCT00931385|657151|P2|NOT COMPLETED|Overall Study||2
271193|NCT00931385|657152|P1|NOT COMPLETED|Overall Study||2
271194|NCT00931385|657149|P4|COMPLETED|Overall Study||21
271195|NCT00931385|657150|P3|COMPLETED|Overall Study||24
271196|NCT00931385|657151|P2|COMPLETED|Overall Study||21
271197|NCT00931385|657152|P1|COMPLETED|Overall Study||23
271198|NCT00931385|657149|P4|STARTED|Overall Study||26
271199|NCT00931385|657150|P3|STARTED|Overall Study||25
271200|NCT00931385|657151|P2|STARTED|Overall Study||23
271201|NCT00931385|657152|P1|STARTED|Overall Study||25
271202|NCT00931359|657208|P2|NOT COMPLETED|Overall Study||13
271203|NCT00931359|657209|P1|NOT COMPLETED|Overall Study||6
271204|NCT00931359|657208|P2|COMPLETED|Overall Study||68
271205|NCT00931359|657209|P1|COMPLETED|Overall Study||33
271206|NCT00931359|657208|P2|STARTED|Overall Study||81
271207|NCT00931359|657209|P1|STARTED|Overall Study||39
271208|NCT00931307|657221|P1|NOT COMPLETED|Overall Study||13
271209|NCT00931307|657221|P1|COMPLETED|Overall Study||9
271210|NCT00931307|657221|P1|STARTED|Overall Study||22
271211|NCT00931268|657225|P1|NOT COMPLETED|Overall Study||6
271212|NCT00931268|657225|P1|COMPLETED|Overall Study||4
271213|NCT00931268|657225|P1|STARTED|Overall Study||10
271214|NCT00931255|657237|P2|NOT COMPLETED|Overall Study||3
271215|NCT00931255|657238|P1|NOT COMPLETED|Overall Study||2
271216|NCT00931255|657237|P2|COMPLETED|Overall Study||12
271217|NCT00931255|657238|P1|COMPLETED|Overall Study||15
271218|NCT00931255|657237|P2|STARTED|Overall Study||15
271219|NCT00931255|657238|P1|STARTED|Overall Study||17
271220|NCT00931242|657262|P2|NOT COMPLETED|Overall Study||2
271221|NCT00931242|657263|P1|NOT COMPLETED|Overall Study||5
271222|NCT00931242|657262|P2|COMPLETED|Overall Study||0
271223|NCT00931242|657263|P1|COMPLETED|Overall Study||5
271224|NCT00931242|657262|P2|STARTED|Overall Study||2
271225|NCT00931242|657263|P1|STARTED|Overall Study||10
271226|NCT00931164|657269|P1|NOT COMPLETED|Overall Study||0
271227|NCT00931164|657269|P1|COMPLETED|Overall Study||6
271228|NCT00931164|657269|P1|STARTED|Overall Study||6
271229|NCT00930982|657275|P2|NOT COMPLETED|Overall Study||29
271230|NCT00930982|657276|P1|NOT COMPLETED|Overall Study||21
271231|NCT00930982|657275|P2|COMPLETED|Overall Study||35
271232|NCT00930982|657276|P1|COMPLETED|Overall Study||39
271233|NCT00930982|657275|P2|STARTED|Overall Study||64
271234|NCT00930982|657276|P1|STARTED|Overall Study||60
271235|NCT00930969|657310|P1|NOT COMPLETED|Overall Study||38
271236|NCT00930969|657310|P1|COMPLETED|Overall Study||137
271237|NCT00930969|657310|P1|STARTED|Overall Study||175
271238|NCT00930930|657320|P2|NOT COMPLETED|Overall Study||9
271239|NCT00930930|657321|P1|NOT COMPLETED|Overall Study||21
271240|NCT00930930|657320|P2|COMPLETED|Overall Study||40
271241|NCT00930930|657321|P1|COMPLETED|Overall Study||75
271242|NCT00930930|657320|P2|STARTED|Overall Study||49
271243|NCT00930930|657321|P1|STARTED|Overall Study||96
271244|NCT00930813|657335|P2|NOT COMPLETED|Overall Study||14
271245|NCT00930813|657336|P1|NOT COMPLETED|Overall Study||8
271246|NCT00930813|657335|P2|COMPLETED|Overall Study||38
271247|NCT00930813|657336|P1|COMPLETED|Overall Study||41
271248|NCT00930813|657335|P2|STARTED|Overall Study||52
271249|NCT00930813|657336|P1|STARTED|Overall Study||49
271250|NCT00930787|657346|P2|NOT COMPLETED|Overall Study||0
271251|NCT00930787|657347|P1|NOT COMPLETED|Overall Study||0
271252|NCT00930787|657346|P2|COMPLETED|Overall Study||9
271253|NCT00930787|657347|P1|COMPLETED|Overall Study||14
271254|NCT00930787|657346|P2|STARTED|Overall Study||9
271255|NCT00930787|657347|P1|STARTED|Overall Study||14
271256|NCT00930774|657357|P4|NOT COMPLETED|Overall Study||0
271257|NCT00930774|657358|P3|NOT COMPLETED|Overall Study||2
271258|NCT00930774|657359|P2|NOT COMPLETED|Overall Study||9
271259|NCT00930774|657360|P1|NOT COMPLETED|Overall Study||1
271260|NCT00930774|657357|P4|COMPLETED|Overall Study||25
271261|NCT00930774|657358|P3|COMPLETED|Overall Study||22
271262|NCT00930774|657359|P2|COMPLETED|Overall Study||16
271263|NCT00930774|657360|P1|COMPLETED|Overall Study||24
271264|NCT00930774|657357|P4|STARTED|Overall Study||25
271265|NCT00930774|657358|P3|STARTED|Overall Study||24
271266|NCT00930774|657359|P2|STARTED|Overall Study||25
271267|NCT00930774|657360|P1|STARTED|Overall Study||25
271268|NCT00930761|657400|P2|NOT COMPLETED|Overall Study||3
271269|NCT00930761|657401|P1|NOT COMPLETED|Overall Study||4
271270|NCT00930761|657400|P2|COMPLETED|Overall Study||48
271271|NCT00930761|657401|P1|COMPLETED|Overall Study||46
271272|NCT00930761|657400|P2|STARTED|Overall Study||51
271273|NCT00930761|657401|P1|STARTED|Overall Study||50
271274|NCT00930722|657413|P1|NOT COMPLETED|Overall Study||27
271275|NCT00930722|657413|P1|COMPLETED|Overall Study||302
271276|NCT00930722|657413|P1|STARTED|Overall Study||329
271277|NCT00930644|657428|P1|NOT COMPLETED|Overall Study||23
271278|NCT00930644|657428|P1|COMPLETED|Overall Study||65
271279|NCT00930644|657428|P1|STARTED|Overall Study||88
271280|NCT00930553|657441|P1|NOT COMPLETED|Overall Study||223
271281|NCT00930553|657441|P1|COMPLETED|Overall Study||1091
271282|NCT00930553|657441|P1|Participants Entered From CAMMS324|Overall Study||685
271283|NCT00930553|657441|P1|Participants Entered From CAMMS323|Overall Study||488
271284|NCT00930553|657441|P1|Participants Entered From CAMMS223|Overall Study||141
271285|NCT00930553|657441|P1|STARTED|Overall Study||1314
271286|NCT00930293|657509|P2|NOT COMPLETED|Overall Study||7
271287|NCT00930293|657510|P1|NOT COMPLETED|Overall Study||7
271288|NCT00930293|657509|P2|COMPLETED|Overall Study||19
271289|NCT00930293|657510|P1|COMPLETED|Overall Study||17
271290|NCT00930293|657509|P2|STARTED|Overall Study||26
271291|NCT00930293|657510|P1|STARTED|Overall Study||24
271292|NCT00930176|657518|P1|NOT COMPLETED|Overall Study||1
271293|NCT00930176|657518|P1|COMPLETED|Overall Study||15
271294|NCT00930176|657518|P1|STARTED|Overall Study||16
271295|NCT00929994|657523|P1|NOT COMPLETED|Overall Study||6
271296|NCT00929994|657523|P1|COMPLETED|Overall Study||14
271297|NCT00929994|657523|P1|STARTED|Overall Study||20
271298|NCT00929981|657530|P1|NOT COMPLETED|Overall Study||0
271299|NCT00929981|657530|P1|COMPLETED|Overall Study||80
271300|NCT00929981|657530|P1|STARTED|Overall Study||80
271301|NCT00929864|657542|P2|NOT COMPLETED|Overall Study||83
271302|NCT00929864|657543|P1|NOT COMPLETED|Overall Study||66
271303|NCT00929864|657542|P2|COMPLETED|Overall Study||245
271304|NCT00929864|657543|P1|COMPLETED|Overall Study||252
271305|NCT00929864|657542|P2|STARTED|Overall Study||328
271306|NCT00929864|657543|P1|STARTED|Overall Study||318
271307|NCT00929838|657565|P4|NOT COMPLETED|Overall Study||9
271308|NCT00929838|657566|P3|NOT COMPLETED|Overall Study||10
271309|NCT00929838|657567|P2|NOT COMPLETED|Overall Study||9
271310|NCT00929838|657568|P1|NOT COMPLETED|Overall Study||10
271311|NCT00929838|657565|P4|COMPLETED|Overall Study||55
271312|NCT00929838|657566|P3|COMPLETED|Overall Study||53
271313|NCT00929838|657567|P2|COMPLETED|Overall Study||56
271314|NCT00929838|657568|P1|COMPLETED|Overall Study||53
271315|NCT00929838|657565|P4|STARTED|Overall Study||64
271316|NCT00929838|657566|P3|STARTED|Overall Study||63
271317|NCT00929838|657567|P2|STARTED|Overall Study||65
271318|NCT00929838|657568|P1|STARTED|Overall Study||63
271319|NCT00929773|657580|P2|NOT COMPLETED|Overall Study||0
271320|NCT00929773|657581|P1|NOT COMPLETED|Overall Study||0
271321|NCT00929773|657580|P2|COMPLETED|Overall Study||50
271322|NCT00929773|657581|P1|COMPLETED|Overall Study||50
271323|NCT00929773|657580|P2|STARTED|Overall Study||50
271324|NCT00929773|657581|P1|STARTED|Overall Study||50
271325|NCT00929734|657599|P2|NOT COMPLETED|Overall Study||3
271326|NCT00929734|657600|P1|NOT COMPLETED|Overall Study||2
271327|NCT00929734|657599|P2|COMPLETED|Overall Study||47
271328|NCT00929734|657600|P1|COMPLETED|Overall Study||47
271329|NCT00929734|657599|P2|STARTED|Overall Study||50
271330|NCT00929734|657600|P1|STARTED|Overall Study||49
271331|NCT00929708|657617|P5|NOT COMPLETED|Overall Study||6
271332|NCT00929708|657618|P4|NOT COMPLETED|Overall Study||6
271333|NCT00929708|657619|P3|NOT COMPLETED|Overall Study||3
271334|NCT00929708|657620|P2|NOT COMPLETED|Overall Study||3
271335|NCT00929708|657621|P1|NOT COMPLETED|Overall Study||4
271336|NCT00929708|657617|P5|COMPLETED|Overall Study||57
271337|NCT00929708|657618|P4|COMPLETED|Overall Study||61
271338|NCT00929708|657619|P3|COMPLETED|Overall Study||62
271339|NCT00929708|657620|P2|COMPLETED|Overall Study||66
271340|NCT00929708|657621|P1|COMPLETED|Overall Study||61
271341|NCT00929708|657617|P5|STARTED|Overall Study||63
271342|NCT00929708|657618|P4|STARTED|Overall Study||67
271343|NCT00929708|657619|P3|STARTED|Overall Study||65
271344|NCT00929708|657620|P2|STARTED|Overall Study||69
271345|NCT00929708|657621|P1|STARTED|Overall Study||65
271346|NCT00929695|657675|P2|NOT COMPLETED|Overall Study||6
271347|NCT00929695|657676|P1|NOT COMPLETED|Overall Study||8
271348|NCT00929695|657675|P2|COMPLETED|Overall Study||77
271349|NCT00929695|657676|P1|COMPLETED|Overall Study||73
271350|NCT00929695|657675|P2|STARTED|Overall Study||83
271351|NCT00929695|657676|P1|STARTED|Overall Study||81
271352|NCT00929669|657706|P1|NOT COMPLETED|Overall Study||1
271353|NCT00929669|657706|P1|COMPLETED|Overall Study||1
271354|NCT00929669|657706|P1|STARTED|Overall Study||2
271355|NCT00929656|657713|P2|NOT COMPLETED|Overall Study||1
271356|NCT00929656|657714|P1|NOT COMPLETED|Overall Study||0
271357|NCT00929656|657713|P2|COMPLETED|Overall Study||8
271358|NCT00929656|657714|P1|COMPLETED|Overall Study||13
271359|NCT00929656|657713|P2|STARTED|Overall Study||9
271360|NCT00929656|657714|P1|STARTED|Overall Study||13
271361|NCT00929643|657728|P1|NOT COMPLETED|Overall Study||2
271362|NCT00929643|657728|P1|COMPLETED|Overall Study||201
271363|NCT00929643|657728|P1|STARTED|Overall Study||203
271364|NCT00929578|657737|P1|NOT COMPLETED|Overall Study||0
271365|NCT00929578|657737|P1|COMPLETED|Overall Study||15
271366|NCT00929578|657737|P1|STARTED|Overall Study||15
271367|NCT00929526|657750|P2|NOT COMPLETED|Overall Study||29
271368|NCT00929526|657751|P1|NOT COMPLETED|Overall Study||17
271369|NCT00929526|657750|P2|COMPLETED|Overall Study||348
271370|NCT00929526|657751|P1|COMPLETED|Overall Study||358
271371|NCT00929526|657750|P2|STARTED|Overall Study||377
271372|NCT00929526|657751|P1|STARTED|Overall Study||375
271373|NCT00929500|657787|P2|NOT COMPLETED|Overall Study||0
271374|NCT00929500|657788|P1|NOT COMPLETED|Overall Study||4
271375|NCT00929500|657787|P2|COMPLETED|Overall Study||4
271376|NCT00929500|657788|P1|COMPLETED|Overall Study||4
271377|NCT00929500|657787|P2|STARTED|Overall Study||4
271378|NCT00929500|657788|P1|STARTED|Overall Study||8
271379|NCT00929474|657802|P2|NOT COMPLETED|Overall Study||9
271380|NCT00929474|657803|P1|NOT COMPLETED|Overall Study||8
271381|NCT00929474|657802|P2|COMPLETED|Overall Study||0
271382|NCT00929474|657803|P1|COMPLETED|Overall Study||0
271383|NCT00929474|657802|P2|STARTED|Overall Study||9
271384|NCT00929474|657803|P1|STARTED|Overall Study||8
271385|NCT00929383|657809|P1|NOT COMPLETED|Overall Study||15
271386|NCT00929383|657809|P1|COMPLETED|Overall Study||67
271387|NCT00929383|657809|P1|STARTED|Overall Study||82
271388|NCT00929357|657819|P2|NOT COMPLETED|Overall Study||0
271389|NCT00929357|657820|P1|NOT COMPLETED|Overall Study||0
271390|NCT00929357|657819|P2|COMPLETED|Overall Study||64
271391|NCT00929357|657820|P1|COMPLETED|Overall Study||92
271392|NCT00929357|657819|P2|STARTED|Overall Study||64
271393|NCT00929357|657820|P1|STARTED|Overall Study||92
271394|NCT00929344|657843|P3|NOT COMPLETED|Overall Study||21
271395|NCT00929344|657844|P2|NOT COMPLETED|Overall Study||13
271396|NCT00929344|657845|P1|NOT COMPLETED|Overall Study||22
271397|NCT00929344|657843|P3|COMPLETED|Overall Study||29
271398|NCT00929344|657844|P2|COMPLETED|Overall Study||37
271399|NCT00929344|657845|P1|COMPLETED|Overall Study||28
271400|NCT00929344|657843|P3|STARTED|Overall Study||50
271401|NCT00929344|657844|P2|STARTED|Overall Study||50
271402|NCT00929344|657845|P1|STARTED|Overall Study||50
271403|NCT00929331|657861|P2|NOT COMPLETED|Overall Study||0
271404|NCT00929331|657862|P1|NOT COMPLETED|Overall Study||0
271405|NCT00929331|657861|P2|COMPLETED|Overall Study||55
271406|NCT00929331|657862|P1|COMPLETED|Overall Study||55
271407|NCT00929331|657861|P2|STARTED|Overall Study||55
271408|NCT00929331|657862|P1|STARTED|Overall Study||55
271409|NCT00929305|657896|P2|NOT COMPLETED|Overall Study||0
271410|NCT00929305|657897|P1|NOT COMPLETED|Overall Study||0
271411|NCT00929305|657896|P2|COMPLETED|Overall Study||43
271412|NCT00929305|657897|P1|COMPLETED|Overall Study||43
271413|NCT00929305|657896|P2|STARTED|Overall Study||43
271414|NCT00929305|657897|P1|STARTED|Overall Study||43
271415|NCT00929240|657905|P3|NOT COMPLETED|Maintenance Phase||91
271416|NCT00929240|657906|P2|NOT COMPLETED|Maintenance Phase||94
271417|NCT00929240|657907|P1|NOT COMPLETED|Maintenance Phase||0
271418|NCT00929240|657905|P3|COMPLETED|Maintenance Phase||0
271419|NCT00929240|657906|P2|COMPLETED|Maintenance Phase||0
271420|NCT00929240|657907|P1|COMPLETED|Maintenance Phase||0
271421|NCT00929240|657905|P3|STARTED|Maintenance Phase||91
271422|NCT00929240|657906|P2|STARTED|Maintenance Phase||94
271423|NCT00929240|657907|P1|STARTED|Maintenance Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
271424|NCT00929240|657905|P3|NOT COMPLETED|Initial Treatment Phase||0
271425|NCT00929240|657906|P2|NOT COMPLETED|Initial Treatment Phase||0
271426|NCT00929240|657907|P1|NOT COMPLETED|Initial Treatment Phase||99
271427|NCT00929240|657905|P3|COMPLETED|Initial Treatment Phase||0
271428|NCT00929240|657906|P2|COMPLETED|Initial Treatment Phase||0
271429|NCT00929240|657907|P1|COMPLETED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|185
271430|NCT00929240|657905|P3|STARTED|Initial Treatment Phase||0
271431|NCT00929240|657906|P2|STARTED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
271432|NCT00929240|657907|P1|STARTED|Initial Treatment Phase|Includes only the participants that received Initial Phase Treatment.|284
271433|NCT00929201|657934|P2|NOT COMPLETED|Period 2||0
271434|NCT00929201|657935|P1|NOT COMPLETED|Period 2||0
271435|NCT00929201|657934|P2|COMPLETED|Period 2||30
271436|NCT00929201|657935|P1|COMPLETED|Period 2||30
271437|NCT00929201|657934|P2|STARTED|Period 2||30
271438|NCT00929201|657935|P1|STARTED|Period 2||30
271439|NCT00929201|657934|P2|NOT COMPLETED|7-day Washout||0
271440|NCT00929201|657935|P1|NOT COMPLETED|7-day Washout||0
271441|NCT00929201|657934|P2|COMPLETED|7-day Washout||30
271442|NCT00929201|657935|P1|COMPLETED|7-day Washout||30
271443|NCT00929201|657934|P2|STARTED|7-day Washout||30
271444|NCT00929201|657935|P1|STARTED|7-day Washout||30
271445|NCT00929201|657934|P2|NOT COMPLETED|Period 1||1
271446|NCT00929201|657935|P1|NOT COMPLETED|Period 1||0
271447|NCT00929201|657934|P2|COMPLETED|Period 1||30
271448|NCT00929201|657935|P1|COMPLETED|Period 1||30
271449|NCT00929201|657934|P2|STARTED|Period 1||31
271450|NCT00929201|657935|P1|STARTED|Period 1||30
271451|NCT00929162|657945|P2|NOT COMPLETED|Overall Study||42
271452|NCT00929162|657946|P1|NOT COMPLETED|Overall Study||48
271453|NCT00929162|657945|P2|COMPLETED|Overall Study||19
271454|NCT00929162|657946|P1|COMPLETED|Overall Study||11
271455|NCT00929162|657945|P2|Patients Who Received Treatment|Overall Study||58
271456|NCT00929162|657946|P1|Patients Who Received Treatment|Overall Study||58
271457|NCT00929162|657945|P2|STARTED|Overall Study||61
271458|NCT00929162|657946|P1|STARTED|Overall Study||59
271459|NCT00929110|657959|P3|NOT COMPLETED|Overall Study||62
271460|NCT00929110|657960|P2|NOT COMPLETED|Overall Study||76
271461|NCT00929110|657961|P1|NOT COMPLETED|Overall Study||118
271462|NCT00929110|657959|P3|COMPLETED|Overall Study||206
271463|NCT00929110|657960|P2|COMPLETED|Overall Study||193
271464|NCT00929110|657961|P1|COMPLETED|Overall Study||411
271465|NCT00929110|657959|P3|STARTED|Overall Study||268
271466|NCT00929110|657960|P2|STARTED|Overall Study||269
271467|NCT00929110|657961|P1|STARTED|Overall Study||529
271468|NCT00929071|658026|P1|NOT COMPLETED|Overall Study||0
271469|NCT00929071|658026|P1|COMPLETED|Overall Study||10
271470|NCT00929071|658026|P1|STARTED|Overall Study||10
271471|NCT00928954|658033|P2|NOT COMPLETED|Overall Study||0
271472|NCT00928954|658034|P1|NOT COMPLETED|Overall Study||0
271473|NCT00928954|658033|P2|COMPLETED|Overall Study||6
271474|NCT00928954|658034|P1|COMPLETED|Overall Study||4
271475|NCT00928954|658033|P2|STARTED|Overall Study||6
271476|NCT00928954|658034|P1|STARTED|Overall Study||4
271477|NCT00928889|658044|P2|NOT COMPLETED|Overall Study||2
271478|NCT00928889|658045|P1|NOT COMPLETED|Overall Study||5
271479|NCT00928889|658044|P2|COMPLETED|Overall Study||78
271480|NCT00928889|658045|P1|COMPLETED|Overall Study||75
271481|NCT00928889|658044|P2|STARTED|Overall Study||80
271482|NCT00928889|658045|P1|STARTED|Overall Study||80
271483|NCT00928772|658072|P3|NOT COMPLETED|Overall Study||0
271484|NCT00928772|658073|P2|NOT COMPLETED|Overall Study||0
271485|NCT00928772|658074|P1|NOT COMPLETED|Overall Study||0
271486|NCT00928772|658072|P3|COMPLETED|Overall Study||38
271487|NCT00928772|658073|P2|COMPLETED|Overall Study||38
271488|NCT00928772|658074|P1|COMPLETED|Overall Study||39
271489|NCT00928772|658072|P3|STARTED|Overall Study||38
271490|NCT00928772|658073|P2|STARTED|Overall Study||38
271491|NCT00928772|658074|P1|STARTED|Overall Study||39
271492|NCT00928746|658091|P1|NOT COMPLETED|Overall Study||6
271493|NCT00928746|658091|P1|COMPLETED|Overall Study||136
271494|NCT00928746|658091|P1|STARTED|Overall Study||142
271495|NCT00928720|658114|P3|NOT COMPLETED|Overall Study||3
271496|NCT00928720|658115|P2|NOT COMPLETED|Overall Study||6
271497|NCT00928720|658116|P1|NOT COMPLETED|Overall Study||2
271498|NCT00928720|658114|P3|COMPLETED|Overall Study||15
271499|NCT00928720|658115|P2|COMPLETED|Overall Study||14
271500|NCT00928720|658116|P1|COMPLETED|Overall Study||17
271501|NCT00928720|658114|P3|STARTED|Overall Study||18
271502|NCT00928720|658115|P2|STARTED|Overall Study||20
271503|NCT00928720|658116|P1|STARTED|Overall Study||19
271504|NCT00928707|658141|P2|NOT COMPLETED|Overall Study||0
271505|NCT00928707|658142|P1|NOT COMPLETED|Overall Study||1
271506|NCT00928707|658141|P2|COMPLETED|Overall Study||22
271507|NCT00928707|658142|P1|COMPLETED|Overall Study||22
271508|NCT00928707|658141|P2|STARTED|Overall Study||22
271509|NCT00928707|658142|P1|STARTED|Overall Study||23
271510|NCT00928694|658154|P2|NOT COMPLETED|Second Intervention||0
271511|NCT00928694|658155|P1|NOT COMPLETED|Second Intervention||0
271512|NCT00928694|658154|P2|COMPLETED|Second Intervention||7
271513|NCT00928694|658155|P1|COMPLETED|Second Intervention||7
271514|NCT00928694|658154|P2|STARTED|Second Intervention||7
271515|NCT00928694|658155|P1|STARTED|Second Intervention||7
271516|NCT00928694|658154|P2|NOT COMPLETED|First Intervention||0
271517|NCT00928694|658155|P1|NOT COMPLETED|First Intervention||0
271518|NCT00928694|658154|P2|COMPLETED|First Intervention||7
271519|NCT00928694|658155|P1|COMPLETED|First Intervention||7
271520|NCT00928694|658154|P2|STARTED|First Intervention||7
271521|NCT00928694|658155|P1|STARTED|First Intervention||7
271522|NCT00928668|658163|P5|NOT COMPLETED|Overall Study||1
271523|NCT00928668|658164|P4|NOT COMPLETED|Overall Study||1
271524|NCT00928668|658165|P3|NOT COMPLETED|Overall Study||1
271525|NCT00928668|658166|P2|NOT COMPLETED|Overall Study||1
271526|NCT00928668|658167|P1|NOT COMPLETED|Overall Study||1
271527|NCT00928668|658163|P5|COMPLETED|Overall Study||5
271528|NCT00928668|658164|P4|COMPLETED|Overall Study||3
271529|NCT00928668|658165|P3|COMPLETED|Overall Study||6
271530|NCT00928668|658166|P2|COMPLETED|Overall Study||6
271531|NCT00928668|658167|P1|COMPLETED|Overall Study||6
271532|NCT00928668|658163|P5|STARTED|Overall Study||6
271533|NCT00928668|658164|P4|STARTED|Overall Study||4
271534|NCT00928668|658165|P3|STARTED|Overall Study||7
271535|NCT00928668|658166|P2|STARTED|Overall Study||7
271536|NCT00928668|658167|P1|STARTED|Overall Study||7
271537|NCT00928642|658209|P1|NOT COMPLETED|Overall Study||0
271538|NCT00928642|658209|P1|COMPLETED|Overall Study|1 subject withdrew after 1st cycle but before disease assessment. 7 of 8 are evaluable for response|8
271539|NCT00928642|658209|P1|STARTED|Overall Study||8
271540|NCT00928512|658223|P5|NOT COMPLETED|Overall Study||15
271541|NCT00928512|658224|P4|NOT COMPLETED|Overall Study||21
271542|NCT00928512|658225|P3|NOT COMPLETED|Overall Study||11
271543|NCT00928512|658226|P2|NOT COMPLETED|Overall Study||6
271544|NCT00928512|658227|P1|NOT COMPLETED|Overall Study||10
271545|NCT00928512|658223|P5|COMPLETED|Overall Study||35
271546|NCT00928512|658224|P4|COMPLETED|Overall Study||33
271547|NCT00928512|658225|P3|COMPLETED|Overall Study||38
271548|NCT00928512|658226|P2|COMPLETED|Overall Study||37
271549|NCT00928512|658227|P1|COMPLETED|Overall Study||31
271550|NCT00928512|658223|P5|Entered/Continued to Week 20 (All)|Overall Study||45
271551|NCT00928512|658224|P4|Entered/Continued to Week 20 (All)|Overall Study||45
271552|NCT00928512|658225|P3|Entered/Continued to Week 20 (All)|Overall Study||46
271553|NCT00928512|658226|P2|Entered/Continued to Week 20 (All)|Overall Study||43
271554|NCT00928512|658227|P1|Entered/Continued to Week 20 (All)|Overall Study||37
271555|NCT00928512|658223|P5|Completed Week 16|Overall Study||45
271556|NCT00928512|658224|P4|Completed Week 16|Overall Study||48
271557|NCT00928512|658225|P3|Completed Week 16|Overall Study||47
271558|NCT00928512|658226|P2|Completed Week 16|Overall Study||43
271559|NCT00928512|658227|P1|Completed Week 16|Overall Study||38
271560|NCT00928512|658223|P5|New Groups After Reassignment|Overall Study||0
271561|NCT00928512|658224|P4|New Groups After Reassignment|Overall Study|2 patients in this group continued at Week 16 but did not receive any study drug at Week 20|18
271562|NCT00928512|658225|P3|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|23
271563|NCT00928512|658226|P2|New Groups After Reassignment|Overall Study||115
271564|NCT00928512|658227|P1|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|60
271565|NCT00928512|658223|P5|Not Reassigned at Week 20 (Responders)|Overall Study||0
271566|NCT00928512|658224|P4|Not Reassigned at Week 20 (Responders)|Overall Study||18
271567|NCT00928512|658225|P3|Not Reassigned at Week 20 (Responders)|Overall Study||23
271568|NCT00928512|658226|P2|Not Reassigned at Week 20 (Responders)|Overall Study||20
271569|NCT00928512|658227|P1|Not Reassigned at Week 20 (Responders)|Overall Study||37
271570|NCT00928512|658223|P5|Reassigned at Week 20 (Non-responders)|Overall Study|All placebo patients (responders & non-responders) were reassigned treatment to the 150 mg group.|45
271571|NCT00928512|658224|P4|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 25 mg group were reassigned treatment to the 150 mg group.|27
271572|NCT00928512|658225|P3|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 75 mg group were reassigned treatment to the 150 mg group.|23
271573|NCT00928512|658226|P2|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 150 mg group were reassigned treatment to the 300 mg group.|23
271574|NCT00928512|658227|P1|Reassigned at Week 20 (Non-responders)|Overall Study|All patients in the 300 mg group at Week 20 remained at this dose in this group.|0
271575|NCT00928512|658223|P5|Discontinued Prior to Week 16|Overall Study||5
271576|NCT00928512|658224|P4|Discontinued Prior to Week 16|Overall Study||6
271577|NCT00928512|658225|P3|Discontinued Prior to Week 16|Overall Study||2
271578|NCT00928512|658226|P2|Discontinued Prior to Week 16|Overall Study||0
271579|NCT00928512|658227|P1|Discontinued Prior to Week 16|Overall Study||3
271580|NCT00928512|658223|P5|STARTED|Overall Study||50
271581|NCT00928512|658224|P4|STARTED|Overall Study||54
271582|NCT00928512|658225|P3|STARTED|Overall Study||49
271583|NCT00928512|658226|P2|STARTED|Overall Study||43
271584|NCT00928512|658227|P1|STARTED|Overall Study||41
271585|NCT00928486|658328|P1|NOT COMPLETED|Overall Study||10
271586|NCT00928486|658328|P1|COMPLETED|Overall Study|Completed = those who continued responding to treatment; upon marketing approval, given lenalidomide|15
271587|NCT00928486|658328|P1|Efficacy Evaluable (EE)|Overall Study|EE population = given at least 1 dose of study drug, evaluated for efficacy and met eligibility|24
271588|NCT00928486|658328|P1|STARTED|Overall Study||25
271589|NCT00928434|658337|P3|NOT COMPLETED|Overall Study||44
271590|NCT00928434|658338|P2|NOT COMPLETED|Overall Study||14
271591|NCT00928434|658339|P1|NOT COMPLETED|Overall Study||44
271592|NCT00928434|658337|P3|COMPLETED|Overall Study||134
271593|NCT00928434|658338|P2|COMPLETED|Overall Study||36
271594|NCT00928434|658339|P1|COMPLETED|Overall Study||131
271595|NCT00928434|658337|P3|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|150
271596|NCT00928434|658338|P2|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|41
271597|NCT00928434|658339|P1|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|137
271598|NCT00928434|658337|P3|STARTED|Overall Study|Full Analysis Set Patients|178
271599|NCT00928434|658338|P2|STARTED|Overall Study|Full Analysis Set Patients|50
271600|NCT00928434|658339|P1|STARTED|Overall Study|Full Analysis Set Patients|175
271601|NCT00928421|658411|P1|NOT COMPLETED|Overall Study||0
271602|NCT00928421|658411|P1|COMPLETED|Overall Study||16
271603|NCT00928421|658411|P1|Treated With Study Drug|Overall Study||16
271604|NCT00928421|658411|P1|STARTED|Overall Study||16
271605|NCT00928408|658415|P1|NOT COMPLETED|Overall Study||23
271606|NCT00928408|658415|P1|COMPLETED|Overall Study||282
271700|NCT00927927|658801|P13|NOT COMPLETED|Overall Study||0
271607|NCT00928408|658415|P1|Full Analysis Set|Overall Study|All enrolled participants who fulfilled the study inclusion/exclusion criteria|303
271608|NCT00928408|658415|P1|STARTED|Overall Study|Number Enrolled|305
271609|NCT00928395|658444|P1|NOT COMPLETED|Overall Study||21
271610|NCT00928395|658444|P1|COMPLETED|Overall Study||29
271611|NCT00928395|658444|P1|STARTED|Overall Study||50
271612|NCT00928304|658448|P2|NOT COMPLETED|Overall Study||0
271613|NCT00928304|658449|P1|NOT COMPLETED|Overall Study||0
271614|NCT00928304|658448|P2|COMPLETED|Overall Study||70
271615|NCT00928304|658449|P1|COMPLETED|Overall Study||39
271616|NCT00928304|658448|P2|STARTED|Overall Study||70
271617|NCT00928304|658449|P1|STARTED|Overall Study||39
271618|NCT00928252|658461|P1|NOT COMPLETED|Overall Study||3
271619|NCT00928252|658461|P1|COMPLETED|Overall Study||42
271620|NCT00928252|658461|P1|STARTED|Overall Study||45
271621|NCT00928200|658467|P1|NOT COMPLETED|Overall Study||0
271622|NCT00928200|658467|P1|COMPLETED|Overall Study||1
271623|NCT00928200|658467|P1|STARTED|Overall Study||1
271624|NCT00928187|658476|P3|NOT COMPLETED|Overall Study||5
271625|NCT00928187|658477|P2|NOT COMPLETED|Overall Study||6
271626|NCT00928187|658478|P1|NOT COMPLETED|Overall Study||2
271627|NCT00928187|658476|P3|COMPLETED|Overall Study||150
271628|NCT00928187|658477|P2|COMPLETED|Overall Study||141
271629|NCT00928187|658478|P1|COMPLETED|Overall Study||150
271630|NCT00928187|658476|P3|Analysed|Overall Study||154
271631|NCT00928187|658477|P2|Analysed|Overall Study||145
271632|NCT00928187|658478|P1|Analysed|Overall Study||152
271633|NCT00928187|658476|P3|STARTED|Overall Study||155
271634|NCT00928187|658477|P2|STARTED|Overall Study||147
271635|NCT00928187|658478|P1|STARTED|Overall Study||152
271636|NCT00928174|658522|P1|NOT COMPLETED|Overall Study||5
271637|NCT00928174|658522|P1|COMPLETED|Overall Study|3 withdrawn before start of participation|22
271638|NCT00928174|658522|P1|STARTED|Overall Study||27
271639|NCT00928083|658529|P9|NOT COMPLETED|Overall Study||0
271640|NCT00928083|658530|P8|NOT COMPLETED|Overall Study||0
271641|NCT00928083|658531|P7|NOT COMPLETED|Overall Study||0
271642|NCT00928083|658532|P6|NOT COMPLETED|Overall Study||0
271643|NCT00928083|658533|P5|NOT COMPLETED|Overall Study||1
271644|NCT00928083|658534|P4|NOT COMPLETED|Overall Study||1
271645|NCT00928083|658535|P3|NOT COMPLETED|Overall Study||0
271646|NCT00928083|658536|P2|NOT COMPLETED|Overall Study||0
271647|NCT00928083|658537|P1|NOT COMPLETED|Overall Study||4
271648|NCT00928083|658529|P9|COMPLETED|Overall Study||6
271649|NCT00928083|658530|P8|COMPLETED|Overall Study||6
271650|NCT00928083|658531|P7|COMPLETED|Overall Study||6
271651|NCT00928083|658532|P6|COMPLETED|Overall Study||6
271652|NCT00928083|658533|P5|COMPLETED|Overall Study||6
271653|NCT00928083|658534|P4|COMPLETED|Overall Study||5
271654|NCT00928083|658535|P3|COMPLETED|Overall Study||8
271655|NCT00928083|658536|P2|COMPLETED|Overall Study||8
271656|NCT00928083|658537|P1|COMPLETED|Overall Study||6
271657|NCT00928083|658529|P9|STARTED|Overall Study||6
271658|NCT00928083|658530|P8|STARTED|Overall Study||6
271659|NCT00928083|658531|P7|STARTED|Overall Study||6
271660|NCT00928083|658532|P6|STARTED|Overall Study||6
271661|NCT00928083|658533|P5|STARTED|Overall Study||7
271662|NCT00928083|658534|P4|STARTED|Overall Study||6
271663|NCT00928083|658535|P3|STARTED|Overall Study||8
271664|NCT00928083|658536|P2|STARTED|Overall Study||8
271665|NCT00928083|658537|P1|STARTED|Overall Study||10
271666|NCT00928070|658648|P2|NOT COMPLETED|Overall Study||57
271667|NCT00928070|658649|P1|NOT COMPLETED|Overall Study||63
271668|NCT00928070|658648|P2|COMPLETED|Overall Study||226
271669|NCT00928070|658649|P1|COMPLETED|Overall Study||220
271670|NCT00928070|658648|P2|Treated|Overall Study||281
271671|NCT00928070|658649|P1|Treated|Overall Study||281
271672|NCT00928070|658648|P2|STARTED|Overall Study||283
271673|NCT00928070|658649|P1|STARTED|Overall Study||283
271674|NCT00928057|658707|P2|NOT COMPLETED|Overall Study||4
271675|NCT00928057|658708|P1|NOT COMPLETED|Overall Study||2
271676|NCT00928057|658707|P2|COMPLETED|Overall Study||85
271677|NCT00928057|658708|P1|COMPLETED|Overall Study||82
271678|NCT00928057|658707|P2|STARTED|Overall Study||89
271679|NCT00928057|658708|P1|STARTED|Overall Study||84
271680|NCT00928018|658733|P2|NOT COMPLETED|Overall Study||0
271681|NCT00928018|658734|P1|NOT COMPLETED|Overall Study||1
271682|NCT00928018|658733|P2|COMPLETED|Overall Study||73
271683|NCT00928018|658734|P1|COMPLETED|Overall Study||65
271684|NCT00928018|658733|P2|STARTED|Overall Study||73
271685|NCT00928018|658734|P1|STARTED|Overall Study|One Arm A patient withdrew consent, treated as Arm B, but analyzed on Arm A based on intent-to-treat|66
271686|NCT00927992|658752|P1|NOT COMPLETED|Overall Study||0
271687|NCT00927992|658752|P1|COMPLETED|Overall Study||11
271688|NCT00927992|658752|P1|STARTED|Overall Study||11
271689|NCT00927953|658764|P2|NOT COMPLETED|Overall Study||1
271690|NCT00927953|658765|P1|NOT COMPLETED|Overall Study||2
271691|NCT00927953|658764|P2|COMPLETED|Overall Study||6
271692|NCT00927953|658765|P1|COMPLETED|Overall Study||4
271693|NCT00927953|658764|P2|STARTED|Overall Study||7
271694|NCT00927953|658765|P1|STARTED|Overall Study||6
271695|NCT00927940|658779|P1|NOT COMPLETED|Overall Study||1
271696|NCT00927940|658779|P1|COMPLETED|Overall Study|A patient died before 30 days follow up. This pasitent is excluded from primary analysis.|99
271697|NCT00927940|658779|P1|STARTED|Overall Study||100
271698|NCT00927927|658799|P15|NOT COMPLETED|Overall Study||0
271699|NCT00927927|658800|P14|NOT COMPLETED|Overall Study||0
271701|NCT00927927|658802|P12|NOT COMPLETED|Overall Study||2
271702|NCT00927927|658803|P11|NOT COMPLETED|Overall Study||0
271703|NCT00927927|658804|P10|NOT COMPLETED|Overall Study||0
271704|NCT00927927|658805|P9|NOT COMPLETED|Overall Study||0
271705|NCT00927927|658806|P8|NOT COMPLETED|Overall Study||2
271706|NCT00927927|658807|P7|NOT COMPLETED|Overall Study||0
271707|NCT00927927|658808|P6|NOT COMPLETED|Overall Study||0
271708|NCT00927927|658809|P5|NOT COMPLETED|Overall Study||0
271709|NCT00927927|658810|P4|NOT COMPLETED|Overall Study||0
271710|NCT00927927|658811|P3|NOT COMPLETED|Overall Study||0
271711|NCT00927927|658812|P2|NOT COMPLETED|Overall Study||0
271712|NCT00927927|658813|P1|NOT COMPLETED|Overall Study||0
271713|NCT00927927|658799|P15|COMPLETED|Overall Study||9
271714|NCT00927927|658800|P14|COMPLETED|Overall Study||5
271715|NCT00927927|658801|P13|COMPLETED|Overall Study||5
271716|NCT00927927|658802|P12|COMPLETED|Overall Study|One subject withdrew consent after being randomised but before receiving any trial product.|4
271717|NCT00927927|658803|P11|COMPLETED|Overall Study||5
271718|NCT00927927|658804|P10|COMPLETED|Overall Study||3
271719|NCT00927927|658805|P9|COMPLETED|Overall Study||8
271720|NCT00927927|658806|P8|COMPLETED|Overall Study||1
271721|NCT00927927|658807|P7|COMPLETED|Overall Study||3
271722|NCT00927927|658808|P6|COMPLETED|Overall Study||3
271723|NCT00927927|658809|P5|COMPLETED|Overall Study||3
271724|NCT00927927|658810|P4|COMPLETED|Overall Study||3
271725|NCT00927927|658811|P3|COMPLETED|Overall Study||3
271726|NCT00927927|658812|P2|COMPLETED|Overall Study||3
271727|NCT00927927|658813|P1|COMPLETED|Overall Study||3
271728|NCT00927927|658799|P15|Exposed|Overall Study||9
271729|NCT00927927|658800|P14|Exposed|Overall Study||5
271730|NCT00927927|658801|P13|Exposed|Overall Study||5
271731|NCT00927927|658802|P12|Exposed|Overall Study||5
271732|NCT00927927|658803|P11|Exposed|Overall Study||5
271733|NCT00927927|658804|P10|Exposed|Overall Study||3
271734|NCT00927927|658805|P9|Exposed|Overall Study||8
271735|NCT00927927|658806|P8|Exposed|Overall Study||3
271736|NCT00927927|658807|P7|Exposed|Overall Study||3
271737|NCT00927927|658808|P6|Exposed|Overall Study||3
271738|NCT00927927|658809|P5|Exposed|Overall Study||3
271739|NCT00927927|658810|P4|Exposed|Overall Study||3
271740|NCT00927927|658811|P3|Exposed|Overall Study||3
271741|NCT00927927|658812|P2|Exposed|Overall Study||3
271742|NCT00927927|658813|P1|Exposed|Overall Study||3
271743|NCT00927927|658799|P15|STARTED|Overall Study||9
271744|NCT00927927|658800|P14|STARTED|Overall Study||5
271745|NCT00927927|658801|P13|STARTED|Overall Study||5
271746|NCT00927927|658802|P12|STARTED|Overall Study||6
271747|NCT00927927|658803|P11|STARTED|Overall Study||5
271748|NCT00927927|658804|P10|STARTED|Overall Study||3
271749|NCT00927927|658805|P9|STARTED|Overall Study||8
271750|NCT00927927|658806|P8|STARTED|Overall Study||3
271751|NCT00927927|658807|P7|STARTED|Overall Study||3
271752|NCT00927927|658808|P6|STARTED|Overall Study||3
271753|NCT00927927|658809|P5|STARTED|Overall Study||3
271754|NCT00927927|658810|P4|STARTED|Overall Study||3
271755|NCT00927927|658811|P3|STARTED|Overall Study||3
271756|NCT00927927|658812|P2|STARTED|Overall Study||3
271757|NCT00927927|658813|P1|STARTED|Overall Study||3
271758|NCT00927901|658860|P4|NOT COMPLETED|Treatment Period 4||1
271759|NCT00927901|658861|P3|NOT COMPLETED|Treatment Period 4||1
271760|NCT00927901|658862|P2|NOT COMPLETED|Treatment Period 4||0
271761|NCT00927901|658863|P1|NOT COMPLETED|Treatment Period 4||0
271762|NCT00927901|658860|P4|COMPLETED|Treatment Period 4||8
271763|NCT00927901|658861|P3|COMPLETED|Treatment Period 4||5
271764|NCT00927901|658862|P2|COMPLETED|Treatment Period 4||7
271765|NCT00927901|658863|P1|COMPLETED|Treatment Period 4||7
271766|NCT00927901|658860|P4|STARTED|Treatment Period 4||9
271767|NCT00927901|658861|P3|STARTED|Treatment Period 4||6
271768|NCT00927901|658862|P2|STARTED|Treatment Period 4||7
271769|NCT00927901|658863|P1|STARTED|Treatment Period 4||7
271770|NCT00927901|658860|P4|NOT COMPLETED|Treatment Period 3||0
271771|NCT00927901|658861|P3|NOT COMPLETED|Treatment Period 3||0
271772|NCT00927901|658862|P2|NOT COMPLETED|Treatment Period 3||0
271773|NCT00927901|658863|P1|NOT COMPLETED|Treatment Period 3||0
271774|NCT00927901|658860|P4|COMPLETED|Treatment Period 3||9
271775|NCT00927901|658861|P3|COMPLETED|Treatment Period 3||6
271776|NCT00927901|658862|P2|COMPLETED|Treatment Period 3||7
271777|NCT00927901|658863|P1|COMPLETED|Treatment Period 3||7
271778|NCT00927901|658860|P4|STARTED|Treatment Period 3||9
271779|NCT00927901|658861|P3|STARTED|Treatment Period 3||6
271780|NCT00927901|658862|P2|STARTED|Treatment Period 3||7
271781|NCT00927901|658863|P1|STARTED|Treatment Period 3||7
271782|NCT00927901|658860|P4|NOT COMPLETED|Treatment Period 2||0
271783|NCT00927901|658861|P3|NOT COMPLETED|Treatment Period 2||0
271784|NCT00927901|658862|P2|NOT COMPLETED|Treatment Period 2||0
271785|NCT00927901|658863|P1|NOT COMPLETED|Treatment Period 2||0
271786|NCT00927901|658860|P4|COMPLETED|Treatment Period 2||9
271787|NCT00927901|658861|P3|COMPLETED|Treatment Period 2||6
271788|NCT00927901|658862|P2|COMPLETED|Treatment Period 2||7
271789|NCT00927901|658863|P1|COMPLETED|Treatment Period 2||7
271790|NCT00927901|658860|P4|STARTED|Treatment Period 2||9
271791|NCT00927901|658861|P3|STARTED|Treatment Period 2||6
271792|NCT00927901|658862|P2|STARTED|Treatment Period 2||7
271793|NCT00927901|658863|P1|STARTED|Treatment Period 2||7
271794|NCT00927901|658860|P4|NOT COMPLETED|Treatment Period 1||0
271795|NCT00927901|658861|P3|NOT COMPLETED|Treatment Period 1||1
271796|NCT00927901|658862|P2|NOT COMPLETED|Treatment Period 1||0
271797|NCT00927901|658863|P1|NOT COMPLETED|Treatment Period 1||0
271798|NCT00927901|658860|P4|COMPLETED|Treatment Period 1||9
271799|NCT00927901|658861|P3|COMPLETED|Treatment Period 1||6
271800|NCT00927901|658862|P2|COMPLETED|Treatment Period 1||7
271801|NCT00927901|658863|P1|COMPLETED|Treatment Period 1||7
271802|NCT00927901|658860|P4|STARTED|Treatment Period 1||9
271803|NCT00927901|658861|P3|STARTED|Treatment Period 1||7
271804|NCT00927901|658862|P2|STARTED|Treatment Period 1||7
271805|NCT00927901|658863|P1|STARTED|Treatment Period 1||7
271806|NCT00927888|658893|P2|NOT COMPLETED|Overall Study||0
271807|NCT00927888|658894|P1|NOT COMPLETED|Overall Study||0
271808|NCT00927888|658893|P2|COMPLETED|Overall Study||27
271809|NCT00927888|658894|P1|COMPLETED|Overall Study||29
271810|NCT00927888|658893|P2|STARTED|Overall Study||27
271811|NCT00927888|658894|P1|STARTED|Overall Study||29
271812|NCT00927862|658904|P2|NOT COMPLETED|Overall Study||45
271813|NCT00927862|658905|P1|NOT COMPLETED|Overall Study||27
271814|NCT00927862|658904|P2|COMPLETED|Overall Study||1866
271815|NCT00927862|658905|P1|COMPLETED|Overall Study|477 patients evaluated in primary analyses and 488 evaluated in secondary analyses.|477
271816|NCT00927862|658904|P2|STARTED|Overall Study||1911
271817|NCT00927862|658905|P1|STARTED|Overall Study||504
271818|NCT00927849|658930|P3|NOT COMPLETED|Overall Study||0
271819|NCT00927849|658931|P2|NOT COMPLETED|Overall Study||0
271820|NCT00927849|658932|P1|NOT COMPLETED|Overall Study||0
271821|NCT00927849|658930|P3|COMPLETED|Overall Study||21
271822|NCT00927849|658931|P2|COMPLETED|Overall Study||21
271823|NCT00927849|658932|P1|COMPLETED|Overall Study||21
271824|NCT00927849|658930|P3|STARTED|Overall Study||21
271825|NCT00927849|658931|P2|STARTED|Overall Study||21
271826|NCT00927849|658932|P1|STARTED|Overall Study||21
271827|NCT00927823|658940|P4|NOT COMPLETED|Continuous Dosing Period||5
271828|NCT00927823|658941|P3|NOT COMPLETED|Continuous Dosing Period||26
271829|NCT00927823|658942|P2|NOT COMPLETED|Continuous Dosing Period||3
271830|NCT00927823|658943|P1|NOT COMPLETED|Continuous Dosing Period||3
271831|NCT00927823|658940|P4|COMPLETED|Continuous Dosing Period||0
271832|NCT00927823|658941|P3|COMPLETED|Continuous Dosing Period||0
271833|NCT00927823|658942|P2|COMPLETED|Continuous Dosing Period||0
271834|NCT00927823|658943|P1|COMPLETED|Continuous Dosing Period||0
271835|NCT00927823|658940|P4|Treated|Continuous Dosing Period||5
271836|NCT00927823|658941|P3|Treated|Continuous Dosing Period||23
271837|NCT00927823|658942|P2|Treated|Continuous Dosing Period||3
271838|NCT00927823|658943|P1|Treated|Continuous Dosing Period||3
271839|NCT00927823|658940|P4|STARTED|Continuous Dosing Period||5
271840|NCT00927823|658941|P3|STARTED|Continuous Dosing Period||26
271841|NCT00927823|658942|P2|STARTED|Continuous Dosing Period||3
271842|NCT00927823|658943|P1|STARTED|Continuous Dosing Period||3
271843|NCT00927823|658940|P4|NOT COMPLETED|Lead-In Period||0
271844|NCT00927823|658941|P3|NOT COMPLETED|Lead-In Period||0
271845|NCT00927823|658942|P2|NOT COMPLETED|Lead-In Period||0
271846|NCT00927823|658943|P1|NOT COMPLETED|Lead-In Period||0
271847|NCT00927823|658940|P4|COMPLETED|Lead-In Period||5
271848|NCT00927823|658941|P3|COMPLETED|Lead-In Period||26
271849|NCT00927823|658942|P2|COMPLETED|Lead-In Period||3
271850|NCT00927823|658943|P1|COMPLETED|Lead-In Period||3
271851|NCT00927823|658940|P4|STARTED|Lead-In Period||5
271852|NCT00927823|658941|P3|STARTED|Lead-In Period||26
271853|NCT00927823|658942|P2|STARTED|Lead-In Period||3
271854|NCT00927823|658943|P1|STARTED|Lead-In Period||3
271855|NCT00927784|659009|P2|NOT COMPLETED|Overall Study||0
271856|NCT00927784|659010|P1|NOT COMPLETED|Overall Study||2
271857|NCT00927784|659009|P2|COMPLETED|Overall Study||2
271858|NCT00927784|659010|P1|COMPLETED|Overall Study||6
271859|NCT00927784|659009|P2|STARTED|Overall Study||2
271860|NCT00927784|659010|P1|STARTED|Overall Study||8
271861|NCT00927758|659040|P6|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
271862|NCT00927758|659041|P5|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
271863|NCT00927758|659042|P4|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
271864|NCT00927758|659043|P3|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
271865|NCT00927758|659044|P2|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
271866|NCT00927758|659045|P1|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
271867|NCT00927758|659040|P6|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||2
271868|NCT00927758|659041|P5|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
271869|NCT00927758|659042|P4|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||1
271870|NCT00927758|659043|P3|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
271871|NCT00927758|659044|P2|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
271872|NCT00927758|659045|P1|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
271873|NCT00927758|659040|P6|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||2
271874|NCT00927758|659041|P5|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
271875|NCT00927758|659042|P4|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||1
271876|NCT00927758|659043|P3|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
271877|NCT00927758|659044|P2|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
271878|NCT00927758|659045|P1|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
271879|NCT00927758|659040|P6|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
271880|NCT00927758|659041|P5|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
271881|NCT00927758|659042|P4|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
271882|NCT00927758|659043|P3|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
271883|NCT00927758|659044|P2|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
271884|NCT00927758|659045|P1|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
271885|NCT00927758|659040|P6|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||2
271886|NCT00927758|659041|P5|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
271887|NCT00927758|659042|P4|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
271888|NCT00927758|659043|P3|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
271889|NCT00927758|659044|P2|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
271890|NCT00927758|659045|P1|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
271891|NCT00927758|659040|P6|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||2
271892|NCT00927758|659041|P5|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
271893|NCT00927758|659042|P4|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||1
271894|NCT00927758|659043|P3|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
271895|NCT00927758|659044|P2|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
271896|NCT00927758|659045|P1|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
271897|NCT00927758|659040|P6|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
271898|NCT00927758|659041|P5|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
271899|NCT00927758|659042|P4|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||2
271900|NCT00927758|659043|P3|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
271901|NCT00927758|659044|P2|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
271902|NCT00927758|659045|P1|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
271903|NCT00927758|659040|P6|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
271904|NCT00927758|659041|P5|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
271905|NCT00927758|659042|P4|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
271906|NCT00927758|659043|P3|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
271907|NCT00927758|659044|P2|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
271908|NCT00927758|659045|P1|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
271909|NCT00927758|659040|P6|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
271910|NCT00927758|659041|P5|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
271911|NCT00927758|659042|P4|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||2
271912|NCT00927758|659043|P3|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
271913|NCT00927758|659044|P2|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
271914|NCT00927758|659045|P1|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
271915|NCT00927758|659040|P6|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
271916|NCT00927758|659041|P5|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
271917|NCT00927758|659042|P4|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||2
271918|NCT00927758|659043|P3|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
271919|NCT00927758|659044|P2|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
271920|NCT00927758|659045|P1|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
271921|NCT00927758|659040|P6|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
271922|NCT00927758|659041|P5|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
271923|NCT00927758|659042|P4|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
271924|NCT00927758|659043|P3|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
271925|NCT00927758|659044|P2|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
271926|NCT00927758|659045|P1|STARTED|Treatment Cycle 1 (Day 1 - Day 7)|"Started  indicates randomized as well as safety set."|4
271927|NCT00927589|659053|P1|NOT COMPLETED|Overall Study||16
271928|NCT00927589|659053|P1|COMPLETED|Overall Study|Participants were considered to have completed the study after receiving 3 cycles of treatment.|43
271929|NCT00927589|659053|P1|STARTED|Overall Study||59
271930|NCT00927576|659077|P2|NOT COMPLETED|Overall Study||0
271931|NCT00927576|659078|P1|NOT COMPLETED|Overall Study||0
271932|NCT00927576|659077|P2|COMPLETED|Overall Study||28
271933|NCT00927576|659078|P1|COMPLETED|Overall Study||237
271934|NCT00927576|659077|P2|Cognitive Testing|Overall Study||28
271935|NCT00927576|659078|P1|Cognitive Testing|Overall Study||237
271936|NCT00927576|659077|P2|STARTED|Overall Study||28
271937|NCT00927576|659078|P1|STARTED|Overall Study||237
271938|NCT00927563|659083|P1|NOT COMPLETED|Overall Study||2
271939|NCT00927563|659083|P1|COMPLETED|Overall Study||22
271940|NCT00927563|659083|P1|STARTED|Overall Study||24
271941|NCT00927472|659091|P2|NOT COMPLETED|Overall Study||22
271942|NCT00927472|659092|P1|NOT COMPLETED|Overall Study||11
271943|NCT00927472|659091|P2|COMPLETED|Overall Study||106
271944|NCT00927472|659092|P1|COMPLETED|Overall Study||115
271945|NCT00927472|659091|P2|STARTED|Overall Study||128
271946|NCT00927472|659092|P1|STARTED|Overall Study||126
271947|NCT00927394|659118|P2|NOT COMPLETED|Overall Study||85
271948|NCT00927394|659119|P1|NOT COMPLETED|Overall Study||77
271949|NCT00927394|659118|P2|COMPLETED|Overall Study||483
271950|NCT00927394|659119|P1|COMPLETED|Overall Study||498
271951|NCT00927394|659118|P2|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||562
271952|NCT00927394|659119|P1|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||574
271953|NCT00927394|659118|P2|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study||323
271954|NCT00927394|659119|P1|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study|consists of all patients in FAS 2 who had both valid baseline and post-baseline ABPM assessments.|342
271955|NCT00927394|659118|P2|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study||398
271956|NCT00927394|659119|P1|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study|FAS 2= all patients randomized to Cohort 2 and who had a valid baseline assessment of 24 hours ABPM.|417
271957|NCT00927394|659118|P2|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study||164
272134|NCT00926367|659616|P1|COMPLETED|Overall Study||23
272135|NCT00926367|659615|P2|STARTED|Overall Study||27
271958|NCT00927394|659119|P1|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study|FAS 1 includes all patients in Cohort 1 to whom study treatments were given through randomization.|157
271959|NCT00927394|659118|P2|Combined Safety Set (Cohort 1 and 2)|Overall Study||565
271960|NCT00927394|659119|P1|Combined Safety Set (Cohort 1 and 2)|Overall Study||574
271961|NCT00927394|659118|P2|Cohort 2 (Randomized)|Overall Study||403
271962|NCT00927394|659119|P1|Cohort 2 (Randomized)|Overall Study|Cohort 2 includes patients with specific eligibility criteria mentioned in protocol section|418
271963|NCT00927394|659118|P2|Cohort 1 (Randomized)|Overall Study||165
271964|NCT00927394|659119|P1|Cohort 1 (Randomized)|Overall Study|Cohort 1 includes patients with specific eligibility criteria mentioned in protocol section|157
271965|NCT00927394|659118|P2|STARTED|Overall Study|One patient was randomized in error and was discontinued by site.|568
271966|NCT00927394|659119|P1|STARTED|Overall Study||575
271967|NCT00927368|659150|P3|NOT COMPLETED|Overall Study||5
271968|NCT00927368|659151|P2|NOT COMPLETED|Overall Study||5
271969|NCT00927368|659152|P1|NOT COMPLETED|Overall Study||6
271970|NCT00927368|659150|P3|COMPLETED|Overall Study||138
271971|NCT00927368|659151|P2|COMPLETED|Overall Study||152
271972|NCT00927368|659152|P1|COMPLETED|Overall Study||147
271973|NCT00927368|659150|P3|STARTED|Overall Study||143
271974|NCT00927368|659151|P2|STARTED|Overall Study||157
271975|NCT00927368|659152|P1|STARTED|Overall Study||153
271976|NCT00927355|659171|P2|NOT COMPLETED|Overall Study||1
271977|NCT00927355|659172|P1|NOT COMPLETED|Overall Study||1
271978|NCT00927355|659171|P2|COMPLETED|Overall Study||4
271979|NCT00927355|659172|P1|COMPLETED|Overall Study||4
271980|NCT00927355|659171|P2|STARTED|Overall Study||5
271981|NCT00927355|659172|P1|STARTED|Overall Study||5
271982|NCT00927264|659192|P2|NOT COMPLETED|Overall Study||25
271983|NCT00927264|659193|P1|NOT COMPLETED|Overall Study||56
271984|NCT00927264|659192|P2|COMPLETED|Overall Study||140
271985|NCT00927264|659193|P1|COMPLETED|Overall Study||109
271986|NCT00927264|659192|P2|STARTED|Overall Study||165
271987|NCT00927264|659193|P1|STARTED|Overall Study||165
271988|NCT00927251|659207|P1|NOT COMPLETED|Overall Study||8
271989|NCT00927251|659207|P1|COMPLETED|Overall Study||82
271990|NCT00927251|659207|P1|STARTED|Overall Study||90
271991|NCT00927186|659213|P2|NOT COMPLETED|12 - 24 Months Extension Treatment||0
271992|NCT00927186|659214|P1|NOT COMPLETED|12 - 24 Months Extension Treatment||0
271993|NCT00927186|659213|P2|COMPLETED|12 - 24 Months Extension Treatment||11
271994|NCT00927186|659214|P1|COMPLETED|12 - 24 Months Extension Treatment||10
271995|NCT00927186|659213|P2|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|11
271996|NCT00927186|659214|P1|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|10
271997|NCT00927186|659213|P2|NOT COMPLETED|12 Months Primary Study||4
271998|NCT00927186|659214|P1|NOT COMPLETED|12 Months Primary Study||7
271999|NCT00927186|659213|P2|COMPLETED|12 Months Primary Study||31
272000|NCT00927186|659214|P1|COMPLETED|12 Months Primary Study||27
272001|NCT00927186|659213|P2|Completed 6 Months Double Blind Phase|12 Months Primary Study||31
272002|NCT00927186|659214|P1|Completed 6 Months Double Blind Phase|12 Months Primary Study||28
272003|NCT00927186|659213|P2|STARTED|12 Months Primary Study||35
272004|NCT00927186|659214|P1|STARTED|12 Months Primary Study||34
272005|NCT00927160|659332|P2|NOT COMPLETED|Overall Study||0
272006|NCT00927160|659333|P1|NOT COMPLETED|Overall Study||0
272007|NCT00927160|659332|P2|COMPLETED|Overall Study||173
272008|NCT00927160|659333|P1|COMPLETED|Overall Study||173
272009|NCT00927160|659332|P2|STARTED|Overall Study||173
272010|NCT00927160|659333|P1|STARTED|Overall Study||173
272011|NCT00927095|659344|P3|NOT COMPLETED|Overall Study||2
272012|NCT00927095|659345|P2|NOT COMPLETED|Overall Study||4
272013|NCT00927095|659346|P1|NOT COMPLETED|Overall Study||6
272014|NCT00927095|659344|P3|COMPLETED|Overall Study||22
272015|NCT00927095|659345|P2|COMPLETED|Overall Study||17
272016|NCT00927095|659346|P1|COMPLETED|Overall Study||16
272017|NCT00927095|659344|P3|STARTED|Overall Study||24
272018|NCT00927095|659345|P2|STARTED|Overall Study||21
272019|NCT00927095|659346|P1|STARTED|Overall Study||22
272020|NCT00927082|659358|P4|NOT COMPLETED|Overall Study||19
272021|NCT00927082|659359|P3|NOT COMPLETED|Overall Study||22
272022|NCT00927082|659360|P2|NOT COMPLETED|Overall Study||10
272023|NCT00927082|659361|P1|NOT COMPLETED|Overall Study||12
272024|NCT00927082|659358|P4|COMPLETED|Overall Study||78
272025|NCT00927082|659359|P3|COMPLETED|Overall Study||86
272026|NCT00927082|659360|P2|COMPLETED|Overall Study||77
272027|NCT00927082|659361|P1|COMPLETED|Overall Study||79
272028|NCT00927082|659358|P4|STARTED|Overall Study||97
272029|NCT00927082|659359|P3|STARTED|Overall Study||108
272030|NCT00927082|659360|P2|STARTED|Overall Study||87
272031|NCT00927082|659361|P1|STARTED|Overall Study||91
272032|NCT00927069|659425|P4|NOT COMPLETED|Week 12 to Week 24||3
272033|NCT00927069|659426|P3|NOT COMPLETED|Week 12 to Week 24||3
272034|NCT00927069|659427|P2|NOT COMPLETED|Week 12 to Week 24||0
272035|NCT00927069|659428|P1|NOT COMPLETED|Week 12 to Week 24||2
272036|NCT00927069|659425|P4|COMPLETED|Week 12 to Week 24||20
272037|NCT00927069|659426|P3|COMPLETED|Week 12 to Week 24||28
272038|NCT00927069|659427|P2|COMPLETED|Week 12 to Week 24||11
272039|NCT00927069|659428|P1|COMPLETED|Week 12 to Week 24||16
272040|NCT00927069|659425|P4|STARTED|Week 12 to Week 24|23 Pts. from Group B had a dose incr. since they did not respond to 40mg adalimumab every other week|23
272136|NCT00926367|659616|P1|STARTED|Overall Study||25
272041|NCT00927069|659426|P3|STARTED|Week 12 to Week 24|31 Pts. from Group A had a dose incr. since they did not respond to 40mg adalimumab every other week|31
272042|NCT00927069|659427|P2|STARTED|Week 12 to Week 24|11 patients stayed at the same dose of 40 mg Adalimumab every other week|11
272043|NCT00927069|659428|P1|STARTED|Week 12 to Week 24|17 patients stayed at the same dose. One patient withdrew at Week 12 and also had no dose increase|18
272044|NCT00927069|659425|P4|NOT COMPLETED|Week 0 to Week 12||0
272045|NCT00927069|659426|P3|NOT COMPLETED|Week 0 to Week 12||0
272046|NCT00927069|659427|P2|NOT COMPLETED|Week 0 to Week 12||1
272047|NCT00927069|659428|P1|NOT COMPLETED|Week 0 to Week 12||1
272048|NCT00927069|659425|P4|COMPLETED|Week 0 to Week 12||0
272049|NCT00927069|659426|P3|COMPLETED|Week 0 to Week 12||0
272050|NCT00927069|659427|P2|COMPLETED|Week 0 to Week 12||34
272051|NCT00927069|659428|P1|COMPLETED|Week 0 to Week 12||49
272052|NCT00927069|659425|P4|STARTED|Week 0 to Week 12||0
272053|NCT00927069|659426|P3|STARTED|Week 0 to Week 12||0
272054|NCT00927069|659427|P2|STARTED|Week 0 to Week 12||35
272055|NCT00927069|659428|P1|STARTED|Week 0 to Week 12||50
272056|NCT00926952|659438|P1|NOT COMPLETED|Overall Study||0
272057|NCT00926952|659438|P1|COMPLETED|Overall Study||20
272058|NCT00926952|659438|P1|STARTED|Overall Study||20
272059|NCT00926887|659452|P2|NOT COMPLETED|Overall Study||0
272060|NCT00926887|659453|P1|NOT COMPLETED|Overall Study||0
272061|NCT00926887|659452|P2|COMPLETED|Overall Study||50
272062|NCT00926887|659453|P1|COMPLETED|Overall Study||54
272063|NCT00926887|659452|P2|STARTED|Overall Study||50
272064|NCT00926887|659453|P1|STARTED|Overall Study||54
272065|NCT00926848|659465|P2|NOT COMPLETED|Overall Study||0
272066|NCT00926848|659466|P1|NOT COMPLETED|Overall Study||0
272067|NCT00926848|659465|P2|COMPLETED|Overall Study||34
272068|NCT00926848|659466|P1|COMPLETED|Overall Study||34
272069|NCT00926848|659465|P2|STARTED|Overall Study||34
272070|NCT00926848|659466|P1|STARTED|Overall Study||34
272071|NCT00926796|659484|P2|NOT COMPLETED|Overall Study||106
272072|NCT00926796|659485|P1|NOT COMPLETED|Overall Study||107
272073|NCT00926796|659484|P2|COMPLETED|Overall Study|Number eligible and in the full analysis set|199
272074|NCT00926796|659485|P1|COMPLETED|Overall Study|Number eligible and in the full analysis set|202
272075|NCT00926796|659484|P2|STARTED|Overall Study|Number randomized|305
272076|NCT00926796|659485|P1|STARTED|Overall Study|Number randomized|309
272077|NCT00926783|659506|P2|NOT COMPLETED|Overall Study||3
272078|NCT00926783|659507|P1|NOT COMPLETED|Overall Study||3
272079|NCT00926783|659506|P2|COMPLETED|Overall Study||38
272080|NCT00926783|659507|P1|COMPLETED|Overall Study||39
272081|NCT00926783|659506|P2|STARTED|Overall Study||41
272082|NCT00926783|659507|P1|STARTED|Overall Study||42
272083|NCT00926588|659525|P2|NOT COMPLETED|Overall Study||4
272084|NCT00926588|659526|P1|NOT COMPLETED|Overall Study||8
272085|NCT00926588|659525|P2|COMPLETED|Overall Study||122
272086|NCT00926588|659526|P1|COMPLETED|Overall Study||116
272087|NCT00926588|659525|P2|STARTED|Overall Study||126
272088|NCT00926588|659526|P1|STARTED|Overall Study||124
272089|NCT00926575|659534|P2|NOT COMPLETED|Overall Study||17
272090|NCT00926575|659535|P1|NOT COMPLETED|Overall Study||16
272091|NCT00926575|659534|P2|COMPLETED|Overall Study||53
272092|NCT00926575|659535|P1|COMPLETED|Overall Study||54
272093|NCT00926575|659534|P2|STARTED|Overall Study||70
272094|NCT00926575|659535|P1|STARTED|Overall Study||70
272095|NCT00926536|659547|P2|NOT COMPLETED|Overall Study||2
272096|NCT00926536|659548|P1|NOT COMPLETED|Overall Study||1
272097|NCT00926536|659547|P2|COMPLETED|Overall Study||41
272098|NCT00926536|659548|P1|COMPLETED|Overall Study||43
272099|NCT00926536|659547|P2|STARTED|Overall Study||43
272100|NCT00926536|659548|P1|STARTED|Overall Study||44
272101|NCT00926497|659558|P2|NOT COMPLETED|Overall Study||0
272102|NCT00926497|659559|P1|NOT COMPLETED|Overall Study||0
272103|NCT00926497|659558|P2|COMPLETED|Overall Study||61
272104|NCT00926497|659559|P1|COMPLETED|Overall Study||60
272105|NCT00926497|659558|P2|STARTED|Overall Study||61
272106|NCT00926497|659559|P1|STARTED|Overall Study||60
272107|NCT00926393|659569|P2|NOT COMPLETED|Overall Study||3
272108|NCT00926393|659570|P1|NOT COMPLETED|Overall Study||2
272109|NCT00926393|659569|P2|COMPLETED|Overall Study||67
272110|NCT00926393|659570|P1|COMPLETED|Overall Study||67
272111|NCT00926393|659569|P2|STARTED|Overall Study||70
272112|NCT00926393|659570|P1|STARTED|Overall Study||69
272113|NCT00926380|659603|P3|NOT COMPLETED|Year 2||5
272114|NCT00926380|659604|P2|NOT COMPLETED|Year 2||2
272115|NCT00926380|659605|P1|NOT COMPLETED|Year 2||2
272116|NCT00926380|659603|P3|COMPLETED|Year 2||24
272117|NCT00926380|659604|P2|COMPLETED|Year 2||28
272118|NCT00926380|659605|P1|COMPLETED|Year 2||31
272119|NCT00926380|659603|P3|STARTED|Year 2||29
272120|NCT00926380|659604|P2|STARTED|Year 2||30
272121|NCT00926380|659605|P1|STARTED|Year 2||33
272122|NCT00926380|659603|P3|NOT COMPLETED|Year 1||1
272123|NCT00926380|659604|P2|NOT COMPLETED|Year 1||1
272124|NCT00926380|659605|P1|NOT COMPLETED|Year 1||0
272125|NCT00926380|659603|P3|COMPLETED|Year 1||29
272126|NCT00926380|659604|P2|COMPLETED|Year 1||30
272127|NCT00926380|659605|P1|COMPLETED|Year 1||33
272128|NCT00926380|659603|P3|STARTED|Year 1||30
272129|NCT00926380|659604|P2|STARTED|Year 1||31
272130|NCT00926380|659605|P1|STARTED|Year 1||33
272131|NCT00926367|659615|P2|NOT COMPLETED|Overall Study||3
272132|NCT00926367|659616|P1|NOT COMPLETED|Overall Study||2
272133|NCT00926367|659615|P2|COMPLETED|Overall Study||24
272137|NCT00926328|659658|P2|NOT COMPLETED|Overall Study||14
272138|NCT00926328|659659|P1|NOT COMPLETED|Overall Study||12
272139|NCT00926328|659658|P2|COMPLETED|Overall Study||46
272140|NCT00926328|659659|P1|COMPLETED|Overall Study||48
272141|NCT00926328|659658|P2|STARTED|Overall Study||60
272142|NCT00926328|659659|P1|STARTED|Overall Study||60
272143|NCT00926289|659669|P2|NOT COMPLETED|Overall Study||36
272144|NCT00926289|659670|P1|NOT COMPLETED|Overall Study||25
272145|NCT00926289|659669|P2|COMPLETED|Overall Study||558
272146|NCT00926289|659670|P1|COMPLETED|Overall Study||269
272147|NCT00926289|659669|P2|STARTED|Overall Study|Number of treated patients|594
272148|NCT00926289|659670|P1|STARTED|Overall Study|Number of treated patients|294
272149|NCT00926263|659706|P2|NOT COMPLETED|Overall Study||0
272150|NCT00926263|659707|P1|NOT COMPLETED|Overall Study||0
272151|NCT00926263|659706|P2|COMPLETED|Overall Study||12
272152|NCT00926263|659707|P1|COMPLETED|Overall Study||16
272153|NCT00926263|659706|P2|STARTED|Overall Study||12
272154|NCT00926263|659707|P1|STARTED|Overall Study||16
272155|NCT00926211|659738|P1|NOT COMPLETED|Overall Study||1
272156|NCT00926211|659738|P1|COMPLETED|Overall Study||35
272157|NCT00926211|659738|P1|STARTED|Overall Study|One additional subject was not randomized and did not receive the treatment procedure.|36
272158|NCT00926185|659749|P4|NOT COMPLETED|Overall Study||10
272159|NCT00926185|659750|P3|NOT COMPLETED|Overall Study||10
272160|NCT00926185|659751|P2|NOT COMPLETED|Overall Study||6
272161|NCT00926185|659752|P1|NOT COMPLETED|Overall Study||3
272162|NCT00926185|659749|P4|COMPLETED|Overall Study||48
272163|NCT00926185|659750|P3|COMPLETED|Overall Study||48
272164|NCT00926185|659751|P2|COMPLETED|Overall Study||51
272165|NCT00926185|659752|P1|COMPLETED|Overall Study||54
272166|NCT00926185|659749|P4|STARTED|Overall Study||58
272167|NCT00926185|659750|P3|STARTED|Overall Study||58
272168|NCT00926185|659751|P2|STARTED|Overall Study||57
272169|NCT00926185|659752|P1|STARTED|Overall Study||57
272170|NCT00926029|659769|P3|NOT COMPLETED|Overall Study||1
272171|NCT00926029|659770|P2|NOT COMPLETED|Overall Study||1
272172|NCT00926029|659771|P1|NOT COMPLETED|Overall Study||2
272173|NCT00926029|659769|P3|COMPLETED|Overall Study||33
272174|NCT00926029|659770|P2|COMPLETED|Overall Study||33
272175|NCT00926029|659771|P1|COMPLETED|Overall Study||32
272176|NCT00926029|659769|P3|STARTED|Overall Study||34
272177|NCT00926029|659770|P2|STARTED|Overall Study||34
272178|NCT00926029|659771|P1|STARTED|Overall Study||34
272179|NCT00926003|659785|P3|NOT COMPLETED|Post-Training 3-month Follow-up||0
272180|NCT00926003|659786|P2|NOT COMPLETED|Post-Training 3-month Follow-up||0
272181|NCT00926003|659787|P1|NOT COMPLETED|Post-Training 3-month Follow-up||1
272182|NCT00926003|659785|P3|COMPLETED|Post-Training 3-month Follow-up||52
272183|NCT00926003|659786|P2|COMPLETED|Post-Training 3-month Follow-up||54
272184|NCT00926003|659787|P1|COMPLETED|Post-Training 3-month Follow-up||51
272185|NCT00926003|659785|P3|STARTED|Post-Training 3-month Follow-up||52
272186|NCT00926003|659786|P2|STARTED|Post-Training 3-month Follow-up||54
272187|NCT00926003|659787|P1|STARTED|Post-Training 3-month Follow-up||52
272188|NCT00926003|659785|P3|NOT COMPLETED|Post-Training Evaluation||0
272189|NCT00926003|659786|P2|NOT COMPLETED|Post-Training Evaluation||0
272190|NCT00926003|659787|P1|NOT COMPLETED|Post-Training Evaluation||1
272191|NCT00926003|659785|P3|COMPLETED|Post-Training Evaluation||52
272192|NCT00926003|659786|P2|COMPLETED|Post-Training Evaluation||54
272193|NCT00926003|659787|P1|COMPLETED|Post-Training Evaluation||52
272194|NCT00926003|659785|P3|STARTED|Post-Training Evaluation||52
272195|NCT00926003|659786|P2|STARTED|Post-Training Evaluation||54
272196|NCT00926003|659787|P1|STARTED|Post-Training Evaluation||53
272197|NCT00926003|659785|P3|NOT COMPLETED|Baseline||0
272198|NCT00926003|659786|P2|NOT COMPLETED|Baseline||0
272199|NCT00926003|659787|P1|NOT COMPLETED|Baseline||0
272200|NCT00926003|659785|P3|COMPLETED|Baseline||52
272201|NCT00926003|659786|P2|COMPLETED|Baseline||54
272202|NCT00926003|659787|P1|COMPLETED|Baseline||53
272203|NCT00926003|659785|P3|STARTED|Baseline||52
272204|NCT00926003|659786|P2|STARTED|Baseline||54
272205|NCT00926003|659787|P1|STARTED|Baseline||53
272206|NCT00925990|659800|P2|NOT COMPLETED|Overall Study||11
272207|NCT00925990|659801|P1|NOT COMPLETED|Overall Study||5
272208|NCT00925990|659800|P2|COMPLETED|Overall Study||24
272209|NCT00925990|659801|P1|COMPLETED|Overall Study||30
272210|NCT00925990|659800|P2|STARTED|Overall Study||35
272211|NCT00925990|659801|P1|STARTED|Overall Study||35
272212|NCT00925938|659812|P3|NOT COMPLETED|Overall Study||0
272213|NCT00925938|659813|P2|NOT COMPLETED|Overall Study||0
272214|NCT00925938|659814|P1|NOT COMPLETED|Overall Study||0
272215|NCT00925938|659812|P3|COMPLETED|Overall Study||17
272216|NCT00925938|659813|P2|COMPLETED|Overall Study||25
272217|NCT00925938|659814|P1|COMPLETED|Overall Study||9
272218|NCT00925938|659812|P3|STARTED|Overall Study||17
272219|NCT00925938|659813|P2|STARTED|Overall Study||25
272220|NCT00925938|659814|P1|STARTED|Overall Study||9
272221|NCT00925899|659836|P2|NOT COMPLETED|Part 2||12
272222|NCT00925899|659837|P1|NOT COMPLETED|Part 2||6
272223|NCT00925899|659836|P2|COMPLETED|Part 2||9
272224|NCT00925899|659837|P1|COMPLETED|Part 2||9
272225|NCT00925899|659836|P2|STARTED|Part 2|Nine patients withdrew because they did not wish to continue in the study|21
272226|NCT00925899|659837|P1|STARTED|Part 2|All patients received the same intervention in the second part of the study (20 mg melatonin)|15
272227|NCT00925899|659836|P2|NOT COMPLETED|Part 1||11
272228|NCT00925899|659837|P1|NOT COMPLETED|Part 1||11
272229|NCT00925899|659836|P2|COMPLETED|Part 1||27
272230|NCT00925899|659837|P1|COMPLETED|Part 1||23
272231|NCT00925899|659836|P2|STARTED|Part 1||38
272232|NCT00925899|659837|P1|STARTED|Part 1||34
272233|NCT00925782|659855|P2|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
272234|NCT00925782|659856|P1|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
272235|NCT00925782|659855|P2|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
272236|NCT00925782|659856|P1|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
272237|NCT00925782|659855|P2|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
272238|NCT00925782|659856|P1|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
272239|NCT00925782|659855|P2|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
272240|NCT00925782|659856|P1|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
272241|NCT00925782|659855|P2|COMPLETED|Study Period (Day -3 to Day 0)||12
272242|NCT00925782|659856|P1|COMPLETED|Study Period (Day -3 to Day 0)||12
272243|NCT00925782|659855|P2|STARTED|Study Period (Day -3 to Day 0)||12
272244|NCT00925782|659856|P1|STARTED|Study Period (Day -3 to Day 0)||12
272245|NCT00925782|659855|P2|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
272246|NCT00925782|659856|P1|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
272247|NCT00925782|659855|P2|COMPLETED|Pretreatment (Day -30 to Day -3)||12
272248|NCT00925782|659856|P1|COMPLETED|Pretreatment (Day -30 to Day -3)||12
272249|NCT00925782|659855|P2|STARTED|Pretreatment (Day -30 to Day -3)||12
272250|NCT00925782|659856|P1|STARTED|Pretreatment (Day -30 to Day -3)||12
272251|NCT00925769|659865|P6|NOT COMPLETED|Overall Study||3
272252|NCT00925769|659866|P5|NOT COMPLETED|Overall Study||3
272253|NCT00925769|659867|P4|NOT COMPLETED|Overall Study||6
272254|NCT00925769|659868|P3|NOT COMPLETED|Overall Study||6
272255|NCT00925769|659869|P2|NOT COMPLETED|Overall Study||6
272256|NCT00925769|659870|P1|NOT COMPLETED|Overall Study||6
272257|NCT00925769|659865|P6|COMPLETED|Overall Study||0
272258|NCT00925769|659866|P5|COMPLETED|Overall Study||0
272259|NCT00925769|659867|P4|COMPLETED|Overall Study||0
272260|NCT00925769|659868|P3|COMPLETED|Overall Study||0
272261|NCT00925769|659869|P2|COMPLETED|Overall Study||0
272262|NCT00925769|659870|P1|COMPLETED|Overall Study||0
272263|NCT00925769|659865|P6|STARTED|Overall Study||3
272264|NCT00925769|659866|P5|STARTED|Overall Study||3
272265|NCT00925769|659867|P4|STARTED|Overall Study||6
272266|NCT00925769|659868|P3|STARTED|Overall Study||6
272267|NCT00925769|659869|P2|STARTED|Overall Study||6
272268|NCT00925769|659870|P1|STARTED|Overall Study||6
272269|NCT00925704|659938|P6|NOT COMPLETED|Third Intervention||1
272270|NCT00925704|659939|P5|NOT COMPLETED|Third Intervention||0
272271|NCT00925704|659940|P4|NOT COMPLETED|Third Intervention||0
272272|NCT00925704|659941|P3|NOT COMPLETED|Third Intervention||0
272273|NCT00925704|659942|P2|NOT COMPLETED|Third Intervention||0
272274|NCT00925704|659943|P1|NOT COMPLETED|Third Intervention||0
272275|NCT00925704|659938|P6|COMPLETED|Third Intervention||6
272276|NCT00925704|659939|P5|COMPLETED|Third Intervention||5
272277|NCT00925704|659940|P4|COMPLETED|Third Intervention||6
272278|NCT00925704|659941|P3|COMPLETED|Third Intervention||7
272279|NCT00925704|659942|P2|COMPLETED|Third Intervention||7
272280|NCT00925704|659943|P1|COMPLETED|Third Intervention||5
272281|NCT00925704|659938|P6|STARTED|Third Intervention||7
272282|NCT00925704|659939|P5|STARTED|Third Intervention||5
272283|NCT00925704|659940|P4|STARTED|Third Intervention||6
272284|NCT00925704|659941|P3|STARTED|Third Intervention||7
272285|NCT00925704|659942|P2|STARTED|Third Intervention||7
272286|NCT00925704|659943|P1|STARTED|Third Intervention||5
272287|NCT00925704|659938|P6|NOT COMPLETED|Washout||0
272288|NCT00925704|659939|P5|NOT COMPLETED|Washout||0
272289|NCT00925704|659940|P4|NOT COMPLETED|Washout||0
272290|NCT00925704|659941|P3|NOT COMPLETED|Washout||0
272291|NCT00925704|659942|P2|NOT COMPLETED|Washout||0
272292|NCT00925704|659943|P1|NOT COMPLETED|Washout||0
272293|NCT00925704|659938|P6|COMPLETED|Washout||7
272294|NCT00925704|659939|P5|COMPLETED|Washout||5
272295|NCT00925704|659940|P4|COMPLETED|Washout||6
272296|NCT00925704|659941|P3|COMPLETED|Washout||7
272297|NCT00925704|659942|P2|COMPLETED|Washout||7
272298|NCT00925704|659943|P1|COMPLETED|Washout||5
272299|NCT00925704|659938|P6|STARTED|Washout||7
272300|NCT00925704|659939|P5|STARTED|Washout||5
272301|NCT00925704|659940|P4|STARTED|Washout||6
272302|NCT00925704|659941|P3|STARTED|Washout||7
272303|NCT00925704|659942|P2|STARTED|Washout||7
272304|NCT00925704|659943|P1|STARTED|Washout||5
272305|NCT00925704|659938|P6|NOT COMPLETED|Second Intervention||0
272306|NCT00925704|659939|P5|NOT COMPLETED|Second Intervention||1
272307|NCT00925704|659940|P4|NOT COMPLETED|Second Intervention||0
272308|NCT00925704|659941|P3|NOT COMPLETED|Second Intervention||0
272309|NCT00925704|659942|P2|NOT COMPLETED|Second Intervention||0
272310|NCT00925704|659943|P1|NOT COMPLETED|Second Intervention||1
272311|NCT00925704|659938|P6|COMPLETED|Second Intervention||7
272312|NCT00925704|659939|P5|COMPLETED|Second Intervention||5
272313|NCT00925704|659940|P4|COMPLETED|Second Intervention||6
272314|NCT00925704|659941|P3|COMPLETED|Second Intervention||7
272315|NCT00925704|659942|P2|COMPLETED|Second Intervention||7
272316|NCT00925704|659943|P1|COMPLETED|Second Intervention||5
272317|NCT00925704|659938|P6|STARTED|Second Intervention||7
272318|NCT00925704|659939|P5|STARTED|Second Intervention||6
272319|NCT00925704|659940|P4|STARTED|Second Intervention||6
272320|NCT00925704|659941|P3|STARTED|Second Intervention||7
272321|NCT00925704|659942|P2|STARTED|Second Intervention||7
272322|NCT00925704|659943|P1|STARTED|Second Intervention||6
272323|NCT00925704|659938|P6|NOT COMPLETED|Washout||0
272324|NCT00925704|659939|P5|NOT COMPLETED|Washout||0
272325|NCT00925704|659940|P4|NOT COMPLETED|Washout||0
272326|NCT00925704|659941|P3|NOT COMPLETED|Washout||0
272327|NCT00925704|659942|P2|NOT COMPLETED|Washout||0
272328|NCT00925704|659943|P1|NOT COMPLETED|Washout||0
272329|NCT00925704|659938|P6|COMPLETED|Washout||7
272330|NCT00925704|659939|P5|COMPLETED|Washout||6
272331|NCT00925704|659940|P4|COMPLETED|Washout||6
272332|NCT00925704|659941|P3|COMPLETED|Washout||7
272333|NCT00925704|659942|P2|COMPLETED|Washout||7
272334|NCT00925704|659943|P1|COMPLETED|Washout||6
272335|NCT00925704|659938|P6|STARTED|Washout||7
272336|NCT00925704|659939|P5|STARTED|Washout||6
272337|NCT00925704|659940|P4|STARTED|Washout||6
272338|NCT00925704|659941|P3|STARTED|Washout||7
272339|NCT00925704|659942|P2|STARTED|Washout||7
272340|NCT00925704|659943|P1|STARTED|Washout||6
272341|NCT00925704|659938|P6|NOT COMPLETED|First Intervention||0
272342|NCT00925704|659939|P5|NOT COMPLETED|First Intervention||1
272343|NCT00925704|659940|P4|NOT COMPLETED|First Intervention||1
272344|NCT00925704|659941|P3|NOT COMPLETED|First Intervention||0
272345|NCT00925704|659942|P2|NOT COMPLETED|First Intervention||0
272346|NCT00925704|659943|P1|NOT COMPLETED|First Intervention||0
272347|NCT00925704|659938|P6|COMPLETED|First Intervention||7
272348|NCT00925704|659939|P5|COMPLETED|First Intervention||6
272349|NCT00925704|659940|P4|COMPLETED|First Intervention||6
272350|NCT00925704|659941|P3|COMPLETED|First Intervention||7
272351|NCT00925704|659942|P2|COMPLETED|First Intervention||7
272352|NCT00925704|659943|P1|COMPLETED|First Intervention||6
272353|NCT00925704|659938|P6|STARTED|First Intervention||7
272354|NCT00925704|659939|P5|STARTED|First Intervention||7
272355|NCT00925704|659940|P4|STARTED|First Intervention||7
272356|NCT00925704|659941|P3|STARTED|First Intervention||7
272357|NCT00925704|659942|P2|STARTED|First Intervention||7
272358|NCT00925704|659943|P1|STARTED|First Intervention||6
272359|NCT00925600|659956|P2|NOT COMPLETED|Overall Study||28
272360|NCT00925600|659957|P1|NOT COMPLETED|Overall Study||32
272361|NCT00925600|659956|P2|COMPLETED|Overall Study||355
272362|NCT00925600|659957|P1|COMPLETED|Overall Study||354
272363|NCT00925600|659956|P2|Received Treatment|Overall Study||382
272364|NCT00925600|659957|P1|Received Treatment|Overall Study|Three participants received at least 1 dose of denosumab in error|383
272365|NCT00925600|659956|P2|STARTED|Overall Study||383
272366|NCT00925600|659957|P1|STARTED|Overall Study||386
272367|NCT00925587|659979|P2|NOT COMPLETED|Overall Study||25
272368|NCT00925587|659980|P1|NOT COMPLETED|Overall Study||36
272369|NCT00925587|659979|P2|COMPLETED|Overall Study||155
272370|NCT00925587|659980|P1|COMPLETED|Overall Study||142
272371|NCT00925587|659979|P2|STARTED|Overall Study||180
272372|NCT00925587|659980|P1|STARTED|Overall Study||178
272373|NCT00925548|660094|P2|NOT COMPLETED|Overall Study||5
272374|NCT00925548|660095|P1|NOT COMPLETED|Overall Study||10
272375|NCT00925548|660094|P2|COMPLETED|Overall Study||0
272376|NCT00925548|660095|P1|COMPLETED|Overall Study||1
272377|NCT00925548|660094|P2|STARTED|Overall Study||5
272378|NCT00925548|660095|P1|STARTED|Overall Study||11
272379|NCT00925522|660121|P1|NOT COMPLETED|Overall Study||20
272380|NCT00925522|660121|P1|COMPLETED|Overall Study||0
272381|NCT00925522|660121|P1|STARTED|Overall Study||20
272382|NCT00925353|660125|P1|NOT COMPLETED|Overall Study||3
272383|NCT00925353|660125|P1|COMPLETED|Overall Study||10
272384|NCT00925353|660125|P1|STARTED|Overall Study||13
272385|NCT00925301|660131|P4|NOT COMPLETED|12-Month Open-label Extension (Optional)||3
272386|NCT00925301|660132|P3|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
272387|NCT00925301|660133|P2|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
272388|NCT00925301|660134|P1|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
272389|NCT00925301|660131|P4|COMPLETED|12-Month Open-label Extension (Optional)||54
272390|NCT00925301|660132|P3|COMPLETED|12-Month Open-label Extension (Optional)||0
272391|NCT00925301|660133|P2|COMPLETED|12-Month Open-label Extension (Optional)||0
272392|NCT00925301|660134|P1|COMPLETED|12-Month Open-label Extension (Optional)||0
272393|NCT00925301|660131|P4|ITT-amenable|12-Month Open-label Extension (Optional)||42
272394|NCT00925301|660132|P3|ITT-amenable|12-Month Open-label Extension (Optional)||0
272395|NCT00925301|660133|P2|ITT-amenable|12-Month Open-label Extension (Optional)||0
272396|NCT00925301|660134|P1|ITT-amenable|12-Month Open-label Extension (Optional)||0
272397|NCT00925301|660131|P4|STARTED|12-Month Open-label Extension (Optional)|The OLE was optional for those who completed Stage 2. Reasons for not entering were not recorded.|57
272398|NCT00925301|660132|P3|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 2.|0
272399|NCT00925301|660133|P2|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 1.|0
272400|NCT00925301|660134|P1|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 1.|0
272401|NCT00925301|660131|P4|NOT COMPLETED|6-Month Open-label (Stage 2)||0
272402|NCT00925301|660132|P3|NOT COMPLETED|6-Month Open-label (Stage 2)||3
272403|NCT00925301|660133|P2|NOT COMPLETED|6-Month Open-label (Stage 2)||0
272404|NCT00925301|660134|P1|NOT COMPLETED|6-Month Open-label (Stage 2)||0
272405|NCT00925301|660131|P4|COMPLETED|6-Month Open-label (Stage 2)||0
272406|NCT00925301|660132|P3|COMPLETED|6-Month Open-label (Stage 2)||60
272407|NCT00925301|660133|P2|COMPLETED|6-Month Open-label (Stage 2)||0
272408|NCT00925301|660134|P1|COMPLETED|6-Month Open-label (Stage 2)||0
272409|NCT00925301|660131|P4|ITT-amenable|6-Month Open-label (Stage 2)||0
272410|NCT00925301|660132|P3|ITT-amenable|6-Month Open-label (Stage 2)||47
272411|NCT00925301|660133|P2|ITT-amenable|6-Month Open-label (Stage 2)||0
272412|NCT00925301|660134|P1|ITT-amenable|6-Month Open-label (Stage 2)||0
272413|NCT00925301|660131|P4|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants did not start the OLE yet.|0
272414|NCT00925301|660132|P3|STARTED|6-Month Open-label (Stage 2)|One participant (Migalastat [0-6 Months]) withdrew consent after completing Month 6.|63
272415|NCT00925301|660133|P2|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants had completed Stage 1.|0
272416|NCT00925301|660134|P1|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants had completed Stage 1.|0
272417|NCT00925301|660131|P4|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
272418|NCT00925301|660132|P3|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
272419|NCT00925301|660133|P2|NOT COMPLETED|6-Month Double-blind (Stage 1)||3
272420|NCT00925301|660134|P1|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
272421|NCT00925301|660131|P4|COMPLETED|6-Month Double-blind (Stage 1)||0
272422|NCT00925301|660132|P3|COMPLETED|6-Month Double-blind (Stage 1)||0
272423|NCT00925301|660133|P2|COMPLETED|6-Month Double-blind (Stage 1)||30
272424|NCT00925301|660134|P1|COMPLETED|6-Month Double-blind (Stage 1)||34
272425|NCT00925301|660131|P4|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0
272426|NCT00925301|660132|P3|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0
272427|NCT00925301|660133|P2|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30
272428|NCT00925301|660134|P1|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30
272429|NCT00925301|660131|P4|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0
272430|NCT00925301|660132|P3|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0
272431|NCT00925301|660133|P2|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||33
272432|NCT00925301|660134|P1|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||34
272433|NCT00925301|660131|P4|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0
272434|NCT00925301|660132|P3|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0
272435|NCT00925301|660133|P2|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||33
272436|NCT00925301|660134|P1|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||34
272437|NCT00925301|660131|P4|STARTED|6-Month Double-blind (Stage 1)|Zero participants noted because participants did not start the OLE yet.|0
272438|NCT00925301|660132|P3|STARTED|6-Month Double-blind (Stage 1)|Zero participants noted because participants did not start Stage 2 yet.|0
272439|NCT00925301|660133|P2|STARTED|6-Month Double-blind (Stage 1)||33
272440|NCT00925301|660134|P1|STARTED|6-Month Double-blind (Stage 1)||34
272441|NCT00925288|660150|P2|NOT COMPLETED|Overall Study||7
272442|NCT00925288|660151|P1|NOT COMPLETED|Overall Study||9
272443|NCT00925288|660150|P2|COMPLETED|Overall Study||93
272444|NCT00925288|660151|P1|COMPLETED|Overall Study||91
272445|NCT00925288|660150|P2|STARTED|Overall Study||100
272446|NCT00925288|660151|P1|STARTED|Overall Study||100
272447|NCT00925132|660163|P5|NOT COMPLETED|Overall Study||5
272448|NCT00925132|660164|P4|NOT COMPLETED|Overall Study||0
272449|NCT00925132|660165|P3|NOT COMPLETED|Overall Study||0
272450|NCT00925132|660166|P2|NOT COMPLETED|Overall Study||0
272451|NCT00925132|660167|P1|NOT COMPLETED|Overall Study||2
272452|NCT00925132|660163|P5|COMPLETED|Overall Study||17
272453|NCT00925132|660164|P4|COMPLETED|Overall Study||4
272454|NCT00925132|660165|P3|COMPLETED|Overall Study||4
272455|NCT00925132|660166|P2|COMPLETED|Overall Study||4
272456|NCT00925132|660167|P1|COMPLETED|Overall Study||3
272457|NCT00925132|660163|P5|STARTED|Overall Study||22
272458|NCT00925132|660164|P4|STARTED|Overall Study||4
272459|NCT00925132|660165|P3|STARTED|Overall Study||4
272460|NCT00925132|660166|P2|STARTED|Overall Study||4
272461|NCT00925132|660167|P1|STARTED|Overall Study||5
272462|NCT00925119|660173|P1|NOT COMPLETED|Overall Study||12
272463|NCT00925119|660173|P1|COMPLETED|Overall Study||19
272464|NCT00925119|660173|P1|STARTED|Overall Study||31
272465|NCT00925054|660188|P5|NOT COMPLETED|Overall Study||0
272466|NCT00925054|660189|P4|NOT COMPLETED|Overall Study||1
272467|NCT00925054|660190|P3|NOT COMPLETED|Overall Study||1
272468|NCT00925054|660191|P2|NOT COMPLETED|Overall Study||1
272469|NCT00925054|660192|P1|NOT COMPLETED|Overall Study||0
272470|NCT00925054|660188|P5|COMPLETED|Overall Study||10
272471|NCT00925054|660189|P4|COMPLETED|Overall Study||0
272472|NCT00925054|660190|P3|COMPLETED|Overall Study||12
272473|NCT00925054|660191|P2|COMPLETED|Overall Study||8
272474|NCT00925054|660192|P1|COMPLETED|Overall Study||7
272475|NCT00925054|660188|P5|STARTED|Overall Study||10
272476|NCT00925054|660189|P4|STARTED|Overall Study||1
272477|NCT00925054|660190|P3|STARTED|Overall Study||13
272478|NCT00925054|660191|P2|STARTED|Overall Study||9
272479|NCT00925054|660192|P1|STARTED|Overall Study||7
272480|NCT00925015|660262|P3|NOT COMPLETED|Overall Study||6
272481|NCT00925015|660263|P2|NOT COMPLETED|Overall Study||6
272482|NCT00925015|660264|P1|NOT COMPLETED|Overall Study||8
272483|NCT00925015|660262|P3|COMPLETED|Overall Study||0
272484|NCT00925015|660263|P2|COMPLETED|Overall Study||0
272485|NCT00925015|660264|P1|COMPLETED|Overall Study||0
272486|NCT00925015|660262|P3|STARTED|Overall Study||6
272487|NCT00925015|660263|P2|STARTED|Overall Study||6
272488|NCT00925015|660264|P1|STARTED|Overall Study||8
272489|NCT00924950|660320|P1|NOT COMPLETED|Overall Study||2
272490|NCT00924950|660320|P1|COMPLETED|Overall Study||28
272491|NCT00924950|660320|P1|STARTED|Overall Study||30
272492|NCT00924898|660327|P1|NOT COMPLETED|Overall Study||2
272493|NCT00924898|660327|P1|COMPLETED|Overall Study||90
272494|NCT00924898|660327|P1|STARTED|Overall Study||92
272495|NCT00924833|660339|P3|NOT COMPLETED|Overall Study||0
272496|NCT00924833|660340|P2|NOT COMPLETED|Overall Study||0
272497|NCT00924833|660341|P1|NOT COMPLETED|Overall Study||0
272498|NCT00924833|660339|P3|COMPLETED|Overall Study|1 subject was excluded from the analysis for medical problems unrelated to the study.|9
272499|NCT00924833|660340|P2|COMPLETED|Overall Study|1 subject was excluded from the analysis for incomplete data.|9
272500|NCT00924833|660341|P1|COMPLETED|Overall Study|7 subjects analyzed (2 were excluded for poor cardiopulmonary exercise stress test quality).|9
272501|NCT00924833|660339|P3|STARTED|Overall Study||9
272502|NCT00924833|660340|P2|STARTED|Overall Study||9
272503|NCT00924833|660341|P1|STARTED|Overall Study||9
272504|NCT00924807|660355|P1|NOT COMPLETED|Overall Study||0
272505|NCT00924807|660355|P1|COMPLETED|Overall Study||4
272506|NCT00924807|660355|P1|STARTED|Overall Study||4
272507|NCT00924781|660364|P2|NOT COMPLETED|Overall Study||10
272508|NCT00924781|660365|P1|NOT COMPLETED|Overall Study||12
272509|NCT00924781|660364|P2|COMPLETED|Overall Study||9
272510|NCT00924781|660365|P1|COMPLETED|Overall Study||8
272511|NCT00924781|660364|P2|STARTED|Overall Study||19
272512|NCT00924781|660365|P1|STARTED|Overall Study||20
272513|NCT00924729|660399|P2|NOT COMPLETED|Overall Study||0
272514|NCT00924729|660400|P1|NOT COMPLETED|Overall Study||2
272515|NCT00924729|660399|P2|COMPLETED|Overall Study||25
272516|NCT00924729|660400|P1|COMPLETED|Overall Study||23
272517|NCT00924729|660399|P2|STARTED|Overall Study||25
272518|NCT00924729|660400|P1|STARTED|Overall Study||25
272519|NCT00924651|660410|P2|NOT COMPLETED|Overall Study||25
272520|NCT00924651|660411|P1|NOT COMPLETED|Overall Study||25
272521|NCT00924651|660410|P2|COMPLETED|Overall Study||312
272522|NCT00924651|660411|P1|COMPLETED|Overall Study||331
272523|NCT00924651|660410|P2|STARTED|Overall Study||337
272524|NCT00924651|660411|P1|STARTED|Overall Study||356
272525|NCT00924638|660419|P2|NOT COMPLETED|Overall Study||13
272526|NCT00924638|660420|P1|NOT COMPLETED|Overall Study||12
272527|NCT00924638|660419|P2|COMPLETED|Overall Study|Completed 6 months of follow-up|207
272528|NCT00924638|660420|P1|COMPLETED|Overall Study|Completed 6 months of follow-up|209
272529|NCT00924638|660419|P2|STARTED|Overall Study|Randomized to Control Arm|220
272530|NCT00924638|660420|P1|STARTED|Overall Study|Randomized to Continuous Monitoring Arm|221
272531|NCT00924560|660442|P3|NOT COMPLETED|Overall Study||83
272532|NCT00924560|660443|P2|NOT COMPLETED|Overall Study||208
272533|NCT00924560|660444|P1|NOT COMPLETED|Overall Study||211
272534|NCT00924560|660442|P3|COMPLETED|Overall Study||372
272535|NCT00924560|660443|P2|COMPLETED|Overall Study||240
272536|NCT00924560|660444|P1|COMPLETED|Overall Study||247
272537|NCT00924560|660442|P3|Received Treatment|Overall Study||0
272538|NCT00924560|660443|P2|Received Treatment|Overall Study|Excludes 9 participants from one site that was closed due to audit findings.|411
272539|NCT00924560|660444|P1|Received Treatment|Overall Study|Excludes 7 participants at 1 site that was closed. One participant received 28-day OC in error.|422
272540|NCT00924560|660442|P3|STARTED|Overall Study||455
272541|NCT00924560|660443|P2|STARTED|Overall Study||448
272542|NCT00924560|660444|P1|STARTED|Overall Study||458
272543|NCT00924508|660488|P1|NOT COMPLETED|Overall Study||3
272544|NCT00924508|660488|P1|COMPLETED|Overall Study||20
272545|NCT00924508|660488|P1|STARTED|Overall Study||23
272546|NCT00924482|660495|P1|NOT COMPLETED|Overall Study||0
272547|NCT00924482|660495|P1|COMPLETED|Overall Study||261
272548|NCT00924482|660495|P1|STARTED|Overall Study||261
272549|NCT00924469|660502|P2|NOT COMPLETED|Overall Study||2
272550|NCT00924469|660503|P1|NOT COMPLETED|Overall Study||2
272551|NCT00924469|660502|P2|COMPLETED|Overall Study||26
272552|NCT00924469|660503|P1|COMPLETED|Overall Study||28
272553|NCT00924469|660502|P2|STARTED|Overall Study||28
272554|NCT00924469|660503|P1|STARTED|Overall Study||30
272555|NCT00924443|660525|P1|NOT COMPLETED|Overall Study||3
272556|NCT00924443|660525|P1|COMPLETED|Overall Study||66
272557|NCT00924443|660525|P1|Full Analysis Set (Received Study Drug)|Overall Study||66
272558|NCT00924443|660525|P1|STARTED|Overall Study||69
272559|NCT00924404|660535|P2|NOT COMPLETED|Overall Study||4
272560|NCT00924404|660536|P1|NOT COMPLETED|Overall Study||6
272561|NCT00924404|660535|P2|COMPLETED|Overall Study||22
272562|NCT00924404|660536|P1|COMPLETED|Overall Study||21
272563|NCT00924404|660535|P2|STARTED|Overall Study||26
272564|NCT00924404|660536|P1|STARTED|Overall Study||27
272565|NCT00924352|660544|P2|NOT COMPLETED|Overall Study||0
272566|NCT00924352|660545|P1|NOT COMPLETED|Overall Study||0
272567|NCT00924352|660544|P2|COMPLETED|Overall Study||44
272568|NCT00924352|660545|P1|COMPLETED|Overall Study||12
272569|NCT00924352|660544|P2|STARTED|Overall Study||44
272570|NCT00924352|660545|P1|STARTED|Overall Study||12
272571|NCT00924326|660567|P9|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
272572|NCT00924326|660568|P8|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
272573|NCT00924326|660569|P7|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
272663|NCT00924040|660743|P1|STARTED|Overall Study||1
272574|NCT00924326|660570|P6|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
272575|NCT00924326|660571|P5|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
272576|NCT00924326|660572|P4|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
272577|NCT00924326|660573|P3|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
272578|NCT00924326|660574|P2|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
272579|NCT00924326|660575|P1|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
272580|NCT00924326|660567|P9|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
272581|NCT00924326|660568|P8|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
272582|NCT00924326|660569|P7|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
272583|NCT00924326|660570|P6|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
272584|NCT00924326|660571|P5|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
272585|NCT00924326|660572|P4|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
272586|NCT00924326|660573|P3|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
272587|NCT00924326|660574|P2|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
272588|NCT00924326|660575|P1|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||3
272589|NCT00924326|660567|P9|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
272590|NCT00924326|660568|P8|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
272591|NCT00924326|660569|P7|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
272592|NCT00924326|660570|P6|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
272593|NCT00924326|660571|P5|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
272594|NCT00924326|660572|P4|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
272595|NCT00924326|660573|P3|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
272596|NCT00924326|660574|P2|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
272597|NCT00924326|660575|P1|STARTED|1x10^9-1x10^10 + High Dose Retreat||3
272598|NCT00924326|660567|P9|NOT COMPLETED|Dose Administration||0
272599|NCT00924326|660568|P8|NOT COMPLETED|Dose Administration||0
272600|NCT00924326|660569|P7|NOT COMPLETED|Dose Administration||0
272601|NCT00924326|660570|P6|NOT COMPLETED|Dose Administration||0
272602|NCT00924326|660571|P5|NOT COMPLETED|Dose Administration||0
272603|NCT00924326|660572|P4|NOT COMPLETED|Dose Administration||0
272604|NCT00924326|660573|P3|NOT COMPLETED|Dose Administration||0
272605|NCT00924326|660574|P2|NOT COMPLETED|Dose Administration||0
272606|NCT00924326|660575|P1|NOT COMPLETED|Dose Administration||0
272607|NCT00924326|660567|P9|COMPLETED|Dose Administration||2
272608|NCT00924326|660568|P8|COMPLETED|Dose Administration||2
272609|NCT00924326|660569|P7|COMPLETED|Dose Administration||1
272610|NCT00924326|660570|P6|COMPLETED|Dose Administration||10
272611|NCT00924326|660571|P5|COMPLETED|Dose Administration||7
272612|NCT00924326|660572|P4|COMPLETED|Dose Administration||6
272613|NCT00924326|660573|P3|COMPLETED|Dose Administration||5
272614|NCT00924326|660574|P2|COMPLETED|Dose Administration||2
272615|NCT00924326|660575|P1|COMPLETED|Dose Administration||8
272616|NCT00924326|660567|P9|STARTED|Dose Administration||2
272617|NCT00924326|660568|P8|STARTED|Dose Administration||2
272618|NCT00924326|660569|P7|STARTED|Dose Administration||1
272619|NCT00924326|660570|P6|STARTED|Dose Administration||10
272620|NCT00924326|660571|P5|STARTED|Dose Administration||7
272621|NCT00924326|660572|P4|STARTED|Dose Administration||6
272622|NCT00924326|660573|P3|STARTED|Dose Administration||5
272623|NCT00924326|660574|P2|STARTED|Dose Administration||2
272624|NCT00924326|660575|P1|STARTED|Dose Administration||8
272625|NCT00924313|660607|P1|NOT COMPLETED|Overall Study||1
272626|NCT00924313|660607|P1|COMPLETED|Overall Study||39
272627|NCT00924313|660607|P1|STARTED|Overall Study||40
272628|NCT00924287|660619|P1|NOT COMPLETED|Overall Study||1
272629|NCT00924287|660619|P1|COMPLETED|Overall Study||0
272630|NCT00924287|660619|P1|STARTED|Overall Study||1
272631|NCT00924209|660625|P1|NOT COMPLETED|Overall Study||0
272632|NCT00924209|660625|P1|COMPLETED|Overall Study||7
272633|NCT00924209|660625|P1|STARTED|Overall Study||7
272634|NCT00924170|660635|P2|NOT COMPLETED|Overall Study||8
272635|NCT00924170|660636|P1|NOT COMPLETED|Overall Study||7
272636|NCT00924170|660635|P2|COMPLETED|Overall Study||0
272637|NCT00924170|660636|P1|COMPLETED|Overall Study||3
272638|NCT00924170|660635|P2|STARTED|Overall Study||8
272639|NCT00924170|660636|P1|STARTED|Overall Study||10
272640|NCT00924118|660676|P2|NOT COMPLETED|Overall Study||0
272641|NCT00924118|660677|P1|NOT COMPLETED|Overall Study||0
272642|NCT00924118|660676|P2|COMPLETED|Overall Study||15
272643|NCT00924118|660677|P1|COMPLETED|Overall Study||15
272644|NCT00924118|660676|P2|STARTED|Overall Study||15
272645|NCT00924118|660677|P1|STARTED|Overall Study||15
272646|NCT00924066|660685|P1|NOT COMPLETED|Overall Study||0
272647|NCT00924066|660685|P1|COMPLETED|Overall Study||41
272648|NCT00924066|660685|P1|STARTED|Overall Study||41
272649|NCT00924053|660694|P4|NOT COMPLETED|Overall Study||0
272650|NCT00924053|660695|P3|NOT COMPLETED|Overall Study||0
272651|NCT00924053|660696|P2|NOT COMPLETED|Overall Study||0
272652|NCT00924053|660697|P1|NOT COMPLETED|Overall Study||0
272653|NCT00924053|660694|P4|COMPLETED|Overall Study||6
272654|NCT00924053|660695|P3|COMPLETED|Overall Study||6
272655|NCT00924053|660696|P2|COMPLETED|Overall Study||6
272656|NCT00924053|660697|P1|COMPLETED|Overall Study||6
272657|NCT00924053|660694|P4|STARTED|Overall Study||6
272658|NCT00924053|660695|P3|STARTED|Overall Study||6
272659|NCT00924053|660696|P2|STARTED|Overall Study||6
272660|NCT00924053|660697|P1|STARTED|Overall Study||6
272661|NCT00924040|660743|P1|NOT COMPLETED|Overall Study||0
272662|NCT00924040|660743|P1|COMPLETED|Overall Study||1
272664|NCT00924001|660755|P1|NOT COMPLETED|Overall Study||0
272665|NCT00924001|660755|P1|COMPLETED|Overall Study||1
272666|NCT00924001|660755|P1|STARTED|Overall Study||1
272667|NCT00923975|660761|P1|NOT COMPLETED|Overall Study||1
272668|NCT00923975|660761|P1|COMPLETED|Overall Study|One subject did not meet inclusion criteria; the data was not used in analysis.|50
272669|NCT00923975|660761|P1|STARTED|Overall Study||51
272670|NCT00923949|660768|P1|NOT COMPLETED|Overall Study||0
272671|NCT00923949|660768|P1|COMPLETED|Overall Study||1
272672|NCT00923949|660768|P1|STARTED|Overall Study||1
272673|NCT00923936|660780|P2|NOT COMPLETED|Overall Study||3
272674|NCT00923936|660781|P1|NOT COMPLETED|Overall Study||8
272675|NCT00923936|660780|P2|COMPLETED|Overall Study||3
272676|NCT00923936|660781|P1|COMPLETED|Overall Study||2
272677|NCT00923936|660780|P2|STARTED|Overall Study||6
272678|NCT00923936|660781|P1|STARTED|Overall Study||10
272679|NCT00923910|660797|P2|NOT COMPLETED|Period 2||0
272680|NCT00923910|660798|P1|NOT COMPLETED|Period 2||0
272681|NCT00923910|660797|P2|COMPLETED|Period 2||5
272682|NCT00923910|660798|P1|COMPLETED|Period 2||5
272683|NCT00923910|660797|P2|STARTED|Period 2||5
272684|NCT00923910|660798|P1|STARTED|Period 2||5
272685|NCT00923910|660797|P2|NOT COMPLETED|Period 1||0
272686|NCT00923910|660798|P1|NOT COMPLETED|Period 1||0
272687|NCT00923910|660797|P2|COMPLETED|Period 1||5
272688|NCT00923910|660798|P1|COMPLETED|Period 1||5
272689|NCT00923910|660797|P2|STARTED|Period 1||5
272690|NCT00923910|660798|P1|STARTED|Period 1||5
272691|NCT00923845|660810|P2|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
272692|NCT00923845|660811|P1|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
272693|NCT00923845|660810|P2|COMPLETED|Allogeneic Stem Cell Therapy||10
272694|NCT00923845|660811|P1|COMPLETED|Allogeneic Stem Cell Therapy||0
272695|NCT00923845|660810|P2|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||6
272696|NCT00923845|660811|P1|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||0
272697|NCT00923845|660810|P2|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||8
272698|NCT00923845|660811|P1|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||0
272699|NCT00923845|660810|P2|STARTED|Allogeneic Stem Cell Therapy||10
272700|NCT00923845|660811|P1|STARTED|Allogeneic Stem Cell Therapy||0
272701|NCT00923845|660810|P2|NOT COMPLETED|Induction Therapy||2
272702|NCT00923845|660811|P1|NOT COMPLETED|Induction Therapy||0
272703|NCT00923845|660810|P2|COMPLETED|Induction Therapy||10
272704|NCT00923845|660811|P1|COMPLETED|Induction Therapy||0
272705|NCT00923845|660810|P2|STARTED|Induction Therapy||12
272706|NCT00923845|660811|P1|STARTED|Induction Therapy||0
272707|NCT00923845|660810|P2|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
272708|NCT00923845|660811|P1|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
272709|NCT00923845|660810|P2|COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
272710|NCT00923845|660811|P1|COMPLETED|Donor Hematopoietic Stem Cell Harvest||13
272711|NCT00923845|660810|P2|STARTED|Donor Hematopoietic Stem Cell Harvest||0
272712|NCT00923845|660811|P1|STARTED|Donor Hematopoietic Stem Cell Harvest||13
272713|NCT00923845|660810|P2|NOT COMPLETED|Donor Lymphocyte Harvest||0
272714|NCT00923845|660811|P1|NOT COMPLETED|Donor Lymphocyte Harvest||0
272715|NCT00923845|660810|P2|COMPLETED|Donor Lymphocyte Harvest||0
272716|NCT00923845|660811|P1|COMPLETED|Donor Lymphocyte Harvest||13
272717|NCT00923845|660810|P2|STARTED|Donor Lymphocyte Harvest||0
272718|NCT00923845|660811|P1|STARTED|Donor Lymphocyte Harvest||13
272719|NCT00923481|660832|P1|NOT COMPLETED|Overall Study||0
272720|NCT00923481|660832|P1|COMPLETED|Overall Study||37
272721|NCT00923481|660832|P1|STARTED|Overall Study||37
272722|NCT00923364|660837|P2|NOT COMPLETED|Overall Study||0
272723|NCT00923364|660838|P1|NOT COMPLETED|Overall Study||4
272724|NCT00923364|660837|P2|COMPLETED|Overall Study||5
272725|NCT00923364|660838|P1|COMPLETED|Overall Study||10
272726|NCT00923364|660837|P2|STARTED|Overall Study||5
272727|NCT00923364|660838|P1|STARTED|Overall Study||14
272728|NCT00923351|660850|P3|NOT COMPLETED|Overall Study||12
272729|NCT00923351|660851|P2|NOT COMPLETED|Overall Study||0
272730|NCT00923351|660852|P1|NOT COMPLETED|Overall Study||0
272731|NCT00923351|660850|P3|COMPLETED|Overall Study||0
272732|NCT00923351|660851|P2|COMPLETED|Overall Study||26
272733|NCT00923351|660852|P1|COMPLETED|Overall Study||6
272734|NCT00923351|660850|P3|STARTED|Overall Study||12
272735|NCT00923351|660851|P2|STARTED|Overall Study||26
272736|NCT00923351|660852|P1|STARTED|Overall Study||6
272737|NCT00923273|660867|P5|NOT COMPLETED|Phase II Treatment Period||0
272738|NCT00923273|660868|P4|NOT COMPLETED|Phase II Treatment Period||7
272739|NCT00923273|660869|P3|NOT COMPLETED|Phase II Treatment Period||0
272740|NCT00923273|660870|P2|NOT COMPLETED|Phase II Treatment Period||0
272741|NCT00923273|660871|P1|NOT COMPLETED|Phase II Treatment Period||0
272742|NCT00923273|660867|P5|COMPLETED|Phase II Treatment Period||0
272743|NCT00923273|660868|P4|COMPLETED|Phase II Treatment Period||20
272744|NCT00923273|660869|P3|COMPLETED|Phase II Treatment Period||0
272745|NCT00923273|660870|P2|COMPLETED|Phase II Treatment Period||0
272746|NCT00923273|660871|P1|COMPLETED|Phase II Treatment Period||0
272747|NCT00923273|660867|P5|STARTED|Phase II Treatment Period||0
272748|NCT00923273|660868|P4|STARTED|Phase II Treatment Period|Includes 8 subjects with prior peme;12 subjects who were peme naive; 7 subjects rolled over from phI|27
272749|NCT00923273|660869|P3|STARTED|Phase II Treatment Period||0
272750|NCT00923273|660870|P2|STARTED|Phase II Treatment Period||0
272836|NCT00923091|661142|P6|STARTED|Period VI (Open-Label)||0
272751|NCT00923273|660871|P1|STARTED|Phase II Treatment Period|The phase II portion will utilize the MTD from the phase I portion.|0
272752|NCT00923273|660867|P5|NOT COMPLETED|Phase I Treatment Period||0
272753|NCT00923273|660868|P4|NOT COMPLETED|Phase I Treatment Period||0
272754|NCT00923273|660869|P3|NOT COMPLETED|Phase I Treatment Period||0
272755|NCT00923273|660870|P2|NOT COMPLETED|Phase I Treatment Period||0
272756|NCT00923273|660871|P1|NOT COMPLETED|Phase I Treatment Period||0
272757|NCT00923273|660867|P5|COMPLETED|Phase I Treatment Period||5
272758|NCT00923273|660868|P4|COMPLETED|Phase I Treatment Period||7
272759|NCT00923273|660869|P3|COMPLETED|Phase I Treatment Period||3
272760|NCT00923273|660870|P2|COMPLETED|Phase I Treatment Period||3
272761|NCT00923273|660871|P1|COMPLETED|Phase I Treatment Period||4
272762|NCT00923273|660867|P5|STARTED|Phase I Treatment Period|5 subjects peme naive.|5
272763|NCT00923273|660868|P4|STARTED|Phase I Treatment Period|3 subjects initially enrolled and 4 subjects added after dose level 5; peme naive.|7
272764|NCT00923273|660869|P3|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
272765|NCT00923273|660870|P2|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
272766|NCT00923273|660871|P1|STARTED|Phase I Treatment Period|The phase I portion will establish the maximum tolerated dose. 4 subjects peme naive.|4
272767|NCT00923260|660896|P2|NOT COMPLETED|Overall Study||1
272768|NCT00923260|660897|P1|NOT COMPLETED|Overall Study||1
272769|NCT00923260|660896|P2|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
272770|NCT00923260|660897|P1|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
272771|NCT00923260|660896|P2|STARTED|Overall Study||12
272772|NCT00923260|660897|P1|STARTED|Overall Study||12
272773|NCT00923247|661031|P2|NOT COMPLETED|Overall Study||0
272774|NCT00923247|661032|P1|NOT COMPLETED|Overall Study||0
272775|NCT00923247|661031|P2|COMPLETED|Overall Study||1
272776|NCT00923247|661032|P1|COMPLETED|Overall Study||21
272777|NCT00923247|661031|P2|STARTED|Overall Study||1
272778|NCT00923247|661032|P1|STARTED|Overall Study||21
272779|NCT00923195|661060|P2|NOT COMPLETED|Overall Study||1
272780|NCT00923195|661061|P1|NOT COMPLETED|Overall Study||0
272781|NCT00923195|661060|P2|COMPLETED|Overall Study||1
272782|NCT00923195|661061|P1|COMPLETED|Overall Study||2
272783|NCT00923195|661060|P2|STARTED|Overall Study||2
272784|NCT00923195|661061|P1|STARTED|Overall Study||2
272785|NCT00923156|661072|P3|NOT COMPLETED|Overall Study||3
272786|NCT00923156|661073|P2|NOT COMPLETED|Overall Study||4
272787|NCT00923156|661074|P1|NOT COMPLETED|Overall Study||0
272788|NCT00923156|661072|P3|COMPLETED|Overall Study||38
272789|NCT00923156|661073|P2|COMPLETED|Overall Study||38
272790|NCT00923156|661074|P1|COMPLETED|Overall Study||40
272791|NCT00923156|661072|P3|STARTED|Overall Study||41
272792|NCT00923156|661073|P2|STARTED|Overall Study||42
272793|NCT00923156|661074|P1|STARTED|Overall Study|"Started indicates randomized, safety and pharmacodynamic population"|40
272794|NCT00923130|661100|P1|NOT COMPLETED|Overall Study||25
272795|NCT00923130|661100|P1|COMPLETED|Overall Study||5
272796|NCT00923130|661100|P1|STARTED|Overall Study||30
272797|NCT00923117|661118|P2|NOT COMPLETED|Overall Study||0
272798|NCT00923117|661119|P1|NOT COMPLETED|Overall Study||0
272799|NCT00923117|661118|P2|COMPLETED|Overall Study||43
272800|NCT00923117|661119|P1|COMPLETED|Overall Study||44
272801|NCT00923117|661118|P2|STARTED|Overall Study||43
272802|NCT00923117|661119|P1|STARTED|Overall Study||44
272803|NCT00923091|661135|P13|NOT COMPLETED|Period VI (Open-Label)||0
272804|NCT00923091|661136|P12|NOT COMPLETED|Period VI (Open-Label)||0
272805|NCT00923091|661137|P11|NOT COMPLETED|Period VI (Open-Label)||0
272806|NCT00923091|661138|P10|NOT COMPLETED|Period VI (Open-Label)||0
272807|NCT00923091|661139|P9|NOT COMPLETED|Period VI (Open-Label)||0
272808|NCT00923091|661140|P8|NOT COMPLETED|Period VI (Open-Label)||0
272809|NCT00923091|661141|P7|NOT COMPLETED|Period VI (Open-Label)||0
272810|NCT00923091|661142|P6|NOT COMPLETED|Period VI (Open-Label)||0
272811|NCT00923091|661143|P5|NOT COMPLETED|Period VI (Open-Label)||7
272812|NCT00923091|661144|P4|NOT COMPLETED|Period VI (Open-Label)||3
272813|NCT00923091|661145|P3|NOT COMPLETED|Period VI (Open-Label)||13
272814|NCT00923091|661146|P2|NOT COMPLETED|Period VI (Open-Label)||8
272815|NCT00923091|661147|P1|NOT COMPLETED|Period VI (Open-Label)||39
272816|NCT00923091|661135|P13|COMPLETED|Period VI (Open-Label)||0
272817|NCT00923091|661136|P12|COMPLETED|Period VI (Open-Label)||0
272818|NCT00923091|661137|P11|COMPLETED|Period VI (Open-Label)||0
272819|NCT00923091|661138|P10|COMPLETED|Period VI (Open-Label)||0
272820|NCT00923091|661139|P9|COMPLETED|Period VI (Open-Label)||0
272821|NCT00923091|661140|P8|COMPLETED|Period VI (Open-Label)||0
272822|NCT00923091|661141|P7|COMPLETED|Period VI (Open-Label)||0
272823|NCT00923091|661142|P6|COMPLETED|Period VI (Open-Label)||0
272824|NCT00923091|661143|P5|COMPLETED|Period VI (Open-Label)||157
272825|NCT00923091|661144|P4|COMPLETED|Period VI (Open-Label)||143
272826|NCT00923091|661145|P3|COMPLETED|Period VI (Open-Label)||467
272827|NCT00923091|661146|P2|COMPLETED|Period VI (Open-Label)||264
272828|NCT00923091|661147|P1|COMPLETED|Period VI (Open-Label)||1408
272829|NCT00923091|661135|P13|STARTED|Period VI (Open-Label)||0
272830|NCT00923091|661136|P12|STARTED|Period VI (Open-Label)||0
272831|NCT00923091|661137|P11|STARTED|Period VI (Open-Label)||0
272832|NCT00923091|661138|P10|STARTED|Period VI (Open-Label)||0
272833|NCT00923091|661139|P9|STARTED|Period VI (Open-Label)||0
272834|NCT00923091|661140|P8|STARTED|Period VI (Open-Label)||0
272835|NCT00923091|661141|P7|STARTED|Period VI (Open-Label)||0
272837|NCT00923091|661143|P5|STARTED|Period VI (Open-Label)||164
272838|NCT00923091|661144|P4|STARTED|Period VI (Open-Label)||146
272839|NCT00923091|661145|P3|STARTED|Period VI (Open-Label)||480
272840|NCT00923091|661146|P2|STARTED|Period VI (Open-Label)||272
272841|NCT00923091|661147|P1|STARTED|Period VI (Open-Label)|1837 from Period III+2 from Period IV + 670 from Period 5 = 2509|1447
272842|NCT00923091|661135|P13|NOT COMPLETED|Period V (Double -Blind)||2
272843|NCT00923091|661136|P12|NOT COMPLETED|Period V (Double -Blind)||0
272844|NCT00923091|661137|P11|NOT COMPLETED|Period V (Double -Blind)||1
272845|NCT00923091|661138|P10|NOT COMPLETED|Period V (Double -Blind)||0
272846|NCT00923091|661139|P9|NOT COMPLETED|Period V (Double -Blind)||1
272847|NCT00923091|661140|P8|NOT COMPLETED|Period V (Double -Blind)||0
272848|NCT00923091|661141|P7|NOT COMPLETED|Period V (Double -Blind)||0
272849|NCT00923091|661142|P6|NOT COMPLETED|Period V (Double -Blind)||0
272850|NCT00923091|661143|P5|NOT COMPLETED|Period V (Double -Blind)||0
272851|NCT00923091|661144|P4|NOT COMPLETED|Period V (Double -Blind)||0
272852|NCT00923091|661145|P3|NOT COMPLETED|Period V (Double -Blind)||0
272853|NCT00923091|661146|P2|NOT COMPLETED|Period V (Double -Blind)||0
272854|NCT00923091|661147|P1|NOT COMPLETED|Period V (Double -Blind)||0
272855|NCT00923091|661135|P13|COMPLETED|Period V (Double -Blind)||73
272856|NCT00923091|661136|P12|COMPLETED|Period V (Double -Blind)||151
272857|NCT00923091|661137|P11|COMPLETED|Period V (Double -Blind)||193
272858|NCT00923091|661138|P10|COMPLETED|Period V (Double -Blind)||119
272859|NCT00923091|661139|P9|COMPLETED|Period V (Double -Blind)||134
272860|NCT00923091|661140|P8|COMPLETED|Period V (Double -Blind)||0
272861|NCT00923091|661141|P7|COMPLETED|Period V (Double -Blind)||0
272862|NCT00923091|661142|P6|COMPLETED|Period V (Double -Blind)||0
272863|NCT00923091|661143|P5|COMPLETED|Period V (Double -Blind)||0
272864|NCT00923091|661144|P4|COMPLETED|Period V (Double -Blind)||0
272865|NCT00923091|661145|P3|COMPLETED|Period V (Double -Blind)||0
272866|NCT00923091|661146|P2|COMPLETED|Period V (Double -Blind)||0
272867|NCT00923091|661147|P1|COMPLETED|Period V (Double -Blind)||0
272868|NCT00923091|661135|P13|STARTED|Period V (Double -Blind)||75
272869|NCT00923091|661136|P12|STARTED|Period V (Double -Blind)||151
272870|NCT00923091|661137|P11|STARTED|Period V (Double -Blind)||194
272871|NCT00923091|661138|P10|STARTED|Period V (Double -Blind)||119
272872|NCT00923091|661139|P9|STARTED|Period V (Double -Blind)||135
272873|NCT00923091|661140|P8|STARTED|Period V (Double -Blind)||0
272874|NCT00923091|661141|P7|STARTED|Period V (Double -Blind)||0
272875|NCT00923091|661142|P6|STARTED|Period V (Double -Blind)||0
272876|NCT00923091|661143|P5|STARTED|Period V (Double -Blind)||0
272877|NCT00923091|661144|P4|STARTED|Period V (Double -Blind)||0
272878|NCT00923091|661145|P3|STARTED|Period V (Double -Blind)||0
272879|NCT00923091|661146|P2|STARTED|Period V (Double -Blind)||0
272880|NCT00923091|661147|P1|STARTED|Period V (Double -Blind)|677 completed Period 4. 1 did not continue and 2 erroneously responders were not counted = 674|0
272881|NCT00923091|661135|P13|NOT COMPLETED|Period IV (Double-Blind)||0
272882|NCT00923091|661136|P12|NOT COMPLETED|Period IV (Double-Blind)||0
272883|NCT00923091|661137|P11|NOT COMPLETED|Period IV (Double-Blind)||0
272884|NCT00923091|661138|P10|NOT COMPLETED|Period IV (Double-Blind)||0
272885|NCT00923091|661139|P9|NOT COMPLETED|Period IV (Double-Blind)||0
272886|NCT00923091|661140|P8|NOT COMPLETED|Period IV (Double-Blind)||0
272887|NCT00923091|661141|P7|NOT COMPLETED|Period IV (Double-Blind)||0
272888|NCT00923091|661142|P6|NOT COMPLETED|Period IV (Double-Blind)||0
272889|NCT00923091|661143|P5|NOT COMPLETED|Period IV (Double-Blind)||0
272890|NCT00923091|661144|P4|NOT COMPLETED|Period IV (Double-Blind)||0
272891|NCT00923091|661145|P3|NOT COMPLETED|Period IV (Double-Blind)||0
272892|NCT00923091|661146|P2|NOT COMPLETED|Period IV (Double-Blind)||2
272893|NCT00923091|661147|P1|NOT COMPLETED|Period IV (Double-Blind)||2
272894|NCT00923091|661135|P13|COMPLETED|Period IV (Double-Blind)||0
272895|NCT00923091|661136|P12|COMPLETED|Period IV (Double-Blind)||0
272896|NCT00923091|661137|P11|COMPLETED|Period IV (Double-Blind)||0
272897|NCT00923091|661138|P10|COMPLETED|Period IV (Double-Blind)||0
272898|NCT00923091|661139|P9|COMPLETED|Period IV (Double-Blind)||0
272899|NCT00923091|661140|P8|COMPLETED|Period IV (Double-Blind)||0
272900|NCT00923091|661141|P7|COMPLETED|Period IV (Double-Blind)||0
272901|NCT00923091|661142|P6|COMPLETED|Period IV (Double-Blind)||0
272902|NCT00923091|661143|P5|COMPLETED|Period IV (Double-Blind)||0
272903|NCT00923091|661144|P4|COMPLETED|Period IV (Double-Blind)||0
272904|NCT00923091|661145|P3|COMPLETED|Period IV (Double-Blind)||0
272905|NCT00923091|661146|P2|COMPLETED|Period IV (Double-Blind)||451
272906|NCT00923091|661147|P1|COMPLETED|Period IV (Double-Blind)||226
272907|NCT00923091|661135|P13|STARTED|Period IV (Double-Blind)||0
272908|NCT00923091|661136|P12|STARTED|Period IV (Double-Blind)||0
272909|NCT00923091|661137|P11|STARTED|Period IV (Double-Blind)||0
272910|NCT00923091|661138|P10|STARTED|Period IV (Double-Blind)||0
272911|NCT00923091|661139|P9|STARTED|Period IV (Double-Blind)||0
272912|NCT00923091|661140|P8|STARTED|Period IV (Double-Blind)||0
272913|NCT00923091|661141|P7|STARTED|Period IV (Double-Blind)||0
272914|NCT00923091|661142|P6|STARTED|Period IV (Double-Blind)||0
272915|NCT00923091|661143|P5|STARTED|Period IV (Double-Blind)||0
272916|NCT00923091|661144|P4|STARTED|Period IV (Double-Blind)||0
272917|NCT00923091|661145|P3|STARTED|Period IV (Double-Blind)||0
272918|NCT00923091|661146|P2|STARTED|Period IV (Double-Blind)||453
272919|NCT00923091|661147|P1|STARTED|Period IV (Double-Blind)|2 did not continue in the study and 1837 responders went directly to Period VI. 228+453+2+1837=2520|228
272920|NCT00923091|661135|P13|NOT COMPLETED|Period III (Single-Blind)||0
272921|NCT00923091|661136|P12|NOT COMPLETED|Period III (Single-Blind)||0
272922|NCT00923091|661137|P11|NOT COMPLETED|Period III (Single-Blind)||0
272923|NCT00923091|661138|P10|NOT COMPLETED|Period III (Single-Blind)||0
272924|NCT00923091|661139|P9|NOT COMPLETED|Period III (Single-Blind)||0
272925|NCT00923091|661140|P8|NOT COMPLETED|Period III (Single-Blind)||0
272926|NCT00923091|661141|P7|NOT COMPLETED|Period III (Single-Blind)||0
272927|NCT00923091|661142|P6|NOT COMPLETED|Period III (Single-Blind)||0
272928|NCT00923091|661143|P5|NOT COMPLETED|Period III (Single-Blind)||0
272929|NCT00923091|661144|P4|NOT COMPLETED|Period III (Single-Blind)||0
272930|NCT00923091|661145|P3|NOT COMPLETED|Period III (Single-Blind)||0
272931|NCT00923091|661146|P2|NOT COMPLETED|Period III (Single-Blind)||0
272932|NCT00923091|661147|P1|NOT COMPLETED|Period III (Single-Blind)||20
272933|NCT00923091|661135|P13|COMPLETED|Period III (Single-Blind)||0
272934|NCT00923091|661136|P12|COMPLETED|Period III (Single-Blind)||0
272935|NCT00923091|661137|P11|COMPLETED|Period III (Single-Blind)||0
272936|NCT00923091|661138|P10|COMPLETED|Period III (Single-Blind)||0
272937|NCT00923091|661139|P9|COMPLETED|Period III (Single-Blind)||0
272938|NCT00923091|661140|P8|COMPLETED|Period III (Single-Blind)||0
272939|NCT00923091|661141|P7|COMPLETED|Period III (Single-Blind)||0
272940|NCT00923091|661142|P6|COMPLETED|Period III (Single-Blind)||0
272941|NCT00923091|661143|P5|COMPLETED|Period III (Single-Blind)||0
272942|NCT00923091|661144|P4|COMPLETED|Period III (Single-Blind)||0
272943|NCT00923091|661145|P3|COMPLETED|Period III (Single-Blind)||0
272944|NCT00923091|661146|P2|COMPLETED|Period III (Single-Blind)||0
272945|NCT00923091|661147|P1|COMPLETED|Period III (Single-Blind)||2520
272946|NCT00923091|661135|P13|STARTED|Period III (Single-Blind)||0
272947|NCT00923091|661136|P12|STARTED|Period III (Single-Blind)||0
272948|NCT00923091|661137|P11|STARTED|Period III (Single-Blind)||0
272949|NCT00923091|661138|P10|STARTED|Period III (Single-Blind)||0
272950|NCT00923091|661139|P9|STARTED|Period III (Single-Blind)||0
272951|NCT00923091|661140|P8|STARTED|Period III (Single-Blind)||0
272952|NCT00923091|661141|P7|STARTED|Period III (Single-Blind)||0
272953|NCT00923091|661142|P6|STARTED|Period III (Single-Blind)||0
272954|NCT00923091|661143|P5|STARTED|Period III (Single-Blind)||0
272955|NCT00923091|661144|P4|STARTED|Period III (Single-Blind)||0
272956|NCT00923091|661145|P3|STARTED|Period III (Single-Blind)||0
272957|NCT00923091|661146|P2|STARTED|Period III (Single-Blind)||0
272958|NCT00923091|661147|P1|STARTED|Period III (Single-Blind)|2543 completed Period 2. Three decided not to continue in the study=2540.|2540
272959|NCT00923091|661135|P13|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
272960|NCT00923091|661136|P12|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
272961|NCT00923091|661137|P11|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
272962|NCT00923091|661138|P10|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
272963|NCT00923091|661139|P9|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
272964|NCT00923091|661140|P8|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||25
272965|NCT00923091|661141|P7|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||18
272966|NCT00923091|661142|P6|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||15
272967|NCT00923091|661143|P5|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||21
272968|NCT00923091|661144|P4|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||27
272969|NCT00923091|661145|P3|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||13
272970|NCT00923091|661146|P2|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||11
272971|NCT00923091|661147|P1|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||16
272972|NCT00923091|661135|P13|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
272973|NCT00923091|661136|P12|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
272974|NCT00923091|661137|P11|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
272975|NCT00923091|661138|P10|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
272976|NCT00923091|661139|P9|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
272977|NCT00923091|661140|P8|COMPLETED|PeriodI-II (Randomized, Double-Blind)||311
272978|NCT00923091|661141|P7|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
272979|NCT00923091|661142|P6|COMPLETED|PeriodI-II (Randomized, Double-Blind)||322
272980|NCT00923091|661143|P5|COMPLETED|PeriodI-II (Randomized, Double-Blind)||315
272981|NCT00923091|661144|P4|COMPLETED|PeriodI-II (Randomized, Double-Blind)||309
272982|NCT00923091|661145|P3|COMPLETED|PeriodI-II (Randomized, Double-Blind)||323
272983|NCT00923091|661146|P2|COMPLETED|PeriodI-II (Randomized, Double-Blind)||325
272984|NCT00923091|661147|P1|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
272985|NCT00923091|661135|P13|STARTED|PeriodI-II (Randomized, Double-Blind)||0
272986|NCT00923091|661136|P12|STARTED|PeriodI-II (Randomized, Double-Blind)||0
272987|NCT00923091|661137|P11|STARTED|PeriodI-II (Randomized, Double-Blind)||0
272988|NCT00923091|661138|P10|STARTED|PeriodI-II (Randomized, Double-Blind)||0
272989|NCT00923091|661139|P9|STARTED|PeriodI-II (Randomized, Double-Blind)||0
272990|NCT00923091|661140|P8|STARTED|PeriodI-II (Randomized, Double-Blind)||336
272991|NCT00923091|661141|P7|STARTED|PeriodI-II (Randomized, Double-Blind)||337
272992|NCT00923091|661142|P6|STARTED|PeriodI-II (Randomized, Double-Blind)||337
272993|NCT00923091|661143|P5|STARTED|PeriodI-II (Randomized, Double-Blind)||336
272994|NCT00923091|661144|P4|STARTED|PeriodI-II (Randomized, Double-Blind)||336
272995|NCT00923091|661145|P3|STARTED|PeriodI-II (Randomized, Double-Blind)||336
272996|NCT00923091|661146|P2|STARTED|PeriodI-II (Randomized, Double-Blind)||336
272997|NCT00923091|661147|P1|STARTED|PeriodI-II (Randomized, Double-Blind)||335
272998|NCT00923078|661197|P3|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
272999|NCT00923078|661198|P2|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
273000|NCT00923078|661199|P1|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
273001|NCT00923078|661197|P3|COMPLETED|Second Intervention (Weeks 5-8)||0
273002|NCT00923078|661198|P2|COMPLETED|Second Intervention (Weeks 5-8)||19
273003|NCT00923078|661199|P1|COMPLETED|Second Intervention (Weeks 5-8)||19
273004|NCT00923078|661197|P3|STARTED|Second Intervention (Weeks 5-8)|Healthy Comparison sample subjects completed only a single test session (baseline)|0
273005|NCT00923078|661198|P2|STARTED|Second Intervention (Weeks 5-8)||19
273006|NCT00923078|661199|P1|STARTED|Second Intervention (Weeks 5-8)||19
273007|NCT00923078|661197|P3|NOT COMPLETED|First Intervention (Weeks 1-4)||20
273008|NCT00923078|661198|P2|NOT COMPLETED|First Intervention (Weeks 1-4)||1
273009|NCT00923078|661199|P1|NOT COMPLETED|First Intervention (Weeks 1-4)||1
273010|NCT00923078|661197|P3|COMPLETED|First Intervention (Weeks 1-4)||0
273011|NCT00923078|661198|P2|COMPLETED|First Intervention (Weeks 1-4)||19
273012|NCT00923078|661199|P1|COMPLETED|First Intervention (Weeks 1-4)||19
273013|NCT00923078|661197|P3|STARTED|First Intervention (Weeks 1-4)||20
273014|NCT00923078|661198|P2|STARTED|First Intervention (Weeks 1-4)||20
273015|NCT00923078|661199|P1|STARTED|First Intervention (Weeks 1-4)||20
273016|NCT00922987|661218|P1|NOT COMPLETED|Overall Study||4
273017|NCT00922987|661218|P1|COMPLETED|Overall Study||277
273018|NCT00922987|661218|P1|STARTED|Overall Study||281
273019|NCT00922974|661233|P2|NOT COMPLETED|Phase III Component||6
273020|NCT00922974|661234|P1|NOT COMPLETED|Phase III Component||8
273021|NCT00922974|661233|P2|COMPLETED|Phase III Component||130
273022|NCT00922974|661234|P1|COMPLETED|Phase III Component||209
273023|NCT00922974|661233|P2|Eligible, Treated, Adverse Event Data|Phase III Component||83
273024|NCT00922974|661234|P1|Eligible, Treated, Adverse Event Data|Phase III Component||148
273025|NCT00922974|661233|P2|Eligible With Adverse Event Data|Phase III Component||117
273026|NCT00922974|661234|P1|Eligible With Adverse Event Data|Phase III Component||202
273027|NCT00922974|661233|P2|Eligible With 3 mo. FACT-G Data|Phase III Component||58
273028|NCT00922974|661234|P1|Eligible With 3 mo. FACT-G Data|Phase III Component||87
273029|NCT00922974|661233|P2|Eligible With 3 mo. NRPS Data|Phase III Component||76
273030|NCT00922974|661234|P1|Eligible With 3 mo. NRPS Data|Phase III Component||139
273031|NCT00922974|661233|P2|Eligible|Phase III Component||130
273032|NCT00922974|661234|P1|Eligible|Phase III Component||209
273033|NCT00922974|661233|P2|STARTED|Phase III Component||136
273034|NCT00922974|661234|P1|STARTED|Phase III Component|The phase III component accrues new subjects; these are not continuing phase II subjects.|217
273035|NCT00922974|661233|P2|NOT COMPLETED|Phase II Component||0
273036|NCT00922974|661234|P1|NOT COMPLETED|Phase II Component||7
273037|NCT00922974|661233|P2|COMPLETED|Phase II Component||0
273038|NCT00922974|661234|P1|COMPLETED|Phase II Component|These subjects do not participate in the phase III component.|39
273039|NCT00922974|661233|P2|Eligible, Treated, Adverse Event Data|Phase II Component||0
273040|NCT00922974|661234|P1|Eligible, Treated, Adverse Event Data|Phase II Component||34
273041|NCT00922974|661233|P2|Eligible and Started Treatment|Phase II Component||0
273042|NCT00922974|661234|P1|Eligible and Started Treatment|Phase II Component||39
273043|NCT00922974|661233|P2|Eligible|Phase II Component||0
273044|NCT00922974|661234|P1|Eligible|Phase II Component||44
273045|NCT00922974|661233|P2|STARTED|Phase II Component||0
273046|NCT00922974|661234|P1|STARTED|Phase II Component||46
273047|NCT00922935|661249|P3|NOT COMPLETED|Overall Study||0
273048|NCT00922935|661250|P2|NOT COMPLETED|Overall Study||5
273049|NCT00922935|661251|P1|NOT COMPLETED|Overall Study||1
273050|NCT00922935|661249|P3|COMPLETED|Overall Study||10
273051|NCT00922935|661250|P2|COMPLETED|Overall Study||11
273052|NCT00922935|661251|P1|COMPLETED|Overall Study||9
273053|NCT00922935|661249|P3|STARTED|Overall Study||10
273054|NCT00922935|661250|P2|STARTED|Overall Study||16
273055|NCT00922935|661251|P1|STARTED|Overall Study||10
273056|NCT00922883|661259|P1|NOT COMPLETED|Overall Study||0
273057|NCT00922883|661259|P1|COMPLETED|Overall Study||43
273058|NCT00922883|661259|P1|STARTED|Overall Study||43
273059|NCT00922779|661263|P1|NOT COMPLETED|Overall Study||2327
273060|NCT00922779|661263|P1|COMPLETED|Overall Study||4334
273061|NCT00922779|661263|P1|STARTED|Overall Study||6661
273062|NCT00922766|661270|P1|NOT COMPLETED|Overall Study||7
273063|NCT00922766|661270|P1|COMPLETED|Overall Study||610
273064|NCT00922766|661270|P1|STARTED|Overall Study||617
273065|NCT00922701|661279|P1|NOT COMPLETED|Overall Study||0
273066|NCT00922701|661279|P1|COMPLETED|Overall Study||4
273067|NCT00922701|661279|P1|STARTED|Overall Study||4
273068|NCT00922636|661288|P5|NOT COMPLETED|Overall Study||16
273069|NCT00922636|661289|P4|NOT COMPLETED|Overall Study||17
273070|NCT00922636|661290|P3|NOT COMPLETED|Overall Study||20
273071|NCT00922636|661291|P2|NOT COMPLETED|Overall Study||16
273072|NCT00922636|661292|P1|NOT COMPLETED|Overall Study||7
273073|NCT00922636|661288|P5|COMPLETED|Overall Study||59
273074|NCT00922636|661289|P4|COMPLETED|Overall Study||58
273075|NCT00922636|661290|P3|COMPLETED|Overall Study||56
273076|NCT00922636|661291|P2|COMPLETED|Overall Study||62
273077|NCT00922636|661292|P1|COMPLETED|Overall Study||29
273078|NCT00922636|661288|P5|Entered Optional Taper Phase|Overall Study||12
273079|NCT00922636|661289|P4|Entered Optional Taper Phase|Overall Study||7
273080|NCT00922636|661290|P3|Entered Optional Taper Phase|Overall Study||15
273081|NCT00922636|661291|P2|Entered Optional Taper Phase|Overall Study||10
273082|NCT00922636|661292|P1|Entered Optional Taper Phase|Overall Study||4
273083|NCT00922636|661288|P5|STARTED|Overall Study||75
273084|NCT00922636|661289|P4|STARTED|Overall Study||75
273085|NCT00922636|661290|P3|STARTED|Overall Study||76
273086|NCT00922636|661291|P2|STARTED|Overall Study||78
273087|NCT00922636|661292|P1|STARTED|Overall Study||36
273088|NCT00922623|661439|P1|NOT COMPLETED|Overall Study||5
273089|NCT00922623|661439|P1|COMPLETED|Overall Study||88
273090|NCT00922623|661439|P1|STARTED|Overall Study||93
273091|NCT00922480|661447|P2|NOT COMPLETED|Extension Study||3
273092|NCT00922480|661448|P1|NOT COMPLETED|Extension Study||5
273093|NCT00922480|661447|P2|COMPLETED|Extension Study||82
273094|NCT00922480|661448|P1|COMPLETED|Extension Study||68
273095|NCT00922480|661447|P2|STARTED|Extension Study||85
273096|NCT00922480|661448|P1|STARTED|Extension Study||73
273097|NCT00922480|661447|P2|NOT COMPLETED|Main Study||29
273098|NCT00922480|661448|P1|NOT COMPLETED|Main Study||37
273099|NCT00922480|661447|P2|COMPLETED|Main Study||226
273100|NCT00922480|661448|P1|COMPLETED|Main Study||213
273101|NCT00922480|661447|P2|STARTED|Main Study||255
273102|NCT00922480|661448|P1|STARTED|Main Study||250
273103|NCT00922441|661459|P3|NOT COMPLETED|Overall Study||3
273104|NCT00922441|661460|P2|NOT COMPLETED|Overall Study||0
273105|NCT00922441|661461|P1|NOT COMPLETED|Overall Study||0
273106|NCT00922441|661459|P3|COMPLETED|Overall Study||29
273107|NCT00922441|661460|P2|COMPLETED|Overall Study||30
273108|NCT00922441|661461|P1|COMPLETED|Overall Study||30
273109|NCT00922441|661459|P3|STARTED|Overall Study||32
273110|NCT00922441|661460|P2|STARTED|Overall Study||30
273111|NCT00922441|661461|P1|STARTED|Overall Study||30
273112|NCT00922428|661469|P1|NOT COMPLETED|Overall Study||15
273113|NCT00922428|661469|P1|COMPLETED|Overall Study|for 11 participants no gender was given|1374
273114|NCT00922428|661469|P1|STARTED|Overall Study|13 patients were completely not analysed, 2 not for demographic or efficacy but for safety|1389
273115|NCT00922272|661498|P2|NOT COMPLETED|Double-blind Phase||6
273116|NCT00922272|661499|P1|NOT COMPLETED|Double-blind Phase||7
273117|NCT00922272|661498|P2|COMPLETED|Double-blind Phase||29
273118|NCT00922272|661499|P1|COMPLETED|Double-blind Phase||27
273119|NCT00922272|661498|P2|STARTED|Double-blind Phase||35
273120|NCT00922272|661499|P1|STARTED|Double-blind Phase||34
273121|NCT00922272|661498|P2|NOT COMPLETED|Open-label Phase||0
273122|NCT00922272|661499|P1|NOT COMPLETED|Open-label Phase||23
273123|NCT00922272|661498|P2|COMPLETED|Open-label Phase||0
273124|NCT00922272|661499|P1|COMPLETED|Open-label Phase||69
273125|NCT00922272|661498|P2|STARTED|Open-label Phase||0
273126|NCT00922272|661499|P1|STARTED|Open-label Phase||92
273127|NCT00922233|661555|P1|NOT COMPLETED|Overall Study||4
273128|NCT00922233|661555|P1|COMPLETED|Overall Study||68
273129|NCT00922233|661555|P1|STARTED|Overall Study||72
273130|NCT00922207|661564|P3|NOT COMPLETED|Overall Study||4
273131|NCT00922207|661565|P2|NOT COMPLETED|Overall Study||7
273132|NCT00922207|661566|P1|NOT COMPLETED|Overall Study||6
273133|NCT00922207|661564|P3|COMPLETED|Overall Study||90
273134|NCT00922207|661565|P2|COMPLETED|Overall Study||88
273135|NCT00922207|661566|P1|COMPLETED|Overall Study||85
273136|NCT00922207|661564|P3|STARTED|Overall Study||94
273137|NCT00922207|661565|P2|STARTED|Overall Study||95
273138|NCT00922207|661566|P1|STARTED|Overall Study||91
273139|NCT00922194|661592|P1|NOT COMPLETED|Metformin for 12 Months or More||0
273140|NCT00922194|661592|P1|COMPLETED|Metformin for 12 Months or More||102
273141|NCT00922194|661592|P1|STARTED|Metformin for 12 Months or More|Gradually increasing dose of Extended Release Metformin|102
273142|NCT00922194|661592|P1|NOT COMPLETED|Metformin in Maximum Tolerated Dose||0
273143|NCT00922194|661592|P1|COMPLETED|Metformin in Maximum Tolerated Dose|June 2009|102
273144|NCT00922194|661592|P1|STARTED|Metformin in Maximum Tolerated Dose|February 2006|102
273145|NCT00922116|661602|P1|NOT COMPLETED|Overall Study||15
273146|NCT00922116|661602|P1|COMPLETED|Overall Study||176
273147|NCT00922116|661602|P1|STARTED|Overall Study||191
273148|NCT00921947|661613|P2|NOT COMPLETED|Day 28||0
273149|NCT00921947|661614|P1|NOT COMPLETED|Day 28||0
273150|NCT00921947|661613|P2|COMPLETED|Day 28||30
273151|NCT00921947|661614|P1|COMPLETED|Day 28||28
273152|NCT00921947|661613|P2|STARTED|Day 28||30
273153|NCT00921947|661614|P1|STARTED|Day 28|2 subjects were lost to follow-up and did not receive the 2nd vaccination of 1.0 ug i.m.|28
273154|NCT00921947|661613|P2|NOT COMPLETED|Day 0||0
273155|NCT00921947|661614|P1|NOT COMPLETED|Day 0||0
273156|NCT00921947|661613|P2|COMPLETED|Day 0||30
273157|NCT00921947|661614|P1|COMPLETED|Day 0||30
273158|NCT00921947|661613|P2|STARTED|Day 0||30
273159|NCT00921947|661614|P1|STARTED|Day 0||30
273160|NCT00921934|661624|P1|NOT COMPLETED|Overall Study||0
273161|NCT00921934|661624|P1|COMPLETED|Overall Study||68
273162|NCT00921934|661624|P1|STARTED|Overall Study||68
273163|NCT00921895|661628|P1|NOT COMPLETED|Overall Study||0
273164|NCT00921895|661628|P1|COMPLETED|Overall Study||128
273165|NCT00921895|661628|P1|STARTED|Overall Study||128
273166|NCT00921843|661637|P4|NOT COMPLETED|Overall Study||0
273167|NCT00921843|661638|P3|NOT COMPLETED|Overall Study||0
273168|NCT00921843|661639|P2|NOT COMPLETED|Overall Study||0
273169|NCT00921843|661640|P1|NOT COMPLETED|Overall Study||0
273170|NCT00921843|661637|P4|COMPLETED|Overall Study||30
273171|NCT00921843|661638|P3|COMPLETED|Overall Study||11
273172|NCT00921843|661639|P2|COMPLETED|Overall Study||10
273173|NCT00921843|661640|P1|COMPLETED|Overall Study||10
273174|NCT00921843|661637|P4|STARTED|Overall Study||30
273175|NCT00921843|661638|P3|STARTED|Overall Study||11
273176|NCT00921843|661639|P2|STARTED|Overall Study||10
273177|NCT00921843|661640|P1|STARTED|Overall Study||10
273178|NCT00921687|661652|P2|NOT COMPLETED|Overall Study||0
273179|NCT00921687|661653|P1|NOT COMPLETED|Overall Study||0
273180|NCT00921687|661652|P2|COMPLETED|Overall Study||363
273181|NCT00921687|661653|P1|COMPLETED|Overall Study||418
273182|NCT00921687|661652|P2|STARTED|Overall Study||363
273183|NCT00921687|661653|P1|STARTED|Overall Study|eligible patients seen in clinic between 1/1/09 and 1/1/10|418
273184|NCT00921557|661664|P3|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
273185|NCT00921557|661665|P2|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
273186|NCT00921557|661666|P1|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||3
273187|NCT00921557|661664|P3|COMPLETED|Weeks 96-144 (Off Study Treatment)||16
273188|NCT00921557|661665|P2|COMPLETED|Weeks 96-144 (Off Study Treatment)||15
273189|NCT00921557|661666|P1|COMPLETED|Weeks 96-144 (Off Study Treatment)||12
273190|NCT00921557|661664|P3|STARTED|Weeks 96-144 (Off Study Treatment)||17
273191|NCT00921557|661665|P2|STARTED|Weeks 96-144 (Off Study Treatment)||16
273192|NCT00921557|661666|P1|STARTED|Weeks 96-144 (Off Study Treatment)||15
273193|NCT00921557|661664|P3|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
273194|NCT00921557|661665|P2|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
273195|NCT00921557|661666|P1|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||0
273196|NCT00921557|661664|P3|COMPLETED|Weeks 48-96 (on Study Treatment)||17
273197|NCT00921557|661665|P2|COMPLETED|Weeks 48-96 (on Study Treatment)||16
273198|NCT00921557|661666|P1|COMPLETED|Weeks 48-96 (on Study Treatment)||15
273199|NCT00921557|661664|P3|STARTED|Weeks 48-96 (on Study Treatment)||18
273200|NCT00921557|661665|P2|STARTED|Weeks 48-96 (on Study Treatment)||17
273201|NCT00921557|661666|P1|STARTED|Weeks 48-96 (on Study Treatment)||15
273202|NCT00921557|661664|P3|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
273203|NCT00921557|661665|P2|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
273204|NCT00921557|661666|P1|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||2
273205|NCT00921557|661664|P3|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|18
273206|NCT00921557|661665|P2|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|17
273207|NCT00921557|661666|P1|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|15
273208|NCT00921557|661664|P3|STARTED|Weeks 0-48 (on Study Treatment)||18
273209|NCT00921557|661665|P2|STARTED|Weeks 0-48 (on Study Treatment)||17
273210|NCT00921557|661666|P1|STARTED|Weeks 0-48 (on Study Treatment)||17
273211|NCT00921518|661726|P2|NOT COMPLETED|Overall Study||0
273212|NCT00921518|661727|P1|NOT COMPLETED|Overall Study||0
273213|NCT00921518|661726|P2|COMPLETED|Overall Study||44
273214|NCT00921518|661727|P1|COMPLETED|Overall Study||48
273215|NCT00921518|661726|P2|STARTED|Overall Study||44
273216|NCT00921518|661727|P1|STARTED|Overall Study||48
273217|NCT00921310|661735|P3|NOT COMPLETED|Overall Study||0
273218|NCT00921310|661736|P2|NOT COMPLETED|Overall Study||0
273219|NCT00921310|661737|P1|NOT COMPLETED|Overall Study||0
273220|NCT00921310|661735|P3|COMPLETED|Overall Study||4
273221|NCT00921310|661736|P2|COMPLETED|Overall Study||6
273222|NCT00921310|661737|P1|COMPLETED|Overall Study||2
273223|NCT00921310|661735|P3|STARTED|Overall Study||4
273224|NCT00921310|661736|P2|STARTED|Overall Study||6
273225|NCT00921310|661737|P1|STARTED|Overall Study||2
273226|NCT00921115|661762|P1|NOT COMPLETED|Overall Study||0
273227|NCT00921115|661762|P1|COMPLETED|Overall Study||42
273228|NCT00921115|661762|P1|STARTED|Overall Study||42
273229|NCT00921024|661768|P2|NOT COMPLETED|Overall Study||3
273230|NCT00921024|661769|P1|NOT COMPLETED|Overall Study||4
273231|NCT00921024|661768|P2|COMPLETED|Overall Study||39
273232|NCT00921024|661769|P1|COMPLETED|Overall Study||81
273233|NCT00921024|661768|P2|STARTED|Overall Study||42
273234|NCT00921024|661769|P1|STARTED|Overall Study||85
273235|NCT00920907|661779|P2|NOT COMPLETED|Maintenance Period||13
273236|NCT00920907|661780|P1|NOT COMPLETED|Maintenance Period||12
273237|NCT00920907|661779|P2|COMPLETED|Maintenance Period|2 participants who entered Maintenance Period did not receive study drug during the period.|2
273238|NCT00920907|661780|P1|COMPLETED|Maintenance Period|All participants who entered Maintenance were treated with study drug.|3
273239|NCT00920907|661779|P2|STARTED|Maintenance Period|1 patient completed Induction phase but discontinued the study prior to start of maintenance phase.|15
273240|NCT00920907|661780|P1|STARTED|Maintenance Period||15
273241|NCT00920907|661779|P2|NOT COMPLETED|Induction Period||22
273242|NCT00920907|661780|P1|NOT COMPLETED|Induction Period||22
273243|NCT00920907|661779|P2|COMPLETED|Induction Period||16
273244|NCT00920907|661780|P1|COMPLETED|Induction Period||15
273245|NCT00920907|661779|P2|STARTED|Induction Period||38
273246|NCT00920907|661780|P1|STARTED|Induction Period||37
273247|NCT00920855|661821|P3|NOT COMPLETED|Overall Study||22
273248|NCT00920855|661822|P2|NOT COMPLETED|Overall Study||3
273249|NCT00920855|661823|P1|NOT COMPLETED|Overall Study||5
273250|NCT00920855|661821|P3|COMPLETED|Overall Study|completed eight cycles of treatment|9
273251|NCT00920855|661822|P2|COMPLETED|Overall Study|completed eight cycles of treatment|1
273252|NCT00920855|661823|P1|COMPLETED|Overall Study|completed eight cycles of treatment|0
273253|NCT00920855|661821|P3|Safety and Efficacy Populations|Overall Study||31
273254|NCT00920855|661822|P2|Safety and Efficacy Populations|Overall Study||4
273255|NCT00920855|661823|P1|Safety and Efficacy Populations|Overall Study||5
273256|NCT00920855|661821|P3|STARTED|Overall Study||31
273257|NCT00920855|661822|P2|STARTED|Overall Study||4
273258|NCT00920855|661823|P1|STARTED|Overall Study||5
273259|NCT00920829|661849|P4|NOT COMPLETED|Available for Analysis||11
273260|NCT00920829|661850|P3|NOT COMPLETED|Available for Analysis||10
273261|NCT00920829|661851|P2|NOT COMPLETED|Available for Analysis||11
273262|NCT00920829|661852|P1|NOT COMPLETED|Available for Analysis||8
273263|NCT00920829|661849|P4|COMPLETED|Available for Analysis||24
273264|NCT00920829|661850|P3|COMPLETED|Available for Analysis||28
273265|NCT00920829|661851|P2|COMPLETED|Available for Analysis||27
273266|NCT00920829|661852|P1|COMPLETED|Available for Analysis||27
273267|NCT00920829|661849|P4|STARTED|Available for Analysis||35
273268|NCT00920829|661850|P3|STARTED|Available for Analysis||38
273269|NCT00920829|661851|P2|STARTED|Available for Analysis||38
273270|NCT00920829|661852|P1|STARTED|Available for Analysis||35
273271|NCT00920829|661849|P4|NOT COMPLETED|Allocation||2
273272|NCT00920829|661850|P3|NOT COMPLETED|Allocation||0
273273|NCT00920829|661851|P2|NOT COMPLETED|Allocation||1
273274|NCT00920829|661852|P1|NOT COMPLETED|Allocation||3
273275|NCT00920829|661849|P4|COMPLETED|Allocation||35
273276|NCT00920829|661850|P3|COMPLETED|Allocation||38
273277|NCT00920829|661851|P2|COMPLETED|Allocation||38
273278|NCT00920829|661852|P1|COMPLETED|Allocation||35
273279|NCT00920829|661849|P4|STARTED|Allocation||37
273280|NCT00920829|661850|P3|STARTED|Allocation||38
273281|NCT00920829|661851|P2|STARTED|Allocation||39
273282|NCT00920829|661852|P1|STARTED|Allocation||38
273283|NCT00920816|661866|P4|NOT COMPLETED|Overall Study||69
273284|NCT00920816|661867|P3|NOT COMPLETED|Overall Study||135
273285|NCT00920816|661868|P2|NOT COMPLETED|Overall Study||96
273286|NCT00920816|661869|P1|NOT COMPLETED|Overall Study||192
273287|NCT00920816|661866|P4|COMPLETED|Overall Study||0
273288|NCT00920816|661867|P3|COMPLETED|Overall Study||0
273289|NCT00920816|661868|P2|COMPLETED|Overall Study||0
273290|NCT00920816|661869|P1|COMPLETED|Overall Study||0
273291|NCT00920816|661866|P4|Treated|Overall Study||69
273292|NCT00920816|661867|P3|Treated|Overall Study||135
273293|NCT00920816|661868|P2|Treated|Overall Study||96
273294|NCT00920816|661869|P1|Treated|Overall Study||189
273295|NCT00920816|661866|P4|STARTED|Overall Study||69
273296|NCT00920816|661867|P3|STARTED|Overall Study||135
273297|NCT00920816|661868|P2|STARTED|Overall Study||96
273298|NCT00920816|661869|P1|STARTED|Overall Study||192
273299|NCT00920790|661907|P1|NOT COMPLETED|Overall Study||14
273300|NCT00920790|661907|P1|COMPLETED|Overall Study||13
273301|NCT00920790|661907|P1|STARTED|Overall Study||27
273302|NCT00920699|661919|P3|NOT COMPLETED|Overall Study||4
273303|NCT00920699|661920|P2|NOT COMPLETED|Overall Study||1
273304|NCT00920699|661921|P1|NOT COMPLETED|Overall Study||2
273305|NCT00920699|661919|P3|COMPLETED|Overall Study||28
273306|NCT00920699|661920|P2|COMPLETED|Overall Study||29
273307|NCT00920699|661921|P1|COMPLETED|Overall Study||27
273308|NCT00920699|661919|P3|STARTED|Overall Study||32
273309|NCT00920699|661920|P2|STARTED|Overall Study||30
273310|NCT00920699|661921|P1|STARTED|Overall Study||29
273311|NCT00920686|661938|P3|NOT COMPLETED|Overall Study||13
273312|NCT00920686|661939|P2|NOT COMPLETED|Overall Study||22
273313|NCT00920686|661940|P1|NOT COMPLETED|Overall Study||19
273314|NCT00920686|661938|P3|COMPLETED|Overall Study||62
273315|NCT00920686|661939|P2|COMPLETED|Overall Study||60
273316|NCT00920686|661940|P1|COMPLETED|Overall Study||63
273317|NCT00920686|661938|P3|STARTED|Overall Study||75
273318|NCT00920686|661939|P2|STARTED|Overall Study||82
273319|NCT00920686|661940|P1|STARTED|Overall Study||82
273320|NCT00920647|661964|P4|NOT COMPLETED|Overall Study||0
273321|NCT00920647|661965|P3|NOT COMPLETED|Overall Study||0
273322|NCT00920647|661966|P2|NOT COMPLETED|Overall Study||0
273323|NCT00920647|661967|P1|NOT COMPLETED|Overall Study||0
273324|NCT00920647|661964|P4|COMPLETED|Overall Study||4
273325|NCT00920647|661965|P3|COMPLETED|Overall Study||4
273326|NCT00920647|661966|P2|COMPLETED|Overall Study||4
273327|NCT00920647|661967|P1|COMPLETED|Overall Study||4
273328|NCT00920647|661964|P4|STARTED|Overall Study||4
273329|NCT00920647|661965|P3|STARTED|Overall Study||4
273330|NCT00920647|661966|P2|STARTED|Overall Study||4
273331|NCT00920647|661967|P1|STARTED|Overall Study||4
273332|NCT00920621|662019|P4|NOT COMPLETED|Overall Study||35
273333|NCT00920621|662020|P3|NOT COMPLETED|Overall Study||35
273334|NCT00920621|662021|P2|NOT COMPLETED|Overall Study||45
273335|NCT00920621|662022|P1|NOT COMPLETED|Overall Study||54
273336|NCT00920621|662019|P4|COMPLETED|Overall Study||401
273337|NCT00920621|662020|P3|COMPLETED|Overall Study||405
273338|NCT00920621|662021|P2|COMPLETED|Overall Study||391
273339|NCT00920621|662022|P1|COMPLETED|Overall Study||386
273340|NCT00920621|662019|P4|STARTED|Overall Study||436
273341|NCT00920621|662020|P3|STARTED|Overall Study||440
273342|NCT00920621|662021|P2|STARTED|Overall Study||436
273343|NCT00920621|662022|P1|STARTED|Overall Study||440
273344|NCT00920556|662052|P1|NOT COMPLETED|Overall Study||24
273345|NCT00920556|662052|P1|COMPLETED|Overall Study||0
273346|NCT00920556|662052|P1|STARTED|Overall Study||24
273347|NCT00920439|662091|P1|NOT COMPLETED|Overall Study||0
273348|NCT00920439|662091|P1|COMPLETED|Overall Study||25
273349|NCT00920439|662091|P1|STARTED|Overall Study||25
273350|NCT00920426|662101|P4|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
273351|NCT00920426|662102|P3|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
273352|NCT00920426|662103|P2|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
273444|NCT00920140|662333|P2|STARTED|Phase 1 (Dose Escalation)||9
273353|NCT00920426|662104|P1|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
273354|NCT00920426|662101|P4|COMPLETED|ITZ112929: Optimized Therapy (OT)||8
273355|NCT00920426|662102|P3|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
273356|NCT00920426|662103|P2|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
273357|NCT00920426|662104|P1|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
273358|NCT00920426|662101|P4|STARTED|ITZ112929: Optimized Therapy (OT)|Out of 9 participants receiving randomized regimen, 8 participants continued to receive OT.|8
273359|NCT00920426|662102|P3|STARTED|ITZ112929: Optimized Therapy (OT)||0
273360|NCT00920426|662103|P2|STARTED|ITZ112929: Optimized Therapy (OT)||0
273361|NCT00920426|662104|P1|STARTED|ITZ112929: Optimized Therapy (OT)||0
273362|NCT00920426|662101|P4|NOT COMPLETED|ITZ112929: Randomized Regimen||0
273363|NCT00920426|662102|P3|NOT COMPLETED|ITZ112929: Randomized Regimen||0
273364|NCT00920426|662103|P2|NOT COMPLETED|ITZ112929: Randomized Regimen||0
273365|NCT00920426|662104|P1|NOT COMPLETED|ITZ112929: Randomized Regimen||0
273366|NCT00920426|662101|P4|COMPLETED|ITZ112929: Randomized Regimen||0
273367|NCT00920426|662102|P3|COMPLETED|ITZ112929: Randomized Regimen||2
273368|NCT00920426|662103|P2|COMPLETED|ITZ112929: Randomized Regimen||7
273369|NCT00920426|662104|P1|COMPLETED|ITZ112929: Randomized Regimen||0
273370|NCT00920426|662101|P4|STARTED|ITZ112929: Randomized Regimen||0
273371|NCT00920426|662102|P3|STARTED|ITZ112929: Randomized Regimen||2
273372|NCT00920426|662103|P2|STARTED|ITZ112929: Randomized Regimen||7
273373|NCT00920426|662104|P1|STARTED|ITZ112929: Randomized Regimen||0
273374|NCT00920426|662101|P4|NOT COMPLETED|ITZ111451||0
273375|NCT00920426|662102|P3|NOT COMPLETED|ITZ111451||0
273376|NCT00920426|662103|P2|NOT COMPLETED|ITZ111451||0
273377|NCT00920426|662104|P1|NOT COMPLETED|ITZ111451||1
273378|NCT00920426|662101|P4|COMPLETED|ITZ111451||0
273379|NCT00920426|662102|P3|COMPLETED|ITZ111451||0
273380|NCT00920426|662103|P2|COMPLETED|ITZ111451||0
273381|NCT00920426|662104|P1|COMPLETED|ITZ111451||7
273382|NCT00920426|662101|P4|STARTED|ITZ111451||0
273383|NCT00920426|662102|P3|STARTED|ITZ111451||0
273384|NCT00920426|662103|P2|STARTED|ITZ111451||0
273385|NCT00920426|662104|P1|STARTED|ITZ111451||8
273386|NCT00920374|662173|P2|NOT COMPLETED|Overall Study||0
273387|NCT00920374|662174|P1|NOT COMPLETED|Overall Study||0
273388|NCT00920374|662173|P2|COMPLETED|Overall Study||57
273389|NCT00920374|662174|P1|COMPLETED|Overall Study||61
273390|NCT00920374|662173|P2|STARTED|Overall Study||57
273391|NCT00920374|662174|P1|STARTED|Overall Study||61
273392|NCT00920309|662200|P2|NOT COMPLETED|Overall Study||0
273393|NCT00920309|662201|P1|NOT COMPLETED|Overall Study||0
273394|NCT00920309|662200|P2|COMPLETED|Overall Study||7
273395|NCT00920309|662201|P1|COMPLETED|Overall Study||14
273396|NCT00920309|662200|P2|STARTED|Overall Study||7
273397|NCT00920309|662201|P1|STARTED|Overall Study||14
273398|NCT00920231|662211|P2|NOT COMPLETED|Overall Study||0
273399|NCT00920231|662212|P1|NOT COMPLETED|Overall Study||0
273400|NCT00920231|662211|P2|COMPLETED|Overall Study||8
273401|NCT00920231|662212|P1|COMPLETED|Overall Study||8
273402|NCT00920231|662211|P2|STARTED|Overall Study||8
273403|NCT00920231|662212|P1|STARTED|Overall Study||8
273404|NCT00920218|662224|P4|NOT COMPLETED|Overall Study||7
273405|NCT00920218|662225|P3|NOT COMPLETED|Overall Study||8
273406|NCT00920218|662226|P2|NOT COMPLETED|Overall Study||5
273407|NCT00920218|662227|P1|NOT COMPLETED|Overall Study||2
273408|NCT00920218|662224|P4|COMPLETED|Overall Study||23
273409|NCT00920218|662225|P3|COMPLETED|Overall Study||23
273410|NCT00920218|662226|P2|COMPLETED|Overall Study||24
273411|NCT00920218|662227|P1|COMPLETED|Overall Study||28
273412|NCT00920218|662224|P4|STARTED|Overall Study||30
273413|NCT00920218|662225|P3|STARTED|Overall Study||31
273414|NCT00920218|662226|P2|STARTED|Overall Study||29
273415|NCT00920218|662227|P1|STARTED|Overall Study||30
273416|NCT00920140|662330|P5|NOT COMPLETED|Phase 2||11
273417|NCT00920140|662331|P4|NOT COMPLETED|Phase 2||22
273418|NCT00920140|662332|P3|NOT COMPLETED|Phase 2||50
273419|NCT00920140|662333|P2|NOT COMPLETED|Phase 2||0
273420|NCT00920140|662334|P1|NOT COMPLETED|Phase 2||0
273421|NCT00920140|662330|P5|COMPLETED|Phase 2||0
273422|NCT00920140|662331|P4|COMPLETED|Phase 2||0
273423|NCT00920140|662332|P3|COMPLETED|Phase 2||0
273424|NCT00920140|662333|P2|COMPLETED|Phase 2||0
273425|NCT00920140|662334|P1|COMPLETED|Phase 2||0
273426|NCT00920140|662330|P5|STARTED|Phase 2||11
273427|NCT00920140|662331|P4|STARTED|Phase 2||22
273428|NCT00920140|662332|P3|STARTED|Phase 2||50
273429|NCT00920140|662333|P2|STARTED|Phase 2||0
273430|NCT00920140|662334|P1|STARTED|Phase 2||0
273431|NCT00920140|662330|P5|NOT COMPLETED|Phase 1 (Dose Escalation)||0
273432|NCT00920140|662331|P4|NOT COMPLETED|Phase 1 (Dose Escalation)||0
273433|NCT00920140|662332|P3|NOT COMPLETED|Phase 1 (Dose Escalation)||0
273434|NCT00920140|662333|P2|NOT COMPLETED|Phase 1 (Dose Escalation)||9
273435|NCT00920140|662334|P1|NOT COMPLETED|Phase 1 (Dose Escalation)||5
273436|NCT00920140|662330|P5|COMPLETED|Phase 1 (Dose Escalation)||0
273437|NCT00920140|662331|P4|COMPLETED|Phase 1 (Dose Escalation)||0
273438|NCT00920140|662332|P3|COMPLETED|Phase 1 (Dose Escalation)||0
273439|NCT00920140|662333|P2|COMPLETED|Phase 1 (Dose Escalation)||0
273440|NCT00920140|662334|P1|COMPLETED|Phase 1 (Dose Escalation)||0
273441|NCT00920140|662330|P5|STARTED|Phase 1 (Dose Escalation)||0
273442|NCT00920140|662331|P4|STARTED|Phase 1 (Dose Escalation)||0
273443|NCT00920140|662332|P3|STARTED|Phase 1 (Dose Escalation)||0
273445|NCT00920140|662334|P1|STARTED|Phase 1 (Dose Escalation)||5
273446|NCT00920075|662372|P1|NOT COMPLETED|Post Study, 11 Pts Responded||0
273447|NCT00920075|662372|P1|COMPLETED|Post Study, 11 Pts Responded||11
273448|NCT00920075|662372|P1|STARTED|Post Study, 11 Pts Responded||11
273449|NCT00920075|662372|P1|NOT COMPLETED|Last Study, 25 Pts Invited,11 Responded||0
273450|NCT00920075|662372|P1|COMPLETED|Last Study, 25 Pts Invited,11 Responded||11
273451|NCT00920075|662372|P1|STARTED|Last Study, 25 Pts Invited,11 Responded||11
273452|NCT00920023|662378|P1|NOT COMPLETED|Overall Study||0
273453|NCT00920023|662378|P1|COMPLETED|Overall Study||15
273454|NCT00920023|662378|P1|STARTED|Overall Study||15
273455|NCT00919932|662385|P2|NOT COMPLETED|Overall Study||0
273456|NCT00919932|662386|P1|NOT COMPLETED|Overall Study||0
273457|NCT00919932|662385|P2|COMPLETED|Overall Study||5
273458|NCT00919932|662386|P1|COMPLETED|Overall Study||4
273459|NCT00919932|662385|P2|STARTED|Overall Study||5
273460|NCT00919932|662386|P1|STARTED|Overall Study||4
273461|NCT00919893|662396|P2|NOT COMPLETED|Overall Study||9
273462|NCT00919893|662397|P1|NOT COMPLETED|Overall Study||19
273463|NCT00919893|662396|P2|COMPLETED|Overall Study||60
273464|NCT00919893|662397|P1|COMPLETED|Overall Study||51
273465|NCT00919893|662396|P2|STARTED|Overall Study||69
273466|NCT00919893|662397|P1|STARTED|Overall Study||70
273467|NCT00919867|662409|P6|NOT COMPLETED|Third Intervention||0
273468|NCT00919867|662410|P5|NOT COMPLETED|Third Intervention||0
273469|NCT00919867|662411|P4|NOT COMPLETED|Third Intervention||0
273470|NCT00919867|662412|P3|NOT COMPLETED|Third Intervention||0
273471|NCT00919867|662413|P2|NOT COMPLETED|Third Intervention||0
273472|NCT00919867|662414|P1|NOT COMPLETED|Third Intervention||0
273473|NCT00919867|662409|P6|COMPLETED|Third Intervention||6
273474|NCT00919867|662410|P5|COMPLETED|Third Intervention||7
273475|NCT00919867|662411|P4|COMPLETED|Third Intervention||7
273476|NCT00919867|662412|P3|COMPLETED|Third Intervention||6
273477|NCT00919867|662413|P2|COMPLETED|Third Intervention||7
273478|NCT00919867|662414|P1|COMPLETED|Third Intervention||7
273479|NCT00919867|662409|P6|STARTED|Third Intervention||6
273480|NCT00919867|662410|P5|STARTED|Third Intervention||7
273481|NCT00919867|662411|P4|STARTED|Third Intervention||7
273482|NCT00919867|662412|P3|STARTED|Third Intervention||6
273483|NCT00919867|662413|P2|STARTED|Third Intervention||7
273484|NCT00919867|662414|P1|STARTED|Third Intervention||7
273485|NCT00919867|662409|P6|NOT COMPLETED|Washout||0
273486|NCT00919867|662410|P5|NOT COMPLETED|Washout||0
273487|NCT00919867|662411|P4|NOT COMPLETED|Washout||0
273488|NCT00919867|662412|P3|NOT COMPLETED|Washout||0
273489|NCT00919867|662413|P2|NOT COMPLETED|Washout||0
273490|NCT00919867|662414|P1|NOT COMPLETED|Washout||0
273491|NCT00919867|662409|P6|COMPLETED|Washout||6
273492|NCT00919867|662410|P5|COMPLETED|Washout||7
273493|NCT00919867|662411|P4|COMPLETED|Washout||7
273494|NCT00919867|662412|P3|COMPLETED|Washout||6
273495|NCT00919867|662413|P2|COMPLETED|Washout||7
273496|NCT00919867|662414|P1|COMPLETED|Washout||7
273497|NCT00919867|662409|P6|STARTED|Washout||6
273498|NCT00919867|662410|P5|STARTED|Washout||7
273499|NCT00919867|662411|P4|STARTED|Washout||7
273500|NCT00919867|662412|P3|STARTED|Washout||6
273501|NCT00919867|662413|P2|STARTED|Washout||7
273502|NCT00919867|662414|P1|STARTED|Washout||7
273503|NCT00919867|662409|P6|NOT COMPLETED|Second Intervention||0
273504|NCT00919867|662410|P5|NOT COMPLETED|Second Intervention||0
273505|NCT00919867|662411|P4|NOT COMPLETED|Second Intervention||0
273506|NCT00919867|662412|P3|NOT COMPLETED|Second Intervention||0
273507|NCT00919867|662413|P2|NOT COMPLETED|Second Intervention||0
273508|NCT00919867|662414|P1|NOT COMPLETED|Second Intervention||0
273509|NCT00919867|662409|P6|COMPLETED|Second Intervention||6
273510|NCT00919867|662410|P5|COMPLETED|Second Intervention||7
273511|NCT00919867|662411|P4|COMPLETED|Second Intervention||7
273512|NCT00919867|662412|P3|COMPLETED|Second Intervention||6
273513|NCT00919867|662413|P2|COMPLETED|Second Intervention||7
273514|NCT00919867|662414|P1|COMPLETED|Second Intervention||7
273515|NCT00919867|662409|P6|STARTED|Second Intervention||6
273516|NCT00919867|662410|P5|STARTED|Second Intervention||7
273517|NCT00919867|662411|P4|STARTED|Second Intervention||7
273518|NCT00919867|662412|P3|STARTED|Second Intervention||6
273519|NCT00919867|662413|P2|STARTED|Second Intervention||7
273520|NCT00919867|662414|P1|STARTED|Second Intervention||7
273521|NCT00919867|662409|P6|NOT COMPLETED|Washout||0
273522|NCT00919867|662410|P5|NOT COMPLETED|Washout||0
273523|NCT00919867|662411|P4|NOT COMPLETED|Washout||0
273524|NCT00919867|662412|P3|NOT COMPLETED|Washout||0
273525|NCT00919867|662413|P2|NOT COMPLETED|Washout||0
273526|NCT00919867|662414|P1|NOT COMPLETED|Washout||0
273527|NCT00919867|662409|P6|COMPLETED|Washout||6
273528|NCT00919867|662410|P5|COMPLETED|Washout||7
273529|NCT00919867|662411|P4|COMPLETED|Washout||7
273530|NCT00919867|662412|P3|COMPLETED|Washout||6
273531|NCT00919867|662413|P2|COMPLETED|Washout||7
273532|NCT00919867|662414|P1|COMPLETED|Washout||7
273533|NCT00919867|662409|P6|STARTED|Washout||6
273534|NCT00919867|662410|P5|STARTED|Washout||7
273535|NCT00919867|662411|P4|STARTED|Washout||7
273536|NCT00919867|662412|P3|STARTED|Washout||6
273537|NCT00919867|662413|P2|STARTED|Washout||7
273538|NCT00919867|662414|P1|STARTED|Washout||7
273539|NCT00919867|662409|P6|NOT COMPLETED|First Intervention||1
273540|NCT00919867|662410|P5|NOT COMPLETED|First Intervention||0
273541|NCT00919867|662411|P4|NOT COMPLETED|First Intervention||0
273542|NCT00919867|662412|P3|NOT COMPLETED|First Intervention||1
273543|NCT00919867|662413|P2|NOT COMPLETED|First Intervention||0
273544|NCT00919867|662414|P1|NOT COMPLETED|First Intervention||0
273545|NCT00919867|662409|P6|COMPLETED|First Intervention||6
273546|NCT00919867|662410|P5|COMPLETED|First Intervention||7
273547|NCT00919867|662411|P4|COMPLETED|First Intervention||7
273548|NCT00919867|662412|P3|COMPLETED|First Intervention||6
273549|NCT00919867|662413|P2|COMPLETED|First Intervention||7
273550|NCT00919867|662414|P1|COMPLETED|First Intervention||7
273551|NCT00919867|662409|P6|STARTED|First Intervention||7
273552|NCT00919867|662410|P5|STARTED|First Intervention||7
273553|NCT00919867|662411|P4|STARTED|First Intervention||7
273554|NCT00919867|662412|P3|STARTED|First Intervention||7
273555|NCT00919867|662413|P2|STARTED|First Intervention||7
273556|NCT00919867|662414|P1|STARTED|First Intervention||7
273557|NCT00919854|662435|P1|NOT COMPLETED|Overall Study||1
273558|NCT00919854|662435|P1|COMPLETED|Overall Study|'Completed' represents the patients that are ongoing at the time of cut-off for the Week 24 analysis|20
273559|NCT00919854|662435|P1|STARTED|Overall Study||21
273560|NCT00919802|662444|P2|NOT COMPLETED|Second Intervention - (24 Hours)||0
273561|NCT00919802|662445|P1|NOT COMPLETED|Second Intervention - (24 Hours)||0
273562|NCT00919802|662444|P2|COMPLETED|Second Intervention - (24 Hours)||13
273563|NCT00919802|662445|P1|COMPLETED|Second Intervention - (24 Hours)||12
273564|NCT00919802|662444|P2|STARTED|Second Intervention - (24 Hours)||13
273565|NCT00919802|662445|P1|STARTED|Second Intervention - (24 Hours)||12
273566|NCT00919802|662444|P2|NOT COMPLETED|First Intervention - (24 Hours)||0
273567|NCT00919802|662445|P1|NOT COMPLETED|First Intervention - (24 Hours)||0
273568|NCT00919802|662444|P2|COMPLETED|First Intervention - (24 Hours)||13
273569|NCT00919802|662445|P1|COMPLETED|First Intervention - (24 Hours)||12
273570|NCT00919802|662444|P2|STARTED|First Intervention - (24 Hours)||13
273571|NCT00919802|662445|P1|STARTED|First Intervention - (24 Hours)||12
273572|NCT00919763|662455|P2|NOT COMPLETED|Overall Study||4
273573|NCT00919763|662456|P1|NOT COMPLETED|Overall Study||12
273574|NCT00919763|662455|P2|COMPLETED|Overall Study||45
273575|NCT00919763|662456|P1|COMPLETED|Overall Study||41
273576|NCT00919763|662455|P2|STARTED|Overall Study||49
273577|NCT00919763|662456|P1|STARTED|Overall Study||53
273578|NCT00919724|662464|P2|NOT COMPLETED|Overall Study||0
273579|NCT00919724|662465|P1|NOT COMPLETED|Overall Study||0
273580|NCT00919724|662464|P2|COMPLETED|Overall Study||44
273581|NCT00919724|662465|P1|COMPLETED|Overall Study||45
273582|NCT00919724|662464|P2|STARTED|Overall Study||44
273583|NCT00919724|662465|P1|STARTED|Overall Study||45
273584|NCT00919711|662473|P2|NOT COMPLETED|Overall Study||13
273585|NCT00919711|662474|P1|NOT COMPLETED|Overall Study||33
273586|NCT00919711|662473|P2|COMPLETED|Overall Study||422
273587|NCT00919711|662474|P1|COMPLETED|Overall Study||402
273588|NCT00919711|662473|P2|STARTED|Overall Study||435
273589|NCT00919711|662474|P1|STARTED|Overall Study||435
273590|NCT00919633|662490|P4|NOT COMPLETED|Overall Study||21
273591|NCT00919633|662491|P3|NOT COMPLETED|Overall Study||23
273592|NCT00919633|662492|P2|NOT COMPLETED|Overall Study||15
273593|NCT00919633|662493|P1|NOT COMPLETED|Overall Study||22
273594|NCT00919633|662490|P4|COMPLETED|Overall Study||5
273595|NCT00919633|662491|P3|COMPLETED|Overall Study||4
273596|NCT00919633|662492|P2|COMPLETED|Overall Study||10
273597|NCT00919633|662493|P1|COMPLETED|Overall Study||6
273598|NCT00919633|662490|P4|STARTED|Overall Study||26
273599|NCT00919633|662491|P3|STARTED|Overall Study||27
273600|NCT00919633|662492|P2|STARTED|Overall Study||25
273601|NCT00919633|662493|P1|STARTED|Overall Study||28
273602|NCT00919191|662511|P1|NOT COMPLETED|Overall Study||0
273603|NCT00919191|662511|P1|COMPLETED|Overall Study||26
273604|NCT00919191|662511|P1|STARTED|Overall Study||26
273605|NCT00919126|662521|P3|NOT COMPLETED|Overall Study||1
273606|NCT00919126|662522|P2|NOT COMPLETED|Overall Study||5
273607|NCT00919126|662523|P1|NOT COMPLETED|Overall Study||1
273608|NCT00919126|662521|P3|COMPLETED|Overall Study||32
273609|NCT00919126|662522|P2|COMPLETED|Overall Study||32
273610|NCT00919126|662523|P1|COMPLETED|Overall Study||31
273611|NCT00919126|662521|P3|STARTED|Overall Study||33
273612|NCT00919126|662522|P2|STARTED|Overall Study||37
273613|NCT00919126|662523|P1|STARTED|Overall Study||32
273614|NCT00919113|662569|P2|NOT COMPLETED|Overall Study||8
273615|NCT00919113|662570|P1|NOT COMPLETED|Overall Study||9
273616|NCT00919113|662569|P2|COMPLETED|Overall Study||40
273617|NCT00919113|662570|P1|COMPLETED|Overall Study||41
273618|NCT00919113|662569|P2|Received Placebo|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
273619|NCT00919113|662570|P1|Received Placebo|Overall Study||0
273620|NCT00919113|662569|P2|Received Uracyst|Overall Study||0
273621|NCT00919113|662570|P1|Received Uracyst|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
273622|NCT00919113|662569|P2|STARTED|Overall Study||48
273623|NCT00919113|662570|P1|STARTED|Overall Study||50
273624|NCT00919100|662580|P2|NOT COMPLETED|Overall Study||0
273625|NCT00919100|662581|P1|NOT COMPLETED|Overall Study||0
273626|NCT00919100|662580|P2|COMPLETED|Overall Study||41
273627|NCT00919100|662581|P1|COMPLETED|Overall Study||40
273628|NCT00919100|662580|P2|STARTED|Overall Study||41
273629|NCT00919100|662581|P1|STARTED|Overall Study||40
273630|NCT00919061|662591|P1|NOT COMPLETED|Overall Study||2
273631|NCT00919061|662591|P1|COMPLETED|Overall Study||37
273632|NCT00919061|662591|P1|STARTED|Overall Study||39
273633|NCT00919035|662596|P1|NOT COMPLETED|Overall Study||0
273634|NCT00919035|662596|P1|COMPLETED|Overall Study||21
273635|NCT00919035|662596|P1|STARTED|Overall Study||21
273636|NCT00918957|662604|P2|NOT COMPLETED|Overall Study||0
273637|NCT00918957|662605|P1|NOT COMPLETED|Overall Study||3
273638|NCT00918957|662604|P2|COMPLETED|Overall Study||30
273639|NCT00918957|662605|P1|COMPLETED|Overall Study||29
273640|NCT00918957|662604|P2|STARTED|Overall Study||30
273641|NCT00918957|662605|P1|STARTED|Overall Study||32
273642|NCT00918931|662632|P1|NOT COMPLETED|Overall Study||0
273643|NCT00918931|662632|P1|COMPLETED|Overall Study||3
273644|NCT00918931|662632|P1|STARTED|Overall Study||3
273645|NCT00918879|662638|P2|NOT COMPLETED|Overall Study||6
273646|NCT00918879|662639|P1|NOT COMPLETED|Overall Study||6
273647|NCT00918879|662638|P2|COMPLETED|Overall Study|Completed 24 weeks of treatment|100
273648|NCT00918879|662639|P1|COMPLETED|Overall Study|Completed 24 weeks of treatment|101
273649|NCT00918879|662638|P2|STARTED|Overall Study|Randomized and treated|106
273650|NCT00918879|662639|P1|STARTED|Overall Study|Randomized and treated|107
273651|NCT00918866|662653|P2|NOT COMPLETED|Overall Study||0
273652|NCT00918866|662654|P1|NOT COMPLETED|Overall Study||0
273653|NCT00918866|662653|P2|COMPLETED|Overall Study||16
273654|NCT00918866|662654|P1|COMPLETED|Overall Study||16
273655|NCT00918866|662653|P2|STARTED|Overall Study||16
273656|NCT00918866|662654|P1|STARTED|Overall Study||16
273657|NCT00918749|662671|P3|NOT COMPLETED|Overall Study||7
273658|NCT00918749|662672|P2|NOT COMPLETED|Overall Study||3
273659|NCT00918749|662673|P1|NOT COMPLETED|Overall Study||7
273660|NCT00918749|662671|P3|COMPLETED|Overall Study||62
273661|NCT00918749|662672|P2|COMPLETED|Overall Study||63
273662|NCT00918749|662673|P1|COMPLETED|Overall Study||63
273663|NCT00918749|662671|P3|ITT (Intent to Treat) Population|Overall Study||69
273664|NCT00918749|662672|P2|ITT (Intent to Treat) Population|Overall Study||66
273665|NCT00918749|662673|P1|ITT (Intent to Treat) Population|Overall Study|One subject took no study drug and was not included in ITT Population|69
273666|NCT00918749|662671|P3|STARTED|Overall Study||69
273667|NCT00918749|662672|P2|STARTED|Overall Study||66
273668|NCT00918749|662673|P1|STARTED|Overall Study||70
273669|NCT00918736|662705|P1|NOT COMPLETED|Overall Study||4
273670|NCT00918736|662705|P1|COMPLETED|Overall Study|October, 2008|46
273671|NCT00918736|662705|P1|STARTED|Overall Study|October, 2007|50
273672|NCT00918723|662709|P1|NOT COMPLETED|Overall Study||0
273673|NCT00918723|662709|P1|COMPLETED|Overall Study||40
273674|NCT00918723|662709|P1|STARTED|Overall Study||40
273675|NCT00918684|662718|P1|NOT COMPLETED|Treatment Phase||25
273676|NCT00918684|662718|P1|COMPLETED|Treatment Phase||65
273677|NCT00918684|662718|P1|STARTED|Treatment Phase||90
273678|NCT00918684|662718|P1|NOT COMPLETED|Two Week Drug Washout and Placebo Phase||16
273679|NCT00918684|662718|P1|COMPLETED|Two Week Drug Washout and Placebo Phase||90
273680|NCT00918684|662718|P1|STARTED|Two Week Drug Washout and Placebo Phase||106
273681|NCT00918671|662724|P1|NOT COMPLETED|Overall Study||0
273682|NCT00918671|662724|P1|COMPLETED|Overall Study||60
273683|NCT00918671|662724|P1|STARTED|Overall Study||60
273684|NCT00918645|662729|P1|NOT COMPLETED|Overall Study||1
273685|NCT00918645|662729|P1|COMPLETED|Overall Study||12
273686|NCT00918645|662729|P1|STARTED|Overall Study||13
273687|NCT00918580|662735|P1|NOT COMPLETED|After 6-month FU to 1-year FU||60
273688|NCT00918580|662735|P1|COMPLETED|After 6-month FU to 1-year FU||87
273689|NCT00918580|662735|P1|Continued After 6-Month FU|After 6-month FU to 1-year FU||89
273690|NCT00918580|662735|P1|STARTED|After 6-month FU to 1-year FU||147
273691|NCT00918580|662735|P1|NOT COMPLETED|Up to 6-month Follow-up(FU)||11
273692|NCT00918580|662735|P1|COMPLETED|Up to 6-month Follow-up(FU)|Completed include 1 participant:withdrew before Dose 2 (protocol violation) but completed 6-month FU|147
273693|NCT00918580|662735|P1|Vaccinated Dose 2|Up to 6-month Follow-up(FU)||146
273694|NCT00918580|662735|P1|Vaccinated Dose 1|Up to 6-month Follow-up(FU)||158
273695|NCT00918580|662735|P1|STARTED|Up to 6-month Follow-up(FU)||158
273696|NCT00918463|662753|P1|NOT COMPLETED|Overall Study||2
273697|NCT00918463|662753|P1|COMPLETED|Overall Study||0
273698|NCT00918463|662753|P1|STARTED|Overall Study||2
273699|NCT00918385|662761|P2|NOT COMPLETED|Combination Nilutamide and Dasatinib||8
273700|NCT00918385|662762|P1|NOT COMPLETED|Combination Nilutamide and Dasatinib||6
273701|NCT00918385|662761|P2|COMPLETED|Combination Nilutamide and Dasatinib||3
273702|NCT00918385|662762|P1|COMPLETED|Combination Nilutamide and Dasatinib||6
273703|NCT00918385|662761|P2|STARTED|Combination Nilutamide and Dasatinib||11
273704|NCT00918385|662762|P1|STARTED|Combination Nilutamide and Dasatinib||12
273705|NCT00918385|662761|P2|NOT COMPLETED|Monotherapy||6
273706|NCT00918385|662762|P1|NOT COMPLETED|Monotherapy||2
273707|NCT00918385|662761|P2|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|11
273708|NCT00918385|662762|P1|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|12
273709|NCT00918385|662761|P2|STARTED|Monotherapy||17
273710|NCT00918385|662762|P1|STARTED|Monotherapy||14
273711|NCT00918346|662771|P2|NOT COMPLETED|Post Study Period||0
273712|NCT00918346|662772|P1|NOT COMPLETED|Post Study Period||0
273713|NCT00918346|662771|P2|COMPLETED|Post Study Period||21
273714|NCT00918346|662772|P1|COMPLETED|Post Study Period||21
273715|NCT00918346|662771|P2|STARTED|Post Study Period||21
273716|NCT00918346|662772|P1|STARTED|Post Study Period||21
273717|NCT00918346|662771|P2|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
273718|NCT00918346|662772|P1|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
273719|NCT00918346|662771|P2|COMPLETED|Second Treatment Period (4 Weeks)||21
273720|NCT00918346|662772|P1|COMPLETED|Second Treatment Period (4 Weeks)||21
273721|NCT00918346|662771|P2|STARTED|Second Treatment Period (4 Weeks)||21
273722|NCT00918346|662772|P1|STARTED|Second Treatment Period (4 Weeks)||21
273723|NCT00918346|662771|P2|NOT COMPLETED|Washout (at Least 4 Weeks)||0
273724|NCT00918346|662772|P1|NOT COMPLETED|Washout (at Least 4 Weeks)||0
273725|NCT00918346|662771|P2|COMPLETED|Washout (at Least 4 Weeks)||21
273726|NCT00918346|662772|P1|COMPLETED|Washout (at Least 4 Weeks)||21
273727|NCT00918346|662771|P2|STARTED|Washout (at Least 4 Weeks)||21
273728|NCT00918346|662772|P1|STARTED|Washout (at Least 4 Weeks)||21
273729|NCT00918346|662771|P2|NOT COMPLETED|First Treatment Period (4 Weeks)||1
273730|NCT00918346|662772|P1|NOT COMPLETED|First Treatment Period (4 Weeks)||0
273731|NCT00918346|662771|P2|COMPLETED|First Treatment Period (4 Weeks)|A patient completed the first treatment period but discontinued thereafter (did not start washout).|21
273732|NCT00918346|662772|P1|COMPLETED|First Treatment Period (4 Weeks)||21
273733|NCT00918346|662771|P2|STARTED|First Treatment Period (4 Weeks)||22
273734|NCT00918346|662772|P1|STARTED|First Treatment Period (4 Weeks)||21
273735|NCT00918333|662788|P2|NOT COMPLETED|Overall Study||5
273736|NCT00918333|662789|P1|NOT COMPLETED|Overall Study||3
273737|NCT00918333|662788|P2|COMPLETED|Overall Study||93
273738|NCT00918333|662789|P1|COMPLETED|Overall Study||23
273739|NCT00918333|662788|P2|STARTED|Overall Study||98
273740|NCT00918333|662789|P1|STARTED|Overall Study||26
273741|NCT00918281|662809|P1|NOT COMPLETED|Overall Study||29
273742|NCT00918281|662809|P1|COMPLETED|Overall Study||41
273743|NCT00918281|662809|P1|STARTED|Overall Study||70
273744|NCT00918255|662819|P3|NOT COMPLETED|Overall Study||5
273745|NCT00918255|662820|P2|NOT COMPLETED|Overall Study||0
273746|NCT00918255|662821|P1|NOT COMPLETED|Overall Study||6
273747|NCT00918255|662819|P3|COMPLETED|Overall Study||46
273748|NCT00918255|662820|P2|COMPLETED|Overall Study||52
273749|NCT00918255|662821|P1|COMPLETED|Overall Study||45
273750|NCT00918255|662819|P3|STARTED|Overall Study||51
273751|NCT00918255|662820|P2|STARTED|Overall Study||52
273752|NCT00918255|662821|P1|STARTED|Overall Study||51
273753|NCT00918229|662847|P1|NOT COMPLETED|Overall Study||0
273754|NCT00918229|662847|P1|COMPLETED|Overall Study||24
273755|NCT00918229|662847|P1|STARTED|Overall Study||24
273756|NCT00918203|662854|P3|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
273757|NCT00918203|662855|P2|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
273758|NCT00918203|662856|P1|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
273759|NCT00918203|662854|P3|COMPLETED|Crossover to Olaratumab Monotherapy||18
273760|NCT00918203|662855|P2|COMPLETED|Crossover to Olaratumab Monotherapy||0
273761|NCT00918203|662856|P1|COMPLETED|Crossover to Olaratumab Monotherapy||0
273762|NCT00918203|662854|P3|STARTED|Crossover to Olaratumab Monotherapy|18 participants who had progressive disease crossed over to monotherapy.|18
273763|NCT00918203|662855|P2|STARTED|Crossover to Olaratumab Monotherapy||0
273764|NCT00918203|662856|P1|STARTED|Crossover to Olaratumab Monotherapy||0
273765|NCT00918203|662854|P3|NOT COMPLETED|Treatment With or Without Olaratumab||0
273766|NCT00918203|662855|P2|NOT COMPLETED|Treatment With or Without Olaratumab||10
273767|NCT00918203|662856|P1|NOT COMPLETED|Treatment With or Without Olaratumab||6
273768|NCT00918203|662854|P3|COMPLETED|Treatment With or Without Olaratumab||0
273769|NCT00918203|662855|P2|COMPLETED|Treatment With or Without Olaratumab||57
273770|NCT00918203|662856|P1|COMPLETED|Treatment With or Without Olaratumab||64
273771|NCT00918203|662854|P3|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||0
273772|NCT00918203|662855|P2|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||10
273773|NCT00918203|662856|P1|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||11
273774|NCT00918203|662854|P3|Death Due to Any Cause|Treatment With or Without Olaratumab||0
273775|NCT00918203|662855|P2|Death Due to Any Cause|Treatment With or Without Olaratumab||47
273776|NCT00918203|662856|P1|Death Due to Any Cause|Treatment With or Without Olaratumab||53
273777|NCT00918203|662854|P3|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||0
273778|NCT00918203|662855|P2|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||64
273779|NCT00918203|662856|P1|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||67
273780|NCT00918203|662854|P3|STARTED|Treatment With or Without Olaratumab||0
273781|NCT00918203|662855|P2|STARTED|Treatment With or Without Olaratumab||67
273782|NCT00918203|662856|P1|STARTED|Treatment With or Without Olaratumab||70
273783|NCT00918138|662887|P2|NOT COMPLETED|Overall Study||1
273784|NCT00918138|662888|P1|NOT COMPLETED|Overall Study||2
273785|NCT00918138|662887|P2|COMPLETED|Overall Study||46
273786|NCT00918138|662888|P1|COMPLETED|Overall Study||44
273787|NCT00918138|662887|P2|STARTED|Overall Study||47
273788|NCT00918138|662888|P1|STARTED|Overall Study||46
273789|NCT00918125|662904|P2|NOT COMPLETED|Overall Study||0
273790|NCT00918125|662905|P1|NOT COMPLETED|Overall Study||0
273791|NCT00918125|662904|P2|COMPLETED|Overall Study||39
273792|NCT00918125|662905|P1|COMPLETED|Overall Study||20
273793|NCT00918125|662904|P2|STARTED|Overall Study||39
273794|NCT00918125|662905|P1|STARTED|Overall Study||20
273795|NCT00917865|662916|P1|NOT COMPLETED|Overall Study||0
273796|NCT00917865|662916|P1|COMPLETED|Overall Study||11
273797|NCT00917865|662916|P1|STARTED|Overall Study||11
273798|NCT00917852|662927|P1|NOT COMPLETED|Overall Study||6
273799|NCT00917852|662927|P1|COMPLETED|Overall Study||45
273800|NCT00917852|662927|P1|STARTED|Overall Study||51
273801|NCT00917735|662934|P2|NOT COMPLETED|Overall Study||63
273802|NCT00917735|662935|P1|NOT COMPLETED|Overall Study||75
273803|NCT00917735|662934|P2|COMPLETED|Overall Study||474
273804|NCT00917735|662935|P1|COMPLETED|Overall Study||463
273805|NCT00917735|662934|P2|STARTED|Overall Study||537
273806|NCT00917735|662935|P1|STARTED|Overall Study||538
273807|NCT00917644|662945|P2|NOT COMPLETED|Period 2: Second Intervention||0
273808|NCT00917644|662946|P1|NOT COMPLETED|Period 2: Second Intervention||1
273809|NCT00917644|662945|P2|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Ref drug = 73.|37
273810|NCT00917644|662946|P1|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Test drug = 74.|36
273811|NCT00917644|662945|P2|STARTED|Period 2: Second Intervention|Washout: Reference drug (Ref) 1st, completed = 37; 2nd period: Ref drug 2nd, completed = 36.|37
273812|NCT00917644|662946|P1|STARTED|Period 2: Second Intervention|Washout: Test drug 1st, completed = 37; 2nd period: Test drug 2nd, completed = 37.|37
273813|NCT00917644|662945|P2|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||0
273814|NCT00917644|662946|P1|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||2
273815|NCT00917644|662945|P2|COMPLETED|Period: Washout Period of > = 2 Weeks||37
273816|NCT00917644|662946|P1|COMPLETED|Period: Washout Period of > = 2 Weeks||37
273817|NCT00917644|662945|P2|STARTED|Period: Washout Period of > = 2 Weeks||37
273818|NCT00917644|662946|P1|STARTED|Period: Washout Period of > = 2 Weeks||39
273819|NCT00917644|662945|P2|NOT COMPLETED|Period 1: First Intervention||0
273820|NCT00917644|662946|P1|NOT COMPLETED|Period 1: First Intervention||0
273821|NCT00917644|662945|P2|COMPLETED|Period 1: First Intervention||37
273822|NCT00917644|662946|P1|COMPLETED|Period 1: First Intervention||39
273823|NCT00917644|662945|P2|STARTED|Period 1: First Intervention||37
273824|NCT00917644|662946|P1|STARTED|Period 1: First Intervention||39
273825|NCT00917579|662960|P2|NOT COMPLETED|Period 2: 2nd Intervention||0
273826|NCT00917579|662961|P1|NOT COMPLETED|Period 2: 2nd Intervention||0
273827|NCT00917579|662960|P2|COMPLETED|Period 2: 2nd Intervention||37
273828|NCT00917579|662961|P1|COMPLETED|Period 2: 2nd Intervention||37
273829|NCT00917579|662960|P2|STARTED|Period 2: 2nd Intervention||37
273830|NCT00917579|662961|P1|STARTED|Period 2: 2nd Intervention||37
273831|NCT00917579|662960|P2|NOT COMPLETED|Washout >= 2 Weeks||0
273832|NCT00917579|662961|P1|NOT COMPLETED|Washout >= 2 Weeks||2
273833|NCT00917579|662960|P2|COMPLETED|Washout >= 2 Weeks||37
273834|NCT00917579|662961|P1|COMPLETED|Washout >= 2 Weeks||37
273835|NCT00917579|662960|P2|STARTED|Washout >= 2 Weeks||37
273836|NCT00917579|662961|P1|STARTED|Washout >= 2 Weeks||39
273837|NCT00917579|662960|P2|NOT COMPLETED|Period 1: 1st Intervention||0
273838|NCT00917579|662961|P1|NOT COMPLETED|Period 1: 1st Intervention||0
273839|NCT00917579|662960|P2|COMPLETED|Period 1: 1st Intervention||37
273840|NCT00917579|662961|P1|COMPLETED|Period 1: 1st Intervention||39
273841|NCT00917579|662960|P2|STARTED|Period 1: 1st Intervention||37
273842|NCT00917579|662961|P1|STARTED|Period 1: 1st Intervention||39
273843|NCT00917553|662977|P2|NOT COMPLETED|Overall Study||1
273844|NCT00917553|662978|P1|NOT COMPLETED|Overall Study||2
273845|NCT00917553|662977|P2|COMPLETED|Overall Study||15
273846|NCT00917553|662978|P1|COMPLETED|Overall Study||15
273847|NCT00917553|662977|P2|STARTED|Overall Study||16
273848|NCT00917553|662978|P1|STARTED|Overall Study||17
273849|NCT00917501|662994|P2|NOT COMPLETED|Overall Study||5
273850|NCT00917501|662995|P1|NOT COMPLETED|Overall Study||8
273851|NCT00917501|662994|P2|COMPLETED|Overall Study||21
273852|NCT00917501|662995|P1|COMPLETED|Overall Study||21
273853|NCT00917501|662994|P2|STARTED|Overall Study||26
273854|NCT00917501|662995|P1|STARTED|Overall Study||29
273855|NCT00917462|663001|P1|NOT COMPLETED|Overall Study||1
273856|NCT00917462|663001|P1|COMPLETED|Overall Study||34
273857|NCT00917462|663001|P1|STARTED|Overall Study||35
273858|NCT00917384|663011|P2|NOT COMPLETED|Overall Study||4
273859|NCT00917384|663012|P1|NOT COMPLETED|Overall Study||14
273860|NCT00917384|663011|P2|COMPLETED|Overall Study||113
273861|NCT00917384|663012|P1|COMPLETED|Overall Study||224
273862|NCT00917384|663011|P2|Received at Least 1 Dose of Study Drug|Overall Study||115
273863|NCT00917384|663012|P1|Received at Least 1 Dose of Study Drug|Overall Study||236
273864|NCT00917384|663011|P2|STARTED|Overall Study||117
273865|NCT00917384|663012|P1|STARTED|Overall Study||238
273866|NCT00917267|663036|P2|NOT COMPLETED|Overall Study||79
273867|NCT00917267|663037|P1|NOT COMPLETED|Overall Study||39
273868|NCT00917267|663036|P2|COMPLETED|Overall Study||266
273869|NCT00917267|663037|P1|COMPLETED|Overall Study||307
273870|NCT00917267|663036|P2|Intent to Treat (ITT)|Overall Study||338
273871|NCT00917267|663037|P1|Intent to Treat (ITT)|Overall Study||340
273872|NCT00917267|663036|P2|STARTED|Overall Study||345
273873|NCT00917267|663037|P1|STARTED|Overall Study||346
273874|NCT00917124|663065|P2|NOT COMPLETED|Overall Study||6
273875|NCT00917124|663066|P1|NOT COMPLETED|Overall Study||4
273876|NCT00917124|663065|P2|COMPLETED|Overall Study||94
273877|NCT00917124|663066|P1|COMPLETED|Overall Study||96
273878|NCT00917124|663065|P2|STARTED|Overall Study||100
273879|NCT00917124|663066|P1|STARTED|Overall Study||100
273880|NCT00916929|663076|P2|NOT COMPLETED|Overall Study||29
273881|NCT00916929|663077|P1|NOT COMPLETED|Overall Study||10
273882|NCT00916929|663076|P2|COMPLETED|Overall Study||53
273883|NCT00916929|663077|P1|COMPLETED|Overall Study||70
273884|NCT00916929|663076|P2|STARTED|Overall Study||82
273885|NCT00916929|663077|P1|STARTED|Overall Study||80
273886|NCT00916721|663087|P2|NOT COMPLETED|Overall Study||10
273887|NCT00916721|663088|P1|NOT COMPLETED|Overall Study||10
273888|NCT00916721|663087|P2|COMPLETED|Overall Study||29
273889|NCT00916721|663088|P1|COMPLETED|Overall Study||25
273890|NCT00916721|663087|P2|STARTED|Overall Study||39
273891|NCT00916721|663088|P1|STARTED|Overall Study||35
273892|NCT00916643|663100|P1|NOT COMPLETED|Overall Study||0
273893|NCT00916643|663100|P1|COMPLETED|Overall Study||113
273894|NCT00916643|663100|P1|STARTED|Overall Study||113
273895|NCT00916617|663111|P4|NOT COMPLETED|Overall Study||7
273896|NCT00916617|663112|P3|NOT COMPLETED|Overall Study||10
273897|NCT00916617|663113|P2|NOT COMPLETED|Overall Study||21
273898|NCT00916617|663114|P1|NOT COMPLETED|Overall Study||23
273899|NCT00916617|663111|P4|COMPLETED|Overall Study||0
273900|NCT00916617|663112|P3|COMPLETED|Overall Study||0
273901|NCT00916617|663113|P2|COMPLETED|Overall Study||0
273902|NCT00916617|663114|P1|COMPLETED|Overall Study||1
273903|NCT00916617|663111|P4|STARTED|Overall Study||7
273904|NCT00916617|663112|P3|STARTED|Overall Study||10
273905|NCT00916617|663113|P2|STARTED|Overall Study||21
273906|NCT00916617|663114|P1|STARTED|Overall Study||24
273907|NCT00916578|663128|P1|NOT COMPLETED|Overall Study||7
273908|NCT00916578|663128|P1|COMPLETED|Overall Study||26
273909|NCT00916578|663128|P1|STARTED|Overall Study||33
273910|NCT00916539|663134|P2|NOT COMPLETED|Overall Study||0
273911|NCT00916539|663135|P1|NOT COMPLETED|Overall Study||0
273912|NCT00916539|663134|P2|COMPLETED|Overall Study||31
273913|NCT00916539|663135|P1|COMPLETED|Overall Study||31
273914|NCT00916539|663134|P2|STARTED|Overall Study||31
273915|NCT00916539|663135|P1|STARTED|Overall Study||31
273916|NCT00916383|663157|P1|NOT COMPLETED|Overall Study||3
273917|NCT00916383|663157|P1|COMPLETED|Overall Study||46
273918|NCT00916383|663157|P1|STARTED|Overall Study||49
273919|NCT00916370|663185|P2|NOT COMPLETED|Overall Study||2
273920|NCT00916370|663186|P1|NOT COMPLETED|Overall Study||5
273921|NCT00916370|663185|P2|COMPLETED|Overall Study||102
273922|NCT00916370|663186|P1|COMPLETED|Overall Study||396
273923|NCT00916370|663185|P2|STARTED|Overall Study||104
273924|NCT00916370|663186|P1|STARTED|Overall Study||401
273925|NCT00916357|663360|P6|NOT COMPLETED|Period 3||0
273926|NCT00916357|663361|P5|NOT COMPLETED|Period 3||0
273927|NCT00916357|663362|P4|NOT COMPLETED|Period 3||0
273928|NCT00916357|663363|P3|NOT COMPLETED|Period 3||0
273929|NCT00916357|663364|P2|NOT COMPLETED|Period 3||0
273930|NCT00916357|663365|P1|NOT COMPLETED|Period 3||0
273931|NCT00916357|663360|P6|COMPLETED|Period 3||4
273932|NCT00916357|663361|P5|COMPLETED|Period 3||3
273933|NCT00916357|663362|P4|COMPLETED|Period 3||3
273934|NCT00916357|663363|P3|COMPLETED|Period 3||4
273935|NCT00916357|663364|P2|COMPLETED|Period 3||4
273936|NCT00916357|663365|P1|COMPLETED|Period 3||3
273937|NCT00916357|663360|P6|STARTED|Period 3||4
273938|NCT00916357|663361|P5|STARTED|Period 3||3
273939|NCT00916357|663362|P4|STARTED|Period 3||3
273940|NCT00916357|663363|P3|STARTED|Period 3||4
273941|NCT00916357|663364|P2|STARTED|Period 3||4
273942|NCT00916357|663365|P1|STARTED|Period 3||3
273943|NCT00916357|663360|P6|NOT COMPLETED|Washout (3 to 14 Days)||0
273944|NCT00916357|663361|P5|NOT COMPLETED|Washout (3 to 14 Days)||0
273945|NCT00916357|663362|P4|NOT COMPLETED|Washout (3 to 14 Days)||0
273946|NCT00916357|663363|P3|NOT COMPLETED|Washout (3 to 14 Days)||0
273947|NCT00916357|663364|P2|NOT COMPLETED|Washout (3 to 14 Days)||0
273948|NCT00916357|663365|P1|NOT COMPLETED|Washout (3 to 14 Days)||0
273949|NCT00916357|663360|P6|COMPLETED|Washout (3 to 14 Days)||4
273950|NCT00916357|663361|P5|COMPLETED|Washout (3 to 14 Days)||3
273951|NCT00916357|663362|P4|COMPLETED|Washout (3 to 14 Days)||3
273952|NCT00916357|663363|P3|COMPLETED|Washout (3 to 14 Days)||4
273953|NCT00916357|663364|P2|COMPLETED|Washout (3 to 14 Days)||4
273954|NCT00916357|663365|P1|COMPLETED|Washout (3 to 14 Days)||3
273955|NCT00916357|663360|P6|STARTED|Washout (3 to 14 Days)||4
273956|NCT00916357|663361|P5|STARTED|Washout (3 to 14 Days)||3
273957|NCT00916357|663362|P4|STARTED|Washout (3 to 14 Days)||3
273958|NCT00916357|663363|P3|STARTED|Washout (3 to 14 Days)||4
273959|NCT00916357|663364|P2|STARTED|Washout (3 to 14 Days)||4
273960|NCT00916357|663365|P1|STARTED|Washout (3 to 14 Days)||3
273961|NCT00916357|663360|P6|NOT COMPLETED|Period 2||0
273962|NCT00916357|663361|P5|NOT COMPLETED|Period 2||0
273963|NCT00916357|663362|P4|NOT COMPLETED|Period 2||1
273964|NCT00916357|663363|P3|NOT COMPLETED|Period 2||0
273965|NCT00916357|663364|P2|NOT COMPLETED|Period 2||0
273966|NCT00916357|663365|P1|NOT COMPLETED|Period 2||0
273967|NCT00916357|663360|P6|COMPLETED|Period 2||4
273968|NCT00916357|663361|P5|COMPLETED|Period 2||3
273969|NCT00916357|663362|P4|COMPLETED|Period 2||3
273970|NCT00916357|663363|P3|COMPLETED|Period 2||4
273971|NCT00916357|663364|P2|COMPLETED|Period 2||4
273972|NCT00916357|663365|P1|COMPLETED|Period 2||3
273973|NCT00916357|663360|P6|STARTED|Period 2||4
273974|NCT00916357|663361|P5|STARTED|Period 2||3
273975|NCT00916357|663362|P4|STARTED|Period 2||4
273976|NCT00916357|663363|P3|STARTED|Period 2||4
273977|NCT00916357|663364|P2|STARTED|Period 2||4
273978|NCT00916357|663365|P1|STARTED|Period 2||3
273979|NCT00916357|663360|P6|NOT COMPLETED|Washout (3 to 14 Days)||0
273980|NCT00916357|663361|P5|NOT COMPLETED|Washout (3 to 14 Days)||0
273981|NCT00916357|663362|P4|NOT COMPLETED|Washout (3 to 14 Days)||0
273982|NCT00916357|663363|P3|NOT COMPLETED|Washout (3 to 14 Days)||0
273983|NCT00916357|663364|P2|NOT COMPLETED|Washout (3 to 14 Days)||0
273984|NCT00916357|663365|P1|NOT COMPLETED|Washout (3 to 14 Days)||0
273985|NCT00916357|663360|P6|COMPLETED|Washout (3 to 14 Days)||4
273986|NCT00916357|663361|P5|COMPLETED|Washout (3 to 14 Days)||3
273987|NCT00916357|663362|P4|COMPLETED|Washout (3 to 14 Days)||4
273988|NCT00916357|663363|P3|COMPLETED|Washout (3 to 14 Days)||4
273989|NCT00916357|663364|P2|COMPLETED|Washout (3 to 14 Days)||4
273990|NCT00916357|663365|P1|COMPLETED|Washout (3 to 14 Days)||3
273991|NCT00916357|663360|P6|STARTED|Washout (3 to 14 Days)||4
273992|NCT00916357|663361|P5|STARTED|Washout (3 to 14 Days)||3
273993|NCT00916357|663362|P4|STARTED|Washout (3 to 14 Days)||4
273994|NCT00916357|663363|P3|STARTED|Washout (3 to 14 Days)||4
273995|NCT00916357|663364|P2|STARTED|Washout (3 to 14 Days)||4
273996|NCT00916357|663365|P1|STARTED|Washout (3 to 14 Days)||3
273997|NCT00916357|663360|P6|NOT COMPLETED|Period 1||0
273998|NCT00916357|663361|P5|NOT COMPLETED|Period 1||0
273999|NCT00916357|663362|P4|NOT COMPLETED|Period 1||0
274000|NCT00916357|663363|P3|NOT COMPLETED|Period 1||0
274001|NCT00916357|663364|P2|NOT COMPLETED|Period 1||0
274002|NCT00916357|663365|P1|NOT COMPLETED|Period 1||1
274003|NCT00916357|663360|P6|COMPLETED|Period 1||4
274004|NCT00916357|663361|P5|COMPLETED|Period 1||3
274005|NCT00916357|663362|P4|COMPLETED|Period 1||4
274006|NCT00916357|663363|P3|COMPLETED|Period 1||4
274007|NCT00916357|663364|P2|COMPLETED|Period 1||4
274008|NCT00916357|663365|P1|COMPLETED|Period 1||3
274009|NCT00916357|663360|P6|Received at Least 1 Dose of Study Drug|Period 1||4
274010|NCT00916357|663361|P5|Received at Least 1 Dose of Study Drug|Period 1||3
274011|NCT00916357|663362|P4|Received at Least 1 Dose of Study Drug|Period 1||4
274012|NCT00916357|663363|P3|Received at Least 1 Dose of Study Drug|Period 1||4
274013|NCT00916357|663364|P2|Received at Least 1 Dose of Study Drug|Period 1||4
274014|NCT00916357|663365|P1|Received at Least 1 Dose of Study Drug|Period 1||4
274015|NCT00916357|663360|P6|STARTED|Period 1||4
274016|NCT00916357|663361|P5|STARTED|Period 1||3
274017|NCT00916357|663362|P4|STARTED|Period 1||4
274018|NCT00916357|663363|P3|STARTED|Period 1||4
274019|NCT00916357|663364|P2|STARTED|Period 1||4
274020|NCT00916357|663365|P1|STARTED|Period 1||4
274021|NCT00916344|663403|P1|NOT COMPLETED|Overall Study||8
274022|NCT00916344|663403|P1|COMPLETED|Overall Study||167
274023|NCT00916344|663403|P1|STARTED|Overall Study||175
274024|NCT00916305|663410|P2|NOT COMPLETED|Overall Study||28
274025|NCT00916305|663411|P1|NOT COMPLETED|Overall Study||21
274026|NCT00916305|663410|P2|COMPLETED|Overall Study||9
274027|NCT00916305|663411|P1|COMPLETED|Overall Study||7
274028|NCT00916305|663410|P2|STARTED|Overall Study||37
274029|NCT00916305|663411|P1|STARTED|Overall Study||28
274030|NCT00916279|663419|P1|NOT COMPLETED|Overall Study||4
274031|NCT00916279|663419|P1|COMPLETED|Overall Study||37
274032|NCT00916279|663419|P1|24 Months|Overall Study||37
274033|NCT00916279|663419|P1|6 Months|Overall Study||41
274034|NCT00916279|663419|P1|30 Days|Overall Study||41
274035|NCT00916279|663419|P1|STARTED|Overall Study||41
274036|NCT00916149|663430|P3|NOT COMPLETED|Overall Study||0
274037|NCT00916149|663431|P2|NOT COMPLETED|Overall Study||2
274038|NCT00916149|663432|P1|NOT COMPLETED|Overall Study||4
274039|NCT00916149|663430|P3|COMPLETED|Overall Study||5
274040|NCT00916149|663431|P2|COMPLETED|Overall Study||8
274041|NCT00916149|663432|P1|COMPLETED|Overall Study||12
274042|NCT00916149|663430|P3|STARTED|Overall Study||5
274043|NCT00916149|663431|P2|STARTED|Overall Study||10
274044|NCT00916149|663432|P1|STARTED|Overall Study||16
274045|NCT00916136|663503|P2|NOT COMPLETED|Overall Study||0
274046|NCT00916136|663504|P1|NOT COMPLETED|Overall Study||0
274047|NCT00916136|663503|P2|COMPLETED|Overall Study||29
274048|NCT00916136|663504|P1|COMPLETED|Overall Study||37
274049|NCT00916136|663503|P2|STARTED|Overall Study||29
274050|NCT00916136|663504|P1|STARTED|Overall Study||37
274051|NCT00916058|663519|P7|NOT COMPLETED|Phase 2||3
274052|NCT00916058|663520|P6|NOT COMPLETED|Phase 2||0
274053|NCT00916058|663521|P5|NOT COMPLETED|Phase 2||0
274054|NCT00916058|663522|P4|NOT COMPLETED|Phase 2||0
274055|NCT00916058|663523|P3|NOT COMPLETED|Phase 2||0
274056|NCT00916058|663524|P2|NOT COMPLETED|Phase 2||0
274057|NCT00916058|663525|P1|NOT COMPLETED|Phase 2||0
274058|NCT00916058|663519|P7|COMPLETED|Phase 2||28
274059|NCT00916058|663520|P6|COMPLETED|Phase 2||0
274060|NCT00916058|663521|P5|COMPLETED|Phase 2||0
274061|NCT00916058|663522|P4|COMPLETED|Phase 2||0
274062|NCT00916058|663523|P3|COMPLETED|Phase 2||0
274063|NCT00916058|663524|P2|COMPLETED|Phase 2||0
274064|NCT00916058|663525|P1|COMPLETED|Phase 2||0
274065|NCT00916058|663519|P7|STARTED|Phase 2||31
274066|NCT00916058|663520|P6|STARTED|Phase 2||0
274067|NCT00916058|663521|P5|STARTED|Phase 2||0
274068|NCT00916058|663522|P4|STARTED|Phase 2||0
274069|NCT00916058|663523|P3|STARTED|Phase 2||0
274070|NCT00916058|663524|P2|STARTED|Phase 2||0
274071|NCT00916058|663525|P1|STARTED|Phase 2||0
274072|NCT00916058|663519|P7|NOT COMPLETED|Phase 1||0
274073|NCT00916058|663520|P6|NOT COMPLETED|Phase 1||1
274074|NCT00916058|663521|P5|NOT COMPLETED|Phase 1||0
274075|NCT00916058|663522|P4|NOT COMPLETED|Phase 1||0
274076|NCT00916058|663523|P3|NOT COMPLETED|Phase 1||0
274077|NCT00916058|663524|P2|NOT COMPLETED|Phase 1||0
274078|NCT00916058|663525|P1|NOT COMPLETED|Phase 1||0
274079|NCT00916058|663519|P7|COMPLETED|Phase 1||0
274080|NCT00916058|663520|P6|COMPLETED|Phase 1||7
274081|NCT00916058|663521|P5|COMPLETED|Phase 1||3
274082|NCT00916058|663522|P4|COMPLETED|Phase 1||3
274083|NCT00916058|663523|P3|COMPLETED|Phase 1||3
274084|NCT00916058|663524|P2|COMPLETED|Phase 1||6
274085|NCT00916058|663525|P1|COMPLETED|Phase 1||3
274086|NCT00916058|663519|P7|STARTED|Phase 1||0
274087|NCT00916058|663520|P6|STARTED|Phase 1||8
274088|NCT00916058|663521|P5|STARTED|Phase 1||3
274089|NCT00916058|663522|P4|STARTED|Phase 1||3
274090|NCT00916058|663523|P3|STARTED|Phase 1||3
274091|NCT00916058|663524|P2|STARTED|Phase 1||6
274092|NCT00916058|663525|P1|STARTED|Phase 1||3
274093|NCT00916032|663545|P2|NOT COMPLETED|Overall Study||0
274094|NCT00916032|663546|P1|NOT COMPLETED|Overall Study||0
274095|NCT00916032|663545|P2|COMPLETED|Overall Study||11
274096|NCT00916032|663546|P1|COMPLETED|Overall Study||12
274097|NCT00916032|663545|P2|STARTED|Overall Study||11
274098|NCT00916032|663546|P1|STARTED|Overall Study||12
274099|NCT00916006|663588|P2|NOT COMPLETED|Overall Study||7
274100|NCT00916006|663589|P1|NOT COMPLETED|Overall Study||3
274101|NCT00916006|663588|P2|COMPLETED|Overall Study||127
274102|NCT00916006|663589|P1|COMPLETED|Overall Study||132
274103|NCT00916006|663588|P2|STARTED|Overall Study||134
274104|NCT00916006|663589|P1|STARTED|Overall Study||135
274105|NCT00915967|663599|P2|NOT COMPLETED|Overall Study||2
274106|NCT00915967|663600|P1|NOT COMPLETED|Overall Study||1
274107|NCT00915967|663599|P2|COMPLETED|Overall Study||98
274108|NCT00915967|663600|P1|COMPLETED|Overall Study||97
274109|NCT00915967|663599|P2|STARTED|Overall Study||100
274110|NCT00915967|663600|P1|STARTED|Overall Study||98
274111|NCT00915954|663609|P3|NOT COMPLETED|Overall Study||0
274112|NCT00915954|663610|P2|NOT COMPLETED|Overall Study||0
274113|NCT00915954|663611|P1|NOT COMPLETED|Overall Study||0
274114|NCT00915954|663609|P3|COMPLETED|Overall Study||10
274115|NCT00915954|663610|P2|COMPLETED|Overall Study||8
274116|NCT00915954|663611|P1|COMPLETED|Overall Study||10
274117|NCT00915954|663609|P3|STARTED|Overall Study||10
274118|NCT00915954|663610|P2|STARTED|Overall Study||8
274119|NCT00915954|663611|P1|STARTED|Overall Study||10
274120|NCT00915902|663630|P2|NOT COMPLETED|2nd Treatment Period||1
274121|NCT00915902|663631|P1|NOT COMPLETED|2nd Treatment Period||0
274122|NCT00915902|663630|P2|COMPLETED|2nd Treatment Period||20
274123|NCT00915902|663631|P1|COMPLETED|2nd Treatment Period||19
274124|NCT00915902|663630|P2|STARTED|2nd Treatment Period||21
274125|NCT00915902|663631|P1|STARTED|2nd Treatment Period||19
274126|NCT00915902|663630|P2|NOT COMPLETED|Washout (4 Weeks)||1
274127|NCT00915902|663631|P1|NOT COMPLETED|Washout (4 Weeks)||0
274128|NCT00915902|663630|P2|COMPLETED|Washout (4 Weeks)||21
274129|NCT00915902|663631|P1|COMPLETED|Washout (4 Weeks)||19
274130|NCT00915902|663630|P2|STARTED|Washout (4 Weeks)||22
274131|NCT00915902|663631|P1|STARTED|Washout (4 Weeks)||19
274132|NCT00915902|663630|P2|NOT COMPLETED|1st Treatment Period||0
274133|NCT00915902|663631|P1|NOT COMPLETED|1st Treatment Period||1
274134|NCT00915902|663630|P2|COMPLETED|1st Treatment Period||22
274135|NCT00915902|663631|P1|COMPLETED|1st Treatment Period||19
274136|NCT00915902|663630|P2|STARTED|1st Treatment Period||22
274137|NCT00915902|663631|P1|STARTED|1st Treatment Period||20
274138|NCT00915876|663641|P2|NOT COMPLETED|Overall Study||1
274139|NCT00915876|663642|P1|NOT COMPLETED|Overall Study||0
274140|NCT00915876|663641|P2|COMPLETED|Overall Study||20
274141|NCT00915876|663642|P1|COMPLETED|Overall Study||20
274142|NCT00915876|663641|P2|Moving Beyond First Dose|Overall Study||20
274143|NCT00915876|663642|P1|Moving Beyond First Dose|Overall Study||20
274144|NCT00915876|663641|P2|STARTED|Overall Study||21
274145|NCT00915876|663642|P1|STARTED|Overall Study||20
274146|NCT00915798|663652|P4|NOT COMPLETED|Overall Study||0
274147|NCT00915798|663653|P3|NOT COMPLETED|Overall Study||0
274148|NCT00915798|663654|P2|NOT COMPLETED|Overall Study||0
274149|NCT00915798|663655|P1|NOT COMPLETED|Overall Study||0
274150|NCT00915798|663652|P4|COMPLETED|Overall Study||26
274151|NCT00915798|663653|P3|COMPLETED|Overall Study||23
274152|NCT00915798|663654|P2|COMPLETED|Overall Study||21
274153|NCT00915798|663655|P1|COMPLETED|Overall Study||19
274154|NCT00915798|663652|P4|STARTED|Overall Study||26
274155|NCT00915798|663653|P3|STARTED|Overall Study||23
274156|NCT00915798|663654|P2|STARTED|Overall Study||21
274157|NCT00915798|663655|P1|STARTED|Overall Study||19
274158|NCT00915772|663678|P3|NOT COMPLETED|Overall Study||29
274159|NCT00915772|663679|P2|NOT COMPLETED|Overall Study||46
274160|NCT00915772|663680|P1|NOT COMPLETED|Overall Study||36
274161|NCT00915772|663678|P3|COMPLETED|Overall Study||142
274162|NCT00915772|663679|P2|COMPLETED|Overall Study||179
274163|NCT00915772|663680|P1|COMPLETED|Overall Study||134
274164|NCT00915772|663678|P3|STARTED|Overall Study||171
274165|NCT00915772|663679|P2|STARTED|Overall Study||225
274166|NCT00915772|663680|P1|STARTED|Overall Study||170
274167|NCT00915759|663725|P1|NOT COMPLETED|Overall Study||0
274168|NCT00915759|663725|P1|COMPLETED|Overall Study|number of participants|40
274169|NCT00915759|663725|P1|STARTED|Overall Study|number of participants|40
274170|NCT00915655|663735|P1|NOT COMPLETED|Overall Study||0
274171|NCT00915655|663735|P1|COMPLETED|Overall Study|'Completed' represents patients who have not discontinued at time of cut-off for Week 24 analysis|12
274172|NCT00915655|663735|P1|STARTED|Overall Study||12
274173|NCT00915603|663742|P2|NOT COMPLETED|Overall Study||55
274174|NCT00915603|663743|P1|NOT COMPLETED|Overall Study||56
274175|NCT00915603|663742|P2|COMPLETED|Overall Study||0
274176|NCT00915603|663743|P1|COMPLETED|Overall Study||0
274177|NCT00915603|663742|P2|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|55
274178|NCT00915603|663743|P1|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|56
274179|NCT00915590|663759|P2|NOT COMPLETED|Overall Study||1
274180|NCT00915590|663760|P1|NOT COMPLETED|Overall Study||2
274181|NCT00915590|663759|P2|COMPLETED|Overall Study||4
274182|NCT00915590|663760|P1|COMPLETED|Overall Study||3
274183|NCT00915590|663759|P2|STARTED|Overall Study||5
274184|NCT00915590|663760|P1|STARTED|Overall Study||5
274185|NCT00915551|663779|P2|NOT COMPLETED|Overall Study||1
274186|NCT00915551|663780|P1|NOT COMPLETED|Overall Study||0
274187|NCT00915551|663779|P2|COMPLETED|Overall Study||135
274188|NCT00915551|663780|P1|COMPLETED|Overall Study||142
274189|NCT00915551|663779|P2|STARTED|Overall Study||136
274190|NCT00915551|663780|P1|STARTED|Overall Study||142
274191|NCT00915525|663790|P2|NOT COMPLETED|Overall Study||135
274192|NCT00915525|663791|P1|NOT COMPLETED|Overall Study||265
274193|NCT00915525|663790|P2|COMPLETED|Overall Study||151
274194|NCT00915525|663791|P1|COMPLETED|Overall Study||278
274195|NCT00915525|663790|P2|STARTED|Overall Study||286
274196|NCT00915525|663791|P1|STARTED|Overall Study||543
274197|NCT00915499|663894|P2|NOT COMPLETED|Overall Study||2
274198|NCT00915499|663895|P1|NOT COMPLETED|Overall Study||4
274199|NCT00915499|663894|P2|COMPLETED|Overall Study||31
274200|NCT00915499|663895|P1|COMPLETED|Overall Study||29
274201|NCT00915499|663894|P2|STARTED|Overall Study||33
274202|NCT00915499|663895|P1|STARTED|Overall Study||33
274203|NCT00915473|663905|P2|NOT COMPLETED|4-week Follow Up||5
274204|NCT00915473|663906|P1|NOT COMPLETED|4-week Follow Up||1
274205|NCT00915473|663905|P2|COMPLETED|4-week Follow Up||30
274206|NCT00915473|663906|P1|COMPLETED|4-week Follow Up||33
274207|NCT00915473|663905|P2|STARTED|4-week Follow Up||35
274208|NCT00915473|663906|P1|STARTED|4-week Follow Up||34
274209|NCT00915473|663905|P2|NOT COMPLETED|Injection||0
274210|NCT00915473|663906|P1|NOT COMPLETED|Injection||0
274211|NCT00915473|663905|P2|COMPLETED|Injection||35
274212|NCT00915473|663906|P1|COMPLETED|Injection||34
274213|NCT00915473|663905|P2|STARTED|Injection||35
274214|NCT00915473|663906|P1|STARTED|Injection||34
274215|NCT00915473|663905|P2|NOT COMPLETED|Screening||0
274216|NCT00915473|663906|P1|NOT COMPLETED|Screening||1
274217|NCT00915473|663905|P2|COMPLETED|Screening||35
274218|NCT00915473|663906|P1|COMPLETED|Screening||34
274219|NCT00915473|663905|P2|STARTED|Screening||35
274220|NCT00915473|663906|P1|STARTED|Screening||35
274221|NCT00915356|663923|P5|NOT COMPLETED|Overall Study||0
274222|NCT00915356|663924|P4|NOT COMPLETED|Overall Study||0
274223|NCT00915356|663925|P3|NOT COMPLETED|Overall Study||0
274224|NCT00915356|663926|P2|NOT COMPLETED|Overall Study||0
274225|NCT00915356|663927|P1|NOT COMPLETED|Overall Study||1
274226|NCT00915356|663923|P5|COMPLETED|Overall Study||43
274227|NCT00915356|663924|P4|COMPLETED|Overall Study||12
274228|NCT00915356|663925|P3|COMPLETED|Overall Study||45
274229|NCT00915356|663926|P2|COMPLETED|Overall Study||45
274230|NCT00915356|663927|P1|COMPLETED|Overall Study||25
274231|NCT00915356|663923|P5|STARTED|Overall Study||43
274232|NCT00915356|663924|P4|STARTED|Overall Study||12
274233|NCT00915356|663925|P3|STARTED|Overall Study||45
274234|NCT00915356|663926|P2|STARTED|Overall Study||45
274235|NCT00915356|663927|P1|STARTED|Overall Study||26
274236|NCT00915343|663989|P3|NOT COMPLETED|Part B - Open Label Period||2
274237|NCT00915343|663990|P2|NOT COMPLETED|Part B - Open Label Period||0
274238|NCT00915343|663991|P1|NOT COMPLETED|Part B - Open Label Period||0
274239|NCT00915343|663989|P3|COMPLETED|Part B - Open Label Period||57
274240|NCT00915343|663990|P2|COMPLETED|Part B - Open Label Period||0
274241|NCT00915343|663991|P1|COMPLETED|Part B - Open Label Period||0
274242|NCT00915343|663989|P3|STARTED|Part B - Open Label Period||59
274243|NCT00915343|663990|P2|STARTED|Part B - Open Label Period||0
274244|NCT00915343|663991|P1|STARTED|Part B - Open Label Period||0
274245|NCT00915343|663989|P3|NOT COMPLETED|Part A - Second Intervention Period||0
274246|NCT00915343|663990|P2|NOT COMPLETED|Part A - Second Intervention Period||0
274247|NCT00915343|663991|P1|NOT COMPLETED|Part A - Second Intervention Period||0
274248|NCT00915343|663989|P3|COMPLETED|Part A - Second Intervention Period||0
274249|NCT00915343|663990|P2|COMPLETED|Part A - Second Intervention Period||32
274250|NCT00915343|663991|P1|COMPLETED|Part A - Second Intervention Period||32
274251|NCT00915343|663989|P3|STARTED|Part A - Second Intervention Period||0
274252|NCT00915343|663990|P2|STARTED|Part A - Second Intervention Period||32
274253|NCT00915343|663991|P1|STARTED|Part A - Second Intervention Period||32
274254|NCT00915343|663989|P3|NOT COMPLETED|Part A - First Intervention Period||0
274255|NCT00915343|663990|P2|NOT COMPLETED|Part A - First Intervention Period||0
274256|NCT00915343|663991|P1|NOT COMPLETED|Part A - First Intervention Period||0
274257|NCT00915343|663989|P3|COMPLETED|Part A - First Intervention Period||0
274258|NCT00915343|663990|P2|COMPLETED|Part A - First Intervention Period||32
274259|NCT00915343|663991|P1|COMPLETED|Part A - First Intervention Period||32
274260|NCT00915343|663989|P3|STARTED|Part A - First Intervention Period||0
274261|NCT00915343|663990|P2|STARTED|Part A - First Intervention Period||32
274262|NCT00915343|663991|P1|STARTED|Part A - First Intervention Period||32
274263|NCT00915278|664076|P6|NOT COMPLETED|Overall Study||8
274264|NCT00915278|664077|P5|NOT COMPLETED|Overall Study||2
274265|NCT00915278|664078|P4|NOT COMPLETED|Overall Study||3
274266|NCT00915278|664079|P3|NOT COMPLETED|Overall Study||1
274267|NCT00915278|664080|P2|NOT COMPLETED|Overall Study||3
274268|NCT00915278|664081|P1|NOT COMPLETED|Overall Study||5
274269|NCT00915278|664076|P6|COMPLETED|Overall Study||1
274270|NCT00915278|664077|P5|COMPLETED|Overall Study||1
274271|NCT00915278|664078|P4|COMPLETED|Overall Study||2
274272|NCT00915278|664079|P3|COMPLETED|Overall Study||2
274273|NCT00915278|664080|P2|COMPLETED|Overall Study||2
274274|NCT00915278|664081|P1|COMPLETED|Overall Study||3
274275|NCT00915278|664076|P6|STARTED|Overall Study||9
274276|NCT00915278|664077|P5|STARTED|Overall Study||3
274277|NCT00915278|664078|P4|STARTED|Overall Study||5
274278|NCT00915278|664079|P3|STARTED|Overall Study||3
274279|NCT00915278|664080|P2|STARTED|Overall Study||5
274280|NCT00915278|664081|P1|STARTED|Overall Study||8
274281|NCT00915148|664227|P1|NOT COMPLETED|Overall Study||0
274282|NCT00915148|664227|P1|COMPLETED|Overall Study|August 2010|110
274283|NCT00915148|664227|P1|STARTED|Overall Study|October 2009|110
274284|NCT00915031|664234|P2|NOT COMPLETED|Overall Study||0
274285|NCT00915031|664235|P1|NOT COMPLETED|Overall Study||0
274286|NCT00915031|664234|P2|COMPLETED|Overall Study||24
274287|NCT00915031|664235|P1|COMPLETED|Overall Study||714
274288|NCT00915031|664234|P2|STARTED|Overall Study||24
274289|NCT00915031|664235|P1|STARTED|Overall Study||714
274290|NCT00915018|664242|P2|NOT COMPLETED|Overall Study||207
274291|NCT00915018|664243|P1|NOT COMPLETED|Overall Study||215
274292|NCT00915018|664242|P2|COMPLETED|Overall Study||30
274293|NCT00915018|664243|P1|COMPLETED|Overall Study||27
274294|NCT00915018|664242|P2|Received Treatment|Overall Study||234
274295|NCT00915018|664243|P1|Received Treatment|Overall Study||240
274296|NCT00915018|664242|P2|STARTED|Overall Study||237
274297|NCT00915018|664243|P1|STARTED|Overall Study||242
274298|NCT00914966|664257|P1|NOT COMPLETED|Step 3: 2500 Units||0
274299|NCT00914966|664257|P1|COMPLETED|Step 3: 2500 Units||12
274300|NCT00914966|664257|P1|STARTED|Step 3: 2500 Units||12
274301|NCT00914966|664257|P1|NOT COMPLETED|Step 2: 2000 Units||1
274302|NCT00914966|664257|P1|COMPLETED|Step 2: 2000 Units||12
274303|NCT00914966|664257|P1|STARTED|Step 2: 2000 Units||13
274304|NCT00914966|664257|P1|NOT COMPLETED|Step 1: 1500 Units||2
274305|NCT00914966|664257|P1|COMPLETED|Step 1: 1500 Units|5/18 subjects completing Step 1 (1500 Units) entered the 3 month follow-up and did not dose escalate|18
274306|NCT00914966|664257|P1|STARTED|Step 1: 1500 Units||20
274307|NCT00914927|664276|P7|NOT COMPLETED|Overall Study||0
274308|NCT00914927|664277|P6|NOT COMPLETED|Overall Study||0
274309|NCT00914927|664278|P5|NOT COMPLETED|Overall Study||2
274310|NCT00914927|664279|P4|NOT COMPLETED|Overall Study||2
274311|NCT00914927|664280|P3|NOT COMPLETED|Overall Study||0
274312|NCT00914927|664281|P2|NOT COMPLETED|Overall Study||2
274313|NCT00914927|664282|P1|NOT COMPLETED|Overall Study||2
274314|NCT00914927|664276|P7|COMPLETED|Overall Study||21
274315|NCT00914927|664277|P6|COMPLETED|Overall Study||21
274316|NCT00914927|664278|P5|COMPLETED|Overall Study||19
274317|NCT00914927|664279|P4|COMPLETED|Overall Study||14
274318|NCT00914927|664280|P3|COMPLETED|Overall Study||17
274319|NCT00914927|664281|P2|COMPLETED|Overall Study||14
274320|NCT00914927|664282|P1|COMPLETED|Overall Study||16
274321|NCT00914927|664276|P7|STARTED|Overall Study||21
274322|NCT00914927|664277|P6|STARTED|Overall Study||21
274323|NCT00914927|664278|P5|STARTED|Overall Study||21
274324|NCT00914927|664279|P4|STARTED|Overall Study||16
274325|NCT00914927|664280|P3|STARTED|Overall Study||17
274326|NCT00914927|664281|P2|STARTED|Overall Study||16
274327|NCT00914927|664282|P1|STARTED|Overall Study||18
274328|NCT00914862|664331|P5|NOT COMPLETED|Overall Study||0
274329|NCT00914862|664332|P4|NOT COMPLETED|Overall Study||0
274330|NCT00914862|664333|P3|NOT COMPLETED|Overall Study||0
274331|NCT00914862|664334|P2|NOT COMPLETED|Overall Study||0
274332|NCT00914862|664335|P1|NOT COMPLETED|Overall Study||0
274333|NCT00914862|664331|P5|COMPLETED|Overall Study||28
274334|NCT00914862|664332|P4|COMPLETED|Overall Study||8
274335|NCT00914862|664333|P3|COMPLETED|Overall Study||8
274336|NCT00914862|664334|P2|COMPLETED|Overall Study||6
274337|NCT00914862|664335|P1|COMPLETED|Overall Study||6
274338|NCT00914862|664331|P5|STARTED|Overall Study||28
274339|NCT00914862|664332|P4|STARTED|Overall Study||8
274340|NCT00914862|664333|P3|STARTED|Overall Study||8
274341|NCT00914862|664334|P2|STARTED|Overall Study||6
274342|NCT00914862|664335|P1|STARTED|Overall Study||6
274343|NCT00914849|664409|P2|NOT COMPLETED|Overall Study||1
274344|NCT00914849|664410|P1|NOT COMPLETED|Overall Study||1
274345|NCT00914849|664409|P2|COMPLETED|Overall Study||33
274346|NCT00914849|664410|P1|COMPLETED|Overall Study||33
274347|NCT00914849|664409|P2|STARTED|Overall Study||34
274348|NCT00914849|664410|P1|STARTED|Overall Study||34
274349|NCT00914810|664444|P2|NOT COMPLETED|Overall Study||1
274350|NCT00914810|664445|P1|NOT COMPLETED|Overall Study||2
274351|NCT00914810|664444|P2|COMPLETED|Overall Study||18
274352|NCT00914810|664445|P1|COMPLETED|Overall Study||18
274353|NCT00914810|664444|P2|STARTED|Overall Study||19
274354|NCT00914810|664445|P1|STARTED|Overall Study||20
274355|NCT00914589|664456|P3|NOT COMPLETED|Overall Study||12
274356|NCT00914589|664457|P2|NOT COMPLETED|Overall Study||16
274357|NCT00914589|664458|P1|NOT COMPLETED|Overall Study||25
274358|NCT00914589|664456|P3|COMPLETED|Overall Study||126
274359|NCT00914589|664457|P2|COMPLETED|Overall Study||127
274360|NCT00914589|664458|P1|COMPLETED|Overall Study||103
274361|NCT00914589|664456|P3|STARTED|Overall Study||138
274362|NCT00914589|664457|P2|STARTED|Overall Study||143
274363|NCT00914589|664458|P1|STARTED|Overall Study||128
274364|NCT00914485|664478|P1|NOT COMPLETED|Overall Study||0
274365|NCT00914485|664478|P1|COMPLETED|Overall Study||369
274366|NCT00914485|664478|P1|STARTED|Overall Study||369
274367|NCT00914459|664484|P2|NOT COMPLETED|Overall Study||1
274368|NCT00914459|664485|P1|NOT COMPLETED|Overall Study||1
274369|NCT00914459|664484|P2|COMPLETED|Overall Study||18
274370|NCT00914459|664485|P1|COMPLETED|Overall Study||17
274371|NCT00914459|664484|P2|STARTED|Overall Study||19
274372|NCT00914459|664485|P1|STARTED|Overall Study||18
274373|NCT00914316|664515|P4|NOT COMPLETED|Phase 2||0
274374|NCT00914316|664516|P3|NOT COMPLETED|Phase 2||1
274375|NCT00914316|664517|P2|NOT COMPLETED|Phase 2||0
274376|NCT00914316|664518|P1|NOT COMPLETED|Phase 2||1
274377|NCT00914316|664515|P4|COMPLETED|Phase 2||6
274378|NCT00914316|664516|P3|COMPLETED|Phase 2||2
274379|NCT00914316|664517|P2|COMPLETED|Phase 2||4
274380|NCT00914316|664518|P1|COMPLETED|Phase 2||1
274381|NCT00914316|664515|P4|STARTED|Phase 2||6
274382|NCT00914316|664516|P3|STARTED|Phase 2||3
274383|NCT00914316|664517|P2|STARTED|Phase 2||4
274384|NCT00914316|664518|P1|STARTED|Phase 2||2
274385|NCT00914316|664515|P4|NOT COMPLETED|Phase 1||2
274386|NCT00914316|664516|P3|NOT COMPLETED|Phase 1||5
274387|NCT00914316|664517|P2|NOT COMPLETED|Phase 1||2
274388|NCT00914316|664518|P1|NOT COMPLETED|Phase 1||5
274389|NCT00914316|664515|P4|COMPLETED|Phase 1||6
274390|NCT00914316|664516|P3|COMPLETED|Phase 1||3
274391|NCT00914316|664517|P2|COMPLETED|Phase 1||4
274392|NCT00914316|664518|P1|COMPLETED|Phase 1||2
274393|NCT00914316|664515|P4|STARTED|Phase 1||8
274394|NCT00914316|664516|P3|STARTED|Phase 1||8
274395|NCT00914316|664517|P2|STARTED|Phase 1||6
274396|NCT00914316|664518|P1|STARTED|Phase 1||7
274397|NCT00914186|664536|P4|NOT COMPLETED|Overall Study||10
274398|NCT00914186|664537|P3|NOT COMPLETED|Overall Study||2
274399|NCT00914186|664538|P2|NOT COMPLETED|Overall Study||2
274400|NCT00914186|664539|P1|NOT COMPLETED|Overall Study||3
274401|NCT00914186|664536|P4|COMPLETED|Overall Study||20
274402|NCT00914186|664537|P3|COMPLETED|Overall Study||29
274403|NCT00914186|664538|P2|COMPLETED|Overall Study||28
274404|NCT00914186|664539|P1|COMPLETED|Overall Study||28
274405|NCT00914186|664536|P4|STARTED|Overall Study||30
274406|NCT00914186|664537|P3|STARTED|Overall Study||31
274407|NCT00914186|664538|P2|STARTED|Overall Study||30
274408|NCT00914186|664539|P1|STARTED|Overall Study||31
274409|NCT00914069|664573|P2|NOT COMPLETED|Overall Study||0
274410|NCT00914069|664574|P1|NOT COMPLETED|Overall Study||0
274411|NCT00914069|664573|P2|COMPLETED|Overall Study||88
274412|NCT00914069|664574|P1|COMPLETED|Overall Study||84
274413|NCT00914069|664573|P2|STARTED|Overall Study||88
274414|NCT00914069|664574|P1|STARTED|Overall Study||84
274415|NCT00913913|664588|P1|NOT COMPLETED|Overall Study||8
274416|NCT00913913|664588|P1|COMPLETED|Overall Study||0
274417|NCT00913913|664588|P1|STARTED|Overall Study||8
274418|NCT00913835|664597|P2|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||3
274419|NCT00913835|664598|P1|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||0
274420|NCT00913835|664597|P2|COMPLETED|Lip Dox: Olaratumab Monotherapy||25
274421|NCT00913835|664598|P1|COMPLETED|Lip Dox: Olaratumab Monotherapy||0
274422|NCT00913835|664597|P2|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||28
274423|NCT00913835|664598|P1|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||0
274424|NCT00913835|664597|P2|STARTED|Lip Dox: Olaratumab Monotherapy||28
274425|NCT00913835|664598|P1|STARTED|Lip Dox: Olaratumab Monotherapy||0
274426|NCT00913835|664597|P2|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||7
274427|NCT00913835|664598|P1|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||8
274428|NCT00913835|664597|P2|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
274429|NCT00913835|664598|P1|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
274430|NCT00913835|664597|P2|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||61
274431|NCT00913835|664598|P1|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||62
274432|NCT00913835|664597|P2|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||62
274433|NCT00913835|664598|P1|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||63
274434|NCT00913770|664637|P3|NOT COMPLETED|Overall Study||21
274435|NCT00913770|664638|P2|NOT COMPLETED|Overall Study||29
274436|NCT00913770|664639|P1|NOT COMPLETED|Overall Study||35
274437|NCT00913770|664637|P3|COMPLETED|Overall Study||93
274438|NCT00913770|664638|P2|COMPLETED|Overall Study||82
274439|NCT00913770|664639|P1|COMPLETED|Overall Study||69
274440|NCT00913770|664637|P3|STARTED|Overall Study||114
274441|NCT00913770|664638|P2|STARTED|Overall Study||111
274442|NCT00913770|664639|P1|STARTED|Overall Study||104
274443|NCT00913744|664652|P2|NOT COMPLETED|Overall Study||1
274444|NCT00913744|664653|P1|NOT COMPLETED|Overall Study||5
274445|NCT00913744|664652|P2|COMPLETED|Overall Study||24
274446|NCT00913744|664653|P1|COMPLETED|Overall Study||70
274447|NCT00913744|664652|P2|STARTED|Overall Study||25
274448|NCT00913744|664653|P1|STARTED|Overall Study||75
274449|NCT00913692|664659|P1|NOT COMPLETED|Treatment Phase 2 (5 Months)||0
274450|NCT00913692|664659|P1|COMPLETED|Treatment Phase 2 (5 Months)||1
274451|NCT00913692|664659|P1|STARTED|Treatment Phase 2 (5 Months)||1
274452|NCT00913692|664659|P1|NOT COMPLETED|Washout (2 Weeks)||0
274453|NCT00913692|664659|P1|COMPLETED|Washout (2 Weeks)||1
274454|NCT00913692|664659|P1|STARTED|Washout (2 Weeks)||1
274455|NCT00913692|664659|P1|NOT COMPLETED|Treatment Phase 1 (5 Months)||1
274456|NCT00913692|664659|P1|COMPLETED|Treatment Phase 1 (5 Months)||1
274457|NCT00913692|664659|P1|STARTED|Treatment Phase 1 (5 Months)||2
274458|NCT00913692|664659|P1|NOT COMPLETED|Screening (4 Months)||9
274459|NCT00913692|664659|P1|COMPLETED|Screening (4 Months)||2
274460|NCT00913692|664659|P1|STARTED|Screening (4 Months)||11
274461|NCT00913627|664673|P4|NOT COMPLETED|Overall Study||0
274462|NCT00913627|664674|P3|NOT COMPLETED|Overall Study||0
274463|NCT00913627|664675|P2|NOT COMPLETED|Overall Study||0
274464|NCT00913627|664676|P1|NOT COMPLETED|Overall Study||0
274465|NCT00913627|664673|P4|COMPLETED|Overall Study||58
274466|NCT00913627|664674|P3|COMPLETED|Overall Study||56
274467|NCT00913627|664675|P2|COMPLETED|Overall Study||53
274468|NCT00913627|664676|P1|COMPLETED|Overall Study||29
274469|NCT00913627|664673|P4|STARTED|Overall Study||58
274470|NCT00913627|664674|P3|STARTED|Overall Study||56
274471|NCT00913627|664675|P2|STARTED|Overall Study||53
274472|NCT00913627|664676|P1|STARTED|Overall Study||29
274473|NCT00913523|664753|P3|NOT COMPLETED|Overall Study||14
274474|NCT00913523|664754|P2|NOT COMPLETED|Overall Study||16
274475|NCT00913523|664755|P1|NOT COMPLETED|Overall Study||18
274476|NCT00913523|664753|P3|COMPLETED|Overall Study||147
274477|NCT00913523|664754|P2|COMPLETED|Overall Study||143
274478|NCT00913523|664755|P1|COMPLETED|Overall Study||144
274479|NCT00913523|664753|P3|STARTED|Overall Study||161
274480|NCT00913523|664754|P2|STARTED|Overall Study||159
274481|NCT00913523|664755|P1|STARTED|Overall Study||162
274482|NCT00913510|664780|P2|NOT COMPLETED|Overall Study||4
274483|NCT00913510|664781|P1|NOT COMPLETED|Overall Study||8
274484|NCT00913510|664780|P2|COMPLETED|Overall Study||3
274485|NCT00913510|664781|P1|COMPLETED|Overall Study||5
274486|NCT00913510|664780|P2|STARTED|Overall Study||7
274487|NCT00913510|664781|P1|STARTED|Overall Study||13
274488|NCT00913458|664787|P7|NOT COMPLETED|Phase 3||8
274489|NCT00913458|664788|P6|NOT COMPLETED|Phase 3||18
274490|NCT00913458|664789|P5|NOT COMPLETED|Phase 3||22
274491|NCT00913458|664790|P4|NOT COMPLETED|Phase 3||0
274492|NCT00913458|664791|P3|NOT COMPLETED|Phase 3||0
274493|NCT00913458|664792|P2|NOT COMPLETED|Phase 3||0
274494|NCT00913458|664793|P1|NOT COMPLETED|Phase 3||0
274495|NCT00913458|664787|P7|COMPLETED|Phase 3||24
274496|NCT00913458|664788|P6|COMPLETED|Phase 3||28
274497|NCT00913458|664789|P5|COMPLETED|Phase 3||31
274498|NCT00913458|664790|P4|COMPLETED|Phase 3||0
274499|NCT00913458|664791|P3|COMPLETED|Phase 3||0
274500|NCT00913458|664792|P2|COMPLETED|Phase 3||0
274501|NCT00913458|664793|P1|COMPLETED|Phase 3|This arm is part of Phase 1 of the study.|0
274502|NCT00913458|664787|P7|STARTED|Phase 3|Participants who completed Phase 2 study|32
274503|NCT00913458|664788|P6|STARTED|Phase 3|Participants who completed Phase 2 study|46
274504|NCT00913458|664789|P5|STARTED|Phase 3|Participants who completed Phase 2 study|53
274505|NCT00913458|664790|P4|STARTED|Phase 3||0
274506|NCT00913458|664791|P3|STARTED|Phase 3||0
274507|NCT00913458|664792|P2|STARTED|Phase 3||0
274508|NCT00913458|664793|P1|STARTED|Phase 3|This arm is part of Phase 1 of the study.|0
274509|NCT00913458|664787|P7|NOT COMPLETED|Phase 2||0
274510|NCT00913458|664788|P6|NOT COMPLETED|Phase 2||0
274511|NCT00913458|664789|P5|NOT COMPLETED|Phase 2||0
274512|NCT00913458|664790|P4|NOT COMPLETED|Phase 2||33
274513|NCT00913458|664791|P3|NOT COMPLETED|Phase 2||19
274514|NCT00913458|664792|P2|NOT COMPLETED|Phase 2||10
274515|NCT00913458|664793|P1|NOT COMPLETED|Phase 2||0
274516|NCT00913458|664787|P7|COMPLETED|Phase 2||0
274517|NCT00913458|664788|P6|COMPLETED|Phase 2||0
274518|NCT00913458|664789|P5|COMPLETED|Phase 2||0
274519|NCT00913458|664790|P4|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|32
274520|NCT00913458|664791|P3|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|46
274521|NCT00913458|664792|P2|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|53
274522|NCT00913458|664793|P1|COMPLETED|Phase 2|This arm is part of Phase 1 of the study.|0
274523|NCT00913458|664787|P7|STARTED|Phase 2||0
274524|NCT00913458|664788|P6|STARTED|Phase 2||0
274525|NCT00913458|664789|P5|STARTED|Phase 2||0
274526|NCT00913458|664790|P4|STARTED|Phase 2||65
274527|NCT00913458|664791|P3|STARTED|Phase 2||65
274528|NCT00913458|664792|P2|STARTED|Phase 2||63
274529|NCT00913458|664793|P1|STARTED|Phase 2|This arm is part of Phase 1 of the study.|0
274530|NCT00913458|664787|P7|NOT COMPLETED|Phase 1||0
274531|NCT00913458|664788|P6|NOT COMPLETED|Phase 1||0
274532|NCT00913458|664789|P5|NOT COMPLETED|Phase 1||0
274533|NCT00913458|664790|P4|NOT COMPLETED|Phase 1||0
274534|NCT00913458|664791|P3|NOT COMPLETED|Phase 1||0
274535|NCT00913458|664792|P2|NOT COMPLETED|Phase 1||0
274536|NCT00913458|664793|P1|NOT COMPLETED|Phase 1||112
274537|NCT00913458|664787|P7|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
274538|NCT00913458|664788|P6|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
274539|NCT00913458|664789|P5|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
274540|NCT00913458|664790|P4|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
274541|NCT00913458|664791|P3|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
274542|NCT00913458|664792|P2|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
274543|NCT00913458|664793|P1|COMPLETED|Phase 1|194 continued to Phase 2 but 1 was randomized in error leaving 193 in the phase 2 analysis.|194
274544|NCT00913458|664787|P7|STARTED|Phase 1|This arm is part of Phase 3 study|0
274545|NCT00913458|664788|P6|STARTED|Phase 1|This arm is part of Phase 3 study|0
274546|NCT00913458|664789|P5|STARTED|Phase 1|This arm is part of Phase 3 study|0
274547|NCT00913458|664790|P4|STARTED|Phase 1|This arm is part of Phase 2 study|0
274548|NCT00913458|664791|P3|STARTED|Phase 1|This arm is part of Phase 2 study|0
274549|NCT00913458|664792|P2|STARTED|Phase 1|This arm is part of Phase 2 study|0
274550|NCT00913458|664793|P1|STARTED|Phase 1||306
274551|NCT00913380|664886|P2|NOT COMPLETED|Clinical Outcomes||6
274552|NCT00913380|664887|P1|NOT COMPLETED|Clinical Outcomes||6
274553|NCT00913380|664886|P2|COMPLETED|Clinical Outcomes||441
274554|NCT00913380|664887|P1|COMPLETED|Clinical Outcomes||438
274555|NCT00913380|664886|P2|STARTED|Clinical Outcomes||447
274556|NCT00913380|664887|P1|STARTED|Clinical Outcomes||444
274557|NCT00913380|664886|P2|NOT COMPLETED|CT Examination||0
274558|NCT00913380|664887|P1|NOT COMPLETED|CT Examination||0
274559|NCT00913380|664886|P2|COMPLETED|CT Examination||447
274560|NCT00913380|664887|P1|COMPLETED|CT Examination||444
274561|NCT00913380|664886|P2|STARTED|CT Examination||447
274562|NCT00913380|664887|P1|STARTED|CT Examination||444
274563|NCT00913263|664913|P1|NOT COMPLETED|Overall Study||0
274564|NCT00913263|664913|P1|COMPLETED|Overall Study||24
274565|NCT00913263|664913|P1|STARTED|Overall Study||24
274566|NCT00913133|664922|P1|NOT COMPLETED|Overall Study||0
274567|NCT00913133|664922|P1|COMPLETED|Overall Study||516
274568|NCT00913133|664922|P1|STARTED|Overall Study||516
274569|NCT00913081|664927|P1|NOT COMPLETED|Placebo + Niacin 500 mg (1day)||0
274570|NCT00913081|664927|P1|COMPLETED|Placebo + Niacin 500 mg (1day)||17
274571|NCT00913081|664927|P1|STARTED|Placebo + Niacin 500 mg (1day)||17
274572|NCT00913081|664927|P1|NOT COMPLETED|Washout #3 (7days)||0
274573|NCT00913081|664927|P1|COMPLETED|Washout #3 (7days)||17
274574|NCT00913081|664927|P1|STARTED|Washout #3 (7days)||17
274575|NCT00913081|664927|P1|NOT COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||0
274576|NCT00913081|664927|P1|COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
274577|NCT00913081|664927|P1|STARTED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
274578|NCT00913081|664927|P1|NOT COMPLETED|Washout #2 (7 Days)||0
274579|NCT00913081|664927|P1|COMPLETED|Washout #2 (7 Days)||17
274580|NCT00913081|664927|P1|STARTED|Washout #2 (7 Days)||17
274581|NCT00913081|664927|P1|NOT COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||0
274582|NCT00913081|664927|P1|COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
274583|NCT00913081|664927|P1|STARTED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
274584|NCT00913081|664927|P1|NOT COMPLETED|Washout #1 (7 Days)||0
274585|NCT00913081|664927|P1|COMPLETED|Washout #1 (7 Days)||17
274586|NCT00913081|664927|P1|STARTED|Washout #1 (7 Days)||17
274587|NCT00913081|664927|P1|NOT COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||0
274588|NCT00913081|664927|P1|COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||17
274589|NCT00913081|664927|P1|STARTED|Quercetin 500 mg + Niacin 500 mg (1day)||17
274590|NCT00913003|664939|P2|NOT COMPLETED|Overall Study||0
274591|NCT00913003|664940|P1|NOT COMPLETED|Overall Study||0
274592|NCT00913003|664939|P2|COMPLETED|Overall Study||11
274593|NCT00913003|664940|P1|COMPLETED|Overall Study||11
274594|NCT00913003|664939|P2|STARTED|Overall Study||11
274595|NCT00913003|664940|P1|STARTED|Overall Study||11
274596|NCT00912964|664953|P3|NOT COMPLETED|Overall Study||54
274597|NCT00912964|664954|P2|NOT COMPLETED|Overall Study||46
274598|NCT00912964|664955|P1|NOT COMPLETED|Overall Study||66
274599|NCT00912964|664953|P3|COMPLETED|Overall Study||386
274600|NCT00912964|664954|P2|COMPLETED|Overall Study||387
274601|NCT00912964|664955|P1|COMPLETED|Overall Study||367
274602|NCT00912964|664953|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|257
274603|NCT00912964|664954|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|254
274604|NCT00912964|664955|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|262
274605|NCT00912964|664953|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|426
274606|NCT00912964|664954|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|410
274607|NCT00912964|664955|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|415
274608|NCT00912964|664953|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|440
274609|NCT00912964|664954|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|432
274610|NCT00912964|664955|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
274611|NCT00912964|664953|P3|STARTED|Overall Study||440
274612|NCT00912964|664954|P2|STARTED|Overall Study||433
274613|NCT00912964|664955|P1|STARTED|Overall Study||433
274614|NCT00912925|665079|P2|NOT COMPLETED|Overall Study||0
274615|NCT00912925|665080|P1|NOT COMPLETED|Overall Study||0
274616|NCT00912925|665079|P2|COMPLETED|Overall Study||22
274617|NCT00912925|665080|P1|COMPLETED|Overall Study||23
274618|NCT00912925|665079|P2|STARTED|Overall Study||22
274619|NCT00912925|665080|P1|STARTED|Overall Study||23
274620|NCT00912912|665098|P1|NOT COMPLETED|Overall Study||4
274621|NCT00912912|665098|P1|COMPLETED|Overall Study||1
274622|NCT00912912|665098|P1|STARTED|Overall Study||5
274623|NCT00912808|665104|P2|NOT COMPLETED|Second Intervention (6 Weeks)||1
274624|NCT00912808|665105|P1|NOT COMPLETED|Second Intervention (6 Weeks)||1
274625|NCT00912808|665104|P2|COMPLETED|Second Intervention (6 Weeks)||9
274626|NCT00912808|665105|P1|COMPLETED|Second Intervention (6 Weeks)||8
274627|NCT00912808|665104|P2|Received Intervention|Second Intervention (6 Weeks)||10
274628|NCT00912808|665105|P1|Received Intervention|Second Intervention (6 Weeks)||9
274629|NCT00912808|665104|P2|STARTED|Second Intervention (6 Weeks)||10
274630|NCT00912808|665105|P1|STARTED|Second Intervention (6 Weeks)||9
274631|NCT00912808|665104|P2|NOT COMPLETED|Washout||1
274632|NCT00912808|665105|P1|NOT COMPLETED|Washout||0
274633|NCT00912808|665104|P2|COMPLETED|Washout||10
274634|NCT00912808|665105|P1|COMPLETED|Washout||9
274635|NCT00912808|665104|P2|STARTED|Washout||11
274636|NCT00912808|665105|P1|STARTED|Washout||9
274637|NCT00912808|665104|P2|NOT COMPLETED|First Intervention (6 Weeks)||1
274638|NCT00912808|665105|P1|NOT COMPLETED|First Intervention (6 Weeks)||2
274639|NCT00912808|665104|P2|COMPLETED|First Intervention (6 Weeks)||11
274640|NCT00912808|665105|P1|COMPLETED|First Intervention (6 Weeks)||9
274641|NCT00912808|665104|P2|Received Intervention|First Intervention (6 Weeks)||12
274642|NCT00912808|665105|P1|Received Intervention|First Intervention (6 Weeks)||11
274643|NCT00912808|665104|P2|STARTED|First Intervention (6 Weeks)||12
274644|NCT00912808|665105|P1|STARTED|First Intervention (6 Weeks)||11
274645|NCT00912795|665115|P2|NOT COMPLETED|Overall Study||58
274646|NCT00912795|665116|P1|NOT COMPLETED|Overall Study||47
274647|NCT00912795|665115|P2|COMPLETED|Overall Study||17
274648|NCT00912795|665116|P1|COMPLETED|Overall Study||29
274649|NCT00912795|665115|P2|STARTED|Overall Study||75
274650|NCT00912795|665116|P1|STARTED|Overall Study||76
274651|NCT00912782|665130|P2|NOT COMPLETED|Overall Study||5
274652|NCT00912782|665131|P1|NOT COMPLETED|Overall Study||3
274653|NCT00912782|665130|P2|COMPLETED|Overall Study||20
274654|NCT00912782|665131|P1|COMPLETED|Overall Study||24
274655|NCT00912782|665130|P2|STARTED|Overall Study||25
274656|NCT00912782|665131|P1|STARTED|Overall Study||27
274657|NCT00912743|665141|P2|NOT COMPLETED|Overall Study||20
274658|NCT00912743|665142|P1|NOT COMPLETED|Overall Study||13
274659|NCT00912743|665141|P2|COMPLETED|Overall Study||0
274660|NCT00912743|665142|P1|COMPLETED|Overall Study||0
274661|NCT00912743|665141|P2|STARTED|Overall Study||20
274662|NCT00912743|665142|P1|STARTED|Overall Study||13
274663|NCT00912509|665154|P2|NOT COMPLETED|Overall Study||3
274664|NCT00912509|665155|P1|NOT COMPLETED|Overall Study||5
274665|NCT00912509|665154|P2|COMPLETED|Overall Study||7
274666|NCT00912509|665155|P1|COMPLETED|Overall Study||15
274667|NCT00912509|665154|P2|STARTED|Overall Study||10
274668|NCT00912509|665155|P1|STARTED|Overall Study||20
274669|NCT00912405|665163|P1|NOT COMPLETED|Overall Study||5
274670|NCT00912405|665163|P1|COMPLETED|Overall Study||45
274671|NCT00912405|665163|P1|STARTED|Overall Study||50
274672|NCT00912340|665173|P3|NOT COMPLETED|Overall Study||4
274673|NCT00912340|665174|P2|NOT COMPLETED|Overall Study||4
274674|NCT00912340|665175|P1|NOT COMPLETED|Overall Study||2
274675|NCT00912340|665173|P3|COMPLETED|Overall Study||0
274676|NCT00912340|665174|P2|COMPLETED|Overall Study||26
274677|NCT00912340|665175|P1|COMPLETED|Overall Study||22
274678|NCT00912340|665173|P3|STARTED|Overall Study||4
274679|NCT00912340|665174|P2|STARTED|Overall Study||30
274680|NCT00912340|665175|P1|STARTED|Overall Study||24
274681|NCT00912301|665189|P3|NOT COMPLETED|Overall Study||0
274682|NCT00912301|665190|P2|NOT COMPLETED|Overall Study||0
274683|NCT00912301|665191|P1|NOT COMPLETED|Overall Study||0
274684|NCT00912301|665189|P3|COMPLETED|Overall Study||13
274685|NCT00912301|665190|P2|COMPLETED|Overall Study||12
274686|NCT00912301|665191|P1|COMPLETED|Overall Study||11
274687|NCT00912301|665189|P3|STARTED|Overall Study||13
274688|NCT00912301|665190|P2|STARTED|Overall Study||12
274689|NCT00912301|665191|P1|STARTED|Overall Study||11
274690|NCT00912288|665213|P2|NOT COMPLETED|Overall Study||40
274691|NCT00912288|665214|P1|NOT COMPLETED|Overall Study||41
274692|NCT00912288|665213|P2|COMPLETED|Overall Study||2
274693|NCT00912288|665214|P1|COMPLETED|Overall Study||3
274694|NCT00912288|665213|P2|STARTED|Overall Study||42
274695|NCT00912288|665214|P1|STARTED|Overall Study||44
274696|NCT00912223|665236|P1|NOT COMPLETED|Overall Study||3
274697|NCT00912223|665236|P1|COMPLETED|Overall Study||62
274698|NCT00912223|665236|P1|STARTED|Overall Study||65
274699|NCT00912158|665255|P3|NOT COMPLETED|Overall Study||0
274700|NCT00912158|665256|P2|NOT COMPLETED|Overall Study||0
274701|NCT00912158|665257|P1|NOT COMPLETED|Overall Study||0
274702|NCT00912158|665255|P3|COMPLETED|Overall Study||41
274703|NCT00912158|665256|P2|COMPLETED|Overall Study||44
274704|NCT00912158|665257|P1|COMPLETED|Overall Study||44
274705|NCT00912158|665255|P3|STARTED|Overall Study||41
274706|NCT00912158|665256|P2|STARTED|Overall Study||44
274707|NCT00912158|665257|P1|STARTED|Overall Study||44
274708|NCT00912093|665267|P5|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
274709|NCT00912093|665268|P4|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
274710|NCT00912093|665269|P3|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
274711|NCT00912093|665270|P2|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
274712|NCT00912093|665271|P1|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
274713|NCT00912093|665267|P5|COMPLETED|The Open Label Extension (OLE) Phase||4
274714|NCT00912093|665268|P4|COMPLETED|The Open Label Extension (OLE) Phase||2
274715|NCT00912093|665269|P3|COMPLETED|The Open Label Extension (OLE) Phase||3
274716|NCT00912093|665270|P2|COMPLETED|The Open Label Extension (OLE) Phase||35
274717|NCT00912093|665271|P1|COMPLETED|The Open Label Extension (OLE) Phase||38
274718|NCT00912093|665267|P5|STARTED|The Open Label Extension (OLE) Phase||4
274719|NCT00912093|665268|P4|STARTED|The Open Label Extension (OLE) Phase||2
274720|NCT00912093|665269|P3|STARTED|The Open Label Extension (OLE) Phase||3
274721|NCT00912093|665270|P2|STARTED|The Open Label Extension (OLE) Phase||35
274722|NCT00912093|665271|P1|STARTED|The Open Label Extension (OLE) Phase||38
274723|NCT00912093|665267|P5|NOT COMPLETED|The Controlled Phase||1
274724|NCT00912093|665268|P4|NOT COMPLETED|The Controlled Phase||0
274725|NCT00912093|665269|P3|NOT COMPLETED|The Controlled Phase||0
274726|NCT00912093|665270|P2|NOT COMPLETED|The Controlled Phase||2
274727|NCT00912093|665271|P1|NOT COMPLETED|The Controlled Phase||0
274728|NCT00912093|665267|P5|COMPLETED|The Controlled Phase||4
274729|NCT00912093|665268|P4|COMPLETED|The Controlled Phase||2
274730|NCT00912093|665269|P3|COMPLETED|The Controlled Phase||3
274731|NCT00912093|665270|P2|COMPLETED|The Controlled Phase||43
274732|NCT00912093|665271|P1|COMPLETED|The Controlled Phase||43
274733|NCT00912093|665267|P5|STARTED|The Controlled Phase||5
274734|NCT00912093|665268|P4|STARTED|The Controlled Phase||2
274735|NCT00912093|665269|P3|STARTED|The Controlled Phase||3
274736|NCT00912093|665270|P2|STARTED|The Controlled Phase||45
274737|NCT00912093|665271|P1|STARTED|The Controlled Phase||43
274738|NCT00912028|665290|P5|NOT COMPLETED|Overall Study||3
274739|NCT00912028|665291|P4|NOT COMPLETED|Overall Study||1
274740|NCT00912028|665292|P3|NOT COMPLETED|Overall Study||0
274741|NCT00912028|665293|P2|NOT COMPLETED|Overall Study||3
274742|NCT00912028|665294|P1|NOT COMPLETED|Overall Study||5
274743|NCT00912028|665290|P5|COMPLETED|Overall Study||0
274744|NCT00912028|665291|P4|COMPLETED|Overall Study||16
274745|NCT00912028|665292|P3|COMPLETED|Overall Study||13
274746|NCT00912028|665293|P2|COMPLETED|Overall Study||0
274747|NCT00912028|665294|P1|COMPLETED|Overall Study||30
274748|NCT00912028|665290|P5|STARTED|Overall Study||3
274749|NCT00912028|665291|P4|STARTED|Overall Study||17
274750|NCT00912028|665292|P3|STARTED|Overall Study||13
274751|NCT00912028|665293|P2|STARTED|Overall Study||3
274752|NCT00912028|665294|P1|STARTED|Overall Study||35
274753|NCT00912015|665323|P4|NOT COMPLETED|Overall Study||2
274754|NCT00912015|665324|P3|NOT COMPLETED|Overall Study||3
274755|NCT00912015|665325|P2|NOT COMPLETED|Overall Study||8
274756|NCT00912015|665326|P1|NOT COMPLETED|Overall Study||16
274757|NCT00912015|665323|P4|COMPLETED|Overall Study||0
274758|NCT00912015|665324|P3|COMPLETED|Overall Study||22
274759|NCT00912015|665325|P2|COMPLETED|Overall Study||62
274760|NCT00912015|665326|P1|COMPLETED|Overall Study||125
274761|NCT00912015|665323|P4|STARTED|Overall Study|Two patients took 100 mg against instructions in protocol that the minimum daily dose was 200 mg.|2
274762|NCT00912015|665324|P3|STARTED|Overall Study|Dose at which a patient spent the longest time.|25
274763|NCT00912015|665325|P2|STARTED|Overall Study|Dose at which a patient spent the longest time.|70
274764|NCT00912015|665326|P1|STARTED|Overall Study|Dose at which a patient spent the longest time.|141
274765|NCT00912002|665336|P1|NOT COMPLETED|Overall Study||0
274766|NCT00912002|665336|P1|COMPLETED|Overall Study||6
274767|NCT00912002|665336|P1|STARTED|Overall Study||6
274768|NCT00911989|665342|P1|NOT COMPLETED|Overall Study||1
274769|NCT00911989|665342|P1|COMPLETED|Overall Study||3
274770|NCT00911989|665342|P1|STARTED|Overall Study||4
274771|NCT00911937|665348|P2|NOT COMPLETED|Overall Study||95
274772|NCT00911937|665349|P1|NOT COMPLETED|Overall Study||87
274773|NCT00911937|665348|P2|COMPLETED|Overall Study||381
274774|NCT00911937|665349|P1|COMPLETED|Overall Study||400
274775|NCT00911937|665348|P2|Treated|Overall Study||463
274776|NCT00911937|665349|P1|Treated|Overall Study||474
274777|NCT00911937|665348|P2|STARTED|Overall Study||476
274778|NCT00911937|665349|P1|STARTED|Overall Study||487
274779|NCT00911898|665409|P1|NOT COMPLETED|Overall Study||0
274780|NCT00911898|665409|P1|COMPLETED|Overall Study||20
274781|NCT00911898|665409|P1|STARTED|Overall Study||20
274782|NCT00911859|665416|P3|NOT COMPLETED|Follow-up Period||41
274783|NCT00911859|665417|P2|NOT COMPLETED|Follow-up Period||46
274784|NCT00911859|665418|P1|NOT COMPLETED|Follow-up Period||11
274785|NCT00911859|665416|P3|COMPLETED|Follow-up Period||11
274786|NCT00911859|665417|P2|COMPLETED|Follow-up Period||7
274787|NCT00911859|665418|P1|COMPLETED|Follow-up Period||1
274788|NCT00911859|665416|P3|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|52
274789|NCT00911859|665417|P2|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|53
274790|NCT00911859|665418|P1|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|12
274791|NCT00911859|665416|P3|NOT COMPLETED|Maintainance Period||21
274792|NCT00911859|665417|P2|NOT COMPLETED|Maintainance Period||0
274793|NCT00911859|665418|P1|NOT COMPLETED|Maintainance Period||0
274794|NCT00911859|665416|P3|COMPLETED|Maintainance Period||0
274795|NCT00911859|665417|P2|COMPLETED|Maintainance Period||0
274796|NCT00911859|665418|P1|COMPLETED|Maintainance Period||0
274797|NCT00911859|665416|P3|STARTED|Maintainance Period|Participants who received siltuximab only during the 18-month maintenance period|21
274798|NCT00911859|665417|P2|STARTED|Maintainance Period||0
274799|NCT00911859|665418|P1|STARTED|Maintainance Period||0
274800|NCT00911859|665416|P3|NOT COMPLETED|Treatment Period||25
274801|NCT00911859|665417|P2|NOT COMPLETED|Treatment Period||21
274802|NCT00911859|665418|P1|NOT COMPLETED|Treatment Period||8
274803|NCT00911859|665416|P3|COMPLETED|Treatment Period||27
274804|NCT00911859|665417|P2|COMPLETED|Treatment Period||33
274805|NCT00911859|665418|P1|COMPLETED|Treatment Period||4
274806|NCT00911859|665416|P3|Received Treatment|Treatment Period||52
274807|NCT00911859|665417|P2|Received Treatment|Treatment Period||53
274808|NCT00911859|665418|P1|Received Treatment|Treatment Period||12
274809|NCT00911859|665416|P3|STARTED|Treatment Period||52
274810|NCT00911859|665417|P2|STARTED|Treatment Period||54
274811|NCT00911859|665418|P1|STARTED|Treatment Period||12
274812|NCT00911820|665444|P2|NOT COMPLETED|Overall Study||43
274813|NCT00911820|665445|P1|NOT COMPLETED|Overall Study||45
274814|NCT00911820|665444|P2|COMPLETED|Overall Study||0
274815|NCT00911820|665445|P1|COMPLETED|Overall Study||0
274816|NCT00911820|665444|P2|Treated|Overall Study|Randomized patients not treated: withdrew consent (n=2)|41
274817|NCT00911820|665445|P1|Treated|Overall Study|Randomized patients not treated: unable to confirm pathology (n=1)|44
274818|NCT00911820|665444|P2|STARTED|Overall Study||43
274819|NCT00911820|665445|P1|STARTED|Overall Study||45
274820|NCT00911807|665462|P3|NOT COMPLETED|Overall Study||23
274821|NCT00911807|665463|P2|NOT COMPLETED|Overall Study||18
274822|NCT00911807|665464|P1|NOT COMPLETED|Overall Study||17
274823|NCT00911807|665462|P3|COMPLETED|Overall Study||52
274824|NCT00911807|665463|P2|COMPLETED|Overall Study||52
274825|NCT00911807|665464|P1|COMPLETED|Overall Study||55
274826|NCT00911807|665462|P3|STARTED|Overall Study||75
274827|NCT00911807|665463|P2|STARTED|Overall Study||70
274828|NCT00911807|665464|P1|STARTED|Overall Study||72
274829|NCT00911768|665474|P2|NOT COMPLETED|Overall Study||4
274830|NCT00911768|665475|P1|NOT COMPLETED|Overall Study||6
274831|NCT00911768|665474|P2|COMPLETED|Overall Study||46
274832|NCT00911768|665475|P1|COMPLETED|Overall Study||44
274833|NCT00911768|665474|P2|STARTED|Overall Study||50
274834|NCT00911768|665475|P1|STARTED|Overall Study||50
274835|NCT00911742|665487|P2|NOT COMPLETED|Treatment Phase II||0
274836|NCT00911742|665488|P1|NOT COMPLETED|Treatment Phase II||0
274837|NCT00911742|665487|P2|COMPLETED|Treatment Phase II||13
274838|NCT00911742|665488|P1|COMPLETED|Treatment Phase II||13
274839|NCT00911742|665487|P2|STARTED|Treatment Phase II||13
274840|NCT00911742|665488|P1|STARTED|Treatment Phase II||13
274841|NCT00911742|665487|P2|NOT COMPLETED|Treatment Phase I||0
274842|NCT00911742|665488|P1|NOT COMPLETED|Treatment Phase I||0
274843|NCT00911742|665487|P2|COMPLETED|Treatment Phase I||13
274844|NCT00911742|665488|P1|COMPLETED|Treatment Phase I||13
274845|NCT00911742|665487|P2|STARTED|Treatment Phase I||13
274846|NCT00911742|665488|P1|STARTED|Treatment Phase I||13
274847|NCT00911625|665504|P2|NOT COMPLETED|Overall Study||0
274848|NCT00911625|665505|P1|NOT COMPLETED|Overall Study||7
274849|NCT00911625|665504|P2|COMPLETED|Overall Study||57
274850|NCT00911625|665505|P1|COMPLETED|Overall Study||50
274851|NCT00911625|665504|P2|STARTED|Overall Study||57
274852|NCT00911625|665505|P1|STARTED|Overall Study||57
274853|NCT00911612|665515|P2|NOT COMPLETED|Overall Study||0
274854|NCT00911612|665516|P1|NOT COMPLETED|Overall Study||0
274855|NCT00911612|665515|P2|COMPLETED|Overall Study||12
274856|NCT00911612|665516|P1|COMPLETED|Overall Study||12
274857|NCT00911612|665515|P2|STARTED|Overall Study||12
274858|NCT00911612|665516|P1|STARTED|Overall Study||12
274859|NCT00911547|665534|P4|NOT COMPLETED|Overall Study||16
274860|NCT00911547|665535|P3|NOT COMPLETED|Overall Study||22
274861|NCT00911547|665536|P2|NOT COMPLETED|Overall Study||42
274862|NCT00911547|665537|P1|NOT COMPLETED|Overall Study||11
274863|NCT00911547|665534|P4|COMPLETED|Overall Study||177
274864|NCT00911547|665535|P3|COMPLETED|Overall Study||178
274865|NCT00911547|665536|P2|COMPLETED|Overall Study||159
274866|NCT00911547|665537|P1|COMPLETED|Overall Study||37
274867|NCT00911547|665534|P4|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|193
274868|NCT00911547|665535|P3|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|200
274869|NCT00911547|665536|P2|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|201
274870|NCT00911547|665537|P1|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|48
274871|NCT00911534|665565|P2|NOT COMPLETED|Overall Study||16
274872|NCT00911534|665566|P1|NOT COMPLETED|Overall Study||15
274873|NCT00911534|665565|P2|COMPLETED|Overall Study||137
274874|NCT00911534|665566|P1|COMPLETED|Overall Study||132
274875|NCT00911534|665565|P2|STARTED|Overall Study|Randomized (treated)|153
274876|NCT00911534|665566|P1|STARTED|Overall Study|Randomized (treated)|147
274877|NCT00911508|665580|P2|NOT COMPLETED|Overall Study||130
274878|NCT00911508|665581|P1|NOT COMPLETED|Overall Study||106
274879|NCT00911508|665580|P2|COMPLETED|Overall Study||966
274880|NCT00911508|665581|P1|COMPLETED|Overall Study||1002
274881|NCT00911508|665580|P2|STARTED|Overall Study||1096
274882|NCT00911508|665581|P1|STARTED|Overall Study||1108
274883|NCT00911495|665613|P1|NOT COMPLETED|Overall Study||1
274884|NCT00911495|665613|P1|COMPLETED|Overall Study||14
274885|NCT00911495|665613|P1|STARTED|Overall Study||15
274886|NCT00911443|665626|P5|NOT COMPLETED|Overall Study||0
274887|NCT00911443|665627|P4|NOT COMPLETED|Overall Study||0
274888|NCT00911443|665628|P3|NOT COMPLETED|Overall Study||0
274889|NCT00911443|665629|P2|NOT COMPLETED|Overall Study||0
274890|NCT00911443|665630|P1|NOT COMPLETED|Overall Study||0
274891|NCT00911443|665626|P5|COMPLETED|Overall Study||97
274892|NCT00911443|665627|P4|COMPLETED|Overall Study||99
274893|NCT00911443|665628|P3|COMPLETED|Overall Study||98
274894|NCT00911443|665629|P2|COMPLETED|Overall Study||97
274895|NCT00911443|665630|P1|COMPLETED|Overall Study||97
274896|NCT00911443|665626|P5|STARTED|Overall Study||97
274897|NCT00911443|665627|P4|STARTED|Overall Study||99
274898|NCT00911443|665628|P3|STARTED|Overall Study||98
274899|NCT00911443|665629|P2|STARTED|Overall Study||97
274900|NCT00911443|665630|P1|STARTED|Overall Study||97
274901|NCT00911326|665647|P1|NOT COMPLETED|Overall Study||16
274902|NCT00911326|665647|P1|COMPLETED|Overall Study||85
274903|NCT00911326|665647|P1|STARTED|Overall Study||101
274904|NCT00911300|665656|P2|NOT COMPLETED|Overall Study||43
274905|NCT00911300|665657|P1|NOT COMPLETED|Overall Study||35
274906|NCT00911300|665656|P2|COMPLETED|Overall Study||131
274907|NCT00911300|665657|P1|COMPLETED|Overall Study||140
274908|NCT00911300|665656|P2|STARTED|Overall Study||174
274909|NCT00911300|665657|P1|STARTED|Overall Study||175
274910|NCT00911274|665683|P2|NOT COMPLETED|Period 2||0
274911|NCT00911274|665684|P1|NOT COMPLETED|Period 2||0
274912|NCT00911274|665683|P2|COMPLETED|Period 2||26
274913|NCT00911274|665684|P1|COMPLETED|Period 2||27
274914|NCT00911274|665683|P2|STARTED|Period 2||26
274915|NCT00911274|665684|P1|STARTED|Period 2||27
274916|NCT00911274|665683|P2|NOT COMPLETED|Period 1||0
274917|NCT00911274|665684|P1|NOT COMPLETED|Period 1||0
274918|NCT00911274|665683|P2|COMPLETED|Period 1||26
274919|NCT00911274|665684|P1|COMPLETED|Period 1||27
274920|NCT00911274|665683|P2|STARTED|Period 1||26
274921|NCT00911274|665684|P1|STARTED|Period 1||27
274922|NCT00911170|665694|P2|NOT COMPLETED|Long Term Follow-Up||422
274923|NCT00911170|665695|P1|NOT COMPLETED|Long Term Follow-Up||423
274924|NCT00911170|665694|P2|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
274925|NCT00911170|665695|P1|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
274926|NCT00911170|665694|P2|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|422
274927|NCT00911170|665695|P1|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|423
274928|NCT00911170|665694|P2|NOT COMPLETED|Treatment Period||37
274929|NCT00911170|665695|P1|NOT COMPLETED|Treatment Period||27
274930|NCT00911170|665694|P2|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|386
274931|NCT00911170|665695|P1|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|397
274932|NCT00911170|665694|P2|Received Investigational Product|Treatment Period||419
274933|NCT00911170|665695|P1|Received Investigational Product|Treatment Period|Includes one participant who received pegfilgrastim in error.|422
274934|NCT00911170|665694|P2|Received Bevacizumab|Treatment Period||420
274935|NCT00911170|665695|P1|Received Bevacizumab|Treatment Period||423
274936|NCT00911170|665694|P2|Received Chemotherapy|Treatment Period|Primary Analysis Set|422
274937|NCT00911170|665695|P1|Received Chemotherapy|Treatment Period|Primary Analysis Set|423
274938|NCT00911170|665694|P2|STARTED|Treatment Period||423
274939|NCT00911170|665695|P1|STARTED|Treatment Period||424
274940|NCT00911157|665719|P2|NOT COMPLETED|Overall Study||2
274941|NCT00911157|665720|P1|NOT COMPLETED|Overall Study||7
274942|NCT00911157|665719|P2|COMPLETED|Overall Study||8
274943|NCT00911157|665720|P1|COMPLETED|Overall Study||22
274944|NCT00911157|665719|P2|STARTED|Overall Study||10
274945|NCT00911157|665720|P1|STARTED|Overall Study||29
274946|NCT00911144|665736|P2|NOT COMPLETED|Overall Study||5
274947|NCT00911144|665737|P1|NOT COMPLETED|Overall Study||16
274948|NCT00911144|665736|P2|COMPLETED|Overall Study||108
274949|NCT00911144|665737|P1|COMPLETED|Overall Study||319
274950|NCT00911144|665736|P2|STARTED|Overall Study||113
274951|NCT00911144|665737|P1|STARTED|Overall Study||335
274952|NCT00911053|665766|P5|NOT COMPLETED|Overall Study||0
274953|NCT00911053|665767|P4|NOT COMPLETED|Overall Study||0
274954|NCT00911053|665768|P3|NOT COMPLETED|Overall Study||0
274955|NCT00911053|665769|P2|NOT COMPLETED|Overall Study||0
274956|NCT00911053|665770|P1|NOT COMPLETED|Overall Study||0
274957|NCT00911053|665766|P5|COMPLETED|Overall Study||0
274958|NCT00911053|665767|P4|COMPLETED|Overall Study||0
274959|NCT00911053|665768|P3|COMPLETED|Overall Study||0
274960|NCT00911053|665769|P2|COMPLETED|Overall Study||0
274961|NCT00911053|665770|P1|COMPLETED|Overall Study||0
274962|NCT00911053|665766|P5|STARTED|Overall Study||0
274963|NCT00911053|665767|P4|STARTED|Overall Study||0
274964|NCT00911053|665768|P3|STARTED|Overall Study||0
274965|NCT00911053|665769|P2|STARTED|Overall Study||0
274966|NCT00911053|665770|P1|STARTED|Overall Study||0
274967|NCT00910988|665791|P4|NOT COMPLETED|Overall Study||0
274968|NCT00910988|665792|P3|NOT COMPLETED|Overall Study||3
274969|NCT00910988|665793|P2|NOT COMPLETED|Overall Study||4
274970|NCT00910988|665794|P1|NOT COMPLETED|Overall Study||2
274971|NCT00910988|665791|P4|COMPLETED|Overall Study||6
274972|NCT00910988|665792|P3|COMPLETED|Overall Study||5
274973|NCT00910988|665793|P2|COMPLETED|Overall Study||12
274974|NCT00910988|665794|P1|COMPLETED|Overall Study||14
274975|NCT00910988|665791|P4|STARTED|Overall Study||6
274976|NCT00910988|665792|P3|STARTED|Overall Study||8
274977|NCT00910988|665793|P2|STARTED|Overall Study||16
274978|NCT00910988|665794|P1|STARTED|Overall Study||16
274979|NCT00910962|665839|P3|NOT COMPLETED|Overall Study||76
274980|NCT00910962|665840|P2|NOT COMPLETED|Overall Study||78
274981|NCT00910962|665841|P1|NOT COMPLETED|Overall Study||43
274982|NCT00910962|665839|P3|COMPLETED|Overall Study||116
274983|NCT00910962|665840|P2|COMPLETED|Overall Study||121
274984|NCT00910962|665841|P1|COMPLETED|Overall Study||92
274985|NCT00910962|665839|P3|STARTED|Overall Study||192
274986|NCT00910962|665840|P2|STARTED|Overall Study||199
274987|NCT00910962|665841|P1|STARTED|Overall Study||135
274988|NCT00910910|665933|P2|NOT COMPLETED|Overall Study||224
274989|NCT00910910|665934|P1|NOT COMPLETED|Overall Study||225
274990|NCT00910910|665933|P2|COMPLETED|Overall Study|Completed includes participants who continued with ongoing treatment|1
274991|NCT00910910|665934|P1|COMPLETED|Overall Study|Completed includes participants who continued with ongoing treatment|0
274992|NCT00910910|665933|P2|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|223
274993|NCT00910910|665934|P1|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|224
274994|NCT00910910|665933|P2|STARTED|Overall Study||225
274995|NCT00910910|665934|P1|STARTED|Overall Study||225
274996|NCT00910871|665970|P1|NOT COMPLETED|Overall Study||54
274997|NCT00910871|665970|P1|COMPLETED|Overall Study||179
274998|NCT00910871|665970|P1|STARTED|Overall Study||233
274999|NCT00910858|665978|P3|NOT COMPLETED|Combined Treatment Phase||4
275000|NCT00910858|665979|P2|NOT COMPLETED|Combined Treatment Phase||10
275001|NCT00910858|665980|P1|NOT COMPLETED|Combined Treatment Phase||9
275002|NCT00910858|665978|P3|COMPLETED|Combined Treatment Phase||0
275003|NCT00910858|665979|P2|COMPLETED|Combined Treatment Phase||0
275004|NCT00910858|665980|P1|COMPLETED|Combined Treatment Phase||0
275005|NCT00910858|665978|P3|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|4
275006|NCT00910858|665979|P2|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|10
275007|NCT00910858|665980|P1|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|9
275008|NCT00910858|665978|P3|NOT COMPLETED|Monotherapy Phase||7
275009|NCT00910858|665979|P2|NOT COMPLETED|Monotherapy Phase||15
275010|NCT00910858|665980|P1|NOT COMPLETED|Monotherapy Phase||17
275011|NCT00910858|665978|P3|COMPLETED|Monotherapy Phase||0
275012|NCT00910858|665979|P2|COMPLETED|Monotherapy Phase||0
275013|NCT00910858|665980|P1|COMPLETED|Monotherapy Phase||0
275014|NCT00910858|665978|P3|Pharmacokinetic Population|Monotherapy Phase||7
275015|NCT00910858|665979|P2|Pharmacokinetic Population|Monotherapy Phase|Patients in the 15 mg Non-del 5q group were not included in the pharmacokinetic assessment.|0
275016|NCT00910858|665980|P1|Pharmacokinetic Population|Monotherapy Phase||17
275017|NCT00910858|665978|P3|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|7
275018|NCT00910858|665979|P2|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|15
275019|NCT00910858|665980|P1|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|17
275020|NCT00910858|665978|P3|STARTED|Monotherapy Phase|Includes 3 participants from the PK Phase and 4 newly enrolled participants.|7
275021|NCT00910858|665979|P2|STARTED|Monotherapy Phase|All 15 participants were newly enrolled into the Monotherapy Phase.|15
275022|NCT00910858|665980|P1|STARTED|Monotherapy Phase|Includes 8 participants from the PK Phase and 9 newly enrolled participants.|17
275023|NCT00910858|665978|P3|NOT COMPLETED|Pharmacokinetic Phase||0
275024|NCT00910858|665979|P2|NOT COMPLETED|Pharmacokinetic Phase||0
275025|NCT00910858|665980|P1|NOT COMPLETED|Pharmacokinetic Phase||1
275026|NCT00910858|665978|P3|COMPLETED|Pharmacokinetic Phase||3
275027|NCT00910858|665979|P2|COMPLETED|Pharmacokinetic Phase||0
275028|NCT00910858|665980|P1|COMPLETED|Pharmacokinetic Phase||8
275029|NCT00910858|665978|P3|STARTED|Pharmacokinetic Phase||3
275030|NCT00910858|665979|P2|STARTED|Pharmacokinetic Phase||0
275031|NCT00910858|665980|P1|STARTED|Pharmacokinetic Phase||9
275032|NCT00910845|666005|P2|NOT COMPLETED|Treatment Cycle 2||9
275033|NCT00910845|666006|P1|NOT COMPLETED|Treatment Cycle 2||5
275034|NCT00910845|666005|P2|COMPLETED|Treatment Cycle 2||203
275035|NCT00910845|666006|P1|COMPLETED|Treatment Cycle 2||136
275036|NCT00910845|666005|P2|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|212
275037|NCT00910845|666006|P1|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|141
275038|NCT00910845|666005|P2|NOT COMPLETED|Treatment Cycle 1||34
275039|NCT00910845|666006|P1|NOT COMPLETED|Treatment Cycle 1||31
275040|NCT00910845|666005|P2|COMPLETED|Treatment Cycle 1||243
275041|NCT00910845|666006|P1|COMPLETED|Treatment Cycle 1||249
275042|NCT00910845|666005|P2|STARTED|Treatment Cycle 1||277
275043|NCT00910845|666006|P1|STARTED|Treatment Cycle 1||280
275044|NCT00910728|666025|P9|NOT COMPLETED|Overall Study||3
275045|NCT00910728|666026|P8|NOT COMPLETED|Overall Study||3
275046|NCT00910728|666027|P7|NOT COMPLETED|Overall Study||6
275047|NCT00910728|666028|P6|NOT COMPLETED|Overall Study||1
275048|NCT00910728|666029|P5|NOT COMPLETED|Overall Study||5
275049|NCT00910728|666030|P4|NOT COMPLETED|Overall Study||3
275050|NCT00910728|666031|P3|NOT COMPLETED|Overall Study||3
275051|NCT00910728|666032|P2|NOT COMPLETED|Overall Study||3
275052|NCT00910728|666033|P1|NOT COMPLETED|Overall Study||6
275053|NCT00910728|666025|P9|COMPLETED|Overall Study||0
275054|NCT00910728|666026|P8|COMPLETED|Overall Study||1
275055|NCT00910728|666027|P7|COMPLETED|Overall Study||0
275056|NCT00910728|666028|P6|COMPLETED|Overall Study||0
275057|NCT00910728|666029|P5|COMPLETED|Overall Study||1
275058|NCT00910728|666030|P4|COMPLETED|Overall Study||0
275059|NCT00910728|666031|P3|COMPLETED|Overall Study||0
275060|NCT00910728|666032|P2|COMPLETED|Overall Study||0
275061|NCT00910728|666033|P1|COMPLETED|Overall Study||0
275062|NCT00910728|666025|P9|STARTED|Overall Study||3
275063|NCT00910728|666026|P8|STARTED|Overall Study||4
275064|NCT00910728|666027|P7|STARTED|Overall Study||6
275065|NCT00910728|666028|P6|STARTED|Overall Study||1
275066|NCT00910728|666029|P5|STARTED|Overall Study||6
275067|NCT00910728|666030|P4|STARTED|Overall Study||3
275068|NCT00910728|666031|P3|STARTED|Overall Study||3
275069|NCT00910728|666032|P2|STARTED|Overall Study||3
275070|NCT00910728|666033|P1|STARTED|Overall Study||6
275071|NCT00910715|666155|P3|NOT COMPLETED|Overall Study||0
275072|NCT00910715|666156|P2|NOT COMPLETED|Overall Study||26
275073|NCT00910715|666157|P1|NOT COMPLETED|Overall Study||22
275074|NCT00910715|666155|P3|COMPLETED|Overall Study||81
275075|NCT00910715|666156|P2|COMPLETED|Overall Study||91
275076|NCT00910715|666157|P1|COMPLETED|Overall Study||86
275077|NCT00910715|666155|P3|STARTED|Overall Study||81
275078|NCT00910715|666156|P2|STARTED|Overall Study||117
275079|NCT00910715|666157|P1|STARTED|Overall Study||108
275080|NCT00910689|666171|P4|NOT COMPLETED|Months 11- 16: Evaluation Period II||6
275081|NCT00910689|666172|P3|NOT COMPLETED|Months 11- 16: Evaluation Period II||7
275082|NCT00910689|666173|P2|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
275083|NCT00910689|666174|P1|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
275084|NCT00910689|666171|P4|COMPLETED|Months 11- 16: Evaluation Period II||35
275085|NCT00910689|666172|P3|COMPLETED|Months 11- 16: Evaluation Period II||28
275086|NCT00910689|666173|P2|COMPLETED|Months 11- 16: Evaluation Period II||25
275087|NCT00910689|666174|P1|COMPLETED|Months 11- 16: Evaluation Period II||30
275088|NCT00910689|666171|P4|STARTED|Months 11- 16: Evaluation Period II||41
275089|NCT00910689|666172|P3|STARTED|Months 11- 16: Evaluation Period II||35
275090|NCT00910689|666173|P2|STARTED|Months 11- 16: Evaluation Period II||35
275091|NCT00910689|666174|P1|STARTED|Months 11- 16: Evaluation Period II||40
275092|NCT00910689|666171|P4|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
275093|NCT00910689|666172|P3|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
275094|NCT00910689|666173|P2|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
275095|NCT00910689|666174|P1|NOT COMPLETED|Months 5 - 10: Evaluation Period I||4
275096|NCT00910689|666171|P4|COMPLETED|Months 5 - 10: Evaluation Period I||41
275097|NCT00910689|666172|P3|COMPLETED|Months 5 - 10: Evaluation Period I||35
275098|NCT00910689|666173|P2|COMPLETED|Months 5 - 10: Evaluation Period I||35
275099|NCT00910689|666174|P1|COMPLETED|Months 5 - 10: Evaluation Period I||40
275100|NCT00910689|666171|P4|STARTED|Months 5 - 10: Evaluation Period I||48
275101|NCT00910689|666172|P3|STARTED|Months 5 - 10: Evaluation Period I||42
275102|NCT00910689|666173|P2|STARTED|Months 5 - 10: Evaluation Period I||42
275103|NCT00910689|666174|P1|STARTED|Months 5 - 10: Evaluation Period I||44
275104|NCT00910689|666171|P4|NOT COMPLETED|Month 2- 4: Treatment Period||11
275105|NCT00910689|666172|P3|NOT COMPLETED|Month 2- 4: Treatment Period||8
275106|NCT00910689|666173|P2|NOT COMPLETED|Month 2- 4: Treatment Period||10
275107|NCT00910689|666174|P1|NOT COMPLETED|Month 2- 4: Treatment Period||9
275108|NCT00910689|666171|P4|COMPLETED|Month 2- 4: Treatment Period||48
275109|NCT00910689|666172|P3|COMPLETED|Month 2- 4: Treatment Period||42
275110|NCT00910689|666173|P2|COMPLETED|Month 2- 4: Treatment Period||42
275111|NCT00910689|666174|P1|COMPLETED|Month 2- 4: Treatment Period||44
275112|NCT00910689|666171|P4|STARTED|Month 2- 4: Treatment Period||59
275113|NCT00910689|666172|P3|STARTED|Month 2- 4: Treatment Period||50
275114|NCT00910689|666173|P2|STARTED|Month 2- 4: Treatment Period||52
275115|NCT00910689|666174|P1|STARTED|Month 2- 4: Treatment Period||53
275116|NCT00910689|666171|P4|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||10
275117|NCT00910689|666172|P3|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||5
275118|NCT00910689|666173|P2|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||1
275119|NCT00910689|666174|P1|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||2
275120|NCT00910689|666171|P4|COMPLETED|Month 1: Optimal Acute Therapy Run in||59
275121|NCT00910689|666172|P3|COMPLETED|Month 1: Optimal Acute Therapy Run in||50
275122|NCT00910689|666173|P2|COMPLETED|Month 1: Optimal Acute Therapy Run in||52
275123|NCT00910689|666174|P1|COMPLETED|Month 1: Optimal Acute Therapy Run in||53
275124|NCT00910689|666171|P4|STARTED|Month 1: Optimal Acute Therapy Run in||69
275125|NCT00910689|666172|P3|STARTED|Month 1: Optimal Acute Therapy Run in||55
275126|NCT00910689|666173|P2|STARTED|Month 1: Optimal Acute Therapy Run in||53
275127|NCT00910689|666174|P1|STARTED|Month 1: Optimal Acute Therapy Run in||55
275128|NCT00910663|666206|P2|NOT COMPLETED|Period 2||0
275129|NCT00910663|666207|P1|NOT COMPLETED|Period 2||0
275130|NCT00910663|666206|P2|COMPLETED|Period 2||29
275131|NCT00910663|666207|P1|COMPLETED|Period 2||30
275132|NCT00910663|666206|P2|STARTED|Period 2||29
275133|NCT00910663|666207|P1|STARTED|Period 2||30
275134|NCT00910663|666206|P2|NOT COMPLETED|Period 1||1
275135|NCT00910663|666207|P1|NOT COMPLETED|Period 1||0
275136|NCT00910663|666206|P2|COMPLETED|Period 1||29
275137|NCT00910663|666207|P1|COMPLETED|Period 1||30
275138|NCT00910663|666206|P2|STARTED|Period 1||30
275139|NCT00910663|666207|P1|STARTED|Period 1||30
275140|NCT00910624|666221|P4|NOT COMPLETED|Follow-Up Phase||0
275141|NCT00910624|666222|P3|NOT COMPLETED|Follow-Up Phase||4
275142|NCT00910624|666223|P2|NOT COMPLETED|Follow-Up Phase||4
275143|NCT00910624|666224|P1|NOT COMPLETED|Follow-Up Phase||6
275144|NCT00910624|666221|P4|COMPLETED|Follow-Up Phase||2
275145|NCT00910624|666222|P3|COMPLETED|Follow-Up Phase||25
275146|NCT00910624|666223|P2|COMPLETED|Follow-Up Phase||76
275147|NCT00910624|666224|P1|COMPLETED|Follow-Up Phase||42
275148|NCT00910624|666221|P4|STARTED|Follow-Up Phase||2
275149|NCT00910624|666222|P3|STARTED|Follow-Up Phase||29
275150|NCT00910624|666223|P2|STARTED|Follow-Up Phase||80
275151|NCT00910624|666224|P1|STARTED|Follow-Up Phase||48
275152|NCT00910624|666221|P4|NOT COMPLETED|Treatment Phase||0
275153|NCT00910624|666222|P3|NOT COMPLETED|Treatment Phase||9
275154|NCT00910624|666223|P2|NOT COMPLETED|Treatment Phase||21
275155|NCT00910624|666224|P1|NOT COMPLETED|Treatment Phase||30
275156|NCT00910624|666221|P4|COMPLETED|Treatment Phase||2
275157|NCT00910624|666222|P3|COMPLETED|Treatment Phase||20
275158|NCT00910624|666223|P2|COMPLETED|Treatment Phase||64
275159|NCT00910624|666224|P1|COMPLETED|Treatment Phase||22
275160|NCT00910624|666221|P4|STARTED|Treatment Phase||2
275161|NCT00910624|666222|P3|STARTED|Treatment Phase||29
275162|NCT00910624|666223|P2|STARTED|Treatment Phase||85
275163|NCT00910624|666224|P1|STARTED|Treatment Phase||52
275164|NCT00910520|666238|P2|NOT COMPLETED|Treatment Cycle 2||8
275165|NCT00910520|666239|P1|NOT COMPLETED|Treatment Cycle 2||7
275166|NCT00910520|666238|P2|COMPLETED|Treatment Cycle 2||215
275167|NCT00910520|666239|P1|COMPLETED|Treatment Cycle 2||156
275168|NCT00910520|666238|P2|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|223
275169|NCT00910520|666239|P1|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|163
275170|NCT00910520|666238|P2|NOT COMPLETED|Treatment Cycle 1||24
275171|NCT00910520|666239|P1|NOT COMPLETED|Treatment Cycle 1||20
275172|NCT00910520|666238|P2|COMPLETED|Treatment Cycle 1||247
275173|NCT00910520|666239|P1|COMPLETED|Treatment Cycle 1||257
275174|NCT00910520|666238|P2|STARTED|Treatment Cycle 1||271
275175|NCT00910520|666239|P1|STARTED|Treatment Cycle 1||277
275176|NCT00910299|666251|P2|NOT COMPLETED|Overall Study||74
275177|NCT00910299|666252|P1|NOT COMPLETED|Overall Study||76
275178|NCT00910299|666251|P2|COMPLETED|Overall Study|1 participant died of sepsis while on study drug and was considered a “protocol completer.”|137
275179|NCT00910299|666252|P1|COMPLETED|Overall Study||136
275180|NCT00910299|666251|P2|Received at Least 1 Dose of Study Drug|Overall Study||210
275181|NCT00910299|666252|P1|Received at Least 1 Dose of Study Drug|Overall Study||210
275182|NCT00910299|666251|P2|STARTED|Overall Study||211
275183|NCT00910299|666252|P1|STARTED|Overall Study||212
275184|NCT00910273|666264|P2|NOT COMPLETED|Overall Study||13
275185|NCT00910273|666265|P1|NOT COMPLETED|Overall Study||18
275186|NCT00910273|666264|P2|COMPLETED|Overall Study||3
275187|NCT00910273|666265|P1|COMPLETED|Overall Study||0
275188|NCT00910273|666264|P2|STARTED|Overall Study||16
275189|NCT00910273|666265|P1|STARTED|Overall Study||18
275190|NCT00910247|666315|P1|NOT COMPLETED|Overall Study||69
275191|NCT00910247|666315|P1|COMPLETED|Overall Study||205
275192|NCT00910247|666315|P1|STARTED|Overall Study||274
275193|NCT00910091|666337|P2|NOT COMPLETED|Treatment and Survival||4
275194|NCT00910091|666338|P1|NOT COMPLETED|Treatment and Survival||4
275195|NCT00910091|666337|P2|COMPLETED|Treatment and Survival||31
275196|NCT00910091|666338|P1|COMPLETED|Treatment and Survival||32
275197|NCT00910091|666337|P2|STARTED|Treatment and Survival||35
275198|NCT00910091|666338|P1|STARTED|Treatment and Survival||36
275199|NCT00910091|666337|P2|NOT COMPLETED|Pre-assignment||2
275200|NCT00910091|666338|P1|NOT COMPLETED|Pre-assignment||0
275201|NCT00910091|666337|P2|COMPLETED|Pre-assignment||35
275202|NCT00910091|666338|P1|COMPLETED|Pre-assignment||36
275203|NCT00910091|666337|P2|STARTED|Pre-assignment||37
275204|NCT00910091|666338|P1|STARTED|Pre-assignment||36
275205|NCT00910039|666366|P1|NOT COMPLETED|Overall Study||1
275206|NCT00910039|666366|P1|COMPLETED|Overall Study||13
275207|NCT00910039|666366|P1|STARTED|Overall Study||14
275208|NCT00910000|666383|P6|NOT COMPLETED|Overall Study||1
275209|NCT00910000|666384|P5|NOT COMPLETED|Overall Study||1
275210|NCT00910000|666385|P4|NOT COMPLETED|Overall Study||2
275211|NCT00910000|666386|P3|NOT COMPLETED|Overall Study||3
275212|NCT00910000|666387|P2|NOT COMPLETED|Overall Study||3
275213|NCT00910000|666388|P1|NOT COMPLETED|Overall Study||0
275214|NCT00910000|666383|P6|COMPLETED|Overall Study||0
275215|NCT00910000|666384|P5|COMPLETED|Overall Study||2
275216|NCT00910000|666385|P4|COMPLETED|Overall Study||0
275217|NCT00910000|666386|P3|COMPLETED|Overall Study||0
275218|NCT00910000|666387|P2|COMPLETED|Overall Study||0
275219|NCT00910000|666388|P1|COMPLETED|Overall Study||3
275220|NCT00910000|666383|P6|STARTED|Overall Study||1
275221|NCT00910000|666384|P5|STARTED|Overall Study||3
275222|NCT00910000|666385|P4|STARTED|Overall Study||2
275223|NCT00910000|666386|P3|STARTED|Overall Study||3
275224|NCT00910000|666387|P2|STARTED|Overall Study||3
275225|NCT00910000|666388|P1|STARTED|Overall Study||3
275226|NCT00909870|666406|P2|NOT COMPLETED|Overall Study||27
275227|NCT00909870|666407|P1|NOT COMPLETED|Overall Study||23
275228|NCT00909870|666406|P2|COMPLETED|Overall Study||236
275229|NCT00909870|666407|P1|COMPLETED|Overall Study||251
275230|NCT00909870|666406|P2|STARTED|Overall Study||263
275231|NCT00909870|666407|P1|STARTED|Overall Study||274
275232|NCT00909857|666419|P2|NOT COMPLETED|Overall Study||45
275233|NCT00909857|666420|P1|NOT COMPLETED|Overall Study||36
275234|NCT00909857|666419|P2|COMPLETED|Overall Study||209
275235|NCT00909857|666420|P1|COMPLETED|Overall Study||217
275236|NCT00909857|666419|P2|Treated|Overall Study||230
275237|NCT00909857|666420|P1|Treated|Overall Study||234
275238|NCT00909857|666419|P2|STARTED|Overall Study||254
275239|NCT00909857|666420|P1|STARTED|Overall Study||253
275240|NCT00909844|666560|P1|NOT COMPLETED|Overall Study||4
275241|NCT00909844|666560|P1|COMPLETED|Overall Study||31
275242|NCT00909844|666560|P1|STARTED|Overall Study||35
275243|NCT00909792|666578|P2|NOT COMPLETED|Period 2||1
275244|NCT00909792|666579|P1|NOT COMPLETED|Period 2||1
275245|NCT00909792|666578|P2|COMPLETED|Period 2||124
275246|NCT00909792|666579|P1|COMPLETED|Period 2||128
275247|NCT00909792|666578|P2|STARTED|Period 2|Two discontinuations between P1 & P2: 1 for fail inc/exc criteria; 1 for lack of efficacy.|125
275248|NCT00909792|666579|P1|STARTED|Period 2|One participant discontinued between Period 1 and Period 2 due to lack of efficacy.|129
275249|NCT00909792|666578|P2|NOT COMPLETED|Period 1||1
275250|NCT00909792|666579|P1|NOT COMPLETED|Period 1||0
275251|NCT00909792|666578|P2|COMPLETED|Period 1||127
275252|NCT00909792|666579|P1|COMPLETED|Period 1||130
275253|NCT00909792|666578|P2|STARTED|Period 1||128
275254|NCT00909792|666579|P1|STARTED|Period 1||130
275255|NCT00909779|666587|P2|NOT COMPLETED|Overall Study||165
275256|NCT00909779|666588|P1|NOT COMPLETED|Overall Study||210
275257|NCT00909779|666587|P2|COMPLETED|Overall Study|All subjects but 42 were followed for 12 months/until death (whichever was earlier).|255
275258|NCT00909779|666588|P1|COMPLETED|Overall Study|All subjects but 47 were followed for 12 months/until death (whichever was earlier).|211
275259|NCT00909779|666587|P2|STARTED|Overall Study||420
275260|NCT00909779|666588|P1|STARTED|Overall Study||421
275261|NCT00909753|666612|P2|NOT COMPLETED|Period: Second Intervention||0
275262|NCT00909753|666613|P1|NOT COMPLETED|Period: Second Intervention||1
275263|NCT00909753|666612|P2|COMPLETED|Period: Second Intervention||43
275264|NCT00909753|666613|P1|COMPLETED|Period: Second Intervention||43
275265|NCT00909753|666612|P2|STARTED|Period: Second Intervention||43
275266|NCT00909753|666613|P1|STARTED|Period: Second Intervention||44
275267|NCT00909753|666612|P2|NOT COMPLETED|Period: Washout of 28 Days||3
275268|NCT00909753|666613|P1|NOT COMPLETED|Period: Washout of 28 Days||2
275269|NCT00909753|666612|P2|COMPLETED|Period: Washout of 28 Days||43
275270|NCT00909753|666613|P1|COMPLETED|Period: Washout of 28 Days||44
275271|NCT00909753|666612|P2|STARTED|Period: Washout of 28 Days||46
275272|NCT00909753|666613|P1|STARTED|Period: Washout of 28 Days||46
275273|NCT00909753|666612|P2|NOT COMPLETED|Period: First Intervention||0
275274|NCT00909753|666613|P1|NOT COMPLETED|Period: First Intervention||0
275275|NCT00909753|666612|P2|COMPLETED|Period: First Intervention||46
275276|NCT00909753|666613|P1|COMPLETED|Period: First Intervention||46
275277|NCT00909753|666612|P2|STARTED|Period: First Intervention||46
275278|NCT00909753|666613|P1|STARTED|Period: First Intervention||46
275279|NCT00909727|666633|P2|NOT COMPLETED|Overall Study||0
275280|NCT00909727|666634|P1|NOT COMPLETED|Overall Study||4
275281|NCT00909727|666633|P2|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|26
275282|NCT00909727|666634|P1|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|22
275283|NCT00909727|666633|P2|Completed Treatment Period, Week 24|Overall Study||26
275284|NCT00909727|666634|P1|Completed Treatment Period, Week 24|Overall Study||23
275285|NCT00909727|666633|P2|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor)|26
275286|NCT00909727|666634|P1|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo)|26
275287|NCT00909649|666650|P2|NOT COMPLETED|Overall Study||0
275288|NCT00909649|666651|P1|NOT COMPLETED|Overall Study||0
275289|NCT00909649|666650|P2|COMPLETED|Overall Study||25
275290|NCT00909649|666651|P1|COMPLETED|Overall Study||25
275291|NCT00909649|666650|P2|STARTED|Overall Study||25
275292|NCT00909649|666651|P1|STARTED|Overall Study||25
275293|NCT00909610|666657|P2|NOT COMPLETED|Period: Second Intervention||0
275294|NCT00909610|666658|P1|NOT COMPLETED|Period: Second Intervention||1
275295|NCT00909610|666657|P2|COMPLETED|Period: Second Intervention||33
275296|NCT00909610|666658|P1|COMPLETED|Period: Second Intervention||36
275297|NCT00909610|666657|P2|STARTED|Period: Second Intervention||33
275298|NCT00909610|666658|P1|STARTED|Period: Second Intervention||37
275299|NCT00909610|666657|P2|NOT COMPLETED|Period: Washout of 28 Days||6
275300|NCT00909610|666658|P1|NOT COMPLETED|Period: Washout of 28 Days||3
275301|NCT00909610|666657|P2|COMPLETED|Period: Washout of 28 Days||33
275302|NCT00909610|666658|P1|COMPLETED|Period: Washout of 28 Days||37
275303|NCT00909610|666657|P2|STARTED|Period: Washout of 28 Days||39
275304|NCT00909610|666658|P1|STARTED|Period: Washout of 28 Days||40
275305|NCT00909610|666657|P2|NOT COMPLETED|Period: First Intervention||1
275306|NCT00909610|666658|P1|NOT COMPLETED|Period: First Intervention||0
275307|NCT00909610|666657|P2|COMPLETED|Period: First Intervention||39
275308|NCT00909610|666658|P1|COMPLETED|Period: First Intervention||40
275309|NCT00909610|666657|P2|STARTED|Period: First Intervention||40
275310|NCT00909610|666658|P1|STARTED|Period: First Intervention||40
275311|NCT00909545|666680|P4|NOT COMPLETED|Overall Study||5
275312|NCT00909545|666681|P3|NOT COMPLETED|Overall Study||1
275313|NCT00909545|666682|P2|NOT COMPLETED|Overall Study||1
275314|NCT00909545|666683|P1|NOT COMPLETED|Overall Study||1
275315|NCT00909545|666680|P4|COMPLETED|Overall Study||19
275316|NCT00909545|666681|P3|COMPLETED|Overall Study||25
275317|NCT00909545|666682|P2|COMPLETED|Overall Study||22
275318|NCT00909545|666683|P1|COMPLETED|Overall Study||25
275319|NCT00909545|666680|P4|STARTED|Overall Study||24
275320|NCT00909545|666681|P3|STARTED|Overall Study||26
275321|NCT00909545|666682|P2|STARTED|Overall Study||23
275322|NCT00909545|666683|P1|STARTED|Overall Study||26
275323|NCT00909532|666819|P2|NOT COMPLETED|Overall Study||6
275324|NCT00909532|666820|P1|NOT COMPLETED|Overall Study||10
275325|NCT00909532|666819|P2|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|77
275326|NCT00909532|666820|P1|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|68
275327|NCT00909532|666819|P2|Completed Treatment Period, Week 24|Overall Study||80
275328|NCT00909532|666820|P1|Completed Treatment Period, Week 24|Overall Study||71
275329|NCT00909532|666819|P2|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor).|83
275330|NCT00909532|666820|P1|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo).|78
275331|NCT00909480|666838|P2|NOT COMPLETED|Overall Study||41
275332|NCT00909480|666839|P1|NOT COMPLETED|Overall Study||38
275333|NCT00909480|666838|P2|COMPLETED|Overall Study||188
275334|NCT00909480|666839|P1|COMPLETED|Overall Study||190
275335|NCT00909480|666838|P2|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|227
275336|NCT00909480|666839|P1|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|226
275337|NCT00909480|666838|P2|STARTED|Overall Study||229
275338|NCT00909480|666839|P1|STARTED|Overall Study||228
275339|NCT00909428|666874|P3|NOT COMPLETED|Overall Study||9
275340|NCT00909428|666875|P2|NOT COMPLETED|Overall Study||10
275341|NCT00909428|666876|P1|NOT COMPLETED|Overall Study||13
275342|NCT00909428|666874|P3|COMPLETED|Overall Study||0
275343|NCT00909428|666875|P2|COMPLETED|Overall Study||5
275344|NCT00909428|666876|P1|COMPLETED|Overall Study||5
275345|NCT00909428|666874|P3|STARTED|Overall Study||9
275346|NCT00909428|666875|P2|STARTED|Overall Study||15
275347|NCT00909428|666876|P1|STARTED|Overall Study||18
275348|NCT00909389|666883|P1|NOT COMPLETED|Overall Study||133
275349|NCT00909389|666883|P1|COMPLETED|Overall Study||4615
275350|NCT00909389|666883|P1|STARTED|Overall Study||4748
275351|NCT00909363|666890|P3|NOT COMPLETED|Overall Study||0
275352|NCT00909363|666891|P2|NOT COMPLETED|Overall Study||0
275353|NCT00909363|666892|P1|NOT COMPLETED|Overall Study||2
275354|NCT00909363|666890|P3|COMPLETED|Overall Study||5
275355|NCT00909363|666891|P2|COMPLETED|Overall Study||8
275356|NCT00909363|666892|P1|COMPLETED|Overall Study|1 patient started bleeding 3 days after starting eltrombopag; he underwent bone marrow transplant|9
275357|NCT00909363|666890|P3|STARTED|Overall Study||5
275358|NCT00909363|666891|P2|STARTED|Overall Study||8
275359|NCT00909363|666892|P1|STARTED|Overall Study||11
275360|NCT00909324|666911|P2|NOT COMPLETED|Overall Study||0
275361|NCT00909324|666912|P1|NOT COMPLETED|Overall Study||0
275362|NCT00909324|666911|P2|COMPLETED|Overall Study||90
275363|NCT00909324|666912|P1|COMPLETED|Overall Study||72
275364|NCT00909324|666911|P2|STARTED|Overall Study||90
275365|NCT00909324|666912|P1|STARTED|Overall Study||72
275366|NCT00909220|666924|P2|NOT COMPLETED|Overall Study||0
275367|NCT00909220|666925|P1|NOT COMPLETED|Overall Study||0
275368|NCT00909220|666924|P2|COMPLETED|Overall Study||36
275369|NCT00909220|666925|P1|COMPLETED|Overall Study||41
275370|NCT00909220|666924|P2|Submission for Publication|Overall Study||36
275371|NCT00909220|666925|P1|Submission for Publication|Overall Study||41
275372|NCT00909220|666924|P2|Data Analyses|Overall Study||36
275373|NCT00909220|666925|P1|Data Analyses|Overall Study||41
275374|NCT00909220|666924|P2|Data Entry|Overall Study||36
275375|NCT00909220|666925|P1|Data Entry|Overall Study||41
275376|NCT00909220|666924|P2|STARTED|Overall Study|Started enrolling participants May 2009|36
275377|NCT00909220|666925|P1|STARTED|Overall Study|Started enrolling participants May 2009|41
275378|NCT00909181|666939|P3|NOT COMPLETED|Overall Study||33
275379|NCT00909181|666940|P2|NOT COMPLETED|Overall Study||18
275380|NCT00909181|666941|P1|NOT COMPLETED|Overall Study||39
275381|NCT00909181|666939|P3|COMPLETED|Overall Study||169
275382|NCT00909181|666940|P2|COMPLETED|Overall Study||196
275383|NCT00909181|666941|P1|COMPLETED|Overall Study||171
275384|NCT00909181|666939|P3|STARTED|Overall Study||202
275385|NCT00909181|666940|P2|STARTED|Overall Study||214
275386|NCT00909181|666941|P1|STARTED|Overall Study||210
275387|NCT00909155|666952|P3|NOT COMPLETED|Overall Study||7
275388|NCT00909155|666953|P2|NOT COMPLETED|Overall Study||5
275389|NCT00909155|666954|P1|NOT COMPLETED|Overall Study||3
275390|NCT00909155|666952|P3|COMPLETED|Overall Study||14
275391|NCT00909155|666953|P2|COMPLETED|Overall Study||9
275392|NCT00909155|666954|P1|COMPLETED|Overall Study||12
275393|NCT00909155|666952|P3|STARTED|Overall Study||21
275394|NCT00909155|666953|P2|STARTED|Overall Study||14
275395|NCT00909155|666954|P1|STARTED|Overall Study||15
275396|NCT00909064|666965|P1|NOT COMPLETED|Overall Study||0
275397|NCT00909064|666965|P1|COMPLETED|Overall Study||114
275398|NCT00909064|666965|P1|STARTED|Overall Study||114
275399|NCT00909038|666971|P1|NOT COMPLETED|Overall Study||417
275400|NCT00909038|666971|P1|COMPLETED|Overall Study||1994
275401|NCT00909038|666971|P1|STARTED|Overall Study||2411
275402|NCT00908960|666983|P3|NOT COMPLETED|Overall Study||2
275403|NCT00908960|666984|P2|NOT COMPLETED|Overall Study||1
275404|NCT00908960|666985|P1|NOT COMPLETED|Overall Study||1
275405|NCT00908960|666983|P3|COMPLETED|Overall Study||32
275406|NCT00908960|666984|P2|COMPLETED|Overall Study||11
275407|NCT00908960|666985|P1|COMPLETED|Overall Study||23
275408|NCT00908960|666983|P3|Evaluable|Overall Study||32
275409|NCT00908960|666984|P2|Evaluable|Overall Study||11
275410|NCT00908960|666985|P1|Evaluable|Overall Study||23
275411|NCT00908960|666983|P3|STARTED|Overall Study||34
275412|NCT00908960|666984|P2|STARTED|Overall Study||12
275413|NCT00908960|666985|P1|STARTED|Overall Study||24
275414|NCT00908947|666999|P1|NOT COMPLETED|Overall Study||90
275415|NCT00908947|666999|P1|COMPLETED|Overall Study||83
275416|NCT00908947|666999|P1|STARTED|Overall Study||173
275417|NCT00908908|667021|P1|NOT COMPLETED|Overall Study||0
275418|NCT00908908|667021|P1|COMPLETED|Overall Study||6
275419|NCT00908908|667021|P1|Physician Decision|Overall Study||0
275420|NCT00908908|667021|P1|Administrative/Other|Overall Study||0
275421|NCT00908908|667021|P1|Withdrawl by Subject|Overall Study||0
275422|NCT00908908|667021|P1|Adverse Event|Overall Study||0
275423|NCT00908908|667021|P1|STARTED|Overall Study||6
275424|NCT00908895|667029|P2|NOT COMPLETED|Overall Study||6
275425|NCT00908895|667030|P1|NOT COMPLETED|Overall Study||4
275426|NCT00908895|667029|P2|COMPLETED|Overall Study||57
275427|NCT00908895|667030|P1|COMPLETED|Overall Study||53
275428|NCT00908895|667029|P2|STARTED|Overall Study||63
275429|NCT00908895|667030|P1|STARTED|Overall Study||57
275430|NCT00908882|667040|P2|NOT COMPLETED|Overall Study||30
275431|NCT00908882|667041|P1|NOT COMPLETED|Overall Study||28
275432|NCT00908882|667040|P2|COMPLETED|Overall Study||59
275433|NCT00908882|667041|P1|COMPLETED|Overall Study||61
275434|NCT00908882|667040|P2|STARTED|Overall Study||89
275435|NCT00908882|667041|P1|STARTED|Overall Study||89
275436|NCT00908830|667067|P2|NOT COMPLETED|Overall Study||0
275437|NCT00908830|667068|P1|NOT COMPLETED|Overall Study||0
275438|NCT00908830|667067|P2|COMPLETED|Overall Study||5
275439|NCT00908830|667068|P1|COMPLETED|Overall Study||5
275440|NCT00908830|667067|P2|STARTED|Overall Study||5
275441|NCT00908830|667068|P1|STARTED|Overall Study||5
275442|NCT00908791|667076|P1|NOT COMPLETED|Overall Study||0
275443|NCT00908791|667076|P1|COMPLETED|Overall Study||24
275444|NCT00908791|667076|P1|STARTED|Overall Study||24
275445|NCT00908687|667099|P6|NOT COMPLETED|Overall Study||6
275446|NCT00908687|667100|P5|NOT COMPLETED|Overall Study||4
275447|NCT00908687|667101|P4|NOT COMPLETED|Overall Study||3
275448|NCT00908687|667102|P3|NOT COMPLETED|Overall Study||3
275449|NCT00908687|667103|P2|NOT COMPLETED|Overall Study||1
275450|NCT00908687|667104|P1|NOT COMPLETED|Overall Study||1
275451|NCT00908687|667099|P6|COMPLETED|Overall Study||94
275452|NCT00908687|667100|P5|COMPLETED|Overall Study||94
275453|NCT00908687|667101|P4|COMPLETED|Overall Study||47
275454|NCT00908687|667102|P3|COMPLETED|Overall Study||99
275455|NCT00908687|667103|P2|COMPLETED|Overall Study||99
275456|NCT00908687|667104|P1|COMPLETED|Overall Study||49
275457|NCT00908687|667099|P6|STARTED|Overall Study||100
275458|NCT00908687|667100|P5|STARTED|Overall Study||98
275459|NCT00908687|667101|P4|STARTED|Overall Study||50
275460|NCT00908687|667102|P3|STARTED|Overall Study||102
275461|NCT00908687|667103|P2|STARTED|Overall Study||100
275462|NCT00908687|667104|P1|STARTED|Overall Study||50
275463|NCT00908648|667120|P2|NOT COMPLETED|Overall Study||0
275464|NCT00908648|667121|P1|NOT COMPLETED|Overall Study||0
275465|NCT00908648|667120|P2|COMPLETED|Overall Study||103
275466|NCT00908648|667121|P1|COMPLETED|Overall Study||108
275467|NCT00908648|667120|P2|STARTED|Overall Study||103
275468|NCT00908648|667121|P1|STARTED|Overall Study||108
275469|NCT00908596|667131|P4|NOT COMPLETED|Overall Study||37
275470|NCT00908596|667132|P3|NOT COMPLETED|Overall Study||74
275471|NCT00908596|667133|P2|NOT COMPLETED|Overall Study||13
275472|NCT00908596|667134|P1|NOT COMPLETED|Overall Study||47
275473|NCT00908596|667131|P4|COMPLETED|Overall Study||48
275474|NCT00908596|667132|P3|COMPLETED|Overall Study||119
275475|NCT00908596|667133|P2|COMPLETED|Overall Study||19
275476|NCT00908596|667134|P1|COMPLETED|Overall Study||0
275477|NCT00908596|667131|P4|STARTED|Overall Study||85
275478|NCT00908596|667132|P3|STARTED|Overall Study||193
275479|NCT00908596|667133|P2|STARTED|Overall Study||32
275480|NCT00908596|667134|P1|STARTED|Overall Study||47
275481|NCT00908583|667164|P1|NOT COMPLETED|Phase 5||3
275482|NCT00908583|667164|P1|COMPLETED|Phase 5||2
275483|NCT00908583|667164|P1|STARTED|Phase 5||5
275484|NCT00908583|667164|P1|NOT COMPLETED|Phase 4||2
275485|NCT00908583|667164|P1|COMPLETED|Phase 4||3
275486|NCT00908583|667164|P1|STARTED|Phase 4||5
275487|NCT00908583|667164|P1|NOT COMPLETED|Phase 3||2
275488|NCT00908583|667164|P1|COMPLETED|Phase 3||8
275489|NCT00908583|667164|P1|STARTED|Phase 3||10
275490|NCT00908583|667164|P1|NOT COMPLETED|Phase 2||2
275491|NCT00908583|667164|P1|COMPLETED|Phase 2||10
275492|NCT00908583|667164|P1|STARTED|Phase 2||12
275493|NCT00908583|667164|P1|NOT COMPLETED|Phase 1||5
275494|NCT00908583|667164|P1|COMPLETED|Phase 1||15
275495|NCT00908583|667164|P1|STARTED|Phase 1||20
275496|NCT00908544|667184|P2|NOT COMPLETED|Overall Study||6
275497|NCT00908544|667185|P1|NOT COMPLETED|Overall Study||5
275498|NCT00908544|667184|P2|COMPLETED|Overall Study||16
275499|NCT00908544|667185|P1|COMPLETED|Overall Study||15
275500|NCT00908544|667184|P2|STARTED|Overall Study||22
275501|NCT00908544|667185|P1|STARTED|Overall Study||20
275502|NCT00908466|667227|P2|NOT COMPLETED|Overall Study||1
275503|NCT00908466|667228|P1|NOT COMPLETED|Overall Study||1
275504|NCT00908466|667227|P2|COMPLETED|Overall Study||14
275505|NCT00908466|667228|P1|COMPLETED|Overall Study||14
275506|NCT00908466|667227|P2|STARTED|Overall Study||15
275507|NCT00908466|667228|P1|STARTED|Overall Study||15
275508|NCT00908388|667234|P1|NOT COMPLETED|Overall Study||10
275509|NCT00908388|667234|P1|COMPLETED|Overall Study||40
275510|NCT00908388|667234|P1|STARTED|Overall Study||50
275511|NCT00908375|667244|P2|NOT COMPLETED|Overall Study||10
275512|NCT00908375|667245|P1|NOT COMPLETED|Overall Study||10
275513|NCT00908375|667244|P2|COMPLETED|Overall Study||9
275514|NCT00908375|667245|P1|COMPLETED|Overall Study||10
275515|NCT00908375|667244|P2|STARTED|Overall Study||19
275516|NCT00908375|667245|P1|STARTED|Overall Study||20
275517|NCT00908349|667255|P1|NOT COMPLETED|Overall Study||35
275518|NCT00908349|667255|P1|COMPLETED|Overall Study||179
275519|NCT00908349|667255|P1|STARTED|Overall Study||214
275520|NCT00908310|667259|P1|NOT COMPLETED|Overall Study||60
275521|NCT00908310|667259|P1|COMPLETED|Overall Study||153
275522|NCT00908310|667259|P1|STARTED|Overall Study||213
275523|NCT00908232|667263|P4|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||0
275524|NCT00908232|667264|P3|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||1
275525|NCT00908232|667265|P2|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||3
275526|NCT00908232|667266|P1|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||35
275527|NCT00908232|667263|P4|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
275528|NCT00908232|667264|P3|COMPLETED|Randomization (Cycle 5) to Cycle 8||7
275529|NCT00908232|667265|P2|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
275530|NCT00908232|667266|P1|COMPLETED|Randomization (Cycle 5) to Cycle 8||63
275531|NCT00908232|667263|P4|STARTED|Randomization (Cycle 5) to Cycle 8||4
275532|NCT00908232|667264|P3|STARTED|Randomization (Cycle 5) to Cycle 8||8
275533|NCT00908232|667265|P2|STARTED|Randomization (Cycle 5) to Cycle 8||7
275534|NCT00908232|667266|P1|STARTED|Randomization (Cycle 5) to Cycle 8|Responding patients (not randomized) who received 4 more cycles of VD|98
275535|NCT00908232|667263|P4|NOT COMPLETED|Cycle 1 to 4||0
275536|NCT00908232|667264|P3|NOT COMPLETED|Cycle 1 to 4||0
275537|NCT00908232|667265|P2|NOT COMPLETED|Cycle 1 to 4||0
275538|NCT00908232|667266|P1|NOT COMPLETED|Cycle 1 to 4||28
275539|NCT00908232|667263|P4|COMPLETED|Cycle 1 to 4||0
275540|NCT00908232|667264|P3|COMPLETED|Cycle 1 to 4||0
275541|NCT00908232|667265|P2|COMPLETED|Cycle 1 to 4||0
275542|NCT00908232|667266|P1|COMPLETED|Cycle 1 to 4|Of those completed, 120 subjects were assessed for response, 117 w/ Response or SD continued.|135
275543|NCT00908232|667263|P4|STARTED|Cycle 1 to 4||0
275544|NCT00908232|667264|P3|STARTED|Cycle 1 to 4||0
275545|NCT00908232|667265|P2|STARTED|Cycle 1 to 4||0
275546|NCT00908232|667266|P1|STARTED|Cycle 1 to 4|All participants started VD treatment for 4 cycles prior to local site response assessments|163
275547|NCT00908141|667284|P2|NOT COMPLETED|Overall Study||1
275548|NCT00908141|667285|P1|NOT COMPLETED|Overall Study||0
275549|NCT00908141|667284|P2|COMPLETED|Overall Study||8
275550|NCT00908141|667285|P1|COMPLETED|Overall Study||8
275551|NCT00908141|667284|P2|STARTED|Overall Study||9
275552|NCT00908141|667285|P1|STARTED|Overall Study||8
275553|NCT00908128|667293|P2|NOT COMPLETED|Period 4||0
275554|NCT00908128|667294|P1|NOT COMPLETED|Period 4||0
275555|NCT00908128|667293|P2|COMPLETED|Period 4||19
275556|NCT00908128|667294|P1|COMPLETED|Period 4||20
275557|NCT00908128|667293|P2|STARTED|Period 4|One subject withdrew prior to Period 4 dosing due to adverse events|19
275558|NCT00908128|667294|P1|STARTED|Period 4||20
275559|NCT00908128|667293|P2|NOT COMPLETED|Period 3||0
275560|NCT00908128|667294|P1|NOT COMPLETED|Period 3||0
275561|NCT00908128|667293|P2|COMPLETED|Period 3||20
275562|NCT00908128|667294|P1|COMPLETED|Period 3||20
275563|NCT00908128|667293|P2|STARTED|Period 3||20
275564|NCT00908128|667294|P1|STARTED|Period 3||20
275565|NCT00908128|667293|P2|NOT COMPLETED|Period 2||0
275566|NCT00908128|667294|P1|NOT COMPLETED|Period 2||0
275567|NCT00908128|667293|P2|COMPLETED|Period 2||20
275568|NCT00908128|667294|P1|COMPLETED|Period 2||20
275569|NCT00908128|667293|P2|STARTED|Period 2||20
275570|NCT00908128|667294|P1|STARTED|Period 2||20
275571|NCT00908128|667293|P2|NOT COMPLETED|Period 1||0
275572|NCT00908128|667294|P1|NOT COMPLETED|Period 1||0
275573|NCT00908128|667293|P2|COMPLETED|Period 1||20
275574|NCT00908128|667294|P1|COMPLETED|Period 1||20
275575|NCT00908128|667293|P2|STARTED|Period 1||20
275576|NCT00908128|667294|P1|STARTED|Period 1||20
275577|NCT00908115|667302|P1|NOT COMPLETED|Overall Study||14
275578|NCT00908115|667302|P1|COMPLETED|Overall Study||1244
275579|NCT00908115|667302|P1|STARTED|Overall Study||1258
275580|NCT00908076|667310|P2|NOT COMPLETED|Overall Study||1
275581|NCT00908076|667311|P1|NOT COMPLETED|Overall Study||1
275582|NCT00908076|667310|P2|COMPLETED|Overall Study||26
275583|NCT00908076|667311|P1|COMPLETED|Overall Study||26
275584|NCT00908076|667310|P2|STARTED|Overall Study||27
275585|NCT00908076|667311|P1|STARTED|Overall Study||27
275586|NCT00908037|667324|P12|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
275587|NCT00908037|667325|P11|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||4
275588|NCT00908037|667326|P10|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
275589|NCT00908037|667327|P9|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
275590|NCT00908037|667328|P8|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
275591|NCT00908037|667329|P7|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
275592|NCT00908037|667330|P6|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
275593|NCT00908037|667331|P5|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
275594|NCT00908037|667332|P4|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
275595|NCT00908037|667333|P3|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
275596|NCT00908037|667334|P2|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
275597|NCT00908037|667335|P1|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
275598|NCT00908037|667324|P12|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||12
275599|NCT00908037|667325|P11|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|24
275600|NCT00908037|667326|P10|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||21
275601|NCT00908037|667327|P9|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
275602|NCT00908037|667328|P8|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
275603|NCT00908037|667329|P7|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
275604|NCT00908037|667330|P6|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
275605|NCT00908037|667331|P5|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
275606|NCT00908037|667332|P4|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
275607|NCT00908037|667333|P3|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
275608|NCT00908037|667334|P2|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
275609|NCT00908037|667335|P1|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
275610|NCT00908037|667324|P12|STARTED|Part 2/3(Eltrombopag Open-Label Period)||15
275611|NCT00908037|667325|P11|STARTED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|28
275612|NCT00908037|667326|P10|STARTED|Part 2/3(Eltrombopag Open-Label Period)||24
275613|NCT00908037|667327|P9|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
275614|NCT00908037|667328|P8|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
275615|NCT00908037|667329|P7|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
275616|NCT00908037|667330|P6|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
275617|NCT00908037|667331|P5|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
275618|NCT00908037|667332|P4|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
275619|NCT00908037|667333|P3|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
275620|NCT00908037|667334|P2|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
275621|NCT00908037|667335|P1|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
275622|NCT00908037|667324|P12|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
275623|NCT00908037|667325|P11|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
275624|NCT00908037|667326|P10|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
275625|NCT00908037|667327|P9|NOT COMPLETED|Part 2 (7 Week Randomized Period)||5
275626|NCT00908037|667328|P8|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
275627|NCT00908037|667329|P7|NOT COMPLETED|Part 2 (7 Week Randomized Period)||4
275628|NCT00908037|667330|P6|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
275629|NCT00908037|667331|P5|NOT COMPLETED|Part 2 (7 Week Randomized Period)||3
275630|NCT00908037|667332|P4|NOT COMPLETED|Part 2 (7 Week Randomized Period)||1
275631|NCT00908037|667333|P3|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
275632|NCT00908037|667334|P2|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
275633|NCT00908037|667335|P1|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
275634|NCT00908037|667324|P12|COMPLETED|Part 2 (7 Week Randomized Period)||0
275635|NCT00908037|667325|P11|COMPLETED|Part 2 (7 Week Randomized Period)||0
275636|NCT00908037|667326|P10|COMPLETED|Part 2 (7 Week Randomized Period)||0
275637|NCT00908037|667327|P9|COMPLETED|Part 2 (7 Week Randomized Period)||5
275638|NCT00908037|667328|P8|COMPLETED|Part 2 (7 Week Randomized Period)||5
275639|NCT00908037|667329|P7|COMPLETED|Part 2 (7 Week Randomized Period)||15
275640|NCT00908037|667330|P6|COMPLETED|Part 2 (7 Week Randomized Period)||9
275641|NCT00908037|667331|P5|COMPLETED|Part 2 (7 Week Randomized Period)||13
275642|NCT00908037|667332|P4|COMPLETED|Part 2 (7 Week Randomized Period)||7
275643|NCT00908037|667333|P3|COMPLETED|Part 2 (7 Week Randomized Period)||0
275644|NCT00908037|667334|P2|COMPLETED|Part 2 (7 Week Randomized Period)||0
275645|NCT00908037|667335|P1|COMPLETED|Part 2 (7 Week Randomized Period)||0
275646|NCT00908037|667324|P12|STARTED|Part 2 (7 Week Randomized Period)||0
275647|NCT00908037|667325|P11|STARTED|Part 2 (7 Week Randomized Period)||0
275648|NCT00908037|667326|P10|STARTED|Part 2 (7 Week Randomized Period)||0
275649|NCT00908037|667327|P9|STARTED|Part 2 (7 Week Randomized Period)||10
275650|NCT00908037|667328|P8|STARTED|Part 2 (7 Week Randomized Period)||5
275651|NCT00908037|667329|P7|STARTED|Part 2 (7 Week Randomized Period)||19
275652|NCT00908037|667330|P6|STARTED|Part 2 (7 Week Randomized Period)||9
275653|NCT00908037|667331|P5|STARTED|Part 2 (7 Week Randomized Period)||16
275654|NCT00908037|667332|P4|STARTED|Part 2 (7 Week Randomized Period)||8
275655|NCT00908037|667333|P3|STARTED|Part 2 (7 Week Randomized Period)||0
275656|NCT00908037|667334|P2|STARTED|Part 2 (7 Week Randomized Period)||0
275657|NCT00908037|667335|P1|STARTED|Part 2 (7 Week Randomized Period)||0
275658|NCT00908037|667324|P12|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
275659|NCT00908037|667325|P11|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
275660|NCT00908037|667326|P10|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
275661|NCT00908037|667327|P9|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
275662|NCT00908037|667328|P8|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
275663|NCT00908037|667329|P7|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
275664|NCT00908037|667330|P6|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
275665|NCT00908037|667331|P5|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
275666|NCT00908037|667332|P4|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
275667|NCT00908037|667333|P3|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
275668|NCT00908037|667334|P2|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
275669|NCT00908037|667335|P1|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
275670|NCT00908037|667324|P12|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
275671|NCT00908037|667325|P11|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
275672|NCT00908037|667326|P10|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
275673|NCT00908037|667327|P9|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
275674|NCT00908037|667328|P8|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
275675|NCT00908037|667329|P7|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
275676|NCT00908037|667330|P6|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
275677|NCT00908037|667331|P5|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
275678|NCT00908037|667332|P4|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
275679|NCT00908037|667333|P3|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
275680|NCT00908037|667334|P2|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
275681|NCT00908037|667335|P1|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
275682|NCT00908037|667324|P12|STARTED|Part1 (24 Week Dose-Finding Period)||0
275683|NCT00908037|667325|P11|STARTED|Part1 (24 Week Dose-Finding Period)||0
275684|NCT00908037|667326|P10|STARTED|Part1 (24 Week Dose-Finding Period)||0
275685|NCT00908037|667327|P9|STARTED|Part1 (24 Week Dose-Finding Period)||0
275686|NCT00908037|667328|P8|STARTED|Part1 (24 Week Dose-Finding Period)||0
275687|NCT00908037|667329|P7|STARTED|Part1 (24 Week Dose-Finding Period)||0
275688|NCT00908037|667330|P6|STARTED|Part1 (24 Week Dose-Finding Period)||0
275689|NCT00908037|667331|P5|STARTED|Part1 (24 Week Dose-Finding Period)||0
275690|NCT00908037|667332|P4|STARTED|Part1 (24 Week Dose-Finding Period)||0
275691|NCT00908037|667333|P3|STARTED|Part1 (24 Week Dose-Finding Period)||5
275692|NCT00908037|667334|P2|STARTED|Part1 (24 Week Dose-Finding Period)||5
275693|NCT00908037|667335|P1|STARTED|Part1 (24 Week Dose-Finding Period)||5
275694|NCT00908011|667484|P2|NOT COMPLETED|Overall Study||2
275695|NCT00908011|667485|P1|NOT COMPLETED|Overall Study||2
275696|NCT00908011|667484|P2|COMPLETED|Overall Study||18
275697|NCT00908011|667485|P1|COMPLETED|Overall Study||21
275698|NCT00908011|667484|P2|STARTED|Overall Study||20
275699|NCT00908011|667485|P1|STARTED|Overall Study||23
275700|NCT00907907|667493|P2|NOT COMPLETED|Period 4||0
275701|NCT00907907|667494|P1|NOT COMPLETED|Period 4||0
275702|NCT00907907|667493|P2|COMPLETED|Period 4||18
275703|NCT00907907|667494|P1|COMPLETED|Period 4||19
275704|NCT00907907|667493|P2|STARTED|Period 4|two subjects were withdrawn prior to Period 4 dosing|18
275705|NCT00907907|667494|P1|STARTED|Period 4|one subject withdrew prior to Period 4 dosing|19
275706|NCT00907907|667493|P2|NOT COMPLETED|Period 3||0
275707|NCT00907907|667494|P1|NOT COMPLETED|Period 3||0
275708|NCT00907907|667493|P2|COMPLETED|Period 3||20
275709|NCT00907907|667494|P1|COMPLETED|Period 3||20
275710|NCT00907907|667493|P2|STARTED|Period 3||20
275711|NCT00907907|667494|P1|STARTED|Period 3||20
275712|NCT00907907|667493|P2|NOT COMPLETED|Period 2||0
275713|NCT00907907|667494|P1|NOT COMPLETED|Period 2||0
275714|NCT00907907|667493|P2|COMPLETED|Period 2||20
275715|NCT00907907|667494|P1|COMPLETED|Period 2||20
275716|NCT00907907|667493|P2|STARTED|Period 2||20
275717|NCT00907907|667494|P1|STARTED|Period 2||20
275718|NCT00907907|667493|P2|NOT COMPLETED|Period 1||0
275719|NCT00907907|667494|P1|NOT COMPLETED|Period 1||0
275720|NCT00907907|667493|P2|COMPLETED|Period 1||20
275721|NCT00907907|667494|P1|COMPLETED|Period 1||20
275722|NCT00907907|667493|P2|STARTED|Period 1||20
275723|NCT00907907|667494|P1|STARTED|Period 1||20
275724|NCT00907881|667502|P1|NOT COMPLETED|Overall Study||85
275725|NCT00907881|667502|P1|COMPLETED|Overall Study||984
275726|NCT00907881|667502|P1|STARTED|Overall Study||1069
275727|NCT00907803|667512|P3|NOT COMPLETED|Overall Study||0
275728|NCT00907803|667513|P2|NOT COMPLETED|Overall Study||3
275729|NCT00907803|667514|P1|NOT COMPLETED|Overall Study||3
275730|NCT00907803|667512|P3|COMPLETED|Overall Study||16
275731|NCT00907803|667513|P2|COMPLETED|Overall Study||43
275732|NCT00907803|667514|P1|COMPLETED|Overall Study||42
275733|NCT00907803|667512|P3|STARTED|Overall Study||16
275734|NCT00907803|667513|P2|STARTED|Overall Study||46
275735|NCT00907803|667514|P1|STARTED|Overall Study||45
275736|NCT00907777|667545|P2|NOT COMPLETED|Overall Study||1
275737|NCT00907777|667546|P1|NOT COMPLETED|Overall Study||0
275738|NCT00907777|667545|P2|COMPLETED|Overall Study||26
275739|NCT00907777|667546|P1|COMPLETED|Overall Study||25
275740|NCT00907777|667545|P2|STARTED|Overall Study||27
275741|NCT00907777|667546|P1|STARTED|Overall Study||25
275742|NCT00907738|667573|P5|NOT COMPLETED|Overall Study||2
275743|NCT00907738|667574|P4|NOT COMPLETED|Overall Study||4
275744|NCT00907738|667575|P3|NOT COMPLETED|Overall Study||7
275745|NCT00907738|667576|P2|NOT COMPLETED|Overall Study||1
275746|NCT00907738|667577|P1|NOT COMPLETED|Overall Study||13
275747|NCT00907738|667573|P5|COMPLETED|Overall Study||0
275748|NCT00907738|667574|P4|COMPLETED|Overall Study||0
275749|NCT00907738|667575|P3|COMPLETED|Overall Study||0
275750|NCT00907738|667576|P2|COMPLETED|Overall Study||0
275751|NCT00907738|667577|P1|COMPLETED|Overall Study||0
275752|NCT00907738|667573|P5|STARTED|Overall Study||2
275753|NCT00907738|667574|P4|STARTED|Overall Study||4
275754|NCT00907738|667575|P3|STARTED|Overall Study||7
275755|NCT00907738|667576|P2|STARTED|Overall Study||1
275756|NCT00907738|667577|P1|STARTED|Overall Study||13
275757|NCT00907621|667595|P2|NOT COMPLETED|Overall Study||4
275758|NCT00907621|667596|P1|NOT COMPLETED|Overall Study||7
275759|NCT00907621|667595|P2|COMPLETED|Overall Study||41
275760|NCT00907621|667596|P1|COMPLETED|Overall Study||38
275761|NCT00907621|667595|P2|STARTED|Overall Study||45
275762|NCT00907621|667596|P1|STARTED|Overall Study||45
275763|NCT00907517|667609|P5|NOT COMPLETED|Overall Study||5
275764|NCT00907517|667610|P4|NOT COMPLETED|Overall Study||4
275765|NCT00907517|667611|P3|NOT COMPLETED|Overall Study||4
275766|NCT00907517|667612|P2|NOT COMPLETED|Overall Study||3
275767|NCT00907517|667613|P1|NOT COMPLETED|Overall Study||3
275768|NCT00907517|667609|P5|COMPLETED|Overall Study||1
275769|NCT00907517|667610|P4|COMPLETED|Overall Study||2
275770|NCT00907517|667611|P3|COMPLETED|Overall Study||2
275771|NCT00907517|667612|P2|COMPLETED|Overall Study||0
275772|NCT00907517|667613|P1|COMPLETED|Overall Study||0
275773|NCT00907517|667609|P5|STARTED|Overall Study||6
275774|NCT00907517|667610|P4|STARTED|Overall Study||6
275775|NCT00907517|667611|P3|STARTED|Overall Study||6
275776|NCT00907517|667612|P2|STARTED|Overall Study||3
275777|NCT00907517|667613|P1|STARTED|Overall Study||3
275778|NCT00907478|667638|P3|NOT COMPLETED|Overall Study||22
275779|NCT00907478|667639|P2|NOT COMPLETED|Overall Study||17
275780|NCT00907478|667640|P1|NOT COMPLETED|Overall Study||27
275781|NCT00907478|667638|P3|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|47
275782|NCT00907478|667639|P2|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|33
275783|NCT00907478|667640|P1|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|23
275784|NCT00907478|667638|P3|STARTED|Overall Study||69
275785|NCT00907478|667639|P2|STARTED|Overall Study||50
275786|NCT00907478|667640|P1|STARTED|Overall Study||50
275787|NCT00907426|667671|P3|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||7
275788|NCT00907426|667672|P2|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||3
275789|NCT00907426|667673|P1|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||11
275790|NCT00907426|667671|P3|COMPLETED|Treatment Period 2 (6 to 12 Months)||77
275791|NCT00907426|667672|P2|COMPLETED|Treatment Period 2 (6 to 12 Months)||52
275792|NCT00907426|667673|P1|COMPLETED|Treatment Period 2 (6 to 12 Months)||184
275793|NCT00907426|667671|P3|STARTED|Treatment Period 2 (6 to 12 Months)||84
275794|NCT00907426|667672|P2|STARTED|Treatment Period 2 (6 to 12 Months)||55
275795|NCT00907426|667673|P1|STARTED|Treatment Period 2 (6 to 12 Months)||195
275796|NCT00907426|667671|P3|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||9
275797|NCT00907426|667672|P2|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||5
275798|NCT00907426|667673|P1|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||20
275799|NCT00907426|667671|P3|COMPLETED|Treatment Period 1 (0 to 6 Months)||84
275800|NCT00907426|667672|P2|COMPLETED|Treatment Period 1 (0 to 6 Months)||55
275801|NCT00907426|667673|P1|COMPLETED|Treatment Period 1 (0 to 6 Months)||195
275802|NCT00907426|667671|P3|STARTED|Treatment Period 1 (0 to 6 Months)||93
275803|NCT00907426|667672|P2|STARTED|Treatment Period 1 (0 to 6 Months)||60
275804|NCT00907426|667673|P1|STARTED|Treatment Period 1 (0 to 6 Months)||215
275805|NCT00907374|667690|P2|NOT COMPLETED|Overall Study||2
275806|NCT00907374|667691|P1|NOT COMPLETED|Overall Study||2
275807|NCT00907374|667690|P2|COMPLETED|Overall Study||11
275808|NCT00907374|667691|P1|COMPLETED|Overall Study||12
275809|NCT00907374|667690|P2|STARTED|Overall Study||13
275810|NCT00907374|667691|P1|STARTED|Overall Study||14
275811|NCT00907335|667705|P2|NOT COMPLETED|Overall Study||1
275812|NCT00907335|667706|P1|NOT COMPLETED|Overall Study||8
275813|NCT00907335|667705|P2|COMPLETED|Overall Study||54
275814|NCT00907335|667706|P1|COMPLETED|Overall Study||47
275815|NCT00907335|667705|P2|STARTED|Overall Study||55
275816|NCT00907335|667706|P1|STARTED|Overall Study||55
275817|NCT00907296|667732|P10|NOT COMPLETED|Overall Study||7
275818|NCT00907296|667733|P9|NOT COMPLETED|Overall Study||4
275819|NCT00907296|667734|P8|NOT COMPLETED|Overall Study||7
275820|NCT00907296|667735|P7|NOT COMPLETED|Overall Study||6
275821|NCT00907296|667736|P6|NOT COMPLETED|Overall Study||9
275822|NCT00907296|667737|P5|NOT COMPLETED|Overall Study||1
275823|NCT00907296|667738|P4|NOT COMPLETED|Overall Study||4
275824|NCT00907296|667739|P3|NOT COMPLETED|Overall Study||2
275825|NCT00907296|667740|P2|NOT COMPLETED|Overall Study||5
275826|NCT00907296|667741|P1|NOT COMPLETED|Overall Study||20
275827|NCT00907296|667732|P10|COMPLETED|Overall Study||28
275828|NCT00907296|667733|P9|COMPLETED|Overall Study||27
275829|NCT00907296|667734|P8|COMPLETED|Overall Study||26
275830|NCT00907296|667735|P7|COMPLETED|Overall Study||27
275831|NCT00907296|667736|P6|COMPLETED|Overall Study||24
275832|NCT00907296|667737|P5|COMPLETED|Overall Study||32
275833|NCT00907296|667738|P4|COMPLETED|Overall Study||29
275834|NCT00907296|667739|P3|COMPLETED|Overall Study||32
275835|NCT00907296|667740|P2|COMPLETED|Overall Study||29
275836|NCT00907296|667741|P1|COMPLETED|Overall Study||83
275837|NCT00907296|667732|P10|Received Treatment|Overall Study||35
275838|NCT00907296|667733|P9|Received Treatment|Overall Study||30
275839|NCT00907296|667734|P8|Received Treatment|Overall Study||32
275840|NCT00907296|667735|P7|Received Treatment|Overall Study||31
275841|NCT00907296|667736|P6|Received Treatment|Overall Study||32
275842|NCT00907296|667737|P5|Received Treatment|Overall Study||33
275843|NCT00907296|667738|P4|Received Treatment|Overall Study||32
275844|NCT00907296|667739|P3|Received Treatment|Overall Study||34
275845|NCT00907296|667740|P2|Received Treatment|Overall Study||34
275846|NCT00907296|667741|P1|Received Treatment|Overall Study||100
275847|NCT00907296|667732|P10|STARTED|Overall Study||35
275848|NCT00907296|667733|P9|STARTED|Overall Study||31
275849|NCT00907296|667734|P8|STARTED|Overall Study||33
275850|NCT00907296|667735|P7|STARTED|Overall Study||33
275851|NCT00907296|667736|P6|STARTED|Overall Study||33
275852|NCT00907296|667737|P5|STARTED|Overall Study||33
275853|NCT00907296|667738|P4|STARTED|Overall Study||33
275854|NCT00907296|667739|P3|STARTED|Overall Study||34
275855|NCT00907296|667740|P2|STARTED|Overall Study||34
275856|NCT00907296|667741|P1|STARTED|Overall Study||103
275857|NCT00907257|667795|P2|NOT COMPLETED|Overall Study||12
275858|NCT00907257|667796|P1|NOT COMPLETED|Overall Study||13
275859|NCT00907257|667795|P2|COMPLETED|Overall Study||112
275860|NCT00907257|667796|P1|COMPLETED|Overall Study||110
275861|NCT00907257|667795|P2|STARTED|Overall Study||124
275862|NCT00907257|667796|P1|STARTED|Overall Study||123
275863|NCT00907218|667806|P1|NOT COMPLETED|Overall Study||0
275864|NCT00907218|667806|P1|COMPLETED|Overall Study||2
275865|NCT00907218|667806|P1|STARTED|Overall Study||2
275866|NCT00907153|667818|P2|NOT COMPLETED|Overall Study||4
275867|NCT00907153|667819|P1|NOT COMPLETED|Overall Study||2
275868|NCT00907153|667818|P2|COMPLETED|Overall Study||11
275869|NCT00907153|667819|P1|COMPLETED|Overall Study||11
275870|NCT00907153|667818|P2|STARTED|Overall Study||15
275871|NCT00907153|667819|P1|STARTED|Overall Study||13
275872|NCT00907101|667861|P1|NOT COMPLETED|Overall Study||0
275873|NCT00907101|667861|P1|COMPLETED|Overall Study||30
275874|NCT00907101|667861|P1|STARTED|Overall Study||30
275875|NCT00907088|667871|P2|NOT COMPLETED|Overall Study||30
275876|NCT00907088|667872|P1|NOT COMPLETED|Overall Study||20
275877|NCT00907088|667871|P2|COMPLETED|Overall Study||99
275878|NCT00907088|667872|P1|COMPLETED|Overall Study||102
275879|NCT00907088|667871|P2|STARTED|Overall Study||129
275880|NCT00907088|667872|P1|STARTED|Overall Study||122
275881|NCT00906971|667880|P2|NOT COMPLETED|Overall Study||3
275882|NCT00906971|667881|P1|NOT COMPLETED|Overall Study||8
275883|NCT00906971|667880|P2|COMPLETED|Overall Study||33
275884|NCT00906971|667881|P1|COMPLETED|Overall Study||28
275885|NCT00906971|667880|P2|STARTED|Overall Study||36
275886|NCT00906971|667881|P1|STARTED|Overall Study||36
275887|NCT00906945|667894|P6|NOT COMPLETED|Overall Study||2
275888|NCT00906945|667895|P5|NOT COMPLETED|Overall Study||1
275889|NCT00906945|667896|P4|NOT COMPLETED|Overall Study||1
275890|NCT00906945|667897|P3|NOT COMPLETED|Overall Study||0
275891|NCT00906945|667898|P2|NOT COMPLETED|Overall Study||0
275892|NCT00906945|667899|P1|NOT COMPLETED|Overall Study||0
275893|NCT00906945|667894|P6|COMPLETED|Overall Study||14
275894|NCT00906945|667895|P5|COMPLETED|Overall Study||6
275895|NCT00906945|667896|P4|COMPLETED|Overall Study||6
275896|NCT00906945|667897|P3|COMPLETED|Overall Study||3
275897|NCT00906945|667898|P2|COMPLETED|Overall Study||3
275898|NCT00906945|667899|P1|COMPLETED|Overall Study||3
275899|NCT00906945|667894|P6|STARTED|Overall Study||16
275900|NCT00906945|667895|P5|STARTED|Overall Study||7
275901|NCT00906945|667896|P4|STARTED|Overall Study||7
275902|NCT00906945|667897|P3|STARTED|Overall Study||3
275903|NCT00906945|667898|P2|STARTED|Overall Study||3
275904|NCT00906945|667899|P1|STARTED|Overall Study||3
275905|NCT00906789|667926|P1|NOT COMPLETED|Overall Study||0
275906|NCT00906789|667926|P1|COMPLETED|Overall Study||15
275907|NCT00906789|667926|P1|STARTED|Overall Study|Radiologists served as own control. Total enrollment is 15 radiologists.|15
275908|NCT00906776|667936|P2|NOT COMPLETED|Overall Study||0
275909|NCT00906776|667937|P1|NOT COMPLETED|Overall Study||0
275910|NCT00906776|667936|P2|COMPLETED|Overall Study||8
275911|NCT00906776|667937|P1|COMPLETED|Overall Study||11
275912|NCT00906776|667936|P2|STARTED|Overall Study||8
275913|NCT00906776|667937|P1|STARTED|Overall Study||11
275914|NCT00906698|667959|P6|NOT COMPLETED|Overall Study||5
275915|NCT00906698|667960|P5|NOT COMPLETED|Overall Study||18
275916|NCT00906698|667961|P4|NOT COMPLETED|Overall Study||4
275917|NCT00906698|667962|P3|NOT COMPLETED|Overall Study||6
275918|NCT00906698|667963|P2|NOT COMPLETED|Overall Study||19
275919|NCT00906698|667964|P1|NOT COMPLETED|Overall Study||3
275920|NCT00906698|667959|P6|COMPLETED|Overall Study||0
275921|NCT00906698|667960|P5|COMPLETED|Overall Study||0
275922|NCT00906698|667961|P4|COMPLETED|Overall Study||0
275923|NCT00906698|667962|P3|COMPLETED|Overall Study||0
275924|NCT00906698|667963|P2|COMPLETED|Overall Study||0
275925|NCT00906698|667964|P1|COMPLETED|Overall Study||0
275926|NCT00906698|667959|P6|STARTED|Overall Study||5
275927|NCT00906698|667960|P5|STARTED|Overall Study||18
275928|NCT00906698|667961|P4|STARTED|Overall Study||4
275929|NCT00906698|667962|P3|STARTED|Overall Study||6
275930|NCT00906698|667963|P2|STARTED|Overall Study||19
275931|NCT00906698|667964|P1|STARTED|Overall Study||3
275932|NCT00906503|668046|P1|NOT COMPLETED|Overall Study||0
275933|NCT00906503|668046|P1|COMPLETED|Overall Study||9
275934|NCT00906503|668046|P1|STARTED|Overall Study||9
275935|NCT00906425|668052|P2|NOT COMPLETED|Overall Study||72
275936|NCT00906425|668053|P1|NOT COMPLETED|Overall Study||73
275937|NCT00906425|668052|P2|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
275938|NCT00906425|668053|P1|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
275939|NCT00906425|668052|P2|2 Year|Overall Study|ITT population|58
275940|NCT00906425|668053|P1|2 Year|Overall Study|ITT population|62
275941|NCT00906425|668052|P2|1 Year|Overall Study|ITT population|60
275942|NCT00906425|668053|P1|1 Year|Overall Study|ITT population|67
275943|NCT00906425|668052|P2|6 Months|Overall Study|ITT population|64
275944|NCT00906425|668053|P1|6 Months|Overall Study|ITT population|69
275945|NCT00906425|668052|P2|STARTED|Overall Study||72
275946|NCT00906425|668053|P1|STARTED|Overall Study||73
275947|NCT00906399|668066|P7|NOT COMPLETED|Year 2||29
275948|NCT00906399|668067|P6|NOT COMPLETED|Year 2||47
275949|NCT00906399|668068|P5|NOT COMPLETED|Year 2||35
275950|NCT00906399|668069|P4|NOT COMPLETED|Year 2||30
275951|NCT00906399|668070|P3|NOT COMPLETED|Year 2||0
275952|NCT00906399|668071|P2|NOT COMPLETED|Year 2||0
275953|NCT00906399|668072|P1|NOT COMPLETED|Year 2||0
275954|NCT00906399|668066|P7|COMPLETED|Year 2||409
275955|NCT00906399|668067|P6|COMPLETED|Year 2||391
275956|NCT00906399|668068|P5|COMPLETED|Year 2||193
275957|NCT00906399|668069|P4|COMPLETED|Year 2||198
275958|NCT00906399|668070|P3|COMPLETED|Year 2||0
275959|NCT00906399|668071|P2|COMPLETED|Year 2||0
275960|NCT00906399|668072|P1|COMPLETED|Year 2||0
275961|NCT00906399|668066|P7|Completed Year 2 Study Treatment|Year 2||411
275962|NCT00906399|668067|P6|Completed Year 2 Study Treatment|Year 2||391
275963|NCT00906399|668068|P5|Completed Year 2 Study Treatment|Year 2||196
275964|NCT00906399|668069|P4|Completed Year 2 Study Treatment|Year 2||200
275965|NCT00906399|668070|P3|Completed Year 2 Study Treatment|Year 2||0
275966|NCT00906399|668071|P2|Completed Year 2 Study Treatment|Year 2||0
275967|NCT00906399|668072|P1|Completed Year 2 Study Treatment|Year 2||0
275968|NCT00906399|668066|P7|STARTED|Year 2||438
275969|NCT00906399|668067|P6|STARTED|Year 2||438
275970|NCT00906399|668068|P5|STARTED|Year 2||228
275971|NCT00906399|668069|P4|STARTED|Year 2||228
275972|NCT00906399|668070|P3|STARTED|Year 2||0
275973|NCT00906399|668071|P2|STARTED|Year 2||0
275974|NCT00906399|668072|P1|STARTED|Year 2||0
275975|NCT00906399|668066|P7|NOT COMPLETED|Year 1||0
275976|NCT00906399|668067|P6|NOT COMPLETED|Year 1||0
275977|NCT00906399|668068|P5|NOT COMPLETED|Year 1||0
275978|NCT00906399|668069|P4|NOT COMPLETED|Year 1||0
275979|NCT00906399|668070|P3|NOT COMPLETED|Year 1||76
275980|NCT00906399|668071|P2|NOT COMPLETED|Year 1||63
275981|NCT00906399|668072|P1|NOT COMPLETED|Year 1||44
275982|NCT00906399|668066|P7|COMPLETED|Year 1||0
275983|NCT00906399|668067|P6|COMPLETED|Year 1||0
275984|NCT00906399|668068|P5|COMPLETED|Year 1||0
275985|NCT00906399|668069|P4|COMPLETED|Year 1||0
275986|NCT00906399|668070|P3|COMPLETED|Year 1|1 participant discontinued treatment before end of study period but remained to complete follow-up.|439
275987|NCT00906399|668071|P2|COMPLETED|Year 1||438
275988|NCT00906399|668072|P1|COMPLETED|Year 1||456
275989|NCT00906399|668066|P7|Completed Year 1 Study Treatment|Year 1||0
275990|NCT00906399|668067|P6|Completed Year 1 Study Treatment|Year 1||0
275991|NCT00906399|668068|P5|Completed Year 1 Study Treatment|Year 1||0
275992|NCT00906399|668069|P4|Completed Year 1 Study Treatment|Year 1||0
275993|NCT00906399|668070|P3|Completed Year 1 Study Treatment|Year 1||438
275994|NCT00906399|668071|P2|Completed Year 1 Study Treatment|Year 1||438
275995|NCT00906399|668072|P1|Completed Year 1 Study Treatment|Year 1||456
275996|NCT00906399|668066|P7|STARTED|Year 1||0
275997|NCT00906399|668067|P6|STARTED|Year 1||0
275998|NCT00906399|668068|P5|STARTED|Year 1||0
275999|NCT00906399|668069|P4|STARTED|Year 1||0
276000|NCT00906399|668070|P3|STARTED|Year 1||515
276001|NCT00906399|668071|P2|STARTED|Year 1||501
276002|NCT00906399|668072|P1|STARTED|Year 1||500
276003|NCT00906373|668095|P2|NOT COMPLETED|Overall Study||8
276004|NCT00906373|668096|P1|NOT COMPLETED|Overall Study||0
276005|NCT00906373|668095|P2|COMPLETED|Overall Study||33
276006|NCT00906373|668096|P1|COMPLETED|Overall Study||6
276007|NCT00906373|668095|P2|Received Any Amount of Study Drug|Overall Study||41
276008|NCT00906373|668096|P1|Received Any Amount of Study Drug|Overall Study||6
276009|NCT00906373|668095|P2|STARTED|Overall Study||41
276010|NCT00906373|668096|P1|STARTED|Overall Study||6
276011|NCT00906347|668135|P2|NOT COMPLETED|Received Study Drug||31
276012|NCT00906347|668136|P1|NOT COMPLETED|Received Study Drug||40
276013|NCT00906347|668135|P2|COMPLETED|Received Study Drug||143
276014|NCT00906347|668136|P1|COMPLETED|Received Study Drug||136
276015|NCT00906347|668135|P2|STARTED|Received Study Drug||174
276016|NCT00906347|668136|P1|STARTED|Received Study Drug||176
276017|NCT00906347|668135|P2|NOT COMPLETED|Randomized||0
276018|NCT00906347|668136|P1|NOT COMPLETED|Randomized||0
276019|NCT00906347|668135|P2|COMPLETED|Randomized||174
276020|NCT00906347|668136|P1|COMPLETED|Randomized||176
276021|NCT00906347|668135|P2|STARTED|Randomized||174
276022|NCT00906347|668136|P1|STARTED|Randomized||176
276023|NCT00906282|668156|P1|NOT COMPLETED|Surgical Resection||0
276024|NCT00906282|668156|P1|COMPLETED|Surgical Resection||27
276025|NCT00906282|668156|P1|STARTED|Surgical Resection||27
276026|NCT00906282|668156|P1|NOT COMPLETED|Preoperative Chemotherapy||19
276027|NCT00906282|668156|P1|COMPLETED|Preoperative Chemotherapy|2 of 27 patients completed less than 4 cycles and were deemed surgical candidates.|27
276028|NCT00906282|668156|P1|STARTED|Preoperative Chemotherapy||46
276029|NCT00906243|668164|P1|NOT COMPLETED|Overall Study||0
276030|NCT00906243|668164|P1|COMPLETED|Overall Study||6
276031|NCT00906243|668164|P1|STARTED|Overall Study||6
276032|NCT00906204|668170|P2|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||3
276033|NCT00906204|668171|P1|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||2
276034|NCT00906204|668170|P2|COMPLETED|Secondary Endpoints (Long-term Safety)||48
276035|NCT00906204|668171|P1|COMPLETED|Secondary Endpoints (Long-term Safety)||41
276036|NCT00906204|668170|P2|STARTED|Secondary Endpoints (Long-term Safety)||51
276037|NCT00906204|668171|P1|STARTED|Secondary Endpoints (Long-term Safety)||43
276038|NCT00906204|668170|P2|NOT COMPLETED|Primary Endpoint (Early Safety)||1
276039|NCT00906204|668171|P1|NOT COMPLETED|Primary Endpoint (Early Safety)||2
276040|NCT00906204|668170|P2|COMPLETED|Primary Endpoint (Early Safety)||51
276041|NCT00906204|668171|P1|COMPLETED|Primary Endpoint (Early Safety)||43
276042|NCT00906204|668170|P2|STARTED|Primary Endpoint (Early Safety)||52
276043|NCT00906204|668171|P1|STARTED|Primary Endpoint (Early Safety)||45
276044|NCT00906178|668189|P2|NOT COMPLETED|Overall Study||16
276045|NCT00906178|668190|P1|NOT COMPLETED|Overall Study||15
276046|NCT00906178|668189|P2|COMPLETED|Overall Study||167
276047|NCT00906178|668190|P1|COMPLETED|Overall Study||168
276048|NCT00906178|668189|P2|STARTED|Overall Study||183
276049|NCT00906178|668190|P1|STARTED|Overall Study||183
276050|NCT00906165|668204|P2|NOT COMPLETED|Overall Study||0
276051|NCT00906165|668205|P1|NOT COMPLETED|Overall Study||4
276052|NCT00906165|668204|P2|COMPLETED|Overall Study||14
276053|NCT00906165|668205|P1|COMPLETED|Overall Study||10
276054|NCT00906165|668204|P2|STARTED|Overall Study||14
276055|NCT00906165|668205|P1|STARTED|Overall Study||14
276056|NCT00906087|668225|P1|NOT COMPLETED|Final Washout Period 4 Weeks||0
276057|NCT00906087|668225|P1|COMPLETED|Final Washout Period 4 Weeks||12
276058|NCT00906087|668225|P1|STARTED|Final Washout Period 4 Weeks||12
276059|NCT00906087|668225|P1|NOT COMPLETED|Cosopt Treatment 6 Weeks||0
276060|NCT00906087|668225|P1|COMPLETED|Cosopt Treatment 6 Weeks||12
276061|NCT00906087|668225|P1|STARTED|Cosopt Treatment 6 Weeks||12
276062|NCT00906087|668225|P1|NOT COMPLETED|Initial Washout||2
276063|NCT00906087|668225|P1|COMPLETED|Initial Washout||12
276064|NCT00906087|668225|P1|Completed Washout and Continue Protocol|Initial Washout||12
276065|NCT00906087|668225|P1|Begin Washout|Initial Washout||13
276066|NCT00906087|668225|P1|Completed Screening|Initial Washout||14
276067|NCT00906087|668225|P1|STARTED|Initial Washout||14
276068|NCT00906074|668234|P2|NOT COMPLETED|Overall Study||0
276069|NCT00906074|668235|P1|NOT COMPLETED|Overall Study||0
276070|NCT00906074|668234|P2|COMPLETED|Overall Study||90
276071|NCT00906074|668235|P1|COMPLETED|Overall Study||90
276072|NCT00906074|668234|P2|STARTED|Overall Study||90
276073|NCT00906074|668235|P1|STARTED|Overall Study||90
276074|NCT00906035|668262|P3|NOT COMPLETED|Overall Study||0
276075|NCT00906035|668263|P2|NOT COMPLETED|Overall Study||3
276076|NCT00906035|668264|P1|NOT COMPLETED|Overall Study||2
276077|NCT00906035|668262|P3|COMPLETED|Overall Study||8
276078|NCT00906035|668263|P2|COMPLETED|Overall Study|2 subjects Withdrew after Visit 1 and 1 subject Withdrew shortly after Visit 1due to an AE|6
276079|NCT00906035|668264|P1|COMPLETED|Overall Study|One Drop-Out; SAE day before Visit 1 and One subject Withrew prior to visit 1|6
276080|NCT00906035|668262|P3|STARTED|Overall Study||8
276081|NCT00906035|668263|P2|STARTED|Overall Study||9
276082|NCT00906035|668264|P1|STARTED|Overall Study||8
276083|NCT00905840|668278|P1|NOT COMPLETED|Overall Study||16
276084|NCT00905840|668278|P1|COMPLETED|Overall Study||75
276085|NCT00905840|668278|P1|STARTED|Overall Study||91
276086|NCT00905827|668290|P3|NOT COMPLETED|Overall Study||0
276087|NCT00905827|668291|P2|NOT COMPLETED|Overall Study||0
276088|NCT00905827|668292|P1|NOT COMPLETED|Overall Study||0
276089|NCT00905827|668290|P3|COMPLETED|Overall Study||73
276090|NCT00905827|668291|P2|COMPLETED|Overall Study||69
276091|NCT00905827|668292|P1|COMPLETED|Overall Study||70
276092|NCT00905827|668290|P3|STARTED|Overall Study||73
276093|NCT00905827|668291|P2|STARTED|Overall Study||69
276094|NCT00905827|668292|P1|STARTED|Overall Study||70
276095|NCT00905632|668309|P7|NOT COMPLETED|Overall Study||4
276096|NCT00905632|668310|P6|NOT COMPLETED|Overall Study||1
276097|NCT00905632|668311|P5|NOT COMPLETED|Overall Study||0
276098|NCT00905632|668312|P4|NOT COMPLETED|Overall Study||0
276099|NCT00905632|668313|P3|NOT COMPLETED|Overall Study||0
276100|NCT00905632|668314|P2|NOT COMPLETED|Overall Study||0
276101|NCT00905632|668315|P1|NOT COMPLETED|Overall Study||0
276102|NCT00905632|668309|P7|COMPLETED|Overall Study||7
276103|NCT00905632|668310|P6|COMPLETED|Overall Study||8
276104|NCT00905632|668311|P5|COMPLETED|Overall Study||10
276105|NCT00905632|668312|P4|COMPLETED|Overall Study||6
276106|NCT00905632|668313|P3|COMPLETED|Overall Study||7
276107|NCT00905632|668314|P2|COMPLETED|Overall Study||6
276108|NCT00905632|668315|P1|COMPLETED|Overall Study||8
276109|NCT00905632|668309|P7|STARTED|Overall Study||11
276110|NCT00905632|668310|P6|STARTED|Overall Study||9
276111|NCT00905632|668311|P5|STARTED|Overall Study||10
276112|NCT00905632|668312|P4|STARTED|Overall Study||6
276113|NCT00905632|668313|P3|STARTED|Overall Study||7
276114|NCT00905632|668314|P2|STARTED|Overall Study||6
276115|NCT00905632|668315|P1|STARTED|Overall Study||8
276116|NCT00905606|668453|P2|NOT COMPLETED|Period 2||0
276117|NCT00905606|668454|P1|NOT COMPLETED|Period 2||0
276118|NCT00905606|668453|P2|COMPLETED|Period 2||14
276119|NCT00905606|668454|P1|COMPLETED|Period 2||14
276120|NCT00905606|668453|P2|STARTED|Period 2||14
276121|NCT00905606|668454|P1|STARTED|Period 2||14
276122|NCT00905606|668453|P2|NOT COMPLETED|Washout||0
276123|NCT00905606|668454|P1|NOT COMPLETED|Washout||1
276124|NCT00905606|668453|P2|COMPLETED|Washout||14
276125|NCT00905606|668454|P1|COMPLETED|Washout||14
276126|NCT00905606|668453|P2|STARTED|Washout||14
276127|NCT00905606|668454|P1|STARTED|Washout||15
276128|NCT00905606|668453|P2|NOT COMPLETED|Period 1||1
276129|NCT00905606|668454|P1|NOT COMPLETED|Period 1||0
276130|NCT00905606|668453|P2|COMPLETED|Period 1||14
276131|NCT00905606|668454|P1|COMPLETED|Period 1||15
276132|NCT00905606|668453|P2|STARTED|Period 1||15
276133|NCT00905606|668454|P1|STARTED|Period 1||15
276134|NCT00905580|668464|P2|NOT COMPLETED|Overall Study||3
276135|NCT00905580|668465|P1|NOT COMPLETED|Overall Study||2
276136|NCT00905580|668464|P2|COMPLETED|Overall Study||47
276137|NCT00905580|668465|P1|COMPLETED|Overall Study||47
276138|NCT00905580|668464|P2|STARTED|Overall Study||50
276139|NCT00905580|668465|P1|STARTED|Overall Study||49
276140|NCT00905567|668479|P2|NOT COMPLETED|Period 2||0
276141|NCT00905567|668480|P1|NOT COMPLETED|Period 2||0
276142|NCT00905567|668479|P2|COMPLETED|Period 2||11
276143|NCT00905567|668480|P1|COMPLETED|Period 2||12
276144|NCT00905567|668479|P2|STARTED|Period 2||11
276145|NCT00905567|668480|P1|STARTED|Period 2||12
276146|NCT00905567|668479|P2|NOT COMPLETED|Washout||1
276147|NCT00905567|668480|P1|NOT COMPLETED|Washout||0
276148|NCT00905567|668479|P2|COMPLETED|Washout||11
276149|NCT00905567|668480|P1|COMPLETED|Washout||12
276150|NCT00905567|668479|P2|STARTED|Washout||12
276151|NCT00905567|668480|P1|STARTED|Washout||12
276152|NCT00905567|668479|P2|NOT COMPLETED|Period 1||0
276153|NCT00905567|668480|P1|NOT COMPLETED|Period 1||0
276154|NCT00905567|668479|P2|COMPLETED|Period 1||12
276155|NCT00905567|668480|P1|COMPLETED|Period 1||12
276156|NCT00905567|668479|P2|STARTED|Period 1||12
276157|NCT00905567|668480|P1|STARTED|Period 1||12
276158|NCT00905554|668490|P2|NOT COMPLETED|Overall Study||0
276159|NCT00905554|668491|P1|NOT COMPLETED|Overall Study||0
276160|NCT00905554|668490|P2|COMPLETED|Overall Study||114
276161|NCT00905554|668491|P1|COMPLETED|Overall Study||116
276162|NCT00905554|668490|P2|STARTED|Overall Study||114
276163|NCT00905554|668491|P1|STARTED|Overall Study||116
276164|NCT00905515|668502|P3|NOT COMPLETED|Overall Study||2
276165|NCT00905515|668503|P2|NOT COMPLETED|Overall Study||0
276166|NCT00905515|668504|P1|NOT COMPLETED|Overall Study||2
276167|NCT00905515|668502|P3|COMPLETED|Overall Study||20
276168|NCT00905515|668503|P2|COMPLETED|Overall Study||20
276169|NCT00905515|668504|P1|COMPLETED|Overall Study||19
276170|NCT00905515|668502|P3|STARTED|Overall Study||22
276171|NCT00905515|668503|P2|STARTED|Overall Study||20
276172|NCT00905515|668504|P1|STARTED|Overall Study||21
276173|NCT00905489|668512|P1|NOT COMPLETED|Optional Extension Phase (OEP)||1
276174|NCT00905489|668512|P1|COMPLETED|Optional Extension Phase (OEP)||39
276175|NCT00905489|668512|P1|STARTED|Optional Extension Phase (OEP)|Includes only subjects who chose to continue trt with nevirapine XR after completing the PK phase.|40
276176|NCT00905489|668512|P1|NOT COMPLETED|Pharmaco-kinetic (PK) Phase||5
276177|NCT00905489|668512|P1|COMPLETED|Pharmaco-kinetic (PK) Phase||80
276178|NCT00905489|668512|P1|STARTED|Pharmaco-kinetic (PK) Phase||85
276179|NCT00905437|668561|P2|NOT COMPLETED|Overall Study||10
276180|NCT00905437|668562|P1|NOT COMPLETED|Overall Study||8
276181|NCT00905437|668561|P2|COMPLETED|Overall Study||27
276182|NCT00905437|668562|P1|COMPLETED|Overall Study||27
276183|NCT00905437|668561|P2|STARTED|Overall Study||37
276184|NCT00905437|668562|P1|STARTED|Overall Study||35
276185|NCT00905424|668582|P2|NOT COMPLETED|Overall Study||9
276186|NCT00905424|668583|P1|NOT COMPLETED|Overall Study||11
276187|NCT00905424|668582|P2|COMPLETED|Overall Study||79
276188|NCT00905424|668583|P1|COMPLETED|Overall Study||78
276189|NCT00905424|668582|P2|STARTED|Overall Study||88
276190|NCT00905424|668583|P1|STARTED|Overall Study||89
276191|NCT00905359|668625|P2|NOT COMPLETED|Overall Study||16
276192|NCT00905359|668626|P1|NOT COMPLETED|Overall Study||24
276193|NCT00905359|668625|P2|COMPLETED|Overall Study||65
276194|NCT00905359|668626|P1|COMPLETED|Overall Study||58
276195|NCT00905359|668625|P2|24 Months Follow up|Overall Study||65
276196|NCT00905359|668626|P1|24 Months Follow up|Overall Study||58
276197|NCT00905359|668625|P2|12 Months Follow up|Overall Study||72
276198|NCT00905359|668626|P1|12 Months Follow up|Overall Study||68
276199|NCT00905359|668625|P2|STARTED|Overall Study||81
276200|NCT00905359|668626|P1|STARTED|Overall Study||82
276201|NCT00905346|668662|P2|NOT COMPLETED|Period 2||0
276202|NCT00905346|668663|P1|NOT COMPLETED|Period 2||0
276203|NCT00905346|668662|P2|COMPLETED|Period 2||11
276204|NCT00905346|668663|P1|COMPLETED|Period 2||10
276205|NCT00905346|668662|P2|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|11
276206|NCT00905346|668663|P1|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|10
276207|NCT00905346|668662|P2|NOT COMPLETED|Period 1||0
276208|NCT00905346|668663|P1|NOT COMPLETED|Period 1||1
276209|NCT00905346|668662|P2|COMPLETED|Period 1||12
276210|NCT00905346|668663|P1|COMPLETED|Period 1||11
276211|NCT00905346|668662|P2|STARTED|Period 1||12
276212|NCT00905346|668663|P1|STARTED|Period 1||12
276213|NCT00905307|668677|P6|NOT COMPLETED|Overall Study||42
276214|NCT00905307|668678|P5|NOT COMPLETED|Overall Study||16
276215|NCT00905307|668679|P4|NOT COMPLETED|Overall Study||37
276216|NCT00905307|668680|P3|NOT COMPLETED|Overall Study||37
276217|NCT00905307|668681|P2|NOT COMPLETED|Overall Study||37
276218|NCT00905307|668682|P1|NOT COMPLETED|Overall Study||22
276219|NCT00905307|668677|P6|COMPLETED|Overall Study||53
276220|NCT00905307|668678|P5|COMPLETED|Overall Study||34
276221|NCT00905307|668679|P4|COMPLETED|Overall Study||56
276222|NCT00905307|668680|P3|COMPLETED|Overall Study||53
276223|NCT00905307|668681|P2|COMPLETED|Overall Study||52
276224|NCT00905307|668682|P1|COMPLETED|Overall Study||20
276225|NCT00905307|668677|P6|STARTED|Overall Study||95
276226|NCT00905307|668678|P5|STARTED|Overall Study||50
276227|NCT00905307|668679|P4|STARTED|Overall Study||93
276228|NCT00905307|668680|P3|STARTED|Overall Study||90
276229|NCT00905307|668681|P2|STARTED|Overall Study||89
276230|NCT00905307|668682|P1|STARTED|Overall Study||42
276231|NCT00905268|668742|P4|NOT COMPLETED|Overall Study||2
276232|NCT00905268|668743|P3|NOT COMPLETED|Overall Study||0
276233|NCT00905268|668744|P2|NOT COMPLETED|Overall Study||1
276234|NCT00905268|668745|P1|NOT COMPLETED|Overall Study||4
276235|NCT00905268|668742|P4|COMPLETED|Overall Study||57
276236|NCT00905268|668743|P3|COMPLETED|Overall Study||59
276237|NCT00905268|668744|P2|COMPLETED|Overall Study||56
276238|NCT00905268|668745|P1|COMPLETED|Overall Study||53
276239|NCT00905268|668742|P4|STARTED|Overall Study||59
276240|NCT00905268|668743|P3|STARTED|Overall Study||59
276241|NCT00905268|668744|P2|STARTED|Overall Study||57
276242|NCT00905268|668745|P1|STARTED|Overall Study||57
276243|NCT00905255|668777|P2|NOT COMPLETED|Overall Study||9
276244|NCT00905255|668778|P1|NOT COMPLETED|Overall Study||13
276245|NCT00905255|668777|P2|COMPLETED|Overall Study||27
276246|NCT00905255|668778|P1|COMPLETED|Overall Study||20
276247|NCT00905255|668777|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||36
276248|NCT00905255|668778|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|33
276249|NCT00905255|668777|P2|Safety Population|Overall Study||36
276250|NCT00905255|668778|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|33
276251|NCT00905255|668777|P2|STARTED|Overall Study||36
276252|NCT00905255|668778|P1|STARTED|Overall Study|Randomized.|33
276253|NCT00905164|668796|P2|NOT COMPLETED|Period 2||0
276254|NCT00905164|668797|P1|NOT COMPLETED|Period 2||0
276255|NCT00905164|668796|P2|COMPLETED|Period 2||11
276256|NCT00905164|668797|P1|COMPLETED|Period 2||12
276257|NCT00905164|668796|P2|STARTED|Period 2||11
276258|NCT00905164|668797|P1|STARTED|Period 2||12
276259|NCT00905164|668796|P2|NOT COMPLETED|Period 1||1
276260|NCT00905164|668797|P1|NOT COMPLETED|Period 1||0
276261|NCT00905164|668796|P2|COMPLETED|Period 1||11
276262|NCT00905164|668797|P1|COMPLETED|Period 1||12
276263|NCT00905164|668796|P2|STARTED|Period 1||12
276264|NCT00905164|668797|P1|STARTED|Period 1||12
276265|NCT00905151|668805|P1|NOT COMPLETED|Overall Study||6
276266|NCT00905151|668805|P1|COMPLETED|Overall Study||200
276267|NCT00905151|668805|P1|STARTED|Overall Study||206
276268|NCT00905125|668811|P2|NOT COMPLETED|Overall Study||3
276269|NCT00905125|668812|P1|NOT COMPLETED|Overall Study||4
276270|NCT00905125|668811|P2|COMPLETED|Overall Study||53
276271|NCT00905125|668812|P1|COMPLETED|Overall Study||42
276272|NCT00905125|668811|P2|STARTED|Overall Study||56
276273|NCT00905125|668812|P1|STARTED|Overall Study||46
276274|NCT00905034|668844|P1|NOT COMPLETED|Overall Study||1
276275|NCT00905034|668844|P1|COMPLETED|Overall Study||36
276276|NCT00905034|668844|P1|STARTED|Overall Study||37
276277|NCT00905021|668848|P1|NOT COMPLETED|Overall Study||2
276278|NCT00905021|668848|P1|COMPLETED|Overall Study|2 patients were off study due to AE.|2
276279|NCT00905021|668848|P1|STARTED|Overall Study||4
276280|NCT00904995|668855|P2|NOT COMPLETED|Overall Study||0
276281|NCT00904995|668856|P1|NOT COMPLETED|Overall Study||0
276282|NCT00904995|668855|P2|COMPLETED|Overall Study||11
276283|NCT00904995|668856|P1|COMPLETED|Overall Study||10
276284|NCT00904995|668855|P2|STARTED|Overall Study||11
276285|NCT00904995|668856|P1|STARTED|Overall Study||10
276286|NCT00904982|668866|P4|NOT COMPLETED|Overall Study||0
276287|NCT00904982|668867|P3|NOT COMPLETED|Overall Study||0
276288|NCT00904982|668868|P2|NOT COMPLETED|Overall Study||0
276289|NCT00904982|668869|P1|NOT COMPLETED|Overall Study||2
276290|NCT00904982|668866|P4|COMPLETED|Overall Study||68
276291|NCT00904982|668867|P3|COMPLETED|Overall Study||67
276292|NCT00904982|668868|P2|COMPLETED|Overall Study||67
276293|NCT00904982|668869|P1|COMPLETED|Overall Study||66
276294|NCT00904982|668866|P4|STARTED|Overall Study||68
276295|NCT00904982|668867|P3|STARTED|Overall Study||67
276296|NCT00904982|668868|P2|STARTED|Overall Study||67
276297|NCT00904982|668869|P1|STARTED|Overall Study||68
276298|NCT00904969|668879|P1|NOT COMPLETED|Overall Study||19
276299|NCT00904969|668879|P1|COMPLETED|Overall Study|# of Implanted Subjects Who Completed the Study|31
276300|NCT00904969|668879|P1|STARTED|Overall Study|Number of patients with an attempted implant; 1 subject with procedure aborted|50
276301|NCT00904943|668931|P2|NOT COMPLETED|Period 2||0
276302|NCT00904943|668932|P1|NOT COMPLETED|Period 2||0
276303|NCT00904943|668931|P2|COMPLETED|Period 2||8
276304|NCT00904943|668932|P1|COMPLETED|Period 2||9
276305|NCT00904943|668931|P2|STARTED|Period 2|one subject was withdrawn prior to Pd. 2 dosing|8
276306|NCT00904943|668932|P1|STARTED|Period 2||9
276307|NCT00904943|668931|P2|NOT COMPLETED|Period 1||0
276308|NCT00904943|668932|P1|NOT COMPLETED|Period 1||0
276309|NCT00904943|668931|P2|COMPLETED|Period 1||9
276310|NCT00904943|668932|P1|COMPLETED|Period 1||9
276311|NCT00904943|668931|P2|STARTED|Period 1||9
276312|NCT00904943|668932|P1|STARTED|Period 1||9
276313|NCT00904917|668944|P4|NOT COMPLETED|Overall Study||2
276314|NCT00904917|668945|P3|NOT COMPLETED|Overall Study||2
276315|NCT00904917|668946|P2|NOT COMPLETED|Overall Study||2
276316|NCT00904917|668947|P1|NOT COMPLETED|Overall Study||2
276317|NCT00904917|668944|P4|COMPLETED|Overall Study||6
276318|NCT00904917|668945|P3|COMPLETED|Overall Study||6
276319|NCT00904917|668946|P2|COMPLETED|Overall Study||9
276320|NCT00904917|668947|P1|COMPLETED|Overall Study||5
276321|NCT00904917|668944|P4|STARTED|Overall Study||8
276322|NCT00904917|668945|P3|STARTED|Overall Study||8
276323|NCT00904917|668946|P2|STARTED|Overall Study||11
276324|NCT00904917|668947|P1|STARTED|Overall Study||7
276325|NCT00904839|668965|P3|NOT COMPLETED|Overall Study||15
276326|NCT00904839|668966|P2|NOT COMPLETED|Overall Study||18
276327|NCT00904839|668967|P1|NOT COMPLETED|Overall Study||1
276328|NCT00904839|668965|P3|COMPLETED|Overall Study||27
276329|NCT00904839|668966|P2|COMPLETED|Overall Study||64
276330|NCT00904839|668967|P1|COMPLETED|Overall Study||3
276331|NCT00904839|668965|P3|STARTED|Overall Study|Randomised|42
276332|NCT00904839|668966|P2|STARTED|Overall Study|11 patients were randomised to Maximum Tolerable Dose analysis set.|82
276333|NCT00904839|668967|P1|STARTED|Overall Study|All 4 patients were randomised to Maximum Tolerable Dose analysis set.|4
276334|NCT00904826|669001|P1|NOT COMPLETED|Overall Study||0
276335|NCT00904826|669001|P1|COMPLETED|Overall Study||14
276336|NCT00904826|669001|P1|STARTED|Overall Study||14
276337|NCT00904748|669013|P6|NOT COMPLETED|Overall Study||0
276338|NCT00904748|669014|P5|NOT COMPLETED|Overall Study||1
276339|NCT00904748|669015|P4|NOT COMPLETED|Overall Study||2
276340|NCT00904748|669016|P3|NOT COMPLETED|Overall Study||1
276341|NCT00904748|669017|P2|NOT COMPLETED|Overall Study||1
276342|NCT00904748|669018|P1|NOT COMPLETED|Overall Study||1
276343|NCT00904748|669013|P6|COMPLETED|Overall Study||8
276344|NCT00904748|669014|P5|COMPLETED|Overall Study||7
276345|NCT00904748|669015|P4|COMPLETED|Overall Study||6
276346|NCT00904748|669016|P3|COMPLETED|Overall Study||7
276347|NCT00904748|669017|P2|COMPLETED|Overall Study||7
276348|NCT00904748|669018|P1|COMPLETED|Overall Study||7
276349|NCT00904748|669013|P6|Received Treatment|Overall Study||8
276350|NCT00904748|669014|P5|Received Treatment|Overall Study||7
276351|NCT00904748|669015|P4|Received Treatment|Overall Study||8
276352|NCT00904748|669016|P3|Received Treatment|Overall Study||8
276353|NCT00904748|669017|P2|Received Treatment|Overall Study||8
276354|NCT00904748|669018|P1|Received Treatment|Overall Study||8
276355|NCT00904748|669013|P6|STARTED|Overall Study||8
276356|NCT00904748|669014|P5|STARTED|Overall Study|1 participant randomized to this sequence discontinued prior to receipt of study medication.|8
276357|NCT00904748|669015|P4|STARTED|Overall Study||8
276358|NCT00904748|669016|P3|STARTED|Overall Study||8
276359|NCT00904748|669017|P2|STARTED|Overall Study||8
276360|NCT00904748|669018|P1|STARTED|Overall Study||8
276361|NCT00904722|669042|P1|NOT COMPLETED|Overall Study||1
276362|NCT00904722|669042|P1|COMPLETED|Overall Study||29
276363|NCT00904722|669042|P1|STARTED|Overall Study||30
276364|NCT00904670|669047|P2|NOT COMPLETED|Second Intervention Period||0
276365|NCT00904670|669048|P1|NOT COMPLETED|Second Intervention Period||0
276366|NCT00904670|669047|P2|COMPLETED|Second Intervention Period||22
276367|NCT00904670|669048|P1|COMPLETED|Second Intervention Period||17
276368|NCT00904670|669047|P2|STARTED|Second Intervention Period||22
276369|NCT00904670|669048|P1|STARTED|Second Intervention Period||17
276370|NCT00904670|669047|P2|NOT COMPLETED|First Intervention Period||0
276371|NCT00904670|669048|P1|NOT COMPLETED|First Intervention Period||0
276372|NCT00904670|669047|P2|COMPLETED|First Intervention Period||22
276373|NCT00904670|669048|P1|COMPLETED|First Intervention Period||17
276374|NCT00904670|669047|P2|STARTED|First Intervention Period||22
276375|NCT00904670|669048|P1|STARTED|First Intervention Period||17
276376|NCT00904670|669047|P2|NOT COMPLETED|Open Label Phase||0
276377|NCT00904670|669048|P1|NOT COMPLETED|Open Label Phase||6
276378|NCT00904670|669047|P2|COMPLETED|Open Label Phase||22
276379|NCT00904670|669048|P1|COMPLETED|Open Label Phase||17
276380|NCT00904670|669047|P2|STARTED|Open Label Phase||22
276381|NCT00904670|669048|P1|STARTED|Open Label Phase||23
276382|NCT00904618|669069|P1|NOT COMPLETED|Overall Study||0
276383|NCT00904618|669069|P1|COMPLETED|Overall Study||48
276384|NCT00904618|669069|P1|STARTED|Overall Study||48
276385|NCT00904488|669079|P2|NOT COMPLETED|Overall Study||0
276386|NCT00904488|669080|P1|NOT COMPLETED|Overall Study||0
276387|NCT00904488|669079|P2|COMPLETED|Overall Study||6
276388|NCT00904488|669080|P1|COMPLETED|Overall Study||5
276389|NCT00904488|669079|P2|STARTED|Overall Study||6
276390|NCT00904488|669080|P1|STARTED|Overall Study||5
276391|NCT00904423|669110|P1|NOT COMPLETED|Overall Study||0
276392|NCT00904423|669110|P1|COMPLETED|Overall Study||8
276393|NCT00904423|669110|P1|STARTED|Overall Study||8
276394|NCT00904371|669118|P1|NOT COMPLETED|Overall Study||9
276395|NCT00904371|669118|P1|COMPLETED|Overall Study||202
276396|NCT00904371|669118|P1|STARTED|Overall Study||211
276397|NCT00904215|669132|P1|NOT COMPLETED|Overall Study||135
276398|NCT00904215|669132|P1|COMPLETED|Overall Study||960
276399|NCT00904215|669132|P1|STARTED|Overall Study||1095
276400|NCT00904189|669139|P1|NOT COMPLETED|Overall Study||0
276401|NCT00904189|669139|P1|COMPLETED|Overall Study||2
276402|NCT00904189|669139|P1|STARTED|Overall Study||2
276403|NCT00904150|669146|P2|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
276404|NCT00904150|669147|P1|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
276405|NCT00904150|669146|P2|COMPLETED|Blood Samples (RNA): Luteal Phase||30
276406|NCT00904150|669147|P1|COMPLETED|Blood Samples (RNA): Luteal Phase||34
276407|NCT00904150|669146|P2|STARTED|Blood Samples (RNA): Luteal Phase||30
276408|NCT00904150|669147|P1|STARTED|Blood Samples (RNA): Luteal Phase||34
276409|NCT00904150|669146|P2|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
276410|NCT00904150|669147|P1|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
276411|NCT00904150|669146|P2|COMPLETED|Blood Samples (RNA): Follicular Phase||32
276412|NCT00904150|669147|P1|COMPLETED|Blood Samples (RNA): Follicular Phase||37
276413|NCT00904150|669146|P2|STARTED|Blood Samples (RNA): Follicular Phase||32
276414|NCT00904150|669147|P1|STARTED|Blood Samples (RNA): Follicular Phase||37
276415|NCT00904150|669146|P2|NOT COMPLETED|Saliva Samples (DNA)||145
276416|NCT00904150|669147|P1|NOT COMPLETED|Saliva Samples (DNA)||3
276417|NCT00904150|669146|P2|COMPLETED|Saliva Samples (DNA)||155
276418|NCT00904150|669147|P1|COMPLETED|Saliva Samples (DNA)||282
276419|NCT00904150|669146|P2|STARTED|Saliva Samples (DNA)||300
276420|NCT00904150|669147|P1|STARTED|Saliva Samples (DNA)||285
276421|NCT00904033|669169|P4|NOT COMPLETED|Overall Study||2
276422|NCT00904033|669170|P3|NOT COMPLETED|Overall Study||1
276423|NCT00904033|669171|P2|NOT COMPLETED|Overall Study||1
276424|NCT00904033|669172|P1|NOT COMPLETED|Overall Study||1
276425|NCT00904033|669169|P4|COMPLETED|Overall Study||9
276426|NCT00904033|669170|P3|COMPLETED|Overall Study||9
276427|NCT00904033|669171|P2|COMPLETED|Overall Study||9
276428|NCT00904033|669172|P1|COMPLETED|Overall Study||9
276429|NCT00904033|669169|P4|STARTED|Overall Study||11
276430|NCT00904033|669170|P3|STARTED|Overall Study||10
276431|NCT00904033|669171|P2|STARTED|Overall Study||10
276432|NCT00904033|669172|P1|STARTED|Overall Study||10
276433|NCT00904007|669196|P2|NOT COMPLETED|Overall Study||0
276434|NCT00904007|669197|P1|NOT COMPLETED|Overall Study||0
276435|NCT00904007|669196|P2|COMPLETED|Overall Study||56
276436|NCT00904007|669197|P1|COMPLETED|Overall Study||55
276437|NCT00904007|669196|P2|STARTED|Overall Study||56
276438|NCT00904007|669197|P1|STARTED|Overall Study||55
276439|NCT00903968|669237|P8|NOT COMPLETED|Overall Study||33
276440|NCT00903968|669238|P7|NOT COMPLETED|Overall Study||3
276441|NCT00903968|669239|P6|NOT COMPLETED|Overall Study||6
276442|NCT00903968|669240|P5|NOT COMPLETED|Overall Study||4
276443|NCT00903968|669241|P4|NOT COMPLETED|Overall Study||3
276444|NCT00903968|669242|P3|NOT COMPLETED|Overall Study||3
276445|NCT00903968|669243|P2|NOT COMPLETED|Overall Study||3
276446|NCT00903968|669244|P1|NOT COMPLETED|Overall Study||3
276447|NCT00903968|669237|P8|COMPLETED|Overall Study||0
276448|NCT00903968|669238|P7|COMPLETED|Overall Study||0
276449|NCT00903968|669239|P6|COMPLETED|Overall Study||0
276450|NCT00903968|669240|P5|COMPLETED|Overall Study||0
276451|NCT00903968|669241|P4|COMPLETED|Overall Study||0
276452|NCT00903968|669242|P3|COMPLETED|Overall Study||0
276453|NCT00903968|669243|P2|COMPLETED|Overall Study||0
276454|NCT00903968|669244|P1|COMPLETED|Overall Study||0
276455|NCT00903968|669237|P8|STARTED|Overall Study||33
276456|NCT00903968|669238|P7|STARTED|Overall Study||3
276457|NCT00903968|669239|P6|STARTED|Overall Study||6
276458|NCT00903968|669240|P5|STARTED|Overall Study||4
276459|NCT00903968|669241|P4|STARTED|Overall Study||3
276460|NCT00903968|669242|P3|STARTED|Overall Study||3
276461|NCT00903968|669243|P2|STARTED|Overall Study||3
276462|NCT00903968|669244|P1|STARTED|Overall Study||3
276463|NCT00903929|669274|P4|NOT COMPLETED|Overall Study||3
276464|NCT00903929|669275|P3|NOT COMPLETED|Overall Study||1
276465|NCT00903929|669276|P2|NOT COMPLETED|Overall Study||0
276466|NCT00903929|669277|P1|NOT COMPLETED|Overall Study||0
276467|NCT00903929|669274|P4|COMPLETED|Overall Study||6
276468|NCT00903929|669275|P3|COMPLETED|Overall Study||3
276469|NCT00903929|669276|P2|COMPLETED|Overall Study||3
276470|NCT00903929|669277|P1|COMPLETED|Overall Study||3
276471|NCT00903929|669274|P4|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|9
276472|NCT00903929|669275|P3|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|4
276473|NCT00903929|669276|P2|STARTED|Overall Study||3
276474|NCT00903929|669277|P1|STARTED|Overall Study||3
276475|NCT00903877|669283|P1|NOT COMPLETED|Overall Study||43
276476|NCT00903877|669283|P1|COMPLETED|Overall Study||8
276477|NCT00903877|669283|P1|STARTED|Overall Study||51
276478|NCT00903786|669287|P1|NOT COMPLETED|Overall Study||15
276479|NCT00903786|669287|P1|COMPLETED|Overall Study||6
276480|NCT00903786|669287|P1|STARTED|Overall Study||21
276481|NCT00903760|669297|P2|NOT COMPLETED|Overall Study||16
276482|NCT00903760|669298|P1|NOT COMPLETED|Overall Study||19
276483|NCT00903760|669297|P2|COMPLETED|Overall Study|Completed all 24 courses|2
276484|NCT00903760|669298|P1|COMPLETED|Overall Study|Completed all 24 courses|0
276485|NCT00903760|669297|P2|STARTED|Overall Study||18
276486|NCT00903760|669298|P1|STARTED|Overall Study||19
276487|NCT00903695|669308|P2|NOT COMPLETED|Overall Study||0
276488|NCT00903695|669309|P1|NOT COMPLETED|Overall Study||2
276489|NCT00903695|669308|P2|COMPLETED|Overall Study||2
276490|NCT00903695|669309|P1|COMPLETED|Overall Study||6
276491|NCT00903695|669308|P2|STARTED|Overall Study||2
276492|NCT00903695|669309|P1|STARTED|Overall Study||8
276493|NCT00903682|669331|P2|NOT COMPLETED|Overall Study||15
276494|NCT00903682|669332|P1|NOT COMPLETED|Overall Study||16
276495|NCT00903682|669331|P2|COMPLETED|Overall Study||63
276496|NCT00903682|669332|P1|COMPLETED|Overall Study||63
276497|NCT00903682|669331|P2|STARTED|Overall Study||78
276498|NCT00903682|669332|P1|STARTED|Overall Study||79
276499|NCT00903630|669353|P3|NOT COMPLETED|Phase 2||1
276500|NCT00903630|669354|P2|NOT COMPLETED|Phase 2||0
276501|NCT00903630|669355|P1|NOT COMPLETED|Phase 2||0
276502|NCT00903630|669353|P3|COMPLETED|Phase 2|One participant was removed from the study after 2 weeks of treatment due to skin toxicity.|3
276503|NCT00903630|669354|P2|COMPLETED|Phase 2||0
276504|NCT00903630|669355|P1|COMPLETED|Phase 2||6
276505|NCT00903630|669353|P3|STARTED|Phase 2||4
276506|NCT00903630|669354|P2|STARTED|Phase 2||0
276507|NCT00903630|669355|P1|STARTED|Phase 2||6
276508|NCT00903630|669353|P3|NOT COMPLETED|Phase l||0
276509|NCT00903630|669354|P2|NOT COMPLETED|Phase l||0
276510|NCT00903630|669355|P1|NOT COMPLETED|Phase l||0
276511|NCT00903630|669353|P3|COMPLETED|Phase l||0
276512|NCT00903630|669354|P2|COMPLETED|Phase l||5
276513|NCT00903630|669355|P1|COMPLETED|Phase l||6
276514|NCT00903630|669353|P3|STARTED|Phase l||0
276515|NCT00903630|669354|P2|STARTED|Phase l||5
276516|NCT00903630|669355|P1|STARTED|Phase l||6
276517|NCT00903617|669373|P4|NOT COMPLETED|Overall Study||1
276518|NCT00903617|669374|P3|NOT COMPLETED|Overall Study||5
276519|NCT00903617|669375|P2|NOT COMPLETED|Overall Study||5
276520|NCT00903617|669376|P1|NOT COMPLETED|Overall Study||3
276521|NCT00903617|669373|P4|COMPLETED|Overall Study||20
276522|NCT00903617|669374|P3|COMPLETED|Overall Study||15
276523|NCT00903617|669375|P2|COMPLETED|Overall Study||15
276524|NCT00903617|669376|P1|COMPLETED|Overall Study||16
276525|NCT00903617|669373|P4|STARTED|Overall Study||21
276526|NCT00903617|669374|P3|STARTED|Overall Study||20
276527|NCT00903617|669375|P2|STARTED|Overall Study||20
276528|NCT00903617|669376|P1|STARTED|Overall Study||19
276529|NCT00903448|669470|P2|NOT COMPLETED|Period 3: 5 Days||0
276530|NCT00903448|669471|P1|NOT COMPLETED|Period 3: 5 Days||0
276531|NCT00903448|669470|P2|COMPLETED|Period 3: 5 Days||20
276532|NCT00903448|669471|P1|COMPLETED|Period 3: 5 Days||20
276533|NCT00903448|669470|P2|STARTED|Period 3: 5 Days||20
276534|NCT00903448|669471|P1|STARTED|Period 3: 5 Days||20
276535|NCT00903448|669470|P2|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
276536|NCT00903448|669471|P1|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
276537|NCT00903448|669470|P2|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
276538|NCT00903448|669471|P1|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
276539|NCT00903448|669470|P2|STARTED|Period 2: 5 Days Then 10 Day Washout||20
276540|NCT00903448|669471|P1|STARTED|Period 2: 5 Days Then 10 Day Washout||20
276541|NCT00903448|669470|P2|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
276542|NCT00903448|669471|P1|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
276543|NCT00903448|669470|P2|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
276544|NCT00903448|669471|P1|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
276545|NCT00903448|669470|P2|STARTED|Period 1: 5 Days Then 10 Day Washout||20
276546|NCT00903448|669471|P1|STARTED|Period 1: 5 Days Then 10 Day Washout||20
276547|NCT00903409|669479|P2|NOT COMPLETED|Overall Study||27
276548|NCT00903409|669480|P1|NOT COMPLETED|Overall Study||26
276549|NCT00903409|669479|P2|COMPLETED|Overall Study||73
276550|NCT00903409|669480|P1|COMPLETED|Overall Study||62
276551|NCT00903409|669479|P2|STARTED|Overall Study||100
276552|NCT00903409|669480|P1|STARTED|Overall Study||88
276553|NCT00903396|669498|P4|NOT COMPLETED|Overall Study||0
276554|NCT00903396|669499|P3|NOT COMPLETED|Overall Study||0
276555|NCT00903396|669500|P2|NOT COMPLETED|Overall Study||0
276556|NCT00903396|669501|P1|NOT COMPLETED|Overall Study||0
276557|NCT00903396|669498|P4|COMPLETED|Overall Study||1
276558|NCT00903396|669499|P3|COMPLETED|Overall Study||3
276559|NCT00903396|669500|P2|COMPLETED|Overall Study||1
276560|NCT00903396|669501|P1|COMPLETED|Overall Study||2
276561|NCT00903396|669498|P4|STARTED|Overall Study||1
276562|NCT00903396|669499|P3|STARTED|Overall Study||3
276563|NCT00903396|669500|P2|STARTED|Overall Study||1
276564|NCT00903396|669501|P1|STARTED|Overall Study||2
276565|NCT00903383|669531|P4|NOT COMPLETED|Overall Study||5
276566|NCT00903383|669532|P3|NOT COMPLETED|Overall Study||3
276567|NCT00903383|669533|P2|NOT COMPLETED|Overall Study||6
276568|NCT00903383|669534|P1|NOT COMPLETED|Overall Study||7
276569|NCT00903383|669531|P4|COMPLETED|Overall Study||44
276570|NCT00903383|669532|P3|COMPLETED|Overall Study||47
276571|NCT00903383|669533|P2|COMPLETED|Overall Study||48
276572|NCT00903383|669534|P1|COMPLETED|Overall Study||48
276573|NCT00903383|669531|P4|STARTED|Overall Study||49
276574|NCT00903383|669532|P3|STARTED|Overall Study||50
276575|NCT00903383|669533|P2|STARTED|Overall Study||54
276576|NCT00903383|669534|P1|STARTED|Overall Study||55
276577|NCT00903370|669566|P2|NOT COMPLETED|Overall Study||24
276578|NCT00903370|669567|P1|NOT COMPLETED|Overall Study||28
276579|NCT00903370|669566|P2|COMPLETED|Overall Study||109
276580|NCT00903370|669567|P1|COMPLETED|Overall Study||99
276581|NCT00903370|669566|P2|STARTED|Overall Study||133
276582|NCT00903370|669567|P1|STARTED|Overall Study||127
276583|NCT00903357|669575|P2|NOT COMPLETED|Second Intervention||0
276584|NCT00903357|669576|P1|NOT COMPLETED|Second Intervention||1
276585|NCT00903357|669575|P2|COMPLETED|Second Intervention||22
276586|NCT00903357|669576|P1|COMPLETED|Second Intervention||21
276587|NCT00903357|669575|P2|STARTED|Second Intervention||22
276588|NCT00903357|669576|P1|STARTED|Second Intervention||22
276589|NCT00903357|669575|P2|NOT COMPLETED|Wash Out Period of 2 Weeks||1
276590|NCT00903357|669576|P1|NOT COMPLETED|Wash Out Period of 2 Weeks||0
276591|NCT00903357|669575|P2|COMPLETED|Wash Out Period of 2 Weeks||22
276592|NCT00903357|669576|P1|COMPLETED|Wash Out Period of 2 Weeks||22
276593|NCT00903357|669575|P2|STARTED|Wash Out Period of 2 Weeks||23
276594|NCT00903357|669576|P1|STARTED|Wash Out Period of 2 Weeks||22
276595|NCT00903357|669575|P2|NOT COMPLETED|First Intervention||4
276596|NCT00903357|669576|P1|NOT COMPLETED|First Intervention||5
276597|NCT00903357|669575|P2|COMPLETED|First Intervention||23
276598|NCT00903357|669576|P1|COMPLETED|First Intervention||22
276599|NCT00903357|669575|P2|STARTED|First Intervention||27
276600|NCT00903357|669576|P1|STARTED|First Intervention||27
276601|NCT00903344|669588|P2|NOT COMPLETED|Overall Study||3
276602|NCT00903344|669589|P1|NOT COMPLETED|Overall Study||5
276603|NCT00903344|669588|P2|COMPLETED|Overall Study||7
276604|NCT00903344|669589|P1|COMPLETED|Overall Study||7
276605|NCT00903344|669588|P2|6 Month Visit|Overall Study||10
276606|NCT00903344|669589|P1|6 Month Visit|Overall Study||9
276607|NCT00903344|669588|P2|3 Month Visit|Overall Study||10
276608|NCT00903344|669589|P1|3 Month Visit|Overall Study||10
276609|NCT00903344|669588|P2|STARTED|Overall Study||10
276610|NCT00903344|669589|P1|STARTED|Overall Study||12
276611|NCT00903331|669607|P2|NOT COMPLETED|Overall Study||18
276612|NCT00903331|669608|P1|NOT COMPLETED|Overall Study||5
276613|NCT00903331|669607|P2|COMPLETED|Overall Study||101
276614|NCT00903331|669608|P1|COMPLETED|Overall Study||54
276615|NCT00903331|669607|P2|STARTED|Overall Study||119
276616|NCT00903331|669608|P1|STARTED|Overall Study||59
276617|NCT00903201|669619|P3|NOT COMPLETED|Overall Study||2
276618|NCT00903201|669620|P2|NOT COMPLETED|Overall Study||6
276619|NCT00903201|669621|P1|NOT COMPLETED|Overall Study||5
276620|NCT00903201|669619|P3|COMPLETED|Overall Study||39
276621|NCT00903201|669620|P2|COMPLETED|Overall Study||38
276622|NCT00903201|669621|P1|COMPLETED|Overall Study||56
276623|NCT00903201|669619|P3|STARTED|Overall Study||41
276624|NCT00903201|669620|P2|STARTED|Overall Study||44
276625|NCT00903201|669621|P1|STARTED|Overall Study||61
276626|NCT00903175|669679|P2|NOT COMPLETED|Period 2 - Second Line||36
276627|NCT00903175|669680|P1|NOT COMPLETED|Period 2 - Second Line||49
276628|NCT00903175|669679|P2|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|80
276629|NCT00903175|669680|P1|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|79
276630|NCT00903175|669679|P2|STARTED|Period 2 - Second Line|130 from Sunitinib 1L planned to enter 2L period and cross over to everolimus but only 116 did.|116
276631|NCT00903175|669680|P1|STARTED|Period 2 - Second Line|139 from everolimus 1L planned to enter 2L period and cross over to sunitinib but only 128 did.|128
276632|NCT00903175|669679|P2|NOT COMPLETED|Period 1 - First Line||89
276633|NCT00903175|669680|P1|NOT COMPLETED|Period 1 - First Line||77
276634|NCT00903175|669679|P2|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|142
276635|NCT00903175|669680|P1|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|161
276636|NCT00903175|669679|P2|STARTED|Period 1 - First Line||231
276637|NCT00903175|669680|P1|STARTED|Period 1 - First Line||238
276638|NCT00903162|669710|P1|NOT COMPLETED|Overall Study||4
276639|NCT00903162|669710|P1|COMPLETED|Overall Study||12
276640|NCT00903162|669710|P1|STARTED|Overall Study||16
276641|NCT00903032|669718|P2|NOT COMPLETED|Overall Study||5
276642|NCT00903032|669719|P1|NOT COMPLETED|Overall Study||7
276643|NCT00903032|669718|P2|COMPLETED|Overall Study||119
276644|NCT00903032|669719|P1|COMPLETED|Overall Study||122
276645|NCT00903032|669718|P2|STARTED|Overall Study||124
276646|NCT00903032|669719|P1|STARTED|Overall Study||129
276647|NCT00903006|669729|P4|NOT COMPLETED|Overall Study||0
276648|NCT00903006|669730|P3|NOT COMPLETED|Overall Study||1
276649|NCT00903006|669731|P2|NOT COMPLETED|Overall Study||3
276650|NCT00903006|669732|P1|NOT COMPLETED|Overall Study||2
276651|NCT00903006|669729|P4|COMPLETED|Overall Study||0
276652|NCT00903006|669730|P3|COMPLETED|Overall Study||0
276653|NCT00903006|669731|P2|COMPLETED|Overall Study||0
276654|NCT00903006|669732|P1|COMPLETED|Overall Study||0
276655|NCT00903006|669729|P4|STARTED|Overall Study|Zero participants started due to smaller sample size.|0
276656|NCT00903006|669730|P3|STARTED|Overall Study||1
276657|NCT00903006|669731|P2|STARTED|Overall Study||3
276658|NCT00903006|669732|P1|STARTED|Overall Study||2
276659|NCT00902850|669744|P2|NOT COMPLETED|Overall Study||2
276660|NCT00902850|669745|P1|NOT COMPLETED|Overall Study||2
276661|NCT00902850|669744|P2|COMPLETED|Overall Study||12
276662|NCT00902850|669745|P1|COMPLETED|Overall Study||12
276663|NCT00902850|669744|P2|STARTED|Overall Study||14
276664|NCT00902850|669745|P1|STARTED|Overall Study||14
276665|NCT00902746|669751|P1|NOT COMPLETED|Overall Study||36
276666|NCT00902746|669751|P1|COMPLETED|Overall Study||113
276667|NCT00902746|669751|P1|Transfer to Step 2|Overall Study||133
276668|NCT00902746|669751|P1|Initiation of Study Drug Administration|Overall Study||148
276669|NCT00902746|669751|P1|STARTED|Overall Study||149
276670|NCT00902668|669756|P1|NOT COMPLETED|Overall Study||3
276671|NCT00902668|669756|P1|COMPLETED|Overall Study||0
276672|NCT00902668|669756|P1|STARTED|Overall Study||3
276673|NCT00902577|669760|P1|NOT COMPLETED|Overall Study||8
276674|NCT00902577|669760|P1|COMPLETED|Overall Study||42
276675|NCT00902577|669760|P1|DWI MRI|Overall Study||39
276676|NCT00902577|669760|P1|DSE MRI|Overall Study||37
276677|NCT00902577|669760|P1|DCE MRI|Overall Study||31
276678|NCT00902577|669760|P1|FMISO/PET|Overall Study||38
276679|NCT00902577|669760|P1|STARTED|Overall Study||50
276680|NCT00902564|669789|P1|NOT COMPLETED|Overall Study||2
276681|NCT00902564|669789|P1|COMPLETED|Overall Study||28
276682|NCT00902564|669789|P1|STARTED|Overall Study||30
276683|NCT00902538|669804|P6|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||1
276684|NCT00902538|669805|P5|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||2
276685|NCT00902538|669806|P4|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||9
276686|NCT00902538|669807|P3|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
276687|NCT00902538|669808|P2|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
276688|NCT00902538|669809|P1|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
276689|NCT00902538|669804|P6|COMPLETED|4-Randomized Double-blind 2 Treatments||196
276690|NCT00902538|669805|P5|COMPLETED|4-Randomized Double-blind 2 Treatments||95
276691|NCT00902538|669806|P4|COMPLETED|4-Randomized Double-blind 2 Treatments||458
276692|NCT00902538|669807|P3|COMPLETED|4-Randomized Double-blind 2 Treatments||0
276693|NCT00902538|669808|P2|COMPLETED|4-Randomized Double-blind 2 Treatments||0
276694|NCT00902538|669809|P1|COMPLETED|4-Randomized Double-blind 2 Treatments||0
276695|NCT00902538|669804|P6|STARTED|4-Randomized Double-blind 2 Treatments||197
276696|NCT00902538|669805|P5|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 non-responders were randomized to OLM 40-AML 10-HCTZ 12.5 or 25 in a 2:1 ratio|97
276697|NCT00902538|669806|P4|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 responders were continued on OLM 40-AML 10-HCTZ 12.5|467
276698|NCT00902538|669807|P3|STARTED|4-Randomized Double-blind 2 Treatments||0
276699|NCT00902538|669808|P2|STARTED|4-Randomized Double-blind 2 Treatments||0
276700|NCT00902538|669809|P1|STARTED|4-Randomized Double-blind 2 Treatments||0
276701|NCT00902538|669804|P6|NOT COMPLETED|3-Single-blind, Single Treatment||0
276702|NCT00902538|669805|P5|NOT COMPLETED|3-Single-blind, Single Treatment||0
276703|NCT00902538|669806|P4|NOT COMPLETED|3-Single-blind, Single Treatment||0
276704|NCT00902538|669807|P3|NOT COMPLETED|3-Single-blind, Single Treatment||0
276705|NCT00902538|669808|P2|NOT COMPLETED|3-Single-blind, Single Treatment||15
276706|NCT00902538|669809|P1|NOT COMPLETED|3-Single-blind, Single Treatment||0
276707|NCT00902538|669804|P6|COMPLETED|3-Single-blind, Single Treatment||0
276708|NCT00902538|669805|P5|COMPLETED|3-Single-blind, Single Treatment||0
276709|NCT00902538|669806|P4|COMPLETED|3-Single-blind, Single Treatment||0
276710|NCT00902538|669807|P3|COMPLETED|3-Single-blind, Single Treatment||0
276711|NCT00902538|669808|P2|COMPLETED|3-Single-blind, Single Treatment||767
276712|NCT00902538|669809|P1|COMPLETED|3-Single-blind, Single Treatment||0
276713|NCT00902538|669804|P6|STARTED|3-Single-blind, Single Treatment||0
276714|NCT00902538|669805|P5|STARTED|3-Single-blind, Single Treatment||0
276715|NCT00902538|669806|P4|STARTED|3-Single-blind, Single Treatment||0
276716|NCT00902538|669807|P3|STARTED|3-Single-blind, Single Treatment||0
276717|NCT00902538|669808|P2|STARTED|3-Single-blind, Single Treatment|Number starting is < total completing previous arm since 3 subjects did not receive at least 1 dose.|782
276718|NCT00902538|669809|P1|STARTED|3-Single-blind, Single Treatment||0
276719|NCT00902538|669804|P6|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
276720|NCT00902538|669805|P5|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
276721|NCT00902538|669806|P4|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
276722|NCT00902538|669807|P3|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||8
276723|NCT00902538|669808|P2|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||6
276724|NCT00902538|669809|P1|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||9
276725|NCT00902538|669804|P6|COMPLETED|2-Randomized Double-blind 3 Treatments||0
276726|NCT00902538|669805|P5|COMPLETED|2-Randomized Double-blind 3 Treatments||0
276727|NCT00902538|669806|P4|COMPLETED|2-Randomized Double-blind 3 Treatments||0
276728|NCT00902538|669807|P3|COMPLETED|2-Randomized Double-blind 3 Treatments||262
276729|NCT00902538|669808|P2|COMPLETED|2-Randomized Double-blind 3 Treatments||263
276730|NCT00902538|669809|P1|COMPLETED|2-Randomized Double-blind 3 Treatments||260
276731|NCT00902538|669804|P6|STARTED|2-Randomized Double-blind 3 Treatments||0
276732|NCT00902538|669805|P5|STARTED|2-Randomized Double-blind 3 Treatments||0
276733|NCT00902538|669806|P4|STARTED|2-Randomized Double-blind 3 Treatments||0
276734|NCT00902538|669807|P3|STARTED|2-Randomized Double-blind 3 Treatments||270
276735|NCT00902538|669808|P2|STARTED|2-Randomized Double-blind 3 Treatments||269
276736|NCT00902538|669809|P1|STARTED|2-Randomized Double-blind 3 Treatments|Only 808 began Period 2 because the others finishing Period 1 did not meet the entry criteria.|269
276737|NCT00902538|669804|P6|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
276738|NCT00902538|669805|P5|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
276739|NCT00902538|669806|P4|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
276740|NCT00902538|669807|P3|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
276741|NCT00902538|669808|P2|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
276742|NCT00902538|669809|P1|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||118
276743|NCT00902538|669804|P6|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
276744|NCT00902538|669805|P5|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
276745|NCT00902538|669806|P4|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
276746|NCT00902538|669807|P3|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
276747|NCT00902538|669808|P2|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
276748|NCT00902538|669809|P1|COMPLETED|1-Single-blind, Run-in, Single-Treatment||2086
276749|NCT00902538|669804|P6|STARTED|1-Single-blind, Run-in, Single-Treatment||0
276750|NCT00902538|669805|P5|STARTED|1-Single-blind, Run-in, Single-Treatment||0
276751|NCT00902538|669806|P4|STARTED|1-Single-blind, Run-in, Single-Treatment||0
276752|NCT00902538|669807|P3|STARTED|1-Single-blind, Run-in, Single-Treatment||0
276753|NCT00902538|669808|P2|STARTED|1-Single-blind, Run-in, Single-Treatment||0
276754|NCT00902538|669809|P1|STARTED|1-Single-blind, Run-in, Single-Treatment||2204
276755|NCT00902486|669843|P6|NOT COMPLETED|Follow-up (After Week 24)||0
276756|NCT00902486|669844|P5|NOT COMPLETED|Follow-up (After Week 24)||0
276757|NCT00902486|669845|P4|NOT COMPLETED|Follow-up (After Week 24)||1
276758|NCT00902486|669846|P3|NOT COMPLETED|Follow-up (After Week 24)||0
276759|NCT00902486|669847|P2|NOT COMPLETED|Follow-up (After Week 24)||0
276760|NCT00902486|669848|P1|NOT COMPLETED|Follow-up (After Week 24)||0
276761|NCT00902486|669843|P6|COMPLETED|Follow-up (After Week 24)||24
276762|NCT00902486|669844|P5|COMPLETED|Follow-up (After Week 24)||29
276763|NCT00902486|669845|P4|COMPLETED|Follow-up (After Week 24)||26
276764|NCT00902486|669846|P3|COMPLETED|Follow-up (After Week 24)||13
276765|NCT00902486|669847|P2|COMPLETED|Follow-up (After Week 24)||14
276766|NCT00902486|669848|P1|COMPLETED|Follow-up (After Week 24)||0
276767|NCT00902486|669843|P6|Safety Evaluable Participants|Follow-up (After Week 24)||27
276768|NCT00902486|669844|P5|Safety Evaluable Participants|Follow-up (After Week 24)||30
276769|NCT00902486|669845|P4|Safety Evaluable Participants|Follow-up (After Week 24)||29
276770|NCT00902486|669846|P3|Safety Evaluable Participants|Follow-up (After Week 24)||15
276771|NCT00902486|669847|P2|Safety Evaluable Participants|Follow-up (After Week 24)||14
276772|NCT00902486|669848|P1|Safety Evaluable Participants|Follow-up (After Week 24)||0
276773|NCT00902486|669843|P6|STARTED|Follow-up (After Week 24)||24
276774|NCT00902486|669844|P5|STARTED|Follow-up (After Week 24)||29
276775|NCT00902486|669845|P4|STARTED|Follow-up (After Week 24)||27
276776|NCT00902486|669846|P3|STARTED|Follow-up (After Week 24)||13
276777|NCT00902486|669847|P2|STARTED|Follow-up (After Week 24)||14
276778|NCT00902486|669848|P1|STARTED|Follow-up (After Week 24)||0
276779|NCT00902486|669843|P6|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||3
276780|NCT00902486|669844|P5|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||1
276781|NCT00902486|669845|P4|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2
276782|NCT00902486|669846|P3|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2
276783|NCT00902486|669847|P2|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0
276784|NCT00902486|669848|P1|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0
276785|NCT00902486|669843|P6|COMPLETED|Extension Period (Weeks 12 Through 24)||24
276786|NCT00902486|669844|P5|COMPLETED|Extension Period (Weeks 12 Through 24)||29
276787|NCT00902486|669845|P4|COMPLETED|Extension Period (Weeks 12 Through 24)||27
276788|NCT00902486|669846|P3|COMPLETED|Extension Period (Weeks 12 Through 24)||13
276789|NCT00902486|669847|P2|COMPLETED|Extension Period (Weeks 12 Through 24)||14
276790|NCT00902486|669848|P1|COMPLETED|Extension Period (Weeks 12 Through 24)||0
276791|NCT00902486|669843|P6|STARTED|Extension Period (Weeks 12 Through 24)||27
276792|NCT00902486|669844|P5|STARTED|Extension Period (Weeks 12 Through 24)||30
276793|NCT00902486|669845|P4|STARTED|Extension Period (Weeks 12 Through 24)||29
276794|NCT00902486|669846|P3|STARTED|Extension Period (Weeks 12 Through 24)||15
276795|NCT00902486|669847|P2|STARTED|Extension Period (Weeks 12 Through 24)||14
276796|NCT00902486|669848|P1|STARTED|Extension Period (Weeks 12 Through 24)||0
276797|NCT00902486|669843|P6|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||5
276798|NCT00902486|669844|P5|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2
276799|NCT00902486|669845|P4|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||3
276800|NCT00902486|669846|P3|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0
276801|NCT00902486|669847|P2|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0
276802|NCT00902486|669848|P1|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2
276803|NCT00902486|669843|P6|COMPLETED|Treatment Period (Weeks 0 Through 12)||27
276804|NCT00902486|669844|P5|COMPLETED|Treatment Period (Weeks 0 Through 12)||30
276805|NCT00902486|669845|P4|COMPLETED|Treatment Period (Weeks 0 Through 12)||29
276806|NCT00902486|669846|P3|COMPLETED|Treatment Period (Weeks 0 Through 12)||0
276807|NCT00902486|669847|P2|COMPLETED|Treatment Period (Weeks 0 Through 12)||0
276808|NCT00902486|669848|P1|COMPLETED|Treatment Period (Weeks 0 Through 12)||29
276809|NCT00902486|669843|P6|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||30
276810|NCT00902486|669844|P5|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||32
276811|NCT00902486|669845|P4|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31
276812|NCT00902486|669846|P3|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0
276813|NCT00902486|669847|P2|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0
276814|NCT00902486|669848|P1|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31
276815|NCT00902486|669843|P6|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
276816|NCT00902486|669844|P5|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||32
276817|NCT00902486|669845|P4|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
276818|NCT00902486|669846|P3|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0
276819|NCT00902486|669847|P2|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0
276820|NCT00902486|669848|P1|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
276821|NCT00902486|669843|P6|STARTED|Treatment Period (Weeks 0 Through 12)||32
276822|NCT00902486|669844|P5|STARTED|Treatment Period (Weeks 0 Through 12)||32
276823|NCT00902486|669845|P4|STARTED|Treatment Period (Weeks 0 Through 12)||32
276824|NCT00902486|669846|P3|STARTED|Treatment Period (Weeks 0 Through 12)||0
276825|NCT00902486|669847|P2|STARTED|Treatment Period (Weeks 0 Through 12)||0
276826|NCT00902486|669848|P1|STARTED|Treatment Period (Weeks 0 Through 12)||31
276827|NCT00902330|669986|P2|NOT COMPLETED|Overall Study||5
276828|NCT00902330|669987|P1|NOT COMPLETED|Overall Study||4
276829|NCT00902330|669986|P2|COMPLETED|Overall Study||75
276830|NCT00902330|669987|P1|COMPLETED|Overall Study||77
276831|NCT00902330|669986|P2|STARTED|Overall Study||80
276832|NCT00902330|669987|P1|STARTED|Overall Study||81
276833|NCT00902304|670024|P3|NOT COMPLETED|Overall Study||110
276834|NCT00902304|670025|P2|NOT COMPLETED|Overall Study||71
276835|NCT00902304|670026|P1|NOT COMPLETED|Overall Study||58
276836|NCT00902304|670024|P3|COMPLETED|Overall Study||568
276837|NCT00902304|670025|P2|COMPLETED|Overall Study||289
276838|NCT00902304|670026|P1|COMPLETED|Overall Study||466
276839|NCT00902304|670024|P3|STARTED|Overall Study||678
276840|NCT00902304|670025|P2|STARTED|Overall Study||360
276841|NCT00902304|670026|P1|STARTED|Overall Study||524
276842|NCT00902278|670076|P5|NOT COMPLETED|Overall Study||2
276843|NCT00902278|670077|P4|NOT COMPLETED|Overall Study||0
276844|NCT00902278|670078|P3|NOT COMPLETED|Overall Study||5
276845|NCT00902278|670079|P2|NOT COMPLETED|Overall Study||2
276846|NCT00902278|670080|P1|NOT COMPLETED|Overall Study||4
276847|NCT00902278|670076|P5|COMPLETED|Overall Study||35
276848|NCT00902278|670077|P4|COMPLETED|Overall Study||12
276849|NCT00902278|670078|P3|COMPLETED|Overall Study||49
276850|NCT00902278|670079|P2|COMPLETED|Overall Study||34
276851|NCT00902278|670080|P1|COMPLETED|Overall Study||50
276852|NCT00902278|670076|P5|STARTED|Overall Study||37
276853|NCT00902278|670077|P4|STARTED|Overall Study||12
276854|NCT00902278|670078|P3|STARTED|Overall Study||54
276855|NCT00902278|670079|P2|STARTED|Overall Study||36
276856|NCT00902278|670080|P1|STARTED|Overall Study||54
276857|NCT00902265|670097|P1|NOT COMPLETED|Overall Study||6
276858|NCT00902265|670097|P1|COMPLETED|Overall Study||132
276859|NCT00902265|670097|P1|Participants Who Received Treatment|Overall Study||137
276860|NCT00902265|670097|P1|STARTED|Overall Study||138
276861|NCT00902226|670109|P1|NOT COMPLETED|Overall Study||0
276862|NCT00902226|670109|P1|COMPLETED|Overall Study||30
276863|NCT00902226|670109|P1|STARTED|Overall Study||30
276864|NCT00902174|670121|P2|NOT COMPLETED|Overall Study||18
276865|NCT00902174|670122|P1|NOT COMPLETED|Overall Study||34
276866|NCT00902174|670121|P2|COMPLETED|Overall Study||81
276867|NCT00902174|670122|P1|COMPLETED|Overall Study||69
276868|NCT00902174|670121|P2|STARTED|Overall Study||99
276869|NCT00902174|670122|P1|STARTED|Overall Study||103
276870|NCT00902161|670160|P3|NOT COMPLETED|Period 2||0
276871|NCT00902161|670161|P2|NOT COMPLETED|Period 2||0
276872|NCT00902161|670162|P1|NOT COMPLETED|Period 2||0
276873|NCT00902161|670160|P3|COMPLETED|Period 2||0
276874|NCT00902161|670161|P2|COMPLETED|Period 2||9
276875|NCT00902161|670162|P1|COMPLETED|Period 2|2 participants discontinued and were replaced; 1 due to protocol deviation and 1 withdrew consent|8
276876|NCT00902161|670160|P3|STARTED|Period 2||0
276877|NCT00902161|670161|P2|STARTED|Period 2||9
276878|NCT00902161|670162|P1|STARTED|Period 2||8
276879|NCT00902161|670160|P3|NOT COMPLETED|Post-clamp Washout||0
276880|NCT00902161|670161|P2|NOT COMPLETED|Post-clamp Washout||0
276881|NCT00902161|670162|P1|NOT COMPLETED|Post-clamp Washout||0
276882|NCT00902161|670160|P3|COMPLETED|Post-clamp Washout|2 participants discontinued washout and were replaced; 1 due to an AE and 1 due to lack of efficacy|22
276883|NCT00902161|670161|P2|COMPLETED|Post-clamp Washout||0
276884|NCT00902161|670162|P1|COMPLETED|Post-clamp Washout||0
276885|NCT00902161|670160|P3|STARTED|Post-clamp Washout||22
276886|NCT00902161|670161|P2|STARTED|Post-clamp Washout||0
276887|NCT00902161|670162|P1|STARTED|Post-clamp Washout||0
276888|NCT00902161|670160|P3|NOT COMPLETED|Period 1||0
276889|NCT00902161|670161|P2|NOT COMPLETED|Period 1||0
276890|NCT00902161|670162|P1|NOT COMPLETED|Period 1||0
276891|NCT00902161|670160|P3|COMPLETED|Period 1||0
276892|NCT00902161|670161|P2|COMPLETED|Period 1||10
276893|NCT00902161|670162|P1|COMPLETED|Period 1||12
276894|NCT00902161|670160|P3|STARTED|Period 1||0
276895|NCT00902161|670161|P2|STARTED|Period 1||10
276896|NCT00902161|670162|P1|STARTED|Period 1||12
276897|NCT00902161|670160|P3|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
276898|NCT00902161|670161|P2|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
276899|NCT00902161|670162|P1|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
276900|NCT00902161|670160|P3|COMPLETED|Pre-study Washout/Propanolol Run-in||22
276901|NCT00902161|670161|P2|COMPLETED|Pre-study Washout/Propanolol Run-in||0
276902|NCT00902161|670162|P1|COMPLETED|Pre-study Washout/Propanolol Run-in||0
276903|NCT00902161|670160|P3|STARTED|Pre-study Washout/Propanolol Run-in||22
276904|NCT00902161|670161|P2|STARTED|Pre-study Washout/Propanolol Run-in||0
276905|NCT00902161|670162|P1|STARTED|Pre-study Washout/Propanolol Run-in||0
276906|NCT00902018|670180|P3|NOT COMPLETED|Overall Study||0
276907|NCT00902018|670181|P2|NOT COMPLETED|Overall Study||0
276908|NCT00902018|670182|P1|NOT COMPLETED|Overall Study||0
276909|NCT00902018|670180|P3|COMPLETED|Overall Study||10
276910|NCT00902018|670181|P2|COMPLETED|Overall Study||3
276911|NCT00902018|670182|P1|COMPLETED|Overall Study||7
276912|NCT00902018|670180|P3|STARTED|Overall Study||10
276913|NCT00902018|670181|P2|STARTED|Overall Study||3
276914|NCT00902018|670182|P1|STARTED|Overall Study||7
276915|NCT00901901|670199|P2|NOT COMPLETED|Follow-up Period||341
276916|NCT00901901|670200|P1|NOT COMPLETED|Follow-up Period||340
276917|NCT00901901|670199|P2|COMPLETED|Follow-up Period||0
276918|NCT00901901|670200|P1|COMPLETED|Follow-up Period||0
276919|NCT00901901|670199|P2|STARTED|Follow-up Period||341
276920|NCT00901901|670200|P1|STARTED|Follow-up Period||340
276921|NCT00901901|670199|P2|NOT COMPLETED|Treatment Period||177
276922|NCT00901901|670200|P1|NOT COMPLETED|Treatment Period||169
276923|NCT00901901|670199|P2|COMPLETED|Treatment Period||181
276924|NCT00901901|670200|P1|COMPLETED|Treatment Period||193
276925|NCT00901901|670199|P2|Participants Received Treatment|Treatment Period||355
276926|NCT00901901|670200|P1|Participants Received Treatment|Treatment Period||362
276927|NCT00901901|670199|P2|STARTED|Treatment Period||358
276928|NCT00901901|670200|P1|STARTED|Treatment Period||362
276929|NCT00901628|670222|P2|NOT COMPLETED|Overall Study||10
276930|NCT00901628|670223|P1|NOT COMPLETED|Overall Study||4
276931|NCT00901628|670222|P2|COMPLETED|Overall Study||42
276932|NCT00901628|670223|P1|COMPLETED|Overall Study||45
276933|NCT00901628|670222|P2|STARTED|Overall Study||52
276934|NCT00901628|670223|P1|STARTED|Overall Study||49
276935|NCT00901576|670245|P6|NOT COMPLETED|Third Intervention||0
276936|NCT00901576|670246|P5|NOT COMPLETED|Third Intervention||0
276937|NCT00901576|670247|P4|NOT COMPLETED|Third Intervention||0
276938|NCT00901576|670248|P3|NOT COMPLETED|Third Intervention||0
276939|NCT00901576|670249|P2|NOT COMPLETED|Third Intervention||0
276940|NCT00901576|670250|P1|NOT COMPLETED|Third Intervention||0
276941|NCT00901576|670245|P6|COMPLETED|Third Intervention||5
276942|NCT00901576|670246|P5|COMPLETED|Third Intervention||6
276943|NCT00901576|670247|P4|COMPLETED|Third Intervention||5
276944|NCT00901576|670248|P3|COMPLETED|Third Intervention||7
276945|NCT00901576|670249|P2|COMPLETED|Third Intervention||7
276946|NCT00901576|670250|P1|COMPLETED|Third Intervention||5
276947|NCT00901576|670245|P6|STARTED|Third Intervention||5
276948|NCT00901576|670246|P5|STARTED|Third Intervention||6
276949|NCT00901576|670247|P4|STARTED|Third Intervention||5
276950|NCT00901576|670248|P3|STARTED|Third Intervention||7
276951|NCT00901576|670249|P2|STARTED|Third Intervention||7
276952|NCT00901576|670250|P1|STARTED|Third Intervention||5
276953|NCT00901576|670245|P6|NOT COMPLETED|Washout||0
276954|NCT00901576|670246|P5|NOT COMPLETED|Washout||0
276955|NCT00901576|670247|P4|NOT COMPLETED|Washout||0
276956|NCT00901576|670248|P3|NOT COMPLETED|Washout||0
276957|NCT00901576|670249|P2|NOT COMPLETED|Washout||0
276958|NCT00901576|670250|P1|NOT COMPLETED|Washout||0
276959|NCT00901576|670245|P6|COMPLETED|Washout||5
276960|NCT00901576|670246|P5|COMPLETED|Washout||6
276961|NCT00901576|670247|P4|COMPLETED|Washout||5
276962|NCT00901576|670248|P3|COMPLETED|Washout||7
276963|NCT00901576|670249|P2|COMPLETED|Washout||7
276964|NCT00901576|670250|P1|COMPLETED|Washout||5
276965|NCT00901576|670245|P6|STARTED|Washout||5
276966|NCT00901576|670246|P5|STARTED|Washout||6
276967|NCT00901576|670247|P4|STARTED|Washout||5
276968|NCT00901576|670248|P3|STARTED|Washout||7
276969|NCT00901576|670249|P2|STARTED|Washout||7
276970|NCT00901576|670250|P1|STARTED|Washout||5
276971|NCT00901576|670245|P6|NOT COMPLETED|Second Intervention||1
276972|NCT00901576|670246|P5|NOT COMPLETED|Second Intervention||0
276973|NCT00901576|670247|P4|NOT COMPLETED|Second Intervention||1
276974|NCT00901576|670248|P3|NOT COMPLETED|Second Intervention||0
276975|NCT00901576|670249|P2|NOT COMPLETED|Second Intervention||0
276976|NCT00901576|670250|P1|NOT COMPLETED|Second Intervention||1
276977|NCT00901576|670245|P6|COMPLETED|Second Intervention||5
276978|NCT00901576|670246|P5|COMPLETED|Second Intervention||6
276979|NCT00901576|670247|P4|COMPLETED|Second Intervention||5
276980|NCT00901576|670248|P3|COMPLETED|Second Intervention||7
276981|NCT00901576|670249|P2|COMPLETED|Second Intervention||7
276982|NCT00901576|670250|P1|COMPLETED|Second Intervention||5
276983|NCT00901576|670245|P6|STARTED|Second Intervention||6
276984|NCT00901576|670246|P5|STARTED|Second Intervention||6
276985|NCT00901576|670247|P4|STARTED|Second Intervention||6
276986|NCT00901576|670248|P3|STARTED|Second Intervention||7
276987|NCT00901576|670249|P2|STARTED|Second Intervention||7
276988|NCT00901576|670250|P1|STARTED|Second Intervention||6
276989|NCT00901576|670245|P6|NOT COMPLETED|Washout||0
276990|NCT00901576|670246|P5|NOT COMPLETED|Washout||0
276991|NCT00901576|670247|P4|NOT COMPLETED|Washout||0
276992|NCT00901576|670248|P3|NOT COMPLETED|Washout||0
276993|NCT00901576|670249|P2|NOT COMPLETED|Washout||0
276994|NCT00901576|670250|P1|NOT COMPLETED|Washout||0
276995|NCT00901576|670245|P6|COMPLETED|Washout||6
276996|NCT00901576|670246|P5|COMPLETED|Washout||6
276997|NCT00901576|670247|P4|COMPLETED|Washout||6
276998|NCT00901576|670248|P3|COMPLETED|Washout||7
276999|NCT00901576|670249|P2|COMPLETED|Washout||7
277000|NCT00901576|670250|P1|COMPLETED|Washout||6
277001|NCT00901576|670245|P6|STARTED|Washout||6
277002|NCT00901576|670246|P5|STARTED|Washout||6
277003|NCT00901576|670247|P4|STARTED|Washout||6
277004|NCT00901576|670248|P3|STARTED|Washout||7
277005|NCT00901576|670249|P2|STARTED|Washout||7
277006|NCT00901576|670250|P1|STARTED|Washout||6
277007|NCT00901576|670245|P6|NOT COMPLETED|First Intervention||0
277008|NCT00901576|670246|P5|NOT COMPLETED|First Intervention||0
277009|NCT00901576|670247|P4|NOT COMPLETED|First Intervention||0
277010|NCT00901576|670248|P3|NOT COMPLETED|First Intervention||0
277011|NCT00901576|670249|P2|NOT COMPLETED|First Intervention||0
277012|NCT00901576|670250|P1|NOT COMPLETED|First Intervention||0
277013|NCT00901576|670245|P6|COMPLETED|First Intervention||6
277014|NCT00901576|670246|P5|COMPLETED|First Intervention||6
277015|NCT00901576|670247|P4|COMPLETED|First Intervention||6
277016|NCT00901576|670248|P3|COMPLETED|First Intervention||7
277017|NCT00901576|670249|P2|COMPLETED|First Intervention||7
277018|NCT00901576|670250|P1|COMPLETED|First Intervention||6
277019|NCT00901576|670245|P6|STARTED|First Intervention||6
277020|NCT00901576|670246|P5|STARTED|First Intervention||6
277021|NCT00901576|670247|P4|STARTED|First Intervention||6
277022|NCT00901576|670248|P3|STARTED|First Intervention||7
277023|NCT00901576|670249|P2|STARTED|First Intervention||7
277024|NCT00901576|670250|P1|STARTED|First Intervention||6
277025|NCT00901459|670271|P1|NOT COMPLETED|Overall Study||6
277026|NCT00901459|670271|P1|COMPLETED|Overall Study||15
277027|NCT00901459|670271|P1|STARTED|Overall Study||21
277028|NCT00901342|670282|P1|NOT COMPLETED|Overall Study||15
277029|NCT00901342|670282|P1|COMPLETED|Overall Study|89 subjects completed the study completion visit|89
277030|NCT00901342|670282|P1|Received at Least 1 Infusion|Overall Study||98
277031|NCT00901342|670282|P1|STARTED|Overall Study||104
277032|NCT00901316|670288|P2|NOT COMPLETED|Overall Study||0
277033|NCT00901316|670289|P1|NOT COMPLETED|Overall Study||0
277034|NCT00901316|670288|P2|COMPLETED|Overall Study||495
277035|NCT00901316|670289|P1|COMPLETED|Overall Study||492
277036|NCT00901316|670288|P2|STARTED|Overall Study||495
277037|NCT00901316|670289|P1|STARTED|Overall Study||492
277038|NCT00901303|670297|P2|NOT COMPLETED|Overall Study||0
277039|NCT00901303|670298|P1|NOT COMPLETED|Overall Study||0
277040|NCT00901303|670297|P2|COMPLETED|Overall Study||1
277041|NCT00901303|670298|P1|COMPLETED|Overall Study||5
277042|NCT00901303|670297|P2|STARTED|Overall Study||1
277043|NCT00901303|670298|P1|STARTED|Overall Study||5
277044|NCT00901225|670304|P1|NOT COMPLETED|Overall Study||1
277045|NCT00901225|670304|P1|COMPLETED|Overall Study||20
277046|NCT00901225|670304|P1|STARTED|Overall Study||21
277047|NCT00901186|670315|P2|NOT COMPLETED|Overall Study||11
277048|NCT00901186|670316|P1|NOT COMPLETED|Overall Study||9
277049|NCT00901186|670315|P2|COMPLETED|Overall Study||32
277050|NCT00901186|670316|P1|COMPLETED|Overall Study||31
277051|NCT00901186|670315|P2|Intent to Treat|Overall Study|Five treated participants did not have at least a baseline and one post-treatment BCVA.|38
277052|NCT00901186|670316|P1|Intent to Treat|Overall Study|Four treated participants did not have at least a baseline and one post-treatment BCVA.|35
277053|NCT00901186|670315|P2|Safety Set|Overall Study||43
277054|NCT00901186|670316|P1|Safety Set|Overall Study|One participant did not receive one intravitreal RFB002 injection.|39
277055|NCT00901186|670315|P2|STARTED|Overall Study||43
277056|NCT00901186|670316|P1|STARTED|Overall Study||40
277057|NCT00901017|670332|P1|NOT COMPLETED|Overall Study||0
277058|NCT00901017|670332|P1|COMPLETED|Overall Study||14
277059|NCT00901017|670332|P1|STARTED|Overall Study||14
277060|NCT00900822|670346|P1|NOT COMPLETED|12 Months Clinical Evaluation||0
277061|NCT00900822|670346|P1|COMPLETED|12 Months Clinical Evaluation||11
277062|NCT00900822|670346|P1|STARTED|12 Months Clinical Evaluation||11
277063|NCT00900822|670346|P1|NOT COMPLETED|9 Months Histological Evaluation||0
277064|NCT00900822|670346|P1|COMPLETED|9 Months Histological Evaluation||11
277065|NCT00900822|670346|P1|STARTED|9 Months Histological Evaluation||11
277066|NCT00900796|670356|P1|NOT COMPLETED|Phase 2||5
277067|NCT00900796|670356|P1|COMPLETED|Phase 2||6
277068|NCT00900796|670356|P1|STARTED|Phase 2||11
277069|NCT00900796|670356|P1|NOT COMPLETED|Between Phase 1 and Phase 2||110
277070|NCT00900796|670356|P1|COMPLETED|Between Phase 1 and Phase 2||11
277071|NCT00900796|670356|P1|STARTED|Between Phase 1 and Phase 2||121
277072|NCT00900796|670356|P1|NOT COMPLETED|Phase 1||11
277073|NCT00900796|670356|P1|COMPLETED|Phase 1||121
277074|NCT00900796|670356|P1|STARTED|Phase 1||132
277075|NCT00900757|670366|P1|NOT COMPLETED|Overall Study||19
277076|NCT00900757|670366|P1|COMPLETED|Overall Study||38
277077|NCT00900757|670366|P1|STARTED|Overall Study||57
277078|NCT00900731|670376|P2|NOT COMPLETED|Overall Study||61
277079|NCT00900731|670377|P1|NOT COMPLETED|Overall Study||60
277080|NCT00900731|670376|P2|COMPLETED|Overall Study||740
277081|NCT00900731|670377|P1|COMPLETED|Overall Study||737
277082|NCT00900731|670376|P2|Safety Set: Received Study Drug|Overall Study||799
277083|NCT00900731|670377|P1|Safety Set: Received Study Drug|Overall Study||794
277084|NCT00900731|670376|P2|STARTED|Overall Study||801
277085|NCT00900731|670377|P1|STARTED|Overall Study|Randomized participants|797
277086|NCT00900666|670399|P2|NOT COMPLETED|Overall Study||0
277087|NCT00900666|670400|P1|NOT COMPLETED|Overall Study||0
277088|NCT00900666|670399|P2|COMPLETED|Overall Study||9
277089|NCT00900666|670400|P1|COMPLETED|Overall Study||10
277090|NCT00900666|670399|P2|STARTED|Overall Study||9
277091|NCT00900666|670400|P1|STARTED|Overall Study||10
277092|NCT00900627|670414|P6|NOT COMPLETED|Overall Study||26
277093|NCT00900627|670415|P5|NOT COMPLETED|Overall Study||29
277094|NCT00900627|670416|P4|NOT COMPLETED|Overall Study||6
277095|NCT00900627|670417|P3|NOT COMPLETED|Overall Study||6
277096|NCT00900627|670418|P2|NOT COMPLETED|Overall Study||2
277097|NCT00900627|670419|P1|NOT COMPLETED|Overall Study||6
277098|NCT00900627|670414|P6|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|70
277099|NCT00900627|670415|P5|COMPLETED|Overall Study|No set completion, pts were to remain in study until withdrawn|65
277100|NCT00900627|670416|P4|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
277101|NCT00900627|670417|P3|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
277102|NCT00900627|670418|P2|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
277103|NCT00900627|670419|P1|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
277104|NCT00900627|670414|P6|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|96
277105|NCT00900627|670415|P5|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|94
277106|NCT00900627|670416|P4|STARTED|Overall Study||6
277107|NCT00900627|670417|P3|STARTED|Overall Study||6
277108|NCT00900627|670418|P2|STARTED|Overall Study||2
277109|NCT00900627|670419|P1|STARTED|Overall Study||6
277110|NCT00900601|670437|P1|NOT COMPLETED|Overall Study||1
277111|NCT00900601|670437|P1|COMPLETED|Overall Study||8
277112|NCT00900601|670437|P1|STARTED|Overall Study||9
277113|NCT00900237|670445|P2|NOT COMPLETED|Overall Study||0
277114|NCT00900237|670446|P1|NOT COMPLETED|Overall Study||0
277115|NCT00900237|670445|P2|COMPLETED|Overall Study||7
277116|NCT00900237|670446|P1|COMPLETED|Overall Study||7
277117|NCT00900237|670445|P2|STARTED|Overall Study||7
277118|NCT00900237|670446|P1|STARTED|Overall Study||7
277119|NCT00900159|670456|P2|NOT COMPLETED|Second Intervention||0
277120|NCT00900159|670457|P1|NOT COMPLETED|Second Intervention||1
277121|NCT00900159|670456|P2|COMPLETED|Second Intervention||13
277122|NCT00900159|670457|P1|COMPLETED|Second Intervention||10
277123|NCT00900159|670456|P2|STARTED|Second Intervention||13
277124|NCT00900159|670457|P1|STARTED|Second Intervention||11
277125|NCT00900159|670456|P2|NOT COMPLETED|Washout||0
277126|NCT00900159|670457|P1|NOT COMPLETED|Washout||0
277127|NCT00900159|670456|P2|COMPLETED|Washout||13
277128|NCT00900159|670457|P1|COMPLETED|Washout||11
277129|NCT00900159|670456|P2|STARTED|Washout||13
277130|NCT00900159|670457|P1|STARTED|Washout||11
277131|NCT00900159|670456|P2|NOT COMPLETED|First Intervention||0
277132|NCT00900159|670457|P1|NOT COMPLETED|First Intervention||0
277133|NCT00900159|670456|P2|COMPLETED|First Intervention||13
277134|NCT00900159|670457|P1|COMPLETED|First Intervention||11
277135|NCT00900159|670456|P2|STARTED|First Intervention||13
277136|NCT00900159|670457|P1|STARTED|First Intervention||11
277137|NCT00900146|670476|P5|NOT COMPLETED|Intermediate: Period III||167
277138|NCT00900146|670477|P4|NOT COMPLETED|Intermediate: Period III||90
277139|NCT00900146|670478|P3|NOT COMPLETED|Intermediate: Period III||84
277140|NCT00900146|670479|P2|NOT COMPLETED|Intermediate: Period III||93
277141|NCT00900146|670480|P1|NOT COMPLETED|Intermediate: Period III||87
277142|NCT00900146|670476|P5|COMPLETED|Intermediate: Period III||0
277143|NCT00900146|670477|P4|COMPLETED|Intermediate: Period III||0
277144|NCT00900146|670478|P3|COMPLETED|Intermediate: Period III||0
277145|NCT00900146|670479|P2|COMPLETED|Intermediate: Period III||0
277146|NCT00900146|670480|P1|COMPLETED|Intermediate: Period III||0
277147|NCT00900146|670476|P5|Safety Set|Intermediate: Period III||166
277148|NCT00900146|670477|P4|Safety Set|Intermediate: Period III||90
277149|NCT00900146|670478|P3|Safety Set|Intermediate: Period III||84
277150|NCT00900146|670479|P2|Safety Set|Intermediate: Period III||92
277151|NCT00900146|670480|P1|Safety Set|Intermediate: Period III||86
277152|NCT00900146|670476|P5|STARTED|Intermediate: Period III||167
277153|NCT00900146|670477|P4|STARTED|Intermediate: Period III||90
277154|NCT00900146|670478|P3|STARTED|Intermediate: Period III||84
277155|NCT00900146|670479|P2|STARTED|Intermediate: Period III||93
277156|NCT00900146|670480|P1|STARTED|Intermediate: Period III||87
277157|NCT00900146|670476|P5|NOT COMPLETED|Dose Finding: Period II (4 Months)||12
277158|NCT00900146|670477|P4|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
277159|NCT00900146|670478|P3|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
277160|NCT00900146|670479|P2|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
277161|NCT00900146|670480|P1|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
277162|NCT00900146|670476|P5|COMPLETED|Dose Finding: Period II (4 Months)|Placebo also included 1 patient with no study completion page.|167
277163|NCT00900146|670477|P4|COMPLETED|Dose Finding: Period II (4 Months)||90
277164|NCT00900146|670478|P3|COMPLETED|Dose Finding: Period II (4 Months)||87
277165|NCT00900146|670479|P2|COMPLETED|Dose Finding: Period II (4 Months)||93
277166|NCT00900146|670480|P1|COMPLETED|Dose Finding: Period II (4 Months)||88
277167|NCT00900146|670476|P5|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||179
277168|NCT00900146|670477|P4|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
277169|NCT00900146|670478|P3|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
277170|NCT00900146|670479|P2|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||95
277171|NCT00900146|670480|P1|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||93
277172|NCT00900146|670476|P5|STARTED|Dose Finding: Period II (4 Months)||179
277173|NCT00900146|670477|P4|STARTED|Dose Finding: Period II (4 Months)||92
277174|NCT00900146|670478|P3|STARTED|Dose Finding: Period II (4 Months)||92
277175|NCT00900146|670479|P2|STARTED|Dose Finding: Period II (4 Months)||95
277176|NCT00900146|670480|P1|STARTED|Dose Finding: Period II (4 Months)||93
277177|NCT00900029|670597|P5|NOT COMPLETED|Overall Study||6
277178|NCT00900029|670598|P4|NOT COMPLETED|Overall Study||7
277179|NCT00900029|670599|P3|NOT COMPLETED|Overall Study||3
277180|NCT00900029|670600|P2|NOT COMPLETED|Overall Study||4
277181|NCT00900029|670601|P1|NOT COMPLETED|Overall Study||3
277182|NCT00900029|670597|P5|COMPLETED|Overall Study||38
277183|NCT00900029|670598|P4|COMPLETED|Overall Study||35
277184|NCT00900029|670599|P3|COMPLETED|Overall Study||38
277185|NCT00900029|670600|P2|COMPLETED|Overall Study||37
277186|NCT00900029|670601|P1|COMPLETED|Overall Study||35
277187|NCT00900029|670597|P5|STARTED|Overall Study||44
277188|NCT00900029|670598|P4|STARTED|Overall Study||42
277189|NCT00900029|670599|P3|STARTED|Overall Study||41
277190|NCT00900029|670600|P2|STARTED|Overall Study||41
277191|NCT00900029|670601|P1|STARTED|Overall Study||38
277192|NCT00899847|670618|P1|NOT COMPLETED|Overall Study||2
277193|NCT00899847|670618|P1|COMPLETED|Overall Study||7
277194|NCT00899847|670618|P1|STARTED|Overall Study||9
277195|NCT00899717|670631|P2|NOT COMPLETED|Overall Study||0
277196|NCT00899717|670632|P1|NOT COMPLETED|Overall Study||0
277197|NCT00899717|670631|P2|COMPLETED|Overall Study||11
277198|NCT00899717|670632|P1|COMPLETED|Overall Study||10
277199|NCT00899717|670631|P2|STARTED|Overall Study||11
277200|NCT00899717|670632|P1|STARTED|Overall Study||10
277201|NCT00899678|670649|P3|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||28
277202|NCT00899678|670650|P2|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||25
277203|NCT00899678|670651|P1|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||0
277204|NCT00899678|670649|P3|COMPLETED|Maintenance Period (Weeks 8 to 62)||7
277205|NCT00899678|670650|P2|COMPLETED|Maintenance Period (Weeks 8 to 62)||12
277206|NCT00899678|670651|P1|COMPLETED|Maintenance Period (Weeks 8 to 62)||0
277207|NCT00899678|670649|P3|STARTED|Maintenance Period (Weeks 8 to 62)||35
277208|NCT00899678|670650|P2|STARTED|Maintenance Period (Weeks 8 to 62)||37
277209|NCT00899678|670651|P1|STARTED|Maintenance Period (Weeks 8 to 62)|Induction only includes subjects that discontinued before Maintenance Period.|0
277210|NCT00899678|670649|P3|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
277211|NCT00899678|670650|P2|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
277212|NCT00899678|670651|P1|NOT COMPLETED|Induction Period (Weeks 0 to 6)||25
277213|NCT00899678|670649|P3|COMPLETED|Induction Period (Weeks 0 to 6)||35
277214|NCT00899678|670650|P2|COMPLETED|Induction Period (Weeks 0 to 6)||37
277215|NCT00899678|670651|P1|COMPLETED|Induction Period (Weeks 0 to 6)|2 subjects completed the Induction Phase, but discontinued prior to receiving any Maintenance doses.|2
277216|NCT00899678|670649|P3|STARTED|Induction Period (Weeks 0 to 6)||35
277217|NCT00899678|670650|P2|STARTED|Induction Period (Weeks 0 to 6)||37
277218|NCT00899678|670651|P1|STARTED|Induction Period (Weeks 0 to 6)|Induction only includes subjects that discontinued before Maintenance Period.|27
277219|NCT00899600|670681|P2|NOT COMPLETED|Overall Study||0
277220|NCT00899600|670682|P1|NOT COMPLETED|Overall Study||0
277221|NCT00899600|670681|P2|COMPLETED|Overall Study||52
277222|NCT00899600|670682|P1|COMPLETED|Overall Study||50
277223|NCT00899600|670681|P2|STARTED|Overall Study||52
277224|NCT00899600|670682|P1|STARTED|Overall Study||50
277225|NCT00899574|670696|P1|NOT COMPLETED|Overall Study||0
277226|NCT00899574|670696|P1|COMPLETED|Overall Study||10
277227|NCT00899574|670696|P1|STARTED|Overall Study||10
277228|NCT00899548|670701|P1|NOT COMPLETED|Overall Study||3
277229|NCT00899548|670701|P1|COMPLETED|Overall Study||179
277230|NCT00899548|670701|P1|STARTED|Overall Study||182
277231|NCT00899470|670713|P4|NOT COMPLETED|Fourth Therapy||0
277232|NCT00899470|670714|P3|NOT COMPLETED|Fourth Therapy||0
277233|NCT00899470|670715|P2|NOT COMPLETED|Fourth Therapy||0
277234|NCT00899470|670716|P1|NOT COMPLETED|Fourth Therapy||0
277235|NCT00899470|670713|P4|COMPLETED|Fourth Therapy||6
277236|NCT00899470|670714|P3|COMPLETED|Fourth Therapy||6
277237|NCT00899470|670715|P2|COMPLETED|Fourth Therapy||6
277238|NCT00899470|670716|P1|COMPLETED|Fourth Therapy||6
277239|NCT00899470|670713|P4|STARTED|Fourth Therapy||6
277240|NCT00899470|670714|P3|STARTED|Fourth Therapy||6
277241|NCT00899470|670715|P2|STARTED|Fourth Therapy||6
277242|NCT00899470|670716|P1|STARTED|Fourth Therapy||6
277243|NCT00899470|670713|P4|NOT COMPLETED|Third Washout||0
277244|NCT00899470|670714|P3|NOT COMPLETED|Third Washout||0
277245|NCT00899470|670715|P2|NOT COMPLETED|Third Washout||0
277246|NCT00899470|670716|P1|NOT COMPLETED|Third Washout||0
277247|NCT00899470|670713|P4|COMPLETED|Third Washout||6
277248|NCT00899470|670714|P3|COMPLETED|Third Washout||6
277249|NCT00899470|670715|P2|COMPLETED|Third Washout||6
277250|NCT00899470|670716|P1|COMPLETED|Third Washout||6
277251|NCT00899470|670713|P4|STARTED|Third Washout||6
277252|NCT00899470|670714|P3|STARTED|Third Washout||6
277253|NCT00899470|670715|P2|STARTED|Third Washout||6
277254|NCT00899470|670716|P1|STARTED|Third Washout||6
277255|NCT00899470|670713|P4|NOT COMPLETED|Third Therapy||0
277256|NCT00899470|670714|P3|NOT COMPLETED|Third Therapy||0
277257|NCT00899470|670715|P2|NOT COMPLETED|Third Therapy||0
277258|NCT00899470|670716|P1|NOT COMPLETED|Third Therapy||0
277259|NCT00899470|670713|P4|COMPLETED|Third Therapy||6
277260|NCT00899470|670714|P3|COMPLETED|Third Therapy||6
277261|NCT00899470|670715|P2|COMPLETED|Third Therapy||6
277262|NCT00899470|670716|P1|COMPLETED|Third Therapy||6
277263|NCT00899470|670713|P4|STARTED|Third Therapy||6
277264|NCT00899470|670714|P3|STARTED|Third Therapy||6
277265|NCT00899470|670715|P2|STARTED|Third Therapy||6
277266|NCT00899470|670716|P1|STARTED|Third Therapy||6
277267|NCT00899470|670713|P4|NOT COMPLETED|Second Washout||0
277268|NCT00899470|670714|P3|NOT COMPLETED|Second Washout||0
277269|NCT00899470|670715|P2|NOT COMPLETED|Second Washout||0
277270|NCT00899470|670716|P1|NOT COMPLETED|Second Washout||0
277271|NCT00899470|670713|P4|COMPLETED|Second Washout||6
277272|NCT00899470|670714|P3|COMPLETED|Second Washout||6
277273|NCT00899470|670715|P2|COMPLETED|Second Washout||6
277274|NCT00899470|670716|P1|COMPLETED|Second Washout||6
277275|NCT00899470|670713|P4|STARTED|Second Washout||6
277276|NCT00899470|670714|P3|STARTED|Second Washout||6
277277|NCT00899470|670715|P2|STARTED|Second Washout||6
277278|NCT00899470|670716|P1|STARTED|Second Washout||6
277279|NCT00899470|670713|P4|NOT COMPLETED|Second Therapy||0
277280|NCT00899470|670714|P3|NOT COMPLETED|Second Therapy||0
277281|NCT00899470|670715|P2|NOT COMPLETED|Second Therapy||0
277282|NCT00899470|670716|P1|NOT COMPLETED|Second Therapy||0
277283|NCT00899470|670713|P4|COMPLETED|Second Therapy||6
277284|NCT00899470|670714|P3|COMPLETED|Second Therapy||6
277285|NCT00899470|670715|P2|COMPLETED|Second Therapy||6
277286|NCT00899470|670716|P1|COMPLETED|Second Therapy||6
277287|NCT00899470|670713|P4|STARTED|Second Therapy||6
277288|NCT00899470|670714|P3|STARTED|Second Therapy||6
277289|NCT00899470|670715|P2|STARTED|Second Therapy||6
277290|NCT00899470|670716|P1|STARTED|Second Therapy||6
277291|NCT00899470|670713|P4|NOT COMPLETED|First Washout Period||0
277292|NCT00899470|670714|P3|NOT COMPLETED|First Washout Period||0
277293|NCT00899470|670715|P2|NOT COMPLETED|First Washout Period||0
277294|NCT00899470|670716|P1|NOT COMPLETED|First Washout Period||0
277295|NCT00899470|670713|P4|COMPLETED|First Washout Period||6
277296|NCT00899470|670714|P3|COMPLETED|First Washout Period||6
277297|NCT00899470|670715|P2|COMPLETED|First Washout Period||6
277298|NCT00899470|670716|P1|COMPLETED|First Washout Period||6
277299|NCT00899470|670713|P4|STARTED|First Washout Period||6
277300|NCT00899470|670714|P3|STARTED|First Washout Period||6
277301|NCT00899470|670715|P2|STARTED|First Washout Period||6
277302|NCT00899470|670716|P1|STARTED|First Washout Period||6
277303|NCT00899470|670713|P4|NOT COMPLETED|First Therapy||0
277304|NCT00899470|670714|P3|NOT COMPLETED|First Therapy||0
277305|NCT00899470|670715|P2|NOT COMPLETED|First Therapy||0
277306|NCT00899470|670716|P1|NOT COMPLETED|First Therapy||0
277307|NCT00899470|670713|P4|COMPLETED|First Therapy||6
277308|NCT00899470|670714|P3|COMPLETED|First Therapy||6
277309|NCT00899470|670715|P2|COMPLETED|First Therapy||6
277310|NCT00899470|670716|P1|COMPLETED|First Therapy||6
277311|NCT00899470|670713|P4|STARTED|First Therapy||6
277312|NCT00899470|670714|P3|STARTED|First Therapy||6
277313|NCT00899470|670715|P2|STARTED|First Therapy||6
277314|NCT00899470|670716|P1|STARTED|First Therapy||6
277315|NCT00899392|670794|P2|NOT COMPLETED|Overall Study||24
277316|NCT00899392|670795|P1|NOT COMPLETED|Overall Study||21
277317|NCT00899392|670794|P2|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|50
277318|NCT00899392|670795|P1|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|47
277319|NCT00899392|670794|P2|STARTED|Overall Study||74
277320|NCT00899392|670795|P1|STARTED|Overall Study||68
277321|NCT00899379|670812|P5|NOT COMPLETED|Overall Study||31
277322|NCT00899379|670813|P4|NOT COMPLETED|Overall Study||37
277323|NCT00899379|670814|P3|NOT COMPLETED|Overall Study||29
277324|NCT00899379|670815|P2|NOT COMPLETED|Overall Study||29
277325|NCT00899379|670816|P1|NOT COMPLETED|Overall Study||34
277326|NCT00899379|670812|P5|COMPLETED|Overall Study|Patients who took study drug and completed the study|63
277327|NCT00899379|670813|P4|COMPLETED|Overall Study|Patients who took study drug and completed the study|57
277328|NCT00899379|670814|P3|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
277329|NCT00899379|670815|P2|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
277330|NCT00899379|670816|P1|COMPLETED|Overall Study|Patients who took study drug and completed the study|61
277331|NCT00899379|670812|P5|Patients Not Treated|Overall Study|Patients who did not take study drug|13
277332|NCT00899379|670813|P4|Patients Not Treated|Overall Study|Patients who did not take study drug|17
277333|NCT00899379|670814|P3|Patients Not Treated|Overall Study|Patients who did not take study drug|11
277334|NCT00899379|670815|P2|Patients Not Treated|Overall Study|Patients who did not take study drug|13
277335|NCT00899379|670816|P1|Patients Not Treated|Overall Study|Patients who did not take study drug|12
277336|NCT00899379|670812|P5|Patients Treated|Overall Study|Patients who took study drug|81
277337|NCT00899379|670813|P4|Patients Treated|Overall Study|Patients who took study drug|77
277338|NCT00899379|670814|P3|Patients Treated|Overall Study|Patients who took study drug|84
277339|NCT00899379|670815|P2|Patients Treated|Overall Study|Patients who took study drug|82
277340|NCT00899379|670816|P1|Patients Treated|Overall Study|Patients who took study drug|83
277341|NCT00899379|670812|P5|STARTED|Overall Study|Patients who were allocated study drug|94
277342|NCT00899379|670813|P4|STARTED|Overall Study|Patients who were allocated study drug|94
277343|NCT00899379|670814|P3|STARTED|Overall Study|Patients who were allocated study drug|95
277431|NCT00897104|671090|P3|NOT COMPLETED|Overall Study||8
277344|NCT00899379|670815|P2|STARTED|Overall Study|Patients who were allocated study drug|95
277345|NCT00899379|670816|P1|STARTED|Overall Study|Patients who were allocated study drug|95
277346|NCT00899353|670828|P1|NOT COMPLETED|Overall Study||5
277347|NCT00899353|670828|P1|COMPLETED|Overall Study||11
277348|NCT00899353|670828|P1|STARTED|Overall Study||16
277349|NCT00898937|670852|P3|NOT COMPLETED|Overall Study||0
277350|NCT00898937|670853|P2|NOT COMPLETED|Overall Study||0
277351|NCT00898937|670854|P1|NOT COMPLETED|Overall Study||0
277352|NCT00898937|670852|P3|COMPLETED|Overall Study||9
277353|NCT00898937|670853|P2|COMPLETED|Overall Study||21
277354|NCT00898937|670854|P1|COMPLETED|Overall Study||25
277355|NCT00898937|670852|P3|STARTED|Overall Study||9
277356|NCT00898937|670853|P2|STARTED|Overall Study||21
277357|NCT00898937|670854|P1|STARTED|Overall Study||25
277358|NCT00898807|670864|P2|NOT COMPLETED|Overall Study||9
277359|NCT00898807|670865|P1|NOT COMPLETED|Overall Study||8
277360|NCT00898807|670864|P2|COMPLETED|Overall Study||83
277361|NCT00898807|670865|P1|COMPLETED|Overall Study||86
277362|NCT00898807|670864|P2|STARTED|Overall Study||92
277363|NCT00898807|670865|P1|STARTED|Overall Study||94
277364|NCT00898677|670881|P4|NOT COMPLETED|Overall Study||19
277365|NCT00898677|670882|P3|NOT COMPLETED|Overall Study||72
277366|NCT00898677|670883|P2|NOT COMPLETED|Overall Study||69
277367|NCT00898677|670884|P1|NOT COMPLETED|Overall Study||17
277368|NCT00898677|670881|P4|COMPLETED|Overall Study||159
277369|NCT00898677|670882|P3|COMPLETED|Overall Study||383
277370|NCT00898677|670883|P2|COMPLETED|Overall Study||386
277371|NCT00898677|670884|P1|COMPLETED|Overall Study||163
277372|NCT00898677|670881|P4|Patients Treated|Overall Study|Patients Not Treated: 18|160
277373|NCT00898677|670882|P3|Patients Treated|Overall Study|Patients Not Treated: 67|388
277374|NCT00898677|670883|P2|Patients Treated|Overall Study|Patients Not Treated: 68|387
277375|NCT00898677|670884|P1|Patients Treated|Overall Study|Patients Not Treated: 16|164
277376|NCT00898677|670881|P4|STARTED|Overall Study||178
277377|NCT00898677|670882|P3|STARTED|Overall Study||455
277378|NCT00898677|670883|P2|STARTED|Overall Study||455
277379|NCT00898677|670884|P1|STARTED|Overall Study||180
277380|NCT00898560|670910|P1|NOT COMPLETED|Overall Study||1
277381|NCT00898560|670910|P1|COMPLETED|Overall Study||19
277382|NCT00898560|670910|P1|STARTED|Overall Study||20
277383|NCT00898443|670922|P2|NOT COMPLETED|Overall Study||0
277384|NCT00898443|670923|P1|NOT COMPLETED|Overall Study||1
277385|NCT00898443|670922|P2|COMPLETED|Overall Study||8
277386|NCT00898443|670923|P1|COMPLETED|Overall Study||9
277387|NCT00898443|670922|P2|STARTED|Overall Study||8
277388|NCT00898443|670923|P1|STARTED|Overall Study||10
277389|NCT00898222|670931|P1|NOT COMPLETED|Overall Study||0
277390|NCT00898222|670931|P1|COMPLETED|Overall Study||4
277391|NCT00898222|670931|P1|STARTED|Overall Study||4
277392|NCT00897949|670938|P3|NOT COMPLETED|Overall Study||69
277393|NCT00897949|670939|P2|NOT COMPLETED|Overall Study||103
277394|NCT00897949|670940|P1|NOT COMPLETED|Overall Study||104
277395|NCT00897949|670938|P3|COMPLETED|Overall Study|Patients who took study drug and completed the study|301
277396|NCT00897949|670939|P2|COMPLETED|Overall Study|Patients who took study drug and completed the study|446
277397|NCT00897949|670940|P1|COMPLETED|Overall Study|Patients who took study drug and completed the study|450
277398|NCT00897949|670938|P3|Patients Treated|Overall Study|Patients who took study drug|304
277399|NCT00897949|670939|P2|Patients Treated|Overall Study|Patients who took study drug|456
277400|NCT00897949|670940|P1|Patients Treated|Overall Study|Patients who took study drug|458
277401|NCT00897949|670938|P3|STARTED|Overall Study|Patients who were allocated study drug|370
277402|NCT00897949|670939|P2|STARTED|Overall Study|Patients who were allocated study drug|549
277403|NCT00897949|670940|P1|STARTED|Overall Study|Patients who were allocated study drug|554
277404|NCT00897910|670963|P1|NOT COMPLETED|Overall Study||0
277405|NCT00897910|670963|P1|COMPLETED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected|6
277406|NCT00897910|670963|P1|STARTED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected.|6
277407|NCT00897897|670967|P1|NOT COMPLETED|Overall Study||0
277408|NCT00897897|670967|P1|COMPLETED|Overall Study||33
277409|NCT00897897|670967|P1|STARTED|Overall Study||33
277410|NCT00897715|670974|P2|NOT COMPLETED|Overall Study||1
277411|NCT00897715|670975|P1|NOT COMPLETED|Overall Study||2
277412|NCT00897715|670974|P2|COMPLETED|Overall Study||6
277413|NCT00897715|670975|P1|COMPLETED|Overall Study||6
277414|NCT00897715|670974|P2|STARTED|Overall Study||7
277415|NCT00897715|670975|P1|STARTED|Overall Study||8
277416|NCT00897676|670983|P2|NOT COMPLETED|Intervention 2(6 Hours)||0
277417|NCT00897676|670984|P1|NOT COMPLETED|Intervention 2(6 Hours)||0
277418|NCT00897676|670983|P2|COMPLETED|Intervention 2(6 Hours)||7
277419|NCT00897676|670984|P1|COMPLETED|Intervention 2(6 Hours)||9
277420|NCT00897676|670983|P2|STARTED|Intervention 2(6 Hours)||7
277421|NCT00897676|670984|P1|STARTED|Intervention 2(6 Hours)||9
277422|NCT00897676|670983|P2|NOT COMPLETED|Intervention 1(6 Hours)||0
277423|NCT00897676|670984|P1|NOT COMPLETED|Intervention 1(6 Hours)||0
277424|NCT00897676|670983|P2|COMPLETED|Intervention 1(6 Hours)||7
277425|NCT00897676|670984|P1|COMPLETED|Intervention 1(6 Hours)||9
277426|NCT00897676|670983|P2|STARTED|Intervention 1(6 Hours)||7
277427|NCT00897676|670984|P1|STARTED|Intervention 1(6 Hours)||9
277428|NCT00897390|671000|P1|NOT COMPLETED|Overall Study||6
277429|NCT00897390|671000|P1|COMPLETED|Overall Study||18
277430|NCT00897390|671000|P1|STARTED|Overall Study||24
277432|NCT00897104|671091|P2|NOT COMPLETED|Overall Study||71
277433|NCT00897104|671092|P1|NOT COMPLETED|Overall Study||64
277434|NCT00897104|671090|P3|COMPLETED|Overall Study|Participants who took study drug and completed the study|79
277435|NCT00897104|671091|P2|COMPLETED|Overall Study|Participants who took study drug and completed the study|357
277436|NCT00897104|671092|P1|COMPLETED|Overall Study|Participants who took study drug and completed the study|354
277437|NCT00897104|671090|P3|Participants Not Treated|Overall Study|Participants who did not take study drug|7
277438|NCT00897104|671091|P2|Participants Not Treated|Overall Study|Participants who did not take study drug|71
277439|NCT00897104|671092|P1|Participants Not Treated|Overall Study|Participants who did not take study drug|63
277440|NCT00897104|671090|P3|Participants Treated|Overall Study|Participants who took study drug|80
277441|NCT00897104|671091|P2|Participants Treated|Overall Study|Participants who took study drug|357
277442|NCT00897104|671092|P1|Participants Treated|Overall Study|Participants who took study drug|355
277443|NCT00897104|671090|P3|STARTED|Overall Study|Participants who were allocated study drug|87
277444|NCT00897104|671091|P2|STARTED|Overall Study|Participants who were allocated study drug|428
277445|NCT00897104|671092|P1|STARTED|Overall Study|Participants who were allocated study drug|418
277446|NCT00896779|671120|P2|NOT COMPLETED|Overall Study||1
277447|NCT00896779|671121|P1|NOT COMPLETED|Overall Study||0
277448|NCT00896779|671120|P2|COMPLETED|Overall Study||11
277449|NCT00896779|671121|P1|COMPLETED|Overall Study||8
277450|NCT00896779|671120|P2|STARTED|Overall Study||12
277451|NCT00896779|671121|P1|STARTED|Overall Study||8
277452|NCT00896649|671127|P1|NOT COMPLETED|Overall Study||5
277453|NCT00896649|671127|P1|COMPLETED|Overall Study||188
277454|NCT00896649|671127|P1|STARTED|Overall Study||193
277455|NCT00896532|671140|P23|NOT COMPLETED|Months 48-72: Follow-on Phase||0
277456|NCT00896532|671141|P22|NOT COMPLETED|Months 48-72: Follow-on Phase||2
277457|NCT00896532|671142|P21|NOT COMPLETED|Months 48-72: Follow-on Phase||0
277458|NCT00896532|671143|P20|NOT COMPLETED|Months 48-72: Follow-on Phase||0
277459|NCT00896532|671144|P19|NOT COMPLETED|Months 48-72: Follow-on Phase||1
277460|NCT00896532|671145|P18|NOT COMPLETED|Months 48-72: Follow-on Phase||0
277461|NCT00896532|671146|P17|NOT COMPLETED|Months 48-72: Follow-on Phase||0
277462|NCT00896532|671147|P16|NOT COMPLETED|Months 48-72: Follow-on Phase||0
277463|NCT00896532|671148|P15|NOT COMPLETED|Months 48-72: Follow-on Phase||0
277464|NCT00896532|671149|P14|NOT COMPLETED|Months 48-72: Follow-on Phase||0
277465|NCT00896532|671150|P13|NOT COMPLETED|Months 48-72: Follow-on Phase||0
277466|NCT00896532|671151|P12|NOT COMPLETED|Months 48-72: Follow-on Phase||0
277467|NCT00896532|671152|P11|NOT COMPLETED|Months 48-72: Follow-on Phase||0
277468|NCT00896532|671153|P10|NOT COMPLETED|Months 48-72: Follow-on Phase||0
277469|NCT00896532|671154|P9|NOT COMPLETED|Months 48-72: Follow-on Phase||0
277470|NCT00896532|671155|P8|NOT COMPLETED|Months 48-72: Follow-on Phase||0
277471|NCT00896532|671156|P7|NOT COMPLETED|Months 48-72: Follow-on Phase||0
277472|NCT00896532|671157|P6|NOT COMPLETED|Months 48-72: Follow-on Phase||0
277473|NCT00896532|671158|P5|NOT COMPLETED|Months 48-72: Follow-on Phase||0
277474|NCT00896532|671159|P4|NOT COMPLETED|Months 48-72: Follow-on Phase||0
277475|NCT00896532|671160|P3|NOT COMPLETED|Months 48-72: Follow-on Phase||0
277476|NCT00896532|671161|P2|NOT COMPLETED|Months 48-72: Follow-on Phase||0
277477|NCT00896532|671162|P1|NOT COMPLETED|Months 48-72: Follow-on Phase||0
277478|NCT00896532|671140|P23|COMPLETED|Months 48-72: Follow-on Phase||8
277479|NCT00896532|671141|P22|COMPLETED|Months 48-72: Follow-on Phase||57
277480|NCT00896532|671142|P21|COMPLETED|Months 48-72: Follow-on Phase||12
277481|NCT00896532|671143|P20|COMPLETED|Months 48-72: Follow-on Phase||11
277482|NCT00896532|671144|P19|COMPLETED|Months 48-72: Follow-on Phase||50
277483|NCT00896532|671145|P18|COMPLETED|Months 48-72: Follow-on Phase||0
277484|NCT00896532|671146|P17|COMPLETED|Months 48-72: Follow-on Phase||0
277485|NCT00896532|671147|P16|COMPLETED|Months 48-72: Follow-on Phase||0
277486|NCT00896532|671148|P15|COMPLETED|Months 48-72: Follow-on Phase||0
277487|NCT00896532|671149|P14|COMPLETED|Months 48-72: Follow-on Phase||0
277488|NCT00896532|671150|P13|COMPLETED|Months 48-72: Follow-on Phase||0
277489|NCT00896532|671151|P12|COMPLETED|Months 48-72: Follow-on Phase||0
277490|NCT00896532|671152|P11|COMPLETED|Months 48-72: Follow-on Phase||0
277491|NCT00896532|671153|P10|COMPLETED|Months 48-72: Follow-on Phase||0
277492|NCT00896532|671154|P9|COMPLETED|Months 48-72: Follow-on Phase||0
277493|NCT00896532|671155|P8|COMPLETED|Months 48-72: Follow-on Phase||0
277494|NCT00896532|671156|P7|COMPLETED|Months 48-72: Follow-on Phase||0
277495|NCT00896532|671157|P6|COMPLETED|Months 48-72: Follow-on Phase||0
277496|NCT00896532|671158|P5|COMPLETED|Months 48-72: Follow-on Phase||0
277497|NCT00896532|671159|P4|COMPLETED|Months 48-72: Follow-on Phase||0
277498|NCT00896532|671160|P3|COMPLETED|Months 48-72: Follow-on Phase||0
277499|NCT00896532|671161|P2|COMPLETED|Months 48-72: Follow-on Phase||0
277500|NCT00896532|671162|P1|COMPLETED|Months 48-72: Follow-on Phase||0
277501|NCT00896532|671140|P23|Received Zoledronic Acid|Months 48-72: Follow-on Phase||8
277502|NCT00896532|671141|P22|Received Zoledronic Acid|Months 48-72: Follow-on Phase||56
277503|NCT00896532|671142|P21|Received Zoledronic Acid|Months 48-72: Follow-on Phase||12
277504|NCT00896532|671143|P20|Received Zoledronic Acid|Months 48-72: Follow-on Phase||11
277505|NCT00896532|671144|P19|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
277506|NCT00896532|671145|P18|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
277507|NCT00896532|671146|P17|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
277508|NCT00896532|671147|P16|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
277509|NCT00896532|671148|P15|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
277510|NCT00896532|671149|P14|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
277511|NCT00896532|671150|P13|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
277512|NCT00896532|671151|P12|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
277513|NCT00896532|671152|P11|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
277514|NCT00896532|671153|P10|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
277515|NCT00896532|671154|P9|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
277516|NCT00896532|671155|P8|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
277517|NCT00896532|671156|P7|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
277518|NCT00896532|671157|P6|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
277519|NCT00896532|671158|P5|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
277520|NCT00896532|671159|P4|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
277521|NCT00896532|671160|P3|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
277522|NCT00896532|671161|P2|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
277523|NCT00896532|671162|P1|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
277524|NCT00896532|671140|P23|STARTED|Months 48-72: Follow-on Phase||8
277525|NCT00896532|671141|P22|STARTED|Months 48-72: Follow-on Phase||59
277526|NCT00896532|671142|P21|STARTED|Months 48-72: Follow-on Phase||12
277527|NCT00896532|671143|P20|STARTED|Months 48-72: Follow-on Phase||11
277528|NCT00896532|671144|P19|STARTED|Months 48-72: Follow-on Phase||51
277529|NCT00896532|671145|P18|STARTED|Months 48-72: Follow-on Phase||0
277530|NCT00896532|671146|P17|STARTED|Months 48-72: Follow-on Phase||0
277531|NCT00896532|671147|P16|STARTED|Months 48-72: Follow-on Phase||0
277532|NCT00896532|671148|P15|STARTED|Months 48-72: Follow-on Phase||0
277533|NCT00896532|671149|P14|STARTED|Months 48-72: Follow-on Phase||0
277534|NCT00896532|671150|P13|STARTED|Months 48-72: Follow-on Phase||0
277535|NCT00896532|671151|P12|STARTED|Months 48-72: Follow-on Phase||0
277536|NCT00896532|671152|P11|STARTED|Months 48-72: Follow-on Phase||0
277537|NCT00896532|671153|P10|STARTED|Months 48-72: Follow-on Phase||0
277538|NCT00896532|671154|P9|STARTED|Months 48-72: Follow-on Phase||0
277539|NCT00896532|671155|P8|STARTED|Months 48-72: Follow-on Phase||0
277540|NCT00896532|671156|P7|STARTED|Months 48-72: Follow-on Phase||0
277541|NCT00896532|671157|P6|STARTED|Months 48-72: Follow-on Phase||0
277542|NCT00896532|671158|P5|STARTED|Months 48-72: Follow-on Phase||0
277543|NCT00896532|671159|P4|STARTED|Months 48-72: Follow-on Phase||0
277544|NCT00896532|671160|P3|STARTED|Months 48-72: Follow-on Phase||0
277545|NCT00896532|671161|P2|STARTED|Months 48-72: Follow-on Phase||0
277546|NCT00896532|671162|P1|STARTED|Months 48-72: Follow-on Phase||0
277547|NCT00896532|671140|P23|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
277548|NCT00896532|671141|P22|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
277549|NCT00896532|671142|P21|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
277550|NCT00896532|671143|P20|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
277551|NCT00896532|671144|P19|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
277552|NCT00896532|671145|P18|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||3
277553|NCT00896532|671146|P17|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||7
277554|NCT00896532|671147|P16|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||2
277555|NCT00896532|671148|P15|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
277556|NCT00896532|671149|P14|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
277557|NCT00896532|671150|P13|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
277558|NCT00896532|671151|P12|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
277559|NCT00896532|671152|P11|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
277560|NCT00896532|671153|P10|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
277561|NCT00896532|671154|P9|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
277562|NCT00896532|671155|P8|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
277563|NCT00896532|671156|P7|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
277564|NCT00896532|671157|P6|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
277565|NCT00896532|671158|P5|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
277566|NCT00896532|671159|P4|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
277567|NCT00896532|671160|P3|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
277568|NCT00896532|671161|P2|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
277569|NCT00896532|671162|P1|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
277570|NCT00896532|671140|P23|COMPLETED|Months 36-48: Romosozumab Retreatment||0
277571|NCT00896532|671141|P22|COMPLETED|Months 36-48: Romosozumab Retreatment||0
277572|NCT00896532|671142|P21|COMPLETED|Months 36-48: Romosozumab Retreatment||0
277573|NCT00896532|671143|P20|COMPLETED|Months 36-48: Romosozumab Retreatment||0
277574|NCT00896532|671144|P19|COMPLETED|Months 36-48: Romosozumab Retreatment||0
277575|NCT00896532|671145|P18|COMPLETED|Months 36-48: Romosozumab Retreatment||64
277576|NCT00896532|671146|P17|COMPLETED|Months 36-48: Romosozumab Retreatment||65
277577|NCT00896532|671147|P16|COMPLETED|Months 36-48: Romosozumab Retreatment||14
277578|NCT00896532|671148|P15|COMPLETED|Months 36-48: Romosozumab Retreatment||12
277579|NCT00896532|671149|P14|COMPLETED|Months 36-48: Romosozumab Retreatment||0
277580|NCT00896532|671150|P13|COMPLETED|Months 36-48: Romosozumab Retreatment||0
277581|NCT00896532|671151|P12|COMPLETED|Months 36-48: Romosozumab Retreatment||0
277582|NCT00896532|671152|P11|COMPLETED|Months 36-48: Romosozumab Retreatment||0
277583|NCT00896532|671153|P10|COMPLETED|Months 36-48: Romosozumab Retreatment||0
277584|NCT00896532|671154|P9|COMPLETED|Months 36-48: Romosozumab Retreatment||0
277585|NCT00896532|671155|P8|COMPLETED|Months 36-48: Romosozumab Retreatment||0
277586|NCT00896532|671156|P7|COMPLETED|Months 36-48: Romosozumab Retreatment||0
277587|NCT00896532|671157|P6|COMPLETED|Months 36-48: Romosozumab Retreatment||0
277588|NCT00896532|671158|P5|COMPLETED|Months 36-48: Romosozumab Retreatment||0
277589|NCT00896532|671159|P4|COMPLETED|Months 36-48: Romosozumab Retreatment||0
277590|NCT00896532|671160|P3|COMPLETED|Months 36-48: Romosozumab Retreatment||0
277591|NCT00896532|671161|P2|COMPLETED|Months 36-48: Romosozumab Retreatment||0
277592|NCT00896532|671162|P1|COMPLETED|Months 36-48: Romosozumab Retreatment||0
277593|NCT00896532|671140|P23|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
277594|NCT00896532|671141|P22|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
277595|NCT00896532|671142|P21|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
277596|NCT00896532|671143|P20|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
277597|NCT00896532|671144|P19|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
277598|NCT00896532|671145|P18|Received Romosozumab|Months 36-48: Romosozumab Retreatment||67
277599|NCT00896532|671146|P17|Received Romosozumab|Months 36-48: Romosozumab Retreatment||72
277600|NCT00896532|671147|P16|Received Romosozumab|Months 36-48: Romosozumab Retreatment|Includes one participant who received 1 dose of romosozumab 70 mg in error in first 12 months|16
277601|NCT00896532|671148|P15|Received Romosozumab|Months 36-48: Romosozumab Retreatment||12
277602|NCT00896532|671149|P14|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
277603|NCT00896532|671150|P13|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
277604|NCT00896532|671151|P12|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
277605|NCT00896532|671152|P11|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
277606|NCT00896532|671153|P10|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
277607|NCT00896532|671154|P9|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
277608|NCT00896532|671155|P8|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
277609|NCT00896532|671156|P7|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
277610|NCT00896532|671157|P6|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
277611|NCT00896532|671158|P5|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
277612|NCT00896532|671159|P4|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
277613|NCT00896532|671160|P3|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
277614|NCT00896532|671161|P2|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
277615|NCT00896532|671162|P1|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
277616|NCT00896532|671140|P23|STARTED|Months 36-48: Romosozumab Retreatment||0
277617|NCT00896532|671141|P22|STARTED|Months 36-48: Romosozumab Retreatment||0
277618|NCT00896532|671142|P21|STARTED|Months 36-48: Romosozumab Retreatment||0
277619|NCT00896532|671143|P20|STARTED|Months 36-48: Romosozumab Retreatment||0
277620|NCT00896532|671144|P19|STARTED|Months 36-48: Romosozumab Retreatment||0
277621|NCT00896532|671145|P18|STARTED|Months 36-48: Romosozumab Retreatment||67
277622|NCT00896532|671146|P17|STARTED|Months 36-48: Romosozumab Retreatment||72
277623|NCT00896532|671147|P16|STARTED|Months 36-48: Romosozumab Retreatment||16
277624|NCT00896532|671148|P15|STARTED|Months 36-48: Romosozumab Retreatment||12
277625|NCT00896532|671149|P14|STARTED|Months 36-48: Romosozumab Retreatment||0
277626|NCT00896532|671150|P13|STARTED|Months 36-48: Romosozumab Retreatment||0
277627|NCT00896532|671151|P12|STARTED|Months 36-48: Romosozumab Retreatment||0
277628|NCT00896532|671152|P11|STARTED|Months 36-48: Romosozumab Retreatment||0
277629|NCT00896532|671153|P10|STARTED|Months 36-48: Romosozumab Retreatment||0
277630|NCT00896532|671154|P9|STARTED|Months 36-48: Romosozumab Retreatment||0
277631|NCT00896532|671155|P8|STARTED|Months 36-48: Romosozumab Retreatment||0
277632|NCT00896532|671156|P7|STARTED|Months 36-48: Romosozumab Retreatment||0
277633|NCT00896532|671157|P6|STARTED|Months 36-48: Romosozumab Retreatment||0
277634|NCT00896532|671158|P5|STARTED|Months 36-48: Romosozumab Retreatment||0
277635|NCT00896532|671159|P4|STARTED|Months 36-48: Romosozumab Retreatment||0
277636|NCT00896532|671160|P3|STARTED|Months 36-48: Romosozumab Retreatment||0
277637|NCT00896532|671161|P2|STARTED|Months 36-48: Romosozumab Retreatment||0
277638|NCT00896532|671162|P1|STARTED|Months 36-48: Romosozumab Retreatment||0
277639|NCT00896532|671140|P23|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
277640|NCT00896532|671141|P22|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
277641|NCT00896532|671142|P21|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
277642|NCT00896532|671143|P20|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
277643|NCT00896532|671144|P19|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
277644|NCT00896532|671145|P18|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
277645|NCT00896532|671146|P17|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
277646|NCT00896532|671147|P16|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
277647|NCT00896532|671148|P15|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
277648|NCT00896532|671149|P14|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
277649|NCT00896532|671150|P13|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||5
277650|NCT00896532|671151|P12|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
277651|NCT00896532|671152|P11|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
277652|NCT00896532|671153|P10|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
277653|NCT00896532|671154|P9|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||1
277654|NCT00896532|671155|P8|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
277655|NCT00896532|671156|P7|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
277656|NCT00896532|671157|P6|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
277657|NCT00896532|671158|P5|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
277658|NCT00896532|671159|P4|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
277659|NCT00896532|671160|P3|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
277660|NCT00896532|671161|P2|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
277661|NCT00896532|671162|P1|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
277662|NCT00896532|671140|P23|COMPLETED|Months 24-36: Denosumab Extension Phase||0
277663|NCT00896532|671141|P22|COMPLETED|Months 24-36: Denosumab Extension Phase||0
277664|NCT00896532|671142|P21|COMPLETED|Months 24-36: Denosumab Extension Phase||0
277665|NCT00896532|671143|P20|COMPLETED|Months 24-36: Denosumab Extension Phase||0
277666|NCT00896532|671144|P19|COMPLETED|Months 24-36: Denosumab Extension Phase||0
277667|NCT00896532|671145|P18|COMPLETED|Months 24-36: Denosumab Extension Phase||0
277668|NCT00896532|671146|P17|COMPLETED|Months 24-36: Denosumab Extension Phase||0
277669|NCT00896532|671147|P16|COMPLETED|Months 24-36: Denosumab Extension Phase||0
277670|NCT00896532|671148|P15|COMPLETED|Months 24-36: Denosumab Extension Phase||0
277671|NCT00896532|671149|P14|COMPLETED|Months 24-36: Denosumab Extension Phase||88
277672|NCT00896532|671150|P13|COMPLETED|Months 24-36: Denosumab Extension Phase||88
277673|NCT00896532|671151|P12|COMPLETED|Months 24-36: Denosumab Extension Phase||19
277674|NCT00896532|671152|P11|COMPLETED|Months 24-36: Denosumab Extension Phase||18
277675|NCT00896532|671153|P10|COMPLETED|Months 24-36: Denosumab Extension Phase||18
277676|NCT00896532|671154|P9|COMPLETED|Months 24-36: Denosumab Extension Phase||17
277677|NCT00896532|671155|P8|COMPLETED|Months 24-36: Denosumab Extension Phase||0
277678|NCT00896532|671156|P7|COMPLETED|Months 24-36: Denosumab Extension Phase||0
277679|NCT00896532|671157|P6|COMPLETED|Months 24-36: Denosumab Extension Phase||0
277680|NCT00896532|671158|P5|COMPLETED|Months 24-36: Denosumab Extension Phase||0
277681|NCT00896532|671159|P4|COMPLETED|Months 24-36: Denosumab Extension Phase||0
277682|NCT00896532|671160|P3|COMPLETED|Months 24-36: Denosumab Extension Phase||0
277683|NCT00896532|671161|P2|COMPLETED|Months 24-36: Denosumab Extension Phase||0
277684|NCT00896532|671162|P1|COMPLETED|Months 24-36: Denosumab Extension Phase||0
277685|NCT00896532|671140|P23|Received Treatment|Months 24-36: Denosumab Extension Phase||0
277686|NCT00896532|671141|P22|Received Treatment|Months 24-36: Denosumab Extension Phase||0
277687|NCT00896532|671142|P21|Received Treatment|Months 24-36: Denosumab Extension Phase||0
277688|NCT00896532|671143|P20|Received Treatment|Months 24-36: Denosumab Extension Phase||0
277689|NCT00896532|671144|P19|Received Treatment|Months 24-36: Denosumab Extension Phase||0
277690|NCT00896532|671145|P18|Received Treatment|Months 24-36: Denosumab Extension Phase||0
277691|NCT00896532|671146|P17|Received Treatment|Months 24-36: Denosumab Extension Phase||0
277692|NCT00896532|671147|P16|Received Treatment|Months 24-36: Denosumab Extension Phase||0
277693|NCT00896532|671148|P15|Received Treatment|Months 24-36: Denosumab Extension Phase||0
277694|NCT00896532|671149|P14|Received Treatment|Months 24-36: Denosumab Extension Phase||88
277695|NCT00896532|671150|P13|Received Treatment|Months 24-36: Denosumab Extension Phase||90
277696|NCT00896532|671151|P12|Received Treatment|Months 24-36: Denosumab Extension Phase||19
277697|NCT00896532|671152|P11|Received Treatment|Months 24-36: Denosumab Extension Phase||19
277698|NCT00896532|671153|P10|Received Treatment|Months 24-36: Denosumab Extension Phase|Includes one participant who received 1 dose of romosozumab 70 mg in error in first 12 months|18
277699|NCT00896532|671154|P9|Received Treatment|Months 24-36: Denosumab Extension Phase||18
277700|NCT00896532|671155|P8|Received Treatment|Months 24-36: Denosumab Extension Phase||0
277701|NCT00896532|671156|P7|Received Treatment|Months 24-36: Denosumab Extension Phase||0
277702|NCT00896532|671157|P6|Received Treatment|Months 24-36: Denosumab Extension Phase||0
277703|NCT00896532|671158|P5|Received Treatment|Months 24-36: Denosumab Extension Phase||0
277704|NCT00896532|671159|P4|Received Treatment|Months 24-36: Denosumab Extension Phase||0
277705|NCT00896532|671160|P3|Received Treatment|Months 24-36: Denosumab Extension Phase||0
277706|NCT00896532|671161|P2|Received Treatment|Months 24-36: Denosumab Extension Phase||0
277707|NCT00896532|671162|P1|Received Treatment|Months 24-36: Denosumab Extension Phase||0
277708|NCT00896532|671140|P23|STARTED|Months 24-36: Denosumab Extension Phase||0
277709|NCT00896532|671141|P22|STARTED|Months 24-36: Denosumab Extension Phase||0
277710|NCT00896532|671142|P21|STARTED|Months 24-36: Denosumab Extension Phase||0
277711|NCT00896532|671143|P20|STARTED|Months 24-36: Denosumab Extension Phase||0
277712|NCT00896532|671144|P19|STARTED|Months 24-36: Denosumab Extension Phase||0
277713|NCT00896532|671145|P18|STARTED|Months 24-36: Denosumab Extension Phase||0
277714|NCT00896532|671146|P17|STARTED|Months 24-36: Denosumab Extension Phase||0
277715|NCT00896532|671147|P16|STARTED|Months 24-36: Denosumab Extension Phase||0
277716|NCT00896532|671148|P15|STARTED|Months 24-36: Denosumab Extension Phase||0
277717|NCT00896532|671149|P14|STARTED|Months 24-36: Denosumab Extension Phase||90
277718|NCT00896532|671150|P13|STARTED|Months 24-36: Denosumab Extension Phase||93
277719|NCT00896532|671151|P12|STARTED|Months 24-36: Denosumab Extension Phase||21
277720|NCT00896532|671152|P11|STARTED|Months 24-36: Denosumab Extension Phase||20
277721|NCT00896532|671153|P10|STARTED|Months 24-36: Denosumab Extension Phase||18
277722|NCT00896532|671154|P9|STARTED|Months 24-36: Denosumab Extension Phase||18
277723|NCT00896532|671155|P8|STARTED|Months 24-36: Denosumab Extension Phase||0
277724|NCT00896532|671156|P7|STARTED|Months 24-36: Denosumab Extension Phase||0
277725|NCT00896532|671157|P6|STARTED|Months 24-36: Denosumab Extension Phase||0
277726|NCT00896532|671158|P5|STARTED|Months 24-36: Denosumab Extension Phase||0
277727|NCT00896532|671159|P4|STARTED|Months 24-36: Denosumab Extension Phase||0
277728|NCT00896532|671160|P3|STARTED|Months 24-36: Denosumab Extension Phase||0
277729|NCT00896532|671161|P2|STARTED|Months 24-36: Denosumab Extension Phase||0
277730|NCT00896532|671162|P1|STARTED|Months 24-36: Denosumab Extension Phase||0
277731|NCT00896532|671140|P23|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
277732|NCT00896532|671141|P22|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
277733|NCT00896532|671142|P21|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
277734|NCT00896532|671143|P20|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
277735|NCT00896532|671144|P19|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
277736|NCT00896532|671145|P18|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
277737|NCT00896532|671146|P17|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
277738|NCT00896532|671147|P16|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
277739|NCT00896532|671148|P15|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
277740|NCT00896532|671149|P14|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
277741|NCT00896532|671150|P13|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
277742|NCT00896532|671151|P12|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
277743|NCT00896532|671152|P11|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
277744|NCT00896532|671153|P10|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
277745|NCT00896532|671154|P9|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
277746|NCT00896532|671155|P8|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||4
277747|NCT00896532|671156|P7|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||5
277748|NCT00896532|671157|P6|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8
277749|NCT00896532|671158|P5|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8
277750|NCT00896532|671159|P4|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||12
277751|NCT00896532|671160|P3|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||9
277752|NCT00896532|671161|P2|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6
277753|NCT00896532|671162|P1|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6
277754|NCT00896532|671140|P23|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
277755|NCT00896532|671141|P22|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
277756|NCT00896532|671142|P21|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
277757|NCT00896532|671143|P20|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
277758|NCT00896532|671144|P19|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
277759|NCT00896532|671145|P18|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
277760|NCT00896532|671146|P17|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
277761|NCT00896532|671147|P16|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
277762|NCT00896532|671148|P15|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
277763|NCT00896532|671149|P14|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
277764|NCT00896532|671150|P13|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
277765|NCT00896532|671151|P12|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
277766|NCT00896532|671152|P11|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
277767|NCT00896532|671153|P10|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
277768|NCT00896532|671154|P9|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
277769|NCT00896532|671155|P8|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48
277770|NCT00896532|671156|P7|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48
277771|NCT00896532|671157|P6|COMPLETED|Months 1-24: Romosozumab Treatment Phase||43
277772|NCT00896532|671158|P5|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
277773|NCT00896532|671159|P4|COMPLETED|Months 1-24: Romosozumab Treatment Phase||39
277774|NCT00896532|671160|P3|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
277775|NCT00896532|671161|P2|COMPLETED|Months 1-24: Romosozumab Treatment Phase||45
277776|NCT00896532|671162|P1|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
277777|NCT00896532|671140|P23|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
277778|NCT00896532|671141|P22|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
277779|NCT00896532|671142|P21|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
277780|NCT00896532|671143|P20|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
277781|NCT00896532|671144|P19|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
277782|NCT00896532|671145|P18|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
277783|NCT00896532|671146|P17|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
277784|NCT00896532|671147|P16|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
277785|NCT00896532|671148|P15|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
277786|NCT00896532|671149|P14|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
277787|NCT00896532|671150|P13|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
277788|NCT00896532|671151|P12|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
277789|NCT00896532|671152|P11|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
277790|NCT00896532|671153|P10|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
277791|NCT00896532|671154|P9|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
277792|NCT00896532|671155|P8|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49
277793|NCT00896532|671156|P7|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||51
277794|NCT00896532|671157|P6|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46
277795|NCT00896532|671158|P5|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||50
277796|NCT00896532|671159|P4|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||45
277874|NCT00896363|671377|P2|STARTED|Overall Study||36
277797|NCT00896532|671160|P3|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46
277798|NCT00896532|671161|P2|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49
277799|NCT00896532|671162|P1|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||47
277800|NCT00896532|671140|P23|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
277801|NCT00896532|671141|P22|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
277802|NCT00896532|671142|P21|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
277803|NCT00896532|671143|P20|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
277804|NCT00896532|671144|P19|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
277805|NCT00896532|671145|P18|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
277806|NCT00896532|671146|P17|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
277807|NCT00896532|671147|P16|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
277808|NCT00896532|671148|P15|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
277809|NCT00896532|671149|P14|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
277810|NCT00896532|671150|P13|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
277811|NCT00896532|671151|P12|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
277812|NCT00896532|671152|P11|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
277813|NCT00896532|671153|P10|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
277814|NCT00896532|671154|P9|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
277815|NCT00896532|671155|P8|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51
277816|NCT00896532|671156|P7|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53
277817|NCT00896532|671157|P6|Received Treatment|Months 1-24: Romosozumab Treatment Phase||48
277818|NCT00896532|671158|P5|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53
277819|NCT00896532|671159|P4|Received Treatment|Months 1-24: Romosozumab Treatment Phase||49
277820|NCT00896532|671160|P3|Received Treatment|Months 1-24: Romosozumab Treatment Phase||54
277821|NCT00896532|671161|P2|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51
277822|NCT00896532|671162|P1|Received Treatment|Months 1-24: Romosozumab Treatment Phase|One participant received 1 dose of romosozumab 70 mg in error|51
277823|NCT00896532|671140|P23|STARTED|Months 1-24: Romosozumab Treatment Phase||0
277824|NCT00896532|671141|P22|STARTED|Months 1-24: Romosozumab Treatment Phase||0
277825|NCT00896532|671142|P21|STARTED|Months 1-24: Romosozumab Treatment Phase||0
277826|NCT00896532|671143|P20|STARTED|Months 1-24: Romosozumab Treatment Phase||0
277827|NCT00896532|671144|P19|STARTED|Months 1-24: Romosozumab Treatment Phase||0
277828|NCT00896532|671145|P18|STARTED|Months 1-24: Romosozumab Treatment Phase||0
277829|NCT00896532|671146|P17|STARTED|Months 1-24: Romosozumab Treatment Phase||0
277830|NCT00896532|671147|P16|STARTED|Months 1-24: Romosozumab Treatment Phase||0
277831|NCT00896532|671148|P15|STARTED|Months 1-24: Romosozumab Treatment Phase||0
277832|NCT00896532|671149|P14|STARTED|Months 1-24: Romosozumab Treatment Phase||0
277833|NCT00896532|671150|P13|STARTED|Months 1-24: Romosozumab Treatment Phase||0
277834|NCT00896532|671151|P12|STARTED|Months 1-24: Romosozumab Treatment Phase||0
277835|NCT00896532|671152|P11|STARTED|Months 1-24: Romosozumab Treatment Phase||0
277836|NCT00896532|671153|P10|STARTED|Months 1-24: Romosozumab Treatment Phase||0
277837|NCT00896532|671154|P9|STARTED|Months 1-24: Romosozumab Treatment Phase||0
277838|NCT00896532|671155|P8|STARTED|Months 1-24: Romosozumab Treatment Phase||52
277839|NCT00896532|671156|P7|STARTED|Months 1-24: Romosozumab Treatment Phase||53
277840|NCT00896532|671157|P6|STARTED|Months 1-24: Romosozumab Treatment Phase||51
277841|NCT00896532|671158|P5|STARTED|Months 1-24: Romosozumab Treatment Phase||54
277842|NCT00896532|671159|P4|STARTED|Months 1-24: Romosozumab Treatment Phase||51
277843|NCT00896532|671160|P3|STARTED|Months 1-24: Romosozumab Treatment Phase||55
277844|NCT00896532|671161|P2|STARTED|Months 1-24: Romosozumab Treatment Phase||51
277845|NCT00896532|671162|P1|STARTED|Months 1-24: Romosozumab Treatment Phase||52
277846|NCT00896480|671289|P1|NOT COMPLETED|Overall Study||21
277847|NCT00896480|671289|P1|COMPLETED|Overall Study||3
277848|NCT00896480|671289|P1|STARTED|Overall Study||24
277849|NCT00896454|671337|P1|NOT COMPLETED|Overall Study||33
277850|NCT00896454|671337|P1|COMPLETED|Overall Study||0
277851|NCT00896454|671337|P1|STARTED|Overall Study||33
277852|NCT00896441|671351|P2|NOT COMPLETED|Overall Study||0
277853|NCT00896441|671352|P1|NOT COMPLETED|Overall Study||2
277854|NCT00896441|671351|P2|COMPLETED|Overall Study||9
277855|NCT00896441|671352|P1|COMPLETED|Overall Study||15
277856|NCT00896441|671351|P2|STARTED|Overall Study||9
277857|NCT00896441|671352|P1|STARTED|Overall Study||17
277858|NCT00896389|671359|P1|NOT COMPLETED|HCTZ High Dose||0
277859|NCT00896389|671359|P1|COMPLETED|HCTZ High Dose||25
277860|NCT00896389|671359|P1|STARTED|HCTZ High Dose||25
277861|NCT00896389|671359|P1|NOT COMPLETED|HCTZ Low Dose||0
277862|NCT00896389|671359|P1|COMPLETED|HCTZ Low Dose||28
277863|NCT00896389|671359|P1|STARTED|HCTZ Low Dose|Only subjects with SBP > 120 mmHg and agreeable to the HCTZ protocol continued to the next period.|28
277864|NCT00896389|671359|P1|NOT COMPLETED|Salt Loading||0
277865|NCT00896389|671359|P1|COMPLETED|Salt Loading||124
277866|NCT00896389|671359|P1|STARTED|Salt Loading||124
277867|NCT00896363|671376|P3|NOT COMPLETED|Overall Study||8
277868|NCT00896363|671377|P2|NOT COMPLETED|Overall Study||11
277869|NCT00896363|671378|P1|NOT COMPLETED|Overall Study||6
277870|NCT00896363|671376|P3|COMPLETED|Overall Study||24
277871|NCT00896363|671377|P2|COMPLETED|Overall Study||25
277872|NCT00896363|671378|P1|COMPLETED|Overall Study||25
277873|NCT00896363|671376|P3|STARTED|Overall Study||32
277875|NCT00896363|671378|P1|STARTED|Overall Study||31
277876|NCT00896337|671430|P1|NOT COMPLETED|Overall Study||25
277877|NCT00896337|671430|P1|COMPLETED|Overall Study||100
277878|NCT00896337|671430|P1|STARTED|Overall Study||125
277879|NCT00896298|671499|P2|NOT COMPLETED|Overall Study||3
277880|NCT00896298|671500|P1|NOT COMPLETED|Overall Study||3
277881|NCT00896298|671499|P2|COMPLETED|Overall Study||9
277882|NCT00896298|671500|P1|COMPLETED|Overall Study||10
277883|NCT00896298|671499|P2|STARTED|Overall Study||12
277884|NCT00896298|671500|P1|STARTED|Overall Study||13
277885|NCT00896233|671512|P1|NOT COMPLETED|Overall Study||1
277886|NCT00896233|671512|P1|COMPLETED|Overall Study||9
277887|NCT00896233|671512|P1|STARTED|Overall Study||10
277888|NCT00896168|671525|P2|NOT COMPLETED|Overall Study||19
277889|NCT00896168|671526|P1|NOT COMPLETED|Overall Study||14
277890|NCT00896168|671525|P2|COMPLETED|Overall Study||111
277891|NCT00896168|671526|P1|COMPLETED|Overall Study||90
277892|NCT00896168|671525|P2|STARTED|Overall Study||130
277893|NCT00896168|671526|P1|STARTED|Overall Study||104
277894|NCT00896064|671556|P2|NOT COMPLETED|Overall Study||0
277895|NCT00896064|671557|P1|NOT COMPLETED|Overall Study||0
277896|NCT00896064|671556|P2|COMPLETED|Overall Study||21
277897|NCT00896064|671557|P1|COMPLETED|Overall Study||22
277898|NCT00896064|671556|P2|STARTED|Overall Study||21
277899|NCT00896064|671557|P1|STARTED|Overall Study||22
277900|NCT00896051|671587|P2|NOT COMPLETED|Overall Study||9
277901|NCT00896051|671588|P1|NOT COMPLETED|Overall Study||10
277902|NCT00896051|671587|P2|COMPLETED|Overall Study||16
277903|NCT00896051|671588|P1|COMPLETED|Overall Study||15
277904|NCT00896051|671587|P2|STARTED|Overall Study||25
277905|NCT00896051|671588|P1|STARTED|Overall Study||25
277906|NCT00896038|671630|P2|NOT COMPLETED|Overall Study||1
277907|NCT00896038|671631|P1|NOT COMPLETED|Overall Study||4
277908|NCT00896038|671630|P2|COMPLETED|Overall Study||27
277909|NCT00896038|671631|P1|COMPLETED|Overall Study||26
277910|NCT00896038|671630|P2|STARTED|Overall Study||28
277911|NCT00896038|671631|P1|STARTED|Overall Study||30
277912|NCT00896025|671669|P1|NOT COMPLETED|Overall Study||0
277913|NCT00896025|671669|P1|COMPLETED|Overall Study||8
277914|NCT00896025|671669|P1|STARTED|Overall Study||8
277915|NCT00895947|671683|P2|NOT COMPLETED|Overall Study||10
277916|NCT00895947|671684|P1|NOT COMPLETED|Overall Study||12
277917|NCT00895947|671683|P2|COMPLETED|Overall Study||90
277918|NCT00895947|671684|P1|COMPLETED|Overall Study||88
277919|NCT00895947|671683|P2|STARTED|Overall Study||100
277920|NCT00895947|671684|P1|STARTED|Overall Study||100
277921|NCT00895934|671702|P4|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
277922|NCT00895934|671703|P3|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
277923|NCT00895934|671704|P2|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
277924|NCT00895934|671705|P1|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
277925|NCT00895934|671702|P4|COMPLETED|Efficacy of Most Tolerated Dose||37
277926|NCT00895934|671703|P3|COMPLETED|Efficacy of Most Tolerated Dose||0
277927|NCT00895934|671704|P2|COMPLETED|Efficacy of Most Tolerated Dose||0
277928|NCT00895934|671705|P1|COMPLETED|Efficacy of Most Tolerated Dose||0
277929|NCT00895934|671702|P4|STARTED|Efficacy of Most Tolerated Dose||37
277930|NCT00895934|671703|P3|STARTED|Efficacy of Most Tolerated Dose||0
277931|NCT00895934|671704|P2|STARTED|Efficacy of Most Tolerated Dose||0
277932|NCT00895934|671705|P1|STARTED|Efficacy of Most Tolerated Dose||0
277933|NCT00895934|671702|P4|NOT COMPLETED|Dose Escalation||0
277934|NCT00895934|671703|P3|NOT COMPLETED|Dose Escalation||0
277935|NCT00895934|671704|P2|NOT COMPLETED|Dose Escalation||0
277936|NCT00895934|671705|P1|NOT COMPLETED|Dose Escalation||0
277937|NCT00895934|671702|P4|COMPLETED|Dose Escalation||6
277938|NCT00895934|671703|P3|COMPLETED|Dose Escalation||3
277939|NCT00895934|671704|P2|COMPLETED|Dose Escalation||3
277940|NCT00895934|671705|P1|COMPLETED|Dose Escalation||3
277941|NCT00895934|671702|P4|STARTED|Dose Escalation||6
277942|NCT00895934|671703|P3|STARTED|Dose Escalation||3
277943|NCT00895934|671704|P2|STARTED|Dose Escalation||3
277944|NCT00895934|671705|P1|STARTED|Dose Escalation||3
277945|NCT00895895|671722|P5|NOT COMPLETED|Period 2||49
277946|NCT00895895|671723|P4|NOT COMPLETED|Period 2||54
277947|NCT00895895|671724|P3|NOT COMPLETED|Period 2||49
277948|NCT00895895|671725|P2|NOT COMPLETED|Period 2||53
277949|NCT00895895|671726|P1|NOT COMPLETED|Period 2||56
277950|NCT00895895|671722|P5|COMPLETED|Period 2||35
277951|NCT00895895|671723|P4|COMPLETED|Period 2||37
277952|NCT00895895|671724|P3|COMPLETED|Period 2||33
277953|NCT00895895|671725|P2|COMPLETED|Period 2||31
277954|NCT00895895|671726|P1|COMPLETED|Period 2||30
277955|NCT00895895|671722|P5|STARTED|Period 2||84
277956|NCT00895895|671723|P4|STARTED|Period 2||91
277957|NCT00895895|671724|P3|STARTED|Period 2||82
277958|NCT00895895|671725|P2|STARTED|Period 2||84
277959|NCT00895895|671726|P1|STARTED|Period 2||86
277960|NCT00895895|671722|P5|NOT COMPLETED|After Period 1, Prior to Period 2||2
277961|NCT00895895|671723|P4|NOT COMPLETED|After Period 1, Prior to Period 2||0
277962|NCT00895895|671724|P3|NOT COMPLETED|After Period 1, Prior to Period 2||2
277963|NCT00895895|671725|P2|NOT COMPLETED|After Period 1, Prior to Period 2||0
277964|NCT00895895|671726|P1|NOT COMPLETED|After Period 1, Prior to Period 2||0
277965|NCT00895895|671722|P5|COMPLETED|After Period 1, Prior to Period 2||84
277966|NCT00895895|671723|P4|COMPLETED|After Period 1, Prior to Period 2||91
277967|NCT00895895|671724|P3|COMPLETED|After Period 1, Prior to Period 2||82
277968|NCT00895895|671725|P2|COMPLETED|After Period 1, Prior to Period 2||84
277969|NCT00895895|671726|P1|COMPLETED|After Period 1, Prior to Period 2||86
277970|NCT00895895|671722|P5|STARTED|After Period 1, Prior to Period 2||86
277971|NCT00895895|671723|P4|STARTED|After Period 1, Prior to Period 2||91
277972|NCT00895895|671724|P3|STARTED|After Period 1, Prior to Period 2||84
277973|NCT00895895|671725|P2|STARTED|After Period 1, Prior to Period 2||84
277974|NCT00895895|671726|P1|STARTED|After Period 1, Prior to Period 2||86
277975|NCT00895895|671722|P5|NOT COMPLETED|Period 1||20
277976|NCT00895895|671723|P4|NOT COMPLETED|Period 1||13
277977|NCT00895895|671724|P3|NOT COMPLETED|Period 1||20
277978|NCT00895895|671725|P2|NOT COMPLETED|Period 1||21
277979|NCT00895895|671726|P1|NOT COMPLETED|Period 1||21
277980|NCT00895895|671722|P5|COMPLETED|Period 1||86
277981|NCT00895895|671723|P4|COMPLETED|Period 1||91
277982|NCT00895895|671724|P3|COMPLETED|Period 1||84
277983|NCT00895895|671725|P2|COMPLETED|Period 1||84
277984|NCT00895895|671726|P1|COMPLETED|Period 1||86
277985|NCT00895895|671722|P5|Randomized But Not Treated|Period 1||2
277986|NCT00895895|671723|P4|Randomized But Not Treated|Period 1||1
277987|NCT00895895|671724|P3|Randomized But Not Treated|Period 1||1
277988|NCT00895895|671725|P2|Randomized But Not Treated|Period 1||3
277989|NCT00895895|671726|P1|Randomized But Not Treated|Period 1||1
277990|NCT00895895|671722|P5|STARTED|Period 1||106
277991|NCT00895895|671723|P4|STARTED|Period 1||104
277992|NCT00895895|671724|P3|STARTED|Period 1||104
277993|NCT00895895|671725|P2|STARTED|Period 1||105
277994|NCT00895895|671726|P1|STARTED|Period 1||107
277995|NCT00895843|671840|P2|NOT COMPLETED|Overall Study||12
277996|NCT00895843|671841|P1|NOT COMPLETED|Overall Study||12
277997|NCT00895843|671840|P2|COMPLETED|Overall Study||50
277998|NCT00895843|671841|P1|COMPLETED|Overall Study||48
277999|NCT00895843|671840|P2|STARTED|Overall Study||62
278000|NCT00895843|671841|P1|STARTED|Overall Study||60
278001|NCT00895830|671852|P5|NOT COMPLETED|Overall Study||0
278002|NCT00895830|671853|P4|NOT COMPLETED|Overall Study||0
278003|NCT00895830|671854|P3|NOT COMPLETED|Overall Study||0
278004|NCT00895830|671855|P2|NOT COMPLETED|Overall Study||0
278005|NCT00895830|671856|P1|NOT COMPLETED|Overall Study||0
278006|NCT00895830|671852|P5|COMPLETED|Overall Study||55
278007|NCT00895830|671853|P4|COMPLETED|Overall Study||52
278008|NCT00895830|671854|P3|COMPLETED|Overall Study||49
278009|NCT00895830|671855|P2|COMPLETED|Overall Study||50
278010|NCT00895830|671856|P1|COMPLETED|Overall Study||51
278011|NCT00895830|671852|P5|STARTED|Overall Study||55
278012|NCT00895830|671853|P4|STARTED|Overall Study||52
278013|NCT00895830|671854|P3|STARTED|Overall Study||49
278014|NCT00895830|671855|P2|STARTED|Overall Study||50
278015|NCT00895830|671856|P1|STARTED|Overall Study||51
278016|NCT00895817|671870|P2|NOT COMPLETED|Overall Study||0
278017|NCT00895817|671871|P1|NOT COMPLETED|Overall Study||0
278018|NCT00895817|671870|P2|COMPLETED|Overall Study||21
278019|NCT00895817|671871|P1|COMPLETED|Overall Study||21
278020|NCT00895817|671870|P2|STARTED|Overall Study||21
278021|NCT00895817|671871|P1|STARTED|Overall Study||21
278022|NCT00895752|671877|P1|NOT COMPLETED|Overall Study||0
278023|NCT00895752|671877|P1|COMPLETED|Overall Study||6
278024|NCT00895752|671877|P1|STARTED|Overall Study||6
278025|NCT00895661|671888|P1|NOT COMPLETED|Overall Study||3
278026|NCT00895661|671888|P1|COMPLETED|Overall Study||37
278027|NCT00895661|671888|P1|STARTED|Overall Study||40
278028|NCT00895622|671898|P3|NOT COMPLETED|Overall Study||4
278029|NCT00895622|671899|P2|NOT COMPLETED|Overall Study||4
278030|NCT00895622|671900|P1|NOT COMPLETED|Overall Study||5
278031|NCT00895622|671898|P3|COMPLETED|Overall Study||53
278032|NCT00895622|671899|P2|COMPLETED|Overall Study||52
278033|NCT00895622|671900|P1|COMPLETED|Overall Study||60
278034|NCT00895622|671898|P3|STARTED|Overall Study||57
278035|NCT00895622|671899|P2|STARTED|Overall Study||56
278036|NCT00895622|671900|P1|STARTED|Overall Study||65
278037|NCT00895583|671923|P2|NOT COMPLETED|Overall Study||12
278038|NCT00895583|671924|P1|NOT COMPLETED|Overall Study||44
278039|NCT00895583|671923|P2|COMPLETED|Overall Study||111
278040|NCT00895583|671924|P1|COMPLETED|Overall Study||87
278041|NCT00895583|671923|P2|STARTED|Overall Study||123
278042|NCT00895583|671924|P1|STARTED|Overall Study||131
278043|NCT00895531|672004|P2|NOT COMPLETED|Overall Study||0
278044|NCT00895531|672005|P1|NOT COMPLETED|Overall Study||0
278045|NCT00895531|672004|P2|COMPLETED|Overall Study||37
278046|NCT00895531|672005|P1|COMPLETED|Overall Study||38
278047|NCT00895531|672004|P2|STARTED|Overall Study||37
278048|NCT00895531|672005|P1|STARTED|Overall Study||38
278049|NCT00895453|672014|P3|NOT COMPLETED|Overall Study||23
278050|NCT00895453|672015|P2|NOT COMPLETED|Overall Study||25
278051|NCT00895453|672016|P1|NOT COMPLETED|Overall Study||25
278052|NCT00895453|672014|P3|COMPLETED|Overall Study||23
278053|NCT00895453|672015|P2|COMPLETED|Overall Study||25
278054|NCT00895453|672016|P1|COMPLETED|Overall Study||23
278055|NCT00895453|672014|P3|STARTED|Overall Study||46
278056|NCT00895453|672015|P2|STARTED|Overall Study||50
278057|NCT00895453|672016|P1|STARTED|Overall Study||48
278058|NCT00895414|672024|P2|NOT COMPLETED|Second Intervention (14 Days)||0
278059|NCT00895414|672025|P1|NOT COMPLETED|Second Intervention (14 Days)||0
278060|NCT00895414|672024|P2|COMPLETED|Second Intervention (14 Days)||9
278061|NCT00895414|672025|P1|COMPLETED|Second Intervention (14 Days)||8
278062|NCT00895414|672024|P2|STARTED|Second Intervention (14 Days)||9
278063|NCT00895414|672025|P1|STARTED|Second Intervention (14 Days)||8
278064|NCT00895414|672024|P2|NOT COMPLETED|First Intervention (14 Days)||1
278065|NCT00895414|672025|P1|NOT COMPLETED|First Intervention (14 Days)||1
278066|NCT00895414|672024|P2|COMPLETED|First Intervention (14 Days)||9
278067|NCT00895414|672025|P1|COMPLETED|First Intervention (14 Days)||8
278068|NCT00895414|672024|P2|STARTED|First Intervention (14 Days)||10
278069|NCT00895414|672025|P1|STARTED|First Intervention (14 Days)||9
278070|NCT00895310|672035|P1|NOT COMPLETED|Overall Study||1
278071|NCT00895310|672035|P1|COMPLETED|Overall Study||29
278072|NCT00895310|672035|P1|STARTED|Overall Study||30
278073|NCT00895284|672044|P2|NOT COMPLETED|Overall Study||0
278074|NCT00895284|672045|P1|NOT COMPLETED|Overall Study||0
278075|NCT00895284|672044|P2|COMPLETED|Overall Study||0
278076|NCT00895284|672045|P1|COMPLETED|Overall Study||3
278077|NCT00895284|672044|P2|STARTED|Overall Study||0
278078|NCT00895284|672045|P1|STARTED|Overall Study||3
278079|NCT00895245|672051|P1|NOT COMPLETED|Overall Study||6
278080|NCT00895245|672051|P1|COMPLETED|Overall Study||0
278081|NCT00895245|672051|P1|STARTED|Overall Study||6
278082|NCT00895232|672061|P3|NOT COMPLETED|Overall Study||5
278083|NCT00895232|672062|P2|NOT COMPLETED|Overall Study||4
278084|NCT00895232|672063|P1|NOT COMPLETED|Overall Study||3
278085|NCT00895232|672061|P3|COMPLETED|Overall Study||3
278086|NCT00895232|672062|P2|COMPLETED|Overall Study||2
278087|NCT00895232|672063|P1|COMPLETED|Overall Study||4
278088|NCT00895232|672061|P3|STARTED|Overall Study||8
278089|NCT00895232|672062|P2|STARTED|Overall Study||6
278090|NCT00895232|672063|P1|STARTED|Overall Study||7
278091|NCT00895193|672081|P4|NOT COMPLETED|Overall Study||0
278092|NCT00895193|672082|P3|NOT COMPLETED|Overall Study||0
278093|NCT00895193|672083|P2|NOT COMPLETED|Overall Study||0
278094|NCT00895193|672084|P1|NOT COMPLETED|Overall Study||0
278095|NCT00895193|672081|P4|COMPLETED|Overall Study||25
278096|NCT00895193|672082|P3|COMPLETED|Overall Study||25
278097|NCT00895193|672083|P2|COMPLETED|Overall Study||25
278098|NCT00895193|672084|P1|COMPLETED|Overall Study||25
278099|NCT00895193|672081|P4|STARTED|Overall Study||25
278100|NCT00895193|672082|P3|STARTED|Overall Study||25
278101|NCT00895193|672083|P2|STARTED|Overall Study||25
278102|NCT00895193|672084|P1|STARTED|Overall Study||25
278103|NCT00895180|672108|P2|NOT COMPLETED|Overall Study||0
278104|NCT00895180|672109|P1|NOT COMPLETED|Overall Study||0
278105|NCT00895180|672108|P2|COMPLETED|Overall Study||40
278106|NCT00895180|672109|P1|COMPLETED|Overall Study||40
278107|NCT00895180|672108|P2|Received at Least 1 Dose of Study Drug|Overall Study||40
278108|NCT00895180|672109|P1|Received at Least 1 Dose of Study Drug|Overall Study||40
278109|NCT00895180|672108|P2|STARTED|Overall Study||40
278110|NCT00895180|672109|P1|STARTED|Overall Study||40
278111|NCT00895154|672129|P2|NOT COMPLETED|Overall Study||2
278112|NCT00895154|672130|P1|NOT COMPLETED|Overall Study||1
278113|NCT00895154|672129|P2|COMPLETED|Overall Study||8
278114|NCT00895154|672130|P1|COMPLETED|Overall Study||7
278115|NCT00895154|672129|P2|Follow Up|Overall Study||8
278116|NCT00895154|672130|P1|Follow Up|Overall Study||7
278117|NCT00895154|672129|P2|STARTED|Overall Study||10
278118|NCT00895154|672130|P1|STARTED|Overall Study||8
278119|NCT00895037|672165|P3|NOT COMPLETED|Overall Study||1
278120|NCT00895037|672166|P2|NOT COMPLETED|Overall Study||2
278121|NCT00895037|672167|P1|NOT COMPLETED|Overall Study||0
278122|NCT00895037|672165|P3|COMPLETED|Overall Study||1
278123|NCT00895037|672166|P2|COMPLETED|Overall Study||75
278124|NCT00895037|672167|P1|COMPLETED|Overall Study||22
278125|NCT00895037|672165|P3|STARTED|Overall Study||2
278126|NCT00895037|672166|P2|STARTED|Overall Study||77
278127|NCT00895037|672167|P1|STARTED|Overall Study||22
278128|NCT00895011|672198|P3|NOT COMPLETED|Overall Study||8
278129|NCT00895011|672199|P2|NOT COMPLETED|Overall Study||14
278130|NCT00895011|672200|P1|NOT COMPLETED|Overall Study||24
278131|NCT00895011|672198|P3|COMPLETED|Overall Study||91
278132|NCT00895011|672199|P2|COMPLETED|Overall Study||85
278133|NCT00895011|672200|P1|COMPLETED|Overall Study||76
278134|NCT00895011|672198|P3|STARTED|Overall Study||99
278135|NCT00895011|672199|P2|STARTED|Overall Study||99
278136|NCT00895011|672200|P1|STARTED|Overall Study||100
278137|NCT00894933|672214|P1|NOT COMPLETED|Overall Study||4
278138|NCT00894933|672214|P1|COMPLETED|Overall Study||29
278139|NCT00894933|672214|P1|STARTED|Overall Study||33
278140|NCT00894803|672232|P2|NOT COMPLETED|Overall Study||5
278141|NCT00894803|672233|P1|NOT COMPLETED|Overall Study||20
278142|NCT00894803|672232|P2|COMPLETED|Overall Study||20
278143|NCT00894803|672233|P1|COMPLETED|Overall Study||81
278144|NCT00894803|672232|P2|STARTED|Overall Study||25
278145|NCT00894803|672233|P1|STARTED|Overall Study||101
278146|NCT00894790|672269|P2|NOT COMPLETED|Overall Study||2
278147|NCT00894790|672270|P1|NOT COMPLETED|Overall Study||1
278148|NCT00894790|672269|P2|COMPLETED|Overall Study||2
278149|NCT00894790|672270|P1|COMPLETED|Overall Study||3
278150|NCT00894790|672269|P2|STARTED|Overall Study||4
278151|NCT00894790|672270|P1|STARTED|Overall Study||4
278152|NCT00894738|672294|P2|NOT COMPLETED|Overall Study||0
278153|NCT00894738|672295|P1|NOT COMPLETED|Overall Study||0
278154|NCT00894738|672294|P2|COMPLETED|Overall Study||19
278155|NCT00894738|672295|P1|COMPLETED|Overall Study||25
278156|NCT00894738|672294|P2|STARTED|Overall Study||19
278157|NCT00894738|672295|P1|STARTED|Overall Study||25
278158|NCT00894699|672305|P2|NOT COMPLETED|Overall Study||0
278159|NCT00894699|672306|P1|NOT COMPLETED|Overall Study||0
278160|NCT00894699|672305|P2|COMPLETED|Overall Study||19
278161|NCT00894699|672306|P1|COMPLETED|Overall Study||21
278162|NCT00894699|672305|P2|STARTED|Overall Study||19
278163|NCT00894699|672306|P1|STARTED|Overall Study||21
278164|NCT00894686|672312|P1|NOT COMPLETED|Overall Study||56
278165|NCT00894686|672312|P1|COMPLETED|Overall Study||123
278166|NCT00894686|672312|P1|STARTED|Overall Study||179
278167|NCT00894647|672336|P2|NOT COMPLETED|Overall Study||14
278168|NCT00894647|672337|P1|NOT COMPLETED|Overall Study||10
278169|NCT00894647|672336|P2|COMPLETED|Overall Study||112
278170|NCT00894647|672337|P1|COMPLETED|Overall Study||111
278171|NCT00894647|672336|P2|STARTED|Overall Study||126
278172|NCT00894647|672337|P1|STARTED|Overall Study||121
278173|NCT00894556|672350|P4|NOT COMPLETED|Treatment Phase||0
278174|NCT00894556|672351|P3|NOT COMPLETED|Treatment Phase||1
278175|NCT00894556|672352|P2|NOT COMPLETED|Treatment Phase||4
278176|NCT00894556|672353|P1|NOT COMPLETED|Treatment Phase||4
278177|NCT00894556|672350|P4|COMPLETED|Treatment Phase||0
278178|NCT00894556|672351|P3|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|35
278179|NCT00894556|672352|P2|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|32
278180|NCT00894556|672353|P1|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|33
278181|NCT00894556|672350|P4|STARTED|Treatment Phase||0
278182|NCT00894556|672351|P3|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
278183|NCT00894556|672352|P2|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
278184|NCT00894556|672353|P1|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|37
278185|NCT00894556|672350|P4|NOT COMPLETED|Baseline Phase||85
278186|NCT00894556|672351|P3|NOT COMPLETED|Baseline Phase||0
278187|NCT00894556|672352|P2|NOT COMPLETED|Baseline Phase||0
278188|NCT00894556|672353|P1|NOT COMPLETED|Baseline Phase||0
278189|NCT00894556|672350|P4|COMPLETED|Baseline Phase||109
278190|NCT00894556|672351|P3|COMPLETED|Baseline Phase||0
278191|NCT00894556|672352|P2|COMPLETED|Baseline Phase||0
278192|NCT00894556|672353|P1|COMPLETED|Baseline Phase||0
278193|NCT00894556|672350|P4|STARTED|Baseline Phase||194
278194|NCT00894556|672351|P3|STARTED|Baseline Phase||0
278195|NCT00894556|672352|P2|STARTED|Baseline Phase||0
278196|NCT00894556|672353|P1|STARTED|Baseline Phase||0
278197|NCT00894543|672364|P2|NOT COMPLETED|Week 4 to Week 8||2
278198|NCT00894543|672365|P1|NOT COMPLETED|Week 4 to Week 8||4
278199|NCT00894543|672364|P2|COMPLETED|Week 4 to Week 8||97
278200|NCT00894543|672365|P1|COMPLETED|Week 4 to Week 8||97
278201|NCT00894543|672364|P2|STARTED|Week 4 to Week 8||99
278202|NCT00894543|672365|P1|STARTED|Week 4 to Week 8||101
278203|NCT00894543|672364|P2|NOT COMPLETED|Baseline to Week 4||2
278204|NCT00894543|672365|P1|NOT COMPLETED|Baseline to Week 4||3
278205|NCT00894543|672364|P2|COMPLETED|Baseline to Week 4||99
278206|NCT00894543|672365|P1|COMPLETED|Baseline to Week 4||101
278207|NCT00894543|672364|P2|STARTED|Baseline to Week 4||101
278208|NCT00894543|672365|P1|STARTED|Baseline to Week 4||104
278209|NCT00894543|672364|P2|NOT COMPLETED|Baseline||0
278210|NCT00894543|672365|P1|NOT COMPLETED|Baseline||0
278211|NCT00894543|672364|P2|COMPLETED|Baseline||101
278212|NCT00894543|672365|P1|COMPLETED|Baseline||104
278213|NCT00894543|672364|P2|STARTED|Baseline||101
278214|NCT00894543|672365|P1|STARTED|Baseline||104
278215|NCT00894517|672389|P2|NOT COMPLETED|Overall Study||5
278216|NCT00894517|672390|P1|NOT COMPLETED|Overall Study||2
278217|NCT00894517|672389|P2|COMPLETED|Overall Study||26
278218|NCT00894517|672390|P1|COMPLETED|Overall Study||28
278219|NCT00894517|672389|P2|STARTED|Overall Study||31
278220|NCT00894517|672390|P1|STARTED|Overall Study||30
278221|NCT00894504|672404|P1|NOT COMPLETED|Overall Study||71
278222|NCT00894504|672404|P1|COMPLETED|Overall Study||0
278223|NCT00894504|672404|P1|STARTED|Overall Study||71
278224|NCT00894465|672420|P2|NOT COMPLETED|Overall Study||0
278225|NCT00894465|672421|P1|NOT COMPLETED|Overall Study||0
278226|NCT00894465|672420|P2|COMPLETED|Overall Study||22
278227|NCT00894465|672421|P1|COMPLETED|Overall Study||22
278228|NCT00894465|672420|P2|STARTED|Overall Study||22
278229|NCT00894465|672421|P1|STARTED|Overall Study||22
278230|NCT00894413|672431|P2|NOT COMPLETED|Overall Study||8
278231|NCT00894413|672432|P1|NOT COMPLETED|Overall Study||0
278232|NCT00894413|672431|P2|COMPLETED|Overall Study||17
278233|NCT00894413|672432|P1|COMPLETED|Overall Study||15
278234|NCT00894413|672431|P2|STARTED|Overall Study||25
278235|NCT00894413|672432|P1|STARTED|Overall Study||15
278236|NCT00894387|672440|P2|NOT COMPLETED|Overall Study||175
278237|NCT00894387|672441|P1|NOT COMPLETED|Overall Study||175
278238|NCT00894387|672440|P2|COMPLETED|Overall Study||643
278239|NCT00894387|672441|P1|COMPLETED|Overall Study|"Completed indicates patients whose treatment duration completed as per protocol"|646
278240|NCT00894387|672440|P2|Completed Secondary Efficacy Phase (12m)|Overall Study||640
278241|NCT00894387|672441|P1|Completed Secondary Efficacy Phase (12m)|Overall Study||654
278242|NCT00894387|672440|P2|Completed Primary Efficacy Phase (6 m)|Overall Study||707
278243|NCT00894387|672441|P1|Completed Primary Efficacy Phase (6 m)|Overall Study||717
278244|NCT00894387|672440|P2|Full Analysis Set|Overall Study||807
278245|NCT00894387|672441|P1|Full Analysis Set|Overall Study||808
278246|NCT00894387|672440|P2|Safety Set|Overall Study||810
278247|NCT00894387|672441|P1|Safety Set|Overall Study||808
278248|NCT00894387|672440|P2|STARTED|Overall Study||818
278249|NCT00894387|672441|P1|STARTED|Overall Study|"Started indicates all randomized patients"|821
278250|NCT00894361|672461|P2|NOT COMPLETED|Overall Study||64
278251|NCT00894361|672462|P1|NOT COMPLETED|Overall Study||24
278252|NCT00894361|672461|P2|COMPLETED|Overall Study||136
278253|NCT00894361|672462|P1|COMPLETED|Overall Study||176
278254|NCT00894361|672461|P2|STARTED|Overall Study||200
278255|NCT00894361|672462|P1|STARTED|Overall Study||200
278256|NCT00894322|672471|P3|NOT COMPLETED|Overall Study||0
278257|NCT00894322|672472|P2|NOT COMPLETED|Overall Study||0
278258|NCT00894322|672473|P1|NOT COMPLETED|Overall Study||1
278259|NCT00894322|672471|P3|COMPLETED|Overall Study||12
278260|NCT00894322|672472|P2|COMPLETED|Overall Study||23
278261|NCT00894322|672473|P1|COMPLETED|Overall Study||29
278262|NCT00894322|672471|P3|STARTED|Overall Study||12
278263|NCT00894322|672472|P2|STARTED|Overall Study||23
278264|NCT00894322|672473|P1|STARTED|Overall Study||30
278265|NCT00894244|672512|P1|NOT COMPLETED|Overall Study||1
278266|NCT00894244|672512|P1|COMPLETED|Overall Study||24
278267|NCT00894244|672512|P1|STARTED|Overall Study||25
278268|NCT00894166|672524|P8|NOT COMPLETED|Overall Study||34
278269|NCT00894166|672525|P7|NOT COMPLETED|Overall Study||16
278270|NCT00894166|672526|P6|NOT COMPLETED|Overall Study||16
278271|NCT00894166|672527|P5|NOT COMPLETED|Overall Study||24
278272|NCT00894166|672528|P4|NOT COMPLETED|Overall Study||69
278273|NCT00894166|672529|P3|NOT COMPLETED|Overall Study||62
278274|NCT00894166|672530|P2|NOT COMPLETED|Overall Study||63
278275|NCT00894166|672531|P1|NOT COMPLETED|Overall Study||61
278276|NCT00894166|672524|P8|COMPLETED|Overall Study||0
278277|NCT00894166|672525|P7|COMPLETED|Overall Study||19
278278|NCT00894166|672526|P6|COMPLETED|Overall Study||20
278279|NCT00894166|672527|P5|COMPLETED|Overall Study||10
278280|NCT00894166|672528|P4|COMPLETED|Overall Study||45
278281|NCT00894166|672529|P3|COMPLETED|Overall Study||50
278282|NCT00894166|672530|P2|COMPLETED|Overall Study||46
278283|NCT00894166|672531|P1|COMPLETED|Overall Study||71
278284|NCT00894166|672524|P8|STARTED|Overall Study||34
278285|NCT00894166|672525|P7|STARTED|Overall Study||35
278286|NCT00894166|672526|P6|STARTED|Overall Study||36
278287|NCT00894166|672527|P5|STARTED|Overall Study||34
278288|NCT00894166|672528|P4|STARTED|Overall Study||114
278289|NCT00894166|672529|P3|STARTED|Overall Study||112
278290|NCT00894166|672530|P2|STARTED|Overall Study||109
278291|NCT00894166|672531|P1|STARTED|Overall Study||132
278292|NCT00894127|672561|P1|NOT COMPLETED|Overall Study||0
278293|NCT00894127|672561|P1|COMPLETED|Overall Study||128
278294|NCT00894127|672561|P1|STARTED|Overall Study||128
278295|NCT00893997|672565|P1|NOT COMPLETED|Overall Study||0
278296|NCT00893997|672565|P1|COMPLETED|Overall Study||10
278297|NCT00893997|672565|P1|STARTED|Overall Study||10
278298|NCT00893984|672570|P1|NOT COMPLETED|Overall Study||6
278299|NCT00893984|672570|P1|COMPLETED|Overall Study||0
278300|NCT00893984|672570|P1|STARTED|Overall Study||6
278301|NCT00893971|672577|P1|NOT COMPLETED|Overall Study||3
278302|NCT00893971|672577|P1|COMPLETED|Overall Study||13
278303|NCT00893971|672577|P1|GP MDI (PT001) + FF MDI (PT005)|Overall Study||16
278304|NCT00893971|672577|P1|Placebo + FF MDI (PT005)|Overall Study||13
278305|NCT00893971|672577|P1|Placebo + GFF MDI (PT003)|Overall Study||15
278306|NCT00893971|672577|P1|Placebo + GP MDI (PT001)|Overall Study||15
278307|NCT00893971|672577|P1|STARTED|Overall Study||16
278308|NCT00893789|672695|P4|NOT COMPLETED|Overall Study||13
278309|NCT00893789|672696|P3|NOT COMPLETED|Overall Study||7
278310|NCT00893789|672697|P2|NOT COMPLETED|Overall Study||4
278311|NCT00893789|672698|P1|NOT COMPLETED|Overall Study||6
278312|NCT00893789|672695|P4|COMPLETED|Overall Study||16
278313|NCT00893789|672696|P3|COMPLETED|Overall Study||22
278314|NCT00893789|672697|P2|COMPLETED|Overall Study||26
278315|NCT00893789|672698|P1|COMPLETED|Overall Study||23
278316|NCT00893789|672695|P4|Full Analysis Set (FAS)|Overall Study||27
278317|NCT00893789|672696|P3|Full Analysis Set (FAS)|Overall Study||28
278318|NCT00893789|672697|P2|Full Analysis Set (FAS)|Overall Study||29
278319|NCT00893789|672698|P1|Full Analysis Set (FAS)|Overall Study|FAS = participants in the safety analysis set with ≥1 postbaseline primary efficacy assessment.|29
278320|NCT00893789|672695|P4|Safety Analysis Set (SAS)|Overall Study||29
278321|NCT00893789|672696|P3|Safety Analysis Set (SAS)|Overall Study||29
278322|NCT00893789|672697|P2|Safety Analysis Set (SAS)|Overall Study||30
278323|NCT00893789|672698|P1|Safety Analysis Set (SAS)|Overall Study|SAS = all participants who received 1 or more doses of study drug.|29
278324|NCT00893789|672695|P4|STARTED|Overall Study||29
278325|NCT00893789|672696|P3|STARTED|Overall Study||29
278326|NCT00893789|672697|P2|STARTED|Overall Study||30
278327|NCT00893789|672698|P1|STARTED|Overall Study||29
278328|NCT00893763|672782|P2|NOT COMPLETED|Overall Study||110
278329|NCT00893763|672783|P1|NOT COMPLETED|Overall Study||110
278330|NCT00893763|672782|P2|COMPLETED|Overall Study||47
278331|NCT00893763|672783|P1|COMPLETED|Overall Study||47
278332|NCT00893763|672782|P2|STARTED|Overall Study||157
278333|NCT00893763|672783|P1|STARTED|Overall Study||157
278334|NCT00893737|672791|P1|NOT COMPLETED|Overall Study||12
278335|NCT00893737|672791|P1|COMPLETED|Overall Study||135
278336|NCT00893737|672791|P1|STARTED|Overall Study||147
278337|NCT00893464|672805|P8|NOT COMPLETED|Overall Study||2
278338|NCT00893464|672806|P7|NOT COMPLETED|Overall Study||2
278339|NCT00893464|672807|P6|NOT COMPLETED|Overall Study||0
278340|NCT00893464|672808|P5|NOT COMPLETED|Overall Study||0
278341|NCT00893464|672809|P4|NOT COMPLETED|Overall Study||0
278342|NCT00893464|672810|P3|NOT COMPLETED|Overall Study||0
278343|NCT00893464|672811|P2|NOT COMPLETED|Overall Study||0
278344|NCT00893464|672812|P1|NOT COMPLETED|Overall Study||0
278345|NCT00893464|672805|P8|COMPLETED|Overall Study||3
278346|NCT00893464|672806|P7|COMPLETED|Overall Study||8
278347|NCT00893464|672807|P6|COMPLETED|Overall Study||7
278348|NCT00893464|672808|P5|COMPLETED|Overall Study||4
278349|NCT00893464|672809|P4|COMPLETED|Overall Study||1
278350|NCT00893464|672810|P3|COMPLETED|Overall Study||1
278351|NCT00893464|672811|P2|COMPLETED|Overall Study||1
278352|NCT00893464|672812|P1|COMPLETED|Overall Study||1
278353|NCT00893464|672805|P8|STARTED|Overall Study||5
278354|NCT00893464|672806|P7|STARTED|Overall Study||10
278355|NCT00893464|672807|P6|STARTED|Overall Study||7
278356|NCT00893464|672808|P5|STARTED|Overall Study||4
278357|NCT00893464|672809|P4|STARTED|Overall Study||1
278358|NCT00893464|672810|P3|STARTED|Overall Study||1
278359|NCT00893464|672811|P2|STARTED|Overall Study||1
278360|NCT00893464|672812|P1|STARTED|Overall Study||1
278361|NCT00893152|672930|P2|NOT COMPLETED|Overall Study||0
278362|NCT00893152|672931|P1|NOT COMPLETED|Overall Study||0
278363|NCT00893152|672930|P2|COMPLETED|Overall Study||36
278364|NCT00893152|672931|P1|COMPLETED|Overall Study||47
278365|NCT00893152|672930|P2|STARTED|Overall Study||36
278366|NCT00893152|672931|P1|STARTED|Overall Study||47
278367|NCT00893113|672939|P2|NOT COMPLETED|Overall Study||16
278368|NCT00893113|672940|P1|NOT COMPLETED|Overall Study||13
278369|NCT00893113|672939|P2|COMPLETED|Overall Study||22
278370|NCT00893113|672940|P1|COMPLETED|Overall Study||23
278371|NCT00893113|672939|P2|STARTED|Overall Study||38
278372|NCT00893113|672940|P1|STARTED|Overall Study||36
278373|NCT00893074|672950|P1|NOT COMPLETED|Overall Study||11
278374|NCT00893074|672950|P1|COMPLETED|Overall Study||13
278375|NCT00893074|672950|P1|STARTED|Overall Study||24
278376|NCT00892957|672970|P2|NOT COMPLETED|Postoperative Day 30 Assessment||0
278377|NCT00892957|672971|P1|NOT COMPLETED|Postoperative Day 30 Assessment||0
278378|NCT00892957|672970|P2|COMPLETED|Postoperative Day 30 Assessment||66
278379|NCT00892957|672971|P1|COMPLETED|Postoperative Day 30 Assessment||70
278380|NCT00892957|672970|P2|STARTED|Postoperative Day 30 Assessment||66
278381|NCT00892957|672971|P1|STARTED|Postoperative Day 30 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|70
278382|NCT00892957|672970|P2|NOT COMPLETED|Postoperative Day 14 Assessment||0
278383|NCT00892957|672971|P1|NOT COMPLETED|Postoperative Day 14 Assessment||0
278384|NCT00892957|672970|P2|COMPLETED|Postoperative Day 14 Assessment||66
278385|NCT00892957|672971|P1|COMPLETED|Postoperative Day 14 Assessment||68
278386|NCT00892957|672970|P2|STARTED|Postoperative Day 14 Assessment||66
278387|NCT00892957|672971|P1|STARTED|Postoperative Day 14 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|68
278388|NCT00892957|672970|P2|NOT COMPLETED|Between Postoperative Day 1 and Day 14||4
278389|NCT00892957|672971|P1|NOT COMPLETED|Between Postoperative Day 1 and Day 14||0
278390|NCT00892957|672970|P2|COMPLETED|Between Postoperative Day 1 and Day 14||66
278391|NCT00892957|672971|P1|COMPLETED|Between Postoperative Day 1 and Day 14||70
278392|NCT00892957|672970|P2|STARTED|Between Postoperative Day 1 and Day 14||70
278393|NCT00892957|672971|P1|STARTED|Between Postoperative Day 1 and Day 14||70
278394|NCT00892957|672970|P2|NOT COMPLETED|Postoperative Day 1 Assessment||0
278395|NCT00892957|672971|P1|NOT COMPLETED|Postoperative Day 1 Assessment||0
278396|NCT00892957|672970|P2|COMPLETED|Postoperative Day 1 Assessment||70
278397|NCT00892957|672971|P1|COMPLETED|Postoperative Day 1 Assessment||70
278398|NCT00892957|672970|P2|STARTED|Postoperative Day 1 Assessment||70
278399|NCT00892957|672971|P1|STARTED|Postoperative Day 1 Assessment||70
278400|NCT00892957|672970|P2|NOT COMPLETED|Intraoperative Day 0||0
278401|NCT00892957|672971|P1|NOT COMPLETED|Intraoperative Day 0||0
278402|NCT00892957|672970|P2|COMPLETED|Intraoperative Day 0||70
278403|NCT00892957|672971|P1|COMPLETED|Intraoperative Day 0||70
278404|NCT00892957|672970|P2|STARTED|Intraoperative Day 0||70
278405|NCT00892957|672971|P1|STARTED|Intraoperative Day 0||70
278406|NCT00892775|673059|P2|NOT COMPLETED|Overall Study||1
278407|NCT00892775|673060|P1|NOT COMPLETED|Overall Study||5
278408|NCT00892775|673059|P2|COMPLETED|Overall Study||165
278409|NCT00892775|673060|P1|COMPLETED|Overall Study||327
278410|NCT00892775|673059|P2|STARTED|Overall Study||166
278411|NCT00892775|673060|P1|STARTED|Overall Study||332
278412|NCT00892723|673087|P3|NOT COMPLETED|Overall Study||2
278413|NCT00892723|673088|P2|NOT COMPLETED|Overall Study||4
278414|NCT00892723|673089|P1|NOT COMPLETED|Overall Study||2
278415|NCT00892723|673087|P3|COMPLETED|Overall Study||17
278416|NCT00892723|673088|P2|COMPLETED|Overall Study||15
278417|NCT00892723|673089|P1|COMPLETED|Overall Study||19
278418|NCT00892723|673087|P3|STARTED|Overall Study||19
278419|NCT00892723|673088|P2|STARTED|Overall Study||19
278420|NCT00892723|673089|P1|STARTED|Overall Study||21
278421|NCT00892710|673133|P3|NOT COMPLETED|Overall Study||55
278422|NCT00892710|673134|P2|NOT COMPLETED|Overall Study||59
278423|NCT00892710|673135|P1|NOT COMPLETED|Overall Study||48
278424|NCT00892710|673133|P3|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
278425|NCT00892710|673134|P2|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
278426|NCT00892710|673135|P1|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
278427|NCT00892710|673133|P3|STARTED|Overall Study||55
278428|NCT00892710|673134|P2|STARTED|Overall Study||59
278429|NCT00892710|673135|P1|STARTED|Overall Study||48
278430|NCT00892697|673158|P1|NOT COMPLETED|Overall Study||0
278431|NCT00892697|673158|P1|COMPLETED|Overall Study||15
278432|NCT00892697|673158|P1|STARTED|Overall Study||15
278433|NCT00892606|673165|P2|NOT COMPLETED|Overall Study||4
278434|NCT00892606|673166|P1|NOT COMPLETED|Overall Study||5
278435|NCT00892606|673165|P2|COMPLETED|Overall Study||33
278436|NCT00892606|673166|P1|COMPLETED|Overall Study||33
278437|NCT00892606|673165|P2|STARTED|Overall Study||37
278438|NCT00892606|673166|P1|STARTED|Overall Study||38
278439|NCT00892437|673178|P2|NOT COMPLETED|Open-Label Extension Phase||4
278440|NCT00892437|673179|P1|NOT COMPLETED|Open-Label Extension Phase||12
278441|NCT00892437|673178|P2|COMPLETED|Open-Label Extension Phase||15
278442|NCT00892437|673179|P1|COMPLETED|Open-Label Extension Phase||32
278443|NCT00892437|673178|P2|STARTED|Open-Label Extension Phase|5 participants completed the randomized phase but did not enter the open-label extension phase.|19
278444|NCT00892437|673179|P1|STARTED|Open-Label Extension Phase|1 participant completed the randomized phase but did not enter the open-label extension phase.|44
278445|NCT00892437|673178|P2|NOT COMPLETED|Randomized Phase||5
278446|NCT00892437|673179|P1|NOT COMPLETED|Randomized Phase||11
278447|NCT00892437|673178|P2|COMPLETED|Randomized Phase||24
278448|NCT00892437|673179|P1|COMPLETED|Randomized Phase||45
278449|NCT00892437|673178|P2|Randomized and Treated|Randomized Phase||29
278450|NCT00892437|673179|P1|Randomized and Treated|Randomized Phase||50
278451|NCT00892437|673178|P2|STARTED|Randomized Phase||29
278452|NCT00892437|673179|P1|STARTED|Randomized Phase||56
278453|NCT00892281|673198|P2|NOT COMPLETED|Overall Study||37
278454|NCT00892281|673199|P1|NOT COMPLETED|Overall Study||267
278455|NCT00892281|673198|P2|COMPLETED|Overall Study||187
278456|NCT00892281|673199|P1|COMPLETED|Overall Study||930
278457|NCT00892281|673198|P2|STARTED|Overall Study||224
278458|NCT00892281|673199|P1|STARTED|Overall Study||1197
278459|NCT00892177|673212|P6|NOT COMPLETED|Phase II||2
278460|NCT00892177|673213|P5|NOT COMPLETED|Phase II||5
278461|NCT00892177|673214|P4|NOT COMPLETED|Phase II||0
278462|NCT00892177|673215|P3|NOT COMPLETED|Phase II||0
278463|NCT00892177|673216|P2|NOT COMPLETED|Phase II||0
278464|NCT00892177|673217|P1|NOT COMPLETED|Phase II||0
278465|NCT00892177|673212|P6|COMPLETED|Phase II||38
278466|NCT00892177|673213|P5|COMPLETED|Phase II||83
278467|NCT00892177|673214|P4|COMPLETED|Phase II||0
278468|NCT00892177|673215|P3|COMPLETED|Phase II||0
278469|NCT00892177|673216|P2|COMPLETED|Phase II||0
278470|NCT00892177|673217|P1|COMPLETED|Phase II||0
278471|NCT00892177|673212|P6|STARTED|Phase II||40
278472|NCT00892177|673213|P5|STARTED|Phase II||88
278473|NCT00892177|673214|P4|STARTED|Phase II||0
278474|NCT00892177|673215|P3|STARTED|Phase II||0
278475|NCT00892177|673216|P2|STARTED|Phase II||0
278476|NCT00892177|673217|P1|STARTED|Phase II||0
278477|NCT00892177|673212|P6|NOT COMPLETED|Phase I: Dose Level 3||0
278478|NCT00892177|673213|P5|NOT COMPLETED|Phase I: Dose Level 3||0
278479|NCT00892177|673214|P4|NOT COMPLETED|Phase I: Dose Level 3||0
278480|NCT00892177|673215|P3|NOT COMPLETED|Phase I: Dose Level 3||0
278481|NCT00892177|673216|P2|NOT COMPLETED|Phase I: Dose Level 3||0
278482|NCT00892177|673217|P1|NOT COMPLETED|Phase I: Dose Level 3||0
278483|NCT00892177|673212|P6|COMPLETED|Phase I: Dose Level 3||0
278484|NCT00892177|673213|P5|COMPLETED|Phase I: Dose Level 3||0
278485|NCT00892177|673214|P4|COMPLETED|Phase I: Dose Level 3||6
278486|NCT00892177|673215|P3|COMPLETED|Phase I: Dose Level 3||0
278487|NCT00892177|673216|P2|COMPLETED|Phase I: Dose Level 3||0
278488|NCT00892177|673217|P1|COMPLETED|Phase I: Dose Level 3||0
278489|NCT00892177|673212|P6|STARTED|Phase I: Dose Level 3||0
278490|NCT00892177|673213|P5|STARTED|Phase I: Dose Level 3||0
278491|NCT00892177|673214|P4|STARTED|Phase I: Dose Level 3||6
278492|NCT00892177|673215|P3|STARTED|Phase I: Dose Level 3||0
278493|NCT00892177|673216|P2|STARTED|Phase I: Dose Level 3||0
278494|NCT00892177|673217|P1|STARTED|Phase I: Dose Level 3||0
278495|NCT00892177|673212|P6|NOT COMPLETED|Phase I: Dose Level 2||0
278496|NCT00892177|673213|P5|NOT COMPLETED|Phase I: Dose Level 2||0
278497|NCT00892177|673214|P4|NOT COMPLETED|Phase I: Dose Level 2||0
278498|NCT00892177|673215|P3|NOT COMPLETED|Phase I: Dose Level 2||0
278499|NCT00892177|673216|P2|NOT COMPLETED|Phase I: Dose Level 2||0
278500|NCT00892177|673217|P1|NOT COMPLETED|Phase I: Dose Level 2||0
278501|NCT00892177|673212|P6|COMPLETED|Phase I: Dose Level 2||0
278502|NCT00892177|673213|P5|COMPLETED|Phase I: Dose Level 2||0
278503|NCT00892177|673214|P4|COMPLETED|Phase I: Dose Level 2||0
278504|NCT00892177|673215|P3|COMPLETED|Phase I: Dose Level 2||3
278505|NCT00892177|673216|P2|COMPLETED|Phase I: Dose Level 2||0
278506|NCT00892177|673217|P1|COMPLETED|Phase I: Dose Level 2||0
278507|NCT00892177|673212|P6|STARTED|Phase I: Dose Level 2||0
278508|NCT00892177|673213|P5|STARTED|Phase I: Dose Level 2||0
278509|NCT00892177|673214|P4|STARTED|Phase I: Dose Level 2||0
278510|NCT00892177|673215|P3|STARTED|Phase I: Dose Level 2||3
278511|NCT00892177|673216|P2|STARTED|Phase I: Dose Level 2||0
278512|NCT00892177|673217|P1|STARTED|Phase I: Dose Level 2||0
278513|NCT00892177|673212|P6|NOT COMPLETED|Phase I: Dose Level 1||0
278514|NCT00892177|673213|P5|NOT COMPLETED|Phase I: Dose Level 1||0
278515|NCT00892177|673214|P4|NOT COMPLETED|Phase I: Dose Level 1||0
278516|NCT00892177|673215|P3|NOT COMPLETED|Phase I: Dose Level 1||0
278517|NCT00892177|673216|P2|NOT COMPLETED|Phase I: Dose Level 1||0
278518|NCT00892177|673217|P1|NOT COMPLETED|Phase I: Dose Level 1||0
278519|NCT00892177|673212|P6|COMPLETED|Phase I: Dose Level 1||0
278520|NCT00892177|673213|P5|COMPLETED|Phase I: Dose Level 1||0
278521|NCT00892177|673214|P4|COMPLETED|Phase I: Dose Level 1||0
278522|NCT00892177|673215|P3|COMPLETED|Phase I: Dose Level 1||0
278523|NCT00892177|673216|P2|COMPLETED|Phase I: Dose Level 1||4
278524|NCT00892177|673217|P1|COMPLETED|Phase I: Dose Level 1||0
278525|NCT00892177|673212|P6|STARTED|Phase I: Dose Level 1||0
278526|NCT00892177|673213|P5|STARTED|Phase I: Dose Level 1||0
278527|NCT00892177|673214|P4|STARTED|Phase I: Dose Level 1||0
278528|NCT00892177|673215|P3|STARTED|Phase I: Dose Level 1||0
278529|NCT00892177|673216|P2|STARTED|Phase I: Dose Level 1||4
278530|NCT00892177|673217|P1|STARTED|Phase I: Dose Level 1||0
278531|NCT00892177|673212|P6|NOT COMPLETED|Phase I: Dose Level 0||0
278532|NCT00892177|673213|P5|NOT COMPLETED|Phase I: Dose Level 0||0
278533|NCT00892177|673214|P4|NOT COMPLETED|Phase I: Dose Level 0||0
278534|NCT00892177|673215|P3|NOT COMPLETED|Phase I: Dose Level 0||0
278535|NCT00892177|673216|P2|NOT COMPLETED|Phase I: Dose Level 0||0
278536|NCT00892177|673217|P1|NOT COMPLETED|Phase I: Dose Level 0||0
278537|NCT00892177|673212|P6|COMPLETED|Phase I: Dose Level 0||0
278538|NCT00892177|673213|P5|COMPLETED|Phase I: Dose Level 0||0
278539|NCT00892177|673214|P4|COMPLETED|Phase I: Dose Level 0||0
278540|NCT00892177|673215|P3|COMPLETED|Phase I: Dose Level 0||0
278541|NCT00892177|673216|P2|COMPLETED|Phase I: Dose Level 0||0
278542|NCT00892177|673217|P1|COMPLETED|Phase I: Dose Level 0||3
278543|NCT00892177|673212|P6|STARTED|Phase I: Dose Level 0||0
278544|NCT00892177|673213|P5|STARTED|Phase I: Dose Level 0||0
278545|NCT00892177|673214|P4|STARTED|Phase I: Dose Level 0||0
278546|NCT00892177|673215|P3|STARTED|Phase I: Dose Level 0||0
278547|NCT00892177|673216|P2|STARTED|Phase I: Dose Level 0||0
278548|NCT00892177|673217|P1|STARTED|Phase I: Dose Level 0||3
278549|NCT00892151|673242|P1|NOT COMPLETED|Overall Study||1
278550|NCT00892151|673242|P1|COMPLETED|Overall Study||50
278551|NCT00892151|673242|P1|STARTED|Overall Study||51
278552|NCT00892099|673251|P3|NOT COMPLETED|Overall Study||7
278553|NCT00892099|673252|P2|NOT COMPLETED|Overall Study||1
278554|NCT00892099|673253|P1|NOT COMPLETED|Overall Study||5
278555|NCT00892099|673251|P3|COMPLETED|Overall Study||29
278556|NCT00892099|673252|P2|COMPLETED|Overall Study||32
278557|NCT00892099|673253|P1|COMPLETED|Overall Study||31
278558|NCT00892099|673251|P3|STARTED|Overall Study||36
278559|NCT00892099|673252|P2|STARTED|Overall Study||33
278560|NCT00892099|673253|P1|STARTED|Overall Study||36
278561|NCT00892047|673278|P2|NOT COMPLETED|Overall Study||7
278562|NCT00892047|673279|P1|NOT COMPLETED|Overall Study||4
278563|NCT00892047|673278|P2|COMPLETED|Overall Study||83
278564|NCT00892047|673279|P1|COMPLETED|Overall Study||87
278565|NCT00892047|673278|P2|STARTED|Overall Study||90
278566|NCT00892047|673279|P1|STARTED|Overall Study||91
278567|NCT00892008|673295|P1|NOT COMPLETED|Overall Study||565
278568|NCT00892008|673295|P1|COMPLETED|Overall Study||1713
278569|NCT00892008|673295|P1|STARTED|Overall Study||2278
278570|NCT00891995|673311|P2|NOT COMPLETED|Overall Study||0
278571|NCT00891995|673312|P1|NOT COMPLETED|Overall Study||0
278572|NCT00891995|673311|P2|COMPLETED|Overall Study||21
278573|NCT00891995|673312|P1|COMPLETED|Overall Study||50
278574|NCT00891995|673311|P2|STARTED|Overall Study||21
278575|NCT00891995|673312|P1|STARTED|Overall Study||50
278576|NCT00891982|673336|P2|NOT COMPLETED|Overall Study||1
278577|NCT00891982|673337|P1|NOT COMPLETED|Overall Study||2
278578|NCT00891982|673336|P2|COMPLETED|Overall Study||30
278579|NCT00891982|673337|P1|COMPLETED|Overall Study||28
278580|NCT00891982|673336|P2|STARTED|Overall Study||31
278581|NCT00891982|673337|P1|STARTED|Overall Study||30
278582|NCT00891930|673381|P1|NOT COMPLETED|Part 2: Panitumumab + Ganitumab||31
278583|NCT00891930|673381|P1|COMPLETED|Part 2: Panitumumab + Ganitumab||5
278584|NCT00891930|673381|P1|STARTED|Part 2: Panitumumab + Ganitumab||36
278585|NCT00891930|673381|P1|NOT COMPLETED|Part 1: Panitumumab +Irinotecan||40
278586|NCT00891930|673381|P1|COMPLETED|Part 1: Panitumumab +Irinotecan||36
278587|NCT00891930|673381|P1|Received Treatment|Part 1: Panitumumab +Irinotecan||74
278588|NCT00891930|673381|P1|STARTED|Part 1: Panitumumab +Irinotecan||76
278589|NCT00891904|673402|P1|NOT COMPLETED|Overall Study||2
278590|NCT00891904|673402|P1|COMPLETED|Overall Study||0
278591|NCT00891904|673402|P1|STARTED|Overall Study||2
278592|NCT00891878|673411|P2|NOT COMPLETED|Overall Study||0
278593|NCT00891878|673412|P1|NOT COMPLETED|Overall Study||0
278594|NCT00891878|673411|P2|COMPLETED|Overall Study||6
278595|NCT00891878|673412|P1|COMPLETED|Overall Study||6
278596|NCT00891878|673411|P2|STARTED|Overall Study||6
278597|NCT00891878|673412|P1|STARTED|Overall Study||6
278598|NCT00891839|673428|P1|NOT COMPLETED|Overall Study||7
278599|NCT00891839|673428|P1|COMPLETED|Overall Study|completed treatment|38
278600|NCT00891839|673428|P1|STARTED|Overall Study||45
278601|NCT00891813|673437|P1|NOT COMPLETED|Overall Study||12
278602|NCT00891813|673437|P1|COMPLETED|Overall Study||88
278603|NCT00891813|673437|P1|STARTED|Overall Study||100
278604|NCT00891774|673443|P1|NOT COMPLETED|Overall Study||14
278605|NCT00891774|673443|P1|COMPLETED|Overall Study||158
278606|NCT00891774|673443|P1|STARTED|Overall Study||172
278607|NCT00891735|673454|P4|NOT COMPLETED|Overall Study||15
278608|NCT00891735|673455|P3|NOT COMPLETED|Overall Study||12
278609|NCT00891735|673456|P2|NOT COMPLETED|Overall Study||16
278610|NCT00891735|673457|P1|NOT COMPLETED|Overall Study||17
278611|NCT00891735|673454|P4|COMPLETED|Overall Study||258
278612|NCT00891735|673455|P3|COMPLETED|Overall Study||263
278613|NCT00891735|673456|P2|COMPLETED|Overall Study||258
278614|NCT00891735|673457|P1|COMPLETED|Overall Study||258
278615|NCT00891735|673454|P4|STARTED|Overall Study||273
278616|NCT00891735|673455|P3|STARTED|Overall Study||275
278617|NCT00891735|673456|P2|STARTED|Overall Study||274
278618|NCT00891735|673457|P1|STARTED|Overall Study||275
278619|NCT00891657|673497|P2|NOT COMPLETED|Overall Study||1
278620|NCT00891657|673498|P1|NOT COMPLETED|Overall Study||1
278621|NCT00891657|673497|P2|COMPLETED|Overall Study||5
278622|NCT00891657|673498|P1|COMPLETED|Overall Study||8
278623|NCT00891657|673497|P2|STARTED|Overall Study||6
278624|NCT00891657|673498|P1|STARTED|Overall Study||9
278625|NCT00891618|673510|P1|NOT COMPLETED|Overall Study||1
278626|NCT00891618|673510|P1|COMPLETED|Overall Study||20
278627|NCT00891618|673510|P1|STARTED|Overall Study||21
278628|NCT00891527|673514|P1|NOT COMPLETED|Overall Study||2
278629|NCT00891527|673514|P1|COMPLETED|Overall Study||48
278630|NCT00891527|673514|P1|STARTED|Overall Study||50
278631|NCT00891462|673523|P3|NOT COMPLETED|Overall Study||24
278632|NCT00891462|673524|P2|NOT COMPLETED|Overall Study||33
278633|NCT00891462|673525|P1|NOT COMPLETED|Overall Study||37
278634|NCT00891462|673523|P3|COMPLETED|Overall Study||166
278635|NCT00891462|673524|P2|COMPLETED|Overall Study||152
278636|NCT00891462|673525|P1|COMPLETED|Overall Study||149
278637|NCT00891462|673523|P3|STARTED|Overall Study||190
278638|NCT00891462|673524|P2|STARTED|Overall Study||185
278639|NCT00891462|673525|P1|STARTED|Overall Study||186
278640|NCT00891436|673538|P2|NOT COMPLETED|Overall Study||0
278641|NCT00891436|673539|P1|NOT COMPLETED|Overall Study||0
278642|NCT00891436|673538|P2|COMPLETED|Overall Study||10
278643|NCT00891436|673539|P1|COMPLETED|Overall Study||10
278644|NCT00891436|673538|P2|STARTED|Overall Study||10
278645|NCT00891436|673539|P1|STARTED|Overall Study||10
278646|NCT00891371|673547|P1|NOT COMPLETED|Treatment||9
278647|NCT00891371|673547|P1|COMPLETED|Treatment||27
278648|NCT00891371|673547|P1|STARTED|Treatment||36
278649|NCT00891371|673547|P1|NOT COMPLETED|Pre-assignment||6
278650|NCT00891371|673547|P1|COMPLETED|Pre-assignment||36
278651|NCT00891371|673547|P1|STARTED|Pre-assignment||42
278652|NCT00891319|673558|P2|NOT COMPLETED|Overall Study||0
278653|NCT00891319|673559|P1|NOT COMPLETED|Overall Study||8
278654|NCT00891319|673558|P2|COMPLETED|Overall Study||40
278655|NCT00891319|673559|P1|COMPLETED|Overall Study||32
278656|NCT00891319|673558|P2|STARTED|Overall Study||40
278657|NCT00891319|673559|P1|STARTED|Overall Study||40
278658|NCT00891293|673569|P1|NOT COMPLETED|Overall Study||84
278659|NCT00891293|673569|P1|COMPLETED|Overall Study||9
278660|NCT00891293|673569|P1|STARTED|Overall Study|93 participants were enrolled; baseline data are provided for 89 participants (Safety Population).|93
278661|NCT00891228|673584|P3|NOT COMPLETED|Overall Study||15
278662|NCT00891228|673585|P2|NOT COMPLETED|Overall Study||13
278663|NCT00891228|673586|P1|NOT COMPLETED|Overall Study||11
278664|NCT00891228|673584|P3|COMPLETED|Overall Study||19
278665|NCT00891228|673585|P2|COMPLETED|Overall Study||20
278666|NCT00891228|673586|P1|COMPLETED|Overall Study||21
278667|NCT00891228|673584|P3|STARTED|Overall Study||34
278668|NCT00891228|673585|P2|STARTED|Overall Study||33
278669|NCT00891228|673586|P1|STARTED|Overall Study||32
278670|NCT00891202|673608|P4|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||5
278671|NCT00891202|673609|P3|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||7
278672|NCT00891202|673610|P2|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
278673|NCT00891202|673611|P1|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
278674|NCT00891202|673608|P4|COMPLETED|LTTP (Post-Week 39 up to Week 312)||15
278675|NCT00891202|673609|P3|COMPLETED|LTTP (Post-Week 39 up to Week 312)||12
278676|NCT00891202|673610|P2|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
278677|NCT00891202|673611|P1|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
278678|NCT00891202|673608|P4|STARTED|LTTP (Post-Week 39 up to Week 312)||20
278679|NCT00891202|673609|P3|STARTED|LTTP (Post-Week 39 up to Week 312)||19
278680|NCT00891202|673610|P2|STARTED|LTTP (Post-Week 39 up to Week 312)||0
278681|NCT00891202|673611|P1|STARTED|LTTP (Post-Week 39 up to Week 312)||0
278682|NCT00891202|673608|P4|NOT COMPLETED|PAP (Up To Week 39)||0
278683|NCT00891202|673609|P3|NOT COMPLETED|PAP (Up To Week 39)||0
278684|NCT00891202|673610|P2|NOT COMPLETED|PAP (Up To Week 39)||0
278685|NCT00891202|673611|P1|NOT COMPLETED|PAP (Up To Week 39)||1
278686|NCT00891202|673608|P4|COMPLETED|PAP (Up To Week 39)||0
278687|NCT00891202|673609|P3|COMPLETED|PAP (Up To Week 39)||0
278688|NCT00891202|673610|P2|COMPLETED|PAP (Up To Week 39)||20
278689|NCT00891202|673611|P1|COMPLETED|PAP (Up To Week 39)||19
278690|NCT00891202|673608|P4|STARTED|PAP (Up To Week 39)||0
278691|NCT00891202|673609|P3|STARTED|PAP (Up To Week 39)||0
278692|NCT00891202|673610|P2|STARTED|PAP (Up To Week 39)||20
278693|NCT00891202|673611|P1|STARTED|PAP (Up To Week 39)||20
278694|NCT00891176|673637|P4|NOT COMPLETED|At 6 Years of Age||0
278695|NCT00891176|673638|P3|NOT COMPLETED|At 6 Years of Age||0
278696|NCT00891176|673639|P2|NOT COMPLETED|At 6 Years of Age||0
278697|NCT00891176|673640|P1|NOT COMPLETED|At 6 Years of Age||0
278698|NCT00891176|673637|P4|COMPLETED|At 6 Years of Age||135
278699|NCT00891176|673638|P3|COMPLETED|At 6 Years of Age||135
278700|NCT00891176|673639|P2|COMPLETED|At 6 Years of Age||138
278701|NCT00891176|673640|P1|COMPLETED|At 6 Years of Age||131
278702|NCT00891176|673637|P4|STARTED|At 6 Years of Age||135
278703|NCT00891176|673638|P3|STARTED|At 6 Years of Age||135
278704|NCT00891176|673639|P2|STARTED|At 6 Years of Age||138
278705|NCT00891176|673640|P1|STARTED|At 6 Years of Age||131
278706|NCT00891176|673637|P4|NOT COMPLETED|At 4 Years of Age||0
278707|NCT00891176|673638|P3|NOT COMPLETED|At 4 Years of Age||0
278708|NCT00891176|673639|P2|NOT COMPLETED|At 4 Years of Age||0
278709|NCT00891176|673640|P1|NOT COMPLETED|At 4 Years of Age||0
278710|NCT00891176|673637|P4|COMPLETED|At 4 Years of Age||137
278711|NCT00891176|673638|P3|COMPLETED|At 4 Years of Age||142
278712|NCT00891176|673639|P2|COMPLETED|At 4 Years of Age||142
278713|NCT00891176|673640|P1|COMPLETED|At 4 Years of Age||140
278714|NCT00891176|673637|P4|STARTED|At 4 Years of Age||137
278715|NCT00891176|673638|P3|STARTED|At 4 Years of Age||142
278716|NCT00891176|673639|P2|STARTED|At 4 Years of Age||142
278717|NCT00891176|673640|P1|STARTED|At 4 Years of Age||140
278718|NCT00891176|673637|P4|NOT COMPLETED|At 3 Years of Age||0
278719|NCT00891176|673638|P3|NOT COMPLETED|At 3 Years of Age||0
278720|NCT00891176|673639|P2|NOT COMPLETED|At 3 Years of Age||0
278721|NCT00891176|673640|P1|NOT COMPLETED|At 3 Years of Age||0
278722|NCT00891176|673637|P4|COMPLETED|At 3 Years of Age||141
278723|NCT00891176|673638|P3|COMPLETED|At 3 Years of Age||149
278724|NCT00891176|673639|P2|COMPLETED|At 3 Years of Age||147
278725|NCT00891176|673640|P1|COMPLETED|At 3 Years of Age||144
278726|NCT00891176|673637|P4|STARTED|At 3 Years of Age||141
278727|NCT00891176|673638|P3|STARTED|At 3 Years of Age||149
278728|NCT00891176|673639|P2|STARTED|At 3 Years of Age||147
278729|NCT00891176|673640|P1|STARTED|At 3 Years of Age||144
278730|NCT00891046|673787|P5|NOT COMPLETED|Overall Study||39
278731|NCT00891046|673788|P4|NOT COMPLETED|Overall Study||3
278732|NCT00891046|673789|P3|NOT COMPLETED|Overall Study||23
278733|NCT00891046|673790|P2|NOT COMPLETED|Overall Study||9
278734|NCT00891046|673791|P1|NOT COMPLETED|Overall Study||12
278735|NCT00891046|673787|P5|COMPLETED|Overall Study||84
278736|NCT00891046|673788|P4|COMPLETED|Overall Study||8
278737|NCT00891046|673789|P3|COMPLETED|Overall Study||17
278738|NCT00891046|673790|P2|COMPLETED|Overall Study||54
278739|NCT00891046|673791|P1|COMPLETED|Overall Study||21
278740|NCT00891046|673787|P5|STARTED|Overall Study||123
278741|NCT00891046|673788|P4|STARTED|Overall Study||11
278742|NCT00891046|673789|P3|STARTED|Overall Study||40
278743|NCT00891046|673790|P2|STARTED|Overall Study||63
278744|NCT00891046|673791|P1|STARTED|Overall Study||33
278745|NCT00891020|673867|P3|NOT COMPLETED|Long-term Extension Period||23
278746|NCT00891020|673868|P2|NOT COMPLETED|Long-term Extension Period||24
278747|NCT00891020|673869|P1|NOT COMPLETED|Long-term Extension Period||6
278748|NCT00891020|673867|P3|COMPLETED|Long-term Extension Period||170
278749|NCT00891020|673868|P2|COMPLETED|Long-term Extension Period||172
278750|NCT00891020|673869|P1|COMPLETED|Long-term Extension Period||49
278751|NCT00891020|673867|P3|STARTED|Long-term Extension Period||193
278752|NCT00891020|673868|P2|STARTED|Long-term Extension Period||196
278753|NCT00891020|673869|P1|STARTED|Long-term Extension Period||55
278754|NCT00891020|673867|P3|NOT COMPLETED|24 Week Treatment Period||58
278755|NCT00891020|673868|P2|NOT COMPLETED|24 Week Treatment Period||60
278756|NCT00891020|673869|P1|NOT COMPLETED|24 Week Treatment Period||37
278757|NCT00891020|673867|P3|COMPLETED|24 Week Treatment Period||302
278758|NCT00891020|673868|P2|COMPLETED|24 Week Treatment Period||303
278759|NCT00891020|673869|P1|COMPLETED|24 Week Treatment Period||126
278760|NCT00891020|673867|P3|Safety Set|24 Week Treatment Period|28 patients from Monotherapy arm received DMARD, included in 8 mg/kg +DMARD arm for safety.|381
278761|NCT00891020|673868|P2|Safety Set|24 Week Treatment Period|1 patient from Monotherapy arm and 1 from 8 mg/kg +DMARD, included in 4 mg/kg +DMARD arm for safety.|364
278762|NCT00891020|673869|P1|Safety Set|24 Week Treatment Period|4 patients from 8 mg/kg +DMARD arm did not receive DMARD, included in Monotherapy arm for safety.|138
278763|NCT00891020|673867|P3|Intent-to-Treat (ITT)|24 Week Treatment Period||358
278764|NCT00891020|673868|P2|Intent-to-Treat (ITT)|24 Week Treatment Period||362
278765|NCT00891020|673869|P1|Intent-to-Treat (ITT)|24 Week Treatment Period||163
278766|NCT00891020|673867|P3|STARTED|24 Week Treatment Period||360
278767|NCT00891020|673868|P2|STARTED|24 Week Treatment Period||363
278768|NCT00891020|673869|P1|STARTED|24 Week Treatment Period||163
278769|NCT00890981|673902|P2|NOT COMPLETED|Overall Study||0
278770|NCT00890981|673903|P1|NOT COMPLETED|Overall Study||0
278771|NCT00890981|673902|P2|COMPLETED|Overall Study||40
278772|NCT00890981|673903|P1|COMPLETED|Overall Study||39
278773|NCT00890981|673902|P2|STARTED|Overall Study||40
278774|NCT00890981|673903|P1|STARTED|Overall Study||39
278775|NCT00890929|673933|P1|NOT COMPLETED|Overall Study||6
278776|NCT00890929|673933|P1|COMPLETED|Overall Study||39
278777|NCT00890929|673933|P1|Initiated Treatment|Overall Study||43
278778|NCT00890929|673933|P1|Consented & Enrolled|Overall Study||45
278779|NCT00890929|673933|P1|STARTED|Overall Study||45
278780|NCT00890916|673945|P1|NOT COMPLETED|"Rehab - NP Off"||0
278781|NCT00890916|673945|P1|COMPLETED|"Rehab - NP Off"||10
278782|NCT00890916|673945|P1|"Grasp Release Pre-Test OFF"|"Rehab - NP Off"||10
278783|NCT00890916|673945|P1|STARTED|"Rehab - NP Off"||10
278784|NCT00890916|673945|P1|NOT COMPLETED|"Rehab - Neuroprosthesis (NP) On"||0
278785|NCT00890916|673945|P1|COMPLETED|"Rehab - Neuroprosthesis (NP) On"||10
278786|NCT00890916|673945|P1|"Grasp Release Pre-Test ON"|"Rehab - Neuroprosthesis (NP) On"||10
278787|NCT00890916|673945|P1|STARTED|"Rehab - Neuroprosthesis (NP) On"|First Implanted Stimulator-Telemeter (IST-12) Implant.|10
278788|NCT00890825|673951|P2|NOT COMPLETED|Overall Study||14
278789|NCT00890825|673952|P1|NOT COMPLETED|Overall Study||14
278790|NCT00890825|673951|P2|COMPLETED|Overall Study||29
278791|NCT00890825|673952|P1|COMPLETED|Overall Study||30
278792|NCT00890825|673951|P2|STARTED|Overall Study|A patient randomized to this arm was excluded from the safety population for not receiving treatment|43
278793|NCT00890825|673952|P1|STARTED|Overall Study||44
278794|NCT00890721|673972|P2|NOT COMPLETED|Overall Study||1
278795|NCT00890721|673973|P1|NOT COMPLETED|Overall Study||1
278796|NCT00890721|673972|P2|COMPLETED|Overall Study||93
278797|NCT00890721|673973|P1|COMPLETED|Overall Study||94
278798|NCT00890721|673972|P2|STARTED|Overall Study||94
278799|NCT00890721|673973|P1|STARTED|Overall Study||95
278800|NCT00890695|673981|P2|NOT COMPLETED|Overall Study||0
278801|NCT00890695|673982|P1|NOT COMPLETED|Overall Study||1
278802|NCT00890695|673981|P2|COMPLETED|Overall Study||33
278803|NCT00890695|673982|P1|COMPLETED|Overall Study||31
278804|NCT00890695|673981|P2|STARTED|Overall Study||33
278805|NCT00890695|673982|P1|STARTED|Overall Study||32
278806|NCT00890682|674000|P2|NOT COMPLETED|Overall Study||2
278807|NCT00890682|674001|P1|NOT COMPLETED|Overall Study||4
278808|NCT00890682|674000|P2|COMPLETED|Overall Study||94
278809|NCT00890682|674001|P1|COMPLETED|Overall Study||93
278810|NCT00890682|674000|P2|STARTED|Overall Study||96
278811|NCT00890682|674001|P1|STARTED|Overall Study||97
278812|NCT00890656|674007|P1|NOT COMPLETED|Overall Study||0
278813|NCT00890656|674007|P1|COMPLETED|Overall Study||90
278814|NCT00890656|674007|P1|STARTED|Overall Study||90
278815|NCT00890591|674011|P1|NOT COMPLETED|Overall Study||20
278816|NCT00890591|674011|P1|COMPLETED|Overall Study||124
278817|NCT00890591|674011|P1|STARTED|Overall Study||144
278818|NCT00890552|674017|P1|NOT COMPLETED|On-treatment||10
278819|NCT00890552|674017|P1|COMPLETED|On-treatment||14
278820|NCT00890552|674017|P1|STARTED|On-treatment||24
278821|NCT00890552|674017|P1|NOT COMPLETED|Enrollment and Pre-treatment||1
278822|NCT00890552|674017|P1|COMPLETED|Enrollment and Pre-treatment||24
278823|NCT00890552|674017|P1|STARTED|Enrollment and Pre-treatment||25
278824|NCT00890409|674026|P2|NOT COMPLETED|Overall Study||21
278825|NCT00890409|674027|P1|NOT COMPLETED|Overall Study||20
278826|NCT00890409|674026|P2|COMPLETED|Overall Study||119
278827|NCT00890409|674027|P1|COMPLETED|Overall Study||96
278828|NCT00890409|674026|P2|STARTED|Overall Study||140
278829|NCT00890409|674027|P1|STARTED|Overall Study||116
278830|NCT00890201|674037|P2|NOT COMPLETED|Overall Study||56
278831|NCT00890201|674038|P1|NOT COMPLETED|Overall Study||5
278832|NCT00890201|674037|P2|COMPLETED|Overall Study|103 patients without acute cholecystitis or common bile duct stones|103
278833|NCT00890201|674038|P1|COMPLETED|Overall Study|33 patients with gastric cancer and without gallstone disease|33
278834|NCT00890201|674037|P2|STARTED|Overall Study|41 patients with acute cholecystitis and 15 patients with common bile duct stones|159
278835|NCT00890201|674038|P1|STARTED|Overall Study|5 patients with gastric cancer and gallstone disease|38
278836|NCT00890162|674046|P2|NOT COMPLETED|Overall Study||1
278837|NCT00890162|674047|P1|NOT COMPLETED|Overall Study||2
278838|NCT00890162|674046|P2|COMPLETED|Overall Study||7
278839|NCT00890162|674047|P1|COMPLETED|Overall Study||6
278840|NCT00890162|674046|P2|STARTED|Overall Study||8
278841|NCT00890162|674047|P1|STARTED|Overall Study||8
278842|NCT00890097|674056|P3|NOT COMPLETED|Overall Study||77
278843|NCT00890097|674057|P2|NOT COMPLETED|Overall Study||86
278844|NCT00890097|674058|P1|NOT COMPLETED|Overall Study||68
278845|NCT00890097|674056|P3|COMPLETED|Overall Study||184
278846|NCT00890097|674057|P2|COMPLETED|Overall Study||173
278847|NCT00890097|674058|P1|COMPLETED|Overall Study||184
278848|NCT00890097|674056|P3|STARTED|Overall Study||261
278849|NCT00890097|674057|P2|STARTED|Overall Study||259
278850|NCT00890097|674058|P1|STARTED|Overall Study||252
278851|NCT00890084|674066|P1|NOT COMPLETED|Overall Study||142
278852|NCT00890084|674066|P1|COMPLETED|Overall Study||2771
278853|NCT00890084|674066|P1|STARTED|Overall Study||2913
278854|NCT00889928|674077|P1|NOT COMPLETED|Overall Study||0
278855|NCT00889928|674077|P1|COMPLETED|Overall Study||7
278856|NCT00889928|674077|P1|STARTED|Overall Study||7
278857|NCT00889915|674085|P4|NOT COMPLETED|Overall Study||8
278858|NCT00889915|674086|P3|NOT COMPLETED|Overall Study||13
278859|NCT00889915|674087|P2|NOT COMPLETED|Overall Study||5
278860|NCT00889915|674088|P1|NOT COMPLETED|Overall Study||2
278861|NCT00889915|674085|P4|COMPLETED|Overall Study||40
278862|NCT00889915|674086|P3|COMPLETED|Overall Study||54
278863|NCT00889915|674087|P2|COMPLETED|Overall Study||71
278864|NCT00889915|674088|P1|COMPLETED|Overall Study||35
278865|NCT00889915|674085|P4|STARTED|Overall Study||48
278866|NCT00889915|674086|P3|STARTED|Overall Study||67
278867|NCT00889915|674087|P2|STARTED|Overall Study||76
278868|NCT00889915|674088|P1|STARTED|Overall Study||37
278869|NCT00889863|674106|P2|NOT COMPLETED|Part II: Randomized Double Blind||26
278870|NCT00889863|674107|P1|NOT COMPLETED|Part II: Randomized Double Blind||11
278871|NCT00889863|674106|P2|COMPLETED|Part II: Randomized Double Blind||24
278872|NCT00889863|674107|P1|COMPLETED|Part II: Randomized Double Blind||39
278873|NCT00889863|674106|P2|STARTED|Part II: Randomized Double Blind||50
278874|NCT00889863|674107|P1|STARTED|Part II: Randomized Double Blind||50
278875|NCT00889863|674106|P2|NOT COMPLETED|Part I: Open Label||0
278876|NCT00889863|674107|P1|NOT COMPLETED|Part I: Open Label||77
278877|NCT00889863|674106|P2|COMPLETED|Part I: Open Label||0
278878|NCT00889863|674107|P1|COMPLETED|Part I: Open Label||100
278879|NCT00889863|674106|P2|Entered Part 1d|Part I: Open Label||0
278880|NCT00889863|674107|P1|Entered Part 1d|Part I: Open Label||103
278881|NCT00889863|674106|P2|Entered Part Ic|Part I: Open Label||0
278882|NCT00889863|674107|P1|Entered Part Ic|Part I: Open Label|Patients steroid free at study entry entered Part Id directly and did not participate in Part Ic.|92
278883|NCT00889863|674106|P2|Entered Part Ib|Part I: Open Label||0
278884|NCT00889863|674107|P1|Entered Part Ib|Part I: Open Label||142
278885|NCT00889863|674106|P2|Entered Part Ia|Part I: Open Label||0
278886|NCT00889863|674107|P1|Entered Part Ia|Part I: Open Label||145
278887|NCT00889863|674106|P2|STARTED|Part I: Open Label|No participants received placebo in Part I.|0
278888|NCT00889863|674107|P1|STARTED|Part I: Open Label||177
278889|NCT00889824|674129|P1|NOT COMPLETED|Overall Study||0
278890|NCT00889824|674129|P1|COMPLETED|Overall Study||5
278891|NCT00889824|674129|P1|STARTED|Overall Study||5
278892|NCT00889720|674133|P1|NOT COMPLETED|Overall Study||8
278893|NCT00889720|674133|P1|COMPLETED|Overall Study||8
278894|NCT00889720|674133|P1|Surgical Population|Overall Study||12
278895|NCT00889720|674133|P1|STARTED|Overall Study||16
278896|NCT00889707|674160|P2|NOT COMPLETED|Overall Study||10
278897|NCT00889707|674161|P1|NOT COMPLETED|Overall Study||7
278898|NCT00889707|674160|P2|COMPLETED|Overall Study||21
278899|NCT00889707|674161|P1|COMPLETED|Overall Study||54
278900|NCT00889707|674160|P2|STARTED|Overall Study||31
278901|NCT00889707|674161|P1|STARTED|Overall Study||61
278902|NCT00889681|674169|P1|NOT COMPLETED|Overall Study||3
278903|NCT00889681|674169|P1|COMPLETED|Overall Study||78
278904|NCT00889681|674169|P1|Received Treatment|Overall Study||78
278905|NCT00889681|674169|P1|STARTED|Overall Study||81
278906|NCT00889603|674176|P1|NOT COMPLETED|Overall Study||37
278907|NCT00889603|674176|P1|COMPLETED|Overall Study||333
278908|NCT00889603|674176|P1|STARTED|Overall Study||370
278909|NCT00889512|674191|P2|NOT COMPLETED|Overall Study||0
278910|NCT00889512|674192|P1|NOT COMPLETED|Overall Study||0
278911|NCT00889512|674191|P2|COMPLETED|Overall Study||9
278912|NCT00889512|674192|P1|COMPLETED|Overall Study||5
278913|NCT00889512|674191|P2|STARTED|Overall Study||9
278914|NCT00889512|674192|P1|STARTED|Overall Study||5
278915|NCT00889421|674198|P1|NOT COMPLETED|Overall Study||3
278916|NCT00889421|674198|P1|COMPLETED|Overall Study||0
278917|NCT00889421|674198|P1|STARTED|Overall Study||3
278918|NCT00889330|674208|P2|NOT COMPLETED|Overall Study||0
278919|NCT00889330|674209|P1|NOT COMPLETED|Overall Study||0
278920|NCT00889330|674208|P2|COMPLETED|Overall Study||30
278921|NCT00889330|674209|P1|COMPLETED|Overall Study||30
278922|NCT00889330|674208|P2|STARTED|Overall Study||30
278923|NCT00889330|674209|P1|STARTED|Overall Study||30
278924|NCT00889265|674239|P1|NOT COMPLETED|Overall Study||7
278925|NCT00889265|674239|P1|COMPLETED|Overall Study||44
278926|NCT00889265|674239|P1|STARTED|Overall Study|Date Enrollment Started: 07/21/2009 Date Enrollment Completed: 02/15/2011 Total enrolled: 51|51
278927|NCT00889252|674246|P2|NOT COMPLETED|Overall Study||4
278928|NCT00889252|674247|P1|NOT COMPLETED|Overall Study||7
278929|NCT00889252|674246|P2|COMPLETED|Overall Study||78
278930|NCT00889252|674247|P1|COMPLETED|Overall Study||161
278931|NCT00889252|674246|P2|STARTED|Overall Study||82
278932|NCT00889252|674247|P1|STARTED|Overall Study||168
278933|NCT00889226|674291|P2|NOT COMPLETED|Overall Study||35
278934|NCT00889226|674292|P1|NOT COMPLETED|Overall Study||25
278935|NCT00889226|674291|P2|COMPLETED|Overall Study||43
278936|NCT00889226|674292|P1|COMPLETED|Overall Study||58
278937|NCT00889226|674291|P2|STARTED|Overall Study||78
278938|NCT00889226|674292|P1|STARTED|Overall Study||83
278939|NCT00889200|674300|P1|NOT COMPLETED|Overall Study||0
278940|NCT00889200|674300|P1|COMPLETED|Overall Study||12
278941|NCT00889200|674300|P1|STARTED|Overall Study||12
278942|NCT00889187|674304|P4|NOT COMPLETED|Overall Study||0
278943|NCT00889187|674305|P3|NOT COMPLETED|Overall Study||0
278944|NCT00889187|674306|P2|NOT COMPLETED|Overall Study||0
278945|NCT00889187|674307|P1|NOT COMPLETED|Overall Study||0
278946|NCT00889187|674304|P4|COMPLETED|Overall Study||0
278947|NCT00889187|674305|P3|COMPLETED|Overall Study||4
278948|NCT00889187|674306|P2|COMPLETED|Overall Study||3
278949|NCT00889187|674307|P1|COMPLETED|Overall Study||3
278950|NCT00889187|674304|P4|STARTED|Overall Study||0
278951|NCT00889187|674305|P3|STARTED|Overall Study||4
278952|NCT00889187|674306|P2|STARTED|Overall Study||3
278953|NCT00889187|674307|P1|STARTED|Overall Study||3
278954|NCT00889005|674324|P2|NOT COMPLETED|Overall Study||2
278955|NCT00889005|674325|P1|NOT COMPLETED|Overall Study||8
278956|NCT00889005|674324|P2|COMPLETED|Overall Study||72
278957|NCT00889005|674325|P1|COMPLETED|Overall Study||57
278958|NCT00889005|674324|P2|STARTED|Overall Study||74
278959|NCT00889005|674325|P1|STARTED|Overall Study||65
278960|NCT00888979|674331|P1|NOT COMPLETED|Overall Study||4
278961|NCT00888979|674331|P1|COMPLETED|Overall Study||6
278962|NCT00888979|674331|P1|Received the Inhaler/Counseling|Overall Study||8
278963|NCT00888979|674331|P1|STARTED|Overall Study||10
278964|NCT00888940|674339|P2|NOT COMPLETED|Overall Study||21
278965|NCT00888940|674340|P1|NOT COMPLETED|Overall Study||28
278966|NCT00888940|674339|P2|COMPLETED|Overall Study||101
278967|NCT00888940|674340|P1|COMPLETED|Overall Study||92
278968|NCT00888940|674339|P2|Completed Therapy|Overall Study||106
278969|NCT00888940|674340|P1|Completed Therapy|Overall Study||107
278970|NCT00888940|674339|P2|STARTED|Overall Study||122
278971|NCT00888940|674340|P1|STARTED|Overall Study||120
278972|NCT00888849|674350|P2|NOT COMPLETED|Overall Study||9
278973|NCT00888849|674351|P1|NOT COMPLETED|Overall Study||5
278974|NCT00888849|674350|P2|COMPLETED|Overall Study||129
278975|NCT00888849|674351|P1|COMPLETED|Overall Study||137
278976|NCT00888849|674350|P2|STARTED|Overall Study||138
278977|NCT00888849|674351|P1|STARTED|Overall Study||142
278978|NCT00888654|674361|P1|NOT COMPLETED|Overall Study||10
278979|NCT00888654|674361|P1|COMPLETED|Overall Study||31
278980|NCT00888654|674361|P1|STARTED|Overall Study||41
278981|NCT00888628|674367|P1|NOT COMPLETED|Overall Study||3
278982|NCT00888628|674367|P1|COMPLETED|Overall Study||4
278983|NCT00888628|674367|P1|Transplanted|Overall Study||4
278984|NCT00888628|674367|P1|Withdrawn|Overall Study||1
278985|NCT00888628|674367|P1|Screen Failure|Overall Study||2
278986|NCT00888628|674367|P1|Enrolled|Overall Study||7
278987|NCT00888628|674367|P1|STARTED|Overall Study||7
278988|NCT00888615|674379|P1|NOT COMPLETED|Overall Study||2
278989|NCT00888615|674379|P1|COMPLETED|Overall Study||56
278990|NCT00888615|674379|P1|STARTED|Overall Study||58
278991|NCT00888459|674390|P2|NOT COMPLETED|Overall Study||0
278992|NCT00888459|674391|P1|NOT COMPLETED|Overall Study||0
278993|NCT00888459|674390|P2|COMPLETED|Overall Study||30
278994|NCT00888459|674391|P1|COMPLETED|Overall Study||30
278995|NCT00888459|674390|P2|STARTED|Overall Study||30
278996|NCT00888459|674391|P1|STARTED|Overall Study||30
278997|NCT00888433|674399|P2|NOT COMPLETED|Overall Study||3
278998|NCT00888433|674400|P1|NOT COMPLETED|Overall Study||3
278999|NCT00888433|674399|P2|COMPLETED|Overall Study||51
279000|NCT00888433|674400|P1|COMPLETED|Overall Study||49
279001|NCT00888433|674399|P2|STARTED|Overall Study||54
279002|NCT00888433|674400|P1|STARTED|Overall Study||52
279003|NCT00888381|674408|P2|NOT COMPLETED|Overall Study||1
279004|NCT00888381|674409|P1|NOT COMPLETED|Overall Study||0
279005|NCT00888381|674408|P2|COMPLETED|Overall Study||59
279006|NCT00888381|674409|P1|COMPLETED|Overall Study||60
279007|NCT00888381|674408|P2|STARTED|Overall Study||60
279008|NCT00888381|674409|P1|STARTED|Overall Study||60
279009|NCT00888355|674429|P4|NOT COMPLETED|Overall Study||10
279010|NCT00888355|674430|P3|NOT COMPLETED|Overall Study||12
279011|NCT00888355|674431|P2|NOT COMPLETED|Overall Study||9
279012|NCT00888355|674432|P1|NOT COMPLETED|Overall Study||22
279013|NCT00888355|674429|P4|COMPLETED|Overall Study||96
279014|NCT00888355|674430|P3|COMPLETED|Overall Study||94
279015|NCT00888355|674431|P2|COMPLETED|Overall Study||99
279016|NCT00888355|674432|P1|COMPLETED|Overall Study||86
279017|NCT00888355|674429|P4|STARTED|Overall Study||106
279018|NCT00888355|674430|P3|STARTED|Overall Study||106
279019|NCT00888355|674431|P2|STARTED|Overall Study||108
279020|NCT00888355|674432|P1|STARTED|Overall Study||108
279021|NCT00888329|674488|P2|NOT COMPLETED|Overall Study||9
279022|NCT00888329|674489|P1|NOT COMPLETED|Overall Study||6
279023|NCT00888329|674488|P2|COMPLETED|Overall Study||122
279024|NCT00888329|674489|P1|COMPLETED|Overall Study||119
279025|NCT00888329|674488|P2|STARTED|Overall Study||131
279026|NCT00888329|674489|P1|STARTED|Overall Study||125
279027|NCT00888238|674495|P3|NOT COMPLETED|Third Period of Treatment Intervention||0
279028|NCT00888238|674496|P2|NOT COMPLETED|Third Period of Treatment Intervention||0
279029|NCT00888238|674497|P1|NOT COMPLETED|Third Period of Treatment Intervention||0
279030|NCT00888238|674495|P3|COMPLETED|Third Period of Treatment Intervention||3
279031|NCT00888238|674496|P2|COMPLETED|Third Period of Treatment Intervention||4
279032|NCT00888238|674497|P1|COMPLETED|Third Period of Treatment Intervention||4
279033|NCT00888238|674495|P3|STARTED|Third Period of Treatment Intervention||3
279034|NCT00888238|674496|P2|STARTED|Third Period of Treatment Intervention||4
279035|NCT00888238|674497|P1|STARTED|Third Period of Treatment Intervention||4
279036|NCT00888238|674495|P3|NOT COMPLETED|Washout Period After Period 2||1
279037|NCT00888238|674496|P2|NOT COMPLETED|Washout Period After Period 2||0
279038|NCT00888238|674497|P1|NOT COMPLETED|Washout Period After Period 2||0
279039|NCT00888238|674495|P3|COMPLETED|Washout Period After Period 2||3
279040|NCT00888238|674496|P2|COMPLETED|Washout Period After Period 2||4
279041|NCT00888238|674497|P1|COMPLETED|Washout Period After Period 2||4
279042|NCT00888238|674495|P3|STARTED|Washout Period After Period 2||4
279043|NCT00888238|674496|P2|STARTED|Washout Period After Period 2||4
279044|NCT00888238|674497|P1|STARTED|Washout Period After Period 2||4
279045|NCT00888238|674495|P3|NOT COMPLETED|Second Period of Treatment Intervention||0
279046|NCT00888238|674496|P2|NOT COMPLETED|Second Period of Treatment Intervention||0
279047|NCT00888238|674497|P1|NOT COMPLETED|Second Period of Treatment Intervention||0
279048|NCT00888238|674495|P3|COMPLETED|Second Period of Treatment Intervention||4
279049|NCT00888238|674496|P2|COMPLETED|Second Period of Treatment Intervention||4
279050|NCT00888238|674497|P1|COMPLETED|Second Period of Treatment Intervention||4
279051|NCT00888238|674495|P3|STARTED|Second Period of Treatment Intervention||4
279052|NCT00888238|674496|P2|STARTED|Second Period of Treatment Intervention||4
279053|NCT00888238|674497|P1|STARTED|Second Period of Treatment Intervention||4
279054|NCT00888238|674495|P3|NOT COMPLETED|Washout Period After Period 1||0
279055|NCT00888238|674496|P2|NOT COMPLETED|Washout Period After Period 1||0
279056|NCT00888238|674497|P1|NOT COMPLETED|Washout Period After Period 1||0
279057|NCT00888238|674495|P3|COMPLETED|Washout Period After Period 1||4
279058|NCT00888238|674496|P2|COMPLETED|Washout Period After Period 1||4
279059|NCT00888238|674497|P1|COMPLETED|Washout Period After Period 1||4
279060|NCT00888238|674495|P3|STARTED|Washout Period After Period 1||4
279061|NCT00888238|674496|P2|STARTED|Washout Period After Period 1||4
279062|NCT00888238|674497|P1|STARTED|Washout Period After Period 1||4
279063|NCT00888238|674495|P3|NOT COMPLETED|First Period of Treatment Intervention||0
279064|NCT00888238|674496|P2|NOT COMPLETED|First Period of Treatment Intervention||0
279065|NCT00888238|674497|P1|NOT COMPLETED|First Period of Treatment Intervention||0
279066|NCT00888238|674495|P3|COMPLETED|First Period of Treatment Intervention||4
279067|NCT00888238|674496|P2|COMPLETED|First Period of Treatment Intervention||4
279068|NCT00888238|674497|P1|COMPLETED|First Period of Treatment Intervention||4
279069|NCT00888238|674495|P3|STARTED|First Period of Treatment Intervention||4
279070|NCT00888238|674496|P2|STARTED|First Period of Treatment Intervention||4
279071|NCT00888238|674497|P1|STARTED|First Period of Treatment Intervention||4
279072|NCT00888173|674505|P1|NOT COMPLETED|Overall Study||2
279073|NCT00888173|674505|P1|COMPLETED|Overall Study||43
279074|NCT00888173|674505|P1|STARTED|Overall Study||45
279075|NCT00888134|674513|P1|NOT COMPLETED|Follow-up||1
279076|NCT00888134|674513|P1|COMPLETED|Follow-up|23 died; 3 were lost-to-follow-up|26
279077|NCT00888134|674513|P1|STARTED|Follow-up||27
279078|NCT00888134|674513|P1|NOT COMPLETED|Treatment With Study Drug||1
279079|NCT00888134|674513|P1|COMPLETED|Treatment With Study Drug|21 had progressive disease; 5 had unacceptable toxicity; 1 finished treatment|27
279080|NCT00888134|674513|P1|STARTED|Treatment With Study Drug||28
279081|NCT00887978|674523|P2|NOT COMPLETED|Overall Study||15
279082|NCT00887978|674524|P1|NOT COMPLETED|Overall Study||25
279083|NCT00887978|674523|P2|COMPLETED|Overall Study||138
279084|NCT00887978|674524|P1|COMPLETED|Overall Study||132
279085|NCT00887978|674523|P2|STARTED|Overall Study||153
279086|NCT00887978|674524|P1|STARTED|Overall Study||157
279087|NCT00887965|674560|P1|NOT COMPLETED|Overall Study||0
279088|NCT00887965|674560|P1|COMPLETED|Overall Study||15
279089|NCT00887965|674560|P1|STARTED|Overall Study||15
279090|NCT00887926|674594|P4|NOT COMPLETED|Overall Study||0
279091|NCT00887926|674595|P3|NOT COMPLETED|Overall Study||0
279092|NCT00887926|674596|P2|NOT COMPLETED|Overall Study||1
279093|NCT00887926|674597|P1|NOT COMPLETED|Overall Study||0
279094|NCT00887926|674594|P4|COMPLETED|Overall Study||5
279095|NCT00887926|674595|P3|COMPLETED|Overall Study||3
279096|NCT00887926|674596|P2|COMPLETED|Overall Study||13
279097|NCT00887926|674597|P1|COMPLETED|Overall Study||3
279098|NCT00887926|674594|P4|Received at Least 1 Dose of Study Drug|Overall Study||5
279099|NCT00887926|674595|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
279100|NCT00887926|674596|P2|Received at Least 1 Dose of Study Drug|Overall Study||13
279101|NCT00887926|674597|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
279102|NCT00887926|674594|P4|STARTED|Overall Study||5
279103|NCT00887926|674595|P3|STARTED|Overall Study||3
279104|NCT00887926|674596|P2|STARTED|Overall Study||14
279105|NCT00887926|674597|P1|STARTED|Overall Study||3
279106|NCT00887913|674632|P1|NOT COMPLETED|Overall Study||6
279107|NCT00887913|674632|P1|COMPLETED|Overall Study||63
279108|NCT00887913|674632|P1|STARTED|Overall Study||69
279109|NCT00887822|674640|P2|NOT COMPLETED|Overall Study||102
279110|NCT00887822|674641|P1|NOT COMPLETED|Overall Study||97
279111|NCT00887822|674640|P2|COMPLETED|Overall Study||0
279112|NCT00887822|674641|P1|COMPLETED|Overall Study||3
279113|NCT00887822|674640|P2|Treated (Safety Population)|Overall Study||101
279114|NCT00887822|674641|P1|Treated (Safety Population)|Overall Study||100
279115|NCT00887822|674640|P2|STARTED|Overall Study||102
279116|NCT00887822|674641|P1|STARTED|Overall Study||100
279117|NCT00887809|674673|P2|NOT COMPLETED|Overall Study||0
279118|NCT00887809|674674|P1|NOT COMPLETED|Overall Study||4
279119|NCT00887809|674673|P2|COMPLETED|Overall Study||10
279120|NCT00887809|674674|P1|COMPLETED|Overall Study||33
279121|NCT00887809|674673|P2|STARTED|Overall Study||10
279122|NCT00887809|674674|P1|STARTED|Overall Study||37
279123|NCT00887744|674680|P1|NOT COMPLETED|Overall Study||34
279124|NCT00887744|674680|P1|COMPLETED|Overall Study||128
279125|NCT00887744|674680|P1|STARTED|Overall Study|162 patients signed an informed consent but only 157 patients were treated with the Aperius.|162
279126|NCT00887679|674689|P1|NOT COMPLETED|Overall Study||10
279127|NCT00887679|674689|P1|COMPLETED|Overall Study|20 subjects completed the study.|20
279128|NCT00887679|674689|P1|STARTED|Overall Study||30
279129|NCT00887653|674698|P1|NOT COMPLETED|Overall Study||0
279130|NCT00887653|674698|P1|COMPLETED|Overall Study||20
279131|NCT00887653|674698|P1|STARTED|Overall Study||20
279132|NCT00887640|674704|P1|NOT COMPLETED|Overall Study||0
279133|NCT00887640|674704|P1|COMPLETED|Overall Study||11
279134|NCT00887640|674704|P1|STARTED|Overall Study||11
279135|NCT00887588|674719|P2|NOT COMPLETED|Extension Period||5
279136|NCT00887588|674720|P1|NOT COMPLETED|Extension Period||6
279137|NCT00887588|674719|P2|COMPLETED|Extension Period||120
279138|NCT00887588|674720|P1|COMPLETED|Extension Period||121
279139|NCT00887588|674719|P2|Arterial Stiffness Set|Extension Period||94
279140|NCT00887588|674720|P1|Arterial Stiffness Set|Extension Period||86
279141|NCT00887588|674719|P2|STARTED|Extension Period||125
279142|NCT00887588|674720|P1|STARTED|Extension Period||127
279143|NCT00887588|674719|P2|NOT COMPLETED|Core Period||21
279144|NCT00887588|674720|P1|NOT COMPLETED|Core Period||19
279145|NCT00887588|674719|P2|COMPLETED|Core Period||131
279146|NCT00887588|674720|P1|COMPLETED|Core Period||130
279147|NCT00887588|674719|P2|Arterial Stiffness Set|Core Period||94
279148|NCT00887588|674720|P1|Arterial Stiffness Set|Core Period||86
279149|NCT00887588|674719|P2|Full Analysis Set|Core Period||146
279150|NCT00887588|674720|P1|Full Analysis Set|Core Period||148
279151|NCT00887588|674719|P2|Extension Efficacy Set|Core Period||125
279152|NCT00887588|674720|P1|Extension Efficacy Set|Core Period||127
279153|NCT00887588|674719|P2|STARTED|Core Period||152
279154|NCT00887588|674720|P1|STARTED|Core Period||149
279155|NCT00887575|674772|P3|NOT COMPLETED|Phase II - Maintenance Therapy||0
279156|NCT00887575|674773|P2|NOT COMPLETED|Phase II - Maintenance Therapy||0
279157|NCT00887575|674774|P1|NOT COMPLETED|Phase II - Maintenance Therapy||2
279158|NCT00887575|674772|P3|COMPLETED|Phase II - Maintenance Therapy||0
279159|NCT00887575|674773|P2|COMPLETED|Phase II - Maintenance Therapy||0
279160|NCT00887575|674774|P1|COMPLETED|Phase II - Maintenance Therapy||6
279161|NCT00887575|674772|P3|STARTED|Phase II - Maintenance Therapy||0
279162|NCT00887575|674773|P2|STARTED|Phase II - Maintenance Therapy||0
279163|NCT00887575|674774|P1|STARTED|Phase II - Maintenance Therapy|Pts who completed 6 cycles of Neoadjuvant Therapy & underwent surgery were eligible for maintenance|8
279164|NCT00887575|674772|P3|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
279165|NCT00887575|674773|P2|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
279166|NCT00887575|674774|P1|NOT COMPLETED|Phase II - Neoadjuvant Therapy||25
279167|NCT00887575|674772|P3|COMPLETED|Phase II - Neoadjuvant Therapy||0
279168|NCT00887575|674773|P2|COMPLETED|Phase II - Neoadjuvant Therapy||0
279169|NCT00887575|674774|P1|COMPLETED|Phase II - Neoadjuvant Therapy||16
279170|NCT00887575|674772|P3|STARTED|Phase II - Neoadjuvant Therapy||0
279171|NCT00887575|674773|P2|STARTED|Phase II - Neoadjuvant Therapy||0
279172|NCT00887575|674774|P1|STARTED|Phase II - Neoadjuvant Therapy|Includes patients treated at MTD during Phase I, 39 additional patients enrolled, 4 were not treated|41
279173|NCT00887575|674772|P3|NOT COMPLETED|Phase I||3
279174|NCT00887575|674773|P2|NOT COMPLETED|Phase I||6
279175|NCT00887575|674774|P1|NOT COMPLETED|Phase I||0
279176|NCT00887575|674772|P3|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
279177|NCT00887575|674773|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
279178|NCT00887575|674774|P1|COMPLETED|Phase I||6
279179|NCT00887575|674772|P3|STARTED|Phase I||3
279180|NCT00887575|674773|P2|STARTED|Phase I||6
279181|NCT00887575|674774|P1|STARTED|Phase I||6
279182|NCT00887562|674785|P3|NOT COMPLETED|Overall Study||1
279183|NCT00887562|674786|P2|NOT COMPLETED|Overall Study||2
279184|NCT00887562|674787|P1|NOT COMPLETED|Overall Study||3
279185|NCT00887562|674785|P3|COMPLETED|Overall Study||7
279186|NCT00887562|674786|P2|COMPLETED|Overall Study||7
279187|NCT00887562|674787|P1|COMPLETED|Overall Study||7
279188|NCT00887562|674785|P3|STARTED|Overall Study||8
279189|NCT00887562|674786|P2|STARTED|Overall Study||9
279190|NCT00887562|674787|P1|STARTED|Overall Study||10
279191|NCT00887549|674801|P1|NOT COMPLETED|Maintenance Therapy||43
279192|NCT00887549|674801|P1|COMPLETED|Maintenance Therapy||0
279193|NCT00887549|674801|P1|STARTED|Maintenance Therapy||43
279194|NCT00887549|674801|P1|NOT COMPLETED|Induction Therapy||27
279195|NCT00887549|674801|P1|COMPLETED|Induction Therapy||43
279196|NCT00887549|674801|P1|STARTED|Induction Therapy||70
279197|NCT00887510|674810|P2|NOT COMPLETED|Overall Study||0
279198|NCT00887510|674811|P1|NOT COMPLETED|Overall Study||0
279199|NCT00887510|674810|P2|COMPLETED|Overall Study||12
279200|NCT00887510|674811|P1|COMPLETED|Overall Study||12
279201|NCT00887510|674810|P2|STARTED|Overall Study||12
279202|NCT00887510|674811|P1|STARTED|Overall Study||12
279203|NCT00887484|674819|P1|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||3
279204|NCT00887484|674819|P1|COMPLETED|Full Face Treatment (Weeks 5 and 8)||45
279205|NCT00887484|674819|P1|STARTED|Full Face Treatment (Weeks 5 and 8)||48
279206|NCT00887484|674819|P1|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
279207|NCT00887484|674819|P1|COMPLETED|Split Face Treatment (Weeks 1 and 2)||48
279208|NCT00887484|674819|P1|STARTED|Split Face Treatment (Weeks 1 and 2)||48
279209|NCT00887471|674885|P2|NOT COMPLETED|Overall Study||0
279210|NCT00887471|674886|P1|NOT COMPLETED|Overall Study||0
279211|NCT00887471|674885|P2|COMPLETED|Overall Study||15
279212|NCT00887471|674886|P1|COMPLETED|Overall Study||15
279213|NCT00887471|674885|P2|STARTED|Overall Study||15
279214|NCT00887471|674886|P1|STARTED|Overall Study||15
279215|NCT00887458|674896|P2|NOT COMPLETED|Overall Study||4
279216|NCT00887458|674897|P1|NOT COMPLETED|Overall Study||0
279217|NCT00887458|674896|P2|COMPLETED|Overall Study||25
279218|NCT00887458|674897|P1|COMPLETED|Overall Study||17
279219|NCT00887458|674896|P2|STARTED|Overall Study||29
279220|NCT00887458|674897|P1|STARTED|Overall Study||17
279221|NCT00887354|674907|P2|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||6
279222|NCT00887354|674908|P1|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||3
279223|NCT00887354|674907|P2|COMPLETED|Open Label Phase (Week 26 to Week 78)||59
279224|NCT00887354|674908|P1|COMPLETED|Open Label Phase (Week 26 to Week 78)||57
279225|NCT00887354|674907|P2|STARTED|Open Label Phase (Week 26 to Week 78)||65
279226|NCT00887354|674908|P1|STARTED|Open Label Phase (Week 26 to Week 78)||60
279227|NCT00887354|674907|P2|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||48
279228|NCT00887354|674908|P1|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||51
279229|NCT00887354|674907|P2|COMPLETED|Treatment Phase (Week 0 to Week 26)||65
279230|NCT00887354|674908|P1|COMPLETED|Treatment Phase (Week 0 to Week 26)||60
279231|NCT00887354|674907|P2|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||85
279232|NCT00887354|674908|P1|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||86
279233|NCT00887354|674907|P2|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||110
279234|NCT00887354|674908|P1|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||106
279235|NCT00887354|674907|P2|STARTED|Treatment Phase (Week 0 to Week 26)||113
279236|NCT00887354|674908|P1|STARTED|Treatment Phase (Week 0 to Week 26)||111
279237|NCT00887341|674928|P2|NOT COMPLETED|Overall Study||3
279238|NCT00887341|674929|P1|NOT COMPLETED|Overall Study||2
279239|NCT00887341|674928|P2|COMPLETED|Overall Study||36
279240|NCT00887341|674929|P1|COMPLETED|Overall Study||35
279241|NCT00887341|674928|P2|STARTED|Overall Study||39
279242|NCT00887341|674929|P1|STARTED|Overall Study||37
279243|NCT00887315|674965|P2|NOT COMPLETED|Overall Study||4
279244|NCT00887315|674966|P1|NOT COMPLETED|Overall Study||7
279245|NCT00887315|674965|P2|COMPLETED|Overall Study||0
279246|NCT00887315|674966|P1|COMPLETED|Overall Study||0
279247|NCT00887315|674965|P2|STARTED|Overall Study||4
279248|NCT00887315|674966|P1|STARTED|Overall Study||7
279249|NCT00887289|674974|P1|NOT COMPLETED|Overall Study||95
279250|NCT00887289|674974|P1|COMPLETED|Overall Study||1409
279251|NCT00887289|674974|P1|STARTED|Overall Study||1504
279252|NCT00887250|674986|P3|NOT COMPLETED|Overall Study||13
279253|NCT00887250|674987|P2|NOT COMPLETED|Overall Study||12
279254|NCT00887250|674988|P1|NOT COMPLETED|Overall Study||18
279255|NCT00887250|674986|P3|COMPLETED|Overall Study||110
279256|NCT00887250|674987|P2|COMPLETED|Overall Study||115
279257|NCT00887250|674988|P1|COMPLETED|Overall Study||98
279258|NCT00887250|674986|P3|STARTED|Overall Study||123
279259|NCT00887250|674987|P2|STARTED|Overall Study||127
279260|NCT00887250|674988|P1|STARTED|Overall Study||116
279261|NCT00887224|675011|P3|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||30
279262|NCT00887224|675012|P2|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||41
279263|NCT00887224|675013|P1|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||0
279264|NCT00887224|675011|P3|COMPLETED|DB Taper Phase / Post Study Follow Up||235
279265|NCT00887224|675012|P2|COMPLETED|DB Taper Phase / Post Study Follow Up||226
279266|NCT00887224|675013|P1|COMPLETED|DB Taper Phase / Post Study Follow Up||0
279267|NCT00887224|675011|P3|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||30
279268|NCT00887224|675012|P2|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up|DBp could have discontinued at anytime during DB taper period or Follow-up (7 days after last dose).|41
279269|NCT00887224|675013|P1|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||0
279270|NCT00887224|675011|P3|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||7
279271|NCT00887224|675012|P2|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||9
279272|NCT00887224|675013|P1|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||0
279273|NCT00887224|675011|P3|STARTED|DB Taper Phase / Post Study Follow Up||265
279274|NCT00887224|675012|P2|STARTED|DB Taper Phase / Post Study Follow Up|Double-blind participants (DBp) could have entered 7-day taper period at any time during DB phase.|267
279275|NCT00887224|675013|P1|STARTED|DB Taper Phase / Post Study Follow Up||0
279276|NCT00887224|675011|P3|NOT COMPLETED|Double-blind (DB) Phase||62
279277|NCT00887224|675012|P2|NOT COMPLETED|Double-blind (DB) Phase||100
279278|NCT00887224|675013|P1|NOT COMPLETED|Double-blind (DB) Phase||0
279279|NCT00887224|675011|P3|COMPLETED|Double-blind (DB) Phase||210
279280|NCT00887224|675012|P2|COMPLETED|Double-blind (DB) Phase||176
279281|NCT00887224|675013|P1|COMPLETED|Double-blind (DB) Phase||0
279282|NCT00887224|675011|P3|STARTED|Double-blind (DB) Phase||272
279283|NCT00887224|675012|P2|STARTED|Double-blind (DB) Phase|2 participants randomized in error to DB, then entered OL Taper; counted in OL Taper and DB phases.|276
279284|NCT00887224|675013|P1|STARTED|Double-blind (DB) Phase||0
279285|NCT00887224|675011|P3|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
279286|NCT00887224|675012|P2|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
279287|NCT00887224|675013|P1|NOT COMPLETED|OL Taper Phase / OL Follow Up||144
279288|NCT00887224|675011|P3|COMPLETED|OL Taper Phase / OL Follow Up||0
279289|NCT00887224|675012|P2|COMPLETED|OL Taper Phase / OL Follow Up||0
279290|NCT00887224|675013|P1|COMPLETED|OL Taper Phase / OL Follow Up||163
279291|NCT00887224|675011|P3|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
279292|NCT00887224|675012|P2|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
279293|NCT00887224|675013|P1|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up|Could have discontinued at any time during OL taper phase or OL Follow-up (7 days after last dose).|144
279294|NCT00887224|675011|P3|STARTED|OL Taper Phase / OL Follow Up||0
279295|NCT00887224|675012|P2|STARTED|OL Taper Phase / OL Follow Up||0
279296|NCT00887224|675013|P1|STARTED|OL Taper Phase / OL Follow Up|Could have entered 7-day taper period at any time during either the OLR phase or OLS phase.|307
279297|NCT00887224|675011|P3|NOT COMPLETED|Between OLS and DB Phases||0
279298|NCT00887224|675012|P2|NOT COMPLETED|Between OLS and DB Phases||0
279299|NCT00887224|675013|P1|NOT COMPLETED|Between OLS and DB Phases||28
279300|NCT00887224|675011|P3|COMPLETED|Between OLS and DB Phases||0
279301|NCT00887224|675012|P2|COMPLETED|Between OLS and DB Phases||0
279302|NCT00887224|675013|P1|COMPLETED|Between OLS and DB Phases||548
279303|NCT00887224|675011|P3|STARTED|Between OLS and DB Phases||0
279304|NCT00887224|675012|P2|STARTED|Between OLS and DB Phases||0
279305|NCT00887224|675013|P1|STARTED|Between OLS and DB Phases||576
279306|NCT00887224|675011|P3|NOT COMPLETED|Open-label Stability (OLS) Phase||0
279307|NCT00887224|675012|P2|NOT COMPLETED|Open-label Stability (OLS) Phase||0
279308|NCT00887224|675013|P1|NOT COMPLETED|Open-label Stability (OLS) Phase||83
279309|NCT00887224|675011|P3|COMPLETED|Open-label Stability (OLS) Phase||0
279310|NCT00887224|675012|P2|COMPLETED|Open-label Stability (OLS) Phase||0
279311|NCT00887224|675013|P1|COMPLETED|Open-label Stability (OLS) Phase||576
279312|NCT00887224|675011|P3|STARTED|Open-label Stability (OLS) Phase||0
279313|NCT00887224|675012|P2|STARTED|Open-label Stability (OLS) Phase||0
279314|NCT00887224|675013|P1|STARTED|Open-label Stability (OLS) Phase||659
279315|NCT00887224|675011|P3|NOT COMPLETED|Between OLR and OLS Phases||0
279316|NCT00887224|675012|P2|NOT COMPLETED|Between OLR and OLS Phases||0
279317|NCT00887224|675013|P1|NOT COMPLETED|Between OLR and OLS Phases||93
279318|NCT00887224|675011|P3|COMPLETED|Between OLR and OLS Phases||0
279319|NCT00887224|675012|P2|COMPLETED|Between OLR and OLS Phases||0
279320|NCT00887224|675013|P1|COMPLETED|Between OLR and OLS Phases||659
279321|NCT00887224|675011|P3|STARTED|Between OLR and OLS Phases||0
279322|NCT00887224|675012|P2|STARTED|Between OLR and OLS Phases||0
279323|NCT00887224|675013|P1|STARTED|Between OLR and OLS Phases||752
279324|NCT00887224|675011|P3|NOT COMPLETED|Open-label Response (OLR) Phase||0
279325|NCT00887224|675012|P2|NOT COMPLETED|Open-label Response (OLR) Phase||0
279326|NCT00887224|675013|P1|NOT COMPLETED|Open-label Response (OLR) Phase||122
279327|NCT00887224|675011|P3|COMPLETED|Open-label Response (OLR) Phase||0
279328|NCT00887224|675012|P2|COMPLETED|Open-label Response (OLR) Phase||0
279329|NCT00887224|675013|P1|COMPLETED|Open-label Response (OLR) Phase||752
279330|NCT00887224|675011|P3|STARTED|Open-label Response (OLR) Phase||0
279331|NCT00887224|675012|P2|STARTED|Open-label Response (OLR) Phase||0
279332|NCT00887224|675013|P1|STARTED|Open-label Response (OLR) Phase||874
279333|NCT00887198|675040|P3|NOT COMPLETED|Cross Over (Placebo to AA)||93
279334|NCT00887198|675041|P2|NOT COMPLETED|Cross Over (Placebo to AA)||0
279335|NCT00887198|675042|P1|NOT COMPLETED|Cross Over (Placebo to AA)||0
279336|NCT00887198|675040|P3|COMPLETED|Cross Over (Placebo to AA)||0
279337|NCT00887198|675041|P2|COMPLETED|Cross Over (Placebo to AA)||0
279338|NCT00887198|675042|P1|COMPLETED|Cross Over (Placebo to AA)||0
279339|NCT00887198|675040|P3|STARTED|Cross Over (Placebo to AA)|93= 51 participants(crossed over under amendment 3)+42 participants (crossed over under amendment 4)|93
279340|NCT00887198|675041|P2|STARTED|Cross Over (Placebo to AA)||0
279341|NCT00887198|675042|P1|STARTED|Cross Over (Placebo to AA)||0
279342|NCT00887198|675040|P3|NOT COMPLETED|Randomized Period||0
279343|NCT00887198|675041|P2|NOT COMPLETED|Randomized Period||542
279344|NCT00887198|675042|P1|NOT COMPLETED|Randomized Period||546
279345|NCT00887198|675040|P3|COMPLETED|Randomized Period||0
279346|NCT00887198|675041|P2|COMPLETED|Randomized Period||0
279347|NCT00887198|675042|P1|COMPLETED|Randomized Period||0
279348|NCT00887198|675040|P3|Treated|Randomized Period||0
279349|NCT00887198|675041|P2|Treated|Randomized Period||540
279350|NCT00887198|675042|P1|Treated|Randomized Period||542
279351|NCT00887198|675040|P3|STARTED|Randomized Period||0
279352|NCT00887198|675041|P2|STARTED|Randomized Period||542
279353|NCT00887198|675042|P1|STARTED|Randomized Period||546
279354|NCT00887159|675073|P3|NOT COMPLETED|Overall Study||56
279355|NCT00887159|675074|P2|NOT COMPLETED|Overall Study||56
279356|NCT00887159|675075|P1|NOT COMPLETED|Overall Study||29
279357|NCT00887159|675073|P3|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
279358|NCT00887159|675074|P2|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
279359|NCT00887159|675075|P1|COMPLETED|Overall Study||27
279360|NCT00887159|675073|P3|Eligible/Treated Pts With CTCs Results|Overall Study||38
279361|NCT00887159|675074|P2|Eligible/Treated Pts With CTCs Results|Overall Study||42
279362|NCT00887159|675075|P1|Eligible/Treated Pts With CTCs Results|Overall Study||40
279363|NCT00887159|675073|P3|Eligible and Treated Patients|Overall Study||52
279364|NCT00887159|675074|P2|Eligible and Treated Patients|Overall Study||52
279365|NCT00887159|675075|P1|Eligible and Treated Patients|Overall Study||48
279366|NCT00887159|675073|P3|Patients Who Started Assigned Treatment|Overall Study||52
279367|NCT00887159|675074|P2|Patients Who Started Assigned Treatment|Overall Study||53
279368|NCT00887159|675075|P1|Patients Who Started Assigned Treatment|Overall Study||53
279369|NCT00887159|675073|P3|STARTED|Overall Study||56
279370|NCT00887159|675074|P2|STARTED|Overall Study||56
279371|NCT00887159|675075|P1|STARTED|Overall Study||56
279372|NCT00886938|675091|P1|NOT COMPLETED|Overall Study||2
279373|NCT00886938|675091|P1|COMPLETED|Overall Study||10
279374|NCT00886938|675091|P1|STARTED|Overall Study||12
279375|NCT00886899|675095|P1|NOT COMPLETED|Overall Study||0
279376|NCT00886899|675095|P1|COMPLETED|Overall Study||147
279377|NCT00886899|675095|P1|STARTED|Overall Study||147
279378|NCT00886834|675104|P2|NOT COMPLETED|Overall Study||3
279379|NCT00886834|675105|P1|NOT COMPLETED|Overall Study||0
279380|NCT00886834|675104|P2|COMPLETED|Overall Study||51
279381|NCT00886834|675105|P1|COMPLETED|Overall Study||54
279382|NCT00886834|675104|P2|STARTED|Overall Study||54
279383|NCT00886834|675105|P1|STARTED|Overall Study||54
279384|NCT00886821|675127|P14|NOT COMPLETED|Stage 2||1
279385|NCT00886821|675128|P13|NOT COMPLETED|Stage 2||5
279386|NCT00886821|675129|P12|NOT COMPLETED|Stage 2||1
279387|NCT00886821|675130|P11|NOT COMPLETED|Stage 2||0
279388|NCT00886821|675131|P10|NOT COMPLETED|Stage 2||0
279389|NCT00886821|675132|P9|NOT COMPLETED|Stage 2||0
279390|NCT00886821|675133|P8|NOT COMPLETED|Stage 2||0
279391|NCT00886821|675134|P7|NOT COMPLETED|Stage 2||0
279392|NCT00886821|675135|P6|NOT COMPLETED|Stage 2||0
279393|NCT00886821|675136|P5|NOT COMPLETED|Stage 2||0
279394|NCT00886821|675137|P4|NOT COMPLETED|Stage 2||0
279395|NCT00886821|675138|P3|NOT COMPLETED|Stage 2||0
279396|NCT00886821|675139|P2|NOT COMPLETED|Stage 2||0
279397|NCT00886821|675140|P1|NOT COMPLETED|Stage 2||0
279398|NCT00886821|675127|P14|COMPLETED|Stage 2||8
279399|NCT00886821|675128|P13|COMPLETED|Stage 2||8
279400|NCT00886821|675129|P12|COMPLETED|Stage 2||8
279401|NCT00886821|675130|P11|COMPLETED|Stage 2||9
279402|NCT00886821|675131|P10|COMPLETED|Stage 2||0
279403|NCT00886821|675132|P9|COMPLETED|Stage 2||0
279404|NCT00886821|675133|P8|COMPLETED|Stage 2||0
279405|NCT00886821|675134|P7|COMPLETED|Stage 2||0
279406|NCT00886821|675135|P6|COMPLETED|Stage 2||0
279407|NCT00886821|675136|P5|COMPLETED|Stage 2||0
279408|NCT00886821|675137|P4|COMPLETED|Stage 2||0
279409|NCT00886821|675138|P3|COMPLETED|Stage 2||0
279410|NCT00886821|675139|P2|COMPLETED|Stage 2||0
279411|NCT00886821|675140|P1|COMPLETED|Stage 2||0
279412|NCT00886821|675127|P14|STARTED|Stage 2||9
279413|NCT00886821|675128|P13|STARTED|Stage 2||13
279414|NCT00886821|675129|P12|STARTED|Stage 2||9
279415|NCT00886821|675130|P11|STARTED|Stage 2||9
279416|NCT00886821|675131|P10|STARTED|Stage 2||0
279417|NCT00886821|675132|P9|STARTED|Stage 2||0
279418|NCT00886821|675133|P8|STARTED|Stage 2||0
279419|NCT00886821|675134|P7|STARTED|Stage 2||0
279420|NCT00886821|675135|P6|STARTED|Stage 2||0
279421|NCT00886821|675136|P5|STARTED|Stage 2||0
279422|NCT00886821|675137|P4|STARTED|Stage 2||0
279423|NCT00886821|675138|P3|STARTED|Stage 2||0
279424|NCT00886821|675139|P2|STARTED|Stage 2||0
279425|NCT00886821|675140|P1|STARTED|Stage 2||0
279426|NCT00886821|675127|P14|NOT COMPLETED|Stage 1||0
279427|NCT00886821|675128|P13|NOT COMPLETED|Stage 1||0
279428|NCT00886821|675129|P12|NOT COMPLETED|Stage 1||0
279429|NCT00886821|675130|P11|NOT COMPLETED|Stage 1||0
279430|NCT00886821|675131|P10|NOT COMPLETED|Stage 1||0
279431|NCT00886821|675132|P9|NOT COMPLETED|Stage 1||0
279432|NCT00886821|675133|P8|NOT COMPLETED|Stage 1||0
279433|NCT00886821|675134|P7|NOT COMPLETED|Stage 1||0
279434|NCT00886821|675135|P6|NOT COMPLETED|Stage 1||0
279435|NCT00886821|675136|P5|NOT COMPLETED|Stage 1||0
279436|NCT00886821|675137|P4|NOT COMPLETED|Stage 1||0
279437|NCT00886821|675138|P3|NOT COMPLETED|Stage 1||0
279438|NCT00886821|675139|P2|NOT COMPLETED|Stage 1||0
279439|NCT00886821|675140|P1|NOT COMPLETED|Stage 1||0
279440|NCT00886821|675127|P14|COMPLETED|Stage 1||0
279441|NCT00886821|675128|P13|COMPLETED|Stage 1||0
279442|NCT00886821|675129|P12|COMPLETED|Stage 1||0
279443|NCT00886821|675130|P11|COMPLETED|Stage 1||0
279444|NCT00886821|675131|P10|COMPLETED|Stage 1||18
279445|NCT00886821|675132|P9|COMPLETED|Stage 1||6
279446|NCT00886821|675133|P8|COMPLETED|Stage 1||6
279447|NCT00886821|675134|P7|COMPLETED|Stage 1||6
279448|NCT00886821|675135|P6|COMPLETED|Stage 1||6
279449|NCT00886821|675136|P5|COMPLETED|Stage 1||6
279450|NCT00886821|675137|P4|COMPLETED|Stage 1||7
279451|NCT00886821|675138|P3|COMPLETED|Stage 1||6
279452|NCT00886821|675139|P2|COMPLETED|Stage 1||6
279453|NCT00886821|675140|P1|COMPLETED|Stage 1||7
279454|NCT00886821|675127|P14|STARTED|Stage 1||0
279455|NCT00886821|675128|P13|STARTED|Stage 1||0
279456|NCT00886821|675129|P12|STARTED|Stage 1||0
279457|NCT00886821|675130|P11|STARTED|Stage 1||0
279458|NCT00886821|675131|P10|STARTED|Stage 1||18
279459|NCT00886821|675132|P9|STARTED|Stage 1||6
279460|NCT00886821|675133|P8|STARTED|Stage 1||6
279461|NCT00886821|675134|P7|STARTED|Stage 1||6
279462|NCT00886821|675135|P6|STARTED|Stage 1||6
279463|NCT00886821|675136|P5|STARTED|Stage 1||6
279464|NCT00886821|675137|P4|STARTED|Stage 1||7
279465|NCT00886821|675138|P3|STARTED|Stage 1||6
279466|NCT00886821|675139|P2|STARTED|Stage 1||6
279467|NCT00886821|675140|P1|STARTED|Stage 1||7
279468|NCT00886795|675365|P1|NOT COMPLETED|Overall Study||1
279469|NCT00886795|675365|P1|COMPLETED|Overall Study||3
279470|NCT00886795|675365|P1|STARTED|Overall Study||4
279471|NCT00886769|675372|P2|NOT COMPLETED|Overall Study||37
279472|NCT00886769|675373|P1|NOT COMPLETED|Overall Study||6
279473|NCT00886769|675372|P2|COMPLETED|Overall Study||4
279474|NCT00886769|675373|P1|COMPLETED|Overall Study||37
279475|NCT00886769|675372|P2|STARTED|Overall Study||41
279476|NCT00886769|675373|P1|STARTED|Overall Study||43
279477|NCT00886743|675397|P1|NOT COMPLETED|Overall Study||4
279478|NCT00886743|675397|P1|COMPLETED|Overall Study||15
279479|NCT00886743|675397|P1|STARTED|Overall Study|Received treatment|19
279480|NCT00886704|675407|P2|NOT COMPLETED|Overall Study||0
279481|NCT00886704|675408|P1|NOT COMPLETED|Overall Study||0
279482|NCT00886704|675407|P2|COMPLETED|Overall Study||10
279483|NCT00886704|675408|P1|COMPLETED|Overall Study||40
279484|NCT00886704|675407|P2|STARTED|Overall Study||10
279485|NCT00886704|675408|P1|STARTED|Overall Study||40
279486|NCT00886691|675418|P2|NOT COMPLETED|Overall Study||0
279487|NCT00886691|675419|P1|NOT COMPLETED|Overall Study||0
279488|NCT00886691|675418|P2|COMPLETED|Overall Study||75
279489|NCT00886691|675419|P1|COMPLETED|Overall Study||75
279490|NCT00886691|675418|P2|STARTED|Overall Study||75
279491|NCT00886691|675419|P1|STARTED|Overall Study||75
279492|NCT00886639|675435|P1|NOT COMPLETED|Overall Study||16
279493|NCT00886639|675435|P1|COMPLETED|Overall Study||111
279494|NCT00886639|675435|P1|STARTED|Overall Study||127
279495|NCT00886626|675439|P2|NOT COMPLETED|Period 2 (90 Days)||0
279496|NCT00886626|675440|P1|NOT COMPLETED|Period 2 (90 Days)||0
279497|NCT00886626|675439|P2|COMPLETED|Period 2 (90 Days)||6
279498|NCT00886626|675440|P1|COMPLETED|Period 2 (90 Days)||5
279499|NCT00886626|675439|P2|STARTED|Period 2 (90 Days)||6
279500|NCT00886626|675440|P1|STARTED|Period 2 (90 Days)||5
279501|NCT00886626|675439|P2|NOT COMPLETED|Period 1 (90 Days)||0
279502|NCT00886626|675440|P1|NOT COMPLETED|Period 1 (90 Days)||1
279503|NCT00886626|675439|P2|COMPLETED|Period 1 (90 Days)||6
279504|NCT00886626|675440|P1|COMPLETED|Period 1 (90 Days)||5
279505|NCT00886626|675439|P2|STARTED|Period 1 (90 Days)||6
279506|NCT00886626|675440|P1|STARTED|Period 1 (90 Days)||6
279507|NCT00886613|675449|P3|NOT COMPLETED|Overall Study||3
279508|NCT00886613|675450|P2|NOT COMPLETED|Overall Study||0
279509|NCT00886613|675451|P1|NOT COMPLETED|Overall Study||2
279510|NCT00886613|675449|P3|COMPLETED|Overall Study||37
279511|NCT00886613|675450|P2|COMPLETED|Overall Study||39
279512|NCT00886613|675451|P1|COMPLETED|Overall Study||39
279513|NCT00886613|675449|P3|STARTED|Overall Study||40
279514|NCT00886613|675450|P2|STARTED|Overall Study||39
279515|NCT00886613|675451|P1|STARTED|Overall Study||41
279516|NCT00886600|675473|P4|NOT COMPLETED|Combination Therapy Period||0
279517|NCT00886600|675474|P3|NOT COMPLETED|Combination Therapy Period||2
279518|NCT00886600|675475|P2|NOT COMPLETED|Combination Therapy Period||0
279519|NCT00886600|675476|P1|NOT COMPLETED|Combination Therapy Period||0
279520|NCT00886600|675473|P4|COMPLETED|Combination Therapy Period||23
279521|NCT00886600|675474|P3|COMPLETED|Combination Therapy Period||19
279522|NCT00886600|675475|P2|COMPLETED|Combination Therapy Period||21
279523|NCT00886600|675476|P1|COMPLETED|Combination Therapy Period||28
279524|NCT00886600|675473|P4|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 5-(SiDBP <85); 1-(SiDBP ≥85)|23
279525|NCT00886600|675474|P3|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 7-(SiDBP <85); 1-(SiDBP ≥85)|21
279526|NCT00886600|675475|P2|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 4-(SiDBP <85); 3-(SiDBP ≥85)|21
279527|NCT00886600|675476|P1|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 2-(Sitting Diastolic Blood Pressure (SiDBP) <85)|28
279528|NCT00886600|675473|P4|NOT COMPLETED|Double-blind Monotherapy||2
279529|NCT00886600|675474|P3|NOT COMPLETED|Double-blind Monotherapy||1
279530|NCT00886600|675475|P2|NOT COMPLETED|Double-blind Monotherapy||1
279531|NCT00886600|675476|P1|NOT COMPLETED|Double-blind Monotherapy||2
279532|NCT00886600|675473|P4|COMPLETED|Double-blind Monotherapy||29
279533|NCT00886600|675474|P3|COMPLETED|Double-blind Monotherapy||29
279534|NCT00886600|675475|P2|COMPLETED|Double-blind Monotherapy|1 pt discontinued after Wk 4 due to AE starting in placebo baseline and continuing into double-blind|28
279535|NCT00886600|675476|P1|COMPLETED|Double-blind Monotherapy||30
279536|NCT00886600|675473|P4|STARTED|Double-blind Monotherapy||31
279537|NCT00886600|675474|P3|STARTED|Double-blind Monotherapy||30
279538|NCT00886600|675475|P2|STARTED|Double-blind Monotherapy||29
279539|NCT00886600|675476|P1|STARTED|Double-blind Monotherapy||32
279540|NCT00886587|675500|P2|NOT COMPLETED|Overall Study||2
279541|NCT00886587|675501|P1|NOT COMPLETED|Overall Study||4
279542|NCT00886587|675500|P2|COMPLETED|Overall Study||39
279543|NCT00886587|675501|P1|COMPLETED|Overall Study||37
279544|NCT00886587|675500|P2|STARTED|Overall Study||41
279545|NCT00886587|675501|P1|STARTED|Overall Study||41
279546|NCT00886483|675515|P2|NOT COMPLETED|Overall Study||3
279547|NCT00886483|675516|P1|NOT COMPLETED|Overall Study||2
279548|NCT00886483|675515|P2|COMPLETED|Overall Study||10
279549|NCT00886483|675516|P1|COMPLETED|Overall Study||24
279550|NCT00886483|675515|P2|Completed 20 Treatments|Overall Study||11
279551|NCT00886483|675516|P1|Completed 20 Treatments|Overall Study||25
279552|NCT00886483|675515|P2|STARTED|Overall Study||13
279553|NCT00886483|675516|P1|STARTED|Overall Study||26
279554|NCT00886340|675534|P2|NOT COMPLETED|Overall Study||7
279555|NCT00886340|675535|P1|NOT COMPLETED|Overall Study||0
279556|NCT00886340|675534|P2|COMPLETED|Overall Study||24
279557|NCT00886340|675535|P1|COMPLETED|Overall Study||27
279558|NCT00886340|675534|P2|STARTED|Overall Study||31
279559|NCT00886340|675535|P1|STARTED|Overall Study||27
279560|NCT00886288|675543|P2|NOT COMPLETED|Overall Study||227
279561|NCT00886288|675544|P1|NOT COMPLETED|Overall Study||743
279562|NCT00886288|675543|P2|COMPLETED|Overall Study||457
279563|NCT00886288|675544|P1|COMPLETED|Overall Study||1284
279564|NCT00886288|675543|P2|STARTED|Overall Study|Baseline Population|684
279565|NCT00886288|675544|P1|STARTED|Overall Study|Baseline Population|2027
279566|NCT00886262|675562|P2|NOT COMPLETED|Overall Study||3
279567|NCT00886262|675563|P1|NOT COMPLETED|Overall Study||0
279568|NCT00886262|675562|P2|COMPLETED|Overall Study||7
279569|NCT00886262|675563|P1|COMPLETED|Overall Study||8
279570|NCT00886262|675562|P2|STARTED|Overall Study||10
279571|NCT00886262|675563|P1|STARTED|Overall Study||8
279572|NCT00886236|675578|P3|NOT COMPLETED|Overall Study||4
279573|NCT00886236|675579|P2|NOT COMPLETED|Overall Study||4
279574|NCT00886236|675580|P1|NOT COMPLETED|Overall Study||2
279575|NCT00886236|675578|P3|COMPLETED|Overall Study||17
279576|NCT00886236|675579|P2|COMPLETED|Overall Study||17
279577|NCT00886236|675580|P1|COMPLETED|Overall Study||18
279578|NCT00886236|675578|P3|STARTED|Overall Study||21
279579|NCT00886236|675579|P2|STARTED|Overall Study||21
279580|NCT00886236|675580|P1|STARTED|Overall Study||20
279581|NCT00886145|675594|P1|NOT COMPLETED|Overall Study||0
279582|NCT00886145|675594|P1|COMPLETED|Overall Study||1
279583|NCT00886145|675594|P1|STARTED|Overall Study||1
279584|NCT00886119|675600|P2|NOT COMPLETED|Period 2||0
279585|NCT00886119|675601|P1|NOT COMPLETED|Period 2||0
279586|NCT00886119|675600|P2|COMPLETED|Period 2||22
279587|NCT00886119|675601|P1|COMPLETED|Period 2||23
279588|NCT00886119|675600|P2|STARTED|Period 2||22
279589|NCT00886119|675601|P1|STARTED|Period 2||23
279590|NCT00886119|675600|P2|NOT COMPLETED|Period 1||0
279591|NCT00886119|675601|P1|NOT COMPLETED|Period 1||1
279592|NCT00886119|675600|P2|COMPLETED|Period 1||22
279593|NCT00886119|675601|P1|COMPLETED|Period 1||23
279594|NCT00886119|675600|P2|STARTED|Period 1||22
279595|NCT00886119|675601|P1|STARTED|Period 1||24
279596|NCT00886015|675609|P2|NOT COMPLETED|Overall Study||2
279597|NCT00886015|675610|P1|NOT COMPLETED|Overall Study||0
279598|NCT00886015|675609|P2|COMPLETED|Overall Study|1669 eyes; 956 participants|1669
279599|NCT00886015|675610|P1|COMPLETED|Overall Study|1674 eyes; 960 participants|1674
279600|NCT00886015|675609|P2|STARTED|Overall Study|1671 eyes; 957 participants|1671
279601|NCT00886015|675610|P1|STARTED|Overall Study|1674 eyes; 960 participants|1674
279602|NCT00885846|675629|P3|NOT COMPLETED|Overall Study||2
279603|NCT00885846|675630|P2|NOT COMPLETED|Overall Study||5
279604|NCT00885846|675631|P1|NOT COMPLETED|Overall Study||2
279605|NCT00885846|675629|P3|COMPLETED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|8
279606|NCT00885846|675630|P2|COMPLETED|Overall Study|Cohort 1 = 1 Cohort 2 = 5|6
279607|NCT00885846|675631|P1|COMPLETED|Overall Study|Cohort 1 = 3 Cohort 2 = 6|9
279608|NCT00885846|675629|P3|STARTED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|10
279609|NCT00885846|675630|P2|STARTED|Overall Study|Cohort 1 = 6 Cohort 2 = 5|11
279610|NCT00885846|675631|P1|STARTED|Overall Study|Cohort 1 = 5 Cohort 2 = 6|11
279611|NCT00885768|675639|P1|NOT COMPLETED|Overall Study||0
279612|NCT00885768|675639|P1|COMPLETED|Overall Study|all patients with including criteria completed the study|146
279613|NCT00885768|675639|P1|STARTED|Overall Study|all patients with coronary artery stenosis on angiography entered the study|146
279614|NCT00885755|675646|P3|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
279615|NCT00885755|675647|P2|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
279616|NCT00885755|675648|P1|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||5
279617|NCT00885755|675646|P3|COMPLETED|Part II: Trastuzumab + Capecitabine.||0
279618|NCT00885755|675647|P2|COMPLETED|Part II: Trastuzumab + Capecitabine.||1
279619|NCT00885755|675648|P1|COMPLETED|Part II: Trastuzumab + Capecitabine.||8
279620|NCT00885755|675646|P3|STARTED|Part II: Trastuzumab + Capecitabine.||0
279621|NCT00885755|675647|P2|STARTED|Part II: Trastuzumab + Capecitabine.||1
279622|NCT00885755|675648|P1|STARTED|Part II: Trastuzumab + Capecitabine.||13
279623|NCT00885755|675646|P3|NOT COMPLETED|Part I: Trastuzumab+Taxane||1
279624|NCT00885755|675647|P2|NOT COMPLETED|Part I: Trastuzumab+Taxane||0
279625|NCT00885755|675648|P1|NOT COMPLETED|Part I: Trastuzumab+Taxane||18
279626|NCT00885755|675646|P3|COMPLETED|Part I: Trastuzumab+Taxane||0
279627|NCT00885755|675647|P2|COMPLETED|Part I: Trastuzumab+Taxane||1
279628|NCT00885755|675648|P1|COMPLETED|Part I: Trastuzumab+Taxane||13
279629|NCT00885755|675646|P3|STARTED|Part I: Trastuzumab+Taxane||1
279630|NCT00885755|675647|P2|STARTED|Part I: Trastuzumab+Taxane||1
279631|NCT00885755|675648|P1|STARTED|Part I: Trastuzumab+Taxane||31
279632|NCT00885742|675673|P1|NOT COMPLETED|Overall Study||0
279633|NCT00885742|675673|P1|COMPLETED|Overall Study||41
279634|NCT00885742|675673|P1|STARTED|Overall Study||41
279635|NCT00885703|675691|P7|NOT COMPLETED|Overall Study||6
279636|NCT00885703|675692|P6|NOT COMPLETED|Overall Study||13
279637|NCT00885703|675693|P5|NOT COMPLETED|Overall Study||12
279638|NCT00885703|675694|P4|NOT COMPLETED|Overall Study||9
279639|NCT00885703|675695|P3|NOT COMPLETED|Overall Study||11
279640|NCT00885703|675696|P2|NOT COMPLETED|Overall Study||10
279641|NCT00885703|675697|P1|NOT COMPLETED|Overall Study||10
279642|NCT00885703|675691|P7|COMPLETED|Overall Study||18
279643|NCT00885703|675692|P6|COMPLETED|Overall Study||11
279644|NCT00885703|675693|P5|COMPLETED|Overall Study||12
279645|NCT00885703|675694|P4|COMPLETED|Overall Study||15
279646|NCT00885703|675695|P3|COMPLETED|Overall Study||13
279647|NCT00885703|675696|P2|COMPLETED|Overall Study||16
279648|NCT00885703|675697|P1|COMPLETED|Overall Study||12
279649|NCT00885703|675691|P7|STARTED|Overall Study||24
279650|NCT00885703|675692|P6|STARTED|Overall Study||24
279651|NCT00885703|675693|P5|STARTED|Overall Study||24
279652|NCT00885703|675694|P4|STARTED|Overall Study||24
279653|NCT00885703|675695|P3|STARTED|Overall Study||24
279654|NCT00885703|675696|P2|STARTED|Overall Study||26
279655|NCT00885703|675697|P1|STARTED|Overall Study||22
279656|NCT00885677|675755|P2|NOT COMPLETED|Overall Study||178
279657|NCT00885677|675756|P1|NOT COMPLETED|Overall Study||183
279658|NCT00885677|675755|P2|COMPLETED|Overall Study||277
279659|NCT00885677|675756|P1|COMPLETED|Overall Study||279
279660|NCT00885677|675755|P2|Intention To Treat|Overall Study||428
279661|NCT00885677|675756|P1|Intention To Treat|Overall Study||437
279662|NCT00885677|675755|P2|STARTED|Overall Study||455
279663|NCT00885677|675756|P1|STARTED|Overall Study||462
279664|NCT00885638|675764|P2|NOT COMPLETED|Overall Study||0
279665|NCT00885638|675765|P1|NOT COMPLETED|Overall Study||0
279666|NCT00885638|675764|P2|COMPLETED|Overall Study||6
279667|NCT00885638|675765|P1|COMPLETED|Overall Study||6
279668|NCT00885638|675764|P2|STARTED|Overall Study||6
279669|NCT00885638|675765|P1|STARTED|Overall Study||6
279670|NCT00885534|675772|P1|NOT COMPLETED|Overall Study||1
279671|NCT00885534|675772|P1|COMPLETED|Overall Study||6
279672|NCT00885534|675772|P1|STARTED|Overall Study||7
279673|NCT00885482|675776|P1|NOT COMPLETED|Overall Study||4
279674|NCT00885482|675776|P1|COMPLETED|Overall Study||36
279675|NCT00885482|675776|P1|STARTED|Overall Study||40
279676|NCT00885378|675782|P2|NOT COMPLETED|Overall Study||8
279677|NCT00885378|675783|P1|NOT COMPLETED|Overall Study||8
279678|NCT00885378|675782|P2|COMPLETED|Overall Study||78
279679|NCT00885378|675783|P1|COMPLETED|Overall Study||66
279680|NCT00885378|675782|P2|STARTED|Overall Study|Number randomized.|86
279681|NCT00885378|675783|P1|STARTED|Overall Study|Number randomized.|74
279682|NCT00885365|675813|P2|NOT COMPLETED|4 Weeks OFF Treatment||0
279683|NCT00885365|675814|P1|NOT COMPLETED|4 Weeks OFF Treatment||0
279684|NCT00885365|675813|P2|COMPLETED|4 Weeks OFF Treatment||159
279685|NCT00885365|675814|P1|COMPLETED|4 Weeks OFF Treatment||155
279686|NCT00885365|675813|P2|STARTED|4 Weeks OFF Treatment||159
279687|NCT00885365|675814|P1|STARTED|4 Weeks OFF Treatment||155
279688|NCT00885365|675813|P2|NOT COMPLETED|4 Weeks ON Treatment||6
279689|NCT00885365|675814|P1|NOT COMPLETED|4 Weeks ON Treatment||4
279690|NCT00885365|675813|P2|COMPLETED|4 Weeks ON Treatment||159
279691|NCT00885365|675814|P1|COMPLETED|4 Weeks ON Treatment||155
279692|NCT00885365|675813|P2|Safety Population|4 Weeks ON Treatment|Six participants randomized to TOBI were administered Bramitob|168
279693|NCT00885365|675814|P1|Safety Population|4 Weeks ON Treatment|Nine participants randomized to Bramitob were administered TOBI.|156
279694|NCT00885365|675813|P2|Intent-to-Treat Population|4 Weeks ON Treatment||163
279695|NCT00885365|675814|P1|Intent-to-Treat Population|4 Weeks ON Treatment|Participants who took 1 dose of study medication and had baseline and at least 1 post-treatment FEV1|158
279696|NCT00885365|675813|P2|STARTED|4 Weeks ON Treatment||165
279697|NCT00885365|675814|P1|STARTED|4 Weeks ON Treatment||159
279698|NCT00885352|675850|P2|NOT COMPLETED|Overall Study||20
279699|NCT00885352|675851|P1|NOT COMPLETED|Overall Study||8
279700|NCT00885352|675850|P2|COMPLETED|Overall Study||136
279701|NCT00885352|675851|P1|COMPLETED|Overall Study||149
279702|NCT00885352|675850|P2|STARTED|Overall Study||156
279703|NCT00885352|675851|P1|STARTED|Overall Study||157
279704|NCT00885170|675863|P2|NOT COMPLETED|Overall Study||23
279705|NCT00885170|675864|P1|NOT COMPLETED|Overall Study||38
279706|NCT00885170|675863|P2|COMPLETED|Overall Study||99
279707|NCT00885170|675864|P1|COMPLETED|Overall Study||86
279708|NCT00885170|675863|P2|Treated|Overall Study||121
279709|NCT00885170|675864|P1|Treated|Overall Study||122
279710|NCT00885170|675863|P2|STARTED|Overall Study||122
279711|NCT00885170|675864|P1|STARTED|Overall Study||124
279712|NCT00885118|675923|P5|NOT COMPLETED|Overall Study||1
279713|NCT00885118|675924|P4|NOT COMPLETED|Overall Study||0
279714|NCT00885118|675925|P3|NOT COMPLETED|Overall Study||1
279715|NCT00885118|675926|P2|NOT COMPLETED|Overall Study||0
279716|NCT00885118|675927|P1|NOT COMPLETED|Overall Study||1
279717|NCT00885118|675923|P5|COMPLETED|Overall Study||18
279718|NCT00885118|675924|P4|COMPLETED|Overall Study||20
279719|NCT00885118|675925|P3|COMPLETED|Overall Study||20
279720|NCT00885118|675926|P2|COMPLETED|Overall Study||19
279721|NCT00885118|675927|P1|COMPLETED|Overall Study||20
279722|NCT00885118|675923|P5|STARTED|Overall Study||19
279723|NCT00885118|675924|P4|STARTED|Overall Study||20
279724|NCT00885118|675925|P3|STARTED|Overall Study||21
279725|NCT00885118|675926|P2|STARTED|Overall Study||19
279726|NCT00885118|675927|P1|STARTED|Overall Study||21
279727|NCT00885105|676066|P2|NOT COMPLETED|Overall Study||10
279728|NCT00885105|676067|P1|NOT COMPLETED|Overall Study||1
279729|NCT00885105|676066|P2|COMPLETED|Overall Study||120
279730|NCT00885105|676067|P1|COMPLETED|Overall Study||111
279731|NCT00885105|676066|P2|STARTED|Overall Study||130
279732|NCT00885105|676067|P1|STARTED|Overall Study||112
279733|NCT00885092|676085|P2|NOT COMPLETED|Period 2, 7 Days||0
279734|NCT00885092|676086|P1|NOT COMPLETED|Period 2, 7 Days||0
279735|NCT00885092|676085|P2|COMPLETED|Period 2, 7 Days||20
279736|NCT00885092|676086|P1|COMPLETED|Period 2, 7 Days||20
279737|NCT00885092|676085|P2|STARTED|Period 2, 7 Days||20
279738|NCT00885092|676086|P1|STARTED|Period 2, 7 Days||20
279739|NCT00885092|676085|P2|NOT COMPLETED|Period 1, 7 Days||0
279740|NCT00885092|676086|P1|NOT COMPLETED|Period 1, 7 Days||0
279741|NCT00885092|676085|P2|COMPLETED|Period 1, 7 Days||20
279742|NCT00885092|676086|P1|COMPLETED|Period 1, 7 Days||20
279743|NCT00885092|676085|P2|STARTED|Period 1, 7 Days||20
279744|NCT00885092|676086|P1|STARTED|Period 1, 7 Days||20
279745|NCT00885079|676098|P2|NOT COMPLETED|Overall Study||4
279746|NCT00885079|676099|P1|NOT COMPLETED|Overall Study||2
279747|NCT00885079|676098|P2|COMPLETED|Overall Study||91
279748|NCT00885079|676099|P1|COMPLETED|Overall Study||91
279749|NCT00885079|676098|P2|STARTED|Overall Study||95
279750|NCT00885079|676099|P1|STARTED|Overall Study||93
279751|NCT00884949|676107|P1|NOT COMPLETED|Continuation Period||0
279752|NCT00884949|676107|P1|COMPLETED|Continuation Period||18
279753|NCT00884949|676107|P1|STARTED|Continuation Period||18
279754|NCT00884949|676107|P1|NOT COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||0
279755|NCT00884949|676107|P1|COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||18
279756|NCT00884949|676107|P1|STARTED|Weeks 25-36: 2.0 mg/kg/Week||18
279757|NCT00884949|676107|P1|NOT COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||0
279758|NCT00884949|676107|P1|COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||18
279759|NCT00884949|676107|P1|STARTED|Weeks 13-24: 1.0 mg/kg/Week||18
279760|NCT00884949|676107|P1|NOT COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||2
279761|NCT00884949|676107|P1|COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||18
279762|NCT00884949|676107|P1|STARTED|Weeks 1-12: 0.1 mg/kg/Week||20
279763|NCT00884910|676124|P1|NOT COMPLETED|Overall Study||1
279764|NCT00884910|676124|P1|COMPLETED|Overall Study|patient diagnosed with primary pulmonary tumor during study|32
279765|NCT00884910|676124|P1|STARTED|Overall Study||33
279766|NCT00884897|676131|P2|NOT COMPLETED|Overall Study||0
279767|NCT00884897|676132|P1|NOT COMPLETED|Overall Study||0
279768|NCT00884897|676131|P2|COMPLETED|Overall Study||15
279769|NCT00884897|676132|P1|COMPLETED|Overall Study||13
279770|NCT00884897|676131|P2|STARTED|Overall Study||15
279771|NCT00884897|676132|P1|STARTED|Overall Study||13
279772|NCT00884832|676142|P2|NOT COMPLETED|Overall Study||1
279773|NCT00884832|676143|P1|NOT COMPLETED|Overall Study||0
279774|NCT00884832|676142|P2|COMPLETED|Overall Study||21
279775|NCT00884832|676143|P1|COMPLETED|Overall Study||22
279776|NCT00884832|676142|P2|STARTED|Overall Study||22
279777|NCT00884832|676143|P1|STARTED|Overall Study||22
279778|NCT00884806|676173|P1|NOT COMPLETED|Overall Study||0
279779|NCT00884806|676173|P1|COMPLETED|Overall Study||110
279780|NCT00884806|676173|P1|STARTED|Overall Study||110
279781|NCT00884793|676178|P1|NOT COMPLETED|Overall Study||1
279782|NCT00884793|676178|P1|COMPLETED|Overall Study||7
279783|NCT00884793|676178|P1|STARTED|Overall Study||8
279784|NCT00884754|676187|P2|NOT COMPLETED|Overall Study||0
279785|NCT00884754|676188|P1|NOT COMPLETED|Overall Study||0
279786|NCT00884754|676187|P2|COMPLETED|Overall Study||30
279787|NCT00884754|676188|P1|COMPLETED|Overall Study||30
279788|NCT00884754|676187|P2|STARTED|Overall Study||30
279789|NCT00884754|676188|P1|STARTED|Overall Study||30
279790|NCT00884741|676197|P4|NOT COMPLETED|Randomization||8
279791|NCT00884741|676198|P3|NOT COMPLETED|Randomization||8
279792|NCT00884741|676199|P2|NOT COMPLETED|Randomization||0
279793|NCT00884741|676200|P1|NOT COMPLETED|Randomization||0
279794|NCT00884741|676197|P4|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|312
279795|NCT00884741|676198|P3|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|309
279796|NCT00884741|676199|P2|COMPLETED|Randomization||0
279797|NCT00884741|676200|P1|COMPLETED|Randomization||0
279798|NCT00884741|676197|P4|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|320
279799|NCT00884741|676198|P3|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|317
279800|NCT00884741|676199|P2|STARTED|Randomization|Step 2 Registration Arm goes to a randomized arm.|0
279801|NCT00884741|676200|P1|STARTED|Randomization||0
279802|NCT00884741|676197|P4|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
279803|NCT00884741|676198|P3|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
279804|NCT00884741|676199|P2|NOT COMPLETED|Step 2 Registration: Tissue Analysis||29
279805|NCT00884741|676200|P1|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
279806|NCT00884741|676197|P4|COMPLETED|Step 2 Registration: Tissue Analysis||0
279807|NCT00884741|676198|P3|COMPLETED|Step 2 Registration: Tissue Analysis||0
279808|NCT00884741|676199|P2|COMPLETED|Step 2 Registration: Tissue Analysis||637
279809|NCT00884741|676200|P1|COMPLETED|Step 2 Registration: Tissue Analysis||0
279810|NCT00884741|676197|P4|STARTED|Step 2 Registration: Tissue Analysis||0
279811|NCT00884741|676198|P3|STARTED|Step 2 Registration: Tissue Analysis||0
279812|NCT00884741|676199|P2|STARTED|Step 2 Registration: Tissue Analysis|These patients completed the previous period on the Step 1 Registration arm.|666
279813|NCT00884741|676200|P1|STARTED|Step 2 Registration: Tissue Analysis|Step 1 Registration Arm goes to Step 2 Registration Arm|0
279814|NCT00884741|676197|P4|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
279815|NCT00884741|676198|P3|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
279816|NCT00884741|676199|P2|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
279817|NCT00884741|676200|P1|NOT COMPLETED|Step 1 Registration: Tissue Screening||312
279818|NCT00884741|676197|P4|COMPLETED|Step 1 Registration: Tissue Screening||0
279819|NCT00884741|676198|P3|COMPLETED|Step 1 Registration: Tissue Screening||0
279820|NCT00884741|676199|P2|COMPLETED|Step 1 Registration: Tissue Screening||0
279821|NCT00884741|676200|P1|COMPLETED|Step 1 Registration: Tissue Screening||666
279822|NCT00884741|676197|P4|STARTED|Step 1 Registration: Tissue Screening||0
279823|NCT00884741|676198|P3|STARTED|Step 1 Registration: Tissue Screening||0
279824|NCT00884741|676199|P2|STARTED|Step 1 Registration: Tissue Screening||0
279825|NCT00884741|676200|P1|STARTED|Step 1 Registration: Tissue Screening||978
279826|NCT00884611|676211|P1|NOT COMPLETED|Overall Study||1
279827|NCT00884611|676211|P1|COMPLETED|Overall Study||19
279828|NCT00884611|676211|P1|Enrolled, Not Treated|Overall Study||1
279829|NCT00884611|676211|P1|STARTED|Overall Study||20
279830|NCT00884585|676235|P2|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||0
279831|NCT00884585|676236|P1|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||3
279832|NCT00884585|676235|P2|COMPLETED|Open-Label Maintenance (Months 9-12)||0
279833|NCT00884585|676236|P1|COMPLETED|Open-Label Maintenance (Months 9-12)||144
279834|NCT00884585|676235|P2|STARTED|Open-Label Maintenance (Months 9-12)||0
279835|NCT00884585|676236|P1|STARTED|Open-Label Maintenance (Months 9-12)||147
279836|NCT00884585|676235|P2|NOT COMPLETED|Open-Label Phase (Months 3-9)||0
279837|NCT00884585|676236|P1|NOT COMPLETED|Open-Label Phase (Months 3-9)||15
279838|NCT00884585|676235|P2|COMPLETED|Open-Label Phase (Months 3-9)||0
279839|NCT00884585|676236|P1|COMPLETED|Open-Label Phase (Months 3-9)||147
279840|NCT00884585|676235|P2|STARTED|Open-Label Phase (Months 3-9)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|0
279841|NCT00884585|676236|P1|STARTED|Open-Label Phase (Months 3-9)|All patients who completed the double-masked phase received COS in the open-label phase.|162
279842|NCT00884585|676235|P2|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||4
279843|NCT00884585|676236|P1|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||10
279844|NCT00884585|676235|P2|COMPLETED|Double-Masked Phase (Day 1-Month 3)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|83
279845|NCT00884585|676236|P1|COMPLETED|Double-Masked Phase (Day 1-Month 3)||79
279846|NCT00884585|676235|P2|STARTED|Double-Masked Phase (Day 1-Month 3)||87
279847|NCT00884585|676236|P1|STARTED|Double-Masked Phase (Day 1-Month 3)||89
279848|NCT00884390|676250|P2|NOT COMPLETED|Overall Study||8
279849|NCT00884390|676251|P1|NOT COMPLETED|Overall Study||23
279850|NCT00884390|676250|P2|COMPLETED|Overall Study||54
279851|NCT00884390|676251|P1|COMPLETED|Overall Study||123
279852|NCT00884390|676250|P2|STARTED|Overall Study||62
279853|NCT00884390|676251|P1|STARTED|Overall Study||146
279854|NCT00884377|676269|P2|NOT COMPLETED|Overall Study||1
279855|NCT00884377|676270|P1|NOT COMPLETED|Overall Study||2
279856|NCT00884377|676269|P2|COMPLETED|Overall Study||27
279857|NCT00884377|676270|P1|COMPLETED|Overall Study|1 received full course of therapy,withdrew consent before completion of the 12 month follow up|26
279858|NCT00884377|676269|P2|STARTED|Overall Study|1 was not treated due to concerns arising from the location of cutaneous leishmaniasis lesion|28
279859|NCT00884377|676270|P1|STARTED|Overall Study|1 not treated because infecting parasite could not be confirmed as L. major on rapid PCR testing,|28
279860|NCT00884325|676292|P2|NOT COMPLETED|Overall Study||4
279861|NCT00884325|676293|P1|NOT COMPLETED|Overall Study||3
279862|NCT00884325|676292|P2|COMPLETED|Overall Study||16
279863|NCT00884325|676293|P1|COMPLETED|Overall Study||17
279864|NCT00884325|676292|P2|STARTED|Overall Study||20
279865|NCT00884325|676293|P1|STARTED|Overall Study||20
279866|NCT00884312|676303|P2|NOT COMPLETED|Overall Study||25
279867|NCT00884312|676304|P1|NOT COMPLETED|Overall Study||2
279868|NCT00884312|676303|P2|COMPLETED|Overall Study||67
279869|NCT00884312|676304|P1|COMPLETED|Overall Study||7
279870|NCT00884312|676303|P2|Received Treatment|Overall Study||91
279871|NCT00884312|676304|P1|Received Treatment|Overall Study||9
279872|NCT00884312|676303|P2|STARTED|Overall Study||92
279873|NCT00884312|676304|P1|STARTED|Overall Study||9
279874|NCT00884286|676320|P2|NOT COMPLETED|Overall Study||33
279875|NCT00884286|676321|P1|NOT COMPLETED|Overall Study||32
279876|NCT00884286|676320|P2|COMPLETED|Overall Study||0
279877|NCT00884286|676321|P1|COMPLETED|Overall Study||2
279878|NCT00884286|676320|P2|STARTED|Overall Study||33
279879|NCT00884286|676321|P1|STARTED|Overall Study||34
279880|NCT00884273|676335|P2|NOT COMPLETED|Overall Study||5
279881|NCT00884273|676336|P1|NOT COMPLETED|Overall Study||2
279882|NCT00884273|676335|P2|COMPLETED|Overall Study||93
279883|NCT00884273|676336|P1|COMPLETED|Overall Study||82
279884|NCT00884273|676335|P2|Safety Analysis Set|Overall Study||98
279885|NCT00884273|676336|P1|Safety Analysis Set|Overall Study||84
279886|NCT00884273|676335|P2|Per Protocol (PP) Analysis Set|Overall Study||92
279887|NCT00884273|676336|P1|Per Protocol (PP) Analysis Set|Overall Study||81
279888|NCT00884273|676335|P2|Full Analysis Set (FAS)|Overall Study|One participant did not have any post-dose efficacy assessment and was excluded from the FAS.|97
279889|NCT00884273|676336|P1|Full Analysis Set (FAS)|Overall Study|Two participants did not have any post-dose efficacy assessment and were excluded from the FAS.|82
279890|NCT00884273|676335|P2|STARTED|Overall Study|ITT population.|98
279891|NCT00884273|676336|P1|STARTED|Overall Study|Intention-to-treat (ITT) population.|84
279892|NCT00884221|676362|P2|NOT COMPLETED|Overall Study||32
279893|NCT00884221|676363|P1|NOT COMPLETED|Overall Study||34
279894|NCT00884221|676362|P2|COMPLETED|Overall Study||343
279895|NCT00884221|676363|P1|COMPLETED|Overall Study||340
279896|NCT00884221|676362|P2|STARTED|Overall Study||375
279897|NCT00884221|676363|P1|STARTED|Overall Study||374
279898|NCT00884117|676399|P1|NOT COMPLETED|Overall Study||249
279899|NCT00884117|676399|P1|COMPLETED|Overall Study|Defined as Day 6 visit for those enrolled before Amendment D; thereafter defined as Day 10 visit.|4312
279900|NCT00884117|676399|P1|STARTED|Overall Study||4561
279901|NCT00884065|676443|P2|NOT COMPLETED|Overall Study||0
279902|NCT00884065|676444|P1|NOT COMPLETED|Overall Study||0
279903|NCT00884065|676443|P2|COMPLETED|Overall Study||25
279904|NCT00884065|676444|P1|COMPLETED|Overall Study||25
279905|NCT00884065|676443|P2|STARTED|Overall Study||25
279906|NCT00884065|676444|P1|STARTED|Overall Study||25
279907|NCT00884039|676462|P2|NOT COMPLETED|Overall Study||1
279908|NCT00884039|676463|P1|NOT COMPLETED|Overall Study||2
279909|NCT00884039|676462|P2|COMPLETED|Overall Study||1
279910|NCT00884039|676463|P1|COMPLETED|Overall Study||3
279911|NCT00884039|676462|P2|STARTED|Overall Study||2
279912|NCT00884039|676463|P1|STARTED|Overall Study||5
279913|NCT00883779|676471|P2|NOT COMPLETED|Off-study Phase||202
279914|NCT00883779|676472|P1|NOT COMPLETED|Off-study Phase||209
279915|NCT00883779|676471|P2|COMPLETED|Off-study Phase||0
279916|NCT00883779|676472|P1|COMPLETED|Off-study Phase||0
279917|NCT00883779|676471|P2|STARTED|Off-study Phase||202
279918|NCT00883779|676472|P1|STARTED|Off-study Phase||209
279919|NCT00883779|676471|P2|NOT COMPLETED|Post-Study Treatment Phase||135
279920|NCT00883779|676472|P1|NOT COMPLETED|Post-Study Treatment Phase||112
279921|NCT00883779|676471|P2|COMPLETED|Post-Study Treatment Phase||0
279922|NCT00883779|676472|P1|COMPLETED|Post-Study Treatment Phase||0
279923|NCT00883779|676471|P2|STARTED|Post-Study Treatment Phase||135
279924|NCT00883779|676472|P1|STARTED|Post-Study Treatment Phase||112
279925|NCT00883779|676471|P2|NOT COMPLETED|Primary Study Treatment Phase||86
279926|NCT00883779|676472|P1|NOT COMPLETED|Primary Study Treatment Phase||105
279927|NCT00883779|676471|P2|COMPLETED|Primary Study Treatment Phase||140
279928|NCT00883779|676472|P1|COMPLETED|Primary Study Treatment Phase||120
279929|NCT00883779|676471|P2|STARTED|Primary Study Treatment Phase||226
279930|NCT00883779|676472|P1|STARTED|Primary Study Treatment Phase||225
279931|NCT00883753|676508|P1|NOT COMPLETED|Overall Study||107
279932|NCT00883753|676508|P1|COMPLETED|Overall Study||827
279933|NCT00883753|676508|P1|STARTED|Overall Study||934
279934|NCT00883740|676548|P2|NOT COMPLETED|Second Intervention||1
279935|NCT00883740|676549|P1|NOT COMPLETED|Second Intervention||1
279936|NCT00883740|676548|P2|COMPLETED|Second Intervention||50
279937|NCT00883740|676549|P1|COMPLETED|Second Intervention||52
279938|NCT00883740|676548|P2|STARTED|Second Intervention||51
279939|NCT00883740|676549|P1|STARTED|Second Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
279940|NCT00883740|676548|P2|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
279941|NCT00883740|676549|P1|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
279942|NCT00883740|676548|P2|COMPLETED|Taper and Washout Period (2 Weeks)||51
279943|NCT00883740|676549|P1|COMPLETED|Taper and Washout Period (2 Weeks)||54
279944|NCT00883740|676548|P2|STARTED|Taper and Washout Period (2 Weeks)||51
279945|NCT00883740|676549|P1|STARTED|Taper and Washout Period (2 Weeks)|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|54
279946|NCT00883740|676548|P2|NOT COMPLETED|First Intervention||8
279947|NCT00883740|676549|P1|NOT COMPLETED|First Intervention||7
279948|NCT00883740|676548|P2|COMPLETED|First Intervention||51
279949|NCT00883740|676549|P1|COMPLETED|First Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
279950|NCT00883740|676548|P2|STARTED|First Intervention||59
279951|NCT00883740|676549|P1|STARTED|First Intervention||60
279952|NCT00883675|676589|P1|NOT COMPLETED|Overall Study||0
279953|NCT00883675|676589|P1|COMPLETED|Overall Study||133
279954|NCT00883675|676589|P1|STARTED|Overall Study||133
279955|NCT00883558|676593|P3|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||1
279956|NCT00883558|676594|P2|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
279957|NCT00883558|676595|P1|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
279958|NCT00883558|676593|P3|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||22
279959|NCT00883558|676594|P2|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||19
279960|NCT00883558|676595|P1|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
279961|NCT00883558|676593|P3|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||23
279962|NCT00883558|676594|P2|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||19
279963|NCT00883558|676595|P1|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||0
279964|NCT00883558|676593|P3|STARTED|Second Treatment Cycle (Weeks 16 to 28)||23
279965|NCT00883558|676594|P2|STARTED|Second Treatment Cycle (Weeks 16 to 28)||19
279966|NCT00883558|676595|P1|STARTED|Second Treatment Cycle (Weeks 16 to 28)||0
279967|NCT00883558|676593|P3|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||1
279968|NCT00883558|676594|P2|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||3
279969|NCT00883558|676595|P1|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
279970|NCT00883558|676593|P3|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||23
279971|NCT00883558|676594|P2|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||19
279972|NCT00883558|676595|P1|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
279973|NCT00883558|676593|P3|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||24
279974|NCT00883558|676594|P2|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||22
279975|NCT00883558|676595|P1|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||0
279976|NCT00883558|676593|P3|STARTED|First Treatment Cycle (Weeks 4 to 16)||24
279977|NCT00883558|676594|P2|STARTED|First Treatment Cycle (Weeks 4 to 16)||22
279978|NCT00883558|676595|P1|STARTED|First Treatment Cycle (Weeks 4 to 16)||0
279979|NCT00883558|676593|P3|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
279980|NCT00883558|676594|P2|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
279981|NCT00883558|676595|P1|NOT COMPLETED|Titration Period (Weeks 0 to 4)||2
279982|NCT00883558|676593|P3|COMPLETED|Titration Period (Weeks 0 to 4)||0
279983|NCT00883558|676594|P2|COMPLETED|Titration Period (Weeks 0 to 4)||0
279984|NCT00883558|676595|P1|COMPLETED|Titration Period (Weeks 0 to 4)||46
279985|NCT00883558|676593|P3|STARTED|Titration Period (Weeks 0 to 4)||0
279986|NCT00883558|676594|P2|STARTED|Titration Period (Weeks 0 to 4)||0
279987|NCT00883558|676595|P1|STARTED|Titration Period (Weeks 0 to 4)||48
279988|NCT00883493|676607|P2|NOT COMPLETED|Overall Study||50
279989|NCT00883493|676608|P1|NOT COMPLETED|Overall Study||46
279990|NCT00883493|676607|P2|COMPLETED|Overall Study||159
279991|NCT00883493|676608|P1|COMPLETED|Overall Study||166
279992|NCT00883493|676607|P2|Per Protocol Analysis Population|Overall Study||155
279993|NCT00883493|676608|P1|Per Protocol Analysis Population|Overall Study||162
280081|NCT00882999|677020|P1|NOT COMPLETED|Overall Study||8
279994|NCT00883493|676607|P2|Intention To Treat Analysis Population|Overall Study||195
279995|NCT00883493|676608|P1|Intention To Treat Analysis Population|Overall Study||204
279996|NCT00883493|676607|P2|STARTED|Overall Study||209
279997|NCT00883493|676608|P1|STARTED|Overall Study||212
279998|NCT00883389|676632|P1|NOT COMPLETED|Overall Study||0
279999|NCT00883389|676632|P1|COMPLETED|Overall Study||26
280000|NCT00883389|676632|P1|STARTED|Overall Study||26
280001|NCT00883337|676639|P3|NOT COMPLETED|Extension Treatment Period||19
280002|NCT00883337|676640|P2|NOT COMPLETED|Extension Treatment Period||23
280003|NCT00883337|676641|P1|NOT COMPLETED|Extension Treatment Period||28
280004|NCT00883337|676639|P3|COMPLETED|Extension Treatment Period||40
280005|NCT00883337|676640|P2|COMPLETED|Extension Treatment Period||66
280006|NCT00883337|676641|P1|COMPLETED|Extension Treatment Period||61
280007|NCT00883337|676639|P3|STARTED|Extension Treatment Period|12 participants completed the core period but didn't enter the extension period.|59
280008|NCT00883337|676640|P2|STARTED|Extension Treatment Period||89
280009|NCT00883337|676641|P1|STARTED|Extension Treatment Period||89
280010|NCT00883337|676639|P3|NOT COMPLETED|Core Treatment Period||33
280011|NCT00883337|676640|P2|NOT COMPLETED|Core Treatment Period||22
280012|NCT00883337|676641|P1|NOT COMPLETED|Core Treatment Period||20
280013|NCT00883337|676639|P3|COMPLETED|Core Treatment Period||71
280014|NCT00883337|676640|P2|COMPLETED|Core Treatment Period||89
280015|NCT00883337|676641|P1|COMPLETED|Core Treatment Period||89
280016|NCT00883337|676639|P3|Treated|Core Treatment Period|3 participants refused treatment with Rebif®|101
280017|NCT00883337|676640|P2|Treated|Core Treatment Period|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|111
280018|NCT00883337|676641|P1|Treated|Core Treatment Period||109
280019|NCT00883337|676639|P3|STARTED|Core Treatment Period||104
280020|NCT00883337|676640|P2|STARTED|Core Treatment Period||111
280021|NCT00883337|676641|P1|STARTED|Core Treatment Period||109
280022|NCT00883246|676673|P1|NOT COMPLETED|Overall Study||173
280023|NCT00883246|676673|P1|COMPLETED|Overall Study||626
280024|NCT00883246|676673|P1|STARTED|Overall Study||799
280025|NCT00883233|676695|P4|NOT COMPLETED|Overall Study||5
280026|NCT00883233|676696|P3|NOT COMPLETED|Overall Study||4
280027|NCT00883233|676697|P2|NOT COMPLETED|Overall Study||4
280028|NCT00883233|676698|P1|NOT COMPLETED|Overall Study||5
280029|NCT00883233|676695|P4|COMPLETED|Overall Study||25
280030|NCT00883233|676696|P3|COMPLETED|Overall Study||25
280031|NCT00883233|676697|P2|COMPLETED|Overall Study||28
280032|NCT00883233|676698|P1|COMPLETED|Overall Study||27
280033|NCT00883233|676695|P4|STARTED|Overall Study||30
280034|NCT00883233|676696|P3|STARTED|Overall Study||29
280035|NCT00883233|676697|P2|STARTED|Overall Study||32
280036|NCT00883233|676698|P1|STARTED|Overall Study||32
280037|NCT00883181|676708|P1|NOT COMPLETED|Overall Study||278
280038|NCT00883181|676708|P1|COMPLETED|Overall Study|Completed planned chemotherapy|1069
280039|NCT00883181|676708|P1|STARTED|Overall Study|Full analysis set|1347
280040|NCT00883168|676921|P4|NOT COMPLETED|Overall Study||15
280041|NCT00883168|676922|P3|NOT COMPLETED|Overall Study||19
280042|NCT00883168|676923|P2|NOT COMPLETED|Overall Study||15
280043|NCT00883168|676924|P1|NOT COMPLETED|Overall Study||14
280044|NCT00883168|676921|P4|COMPLETED|Overall Study||433
280045|NCT00883168|676922|P3|COMPLETED|Overall Study||431
280046|NCT00883168|676923|P2|COMPLETED|Overall Study||430
280047|NCT00883168|676924|P1|COMPLETED|Overall Study||434
280048|NCT00883168|676921|P4|STARTED|Overall Study||448
280049|NCT00883168|676922|P3|STARTED|Overall Study||450
280050|NCT00883168|676923|P2|STARTED|Overall Study||445
280051|NCT00883168|676924|P1|STARTED|Overall Study||448
280052|NCT00883129|676944|P2|NOT COMPLETED|Overall Study||36
280053|NCT00883129|676945|P1|NOT COMPLETED|Overall Study||20
280054|NCT00883129|676944|P2|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 16 of whom had prematurely withdrawn from drug treatment.|37
280055|NCT00883129|676945|P1|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 4 of whom had prematurely withdrawn from drug treatment.|49
280056|NCT00883129|676944|P2|STARTED|Overall Study||73
280057|NCT00883129|676945|P1|STARTED|Overall Study||69
280058|NCT00883116|676969|P2|NOT COMPLETED|Overall Study||219
280059|NCT00883116|676970|P1|NOT COMPLETED|Overall Study||209
280060|NCT00883116|676969|P2|COMPLETED|Overall Study||29
280061|NCT00883116|676970|P1|COMPLETED|Overall Study||39
280062|NCT00883116|676969|P2|Received Treatment|Overall Study||239
280063|NCT00883116|676970|P1|Received Treatment|Overall Study||248
280064|NCT00883116|676969|P2|STARTED|Overall Study||248
280065|NCT00883116|676970|P1|STARTED|Overall Study||248
280066|NCT00883103|676985|P2|NOT COMPLETED|Overall Study||0
280067|NCT00883103|676986|P1|NOT COMPLETED|Overall Study||0
280068|NCT00883103|676985|P2|COMPLETED|Overall Study||68
280069|NCT00883103|676986|P1|COMPLETED|Overall Study||69
280070|NCT00883103|676985|P2|STARTED|Overall Study||68
280071|NCT00883103|676986|P1|STARTED|Overall Study||69
280072|NCT00883090|676992|P1|NOT COMPLETED|Overall Study||2
280073|NCT00883090|676992|P1|COMPLETED|Overall Study||13
280074|NCT00883090|676992|P1|STARTED|Overall Study|Of the 15 participants started, 14 were administered FXIII|15
280075|NCT00882999|677014|P7|NOT COMPLETED|Overall Study||8
280076|NCT00882999|677015|P6|NOT COMPLETED|Overall Study||7
280077|NCT00882999|677016|P5|NOT COMPLETED|Overall Study||8
280078|NCT00882999|677017|P4|NOT COMPLETED|Overall Study||5
280079|NCT00882999|677018|P3|NOT COMPLETED|Overall Study||4
280080|NCT00882999|677019|P2|NOT COMPLETED|Overall Study||8
280082|NCT00882999|677014|P7|COMPLETED|Overall Study||27
280083|NCT00882999|677015|P6|COMPLETED|Overall Study||28
280084|NCT00882999|677016|P5|COMPLETED|Overall Study||28
280085|NCT00882999|677017|P4|COMPLETED|Overall Study||31
280086|NCT00882999|677018|P3|COMPLETED|Overall Study||30
280087|NCT00882999|677019|P2|COMPLETED|Overall Study||26
280088|NCT00882999|677020|P1|COMPLETED|Overall Study||27
280089|NCT00882999|677014|P7|Completed Study Treatment|Overall Study||31
280090|NCT00882999|677015|P6|Completed Study Treatment|Overall Study||30
280091|NCT00882999|677016|P5|Completed Study Treatment|Overall Study||29
280092|NCT00882999|677017|P4|Completed Study Treatment|Overall Study||33
280093|NCT00882999|677018|P3|Completed Study Treatment|Overall Study||31
280094|NCT00882999|677019|P2|Completed Study Treatment|Overall Study||29
280095|NCT00882999|677020|P1|Completed Study Treatment|Overall Study||29
280096|NCT00882999|677014|P7|Received Any Amount of Study Drug|Overall Study||35
280097|NCT00882999|677015|P6|Received Any Amount of Study Drug|Overall Study||35
280098|NCT00882999|677016|P5|Received Any Amount of Study Drug|Overall Study||36
280099|NCT00882999|677017|P4|Received Any Amount of Study Drug|Overall Study||36
280100|NCT00882999|677018|P3|Received Any Amount of Study Drug|Overall Study||34
280101|NCT00882999|677019|P2|Received Any Amount of Study Drug|Overall Study||34
280102|NCT00882999|677020|P1|Received Any Amount of Study Drug|Overall Study||35
280103|NCT00882999|677014|P7|STARTED|Overall Study||35
280104|NCT00882999|677015|P6|STARTED|Overall Study||35
280105|NCT00882999|677016|P5|STARTED|Overall Study||36
280106|NCT00882999|677017|P4|STARTED|Overall Study||36
280107|NCT00882999|677018|P3|STARTED|Overall Study||34
280108|NCT00882999|677019|P2|STARTED|Overall Study||34
280109|NCT00882999|677020|P1|STARTED|Overall Study||35
280110|NCT00882921|677147|P1|NOT COMPLETED|Overall Study||11
280111|NCT00882921|677147|P1|COMPLETED|Overall Study||15
280112|NCT00882921|677147|P1|STARTED|Overall Study||26
280113|NCT00882908|677157|P5|NOT COMPLETED|Overall Study||6
280114|NCT00882908|677158|P4|NOT COMPLETED|Overall Study||7
280115|NCT00882908|677159|P3|NOT COMPLETED|Overall Study||7
280116|NCT00882908|677160|P2|NOT COMPLETED|Overall Study||6
280117|NCT00882908|677161|P1|NOT COMPLETED|Overall Study||3
280118|NCT00882908|677157|P5|COMPLETED|Overall Study||71
280119|NCT00882908|677158|P4|COMPLETED|Overall Study||72
280120|NCT00882908|677159|P3|COMPLETED|Overall Study||70
280121|NCT00882908|677160|P2|COMPLETED|Overall Study||69
280122|NCT00882908|677161|P1|COMPLETED|Overall Study||75
280123|NCT00882908|677157|P5|STARTED|Overall Study||77
280124|NCT00882908|677158|P4|STARTED|Overall Study||79
280125|NCT00882908|677159|P3|STARTED|Overall Study||77
280126|NCT00882908|677160|P2|STARTED|Overall Study||75
280127|NCT00882908|677161|P1|STARTED|Overall Study||78
280128|NCT00882778|677236|P1|NOT COMPLETED|Overall Study||0
280129|NCT00882778|677236|P1|COMPLETED|Overall Study||86
280130|NCT00882778|677236|P1|STARTED|Overall Study||86
280131|NCT00882713|677267|P1|NOT COMPLETED|Overall Study||22
280132|NCT00882713|677267|P1|COMPLETED|Overall Study||172
280133|NCT00882713|677267|P1|STARTED|Overall Study||194
280134|NCT00882687|677293|P4|NOT COMPLETED|Overall Study||2
280135|NCT00882687|677294|P3|NOT COMPLETED|Overall Study||3
280136|NCT00882687|677295|P2|NOT COMPLETED|Overall Study||2
280137|NCT00882687|677296|P1|NOT COMPLETED|Overall Study||2
280138|NCT00882687|677293|P4|COMPLETED|Overall Study||13
280139|NCT00882687|677294|P3|COMPLETED|Overall Study||12
280140|NCT00882687|677295|P2|COMPLETED|Overall Study||13
280141|NCT00882687|677296|P1|COMPLETED|Overall Study||13
280142|NCT00882687|677293|P4|STARTED|Overall Study||15
280143|NCT00882687|677294|P3|STARTED|Overall Study||15
280144|NCT00882687|677295|P2|STARTED|Overall Study||15
280145|NCT00882687|677296|P1|STARTED|Overall Study||15
280146|NCT00882661|677329|P2|NOT COMPLETED|Treatment||26
280147|NCT00882661|677330|P1|NOT COMPLETED|Treatment||10
280148|NCT00882661|677329|P2|COMPLETED|Treatment||114
280149|NCT00882661|677330|P1|COMPLETED|Treatment||141
280150|NCT00882661|677329|P2|STARTED|Treatment||140
280151|NCT00882661|677330|P1|STARTED|Treatment||151
280152|NCT00882661|677329|P2|NOT COMPLETED|Investigational Training||0
280153|NCT00882661|677330|P1|NOT COMPLETED|Investigational Training||10
280154|NCT00882661|677329|P2|COMPLETED|Investigational Training||0
280155|NCT00882661|677330|P1|COMPLETED|Investigational Training||79
280156|NCT00882661|677329|P2|STARTED|Investigational Training||0
280157|NCT00882661|677330|P1|STARTED|Investigational Training||89
280158|NCT00882583|677360|P2|NOT COMPLETED|Overall Study||1
280159|NCT00882583|677361|P1|NOT COMPLETED|Overall Study||1
280160|NCT00882583|677360|P2|COMPLETED|Overall Study||11
280161|NCT00882583|677361|P1|COMPLETED|Overall Study||6
280162|NCT00882583|677360|P2|STARTED|Overall Study||12
280163|NCT00882583|677361|P1|STARTED|Overall Study||7
280164|NCT00882557|677369|P2|NOT COMPLETED|Overall Study||1
280165|NCT00882557|677370|P1|NOT COMPLETED|Overall Study||2
280166|NCT00882557|677369|P2|COMPLETED|Overall Study||7
280167|NCT00882557|677370|P1|COMPLETED|Overall Study||6
280168|NCT00882557|677369|P2|Completed Dose 2|Overall Study||7
280169|NCT00882557|677370|P1|Completed Dose 2|Overall Study||6
280170|NCT00882557|677369|P2|Completed Dose 1|Overall Study||7
280171|NCT00882557|677370|P1|Completed Dose 1|Overall Study||8
280172|NCT00882557|677369|P2|STARTED|Overall Study||8
280173|NCT00882557|677370|P1|STARTED|Overall Study||8
280174|NCT00882518|677390|P2|NOT COMPLETED|Overall Study||44
280175|NCT00882518|677391|P1|NOT COMPLETED|Overall Study||38
280176|NCT00882518|677390|P2|COMPLETED|Overall Study||148
280177|NCT00882518|677391|P1|COMPLETED|Overall Study||158
280178|NCT00882518|677390|P2|STARTED|Overall Study||192
280179|NCT00882518|677391|P1|STARTED|Overall Study||196
280180|NCT00882440|677420|P7|NOT COMPLETED|Overall Study||4
280181|NCT00882440|677421|P6|NOT COMPLETED|Overall Study||7
280182|NCT00882440|677422|P5|NOT COMPLETED|Overall Study||10
280183|NCT00882440|677423|P4|NOT COMPLETED|Overall Study||3
280184|NCT00882440|677424|P3|NOT COMPLETED|Overall Study||7
280185|NCT00882440|677425|P2|NOT COMPLETED|Overall Study||8
280186|NCT00882440|677426|P1|NOT COMPLETED|Overall Study||11
280187|NCT00882440|677420|P7|COMPLETED|Overall Study||79
280188|NCT00882440|677421|P6|COMPLETED|Overall Study||77
280189|NCT00882440|677422|P5|COMPLETED|Overall Study||80
280190|NCT00882440|677423|P4|COMPLETED|Overall Study||76
280191|NCT00882440|677424|P3|COMPLETED|Overall Study||75
280192|NCT00882440|677425|P2|COMPLETED|Overall Study||72
280193|NCT00882440|677426|P1|COMPLETED|Overall Study||67
280194|NCT00882440|677420|P7|STARTED|Overall Study||83
280195|NCT00882440|677421|P6|STARTED|Overall Study||84
280196|NCT00882440|677422|P5|STARTED|Overall Study||90
280197|NCT00882440|677423|P4|STARTED|Overall Study||79
280198|NCT00882440|677424|P3|STARTED|Overall Study||82
280199|NCT00882440|677425|P2|STARTED|Overall Study||80
280200|NCT00882440|677426|P1|STARTED|Overall Study||78
280201|NCT00882362|677451|P2|NOT COMPLETED|Overall Study||23
280202|NCT00882362|677452|P1|NOT COMPLETED|Overall Study||49
280203|NCT00882362|677451|P2|COMPLETED|Overall Study||10
280204|NCT00882362|677452|P1|COMPLETED|Overall Study||73
280205|NCT00882362|677451|P2|STARTED|Overall Study||33
280206|NCT00882362|677452|P1|STARTED|Overall Study||122
280207|NCT00882310|677458|P1|NOT COMPLETED|Overall Study||22
280208|NCT00882310|677458|P1|COMPLETED|Overall Study||15
280209|NCT00882310|677458|P1|STARTED|Overall Study||37
280210|NCT00882206|677464|P1|NOT COMPLETED|Overall Study||0
280211|NCT00882206|677464|P1|COMPLETED|Overall Study||13
280212|NCT00882206|677464|P1|STARTED|Overall Study||13
280213|NCT00882115|677471|P1|NOT COMPLETED|Overall Study||9
280214|NCT00882115|677471|P1|COMPLETED|Overall Study||29
280215|NCT00882115|677471|P1|STARTED|Overall Study||38
280216|NCT00882102|677475|P1|NOT COMPLETED|Overall Study||0
280217|NCT00882102|677475|P1|COMPLETED|Overall Study||40
280218|NCT00882102|677475|P1|STARTED|Overall Study||40
280219|NCT00881959|677481|P2|NOT COMPLETED|Overall Study||4
280220|NCT00881959|677482|P1|NOT COMPLETED|Overall Study||2
280221|NCT00881959|677481|P2|COMPLETED|Overall Study||38
280222|NCT00881959|677482|P1|COMPLETED|Overall Study||36
280223|NCT00881959|677481|P2|STARTED|Overall Study||42
280224|NCT00881959|677482|P1|STARTED|Overall Study||38
280225|NCT00881894|677490|P2|NOT COMPLETED|Overall Study||3
280226|NCT00881894|677491|P1|NOT COMPLETED|Overall Study||1
280227|NCT00881894|677490|P2|COMPLETED|Overall Study||23
280228|NCT00881894|677491|P1|COMPLETED|Overall Study||25
280229|NCT00881894|677490|P2|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|21
280230|NCT00881894|677491|P1|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|23
280231|NCT00881894|677490|P2|STARTED|Overall Study||26
280232|NCT00881894|677491|P1|STARTED|Overall Study||26
280233|NCT00881868|677523|P2|NOT COMPLETED|Overall Study||2
280234|NCT00881868|677524|P1|NOT COMPLETED|Overall Study||8
280235|NCT00881868|677523|P2|COMPLETED|Overall Study||38
280236|NCT00881868|677524|P1|COMPLETED|Overall Study||33
280237|NCT00881868|677523|P2|STARTED|Overall Study||40
280238|NCT00881868|677524|P1|STARTED|Overall Study||41
280239|NCT00881751|677538|P2|NOT COMPLETED|Overall Study||5
280240|NCT00881751|677539|P1|NOT COMPLETED|Overall Study||0
280241|NCT00881751|677538|P2|COMPLETED|Overall Study||43
280242|NCT00881751|677539|P1|COMPLETED|Overall Study||47
280243|NCT00881751|677538|P2|STARTED|Overall Study||48
280244|NCT00881751|677539|P1|STARTED|Overall Study||47
280245|NCT00881712|677554|P3|NOT COMPLETED|Overall Study||0
280246|NCT00881712|677555|P2|NOT COMPLETED|Overall Study||0
280247|NCT00881712|677556|P1|NOT COMPLETED|Overall Study||2
280248|NCT00881712|677554|P3|COMPLETED|Overall Study||0
280249|NCT00881712|677555|P2|COMPLETED|Overall Study||0
280250|NCT00881712|677556|P1|COMPLETED|Overall Study||13
280251|NCT00881712|677554|P3|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
280252|NCT00881712|677555|P2|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
280253|NCT00881712|677556|P1|STARTED|Overall Study||15
280254|NCT00881647|677578|P2|NOT COMPLETED|Overall Study||1
280255|NCT00881647|677579|P1|NOT COMPLETED|Overall Study||2
280256|NCT00881647|677578|P2|COMPLETED|Overall Study||15
280257|NCT00881647|677579|P1|COMPLETED|Overall Study||27
280258|NCT00881647|677578|P2|STARTED|Overall Study||16
280259|NCT00881647|677579|P1|STARTED|Overall Study||29
280260|NCT00881621|677589|P1|NOT COMPLETED|Overall Study||34
280261|NCT00881621|677589|P1|COMPLETED|Overall Study||17
280262|NCT00881621|677589|P1|STARTED|Overall Study||51
280263|NCT00881608|677601|P1|NOT COMPLETED|Overall Study||11
280264|NCT00881608|677601|P1|COMPLETED|Overall Study||0
280265|NCT00881608|677601|P1|STARTED|Overall Study||11
280266|NCT00881530|677624|P6|NOT COMPLETED|Overall Study||5
280267|NCT00881530|677625|P5|NOT COMPLETED|Overall Study||14
280268|NCT00881530|677626|P4|NOT COMPLETED|Overall Study||9
280269|NCT00881530|677627|P3|NOT COMPLETED|Overall Study||5
280270|NCT00881530|677628|P2|NOT COMPLETED|Overall Study||5
280271|NCT00881530|677629|P1|NOT COMPLETED|Overall Study||14
280272|NCT00881530|677624|P6|COMPLETED|Overall Study||51
280273|NCT00881530|677625|P5|COMPLETED|Overall Study||152
280274|NCT00881530|677626|P4|COMPLETED|Overall Study||157
280275|NCT00881530|677627|P3|COMPLETED|Overall Study||51
280276|NCT00881530|677628|P2|COMPLETED|Overall Study||104
280277|NCT00881530|677629|P1|COMPLETED|Overall Study||92
280278|NCT00881530|677624|P6|STARTED|Overall Study||56
280279|NCT00881530|677625|P5|STARTED|Overall Study||166
280280|NCT00881530|677626|P4|STARTED|Overall Study||166
280281|NCT00881530|677627|P3|STARTED|Overall Study||56
280282|NCT00881530|677628|P2|STARTED|Overall Study||109
280283|NCT00881530|677629|P1|STARTED|Overall Study||106
280284|NCT00881504|677685|P1|NOT COMPLETED|Overall Study||1
280285|NCT00881504|677685|P1|COMPLETED|Overall Study||8
280286|NCT00881504|677685|P1|STARTED|Overall Study||9
280287|NCT00881465|677692|P2|NOT COMPLETED|Overall Study||0
280288|NCT00881465|677693|P1|NOT COMPLETED|Overall Study||2
280289|NCT00881465|677692|P2|COMPLETED|Overall Study||15
280290|NCT00881465|677693|P1|COMPLETED|Overall Study||14
280291|NCT00881465|677692|P2|STARTED|Overall Study||15
280292|NCT00881465|677693|P1|STARTED|Overall Study||16
280293|NCT00881361|677705|P3|NOT COMPLETED|Overall Study||2
280294|NCT00881361|677706|P2|NOT COMPLETED|Overall Study||9
280295|NCT00881361|677707|P1|NOT COMPLETED|Overall Study||44
280296|NCT00881361|677705|P3|COMPLETED|Overall Study||0
280297|NCT00881361|677706|P2|COMPLETED|Overall Study||38
280298|NCT00881361|677707|P1|COMPLETED|Overall Study||663
280299|NCT00881361|677705|P3|STARTED|Overall Study||2
280300|NCT00881361|677706|P2|STARTED|Overall Study||47
280301|NCT00881361|677707|P1|STARTED|Overall Study||707
280302|NCT00881335|677722|P2|NOT COMPLETED|Overall Study||2
280303|NCT00881335|677723|P1|NOT COMPLETED|Overall Study||3
280304|NCT00881335|677722|P2|COMPLETED|Overall Study|2 participants did not complete the period|28
280305|NCT00881335|677723|P1|COMPLETED|Overall Study|3 participants did not complete the period|27
280306|NCT00881335|677722|P2|STARTED|Overall Study||30
280307|NCT00881335|677723|P1|STARTED|Overall Study||30
280308|NCT00881205|677743|P2|NOT COMPLETED|Overall Study||7
280309|NCT00881205|677744|P1|NOT COMPLETED|Overall Study||11
280310|NCT00881205|677743|P2|COMPLETED|Overall Study||34
280311|NCT00881205|677744|P1|COMPLETED|Overall Study||34
280312|NCT00881205|677743|P2|STARTED|Overall Study||41
280313|NCT00881205|677744|P1|STARTED|Overall Study||45
280314|NCT00880997|677754|P3|NOT COMPLETED|Overall Study||8
280315|NCT00880997|677755|P2|NOT COMPLETED|Overall Study||2
280316|NCT00880997|677756|P1|NOT COMPLETED|Overall Study||3
280317|NCT00880997|677754|P3|COMPLETED|Overall Study||5
280318|NCT00880997|677755|P2|COMPLETED|Overall Study||6
280319|NCT00880997|677756|P1|COMPLETED|Overall Study||6
280320|NCT00880997|677754|P3|STARTED|Overall Study||13
280321|NCT00880997|677755|P2|STARTED|Overall Study||8
280322|NCT00880997|677756|P1|STARTED|Overall Study||9
280323|NCT00880919|677776|P3|NOT COMPLETED|Overall Study||6
280324|NCT00880919|677777|P2|NOT COMPLETED|Overall Study||14
280325|NCT00880919|677778|P1|NOT COMPLETED|Overall Study||15
280326|NCT00880919|677776|P3|COMPLETED|Overall Study||23
280327|NCT00880919|677777|P2|COMPLETED|Overall Study||19
280328|NCT00880919|677778|P1|COMPLETED|Overall Study||18
280329|NCT00880919|677776|P3|STARTED|Overall Study||29
280330|NCT00880919|677777|P2|STARTED|Overall Study||33
280331|NCT00880919|677778|P1|STARTED|Overall Study||33
280332|NCT00880906|677812|P2|NOT COMPLETED|Overall Study||7
280333|NCT00880906|677813|P1|NOT COMPLETED|Overall Study||12
280334|NCT00880906|677812|P2|COMPLETED|Overall Study||14
280335|NCT00880906|677813|P1|COMPLETED|Overall Study||17
280336|NCT00880906|677812|P2|STARTED|Overall Study||21
280337|NCT00880906|677813|P1|STARTED|Overall Study||29
280338|NCT00880893|677823|P2|NOT COMPLETED|Overall Study||45
280339|NCT00880893|677824|P1|NOT COMPLETED|Overall Study||107
280340|NCT00880893|677823|P2|COMPLETED|Overall Study||255
280341|NCT00880893|677824|P1|COMPLETED|Overall Study||791
280342|NCT00880893|677823|P2|STARTED|Overall Study||300
280343|NCT00880893|677824|P1|STARTED|Overall Study||898
280344|NCT00880763|677876|P4|NOT COMPLETED|Extension Period (Part 2)||3
280345|NCT00880763|677877|P3|NOT COMPLETED|Extension Period (Part 2)||3
280346|NCT00880763|677878|P2|NOT COMPLETED|Extension Period (Part 2)||3
280347|NCT00880763|677879|P1|NOT COMPLETED|Extension Period (Part 2)||0
280348|NCT00880763|677876|P4|COMPLETED|Extension Period (Part 2)||19
280349|NCT00880763|677877|P3|COMPLETED|Extension Period (Part 2)||20
280350|NCT00880763|677878|P2|COMPLETED|Extension Period (Part 2)||19
280351|NCT00880763|677879|P1|COMPLETED|Extension Period (Part 2)||23
280352|NCT00880763|677876|P4|STARTED|Extension Period (Part 2)||22
280353|NCT00880763|677877|P3|STARTED|Extension Period (Part 2)||23
280354|NCT00880763|677878|P2|STARTED|Extension Period (Part 2)||22
280355|NCT00880763|677879|P1|STARTED|Extension Period (Part 2)||23
280356|NCT00880763|677876|P4|NOT COMPLETED|Initial Treatment Period (Part 1)||0
280357|NCT00880763|677877|P3|NOT COMPLETED|Initial Treatment Period (Part 1)||0
280358|NCT00880763|677878|P2|NOT COMPLETED|Initial Treatment Period (Part 1)||0
280359|NCT00880763|677879|P1|NOT COMPLETED|Initial Treatment Period (Part 1)||0
280360|NCT00880763|677876|P4|COMPLETED|Initial Treatment Period (Part 1)||22
280361|NCT00880763|677877|P3|COMPLETED|Initial Treatment Period (Part 1)||23
280362|NCT00880763|677878|P2|COMPLETED|Initial Treatment Period (Part 1)||22
280363|NCT00880763|677879|P1|COMPLETED|Initial Treatment Period (Part 1)||23
280364|NCT00880763|677876|P4|STARTED|Initial Treatment Period (Part 1)||22
280365|NCT00880763|677877|P3|STARTED|Initial Treatment Period (Part 1)||23
280366|NCT00880763|677878|P2|STARTED|Initial Treatment Period (Part 1)||22
280367|NCT00880763|677879|P1|STARTED|Initial Treatment Period (Part 1)||23
280368|NCT00880750|677911|P2|NOT COMPLETED|Second Intervention||2
280369|NCT00880750|677912|P1|NOT COMPLETED|Second Intervention||4
280370|NCT00880750|677911|P2|COMPLETED|Second Intervention||30
280371|NCT00880750|677912|P1|COMPLETED|Second Intervention||26
280372|NCT00880750|677911|P2|STARTED|Second Intervention||32
280373|NCT00880750|677912|P1|STARTED|Second Intervention||30
280374|NCT00880750|677911|P2|NOT COMPLETED|Washout Period||0
280375|NCT00880750|677912|P1|NOT COMPLETED|Washout Period||0
280376|NCT00880750|677911|P2|COMPLETED|Washout Period||32
280377|NCT00880750|677912|P1|COMPLETED|Washout Period||30
280378|NCT00880750|677911|P2|STARTED|Washout Period||32
280379|NCT00880750|677912|P1|STARTED|Washout Period||30
280380|NCT00880750|677911|P2|NOT COMPLETED|First Intervention||1
280381|NCT00880750|677912|P1|NOT COMPLETED|First Intervention||9
280382|NCT00880750|677911|P2|COMPLETED|First Intervention||32
280383|NCT00880750|677912|P1|COMPLETED|First Intervention||30
280384|NCT00880750|677911|P2|STARTED|First Intervention||33
280385|NCT00880750|677912|P1|STARTED|First Intervention||39
280386|NCT00880698|677930|P4|NOT COMPLETED|Overall Study||3
280387|NCT00880698|677931|P3|NOT COMPLETED|Overall Study||1
280388|NCT00880698|677932|P2|NOT COMPLETED|Overall Study||3
280389|NCT00880698|677933|P1|NOT COMPLETED|Overall Study||1
280390|NCT00880698|677930|P4|COMPLETED|Overall Study||36
280391|NCT00880698|677931|P3|COMPLETED|Overall Study||36
280392|NCT00880698|677932|P2|COMPLETED|Overall Study||61
280393|NCT00880698|677933|P1|COMPLETED|Overall Study||61
280394|NCT00880698|677930|P4|STARTED|Overall Study||39
280395|NCT00880698|677931|P3|STARTED|Overall Study||37
280396|NCT00880698|677932|P2|STARTED|Overall Study||64
280397|NCT00880698|677933|P1|STARTED|Overall Study||62
280398|NCT00880685|677959|P1|NOT COMPLETED|Memantine 30mg||0
280399|NCT00880685|677959|P1|COMPLETED|Memantine 30mg||9
280400|NCT00880685|677959|P1|STARTED|Memantine 30mg||9
280401|NCT00880685|677959|P1|NOT COMPLETED|Memantine 20mg||1
280402|NCT00880685|677959|P1|COMPLETED|Memantine 20mg||9
280403|NCT00880685|677959|P1|STARTED|Memantine 20mg||10
280404|NCT00880685|677959|P1|NOT COMPLETED|Memantine 10mg||2
280405|NCT00880685|677959|P1|COMPLETED|Memantine 10mg||10
280406|NCT00880685|677959|P1|STARTED|Memantine 10mg||12
280407|NCT00880620|677971|P4|NOT COMPLETED|Overall Study||24
280408|NCT00880620|677972|P3|NOT COMPLETED|Overall Study||21
280409|NCT00880620|677973|P2|NOT COMPLETED|Overall Study||15
280410|NCT00880620|677974|P1|NOT COMPLETED|Overall Study||21
280411|NCT00880620|677971|P4|COMPLETED|Overall Study||74
280412|NCT00880620|677972|P3|COMPLETED|Overall Study||83
280413|NCT00880620|677973|P2|COMPLETED|Overall Study||72
280414|NCT00880620|677974|P1|COMPLETED|Overall Study||71
280415|NCT00880620|677971|P4|Week 23|Overall Study||74
280416|NCT00880620|677972|P3|Week 23|Overall Study||85
280417|NCT00880620|677973|P2|Week 23|Overall Study||72
280418|NCT00880620|677974|P1|Week 23|Overall Study||71
280419|NCT00880620|677971|P4|Week 16|Overall Study||74
280420|NCT00880620|677972|P3|Week 16|Overall Study||87
280421|NCT00880620|677973|P2|Week 16|Overall Study||73
280422|NCT00880620|677974|P1|Week 16|Overall Study||74
280423|NCT00880620|677971|P4|Week 9|Overall Study||78
280424|NCT00880620|677972|P3|Week 9|Overall Study||88
280425|NCT00880620|677973|P2|Week 9|Overall Study||73
280426|NCT00880620|677974|P1|Week 9|Overall Study||80
280427|NCT00880620|677971|P4|Week 4|Overall Study||86
280428|NCT00880620|677972|P3|Week 4|Overall Study||94
280429|NCT00880620|677973|P2|Week 4|Overall Study||79
280430|NCT00880620|677974|P1|Week 4|Overall Study||88
280431|NCT00880620|677971|P4|STARTED|Overall Study||98
280432|NCT00880620|677972|P3|STARTED|Overall Study||104
280433|NCT00880620|677973|P2|STARTED|Overall Study||87
280434|NCT00880620|677974|P1|STARTED|Overall Study||92
280435|NCT00880581|677988|P1|NOT COMPLETED|Cycle 2 Re-treatment||0
280436|NCT00880581|677988|P1|COMPLETED|Cycle 2 Re-treatment||24
280437|NCT00880581|677988|P1|STARTED|Cycle 2 Re-treatment|6 subjects with progessive disease were not treated and evaluated in Cycle 2|24
280438|NCT00880581|677988|P1|NOT COMPLETED|Cycle 1||0
280439|NCT00880581|677988|P1|COMPLETED|Cycle 1||30
280440|NCT00880581|677988|P1|STARTED|Cycle 1||30
280441|NCT00880568|678002|P9|NOT COMPLETED|Overall Study||3
280442|NCT00880568|678003|P8|NOT COMPLETED|Overall Study||2
280443|NCT00880568|678004|P7|NOT COMPLETED|Overall Study||6
280444|NCT00880568|678005|P6|NOT COMPLETED|Overall Study||3
280445|NCT00880568|678006|P5|NOT COMPLETED|Overall Study||3
280446|NCT00880568|678007|P4|NOT COMPLETED|Overall Study||1
280447|NCT00880568|678008|P3|NOT COMPLETED|Overall Study||3
280448|NCT00880568|678009|P2|NOT COMPLETED|Overall Study||3
280449|NCT00880568|678010|P1|NOT COMPLETED|Overall Study||3
280450|NCT00880568|678002|P9|COMPLETED|Overall Study||0
280451|NCT00880568|678003|P8|COMPLETED|Overall Study||0
280452|NCT00880568|678004|P7|COMPLETED|Overall Study||0
280453|NCT00880568|678005|P6|COMPLETED|Overall Study||0
280454|NCT00880568|678006|P5|COMPLETED|Overall Study||0
280455|NCT00880568|678007|P4|COMPLETED|Overall Study||0
280456|NCT00880568|678008|P3|COMPLETED|Overall Study||0
280457|NCT00880568|678009|P2|COMPLETED|Overall Study||0
280458|NCT00880568|678010|P1|COMPLETED|Overall Study||0
280459|NCT00880568|678002|P9|STARTED|Overall Study||3
280460|NCT00880568|678003|P8|STARTED|Overall Study||2
280461|NCT00880568|678004|P7|STARTED|Overall Study||6
280462|NCT00880568|678005|P6|STARTED|Overall Study||3
280463|NCT00880568|678006|P5|STARTED|Overall Study||3
280464|NCT00880568|678007|P4|STARTED|Overall Study||1
280465|NCT00880568|678008|P3|STARTED|Overall Study||3
280466|NCT00880568|678009|P2|STARTED|Overall Study||3
280467|NCT00880568|678010|P1|STARTED|Overall Study||3
280468|NCT00880555|678056|P6|NOT COMPLETED|Overall Study||1
280469|NCT00880555|678057|P5|NOT COMPLETED|Overall Study||1
280470|NCT00880555|678058|P4|NOT COMPLETED|Overall Study||2
280471|NCT00880555|678059|P3|NOT COMPLETED|Overall Study||5
280472|NCT00880555|678060|P2|NOT COMPLETED|Overall Study||17
280473|NCT00880555|678061|P1|NOT COMPLETED|Overall Study||10
280474|NCT00880555|678056|P6|COMPLETED|Overall Study||0
280475|NCT00880555|678057|P5|COMPLETED|Overall Study||0
280476|NCT00880555|678058|P4|COMPLETED|Overall Study||0
280477|NCT00880555|678059|P3|COMPLETED|Overall Study||6
280478|NCT00880555|678060|P2|COMPLETED|Overall Study||23
280479|NCT00880555|678061|P1|COMPLETED|Overall Study||13
280480|NCT00880555|678056|P6|STARTED|Overall Study||1
280481|NCT00880555|678057|P5|STARTED|Overall Study||1
280482|NCT00880555|678058|P4|STARTED|Overall Study||2
280483|NCT00880555|678059|P3|STARTED|Overall Study||11
280484|NCT00880555|678060|P2|STARTED|Overall Study||40
280485|NCT00880555|678061|P1|STARTED|Overall Study||23
280486|NCT00880542|678072|P1|NOT COMPLETED|Follow-up Period||0
280487|NCT00880542|678072|P1|COMPLETED|Follow-up Period||7
280488|NCT00880542|678072|P1|STARTED|Follow-up Period|All 7 patients who started the treatment period completed the follow-up period.|7
280489|NCT00880542|678072|P1|NOT COMPLETED|Continued Treatment Period||0
280490|NCT00880542|678072|P1|COMPLETED|Continued Treatment Period||0
280491|NCT00880542|678072|P1|STARTED|Continued Treatment Period|None of the 3 subjects from previous period met study criteria for continuation of therapy.|0
280492|NCT00880542|678072|P1|NOT COMPLETED|Post Surgical Evaluation||0
280493|NCT00880542|678072|P1|COMPLETED|Post Surgical Evaluation|none of the 3 subjects met study criteria for continuation of therapy.|3
280494|NCT00880542|678072|P1|STARTED|Post Surgical Evaluation||3
280495|NCT00880542|678072|P1|NOT COMPLETED|REP: Surgical Resection||1
280496|NCT00880542|678072|P1|COMPLETED|REP: Surgical Resection||3
280497|NCT00880542|678072|P1|STARTED|REP: Surgical Resection||4
280498|NCT00880542|678072|P1|NOT COMPLETED|Response Evaluation Period(REP): PET/CT||0
280499|NCT00880542|678072|P1|COMPLETED|Response Evaluation Period(REP): PET/CT||4
280500|NCT00880542|678072|P1|STARTED|Response Evaluation Period(REP): PET/CT||4
280501|NCT00880542|678072|P1|NOT COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||3
280502|NCT00880542|678072|P1|COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||4
280503|NCT00880542|678072|P1|STARTED|Treatment Period (Sorafenib+Ifosfamide)||7
280504|NCT00880425|678077|P2|NOT COMPLETED|Overall Study||0
280505|NCT00880425|678078|P1|NOT COMPLETED|Overall Study||0
280506|NCT00880425|678077|P2|COMPLETED|Overall Study||27
280507|NCT00880425|678078|P1|COMPLETED|Overall Study||18
280508|NCT00880425|678077|P2|STARTED|Overall Study||27
280509|NCT00880425|678078|P1|STARTED|Overall Study||18
280510|NCT00880399|678089|P3|NOT COMPLETED|Overall Study||26
280511|NCT00880399|678090|P2|NOT COMPLETED|Overall Study||29
280512|NCT00880399|678091|P1|NOT COMPLETED|Overall Study||31
280513|NCT00880399|678089|P3|COMPLETED|Overall Study||81
280514|NCT00880399|678090|P2|COMPLETED|Overall Study||84
280515|NCT00880399|678091|P1|COMPLETED|Overall Study||77
280516|NCT00880399|678089|P3|STARTED|Overall Study||107
280517|NCT00880399|678090|P2|STARTED|Overall Study||113
280518|NCT00880399|678091|P1|STARTED|Overall Study||108
280519|NCT00880360|678147|P1|NOT COMPLETED|Overall Study||0
280520|NCT00880360|678147|P1|COMPLETED|Overall Study||19
280521|NCT00880360|678147|P1|STARTED|Overall Study||19
280522|NCT00880334|678154|P2|NOT COMPLETED|Crossover Phase||0
280523|NCT00880334|678155|P1|NOT COMPLETED|Crossover Phase||0
280524|NCT00880334|678154|P2|COMPLETED|Crossover Phase||37
280525|NCT00880334|678155|P1|COMPLETED|Crossover Phase||0
280526|NCT00880334|678154|P2|STARTED|Crossover Phase|Only participants randomized to placebo and docetaxel potentially received crossover treatment.|37
280527|NCT00880334|678155|P1|STARTED|Crossover Phase||0
280528|NCT00880334|678154|P2|NOT COMPLETED|Randomized Phase||40
280529|NCT00880334|678155|P1|NOT COMPLETED|Randomized Phase||4
280530|NCT00880334|678154|P2|COMPLETED|Randomized Phase||35
280531|NCT00880334|678155|P1|COMPLETED|Randomized Phase||70
280532|NCT00880334|678154|P2|Eligible & Treated|Randomized Phase||72
280533|NCT00880334|678155|P1|Eligible & Treated|Randomized Phase||70
280534|NCT00880334|678154|P2|STARTED|Randomized Phase||75
280535|NCT00880334|678155|P1|STARTED|Randomized Phase||74
280536|NCT00880269|678172|P2|NOT COMPLETED|Overall Study||27
280537|NCT00880269|678173|P1|NOT COMPLETED|Overall Study||32
280538|NCT00880269|678172|P2|COMPLETED|Overall Study||0
280539|NCT00880269|678173|P1|COMPLETED|Overall Study||0
280540|NCT00880269|678172|P2|Discontinued Treatment|Overall Study||27
280541|NCT00880269|678173|P1|Discontinued Treatment|Overall Study||32
280542|NCT00880269|678172|P2|STARTED|Overall Study||27
280543|NCT00880269|678173|P1|STARTED|Overall Study||32
280544|NCT00880256|678189|P1|NOT COMPLETED|Overall Study||28
280545|NCT00880256|678189|P1|COMPLETED|Overall Study||65
280546|NCT00880256|678189|P1|STARTED|Overall Study||93
280547|NCT00880230|678194|P1|NOT COMPLETED|Overall Study||7
280548|NCT00880230|678194|P1|COMPLETED|Overall Study||134
280549|NCT00880230|678194|P1|STARTED|Overall Study||141
280550|NCT00880191|678216|P2|NOT COMPLETED|Overall Study||8
280551|NCT00880191|678217|P1|NOT COMPLETED|Overall Study||13
280552|NCT00880191|678216|P2|COMPLETED|Overall Study||198
280553|NCT00880191|678217|P1|COMPLETED|Overall Study||194
280554|NCT00880191|678216|P2|Available for Primary Endpoint Analysis|Overall Study||206
280555|NCT00880191|678217|P1|Available for Primary Endpoint Analysis|Overall Study||207
280556|NCT00880191|678216|P2|STARTED|Overall Study||206
280557|NCT00880191|678217|P1|STARTED|Overall Study||207
280558|NCT00880165|678237|P2|NOT COMPLETED|Overall Study||50
280559|NCT00880165|678238|P1|NOT COMPLETED|Overall Study||62
280560|NCT00880165|678237|P2|COMPLETED|Overall Study||98
280561|NCT00880165|678238|P1|COMPLETED|Overall Study||86
280562|NCT00880165|678237|P2|STARTED|Overall Study||148
280563|NCT00880165|678238|P1|STARTED|Overall Study||148
280564|NCT00880100|678248|P1|NOT COMPLETED|Treatment Phase With Ultrase® MT12||3
280565|NCT00880100|678248|P1|COMPLETED|Treatment Phase With Ultrase® MT12||45
280566|NCT00880100|678248|P1|STARTED|Treatment Phase With Ultrase® MT12||48
280567|NCT00880100|678248|P1|NOT COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||1
280568|NCT00880100|678248|P1|COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||48
280569|NCT00880100|678248|P1|STARTED|Baseline Phase-Usual Pancreatic Enzymes||49
280570|NCT00880087|678261|P2|NOT COMPLETED|Overall Study||2
280571|NCT00880087|678262|P1|NOT COMPLETED|Overall Study||0
280572|NCT00880087|678261|P2|COMPLETED|Overall Study|Of 161 with 1-year vital status, 158 had received Therapeutic Normothermia, 3 received no treatment.|161
280573|NCT00880087|678262|P1|COMPLETED|Overall Study|1-year vital status available for all 166 Started patients.|166
280574|NCT00880087|678261|P2|STARTED|Overall Study|Among the 163 Started, 160 received Therapeutic Normothermia and 3 received no treatment.|163
280575|NCT00880087|678262|P1|STARTED|Overall Study|Among the 166 Started, 161 received Therapeutic Hypothermia and 5 received no treatment.|166
280576|NCT00880048|678277|P3|NOT COMPLETED|Overall Study||35
280577|NCT00880048|678278|P2|NOT COMPLETED|Overall Study||33
280578|NCT00880048|678279|P1|NOT COMPLETED|Overall Study||28
280579|NCT00880048|678277|P3|COMPLETED|Overall Study||77
280580|NCT00880048|678278|P2|COMPLETED|Overall Study||82
280581|NCT00880048|678279|P1|COMPLETED|Overall Study||88
280582|NCT00880048|678277|P3|STARTED|Overall Study||112
280583|NCT00880048|678278|P2|STARTED|Overall Study||115
280584|NCT00880048|678279|P1|STARTED|Overall Study||116
280585|NCT00880022|678337|P2|NOT COMPLETED|Overall Study||3
280586|NCT00880022|678338|P1|NOT COMPLETED|Overall Study||2
280587|NCT00880022|678337|P2|COMPLETED|Overall Study||21
280588|NCT00880022|678338|P1|COMPLETED|Overall Study||21
280589|NCT00880022|678337|P2|STARTED|Overall Study||24
280590|NCT00880022|678338|P1|STARTED|Overall Study||23
280591|NCT00880009|678346|P1|NOT COMPLETED|Overall Study||16
280592|NCT00880009|678346|P1|COMPLETED|Overall Study||0
280593|NCT00880009|678346|P1|STARTED|Overall Study||16
280594|NCT00879996|678370|P2|NOT COMPLETED|Overall Study||13
280595|NCT00879996|678371|P1|NOT COMPLETED|Overall Study||15
280596|NCT00879996|678370|P2|COMPLETED|Overall Study||13
280597|NCT00879996|678371|P1|COMPLETED|Overall Study||13
280598|NCT00879996|678370|P2|STARTED|Overall Study||26
280599|NCT00879996|678371|P1|STARTED|Overall Study||28
280600|NCT00879970|678386|P5|NOT COMPLETED|Period 2 Vitamin D Randomization||7
280601|NCT00879970|678387|P4|NOT COMPLETED|Period 2 Vitamin D Randomization||4
280602|NCT00879970|678388|P3|NOT COMPLETED|Period 2 Vitamin D Randomization||0
280603|NCT00879970|678389|P2|NOT COMPLETED|Period 2 Vitamin D Randomization||0
280604|NCT00879970|678390|P1|NOT COMPLETED|Period 2 Vitamin D Randomization||0
280605|NCT00879970|678386|P5|COMPLETED|Period 2 Vitamin D Randomization||600
280606|NCT00879970|678387|P4|COMPLETED|Period 2 Vitamin D Randomization||610
280607|NCT00879970|678388|P3|COMPLETED|Period 2 Vitamin D Randomization||0
280608|NCT00879970|678389|P2|COMPLETED|Period 2 Vitamin D Randomization||0
280609|NCT00879970|678390|P1|COMPLETED|Period 2 Vitamin D Randomization||0
280610|NCT00879970|678386|P5|STARTED|Period 2 Vitamin D Randomization||607
280611|NCT00879970|678387|P4|STARTED|Period 2 Vitamin D Randomization||614
280612|NCT00879970|678388|P3|STARTED|Period 2 Vitamin D Randomization||0
280613|NCT00879970|678389|P2|STARTED|Period 2 Vitamin D Randomization||0
280614|NCT00879970|678390|P1|STARTED|Period 2 Vitamin D Randomization||0
280615|NCT00879970|678386|P5|NOT COMPLETED|Period 1 TZD Randomization||0
280616|NCT00879970|678387|P4|NOT COMPLETED|Period 1 TZD Randomization||0
280617|NCT00879970|678388|P3|NOT COMPLETED|Period 1 TZD Randomization||6
280618|NCT00879970|678389|P2|NOT COMPLETED|Period 1 TZD Randomization||4
280619|NCT00879970|678390|P1|NOT COMPLETED|Period 1 TZD Randomization||8
280620|NCT00879970|678386|P5|COMPLETED|Period 1 TZD Randomization||0
280621|NCT00879970|678387|P4|COMPLETED|Period 1 TZD Randomization||0
280622|NCT00879970|678388|P3|COMPLETED|Period 1 TZD Randomization||393
280623|NCT00879970|678389|P2|COMPLETED|Period 1 TZD Randomization||388
280624|NCT00879970|678390|P1|COMPLETED|Period 1 TZD Randomization||533
280625|NCT00879970|678386|P5|STARTED|Period 1 TZD Randomization||0
280626|NCT00879970|678387|P4|STARTED|Period 1 TZD Randomization||0
280627|NCT00879970|678388|P3|STARTED|Period 1 TZD Randomization||399
280628|NCT00879970|678389|P2|STARTED|Period 1 TZD Randomization||392
280629|NCT00879970|678390|P1|STARTED|Period 1 TZD Randomization||541
280630|NCT00879879|678472|P1|NOT COMPLETED|Overall Study||3
280631|NCT00879879|678472|P1|COMPLETED|Overall Study||17
280632|NCT00879879|678472|P1|STARTED|Overall Study||20
280633|NCT00879814|678480|P4|NOT COMPLETED|Overall Study||5
280634|NCT00879814|678481|P3|NOT COMPLETED|Overall Study||3
280635|NCT00879814|678482|P2|NOT COMPLETED|Overall Study||2
280636|NCT00879814|678483|P1|NOT COMPLETED|Overall Study||4
280637|NCT00879814|678480|P4|COMPLETED|Overall Study||7
280638|NCT00879814|678481|P3|COMPLETED|Overall Study||9
280639|NCT00879814|678482|P2|COMPLETED|Overall Study||10
280640|NCT00879814|678483|P1|COMPLETED|Overall Study||8
280641|NCT00879814|678480|P4|STARTED|Overall Study||12
280642|NCT00879814|678481|P3|STARTED|Overall Study||12
280643|NCT00879814|678482|P2|STARTED|Overall Study||12
280644|NCT00879814|678483|P1|STARTED|Overall Study||12
280645|NCT00879775|678591|P2|NOT COMPLETED|Overall Study||1
280646|NCT00879775|678592|P1|NOT COMPLETED|Overall Study||2
280647|NCT00879775|678591|P2|COMPLETED|Overall Study||20
280648|NCT00879775|678592|P1|COMPLETED|Overall Study||18
280649|NCT00879775|678591|P2|STARTED|Overall Study||21
280650|NCT00879775|678592|P1|STARTED|Overall Study||20
280651|NCT00879710|678608|P4|NOT COMPLETED|Phase 2 6 Weeks||0
280652|NCT00879710|678609|P3|NOT COMPLETED|Phase 2 6 Weeks||0
280653|NCT00879710|678610|P2|NOT COMPLETED|Phase 2 6 Weeks||0
280654|NCT00879710|678611|P1|NOT COMPLETED|Phase 2 6 Weeks||0
280655|NCT00879710|678608|P4|COMPLETED|Phase 2 6 Weeks||13
280656|NCT00879710|678609|P3|COMPLETED|Phase 2 6 Weeks||10
280657|NCT00879710|678610|P2|COMPLETED|Phase 2 6 Weeks||14
280658|NCT00879710|678611|P1|COMPLETED|Phase 2 6 Weeks||10
280659|NCT00879710|678608|P4|STARTED|Phase 2 6 Weeks||13
280660|NCT00879710|678609|P3|STARTED|Phase 2 6 Weeks||10
280661|NCT00879710|678610|P2|STARTED|Phase 2 6 Weeks||14
280662|NCT00879710|678611|P1|STARTED|Phase 2 6 Weeks||10
280663|NCT00879710|678608|P4|NOT COMPLETED|Wash Out Period of 4 Weeks||0
280664|NCT00879710|678609|P3|NOT COMPLETED|Wash Out Period of 4 Weeks||0
280665|NCT00879710|678610|P2|NOT COMPLETED|Wash Out Period of 4 Weeks||0
280666|NCT00879710|678611|P1|NOT COMPLETED|Wash Out Period of 4 Weeks||0
280667|NCT00879710|678608|P4|COMPLETED|Wash Out Period of 4 Weeks||13
280668|NCT00879710|678609|P3|COMPLETED|Wash Out Period of 4 Weeks||10
280669|NCT00879710|678610|P2|COMPLETED|Wash Out Period of 4 Weeks||14
280670|NCT00879710|678611|P1|COMPLETED|Wash Out Period of 4 Weeks||10
280671|NCT00879710|678608|P4|STARTED|Wash Out Period of 4 Weeks||13
280672|NCT00879710|678609|P3|STARTED|Wash Out Period of 4 Weeks|The person who did not complete ezetimibe arm came back to complete simvastatin arm.|10
280673|NCT00879710|678610|P2|STARTED|Wash Out Period of 4 Weeks||14
280674|NCT00879710|678611|P1|STARTED|Wash Out Period of 4 Weeks||10
280675|NCT00879710|678608|P4|NOT COMPLETED|Phase 1 - 6 Weeks||4
280676|NCT00879710|678609|P3|NOT COMPLETED|Phase 1 - 6 Weeks||2
280677|NCT00879710|678610|P2|NOT COMPLETED|Phase 1 - 6 Weeks||3
280678|NCT00879710|678611|P1|NOT COMPLETED|Phase 1 - 6 Weeks||2
280679|NCT00879710|678608|P4|COMPLETED|Phase 1 - 6 Weeks||13
280680|NCT00879710|678609|P3|COMPLETED|Phase 1 - 6 Weeks||9
280681|NCT00879710|678610|P2|COMPLETED|Phase 1 - 6 Weeks||14
280682|NCT00879710|678611|P1|COMPLETED|Phase 1 - 6 Weeks||10
280683|NCT00879710|678608|P4|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|17
280684|NCT00879710|678609|P3|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|11
280685|NCT00879710|678610|P2|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|17
280686|NCT00879710|678611|P1|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|12
280687|NCT00879697|678621|P2|NOT COMPLETED|Overall Study||2
280688|NCT00879697|678622|P1|NOT COMPLETED|Overall Study||2
280689|NCT00879697|678621|P2|COMPLETED|Overall Study|Two patients did not finish the trial|15
280690|NCT00879697|678622|P1|COMPLETED|Overall Study|Two patients did not finish the trial|15
280691|NCT00879697|678621|P2|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
280692|NCT00879697|678622|P1|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
280693|NCT00879684|678628|P7|NOT COMPLETED|Stage 2: Expanded Cohort||13
280694|NCT00879684|678629|P6|NOT COMPLETED|Stage 2: Expanded Cohort||0
280695|NCT00879684|678630|P5|NOT COMPLETED|Stage 2: Expanded Cohort||0
280696|NCT00879684|678631|P4|NOT COMPLETED|Stage 2: Expanded Cohort||0
280697|NCT00879684|678632|P3|NOT COMPLETED|Stage 2: Expanded Cohort||0
280698|NCT00879684|678633|P2|NOT COMPLETED|Stage 2: Expanded Cohort||0
280699|NCT00879684|678634|P1|NOT COMPLETED|Stage 2: Expanded Cohort||0
280700|NCT00879684|678628|P7|COMPLETED|Stage 2: Expanded Cohort||0
280701|NCT00879684|678629|P6|COMPLETED|Stage 2: Expanded Cohort||0
280702|NCT00879684|678630|P5|COMPLETED|Stage 2: Expanded Cohort||0
280703|NCT00879684|678631|P4|COMPLETED|Stage 2: Expanded Cohort||0
280704|NCT00879684|678632|P3|COMPLETED|Stage 2: Expanded Cohort||0
280705|NCT00879684|678633|P2|COMPLETED|Stage 2: Expanded Cohort||0
280706|NCT00879684|678634|P1|COMPLETED|Stage 2: Expanded Cohort||0
280707|NCT00879684|678628|P7|STARTED|Stage 2: Expanded Cohort||13
280708|NCT00879684|678629|P6|STARTED|Stage 2: Expanded Cohort||0
280709|NCT00879684|678630|P5|STARTED|Stage 2: Expanded Cohort||0
280710|NCT00879684|678631|P4|STARTED|Stage 2: Expanded Cohort||0
280711|NCT00879684|678632|P3|STARTED|Stage 2: Expanded Cohort||0
280712|NCT00879684|678633|P2|STARTED|Stage 2: Expanded Cohort||0
280713|NCT00879684|678634|P1|STARTED|Stage 2: Expanded Cohort||0
280714|NCT00879684|678628|P7|NOT COMPLETED|Stage 1: Dose Escalation||0
280715|NCT00879684|678629|P6|NOT COMPLETED|Stage 1: Dose Escalation||3
280716|NCT00879684|678630|P5|NOT COMPLETED|Stage 1: Dose Escalation||3
280717|NCT00879684|678631|P4|NOT COMPLETED|Stage 1: Dose Escalation||6
280718|NCT00879684|678632|P3|NOT COMPLETED|Stage 1: Dose Escalation||3
280719|NCT00879684|678633|P2|NOT COMPLETED|Stage 1: Dose Escalation||3
280720|NCT00879684|678634|P1|NOT COMPLETED|Stage 1: Dose Escalation||3
280721|NCT00879684|678628|P7|COMPLETED|Stage 1: Dose Escalation||0
280722|NCT00879684|678629|P6|COMPLETED|Stage 1: Dose Escalation||0
280723|NCT00879684|678630|P5|COMPLETED|Stage 1: Dose Escalation||0
280724|NCT00879684|678631|P4|COMPLETED|Stage 1: Dose Escalation||0
280725|NCT00879684|678632|P3|COMPLETED|Stage 1: Dose Escalation||0
280726|NCT00879684|678633|P2|COMPLETED|Stage 1: Dose Escalation||0
280727|NCT00879684|678634|P1|COMPLETED|Stage 1: Dose Escalation||0
280728|NCT00879684|678628|P7|STARTED|Stage 1: Dose Escalation||0
280729|NCT00879684|678629|P6|STARTED|Stage 1: Dose Escalation||3
280730|NCT00879684|678630|P5|STARTED|Stage 1: Dose Escalation||3
280731|NCT00879684|678631|P4|STARTED|Stage 1: Dose Escalation||6
280732|NCT00879684|678632|P3|STARTED|Stage 1: Dose Escalation||3
280733|NCT00879684|678633|P2|STARTED|Stage 1: Dose Escalation||3
280734|NCT00879684|678634|P1|STARTED|Stage 1: Dose Escalation||3
280735|NCT00879645|678700|P4|NOT COMPLETED|Overall Study||0
280736|NCT00879645|678701|P3|NOT COMPLETED|Overall Study||0
280737|NCT00879645|678702|P2|NOT COMPLETED|Overall Study||0
280738|NCT00879645|678703|P1|NOT COMPLETED|Overall Study||1
280739|NCT00879645|678700|P4|COMPLETED|Overall Study||7
280740|NCT00879645|678701|P3|COMPLETED|Overall Study||6
280741|NCT00879645|678702|P2|COMPLETED|Overall Study||6
280742|NCT00879645|678703|P1|COMPLETED|Overall Study||8
280743|NCT00879645|678700|P4|STARTED|Overall Study||7
280744|NCT00879645|678701|P3|STARTED|Overall Study||6
280745|NCT00879645|678702|P2|STARTED|Overall Study||6
280746|NCT00879645|678703|P1|STARTED|Overall Study||9
280747|NCT00879619|678721|P1|NOT COMPLETED|Overall Study||0
280748|NCT00879619|678721|P1|COMPLETED|Overall Study||4
280749|NCT00879619|678721|P1|STARTED|Overall Study||4
280750|NCT00879411|678730|P1|NOT COMPLETED|Overall Study||162
280751|NCT00879411|678730|P1|COMPLETED|Overall Study||539
280752|NCT00879411|678730|P1|STARTED|Overall Study||701
280753|NCT00879398|678736|P1|NOT COMPLETED|Overall Study||675
280754|NCT00879398|678736|P1|COMPLETED|Overall Study||2434
280755|NCT00879398|678736|P1|STARTED|Overall Study||3109
280756|NCT00879359|678746|P1|NOT COMPLETED|Overall Study||0
280757|NCT00879359|678746|P1|COMPLETED|Overall Study||15
280758|NCT00879359|678746|P1|STARTED|Overall Study||15
280759|NCT00879333|678754|P2|NOT COMPLETED|Overall Study||217
280760|NCT00879333|678755|P1|NOT COMPLETED|Overall Study||428
280761|NCT00879333|678754|P2|COMPLETED|Overall Study||0
280762|NCT00879333|678755|P1|COMPLETED|Overall Study|Completed=Patients Still on Treatment; At data cutoff final analysis, 11 patients were on treatment|11
280763|NCT00879333|678754|P2|Discontinued Study Treatment|Overall Study||217
280764|NCT00879333|678755|P1|Discontinued Study Treatment|Overall Study||428
280765|NCT00879333|678754|P2|STARTED|Overall Study||217
280766|NCT00879333|678755|P1|STARTED|Overall Study||439
280767|NCT00879255|678775|P2|NOT COMPLETED|Overall Study||19
280768|NCT00879255|678776|P1|NOT COMPLETED|Overall Study||16
280769|NCT00879255|678775|P2|COMPLETED|Overall Study|Completed 6-mo follow-up|45
280770|NCT00879255|678776|P1|COMPLETED|Overall Study|Completed 6-mo follow-up|45
280771|NCT00879255|678775|P2|Completed 3-mo Follow-up|Overall Study||49
280772|NCT00879255|678776|P1|Completed 3-mo Follow-up|Overall Study||48
280773|NCT00879255|678775|P2|Completed Posttreatment Follow-up|Overall Study||55
280774|NCT00879255|678776|P1|Completed Posttreatment Follow-up|Overall Study||50
280775|NCT00879255|678775|P2|Received Allocated Intervention:|Overall Study||56
280776|NCT00879255|678776|P1|Received Allocated Intervention:|Overall Study||51
280777|NCT00879255|678775|P2|STARTED|Overall Study||64
280778|NCT00879255|678776|P1|STARTED|Overall Study||61
280779|NCT00879229|678788|P2|NOT COMPLETED|Overall Study||14
280780|NCT00879229|678789|P1|NOT COMPLETED|Overall Study||22
280781|NCT00879229|678788|P2|COMPLETED|Overall Study||1
280782|NCT00879229|678789|P1|COMPLETED|Overall Study||3
280783|NCT00879229|678788|P2|STARTED|Overall Study||15
280784|NCT00879229|678789|P1|STARTED|Overall Study||25
280785|NCT00879190|678815|P2|NOT COMPLETED|Overall Study||0
280786|NCT00879190|678816|P1|NOT COMPLETED|Overall Study||0
280787|NCT00879190|678815|P2|COMPLETED|Overall Study||49
280788|NCT00879190|678816|P1|COMPLETED|Overall Study||43
280789|NCT00879190|678815|P2|STARTED|Overall Study||49
280790|NCT00879190|678816|P1|STARTED|Overall Study||43
280791|NCT00879034|678826|P1|NOT COMPLETED|Overall Study||0
280792|NCT00879034|678826|P1|COMPLETED|Overall Study||5
280793|NCT00879034|678826|P1|Received Treatment|Overall Study||4
280794|NCT00879034|678826|P1|STARTED|Overall Study||5
280795|NCT00878995|678837|P2|NOT COMPLETED|Midpoint Study - Post Study||0
280796|NCT00878995|678838|P1|NOT COMPLETED|Midpoint Study - Post Study||0
280797|NCT00878995|678837|P2|COMPLETED|Midpoint Study - Post Study||10
280798|NCT00878995|678838|P1|COMPLETED|Midpoint Study - Post Study||12
280799|NCT00878995|678837|P2|STARTED|Midpoint Study - Post Study||10
280800|NCT00878995|678838|P1|STARTED|Midpoint Study - Post Study||12
280801|NCT00878995|678837|P2|NOT COMPLETED|Baseline Study - Midpoint Study||2
280802|NCT00878995|678838|P1|NOT COMPLETED|Baseline Study - Midpoint Study||0
280803|NCT00878995|678837|P2|COMPLETED|Baseline Study - Midpoint Study|2 subjects dropped after the baseline study. They decided to seek treatment closer to home.|10
280804|NCT00878995|678838|P1|COMPLETED|Baseline Study - Midpoint Study||12
280805|NCT00878995|678837|P2|Baseline Study|Baseline Study - Midpoint Study||12
280806|NCT00878995|678838|P1|Baseline Study|Baseline Study - Midpoint Study||12
280807|NCT00878995|678837|P2|STARTED|Baseline Study - Midpoint Study||12
280808|NCT00878995|678838|P1|STARTED|Baseline Study - Midpoint Study||12
280809|NCT00878969|678939|P3|NOT COMPLETED|Overall Study||11
280810|NCT00878969|678940|P2|NOT COMPLETED|Overall Study||15
280811|NCT00878969|678941|P1|NOT COMPLETED|Overall Study||15
280812|NCT00878969|678939|P3|COMPLETED|Overall Study||15
280813|NCT00878969|678940|P2|COMPLETED|Overall Study||12
280814|NCT00878969|678941|P1|COMPLETED|Overall Study||10
280815|NCT00878969|678939|P3|STARTED|Overall Study||26
280816|NCT00878969|678940|P2|STARTED|Overall Study||27
280817|NCT00878969|678941|P1|STARTED|Overall Study||25
280818|NCT00878878|678951|P2|NOT COMPLETED|Overall Study||0
280819|NCT00878878|678952|P1|NOT COMPLETED|Overall Study||0
280820|NCT00878878|678951|P2|COMPLETED|Overall Study||15
280821|NCT00878878|678952|P1|COMPLETED|Overall Study||15
280822|NCT00878878|678951|P2|STARTED|Overall Study||15
280823|NCT00878878|678952|P1|STARTED|Overall Study||15
280824|NCT00878826|678965|P3|NOT COMPLETED|Overall Study||0
280825|NCT00878826|678966|P2|NOT COMPLETED|Overall Study||0
280826|NCT00878826|678967|P1|NOT COMPLETED|Overall Study||0
280827|NCT00878826|678965|P3|COMPLETED|Overall Study||2
280828|NCT00878826|678966|P2|COMPLETED|Overall Study||6
280829|NCT00878826|678967|P1|COMPLETED|Overall Study||3
280830|NCT00878826|678965|P3|STARTED|Overall Study||2
280831|NCT00878826|678966|P2|STARTED|Overall Study||6
280832|NCT00878826|678967|P1|STARTED|Overall Study||3
280833|NCT00878800|678989|P5|NOT COMPLETED|Overall Study||16
280834|NCT00878800|678990|P4|NOT COMPLETED|Overall Study||6
280835|NCT00878800|678991|P3|NOT COMPLETED|Overall Study||9
280836|NCT00878800|678992|P2|NOT COMPLETED|Overall Study||7
280837|NCT00878800|678993|P1|NOT COMPLETED|Overall Study||3
280838|NCT00878800|678989|P5|COMPLETED|Overall Study|Mean number of cycles administered: 6.4|0
280839|NCT00878800|678990|P4|COMPLETED|Overall Study|Mean number of cycles administered: 5.3|0
280840|NCT00878800|678991|P3|COMPLETED|Overall Study|Mean number of cycles administered: 3.0|0
280841|NCT00878800|678992|P2|COMPLETED|Overall Study|Mean number of cycles administered: 4.6|0
280842|NCT00878800|678993|P1|COMPLETED|Overall Study|Mean number of cycles administered: 4.0|0
280843|NCT00878800|678989|P5|STARTED|Overall Study||16
280844|NCT00878800|678990|P4|STARTED|Overall Study||6
280845|NCT00878800|678991|P3|STARTED|Overall Study||9
280846|NCT00878800|678992|P2|STARTED|Overall Study||7
280847|NCT00878800|678993|P1|STARTED|Overall Study||3
280848|NCT00878722|679028|P8|NOT COMPLETED|Overall Study||7
280849|NCT00878722|679029|P7|NOT COMPLETED|Overall Study||6
280850|NCT00878722|679030|P6|NOT COMPLETED|Overall Study||2
280851|NCT00878722|679031|P5|NOT COMPLETED|Overall Study||7
280852|NCT00878722|679032|P4|NOT COMPLETED|Overall Study||9
280853|NCT00878722|679033|P3|NOT COMPLETED|Overall Study||3
280854|NCT00878722|679034|P2|NOT COMPLETED|Overall Study||3
280855|NCT00878722|679035|P1|NOT COMPLETED|Overall Study||3
280856|NCT00878722|679028|P8|COMPLETED|Overall Study||0
280857|NCT00878722|679029|P7|COMPLETED|Overall Study||0
280858|NCT00878722|679030|P6|COMPLETED|Overall Study||1
280859|NCT00878722|679031|P5|COMPLETED|Overall Study||0
280860|NCT00878722|679032|P4|COMPLETED|Overall Study||0
280861|NCT00878722|679033|P3|COMPLETED|Overall Study||0
280862|NCT00878722|679034|P2|COMPLETED|Overall Study||0
280863|NCT00878722|679035|P1|COMPLETED|Overall Study||0
280864|NCT00878722|679028|P8|STARTED|Overall Study||7
280865|NCT00878722|679029|P7|STARTED|Overall Study||6
280866|NCT00878722|679030|P6|STARTED|Overall Study||3
280867|NCT00878722|679031|P5|STARTED|Overall Study||7
280868|NCT00878722|679032|P4|STARTED|Overall Study||9
280869|NCT00878722|679033|P3|STARTED|Overall Study||3
280870|NCT00878722|679034|P2|STARTED|Overall Study||3
280871|NCT00878722|679035|P1|STARTED|Overall Study||3
280872|NCT00878709|679120|P2|NOT COMPLETED|Overall Study||237
280873|NCT00878709|679121|P1|NOT COMPLETED|Overall Study||325
280874|NCT00878709|679120|P2|COMPLETED|Overall Study||1183
280875|NCT00878709|679121|P1|COMPLETED|Overall Study||1095
280876|NCT00878709|679120|P2|STARTED|Overall Study||1420
280877|NCT00878709|679121|P1|STARTED|Overall Study||1420
280878|NCT00878644|679147|P2|NOT COMPLETED|Overall Study||4
280879|NCT00878644|679148|P1|NOT COMPLETED|Overall Study||4
280880|NCT00878644|679147|P2|COMPLETED|Overall Study||136
280881|NCT00878644|679148|P1|COMPLETED|Overall Study||151
280882|NCT00878644|679147|P2|STARTED|Overall Study||140
280883|NCT00878644|679148|P1|STARTED|Overall Study||155
280884|NCT00878605|679164|P4|NOT COMPLETED|Overall Study||3
280885|NCT00878605|679165|P3|NOT COMPLETED|Overall Study||1
280886|NCT00878605|679166|P2|NOT COMPLETED|Overall Study||3
280887|NCT00878605|679167|P1|NOT COMPLETED|Overall Study||3
280888|NCT00878605|679164|P4|COMPLETED|Overall Study||6
280889|NCT00878605|679165|P3|COMPLETED|Overall Study||8
280890|NCT00878605|679166|P2|COMPLETED|Overall Study||7
280891|NCT00878605|679167|P1|COMPLETED|Overall Study||7
280892|NCT00878605|679164|P4|STARTED|Overall Study||9
280893|NCT00878605|679165|P3|STARTED|Overall Study||9
280894|NCT00878605|679166|P2|STARTED|Overall Study||10
280895|NCT00878605|679167|P1|STARTED|Overall Study||10
280896|NCT00878553|679181|P5|NOT COMPLETED|PK Study||0
280897|NCT00878553|679182|P4|NOT COMPLETED|PK Study||1
280898|NCT00878553|679183|P3|NOT COMPLETED|PK Study||0
280899|NCT00878553|679184|P2|NOT COMPLETED|PK Study||0
280900|NCT00878553|679185|P1|NOT COMPLETED|PK Study||0
280901|NCT00878553|679181|P5|COMPLETED|PK Study||15
280902|NCT00878553|679182|P4|COMPLETED|PK Study|One patient withdrew consent after completing the Sleep Substudy and prior to starting PK substudy.|13
280903|NCT00878553|679183|P3|COMPLETED|PK Study||17
280904|NCT00878553|679184|P2|COMPLETED|PK Study||16
280905|NCT00878553|679185|P1|COMPLETED|PK Study|A total of 61 randomized patients completed this parallel group, single dose PK substudy.|0
280906|NCT00878553|679181|P5|STARTED|PK Study|During the PK period, 15 randomized participants received one bedtime dose of 20mg SKP-1041.|15
280907|NCT00878553|679182|P4|STARTED|PK Study|During the PK period, 14 participants were randomized to receive one bedtime dose of 15mg SKP-1041.|14
280908|NCT00878553|679183|P3|STARTED|PK Study|During the PK period, 17 randomized participants received one bedtime dose of 10mg SKP-1041.|17
280909|NCT00878553|679184|P2|STARTED|PK Study|During the PK period, 16 randomized participants received one bedtime dose of SKP-1041 placebo.|16
280910|NCT00878553|679185|P1|STARTED|PK Study|A total of 62 randomized patients started this parallel group, single dose PK substudy.|0
280911|NCT00878553|679181|P5|NOT COMPLETED|Sleep Study||0
280912|NCT00878553|679182|P4|NOT COMPLETED|Sleep Study||0
280913|NCT00878553|679183|P3|NOT COMPLETED|Sleep Study||0
280914|NCT00878553|679184|P2|NOT COMPLETED|Sleep Study||0
280915|NCT00878553|679185|P1|NOT COMPLETED|Sleep Study||5
280916|NCT00878553|679181|P5|COMPLETED|Sleep Study||0
280917|NCT00878553|679182|P4|COMPLETED|Sleep Study||0
280918|NCT00878553|679183|P3|COMPLETED|Sleep Study||0
280919|NCT00878553|679184|P2|COMPLETED|Sleep Study||0
280920|NCT00878553|679185|P1|COMPLETED|Sleep Study|5 patient withdraws result in greater than 5 lost patient data across groups due to CROSSOVER design|62
280921|NCT00878553|679181|P5|Number of Patients Receiving 20mg|Sleep Study||0
280922|NCT00878553|679182|P4|Number of Patients Receiving 20mg|Sleep Study||0
280923|NCT00878553|679183|P3|Number of Patients Receiving 20mg|Sleep Study||0
280924|NCT00878553|679184|P2|Number of Patients Receiving 20mg|Sleep Study||0
280925|NCT00878553|679185|P1|Number of Patients Receiving 20mg|Sleep Study||65
280926|NCT00878553|679181|P5|Number of Patients Receiving 15mg|Sleep Study||0
280927|NCT00878553|679182|P4|Number of Patients Receiving 15mg|Sleep Study||0
280928|NCT00878553|679183|P3|Number of Patients Receiving 15mg|Sleep Study||0
280929|NCT00878553|679184|P2|Number of Patients Receiving 15mg|Sleep Study||0
280930|NCT00878553|679185|P1|Number of Patients Receiving 15mg|Sleep Study||65
280931|NCT00878553|679181|P5|Number of Patients Receiving 10mg|Sleep Study||0
280932|NCT00878553|679182|P4|Number of Patients Receiving 10mg|Sleep Study||0
280933|NCT00878553|679183|P3|Number of Patients Receiving 10mg|Sleep Study||0
280934|NCT00878553|679184|P2|Number of Patients Receiving 10mg|Sleep Study||0
280935|NCT00878553|679185|P1|Number of Patients Receiving 10mg|Sleep Study||65
280936|NCT00878553|679181|P5|Number of Patients Receiving Placebo|Sleep Study||0
280937|NCT00878553|679182|P4|Number of Patients Receiving Placebo|Sleep Study||0
280938|NCT00878553|679183|P3|Number of Patients Receiving Placebo|Sleep Study||0
280939|NCT00878553|679184|P2|Number of Patients Receiving Placebo|Sleep Study||0
280940|NCT00878553|679185|P1|Number of Patients Receiving Placebo|Sleep Study||66
280941|NCT00878553|679181|P5|STARTED|Sleep Study||0
280942|NCT00878553|679182|P4|STARTED|Sleep Study||0
280943|NCT00878553|679183|P3|STARTED|Sleep Study||0
280944|NCT00878553|679184|P2|STARTED|Sleep Study||0
280945|NCT00878553|679185|P1|STARTED|Sleep Study|This Intention to Treat population includes all randomized patients; one dropped prior to treatment.|67
280946|NCT00878501|679244|P3|NOT COMPLETED|Overall Study||8
280947|NCT00878501|679245|P2|NOT COMPLETED|Overall Study||7
280948|NCT00878501|679246|P1|NOT COMPLETED|Overall Study||17
280949|NCT00878501|679244|P3|COMPLETED|Overall Study||85
280950|NCT00878501|679245|P2|COMPLETED|Overall Study||37
280951|NCT00878501|679246|P1|COMPLETED|Overall Study||87
280952|NCT00878501|679244|P3|Interim Analysis|Overall Study||81
280953|NCT00878501|679245|P2|Interim Analysis|Overall Study||37
280954|NCT00878501|679246|P1|Interim Analysis|Overall Study||83
280955|NCT00878501|679244|P3|STARTED|Overall Study||93
280956|NCT00878501|679245|P2|STARTED|Overall Study||44
280957|NCT00878501|679246|P1|STARTED|Overall Study|One of these patients did not receive study drug since incorrectly enrolled (mis-randomisation)|104
280958|NCT00878436|679265|P2|NOT COMPLETED|Overall Study||24
280959|NCT00878436|679266|P1|NOT COMPLETED|Overall Study||23
280960|NCT00878436|679265|P2|COMPLETED|Overall Study||0
280961|NCT00878436|679266|P1|COMPLETED|Overall Study||5
280962|NCT00878436|679265|P2|6 Months|Overall Study||0
280963|NCT00878436|679266|P1|6 Months|Overall Study||8
280964|NCT00878436|679265|P2|Completed 2 Cycles|Overall Study||20
280965|NCT00878436|679266|P1|Completed 2 Cycles|Overall Study||21
280966|NCT00878436|679265|P2|STARTED|Overall Study||24
280967|NCT00878436|679266|P1|STARTED|Overall Study||28
280968|NCT00878228|679280|P2|NOT COMPLETED|Overall Study||12
280969|NCT00878228|679281|P1|NOT COMPLETED|Overall Study||10
280970|NCT00878228|679280|P2|COMPLETED|Overall Study||37
280971|NCT00878228|679281|P1|COMPLETED|Overall Study||39
280972|NCT00878228|679280|P2|STARTED|Overall Study||49
280973|NCT00878228|679281|P1|STARTED|Overall Study||49
280974|NCT00878215|679295|P4|NOT COMPLETED|Overall Study||0
280975|NCT00878215|679296|P3|NOT COMPLETED|Overall Study||0
280976|NCT00878215|679297|P2|NOT COMPLETED|Overall Study||10
280977|NCT00878215|679298|P1|NOT COMPLETED|Overall Study||0
280978|NCT00878215|679295|P4|COMPLETED|Overall Study||0
280979|NCT00878215|679296|P3|COMPLETED|Overall Study||0
280980|NCT00878215|679297|P2|COMPLETED|Overall Study||9
280981|NCT00878215|679298|P1|COMPLETED|Overall Study||21
280982|NCT00878215|679295|P4|STARTED|Overall Study|Phase 4 not performed because the liver imaging system became commercially available|0
280983|NCT00878215|679296|P3|STARTED|Overall Study|Phase 3 not performed because the liver imaging system became commercially available|0
280984|NCT00878215|679297|P2|STARTED|Overall Study||19
280985|NCT00878215|679298|P1|STARTED|Overall Study||21
280986|NCT00878189|679310|P9|NOT COMPLETED|Overall Study||8
280987|NCT00878189|679311|P8|NOT COMPLETED|Overall Study||3
280988|NCT00878189|679312|P7|NOT COMPLETED|Overall Study||16
280989|NCT00878189|679313|P6|NOT COMPLETED|Overall Study||23
280990|NCT00878189|679314|P5|NOT COMPLETED|Overall Study||4
280991|NCT00878189|679315|P4|NOT COMPLETED|Overall Study||8
280992|NCT00878189|679316|P3|NOT COMPLETED|Overall Study||4
280993|NCT00878189|679317|P2|NOT COMPLETED|Overall Study||3
280994|NCT00878189|679318|P1|NOT COMPLETED|Overall Study||3
280995|NCT00878189|679310|P9|COMPLETED|Overall Study||0
280996|NCT00878189|679311|P8|COMPLETED|Overall Study||0
280997|NCT00878189|679312|P7|COMPLETED|Overall Study||0
280998|NCT00878189|679313|P6|COMPLETED|Overall Study||0
280999|NCT00878189|679314|P5|COMPLETED|Overall Study||0
281000|NCT00878189|679315|P4|COMPLETED|Overall Study||0
281001|NCT00878189|679316|P3|COMPLETED|Overall Study||0
281002|NCT00878189|679317|P2|COMPLETED|Overall Study||0
281003|NCT00878189|679318|P1|COMPLETED|Overall Study||0
281004|NCT00878189|679310|P9|STARTED|Overall Study||8
281005|NCT00878189|679311|P8|STARTED|Overall Study||3
281006|NCT00878189|679312|P7|STARTED|Overall Study||16
281007|NCT00878189|679313|P6|STARTED|Overall Study||23
281008|NCT00878189|679314|P5|STARTED|Overall Study||4
281009|NCT00878189|679315|P4|STARTED|Overall Study||8
281010|NCT00878189|679316|P3|STARTED|Overall Study||4
281011|NCT00878189|679317|P2|STARTED|Overall Study||3
281012|NCT00878189|679318|P1|STARTED|Overall Study||3
281013|NCT00877929|679586|P2|NOT COMPLETED|Overall Study||35
281014|NCT00877929|679587|P1|NOT COMPLETED|Overall Study||20
281015|NCT00877929|679586|P2|COMPLETED|Overall Study||319
281016|NCT00877929|679587|P1|COMPLETED|Overall Study||332
281017|NCT00877929|679586|P2|STARTED|Overall Study||354
281018|NCT00877929|679587|P1|STARTED|Overall Study||352
281019|NCT00877890|679675|P2|NOT COMPLETED|Overall Study||30
281020|NCT00877890|679676|P1|NOT COMPLETED|Overall Study||20
281021|NCT00877890|679675|P2|COMPLETED|Overall Study||95
281022|NCT00877890|679676|P1|COMPLETED|Overall Study||109
281023|NCT00877890|679675|P2|Intent to Treat (ITT)|Overall Study||123
281024|NCT00877890|679676|P1|Intent to Treat (ITT)|Overall Study||129
281025|NCT00877890|679675|P2|STARTED|Overall Study||125
281026|NCT00877890|679676|P1|STARTED|Overall Study||129
281027|NCT00877877|679710|P1|NOT COMPLETED|Year 10||0
281028|NCT00877877|679710|P1|COMPLETED|Year 10||495
281029|NCT00877877|679710|P1|STARTED|Year 10||495
281030|NCT00877877|679710|P1|NOT COMPLETED|Year 9||0
281031|NCT00877877|679710|P1|COMPLETED|Year 9||507
281032|NCT00877877|679710|P1|STARTED|Year 9||507
281033|NCT00877877|679710|P1|NOT COMPLETED|Year 8||0
281034|NCT00877877|679710|P1|COMPLETED|Year 8||522
281035|NCT00877877|679710|P1|STARTED|Year 8||522
281036|NCT00877877|679710|P1|NOT COMPLETED|Year 7||0
281037|NCT00877877|679710|P1|COMPLETED|Year 7||523
281038|NCT00877877|679710|P1|STARTED|Year 7||523
281039|NCT00877877|679710|P1|NOT COMPLETED|Year 6||0
281040|NCT00877877|679710|P1|COMPLETED|Year 6||529
281041|NCT00877877|679710|P1|STARTED|Year 6||529
281042|NCT00877877|679710|P1|NOT COMPLETED|Year 5||0
281043|NCT00877877|679710|P1|COMPLETED|Year 5||397
281044|NCT00877877|679710|P1|STARTED|Year 5||397
281045|NCT00877799|679741|P5|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||1
281046|NCT00877799|679742|P4|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||2
281047|NCT00877799|679743|P3|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
281048|NCT00877799|679744|P2|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
281049|NCT00877799|679745|P1|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
281050|NCT00877799|679741|P5|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||19
281051|NCT00877799|679742|P4|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||24
281052|NCT00877799|679743|P3|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
281053|NCT00877799|679744|P2|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
281054|NCT00877799|679745|P1|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
281055|NCT00877799|679741|P5|STARTED|Cohort 2: Immediately Post-op (Day 0)||20
281056|NCT00877799|679742|P4|STARTED|Cohort 2: Immediately Post-op (Day 0)||26
281057|NCT00877799|679743|P3|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
281058|NCT00877799|679744|P2|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
281059|NCT00877799|679745|P1|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
281060|NCT00877799|679741|P5|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
281061|NCT00877799|679742|P4|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
281151|NCT00877032|679882|P1|COMPLETED|Overall Study||6
281062|NCT00877799|679743|P3|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
281063|NCT00877799|679744|P2|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||5
281064|NCT00877799|679745|P1|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
281065|NCT00877799|679741|P5|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
281066|NCT00877799|679742|P4|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
281067|NCT00877799|679743|P3|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||18
281068|NCT00877799|679744|P2|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||17
281069|NCT00877799|679745|P1|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||22
281070|NCT00877799|679741|P5|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
281071|NCT00877799|679742|P4|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
281072|NCT00877799|679743|P3|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||21
281073|NCT00877799|679744|P2|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||22
281074|NCT00877799|679745|P1|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||25
281075|NCT00877773|679760|P1|NOT COMPLETED|Overall Study||44
281076|NCT00877773|679760|P1|COMPLETED|Overall Study|No participant reached to first restaging.|0
281077|NCT00877773|679760|P1|STARTED|Overall Study||44
281078|NCT00877604|679766|P2|NOT COMPLETED|Overall Study||3
281079|NCT00877604|679767|P1|NOT COMPLETED|Overall Study||2
281080|NCT00877604|679766|P2|COMPLETED|Overall Study||14
281081|NCT00877604|679767|P1|COMPLETED|Overall Study||15
281082|NCT00877604|679766|P2|STARTED|Overall Study||17
281083|NCT00877604|679767|P1|STARTED|Overall Study||17
281084|NCT00877487|679773|P2|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||47
281085|NCT00877487|679774|P1|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||6
281086|NCT00877487|679773|P2|COMPLETED|Double-blind Randomized Withdrawal Phase||13
281087|NCT00877487|679774|P1|COMPLETED|Double-blind Randomized Withdrawal Phase||50
281088|NCT00877487|679773|P2|STARTED|Double-blind Randomized Withdrawal Phase||60
281089|NCT00877487|679774|P1|STARTED|Double-blind Randomized Withdrawal Phase||56
281090|NCT00877487|679773|P2|NOT COMPLETED|Open-label Treatment Phase||0
281091|NCT00877487|679774|P1|NOT COMPLETED|Open-label Treatment Phase||7
281092|NCT00877487|679773|P2|COMPLETED|Open-label Treatment Phase||0
281093|NCT00877487|679774|P1|COMPLETED|Open-label Treatment Phase||116
281094|NCT00877487|679773|P2|STARTED|Open-label Treatment Phase||0
281095|NCT00877487|679774|P1|STARTED|Open-label Treatment Phase||123
281096|NCT00877448|679791|P7|NOT COMPLETED|Overall Study||0
281097|NCT00877448|679792|P6|NOT COMPLETED|Overall Study||1
281098|NCT00877448|679793|P5|NOT COMPLETED|Overall Study||0
281099|NCT00877448|679794|P4|NOT COMPLETED|Overall Study||1
281100|NCT00877448|679795|P3|NOT COMPLETED|Overall Study||0
281101|NCT00877448|679796|P2|NOT COMPLETED|Overall Study||1
281102|NCT00877448|679797|P1|NOT COMPLETED|Overall Study||0
281103|NCT00877448|679791|P7|COMPLETED|Overall Study||3
281104|NCT00877448|679792|P6|COMPLETED|Overall Study||9
281105|NCT00877448|679793|P5|COMPLETED|Overall Study||10
281106|NCT00877448|679794|P4|COMPLETED|Overall Study||9
281107|NCT00877448|679795|P3|COMPLETED|Overall Study||10
281108|NCT00877448|679796|P2|COMPLETED|Overall Study||9
281109|NCT00877448|679797|P1|COMPLETED|Overall Study||10
281110|NCT00877448|679791|P7|STARTED|Overall Study||3
281111|NCT00877448|679792|P6|STARTED|Overall Study||10
281112|NCT00877448|679793|P5|STARTED|Overall Study||10
281113|NCT00877448|679794|P4|STARTED|Overall Study||10
281114|NCT00877448|679795|P3|STARTED|Overall Study||10
281115|NCT00877448|679796|P2|STARTED|Overall Study||10
281116|NCT00877448|679797|P1|STARTED|Overall Study||10
281117|NCT00877383|679822|P2|NOT COMPLETED|Overall Study||37
281118|NCT00877383|679823|P1|NOT COMPLETED|Overall Study||29
281119|NCT00877383|679822|P2|COMPLETED|Overall Study||533
281120|NCT00877383|679823|P1|COMPLETED|Overall Study||543
281121|NCT00877383|679822|P2|STARTED|Overall Study||570
281122|NCT00877383|679823|P1|STARTED|Overall Study||572
281123|NCT00877370|679839|P1|NOT COMPLETED|Overall Study||0
281124|NCT00877370|679839|P1|COMPLETED|Overall Study||8
281125|NCT00877370|679839|P1|STARTED|Overall Study||8
281126|NCT00877071|679843|P1|NOT COMPLETED|Overall Study||2
281127|NCT00877071|679843|P1|COMPLETED|Overall Study||0
281128|NCT00877071|679843|P1|STARTED|Overall Study||2
281129|NCT00877058|679853|P3|NOT COMPLETED|Overall Study||39
281130|NCT00877058|679854|P2|NOT COMPLETED|Overall Study||40
281131|NCT00877058|679855|P1|NOT COMPLETED|Overall Study||37
281132|NCT00877058|679853|P3|COMPLETED|Overall Study||75
281133|NCT00877058|679854|P2|COMPLETED|Overall Study||131
281134|NCT00877058|679855|P1|COMPLETED|Overall Study||137
281135|NCT00877058|679853|P3|STARTED|Overall Study||114
281136|NCT00877058|679854|P2|STARTED|Overall Study||171
281137|NCT00877058|679855|P1|STARTED|Overall Study||174
281138|NCT00877032|679876|P7|NOT COMPLETED|Overall Study||2
281139|NCT00877032|679877|P6|NOT COMPLETED|Overall Study||0
281140|NCT00877032|679878|P5|NOT COMPLETED|Overall Study||0
281141|NCT00877032|679879|P4|NOT COMPLETED|Overall Study||1
281142|NCT00877032|679880|P3|NOT COMPLETED|Overall Study||0
281143|NCT00877032|679881|P2|NOT COMPLETED|Overall Study||0
281144|NCT00877032|679882|P1|NOT COMPLETED|Overall Study||0
281145|NCT00877032|679876|P7|COMPLETED|Overall Study||18
281146|NCT00877032|679877|P6|COMPLETED|Overall Study||6
281147|NCT00877032|679878|P5|COMPLETED|Overall Study||6
281148|NCT00877032|679879|P4|COMPLETED|Overall Study||6
281149|NCT00877032|679880|P3|COMPLETED|Overall Study||6
281150|NCT00877032|679881|P2|COMPLETED|Overall Study||6
281152|NCT00877032|679876|P7|Treated|Overall Study||18
281153|NCT00877032|679877|P6|Treated|Overall Study||6
281154|NCT00877032|679878|P5|Treated|Overall Study||6
281155|NCT00877032|679879|P4|Treated|Overall Study||6
281156|NCT00877032|679880|P3|Treated|Overall Study||6
281157|NCT00877032|679881|P2|Treated|Overall Study||6
281158|NCT00877032|679882|P1|Treated|Overall Study||6
281159|NCT00877032|679876|P7|STARTED|Overall Study||20
281160|NCT00877032|679877|P6|STARTED|Overall Study||6
281161|NCT00877032|679878|P5|STARTED|Overall Study||6
281162|NCT00877032|679879|P4|STARTED|Overall Study||7
281163|NCT00877032|679880|P3|STARTED|Overall Study||6
281164|NCT00877032|679881|P2|STARTED|Overall Study||6
281165|NCT00877032|679882|P1|STARTED|Overall Study||6
281166|NCT00877006|679983|P2|NOT COMPLETED|Long-Term Follow-up Period||55
281167|NCT00877006|679984|P1|NOT COMPLETED|Long-Term Follow-up Period||53
281168|NCT00877006|679983|P2|COMPLETED|Long-Term Follow-up Period||154
281169|NCT00877006|679984|P1|COMPLETED|Long-Term Follow-up Period||157
281170|NCT00877006|679983|P2|STARTED|Long-Term Follow-up Period||209
281171|NCT00877006|679984|P1|STARTED|Long-Term Follow-up Period||210
281172|NCT00877006|679983|P2|NOT COMPLETED|Treatment Period||27
281173|NCT00877006|679984|P1|NOT COMPLETED|Treatment Period||25
281174|NCT00877006|679983|P2|COMPLETED|Treatment Period||196
281175|NCT00877006|679984|P1|COMPLETED|Treatment Period||199
281176|NCT00877006|679983|P2|STARTED|Treatment Period||223
281177|NCT00877006|679984|P1|STARTED|Treatment Period||224
281178|NCT00876993|680027|P5|NOT COMPLETED|Overall Study||2
281179|NCT00876993|680028|P4|NOT COMPLETED|Overall Study||0
281180|NCT00876993|680029|P3|NOT COMPLETED|Overall Study||2
281181|NCT00876993|680030|P2|NOT COMPLETED|Overall Study||0
281182|NCT00876993|680031|P1|NOT COMPLETED|Overall Study||1
281183|NCT00876993|680027|P5|COMPLETED|Overall Study||3
281184|NCT00876993|680028|P4|COMPLETED|Overall Study||5
281185|NCT00876993|680029|P3|COMPLETED|Overall Study||3
281186|NCT00876993|680030|P2|COMPLETED|Overall Study||6
281187|NCT00876993|680031|P1|COMPLETED|Overall Study||4
281188|NCT00876993|680027|P5|STARTED|Overall Study||5
281189|NCT00876993|680028|P4|STARTED|Overall Study||5
281190|NCT00876993|680029|P3|STARTED|Overall Study||5
281191|NCT00876993|680030|P2|STARTED|Overall Study||6
281192|NCT00876993|680031|P1|STARTED|Overall Study||5
281193|NCT00876928|680060|P2|NOT COMPLETED|Overall Study||5
281194|NCT00876928|680061|P1|NOT COMPLETED|Overall Study||3
281195|NCT00876928|680060|P2|COMPLETED|Overall Study||56
281196|NCT00876928|680061|P1|COMPLETED|Overall Study||53
281197|NCT00876928|680060|P2|STARTED|Overall Study||61
281198|NCT00876928|680061|P1|STARTED|Overall Study||56
281199|NCT00876915|680072|P3|NOT COMPLETED|Overall Study||0
281200|NCT00876915|680073|P2|NOT COMPLETED|Overall Study||14
281201|NCT00876915|680074|P1|NOT COMPLETED|Overall Study||19
281202|NCT00876915|680072|P3|COMPLETED|Overall Study||101
281203|NCT00876915|680073|P2|COMPLETED|Overall Study||34
281204|NCT00876915|680074|P1|COMPLETED|Overall Study||31
281205|NCT00876915|680072|P3|Week 8|Overall Study||0
281206|NCT00876915|680073|P2|Week 8|Overall Study||36
281207|NCT00876915|680074|P1|Week 8|Overall Study||33
281208|NCT00876915|680072|P3|Week 4|Overall Study||0
281209|NCT00876915|680073|P2|Week 4|Overall Study||45
281210|NCT00876915|680074|P1|Week 4|Overall Study||38
281211|NCT00876915|680072|P3|STARTED|Overall Study||101
281212|NCT00876915|680073|P2|STARTED|Overall Study||48
281213|NCT00876915|680074|P1|STARTED|Overall Study||50
281214|NCT00876733|680098|P4|NOT COMPLETED|Overall Study||7
281215|NCT00876733|680099|P3|NOT COMPLETED|Overall Study||30
281216|NCT00876733|680100|P2|NOT COMPLETED|Overall Study||42
281217|NCT00876733|680101|P1|NOT COMPLETED|Overall Study||91
281218|NCT00876733|680098|P4|COMPLETED|Overall Study||14
281219|NCT00876733|680099|P3|COMPLETED|Overall Study||63
281220|NCT00876733|680100|P2|COMPLETED|Overall Study||161
281221|NCT00876733|680101|P1|COMPLETED|Overall Study||197
281222|NCT00876733|680098|P4|STARTED|Overall Study||21
281223|NCT00876733|680099|P3|STARTED|Overall Study||93
281224|NCT00876733|680100|P2|STARTED|Overall Study||203
281225|NCT00876733|680101|P1|STARTED|Overall Study||288
281226|NCT00876694|680209|P2|NOT COMPLETED|Overall Study||12
281227|NCT00876694|680210|P1|NOT COMPLETED|Overall Study||21
281228|NCT00876694|680209|P2|COMPLETED|Overall Study||49
281229|NCT00876694|680210|P1|COMPLETED|Overall Study||104
281230|NCT00876694|680209|P2|STARTED|Overall Study||61
281231|NCT00876694|680210|P1|STARTED|Overall Study||125
281232|NCT00876460|680236|P8|NOT COMPLETED|Mono Therapy Phase||3
281233|NCT00876460|680237|P7|NOT COMPLETED|Mono Therapy Phase||1
281234|NCT00876460|680238|P6|NOT COMPLETED|Mono Therapy Phase||0
281235|NCT00876460|680239|P5|NOT COMPLETED|Mono Therapy Phase||2
281236|NCT00876460|680240|P4|NOT COMPLETED|Mono Therapy Phase||1
281237|NCT00876460|680241|P3|NOT COMPLETED|Mono Therapy Phase||0
281238|NCT00876460|680242|P2|NOT COMPLETED|Mono Therapy Phase||1
281239|NCT00876460|680243|P1|NOT COMPLETED|Mono Therapy Phase||0
281240|NCT00876460|680236|P8|COMPLETED|Mono Therapy Phase||0
281241|NCT00876460|680237|P7|COMPLETED|Mono Therapy Phase||0
281242|NCT00876460|680238|P6|COMPLETED|Mono Therapy Phase||0
281243|NCT00876460|680239|P5|COMPLETED|Mono Therapy Phase||0
281244|NCT00876460|680240|P4|COMPLETED|Mono Therapy Phase||0
281245|NCT00876460|680241|P3|COMPLETED|Mono Therapy Phase||0
281246|NCT00876460|680242|P2|COMPLETED|Mono Therapy Phase||0
281247|NCT00876460|680243|P1|COMPLETED|Mono Therapy Phase||0
281248|NCT00876460|680236|P8|STARTED|Mono Therapy Phase|Three patients started mono therapy phase after discontinued from combination therapy phase.|3
281249|NCT00876460|680237|P7|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
281250|NCT00876460|680238|P6|STARTED|Mono Therapy Phase||0
281251|NCT00876460|680239|P5|STARTED|Mono Therapy Phase|Two patients started mono therapy phase after discontinued from combination therapy phase.|2
281252|NCT00876460|680240|P4|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
281253|NCT00876460|680241|P3|STARTED|Mono Therapy Phase||0
281254|NCT00876460|680242|P2|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
281255|NCT00876460|680243|P1|STARTED|Mono Therapy Phase||0
281256|NCT00876460|680236|P8|NOT COMPLETED|Combination Therapy Phase||6
281257|NCT00876460|680237|P7|NOT COMPLETED|Combination Therapy Phase||8
281258|NCT00876460|680238|P6|NOT COMPLETED|Combination Therapy Phase||3
281259|NCT00876460|680239|P5|NOT COMPLETED|Combination Therapy Phase||7
281260|NCT00876460|680240|P4|NOT COMPLETED|Combination Therapy Phase||6
281261|NCT00876460|680241|P3|NOT COMPLETED|Combination Therapy Phase||3
281262|NCT00876460|680242|P2|NOT COMPLETED|Combination Therapy Phase||7
281263|NCT00876460|680243|P1|NOT COMPLETED|Combination Therapy Phase||3
281264|NCT00876460|680236|P8|COMPLETED|Combination Therapy Phase||0
281265|NCT00876460|680237|P7|COMPLETED|Combination Therapy Phase||0
281266|NCT00876460|680238|P6|COMPLETED|Combination Therapy Phase||0
281267|NCT00876460|680239|P5|COMPLETED|Combination Therapy Phase||0
281268|NCT00876460|680240|P4|COMPLETED|Combination Therapy Phase||0
281269|NCT00876460|680241|P3|COMPLETED|Combination Therapy Phase||0
281270|NCT00876460|680242|P2|COMPLETED|Combination Therapy Phase||0
281271|NCT00876460|680243|P1|COMPLETED|Combination Therapy Phase||0
281272|NCT00876460|680236|P8|STARTED|Combination Therapy Phase||6
281273|NCT00876460|680237|P7|STARTED|Combination Therapy Phase||8
281274|NCT00876460|680238|P6|STARTED|Combination Therapy Phase||3
281275|NCT00876460|680239|P5|STARTED|Combination Therapy Phase||7
281276|NCT00876460|680240|P4|STARTED|Combination Therapy Phase||6
281277|NCT00876460|680241|P3|STARTED|Combination Therapy Phase||3
281278|NCT00876460|680242|P2|STARTED|Combination Therapy Phase||7
281279|NCT00876460|680243|P1|STARTED|Combination Therapy Phase||3
281280|NCT00876447|680315|P2|NOT COMPLETED|Overall Study||81
281281|NCT00876447|680316|P1|NOT COMPLETED|Overall Study||80
281282|NCT00876447|680315|P2|COMPLETED|Overall Study||122
281283|NCT00876447|680316|P1|COMPLETED|Overall Study||105
281284|NCT00876447|680315|P2|STARTED|Overall Study||203
281285|NCT00876447|680316|P1|STARTED|Overall Study||185
281286|NCT00876395|680376|P2|NOT COMPLETED|Overall Study||239
281287|NCT00876395|680377|P1|NOT COMPLETED|Overall Study||480
281288|NCT00876395|680376|P2|COMPLETED|Overall Study||0
281289|NCT00876395|680377|P1|COMPLETED|Overall Study||0
281290|NCT00876395|680376|P2|Untreated|Overall Study||1
281291|NCT00876395|680377|P1|Untreated|Overall Study||8
281292|NCT00876395|680376|P2|STARTED|Overall Study||239
281293|NCT00876395|680377|P1|STARTED|Overall Study||480
281294|NCT00876343|680418|P3|NOT COMPLETED|Overall Study||12
281295|NCT00876343|680419|P2|NOT COMPLETED|Overall Study||17
281296|NCT00876343|680420|P1|NOT COMPLETED|Overall Study||17
281297|NCT00876343|680418|P3|COMPLETED|Overall Study||183
281298|NCT00876343|680419|P2|COMPLETED|Overall Study||180
281299|NCT00876343|680420|P1|COMPLETED|Overall Study||177
281300|NCT00876343|680418|P3|STARTED|Overall Study||195
281301|NCT00876343|680419|P2|STARTED|Overall Study||197
281302|NCT00876343|680420|P1|STARTED|Overall Study||194
281303|NCT00876265|680434|P1|NOT COMPLETED|Overall Study||12
281304|NCT00876265|680434|P1|COMPLETED|Overall Study||106
281305|NCT00876265|680434|P1|STARTED|Overall Study||118
281306|NCT00876200|680442|P2|NOT COMPLETED|Overall Study||3
281307|NCT00876200|680443|P1|NOT COMPLETED|Overall Study||1
281308|NCT00876200|680442|P2|COMPLETED|Overall Study||9
281309|NCT00876200|680443|P1|COMPLETED|Overall Study||8
281310|NCT00876200|680442|P2|STARTED|Overall Study||12
281311|NCT00876200|680443|P1|STARTED|Overall Study||9
281312|NCT00876018|680452|P3|NOT COMPLETED|Overall Study||3
281313|NCT00876018|680453|P2|NOT COMPLETED|Overall Study||5
281314|NCT00876018|680454|P1|NOT COMPLETED|Overall Study||5
281315|NCT00876018|680452|P3|COMPLETED|Overall Study||97
281316|NCT00876018|680453|P2|COMPLETED|Overall Study||95
281317|NCT00876018|680454|P1|COMPLETED|Overall Study||95
281318|NCT00876018|680452|P3|STARTED|Overall Study||100
281319|NCT00876018|680453|P2|STARTED|Overall Study||100
281320|NCT00876018|680454|P1|STARTED|Overall Study||100
281321|NCT00875979|680509|P2|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||47
281322|NCT00875979|680510|P1|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
281323|NCT00875979|680509|P2|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||11
281324|NCT00875979|680510|P1|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
281325|NCT00875979|680509|P2|STARTED|Dose Expansion Phase - 3.6 mg/kg||58
281326|NCT00875979|680510|P1|STARTED|Dose Expansion Phase - 3.6 mg/kg||0
281327|NCT00875979|680509|P2|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||6
281328|NCT00875979|680510|P1|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
281329|NCT00875979|680509|P2|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
281330|NCT00875979|680510|P1|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
281331|NCT00875979|680509|P2|STARTED|Dose Escalation Phase - 3.6 mg/kg||6
281332|NCT00875979|680510|P1|STARTED|Dose Escalation Phase - 3.6 mg/kg||0
281333|NCT00875979|680509|P2|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
281334|NCT00875979|680510|P1|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||3
281335|NCT00875979|680509|P2|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
281336|NCT00875979|680510|P1|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
281337|NCT00875979|680509|P2|STARTED|Dose Escalation Phase - 3.0 mg/kg||0
281338|NCT00875979|680510|P1|STARTED|Dose Escalation Phase - 3.0 mg/kg||3
281339|NCT00875836|680522|P2|NOT COMPLETED|Overall Study||40
281340|NCT00875836|680523|P1|NOT COMPLETED|Overall Study||43
281341|NCT00875836|680522|P2|COMPLETED|Overall Study||47
281342|NCT00875836|680523|P1|COMPLETED|Overall Study||45
281343|NCT00875836|680522|P2|STARTED|Overall Study||87
281344|NCT00875836|680523|P1|STARTED|Overall Study||88
281345|NCT00875810|680533|P1|NOT COMPLETED|Overall Study||46
281346|NCT00875810|680533|P1|COMPLETED|Overall Study||148
281347|NCT00875810|680533|P1|24 Months Follow up|Overall Study||148
281348|NCT00875810|680533|P1|12 Months Follow up|Overall Study||112
281349|NCT00875810|680533|P1|6 Months Follow up|Overall Study||80
281350|NCT00875810|680533|P1|3 Months Follow up|Overall Study||175
281351|NCT00875810|680533|P1|Discharged|Overall Study||177
281352|NCT00875810|680533|P1|Implanted|Overall Study||190
281353|NCT00875810|680533|P1|STARTED|Overall Study||194
281354|NCT00875797|680542|P2|NOT COMPLETED|Overall Study||3
281355|NCT00875797|680543|P1|NOT COMPLETED|Overall Study||6
281356|NCT00875797|680542|P2|COMPLETED|Overall Study||42
281357|NCT00875797|680543|P1|COMPLETED|Overall Study||39
281358|NCT00875797|680542|P2|STARTED|Overall Study||45
281359|NCT00875797|680543|P1|STARTED|Overall Study||45
281360|NCT00875706|680556|P3|NOT COMPLETED|Overall Study||0
281361|NCT00875706|680557|P2|NOT COMPLETED|Overall Study||0
281362|NCT00875706|680558|P1|NOT COMPLETED|Overall Study||1
281363|NCT00875706|680556|P3|COMPLETED|Overall Study||13
281364|NCT00875706|680557|P2|COMPLETED|Overall Study||24
281365|NCT00875706|680558|P1|COMPLETED|Overall Study||7
281366|NCT00875706|680556|P3|STARTED|Overall Study||13
281367|NCT00875706|680557|P2|STARTED|Overall Study||24
281368|NCT00875706|680558|P1|STARTED|Overall Study||8
281369|NCT00875667|680577|P2|NOT COMPLETED|Overall Study||73
281370|NCT00875667|680578|P1|NOT COMPLETED|Overall Study||170
281371|NCT00875667|680577|P2|COMPLETED|Overall Study|Participants completed 6 cycles of IC single agent cytarabine, fludarabine, or gemcitabine.|11
281372|NCT00875667|680578|P1|COMPLETED|Overall Study||0
281373|NCT00875667|680577|P2|Participants Treated|Overall Study||83
281374|NCT00875667|680578|P1|Participants Treated|Overall Study||167
281375|NCT00875667|680577|P2|Crossover From IC to Lenalidomide|Overall Study|Upon disease progression, participants crossed over to lenalidomide|40
281376|NCT00875667|680578|P1|Crossover From IC to Lenalidomide|Overall Study|NA = Participants in the IC arm were able to crossover to lenalidomide|0
281377|NCT00875667|680577|P2|STARTED|Overall Study||84
281378|NCT00875667|680578|P1|STARTED|Overall Study||170
281379|NCT00875641|680679|P3|NOT COMPLETED|Overall Study||0
281380|NCT00875641|680680|P2|NOT COMPLETED|Overall Study||0
281381|NCT00875641|680681|P1|NOT COMPLETED|Overall Study||0
281382|NCT00875641|680679|P3|COMPLETED|Overall Study||159344
281383|NCT00875641|680680|P2|COMPLETED|Overall Study||173384
281384|NCT00875641|680681|P1|COMPLETED|Overall Study||57931
281385|NCT00875641|680679|P3|STARTED|Overall Study||159344
281386|NCT00875641|680680|P2|STARTED|Overall Study||173384
281387|NCT00875641|680681|P1|STARTED|Overall Study||57931
281388|NCT00875615|680713|P1|NOT COMPLETED|Overall Study||1
281389|NCT00875615|680713|P1|COMPLETED|Overall Study||10
281390|NCT00875615|680713|P1|STARTED|Overall Study||11
281391|NCT00875589|680720|P2|NOT COMPLETED|Overall Study||0
281392|NCT00875589|680721|P1|NOT COMPLETED|Overall Study||0
281393|NCT00875589|680720|P2|COMPLETED|Overall Study||11
281394|NCT00875589|680721|P1|COMPLETED|Overall Study||15
281395|NCT00875589|680720|P2|STARTED|Overall Study||11
281396|NCT00875589|680721|P1|STARTED|Overall Study||15
281397|NCT00875563|680727|P1|NOT COMPLETED|Overall Study||24
281398|NCT00875563|680727|P1|COMPLETED|Overall Study||18
281399|NCT00875563|680727|P1|STARTED|Overall Study||42
281400|NCT00875550|680733|P2|NOT COMPLETED|Overall Study||10
281401|NCT00875550|680734|P1|NOT COMPLETED|Overall Study||12
281402|NCT00875550|680733|P2|COMPLETED|Overall Study||76
281403|NCT00875550|680734|P1|COMPLETED|Overall Study||77
281404|NCT00875550|680733|P2|STARTED|Overall Study||86
281405|NCT00875550|680734|P1|STARTED|Overall Study||89
281406|NCT00875524|680752|P2|NOT COMPLETED|Overall Study||6
281407|NCT00875524|680753|P1|NOT COMPLETED|Overall Study||8
281408|NCT00875524|680752|P2|COMPLETED|Overall Study||54
281409|NCT00875524|680753|P1|COMPLETED|Overall Study||112
281410|NCT00875524|680752|P2|Received Vaccination 3|Overall Study||58
281411|NCT00875524|680753|P1|Received Vaccination 3|Overall Study||114
281412|NCT00875524|680752|P2|Received Vaccination 2|Overall Study||58
281413|NCT00875524|680753|P1|Received Vaccination 2|Overall Study||116
281414|NCT00875524|680752|P2|Received Vaccination 1|Overall Study||60
281415|NCT00875524|680753|P1|Received Vaccination 1|Overall Study||120
281416|NCT00875524|680752|P2|STARTED|Overall Study||60
281417|NCT00875524|680753|P1|STARTED|Overall Study||120
281418|NCT00875485|680771|P2|NOT COMPLETED|Challenge Dose Epoch||0
281419|NCT00875485|680772|P1|NOT COMPLETED|Challenge Dose Epoch||1
281420|NCT00875485|680771|P2|COMPLETED|Challenge Dose Epoch||11
281421|NCT00875485|680772|P1|COMPLETED|Challenge Dose Epoch||7
281422|NCT00875485|680771|P2|STARTED|Challenge Dose Epoch||11
281423|NCT00875485|680772|P1|STARTED|Challenge Dose Epoch||8
281424|NCT00875485|680771|P2|NOT COMPLETED|Year 15||0
281425|NCT00875485|680772|P1|NOT COMPLETED|Year 15||0
281426|NCT00875485|680771|P2|COMPLETED|Year 15||111
281427|NCT00875485|680772|P1|COMPLETED|Year 15||98
281428|NCT00875485|680771|P2|STARTED|Year 15||111
281429|NCT00875485|680772|P1|STARTED|Year 15||98
281430|NCT00875485|680771|P2|NOT COMPLETED|Year 14||0
281431|NCT00875485|680772|P1|NOT COMPLETED|Year 14||0
281432|NCT00875485|680771|P2|COMPLETED|Year 14||113
281433|NCT00875485|680772|P1|COMPLETED|Year 14||100
281434|NCT00875485|680771|P2|STARTED|Year 14||113
281435|NCT00875485|680772|P1|STARTED|Year 14||100
281436|NCT00875485|680771|P2|NOT COMPLETED|Year 13||0
281437|NCT00875485|680772|P1|NOT COMPLETED|Year 13||0
281438|NCT00875485|680771|P2|COMPLETED|Year 13||113
281439|NCT00875485|680772|P1|COMPLETED|Year 13||102
281440|NCT00875485|680771|P2|STARTED|Year 13||113
281441|NCT00875485|680772|P1|STARTED|Year 13||102
281442|NCT00875485|680771|P2|NOT COMPLETED|Year 12||0
281443|NCT00875485|680772|P1|NOT COMPLETED|Year 12||0
281444|NCT00875485|680771|P2|COMPLETED|Year 12||109
281445|NCT00875485|680772|P1|COMPLETED|Year 12||101
281446|NCT00875485|680771|P2|STARTED|Year 12||109
281447|NCT00875485|680772|P1|STARTED|Year 12||101
281448|NCT00875485|680771|P2|NOT COMPLETED|Year 11||0
281449|NCT00875485|680772|P1|NOT COMPLETED|Year 11||0
281450|NCT00875485|680771|P2|COMPLETED|Year 11||111
281451|NCT00875485|680772|P1|COMPLETED|Year 11||99
281452|NCT00875485|680771|P2|STARTED|Year 11||111
281453|NCT00875485|680772|P1|STARTED|Year 11||99
281454|NCT00875433|680812|P1|NOT COMPLETED|Overall Study||60
281455|NCT00875433|680812|P1|COMPLETED|Overall Study||0
281456|NCT00875433|680812|P1|STARTED|Overall Study|Treated|60
281457|NCT00875420|680842|P5|NOT COMPLETED|Overall Study||2
281458|NCT00875420|680843|P4|NOT COMPLETED|Overall Study||2
281459|NCT00875420|680844|P3|NOT COMPLETED|Overall Study||3
281460|NCT00875420|680845|P2|NOT COMPLETED|Overall Study||2
281461|NCT00875420|680846|P1|NOT COMPLETED|Overall Study||2
281462|NCT00875420|680842|P5|COMPLETED|Overall Study||17
281463|NCT00875420|680843|P4|COMPLETED|Overall Study||16
281464|NCT00875420|680844|P3|COMPLETED|Overall Study||18
281465|NCT00875420|680845|P2|COMPLETED|Overall Study||18
281466|NCT00875420|680846|P1|COMPLETED|Overall Study||20
281467|NCT00875420|680842|P5|STARTED|Overall Study||19
281468|NCT00875420|680843|P4|STARTED|Overall Study||18
281469|NCT00875420|680844|P3|STARTED|Overall Study||21
281470|NCT00875420|680845|P2|STARTED|Overall Study||20
281471|NCT00875420|680846|P1|STARTED|Overall Study||22
281472|NCT00875394|680876|P3|NOT COMPLETED|Overall Study||0
281473|NCT00875394|680877|P2|NOT COMPLETED|Overall Study||0
281474|NCT00875394|680878|P1|NOT COMPLETED|Overall Study||0
281475|NCT00875394|680876|P3|COMPLETED|Overall Study||9
281476|NCT00875394|680877|P2|COMPLETED|Overall Study||23
281477|NCT00875394|680878|P1|COMPLETED|Overall Study||36
281478|NCT00875394|680876|P3|STARTED|Overall Study||9
281479|NCT00875394|680877|P2|STARTED|Overall Study||23
281480|NCT00875394|680878|P1|STARTED|Overall Study||36
281481|NCT00875329|680886|P1|NOT COMPLETED|Overall Study||0
281482|NCT00875329|680886|P1|COMPLETED|Overall Study||97
281483|NCT00875329|680886|P1|STARTED|Overall Study||97
281484|NCT00875212|680890|P1|NOT COMPLETED|CaGP and Fluoride Dentifrice||0
281485|NCT00875212|680890|P1|COMPLETED|CaGP and Fluoride Dentifrice||12
281486|NCT00875212|680890|P1|STARTED|CaGP and Fluoride Dentifrice||12
281487|NCT00875212|680890|P1|NOT COMPLETED|Fluoride Only Dentifrice||0
281488|NCT00875212|680890|P1|COMPLETED|Fluoride Only Dentifrice||12
281489|NCT00875212|680890|P1|STARTED|Fluoride Only Dentifrice||12
281490|NCT00875212|680890|P1|NOT COMPLETED|CaGP Only Dentifrice||0
281491|NCT00875212|680890|P1|COMPLETED|CaGP Only Dentifrice||12
281492|NCT00875212|680890|P1|STARTED|CaGP Only Dentifrice||12
281493|NCT00875212|680890|P1|NOT COMPLETED|Placebo Dentifrice||0
281494|NCT00875212|680890|P1|COMPLETED|Placebo Dentifrice|all participants completed this group|12
281495|NCT00875212|680890|P1|STARTED|Placebo Dentifrice||12
281496|NCT00875017|680907|P6|NOT COMPLETED|Fourth Intervention||1
281497|NCT00875017|680908|P5|NOT COMPLETED|Fourth Intervention||0
281498|NCT00875017|680909|P4|NOT COMPLETED|Fourth Intervention||0
281499|NCT00875017|680910|P3|NOT COMPLETED|Fourth Intervention||0
281500|NCT00875017|680911|P2|NOT COMPLETED|Fourth Intervention||0
281501|NCT00875017|680912|P1|NOT COMPLETED|Fourth Intervention||0
281502|NCT00875017|680907|P6|COMPLETED|Fourth Intervention||4
281503|NCT00875017|680908|P5|COMPLETED|Fourth Intervention||3
281504|NCT00875017|680909|P4|COMPLETED|Fourth Intervention||4
281505|NCT00875017|680910|P3|COMPLETED|Fourth Intervention||2
281506|NCT00875017|680911|P2|COMPLETED|Fourth Intervention||3
281507|NCT00875017|680912|P1|COMPLETED|Fourth Intervention||3
281508|NCT00875017|680907|P6|STARTED|Fourth Intervention||5
281509|NCT00875017|680908|P5|STARTED|Fourth Intervention||3
281510|NCT00875017|680909|P4|STARTED|Fourth Intervention||4
281511|NCT00875017|680910|P3|STARTED|Fourth Intervention||2
281512|NCT00875017|680911|P2|STARTED|Fourth Intervention||3
281513|NCT00875017|680912|P1|STARTED|Fourth Intervention||3
281514|NCT00875017|680907|P6|NOT COMPLETED|Washout||0
281515|NCT00875017|680908|P5|NOT COMPLETED|Washout||1
281516|NCT00875017|680909|P4|NOT COMPLETED|Washout||0
281517|NCT00875017|680910|P3|NOT COMPLETED|Washout||0
281518|NCT00875017|680911|P2|NOT COMPLETED|Washout||0
281519|NCT00875017|680912|P1|NOT COMPLETED|Washout||0
281520|NCT00875017|680907|P6|COMPLETED|Washout||5
281521|NCT00875017|680908|P5|COMPLETED|Washout||3
281522|NCT00875017|680909|P4|COMPLETED|Washout||4
281523|NCT00875017|680910|P3|COMPLETED|Washout||2
281524|NCT00875017|680911|P2|COMPLETED|Washout||3
281525|NCT00875017|680912|P1|COMPLETED|Washout||3
281526|NCT00875017|680907|P6|STARTED|Washout||5
281527|NCT00875017|680908|P5|STARTED|Washout||4
281528|NCT00875017|680909|P4|STARTED|Washout||4
281529|NCT00875017|680910|P3|STARTED|Washout||2
281530|NCT00875017|680911|P2|STARTED|Washout||3
281531|NCT00875017|680912|P1|STARTED|Washout||3
281532|NCT00875017|680907|P6|NOT COMPLETED|Third Intervention||0
281533|NCT00875017|680908|P5|NOT COMPLETED|Third Intervention||0
281534|NCT00875017|680909|P4|NOT COMPLETED|Third Intervention||0
281535|NCT00875017|680910|P3|NOT COMPLETED|Third Intervention||1
281536|NCT00875017|680911|P2|NOT COMPLETED|Third Intervention||1
281537|NCT00875017|680912|P1|NOT COMPLETED|Third Intervention||0
281538|NCT00875017|680907|P6|COMPLETED|Third Intervention||5
281539|NCT00875017|680908|P5|COMPLETED|Third Intervention||4
281540|NCT00875017|680909|P4|COMPLETED|Third Intervention||4
281541|NCT00875017|680910|P3|COMPLETED|Third Intervention||2
281542|NCT00875017|680911|P2|COMPLETED|Third Intervention||3
281543|NCT00875017|680912|P1|COMPLETED|Third Intervention||3
281544|NCT00875017|680907|P6|STARTED|Third Intervention||5
281545|NCT00875017|680908|P5|STARTED|Third Intervention||4
281546|NCT00875017|680909|P4|STARTED|Third Intervention||4
281547|NCT00875017|680910|P3|STARTED|Third Intervention||3
281548|NCT00875017|680911|P2|STARTED|Third Intervention||4
281549|NCT00875017|680912|P1|STARTED|Third Intervention||3
281550|NCT00875017|680907|P6|NOT COMPLETED|Washout||0
281551|NCT00875017|680908|P5|NOT COMPLETED|Washout||0
281552|NCT00875017|680909|P4|NOT COMPLETED|Washout||0
281553|NCT00875017|680910|P3|NOT COMPLETED|Washout||0
281554|NCT00875017|680911|P2|NOT COMPLETED|Washout||1
281555|NCT00875017|680912|P1|NOT COMPLETED|Washout||0
281556|NCT00875017|680907|P6|COMPLETED|Washout||5
281557|NCT00875017|680908|P5|COMPLETED|Washout||4
281558|NCT00875017|680909|P4|COMPLETED|Washout||4
281559|NCT00875017|680910|P3|COMPLETED|Washout||3
281560|NCT00875017|680911|P2|COMPLETED|Washout||4
281561|NCT00875017|680912|P1|COMPLETED|Washout||3
281562|NCT00875017|680907|P6|STARTED|Washout||5
281563|NCT00875017|680908|P5|STARTED|Washout||4
281564|NCT00875017|680909|P4|STARTED|Washout||4
281565|NCT00875017|680910|P3|STARTED|Washout||3
281566|NCT00875017|680911|P2|STARTED|Washout||5
281567|NCT00875017|680912|P1|STARTED|Washout||3
281568|NCT00875017|680907|P6|NOT COMPLETED|Second Intervention||0
281569|NCT00875017|680908|P5|NOT COMPLETED|Second Intervention||0
281570|NCT00875017|680909|P4|NOT COMPLETED|Second Intervention||1
281571|NCT00875017|680910|P3|NOT COMPLETED|Second Intervention||0
281572|NCT00875017|680911|P2|NOT COMPLETED|Second Intervention||0
281573|NCT00875017|680912|P1|NOT COMPLETED|Second Intervention||0
281574|NCT00875017|680907|P6|COMPLETED|Second Intervention||5
281575|NCT00875017|680908|P5|COMPLETED|Second Intervention||4
281576|NCT00875017|680909|P4|COMPLETED|Second Intervention||4
281577|NCT00875017|680910|P3|COMPLETED|Second Intervention||3
281578|NCT00875017|680911|P2|COMPLETED|Second Intervention||5
281579|NCT00875017|680912|P1|COMPLETED|Second Intervention||3
281580|NCT00875017|680907|P6|STARTED|Second Intervention||5
281581|NCT00875017|680908|P5|STARTED|Second Intervention||4
281582|NCT00875017|680909|P4|STARTED|Second Intervention||5
281583|NCT00875017|680910|P3|STARTED|Second Intervention||3
281584|NCT00875017|680911|P2|STARTED|Second Intervention||5
281585|NCT00875017|680912|P1|STARTED|Second Intervention||3
281586|NCT00875017|680907|P6|NOT COMPLETED|Washout||0
281587|NCT00875017|680908|P5|NOT COMPLETED|Washout||0
281588|NCT00875017|680909|P4|NOT COMPLETED|Washout||0
281589|NCT00875017|680910|P3|NOT COMPLETED|Washout||1
281590|NCT00875017|680911|P2|NOT COMPLETED|Washout||0
281591|NCT00875017|680912|P1|NOT COMPLETED|Washout||0
281592|NCT00875017|680907|P6|COMPLETED|Washout||5
281593|NCT00875017|680908|P5|COMPLETED|Washout||4
281594|NCT00875017|680909|P4|COMPLETED|Washout||5
281595|NCT00875017|680910|P3|COMPLETED|Washout||3
281596|NCT00875017|680911|P2|COMPLETED|Washout||5
281597|NCT00875017|680912|P1|COMPLETED|Washout||3
281598|NCT00875017|680907|P6|STARTED|Washout||5
281599|NCT00875017|680908|P5|STARTED|Washout||4
281600|NCT00875017|680909|P4|STARTED|Washout||5
281601|NCT00875017|680910|P3|STARTED|Washout||4
281602|NCT00875017|680911|P2|STARTED|Washout||5
281603|NCT00875017|680912|P1|STARTED|Washout||3
281604|NCT00875017|680907|P6|NOT COMPLETED|First Intervention||0
281605|NCT00875017|680908|P5|NOT COMPLETED|First Intervention||1
281606|NCT00875017|680909|P4|NOT COMPLETED|First Intervention||1
281607|NCT00875017|680910|P3|NOT COMPLETED|First Intervention||1
281608|NCT00875017|680911|P2|NOT COMPLETED|First Intervention||0
281609|NCT00875017|680912|P1|NOT COMPLETED|First Intervention||2
281610|NCT00875017|680907|P6|COMPLETED|First Intervention||5
281611|NCT00875017|680908|P5|COMPLETED|First Intervention||4
281612|NCT00875017|680909|P4|COMPLETED|First Intervention||5
281613|NCT00875017|680910|P3|COMPLETED|First Intervention||4
281614|NCT00875017|680911|P2|COMPLETED|First Intervention||5
281615|NCT00875017|680912|P1|COMPLETED|First Intervention||3
281616|NCT00875017|680907|P6|STARTED|First Intervention||5
281617|NCT00875017|680908|P5|STARTED|First Intervention||5
281618|NCT00875017|680909|P4|STARTED|First Intervention||6
281619|NCT00875017|680910|P3|STARTED|First Intervention||5
281620|NCT00875017|680911|P2|STARTED|First Intervention||5
281621|NCT00875017|680912|P1|STARTED|First Intervention||5
281622|NCT00874939|680926|P1|NOT COMPLETED|Overall Study||4
281623|NCT00874939|680926|P1|COMPLETED|Overall Study||0
281624|NCT00874939|680926|P1|Treated|Overall Study||0
281625|NCT00874939|680926|P1|STARTED|Overall Study||4
281626|NCT00874887|680942|P2|NOT COMPLETED|Overall Study||0
281627|NCT00874887|680943|P1|NOT COMPLETED|Overall Study||0
281628|NCT00874887|680942|P2|COMPLETED|Overall Study||34
281629|NCT00874887|680943|P1|COMPLETED|Overall Study||32
281630|NCT00874887|680942|P2|STARTED|Overall Study||34
281631|NCT00874887|680943|P1|STARTED|Overall Study||32
281632|NCT00874848|680959|P2|NOT COMPLETED|Overall Study||28
281633|NCT00874848|680960|P1|NOT COMPLETED|Overall Study||59
281634|NCT00874848|680959|P2|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|1
281635|NCT00874848|680960|P1|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|0
281636|NCT00874848|680959|P2|Discontinued|Overall Study||28
281637|NCT00874848|680960|P1|Discontinued|Overall Study||59
281638|NCT00874848|680959|P2|STARTED|Overall Study||29
281639|NCT00874848|680960|P1|STARTED|Overall Study||59
281640|NCT00874822|680976|P1|NOT COMPLETED|Overall Study||8
281641|NCT00874822|680976|P1|COMPLETED|Overall Study||208
281642|NCT00874822|680976|P1|STARTED|Overall Study||216
281643|NCT00874770|680984|P4|NOT COMPLETED|Overall Study||5
281644|NCT00874770|680985|P3|NOT COMPLETED|Overall Study||4
281645|NCT00874770|680986|P2|NOT COMPLETED|Overall Study||1
281646|NCT00874770|680987|P1|NOT COMPLETED|Overall Study||5
281647|NCT00874770|680984|P4|COMPLETED|Overall Study||7
281648|NCT00874770|680985|P3|COMPLETED|Overall Study||8
281649|NCT00874770|680986|P2|COMPLETED|Overall Study||11
281650|NCT00874770|680987|P1|COMPLETED|Overall Study||7
281651|NCT00874770|680984|P4|STARTED|Overall Study||12
281652|NCT00874770|680985|P3|STARTED|Overall Study||12
281653|NCT00874770|680986|P2|STARTED|Overall Study||12
281654|NCT00874770|680987|P1|STARTED|Overall Study||12
281655|NCT00874731|681021|P3|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||22
281656|NCT00874731|681022|P2|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||0
281657|NCT00874731|681023|P1|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||0
281658|NCT00874731|681021|P3|COMPLETED|Part 2: Ridaforolimus 40 mg||0
281659|NCT00874731|681022|P2|COMPLETED|Part 2: Ridaforolimus 40 mg||0
281660|NCT00874731|681023|P1|COMPLETED|Part 2: Ridaforolimus 40 mg||0
281661|NCT00874731|681021|P3|STARTED|Part 2: Ridaforolimus 40 mg|Participants completing Pt 1 and washout, started this period in “Pt 2. Ridaforolimus 40 mg” arm.|22
281662|NCT00874731|681022|P2|STARTED|Part 2: Ridaforolimus 40 mg|Participants completing Pt 1 and washout, enter into the “Pt 2. Ridaforolimus 40 mg” arm.|0
281663|NCT00874731|681023|P1|STARTED|Part 2: Ridaforolimus 40 mg||0
281664|NCT00874731|681021|P3|NOT COMPLETED|Washout Period||0
281665|NCT00874731|681022|P2|NOT COMPLETED|Washout Period||0
281666|NCT00874731|681023|P1|NOT COMPLETED|Washout Period||0
281667|NCT00874731|681021|P3|COMPLETED|Washout Period||0
281668|NCT00874731|681022|P2|COMPLETED|Washout Period||22
281669|NCT00874731|681023|P1|COMPLETED|Washout Period||0
281670|NCT00874731|681021|P3|STARTED|Washout Period||0
281671|NCT00874731|681022|P2|STARTED|Washout Period||22
281672|NCT00874731|681023|P1|STARTED|Washout Period||0
281673|NCT00874731|681021|P3|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
281674|NCT00874731|681022|P2|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
281675|NCT00874731|681023|P1|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
281676|NCT00874731|681021|P3|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
281677|NCT00874731|681022|P2|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||22
281678|NCT00874731|681023|P1|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
281679|NCT00874731|681021|P3|STARTED|Part 1, Day 2: Ridaforolimus 100 mg||0
281680|NCT00874731|681022|P2|STARTED|Part 1, Day 2: Ridaforolimus 100 mg|Participants completing Pt 1, Day 1, started this period in “Pt 1, Day 2. Ridaforolimus 100 mg” arm.|22
281681|NCT00874731|681023|P1|STARTED|Part 1, Day 2: Ridaforolimus 100 mg|Participants completing Pt 1, Day 1, enter into the “Pt 1, Day 2. Ridaforolimus 100 mg” arm.|0
281682|NCT00874731|681021|P3|NOT COMPLETED|Part 1, Day 1: Placebo||0
281683|NCT00874731|681022|P2|NOT COMPLETED|Part 1, Day 1: Placebo||0
281684|NCT00874731|681023|P1|NOT COMPLETED|Part 1, Day 1: Placebo||1
281685|NCT00874731|681021|P3|COMPLETED|Part 1, Day 1: Placebo||0
281686|NCT00874731|681022|P2|COMPLETED|Part 1, Day 1: Placebo||0
281687|NCT00874731|681023|P1|COMPLETED|Part 1, Day 1: Placebo||22
281688|NCT00874731|681021|P3|STARTED|Part 1, Day 1: Placebo||0
281689|NCT00874731|681022|P2|STARTED|Part 1, Day 1: Placebo||0
281690|NCT00874731|681023|P1|STARTED|Part 1, Day 1: Placebo||23
281691|NCT00874614|681052|P1|NOT COMPLETED|Overall Study||58
281692|NCT00874614|681052|P1|COMPLETED|Overall Study|As of December 2017|16
281693|NCT00874614|681052|P1|Received Two Therapeutic Doses|Overall Study||50
281694|NCT00874614|681052|P1|Received at Least One Therapeutic Dose|Overall Study||68
281695|NCT00874614|681052|P1|STARTED|Overall Study||74
281696|NCT00874549|681064|P4|NOT COMPLETED|Overall Study||2
281697|NCT00874549|681065|P3|NOT COMPLETED|Overall Study||4
281698|NCT00874549|681066|P2|NOT COMPLETED|Overall Study||1
281699|NCT00874549|681067|P1|NOT COMPLETED|Overall Study||1
281700|NCT00874549|681064|P4|COMPLETED|Overall Study||56
281701|NCT00874549|681065|P3|COMPLETED|Overall Study||47
281702|NCT00874549|681066|P2|COMPLETED|Overall Study||55
281703|NCT00874549|681067|P1|COMPLETED|Overall Study||50
281704|NCT00874549|681064|P4|STARTED|Overall Study||58
281705|NCT00874549|681065|P3|STARTED|Overall Study||51
281706|NCT00874549|681066|P2|STARTED|Overall Study||56
281707|NCT00874549|681067|P1|STARTED|Overall Study||51
281708|NCT00874510|681135|P2|NOT COMPLETED|Year 2||0
281709|NCT00874510|681136|P1|NOT COMPLETED|Year 2||0
281710|NCT00874510|681135|P2|COMPLETED|Year 2||87
281711|NCT00874510|681136|P1|COMPLETED|Year 2||92
281712|NCT00874510|681135|P2|STARTED|Year 2||87
281713|NCT00874510|681136|P1|STARTED|Year 2||92
281714|NCT00874510|681135|P2|NOT COMPLETED|Year 1||0
281715|NCT00874510|681136|P1|NOT COMPLETED|Year 1||0
281716|NCT00874510|681135|P2|COMPLETED|Year 1||85
281717|NCT00874510|681136|P1|COMPLETED|Year 1||88
281718|NCT00874510|681135|P2|STARTED|Year 1||85
281719|NCT00874510|681136|P1|STARTED|Year 1||88
281720|NCT00874497|681144|P2|NOT COMPLETED|Overall Study||18
281721|NCT00874497|681145|P1|NOT COMPLETED|Overall Study||28
281722|NCT00874497|681144|P2|COMPLETED|Overall Study||15
281723|NCT00874497|681145|P1|COMPLETED|Overall Study||23
281724|NCT00874497|681144|P2|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|33
281725|NCT00874497|681145|P1|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|51
281726|NCT00874276|681185|P2|NOT COMPLETED|Overall Study||1
281727|NCT00874276|681186|P1|NOT COMPLETED|Overall Study||1
281728|NCT00874276|681185|P2|COMPLETED|Overall Study||7
281729|NCT00874276|681186|P1|COMPLETED|Overall Study||5
281730|NCT00874276|681185|P2|STARTED|Overall Study||8
281731|NCT00874276|681186|P1|STARTED|Overall Study||6
281732|NCT00874250|681194|P1|NOT COMPLETED|Overall Study||51
281733|NCT00874250|681194|P1|COMPLETED|Overall Study||0
281734|NCT00874250|681194|P1|STARTED|Overall Study||51
281735|NCT00874237|681206|P6|NOT COMPLETED|Overall Study||0
281736|NCT00874237|681207|P5|NOT COMPLETED|Overall Study||0
281737|NCT00874237|681208|P4|NOT COMPLETED|Overall Study||0
281738|NCT00874237|681209|P3|NOT COMPLETED|Overall Study||1
281739|NCT00874237|681210|P2|NOT COMPLETED|Overall Study||1
281740|NCT00874237|681211|P1|NOT COMPLETED|Overall Study||0
281741|NCT00874237|681206|P6|COMPLETED|Overall Study||8
281742|NCT00874237|681207|P5|COMPLETED|Overall Study||8
281743|NCT00874237|681208|P4|COMPLETED|Overall Study||8
281744|NCT00874237|681209|P3|COMPLETED|Overall Study||7
281745|NCT00874237|681210|P2|COMPLETED|Overall Study||7
281746|NCT00874237|681211|P1|COMPLETED|Overall Study||8
281747|NCT00874237|681206|P6|STARTED|Overall Study||8
281748|NCT00874237|681207|P5|STARTED|Overall Study||8
281749|NCT00874237|681208|P4|STARTED|Overall Study||8
281750|NCT00874237|681209|P3|STARTED|Overall Study||8
281751|NCT00874237|681210|P2|STARTED|Overall Study||8
281752|NCT00874237|681211|P1|STARTED|Overall Study||8
281753|NCT00874120|681229|P2|NOT COMPLETED|Second Intervention||0
281754|NCT00874120|681230|P1|NOT COMPLETED|Second Intervention||2
281755|NCT00874120|681229|P2|COMPLETED|Second Intervention||56
281756|NCT00874120|681230|P1|COMPLETED|Second Intervention||50
281757|NCT00874120|681229|P2|STARTED|Second Intervention||56
281758|NCT00874120|681230|P1|STARTED|Second Intervention||52
281759|NCT00874120|681229|P2|NOT COMPLETED|Wash-out Period||0
281760|NCT00874120|681230|P1|NOT COMPLETED|Wash-out Period||0
281761|NCT00874120|681229|P2|COMPLETED|Wash-out Period||56
281762|NCT00874120|681230|P1|COMPLETED|Wash-out Period||52
281763|NCT00874120|681229|P2|STARTED|Wash-out Period||56
281764|NCT00874120|681230|P1|STARTED|Wash-out Period||52
281765|NCT00874120|681229|P2|NOT COMPLETED|First Intervention||2
281766|NCT00874120|681230|P1|NOT COMPLETED|First Intervention||6
281767|NCT00874120|681229|P2|COMPLETED|First Intervention||56
281768|NCT00874120|681230|P1|COMPLETED|First Intervention||52
281769|NCT00874120|681229|P2|STARTED|First Intervention||58
281770|NCT00874120|681230|P1|STARTED|First Intervention||58
281771|NCT00874094|681236|P1|NOT COMPLETED|Overall Study||0
281772|NCT00874094|681236|P1|COMPLETED|Overall Study||15
281773|NCT00874094|681236|P1|STARTED|Overall Study||15
281774|NCT00874029|681243|P1|NOT COMPLETED|Overall Study||21
281775|NCT00874029|681243|P1|COMPLETED|Overall Study||116
281776|NCT00874029|681243|P1|STARTED|Overall Study||137
281777|NCT00873912|681259|P2|NOT COMPLETED|Overall Study||0
281778|NCT00873912|681260|P1|NOT COMPLETED|Overall Study||3
281779|NCT00873912|681259|P2|COMPLETED|Overall Study||60
281780|NCT00873912|681260|P1|COMPLETED|Overall Study||237
281781|NCT00873912|681259|P2|STARTED|Overall Study||60
281782|NCT00873912|681260|P1|STARTED|Overall Study||240
281783|NCT00873873|681278|P4|NOT COMPLETED|Overall Study||0
281784|NCT00873873|681279|P3|NOT COMPLETED|Overall Study||0
281785|NCT00873873|681280|P2|NOT COMPLETED|Overall Study||0
281786|NCT00873873|681281|P1|NOT COMPLETED|Overall Study||0
281787|NCT00873873|681278|P4|COMPLETED|Overall Study||18
281788|NCT00873873|681279|P3|COMPLETED|Overall Study||9
281789|NCT00873873|681280|P2|COMPLETED|Overall Study||8
281790|NCT00873873|681281|P1|COMPLETED|Overall Study||20
281791|NCT00873873|681278|P4|STARTED|Overall Study||18
281792|NCT00873873|681279|P3|STARTED|Overall Study||9
281793|NCT00873873|681280|P2|STARTED|Overall Study||8
281794|NCT00873873|681281|P1|STARTED|Overall Study||20
281795|NCT00873860|681299|P4|NOT COMPLETED|Overall Study||1
281796|NCT00873860|681300|P3|NOT COMPLETED|Overall Study||3
281797|NCT00873860|681301|P2|NOT COMPLETED|Overall Study||0
281798|NCT00873860|681302|P1|NOT COMPLETED|Overall Study||4
281799|NCT00873860|681299|P4|COMPLETED|Overall Study||47
281800|NCT00873860|681300|P3|COMPLETED|Overall Study||48
281801|NCT00873860|681301|P2|COMPLETED|Overall Study||47
281802|NCT00873860|681302|P1|COMPLETED|Overall Study||44
281803|NCT00873860|681299|P4|Treated|Overall Study||48
281804|NCT00873860|681300|P3|Treated|Overall Study||51
281805|NCT00873860|681301|P2|Treated|Overall Study||47
281806|NCT00873860|681302|P1|Treated|Overall Study||47
281807|NCT00873860|681299|P4|STARTED|Overall Study||48
281808|NCT00873860|681300|P3|STARTED|Overall Study||51
281809|NCT00873860|681301|P2|STARTED|Overall Study||47
281810|NCT00873860|681302|P1|STARTED|Overall Study||48
281811|NCT00873821|681373|P2|NOT COMPLETED|Overall Study||0
281812|NCT00873821|681374|P1|NOT COMPLETED|Overall Study||0
281813|NCT00873821|681373|P2|COMPLETED|Overall Study||22
281814|NCT00873821|681374|P1|COMPLETED|Overall Study||22
281815|NCT00873821|681373|P2|STARTED|Overall Study||22
281816|NCT00873821|681374|P1|STARTED|Overall Study||22
281817|NCT00873782|681384|P1|NOT COMPLETED|Overall Study||0
281818|NCT00873782|681384|P1|COMPLETED|Overall Study||16
281819|NCT00873782|681384|P1|STARTED|Overall Study||16
281820|NCT00873730|681390|P2|NOT COMPLETED|Overall Study||5
281821|NCT00873730|681391|P1|NOT COMPLETED|Overall Study||6
281822|NCT00873730|681390|P2|COMPLETED|Overall Study||49
281823|NCT00873730|681391|P1|COMPLETED|Overall Study||48
281824|NCT00873730|681390|P2|STARTED|Overall Study||54
281825|NCT00873730|681391|P1|STARTED|Overall Study||54
281826|NCT00873457|681427|P1|NOT COMPLETED|Overall Study||0
281827|NCT00873457|681427|P1|COMPLETED|Overall Study||16
281828|NCT00873457|681427|P1|STARTED|Overall Study||16
281829|NCT00873366|681434|P1|NOT COMPLETED|Overall Study||6
281830|NCT00873366|681434|P1|COMPLETED|Overall Study||71
281831|NCT00873366|681434|P1|STARTED|Overall Study||77
281832|NCT00873327|681453|P1|NOT COMPLETED|Overall Study||0
281833|NCT00873327|681453|P1|COMPLETED|Overall Study||32
281834|NCT00873327|681453|P1|STARTED|Overall Study||32
281835|NCT00873119|681459|P2|NOT COMPLETED|Overall Study||26
281836|NCT00873119|681460|P1|NOT COMPLETED|Overall Study||44
281837|NCT00873119|681459|P2|COMPLETED|Overall Study||19
281838|NCT00873119|681460|P1|COMPLETED|Overall Study|Of 42 patients treated with belinostat, 23 patients received 6 or more treatment cycles.|0
281839|NCT00873119|681459|P2|STARTED|Overall Study||45
281840|NCT00873119|681460|P1|STARTED|Overall Study||44
281841|NCT00873093|681481|P5|NOT COMPLETED|Overall Study||2
281842|NCT00873093|681482|P4|NOT COMPLETED|Overall Study||11
281843|NCT00873093|681483|P3|NOT COMPLETED|Overall Study||16
281844|NCT00873093|681484|P2|NOT COMPLETED|Overall Study||27
281845|NCT00873093|681485|P1|NOT COMPLETED|Overall Study||1
281846|NCT00873093|681481|P5|COMPLETED|Overall Study||8
281847|NCT00873093|681482|P4|COMPLETED|Overall Study||12
281848|NCT00873093|681483|P3|COMPLETED|Overall Study||33
281849|NCT00873093|681484|P2|COMPLETED|Overall Study||35
281850|NCT00873093|681485|P1|COMPLETED|Overall Study||3
281851|NCT00873093|681481|P5|STARTED|Overall Study||10
281852|NCT00873093|681482|P4|STARTED|Overall Study||23
281853|NCT00873093|681483|P3|STARTED|Overall Study||49
281854|NCT00873093|681484|P2|STARTED|Overall Study||62
281855|NCT00873093|681485|P1|STARTED|Overall Study||4
281856|NCT00873041|681542|P3|NOT COMPLETED|Extension Study||2
281857|NCT00873041|681543|P2|NOT COMPLETED|Extension Study||0
281858|NCT00873041|681544|P1|NOT COMPLETED|Extension Study||1
281859|NCT00873041|681542|P3|COMPLETED|Extension Study||46
281860|NCT00873041|681543|P2|COMPLETED|Extension Study||44
281861|NCT00873041|681544|P1|COMPLETED|Extension Study||40
281862|NCT00873041|681542|P3|STARTED|Extension Study||48
281863|NCT00873041|681543|P2|STARTED|Extension Study||44
281864|NCT00873041|681544|P1|STARTED|Extension Study||41
281865|NCT00873041|681542|P3|NOT COMPLETED|Core Study||5
281866|NCT00873041|681543|P2|NOT COMPLETED|Core Study||6
281867|NCT00873041|681544|P1|NOT COMPLETED|Core Study||7
281868|NCT00873041|681542|P3|COMPLETED|Core Study||51
281869|NCT00873041|681543|P2|COMPLETED|Core Study||49
281870|NCT00873041|681544|P1|COMPLETED|Core Study||48
281871|NCT00873041|681542|P3|STARTED|Core Study||56
281872|NCT00873041|681543|P2|STARTED|Core Study||55
281873|NCT00873041|681544|P1|STARTED|Core Study||55
281874|NCT00873015|681602|P4|NOT COMPLETED|Overall Study||0
281875|NCT00873015|681603|P3|NOT COMPLETED|Overall Study||0
281876|NCT00873015|681604|P2|NOT COMPLETED|Overall Study||1
281877|NCT00873015|681605|P1|NOT COMPLETED|Overall Study||0
281878|NCT00873015|681602|P4|COMPLETED|Overall Study||3
281879|NCT00873015|681603|P3|COMPLETED|Overall Study||3
281880|NCT00873015|681604|P2|COMPLETED|Overall Study||3
281881|NCT00873015|681605|P1|COMPLETED|Overall Study||9
281882|NCT00873015|681602|P4|STARTED|Overall Study||3
281883|NCT00873015|681603|P3|STARTED|Overall Study||3
281884|NCT00873015|681604|P2|STARTED|Overall Study||4
281885|NCT00873015|681605|P1|STARTED|Overall Study||9
281886|NCT00872989|681614|P2|NOT COMPLETED|Overall Study||63
281887|NCT00872989|681615|P1|NOT COMPLETED|Overall Study||65
281888|NCT00872989|681614|P2|COMPLETED|Overall Study||0
281889|NCT00872989|681615|P1|COMPLETED|Overall Study||1
281890|NCT00872989|681614|P2|STARTED|Overall Study||63
281891|NCT00872989|681615|P1|STARTED|Overall Study||66
281892|NCT00872898|681634|P2|NOT COMPLETED|Part Two - Double Blind||6
281893|NCT00872898|681635|P1|NOT COMPLETED|Part Two - Double Blind||11
281894|NCT00872898|681634|P2|COMPLETED|Part Two - Double Blind||54
281895|NCT00872898|681635|P1|COMPLETED|Part Two - Double Blind||50
281896|NCT00872898|681634|P2|STARTED|Part Two - Double Blind||60
281897|NCT00872898|681635|P1|STARTED|Part Two - Double Blind||61
281898|NCT00872898|681634|P2|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
281899|NCT00872898|681635|P1|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
281900|NCT00872898|681634|P2|COMPLETED|Part One - Open Label, Pharmacokinetics||4
281901|NCT00872898|681635|P1|COMPLETED|Part One - Open Label, Pharmacokinetics||0
281902|NCT00872898|681634|P2|STARTED|Part One - Open Label, Pharmacokinetics||4
281903|NCT00872898|681635|P1|STARTED|Part One - Open Label, Pharmacokinetics||0
281904|NCT00872833|681669|P2|NOT COMPLETED|Overall Study||0
281905|NCT00872833|681670|P1|NOT COMPLETED|Overall Study||0
281906|NCT00872833|681669|P2|COMPLETED|Overall Study||17
281907|NCT00872833|681670|P1|COMPLETED|Overall Study||15
281908|NCT00872833|681669|P2|STARTED|Overall Study||17
281909|NCT00872833|681670|P1|STARTED|Overall Study||15
281910|NCT00872729|681679|P1|NOT COMPLETED|Overall Study||0
281911|NCT00872729|681679|P1|COMPLETED|Overall Study||9
281912|NCT00872729|681679|P1|STARTED|Overall Study||9
281913|NCT00872599|681709|P2|NOT COMPLETED|Second Drug During High Salt Intake||0
281914|NCT00872599|681710|P1|NOT COMPLETED|Second Drug During High Salt Intake||0
281915|NCT00872599|681709|P2|COMPLETED|Second Drug During High Salt Intake||16
281916|NCT00872599|681710|P1|COMPLETED|Second Drug During High Salt Intake||15
281917|NCT00872599|681709|P2|STARTED|Second Drug During High Salt Intake||16
281918|NCT00872599|681710|P1|STARTED|Second Drug During High Salt Intake||15
281919|NCT00872599|681709|P2|NOT COMPLETED|Second Washout Period||1
281920|NCT00872599|681710|P1|NOT COMPLETED|Second Washout Period||1
281921|NCT00872599|681709|P2|COMPLETED|Second Washout Period||16
281922|NCT00872599|681710|P1|COMPLETED|Second Washout Period||15
281923|NCT00872599|681709|P2|STARTED|Second Washout Period||17
281924|NCT00872599|681710|P1|STARTED|Second Washout Period||16
281925|NCT00872599|681709|P2|NOT COMPLETED|First Drug During High Salt Intake||0
281926|NCT00872599|681710|P1|NOT COMPLETED|First Drug During High Salt Intake||0
281927|NCT00872599|681709|P2|COMPLETED|First Drug During High Salt Intake||17
281928|NCT00872599|681710|P1|COMPLETED|First Drug During High Salt Intake||16
281929|NCT00872599|681709|P2|STARTED|First Drug During High Salt Intake||17
281930|NCT00872599|681710|P1|STARTED|First Drug During High Salt Intake||16
281931|NCT00872599|681709|P2|NOT COMPLETED|First Washout Period After Low Salt||0
281932|NCT00872599|681710|P1|NOT COMPLETED|First Washout Period After Low Salt||0
281933|NCT00872599|681709|P2|COMPLETED|First Washout Period After Low Salt||17
281934|NCT00872599|681710|P1|COMPLETED|First Washout Period After Low Salt||16
281935|NCT00872599|681709|P2|STARTED|First Washout Period After Low Salt||17
281936|NCT00872599|681710|P1|STARTED|First Washout Period After Low Salt||16
281937|NCT00872534|681720|P2|NOT COMPLETED|Overall Study||3
281938|NCT00872534|681721|P1|NOT COMPLETED|Overall Study||3
281939|NCT00872534|681720|P2|COMPLETED|Overall Study||101
281940|NCT00872534|681721|P1|COMPLETED|Overall Study||97
281941|NCT00872534|681720|P2|STARTED|Overall Study||104
281942|NCT00872534|681721|P1|STARTED|Overall Study||100
281943|NCT00872521|681730|P3|NOT COMPLETED|Secondary Endpoint Analysis||1
281944|NCT00872521|681731|P2|NOT COMPLETED|Secondary Endpoint Analysis||2
281945|NCT00872521|681732|P1|NOT COMPLETED|Secondary Endpoint Analysis||0
281946|NCT00872521|681730|P3|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|7
281947|NCT00872521|681731|P2|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|58
281948|NCT00872521|681732|P1|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|20
281949|NCT00872521|681730|P3|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|8
281950|NCT00872521|681731|P2|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|60
281951|NCT00872521|681732|P1|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|20
281952|NCT00872521|681730|P3|NOT COMPLETED|Completed 3-month Follow up||0
281953|NCT00872521|681731|P2|NOT COMPLETED|Completed 3-month Follow up||3
281954|NCT00872521|681732|P1|NOT COMPLETED|Completed 3-month Follow up||0
281955|NCT00872521|681730|P3|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|8
281956|NCT00872521|681731|P2|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|60
281957|NCT00872521|681732|P1|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|20
281958|NCT00872521|681730|P3|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|8
281959|NCT00872521|681731|P2|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|63
281960|NCT00872521|681732|P1|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|20
281961|NCT00872521|681730|P3|NOT COMPLETED|Primary Endpoint Analysis||1
281962|NCT00872521|681731|P2|NOT COMPLETED|Primary Endpoint Analysis||5
281963|NCT00872521|681732|P1|NOT COMPLETED|Primary Endpoint Analysis||1
281964|NCT00872521|681730|P3|COMPLETED|Primary Endpoint Analysis|participants analyzed|8
281965|NCT00872521|681731|P2|COMPLETED|Primary Endpoint Analysis|participants analyzed|63
281966|NCT00872521|681732|P1|COMPLETED|Primary Endpoint Analysis|participants analyzed|20
281967|NCT00872521|681730|P3|STARTED|Primary Endpoint Analysis|Completed PAD induction|9
281968|NCT00872521|681731|P2|STARTED|Primary Endpoint Analysis|Completed PAD induction|68
281969|NCT00872521|681732|P1|STARTED|Primary Endpoint Analysis|Completed PAD induction|21
281970|NCT00872521|681730|P3|NOT COMPLETED|Completed PAD Induction||0
281971|NCT00872521|681731|P2|NOT COMPLETED|Completed PAD Induction||4
281972|NCT00872521|681732|P1|NOT COMPLETED|Completed PAD Induction||5
281973|NCT00872521|681730|P3|COMPLETED|Completed PAD Induction|Completed PAD induction|9
281974|NCT00872521|681731|P2|COMPLETED|Completed PAD Induction|Completed PAD induction|68
281975|NCT00872521|681732|P1|COMPLETED|Completed PAD Induction|Completed PAD induction|21
281976|NCT00872521|681730|P3|STARTED|Completed PAD Induction|Received allocated treatment|9
281977|NCT00872521|681731|P2|STARTED|Completed PAD Induction|Received allocated treatment|72
281978|NCT00872521|681732|P1|STARTED|Completed PAD Induction|Received allocated treatment|26
281979|NCT00872430|681780|P2|NOT COMPLETED|Second Intervention||0
281980|NCT00872430|681781|P1|NOT COMPLETED|Second Intervention||0
281981|NCT00872430|681780|P2|COMPLETED|Second Intervention||10
281982|NCT00872430|681781|P1|COMPLETED|Second Intervention||10
281983|NCT00872430|681780|P2|STARTED|Second Intervention||10
281984|NCT00872430|681781|P1|STARTED|Second Intervention||10
281985|NCT00872430|681780|P2|NOT COMPLETED|Washout Period||0
281986|NCT00872430|681781|P1|NOT COMPLETED|Washout Period||0
281987|NCT00872430|681780|P2|COMPLETED|Washout Period||10
281988|NCT00872430|681781|P1|COMPLETED|Washout Period||10
281989|NCT00872430|681780|P2|STARTED|Washout Period||10
281990|NCT00872430|681781|P1|STARTED|Washout Period||10
281991|NCT00872430|681780|P2|NOT COMPLETED|First Intervention||0
281992|NCT00872430|681781|P1|NOT COMPLETED|First Intervention||0
281993|NCT00872430|681780|P2|COMPLETED|First Intervention||10
281994|NCT00872430|681781|P1|COMPLETED|First Intervention||10
281995|NCT00872430|681780|P2|STARTED|First Intervention||10
281996|NCT00872430|681781|P1|STARTED|First Intervention||10
281997|NCT00872339|681790|P3|NOT COMPLETED|Overall Study||0
281998|NCT00872339|681791|P2|NOT COMPLETED|Overall Study||0
281999|NCT00872339|681792|P1|NOT COMPLETED|Overall Study||0
282000|NCT00872339|681790|P3|COMPLETED|Overall Study||37
282001|NCT00872339|681791|P2|COMPLETED|Overall Study||14
282002|NCT00872339|681792|P1|COMPLETED|Overall Study||201
282003|NCT00872339|681790|P3|STARTED|Overall Study||37
282004|NCT00872339|681791|P2|STARTED|Overall Study||14
282005|NCT00872339|681792|P1|STARTED|Overall Study||201
282006|NCT00872170|681803|P2|NOT COMPLETED|Overall Study||0
282007|NCT00872170|681804|P1|NOT COMPLETED|Overall Study||1
282008|NCT00872170|681803|P2|COMPLETED|Overall Study||13
282009|NCT00872170|681804|P1|COMPLETED|Overall Study|One patient withdrew from study at week 2.|13
282010|NCT00872170|681803|P2|STARTED|Overall Study||13
282011|NCT00872170|681804|P1|STARTED|Overall Study||14
282012|NCT00872079|681819|P1|NOT COMPLETED|Overall Study||0
282013|NCT00872079|681819|P1|COMPLETED|Overall Study||175
282014|NCT00872079|681819|P1|STARTED|Overall Study||175
282015|NCT00872027|681825|P2|NOT COMPLETED|Overall Study||0
282016|NCT00872027|681826|P1|NOT COMPLETED|Overall Study||0
282017|NCT00872027|681825|P2|COMPLETED|Overall Study||8
282018|NCT00872027|681826|P1|COMPLETED|Overall Study||7
282019|NCT00872027|681825|P2|STARTED|Overall Study||8
282020|NCT00872027|681826|P1|STARTED|Overall Study||7
282021|NCT00872001|681834|P2|NOT COMPLETED|Overall Study||131
282022|NCT00872001|681835|P1|NOT COMPLETED|Overall Study||136
282023|NCT00872001|681834|P2|COMPLETED|Overall Study||1413
282024|NCT00872001|681835|P1|COMPLETED|Overall Study||1400
282025|NCT00872001|681834|P2|STARTED|Overall Study||1544
282026|NCT00872001|681835|P1|STARTED|Overall Study||1536
282027|NCT00871975|681843|P1|NOT COMPLETED|Overall Study||22
282028|NCT00871975|681843|P1|COMPLETED|Overall Study||133
282029|NCT00871975|681843|P1|STARTED|Overall Study||155
282030|NCT00871871|681849|P4|NOT COMPLETED|Part II||4
282031|NCT00871871|681850|P3|NOT COMPLETED|Part II||4
282032|NCT00871871|681851|P2|NOT COMPLETED|Part II||0
282033|NCT00871871|681852|P1|NOT COMPLETED|Part II||0
282034|NCT00871871|681849|P4|COMPLETED|Part II||11
282035|NCT00871871|681850|P3|COMPLETED|Part II||9
282036|NCT00871871|681851|P2|COMPLETED|Part II||0
282037|NCT00871871|681852|P1|COMPLETED|Part II||0
282038|NCT00871871|681849|P4|STARTED|Part II||15
282039|NCT00871871|681850|P3|STARTED|Part II||13
282040|NCT00871871|681851|P2|STARTED|Part II||0
282041|NCT00871871|681852|P1|STARTED|Part II||0
282042|NCT00871871|681849|P4|NOT COMPLETED|Part I||0
282043|NCT00871871|681850|P3|NOT COMPLETED|Part I||0
282044|NCT00871871|681851|P2|NOT COMPLETED|Part I||3
282045|NCT00871871|681852|P1|NOT COMPLETED|Part I||3
282046|NCT00871871|681849|P4|COMPLETED|Part I||0
282047|NCT00871871|681850|P3|COMPLETED|Part I||0
282048|NCT00871871|681851|P2|COMPLETED|Part I||15
282049|NCT00871871|681852|P1|COMPLETED|Part I||15
282050|NCT00871871|681849|P4|STARTED|Part I||0
282051|NCT00871871|681850|P3|STARTED|Part I||0
282052|NCT00871871|681851|P2|STARTED|Part I||18
282053|NCT00871871|681852|P1|STARTED|Part I||18
282054|NCT00871845|681874|P2|NOT COMPLETED|Overall Study||0
282055|NCT00871845|681875|P1|NOT COMPLETED|Overall Study||0
282056|NCT00871845|681874|P2|COMPLETED|Overall Study||25
282057|NCT00871845|681875|P1|COMPLETED|Overall Study||11
282058|NCT00871845|681874|P2|STARTED|Overall Study||25
282059|NCT00871845|681875|P1|STARTED|Overall Study||11
282060|NCT00871819|681885|P1|NOT COMPLETED|Overall Study||0
282061|NCT00871819|681885|P1|COMPLETED|Overall Study||20
282062|NCT00871819|681885|P1|STARTED|Overall Study||20
282063|NCT00871780|681889|P1|NOT COMPLETED|Overall Study||27
282064|NCT00871780|681889|P1|COMPLETED|Overall Study||197
282065|NCT00871780|681889|P1|Efficacy Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab and completed at least 1 on-treatment evaluation|215
282066|NCT00871780|681889|P1|Safety Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab during the study|218
282067|NCT00871780|681889|P1|STARTED|Overall Study|number enrolled|224
282068|NCT00871741|681909|P2|NOT COMPLETED|Overall Study||7
282069|NCT00871741|681910|P1|NOT COMPLETED|Overall Study||9
282070|NCT00871741|681909|P2|COMPLETED|Overall Study||0
282071|NCT00871741|681910|P1|COMPLETED|Overall Study||0
282072|NCT00871741|681909|P2|STARTED|Overall Study||7
282073|NCT00871741|681910|P1|STARTED|Overall Study||9
282074|NCT00871728|681924|P1|NOT COMPLETED|Overall Study||20
282075|NCT00871728|681924|P1|COMPLETED|Overall Study||112
282076|NCT00871728|681924|P1|Treated|Overall Study||130
282077|NCT00871728|681924|P1|STARTED|Overall Study||132
282078|NCT00871715|681937|P3|NOT COMPLETED|Overall Study||26
282079|NCT00871715|681938|P2|NOT COMPLETED|Overall Study||16
282080|NCT00871715|681939|P1|NOT COMPLETED|Overall Study||15
282081|NCT00871715|681937|P3|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|96
282082|NCT00871715|681938|P2|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
282083|NCT00871715|681939|P1|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
282084|NCT00871715|681937|P3|6-mo Follow-up|Overall Study||112
282085|NCT00871715|681938|P2|6-mo Follow-up|Overall Study||113
282086|NCT00871715|681939|P1|6-mo Follow-up|Overall Study||110
282087|NCT00871715|681937|P3|Post-Intervention|Overall Study||115
282088|NCT00871715|681938|P2|Post-Intervention|Overall Study||115
282089|NCT00871715|681939|P1|Post-Intervention|Overall Study||112
282090|NCT00871715|681937|P3|STARTED|Overall Study||122
282091|NCT00871715|681938|P2|STARTED|Overall Study||120
282092|NCT00871715|681939|P1|STARTED|Overall Study||119
282093|NCT00871689|681990|P1|NOT COMPLETED|Overall Study||0
282094|NCT00871689|681990|P1|COMPLETED|Overall Study||2
282095|NCT00871689|681990|P1|STARTED|Overall Study||2
282096|NCT00871624|682003|P2|NOT COMPLETED|Overall Study||1
282097|NCT00871624|682004|P1|NOT COMPLETED|Overall Study||2
282098|NCT00871624|682003|P2|COMPLETED|Overall Study||17
282099|NCT00871624|682004|P1|COMPLETED|Overall Study||16
282100|NCT00871624|682003|P2|STARTED|Overall Study||18
282101|NCT00871624|682004|P1|STARTED|Overall Study||18
282102|NCT00871572|682016|P4|NOT COMPLETED|Overall Study||7
282103|NCT00871572|682017|P3|NOT COMPLETED|Overall Study||4
282104|NCT00871572|682018|P2|NOT COMPLETED|Overall Study||6
282105|NCT00871572|682019|P1|NOT COMPLETED|Overall Study||2
282106|NCT00871572|682016|P4|COMPLETED|Overall Study||19
282107|NCT00871572|682017|P3|COMPLETED|Overall Study||30
282108|NCT00871572|682018|P2|COMPLETED|Overall Study||11
282109|NCT00871572|682019|P1|COMPLETED|Overall Study||8
282110|NCT00871572|682016|P4|Received at Least 1 Dose of Study Drug|Overall Study||25
282111|NCT00871572|682017|P3|Received at Least 1 Dose of Study Drug|Overall Study||34
282112|NCT00871572|682018|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
282113|NCT00871572|682019|P1|Received at Least 1 Dose of Study Drug|Overall Study||9
282114|NCT00871572|682016|P4|≥1 Post Baseline Value by Assigned Group|Overall Study||25
282115|NCT00871572|682017|P3|≥1 Post Baseline Value by Assigned Group|Overall Study||34
282116|NCT00871572|682018|P2|≥1 Post Baseline Value by Assigned Group|Overall Study||17
282117|NCT00871572|682019|P1|≥1 Post Baseline Value by Assigned Group|Overall Study||9
282118|NCT00871572|682016|P4|STARTED|Overall Study||26
282119|NCT00871572|682017|P3|STARTED|Overall Study||34
282120|NCT00871572|682018|P2|STARTED|Overall Study||17
282121|NCT00871572|682019|P1|STARTED|Overall Study||10
282122|NCT00871494|682089|P1|NOT COMPLETED|Overall Study||14
282123|NCT00871494|682089|P1|COMPLETED|Overall Study||62
282124|NCT00871494|682089|P1|STARTED|Overall Study||76
282125|NCT00871429|682096|P1|NOT COMPLETED|Overall Study||24
282126|NCT00871429|682096|P1|COMPLETED|Overall Study||75
282127|NCT00871429|682096|P1|STARTED|Overall Study||99
282128|NCT00871403|682107|P3|NOT COMPLETED|Monotherapy Treatment Phase||1
282129|NCT00871403|682108|P2|NOT COMPLETED|Monotherapy Treatment Phase||13
282130|NCT00871403|682109|P1|NOT COMPLETED|Monotherapy Treatment Phase||0
282131|NCT00871403|682107|P3|COMPLETED|Monotherapy Treatment Phase||0
282132|NCT00871403|682108|P2|COMPLETED|Monotherapy Treatment Phase||0
282133|NCT00871403|682109|P1|COMPLETED|Monotherapy Treatment Phase||0
282134|NCT00871403|682107|P3|STARTED|Monotherapy Treatment Phase||1
282135|NCT00871403|682108|P2|STARTED|Monotherapy Treatment Phase||13
282136|NCT00871403|682109|P1|STARTED|Monotherapy Treatment Phase||0
282137|NCT00871403|682107|P3|NOT COMPLETED|Combination Treatment Phase||12
282138|NCT00871403|682108|P2|NOT COMPLETED|Combination Treatment Phase||49
282139|NCT00871403|682109|P1|NOT COMPLETED|Combination Treatment Phase||9
282140|NCT00871403|682107|P3|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|23
282141|NCT00871403|682108|P2|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|13
282142|NCT00871403|682109|P1|COMPLETED|Combination Treatment Phase|No particiapants completed Combination Treatement.|0
282143|NCT00871403|682107|P3|STARTED|Combination Treatment Phase||35
282144|NCT00871403|682108|P2|STARTED|Combination Treatment Phase||62
282145|NCT00871403|682109|P1|STARTED|Combination Treatment Phase||9
282146|NCT00871377|682122|P6|NOT COMPLETED|Third Intervention (10 Weeks)||0
282147|NCT00871377|682123|P5|NOT COMPLETED|Third Intervention (10 Weeks)||0
282148|NCT00871377|682124|P4|NOT COMPLETED|Third Intervention (10 Weeks)||1
282149|NCT00871377|682125|P3|NOT COMPLETED|Third Intervention (10 Weeks)||0
282150|NCT00871377|682126|P2|NOT COMPLETED|Third Intervention (10 Weeks)||0
282151|NCT00871377|682127|P1|NOT COMPLETED|Third Intervention (10 Weeks)||0
282152|NCT00871377|682122|P6|COMPLETED|Third Intervention (10 Weeks)||3
282153|NCT00871377|682123|P5|COMPLETED|Third Intervention (10 Weeks)||4
282154|NCT00871377|682124|P4|COMPLETED|Third Intervention (10 Weeks)||3
282155|NCT00871377|682125|P3|COMPLETED|Third Intervention (10 Weeks)||3
282156|NCT00871377|682126|P2|COMPLETED|Third Intervention (10 Weeks)||4
282157|NCT00871377|682127|P1|COMPLETED|Third Intervention (10 Weeks)||2
282158|NCT00871377|682122|P6|STARTED|Third Intervention (10 Weeks)||3
282159|NCT00871377|682123|P5|STARTED|Third Intervention (10 Weeks)||4
282160|NCT00871377|682124|P4|STARTED|Third Intervention (10 Weeks)||4
282161|NCT00871377|682125|P3|STARTED|Third Intervention (10 Weeks)||3
282162|NCT00871377|682126|P2|STARTED|Third Intervention (10 Weeks)||4
282163|NCT00871377|682127|P1|STARTED|Third Intervention (10 Weeks)||2
282164|NCT00871377|682122|P6|NOT COMPLETED|Washout (6 Weeks)||1
282165|NCT00871377|682123|P5|NOT COMPLETED|Washout (6 Weeks)||0
282166|NCT00871377|682124|P4|NOT COMPLETED|Washout (6 Weeks)||0
282167|NCT00871377|682125|P3|NOT COMPLETED|Washout (6 Weeks)||0
282168|NCT00871377|682126|P2|NOT COMPLETED|Washout (6 Weeks)||0
282169|NCT00871377|682127|P1|NOT COMPLETED|Washout (6 Weeks)||0
282170|NCT00871377|682122|P6|COMPLETED|Washout (6 Weeks)||3
282171|NCT00871377|682123|P5|COMPLETED|Washout (6 Weeks)||4
282172|NCT00871377|682124|P4|COMPLETED|Washout (6 Weeks)||4
282173|NCT00871377|682125|P3|COMPLETED|Washout (6 Weeks)||3
282174|NCT00871377|682126|P2|COMPLETED|Washout (6 Weeks)||4
282175|NCT00871377|682127|P1|COMPLETED|Washout (6 Weeks)||2
282176|NCT00871377|682122|P6|STARTED|Washout (6 Weeks)||4
282177|NCT00871377|682123|P5|STARTED|Washout (6 Weeks)||4
282178|NCT00871377|682124|P4|STARTED|Washout (6 Weeks)||4
282179|NCT00871377|682125|P3|STARTED|Washout (6 Weeks)||3
282180|NCT00871377|682126|P2|STARTED|Washout (6 Weeks)||4
282181|NCT00871377|682127|P1|STARTED|Washout (6 Weeks)||2
282182|NCT00871377|682122|P6|NOT COMPLETED|Second Intervention (10 Weeks)||0
282183|NCT00871377|682123|P5|NOT COMPLETED|Second Intervention (10 Weeks)||0
282184|NCT00871377|682124|P4|NOT COMPLETED|Second Intervention (10 Weeks)||0
282185|NCT00871377|682125|P3|NOT COMPLETED|Second Intervention (10 Weeks)||0
282186|NCT00871377|682126|P2|NOT COMPLETED|Second Intervention (10 Weeks)||0
282187|NCT00871377|682127|P1|NOT COMPLETED|Second Intervention (10 Weeks)||0
282188|NCT00871377|682122|P6|COMPLETED|Second Intervention (10 Weeks)||4
282189|NCT00871377|682123|P5|COMPLETED|Second Intervention (10 Weeks)||4
282190|NCT00871377|682124|P4|COMPLETED|Second Intervention (10 Weeks)||4
282191|NCT00871377|682125|P3|COMPLETED|Second Intervention (10 Weeks)||3
282192|NCT00871377|682126|P2|COMPLETED|Second Intervention (10 Weeks)||4
282193|NCT00871377|682127|P1|COMPLETED|Second Intervention (10 Weeks)||2
282194|NCT00871377|682122|P6|STARTED|Second Intervention (10 Weeks)||4
282195|NCT00871377|682123|P5|STARTED|Second Intervention (10 Weeks)||4
282196|NCT00871377|682124|P4|STARTED|Second Intervention (10 Weeks)||4
282197|NCT00871377|682125|P3|STARTED|Second Intervention (10 Weeks)||3
282198|NCT00871377|682126|P2|STARTED|Second Intervention (10 Weeks)||4
282199|NCT00871377|682127|P1|STARTED|Second Intervention (10 Weeks)||2
282200|NCT00871377|682122|P6|NOT COMPLETED|Washout (6 Weeks)||0
282201|NCT00871377|682123|P5|NOT COMPLETED|Washout (6 Weeks)||0
282202|NCT00871377|682124|P4|NOT COMPLETED|Washout (6 Weeks)||0
282203|NCT00871377|682125|P3|NOT COMPLETED|Washout (6 Weeks)||0
282204|NCT00871377|682126|P2|NOT COMPLETED|Washout (6 Weeks)||0
282205|NCT00871377|682127|P1|NOT COMPLETED|Washout (6 Weeks)||1
282206|NCT00871377|682122|P6|COMPLETED|Washout (6 Weeks)||4
282207|NCT00871377|682123|P5|COMPLETED|Washout (6 Weeks)||4
282208|NCT00871377|682124|P4|COMPLETED|Washout (6 Weeks)||4
282209|NCT00871377|682125|P3|COMPLETED|Washout (6 Weeks)||3
282210|NCT00871377|682126|P2|COMPLETED|Washout (6 Weeks)||4
282211|NCT00871377|682127|P1|COMPLETED|Washout (6 Weeks)||2
282212|NCT00871377|682122|P6|STARTED|Washout (6 Weeks)||4
282213|NCT00871377|682123|P5|STARTED|Washout (6 Weeks)||4
282214|NCT00871377|682124|P4|STARTED|Washout (6 Weeks)||4
282215|NCT00871377|682125|P3|STARTED|Washout (6 Weeks)||3
282216|NCT00871377|682126|P2|STARTED|Washout (6 Weeks)||4
282217|NCT00871377|682127|P1|STARTED|Washout (6 Weeks)||3
282218|NCT00871377|682122|P6|NOT COMPLETED|First Intervention (10 Weeks)||1
282219|NCT00871377|682123|P5|NOT COMPLETED|First Intervention (10 Weeks)||0
282220|NCT00871377|682124|P4|NOT COMPLETED|First Intervention (10 Weeks)||0
282221|NCT00871377|682125|P3|NOT COMPLETED|First Intervention (10 Weeks)||1
282222|NCT00871377|682126|P2|NOT COMPLETED|First Intervention (10 Weeks)||0
282223|NCT00871377|682127|P1|NOT COMPLETED|First Intervention (10 Weeks)||0
282224|NCT00871377|682122|P6|COMPLETED|First Intervention (10 Weeks)||4
282225|NCT00871377|682123|P5|COMPLETED|First Intervention (10 Weeks)||4
282226|NCT00871377|682124|P4|COMPLETED|First Intervention (10 Weeks)||4
282227|NCT00871377|682125|P3|COMPLETED|First Intervention (10 Weeks)||3
282228|NCT00871377|682126|P2|COMPLETED|First Intervention (10 Weeks)||4
282229|NCT00871377|682127|P1|COMPLETED|First Intervention (10 Weeks)||3
282230|NCT00871377|682122|P6|STARTED|First Intervention (10 Weeks)||5
282231|NCT00871377|682123|P5|STARTED|First Intervention (10 Weeks)||4
282232|NCT00871377|682124|P4|STARTED|First Intervention (10 Weeks)||4
282233|NCT00871377|682125|P3|STARTED|First Intervention (10 Weeks)||4
282234|NCT00871377|682126|P2|STARTED|First Intervention (10 Weeks)||4
282235|NCT00871377|682127|P1|STARTED|First Intervention (10 Weeks)||3
282236|NCT00871351|682138|P3|NOT COMPLETED|Overall Study||0
282237|NCT00871351|682139|P2|NOT COMPLETED|Overall Study||1
282238|NCT00871351|682140|P1|NOT COMPLETED|Overall Study||4
282239|NCT00871351|682138|P3|COMPLETED|Overall Study||32
282240|NCT00871351|682139|P2|COMPLETED|Overall Study||45
282241|NCT00871351|682140|P1|COMPLETED|Overall Study||43
282242|NCT00871351|682138|P3|STARTED|Overall Study||32
282243|NCT00871351|682139|P2|STARTED|Overall Study||46
282244|NCT00871351|682140|P1|STARTED|Overall Study||47
282245|NCT00871338|682162|P2|NOT COMPLETED|After Booster||0
282246|NCT00871338|682163|P1|NOT COMPLETED|After Booster||0
282247|NCT00871338|682162|P2|COMPLETED|After Booster||135
282248|NCT00871338|682163|P1|COMPLETED|After Booster||139
282249|NCT00871338|682162|P2|STARTED|After Booster||135
282250|NCT00871338|682163|P1|STARTED|After Booster||139
282251|NCT00871338|682162|P2|NOT COMPLETED|Prior to Booster||3
282252|NCT00871338|682163|P1|NOT COMPLETED|Prior to Booster||2
282253|NCT00871338|682162|P2|COMPLETED|Prior to Booster||139
282254|NCT00871338|682163|P1|COMPLETED|Prior to Booster||140
282255|NCT00871338|682162|P2|STARTED|Prior to Booster||142
282256|NCT00871338|682163|P1|STARTED|Prior to Booster||142
282257|NCT00871286|682243|P2|NOT COMPLETED|Overall Study||6
282258|NCT00871286|682244|P1|NOT COMPLETED|Overall Study||0
282259|NCT00871286|682243|P2|COMPLETED|Overall Study||14
282260|NCT00871286|682244|P1|COMPLETED|Overall Study||20
282261|NCT00871286|682243|P2|STARTED|Overall Study||20
282262|NCT00871286|682244|P1|STARTED|Overall Study||20
282263|NCT00871234|682252|P1|NOT COMPLETED|Overall Study||5
282264|NCT00871234|682252|P1|COMPLETED|Overall Study||23
282265|NCT00871234|682252|P1|STARTED|Overall Study||28
282266|NCT00871169|682256|P1|NOT COMPLETED|Overall Study||3
282267|NCT00871169|682256|P1|COMPLETED|Overall Study||58
282268|NCT00871169|682256|P1|STARTED|Overall Study||61
282269|NCT00871143|682263|P2|NOT COMPLETED|Overall Study||0
282270|NCT00871143|682264|P1|NOT COMPLETED|Overall Study||0
282271|NCT00871143|682263|P2|COMPLETED|Overall Study||25
282272|NCT00871143|682264|P1|COMPLETED|Overall Study||21
282273|NCT00871143|682263|P2|STARTED|Overall Study||25
282274|NCT00871143|682264|P1|STARTED|Overall Study||21
282275|NCT00871117|682284|P2|NOT COMPLETED|Overall Study||10
282276|NCT00871117|682285|P1|NOT COMPLETED|Overall Study||5
282277|NCT00871117|682284|P2|COMPLETED|Overall Study||227
282278|NCT00871117|682285|P1|COMPLETED|Overall Study||234
282279|NCT00871117|682284|P2|STARTED|Overall Study||237
282280|NCT00871117|682285|P1|STARTED|Overall Study||239
282281|NCT00871000|682319|P2|NOT COMPLETED|Overall Study||0
282282|NCT00871000|682320|P1|NOT COMPLETED|Overall Study||1
282283|NCT00871000|682319|P2|COMPLETED|Overall Study||152
282284|NCT00871000|682320|P1|COMPLETED|Overall Study||150
282285|NCT00871000|682319|P2|STARTED|Overall Study||152
282286|NCT00871000|682320|P1|STARTED|Overall Study||151
282287|NCT00870896|682362|P1|NOT COMPLETED|Overall Study||0
282288|NCT00870896|682362|P1|COMPLETED|Overall Study||5
282289|NCT00870896|682362|P1|STARTED|Overall Study||5
282290|NCT00870870|682372|P4|NOT COMPLETED|Overall Study||5
282291|NCT00870870|682373|P3|NOT COMPLETED|Overall Study||3
282292|NCT00870870|682374|P2|NOT COMPLETED|Overall Study||1
282293|NCT00870870|682375|P1|NOT COMPLETED|Overall Study||0
282294|NCT00870870|682372|P4|COMPLETED|Overall Study||20
282295|NCT00870870|682373|P3|COMPLETED|Overall Study||26
282296|NCT00870870|682374|P2|COMPLETED|Overall Study||5
282297|NCT00870870|682375|P1|COMPLETED|Overall Study||4
282298|NCT00870870|682372|P4|STARTED|Overall Study||25
282299|NCT00870870|682373|P3|STARTED|Overall Study||29
282300|NCT00870870|682374|P2|STARTED|Overall Study||6
282301|NCT00870870|682375|P1|STARTED|Overall Study||4
282302|NCT00870740|682419|P6|NOT COMPLETED|Overall Study||17
282303|NCT00870740|682420|P5|NOT COMPLETED|Overall Study||11
282304|NCT00870740|682421|P4|NOT COMPLETED|Overall Study||12
282305|NCT00870740|682422|P3|NOT COMPLETED|Overall Study||10
282306|NCT00870740|682423|P2|NOT COMPLETED|Overall Study||9
282307|NCT00870740|682424|P1|NOT COMPLETED|Overall Study||12
282308|NCT00870740|682419|P6|COMPLETED|Overall Study||70
282309|NCT00870740|682420|P5|COMPLETED|Overall Study||77
282310|NCT00870740|682421|P4|COMPLETED|Overall Study||74
282311|NCT00870740|682422|P3|COMPLETED|Overall Study||76
282312|NCT00870740|682423|P2|COMPLETED|Overall Study||75
282313|NCT00870740|682424|P1|COMPLETED|Overall Study||74
282314|NCT00870740|682419|P6|STARTED|Overall Study|number randomized and dosed|87
282315|NCT00870740|682420|P5|STARTED|Overall Study|number randomized and dosed|88
282316|NCT00870740|682421|P4|STARTED|Overall Study|number randomized and dosed|86
282317|NCT00870740|682422|P3|STARTED|Overall Study|number randomized and dosed|86
282318|NCT00870740|682423|P2|STARTED|Overall Study|number randomized and dosed|84
282319|NCT00870740|682424|P1|STARTED|Overall Study|number randomized and dosed|86
282320|NCT00870727|682500|P2|NOT COMPLETED|Overall Study||5
282321|NCT00870727|682501|P1|NOT COMPLETED|Overall Study||1
282322|NCT00870727|682500|P2|COMPLETED|Overall Study||11
282323|NCT00870727|682501|P1|COMPLETED|Overall Study||16
282324|NCT00870727|682500|P2|STARTED|Overall Study||16
282325|NCT00870727|682501|P1|STARTED|Overall Study||17
282326|NCT00870688|682517|P1|NOT COMPLETED|Overall Study||4
282327|NCT00870688|682517|P1|COMPLETED|Overall Study||78
282328|NCT00870688|682517|P1|STARTED|Overall Study||82
282329|NCT00870584|682522|P2|NOT COMPLETED|Overall Study||13
282330|NCT00870584|682523|P1|NOT COMPLETED|Overall Study||16
282331|NCT00870584|682522|P2|COMPLETED|Overall Study||122
282332|NCT00870584|682523|P1|COMPLETED|Overall Study||120
282333|NCT00870584|682522|P2|STARTED|Overall Study||135
282334|NCT00870584|682523|P1|STARTED|Overall Study||136
282335|NCT00870545|682531|P1|NOT COMPLETED|Overall Study||17
282336|NCT00870545|682531|P1|COMPLETED|Overall Study||69
282337|NCT00870545|682531|P1|STARTED|Overall Study||86
282338|NCT00870467|682542|P6|NOT COMPLETED|Open-label||3
282339|NCT00870467|682543|P5|NOT COMPLETED|Open-label||5
282340|NCT00870467|682544|P4|NOT COMPLETED|Open-label||7
282341|NCT00870467|682545|P3|NOT COMPLETED|Open-label||13
282342|NCT00870467|682546|P2|NOT COMPLETED|Open-label||0
282343|NCT00870467|682547|P1|NOT COMPLETED|Open-label||0
282344|NCT00870467|682542|P6|COMPLETED|Open-label||21
282345|NCT00870467|682543|P5|COMPLETED|Open-label||5
282346|NCT00870467|682544|P4|COMPLETED|Open-label||120
282347|NCT00870467|682545|P3|COMPLETED|Open-label||132
282348|NCT00870467|682546|P2|COMPLETED|Open-label||0
282349|NCT00870467|682547|P1|COMPLETED|Open-label||0
282350|NCT00870467|682542|P6|STARTED|Open-label||24
282351|NCT00870467|682543|P5|STARTED|Open-label||10
282352|NCT00870467|682544|P4|STARTED|Open-label||127
282353|NCT00870467|682545|P3|STARTED|Open-label||145
282354|NCT00870467|682546|P2|STARTED|Open-label||0
282355|NCT00870467|682547|P1|STARTED|Open-label||0
282356|NCT00870467|682542|P6|NOT COMPLETED|Double-blind||0
282357|NCT00870467|682543|P5|NOT COMPLETED|Double-blind||0
282358|NCT00870467|682544|P4|NOT COMPLETED|Double-blind||0
282359|NCT00870467|682545|P3|NOT COMPLETED|Double-blind||0
282360|NCT00870467|682546|P2|NOT COMPLETED|Double-blind||12
282361|NCT00870467|682547|P1|NOT COMPLETED|Double-blind||16
282362|NCT00870467|682542|P6|COMPLETED|Double-blind||0
282363|NCT00870467|682543|P5|COMPLETED|Double-blind||0
282364|NCT00870467|682544|P4|COMPLETED|Double-blind||0
282365|NCT00870467|682545|P3|COMPLETED|Double-blind||0
282366|NCT00870467|682546|P2|COMPLETED|Double-blind|24 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|151
282367|NCT00870467|682547|P1|COMPLETED|Double-blind|10 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|155
282368|NCT00870467|682542|P6|STARTED|Double-blind||0
282369|NCT00870467|682543|P5|STARTED|Double-blind||0
282370|NCT00870467|682544|P4|STARTED|Double-blind||0
282371|NCT00870467|682545|P3|STARTED|Double-blind||0
282372|NCT00870467|682546|P2|STARTED|Double-blind||163
282373|NCT00870467|682547|P1|STARTED|Double-blind||171
282374|NCT00870363|682595|P4|NOT COMPLETED|Overall Study||0
282375|NCT00870363|682596|P3|NOT COMPLETED|Overall Study||3
282376|NCT00870363|682597|P2|NOT COMPLETED|Overall Study||3
282377|NCT00870363|682598|P1|NOT COMPLETED|Overall Study||0
282378|NCT00870363|682595|P4|COMPLETED|Overall Study||12
282379|NCT00870363|682596|P3|COMPLETED|Overall Study||8
282380|NCT00870363|682597|P2|COMPLETED|Overall Study||8
282381|NCT00870363|682598|P1|COMPLETED|Overall Study||10
282382|NCT00870363|682595|P4|STARTED|Overall Study||12
282383|NCT00870363|682596|P3|STARTED|Overall Study||11
282384|NCT00870363|682597|P2|STARTED|Overall Study||11
282385|NCT00870363|682598|P1|STARTED|Overall Study||10
282386|NCT00870233|682632|P1|NOT COMPLETED|Overall Study||24
282387|NCT00870233|682632|P1|COMPLETED|Overall Study||96
282388|NCT00870233|682632|P1|STARTED|Overall Study||120
282389|NCT00870194|682641|P2|NOT COMPLETED|Overall Study||14
282390|NCT00870194|682642|P1|NOT COMPLETED|Overall Study||26
282391|NCT00870194|682641|P2|COMPLETED|Overall Study||114
282392|NCT00870194|682642|P1|COMPLETED|Overall Study||101
282393|NCT00870194|682641|P2|Per Protocol Set|Overall Study||111
282394|NCT00870194|682642|P1|Per Protocol Set|Overall Study||97
282395|NCT00870194|682641|P2|STARTED|Overall Study||128
282396|NCT00870194|682642|P1|STARTED|Overall Study||127
282397|NCT00870103|682680|P1|NOT COMPLETED|Overall Study||4
282398|NCT00870103|682680|P1|COMPLETED|Overall Study||60
282399|NCT00870103|682680|P1|STARTED|Overall Study||64
282400|NCT00869999|682685|P1|NOT COMPLETED|Overall Study||2
282401|NCT00869999|682685|P1|COMPLETED|Overall Study||24
282402|NCT00869999|682685|P1|STARTED|Overall Study||26
282403|NCT00869960|682691|P1|NOT COMPLETED|Overall Study||2
282404|NCT00869960|682691|P1|COMPLETED|Overall Study||22
282405|NCT00869960|682691|P1|STARTED|Overall Study||24
282406|NCT00869947|682704|P2|NOT COMPLETED|Overall Study||0
282407|NCT00869947|682705|P1|NOT COMPLETED|Overall Study||0
282408|NCT00869947|682704|P2|COMPLETED|Overall Study||8
282409|NCT00869947|682705|P1|COMPLETED|Overall Study||8
282410|NCT00869947|682704|P2|STARTED|Overall Study||8
282411|NCT00869947|682705|P1|STARTED|Overall Study||8
282412|NCT00869791|682718|P2|NOT COMPLETED|Period 2 Treatment for 7 Days||0
282413|NCT00869791|682719|P1|NOT COMPLETED|Period 2 Treatment for 7 Days||0
282414|NCT00869791|682718|P2|COMPLETED|Period 2 Treatment for 7 Days||13
282415|NCT00869791|682719|P1|COMPLETED|Period 2 Treatment for 7 Days||14
282416|NCT00869791|682718|P2|STARTED|Period 2 Treatment for 7 Days||13
282417|NCT00869791|682719|P1|STARTED|Period 2 Treatment for 7 Days||14
282418|NCT00869791|682718|P2|NOT COMPLETED|Period 1 Treatment for 7 Days||0
282419|NCT00869791|682719|P1|NOT COMPLETED|Period 1 Treatment for 7 Days||0
282420|NCT00869791|682718|P2|COMPLETED|Period 1 Treatment for 7 Days||13
282421|NCT00869791|682719|P1|COMPLETED|Period 1 Treatment for 7 Days||14
282422|NCT00869791|682718|P2|STARTED|Period 1 Treatment for 7 Days||13
282423|NCT00869791|682719|P1|STARTED|Period 1 Treatment for 7 Days||14
282424|NCT00869778|682740|P3|NOT COMPLETED|Overall Study||10
282425|NCT00869778|682741|P2|NOT COMPLETED|Overall Study||7
282426|NCT00869778|682742|P1|NOT COMPLETED|Overall Study||12
282427|NCT00869778|682740|P3|COMPLETED|Overall Study||110
282428|NCT00869778|682741|P2|COMPLETED|Overall Study||113
282429|NCT00869778|682742|P1|COMPLETED|Overall Study||108
282430|NCT00869778|682740|P3|STARTED|Overall Study||120
282431|NCT00869778|682741|P2|STARTED|Overall Study||120
282432|NCT00869778|682742|P1|STARTED|Overall Study||120
282433|NCT00869622|682779|P2|NOT COMPLETED|Overall Study||14
282434|NCT00869622|682780|P1|NOT COMPLETED|Overall Study||13
282435|NCT00869622|682779|P2|COMPLETED|Overall Study||26
282436|NCT00869622|682780|P1|COMPLETED|Overall Study||27
282437|NCT00869622|682779|P2|STARTED|Overall Study||40
282438|NCT00869622|682780|P1|STARTED|Overall Study||40
282439|NCT00869609|682790|P2|NOT COMPLETED|Overall Study||3
282440|NCT00869609|682791|P1|NOT COMPLETED|Overall Study||6
282441|NCT00869609|682790|P2|COMPLETED|Overall Study||26
282442|NCT00869609|682791|P1|COMPLETED|Overall Study||25
282443|NCT00869609|682790|P2|STARTED|Overall Study||29
282444|NCT00869609|682791|P1|STARTED|Overall Study||31
282445|NCT00869557|682817|P2|NOT COMPLETED|Extension Phase||3
282446|NCT00869557|682818|P1|NOT COMPLETED|Extension Phase||10
282447|NCT00869557|682817|P2|COMPLETED|Extension Phase||11
282448|NCT00869557|682818|P1|COMPLETED|Extension Phase||35
282449|NCT00869557|682817|P2|STARTED|Extension Phase|Seven participants completing randomized Atripla treatment did not enter open-label extension phase.|14
282450|NCT00869557|682818|P1|STARTED|Extension Phase||45
282451|NCT00869557|682817|P2|NOT COMPLETED|Randomized Phase||2
282452|NCT00869557|682818|P1|NOT COMPLETED|Randomized Phase||3
282453|NCT00869557|682817|P2|COMPLETED|Randomized Phase||21
282454|NCT00869557|682818|P1|COMPLETED|Randomized Phase||45
282455|NCT00869557|682817|P2|STARTED|Randomized Phase||23
282456|NCT00869557|682818|P1|STARTED|Randomized Phase||48
282457|NCT00869518|682837|P2|NOT COMPLETED|Overall Study||1
282458|NCT00869518|682838|P1|NOT COMPLETED|Overall Study||1
282459|NCT00869518|682837|P2|COMPLETED|Overall Study||5
282460|NCT00869518|682838|P1|COMPLETED|Overall Study||5
282461|NCT00869518|682837|P2|STARTED|Overall Study||6
282462|NCT00869518|682838|P1|STARTED|Overall Study||6
282463|NCT00869440|682854|P4|NOT COMPLETED|Overall Study||0
282464|NCT00869440|682855|P3|NOT COMPLETED|Overall Study||0
282465|NCT00869440|682856|P2|NOT COMPLETED|Overall Study||1
282466|NCT00869440|682857|P1|NOT COMPLETED|Overall Study||2
282467|NCT00869440|682854|P4|COMPLETED|Overall Study||25
282468|NCT00869440|682855|P3|COMPLETED|Overall Study||25
282469|NCT00869440|682856|P2|COMPLETED|Overall Study||24
282470|NCT00869440|682857|P1|COMPLETED|Overall Study||23
282471|NCT00869440|682854|P4|STARTED|Overall Study||25
282472|NCT00869440|682855|P3|STARTED|Overall Study||25
282473|NCT00869440|682856|P2|STARTED|Overall Study||25
282474|NCT00869440|682857|P1|STARTED|Overall Study||25
282475|NCT00869414|682875|P3|NOT COMPLETED|Overall Study||0
282476|NCT00869414|682876|P2|NOT COMPLETED|Overall Study||0
282477|NCT00869414|682877|P1|NOT COMPLETED|Overall Study||0
282478|NCT00869414|682875|P3|COMPLETED|Overall Study||0
282479|NCT00869414|682876|P2|COMPLETED|Overall Study||0
282480|NCT00869414|682877|P1|COMPLETED|Overall Study||0
282481|NCT00869414|682875|P3|STARTED|Overall Study||0
282482|NCT00869414|682876|P2|STARTED|Overall Study||0
282483|NCT00869414|682877|P1|STARTED|Overall Study||0
282484|NCT00869401|682891|P5|NOT COMPLETED|Overall Study||3
282485|NCT00869401|682892|P4|NOT COMPLETED|Overall Study||5
282486|NCT00869401|682893|P3|NOT COMPLETED|Overall Study||0
282487|NCT00869401|682894|P2|NOT COMPLETED|Overall Study||0
282488|NCT00869401|682895|P1|NOT COMPLETED|Overall Study||0
282489|NCT00869401|682891|P5|COMPLETED|Overall Study||63
282490|NCT00869401|682892|P4|COMPLETED|Overall Study||133
282491|NCT00869401|682893|P3|COMPLETED|Overall Study||7
282492|NCT00869401|682894|P2|COMPLETED|Overall Study||3
282493|NCT00869401|682895|P1|COMPLETED|Overall Study||3
282494|NCT00869401|682891|P5|STARTED|Overall Study||66
282495|NCT00869401|682892|P4|STARTED|Overall Study||138
282496|NCT00869401|682893|P3|STARTED|Overall Study||7
282497|NCT00869401|682894|P2|STARTED|Overall Study||3
282498|NCT00869401|682895|P1|STARTED|Overall Study||3
282499|NCT00869375|682913|P2|NOT COMPLETED|Overall Study||0
282500|NCT00869375|682914|P1|NOT COMPLETED|Overall Study||0
282501|NCT00869375|682913|P2|COMPLETED|Overall Study||3
282502|NCT00869375|682914|P1|COMPLETED|Overall Study||3
282503|NCT00869375|682913|P2|STARTED|Overall Study||3
282504|NCT00869375|682914|P1|STARTED|Overall Study||3
282505|NCT00869362|682924|P2|NOT COMPLETED|Overall Study||5
282506|NCT00869362|682925|P1|NOT COMPLETED|Overall Study||1
282507|NCT00869362|682924|P2|COMPLETED|Overall Study||11
282508|NCT00869362|682925|P1|COMPLETED|Overall Study||14
282509|NCT00869362|682924|P2|STARTED|Overall Study||16
282510|NCT00869362|682925|P1|STARTED|Overall Study||15
282511|NCT00869349|682935|P2|NOT COMPLETED|Overall Study||4
282512|NCT00869349|682936|P1|NOT COMPLETED|Overall Study||7
282513|NCT00869349|682935|P2|COMPLETED|Overall Study||36
282514|NCT00869349|682936|P1|COMPLETED|Overall Study||32
282515|NCT00869349|682935|P2|STARTED|Overall Study||40
282516|NCT00869349|682936|P1|STARTED|Overall Study||39
282517|NCT00869323|682946|P1|NOT COMPLETED|Maintenance Therapy||1
282518|NCT00869323|682946|P1|COMPLETED|Maintenance Therapy||1
282519|NCT00869323|682946|P1|STARTED|Maintenance Therapy|One participant removed from study after completing induction therapy due to progressive disease.|2
282520|NCT00869323|682946|P1|NOT COMPLETED|Induction Therapy||0
282521|NCT00869323|682946|P1|COMPLETED|Induction Therapy||3
282522|NCT00869323|682946|P1|STARTED|Induction Therapy||3
282523|NCT00869258|682954|P1|NOT COMPLETED|Overall Study||1
282524|NCT00869258|682954|P1|COMPLETED|Overall Study||31
282525|NCT00869258|682954|P1|STARTED|Overall Study||32
282526|NCT00869206|682960|P2|NOT COMPLETED|Overall Study||27
282527|NCT00869206|682961|P1|NOT COMPLETED|Overall Study||29
282528|NCT00869206|682960|P2|COMPLETED|Overall Study||884
282529|NCT00869206|682961|P1|COMPLETED|Overall Study||882
282530|NCT00869206|682960|P2|STARTED|Overall Study||911
282531|NCT00869206|682961|P1|STARTED|Overall Study||911
282532|NCT00869167|682991|P2|NOT COMPLETED|Overall Study||1
282533|NCT00869167|682992|P1|NOT COMPLETED|Overall Study||0
282534|NCT00869167|682991|P2|COMPLETED|Overall Study||0
282535|NCT00869167|682992|P1|COMPLETED|Overall Study||2
282536|NCT00869167|682991|P2|STARTED|Overall Study||1
282537|NCT00869167|682992|P1|STARTED|Overall Study||2
282538|NCT00869141|683008|P2|NOT COMPLETED|Overall Study||0
282539|NCT00869141|683009|P1|NOT COMPLETED|Overall Study||0
282540|NCT00869141|683008|P2|COMPLETED|Overall Study||26
282541|NCT00869141|683009|P1|COMPLETED|Overall Study||26
282542|NCT00869141|683008|P2|STARTED|Overall Study||26
282543|NCT00869141|683009|P1|STARTED|Overall Study||26
282544|NCT00869128|683019|P2|NOT COMPLETED|Overall Study||6
282545|NCT00869128|683020|P1|NOT COMPLETED|Overall Study||6
282546|NCT00869128|683019|P2|COMPLETED|Overall Study||12
282547|NCT00869128|683020|P1|COMPLETED|Overall Study||12
282548|NCT00869128|683019|P2|STARTED|Overall Study||18
282549|NCT00869128|683020|P1|STARTED|Overall Study||18
282550|NCT00869089|683024|P1|NOT COMPLETED|Overall Study||3
282551|NCT00869089|683024|P1|COMPLETED|Overall Study||2
282552|NCT00869089|683024|P1|STARTED|Overall Study||5
282553|NCT00869050|683028|P1|NOT COMPLETED|Overall Study||3
282554|NCT00869050|683028|P1|COMPLETED|Overall Study||38
282555|NCT00869050|683028|P1|STARTED|Overall Study||41
282556|NCT00868998|683033|P1|NOT COMPLETED|Overall Study||5
282557|NCT00868998|683033|P1|COMPLETED|Overall Study||0
282558|NCT00868998|683033|P1|STARTED|Overall Study||5
282559|NCT00868959|683038|P1|NOT COMPLETED|Overall Study||258
282560|NCT00868959|683038|P1|COMPLETED|Overall Study||559
282561|NCT00868959|683038|P1|STARTED|Overall Study|817 represents total number of subjects who provided informed consent.|817
282562|NCT00868790|683044|P14|NOT COMPLETED|Post-study||0
282563|NCT00868790|683045|P13|NOT COMPLETED|Post-study||0
282564|NCT00868790|683046|P12|NOT COMPLETED|Post-study||0
282565|NCT00868790|683047|P11|NOT COMPLETED|Post-study||0
282566|NCT00868790|683048|P10|NOT COMPLETED|Post-study||1
282567|NCT00868790|683049|P9|NOT COMPLETED|Post-study||0
282568|NCT00868790|683050|P8|NOT COMPLETED|Post-study||2
282569|NCT00868790|683051|P7|NOT COMPLETED|Post-study||0
282570|NCT00868790|683052|P6|NOT COMPLETED|Post-study||0
282571|NCT00868790|683053|P5|NOT COMPLETED|Post-study||1
282572|NCT00868790|683054|P4|NOT COMPLETED|Post-study||0
282573|NCT00868790|683055|P3|NOT COMPLETED|Post-study||0
282574|NCT00868790|683056|P2|NOT COMPLETED|Post-study||0
282575|NCT00868790|683057|P1|NOT COMPLETED|Post-study||0
282576|NCT00868790|683044|P14|COMPLETED|Post-study||7
282577|NCT00868790|683045|P13|COMPLETED|Post-study||6
282578|NCT00868790|683046|P12|COMPLETED|Post-study||3
282579|NCT00868790|683047|P11|COMPLETED|Post-study||5
282580|NCT00868790|683048|P10|COMPLETED|Post-study||1
282581|NCT00868790|683049|P9|COMPLETED|Post-study||6
282582|NCT00868790|683050|P8|COMPLETED|Post-study||12
282583|NCT00868790|683051|P7|COMPLETED|Post-study||4
282584|NCT00868790|683052|P6|COMPLETED|Post-study||1
282585|NCT00868790|683053|P5|COMPLETED|Post-study||17
282586|NCT00868790|683054|P4|COMPLETED|Post-study||3
282587|NCT00868790|683055|P3|COMPLETED|Post-study||3
282588|NCT00868790|683056|P2|COMPLETED|Post-study||6
282589|NCT00868790|683057|P1|COMPLETED|Post-study||7
282590|NCT00868790|683044|P14|STARTED|Post-study||7
282591|NCT00868790|683045|P13|STARTED|Post-study||6
282592|NCT00868790|683046|P12|STARTED|Post-study||3
282593|NCT00868790|683047|P11|STARTED|Post-study||5
282594|NCT00868790|683048|P10|STARTED|Post-study||2
282595|NCT00868790|683049|P9|STARTED|Post-study||6
282596|NCT00868790|683050|P8|STARTED|Post-study||14
282597|NCT00868790|683051|P7|STARTED|Post-study||4
282598|NCT00868790|683052|P6|STARTED|Post-study||1
282599|NCT00868790|683053|P5|STARTED|Post-study||18
282600|NCT00868790|683054|P4|STARTED|Post-study||3
282601|NCT00868790|683055|P3|STARTED|Post-study||3
282602|NCT00868790|683056|P2|STARTED|Post-study||6
282603|NCT00868790|683057|P1|STARTED|Post-study||7
282604|NCT00868790|683044|P14|NOT COMPLETED|Period 4||1
282605|NCT00868790|683045|P13|NOT COMPLETED|Period 4||1
282606|NCT00868790|683046|P12|NOT COMPLETED|Period 4||1
282607|NCT00868790|683047|P11|NOT COMPLETED|Period 4||3
282608|NCT00868790|683048|P10|NOT COMPLETED|Period 4||0
282609|NCT00868790|683049|P9|NOT COMPLETED|Period 4||2
282610|NCT00868790|683050|P8|NOT COMPLETED|Period 4||3
282611|NCT00868790|683051|P7|NOT COMPLETED|Period 4||0
282612|NCT00868790|683052|P6|NOT COMPLETED|Period 4||0
282613|NCT00868790|683053|P5|NOT COMPLETED|Period 4||0
282614|NCT00868790|683054|P4|NOT COMPLETED|Period 4||0
282615|NCT00868790|683055|P3|NOT COMPLETED|Period 4||1
282616|NCT00868790|683056|P2|NOT COMPLETED|Period 4||0
282617|NCT00868790|683057|P1|NOT COMPLETED|Period 4||2
282618|NCT00868790|683044|P14|COMPLETED|Period 4||7
282619|NCT00868790|683045|P13|COMPLETED|Period 4||6
282620|NCT00868790|683046|P12|COMPLETED|Period 4||3
282621|NCT00868790|683047|P11|COMPLETED|Period 4||5
282622|NCT00868790|683048|P10|COMPLETED|Period 4||2
282623|NCT00868790|683049|P9|COMPLETED|Period 4||6
282624|NCT00868790|683050|P8|COMPLETED|Period 4||14
282625|NCT00868790|683051|P7|COMPLETED|Period 4||4
282626|NCT00868790|683052|P6|COMPLETED|Period 4||1
282627|NCT00868790|683053|P5|COMPLETED|Period 4||18
282628|NCT00868790|683054|P4|COMPLETED|Period 4||3
282629|NCT00868790|683055|P3|COMPLETED|Period 4|One non-completion due to abnormal alanine aminotransferase/aspartate aminotransferase (ALT/AST)|3
282630|NCT00868790|683056|P2|COMPLETED|Period 4||6
282631|NCT00868790|683057|P1|COMPLETED|Period 4||7
282632|NCT00868790|683044|P14|STARTED|Period 4||8
282633|NCT00868790|683045|P13|STARTED|Period 4||7
282634|NCT00868790|683046|P12|STARTED|Period 4||4
282635|NCT00868790|683047|P11|STARTED|Period 4||8
282636|NCT00868790|683048|P10|STARTED|Period 4||2
282637|NCT00868790|683049|P9|STARTED|Period 4||8
282638|NCT00868790|683050|P8|STARTED|Period 4||17
282639|NCT00868790|683051|P7|STARTED|Period 4||4
282640|NCT00868790|683052|P6|STARTED|Period 4||1
282641|NCT00868790|683053|P5|STARTED|Period 4||18
282642|NCT00868790|683054|P4|STARTED|Period 4||3
282643|NCT00868790|683055|P3|STARTED|Period 4||4
282644|NCT00868790|683056|P2|STARTED|Period 4||6
282645|NCT00868790|683057|P1|STARTED|Period 4||9
282646|NCT00868790|683044|P14|NOT COMPLETED|Period 3||0
282647|NCT00868790|683045|P13|NOT COMPLETED|Period 3||0
282648|NCT00868790|683046|P12|NOT COMPLETED|Period 3||0
282649|NCT00868790|683047|P11|NOT COMPLETED|Period 3||1
282650|NCT00868790|683048|P10|NOT COMPLETED|Period 3||1
282651|NCT00868790|683049|P9|NOT COMPLETED|Period 3||0
282652|NCT00868790|683050|P8|NOT COMPLETED|Period 3||0
282653|NCT00868790|683051|P7|NOT COMPLETED|Period 3||0
282654|NCT00868790|683052|P6|NOT COMPLETED|Period 3||0
282655|NCT00868790|683053|P5|NOT COMPLETED|Period 3||0
282656|NCT00868790|683054|P4|NOT COMPLETED|Period 3||1
282657|NCT00868790|683055|P3|NOT COMPLETED|Period 3||0
282658|NCT00868790|683056|P2|NOT COMPLETED|Period 3||0
282659|NCT00868790|683057|P1|NOT COMPLETED|Period 3||0
282660|NCT00868790|683044|P14|COMPLETED|Period 3||8
282661|NCT00868790|683045|P13|COMPLETED|Period 3||7
282662|NCT00868790|683046|P12|COMPLETED|Period 3||4
282663|NCT00868790|683047|P11|COMPLETED|Period 3||8
282664|NCT00868790|683048|P10|COMPLETED|Period 3||2
282665|NCT00868790|683049|P9|COMPLETED|Period 3||8
282666|NCT00868790|683050|P8|COMPLETED|Period 3||17
282667|NCT00868790|683051|P7|COMPLETED|Period 3||4
282668|NCT00868790|683052|P6|COMPLETED|Period 3||1
282669|NCT00868790|683053|P5|COMPLETED|Period 3||18
282670|NCT00868790|683054|P4|COMPLETED|Period 3||3
282671|NCT00868790|683055|P3|COMPLETED|Period 3||4
282672|NCT00868790|683056|P2|COMPLETED|Period 3||6
282673|NCT00868790|683057|P1|COMPLETED|Period 3||9
282674|NCT00868790|683044|P14|STARTED|Period 3||8
282675|NCT00868790|683045|P13|STARTED|Period 3||7
282676|NCT00868790|683046|P12|STARTED|Period 3||4
282677|NCT00868790|683047|P11|STARTED|Period 3||9
282678|NCT00868790|683048|P10|STARTED|Period 3||3
282679|NCT00868790|683049|P9|STARTED|Period 3||8
282680|NCT00868790|683050|P8|STARTED|Period 3||17
282681|NCT00868790|683051|P7|STARTED|Period 3||4
282682|NCT00868790|683052|P6|STARTED|Period 3||1
282683|NCT00868790|683053|P5|STARTED|Period 3||18
282684|NCT00868790|683054|P4|STARTED|Period 3||4
282685|NCT00868790|683055|P3|STARTED|Period 3||4
282686|NCT00868790|683056|P2|STARTED|Period 3||6
282687|NCT00868790|683057|P1|STARTED|Period 3||9
282688|NCT00868790|683044|P14|NOT COMPLETED|Period 2||1
282689|NCT00868790|683045|P13|NOT COMPLETED|Period 2||0
282690|NCT00868790|683046|P12|NOT COMPLETED|Period 2||0
282691|NCT00868790|683047|P11|NOT COMPLETED|Period 2||0
282692|NCT00868790|683048|P10|NOT COMPLETED|Period 2||0
282693|NCT00868790|683049|P9|NOT COMPLETED|Period 2||2
282694|NCT00868790|683050|P8|NOT COMPLETED|Period 2||0
282695|NCT00868790|683051|P7|NOT COMPLETED|Period 2||0
282696|NCT00868790|683052|P6|NOT COMPLETED|Period 2||1
282697|NCT00868790|683053|P5|NOT COMPLETED|Period 2||0
282698|NCT00868790|683054|P4|NOT COMPLETED|Period 2||0
282699|NCT00868790|683055|P3|NOT COMPLETED|Period 2||0
282700|NCT00868790|683056|P2|NOT COMPLETED|Period 2||1
282701|NCT00868790|683057|P1|NOT COMPLETED|Period 2||0
282702|NCT00868790|683044|P14|COMPLETED|Period 2||8
282703|NCT00868790|683045|P13|COMPLETED|Period 2||7
282704|NCT00868790|683046|P12|COMPLETED|Period 2||4
282705|NCT00868790|683047|P11|COMPLETED|Period 2||9
282706|NCT00868790|683048|P10|COMPLETED|Period 2||3
282707|NCT00868790|683049|P9|COMPLETED|Period 2||8
282708|NCT00868790|683050|P8|COMPLETED|Period 2||17
282709|NCT00868790|683051|P7|COMPLETED|Period 2||4
282710|NCT00868790|683052|P6|COMPLETED|Period 2||1
282711|NCT00868790|683053|P5|COMPLETED|Period 2||18
282712|NCT00868790|683054|P4|COMPLETED|Period 2||4
282713|NCT00868790|683055|P3|COMPLETED|Period 2||4
282714|NCT00868790|683056|P2|COMPLETED|Period 2||6
282715|NCT00868790|683057|P1|COMPLETED|Period 2||9
282716|NCT00868790|683044|P14|STARTED|Period 2||9
282717|NCT00868790|683045|P13|STARTED|Period 2||7
282718|NCT00868790|683046|P12|STARTED|Period 2||4
282719|NCT00868790|683047|P11|STARTED|Period 2||9
282720|NCT00868790|683048|P10|STARTED|Period 2||3
282721|NCT00868790|683049|P9|STARTED|Period 2||10
282722|NCT00868790|683050|P8|STARTED|Period 2||17
282723|NCT00868790|683051|P7|STARTED|Period 2||4
282724|NCT00868790|683052|P6|STARTED|Period 2||2
282725|NCT00868790|683053|P5|STARTED|Period 2||18
282726|NCT00868790|683054|P4|STARTED|Period 2||4
282727|NCT00868790|683055|P3|STARTED|Period 2||4
282728|NCT00868790|683056|P2|STARTED|Period 2||7
282729|NCT00868790|683057|P1|STARTED|Period 2||9
282730|NCT00868790|683044|P14|NOT COMPLETED|Period 1||2
282731|NCT00868790|683045|P13|NOT COMPLETED|Period 1||0
282732|NCT00868790|683046|P12|NOT COMPLETED|Period 1||0
282733|NCT00868790|683047|P11|NOT COMPLETED|Period 1||0
282734|NCT00868790|683048|P10|NOT COMPLETED|Period 1||0
282735|NCT00868790|683049|P9|NOT COMPLETED|Period 1||1
282736|NCT00868790|683050|P8|NOT COMPLETED|Period 1||3
282737|NCT00868790|683051|P7|NOT COMPLETED|Period 1||0
282738|NCT00868790|683052|P6|NOT COMPLETED|Period 1||1
282739|NCT00868790|683053|P5|NOT COMPLETED|Period 1||1
282740|NCT00868790|683054|P4|NOT COMPLETED|Period 1||0
282741|NCT00868790|683055|P3|NOT COMPLETED|Period 1||0
282742|NCT00868790|683056|P2|NOT COMPLETED|Period 1||1
282743|NCT00868790|683057|P1|NOT COMPLETED|Period 1||2
282744|NCT00868790|683044|P14|COMPLETED|Period 1||9
282745|NCT00868790|683045|P13|COMPLETED|Period 1||7
282746|NCT00868790|683046|P12|COMPLETED|Period 1||4
282747|NCT00868790|683047|P11|COMPLETED|Period 1||9
282748|NCT00868790|683048|P10|COMPLETED|Period 1||3
282749|NCT00868790|683049|P9|COMPLETED|Period 1||10
282750|NCT00868790|683050|P8|COMPLETED|Period 1||17
282751|NCT00868790|683051|P7|COMPLETED|Period 1||4
282752|NCT00868790|683052|P6|COMPLETED|Period 1||2
282753|NCT00868790|683053|P5|COMPLETED|Period 1||18
282754|NCT00868790|683054|P4|COMPLETED|Period 1||4
282755|NCT00868790|683055|P3|COMPLETED|Period 1||4
282756|NCT00868790|683056|P2|COMPLETED|Period 1||7
282757|NCT00868790|683057|P1|COMPLETED|Period 1||9
282758|NCT00868790|683044|P14|STARTED|Period 1||11
282759|NCT00868790|683045|P13|STARTED|Period 1||7
282760|NCT00868790|683046|P12|STARTED|Period 1||4
282761|NCT00868790|683047|P11|STARTED|Period 1||9
282762|NCT00868790|683048|P10|STARTED|Period 1||3
282763|NCT00868790|683049|P9|STARTED|Period 1||11
282764|NCT00868790|683050|P8|STARTED|Period 1||20
282765|NCT00868790|683051|P7|STARTED|Period 1||4
282766|NCT00868790|683052|P6|STARTED|Period 1||3
282767|NCT00868790|683053|P5|STARTED|Period 1||19
282768|NCT00868790|683054|P4|STARTED|Period 1||4
282769|NCT00868790|683055|P3|STARTED|Period 1||4
282770|NCT00868790|683056|P2|STARTED|Period 1||8
282771|NCT00868790|683057|P1|STARTED|Period 1||11
282772|NCT00868751|683094|P1|NOT COMPLETED|Overall Study||1
282773|NCT00868751|683094|P1|COMPLETED|Overall Study||0
282774|NCT00868751|683094|P1|STARTED|Overall Study||1
282775|NCT00868712|683105|P3|NOT COMPLETED|Overall Study||0
282776|NCT00868712|683106|P2|NOT COMPLETED|Overall Study||0
282777|NCT00868712|683107|P1|NOT COMPLETED|Overall Study||0
282778|NCT00868712|683105|P3|COMPLETED|Overall Study||28
282779|NCT00868712|683106|P2|COMPLETED|Overall Study||11
282780|NCT00868712|683107|P1|COMPLETED|Overall Study||31
282781|NCT00868712|683105|P3|STARTED|Overall Study||28
282782|NCT00868712|683106|P2|STARTED|Overall Study||11
282783|NCT00868712|683107|P1|STARTED|Overall Study||31
282784|NCT00868699|683121|P3|NOT COMPLETED|Overall Study||43
282785|NCT00868699|683122|P2|NOT COMPLETED|Overall Study||45
282786|NCT00868699|683123|P1|NOT COMPLETED|Overall Study||43
282787|NCT00868699|683121|P3|COMPLETED|Overall Study||123
282788|NCT00868699|683122|P2|COMPLETED|Overall Study||124
282789|NCT00868699|683123|P1|COMPLETED|Overall Study||127
282790|NCT00868699|683121|P3|Safety Population|Overall Study||164
282791|NCT00868699|683122|P2|Safety Population|Overall Study||167
282792|NCT00868699|683123|P1|Safety Population|Overall Study||168
282793|NCT00868699|683121|P3|Intent-to-Treat Population|Overall Study||161
282794|NCT00868699|683122|P2|Intent-to-Treat Population|Overall Study||162
282795|NCT00868699|683123|P1|Intent-to-Treat Population|Overall Study||162
282796|NCT00868699|683121|P3|STARTED|Overall Study||166
282797|NCT00868699|683122|P2|STARTED|Overall Study||169
282798|NCT00868699|683123|P1|STARTED|Overall Study||170
282799|NCT00868608|683140|P3|NOT COMPLETED|Overall Study||5
282800|NCT00868608|683141|P2|NOT COMPLETED|Overall Study||3
282801|NCT00868608|683142|P1|NOT COMPLETED|Overall Study||23
282802|NCT00868608|683140|P3|COMPLETED|Overall Study||0
282803|NCT00868608|683141|P2|COMPLETED|Overall Study||1
282804|NCT00868608|683142|P1|COMPLETED|Overall Study||49
282805|NCT00868608|683140|P3|STARTED|Overall Study||5
282806|NCT00868608|683141|P2|STARTED|Overall Study||4
282807|NCT00868608|683142|P1|STARTED|Overall Study||72
282808|NCT00868530|683166|P1|NOT COMPLETED|Overall Study||4
282809|NCT00868530|683166|P1|COMPLETED|Overall Study||49
282810|NCT00868530|683166|P1|STARTED|Overall Study||53
282811|NCT00868517|683181|P3|NOT COMPLETED|Overall Study||2
282812|NCT00868517|683182|P2|NOT COMPLETED|Overall Study||4
282813|NCT00868517|683183|P1|NOT COMPLETED|Overall Study||4
282814|NCT00868517|683181|P3|COMPLETED|Overall Study||9
282815|NCT00868517|683182|P2|COMPLETED|Overall Study||8
282816|NCT00868517|683183|P1|COMPLETED|Overall Study||8
282817|NCT00868517|683181|P3|STARTED|Overall Study||11
282818|NCT00868517|683182|P2|STARTED|Overall Study||12
282819|NCT00868517|683183|P1|STARTED|Overall Study||12
282820|NCT00868452|683208|P2|NOT COMPLETED|Overall Study||29
282821|NCT00868452|683209|P1|NOT COMPLETED|Overall Study||40
282822|NCT00868452|683208|P2|COMPLETED|Overall Study||136
282823|NCT00868452|683209|P1|COMPLETED|Overall Study||143
282824|NCT00868452|683208|P2|STARTED|Overall Study||165
282825|NCT00868452|683209|P1|STARTED|Overall Study||183
282826|NCT00868439|683221|P2|NOT COMPLETED|Overall Study||9
282827|NCT00868439|683222|P1|NOT COMPLETED|Overall Study||8
282828|NCT00868439|683221|P2|COMPLETED|Overall Study||40
282829|NCT00868439|683222|P1|COMPLETED|Overall Study||48
282830|NCT00868439|683221|P2|STARTED|Overall Study||49
282831|NCT00868439|683222|P1|STARTED|Overall Study||56
282832|NCT00868374|683240|P2|NOT COMPLETED|Overall Study||7
282833|NCT00868374|683241|P1|NOT COMPLETED|Overall Study||7
282834|NCT00868374|683240|P2|COMPLETED|Overall Study||4
282835|NCT00868374|683241|P1|COMPLETED|Overall Study||5
282836|NCT00868374|683240|P2|STARTED|Overall Study||11
282837|NCT00868374|683241|P1|STARTED|Overall Study||12
282838|NCT00868348|683249|P2|NOT COMPLETED|Overall Study||0
282839|NCT00868348|683250|P1|NOT COMPLETED|Overall Study||0
282840|NCT00868348|683249|P2|COMPLETED|Overall Study||30
282841|NCT00868348|683250|P1|COMPLETED|Overall Study||30
282842|NCT00868348|683249|P2|STARTED|Overall Study||30
282843|NCT00868348|683250|P1|STARTED|Overall Study||30
282844|NCT00868309|683268|P2|NOT COMPLETED|Overall Study||0
282845|NCT00868309|683269|P1|NOT COMPLETED|Overall Study||0
282846|NCT00868309|683268|P2|COMPLETED|Overall Study||6
282847|NCT00868309|683269|P1|COMPLETED|Overall Study||6
282848|NCT00868309|683268|P2|STARTED|Overall Study||6
282849|NCT00868309|683269|P1|STARTED|Overall Study||6
282850|NCT00868296|683279|P2|NOT COMPLETED|Overall Study||3
282851|NCT00868296|683280|P1|NOT COMPLETED|Overall Study||0
282852|NCT00868296|683279|P2|COMPLETED|Overall Study||43
282853|NCT00868296|683280|P1|COMPLETED|Overall Study||12
282854|NCT00868296|683279|P2|STARTED|Overall Study||46
282855|NCT00868296|683280|P1|STARTED|Overall Study||12
282856|NCT00868231|683288|P6|NOT COMPLETED|Treatment Period 3||0
282857|NCT00868231|683289|P5|NOT COMPLETED|Treatment Period 3||0
282858|NCT00868231|683290|P4|NOT COMPLETED|Treatment Period 3||0
282859|NCT00868231|683291|P3|NOT COMPLETED|Treatment Period 3||1
282860|NCT00868231|683292|P2|NOT COMPLETED|Treatment Period 3||0
282861|NCT00868231|683293|P1|NOT COMPLETED|Treatment Period 3||0
282862|NCT00868231|683288|P6|COMPLETED|Treatment Period 3||5
282863|NCT00868231|683289|P5|COMPLETED|Treatment Period 3||4
282864|NCT00868231|683290|P4|COMPLETED|Treatment Period 3||5
282865|NCT00868231|683291|P3|COMPLETED|Treatment Period 3||4
282866|NCT00868231|683292|P2|COMPLETED|Treatment Period 3||5
282867|NCT00868231|683293|P1|COMPLETED|Treatment Period 3||4
282868|NCT00868231|683288|P6|STARTED|Treatment Period 3||5
282869|NCT00868231|683289|P5|STARTED|Treatment Period 3||4
282870|NCT00868231|683290|P4|STARTED|Treatment Period 3||5
282871|NCT00868231|683291|P3|STARTED|Treatment Period 3||5
282872|NCT00868231|683292|P2|STARTED|Treatment Period 3||5
282873|NCT00868231|683293|P1|STARTED|Treatment Period 3||4
282874|NCT00868231|683288|P6|NOT COMPLETED|Treatment Period 2||0
282875|NCT00868231|683289|P5|NOT COMPLETED|Treatment Period 2||0
282876|NCT00868231|683290|P4|NOT COMPLETED|Treatment Period 2||0
282877|NCT00868231|683291|P3|NOT COMPLETED|Treatment Period 2||0
282878|NCT00868231|683292|P2|NOT COMPLETED|Treatment Period 2||0
282879|NCT00868231|683293|P1|NOT COMPLETED|Treatment Period 2||1
282880|NCT00868231|683288|P6|COMPLETED|Treatment Period 2||5
282881|NCT00868231|683289|P5|COMPLETED|Treatment Period 2||4
282882|NCT00868231|683290|P4|COMPLETED|Treatment Period 2||5
282883|NCT00868231|683291|P3|COMPLETED|Treatment Period 2||5
282884|NCT00868231|683292|P2|COMPLETED|Treatment Period 2||5
282885|NCT00868231|683293|P1|COMPLETED|Treatment Period 2||4
282886|NCT00868231|683288|P6|STARTED|Treatment Period 2||5
282887|NCT00868231|683289|P5|STARTED|Treatment Period 2||4
282888|NCT00868231|683290|P4|STARTED|Treatment Period 2||5
282889|NCT00868231|683291|P3|STARTED|Treatment Period 2||5
282890|NCT00868231|683292|P2|STARTED|Treatment Period 2||5
282891|NCT00868231|683293|P1|STARTED|Treatment Period 2||5
282892|NCT00868231|683288|P6|NOT COMPLETED|Treatment Period 1||0
282893|NCT00868231|683289|P5|NOT COMPLETED|Treatment Period 1||1
282894|NCT00868231|683290|P4|NOT COMPLETED|Treatment Period 1||0
282895|NCT00868231|683291|P3|NOT COMPLETED|Treatment Period 1||0
282896|NCT00868231|683292|P2|NOT COMPLETED|Treatment Period 1||0
282897|NCT00868231|683293|P1|NOT COMPLETED|Treatment Period 1||0
282898|NCT00868231|683288|P6|COMPLETED|Treatment Period 1||5
282899|NCT00868231|683289|P5|COMPLETED|Treatment Period 1||4
282900|NCT00868231|683290|P4|COMPLETED|Treatment Period 1||5
282901|NCT00868231|683291|P3|COMPLETED|Treatment Period 1||5
282902|NCT00868231|683292|P2|COMPLETED|Treatment Period 1||5
282903|NCT00868231|683293|P1|COMPLETED|Treatment Period 1||5
282904|NCT00868231|683288|P6|STARTED|Treatment Period 1||5
282905|NCT00868231|683289|P5|STARTED|Treatment Period 1||5
282906|NCT00868231|683290|P4|STARTED|Treatment Period 1||5
282907|NCT00868231|683291|P3|STARTED|Treatment Period 1||5
282908|NCT00868231|683292|P2|STARTED|Treatment Period 1||5
282909|NCT00868231|683293|P1|STARTED|Treatment Period 1||5
282910|NCT00868218|683338|P4|NOT COMPLETED|Overall Study||0
282911|NCT00868218|683339|P3|NOT COMPLETED|Overall Study||0
282912|NCT00868218|683340|P2|NOT COMPLETED|Overall Study||0
282913|NCT00868218|683341|P1|NOT COMPLETED|Overall Study||0
282914|NCT00868218|683338|P4|COMPLETED|Overall Study||15
282915|NCT00868218|683339|P3|COMPLETED|Overall Study||15
282916|NCT00868218|683340|P2|COMPLETED|Overall Study||15
282917|NCT00868218|683341|P1|COMPLETED|Overall Study||15
282918|NCT00868218|683338|P4|STARTED|Overall Study||15
282919|NCT00868218|683339|P3|STARTED|Overall Study||15
282920|NCT00868218|683340|P2|STARTED|Overall Study||15
282921|NCT00868218|683341|P1|STARTED|Overall Study||15
282922|NCT00868192|683359|P1|NOT COMPLETED|Overall Study||4
282923|NCT00868192|683359|P1|COMPLETED|Overall Study||34
282924|NCT00868192|683359|P1|STARTED|Overall Study||38
282925|NCT00868166|683376|P2|NOT COMPLETED|Overall Study||114
282926|NCT00868166|683377|P1|NOT COMPLETED|Overall Study||112
282927|NCT00868166|683376|P2|COMPLETED|Overall Study||139
282928|NCT00868166|683377|P1|COMPLETED|Overall Study||147
282929|NCT00868166|683376|P2|STARTED|Overall Study||253
282930|NCT00868166|683377|P1|STARTED|Overall Study||259
282931|NCT00868140|683399|P2|NOT COMPLETED|Overall Study||0
282932|NCT00868140|683400|P1|NOT COMPLETED|Overall Study||0
282933|NCT00868140|683399|P2|COMPLETED|Overall Study||25
282934|NCT00868140|683400|P1|COMPLETED|Overall Study||26
282935|NCT00868140|683399|P2|STARTED|Overall Study||25
282936|NCT00868140|683400|P1|STARTED|Overall Study||26
282937|NCT00868101|683418|P2|NOT COMPLETED|Overall Study||0
282938|NCT00868101|683419|P1|NOT COMPLETED|Overall Study||0
282939|NCT00868101|683418|P2|COMPLETED|Overall Study||10
282940|NCT00868101|683419|P1|COMPLETED|Overall Study||12
282941|NCT00868101|683418|P2|STARTED|Overall Study||10
282942|NCT00868101|683419|P1|STARTED|Overall Study||12
282943|NCT00867932|683431|P1|NOT COMPLETED|Overall Study||0
282944|NCT00867932|683431|P1|COMPLETED|Overall Study||7
282945|NCT00867932|683431|P1|Intent-to-Treat (ITT) Population|Overall Study||7
282946|NCT00867932|683431|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
282947|NCT00867932|683431|P1|Maintenance Phase|Overall Study||7
282948|NCT00867932|683431|P1|Induction Phase|Overall Study||7
282949|NCT00867932|683431|P1|STARTED|Overall Study||7
282950|NCT00867815|683439|P1|NOT COMPLETED|Overall Study||1
282951|NCT00867815|683439|P1|COMPLETED|Overall Study||9
282952|NCT00867815|683439|P1|STARTED|Overall Study||10
282953|NCT00867659|683445|P1|NOT COMPLETED|Overall Study||0
282954|NCT00867659|683445|P1|COMPLETED|Overall Study|January 2010|20
282955|NCT00867659|683445|P1|STARTED|Overall Study|October 2009|20
282956|NCT00867568|683450|P1|NOT COMPLETED|Overall Study||15
282957|NCT00867568|683450|P1|COMPLETED|Overall Study||3
282958|NCT00867568|683450|P1|STARTED|Overall Study||18
282959|NCT00867529|683459|P1|NOT COMPLETED|Overall Study||0
282960|NCT00867529|683459|P1|COMPLETED|Overall Study||63
282961|NCT00867529|683459|P1|STARTED|Overall Study||63
282962|NCT00867503|683467|P1|NOT COMPLETED|Overall Study||1
282963|NCT00867503|683467|P1|COMPLETED|Overall Study||9
282964|NCT00867503|683467|P1|STARTED|Overall Study||10
282965|NCT00867490|683473|P1|NOT COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||0
282966|NCT00867490|683473|P1|COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||61
282967|NCT00867490|683473|P1|STARTED|Phase 3 - Aliskiren+HCTZ+Amlodipine|The first 60 patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg entered this phase.|61
282968|NCT00867490|683473|P1|NOT COMPLETED|Phase 2 - Aliskiren+HCTZ||3
282969|NCT00867490|683473|P1|COMPLETED|Phase 2 - Aliskiren+HCTZ||120
282970|NCT00867490|683473|P1|STARTED|Phase 2 - Aliskiren+HCTZ|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|123
282971|NCT00867490|683473|P1|NOT COMPLETED|Phase 1 - Candesartan+HCTZ||10
282972|NCT00867490|683473|P1|COMPLETED|Phase 1 - Candesartan+HCTZ||176
282973|NCT00867490|683473|P1|STARTED|Phase 1 - Candesartan+HCTZ||186
282974|NCT00867451|683492|P2|NOT COMPLETED|Overall Study||0
282975|NCT00867451|683493|P1|NOT COMPLETED|Overall Study||0
282976|NCT00867451|683492|P2|COMPLETED|Overall Study||4
282977|NCT00867451|683493|P1|COMPLETED|Overall Study||4
282978|NCT00867451|683492|P2|STARTED|Overall Study||4
282979|NCT00867451|683493|P1|STARTED|Overall Study||4
282980|NCT00867360|683515|P2|NOT COMPLETED|Overall Study||1
282981|NCT00867360|683516|P1|NOT COMPLETED|Overall Study||1
282982|NCT00867360|683515|P2|COMPLETED|Overall Study||5
282983|NCT00867360|683516|P1|COMPLETED|Overall Study||3
282984|NCT00867360|683515|P2|STARTED|Overall Study||6
282985|NCT00867360|683516|P1|STARTED|Overall Study||4
282986|NCT00867334|683528|P2|NOT COMPLETED|Overall Study||1
282987|NCT00867334|683529|P1|NOT COMPLETED|Overall Study||2
282988|NCT00867334|683528|P2|COMPLETED|Overall Study||0
282989|NCT00867334|683529|P1|COMPLETED|Overall Study||4
282990|NCT00867334|683528|P2|STARTED|Overall Study||1
282991|NCT00867334|683529|P1|STARTED|Overall Study||6
282992|NCT00867321|683540|P6|NOT COMPLETED|Overall Study||0
282993|NCT00867321|683541|P5|NOT COMPLETED|Overall Study||0
282994|NCT00867321|683542|P4|NOT COMPLETED|Overall Study||0
282995|NCT00867321|683543|P3|NOT COMPLETED|Overall Study||0
282996|NCT00867321|683544|P2|NOT COMPLETED|Overall Study||1
282997|NCT00867321|683545|P1|NOT COMPLETED|Overall Study||0
282998|NCT00867321|683540|P6|COMPLETED|Overall Study||3
282999|NCT00867321|683541|P5|COMPLETED|Overall Study||5
283000|NCT00867321|683542|P4|COMPLETED|Overall Study||6
283001|NCT00867321|683543|P3|COMPLETED|Overall Study||3
283002|NCT00867321|683544|P2|COMPLETED|Overall Study||2
283003|NCT00867321|683545|P1|COMPLETED|Overall Study||4
283004|NCT00867321|683540|P6|STARTED|Overall Study||3
283005|NCT00867321|683541|P5|STARTED|Overall Study||5
283006|NCT00867321|683542|P4|STARTED|Overall Study||6
283007|NCT00867321|683543|P3|STARTED|Overall Study||3
283008|NCT00867321|683544|P2|STARTED|Overall Study||3
283009|NCT00867321|683545|P1|STARTED|Overall Study||4
283010|NCT00867308|683565|P2|NOT COMPLETED|Overall Study||18
283011|NCT00867308|683566|P1|NOT COMPLETED|Overall Study||9
283012|NCT00867308|683565|P2|COMPLETED|Overall Study||0
283013|NCT00867308|683566|P1|COMPLETED|Overall Study||0
283014|NCT00867308|683565|P2|STARTED|Overall Study||18
283015|NCT00867308|683566|P1|STARTED|Overall Study||9
283016|NCT00867217|683576|P2|NOT COMPLETED|Overall Study||10
283017|NCT00867217|683577|P1|NOT COMPLETED|Overall Study||3
283018|NCT00867217|683576|P2|COMPLETED|Overall Study||70
283019|NCT00867217|683577|P1|COMPLETED|Overall Study||77
283020|NCT00867217|683576|P2|STARTED|Overall Study||80
283021|NCT00867217|683577|P1|STARTED|Overall Study||80
283022|NCT00867165|683585|P2|NOT COMPLETED|Overall Study||0
283023|NCT00867165|683586|P1|NOT COMPLETED|Overall Study||4
283024|NCT00867165|683585|P2|COMPLETED|Overall Study||45
283025|NCT00867165|683586|P1|COMPLETED|Overall Study||89
283026|NCT00867165|683585|P2|STARTED|Overall Study||45
283027|NCT00867165|683586|P1|STARTED|Overall Study||93
283028|NCT00867139|683691|P3|NOT COMPLETED|Overall Study||1
283029|NCT00867139|683692|P2|NOT COMPLETED|Overall Study||0
283030|NCT00867139|683693|P1|NOT COMPLETED|Overall Study||0
283031|NCT00867139|683691|P3|COMPLETED|Overall Study|One open-labeled patient withdrew on day 5.|3
283032|NCT00867139|683692|P2|COMPLETED|Overall Study||1
283033|NCT00867139|683693|P1|COMPLETED|Overall Study||2
283034|NCT00867139|683691|P3|STARTED|Overall Study||4
283035|NCT00867139|683692|P2|STARTED|Overall Study||1
283036|NCT00867139|683693|P1|STARTED|Overall Study||2
283037|NCT00867113|683734|P1|NOT COMPLETED|Post Treatment After Survival Follow-up||11
283038|NCT00867113|683734|P1|COMPLETED|Post Treatment After Survival Follow-up||57
283039|NCT00867113|683734|P1|STARTED|Post Treatment After Survival Follow-up||68
283040|NCT00867113|683734|P1|NOT COMPLETED|Treatment Period||45
283041|NCT00867113|683734|P1|COMPLETED|Treatment Period||46
283042|NCT00867113|683734|P1|Full Analysis Set (FAS)|Treatment Period||91
283043|NCT00867113|683734|P1|Safety Set|Treatment Period||91
283044|NCT00867113|683734|P1|STARTED|Treatment Period||91
283045|NCT00867100|683754|P13|NOT COMPLETED|Overall Study||0
283046|NCT00867100|683755|P12|NOT COMPLETED|Overall Study||0
283047|NCT00867100|683756|P11|NOT COMPLETED|Overall Study||1
283048|NCT00867100|683757|P10|NOT COMPLETED|Overall Study||0
283049|NCT00867100|683758|P9|NOT COMPLETED|Overall Study||0
283050|NCT00867100|683759|P8|NOT COMPLETED|Overall Study||0
283051|NCT00867100|683760|P7|NOT COMPLETED|Overall Study||1
283052|NCT00867100|683761|P6|NOT COMPLETED|Overall Study||0
283053|NCT00867100|683762|P5|NOT COMPLETED|Overall Study||0
283054|NCT00867100|683763|P4|NOT COMPLETED|Overall Study||0
283055|NCT00867100|683764|P3|NOT COMPLETED|Overall Study||0
283056|NCT00867100|683765|P2|NOT COMPLETED|Overall Study||1
283057|NCT00867100|683766|P1|NOT COMPLETED|Overall Study||0
283058|NCT00867100|683754|P13|COMPLETED|Overall Study||6
283059|NCT00867100|683755|P12|COMPLETED|Overall Study||6
283060|NCT00867100|683756|P11|COMPLETED|Overall Study||3
283061|NCT00867100|683757|P10|COMPLETED|Overall Study||6
283062|NCT00867100|683758|P9|COMPLETED|Overall Study||6
283063|NCT00867100|683759|P8|COMPLETED|Overall Study||3
283064|NCT00867100|683760|P7|COMPLETED|Overall Study||6
283065|NCT00867100|683761|P6|COMPLETED|Overall Study||6
283066|NCT00867100|683762|P5|COMPLETED|Overall Study||14
283067|NCT00867100|683763|P4|COMPLETED|Overall Study||8
283068|NCT00867100|683764|P3|COMPLETED|Overall Study||8
283069|NCT00867100|683765|P2|COMPLETED|Overall Study||4
283070|NCT00867100|683766|P1|COMPLETED|Overall Study||5
283071|NCT00867100|683754|P13|STARTED|Overall Study||6
283072|NCT00867100|683755|P12|STARTED|Overall Study||6
283073|NCT00867100|683756|P11|STARTED|Overall Study||4
283074|NCT00867100|683757|P10|STARTED|Overall Study||6
283075|NCT00867100|683758|P9|STARTED|Overall Study||6
283076|NCT00867100|683759|P8|STARTED|Overall Study||3
283077|NCT00867100|683760|P7|STARTED|Overall Study||7
283078|NCT00867100|683761|P6|STARTED|Overall Study||6
283079|NCT00867100|683762|P5|STARTED|Overall Study||14
283080|NCT00867100|683763|P4|STARTED|Overall Study||8
283081|NCT00867100|683764|P3|STARTED|Overall Study||8
283082|NCT00867100|683765|P2|STARTED|Overall Study||5
283083|NCT00867100|683766|P1|STARTED|Overall Study||5
283084|NCT00867087|683798|P1|NOT COMPLETED|Overall Study||42
283085|NCT00867087|683798|P1|COMPLETED|Overall Study||21
283086|NCT00867087|683798|P1|STARTED|Overall Study||63
283087|NCT00867035|683814|P2|NOT COMPLETED|Baseline to 1 Week||0
283088|NCT00867035|683815|P1|NOT COMPLETED|Baseline to 1 Week||1
283089|NCT00867035|683814|P2|COMPLETED|Baseline to 1 Week||8
283090|NCT00867035|683815|P1|COMPLETED|Baseline to 1 Week||11
283091|NCT00867035|683814|P2|STARTED|Baseline to 1 Week||8
283092|NCT00867035|683815|P1|STARTED|Baseline to 1 Week||12
283093|NCT00867035|683814|P2|NOT COMPLETED|Baseline to 4 Hours||0
283094|NCT00867035|683815|P1|NOT COMPLETED|Baseline to 4 Hours||0
283095|NCT00867035|683814|P2|COMPLETED|Baseline to 4 Hours||8
283096|NCT00867035|683815|P1|COMPLETED|Baseline to 4 Hours||12
283097|NCT00867035|683814|P2|STARTED|Baseline to 4 Hours||8
283098|NCT00867035|683815|P1|STARTED|Baseline to 4 Hours||12
283099|NCT00867035|683814|P2|NOT COMPLETED|Baseline to 2 Hours||0
283100|NCT00867035|683815|P1|NOT COMPLETED|Baseline to 2 Hours||0
283101|NCT00867035|683814|P2|COMPLETED|Baseline to 2 Hours||8
283102|NCT00867035|683815|P1|COMPLETED|Baseline to 2 Hours||12
283103|NCT00867035|683814|P2|STARTED|Baseline to 2 Hours||8
283104|NCT00867035|683815|P1|STARTED|Baseline to 2 Hours||12
283105|NCT00867035|683814|P2|NOT COMPLETED|Baseline to 1 Hour||1
283106|NCT00867035|683815|P1|NOT COMPLETED|Baseline to 1 Hour||1
283107|NCT00867035|683814|P2|COMPLETED|Baseline to 1 Hour||8
283108|NCT00867035|683815|P1|COMPLETED|Baseline to 1 Hour||12
283109|NCT00867035|683814|P2|STARTED|Baseline to 1 Hour||9
283110|NCT00867035|683815|P1|STARTED|Baseline to 1 Hour||13
283111|NCT00867009|683841|P1|NOT COMPLETED|Maintenance Period||4
283112|NCT00867009|683841|P1|COMPLETED|Maintenance Period|Participant was considered completed if they had PD, death, or stopped receiving study drug.|47
283113|NCT00867009|683841|P1|STARTED|Maintenance Period||51
283114|NCT00867009|683841|P1|NOT COMPLETED|Induction Period||62
283115|NCT00867009|683841|P1|COMPLETED|Induction Period|Participants continued on the study in the Maintenance Period.|51
283116|NCT00867009|683841|P1|Protocol Qualified (PQ) Population|Induction Period|Stage IIIB/IV NS-NSCLC, no concurrent chemotherapy, measurable disease, ≥1 dose study drug.|109
283117|NCT00867009|683841|P1|Received at Least 1 Dose of Study Drug|Induction Period||113
283118|NCT00867009|683841|P1|STARTED|Induction Period|Participants with Stage IIIB/IV non-squamous (NS) non-small cell lung cancer (NSCLC)|113
283119|NCT00866918|683850|P2|NOT COMPLETED|Overall Study||12
283120|NCT00866918|683851|P1|NOT COMPLETED|Overall Study||16
283121|NCT00866918|683850|P2|COMPLETED|Overall Study||27
283122|NCT00866918|683851|P1|COMPLETED|Overall Study||53
283123|NCT00866918|683850|P2|STARTED|Overall Study||39
283124|NCT00866918|683851|P1|STARTED|Overall Study||69
283125|NCT00866905|683863|P1|NOT COMPLETED|Overall Study||33
283126|NCT00866905|683863|P1|COMPLETED|Overall Study||135
283127|NCT00866905|683863|P1|STARTED|Overall Study||168
283128|NCT00866879|683870|P2|NOT COMPLETED|Overall Study||0
283129|NCT00866879|683871|P1|NOT COMPLETED|Overall Study||0
283130|NCT00866879|683870|P2|COMPLETED|Overall Study||185
283131|NCT00866879|683871|P1|COMPLETED|Overall Study||90
283132|NCT00866879|683870|P2|STARTED|Overall Study||185
283133|NCT00866879|683871|P1|STARTED|Overall Study||90
283134|NCT00866814|683885|P1|NOT COMPLETED|Overall Study||20
283135|NCT00866814|683885|P1|COMPLETED|Overall Study||99
283136|NCT00866814|683885|P1|STARTED|Overall Study||119
283137|NCT00866788|683898|P4|NOT COMPLETED|Overall Study||5
283138|NCT00866788|683899|P3|NOT COMPLETED|Overall Study||2
283139|NCT00866788|683900|P2|NOT COMPLETED|Overall Study||6
283140|NCT00866788|683901|P1|NOT COMPLETED|Overall Study||6
283141|NCT00866788|683898|P4|COMPLETED|Overall Study||16
283142|NCT00866788|683899|P3|COMPLETED|Overall Study||23
283143|NCT00866788|683900|P2|COMPLETED|Overall Study||17
283144|NCT00866788|683901|P1|COMPLETED|Overall Study||15
283145|NCT00866788|683898|P4|STARTED|Overall Study||21
283146|NCT00866788|683899|P3|STARTED|Overall Study||25
283147|NCT00866788|683900|P2|STARTED|Overall Study||23
283148|NCT00866788|683901|P1|STARTED|Overall Study||21
283149|NCT00866775|683949|P2|NOT COMPLETED|Overall Study||52
283150|NCT00866775|683950|P1|NOT COMPLETED|Overall Study||36
283151|NCT00866775|683949|P2|COMPLETED|Overall Study||76
283152|NCT00866775|683950|P1|COMPLETED|Overall Study||29
283153|NCT00866775|683949|P2|STARTED|Overall Study||128
283154|NCT00866775|683950|P1|STARTED|Overall Study||65
283155|NCT00866749|683986|P1|NOT COMPLETED|Overall Study||0
283156|NCT00866749|683986|P1|COMPLETED|Overall Study||120
283157|NCT00866749|683986|P1|STARTED|Overall Study||120
283158|NCT00866723|683993|P1|NOT COMPLETED|Overall Study||5
283159|NCT00866723|683993|P1|COMPLETED|Overall Study||0
283160|NCT00866723|683993|P1|STARTED|Overall Study||5
283161|NCT00866697|684000|P2|NOT COMPLETED|Overall Study||228
283162|NCT00866697|684001|P1|NOT COMPLETED|Overall Study||214
283163|NCT00866697|684000|P2|COMPLETED|Overall Study||244
283164|NCT00866697|684001|P1|COMPLETED|Overall Study||254
283165|NCT00866697|684000|P2|STARTED|Overall Study||472
283166|NCT00866697|684001|P1|STARTED|Overall Study||468
283167|NCT00866658|684043|P2|NOT COMPLETED|Overall Study||21
283168|NCT00866658|684044|P1|NOT COMPLETED|Overall Study||13
283169|NCT00866658|684043|P2|COMPLETED|Overall Study||133
283170|NCT00866658|684044|P1|COMPLETED|Overall Study||144
283171|NCT00866658|684043|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||154
283172|NCT00866658|684044|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|157
283173|NCT00866658|684043|P2|Safety Population|Overall Study||154
283174|NCT00866658|684044|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|157
283175|NCT00866658|684043|P2|STARTED|Overall Study||154
283176|NCT00866658|684044|P1|STARTED|Overall Study|Randomized.|157
283177|NCT00866619|684076|P4|NOT COMPLETED|Overall Study||630
283178|NCT00866619|684077|P3|NOT COMPLETED|Overall Study||889
283179|NCT00866619|684078|P2|NOT COMPLETED|Overall Study||1270
283180|NCT00866619|684079|P1|NOT COMPLETED|Overall Study||1846
283181|NCT00866619|684076|P4|COMPLETED|Overall Study||1549
283182|NCT00866619|684077|P3|COMPLETED|Overall Study||2085
283183|NCT00866619|684078|P2|COMPLETED|Overall Study||3088
283184|NCT00866619|684079|P1|COMPLETED|Overall Study||4102
283185|NCT00866619|684076|P4|STARTED|Overall Study||2179
283186|NCT00866619|684077|P3|STARTED|Overall Study||2974
283187|NCT00866619|684078|P2|STARTED|Overall Study||4358
283188|NCT00866619|684079|P1|STARTED|Overall Study||5948
283189|NCT00866606|684399|P1|NOT COMPLETED|Overall Study||4
283190|NCT00866606|684399|P1|COMPLETED|Overall Study||31
283191|NCT00866606|684399|P1|STARTED|Overall Study||35
283192|NCT00866359|684413|P4|NOT COMPLETED|Observational Follow-Up Phase||0
283193|NCT00866359|684414|P3|NOT COMPLETED|Observational Follow-Up Phase||0
283194|NCT00866359|684415|P2|NOT COMPLETED|Observational Follow-Up Phase||0
283195|NCT00866359|684416|P1|NOT COMPLETED|Observational Follow-Up Phase||0
283196|NCT00866359|684413|P4|COMPLETED|Observational Follow-Up Phase||54
283197|NCT00866359|684414|P3|COMPLETED|Observational Follow-Up Phase||54
283198|NCT00866359|684415|P2|COMPLETED|Observational Follow-Up Phase||0
283199|NCT00866359|684416|P1|COMPLETED|Observational Follow-Up Phase||0
283200|NCT00866359|684413|P4|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
283201|NCT00866359|684414|P3|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
283202|NCT00866359|684415|P2|STARTED|Observational Follow-Up Phase||0
283203|NCT00866359|684416|P1|STARTED|Observational Follow-Up Phase||0
283204|NCT00866359|684413|P4|NOT COMPLETED|Extension Phase (Day 86 to 169)||3
283205|NCT00866359|684414|P3|NOT COMPLETED|Extension Phase (Day 86 to 169)||1
283206|NCT00866359|684415|P2|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
283207|NCT00866359|684416|P1|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
283208|NCT00866359|684413|P4|COMPLETED|Extension Phase (Day 86 to 169)||47
283209|NCT00866359|684414|P3|COMPLETED|Extension Phase (Day 86 to 169)||44
283210|NCT00866359|684415|P2|COMPLETED|Extension Phase (Day 86 to 169)||0
283211|NCT00866359|684416|P1|COMPLETED|Extension Phase (Day 86 to 169)||0
283212|NCT00866359|684413|P4|STARTED|Extension Phase (Day 86 to 169)||50
283213|NCT00866359|684414|P3|STARTED|Extension Phase (Day 86 to 169)||45
283214|NCT00866359|684415|P2|STARTED|Extension Phase (Day 86 to 169)||0
283215|NCT00866359|684416|P1|STARTED|Extension Phase (Day 86 to 169)||0
283216|NCT00866359|684413|P4|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
283217|NCT00866359|684414|P3|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
283218|NCT00866359|684415|P2|NOT COMPLETED|Treatment Phase (Days 1 to 85)||5
283219|NCT00866359|684416|P1|NOT COMPLETED|Treatment Phase (Days 1 to 85)||11
283220|NCT00866359|684413|P4|COMPLETED|Treatment Phase (Days 1 to 85)||0
283221|NCT00866359|684414|P3|COMPLETED|Treatment Phase (Days 1 to 85)||0
283222|NCT00866359|684415|P2|COMPLETED|Treatment Phase (Days 1 to 85)||50
283223|NCT00866359|684416|P1|COMPLETED|Treatment Phase (Days 1 to 85)||45
283224|NCT00866359|684413|P4|STARTED|Treatment Phase (Days 1 to 85)||0
283225|NCT00866359|684414|P3|STARTED|Treatment Phase (Days 1 to 85)||0
283226|NCT00866359|684415|P2|STARTED|Treatment Phase (Days 1 to 85)||55
283227|NCT00866359|684416|P1|STARTED|Treatment Phase (Days 1 to 85)||56
283228|NCT00866333|684472|P3|NOT COMPLETED|Overall Study||12
283229|NCT00866333|684473|P2|NOT COMPLETED|Overall Study||7
283230|NCT00866333|684474|P1|NOT COMPLETED|Overall Study||5
283231|NCT00866333|684472|P3|COMPLETED|Overall Study||4
283232|NCT00866333|684473|P2|COMPLETED|Overall Study||10
283233|NCT00866333|684474|P1|COMPLETED|Overall Study||11
283234|NCT00866333|684472|P3|STARTED|Overall Study||16
283235|NCT00866333|684473|P2|STARTED|Overall Study||17
283236|NCT00866333|684474|P1|STARTED|Overall Study||16
283237|NCT00866320|684491|P1|NOT COMPLETED|Overall Study||6
283238|NCT00866320|684491|P1|COMPLETED|Overall Study|All patients that received treatment were analyzed.|43
283239|NCT00866320|684491|P1|STARTED|Overall Study||49
283240|NCT00866307|684498|P3|NOT COMPLETED|Consolidation/Maintenance||16
283241|NCT00866307|684499|P2|NOT COMPLETED|Consolidation/Maintenance||9
283242|NCT00866307|684500|P1|NOT COMPLETED|Consolidation/Maintenance||0
283243|NCT00866307|684498|P3|COMPLETED|Consolidation/Maintenance||14
283244|NCT00866307|684499|P2|COMPLETED|Consolidation/Maintenance||45
283245|NCT00866307|684500|P1|COMPLETED|Consolidation/Maintenance||0
283246|NCT00866307|684498|P3|STARTED|Consolidation/Maintenance||30
283247|NCT00866307|684499|P2|STARTED|Consolidation/Maintenance||54
283248|NCT00866307|684500|P1|STARTED|Consolidation/Maintenance||0
283249|NCT00866307|684498|P3|NOT COMPLETED|Induction||0
283250|NCT00866307|684499|P2|NOT COMPLETED|Induction||0
283251|NCT00866307|684500|P1|NOT COMPLETED|Induction||20
283252|NCT00866307|684498|P3|COMPLETED|Induction||0
283253|NCT00866307|684499|P2|COMPLETED|Induction||0
283254|NCT00866307|684500|P1|COMPLETED|Induction||84
283255|NCT00866307|684498|P3|STARTED|Induction||0
283256|NCT00866307|684499|P2|STARTED|Induction||0
283257|NCT00866307|684500|P1|STARTED|Induction||104
283258|NCT00866294|684510|P3|NOT COMPLETED|Overall Study||11
283259|NCT00866294|684511|P2|NOT COMPLETED|Overall Study||20
283260|NCT00866294|684512|P1|NOT COMPLETED|Overall Study||33
283261|NCT00866294|684510|P3|COMPLETED|Overall Study||72
283262|NCT00866294|684511|P2|COMPLETED|Overall Study||141
283263|NCT00866294|684512|P1|COMPLETED|Overall Study||139
283264|NCT00866294|684510|P3|STARTED|Overall Study||83
283265|NCT00866294|684511|P2|STARTED|Overall Study||161
283266|NCT00866294|684512|P1|STARTED|Overall Study||172
283267|NCT00866281|684541|P2|NOT COMPLETED|Overall Study||15
283268|NCT00866281|684542|P1|NOT COMPLETED|Overall Study||7
283269|NCT00866281|684541|P2|COMPLETED|Overall Study||0
283270|NCT00866281|684542|P1|COMPLETED|Overall Study||0
283271|NCT00866281|684541|P2|STARTED|Overall Study||15
283272|NCT00866281|684542|P1|STARTED|Overall Study||7
283273|NCT00866177|684558|P1|NOT COMPLETED|Overall Study||152
283274|NCT00866177|684558|P1|COMPLETED|Overall Study||15
283275|NCT00866177|684558|P1|STARTED|Overall Study||167
283276|NCT00866047|684562|P1|NOT COMPLETED|Follow-up Period||5
283277|NCT00866047|684562|P1|COMPLETED|Follow-up Period|Completed survival follow-up due to death [25] or study completion [28]|53
283278|NCT00866047|684562|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|58
283279|NCT00866047|684562|P1|NOT COMPLETED|Treatment Period||48
283280|NCT00866047|684562|P1|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|10
283281|NCT00866047|684562|P1|STARTED|Treatment Period||58
283282|NCT00866034|684580|P2|NOT COMPLETED|Overall Study||8
283283|NCT00866034|684581|P1|NOT COMPLETED|Overall Study||16
283284|NCT00866034|684580|P2|COMPLETED|Overall Study||301
283285|NCT00866034|684581|P1|COMPLETED|Overall Study||292
283286|NCT00866034|684580|P2|STARTED|Overall Study||309
283287|NCT00866034|684581|P1|STARTED|Overall Study||308
283288|NCT00865904|684594|P5|NOT COMPLETED|Overall Study||1
283289|NCT00865904|684595|P4|NOT COMPLETED|Overall Study||1
283290|NCT00865904|684596|P3|NOT COMPLETED|Overall Study||0
283291|NCT00865904|684597|P2|NOT COMPLETED|Overall Study||0
283292|NCT00865904|684598|P1|NOT COMPLETED|Overall Study||2
283293|NCT00865904|684594|P5|COMPLETED|Overall Study|Completed 14-day follow-up.|19
283294|NCT00865904|684595|P4|COMPLETED|Overall Study|Completed 14-day follow-up.|17
283295|NCT00865904|684596|P3|COMPLETED|Overall Study|Completed 14-day follow-up.|18
283296|NCT00865904|684597|P2|COMPLETED|Overall Study|Completed 14-day follow-up.|18
283297|NCT00865904|684598|P1|COMPLETED|Overall Study|Completed 14-day follow-up.|17
283298|NCT00865904|684594|P5|STARTED|Overall Study|Randomized.|20
283299|NCT00865904|684595|P4|STARTED|Overall Study|Randomized.|18
283300|NCT00865904|684596|P3|STARTED|Overall Study|Randomized.|18
283301|NCT00865904|684597|P2|STARTED|Overall Study|Randomized.|18
283302|NCT00865904|684598|P1|STARTED|Overall Study|Randomized.|19
283303|NCT00865709|684655|P2|NOT COMPLETED|Long Term Follow-up||49
283304|NCT00865709|684656|P1|NOT COMPLETED|Long Term Follow-up||46
283305|NCT00865709|684655|P2|COMPLETED|Long Term Follow-up||33
283306|NCT00865709|684656|P1|COMPLETED|Long Term Follow-up||24
283307|NCT00865709|684655|P2|STARTED|Long Term Follow-up||82
283308|NCT00865709|684656|P1|STARTED|Long Term Follow-up||70
283309|NCT00865709|684655|P2|NOT COMPLETED|Active Follow-up||1
283310|NCT00865709|684656|P1|NOT COMPLETED|Active Follow-up||8
283311|NCT00865709|684655|P2|COMPLETED|Active Follow-up||15
283312|NCT00865709|684656|P1|COMPLETED|Active Follow-up||17
283313|NCT00865709|684655|P2|STARTED|Active Follow-up||16
283314|NCT00865709|684656|P1|STARTED|Active Follow-up||25
283315|NCT00865709|684655|P2|NOT COMPLETED|Treatment||18
283316|NCT00865709|684656|P1|NOT COMPLETED|Treatment||30
283317|NCT00865709|684655|P2|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|83
283318|NCT00865709|684656|P1|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|67
283319|NCT00865709|684655|P2|Received Treatment|Treatment|Safety population|101
283320|NCT00865709|684656|P1|Received Treatment|Treatment|Safety population|97
283321|NCT00865709|684655|P2|STARTED|Treatment||101
283322|NCT00865709|684656|P1|STARTED|Treatment||97
283323|NCT00865566|684674|P2|NOT COMPLETED|Overall Study||687
283324|NCT00865566|684675|P1|NOT COMPLETED|Overall Study||624
283325|NCT00865566|684674|P2|COMPLETED|Overall Study||564
283326|NCT00865566|684675|P1|COMPLETED|Overall Study||629
283327|NCT00865566|684674|P2|Modified Intent-to-Treat Population|Overall Study||1245
283328|NCT00865566|684675|P1|Modified Intent-to-Treat Population|Overall Study||1251
283329|NCT00865566|684674|P2|STARTED|Overall Study||1251
283330|NCT00865566|684675|P1|STARTED|Overall Study||1253
283331|NCT00865514|684695|P1|NOT COMPLETED|Overall Study||2
283332|NCT00865514|684695|P1|COMPLETED|Overall Study||0
283333|NCT00865514|684695|P1|STARTED|Overall Study||2
283334|NCT00865345|684700|P1|NOT COMPLETED|Overall Study||2
283335|NCT00865345|684700|P1|COMPLETED|Overall Study||61
283336|NCT00865345|684700|P1|STARTED|Overall Study||63
283337|NCT00865306|684707|P2|NOT COMPLETED|One-Year Follow-Up||0
283338|NCT00865306|684708|P1|NOT COMPLETED|One-Year Follow-Up||0
283339|NCT00865306|684707|P2|COMPLETED|One-Year Follow-Up||15
283340|NCT00865306|684708|P1|COMPLETED|One-Year Follow-Up||29
283341|NCT00865306|684707|P2|STARTED|One-Year Follow-Up|Only controls who opted for CBT after the waitlist (n=17) were included. 2 were lost (15 included).|15
283342|NCT00865306|684708|P1|STARTED|One-Year Follow-Up||29
283343|NCT00865306|684707|P2|NOT COMPLETED|Controlled Trial||2
283344|NCT00865306|684708|P1|NOT COMPLETED|Controlled Trial||5
283345|NCT00865306|684707|P2|COMPLETED|Controlled Trial||28
283346|NCT00865306|684708|P1|COMPLETED|Controlled Trial||29
283347|NCT00865306|684707|P2|STARTED|Controlled Trial||30
283438|NCT00864513|684933|P1|STARTED|Overall Study||15
283348|NCT00865306|684708|P1|STARTED|Controlled Trial|35 assigned to CBT. One child in trial had 0 anxiety disorders, so we excluded her from analysis.|34
283349|NCT00865202|684720|P2|NOT COMPLETED|Overall Study||0
283350|NCT00865202|684721|P1|NOT COMPLETED|Overall Study||0
283351|NCT00865202|684720|P2|COMPLETED|Overall Study||149
283352|NCT00865202|684721|P1|COMPLETED|Overall Study||152
283353|NCT00865202|684720|P2|STARTED|Overall Study||149
283354|NCT00865202|684721|P1|STARTED|Overall Study||152
283355|NCT00865189|684737|P2|NOT COMPLETED|Overall Study||19
283356|NCT00865189|684738|P1|NOT COMPLETED|Overall Study||12
283357|NCT00865189|684737|P2|COMPLETED|Overall Study||26
283358|NCT00865189|684738|P1|COMPLETED|Overall Study||34
283359|NCT00865189|684737|P2|STARTED|Overall Study||45
283360|NCT00865189|684738|P1|STARTED|Overall Study||46
283361|NCT00865124|684766|P3|NOT COMPLETED|Overall Study||0
283362|NCT00865124|684767|P2|NOT COMPLETED|Overall Study||1
283363|NCT00865124|684768|P1|NOT COMPLETED|Overall Study||4
283364|NCT00865124|684766|P3|COMPLETED|Overall Study||17
283365|NCT00865124|684767|P2|COMPLETED|Overall Study||24
283366|NCT00865124|684768|P1|COMPLETED|Overall Study||23
283367|NCT00865124|684766|P3|STARTED|Overall Study||17
283368|NCT00865124|684767|P2|STARTED|Overall Study||25
283369|NCT00865124|684768|P1|STARTED|Overall Study||27
283370|NCT00865098|684785|P1|NOT COMPLETED|Overall Study||1
283371|NCT00865098|684785|P1|COMPLETED|Overall Study|Discontinued from the study due to progressive disease, after completing planned treatment schedule|21
283372|NCT00865098|684785|P1|STARTED|Overall Study||22
283373|NCT00865046|684797|P3|NOT COMPLETED|Overall Study||1
283374|NCT00865046|684798|P2|NOT COMPLETED|Overall Study||5
283375|NCT00865046|684799|P1|NOT COMPLETED|Overall Study||6
283376|NCT00865046|684797|P3|COMPLETED|Overall Study||62
283377|NCT00865046|684798|P2|COMPLETED|Overall Study||59
283378|NCT00865046|684799|P1|COMPLETED|Overall Study||57
283379|NCT00865046|684797|P3|STARTED|Overall Study||63
283380|NCT00865046|684798|P2|STARTED|Overall Study||64
283381|NCT00865046|684799|P1|STARTED|Overall Study||63
283382|NCT00865020|684809|P2|NOT COMPLETED|Overall Study||51
283383|NCT00865020|684810|P1|NOT COMPLETED|Overall Study||49
283384|NCT00865020|684809|P2|COMPLETED|Overall Study||357
283385|NCT00865020|684810|P1|COMPLETED|Overall Study||365
283386|NCT00865020|684809|P2|STARTED|Overall Study||408
283387|NCT00865020|684810|P1|STARTED|Overall Study||414
283388|NCT00864916|684826|P2|NOT COMPLETED|Overall Study||4
283389|NCT00864916|684827|P1|NOT COMPLETED|Overall Study||6
283390|NCT00864916|684826|P2|COMPLETED|Overall Study||5
283391|NCT00864916|684827|P1|COMPLETED|Overall Study||4
283392|NCT00864916|684826|P2|STARTED|Overall Study||9
283393|NCT00864916|684827|P1|STARTED|Overall Study||10
283394|NCT00864851|684836|P3|NOT COMPLETED|Overall Study||0
283395|NCT00864851|684837|P2|NOT COMPLETED|Overall Study||1
283396|NCT00864851|684838|P1|NOT COMPLETED|Overall Study||3
283397|NCT00864851|684836|P3|COMPLETED|Overall Study||5
283398|NCT00864851|684837|P2|COMPLETED|Overall Study||18
283399|NCT00864851|684838|P1|COMPLETED|Overall Study||17
283400|NCT00864851|684836|P3|STARTED|Overall Study||5
283401|NCT00864851|684837|P2|STARTED|Overall Study||19
283402|NCT00864851|684838|P1|STARTED|Overall Study||20
283403|NCT00864721|684872|P1|NOT COMPLETED|Overall Study||34
283404|NCT00864721|684872|P1|COMPLETED|Overall Study||29
283405|NCT00864721|684872|P1|STARTED|Overall Study||63
283406|NCT00864708|684880|P1|NOT COMPLETED|Overall Study||0
283407|NCT00864708|684880|P1|COMPLETED|Overall Study||1
283408|NCT00864708|684880|P1|STARTED|Overall Study||1
283409|NCT00864682|684892|P3|NOT COMPLETED|Overall Study||2
283410|NCT00864682|684893|P2|NOT COMPLETED|Overall Study||1
283411|NCT00864682|684894|P1|NOT COMPLETED|Overall Study||2
283412|NCT00864682|684892|P3|COMPLETED|Overall Study||51
283413|NCT00864682|684893|P2|COMPLETED|Overall Study||50
283414|NCT00864682|684894|P1|COMPLETED|Overall Study||50
283415|NCT00864682|684892|P3|STARTED|Overall Study||53
283416|NCT00864682|684893|P2|STARTED|Overall Study||51
283417|NCT00864682|684894|P1|STARTED|Overall Study||52
283418|NCT00864539|684914|P6|NOT COMPLETED|Overall Study||14
283419|NCT00864539|684915|P5|NOT COMPLETED|Overall Study||22
283420|NCT00864539|684916|P4|NOT COMPLETED|Overall Study||7
283421|NCT00864539|684917|P3|NOT COMPLETED|Overall Study||10
283422|NCT00864539|684918|P2|NOT COMPLETED|Overall Study||23
283423|NCT00864539|684919|P1|NOT COMPLETED|Overall Study||9
283424|NCT00864539|684914|P6|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|71
283425|NCT00864539|684915|P5|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|81
283426|NCT00864539|684916|P4|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|89
283427|NCT00864539|684917|P3|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|92
283428|NCT00864539|684918|P2|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|72
283429|NCT00864539|684919|P1|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|95
283430|NCT00864539|684914|P6|STARTED|Overall Study||85
283431|NCT00864539|684915|P5|STARTED|Overall Study||103
283432|NCT00864539|684916|P4|STARTED|Overall Study||96
283433|NCT00864539|684917|P3|STARTED|Overall Study||102
283434|NCT00864539|684918|P2|STARTED|Overall Study||95
283435|NCT00864539|684919|P1|STARTED|Overall Study||104
283436|NCT00864513|684933|P1|NOT COMPLETED|Overall Study||3
283437|NCT00864513|684933|P1|COMPLETED|Overall Study||12
283439|NCT00864383|684943|P3|NOT COMPLETED|Modified Intent to Treat||85
283440|NCT00864383|684944|P2|NOT COMPLETED|Modified Intent to Treat||87
283441|NCT00864383|684945|P1|NOT COMPLETED|Modified Intent to Treat||85
283442|NCT00864383|684943|P3|COMPLETED|Modified Intent to Treat||551
283443|NCT00864383|684944|P2|COMPLETED|Modified Intent to Treat||568
283444|NCT00864383|684945|P1|COMPLETED|Modified Intent to Treat||555
283445|NCT00864383|684943|P3|STARTED|Modified Intent to Treat||636
283446|NCT00864383|684944|P2|STARTED|Modified Intent to Treat||655
283447|NCT00864383|684945|P1|STARTED|Modified Intent to Treat||640
283448|NCT00864383|684943|P3|NOT COMPLETED|Per- Protocol||112
283449|NCT00864383|684944|P2|NOT COMPLETED|Per- Protocol||141
283450|NCT00864383|684945|P1|NOT COMPLETED|Per- Protocol||130
283451|NCT00864383|684943|P3|COMPLETED|Per- Protocol||524
283452|NCT00864383|684944|P2|COMPLETED|Per- Protocol||514
283453|NCT00864383|684945|P1|COMPLETED|Per- Protocol||510
283454|NCT00864383|684943|P3|STARTED|Per- Protocol||636
283455|NCT00864383|684944|P2|STARTED|Per- Protocol||655
283456|NCT00864383|684945|P1|STARTED|Per- Protocol||640
283457|NCT00864253|684979|P2|NOT COMPLETED|Overall Study||58
283458|NCT00864253|684980|P1|NOT COMPLETED|Overall Study||99
283459|NCT00864253|684979|P2|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|207
283460|NCT00864253|684980|P1|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|165
283461|NCT00864253|684979|P2|Treated|Overall Study||258
283462|NCT00864253|684980|P1|Treated|Overall Study||257
283463|NCT00864253|684979|P2|STARTED|Overall Study||265
283464|NCT00864253|684980|P1|STARTED|Overall Study||264
283465|NCT00864227|685010|P1|NOT COMPLETED|Overall Study||4
283466|NCT00864227|685010|P1|COMPLETED|Overall Study||50
283467|NCT00864227|685010|P1|STARTED|Overall Study||54
283468|NCT00864123|685027|P2|NOT COMPLETED|Overall Study||0
283469|NCT00864123|685028|P1|NOT COMPLETED|Overall Study||0
283470|NCT00864123|685027|P2|COMPLETED|Overall Study||15
283471|NCT00864123|685028|P1|COMPLETED|Overall Study||15
283472|NCT00864123|685027|P2|STARTED|Overall Study||15
283473|NCT00864123|685028|P1|STARTED|Overall Study||15
283474|NCT00864084|685038|P1|NOT COMPLETED|Overall Study||3
283475|NCT00864084|685038|P1|COMPLETED|Overall Study||11
283476|NCT00864084|685038|P1|STARTED|Overall Study||14
283477|NCT00864032|685061|P3|NOT COMPLETED|Overall Study||0
283478|NCT00864032|685062|P2|NOT COMPLETED|Overall Study||0
283479|NCT00864032|685063|P1|NOT COMPLETED|Overall Study||0
283480|NCT00864032|685061|P3|COMPLETED|Overall Study||0
283481|NCT00864032|685062|P2|COMPLETED|Overall Study||5
283482|NCT00864032|685063|P1|COMPLETED|Overall Study||3
283483|NCT00864032|685061|P3|STARTED|Overall Study||0
283484|NCT00864032|685062|P2|STARTED|Overall Study||5
283485|NCT00864032|685063|P1|STARTED|Overall Study||3
283486|NCT00863928|685071|P2|NOT COMPLETED|Overall Study||0
283487|NCT00863928|685072|P1|NOT COMPLETED|Overall Study||36
283488|NCT00863928|685071|P2|COMPLETED|Overall Study||41
283489|NCT00863928|685072|P1|COMPLETED|Overall Study||58
283490|NCT00863928|685071|P2|STARTED|Overall Study||41
283491|NCT00863928|685072|P1|STARTED|Overall Study||94
283492|NCT00863798|685081|P3|NOT COMPLETED|Overall Study||25
283493|NCT00863798|685082|P2|NOT COMPLETED|Overall Study||30
283494|NCT00863798|685083|P1|NOT COMPLETED|Overall Study||32
283495|NCT00863798|685081|P3|COMPLETED|Overall Study||202
283496|NCT00863798|685082|P2|COMPLETED|Overall Study||198
283497|NCT00863798|685083|P1|COMPLETED|Overall Study||195
283498|NCT00863798|685081|P3|Treated|Overall Study||224
283499|NCT00863798|685082|P2|Treated|Overall Study||226
283500|NCT00863798|685083|P1|Treated|Overall Study||223
283501|NCT00863798|685081|P3|STARTED|Overall Study||227
283502|NCT00863798|685082|P2|STARTED|Overall Study||228
283503|NCT00863798|685083|P1|STARTED|Overall Study||227
283504|NCT00863746|685135|P2|NOT COMPLETED|Survival Follow up||280
283505|NCT00863746|685136|P1|NOT COMPLETED|Survival Follow up||253
283506|NCT00863746|685135|P2|COMPLETED|Survival Follow up||51
283507|NCT00863746|685136|P1|COMPLETED|Survival Follow up||45
283508|NCT00863746|685135|P2|STARTED|Survival Follow up|331 patients of 339 patients (=353 randomized - 14 death) entered the survival follow-up.|331
283509|NCT00863746|685136|P1|STARTED|Survival Follow up|298 patients of 317 patients (= 346 randomized - 29 deaths) entered the survival follow-up|298
283510|NCT00863746|685135|P2|NOT COMPLETED|Treatment||35
283511|NCT00863746|685136|P1|NOT COMPLETED|Treatment||71
283512|NCT00863746|685135|P2|COMPLETED|Treatment||318
283513|NCT00863746|685136|P1|COMPLETED|Treatment||279
283514|NCT00863746|685135|P2|Participants Received Treatment|Treatment|Safety population|351
283515|NCT00863746|685136|P1|Participants Received Treatment|Treatment|Safety population|346
283516|NCT00863746|685135|P2|STARTED|Treatment||353
283517|NCT00863746|685136|P1|STARTED|Treatment||350
283518|NCT00863707|685162|P2|NOT COMPLETED|Overall Study||3
283519|NCT00863707|685163|P1|NOT COMPLETED|Overall Study||4
283520|NCT00863707|685162|P2|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|334
283521|NCT00863707|685163|P1|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|170
283522|NCT00863707|685162|P2|STARTED|Overall Study||337
283523|NCT00863707|685163|P1|STARTED|Overall Study||174
283524|NCT00863655|685171|P2|NOT COMPLETED|Overall Study||239
283525|NCT00863655|685172|P1|NOT COMPLETED|Overall Study||485
283526|NCT00863655|685171|P2|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
283527|NCT00863655|685172|P1|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
283528|NCT00863655|685171|P2|STARTED|Overall Study||239
283529|NCT00863655|685172|P1|STARTED|Overall Study||485
283530|NCT00863551|685199|P1|NOT COMPLETED|Overall Study||0
283531|NCT00863551|685199|P1|COMPLETED|Overall Study||12
283532|NCT00863551|685199|P1|STARTED|Overall Study||12
283533|NCT00863512|685209|P2|NOT COMPLETED|Overall Study||0
283534|NCT00863512|685210|P1|NOT COMPLETED|Overall Study||14
283535|NCT00863512|685209|P2|COMPLETED|Overall Study||17
283536|NCT00863512|685210|P1|COMPLETED|Overall Study||3
283537|NCT00863512|685209|P2|STARTED|Overall Study||17
283538|NCT00863512|685210|P1|STARTED|Overall Study||17
283539|NCT00863434|685216|P1|NOT COMPLETED|Overall Study||0
283540|NCT00863434|685216|P1|COMPLETED|Overall Study||2
283541|NCT00863434|685216|P1|STARTED|Overall Study||2
283542|NCT00863356|685222|P1|NOT COMPLETED|Overall Study||0
283543|NCT00863356|685222|P1|COMPLETED|Overall Study||20
283544|NCT00863356|685222|P1|STARTED|Overall Study||20
283545|NCT00863343|685228|P2|NOT COMPLETED|Overall Study||0
283546|NCT00863343|685229|P1|NOT COMPLETED|Overall Study||0
283547|NCT00863343|685228|P2|COMPLETED|Overall Study||374
283548|NCT00863343|685229|P1|COMPLETED|Overall Study||17
283549|NCT00863343|685228|P2|STARTED|Overall Study||374
283550|NCT00863343|685229|P1|STARTED|Overall Study||17
283551|NCT00863330|685241|P1|NOT COMPLETED|Overall Study||6
283552|NCT00863330|685241|P1|COMPLETED|Overall Study||0
283553|NCT00863330|685241|P1|STARTED|Overall Study||6
283554|NCT00863317|685247|P2|NOT COMPLETED|Overall Study||9
283555|NCT00863317|685248|P1|NOT COMPLETED|Overall Study||8
283556|NCT00863317|685247|P2|COMPLETED|Overall Study||64
283557|NCT00863317|685248|P1|COMPLETED|Overall Study||60
283558|NCT00863317|685247|P2|STARTED|Overall Study||73
283559|NCT00863317|685248|P1|STARTED|Overall Study||68
283560|NCT00863265|685254|P6|NOT COMPLETED|Overall Study||0
283561|NCT00863265|685255|P5|NOT COMPLETED|Overall Study||1
283562|NCT00863265|685256|P4|NOT COMPLETED|Overall Study||0
283563|NCT00863265|685257|P3|NOT COMPLETED|Overall Study||0
283564|NCT00863265|685258|P2|NOT COMPLETED|Overall Study||0
283565|NCT00863265|685259|P1|NOT COMPLETED|Overall Study||0
283566|NCT00863265|685254|P6|COMPLETED|Overall Study||3
283567|NCT00863265|685255|P5|COMPLETED|Overall Study||3
283568|NCT00863265|685256|P4|COMPLETED|Overall Study||4
283569|NCT00863265|685257|P3|COMPLETED|Overall Study||4
283570|NCT00863265|685258|P2|COMPLETED|Overall Study||3
283571|NCT00863265|685259|P1|COMPLETED|Overall Study||4
283572|NCT00863265|685254|P6|STARTED|Overall Study||3
283573|NCT00863265|685255|P5|STARTED|Overall Study||4
283574|NCT00863265|685256|P4|STARTED|Overall Study||4
283575|NCT00863265|685257|P3|STARTED|Overall Study||4
283576|NCT00863265|685258|P2|STARTED|Overall Study||3
283577|NCT00863265|685259|P1|STARTED|Overall Study||4
283578|NCT00863122|685275|P2|NOT COMPLETED|Overall Study||0
283579|NCT00863122|685276|P1|NOT COMPLETED|Overall Study||0
283580|NCT00863122|685275|P2|COMPLETED|Overall Study||7
283581|NCT00863122|685276|P1|COMPLETED|Overall Study||19
283582|NCT00863122|685275|P2|STARTED|Overall Study||7
283583|NCT00863122|685276|P1|STARTED|Overall Study||19
283584|NCT00863109|685287|P1|NOT COMPLETED|Follow-up Period||11
283585|NCT00863109|685287|P1|COMPLETED|Follow-up Period||48
283586|NCT00863109|685287|P1|STARTED|Follow-up Period|Follow-up performed on 53 who completed Treatment Period plus 6 who discontinued treatment|59
283587|NCT00863109|685287|P1|NOT COMPLETED|Treatment Period||77
283588|NCT00863109|685287|P1|COMPLETED|Treatment Period||53
283589|NCT00863109|685287|P1|STARTED|Treatment Period||130
283590|NCT00863057|685304|P4|NOT COMPLETED|Period 4 (Weeks 16-20)||0
283591|NCT00863057|685305|P3|NOT COMPLETED|Period 4 (Weeks 16-20)||0
283592|NCT00863057|685306|P2|NOT COMPLETED|Period 4 (Weeks 16-20)||0
283593|NCT00863057|685307|P1|NOT COMPLETED|Period 4 (Weeks 16-20)||0
283594|NCT00863057|685304|P4|COMPLETED|Period 4 (Weeks 16-20)||2
283595|NCT00863057|685305|P3|COMPLETED|Period 4 (Weeks 16-20)||2
283596|NCT00863057|685306|P2|COMPLETED|Period 4 (Weeks 16-20)||1
283597|NCT00863057|685307|P1|COMPLETED|Period 4 (Weeks 16-20)||3
283598|NCT00863057|685304|P4|STARTED|Period 4 (Weeks 16-20)||2
283599|NCT00863057|685305|P3|STARTED|Period 4 (Weeks 16-20)||2
283600|NCT00863057|685306|P2|STARTED|Period 4 (Weeks 16-20)||1
283601|NCT00863057|685307|P1|STARTED|Period 4 (Weeks 16-20)||3
283602|NCT00863057|685304|P4|NOT COMPLETED|Period 3 (Weeks 11-15)||0
283603|NCT00863057|685305|P3|NOT COMPLETED|Period 3 (Weeks 11-15)||0
283604|NCT00863057|685306|P2|NOT COMPLETED|Period 3 (Weeks 11-15)||0
283605|NCT00863057|685307|P1|NOT COMPLETED|Period 3 (Weeks 11-15)||0
283606|NCT00863057|685304|P4|COMPLETED|Period 3 (Weeks 11-15)||2
283607|NCT00863057|685305|P3|COMPLETED|Period 3 (Weeks 11-15)||2
283608|NCT00863057|685306|P2|COMPLETED|Period 3 (Weeks 11-15)||1
283609|NCT00863057|685307|P1|COMPLETED|Period 3 (Weeks 11-15)||3
283610|NCT00863057|685304|P4|STARTED|Period 3 (Weeks 11-15)||2
283611|NCT00863057|685305|P3|STARTED|Period 3 (Weeks 11-15)||2
283612|NCT00863057|685306|P2|STARTED|Period 3 (Weeks 11-15)||1
283613|NCT00863057|685307|P1|STARTED|Period 3 (Weeks 11-15)||3
283614|NCT00863057|685304|P4|NOT COMPLETED|Period 2 (Weeks 6-10)||1
283615|NCT00863057|685305|P3|NOT COMPLETED|Period 2 (Weeks 6-10)||1
283616|NCT00863057|685306|P2|NOT COMPLETED|Period 2 (Weeks 6-10)||1
283617|NCT00863057|685307|P1|NOT COMPLETED|Period 2 (Weeks 6-10)||0
283618|NCT00863057|685304|P4|COMPLETED|Period 2 (Weeks 6-10)||2
283619|NCT00863057|685305|P3|COMPLETED|Period 2 (Weeks 6-10)||2
283620|NCT00863057|685306|P2|COMPLETED|Period 2 (Weeks 6-10)||1
283621|NCT00863057|685307|P1|COMPLETED|Period 2 (Weeks 6-10)||3
283622|NCT00863057|685304|P4|STARTED|Period 2 (Weeks 6-10)||3
283623|NCT00863057|685305|P3|STARTED|Period 2 (Weeks 6-10)||3
283624|NCT00863057|685306|P2|STARTED|Period 2 (Weeks 6-10)||2
283625|NCT00863057|685307|P1|STARTED|Period 2 (Weeks 6-10)||3
283626|NCT00863057|685304|P4|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
283627|NCT00863057|685305|P3|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||0
283628|NCT00863057|685306|P2|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||2
283629|NCT00863057|685307|P1|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
283630|NCT00863057|685304|P4|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
283631|NCT00863057|685305|P3|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
283632|NCT00863057|685306|P2|COMPLETED|Milestones Period 1 (Weeks 0-5)||2
283633|NCT00863057|685307|P1|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
283634|NCT00863057|685304|P4|STARTED|Milestones Period 1 (Weeks 0-5)||4
283635|NCT00863057|685305|P3|STARTED|Milestones Period 1 (Weeks 0-5)||3
283636|NCT00863057|685306|P2|STARTED|Milestones Period 1 (Weeks 0-5)||4
283637|NCT00863057|685307|P1|STARTED|Milestones Period 1 (Weeks 0-5)||4
283638|NCT00862979|685365|P2|NOT COMPLETED|Overall Study||7
283639|NCT00862979|685366|P1|NOT COMPLETED|Overall Study||8
283640|NCT00862979|685365|P2|COMPLETED|Overall Study||71
283641|NCT00862979|685366|P1|COMPLETED|Overall Study||76
283642|NCT00862979|685365|P2|Full Analysis Set (FAS)|Overall Study||71
283643|NCT00862979|685366|P1|Full Analysis Set (FAS)|Overall Study||74
283644|NCT00862979|685365|P2|STARTED|Overall Study||78
283645|NCT00862979|685366|P1|STARTED|Overall Study||84
283646|NCT00862940|685384|P2|NOT COMPLETED|Overall Study||30
283647|NCT00862940|685385|P1|NOT COMPLETED|Overall Study||30
283648|NCT00862940|685384|P2|COMPLETED|Overall Study||114
283649|NCT00862940|685385|P1|COMPLETED|Overall Study||103
283650|NCT00862940|685384|P2|STARTED|Overall Study||144
283651|NCT00862940|685385|P1|STARTED|Overall Study||133
283652|NCT00862849|685397|P6|NOT COMPLETED|Intervention 6||0
283653|NCT00862849|685398|P5|NOT COMPLETED|Intervention 6||0
283654|NCT00862849|685399|P4|NOT COMPLETED|Intervention 6||0
283655|NCT00862849|685400|P3|NOT COMPLETED|Intervention 6||0
283656|NCT00862849|685401|P2|NOT COMPLETED|Intervention 6||0
283657|NCT00862849|685402|P1|NOT COMPLETED|Intervention 6||0
283658|NCT00862849|685397|P6|COMPLETED|Intervention 6||3
283659|NCT00862849|685398|P5|COMPLETED|Intervention 6||4
283660|NCT00862849|685399|P4|COMPLETED|Intervention 6||4
283661|NCT00862849|685400|P3|COMPLETED|Intervention 6||3
283662|NCT00862849|685401|P2|COMPLETED|Intervention 6||3
283663|NCT00862849|685402|P1|COMPLETED|Intervention 6||3
283664|NCT00862849|685397|P6|STARTED|Intervention 6||3
283665|NCT00862849|685398|P5|STARTED|Intervention 6||4
283666|NCT00862849|685399|P4|STARTED|Intervention 6||4
283667|NCT00862849|685400|P3|STARTED|Intervention 6||3
283668|NCT00862849|685401|P2|STARTED|Intervention 6||3
283669|NCT00862849|685402|P1|STARTED|Intervention 6||3
283670|NCT00862849|685397|P6|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
283671|NCT00862849|685398|P5|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
283672|NCT00862849|685399|P4|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
283673|NCT00862849|685400|P3|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
283674|NCT00862849|685401|P2|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
283675|NCT00862849|685402|P1|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
283676|NCT00862849|685397|P6|COMPLETED|Washout 5 (3 to 14 Days)||3
283677|NCT00862849|685398|P5|COMPLETED|Washout 5 (3 to 14 Days)||4
283678|NCT00862849|685399|P4|COMPLETED|Washout 5 (3 to 14 Days)||4
283679|NCT00862849|685400|P3|COMPLETED|Washout 5 (3 to 14 Days)||3
283680|NCT00862849|685401|P2|COMPLETED|Washout 5 (3 to 14 Days)||3
283681|NCT00862849|685402|P1|COMPLETED|Washout 5 (3 to 14 Days)||3
283682|NCT00862849|685397|P6|STARTED|Washout 5 (3 to 14 Days)||3
283683|NCT00862849|685398|P5|STARTED|Washout 5 (3 to 14 Days)||4
283684|NCT00862849|685399|P4|STARTED|Washout 5 (3 to 14 Days)||4
283685|NCT00862849|685400|P3|STARTED|Washout 5 (3 to 14 Days)||3
283686|NCT00862849|685401|P2|STARTED|Washout 5 (3 to 14 Days)||3
283687|NCT00862849|685402|P1|STARTED|Washout 5 (3 to 14 Days)||3
283688|NCT00862849|685397|P6|NOT COMPLETED|Intervention 5||0
283689|NCT00862849|685398|P5|NOT COMPLETED|Intervention 5||0
283690|NCT00862849|685399|P4|NOT COMPLETED|Intervention 5||0
283691|NCT00862849|685400|P3|NOT COMPLETED|Intervention 5||0
283692|NCT00862849|685401|P2|NOT COMPLETED|Intervention 5||0
283693|NCT00862849|685402|P1|NOT COMPLETED|Intervention 5||0
283694|NCT00862849|685397|P6|COMPLETED|Intervention 5||3
283695|NCT00862849|685398|P5|COMPLETED|Intervention 5||4
283696|NCT00862849|685399|P4|COMPLETED|Intervention 5||4
283697|NCT00862849|685400|P3|COMPLETED|Intervention 5||3
283698|NCT00862849|685401|P2|COMPLETED|Intervention 5||3
283699|NCT00862849|685402|P1|COMPLETED|Intervention 5||3
283700|NCT00862849|685397|P6|STARTED|Intervention 5||3
283701|NCT00862849|685398|P5|STARTED|Intervention 5||4
283702|NCT00862849|685399|P4|STARTED|Intervention 5||4
283703|NCT00862849|685400|P3|STARTED|Intervention 5||3
283704|NCT00862849|685401|P2|STARTED|Intervention 5||3
283705|NCT00862849|685402|P1|STARTED|Intervention 5||3
283706|NCT00862849|685397|P6|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
283707|NCT00862849|685398|P5|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
283708|NCT00862849|685399|P4|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
283709|NCT00862849|685400|P3|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
283710|NCT00862849|685401|P2|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
283711|NCT00862849|685402|P1|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
283712|NCT00862849|685397|P6|COMPLETED|Washout 4 (3 to 14 Days)||3
283713|NCT00862849|685398|P5|COMPLETED|Washout 4 (3 to 14 Days)||4
283714|NCT00862849|685399|P4|COMPLETED|Washout 4 (3 to 14 Days)||4
283715|NCT00862849|685400|P3|COMPLETED|Washout 4 (3 to 14 Days)||3
283716|NCT00862849|685401|P2|COMPLETED|Washout 4 (3 to 14 Days)||3
283717|NCT00862849|685402|P1|COMPLETED|Washout 4 (3 to 14 Days)||3
283718|NCT00862849|685397|P6|STARTED|Washout 4 (3 to 14 Days)||3
283719|NCT00862849|685398|P5|STARTED|Washout 4 (3 to 14 Days)||4
283720|NCT00862849|685399|P4|STARTED|Washout 4 (3 to 14 Days)||4
283721|NCT00862849|685400|P3|STARTED|Washout 4 (3 to 14 Days)||3
283722|NCT00862849|685401|P2|STARTED|Washout 4 (3 to 14 Days)||3
283723|NCT00862849|685402|P1|STARTED|Washout 4 (3 to 14 Days)||3
283724|NCT00862849|685397|P6|NOT COMPLETED|Intervention 4||0
283725|NCT00862849|685398|P5|NOT COMPLETED|Intervention 4||0
283726|NCT00862849|685399|P4|NOT COMPLETED|Intervention 4||0
283727|NCT00862849|685400|P3|NOT COMPLETED|Intervention 4||0
283728|NCT00862849|685401|P2|NOT COMPLETED|Intervention 4||0
283729|NCT00862849|685402|P1|NOT COMPLETED|Intervention 4||0
283730|NCT00862849|685397|P6|COMPLETED|Intervention 4||3
283731|NCT00862849|685398|P5|COMPLETED|Intervention 4||4
283732|NCT00862849|685399|P4|COMPLETED|Intervention 4||4
283733|NCT00862849|685400|P3|COMPLETED|Intervention 4||3
283734|NCT00862849|685401|P2|COMPLETED|Intervention 4||3
283735|NCT00862849|685402|P1|COMPLETED|Intervention 4||3
283736|NCT00862849|685397|P6|STARTED|Intervention 4||3
283737|NCT00862849|685398|P5|STARTED|Intervention 4||4
283738|NCT00862849|685399|P4|STARTED|Intervention 4||4
283739|NCT00862849|685400|P3|STARTED|Intervention 4||3
283740|NCT00862849|685401|P2|STARTED|Intervention 4||3
283741|NCT00862849|685402|P1|STARTED|Intervention 4||3
283742|NCT00862849|685397|P6|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
283743|NCT00862849|685398|P5|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
283744|NCT00862849|685399|P4|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
283745|NCT00862849|685400|P3|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
283746|NCT00862849|685401|P2|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
283747|NCT00862849|685402|P1|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
283748|NCT00862849|685397|P6|COMPLETED|Washout 3 (3 to 14 Days)||3
283749|NCT00862849|685398|P5|COMPLETED|Washout 3 (3 to 14 Days)||4
283750|NCT00862849|685399|P4|COMPLETED|Washout 3 (3 to 14 Days)||4
283751|NCT00862849|685400|P3|COMPLETED|Washout 3 (3 to 14 Days)||3
283752|NCT00862849|685401|P2|COMPLETED|Washout 3 (3 to 14 Days)||3
283753|NCT00862849|685402|P1|COMPLETED|Washout 3 (3 to 14 Days)||3
283754|NCT00862849|685397|P6|STARTED|Washout 3 (3 to 14 Days)||3
283755|NCT00862849|685398|P5|STARTED|Washout 3 (3 to 14 Days)||4
283756|NCT00862849|685399|P4|STARTED|Washout 3 (3 to 14 Days)||4
283757|NCT00862849|685400|P3|STARTED|Washout 3 (3 to 14 Days)||3
283758|NCT00862849|685401|P2|STARTED|Washout 3 (3 to 14 Days)||3
283759|NCT00862849|685402|P1|STARTED|Washout 3 (3 to 14 Days)||3
283760|NCT00862849|685397|P6|NOT COMPLETED|Intervention 3||0
283761|NCT00862849|685398|P5|NOT COMPLETED|Intervention 3||0
283762|NCT00862849|685399|P4|NOT COMPLETED|Intervention 3||0
283763|NCT00862849|685400|P3|NOT COMPLETED|Intervention 3||0
283764|NCT00862849|685401|P2|NOT COMPLETED|Intervention 3||0
283765|NCT00862849|685402|P1|NOT COMPLETED|Intervention 3||0
283766|NCT00862849|685397|P6|COMPLETED|Intervention 3||3
283767|NCT00862849|685398|P5|COMPLETED|Intervention 3||4
283768|NCT00862849|685399|P4|COMPLETED|Intervention 3||4
283769|NCT00862849|685400|P3|COMPLETED|Intervention 3||3
283770|NCT00862849|685401|P2|COMPLETED|Intervention 3||3
283771|NCT00862849|685402|P1|COMPLETED|Intervention 3||3
283772|NCT00862849|685397|P6|STARTED|Intervention 3||3
283773|NCT00862849|685398|P5|STARTED|Intervention 3||4
283774|NCT00862849|685399|P4|STARTED|Intervention 3||4
283775|NCT00862849|685400|P3|STARTED|Intervention 3||3
283776|NCT00862849|685401|P2|STARTED|Intervention 3||3
283777|NCT00862849|685402|P1|STARTED|Intervention 3||3
283778|NCT00862849|685397|P6|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
283779|NCT00862849|685398|P5|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
283780|NCT00862849|685399|P4|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
283781|NCT00862849|685400|P3|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
283782|NCT00862849|685401|P2|NOT COMPLETED|Washout 2 (3 to 14 Days)||1
283783|NCT00862849|685402|P1|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
283784|NCT00862849|685397|P6|COMPLETED|Washout 2 (3 to 14 Days)||3
283785|NCT00862849|685398|P5|COMPLETED|Washout 2 (3 to 14 Days)||4
283786|NCT00862849|685399|P4|COMPLETED|Washout 2 (3 to 14 Days)||4
283787|NCT00862849|685400|P3|COMPLETED|Washout 2 (3 to 14 Days)||3
283788|NCT00862849|685401|P2|COMPLETED|Washout 2 (3 to 14 Days)||3
283789|NCT00862849|685402|P1|COMPLETED|Washout 2 (3 to 14 Days)||3
283790|NCT00862849|685397|P6|STARTED|Washout 2 (3 to 14 Days)||3
283791|NCT00862849|685398|P5|STARTED|Washout 2 (3 to 14 Days)||4
283792|NCT00862849|685399|P4|STARTED|Washout 2 (3 to 14 Days)||4
283793|NCT00862849|685400|P3|STARTED|Washout 2 (3 to 14 Days)||3
283794|NCT00862849|685401|P2|STARTED|Washout 2 (3 to 14 Days)||4
283795|NCT00862849|685402|P1|STARTED|Washout 2 (3 to 14 Days)||3
283796|NCT00862849|685397|P6|NOT COMPLETED|Intervention 2||0
283797|NCT00862849|685398|P5|NOT COMPLETED|Intervention 2||0
283798|NCT00862849|685399|P4|NOT COMPLETED|Intervention 2||0
283799|NCT00862849|685400|P3|NOT COMPLETED|Intervention 2||0
283800|NCT00862849|685401|P2|NOT COMPLETED|Intervention 2||0
283801|NCT00862849|685402|P1|NOT COMPLETED|Intervention 2||0
283802|NCT00862849|685397|P6|COMPLETED|Intervention 2||3
283803|NCT00862849|685398|P5|COMPLETED|Intervention 2||4
283804|NCT00862849|685399|P4|COMPLETED|Intervention 2||4
283805|NCT00862849|685400|P3|COMPLETED|Intervention 2||3
283806|NCT00862849|685401|P2|COMPLETED|Intervention 2||4
283807|NCT00862849|685402|P1|COMPLETED|Intervention 2||3
283808|NCT00862849|685397|P6|STARTED|Intervention 2||3
283809|NCT00862849|685398|P5|STARTED|Intervention 2||4
283810|NCT00862849|685399|P4|STARTED|Intervention 2||4
283811|NCT00862849|685400|P3|STARTED|Intervention 2||3
283812|NCT00862849|685401|P2|STARTED|Intervention 2||4
283813|NCT00862849|685402|P1|STARTED|Intervention 2||3
283814|NCT00862849|685397|P6|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
283815|NCT00862849|685398|P5|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
283816|NCT00862849|685399|P4|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
283817|NCT00862849|685400|P3|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
283818|NCT00862849|685401|P2|NOT COMPLETED|Washout 1 (3 to 14 Days)||1
283819|NCT00862849|685402|P1|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
283820|NCT00862849|685397|P6|COMPLETED|Washout 1 (3 to 14 Days)||3
283821|NCT00862849|685398|P5|COMPLETED|Washout 1 (3 to 14 Days)||4
283822|NCT00862849|685399|P4|COMPLETED|Washout 1 (3 to 14 Days)||4
283823|NCT00862849|685400|P3|COMPLETED|Washout 1 (3 to 14 Days)||3
283824|NCT00862849|685401|P2|COMPLETED|Washout 1 (3 to 14 Days)||4
283825|NCT00862849|685402|P1|COMPLETED|Washout 1 (3 to 14 Days)||3
283826|NCT00862849|685397|P6|STARTED|Washout 1 (3 to 14 Days)||3
283827|NCT00862849|685398|P5|STARTED|Washout 1 (3 to 14 Days)||4
283828|NCT00862849|685399|P4|STARTED|Washout 1 (3 to 14 Days)||4
283829|NCT00862849|685400|P3|STARTED|Washout 1 (3 to 14 Days)||3
283830|NCT00862849|685401|P2|STARTED|Washout 1 (3 to 14 Days)||5
283831|NCT00862849|685402|P1|STARTED|Washout 1 (3 to 14 Days)||3
283832|NCT00862849|685397|P6|NOT COMPLETED|Intervention 1||0
283833|NCT00862849|685398|P5|NOT COMPLETED|Intervention 1||0
283834|NCT00862849|685399|P4|NOT COMPLETED|Intervention 1||0
283835|NCT00862849|685400|P3|NOT COMPLETED|Intervention 1||0
283836|NCT00862849|685401|P2|NOT COMPLETED|Intervention 1||0
283837|NCT00862849|685402|P1|NOT COMPLETED|Intervention 1||0
283838|NCT00862849|685397|P6|COMPLETED|Intervention 1||3
283839|NCT00862849|685398|P5|COMPLETED|Intervention 1||4
283840|NCT00862849|685399|P4|COMPLETED|Intervention 1||4
283841|NCT00862849|685400|P3|COMPLETED|Intervention 1||3
283842|NCT00862849|685401|P2|COMPLETED|Intervention 1||5
283843|NCT00862849|685402|P1|COMPLETED|Intervention 1||3
283844|NCT00862849|685397|P6|Received at Least One Dose of Study Drug|Intervention 1||3
283845|NCT00862849|685398|P5|Received at Least One Dose of Study Drug|Intervention 1||4
283846|NCT00862849|685399|P4|Received at Least One Dose of Study Drug|Intervention 1||4
283847|NCT00862849|685400|P3|Received at Least One Dose of Study Drug|Intervention 1||3
283848|NCT00862849|685401|P2|Received at Least One Dose of Study Drug|Intervention 1||5
283849|NCT00862849|685402|P1|Received at Least One Dose of Study Drug|Intervention 1||3
283850|NCT00862849|685397|P6|STARTED|Intervention 1||3
283851|NCT00862849|685398|P5|STARTED|Intervention 1||4
283852|NCT00862849|685399|P4|STARTED|Intervention 1||4
283853|NCT00862849|685400|P3|STARTED|Intervention 1||3
283854|NCT00862849|685401|P2|STARTED|Intervention 1||5
283855|NCT00862849|685402|P1|STARTED|Intervention 1||3
283856|NCT00862836|685425|P1|NOT COMPLETED|Overall Study||1
283857|NCT00862836|685425|P1|COMPLETED|Overall Study||14
283858|NCT00862836|685425|P1|Evaluable for Activity (Tumour Response)|Overall Study||10
283859|NCT00862836|685425|P1|Evaluable for Safety/Toxicity|Overall Study|1 patient withdrew consent before first cycle|14
283860|NCT00862836|685425|P1|STARTED|Overall Study||15
283861|NCT00862823|685436|P2|NOT COMPLETED|Second Intervention||0
283862|NCT00862823|685437|P1|NOT COMPLETED|Second Intervention||0
283863|NCT00862823|685436|P2|COMPLETED|Second Intervention||9
283864|NCT00862823|685437|P1|COMPLETED|Second Intervention||5
283865|NCT00862823|685436|P2|STARTED|Second Intervention||9
283866|NCT00862823|685437|P1|STARTED|Second Intervention||5
283867|NCT00862823|685436|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
283868|NCT00862823|685437|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
283869|NCT00862823|685436|P2|COMPLETED|Washout Period of 2 Weeks||9
283870|NCT00862823|685437|P1|COMPLETED|Washout Period of 2 Weeks||5
283871|NCT00862823|685436|P2|STARTED|Washout Period of 2 Weeks||9
283872|NCT00862823|685437|P1|STARTED|Washout Period of 2 Weeks||5
283873|NCT00862823|685436|P2|NOT COMPLETED|First Intervention||1
283874|NCT00862823|685437|P1|NOT COMPLETED|First Intervention||1
283875|NCT00862823|685436|P2|COMPLETED|First Intervention||9
283876|NCT00862823|685437|P1|COMPLETED|First Intervention||5
283877|NCT00862823|685436|P2|STARTED|First Intervention||10
283878|NCT00862823|685437|P1|STARTED|First Intervention||6
283879|NCT00862810|685446|P2|NOT COMPLETED|Overall Study||4
283880|NCT00862810|685447|P1|NOT COMPLETED|Overall Study||4
283881|NCT00862810|685446|P2|COMPLETED|Overall Study||35
283882|NCT00862810|685447|P1|COMPLETED|Overall Study||29
283883|NCT00862810|685446|P2|STARTED|Overall Study||39
283884|NCT00862810|685447|P1|STARTED|Overall Study||33
283885|NCT00862784|685453|P1|NOT COMPLETED|Overall Study||0
283886|NCT00862784|685453|P1|COMPLETED|Overall Study||48
283887|NCT00862784|685453|P1|Received Any Amount of Study Drug|Overall Study||48
283888|NCT00862784|685453|P1|STARTED|Overall Study||48
283889|NCT00862745|685475|P2|NOT COMPLETED|Open-label Follow-up||49
283890|NCT00862745|685476|P1|NOT COMPLETED|Open-label Follow-up||39
283891|NCT00862745|685475|P2|COMPLETED|Open-label Follow-up||225
283892|NCT00862745|685476|P1|COMPLETED|Open-label Follow-up||229
283893|NCT00862745|685475|P2|STARTED|Open-label Follow-up|10 participants elected not to enter the open-label portion of the study after completing the RCT.|274
283894|NCT00862745|685476|P1|STARTED|Open-label Follow-up|19 participants elected not to enter the open-label portion of the study after completing the RCT.|268
283895|NCT00862745|685475|P2|NOT COMPLETED|Randomized Control Trial||39
283896|NCT00862745|685476|P1|NOT COMPLETED|Randomized Control Trial||38
283897|NCT00862745|685475|P2|COMPLETED|Randomized Control Trial||284
283898|NCT00862745|685476|P1|COMPLETED|Randomized Control Trial||284
283899|NCT00862745|685475|P2|STARTED|Randomized Control Trial||323
283900|NCT00862745|685476|P1|STARTED|Randomized Control Trial||322
283901|NCT00862719|685486|P4|NOT COMPLETED|Overall Study||1
283902|NCT00862719|685487|P3|NOT COMPLETED|Overall Study||4
283903|NCT00862719|685488|P2|NOT COMPLETED|Overall Study||6
283904|NCT00862719|685489|P1|NOT COMPLETED|Overall Study||10
283905|NCT00862719|685486|P4|COMPLETED|Overall Study||0
283906|NCT00862719|685487|P3|COMPLETED|Overall Study||0
283907|NCT00862719|685488|P2|COMPLETED|Overall Study||1
283908|NCT00862719|685489|P1|COMPLETED|Overall Study||7
283909|NCT00862719|685486|P4|STARTED|Overall Study||1
283910|NCT00862719|685487|P3|STARTED|Overall Study||4
283911|NCT00862719|685488|P2|STARTED|Overall Study||7
283912|NCT00862719|685489|P1|STARTED|Overall Study||17
283913|NCT00862654|685512|P4|NOT COMPLETED|Overall Study||6
283914|NCT00862654|685513|P3|NOT COMPLETED|Overall Study||6
283915|NCT00862654|685514|P2|NOT COMPLETED|Overall Study||8
283916|NCT00862654|685515|P1|NOT COMPLETED|Overall Study||6
283917|NCT00862654|685512|P4|COMPLETED|Overall Study||74
283918|NCT00862654|685513|P3|COMPLETED|Overall Study||76
283919|NCT00862654|685514|P2|COMPLETED|Overall Study||74
283920|NCT00862654|685515|P1|COMPLETED|Overall Study||76
283921|NCT00862654|685512|P4|STARTED|Overall Study||80
283922|NCT00862654|685513|P3|STARTED|Overall Study||82
283923|NCT00862654|685514|P2|STARTED|Overall Study||82
283924|NCT00862654|685515|P1|STARTED|Overall Study||82
283925|NCT00862641|685529|P4|NOT COMPLETED|Overall Study||4
283926|NCT00862641|685530|P3|NOT COMPLETED|Overall Study||1
283927|NCT00862641|685531|P2|NOT COMPLETED|Overall Study||4
283928|NCT00862641|685532|P1|NOT COMPLETED|Overall Study||1
283929|NCT00862641|685529|P4|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|316
283930|NCT00862641|685530|P3|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|151
283931|NCT00862641|685531|P2|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|356
283932|NCT00862641|685532|P1|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|176
283933|NCT00862641|685529|P4|STARTED|Overall Study||320
283934|NCT00862641|685530|P3|STARTED|Overall Study||152
283935|NCT00862641|685531|P2|STARTED|Overall Study||360
283936|NCT00862641|685532|P1|STARTED|Overall Study||177
283937|NCT00862563|685578|P4|NOT COMPLETED|Overall Study||5
283938|NCT00862563|685579|P3|NOT COMPLETED|Overall Study||6
283939|NCT00862563|685580|P2|NOT COMPLETED|Overall Study||4
283940|NCT00862563|685581|P1|NOT COMPLETED|Overall Study||4
283941|NCT00862563|685578|P4|COMPLETED|Overall Study||19
283942|NCT00862563|685579|P3|COMPLETED|Overall Study||15
283943|NCT00862563|685580|P2|COMPLETED|Overall Study||17
283944|NCT00862563|685581|P1|COMPLETED|Overall Study||15
283945|NCT00862563|685578|P4|STARTED|Overall Study||24
283946|NCT00862563|685579|P3|STARTED|Overall Study||21
283947|NCT00862563|685580|P2|STARTED|Overall Study||21
283948|NCT00862563|685581|P1|STARTED|Overall Study||19
283949|NCT00862537|685619|P1|NOT COMPLETED|Overall Study||7
283950|NCT00862537|685619|P1|COMPLETED|Overall Study||11
283951|NCT00862537|685619|P1|STARTED|Overall Study||18
283952|NCT00862459|685626|P3|NOT COMPLETED|Overall Study||6
283953|NCT00862459|685627|P2|NOT COMPLETED|Overall Study||8
283954|NCT00862459|685628|P1|NOT COMPLETED|Overall Study||6
283955|NCT00862459|685626|P3|COMPLETED|Overall Study||66
283956|NCT00862459|685627|P2|COMPLETED|Overall Study||85
283957|NCT00862459|685628|P1|COMPLETED|Overall Study||66
283958|NCT00862459|685626|P3|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 68 received Gadobutrol and 69 received OptiMARK|69
283959|NCT00862459|685627|P2|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 90 received Gadobutrol and 88 received OptiMARK|90
283960|NCT00862459|685628|P1|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 67 received Gadobutrol and 70 received OptiMARK|70
283961|NCT00862459|685626|P3|STARTED|Overall Study||72
283962|NCT00862459|685627|P2|STARTED|Overall Study||93
283963|NCT00862459|685628|P1|STARTED|Overall Study||72
283964|NCT00862277|685775|P3|NOT COMPLETED|Overall Study||5
283965|NCT00862277|685776|P2|NOT COMPLETED|Overall Study||2
283966|NCT00862277|685777|P1|NOT COMPLETED|Overall Study||1
283967|NCT00862277|685775|P3|COMPLETED|Overall Study||100
283968|NCT00862277|685776|P2|COMPLETED|Overall Study||94
283969|NCT00862277|685777|P1|COMPLETED|Overall Study||560
283970|NCT00862277|685775|P3|STARTED|Overall Study||105
283971|NCT00862277|685776|P2|STARTED|Overall Study||96
283972|NCT00862277|685777|P1|STARTED|Overall Study||561
283973|NCT00862251|685791|P3|NOT COMPLETED|Overall Study||9
283974|NCT00862251|685792|P2|NOT COMPLETED|Overall Study||5
283975|NCT00862251|685793|P1|NOT COMPLETED|Overall Study||19
283976|NCT00862251|685791|P3|COMPLETED|Overall Study||315
283977|NCT00862251|685792|P2|COMPLETED|Overall Study||157
283978|NCT00862251|685793|P1|COMPLETED|Overall Study||303
283979|NCT00862251|685791|P3|STARTED|Overall Study||324
283980|NCT00862251|685792|P2|STARTED|Overall Study||162
283981|NCT00862251|685793|P1|STARTED|Overall Study||322
283982|NCT00862186|685846|P1|NOT COMPLETED|Overall Study||0
283983|NCT00862186|685846|P1|COMPLETED|Overall Study||15
283984|NCT00862186|685846|P1|STARTED|Overall Study||15
283985|NCT00862134|685853|P2|NOT COMPLETED|Overall Study||12
283986|NCT00862134|685854|P1|NOT COMPLETED|Overall Study||11
283987|NCT00862134|685853|P2|COMPLETED|Overall Study||11
283988|NCT00862134|685854|P1|COMPLETED|Overall Study||8
283989|NCT00862134|685853|P2|STARTED|Overall Study||23
283990|NCT00862134|685854|P1|STARTED|Overall Study||19
283991|NCT00862121|685866|P2|NOT COMPLETED|Overall Study||8
283992|NCT00862121|685867|P1|NOT COMPLETED|Overall Study||1
283993|NCT00862121|685866|P2|COMPLETED|Overall Study||4
283994|NCT00862121|685867|P1|COMPLETED|Overall Study||7
283995|NCT00862121|685866|P2|Safety Analysis Set|Overall Study||11
283996|NCT00862121|685867|P1|Safety Analysis Set|Overall Study|The participant with no evaluable post-baseline CDAI score was included in the Safety Analysis Set.|8
283997|NCT00862121|685866|P2|Full Analysis Set (FAS)|Overall Study|One participant randomised in error (no IMP taken).|11
283998|NCT00862121|685867|P1|Full Analysis Set (FAS)|Overall Study|One participant had no evaluable post-baseline CDAI score.|7
283999|NCT00862121|685866|P2|STARTED|Overall Study|Randomised, intent-to-treat (ITT)|12
284000|NCT00862121|685867|P1|STARTED|Overall Study||8
284001|NCT00862082|685885|P2|NOT COMPLETED|Overall Study||1
284002|NCT00862082|685886|P1|NOT COMPLETED|Overall Study||5
284003|NCT00862082|685885|P2|COMPLETED|Overall Study||5
284004|NCT00862082|685886|P1|COMPLETED|Overall Study||3
284005|NCT00862082|685885|P2|STARTED|Overall Study||6
284006|NCT00862082|685886|P1|STARTED|Overall Study||8
284007|NCT00861913|685929|P1|NOT COMPLETED|Overall Study||0
284008|NCT00861913|685929|P1|COMPLETED|Overall Study||13
284009|NCT00861913|685929|P1|STARTED|Overall Study||13
284010|NCT00861757|685941|P4|NOT COMPLETED|Overall Study||9
284011|NCT00861757|685942|P3|NOT COMPLETED|Overall Study||18
284012|NCT00861757|685943|P2|NOT COMPLETED|Overall Study||15
284013|NCT00861757|685944|P1|NOT COMPLETED|Overall Study||9
284014|NCT00861757|685941|P4|COMPLETED|Overall Study||143
284015|NCT00861757|685942|P3|COMPLETED|Overall Study||137
284016|NCT00861757|685943|P2|COMPLETED|Overall Study||136
284017|NCT00861757|685944|P1|COMPLETED|Overall Study||145
284018|NCT00861757|685941|P4|STARTED|Overall Study||152
284019|NCT00861757|685942|P3|STARTED|Overall Study||155
284020|NCT00861757|685943|P2|STARTED|Overall Study||151
284021|NCT00861757|685944|P1|STARTED|Overall Study||154
284022|NCT00861744|686002|P4|NOT COMPLETED|Overall Study||33
284023|NCT00861744|686003|P3|NOT COMPLETED|Overall Study||24
284024|NCT00861744|686004|P2|NOT COMPLETED|Overall Study||29
284025|NCT00861744|686005|P1|NOT COMPLETED|Overall Study||17
284026|NCT00861744|686002|P4|COMPLETED|Overall Study||275
284027|NCT00861744|686003|P3|COMPLETED|Overall Study||280
284028|NCT00861744|686004|P2|COMPLETED|Overall Study||275
284029|NCT00861744|686005|P1|COMPLETED|Overall Study||287
284030|NCT00861744|686002|P4|STARTED|Overall Study||308
284031|NCT00861744|686003|P3|STARTED|Overall Study||304
284032|NCT00861744|686004|P2|STARTED|Overall Study||304
284033|NCT00861744|686005|P1|STARTED|Overall Study||304
284034|NCT00861705|686187|P4|NOT COMPLETED|Overall Study||1
284035|NCT00861705|686188|P3|NOT COMPLETED|Overall Study||0
284036|NCT00861705|686189|P2|NOT COMPLETED|Overall Study||3
284037|NCT00861705|686190|P1|NOT COMPLETED|Overall Study||7
284038|NCT00861705|686187|P4|COMPLETED|Overall Study||112
284039|NCT00861705|686188|P3|COMPLETED|Overall Study||113
284040|NCT00861705|686189|P2|COMPLETED|Overall Study||110
284041|NCT00861705|686190|P1|COMPLETED|Overall Study||108
284042|NCT00861705|686187|P4|STARTED|Overall Study||113
284043|NCT00861705|686188|P3|STARTED|Overall Study||113
284044|NCT00861705|686189|P2|STARTED|Overall Study||113
284045|NCT00861705|686190|P1|STARTED|Overall Study||115
284046|NCT00861692|686206|P1|NOT COMPLETED|Overall Study||6
284047|NCT00861692|686206|P1|COMPLETED|Overall Study||14
284048|NCT00861692|686206|P1|STARTED|Overall Study||20
284049|NCT00861614|686218|P2|NOT COMPLETED|Overall Study||368
284050|NCT00861614|686219|P1|NOT COMPLETED|Overall Study||371
284051|NCT00861614|686218|P2|COMPLETED|Overall Study||28
284052|NCT00861614|686219|P1|COMPLETED|Overall Study||22
284053|NCT00861614|686218|P2|STARTED|Overall Study||396
284054|NCT00861614|686219|P1|STARTED|Overall Study||393
284055|NCT00861601|686252|P3|NOT COMPLETED|Overall Study||0
284056|NCT00861601|686253|P2|NOT COMPLETED|Overall Study||0
284057|NCT00861601|686254|P1|NOT COMPLETED|Overall Study||0
284058|NCT00861601|686252|P3|COMPLETED|Overall Study||12
284059|NCT00861601|686253|P2|COMPLETED|Overall Study||14
284060|NCT00861601|686254|P1|COMPLETED|Overall Study||12
284061|NCT00861601|686252|P3|STARTED|Overall Study||12
284062|NCT00861601|686253|P2|STARTED|Overall Study||14
284063|NCT00861601|686254|P1|STARTED|Overall Study||12
284064|NCT00861471|686304|P1|NOT COMPLETED|Overall Study||9
284065|NCT00861471|686304|P1|COMPLETED|Overall Study||3
284066|NCT00861471|686304|P1|STARTED|Overall Study||12
284067|NCT00861341|686312|P1|NOT COMPLETED|Overall Study||2
284068|NCT00861341|686312|P1|COMPLETED|Overall Study||38
284069|NCT00861341|686312|P1|STARTED|Overall Study||40
284070|NCT00861263|686317|P1|NOT COMPLETED|Overall Study||0
284071|NCT00861263|686317|P1|COMPLETED|Overall Study||193
284072|NCT00861263|686317|P1|STARTED|Overall Study||193
284073|NCT00861198|686321|P1|NOT COMPLETED|Overall Study||5
284074|NCT00861198|686321|P1|COMPLETED|Overall Study||70
284075|NCT00861198|686321|P1|STARTED|Overall Study||75
284076|NCT00861146|686327|P2|NOT COMPLETED|Overall Study||8
284077|NCT00861146|686328|P1|NOT COMPLETED|Overall Study||20
284078|NCT00861146|686327|P2|COMPLETED|Overall Study||38
284079|NCT00861146|686328|P1|COMPLETED|Overall Study||85
284080|NCT00861146|686327|P2|Week 13 Assessment|Overall Study||38
284081|NCT00861146|686328|P1|Week 13 Assessment|Overall Study||85
284082|NCT00861146|686327|P2|Week 2 Assessment|Overall Study||45
284083|NCT00861146|686328|P1|Week 2 Assessment|Overall Study||97
284084|NCT00861146|686327|P2|STARTED|Overall Study||46
284085|NCT00861146|686328|P1|STARTED|Overall Study||105
284086|NCT00860951|686338|P1|NOT COMPLETED|Overall Study||7
284087|NCT00860951|686338|P1|COMPLETED|Overall Study||22
284088|NCT00860951|686338|P1|STARTED|Overall Study||29
284089|NCT00860938|686346|P2|NOT COMPLETED|Overall Study||8
284090|NCT00860938|686347|P1|NOT COMPLETED|Overall Study||14
284091|NCT00860938|686346|P2|COMPLETED|Overall Study||37
284092|NCT00860938|686347|P1|COMPLETED|Overall Study||31
284093|NCT00860938|686346|P2|STARTED|Overall Study||45
284094|NCT00860938|686347|P1|STARTED|Overall Study||45
284095|NCT00860847|686361|P2|NOT COMPLETED|Overall Study||5
284096|NCT00860847|686362|P1|NOT COMPLETED|Overall Study||4
284097|NCT00860847|686361|P2|COMPLETED|Overall Study||28
284098|NCT00860847|686362|P1|COMPLETED|Overall Study||28
284099|NCT00860847|686361|P2|STARTED|Overall Study||33
284100|NCT00860847|686362|P1|STARTED|Overall Study||32
284101|NCT00860795|686370|P2|NOT COMPLETED|Overall Study||0
284102|NCT00860795|686371|P1|NOT COMPLETED|Overall Study||0
284103|NCT00860795|686370|P2|COMPLETED|Overall Study||10
284104|NCT00860795|686371|P1|COMPLETED|Overall Study|One participant discontinued study medication on day 5, but completed safety evaluations|10
284105|NCT00860795|686370|P2|Number to Complete Study Medication|Overall Study||10
284106|NCT00860795|686371|P1|Number to Complete Study Medication|Overall Study||9
284107|NCT00860795|686370|P2|STARTED|Overall Study||10
284108|NCT00860795|686371|P1|STARTED|Overall Study||10
284109|NCT00860743|686395|P2|NOT COMPLETED|Overall Study||0
284110|NCT00860743|686396|P1|NOT COMPLETED|Overall Study||3
284111|NCT00860743|686395|P2|COMPLETED|Overall Study||23
284112|NCT00860743|686396|P1|COMPLETED|Overall Study||37
284113|NCT00860743|686395|P2|STARTED|Overall Study||23
284114|NCT00860743|686396|P1|STARTED|Overall Study||40
284115|NCT00860535|686402|P1|NOT COMPLETED|Overall Study||1
284116|NCT00860535|686402|P1|COMPLETED|Overall Study||8
284117|NCT00860535|686402|P1|DISCONTINUED|Overall Study|Participant did not meet inclusion criteria and did not complete the study.|1
284118|NCT00860535|686402|P1|STARTED|Overall Study||9
284119|NCT00860470|686409|P2|NOT COMPLETED|Overall Study||59
284120|NCT00860470|686410|P1|NOT COMPLETED|Overall Study||48
284121|NCT00860470|686409|P2|COMPLETED|Overall Study||22346
284122|NCT00860470|686410|P1|COMPLETED|Overall Study||22114
284123|NCT00860470|686409|P2|STARTED|Overall Study||22405
284124|NCT00860470|686410|P1|STARTED|Overall Study||22162
284125|NCT00860457|686434|P1|NOT COMPLETED|Overall Study||11
284126|NCT00860457|686434|P1|COMPLETED|Overall Study||11
284127|NCT00860457|686434|P1|STARTED|Overall Study||22
284128|NCT00860405|686440|P2|NOT COMPLETED|Overall Study||4
284129|NCT00860405|686441|P1|NOT COMPLETED|Overall Study||5
284130|NCT00860405|686440|P2|COMPLETED|Overall Study||26
284131|NCT00860405|686441|P1|COMPLETED|Overall Study|completed overall study|26
284132|NCT00860405|686440|P2|Day 28 Follow-up Performed|Overall Study||29
284133|NCT00860405|686441|P1|Day 28 Follow-up Performed|Overall Study||31
284134|NCT00860405|686440|P2|Completed Treatment|Overall Study||29
284135|NCT00860405|686441|P1|Completed Treatment|Overall Study||31
284136|NCT00860405|686440|P2|STARTED|Overall Study||30
284137|NCT00860405|686441|P1|STARTED|Overall Study||31
284138|NCT00860314|686465|P2|NOT COMPLETED|Overall Study||0
284139|NCT00860314|686466|P1|NOT COMPLETED|Overall Study||0
284140|NCT00860314|686465|P2|COMPLETED|Overall Study||48
284141|NCT00860314|686466|P1|COMPLETED|Overall Study||48
284142|NCT00860314|686465|P2|STARTED|Overall Study||48
284143|NCT00860314|686466|P1|STARTED|Overall Study||48
284144|NCT00860262|686481|P3|NOT COMPLETED|Overall Study||18
284145|NCT00860262|686482|P2|NOT COMPLETED|Overall Study||22
284146|NCT00860262|686483|P1|NOT COMPLETED|Overall Study||20
284147|NCT00860262|686481|P3|COMPLETED|Overall Study||202
284148|NCT00860262|686482|P2|COMPLETED|Overall Study||195
284149|NCT00860262|686483|P1|COMPLETED|Overall Study||401
284150|NCT00860262|686481|P3|STARTED|Overall Study||220
284151|NCT00860262|686482|P2|STARTED|Overall Study||217
284152|NCT00860262|686483|P1|STARTED|Overall Study||421
284153|NCT00860249|686596|P3|NOT COMPLETED|Overall Study||21
284154|NCT00860249|686597|P2|NOT COMPLETED|Overall Study||18
284155|NCT00860249|686598|P1|NOT COMPLETED|Overall Study||21
284156|NCT00860249|686596|P3|COMPLETED|Overall Study||0
284157|NCT00860249|686597|P2|COMPLETED|Overall Study||0
284158|NCT00860249|686598|P1|COMPLETED|Overall Study||0
284159|NCT00860249|686596|P3|STARTED|Overall Study||21
284160|NCT00860249|686597|P2|STARTED|Overall Study||18
284161|NCT00860249|686598|P1|STARTED|Overall Study||21
284162|NCT00860171|686609|P1|NOT COMPLETED|Overall Study||0
284163|NCT00860171|686609|P1|COMPLETED|Overall Study||16
284164|NCT00860171|686609|P1|STARTED|Overall Study||16
284165|NCT00860158|686618|P1|NOT COMPLETED|Overall Study||1
284166|NCT00860158|686618|P1|COMPLETED|Overall Study||0
284167|NCT00860158|686618|P1|STARTED|Overall Study||1
284168|NCT00860067|686630|P3|NOT COMPLETED|Overall Study||9
284169|NCT00860067|686631|P2|NOT COMPLETED|Overall Study||9
284170|NCT00860067|686632|P1|NOT COMPLETED|Overall Study||51
284171|NCT00860067|686630|P3|COMPLETED|Overall Study||292
284172|NCT00860067|686631|P2|COMPLETED|Overall Study||290
284173|NCT00860067|686632|P1|COMPLETED|Overall Study||1149
284174|NCT00860067|686630|P3|STARTED|Overall Study||301
284175|NCT00860067|686631|P2|STARTED|Overall Study||299
284176|NCT00860067|686632|P1|STARTED|Overall Study||1200
284177|NCT00860028|686692|P2|NOT COMPLETED|Smoking Cessation Phase||2
284178|NCT00860028|686693|P1|NOT COMPLETED|Smoking Cessation Phase||0
284179|NCT00860028|686692|P2|COMPLETED|Smoking Cessation Phase||12
284180|NCT00860028|686693|P1|COMPLETED|Smoking Cessation Phase||13
284181|NCT00860028|686692|P2|STARTED|Smoking Cessation Phase||14
284182|NCT00860028|686693|P1|STARTED|Smoking Cessation Phase||13
284183|NCT00860028|686692|P2|NOT COMPLETED|Placebo Controlled Pretreatment Period||1
284184|NCT00860028|686693|P1|NOT COMPLETED|Placebo Controlled Pretreatment Period||2
284185|NCT00860028|686692|P2|COMPLETED|Placebo Controlled Pretreatment Period||14
284186|NCT00860028|686693|P1|COMPLETED|Placebo Controlled Pretreatment Period||13
284187|NCT00860028|686692|P2|STARTED|Placebo Controlled Pretreatment Period||15
284188|NCT00860028|686693|P1|STARTED|Placebo Controlled Pretreatment Period||15
284189|NCT00859976|686705|P2|NOT COMPLETED|Overall Study||18
284190|NCT00859976|686706|P1|NOT COMPLETED|Overall Study||16
284191|NCT00859976|686705|P2|COMPLETED|Overall Study||67
284192|NCT00859976|686706|P1|COMPLETED|Overall Study||66
284193|NCT00859976|686705|P2|STARTED|Overall Study||85
284194|NCT00859976|686706|P1|STARTED|Overall Study||82
284195|NCT00859950|686722|P2|NOT COMPLETED|Overall Study||0
284196|NCT00859950|686723|P1|NOT COMPLETED|Overall Study||0
284197|NCT00859950|686722|P2|COMPLETED|Overall Study||21
284198|NCT00859950|686723|P1|COMPLETED|Overall Study||49
284199|NCT00859950|686722|P2|STARTED|Overall Study||21
284200|NCT00859950|686723|P1|STARTED|Overall Study||49
284201|NCT00859937|686731|P2|NOT COMPLETED|Overall Study||0
284202|NCT00859937|686732|P1|NOT COMPLETED|Overall Study||1
284203|NCT00859937|686731|P2|COMPLETED|Overall Study||14
284204|NCT00859937|686732|P1|COMPLETED|Overall Study||40
284205|NCT00859937|686731|P2|STARTED|Overall Study||14
284206|NCT00859937|686732|P1|STARTED|Overall Study||41
284207|NCT00859898|686747|P3|NOT COMPLETED|Overall Study||27
284208|NCT00859898|686748|P2|NOT COMPLETED|Overall Study||31
284209|NCT00859898|686749|P1|NOT COMPLETED|Overall Study||28
284210|NCT00859898|686747|P3|COMPLETED|Overall Study||181
284211|NCT00859898|686748|P2|COMPLETED|Overall Study||188
284212|NCT00859898|686749|P1|COMPLETED|Overall Study||183
284213|NCT00859898|686747|P3|STARTED|Overall Study||208
284214|NCT00859898|686748|P2|STARTED|Overall Study||219
284215|NCT00859898|686749|P1|STARTED|Overall Study||211
284216|NCT00859833|686790|P1|NOT COMPLETED|Overall Study||0
284217|NCT00859833|686790|P1|COMPLETED|Overall Study||30
284218|NCT00859833|686790|P1|STARTED|Overall Study||30
284219|NCT00859651|686797|P2|NOT COMPLETED|Overall Study||0
284220|NCT00859651|686798|P1|NOT COMPLETED|Overall Study||0
284221|NCT00859651|686797|P2|COMPLETED|Overall Study||22
284222|NCT00859651|686798|P1|COMPLETED|Overall Study||18
284223|NCT00859651|686797|P2|STARTED|Overall Study||22
284224|NCT00859651|686798|P1|STARTED|Overall Study||18
284225|NCT00859638|686808|P2|NOT COMPLETED|Overall Study||4
284226|NCT00859638|686809|P1|NOT COMPLETED|Overall Study||10
284227|NCT00859638|686808|P2|COMPLETED|Overall Study||55
284228|NCT00859638|686809|P1|COMPLETED|Overall Study||55
284229|NCT00859638|686808|P2|STARTED|Overall Study||59
284230|NCT00859638|686809|P1|STARTED|Overall Study||65
284231|NCT00859586|686815|P1|NOT COMPLETED|Overall Study||4
284232|NCT00859586|686815|P1|COMPLETED|Overall Study||4
284233|NCT00859586|686815|P1|STARTED|Overall Study||8
284234|NCT00859573|686821|P2|NOT COMPLETED|Overall Study||2
284235|NCT00859573|686822|P1|NOT COMPLETED|Overall Study||5
284236|NCT00859573|686821|P2|COMPLETED|Overall Study||1
284237|NCT00859573|686822|P1|COMPLETED|Overall Study||1
284238|NCT00859573|686821|P2|STARTED|Overall Study||3
284239|NCT00859573|686822|P1|STARTED|Overall Study||6
284240|NCT00859547|686828|P1|NOT COMPLETED|Overall Study||2
284241|NCT00859547|686828|P1|COMPLETED|Overall Study||28
284242|NCT00859547|686828|P1|STARTED|Overall Study||30
284243|NCT00859521|686841|P2|NOT COMPLETED|Second Intervention||0
284244|NCT00859521|686842|P1|NOT COMPLETED|Second Intervention||0
284245|NCT00859521|686841|P2|COMPLETED|Second Intervention||14
284246|NCT00859521|686842|P1|COMPLETED|Second Intervention||15
284247|NCT00859521|686841|P2|STARTED|Second Intervention||14
284248|NCT00859521|686842|P1|STARTED|Second Intervention||15
284249|NCT00859521|686841|P2|NOT COMPLETED|Washout||1
284250|NCT00859521|686842|P1|NOT COMPLETED|Washout||0
284251|NCT00859521|686841|P2|COMPLETED|Washout||14
284252|NCT00859521|686842|P1|COMPLETED|Washout||15
284253|NCT00859521|686841|P2|STARTED|Washout||15
284254|NCT00859521|686842|P1|STARTED|Washout||15
284255|NCT00859521|686841|P2|NOT COMPLETED|First Intervention||0
284256|NCT00859521|686842|P1|NOT COMPLETED|First Intervention||0
284257|NCT00859521|686841|P2|COMPLETED|First Intervention||15
284258|NCT00859521|686842|P1|COMPLETED|First Intervention||15
284259|NCT00859521|686841|P2|STARTED|First Intervention||15
284260|NCT00859521|686842|P1|STARTED|First Intervention||15
284261|NCT00859508|686852|P2|NOT COMPLETED|Overall Study||0
284262|NCT00859508|686853|P1|NOT COMPLETED|Overall Study||6
284263|NCT00859508|686852|P2|COMPLETED|Overall Study||37
284264|NCT00859508|686853|P1|COMPLETED|Overall Study||62
284265|NCT00859508|686852|P2|STARTED|Overall Study||37
284266|NCT00859508|686853|P1|STARTED|Overall Study||68
284267|NCT00859469|686859|P1|NOT COMPLETED|Overall Study||28
284268|NCT00859469|686859|P1|COMPLETED|Overall Study||1
284269|NCT00859469|686859|P1|6 Cycles|Overall Study||16
284270|NCT00859469|686859|P1|STARTED|Overall Study||29
284271|NCT00859456|686865|P1|NOT COMPLETED|Overall Study||8
284272|NCT00859456|686865|P1|COMPLETED|Overall Study||1
284273|NCT00859456|686865|P1|STARTED|Overall Study||9
284274|NCT00859430|686871|P2|NOT COMPLETED|Second Intervention||0
284275|NCT00859430|686872|P1|NOT COMPLETED|Second Intervention||0
284276|NCT00859430|686871|P2|COMPLETED|Second Intervention||10
284277|NCT00859430|686872|P1|COMPLETED|Second Intervention||11
284278|NCT00859430|686871|P2|STARTED|Second Intervention||10
284279|NCT00859430|686872|P1|STARTED|Second Intervention||11
284280|NCT00859430|686871|P2|NOT COMPLETED|First Intervention||1
284281|NCT00859430|686872|P1|NOT COMPLETED|First Intervention||0
284282|NCT00859430|686871|P2|COMPLETED|First Intervention||10
284283|NCT00859430|686872|P1|COMPLETED|First Intervention||11
284284|NCT00859430|686871|P2|STARTED|First Intervention||11
284285|NCT00859430|686872|P1|STARTED|First Intervention||11
284286|NCT00859339|686880|P1|NOT COMPLETED|Overall Study||0
284287|NCT00859339|686880|P1|COMPLETED|Overall Study||9
284288|NCT00859339|686880|P1|STARTED|Overall Study||9
284289|NCT00859313|686888|P1|NOT COMPLETED|Overall Study||4
284290|NCT00859313|686888|P1|COMPLETED|Overall Study||26
284291|NCT00859313|686888|P1|STARTED|Overall Study||30
284292|NCT00859222|686895|P5|NOT COMPLETED|Overall Study||15
284293|NCT00859222|686896|P4|NOT COMPLETED|Overall Study||24
284294|NCT00859222|686897|P3|NOT COMPLETED|Overall Study||6
284295|NCT00859222|686898|P2|NOT COMPLETED|Overall Study||3
284296|NCT00859222|686899|P1|NOT COMPLETED|Overall Study||3
284297|NCT00859222|686895|P5|COMPLETED|Overall Study||0
284298|NCT00859222|686896|P4|COMPLETED|Overall Study||0
284299|NCT00859222|686897|P3|COMPLETED|Overall Study||0
284300|NCT00859222|686898|P2|COMPLETED|Overall Study||0
284301|NCT00859222|686899|P1|COMPLETED|Overall Study||0
284302|NCT00859222|686895|P5|STARTED|Overall Study||15
284303|NCT00859222|686896|P4|STARTED|Overall Study||24
284304|NCT00859222|686897|P3|STARTED|Overall Study||6
284305|NCT00859222|686898|P2|STARTED|Overall Study||3
284306|NCT00859222|686899|P1|STARTED|Overall Study||3
284307|NCT00859131|686926|P2|NOT COMPLETED|Overall Study||0
284308|NCT00859131|686927|P1|NOT COMPLETED|Overall Study||0
284309|NCT00859131|686926|P2|COMPLETED|Overall Study||98
284310|NCT00859131|686927|P1|COMPLETED|Overall Study||102
284311|NCT00859131|686926|P2|STARTED|Overall Study||98
284312|NCT00859131|686927|P1|STARTED|Overall Study||102
284313|NCT00859053|686949|P4|NOT COMPLETED|Overall Study||0
284314|NCT00859053|686950|P3|NOT COMPLETED|Overall Study||0
284315|NCT00859053|686951|P2|NOT COMPLETED|Overall Study||0
284316|NCT00859053|686952|P1|NOT COMPLETED|Overall Study||0
284317|NCT00859053|686949|P4|COMPLETED|Overall Study||12
284318|NCT00859053|686950|P3|COMPLETED|Overall Study||6
284319|NCT00859053|686951|P2|COMPLETED|Overall Study||6
284320|NCT00859053|686952|P1|COMPLETED|Overall Study||6
284321|NCT00859053|686949|P4|STARTED|Overall Study||12
284322|NCT00859053|686950|P3|STARTED|Overall Study||6
284323|NCT00859053|686951|P2|STARTED|Overall Study||6
284324|NCT00859053|686952|P1|STARTED|Overall Study||6
284325|NCT00859040|686996|P2|NOT COMPLETED|Overall Study||0
284326|NCT00859040|686997|P1|NOT COMPLETED|Overall Study||0
284327|NCT00859040|686996|P2|COMPLETED|Overall Study||16
284328|NCT00859040|686997|P1|COMPLETED|Overall Study||18
284329|NCT00859040|686996|P2|STARTED|Overall Study||16
284330|NCT00859040|686997|P1|STARTED|Overall Study||18
284331|NCT00859027|687012|P2|NOT COMPLETED|Overall Study||5
284332|NCT00859027|687013|P1|NOT COMPLETED|Overall Study||5
284333|NCT00859027|687012|P2|COMPLETED|Overall Study||20
284334|NCT00859027|687013|P1|COMPLETED|Overall Study||20
284335|NCT00859027|687012|P2|STARTED|Overall Study||25
284336|NCT00859027|687013|P1|STARTED|Overall Study||25
284337|NCT00859014|687021|P1|NOT COMPLETED|Overall Study||5
284338|NCT00859014|687021|P1|COMPLETED|Overall Study||20
284339|NCT00859014|687021|P1|STARTED|Overall Study||25
284340|NCT00858988|687028|P2|NOT COMPLETED|Analysis||1
284341|NCT00858988|687029|P1|NOT COMPLETED|Analysis||2
284342|NCT00858988|687028|P2|COMPLETED|Analysis||72
284343|NCT00858988|687029|P1|COMPLETED|Analysis||72
284344|NCT00858988|687028|P2|STARTED|Analysis||73
284345|NCT00858988|687029|P1|STARTED|Analysis||74
284346|NCT00858988|687028|P2|NOT COMPLETED|Randomized and Allocation||0
284347|NCT00858988|687029|P1|NOT COMPLETED|Randomized and Allocation||0
284348|NCT00858988|687028|P2|COMPLETED|Randomized and Allocation||73
284349|NCT00858988|687029|P1|COMPLETED|Randomized and Allocation||74
284350|NCT00858988|687028|P2|STARTED|Randomized and Allocation||73
284351|NCT00858988|687029|P1|STARTED|Randomized and Allocation||74
284352|NCT00858962|687035|P1|NOT COMPLETED|Overall Study||0
284353|NCT00858962|687035|P1|COMPLETED|Overall Study||12
284354|NCT00858962|687035|P1|STARTED|Overall Study||12
284355|NCT00858858|687039|P1|NOT COMPLETED|Overall Study||18
284356|NCT00858858|687039|P1|COMPLETED|Overall Study||42
284357|NCT00858858|687039|P1|STARTED|Overall Study||60
284358|NCT00858845|687045|P2|NOT COMPLETED|Overall Study||1
284359|NCT00858845|687046|P1|NOT COMPLETED|Overall Study||0
284360|NCT00858845|687045|P2|COMPLETED|Overall Study||5
284361|NCT00858845|687046|P1|COMPLETED|Overall Study||5
284362|NCT00858845|687045|P2|STARTED|Overall Study||6
284363|NCT00858845|687046|P1|STARTED|Overall Study||5
284364|NCT00858832|687058|P2|NOT COMPLETED|Overall Study||1
284365|NCT00858832|687059|P1|NOT COMPLETED|Overall Study||1
284366|NCT00858832|687058|P2|COMPLETED|Overall Study||22
284367|NCT00858832|687059|P1|COMPLETED|Overall Study||20
284368|NCT00858832|687058|P2|STARTED|Overall Study||23
284369|NCT00858832|687059|P1|STARTED|Overall Study|study terminated early due to enrollment deficiencies|21
284370|NCT00858780|687065|P5|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||2
284371|NCT00858780|687066|P4|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
284372|NCT00858780|687067|P3|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
284373|NCT00858780|687068|P2|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
284374|NCT00858780|687069|P1|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
284375|NCT00858780|687065|P5|COMPLETED|OL Re-Treatment (Failure to Week 48)||41
284376|NCT00858780|687066|P4|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
284377|NCT00858780|687067|P3|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
284378|NCT00858780|687068|P2|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
284379|NCT00858780|687069|P1|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
284380|NCT00858780|687065|P5|STARTED|OL Re-Treatment (Failure to Week 48)|43 participants showed treatment failure in Period 2 and entered in Period 3.|43
284381|NCT00858780|687066|P4|STARTED|OL Re-Treatment (Failure to Week 48)||0
284382|NCT00858780|687067|P3|STARTED|OL Re-Treatment (Failure to Week 48)||0
284383|NCT00858780|687068|P2|STARTED|OL Re-Treatment (Failure to Week 48)||0
284384|NCT00858780|687069|P1|STARTED|OL Re-Treatment (Failure to Week 48)||0
284385|NCT00858780|687065|P5|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
284386|NCT00858780|687066|P4|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||1
284387|NCT00858780|687067|P3|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
284388|NCT00858780|687068|P2|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
284389|NCT00858780|687069|P1|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
284390|NCT00858780|687065|P5|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
284391|NCT00858780|687066|P4|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||22
284392|NCT00858780|687067|P3|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||25
284393|NCT00858780|687068|P2|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||21
284394|NCT00858780|687069|P1|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
284395|NCT00858780|687065|P5|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
284396|NCT00858780|687066|P4|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
284397|NCT00858780|687067|P3|STARTED|Double-Blind (Week 0 to Failure/Week 48)||27
284398|NCT00858780|687068|P2|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
284399|NCT00858780|687069|P1|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
284400|NCT00858780|687065|P5|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
284401|NCT00858780|687066|P4|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
284402|NCT00858780|687067|P3|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
284403|NCT00858780|687068|P2|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
284404|NCT00858780|687069|P1|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||18
284405|NCT00858780|687065|P5|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
284406|NCT00858780|687066|P4|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
284407|NCT00858780|687067|P3|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
284408|NCT00858780|687068|P2|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
284409|NCT00858780|687069|P1|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||73
284410|NCT00858780|687065|P5|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
284411|NCT00858780|687066|P4|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
284412|NCT00858780|687067|P3|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
284413|NCT00858780|687068|P2|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
284414|NCT00858780|687069|P1|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||91
284415|NCT00858702|687144|P2|NOT COMPLETED|Overall Study||2
284416|NCT00858702|687145|P1|NOT COMPLETED|Overall Study||5
284417|NCT00858702|687144|P2|COMPLETED|Overall Study||50
284418|NCT00858702|687145|P1|COMPLETED|Overall Study||48
284419|NCT00858702|687144|P2|STARTED|Overall Study||52
284420|NCT00858702|687145|P1|STARTED|Overall Study||53
284421|NCT00858689|687153|P1|NOT COMPLETED|Overall Study||1
284422|NCT00858689|687153|P1|COMPLETED|Overall Study||19
284423|NCT00858689|687153|P1|STARTED|Overall Study||20
284424|NCT00858637|687160|P6|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
284425|NCT00858637|687161|P5|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
284426|NCT00858637|687162|P4|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
284427|NCT00858637|687163|P3|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
284428|NCT00858637|687164|P2|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
284429|NCT00858637|687165|P1|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
284430|NCT00858637|687160|P6|COMPLETED|Placebo-controlled Withdrawal Phase||58
284431|NCT00858637|687161|P5|COMPLETED|Placebo-controlled Withdrawal Phase||55
284432|NCT00858637|687162|P4|COMPLETED|Placebo-controlled Withdrawal Phase||0
284433|NCT00858637|687163|P3|COMPLETED|Placebo-controlled Withdrawal Phase||53
284434|NCT00858637|687164|P2|COMPLETED|Placebo-controlled Withdrawal Phase||49
284435|NCT00858637|687165|P1|COMPLETED|Placebo-controlled Withdrawal Phase||0
284436|NCT00858637|687160|P6|STARTED|Placebo-controlled Withdrawal Phase||59
284437|NCT00858637|687161|P5|STARTED|Placebo-controlled Withdrawal Phase||56
284438|NCT00858637|687162|P4|STARTED|Placebo-controlled Withdrawal Phase||0
284439|NCT00858637|687163|P3|STARTED|Placebo-controlled Withdrawal Phase||54
284440|NCT00858637|687164|P2|STARTED|Placebo-controlled Withdrawal Phase||49
284441|NCT00858637|687165|P1|STARTED|Placebo-controlled Withdrawal Phase||0
284442|NCT00858637|687160|P6|NOT COMPLETED|Active Comparison Phase||0
284443|NCT00858637|687161|P5|NOT COMPLETED|Active Comparison Phase||0
284444|NCT00858637|687162|P4|NOT COMPLETED|Active Comparison Phase||18
284445|NCT00858637|687163|P3|NOT COMPLETED|Active Comparison Phase||0
284446|NCT00858637|687164|P2|NOT COMPLETED|Active Comparison Phase||0
284447|NCT00858637|687165|P1|NOT COMPLETED|Active Comparison Phase||24
284448|NCT00858637|687160|P6|COMPLETED|Active Comparison Phase||0
284449|NCT00858637|687161|P5|COMPLETED|Active Comparison Phase||0
284450|NCT00858637|687162|P4|COMPLETED|Active Comparison Phase||115
284451|NCT00858637|687163|P3|COMPLETED|Active Comparison Phase||0
284452|NCT00858637|687164|P2|COMPLETED|Active Comparison Phase||0
284453|NCT00858637|687165|P1|COMPLETED|Active Comparison Phase||103
284454|NCT00858637|687160|P6|STARTED|Active Comparison Phase||0
284455|NCT00858637|687161|P5|STARTED|Active Comparison Phase||0
284456|NCT00858637|687162|P4|STARTED|Active Comparison Phase||133
284457|NCT00858637|687163|P3|STARTED|Active Comparison Phase||0
284458|NCT00858637|687164|P2|STARTED|Active Comparison Phase||0
284459|NCT00858637|687165|P1|STARTED|Active Comparison Phase||127
284460|NCT00858507|687177|P2|NOT COMPLETED|Overall Study||15
284461|NCT00858507|687178|P1|NOT COMPLETED|Overall Study||22
284462|NCT00858507|687177|P2|COMPLETED|Overall Study||101
284463|NCT00858507|687178|P1|COMPLETED|Overall Study||83
284464|NCT00858507|687177|P2|STARTED|Overall Study||116
284465|NCT00858507|687178|P1|STARTED|Overall Study||105
284466|NCT00858494|687184|P1|NOT COMPLETED|Overall Study||4
284467|NCT00858494|687184|P1|COMPLETED|Overall Study|2 participants dropped out before giving study medication. Symptoms resolved without a dose in 2.|45
284468|NCT00858494|687184|P1|STARTED|Overall Study||49
284469|NCT00858468|687191|P2|NOT COMPLETED|Overall Study||0
284470|NCT00858468|687192|P1|NOT COMPLETED|Overall Study||0
284471|NCT00858468|687191|P2|COMPLETED|Overall Study||192
284472|NCT00858468|687192|P1|COMPLETED|Overall Study||201
284473|NCT00858468|687191|P2|STARTED|Overall Study||192
284474|NCT00858468|687192|P1|STARTED|Overall Study|1 enrolled participant was not vaccinated and removed from analysis|201
284475|NCT00858442|687206|P2|NOT COMPLETED|Compression:Start to Finish||3
284476|NCT00858442|687207|P1|NOT COMPLETED|Compression:Start to Finish||1
284477|NCT00858442|687206|P2|COMPLETED|Compression:Start to Finish||20
284478|NCT00858442|687207|P1|COMPLETED|Compression:Start to Finish||20
284479|NCT00858442|687206|P2|STARTED|Compression:Start to Finish||23
284480|NCT00858442|687207|P1|STARTED|Compression:Start to Finish||21
284481|NCT00858442|687206|P2|NOT COMPLETED|From Surgery to Start Compression;||0
284482|NCT00858442|687207|P1|NOT COMPLETED|From Surgery to Start Compression;||0
284483|NCT00858442|687206|P2|COMPLETED|From Surgery to Start Compression;||23
284484|NCT00858442|687207|P1|COMPLETED|From Surgery to Start Compression;||21
284485|NCT00858442|687206|P2|STARTED|From Surgery to Start Compression;||23
284486|NCT00858442|687207|P1|STARTED|From Surgery to Start Compression;||21
284487|NCT00858403|687217|P1|NOT COMPLETED|Overall Study||5
284488|NCT00858403|687217|P1|COMPLETED|Overall Study||2
284489|NCT00858403|687217|P1|STARTED|Overall Study||7
284490|NCT00858390|687229|P2|NOT COMPLETED|Overall Study||0
284491|NCT00858390|687230|P1|NOT COMPLETED|Overall Study||0
284492|NCT00858390|687229|P2|COMPLETED|Overall Study||18
284493|NCT00858390|687230|P1|COMPLETED|Overall Study||18
284494|NCT00858390|687229|P2|STARTED|Overall Study||18
284495|NCT00858390|687230|P1|STARTED|Overall Study||18
284496|NCT00858364|687238|P2|NOT COMPLETED|Overall Study||457
284497|NCT00858364|687239|P1|NOT COMPLETED|Overall Study||204
284498|NCT00858364|687238|P2|COMPLETED|Overall Study||1246
284499|NCT00858364|687239|P1|COMPLETED|Overall Study||642
284500|NCT00858364|687238|P2|Received Study Drug|Overall Study||1681
284501|NCT00858364|687239|P1|Received Study Drug|Overall Study||837
284502|NCT00858364|687238|P2|STARTED|Overall Study||1703
284503|NCT00858364|687239|P1|STARTED|Overall Study||846
284504|NCT00858247|687261|P2|NOT COMPLETED|Week 12 Follow-up||1
284505|NCT00858247|687262|P1|NOT COMPLETED|Week 12 Follow-up||0
284506|NCT00858247|687261|P2|COMPLETED|Week 12 Follow-up||23
284507|NCT00858247|687262|P1|COMPLETED|Week 12 Follow-up||23
284508|NCT00858247|687261|P2|STARTED|Week 12 Follow-up||24
284509|NCT00858247|687262|P1|STARTED|Week 12 Follow-up||23
284510|NCT00858247|687261|P2|NOT COMPLETED|Baseline Assessment||2
284511|NCT00858247|687262|P1|NOT COMPLETED|Baseline Assessment||2
284512|NCT00858247|687261|P2|COMPLETED|Baseline Assessment||24
284513|NCT00858247|687262|P1|COMPLETED|Baseline Assessment||23
284514|NCT00858247|687261|P2|STARTED|Baseline Assessment||26
284515|NCT00858247|687262|P1|STARTED|Baseline Assessment||25
284516|NCT00858208|687278|P1|NOT COMPLETED|Overall Study||79
284517|NCT00858208|687278|P1|COMPLETED|Overall Study||6
284518|NCT00858208|687278|P1|STARTED|Overall Study||85
284519|NCT00858143|687295|P1|NOT COMPLETED|Overall Study||50
284520|NCT00858143|687295|P1|COMPLETED|Overall Study||261
284521|NCT00858143|687295|P1|STARTED|Overall Study|Baseline|311
284522|NCT00858130|687344|P1|NOT COMPLETED|Overall Study||0
284523|NCT00858130|687344|P1|COMPLETED|Overall Study||12
284524|NCT00858130|687344|P1|STARTED|Overall Study||12
284525|NCT00858013|687354|P2|NOT COMPLETED|Overall Study||19
284526|NCT00858013|687355|P1|NOT COMPLETED|Overall Study||22
284527|NCT00858013|687354|P2|COMPLETED|Overall Study||23
284528|NCT00858013|687355|P1|COMPLETED|Overall Study||24
284529|NCT00858013|687354|P2|STARTED|Overall Study||42
284530|NCT00858013|687355|P1|STARTED|Overall Study||46
284531|NCT00857961|687369|P1|NOT COMPLETED|Overall Study||0
284532|NCT00857961|687369|P1|COMPLETED|Overall Study||21
284533|NCT00857961|687369|P1|STARTED|Overall Study||21
284534|NCT00857948|687407|P4|NOT COMPLETED|Overall Study||0
284535|NCT00857948|687408|P3|NOT COMPLETED|Overall Study||1
284536|NCT00857948|687409|P2|NOT COMPLETED|Overall Study||0
284537|NCT00857948|687410|P1|NOT COMPLETED|Overall Study||3
284538|NCT00857948|687407|P4|COMPLETED|Overall Study||23
284539|NCT00857948|687408|P3|COMPLETED|Overall Study||18
284540|NCT00857948|687409|P2|COMPLETED|Overall Study||18
284541|NCT00857948|687410|P1|COMPLETED|Overall Study||15
284542|NCT00857948|687407|P4|STARTED|Overall Study||23
284543|NCT00857948|687408|P3|STARTED|Overall Study||19
284544|NCT00857948|687409|P2|STARTED|Overall Study||18
284545|NCT00857948|687410|P1|STARTED|Overall Study||18
284546|NCT00857896|687432|P1|NOT COMPLETED|Week 5 to Week 8||0
284547|NCT00857896|687432|P1|COMPLETED|Week 5 to Week 8||20
284548|NCT00857896|687432|P1|STARTED|Week 5 to Week 8||20
284549|NCT00857896|687432|P1|NOT COMPLETED|Baseline to Week 4||1
284550|NCT00857896|687432|P1|COMPLETED|Baseline to Week 4||20
284551|NCT00857896|687432|P1|STARTED|Baseline to Week 4||21
284552|NCT00857857|687444|P1|NOT COMPLETED|Overall Study||0
284553|NCT00857857|687444|P1|COMPLETED|Overall Study||24
284554|NCT00857857|687444|P1|STARTED|Overall Study||24
284555|NCT00857818|687588|P2|NOT COMPLETED|Overall Study||8
284556|NCT00857818|687589|P1|NOT COMPLETED|Overall Study||11
284557|NCT00857818|687588|P2|COMPLETED|Overall Study||6
284558|NCT00857818|687589|P1|COMPLETED|Overall Study||3
284559|NCT00857818|687588|P2|Received Treatment|Overall Study||12
284560|NCT00857818|687589|P1|Received Treatment|Overall Study||14
284561|NCT00857818|687588|P2|STARTED|Overall Study||14
284562|NCT00857818|687589|P1|STARTED|Overall Study||14
284563|NCT00857792|687617|P1|NOT COMPLETED|Overall Study||12
284564|NCT00857792|687617|P1|COMPLETED|Overall Study||108
284565|NCT00857792|687617|P1|STARTED|Overall Study||120
284566|NCT00857766|687623|P2|NOT COMPLETED|Overall Study||30
284567|NCT00857766|687624|P1|NOT COMPLETED|Overall Study||31
284568|NCT00857766|687623|P2|COMPLETED|Overall Study||96
284569|NCT00857766|687624|P1|COMPLETED|Overall Study||92
284570|NCT00857766|687623|P2|STARTED|Overall Study||126
284571|NCT00857766|687624|P1|STARTED|Overall Study||123
284572|NCT00857727|687636|P2|NOT COMPLETED|Overall Study||0
284573|NCT00857727|687637|P1|NOT COMPLETED|Overall Study||0
284574|NCT00857727|687636|P2|COMPLETED|Overall Study||14
284575|NCT00857727|687637|P1|COMPLETED|Overall Study||14
284576|NCT00857727|687636|P2|STARTED|Overall Study||14
284577|NCT00857727|687637|P1|STARTED|Overall Study||14
284578|NCT00857714|687659|P1|NOT COMPLETED|Overall Study||0
284579|NCT00857714|687659|P1|COMPLETED|Overall Study||1
284580|NCT00857714|687659|P1|STARTED|Overall Study||1
284581|NCT00857649|687666|P2|NOT COMPLETED|Overall Study||32
284582|NCT00857649|687667|P1|NOT COMPLETED|Overall Study||31
284583|NCT00857649|687666|P2|COMPLETED|Overall Study||155
284584|NCT00857649|687667|P1|COMPLETED|Overall Study||151
284585|NCT00857649|687666|P2|STARTED|Overall Study||187
284586|NCT00857649|687667|P1|STARTED|Overall Study||182
284587|NCT00857623|687683|P2|NOT COMPLETED|Overall Study||10
284588|NCT00857623|687684|P1|NOT COMPLETED|Overall Study||14
284589|NCT00857623|687683|P2|COMPLETED|Overall Study||55
284590|NCT00857623|687684|P1|COMPLETED|Overall Study||48
284591|NCT00857623|687683|P2|STARTED|Overall Study||65
284592|NCT00857623|687684|P1|STARTED|Overall Study||62
284593|NCT00857584|687708|P2|NOT COMPLETED|Overall Study||5
284594|NCT00857584|687709|P1|NOT COMPLETED|Overall Study||4
284595|NCT00857584|687708|P2|COMPLETED|Overall Study||8
284596|NCT00857584|687709|P1|COMPLETED|Overall Study||10
284597|NCT00857584|687708|P2|Week 8|Overall Study||8
284598|NCT00857584|687709|P1|Week 8|Overall Study||10
284599|NCT00857584|687708|P2|Week 4|Overall Study||9
284600|NCT00857584|687709|P1|Week 4|Overall Study||11
284601|NCT00857584|687708|P2|Week 2|Overall Study||11
284602|NCT00857584|687709|P1|Week 2|Overall Study||14
284603|NCT00857584|687708|P2|Week 1|Overall Study||13
284604|NCT00857584|687709|P1|Week 1|Overall Study||14
284605|NCT00857584|687708|P2|STARTED|Overall Study||13
284606|NCT00857584|687709|P1|STARTED|Overall Study||14
284607|NCT00857545|687751|P2|NOT COMPLETED|Overall Study||0
284608|NCT00857545|687752|P1|NOT COMPLETED|Overall Study||0
284609|NCT00857545|687751|P2|COMPLETED|Overall Study||85
284610|NCT00857545|687752|P1|COMPLETED|Overall Study|Enrolled and randomized participants.|86
284611|NCT00857545|687751|P2|STARTED|Overall Study||85
284612|NCT00857545|687752|P1|STARTED|Overall Study||86
284613|NCT00857532|687762|P1|NOT COMPLETED|Overall Study||0
284614|NCT00857532|687762|P1|COMPLETED|Overall Study||31
284615|NCT00857532|687762|P1|STARTED|Overall Study||31
284616|NCT00857506|687773|P3|NOT COMPLETED|Overall Study||18
284617|NCT00857506|687774|P2|NOT COMPLETED|Overall Study||15
284618|NCT00857506|687775|P1|NOT COMPLETED|Overall Study||15
284619|NCT00857506|687773|P3|COMPLETED|Overall Study||51
284620|NCT00857506|687774|P2|COMPLETED|Overall Study||37
284621|NCT00857506|687775|P1|COMPLETED|Overall Study||16
284622|NCT00857506|687773|P3|STARTED|Overall Study||69
284623|NCT00857506|687774|P2|STARTED|Overall Study||52
284624|NCT00857506|687775|P1|STARTED|Overall Study||31
284625|NCT00857493|687803|P2|NOT COMPLETED|Overall Study||0
284626|NCT00857493|687804|P1|NOT COMPLETED|Overall Study||3
284627|NCT00857493|687803|P2|COMPLETED|Overall Study||58
284628|NCT00857493|687804|P1|COMPLETED|Overall Study||59
284629|NCT00857493|687803|P2|STARTED|Overall Study||58
284630|NCT00857493|687804|P1|STARTED|Overall Study||62
284631|NCT00857454|687836|P1|NOT COMPLETED|Overall Study||20
284632|NCT00857454|687836|P1|COMPLETED|Overall Study||51
284633|NCT00857454|687836|P1|STARTED|Overall Study||71
284634|NCT00857415|687849|P2|NOT COMPLETED|Overall Study||0
284635|NCT00857415|687850|P1|NOT COMPLETED|Overall Study||117
284636|NCT00857415|687849|P2|COMPLETED|Overall Study||74
284637|NCT00857415|687850|P1|COMPLETED|Overall Study||35
284638|NCT00857415|687849|P2|Deceased Within One Year of AV-45 Scan|Overall Study|Subjects in the specificity cohort were not followed to autopsy|0
284639|NCT00857415|687850|P1|Deceased Within One Year of AV-45 Scan|Overall Study||37
284640|NCT00857415|687849|P2|STARTED|Overall Study||74
284641|NCT00857415|687850|P1|STARTED|Overall Study||152
284642|NCT00857311|687861|P4|NOT COMPLETED|Overall Study||0
284643|NCT00857311|687862|P3|NOT COMPLETED|Overall Study||0
284644|NCT00857311|687863|P2|NOT COMPLETED|Overall Study||0
284645|NCT00857311|687864|P1|NOT COMPLETED|Overall Study||1
284646|NCT00857311|687861|P4|COMPLETED|Overall Study||0
284647|NCT00857311|687862|P3|COMPLETED|Overall Study||8
284648|NCT00857311|687863|P2|COMPLETED|Overall Study||0
284649|NCT00857311|687864|P1|COMPLETED|Overall Study||8
284650|NCT00857311|687861|P4|STARTED|Overall Study||0
284651|NCT00857311|687862|P3|STARTED|Overall Study||8
284652|NCT00857311|687863|P2|STARTED|Overall Study||0
284653|NCT00857311|687864|P1|STARTED|Overall Study||9
284654|NCT00857285|687876|P2|NOT COMPLETED|Overall Study||6
284655|NCT00857285|687877|P1|NOT COMPLETED|Overall Study||12
284656|NCT00857285|687876|P2|COMPLETED|Overall Study||59
284657|NCT00857285|687877|P1|COMPLETED|Overall Study||53
284658|NCT00857285|687876|P2|STARTED|Overall Study||65
284659|NCT00857285|687877|P1|STARTED|Overall Study||65
284660|NCT00857272|687883|P2|NOT COMPLETED|Overall Study||9
284661|NCT00857272|687884|P1|NOT COMPLETED|Overall Study||9
284662|NCT00857272|687883|P2|COMPLETED|Overall Study||145
284663|NCT00857272|687884|P1|COMPLETED|Overall Study||145
284664|NCT00857272|687883|P2|STARTED|Overall Study|Includes 7 non-ITT patients that withdrew consent|154
284665|NCT00857272|687884|P1|STARTED|Overall Study|Includes 6 non-ITT patients that withdrew consent|154
284666|NCT00857259|687893|P3|NOT COMPLETED|Overall Study||1
284667|NCT00857259|687894|P2|NOT COMPLETED|Overall Study||0
284668|NCT00857259|687895|P1|NOT COMPLETED|Overall Study||1
284669|NCT00857259|687893|P3|COMPLETED|Overall Study||6
284670|NCT00857259|687894|P2|COMPLETED|Overall Study||1
284671|NCT00857259|687895|P1|COMPLETED|Overall Study||7
284672|NCT00857259|687893|P3|STARTED|Overall Study||7
284673|NCT00857259|687894|P2|STARTED|Overall Study||1
284674|NCT00857259|687895|P1|STARTED|Overall Study||8
284675|NCT00857246|687905|P1|NOT COMPLETED|ChemoRT||3
284676|NCT00857246|687905|P1|COMPLETED|ChemoRT||12
284677|NCT00857246|687905|P1|STARTED|ChemoRT|6 did not start adjuvant therapy due to disease-related complications or patient withdrawal.|15
284678|NCT00857246|687905|P1|NOT COMPLETED|Surgery (Curative)||6
284679|NCT00857246|687905|P1|COMPLETED|Surgery (Curative)||21
284680|NCT00857246|687905|P1|STARTED|Surgery (Curative)||27
284681|NCT00857246|687905|P1|NOT COMPLETED|Induction Regimen||3
284682|NCT00857246|687905|P1|COMPLETED|Induction Regimen||27
284683|NCT00857246|687905|P1|STARTED|Induction Regimen||30
284684|NCT00857233|687915|P1|NOT COMPLETED|Overall Study||55
284685|NCT00857233|687915|P1|COMPLETED|Overall Study||242
284686|NCT00857233|687915|P1|STARTED|Overall Study||297
284687|NCT00857220|687924|P1|NOT COMPLETED|Overall Study||183
284688|NCT00857220|687924|P1|COMPLETED|Overall Study||121
284689|NCT00857220|687924|P1|STARTED|Overall Study||304
284690|NCT00856999|687941|P1|NOT COMPLETED|Overall Study||5
284691|NCT00856999|687941|P1|COMPLETED|Overall Study||45
284692|NCT00856999|687941|P1|STARTED|Overall Study||50
284693|NCT00856986|687951|P5|NOT COMPLETED|Extension Period, Weeks 26-52||0
284694|NCT00856986|687952|P4|NOT COMPLETED|Extension Period, Weeks 26-52||0
284695|NCT00856986|687953|P3|NOT COMPLETED|Extension Period, Weeks 26-52||38
284696|NCT00856986|687954|P2|NOT COMPLETED|Extension Period, Weeks 26-52||14
284697|NCT00856986|687955|P1|NOT COMPLETED|Extension Period, Weeks 26-52||19
284698|NCT00856986|687951|P5|COMPLETED|Extension Period, Weeks 26-52||0
284699|NCT00856986|687952|P4|COMPLETED|Extension Period, Weeks 26-52||0
284700|NCT00856986|687953|P3|COMPLETED|Extension Period, Weeks 26-52||432
284701|NCT00856986|687954|P2|COMPLETED|Extension Period, Weeks 26-52||130
284702|NCT00856986|687955|P1|COMPLETED|Extension Period, Weeks 26-52||108
284703|NCT00856986|687951|P5|Enrolled in Extension|Extension Period, Weeks 26-52||0
284704|NCT00856986|687952|P4|Enrolled in Extension|Extension Period, Weeks 26-52||0
284705|NCT00856986|687953|P3|Enrolled in Extension|Extension Period, Weeks 26-52||461
284706|NCT00856986|687954|P2|Enrolled in Extension|Extension Period, Weeks 26-52||140
284707|NCT00856986|687955|P1|Enrolled in Extension|Extension Period, Weeks 26-52||122
284708|NCT00856986|687951|P5|STARTED|Extension Period, Weeks 26-52||0
284709|NCT00856986|687952|P4|STARTED|Extension Period, Weeks 26-52||0
284710|NCT00856986|687953|P3|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 7 (Intensified Group)|470
284711|NCT00856986|687954|P2|STARTED|Extension Period, Weeks 26-52||144
284712|NCT00856986|687955|P1|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 17 (Intensified Group)|127
284713|NCT00856986|687951|P5|NOT COMPLETED|Main Period, Weeks 0-26||0
284714|NCT00856986|687952|P4|NOT COMPLETED|Main Period, Weeks 0-26||0
284715|NCT00856986|687953|P3|NOT COMPLETED|Main Period, Weeks 0-26||28
284716|NCT00856986|687954|P2|NOT COMPLETED|Main Period, Weeks 0-26||18
284717|NCT00856986|687955|P1|NOT COMPLETED|Main Period, Weeks 0-26||34
284718|NCT00856986|687951|P5|COMPLETED|Main Period, Weeks 0-26||0
284719|NCT00856986|687952|P4|COMPLETED|Main Period, Weeks 0-26||0
284720|NCT00856986|687953|P3|COMPLETED|Main Period, Weeks 0-26||470
284721|NCT00856986|687954|P2|COMPLETED|Main Period, Weeks 0-26||144
284722|NCT00856986|687955|P1|COMPLETED|Main Period, Weeks 0-26||127
284723|NCT00856986|687951|P5|STARTED|Main Period, Weeks 0-26||0
284724|NCT00856986|687952|P4|STARTED|Main Period, Weeks 0-26||0
284725|NCT00856986|687953|P3|STARTED|Main Period, Weeks 0-26||498
284726|NCT00856986|687954|P2|STARTED|Main Period, Weeks 0-26||162
284727|NCT00856986|687955|P1|STARTED|Main Period, Weeks 0-26||161
284728|NCT00856986|687951|P5|NOT COMPLETED|Run-in Period, Weeks -12-0||0
284729|NCT00856986|687952|P4|NOT COMPLETED|Run-in Period, Weeks -12-0||167
284730|NCT00856986|687953|P3|NOT COMPLETED|Run-in Period, Weeks -12-0||0
284731|NCT00856986|687954|P2|NOT COMPLETED|Run-in Period, Weeks -12-0||0
284732|NCT00856986|687955|P1|NOT COMPLETED|Run-in Period, Weeks -12-0||0
284733|NCT00856986|687951|P5|COMPLETED|Run-in Period, Weeks -12-0||0
284734|NCT00856986|687952|P4|COMPLETED|Run-in Period, Weeks -12-0|Subjects who withdrew during run-in and before randomisation were Early Withdrawals|0
284735|NCT00856986|687953|P3|COMPLETED|Run-in Period, Weeks -12-0||498
284736|NCT00856986|687954|P2|COMPLETED|Run-in Period, Weeks -12-0||162
284737|NCT00856986|687955|P1|COMPLETED|Run-in Period, Weeks -12-0||161
284738|NCT00856986|687951|P5|STARTED|Run-in Period, Weeks -12-0||0
284739|NCT00856986|687952|P4|STARTED|Run-in Period, Weeks -12-0||167
284740|NCT00856986|687953|P3|STARTED|Run-in Period, Weeks -12-0||498
284741|NCT00856986|687954|P2|STARTED|Run-in Period, Weeks -12-0||162
284742|NCT00856986|687955|P1|STARTED|Run-in Period, Weeks -12-0||161
284743|NCT00856973|688125|P3|NOT COMPLETED|Overall Study||38
284744|NCT00856973|688126|P2|NOT COMPLETED|Overall Study||41
284745|NCT00856973|688127|P1|NOT COMPLETED|Overall Study||36
284746|NCT00856973|688125|P3|COMPLETED|Overall Study||123
284747|NCT00856973|688126|P2|COMPLETED|Overall Study||122
284748|NCT00856973|688127|P1|COMPLETED|Overall Study||126
284749|NCT00856973|688125|P3|STARTED|Overall Study||161
284750|NCT00856973|688126|P2|STARTED|Overall Study||163
284751|NCT00856973|688127|P1|STARTED|Overall Study||162
284752|NCT00856934|688195|P3|NOT COMPLETED|Overall Study||0
284753|NCT00856934|688196|P2|NOT COMPLETED|Overall Study||0
284754|NCT00856934|688197|P1|NOT COMPLETED|Overall Study||0
284755|NCT00856934|688195|P3|COMPLETED|Overall Study||15
284756|NCT00856934|688196|P2|COMPLETED|Overall Study||15
284757|NCT00856934|688197|P1|COMPLETED|Overall Study||15
284758|NCT00856934|688195|P3|STARTED|Overall Study||15
284759|NCT00856934|688196|P2|STARTED|Overall Study||15
284760|NCT00856934|688197|P1|STARTED|Overall Study||15
284761|NCT00856908|688207|P2|NOT COMPLETED|Overall Study||0
284762|NCT00856908|688208|P1|NOT COMPLETED|Overall Study||1
284763|NCT00856908|688207|P2|COMPLETED|Overall Study||5
284764|NCT00856908|688208|P1|COMPLETED|Overall Study||14
284765|NCT00856908|688207|P2|STARTED|Overall Study||5
284766|NCT00856908|688208|P1|STARTED|Overall Study||15
284767|NCT00856856|688233|P1|NOT COMPLETED|5-year Clinical Follow-up||0
284768|NCT00856856|688233|P1|COMPLETED|5-year Clinical Follow-up|One patient missed the 4-year clinical follow-up but returned at 5 year.|100
284769|NCT00856856|688233|P1|STARTED|5-year Clinical Follow-up||100
284770|NCT00856856|688233|P1|NOT COMPLETED|4-year Clinical Follow-up||1
284771|NCT00856856|688233|P1|COMPLETED|4-year Clinical Follow-up||99
284772|NCT00856856|688233|P1|STARTED|4-year Clinical Follow-up||100
284773|NCT00856856|688233|P1|NOT COMPLETED|3-year Clinical Follow-up||0
284774|NCT00856856|688233|P1|COMPLETED|3-year Clinical Follow-up||100
284775|NCT00856856|688233|P1|STARTED|3-year Clinical Follow-up||100
284776|NCT00856856|688233|P1|NOT COMPLETED|2-year Clinical Follow-up||1
284777|NCT00856856|688233|P1|COMPLETED|2-year Clinical Follow-up||100
284778|NCT00856856|688233|P1|STARTED|2-year Clinical Follow-up||101
284779|NCT00856856|688233|P1|NOT COMPLETED|1-year Clinical Follow-up||0
284780|NCT00856856|688233|P1|COMPLETED|1-year Clinical Follow-up||101
284781|NCT00856856|688233|P1|STARTED|1-year Clinical Follow-up||101
284782|NCT00856856|688233|P1|NOT COMPLETED|270-day Clinical Follow-up||0
284783|NCT00856856|688233|P1|COMPLETED|270-day Clinical Follow-up||101
284784|NCT00856856|688233|P1|STARTED|270-day Clinical Follow-up||101
284785|NCT00856856|688233|P1|NOT COMPLETED|180-day Clinical Follow-up||0
284786|NCT00856856|688233|P1|COMPLETED|180-day Clinical Follow-up||101
284787|NCT00856856|688233|P1|STARTED|180-day Clinical Follow-up||101
284788|NCT00856856|688233|P1|NOT COMPLETED|30-day Clinical Follow-up||0
284789|NCT00856856|688233|P1|COMPLETED|30-day Clinical Follow-up||101
284790|NCT00856856|688233|P1|STARTED|30-day Clinical Follow-up||101
284791|NCT00856856|688233|P1|NOT COMPLETED|Baseline||0
284792|NCT00856856|688233|P1|COMPLETED|Baseline||101
284793|NCT00856856|688233|P1|STARTED|Baseline||101
284794|NCT00856843|688432|P2|NOT COMPLETED|Overall Study||5
284795|NCT00856843|688433|P1|NOT COMPLETED|Overall Study||2
284796|NCT00856843|688432|P2|COMPLETED|Overall Study||63
284797|NCT00856843|688433|P1|COMPLETED|Overall Study||66
284798|NCT00856843|688432|P2|STARTED|Overall Study||68
284799|NCT00856843|688433|P1|STARTED|Overall Study||68
284800|NCT00856830|688469|P4|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
284801|NCT00856830|688470|P3|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
284802|NCT00856830|688471|P2|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
284803|NCT00856830|688472|P1|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
284804|NCT00856830|688469|P4|COMPLETED|Regimen - B (Carboplatin & Etoposide)||12
284805|NCT00856830|688470|P3|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
284806|NCT00856830|688471|P2|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
284807|NCT00856830|688472|P1|COMPLETED|Regimen - B (Carboplatin & Etoposide)||3
284808|NCT00856830|688469|P4|STARTED|Regimen - B (Carboplatin & Etoposide)||12
284809|NCT00856830|688470|P3|STARTED|Regimen - B (Carboplatin & Etoposide)||6
284810|NCT00856830|688471|P2|STARTED|Regimen - B (Carboplatin & Etoposide)||6
284811|NCT00856830|688472|P1|STARTED|Regimen - B (Carboplatin & Etoposide)||3
284812|NCT00856830|688469|P4|NOT COMPLETED|Irinotecan & Bendamustine||3
284813|NCT00856830|688470|P3|NOT COMPLETED|Irinotecan & Bendamustine||0
284814|NCT00856830|688471|P2|NOT COMPLETED|Irinotecan & Bendamustine||0
284815|NCT00856830|688472|P1|NOT COMPLETED|Irinotecan & Bendamustine||0
284816|NCT00856830|688469|P4|COMPLETED|Irinotecan & Bendamustine||12
284817|NCT00856830|688470|P3|COMPLETED|Irinotecan & Bendamustine||6
284818|NCT00856830|688471|P2|COMPLETED|Irinotecan & Bendamustine||6
284819|NCT00856830|688472|P1|COMPLETED|Irinotecan & Bendamustine||3
284820|NCT00856830|688469|P4|Maximum Tolerated Dose|Irinotecan & Bendamustine||12
284821|NCT00856830|688470|P3|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
284822|NCT00856830|688471|P2|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
284823|NCT00856830|688472|P1|Maximum Tolerated Dose|Irinotecan & Bendamustine||3
284824|NCT00856830|688469|P4|STARTED|Irinotecan & Bendamustine||15
284825|NCT00856830|688470|P3|STARTED|Irinotecan & Bendamustine||6
284826|NCT00856830|688471|P2|STARTED|Irinotecan & Bendamustine||6
284827|NCT00856830|688472|P1|STARTED|Irinotecan & Bendamustine||3
284828|NCT00856791|688478|P1|NOT COMPLETED|Overall Study||0
284829|NCT00856791|688478|P1|COMPLETED|Overall Study||1
284830|NCT00856791|688478|P1|STARTED|Overall Study||1
284831|NCT00856778|688483|P1|NOT COMPLETED|Overall Study||24
284832|NCT00856778|688483|P1|COMPLETED|Overall Study||74
284833|NCT00856778|688483|P1|STARTED|Overall Study||98
284834|NCT00856739|688502|P3|NOT COMPLETED|Overall Study||0
284835|NCT00856739|688503|P2|NOT COMPLETED|Overall Study||0
284836|NCT00856739|688504|P1|NOT COMPLETED|Overall Study||0
284837|NCT00856739|688502|P3|COMPLETED|Overall Study||55
284838|NCT00856739|688503|P2|COMPLETED|Overall Study||52
284839|NCT00856739|688504|P1|COMPLETED|Overall Study||70
284840|NCT00856739|688502|P3|STARTED|Overall Study||55
284841|NCT00856739|688503|P2|STARTED|Overall Study||52
284842|NCT00856739|688504|P1|STARTED|Overall Study||70
284843|NCT00856726|688515|P1|NOT COMPLETED|Overall Study||0
284844|NCT00856726|688515|P1|COMPLETED|Overall Study||26
284845|NCT00856726|688515|P1|STARTED|Overall Study||26
284846|NCT00856661|688526|P2|NOT COMPLETED|Overall Study||29
284847|NCT00856661|688527|P1|NOT COMPLETED|Overall Study||27
284848|NCT00856661|688526|P2|COMPLETED|Overall Study||106
284849|NCT00856661|688527|P1|COMPLETED|Overall Study||108
284850|NCT00856661|688526|P2|Randomized Not Treated|Overall Study||4
284851|NCT00856661|688527|P1|Randomized Not Treated|Overall Study||9
284852|NCT00856661|688526|P2|Treated|Overall Study||131
284853|NCT00856661|688527|P1|Treated|Overall Study||126
284854|NCT00856661|688526|P2|STARTED|Overall Study|Randomised|135
284855|NCT00856661|688527|P1|STARTED|Overall Study|Randomised|135
284856|NCT00856635|688541|P2|NOT COMPLETED|Overall Study||8
284857|NCT00856635|688542|P1|NOT COMPLETED|Overall Study||10
284858|NCT00856635|688541|P2|COMPLETED|Overall Study||14
284859|NCT00856635|688542|P1|COMPLETED|Overall Study||12
284860|NCT00856635|688541|P2|Received Study Drug|Overall Study||20
284861|NCT00856635|688542|P1|Received Study Drug|Overall Study||20
284862|NCT00856635|688541|P2|STARTED|Overall Study||22
284863|NCT00856635|688542|P1|STARTED|Overall Study||22
284864|NCT00856609|688552|P2|NOT COMPLETED|Overall Study||0
284865|NCT00856609|688553|P1|NOT COMPLETED|Overall Study||1
284866|NCT00856609|688552|P2|COMPLETED|Overall Study||39
284867|NCT00856609|688553|P1|COMPLETED|Overall Study||40
284868|NCT00856609|688552|P2|STARTED|Overall Study||39
284869|NCT00856609|688553|P1|STARTED|Overall Study||41
284870|NCT00856583|688565|P2|NOT COMPLETED|Overall Study||2597
284871|NCT00856583|688566|P1|NOT COMPLETED|Overall Study||3137
284872|NCT00856583|688565|P2|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|2307
284873|NCT00856583|688566|P1|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|1768
284874|NCT00856583|688565|P2|STARTED|Overall Study|Patients treated|4904
284875|NCT00856583|688566|P1|STARTED|Overall Study|Patients treated|4905
284876|NCT00856557|688596|P2|NOT COMPLETED|Overall Study||16
284877|NCT00856557|688597|P1|NOT COMPLETED|Overall Study||12
284878|NCT00856557|688596|P2|COMPLETED|Overall Study||60
284879|NCT00856557|688597|P1|COMPLETED|Overall Study||50
284880|NCT00856557|688596|P2|With Patients With Contextual Flags|Overall Study||60
284881|NCT00856557|688597|P1|With Patients With Contextual Flags|Overall Study||50
284882|NCT00856557|688596|P2|Tested With Standardized Patients|Overall Study||76
284883|NCT00856557|688597|P1|Tested With Standardized Patients|Overall Study||62
284884|NCT00856557|688596|P2|Received Intervention/Control|Overall Study||76
284885|NCT00856557|688597|P1|Received Intervention/Control|Overall Study||62
284886|NCT00856557|688596|P2|STARTED|Overall Study||76
284887|NCT00856557|688597|P1|STARTED|Overall Study||62
284888|NCT00856544|688611|P4|NOT COMPLETED|Overall Study||13
284889|NCT00856544|688612|P3|NOT COMPLETED|Overall Study||8
284890|NCT00856544|688613|P2|NOT COMPLETED|Overall Study||66
284891|NCT00856544|688614|P1|NOT COMPLETED|Overall Study||57
284892|NCT00856544|688611|P4|COMPLETED|Overall Study||67
284893|NCT00856544|688612|P3|COMPLETED|Overall Study||71
284894|NCT00856544|688613|P2|COMPLETED|Overall Study||252
284895|NCT00856544|688614|P1|COMPLETED|Overall Study||261
284896|NCT00856544|688611|P4|Treated|Overall Study||80
284897|NCT00856544|688612|P3|Treated|Overall Study||79
284898|NCT00856544|688613|P2|Treated|Overall Study||318
284899|NCT00856544|688614|P1|Treated|Overall Study||315
284900|NCT00856544|688611|P4|STARTED|Overall Study||80
284901|NCT00856544|688612|P3|STARTED|Overall Study||79
284902|NCT00856544|688613|P2|STARTED|Overall Study||318
284903|NCT00856544|688614|P1|STARTED|Overall Study||318
284904|NCT00856518|688793|P2|NOT COMPLETED|Overall Study||2
284905|NCT00856518|688794|P1|NOT COMPLETED|Overall Study||4
284906|NCT00856518|688793|P2|COMPLETED|Overall Study||16
284907|NCT00856518|688794|P1|COMPLETED|Overall Study||20
284908|NCT00856518|688793|P2|STARTED|Overall Study||18
284909|NCT00856518|688794|P1|STARTED|Overall Study||24
284910|NCT00856492|688807|P3|NOT COMPLETED|Overall Study||2
284911|NCT00856492|688808|P2|NOT COMPLETED|Overall Study||1
284912|NCT00856492|688809|P1|NOT COMPLETED|Overall Study||1
284913|NCT00856492|688807|P3|COMPLETED|Overall Study||51
284914|NCT00856492|688808|P2|COMPLETED|Overall Study||62
284915|NCT00856492|688809|P1|COMPLETED|Overall Study||98
284916|NCT00856492|688807|P3|Toxicity Eval|Overall Study||51
284917|NCT00856492|688808|P2|Toxicity Eval|Overall Study||60
284918|NCT00856492|688809|P1|Toxicity Eval|Overall Study||96
284919|NCT00856492|688807|P3|STARTED|Overall Study||53
284920|NCT00856492|688808|P2|STARTED|Overall Study||63
284921|NCT00856492|688809|P1|STARTED|Overall Study||99
284922|NCT00856414|688823|P1|NOT COMPLETED|Overall Study||0
284923|NCT00856414|688823|P1|COMPLETED|Overall Study||45
284924|NCT00856414|688823|P1|STARTED|Overall Study||45
284925|NCT00856388|688831|P1|NOT COMPLETED|Overall Study||1
284926|NCT00856388|688831|P1|COMPLETED|Overall Study||61
284927|NCT00856388|688831|P1|STARTED|Overall Study||62
284928|NCT00856349|688842|P1|NOT COMPLETED|Overall Study||1021
284929|NCT00856349|688842|P1|COMPLETED|Overall Study||3111
284930|NCT00856349|688842|P1|24 Month Follow-up|Overall Study||1698
284931|NCT00856349|688842|P1|18 Month Follow-up|Overall Study||2467
284932|NCT00856349|688842|P1|12 Month Follow-up|Overall Study||3228
284933|NCT00856349|688842|P1|STARTED|Overall Study||4132
284934|NCT00856323|688851|P1|NOT COMPLETED|Overall Study||2
284935|NCT00856323|688851|P1|COMPLETED|Overall Study||51
284936|NCT00856323|688851|P1|STARTED|Overall Study||53
284937|NCT00856297|688863|P5|NOT COMPLETED|Overall Study||0
284938|NCT00856297|688864|P4|NOT COMPLETED|Overall Study||0
284939|NCT00856297|688865|P3|NOT COMPLETED|Overall Study||0
284940|NCT00856297|688866|P2|NOT COMPLETED|Overall Study||0
284941|NCT00856297|688867|P1|NOT COMPLETED|Overall Study||2
284942|NCT00856297|688863|P5|COMPLETED|Overall Study||31
284943|NCT00856297|688864|P4|COMPLETED|Overall Study||44
284944|NCT00856297|688865|P3|COMPLETED|Overall Study||107
284945|NCT00856297|688866|P2|COMPLETED|Overall Study||76
284946|NCT00856297|688867|P1|COMPLETED|Overall Study||129
284947|NCT00856297|688863|P5|STARTED|Overall Study||31
284948|NCT00856297|688864|P4|STARTED|Overall Study||44
284949|NCT00856297|688865|P3|STARTED|Overall Study||107
284950|NCT00856297|688866|P2|STARTED|Overall Study||76
284951|NCT00856297|688867|P1|STARTED|Overall Study||131
284952|NCT00856284|688900|P3|NOT COMPLETED|Overall Study||447
284953|NCT00856284|688901|P2|NOT COMPLETED|Overall Study||392
284954|NCT00856284|688902|P1|NOT COMPLETED|Overall Study||408
284955|NCT00856284|688900|P3|COMPLETED|Overall Study||427
284956|NCT00856284|688901|P2|COMPLETED|Overall Study||493
284957|NCT00856284|688902|P1|COMPLETED|Overall Study||472
284958|NCT00856284|688900|P3|Received Study Drug|Overall Study||869
284959|NCT00856284|688901|P2|Received Study Drug|Overall Study||878
284960|NCT00856284|688902|P1|Received Study Drug|Overall Study||873
284961|NCT00856284|688900|P3|STARTED|Overall Study||874
284962|NCT00856284|688901|P2|STARTED|Overall Study||885
284963|NCT00856284|688902|P1|STARTED|Overall Study||880
284964|NCT00856245|688928|P1|NOT COMPLETED|Overall Study||5
284965|NCT00856245|688928|P1|COMPLETED|Overall Study||14
284966|NCT00856245|688928|P1|STARTED|Overall Study||19
284967|NCT00856232|688936|P3|NOT COMPLETED|Overall Study||0
284968|NCT00856232|688937|P2|NOT COMPLETED|Overall Study||0
284969|NCT00856232|688938|P1|NOT COMPLETED|Overall Study||0
284970|NCT00856232|688936|P3|COMPLETED|Overall Study||36
284971|NCT00856232|688937|P2|COMPLETED|Overall Study||29
284972|NCT00856232|688938|P1|COMPLETED|Overall Study||26
284973|NCT00856232|688936|P3|STARTED|Overall Study||36
284974|NCT00856232|688937|P2|STARTED|Overall Study||29
284975|NCT00856232|688938|P1|STARTED|Overall Study||26
284976|NCT00856206|688951|P2|NOT COMPLETED|Overall Study||161
284977|NCT00856206|688952|P1|NOT COMPLETED|Overall Study||54
284978|NCT00856206|688951|P2|COMPLETED|Overall Study||824
284979|NCT00856206|688952|P1|COMPLETED|Overall Study||276
284980|NCT00856206|688951|P2|STARTED|Overall Study||985
284981|NCT00856206|688952|P1|STARTED|Overall Study||330
284982|NCT00856193|688966|P2|NOT COMPLETED|Period 2||2
284983|NCT00856193|688967|P1|NOT COMPLETED|Period 2||0
284984|NCT00856193|688966|P2|COMPLETED|Period 2||15
284985|NCT00856193|688967|P1|COMPLETED|Period 2||16
284986|NCT00856193|688966|P2|STARTED|Period 2||17
284987|NCT00856193|688967|P1|STARTED|Period 2||16
284988|NCT00856193|688966|P2|NOT COMPLETED|Period 1||0
284989|NCT00856193|688967|P1|NOT COMPLETED|Period 1||0
284990|NCT00856193|688966|P2|COMPLETED|Period 1||17
284991|NCT00856193|688967|P1|COMPLETED|Period 1||16
284992|NCT00856193|688966|P2|STARTED|Period 1||17
284993|NCT00856193|688967|P1|STARTED|Period 1||16
284994|NCT00856180|688979|P1|NOT COMPLETED|Overall Study||20
284995|NCT00856180|688979|P1|COMPLETED|Overall Study||0
284996|NCT00856180|688979|P1|STARTED|Overall Study||20
284997|NCT00856050|688988|P1|NOT COMPLETED|Overall Study||0
284998|NCT00856050|688988|P1|COMPLETED|Overall Study||26
284999|NCT00856050|688988|P1|STARTED|Overall Study||26
285000|NCT00856024|688992|P1|NOT COMPLETED|Overall Study||0
285001|NCT00856024|688992|P1|COMPLETED|Overall Study||902
285002|NCT00856024|688992|P1|STARTED|Overall Study||902
285003|NCT00855959|689004|P1|NOT COMPLETED|Overall Study||9
285004|NCT00855959|689004|P1|COMPLETED|Overall Study||99
285005|NCT00855959|689004|P1|Patients Who Received Pulmicort Respules|Overall Study||105
285006|NCT00855959|689004|P1|STARTED|Overall Study||108
285007|NCT00855933|689021|P2|NOT COMPLETED|Overall Study||1
285008|NCT00855933|689022|P1|NOT COMPLETED|Overall Study||0
285009|NCT00855933|689021|P2|COMPLETED|Overall Study||29
285010|NCT00855933|689022|P1|COMPLETED|Overall Study||30
285011|NCT00855933|689021|P2|STARTED|Overall Study||30
285012|NCT00855933|689022|P1|STARTED|Overall Study||30
285013|NCT00855920|689031|P3|NOT COMPLETED|Overall Study||11
285014|NCT00855920|689032|P2|NOT COMPLETED|Overall Study||9
285015|NCT00855920|689033|P1|NOT COMPLETED|Overall Study||8
285016|NCT00855920|689031|P3|COMPLETED|Overall Study||64
285017|NCT00855920|689032|P2|COMPLETED|Overall Study||65
285018|NCT00855920|689033|P1|COMPLETED|Overall Study||68
285019|NCT00855920|689031|P3|Safety Population|Overall Study||75
285020|NCT00855920|689032|P2|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|73
285021|NCT00855920|689033|P1|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|77
285022|NCT00855920|689031|P3|STARTED|Overall Study||75
285023|NCT00855920|689032|P2|STARTED|Overall Study||74
285024|NCT00855920|689033|P1|STARTED|Overall Study||76
285025|NCT00855894|689050|P1|NOT COMPLETED|Overall Study||33
285026|NCT00855894|689050|P1|COMPLETED|Overall Study||8
285027|NCT00855894|689050|P1|STARTED|Overall Study||41
285028|NCT00855868|689060|P2|NOT COMPLETED|Overall Study||1
285029|NCT00855868|689061|P1|NOT COMPLETED|Overall Study||1
285030|NCT00855868|689060|P2|COMPLETED|Overall Study||14
285031|NCT00855868|689061|P1|COMPLETED|Overall Study||12
285032|NCT00855868|689060|P2|STARTED|Overall Study||15
285033|NCT00855868|689061|P1|STARTED|Overall Study||13
285034|NCT00855842|689067|P1|NOT COMPLETED|Overall Study||0
285035|NCT00855842|689067|P1|COMPLETED|Overall Study||4
285036|NCT00855842|689067|P1|STARTED|Overall Study||4
285037|NCT00855816|689073|P2|NOT COMPLETED|Overall Study||21
285038|NCT00855816|689074|P1|NOT COMPLETED|Overall Study||26
285039|NCT00855816|689073|P2|COMPLETED|Overall Study||12
285040|NCT00855816|689074|P1|COMPLETED|Overall Study||21
285041|NCT00855816|689073|P2|STARTED|Overall Study||33
285042|NCT00855816|689074|P1|STARTED|Overall Study||47
285043|NCT00855738|689080|P1|NOT COMPLETED|Overall Study||5
285044|NCT00855738|689080|P1|COMPLETED|Overall Study||106
285045|NCT00855738|689080|P1|At Least 1 Dose and 1 Endpoint|Overall Study|Received at least 1 dose of study drug and had data for at least 1 efficacy endpoint.|108
285046|NCT00855738|689080|P1|STARTED|Overall Study||111
285047|NCT00855595|689108|P2|NOT COMPLETED|Overall Study||7
285048|NCT00855595|689109|P1|NOT COMPLETED|Overall Study||6
285049|NCT00855595|689108|P2|COMPLETED|Overall Study||94
285050|NCT00855595|689109|P1|COMPLETED|Overall Study||100
285051|NCT00855595|689108|P2|STARTED|Overall Study||101
285052|NCT00855595|689109|P1|STARTED|Overall Study||106
285053|NCT00855582|689148|P3|NOT COMPLETED|Overall Study||30
285054|NCT00855582|689149|P2|NOT COMPLETED|Overall Study||24
285055|NCT00855582|689150|P1|NOT COMPLETED|Overall Study||26
285056|NCT00855582|689148|P3|COMPLETED|Overall Study||170
285057|NCT00855582|689149|P2|COMPLETED|Overall Study||184
285058|NCT00855582|689150|P1|COMPLETED|Overall Study||172
285059|NCT00855582|689148|P3|STARTED|Overall Study||200
285060|NCT00855582|689149|P2|STARTED|Overall Study||208
285061|NCT00855582|689150|P1|STARTED|Overall Study||198
285062|NCT00855465|689239|P2|NOT COMPLETED|Follow-up Period (FUP)||2
285063|NCT00855465|689240|P1|NOT COMPLETED|Follow-up Period (FUP)||8
285064|NCT00855465|689239|P2|COMPLETED|Follow-up Period (FUP)||2
285065|NCT00855465|689240|P1|COMPLETED|Follow-up Period (FUP)||9
285066|NCT00855465|689239|P2|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|4
285067|NCT00855465|689240|P1|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|17
285068|NCT00855465|689239|P2|NOT COMPLETED|Treatment Period||5
285069|NCT00855465|689240|P1|NOT COMPLETED|Treatment Period||14
285070|NCT00855465|689239|P2|COMPLETED|Treatment Period||83
285071|NCT00855465|689240|P1|COMPLETED|Treatment Period||160
285072|NCT00855465|689239|P2|Participants Received Treatment|Treatment Period||88
285073|NCT00855465|689240|P1|Participants Received Treatment|Treatment Period|1 subject randomized but not treated|173
285074|NCT00855465|689239|P2|STARTED|Treatment Period||88
285075|NCT00855465|689240|P1|STARTED|Treatment Period||174
285076|NCT00855439|689330|P2|NOT COMPLETED|Overall Study||0
285077|NCT00855439|689331|P1|NOT COMPLETED|Overall Study||3
285078|NCT00855439|689330|P2|COMPLETED|Overall Study||24
285079|NCT00855439|689331|P1|COMPLETED|Overall Study||19
285080|NCT00855439|689330|P2|STARTED|Overall Study||24
285081|NCT00855439|689331|P1|STARTED|Overall Study||22
285082|NCT00855413|689343|P1|NOT COMPLETED|Overall Study||0
285083|NCT00855413|689343|P1|COMPLETED|Overall Study||15
285084|NCT00855413|689343|P1|STARTED|Overall Study||15
285085|NCT00855335|689389|P5|NOT COMPLETED|Overall Study||1
285086|NCT00855335|689390|P4|NOT COMPLETED|Overall Study||7
285087|NCT00855335|689391|P3|NOT COMPLETED|Overall Study||5
285088|NCT00855335|689392|P2|NOT COMPLETED|Overall Study||2
285089|NCT00855335|689393|P1|NOT COMPLETED|Overall Study||5
285090|NCT00855335|689389|P5|COMPLETED|Overall Study||6
285091|NCT00855335|689390|P4|COMPLETED|Overall Study||12
285092|NCT00855335|689391|P3|COMPLETED|Overall Study||10
285093|NCT00855335|689392|P2|COMPLETED|Overall Study||16
285094|NCT00855335|689393|P1|COMPLETED|Overall Study||13
285095|NCT00855335|689389|P5|STARTED|Overall Study||7
285096|NCT00855335|689390|P4|STARTED|Overall Study||19
285097|NCT00855335|689391|P3|STARTED|Overall Study||15
285098|NCT00855335|689392|P2|STARTED|Overall Study||18
285099|NCT00855335|689393|P1|STARTED|Overall Study||18
285100|NCT00855309|689480|P2|NOT COMPLETED|Overall Study||0
285101|NCT00855309|689481|P1|NOT COMPLETED|Overall Study||1
285102|NCT00855309|689480|P2|COMPLETED|Overall Study||55
285103|NCT00855309|689481|P1|COMPLETED|Overall Study||56
285104|NCT00855309|689480|P2|STARTED|Overall Study||55
285105|NCT00855309|689481|P1|STARTED|Overall Study||57
285106|NCT00855218|689489|P2|NOT COMPLETED|Overall Study||153
285107|NCT00855218|689490|P1|NOT COMPLETED|Overall Study||154
285108|NCT00855218|689489|P2|COMPLETED|Overall Study||0
285109|NCT00855218|689490|P1|COMPLETED|Overall Study||0
285110|NCT00855218|689489|P2|Participants Received Treatment|Overall Study||151
285111|NCT00855218|689490|P1|Participants Received Treatment|Overall Study||153
285112|NCT00855218|689489|P2|STARTED|Overall Study||153
285113|NCT00855218|689490|P1|STARTED|Overall Study||154
285114|NCT00855166|689508|P2|NOT COMPLETED|Overall Study||8
285115|NCT00855166|689509|P1|NOT COMPLETED|Overall Study||5
285116|NCT00855166|689508|P2|COMPLETED|Overall Study||83
285117|NCT00855166|689509|P1|COMPLETED|Overall Study||86
285118|NCT00855166|689508|P2|STARTED|Overall Study|Of the 91 randomized participants only 89 were included in the full analysis set.|91
285119|NCT00855166|689509|P1|STARTED|Overall Study||91
285120|NCT00855062|689529|P2|NOT COMPLETED|Step2||6
285121|NCT00855062|689530|P1|NOT COMPLETED|Step2||6
285122|NCT00855062|689529|P2|COMPLETED|Step2||15
285123|NCT00855062|689530|P1|COMPLETED|Step2||13
285124|NCT00855062|689529|P2|STARTED|Step2|26 participants completed STEP1; however, only 21 out of the 26 decided to enroll in STEP2.|21
285125|NCT00855062|689530|P1|STARTED|Step2|26 participants completed STEP1; however, only 19 out of the 26 decided to enroll in STEP2.|19
285126|NCT00855062|689529|P2|NOT COMPLETED|Step1||11
285127|NCT00855062|689530|P1|NOT COMPLETED|Step1||10
285128|NCT00855062|689529|P2|COMPLETED|Step1||26
285129|NCT00855062|689530|P1|COMPLETED|Step1||26
285130|NCT00855062|689529|P2|STARTED|Step1||37
285131|NCT00855062|689530|P1|STARTED|Step1||36
285132|NCT00855010|689556|P2|NOT COMPLETED|Overall Study||1
285133|NCT00855010|689557|P1|NOT COMPLETED|Overall Study||4
285134|NCT00855010|689556|P2|COMPLETED|Overall Study||18
285135|NCT00855010|689557|P1|COMPLETED|Overall Study||19
285136|NCT00855010|689556|P2|STARTED|Overall Study||19
285137|NCT00855010|689557|P1|STARTED|Overall Study||23
285138|NCT00854906|689579|P1|NOT COMPLETED|Overall Study||1
285139|NCT00854906|689579|P1|COMPLETED|Overall Study|There were 26 participants in this group. One person was excluded be causes of no ocular history.|25
285140|NCT00854906|689579|P1|STARTED|Overall Study|There were 26 participants whose eyes were measured in the KTBUT group.|26
285141|NCT00854724|689588|P2|NOT COMPLETED|Second Intervention||1
285142|NCT00854724|689589|P1|NOT COMPLETED|Second Intervention||1
285143|NCT00854724|689588|P2|COMPLETED|Second Intervention||5
285144|NCT00854724|689589|P1|COMPLETED|Second Intervention||5
285145|NCT00854724|689588|P2|STARTED|Second Intervention||6
285146|NCT00854724|689589|P1|STARTED|Second Intervention||6
285147|NCT00854724|689588|P2|NOT COMPLETED|Washout||1
285148|NCT00854724|689589|P1|NOT COMPLETED|Washout||1
285149|NCT00854724|689588|P2|COMPLETED|Washout||6
285150|NCT00854724|689589|P1|COMPLETED|Washout||6
285151|NCT00854724|689588|P2|STARTED|Washout||7
285152|NCT00854724|689589|P1|STARTED|Washout||7
285153|NCT00854724|689588|P2|NOT COMPLETED|First Intervention||1
285154|NCT00854724|689589|P1|NOT COMPLETED|First Intervention||1
285155|NCT00854724|689588|P2|COMPLETED|First Intervention||7
285156|NCT00854724|689589|P1|COMPLETED|First Intervention||7
285157|NCT00854724|689588|P2|STARTED|First Intervention||8
285158|NCT00854724|689589|P1|STARTED|First Intervention||8
285159|NCT00854620|689595|P1|NOT COMPLETED|Overall Study||1
285160|NCT00854620|689595|P1|COMPLETED|Overall Study||8
285161|NCT00854620|689595|P1|STARTED|Overall Study||9
285162|NCT00854607|689599|P1|NOT COMPLETED|2 Weeks After Start Anti-fungal Therapy||65
285163|NCT00854607|689599|P1|COMPLETED|2 Weeks After Start Anti-fungal Therapy||51
285164|NCT00854607|689599|P1|STARTED|2 Weeks After Start Anti-fungal Therapy||116
285165|NCT00854607|689599|P1|NOT COMPLETED|Enrollment||0
285166|NCT00854607|689599|P1|COMPLETED|Enrollment||116
285167|NCT00854607|689599|P1|STARTED|Enrollment||116
285168|NCT00854594|689634|P2|NOT COMPLETED|Overall Study||0
285169|NCT00854594|689635|P1|NOT COMPLETED|Overall Study||0
285170|NCT00854594|689634|P2|COMPLETED|Overall Study||69
285171|NCT00854594|689635|P1|COMPLETED|Overall Study||48
285172|NCT00854594|689634|P2|STARTED|Overall Study|9 sites randomized to intervention, providers completed surveys before and/or after study period|69
285173|NCT00854594|689635|P1|STARTED|Overall Study|9 sites randomized to control arm, providers completed surveys before and/or after study period|48
285174|NCT00854581|689647|P1|NOT COMPLETED|Part 2 Maintenance (Up to 12 Months)||3
285175|NCT00854581|689647|P1|COMPLETED|Part 2 Maintenance (Up to 12 Months)||2
285176|NCT00854581|689647|P1|STARTED|Part 2 Maintenance (Up to 12 Months)||5
285177|NCT00854581|689647|P1|NOT COMPLETED|Part 1 Maintenance (Up to Day 60)||2
285178|NCT00854581|689647|P1|COMPLETED|Part 1 Maintenance (Up to Day 60)||5
285179|NCT00854581|689647|P1|STARTED|Part 1 Maintenance (Up to Day 60)||7
285180|NCT00854581|689647|P1|NOT COMPLETED|Induction (Up to Day 21)||6
285181|NCT00854581|689647|P1|COMPLETED|Induction (Up to Day 21)||7
285182|NCT00854581|689647|P1|STARTED|Induction (Up to Day 21)||13
285183|NCT00854373|689662|P2|NOT COMPLETED|Overall Study||4
285184|NCT00854373|689663|P1|NOT COMPLETED|Overall Study||2
285185|NCT00854373|689662|P2|COMPLETED|Overall Study||89
285186|NCT00854373|689663|P1|COMPLETED|Overall Study||93
285187|NCT00854373|689662|P2|STARTED|Overall Study||93
285188|NCT00854373|689663|P1|STARTED|Overall Study||95
285189|NCT00854360|689677|P4|NOT COMPLETED|Overall Study||10
285190|NCT00854360|689678|P3|NOT COMPLETED|Overall Study||2
285191|NCT00854360|689679|P2|NOT COMPLETED|Overall Study||3
285192|NCT00854360|689680|P1|NOT COMPLETED|Overall Study||2
285193|NCT00854360|689677|P4|COMPLETED|Overall Study||114
285194|NCT00854360|689678|P3|COMPLETED|Overall Study||120
285195|NCT00854360|689679|P2|COMPLETED|Overall Study|One patient discontinued due to both an AE and study medication discontinuation.|120
285196|NCT00854360|689680|P1|COMPLETED|Overall Study||116
285197|NCT00854360|689677|P4|Intent to Treat / Safety Population|Overall Study|One patient did not receive any double-blind study medication.|123
285198|NCT00854360|689678|P3|Intent to Treat / Safety Population|Overall Study||122
285199|NCT00854360|689679|P2|Intent to Treat / Safety Population|Overall Study||123
285200|NCT00854360|689680|P1|Intent to Treat / Safety Population|Overall Study||118
285201|NCT00854360|689677|P4|STARTED|Overall Study||124
285202|NCT00854360|689678|P3|STARTED|Overall Study||122
285203|NCT00854360|689679|P2|STARTED|Overall Study||123
285204|NCT00854360|689680|P1|STARTED|Overall Study||118
285205|NCT00854308|689712|P2|NOT COMPLETED|Overall Study||67
285206|NCT00854308|689713|P1|NOT COMPLETED|Overall Study||62
285207|NCT00854308|689712|P2|COMPLETED|Overall Study||1
285208|NCT00854308|689713|P1|COMPLETED|Overall Study|Completed participants in both arms were still receiving study drug when analyses were performed.|7
285209|NCT00854308|689712|P2|Received Study Drug|Overall Study||67
285210|NCT00854308|689713|P1|Received Study Drug|Overall Study||69
285211|NCT00854308|689712|P2|STARTED|Overall Study||68
285212|NCT00854308|689713|P1|STARTED|Overall Study||69
285213|NCT00854113|689738|P11|NOT COMPLETED|Overall Study||0
285214|NCT00854113|689739|P10|NOT COMPLETED|Overall Study||0
285215|NCT00854113|689740|P9|NOT COMPLETED|Overall Study||1
285216|NCT00854113|689741|P8|NOT COMPLETED|Overall Study||3
285217|NCT00854113|689742|P7|NOT COMPLETED|Overall Study||0
285218|NCT00854113|689743|P6|NOT COMPLETED|Overall Study||0
285219|NCT00854113|689744|P5|NOT COMPLETED|Overall Study||0
285220|NCT00854113|689745|P4|NOT COMPLETED|Overall Study||0
285221|NCT00854113|689746|P3|NOT COMPLETED|Overall Study||0
285222|NCT00854113|689747|P2|NOT COMPLETED|Overall Study||0
285223|NCT00854113|689748|P1|NOT COMPLETED|Overall Study||0
285224|NCT00854113|689738|P11|COMPLETED|Overall Study||6
285225|NCT00854113|689739|P10|COMPLETED|Overall Study||8
285226|NCT00854113|689740|P9|COMPLETED|Overall Study||7
285227|NCT00854113|689741|P8|COMPLETED|Overall Study||5
285228|NCT00854113|689742|P7|COMPLETED|Overall Study||12
285229|NCT00854113|689743|P6|COMPLETED|Overall Study||6
285230|NCT00854113|689744|P5|COMPLETED|Overall Study||6
285231|NCT00854113|689745|P4|COMPLETED|Overall Study||6
285232|NCT00854113|689746|P3|COMPLETED|Overall Study||6
285233|NCT00854113|689747|P2|COMPLETED|Overall Study||6
285234|NCT00854113|689748|P1|COMPLETED|Overall Study||6
285235|NCT00854113|689738|P11|STARTED|Overall Study||6
285236|NCT00854113|689739|P10|STARTED|Overall Study||8
285237|NCT00854113|689740|P9|STARTED|Overall Study||8
285238|NCT00854113|689741|P8|STARTED|Overall Study||8
285239|NCT00854113|689742|P7|STARTED|Overall Study||12
285240|NCT00854113|689743|P6|STARTED|Overall Study||6
285241|NCT00854113|689744|P5|STARTED|Overall Study||6
285242|NCT00854113|689745|P4|STARTED|Overall Study||6
285243|NCT00854113|689746|P3|STARTED|Overall Study||6
285244|NCT00854113|689747|P2|STARTED|Overall Study||6
285245|NCT00854113|689748|P1|STARTED|Overall Study||6
285246|NCT00854100|689852|P3|NOT COMPLETED|Overall Study||11
285247|NCT00854100|689853|P2|NOT COMPLETED|Overall Study||6
285248|NCT00854100|689854|P1|NOT COMPLETED|Overall Study||9
285249|NCT00854100|689852|P3|COMPLETED|Overall Study||63
285250|NCT00854100|689853|P2|COMPLETED|Overall Study||70
285251|NCT00854100|689854|P1|COMPLETED|Overall Study||72
285252|NCT00854100|689852|P3|STARTED|Overall Study||74
285253|NCT00854100|689853|P2|STARTED|Overall Study||76
285254|NCT00854100|689854|P1|STARTED|Overall Study||81
285255|NCT00854087|689868|P2|NOT COMPLETED|Overall Study||19
285256|NCT00854087|689869|P1|NOT COMPLETED|Overall Study||19
285257|NCT00854087|689868|P2|COMPLETED|Overall Study||40
285258|NCT00854087|689869|P1|COMPLETED|Overall Study||40
285259|NCT00854087|689868|P2|STARTED|Overall Study||59
285260|NCT00854087|689869|P1|STARTED|Overall Study||59
285261|NCT00853996|689875|P1|NOT COMPLETED|Overall Study||0
285262|NCT00853996|689875|P1|COMPLETED|Overall Study||25
285263|NCT00853996|689875|P1|STARTED|Overall Study||25
285264|NCT00853970|689887|P2|NOT COMPLETED|Overall Study||3
285265|NCT00853970|689888|P1|NOT COMPLETED|Overall Study||6
285266|NCT00853970|689887|P2|COMPLETED|Overall Study||144
285267|NCT00853970|689888|P1|COMPLETED|Overall Study||146
285268|NCT00853970|689887|P2|STARTED|Overall Study||147
285269|NCT00853970|689888|P1|STARTED|Overall Study||152
285270|NCT00853957|689898|P2|NOT COMPLETED|Overall Study||19
285271|NCT00853957|689899|P1|NOT COMPLETED|Overall Study||14
285272|NCT00853957|689898|P2|COMPLETED|Overall Study||204
285273|NCT00853957|689899|P1|COMPLETED|Overall Study||206
285274|NCT00853957|689898|P2|STARTED|Overall Study||223
285275|NCT00853957|689899|P1|STARTED|Overall Study||220
285276|NCT00853905|689917|P2|NOT COMPLETED|Overall Study||4
285277|NCT00853905|689918|P1|NOT COMPLETED|Overall Study||2
285278|NCT00853905|689917|P2|COMPLETED|Overall Study||36
285279|NCT00853905|689918|P1|COMPLETED|Overall Study||35
285280|NCT00853905|689917|P2|STARTED|Overall Study||40
285281|NCT00853905|689918|P1|STARTED|Overall Study||37
285282|NCT00853840|689932|P2|NOT COMPLETED|Period 2||0
285283|NCT00853840|689933|P1|NOT COMPLETED|Period 2||0
285284|NCT00853840|689932|P2|COMPLETED|Period 2||9
285285|NCT00853840|689933|P1|COMPLETED|Period 2||9
285286|NCT00853840|689932|P2|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
285287|NCT00853840|689933|P1|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
285288|NCT00853840|689932|P2|Maraviroc (Days 1 - 3)|Period 2||9
285289|NCT00853840|689933|P1|Maraviroc (Days 1 - 3)|Period 2||9
285290|NCT00853840|689932|P2|STARTED|Period 2||9
285291|NCT00853840|689933|P1|STARTED|Period 2||9
285292|NCT00853840|689932|P2|NOT COMPLETED|Period 1||0
285293|NCT00853840|689933|P1|NOT COMPLETED|Period 1||0
285294|NCT00853840|689932|P2|COMPLETED|Period 1||9
285295|NCT00853840|689933|P1|COMPLETED|Period 1||9
285296|NCT00853840|689932|P2|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
285297|NCT00853840|689933|P1|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
285298|NCT00853840|689932|P2|Maraviroc (Days 1 - 4)|Period 1||9
285299|NCT00853840|689933|P1|Maraviroc (Days 1 - 4)|Period 1||9
285300|NCT00853840|689932|P2|STARTED|Period 1||9
285301|NCT00853840|689933|P1|STARTED|Period 1||9
285302|NCT00853827|689950|P2|NOT COMPLETED|Double Blind Period (103 Weeks)||109
285303|NCT00853827|689951|P1|NOT COMPLETED|Double Blind Period (103 Weeks)||104
285304|NCT00853827|689950|P2|COMPLETED|Double Blind Period (103 Weeks)||199
285305|NCT00853827|689951|P1|COMPLETED|Double Blind Period (103 Weeks)||201
285306|NCT00853827|689950|P2|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||233
285307|NCT00853827|689951|P1|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||225
285308|NCT00853827|689950|P2|STARTED|Double Blind Period (103 Weeks)||308
285309|NCT00853827|689951|P1|STARTED|Double Blind Period (103 Weeks)|"Started indicates number of patients in randomized set, full analysis set (FAS) and safety set."|305
285310|NCT00853827|689950|P2|NOT COMPLETED|Single Blind Period (1 Week)||0
285311|NCT00853827|689951|P1|NOT COMPLETED|Single Blind Period (1 Week)||39
285312|NCT00853827|689950|P2|COMPLETED|Single Blind Period (1 Week)||0
285313|NCT00853827|689951|P1|COMPLETED|Single Blind Period (1 Week)|Completed patients in single blind period|613
285314|NCT00853827|689950|P2|STARTED|Single Blind Period (1 Week)|This arm was only used in double blind period|0
285315|NCT00853827|689951|P1|STARTED|Single Blind Period (1 Week)|Enrolled patients in single blind|652
285316|NCT00853762|689967|P4|NOT COMPLETED|Overall Study||22
285317|NCT00853762|689968|P3|NOT COMPLETED|Overall Study||17
285318|NCT00853762|689969|P2|NOT COMPLETED|Overall Study||19
285319|NCT00853762|689970|P1|NOT COMPLETED|Overall Study||16
285320|NCT00853762|689967|P4|COMPLETED|Overall Study||0
285321|NCT00853762|689968|P3|COMPLETED|Overall Study||0
285322|NCT00853762|689969|P2|COMPLETED|Overall Study||0
285323|NCT00853762|689970|P1|COMPLETED|Overall Study||0
285324|NCT00853762|689967|P4|STARTED|Overall Study||22
285325|NCT00853762|689968|P3|STARTED|Overall Study||17
285326|NCT00853762|689969|P2|STARTED|Overall Study||19
285327|NCT00853762|689970|P1|STARTED|Overall Study||16
285328|NCT00853749|690038|P2|NOT COMPLETED|Overall Study||1
285329|NCT00853749|690039|P1|NOT COMPLETED|Overall Study||0
285330|NCT00853749|690038|P2|COMPLETED|Overall Study||38
285331|NCT00853749|690039|P1|COMPLETED|Overall Study||50
285332|NCT00853749|690038|P2|Vaccinated|Overall Study||39
285333|NCT00853749|690039|P1|Vaccinated|Overall Study||50
285334|NCT00853749|690038|P2|STARTED|Overall Study||39
285335|NCT00853749|690039|P1|STARTED|Overall Study||50
285336|NCT00853723|690060|P3|NOT COMPLETED|Overall Study||2
285337|NCT00853723|690061|P2|NOT COMPLETED|Overall Study||7
285338|NCT00853723|690062|P1|NOT COMPLETED|Overall Study||6
285339|NCT00853723|690060|P3|COMPLETED|Overall Study||33
285340|NCT00853723|690061|P2|COMPLETED|Overall Study||28
285341|NCT00853723|690062|P1|COMPLETED|Overall Study||29
285342|NCT00853723|690060|P3|STARTED|Overall Study||35
285343|NCT00853723|690061|P2|STARTED|Overall Study||35
285344|NCT00853723|690062|P1|STARTED|Overall Study||35
285345|NCT00853671|690106|P1|NOT COMPLETED|Overall Study||0
285346|NCT00853671|690106|P1|COMPLETED|Overall Study||50
285347|NCT00853671|690106|P1|STARTED|Overall Study||50
285348|NCT00853658|690116|P3|NOT COMPLETED|Overall Study||815
285349|NCT00853658|690117|P2|NOT COMPLETED|Overall Study||832
285350|NCT00853658|690118|P1|NOT COMPLETED|Overall Study||787
285351|NCT00853658|690116|P3|COMPLETED|Overall Study||1539
285352|NCT00853658|690117|P2|COMPLETED|Overall Study||1524
285353|NCT00853658|690118|P1|COMPLETED|Overall Study||1567
285354|NCT00853658|690116|P3|Safety Set|Overall Study||2345
285355|NCT00853658|690117|P2|Safety Set|Overall Study||2348
285356|NCT00853658|690118|P1|Safety Set|Overall Study||2347
285357|NCT00853658|690116|P3|Full Analysis Set (FAS)|Overall Study||2336
285358|NCT00853658|690117|P2|Full Analysis Set (FAS)|Overall Study||2340
285359|NCT00853658|690118|P1|Full Analysis Set (FAS)|Overall Study||2340
285360|NCT00853658|690116|P3|STARTED|Overall Study||2354
285361|NCT00853658|690117|P2|STARTED|Overall Study||2356
285362|NCT00853658|690118|P1|STARTED|Overall Study||2354
285363|NCT00853606|690132|P1|NOT COMPLETED|Overall Study||220
285364|NCT00853606|690132|P1|COMPLETED|Overall Study||492
285365|NCT00853606|690132|P1|STARTED|Overall Study||712
285366|NCT00853593|690138|P1|NOT COMPLETED|Overall Study||45
285367|NCT00853593|690138|P1|COMPLETED|Overall Study||152
285368|NCT00853593|690138|P1|Model 4396 Lead Attempted|Overall Study||164
285369|NCT00853593|690138|P1|Implant Attempted|Overall Study||193
285370|NCT00853593|690138|P1|STARTED|Overall Study||197
285371|NCT00853580|690165|P2|NOT COMPLETED|Overall Study||16
285372|NCT00853580|690166|P1|NOT COMPLETED|Overall Study||7
285373|NCT00853580|690165|P2|COMPLETED|Overall Study||56
285374|NCT00853580|690166|P1|COMPLETED|Overall Study||67
285375|NCT00853580|690165|P2|STARTED|Overall Study||72
285376|NCT00853580|690166|P1|STARTED|Overall Study||74
285377|NCT00853567|690213|P1|NOT COMPLETED|Overall Study||71
285378|NCT00853567|690213|P1|COMPLETED|Overall Study||0
285379|NCT00853567|690213|P1|STARTED|Overall Study||71
285380|NCT00853489|690223|P2|NOT COMPLETED|Overall Study||2
285381|NCT00853489|690224|P1|NOT COMPLETED|Overall Study||5
285382|NCT00853489|690223|P2|COMPLETED|Overall Study||12
285383|NCT00853489|690224|P1|COMPLETED|Overall Study||11
285384|NCT00853489|690223|P2|STARTED|Overall Study||14
285385|NCT00853489|690224|P1|STARTED|Overall Study||16
285386|NCT00853385|690239|P5|NOT COMPLETED|Overall Study||42
285387|NCT00853385|690240|P4|NOT COMPLETED|Overall Study||13
285388|NCT00853385|690241|P3|NOT COMPLETED|Overall Study||9
285389|NCT00853385|690242|P2|NOT COMPLETED|Overall Study||43
285390|NCT00853385|690243|P1|NOT COMPLETED|Overall Study||54
285391|NCT00853385|690239|P5|COMPLETED|Overall Study||162
285392|NCT00853385|690240|P4|COMPLETED|Overall Study||39
285393|NCT00853385|690241|P3|COMPLETED|Overall Study||47
285394|NCT00853385|690242|P2|COMPLETED|Overall Study||158
285395|NCT00853385|690243|P1|COMPLETED|Overall Study||150
285396|NCT00853385|690239|P5|STARTED|Overall Study||204
285397|NCT00853385|690240|P4|STARTED|Overall Study||52
285398|NCT00853385|690241|P3|STARTED|Overall Study||56
285399|NCT00853385|690242|P2|STARTED|Overall Study||201
285400|NCT00853385|690243|P1|STARTED|Overall Study||204
285401|NCT00853333|690459|P3|NOT COMPLETED|Overall Study||0
285402|NCT00853333|690460|P2|NOT COMPLETED|Overall Study||0
285403|NCT00853333|690461|P1|NOT COMPLETED|Overall Study||0
285404|NCT00853333|690459|P3|COMPLETED|Overall Study||31
285405|NCT00853333|690460|P2|COMPLETED|Overall Study||27
285406|NCT00853333|690461|P1|COMPLETED|Overall Study||28
285407|NCT00853333|690459|P3|STARTED|Overall Study||31
285408|NCT00853333|690460|P2|STARTED|Overall Study||27
285409|NCT00853333|690461|P1|STARTED|Overall Study||28
285410|NCT00853307|690471|P2|NOT COMPLETED|Overall Study||5
285411|NCT00853307|690472|P1|NOT COMPLETED|Overall Study||2
285412|NCT00853307|690471|P2|COMPLETED|Overall Study||20
285413|NCT00853307|690472|P1|COMPLETED|Overall Study|Completed = participants who completed the study treatment.|4
285414|NCT00853307|690471|P2|STARTED|Overall Study||25
285415|NCT00853307|690472|P1|STARTED|Overall Study||6
285416|NCT00853242|690499|P7|NOT COMPLETED|Overall Study||5
285417|NCT00853242|690500|P6|NOT COMPLETED|Overall Study||2
285418|NCT00853242|690501|P5|NOT COMPLETED|Overall Study||4
285419|NCT00853242|690502|P4|NOT COMPLETED|Overall Study||4
285420|NCT00853242|690503|P3|NOT COMPLETED|Overall Study||3
285421|NCT00853242|690504|P2|NOT COMPLETED|Overall Study||3
285422|NCT00853242|690505|P1|NOT COMPLETED|Overall Study||3
285423|NCT00853242|690499|P7|COMPLETED|Overall Study||44
285424|NCT00853242|690500|P6|COMPLETED|Overall Study||49
285425|NCT00853242|690501|P5|COMPLETED|Overall Study||46
285426|NCT00853242|690502|P4|COMPLETED|Overall Study||46
285427|NCT00853242|690503|P3|COMPLETED|Overall Study||46
285428|NCT00853242|690504|P2|COMPLETED|Overall Study||47
285429|NCT00853242|690505|P1|COMPLETED|Overall Study||47
285430|NCT00853242|690499|P7|Treated|Overall Study||48
285431|NCT00853242|690500|P6|Treated|Overall Study||51
285432|NCT00853242|690501|P5|Treated|Overall Study||50
285433|NCT00853242|690502|P4|Treated|Overall Study||50
285434|NCT00853242|690503|P3|Treated|Overall Study||48
285435|NCT00853242|690504|P2|Treated|Overall Study||49
285436|NCT00853242|690505|P1|Treated|Overall Study||50
285437|NCT00853242|690499|P7|STARTED|Overall Study||49
285438|NCT00853242|690500|P6|STARTED|Overall Study||51
285439|NCT00853242|690501|P5|STARTED|Overall Study||50
285440|NCT00853242|690502|P4|STARTED|Overall Study||50
285441|NCT00853242|690503|P3|STARTED|Overall Study||49
285442|NCT00853242|690504|P2|STARTED|Overall Study||50
285443|NCT00853242|690505|P1|STARTED|Overall Study||50
285444|NCT00853229|690547|P2|NOT COMPLETED|Phase 2: Cross Over||0
285445|NCT00853229|690548|P1|NOT COMPLETED|Phase 2: Cross Over||0
285446|NCT00853229|690547|P2|COMPLETED|Phase 2: Cross Over||0
285447|NCT00853229|690548|P1|COMPLETED|Phase 2: Cross Over||0
285448|NCT00853229|690547|P2|STARTED|Phase 2: Cross Over||0
285449|NCT00853229|690548|P1|STARTED|Phase 2: Cross Over||0
285450|NCT00853229|690547|P2|NOT COMPLETED|Phase 1: Initial Intervention||8
285451|NCT00853229|690548|P1|NOT COMPLETED|Phase 1: Initial Intervention||8
285452|NCT00853229|690547|P2|COMPLETED|Phase 1: Initial Intervention||0
285453|NCT00853229|690548|P1|COMPLETED|Phase 1: Initial Intervention||0
285454|NCT00853229|690547|P2|STARTED|Phase 1: Initial Intervention||8
285455|NCT00853229|690548|P1|STARTED|Phase 1: Initial Intervention||8
285456|NCT00853151|690558|P4|NOT COMPLETED|Overall Study||3
285457|NCT00853151|690559|P3|NOT COMPLETED|Overall Study||8
285458|NCT00853151|690560|P2|NOT COMPLETED|Overall Study||13
285459|NCT00853151|690561|P1|NOT COMPLETED|Overall Study||10
285460|NCT00853151|690558|P4|COMPLETED|Overall Study||15
285461|NCT00853151|690559|P3|COMPLETED|Overall Study||30
285462|NCT00853151|690560|P2|COMPLETED|Overall Study||24
285463|NCT00853151|690561|P1|COMPLETED|Overall Study||28
285464|NCT00853151|690558|P4|STARTED|Overall Study||18
285465|NCT00853151|690559|P3|STARTED|Overall Study||38
285466|NCT00853151|690560|P2|STARTED|Overall Study||37
285467|NCT00853151|690561|P1|STARTED|Overall Study||38
285468|NCT00853125|690703|P1|NOT COMPLETED|Overall Study||1
285469|NCT00853125|690703|P1|COMPLETED|Overall Study||9
285470|NCT00853125|690703|P1|STARTED|Overall Study||10
285471|NCT00853112|690715|P7|NOT COMPLETED|Overall Study||1
285472|NCT00853112|690716|P6|NOT COMPLETED|Overall Study||0
285473|NCT00853112|690717|P5|NOT COMPLETED|Overall Study||0
285474|NCT00853112|690718|P4|NOT COMPLETED|Overall Study||2
285475|NCT00853112|690719|P3|NOT COMPLETED|Overall Study||0
285476|NCT00853112|690720|P2|NOT COMPLETED|Overall Study||1
285477|NCT00853112|690721|P1|NOT COMPLETED|Overall Study||0
285478|NCT00853112|690715|P7|COMPLETED|Overall Study||6
285479|NCT00853112|690716|P6|COMPLETED|Overall Study||7
285480|NCT00853112|690717|P5|COMPLETED|Overall Study||6
285481|NCT00853112|690718|P4|COMPLETED|Overall Study||6
285482|NCT00853112|690719|P3|COMPLETED|Overall Study||7
285483|NCT00853112|690720|P2|COMPLETED|Overall Study||6
285484|NCT00853112|690721|P1|COMPLETED|Overall Study||6
285485|NCT00853112|690715|P7|Treated|Overall Study||6
285486|NCT00853112|690716|P6|Treated|Overall Study||7
285487|NCT00853112|690717|P5|Treated|Overall Study||6
285488|NCT00853112|690718|P4|Treated|Overall Study||6
285489|NCT00853112|690719|P3|Treated|Overall Study||7
285490|NCT00853112|690720|P2|Treated|Overall Study||6
285491|NCT00853112|690721|P1|Treated|Overall Study||6
285492|NCT00853112|690715|P7|STARTED|Overall Study||7
285493|NCT00853112|690716|P6|STARTED|Overall Study||7
285494|NCT00853112|690717|P5|STARTED|Overall Study||6
285495|NCT00853112|690718|P4|STARTED|Overall Study||8
285496|NCT00853112|690719|P3|STARTED|Overall Study||7
285497|NCT00853112|690720|P2|STARTED|Overall Study||7
285498|NCT00853112|690721|P1|STARTED|Overall Study||6
285499|NCT00853099|690831|P4|NOT COMPLETED|Double-blind + Open-label Periods||147
285500|NCT00853099|690832|P3|NOT COMPLETED|Double-blind + Open-label Periods||0
285501|NCT00853099|690833|P2|NOT COMPLETED|Double-blind + Open-label Periods||0
285502|NCT00853099|690834|P1|NOT COMPLETED|Double-blind + Open-label Periods||0
285503|NCT00853099|690831|P4|COMPLETED|Double-blind + Open-label Periods||119
285504|NCT00853099|690832|P3|COMPLETED|Double-blind + Open-label Periods||0
285505|NCT00853099|690833|P2|COMPLETED|Double-blind + Open-label Periods||0
285506|NCT00853099|690834|P1|COMPLETED|Double-blind + Open-label Periods||0
285507|NCT00853099|690831|P4|STARTED|Double-blind + Open-label Periods|7 participants randomized to placebo did not receive any adalimumab; 1 participant was excluded.|266
285508|NCT00853099|690832|P3|STARTED|Double-blind + Open-label Periods||0
285509|NCT00853099|690833|P2|STARTED|Double-blind + Open-label Periods||0
285510|NCT00853099|690834|P1|STARTED|Double-blind + Open-label Periods||0
285511|NCT00853099|690831|P4|NOT COMPLETED|Double-blind Period||0
285512|NCT00853099|690832|P3|NOT COMPLETED|Double-blind Period||31
285513|NCT00853099|690833|P2|NOT COMPLETED|Double-blind Period||29
285514|NCT00853099|690834|P1|NOT COMPLETED|Double-blind Period||23
285515|NCT00853099|690831|P4|COMPLETED|Double-blind Period||0
285516|NCT00853099|690832|P3|COMPLETED|Double-blind Period|Participants who completed Week 52.|60
285517|NCT00853099|690833|P2|COMPLETED|Double-blind Period|Participants who completed Week 52.|58
285518|NCT00853099|690834|P1|COMPLETED|Double-blind Period|Participants who completed Week 52.|73
285519|NCT00853099|690831|P4|Completed Week 8|Double-blind Period||0
285520|NCT00853099|690832|P3|Completed Week 8|Double-blind Period||86
285521|NCT00853099|690833|P2|Completed Week 8|Double-blind Period||85
285522|NCT00853099|690834|P1|Completed Week 8|Double-blind Period||92
285523|NCT00853099|690831|P4|Treated|Double-blind Period||0
285524|NCT00853099|690832|P3|Treated|Double-blind Period|1 participant, incorrectly treated with open-label (rescue) study drug at Week 0, was excluded.|90
285525|NCT00853099|690833|P2|Treated|Double-blind Period||87
285526|NCT00853099|690834|P1|Treated|Double-blind Period||96
285527|NCT00853099|690831|P4|STARTED|Double-blind Period||0
285528|NCT00853099|690832|P3|STARTED|Double-blind Period||91
285529|NCT00853099|690833|P2|STARTED|Double-blind Period||87
285530|NCT00853099|690834|P1|STARTED|Double-blind Period||96
285531|NCT00853073|690876|P2|NOT COMPLETED|Overall Study||2
285532|NCT00853073|690877|P1|NOT COMPLETED|Overall Study||3
285533|NCT00853073|690876|P2|COMPLETED|Overall Study||29
285534|NCT00853073|690877|P1|COMPLETED|Overall Study||29
285535|NCT00853073|690876|P2|STARTED|Overall Study||31
285536|NCT00853073|690877|P1|STARTED|Overall Study||32
285537|NCT00853047|690890|P6|NOT COMPLETED|Open-Label Extension Phase||17
285538|NCT00853047|690891|P5|NOT COMPLETED|Open-Label Extension Phase||0
285539|NCT00853047|690892|P4|NOT COMPLETED|Open-Label Extension Phase||0
285540|NCT00853047|690893|P3|NOT COMPLETED|Open-Label Extension Phase||0
285541|NCT00853047|690894|P2|NOT COMPLETED|Open-Label Extension Phase||0
285542|NCT00853047|690895|P1|NOT COMPLETED|Open-Label Extension Phase||0
285543|NCT00853047|690890|P6|COMPLETED|Open-Label Extension Phase||2
285544|NCT00853047|690891|P5|COMPLETED|Open-Label Extension Phase||0
285545|NCT00853047|690892|P4|COMPLETED|Open-Label Extension Phase||0
285546|NCT00853047|690893|P3|COMPLETED|Open-Label Extension Phase||0
285547|NCT00853047|690894|P2|COMPLETED|Open-Label Extension Phase||0
285548|NCT00853047|690895|P1|COMPLETED|Open-Label Extension Phase||0
285549|NCT00853047|690890|P6|Completed 8-week Extension Period|Open-Label Extension Phase||16
285550|NCT00853047|690891|P5|Completed 8-week Extension Period|Open-Label Extension Phase||0
285551|NCT00853047|690892|P4|Completed 8-week Extension Period|Open-Label Extension Phase||0
285552|NCT00853047|690893|P3|Completed 8-week Extension Period|Open-Label Extension Phase||0
285553|NCT00853047|690894|P2|Completed 8-week Extension Period|Open-Label Extension Phase||0
285554|NCT00853047|690895|P1|Completed 8-week Extension Period|Open-Label Extension Phase||0
285555|NCT00853047|690890|P6|STARTED|Open-Label Extension Phase|19 of the 22 participants who completed the Core Phase entered the optional Open-Label Extension.|19
285556|NCT00853047|690891|P5|STARTED|Open-Label Extension Phase||0
285557|NCT00853047|690892|P4|STARTED|Open-Label Extension Phase||0
285558|NCT00853047|690893|P3|STARTED|Open-Label Extension Phase||0
285559|NCT00853047|690894|P2|STARTED|Open-Label Extension Phase||0
285560|NCT00853047|690895|P1|STARTED|Open-Label Extension Phase||0
285561|NCT00853047|690890|P6|NOT COMPLETED|Core Phase||0
285562|NCT00853047|690891|P5|NOT COMPLETED|Core Phase||0
285563|NCT00853047|690892|P4|NOT COMPLETED|Core Phase||1
285564|NCT00853047|690893|P3|NOT COMPLETED|Core Phase||0
285565|NCT00853047|690894|P2|NOT COMPLETED|Core Phase||0
285566|NCT00853047|690895|P1|NOT COMPLETED|Core Phase||0
285567|NCT00853047|690890|P6|COMPLETED|Core Phase||0
285568|NCT00853047|690891|P5|COMPLETED|Core Phase||9
285569|NCT00853047|690892|P4|COMPLETED|Core Phase||2
285570|NCT00853047|690893|P3|COMPLETED|Core Phase||3
285571|NCT00853047|690894|P2|COMPLETED|Core Phase||3
285572|NCT00853047|690895|P1|COMPLETED|Core Phase||5
285573|NCT00853047|690890|P6|STARTED|Core Phase||0
285574|NCT00853047|690891|P5|STARTED|Core Phase||9
285575|NCT00853047|690892|P4|STARTED|Core Phase||3
285576|NCT00853047|690893|P3|STARTED|Core Phase||3
285577|NCT00853047|690894|P2|STARTED|Core Phase||3
285578|NCT00853047|690895|P1|STARTED|Core Phase||5
285579|NCT00853021|690961|P1|NOT COMPLETED|Overall Study||5
285580|NCT00853021|690961|P1|COMPLETED|Overall Study||21
285581|NCT00853021|690961|P1|STARTED|Overall Study||26
285582|NCT00852995|690973|P5|NOT COMPLETED|Overall Study||4
285583|NCT00852995|690974|P4|NOT COMPLETED|Overall Study||5
285584|NCT00852995|690975|P3|NOT COMPLETED|Overall Study||5
285585|NCT00852995|690976|P2|NOT COMPLETED|Overall Study||1
285586|NCT00852995|690977|P1|NOT COMPLETED|Overall Study||8
285587|NCT00852995|690973|P5|COMPLETED|Overall Study||46
285588|NCT00852995|690974|P4|COMPLETED|Overall Study||40
285589|NCT00852995|690975|P3|COMPLETED|Overall Study||39
285590|NCT00852995|690976|P2|COMPLETED|Overall Study||42
285591|NCT00852995|690977|P1|COMPLETED|Overall Study||38
285592|NCT00852995|690973|P5|STARTED|Overall Study||50
285593|NCT00852995|690974|P4|STARTED|Overall Study||45
285594|NCT00852995|690975|P3|STARTED|Overall Study||44
285595|NCT00852995|690976|P2|STARTED|Overall Study||43
285596|NCT00852995|690977|P1|STARTED|Overall Study||46
285597|NCT00852969|691021|P2|NOT COMPLETED|Overall Study||2
285598|NCT00852969|691022|P1|NOT COMPLETED|Overall Study||0
285599|NCT00852969|691021|P2|COMPLETED|Overall Study||13
285600|NCT00852969|691022|P1|COMPLETED|Overall Study||15
285601|NCT00852969|691021|P2|STARTED|Overall Study||15
285602|NCT00852969|691022|P1|STARTED|Overall Study||15
285603|NCT00852930|691033|P3|NOT COMPLETED|Overall Study||2
285604|NCT00852930|691034|P2|NOT COMPLETED|Overall Study||1
285605|NCT00852930|691035|P1|NOT COMPLETED|Overall Study||1
285606|NCT00852930|691033|P3|COMPLETED|Overall Study||15
285607|NCT00852930|691034|P2|COMPLETED|Overall Study||16
285608|NCT00852930|691035|P1|COMPLETED|Overall Study||15
285609|NCT00852930|691033|P3|STARTED|Overall Study||17
285610|NCT00852930|691034|P2|STARTED|Overall Study||17
285611|NCT00852930|691035|P1|STARTED|Overall Study||16
285612|NCT00852917|691056|P4|NOT COMPLETED|Overall Study||93
285613|NCT00852917|691057|P3|NOT COMPLETED|Overall Study||58
285614|NCT00852917|691058|P2|NOT COMPLETED|Overall Study||46
285615|NCT00852917|691059|P1|NOT COMPLETED|Overall Study||44
285616|NCT00852917|691056|P4|COMPLETED|Overall Study||134
285617|NCT00852917|691057|P3|COMPLETED|Overall Study||50
285618|NCT00852917|691058|P2|COMPLETED|Overall Study||65
285619|NCT00852917|691059|P1|COMPLETED|Overall Study||62
285620|NCT00852917|691056|P4|STARTED|Overall Study||227
285621|NCT00852917|691057|P3|STARTED|Overall Study||108
285622|NCT00852917|691058|P2|STARTED|Overall Study||111
285623|NCT00852917|691059|P1|STARTED|Overall Study||106
285624|NCT00852761|691099|P2|NOT COMPLETED|Overall Study||0
285625|NCT00852761|691100|P1|NOT COMPLETED|Overall Study||0
285626|NCT00852761|691099|P2|COMPLETED|Overall Study||17
285627|NCT00852761|691100|P1|COMPLETED|Overall Study||17
285628|NCT00852761|691099|P2|STARTED|Overall Study||17
285629|NCT00852761|691100|P1|STARTED|Overall Study||17
285630|NCT00852644|691142|P6|NOT COMPLETED|Overall Study||0
285631|NCT00852644|691143|P5|NOT COMPLETED|Overall Study||0
285632|NCT00852644|691144|P4|NOT COMPLETED|Overall Study||0
285633|NCT00852644|691145|P3|NOT COMPLETED|Overall Study||0
285634|NCT00852644|691146|P2|NOT COMPLETED|Overall Study||0
285635|NCT00852644|691147|P1|NOT COMPLETED|Overall Study||0
285636|NCT00852644|691142|P6|COMPLETED|Overall Study||0
285637|NCT00852644|691143|P5|COMPLETED|Overall Study||0
285638|NCT00852644|691144|P4|COMPLETED|Overall Study||3
285639|NCT00852644|691145|P3|COMPLETED|Overall Study||0
285640|NCT00852644|691146|P2|COMPLETED|Overall Study||3
285641|NCT00852644|691147|P1|COMPLETED|Overall Study||3
285642|NCT00852644|691142|P6|STARTED|Overall Study||0
285643|NCT00852644|691143|P5|STARTED|Overall Study||0
285644|NCT00852644|691144|P4|STARTED|Overall Study||3
285645|NCT00852644|691145|P3|STARTED|Overall Study||0
285646|NCT00852644|691146|P2|STARTED|Overall Study||3
285647|NCT00852644|691147|P1|STARTED|Overall Study||3
285648|NCT00852631|691168|P1|NOT COMPLETED|Overall Study||11
285649|NCT00852631|691168|P1|COMPLETED|Overall Study||17
285650|NCT00852631|691168|P1|STARTED|Overall Study||28
285651|NCT00852592|691176|P2|NOT COMPLETED|Overall Study||4
285652|NCT00852592|691177|P1|NOT COMPLETED|Overall Study||3
285653|NCT00852592|691176|P2|COMPLETED|Overall Study||19
285654|NCT00852592|691177|P1|COMPLETED|Overall Study||20
285655|NCT00852592|691176|P2|STARTED|Overall Study||23
285656|NCT00852592|691177|P1|STARTED|Overall Study||23
285657|NCT00852540|691187|P2|NOT COMPLETED|Overall Study||18
285658|NCT00852540|691188|P1|NOT COMPLETED|Overall Study||36
285659|NCT00852540|691187|P2|COMPLETED|Overall Study||122
285660|NCT00852540|691188|P1|COMPLETED|Overall Study||234
285661|NCT00852540|691187|P2|STARTED|Overall Study||140
285662|NCT00852540|691188|P1|STARTED|Overall Study||270
285663|NCT00852527|691214|P2|NOT COMPLETED|Overall Study||0
285664|NCT00852527|691215|P1|NOT COMPLETED|Overall Study||0
285665|NCT00852527|691214|P2|COMPLETED|Overall Study||242
285666|NCT00852527|691215|P1|COMPLETED|Overall Study||196
285667|NCT00852527|691214|P2|STARTED|Overall Study||242
285668|NCT00852527|691215|P1|STARTED|Overall Study||196
285669|NCT00852475|691222|P2|NOT COMPLETED|Overall Study||4
285670|NCT00852475|691223|P1|NOT COMPLETED|Overall Study||3
285671|NCT00852475|691222|P2|COMPLETED|Overall Study||16
285672|NCT00852475|691223|P1|COMPLETED|Overall Study||23
285673|NCT00852475|691222|P2|STARTED|Overall Study||20
285674|NCT00852475|691223|P1|STARTED|Overall Study||26
285675|NCT00852397|691234|P3|NOT COMPLETED|Overall Study||14
285676|NCT00852397|691235|P2|NOT COMPLETED|Overall Study||8
285677|NCT00852397|691236|P1|NOT COMPLETED|Overall Study||11
285678|NCT00852397|691234|P3|COMPLETED|Overall Study||36
285679|NCT00852397|691235|P2|COMPLETED|Overall Study||41
285680|NCT00852397|691236|P1|COMPLETED|Overall Study||41
285681|NCT00852397|691234|P3|Treated Participants|Overall Study||49
285682|NCT00852397|691235|P2|Treated Participants|Overall Study||49
285683|NCT00852397|691236|P1|Treated Participants|Overall Study||51
285684|NCT00852397|691234|P3|STARTED|Overall Study||50
285685|NCT00852397|691235|P2|STARTED|Overall Study||49
285686|NCT00852397|691236|P1|STARTED|Overall Study||52
285687|NCT00852241|691265|P1|NOT COMPLETED|Overall Study||18
285688|NCT00852241|691265|P1|COMPLETED|Overall Study||0
285689|NCT00852241|691265|P1|STARTED|Overall Study||18
285690|NCT00852202|691272|P3|NOT COMPLETED|Overall Study||26
285691|NCT00852202|691273|P2|NOT COMPLETED|Overall Study||12
285692|NCT00852202|691274|P1|NOT COMPLETED|Overall Study||17
285693|NCT00852202|691272|P3|COMPLETED|Overall Study||49
285694|NCT00852202|691273|P2|COMPLETED|Overall Study||63
285695|NCT00852202|691274|P1|COMPLETED|Overall Study||60
285696|NCT00852202|691272|P3|STARTED|Overall Study||75
285697|NCT00852202|691273|P2|STARTED|Overall Study||75
285698|NCT00852202|691274|P1|STARTED|Overall Study||77
285699|NCT00852137|691287|P2|NOT COMPLETED|Overall Study||0
285700|NCT00852137|691288|P1|NOT COMPLETED|Overall Study||0
285701|NCT00852137|691287|P2|COMPLETED|Overall Study||3
285702|NCT00852137|691288|P1|COMPLETED|Overall Study||13
285703|NCT00852137|691287|P2|STARTED|Overall Study||3
285704|NCT00852137|691288|P1|STARTED|Overall Study||13
285705|NCT00852124|691310|P2|NOT COMPLETED|Overall Study||0
285706|NCT00852124|691311|P1|NOT COMPLETED|Overall Study||0
285707|NCT00852124|691310|P2|COMPLETED|Overall Study||0
285708|NCT00852124|691311|P1|COMPLETED|Overall Study||3
285709|NCT00852124|691310|P2|STARTED|Overall Study||0
285710|NCT00852124|691311|P1|STARTED|Overall Study||3
285711|NCT00851903|691316|P1|NOT COMPLETED|Overall Study||2
285712|NCT00851903|691316|P1|COMPLETED|Overall Study||110
285713|NCT00851903|691316|P1|Modified Intent-To-Treat Population|Overall Study|mITT population: patients treated by combination with at least 1 on-treatment efficacy measure|111
285714|NCT00851903|691316|P1|Treated by Combination|Overall Study|patients treated with at least one dose of insulin glargine AND one dose of sitagliptin|111
285715|NCT00851903|691316|P1|Safety Population|Overall Study|patients treated with at least one dose of insulin glargine OR one dose of sitagliptin|112
285716|NCT00851903|691316|P1|STARTED|Overall Study||112
285717|NCT00851890|691330|P4|NOT COMPLETED|Overall Study||1
285718|NCT00851890|691331|P3|NOT COMPLETED|Overall Study||0
285719|NCT00851890|691332|P2|NOT COMPLETED|Overall Study||1
285720|NCT00851890|691333|P1|NOT COMPLETED|Overall Study||0
285721|NCT00851890|691330|P4|COMPLETED|Overall Study||5
285722|NCT00851890|691331|P3|COMPLETED|Overall Study||8
285723|NCT00851890|691332|P2|COMPLETED|Overall Study||7
285724|NCT00851890|691333|P1|COMPLETED|Overall Study||8
285725|NCT00851890|691330|P4|STARTED|Overall Study||6
285726|NCT00851890|691331|P3|STARTED|Overall Study||8
285727|NCT00851890|691332|P2|STARTED|Overall Study||8
285728|NCT00851890|691333|P1|STARTED|Overall Study||8
285729|NCT00851877|691390|P3|NOT COMPLETED|Phase II||3
285730|NCT00851877|691391|P2|NOT COMPLETED|Phase II||0
285731|NCT00851877|691392|P1|NOT COMPLETED|Phase II||0
285732|NCT00851877|691390|P3|COMPLETED|Phase II||22
285733|NCT00851877|691391|P2|COMPLETED|Phase II||0
285734|NCT00851877|691392|P1|COMPLETED|Phase II||0
285735|NCT00851877|691390|P3|STARTED|Phase II||25
285736|NCT00851877|691391|P2|STARTED|Phase II||0
285737|NCT00851877|691392|P1|STARTED|Phase II||0
285738|NCT00851877|691390|P3|NOT COMPLETED|Phase I-2||0
285739|NCT00851877|691391|P2|NOT COMPLETED|Phase I-2||0
285740|NCT00851877|691392|P1|NOT COMPLETED|Phase I-2||0
285741|NCT00851877|691390|P3|COMPLETED|Phase I-2||0
285742|NCT00851877|691391|P2|COMPLETED|Phase I-2||5
285743|NCT00851877|691392|P1|COMPLETED|Phase I-2||0
285744|NCT00851877|691390|P3|STARTED|Phase I-2||0
285745|NCT00851877|691391|P2|STARTED|Phase I-2||5
285746|NCT00851877|691392|P1|STARTED|Phase I-2||0
285747|NCT00851877|691390|P3|NOT COMPLETED|Phase I-1||0
285748|NCT00851877|691391|P2|NOT COMPLETED|Phase I-1||0
285749|NCT00851877|691392|P1|NOT COMPLETED|Phase I-1||1
285750|NCT00851877|691390|P3|COMPLETED|Phase I-1||0
285751|NCT00851877|691391|P2|COMPLETED|Phase I-1||0
285752|NCT00851877|691392|P1|COMPLETED|Phase I-1||6
285753|NCT00851877|691390|P3|STARTED|Phase I-1||0
285754|NCT00851877|691391|P2|STARTED|Phase I-1||0
285755|NCT00851877|691392|P1|STARTED|Phase I-1||7
285756|NCT00851799|691402|P3|NOT COMPLETED|Overall Study||24
285757|NCT00851799|691403|P2|NOT COMPLETED|Overall Study||13
285758|NCT00851799|691404|P1|NOT COMPLETED|Overall Study||16
285759|NCT00851799|691402|P3|COMPLETED|Overall Study||89
285760|NCT00851799|691403|P2|COMPLETED|Overall Study||93
285761|NCT00851799|691404|P1|COMPLETED|Overall Study||93
285762|NCT00851799|691402|P3|STARTED|Overall Study||113
285763|NCT00851799|691403|P2|STARTED|Overall Study||106
285764|NCT00851799|691404|P1|STARTED|Overall Study||109
285765|NCT00851786|691492|P2|NOT COMPLETED|Overall Study||2
285766|NCT00851786|691493|P1|NOT COMPLETED|Overall Study||5
285767|NCT00851786|691492|P2|COMPLETED|Overall Study||97
285768|NCT00851786|691493|P1|COMPLETED|Overall Study||291
285769|NCT00851786|691492|P2|STARTED|Overall Study|Two subjects (one found ineligible and one withdrew consent) were off study with no vaccine.|99
285770|NCT00851786|691493|P1|STARTED|Overall Study|One subject cannot adhere to protocol requirement and was off study with no vaccine.|296
285771|NCT00851747|691506|P3|NOT COMPLETED|Overall Study||6
285772|NCT00851747|691507|P2|NOT COMPLETED|Overall Study||6
285773|NCT00851747|691508|P1|NOT COMPLETED|Overall Study||6
285774|NCT00851747|691506|P3|COMPLETED|Overall Study||0
285775|NCT00851747|691507|P2|COMPLETED|Overall Study||0
285776|NCT00851747|691508|P1|COMPLETED|Overall Study||0
285777|NCT00851747|691506|P3|STARTED|Overall Study||6
285778|NCT00851747|691507|P2|STARTED|Overall Study||6
285779|NCT00851747|691508|P1|STARTED|Overall Study||6
285780|NCT00851721|691517|P2|NOT COMPLETED|Overall Study||1
285781|NCT00851721|691518|P1|NOT COMPLETED|Overall Study||2
285782|NCT00851721|691517|P2|COMPLETED|Overall Study||16
285783|NCT00851721|691518|P1|COMPLETED|Overall Study||17
285784|NCT00851721|691517|P2|STARTED|Overall Study||17
285785|NCT00851721|691518|P1|STARTED|Overall Study||19
285786|NCT00851682|691608|P2|NOT COMPLETED|Overall Study||0
285787|NCT00851682|691609|P1|NOT COMPLETED|Overall Study||5
285788|NCT00851682|691608|P2|COMPLETED|Overall Study||5
285789|NCT00851682|691609|P1|COMPLETED|Overall Study||55
285790|NCT00851682|691608|P2|STARTED|Overall Study||5
285791|NCT00851682|691609|P1|STARTED|Overall Study||60
285792|NCT00851643|691623|P6|NOT COMPLETED|Extension Study (Up to 36 Months)||1
285793|NCT00851643|691624|P5|NOT COMPLETED|Extension Study (Up to 36 Months)||2
285794|NCT00851643|691625|P4|NOT COMPLETED|Extension Study (Up to 36 Months)||2
285795|NCT00851643|691626|P3|NOT COMPLETED|Extension Study (Up to 36 Months)||5
285796|NCT00851643|691627|P2|NOT COMPLETED|Extension Study (Up to 36 Months)||4
285797|NCT00851643|691628|P1|NOT COMPLETED|Extension Study (Up to 36 Months)||4
285798|NCT00851643|691623|P6|COMPLETED|Extension Study (Up to 36 Months)||14
285799|NCT00851643|691624|P5|COMPLETED|Extension Study (Up to 36 Months)||19
285800|NCT00851643|691625|P4|COMPLETED|Extension Study (Up to 36 Months)||5
285801|NCT00851643|691626|P3|COMPLETED|Extension Study (Up to 36 Months)||14
285802|NCT00851643|691627|P2|COMPLETED|Extension Study (Up to 36 Months)||15
285803|NCT00851643|691628|P1|COMPLETED|Extension Study (Up to 36 Months)||6
285804|NCT00851643|691623|P6|STARTED|Extension Study (Up to 36 Months)||15
285805|NCT00851643|691624|P5|STARTED|Extension Study (Up to 36 Months)||21
285806|NCT00851643|691625|P4|STARTED|Extension Study (Up to 36 Months)||7
285807|NCT00851643|691626|P3|STARTED|Extension Study (Up to 36 Months)||19
285808|NCT00851643|691627|P2|STARTED|Extension Study (Up to 36 Months)||19
285809|NCT00851643|691628|P1|STARTED|Extension Study (Up to 36 Months)||10
285810|NCT00851643|691623|P6|NOT COMPLETED|Base Study (Up to 12 Months)||1
285811|NCT00851643|691624|P5|NOT COMPLETED|Base Study (Up to 12 Months)||0
285812|NCT00851643|691625|P4|NOT COMPLETED|Base Study (Up to 12 Months)||0
285813|NCT00851643|691626|P3|NOT COMPLETED|Base Study (Up to 12 Months)||0
285814|NCT00851643|691627|P2|NOT COMPLETED|Base Study (Up to 12 Months)||0
285815|NCT00851643|691628|P1|NOT COMPLETED|Base Study (Up to 12 Months)||1
285816|NCT00851643|691623|P6|COMPLETED|Base Study (Up to 12 Months)||29
285817|NCT00851643|691624|P5|COMPLETED|Base Study (Up to 12 Months)||30
285818|NCT00851643|691625|P4|COMPLETED|Base Study (Up to 12 Months)||15
285819|NCT00851643|691626|P3|COMPLETED|Base Study (Up to 12 Months)||30
285820|NCT00851643|691627|P2|COMPLETED|Base Study (Up to 12 Months)||30
285821|NCT00851643|691628|P1|COMPLETED|Base Study (Up to 12 Months)||14
285822|NCT00851643|691623|P6|STARTED|Base Study (Up to 12 Months)||30
285823|NCT00851643|691624|P5|STARTED|Base Study (Up to 12 Months)||30
285824|NCT00851643|691625|P4|STARTED|Base Study (Up to 12 Months)||15
285825|NCT00851643|691626|P3|STARTED|Base Study (Up to 12 Months)||30
285826|NCT00851643|691627|P2|STARTED|Base Study (Up to 12 Months)||30
285827|NCT00851643|691628|P1|STARTED|Base Study (Up to 12 Months)||15
285828|NCT00851630|691649|P2|NOT COMPLETED|Overall Study||2
285829|NCT00851630|691650|P1|NOT COMPLETED|Overall Study||2
285830|NCT00851630|691649|P2|COMPLETED|Overall Study||33
285831|NCT00851630|691650|P1|COMPLETED|Overall Study||33
285832|NCT00851630|691649|P2|STARTED|Overall Study||35
285833|NCT00851630|691650|P1|STARTED|Overall Study||35
285834|NCT00851591|691664|P2|NOT COMPLETED|Overall Study||0
285835|NCT00851591|691665|P1|NOT COMPLETED|Overall Study||2
285836|NCT00851591|691664|P2|COMPLETED|Overall Study||1
285837|NCT00851591|691665|P1|COMPLETED|Overall Study||0
285838|NCT00851591|691664|P2|STARTED|Overall Study|One received treatment.|1
285839|NCT00851591|691665|P1|STARTED|Overall Study|These 2 participants did not receive treatment.|2
285840|NCT00851552|691671|P1|NOT COMPLETED|Overall Study||7
285841|NCT00851552|691671|P1|COMPLETED|Overall Study||2
285842|NCT00851552|691671|P1|STARTED|Overall Study||9
285843|NCT00851409|691676|P1|NOT COMPLETED|Overall Study||0
285844|NCT00851409|691676|P1|COMPLETED|Overall Study||25
285845|NCT00851409|691676|P1|STARTED|Overall Study||25
285846|NCT00851318|691685|P4|NOT COMPLETED|Overall Study||19
285847|NCT00851318|691686|P3|NOT COMPLETED|Overall Study||21
285848|NCT00851318|691687|P2|NOT COMPLETED|Overall Study||5
285849|NCT00851318|691688|P1|NOT COMPLETED|Overall Study||30
285850|NCT00851318|691685|P4|COMPLETED|Overall Study||73
285851|NCT00851318|691686|P3|COMPLETED|Overall Study||72
285852|NCT00851318|691687|P2|COMPLETED|Overall Study||14
285853|NCT00851318|691688|P1|COMPLETED|Overall Study||51
285854|NCT00851318|691685|P4|Completed Week 52|Overall Study||85
285855|NCT00851318|691686|P3|Completed Week 52|Overall Study||87
285856|NCT00851318|691687|P2|Completed Week 52|Overall Study||16
285857|NCT00851318|691688|P1|Completed Week 52|Overall Study||64
285858|NCT00851318|691685|P4|Completed Week 24|Overall Study||87
285859|NCT00851318|691686|P3|Completed Week 24|Overall Study||90
285860|NCT00851318|691687|P2|Completed Week 24|Overall Study||17
285861|NCT00851318|691688|P1|Completed Week 24|Overall Study||69
285862|NCT00851318|691685|P4|STARTED|Overall Study||92
285863|NCT00851318|691686|P3|STARTED|Overall Study||93
285864|NCT00851318|691687|P2|STARTED|Overall Study||19
285865|NCT00851318|691688|P1|STARTED|Overall Study||81
285866|NCT00851279|691718|P1|NOT COMPLETED|Overall Study||0
285867|NCT00851279|691718|P1|COMPLETED|Overall Study||53
285868|NCT00851279|691718|P1|STARTED|Overall Study||53
285869|NCT00851253|691724|P2|NOT COMPLETED|Overall Study||0
285870|NCT00851253|691725|P1|NOT COMPLETED|Overall Study||1
285871|NCT00851253|691724|P2|COMPLETED|Overall Study||10
285872|NCT00851253|691725|P1|COMPLETED|Overall Study||1
285873|NCT00851253|691724|P2|STARTED|Overall Study||10
285874|NCT00851253|691725|P1|STARTED|Overall Study||2
285875|NCT00851084|691735|P2|NOT COMPLETED|Overall Study||119
285876|NCT00851084|691736|P1|NOT COMPLETED|Overall Study||117
285877|NCT00851084|691735|P2|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
285878|NCT00851084|691736|P1|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
285879|NCT00851084|691735|P2|STARTED|Overall Study||119
285880|NCT00851084|691736|P1|STARTED|Overall Study||117
285881|NCT00851006|691752|P2|NOT COMPLETED|Overall Study||0
285882|NCT00851006|691753|P1|NOT COMPLETED|Overall Study||0
285883|NCT00851006|691752|P2|COMPLETED|Overall Study||6
285884|NCT00851006|691753|P1|COMPLETED|Overall Study||7
285885|NCT00851006|691752|P2|STARTED|Overall Study||6
285886|NCT00851006|691753|P1|STARTED|Overall Study||7
285887|NCT00850993|691764|P4|NOT COMPLETED|Overall Study||1
285888|NCT00850993|691765|P3|NOT COMPLETED|Overall Study||0
285889|NCT00850993|691766|P2|NOT COMPLETED|Overall Study||0
285890|NCT00850993|691767|P1|NOT COMPLETED|Overall Study||1
285891|NCT00850993|691764|P4|COMPLETED|Overall Study||14
285892|NCT00850993|691765|P3|COMPLETED|Overall Study||8
285893|NCT00850993|691766|P2|COMPLETED|Overall Study||18
285894|NCT00850993|691767|P1|COMPLETED|Overall Study||16
285895|NCT00850993|691764|P4|Per Protocol|Overall Study||13
285896|NCT00850993|691765|P3|Per Protocol|Overall Study||5
285897|NCT00850993|691766|P2|Per Protocol|Overall Study||13
285898|NCT00850993|691767|P1|Per Protocol|Overall Study||10
285899|NCT00850993|691764|P4|Received Phototherapy|Overall Study||8
285900|NCT00850993|691765|P3|Received Phototherapy|Overall Study||2
285901|NCT00850993|691766|P2|Received Phototherapy|Overall Study||6
285902|NCT00850993|691767|P1|Received Phototherapy|Overall Study||3
285903|NCT00850993|691764|P4|Intent-to-treat|Overall Study||15
285904|NCT00850993|691765|P3|Intent-to-treat|Overall Study||8
285905|NCT00850993|691766|P2|Intent-to-treat|Overall Study||18
285906|NCT00850993|691767|P1|Intent-to-treat|Overall Study||17
285907|NCT00850993|691764|P4|Safety|Overall Study||15
285908|NCT00850993|691765|P3|Safety|Overall Study||8
285909|NCT00850993|691766|P2|Safety|Overall Study||18
285910|NCT00850993|691767|P1|Safety|Overall Study||17
285911|NCT00850993|691764|P4|STARTED|Overall Study||15
285912|NCT00850993|691765|P3|STARTED|Overall Study||8
285913|NCT00850993|691766|P2|STARTED|Overall Study||18
285914|NCT00850993|691767|P1|STARTED|Overall Study||17
285915|NCT00850889|691781|P1|NOT COMPLETED|Overall Study||0
285916|NCT00850889|691781|P1|COMPLETED|Overall Study||32
285917|NCT00850889|691781|P1|STARTED|Overall Study||32
285918|NCT00850759|691796|P4|NOT COMPLETED|Overall Study||3
285919|NCT00850759|691797|P3|NOT COMPLETED|Overall Study||5
285920|NCT00850759|691798|P2|NOT COMPLETED|Overall Study||5
285921|NCT00850759|691799|P1|NOT COMPLETED|Overall Study||7
285922|NCT00850759|691796|P4|COMPLETED|Overall Study||55
285923|NCT00850759|691797|P3|COMPLETED|Overall Study||52
285924|NCT00850759|691798|P2|COMPLETED|Overall Study||52
285925|NCT00850759|691799|P1|COMPLETED|Overall Study||52
285926|NCT00850759|691796|P4|STARTED|Overall Study||58
285927|NCT00850759|691797|P3|STARTED|Overall Study||57
285928|NCT00850759|691798|P2|STARTED|Overall Study||57
285929|NCT00850759|691799|P1|STARTED|Overall Study||59
285930|NCT00850720|691809|P1|NOT COMPLETED|Overall Study||0
285931|NCT00850720|691809|P1|COMPLETED|Overall Study||0
285932|NCT00850720|691809|P1|STARTED|Overall Study||0
285933|NCT00850642|691815|P2|NOT COMPLETED|Overall Study||0
285934|NCT00850642|691816|P1|NOT COMPLETED|Overall Study||0
285935|NCT00850642|691815|P2|COMPLETED|Overall Study||4
285936|NCT00850642|691816|P1|COMPLETED|Overall Study||3
285937|NCT00850642|691815|P2|STARTED|Overall Study||4
285938|NCT00850642|691816|P1|STARTED|Overall Study||3
285939|NCT00850603|691854|P5|NOT COMPLETED|Overall Study||0
285940|NCT00850603|691855|P4|NOT COMPLETED|Overall Study||0
285941|NCT00850603|691856|P3|NOT COMPLETED|Overall Study||0
285942|NCT00850603|691857|P2|NOT COMPLETED|Overall Study||0
285943|NCT00850603|691858|P1|NOT COMPLETED|Overall Study||0
285944|NCT00850603|691854|P5|COMPLETED|Overall Study||34
285945|NCT00850603|691855|P4|COMPLETED|Overall Study||34
285946|NCT00850603|691856|P3|COMPLETED|Overall Study||34
285947|NCT00850603|691857|P2|COMPLETED|Overall Study||34
285948|NCT00850603|691858|P1|COMPLETED|Overall Study||34
285949|NCT00850603|691854|P5|STARTED|Overall Study||34
285950|NCT00850603|691855|P4|STARTED|Overall Study||34
285951|NCT00850603|691856|P3|STARTED|Overall Study||34
285952|NCT00850603|691857|P2|STARTED|Overall Study||34
285953|NCT00850603|691858|P1|STARTED|Overall Study||34
285954|NCT00850564|691880|P1|NOT COMPLETED|Overall Study||2
285955|NCT00850564|691880|P1|COMPLETED|Overall Study||13
285956|NCT00850564|691880|P1|STARTED|Overall Study||15
285957|NCT00850538|691885|P1|NOT COMPLETED|Overall Study||41
285958|NCT00850538|691885|P1|COMPLETED|Overall Study||60
285959|NCT00850538|691885|P1|STARTED|Overall Study||101
285960|NCT00850499|691891|P2|NOT COMPLETED|Overall Study||2
285961|NCT00850499|691892|P1|NOT COMPLETED|Overall Study||3
285962|NCT00850499|691891|P2|COMPLETED|Overall Study||6
285963|NCT00850499|691892|P1|COMPLETED|Overall Study||1
285964|NCT00850499|691891|P2|STARTED|Overall Study||8
285965|NCT00850499|691892|P1|STARTED|Overall Study||4
285966|NCT00850473|691900|P1|NOT COMPLETED|Overall Study||0
285967|NCT00850473|691900|P1|COMPLETED|Overall Study||3
285968|NCT00850473|691900|P1|STARTED|Overall Study||3
285969|NCT00850460|691906|P2|NOT COMPLETED|Overall Study||4
285970|NCT00850460|691907|P1|NOT COMPLETED|Overall Study||4
285971|NCT00850460|691906|P2|COMPLETED|Overall Study||3
285972|NCT00850460|691907|P1|COMPLETED|Overall Study||3
285973|NCT00850460|691906|P2|Completion - Week 8|Overall Study||3
285974|NCT00850460|691907|P1|Completion - Week 8|Overall Study||3
285975|NCT00850460|691906|P2|Started - Week 0|Overall Study||7
285976|NCT00850460|691907|P1|Started - Week 0|Overall Study||7
285977|NCT00850460|691906|P2|STARTED|Overall Study||7
285978|NCT00850460|691907|P1|STARTED|Overall Study||7
285979|NCT00850421|691915|P1|NOT COMPLETED|Overall Study||17
285980|NCT00850421|691915|P1|COMPLETED|Overall Study||18
285981|NCT00850421|691915|P1|STARTED|Overall Study||35
285982|NCT00850395|691921|P1|NOT COMPLETED|Overall Study||10
285983|NCT00850395|691921|P1|COMPLETED|Overall Study||69
285984|NCT00850395|691921|P1|STARTED|Overall Study||79
285985|NCT00850343|691941|P4|NOT COMPLETED|Overall Study||13
285986|NCT00850343|691942|P3|NOT COMPLETED|Overall Study||14
285987|NCT00850343|691943|P2|NOT COMPLETED|Overall Study||3
285988|NCT00850343|691944|P1|NOT COMPLETED|Overall Study||46
285989|NCT00850343|691941|P4|COMPLETED|Overall Study||30
285990|NCT00850343|691942|P3|COMPLETED|Overall Study||29
285991|NCT00850343|691943|P2|COMPLETED|Overall Study||9
285992|NCT00850343|691944|P1|COMPLETED|Overall Study||64
285993|NCT00850343|691941|P4|Completed Week 52|Overall Study||37
285994|NCT00850343|691942|P3|Completed Week 52|Overall Study||37
285995|NCT00850343|691943|P2|Completed Week 52|Overall Study||11
285996|NCT00850343|691944|P1|Completed Week 52|Overall Study||88
285997|NCT00850343|691941|P4|Completed Week 24|Overall Study||39
285998|NCT00850343|691942|P3|Completed Week 24|Overall Study||39
285999|NCT00850343|691943|P2|Completed Week 24|Overall Study||12
286000|NCT00850343|691944|P1|Completed Week 24|Overall Study||94
286001|NCT00850343|691941|P4|STARTED|Overall Study||43
286002|NCT00850343|691942|P3|STARTED|Overall Study||43
286003|NCT00850343|691943|P2|STARTED|Overall Study||12
286004|NCT00850343|691944|P1|STARTED|Overall Study||110
286005|NCT00850200|691974|P1|NOT COMPLETED|Overall Study||5
286006|NCT00850200|691974|P1|COMPLETED|Overall Study||15
286007|NCT00850200|691974|P1|STARTED|Overall Study||20
286008|NCT00850174|691984|P2|NOT COMPLETED|Second Intervention||0
286009|NCT00850174|691985|P1|NOT COMPLETED|Second Intervention||1
286010|NCT00850174|691984|P2|COMPLETED|Second Intervention||28
286011|NCT00850174|691985|P1|COMPLETED|Second Intervention||29
286012|NCT00850174|691984|P2|STARTED|Second Intervention||28
286013|NCT00850174|691985|P1|STARTED|Second Intervention||30
286014|NCT00850174|691984|P2|NOT COMPLETED|Washout: One Week||2
286015|NCT00850174|691985|P1|NOT COMPLETED|Washout: One Week||0
286016|NCT00850174|691984|P2|COMPLETED|Washout: One Week||28
286017|NCT00850174|691985|P1|COMPLETED|Washout: One Week||30
286018|NCT00850174|691984|P2|STARTED|Washout: One Week||30
286019|NCT00850174|691985|P1|STARTED|Washout: One Week||30
286020|NCT00850174|691984|P2|NOT COMPLETED|First Intervention||0
286021|NCT00850174|691985|P1|NOT COMPLETED|First Intervention||0
286022|NCT00850174|691984|P2|COMPLETED|First Intervention||30
286023|NCT00850174|691985|P1|COMPLETED|First Intervention||30
286024|NCT00850174|691984|P2|STARTED|First Intervention||30
286025|NCT00850174|691985|P1|STARTED|First Intervention||30
286026|NCT00850135|691999|P1|NOT COMPLETED|Overall Study||1
286027|NCT00850135|691999|P1|COMPLETED|Overall Study||56
286028|NCT00850135|691999|P1|STARTED|Overall Study||57
286029|NCT00850096|692007|P2|NOT COMPLETED|Overall Study||2
286030|NCT00850096|692008|P1|NOT COMPLETED|Overall Study||3
286031|NCT00850096|692007|P2|COMPLETED|Overall Study||45
286032|NCT00850096|692008|P1|COMPLETED|Overall Study||44
286033|NCT00850096|692007|P2|STARTED|Overall Study||47
286034|NCT00850096|692008|P1|STARTED|Overall Study||47
286035|NCT00850070|692018|P2|NOT COMPLETED|Overall Study||1
286036|NCT00850070|692019|P1|NOT COMPLETED|Overall Study||3
286037|NCT00850070|692018|P2|COMPLETED|Overall Study||22
286038|NCT00850070|692019|P1|COMPLETED|Overall Study||20
286039|NCT00850070|692018|P2|STARTED|Overall Study||23
286040|NCT00850070|692019|P1|STARTED|Overall Study||23
286041|NCT00850031|692043|P1|NOT COMPLETED|Overall Study||17
286042|NCT00850031|692043|P1|COMPLETED|Overall Study||101
286043|NCT00850031|692043|P1|STARTED|Overall Study||118
286044|NCT00849940|692048|P1|NOT COMPLETED|Overall Study||4
286045|NCT00849940|692048|P1|COMPLETED|Overall Study||68
286046|NCT00849940|692048|P1|STARTED|Overall Study||72
286047|NCT00849901|692059|P3|NOT COMPLETED|Extension Phase||17
286048|NCT00849901|692060|P2|NOT COMPLETED|Extension Phase||26
286049|NCT00849901|692061|P1|NOT COMPLETED|Extension Phase||27
286050|NCT00849901|692059|P3|COMPLETED|Extension Phase||69
286051|NCT00849901|692060|P2|COMPLETED|Extension Phase||65
286052|NCT00849901|692061|P1|COMPLETED|Extension Phase||56
286053|NCT00849901|692059|P3|STARTED|Extension Phase||86
286054|NCT00849901|692060|P2|STARTED|Extension Phase||91
286055|NCT00849901|692061|P1|STARTED|Extension Phase||83
286056|NCT00849901|692059|P3|NOT COMPLETED|Acute Treatment Phase||16
286057|NCT00849901|692060|P2|NOT COMPLETED|Acute Treatment Phase||26
286058|NCT00849901|692061|P1|NOT COMPLETED|Acute Treatment Phase||30
286059|NCT00849901|692059|P3|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase.|87
286060|NCT00849901|692060|P2|COMPLETED|Acute Treatment Phase||91
286061|NCT00849901|692061|P1|COMPLETED|Acute Treatment Phase|4 didn't enter extension phase.|87
286062|NCT00849901|692059|P3|STARTED|Acute Treatment Phase||103
286063|NCT00849901|692060|P2|STARTED|Acute Treatment Phase||117
286064|NCT00849901|692061|P1|STARTED|Acute Treatment Phase||117
286065|NCT00849875|692108|P1|NOT COMPLETED|Overall Study||47
286066|NCT00849875|692108|P1|COMPLETED|Overall Study||1
286067|NCT00849875|692108|P1|STARTED|Overall Study||48
286068|NCT00849862|692190|P2|NOT COMPLETED|Second Intervention||0
286069|NCT00849862|692191|P1|NOT COMPLETED|Second Intervention||0
286070|NCT00849862|692190|P2|COMPLETED|Second Intervention||11
286071|NCT00849862|692191|P1|COMPLETED|Second Intervention||11
286072|NCT00849862|692190|P2|STARTED|Second Intervention||11
286073|NCT00849862|692191|P1|STARTED|Second Intervention||11
286074|NCT00849862|692190|P2|NOT COMPLETED|Washout: 7 Days||0
286075|NCT00849862|692191|P1|NOT COMPLETED|Washout: 7 Days||0
286076|NCT00849862|692190|P2|COMPLETED|Washout: 7 Days||11
286077|NCT00849862|692191|P1|COMPLETED|Washout: 7 Days||11
286078|NCT00849862|692190|P2|STARTED|Washout: 7 Days||11
286079|NCT00849862|692191|P1|STARTED|Washout: 7 Days||11
286080|NCT00849862|692190|P2|NOT COMPLETED|First Intervention||0
286081|NCT00849862|692191|P1|NOT COMPLETED|First Intervention||0
286082|NCT00849862|692190|P2|COMPLETED|First Intervention||11
286083|NCT00849862|692191|P1|COMPLETED|First Intervention||11
286084|NCT00849862|692190|P2|STARTED|First Intervention||11
286085|NCT00849862|692191|P1|STARTED|First Intervention||11
286086|NCT00849810|692199|P1|NOT COMPLETED|Overall Study||0
286087|NCT00849810|692199|P1|COMPLETED|Overall Study||1
286088|NCT00849810|692199|P1|STARTED|Overall Study||1
286089|NCT00849797|692205|P2|NOT COMPLETED|Second Intervention||0
286090|NCT00849797|692206|P1|NOT COMPLETED|Second Intervention||0
286091|NCT00849797|692205|P2|COMPLETED|Second Intervention||57
286092|NCT00849797|692206|P1|COMPLETED|Second Intervention||59
286093|NCT00849797|692205|P2|STARTED|Second Intervention||57
286094|NCT00849797|692206|P1|STARTED|Second Intervention||59
286095|NCT00849797|692205|P2|NOT COMPLETED|Washout: One Week||2
286096|NCT00849797|692206|P1|NOT COMPLETED|Washout: One Week||0
286097|NCT00849797|692205|P2|COMPLETED|Washout: One Week||57
286098|NCT00849797|692206|P1|COMPLETED|Washout: One Week||59
286099|NCT00849797|692205|P2|STARTED|Washout: One Week||59
286100|NCT00849797|692206|P1|STARTED|Washout: One Week||59
286101|NCT00849797|692205|P2|NOT COMPLETED|First Intervention||1
286102|NCT00849797|692206|P1|NOT COMPLETED|First Intervention||1
286103|NCT00849797|692205|P2|COMPLETED|First Intervention||59
286104|NCT00849797|692206|P1|COMPLETED|First Intervention||59
286105|NCT00849797|692205|P2|STARTED|First Intervention||60
286106|NCT00849797|692206|P1|STARTED|First Intervention||60
286107|NCT00849693|692224|P4|NOT COMPLETED|Extension Phase||38
286108|NCT00849693|692225|P3|NOT COMPLETED|Extension Phase||35
286109|NCT00849693|692226|P2|NOT COMPLETED|Extension Phase||30
286110|NCT00849693|692227|P1|NOT COMPLETED|Extension Phase||30
286111|NCT00849693|692224|P4|COMPLETED|Extension Phase||44
286112|NCT00849693|692225|P3|COMPLETED|Extension Phase||49
286113|NCT00849693|692226|P2|COMPLETED|Extension Phase||50
286114|NCT00849693|692227|P1|COMPLETED|Extension Phase||43
286115|NCT00849693|692224|P4|STARTED|Extension Phase||82
286116|NCT00849693|692225|P3|STARTED|Extension Phase||84
286117|NCT00849693|692226|P2|STARTED|Extension Phase||80
286118|NCT00849693|692227|P1|STARTED|Extension Phase||73
286119|NCT00849693|692224|P4|NOT COMPLETED|Acute Treatment Phase||37
286120|NCT00849693|692225|P3|NOT COMPLETED|Acute Treatment Phase||33
286121|NCT00849693|692226|P2|NOT COMPLETED|Acute Treatment Phase||35
286122|NCT00849693|692227|P1|NOT COMPLETED|Acute Treatment Phase||33
286123|NCT00849693|692224|P4|COMPLETED|Acute Treatment Phase|3 didn't enter extension phase|85
286124|NCT00849693|692225|P3|COMPLETED|Acute Treatment Phase||84
286125|NCT00849693|692226|P2|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase|81
286126|NCT00849693|692227|P1|COMPLETED|Acute Treatment Phase|2 didn't enter extension phase.|75
286127|NCT00849693|692224|P4|STARTED|Acute Treatment Phase||122
286128|NCT00849693|692225|P3|STARTED|Acute Treatment Phase||117
286129|NCT00849693|692226|P2|STARTED|Acute Treatment Phase||116
286130|NCT00849693|692227|P1|STARTED|Acute Treatment Phase||108
286131|NCT00849680|692294|P8|NOT COMPLETED|Overall Study||8
286132|NCT00849680|692295|P7|NOT COMPLETED|Overall Study||17
286133|NCT00849680|692296|P6|NOT COMPLETED|Overall Study||15
286134|NCT00849680|692297|P5|NOT COMPLETED|Overall Study||10
286135|NCT00849680|692298|P4|NOT COMPLETED|Overall Study||14
286136|NCT00849680|692299|P3|NOT COMPLETED|Overall Study||15
286137|NCT00849680|692300|P2|NOT COMPLETED|Overall Study||3
286138|NCT00849680|692301|P1|NOT COMPLETED|Overall Study||11
286139|NCT00849680|692294|P8|COMPLETED|Overall Study||23
286140|NCT00849680|692295|P7|COMPLETED|Overall Study||61
286141|NCT00849680|692296|P6|COMPLETED|Overall Study||27
286142|NCT00849680|692297|P5|COMPLETED|Overall Study||32
286143|NCT00849680|692298|P4|COMPLETED|Overall Study||28
286144|NCT00849680|692299|P3|COMPLETED|Overall Study||27
286145|NCT00849680|692300|P2|COMPLETED|Overall Study||10
286146|NCT00849680|692301|P1|COMPLETED|Overall Study||16
286147|NCT00849680|692294|P8|STARTED|Overall Study||31
286148|NCT00849680|692295|P7|STARTED|Overall Study||78
286149|NCT00849680|692296|P6|STARTED|Overall Study||42
286150|NCT00849680|692297|P5|STARTED|Overall Study||42
286151|NCT00849680|692298|P4|STARTED|Overall Study||42
286152|NCT00849680|692299|P3|STARTED|Overall Study||42
286153|NCT00849680|692300|P2|STARTED|Overall Study||13
286154|NCT00849680|692301|P1|STARTED|Overall Study||27
286155|NCT00849524|692343|P1|NOT COMPLETED|Overall Study||3
286156|NCT00849524|692343|P1|COMPLETED|Overall Study||3
286157|NCT00849524|692343|P1|STARTED|Overall Study||6
286158|NCT00849485|692351|P2|NOT COMPLETED|Second Intervention||0
286159|NCT00849485|692352|P1|NOT COMPLETED|Second Intervention||0
286160|NCT00849485|692351|P2|COMPLETED|Second Intervention||11
286161|NCT00849485|692352|P1|COMPLETED|Second Intervention||11
286162|NCT00849485|692351|P2|STARTED|Second Intervention||11
286163|NCT00849485|692352|P1|STARTED|Second Intervention||11
286164|NCT00849485|692351|P2|NOT COMPLETED|Washout: 7 Days||0
286165|NCT00849485|692352|P1|NOT COMPLETED|Washout: 7 Days||0
286166|NCT00849485|692351|P2|COMPLETED|Washout: 7 Days||11
286167|NCT00849485|692352|P1|COMPLETED|Washout: 7 Days||11
286168|NCT00849485|692351|P2|STARTED|Washout: 7 Days||11
286169|NCT00849485|692352|P1|STARTED|Washout: 7 Days||11
286170|NCT00849485|692351|P2|NOT COMPLETED|First Intervention||0
286171|NCT00849485|692352|P1|NOT COMPLETED|First Intervention||0
286172|NCT00849485|692351|P2|COMPLETED|First Intervention||11
286173|NCT00849485|692352|P1|COMPLETED|First Intervention||11
286174|NCT00849485|692351|P2|STARTED|First Intervention||11
286175|NCT00849485|692352|P1|STARTED|First Intervention||11
286176|NCT00849472|692360|P1|NOT COMPLETED|Pazopanib Postsurgery Treatment||26
286177|NCT00849472|692360|P1|COMPLETED|Pazopanib Postsurgery Treatment||16
286178|NCT00849472|692360|P1|STARTED|Pazopanib Postsurgery Treatment|36 participants completed PPT; 7 participants who discontinued PPT resumed treatment postsurgery.|42
286179|NCT00849472|692360|P1|NOT COMPLETED|Pazopanib Presurgery Treatment (PPT)||58
286180|NCT00849472|692360|P1|COMPLETED|Pazopanib Presurgery Treatment (PPT)||36
286181|NCT00849472|692360|P1|STARTED|Pazopanib Presurgery Treatment (PPT)||94
286182|NCT00849472|692360|P1|NOT COMPLETED|Weekly Paclitaxel||16
286183|NCT00849472|692360|P1|COMPLETED|Weekly Paclitaxel||78
286184|NCT00849472|692360|P1|STARTED|Weekly Paclitaxel|One par. was deemed ineligible after completing AC therapy and did not start paclitaxel+pazopanib.|94
286185|NCT00849472|692360|P1|NOT COMPLETED|Doxorubicin and Cyclophosphamide (AC)||6
286186|NCT00849472|692360|P1|COMPLETED|Doxorubicin and Cyclophosphamide (AC)||95
286187|NCT00849472|692360|P1|STARTED|Doxorubicin and Cyclophosphamide (AC)||101
286188|NCT00849381|692374|P1|NOT COMPLETED|Overall Study||145
286189|NCT00849381|692374|P1|COMPLETED|Overall Study|Out of the subjects who completed, 167 were enrolled at the center having compliance issues.|1092
286190|NCT00849381|692374|P1|STARTED|Overall Study|Out of the subjects who started, 243 were enrolled at the center having compliance issues.|1237
286191|NCT00849290|692380|P1|NOT COMPLETED|Overall Study||55
286192|NCT00849290|692380|P1|COMPLETED|Overall Study||58
286193|NCT00849290|692380|P1|STARTED|Overall Study||113
286194|NCT00849251|692384|P2|NOT COMPLETED|Overall Study||1
286195|NCT00849251|692385|P1|NOT COMPLETED|Overall Study||1
286196|NCT00849251|692384|P2|COMPLETED|Overall Study||24
286197|NCT00849251|692385|P1|COMPLETED|Overall Study||5
286198|NCT00849251|692384|P2|STARTED|Overall Study||25
286199|NCT00849251|692385|P1|STARTED|Overall Study||6
286200|NCT00849212|692391|P1|NOT COMPLETED|Overall Study||7
286201|NCT00849212|692391|P1|COMPLETED|Overall Study||23
286202|NCT00849212|692391|P1|STARTED|Overall Study||30
286203|NCT00849186|692396|P1|NOT COMPLETED|Overall Study||10
286204|NCT00849186|692396|P1|COMPLETED|Overall Study||16
286205|NCT00849186|692396|P1|STARTED|Overall Study||26
286206|NCT00849147|692402|P1|NOT COMPLETED|Overall Study||5
286207|NCT00849147|692402|P1|COMPLETED|Overall Study||50
286208|NCT00849147|692402|P1|STARTED|Overall Study||55
286209|NCT00849121|692419|P2|NOT COMPLETED|Overall Study||0
286210|NCT00849121|692420|P1|NOT COMPLETED|Overall Study||0
286211|NCT00849121|692419|P2|COMPLETED|Overall Study||9
286212|NCT00849121|692420|P1|COMPLETED|Overall Study||8
286213|NCT00849121|692419|P2|STARTED|Overall Study||9
286214|NCT00849121|692420|P1|STARTED|Overall Study||8
286215|NCT00849108|692435|P2|NOT COMPLETED|Cohort 2 Efficacy||10
286216|NCT00849108|692436|P1|NOT COMPLETED|Cohort 2 Efficacy||0
286217|NCT00849108|692435|P2|COMPLETED|Cohort 2 Efficacy||133
286218|NCT00849108|692436|P1|COMPLETED|Cohort 2 Efficacy||0
286219|NCT00849108|692435|P2|STARTED|Cohort 2 Efficacy||143
286220|NCT00849108|692436|P1|STARTED|Cohort 2 Efficacy|Cohort 1 subjects did not participate in period 2: efficacy|0
286221|NCT00849108|692435|P2|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
286222|NCT00849108|692436|P1|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||1
286223|NCT00849108|692435|P2|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
286224|NCT00849108|692436|P1|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||32
286225|NCT00849108|692435|P2|STARTED|Cohort 1 Dose Ranging and Dose Interval|Cohort 2(Pharm Stress) subjects did not participate in dose range, dose frequency|0
286226|NCT00849108|692436|P1|STARTED|Cohort 1 Dose Ranging and Dose Interval||33
286227|NCT00849056|692446|P2|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||25
286228|NCT00849056|692447|P1|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||27
286229|NCT00849056|692446|P2|COMPLETED|Follow-up Period (FUP) (8 Weeks)||124
286230|NCT00849056|692447|P1|COMPLETED|Follow-up Period (FUP) (8 Weeks)||122
286231|NCT00849056|692446|P2|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|149
286232|NCT00849056|692447|P1|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Two par. did not participate in the FUP.|149
286399|NCT00848393|692844|P1|COMPLETED|Overall Study||17
286233|NCT00849056|692446|P2|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||50
286234|NCT00849056|692447|P1|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||63
286235|NCT00849056|692446|P2|COMPLETED|Treatment Period (TP) (156 Weeks)||100
286236|NCT00849056|692447|P1|COMPLETED|Treatment Period (TP) (156 Weeks)||88
286237|NCT00849056|692446|P2|STARTED|Treatment Period (TP) (156 Weeks)||150
286238|NCT00849056|692447|P1|STARTED|Treatment Period (TP) (156 Weeks)||151
286239|NCT00849017|692472|P3|NOT COMPLETED|Follow-up Period (8 Weeks)||25
286240|NCT00849017|692473|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||18
286241|NCT00849017|692474|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||25
286242|NCT00849017|692472|P3|COMPLETED|Follow-up Period (8 Weeks)||74
286243|NCT00849017|692473|P2|COMPLETED|Follow-up Period (8 Weeks)||83
286244|NCT00849017|692474|P1|COMPLETED|Follow-up Period (8 Weeks)||76
286245|NCT00849017|692472|P3|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|99
286246|NCT00849017|692473|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
286247|NCT00849017|692474|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
286248|NCT00849017|692472|P3|NOT COMPLETED|Treatment Period (156 Weeks)||42
286249|NCT00849017|692473|P2|NOT COMPLETED|Treatment Period (156 Weeks)||33
286250|NCT00849017|692474|P1|NOT COMPLETED|Treatment Period (156 Weeks)||43
286251|NCT00849017|692472|P3|COMPLETED|Treatment Period (156 Weeks)||57
286252|NCT00849017|692473|P2|COMPLETED|Treatment Period (156 Weeks)||68
286253|NCT00849017|692474|P1|COMPLETED|Treatment Period (156 Weeks)||58
286254|NCT00849017|692472|P3|STARTED|Treatment Period (156 Weeks)||99
286255|NCT00849017|692473|P2|STARTED|Treatment Period (156 Weeks)||101
286256|NCT00849017|692474|P1|STARTED|Treatment Period (156 Weeks)||101
286257|NCT00848965|692517|P1|NOT COMPLETED|Overall Study||2
286258|NCT00848965|692517|P1|COMPLETED|Overall Study||57
286259|NCT00848965|692517|P1|STARTED|Overall Study||59
286260|NCT00848926|692559|P1|NOT COMPLETED|Follow-up Period||12
286261|NCT00848926|692559|P1|COMPLETED|Follow-up Period|Completed survival follow-up due to death [57] or study termination by sponsor [33]|90
286262|NCT00848926|692559|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|102
286263|NCT00848926|692559|P1|NOT COMPLETED|Treatment Period||84
286264|NCT00848926|692559|P1|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|18
286265|NCT00848926|692559|P1|STARTED|Treatment Period||102
286266|NCT00848783|692578|P3|NOT COMPLETED|Overall Study||0
286267|NCT00848783|692579|P2|NOT COMPLETED|Overall Study||2
286268|NCT00848783|692580|P1|NOT COMPLETED|Overall Study||3
286269|NCT00848783|692578|P3|COMPLETED|Overall Study||1
286270|NCT00848783|692579|P2|COMPLETED|Overall Study||1
286271|NCT00848783|692580|P1|COMPLETED|Overall Study||1
286272|NCT00848783|692578|P3|STARTED|Overall Study||1
286273|NCT00848783|692579|P2|STARTED|Overall Study||3
286274|NCT00848783|692580|P1|STARTED|Overall Study||4
286275|NCT00848744|692589|P1|NOT COMPLETED|Overall Study||0
286276|NCT00848744|692589|P1|COMPLETED|Overall Study||10
286277|NCT00848744|692589|P1|STARTED|Overall Study||10
286278|NCT00848718|692609|P13|NOT COMPLETED|Overall Study||8
286279|NCT00848718|692610|P12|NOT COMPLETED|Overall Study||6
286280|NCT00848718|692611|P11|NOT COMPLETED|Overall Study||4
286281|NCT00848718|692612|P10|NOT COMPLETED|Overall Study||9
286282|NCT00848718|692613|P9|NOT COMPLETED|Overall Study||4
286283|NCT00848718|692614|P8|NOT COMPLETED|Overall Study||5
286284|NCT00848718|692615|P7|NOT COMPLETED|Overall Study||3
286285|NCT00848718|692616|P6|NOT COMPLETED|Overall Study||5
286286|NCT00848718|692617|P5|NOT COMPLETED|Overall Study||6
286287|NCT00848718|692618|P4|NOT COMPLETED|Overall Study||5
286288|NCT00848718|692619|P3|NOT COMPLETED|Overall Study||6
286289|NCT00848718|692620|P2|NOT COMPLETED|Overall Study||9
286290|NCT00848718|692621|P1|NOT COMPLETED|Overall Study||7
286291|NCT00848718|692609|P13|COMPLETED|Overall Study||0
286292|NCT00848718|692610|P12|COMPLETED|Overall Study||0
286293|NCT00848718|692611|P11|COMPLETED|Overall Study||0
286294|NCT00848718|692612|P10|COMPLETED|Overall Study||0
286295|NCT00848718|692613|P9|COMPLETED|Overall Study||0
286296|NCT00848718|692614|P8|COMPLETED|Overall Study||0
286297|NCT00848718|692615|P7|COMPLETED|Overall Study||0
286298|NCT00848718|692616|P6|COMPLETED|Overall Study||0
286299|NCT00848718|692617|P5|COMPLETED|Overall Study||0
286300|NCT00848718|692618|P4|COMPLETED|Overall Study||0
286301|NCT00848718|692619|P3|COMPLETED|Overall Study||0
286302|NCT00848718|692620|P2|COMPLETED|Overall Study||0
286303|NCT00848718|692621|P1|COMPLETED|Overall Study||0
286304|NCT00848718|692609|P13|Treated|Overall Study|2 participants were allocated but did not receive treatment due to progression of disease|6
286305|NCT00848718|692610|P12|Treated|Overall Study||6
286306|NCT00848718|692611|P11|Treated|Overall Study||4
286307|NCT00848718|692612|P10|Treated|Overall Study||9
286308|NCT00848718|692613|P9|Treated|Overall Study||4
286309|NCT00848718|692614|P8|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|4
286310|NCT00848718|692615|P7|Treated|Overall Study||3
286311|NCT00848718|692616|P6|Treated|Overall Study||5
286312|NCT00848718|692617|P5|Treated|Overall Study||6
286313|NCT00848718|692618|P4|Treated|Overall Study||5
286314|NCT00848718|692619|P3|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|5
286315|NCT00848718|692620|P2|Treated|Overall Study||9
286316|NCT00848718|692621|P1|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|6
286317|NCT00848718|692609|P13|STARTED|Overall Study||8
286318|NCT00848718|692610|P12|STARTED|Overall Study||6
286319|NCT00848718|692611|P11|STARTED|Overall Study||4
286320|NCT00848718|692612|P10|STARTED|Overall Study||9
286321|NCT00848718|692613|P9|STARTED|Overall Study||4
286322|NCT00848718|692614|P8|STARTED|Overall Study||5
286323|NCT00848718|692615|P7|STARTED|Overall Study||3
286324|NCT00848718|692616|P6|STARTED|Overall Study||5
286325|NCT00848718|692617|P5|STARTED|Overall Study||6
286326|NCT00848718|692618|P4|STARTED|Overall Study||5
286327|NCT00848718|692619|P3|STARTED|Overall Study||6
286328|NCT00848718|692620|P2|STARTED|Overall Study||9
286329|NCT00848718|692621|P1|STARTED|Overall Study||7
286330|NCT00848549|692722|P2|NOT COMPLETED|E2090-E044-314 (Extension Study)||24
286331|NCT00848549|692723|P1|NOT COMPLETED|E2090-E044-314 (Extension Study)||17
286332|NCT00848549|692722|P2|COMPLETED|E2090-E044-314 (Extension Study)||134
286333|NCT00848549|692723|P1|COMPLETED|E2090-E044-314 (Extension Study)||120
286334|NCT00848549|692722|P2|STARTED|E2090-E044-314 (Extension Study)||158
286335|NCT00848549|692723|P1|STARTED|E2090-E044-314 (Extension Study)||137
286336|NCT00848549|692722|P2|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||34
286337|NCT00848549|692723|P1|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||24
286338|NCT00848549|692722|P2|COMPLETED|E2090-E044-310 (Base Study) Transition||158
286339|NCT00848549|692723|P1|COMPLETED|E2090-E044-310 (Base Study) Transition||137
286340|NCT00848549|692722|P2|STARTED|E2090-E044-310 (Base Study) Transition||192
286341|NCT00848549|692723|P1|STARTED|E2090-E044-310 (Base Study) Transition||161
286342|NCT00848549|692722|P2|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||109
286343|NCT00848549|692723|P1|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||121
286344|NCT00848549|692722|P2|COMPLETED|E2090-E044-310 (Base Study) Disposition||192
286345|NCT00848549|692723|P1|COMPLETED|E2090-E044-310 (Base Study) Disposition||161
286346|NCT00848549|692722|P2|STARTED|E2090-E044-310 (Base Study) Disposition||301
286347|NCT00848549|692723|P1|STARTED|E2090-E044-310 (Base Study) Disposition||282
286348|NCT00848536|692741|P2|NOT COMPLETED|Overall Study||7
286349|NCT00848536|692742|P1|NOT COMPLETED|Overall Study||4
286350|NCT00848536|692741|P2|COMPLETED|Overall Study||179
286351|NCT00848536|692742|P1|COMPLETED|Overall Study||181
286352|NCT00848536|692741|P2|STARTED|Overall Study||186
286353|NCT00848536|692742|P1|STARTED|Overall Study||185
286354|NCT00848510|692756|P4|NOT COMPLETED|Overall Study||0
286355|NCT00848510|692757|P3|NOT COMPLETED|Overall Study||0
286356|NCT00848510|692758|P2|NOT COMPLETED|Overall Study||0
286357|NCT00848510|692759|P1|NOT COMPLETED|Overall Study||0
286358|NCT00848510|692756|P4|COMPLETED|Overall Study||10
286359|NCT00848510|692757|P3|COMPLETED|Overall Study||8
286360|NCT00848510|692758|P2|COMPLETED|Overall Study||13
286361|NCT00848510|692759|P1|COMPLETED|Overall Study||10
286362|NCT00848510|692756|P4|STARTED|Overall Study||10
286363|NCT00848510|692757|P3|STARTED|Overall Study||8
286364|NCT00848510|692758|P2|STARTED|Overall Study||13
286365|NCT00848510|692759|P1|STARTED|Overall Study||10
286366|NCT00848497|692807|P2|NOT COMPLETED|Overall Study||1
286367|NCT00848497|692808|P1|NOT COMPLETED|Overall Study||2
286368|NCT00848497|692807|P2|COMPLETED|Overall Study||0
286369|NCT00848497|692808|P1|COMPLETED|Overall Study||0
286370|NCT00848497|692807|P2|STARTED|Overall Study|Completed Visit 4|1
286371|NCT00848497|692808|P1|STARTED|Overall Study||2
286372|NCT00848484|692822|P2|NOT COMPLETED|Second Intervention (Treatment Period 2)||1
286373|NCT00848484|692823|P1|NOT COMPLETED|Second Intervention (Treatment Period 2)||0
286374|NCT00848484|692822|P2|COMPLETED|Second Intervention (Treatment Period 2)||20
286375|NCT00848484|692823|P1|COMPLETED|Second Intervention (Treatment Period 2)||25
286376|NCT00848484|692822|P2|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
286377|NCT00848484|692823|P1|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
286378|NCT00848484|692822|P2|STARTED|Second Intervention (Treatment Period 2)||21
286379|NCT00848484|692823|P1|STARTED|Second Intervention (Treatment Period 2)||25
286380|NCT00848484|692822|P2|NOT COMPLETED|Washout Period of Two Weeks||3
286381|NCT00848484|692823|P1|NOT COMPLETED|Washout Period of Two Weeks||0
286382|NCT00848484|692822|P2|COMPLETED|Washout Period of Two Weeks||21
286383|NCT00848484|692823|P1|COMPLETED|Washout Period of Two Weeks||25
286384|NCT00848484|692822|P2|STARTED|Washout Period of Two Weeks||24
286385|NCT00848484|692823|P1|STARTED|Washout Period of Two Weeks||25
286386|NCT00848484|692822|P2|NOT COMPLETED|First Intervention (Treatment Period 1)||3
286387|NCT00848484|692823|P1|NOT COMPLETED|First Intervention (Treatment Period 1)||2
286388|NCT00848484|692822|P2|COMPLETED|First Intervention (Treatment Period 1)||24
286389|NCT00848484|692823|P1|COMPLETED|First Intervention (Treatment Period 1)||25
286390|NCT00848484|692822|P2|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||1
286391|NCT00848484|692823|P1|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||2
286392|NCT00848484|692822|P2|STARTED|First Intervention (Treatment Period 1)||27
286393|NCT00848484|692823|P1|STARTED|First Intervention (Treatment Period 1)||27
286394|NCT00848393|692842|P3|NOT COMPLETED|Overall Study||3
286395|NCT00848393|692843|P2|NOT COMPLETED|Overall Study||0
286396|NCT00848393|692844|P1|NOT COMPLETED|Overall Study||0
286397|NCT00848393|692842|P3|COMPLETED|Overall Study||15
286398|NCT00848393|692843|P2|COMPLETED|Overall Study||16
286400|NCT00848393|692842|P3|STARTED|Overall Study||18
286401|NCT00848393|692843|P2|STARTED|Overall Study||16
286402|NCT00848393|692844|P1|STARTED|Overall Study||17
286403|NCT00848367|692872|P2|NOT COMPLETED|Overall Study||9
286404|NCT00848367|692873|P1|NOT COMPLETED|Overall Study||9
286405|NCT00848367|692872|P2|COMPLETED|Overall Study||41
286406|NCT00848367|692873|P1|COMPLETED|Overall Study||43
286407|NCT00848367|692872|P2|STARTED|Overall Study||50
286408|NCT00848367|692873|P1|STARTED|Overall Study||52
286409|NCT00848354|692883|P2|NOT COMPLETED|Phase 2 Year 2||7
286410|NCT00848354|692884|P1|NOT COMPLETED|Phase 2 Year 2||23
286411|NCT00848354|692883|P2|COMPLETED|Phase 2 Year 2||113
286412|NCT00848354|692884|P1|COMPLETED|Phase 2 Year 2||218
286413|NCT00848354|692883|P2|STARTED|Phase 2 Year 2|Randomized Phase 1 treatment assignment.|120
286414|NCT00848354|692884|P1|STARTED|Phase 2 Year 2|"Randomized Phase 1 treatment assignment.~1 participant discontinued between Year 1 and Year 2."|241
286415|NCT00848354|692883|P2|NOT COMPLETED|Phase 2 Year 1||6
286416|NCT00848354|692884|P1|NOT COMPLETED|Phase 2 Year 1||18
286417|NCT00848354|692883|P2|COMPLETED|Phase 2 Year 1||120
286418|NCT00848354|692884|P1|COMPLETED|Phase 2 Year 1||242
286419|NCT00848354|692883|P2|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 3 participants discontinued between Phase 1 and Phase 2.|126
286420|NCT00848354|692884|P1|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 9 participants discontinued between Phase 1 and Phase 2.|260
286421|NCT00848354|692883|P2|NOT COMPLETED|Phase 1||14
286422|NCT00848354|692884|P1|NOT COMPLETED|Phase 1||12
286423|NCT00848354|692883|P2|COMPLETED|Phase 1||129
286424|NCT00848354|692884|P1|COMPLETED|Phase 1||269
286425|NCT00848354|692883|P2|STARTED|Phase 1||143
286426|NCT00848354|692884|P1|STARTED|Phase 1|One participant was randomized to the Etanercept + Methotrexate group but received SSZ in error.|281
286427|NCT00848250|693036|P2|NOT COMPLETED|Overall Study||1
286428|NCT00848250|693037|P1|NOT COMPLETED|Overall Study||0
286429|NCT00848250|693036|P2|COMPLETED|Overall Study||9
286430|NCT00848250|693037|P1|COMPLETED|Overall Study||11
286431|NCT00848250|693036|P2|STARTED|Overall Study||10
286432|NCT00848250|693037|P1|STARTED|Overall Study||11
286433|NCT00848237|693055|P1|NOT COMPLETED|Overall Study||539
286434|NCT00848237|693055|P1|COMPLETED|Overall Study||4982
286435|NCT00848237|693055|P1|STARTED|Overall Study||5521
286436|NCT00848211|693068|P4|NOT COMPLETED|Overall Study||0
286437|NCT00848211|693069|P3|NOT COMPLETED|Overall Study||1
286438|NCT00848211|693070|P2|NOT COMPLETED|Overall Study||1
286439|NCT00848211|693071|P1|NOT COMPLETED|Overall Study||0
286440|NCT00848211|693068|P4|COMPLETED|Overall Study||5
286441|NCT00848211|693069|P3|COMPLETED|Overall Study||5
286442|NCT00848211|693070|P2|COMPLETED|Overall Study||6
286443|NCT00848211|693071|P1|COMPLETED|Overall Study||6
286444|NCT00848211|693068|P4|STARTED|Overall Study||5
286445|NCT00848211|693069|P3|STARTED|Overall Study||6
286446|NCT00848211|693070|P2|STARTED|Overall Study||7
286447|NCT00848211|693071|P1|STARTED|Overall Study||6
286448|NCT00848198|693089|P1|NOT COMPLETED|Overall Study||15
286449|NCT00848198|693089|P1|COMPLETED|Overall Study||299
286450|NCT00848198|693089|P1|STARTED|Overall Study||314
286451|NCT00848185|693130|P3|NOT COMPLETED|Overall Study||0
286452|NCT00848185|693131|P2|NOT COMPLETED|Overall Study||0
286453|NCT00848185|693132|P1|NOT COMPLETED|Overall Study||0
286454|NCT00848185|693130|P3|COMPLETED|Overall Study||32
286455|NCT00848185|693131|P2|COMPLETED|Overall Study||32
286456|NCT00848185|693132|P1|COMPLETED|Overall Study||32
286457|NCT00848185|693130|P3|STARTED|Overall Study||32
286458|NCT00848185|693131|P2|STARTED|Overall Study||32
286459|NCT00848185|693132|P1|STARTED|Overall Study||32
286460|NCT00848172|693142|P2|NOT COMPLETED|Visit 3 - Follow Up||0
286461|NCT00848172|693143|P1|NOT COMPLETED|Visit 3 - Follow Up||0
286462|NCT00848172|693142|P2|COMPLETED|Visit 3 - Follow Up||8
286463|NCT00848172|693143|P1|COMPLETED|Visit 3 - Follow Up||10
286464|NCT00848172|693142|P2|STARTED|Visit 3 - Follow Up||8
286465|NCT00848172|693143|P1|STARTED|Visit 3 - Follow Up||10
286466|NCT00848172|693142|P2|NOT COMPLETED|Visit 2 - Drug Administration||1
286467|NCT00848172|693143|P1|NOT COMPLETED|Visit 2 - Drug Administration||0
286468|NCT00848172|693142|P2|COMPLETED|Visit 2 - Drug Administration||8
286469|NCT00848172|693143|P1|COMPLETED|Visit 2 - Drug Administration||10
286470|NCT00848172|693142|P2|STARTED|Visit 2 - Drug Administration||9
286471|NCT00848172|693143|P1|STARTED|Visit 2 - Drug Administration||10
286472|NCT00848120|693154|P1|NOT COMPLETED|Overall Study||1
286473|NCT00848120|693154|P1|COMPLETED|Overall Study||28
286474|NCT00848120|693154|P1|STARTED|Overall Study||29
286475|NCT00848107|693166|P1|NOT COMPLETED|Overall Study||21
286476|NCT00848107|693166|P1|COMPLETED|Overall Study||94
286477|NCT00848107|693166|P1|STARTED|Overall Study||115
286478|NCT00848081|693176|P2|NOT COMPLETED|Overall Study||18
286479|NCT00848081|693177|P1|NOT COMPLETED|Overall Study||20
286480|NCT00848081|693176|P2|COMPLETED|Overall Study||140
286481|NCT00848081|693177|P1|COMPLETED|Overall Study||140
286482|NCT00848081|693176|P2|STARTED|Overall Study||158
286483|NCT00848081|693177|P1|STARTED|Overall Study||160
286484|NCT00848042|693194|P3|NOT COMPLETED|Overall Study||0
286485|NCT00848042|693195|P2|NOT COMPLETED|Overall Study||2
286486|NCT00848042|693196|P1|NOT COMPLETED|Overall Study||4
286487|NCT00848042|693194|P3|COMPLETED|Overall Study||1
286488|NCT00848042|693195|P2|COMPLETED|Overall Study||3
286489|NCT00848042|693196|P1|COMPLETED|Overall Study||1
286490|NCT00848042|693194|P3|Month 6|Overall Study||1
286491|NCT00848042|693195|P2|Month 6|Overall Study||3
286492|NCT00848042|693196|P1|Month 6|Overall Study||1
286493|NCT00848042|693194|P3|Month 5|Overall Study||1
286494|NCT00848042|693195|P2|Month 5|Overall Study||3
286495|NCT00848042|693196|P1|Month 5|Overall Study||1
286496|NCT00848042|693194|P3|Month 4|Overall Study||1
286497|NCT00848042|693195|P2|Month 4|Overall Study||4
286498|NCT00848042|693196|P1|Month 4|Overall Study||1
286499|NCT00848042|693194|P3|Month 3|Overall Study||1
286500|NCT00848042|693195|P2|Month 3|Overall Study||4
286501|NCT00848042|693196|P1|Month 3|Overall Study||1
286502|NCT00848042|693194|P3|Month 2|Overall Study||1
286503|NCT00848042|693195|P2|Month 2|Overall Study||5
286504|NCT00848042|693196|P1|Month 2|Overall Study||1
286505|NCT00848042|693194|P3|Month 1|Overall Study||1
286506|NCT00848042|693195|P2|Month 1|Overall Study||5
286507|NCT00848042|693196|P1|Month 1|Overall Study||4
286508|NCT00848042|693194|P3|Day 15|Overall Study||1
286509|NCT00848042|693195|P2|Day 15|Overall Study||5
286510|NCT00848042|693196|P1|Day 15|Overall Study||4
286511|NCT00848042|693194|P3|Day 8|Overall Study||1
286512|NCT00848042|693195|P2|Day 8|Overall Study||5
286513|NCT00848042|693196|P1|Day 8|Overall Study||5
286514|NCT00848042|693194|P3|Day 3|Overall Study||1
286515|NCT00848042|693195|P2|Day 3|Overall Study||5
286516|NCT00848042|693196|P1|Day 3|Overall Study||5
286517|NCT00848042|693194|P3|Day 2|Overall Study||1
286518|NCT00848042|693195|P2|Day 2|Overall Study||5
286519|NCT00848042|693196|P1|Day 2|Overall Study||5
286520|NCT00848042|693194|P3|Day 1|Overall Study||1
286521|NCT00848042|693195|P2|Day 1|Overall Study||5
286522|NCT00848042|693196|P1|Day 1|Overall Study||5
286523|NCT00848042|693194|P3|STARTED|Overall Study||1
286524|NCT00848042|693195|P2|STARTED|Overall Study||5
286525|NCT00848042|693196|P1|STARTED|Overall Study||5
286526|NCT00848016|693207|P1|NOT COMPLETED|Overall Study||0
286527|NCT00848016|693207|P1|COMPLETED|Overall Study||29
286528|NCT00848016|693207|P1|STARTED|Overall Study||29
286529|NCT00847938|693217|P4|NOT COMPLETED|Overall Study||0
286530|NCT00847938|693218|P3|NOT COMPLETED|Overall Study||1
286531|NCT00847938|693219|P2|NOT COMPLETED|Overall Study||1
286532|NCT00847938|693220|P1|NOT COMPLETED|Overall Study||0
286533|NCT00847938|693217|P4|COMPLETED|Overall Study||15
286534|NCT00847938|693218|P3|COMPLETED|Overall Study||15
286535|NCT00847938|693219|P2|COMPLETED|Overall Study||14
286536|NCT00847938|693220|P1|COMPLETED|Overall Study||16
286537|NCT00847938|693217|P4|STARTED|Overall Study||15
286538|NCT00847938|693218|P3|STARTED|Overall Study||16
286539|NCT00847938|693219|P2|STARTED|Overall Study||15
286540|NCT00847938|693220|P1|STARTED|Overall Study||16
286541|NCT00847912|693232|P2|NOT COMPLETED|Overall Study||13
286542|NCT00847912|693233|P1|NOT COMPLETED|Overall Study||9
286543|NCT00847912|693232|P2|COMPLETED|Overall Study||464
286544|NCT00847912|693233|P1|COMPLETED|Overall Study||468
286545|NCT00847912|693232|P2|STARTED|Overall Study||477
286546|NCT00847912|693233|P1|STARTED|Overall Study||477
286547|NCT00847886|693243|P2|NOT COMPLETED|Overall Study||1
286548|NCT00847886|693244|P1|NOT COMPLETED|Overall Study||0
286549|NCT00847886|693243|P2|COMPLETED|Overall Study||3
286550|NCT00847886|693244|P1|COMPLETED|Overall Study||12
286551|NCT00847886|693243|P2|STARTED|Overall Study||4
286552|NCT00847886|693244|P1|STARTED|Overall Study||12
286553|NCT00847808|693270|P1|NOT COMPLETED|Overall Study||15
286554|NCT00847808|693270|P1|COMPLETED|Overall Study||163
286555|NCT00847808|693270|P1|STARTED|Overall Study||178
286556|NCT00847730|693287|P1|NOT COMPLETED|Overall Study||8
286557|NCT00847730|693287|P1|COMPLETED|Overall Study||25
286558|NCT00847730|693287|P1|STARTED|Overall Study||33
286559|NCT00847704|693291|P1|NOT COMPLETED|Overall Study||1
286560|NCT00847704|693291|P1|COMPLETED|Overall Study||2
286561|NCT00847704|693291|P1|STARTED|Overall Study||3
286562|NCT00847665|693302|P2|NOT COMPLETED|Overall Study||0
286563|NCT00847665|693303|P1|NOT COMPLETED|Overall Study||1
286564|NCT00847665|693302|P2|COMPLETED|Overall Study||165
286565|NCT00847665|693303|P1|COMPLETED|Overall Study||164
286566|NCT00847665|693302|P2|STARTED|Overall Study||165
286567|NCT00847665|693303|P1|STARTED|Overall Study||165
286568|NCT00847626|693326|P11|NOT COMPLETED|Overall Study||20
286569|NCT00847626|693327|P10|NOT COMPLETED|Overall Study||14
286570|NCT00847626|693328|P9|NOT COMPLETED|Overall Study||14
286571|NCT00847626|693329|P8|NOT COMPLETED|Overall Study||19
286572|NCT00847626|693330|P7|NOT COMPLETED|Overall Study||22
286573|NCT00847626|693331|P6|NOT COMPLETED|Overall Study||37
286574|NCT00847626|693332|P5|NOT COMPLETED|Overall Study||28
286575|NCT00847626|693333|P4|NOT COMPLETED|Overall Study||31
286576|NCT00847626|693334|P3|NOT COMPLETED|Overall Study||16
286577|NCT00847626|693335|P2|NOT COMPLETED|Overall Study||23
286578|NCT00847626|693336|P1|NOT COMPLETED|Overall Study||21
286579|NCT00847626|693326|P11|COMPLETED|Overall Study||142
286580|NCT00847626|693327|P10|COMPLETED|Overall Study||139
286581|NCT00847626|693328|P9|COMPLETED|Overall Study||141
286582|NCT00847626|693329|P8|COMPLETED|Overall Study||141
286583|NCT00847626|693330|P7|COMPLETED|Overall Study||135
286584|NCT00847626|693331|P6|COMPLETED|Overall Study||125
286585|NCT00847626|693332|P5|COMPLETED|Overall Study||125
286586|NCT00847626|693333|P4|COMPLETED|Overall Study||125
286587|NCT00847626|693334|P3|COMPLETED|Overall Study||131
286588|NCT00847626|693335|P2|COMPLETED|Overall Study||131
286589|NCT00847626|693336|P1|COMPLETED|Overall Study||135
286590|NCT00847626|693326|P11|STARTED|Overall Study||162
286591|NCT00847626|693327|P10|STARTED|Overall Study||153
286592|NCT00847626|693328|P9|STARTED|Overall Study||155
286593|NCT00847626|693329|P8|STARTED|Overall Study|Includes participant who was treated with double-blind study medication but not randomized.|160
286594|NCT00847626|693330|P7|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|157
286595|NCT00847626|693331|P6|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|162
286596|NCT00847626|693332|P5|STARTED|Overall Study||153
286597|NCT00847626|693333|P4|STARTED|Overall Study||156
286598|NCT00847626|693334|P3|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|147
286599|NCT00847626|693335|P2|STARTED|Overall Study||154
286600|NCT00847626|693336|P1|STARTED|Overall Study||156
286601|NCT00847613|693535|P4|NOT COMPLETED|Overall Study||79
286602|NCT00847613|693536|P3|NOT COMPLETED|Overall Study||81
286603|NCT00847613|693537|P2|NOT COMPLETED|Overall Study||319
286604|NCT00847613|693538|P1|NOT COMPLETED|Overall Study||321
286605|NCT00847613|693535|P4|COMPLETED|Overall Study||0
286606|NCT00847613|693536|P3|COMPLETED|Overall Study||0
286607|NCT00847613|693537|P2|COMPLETED|Overall Study||0
286608|NCT00847613|693538|P1|COMPLETED|Overall Study||0
286609|NCT00847613|693535|P4|Treated|Overall Study||79
286610|NCT00847613|693536|P3|Treated|Overall Study||81
286611|NCT00847613|693537|P2|Treated|Overall Study||316
286612|NCT00847613|693538|P1|Treated|Overall Study||321
286613|NCT00847613|693535|P4|STARTED|Overall Study||79
286614|NCT00847613|693536|P3|STARTED|Overall Study||81
286615|NCT00847613|693537|P2|STARTED|Overall Study||319
286616|NCT00847613|693538|P1|STARTED|Overall Study||321
286617|NCT00847587|693778|P2|NOT COMPLETED|Overall Study||0
286618|NCT00847587|693779|P1|NOT COMPLETED|Overall Study||1
286619|NCT00847587|693778|P2|COMPLETED|Overall Study||34
286620|NCT00847587|693779|P1|COMPLETED|Overall Study|Patient declined study after randomization.|34
286621|NCT00847587|693778|P2|STARTED|Overall Study||34
286622|NCT00847587|693779|P1|STARTED|Overall Study||35
286623|NCT00847561|693789|P2|NOT COMPLETED|Overall Study||4
286624|NCT00847561|693790|P1|NOT COMPLETED|Overall Study||13
286625|NCT00847561|693789|P2|COMPLETED|Overall Study||62
286626|NCT00847561|693790|P1|COMPLETED|Overall Study||57
286627|NCT00847561|693789|P2|STARTED|Overall Study||66
286628|NCT00847561|693790|P1|STARTED|Overall Study||70
286629|NCT00847535|693796|P3|NOT COMPLETED|Overall Study||1
286630|NCT00847535|693797|P2|NOT COMPLETED|Overall Study||2
286631|NCT00847535|693798|P1|NOT COMPLETED|Overall Study||2
286632|NCT00847535|693796|P3|COMPLETED|Overall Study||15
286633|NCT00847535|693797|P2|COMPLETED|Overall Study||22
286634|NCT00847535|693798|P1|COMPLETED|Overall Study||22
286635|NCT00847535|693796|P3|200 Million AMDC|Overall Study||8
286636|NCT00847535|693797|P2|200 Million AMDC|Overall Study||0
286637|NCT00847535|693798|P1|200 Million AMDC|Overall Study||0
286638|NCT00847535|693796|P3|100 Million AMDC|Overall Study||8
286639|NCT00847535|693797|P2|100 Million AMDC|Overall Study||8
286640|NCT00847535|693798|P1|100 Million AMDC|Overall Study||8
286641|NCT00847535|693796|P3|50 Million AMDC|Overall Study||0
286642|NCT00847535|693797|P2|50 Million AMDC|Overall Study||8
286643|NCT00847535|693798|P1|50 Million AMDC|Overall Study||8
286644|NCT00847535|693796|P3|10 Million AMDC|Overall Study||0
286645|NCT00847535|693797|P2|10 Million AMDC|Overall Study||8
286646|NCT00847535|693798|P1|10 Million AMDC|Overall Study||8
286647|NCT00847535|693796|P3|STARTED|Overall Study||16
286648|NCT00847535|693797|P2|STARTED|Overall Study||24
286649|NCT00847535|693798|P1|STARTED|Overall Study||24
286650|NCT00847522|693806|P1|NOT COMPLETED|Overall Study||0
286651|NCT00847522|693806|P1|COMPLETED|Overall Study||90
286652|NCT00847522|693806|P1|Phase II|Overall Study||80
286653|NCT00847522|693806|P1|Phase I|Overall Study||10
286654|NCT00847522|693806|P1|STARTED|Overall Study||90
286655|NCT00847509|693811|P1|NOT COMPLETED|Overall Study||11
286656|NCT00847509|693811|P1|COMPLETED|Overall Study||38
286657|NCT00847509|693811|P1|STARTED|Overall Study||49
286658|NCT00847405|693817|P2|NOT COMPLETED|Second Intervention||0
286659|NCT00847405|693818|P1|NOT COMPLETED|Second Intervention||0
286660|NCT00847405|693817|P2|COMPLETED|Second Intervention||13
286661|NCT00847405|693818|P1|COMPLETED|Second Intervention||13
286662|NCT00847405|693817|P2|STARTED|Second Intervention||13
286663|NCT00847405|693818|P1|STARTED|Second Intervention||13
286664|NCT00847405|693817|P2|NOT COMPLETED|Washout of 7 Days||0
286665|NCT00847405|693818|P1|NOT COMPLETED|Washout of 7 Days||1
286666|NCT00847405|693817|P2|COMPLETED|Washout of 7 Days||13
286667|NCT00847405|693818|P1|COMPLETED|Washout of 7 Days||13
286668|NCT00847405|693817|P2|STARTED|Washout of 7 Days||13
286669|NCT00847405|693818|P1|STARTED|Washout of 7 Days||14
286670|NCT00847405|693817|P2|NOT COMPLETED|First Intervention||1
286671|NCT00847405|693818|P1|NOT COMPLETED|First Intervention||0
286672|NCT00847405|693817|P2|COMPLETED|First Intervention||13
286673|NCT00847405|693818|P1|COMPLETED|First Intervention||14
286674|NCT00847405|693817|P2|STARTED|First Intervention||14
286675|NCT00847405|693818|P1|STARTED|First Intervention||14
286676|NCT00847301|693826|P1|NOT COMPLETED|Overall Study||54
286677|NCT00847301|693826|P1|COMPLETED|Overall Study||374
286678|NCT00847301|693826|P1|STARTED|Overall Study||428
286679|NCT00847288|693836|P2|NOT COMPLETED|Overall Study||47
286680|NCT00847288|693837|P1|NOT COMPLETED|Overall Study||30
286681|NCT00847288|693836|P2|COMPLETED|Overall Study||780
286682|NCT00847288|693837|P1|COMPLETED|Overall Study||811
286683|NCT00847288|693836|P2|STARTED|Overall Study||827
286684|NCT00847288|693837|P1|STARTED|Overall Study||841
286685|NCT00847210|693851|P2|NOT COMPLETED|Overall Study||0
286686|NCT00847210|693852|P1|NOT COMPLETED|Overall Study||0
286687|NCT00847210|693851|P2|COMPLETED|Overall Study||18
286688|NCT00847210|693852|P1|COMPLETED|Overall Study||18
286689|NCT00847210|693851|P2|STARTED|Overall Study||18
286690|NCT00847210|693852|P1|STARTED|Overall Study||18
286691|NCT00847197|693874|P2|NOT COMPLETED|Overall Study||5
286692|NCT00847197|693875|P1|NOT COMPLETED|Overall Study||24
286693|NCT00847197|693874|P2|COMPLETED|Overall Study||70
286694|NCT00847197|693875|P1|COMPLETED|Overall Study||92
286695|NCT00847197|693874|P2|STARTED|Overall Study||75
286696|NCT00847197|693875|P1|STARTED|Overall Study||116
286697|NCT00847171|693885|P1|NOT COMPLETED|Overall Study||0
286698|NCT00847171|693885|P1|COMPLETED|Overall Study||20
286699|NCT00847171|693885|P1|STARTED|Overall Study||20
286700|NCT00847145|693899|P8|NOT COMPLETED|Overall Study||4
286701|NCT00847145|693900|P7|NOT COMPLETED|Overall Study||9
286702|NCT00847145|693901|P6|NOT COMPLETED|Overall Study||4
286703|NCT00847145|693902|P5|NOT COMPLETED|Overall Study||6
286704|NCT00847145|693903|P4|NOT COMPLETED|Overall Study||1
286705|NCT00847145|693904|P3|NOT COMPLETED|Overall Study||11
286706|NCT00847145|693905|P2|NOT COMPLETED|Overall Study||6
286707|NCT00847145|693906|P1|NOT COMPLETED|Overall Study||6
286708|NCT00847145|693899|P8|COMPLETED|Overall Study||136
286709|NCT00847145|693900|P7|COMPLETED|Overall Study||143
286710|NCT00847145|693901|P6|COMPLETED|Overall Study||152
286711|NCT00847145|693902|P5|COMPLETED|Overall Study||131
286712|NCT00847145|693903|P4|COMPLETED|Overall Study||116
286713|NCT00847145|693904|P3|COMPLETED|Overall Study||274
286714|NCT00847145|693905|P2|COMPLETED|Overall Study||627
286715|NCT00847145|693906|P1|COMPLETED|Overall Study||623
286716|NCT00847145|693899|P8|STARTED|Overall Study||140
286717|NCT00847145|693900|P7|STARTED|Overall Study||152
286718|NCT00847145|693901|P6|STARTED|Overall Study||156
286719|NCT00847145|693902|P5|STARTED|Overall Study||137
286720|NCT00847145|693903|P4|STARTED|Overall Study||117
286721|NCT00847145|693904|P3|STARTED|Overall Study||285
286722|NCT00847145|693905|P2|STARTED|Overall Study||633
286723|NCT00847145|693906|P1|STARTED|Overall Study||629
286724|NCT00847132|693956|P2|NOT COMPLETED|Overall Study||1
286725|NCT00847132|693957|P1|NOT COMPLETED|Overall Study||1
286726|NCT00847132|693956|P2|COMPLETED|Overall Study||84
286727|NCT00847132|693957|P1|COMPLETED|Overall Study||89
286728|NCT00847132|693956|P2|STARTED|Overall Study||85
286729|NCT00847132|693957|P1|STARTED|Overall Study||90
286730|NCT00847015|693965|P1|NOT COMPLETED|Overall Study||3
286731|NCT00847015|693965|P1|COMPLETED|Overall Study||15
286732|NCT00847015|693965|P1|STARTED|Overall Study||18
286733|NCT00847002|693973|P2|NOT COMPLETED|Overall Study||0
286734|NCT00847002|693974|P1|NOT COMPLETED|Overall Study||0
286735|NCT00847002|693973|P2|COMPLETED|Overall Study||4
286736|NCT00847002|693974|P1|COMPLETED|Overall Study||4
286737|NCT00847002|693973|P2|STARTED|Overall Study||4
286738|NCT00847002|693974|P1|STARTED|Overall Study||4
286739|NCT00846885|693984|P2|NOT COMPLETED|Second Intervention||0
286740|NCT00846885|693985|P1|NOT COMPLETED|Second Intervention||0
286741|NCT00846885|693984|P2|COMPLETED|Second Intervention||14
286742|NCT00846885|693985|P1|COMPLETED|Second Intervention||14
286743|NCT00846885|693984|P2|STARTED|Second Intervention||14
286744|NCT00846885|693985|P1|STARTED|Second Intervention||14
286745|NCT00846885|693984|P2|NOT COMPLETED|Washout of 7 Days||0
286746|NCT00846885|693985|P1|NOT COMPLETED|Washout of 7 Days||0
286747|NCT00846885|693984|P2|COMPLETED|Washout of 7 Days||14
286748|NCT00846885|693985|P1|COMPLETED|Washout of 7 Days||14
286749|NCT00846885|693984|P2|STARTED|Washout of 7 Days||14
286750|NCT00846885|693985|P1|STARTED|Washout of 7 Days||14
286751|NCT00846885|693984|P2|NOT COMPLETED|First Intervention||0
286752|NCT00846885|693985|P1|NOT COMPLETED|First Intervention||0
286753|NCT00846885|693984|P2|COMPLETED|First Intervention||14
286754|NCT00846885|693985|P1|COMPLETED|First Intervention||14
286755|NCT00846885|693984|P2|STARTED|First Intervention||14
286756|NCT00846885|693985|P1|STARTED|First Intervention||14
286757|NCT00846846|693993|P1|NOT COMPLETED|Overall Study||75
286758|NCT00846846|693993|P1|COMPLETED|Overall Study|Study ongoing but not recruiting participants.|943
286759|NCT00846846|693993|P1|STARTED|Overall Study||1018
286760|NCT00846807|693998|P1|NOT COMPLETED|Overall Study||632
286761|NCT00846807|693998|P1|COMPLETED|Overall Study|Completed treatment.|4660
286762|NCT00846807|693998|P1|STARTED|Overall Study|Entered and treated.|5292
286763|NCT00846768|694006|P4|NOT COMPLETED|Overall Study||0
286764|NCT00846768|694007|P3|NOT COMPLETED|Overall Study||0
286765|NCT00846768|694008|P2|NOT COMPLETED|Overall Study||1
286766|NCT00846768|694009|P1|NOT COMPLETED|Overall Study||0
286767|NCT00846768|694006|P4|COMPLETED|Overall Study||12
286768|NCT00846768|694007|P3|COMPLETED|Overall Study||12
286769|NCT00846768|694008|P2|COMPLETED|Overall Study||11
286770|NCT00846768|694009|P1|COMPLETED|Overall Study||11
286771|NCT00846768|694006|P4|STARTED|Overall Study||12
286772|NCT00846768|694007|P3|STARTED|Overall Study||12
286773|NCT00846768|694008|P2|STARTED|Overall Study||12
286774|NCT00846768|694009|P1|STARTED|Overall Study||11
286775|NCT00846651|694081|P2|NOT COMPLETED|Overall Study||4
286776|NCT00846651|694082|P1|NOT COMPLETED|Overall Study||4
286777|NCT00846651|694081|P2|COMPLETED|Overall Study||37
286778|NCT00846651|694082|P1|COMPLETED|Overall Study||37
286779|NCT00846651|694081|P2|STARTED|Overall Study||41
286780|NCT00846651|694082|P1|STARTED|Overall Study||41
286781|NCT00846586|694100|P2|NOT COMPLETED|Overall Study||35
286782|NCT00846586|694101|P1|NOT COMPLETED|Overall Study||39
286783|NCT00846586|694100|P2|COMPLETED|Overall Study||529
286784|NCT00846586|694101|P1|COMPLETED|Overall Study||531
286785|NCT00846586|694100|P2|Received Study Drug|Overall Study|Three patients were not exposed to study treatment in this group.|561
286786|NCT00846586|694101|P1|Received Study Drug|Overall Study||570
286787|NCT00846586|694100|P2|STARTED|Overall Study||564
286788|NCT00846586|694101|P1|STARTED|Overall Study||570
286789|NCT00846573|694120|P4|NOT COMPLETED|Overall Study||0
286790|NCT00846573|694121|P3|NOT COMPLETED|Overall Study||0
286791|NCT00846573|694122|P2|NOT COMPLETED|Overall Study||0
286792|NCT00846573|694123|P1|NOT COMPLETED|Overall Study||0
286793|NCT00846573|694120|P4|COMPLETED|Overall Study||0
286794|NCT00846573|694121|P3|COMPLETED|Overall Study||7
286795|NCT00846573|694122|P2|COMPLETED|Overall Study||2
286796|NCT00846573|694123|P1|COMPLETED|Overall Study||5
286797|NCT00846573|694120|P4|STARTED|Overall Study||0
286798|NCT00846573|694121|P3|STARTED|Overall Study||7
286799|NCT00846573|694122|P2|STARTED|Overall Study||2
286800|NCT00846573|694123|P1|STARTED|Overall Study||5
286801|NCT00846547|694131|P1|NOT COMPLETED|Overall Study||7
286802|NCT00846547|694131|P1|COMPLETED|Overall Study||25
286803|NCT00846547|694131|P1|STARTED|Overall Study||32
286804|NCT00846521|694135|P1|NOT COMPLETED|Overall Study||11
286805|NCT00846521|694135|P1|COMPLETED|Overall Study||12
286806|NCT00846521|694135|P1|STARTED|Overall Study||23
286807|NCT00846495|694142|P2|NOT COMPLETED|Overall Study||3
286808|NCT00846495|694143|P1|NOT COMPLETED|Overall Study||8
286809|NCT00846495|694142|P2|COMPLETED|Overall Study||24
286810|NCT00846495|694143|P1|COMPLETED|Overall Study||20
286811|NCT00846495|694142|P2|STARTED|Overall Study||27
286812|NCT00846495|694143|P1|STARTED|Overall Study||28
286813|NCT00846391|694166|P3|NOT COMPLETED|Overall Study||3
286814|NCT00846391|694167|P2|NOT COMPLETED|Overall Study||2
286815|NCT00846391|694168|P1|NOT COMPLETED|Overall Study||1
286816|NCT00846391|694166|P3|COMPLETED|Overall Study||3
286817|NCT00846391|694167|P2|COMPLETED|Overall Study||2
286818|NCT00846391|694168|P1|COMPLETED|Overall Study||3
286819|NCT00846391|694166|P3|STARTED|Overall Study||6
286820|NCT00846391|694167|P2|STARTED|Overall Study||4
286821|NCT00846391|694168|P1|STARTED|Overall Study||4
286822|NCT00846365|694179|P3|NOT COMPLETED|Overall Study||33
286823|NCT00846365|694180|P2|NOT COMPLETED|Overall Study||49
286824|NCT00846365|694181|P1|NOT COMPLETED|Overall Study||55
286825|NCT00846365|694179|P3|COMPLETED|Overall Study||323
286826|NCT00846365|694180|P2|COMPLETED|Overall Study||308
286827|NCT00846365|694181|P1|COMPLETED|Overall Study||317
286828|NCT00846365|694179|P3|STARTED|Overall Study||356
286829|NCT00846365|694180|P2|STARTED|Overall Study||357
286830|NCT00846365|694181|P1|STARTED|Overall Study||372
286831|NCT00846287|694236|P2|NOT COMPLETED|Overall Study||5
286832|NCT00846287|694237|P1|NOT COMPLETED|Overall Study||10
286833|NCT00846287|694236|P2|COMPLETED|Overall Study||10
286834|NCT00846287|694237|P1|COMPLETED|Overall Study||6
286835|NCT00846287|694236|P2|STARTED|Overall Study||15
286836|NCT00846287|694237|P1|STARTED|Overall Study||16
286837|NCT00846066|694247|P2|NOT COMPLETED|Overall Study||0
286838|NCT00846066|694248|P1|NOT COMPLETED|Overall Study||0
286839|NCT00846066|694247|P2|COMPLETED|Overall Study||29
286840|NCT00846066|694248|P1|COMPLETED|Overall Study||27
286841|NCT00846066|694247|P2|STARTED|Overall Study||29
286842|NCT00846066|694248|P1|STARTED|Overall Study||27
286843|NCT00846053|694262|P2|NOT COMPLETED|Overall Study||0
286844|NCT00846053|694263|P1|NOT COMPLETED|Overall Study||3
286845|NCT00846053|694262|P2|COMPLETED|Overall Study||8
286846|NCT00846053|694263|P1|COMPLETED|Overall Study|No milestones. Enrollment continued until end of study. 21 subjects enrolled.|10
286847|NCT00846053|694262|P2|STARTED|Overall Study||8
286848|NCT00846053|694263|P1|STARTED|Overall Study|No milestones. Enrollment continued until end of study.|13
286849|NCT00846027|694271|P1|NOT COMPLETED|Overall Study||90
286850|NCT00846027|694271|P1|COMPLETED|Overall Study||0
286851|NCT00846027|694271|P1|Received Treatment|Overall Study||83
286852|NCT00846027|694271|P1|STARTED|Overall Study||90
286853|NCT00845975|694280|P2|NOT COMPLETED|Overall Study||0
286854|NCT00845975|694281|P1|NOT COMPLETED|Overall Study||0
286855|NCT00845975|694280|P2|COMPLETED|Overall Study||9
286856|NCT00845975|694281|P1|COMPLETED|Overall Study||9
286857|NCT00845975|694280|P2|STARTED|Overall Study||9
286858|NCT00845975|694281|P1|STARTED|Overall Study||9
286859|NCT00845897|694294|P3|NOT COMPLETED|Overall Study||3
286860|NCT00845897|694295|P2|NOT COMPLETED|Overall Study||5
286861|NCT00845897|694296|P1|NOT COMPLETED|Overall Study||2
286862|NCT00845897|694294|P3|COMPLETED|Overall Study||2
286863|NCT00845897|694295|P2|COMPLETED|Overall Study||2
286864|NCT00845897|694296|P1|COMPLETED|Overall Study||3
286865|NCT00845897|694294|P3|STARTED|Overall Study||5
286866|NCT00845897|694295|P2|STARTED|Overall Study||7
286867|NCT00845897|694296|P1|STARTED|Overall Study||5
286868|NCT00845858|694310|P3|NOT COMPLETED|Overall Study||8
286869|NCT00845858|694311|P2|NOT COMPLETED|Overall Study||12
286870|NCT00845858|694312|P1|NOT COMPLETED|Overall Study||8
286871|NCT00845858|694310|P3|COMPLETED|Overall Study||87
286872|NCT00845858|694311|P2|COMPLETED|Overall Study||84
286873|NCT00845858|694312|P1|COMPLETED|Overall Study||88
286874|NCT00845858|694310|P3|STARTED|Overall Study||95
286875|NCT00845858|694311|P2|STARTED|Overall Study|"95 subjects received allocated intervention.~1 subject was not eligible and was not dosed."|96
286876|NCT00845858|694312|P1|STARTED|Overall Study|"95 subjects received allocated intervention.~1 subject withdrew consent and was not dosed."|96
286877|NCT00845845|694325|P2|NOT COMPLETED|Overall Study||4
286878|NCT00845845|694326|P1|NOT COMPLETED|Overall Study||0
286879|NCT00845845|694325|P2|COMPLETED|Overall Study||2
286880|NCT00845845|694326|P1|COMPLETED|Overall Study||3
286881|NCT00845845|694325|P2|STARTED|Overall Study||6
286882|NCT00845845|694326|P1|STARTED|Overall Study||3
286883|NCT00845832|694337|P3|NOT COMPLETED|Extended Safety Follow-Up||7
286884|NCT00845832|694338|P2|NOT COMPLETED|Extended Safety Follow-Up||0
286885|NCT00845832|694339|P1|NOT COMPLETED|Extended Safety Follow-Up||0
286886|NCT00845832|694337|P3|COMPLETED|Extended Safety Follow-Up||0
286887|NCT00845832|694338|P2|COMPLETED|Extended Safety Follow-Up||5
286888|NCT00845832|694339|P1|COMPLETED|Extended Safety Follow-Up||2
286889|NCT00845832|694337|P3|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|7
286890|NCT00845832|694338|P2|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|5
286891|NCT00845832|694339|P1|STARTED|Extended Safety Follow-Up||2
286892|NCT00845832|694337|P3|NOT COMPLETED|Safety Follow-Up||0
286893|NCT00845832|694338|P2|NOT COMPLETED|Safety Follow-Up||0
286894|NCT00845832|694339|P1|NOT COMPLETED|Safety Follow-Up||1
286895|NCT00845832|694337|P3|COMPLETED|Safety Follow-Up||12
286896|NCT00845832|694338|P2|COMPLETED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|9
286897|NCT00845832|694339|P1|COMPLETED|Safety Follow-Up||2
286898|NCT00845832|694337|P3|STARTED|Safety Follow-Up|One participant each from the placebo and TCZ (2 mg/kg) groups were re-assigned to this group.|12
286899|NCT00845832|694338|P2|STARTED|Safety Follow-Up|All participants who withdrew from study were asked to return for safety follow-up.|9
286900|NCT00845832|694339|P1|STARTED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|3
286901|NCT00845832|694337|P3|NOT COMPLETED|Treatment Period||0
286902|NCT00845832|694338|P2|NOT COMPLETED|Treatment Period||3
286903|NCT00845832|694339|P1|NOT COMPLETED|Treatment Period||1
286904|NCT00845832|694337|P3|COMPLETED|Treatment Period||10
286905|NCT00845832|694338|P2|COMPLETED|Treatment Period||7
286906|NCT00845832|694339|P1|COMPLETED|Treatment Period||3
286907|NCT00845832|694337|P3|STARTED|Treatment Period||10
286908|NCT00845832|694338|P2|STARTED|Treatment Period||10
286909|NCT00845832|694339|P1|STARTED|Treatment Period||4
286910|NCT00845728|694385|P2|NOT COMPLETED|Overall Study||342
286911|NCT00845728|694386|P1|NOT COMPLETED|Overall Study||386
286912|NCT00845728|694385|P2|COMPLETED|Overall Study||1379
286913|NCT00845728|694386|P1|COMPLETED|Overall Study||1337
286914|NCT00845728|694385|P2|Exposed|Overall Study||1718
286915|NCT00845728|694386|P1|Exposed|Overall Study||1721
286916|NCT00845728|694385|P2|STARTED|Overall Study||1721
286917|NCT00845728|694386|P1|STARTED|Overall Study||1723
286918|NCT00845702|694394|P1|NOT COMPLETED|Dotarem MRA||0
286919|NCT00845702|694394|P1|COMPLETED|Dotarem MRA||32
286920|NCT00845702|694394|P1|STARTED|Dotarem MRA||32
286921|NCT00845702|694394|P1|NOT COMPLETED|TOF MRA||1
286922|NCT00845702|694394|P1|COMPLETED|TOF MRA|One patient did not perform study MRA procedures.|32
286923|NCT00845702|694394|P1|STARTED|TOF MRA||33
286924|NCT00845676|694400|P1|NOT COMPLETED|Overall Study||2
286925|NCT00845676|694400|P1|COMPLETED|Overall Study||19
286926|NCT00845676|694400|P1|STARTED|Overall Study||21
286927|NCT00845663|694406|P2|NOT COMPLETED|Overall Study||0
286928|NCT00845663|694407|P1|NOT COMPLETED|Overall Study||0
286929|NCT00845663|694406|P2|COMPLETED|Overall Study||49
286930|NCT00845663|694407|P1|COMPLETED|Overall Study||49
286931|NCT00845663|694406|P2|STARTED|Overall Study||49
286932|NCT00845663|694407|P1|STARTED|Overall Study||49
286933|NCT00845650|694461|P6|NOT COMPLETED|Overall Study||2
286934|NCT00845650|694462|P5|NOT COMPLETED|Overall Study||3
286935|NCT00845650|694463|P4|NOT COMPLETED|Overall Study||1
286936|NCT00845650|694464|P3|NOT COMPLETED|Overall Study||3
286937|NCT00845650|694465|P2|NOT COMPLETED|Overall Study||0
286938|NCT00845650|694466|P1|NOT COMPLETED|Overall Study||1
286939|NCT00845650|694461|P6|COMPLETED|Overall Study||15
286940|NCT00845650|694462|P5|COMPLETED|Overall Study||28
286941|NCT00845650|694463|P4|COMPLETED|Overall Study||13
286942|NCT00845650|694464|P3|COMPLETED|Overall Study||28
286943|NCT00845650|694465|P2|COMPLETED|Overall Study||5
286944|NCT00845650|694466|P1|COMPLETED|Overall Study||30
286945|NCT00845650|694461|P6|STARTED|Overall Study|1 subject not dosed|17
286946|NCT00845650|694462|P5|STARTED|Overall Study|2 subjects not dosed|31
286947|NCT00845650|694463|P4|STARTED|Overall Study||14
286948|NCT00845650|694464|P3|STARTED|Overall Study||31
286949|NCT00845650|694465|P2|STARTED|Overall Study||5
286950|NCT00845650|694466|P1|STARTED|Overall Study|1 subject not dosed|31
286951|NCT00845520|694504|P3|NOT COMPLETED|Overall Study||1
286952|NCT00845520|694505|P2|NOT COMPLETED|Overall Study||2
286953|NCT00845520|694506|P1|NOT COMPLETED|Overall Study||2
286954|NCT00845520|694504|P3|COMPLETED|Overall Study||23
286955|NCT00845520|694505|P2|COMPLETED|Overall Study||23
286956|NCT00845520|694506|P1|COMPLETED|Overall Study||23
286957|NCT00845520|694504|P3|STARTED|Overall Study||24
286958|NCT00845520|694505|P2|STARTED|Overall Study||25
286959|NCT00845520|694506|P1|STARTED|Overall Study||25
286960|NCT00845507|694522|P2|NOT COMPLETED|Overall Study||1
286961|NCT00845507|694523|P1|NOT COMPLETED|Overall Study||2
286962|NCT00845507|694522|P2|COMPLETED|Overall Study||29
286963|NCT00845507|694523|P1|COMPLETED|Overall Study||22
286964|NCT00845507|694522|P2|STARTED|Overall Study||30
286965|NCT00845507|694523|P1|STARTED|Overall Study||24
286966|NCT00845481|694531|P1|NOT COMPLETED|Overall Study||0
286967|NCT00845481|694531|P1|COMPLETED|Overall Study||24
286968|NCT00845481|694531|P1|STARTED|Overall Study||24
286969|NCT00845429|694543|P3|NOT COMPLETED|Overall Study||20
286970|NCT00845429|694544|P2|NOT COMPLETED|Overall Study||15
286971|NCT00845429|694545|P1|NOT COMPLETED|Overall Study||14
286972|NCT00845429|694543|P3|COMPLETED|Overall Study||224
286973|NCT00845429|694544|P2|COMPLETED|Overall Study||226
286974|NCT00845429|694545|P1|COMPLETED|Overall Study||230
286975|NCT00845429|694543|P3|STARTED|Overall Study||244
286976|NCT00845429|694544|P2|STARTED|Overall Study||241
286977|NCT00845429|694545|P1|STARTED|Overall Study||244
286978|NCT00845195|694564|P2|NOT COMPLETED|Overall Study||0
286979|NCT00845195|694565|P1|NOT COMPLETED|Overall Study||0
286980|NCT00845195|694564|P2|COMPLETED|Overall Study||75
286981|NCT00845195|694565|P1|COMPLETED|Overall Study||75
286982|NCT00845195|694564|P2|STARTED|Overall Study||75
286983|NCT00845195|694565|P1|STARTED|Overall Study||75
286984|NCT00845182|694580|P3|NOT COMPLETED|Overall Study||6
286985|NCT00845182|694581|P2|NOT COMPLETED|Overall Study||4
286986|NCT00845182|694582|P1|NOT COMPLETED|Overall Study||3
286987|NCT00845182|694580|P3|COMPLETED|Overall Study||9
286988|NCT00845182|694581|P2|COMPLETED|Overall Study||11
286989|NCT00845182|694582|P1|COMPLETED|Overall Study||10
286990|NCT00845182|694580|P3|STARTED|Overall Study||15
286991|NCT00845182|694581|P2|STARTED|Overall Study||15
286992|NCT00845182|694582|P1|STARTED|Overall Study||13
286993|NCT00845130|694596|P2|NOT COMPLETED|Overall Study||3
286994|NCT00845130|694597|P1|NOT COMPLETED|Overall Study||4
286995|NCT00845130|694596|P2|COMPLETED|Overall Study||19
286996|NCT00845130|694597|P1|COMPLETED|Overall Study||16
286997|NCT00845130|694596|P2|STARTED|Overall Study||22
286998|NCT00845130|694597|P1|STARTED|Overall Study||20
286999|NCT00845065|694607|P2|NOT COMPLETED|Overall Study||55
287000|NCT00845065|694608|P1|NOT COMPLETED|Overall Study||47
287001|NCT00845065|694607|P2|COMPLETED|Overall Study||79
287002|NCT00845065|694608|P1|COMPLETED|Overall Study||20
287003|NCT00845065|694607|P2|STARTED|Overall Study||134
287004|NCT00845065|694608|P1|STARTED|Overall Study||67
287005|NCT00845039|694624|P2|NOT COMPLETED|Overall Study||0
287006|NCT00845039|694625|P1|NOT COMPLETED|Overall Study||0
287007|NCT00845039|694624|P2|COMPLETED|Overall Study||2
287008|NCT00845039|694625|P1|COMPLETED|Overall Study||2
287009|NCT00845039|694624|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
287010|NCT00845039|694625|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
287011|NCT00845039|694624|P2|STARTED|Overall Study||2
287012|NCT00845039|694625|P1|STARTED|Overall Study||2
287013|NCT00845000|694652|P6|NOT COMPLETED|Period 3||0
287014|NCT00845000|694653|P5|NOT COMPLETED|Period 3||0
287015|NCT00845000|694654|P4|NOT COMPLETED|Period 3||0
287016|NCT00845000|694655|P3|NOT COMPLETED|Period 3||0
287017|NCT00845000|694656|P2|NOT COMPLETED|Period 3||0
287018|NCT00845000|694657|P1|NOT COMPLETED|Period 3||0
287019|NCT00845000|694652|P6|COMPLETED|Period 3||2
287020|NCT00845000|694653|P5|COMPLETED|Period 3||2
287021|NCT00845000|694654|P4|COMPLETED|Period 3||2
287022|NCT00845000|694655|P3|COMPLETED|Period 3||2
287023|NCT00845000|694656|P2|COMPLETED|Period 3||2
287024|NCT00845000|694657|P1|COMPLETED|Period 3||2
287025|NCT00845000|694652|P6|STARTED|Period 3||2
287026|NCT00845000|694653|P5|STARTED|Period 3||2
287027|NCT00845000|694654|P4|STARTED|Period 3||2
287028|NCT00845000|694655|P3|STARTED|Period 3||2
287029|NCT00845000|694656|P2|STARTED|Period 3||2
287030|NCT00845000|694657|P1|STARTED|Period 3||2
287031|NCT00845000|694652|P6|NOT COMPLETED|Period 2||0
287032|NCT00845000|694653|P5|NOT COMPLETED|Period 2||0
287033|NCT00845000|694654|P4|NOT COMPLETED|Period 2||0
287034|NCT00845000|694655|P3|NOT COMPLETED|Period 2||0
287035|NCT00845000|694656|P2|NOT COMPLETED|Period 2||0
287036|NCT00845000|694657|P1|NOT COMPLETED|Period 2||0
287037|NCT00845000|694652|P6|COMPLETED|Period 2||2
287038|NCT00845000|694653|P5|COMPLETED|Period 2||2
287039|NCT00845000|694654|P4|COMPLETED|Period 2||2
287040|NCT00845000|694655|P3|COMPLETED|Period 2||2
287041|NCT00845000|694656|P2|COMPLETED|Period 2||2
287042|NCT00845000|694657|P1|COMPLETED|Period 2||2
287043|NCT00845000|694652|P6|STARTED|Period 2||2
287044|NCT00845000|694653|P5|STARTED|Period 2||2
287045|NCT00845000|694654|P4|STARTED|Period 2||2
287046|NCT00845000|694655|P3|STARTED|Period 2||2
287047|NCT00845000|694656|P2|STARTED|Period 2||2
287048|NCT00845000|694657|P1|STARTED|Period 2||2
287049|NCT00845000|694652|P6|NOT COMPLETED|Period 1||0
287050|NCT00845000|694653|P5|NOT COMPLETED|Period 1||0
287051|NCT00845000|694654|P4|NOT COMPLETED|Period 1||0
287052|NCT00845000|694655|P3|NOT COMPLETED|Period 1||0
287053|NCT00845000|694656|P2|NOT COMPLETED|Period 1||0
287054|NCT00845000|694657|P1|NOT COMPLETED|Period 1||0
287055|NCT00845000|694652|P6|COMPLETED|Period 1||2
287056|NCT00845000|694653|P5|COMPLETED|Period 1||2
287057|NCT00845000|694654|P4|COMPLETED|Period 1||2
287058|NCT00845000|694655|P3|COMPLETED|Period 1||2
287059|NCT00845000|694656|P2|COMPLETED|Period 1||2
287060|NCT00845000|694657|P1|COMPLETED|Period 1||2
287061|NCT00845000|694652|P6|STARTED|Period 1||2
287062|NCT00845000|694653|P5|STARTED|Period 1||2
287063|NCT00845000|694654|P4|STARTED|Period 1||2
287064|NCT00845000|694655|P3|STARTED|Period 1||2
287065|NCT00845000|694656|P2|STARTED|Period 1||2
287066|NCT00845000|694657|P1|STARTED|Period 1||2
287067|NCT00844896|694676|P2|NOT COMPLETED|Overall Study||17
287068|NCT00844896|694677|P1|NOT COMPLETED|Overall Study||12
287069|NCT00844896|694676|P2|COMPLETED|Overall Study||11
287070|NCT00844896|694677|P1|COMPLETED|Overall Study||17
287071|NCT00844896|694676|P2|STARTED|Overall Study||28
287072|NCT00844896|694677|P1|STARTED|Overall Study||29
287073|NCT00844883|694699|P1|NOT COMPLETED|Overall Study||4
287074|NCT00844883|694699|P1|COMPLETED|Overall Study||46
287075|NCT00844883|694699|P1|Patients Who Received TACE|Overall Study|2 patients withdrawn at Week 1 prior to TACE for intolerance to sorafenib|48
287076|NCT00844883|694699|P1|STARTED|Overall Study||50
287077|NCT00844857|694711|P2|NOT COMPLETED|Overall Study||37
287078|NCT00844857|694712|P1|NOT COMPLETED|Overall Study||78
287079|NCT00844857|694711|P2|COMPLETED|Overall Study||60
287080|NCT00844857|694712|P1|COMPLETED|Overall Study||116
287081|NCT00844857|694711|P2|Population Analyzed|Overall Study|randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|85
287082|NCT00844857|694712|P1|Population Analyzed|Overall Study|Randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|170
287083|NCT00844857|694711|P2|STARTED|Overall Study||97
287084|NCT00844857|694712|P1|STARTED|Overall Study||194
287085|NCT00844844|694756|P1|NOT COMPLETED|Post Treatment Period||1
287086|NCT00844844|694756|P1|COMPLETED|Post Treatment Period||5
287087|NCT00844844|694756|P1|STARTED|Post Treatment Period||6
287088|NCT00844844|694756|P1|NOT COMPLETED|Extension Treatment Period||2
287089|NCT00844844|694756|P1|COMPLETED|Extension Treatment Period||11
287090|NCT00844844|694756|P1|STARTED|Extension Treatment Period||13
287091|NCT00844844|694756|P1|NOT COMPLETED|Treatment Period (26 Weeks)||2
287092|NCT00844844|694756|P1|COMPLETED|Treatment Period (26 Weeks)||15
287093|NCT00844844|694756|P1|STARTED|Treatment Period (26 Weeks)||17
287094|NCT00844844|694756|P1|NOT COMPLETED|Screening Period||0
287095|NCT00844844|694756|P1|COMPLETED|Screening Period||17
287096|NCT00844844|694756|P1|STARTED|Screening Period||17
287097|NCT00844831|694770|P1|NOT COMPLETED|Overall Study||6
287098|NCT00844831|694770|P1|COMPLETED|Overall Study||19
287099|NCT00844831|694770|P1|STARTED|Overall Study||25
287100|NCT00844805|694780|P4|NOT COMPLETED|Follow-Up Phase||9
287101|NCT00844805|694781|P3|NOT COMPLETED|Follow-Up Phase||9
287102|NCT00844805|694782|P2|NOT COMPLETED|Follow-Up Phase||0
287103|NCT00844805|694783|P1|NOT COMPLETED|Follow-Up Phase||0
287104|NCT00844805|694780|P4|COMPLETED|Follow-Up Phase||32
287105|NCT00844805|694781|P3|COMPLETED|Follow-Up Phase||32
287106|NCT00844805|694782|P2|COMPLETED|Follow-Up Phase||0
287107|NCT00844805|694783|P1|COMPLETED|Follow-Up Phase||0
287108|NCT00844805|694780|P4|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
287109|NCT00844805|694781|P3|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
287110|NCT00844805|694782|P2|STARTED|Follow-Up Phase||0
287111|NCT00844805|694783|P1|STARTED|Follow-Up Phase||0
287112|NCT00844805|694780|P4|NOT COMPLETED|Treatment Phase||0
287113|NCT00844805|694781|P3|NOT COMPLETED|Treatment Phase||0
287114|NCT00844805|694782|P2|NOT COMPLETED|Treatment Phase||7
287115|NCT00844805|694783|P1|NOT COMPLETED|Treatment Phase||10
287116|NCT00844805|694780|P4|COMPLETED|Treatment Phase||0
287117|NCT00844805|694781|P3|COMPLETED|Treatment Phase||0
287118|NCT00844805|694782|P2|COMPLETED|Treatment Phase||45
287119|NCT00844805|694783|P1|COMPLETED|Treatment Phase||96
287120|NCT00844805|694780|P4|STARTED|Treatment Phase||0
287121|NCT00844805|694781|P3|STARTED|Treatment Phase||0
287122|NCT00844805|694782|P2|STARTED|Treatment Phase||52
287123|NCT00844805|694783|P1|STARTED|Treatment Phase||106
287124|NCT00844753|694827|P4|NOT COMPLETED|Overall Study||11
287125|NCT00844753|694828|P3|NOT COMPLETED|Overall Study||7
287126|NCT00844753|694829|P2|NOT COMPLETED|Overall Study||3
287127|NCT00844753|694830|P1|NOT COMPLETED|Overall Study||8
287128|NCT00844753|694827|P4|COMPLETED|Overall Study||21
287129|NCT00844753|694828|P3|COMPLETED|Overall Study||25
287130|NCT00844753|694829|P2|COMPLETED|Overall Study||29
287131|NCT00844753|694830|P1|COMPLETED|Overall Study||24
287132|NCT00844753|694827|P4|STARTED|Overall Study||32
287133|NCT00844753|694828|P3|STARTED|Overall Study||32
287134|NCT00844753|694829|P2|STARTED|Overall Study||32
287135|NCT00844753|694830|P1|STARTED|Overall Study||32
287136|NCT00844714|694842|P1|NOT COMPLETED|Overall Study||0
287137|NCT00844714|694842|P1|COMPLETED|Overall Study||20
287138|NCT00844714|694842|P1|STARTED|Overall Study||20
287139|NCT00844649|694848|P2|NOT COMPLETED|Overall Study||418
287140|NCT00844649|694849|P1|NOT COMPLETED|Overall Study||405
287311|NCT00843518|695435|P1|COMPLETED|Period 2 (Double-blind Treatment)||43
287141|NCT00844649|694848|P2|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|12
287142|NCT00844649|694849|P1|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|26
287143|NCT00844649|694848|P2|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|402
287144|NCT00844649|694849|P1|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|421
287145|NCT00844649|694848|P2|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|430
287146|NCT00844649|694849|P1|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|431
287147|NCT00844597|694873|P6|NOT COMPLETED|Overall Study||0
287148|NCT00844597|694874|P5|NOT COMPLETED|Overall Study||0
287149|NCT00844597|694875|P4|NOT COMPLETED|Overall Study||1
287150|NCT00844597|694876|P3|NOT COMPLETED|Overall Study||0
287151|NCT00844597|694877|P2|NOT COMPLETED|Overall Study||0
287152|NCT00844597|694878|P1|NOT COMPLETED|Overall Study||0
287153|NCT00844597|694873|P6|COMPLETED|Overall Study||4
287154|NCT00844597|694874|P5|COMPLETED|Overall Study||4
287155|NCT00844597|694875|P4|COMPLETED|Overall Study||2
287156|NCT00844597|694876|P3|COMPLETED|Overall Study||2
287157|NCT00844597|694877|P2|COMPLETED|Overall Study||2
287158|NCT00844597|694878|P1|COMPLETED|Overall Study||4
287159|NCT00844597|694873|P6|STARTED|Overall Study||4
287160|NCT00844597|694874|P5|STARTED|Overall Study||4
287161|NCT00844597|694875|P4|STARTED|Overall Study||3
287162|NCT00844597|694876|P3|STARTED|Overall Study||2
287163|NCT00844597|694877|P2|STARTED|Overall Study||2
287164|NCT00844597|694878|P1|STARTED|Overall Study||4
287165|NCT00844558|694898|P2|NOT COMPLETED|Overall Study||4
287166|NCT00844558|694899|P1|NOT COMPLETED|Overall Study||12
287167|NCT00844558|694898|P2|COMPLETED|Overall Study||18
287168|NCT00844558|694899|P1|COMPLETED|Overall Study||24
287169|NCT00844558|694898|P2|12 Month Visit|Overall Study|-Discontinued intervention (n=0)|18
287170|NCT00844558|694899|P1|12 Month Visit|Overall Study|Discontinued intervention (n=4)|24
287171|NCT00844558|694898|P2|6 Month Visit|Overall Study|-Discontinued intervention (n=1)|18
287172|NCT00844558|694899|P1|6 Month Visit|Overall Study|Discontinued intervention (n=1)|28
287173|NCT00844558|694898|P2|3 Month Visit|Overall Study|"Lost to follow-up (n=1)~Discontinued Intervention (n=1)"|19
287174|NCT00844558|694899|P1|3 Month Visit|Overall Study|Discontinued intervention (n=4)|29
287175|NCT00844558|694898|P2|Received Allocated Intervention|Overall Study||21
287176|NCT00844558|694899|P1|Received Allocated Intervention|Overall Study||33
287177|NCT00844558|694898|P2|STARTED|Overall Study|"Received allocated intervention (n=21)~Did not receive allocated intervention (n=1)"|22
287178|NCT00844558|694899|P1|STARTED|Overall Study|"Received allocated intervention (n=33)~Did not receive allocated intervention (n=3)"|36
287179|NCT00844545|694915|P1|NOT COMPLETED|Post Treatment Period||1
287180|NCT00844545|694915|P1|COMPLETED|Post Treatment Period||5
287181|NCT00844545|694915|P1|STARTED|Post Treatment Period||6
287182|NCT00844545|694915|P1|NOT COMPLETED|Extension Treatment Period||2
287183|NCT00844545|694915|P1|COMPLETED|Extension Treatment Period||11
287184|NCT00844545|694915|P1|STARTED|Extension Treatment Period||13
287185|NCT00844545|694915|P1|NOT COMPLETED|Treatment Period (26 Weeks)||2
287186|NCT00844545|694915|P1|COMPLETED|Treatment Period (26 Weeks)||15
287187|NCT00844545|694915|P1|STARTED|Treatment Period (26 Weeks)||17
287188|NCT00844545|694915|P1|NOT COMPLETED|Screening Period||0
287189|NCT00844545|694915|P1|COMPLETED|Screening Period||17
287190|NCT00844545|694915|P1|STARTED|Screening Period||17
287191|NCT00844532|694929|P1|NOT COMPLETED|Overall Study||39
287192|NCT00844532|694929|P1|COMPLETED|Overall Study||112
287193|NCT00844532|694929|P1|STARTED|Overall Study||151
287194|NCT00844519|695015|P2|NOT COMPLETED|Overall Study||1
287195|NCT00844519|695016|P1|NOT COMPLETED|Overall Study||2
287196|NCT00844519|695015|P2|COMPLETED|Overall Study||25
287197|NCT00844519|695016|P1|COMPLETED|Overall Study||24
287198|NCT00844519|695015|P2|STARTED|Overall Study||26
287199|NCT00844519|695016|P1|STARTED|Overall Study||26
287200|NCT00844480|695024|P2|NOT COMPLETED|Overall Study||3
287201|NCT00844480|695025|P1|NOT COMPLETED|Overall Study||2
287202|NCT00844480|695024|P2|COMPLETED|Overall Study||6
287203|NCT00844480|695025|P1|COMPLETED|Overall Study||6
287204|NCT00844480|695024|P2|STARTED|Overall Study||9
287205|NCT00844480|695025|P1|STARTED|Overall Study||8
287206|NCT00844428|695033|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
287207|NCT00844428|695033|P1|COMPLETED|Post Treatment Period (Patients Who Disc||4
287208|NCT00844428|695033|P1|STARTED|Post Treatment Period (Patients Who Disc||5
287209|NCT00844428|695033|P1|NOT COMPLETED|Extension Treatment Period||1
287210|NCT00844428|695033|P1|COMPLETED|Extension Treatment Period||18
287211|NCT00844428|695033|P1|STARTED|Extension Treatment Period||19
287212|NCT00844428|695033|P1|NOT COMPLETED|Treatment Period (26 Weeks)||0
287213|NCT00844428|695033|P1|COMPLETED|Treatment Period (26 Weeks)||20
287214|NCT00844428|695033|P1|STARTED|Treatment Period (26 Weeks)||20
287215|NCT00844428|695033|P1|NOT COMPLETED|Observation Period (8 Weeks)||0
287216|NCT00844428|695033|P1|COMPLETED|Observation Period (8 Weeks)||20
287217|NCT00844428|695033|P1|STARTED|Observation Period (8 Weeks)||20
287218|NCT00844428|695033|P1|NOT COMPLETED|Screening Period||3
287219|NCT00844428|695033|P1|COMPLETED|Screening Period||20
287220|NCT00844428|695033|P1|STARTED|Screening Period||23
287221|NCT00844415|695049|P1|NOT COMPLETED|Overall Study||1
287222|NCT00844415|695049|P1|COMPLETED|Overall Study|Completed.|8
287223|NCT00844415|695049|P1|Pat. Received Single Dose 75mg|Overall Study||1
287224|NCT00844415|695049|P1|Pat. Received 125mg Followed by 150mg|Overall Study||2
287225|NCT00844415|695049|P1|Pat. Received 100mg Followed by 125mg|Overall Study||3
287226|NCT00844415|695049|P1|Pat. Received 75mg Followed by 100mg|Overall Study||3
287227|NCT00844415|695049|P1|STARTED|Overall Study|Entered and treated.|9
287228|NCT00844376|695063|P2|NOT COMPLETED|Period 2: Second Intervention||0
287229|NCT00844376|695064|P1|NOT COMPLETED|Period 2: Second Intervention||0
287230|NCT00844376|695063|P2|COMPLETED|Period 2: Second Intervention||6
287231|NCT00844376|695064|P1|COMPLETED|Period 2: Second Intervention|Total subjects administered Test drug = 12; total subjects administered Reference drug = 11.|5
287232|NCT00844376|695063|P2|STARTED|Period 2: Second Intervention||6
287233|NCT00844376|695064|P1|STARTED|Period 2: Second Intervention||5
287234|NCT00844376|695063|P2|NOT COMPLETED|Period 1: First Intervention||0
287235|NCT00844376|695064|P1|NOT COMPLETED|Period 1: First Intervention||1
287236|NCT00844376|695063|P2|COMPLETED|Period 1: First Intervention||6
287237|NCT00844376|695064|P1|COMPLETED|Period 1: First Intervention||5
287238|NCT00844376|695063|P2|STARTED|Period 1: First Intervention||6
287239|NCT00844376|695064|P1|STARTED|Period 1: First Intervention||6
287240|NCT00844298|695082|P1|NOT COMPLETED|Overall Study||0
287241|NCT00844298|695082|P1|COMPLETED|Overall Study||91
287242|NCT00844298|695082|P1|STARTED|Overall Study||91
287243|NCT00844194|695088|P2|NOT COMPLETED|Overall Study||8
287244|NCT00844194|695089|P1|NOT COMPLETED|Overall Study||25
287245|NCT00844194|695088|P2|COMPLETED|Overall Study||22
287246|NCT00844194|695089|P1|COMPLETED|Overall Study||53
287247|NCT00844194|695088|P2|STARTED|Overall Study||30
287248|NCT00844194|695089|P1|STARTED|Overall Study||78
287249|NCT00844090|695295|P2|NOT COMPLETED|Overall Study||8
287250|NCT00844090|695296|P1|NOT COMPLETED|Overall Study||6
287251|NCT00844090|695295|P2|COMPLETED|Overall Study||46
287252|NCT00844090|695296|P1|COMPLETED|Overall Study||46
287253|NCT00844090|695295|P2|STARTED|Overall Study||54
287254|NCT00844090|695296|P1|STARTED|Overall Study||52
287255|NCT00844051|695304|P2|NOT COMPLETED|Overall Study||0
287256|NCT00844051|695305|P1|NOT COMPLETED|Overall Study||0
287257|NCT00844051|695304|P2|COMPLETED|Overall Study||2368
287258|NCT00844051|695305|P1|COMPLETED|Overall Study||2087
287259|NCT00844051|695304|P2|STARTED|Overall Study||2368
287260|NCT00844051|695305|P1|STARTED|Overall Study||2087
287261|NCT00843986|695315|P2|NOT COMPLETED|Overall Study||1
287262|NCT00843986|695316|P1|NOT COMPLETED|Overall Study||1
287263|NCT00843986|695315|P2|COMPLETED|Overall Study||5
287264|NCT00843986|695316|P1|COMPLETED|Overall Study||2
287265|NCT00843986|695315|P2|Completed Treatment (Infusion)|Overall Study||6
287266|NCT00843986|695316|P1|Completed Treatment (Infusion)|Overall Study||2
287267|NCT00843986|695315|P2|STARTED|Overall Study||6
287268|NCT00843986|695316|P1|STARTED|Overall Study||3
287269|NCT00843843|695344|P2|NOT COMPLETED|Overall Study||2
287270|NCT00843843|695345|P1|NOT COMPLETED|Overall Study||2
287271|NCT00843843|695344|P2|COMPLETED|Overall Study||6
287272|NCT00843843|695345|P1|COMPLETED|Overall Study||6
287273|NCT00843843|695344|P2|STARTED|Overall Study||8
287274|NCT00843843|695345|P1|STARTED|Overall Study||8
287275|NCT00843830|695353|P1|NOT COMPLETED|Overall Study||0
287276|NCT00843830|695353|P1|COMPLETED|Overall Study||4
287277|NCT00843830|695353|P1|STARTED|Overall Study||4
287278|NCT00843778|695358|P1|NOT COMPLETED|Overall Study||35
287279|NCT00843778|695358|P1|COMPLETED|Overall Study||96
287280|NCT00843778|695358|P1|STARTED|Overall Study||131
287281|NCT00843713|695393|P2|NOT COMPLETED|Overall Study||0
287282|NCT00843713|695394|P1|NOT COMPLETED|Overall Study||0
287283|NCT00843713|695393|P2|COMPLETED|Overall Study||26
287284|NCT00843713|695394|P1|COMPLETED|Overall Study||30
287285|NCT00843713|695393|P2|STARTED|Overall Study||26
287286|NCT00843713|695394|P1|STARTED|Overall Study||30
287287|NCT00843635|695403|P3|NOT COMPLETED|Overall Study||0
287288|NCT00843635|695404|P2|NOT COMPLETED|Overall Study||2
287289|NCT00843635|695405|P1|NOT COMPLETED|Overall Study||2
287290|NCT00843635|695403|P3|COMPLETED|Overall Study||5
287291|NCT00843635|695404|P2|COMPLETED|Overall Study||13
287292|NCT00843635|695405|P1|COMPLETED|Overall Study||13
287293|NCT00843635|695403|P3|STARTED|Overall Study||5
287294|NCT00843635|695404|P2|STARTED|Overall Study||15
287295|NCT00843635|695405|P1|STARTED|Overall Study||15
287296|NCT00843622|695425|P2|NOT COMPLETED|Overall Study||55
287297|NCT00843622|695426|P1|NOT COMPLETED|Overall Study||43
287298|NCT00843622|695425|P2|COMPLETED|Overall Study||70
287299|NCT00843622|695426|P1|COMPLETED|Overall Study||82
287300|NCT00843622|695425|P2|STARTED|Overall Study||125
287301|NCT00843622|695426|P1|STARTED|Overall Study||125
287302|NCT00843518|695434|P2|NOT COMPLETED|Period 3 (Single-blind Washout)||0
287303|NCT00843518|695435|P1|NOT COMPLETED|Period 3 (Single-blind Washout)||0
287304|NCT00843518|695434|P2|COMPLETED|Period 3 (Single-blind Washout)||49
287305|NCT00843518|695435|P1|COMPLETED|Period 3 (Single-blind Washout)||42
287306|NCT00843518|695434|P2|STARTED|Period 3 (Single-blind Washout)||49
287307|NCT00843518|695435|P1|STARTED|Period 3 (Single-blind Washout)|1 LY451395 participant completed double-blind treatment, but did not enter washout period.|42
287308|NCT00843518|695434|P2|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
287309|NCT00843518|695435|P1|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
287310|NCT00843518|695434|P2|COMPLETED|Period 2 (Double-blind Treatment)||49
287312|NCT00843518|695434|P2|STARTED|Period 2 (Double-blind Treatment)||69
287313|NCT00843518|695435|P1|STARTED|Period 2 (Double-blind Treatment)||63
287314|NCT00843492|695465|P2|NOT COMPLETED|Overall Study||14
287315|NCT00843492|695466|P1|NOT COMPLETED|Overall Study||8
287316|NCT00843492|695465|P2|COMPLETED|Overall Study||607
287317|NCT00843492|695466|P1|COMPLETED|Overall Study||614
287318|NCT00843492|695465|P2|STARTED|Overall Study||621
287319|NCT00843492|695466|P1|STARTED|Overall Study||622
287320|NCT00843479|695486|P2|NOT COMPLETED|Overall Study||0
287321|NCT00843479|695487|P1|NOT COMPLETED|Overall Study||0
287322|NCT00843479|695486|P2|COMPLETED|Overall Study||12
287323|NCT00843479|695487|P1|COMPLETED|Overall Study||12
287324|NCT00843479|695486|P2|STARTED|Overall Study||12
287325|NCT00843479|695487|P1|STARTED|Overall Study||12
287326|NCT00843466|695505|P2|NOT COMPLETED|Overall Study||0
287327|NCT00843466|695506|P1|NOT COMPLETED|Overall Study||0
287328|NCT00843466|695505|P2|COMPLETED|Overall Study||18
287329|NCT00843466|695506|P1|COMPLETED|Overall Study||24
287330|NCT00843466|695505|P2|STARTED|Overall Study||18
287331|NCT00843466|695506|P1|STARTED|Overall Study||24
287332|NCT00843349|695516|P4|NOT COMPLETED|Overall Study||1
287333|NCT00843349|695517|P3|NOT COMPLETED|Overall Study||0
287334|NCT00843349|695518|P2|NOT COMPLETED|Overall Study||0
287335|NCT00843349|695519|P1|NOT COMPLETED|Overall Study||3
287336|NCT00843349|695516|P4|COMPLETED|Overall Study||10
287337|NCT00843349|695517|P3|COMPLETED|Overall Study||10
287338|NCT00843349|695518|P2|COMPLETED|Overall Study||11
287339|NCT00843349|695519|P1|COMPLETED|Overall Study||8
287340|NCT00843349|695516|P4|STARTED|Overall Study||11
287341|NCT00843349|695517|P3|STARTED|Overall Study||10
287342|NCT00843349|695518|P2|STARTED|Overall Study||11
287343|NCT00843349|695519|P1|STARTED|Overall Study||11
287344|NCT00843310|695533|P1|NOT COMPLETED|Overall Study||7
287345|NCT00843310|695533|P1|COMPLETED|Overall Study||1
287346|NCT00843310|695533|P1|STARTED|Overall Study||8
287347|NCT00843284|695537|P1|NOT COMPLETED|Overall Study||72
287348|NCT00843284|695537|P1|COMPLETED|Overall Study||619
287349|NCT00843284|695537|P1|STARTED|Overall Study||691
287350|NCT00843193|695547|P2|NOT COMPLETED|Overall Study||11
287351|NCT00843193|695548|P1|NOT COMPLETED|Overall Study||8
287352|NCT00843193|695547|P2|COMPLETED|Overall Study||88
287353|NCT00843193|695548|P1|COMPLETED|Overall Study||91
287354|NCT00843193|695547|P2|STARTED|Overall Study||99
287355|NCT00843193|695548|P1|STARTED|Overall Study||99
287356|NCT00843180|695584|P2|NOT COMPLETED|Overall Study||0
287357|NCT00843180|695585|P1|NOT COMPLETED|Overall Study||0
287358|NCT00843180|695584|P2|COMPLETED|Overall Study||7
287359|NCT00843180|695585|P1|COMPLETED|Overall Study||16
287360|NCT00843180|695584|P2|STARTED|Overall Study||7
287361|NCT00843180|695585|P1|STARTED|Overall Study||16
287362|NCT00843167|695599|P2|NOT COMPLETED|Follow-up||0
287363|NCT00843167|695600|P1|NOT COMPLETED|Follow-up||0
287364|NCT00843167|695599|P2|COMPLETED|Follow-up||24
287365|NCT00843167|695600|P1|COMPLETED|Follow-up||24
287366|NCT00843167|695599|P2|Completed Final Visit|Follow-up||24
287367|NCT00843167|695600|P1|Completed Final Visit|Follow-up||24
287368|NCT00843167|695599|P2|STARTED|Follow-up||24
287369|NCT00843167|695600|P1|STARTED|Follow-up||24
287370|NCT00843167|695599|P2|NOT COMPLETED|Treatment Period||8
287371|NCT00843167|695600|P1|NOT COMPLETED|Treatment Period||3
287372|NCT00843167|695599|P2|COMPLETED|Treatment Period||19
287373|NCT00843167|695600|P1|COMPLETED|Treatment Period||24
287374|NCT00843167|695599|P2|STARTED|Treatment Period||27
287375|NCT00843167|695600|P1|STARTED|Treatment Period||27
287376|NCT00843115|695613|P1|NOT COMPLETED|Overall Study||66
287377|NCT00843115|695613|P1|COMPLETED|Overall Study||304
287378|NCT00843115|695613|P1|STARTED|Overall Study||370
287379|NCT00843050|695659|P1|NOT COMPLETED|Overall Study||13
287380|NCT00843050|695659|P1|COMPLETED|Overall Study||0
287381|NCT00843050|695659|P1|STARTED|Overall Study||13
287382|NCT00843024|695669|P6|NOT COMPLETED|Double-blind Treatment Phase||25
287383|NCT00843024|695670|P5|NOT COMPLETED|Double-blind Treatment Phase||20
287384|NCT00843024|695671|P4|NOT COMPLETED|Double-blind Treatment Phase||23
287385|NCT00843024|695672|P3|NOT COMPLETED|Double-blind Treatment Phase||31
287386|NCT00843024|695673|P2|NOT COMPLETED|Double-blind Treatment Phase||0
287387|NCT00843024|695674|P1|NOT COMPLETED|Double-blind Treatment Phase||0
287388|NCT00843024|695669|P6|COMPLETED|Double-blind Treatment Phase||152
287389|NCT00843024|695670|P5|COMPLETED|Double-blind Treatment Phase||97
287390|NCT00843024|695671|P4|COMPLETED|Double-blind Treatment Phase||96
287391|NCT00843024|695672|P3|COMPLETED|Double-blind Treatment Phase||145
287392|NCT00843024|695673|P2|COMPLETED|Double-blind Treatment Phase||0
287393|NCT00843024|695674|P1|COMPLETED|Double-blind Treatment Phase||0
287394|NCT00843024|695669|P6|STARTED|Double-blind Treatment Phase||177
287395|NCT00843024|695670|P5|STARTED|Double-blind Treatment Phase||117
287396|NCT00843024|695671|P4|STARTED|Double-blind Treatment Phase||119
287397|NCT00843024|695672|P3|STARTED|Double-blind Treatment Phase||176
287398|NCT00843024|695673|P2|STARTED|Double-blind Treatment Phase||0
287399|NCT00843024|695674|P1|STARTED|Double-blind Treatment Phase||0
287400|NCT00843024|695669|P6|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
287401|NCT00843024|695670|P5|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
287402|NCT00843024|695671|P4|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
287403|NCT00843024|695672|P3|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
287404|NCT00843024|695673|P2|NOT COMPLETED|Single-blind Placebo Run-In Phase||136
287405|NCT00843024|695674|P1|NOT COMPLETED|Single-blind Placebo Run-In Phase||140
287406|NCT00843024|695669|P6|COMPLETED|Single-blind Placebo Run-In Phase||0
287407|NCT00843024|695670|P5|COMPLETED|Single-blind Placebo Run-In Phase||0
287408|NCT00843024|695671|P4|COMPLETED|Single-blind Placebo Run-In Phase||0
287409|NCT00843024|695672|P3|COMPLETED|Single-blind Placebo Run-In Phase||0
287410|NCT00843024|695673|P2|COMPLETED|Single-blind Placebo Run-In Phase||321
287411|NCT00843024|695674|P1|COMPLETED|Single-blind Placebo Run-In Phase||268
287412|NCT00843024|695669|P6|STARTED|Single-blind Placebo Run-In Phase||0
287413|NCT00843024|695670|P5|STARTED|Single-blind Placebo Run-In Phase||0
287414|NCT00843024|695671|P4|STARTED|Single-blind Placebo Run-In Phase||0
287415|NCT00843024|695672|P3|STARTED|Single-blind Placebo Run-In Phase||0
287416|NCT00843024|695673|P2|STARTED|Single-blind Placebo Run-In Phase||457
287417|NCT00843024|695674|P1|STARTED|Single-blind Placebo Run-In Phase||408
287418|NCT00842985|695739|P1|NOT COMPLETED|Fourth Intervention||0
287419|NCT00842985|695739|P1|COMPLETED|Fourth Intervention||15
287420|NCT00842985|695739|P1|STARTED|Fourth Intervention||15
287421|NCT00842985|695739|P1|NOT COMPLETED|Washout Period of GE 4 Days||0
287422|NCT00842985|695739|P1|COMPLETED|Washout Period of GE 4 Days||15
287423|NCT00842985|695739|P1|STARTED|Washout Period of GE 4 Days||15
287424|NCT00842985|695739|P1|NOT COMPLETED|Third Intervention||0
287425|NCT00842985|695739|P1|COMPLETED|Third Intervention||15
287426|NCT00842985|695739|P1|STARTED|Third Intervention||15
287427|NCT00842985|695739|P1|NOT COMPLETED|Washout Period of GE 4 Days||2
287428|NCT00842985|695739|P1|COMPLETED|Washout Period of GE 4 Days||15
287429|NCT00842985|695739|P1|STARTED|Washout Period of GE 4 Days||17
287430|NCT00842985|695739|P1|NOT COMPLETED|Second Intervention||1
287431|NCT00842985|695739|P1|COMPLETED|Second Intervention||17
287432|NCT00842985|695739|P1|STARTED|Second Intervention||18
287433|NCT00842985|695739|P1|NOT COMPLETED|Washout Period of GE 4 Days||2
287434|NCT00842985|695739|P1|COMPLETED|Washout Period of GE 4 Days||18
287435|NCT00842985|695739|P1|STARTED|Washout Period of GE 4 Days||20
287436|NCT00842985|695739|P1|NOT COMPLETED|First Intervention||6
287437|NCT00842985|695739|P1|COMPLETED|First Intervention|Completed 1st Intervention|20
287438|NCT00842985|695739|P1|STARTED|First Intervention|Signed Consent|26
287439|NCT00842985|695739|P1|NOT COMPLETED|Screening||27
287440|NCT00842985|695739|P1|COMPLETED|Screening||26
287441|NCT00842985|695739|P1|STARTED|Screening||53
287442|NCT00842946|695748|P2|NOT COMPLETED|Overall Study||5
287443|NCT00842946|695749|P1|NOT COMPLETED|Overall Study||5
287444|NCT00842946|695748|P2|COMPLETED|Overall Study||19
287445|NCT00842946|695749|P1|COMPLETED|Overall Study||16
287446|NCT00842946|695748|P2|STARTED|Overall Study||24
287447|NCT00842946|695749|P1|STARTED|Overall Study||21
287448|NCT00842829|695757|P3|NOT COMPLETED|Continuation Period||61
287449|NCT00842829|695758|P2|NOT COMPLETED|Continuation Period||0
287450|NCT00842829|695759|P1|NOT COMPLETED|Continuation Period||0
287451|NCT00842829|695757|P3|COMPLETED|Continuation Period||27
287452|NCT00842829|695758|P2|COMPLETED|Continuation Period||0
287453|NCT00842829|695759|P1|COMPLETED|Continuation Period||0
287454|NCT00842829|695757|P3|Continuation Safety Analysis Set|Continuation Period|Received at least one dose of study drug|87
287455|NCT00842829|695758|P2|Continuation Safety Analysis Set|Continuation Period||0
287456|NCT00842829|695759|P1|Continuation Safety Analysis Set|Continuation Period||0
287457|NCT00842829|695757|P3|STARTED|Continuation Period|Eligible for Continuation Period|88
287458|NCT00842829|695758|P2|STARTED|Continuation Period||0
287459|NCT00842829|695759|P1|STARTED|Continuation Period||0
287460|NCT00842829|695757|P3|NOT COMPLETED|Treatment Period||63
287461|NCT00842829|695758|P2|NOT COMPLETED|Treatment Period||0
287462|NCT00842829|695759|P1|NOT COMPLETED|Treatment Period||0
287463|NCT00842829|695757|P3|COMPLETED|Treatment Period||218
287464|NCT00842829|695758|P2|COMPLETED|Treatment Period||0
287465|NCT00842829|695759|P1|COMPLETED|Treatment Period||0
287466|NCT00842829|695757|P3|Safety Analysis Set|Treatment Period|Received at least one dose of study drug|223
287467|NCT00842829|695758|P2|Safety Analysis Set|Treatment Period||0
287468|NCT00842829|695759|P1|Safety Analysis Set|Treatment Period||0
287469|NCT00842829|695757|P3|STARTED|Treatment Period||281
287470|NCT00842829|695758|P2|STARTED|Treatment Period||0
287471|NCT00842829|695759|P1|STARTED|Treatment Period||0
287472|NCT00842829|695757|P3|NOT COMPLETED|Dose Titration Period||0
287473|NCT00842829|695758|P2|NOT COMPLETED|Dose Titration Period||23
287474|NCT00842829|695759|P1|NOT COMPLETED|Dose Titration Period||26
287475|NCT00842829|695757|P3|COMPLETED|Dose Titration Period||0
287476|NCT00842829|695758|P2|COMPLETED|Dose Titration Period||151
287477|NCT00842829|695759|P1|COMPLETED|Dose Titration Period||130
287478|NCT00842829|695757|P3|Titration Safety Analysis Set|Dose Titration Period||0
287479|NCT00842829|695758|P2|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|167
287480|NCT00842829|695759|P1|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|145
287481|NCT00842829|695757|P3|STARTED|Dose Titration Period||0
287482|NCT00842829|695758|P2|STARTED|Dose Titration Period||174
287483|NCT00842829|695759|P1|STARTED|Dose Titration Period||156
287484|NCT00842764|695793|P1|NOT COMPLETED|Overall Study||2
287485|NCT00842764|695793|P1|COMPLETED|Overall Study||5
287486|NCT00842764|695793|P1|STARTED|Overall Study||7
287487|NCT00842751|695797|P1|NOT COMPLETED|Overall Study||0
287488|NCT00842751|695797|P1|COMPLETED|Overall Study||11
287489|NCT00842751|695797|P1|STARTED|Overall Study||11
287490|NCT00842712|695818|P7|NOT COMPLETED|Randomized Part||6
287491|NCT00842712|695819|P6|NOT COMPLETED|Randomized Part||1
287492|NCT00842712|695820|P5|NOT COMPLETED|Randomized Part||0
287493|NCT00842712|695821|P4|NOT COMPLETED|Randomized Part||0
287494|NCT00842712|695822|P3|NOT COMPLETED|Randomized Part||0
287495|NCT00842712|695823|P2|NOT COMPLETED|Randomized Part||0
287496|NCT00842712|695824|P1|NOT COMPLETED|Randomized Part||0
287497|NCT00842712|695818|P7|COMPLETED|Randomized Part||78
287498|NCT00842712|695819|P6|COMPLETED|Randomized Part||50
287499|NCT00842712|695820|P5|COMPLETED|Randomized Part||85
287500|NCT00842712|695821|P4|COMPLETED|Randomized Part||0
287501|NCT00842712|695822|P3|COMPLETED|Randomized Part||0
287502|NCT00842712|695823|P2|COMPLETED|Randomized Part||0
287503|NCT00842712|695824|P1|COMPLETED|Randomized Part||0
287504|NCT00842712|695818|P7|Treated|Randomized Part||80
287505|NCT00842712|695819|P6|Treated|Randomized Part||50
287506|NCT00842712|695820|P5|Treated|Randomized Part||85
287507|NCT00842712|695821|P4|Treated|Randomized Part||0
287508|NCT00842712|695822|P3|Treated|Randomized Part||0
287509|NCT00842712|695823|P2|Treated|Randomized Part||0
287510|NCT00842712|695824|P1|Treated|Randomized Part||0
287511|NCT00842712|695818|P7|STARTED|Randomized Part||84
287512|NCT00842712|695819|P6|STARTED|Randomized Part||51
287513|NCT00842712|695820|P5|STARTED|Randomized Part||85
287514|NCT00842712|695821|P4|STARTED|Randomized Part||0
287515|NCT00842712|695822|P3|STARTED|Randomized Part||0
287516|NCT00842712|695823|P2|STARTED|Randomized Part||0
287517|NCT00842712|695824|P1|STARTED|Randomized Part||0
287518|NCT00842712|695818|P7|NOT COMPLETED|Safety Run-in Part||0
287519|NCT00842712|695819|P6|NOT COMPLETED|Safety Run-in Part||0
287520|NCT00842712|695820|P5|NOT COMPLETED|Safety Run-in Part||0
287521|NCT00842712|695821|P4|NOT COMPLETED|Safety Run-in Part||1
287522|NCT00842712|695822|P3|NOT COMPLETED|Safety Run-in Part||0
287523|NCT00842712|695823|P2|NOT COMPLETED|Safety Run-in Part||2
287524|NCT00842712|695824|P1|NOT COMPLETED|Safety Run-in Part||3
287525|NCT00842712|695818|P7|COMPLETED|Safety Run-in Part||0
287526|NCT00842712|695819|P6|COMPLETED|Safety Run-in Part||0
287527|NCT00842712|695820|P5|COMPLETED|Safety Run-in Part||0
287528|NCT00842712|695821|P4|COMPLETED|Safety Run-in Part||2
287529|NCT00842712|695822|P3|COMPLETED|Safety Run-in Part||3
287530|NCT00842712|695823|P2|COMPLETED|Safety Run-in Part||1
287531|NCT00842712|695824|P1|COMPLETED|Safety Run-in Part||0
287532|NCT00842712|695818|P7|STARTED|Safety Run-in Part||0
287533|NCT00842712|695819|P6|STARTED|Safety Run-in Part||0
287534|NCT00842712|695820|P5|STARTED|Safety Run-in Part||0
287535|NCT00842712|695821|P4|STARTED|Safety Run-in Part||3
287536|NCT00842712|695822|P3|STARTED|Safety Run-in Part||3
287537|NCT00842712|695823|P2|STARTED|Safety Run-in Part||3
287538|NCT00842712|695824|P1|STARTED|Safety Run-in Part||3
287539|NCT00842608|695856|P4|NOT COMPLETED|Overall Study||1
287540|NCT00842608|695857|P3|NOT COMPLETED|Overall Study||0
287541|NCT00842608|695858|P2|NOT COMPLETED|Overall Study||1
287542|NCT00842608|695859|P1|NOT COMPLETED|Overall Study||4
287543|NCT00842608|695856|P4|COMPLETED|Overall Study||100
287544|NCT00842608|695857|P3|COMPLETED|Overall Study||99
287545|NCT00842608|695858|P2|COMPLETED|Overall Study||176
287546|NCT00842608|695859|P1|COMPLETED|Overall Study||170
287547|NCT00842608|695856|P4|STARTED|Overall Study||101
287548|NCT00842608|695857|P3|STARTED|Overall Study||99
287549|NCT00842608|695858|P2|STARTED|Overall Study||177
287550|NCT00842608|695859|P1|STARTED|Overall Study||174
287551|NCT00842543|695881|P4|NOT COMPLETED|Overall Study||4
287552|NCT00842543|695882|P3|NOT COMPLETED|Overall Study||3
287553|NCT00842543|695883|P2|NOT COMPLETED|Overall Study||0
287554|NCT00842543|695884|P1|NOT COMPLETED|Overall Study||2
287555|NCT00842543|695881|P4|COMPLETED|Overall Study||4
287556|NCT00842543|695882|P3|COMPLETED|Overall Study||10
287557|NCT00842543|695883|P2|COMPLETED|Overall Study||5
287558|NCT00842543|695884|P1|COMPLETED|Overall Study||11
287559|NCT00842543|695881|P4|STARTED|Overall Study||8
287560|NCT00842543|695882|P3|STARTED|Overall Study||13
287561|NCT00842543|695883|P2|STARTED|Overall Study||5
287562|NCT00842543|695884|P1|STARTED|Overall Study||13
287563|NCT00842530|695898|P2|NOT COMPLETED|Overall Study||57
287564|NCT00842530|695899|P1|NOT COMPLETED|Overall Study||117
287565|NCT00842530|695898|P2|COMPLETED|Overall Study||1276
287566|NCT00842530|695899|P1|COMPLETED|Overall Study||2552
287567|NCT00842530|695898|P2|Received Vaccination 3|Overall Study||1282
287568|NCT00842530|695899|P1|Received Vaccination 3|Overall Study||2557
287569|NCT00842530|695898|P2|Received Vaccination 2|Overall Study||1300
287570|NCT00842530|695899|P1|Received Vaccination 2|Overall Study||2584
287571|NCT00842530|695898|P2|Received Vaccination 1|Overall Study||1331
287572|NCT00842530|695899|P1|Received Vaccination 1|Overall Study||2666
287573|NCT00842530|695898|P2|STARTED|Overall Study||1333
287574|NCT00842530|695899|P1|STARTED|Overall Study||2669
287575|NCT00842361|695929|P2|NOT COMPLETED|Overall Study||2
287576|NCT00842361|695930|P1|NOT COMPLETED|Overall Study||1
287577|NCT00842361|695929|P2|COMPLETED|Overall Study||31
287578|NCT00842361|695930|P1|COMPLETED|Overall Study||32
287579|NCT00842361|695929|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|32
287580|NCT00842361|695930|P1|Exposed|Overall Study||33
287581|NCT00842361|695929|P2|STARTED|Overall Study||33
287582|NCT00842361|695930|P1|STARTED|Overall Study||33
287583|NCT00842348|695950|P2|NOT COMPLETED|Study 729||38
287584|NCT00842348|695951|P1|NOT COMPLETED|Study 729||26
287585|NCT00842348|695950|P2|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|9
287586|NCT00842348|695951|P1|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|16
287587|NCT00842348|695950|P2|STARTED|Study 729||47
287588|NCT00842348|695951|P1|STARTED|Study 729||42
287589|NCT00842348|695950|P2|NOT COMPLETED|Patients Randomised in Study 726||56
287590|NCT00842348|695951|P1|NOT COMPLETED|Patients Randomised in Study 726||59
287591|NCT00842348|695950|P2|COMPLETED|Patients Randomised in Study 726|15 patients had stable disease and 32 patients had progressive disease.|47
287592|NCT00842348|695951|P1|COMPLETED|Patients Randomised in Study 726|41 patients had stable disease and 1 patient had progressive disease.|42
287593|NCT00842348|695950|P2|STARTED|Patients Randomised in Study 726||103
287594|NCT00842348|695951|P1|STARTED|Patients Randomised in Study 726||101
287595|NCT00842335|695961|P1|NOT COMPLETED|Overall Study||0
287596|NCT00842335|695961|P1|COMPLETED|Overall Study||18
287597|NCT00842335|695961|P1|STARTED|Overall Study||18
287598|NCT00842309|695970|P2|NOT COMPLETED|Overall Study||1
287599|NCT00842309|695971|P1|NOT COMPLETED|Overall Study||3
287600|NCT00842309|695970|P2|COMPLETED|Overall Study||13
287601|NCT00842309|695971|P1|COMPLETED|Overall Study||11
287602|NCT00842309|695970|P2|STARTED|Overall Study||14
287603|NCT00842309|695971|P1|STARTED|Overall Study|14 randomized. 2 withdrew prior to initiating DCS-not included in modified intent-to-treat analyses.|14
287604|NCT00842296|695979|P1|NOT COMPLETED|Overall Study||0
287605|NCT00842296|695979|P1|COMPLETED|Overall Study||326
287606|NCT00842296|695979|P1|STARTED|Overall Study||326
287607|NCT00842257|696005|P1|NOT COMPLETED|Overall Study||1
287608|NCT00842257|696005|P1|COMPLETED|Overall Study||19
287609|NCT00842257|696005|P1|STARTED|Overall Study||20
287610|NCT00842244|696012|P1|NOT COMPLETED|Overall Study||21
287611|NCT00842244|696012|P1|COMPLETED|Overall Study||1
287612|NCT00842244|696012|P1|STARTED|Overall Study||22
287613|NCT00842231|696031|P1|NOT COMPLETED|Overall Study||0
287614|NCT00842231|696031|P1|COMPLETED|Overall Study||40
287615|NCT00842231|696031|P1|STARTED|Overall Study||40
287616|NCT00842153|696039|P2|NOT COMPLETED|Overall Study||3
287617|NCT00842153|696040|P1|NOT COMPLETED|Overall Study||1
287618|NCT00842153|696039|P2|COMPLETED|Overall Study||27
287619|NCT00842153|696040|P1|COMPLETED|Overall Study||27
287620|NCT00842153|696039|P2|STARTED|Overall Study||30
287621|NCT00842153|696040|P1|STARTED|Overall Study||28
287622|NCT00842075|696080|P2|NOT COMPLETED|Overall Study||0
287623|NCT00842075|696081|P1|NOT COMPLETED|Overall Study||0
287624|NCT00842075|696080|P2|COMPLETED|Overall Study||5
287625|NCT00842075|696081|P1|COMPLETED|Overall Study||5
287626|NCT00842075|696080|P2|STARTED|Overall Study||5
287627|NCT00842075|696081|P1|STARTED|Overall Study||5
287628|NCT00842023|696091|P2|NOT COMPLETED|Overall Study||0
287629|NCT00842023|696092|P1|NOT COMPLETED|Overall Study||0
287630|NCT00842023|696091|P2|COMPLETED|Overall Study||44
287631|NCT00842023|696092|P1|COMPLETED|Overall Study||45
287632|NCT00842023|696091|P2|STARTED|Overall Study||44
287633|NCT00842023|696092|P1|STARTED|Overall Study||45
287634|NCT00841971|696104|P2|NOT COMPLETED|Overall Study||1
287635|NCT00841971|696105|P1|NOT COMPLETED|Overall Study||2
287636|NCT00841971|696104|P2|COMPLETED|Overall Study||99
287637|NCT00841971|696105|P1|COMPLETED|Overall Study||98
287638|NCT00841971|696104|P2|STARTED|Overall Study||100
287639|NCT00841971|696105|P1|STARTED|Overall Study||100
287640|NCT00841906|696115|P2|NOT COMPLETED|Overall Study||0
287641|NCT00841906|696116|P1|NOT COMPLETED|Overall Study||2
287642|NCT00841906|696115|P2|COMPLETED|Overall Study||14
287643|NCT00841906|696116|P1|COMPLETED|Overall Study||16
287644|NCT00841906|696115|P2|STARTED|Overall Study||14
287645|NCT00841906|696116|P1|STARTED|Overall Study||18
287646|NCT00841828|696130|P2|NOT COMPLETED|Overall Study||2
287647|NCT00841828|696131|P1|NOT COMPLETED|Overall Study||10
287648|NCT00841828|696130|P2|COMPLETED|Overall Study||48
287649|NCT00841828|696131|P1|COMPLETED|Overall Study||42
287650|NCT00841828|696130|P2|STARTED|Overall Study||50
287651|NCT00841828|696131|P1|STARTED|Overall Study||52
287652|NCT00841815|696141|P2|NOT COMPLETED|Period 2||0
287653|NCT00841815|696142|P1|NOT COMPLETED|Period 2||0
287654|NCT00841815|696141|P2|COMPLETED|Period 2||13
287655|NCT00841815|696142|P1|COMPLETED|Period 2||14
287656|NCT00841815|696141|P2|STARTED|Period 2||13
287657|NCT00841815|696142|P1|STARTED|Period 2||14
287658|NCT00841815|696141|P2|NOT COMPLETED|Washout||1
287659|NCT00841815|696142|P1|NOT COMPLETED|Washout||0
287660|NCT00841815|696141|P2|COMPLETED|Washout||13
287661|NCT00841815|696142|P1|COMPLETED|Washout||14
287662|NCT00841815|696141|P2|STARTED|Washout||14
287663|NCT00841815|696142|P1|STARTED|Washout||14
287664|NCT00841815|696141|P2|NOT COMPLETED|Period 1||0
287665|NCT00841815|696142|P1|NOT COMPLETED|Period 1||0
287666|NCT00841815|696141|P2|COMPLETED|Period 1||14
287667|NCT00841815|696142|P1|COMPLETED|Period 1||14
287668|NCT00841815|696141|P2|STARTED|Period 1||14
287669|NCT00841815|696142|P1|STARTED|Period 1||14
287670|NCT00841776|696152|P2|NOT COMPLETED|Overall Study||3
287671|NCT00841776|696153|P1|NOT COMPLETED|Overall Study||2
287672|NCT00841776|696152|P2|COMPLETED|Overall Study||24
287673|NCT00841776|696153|P1|COMPLETED|Overall Study||25
287674|NCT00841776|696152|P2|STARTED|Overall Study||27
287675|NCT00841776|696153|P1|STARTED|Overall Study||27
287676|NCT00841763|696171|P4|NOT COMPLETED|Overall Study||3
287677|NCT00841763|696172|P3|NOT COMPLETED|Overall Study||8
287678|NCT00841763|696173|P2|NOT COMPLETED|Overall Study||57
287679|NCT00841763|696174|P1|NOT COMPLETED|Overall Study||162
287680|NCT00841763|696171|P4|COMPLETED|Overall Study||53
287681|NCT00841763|696172|P3|COMPLETED|Overall Study||211
287682|NCT00841763|696173|P2|COMPLETED|Overall Study||624
287683|NCT00841763|696174|P1|COMPLETED|Overall Study||2529
287684|NCT00841763|696171|P4|STARTED|Overall Study||56
287685|NCT00841763|696172|P3|STARTED|Overall Study||219
287686|NCT00841763|696173|P2|STARTED|Overall Study||681
287687|NCT00841763|696174|P1|STARTED|Overall Study||2691
287688|NCT00841698|696236|P2|NOT COMPLETED|Second Intervention||0
287689|NCT00841698|696237|P1|NOT COMPLETED|Second Intervention||0
287690|NCT00841698|696236|P2|COMPLETED|Second Intervention||25
287691|NCT00841698|696237|P1|COMPLETED|Second Intervention||24
287692|NCT00841698|696236|P2|STARTED|Second Intervention||25
287693|NCT00841698|696237|P1|STARTED|Second Intervention||24
287694|NCT00841698|696236|P2|NOT COMPLETED|Washout: 2 Weeks||0
287695|NCT00841698|696237|P1|NOT COMPLETED|Washout: 2 Weeks||0
287696|NCT00841698|696236|P2|COMPLETED|Washout: 2 Weeks||25
287697|NCT00841698|696237|P1|COMPLETED|Washout: 2 Weeks||24
287698|NCT00841698|696236|P2|STARTED|Washout: 2 Weeks||25
287699|NCT00841698|696237|P1|STARTED|Washout: 2 Weeks||24
287700|NCT00841698|696236|P2|NOT COMPLETED|First Intervention||0
287701|NCT00841698|696237|P1|NOT COMPLETED|First Intervention||1
287702|NCT00841698|696236|P2|COMPLETED|First Intervention||25
287703|NCT00841698|696237|P1|COMPLETED|First Intervention||24
287704|NCT00841698|696236|P2|STARTED|First Intervention||25
287705|NCT00841698|696237|P1|STARTED|First Intervention||25
287706|NCT00841672|696247|P2|NOT COMPLETED|Overall Study||32
287707|NCT00841672|696248|P1|NOT COMPLETED|Overall Study||20
287708|NCT00841672|696247|P2|COMPLETED|Overall Study||209
287709|NCT00841672|696248|P1|COMPLETED|Overall Study||224
287710|NCT00841672|696247|P2|STARTED|Overall Study||241
287711|NCT00841672|696248|P1|STARTED|Overall Study|One patient was mis-randomized and was not treated in the double-blind treatment period.|244
287712|NCT00841659|696264|P2|NOT COMPLETED|Second Intervention||0
287713|NCT00841659|696265|P1|NOT COMPLETED|Second Intervention||0
287714|NCT00841659|696264|P2|COMPLETED|Second Intervention||12
287715|NCT00841659|696265|P1|COMPLETED|Second Intervention||11
287716|NCT00841659|696264|P2|STARTED|Second Intervention||12
287717|NCT00841659|696265|P1|STARTED|Second Intervention||11
287718|NCT00841659|696264|P2|NOT COMPLETED|Washout: 2 Weeks||0
287719|NCT00841659|696265|P1|NOT COMPLETED|Washout: 2 Weeks||1
287720|NCT00841659|696264|P2|COMPLETED|Washout: 2 Weeks||12
287721|NCT00841659|696265|P1|COMPLETED|Washout: 2 Weeks||11
287722|NCT00841659|696264|P2|STARTED|Washout: 2 Weeks||12
287723|NCT00841659|696265|P1|STARTED|Washout: 2 Weeks||12
287724|NCT00841659|696264|P2|NOT COMPLETED|First Intervention||0
287725|NCT00841659|696265|P1|NOT COMPLETED|First Intervention||0
287726|NCT00841659|696264|P2|COMPLETED|First Intervention||12
287727|NCT00841659|696265|P1|COMPLETED|First Intervention||12
287728|NCT00841659|696264|P2|STARTED|First Intervention||12
287729|NCT00841659|696265|P1|STARTED|First Intervention||12
287730|NCT00841568|696273|P1|NOT COMPLETED|Overall Study||5
287731|NCT00841568|696273|P1|COMPLETED|Overall Study||12
287732|NCT00841568|696273|P1|STARTED|Overall Study||17
287733|NCT00841555|696289|P3|NOT COMPLETED|Overall Study||0
287734|NCT00841555|696290|P2|NOT COMPLETED|Overall Study||0
287735|NCT00841555|696291|P1|NOT COMPLETED|Overall Study||0
287736|NCT00841555|696289|P3|COMPLETED|Overall Study||3
287737|NCT00841555|696290|P2|COMPLETED|Overall Study||3
287738|NCT00841555|696291|P1|COMPLETED|Overall Study||3
287739|NCT00841555|696289|P3|STARTED|Overall Study||3
287740|NCT00841555|696290|P2|STARTED|Overall Study||3
287741|NCT00841555|696291|P1|STARTED|Overall Study||3
287742|NCT00841542|696301|P2|NOT COMPLETED|Period 2||0
287743|NCT00841542|696302|P1|NOT COMPLETED|Period 2||0
287744|NCT00841542|696301|P2|COMPLETED|Period 2||14
287745|NCT00841542|696302|P1|COMPLETED|Period 2||13
287746|NCT00841542|696301|P2|STARTED|Period 2||14
287747|NCT00841542|696302|P1|STARTED|Period 2||13
287748|NCT00841542|696301|P2|NOT COMPLETED|Period 1||0
287749|NCT00841542|696302|P1|NOT COMPLETED|Period 1||1
287750|NCT00841542|696301|P2|COMPLETED|Period 1||14
287751|NCT00841542|696302|P1|COMPLETED|Period 1||13
287752|NCT00841542|696301|P2|STARTED|Period 1||14
287753|NCT00841542|696302|P1|STARTED|Period 1||14
287754|NCT00841412|696310|P2|NOT COMPLETED|Overall Study||30
287755|NCT00841412|696311|P1|NOT COMPLETED|Overall Study||40
287756|NCT00841412|696310|P2|COMPLETED|Overall Study||50
287757|NCT00841412|696311|P1|COMPLETED|Overall Study|130 residents completed all study phases across both groups, including follow-up.|80
287758|NCT00841412|696310|P2|STARTED|Overall Study|80 residents were in the delayed intervention group, but all residents received intervention.|80
287759|NCT00841412|696311|P1|STARTED|Overall Study|200 of 222 consented residents completed baseline assessments across both groups.|120
287760|NCT00841321|696317|P2|NOT COMPLETED|Overall Study||3
287761|NCT00841321|696318|P1|NOT COMPLETED|Overall Study||1
287762|NCT00841321|696317|P2|COMPLETED|Overall Study||58
287763|NCT00841321|696318|P1|COMPLETED|Overall Study||58
287764|NCT00841321|696317|P2|STARTED|Overall Study||61
287765|NCT00841321|696318|P1|STARTED|Overall Study||59
287766|NCT00841269|696332|P2|NOT COMPLETED|Overall Study||9
287767|NCT00841269|696333|P1|NOT COMPLETED|Overall Study||8
287768|NCT00841269|696332|P2|COMPLETED|Overall Study||13
287769|NCT00841269|696333|P1|COMPLETED|Overall Study||12
287770|NCT00841269|696332|P2|STARTED|Overall Study||22
287771|NCT00841269|696333|P1|STARTED|Overall Study||20
287772|NCT00841204|696344|P2|NOT COMPLETED|Overall Study||0
287773|NCT00841204|696345|P1|NOT COMPLETED|Overall Study||0
287774|NCT00841204|696344|P2|COMPLETED|Overall Study||25
287775|NCT00841204|696345|P1|COMPLETED|Overall Study||25
287776|NCT00841204|696344|P2|STARTED|Overall Study||25
287777|NCT00841204|696345|P1|STARTED|Overall Study||25
287778|NCT00841100|696365|P1|NOT COMPLETED|Phase 3||0
287779|NCT00841100|696365|P1|COMPLETED|Phase 3||4
287780|NCT00841100|696365|P1|STARTED|Phase 3|Participants who achieved a fasting blood phenylalanine of <600 umol/l can continue to Phase 3.|4
287781|NCT00841100|696365|P1|NOT COMPLETED|Phase 2||0
287782|NCT00841100|696365|P1|COMPLETED|Phase 2||5
287783|NCT00841100|696365|P1|STARTED|Phase 2|Participants who were non-responsive on the Phase 1 component of the study continued on to Phase 2.|5
287784|NCT00841100|696365|P1|NOT COMPLETED|Phase 1||3
287785|NCT00841100|696365|P1|COMPLETED|Phase 1||15
287786|NCT00841100|696365|P1|STARTED|Phase 1|3 participants from the acute phase elected not to continue to the Phase 1 component of the study.|18
287787|NCT00841100|696365|P1|NOT COMPLETED|Acute Component (24 Hours)||0
287788|NCT00841100|696365|P1|COMPLETED|Acute Component (24 Hours)||21
287789|NCT00841100|696365|P1|STARTED|Acute Component (24 Hours)||21
287790|NCT00841087|696371|P2|NOT COMPLETED|Overall Study||0
287791|NCT00841087|696372|P1|NOT COMPLETED|Overall Study||0
287792|NCT00841087|696371|P2|COMPLETED|Overall Study||32
287793|NCT00841087|696372|P1|COMPLETED|Overall Study||33
287794|NCT00841087|696371|P2|STARTED|Overall Study||32
287795|NCT00841087|696372|P1|STARTED|Overall Study||33
287796|NCT00841035|696390|P1|NOT COMPLETED|Phase 2 of Overall Study||0
287797|NCT00841035|696390|P1|COMPLETED|Phase 2 of Overall Study||6
287798|NCT00841035|696390|P1|STARTED|Phase 2 of Overall Study||6
287799|NCT00841035|696390|P1|NOT COMPLETED|Phase 1 Overall Study||13
287800|NCT00841035|696390|P1|COMPLETED|Phase 1 Overall Study||6
287801|NCT00841035|696390|P1|STARTED|Phase 1 Overall Study|2 phase enrollment,1st phase enrolled with cancer by fine needle aspiration in endoscopic ultrasound|19
287802|NCT00840996|696397|P2|NOT COMPLETED|Overall Study||0
287803|NCT00840996|696398|P1|NOT COMPLETED|Overall Study||1
287804|NCT00840996|696397|P2|COMPLETED|Overall Study||58
287805|NCT00840996|696398|P1|COMPLETED|Overall Study||57
287806|NCT00840996|696397|P2|STARTED|Overall Study||58
287807|NCT00840996|696398|P1|STARTED|Overall Study||58
287808|NCT00840879|696418|P2|NOT COMPLETED|Second Intervention||0
287809|NCT00840879|696419|P1|NOT COMPLETED|Second Intervention||1
287810|NCT00840879|696418|P2|COMPLETED|Second Intervention||14
287811|NCT00840879|696419|P1|COMPLETED|Second Intervention||13
287812|NCT00840879|696418|P2|STARTED|Second Intervention||14
287813|NCT00840879|696419|P1|STARTED|Second Intervention||14
287814|NCT00840879|696418|P2|NOT COMPLETED|Washout: 14 Days||0
287815|NCT00840879|696419|P1|NOT COMPLETED|Washout: 14 Days||0
287816|NCT00840879|696418|P2|COMPLETED|Washout: 14 Days||14
287817|NCT00840879|696419|P1|COMPLETED|Washout: 14 Days||14
287818|NCT00840879|696418|P2|STARTED|Washout: 14 Days||14
287819|NCT00840879|696419|P1|STARTED|Washout: 14 Days||14
287820|NCT00840879|696418|P2|NOT COMPLETED|First Intervention||0
287821|NCT00840879|696419|P1|NOT COMPLETED|First Intervention||0
287822|NCT00840879|696418|P2|COMPLETED|First Intervention||14
287823|NCT00840879|696419|P1|COMPLETED|First Intervention||14
287824|NCT00840879|696418|P2|STARTED|First Intervention||14
287825|NCT00840879|696419|P1|STARTED|First Intervention||14
287826|NCT00840866|696429|P2|NOT COMPLETED|Second Intervention||0
287827|NCT00840866|696430|P1|NOT COMPLETED|Second Intervention||0
287828|NCT00840866|696429|P2|COMPLETED|Second Intervention||19
287829|NCT00840866|696430|P1|COMPLETED|Second Intervention||20
287830|NCT00840866|696429|P2|STARTED|Second Intervention||19
287831|NCT00840866|696430|P1|STARTED|Second Intervention||20
287832|NCT00840866|696429|P2|NOT COMPLETED|Washout of 7 Days||0
287833|NCT00840866|696430|P1|NOT COMPLETED|Washout of 7 Days||0
287834|NCT00840866|696429|P2|COMPLETED|Washout of 7 Days||19
287835|NCT00840866|696430|P1|COMPLETED|Washout of 7 Days||20
287836|NCT00840866|696429|P2|STARTED|Washout of 7 Days||19
287837|NCT00840866|696430|P1|STARTED|Washout of 7 Days||20
287838|NCT00840866|696429|P2|NOT COMPLETED|First Intervention||0
287839|NCT00840866|696430|P1|NOT COMPLETED|First Intervention||0
287840|NCT00840866|696429|P2|COMPLETED|First Intervention||19
287841|NCT00840866|696430|P1|COMPLETED|First Intervention||20
287842|NCT00840866|696429|P2|STARTED|First Intervention||19
287843|NCT00840866|696430|P1|STARTED|First Intervention||20
287844|NCT00840840|696440|P2|NOT COMPLETED|Period 2||0
287845|NCT00840840|696441|P1|NOT COMPLETED|Period 2||0
287846|NCT00840840|696440|P2|COMPLETED|Period 2||24
287847|NCT00840840|696441|P1|COMPLETED|Period 2||23
287848|NCT00840840|696440|P2|STARTED|Period 2||24
287849|NCT00840840|696441|P1|STARTED|Period 2|One subject was withdrawn due to AE after Period 1|23
287850|NCT00840840|696440|P2|NOT COMPLETED|Period 1||0
287851|NCT00840840|696441|P1|NOT COMPLETED|Period 1||0
287852|NCT00840840|696440|P2|COMPLETED|Period 1||24
287853|NCT00840840|696441|P1|COMPLETED|Period 1||24
287854|NCT00840840|696440|P2|STARTED|Period 1||24
287855|NCT00840840|696441|P1|STARTED|Period 1||24
287856|NCT00840827|696455|P1|NOT COMPLETED|Overall Study||6
287857|NCT00840827|696455|P1|COMPLETED|Overall Study||0
287858|NCT00840827|696455|P1|STARTED|Overall Study||6
287859|NCT00840658|696472|P4|NOT COMPLETED|Overall Study||4
287860|NCT00840658|696473|P3|NOT COMPLETED|Overall Study||5
287861|NCT00840658|696474|P2|NOT COMPLETED|Overall Study||3
287862|NCT00840658|696475|P1|NOT COMPLETED|Overall Study||5
287863|NCT00840658|696472|P4|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|142
287864|NCT00840658|696473|P3|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
287865|NCT00840658|696474|P2|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
287866|NCT00840658|696475|P1|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|139
287867|NCT00840658|696472|P4|STARTED|Overall Study||146
287868|NCT00840658|696473|P3|STARTED|Overall Study||148
287869|NCT00840658|696474|P2|STARTED|Overall Study||146
287870|NCT00840658|696475|P1|STARTED|Overall Study||144
287871|NCT00840632|696487|P2|NOT COMPLETED|Second Intervention||0
287872|NCT00840632|696488|P1|NOT COMPLETED|Second Intervention||0
287873|NCT00840632|696487|P2|COMPLETED|Second Intervention||18
287874|NCT00840632|696488|P1|COMPLETED|Second Intervention||19
287875|NCT00840632|696487|P2|STARTED|Second Intervention||18
287876|NCT00840632|696488|P1|STARTED|Second Intervention||19
287877|NCT00840632|696487|P2|NOT COMPLETED|Washout||1
287878|NCT00840632|696488|P1|NOT COMPLETED|Washout||1
287879|NCT00840632|696487|P2|COMPLETED|Washout||18
287880|NCT00840632|696488|P1|COMPLETED|Washout||19
287881|NCT00840632|696487|P2|STARTED|Washout||19
287882|NCT00840632|696488|P1|STARTED|Washout||20
287883|NCT00840632|696487|P2|NOT COMPLETED|First Intervention||1
287884|NCT00840632|696488|P1|NOT COMPLETED|First Intervention||0
287885|NCT00840632|696487|P2|COMPLETED|First Intervention||19
287886|NCT00840632|696488|P1|COMPLETED|First Intervention||20
287887|NCT00840632|696487|P2|STARTED|First Intervention||20
287888|NCT00840632|696488|P1|STARTED|First Intervention||20
287889|NCT00840476|696504|P2|NOT COMPLETED|Second Intervention||0
287890|NCT00840476|696505|P1|NOT COMPLETED|Second Intervention||0
287891|NCT00840476|696504|P2|COMPLETED|Second Intervention||14
287892|NCT00840476|696505|P1|COMPLETED|Second Intervention||14
287893|NCT00840476|696504|P2|STARTED|Second Intervention||14
287894|NCT00840476|696505|P1|STARTED|Second Intervention||14
287895|NCT00840476|696504|P2|NOT COMPLETED|Washout: 14 Days||0
287896|NCT00840476|696505|P1|NOT COMPLETED|Washout: 14 Days||0
287897|NCT00840476|696504|P2|COMPLETED|Washout: 14 Days||14
287898|NCT00840476|696505|P1|COMPLETED|Washout: 14 Days||14
287899|NCT00840476|696504|P2|STARTED|Washout: 14 Days||14
287900|NCT00840476|696505|P1|STARTED|Washout: 14 Days||14
287901|NCT00840476|696504|P2|NOT COMPLETED|First Intervention||0
287902|NCT00840476|696505|P1|NOT COMPLETED|First Intervention||0
287903|NCT00840476|696504|P2|COMPLETED|First Intervention||14
287904|NCT00840476|696505|P1|COMPLETED|First Intervention||14
287905|NCT00840476|696504|P2|STARTED|First Intervention||14
287906|NCT00840476|696505|P1|STARTED|First Intervention||14
287907|NCT00840463|696515|P2|NOT COMPLETED|Overall Study||0
287908|NCT00840463|696516|P1|NOT COMPLETED|Overall Study||1
287909|NCT00840463|696515|P2|COMPLETED|Overall Study||1
287910|NCT00840463|696516|P1|COMPLETED|Overall Study||2
287911|NCT00840463|696515|P2|STARTED|Overall Study||1
287912|NCT00840463|696516|P1|STARTED|Overall Study||3
287913|NCT00840450|696530|P1|NOT COMPLETED|Overall Study||3
287914|NCT00840450|696530|P1|COMPLETED|Overall Study||9
287915|NCT00840450|696530|P1|STARTED|Overall Study||12
287916|NCT00840411|696538|P2|NOT COMPLETED|Second Intervention||0
287917|NCT00840411|696539|P1|NOT COMPLETED|Second Intervention||0
287918|NCT00840411|696538|P2|COMPLETED|Second Intervention||33
287919|NCT00840411|696539|P1|COMPLETED|Second Intervention||31
287920|NCT00840411|696538|P2|STARTED|Second Intervention||33
287921|NCT00840411|696539|P1|STARTED|Second Intervention||31
287922|NCT00840411|696538|P2|NOT COMPLETED|Washout||0
287923|NCT00840411|696539|P1|NOT COMPLETED|Washout||1
287924|NCT00840411|696538|P2|COMPLETED|Washout||33
287925|NCT00840411|696539|P1|COMPLETED|Washout||31
287926|NCT00840411|696538|P2|STARTED|Washout||33
287927|NCT00840411|696539|P1|STARTED|Washout||32
287928|NCT00840411|696538|P2|NOT COMPLETED|First Intervention||0
287929|NCT00840411|696539|P1|NOT COMPLETED|First Intervention||1
287930|NCT00840411|696538|P2|COMPLETED|First Intervention||33
287931|NCT00840411|696539|P1|COMPLETED|First Intervention||32
287932|NCT00840411|696538|P2|STARTED|First Intervention||33
287933|NCT00840411|696539|P1|STARTED|First Intervention||33
287934|NCT00840307|696547|P1|NOT COMPLETED|Overall Study||4
287935|NCT00840307|696547|P1|COMPLETED|Overall Study||16
287936|NCT00840307|696547|P1|STARTED|Overall Study||20
287937|NCT00840294|696553|P2|NOT COMPLETED|Overall Study||5
287938|NCT00840294|696554|P1|NOT COMPLETED|Overall Study||3
287939|NCT00840294|696553|P2|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|38
287940|NCT00840294|696554|P1|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|39
287941|NCT00840294|696553|P2|STARTED|Overall Study||43
287942|NCT00840294|696554|P1|STARTED|Overall Study||42
287943|NCT00840281|696564|P2|NOT COMPLETED|Second Intervention||0
287944|NCT00840281|696565|P1|NOT COMPLETED|Second Intervention||0
287945|NCT00840281|696564|P2|COMPLETED|Second Intervention||19
287946|NCT00840281|696565|P1|COMPLETED|Second Intervention||19
287947|NCT00840281|696564|P2|STARTED|Second Intervention||19
287948|NCT00840281|696565|P1|STARTED|Second Intervention||19
287949|NCT00840281|696564|P2|NOT COMPLETED|Washout of 7 Days||0
287950|NCT00840281|696565|P1|NOT COMPLETED|Washout of 7 Days||0
287951|NCT00840281|696564|P2|COMPLETED|Washout of 7 Days||19
287952|NCT00840281|696565|P1|COMPLETED|Washout of 7 Days||19
287953|NCT00840281|696564|P2|STARTED|Washout of 7 Days||19
287954|NCT00840281|696565|P1|STARTED|Washout of 7 Days||19
287955|NCT00840281|696564|P2|NOT COMPLETED|First Intervention||0
287956|NCT00840281|696565|P1|NOT COMPLETED|First Intervention||0
287957|NCT00840281|696564|P2|COMPLETED|First Intervention||19
287958|NCT00840281|696565|P1|COMPLETED|First Intervention||19
287959|NCT00840281|696564|P2|STARTED|First Intervention||19
287960|NCT00840281|696565|P1|STARTED|First Intervention||19
287961|NCT00840216|696575|P2|NOT COMPLETED|Second Intervention||0
287962|NCT00840216|696576|P1|NOT COMPLETED|Second Intervention||0
287963|NCT00840216|696575|P2|COMPLETED|Second Intervention||11
287964|NCT00840216|696576|P1|COMPLETED|Second Intervention||10
287965|NCT00840216|696575|P2|STARTED|Second Intervention||11
287966|NCT00840216|696576|P1|STARTED|Second Intervention||10
287967|NCT00840216|696575|P2|NOT COMPLETED|Washout: 7 Days||0
287968|NCT00840216|696576|P1|NOT COMPLETED|Washout: 7 Days||1
287969|NCT00840216|696575|P2|COMPLETED|Washout: 7 Days||11
287970|NCT00840216|696576|P1|COMPLETED|Washout: 7 Days||10
287971|NCT00840216|696575|P2|STARTED|Washout: 7 Days||11
287972|NCT00840216|696576|P1|STARTED|Washout: 7 Days||11
287973|NCT00840216|696575|P2|NOT COMPLETED|First Intervention||0
287974|NCT00840216|696576|P1|NOT COMPLETED|First Intervention||0
287975|NCT00840216|696575|P2|COMPLETED|First Intervention||11
287976|NCT00840216|696576|P1|COMPLETED|First Intervention||11
287977|NCT00840216|696575|P2|STARTED|First Intervention||11
287978|NCT00840216|696576|P1|STARTED|First Intervention||11
287979|NCT00840203|696586|P2|NOT COMPLETED|Second Intervention||0
287980|NCT00840203|696587|P1|NOT COMPLETED|Second Intervention||0
287981|NCT00840203|696586|P2|COMPLETED|Second Intervention||34
287982|NCT00840203|696587|P1|COMPLETED|Second Intervention||35
287983|NCT00840203|696586|P2|STARTED|Second Intervention||34
287984|NCT00840203|696587|P1|STARTED|Second Intervention||35
287985|NCT00840203|696586|P2|NOT COMPLETED|Washout||0
287986|NCT00840203|696587|P1|NOT COMPLETED|Washout||1
287987|NCT00840203|696586|P2|COMPLETED|Washout||34
287988|NCT00840203|696587|P1|COMPLETED|Washout||35
287989|NCT00840203|696586|P2|STARTED|Washout||34
287990|NCT00840203|696587|P1|STARTED|Washout||36
287991|NCT00840203|696586|P2|NOT COMPLETED|First Intervention||1
287992|NCT00840203|696587|P1|NOT COMPLETED|First Intervention||1
287993|NCT00840203|696586|P2|COMPLETED|First Intervention||34
287994|NCT00840203|696587|P1|COMPLETED|First Intervention||36
287995|NCT00840203|696586|P2|STARTED|First Intervention||35
287996|NCT00840203|696587|P1|STARTED|First Intervention||37
287997|NCT00840099|696603|P2|NOT COMPLETED|Period 2||0
287998|NCT00840099|696604|P1|NOT COMPLETED|Period 2||0
287999|NCT00840099|696603|P2|COMPLETED|Period 2||24
288000|NCT00840099|696604|P1|COMPLETED|Period 2||21
288001|NCT00840099|696603|P2|STARTED|Period 2||24
288002|NCT00840099|696604|P1|STARTED|Period 2|3 subjects were dismissed from study prior to period 2 dosing|21
288003|NCT00840099|696603|P2|NOT COMPLETED|Period 1||0
288004|NCT00840099|696604|P1|NOT COMPLETED|Period 1||0
288005|NCT00840099|696603|P2|COMPLETED|Period 1||24
288006|NCT00840099|696604|P1|COMPLETED|Period 1||24
288007|NCT00840099|696603|P2|STARTED|Period 1||24
288008|NCT00840099|696604|P1|STARTED|Period 1||24
288009|NCT00840086|696618|P1|NOT COMPLETED|Overall Study||4
288010|NCT00840086|696618|P1|COMPLETED|Overall Study||146
288011|NCT00840086|696618|P1|STARTED|Overall Study||150
288012|NCT00840073|696627|P2|NOT COMPLETED|Second Intervention||1
288013|NCT00840073|696628|P1|NOT COMPLETED|Second Intervention||1
288014|NCT00840073|696627|P2|COMPLETED|Second Intervention||24
288015|NCT00840073|696628|P1|COMPLETED|Second Intervention||24
288016|NCT00840073|696627|P2|STARTED|Second Intervention||25
288017|NCT00840073|696628|P1|STARTED|Second Intervention||25
288018|NCT00840073|696627|P2|NOT COMPLETED|First Intervention||0
288019|NCT00840073|696628|P1|NOT COMPLETED|First Intervention||0
288020|NCT00840073|696627|P2|COMPLETED|First Intervention||25
288021|NCT00840073|696628|P1|COMPLETED|First Intervention||25
288022|NCT00840073|696627|P2|STARTED|First Intervention||25
288023|NCT00840073|696628|P1|STARTED|First Intervention||25
288024|NCT00840060|696642|P2|NOT COMPLETED|Overall Study||1
288025|NCT00840060|696643|P1|NOT COMPLETED|Overall Study||1
288026|NCT00840060|696642|P2|COMPLETED|Overall Study||19
288027|NCT00840060|696643|P1|COMPLETED|Overall Study||19
288028|NCT00840060|696642|P2|STARTED|Overall Study||20
288029|NCT00840060|696643|P1|STARTED|Overall Study||20
288030|NCT00840034|696653|P2|NOT COMPLETED|Taper Phase||2
288031|NCT00840034|696654|P1|NOT COMPLETED|Taper Phase||3
288032|NCT00840034|696653|P2|COMPLETED|Taper Phase||80
288033|NCT00840034|696654|P1|COMPLETED|Taper Phase||87
288034|NCT00840034|696653|P2|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|82
288035|NCT00840034|696654|P1|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|90
288036|NCT00840034|696653|P2|NOT COMPLETED|Acute Treatment Phase||36
288037|NCT00840034|696654|P1|NOT COMPLETED|Acute Treatment Phase||21
288038|NCT00840034|696653|P2|COMPLETED|Acute Treatment Phase||80
288039|NCT00840034|696654|P1|COMPLETED|Acute Treatment Phase||90
288040|NCT00840034|696653|P2|STARTED|Acute Treatment Phase||116
288041|NCT00840034|696654|P1|STARTED|Acute Treatment Phase||111
288042|NCT00839982|696690|P4|NOT COMPLETED|Overall Study||0
288043|NCT00839982|696691|P3|NOT COMPLETED|Overall Study||0
288044|NCT00839982|696692|P2|NOT COMPLETED|Overall Study||0
288045|NCT00839982|696693|P1|NOT COMPLETED|Overall Study||0
288046|NCT00839982|696690|P4|COMPLETED|Overall Study||3
288047|NCT00839982|696691|P3|COMPLETED|Overall Study||2
288048|NCT00839982|696692|P2|COMPLETED|Overall Study||26
288049|NCT00839982|696693|P1|COMPLETED|Overall Study||4
288050|NCT00839982|696690|P4|STARTED|Overall Study||3
288051|NCT00839982|696691|P3|STARTED|Overall Study||2
288052|NCT00839982|696692|P2|STARTED|Overall Study||26
288053|NCT00839982|696693|P1|STARTED|Overall Study||4
288054|NCT00839956|696707|P1|NOT COMPLETED|Overall Study||12
288055|NCT00839956|696707|P1|COMPLETED|Overall Study||19
288056|NCT00839956|696707|P1|STARTED|Overall Study||31
288057|NCT00839930|696716|P2|NOT COMPLETED|Second Intervention||0
288058|NCT00839930|696717|P1|NOT COMPLETED|Second Intervention||0
288059|NCT00839930|696716|P2|COMPLETED|Second Intervention||15
288060|NCT00839930|696717|P1|COMPLETED|Second Intervention||15
288061|NCT00839930|696716|P2|STARTED|Second Intervention||15
288062|NCT00839930|696717|P1|STARTED|Second Intervention||15
288063|NCT00839930|696716|P2|NOT COMPLETED|Washout: 7 Days||0
288064|NCT00839930|696717|P1|NOT COMPLETED|Washout: 7 Days||0
288065|NCT00839930|696716|P2|COMPLETED|Washout: 7 Days||15
288066|NCT00839930|696717|P1|COMPLETED|Washout: 7 Days||15
288067|NCT00839930|696716|P2|STARTED|Washout: 7 Days||15
288068|NCT00839930|696717|P1|STARTED|Washout: 7 Days||15
288069|NCT00839930|696716|P2|NOT COMPLETED|First Intervention||0
288070|NCT00839930|696717|P1|NOT COMPLETED|First Intervention||0
288071|NCT00839930|696716|P2|COMPLETED|First Intervention||15
288072|NCT00839930|696717|P1|COMPLETED|First Intervention||15
288073|NCT00839930|696716|P2|STARTED|First Intervention||15
288074|NCT00839930|696717|P1|STARTED|First Intervention||15
288075|NCT00839917|696727|P2|NOT COMPLETED|Overall Study||1
288076|NCT00839917|696728|P1|NOT COMPLETED|Overall Study||1
288077|NCT00839917|696727|P2|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|16
288078|NCT00839917|696728|P1|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|12
288079|NCT00839917|696727|P2|STARTED|Overall Study||17
288080|NCT00839917|696728|P1|STARTED|Overall Study||13
288081|NCT00839852|696764|P1|NOT COMPLETED|Overall Study||47
288082|NCT00839852|696764|P1|COMPLETED|Overall Study||46
288083|NCT00839852|696764|P1|STARTED|Overall Study||93
288084|NCT00839800|696771|P2|NOT COMPLETED|Overall Study||110
288085|NCT00839800|696772|P1|NOT COMPLETED|Overall Study||93
288086|NCT00839800|696771|P2|COMPLETED|Overall Study||932
288087|NCT00839800|696772|P1|COMPLETED|Overall Study||956
288088|NCT00839800|696771|P2|STARTED|Overall Study||1042
288089|NCT00839800|696772|P1|STARTED|Overall Study||1049
288090|NCT00839540|696805|P3|NOT COMPLETED|Overall Study||0
288091|NCT00839540|696806|P2|NOT COMPLETED|Overall Study||0
288092|NCT00839540|696807|P1|NOT COMPLETED|Overall Study||0
288093|NCT00839540|696805|P3|COMPLETED|Overall Study||5
288094|NCT00839540|696806|P2|COMPLETED|Overall Study||8
288095|NCT00839540|696807|P1|COMPLETED|Overall Study||8
288096|NCT00839540|696805|P3|STARTED|Overall Study||5
288097|NCT00839540|696806|P2|STARTED|Overall Study||8
288098|NCT00839540|696807|P1|STARTED|Overall Study||8
288099|NCT00839527|696818|P3|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||62
288100|NCT00839527|696819|P2|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||56
288101|NCT00839527|696820|P1|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||28
288102|NCT00839527|696818|P3|COMPLETED|Follow-up Period (FUP) (8 Weeks)||204
288103|NCT00839527|696819|P2|COMPLETED|Follow-up Period (FUP) (8 Weeks)||217
288104|NCT00839527|696820|P1|COMPLETED|Follow-up Period (FUP) (8 Weeks)||86
288105|NCT00839527|696818|P3|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Five par. did not participate in the FUP.|266
288106|NCT00839527|696819|P2|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Four par. did not participate in the FUP.|273
288107|NCT00839527|696820|P1|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|114
288108|NCT00839527|696818|P3|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||119
288109|NCT00839527|696819|P2|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||118
288110|NCT00839527|696820|P1|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||60
288111|NCT00839527|696818|P3|COMPLETED|Treatment Period (TP) (156 Weeks)||152
288112|NCT00839527|696819|P2|COMPLETED|Treatment Period (TP) (156 Weeks)||159
288113|NCT00839527|696820|P1|COMPLETED|Treatment Period (TP) (156 Weeks)||55
288114|NCT00839527|696818|P3|STARTED|Treatment Period (TP) (156 Weeks)||271
288115|NCT00839527|696819|P2|STARTED|Treatment Period (TP) (156 Weeks)||277
288116|NCT00839527|696820|P1|STARTED|Treatment Period (TP) (156 Weeks)||115
288117|NCT00839436|696855|P3|NOT COMPLETED|Overall Study||1
288118|NCT00839436|696856|P2|NOT COMPLETED|Overall Study||1
288119|NCT00839436|696857|P1|NOT COMPLETED|Overall Study||1
288120|NCT00839436|696855|P3|COMPLETED|Overall Study||0
288121|NCT00839436|696856|P2|COMPLETED|Overall Study||4
288122|NCT00839436|696857|P1|COMPLETED|Overall Study||2
288123|NCT00839436|696855|P3|STARTED|Overall Study||1
288124|NCT00839436|696856|P2|STARTED|Overall Study||5
288125|NCT00839436|696857|P1|STARTED|Overall Study||3
288126|NCT00839423|696869|P4|NOT COMPLETED|Overall Study||20
288127|NCT00839423|696870|P3|NOT COMPLETED|Overall Study||18
288128|NCT00839423|696871|P2|NOT COMPLETED|Overall Study||10
288129|NCT00839423|696872|P1|NOT COMPLETED|Overall Study||18
288130|NCT00839423|696869|P4|COMPLETED|Overall Study||93
288131|NCT00839423|696870|P3|COMPLETED|Overall Study||82
288132|NCT00839423|696871|P2|COMPLETED|Overall Study||98
288133|NCT00839423|696872|P1|COMPLETED|Overall Study||87
288134|NCT00839423|696869|P4|STARTED|Overall Study||113
288135|NCT00839423|696870|P3|STARTED|Overall Study||100
288136|NCT00839423|696871|P2|STARTED|Overall Study||108
288137|NCT00839423|696872|P1|STARTED|Overall Study||105
288138|NCT00839332|696913|P3|NOT COMPLETED|Phase 2||39
288139|NCT00839332|696914|P2|NOT COMPLETED|Phase 2||68
288140|NCT00839332|696915|P1|NOT COMPLETED|Phase 2||0
288141|NCT00839332|696913|P3|COMPLETED|Phase 2||0
288142|NCT00839332|696914|P2|COMPLETED|Phase 2||0
288143|NCT00839332|696915|P1|COMPLETED|Phase 2||0
288144|NCT00839332|696913|P3|Received at Least 1 Dose of Study Drug|Phase 2||34
288145|NCT00839332|696914|P2|Received at Least 1 Dose of Study Drug|Phase 2||65
288146|NCT00839332|696915|P1|Received at Least 1 Dose of Study Drug|Phase 2||0
288147|NCT00839332|696913|P3|STARTED|Phase 2||39
288148|NCT00839332|696914|P2|STARTED|Phase 2||68
288149|NCT00839332|696915|P1|STARTED|Phase 2|Participants in Phase 1 did not participate in Phase 2.|0
288150|NCT00839332|696913|P3|NOT COMPLETED|Phase 1||0
288151|NCT00839332|696914|P2|NOT COMPLETED|Phase 1||0
288152|NCT00839332|696915|P1|NOT COMPLETED|Phase 1||50
288153|NCT00839332|696913|P3|COMPLETED|Phase 1||0
288154|NCT00839332|696914|P2|COMPLETED|Phase 1||0
288155|NCT00839332|696915|P1|COMPLETED|Phase 1||0
288156|NCT00839332|696913|P3|Received at Least 1 Dose of Study Drug|Phase 1||0
288157|NCT00839332|696914|P2|Received at Least 1 Dose of Study Drug|Phase 1||0
288158|NCT00839332|696915|P1|Received at Least 1 Dose of Study Drug|Phase 1||50
288159|NCT00839332|696913|P3|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
288160|NCT00839332|696914|P2|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
288161|NCT00839332|696915|P1|STARTED|Phase 1||50
288162|NCT00839319|696943|P5|NOT COMPLETED|Overall Study||0
288163|NCT00839319|696944|P4|NOT COMPLETED|Overall Study||3
288164|NCT00839319|696945|P3|NOT COMPLETED|Overall Study||3
288165|NCT00839319|696946|P2|NOT COMPLETED|Overall Study||1
288166|NCT00839319|696947|P1|NOT COMPLETED|Overall Study||2
288167|NCT00839319|696943|P5|COMPLETED|Overall Study||8
288168|NCT00839319|696944|P4|COMPLETED|Overall Study|1 withdrawn by investigator for syncopal reaction , 2 excluded from analysis (low serum LH)|5
288169|NCT00839319|696945|P3|COMPLETED|Overall Study|1 dropped out after Day 1 visit, 2 excluded from analysis (low serum LH)|5
288170|NCT00839319|696946|P2|COMPLETED|Overall Study|1 excluded from analysis (low serum LH)|7
288171|NCT00839319|696947|P1|COMPLETED|Overall Study|1 withdrew consent prior to procedures; 1 excluded from analysis (low serum LH)|6
288172|NCT00839319|696943|P5|STARTED|Overall Study||8
288173|NCT00839319|696944|P4|STARTED|Overall Study||8
288174|NCT00839319|696945|P3|STARTED|Overall Study||8
288175|NCT00839319|696946|P2|STARTED|Overall Study||8
288176|NCT00839319|696947|P1|STARTED|Overall Study||8
288177|NCT00839306|696976|P2|NOT COMPLETED|Overall Study||43
288178|NCT00839306|696977|P1|NOT COMPLETED|Overall Study||25
288179|NCT00839306|696976|P2|COMPLETED|Overall Study||134
288180|NCT00839306|696977|P1|COMPLETED|Overall Study||35
288181|NCT00839306|696976|P2|STARTED|Overall Study|Treated|177
288182|NCT00839306|696977|P1|STARTED|Overall Study|Treated|60
288183|NCT00839241|696987|P2|NOT COMPLETED|Overall Study||17
288184|NCT00839241|696988|P1|NOT COMPLETED|Overall Study||5
288185|NCT00839241|696987|P2|COMPLETED|Overall Study||8
288186|NCT00839241|696988|P1|COMPLETED|Overall Study||15
288187|NCT00839241|696987|P2|STARTED|Overall Study||25
288188|NCT00839241|696988|P1|STARTED|Overall Study||20
288189|NCT00839098|697075|P3|NOT COMPLETED|Overall Study||7
288190|NCT00839098|697076|P2|NOT COMPLETED|Overall Study||1
288191|NCT00839098|697077|P1|NOT COMPLETED|Overall Study||2
288192|NCT00839098|697075|P3|COMPLETED|Overall Study||6
288193|NCT00839098|697076|P2|COMPLETED|Overall Study||11
288194|NCT00839098|697077|P1|COMPLETED|Overall Study||1
288195|NCT00839098|697075|P3|STARTED|Overall Study||13
288196|NCT00839098|697076|P2|STARTED|Overall Study||12
288197|NCT00839098|697077|P1|STARTED|Overall Study||3
288198|NCT00839072|697103|P2|NOT COMPLETED|Second Intervention Period||0
288199|NCT00839072|697104|P1|NOT COMPLETED|Second Intervention Period||1
288200|NCT00839072|697103|P2|COMPLETED|Second Intervention Period||11
288201|NCT00839072|697104|P1|COMPLETED|Second Intervention Period||9
288202|NCT00839072|697103|P2|STARTED|Second Intervention Period||11
288203|NCT00839072|697104|P1|STARTED|Second Intervention Period||10
288204|NCT00839072|697103|P2|NOT COMPLETED|Washout Period of 7 Days||0
288205|NCT00839072|697104|P1|NOT COMPLETED|Washout Period of 7 Days||0
288206|NCT00839072|697103|P2|COMPLETED|Washout Period of 7 Days||11
288207|NCT00839072|697104|P1|COMPLETED|Washout Period of 7 Days||10
288208|NCT00839072|697103|P2|STARTED|Washout Period of 7 Days||11
288209|NCT00839072|697104|P1|STARTED|Washout Period of 7 Days||10
288210|NCT00839072|697103|P2|NOT COMPLETED|First Intervention Period||1
288211|NCT00839072|697104|P1|NOT COMPLETED|First Intervention Period||2
288212|NCT00839072|697103|P2|COMPLETED|First Intervention Period||11
288213|NCT00839072|697104|P1|COMPLETED|First Intervention Period||10
288214|NCT00839072|697103|P2|STARTED|First Intervention Period||12
288215|NCT00839072|697104|P1|STARTED|First Intervention Period||12
288216|NCT00838981|697124|P4|NOT COMPLETED|Day 4 to Week 11||7
288217|NCT00838981|697125|P3|NOT COMPLETED|Day 4 to Week 11||11
288218|NCT00838981|697126|P2|NOT COMPLETED|Day 4 to Week 11||8
288219|NCT00838981|697127|P1|NOT COMPLETED|Day 4 to Week 11||7
288220|NCT00838981|697124|P4|COMPLETED|Day 4 to Week 11||12
288221|NCT00838981|697125|P3|COMPLETED|Day 4 to Week 11||16
288222|NCT00838981|697126|P2|COMPLETED|Day 4 to Week 11||11
288223|NCT00838981|697127|P1|COMPLETED|Day 4 to Week 11||19
288224|NCT00838981|697124|P4|Completed Main Treatment on 400mg|Day 4 to Week 11||14
288225|NCT00838981|697125|P3|Completed Main Treatment on 400mg|Day 4 to Week 11||17
288226|NCT00838981|697126|P2|Completed Main Treatment on 400mg|Day 4 to Week 11||13
288227|NCT00838981|697127|P1|Completed Main Treatment on 400mg|Day 4 to Week 11||22
288228|NCT00838981|697124|P4|STARTED|Day 4 to Week 11||19
288229|NCT00838981|697125|P3|STARTED|Day 4 to Week 11||27
288230|NCT00838981|697126|P2|STARTED|Day 4 to Week 11||19
288231|NCT00838981|697127|P1|STARTED|Day 4 to Week 11||26
288232|NCT00838981|697124|P4|NOT COMPLETED|Week 1 Days 1-3||0
288233|NCT00838981|697125|P3|NOT COMPLETED|Week 1 Days 1-3||0
288234|NCT00838981|697126|P2|NOT COMPLETED|Week 1 Days 1-3||0
288235|NCT00838981|697127|P1|NOT COMPLETED|Week 1 Days 1-3||0
288236|NCT00838981|697124|P4|COMPLETED|Week 1 Days 1-3||19
288237|NCT00838981|697125|P3|COMPLETED|Week 1 Days 1-3||27
288238|NCT00838981|697126|P2|COMPLETED|Week 1 Days 1-3||19
288239|NCT00838981|697127|P1|COMPLETED|Week 1 Days 1-3||26
288240|NCT00838981|697124|P4|STARTED|Week 1 Days 1-3||19
288241|NCT00838981|697125|P3|STARTED|Week 1 Days 1-3||27
288242|NCT00838981|697126|P2|STARTED|Week 1 Days 1-3||19
288243|NCT00838981|697127|P1|STARTED|Week 1 Days 1-3||26
288244|NCT00838929|697148|P3|NOT COMPLETED|Overall Study||1
288245|NCT00838929|697149|P2|NOT COMPLETED|Overall Study||3
288246|NCT00838929|697150|P1|NOT COMPLETED|Overall Study||0
288247|NCT00838929|697148|P3|COMPLETED|Overall Study||5
288248|NCT00838929|697149|P2|COMPLETED|Overall Study||5
288249|NCT00838929|697150|P1|COMPLETED|Overall Study||3
288250|NCT00838929|697148|P3|STARTED|Overall Study||6
288251|NCT00838929|697149|P2|STARTED|Overall Study||8
288252|NCT00838929|697150|P1|STARTED|Overall Study||3
288253|NCT00838916|697158|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||51
288254|NCT00838916|697159|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||96
288255|NCT00838916|697158|P2|COMPLETED|Follow-up Period (8 Weeks)||190
288256|NCT00838916|697159|P1|COMPLETED|Follow-up Period (8 Weeks)||408
288257|NCT00838916|697158|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|241
288258|NCT00838916|697159|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|504
288259|NCT00838916|697158|P2|NOT COMPLETED|Treatment Period (156 Weeks)||77
288260|NCT00838916|697159|P1|NOT COMPLETED|Treatment Period (156 Weeks)||196
288261|NCT00838916|697158|P2|COMPLETED|Treatment Period (156 Weeks)||164
288262|NCT00838916|697159|P1|COMPLETED|Treatment Period (156 Weeks)||308
288263|NCT00838916|697158|P2|STARTED|Treatment Period (156 Weeks)||241
288264|NCT00838916|697159|P1|STARTED|Treatment Period (156 Weeks)||504
288265|NCT00838903|697188|P4|NOT COMPLETED|Follow-up Period (8 Weeks)||58
288266|NCT00838903|697189|P3|NOT COMPLETED|Follow-up Period (8 Weeks)||64
288267|NCT00838903|697190|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||65
288268|NCT00838903|697191|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||26
288269|NCT00838903|697188|P4|COMPLETED|Follow-up Period (8 Weeks)||244
288270|NCT00838903|697189|P3|COMPLETED|Follow-up Period (8 Weeks)||243
288271|NCT00838903|697190|P2|COMPLETED|Follow-up Period (8 Weeks)||237
288272|NCT00838903|697191|P1|COMPLETED|Follow-up Period (8 Weeks)||75
288273|NCT00838903|697188|P4|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
288274|NCT00838903|697189|P3|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|307
288275|NCT00838903|697190|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
288276|NCT00838903|697191|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
288277|NCT00838903|697188|P4|NOT COMPLETED|Treatment Period (156 Weeks)||110
288278|NCT00838903|697189|P3|NOT COMPLETED|Treatment Period (156 Weeks)||116
288279|NCT00838903|697190|P2|NOT COMPLETED|Treatment Period (156 Weeks)||112
288280|NCT00838903|697191|P1|NOT COMPLETED|Treatment Period (156 Weeks)||46
288281|NCT00838903|697188|P4|COMPLETED|Treatment Period (156 Weeks)||192
288282|NCT00838903|697189|P3|COMPLETED|Treatment Period (156 Weeks)||191
288283|NCT00838903|697190|P2|COMPLETED|Treatment Period (156 Weeks)||190
288284|NCT00838903|697191|P1|COMPLETED|Treatment Period (156 Weeks)||55
288285|NCT00838903|697188|P4|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
288286|NCT00838903|697189|P3|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
288287|NCT00838903|697190|P2|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
288288|NCT00838903|697191|P1|Missing Active Treatment Status|Treatment Period (156 Weeks)||1
288289|NCT00838903|697188|P4|STARTED|Treatment Period (156 Weeks)||302
288290|NCT00838903|697189|P3|STARTED|Treatment Period (156 Weeks)||307
288291|NCT00838903|697190|P2|STARTED|Treatment Period (156 Weeks)||302
288292|NCT00838903|697191|P1|STARTED|Treatment Period (156 Weeks)||101
288293|NCT00838695|697235|P2|NOT COMPLETED|Overall Study||0
288294|NCT00838695|697236|P1|NOT COMPLETED|Overall Study||0
288295|NCT00838695|697235|P2|COMPLETED|Overall Study||64
288296|NCT00838695|697236|P1|COMPLETED|Overall Study||42
288297|NCT00838695|697235|P2|STARTED|Overall Study||64
288298|NCT00838695|697236|P1|STARTED|Overall Study||42
288299|NCT00838682|697246|P2|NOT COMPLETED|Overall Study||19
288300|NCT00838682|697247|P1|NOT COMPLETED|Overall Study||25
288301|NCT00838682|697246|P2|COMPLETED|Overall Study||33
288302|NCT00838682|697247|P1|COMPLETED|Overall Study||29
288303|NCT00838682|697246|P2|STARTED|Overall Study||52
288304|NCT00838682|697247|P1|STARTED|Overall Study||54
288305|NCT00838630|697265|P2|NOT COMPLETED|Second Intervention||0
288306|NCT00838630|697266|P1|NOT COMPLETED|Second Intervention||0
288307|NCT00838630|697265|P2|COMPLETED|Second Intervention||18
288308|NCT00838630|697266|P1|COMPLETED|Second Intervention||16
288309|NCT00838630|697265|P2|STARTED|Second Intervention||18
288310|NCT00838630|697266|P1|STARTED|Second Intervention||16
288311|NCT00838630|697265|P2|NOT COMPLETED|Washout: 7 Days||0
288312|NCT00838630|697266|P1|NOT COMPLETED|Washout: 7 Days||1
288313|NCT00838630|697265|P2|COMPLETED|Washout: 7 Days||18
288314|NCT00838630|697266|P1|COMPLETED|Washout: 7 Days||16
288315|NCT00838630|697265|P2|STARTED|Washout: 7 Days||18
288316|NCT00838630|697266|P1|STARTED|Washout: 7 Days||17
288317|NCT00838630|697265|P2|NOT COMPLETED|First Intervention||0
288318|NCT00838630|697266|P1|NOT COMPLETED|First Intervention||1
288319|NCT00838630|697265|P2|COMPLETED|First Intervention||18
288320|NCT00838630|697266|P1|COMPLETED|First Intervention||17
288321|NCT00838630|697265|P2|STARTED|First Intervention||18
288322|NCT00838630|697266|P1|STARTED|First Intervention||18
288323|NCT00838578|697274|P1|NOT COMPLETED|Overall Study||2
288324|NCT00838578|697274|P1|COMPLETED|Overall Study||63
288325|NCT00838578|697274|P1|STARTED|Overall Study|In this Ph 1/2 study, 65 subjects were enrolled; 2 were protocol violators, so only 63 treated.|65
288326|NCT00838565|697288|P6|NOT COMPLETED|Overall Study||2
288327|NCT00838565|697289|P5|NOT COMPLETED|Overall Study||0
288328|NCT00838565|697290|P4|NOT COMPLETED|Overall Study||0
288329|NCT00838565|697291|P3|NOT COMPLETED|Overall Study||1
288330|NCT00838565|697292|P2|NOT COMPLETED|Overall Study||3
288331|NCT00838565|697293|P1|NOT COMPLETED|Overall Study||0
288332|NCT00838565|697288|P6|COMPLETED|Overall Study||5
288333|NCT00838565|697289|P5|COMPLETED|Overall Study||6
288334|NCT00838565|697290|P4|COMPLETED|Overall Study||6
288335|NCT00838565|697291|P3|COMPLETED|Overall Study||5
288336|NCT00838565|697292|P2|COMPLETED|Overall Study||4
288337|NCT00838565|697293|P1|COMPLETED|Overall Study||9
288338|NCT00838565|697288|P6|Treated|Overall Study||7
288339|NCT00838565|697289|P5|Treated|Overall Study||6
288340|NCT00838565|697290|P4|Treated|Overall Study||6
288341|NCT00838565|697291|P3|Treated|Overall Study||6
288342|NCT00838565|697292|P2|Treated|Overall Study||6
288343|NCT00838565|697293|P1|Treated|Overall Study||9
288344|NCT00838565|697288|P6|STARTED|Overall Study||7
288345|NCT00838565|697289|P5|STARTED|Overall Study||6
288346|NCT00838565|697290|P4|STARTED|Overall Study||6
288347|NCT00838565|697291|P3|STARTED|Overall Study||6
288348|NCT00838565|697292|P2|STARTED|Overall Study||7
288349|NCT00838565|697293|P1|STARTED|Overall Study||9
288350|NCT00838539|697398|P12|NOT COMPLETED|Overall Study||4
288351|NCT00838539|697399|P11|NOT COMPLETED|Overall Study||5
288352|NCT00838539|697400|P10|NOT COMPLETED|Overall Study||8
288353|NCT00838539|697401|P9|NOT COMPLETED|Overall Study||5
288354|NCT00838539|697402|P8|NOT COMPLETED|Overall Study||6
288355|NCT00838539|697403|P7|NOT COMPLETED|Overall Study||5
288356|NCT00838539|697404|P6|NOT COMPLETED|Overall Study||4
288357|NCT00838539|697405|P5|NOT COMPLETED|Overall Study||6
288358|NCT00838539|697406|P4|NOT COMPLETED|Overall Study||4
288359|NCT00838539|697407|P3|NOT COMPLETED|Overall Study||5
288360|NCT00838539|697408|P2|NOT COMPLETED|Overall Study||6
288361|NCT00838539|697409|P1|NOT COMPLETED|Overall Study||3
288362|NCT00838539|697398|P12|COMPLETED|Overall Study||0
288363|NCT00838539|697399|P11|COMPLETED|Overall Study||0
288364|NCT00838539|697400|P10|COMPLETED|Overall Study||0
288365|NCT00838539|697401|P9|COMPLETED|Overall Study||0
288366|NCT00838539|697402|P8|COMPLETED|Overall Study||0
288367|NCT00838539|697403|P7|COMPLETED|Overall Study||2
288368|NCT00838539|697404|P6|COMPLETED|Overall Study||0
288369|NCT00838539|697405|P5|COMPLETED|Overall Study||0
288370|NCT00838539|697406|P4|COMPLETED|Overall Study||0
288371|NCT00838539|697407|P3|COMPLETED|Overall Study||0
288372|NCT00838539|697408|P2|COMPLETED|Overall Study||0
288373|NCT00838539|697409|P1|COMPLETED|Overall Study||0
288374|NCT00838539|697398|P12|Received Treatment|Overall Study||4
288375|NCT00838539|697399|P11|Received Treatment|Overall Study||5
288376|NCT00838539|697400|P10|Received Treatment|Overall Study||8
288377|NCT00838539|697401|P9|Received Treatment|Overall Study||5
288378|NCT00838539|697402|P8|Received Treatment|Overall Study||6
288379|NCT00838539|697403|P7|Received Treatment|Overall Study||7
288380|NCT00838539|697404|P6|Received Treatment|Overall Study||4
288381|NCT00838539|697405|P5|Received Treatment|Overall Study||4
288382|NCT00838539|697406|P4|Received Treatment|Overall Study||4
288383|NCT00838539|697407|P3|Received Treatment|Overall Study||5
288384|NCT00838539|697408|P2|Received Treatment|Overall Study||5
288385|NCT00838539|697409|P1|Received Treatment|Overall Study||3
288386|NCT00838539|697398|P12|STARTED|Overall Study||4
288387|NCT00838539|697399|P11|STARTED|Overall Study||5
288388|NCT00838539|697400|P10|STARTED|Overall Study||8
288389|NCT00838539|697401|P9|STARTED|Overall Study||5
288390|NCT00838539|697402|P8|STARTED|Overall Study||6
288391|NCT00838539|697403|P7|STARTED|Overall Study||7
288392|NCT00838539|697404|P6|STARTED|Overall Study||4
288393|NCT00838539|697405|P5|STARTED|Overall Study||6
288394|NCT00838539|697406|P4|STARTED|Overall Study||4
288395|NCT00838539|697407|P3|STARTED|Overall Study||5
288396|NCT00838539|697408|P2|STARTED|Overall Study||6
288397|NCT00838539|697409|P1|STARTED|Overall Study||3
288398|NCT00838526|697459|P2|NOT COMPLETED|Overall Study||39
288399|NCT00838526|697460|P1|NOT COMPLETED|Overall Study||24
288400|NCT00838526|697459|P2|COMPLETED|Overall Study||137
288401|NCT00838526|697460|P1|COMPLETED|Overall Study||35
288402|NCT00838526|697459|P2|STARTED|Overall Study|Treated|176
288403|NCT00838526|697460|P1|STARTED|Overall Study|Treated|59
288404|NCT00838513|697468|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
288405|NCT00838513|697468|P1|COMPLETED|Post Treatment Period (Patients Who Disc||4
288406|NCT00838513|697468|P1|STARTED|Post Treatment Period (Patients Who Disc||5
288407|NCT00838513|697468|P1|NOT COMPLETED|Extension Treatment Period||1
288408|NCT00838513|697468|P1|COMPLETED|Extension Treatment Period||18
288409|NCT00838513|697468|P1|STARTED|Extension Treatment Period||19
288410|NCT00838513|697468|P1|NOT COMPLETED|Treatment Period (26 Weeks)||0
288411|NCT00838513|697468|P1|COMPLETED|Treatment Period (26 Weeks)||20
288412|NCT00838513|697468|P1|STARTED|Treatment Period (26 Weeks)||20
288413|NCT00838513|697468|P1|NOT COMPLETED|Observation Period (8 Weeks)||0
288414|NCT00838513|697468|P1|COMPLETED|Observation Period (8 Weeks)||20
288415|NCT00838513|697468|P1|STARTED|Observation Period (8 Weeks)||20
288416|NCT00838513|697468|P1|NOT COMPLETED|Screening Period||3
288417|NCT00838513|697468|P1|COMPLETED|Screening Period||20
288418|NCT00838513|697468|P1|STARTED|Screening Period||23
288419|NCT00838331|697484|P1|NOT COMPLETED|Aged Blood Transfusion||9
288420|NCT00838331|697484|P1|COMPLETED|Aged Blood Transfusion||8
288421|NCT00838331|697484|P1|STARTED|Aged Blood Transfusion||17
288422|NCT00838331|697484|P1|NOT COMPLETED|Fresh Blood Transfusion||0
288423|NCT00838331|697484|P1|COMPLETED|Fresh Blood Transfusion||17
288424|NCT00838331|697484|P1|STARTED|Fresh Blood Transfusion||17
288425|NCT00838279|697490|P2|NOT COMPLETED|Second Intervention||0
288426|NCT00838279|697491|P1|NOT COMPLETED|Second Intervention||0
288427|NCT00838279|697490|P2|COMPLETED|Second Intervention||15
288428|NCT00838279|697491|P1|COMPLETED|Second Intervention||15
288429|NCT00838279|697490|P2|STARTED|Second Intervention||15
288430|NCT00838279|697491|P1|STARTED|Second Intervention||15
288431|NCT00838279|697490|P2|NOT COMPLETED|Washout||1
288432|NCT00838279|697491|P1|NOT COMPLETED|Washout||1
288433|NCT00838279|697490|P2|COMPLETED|Washout||15
288434|NCT00838279|697491|P1|COMPLETED|Washout||15
288435|NCT00838279|697490|P2|STARTED|Washout||16
288436|NCT00838279|697491|P1|STARTED|Washout||16
288437|NCT00838279|697490|P2|NOT COMPLETED|First Intervention||0
288438|NCT00838279|697491|P1|NOT COMPLETED|First Intervention||0
288439|NCT00838279|697490|P2|COMPLETED|First Intervention||16
288440|NCT00838279|697491|P1|COMPLETED|First Intervention||16
288441|NCT00838279|697490|P2|STARTED|First Intervention||16
288442|NCT00838279|697491|P1|STARTED|First Intervention||16
288443|NCT00838201|697501|P2|NOT COMPLETED|Overall Study||53
288444|NCT00838201|697502|P1|NOT COMPLETED|Overall Study||42
288445|NCT00838201|697501|P2|COMPLETED|Overall Study||145
288446|NCT00838201|697502|P1|COMPLETED|Overall Study||144
288447|NCT00838201|697501|P2|STARTED|Overall Study||198
288448|NCT00838201|697502|P1|STARTED|Overall Study||186
288449|NCT00838162|697512|P4|NOT COMPLETED|Overall Study||0
288450|NCT00838162|697513|P3|NOT COMPLETED|Overall Study||0
288451|NCT00838162|697514|P2|NOT COMPLETED|Overall Study||0
288452|NCT00838162|697515|P1|NOT COMPLETED|Overall Study||0
288453|NCT00838162|697512|P4|COMPLETED|Overall Study||8
288454|NCT00838162|697513|P3|COMPLETED|Overall Study||8
288455|NCT00838162|697514|P2|COMPLETED|Overall Study||8
288456|NCT00838162|697515|P1|COMPLETED|Overall Study||9
288457|NCT00838162|697512|P4|STARTED|Overall Study||8
288458|NCT00838162|697513|P3|STARTED|Overall Study||8
288459|NCT00838162|697514|P2|STARTED|Overall Study||8
288460|NCT00838162|697515|P1|STARTED|Overall Study||9
288461|NCT00838136|697559|P2|NOT COMPLETED|Second Intervention||1
288462|NCT00838136|697560|P1|NOT COMPLETED|Second Intervention||0
288463|NCT00838136|697559|P2|COMPLETED|Second Intervention||15
288464|NCT00838136|697560|P1|COMPLETED|Second Intervention||16
288465|NCT00838136|697559|P2|STARTED|Second Intervention||16
288466|NCT00838136|697560|P1|STARTED|Second Intervention||16
288467|NCT00838136|697559|P2|NOT COMPLETED|First Intervention||0
288468|NCT00838136|697560|P1|NOT COMPLETED|First Intervention||0
288469|NCT00838136|697559|P2|COMPLETED|First Intervention||16
288470|NCT00838136|697560|P1|COMPLETED|First Intervention||16
288471|NCT00838136|697559|P2|STARTED|First Intervention||16
288472|NCT00838136|697560|P1|STARTED|First Intervention||16
288473|NCT00838110|697570|P4|NOT COMPLETED|Overall Study||18
288474|NCT00838110|697571|P3|NOT COMPLETED|Overall Study||17
288475|NCT00838110|697572|P2|NOT COMPLETED|Overall Study||22
288476|NCT00838110|697573|P1|NOT COMPLETED|Overall Study||22
288477|NCT00838110|697570|P4|COMPLETED|Overall Study||226
288478|NCT00838110|697571|P3|COMPLETED|Overall Study||226
288479|NCT00838110|697572|P2|COMPLETED|Overall Study||106
288480|NCT00838110|697573|P1|COMPLETED|Overall Study||105
288481|NCT00838110|697570|P4|Treated|Overall Study||244
288482|NCT00838110|697571|P3|Treated|Overall Study||243
288483|NCT00838110|697572|P2|Treated|Overall Study||127
288484|NCT00838110|697573|P1|Treated|Overall Study||127
288485|NCT00838110|697570|P4|STARTED|Overall Study||244
288486|NCT00838110|697571|P3|STARTED|Overall Study||243
288487|NCT00838110|697572|P2|STARTED|Overall Study||128
288488|NCT00838110|697573|P1|STARTED|Overall Study||127
288489|NCT00838097|697593|P1|NOT COMPLETED|Overall Study||176
288490|NCT00838097|697593|P1|COMPLETED|Overall Study||145
288491|NCT00838097|697593|P1|Received Darbepoetin Alfa|Overall Study||319
288492|NCT00838097|697593|P1|STARTED|Overall Study||321
288493|NCT00837967|697601|P2|NOT COMPLETED|Second Intervention||0
288494|NCT00837967|697602|P1|NOT COMPLETED|Second Intervention||0
288495|NCT00837967|697601|P2|COMPLETED|Second Intervention||12
288496|NCT00837967|697602|P1|COMPLETED|Second Intervention||11
288497|NCT00837967|697601|P2|STARTED|Second Intervention||12
288498|NCT00837967|697602|P1|STARTED|Second Intervention||11
288499|NCT00837967|697601|P2|NOT COMPLETED|Washout Period of 7 - 14 Days||0
288500|NCT00837967|697602|P1|NOT COMPLETED|Washout Period of 7 - 14 Days||2
288501|NCT00837967|697601|P2|COMPLETED|Washout Period of 7 - 14 Days||12
288502|NCT00837967|697602|P1|COMPLETED|Washout Period of 7 - 14 Days||11
288503|NCT00837967|697601|P2|STARTED|Washout Period of 7 - 14 Days||12
288504|NCT00837967|697602|P1|STARTED|Washout Period of 7 - 14 Days||13
288505|NCT00837967|697601|P2|NOT COMPLETED|First Intervention||0
288506|NCT00837967|697602|P1|NOT COMPLETED|First Intervention||0
288507|NCT00837967|697601|P2|COMPLETED|First Intervention||12
288508|NCT00837967|697602|P1|COMPLETED|First Intervention||13
288509|NCT00837967|697601|P2|STARTED|First Intervention||12
288510|NCT00837967|697602|P1|STARTED|First Intervention||13
288511|NCT00837902|697620|P2|NOT COMPLETED|Overall Study||0
288512|NCT00837902|697621|P1|NOT COMPLETED|Overall Study||0
288513|NCT00837902|697620|P2|COMPLETED|Overall Study||69
288514|NCT00837902|697621|P1|COMPLETED|Overall Study||85
288515|NCT00837902|697620|P2|STARTED|Overall Study||69
288516|NCT00837902|697621|P1|STARTED|Overall Study||85
288517|NCT00837876|697628|P1|NOT COMPLETED|Overall Study||37
288518|NCT00837876|697628|P1|COMPLETED|Overall Study||0
288519|NCT00837876|697628|P1|STARTED|Overall Study||37
288520|NCT00837824|697637|P2|NOT COMPLETED|Overall Study||0
288521|NCT00837824|697638|P1|NOT COMPLETED|Overall Study||0
288522|NCT00837824|697637|P2|COMPLETED|Overall Study||9
288523|NCT00837824|697638|P1|COMPLETED|Overall Study||11
288524|NCT00837824|697637|P2|STARTED|Overall Study||9
288525|NCT00837824|697638|P1|STARTED|Overall Study||11
288526|NCT00837811|697650|P3|NOT COMPLETED|Overall Study||1
288527|NCT00837811|697651|P2|NOT COMPLETED|Overall Study||34
288528|NCT00837811|697652|P1|NOT COMPLETED|Overall Study||7
288529|NCT00837811|697650|P3|COMPLETED|Overall Study||0
288530|NCT00837811|697651|P2|COMPLETED|Overall Study||87
288531|NCT00837811|697652|P1|COMPLETED|Overall Study||53
288532|NCT00837811|697650|P3|Included in Efficacy Analyses|Overall Study||1
288533|NCT00837811|697651|P2|Included in Efficacy Analyses|Overall Study|Excludes participant from site with Good Clinical Practice (GCP) violations.|120
288534|NCT00837811|697652|P1|Included in Efficacy Analyses|Overall Study||59
288535|NCT00837811|697650|P3|Had at Least 1 Efficacy Assessment|Overall Study||1
288536|NCT00837811|697651|P2|Had at Least 1 Efficacy Assessment|Overall Study||121
288537|NCT00837811|697652|P1|Had at Least 1 Efficacy Assessment|Overall Study||59
288538|NCT00837811|697650|P3|Received Any Amount of Study Drug|Overall Study||1
288539|NCT00837811|697651|P2|Received Any Amount of Study Drug|Overall Study||121
288540|NCT00837811|697652|P1|Received Any Amount of Study Drug|Overall Study||60
288541|NCT00837811|697650|P3|STARTED|Overall Study||1
288542|NCT00837811|697651|P2|STARTED|Overall Study||121
288543|NCT00837811|697652|P1|STARTED|Overall Study||60
288544|NCT00837759|697737|P1|NOT COMPLETED|Overall Study||4
288545|NCT00837759|697737|P1|COMPLETED|Overall Study||3
288546|NCT00837759|697737|P1|STARTED|Overall Study||7
288547|NCT00837694|697752|P6|NOT COMPLETED|Overall Study||1
288548|NCT00837694|697753|P5|NOT COMPLETED|Overall Study||1
288549|NCT00837694|697754|P4|NOT COMPLETED|Overall Study||1
288550|NCT00837694|697755|P3|NOT COMPLETED|Overall Study||2
288551|NCT00837694|697756|P2|NOT COMPLETED|Overall Study||0
288552|NCT00837694|697757|P1|NOT COMPLETED|Overall Study||2
288553|NCT00837694|697752|P6|COMPLETED|Overall Study||10
288554|NCT00837694|697753|P5|COMPLETED|Overall Study||11
288555|NCT00837694|697754|P4|COMPLETED|Overall Study||10
288556|NCT00837694|697755|P3|COMPLETED|Overall Study||8
288557|NCT00837694|697756|P2|COMPLETED|Overall Study||11
288558|NCT00837694|697757|P1|COMPLETED|Overall Study||8
288559|NCT00837694|697752|P6|STARTED|Overall Study||11
288560|NCT00837694|697753|P5|STARTED|Overall Study||12
288561|NCT00837694|697754|P4|STARTED|Overall Study||11
288562|NCT00837694|697755|P3|STARTED|Overall Study||10
288563|NCT00837694|697756|P2|STARTED|Overall Study||11
288564|NCT00837694|697757|P1|STARTED|Overall Study||10
288565|NCT00837616|697773|P2|NOT COMPLETED|Overall Study||1
288566|NCT00837616|697774|P1|NOT COMPLETED|Overall Study||0
288567|NCT00837616|697773|P2|COMPLETED|Overall Study||20
288568|NCT00837616|697774|P1|COMPLETED|Overall Study||20
288569|NCT00837616|697773|P2|STARTED|Overall Study||21
288570|NCT00837616|697774|P1|STARTED|Overall Study||20
288571|NCT00837590|697801|P3|NOT COMPLETED|Overall Study||1
288572|NCT00837590|697802|P2|NOT COMPLETED|Overall Study||1
288573|NCT00837590|697803|P1|NOT COMPLETED|Overall Study||0
288574|NCT00837590|697801|P3|COMPLETED|Overall Study||4
288575|NCT00837590|697802|P2|COMPLETED|Overall Study||4
288576|NCT00837590|697803|P1|COMPLETED|Overall Study||6
288577|NCT00837590|697801|P3|STARTED|Overall Study||5
288578|NCT00837590|697802|P2|STARTED|Overall Study||5
288579|NCT00837590|697803|P1|STARTED|Overall Study||6
288580|NCT00837577|697813|P2|NOT COMPLETED|Open-label Period||9
288581|NCT00837577|697814|P1|NOT COMPLETED|Open-label Period||8
288582|NCT00837577|697813|P2|COMPLETED|Open-label Period||54
288583|NCT00837577|697814|P1|COMPLETED|Open-label Period||60
288584|NCT00837577|697813|P2|STARTED|Open-label Period||63
288585|NCT00837577|697814|P1|STARTED|Open-label Period||68
288586|NCT00837577|697813|P2|NOT COMPLETED|Double-blind Period||0
288587|NCT00837577|697814|P1|NOT COMPLETED|Double-blind Period||2
288588|NCT00837577|697813|P2|COMPLETED|Double-blind Period||63
288589|NCT00837577|697814|P1|COMPLETED|Double-blind Period||68
288590|NCT00837577|697813|P2|STARTED|Double-blind Period||63
288591|NCT00837577|697814|P1|STARTED|Double-blind Period||70
288592|NCT00837512|697825|P2|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
288593|NCT00837512|697826|P1|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
288594|NCT00837512|697825|P2|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
288595|NCT00837512|697826|P1|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
288596|NCT00837512|697825|P2|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
288597|NCT00837512|697826|P1|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
288598|NCT00837512|697825|P2|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
288599|NCT00837512|697826|P1|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
288600|NCT00837512|697825|P2|COMPLETED|Both Arms: Washout (7-28 Days)||8
288601|NCT00837512|697826|P1|COMPLETED|Both Arms: Washout (7-28 Days)||8
288602|NCT00837512|697825|P2|STARTED|Both Arms: Washout (7-28 Days)||8
288603|NCT00837512|697826|P1|STARTED|Both Arms: Washout (7-28 Days)||8
288604|NCT00837512|697825|P2|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
288605|NCT00837512|697826|P1|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
288606|NCT00837512|697825|P2|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
288607|NCT00837512|697826|P1|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
288608|NCT00837512|697825|P2|STARTED|First Intervention (6hrs) - RANDOMIZED||8
288609|NCT00837512|697826|P1|STARTED|First Intervention (6hrs) - RANDOMIZED||8
288610|NCT00837486|697834|P2|NOT COMPLETED|Long-term Follow-up Phase - Open Label||0
288611|NCT00837486|697835|P1|NOT COMPLETED|Long-term Follow-up Phase - Open Label||5
288612|NCT00837486|697834|P2|COMPLETED|Long-term Follow-up Phase - Open Label||0
288613|NCT00837486|697835|P1|COMPLETED|Long-term Follow-up Phase - Open Label||24
288614|NCT00837486|697834|P2|STARTED|Long-term Follow-up Phase - Open Label||0
288615|NCT00837486|697835|P1|STARTED|Long-term Follow-up Phase - Open Label|All subjects received open-label stimulation during this phase.|29
288616|NCT00837486|697834|P2|NOT COMPLETED|Blinded-treatment Phase||0
288617|NCT00837486|697835|P1|NOT COMPLETED|Blinded-treatment Phase||1
288618|NCT00837486|697834|P2|COMPLETED|Blinded-treatment Phase||14
288619|NCT00837486|697835|P1|COMPLETED|Blinded-treatment Phase|One subject did not receive the allocated intervention.|15
288620|NCT00837486|697834|P2|STARTED|Blinded-treatment Phase||14
288621|NCT00837486|697835|P1|STARTED|Blinded-treatment Phase||16
288622|NCT00837473|697847|P1|NOT COMPLETED|Overall Study||3
288623|NCT00837473|697847|P1|COMPLETED|Overall Study||12
288624|NCT00837473|697847|P1|STARTED|Overall Study||15
288625|NCT00837447|697860|P1|NOT COMPLETED|Overall Study||0
288626|NCT00837447|697860|P1|COMPLETED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
288627|NCT00837447|697860|P1|STARTED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
288628|NCT00837434|697867|P2|NOT COMPLETED|Overall Study||1
288629|NCT00837434|697868|P1|NOT COMPLETED|Overall Study||9
288630|NCT00837434|697867|P2|COMPLETED|Overall Study||19
288631|NCT00837434|697868|P1|COMPLETED|Overall Study||34
288632|NCT00837434|697867|P2|STARTED|Overall Study||20
288633|NCT00837434|697868|P1|STARTED|Overall Study||43
288634|NCT00837330|697888|P2|NOT COMPLETED|Overall Study||3
288635|NCT00837330|697889|P1|NOT COMPLETED|Overall Study||1
288636|NCT00837330|697888|P2|COMPLETED|Overall Study||7
288637|NCT00837330|697889|P1|COMPLETED|Overall Study||9
288638|NCT00837330|697888|P2|STARTED|Overall Study||10
288639|NCT00837330|697889|P1|STARTED|Overall Study||10
288640|NCT00837252|697895|P1|NOT COMPLETED|Overall Study||0
288641|NCT00837252|697895|P1|COMPLETED|Overall Study||5
288642|NCT00837252|697895|P1|STARTED|Overall Study||5
288643|NCT00837213|697912|P2|NOT COMPLETED|Overall Study||5
288644|NCT00837213|697913|P1|NOT COMPLETED|Overall Study||6
288645|NCT00837213|697912|P2|COMPLETED|Overall Study||12
288646|NCT00837213|697913|P1|COMPLETED|Overall Study||10
288647|NCT00837213|697912|P2|STARTED|Overall Study||17
288648|NCT00837213|697913|P1|STARTED|Overall Study||16
288649|NCT00837200|697933|P1|NOT COMPLETED|Overall Study||0
288650|NCT00837200|697933|P1|COMPLETED|Overall Study||13
288651|NCT00837200|697933|P1|STARTED|Overall Study||13
288652|NCT00837161|697939|P1|NOT COMPLETED|Overall Study||2
288653|NCT00837161|697939|P1|COMPLETED|Overall Study||9
288654|NCT00837161|697939|P1|STARTED|Overall Study||11
288655|NCT00837148|697947|P1|NOT COMPLETED|Overall Study||2
288656|NCT00837148|697947|P1|COMPLETED|Overall Study||35
288657|NCT00837148|697947|P1|STARTED|Overall Study||37
288658|NCT00837096|697953|P2|NOT COMPLETED|Overall Study||9
288659|NCT00837096|697954|P1|NOT COMPLETED|Overall Study||10
288660|NCT00837096|697953|P2|COMPLETED|Overall Study||0
288661|NCT00837096|697954|P1|COMPLETED|Overall Study||0
288662|NCT00837096|697953|P2|STARTED|Overall Study||9
288663|NCT00837096|697954|P1|STARTED|Overall Study||10
288664|NCT00837031|697960|P1|NOT COMPLETED|Overall Study||0
288665|NCT00837031|697960|P1|COMPLETED|Overall Study||72
288666|NCT00837031|697960|P1|STARTED|Overall Study||72
288667|NCT00836953|697966|P1|NOT COMPLETED|Overall Study||2
288668|NCT00836953|697966|P1|COMPLETED|Overall Study||31
288669|NCT00836953|697966|P1|STARTED|Overall Study||33
288670|NCT00836927|697977|P5|NOT COMPLETED|Overall Study||1
288671|NCT00836927|697978|P4|NOT COMPLETED|Overall Study||1
288672|NCT00836927|697979|P3|NOT COMPLETED|Overall Study||0
288673|NCT00836927|697980|P2|NOT COMPLETED|Overall Study||0
288674|NCT00836927|697981|P1|NOT COMPLETED|Overall Study||3
288675|NCT00836927|697977|P5|COMPLETED|Overall Study||0
288676|NCT00836927|697978|P4|COMPLETED|Overall Study||0
288677|NCT00836927|697979|P3|COMPLETED|Overall Study|Participant completed treatment by 04 Feb 2018|1
288678|NCT00836927|697980|P2|COMPLETED|Overall Study|Participant completed treatment by 04 Feb 2018|1
288679|NCT00836927|697981|P1|COMPLETED|Overall Study||0
288680|NCT00836927|697977|P5|Completed Dosing Through 03 Apr 2017|Overall Study||0
288681|NCT00836927|697978|P4|Completed Dosing Through 03 Apr 2017|Overall Study||0
288682|NCT00836927|697979|P3|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continued to receive study drug past the data cut-off date of 03 Apr 2017|1
288683|NCT00836927|697980|P2|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continued to receive study drug past the data cut-off date of 03 Apr 2017|1
288684|NCT00836927|697981|P1|Completed Dosing Through 03 Apr 2017|Overall Study||0
288685|NCT00836927|697977|P5|STARTED|Overall Study||1
288686|NCT00836927|697978|P4|STARTED|Overall Study||1
288687|NCT00836927|697979|P3|STARTED|Overall Study|One participant received ridaforolimus 3 mg IV infusion before being switched to the oral tablet.|1
288688|NCT00836927|697980|P2|STARTED|Overall Study||1
288689|NCT00836927|697981|P1|STARTED|Overall Study||3
288690|NCT00836901|698017|P2|NOT COMPLETED|Second Intervention||0
288691|NCT00836901|698018|P1|NOT COMPLETED|Second Intervention||0
288692|NCT00836901|698017|P2|COMPLETED|Second Intervention||28
288693|NCT00836901|698018|P1|COMPLETED|Second Intervention||23
288694|NCT00836901|698017|P2|STARTED|Second Intervention||28
288695|NCT00836901|698018|P1|STARTED|Second Intervention||23
288696|NCT00836901|698017|P2|NOT COMPLETED|First Intervention||0
288697|NCT00836901|698018|P1|NOT COMPLETED|First Intervention||1
288698|NCT00836901|698017|P2|COMPLETED|First Intervention||28
288699|NCT00836901|698018|P1|COMPLETED|First Intervention||23
288700|NCT00836901|698017|P2|STARTED|First Intervention||28
288701|NCT00836901|698018|P1|STARTED|First Intervention||24
288702|NCT00836875|698034|P2|NOT COMPLETED|Overall Study||3
288703|NCT00836875|698035|P1|NOT COMPLETED|Overall Study||3
288704|NCT00836875|698034|P2|COMPLETED|Overall Study||17
288705|NCT00836875|698035|P1|COMPLETED|Overall Study||8
288706|NCT00836875|698034|P2|STARTED|Overall Study||20
288707|NCT00836875|698035|P1|STARTED|Overall Study||11
288708|NCT00836810|698051|P2|NOT COMPLETED|Overall Study||0
288709|NCT00836810|698052|P1|NOT COMPLETED|Overall Study||1
288710|NCT00836810|698051|P2|COMPLETED|Overall Study||6
288711|NCT00836810|698052|P1|COMPLETED|Overall Study|1 patient was subsequently diagnosed with SLE and, per protocol, was not included.|4
288712|NCT00836810|698051|P2|STARTED|Overall Study||6
288713|NCT00836810|698052|P1|STARTED|Overall Study||5
288714|NCT00836758|698068|P1|NOT COMPLETED|Overall Study||0
288715|NCT00836758|698068|P1|COMPLETED|Overall Study||115
288716|NCT00836758|698068|P1|STARTED|Overall Study||115
288717|NCT00836745|698074|P1|NOT COMPLETED|Overall Study||21
288718|NCT00836745|698074|P1|COMPLETED|Overall Study||15
288719|NCT00836745|698074|P1|STARTED|Overall Study||36
288720|NCT00836719|698081|P1|NOT COMPLETED|Overall Study||0
288721|NCT00836719|698081|P1|COMPLETED|Overall Study||10
288722|NCT00836719|698081|P1|STARTED|Overall Study||10
288723|NCT00836706|698088|P2|NOT COMPLETED|Second Intervention||0
288724|NCT00836706|698089|P1|NOT COMPLETED|Second Intervention||0
288725|NCT00836706|698088|P2|COMPLETED|Second Intervention||11
288726|NCT00836706|698089|P1|COMPLETED|Second Intervention||11
288727|NCT00836706|698088|P2|STARTED|Second Intervention||11
288728|NCT00836706|698089|P1|STARTED|Second Intervention||11
288729|NCT00836706|698088|P2|NOT COMPLETED|Washout: 7 Days||1
288730|NCT00836706|698089|P1|NOT COMPLETED|Washout: 7 Days||0
288731|NCT00836706|698088|P2|COMPLETED|Washout: 7 Days||11
288732|NCT00836706|698089|P1|COMPLETED|Washout: 7 Days||11
288733|NCT00836706|698088|P2|STARTED|Washout: 7 Days||12
288734|NCT00836706|698089|P1|STARTED|Washout: 7 Days||11
288735|NCT00836706|698088|P2|NOT COMPLETED|First Intervention||0
288736|NCT00836706|698089|P1|NOT COMPLETED|First Intervention||0
288737|NCT00836706|698088|P2|COMPLETED|First Intervention||12
288738|NCT00836706|698089|P1|COMPLETED|First Intervention||11
288739|NCT00836706|698088|P2|STARTED|First Intervention||12
288740|NCT00836706|698089|P1|STARTED|First Intervention||11
288741|NCT00836693|698099|P2|NOT COMPLETED|Overall Study||6
288742|NCT00836693|698100|P1|NOT COMPLETED|Overall Study||17
288743|NCT00836693|698099|P2|COMPLETED|Overall Study||64
288744|NCT00836693|698100|P1|COMPLETED|Overall Study||130
288745|NCT00836693|698099|P2|STARTED|Overall Study||70
288746|NCT00836693|698100|P1|STARTED|Overall Study||147
288747|NCT00836641|698142|P2|NOT COMPLETED|Overall Study||0
288748|NCT00836641|698143|P1|NOT COMPLETED|Overall Study||0
288749|NCT00836641|698142|P2|COMPLETED|Overall Study||34
288750|NCT00836641|698143|P1|COMPLETED|Overall Study||36
288751|NCT00836641|698142|P2|STARTED|Overall Study||34
288752|NCT00836641|698143|P1|STARTED|Overall Study||36
288753|NCT00836589|698150|P1|NOT COMPLETED|Overall Study||1266
288754|NCT00836589|698150|P1|COMPLETED|Overall Study||731
288755|NCT00836589|698150|P1|STARTED|Overall Study||1997
288756|NCT00836498|698183|P2|NOT COMPLETED|Overall Study||1
288757|NCT00836498|698184|P1|NOT COMPLETED|Overall Study||4
288758|NCT00836498|698183|P2|COMPLETED|Overall Study||21
288759|NCT00836498|698184|P1|COMPLETED|Overall Study|Participant who discontinued the study vaccination due to AE completed the 180-day safety follow-up.|40
288760|NCT00836498|698183|P2|STARTED|Overall Study||22
288761|NCT00836498|698184|P1|STARTED|Overall Study||44
288762|NCT00836472|698216|P2|NOT COMPLETED|Second Intervention||0
288763|NCT00836472|698217|P1|NOT COMPLETED|Second Intervention||0
288764|NCT00836472|698216|P2|COMPLETED|Second Intervention||27
288765|NCT00836472|698217|P1|COMPLETED|Second Intervention||28
288766|NCT00836472|698216|P2|STARTED|Second Intervention||27
288767|NCT00836472|698217|P1|STARTED|Second Intervention||28
288768|NCT00836472|698216|P2|NOT COMPLETED|Washout||3
288769|NCT00836472|698217|P1|NOT COMPLETED|Washout||2
288770|NCT00836472|698216|P2|COMPLETED|Washout||27
288771|NCT00836472|698217|P1|COMPLETED|Washout||28
288772|NCT00836472|698216|P2|STARTED|Washout||30
288773|NCT00836472|698217|P1|STARTED|Washout||30
288774|NCT00836472|698216|P2|NOT COMPLETED|First Intervention||0
288775|NCT00836472|698217|P1|NOT COMPLETED|First Intervention||0
288776|NCT00836472|698216|P2|COMPLETED|First Intervention||30
288777|NCT00836472|698217|P1|COMPLETED|First Intervention||30
288778|NCT00836472|698216|P2|STARTED|First Intervention||30
288779|NCT00836472|698217|P1|STARTED|First Intervention||30
288780|NCT00836433|698233|P2|NOT COMPLETED|Overall Study||7
288781|NCT00836433|698234|P1|NOT COMPLETED|Overall Study||12
288782|NCT00836433|698233|P2|COMPLETED|Overall Study||321
288783|NCT00836433|698234|P1|COMPLETED|Overall Study||349
288784|NCT00836433|698233|P2|STARTED|Overall Study||328
288785|NCT00836433|698234|P1|STARTED|Overall Study||361
288786|NCT00836407|698244|P2|NOT COMPLETED|Overall Study||8
288787|NCT00836407|698245|P1|NOT COMPLETED|Overall Study||11
288788|NCT00836407|698244|P2|COMPLETED|Overall Study||7
288789|NCT00836407|698245|P1|COMPLETED|Overall Study||4
288790|NCT00836407|698244|P2|STARTED|Overall Study||15
288791|NCT00836407|698245|P1|STARTED|Overall Study||15
288792|NCT00836355|698257|P4|NOT COMPLETED|Overall Study||0
288793|NCT00836355|698258|P3|NOT COMPLETED|Overall Study||0
288794|NCT00836355|698259|P2|NOT COMPLETED|Overall Study||0
288795|NCT00836355|698260|P1|NOT COMPLETED|Overall Study||0
288796|NCT00836355|698257|P4|COMPLETED|Overall Study||2
288797|NCT00836355|698258|P3|COMPLETED|Overall Study||0
288798|NCT00836355|698259|P2|COMPLETED|Overall Study||4
288799|NCT00836355|698260|P1|COMPLETED|Overall Study||0
288800|NCT00836355|698257|P4|STARTED|Overall Study||2
288801|NCT00836355|698258|P3|STARTED|Overall Study||0
288802|NCT00836355|698259|P2|STARTED|Overall Study||4
288803|NCT00836355|698260|P1|STARTED|Overall Study||0
288804|NCT00836342|698281|P3|NOT COMPLETED|Overall Study||0
288805|NCT00836342|698282|P2|NOT COMPLETED|Overall Study||0
288806|NCT00836342|698283|P1|NOT COMPLETED|Overall Study||0
288807|NCT00836342|698281|P3|COMPLETED|Overall Study||36
288808|NCT00836342|698282|P2|COMPLETED|Overall Study||23
288809|NCT00836342|698283|P1|COMPLETED|Overall Study||22
288810|NCT00836342|698281|P3|STARTED|Overall Study||36
288811|NCT00836342|698282|P2|STARTED|Overall Study||23
288812|NCT00836342|698283|P1|STARTED|Overall Study||22
288813|NCT00836277|698294|P1|NOT COMPLETED|Overall Study||6
288814|NCT00836277|698294|P1|COMPLETED|Overall Study||18
288815|NCT00836277|698294|P1|STARTED|Overall Study||24
288816|NCT00836095|698304|P2|NOT COMPLETED|Overall Study||3
288817|NCT00836095|698305|P1|NOT COMPLETED|Overall Study||0
288818|NCT00836095|698304|P2|COMPLETED|Overall Study||27
288819|NCT00836095|698305|P1|COMPLETED|Overall Study||22
288820|NCT00836095|698304|P2|STARTED|Overall Study||30
288821|NCT00836095|698305|P1|STARTED|Overall Study||22
288822|NCT00836056|698315|P2|NOT COMPLETED|Second Intervention||0
288823|NCT00836056|698316|P1|NOT COMPLETED|Second Intervention||0
288824|NCT00836056|698315|P2|COMPLETED|Second Intervention||12
288825|NCT00836056|698316|P1|COMPLETED|Second Intervention||11
288826|NCT00836056|698315|P2|STARTED|Second Intervention||12
288827|NCT00836056|698316|P1|STARTED|Second Intervention||11
288828|NCT00836056|698315|P2|NOT COMPLETED|Washout: 7 Days||0
288829|NCT00836056|698316|P1|NOT COMPLETED|Washout: 7 Days||0
288830|NCT00836056|698315|P2|COMPLETED|Washout: 7 Days||12
288831|NCT00836056|698316|P1|COMPLETED|Washout: 7 Days||11
288832|NCT00836056|698315|P2|STARTED|Washout: 7 Days||12
288833|NCT00836056|698316|P1|STARTED|Washout: 7 Days||11
288834|NCT00836056|698315|P2|NOT COMPLETED|First Intervention||0
288835|NCT00836056|698316|P1|NOT COMPLETED|First Intervention||1
288836|NCT00836056|698315|P2|COMPLETED|First Intervention||12
288837|NCT00836056|698316|P1|COMPLETED|First Intervention||11
288838|NCT00836056|698315|P2|STARTED|First Intervention||12
288839|NCT00836056|698316|P1|STARTED|First Intervention||12
288840|NCT00836017|698324|P1|NOT COMPLETED|Overall Study||544
288841|NCT00836017|698324|P1|COMPLETED|Overall Study||502
288842|NCT00836017|698324|P1|STARTED|Overall Study||1046
288843|NCT00836004|698334|P2|NOT COMPLETED|Second Intervention||0
288844|NCT00836004|698335|P1|NOT COMPLETED|Second Intervention||0
288845|NCT00836004|698334|P2|COMPLETED|Second Intervention||12
288846|NCT00836004|698335|P1|COMPLETED|Second Intervention||12
288847|NCT00836004|698334|P2|STARTED|Second Intervention||12
288848|NCT00836004|698335|P1|STARTED|Second Intervention||12
288849|NCT00836004|698334|P2|NOT COMPLETED|Washout: 7 Days||0
288850|NCT00836004|698335|P1|NOT COMPLETED|Washout: 7 Days||0
288851|NCT00836004|698334|P2|COMPLETED|Washout: 7 Days||12
288852|NCT00836004|698335|P1|COMPLETED|Washout: 7 Days||12
288853|NCT00836004|698334|P2|STARTED|Washout: 7 Days||12
288854|NCT00836004|698335|P1|STARTED|Washout: 7 Days||12
288855|NCT00836004|698334|P2|NOT COMPLETED|First Intervention||0
288856|NCT00836004|698335|P1|NOT COMPLETED|First Intervention||0
288857|NCT00836004|698334|P2|COMPLETED|First Intervention||12
288858|NCT00836004|698335|P1|COMPLETED|First Intervention||12
288859|NCT00836004|698334|P2|STARTED|First Intervention||12
288860|NCT00836004|698335|P1|STARTED|First Intervention||12
288861|NCT00835991|698345|P2|NOT COMPLETED|Second Intervention||0
288862|NCT00835991|698346|P1|NOT COMPLETED|Second Intervention||0
288863|NCT00835991|698345|P2|COMPLETED|Second Intervention||26
288864|NCT00835991|698346|P1|COMPLETED|Second Intervention||27
288865|NCT00835991|698345|P2|STARTED|Second Intervention||26
288866|NCT00835991|698346|P1|STARTED|Second Intervention||27
288867|NCT00835991|698345|P2|NOT COMPLETED|Washout||3
288868|NCT00835991|698346|P1|NOT COMPLETED|Washout||3
288869|NCT00835991|698345|P2|COMPLETED|Washout||26
288870|NCT00835991|698346|P1|COMPLETED|Washout||27
288871|NCT00835991|698345|P2|STARTED|Washout||29
288872|NCT00835991|698346|P1|STARTED|Washout||30
288873|NCT00835991|698345|P2|NOT COMPLETED|First Intervention||1
288874|NCT00835991|698346|P1|NOT COMPLETED|First Intervention||0
288875|NCT00835991|698345|P2|COMPLETED|First Intervention||29
288876|NCT00835991|698346|P1|COMPLETED|First Intervention||30
288877|NCT00835991|698345|P2|STARTED|First Intervention||30
288878|NCT00835991|698346|P1|STARTED|First Intervention||30
288879|NCT00835978|698364|P4|NOT COMPLETED|Overall Study||10
288880|NCT00835978|698365|P3|NOT COMPLETED|Overall Study||91
288881|NCT00835978|698366|P2|NOT COMPLETED|Overall Study||56
288882|NCT00835978|698367|P1|NOT COMPLETED|Overall Study||56
288883|NCT00835978|698364|P4|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
288884|NCT00835978|698365|P3|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
288885|NCT00835978|698366|P2|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
288886|NCT00835978|698367|P1|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
288887|NCT00835978|698364|P4|Treated|Overall Study||10
288888|NCT00835978|698365|P3|Treated|Overall Study||91
288889|NCT00835978|698366|P2|Treated|Overall Study||56
288890|NCT00835978|698367|P1|Treated|Overall Study||56
288891|NCT00835978|698364|P4|STARTED|Overall Study||10
288892|NCT00835978|698365|P3|STARTED|Overall Study||91
288893|NCT00835978|698366|P2|STARTED|Overall Study||56
288894|NCT00835978|698367|P1|STARTED|Overall Study||56
288895|NCT00835926|698427|P2|NOT COMPLETED|Overall Study||0
288896|NCT00835926|698428|P1|NOT COMPLETED|Overall Study||0
288897|NCT00835926|698427|P2|COMPLETED|Overall Study||60
288898|NCT00835926|698428|P1|COMPLETED|Overall Study||61
288899|NCT00835926|698427|P2|STARTED|Overall Study||60
288900|NCT00835926|698428|P1|STARTED|Overall Study||61
288901|NCT00835900|698442|P2|NOT COMPLETED|Overall Study||6
288902|NCT00835900|698443|P1|NOT COMPLETED|Overall Study||5
288903|NCT00835900|698442|P2|COMPLETED|Overall Study||22
288904|NCT00835900|698443|P1|COMPLETED|Overall Study||27
288905|NCT00835900|698442|P2|STARTED|Overall Study||28
288906|NCT00835900|698443|P1|STARTED|Overall Study||32
288907|NCT00835861|698453|P2|NOT COMPLETED|Overall Study||2
288908|NCT00835861|698454|P1|NOT COMPLETED|Overall Study||1
288909|NCT00835861|698453|P2|COMPLETED|Overall Study||14
288910|NCT00835861|698454|P1|COMPLETED|Overall Study||14
288911|NCT00835861|698453|P2|STARTED|Overall Study||16
288912|NCT00835861|698454|P1|STARTED|Overall Study||15
288913|NCT00835796|698478|P2|NOT COMPLETED|Second Intervention||0
288914|NCT00835796|698479|P1|NOT COMPLETED|Second Intervention||0
288915|NCT00835796|698478|P2|COMPLETED|Second Intervention||9
288916|NCT00835796|698479|P1|COMPLETED|Second Intervention||10
288917|NCT00835796|698478|P2|STARTED|Second Intervention||9
288918|NCT00835796|698479|P1|STARTED|Second Intervention||10
288919|NCT00835796|698478|P2|NOT COMPLETED|Washout||0
288920|NCT00835796|698479|P1|NOT COMPLETED|Washout||0
288921|NCT00835796|698478|P2|COMPLETED|Washout||9
288922|NCT00835796|698479|P1|COMPLETED|Washout||10
288923|NCT00835796|698478|P2|STARTED|Washout||9
288924|NCT00835796|698479|P1|STARTED|Washout||10
288925|NCT00835796|698478|P2|NOT COMPLETED|First Intervention||1
288926|NCT00835796|698479|P1|NOT COMPLETED|First Intervention||0
288927|NCT00835796|698478|P2|COMPLETED|First Intervention||9
288928|NCT00835796|698479|P1|COMPLETED|First Intervention||10
288929|NCT00835796|698478|P2|STARTED|First Intervention||10
288930|NCT00835796|698479|P1|STARTED|First Intervention||10
288931|NCT00835731|698489|P2|NOT COMPLETED|Overall Study||1
288932|NCT00835731|698490|P1|NOT COMPLETED|Overall Study||2
288933|NCT00835731|698489|P2|COMPLETED|Overall Study||60
288934|NCT00835731|698490|P1|COMPLETED|Overall Study||62
288935|NCT00835731|698489|P2|STARTED|Overall Study||61
288936|NCT00835731|698490|P1|STARTED|Overall Study||64
288937|NCT00835705|698510|P2|NOT COMPLETED|Second Intervention||0
288938|NCT00835705|698511|P1|NOT COMPLETED|Second Intervention||1
288939|NCT00835705|698510|P2|COMPLETED|Second Intervention||28
288940|NCT00835705|698511|P1|COMPLETED|Second Intervention||22
288941|NCT00835705|698510|P2|STARTED|Second Intervention||28
288942|NCT00835705|698511|P1|STARTED|Second Intervention||23
288943|NCT00835705|698510|P2|NOT COMPLETED|First Intervention||0
288944|NCT00835705|698511|P1|NOT COMPLETED|First Intervention||1
288945|NCT00835705|698510|P2|COMPLETED|First Intervention||28
288946|NCT00835705|698511|P1|COMPLETED|First Intervention||23
288947|NCT00835705|698510|P2|STARTED|First Intervention||28
288948|NCT00835705|698511|P1|STARTED|First Intervention||24
288949|NCT00835692|698527|P2|NOT COMPLETED|Second Intervention||0
288950|NCT00835692|698528|P1|NOT COMPLETED|Second Intervention||0
288951|NCT00835692|698527|P2|COMPLETED|Second Intervention||28
288952|NCT00835692|698528|P1|COMPLETED|Second Intervention||27
288953|NCT00835692|698527|P2|STARTED|Second Intervention||28
288954|NCT00835692|698528|P1|STARTED|Second Intervention||27
288955|NCT00835692|698527|P2|NOT COMPLETED|Washout||0
288956|NCT00835692|698528|P1|NOT COMPLETED|Washout||0
288957|NCT00835692|698527|P2|COMPLETED|Washout||28
288958|NCT00835692|698528|P1|COMPLETED|Washout||27
288959|NCT00835692|698527|P2|STARTED|Washout||28
288960|NCT00835692|698528|P1|STARTED|Washout||27
288961|NCT00835692|698527|P2|NOT COMPLETED|First Intervention||0
288962|NCT00835692|698528|P1|NOT COMPLETED|First Intervention||1
288963|NCT00835692|698527|P2|COMPLETED|First Intervention||28
288964|NCT00835692|698528|P1|COMPLETED|First Intervention||27
288965|NCT00835692|698527|P2|STARTED|First Intervention||28
288966|NCT00835692|698528|P1|STARTED|First Intervention||28
288967|NCT00835679|698540|P4|NOT COMPLETED|Overall Study||0
288968|NCT00835679|698541|P3|NOT COMPLETED|Overall Study||0
288969|NCT00835679|698542|P2|NOT COMPLETED|Overall Study||0
288970|NCT00835679|698543|P1|NOT COMPLETED|Overall Study||1
288971|NCT00835679|698540|P4|COMPLETED|Overall Study||0
288972|NCT00835679|698541|P3|COMPLETED|Overall Study||0
288973|NCT00835679|698542|P2|COMPLETED|Overall Study||0
288974|NCT00835679|698543|P1|COMPLETED|Overall Study||8
288975|NCT00835679|698540|P4|STARTED|Overall Study||0
288976|NCT00835679|698541|P3|STARTED|Overall Study||0
288977|NCT00835679|698542|P2|STARTED|Overall Study|This study closed prematurely, thus no patients went on Cohort B, C or D.|0
288978|NCT00835679|698543|P1|STARTED|Overall Study||9
288979|NCT00835666|698567|P2|NOT COMPLETED|Second Intervention||0
288980|NCT00835666|698568|P1|NOT COMPLETED|Second Intervention||0
288981|NCT00835666|698567|P2|COMPLETED|Second Intervention||16
288982|NCT00835666|698568|P1|COMPLETED|Second Intervention||14
288983|NCT00835666|698567|P2|STARTED|Second Intervention||16
288984|NCT00835666|698568|P1|STARTED|Second Intervention||14
288985|NCT00835666|698567|P2|NOT COMPLETED|Washout||0
288986|NCT00835666|698568|P1|NOT COMPLETED|Washout||2
288987|NCT00835666|698567|P2|COMPLETED|Washout||16
288988|NCT00835666|698568|P1|COMPLETED|Washout||14
288989|NCT00835666|698567|P2|STARTED|Washout||16
288990|NCT00835666|698568|P1|STARTED|Washout||16
288991|NCT00835666|698567|P2|NOT COMPLETED|First Intervention||0
288992|NCT00835666|698568|P1|NOT COMPLETED|First Intervention||0
288993|NCT00835666|698567|P2|COMPLETED|First Intervention||16
288994|NCT00835666|698568|P1|COMPLETED|First Intervention||16
288995|NCT00835666|698567|P2|STARTED|First Intervention||16
288996|NCT00835666|698568|P1|STARTED|First Intervention||16
288997|NCT00835640|698578|P2|NOT COMPLETED|Second Intervention||0
288998|NCT00835640|698579|P1|NOT COMPLETED|Second Intervention||1
288999|NCT00835640|698578|P2|COMPLETED|Second Intervention||12
289000|NCT00835640|698579|P1|COMPLETED|Second Intervention||11
289001|NCT00835640|698578|P2|STARTED|Second Intervention||12
289002|NCT00835640|698579|P1|STARTED|Second Intervention||12
289003|NCT00835640|698578|P2|NOT COMPLETED|Washout of 7 Days||0
289004|NCT00835640|698579|P1|NOT COMPLETED|Washout of 7 Days||0
289005|NCT00835640|698578|P2|COMPLETED|Washout of 7 Days||12
289006|NCT00835640|698579|P1|COMPLETED|Washout of 7 Days||12
289007|NCT00835640|698578|P2|STARTED|Washout of 7 Days||12
289008|NCT00835640|698579|P1|STARTED|Washout of 7 Days||12
289009|NCT00835640|698578|P2|NOT COMPLETED|First Intervention||0
289010|NCT00835640|698579|P1|NOT COMPLETED|First Intervention||0
289011|NCT00835640|698578|P2|COMPLETED|First Intervention||12
289012|NCT00835640|698579|P1|COMPLETED|First Intervention||12
289013|NCT00835640|698578|P2|STARTED|First Intervention||12
289014|NCT00835640|698579|P1|STARTED|First Intervention||12
289015|NCT00835614|698589|P2|NOT COMPLETED|Second Intervention||0
289016|NCT00835614|698590|P1|NOT COMPLETED|Second Intervention||0
289017|NCT00835614|698589|P2|COMPLETED|Second Intervention||13
289018|NCT00835614|698590|P1|COMPLETED|Second Intervention||13
289019|NCT00835614|698589|P2|STARTED|Second Intervention||13
289020|NCT00835614|698590|P1|STARTED|Second Intervention||13
289021|NCT00835614|698589|P2|NOT COMPLETED|Washout of 7 Days||0
289022|NCT00835614|698590|P1|NOT COMPLETED|Washout of 7 Days||0
289023|NCT00835614|698589|P2|COMPLETED|Washout of 7 Days||13
289024|NCT00835614|698590|P1|COMPLETED|Washout of 7 Days||13
289025|NCT00835614|698589|P2|STARTED|Washout of 7 Days||13
289026|NCT00835614|698590|P1|STARTED|Washout of 7 Days||13
289027|NCT00835614|698589|P2|NOT COMPLETED|First Intervention||0
289028|NCT00835614|698590|P1|NOT COMPLETED|First Intervention||0
289029|NCT00835614|698589|P2|COMPLETED|First Intervention||13
289030|NCT00835614|698590|P1|COMPLETED|First Intervention||13
289031|NCT00835614|698589|P2|STARTED|First Intervention||13
289032|NCT00835614|698590|P1|STARTED|First Intervention||13
289033|NCT00835588|698600|P2|NOT COMPLETED|Second Intervention||0
289034|NCT00835588|698601|P1|NOT COMPLETED|Second Intervention||0
289035|NCT00835588|698600|P2|COMPLETED|Second Intervention||50
289036|NCT00835588|698601|P1|COMPLETED|Second Intervention||50
289037|NCT00835588|698600|P2|STARTED|Second Intervention||50
289038|NCT00835588|698601|P1|STARTED|Second Intervention||50
289039|NCT00835588|698600|P2|NOT COMPLETED|Washout: 5 Days||0
289040|NCT00835588|698601|P1|NOT COMPLETED|Washout: 5 Days||0
289041|NCT00835588|698600|P2|COMPLETED|Washout: 5 Days||50
289042|NCT00835588|698601|P1|COMPLETED|Washout: 5 Days||50
289043|NCT00835588|698600|P2|STARTED|Washout: 5 Days||50
289044|NCT00835588|698601|P1|STARTED|Washout: 5 Days||50
289045|NCT00835588|698600|P2|NOT COMPLETED|First Intervention||0
289046|NCT00835588|698601|P1|NOT COMPLETED|First Intervention||0
289047|NCT00835588|698600|P2|COMPLETED|First Intervention||50
289048|NCT00835588|698601|P1|COMPLETED|First Intervention||50
289049|NCT00835588|698600|P2|STARTED|First Intervention||50
289050|NCT00835588|698601|P1|STARTED|First Intervention||50
289051|NCT00835575|698611|P2|NOT COMPLETED|Second Intervention||0
289052|NCT00835575|698612|P1|NOT COMPLETED|Second Intervention||0
289053|NCT00835575|698611|P2|COMPLETED|Second Intervention||16
289054|NCT00835575|698612|P1|COMPLETED|Second Intervention||15
289055|NCT00835575|698611|P2|STARTED|Second Intervention||16
289056|NCT00835575|698612|P1|STARTED|Second Intervention||15
289057|NCT00835575|698611|P2|NOT COMPLETED|Washout of 14 Days||0
289058|NCT00835575|698612|P1|NOT COMPLETED|Washout of 14 Days||1
289059|NCT00835575|698611|P2|COMPLETED|Washout of 14 Days||16
289060|NCT00835575|698612|P1|COMPLETED|Washout of 14 Days||15
289061|NCT00835575|698611|P2|STARTED|Washout of 14 Days||16
289062|NCT00835575|698612|P1|STARTED|Washout of 14 Days||16
289063|NCT00835575|698611|P2|NOT COMPLETED|First Intervention||0
289064|NCT00835575|698612|P1|NOT COMPLETED|First Intervention||0
289065|NCT00835575|698611|P2|COMPLETED|First Intervention||16
289066|NCT00835575|698612|P1|COMPLETED|First Intervention||16
289067|NCT00835575|698611|P2|STARTED|First Intervention||16
289068|NCT00835575|698612|P1|STARTED|First Intervention||16
289069|NCT00835549|698622|P2|NOT COMPLETED|Second Intervention||0
289070|NCT00835549|698623|P1|NOT COMPLETED|Second Intervention||0
289071|NCT00835549|698622|P2|COMPLETED|Second Intervention||16
289072|NCT00835549|698623|P1|COMPLETED|Second Intervention||14
289073|NCT00835549|698622|P2|STARTED|Second Intervention||16
289074|NCT00835549|698623|P1|STARTED|Second Intervention||14
289075|NCT00835549|698622|P2|NOT COMPLETED|Washout of 7 Days||0
289076|NCT00835549|698623|P1|NOT COMPLETED|Washout of 7 Days||2
289077|NCT00835549|698622|P2|COMPLETED|Washout of 7 Days||16
289078|NCT00835549|698623|P1|COMPLETED|Washout of 7 Days||14
289079|NCT00835549|698622|P2|STARTED|Washout of 7 Days||16
289080|NCT00835549|698623|P1|STARTED|Washout of 7 Days||16
289081|NCT00835549|698622|P2|NOT COMPLETED|First Intervention||0
289082|NCT00835549|698623|P1|NOT COMPLETED|First Intervention||0
289083|NCT00835549|698622|P2|COMPLETED|First Intervention||16
289084|NCT00835549|698623|P1|COMPLETED|First Intervention||16
289085|NCT00835549|698622|P2|STARTED|First Intervention||16
289086|NCT00835549|698623|P1|STARTED|First Intervention||16
289087|NCT00835536|698633|P2|NOT COMPLETED|Second Intervention||0
289088|NCT00835536|698634|P1|NOT COMPLETED|Second Intervention||0
289089|NCT00835536|698633|P2|COMPLETED|Second Intervention||14
289090|NCT00835536|698634|P1|COMPLETED|Second Intervention||12
289091|NCT00835536|698633|P2|STARTED|Second Intervention||14
289092|NCT00835536|698634|P1|STARTED|Second Intervention||12
289093|NCT00835536|698633|P2|NOT COMPLETED|Washout of 5 Weeks||0
289094|NCT00835536|698634|P1|NOT COMPLETED|Washout of 5 Weeks||1
289095|NCT00835536|698633|P2|COMPLETED|Washout of 5 Weeks||14
289096|NCT00835536|698634|P1|COMPLETED|Washout of 5 Weeks||12
289097|NCT00835536|698633|P2|STARTED|Washout of 5 Weeks||14
289098|NCT00835536|698634|P1|STARTED|Washout of 5 Weeks||13
289099|NCT00835536|698633|P2|NOT COMPLETED|First Intervention||0
289100|NCT00835536|698634|P1|NOT COMPLETED|First Intervention||0
289101|NCT00835536|698633|P2|COMPLETED|First Intervention||14
289102|NCT00835536|698634|P1|COMPLETED|First Intervention||13
289103|NCT00835536|698633|P2|STARTED|First Intervention||14
289104|NCT00835536|698634|P1|STARTED|First Intervention||13
289105|NCT00835510|698643|P3|NOT COMPLETED|Overall Study||38
289106|NCT00835510|698644|P2|NOT COMPLETED|Overall Study||69
289107|NCT00835510|698645|P1|NOT COMPLETED|Overall Study||76
289108|NCT00835510|698643|P3|COMPLETED|Overall Study||70
289109|NCT00835510|698644|P2|COMPLETED|Overall Study||152
289110|NCT00835510|698645|P1|COMPLETED|Overall Study||143
289111|NCT00835510|698643|P3|Positive Fungal Culture|Overall Study||71
289112|NCT00835510|698644|P2|Positive Fungal Culture|Overall Study||155
289113|NCT00835510|698645|P1|Positive Fungal Culture|Overall Study||149
289114|NCT00835510|698643|P3|STARTED|Overall Study||108
289115|NCT00835510|698644|P2|STARTED|Overall Study||221
289116|NCT00835510|698645|P1|STARTED|Overall Study||219
289117|NCT00835497|698667|P2|NOT COMPLETED|Second Intervention||0
289118|NCT00835497|698668|P1|NOT COMPLETED|Second Intervention||0
289119|NCT00835497|698667|P2|COMPLETED|Second Intervention||20
289120|NCT00835497|698668|P1|COMPLETED|Second Intervention||20
289121|NCT00835497|698667|P2|STARTED|Second Intervention||20
289122|NCT00835497|698668|P1|STARTED|Second Intervention||20
289123|NCT00835497|698667|P2|NOT COMPLETED|Washout: 7 Days||0
289124|NCT00835497|698668|P1|NOT COMPLETED|Washout: 7 Days||0
289125|NCT00835497|698667|P2|COMPLETED|Washout: 7 Days||20
289126|NCT00835497|698668|P1|COMPLETED|Washout: 7 Days||20
289127|NCT00835497|698667|P2|STARTED|Washout: 7 Days||20
289128|NCT00835497|698668|P1|STARTED|Washout: 7 Days||20
289129|NCT00835497|698667|P2|NOT COMPLETED|First Intervention||0
289130|NCT00835497|698668|P1|NOT COMPLETED|First Intervention||0
289131|NCT00835497|698667|P2|COMPLETED|First Intervention||20
289132|NCT00835497|698668|P1|COMPLETED|First Intervention||20
289133|NCT00835497|698667|P2|STARTED|First Intervention||20
289134|NCT00835497|698668|P1|STARTED|First Intervention||20
289135|NCT00835484|698684|P2|NOT COMPLETED|Second Intervention||0
289136|NCT00835484|698685|P1|NOT COMPLETED|Second Intervention||0
289137|NCT00835484|698684|P2|COMPLETED|Second Intervention||16
289138|NCT00835484|698685|P1|COMPLETED|Second Intervention||16
289139|NCT00835484|698684|P2|STARTED|Second Intervention||16
289140|NCT00835484|698685|P1|STARTED|Second Intervention||16
289141|NCT00835484|698684|P2|NOT COMPLETED|Washout of 7 Days||0
289142|NCT00835484|698685|P1|NOT COMPLETED|Washout of 7 Days||0
289143|NCT00835484|698684|P2|COMPLETED|Washout of 7 Days||16
289144|NCT00835484|698685|P1|COMPLETED|Washout of 7 Days||16
289145|NCT00835484|698684|P2|STARTED|Washout of 7 Days||16
289146|NCT00835484|698685|P1|STARTED|Washout of 7 Days||16
289147|NCT00835484|698684|P2|NOT COMPLETED|First Intervention||0
289148|NCT00835484|698685|P1|NOT COMPLETED|First Intervention||0
289149|NCT00835484|698684|P2|COMPLETED|First Intervention||16
289150|NCT00835484|698685|P1|COMPLETED|First Intervention||16
289151|NCT00835484|698684|P2|STARTED|First Intervention||16
289152|NCT00835484|698685|P1|STARTED|First Intervention||16
289153|NCT00835406|698695|P2|NOT COMPLETED|Period: Second Intervention||0
289154|NCT00835406|698696|P1|NOT COMPLETED|Period: Second Intervention||0
289155|NCT00835406|698695|P2|COMPLETED|Period: Second Intervention||67
289156|NCT00835406|698696|P1|COMPLETED|Period: Second Intervention||68
289157|NCT00835406|698695|P2|STARTED|Period: Second Intervention||67
289158|NCT00835406|698696|P1|STARTED|Period: Second Intervention||68
289159|NCT00835406|698695|P2|NOT COMPLETED|Period: Washout of 7 Days||2
289160|NCT00835406|698696|P1|NOT COMPLETED|Period: Washout of 7 Days||0
289161|NCT00835406|698695|P2|COMPLETED|Period: Washout of 7 Days||67
289162|NCT00835406|698696|P1|COMPLETED|Period: Washout of 7 Days||68
289163|NCT00835406|698695|P2|STARTED|Period: Washout of 7 Days||69
289164|NCT00835406|698696|P1|STARTED|Period: Washout of 7 Days||68
289165|NCT00835406|698695|P2|NOT COMPLETED|Period: First Intervention||1
289166|NCT00835406|698696|P1|NOT COMPLETED|Period: First Intervention||2
289167|NCT00835406|698695|P2|COMPLETED|Period: First Intervention||69
289168|NCT00835406|698696|P1|COMPLETED|Period: First Intervention||68
289169|NCT00835406|698695|P2|STARTED|Period: First Intervention||70
289170|NCT00835406|698696|P1|STARTED|Period: First Intervention||70
289171|NCT00835380|698702|P1|NOT COMPLETED|Overall Study||2
289172|NCT00835380|698702|P1|COMPLETED|Overall Study||78
289173|NCT00835380|698702|P1|STARTED|Overall Study||80
289174|NCT00835367|698709|P2|NOT COMPLETED|Second Intervention||1
289175|NCT00835367|698710|P1|NOT COMPLETED|Second Intervention||1
289176|NCT00835367|698709|P2|COMPLETED|Second Intervention||33
289177|NCT00835367|698710|P1|COMPLETED|Second Intervention||30
289178|NCT00835367|698709|P2|STARTED|Second Intervention||34
289179|NCT00835367|698710|P1|STARTED|Second Intervention||31
289180|NCT00835367|698709|P2|NOT COMPLETED|Washout||0
289181|NCT00835367|698710|P1|NOT COMPLETED|Washout||3
289182|NCT00835367|698709|P2|COMPLETED|Washout||34
289183|NCT00835367|698710|P1|COMPLETED|Washout||31
289184|NCT00835367|698709|P2|STARTED|Washout||34
289185|NCT00835367|698710|P1|STARTED|Washout||34
289186|NCT00835367|698709|P2|NOT COMPLETED|First Intervention||0
289187|NCT00835367|698710|P1|NOT COMPLETED|First Intervention||0
289188|NCT00835367|698709|P2|COMPLETED|First Intervention||34
289189|NCT00835367|698710|P1|COMPLETED|First Intervention||34
289190|NCT00835367|698709|P2|STARTED|First Intervention||34
289191|NCT00835367|698710|P1|STARTED|First Intervention||34
289192|NCT00835354|698732|P2|NOT COMPLETED|Second Intervention||0
289193|NCT00835354|698733|P1|NOT COMPLETED|Second Intervention||0
289194|NCT00835354|698732|P2|COMPLETED|Second Intervention||12
289195|NCT00835354|698733|P1|COMPLETED|Second Intervention||13
289196|NCT00835354|698732|P2|STARTED|Second Intervention||12
289197|NCT00835354|698733|P1|STARTED|Second Intervention||13
289198|NCT00835354|698732|P2|NOT COMPLETED|Washout of 7 Days||0
289199|NCT00835354|698733|P1|NOT COMPLETED|Washout of 7 Days||0
289200|NCT00835354|698732|P2|COMPLETED|Washout of 7 Days||12
289201|NCT00835354|698733|P1|COMPLETED|Washout of 7 Days||13
289202|NCT00835354|698732|P2|STARTED|Washout of 7 Days||12
289203|NCT00835354|698733|P1|STARTED|Washout of 7 Days||13
289204|NCT00835354|698732|P2|NOT COMPLETED|First Intervention||1
289205|NCT00835354|698733|P1|NOT COMPLETED|First Intervention||0
289206|NCT00835354|698732|P2|COMPLETED|First Intervention||12
289207|NCT00835354|698733|P1|COMPLETED|First Intervention||13
289208|NCT00835354|698732|P2|STARTED|First Intervention||13
289209|NCT00835354|698733|P1|STARTED|First Intervention||13
289210|NCT00835341|698743|P2|NOT COMPLETED|Overall Study||12
289211|NCT00835341|698744|P1|NOT COMPLETED|Overall Study||3
289212|NCT00835341|698743|P2|COMPLETED|Overall Study||46
289213|NCT00835341|698744|P1|COMPLETED|Overall Study||32
289214|NCT00835341|698743|P2|STARTED|Overall Study||58
289215|NCT00835341|698744|P1|STARTED|Overall Study||35
289216|NCT00835276|698752|P2|NOT COMPLETED|Second Intervention||0
289217|NCT00835276|698753|P1|NOT COMPLETED|Second Intervention||0
289218|NCT00835276|698752|P2|COMPLETED|Second Intervention||24
289219|NCT00835276|698753|P1|COMPLETED|Second Intervention||24
289220|NCT00835276|698752|P2|STARTED|Second Intervention||24
289221|NCT00835276|698753|P1|STARTED|Second Intervention||24
289222|NCT00835276|698752|P2|NOT COMPLETED|Washout of 7 Days||0
289223|NCT00835276|698753|P1|NOT COMPLETED|Washout of 7 Days||0
289224|NCT00835276|698752|P2|COMPLETED|Washout of 7 Days||24
289225|NCT00835276|698753|P1|COMPLETED|Washout of 7 Days||24
289226|NCT00835276|698752|P2|STARTED|Washout of 7 Days||24
289227|NCT00835276|698753|P1|STARTED|Washout of 7 Days||24
289228|NCT00835276|698752|P2|NOT COMPLETED|First Intervention||0
289229|NCT00835276|698753|P1|NOT COMPLETED|First Intervention||0
289230|NCT00835276|698752|P2|COMPLETED|First Intervention||24
289231|NCT00835276|698753|P1|COMPLETED|First Intervention||24
289232|NCT00835276|698752|P2|STARTED|First Intervention||24
289233|NCT00835276|698753|P1|STARTED|First Intervention||24
289234|NCT00835263|698763|P2|NOT COMPLETED|Second Intervention||0
289235|NCT00835263|698764|P1|NOT COMPLETED|Second Intervention||1
289236|NCT00835263|698763|P2|COMPLETED|Second Intervention||16
289237|NCT00835263|698764|P1|COMPLETED|Second Intervention||15
289238|NCT00835263|698763|P2|STARTED|Second Intervention||16
289239|NCT00835263|698764|P1|STARTED|Second Intervention||16
289240|NCT00835263|698763|P2|NOT COMPLETED|First Intervention||0
289241|NCT00835263|698764|P1|NOT COMPLETED|First Intervention||0
289242|NCT00835263|698763|P2|COMPLETED|First Intervention||16
289243|NCT00835263|698764|P1|COMPLETED|First Intervention||16
289244|NCT00835263|698763|P2|STARTED|First Intervention||16
289245|NCT00835263|698764|P1|STARTED|First Intervention||16
289246|NCT00835237|698774|P2|NOT COMPLETED|Overall Study||0
289247|NCT00835237|698775|P1|NOT COMPLETED|Overall Study||6
289248|NCT00835237|698774|P2|COMPLETED|Overall Study||445
289249|NCT00835237|698775|P1|COMPLETED|Overall Study||881
289250|NCT00835237|698774|P2|STARTED|Overall Study||445
289251|NCT00835237|698775|P1|STARTED|Overall Study||887
289252|NCT00835224|698799|P1|NOT COMPLETED|Overall Study||10
289253|NCT00835224|698799|P1|COMPLETED|Overall Study||24
289254|NCT00835224|698799|P1|STARTED|Overall Study||34
289255|NCT00835211|698815|P2|NOT COMPLETED|Second Intervention||0
289256|NCT00835211|698816|P1|NOT COMPLETED|Second Intervention||0
289257|NCT00835211|698815|P2|COMPLETED|Second Intervention||22
289258|NCT00835211|698816|P1|COMPLETED|Second Intervention||21
289259|NCT00835211|698815|P2|STARTED|Second Intervention||22
289260|NCT00835211|698816|P1|STARTED|Second Intervention||21
289261|NCT00835211|698815|P2|NOT COMPLETED|Washout: 7 Days||1
289262|NCT00835211|698816|P1|NOT COMPLETED|Washout: 7 Days||3
289263|NCT00835211|698815|P2|COMPLETED|Washout: 7 Days||22
289264|NCT00835211|698816|P1|COMPLETED|Washout: 7 Days||21
289265|NCT00835211|698815|P2|STARTED|Washout: 7 Days||23
289266|NCT00835211|698816|P1|STARTED|Washout: 7 Days||24
289267|NCT00835211|698815|P2|NOT COMPLETED|First Intervention||1
289268|NCT00835211|698816|P1|NOT COMPLETED|First Intervention||0
289269|NCT00835211|698815|P2|COMPLETED|First Intervention||23
289270|NCT00835211|698816|P1|COMPLETED|First Intervention||24
289271|NCT00835211|698815|P2|STARTED|First Intervention||24
289272|NCT00835211|698816|P1|STARTED|First Intervention||24
289273|NCT00835198|698826|P2|NOT COMPLETED|Overall Study||7
289274|NCT00835198|698827|P1|NOT COMPLETED|Overall Study||8
289275|NCT00835198|698826|P2|COMPLETED|Overall Study||74
289276|NCT00835198|698827|P1|COMPLETED|Overall Study||74
289277|NCT00835198|698826|P2|STARTED|Overall Study||81
289278|NCT00835198|698827|P1|STARTED|Overall Study||82
289279|NCT00835185|698839|P1|NOT COMPLETED|Overall Study||0
289280|NCT00835185|698839|P1|COMPLETED|Overall Study||44
289281|NCT00835185|698839|P1|Received at Least 1 Dose of Study Drug|Overall Study||44
289282|NCT00835185|698839|P1|STARTED|Overall Study||44
289283|NCT00835172|698862|P2|NOT COMPLETED|Second Intervention||0
289284|NCT00835172|698863|P1|NOT COMPLETED|Second Intervention||0
289285|NCT00835172|698862|P2|COMPLETED|Second Intervention||15
289286|NCT00835172|698863|P1|COMPLETED|Second Intervention||16
289287|NCT00835172|698862|P2|STARTED|Second Intervention||15
289288|NCT00835172|698863|P1|STARTED|Second Intervention||16
289289|NCT00835172|698862|P2|NOT COMPLETED|Washout||1
289290|NCT00835172|698863|P1|NOT COMPLETED|Washout||0
289291|NCT00835172|698862|P2|COMPLETED|Washout||15
289292|NCT00835172|698863|P1|COMPLETED|Washout||16
289293|NCT00835172|698862|P2|STARTED|Washout||16
289294|NCT00835172|698863|P1|STARTED|Washout||16
289295|NCT00835172|698862|P2|NOT COMPLETED|First Intervention||0
289296|NCT00835172|698863|P1|NOT COMPLETED|First Intervention||0
289297|NCT00835172|698862|P2|COMPLETED|First Intervention||16
289298|NCT00835172|698863|P1|COMPLETED|First Intervention||16
289299|NCT00835172|698862|P2|STARTED|First Intervention||16
289300|NCT00835172|698863|P1|STARTED|First Intervention||16
289301|NCT00835159|698873|P2|NOT COMPLETED|Overall Study||0
289302|NCT00835159|698874|P1|NOT COMPLETED|Overall Study||0
289303|NCT00835159|698873|P2|COMPLETED|Overall Study||17
289304|NCT00835159|698874|P1|COMPLETED|Overall Study||11
289305|NCT00835159|698873|P2|STARTED|Overall Study||17
289306|NCT00835159|698874|P1|STARTED|Overall Study||11
289307|NCT00835146|698882|P2|NOT COMPLETED|Second Intervention||0
289308|NCT00835146|698883|P1|NOT COMPLETED|Second Intervention||0
289309|NCT00835146|698882|P2|COMPLETED|Second Intervention||14
289310|NCT00835146|698883|P1|COMPLETED|Second Intervention||14
289311|NCT00835146|698882|P2|STARTED|Second Intervention||14
289312|NCT00835146|698883|P1|STARTED|Second Intervention||14
289313|NCT00835146|698882|P2|NOT COMPLETED|Washout of 5 Weeks||0
289314|NCT00835146|698883|P1|NOT COMPLETED|Washout of 5 Weeks||0
289315|NCT00835146|698882|P2|COMPLETED|Washout of 5 Weeks||14
289316|NCT00835146|698883|P1|COMPLETED|Washout of 5 Weeks||14
289317|NCT00835146|698882|P2|STARTED|Washout of 5 Weeks||14
289318|NCT00835146|698883|P1|STARTED|Washout of 5 Weeks||14
289319|NCT00835146|698882|P2|NOT COMPLETED|First Intervention||0
289320|NCT00835146|698883|P1|NOT COMPLETED|First Intervention||0
289321|NCT00835146|698882|P2|COMPLETED|First Intervention||14
289322|NCT00835146|698883|P1|COMPLETED|First Intervention||14
289323|NCT00835146|698882|P2|STARTED|First Intervention||14
289324|NCT00835146|698883|P1|STARTED|First Intervention||14
289325|NCT00835120|698889|P1|NOT COMPLETED|Overall Study||8
289326|NCT00835120|698889|P1|COMPLETED|Overall Study||26
289327|NCT00835120|698889|P1|STARTED|Overall Study||34
289328|NCT00835081|698899|P2|NOT COMPLETED|Second Intervention||0
289329|NCT00835081|698900|P1|NOT COMPLETED|Second Intervention||0
289330|NCT00835081|698899|P2|COMPLETED|Second Intervention||13
289331|NCT00835081|698900|P1|COMPLETED|Second Intervention||12
289332|NCT00835081|698899|P2|STARTED|Second Intervention||13
289333|NCT00835081|698900|P1|STARTED|Second Intervention||12
289334|NCT00835081|698899|P2|NOT COMPLETED|Washout of 7 Days||0
289335|NCT00835081|698900|P1|NOT COMPLETED|Washout of 7 Days||1
289336|NCT00835081|698899|P2|COMPLETED|Washout of 7 Days||13
289337|NCT00835081|698900|P1|COMPLETED|Washout of 7 Days||12
289338|NCT00835081|698899|P2|STARTED|Washout of 7 Days||13
289339|NCT00835081|698900|P1|STARTED|Washout of 7 Days||13
289340|NCT00835081|698899|P2|NOT COMPLETED|First Intervention||0
289341|NCT00835081|698900|P1|NOT COMPLETED|First Intervention||0
289342|NCT00835081|698899|P2|COMPLETED|First Intervention||13
289343|NCT00835081|698900|P1|COMPLETED|First Intervention||13
289344|NCT00835081|698899|P2|STARTED|First Intervention||13
289345|NCT00835081|698900|P1|STARTED|First Intervention||13
289346|NCT00835068|698910|P2|NOT COMPLETED|Overall Study||1
289347|NCT00835068|698911|P1|NOT COMPLETED|Overall Study||10
289348|NCT00835068|698910|P2|COMPLETED|Overall Study||0
289349|NCT00835068|698911|P1|COMPLETED|Overall Study||47
289350|NCT00835068|698910|P2|STARTED|Overall Study||1
289351|NCT00835068|698911|P1|STARTED|Overall Study||57
289352|NCT00835042|698931|P2|NOT COMPLETED|Second Intervention||0
289353|NCT00835042|698932|P1|NOT COMPLETED|Second Intervention||0
289354|NCT00835042|698931|P2|COMPLETED|Second Intervention||24
289355|NCT00835042|698932|P1|COMPLETED|Second Intervention||26
289356|NCT00835042|698931|P2|STARTED|Second Intervention||24
289357|NCT00835042|698932|P1|STARTED|Second Intervention||26
289358|NCT00835042|698931|P2|NOT COMPLETED|Washout of 21 Days||2
289359|NCT00835042|698932|P1|NOT COMPLETED|Washout of 21 Days||0
289360|NCT00835042|698931|P2|COMPLETED|Washout of 21 Days||24
289361|NCT00835042|698932|P1|COMPLETED|Washout of 21 Days||26
289362|NCT00835042|698931|P2|STARTED|Washout of 21 Days||26
289363|NCT00835042|698932|P1|STARTED|Washout of 21 Days||26
289364|NCT00835042|698931|P2|NOT COMPLETED|First Intervention||2
289365|NCT00835042|698932|P1|NOT COMPLETED|First Intervention||4
289366|NCT00835042|698931|P2|COMPLETED|First Intervention||26
289367|NCT00835042|698932|P1|COMPLETED|First Intervention||26
289368|NCT00835042|698931|P2|STARTED|First Intervention||28
289369|NCT00835042|698932|P1|STARTED|First Intervention||30
289370|NCT00835003|698954|P2|NOT COMPLETED|Overall Study||0
289371|NCT00835003|698955|P1|NOT COMPLETED|Overall Study||0
289372|NCT00835003|698954|P2|COMPLETED|Overall Study||638
289373|NCT00835003|698955|P1|COMPLETED|Overall Study||636
289374|NCT00835003|698954|P2|STARTED|Overall Study||638
289375|NCT00835003|698955|P1|STARTED|Overall Study||636
289376|NCT00834990|698963|P2|NOT COMPLETED|Second Intervention||0
289377|NCT00834990|698964|P1|NOT COMPLETED|Second Intervention||0
289378|NCT00834990|698963|P2|COMPLETED|Second Intervention||11
289379|NCT00834990|698964|P1|COMPLETED|Second Intervention||12
289380|NCT00834990|698963|P2|STARTED|Second Intervention||11
289381|NCT00834990|698964|P1|STARTED|Second Intervention||12
289382|NCT00834990|698963|P2|NOT COMPLETED|Washout of 7 Days||0
289383|NCT00834990|698964|P1|NOT COMPLETED|Washout of 7 Days||0
289384|NCT00834990|698963|P2|COMPLETED|Washout of 7 Days||11
289385|NCT00834990|698964|P1|COMPLETED|Washout of 7 Days||12
289386|NCT00834990|698963|P2|STARTED|Washout of 7 Days||11
289387|NCT00834990|698964|P1|STARTED|Washout of 7 Days||12
289388|NCT00834990|698963|P2|NOT COMPLETED|First Intervention||0
289389|NCT00834990|698964|P1|NOT COMPLETED|First Intervention||0
289390|NCT00834990|698963|P2|COMPLETED|First Intervention||11
289391|NCT00834990|698964|P1|COMPLETED|First Intervention||12
289392|NCT00834990|698963|P2|STARTED|First Intervention||11
289393|NCT00834990|698964|P1|STARTED|First Intervention||12
289394|NCT00834977|698974|P2|NOT COMPLETED|Second Intervention||0
289395|NCT00834977|698975|P1|NOT COMPLETED|Second Intervention||0
289396|NCT00834977|698974|P2|COMPLETED|Second Intervention||24
289397|NCT00834977|698975|P1|COMPLETED|Second Intervention||24
289398|NCT00834977|698974|P2|STARTED|Second Intervention||24
289399|NCT00834977|698975|P1|STARTED|Second Intervention||24
289400|NCT00834977|698974|P2|NOT COMPLETED|First Intervention||0
289401|NCT00834977|698975|P1|NOT COMPLETED|First Intervention||0
289402|NCT00834977|698974|P2|COMPLETED|First Intervention||24
289403|NCT00834977|698975|P1|COMPLETED|First Intervention||24
289404|NCT00834977|698974|P2|STARTED|First Intervention||24
289405|NCT00834977|698975|P1|STARTED|First Intervention||24
289406|NCT00834964|698997|P2|NOT COMPLETED|Second Intervention||0
289407|NCT00834964|698998|P1|NOT COMPLETED|Second Intervention||0
289408|NCT00834964|698997|P2|COMPLETED|Second Intervention||15
289409|NCT00834964|698998|P1|COMPLETED|Second Intervention||15
289410|NCT00834964|698997|P2|STARTED|Second Intervention||15
289411|NCT00834964|698998|P1|STARTED|Second Intervention||15
289412|NCT00834964|698997|P2|NOT COMPLETED|Washout: 7 Days||0
289413|NCT00834964|698998|P1|NOT COMPLETED|Washout: 7 Days||0
289414|NCT00834964|698997|P2|COMPLETED|Washout: 7 Days||15
289415|NCT00834964|698998|P1|COMPLETED|Washout: 7 Days||15
289416|NCT00834964|698997|P2|STARTED|Washout: 7 Days||15
289417|NCT00834964|698998|P1|STARTED|Washout: 7 Days||15
289418|NCT00834964|698997|P2|NOT COMPLETED|First Intervention||0
289419|NCT00834964|698998|P1|NOT COMPLETED|First Intervention||0
289420|NCT00834964|698997|P2|COMPLETED|First Intervention||15
289421|NCT00834964|698998|P1|COMPLETED|First Intervention||15
289422|NCT00834964|698997|P2|STARTED|First Intervention||15
289423|NCT00834964|698998|P1|STARTED|First Intervention||15
289424|NCT00834912|699018|P6|NOT COMPLETED|Treatment Period 3||0
289425|NCT00834912|699019|P5|NOT COMPLETED|Treatment Period 3||0
289426|NCT00834912|699020|P4|NOT COMPLETED|Treatment Period 3||0
289427|NCT00834912|699021|P3|NOT COMPLETED|Treatment Period 3||0
289428|NCT00834912|699022|P2|NOT COMPLETED|Treatment Period 3||0
289429|NCT00834912|699023|P1|NOT COMPLETED|Treatment Period 3||0
289430|NCT00834912|699018|P6|COMPLETED|Treatment Period 3||6
289431|NCT00834912|699019|P5|COMPLETED|Treatment Period 3||5
289432|NCT00834912|699020|P4|COMPLETED|Treatment Period 3||5
289433|NCT00834912|699021|P3|COMPLETED|Treatment Period 3||5
289434|NCT00834912|699022|P2|COMPLETED|Treatment Period 3||5
289435|NCT00834912|699023|P1|COMPLETED|Treatment Period 3||6
289436|NCT00834912|699018|P6|STARTED|Treatment Period 3||6
289437|NCT00834912|699019|P5|STARTED|Treatment Period 3||5
289438|NCT00834912|699020|P4|STARTED|Treatment Period 3||5
289439|NCT00834912|699021|P3|STARTED|Treatment Period 3||5
289440|NCT00834912|699022|P2|STARTED|Treatment Period 3||5
289441|NCT00834912|699023|P1|STARTED|Treatment Period 3||6
289442|NCT00834912|699018|P6|NOT COMPLETED|Treatment Period 2||0
289443|NCT00834912|699019|P5|NOT COMPLETED|Treatment Period 2||1
289444|NCT00834912|699020|P4|NOT COMPLETED|Treatment Period 2||0
289445|NCT00834912|699021|P3|NOT COMPLETED|Treatment Period 2||1
289446|NCT00834912|699022|P2|NOT COMPLETED|Treatment Period 2||0
289447|NCT00834912|699023|P1|NOT COMPLETED|Treatment Period 2||0
289448|NCT00834912|699018|P6|COMPLETED|Treatment Period 2||6
289449|NCT00834912|699019|P5|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
289450|NCT00834912|699020|P4|COMPLETED|Treatment Period 2||5
289451|NCT00834912|699021|P3|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
289452|NCT00834912|699022|P2|COMPLETED|Treatment Period 2||5
289453|NCT00834912|699023|P1|COMPLETED|Treatment Period 2||6
289454|NCT00834912|699018|P6|STARTED|Treatment Period 2||6
289455|NCT00834912|699019|P5|STARTED|Treatment Period 2||6
289456|NCT00834912|699020|P4|STARTED|Treatment Period 2||5
289457|NCT00834912|699021|P3|STARTED|Treatment Period 2||6
289458|NCT00834912|699022|P2|STARTED|Treatment Period 2||5
289459|NCT00834912|699023|P1|STARTED|Treatment Period 2||6
289460|NCT00834912|699018|P6|NOT COMPLETED|Treatment Period 1||0
289461|NCT00834912|699019|P5|NOT COMPLETED|Treatment Period 1||0
289462|NCT00834912|699020|P4|NOT COMPLETED|Treatment Period 1||1
289463|NCT00834912|699021|P3|NOT COMPLETED|Treatment Period 1||0
289464|NCT00834912|699022|P2|NOT COMPLETED|Treatment Period 1||1
289465|NCT00834912|699023|P1|NOT COMPLETED|Treatment Period 1||0
289466|NCT00834912|699018|P6|COMPLETED|Treatment Period 1||6
289467|NCT00834912|699019|P5|COMPLETED|Treatment Period 1||6
289468|NCT00834912|699020|P4|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
289469|NCT00834912|699021|P3|COMPLETED|Treatment Period 1||6
289470|NCT00834912|699022|P2|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
289471|NCT00834912|699023|P1|COMPLETED|Treatment Period 1||6
289472|NCT00834912|699018|P6|STARTED|Treatment Period 1||6
289473|NCT00834912|699019|P5|STARTED|Treatment Period 1||6
289474|NCT00834912|699020|P4|STARTED|Treatment Period 1||6
289475|NCT00834912|699021|P3|STARTED|Treatment Period 1||6
289476|NCT00834912|699022|P2|STARTED|Treatment Period 1||6
289477|NCT00834912|699023|P1|STARTED|Treatment Period 1||6
289478|NCT00834899|699045|P2|NOT COMPLETED|Overall Study||1
289479|NCT00834899|699046|P1|NOT COMPLETED|Overall Study||1
289480|NCT00834899|699045|P2|COMPLETED|Overall Study|One patient was withdrawn early because she did not meet eligibility criteria.|3
289481|NCT00834899|699046|P1|COMPLETED|Overall Study|One patient withdrew consent following completion of the study drug infusion.|8
289482|NCT00834899|699045|P2|STARTED|Overall Study||4
289483|NCT00834899|699046|P1|STARTED|Overall Study||9
289484|NCT00834886|699062|P4|NOT COMPLETED|Overall Study||0
289485|NCT00834886|699063|P3|NOT COMPLETED|Overall Study||1
289486|NCT00834886|699064|P2|NOT COMPLETED|Overall Study||1
289487|NCT00834886|699065|P1|NOT COMPLETED|Overall Study||0
289488|NCT00834886|699062|P4|COMPLETED|Overall Study||10
289489|NCT00834886|699063|P3|COMPLETED|Overall Study||9
289490|NCT00834886|699064|P2|COMPLETED|Overall Study||9
289491|NCT00834886|699065|P1|COMPLETED|Overall Study||10
289492|NCT00834886|699062|P4|STARTED|Overall Study||10
289493|NCT00834886|699063|P3|STARTED|Overall Study||10
289494|NCT00834886|699064|P2|STARTED|Overall Study||10
289495|NCT00834886|699065|P1|STARTED|Overall Study||10
289496|NCT00834873|699085|P2|NOT COMPLETED|Second Intervention||0
289497|NCT00834873|699086|P1|NOT COMPLETED|Second Intervention||0
289498|NCT00834873|699085|P2|COMPLETED|Second Intervention||11
289499|NCT00834873|699086|P1|COMPLETED|Second Intervention||12
289500|NCT00834873|699085|P2|STARTED|Second Intervention||11
289501|NCT00834873|699086|P1|STARTED|Second Intervention||12
289502|NCT00834873|699085|P2|NOT COMPLETED|Washout: 7 Days||0
289503|NCT00834873|699086|P1|NOT COMPLETED|Washout: 7 Days||0
289504|NCT00834873|699085|P2|COMPLETED|Washout: 7 Days||11
289505|NCT00834873|699086|P1|COMPLETED|Washout: 7 Days||12
289506|NCT00834873|699085|P2|STARTED|Washout: 7 Days||11
289507|NCT00834873|699086|P1|STARTED|Washout: 7 Days||12
289508|NCT00834873|699085|P2|NOT COMPLETED|First Intervention||1
289509|NCT00834873|699086|P1|NOT COMPLETED|First Intervention||0
289510|NCT00834873|699085|P2|COMPLETED|First Intervention||11
289511|NCT00834873|699086|P1|COMPLETED|First Intervention||12
289512|NCT00834873|699085|P2|STARTED|First Intervention||12
289513|NCT00834873|699086|P1|STARTED|First Intervention||12
289514|NCT00834834|699096|P2|NOT COMPLETED|Overall Study||3
289515|NCT00834834|699097|P1|NOT COMPLETED|Overall Study||4
289516|NCT00834834|699096|P2|COMPLETED|Overall Study||39
289517|NCT00834834|699097|P1|COMPLETED|Overall Study||38
289518|NCT00834834|699096|P2|STARTED|Overall Study||42
289519|NCT00834834|699097|P1|STARTED|Overall Study||42
289520|NCT00834808|699108|P3|NOT COMPLETED|Treatment Period 3 (Day 15)||0
289521|NCT00834808|699109|P2|NOT COMPLETED|Treatment Period 3 (Day 15)||0
289522|NCT00834808|699110|P1|NOT COMPLETED|Treatment Period 3 (Day 15)||0
289523|NCT00834808|699108|P3|COMPLETED|Treatment Period 3 (Day 15)||9
289524|NCT00834808|699109|P2|COMPLETED|Treatment Period 3 (Day 15)||9
289525|NCT00834808|699110|P1|COMPLETED|Treatment Period 3 (Day 15)||9
289526|NCT00834808|699108|P3|STARTED|Treatment Period 3 (Day 15)||9
289527|NCT00834808|699109|P2|STARTED|Treatment Period 3 (Day 15)||9
289528|NCT00834808|699110|P1|STARTED|Treatment Period 3 (Day 15)||9
289529|NCT00834808|699108|P3|NOT COMPLETED|Treatment Period 2 (Day 8)||0
289530|NCT00834808|699109|P2|NOT COMPLETED|Treatment Period 2 (Day 8)||0
289531|NCT00834808|699110|P1|NOT COMPLETED|Treatment Period 2 (Day 8)||0
289532|NCT00834808|699108|P3|COMPLETED|Treatment Period 2 (Day 8)||9
289533|NCT00834808|699109|P2|COMPLETED|Treatment Period 2 (Day 8)||9
289534|NCT00834808|699110|P1|COMPLETED|Treatment Period 2 (Day 8)||9
289535|NCT00834808|699108|P3|STARTED|Treatment Period 2 (Day 8)||9
289536|NCT00834808|699109|P2|STARTED|Treatment Period 2 (Day 8)||9
289537|NCT00834808|699110|P1|STARTED|Treatment Period 2 (Day 8)||9
289538|NCT00834808|699108|P3|NOT COMPLETED|Treatment Period 1 (Day 1)||0
289539|NCT00834808|699109|P2|NOT COMPLETED|Treatment Period 1 (Day 1)||0
289540|NCT00834808|699110|P1|NOT COMPLETED|Treatment Period 1 (Day 1)||0
289541|NCT00834808|699108|P3|COMPLETED|Treatment Period 1 (Day 1)||9
289542|NCT00834808|699109|P2|COMPLETED|Treatment Period 1 (Day 1)||9
289543|NCT00834808|699110|P1|COMPLETED|Treatment Period 1 (Day 1)||9
289544|NCT00834808|699108|P3|STARTED|Treatment Period 1 (Day 1)||9
289545|NCT00834808|699109|P2|STARTED|Treatment Period 1 (Day 1)||9
289546|NCT00834808|699110|P1|STARTED|Treatment Period 1 (Day 1)||9
289547|NCT00834795|699132|P2|NOT COMPLETED|Second Intervention||0
289548|NCT00834795|699133|P1|NOT COMPLETED|Second Intervention||1
289549|NCT00834795|699132|P2|COMPLETED|Second Intervention||17
289550|NCT00834795|699133|P1|COMPLETED|Second Intervention||17
289551|NCT00834795|699132|P2|STARTED|Second Intervention||17
289552|NCT00834795|699133|P1|STARTED|Second Intervention||18
289553|NCT00834795|699132|P2|NOT COMPLETED|Washout: 7 Days||1
289554|NCT00834795|699133|P1|NOT COMPLETED|Washout: 7 Days||0
289555|NCT00834795|699132|P2|COMPLETED|Washout: 7 Days||17
289556|NCT00834795|699133|P1|COMPLETED|Washout: 7 Days||18
289557|NCT00834795|699132|P2|STARTED|Washout: 7 Days||18
289558|NCT00834795|699133|P1|STARTED|Washout: 7 Days||18
289559|NCT00834795|699132|P2|NOT COMPLETED|First Intervention||0
289560|NCT00834795|699133|P1|NOT COMPLETED|First Intervention||0
289561|NCT00834795|699132|P2|COMPLETED|First Intervention||18
289562|NCT00834795|699133|P1|COMPLETED|First Intervention||18
289563|NCT00834795|699132|P2|STARTED|First Intervention||18
289564|NCT00834795|699133|P1|STARTED|First Intervention||18
289565|NCT00834756|699143|P2|NOT COMPLETED|Second Intervention||0
289566|NCT00834756|699144|P1|NOT COMPLETED|Second Intervention||0
289567|NCT00834756|699143|P2|COMPLETED|Second Intervention||18
289568|NCT00834756|699144|P1|COMPLETED|Second Intervention||16
289569|NCT00834756|699143|P2|STARTED|Second Intervention||18
289570|NCT00834756|699144|P1|STARTED|Second Intervention||16
289571|NCT00834756|699143|P2|NOT COMPLETED|Washout: 21 Days||0
289572|NCT00834756|699144|P1|NOT COMPLETED|Washout: 21 Days||1
289573|NCT00834756|699143|P2|COMPLETED|Washout: 21 Days||18
289574|NCT00834756|699144|P1|COMPLETED|Washout: 21 Days||16
289575|NCT00834756|699143|P2|STARTED|Washout: 21 Days||18
289576|NCT00834756|699144|P1|STARTED|Washout: 21 Days||17
289577|NCT00834756|699143|P2|NOT COMPLETED|First Intervention||0
289578|NCT00834756|699144|P1|NOT COMPLETED|First Intervention||1
289579|NCT00834756|699143|P2|COMPLETED|First Intervention||18
289580|NCT00834756|699144|P1|COMPLETED|First Intervention||17
289581|NCT00834756|699143|P2|STARTED|First Intervention||18
289582|NCT00834756|699144|P1|STARTED|First Intervention||18
289583|NCT00834743|699154|P2|NOT COMPLETED|Second Intervention||0
289584|NCT00834743|699155|P1|NOT COMPLETED|Second Intervention||1
289585|NCT00834743|699154|P2|COMPLETED|Second Intervention||16
289586|NCT00834743|699155|P1|COMPLETED|Second Intervention||15
289587|NCT00834743|699154|P2|STARTED|Second Intervention||16
289588|NCT00834743|699155|P1|STARTED|Second Intervention||16
289589|NCT00834743|699154|P2|NOT COMPLETED|Washout of 7 Days||0
289590|NCT00834743|699155|P1|NOT COMPLETED|Washout of 7 Days||0
289591|NCT00834743|699154|P2|COMPLETED|Washout of 7 Days||16
289592|NCT00834743|699155|P1|COMPLETED|Washout of 7 Days||16
289593|NCT00834743|699154|P2|STARTED|Washout of 7 Days||16
289594|NCT00834743|699155|P1|STARTED|Washout of 7 Days||16
289595|NCT00834743|699154|P2|NOT COMPLETED|First Intervention||0
289596|NCT00834743|699155|P1|NOT COMPLETED|First Intervention||0
289597|NCT00834743|699154|P2|COMPLETED|First Intervention||16
289598|NCT00834743|699155|P1|COMPLETED|First Intervention||16
289599|NCT00834743|699154|P2|STARTED|First Intervention||16
289600|NCT00834743|699155|P1|STARTED|First Intervention||16
289601|NCT00834717|699165|P2|NOT COMPLETED|Second Intervention||0
289602|NCT00834717|699166|P1|NOT COMPLETED|Second Intervention||0
289603|NCT00834717|699165|P2|COMPLETED|Second Intervention||19
289604|NCT00834717|699166|P1|COMPLETED|Second Intervention||19
289605|NCT00834717|699165|P2|STARTED|Second Intervention||19
289606|NCT00834717|699166|P1|STARTED|Second Intervention||19
289607|NCT00834717|699165|P2|NOT COMPLETED|First Intervention||1
289608|NCT00834717|699166|P1|NOT COMPLETED|First Intervention||1
289609|NCT00834717|699165|P2|COMPLETED|First Intervention||19
289610|NCT00834717|699166|P1|COMPLETED|First Intervention||19
289611|NCT00834717|699165|P2|STARTED|First Intervention||20
289612|NCT00834717|699166|P1|STARTED|First Intervention||20
289613|NCT00834678|699174|P1|NOT COMPLETED|Overall Study||0
289614|NCT00834678|699174|P1|COMPLETED|Overall Study||11
289615|NCT00834678|699174|P1|STARTED|Overall Study||11
289616|NCT00834652|699188|P2|NOT COMPLETED|Overall Study||40
289617|NCT00834652|699189|P1|NOT COMPLETED|Overall Study||38
289618|NCT00834652|699188|P2|COMPLETED|Overall Study||62
289619|NCT00834652|699189|P1|COMPLETED|Overall Study||66
289620|NCT00834652|699188|P2|STARTED|Overall Study||102
289621|NCT00834652|699189|P1|STARTED|Overall Study||104
289622|NCT00834639|699197|P2|NOT COMPLETED|Second Intervention||2
289623|NCT00834639|699198|P1|NOT COMPLETED|Second Intervention||0
289624|NCT00834639|699197|P2|COMPLETED|Second Intervention||10
289625|NCT00834639|699198|P1|COMPLETED|Second Intervention||12
289626|NCT00834639|699197|P2|STARTED|Second Intervention||12
289627|NCT00834639|699198|P1|STARTED|Second Intervention||12
289628|NCT00834639|699197|P2|NOT COMPLETED|Washout of 7 Days||0
289629|NCT00834639|699198|P1|NOT COMPLETED|Washout of 7 Days||0
289630|NCT00834639|699197|P2|COMPLETED|Washout of 7 Days||12
289631|NCT00834639|699198|P1|COMPLETED|Washout of 7 Days||12
289632|NCT00834639|699197|P2|STARTED|Washout of 7 Days||12
289633|NCT00834639|699198|P1|STARTED|Washout of 7 Days||12
289634|NCT00834639|699197|P2|NOT COMPLETED|First Intervention||0
289635|NCT00834639|699198|P1|NOT COMPLETED|First Intervention||0
289636|NCT00834639|699197|P2|COMPLETED|First Intervention||12
289637|NCT00834639|699198|P1|COMPLETED|First Intervention||12
289638|NCT00834639|699197|P2|STARTED|First Intervention||12
289639|NCT00834639|699198|P1|STARTED|First Intervention||12
289640|NCT00834626|699206|P1|NOT COMPLETED|Overall Study||0
289641|NCT00834626|699206|P1|COMPLETED|Overall Study||30
289642|NCT00834626|699206|P1|1 Year Follow-up|Overall Study||30
289643|NCT00834626|699206|P1|STARTED|Overall Study||30
289644|NCT00834613|699215|P2|NOT COMPLETED|Second Intervention||0
289645|NCT00834613|699216|P1|NOT COMPLETED|Second Intervention||0
289646|NCT00834613|699215|P2|COMPLETED|Second Intervention||16
289647|NCT00834613|699216|P1|COMPLETED|Second Intervention||15
289648|NCT00834613|699215|P2|STARTED|Second Intervention||16
289649|NCT00834613|699216|P1|STARTED|Second Intervention||15
289650|NCT00834613|699215|P2|NOT COMPLETED|Washout of 7 Days||0
289651|NCT00834613|699216|P1|NOT COMPLETED|Washout of 7 Days||0
289652|NCT00834613|699215|P2|COMPLETED|Washout of 7 Days||16
289653|NCT00834613|699216|P1|COMPLETED|Washout of 7 Days||15
289654|NCT00834613|699215|P2|STARTED|Washout of 7 Days||16
289655|NCT00834613|699216|P1|STARTED|Washout of 7 Days||15
289656|NCT00834613|699215|P2|NOT COMPLETED|First Intervention||0
289657|NCT00834613|699216|P1|NOT COMPLETED|First Intervention||1
289658|NCT00834613|699215|P2|COMPLETED|First Intervention||16
289659|NCT00834613|699216|P1|COMPLETED|First Intervention||15
289660|NCT00834613|699215|P2|STARTED|First Intervention||16
289661|NCT00834613|699216|P1|STARTED|First Intervention||16
289662|NCT00834587|699226|P2|NOT COMPLETED|Second Intervention||0
289663|NCT00834587|699227|P1|NOT COMPLETED|Second Intervention||0
289664|NCT00834587|699226|P2|COMPLETED|Second Intervention||20
289665|NCT00834587|699227|P1|COMPLETED|Second Intervention||19
289666|NCT00834587|699226|P2|STARTED|Second Intervention||20
289667|NCT00834587|699227|P1|STARTED|Second Intervention||19
289668|NCT00834587|699226|P2|NOT COMPLETED|Washout: 7 Days||0
289669|NCT00834587|699227|P1|NOT COMPLETED|Washout: 7 Days||1
289670|NCT00834587|699226|P2|COMPLETED|Washout: 7 Days||20
289671|NCT00834587|699227|P1|COMPLETED|Washout: 7 Days||19
289672|NCT00834587|699226|P2|STARTED|Washout: 7 Days||20
289673|NCT00834587|699227|P1|STARTED|Washout: 7 Days||20
289674|NCT00834587|699226|P2|NOT COMPLETED|First Intervention||0
289675|NCT00834587|699227|P1|NOT COMPLETED|First Intervention||0
289676|NCT00834587|699226|P2|COMPLETED|First Intervention||20
289677|NCT00834587|699227|P1|COMPLETED|First Intervention||20
289678|NCT00834587|699226|P2|STARTED|First Intervention||20
289679|NCT00834587|699227|P1|STARTED|First Intervention||20
289680|NCT00834574|699243|P2|NOT COMPLETED|Second Intervention||0
289681|NCT00834574|699244|P1|NOT COMPLETED|Second Intervention||0
289682|NCT00834574|699243|P2|COMPLETED|Second Intervention||16
289683|NCT00834574|699244|P1|COMPLETED|Second Intervention||16
289684|NCT00834574|699243|P2|STARTED|Second Intervention||16
289685|NCT00834574|699244|P1|STARTED|Second Intervention||16
289686|NCT00834574|699243|P2|NOT COMPLETED|Washout of 7 Days||0
289687|NCT00834574|699244|P1|NOT COMPLETED|Washout of 7 Days||0
289688|NCT00834574|699243|P2|COMPLETED|Washout of 7 Days||16
289689|NCT00834574|699244|P1|COMPLETED|Washout of 7 Days||16
289690|NCT00834574|699243|P2|STARTED|Washout of 7 Days||16
289691|NCT00834574|699244|P1|STARTED|Washout of 7 Days||16
289692|NCT00834574|699243|P2|NOT COMPLETED|First Intervention||0
289693|NCT00834574|699244|P1|NOT COMPLETED|First Intervention||0
289694|NCT00834574|699243|P2|COMPLETED|First Intervention||16
289695|NCT00834574|699244|P1|COMPLETED|First Intervention||16
289696|NCT00834574|699243|P2|STARTED|First Intervention||16
289697|NCT00834574|699244|P1|STARTED|First Intervention||16
289698|NCT00834561|699254|P2|NOT COMPLETED|Second Intervention||0
289699|NCT00834561|699255|P1|NOT COMPLETED|Second Intervention||0
289700|NCT00834561|699254|P2|COMPLETED|Second Intervention||16
289701|NCT00834561|699255|P1|COMPLETED|Second Intervention||16
289702|NCT00834561|699254|P2|STARTED|Second Intervention||16
289703|NCT00834561|699255|P1|STARTED|Second Intervention||16
289704|NCT00834561|699254|P2|NOT COMPLETED|First Intervention||0
289705|NCT00834561|699255|P1|NOT COMPLETED|First Intervention||0
289706|NCT00834561|699254|P2|COMPLETED|First Intervention||16
289707|NCT00834561|699255|P1|COMPLETED|First Intervention||16
289708|NCT00834561|699254|P2|STARTED|First Intervention||16
289709|NCT00834561|699255|P1|STARTED|First Intervention||16
289710|NCT00834535|699265|P2|NOT COMPLETED|Second Intervention||0
289711|NCT00834535|699266|P1|NOT COMPLETED|Second Intervention||0
289712|NCT00834535|699265|P2|COMPLETED|Second Intervention||16
289713|NCT00834535|699266|P1|COMPLETED|Second Intervention||16
289714|NCT00834535|699265|P2|STARTED|Second Intervention||16
289715|NCT00834535|699266|P1|STARTED|Second Intervention||16
289716|NCT00834535|699265|P2|NOT COMPLETED|Washout of 7 Days||0
289717|NCT00834535|699266|P1|NOT COMPLETED|Washout of 7 Days||0
289718|NCT00834535|699265|P2|COMPLETED|Washout of 7 Days||16
289719|NCT00834535|699266|P1|COMPLETED|Washout of 7 Days||16
289720|NCT00834535|699265|P2|STARTED|Washout of 7 Days||16
289721|NCT00834535|699266|P1|STARTED|Washout of 7 Days||16
289722|NCT00834535|699265|P2|NOT COMPLETED|First Intervention||0
289723|NCT00834535|699266|P1|NOT COMPLETED|First Intervention||0
289724|NCT00834535|699265|P2|COMPLETED|First Intervention||16
289725|NCT00834535|699266|P1|COMPLETED|First Intervention||16
289726|NCT00834535|699265|P2|STARTED|First Intervention||16
289727|NCT00834535|699266|P1|STARTED|First Intervention||16
289728|NCT00834522|699276|P2|NOT COMPLETED|Second Intervention||0
289729|NCT00834522|699277|P1|NOT COMPLETED|Second Intervention||0
289730|NCT00834522|699276|P2|COMPLETED|Second Intervention||39
289731|NCT00834522|699277|P1|COMPLETED|Second Intervention||37
289732|NCT00834522|699276|P2|STARTED|Second Intervention||39
289733|NCT00834522|699277|P1|STARTED|Second Intervention||37
289734|NCT00834522|699276|P2|NOT COMPLETED|Washout||1
289735|NCT00834522|699277|P1|NOT COMPLETED|Washout||3
289736|NCT00834522|699276|P2|COMPLETED|Washout||39
289737|NCT00834522|699277|P1|COMPLETED|Washout||37
289738|NCT00834522|699276|P2|STARTED|Washout||40
289739|NCT00834522|699277|P1|STARTED|Washout||40
289740|NCT00834522|699276|P2|NOT COMPLETED|First Intervention||0
289741|NCT00834522|699277|P1|NOT COMPLETED|First Intervention||0
289742|NCT00834522|699276|P2|COMPLETED|First Intervention||40
289743|NCT00834522|699277|P1|COMPLETED|First Intervention||40
289744|NCT00834522|699276|P2|STARTED|First Intervention||40
289745|NCT00834522|699277|P1|STARTED|First Intervention||40
289746|NCT00834483|699287|P2|NOT COMPLETED|Overall Study||0
289747|NCT00834483|699288|P1|NOT COMPLETED|Overall Study||0
289748|NCT00834483|699287|P2|COMPLETED|Overall Study||29
289749|NCT00834483|699288|P1|COMPLETED|Overall Study||31
289750|NCT00834483|699287|P2|STARTED|Overall Study||29
289751|NCT00834483|699288|P1|STARTED|Overall Study||31
289752|NCT00834444|699300|P2|NOT COMPLETED|Second Intervention||0
289753|NCT00834444|699301|P1|NOT COMPLETED|Second Intervention||1
289754|NCT00834444|699300|P2|COMPLETED|Second Intervention||16
289755|NCT00834444|699301|P1|COMPLETED|Second Intervention||16
289756|NCT00834444|699300|P2|STARTED|Second Intervention||16
289757|NCT00834444|699301|P1|STARTED|Second Intervention||17
289758|NCT00834444|699300|P2|NOT COMPLETED|Washout of 7 Days||1
289759|NCT00834444|699301|P1|NOT COMPLETED|Washout of 7 Days||0
289760|NCT00834444|699300|P2|COMPLETED|Washout of 7 Days||16
289761|NCT00834444|699301|P1|COMPLETED|Washout of 7 Days||17
289762|NCT00834444|699300|P2|STARTED|Washout of 7 Days||17
289763|NCT00834444|699301|P1|STARTED|Washout of 7 Days||17
289764|NCT00834444|699300|P2|NOT COMPLETED|First Intervention||1
289765|NCT00834444|699301|P1|NOT COMPLETED|First Intervention||1
289766|NCT00834444|699300|P2|COMPLETED|First Intervention||17
289767|NCT00834444|699301|P1|COMPLETED|First Intervention||17
289768|NCT00834444|699300|P2|STARTED|First Intervention||18
289769|NCT00834444|699301|P1|STARTED|First Intervention||18
289770|NCT00834431|699311|P2|NOT COMPLETED|Second Intervention||0
289771|NCT00834431|699312|P1|NOT COMPLETED|Second Intervention||0
289772|NCT00834431|699311|P2|COMPLETED|Second Intervention||16
289773|NCT00834431|699312|P1|COMPLETED|Second Intervention||18
289774|NCT00834431|699311|P2|STARTED|Second Intervention||16
289775|NCT00834431|699312|P1|STARTED|Second Intervention||18
289776|NCT00834431|699311|P2|NOT COMPLETED|Washout of 7 Days||1
289777|NCT00834431|699312|P1|NOT COMPLETED|Washout of 7 Days||0
289778|NCT00834431|699311|P2|COMPLETED|Washout of 7 Days||16
289779|NCT00834431|699312|P1|COMPLETED|Washout of 7 Days||18
289780|NCT00834431|699311|P2|STARTED|Washout of 7 Days||17
289781|NCT00834431|699312|P1|STARTED|Washout of 7 Days||18
289782|NCT00834431|699311|P2|NOT COMPLETED|First Intervention||1
289783|NCT00834431|699312|P1|NOT COMPLETED|First Intervention||0
289784|NCT00834431|699311|P2|COMPLETED|First Intervention||17
289785|NCT00834431|699312|P1|COMPLETED|First Intervention||18
289786|NCT00834431|699311|P2|STARTED|First Intervention||18
289787|NCT00834431|699312|P1|STARTED|First Intervention||18
289788|NCT00834418|699322|P2|NOT COMPLETED|Overall Study||2
289789|NCT00834418|699323|P1|NOT COMPLETED|Overall Study||0
289790|NCT00834418|699322|P2|COMPLETED|Overall Study||40
289791|NCT00834418|699323|P1|COMPLETED|Overall Study||42
289792|NCT00834418|699322|P2|STARTED|Overall Study||42
289793|NCT00834418|699323|P1|STARTED|Overall Study||42
289794|NCT00834405|699331|P2|NOT COMPLETED|Overall Study||0
289795|NCT00834405|699332|P1|NOT COMPLETED|Overall Study||0
289796|NCT00834405|699331|P2|COMPLETED|Overall Study||17
289797|NCT00834405|699332|P1|COMPLETED|Overall Study||20
289798|NCT00834405|699331|P2|STARTED|Overall Study||17
289799|NCT00834405|699332|P1|STARTED|Overall Study||20
289800|NCT00834366|699340|P2|NOT COMPLETED|Treatment Period 2||0
289801|NCT00834366|699341|P1|NOT COMPLETED|Treatment Period 2||0
289802|NCT00834366|699340|P2|COMPLETED|Treatment Period 2||12
289803|NCT00834366|699341|P1|COMPLETED|Treatment Period 2||12
289804|NCT00834366|699340|P2|STARTED|Treatment Period 2||12
289805|NCT00834366|699341|P1|STARTED|Treatment Period 2||12
289806|NCT00834366|699340|P2|NOT COMPLETED|Treatment Period 1||1
289807|NCT00834366|699341|P1|NOT COMPLETED|Treatment Period 1||1
289808|NCT00834366|699340|P2|COMPLETED|Treatment Period 1||12
289809|NCT00834366|699341|P1|COMPLETED|Treatment Period 1||12
289810|NCT00834366|699340|P2|STARTED|Treatment Period 1||13
289811|NCT00834366|699341|P1|STARTED|Treatment Period 1||13
289812|NCT00834340|699357|P2|NOT COMPLETED|Second Intervention||0
289813|NCT00834340|699358|P1|NOT COMPLETED|Second Intervention||0
289814|NCT00834340|699357|P2|COMPLETED|Second Intervention||16
289815|NCT00834340|699358|P1|COMPLETED|Second Intervention||14
289816|NCT00834340|699357|P2|STARTED|Second Intervention||16
289817|NCT00834340|699358|P1|STARTED|Second Intervention||14
289818|NCT00834340|699357|P2|NOT COMPLETED|Washout||0
289819|NCT00834340|699358|P1|NOT COMPLETED|Washout||2
289820|NCT00834340|699357|P2|COMPLETED|Washout||16
289821|NCT00834340|699358|P1|COMPLETED|Washout||14
289822|NCT00834340|699357|P2|STARTED|Washout||16
289823|NCT00834340|699358|P1|STARTED|Washout||16
289824|NCT00834340|699357|P2|NOT COMPLETED|First Intervention||0
289825|NCT00834340|699358|P1|NOT COMPLETED|First Intervention||0
289826|NCT00834340|699357|P2|COMPLETED|First Intervention||16
289827|NCT00834340|699358|P1|COMPLETED|First Intervention||16
289828|NCT00834340|699357|P2|STARTED|First Intervention||16
289829|NCT00834340|699358|P1|STARTED|First Intervention||16
289830|NCT00834288|699368|P2|NOT COMPLETED|Treatment Phase II||0
289831|NCT00834288|699369|P1|NOT COMPLETED|Treatment Phase II||0
289832|NCT00834288|699368|P2|COMPLETED|Treatment Phase II||13
289833|NCT00834288|699369|P1|COMPLETED|Treatment Phase II||13
289834|NCT00834288|699368|P2|STARTED|Treatment Phase II||13
289835|NCT00834288|699369|P1|STARTED|Treatment Phase II||13
289836|NCT00834288|699368|P2|NOT COMPLETED|Treatment Phase I||0
289837|NCT00834288|699369|P1|NOT COMPLETED|Treatment Phase I||0
289838|NCT00834288|699368|P2|COMPLETED|Treatment Phase I||13
289839|NCT00834288|699369|P1|COMPLETED|Treatment Phase I||13
289840|NCT00834288|699368|P2|STARTED|Treatment Phase I||13
289841|NCT00834288|699369|P1|STARTED|Treatment Phase I||13
289842|NCT00834275|699391|P2|NOT COMPLETED|Second Intervention||0
289843|NCT00834275|699392|P1|NOT COMPLETED|Second Intervention||0
289844|NCT00834275|699391|P2|COMPLETED|Second Intervention||13
289845|NCT00834275|699392|P1|COMPLETED|Second Intervention||13
289846|NCT00834275|699391|P2|STARTED|Second Intervention||13
289847|NCT00834275|699392|P1|STARTED|Second Intervention||13
289848|NCT00834275|699391|P2|NOT COMPLETED|Washout of 7 Days||0
289849|NCT00834275|699392|P1|NOT COMPLETED|Washout of 7 Days||0
289850|NCT00834275|699391|P2|COMPLETED|Washout of 7 Days||13
289851|NCT00834275|699392|P1|COMPLETED|Washout of 7 Days||13
289852|NCT00834275|699391|P2|STARTED|Washout of 7 Days||13
289853|NCT00834275|699392|P1|STARTED|Washout of 7 Days||13
289854|NCT00834275|699391|P2|NOT COMPLETED|First Intervention||0
289855|NCT00834275|699392|P1|NOT COMPLETED|First Intervention||0
289856|NCT00834275|699391|P2|COMPLETED|First Intervention||13
289857|NCT00834275|699392|P1|COMPLETED|First Intervention||13
289858|NCT00834275|699391|P2|STARTED|First Intervention||13
289859|NCT00834275|699392|P1|STARTED|First Intervention||13
289860|NCT00834249|699402|P2|NOT COMPLETED|Second Intervention||0
289861|NCT00834249|699403|P1|NOT COMPLETED|Second Intervention||1
289862|NCT00834249|699402|P2|COMPLETED|Second Intervention||8
289863|NCT00834249|699403|P1|COMPLETED|Second Intervention||7
289864|NCT00834249|699402|P2|STARTED|Second Intervention||8
289865|NCT00834249|699403|P1|STARTED|Second Intervention||8
289866|NCT00834249|699402|P2|NOT COMPLETED|Washout: 7 Days||1
289867|NCT00834249|699403|P1|NOT COMPLETED|Washout: 7 Days||1
289868|NCT00834249|699402|P2|COMPLETED|Washout: 7 Days||8
289869|NCT00834249|699403|P1|COMPLETED|Washout: 7 Days||8
289870|NCT00834249|699402|P2|STARTED|Washout: 7 Days||9
289871|NCT00834249|699403|P1|STARTED|Washout: 7 Days||9
289872|NCT00834249|699402|P2|NOT COMPLETED|First Intervention||0
289873|NCT00834249|699403|P1|NOT COMPLETED|First Intervention||0
289874|NCT00834249|699402|P2|COMPLETED|First Intervention||9
289875|NCT00834249|699403|P1|COMPLETED|First Intervention||9
289876|NCT00834249|699402|P2|STARTED|First Intervention||9
289877|NCT00834249|699403|P1|STARTED|First Intervention||9
289878|NCT00834236|699419|P2|NOT COMPLETED|Overall Study||0
289879|NCT00834236|699420|P1|NOT COMPLETED|Overall Study||0
289880|NCT00834236|699419|P2|COMPLETED|Overall Study||47
289881|NCT00834236|699420|P1|COMPLETED|Overall Study||29
289882|NCT00834236|699419|P2|STARTED|Overall Study||47
289883|NCT00834236|699420|P1|STARTED|Overall Study||29
289884|NCT00834210|699428|P2|NOT COMPLETED|Overall Study||8
289885|NCT00834210|699429|P1|NOT COMPLETED|Overall Study||3
289886|NCT00834210|699428|P2|COMPLETED|Overall Study||77
289887|NCT00834210|699429|P1|COMPLETED|Overall Study||83
289888|NCT00834210|699428|P2|STARTED|Overall Study||85
289889|NCT00834210|699429|P1|STARTED|Overall Study||86
289890|NCT00834197|699443|P2|NOT COMPLETED|Second Intervention||0
289891|NCT00834197|699444|P1|NOT COMPLETED|Second Intervention||0
289892|NCT00834197|699443|P2|COMPLETED|Second Intervention||16
289893|NCT00834197|699444|P1|COMPLETED|Second Intervention||16
289894|NCT00834197|699443|P2|STARTED|Second Intervention||16
289895|NCT00834197|699444|P1|STARTED|Second Intervention||16
289896|NCT00834197|699443|P2|NOT COMPLETED|Washout of 14 Days||0
289897|NCT00834197|699444|P1|NOT COMPLETED|Washout of 14 Days||0
289898|NCT00834197|699443|P2|COMPLETED|Washout of 14 Days||16
289899|NCT00834197|699444|P1|COMPLETED|Washout of 14 Days||16
289900|NCT00834197|699443|P2|STARTED|Washout of 14 Days||16
289901|NCT00834197|699444|P1|STARTED|Washout of 14 Days||16
289902|NCT00834197|699443|P2|NOT COMPLETED|First Intervention||0
289903|NCT00834197|699444|P1|NOT COMPLETED|First Intervention||0
289904|NCT00834197|699443|P2|COMPLETED|First Intervention||16
289905|NCT00834197|699444|P1|COMPLETED|First Intervention||16
289906|NCT00834197|699443|P2|STARTED|First Intervention||16
289907|NCT00834197|699444|P1|STARTED|First Intervention||16
289908|NCT00834171|699454|P2|NOT COMPLETED|Overall Study||0
289909|NCT00834171|699455|P1|NOT COMPLETED|Overall Study||0
289910|NCT00834171|699454|P2|COMPLETED|Overall Study||7
289911|NCT00834171|699455|P1|COMPLETED|Overall Study||43
289912|NCT00834171|699454|P2|STARTED|Overall Study||7
289913|NCT00834171|699455|P1|STARTED|Overall Study||43
289914|NCT00834132|699463|P2|NOT COMPLETED|Second Intervention||0
289915|NCT00834132|699464|P1|NOT COMPLETED|Second Intervention||0
289916|NCT00834132|699463|P2|COMPLETED|Second Intervention||12
289917|NCT00834132|699464|P1|COMPLETED|Second Intervention||12
289918|NCT00834132|699463|P2|STARTED|Second Intervention||12
289919|NCT00834132|699464|P1|STARTED|Second Intervention||12
289920|NCT00834132|699463|P2|NOT COMPLETED|Washout: 21 Days||0
289921|NCT00834132|699464|P1|NOT COMPLETED|Washout: 21 Days||0
289922|NCT00834132|699463|P2|COMPLETED|Washout: 21 Days||12
289923|NCT00834132|699464|P1|COMPLETED|Washout: 21 Days||12
289924|NCT00834132|699463|P2|STARTED|Washout: 21 Days||12
289925|NCT00834132|699464|P1|STARTED|Washout: 21 Days||12
289926|NCT00834132|699463|P2|NOT COMPLETED|First Intervention||0
289927|NCT00834132|699464|P1|NOT COMPLETED|First Intervention||0
289928|NCT00834132|699463|P2|COMPLETED|First Intervention||12
289929|NCT00834132|699464|P1|COMPLETED|First Intervention||12
289930|NCT00834132|699463|P2|STARTED|First Intervention||12
289931|NCT00834132|699464|P1|STARTED|First Intervention||12
289932|NCT00834106|699474|P2|NOT COMPLETED|Extension Study (Month 42 to Month 90)||74
289933|NCT00834106|699475|P1|NOT COMPLETED|Extension Study (Month 42 to Month 90)||96
289934|NCT00834106|699474|P2|COMPLETED|Extension Study (Month 42 to Month 90)||1294
289935|NCT00834106|699475|P1|COMPLETED|Extension Study (Month 42 to Month 90)||1308
289936|NCT00834106|699474|P2|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1368
289937|NCT00834106|699475|P1|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1404
289938|NCT00834106|699474|P2|NOT COMPLETED|Base Study (Day 1 to Month 30)||145
289939|NCT00834106|699475|P1|NOT COMPLETED|Base Study (Day 1 to Month 30)||102
289940|NCT00834106|699474|P2|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1358
289941|NCT00834106|699475|P1|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1401
289942|NCT00834106|699474|P2|Completed Vaccinations|Base Study (Day 1 to Month 30)||1463
289943|NCT00834106|699475|P1|Completed Vaccinations|Base Study (Day 1 to Month 30)||1473
289944|NCT00834106|699474|P2|Vaccinated|Base Study (Day 1 to Month 30)||1503
289945|NCT00834106|699475|P1|Vaccinated|Base Study (Day 1 to Month 30)||1503
289946|NCT00834106|699474|P2|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
289947|NCT00834106|699475|P1|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
289948|NCT00834080|699499|P1|NOT COMPLETED|Overall Study||23
289949|NCT00834080|699499|P1|COMPLETED|Overall Study||15
289950|NCT00834080|699499|P1|STARTED|Overall Study||38
289951|NCT00834067|699505|P2|NOT COMPLETED|Second Intervention||0
289952|NCT00834067|699506|P1|NOT COMPLETED|Second Intervention||0
289953|NCT00834067|699505|P2|COMPLETED|Second Intervention||29
289954|NCT00834067|699506|P1|COMPLETED|Second Intervention||30
289955|NCT00834067|699505|P2|STARTED|Second Intervention||29
289956|NCT00834067|699506|P1|STARTED|Second Intervention||30
289957|NCT00834067|699505|P2|NOT COMPLETED|Washout of 21 Days||1
289958|NCT00834067|699506|P1|NOT COMPLETED|Washout of 21 Days||0
289959|NCT00834067|699505|P2|COMPLETED|Washout of 21 Days||29
289960|NCT00834067|699506|P1|COMPLETED|Washout of 21 Days||30
289961|NCT00834067|699505|P2|STARTED|Washout of 21 Days||30
289962|NCT00834067|699506|P1|STARTED|Washout of 21 Days||30
289963|NCT00834067|699505|P2|NOT COMPLETED|First Intervention||0
289964|NCT00834067|699506|P1|NOT COMPLETED|First Intervention||0
289965|NCT00834067|699505|P2|COMPLETED|First Intervention||30
289966|NCT00834067|699506|P1|COMPLETED|First Intervention||30
289967|NCT00834067|699505|P2|STARTED|First Intervention||30
289968|NCT00834067|699506|P1|STARTED|First Intervention||30
289969|NCT00834041|699528|P2|NOT COMPLETED|Overall Study||1
289970|NCT00834041|699529|P1|NOT COMPLETED|Overall Study||1
289971|NCT00834041|699528|P2|COMPLETED|Overall Study||19
289972|NCT00834041|699529|P1|COMPLETED|Overall Study||18
289973|NCT00834041|699528|P2|STARTED|Overall Study||20
289974|NCT00834041|699529|P1|STARTED|Overall Study||19
289975|NCT00833989|699547|P4|NOT COMPLETED|Overall Study||2
289976|NCT00833989|699548|P3|NOT COMPLETED|Overall Study||1
289977|NCT00833989|699549|P2|NOT COMPLETED|Overall Study||0
289978|NCT00833989|699550|P1|NOT COMPLETED|Overall Study||3
289979|NCT00833989|699547|P4|COMPLETED|Overall Study||6
289980|NCT00833989|699548|P3|COMPLETED|Overall Study||8
289981|NCT00833989|699549|P2|COMPLETED|Overall Study||8
289982|NCT00833989|699550|P1|COMPLETED|Overall Study||14
289983|NCT00833989|699547|P4|STARTED|Overall Study||8
289984|NCT00833989|699548|P3|STARTED|Overall Study||9
289985|NCT00833989|699549|P2|STARTED|Overall Study||8
289986|NCT00833989|699550|P1|STARTED|Overall Study||17
289987|NCT00833976|699654|P1|NOT COMPLETED|Overall Study||51
289988|NCT00833976|699654|P1|COMPLETED|Overall Study||14
289989|NCT00833976|699654|P1|STARTED|Overall Study||65
289990|NCT00833937|699662|P2|NOT COMPLETED|Second Intervention||0
289991|NCT00833937|699663|P1|NOT COMPLETED|Second Intervention||0
289992|NCT00833937|699662|P2|COMPLETED|Second Intervention||12
289993|NCT00833937|699663|P1|COMPLETED|Second Intervention||11
289994|NCT00833937|699662|P2|STARTED|Second Intervention||12
289995|NCT00833937|699663|P1|STARTED|Second Intervention||11
289996|NCT00833937|699662|P2|NOT COMPLETED|Washout||0
289997|NCT00833937|699663|P1|NOT COMPLETED|Washout||1
289998|NCT00833937|699662|P2|COMPLETED|Washout||12
289999|NCT00833937|699663|P1|COMPLETED|Washout||11
290000|NCT00833937|699662|P2|STARTED|Washout||12
290001|NCT00833937|699663|P1|STARTED|Washout||12
290002|NCT00833937|699662|P2|NOT COMPLETED|First Intervention||0
290003|NCT00833937|699663|P1|NOT COMPLETED|First Intervention||0
290004|NCT00833937|699662|P2|COMPLETED|First Intervention||12
290005|NCT00833937|699663|P1|COMPLETED|First Intervention||12
290006|NCT00833937|699662|P2|STARTED|First Intervention||12
290007|NCT00833937|699663|P1|STARTED|First Intervention||12
290008|NCT00833924|699671|P1|NOT COMPLETED|Overall Study||109
290009|NCT00833924|699671|P1|COMPLETED|Overall Study||11
290010|NCT00833924|699671|P1|12-month|Overall Study||113
290011|NCT00833924|699671|P1|30-day|Overall Study||120
290012|NCT00833924|699671|P1|STARTED|Overall Study||120
290013|NCT00833911|699676|P1|NOT COMPLETED|Maintenance Phase II||10
290014|NCT00833911|699676|P1|COMPLETED|Maintenance Phase II||166
290015|NCT00833911|699676|P1|STARTED|Maintenance Phase II|97 patients chose not to continue into Maintenance Phase II|176
290016|NCT00833911|699676|P1|NOT COMPLETED|Maintenance Phase I||98
290017|NCT00833911|699676|P1|COMPLETED|Maintenance Phase I||273
290018|NCT00833911|699676|P1|STARTED|Maintenance Phase I||371
290019|NCT00833911|699676|P1|NOT COMPLETED|Titration||21
290020|NCT00833911|699676|P1|COMPLETED|Titration||371
290021|NCT00833911|699676|P1|STARTED|Titration||392
290022|NCT00833898|699686|P2|NOT COMPLETED|Overall Study||36
290023|NCT00833898|699687|P1|NOT COMPLETED|Overall Study||40
290024|NCT00833898|699686|P2|COMPLETED|Overall Study||38
290025|NCT00833898|699687|P1|COMPLETED|Overall Study||34
290026|NCT00833898|699686|P2|Month 12 (Post Transplantation)|Overall Study||50
290027|NCT00833898|699687|P1|Month 12 (Post Transplantation)|Overall Study||50
290028|NCT00833898|699686|P2|Month 6 (Post Transplantation)|Overall Study||54
290029|NCT00833898|699687|P1|Month 6 (Post Transplantation)|Overall Study||59
290030|NCT00833898|699686|P2|Month 3 (Post Transplantation)|Overall Study||64
290031|NCT00833898|699687|P1|Month 3 (Post Transplantation)|Overall Study||66
290032|NCT00833898|699686|P2|Month 1 (Post Transplantation)|Overall Study||74
290033|NCT00833898|699687|P1|Month 1 (Post Transplantation)|Overall Study||72
290034|NCT00833898|699686|P2|STARTED|Overall Study||74
290035|NCT00833898|699687|P1|STARTED|Overall Study||74
290036|NCT00833859|699733|P1|NOT COMPLETED|Overall Study||0
290037|NCT00833859|699733|P1|COMPLETED|Overall Study||2
290038|NCT00833859|699733|P1|STARTED|Overall Study||2
290039|NCT00833833|699746|P6|NOT COMPLETED|Phase 2 (as of 01 April 2011)||61
290040|NCT00833833|699747|P5|NOT COMPLETED|Phase 2 (as of 01 April 2011)||55
290041|NCT00833833|699748|P4|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
290042|NCT00833833|699749|P3|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
290043|NCT00833833|699750|P2|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
290044|NCT00833833|699751|P1|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
290045|NCT00833833|699746|P6|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|47
290046|NCT00833833|699747|P5|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|58
290047|NCT00833833|699748|P4|COMPLETED|Phase 2 (as of 01 April 2011)||0
290048|NCT00833833|699749|P3|COMPLETED|Phase 2 (as of 01 April 2011)||0
290049|NCT00833833|699750|P2|COMPLETED|Phase 2 (as of 01 April 2011)||0
290050|NCT00833833|699751|P1|COMPLETED|Phase 2 (as of 01 April 2011)||0
290051|NCT00833833|699746|P6|Safety Population|Phase 2 (as of 01 April 2011)||107
290052|NCT00833833|699747|P5|Safety Population|Phase 2 (as of 01 April 2011)||112
290053|NCT00833833|699748|P4|Safety Population|Phase 2 (as of 01 April 2011)||0
290054|NCT00833833|699749|P3|Safety Population|Phase 2 (as of 01 April 2011)||0
290055|NCT00833833|699750|P2|Safety Population|Phase 2 (as of 01 April 2011)||0
290056|NCT00833833|699751|P1|Safety Population|Phase 2 (as of 01 April 2011)||0
290057|NCT00833833|699746|P6|STARTED|Phase 2 (as of 01 April 2011)||108
290058|NCT00833833|699747|P5|STARTED|Phase 2 (as of 01 April 2011)||113
290059|NCT00833833|699748|P4|STARTED|Phase 2 (as of 01 April 2011)||0
290060|NCT00833833|699749|P3|STARTED|Phase 2 (as of 01 April 2011)||0
290061|NCT00833833|699750|P2|STARTED|Phase 2 (as of 01 April 2011)||0
290062|NCT00833833|699751|P1|STARTED|Phase 2 (as of 01 April 2011)||0
290063|NCT00833833|699746|P6|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
290064|NCT00833833|699747|P5|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
290065|NCT00833833|699748|P4|NOT COMPLETED|Phase 1 (as of 01 April 2011)||6
290066|NCT00833833|699749|P3|NOT COMPLETED|Phase 1 (as of 01 April 2011)||9
290067|NCT00833833|699750|P2|NOT COMPLETED|Phase 1 (as of 01 April 2011)||5
290068|NCT00833833|699751|P1|NOT COMPLETED|Phase 1 (as of 01 April 2011)||4
290069|NCT00833833|699746|P6|COMPLETED|Phase 1 (as of 01 April 2011)||0
290070|NCT00833833|699747|P5|COMPLETED|Phase 1 (as of 01 April 2011)||0
290071|NCT00833833|699748|P4|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|4
290072|NCT00833833|699749|P3|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|5
290073|NCT00833833|699750|P2|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|3
290074|NCT00833833|699751|P1|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|2
290075|NCT00833833|699746|P6|STARTED|Phase 1 (as of 01 April 2011)||0
290076|NCT00833833|699747|P5|STARTED|Phase 1 (as of 01 April 2011)||0
290077|NCT00833833|699748|P4|STARTED|Phase 1 (as of 01 April 2011)||10
290078|NCT00833833|699749|P3|STARTED|Phase 1 (as of 01 April 2011)||14
290079|NCT00833833|699750|P2|STARTED|Phase 1 (as of 01 April 2011)||8
290080|NCT00833833|699751|P1|STARTED|Phase 1 (as of 01 April 2011)||6
290081|NCT00833794|699791|P2|NOT COMPLETED|Double-blind Phase||49
290082|NCT00833794|699792|P1|NOT COMPLETED|Double-blind Phase||106
290083|NCT00833794|699791|P2|COMPLETED|Double-blind Phase||165
290084|NCT00833794|699792|P1|COMPLETED|Double-blind Phase||326
290085|NCT00833794|699791|P2|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 214 were randomized to Placebo|214
290086|NCT00833794|699792|P1|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 432 were randomized to Tramadol Once A Day|432
290087|NCT00833794|699791|P2|NOT COMPLETED|Open-label Phase||0
290088|NCT00833794|699792|P1|NOT COMPLETED|Open-label Phase||382
290089|NCT00833794|699791|P2|COMPLETED|Open-label Phase||0
290090|NCT00833794|699792|P1|COMPLETED|Open-label Phase|Randomized in double-blind phase|646
290091|NCT00833794|699791|P2|Received Open-Label Treatment|Open-label Phase||0
290092|NCT00833794|699792|P1|Received Open-Label Treatment|Open-label Phase||1023
290093|NCT00833794|699791|P2|Entered run-in Period|Open-label Phase||0
290094|NCT00833794|699792|P1|Entered run-in Period|Open-label Phase||1027
290095|NCT00833794|699791|P2|STARTED|Open-label Phase|No Placebo arm during open-label phase.|0
290096|NCT00833794|699792|P1|STARTED|Open-label Phase|Enrolled. Population described in the baseline characteristics is 1023 patients (Open-Label safety).|1028
290097|NCT00833781|699820|P2|NOT COMPLETED|Overall Study||0
290098|NCT00833781|699821|P1|NOT COMPLETED|Overall Study||0
290099|NCT00833781|699820|P2|COMPLETED|Overall Study||5
290100|NCT00833781|699821|P1|COMPLETED|Overall Study||10
290101|NCT00833781|699820|P2|STARTED|Overall Study||5
290102|NCT00833781|699821|P1|STARTED|Overall Study||10
290103|NCT00833755|699836|P4|NOT COMPLETED|Overall Study||6
290104|NCT00833755|699837|P3|NOT COMPLETED|Overall Study||2
290105|NCT00833755|699838|P2|NOT COMPLETED|Overall Study||5
290106|NCT00833755|699839|P1|NOT COMPLETED|Overall Study||4
290107|NCT00833755|699836|P4|COMPLETED|Overall Study||17
290108|NCT00833755|699837|P3|COMPLETED|Overall Study||20
290109|NCT00833755|699838|P2|COMPLETED|Overall Study||13
290110|NCT00833755|699839|P1|COMPLETED|Overall Study||12
290111|NCT00833755|699836|P4|STARTED|Overall Study||23
290112|NCT00833755|699837|P3|STARTED|Overall Study||22
290113|NCT00833755|699838|P2|STARTED|Overall Study||18
290114|NCT00833755|699839|P1|STARTED|Overall Study||16
290115|NCT00833703|699859|P2|NOT COMPLETED|Overall Study||1
290116|NCT00833703|699860|P1|NOT COMPLETED|Overall Study||0
290117|NCT00833703|699859|P2|COMPLETED|Overall Study|Completed follow-up|25
290118|NCT00833703|699860|P1|COMPLETED|Overall Study|Completed follow-up|23
290119|NCT00833703|699859|P2|Completed Treatment|Overall Study||24
290120|NCT00833703|699860|P1|Completed Treatment|Overall Study||22
290121|NCT00833703|699859|P2|Treated|Overall Study||26
290122|NCT00833703|699860|P1|Treated|Overall Study||23
290123|NCT00833703|699859|P2|STARTED|Overall Study|Included|26
290124|NCT00833703|699860|P1|STARTED|Overall Study|Included|23
290125|NCT00833690|699873|P3|NOT COMPLETED|Overall Study||0
290126|NCT00833690|699874|P2|NOT COMPLETED|Overall Study||2
290127|NCT00833690|699875|P1|NOT COMPLETED|Overall Study||4
290128|NCT00833690|699873|P3|COMPLETED|Overall Study||26
290129|NCT00833690|699874|P2|COMPLETED|Overall Study||22
290130|NCT00833690|699875|P1|COMPLETED|Overall Study||21
290131|NCT00833690|699873|P3|STARTED|Overall Study||26
290132|NCT00833690|699874|P2|STARTED|Overall Study||24
290133|NCT00833690|699875|P1|STARTED|Overall Study||25
290134|NCT00833664|699999|P2|NOT COMPLETED|Second Intervention||0
290135|NCT00833664|700000|P1|NOT COMPLETED|Second Intervention||0
290136|NCT00833664|699999|P2|COMPLETED|Second Intervention||11
290137|NCT00833664|700000|P1|COMPLETED|Second Intervention||10
290138|NCT00833664|699999|P2|STARTED|Second Intervention||11
290139|NCT00833664|700000|P1|STARTED|Second Intervention||10
290140|NCT00833664|699999|P2|NOT COMPLETED|Washout: 14 Days||0
290141|NCT00833664|700000|P1|NOT COMPLETED|Washout: 14 Days||1
290142|NCT00833664|699999|P2|COMPLETED|Washout: 14 Days||11
290143|NCT00833664|700000|P1|COMPLETED|Washout: 14 Days||10
290144|NCT00833664|699999|P2|STARTED|Washout: 14 Days||11
290145|NCT00833664|700000|P1|STARTED|Washout: 14 Days||11
290146|NCT00833664|699999|P2|NOT COMPLETED|First Intervention||0
290147|NCT00833664|700000|P1|NOT COMPLETED|First Intervention||0
290148|NCT00833664|699999|P2|COMPLETED|First Intervention||11
290149|NCT00833664|700000|P1|COMPLETED|First Intervention||11
290150|NCT00833664|699999|P2|STARTED|First Intervention||11
290151|NCT00833664|700000|P1|STARTED|First Intervention||11
290152|NCT00833638|700011|P3|NOT COMPLETED|Phase 3: Open-label Extension Phase||2
290153|NCT00833638|700012|P2|NOT COMPLETED|Phase 3: Open-label Extension Phase||3
290154|NCT00833638|700013|P1|NOT COMPLETED|Phase 3: Open-label Extension Phase||1
290155|NCT00833638|700011|P3|COMPLETED|Phase 3: Open-label Extension Phase||122
290156|NCT00833638|700012|P2|COMPLETED|Phase 3: Open-label Extension Phase||105
290157|NCT00833638|700013|P1|COMPLETED|Phase 3: Open-label Extension Phase||110
290158|NCT00833638|700011|P3|STARTED|Phase 3: Open-label Extension Phase||124
290159|NCT00833638|700012|P2|STARTED|Phase 3: Open-label Extension Phase||108
290160|NCT00833638|700013|P1|STARTED|Phase 3: Open-label Extension Phase||111
290161|NCT00833638|700011|P3|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||9
290162|NCT00833638|700012|P2|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
290163|NCT00833638|700013|P1|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
290164|NCT00833638|700011|P3|COMPLETED|Phase 2: Double-blind Treatment Phase||124
290165|NCT00833638|700012|P2|COMPLETED|Phase 2: Double-blind Treatment Phase||108
290166|NCT00833638|700013|P1|COMPLETED|Phase 2: Double-blind Treatment Phase||111
290167|NCT00833638|700011|P3|STARTED|Phase 2: Double-blind Treatment Phase||133
290168|NCT00833638|700012|P2|STARTED|Phase 2: Double-blind Treatment Phase||118
290169|NCT00833638|700013|P1|STARTED|Phase 2: Double-blind Treatment Phase||121
290170|NCT00833586|700055|P2|NOT COMPLETED|Second Intervention||0
290171|NCT00833586|700056|P1|NOT COMPLETED|Second Intervention||0
290172|NCT00833586|700055|P2|COMPLETED|Second Intervention||14
290173|NCT00833586|700056|P1|COMPLETED|Second Intervention||14
290174|NCT00833586|700055|P2|STARTED|Second Intervention||14
290175|NCT00833586|700056|P1|STARTED|Second Intervention||14
290176|NCT00833586|700055|P2|NOT COMPLETED|Washout: 14 Days||0
290177|NCT00833586|700056|P1|NOT COMPLETED|Washout: 14 Days||0
290178|NCT00833586|700055|P2|COMPLETED|Washout: 14 Days||14
290179|NCT00833586|700056|P1|COMPLETED|Washout: 14 Days||14
290180|NCT00833586|700055|P2|STARTED|Washout: 14 Days||14
290181|NCT00833586|700056|P1|STARTED|Washout: 14 Days||14
290182|NCT00833586|700055|P2|NOT COMPLETED|First Intervention||0
290183|NCT00833586|700056|P1|NOT COMPLETED|First Intervention||0
290184|NCT00833586|700055|P2|COMPLETED|First Intervention||14
290185|NCT00833586|700056|P1|COMPLETED|First Intervention||14
290186|NCT00833586|700055|P2|STARTED|First Intervention||14
290187|NCT00833586|700056|P1|STARTED|First Intervention||14
290188|NCT00833560|700064|P1|NOT COMPLETED|Overall Study||42
290189|NCT00833560|700064|P1|COMPLETED|Overall Study||353
290190|NCT00833560|700064|P1|STARTED|Overall Study||395
290191|NCT00833547|700073|P2|NOT COMPLETED|Overall Study||2
290192|NCT00833547|700074|P1|NOT COMPLETED|Overall Study||2
290193|NCT00833547|700073|P2|COMPLETED|Overall Study||10
290194|NCT00833547|700074|P1|COMPLETED|Overall Study||11
290195|NCT00833547|700073|P2|STARTED|Overall Study||12
290196|NCT00833547|700074|P1|STARTED|Overall Study||13
290197|NCT00833521|700084|P2|NOT COMPLETED|Second Intervention||0
290198|NCT00833521|700085|P1|NOT COMPLETED|Second Intervention||0
290199|NCT00833521|700084|P2|COMPLETED|Second Intervention||19
290200|NCT00833521|700085|P1|COMPLETED|Second Intervention||19
290201|NCT00833521|700084|P2|STARTED|Second Intervention||19
290202|NCT00833521|700085|P1|STARTED|Second Intervention||19
290203|NCT00833521|700084|P2|NOT COMPLETED|First Intervention||0
290204|NCT00833521|700085|P1|NOT COMPLETED|First Intervention||0
290205|NCT00833521|700084|P2|COMPLETED|First Intervention||19
290206|NCT00833521|700085|P1|COMPLETED|First Intervention||19
290207|NCT00833521|700084|P2|STARTED|First Intervention||19
290208|NCT00833521|700085|P1|STARTED|First Intervention||19
290209|NCT00833482|700095|P6|NOT COMPLETED|Days 21-30||0
290210|NCT00833482|700096|P5|NOT COMPLETED|Days 21-30||1
290211|NCT00833482|700097|P4|NOT COMPLETED|Days 21-30||0
290212|NCT00833482|700098|P3|NOT COMPLETED|Days 21-30||1
290213|NCT00833482|700099|P2|NOT COMPLETED|Days 21-30||0
290214|NCT00833482|700100|P1|NOT COMPLETED|Days 21-30||0
290215|NCT00833482|700095|P6|COMPLETED|Days 21-30||0
290216|NCT00833482|700096|P5|COMPLETED|Days 21-30||7
290217|NCT00833482|700097|P4|COMPLETED|Days 21-30||0
290218|NCT00833482|700098|P3|COMPLETED|Days 21-30||20
290219|NCT00833482|700099|P2|COMPLETED|Days 21-30||0
290220|NCT00833482|700100|P1|COMPLETED|Days 21-30||0
290221|NCT00833482|700095|P6|STARTED|Days 21-30||0
290222|NCT00833482|700096|P5|STARTED|Days 21-30||8
290223|NCT00833482|700097|P4|STARTED|Days 21-30||0
290224|NCT00833482|700098|P3|STARTED|Days 21-30||21
290225|NCT00833482|700099|P2|STARTED|Days 21-30||0
290226|NCT00833482|700100|P1|STARTED|Days 21-30||0
290227|NCT00833482|700095|P6|NOT COMPLETED|Days 11-20||0
290228|NCT00833482|700096|P5|NOT COMPLETED|Days 11-20||0
290229|NCT00833482|700097|P4|NOT COMPLETED|Days 11-20||0
290230|NCT00833482|700098|P3|NOT COMPLETED|Days 11-20||0
290231|NCT00833482|700099|P2|NOT COMPLETED|Days 11-20||3
290232|NCT00833482|700100|P1|NOT COMPLETED|Days 11-20||0
290233|NCT00833482|700095|P6|COMPLETED|Days 11-20||8
290234|NCT00833482|700096|P5|COMPLETED|Days 11-20||0
290235|NCT00833482|700097|P4|COMPLETED|Days 11-20||0
290236|NCT00833482|700098|P3|COMPLETED|Days 11-20||0
290237|NCT00833482|700099|P2|COMPLETED|Days 11-20||21
290238|NCT00833482|700100|P1|COMPLETED|Days 11-20||0
290239|NCT00833482|700095|P6|STARTED|Days 11-20|Participants who received treatment.|8
290240|NCT00833482|700096|P5|STARTED|Days 11-20||0
290241|NCT00833482|700097|P4|STARTED|Days 11-20||0
290242|NCT00833482|700098|P3|STARTED|Days 11-20||0
290243|NCT00833482|700099|P2|STARTED|Days 11-20|Participants who received treatment.|24
290244|NCT00833482|700100|P1|STARTED|Days 11-20||0
290245|NCT00833482|700095|P6|NOT COMPLETED|Days 1-3||0
290246|NCT00833482|700096|P5|NOT COMPLETED|Days 1-3||0
290247|NCT00833482|700097|P4|NOT COMPLETED|Days 1-3||0
290248|NCT00833482|700098|P3|NOT COMPLETED|Days 1-3||0
290249|NCT00833482|700099|P2|NOT COMPLETED|Days 1-3||0
290250|NCT00833482|700100|P1|NOT COMPLETED|Days 1-3||0
290251|NCT00833482|700095|P6|COMPLETED|Days 1-3||0
290252|NCT00833482|700096|P5|COMPLETED|Days 1-3||0
290253|NCT00833482|700097|P4|COMPLETED|Days 1-3||8
290254|NCT00833482|700098|P3|COMPLETED|Days 1-3||0
290255|NCT00833482|700099|P2|COMPLETED|Days 1-3||0
290256|NCT00833482|700100|P1|COMPLETED|Days 1-3||24
290257|NCT00833482|700095|P6|STARTED|Days 1-3||0
290258|NCT00833482|700096|P5|STARTED|Days 1-3||0
290259|NCT00833482|700097|P4|STARTED|Days 1-3||8
290260|NCT00833482|700098|P3|STARTED|Days 1-3||0
290261|NCT00833482|700099|P2|STARTED|Days 1-3|Participants who received treatment|0
290262|NCT00833482|700100|P1|STARTED|Days 1-3|Participants who received treatment|24
290263|NCT00833469|700156|P1|NOT COMPLETED|Overall Study||2
290264|NCT00833469|700156|P1|COMPLETED|Overall Study||3
290265|NCT00833469|700156|P1|STARTED|Overall Study||5
290266|NCT00833443|700164|P2|NOT COMPLETED|Overall Study||28
290267|NCT00833443|700165|P1|NOT COMPLETED|Overall Study||20
290268|NCT00833443|700164|P2|COMPLETED|Overall Study||15
290269|NCT00833443|700165|P1|COMPLETED|Overall Study||21
290270|NCT00833443|700164|P2|STARTED|Overall Study||43
290271|NCT00833443|700165|P1|STARTED|Overall Study||41
290272|NCT00833417|700179|P2|NOT COMPLETED|Overall Study||71
290273|NCT00833417|700180|P1|NOT COMPLETED|Overall Study||33
290274|NCT00833417|700179|P2|COMPLETED|Overall Study||0
290275|NCT00833417|700180|P1|COMPLETED|Overall Study||0
290276|NCT00833417|700179|P2|STARTED|Overall Study||71
290277|NCT00833417|700180|P1|STARTED|Overall Study||33
290278|NCT00833365|700195|P2|NOT COMPLETED|Overall Study||0
290279|NCT00833365|700196|P1|NOT COMPLETED|Overall Study||0
290280|NCT00833365|700195|P2|COMPLETED|Overall Study||6
290281|NCT00833365|700196|P1|COMPLETED|Overall Study||9
290282|NCT00833365|700195|P2|STARTED|Overall Study||6
290283|NCT00833365|700196|P1|STARTED|Overall Study||9
290284|NCT00833261|700204|P1|NOT COMPLETED|Overall Study||4
290285|NCT00833261|700204|P1|COMPLETED|Overall Study|3 patients withdrew from the study prior to treatment & 1 receiving it did not complete the course.|33
290286|NCT00833261|700204|P1|STARTED|Overall Study||37
290287|NCT00833248|700211|P2|NOT COMPLETED|Overall Study||3
290288|NCT00833248|700212|P1|NOT COMPLETED|Overall Study||4
290289|NCT00833248|700211|P2|COMPLETED|Overall Study||62
290290|NCT00833248|700212|P1|COMPLETED|Overall Study||177
290291|NCT00833248|700211|P2|Safety Analysis Set|Overall Study||64
290292|NCT00833248|700212|P1|Safety Analysis Set|Overall Study||181
290293|NCT00833248|700211|P2|Per Protocol (PP) Analysis Set|Overall Study||57
290294|NCT00833248|700212|P1|Per Protocol (PP) Analysis Set|Overall Study||164
290295|NCT00833248|700211|P2|Full Analysis Set (FAS)|Overall Study||64
290296|NCT00833248|700212|P1|Full Analysis Set (FAS)|Overall Study||180
290297|NCT00833248|700211|P2|STARTED|Overall Study||65
290298|NCT00833248|700212|P1|STARTED|Overall Study||181
290299|NCT00833105|700234|P1|NOT COMPLETED|Overall Study||3
290300|NCT00833105|700234|P1|COMPLETED|Overall Study||10
290301|NCT00833105|700234|P1|STARTED|Overall Study||13
290302|NCT00833092|700252|P2|NOT COMPLETED|Overall Study||7
290303|NCT00833092|700253|P1|NOT COMPLETED|Overall Study||4
290304|NCT00833092|700252|P2|COMPLETED|Overall Study||50
290305|NCT00833092|700253|P1|COMPLETED|Overall Study||50
290306|NCT00833092|700252|P2|STARTED|Overall Study||57
290307|NCT00833092|700253|P1|STARTED|Overall Study||54
290308|NCT00833053|700261|P2|NOT COMPLETED|Overall Study||3
290309|NCT00833053|700262|P1|NOT COMPLETED|Overall Study||9
290310|NCT00833053|700261|P2|COMPLETED|Overall Study||17
290311|NCT00833053|700262|P1|COMPLETED|Overall Study||10
290312|NCT00833053|700261|P2|STARTED|Overall Study||20
290313|NCT00833053|700262|P1|STARTED|Overall Study||19
290314|NCT00833040|700280|P6|NOT COMPLETED|Overall Study||1
290315|NCT00833040|700281|P5|NOT COMPLETED|Overall Study||0
290316|NCT00833040|700282|P4|NOT COMPLETED|Overall Study||0
290317|NCT00833040|700283|P3|NOT COMPLETED|Overall Study||0
290318|NCT00833040|700284|P2|NOT COMPLETED|Overall Study||0
290319|NCT00833040|700285|P1|NOT COMPLETED|Overall Study||0
290320|NCT00833040|700280|P6|COMPLETED|Overall Study||4
290321|NCT00833040|700281|P5|COMPLETED|Overall Study||5
290322|NCT00833040|700282|P4|COMPLETED|Overall Study||6
290323|NCT00833040|700283|P3|COMPLETED|Overall Study||6
290324|NCT00833040|700284|P2|COMPLETED|Overall Study||6
290325|NCT00833040|700285|P1|COMPLETED|Overall Study||6
290326|NCT00833040|700280|P6|STARTED|Overall Study||5
290327|NCT00833040|700281|P5|STARTED|Overall Study||5
290328|NCT00833040|700282|P4|STARTED|Overall Study||6
290329|NCT00833040|700283|P3|STARTED|Overall Study||6
290330|NCT00833040|700284|P2|STARTED|Overall Study||6
290331|NCT00833040|700285|P1|STARTED|Overall Study||6
290332|NCT00833027|700290|P1|NOT COMPLETED|Overall Study||211
290333|NCT00833027|700290|P1|COMPLETED|Overall Study||397
290334|NCT00833027|700290|P1|STARTED|Overall Study||608
290335|NCT00832975|700295|P1|NOT COMPLETED|Overall Study||39
290336|NCT00832975|700295|P1|COMPLETED|Overall Study||118
290337|NCT00832975|700295|P1|STARTED|Overall Study||157
290338|NCT00832871|700300|P1|NOT COMPLETED|Overall Study||0
290339|NCT00832871|700300|P1|COMPLETED|Overall Study||4
290340|NCT00832871|700300|P1|STARTED|Overall Study||4
290341|NCT00832819|700309|P3|NOT COMPLETED|Overall Study||1
290342|NCT00832819|700310|P2|NOT COMPLETED|Overall Study||1
290343|NCT00832819|700311|P1|NOT COMPLETED|Overall Study||0
290344|NCT00832819|700309|P3|COMPLETED|Overall Study||15
290345|NCT00832819|700310|P2|COMPLETED|Overall Study||5
290346|NCT00832819|700311|P1|COMPLETED|Overall Study||6
290347|NCT00832819|700309|P3|STARTED|Overall Study||16
290348|NCT00832819|700310|P2|STARTED|Overall Study||6
290349|NCT00832819|700311|P1|STARTED|Overall Study||6
290350|NCT00832780|700317|P1|NOT COMPLETED|Overall Study||25
290351|NCT00832780|700317|P1|COMPLETED|Overall Study||19
290352|NCT00832780|700317|P1|STARTED|Overall Study||44
290353|NCT00832767|700327|P2|NOT COMPLETED|Overall Study||18
290354|NCT00832767|700328|P1|NOT COMPLETED|Overall Study||22
290355|NCT00832767|700327|P2|COMPLETED|Overall Study||63
290356|NCT00832767|700328|P1|COMPLETED|Overall Study||99
290357|NCT00832767|700327|P2|STARTED|Overall Study||81
290358|NCT00832767|700328|P1|STARTED|Overall Study||121
290359|NCT00832650|700359|P3|NOT COMPLETED|Overall Study||1
290360|NCT00832650|700360|P2|NOT COMPLETED|Overall Study||0
290361|NCT00832650|700361|P1|NOT COMPLETED|Overall Study||0
290362|NCT00832650|700359|P3|COMPLETED|Overall Study||22
290363|NCT00832650|700360|P2|COMPLETED|Overall Study||12
290364|NCT00832650|700361|P1|COMPLETED|Overall Study||25
290365|NCT00832650|700359|P3|Treated|Overall Study||22
290366|NCT00832650|700360|P2|Treated|Overall Study||12
290367|NCT00832650|700361|P1|Treated|Overall Study||25
290368|NCT00832650|700359|P3|STARTED|Overall Study||23
290369|NCT00832650|700360|P2|STARTED|Overall Study||12
290370|NCT00832650|700361|P1|STARTED|Overall Study||25
290371|NCT00832637|700393|P1|NOT COMPLETED|Overall Study||0
290372|NCT00832637|700393|P1|COMPLETED|Overall Study||33
290373|NCT00832637|700393|P1|STARTED|Overall Study||33
290374|NCT00832624|700401|P1|NOT COMPLETED|Overall Study||10
290375|NCT00832624|700401|P1|COMPLETED|Overall Study||0
290376|NCT00832624|700401|P1|STARTED|Overall Study||10
290377|NCT00832598|700405|P1|NOT COMPLETED|Overall Study||0
290378|NCT00832598|700405|P1|COMPLETED|Overall Study||13
290379|NCT00832598|700405|P1|STARTED|Overall Study||13
290380|NCT00832585|700411|P1|NOT COMPLETED|Overall Study||2
290381|NCT00832585|700411|P1|COMPLETED|Overall Study|Only three subjects completed all of the visits for the study as per protocol.|3
290382|NCT00832585|700411|P1|STARTED|Overall Study|Eight subjects were screened but only 5 started the study and received study drug.|5
290383|NCT00832572|700418|P2|NOT COMPLETED|Period 2||0
290384|NCT00832572|700419|P1|NOT COMPLETED|Period 2||0
290385|NCT00832572|700418|P2|COMPLETED|Period 2||2
290386|NCT00832572|700419|P1|COMPLETED|Period 2||3
290387|NCT00832572|700418|P2|STARTED|Period 2||2
290388|NCT00832572|700419|P1|STARTED|Period 2||3
290389|NCT00832572|700418|P2|NOT COMPLETED|Period 1||0
290390|NCT00832572|700419|P1|NOT COMPLETED|Period 1||0
290391|NCT00832572|700418|P2|COMPLETED|Period 1||2
290392|NCT00832572|700419|P1|COMPLETED|Period 1||3
290393|NCT00832572|700418|P2|STARTED|Period 1||2
290394|NCT00832572|700419|P1|STARTED|Period 1||3
290395|NCT00832520|700431|P1|NOT COMPLETED|Overall Study||0
290396|NCT00832520|700431|P1|COMPLETED|Overall Study||13
290397|NCT00832520|700431|P1|STARTED|Overall Study||13
290398|NCT00832455|700436|P1|NOT COMPLETED|Overall Study||72
290399|NCT00832455|700436|P1|COMPLETED|Overall Study||373
290400|NCT00832455|700436|P1|Week 12|Overall Study||373
290401|NCT00832455|700436|P1|Week 8 (Optional)|Overall Study||247
290402|NCT00832455|700436|P1|Week 4|Overall Study||411
290403|NCT00832455|700436|P1|Baseline|Overall Study|420 –patients that received at least one dose of study medication and had 1 follow-up visit (ITT)|420
290404|NCT00832455|700436|P1|STARTED|Overall Study|445 – number of patients that signed the informed consent form (Safety population)|445
290405|NCT00832416|700460|P4|NOT COMPLETED|Overall Study||83
290406|NCT00832416|700461|P3|NOT COMPLETED|Overall Study||61
290407|NCT00832416|700462|P2|NOT COMPLETED|Overall Study||53
290408|NCT00832416|700463|P1|NOT COMPLETED|Overall Study||46
290409|NCT00832416|700460|P4|COMPLETED|Overall Study||144
290410|NCT00832416|700461|P3|COMPLETED|Overall Study||54
290411|NCT00832416|700462|P2|COMPLETED|Overall Study||60
290412|NCT00832416|700463|P1|COMPLETED|Overall Study||64
290413|NCT00832416|700460|P4|STARTED|Overall Study||227
290414|NCT00832416|700461|P3|STARTED|Overall Study||115
290415|NCT00832416|700462|P2|STARTED|Overall Study||113
290416|NCT00832416|700463|P1|STARTED|Overall Study||110
290417|NCT00832390|700504|P3|NOT COMPLETED|Overall Study||0
290418|NCT00832390|700505|P2|NOT COMPLETED|Overall Study||0
290419|NCT00832390|700506|P1|NOT COMPLETED|Overall Study||0
290420|NCT00832390|700504|P3|COMPLETED|Overall Study||1
290421|NCT00832390|700505|P2|COMPLETED|Overall Study||16
290422|NCT00832390|700506|P1|COMPLETED|Overall Study||12
290423|NCT00832390|700504|P3|STARTED|Overall Study||1
290424|NCT00832390|700505|P2|STARTED|Overall Study||16
290425|NCT00832390|700506|P1|STARTED|Overall Study||12
290426|NCT00832377|700514|P1|NOT COMPLETED|Overall Study||1
290427|NCT00832377|700514|P1|COMPLETED|Overall Study||36
290428|NCT00832377|700514|P1|STARTED|Overall Study||37
290429|NCT00832338|700521|P1|NOT COMPLETED|Overall Study||0
290430|NCT00832338|700521|P1|COMPLETED|Overall Study||23
290431|NCT00832338|700521|P1|STARTED|Overall Study||23
290432|NCT00832299|700525|P1|NOT COMPLETED|Overall Study||0
290433|NCT00832299|700525|P1|COMPLETED|Overall Study||2
290434|NCT00832299|700525|P1|STARTED|Overall Study||2
290435|NCT00832260|700530|P1|NOT COMPLETED|Overall Study||0
290436|NCT00832260|700530|P1|COMPLETED|Overall Study||70
290437|NCT00832260|700530|P1|STARTED|Overall Study||70
290438|NCT00832130|700537|P2|NOT COMPLETED|Overall Study||0
290439|NCT00832130|700538|P1|NOT COMPLETED|Overall Study||0
290440|NCT00832130|700537|P2|COMPLETED|Overall Study||70
290441|NCT00832130|700538|P1|COMPLETED|Overall Study||69
290442|NCT00832130|700537|P2|STARTED|Overall Study||70
290443|NCT00832130|700538|P1|STARTED|Overall Study||69
290444|NCT00832117|700560|P1|NOT COMPLETED|Overall Study||12
290445|NCT00832117|700560|P1|COMPLETED|Overall Study||17
290446|NCT00832117|700560|P1|STARTED|Overall Study||29
290447|NCT00832091|700579|P2|NOT COMPLETED|Overall Study||2
290448|NCT00832091|700580|P1|NOT COMPLETED|Overall Study||5
290449|NCT00832091|700579|P2|COMPLETED|Overall Study||53
290450|NCT00832091|700580|P1|COMPLETED|Overall Study||12
290451|NCT00832091|700579|P2|STARTED|Overall Study||55
290452|NCT00832091|700580|P1|STARTED|Overall Study||17
290453|NCT00832078|700588|P2|NOT COMPLETED|Test Day 2 - 2 Period||0
290454|NCT00832078|700589|P1|NOT COMPLETED|Test Day 2 - 2 Period||1
290455|NCT00832078|700588|P2|COMPLETED|Test Day 2 - 2 Period||10
290456|NCT00832078|700589|P1|COMPLETED|Test Day 2 - 2 Period||12
290457|NCT00832078|700588|P2|STARTED|Test Day 2 - 2 Period||10
290458|NCT00832078|700589|P1|STARTED|Test Day 2 - 2 Period||13
290459|NCT00832078|700588|P2|NOT COMPLETED|Test Day 2 - 1 Period||0
290460|NCT00832078|700589|P1|NOT COMPLETED|Test Day 2 - 1 Period||0
290461|NCT00832078|700588|P2|COMPLETED|Test Day 2 - 1 Period||10
290462|NCT00832078|700589|P1|COMPLETED|Test Day 2 - 1 Period||13
290463|NCT00832078|700588|P2|STARTED|Test Day 2 - 1 Period||10
290464|NCT00832078|700589|P1|STARTED|Test Day 2 - 1 Period||13
290465|NCT00832078|700588|P2|NOT COMPLETED|Test Day 1-2 Period||2
290466|NCT00832078|700589|P1|NOT COMPLETED|Test Day 1-2 Period||0
290467|NCT00832078|700588|P2|COMPLETED|Test Day 1-2 Period||10
290468|NCT00832078|700589|P1|COMPLETED|Test Day 1-2 Period||13
290469|NCT00832078|700588|P2|STARTED|Test Day 1-2 Period||12
290470|NCT00832078|700589|P1|STARTED|Test Day 1-2 Period||13
290471|NCT00832078|700588|P2|NOT COMPLETED|Test Day 1- 1 Period||0
290472|NCT00832078|700589|P1|NOT COMPLETED|Test Day 1- 1 Period||0
290473|NCT00832078|700588|P2|COMPLETED|Test Day 1- 1 Period||12
290474|NCT00832078|700589|P1|COMPLETED|Test Day 1- 1 Period||13
290475|NCT00832078|700588|P2|STARTED|Test Day 1- 1 Period||12
290476|NCT00832078|700589|P1|STARTED|Test Day 1- 1 Period||13
290477|NCT00832000|700595|P2|NOT COMPLETED|Overall Study||1
290478|NCT00832000|700596|P1|NOT COMPLETED|Overall Study||6
290479|NCT00832000|700595|P2|COMPLETED|Overall Study||29
290480|NCT00832000|700596|P1|COMPLETED|Overall Study||23
290481|NCT00832000|700595|P2|Crossed Over to Opposite Intervention|Overall Study|Mexiletine 200 mg orally three times daily|29
290482|NCT00832000|700596|P1|Crossed Over to Opposite Intervention|Overall Study|Placebo|25
290483|NCT00832000|700595|P2|STARTED|Overall Study|Placebo|30
290484|NCT00832000|700596|P1|STARTED|Overall Study|Mexiletine 200 mg orally three times daily|29
290485|NCT00831987|700634|P2|NOT COMPLETED|Overall Study||0
290486|NCT00831987|700635|P1|NOT COMPLETED|Overall Study||0
290487|NCT00831987|700634|P2|COMPLETED|Overall Study||60
290488|NCT00831987|700635|P1|COMPLETED|Overall Study||60
290489|NCT00831987|700634|P2|STARTED|Overall Study||60
290490|NCT00831987|700635|P1|STARTED|Overall Study||60
290491|NCT00831844|700657|P10|NOT COMPLETED|Overall Study||0
290492|NCT00831844|700658|P9|NOT COMPLETED|Overall Study||9
290493|NCT00831844|700659|P8|NOT COMPLETED|Overall Study||10
290494|NCT00831844|700660|P7|NOT COMPLETED|Overall Study||10
290495|NCT00831844|700661|P6|NOT COMPLETED|Overall Study||19
290496|NCT00831844|700662|P5|NOT COMPLETED|Overall Study||14
290497|NCT00831844|700663|P4|NOT COMPLETED|Overall Study||10
290498|NCT00831844|700664|P3|NOT COMPLETED|Overall Study||20
290499|NCT00831844|700665|P2|NOT COMPLETED|Overall Study||12
290500|NCT00831844|700666|P1|NOT COMPLETED|Overall Study||10
290501|NCT00831844|700657|P10|COMPLETED|Overall Study||0
290502|NCT00831844|700658|P9|COMPLETED|Overall Study||0
290503|NCT00831844|700659|P8|COMPLETED|Overall Study||0
290504|NCT00831844|700660|P7|COMPLETED|Overall Study||0
290505|NCT00831844|700661|P6|COMPLETED|Overall Study||1
290506|NCT00831844|700662|P5|COMPLETED|Overall Study||0
290507|NCT00831844|700663|P4|COMPLETED|Overall Study||0
290508|NCT00831844|700664|P3|COMPLETED|Overall Study||1
290509|NCT00831844|700665|P2|COMPLETED|Overall Study||0
290510|NCT00831844|700666|P1|COMPLETED|Overall Study||0
290511|NCT00831844|700657|P10|STARTED|Overall Study||0
290512|NCT00831844|700658|P9|STARTED|Overall Study||9
290513|NCT00831844|700659|P8|STARTED|Overall Study||10
290514|NCT00831844|700660|P7|STARTED|Overall Study||10
290515|NCT00831844|700661|P6|STARTED|Overall Study||20
290516|NCT00831844|700662|P5|STARTED|Overall Study||14
290517|NCT00831844|700663|P4|STARTED|Overall Study||10
290518|NCT00831844|700664|P3|STARTED|Overall Study||21
290519|NCT00831844|700665|P2|STARTED|Overall Study||12
290520|NCT00831844|700666|P1|STARTED|Overall Study||10
290521|NCT00831792|700688|P1|NOT COMPLETED|Overall Study||6
290522|NCT00831792|700688|P1|COMPLETED|Overall Study||40
290523|NCT00831792|700688|P1|STARTED|Overall Study||46
290524|NCT00831779|700694|P2|NOT COMPLETED|Overall Study||1
290525|NCT00831779|700695|P1|NOT COMPLETED|Overall Study||1
290526|NCT00831779|700694|P2|COMPLETED|Overall Study||22
290527|NCT00831779|700695|P1|COMPLETED|Overall Study||20
290528|NCT00831779|700694|P2|STARTED|Overall Study||23
290529|NCT00831779|700695|P1|STARTED|Overall Study||21
290530|NCT00831766|700705|P2|NOT COMPLETED|Overall Study||0
290531|NCT00831766|700706|P1|NOT COMPLETED|Overall Study||0
290532|NCT00831766|700705|P2|COMPLETED|Overall Study||28
290533|NCT00831766|700706|P1|COMPLETED|Overall Study||23
290534|NCT00831766|700705|P2|STARTED|Overall Study||28
290535|NCT00831766|700706|P1|STARTED|Overall Study||23
290536|NCT00831753|700717|P2|NOT COMPLETED|Overall Study||0
290537|NCT00831753|700718|P1|NOT COMPLETED|Overall Study||0
290538|NCT00831753|700717|P2|COMPLETED|Overall Study||131
290539|NCT00831753|700718|P1|COMPLETED|Overall Study||132
290540|NCT00831753|700717|P2|STARTED|Overall Study||131
290541|NCT00831753|700718|P1|STARTED|Overall Study||132
290542|NCT00831701|700732|P2|NOT COMPLETED|Overall Study||5
290543|NCT00831701|700733|P1|NOT COMPLETED|Overall Study||5
290544|NCT00831701|700732|P2|COMPLETED|Overall Study||45
290545|NCT00831701|700733|P1|COMPLETED|Overall Study||45
290546|NCT00831701|700732|P2|STARTED|Overall Study||50
290547|NCT00831701|700733|P1|STARTED|Overall Study||50
290548|NCT00831675|700749|P2|NOT COMPLETED|Overall Study||0
290549|NCT00831675|700750|P1|NOT COMPLETED|Overall Study||0
290550|NCT00831675|700749|P2|COMPLETED|Overall Study||18
290551|NCT00831675|700750|P1|COMPLETED|Overall Study||12
290552|NCT00831675|700749|P2|STARTED|Overall Study||18
290553|NCT00831675|700750|P1|STARTED|Overall Study||12
290554|NCT00831493|700762|P1|NOT COMPLETED|Overall Study||1
290555|NCT00831493|700762|P1|COMPLETED|Overall Study||2
290556|NCT00831493|700762|P1|STARTED|Overall Study||3
290557|NCT00831480|700766|P1|NOT COMPLETED|Overall Study||2
290558|NCT00831480|700766|P1|COMPLETED|Overall Study||7
290559|NCT00831480|700766|P1|STARTED|Overall Study||9
290560|NCT00831441|700772|P2|NOT COMPLETED|Follow Up (30 Days)||174
290561|NCT00831441|700773|P1|NOT COMPLETED|Follow Up (30 Days)||133
290562|NCT00831441|700772|P2|COMPLETED|Follow Up (30 Days)||3355
290563|NCT00831441|700773|P1|COMPLETED|Follow Up (30 Days)||3375
290564|NCT00831441|700772|P2|STARTED|Follow Up (30 Days)|3529 participants entered the follow up period.|3529
290565|NCT00831441|700773|P1|STARTED|Follow Up (30 Days)|3508 participants entered the follow up period.|3508
290566|NCT00831441|700772|P2|NOT COMPLETED|Randomized||3705
290567|NCT00831441|700773|P1|NOT COMPLETED|Randomized||3687
290568|NCT00831441|700772|P2|COMPLETED|Randomized||0
290569|NCT00831441|700773|P1|COMPLETED|Randomized||0
290570|NCT00831441|700772|P2|Treated|Randomized||3672
290571|NCT00831441|700773|P1|Treated|Randomized||3643
290572|NCT00831441|700772|P2|STARTED|Randomized||3705
290573|NCT00831441|700773|P1|STARTED|Randomized||3687
290574|NCT00831428|700801|P1|NOT COMPLETED|Overall Study||0
290575|NCT00831428|700801|P1|COMPLETED|Overall Study||97
290576|NCT00831428|700801|P1|STARTED|Overall Study||97
290577|NCT00831415|700805|P1|NOT COMPLETED|Overall Study||75
290578|NCT00831415|700805|P1|COMPLETED|Overall Study|In addition to Completers for Study includes 2 participants who discontinued after on-therapy period|229
290579|NCT00831415|700805|P1|"Study Completers"|Overall Study|Defined as participants whose conclusion of study participation status was “study completed.”|227
290580|NCT00831415|700805|P1|"Completers for Exposure"|Overall Study|Participants with ≥ 301 days of exposure to study drug and completed study day 308 evaluations.|227
290581|NCT00831415|700805|P1|STARTED|Overall Study||304
290582|NCT00831389|700814|P2|NOT COMPLETED|Overall Study||1
290583|NCT00831389|700815|P1|NOT COMPLETED|Overall Study||0
290584|NCT00831389|700814|P2|COMPLETED|Overall Study||6
290585|NCT00831389|700815|P1|COMPLETED|Overall Study||6
290586|NCT00831389|700814|P2|STARTED|Overall Study||7
290587|NCT00831389|700815|P1|STARTED|Overall Study||6
290588|NCT00831311|700841|P2|NOT COMPLETED|Overall Study||8
290589|NCT00831311|700842|P1|NOT COMPLETED|Overall Study||12
290590|NCT00831311|700841|P2|COMPLETED|Overall Study||304
290591|NCT00831311|700842|P1|COMPLETED|Overall Study||300
290592|NCT00831311|700841|P2|STARTED|Overall Study||312
290593|NCT00831311|700842|P1|STARTED|Overall Study||312
290594|NCT00831272|700864|P4|NOT COMPLETED|Overall Study||10
290595|NCT00831272|700865|P3|NOT COMPLETED|Overall Study||10
290596|NCT00831272|700866|P2|NOT COMPLETED|Overall Study||7
290597|NCT00831272|700867|P1|NOT COMPLETED|Overall Study||8
290598|NCT00831272|700864|P4|COMPLETED|Overall Study||56
290599|NCT00831272|700865|P3|COMPLETED|Overall Study||63
290600|NCT00831272|700866|P2|COMPLETED|Overall Study||37
290601|NCT00831272|700867|P1|COMPLETED|Overall Study||30
290602|NCT00831272|700864|P4|STARTED|Overall Study||66
290603|NCT00831272|700865|P3|STARTED|Overall Study||73
290604|NCT00831272|700866|P2|STARTED|Overall Study||44
290605|NCT00831272|700867|P1|STARTED|Overall Study||38
290606|NCT00831233|700879|P2|NOT COMPLETED|Overall Study||1
290607|NCT00831233|700880|P1|NOT COMPLETED|Overall Study||3
290608|NCT00831233|700879|P2|COMPLETED|Overall Study||12
290609|NCT00831233|700880|P1|COMPLETED|Overall Study||26
290610|NCT00831233|700879|P2|Per Protocol (PP) Analysis Set|Overall Study||11
290611|NCT00831233|700880|P1|Per Protocol (PP) Analysis Set|Overall Study||26
290612|NCT00831233|700879|P2|Full Analysis Set (FAS)|Overall Study||13
290613|NCT00831233|700880|P1|Full Analysis Set (FAS)|Overall Study|2 participants were randomised but never treated.|27
290614|NCT00831233|700879|P2|STARTED|Overall Study|ITT population.|13
290615|NCT00831233|700880|P1|STARTED|Overall Study|Intention-to-treat (ITT) population.|29
290616|NCT00831181|700904|P1|NOT COMPLETED|Overall Study||12
290617|NCT00831181|700904|P1|COMPLETED|Overall Study||15
290618|NCT00831181|700904|P1|STARTED|Overall Study||27
290619|NCT00831129|700917|P2|NOT COMPLETED|Overall Study||10
290620|NCT00831129|700918|P1|NOT COMPLETED|Overall Study||0
290621|NCT00831129|700917|P2|COMPLETED|Overall Study||23
290622|NCT00831129|700918|P1|COMPLETED|Overall Study||20
290623|NCT00831129|700917|P2|STARTED|Overall Study||33
290624|NCT00831129|700918|P1|STARTED|Overall Study||20
290625|NCT00830960|700960|P6|NOT COMPLETED|Overall Study||37
290626|NCT00830960|700961|P5|NOT COMPLETED|Overall Study||32
290627|NCT00830960|700962|P4|NOT COMPLETED|Overall Study||32
290628|NCT00830960|700963|P3|NOT COMPLETED|Overall Study||29
290629|NCT00830960|700964|P2|NOT COMPLETED|Overall Study||28
290630|NCT00830960|700965|P1|NOT COMPLETED|Overall Study||33
290631|NCT00830960|700960|P6|COMPLETED|Overall Study||63
290632|NCT00830960|700961|P5|COMPLETED|Overall Study|6 participants not completed due to death; 1 additional death occurred after study discontinuation.|64
290633|NCT00830960|700962|P4|COMPLETED|Overall Study||106
290634|NCT00830960|700963|P3|COMPLETED|Overall Study||108
290635|NCT00830960|700964|P2|COMPLETED|Overall Study||96
290636|NCT00830960|700965|P1|COMPLETED|Overall Study||91
290637|NCT00830960|700960|P6|Received at Least 1 Dose of Study Drug|Overall Study||93
290638|NCT00830960|700961|P5|Received at Least 1 Dose of Study Drug|Overall Study||91
290639|NCT00830960|700962|P4|Received at Least 1 Dose of Study Drug|Overall Study||135
290640|NCT00830960|700963|P3|Received at Least 1 Dose of Study Drug|Overall Study||133
290641|NCT00830960|700964|P2|Received at Least 1 Dose of Study Drug|Overall Study||122
290642|NCT00830960|700965|P1|Received at Least 1 Dose of Study Drug|Overall Study|Baseline Characteristics (below) include those who received ≥1 dose study drug, not all who STARTED.|117
290643|NCT00830960|700960|P6|STARTED|Overall Study|Total 720 participants were randomized; 1 was not included in a cohort as baseline weight missing.|100
290644|NCT00830960|700961|P5|STARTED|Overall Study||96
290645|NCT00830960|700962|P4|STARTED|Overall Study||138
290646|NCT00830960|700963|P3|STARTED|Overall Study||137
290647|NCT00830960|700964|P2|STARTED|Overall Study||124
290648|NCT00830960|700965|P1|STARTED|Overall Study|"Number of participants STARTED equals the number of participants randomized."|124
290649|NCT00830947|701081|P2|NOT COMPLETED|Overall Study||4
290650|NCT00830947|701082|P1|NOT COMPLETED|Overall Study||4
290651|NCT00830947|701081|P2|COMPLETED|Overall Study||18
290652|NCT00830947|701082|P1|COMPLETED|Overall Study||19
290653|NCT00830947|701081|P2|STARTED|Overall Study||22
290654|NCT00830947|701082|P1|STARTED|Overall Study||23
290655|NCT00830869|701100|P12|NOT COMPLETED|Period 2: Part 2||20
290656|NCT00830869|701101|P11|NOT COMPLETED|Period 2: Part 2||11
290657|NCT00830869|701102|P10|NOT COMPLETED|Period 2: Part 2||20
290658|NCT00830869|701103|P9|NOT COMPLETED|Period 2: Part 2||22
290659|NCT00830869|701104|P8|NOT COMPLETED|Period 2: Part 2||20
290660|NCT00830869|701105|P7|NOT COMPLETED|Period 2: Part 2||0
290661|NCT00830869|701106|P6|NOT COMPLETED|Period 2: Part 2||0
290662|NCT00830869|701107|P5|NOT COMPLETED|Period 2: Part 2||0
290663|NCT00830869|701108|P4|NOT COMPLETED|Period 2: Part 2||0
290664|NCT00830869|701109|P3|NOT COMPLETED|Period 2: Part 2||0
290665|NCT00830869|701110|P2|NOT COMPLETED|Period 2: Part 2||0
290666|NCT00830869|701111|P1|NOT COMPLETED|Period 2: Part 2||0
290667|NCT00830869|701100|P12|COMPLETED|Period 2: Part 2||0
290668|NCT00830869|701101|P11|COMPLETED|Period 2: Part 2||0
290669|NCT00830869|701102|P10|COMPLETED|Period 2: Part 2||0
290670|NCT00830869|701103|P9|COMPLETED|Period 2: Part 2||0
290671|NCT00830869|701104|P8|COMPLETED|Period 2: Part 2||0
290672|NCT00830869|701105|P7|COMPLETED|Period 2: Part 2||0
290673|NCT00830869|701106|P6|COMPLETED|Period 2: Part 2||0
290674|NCT00830869|701107|P5|COMPLETED|Period 2: Part 2||0
290675|NCT00830869|701108|P4|COMPLETED|Period 2: Part 2||0
290676|NCT00830869|701109|P3|COMPLETED|Period 2: Part 2||0
290677|NCT00830869|701110|P2|COMPLETED|Period 2: Part 2||0
290678|NCT00830869|701111|P1|COMPLETED|Period 2: Part 2||0
290679|NCT00830869|701100|P12|STARTED|Period 2: Part 2||20
290680|NCT00830869|701101|P11|STARTED|Period 2: Part 2||11
290681|NCT00830869|701102|P10|STARTED|Period 2: Part 2||20
290682|NCT00830869|701103|P9|STARTED|Period 2: Part 2||22
290683|NCT00830869|701104|P8|STARTED|Period 2: Part 2||20
290684|NCT00830869|701105|P7|STARTED|Period 2: Part 2||0
290685|NCT00830869|701106|P6|STARTED|Period 2: Part 2||0
290686|NCT00830869|701107|P5|STARTED|Period 2: Part 2||0
290687|NCT00830869|701108|P4|STARTED|Period 2: Part 2||0
290688|NCT00830869|701109|P3|STARTED|Period 2: Part 2||0
290689|NCT00830869|701110|P2|STARTED|Period 2: Part 2||0
290690|NCT00830869|701111|P1|STARTED|Period 2: Part 2||0
290691|NCT00830869|701100|P12|NOT COMPLETED|Period 1: Part 1||0
290692|NCT00830869|701101|P11|NOT COMPLETED|Period 1: Part 1||0
290693|NCT00830869|701102|P10|NOT COMPLETED|Period 1: Part 1||0
290694|NCT00830869|701103|P9|NOT COMPLETED|Period 1: Part 1||0
290695|NCT00830869|701104|P8|NOT COMPLETED|Period 1: Part 1||0
290696|NCT00830869|701105|P7|NOT COMPLETED|Period 1: Part 1||3
290697|NCT00830869|701106|P6|NOT COMPLETED|Period 1: Part 1||6
290698|NCT00830869|701107|P5|NOT COMPLETED|Period 1: Part 1||4
290699|NCT00830869|701108|P4|NOT COMPLETED|Period 1: Part 1||7
290700|NCT00830869|701109|P3|NOT COMPLETED|Period 1: Part 1||1
290701|NCT00830869|701110|P2|NOT COMPLETED|Period 1: Part 1||1
290702|NCT00830869|701111|P1|NOT COMPLETED|Period 1: Part 1||1
290703|NCT00830869|701100|P12|COMPLETED|Period 1: Part 1||0
290704|NCT00830869|701101|P11|COMPLETED|Period 1: Part 1||0
290705|NCT00830869|701102|P10|COMPLETED|Period 1: Part 1||0
290706|NCT00830869|701103|P9|COMPLETED|Period 1: Part 1||0
290707|NCT00830869|701104|P8|COMPLETED|Period 1: Part 1||0
290708|NCT00830869|701105|P7|COMPLETED|Period 1: Part 1||0
290709|NCT00830869|701106|P6|COMPLETED|Period 1: Part 1||0
290710|NCT00830869|701107|P5|COMPLETED|Period 1: Part 1||0
290711|NCT00830869|701108|P4|COMPLETED|Period 1: Part 1||0
290712|NCT00830869|701109|P3|COMPLETED|Period 1: Part 1||0
290713|NCT00830869|701110|P2|COMPLETED|Period 1: Part 1||0
290714|NCT00830869|701111|P1|COMPLETED|Period 1: Part 1||0
290715|NCT00830869|701100|P12|STARTED|Period 1: Part 1||0
290716|NCT00830869|701101|P11|STARTED|Period 1: Part 1||0
290717|NCT00830869|701102|P10|STARTED|Period 1: Part 1||0
290718|NCT00830869|701103|P9|STARTED|Period 1: Part 1||0
290719|NCT00830869|701104|P8|STARTED|Period 1: Part 1||0
290720|NCT00830869|701105|P7|STARTED|Period 1: Part 1||3
290721|NCT00830869|701106|P6|STARTED|Period 1: Part 1||6
290722|NCT00830869|701107|P5|STARTED|Period 1: Part 1||4
290723|NCT00830869|701108|P4|STARTED|Period 1: Part 1||7
290724|NCT00830869|701109|P3|STARTED|Period 1: Part 1||1
290725|NCT00830869|701110|P2|STARTED|Period 1: Part 1||1
290726|NCT00830869|701111|P1|STARTED|Period 1: Part 1||1
290727|NCT00830804|701247|P1|NOT COMPLETED|Overall Study||15
290728|NCT00830804|701247|P1|COMPLETED|Overall Study||97
290729|NCT00830804|701247|P1|STARTED|Overall Study|113 subjects enrolled. One subject never started study treatment and was excluded in all analysis.|112
290730|NCT00830791|701273|P6|NOT COMPLETED|Overall Study||0
290731|NCT00830791|701274|P5|NOT COMPLETED|Overall Study||0
290732|NCT00830791|701275|P4|NOT COMPLETED|Overall Study||0
290733|NCT00830791|701276|P3|NOT COMPLETED|Overall Study||0
290734|NCT00830791|701277|P2|NOT COMPLETED|Overall Study||0
290735|NCT00830791|701278|P1|NOT COMPLETED|Overall Study||0
290736|NCT00830791|701273|P6|COMPLETED|Overall Study||0
290737|NCT00830791|701274|P5|COMPLETED|Overall Study||0
290738|NCT00830791|701275|P4|COMPLETED|Overall Study||8
290739|NCT00830791|701276|P3|COMPLETED|Overall Study||8
290740|NCT00830791|701277|P2|COMPLETED|Overall Study||8
290741|NCT00830791|701278|P1|COMPLETED|Overall Study||8
290742|NCT00830791|701273|P6|STARTED|Overall Study||0
290743|NCT00830791|701274|P5|STARTED|Overall Study||0
290744|NCT00830791|701275|P4|STARTED|Overall Study||8
290745|NCT00830791|701276|P3|STARTED|Overall Study||8
290746|NCT00830791|701277|P2|STARTED|Overall Study||8
290747|NCT00830791|701278|P1|STARTED|Overall Study||8
290748|NCT00830765|701327|P2|NOT COMPLETED|Overall Study||2
290749|NCT00830765|701328|P1|NOT COMPLETED|Overall Study||3
290750|NCT00830765|701327|P2|COMPLETED|Overall Study||69
290751|NCT00830765|701328|P1|COMPLETED|Overall Study||70
290752|NCT00830765|701327|P2|STARTED|Overall Study||71
290753|NCT00830765|701328|P1|STARTED|Overall Study||73
290754|NCT00830596|701337|P3|NOT COMPLETED|Overall Study||6
290755|NCT00830596|701338|P2|NOT COMPLETED|Overall Study||2
290756|NCT00830596|701339|P1|NOT COMPLETED|Overall Study||2
290757|NCT00830596|701337|P3|COMPLETED|Overall Study||67
290758|NCT00830596|701338|P2|COMPLETED|Overall Study||72
290759|NCT00830596|701339|P1|COMPLETED|Overall Study||72
290760|NCT00830596|701337|P3|STARTED|Overall Study||73
290761|NCT00830596|701338|P2|STARTED|Overall Study||74
290762|NCT00830596|701339|P1|STARTED|Overall Study||74
290763|NCT00830518|701361|P2|NOT COMPLETED|Overall Study||11
290764|NCT00830518|701362|P1|NOT COMPLETED|Overall Study||46
290765|NCT00830518|701361|P2|COMPLETED|Overall Study||0
290766|NCT00830518|701362|P1|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0
290767|NCT00830518|701361|P2|STARTED|Overall Study||11
290768|NCT00830518|701362|P1|STARTED|Overall Study||46
290769|NCT00830440|701381|P2|NOT COMPLETED|Overall Study||0
290770|NCT00830440|701382|P1|NOT COMPLETED|Overall Study||8
290771|NCT00830440|701381|P2|COMPLETED|Overall Study||11
290772|NCT00830440|701382|P1|COMPLETED|Overall Study||24
290773|NCT00830440|701381|P2|Completed 24 Week Follow up|Overall Study||0
290774|NCT00830440|701382|P1|Completed 24 Week Follow up|Overall Study||3
290775|NCT00830440|701381|P2|Completed 16 Week Follow up|Overall Study||0
290776|NCT00830440|701382|P1|Completed 16 Week Follow up|Overall Study||4
290777|NCT00830440|701381|P2|Completed 12 Week Follow up|Overall Study||11
290778|NCT00830440|701382|P1|Completed 12 Week Follow up|Overall Study||24
290779|NCT00830440|701381|P2|Received Device|Overall Study||0
290780|NCT00830440|701382|P1|Received Device|Overall Study||26
290781|NCT00830440|701381|P2|STARTED|Overall Study||11
290782|NCT00830440|701382|P1|STARTED|Overall Study||32
290783|NCT00830388|701392|P1|NOT COMPLETED|Overall Study||0
290784|NCT00830388|701392|P1|COMPLETED|Overall Study||11
290785|NCT00830388|701392|P1|STARTED|Overall Study||11
290786|NCT00830375|701397|P1|NOT COMPLETED|Overall Study||1
290787|NCT00830375|701397|P1|COMPLETED|Overall Study||9
290788|NCT00830375|701397|P1|STARTED|Overall Study||10
290789|NCT00830362|701403|P2|NOT COMPLETED|Overall Study||4
290790|NCT00830362|701404|P1|NOT COMPLETED|Overall Study||4
290791|NCT00830362|701403|P2|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|20
290792|NCT00830362|701404|P1|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|23
290793|NCT00830362|701403|P2|Completed Sessions 1 and 2|Overall Study|Received palcebo and completed both Test and Retrieval sessions (Session 1 and 2).|24
290794|NCT00830362|701404|P1|Completed Sessions 1 and 2|Overall Study|Received propranolol and completed both Test and Retrieval sessions (Session 1 and 2).|26
290795|NCT00830362|701403|P2|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|24
290796|NCT00830362|701404|P1|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|27
290797|NCT00830336|701412|P2|NOT COMPLETED|Second Intervention||0
290798|NCT00830336|701413|P1|NOT COMPLETED|Second Intervention||0
290799|NCT00830336|701412|P2|COMPLETED|Second Intervention||40
290800|NCT00830336|701413|P1|COMPLETED|Second Intervention||39
290801|NCT00830336|701412|P2|STARTED|Second Intervention||40
290802|NCT00830336|701413|P1|STARTED|Second Intervention||39
290803|NCT00830336|701412|P2|NOT COMPLETED|Washout: 21 Days||0
290804|NCT00830336|701413|P1|NOT COMPLETED|Washout: 21 Days||1
290805|NCT00830336|701412|P2|COMPLETED|Washout: 21 Days||40
290806|NCT00830336|701413|P1|COMPLETED|Washout: 21 Days||39
290807|NCT00830336|701412|P2|STARTED|Washout: 21 Days||40
290808|NCT00830336|701413|P1|STARTED|Washout: 21 Days||40
290809|NCT00830336|701412|P2|NOT COMPLETED|First Intervention||0
290810|NCT00830336|701413|P1|NOT COMPLETED|First Intervention||0
290811|NCT00830336|701412|P2|COMPLETED|First Intervention||40
290812|NCT00830336|701413|P1|COMPLETED|First Intervention||40
290813|NCT00830336|701412|P2|STARTED|First Intervention||40
290814|NCT00830336|701413|P1|STARTED|First Intervention||40
290815|NCT00830310|701421|P1|NOT COMPLETED|Overall Study||13
290816|NCT00830310|701421|P1|COMPLETED|Overall Study||30
290817|NCT00830310|701421|P1|STARTED|Overall Study||43
290818|NCT00830284|701433|P1|NOT COMPLETED|Overall Study||2
290819|NCT00830284|701433|P1|COMPLETED|Overall Study||10
290820|NCT00830284|701433|P1|STARTED|Overall Study|The study was started in our Medical Surgical ICU October of 2008.|12
290821|NCT00830258|701440|P2|NOT COMPLETED|Second Intervention||0
290822|NCT00830258|701441|P1|NOT COMPLETED|Second Intervention||0
290823|NCT00830258|701440|P2|COMPLETED|Second Intervention||30
290824|NCT00830258|701441|P1|COMPLETED|Second Intervention||28
290825|NCT00830258|701440|P2|STARTED|Second Intervention||30
290826|NCT00830258|701441|P1|STARTED|Second Intervention||28
290827|NCT00830258|701440|P2|NOT COMPLETED|Washout: 7 Days||0
290828|NCT00830258|701441|P1|NOT COMPLETED|Washout: 7 Days||1
290829|NCT00830258|701440|P2|COMPLETED|Washout: 7 Days||30
290830|NCT00830258|701441|P1|COMPLETED|Washout: 7 Days||28
290831|NCT00830258|701440|P2|STARTED|Washout: 7 Days||30
290832|NCT00830258|701441|P1|STARTED|Washout: 7 Days||29
290833|NCT00830258|701440|P2|NOT COMPLETED|First Intervention||0
290834|NCT00830258|701441|P1|NOT COMPLETED|First Intervention||1
290835|NCT00830258|701440|P2|COMPLETED|First Intervention||30
290836|NCT00830258|701441|P1|COMPLETED|First Intervention||29
290837|NCT00830258|701440|P2|STARTED|First Intervention||30
290838|NCT00830258|701441|P1|STARTED|First Intervention||30
290839|NCT00830232|701451|P2|NOT COMPLETED|Overall Study||0
290840|NCT00830232|701452|P1|NOT COMPLETED|Overall Study||0
290841|NCT00830232|701451|P2|COMPLETED|Overall Study||20
290842|NCT00830232|701452|P1|COMPLETED|Overall Study||20
290843|NCT00830232|701451|P2|STARTED|Overall Study||20
290844|NCT00830232|701452|P1|STARTED|Overall Study||20
290845|NCT00830219|701460|P2|NOT COMPLETED|Second Intervention||0
290846|NCT00830219|701461|P1|NOT COMPLETED|Second Intervention||0
290847|NCT00830219|701460|P2|COMPLETED|Second Intervention||22
290848|NCT00830219|701461|P1|COMPLETED|Second Intervention||22
290849|NCT00830219|701460|P2|STARTED|Second Intervention||22
290850|NCT00830219|701461|P1|STARTED|Second Intervention||22
290851|NCT00830219|701460|P2|NOT COMPLETED|Washout of 7 Days||1
290852|NCT00830219|701461|P1|NOT COMPLETED|Washout of 7 Days||1
290853|NCT00830219|701460|P2|COMPLETED|Washout of 7 Days||22
290854|NCT00830219|701461|P1|COMPLETED|Washout of 7 Days||22
290855|NCT00830219|701460|P2|STARTED|Washout of 7 Days||23
290856|NCT00830219|701461|P1|STARTED|Washout of 7 Days||23
290857|NCT00830219|701460|P2|NOT COMPLETED|First Intervention||0
290858|NCT00830219|701461|P1|NOT COMPLETED|First Intervention||0
290859|NCT00830219|701460|P2|COMPLETED|First Intervention||23
290860|NCT00830219|701461|P1|COMPLETED|First Intervention||23
290861|NCT00830219|701460|P2|STARTED|First Intervention||23
290862|NCT00830219|701461|P1|STARTED|First Intervention||23
290863|NCT00830206|701471|P2|NOT COMPLETED|Second Intervention||0
290864|NCT00830206|701472|P1|NOT COMPLETED|Second Intervention||0
290865|NCT00830206|701471|P2|COMPLETED|Second Intervention||39
290866|NCT00830206|701472|P1|COMPLETED|Second Intervention||39
290867|NCT00830206|701471|P2|STARTED|Second Intervention||39
290868|NCT00830206|701472|P1|STARTED|Second Intervention||39
290869|NCT00830206|701471|P2|NOT COMPLETED|Washout: 21 Days||1
290870|NCT00830206|701472|P1|NOT COMPLETED|Washout: 21 Days||1
290871|NCT00830206|701471|P2|COMPLETED|Washout: 21 Days||39
290872|NCT00830206|701472|P1|COMPLETED|Washout: 21 Days||39
290873|NCT00830206|701471|P2|STARTED|Washout: 21 Days||40
290874|NCT00830206|701472|P1|STARTED|Washout: 21 Days||40
290875|NCT00830206|701471|P2|NOT COMPLETED|First Intervention||0
290876|NCT00830206|701472|P1|NOT COMPLETED|First Intervention||0
290877|NCT00830206|701471|P2|COMPLETED|First Intervention||40
290878|NCT00830206|701472|P1|COMPLETED|First Intervention||40
290879|NCT00830206|701471|P2|STARTED|First Intervention||40
290880|NCT00830206|701472|P1|STARTED|First Intervention||40
290881|NCT00830167|701482|P2|NOT COMPLETED|Overall Study||43
290882|NCT00830167|701483|P1|NOT COMPLETED|Overall Study||40
290883|NCT00830167|701482|P2|COMPLETED|Overall Study||207
290884|NCT00830167|701483|P1|COMPLETED|Overall Study||208
290885|NCT00830167|701482|P2|STARTED|Overall Study|Treated|250
290886|NCT00830167|701483|P1|STARTED|Overall Study|Treated|248
290887|NCT00830128|701553|P1|NOT COMPLETED|Overall Study||19
290888|NCT00830128|701553|P1|COMPLETED|Overall Study||87
290889|NCT00830128|701553|P1|STARTED|Overall Study||106
290890|NCT00830115|701568|P1|NOT COMPLETED|Overall Study||3
290891|NCT00830115|701568|P1|COMPLETED|Overall Study||1042
290892|NCT00830115|701568|P1|STARTED|Overall Study||1045
290893|NCT00830076|701584|P1|NOT COMPLETED|Placebo Sitagliptin + Placebo Metformin||0
290894|NCT00830076|701584|P1|COMPLETED|Placebo Sitagliptin + Placebo Metformin||18
290895|NCT00830076|701584|P1|STARTED|Placebo Sitagliptin + Placebo Metformin||18
290896|NCT00830076|701584|P1|NOT COMPLETED|7-day Washout||0
290897|NCT00830076|701584|P1|COMPLETED|7-day Washout||18
290898|NCT00830076|701584|P1|STARTED|7-day Washout||18
290899|NCT00830076|701584|P1|NOT COMPLETED|Sitagliptin + Metformin||0
290900|NCT00830076|701584|P1|COMPLETED|Sitagliptin + Metformin||18
290901|NCT00830076|701584|P1|STARTED|Sitagliptin + Metformin||18
290902|NCT00830076|701584|P1|NOT COMPLETED|7-day Washout||0
290903|NCT00830076|701584|P1|COMPLETED|7-day Washout||18
290904|NCT00830076|701584|P1|STARTED|7-day Washout||18
290905|NCT00830076|701584|P1|NOT COMPLETED|Metformin + Placebo Sitagliptin||0
290906|NCT00830076|701584|P1|COMPLETED|Metformin + Placebo Sitagliptin||18
290907|NCT00830076|701584|P1|STARTED|Metformin + Placebo Sitagliptin||18
290908|NCT00830076|701584|P1|NOT COMPLETED|7-day Washout||0
290909|NCT00830076|701584|P1|COMPLETED|7-day Washout||18
290910|NCT00830076|701584|P1|STARTED|7-day Washout||18
290911|NCT00830076|701584|P1|NOT COMPLETED|Sitagliptin + Placebo Metformin||0
290912|NCT00830076|701584|P1|COMPLETED|Sitagliptin + Placebo Metformin||18
290913|NCT00830076|701584|P1|STARTED|Sitagliptin + Placebo Metformin||18
290914|NCT00830037|701595|P2|NOT COMPLETED|Overall Study||19
290915|NCT00830037|701596|P1|NOT COMPLETED|Overall Study||18
290916|NCT00830037|701595|P2|COMPLETED|Overall Study||50
290917|NCT00830037|701596|P1|COMPLETED|Overall Study||49
290918|NCT00830037|701595|P2|STARTED|Overall Study||69
290919|NCT00830037|701596|P1|STARTED|Overall Study||67
290920|NCT00830024|701606|P2|NOT COMPLETED|Second Intervention||0
290921|NCT00830024|701607|P1|NOT COMPLETED|Second Intervention||0
290922|NCT00830024|701606|P2|COMPLETED|Second Intervention||18
290923|NCT00830024|701607|P1|COMPLETED|Second Intervention||17
290924|NCT00830024|701606|P2|STARTED|Second Intervention||18
290925|NCT00830024|701607|P1|STARTED|Second Intervention||17
290926|NCT00830024|701606|P2|NOT COMPLETED|Washout: 7 Days||0
290927|NCT00830024|701607|P1|NOT COMPLETED|Washout: 7 Days||1
290928|NCT00830024|701606|P2|COMPLETED|Washout: 7 Days||18
290929|NCT00830024|701607|P1|COMPLETED|Washout: 7 Days||17
290930|NCT00830024|701606|P2|STARTED|Washout: 7 Days||18
290931|NCT00830024|701607|P1|STARTED|Washout: 7 Days||18
290932|NCT00830024|701606|P2|NOT COMPLETED|First Intervention||0
290933|NCT00830024|701607|P1|NOT COMPLETED|First Intervention||0
290934|NCT00830024|701606|P2|COMPLETED|First Intervention||18
290935|NCT00830024|701607|P1|COMPLETED|First Intervention||18
290936|NCT00830024|701606|P2|STARTED|First Intervention||18
290937|NCT00830024|701607|P1|STARTED|First Intervention||18
290938|NCT00829998|701617|P2|NOT COMPLETED|Second Intervention||0
290939|NCT00829998|701618|P1|NOT COMPLETED|Second Intervention||0
290940|NCT00829998|701617|P2|COMPLETED|Second Intervention||19
290941|NCT00829998|701618|P1|COMPLETED|Second Intervention||21
290942|NCT00829998|701617|P2|STARTED|Second Intervention||19
290943|NCT00829998|701618|P1|STARTED|Second Intervention||21
290944|NCT00829998|701617|P2|NOT COMPLETED|Washout||1
290945|NCT00829998|701618|P1|NOT COMPLETED|Washout||0
290946|NCT00829998|701617|P2|COMPLETED|Washout||19
290947|NCT00829998|701618|P1|COMPLETED|Washout||21
290948|NCT00829998|701617|P2|STARTED|Washout||20
290949|NCT00829998|701618|P1|STARTED|Washout||21
290950|NCT00829998|701617|P2|NOT COMPLETED|First Intervention||0
290951|NCT00829998|701618|P1|NOT COMPLETED|First Intervention||0
290952|NCT00829998|701617|P2|COMPLETED|First Intervention||20
290953|NCT00829998|701618|P1|COMPLETED|First Intervention||21
290954|NCT00829998|701617|P2|STARTED|First Intervention||20
290955|NCT00829998|701618|P1|STARTED|First Intervention||21
290956|NCT00829985|701628|P2|NOT COMPLETED|Overall Study||4
290957|NCT00829985|701629|P1|NOT COMPLETED|Overall Study||9
290958|NCT00829985|701628|P2|COMPLETED|Overall Study||22
290959|NCT00829985|701629|P1|COMPLETED|Overall Study||19
290960|NCT00829985|701628|P2|STARTED|Overall Study||26
290961|NCT00829985|701629|P1|STARTED|Overall Study||28
290962|NCT00829933|701647|P4|NOT COMPLETED|Overall Study||14
290963|NCT00829933|701648|P3|NOT COMPLETED|Overall Study||13
290964|NCT00829933|701649|P2|NOT COMPLETED|Overall Study||13
290965|NCT00829933|701650|P1|NOT COMPLETED|Overall Study||14
290966|NCT00829933|701647|P4|COMPLETED|Overall Study||120
290967|NCT00829933|701648|P3|COMPLETED|Overall Study||119
290968|NCT00829933|701649|P2|COMPLETED|Overall Study||122
290969|NCT00829933|701650|P1|COMPLETED|Overall Study||121
290970|NCT00829933|701647|P4|Baseline Analysis Population|Overall Study||129
290971|NCT00829933|701648|P3|Baseline Analysis Population|Overall Study||131
290972|NCT00829933|701649|P2|Baseline Analysis Population|Overall Study||134
290973|NCT00829933|701650|P1|Baseline Analysis Population|Overall Study||131
290974|NCT00829933|701647|P4|STARTED|Overall Study||134
290975|NCT00829933|701648|P3|STARTED|Overall Study||132
290976|NCT00829933|701649|P2|STARTED|Overall Study||135
290977|NCT00829933|701650|P1|STARTED|Overall Study||135
290978|NCT00829868|701662|P2|NOT COMPLETED|Second Intervention||0
290979|NCT00829868|701663|P1|NOT COMPLETED|Second Intervention||0
290980|NCT00829868|701662|P2|COMPLETED|Second Intervention||21
290981|NCT00829868|701663|P1|COMPLETED|Second Intervention||20
290982|NCT00829868|701662|P2|STARTED|Second Intervention||21
290983|NCT00829868|701663|P1|STARTED|Second Intervention||20
290984|NCT00829868|701662|P2|NOT COMPLETED|Washout||0
290985|NCT00829868|701663|P1|NOT COMPLETED|Washout||1
290986|NCT00829868|701662|P2|COMPLETED|Washout||21
290987|NCT00829868|701663|P1|COMPLETED|Washout||20
290988|NCT00829868|701662|P2|STARTED|Washout||21
290989|NCT00829868|701663|P1|STARTED|Washout||21
290990|NCT00829868|701662|P2|NOT COMPLETED|First Intervention||0
290991|NCT00829868|701663|P1|NOT COMPLETED|First Intervention||0
290992|NCT00829868|701662|P2|COMPLETED|First Intervention||21
290993|NCT00829868|701663|P1|COMPLETED|First Intervention||21
290994|NCT00829868|701662|P2|STARTED|First Intervention||21
290995|NCT00829868|701663|P1|STARTED|First Intervention||21
290996|NCT00829829|701674|P3|NOT COMPLETED|Overall Study||11
290997|NCT00829829|701675|P2|NOT COMPLETED|Overall Study||16
290998|NCT00829829|701676|P1|NOT COMPLETED|Overall Study||22
290999|NCT00829829|701674|P3|COMPLETED|Overall Study||70
291000|NCT00829829|701675|P2|COMPLETED|Overall Study||64
291001|NCT00829829|701676|P1|COMPLETED|Overall Study||58
291002|NCT00829829|701674|P3|Treated|Overall Study||81
291003|NCT00829829|701675|P2|Treated|Overall Study||80
291004|NCT00829829|701676|P1|Treated|Overall Study||79
291005|NCT00829829|701674|P3|STARTED|Overall Study||81
291006|NCT00829829|701675|P2|STARTED|Overall Study||80
291007|NCT00829829|701676|P1|STARTED|Overall Study||80
291008|NCT00829790|701701|P2|NOT COMPLETED|Second Intervention||0
291009|NCT00829790|701702|P1|NOT COMPLETED|Second Intervention||0
291010|NCT00829790|701701|P2|COMPLETED|Second Intervention||14
291011|NCT00829790|701702|P1|COMPLETED|Second Intervention||15
291012|NCT00829790|701701|P2|STARTED|Second Intervention||14
291013|NCT00829790|701702|P1|STARTED|Second Intervention||15
291014|NCT00829790|701701|P2|NOT COMPLETED|Washout of 14 Days||1
291015|NCT00829790|701702|P1|NOT COMPLETED|Washout of 14 Days||0
291016|NCT00829790|701701|P2|COMPLETED|Washout of 14 Days||14
291017|NCT00829790|701702|P1|COMPLETED|Washout of 14 Days||15
291018|NCT00829790|701701|P2|STARTED|Washout of 14 Days||15
291019|NCT00829790|701702|P1|STARTED|Washout of 14 Days||15
291020|NCT00829790|701701|P2|NOT COMPLETED|First Intervention||0
291021|NCT00829790|701702|P1|NOT COMPLETED|First Intervention||0
291022|NCT00829790|701701|P2|COMPLETED|First Intervention||15
291023|NCT00829790|701702|P1|COMPLETED|First Intervention||15
291024|NCT00829790|701701|P2|STARTED|First Intervention||15
291025|NCT00829790|701702|P1|STARTED|First Intervention||15
291026|NCT00829764|701712|P2|NOT COMPLETED|Second Intervention||0
291027|NCT00829764|701713|P1|NOT COMPLETED|Second Intervention||0
291028|NCT00829764|701712|P2|COMPLETED|Second Intervention||14
291029|NCT00829764|701713|P1|COMPLETED|Second Intervention||13
291030|NCT00829764|701712|P2|STARTED|Second Intervention||14
291031|NCT00829764|701713|P1|STARTED|Second Intervention||13
291032|NCT00829764|701712|P2|NOT COMPLETED|Washout of 14 Days||0
291033|NCT00829764|701713|P1|NOT COMPLETED|Washout of 14 Days||0
291034|NCT00829764|701712|P2|COMPLETED|Washout of 14 Days||14
291035|NCT00829764|701713|P1|COMPLETED|Washout of 14 Days||13
291036|NCT00829764|701712|P2|STARTED|Washout of 14 Days||14
291037|NCT00829764|701713|P1|STARTED|Washout of 14 Days||13
291038|NCT00829764|701712|P2|NOT COMPLETED|First Intervention||1
291039|NCT00829764|701713|P1|NOT COMPLETED|First Intervention||2
291040|NCT00829764|701712|P2|COMPLETED|First Intervention||14
291041|NCT00829764|701713|P1|COMPLETED|First Intervention||13
291042|NCT00829764|701712|P2|STARTED|First Intervention||15
291043|NCT00829764|701713|P1|STARTED|First Intervention||15
291044|NCT00829738|701721|P1|NOT COMPLETED|Overall Study||8
291045|NCT00829738|701721|P1|COMPLETED|Overall Study||4180
291046|NCT00829738|701721|P1|STARTED|Overall Study||4188
291047|NCT00829712|701739|P2|NOT COMPLETED|Second Intervention||0
291048|NCT00829712|701740|P1|NOT COMPLETED|Second Intervention||0
291049|NCT00829712|701739|P2|COMPLETED|Second Intervention||11
291050|NCT00829712|701740|P1|COMPLETED|Second Intervention||12
291051|NCT00829712|701739|P2|STARTED|Second Intervention||11
291052|NCT00829712|701740|P1|STARTED|Second Intervention||12
291053|NCT00829712|701739|P2|NOT COMPLETED|Washout of 7 Days||1
291054|NCT00829712|701740|P1|NOT COMPLETED|Washout of 7 Days||0
291055|NCT00829712|701739|P2|COMPLETED|Washout of 7 Days||11
291056|NCT00829712|701740|P1|COMPLETED|Washout of 7 Days||12
291057|NCT00829712|701739|P2|STARTED|Washout of 7 Days||12
291058|NCT00829712|701740|P1|STARTED|Washout of 7 Days||12
291059|NCT00829712|701739|P2|NOT COMPLETED|First Intervention||0
291060|NCT00829712|701740|P1|NOT COMPLETED|First Intervention||0
291061|NCT00829712|701739|P2|COMPLETED|First Intervention||12
291062|NCT00829712|701740|P1|COMPLETED|First Intervention||12
291063|NCT00829712|701739|P2|STARTED|First Intervention||12
291064|NCT00829712|701740|P1|STARTED|First Intervention||12
291065|NCT00829686|701750|P2|NOT COMPLETED|Overall Study||0
291066|NCT00829686|701751|P1|NOT COMPLETED|Overall Study||0
291067|NCT00829686|701750|P2|COMPLETED|Overall Study||18
291068|NCT00829686|701751|P1|COMPLETED|Overall Study||13
291069|NCT00829686|701750|P2|STARTED|Overall Study||18
291070|NCT00829686|701751|P1|STARTED|Overall Study||13
291071|NCT00829673|701759|P2|NOT COMPLETED|Second Intervention||0
291072|NCT00829673|701760|P1|NOT COMPLETED|Second Intervention||0
291073|NCT00829673|701759|P2|COMPLETED|Second Intervention||12
291074|NCT00829673|701760|P1|COMPLETED|Second Intervention||11
291075|NCT00829673|701759|P2|STARTED|Second Intervention||12
291076|NCT00829673|701760|P1|STARTED|Second Intervention||11
291077|NCT00829673|701759|P2|NOT COMPLETED|Washout of 7 Days||0
291078|NCT00829673|701760|P1|NOT COMPLETED|Washout of 7 Days||1
291079|NCT00829673|701759|P2|COMPLETED|Washout of 7 Days||12
291080|NCT00829673|701760|P1|COMPLETED|Washout of 7 Days||11
291081|NCT00829673|701759|P2|STARTED|Washout of 7 Days||12
291082|NCT00829673|701760|P1|STARTED|Washout of 7 Days||12
291083|NCT00829673|701759|P2|NOT COMPLETED|First Intervention||0
291084|NCT00829673|701760|P1|NOT COMPLETED|First Intervention||0
291085|NCT00829673|701759|P2|COMPLETED|First Intervention||12
291086|NCT00829673|701760|P1|COMPLETED|First Intervention||12
291087|NCT00829673|701759|P2|STARTED|First Intervention||12
291088|NCT00829673|701760|P1|STARTED|First Intervention||12
291089|NCT00829621|701770|P2|NOT COMPLETED|Overall Study||4
291090|NCT00829621|701771|P1|NOT COMPLETED|Overall Study||4
291091|NCT00829621|701770|P2|COMPLETED|Overall Study||8
291092|NCT00829621|701771|P1|COMPLETED|Overall Study||4
291093|NCT00829621|701770|P2|STARTED|Overall Study||12
291094|NCT00829621|701771|P1|STARTED|Overall Study||8
291095|NCT00829530|701779|P2|NOT COMPLETED|Second Intervention||0
291096|NCT00829530|701780|P1|NOT COMPLETED|Second Intervention||1
291097|NCT00829530|701779|P2|COMPLETED|Second Intervention||18
291098|NCT00829530|701780|P1|COMPLETED|Second Intervention||19
291099|NCT00829530|701779|P2|STARTED|Second Intervention||18
291100|NCT00829530|701780|P1|STARTED|Second Intervention||20
291101|NCT00829530|701779|P2|NOT COMPLETED|Washout of 42 Days||0
291102|NCT00829530|701780|P1|NOT COMPLETED|Washout of 42 Days||0
291103|NCT00829530|701779|P2|COMPLETED|Washout of 42 Days||18
291104|NCT00829530|701780|P1|COMPLETED|Washout of 42 Days||20
291105|NCT00829530|701779|P2|STARTED|Washout of 42 Days||18
291106|NCT00829530|701780|P1|STARTED|Washout of 42 Days||20
291107|NCT00829530|701779|P2|NOT COMPLETED|First Intervention||2
291108|NCT00829530|701780|P1|NOT COMPLETED|First Intervention||0
291109|NCT00829530|701779|P2|COMPLETED|First Intervention||18
291110|NCT00829530|701780|P1|COMPLETED|First Intervention||20
291111|NCT00829530|701779|P2|STARTED|First Intervention||20
291112|NCT00829530|701780|P1|STARTED|First Intervention||20
291113|NCT00829504|701794|P2|NOT COMPLETED|Second Intervention||0
291114|NCT00829504|701795|P1|NOT COMPLETED|Second Intervention||1
291115|NCT00829504|701794|P2|COMPLETED|Second Intervention||22
291116|NCT00829504|701795|P1|COMPLETED|Second Intervention||19
291117|NCT00829504|701794|P2|STARTED|Second Intervention||22
291118|NCT00829504|701795|P1|STARTED|Second Intervention||20
291119|NCT00829504|701794|P2|NOT COMPLETED|Washout of 7 Days||0
291120|NCT00829504|701795|P1|NOT COMPLETED|Washout of 7 Days||1
291121|NCT00829504|701794|P2|COMPLETED|Washout of 7 Days||22
291122|NCT00829504|701795|P1|COMPLETED|Washout of 7 Days||20
291123|NCT00829504|701794|P2|STARTED|Washout of 7 Days||22
291124|NCT00829504|701795|P1|STARTED|Washout of 7 Days||21
291125|NCT00829504|701794|P2|NOT COMPLETED|First Intervention||0
291126|NCT00829504|701795|P1|NOT COMPLETED|First Intervention||1
291127|NCT00829504|701794|P2|COMPLETED|First Intervention||22
291128|NCT00829504|701795|P1|COMPLETED|First Intervention||21
291129|NCT00829504|701794|P2|STARTED|First Intervention||22
291130|NCT00829504|701795|P1|STARTED|First Intervention||22
291131|NCT00829452|701805|P2|NOT COMPLETED|Second Intervention||1
291132|NCT00829452|701806|P1|NOT COMPLETED|Second Intervention||0
291133|NCT00829452|701805|P2|COMPLETED|Second Intervention||17
291134|NCT00829452|701806|P1|COMPLETED|Second Intervention||20
291135|NCT00829452|701805|P2|STARTED|Second Intervention||18
291136|NCT00829452|701806|P1|STARTED|Second Intervention||20
291137|NCT00829452|701805|P2|NOT COMPLETED|Washout of 42 Days||1
291138|NCT00829452|701806|P1|NOT COMPLETED|Washout of 42 Days||0
291139|NCT00829452|701805|P2|COMPLETED|Washout of 42 Days||18
291140|NCT00829452|701806|P1|COMPLETED|Washout of 42 Days||20
291141|NCT00829452|701805|P2|STARTED|Washout of 42 Days||19
291142|NCT00829452|701806|P1|STARTED|Washout of 42 Days||20
291143|NCT00829452|701805|P2|NOT COMPLETED|First Intervention||1
291144|NCT00829452|701806|P1|NOT COMPLETED|First Intervention||0
291145|NCT00829452|701805|P2|COMPLETED|First Intervention||19
291146|NCT00829452|701806|P1|COMPLETED|First Intervention||20
291147|NCT00829452|701805|P2|STARTED|First Intervention||20
291148|NCT00829452|701806|P1|STARTED|First Intervention||20
291149|NCT00829439|701818|P4|NOT COMPLETED|Overall Study||0
291150|NCT00829439|701819|P3|NOT COMPLETED|Overall Study||1
291151|NCT00829439|701820|P2|NOT COMPLETED|Overall Study||0
291152|NCT00829439|701821|P1|NOT COMPLETED|Overall Study||0
291153|NCT00829439|701818|P4|COMPLETED|Overall Study||4
291154|NCT00829439|701819|P3|COMPLETED|Overall Study||5
291155|NCT00829439|701820|P2|COMPLETED|Overall Study||3
291156|NCT00829439|701821|P1|COMPLETED|Overall Study||3
291157|NCT00829439|701818|P4|STARTED|Overall Study||4
291158|NCT00829439|701819|P3|STARTED|Overall Study||6
291159|NCT00829439|701820|P2|STARTED|Overall Study||3
291160|NCT00829439|701821|P1|STARTED|Overall Study||3
291161|NCT00829426|701827|P2|NOT COMPLETED|Second Intervention||0
291162|NCT00829426|701828|P1|NOT COMPLETED|Second Intervention||0
291163|NCT00829426|701827|P2|COMPLETED|Second Intervention||16
291164|NCT00829426|701828|P1|COMPLETED|Second Intervention||15
291165|NCT00829426|701827|P2|STARTED|Second Intervention||16
291166|NCT00829426|701828|P1|STARTED|Second Intervention||15
291167|NCT00829426|701827|P2|NOT COMPLETED|Washout: 7 Days||0
291168|NCT00829426|701828|P1|NOT COMPLETED|Washout: 7 Days||1
291169|NCT00829426|701827|P2|COMPLETED|Washout: 7 Days||16
291170|NCT00829426|701828|P1|COMPLETED|Washout: 7 Days||15
291171|NCT00829426|701827|P2|STARTED|Washout: 7 Days||16
291172|NCT00829426|701828|P1|STARTED|Washout: 7 Days||16
291173|NCT00829426|701827|P2|NOT COMPLETED|First Intervention||0
291174|NCT00829426|701828|P1|NOT COMPLETED|First Intervention||0
291175|NCT00829426|701827|P2|COMPLETED|First Intervention||16
291176|NCT00829426|701828|P1|COMPLETED|First Intervention||16
291177|NCT00829426|701827|P2|STARTED|First Intervention||16
291178|NCT00829426|701828|P1|STARTED|First Intervention||16
291179|NCT00829413|701836|P1|NOT COMPLETED|Overall Study||94
291180|NCT00829413|701836|P1|COMPLETED|Overall Study||259
291181|NCT00829413|701836|P1|STARTED|Overall Study||353
291182|NCT00829387|701885|P2|NOT COMPLETED|Overall Study||3
291183|NCT00829387|701886|P1|NOT COMPLETED|Overall Study||3
291184|NCT00829387|701885|P2|COMPLETED|Overall Study||21
291185|NCT00829387|701886|P1|COMPLETED|Overall Study||20
291186|NCT00829387|701885|P2|STARTED|Overall Study||24
291187|NCT00829387|701886|P1|STARTED|Overall Study||23
291188|NCT00829309|701904|P2|NOT COMPLETED|Second Intervention||0
291189|NCT00829309|701905|P1|NOT COMPLETED|Second Intervention||0
291190|NCT00829309|701904|P2|COMPLETED|Second Intervention||8
291191|NCT00829309|701905|P1|COMPLETED|Second Intervention||7
291192|NCT00829309|701904|P2|STARTED|Second Intervention||8
291193|NCT00829309|701905|P1|STARTED|Second Intervention||7
291194|NCT00829309|701904|P2|NOT COMPLETED|Washout: 7 Days||0
291195|NCT00829309|701905|P1|NOT COMPLETED|Washout: 7 Days||1
291196|NCT00829309|701904|P2|COMPLETED|Washout: 7 Days||8
291197|NCT00829309|701905|P1|COMPLETED|Washout: 7 Days||7
291198|NCT00829309|701904|P2|STARTED|Washout: 7 Days||8
291199|NCT00829309|701905|P1|STARTED|Washout: 7 Days||8
291200|NCT00829309|701904|P2|NOT COMPLETED|First Intervention||0
291201|NCT00829309|701905|P1|NOT COMPLETED|First Intervention||0
291202|NCT00829309|701904|P2|COMPLETED|First Intervention||8
291203|NCT00829309|701905|P1|COMPLETED|First Intervention||8
291204|NCT00829309|701904|P2|STARTED|First Intervention||8
291205|NCT00829309|701905|P1|STARTED|First Intervention||8
291206|NCT00829296|701915|P2|NOT COMPLETED|Overall Study||4
291207|NCT00829296|701916|P1|NOT COMPLETED|Overall Study||5
291208|NCT00829296|701915|P2|COMPLETED|Overall Study||32
291209|NCT00829296|701916|P1|COMPLETED|Overall Study||29
291210|NCT00829296|701915|P2|STARTED|Overall Study||36
291211|NCT00829296|701916|P1|STARTED|Overall Study||34
291212|NCT00829283|701930|P2|NOT COMPLETED|Overall Study||25
291213|NCT00829283|701931|P1|NOT COMPLETED|Overall Study||7
291214|NCT00829283|701930|P2|COMPLETED|Overall Study||127
291215|NCT00829283|701931|P1|COMPLETED|Overall Study||32
291216|NCT00829283|701930|P2|STARTED|Overall Study||152
291217|NCT00829283|701931|P1|STARTED|Overall Study||39
291218|NCT00829244|701941|P2|NOT COMPLETED|Overall Study||21
291219|NCT00829244|701942|P1|NOT COMPLETED|Overall Study||14
291220|NCT00829244|701941|P2|COMPLETED|Overall Study||83
291221|NCT00829244|701942|P1|COMPLETED|Overall Study||82
291222|NCT00829244|701941|P2|STARTED|Overall Study||104
291223|NCT00829244|701942|P1|STARTED|Overall Study||96
291224|NCT00829179|701972|P1|NOT COMPLETED|Overall Study||1
291225|NCT00829179|701972|P1|COMPLETED|Overall Study||19
291226|NCT00829179|701972|P1|STARTED|Overall Study||20
291227|NCT00829166|701978|P2|NOT COMPLETED|Overall Study||496
291228|NCT00829166|701979|P1|NOT COMPLETED|Overall Study||495
291229|NCT00829166|701978|P2|COMPLETED|Overall Study||0
291230|NCT00829166|701979|P1|COMPLETED|Overall Study||0
291231|NCT00829166|701978|P2|Treated|Overall Study||488
291232|NCT00829166|701979|P1|Treated|Overall Study||490
291233|NCT00829166|701978|P2|STARTED|Overall Study||496
291234|NCT00829166|701979|P1|STARTED|Overall Study||495
291235|NCT00829049|702020|P2|NOT COMPLETED|Overall Study||20
291236|NCT00829049|702021|P1|NOT COMPLETED|Overall Study||17
291237|NCT00829049|702020|P2|COMPLETED|Overall Study||68
291238|NCT00829049|702021|P1|COMPLETED|Overall Study||60
291239|NCT00829049|702020|P2|STARTED|Overall Study||88
291240|NCT00829049|702021|P1|STARTED|Overall Study||77
291241|NCT00829036|702033|P1|NOT COMPLETED|Overall Study||0
291242|NCT00829036|702033|P1|COMPLETED|Overall Study||24
291243|NCT00829036|702033|P1|STARTED|Overall Study||24
291244|NCT00829010|702042|P5|NOT COMPLETED|Overall Study||2
291245|NCT00829010|702043|P4|NOT COMPLETED|Overall Study||8
291246|NCT00829010|702044|P3|NOT COMPLETED|Overall Study||3
291247|NCT00829010|702045|P2|NOT COMPLETED|Overall Study||9
291248|NCT00829010|702046|P1|NOT COMPLETED|Overall Study||10
291249|NCT00829010|702042|P5|COMPLETED|Overall Study||98
291250|NCT00829010|702043|P4|COMPLETED|Overall Study||92
291251|NCT00829010|702044|P3|COMPLETED|Overall Study||97
291252|NCT00829010|702045|P2|COMPLETED|Overall Study||92
291253|NCT00829010|702046|P1|COMPLETED|Overall Study||73
291254|NCT00829010|702042|P5|STARTED|Overall Study||100
291255|NCT00829010|702043|P4|STARTED|Overall Study||100
291256|NCT00829010|702044|P3|STARTED|Overall Study||100
291257|NCT00829010|702045|P2|STARTED|Overall Study||101
291258|NCT00829010|702046|P1|STARTED|Overall Study||83
291259|NCT00828984|702211|P3|NOT COMPLETED|Overall Study||9
291260|NCT00828984|702212|P2|NOT COMPLETED|Overall Study||16
291261|NCT00828984|702213|P1|NOT COMPLETED|Overall Study||14
291262|NCT00828984|702211|P3|COMPLETED|Overall Study||19
291263|NCT00828984|702212|P2|COMPLETED|Overall Study||15
291264|NCT00828984|702213|P1|COMPLETED|Overall Study||14
291265|NCT00828984|702211|P3|Post Intervention Follow-Up|Overall Study||19
291266|NCT00828984|702212|P2|Post Intervention Follow-Up|Overall Study||16
291267|NCT00828984|702213|P1|Post Intervention Follow-Up|Overall Study||15
291268|NCT00828984|702211|P3|Flexible Sigmoidoscopy|Overall Study||19
291269|NCT00828984|702212|P2|Flexible Sigmoidoscopy|Overall Study||19
291270|NCT00828984|702213|P1|Flexible Sigmoidoscopy|Overall Study||20
291271|NCT00828984|702211|P3|Treatment|Overall Study||24
291272|NCT00828984|702212|P2|Treatment|Overall Study||26
291273|NCT00828984|702213|P1|Treatment|Overall Study||24
291274|NCT00828984|702211|P3|Randomization|Overall Study||28
291275|NCT00828984|702212|P2|Randomization|Overall Study||31
291276|NCT00828984|702213|P1|Randomization|Overall Study||28
291277|NCT00828984|702211|P3|STARTED|Overall Study||28
291278|NCT00828984|702212|P2|STARTED|Overall Study||31
291279|NCT00828984|702213|P1|STARTED|Overall Study||28
291280|NCT00828945|702236|P1|NOT COMPLETED|Overall Study||41
291281|NCT00828945|702236|P1|COMPLETED|Overall Study||216
291282|NCT00828945|702236|P1|STARTED|Overall Study||257
291283|NCT00828841|702253|P3|NOT COMPLETED|Overall Study||4
291284|NCT00828841|702254|P2|NOT COMPLETED|Overall Study||4
291285|NCT00828841|702255|P1|NOT COMPLETED|Overall Study||4
291286|NCT00828841|702253|P3|COMPLETED|Overall Study||126
291287|NCT00828841|702254|P2|COMPLETED|Overall Study||232
291288|NCT00828841|702255|P1|COMPLETED|Overall Study||231
291289|NCT00828841|702253|P3|STARTED|Overall Study||130
291290|NCT00828841|702254|P2|STARTED|Overall Study||236
291291|NCT00828841|702255|P1|STARTED|Overall Study||235
291292|NCT00828750|702268|P1|NOT COMPLETED|Overall Study||4
291293|NCT00828750|702268|P1|COMPLETED|Overall Study||15
291294|NCT00828750|702268|P1|STARTED|Overall Study||19
291295|NCT00828711|702282|P3|NOT COMPLETED|Overall Study||0
291296|NCT00828711|702283|P2|NOT COMPLETED|Overall Study||0
291297|NCT00828711|702284|P1|NOT COMPLETED|Overall Study||1
291298|NCT00828711|702282|P3|COMPLETED|Overall Study||131
291299|NCT00828711|702283|P2|COMPLETED|Overall Study||125
291300|NCT00828711|702284|P1|COMPLETED|Overall Study||117
291301|NCT00828711|702282|P3|STARTED|Overall Study||131
291302|NCT00828711|702283|P2|STARTED|Overall Study||125
291303|NCT00828711|702284|P1|STARTED|Overall Study||118
291304|NCT00828672|702315|P2|NOT COMPLETED|Follow-up||0
291305|NCT00828672|702316|P1|NOT COMPLETED|Follow-up||0
291306|NCT00828672|702315|P2|COMPLETED|Follow-up||41
291307|NCT00828672|702316|P1|COMPLETED|Follow-up||42
291308|NCT00828672|702315|P2|STARTED|Follow-up|Patients with no central review material and with adverse event are in followup (joined this period)|41
291309|NCT00828672|702316|P1|STARTED|Follow-up|Patient in Arm 1 with clinical complete response and no surgery is in follow up (joined this period)|42
291310|NCT00828672|702315|P2|NOT COMPLETED|Post-surgery (<30 Days)||1
291311|NCT00828672|702316|P1|NOT COMPLETED|Post-surgery (<30 Days)||0
291312|NCT00828672|702315|P2|COMPLETED|Post-surgery (<30 Days)||38
291313|NCT00828672|702316|P1|COMPLETED|Post-surgery (<30 Days)||41
291314|NCT00828672|702315|P2|STARTED|Post-surgery (<30 Days)||39
291315|NCT00828672|702316|P1|STARTED|Post-surgery (<30 Days)||41
291316|NCT00828672|702315|P2|NOT COMPLETED|Study Treatment||2
291317|NCT00828672|702316|P1|NOT COMPLETED|Study Treatment||2
291318|NCT00828672|702315|P2|COMPLETED|Study Treatment||39
291319|NCT00828672|702316|P1|COMPLETED|Study Treatment||41
291320|NCT00828672|702315|P2|STARTED|Study Treatment||41
291321|NCT00828672|702316|P1|STARTED|Study Treatment||43
291322|NCT00828672|702315|P2|NOT COMPLETED|Pre-treatment (Baseline)||0
291323|NCT00828672|702316|P1|NOT COMPLETED|Pre-treatment (Baseline)||0
291324|NCT00828672|702315|P2|COMPLETED|Pre-treatment (Baseline)||41
291325|NCT00828672|702316|P1|COMPLETED|Pre-treatment (Baseline)||43
291326|NCT00828672|702315|P2|STARTED|Pre-treatment (Baseline)||41
291327|NCT00828672|702316|P1|STARTED|Pre-treatment (Baseline)||43
291328|NCT00828568|702337|P3|NOT COMPLETED|Treated - Received at Least One Dose||5
291329|NCT00828568|702338|P2|NOT COMPLETED|Treated - Received at Least One Dose||29
291330|NCT00828568|702339|P1|NOT COMPLETED|Treated - Received at Least One Dose||30
291331|NCT00828568|702337|P3|COMPLETED|Treated - Received at Least One Dose||55
291332|NCT00828568|702338|P2|COMPLETED|Treated - Received at Least One Dose||150
291333|NCT00828568|702339|P1|COMPLETED|Treated - Received at Least One Dose||153
291334|NCT00828568|702337|P3|STARTED|Treated - Received at Least One Dose||60
291335|NCT00828568|702338|P2|STARTED|Treated - Received at Least One Dose||179
291336|NCT00828568|702339|P1|STARTED|Treated - Received at Least One Dose||183
291337|NCT00828568|702337|P3|NOT COMPLETED|Randomized||2
291338|NCT00828568|702338|P2|NOT COMPLETED|Randomized||0
291339|NCT00828568|702339|P1|NOT COMPLETED|Randomized||1
291340|NCT00828568|702337|P3|COMPLETED|Randomized||60
291341|NCT00828568|702338|P2|COMPLETED|Randomized||179
291342|NCT00828568|702339|P1|COMPLETED|Randomized||183
291343|NCT00828568|702337|P3|STARTED|Randomized||62
291344|NCT00828568|702338|P2|STARTED|Randomized||179
291345|NCT00828568|702339|P1|STARTED|Randomized||184
291346|NCT00828542|702354|P2|NOT COMPLETED|Overall Study||3
291347|NCT00828542|702355|P1|NOT COMPLETED|Overall Study||3
291348|NCT00828542|702354|P2|COMPLETED|Overall Study||20
291349|NCT00828542|702355|P1|COMPLETED|Overall Study||20
291350|NCT00828542|702354|P2|STARTED|Overall Study||23
291351|NCT00828542|702355|P1|STARTED|Overall Study||23
291352|NCT00828516|702361|P1|NOT COMPLETED|Clinical Phase: Series 2||0
291353|NCT00828516|702361|P1|COMPLETED|Clinical Phase: Series 2||30
291354|NCT00828516|702361|P1|STARTED|Clinical Phase: Series 2||30
291355|NCT00828516|702361|P1|NOT COMPLETED|Clinical Phase: Series 1||2
291356|NCT00828516|702361|P1|COMPLETED|Clinical Phase: Series 1||33
291357|NCT00828516|702361|P1|STARTED|Clinical Phase: Series 1||35
291358|NCT00828464|702366|P1|NOT COMPLETED|Overall Study||1
291359|NCT00828464|702366|P1|COMPLETED|Overall Study||29
291360|NCT00828464|702366|P1|STARTED|Overall Study||30
291361|NCT00828451|702383|P1|NOT COMPLETED|Overall Study||11
291362|NCT00828451|702383|P1|COMPLETED|Overall Study||18
291363|NCT00828451|702383|P1|STARTED|Overall Study||29
291364|NCT00828412|702391|P2|NOT COMPLETED|Overall Study||2
291365|NCT00828412|702392|P1|NOT COMPLETED|Overall Study||9
291366|NCT00828412|702391|P2|COMPLETED|Overall Study||48
291367|NCT00828412|702392|P1|COMPLETED|Overall Study||41
291368|NCT00828412|702391|P2|STARTED|Overall Study||50
291369|NCT00828412|702392|P1|STARTED|Overall Study||50
291370|NCT00828347|702400|P2|NOT COMPLETED|Overall Study||0
291371|NCT00828347|702401|P1|NOT COMPLETED|Overall Study||0
291372|NCT00828347|702400|P2|COMPLETED|Overall Study||11
291373|NCT00828347|702401|P1|COMPLETED|Overall Study||12
291374|NCT00828347|702400|P2|STARTED|Overall Study||11
291375|NCT00828347|702401|P1|STARTED|Overall Study||12
291376|NCT00828321|702409|P2|NOT COMPLETED|Second Intervention||1
291377|NCT00828321|702410|P1|NOT COMPLETED|Second Intervention||0
291378|NCT00828321|702409|P2|COMPLETED|Second Intervention||19
291379|NCT00828321|702410|P1|COMPLETED|Second Intervention||18
291380|NCT00828321|702409|P2|STARTED|Second Intervention||20
291381|NCT00828321|702410|P1|STARTED|Second Intervention||18
291382|NCT00828321|702409|P2|NOT COMPLETED|Washout of 42 Days||0
291383|NCT00828321|702410|P1|NOT COMPLETED|Washout of 42 Days||2
291384|NCT00828321|702409|P2|COMPLETED|Washout of 42 Days||20
291385|NCT00828321|702410|P1|COMPLETED|Washout of 42 Days||18
291386|NCT00828321|702409|P2|STARTED|Washout of 42 Days||20
291387|NCT00828321|702410|P1|STARTED|Washout of 42 Days||20
291388|NCT00828321|702409|P2|NOT COMPLETED|First Intervention||0
291389|NCT00828321|702410|P1|NOT COMPLETED|First Intervention||0
291390|NCT00828321|702409|P2|COMPLETED|First Intervention||20
291391|NCT00828321|702410|P1|COMPLETED|First Intervention||20
291392|NCT00828321|702409|P2|STARTED|First Intervention||20
291393|NCT00828321|702410|P1|STARTED|First Intervention||20
291394|NCT00828308|702422|P1|NOT COMPLETED|Overall Study||0
291395|NCT00828308|702422|P1|COMPLETED|Overall Study||16
291396|NCT00828308|702422|P1|STARTED|Overall Study||16
291397|NCT00828295|702428|P2|NOT COMPLETED|Overall Study||0
291398|NCT00828295|702429|P1|NOT COMPLETED|Overall Study||0
291399|NCT00828295|702428|P2|COMPLETED|Overall Study||75
291400|NCT00828295|702429|P1|COMPLETED|Overall Study||75
291401|NCT00828295|702428|P2|STARTED|Overall Study||75
291402|NCT00828295|702429|P1|STARTED|Overall Study||75
291403|NCT00828204|702439|P2|NOT COMPLETED|Extension Study||3
291404|NCT00828204|702440|P1|NOT COMPLETED|Extension Study||0
291405|NCT00828204|702439|P2|COMPLETED|Extension Study||61
291406|NCT00828204|702440|P1|COMPLETED|Extension Study||0
291407|NCT00828204|702439|P2|STARTED|Extension Study|Participation in Extension Study was optional for Main Subset participants completing Main Study.|64
291408|NCT00828204|702440|P1|STARTED|Extension Study|Participation in the Extension Study was not offered to Initial Subset after completing Main Study.|0
291409|NCT00828204|702439|P2|NOT COMPLETED|Main Study: After Study Restart||3
291410|NCT00828204|702440|P1|NOT COMPLETED|Main Study: After Study Restart||0
291411|NCT00828204|702439|P2|COMPLETED|Main Study: After Study Restart||71
291412|NCT00828204|702440|P1|COMPLETED|Main Study: After Study Restart||0
291413|NCT00828204|702439|P2|Continued With Autoinjector Injections|Main Study: After Study Restart||72
291414|NCT00828204|702440|P1|Continued With Autoinjector Injections|Main Study: After Study Restart||0
291415|NCT00828204|702439|P2|Completed Manual Injection|Main Study: After Study Restart||74
291416|NCT00828204|702440|P1|Completed Manual Injection|Main Study: After Study Restart||0
291417|NCT00828204|702439|P2|STARTED|Main Study: After Study Restart|After a protocol amendment, the Main Subset participants were enrolled.|74
291418|NCT00828204|702440|P1|STARTED|Main Study: After Study Restart|Initial Subset participants did not continue after the study was suspended.|0
291419|NCT00828204|702439|P2|NOT COMPLETED|Main Study: Prior to Study Suspension||0
291420|NCT00828204|702440|P1|NOT COMPLETED|Main Study: Prior to Study Suspension||14
291421|NCT00828204|702439|P2|COMPLETED|Main Study: Prior to Study Suspension||0
291422|NCT00828204|702440|P1|COMPLETED|Main Study: Prior to Study Suspension||7
291423|NCT00828204|702439|P2|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||0
291424|NCT00828204|702440|P1|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||19
291425|NCT00828204|702439|P2|Completed Manual Injection|Main Study: Prior to Study Suspension||0
291426|NCT00828204|702440|P1|Completed Manual Injection|Main Study: Prior to Study Suspension||21
291427|NCT00828204|702439|P2|STARTED|Main Study: Prior to Study Suspension|Main Subset was not enrolled until after study suspension (period 2, below).|0
291428|NCT00828204|702440|P1|STARTED|Main Study: Prior to Study Suspension||21
291429|NCT00828191|702459|P2|NOT COMPLETED|Overall Study||10
291430|NCT00828191|702460|P1|NOT COMPLETED|Overall Study||8
291431|NCT00828191|702459|P2|COMPLETED|Overall Study|Patients with at least one embryo transferred.|390
291432|NCT00828191|702460|P1|COMPLETED|Overall Study|Patients with at least one embryo transferred.|392
291433|NCT00828191|702459|P2|STARTED|Overall Study|Randomized patients|400
291434|NCT00828191|702460|P1|STARTED|Overall Study|Randomized patients|400
291435|NCT00828178|702472|P2|NOT COMPLETED|Overall Study||2
291436|NCT00828178|702473|P1|NOT COMPLETED|Overall Study||0
291437|NCT00828178|702472|P2|COMPLETED|Overall Study|Two patients did not complete the study.|43
291438|NCT00828178|702473|P1|COMPLETED|Overall Study||42
291439|NCT00828178|702472|P2|STARTED|Overall Study|Eighty seven participants were randomized.|45
291440|NCT00828178|702473|P1|STARTED|Overall Study||42
291441|NCT00828139|702487|P4|NOT COMPLETED|Overall Study||51
291442|NCT00828139|702488|P3|NOT COMPLETED|Overall Study||55
291443|NCT00828139|702489|P2|NOT COMPLETED|Overall Study||41
291444|NCT00828139|702490|P1|NOT COMPLETED|Overall Study||41
291445|NCT00828139|702487|P4|COMPLETED|Overall Study||0
291446|NCT00828139|702488|P3|COMPLETED|Overall Study||0
291447|NCT00828139|702489|P2|COMPLETED|Overall Study||0
291448|NCT00828139|702490|P1|COMPLETED|Overall Study||1
291449|NCT00828139|702487|P4|STARTED|Overall Study||51
291450|NCT00828139|702488|P3|STARTED|Overall Study||55
291451|NCT00828139|702489|P2|STARTED|Overall Study||41
291452|NCT00828139|702490|P1|STARTED|Overall Study||42
291453|NCT00828113|702510|P2|NOT COMPLETED|Overall Study||31
291454|NCT00828113|702511|P1|NOT COMPLETED|Overall Study||30
291455|NCT00828113|702510|P2|COMPLETED|Overall Study||20
291456|NCT00828113|702511|P1|COMPLETED|Overall Study||20
291457|NCT00828113|702510|P2|STARTED|Overall Study||51
291458|NCT00828113|702511|P1|STARTED|Overall Study||50
291459|NCT00828074|702519|P3|NOT COMPLETED|Overall Study||0
291460|NCT00828074|702520|P2|NOT COMPLETED|Overall Study||0
291461|NCT00828074|702521|P1|NOT COMPLETED|Overall Study||0
291462|NCT00828074|702519|P3|COMPLETED|Overall Study||35
291463|NCT00828074|702520|P2|COMPLETED|Overall Study||5
291464|NCT00828074|702521|P1|COMPLETED|Overall Study||6
291465|NCT00828074|702519|P3|STARTED|Overall Study||35
291466|NCT00828074|702520|P2|STARTED|Overall Study||5
291467|NCT00828074|702521|P1|STARTED|Overall Study||6
291468|NCT00828061|702533|P6|NOT COMPLETED|Period 3||0
291469|NCT00828061|702534|P5|NOT COMPLETED|Period 3||0
291470|NCT00828061|702535|P4|NOT COMPLETED|Period 3||0
291471|NCT00828061|702536|P3|NOT COMPLETED|Period 3||0
291472|NCT00828061|702537|P2|NOT COMPLETED|Period 3||0
291473|NCT00828061|702538|P1|NOT COMPLETED|Period 3||0
291474|NCT00828061|702533|P6|COMPLETED|Period 3||3
291475|NCT00828061|702534|P5|COMPLETED|Period 3||3
291476|NCT00828061|702535|P4|COMPLETED|Period 3||3
291477|NCT00828061|702536|P3|COMPLETED|Period 3||3
291478|NCT00828061|702537|P2|COMPLETED|Period 3||3
291479|NCT00828061|702538|P1|COMPLETED|Period 3||4
291480|NCT00828061|702533|P6|STARTED|Period 3||3
291481|NCT00828061|702534|P5|STARTED|Period 3||3
291482|NCT00828061|702535|P4|STARTED|Period 3||3
291483|NCT00828061|702536|P3|STARTED|Period 3||3
291484|NCT00828061|702537|P2|STARTED|Period 3||3
291485|NCT00828061|702538|P1|STARTED|Period 3||4
291486|NCT00828061|702533|P6|NOT COMPLETED|Period 2||0
291487|NCT00828061|702534|P5|NOT COMPLETED|Period 2||0
291488|NCT00828061|702535|P4|NOT COMPLETED|Period 2||0
291489|NCT00828061|702536|P3|NOT COMPLETED|Period 2||0
291490|NCT00828061|702537|P2|NOT COMPLETED|Period 2||0
291491|NCT00828061|702538|P1|NOT COMPLETED|Period 2||0
291492|NCT00828061|702533|P6|COMPLETED|Period 2||3
291493|NCT00828061|702534|P5|COMPLETED|Period 2||3
291494|NCT00828061|702535|P4|COMPLETED|Period 2||3
291495|NCT00828061|702536|P3|COMPLETED|Period 2||3
291496|NCT00828061|702537|P2|COMPLETED|Period 2||3
291497|NCT00828061|702538|P1|COMPLETED|Period 2||4
291498|NCT00828061|702533|P6|STARTED|Period 2||3
291499|NCT00828061|702534|P5|STARTED|Period 2||3
291500|NCT00828061|702535|P4|STARTED|Period 2||3
291501|NCT00828061|702536|P3|STARTED|Period 2||3
291502|NCT00828061|702537|P2|STARTED|Period 2||3
291503|NCT00828061|702538|P1|STARTED|Period 2||4
291504|NCT00828061|702533|P6|NOT COMPLETED|Period 1||0
291505|NCT00828061|702534|P5|NOT COMPLETED|Period 1||0
291506|NCT00828061|702535|P4|NOT COMPLETED|Period 1||0
291507|NCT00828061|702536|P3|NOT COMPLETED|Period 1||0
291508|NCT00828061|702537|P2|NOT COMPLETED|Period 1||0
291509|NCT00828061|702538|P1|NOT COMPLETED|Period 1||0
291510|NCT00828061|702533|P6|COMPLETED|Period 1||3
291511|NCT00828061|702534|P5|COMPLETED|Period 1||3
291512|NCT00828061|702535|P4|COMPLETED|Period 1||3
291513|NCT00828061|702536|P3|COMPLETED|Period 1||3
291514|NCT00828061|702537|P2|COMPLETED|Period 1||3
291515|NCT00828061|702538|P1|COMPLETED|Period 1||4
291516|NCT00828061|702533|P6|STARTED|Period 1||3
291517|NCT00828061|702534|P5|STARTED|Period 1||3
291518|NCT00828061|702535|P4|STARTED|Period 1||3
291519|NCT00828061|702536|P3|STARTED|Period 1||3
291520|NCT00828061|702537|P2|STARTED|Period 1||3
291521|NCT00828061|702538|P1|STARTED|Period 1||4
291522|NCT00828009|702549|P1|NOT COMPLETED|Step 2 - Maintenance Therapy||33
291523|NCT00828009|702549|P1|COMPLETED|Step 2 - Maintenance Therapy|Max maintenance therapy was 34 cycles. No patients were off treatment due to completion of 34 cycles|0
291524|NCT00828009|702549|P1|STARTED|Step 2 - Maintenance Therapy|Among 39 pts with tx completion, 4 did not register to step 2 and 2 had PD at the end of step 1.|33
291525|NCT00828009|702549|P1|NOT COMPLETED|Step 1 - Chemo RT/Consolidation Chemo||31
291526|NCT00828009|702549|P1|COMPLETED|Step 1 - Chemo RT/Consolidation Chemo||39
291527|NCT00828009|702549|P1|STARTED|Step 1 - Chemo RT/Consolidation Chemo||70
291528|NCT00827983|702558|P2|NOT COMPLETED|Overall Study||16
291529|NCT00827983|702559|P1|NOT COMPLETED|Overall Study||18
291530|NCT00827983|702558|P2|COMPLETED|Overall Study|patients who performed the pregnancy test|328
291531|NCT00827983|702559|P1|COMPLETED|Overall Study|patients who performed the pregnancy test|321
291532|NCT00827983|702558|P2|STARTED|Overall Study|all randomised patients|344
291533|NCT00827983|702559|P1|STARTED|Overall Study|All randomised patients|339
291534|NCT00827944|702571|P2|NOT COMPLETED|Overall Study||59
291535|NCT00827944|702572|P1|NOT COMPLETED|Overall Study||63
291536|NCT00827944|702571|P2|COMPLETED|Overall Study||240
291537|NCT00827944|702572|P1|COMPLETED|Overall Study||241
291538|NCT00827944|702571|P2|STARTED|Overall Study||299
291539|NCT00827944|702572|P1|STARTED|Overall Study||304
291540|NCT00827931|702592|P2|NOT COMPLETED|Overall Study||6
291541|NCT00827931|702593|P1|NOT COMPLETED|Overall Study||6
291542|NCT00827931|702592|P2|COMPLETED|Overall Study||39
291543|NCT00827931|702593|P1|COMPLETED|Overall Study||43
291544|NCT00827931|702592|P2|STARTED|Overall Study||45
291545|NCT00827931|702593|P1|STARTED|Overall Study||49
291546|NCT00827918|702614|P3|NOT COMPLETED|Overall Study||21
291547|NCT00827918|702615|P2|NOT COMPLETED|Overall Study||9
291548|NCT00827918|702616|P1|NOT COMPLETED|Overall Study||28
291549|NCT00827918|702614|P3|COMPLETED|Overall Study||62
291550|NCT00827918|702615|P2|COMPLETED|Overall Study||38
291551|NCT00827918|702616|P1|COMPLETED|Overall Study||58
291552|NCT00827918|702614|P3|STARTED|Overall Study||83
291553|NCT00827918|702615|P2|STARTED|Overall Study||47
291554|NCT00827918|702616|P1|STARTED|Overall Study||86
291555|NCT00827827|702644|P2|NOT COMPLETED|Overall Study||0
291556|NCT00827827|702645|P1|NOT COMPLETED|Overall Study||8
291557|NCT00827827|702644|P2|COMPLETED|Overall Study||16
291558|NCT00827827|702645|P1|COMPLETED|Overall Study||14
291559|NCT00827827|702644|P2|STARTED|Overall Study||16
291560|NCT00827827|702645|P1|STARTED|Overall Study||22
291561|NCT00827632|702689|P2|NOT COMPLETED|Overall Study||23
291562|NCT00827632|702690|P1|NOT COMPLETED|Overall Study||22
291563|NCT00827632|702689|P2|COMPLETED|Overall Study||75
291564|NCT00827632|702690|P1|COMPLETED|Overall Study||106
291565|NCT00827632|702689|P2|STARTED|Overall Study||98
291566|NCT00827632|702690|P1|STARTED|Overall Study||128
291567|NCT00827606|702702|P2|NOT COMPLETED|Overall Study||38
291568|NCT00827606|702703|P1|NOT COMPLETED|Overall Study||27
291569|NCT00827606|702702|P2|COMPLETED|Overall Study||94
291570|NCT00827606|702703|P1|COMPLETED|Overall Study||112
291571|NCT00827606|702702|P2|STARTED|Overall Study||132
291572|NCT00827606|702703|P1|STARTED|Overall Study||139
291573|NCT00827567|702764|P1|NOT COMPLETED|Overall Study||4
291574|NCT00827567|702764|P1|COMPLETED|Overall Study|2 screen failures, 4 withdrew from study to go on to other therapies|0
291575|NCT00827567|702764|P1|STARTED|Overall Study||4
291576|NCT00827541|702770|P2|NOT COMPLETED|Overall Study||11
291577|NCT00827541|702771|P1|NOT COMPLETED|Overall Study||4
291578|NCT00827541|702770|P2|COMPLETED|Overall Study||85
291579|NCT00827541|702771|P1|COMPLETED|Overall Study||15
291580|NCT00827541|702770|P2|STARTED|Overall Study||96
291581|NCT00827541|702771|P1|STARTED|Overall Study||19
291582|NCT00827502|702783|P1|NOT COMPLETED|Overall Study||21
291583|NCT00827502|702783|P1|COMPLETED|Overall Study||400
291584|NCT00827502|702783|P1|Received Treatment (Number Treated)|Overall Study||410
291585|NCT00827502|702783|P1|STARTED|Overall Study||421
291586|NCT00827372|702789|P1|NOT COMPLETED|Overall Study||8
291587|NCT00827372|702789|P1|COMPLETED|Overall Study||2
291588|NCT00827372|702789|P1|STARTED|Overall Study||10
291589|NCT00827255|702797|P1|NOT COMPLETED|Overall Study||0
291590|NCT00827255|702797|P1|COMPLETED|Overall Study||35
291591|NCT00827255|702797|P1|STARTED|Overall Study||35
291592|NCT00827242|702804|P2|NOT COMPLETED|Overall Study||12
291593|NCT00827242|702805|P1|NOT COMPLETED|Overall Study||13
291594|NCT00827242|702804|P2|COMPLETED|Overall Study||152
291595|NCT00827242|702805|P1|COMPLETED|Overall Study||148
291596|NCT00827242|702804|P2|STARTED|Overall Study||164
291597|NCT00827242|702805|P1|STARTED|Overall Study||161
291598|NCT00827112|702843|P2|NOT COMPLETED|Overall Study||12
291599|NCT00827112|702844|P1|NOT COMPLETED|Overall Study||15
291600|NCT00827112|702843|P2|COMPLETED|Overall Study||52
291601|NCT00827112|702844|P1|COMPLETED|Overall Study||50
291602|NCT00827112|702843|P2|Treated|Overall Study||61
291603|NCT00827112|702844|P1|Treated|Overall Study||60
291604|NCT00827112|702843|P2|STARTED|Overall Study||64
291605|NCT00827112|702844|P1|STARTED|Overall Study||65
291606|NCT00827099|702877|P1|NOT COMPLETED|Overall Study||0
291607|NCT00827099|702877|P1|COMPLETED|Overall Study||5
291608|NCT00827099|702877|P1|STARTED|Overall Study||5
291609|NCT00827073|702888|P2|NOT COMPLETED|Overall Study||0
291610|NCT00827073|702889|P1|NOT COMPLETED|Overall Study||0
291611|NCT00827073|702888|P2|COMPLETED|Overall Study||20
291612|NCT00827073|702889|P1|COMPLETED|Overall Study||20
291613|NCT00827073|702888|P2|STARTED|Overall Study||20
291614|NCT00827073|702889|P1|STARTED|Overall Study||20
291615|NCT00826943|702897|P6|NOT COMPLETED|Overall Study||0
291616|NCT00826943|702898|P5|NOT COMPLETED|Overall Study||1
291617|NCT00826943|702899|P4|NOT COMPLETED|Overall Study||0
291618|NCT00826943|702900|P3|NOT COMPLETED|Overall Study||0
291619|NCT00826943|702901|P2|NOT COMPLETED|Overall Study||0
291620|NCT00826943|702902|P1|NOT COMPLETED|Overall Study||0
291621|NCT00826943|702897|P6|COMPLETED|Overall Study||2
291622|NCT00826943|702898|P5|COMPLETED|Overall Study||6
291623|NCT00826943|702899|P4|COMPLETED|Overall Study||5
291624|NCT00826943|702900|P3|COMPLETED|Overall Study||4
291625|NCT00826943|702901|P2|COMPLETED|Overall Study||6
291626|NCT00826943|702902|P1|COMPLETED|Overall Study||6
291627|NCT00826943|702897|P6|STARTED|Overall Study||2
291628|NCT00826943|702898|P5|STARTED|Overall Study||7
291629|NCT00826943|702899|P4|STARTED|Overall Study||5
291630|NCT00826943|702900|P3|STARTED|Overall Study||4
291631|NCT00826943|702901|P2|STARTED|Overall Study||6
291632|NCT00826943|702902|P1|STARTED|Overall Study||6
291633|NCT00826800|702916|P1|NOT COMPLETED|Overall Study||0
291634|NCT00826800|702916|P1|COMPLETED|Overall Study||2
291635|NCT00826800|702916|P1|STARTED|Overall Study||2
291636|NCT00826748|702923|P3|NOT COMPLETED|Overall Study||4
291637|NCT00826748|702924|P2|NOT COMPLETED|Overall Study||0
291638|NCT00826748|702925|P1|NOT COMPLETED|Overall Study||0
291639|NCT00826748|702923|P3|COMPLETED|Overall Study||8
291640|NCT00826748|702924|P2|COMPLETED|Overall Study||4
291641|NCT00826748|702925|P1|COMPLETED|Overall Study||6
291642|NCT00826748|702923|P3|STARTED|Overall Study||12
291643|NCT00826748|702924|P2|STARTED|Overall Study||4
291644|NCT00826748|702925|P1|STARTED|Overall Study||6
291645|NCT00826618|702933|P1|NOT COMPLETED|Overall Study||1
291646|NCT00826618|702933|P1|COMPLETED|Overall Study||5
291647|NCT00826618|702933|P1|STARTED|Overall Study||6
291648|NCT00826540|702937|P1|NOT COMPLETED|Overall Study||4
291649|NCT00826540|702937|P1|COMPLETED|Overall Study||79
291650|NCT00826540|702937|P1|STARTED|Overall Study||83
291651|NCT00826449|702943|P1|NOT COMPLETED|Overall Study||5
291652|NCT00826449|702943|P1|COMPLETED|Overall Study||42
291653|NCT00826449|702943|P1|Phase II|Overall Study||35
291654|NCT00826449|702943|P1|Phase I|Overall Study||12
291655|NCT00826449|702943|P1|STARTED|Overall Study||47
291656|NCT00826280|702952|P3|NOT COMPLETED|Overall Study||46
291657|NCT00826280|702953|P2|NOT COMPLETED|Overall Study||46
291658|NCT00826280|702954|P1|NOT COMPLETED|Overall Study||48
291659|NCT00826280|702952|P3|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|71
291660|NCT00826280|702953|P2|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|70
291661|NCT00826280|702954|P1|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|66
291662|NCT00826280|702952|P3|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|72
291663|NCT00826280|702953|P2|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|71
291664|NCT00826280|702954|P1|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|66
291665|NCT00826280|702952|P3|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
291666|NCT00826280|702953|P2|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
291667|NCT00826280|702954|P1|Safety Analysis Set|Overall Study|Safety Analysis Set (SAF) was all randomized subjects who received at least one dose of regadenoson|113
291668|NCT00826280|702952|P3|STARTED|Overall Study||117
291669|NCT00826280|702953|P2|STARTED|Overall Study||116
291670|NCT00826280|702954|P1|STARTED|Overall Study||114
291671|NCT00826267|702983|P3|NOT COMPLETED|Overall Study||0
291672|NCT00826267|702984|P2|NOT COMPLETED|Overall Study||0
291673|NCT00826267|702985|P1|NOT COMPLETED|Overall Study||1
291674|NCT00826267|702983|P3|COMPLETED|Overall Study||11
291675|NCT00826267|702984|P2|COMPLETED|Overall Study||8
291676|NCT00826267|702985|P1|COMPLETED|Overall Study||9
291677|NCT00826267|702983|P3|STARTED|Overall Study||11
291678|NCT00826267|702984|P2|STARTED|Overall Study||8
291679|NCT00826267|702985|P1|STARTED|Overall Study||10
291680|NCT00826241|703003|P1|NOT COMPLETED|Overall Study||27
291681|NCT00826241|703003|P1|COMPLETED|Overall Study||31
291682|NCT00826241|703003|P1|STARTED|Overall Study||58
291683|NCT00826228|703009|P1|NOT COMPLETED|Overall Study||1
291684|NCT00826228|703009|P1|COMPLETED|Overall Study||11
291685|NCT00826228|703009|P1|STARTED|Overall Study||12
291686|NCT00826202|703016|P2|NOT COMPLETED|Overall Study||13
291687|NCT00826202|703017|P1|NOT COMPLETED|Overall Study||10
291688|NCT00826202|703016|P2|COMPLETED|Overall Study||11
291689|NCT00826202|703017|P1|COMPLETED|Overall Study||10
291690|NCT00826202|703016|P2|Completed Visit 4 (1st Efficacy Visit)|Overall Study||20
291691|NCT00826202|703017|P1|Completed Visit 4 (1st Efficacy Visit)|Overall Study||15
291692|NCT00826202|703016|P2|STARTED|Overall Study||24
291693|NCT00826202|703017|P1|STARTED|Overall Study||20
291694|NCT00826176|703031|P2|NOT COMPLETED|Overall Study||0
291695|NCT00826176|703032|P1|NOT COMPLETED|Overall Study||13
291696|NCT00826176|703031|P2|COMPLETED|Overall Study|treated and completed|36
291697|NCT00826176|703032|P1|COMPLETED|Overall Study|treated and completed|115
291698|NCT00826176|703031|P2|STARTED|Overall Study|enrolled|36
291699|NCT00826176|703032|P1|STARTED|Overall Study|enrolled|128
291700|NCT00826150|703045|P3|NOT COMPLETED|Overall Study||3
291701|NCT00826150|703046|P2|NOT COMPLETED|Overall Study||2
291702|NCT00826150|703047|P1|NOT COMPLETED|Overall Study||6
291703|NCT00826150|703045|P3|COMPLETED|Overall Study||0
291704|NCT00826150|703046|P2|COMPLETED|Overall Study||1
291705|NCT00826150|703047|P1|COMPLETED|Overall Study||2
291706|NCT00826150|703045|P3|STARTED|Overall Study||3
291707|NCT00826150|703046|P2|STARTED|Overall Study||3
291708|NCT00826150|703047|P1|STARTED|Overall Study||8
291709|NCT00826111|703081|P2|NOT COMPLETED|Overall Study||2
291710|NCT00826111|703082|P1|NOT COMPLETED|Overall Study||7
291711|NCT00826111|703081|P2|COMPLETED|Overall Study||3
291712|NCT00826111|703082|P1|COMPLETED|Overall Study||7
291713|NCT00826111|703081|P2|STARTED|Overall Study||5
291714|NCT00826111|703082|P1|STARTED|Overall Study||14
291715|NCT00826020|703104|P1|NOT COMPLETED|Overall Study||0
291716|NCT00826020|703104|P1|COMPLETED|Overall Study||72
291717|NCT00826020|703104|P1|STARTED|Overall Study||72
291718|NCT00826007|703111|P2|NOT COMPLETED|Overall Study||0
291719|NCT00826007|703112|P1|NOT COMPLETED|Overall Study||0
291720|NCT00826007|703111|P2|COMPLETED|Overall Study||279
291721|NCT00826007|703112|P1|COMPLETED|Overall Study|Retrospective review|308
291722|NCT00826007|703111|P2|STARTED|Overall Study||279
291723|NCT00826007|703112|P1|STARTED|Overall Study|Retrospective review|308
291724|NCT00825994|703117|P1|NOT COMPLETED|Overall Study||5
291725|NCT00825994|703117|P1|COMPLETED|Overall Study||19
291726|NCT00825994|703117|P1|STARTED|Overall Study||24
291727|NCT00825916|703125|P3|NOT COMPLETED|Overall Study||1
291728|NCT00825916|703126|P2|NOT COMPLETED|Overall Study||2
291729|NCT00825916|703127|P1|NOT COMPLETED|Overall Study||4
291730|NCT00825916|703125|P3|COMPLETED|Overall Study||19
291731|NCT00825916|703126|P2|COMPLETED|Overall Study||18
291732|NCT00825916|703127|P1|COMPLETED|Overall Study||15
291733|NCT00825916|703125|P3|STARTED|Overall Study||20
291734|NCT00825916|703126|P2|STARTED|Overall Study||20
291735|NCT00825916|703127|P1|STARTED|Overall Study||19
291736|NCT00825825|703168|P6|NOT COMPLETED|Third Medication Period (14 Days)||2
291737|NCT00825825|703169|P5|NOT COMPLETED|Third Medication Period (14 Days)||0
291738|NCT00825825|703170|P4|NOT COMPLETED|Third Medication Period (14 Days)||0
291739|NCT00825825|703171|P3|NOT COMPLETED|Third Medication Period (14 Days)||0
291740|NCT00825825|703172|P2|NOT COMPLETED|Third Medication Period (14 Days)||2
291741|NCT00825825|703173|P1|NOT COMPLETED|Third Medication Period (14 Days)||0
291742|NCT00825825|703168|P6|COMPLETED|Third Medication Period (14 Days)||1
291743|NCT00825825|703169|P5|COMPLETED|Third Medication Period (14 Days)||3
291744|NCT00825825|703170|P4|COMPLETED|Third Medication Period (14 Days)||3
291745|NCT00825825|703171|P3|COMPLETED|Third Medication Period (14 Days)||2
291746|NCT00825825|703172|P2|COMPLETED|Third Medication Period (14 Days)||2
291747|NCT00825825|703173|P1|COMPLETED|Third Medication Period (14 Days)||1
291748|NCT00825825|703168|P6|STARTED|Third Medication Period (14 Days)||3
291749|NCT00825825|703169|P5|STARTED|Third Medication Period (14 Days)||3
291750|NCT00825825|703170|P4|STARTED|Third Medication Period (14 Days)||3
291751|NCT00825825|703171|P3|STARTED|Third Medication Period (14 Days)||2
291752|NCT00825825|703172|P2|STARTED|Third Medication Period (14 Days)||4
291753|NCT00825825|703173|P1|STARTED|Third Medication Period (14 Days)||1
291754|NCT00825825|703168|P6|NOT COMPLETED|Second Washout Period (14 Days)||0
291755|NCT00825825|703169|P5|NOT COMPLETED|Second Washout Period (14 Days)||0
291756|NCT00825825|703170|P4|NOT COMPLETED|Second Washout Period (14 Days)||0
291757|NCT00825825|703171|P3|NOT COMPLETED|Second Washout Period (14 Days)||0
291758|NCT00825825|703172|P2|NOT COMPLETED|Second Washout Period (14 Days)||0
291759|NCT00825825|703173|P1|NOT COMPLETED|Second Washout Period (14 Days)||0
291760|NCT00825825|703168|P6|COMPLETED|Second Washout Period (14 Days)||3
291761|NCT00825825|703169|P5|COMPLETED|Second Washout Period (14 Days)||3
291762|NCT00825825|703170|P4|COMPLETED|Second Washout Period (14 Days)||3
291763|NCT00825825|703171|P3|COMPLETED|Second Washout Period (14 Days)||2
291764|NCT00825825|703172|P2|COMPLETED|Second Washout Period (14 Days)||4
291765|NCT00825825|703173|P1|COMPLETED|Second Washout Period (14 Days)||1
291766|NCT00825825|703168|P6|STARTED|Second Washout Period (14 Days)||3
291767|NCT00825825|703169|P5|STARTED|Second Washout Period (14 Days)||3
291768|NCT00825825|703170|P4|STARTED|Second Washout Period (14 Days)||3
291769|NCT00825825|703171|P3|STARTED|Second Washout Period (14 Days)||2
291770|NCT00825825|703172|P2|STARTED|Second Washout Period (14 Days)||4
291771|NCT00825825|703173|P1|STARTED|Second Washout Period (14 Days)||1
291772|NCT00825825|703168|P6|NOT COMPLETED|Second Medication Period (14 Days)||0
291773|NCT00825825|703169|P5|NOT COMPLETED|Second Medication Period (14 Days)||1
291774|NCT00825825|703170|P4|NOT COMPLETED|Second Medication Period (14 Days)||2
291775|NCT00825825|703171|P3|NOT COMPLETED|Second Medication Period (14 Days)||0
291776|NCT00825825|703172|P2|NOT COMPLETED|Second Medication Period (14 Days)||0
291777|NCT00825825|703173|P1|NOT COMPLETED|Second Medication Period (14 Days)||2
291778|NCT00825825|703168|P6|COMPLETED|Second Medication Period (14 Days)||3
291779|NCT00825825|703169|P5|COMPLETED|Second Medication Period (14 Days)||3
291780|NCT00825825|703170|P4|COMPLETED|Second Medication Period (14 Days)||3
291781|NCT00825825|703171|P3|COMPLETED|Second Medication Period (14 Days)||2
291782|NCT00825825|703172|P2|COMPLETED|Second Medication Period (14 Days)||4
291783|NCT00825825|703173|P1|COMPLETED|Second Medication Period (14 Days)||1
291784|NCT00825825|703168|P6|STARTED|Second Medication Period (14 Days)||3
291785|NCT00825825|703169|P5|STARTED|Second Medication Period (14 Days)||4
291786|NCT00825825|703170|P4|STARTED|Second Medication Period (14 Days)||5
291787|NCT00825825|703171|P3|STARTED|Second Medication Period (14 Days)||2
291788|NCT00825825|703172|P2|STARTED|Second Medication Period (14 Days)||4
291789|NCT00825825|703173|P1|STARTED|Second Medication Period (14 Days)||3
291790|NCT00825825|703168|P6|NOT COMPLETED|First Washout Period (14 Days)||0
291791|NCT00825825|703169|P5|NOT COMPLETED|First Washout Period (14 Days)||0
291792|NCT00825825|703170|P4|NOT COMPLETED|First Washout Period (14 Days)||0
291793|NCT00825825|703171|P3|NOT COMPLETED|First Washout Period (14 Days)||0
291794|NCT00825825|703172|P2|NOT COMPLETED|First Washout Period (14 Days)||0
291795|NCT00825825|703173|P1|NOT COMPLETED|First Washout Period (14 Days)||0
291796|NCT00825825|703168|P6|COMPLETED|First Washout Period (14 Days)||3
291797|NCT00825825|703169|P5|COMPLETED|First Washout Period (14 Days)||4
291798|NCT00825825|703170|P4|COMPLETED|First Washout Period (14 Days)||5
291799|NCT00825825|703171|P3|COMPLETED|First Washout Period (14 Days)||2
291800|NCT00825825|703172|P2|COMPLETED|First Washout Period (14 Days)||4
291801|NCT00825825|703173|P1|COMPLETED|First Washout Period (14 Days)||3
291802|NCT00825825|703168|P6|STARTED|First Washout Period (14 Days)||3
291803|NCT00825825|703169|P5|STARTED|First Washout Period (14 Days)||4
291804|NCT00825825|703170|P4|STARTED|First Washout Period (14 Days)||5
291805|NCT00825825|703171|P3|STARTED|First Washout Period (14 Days)||2
291806|NCT00825825|703172|P2|STARTED|First Washout Period (14 Days)||4
291807|NCT00825825|703173|P1|STARTED|First Washout Period (14 Days)||3
291808|NCT00825825|703168|P6|NOT COMPLETED|First Medication Period (14 Days)||2
291809|NCT00825825|703169|P5|NOT COMPLETED|First Medication Period (14 Days)||0
291810|NCT00825825|703170|P4|NOT COMPLETED|First Medication Period (14 Days)||0
291811|NCT00825825|703171|P3|NOT COMPLETED|First Medication Period (14 Days)||1
291812|NCT00825825|703172|P2|NOT COMPLETED|First Medication Period (14 Days)||0
291813|NCT00825825|703173|P1|NOT COMPLETED|First Medication Period (14 Days)||3
291814|NCT00825825|703168|P6|COMPLETED|First Medication Period (14 Days)||3
291815|NCT00825825|703169|P5|COMPLETED|First Medication Period (14 Days)||4
291816|NCT00825825|703170|P4|COMPLETED|First Medication Period (14 Days)||5
291817|NCT00825825|703171|P3|COMPLETED|First Medication Period (14 Days)||2
291818|NCT00825825|703172|P2|COMPLETED|First Medication Period (14 Days)||4
291819|NCT00825825|703173|P1|COMPLETED|First Medication Period (14 Days)||3
291820|NCT00825825|703168|P6|STARTED|First Medication Period (14 Days)||5
291821|NCT00825825|703169|P5|STARTED|First Medication Period (14 Days)||4
291822|NCT00825825|703170|P4|STARTED|First Medication Period (14 Days)||5
291823|NCT00825825|703171|P3|STARTED|First Medication Period (14 Days)||3
291824|NCT00825825|703172|P2|STARTED|First Medication Period (14 Days)||4
291825|NCT00825825|703173|P1|STARTED|First Medication Period (14 Days)||6
291826|NCT00825812|703189|P4|NOT COMPLETED|Overall Study||10
291827|NCT00825812|703190|P3|NOT COMPLETED|Overall Study||6
291828|NCT00825812|703191|P2|NOT COMPLETED|Overall Study||1
291829|NCT00825812|703192|P1|NOT COMPLETED|Overall Study||0
291830|NCT00825812|703189|P4|COMPLETED|Overall Study||111
291831|NCT00825812|703190|P3|COMPLETED|Overall Study||120
291832|NCT00825812|703191|P2|COMPLETED|Overall Study||31
291833|NCT00825812|703192|P1|COMPLETED|Overall Study||29
291834|NCT00825812|703189|P4|TREATED|Overall Study||111
291835|NCT00825812|703190|P3|TREATED|Overall Study||120
291836|NCT00825812|703191|P2|TREATED|Overall Study||31
291837|NCT00825812|703192|P1|TREATED|Overall Study||29
291838|NCT00825812|703189|P4|STARTED|Overall Study||121
291839|NCT00825812|703190|P3|STARTED|Overall Study||126
291840|NCT00825812|703191|P2|STARTED|Overall Study||32
291841|NCT00825812|703192|P1|STARTED|Overall Study||29
291842|NCT00825786|703208|P2|NOT COMPLETED|Overall Study||0
291843|NCT00825786|703209|P1|NOT COMPLETED|Overall Study||0
291844|NCT00825786|703208|P2|COMPLETED|Overall Study||51
291845|NCT00825786|703209|P1|COMPLETED|Overall Study||52
291846|NCT00825786|703208|P2|STARTED|Overall Study||51
291847|NCT00825786|703209|P1|STARTED|Overall Study||52
291848|NCT00825734|703227|P3|NOT COMPLETED|Phase II||76
291849|NCT00825734|703228|P2|NOT COMPLETED|Phase II||0
291850|NCT00825734|703229|P1|NOT COMPLETED|Phase II||0
291851|NCT00825734|703227|P3|COMPLETED|Phase II||0
291852|NCT00825734|703228|P2|COMPLETED|Phase II||0
291853|NCT00825734|703229|P1|COMPLETED|Phase II||0
291854|NCT00825734|703227|P3|STARTED|Phase II|Includes patients treated at MTD during Phase I and 73 additional patients enrolled for Phase II|76
291855|NCT00825734|703228|P2|STARTED|Phase II||0
291856|NCT00825734|703229|P1|STARTED|Phase II||0
291857|NCT00825734|703227|P3|NOT COMPLETED|Phase I||0
291858|NCT00825734|703228|P2|NOT COMPLETED|Phase I||3
291859|NCT00825734|703229|P1|NOT COMPLETED|Phase I||4
291860|NCT00825734|703227|P3|COMPLETED|Phase I||3
291861|NCT00825734|703228|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
291862|NCT00825734|703229|P1|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
291863|NCT00825734|703227|P3|STARTED|Phase I||3
291864|NCT00825734|703228|P2|STARTED|Phase I||3
291865|NCT00825734|703229|P1|STARTED|Phase I||4
291866|NCT00825682|703239|P2|NOT COMPLETED|Overall Study||5
291867|NCT00825682|703240|P1|NOT COMPLETED|Overall Study||13
291868|NCT00825682|703239|P2|COMPLETED|Overall Study||20
291869|NCT00825682|703240|P1|COMPLETED|Overall Study||34
291870|NCT00825682|703239|P2|STARTED|Overall Study||25
291871|NCT00825682|703240|P1|STARTED|Overall Study||47
291872|NCT00825630|703254|P4|NOT COMPLETED|Overall Study||0
291873|NCT00825630|703255|P3|NOT COMPLETED|Overall Study||0
291874|NCT00825630|703256|P2|NOT COMPLETED|Overall Study||0
291875|NCT00825630|703257|P1|NOT COMPLETED|Overall Study||0
291876|NCT00825630|703254|P4|COMPLETED|Overall Study||13
291877|NCT00825630|703255|P3|COMPLETED|Overall Study||19
291878|NCT00825630|703256|P2|COMPLETED|Overall Study||62
291879|NCT00825630|703257|P1|COMPLETED|Overall Study||29
291880|NCT00825630|703254|P4|STARTED|Overall Study||13
291881|NCT00825630|703255|P3|STARTED|Overall Study||19
291882|NCT00825630|703256|P2|STARTED|Overall Study||62
291883|NCT00825630|703257|P1|STARTED|Overall Study||29
291884|NCT00825565|703267|P1|NOT COMPLETED|Overall Study||0
291885|NCT00825565|703267|P1|COMPLETED|Overall Study||8
291886|NCT00825565|703267|P1|STARTED|Overall Study||8
291887|NCT00825500|703280|P3|NOT COMPLETED|Overall Study||0
291888|NCT00825500|703281|P2|NOT COMPLETED|Overall Study||0
291889|NCT00825500|703282|P1|NOT COMPLETED|Overall Study||0
291890|NCT00825500|703280|P3|COMPLETED|Overall Study||120
291891|NCT00825500|703281|P2|COMPLETED|Overall Study||121
291892|NCT00825500|703282|P1|COMPLETED|Overall Study||125
291893|NCT00825500|703280|P3|STARTED|Overall Study||120
291894|NCT00825500|703281|P2|STARTED|Overall Study||121
291895|NCT00825500|703282|P1|STARTED|Overall Study||125
291896|NCT00825370|703295|P2|NOT COMPLETED|Overall Study||0
291897|NCT00825370|703296|P1|NOT COMPLETED|Overall Study||0
291898|NCT00825370|703295|P2|COMPLETED|Overall Study||175
291899|NCT00825370|703296|P1|COMPLETED|Overall Study||175
291900|NCT00825370|703295|P2|STARTED|Overall Study||175
291901|NCT00825370|703296|P1|STARTED|Overall Study||175
291902|NCT00825344|703310|P2|NOT COMPLETED|Overall Study||1
291903|NCT00825344|703311|P1|NOT COMPLETED|Overall Study||1
291904|NCT00825344|703310|P2|COMPLETED|Overall Study||42
291905|NCT00825344|703311|P1|COMPLETED|Overall Study||33
291906|NCT00825344|703310|P2|STARTED|Overall Study||43
291907|NCT00825344|703311|P1|STARTED|Overall Study||34
291908|NCT00825318|703321|P1|NOT COMPLETED|Overall Study||1
291909|NCT00825318|703321|P1|COMPLETED|Overall Study||12
291910|NCT00825318|703321|P1|STARTED|Overall Study||13
291911|NCT00825305|703331|P2|NOT COMPLETED|Overall Study||23
291912|NCT00825305|703332|P1|NOT COMPLETED|Overall Study||17
291913|NCT00825305|703331|P2|COMPLETED|Overall Study||252
291914|NCT00825305|703332|P1|COMPLETED|Overall Study||533
291915|NCT00825305|703331|P2|STARTED|Overall Study||275
291916|NCT00825305|703332|P1|STARTED|Overall Study||550
291917|NCT00825266|703346|P2|NOT COMPLETED|Overall Study||0
291918|NCT00825266|703347|P1|NOT COMPLETED|Overall Study||0
291919|NCT00825266|703346|P2|COMPLETED|Overall Study||1
291920|NCT00825266|703347|P1|COMPLETED|Overall Study||1
291921|NCT00825266|703346|P2|STARTED|Overall Study||1
291922|NCT00825266|703347|P1|STARTED|Overall Study||1
291923|NCT00825227|703359|P2|NOT COMPLETED|Overall Study||0
291924|NCT00825227|703360|P1|NOT COMPLETED|Overall Study||0
291925|NCT00825227|703359|P2|COMPLETED|Overall Study||4
291926|NCT00825227|703360|P1|COMPLETED|Overall Study||6
291927|NCT00825227|703359|P2|STARTED|Overall Study||4
291928|NCT00825227|703360|P1|STARTED|Overall Study||6
291929|NCT00825175|703372|P2|NOT COMPLETED|Overall Study||5
291930|NCT00825175|703373|P1|NOT COMPLETED|Overall Study||0
291931|NCT00825175|703372|P2|COMPLETED|Overall Study||7
291932|NCT00825175|703373|P1|COMPLETED|Overall Study||10
291933|NCT00825175|703372|P2|STARTED|Overall Study||12
291934|NCT00825175|703373|P1|STARTED|Overall Study||10
291935|NCT00825162|703382|P3|NOT COMPLETED|Overall Study||6
291936|NCT00825162|703383|P2|NOT COMPLETED|Overall Study||21
291937|NCT00825162|703384|P1|NOT COMPLETED|Overall Study||28
291938|NCT00825162|703382|P3|COMPLETED|Overall Study||396
291939|NCT00825162|703383|P2|COMPLETED|Overall Study||859
291940|NCT00825162|703384|P1|COMPLETED|Overall Study||682
291941|NCT00825162|703382|P3|STARTED|Overall Study||402
291942|NCT00825162|703383|P2|STARTED|Overall Study||880
291943|NCT00825162|703384|P1|STARTED|Overall Study||710
291944|NCT00824993|703410|P2|NOT COMPLETED|Overall Study||17
291945|NCT00824993|703411|P1|NOT COMPLETED|Overall Study||14
291946|NCT00824993|703410|P2|COMPLETED|Overall Study||22
291947|NCT00824993|703411|P1|COMPLETED|Overall Study||25
291948|NCT00824993|703410|P2|6 Month Follow up|Overall Study||27
291949|NCT00824993|703411|P1|6 Month Follow up|Overall Study||33
291950|NCT00824993|703410|P2|STARTED|Overall Study||39
291951|NCT00824993|703411|P1|STARTED|Overall Study||39
291952|NCT00824850|703419|P2|NOT COMPLETED|Overall Study||1
291953|NCT00824850|703420|P1|NOT COMPLETED|Overall Study||0
291954|NCT00824850|703419|P2|COMPLETED|Overall Study||36
291955|NCT00824850|703420|P1|COMPLETED|Overall Study||38
291956|NCT00824850|703419|P2|Received Vaccination 13vPnC|Overall Study||36
291957|NCT00824850|703420|P1|Received Vaccination 13vPnC|Overall Study||38
291958|NCT00824850|703419|P2|STARTED|Overall Study||37
291959|NCT00824850|703420|P1|STARTED|Overall Study||38
291960|NCT00824824|703466|P2|NOT COMPLETED|Overall Study||0
291961|NCT00824824|703467|P1|NOT COMPLETED|Overall Study||0
291962|NCT00824824|703466|P2|COMPLETED|Overall Study||3
291963|NCT00824824|703467|P1|COMPLETED|Overall Study||4
291964|NCT00824824|703466|P2|STARTED|Overall Study||3
291965|NCT00824824|703467|P1|STARTED|Overall Study||4
291966|NCT00824772|703473|P1|NOT COMPLETED|Overall Study||8
291967|NCT00824772|703473|P1|COMPLETED|Overall Study||196
291968|NCT00824772|703473|P1|STARTED|Overall Study||204
291969|NCT00824746|703478|P1|NOT COMPLETED|Overall Study||0
291970|NCT00824746|703478|P1|COMPLETED|Overall Study||23
291971|NCT00824746|703478|P1|STARTED|Overall Study||23
291972|NCT00824733|703484|P1|NOT COMPLETED|Overall Study||0
291973|NCT00824733|703484|P1|COMPLETED|Overall Study||6
291974|NCT00824733|703484|P1|STARTED|Overall Study||6
291975|NCT00824720|703493|P3|NOT COMPLETED|Overall Study||1
291976|NCT00824720|703494|P2|NOT COMPLETED|Overall Study||1
291977|NCT00824720|703495|P1|NOT COMPLETED|Overall Study||3
291978|NCT00824720|703493|P3|COMPLETED|Overall Study||19
291979|NCT00824720|703494|P2|COMPLETED|Overall Study||15
291980|NCT00824720|703495|P1|COMPLETED|Overall Study||16
291981|NCT00824720|703493|P3|STARTED|Overall Study||20
291982|NCT00824720|703494|P2|STARTED|Overall Study|1 subject in the low dose group did not receive device - unable to insert.|16
291983|NCT00824720|703495|P1|STARTED|Overall Study|3 subjects in the high dose group did not receive device - unable to insert.|19
291984|NCT00824655|703511|P2|NOT COMPLETED|Toddler Dose (12 Months of Age)||0
291985|NCT00824655|703512|P1|NOT COMPLETED|Toddler Dose (12 Months of Age)||2
291986|NCT00824655|703511|P2|COMPLETED|Toddler Dose (12 Months of Age)||116
291987|NCT00824655|703512|P1|COMPLETED|Toddler Dose (12 Months of Age)||116
291988|NCT00824655|703511|P2|STARTED|Toddler Dose (12 Months of Age)||116
291989|NCT00824655|703512|P1|STARTED|Toddler Dose (12 Months of Age)||118
291990|NCT00824655|703511|P2|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
291991|NCT00824655|703512|P1|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
291992|NCT00824655|703511|P2|COMPLETED|After Infant Dose (6 Months of Age)||0
291993|NCT00824655|703512|P1|COMPLETED|After Infant Dose (6 Months of Age)||118
291994|NCT00824655|703511|P2|STARTED|After Infant Dose (6 Months of Age)||0
291995|NCT00824655|703512|P1|STARTED|After Infant Dose (6 Months of Age)||118
291996|NCT00824655|703511|P2|NOT COMPLETED|Infant Series (5 Months of Age)||0
291997|NCT00824655|703512|P1|NOT COMPLETED|Infant Series (5 Months of Age)||0
291998|NCT00824655|703511|P2|COMPLETED|Infant Series (5 Months of Age)||0
291999|NCT00824655|703512|P1|COMPLETED|Infant Series (5 Months of Age)||118
292000|NCT00824655|703511|P2|STARTED|Infant Series (5 Months of Age)||0
292001|NCT00824655|703512|P1|STARTED|Infant Series (5 Months of Age)||118
292002|NCT00824616|703532|P2|NOT COMPLETED|Overall Study||7
292003|NCT00824616|703533|P1|NOT COMPLETED|Overall Study||6
292004|NCT00824616|703532|P2|COMPLETED|Overall Study||27
292005|NCT00824616|703533|P1|COMPLETED|Overall Study||28
292006|NCT00824616|703532|P2|STARTED|Overall Study||34
292007|NCT00824616|703533|P1|STARTED|Overall Study||34
292008|NCT00824564|703543|P2|NOT COMPLETED|Overall Study||10
292009|NCT00824564|703544|P1|NOT COMPLETED|Overall Study||8
292010|NCT00824564|703543|P2|COMPLETED|Overall Study||30
292011|NCT00824564|703544|P1|COMPLETED|Overall Study||34
292012|NCT00824564|703543|P2|Treated|Overall Study||40
292013|NCT00824564|703544|P1|Treated|Overall Study||41
292014|NCT00824564|703543|P2|STARTED|Overall Study||40
292015|NCT00824564|703544|P1|STARTED|Overall Study||42
292016|NCT00824538|703562|P1|NOT COMPLETED|Overall Study||2
292017|NCT00824538|703562|P1|COMPLETED|Overall Study||11
292018|NCT00824538|703562|P1|STARTED|Overall Study|13 patients entered the study|13
292019|NCT00824512|703572|P2|NOT COMPLETED|Overall Study||0
292020|NCT00824512|703573|P1|NOT COMPLETED|Overall Study||0
292021|NCT00824512|703572|P2|COMPLETED|Overall Study||11
292022|NCT00824512|703573|P1|COMPLETED|Overall Study||11
292023|NCT00824512|703572|P2|STARTED|Overall Study||11
292024|NCT00824512|703573|P1|STARTED|Overall Study||11
292025|NCT00824473|703623|P2|NOT COMPLETED|Overall Study||13
292026|NCT00824473|703624|P1|NOT COMPLETED|Overall Study||15
292027|NCT00824473|703623|P2|COMPLETED|Overall Study||238
292028|NCT00824473|703624|P1|COMPLETED|Overall Study||240
292029|NCT00824473|703623|P2|STARTED|Overall Study||251
292030|NCT00824473|703624|P1|STARTED|Overall Study|1 subject was randomized in error|255
292031|NCT00824460|703646|P6|NOT COMPLETED|Overall Study||8
292032|NCT00824460|703647|P5|NOT COMPLETED|Overall Study||9
292033|NCT00824460|703648|P4|NOT COMPLETED|Overall Study||12
292034|NCT00824460|703649|P3|NOT COMPLETED|Overall Study||5
292035|NCT00824460|703650|P2|NOT COMPLETED|Overall Study||9
292036|NCT00824460|703651|P1|NOT COMPLETED|Overall Study||8
292037|NCT00824460|703646|P6|COMPLETED|Overall Study||18
292038|NCT00824460|703647|P5|COMPLETED|Overall Study||15
292039|NCT00824460|703648|P4|COMPLETED|Overall Study||15
292040|NCT00824460|703649|P3|COMPLETED|Overall Study||20
292041|NCT00824460|703650|P2|COMPLETED|Overall Study||17
292042|NCT00824460|703651|P1|COMPLETED|Overall Study||18
292043|NCT00824460|703646|P6|STARTED|Overall Study||26
292044|NCT00824460|703647|P5|STARTED|Overall Study||24
292045|NCT00824460|703648|P4|STARTED|Overall Study||27
292046|NCT00824460|703649|P3|STARTED|Overall Study||25
292047|NCT00824460|703650|P2|STARTED|Overall Study||26
292048|NCT00824460|703651|P1|STARTED|Overall Study||26
292049|NCT00824434|703683|P1|NOT COMPLETED|Overall Study||0
292050|NCT00824434|703683|P1|COMPLETED|Overall Study||100
292051|NCT00824434|703683|P1|STARTED|Overall Study||100
292052|NCT00824421|703705|P3|NOT COMPLETED|Overall Study||14
292053|NCT00824421|703706|P2|NOT COMPLETED|Overall Study||22
292054|NCT00824421|703707|P1|NOT COMPLETED|Overall Study||17
292055|NCT00824421|703705|P3|COMPLETED|Overall Study||49
292056|NCT00824421|703706|P2|COMPLETED|Overall Study||44
292057|NCT00824421|703707|P1|COMPLETED|Overall Study||49
292058|NCT00824421|703705|P3|Treated|Overall Study||63
292059|NCT00824421|703706|P2|Treated|Overall Study||65
292060|NCT00824421|703707|P1|Treated|Overall Study||65
292061|NCT00824421|703705|P3|STARTED|Overall Study||63
292062|NCT00824421|703706|P2|STARTED|Overall Study||66
292063|NCT00824421|703707|P1|STARTED|Overall Study||66
292064|NCT00824408|703758|P5|NOT COMPLETED|Randomized Phase||46
292065|NCT00824408|703759|P4|NOT COMPLETED|Randomized Phase||46
292066|NCT00824408|703760|P3|NOT COMPLETED|Randomized Phase||36
292067|NCT00824408|703761|P2|NOT COMPLETED|Randomized Phase||0
292068|NCT00824408|703762|P1|NOT COMPLETED|Randomized Phase||0
292069|NCT00824408|703758|P5|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
292070|NCT00824408|703759|P4|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
292071|NCT00824408|703760|P3|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
292072|NCT00824408|703761|P2|COMPLETED|Randomized Phase||0
292073|NCT00824408|703762|P1|COMPLETED|Randomized Phase||0
292074|NCT00824408|703758|P5|STARTED|Randomized Phase||47
292075|NCT00824408|703759|P4|STARTED|Randomized Phase||47
292076|NCT00824408|703760|P3|STARTED|Randomized Phase||37
292077|NCT00824408|703761|P2|STARTED|Randomized Phase||0
292078|NCT00824408|703762|P1|STARTED|Randomized Phase||0
292079|NCT00824408|703758|P5|NOT COMPLETED|Run-in Phase||0
292080|NCT00824408|703759|P4|NOT COMPLETED|Run-in Phase||0
292081|NCT00824408|703760|P3|NOT COMPLETED|Run-in Phase||0
292082|NCT00824408|703761|P2|NOT COMPLETED|Run-in Phase||6
292083|NCT00824408|703762|P1|NOT COMPLETED|Run-in Phase||6
292084|NCT00824408|703758|P5|COMPLETED|Run-in Phase||0
292085|NCT00824408|703759|P4|COMPLETED|Run-in Phase||0
292086|NCT00824408|703760|P3|COMPLETED|Run-in Phase||0
292087|NCT00824408|703761|P2|COMPLETED|Run-in Phase||0
292088|NCT00824408|703762|P1|COMPLETED|Run-in Phase||0
292089|NCT00824408|703758|P5|STARTED|Run-in Phase||0
292090|NCT00824408|703759|P4|STARTED|Run-in Phase||0
292091|NCT00824408|703760|P3|STARTED|Run-in Phase||0
292092|NCT00824408|703761|P2|STARTED|Run-in Phase||6
292093|NCT00824408|703762|P1|STARTED|Run-in Phase||6
292094|NCT00824382|703814|P4|NOT COMPLETED|Overall Study||5
292095|NCT00824382|703815|P3|NOT COMPLETED|Overall Study||3
292096|NCT00824382|703816|P2|NOT COMPLETED|Overall Study||2
292097|NCT00824382|703817|P1|NOT COMPLETED|Overall Study||5
292098|NCT00824382|703814|P4|COMPLETED|Overall Study||81
292099|NCT00824382|703815|P3|COMPLETED|Overall Study||76
292100|NCT00824382|703816|P2|COMPLETED|Overall Study||82
292101|NCT00824382|703817|P1|COMPLETED|Overall Study||74
292102|NCT00824382|703814|P4|STARTED|Overall Study||86
292103|NCT00824382|703815|P3|STARTED|Overall Study||79
292104|NCT00824382|703816|P2|STARTED|Overall Study||84
292105|NCT00824382|703817|P1|STARTED|Overall Study||79
292106|NCT00824369|703893|P6|NOT COMPLETED|Overall Study||1
292107|NCT00824369|703894|P5|NOT COMPLETED|Overall Study||1
292108|NCT00824369|703895|P4|NOT COMPLETED|Overall Study||2
292109|NCT00824369|703896|P3|NOT COMPLETED|Overall Study||1
292110|NCT00824369|703897|P2|NOT COMPLETED|Overall Study||0
292111|NCT00824369|703898|P1|NOT COMPLETED|Overall Study||1
292112|NCT00824369|703893|P6|COMPLETED|Overall Study||16
292113|NCT00824369|703894|P5|COMPLETED|Overall Study||11
292114|NCT00824369|703895|P4|COMPLETED|Overall Study||9
292115|NCT00824369|703896|P3|COMPLETED|Overall Study||2
292116|NCT00824369|703897|P2|COMPLETED|Overall Study||4
292117|NCT00824369|703898|P1|COMPLETED|Overall Study||4
292118|NCT00824369|703893|P6|STARTED|Overall Study||17
292119|NCT00824369|703894|P5|STARTED|Overall Study||12
292120|NCT00824369|703895|P4|STARTED|Overall Study||11
292121|NCT00824369|703896|P3|STARTED|Overall Study||3
292122|NCT00824369|703897|P2|STARTED|Overall Study||4
292123|NCT00824369|703898|P1|STARTED|Overall Study||5
292124|NCT00824291|703938|P2|NOT COMPLETED|Overall Study||35
292125|NCT00824291|703939|P1|NOT COMPLETED|Overall Study||54
292126|NCT00824291|703938|P2|COMPLETED|Overall Study||107
292127|NCT00824291|703939|P1|COMPLETED|Overall Study||231
292128|NCT00824291|703938|P2|STARTED|Overall Study||142
292129|NCT00824291|703939|P1|STARTED|Overall Study||285
292130|NCT00824265|703961|P2|NOT COMPLETED|Survival Follow-up Phase||16
292131|NCT00824265|703962|P1|NOT COMPLETED|Survival Follow-up Phase||9
292132|NCT00824265|703961|P2|COMPLETED|Survival Follow-up Phase||73
292133|NCT00824265|703962|P1|COMPLETED|Survival Follow-up Phase||87
292134|NCT00824265|703961|P2|STARTED|Survival Follow-up Phase||89
292135|NCT00824265|703962|P1|STARTED|Survival Follow-up Phase||96
292136|NCT00824265|703961|P2|NOT COMPLETED|Follow-up Phase||31
292137|NCT00824265|703962|P1|NOT COMPLETED|Follow-up Phase||18
292138|NCT00824265|703961|P2|COMPLETED|Follow-up Phase||129
292139|NCT00824265|703962|P1|COMPLETED|Follow-up Phase||154
292140|NCT00824265|703961|P2|STARTED|Follow-up Phase||160
292141|NCT00824265|703962|P1|STARTED|Follow-up Phase||172
292142|NCT00824265|703961|P2|NOT COMPLETED|Treatment Phase||80
292143|NCT00824265|703962|P1|NOT COMPLETED|Treatment Phase||64
292144|NCT00824265|703961|P2|COMPLETED|Treatment Phase||102
292145|NCT00824265|703962|P1|COMPLETED|Treatment Phase||119
292146|NCT00824265|703961|P2|STARTED|Treatment Phase||182
292147|NCT00824265|703962|P1|STARTED|Treatment Phase||183
292148|NCT00824161|704023|P1|NOT COMPLETED|Overall Study||2
292149|NCT00824161|704023|P1|COMPLETED|Overall Study||26
292150|NCT00824161|704023|P1|STARTED|Overall Study||28
292151|NCT00824070|704032|P3|NOT COMPLETED|Overall Study||0
292152|NCT00824070|704033|P2|NOT COMPLETED|Overall Study||0
292153|NCT00824070|704034|P1|NOT COMPLETED|Overall Study||0
292154|NCT00824070|704032|P3|COMPLETED|Overall Study||36
292155|NCT00824070|704033|P2|COMPLETED|Overall Study||35
292156|NCT00824070|704034|P1|COMPLETED|Overall Study||34
292157|NCT00824070|704032|P3|STARTED|Overall Study||36
292158|NCT00824070|704033|P2|STARTED|Overall Study||35
292159|NCT00824070|704034|P1|STARTED|Overall Study||34
292160|NCT00824044|704044|P2|NOT COMPLETED|Overall Study||6
292161|NCT00824044|704045|P1|NOT COMPLETED|Overall Study||9
292162|NCT00824044|704044|P2|COMPLETED|Overall Study||10
292163|NCT00824044|704045|P1|COMPLETED|Overall Study||14
292164|NCT00824044|704044|P2|STARTED|Overall Study||16
292165|NCT00824044|704045|P1|STARTED|Overall Study||23
292166|NCT00824005|704089|P2|NOT COMPLETED|Overall Study||2
292167|NCT00824005|704090|P1|NOT COMPLETED|Overall Study||0
292168|NCT00824005|704089|P2|COMPLETED|Overall Study||59
292169|NCT00824005|704090|P1|COMPLETED|Overall Study||31
292170|NCT00824005|704089|P2|STARTED|Overall Study||61
292171|NCT00824005|704090|P1|STARTED|Overall Study||31
292172|NCT00823979|704125|P3|NOT COMPLETED|Overall Study||24
292173|NCT00823979|704126|P2|NOT COMPLETED|Overall Study||32
292174|NCT00823979|704127|P1|NOT COMPLETED|Overall Study||29
292175|NCT00823979|704125|P3|COMPLETED|Overall Study||11
292176|NCT00823979|704126|P2|COMPLETED|Overall Study||3
292177|NCT00823979|704127|P1|COMPLETED|Overall Study||6
292178|NCT00823979|704125|P3|Treated|Overall Study||34
292179|NCT00823979|704126|P2|Treated|Overall Study||32
292180|NCT00823979|704127|P1|Treated|Overall Study||31
292181|NCT00823979|704125|P3|STARTED|Overall Study||35
292182|NCT00823979|704126|P2|STARTED|Overall Study||35
292183|NCT00823979|704127|P1|STARTED|Overall Study||35
292184|NCT00823966|704165|P1|NOT COMPLETED|Overall Study||0
292185|NCT00823966|704165|P1|COMPLETED|Overall Study||3
292186|NCT00823966|704165|P1|STARTED|Overall Study||3
292187|NCT00823901|704172|P2|NOT COMPLETED|Overall Study||2
292188|NCT00823901|704173|P1|NOT COMPLETED|Overall Study||4
292189|NCT00823901|704172|P2|COMPLETED|Overall Study|Discontinued intervention (n=1) Only baseline completed (n=1)|38
292190|NCT00823901|704173|P1|COMPLETED|Overall Study|Discontinued intervention (n=2) Only baseline completed (n=2)|39
292191|NCT00823901|704172|P2|STARTED|Overall Study|Randomized to placebo gel|40
292192|NCT00823901|704173|P1|STARTED|Overall Study|Randomized to clindamycin/tretinoin gel|43
292193|NCT00823836|704181|P2|NOT COMPLETED|Long-term Phase||5
292194|NCT00823836|704182|P1|NOT COMPLETED|Long-term Phase||5
292195|NCT00823836|704181|P2|COMPLETED|Long-term Phase||79
292196|NCT00823836|704182|P1|COMPLETED|Long-term Phase||68
292197|NCT00823836|704181|P2|STARTED|Long-term Phase||84
292198|NCT00823836|704182|P1|STARTED|Long-term Phase||73
292199|NCT00823836|704181|P2|NOT COMPLETED|NV and PR/XR Switching Phases||29
292200|NCT00823836|704182|P1|NOT COMPLETED|NV and PR/XR Switching Phases||32
292201|NCT00823836|704181|P2|COMPLETED|NV and PR/XR Switching Phases||117
292202|NCT00823836|704182|P1|COMPLETED|NV and PR/XR Switching Phases||124
292203|NCT00823836|704181|P2|STARTED|NV and PR/XR Switching Phases||146
292204|NCT00823836|704182|P1|STARTED|NV and PR/XR Switching Phases||156
292205|NCT00823823|704288|P2|NOT COMPLETED|Overall Study||6
292206|NCT00823823|704289|P1|NOT COMPLETED|Overall Study||8
292207|NCT00823823|704288|P2|COMPLETED|Overall Study||101
292208|NCT00823823|704289|P1|COMPLETED|Overall Study||101
292209|NCT00823823|704288|P2|STARTED|Overall Study||107
292210|NCT00823823|704289|P1|STARTED|Overall Study||109
292211|NCT00823797|704299|P2|NOT COMPLETED|Overall Study||0
292212|NCT00823797|704300|P1|NOT COMPLETED|Overall Study||0
292213|NCT00823797|704299|P2|COMPLETED|Overall Study||16
292214|NCT00823797|704300|P1|COMPLETED|Overall Study||29
292215|NCT00823797|704299|P2|STARTED|Overall Study||16
292216|NCT00823797|704300|P1|STARTED|Overall Study||29
292217|NCT00823719|704313|P2|NOT COMPLETED|Overall Study||11
292218|NCT00823719|704314|P1|NOT COMPLETED|Overall Study||6
292219|NCT00823719|704313|P2|COMPLETED|Overall Study||24
292220|NCT00823719|704314|P1|COMPLETED|Overall Study||20
292221|NCT00823719|704313|P2|STARTED|Overall Study||35
292222|NCT00823719|704314|P1|STARTED|Overall Study||26
292223|NCT00823615|704367|P2|NOT COMPLETED|Period 2||2
292224|NCT00823615|704368|P1|NOT COMPLETED|Period 2||3
292225|NCT00823615|704367|P2|COMPLETED|Period 2||17
292226|NCT00823615|704368|P1|COMPLETED|Period 2||16
292227|NCT00823615|704367|P2|STARTED|Period 2||19
292228|NCT00823615|704368|P1|STARTED|Period 2||19
292229|NCT00823615|704367|P2|NOT COMPLETED|Period 1||0
292230|NCT00823615|704368|P1|NOT COMPLETED|Period 1||0
292231|NCT00823615|704367|P2|COMPLETED|Period 1||19
292232|NCT00823615|704368|P1|COMPLETED|Period 1||19
292233|NCT00823615|704367|P2|STARTED|Period 1||19
292234|NCT00823615|704368|P1|STARTED|Period 1||19
292235|NCT00823472|704378|P2|NOT COMPLETED|Overall Study||28
292236|NCT00823472|704379|P1|NOT COMPLETED|Overall Study||24
292237|NCT00823472|704378|P2|COMPLETED|Overall Study||39
292238|NCT00823472|704379|P1|COMPLETED|Overall Study||56
292239|NCT00823472|704378|P2|STARTED|Overall Study||67
292240|NCT00823472|704379|P1|STARTED|Overall Study||80
292241|NCT00823459|704387|P1|NOT COMPLETED|Overall Study||0
292242|NCT00823459|704387|P1|COMPLETED|Overall Study||58
292243|NCT00823459|704387|P1|STARTED|Overall Study||58
292244|NCT00823303|704397|P2|NOT COMPLETED|Overall Study||11
292245|NCT00823303|704398|P1|NOT COMPLETED|Overall Study||9
292246|NCT00823303|704397|P2|COMPLETED|Overall Study||45
292247|NCT00823303|704398|P1|COMPLETED|Overall Study||45
292248|NCT00823303|704397|P2|STARTED|Overall Study||56
292249|NCT00823303|704398|P1|STARTED|Overall Study||54
292250|NCT00823264|704406|P2|NOT COMPLETED|Overall Study||0
292251|NCT00823264|704407|P1|NOT COMPLETED|Overall Study||2
292252|NCT00823264|704406|P2|COMPLETED|Overall Study||7
292253|NCT00823264|704407|P1|COMPLETED|Overall Study||8
292254|NCT00823264|704406|P2|STARTED|Overall Study||7
292255|NCT00823264|704407|P1|STARTED|Overall Study||10
292256|NCT00823212|704415|P2|NOT COMPLETED|Overall Study||33
292257|NCT00823212|704416|P1|NOT COMPLETED|Overall Study||35
292258|NCT00823212|704415|P2|COMPLETED|Overall Study|12-month follow-up|735
292259|NCT00823212|704416|P1|COMPLETED|Overall Study|12-month follow-up|727
292260|NCT00823212|704415|P2|STARTED|Overall Study||768
292261|NCT00823212|704416|P1|STARTED|Overall Study||762
292262|NCT00823199|704498|P1|NOT COMPLETED|Overall Study||2
292263|NCT00823199|704498|P1|COMPLETED|Overall Study||8
292264|NCT00823199|704498|P1|STARTED|Overall Study||10
292265|NCT00823095|704504|P1|NOT COMPLETED|Overall Study||0
292266|NCT00823095|704504|P1|COMPLETED|Overall Study||7
292267|NCT00823095|704504|P1|STARTED|Overall Study||7
292268|NCT00823082|704511|P2|NOT COMPLETED|Overall Study||1
292269|NCT00823082|704512|P1|NOT COMPLETED|Overall Study||0
292270|NCT00823082|704511|P2|COMPLETED|Overall Study||99
292271|NCT00823082|704512|P1|COMPLETED|Overall Study||100
292272|NCT00823082|704511|P2|Intent-to-Treat/Per Protocol Populations|Overall Study||94
292273|NCT00823082|704512|P1|Intent-to-Treat/Per Protocol Populations|Overall Study||100
292274|NCT00823082|704511|P2|Safety Population|Overall Study||99
292275|NCT00823082|704512|P1|Safety Population|Overall Study||100
292276|NCT00823082|704511|P2|STARTED|Overall Study||100
292277|NCT00823082|704512|P1|STARTED|Overall Study||100
292278|NCT00823069|704546|P1|NOT COMPLETED|Overall Study||0
292279|NCT00823069|704546|P1|COMPLETED|Overall Study||60
292280|NCT00823069|704546|P1|STARTED|Overall Study||60
292281|NCT00823043|704553|P2|NOT COMPLETED|Overall Study||0
292282|NCT00823043|704554|P1|NOT COMPLETED|Overall Study||0
292283|NCT00823043|704553|P2|COMPLETED|Overall Study||39
292284|NCT00823043|704554|P1|COMPLETED|Overall Study||64
292285|NCT00823043|704553|P2|STARTED|Overall Study||39
292286|NCT00823043|704554|P1|STARTED|Overall Study||64
292287|NCT00822926|704567|P2|NOT COMPLETED|Second Injection Visit||1
292288|NCT00822926|704568|P1|NOT COMPLETED|Second Injection Visit||1
292289|NCT00822926|704567|P2|COMPLETED|Second Injection Visit||2
292290|NCT00822926|704568|P1|COMPLETED|Second Injection Visit||1
292291|NCT00822926|704567|P2|STARTED|Second Injection Visit||3
292292|NCT00822926|704568|P1|STARTED|Second Injection Visit||2
292293|NCT00822926|704567|P2|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
292294|NCT00822926|704568|P1|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
292295|NCT00822926|704567|P2|COMPLETED|Washout (Varies Based on Scheduling)||3
292296|NCT00822926|704568|P1|COMPLETED|Washout (Varies Based on Scheduling)||2
292297|NCT00822926|704567|P2|STARTED|Washout (Varies Based on Scheduling)||3
292298|NCT00822926|704568|P1|STARTED|Washout (Varies Based on Scheduling)||2
292299|NCT00822926|704567|P2|NOT COMPLETED|First Injection Visit||0
292300|NCT00822926|704568|P1|NOT COMPLETED|First Injection Visit||0
292301|NCT00822926|704567|P2|COMPLETED|First Injection Visit||3
292302|NCT00822926|704568|P1|COMPLETED|First Injection Visit||2
292303|NCT00822926|704567|P2|STARTED|First Injection Visit||3
292304|NCT00822926|704568|P1|STARTED|First Injection Visit||2
292305|NCT00822900|704582|P2|NOT COMPLETED|Overall Study||93
292306|NCT00822900|704583|P1|NOT COMPLETED|Overall Study||108
292307|NCT00822900|704582|P2|COMPLETED|Overall Study||347
292308|NCT00822900|704583|P1|COMPLETED|Overall Study||334
292309|NCT00822900|704582|P2|STARTED|Overall Study||440
292310|NCT00822900|704583|P1|STARTED|Overall Study||442
292311|NCT00822770|704611|P1|NOT COMPLETED|Overall Study||0
292312|NCT00822770|704611|P1|COMPLETED|Overall Study||47
292313|NCT00822770|704611|P1|STARTED|Overall Study||47
292314|NCT00822757|704617|P2|NOT COMPLETED|Overall Study||0
292315|NCT00822757|704618|P1|NOT COMPLETED|Overall Study||0
292316|NCT00822757|704617|P2|COMPLETED|Overall Study||10
292317|NCT00822757|704618|P1|COMPLETED|Overall Study||41
292318|NCT00822757|704617|P2|STARTED|Overall Study||10
292319|NCT00822757|704618|P1|STARTED|Overall Study||41
292320|NCT00822692|704630|P2|NOT COMPLETED|Overall Study||25
292321|NCT00822692|704631|P1|NOT COMPLETED|Overall Study||17
292322|NCT00822692|704630|P2|COMPLETED|Overall Study|June 1 , 2009|51
292323|NCT00822692|704631|P1|COMPLETED|Overall Study|June 1, 2009|46
292324|NCT00822692|704630|P2|STARTED|Overall Study|July 1, 2008|76
292325|NCT00822692|704631|P1|STARTED|Overall Study|July 1, 2008|63
292326|NCT00822679|704639|P2|NOT COMPLETED|Overall Study||0
292327|NCT00822679|704640|P1|NOT COMPLETED|Overall Study||0
292328|NCT00822679|704639|P2|COMPLETED|Overall Study||0
292329|NCT00822679|704640|P1|COMPLETED|Overall Study||0
292330|NCT00822679|704639|P2|STARTED|Overall Study||0
292331|NCT00822679|704640|P1|STARTED|Overall Study||0
292332|NCT00822588|704648|P2|NOT COMPLETED|Overall Study||4
292333|NCT00822588|704649|P1|NOT COMPLETED|Overall Study||7
292334|NCT00822588|704648|P2|COMPLETED|Overall Study|APT/ITT analysis set|110
292335|NCT00822588|704649|P1|COMPLETED|Overall Study|APT/ITT analysis set|106
292336|NCT00822588|704648|P2|STARTED|Overall Study|4 participants excluded before surgery. No baseline data available|114
292337|NCT00822588|704649|P1|STARTED|Overall Study|7 participants excluded before surgery. No baseline data available|113
292338|NCT00822523|704658|P3|NOT COMPLETED|Overall Study||0
292339|NCT00822523|704659|P2|NOT COMPLETED|Overall Study||0
292340|NCT00822523|704660|P1|NOT COMPLETED|Overall Study||0
292341|NCT00822523|704658|P3|COMPLETED|Overall Study||4
292342|NCT00822523|704659|P2|COMPLETED|Overall Study||4
292343|NCT00822523|704660|P1|COMPLETED|Overall Study||5
292344|NCT00822523|704658|P3|STARTED|Overall Study||4
292345|NCT00822523|704659|P2|STARTED|Overall Study||4
292346|NCT00822523|704660|P1|STARTED|Overall Study||5
292347|NCT00822510|704706|P2|NOT COMPLETED|Overall Study||5
292348|NCT00822510|704707|P1|NOT COMPLETED|Overall Study||3
292349|NCT00822510|704706|P2|COMPLETED|Overall Study||36
292350|NCT00822510|704707|P1|COMPLETED|Overall Study||35
292351|NCT00822510|704706|P2|STARTED|Overall Study||41
292352|NCT00822510|704707|P1|STARTED|Overall Study||38
292353|NCT00822354|704727|P2|NOT COMPLETED|Second Intervention (28 Days)||0
292354|NCT00822354|704728|P1|NOT COMPLETED|Second Intervention (28 Days)||1
292355|NCT00822354|704727|P2|COMPLETED|Second Intervention (28 Days)||5
292356|NCT00822354|704728|P1|COMPLETED|Second Intervention (28 Days)||3
292357|NCT00822354|704727|P2|STARTED|Second Intervention (28 Days)||5
292358|NCT00822354|704728|P1|STARTED|Second Intervention (28 Days)||4
292359|NCT00822354|704727|P2|NOT COMPLETED|Washout (7 Days)||0
292360|NCT00822354|704728|P1|NOT COMPLETED|Washout (7 Days)||0
292361|NCT00822354|704727|P2|COMPLETED|Washout (7 Days)||5
292362|NCT00822354|704728|P1|COMPLETED|Washout (7 Days)||4
292363|NCT00822354|704727|P2|STARTED|Washout (7 Days)||5
292364|NCT00822354|704728|P1|STARTED|Washout (7 Days)||4
292365|NCT00822354|704727|P2|NOT COMPLETED|First Intervention (28 Days)||0
292366|NCT00822354|704728|P1|NOT COMPLETED|First Intervention (28 Days)||1
292367|NCT00822354|704727|P2|COMPLETED|First Intervention (28 Days)||5
292368|NCT00822354|704728|P1|COMPLETED|First Intervention (28 Days)||4
292369|NCT00822354|704727|P2|STARTED|First Intervention (28 Days)||5
292370|NCT00822354|704728|P1|STARTED|First Intervention (28 Days)||5
292371|NCT00822328|704758|P2|NOT COMPLETED|Overall Study||0
292372|NCT00822328|704759|P1|NOT COMPLETED|Overall Study||0
292373|NCT00822328|704758|P2|COMPLETED|Overall Study||12
292374|NCT00822328|704759|P1|COMPLETED|Overall Study||12
292375|NCT00822328|704758|P2|STARTED|Overall Study||12
292376|NCT00822328|704759|P1|STARTED|Overall Study||12
292377|NCT00822237|704769|P2|NOT COMPLETED|Dose 2 Vaccination||11
292378|NCT00822237|704770|P1|NOT COMPLETED|Dose 2 Vaccination||4
292379|NCT00822237|704769|P2|COMPLETED|Dose 2 Vaccination||262
292380|NCT00822237|704770|P1|COMPLETED|Dose 2 Vaccination||270
292381|NCT00822237|704769|P2|STARTED|Dose 2 Vaccination|Number who received second dose|273
292382|NCT00822237|704770|P1|STARTED|Dose 2 Vaccination|Number who received second dose|274
292383|NCT00822237|704769|P2|NOT COMPLETED|Dose 1 Vaccination||26
292384|NCT00822237|704770|P1|NOT COMPLETED|Dose 1 Vaccination||25
292385|NCT00822237|704769|P2|COMPLETED|Dose 1 Vaccination||273
292386|NCT00822237|704770|P1|COMPLETED|Dose 1 Vaccination||274
292387|NCT00822237|704769|P2|STARTED|Dose 1 Vaccination|Number randomized|299
292388|NCT00822237|704770|P1|STARTED|Dose 1 Vaccination|Number randomized|299
292389|NCT00822185|704780|P5|NOT COMPLETED|Overall Study||0
292390|NCT00822185|704781|P4|NOT COMPLETED|Overall Study||0
292391|NCT00822185|704782|P3|NOT COMPLETED|Overall Study||0
292392|NCT00822185|704783|P2|NOT COMPLETED|Overall Study||0
292393|NCT00822185|704784|P1|NOT COMPLETED|Overall Study||0
292394|NCT00822185|704780|P5|COMPLETED|Overall Study||8
292395|NCT00822185|704781|P4|COMPLETED|Overall Study||6
292396|NCT00822185|704782|P3|COMPLETED|Overall Study||6
292397|NCT00822185|704783|P2|COMPLETED|Overall Study||6
292398|NCT00822185|704784|P1|COMPLETED|Overall Study||6
292399|NCT00822185|704780|P5|STARTED|Overall Study||8
292400|NCT00822185|704781|P4|STARTED|Overall Study||6
292401|NCT00822185|704782|P3|STARTED|Overall Study||6
292402|NCT00822185|704783|P2|STARTED|Overall Study||6
292403|NCT00822185|704784|P1|STARTED|Overall Study||6
292404|NCT00822172|704851|P2|NOT COMPLETED|Overall Study||19
292405|NCT00822172|704852|P1|NOT COMPLETED|Overall Study||15
292406|NCT00822172|704851|P2|COMPLETED|Overall Study||64
292407|NCT00822172|704852|P1|COMPLETED|Overall Study||65
292408|NCT00822172|704851|P2|STARTED|Overall Study||83
292409|NCT00822172|704852|P1|STARTED|Overall Study||80
292410|NCT00822120|704872|P6|NOT COMPLETED|PET-directed Therapy||0
292411|NCT00822120|704873|P5|NOT COMPLETED|PET-directed Therapy||0
292412|NCT00822120|704874|P4|NOT COMPLETED|PET-directed Therapy||10
292413|NCT00822120|704875|P3|NOT COMPLETED|PET-directed Therapy||0
292414|NCT00822120|704876|P2|NOT COMPLETED|PET-directed Therapy||0
292415|NCT00822120|704877|P1|NOT COMPLETED|PET-directed Therapy||0
292416|NCT00822120|704872|P6|COMPLETED|PET-directed Therapy||1
292417|NCT00822120|704873|P5|COMPLETED|PET-directed Therapy||10
292418|NCT00822120|704874|P4|COMPLETED|PET-directed Therapy||45
292419|NCT00822120|704875|P3|COMPLETED|PET-directed Therapy||270
292420|NCT00822120|704876|P2|COMPLETED|PET-directed Therapy||0
292421|NCT00822120|704877|P1|COMPLETED|PET-directed Therapy||0
292422|NCT00822120|704872|P6|Eligibile and Evaluable Patients|PET-directed Therapy||1
292423|NCT00822120|704873|P5|Eligibile and Evaluable Patients|PET-directed Therapy||10
292424|NCT00822120|704874|P4|Eligibile and Evaluable Patients|PET-directed Therapy||55
292425|NCT00822120|704875|P3|Eligibile and Evaluable Patients|PET-directed Therapy||270
292426|NCT00822120|704876|P2|Eligibile and Evaluable Patients|PET-directed Therapy||0
292427|NCT00822120|704877|P1|Eligibile and Evaluable Patients|PET-directed Therapy||0
292428|NCT00822120|704872|P6|STARTED|PET-directed Therapy||1
292429|NCT00822120|704873|P5|STARTED|PET-directed Therapy||10
292430|NCT00822120|704874|P4|STARTED|PET-directed Therapy||55
292431|NCT00822120|704875|P3|STARTED|PET-directed Therapy||270
292432|NCT00822120|704876|P2|STARTED|PET-directed Therapy||0
292433|NCT00822120|704877|P1|STARTED|PET-directed Therapy||0
292434|NCT00822120|704872|P6|NOT COMPLETED|Initial Registration||0
292435|NCT00822120|704873|P5|NOT COMPLETED|Initial Registration||0
292436|NCT00822120|704874|P4|NOT COMPLETED|Initial Registration||0
292437|NCT00822120|704875|P3|NOT COMPLETED|Initial Registration||0
292438|NCT00822120|704876|P2|NOT COMPLETED|Initial Registration||1
292439|NCT00822120|704877|P1|NOT COMPLETED|Initial Registration||26
292440|NCT00822120|704872|P6|COMPLETED|Initial Registration||0
292441|NCT00822120|704873|P5|COMPLETED|Initial Registration||0
292442|NCT00822120|704874|P4|COMPLETED|Initial Registration||0
292443|NCT00822120|704875|P3|COMPLETED|Initial Registration||0
292444|NCT00822120|704876|P2|COMPLETED|Initial Registration||12
292445|NCT00822120|704877|P1|COMPLETED|Initial Registration||332
292446|NCT00822120|704872|P6|Eligible and Evaluable Patients|Initial Registration||0
292447|NCT00822120|704873|P5|Eligible and Evaluable Patients|Initial Registration||0
292448|NCT00822120|704874|P4|Eligible and Evaluable Patients|Initial Registration||0
292449|NCT00822120|704875|P3|Eligible and Evaluable Patients|Initial Registration||0
292450|NCT00822120|704876|P2|Eligible and Evaluable Patients|Initial Registration||12
292451|NCT00822120|704877|P1|Eligible and Evaluable Patients|Initial Registration||336
292452|NCT00822120|704872|P6|STARTED|Initial Registration||0
292453|NCT00822120|704873|P5|STARTED|Initial Registration||0
292454|NCT00822120|704874|P4|STARTED|Initial Registration||0
292455|NCT00822120|704875|P3|STARTED|Initial Registration||0
292456|NCT00822120|704876|P2|STARTED|Initial Registration||13
292457|NCT00822120|704877|P1|STARTED|Initial Registration||358
292458|NCT00822107|704900|P1|NOT COMPLETED|Overall Study||0
292459|NCT00822107|704900|P1|COMPLETED|Overall Study||5
292460|NCT00822107|704900|P1|STARTED|Overall Study||5
292461|NCT00822094|704906|P2|NOT COMPLETED|Overall Study||25
292462|NCT00822094|704907|P1|NOT COMPLETED|Overall Study||44
292463|NCT00822094|704906|P2|COMPLETED|Overall Study||20
292464|NCT00822094|704907|P1|COMPLETED|Overall Study||37
292465|NCT00822094|704906|P2|STARTED|Overall Study||45
292466|NCT00822094|704907|P1|STARTED|Overall Study||81
292467|NCT00821964|704923|P1|NOT COMPLETED|Overall Study||6
292468|NCT00821964|704923|P1|COMPLETED|Overall Study||9
292469|NCT00821964|704923|P1|Evaluable for Pathologic Response|Overall Study||7
292470|NCT00821964|704923|P1|Evaluable for Clinical Response|Overall Study||14
292471|NCT00821964|704923|P1|STARTED|Overall Study||15
292472|NCT00821951|704932|P1|NOT COMPLETED|Overall Study||5
292473|NCT00821951|704932|P1|COMPLETED|Overall Study||12
292474|NCT00821951|704932|P1|STARTED|Overall Study||17
292475|NCT00821886|704936|P1|NOT COMPLETED|Overall Study||9
292476|NCT00821886|704936|P1|COMPLETED|Overall Study||49
292477|NCT00821886|704936|P1|STARTED|Overall Study|Two patients were enrolled, but subsequently found to be ineligible|58
292478|NCT00821873|704943|P1|NOT COMPLETED|Overall Study||4
292479|NCT00821873|704943|P1|COMPLETED|Overall Study||5
292480|NCT00821873|704943|P1|STARTED|Overall Study||9
292481|NCT00821821|704950|P3|NOT COMPLETED|Overall Study||0
292482|NCT00821821|704951|P2|NOT COMPLETED|Overall Study||0
292483|NCT00821821|704952|P1|NOT COMPLETED|Overall Study||0
292484|NCT00821821|704950|P3|COMPLETED|Overall Study||11
292485|NCT00821821|704951|P2|COMPLETED|Overall Study||13
292486|NCT00821821|704952|P1|COMPLETED|Overall Study||12
292487|NCT00821821|704950|P3|STARTED|Overall Study||11
292488|NCT00821821|704951|P2|STARTED|Overall Study||13
292489|NCT00821821|704952|P1|STARTED|Overall Study||12
292490|NCT00821678|704964|P2|NOT COMPLETED|Overall Study||14
292491|NCT00821678|704965|P1|NOT COMPLETED|Overall Study||21
292492|NCT00821678|704964|P2|COMPLETED|Overall Study||118
292493|NCT00821678|704965|P1|COMPLETED|Overall Study||112
292494|NCT00821678|704964|P2|STARTED|Overall Study||132
292495|NCT00821678|704965|P1|STARTED|Overall Study||133
292496|NCT00821587|704987|P2|NOT COMPLETED|Overall Study||1
292497|NCT00821587|704988|P1|NOT COMPLETED|Overall Study||0
292498|NCT00821587|704987|P2|COMPLETED|Overall Study||18
292499|NCT00821587|704988|P1|COMPLETED|Overall Study||20
292500|NCT00821587|704987|P2|STARTED|Overall Study||19
292501|NCT00821587|704988|P1|STARTED|Overall Study||20
292502|NCT00821509|704997|P3|NOT COMPLETED|Overall Study||34
292503|NCT00821509|704998|P2|NOT COMPLETED|Overall Study||11
292504|NCT00821509|704999|P1|NOT COMPLETED|Overall Study||12
292505|NCT00821509|704997|P3|COMPLETED|Overall Study|This is a result of 50 lost-to-follow-up and 16 new recruits|190
292506|NCT00821509|704998|P2|COMPLETED|Overall Study|This is a result of 57 lost-to-follow-up and 46 new recruits|191
292507|NCT00821509|704999|P1|COMPLETED|Overall Study|This is a result of 56 lost-to-follow-up and 44 new recruits|245
292508|NCT00821509|704997|P3|STARTED|Overall Study||224
292509|NCT00821509|704998|P2|STARTED|Overall Study||202
292510|NCT00821509|704999|P1|STARTED|Overall Study||257
292511|NCT00821431|705012|P2|NOT COMPLETED|Overall Study||5
292512|NCT00821431|705013|P1|NOT COMPLETED|Overall Study||15
292513|NCT00821431|705012|P2|COMPLETED|Overall Study||47
292514|NCT00821431|705013|P1|COMPLETED|Overall Study||23
292515|NCT00821431|705012|P2|STARTED|Overall Study||52
292516|NCT00821431|705013|P1|STARTED|Overall Study||38
292517|NCT00821327|705021|P1|NOT COMPLETED|Overall Study||35
292518|NCT00821327|705021|P1|COMPLETED|Overall Study||1
292519|NCT00821327|705021|P1|STARTED|Overall Study||36
292520|NCT00821236|705030|P1|NOT COMPLETED|Overall Study||3
292521|NCT00821236|705030|P1|COMPLETED|Overall Study||37
292522|NCT00821236|705030|P1|STARTED|Overall Study||40
292523|NCT00821184|705046|P2|NOT COMPLETED|Overall Study||0
292524|NCT00821184|705047|P1|NOT COMPLETED|Overall Study||0
292525|NCT00821184|705046|P2|COMPLETED|Overall Study||6
292526|NCT00821184|705047|P1|COMPLETED|Overall Study||6
292527|NCT00821184|705046|P2|STARTED|Overall Study||6
292528|NCT00821184|705047|P1|STARTED|Overall Study||6
292529|NCT00821119|705057|P2|NOT COMPLETED|Overall Study||0
292530|NCT00821119|705058|P1|NOT COMPLETED|Overall Study||0
292531|NCT00821119|705057|P2|COMPLETED|Overall Study||100
292532|NCT00821119|705058|P1|COMPLETED|Overall Study||100
292533|NCT00821119|705057|P2|STARTED|Overall Study||100
292534|NCT00821119|705058|P1|STARTED|Overall Study||100
292535|NCT00821093|705070|P2|NOT COMPLETED|Overall Study||40
292536|NCT00821093|705071|P1|NOT COMPLETED|Overall Study||49
292537|NCT00821093|705070|P2|COMPLETED|Overall Study||523
292538|NCT00821093|705071|P1|COMPLETED|Overall Study||511
292539|NCT00821093|705070|P2|Exposed to Drug|Overall Study||562
292540|NCT00821093|705071|P1|Exposed to Drug|Overall Study||559
292541|NCT00821093|705070|P2|STARTED|Overall Study||563
292542|NCT00821093|705071|P1|STARTED|Overall Study||560
292543|NCT00821041|705081|P2|NOT COMPLETED|Overall Study||0
292544|NCT00821041|705082|P1|NOT COMPLETED|Overall Study||0
292545|NCT00821041|705081|P2|COMPLETED|Overall Study||59
292546|NCT00821041|705082|P1|COMPLETED|Overall Study||59
292547|NCT00821041|705081|P2|STARTED|Overall Study||59
292548|NCT00821041|705082|P1|STARTED|Overall Study||59
292549|NCT00821015|705090|P1|NOT COMPLETED|Overall Study||12
292550|NCT00821015|705090|P1|COMPLETED|Overall Study||15
292551|NCT00821015|705090|P1|STARTED|Overall Study||27
292552|NCT00820898|705101|P1|NOT COMPLETED|Overall Study||1
292553|NCT00820898|705101|P1|COMPLETED|Overall Study||23
292554|NCT00820898|705101|P1|STARTED|Overall Study||24
292555|NCT00820872|705111|P1|NOT COMPLETED|Overall Study||0
292556|NCT00820872|705111|P1|COMPLETED|Overall Study||30
292557|NCT00820872|705111|P1|STARTED|Overall Study||30
292558|NCT00820755|705115|P3|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
292559|NCT00820755|705116|P2|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
292560|NCT00820755|705117|P1|NOT COMPLETED|Period 2: Maintenance Therapy Phase||0
292561|NCT00820755|705115|P3|COMPLETED|Period 2: Maintenance Therapy Phase||109
292562|NCT00820755|705116|P2|COMPLETED|Period 2: Maintenance Therapy Phase||112
292563|NCT00820755|705117|P1|COMPLETED|Period 2: Maintenance Therapy Phase||0
292564|NCT00820755|705115|P3|STARTED|Period 2: Maintenance Therapy Phase||154
292565|NCT00820755|705116|P2|STARTED|Period 2: Maintenance Therapy Phase||157
292566|NCT00820755|705117|P1|STARTED|Period 2: Maintenance Therapy Phase||0
292567|NCT00820755|705115|P3|NOT COMPLETED|Period 1: Combination Therapy Phase||0
292568|NCT00820755|705116|P2|NOT COMPLETED|Period 1: Combination Therapy Phase||0
292569|NCT00820755|705117|P1|NOT COMPLETED|Period 1: Combination Therapy Phase||270
292570|NCT00820755|705115|P3|COMPLETED|Period 1: Combination Therapy Phase||0
292571|NCT00820755|705116|P2|COMPLETED|Period 1: Combination Therapy Phase||0
292572|NCT00820755|705117|P1|COMPLETED|Period 1: Combination Therapy Phase|2 of 313 participants excluded from maintenance phase analysis (reason: not eligible)|313
292573|NCT00820755|705115|P3|STARTED|Period 1: Combination Therapy Phase||0
292574|NCT00820755|705116|P2|STARTED|Period 1: Combination Therapy Phase||0
292575|NCT00820755|705117|P1|STARTED|Period 1: Combination Therapy Phase||583
292576|NCT00820664|705141|P3|NOT COMPLETED|Overall Study||0
292577|NCT00820664|705142|P2|NOT COMPLETED|Overall Study||0
292578|NCT00820664|705143|P1|NOT COMPLETED|Overall Study||0
292579|NCT00820664|705141|P3|COMPLETED|Overall Study||9
292580|NCT00820664|705142|P2|COMPLETED|Overall Study||11
292581|NCT00820664|705143|P1|COMPLETED|Overall Study||9
292582|NCT00820664|705141|P3|STARTED|Overall Study||9
292583|NCT00820664|705142|P2|STARTED|Overall Study||11
292584|NCT00820664|705143|P1|STARTED|Overall Study||9
292585|NCT00820612|705153|P2|NOT COMPLETED|Overall Study||0
292586|NCT00820612|705154|P1|NOT COMPLETED|Overall Study||0
292587|NCT00820612|705153|P2|COMPLETED|Overall Study||295
292588|NCT00820612|705154|P1|COMPLETED|Overall Study||307
292589|NCT00820612|705153|P2|STARTED|Overall Study||295
292590|NCT00820612|705154|P1|STARTED|Overall Study||307
292591|NCT00820573|705164|P4|NOT COMPLETED|Overall Study||0
292592|NCT00820573|705165|P3|NOT COMPLETED|Overall Study||0
292593|NCT00820573|705166|P2|NOT COMPLETED|Overall Study||0
292594|NCT00820573|705167|P1|NOT COMPLETED|Overall Study||0
292595|NCT00820573|705164|P4|COMPLETED|Overall Study||4
292596|NCT00820573|705165|P3|COMPLETED|Overall Study||4
292597|NCT00820573|705166|P2|COMPLETED|Overall Study||4
292598|NCT00820573|705167|P1|COMPLETED|Overall Study||4
292599|NCT00820573|705164|P4|STARTED|Overall Study||4
292600|NCT00820573|705165|P3|STARTED|Overall Study||4
292601|NCT00820573|705166|P2|STARTED|Overall Study||4
292602|NCT00820573|705167|P1|STARTED|Overall Study||4
292603|NCT00820534|705191|P2|NOT COMPLETED|Overall Study||0
292604|NCT00820534|705192|P1|NOT COMPLETED|Overall Study||0
292605|NCT00820534|705191|P2|COMPLETED|Overall Study||62
292606|NCT00820534|705192|P1|COMPLETED|Overall Study||64
292607|NCT00820534|705191|P2|STARTED|Overall Study||62
292608|NCT00820534|705192|P1|STARTED|Overall Study||64
292609|NCT00820443|705200|P1|NOT COMPLETED|24 Month||43
292610|NCT00820443|705200|P1|COMPLETED|24 Month||202
292611|NCT00820443|705200|P1|STARTED|24 Month||245
292612|NCT00820443|705200|P1|NOT COMPLETED|12 Month||24
292613|NCT00820443|705200|P1|COMPLETED|12 Month||226
292614|NCT00820443|705200|P1|STARTED|12 Month||250
292615|NCT00820443|705200|P1|NOT COMPLETED|6 Month||20
292616|NCT00820443|705200|P1|COMPLETED|6 Month||233
292617|NCT00820443|705200|P1|STARTED|6 Month||253
292618|NCT00820443|705200|P1|NOT COMPLETED|3 Month||9
292619|NCT00820443|705200|P1|COMPLETED|3 Month||244
292620|NCT00820443|705200|P1|STARTED|3 Month||253
292621|NCT00820443|705200|P1|NOT COMPLETED|Immediately||5
292622|NCT00820443|705200|P1|COMPLETED|Immediately||248
292623|NCT00820443|705200|P1|STARTED|Immediately||253
292624|NCT00820443|705200|P1|NOT COMPLETED|Op||0
292625|NCT00820443|705200|P1|COMPLETED|Op||253
292626|NCT00820443|705200|P1|STARTED|Op||253
292627|NCT00820443|705200|P1|NOT COMPLETED|Pre-Op||0
292628|NCT00820443|705200|P1|COMPLETED|Pre-Op||253
292629|NCT00820443|705200|P1|STARTED|Pre-Op||253
292630|NCT00820248|705210|P2|NOT COMPLETED|Overall Study||1
292631|NCT00820248|705211|P1|NOT COMPLETED|Overall Study||4
292632|NCT00820248|705210|P2|COMPLETED|Overall Study||159
292633|NCT00820248|705211|P1|COMPLETED|Overall Study||156
292634|NCT00820248|705210|P2|Received Protocol Treatment|Overall Study||159
292635|NCT00820248|705211|P1|Received Protocol Treatment|Overall Study||156
292636|NCT00820248|705210|P2|STARTED|Overall Study||160
292637|NCT00820248|705211|P1|STARTED|Overall Study||160
292638|NCT00820222|705221|P2|NOT COMPLETED|Overall Study||190
292639|NCT00820222|705222|P1|NOT COMPLETED|Overall Study||176
292640|NCT00820222|705221|P2|COMPLETED|Overall Study||79
292641|NCT00820222|705222|P1|COMPLETED|Overall Study||95
292642|NCT00820222|705221|P2|STARTED|Overall Study||269
292643|NCT00820222|705222|P1|STARTED|Overall Study||271
292644|NCT00820170|705253|P5|NOT COMPLETED|Overall Study||4
292645|NCT00820170|705254|P4|NOT COMPLETED|Overall Study||0
292646|NCT00820170|705255|P3|NOT COMPLETED|Overall Study||0
292647|NCT00820170|705256|P2|NOT COMPLETED|Overall Study||0
292648|NCT00820170|705257|P1|NOT COMPLETED|Overall Study||0
292649|NCT00820170|705253|P5|COMPLETED|Overall Study||0
292650|NCT00820170|705254|P4|COMPLETED|Overall Study||40
292651|NCT00820170|705255|P3|COMPLETED|Overall Study||3
292652|NCT00820170|705256|P2|COMPLETED|Overall Study||5
292653|NCT00820170|705257|P1|COMPLETED|Overall Study||3
292654|NCT00820170|705253|P5|STARTED|Overall Study||4
292655|NCT00820170|705254|P4|STARTED|Overall Study||40
292656|NCT00820170|705255|P3|STARTED|Overall Study||3
292657|NCT00820170|705256|P2|STARTED|Overall Study||5
292658|NCT00820170|705257|P1|STARTED|Overall Study||3
292659|NCT00819910|705309|P4|NOT COMPLETED|Overall Study||1
292660|NCT00819910|705310|P3|NOT COMPLETED|Overall Study||3
292661|NCT00819910|705311|P2|NOT COMPLETED|Overall Study||1
292662|NCT00819910|705312|P1|NOT COMPLETED|Overall Study||2
292663|NCT00819910|705309|P4|COMPLETED|Overall Study||10
292664|NCT00819910|705310|P3|COMPLETED|Overall Study||7
292665|NCT00819910|705311|P2|COMPLETED|Overall Study||9
292666|NCT00819910|705312|P1|COMPLETED|Overall Study||8
292667|NCT00819910|705309|P4|STARTED|Overall Study||11
292668|NCT00819910|705310|P3|STARTED|Overall Study||10
292669|NCT00819910|705311|P2|STARTED|Overall Study||10
292670|NCT00819910|705312|P1|STARTED|Overall Study||10
292671|NCT00819832|705344|P6|NOT COMPLETED|Overall Study||0
292672|NCT00819832|705345|P5|NOT COMPLETED|Overall Study||0
292673|NCT00819832|705346|P4|NOT COMPLETED|Overall Study||0
292674|NCT00819832|705347|P3|NOT COMPLETED|Overall Study||0
292675|NCT00819832|705348|P2|NOT COMPLETED|Overall Study||0
292676|NCT00819832|705349|P1|NOT COMPLETED|Overall Study||3
292677|NCT00819832|705344|P6|COMPLETED|Overall Study||0
292678|NCT00819832|705345|P5|COMPLETED|Overall Study||0
292679|NCT00819832|705346|P4|COMPLETED|Overall Study||0
292680|NCT00819832|705347|P3|COMPLETED|Overall Study||0
292681|NCT00819832|705348|P2|COMPLETED|Overall Study||0
292682|NCT00819832|705349|P1|COMPLETED|Overall Study||0
292683|NCT00819832|705344|P6|STARTED|Overall Study||0
292684|NCT00819832|705345|P5|STARTED|Overall Study||0
292685|NCT00819832|705346|P4|STARTED|Overall Study||0
292686|NCT00819832|705347|P3|STARTED|Overall Study||0
292687|NCT00819832|705348|P2|STARTED|Overall Study||0
292688|NCT00819832|705349|P1|STARTED|Overall Study|No patient data analysis.|3
292689|NCT00819793|705363|P1|NOT COMPLETED|Overall Study||0
292690|NCT00819793|705363|P1|COMPLETED|Overall Study||32
292691|NCT00819793|705363|P1|STARTED|Overall Study||32
292692|NCT00819780|705370|P2|NOT COMPLETED|Overall Study||21
292693|NCT00819780|705371|P1|NOT COMPLETED|Overall Study||28
292694|NCT00819780|705370|P2|COMPLETED|Overall Study|Indicates participants who ended study treatment|122
292695|NCT00819780|705371|P1|COMPLETED|Overall Study|Indicates participants who ended study treatment|114
292696|NCT00819780|705370|P2|Received Study Treatment|Overall Study||139
292697|NCT00819780|705371|P1|Received Study Treatment|Overall Study||139
292698|NCT00819780|705370|P2|STARTED|Overall Study||143
292699|NCT00819780|705371|P1|STARTED|Overall Study||142
292700|NCT00819767|705405|P2|NOT COMPLETED|Overall Study||2
292701|NCT00819767|705406|P1|NOT COMPLETED|Overall Study||1
292702|NCT00819767|705405|P2|COMPLETED|Overall Study||33
292703|NCT00819767|705406|P1|COMPLETED|Overall Study||32
292704|NCT00819767|705405|P2|STARTED|Overall Study||35
292705|NCT00819767|705406|P1|STARTED|Overall Study||33
292706|NCT00819741|705418|P2|NOT COMPLETED|Overall Study||14
292707|NCT00819741|705419|P1|NOT COMPLETED|Overall Study||22
292708|NCT00819741|705418|P2|COMPLETED|Overall Study||201
292709|NCT00819741|705419|P1|COMPLETED|Overall Study||196
292710|NCT00819741|705418|P2|Exposed to Drug|Overall Study|One subject after randomisation was not exposed to the treatment due to non-compliance|214
292711|NCT00819741|705419|P1|Exposed to Drug|Overall Study||218
292712|NCT00819741|705418|P2|STARTED|Overall Study||215
292713|NCT00819741|705419|P1|STARTED|Overall Study||218
292714|NCT00819637|705456|P3|NOT COMPLETED|Overall Study||0
292715|NCT00819637|705457|P2|NOT COMPLETED|Overall Study||0
292716|NCT00819637|705458|P1|NOT COMPLETED|Overall Study||0
292717|NCT00819637|705456|P3|COMPLETED|Overall Study||0
292718|NCT00819637|705457|P2|COMPLETED|Overall Study||0
292719|NCT00819637|705458|P1|COMPLETED|Overall Study||2
292720|NCT00819637|705456|P3|STARTED|Overall Study||0
292721|NCT00819637|705457|P2|STARTED|Overall Study||0
292722|NCT00819637|705458|P1|STARTED|Overall Study||2
292723|NCT00819585|705473|P11|NOT COMPLETED|Extension Study||2
292724|NCT00819585|705474|P10|NOT COMPLETED|Extension Study||1
292725|NCT00819585|705475|P9|NOT COMPLETED|Extension Study||8
292726|NCT00819585|705476|P8|NOT COMPLETED|Extension Study||0
292727|NCT00819585|705477|P7|NOT COMPLETED|Extension Study||0
292728|NCT00819585|705478|P6|NOT COMPLETED|Extension Study||0
292729|NCT00819585|705479|P5|NOT COMPLETED|Extension Study||0
292730|NCT00819585|705480|P4|NOT COMPLETED|Extension Study||0
292731|NCT00819585|705481|P3|NOT COMPLETED|Extension Study||0
292732|NCT00819585|705482|P2|NOT COMPLETED|Extension Study||0
292733|NCT00819585|705483|P1|NOT COMPLETED|Extension Study||0
292734|NCT00819585|705473|P11|COMPLETED|Extension Study||58
292735|NCT00819585|705474|P10|COMPLETED|Extension Study||24
292736|NCT00819585|705475|P9|COMPLETED|Extension Study||173
292737|NCT00819585|705476|P8|COMPLETED|Extension Study||75
292738|NCT00819585|705477|P7|COMPLETED|Extension Study||0
292739|NCT00819585|705478|P6|COMPLETED|Extension Study||0
292740|NCT00819585|705479|P5|COMPLETED|Extension Study||0
292741|NCT00819585|705480|P4|COMPLETED|Extension Study||0
292742|NCT00819585|705481|P3|COMPLETED|Extension Study||0
292743|NCT00819585|705482|P2|COMPLETED|Extension Study||0
292744|NCT00819585|705483|P1|COMPLETED|Extension Study||0
292745|NCT00819585|705473|P11|STARTED|Extension Study||60
292746|NCT00819585|705474|P10|STARTED|Extension Study||25
292747|NCT00819585|705475|P9|STARTED|Extension Study||181
292748|NCT00819585|705476|P8|STARTED|Extension Study||75
292749|NCT00819585|705477|P7|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
292750|NCT00819585|705478|P6|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
292751|NCT00819585|705479|P5|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
292752|NCT00819585|705480|P4|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
292753|NCT00819585|705481|P3|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
292754|NCT00819585|705482|P2|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
292755|NCT00819585|705483|P1|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
292756|NCT00819585|705473|P11|NOT COMPLETED|Core Study||0
292757|NCT00819585|705474|P10|NOT COMPLETED|Core Study||0
292758|NCT00819585|705475|P9|NOT COMPLETED|Core Study||0
292759|NCT00819585|705476|P8|NOT COMPLETED|Core Study||0
292760|NCT00819585|705477|P7|NOT COMPLETED|Core Study||13
292761|NCT00819585|705478|P6|NOT COMPLETED|Core Study||2
292762|NCT00819585|705479|P5|NOT COMPLETED|Core Study||3
292763|NCT00819585|705480|P4|NOT COMPLETED|Core Study||5
292764|NCT00819585|705481|P3|NOT COMPLETED|Core Study||6
292765|NCT00819585|705482|P2|NOT COMPLETED|Core Study||6
292766|NCT00819585|705483|P1|NOT COMPLETED|Core Study||6
292767|NCT00819585|705473|P11|COMPLETED|Core Study||0
292768|NCT00819585|705474|P10|COMPLETED|Core Study||0
292769|NCT00819585|705475|P9|COMPLETED|Core Study||0
292770|NCT00819585|705476|P8|COMPLETED|Core Study||0
292771|NCT00819585|705477|P7|COMPLETED|Core Study||95
292772|NCT00819585|705478|P6|COMPLETED|Core Study||52
292773|NCT00819585|705479|P5|COMPLETED|Core Study||50
292774|NCT00819585|705480|P4|COMPLETED|Core Study||49
292775|NCT00819585|705481|P3|COMPLETED|Core Study||48
292776|NCT00819585|705482|P2|COMPLETED|Core Study||48
292777|NCT00819585|705483|P1|COMPLETED|Core Study||49
292778|NCT00819585|705473|P11|Received Study Medication|Core Study||0
292779|NCT00819585|705474|P10|Received Study Medication|Core Study||0
292780|NCT00819585|705475|P9|Received Study Medication|Core Study||0
292781|NCT00819585|705476|P8|Received Study Medication|Core Study||0
292782|NCT00819585|705477|P7|Received Study Medication|Core Study||108
292783|NCT00819585|705478|P6|Received Study Medication|Core Study|One participant in this treatment arm was HIV+ve and did not receive any study medication.|53
292784|NCT00819585|705479|P5|Received Study Medication|Core Study||53
292785|NCT00819585|705480|P4|Received Study Medication|Core Study||54
292786|NCT00819585|705481|P3|Received Study Medication|Core Study||54
292787|NCT00819585|705482|P2|Received Study Medication|Core Study||54
292788|NCT00819585|705483|P1|Received Study Medication|Core Study|Participants who received study medication are included in the safety population.|55
292789|NCT00819585|705473|P11|STARTED|Core Study|There were no participants in this arm during the core study.|0
292790|NCT00819585|705474|P10|STARTED|Core Study|There were no participants in this arm during the core study.|0
292791|NCT00819585|705475|P9|STARTED|Core Study|There were no participants in this arm during the core study.|0
292792|NCT00819585|705476|P8|STARTED|Core Study|There were no participants in this arm during the core study.|0
292793|NCT00819585|705477|P7|STARTED|Core Study||108
292794|NCT00819585|705478|P6|STARTED|Core Study||54
292795|NCT00819585|705479|P5|STARTED|Core Study||53
292796|NCT00819585|705480|P4|STARTED|Core Study||54
292797|NCT00819585|705481|P3|STARTED|Core Study||54
292798|NCT00819585|705482|P2|STARTED|Core Study||54
292799|NCT00819585|705483|P1|STARTED|Core Study|Participants who started the core study are included in the randomized and full analysis sets.|55
292800|NCT00819507|705554|P1|NOT COMPLETED|Overall Study||0
292801|NCT00819507|705554|P1|COMPLETED|Overall Study||25
292802|NCT00819507|705554|P1|STARTED|Overall Study||25
292803|NCT00819403|705561|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
292804|NCT00819403|705562|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
292805|NCT00819403|705561|P2|COMPLETED|Second Intervention (6 Weeks)||8
292806|NCT00819403|705562|P1|COMPLETED|Second Intervention (6 Weeks)||7
292807|NCT00819403|705561|P2|STARTED|Second Intervention (6 Weeks)||8
292808|NCT00819403|705562|P1|STARTED|Second Intervention (6 Weeks)||7
292809|NCT00819403|705561|P2|NOT COMPLETED|Washout (14 Days)||0
292810|NCT00819403|705562|P1|NOT COMPLETED|Washout (14 Days)||0
292811|NCT00819403|705561|P2|COMPLETED|Washout (14 Days)||8
292812|NCT00819403|705562|P1|COMPLETED|Washout (14 Days)||7
292813|NCT00819403|705561|P2|STARTED|Washout (14 Days)||8
292814|NCT00819403|705562|P1|STARTED|Washout (14 Days)||7
292815|NCT00819403|705561|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
292816|NCT00819403|705562|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
292817|NCT00819403|705561|P2|COMPLETED|First Intervention (6 Weeks)||8
292818|NCT00819403|705562|P1|COMPLETED|First Intervention (6 Weeks)||7
292819|NCT00819403|705561|P2|STARTED|First Intervention (6 Weeks)||8
292820|NCT00819403|705562|P1|STARTED|First Intervention (6 Weeks)||7
292821|NCT00819390|705574|P4|NOT COMPLETED|Overall Study||0
292822|NCT00819390|705575|P3|NOT COMPLETED|Overall Study||1
292823|NCT00819390|705576|P2|NOT COMPLETED|Overall Study||1
292824|NCT00819390|705577|P1|NOT COMPLETED|Overall Study||3
292825|NCT00819390|705574|P4|COMPLETED|Overall Study||19
292826|NCT00819390|705575|P3|COMPLETED|Overall Study||17
292827|NCT00819390|705576|P2|COMPLETED|Overall Study||16
292828|NCT00819390|705577|P1|COMPLETED|Overall Study||13
292829|NCT00819390|705574|P4|STARTED|Overall Study||19
292830|NCT00819390|705575|P3|STARTED|Overall Study||18
292831|NCT00819390|705576|P2|STARTED|Overall Study||17
292832|NCT00819390|705577|P1|STARTED|Overall Study||16
292833|NCT00819286|705689|P2|NOT COMPLETED|Overall Study||25
292834|NCT00819286|705690|P1|NOT COMPLETED|Overall Study||14
292835|NCT00819286|705689|P2|COMPLETED|Overall Study||45
292836|NCT00819286|705690|P1|COMPLETED|Overall Study||56
292837|NCT00819286|705689|P2|STARTED|Overall Study||70
292838|NCT00819286|705690|P1|STARTED|Overall Study||70
292839|NCT00819260|705698|P1|NOT COMPLETED|Overall Study||0
292840|NCT00819260|705698|P1|COMPLETED|Overall Study||31
292841|NCT00819260|705698|P1|STARTED|Overall Study||31
292842|NCT00819247|705713|P3|NOT COMPLETED|Overall Study||14
292843|NCT00819247|705714|P2|NOT COMPLETED|Overall Study||16
292844|NCT00819247|705715|P1|NOT COMPLETED|Overall Study||11
292845|NCT00819247|705713|P3|COMPLETED|Overall Study||26
292846|NCT00819247|705714|P2|COMPLETED|Overall Study||30
292847|NCT00819247|705715|P1|COMPLETED|Overall Study||32
292848|NCT00819247|705713|P3|Per Protocol Population|Overall Study|One participant - baseline testosterone outside normal range.|38
292849|NCT00819247|705714|P2|Per Protocol Population|Overall Study|Two participants - prohibited drugs|44
292850|NCT00819247|705715|P1|Per Protocol Population|Overall Study|One participant- baseline testosterone outside normal range. Three participants- prohibited drugs.|38
292851|NCT00819247|705713|P3|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|39
292852|NCT00819247|705714|P2|Intent-to-treat Population|Overall Study||46
292853|NCT00819247|705715|P1|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|42
292854|NCT00819247|705713|P3|Randomized|Overall Study||40
292855|NCT00819247|705714|P2|Randomized|Overall Study||46
292856|NCT00819247|705715|P1|Randomized|Overall Study||43
292857|NCT00819247|705713|P3|STARTED|Overall Study||40
292858|NCT00819247|705714|P2|STARTED|Overall Study||46
292859|NCT00819247|705715|P1|STARTED|Overall Study||43
292860|NCT00819234|705741|P10|NOT COMPLETED|Overall Study||7
292861|NCT00819234|705742|P9|NOT COMPLETED|Overall Study||6
292862|NCT00819234|705743|P8|NOT COMPLETED|Overall Study||9
292863|NCT00819234|705744|P7|NOT COMPLETED|Overall Study||5
292864|NCT00819234|705745|P6|NOT COMPLETED|Overall Study||7
292865|NCT00819234|705746|P5|NOT COMPLETED|Overall Study||1
292866|NCT00819234|705747|P4|NOT COMPLETED|Overall Study||6
292867|NCT00819234|705748|P3|NOT COMPLETED|Overall Study||8
292868|NCT00819234|705749|P2|NOT COMPLETED|Overall Study||15
292869|NCT00819234|705750|P1|NOT COMPLETED|Overall Study||10
292870|NCT00819234|705741|P10|COMPLETED|Overall Study||30
292871|NCT00819234|705742|P9|COMPLETED|Overall Study||31
292872|NCT00819234|705743|P8|COMPLETED|Overall Study||20
292873|NCT00819234|705744|P7|COMPLETED|Overall Study||8
292874|NCT00819234|705745|P6|COMPLETED|Overall Study||7
292875|NCT00819234|705746|P5|COMPLETED|Overall Study||12
292876|NCT00819234|705747|P4|COMPLETED|Overall Study||22
292877|NCT00819234|705748|P3|COMPLETED|Overall Study||28
292878|NCT00819234|705749|P2|COMPLETED|Overall Study||20
292879|NCT00819234|705750|P1|COMPLETED|Overall Study||21
292880|NCT00819234|705741|P10|STARTED|Overall Study||37
292881|NCT00819234|705742|P9|STARTED|Overall Study||37
292882|NCT00819234|705743|P8|STARTED|Overall Study||29
292883|NCT00819234|705744|P7|STARTED|Overall Study||13
292884|NCT00819234|705745|P6|STARTED|Overall Study||14
292885|NCT00819234|705746|P5|STARTED|Overall Study||13
292886|NCT00819234|705747|P4|STARTED|Overall Study||28
292887|NCT00819234|705748|P3|STARTED|Overall Study||36
292888|NCT00819234|705749|P2|STARTED|Overall Study||35
292889|NCT00819234|705750|P1|STARTED|Overall Study||31
292890|NCT00819182|705911|P3|NOT COMPLETED|Overall Study||1
292891|NCT00819182|705912|P2|NOT COMPLETED|Overall Study||8
292892|NCT00819182|705913|P1|NOT COMPLETED|Overall Study||13
292893|NCT00819182|705911|P3|COMPLETED|Overall Study||43
292894|NCT00819182|705912|P2|COMPLETED|Overall Study||78
292895|NCT00819182|705913|P1|COMPLETED|Overall Study||75
292896|NCT00819182|705911|P3|Week 16 Visit|Overall Study||43
292897|NCT00819182|705912|P2|Week 16 Visit|Overall Study||78
292898|NCT00819182|705913|P1|Week 16 Visit|Overall Study||75
292899|NCT00819182|705911|P3|STARTED|Overall Study|Consented participants allocated to this arm.|44
292900|NCT00819182|705912|P2|STARTED|Overall Study|Consented participants allocated to this arm.|86
292901|NCT00819182|705913|P1|STARTED|Overall Study|Consented participants allocated to this arm.|88
292902|NCT00819156|705949|P6|NOT COMPLETED|Overall Study||8
292903|NCT00819156|705950|P5|NOT COMPLETED|Overall Study||6
292904|NCT00819156|705951|P4|NOT COMPLETED|Overall Study||2
292905|NCT00819156|705952|P3|NOT COMPLETED|Overall Study||6
292906|NCT00819156|705953|P2|NOT COMPLETED|Overall Study||10
292907|NCT00819156|705954|P1|NOT COMPLETED|Overall Study||10
292908|NCT00819156|705949|P6|COMPLETED|Overall Study||23
292909|NCT00819156|705950|P5|COMPLETED|Overall Study||27
292910|NCT00819156|705951|P4|COMPLETED|Overall Study||28
292911|NCT00819156|705952|P3|COMPLETED|Overall Study||26
292912|NCT00819156|705953|P2|COMPLETED|Overall Study||23
292913|NCT00819156|705954|P1|COMPLETED|Overall Study||20
292914|NCT00819156|705949|P6|Randomised and Treated (ITT Population)|Overall Study||30
292915|NCT00819156|705950|P5|Randomised and Treated (ITT Population)|Overall Study||33
292916|NCT00819156|705951|P4|Randomised and Treated (ITT Population)|Overall Study||30
292917|NCT00819156|705952|P3|Randomised and Treated (ITT Population)|Overall Study||32
292918|NCT00819156|705953|P2|Randomised and Treated (ITT Population)|Overall Study||32
292919|NCT00819156|705954|P1|Randomised and Treated (ITT Population)|Overall Study||30
292920|NCT00819156|705949|P6|STARTED|Overall Study||31
292921|NCT00819156|705950|P5|STARTED|Overall Study||33
292922|NCT00819156|705951|P4|STARTED|Overall Study||30
292923|NCT00819156|705952|P3|STARTED|Overall Study||32
292924|NCT00819156|705953|P2|STARTED|Overall Study||33
292925|NCT00819156|705954|P1|STARTED|Overall Study||30
292926|NCT00819091|706044|P2|NOT COMPLETED|Overall Study||10
292927|NCT00819091|706045|P1|NOT COMPLETED|Overall Study||7
292928|NCT00819091|706044|P2|COMPLETED|Overall Study||151
292929|NCT00819091|706045|P1|COMPLETED|Overall Study||77
292930|NCT00819091|706044|P2|STARTED|Overall Study||161
292931|NCT00819091|706045|P1|STARTED|Overall Study||84
292932|NCT00819052|706071|P2|NOT COMPLETED|Overall Study||14
292933|NCT00819052|706072|P1|NOT COMPLETED|Overall Study||6
292934|NCT00819052|706071|P2|COMPLETED|Overall Study||281
292935|NCT00819052|706072|P1|COMPLETED|Overall Study||142
292936|NCT00819052|706071|P2|STARTED|Overall Study||295
292937|NCT00819052|706072|P1|STARTED|Overall Study||148
292938|NCT00819039|706187|P3|NOT COMPLETED|Overall Study||1
292939|NCT00819039|706188|P2|NOT COMPLETED|Overall Study||0
292940|NCT00819039|706189|P1|NOT COMPLETED|Overall Study||2
292941|NCT00819039|706187|P3|COMPLETED|Overall Study||24
292942|NCT00819039|706188|P2|COMPLETED|Overall Study||27
292943|NCT00819039|706189|P1|COMPLETED|Overall Study||44
292944|NCT00819039|706187|P3|STARTED|Overall Study||25
292945|NCT00819039|706188|P2|STARTED|Overall Study||27
292946|NCT00819039|706189|P1|STARTED|Overall Study||46
292947|NCT00819013|706219|P4|NOT COMPLETED|Overall Study||4
292948|NCT00819013|706220|P3|NOT COMPLETED|Overall Study||5
292949|NCT00819013|706221|P2|NOT COMPLETED|Overall Study||1
292950|NCT00819013|706222|P1|NOT COMPLETED|Overall Study||3
292951|NCT00819013|706219|P4|COMPLETED|Overall Study||17
292952|NCT00819013|706220|P3|COMPLETED|Overall Study||16
292953|NCT00819013|706221|P2|COMPLETED|Overall Study||22
292954|NCT00819013|706222|P1|COMPLETED|Overall Study||19
292955|NCT00819013|706219|P4|STARTED|Overall Study||21
292956|NCT00819013|706220|P3|STARTED|Overall Study||21
292957|NCT00819013|706221|P2|STARTED|Overall Study||23
292958|NCT00819013|706222|P1|STARTED|Overall Study||22
292959|NCT00818961|706272|P1|NOT COMPLETED|Overall Study||0
292960|NCT00818961|706272|P1|COMPLETED|Overall Study||36
292961|NCT00818961|706272|P1|STARTED|Overall Study||36
292962|NCT00818883|706288|P2|NOT COMPLETED|Overall Study||46
292963|NCT00818883|706289|P1|NOT COMPLETED|Overall Study||51
292964|NCT00818883|706288|P2|COMPLETED|Overall Study||260
292965|NCT00818883|706289|P1|COMPLETED|Overall Study||252
292966|NCT00818883|706288|P2|STARTED|Overall Study||306
292967|NCT00818883|706289|P1|STARTED|Overall Study||303
292968|NCT00818805|706323|P2|NOT COMPLETED|Second Intervention||0
292969|NCT00818805|706324|P1|NOT COMPLETED|Second Intervention||0
292970|NCT00818805|706323|P2|COMPLETED|Second Intervention||25
292971|NCT00818805|706324|P1|COMPLETED|Second Intervention||25
292972|NCT00818805|706323|P2|STARTED|Second Intervention||25
292973|NCT00818805|706324|P1|STARTED|Second Intervention||25
292974|NCT00818805|706323|P2|NOT COMPLETED|First Intervention||0
292975|NCT00818805|706324|P1|NOT COMPLETED|First Intervention||0
292976|NCT00818805|706323|P2|COMPLETED|First Intervention||25
292977|NCT00818805|706324|P1|COMPLETED|First Intervention||25
292978|NCT00818805|706323|P2|STARTED|First Intervention||25
292979|NCT00818805|706324|P1|STARTED|First Intervention||25
292980|NCT00818779|706336|P2|NOT COMPLETED|Overall Study||1
292981|NCT00818779|706337|P1|NOT COMPLETED|Overall Study||6
292982|NCT00818779|706336|P2|COMPLETED|Overall Study||15
292983|NCT00818779|706337|P1|COMPLETED|Overall Study||16
292984|NCT00818779|706336|P2|STARTED|Overall Study||16
292985|NCT00818779|706337|P1|STARTED|Overall Study||22
292986|NCT00818766|706353|P2|NOT COMPLETED|Overall Study||10
292987|NCT00818766|706354|P1|NOT COMPLETED|Overall Study||15
292988|NCT00818766|706353|P2|COMPLETED|Overall Study||116
292989|NCT00818766|706354|P1|COMPLETED|Overall Study||110
292990|NCT00818766|706353|P2|Intent-to-Treat Population|Overall Study|2 participants were randomized twice but only counted once (per first randomization).|124
292991|NCT00818766|706354|P1|Intent-to-Treat Population|Overall Study|1 participant was randomized twice but only counted once (per first randomization).|121
292992|NCT00818766|706353|P2|Received Allocated Intervention|Overall Study||126
292993|NCT00818766|706354|P1|Received Allocated Intervention|Overall Study|1 withdrew consent, 1 had active infection and 1 was given open-label antibiotic after surgery.|122
292994|NCT00818766|706353|P2|STARTED|Overall Study||126
292995|NCT00818766|706354|P1|STARTED|Overall Study||125
292996|NCT00818753|706383|P3|NOT COMPLETED|Overall Study||1
292997|NCT00818753|706384|P2|NOT COMPLETED|Overall Study||0
292998|NCT00818753|706385|P1|NOT COMPLETED|Overall Study||3
292999|NCT00818753|706383|P3|COMPLETED|Overall Study||9
293000|NCT00818753|706384|P2|COMPLETED|Overall Study||21
293001|NCT00818753|706385|P1|COMPLETED|Overall Study||19
293002|NCT00818753|706383|P3|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|10
293003|NCT00818753|706384|P2|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|21
293004|NCT00818753|706385|P1|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|22
293005|NCT00818662|706409|P4|NOT COMPLETED|Overall Study||16
293006|NCT00818662|706410|P3|NOT COMPLETED|Overall Study||9
293007|NCT00818662|706411|P2|NOT COMPLETED|Overall Study||33
293008|NCT00818662|706412|P1|NOT COMPLETED|Overall Study||23
293009|NCT00818662|706409|P4|COMPLETED|Overall Study||47
293010|NCT00818662|706410|P3|COMPLETED|Overall Study||49
293011|NCT00818662|706411|P2|COMPLETED|Overall Study||102
293012|NCT00818662|706412|P1|COMPLETED|Overall Study||104
293013|NCT00818662|706409|P4|STARTED|Overall Study||63
293014|NCT00818662|706410|P3|STARTED|Overall Study||58
293015|NCT00818662|706411|P2|STARTED|Overall Study||135
293016|NCT00818662|706412|P1|STARTED|Overall Study||127
293017|NCT00818649|706498|P1|NOT COMPLETED|Overall Study||4
293018|NCT00818649|706498|P1|COMPLETED|Overall Study||12
293019|NCT00818649|706498|P1|STARTED|Overall Study||16
293020|NCT00818623|706512|P8|NOT COMPLETED|Overall Study||1
293021|NCT00818623|706513|P7|NOT COMPLETED|Overall Study||4
293022|NCT00818623|706514|P6|NOT COMPLETED|Overall Study||3
293023|NCT00818623|706515|P5|NOT COMPLETED|Overall Study||4
293024|NCT00818623|706516|P4|NOT COMPLETED|Overall Study||5
293025|NCT00818623|706517|P3|NOT COMPLETED|Overall Study||4
293026|NCT00818623|706518|P2|NOT COMPLETED|Overall Study||4
293027|NCT00818623|706519|P1|NOT COMPLETED|Overall Study||2
293028|NCT00818623|706512|P8|COMPLETED|Overall Study||26
293029|NCT00818623|706513|P7|COMPLETED|Overall Study||23
293030|NCT00818623|706514|P6|COMPLETED|Overall Study||21
293031|NCT00818623|706515|P5|COMPLETED|Overall Study||23
293032|NCT00818623|706516|P4|COMPLETED|Overall Study||19
293033|NCT00818623|706517|P3|COMPLETED|Overall Study||9
293034|NCT00818623|706518|P2|COMPLETED|Overall Study||8
293035|NCT00818623|706519|P1|COMPLETED|Overall Study||24
293036|NCT00818623|706512|P8|Intent-to-treat (ITT) Population|Overall Study||27
293037|NCT00818623|706513|P7|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
293038|NCT00818623|706514|P6|Intent-to-treat (ITT) Population|Overall Study||24
293039|NCT00818623|706515|P5|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
293040|NCT00818623|706516|P4|Intent-to-treat (ITT) Population|Overall Study||24
293041|NCT00818623|706517|P3|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|12
293042|NCT00818623|706518|P2|Intent-to-treat (ITT) Population|Overall Study||12
293043|NCT00818623|706519|P1|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|25
293044|NCT00818623|706512|P8|STARTED|Overall Study||27
293045|NCT00818623|706513|P7|STARTED|Overall Study||27
293046|NCT00818623|706514|P6|STARTED|Overall Study||24
293047|NCT00818623|706515|P5|STARTED|Overall Study||27
293048|NCT00818623|706516|P4|STARTED|Overall Study||24
293049|NCT00818623|706517|P3|STARTED|Overall Study||13
293050|NCT00818623|706518|P2|STARTED|Overall Study||12
293051|NCT00818623|706519|P1|STARTED|Overall Study||26
293052|NCT00818519|706595|P2|NOT COMPLETED|Overall Study||19
293053|NCT00818519|706596|P1|NOT COMPLETED|Overall Study||14
293054|NCT00818519|706595|P2|COMPLETED|Overall Study||71
293055|NCT00818519|706596|P1|COMPLETED|Overall Study||75
293056|NCT00818519|706595|P2|Participants Received Treatment|Overall Study|= Baseline|86
293057|NCT00818519|706596|P1|Participants Received Treatment|Overall Study|= Baseline|87
293058|NCT00818519|706595|P2|STARTED|Overall Study|4 excluded from FAS because study drug intake unknown or never administered|90
293059|NCT00818519|706596|P1|STARTED|Overall Study|2 excluded from FAS because study drug intake unknown or never administered|89
293060|NCT00818454|706626|P4|NOT COMPLETED|Treatment Period 3||1
293061|NCT00818454|706627|P3|NOT COMPLETED|Treatment Period 3||0
293062|NCT00818454|706628|P2|NOT COMPLETED|Treatment Period 3||0
293063|NCT00818454|706629|P1|NOT COMPLETED|Treatment Period 3||0
293064|NCT00818454|706626|P4|COMPLETED|Treatment Period 3||138
293065|NCT00818454|706627|P3|COMPLETED|Treatment Period 3||26
293066|NCT00818454|706628|P2|COMPLETED|Treatment Period 3||0
293067|NCT00818454|706629|P1|COMPLETED|Treatment Period 3||0
293068|NCT00818454|706626|P4|STARTED|Treatment Period 3||139
293069|NCT00818454|706627|P3|STARTED|Treatment Period 3||26
293070|NCT00818454|706628|P2|STARTED|Treatment Period 3||0
293071|NCT00818454|706629|P1|STARTED|Treatment Period 3||0
293072|NCT00818454|706626|P4|NOT COMPLETED|Treatment Period 2||0
293073|NCT00818454|706627|P3|NOT COMPLETED|Treatment Period 2||0
293074|NCT00818454|706628|P2|NOT COMPLETED|Treatment Period 2||1
293075|NCT00818454|706629|P1|NOT COMPLETED|Treatment Period 2||2
293076|NCT00818454|706626|P4|COMPLETED|Treatment Period 2||0
293077|NCT00818454|706627|P3|COMPLETED|Treatment Period 2||0
293078|NCT00818454|706628|P2|COMPLETED|Treatment Period 2||106
293079|NCT00818454|706629|P1|COMPLETED|Treatment Period 2||106
293080|NCT00818454|706626|P4|STARTED|Treatment Period 2||0
293081|NCT00818454|706627|P3|STARTED|Treatment Period 2||0
293082|NCT00818454|706628|P2|STARTED|Treatment Period 2||107
293083|NCT00818454|706629|P1|STARTED|Treatment Period 2||108
293084|NCT00818454|706626|P4|NOT COMPLETED|Washout Period of 1 Week||0
293085|NCT00818454|706627|P3|NOT COMPLETED|Washout Period of 1 Week||0
293086|NCT00818454|706628|P2|NOT COMPLETED|Washout Period of 1 Week||3
293087|NCT00818454|706629|P1|NOT COMPLETED|Washout Period of 1 Week||4
293088|NCT00818454|706626|P4|COMPLETED|Washout Period of 1 Week||0
293089|NCT00818454|706627|P3|COMPLETED|Washout Period of 1 Week||0
293090|NCT00818454|706628|P2|COMPLETED|Washout Period of 1 Week||107
293091|NCT00818454|706629|P1|COMPLETED|Washout Period of 1 Week||108
293092|NCT00818454|706626|P4|STARTED|Washout Period of 1 Week||0
293093|NCT00818454|706627|P3|STARTED|Washout Period of 1 Week||0
293094|NCT00818454|706628|P2|STARTED|Washout Period of 1 Week||110
293095|NCT00818454|706629|P1|STARTED|Washout Period of 1 Week||112
293096|NCT00818454|706626|P4|NOT COMPLETED|Treatment Period 1||0
293097|NCT00818454|706627|P3|NOT COMPLETED|Treatment Period 1||0
293098|NCT00818454|706628|P2|NOT COMPLETED|Treatment Period 1||1
293099|NCT00818454|706629|P1|NOT COMPLETED|Treatment Period 1||3
293100|NCT00818454|706626|P4|COMPLETED|Treatment Period 1||0
293101|NCT00818454|706627|P3|COMPLETED|Treatment Period 1||0
293102|NCT00818454|706628|P2|COMPLETED|Treatment Period 1||110
293103|NCT00818454|706629|P1|COMPLETED|Treatment Period 1||112
293104|NCT00818454|706626|P4|STARTED|Treatment Period 1||0
293105|NCT00818454|706627|P3|STARTED|Treatment Period 1||0
293106|NCT00818454|706628|P2|STARTED|Treatment Period 1||111
293107|NCT00818454|706629|P1|STARTED|Treatment Period 1||115
293108|NCT00818441|706657|P2|NOT COMPLETED|Overall Study||30
293109|NCT00818441|706658|P1|NOT COMPLETED|Overall Study||89
293110|NCT00818441|706657|P2|COMPLETED|Overall Study||0
293111|NCT00818441|706658|P1|COMPLETED|Overall Study||0
293112|NCT00818441|706657|P2|STARTED|Overall Study||30
293113|NCT00818441|706658|P1|STARTED|Overall Study||89
293114|NCT00818389|706680|P2|NOT COMPLETED|Overall Study||6
293115|NCT00818389|706681|P1|NOT COMPLETED|Overall Study||4
293116|NCT00818389|706680|P2|COMPLETED|Overall Study|6 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|38
293117|NCT00818389|706681|P1|COMPLETED|Overall Study|4 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|36
293118|NCT00818389|706680|P2|STARTED|Overall Study||44
293119|NCT00818389|706681|P1|STARTED|Overall Study||40
293120|NCT00818337|706691|P1|NOT COMPLETED|Overall Study||0
293121|NCT00818337|706691|P1|COMPLETED|Overall Study||36
293122|NCT00818337|706691|P1|STARTED|Overall Study||36
293123|NCT00818324|706696|P1|NOT COMPLETED|Overall Study||27
293124|NCT00818324|706696|P1|COMPLETED|Overall Study||127
293125|NCT00818324|706696|P1|STARTED|Overall Study||154
293126|NCT00818272|706701|P1|NOT COMPLETED|Overall Study||74
293127|NCT00818272|706701|P1|COMPLETED|Overall Study||74
293128|NCT00818272|706701|P1|STARTED|Overall Study||148
293129|NCT00818259|706716|P9|NOT COMPLETED|Part V||0
293130|NCT00818259|706717|P8|NOT COMPLETED|Part V||1
293131|NCT00818259|706718|P7|NOT COMPLETED|Part V||0
293132|NCT00818259|706719|P6|NOT COMPLETED|Part V||0
293133|NCT00818259|706720|P5|NOT COMPLETED|Part V||0
293134|NCT00818259|706721|P4|NOT COMPLETED|Part V||0
293135|NCT00818259|706722|P3|NOT COMPLETED|Part V||0
293136|NCT00818259|706723|P2|NOT COMPLETED|Part V||0
293137|NCT00818259|706724|P1|NOT COMPLETED|Part V||0
293138|NCT00818259|706716|P9|COMPLETED|Part V||6
293139|NCT00818259|706717|P8|COMPLETED|Part V||16
293140|NCT00818259|706718|P7|COMPLETED|Part V||0
293141|NCT00818259|706719|P6|COMPLETED|Part V||0
293142|NCT00818259|706720|P5|COMPLETED|Part V||0
293143|NCT00818259|706721|P4|COMPLETED|Part V||0
293144|NCT00818259|706722|P3|COMPLETED|Part V||0
293145|NCT00818259|706723|P2|COMPLETED|Part V||0
293146|NCT00818259|706724|P1|COMPLETED|Part V||0
293147|NCT00818259|706716|P9|STARTED|Part V|Newly enrolled participants|6
293148|NCT00818259|706717|P8|STARTED|Part V|Participants continuing from Part IV|17
293149|NCT00818259|706718|P7|STARTED|Part V||0
293150|NCT00818259|706719|P6|STARTED|Part V||0
293151|NCT00818259|706720|P5|STARTED|Part V||0
293152|NCT00818259|706721|P4|STARTED|Part V||0
293153|NCT00818259|706722|P3|STARTED|Part V||0
293154|NCT00818259|706723|P2|STARTED|Part V||0
293155|NCT00818259|706724|P1|STARTED|Part V||0
293156|NCT00818259|706716|P9|NOT COMPLETED|Part IV||0
293157|NCT00818259|706717|P8|NOT COMPLETED|Part IV||0
293158|NCT00818259|706718|P7|NOT COMPLETED|Part IV||0
293159|NCT00818259|706719|P6|NOT COMPLETED|Part IV||1
293160|NCT00818259|706720|P5|NOT COMPLETED|Part IV||0
293161|NCT00818259|706721|P4|NOT COMPLETED|Part IV||0
293162|NCT00818259|706722|P3|NOT COMPLETED|Part IV||0
293163|NCT00818259|706723|P2|NOT COMPLETED|Part IV||0
293164|NCT00818259|706724|P1|NOT COMPLETED|Part IV||0
293165|NCT00818259|706716|P9|COMPLETED|Part IV||0
293166|NCT00818259|706717|P8|COMPLETED|Part IV||0
293167|NCT00818259|706718|P7|COMPLETED|Part IV||5
293168|NCT00818259|706719|P6|COMPLETED|Part IV||14
293169|NCT00818259|706720|P5|COMPLETED|Part IV||0
293170|NCT00818259|706721|P4|COMPLETED|Part IV||0
293171|NCT00818259|706722|P3|COMPLETED|Part IV||0
293172|NCT00818259|706723|P2|COMPLETED|Part IV||0
293173|NCT00818259|706724|P1|COMPLETED|Part IV||0
293174|NCT00818259|706716|P9|STARTED|Part IV||0
293175|NCT00818259|706717|P8|STARTED|Part IV||0
293176|NCT00818259|706718|P7|STARTED|Part IV|Newly enrolled participants|5
293177|NCT00818259|706719|P6|STARTED|Part IV|Participants continuing from Part III|15
293178|NCT00818259|706720|P5|STARTED|Part IV||0
293179|NCT00818259|706721|P4|STARTED|Part IV||0
293180|NCT00818259|706722|P3|STARTED|Part IV||0
293181|NCT00818259|706723|P2|STARTED|Part IV||0
293182|NCT00818259|706724|P1|STARTED|Part IV||0
293183|NCT00818259|706716|P9|NOT COMPLETED|Part III||0
293184|NCT00818259|706717|P8|NOT COMPLETED|Part III||0
293185|NCT00818259|706718|P7|NOT COMPLETED|Part III||0
293186|NCT00818259|706719|P6|NOT COMPLETED|Part III||0
293187|NCT00818259|706720|P5|NOT COMPLETED|Part III||0
293188|NCT00818259|706721|P4|NOT COMPLETED|Part III||0
293189|NCT00818259|706722|P3|NOT COMPLETED|Part III||0
293190|NCT00818259|706723|P2|NOT COMPLETED|Part III||0
293191|NCT00818259|706724|P1|NOT COMPLETED|Part III||0
293192|NCT00818259|706716|P9|COMPLETED|Part III||0
293193|NCT00818259|706717|P8|COMPLETED|Part III||0
293194|NCT00818259|706718|P7|COMPLETED|Part III||0
293195|NCT00818259|706719|P6|COMPLETED|Part III||0
293196|NCT00818259|706720|P5|COMPLETED|Part III||19
293197|NCT00818259|706721|P4|COMPLETED|Part III||0
293198|NCT00818259|706722|P3|COMPLETED|Part III||0
293199|NCT00818259|706723|P2|COMPLETED|Part III||0
293200|NCT00818259|706724|P1|COMPLETED|Part III||0
293201|NCT00818259|706716|P9|STARTED|Part III||0
293202|NCT00818259|706717|P8|STARTED|Part III||0
293203|NCT00818259|706718|P7|STARTED|Part III||0
293204|NCT00818259|706719|P6|STARTED|Part III||0
293205|NCT00818259|706720|P5|STARTED|Part III|Newly enrolled participants|19
293206|NCT00818259|706721|P4|STARTED|Part III||0
293207|NCT00818259|706722|P3|STARTED|Part III||0
293208|NCT00818259|706723|P2|STARTED|Part III||0
293209|NCT00818259|706724|P1|STARTED|Part III||0
293210|NCT00818259|706716|P9|NOT COMPLETED|Part II||0
293211|NCT00818259|706717|P8|NOT COMPLETED|Part II||0
293212|NCT00818259|706718|P7|NOT COMPLETED|Part II||0
293213|NCT00818259|706719|P6|NOT COMPLETED|Part II||0
293214|NCT00818259|706720|P5|NOT COMPLETED|Part II||0
293215|NCT00818259|706721|P4|NOT COMPLETED|Part II||2
293216|NCT00818259|706722|P3|NOT COMPLETED|Part II||1
293217|NCT00818259|706723|P2|NOT COMPLETED|Part II||0
293218|NCT00818259|706724|P1|NOT COMPLETED|Part II||0
293219|NCT00818259|706716|P9|COMPLETED|Part II||0
293220|NCT00818259|706717|P8|COMPLETED|Part II||0
293221|NCT00818259|706718|P7|COMPLETED|Part II||0
293222|NCT00818259|706719|P6|COMPLETED|Part II||0
293223|NCT00818259|706720|P5|COMPLETED|Part II||0
293224|NCT00818259|706721|P4|COMPLETED|Part II||18
293225|NCT00818259|706722|P3|COMPLETED|Part II||18
293226|NCT00818259|706723|P2|COMPLETED|Part II||0
293227|NCT00818259|706724|P1|COMPLETED|Part II||0
293228|NCT00818259|706716|P9|Treated|Part II||0
293229|NCT00818259|706717|P8|Treated|Part II||0
293230|NCT00818259|706718|P7|Treated|Part II||0
293231|NCT00818259|706719|P6|Treated|Part II||0
293232|NCT00818259|706720|P5|Treated|Part II||0
293233|NCT00818259|706721|P4|Treated|Part II||19
293234|NCT00818259|706722|P3|Treated|Part II||19
293235|NCT00818259|706723|P2|Treated|Part II||0
293236|NCT00818259|706724|P1|Treated|Part II||0
293237|NCT00818259|706716|P9|STARTED|Part II||0
293238|NCT00818259|706717|P8|STARTED|Part II||0
293239|NCT00818259|706718|P7|STARTED|Part II||0
293240|NCT00818259|706719|P6|STARTED|Part II||0
293241|NCT00818259|706720|P5|STARTED|Part II||0
293242|NCT00818259|706721|P4|STARTED|Part II|Newly enrolled participants|20
293243|NCT00818259|706722|P3|STARTED|Part II|Newly enrolled participants|19
293244|NCT00818259|706723|P2|STARTED|Part II||0
293245|NCT00818259|706724|P1|STARTED|Part II||0
293246|NCT00818259|706716|P9|NOT COMPLETED|Part I||0
293247|NCT00818259|706717|P8|NOT COMPLETED|Part I||0
293248|NCT00818259|706718|P7|NOT COMPLETED|Part I||0
293249|NCT00818259|706719|P6|NOT COMPLETED|Part I||0
293250|NCT00818259|706720|P5|NOT COMPLETED|Part I||0
293251|NCT00818259|706721|P4|NOT COMPLETED|Part I||0
293252|NCT00818259|706722|P3|NOT COMPLETED|Part I||0
293253|NCT00818259|706723|P2|NOT COMPLETED|Part I||0
293254|NCT00818259|706724|P1|NOT COMPLETED|Part I||1
293255|NCT00818259|706716|P9|COMPLETED|Part I||0
293256|NCT00818259|706717|P8|COMPLETED|Part I||0
293257|NCT00818259|706718|P7|COMPLETED|Part I||0
293258|NCT00818259|706719|P6|COMPLETED|Part I||0
293259|NCT00818259|706720|P5|COMPLETED|Part I||0
293260|NCT00818259|706721|P4|COMPLETED|Part I||0
293261|NCT00818259|706722|P3|COMPLETED|Part I||0
293262|NCT00818259|706723|P2|COMPLETED|Part I||11
293263|NCT00818259|706724|P1|COMPLETED|Part I||11
293264|NCT00818259|706716|P9|STARTED|Part I||0
293265|NCT00818259|706717|P8|STARTED|Part I||0
293266|NCT00818259|706718|P7|STARTED|Part I||0
293267|NCT00818259|706719|P6|STARTED|Part I||0
293268|NCT00818259|706720|P5|STARTED|Part I||0
293269|NCT00818259|706721|P4|STARTED|Part I||0
293270|NCT00818259|706722|P3|STARTED|Part I||0
293271|NCT00818259|706723|P2|STARTED|Part I|Newly enrolled participants|11
293272|NCT00818259|706724|P1|STARTED|Part I|Newly enrolled participants|12
293273|NCT00818259|706716|P9|NOT COMPLETED|Randomization||0
293274|NCT00818259|706717|P8|NOT COMPLETED|Randomization||0
293275|NCT00818259|706718|P7|NOT COMPLETED|Randomization||0
293276|NCT00818259|706719|P6|NOT COMPLETED|Randomization||0
293277|NCT00818259|706720|P5|NOT COMPLETED|Randomization||0
293278|NCT00818259|706721|P4|NOT COMPLETED|Randomization||0
293279|NCT00818259|706722|P3|NOT COMPLETED|Randomization||0
293280|NCT00818259|706723|P2|NOT COMPLETED|Randomization||0
293281|NCT00818259|706724|P1|NOT COMPLETED|Randomization||0
293282|NCT00818259|706716|P9|COMPLETED|Randomization||6
293283|NCT00818259|706717|P8|COMPLETED|Randomization||0
293284|NCT00818259|706718|P7|COMPLETED|Randomization||5
293285|NCT00818259|706719|P6|COMPLETED|Randomization||0
293286|NCT00818259|706720|P5|COMPLETED|Randomization||19
293287|NCT00818259|706721|P4|COMPLETED|Randomization||20
293288|NCT00818259|706722|P3|COMPLETED|Randomization||19
293289|NCT00818259|706723|P2|COMPLETED|Randomization||11
293290|NCT00818259|706724|P1|COMPLETED|Randomization||12
293291|NCT00818259|706716|P9|STARTED|Randomization||6
293292|NCT00818259|706717|P8|STARTED|Randomization||0
293293|NCT00818259|706718|P7|STARTED|Randomization||5
293294|NCT00818259|706719|P6|STARTED|Randomization||0
293295|NCT00818259|706720|P5|STARTED|Randomization||19
293296|NCT00818259|706721|P4|STARTED|Randomization||20
293297|NCT00818259|706722|P3|STARTED|Randomization||19
293298|NCT00818259|706723|P2|STARTED|Randomization||11
293299|NCT00818259|706724|P1|STARTED|Randomization||12
293300|NCT00818246|706796|P1|NOT COMPLETED|Overall Study||5
293301|NCT00818246|706796|P1|COMPLETED|Overall Study|split-face study|35
293302|NCT00818246|706796|P1|STARTED|Overall Study||40
293303|NCT00818207|706805|P2|NOT COMPLETED|Overall Study||267
293304|NCT00818207|706806|P1|NOT COMPLETED|Overall Study||222
293305|NCT00818207|706805|P2|COMPLETED|Overall Study||417
293306|NCT00818207|706806|P1|COMPLETED|Overall Study||474
293307|NCT00818207|706805|P2|STARTED|Overall Study||684
293308|NCT00818207|706806|P1|STARTED|Overall Study||696
293309|NCT00818168|706820|P1|NOT COMPLETED|Overall Study||70
293310|NCT00818168|706820|P1|COMPLETED|Overall Study|Includes 78 participants whose completer/non-completer status was not reported (missing)|250
293311|NCT00818168|706820|P1|STARTED|Overall Study||320
293312|NCT00818116|706828|P1|NOT COMPLETED|Overall Study||0
293313|NCT00818116|706828|P1|COMPLETED|Overall Study||34
293314|NCT00818116|706828|P1|STARTED|Overall Study||34
293315|NCT00817999|706834|P2|NOT COMPLETED|No Grapefruit Juice||0
293316|NCT00817999|706835|P1|NOT COMPLETED|No Grapefruit Juice||0
293317|NCT00817999|706834|P2|COMPLETED|No Grapefruit Juice||17
293318|NCT00817999|706835|P1|COMPLETED|No Grapefruit Juice||15
293319|NCT00817999|706834|P2|STARTED|No Grapefruit Juice||17
293320|NCT00817999|706835|P1|STARTED|No Grapefruit Juice||15
293321|NCT00817999|706834|P2|NOT COMPLETED|Grapefruit Juice||0
293322|NCT00817999|706835|P1|NOT COMPLETED|Grapefruit Juice||0
293323|NCT00817999|706834|P2|COMPLETED|Grapefruit Juice||17
293324|NCT00817999|706835|P1|COMPLETED|Grapefruit Juice||15
293325|NCT00817999|706834|P2|STARTED|Grapefruit Juice||17
293326|NCT00817999|706835|P1|STARTED|Grapefruit Juice||15
293327|NCT00817843|706843|P2|NOT COMPLETED|Second Period (6 Weeks)||1
293328|NCT00817843|706844|P1|NOT COMPLETED|Second Period (6 Weeks)||0
293329|NCT00817843|706843|P2|COMPLETED|Second Period (6 Weeks)||44
293330|NCT00817843|706844|P1|COMPLETED|Second Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|41
293331|NCT00817843|706843|P2|STARTED|Second Period (6 Weeks)||45
293332|NCT00817843|706844|P1|STARTED|Second Period (6 Weeks)||41
293333|NCT00817843|706843|P2|NOT COMPLETED|Washout Period (6 Weeks)||1
293334|NCT00817843|706844|P1|NOT COMPLETED|Washout Period (6 Weeks)||1
293335|NCT00817843|706843|P2|COMPLETED|Washout Period (6 Weeks)||45
293336|NCT00817843|706844|P1|COMPLETED|Washout Period (6 Weeks)||41
293337|NCT00817843|706843|P2|STARTED|Washout Period (6 Weeks)||46
293338|NCT00817843|706844|P1|STARTED|Washout Period (6 Weeks)||42
293339|NCT00817843|706843|P2|NOT COMPLETED|First Period (6 Weeks)||4
293340|NCT00817843|706844|P1|NOT COMPLETED|First Period (6 Weeks)||8
293341|NCT00817843|706843|P2|COMPLETED|First Period (6 Weeks)||46
293342|NCT00817843|706844|P1|COMPLETED|First Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|42
293343|NCT00817843|706843|P2|STARTED|First Period (6 Weeks)||50
293344|NCT00817843|706844|P1|STARTED|First Period (6 Weeks)||50
293345|NCT00817804|706851|P2|NOT COMPLETED|Overall Study||0
293346|NCT00817804|706852|P1|NOT COMPLETED|Overall Study||0
293347|NCT00817804|706851|P2|COMPLETED|Overall Study||2
293348|NCT00817804|706852|P1|COMPLETED|Overall Study||1
293349|NCT00817804|706851|P2|STARTED|Overall Study||2
293350|NCT00817804|706852|P1|STARTED|Overall Study||1
293351|NCT00817778|706860|P2|NOT COMPLETED|Overall Study||3
293352|NCT00817778|706861|P1|NOT COMPLETED|Overall Study||3
293353|NCT00817778|706860|P2|COMPLETED|Overall Study||5
293354|NCT00817778|706861|P1|COMPLETED|Overall Study||16
293355|NCT00817778|706860|P2|STARTED|Overall Study||8
293356|NCT00817778|706861|P1|STARTED|Overall Study||19
293357|NCT00817596|706886|P1|NOT COMPLETED|Overall Study||48
293358|NCT00817596|706886|P1|COMPLETED|Overall Study||62
293359|NCT00817596|706886|P1|STARTED|Overall Study||110
293360|NCT00817531|706890|P1|NOT COMPLETED|Overall Study||2
293361|NCT00817531|706890|P1|COMPLETED|Overall Study|20 out of 22 patients finished study treatment. 2 patients stopped the treatment after the 1st week.|20
293362|NCT00817531|706890|P1|STARTED|Overall Study|22 patients were eligible for this study and started the treatment.|22
293363|NCT00817479|706896|P2|NOT COMPLETED|Overall Study||1
293364|NCT00817479|706897|P1|NOT COMPLETED|Overall Study||1
293365|NCT00817479|706896|P2|COMPLETED|Overall Study||13
293366|NCT00817479|706897|P1|COMPLETED|Overall Study||5
293367|NCT00817479|706896|P2|STARTED|Overall Study||14
293368|NCT00817479|706897|P1|STARTED|Overall Study||6
293369|NCT00817336|706907|P2|NOT COMPLETED|Overall Study||1
293370|NCT00817336|706908|P1|NOT COMPLETED|Overall Study||1
293371|NCT00817336|706907|P2|COMPLETED|Overall Study||7
293372|NCT00817336|706908|P1|COMPLETED|Overall Study||7
293373|NCT00817336|706907|P2|STARTED|Overall Study||8
293374|NCT00817336|706908|P1|STARTED|Overall Study||8
293375|NCT00817219|706919|P1|NOT COMPLETED|Overall Study||0
293376|NCT00817219|706919|P1|COMPLETED|Overall Study||33
293377|NCT00817219|706919|P1|STARTED|Overall Study||33
293378|NCT00817206|706934|P2|NOT COMPLETED|Overall Study||9
293379|NCT00817206|706935|P1|NOT COMPLETED|Overall Study||21
293380|NCT00817206|706934|P2|COMPLETED|Overall Study||154
293381|NCT00817206|706935|P1|COMPLETED|Overall Study||142
293382|NCT00817206|706934|P2|STARTED|Overall Study||163
293383|NCT00817206|706935|P1|STARTED|Overall Study||163
293384|NCT00817089|706945|P4|NOT COMPLETED|Second Alcohol Challenge||0
293385|NCT00817089|706946|P3|NOT COMPLETED|Second Alcohol Challenge||0
293386|NCT00817089|706947|P2|NOT COMPLETED|Second Alcohol Challenge||1
293387|NCT00817089|706948|P1|NOT COMPLETED|Second Alcohol Challenge||0
293388|NCT00817089|706945|P4|COMPLETED|Second Alcohol Challenge||5
293389|NCT00817089|706946|P3|COMPLETED|Second Alcohol Challenge||4
293390|NCT00817089|706947|P2|COMPLETED|Second Alcohol Challenge||7
293391|NCT00817089|706948|P1|COMPLETED|Second Alcohol Challenge||6
293392|NCT00817089|706945|P4|STARTED|Second Alcohol Challenge||5
293393|NCT00817089|706946|P3|STARTED|Second Alcohol Challenge||4
293394|NCT00817089|706947|P2|STARTED|Second Alcohol Challenge||8
293395|NCT00817089|706948|P1|STARTED|Second Alcohol Challenge||6
293396|NCT00817089|706945|P4|NOT COMPLETED|First Alcohol Challenge||1
293397|NCT00817089|706946|P3|NOT COMPLETED|First Alcohol Challenge||0
293398|NCT00817089|706947|P2|NOT COMPLETED|First Alcohol Challenge||0
293399|NCT00817089|706948|P1|NOT COMPLETED|First Alcohol Challenge||0
293400|NCT00817089|706945|P4|COMPLETED|First Alcohol Challenge||5
293401|NCT00817089|706946|P3|COMPLETED|First Alcohol Challenge||4
293402|NCT00817089|706947|P2|COMPLETED|First Alcohol Challenge||8
293403|NCT00817089|706948|P1|COMPLETED|First Alcohol Challenge||6
293404|NCT00817089|706945|P4|STARTED|First Alcohol Challenge||6
293405|NCT00817089|706946|P3|STARTED|First Alcohol Challenge||4
293406|NCT00817089|706947|P2|STARTED|First Alcohol Challenge||8
293407|NCT00817089|706948|P1|STARTED|First Alcohol Challenge||6
293408|NCT00817063|706964|P2|NOT COMPLETED|Overall Study||170
293409|NCT00817063|706965|P1|NOT COMPLETED|Overall Study||137
293410|NCT00817063|706964|P2|COMPLETED|Overall Study||128
293411|NCT00817063|706965|P1|COMPLETED|Overall Study||161
293412|NCT00817063|706964|P2|STARTED|Overall Study||298
293413|NCT00817063|706965|P1|STARTED|Overall Study||298
293414|NCT00816907|707009|P2|NOT COMPLETED|Overall Study||17
293415|NCT00816907|707010|P1|NOT COMPLETED|Overall Study||13
293416|NCT00816907|707009|P2|COMPLETED|Overall Study||58
293417|NCT00816907|707010|P1|COMPLETED|Overall Study||58
293418|NCT00816907|707009|P2|STARTED|Overall Study||75
293419|NCT00816907|707010|P1|STARTED|Overall Study||71
293420|NCT00816829|707032|P2|NOT COMPLETED|Overall Study||0
293421|NCT00816829|707033|P1|NOT COMPLETED|Overall Study||0
293422|NCT00816829|707032|P2|COMPLETED|Overall Study||18
293423|NCT00816829|707033|P1|COMPLETED|Overall Study||16
293424|NCT00816829|707032|P2|STARTED|Overall Study||18
293425|NCT00816829|707033|P1|STARTED|Overall Study||16
293426|NCT00816777|707059|P2|NOT COMPLETED|Overall Study||0
293427|NCT00816777|707060|P1|NOT COMPLETED|Overall Study||0
293428|NCT00816777|707059|P2|COMPLETED|Overall Study||2
293429|NCT00816777|707060|P1|COMPLETED|Overall Study||2
293430|NCT00816777|707059|P2|STARTED|Overall Study||2
293431|NCT00816777|707060|P1|STARTED|Overall Study||2
293432|NCT00816751|707082|P2|NOT COMPLETED|Overall Study||0
293433|NCT00816751|707083|P1|NOT COMPLETED|Overall Study||0
293434|NCT00816751|707082|P2|COMPLETED|Overall Study||44
293435|NCT00816751|707083|P1|COMPLETED|Overall Study||45
293436|NCT00816751|707082|P2|STARTED|Overall Study||44
293437|NCT00816751|707083|P1|STARTED|Overall Study||45
293438|NCT00816595|707093|P2|NOT COMPLETED|Overall Study||0
293439|NCT00816595|707094|P1|NOT COMPLETED|Overall Study||2
293440|NCT00816595|707093|P2|COMPLETED|Overall Study||33
293441|NCT00816595|707094|P1|COMPLETED|Overall Study||33
293442|NCT00816595|707093|P2|STARTED|Overall Study||33
293443|NCT00816595|707094|P1|STARTED|Overall Study||35
293444|NCT00816556|707107|P3|NOT COMPLETED|Overall Study||3
293445|NCT00816556|707108|P2|NOT COMPLETED|Overall Study||2
293446|NCT00816556|707109|P1|NOT COMPLETED|Overall Study||2
293447|NCT00816556|707107|P3|COMPLETED|Overall Study||19
293448|NCT00816556|707108|P2|COMPLETED|Overall Study||19
293449|NCT00816556|707109|P1|COMPLETED|Overall Study||18
293450|NCT00816556|707107|P3|STARTED|Overall Study||22
293451|NCT00816556|707108|P2|STARTED|Overall Study||21
293452|NCT00816556|707109|P1|STARTED|Overall Study||20
293453|NCT00816400|707132|P9|NOT COMPLETED|Overall Study||6
293454|NCT00816400|707133|P8|NOT COMPLETED|Overall Study||5
293455|NCT00816400|707134|P7|NOT COMPLETED|Overall Study||2
293456|NCT00816400|707135|P6|NOT COMPLETED|Overall Study||3
293457|NCT00816400|707136|P5|NOT COMPLETED|Overall Study||2
293458|NCT00816400|707137|P4|NOT COMPLETED|Overall Study||3
293459|NCT00816400|707138|P3|NOT COMPLETED|Overall Study||5
293460|NCT00816400|707139|P2|NOT COMPLETED|Overall Study||3
293461|NCT00816400|707140|P1|NOT COMPLETED|Overall Study||2
293462|NCT00816400|707132|P9|COMPLETED|Overall Study||0
293463|NCT00816400|707133|P8|COMPLETED|Overall Study||1
293464|NCT00816400|707134|P7|COMPLETED|Overall Study||1
293465|NCT00816400|707135|P6|COMPLETED|Overall Study||0
293466|NCT00816400|707136|P5|COMPLETED|Overall Study||1
293467|NCT00816400|707137|P4|COMPLETED|Overall Study||0
293468|NCT00816400|707138|P3|COMPLETED|Overall Study||0
293469|NCT00816400|707139|P2|COMPLETED|Overall Study||0
293470|NCT00816400|707140|P1|COMPLETED|Overall Study||1
293471|NCT00816400|707132|P9|STARTED|Overall Study||6
293472|NCT00816400|707133|P8|STARTED|Overall Study||6
293473|NCT00816400|707134|P7|STARTED|Overall Study||3
293474|NCT00816400|707135|P6|STARTED|Overall Study||3
293475|NCT00816400|707136|P5|STARTED|Overall Study||3
293476|NCT00816400|707137|P4|STARTED|Overall Study||3
293477|NCT00816400|707138|P3|STARTED|Overall Study||5
293478|NCT00816400|707139|P2|STARTED|Overall Study||3
293479|NCT00816400|707140|P1|STARTED|Overall Study||3
293480|NCT00816361|707331|P9|NOT COMPLETED|Overall Study||10
293481|NCT00816361|707332|P8|NOT COMPLETED|Overall Study||9
293482|NCT00816361|707333|P7|NOT COMPLETED|Overall Study||3
293483|NCT00816361|707334|P6|NOT COMPLETED|Overall Study||3
293484|NCT00816361|707335|P5|NOT COMPLETED|Overall Study||2
293485|NCT00816361|707336|P4|NOT COMPLETED|Overall Study||3
293486|NCT00816361|707337|P3|NOT COMPLETED|Overall Study||3
293487|NCT00816361|707338|P2|NOT COMPLETED|Overall Study||3
293488|NCT00816361|707339|P1|NOT COMPLETED|Overall Study||4
293489|NCT00816361|707331|P9|COMPLETED|Overall Study||0
293490|NCT00816361|707332|P8|COMPLETED|Overall Study||1
293491|NCT00816361|707333|P7|COMPLETED|Overall Study||0
293492|NCT00816361|707334|P6|COMPLETED|Overall Study||0
293493|NCT00816361|707335|P5|COMPLETED|Overall Study||1
293494|NCT00816361|707336|P4|COMPLETED|Overall Study||0
293495|NCT00816361|707337|P3|COMPLETED|Overall Study||1
293496|NCT00816361|707338|P2|COMPLETED|Overall Study||0
293497|NCT00816361|707339|P1|COMPLETED|Overall Study||0
293498|NCT00816361|707331|P9|STARTED|Overall Study||10
293499|NCT00816361|707332|P8|STARTED|Overall Study||10
293500|NCT00816361|707333|P7|STARTED|Overall Study||3
293501|NCT00816361|707334|P6|STARTED|Overall Study||3
293502|NCT00816361|707335|P5|STARTED|Overall Study||3
293503|NCT00816361|707336|P4|STARTED|Overall Study||3
293504|NCT00816361|707337|P3|STARTED|Overall Study||4
293505|NCT00816361|707338|P2|STARTED|Overall Study||3
293506|NCT00816361|707339|P1|STARTED|Overall Study||4
293507|NCT00816348|707492|P1|NOT COMPLETED|Overall Study||0
293508|NCT00816348|707492|P1|COMPLETED|Overall Study||15
293509|NCT00816348|707492|P1|STARTED|Overall Study||15
293510|NCT00816166|707498|P2|NOT COMPLETED|Overall Study||12
293511|NCT00816166|707499|P1|NOT COMPLETED|Overall Study||10
293512|NCT00816166|707498|P2|COMPLETED|Overall Study||41
293513|NCT00816166|707499|P1|COMPLETED|Overall Study||49
293514|NCT00816166|707498|P2|ITT Population (Met Eligibility)|Overall Study||53
293515|NCT00816166|707499|P1|ITT Population (Met Eligibility)|Overall Study|Of 59 randomized to Stent Arm, 1 subject failed to meet eligibility and was excluded from the ITT|58
293516|NCT00816166|707498|P2|STARTED|Overall Study|Of 53 randomized to Medical Therapy Arm, 9 were treated with Stent+Medical Therapy|53
293517|NCT00816166|707499|P1|STARTED|Overall Study|Of 59 randomized to Stent Arm, 4 were treated with Medical Therapy Only|59
293518|NCT00816101|707508|P3|NOT COMPLETED|Overall Study||0
293519|NCT00816101|707509|P2|NOT COMPLETED|Overall Study||0
293520|NCT00816101|707510|P1|NOT COMPLETED|Overall Study||0
293521|NCT00816101|707508|P3|COMPLETED|Overall Study||5
293522|NCT00816101|707509|P2|COMPLETED|Overall Study||8
293523|NCT00816101|707510|P1|COMPLETED|Overall Study||13
293524|NCT00816101|707508|P3|STARTED|Overall Study||5
293525|NCT00816101|707509|P2|STARTED|Overall Study||8
293526|NCT00816101|707510|P1|STARTED|Overall Study||13
293527|NCT00816062|707524|P1|NOT COMPLETED|Overall Study||127
293528|NCT00816062|707524|P1|COMPLETED|Overall Study||133
293529|NCT00816062|707524|P1|STARTED|Overall Study||260
293530|NCT00816036|707531|P2|NOT COMPLETED|Overall Study||108
293531|NCT00816036|707532|P1|NOT COMPLETED|Overall Study||176
293532|NCT00816036|707531|P2|COMPLETED|Overall Study||287
293533|NCT00816036|707532|P1|COMPLETED|Overall Study||327
293534|NCT00816036|707531|P2|STARTED|Overall Study||395
293535|NCT00816036|707532|P1|STARTED|Overall Study||503
293536|NCT00816023|707546|P4|NOT COMPLETED|Overall Study||12
293537|NCT00816023|707547|P3|NOT COMPLETED|Overall Study||9
293538|NCT00816023|707548|P2|NOT COMPLETED|Overall Study||6
293539|NCT00816023|707549|P1|NOT COMPLETED|Overall Study||9
293540|NCT00816023|707546|P4|COMPLETED|Overall Study||62
293541|NCT00816023|707547|P3|COMPLETED|Overall Study||60
293542|NCT00816023|707548|P2|COMPLETED|Overall Study||56
293543|NCT00816023|707549|P1|COMPLETED|Overall Study||62
293544|NCT00816023|707546|P4|Completed Therapy|Overall Study||63
293545|NCT00816023|707547|P3|Completed Therapy|Overall Study||61
293546|NCT00816023|707548|P2|Completed Therapy|Overall Study||59
293547|NCT00816023|707549|P1|Completed Therapy|Overall Study||65
293548|NCT00816023|707546|P4|STARTED|Overall Study||74
293549|NCT00816023|707547|P3|STARTED|Overall Study||69
293550|NCT00816023|707548|P2|STARTED|Overall Study||62
293551|NCT00816023|707549|P1|STARTED|Overall Study||71
293552|NCT00815997|707565|P2|NOT COMPLETED|Overall Study||0
293553|NCT00815997|707566|P1|NOT COMPLETED|Overall Study||0
293554|NCT00815997|707565|P2|COMPLETED|Overall Study||80
293555|NCT00815997|707566|P1|COMPLETED|Overall Study||80
293556|NCT00815997|707565|P2|STARTED|Overall Study||80
293557|NCT00815997|707566|P1|STARTED|Overall Study||80
293558|NCT00815919|707586|P1|NOT COMPLETED|Overall Study||4
293559|NCT00815919|707586|P1|COMPLETED|Overall Study||18
293560|NCT00815919|707586|P1|STARTED|Overall Study||22
293561|NCT00815776|707597|P3|NOT COMPLETED|Overall Study||6
293562|NCT00815776|707598|P2|NOT COMPLETED|Overall Study||8
293563|NCT00815776|707599|P1|NOT COMPLETED|Overall Study||8
293564|NCT00815776|707597|P3|COMPLETED|Overall Study||22
293565|NCT00815776|707598|P2|COMPLETED|Overall Study||56
293566|NCT00815776|707599|P1|COMPLETED|Overall Study||52
293567|NCT00815776|707597|P3|STARTED|Overall Study||28
293568|NCT00815776|707598|P2|STARTED|Overall Study||64
293569|NCT00815776|707599|P1|STARTED|Overall Study||60
293570|NCT00815698|707615|P2|NOT COMPLETED|Overall Study||0
293571|NCT00815698|707616|P1|NOT COMPLETED|Overall Study||0
293572|NCT00815698|707615|P2|COMPLETED|Overall Study||171
293573|NCT00815698|707616|P1|COMPLETED|Overall Study||163
293574|NCT00815698|707615|P2|STARTED|Overall Study||171
293575|NCT00815698|707616|P1|STARTED|Overall Study||163
293576|NCT00815685|707624|P1|NOT COMPLETED|Overall Study||22
293577|NCT00815685|707624|P1|COMPLETED|Overall Study|Complete pre and post-treatment serum samples were available for 14 participants.|14
293578|NCT00815685|707624|P1|STARTED|Overall Study||36
293579|NCT00815659|707629|P1|NOT COMPLETED|Overall Study||23
293580|NCT00815659|707629|P1|COMPLETED|Overall Study||74
293581|NCT00815659|707629|P1|STARTED|Overall Study||97
293582|NCT00815633|707672|P1|NOT COMPLETED|Overall Study||1
293583|NCT00815633|707672|P1|COMPLETED|Overall Study||0
293584|NCT00815633|707672|P1|STARTED|Overall Study||1
293585|NCT00815516|707679|P2|NOT COMPLETED|Overall Study||1
293586|NCT00815516|707680|P1|NOT COMPLETED|Overall Study||4
293587|NCT00815516|707679|P2|COMPLETED|Overall Study||9
293588|NCT00815516|707680|P1|COMPLETED|Overall Study||16
293589|NCT00815516|707679|P2|STARTED|Overall Study||10
293590|NCT00815516|707680|P1|STARTED|Overall Study||20
293591|NCT00815490|707711|P2|NOT COMPLETED|Overall Study||0
293592|NCT00815490|707712|P1|NOT COMPLETED|Overall Study||0
293593|NCT00815490|707711|P2|COMPLETED|Overall Study||9
293594|NCT00815490|707712|P1|COMPLETED|Overall Study||9
293595|NCT00815490|707711|P2|STARTED|Overall Study||9
293596|NCT00815490|707712|P1|STARTED|Overall Study||9
293597|NCT00815360|707720|P2|NOT COMPLETED|Overall Study||0
293598|NCT00815360|707721|P1|NOT COMPLETED|Overall Study||0
293599|NCT00815360|707720|P2|COMPLETED|Overall Study||11
293600|NCT00815360|707721|P1|COMPLETED|Overall Study||11
293601|NCT00815360|707720|P2|STARTED|Overall Study||11
293602|NCT00815360|707721|P1|STARTED|Overall Study||11
293603|NCT00815347|707729|P1|NOT COMPLETED|Overall Study||4
293604|NCT00815347|707729|P1|COMPLETED|Overall Study||7
293605|NCT00815347|707729|P1|STARTED|Overall Study||11
293606|NCT00815308|707745|P1|NOT COMPLETED|Overall Study||10
293607|NCT00815308|707745|P1|COMPLETED|Overall Study||45
293608|NCT00815308|707745|P1|STARTED|Overall Study||55
293609|NCT00815295|707754|P3|NOT COMPLETED|Overall Study||3
293610|NCT00815295|707755|P2|NOT COMPLETED|Overall Study||1
293611|NCT00815295|707756|P1|NOT COMPLETED|Overall Study||0
293612|NCT00815295|707754|P3|COMPLETED|Overall Study||9
293613|NCT00815295|707755|P2|COMPLETED|Overall Study||7
293614|NCT00815295|707756|P1|COMPLETED|Overall Study||8
293615|NCT00815295|707754|P3|STARTED|Overall Study||12
293616|NCT00815295|707755|P2|STARTED|Overall Study||8
293617|NCT00815295|707756|P1|STARTED|Overall Study||8
293618|NCT00815191|707768|P2|NOT COMPLETED|Overall Study||1
293619|NCT00815191|707769|P1|NOT COMPLETED|Overall Study||1
293620|NCT00815191|707768|P2|COMPLETED|Overall Study||34
293621|NCT00815191|707769|P1|COMPLETED|Overall Study||37
293622|NCT00815191|707768|P2|STARTED|Overall Study||35
293623|NCT00815191|707769|P1|STARTED|Overall Study||38
293624|NCT00815087|707777|P2|NOT COMPLETED|Overall Study||0
293625|NCT00815087|707778|P1|NOT COMPLETED|Overall Study||0
293626|NCT00815087|707777|P2|COMPLETED|Overall Study||10
293627|NCT00815087|707778|P1|COMPLETED|Overall Study||10
293628|NCT00815087|707777|P2|STARTED|Overall Study||10
293629|NCT00815087|707778|P1|STARTED|Overall Study||10
293630|NCT00815035|707786|P3|NOT COMPLETED|Open Label Extension Phase||6
293631|NCT00815035|707787|P2|NOT COMPLETED|Open Label Extension Phase||0
293632|NCT00815035|707788|P1|NOT COMPLETED|Open Label Extension Phase||0
293633|NCT00815035|707786|P3|COMPLETED|Open Label Extension Phase||9
293634|NCT00815035|707787|P2|COMPLETED|Open Label Extension Phase||0
293635|NCT00815035|707788|P1|COMPLETED|Open Label Extension Phase||0
293636|NCT00815035|707786|P3|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|15
293637|NCT00815035|707787|P2|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
293638|NCT00815035|707788|P1|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
293639|NCT00815035|707786|P3|NOT COMPLETED|Blinded Phase||0
293640|NCT00815035|707787|P2|NOT COMPLETED|Blinded Phase||0
293641|NCT00815035|707788|P1|NOT COMPLETED|Blinded Phase||1
293642|NCT00815035|707786|P3|COMPLETED|Blinded Phase||0
293643|NCT00815035|707787|P2|COMPLETED|Blinded Phase||6
293644|NCT00815035|707788|P1|COMPLETED|Blinded Phase||9
293645|NCT00815035|707786|P3|STARTED|Blinded Phase||0
293646|NCT00815035|707787|P2|STARTED|Blinded Phase||6
293647|NCT00815035|707788|P1|STARTED|Blinded Phase||10
293648|NCT00814983|707806|P2|NOT COMPLETED|Overall Study||0
293649|NCT00814983|707807|P1|NOT COMPLETED|Overall Study||3
293650|NCT00814983|707806|P2|COMPLETED|Overall Study||0
293651|NCT00814983|707807|P1|COMPLETED|Overall Study||12
293652|NCT00814983|707806|P2|STARTED|Overall Study||0
293653|NCT00814983|707807|P1|STARTED|Overall Study||15
293654|NCT00814970|707817|P1|NOT COMPLETED|Overall Study||50
293655|NCT00814970|707817|P1|COMPLETED|Overall Study||146
293656|NCT00814970|707817|P1|STARTED|Overall Study||196
293657|NCT00814892|707838|P1|NOT COMPLETED|Overall Study||2
293658|NCT00814892|707838|P1|COMPLETED|Overall Study||0
293659|NCT00814892|707838|P1|STARTED|Overall Study||2
293660|NCT00814879|707850|P2|NOT COMPLETED|By Week 48||3
293661|NCT00814879|707851|P1|NOT COMPLETED|By Week 48||2
293662|NCT00814879|707850|P2|COMPLETED|By Week 48||26
293663|NCT00814879|707851|P1|COMPLETED|By Week 48||25
293664|NCT00814879|707850|P2|STARTED|By Week 48||29
293665|NCT00814879|707851|P1|STARTED|By Week 48||27
293666|NCT00814879|707850|P2|NOT COMPLETED|By Week 24||1
293667|NCT00814879|707851|P1|NOT COMPLETED|By Week 24||1
293668|NCT00814879|707850|P2|COMPLETED|By Week 24||29
293669|NCT00814879|707851|P1|COMPLETED|By Week 24||27
293670|NCT00814879|707850|P2|STARTED|By Week 24||30
293671|NCT00814879|707851|P1|STARTED|By Week 24||28
293672|NCT00814801|707870|P3|NOT COMPLETED|Overall Study||43
293673|NCT00814801|707871|P2|NOT COMPLETED|Overall Study||38
293674|NCT00814801|707872|P1|NOT COMPLETED|Overall Study||34
293675|NCT00814801|707870|P3|COMPLETED|Overall Study||151
293676|NCT00814801|707871|P2|COMPLETED|Overall Study||154
293677|NCT00814801|707872|P1|COMPLETED|Overall Study||160
293678|NCT00814801|707870|P3|STARTED|Overall Study||194
293679|NCT00814801|707871|P2|STARTED|Overall Study||192
293680|NCT00814801|707872|P1|STARTED|Overall Study||194
293681|NCT00814788|707892|P1|NOT COMPLETED|Overall Study||0
293682|NCT00814788|707892|P1|COMPLETED|Overall Study||24
293683|NCT00814788|707892|P1|STARTED|Overall Study||24
293684|NCT00814775|707900|P2|NOT COMPLETED|Overall Study||0
293685|NCT00814775|707901|P1|NOT COMPLETED|Overall Study||0
293686|NCT00814775|707900|P2|COMPLETED|Overall Study||20
293687|NCT00814775|707901|P1|COMPLETED|Overall Study||23
293688|NCT00814775|707900|P2|STARTED|Overall Study||20
293689|NCT00814775|707901|P1|STARTED|Overall Study||23
293690|NCT00814710|707911|P2|NOT COMPLETED|Overall Study||3
293691|NCT00814710|707912|P1|NOT COMPLETED|Overall Study||8
293692|NCT00814710|707911|P2|COMPLETED|Overall Study||117
293693|NCT00814710|707912|P1|COMPLETED|Overall Study||232
293694|NCT00814710|707911|P2|STARTED|Overall Study||120
293695|NCT00814710|707912|P1|STARTED|Overall Study||240
293696|NCT00814697|707950|P1|NOT COMPLETED|Overall Study||0
293697|NCT00814697|707950|P1|COMPLETED|Overall Study||12
293698|NCT00814697|707950|P1|STARTED|Overall Study||12
293699|NCT00814671|707957|P3|NOT COMPLETED|Overall Study||2
293700|NCT00814671|707958|P2|NOT COMPLETED|Overall Study||4
293701|NCT00814671|707959|P1|NOT COMPLETED|Overall Study||7
293702|NCT00814671|707957|P3|COMPLETED|Overall Study||49
293703|NCT00814671|707958|P2|COMPLETED|Overall Study||44
293704|NCT00814671|707959|P1|COMPLETED|Overall Study||47
293705|NCT00814671|707957|P3|STARTED|Overall Study||51
293706|NCT00814671|707958|P2|STARTED|Overall Study||48
293707|NCT00814671|707959|P1|STARTED|Overall Study||54
293708|NCT00814658|707980|P2|NOT COMPLETED|Overall Study||4
293709|NCT00814658|707981|P1|NOT COMPLETED|Overall Study||4
293710|NCT00814658|707980|P2|COMPLETED|Overall Study||8
293711|NCT00814658|707981|P1|COMPLETED|Overall Study||5
293712|NCT00814658|707980|P2|STARTED|Overall Study||12
293713|NCT00814658|707981|P1|STARTED|Overall Study||9
293714|NCT00814632|708047|P1|NOT COMPLETED|Overall Study||2
293715|NCT00814632|708047|P1|COMPLETED|Overall Study|Two subjects withdrew early due to lack of efficacy.|7
293716|NCT00814632|708047|P1|STARTED|Overall Study|Ten were allocated to treatment intervention however one was not treated due to lactose allergy.|9
293717|NCT00814580|708053|P2|NOT COMPLETED|Overall Study||47
293718|NCT00814580|708054|P1|NOT COMPLETED|Overall Study||31
293719|NCT00814580|708053|P2|COMPLETED|Overall Study||141
293720|NCT00814580|708054|P1|COMPLETED|Overall Study||163
293721|NCT00814580|708053|P2|STARTED|Overall Study||188
293722|NCT00814580|708054|P1|STARTED|Overall Study||194
293723|NCT00814502|708184|P2|NOT COMPLETED|Overall Study||2
293724|NCT00814502|708185|P1|NOT COMPLETED|Overall Study||1
293725|NCT00814502|708184|P2|COMPLETED|Overall Study||7
293726|NCT00814502|708185|P1|COMPLETED|Overall Study||7
293727|NCT00814502|708184|P2|STARTED|Overall Study||9
293728|NCT00814502|708185|P1|STARTED|Overall Study||8
293729|NCT00814489|708198|P3|NOT COMPLETED|Overall Study||1
293730|NCT00814489|708199|P2|NOT COMPLETED|Overall Study||0
293731|NCT00814489|708200|P1|NOT COMPLETED|Overall Study||2
293732|NCT00814489|708198|P3|COMPLETED|Overall Study||7
293733|NCT00814489|708199|P2|COMPLETED|Overall Study||17
293734|NCT00814489|708200|P1|COMPLETED|Overall Study||13
293735|NCT00814489|708198|P3|STARTED|Overall Study||8
293736|NCT00814489|708199|P2|STARTED|Overall Study||17
293737|NCT00814489|708200|P1|STARTED|Overall Study||15
293738|NCT00814463|708232|P1|NOT COMPLETED|Overall Study||1
293739|NCT00814463|708232|P1|COMPLETED|Overall Study||0
293740|NCT00814463|708232|P1|STARTED|Overall Study||1
293741|NCT00814346|708245|P2|NOT COMPLETED|Open Phase (17 Months)||0
293742|NCT00814346|708246|P1|NOT COMPLETED|Open Phase (17 Months)||10
293743|NCT00814346|708245|P2|COMPLETED|Open Phase (17 Months)||0
293744|NCT00814346|708246|P1|COMPLETED|Open Phase (17 Months)||31
293745|NCT00814346|708245|P2|AD|Open Phase (17 Months)||0
293746|NCT00814346|708246|P1|AD|Open Phase (17 Months)|Open period was not proposed to AD subjects.|0
293747|NCT00814346|708245|P2|MC|Open Phase (17 Months)||0
293748|NCT00814346|708246|P1|MC|Open Phase (17 Months)||20
293749|NCT00814346|708245|P2|CNE|Open Phase (17 Months)||0
293750|NCT00814346|708246|P1|CNE|Open Phase (17 Months)||21
293751|NCT00814346|708245|P2|STARTED|Open Phase (17 Months)|This was an open period, without placebo arm, the number of subject on placebo is 0.|0
293752|NCT00814346|708246|P1|STARTED|Open Phase (17 Months)|Open period was treated with EGB761®. 41 subjects accepted follow-up open period(21 in CNE,20 in MC)|41
293753|NCT00814346|708245|P2|NOT COMPLETED|Double-blind Phase (4 Weeks)||3
293754|NCT00814346|708246|P1|NOT COMPLETED|Double-blind Phase (4 Weeks)||0
293755|NCT00814346|708245|P2|COMPLETED|Double-blind Phase (4 Weeks)||23
293756|NCT00814346|708246|P1|COMPLETED|Double-blind Phase (4 Weeks)||23
293757|NCT00814346|708245|P2|AD|Double-blind Phase (4 Weeks)||2
293758|NCT00814346|708246|P1|AD|Double-blind Phase (4 Weeks)||3
293759|NCT00814346|708245|P2|MC|Double-blind Phase (4 Weeks)||11
293760|NCT00814346|708246|P1|MC|Double-blind Phase (4 Weeks)||10
293761|NCT00814346|708245|P2|CNE|Double-blind Phase (4 Weeks)||13
293762|NCT00814346|708246|P1|CNE|Double-blind Phase (4 Weeks)||10
293763|NCT00814346|708245|P2|STARTED|Double-blind Phase (4 Weeks)||26
293764|NCT00814346|708246|P1|STARTED|Double-blind Phase (4 Weeks)||23
293765|NCT00814333|708312|P2|NOT COMPLETED|Treatment Period||0
293766|NCT00814333|708313|P1|NOT COMPLETED|Treatment Period||0
293767|NCT00814333|708312|P2|COMPLETED|Treatment Period||0
293768|NCT00814333|708313|P1|COMPLETED|Treatment Period||0
293769|NCT00814333|708312|P2|STARTED|Treatment Period||0
293770|NCT00814333|708313|P1|STARTED|Treatment Period||0
293771|NCT00814333|708312|P2|NOT COMPLETED|Enrollment||0
293772|NCT00814333|708313|P1|NOT COMPLETED|Enrollment||1
293773|NCT00814333|708312|P2|COMPLETED|Enrollment||0
293774|NCT00814333|708313|P1|COMPLETED|Enrollment||0
293775|NCT00814333|708312|P2|STARTED|Enrollment||0
293776|NCT00814333|708313|P1|STARTED|Enrollment||1
293777|NCT00814320|708321|P2|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||10
293778|NCT00814320|708322|P1|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||3
293779|NCT00814320|708321|P2|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)|Three participants who switched to safety follow-up remained in the study.|60
293780|NCT00814320|708322|P1|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||8
293781|NCT00814320|708321|P2|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||70
293782|NCT00814320|708322|P1|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||11
293783|NCT00814320|708321|P2|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||0
293784|NCT00814320|708322|P1|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||2
293785|NCT00814320|708321|P2|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||70
293786|NCT00814320|708322|P1|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||11
293787|NCT00814320|708321|P2|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||70
293788|NCT00814320|708322|P1|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||13
293789|NCT00814320|708321|P2|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||1
293790|NCT00814320|708322|P1|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||0
293791|NCT00814320|708321|P2|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||70
293792|NCT00814320|708322|P1|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
293793|NCT00814320|708321|P2|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||71
293794|NCT00814320|708322|P1|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
293795|NCT00814320|708321|P2|NOT COMPLETED|Epoch 1 (IV Treatment)||2
293796|NCT00814320|708322|P1|NOT COMPLETED|Epoch 1 (IV Treatment)||1
293797|NCT00814320|708321|P2|COMPLETED|Epoch 1 (IV Treatment)||71
293798|NCT00814320|708322|P1|COMPLETED|Epoch 1 (IV Treatment)||13
293799|NCT00814320|708321|P2|STARTED|Epoch 1 (IV Treatment)||73
293800|NCT00814320|708322|P1|STARTED|Epoch 1 (IV Treatment)||14
293801|NCT00814307|708454|P4|NOT COMPLETED|Overall Study||10
293802|NCT00814307|708455|P3|NOT COMPLETED|Overall Study||7
293803|NCT00814307|708456|P2|NOT COMPLETED|Overall Study||27
293804|NCT00814307|708457|P1|NOT COMPLETED|Overall Study||12
293805|NCT00814307|708454|P4|COMPLETED|Overall Study||51
293806|NCT00814307|708455|P3|COMPLETED|Overall Study||54
293807|NCT00814307|708456|P2|COMPLETED|Overall Study||218
293808|NCT00814307|708457|P1|COMPLETED|Overall Study||232
293809|NCT00814307|708454|P4|Treated|Overall Study||61
293810|NCT00814307|708455|P3|Treated|Overall Study||61
293811|NCT00814307|708456|P2|Treated|Overall Study||245
293812|NCT00814307|708457|P1|Treated|Overall Study||243
293813|NCT00814307|708454|P4|STARTED|Overall Study||61
293814|NCT00814307|708455|P3|STARTED|Overall Study||61
293815|NCT00814307|708456|P2|STARTED|Overall Study||245
293816|NCT00814307|708457|P1|STARTED|Overall Study||244
293817|NCT00814255|708622|P3|NOT COMPLETED|Overall Study||1
293818|NCT00814255|708623|P2|NOT COMPLETED|Overall Study||0
293819|NCT00814255|708624|P1|NOT COMPLETED|Overall Study||1
293820|NCT00814255|708622|P3|COMPLETED|Overall Study||7
293821|NCT00814255|708623|P2|COMPLETED|Overall Study||7
293822|NCT00814255|708624|P1|COMPLETED|Overall Study||7
293823|NCT00814255|708622|P3|STARTED|Overall Study||8
293824|NCT00814255|708623|P2|STARTED|Overall Study||7
293825|NCT00814255|708624|P1|STARTED|Overall Study||8
293826|NCT00814177|708646|P2|NOT COMPLETED|Overall Study||0
293827|NCT00814177|708647|P1|NOT COMPLETED|Overall Study||0
293828|NCT00814177|708646|P2|COMPLETED|Overall Study||80
293829|NCT00814177|708647|P1|COMPLETED|Overall Study||80
293830|NCT00814177|708646|P2|STARTED|Overall Study||80
293831|NCT00814177|708647|P1|STARTED|Overall Study||80
293832|NCT00814164|708653|P1|NOT COMPLETED|Overall Study||19
293833|NCT00814164|708653|P1|COMPLETED|Overall Study||2
293834|NCT00814164|708653|P1|STARTED|Overall Study||21
293835|NCT00814138|708666|P2|NOT COMPLETED|Overall Study||7
293836|NCT00814138|708667|P1|NOT COMPLETED|Overall Study||1
293837|NCT00814138|708666|P2|COMPLETED|Overall Study||18
293838|NCT00814138|708667|P1|COMPLETED|Overall Study||24
293839|NCT00814138|708666|P2|STARTED|Overall Study||25
293840|NCT00814138|708667|P1|STARTED|Overall Study||25
293841|NCT00813995|708687|P2|NOT COMPLETED|Overall Study||16
293842|NCT00813995|708688|P1|NOT COMPLETED|Overall Study||23
293843|NCT00813995|708687|P2|COMPLETED|Overall Study||182
293844|NCT00813995|708688|P1|COMPLETED|Overall Study||174
293845|NCT00813995|708687|P2|STARTED|Overall Study||198
293846|NCT00813995|708688|P1|STARTED|Overall Study||197
293847|NCT00813982|708702|P1|NOT COMPLETED|Overall Study||0
293848|NCT00813982|708702|P1|COMPLETED|Overall Study||59
293849|NCT00813982|708702|P1|STARTED|Overall Study||59
293850|NCT00813943|708711|P3|NOT COMPLETED|Overall Study||3
293851|NCT00813943|708712|P2|NOT COMPLETED|Overall Study||5
293852|NCT00813943|708713|P1|NOT COMPLETED|Overall Study||5
293853|NCT00813943|708711|P3|COMPLETED|Overall Study||86
293854|NCT00813943|708712|P2|COMPLETED|Overall Study||83
293855|NCT00813943|708713|P1|COMPLETED|Overall Study||83
293856|NCT00813943|708711|P3|STARTED|Overall Study||89
293857|NCT00813943|708712|P2|STARTED|Overall Study||88
293858|NCT00813943|708713|P1|STARTED|Overall Study||88
293859|NCT00813917|708743|P2|NOT COMPLETED|Overall Study||6
293860|NCT00813917|708744|P1|NOT COMPLETED|Overall Study||6
293861|NCT00813917|708743|P2|COMPLETED|Overall Study||32
293862|NCT00813917|708744|P1|COMPLETED|Overall Study||32
293863|NCT00813917|708743|P2|STARTED|Overall Study||38
293864|NCT00813917|708744|P1|STARTED|Overall Study||38
293865|NCT00813904|708750|P1|NOT COMPLETED|Overall Study||1
293866|NCT00813904|708750|P1|COMPLETED|Overall Study||30
293867|NCT00813904|708750|P1|STARTED|Overall Study||31
293868|NCT00813865|708756|P1|NOT COMPLETED|Overall Study||7
293869|NCT00813865|708756|P1|COMPLETED|Overall Study||1
293870|NCT00813865|708756|P1|Pharmacodynamic (PD) Population|Overall Study||8
293871|NCT00813865|708756|P1|Safety Population|Overall Study||8
293872|NCT00813865|708756|P1|STARTED|Overall Study||8
293873|NCT00813813|708764|P2|NOT COMPLETED|Overall Study||9
293874|NCT00813813|708765|P1|NOT COMPLETED|Overall Study||3
293875|NCT00813813|708764|P2|COMPLETED|Overall Study||16
293876|NCT00813813|708765|P1|COMPLETED|Overall Study||4
293877|NCT00813813|708764|P2|STARTED|Overall Study||25
293878|NCT00813813|708765|P1|STARTED|Overall Study||7
293879|NCT00813800|708781|P1|NOT COMPLETED|Overall Study||6
293880|NCT00813800|708781|P1|COMPLETED|Overall Study||5
293881|NCT00813800|708781|P1|STARTED|Overall Study||11
293882|NCT00813761|708789|P4|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||5
293883|NCT00813761|708790|P3|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
293884|NCT00813761|708791|P2|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
293885|NCT00813761|708792|P1|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||16
293886|NCT00813761|708789|P4|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||100
293887|NCT00813761|708790|P3|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||94
293888|NCT00813761|708791|P2|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||91
293889|NCT00813761|708792|P1|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||101
293890|NCT00813761|708789|P4|STARTED|Phase 2 (4 Weeks to 24 Weeks)||105
293891|NCT00813761|708790|P3|STARTED|Phase 2 (4 Weeks to 24 Weeks)||103
293892|NCT00813761|708791|P2|STARTED|Phase 2 (4 Weeks to 24 Weeks)||100
293893|NCT00813761|708792|P1|STARTED|Phase 2 (4 Weeks to 24 Weeks)||117
293894|NCT00813761|708789|P4|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||2
293895|NCT00813761|708790|P3|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||12
293896|NCT00813761|708791|P2|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||3
293897|NCT00813761|708792|P1|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||4
293898|NCT00813761|708789|P4|COMPLETED|Phase 1 (Baseline to 4 Weeks)||105
293899|NCT00813761|708790|P3|COMPLETED|Phase 1 (Baseline to 4 Weeks)||103
293900|NCT00813761|708791|P2|COMPLETED|Phase 1 (Baseline to 4 Weeks)||100
293901|NCT00813761|708792|P1|COMPLETED|Phase 1 (Baseline to 4 Weeks)||117
293902|NCT00813761|708789|P4|STARTED|Phase 1 (Baseline to 4 Weeks)||107
293903|NCT00813761|708790|P3|STARTED|Phase 1 (Baseline to 4 Weeks)||115
293904|NCT00813761|708791|P2|STARTED|Phase 1 (Baseline to 4 Weeks)||103
293905|NCT00813761|708792|P1|STARTED|Phase 1 (Baseline to 4 Weeks)||121
293906|NCT00813748|708842|P2|NOT COMPLETED|Skin Test Substudy||1
293907|NCT00813748|708843|P1|NOT COMPLETED|Skin Test Substudy||0
293908|NCT00813748|708842|P2|COMPLETED|Skin Test Substudy||7
293909|NCT00813748|708843|P1|COMPLETED|Skin Test Substudy||3
293910|NCT00813748|708842|P2|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|8
293911|NCT00813748|708843|P1|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|3
293912|NCT00813748|708842|P2|NOT COMPLETED|Main Observational Study||0
293913|NCT00813748|708843|P1|NOT COMPLETED|Main Observational Study||0
293914|NCT00813748|708842|P2|COMPLETED|Main Observational Study||88
293915|NCT00813748|708843|P1|COMPLETED|Main Observational Study||30
293916|NCT00813748|708842|P2|STARTED|Main Observational Study||88
293917|NCT00813748|708843|P1|STARTED|Main Observational Study||30
293918|NCT00813709|708872|P6|NOT COMPLETED|Open Label Period||11
293919|NCT00813709|708873|P5|NOT COMPLETED|Open Label Period||10
293920|NCT00813709|708874|P4|NOT COMPLETED|Open Label Period||20
293921|NCT00813709|708875|P3|NOT COMPLETED|Open Label Period||0
293922|NCT00813709|708876|P2|NOT COMPLETED|Open Label Period||0
293923|NCT00813709|708877|P1|NOT COMPLETED|Open Label Period||0
293924|NCT00813709|708872|P6|COMPLETED|Open Label Period||35
293925|NCT00813709|708873|P5|COMPLETED|Open Label Period||41
293926|NCT00813709|708874|P4|COMPLETED|Open Label Period||38
293927|NCT00813709|708875|P3|COMPLETED|Open Label Period||0
293928|NCT00813709|708876|P2|COMPLETED|Open Label Period||0
293929|NCT00813709|708877|P1|COMPLETED|Open Label Period||0
293930|NCT00813709|708872|P6|Treated|Open Label Period||45
293931|NCT00813709|708873|P5|Treated|Open Label Period||51
293932|NCT00813709|708874|P4|Treated|Open Label Period||57
293933|NCT00813709|708875|P3|Treated|Open Label Period||0
293934|NCT00813709|708876|P2|Treated|Open Label Period||0
293935|NCT00813709|708877|P1|Treated|Open Label Period||0
293936|NCT00813709|708872|P6|STARTED|Open Label Period|28 participants in OL period initially + 18 participants from DB converted to CDMS during the study|46
293937|NCT00813709|708873|P5|STARTED|Open Label Period|25 participants in OL period initially + 26 participants from DB converted to CDMS during the study|51
293938|NCT00813709|708874|P4|STARTED|Open Label Period|49 participants in OL period initially + 9 participants from DB converted to CDMS during the study|58
293939|NCT00813709|708875|P3|STARTED|Open Label Period||0
293940|NCT00813709|708876|P2|STARTED|Open Label Period||0
293941|NCT00813709|708877|P1|STARTED|Open Label Period||0
293942|NCT00813709|708872|P6|NOT COMPLETED|Double Blind Period||0
293943|NCT00813709|708873|P5|NOT COMPLETED|Double Blind Period||0
293944|NCT00813709|708874|P4|NOT COMPLETED|Double Blind Period||0
293945|NCT00813709|708875|P3|NOT COMPLETED|Double Blind Period||31
293946|NCT00813709|708876|P2|NOT COMPLETED|Double Blind Period||41
293947|NCT00813709|708877|P1|NOT COMPLETED|Double Blind Period||31
293948|NCT00813709|708872|P6|COMPLETED|Double Blind Period||0
293949|NCT00813709|708873|P5|COMPLETED|Double Blind Period||0
293950|NCT00813709|708874|P4|COMPLETED|Double Blind Period||0
293951|NCT00813709|708875|P3|COMPLETED|Double Blind Period||68
293952|NCT00813709|708876|P2|COMPLETED|Double Blind Period||76
293953|NCT00813709|708877|P1|COMPLETED|Double Blind Period||53
293954|NCT00813709|708872|P6|Treated|Double Blind Period||0
293955|NCT00813709|708873|P5|Treated|Double Blind Period||0
293956|NCT00813709|708874|P4|Treated|Double Blind Period||0
293957|NCT00813709|708875|P3|Treated|Double Blind Period||98
293958|NCT00813709|708876|P2|Treated|Double Blind Period||114
293959|NCT00813709|708877|P1|Treated|Double Blind Period||83
293960|NCT00813709|708872|P6|STARTED|Double Blind Period||0
293961|NCT00813709|708873|P5|STARTED|Double Blind Period||0
293962|NCT00813709|708874|P4|STARTED|Double Blind Period||0
293963|NCT00813709|708875|P3|STARTED|Double Blind Period||99
293964|NCT00813709|708876|P2|STARTED|Double Blind Period||117
293965|NCT00813709|708877|P1|STARTED|Double Blind Period||84
293966|NCT00813592|708957|P1|NOT COMPLETED|Overall Study||2
293967|NCT00813592|708957|P1|COMPLETED|Overall Study||0
293968|NCT00813592|708957|P1|Response Assessment|Overall Study|One patient met the response assessment.|1
293969|NCT00813592|708957|P1|Treated|Overall Study|Two patients were treated.|2
293970|NCT00813592|708957|P1|STARTED|Overall Study||2
293971|NCT00813488|708966|P2|NOT COMPLETED|Open-label Extension||7
293972|NCT00813488|708967|P1|NOT COMPLETED|Open-label Extension||12
293973|NCT00813488|708966|P2|COMPLETED|Open-label Extension|This group received standard of care (including immediate-release oxycodone)|59
293974|NCT00813488|708967|P1|COMPLETED|Open-label Extension|This group received FBT open--label|53
293975|NCT00813488|708966|P2|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|66
293976|NCT00813488|708967|P1|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|65
293977|NCT00813488|708966|P2|NOT COMPLETED|Double-blind Treatment Period 2||1
293978|NCT00813488|708967|P1|NOT COMPLETED|Double-blind Treatment Period 2||5
293979|NCT00813488|708966|P2|COMPLETED|Double-blind Treatment Period 2||65
293980|NCT00813488|708967|P1|COMPLETED|Double-blind Treatment Period 2||66
293981|NCT00813488|708966|P2|STARTED|Double-blind Treatment Period 2||66
293982|NCT00813488|708967|P1|STARTED|Double-blind Treatment Period 2||71
293983|NCT00813488|708966|P2|NOT COMPLETED|Double-blind Treatment Period 1||5
293984|NCT00813488|708967|P1|NOT COMPLETED|Double-blind Treatment Period 1||1
293985|NCT00813488|708966|P2|COMPLETED|Double-blind Treatment Period 1||66
293986|NCT00813488|708967|P1|COMPLETED|Double-blind Treatment Period 1||71
293987|NCT00813488|708966|P2|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|71
293988|NCT00813488|708967|P1|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|72
293989|NCT00813488|708966|P2|NOT COMPLETED|Titration Period 2||10
293990|NCT00813488|708967|P1|NOT COMPLETED|Titration Period 2||16
293991|NCT00813488|708966|P2|COMPLETED|Titration Period 2||79
293992|NCT00813488|708967|P1|COMPLETED|Titration Period 2||64
293993|NCT00813488|708966|P2|STARTED|Titration Period 2||89
293994|NCT00813488|708967|P1|STARTED|Titration Period 2||80
293995|NCT00813488|708966|P2|NOT COMPLETED|Titration Period 1||17
293996|NCT00813488|708967|P1|NOT COMPLETED|Titration Period 1||27
293997|NCT00813488|708966|P2|COMPLETED|Titration Period 1||89
293998|NCT00813488|708967|P1|COMPLETED|Titration Period 1||80
293999|NCT00813488|708966|P2|STARTED|Titration Period 1||106
294000|NCT00813488|708967|P1|STARTED|Titration Period 1||107
294001|NCT00813319|709065|P2|NOT COMPLETED|Overall Study||0
294002|NCT00813319|709066|P1|NOT COMPLETED|Overall Study||0
294003|NCT00813319|709065|P2|COMPLETED|Overall Study|104 out of 108 have complete follow-up data, there were 4 missing charts 7 months post-randomization|108
294004|NCT00813319|709066|P1|COMPLETED|Overall Study|100 out of 108 have complete follow-up data, there were 8 missing charts 7 months post-randomization|108
294005|NCT00813319|709065|P2|STARTED|Overall Study||108
294006|NCT00813319|709066|P1|STARTED|Overall Study||108
294007|NCT00813176|709078|P2|NOT COMPLETED|Overall Study||0
294008|NCT00813176|709079|P1|NOT COMPLETED|Overall Study||0
294009|NCT00813176|709078|P2|COMPLETED|Overall Study||25
294010|NCT00813176|709079|P1|COMPLETED|Overall Study||25
294011|NCT00813176|709078|P2|STARTED|Overall Study||25
294012|NCT00813176|709079|P1|STARTED|Overall Study||25
294013|NCT00813150|709097|P2|NOT COMPLETED|Long Term Follow-up||31
294014|NCT00813150|709098|P1|NOT COMPLETED|Long Term Follow-up||24
294015|NCT00813150|709097|P2|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|0
294016|NCT00813150|709098|P1|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|2
294017|NCT00813150|709097|P2|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|31
294018|NCT00813150|709098|P1|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|26
294019|NCT00813150|709097|P2|NOT COMPLETED|Treatment Period||32
294020|NCT00813150|709098|P1|NOT COMPLETED|Treatment Period||32
294021|NCT00813150|709097|P2|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|15
294022|NCT00813150|709098|P1|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|14
294023|NCT00813150|709097|P2|Intent-to-treat Participants|Treatment Period||47
294024|NCT00813150|709098|P1|Intent-to-treat Participants|Treatment Period||43
294025|NCT00813150|709097|P2|STARTED|Treatment Period|Number of randomized and treated participants|47
294026|NCT00813150|709098|P1|STARTED|Treatment Period|Number of randomized and treated participants|46
294027|NCT00813111|709112|P2|NOT COMPLETED|Overall Study||0
294028|NCT00813111|709113|P1|NOT COMPLETED|Overall Study||2
294029|NCT00813111|709112|P2|COMPLETED|Overall Study||70
294030|NCT00813111|709113|P1|COMPLETED|Overall Study||64
294031|NCT00813111|709112|P2|STARTED|Overall Study||70
294032|NCT00813111|709113|P1|STARTED|Overall Study||66
294033|NCT00813098|709122|P3|NOT COMPLETED|Overall Study||2
294034|NCT00813098|709123|P2|NOT COMPLETED|Overall Study||8
294035|NCT00813098|709124|P1|NOT COMPLETED|Overall Study||3
294036|NCT00813098|709122|P3|COMPLETED|Overall Study||50
294037|NCT00813098|709123|P2|COMPLETED|Overall Study||46
294038|NCT00813098|709124|P1|COMPLETED|Overall Study||46
294039|NCT00813098|709122|P3|STARTED|Overall Study||52
294040|NCT00813098|709123|P2|STARTED|Overall Study||54
294041|NCT00813098|709124|P1|STARTED|Overall Study||49
294042|NCT00812981|709149|P2|NOT COMPLETED|Overall Study||1
294043|NCT00812981|709150|P1|NOT COMPLETED|Overall Study||0
294044|NCT00812981|709149|P2|COMPLETED|Overall Study||159
294045|NCT00812981|709150|P1|COMPLETED|Overall Study||160
294046|NCT00812981|709149|P2|STARTED|Overall Study||160
294047|NCT00812981|709150|P1|STARTED|Overall Study||160
294048|NCT00812968|709188|P1|NOT COMPLETED|Overall Study||11
294049|NCT00812968|709188|P1|COMPLETED|Overall Study||0
294050|NCT00812968|709188|P1|STARTED|Overall Study||11
294051|NCT00812955|709223|P4|NOT COMPLETED|Overall Study||8
294052|NCT00812955|709224|P3|NOT COMPLETED|Overall Study||6
294053|NCT00812955|709225|P2|NOT COMPLETED|Overall Study||7
294054|NCT00812955|709226|P1|NOT COMPLETED|Overall Study||10
294055|NCT00812955|709223|P4|COMPLETED|Overall Study||110
294056|NCT00812955|709224|P3|COMPLETED|Overall Study||113
294057|NCT00812955|709225|P2|COMPLETED|Overall Study||111
294058|NCT00812955|709226|P1|COMPLETED|Overall Study||109
294059|NCT00812955|709223|P4|STARTED|Overall Study||118
294060|NCT00812955|709224|P3|STARTED|Overall Study||119
294061|NCT00812955|709225|P2|STARTED|Overall Study||118
294062|NCT00812955|709226|P1|STARTED|Overall Study||119
294063|NCT00812929|709246|P10|NOT COMPLETED|Treatment Period 5||0
294064|NCT00812929|709247|P9|NOT COMPLETED|Treatment Period 5||0
294065|NCT00812929|709248|P8|NOT COMPLETED|Treatment Period 5||0
294066|NCT00812929|709249|P7|NOT COMPLETED|Treatment Period 5||0
294067|NCT00812929|709250|P6|NOT COMPLETED|Treatment Period 5||0
294068|NCT00812929|709251|P5|NOT COMPLETED|Treatment Period 5||0
294069|NCT00812929|709252|P4|NOT COMPLETED|Treatment Period 5||0
294070|NCT00812929|709253|P3|NOT COMPLETED|Treatment Period 5||0
294071|NCT00812929|709254|P2|NOT COMPLETED|Treatment Period 5||0
294072|NCT00812929|709255|P1|NOT COMPLETED|Treatment Period 5||0
294073|NCT00812929|709246|P10|COMPLETED|Treatment Period 5||4
294074|NCT00812929|709247|P9|COMPLETED|Treatment Period 5||4
294075|NCT00812929|709248|P8|COMPLETED|Treatment Period 5||5
294076|NCT00812929|709249|P7|COMPLETED|Treatment Period 5||5
294077|NCT00812929|709250|P6|COMPLETED|Treatment Period 5||4
294078|NCT00812929|709251|P5|COMPLETED|Treatment Period 5||5
294079|NCT00812929|709252|P4|COMPLETED|Treatment Period 5||4
294080|NCT00812929|709253|P3|COMPLETED|Treatment Period 5||4
294081|NCT00812929|709254|P2|COMPLETED|Treatment Period 5||4
294082|NCT00812929|709255|P1|COMPLETED|Treatment Period 5||5
294083|NCT00812929|709246|P10|STARTED|Treatment Period 5||4
294084|NCT00812929|709247|P9|STARTED|Treatment Period 5||4
294085|NCT00812929|709248|P8|STARTED|Treatment Period 5||5
294086|NCT00812929|709249|P7|STARTED|Treatment Period 5||5
294087|NCT00812929|709250|P6|STARTED|Treatment Period 5||4
294088|NCT00812929|709251|P5|STARTED|Treatment Period 5||5
294089|NCT00812929|709252|P4|STARTED|Treatment Period 5||4
294090|NCT00812929|709253|P3|STARTED|Treatment Period 5||4
294091|NCT00812929|709254|P2|STARTED|Treatment Period 5||4
294092|NCT00812929|709255|P1|STARTED|Treatment Period 5||5
294093|NCT00812929|709246|P10|NOT COMPLETED|Washout Period 4 (7 Days)||0
294094|NCT00812929|709247|P9|NOT COMPLETED|Washout Period 4 (7 Days)||0
294095|NCT00812929|709248|P8|NOT COMPLETED|Washout Period 4 (7 Days)||0
294096|NCT00812929|709249|P7|NOT COMPLETED|Washout Period 4 (7 Days)||0
294097|NCT00812929|709250|P6|NOT COMPLETED|Washout Period 4 (7 Days)||0
294098|NCT00812929|709251|P5|NOT COMPLETED|Washout Period 4 (7 Days)||0
294099|NCT00812929|709252|P4|NOT COMPLETED|Washout Period 4 (7 Days)||0
294100|NCT00812929|709253|P3|NOT COMPLETED|Washout Period 4 (7 Days)||0
294101|NCT00812929|709254|P2|NOT COMPLETED|Washout Period 4 (7 Days)||0
294102|NCT00812929|709255|P1|NOT COMPLETED|Washout Period 4 (7 Days)||0
294103|NCT00812929|709246|P10|COMPLETED|Washout Period 4 (7 Days)||4
294104|NCT00812929|709247|P9|COMPLETED|Washout Period 4 (7 Days)||4
294105|NCT00812929|709248|P8|COMPLETED|Washout Period 4 (7 Days)||5
294106|NCT00812929|709249|P7|COMPLETED|Washout Period 4 (7 Days)||5
294107|NCT00812929|709250|P6|COMPLETED|Washout Period 4 (7 Days)||4
294108|NCT00812929|709251|P5|COMPLETED|Washout Period 4 (7 Days)||5
294109|NCT00812929|709252|P4|COMPLETED|Washout Period 4 (7 Days)||4
294110|NCT00812929|709253|P3|COMPLETED|Washout Period 4 (7 Days)||4
294111|NCT00812929|709254|P2|COMPLETED|Washout Period 4 (7 Days)||4
294112|NCT00812929|709255|P1|COMPLETED|Washout Period 4 (7 Days)||5
294113|NCT00812929|709246|P10|STARTED|Washout Period 4 (7 Days)||4
294114|NCT00812929|709247|P9|STARTED|Washout Period 4 (7 Days)||4
294115|NCT00812929|709248|P8|STARTED|Washout Period 4 (7 Days)||5
294116|NCT00812929|709249|P7|STARTED|Washout Period 4 (7 Days)||5
294117|NCT00812929|709250|P6|STARTED|Washout Period 4 (7 Days)||4
294118|NCT00812929|709251|P5|STARTED|Washout Period 4 (7 Days)||5
294119|NCT00812929|709252|P4|STARTED|Washout Period 4 (7 Days)||4
294120|NCT00812929|709253|P3|STARTED|Washout Period 4 (7 Days)||4
294121|NCT00812929|709254|P2|STARTED|Washout Period 4 (7 Days)||4
294122|NCT00812929|709255|P1|STARTED|Washout Period 4 (7 Days)||5
294123|NCT00812929|709246|P10|NOT COMPLETED|Treatment Period 4||0
294124|NCT00812929|709247|P9|NOT COMPLETED|Treatment Period 4||0
294125|NCT00812929|709248|P8|NOT COMPLETED|Treatment Period 4||0
294126|NCT00812929|709249|P7|NOT COMPLETED|Treatment Period 4||0
294127|NCT00812929|709250|P6|NOT COMPLETED|Treatment Period 4||0
294128|NCT00812929|709251|P5|NOT COMPLETED|Treatment Period 4||0
294129|NCT00812929|709252|P4|NOT COMPLETED|Treatment Period 4||0
294130|NCT00812929|709253|P3|NOT COMPLETED|Treatment Period 4||0
294131|NCT00812929|709254|P2|NOT COMPLETED|Treatment Period 4||0
294132|NCT00812929|709255|P1|NOT COMPLETED|Treatment Period 4||0
294133|NCT00812929|709246|P10|COMPLETED|Treatment Period 4||4
294134|NCT00812929|709247|P9|COMPLETED|Treatment Period 4||4
294135|NCT00812929|709248|P8|COMPLETED|Treatment Period 4||5
294136|NCT00812929|709249|P7|COMPLETED|Treatment Period 4||5
294137|NCT00812929|709250|P6|COMPLETED|Treatment Period 4||4
294138|NCT00812929|709251|P5|COMPLETED|Treatment Period 4||5
294139|NCT00812929|709252|P4|COMPLETED|Treatment Period 4||4
294140|NCT00812929|709253|P3|COMPLETED|Treatment Period 4||4
294141|NCT00812929|709254|P2|COMPLETED|Treatment Period 4||4
294142|NCT00812929|709255|P1|COMPLETED|Treatment Period 4||5
294143|NCT00812929|709246|P10|STARTED|Treatment Period 4||4
294144|NCT00812929|709247|P9|STARTED|Treatment Period 4||4
294145|NCT00812929|709248|P8|STARTED|Treatment Period 4||5
294146|NCT00812929|709249|P7|STARTED|Treatment Period 4||5
294147|NCT00812929|709250|P6|STARTED|Treatment Period 4||4
294148|NCT00812929|709251|P5|STARTED|Treatment Period 4||5
294149|NCT00812929|709252|P4|STARTED|Treatment Period 4||4
294150|NCT00812929|709253|P3|STARTED|Treatment Period 4||4
294151|NCT00812929|709254|P2|STARTED|Treatment Period 4||4
294152|NCT00812929|709255|P1|STARTED|Treatment Period 4||5
294153|NCT00812929|709246|P10|NOT COMPLETED|Washout Period 3 (7 Days)||0
294154|NCT00812929|709247|P9|NOT COMPLETED|Washout Period 3 (7 Days)||0
294155|NCT00812929|709248|P8|NOT COMPLETED|Washout Period 3 (7 Days)||0
294156|NCT00812929|709249|P7|NOT COMPLETED|Washout Period 3 (7 Days)||0
294157|NCT00812929|709250|P6|NOT COMPLETED|Washout Period 3 (7 Days)||1
294158|NCT00812929|709251|P5|NOT COMPLETED|Washout Period 3 (7 Days)||0
294159|NCT00812929|709252|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
294160|NCT00812929|709253|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
294161|NCT00812929|709254|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
294162|NCT00812929|709255|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
294163|NCT00812929|709246|P10|COMPLETED|Washout Period 3 (7 Days)||4
294164|NCT00812929|709247|P9|COMPLETED|Washout Period 3 (7 Days)||4
294165|NCT00812929|709248|P8|COMPLETED|Washout Period 3 (7 Days)||5
294166|NCT00812929|709249|P7|COMPLETED|Washout Period 3 (7 Days)||5
294167|NCT00812929|709250|P6|COMPLETED|Washout Period 3 (7 Days)||4
294168|NCT00812929|709251|P5|COMPLETED|Washout Period 3 (7 Days)||5
294169|NCT00812929|709252|P4|COMPLETED|Washout Period 3 (7 Days)||4
294170|NCT00812929|709253|P3|COMPLETED|Washout Period 3 (7 Days)||4
294171|NCT00812929|709254|P2|COMPLETED|Washout Period 3 (7 Days)||4
294172|NCT00812929|709255|P1|COMPLETED|Washout Period 3 (7 Days)||5
294173|NCT00812929|709246|P10|STARTED|Washout Period 3 (7 Days)||4
294174|NCT00812929|709247|P9|STARTED|Washout Period 3 (7 Days)||4
294175|NCT00812929|709248|P8|STARTED|Washout Period 3 (7 Days)||5
294176|NCT00812929|709249|P7|STARTED|Washout Period 3 (7 Days)||5
294177|NCT00812929|709250|P6|STARTED|Washout Period 3 (7 Days)||5
294178|NCT00812929|709251|P5|STARTED|Washout Period 3 (7 Days)||5
294179|NCT00812929|709252|P4|STARTED|Washout Period 3 (7 Days)||4
294180|NCT00812929|709253|P3|STARTED|Washout Period 3 (7 Days)||4
294181|NCT00812929|709254|P2|STARTED|Washout Period 3 (7 Days)||4
294182|NCT00812929|709255|P1|STARTED|Washout Period 3 (7 Days)||5
294183|NCT00812929|709246|P10|NOT COMPLETED|Treatment Period 3||0
294184|NCT00812929|709247|P9|NOT COMPLETED|Treatment Period 3||0
294185|NCT00812929|709248|P8|NOT COMPLETED|Treatment Period 3||0
294186|NCT00812929|709249|P7|NOT COMPLETED|Treatment Period 3||0
294187|NCT00812929|709250|P6|NOT COMPLETED|Treatment Period 3||0
294188|NCT00812929|709251|P5|NOT COMPLETED|Treatment Period 3||0
294189|NCT00812929|709252|P4|NOT COMPLETED|Treatment Period 3||0
294190|NCT00812929|709253|P3|NOT COMPLETED|Treatment Period 3||0
294191|NCT00812929|709254|P2|NOT COMPLETED|Treatment Period 3||0
294192|NCT00812929|709255|P1|NOT COMPLETED|Treatment Period 3||0
294193|NCT00812929|709246|P10|COMPLETED|Treatment Period 3||4
294194|NCT00812929|709247|P9|COMPLETED|Treatment Period 3||4
294195|NCT00812929|709248|P8|COMPLETED|Treatment Period 3||5
294196|NCT00812929|709249|P7|COMPLETED|Treatment Period 3||5
294197|NCT00812929|709250|P6|COMPLETED|Treatment Period 3||5
294198|NCT00812929|709251|P5|COMPLETED|Treatment Period 3||5
294199|NCT00812929|709252|P4|COMPLETED|Treatment Period 3||4
294200|NCT00812929|709253|P3|COMPLETED|Treatment Period 3||4
294201|NCT00812929|709254|P2|COMPLETED|Treatment Period 3||4
294202|NCT00812929|709255|P1|COMPLETED|Treatment Period 3||5
294203|NCT00812929|709246|P10|STARTED|Treatment Period 3||4
294204|NCT00812929|709247|P9|STARTED|Treatment Period 3||4
294205|NCT00812929|709248|P8|STARTED|Treatment Period 3||5
294206|NCT00812929|709249|P7|STARTED|Treatment Period 3||5
294207|NCT00812929|709250|P6|STARTED|Treatment Period 3||5
294208|NCT00812929|709251|P5|STARTED|Treatment Period 3||5
294209|NCT00812929|709252|P4|STARTED|Treatment Period 3||4
294210|NCT00812929|709253|P3|STARTED|Treatment Period 3||4
294211|NCT00812929|709254|P2|STARTED|Treatment Period 3||4
294212|NCT00812929|709255|P1|STARTED|Treatment Period 3||5
294213|NCT00812929|709246|P10|NOT COMPLETED|Washout Period 2 (7 Days)||1
294214|NCT00812929|709247|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
294215|NCT00812929|709248|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
294216|NCT00812929|709249|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
294217|NCT00812929|709250|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
294218|NCT00812929|709251|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
294219|NCT00812929|709252|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
294220|NCT00812929|709253|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
294221|NCT00812929|709254|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
294222|NCT00812929|709255|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
294223|NCT00812929|709246|P10|COMPLETED|Washout Period 2 (7 Days)||4
294224|NCT00812929|709247|P9|COMPLETED|Washout Period 2 (7 Days)||4
294225|NCT00812929|709248|P8|COMPLETED|Washout Period 2 (7 Days)||5
294226|NCT00812929|709249|P7|COMPLETED|Washout Period 2 (7 Days)||5
294227|NCT00812929|709250|P6|COMPLETED|Washout Period 2 (7 Days)||5
294228|NCT00812929|709251|P5|COMPLETED|Washout Period 2 (7 Days)||5
294229|NCT00812929|709252|P4|COMPLETED|Washout Period 2 (7 Days)||4
294230|NCT00812929|709253|P3|COMPLETED|Washout Period 2 (7 Days)||4
294231|NCT00812929|709254|P2|COMPLETED|Washout Period 2 (7 Days)||4
294232|NCT00812929|709255|P1|COMPLETED|Washout Period 2 (7 Days)||5
294233|NCT00812929|709246|P10|STARTED|Washout Period 2 (7 Days)||5
294234|NCT00812929|709247|P9|STARTED|Washout Period 2 (7 Days)||4
294235|NCT00812929|709248|P8|STARTED|Washout Period 2 (7 Days)||5
294236|NCT00812929|709249|P7|STARTED|Washout Period 2 (7 Days)||5
294237|NCT00812929|709250|P6|STARTED|Washout Period 2 (7 Days)||5
294238|NCT00812929|709251|P5|STARTED|Washout Period 2 (7 Days)||5
294239|NCT00812929|709252|P4|STARTED|Washout Period 2 (7 Days)||4
294240|NCT00812929|709253|P3|STARTED|Washout Period 2 (7 Days)||4
294241|NCT00812929|709254|P2|STARTED|Washout Period 2 (7 Days)||4
294242|NCT00812929|709255|P1|STARTED|Washout Period 2 (7 Days)||5
294243|NCT00812929|709246|P10|NOT COMPLETED|Treatment Period 2||0
294244|NCT00812929|709247|P9|NOT COMPLETED|Treatment Period 2||0
294245|NCT00812929|709248|P8|NOT COMPLETED|Treatment Period 2||0
294246|NCT00812929|709249|P7|NOT COMPLETED|Treatment Period 2||0
294247|NCT00812929|709250|P6|NOT COMPLETED|Treatment Period 2||0
294248|NCT00812929|709251|P5|NOT COMPLETED|Treatment Period 2||0
294249|NCT00812929|709252|P4|NOT COMPLETED|Treatment Period 2||0
294250|NCT00812929|709253|P3|NOT COMPLETED|Treatment Period 2||0
294251|NCT00812929|709254|P2|NOT COMPLETED|Treatment Period 2||0
294252|NCT00812929|709255|P1|NOT COMPLETED|Treatment Period 2||0
294253|NCT00812929|709246|P10|COMPLETED|Treatment Period 2||5
294254|NCT00812929|709247|P9|COMPLETED|Treatment Period 2||4
294255|NCT00812929|709248|P8|COMPLETED|Treatment Period 2||5
294256|NCT00812929|709249|P7|COMPLETED|Treatment Period 2||5
294257|NCT00812929|709250|P6|COMPLETED|Treatment Period 2||5
294258|NCT00812929|709251|P5|COMPLETED|Treatment Period 2||5
294259|NCT00812929|709252|P4|COMPLETED|Treatment Period 2||4
294260|NCT00812929|709253|P3|COMPLETED|Treatment Period 2||4
294261|NCT00812929|709254|P2|COMPLETED|Treatment Period 2||4
294262|NCT00812929|709255|P1|COMPLETED|Treatment Period 2||5
294263|NCT00812929|709246|P10|STARTED|Treatment Period 2||5
294264|NCT00812929|709247|P9|STARTED|Treatment Period 2||4
294265|NCT00812929|709248|P8|STARTED|Treatment Period 2||5
294266|NCT00812929|709249|P7|STARTED|Treatment Period 2||5
294267|NCT00812929|709250|P6|STARTED|Treatment Period 2||5
294268|NCT00812929|709251|P5|STARTED|Treatment Period 2||5
294269|NCT00812929|709252|P4|STARTED|Treatment Period 2||4
294270|NCT00812929|709253|P3|STARTED|Treatment Period 2||4
294271|NCT00812929|709254|P2|STARTED|Treatment Period 2||4
294272|NCT00812929|709255|P1|STARTED|Treatment Period 2||5
294273|NCT00812929|709246|P10|NOT COMPLETED|Washout Period 1 (7 Days)||0
294274|NCT00812929|709247|P9|NOT COMPLETED|Washout Period 1 (7 Days)||0
294275|NCT00812929|709248|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
294276|NCT00812929|709249|P7|NOT COMPLETED|Washout Period 1 (7 Days)||0
294277|NCT00812929|709250|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
294278|NCT00812929|709251|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
294279|NCT00812929|709252|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
294280|NCT00812929|709253|P3|NOT COMPLETED|Washout Period 1 (7 Days)||1
294281|NCT00812929|709254|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
294282|NCT00812929|709255|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
294283|NCT00812929|709246|P10|COMPLETED|Washout Period 1 (7 Days)||5
294284|NCT00812929|709247|P9|COMPLETED|Washout Period 1 (7 Days)||4
294285|NCT00812929|709248|P8|COMPLETED|Washout Period 1 (7 Days)||5
294286|NCT00812929|709249|P7|COMPLETED|Washout Period 1 (7 Days)||5
294287|NCT00812929|709250|P6|COMPLETED|Washout Period 1 (7 Days)||5
294288|NCT00812929|709251|P5|COMPLETED|Washout Period 1 (7 Days)||5
294289|NCT00812929|709252|P4|COMPLETED|Washout Period 1 (7 Days)||4
294290|NCT00812929|709253|P3|COMPLETED|Washout Period 1 (7 Days)||4
294291|NCT00812929|709254|P2|COMPLETED|Washout Period 1 (7 Days)||4
294292|NCT00812929|709255|P1|COMPLETED|Washout Period 1 (7 Days)||5
294293|NCT00812929|709246|P10|STARTED|Washout Period 1 (7 Days)||5
294294|NCT00812929|709247|P9|STARTED|Washout Period 1 (7 Days)||4
294295|NCT00812929|709248|P8|STARTED|Washout Period 1 (7 Days)||5
294296|NCT00812929|709249|P7|STARTED|Washout Period 1 (7 Days)||5
294297|NCT00812929|709250|P6|STARTED|Washout Period 1 (7 Days)||5
294298|NCT00812929|709251|P5|STARTED|Washout Period 1 (7 Days)||5
294299|NCT00812929|709252|P4|STARTED|Washout Period 1 (7 Days)||4
294300|NCT00812929|709253|P3|STARTED|Washout Period 1 (7 Days)||5
294301|NCT00812929|709254|P2|STARTED|Washout Period 1 (7 Days)||4
294302|NCT00812929|709255|P1|STARTED|Washout Period 1 (7 Days)||5
294303|NCT00812929|709246|P10|NOT COMPLETED|Treatment Period 1||0
294304|NCT00812929|709247|P9|NOT COMPLETED|Treatment Period 1||0
294305|NCT00812929|709248|P8|NOT COMPLETED|Treatment Period 1||0
294306|NCT00812929|709249|P7|NOT COMPLETED|Treatment Period 1||0
294307|NCT00812929|709250|P6|NOT COMPLETED|Treatment Period 1||0
294308|NCT00812929|709251|P5|NOT COMPLETED|Treatment Period 1||0
294309|NCT00812929|709252|P4|NOT COMPLETED|Treatment Period 1||0
294310|NCT00812929|709253|P3|NOT COMPLETED|Treatment Period 1||0
294311|NCT00812929|709254|P2|NOT COMPLETED|Treatment Period 1||0
294312|NCT00812929|709255|P1|NOT COMPLETED|Treatment Period 1||0
294313|NCT00812929|709246|P10|COMPLETED|Treatment Period 1||5
294314|NCT00812929|709247|P9|COMPLETED|Treatment Period 1||4
294315|NCT00812929|709248|P8|COMPLETED|Treatment Period 1||5
294316|NCT00812929|709249|P7|COMPLETED|Treatment Period 1||5
294317|NCT00812929|709250|P6|COMPLETED|Treatment Period 1||5
294318|NCT00812929|709251|P5|COMPLETED|Treatment Period 1||5
294319|NCT00812929|709252|P4|COMPLETED|Treatment Period 1||4
294320|NCT00812929|709253|P3|COMPLETED|Treatment Period 1||5
294321|NCT00812929|709254|P2|COMPLETED|Treatment Period 1||4
294322|NCT00812929|709255|P1|COMPLETED|Treatment Period 1||5
294323|NCT00812929|709246|P10|STARTED|Treatment Period 1||5
294324|NCT00812929|709247|P9|STARTED|Treatment Period 1||4
294325|NCT00812929|709248|P8|STARTED|Treatment Period 1||5
294326|NCT00812929|709249|P7|STARTED|Treatment Period 1||5
294327|NCT00812929|709250|P6|STARTED|Treatment Period 1||5
294328|NCT00812929|709251|P5|STARTED|Treatment Period 1||5
294329|NCT00812929|709252|P4|STARTED|Treatment Period 1||4
294330|NCT00812929|709253|P3|STARTED|Treatment Period 1||5
294331|NCT00812929|709254|P2|STARTED|Treatment Period 1||4
294332|NCT00812929|709255|P1|STARTED|Treatment Period 1||5
294333|NCT00812916|709371|P1|NOT COMPLETED|Overall Study||3
294334|NCT00812916|709371|P1|COMPLETED|Overall Study||203
294335|NCT00812916|709371|P1|CFAE - Guided Ablation|Overall Study||203
294336|NCT00812916|709371|P1|Data Available|Overall Study||205
294337|NCT00812916|709371|P1|STARTED|Overall Study|206 enrolled (consented)|206
294338|NCT00812877|709382|P2|NOT COMPLETED|Overall Study||51
294339|NCT00812877|709383|P1|NOT COMPLETED|Overall Study||37
294340|NCT00812877|709382|P2|COMPLETED|Overall Study||130
294341|NCT00812877|709383|P1|COMPLETED|Overall Study||158
294342|NCT00812877|709382|P2|STARTED|Overall Study||181
294343|NCT00812877|709383|P1|STARTED|Overall Study||195
294344|NCT00812812|709393|P2|NOT COMPLETED|Overall Study||4
294345|NCT00812812|709394|P1|NOT COMPLETED|Overall Study||3
294346|NCT00812812|709393|P2|COMPLETED|Overall Study||25
294347|NCT00812812|709394|P1|COMPLETED|Overall Study||24
294348|NCT00812812|709393|P2|STARTED|Overall Study||29
294349|NCT00812812|709394|P1|STARTED|Overall Study||27
294350|NCT00812708|709407|P1|NOT COMPLETED|Overall Study||8
294351|NCT00812708|709407|P1|COMPLETED|Overall Study||64
294352|NCT00812708|709407|P1|Taken to Surgery for Device Implantation|Overall Study|2 patients could not be implanted because of intraoperative complications.|66
294353|NCT00812708|709407|P1|STARTED|Overall Study|6 patients withdrew from the study before being taken to the operating room.|72
294354|NCT00812604|709418|P2|NOT COMPLETED|Overall Study||5
294355|NCT00812604|709419|P1|NOT COMPLETED|Overall Study||5
294356|NCT00812604|709418|P2|COMPLETED|Overall Study||22
294357|NCT00812604|709419|P1|COMPLETED|Overall Study||23
294358|NCT00812604|709418|P2|STARTED|Overall Study||27
294359|NCT00812604|709419|P1|STARTED|Overall Study||28
294360|NCT00812565|709435|P8|NOT COMPLETED|Overall Study||1
294361|NCT00812565|709436|P7|NOT COMPLETED|Overall Study||0
294362|NCT00812565|709437|P6|NOT COMPLETED|Overall Study||1
294363|NCT00812565|709438|P5|NOT COMPLETED|Overall Study||1
294364|NCT00812565|709439|P4|NOT COMPLETED|Overall Study||2
294365|NCT00812565|709440|P3|NOT COMPLETED|Overall Study||0
294366|NCT00812565|709441|P2|NOT COMPLETED|Overall Study||1
294367|NCT00812565|709442|P1|NOT COMPLETED|Overall Study||3
294368|NCT00812565|709435|P8|COMPLETED|Overall Study||6
294369|NCT00812565|709436|P7|COMPLETED|Overall Study||8
294370|NCT00812565|709437|P6|COMPLETED|Overall Study||6
294371|NCT00812565|709438|P5|COMPLETED|Overall Study||6
294372|NCT00812565|709439|P4|COMPLETED|Overall Study||5
294373|NCT00812565|709440|P3|COMPLETED|Overall Study||7
294374|NCT00812565|709441|P2|COMPLETED|Overall Study||6
294375|NCT00812565|709442|P1|COMPLETED|Overall Study||5
294376|NCT00812565|709435|P8|STARTED|Overall Study||7
294377|NCT00812565|709436|P7|STARTED|Overall Study||8
294378|NCT00812565|709437|P6|STARTED|Overall Study||7
294379|NCT00812565|709438|P5|STARTED|Overall Study||7
294380|NCT00812565|709439|P4|STARTED|Overall Study||7
294381|NCT00812565|709440|P3|STARTED|Overall Study||7
294382|NCT00812565|709441|P2|STARTED|Overall Study||7
294383|NCT00812565|709442|P1|STARTED|Overall Study||8
294384|NCT00812487|709566|P2|NOT COMPLETED|Overall Study||3
294385|NCT00812487|709567|P1|NOT COMPLETED|Overall Study||6
294386|NCT00812487|709566|P2|COMPLETED|Overall Study||39
294387|NCT00812487|709567|P1|COMPLETED|Overall Study||26
294388|NCT00812487|709566|P2|STARTED|Overall Study||42
294389|NCT00812487|709567|P1|STARTED|Overall Study||32
294390|NCT00812461|709593|P2|NOT COMPLETED|All Treated Patients||147
294391|NCT00812461|709594|P1|NOT COMPLETED|All Treated Patients||132
294392|NCT00812461|709593|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|194
294393|NCT00812461|709594|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|205
294394|NCT00812461|709593|P2|STARTED|All Treated Patients||341
294395|NCT00812461|709594|P1|STARTED|All Treated Patients||337
294396|NCT00812461|709593|P2|NOT COMPLETED|All Randomised Patients||17
294397|NCT00812461|709594|P1|NOT COMPLETED|All Randomised Patients||23
294398|NCT00812461|709593|P2|COMPLETED|All Randomised Patients||341
294399|NCT00812461|709594|P1|COMPLETED|All Randomised Patients||337
294400|NCT00812461|709593|P2|STARTED|All Randomised Patients||358
294401|NCT00812461|709594|P1|STARTED|All Randomised Patients||360
294402|NCT00812331|709617|P5|NOT COMPLETED|Overall Study||0
294403|NCT00812331|709618|P4|NOT COMPLETED|Overall Study||0
294404|NCT00812331|709619|P3|NOT COMPLETED|Overall Study||0
294405|NCT00812331|709620|P2|NOT COMPLETED|Overall Study||0
294406|NCT00812331|709621|P1|NOT COMPLETED|Overall Study||1
294407|NCT00812331|709617|P5|COMPLETED|Overall Study||8
294408|NCT00812331|709618|P4|COMPLETED|Overall Study||7
294409|NCT00812331|709619|P3|COMPLETED|Overall Study||8
294410|NCT00812331|709620|P2|COMPLETED|Overall Study||8
294411|NCT00812331|709621|P1|COMPLETED|Overall Study||5
294412|NCT00812331|709617|P5|STARTED|Overall Study||8
294413|NCT00812331|709618|P4|STARTED|Overall Study||7
294414|NCT00812331|709619|P3|STARTED|Overall Study||8
294415|NCT00812331|709620|P2|STARTED|Overall Study||8
294416|NCT00812331|709621|P1|STARTED|Overall Study||6
294417|NCT00812253|709696|P2|NOT COMPLETED|Overall Study||3
294418|NCT00812253|709697|P1|NOT COMPLETED|Overall Study||6
294419|NCT00812253|709696|P2|COMPLETED|Overall Study||39
294420|NCT00812253|709697|P1|COMPLETED|Overall Study||26
294421|NCT00812253|709696|P2|STARTED|Overall Study||42
294422|NCT00812253|709697|P1|STARTED|Overall Study||32
294423|NCT00812110|709713|P1|NOT COMPLETED|Overall Study||0
294424|NCT00812110|709713|P1|COMPLETED|Overall Study||292
294425|NCT00812110|709713|P1|STARTED|Overall Study||292
294426|NCT00812097|709722|P4|NOT COMPLETED|Overall Study||35
294427|NCT00812097|709723|P3|NOT COMPLETED|Overall Study||57
294428|NCT00812097|709724|P2|NOT COMPLETED|Overall Study||89
294429|NCT00812097|709725|P1|NOT COMPLETED|Overall Study||245
294430|NCT00812097|709722|P4|COMPLETED|Overall Study||34
294431|NCT00812097|709723|P3|COMPLETED|Overall Study||67
294432|NCT00812097|709724|P2|COMPLETED|Overall Study||101
294433|NCT00812097|709725|P1|COMPLETED|Overall Study||327
294434|NCT00812097|709722|P4|STARTED|Overall Study||69
294435|NCT00812097|709723|P3|STARTED|Overall Study||124
294436|NCT00812097|709724|P2|STARTED|Overall Study||190
294437|NCT00812097|709725|P1|STARTED|Overall Study||572
294438|NCT00812006|709754|P3|NOT COMPLETED|Overall Study||6
294439|NCT00812006|709755|P2|NOT COMPLETED|Overall Study||3
294440|NCT00812006|709756|P1|NOT COMPLETED|Overall Study||6
294441|NCT00812006|709754|P3|COMPLETED|Overall Study||30
294442|NCT00812006|709755|P2|COMPLETED|Overall Study||33
294443|NCT00812006|709756|P1|COMPLETED|Overall Study||30
294444|NCT00812006|709754|P3|STARTED|Overall Study||36
294445|NCT00812006|709755|P2|STARTED|Overall Study||36
294446|NCT00812006|709756|P1|STARTED|Overall Study||36
294447|NCT00811954|709773|P3|NOT COMPLETED|Overall Study||101
294448|NCT00811954|709774|P2|NOT COMPLETED|Overall Study||72
294449|NCT00811954|709775|P1|NOT COMPLETED|Overall Study||89
294450|NCT00811954|709773|P3|COMPLETED|Overall Study||500
294451|NCT00811954|709774|P2|COMPLETED|Overall Study||531
294452|NCT00811954|709775|P1|COMPLETED|Overall Study||516
294453|NCT00811954|709773|P3|STARTED|Overall Study||601
294454|NCT00811954|709774|P2|STARTED|Overall Study||603
294455|NCT00811954|709775|P1|STARTED|Overall Study||605
294456|NCT00811941|709839|P2|NOT COMPLETED|All Treated Patients||191
294457|NCT00811941|709840|P1|NOT COMPLETED|All Treated Patients||52
294458|NCT00811941|709839|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|310
294459|NCT00811941|709840|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|112
294460|NCT00811941|709839|P2|STARTED|All Treated Patients||501
294461|NCT00811941|709840|P1|STARTED|All Treated Patients||164
294462|NCT00811941|709839|P2|NOT COMPLETED|All Randomised Patients||8
294463|NCT00811941|709840|P1|NOT COMPLETED|All Randomised Patients||2
294464|NCT00811941|709839|P2|COMPLETED|All Randomised Patients||501
294465|NCT00811941|709840|P1|COMPLETED|All Randomised Patients||164
294466|NCT00811941|709839|P2|STARTED|All Randomised Patients||509
294467|NCT00811941|709840|P1|STARTED|All Randomised Patients||166
294468|NCT00811928|709878|P2|NOT COMPLETED|Overall Study||33
294469|NCT00811928|709879|P1|NOT COMPLETED|Overall Study||39
294470|NCT00811928|709878|P2|COMPLETED|Overall Study||90
294471|NCT00811928|709879|P1|COMPLETED|Overall Study||90
294472|NCT00811928|709878|P2|STARTED|Overall Study||123
294473|NCT00811928|709879|P1|STARTED|Overall Study||129
294474|NCT00811850|709897|P1|NOT COMPLETED|Treatment Period 3: Combigan® or Cosopt®||0
294475|NCT00811850|709897|P1|COMPLETED|Treatment Period 3: Combigan® or Cosopt®||15
294476|NCT00811850|709897|P1|STARTED|Treatment Period 3: Combigan® or Cosopt®||15
294477|NCT00811850|709897|P1|NOT COMPLETED|Treatment Period 2: Wash Out||0
294478|NCT00811850|709897|P1|COMPLETED|Treatment Period 2: Wash Out||15
294479|NCT00811850|709897|P1|STARTED|Treatment Period 2: Wash Out||15
294480|NCT00811850|709897|P1|NOT COMPLETED|Treatment Period 1: Combigan® or Cosopt®||0
294481|NCT00811850|709897|P1|COMPLETED|Treatment Period 1: Combigan® or Cosopt®||15
294482|NCT00811850|709897|P1|STARTED|Treatment Period 1: Combigan® or Cosopt®||15
294483|NCT00811798|709917|P1|NOT COMPLETED|Overall Study||0
294484|NCT00811798|709917|P1|COMPLETED|Overall Study||92
294485|NCT00811798|709917|P1|STARTED|Overall Study||92
294486|NCT00811733|709923|P2|NOT COMPLETED|Overall Study||10
294487|NCT00811733|709924|P1|NOT COMPLETED|Overall Study||11
294488|NCT00811733|709923|P2|COMPLETED|Overall Study||12
294489|NCT00811733|709924|P1|COMPLETED|Overall Study||4
294490|NCT00811733|709923|P2|STARTED|Overall Study||22
294491|NCT00811733|709924|P1|STARTED|Overall Study||15
294492|NCT00811720|709972|P2|NOT COMPLETED|All Treated Patients||164
294493|NCT00811720|709973|P1|NOT COMPLETED|All Treated Patients||96
294494|NCT00811720|709972|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|138
294495|NCT00811720|709973|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|200
294496|NCT00811720|709972|P2|STARTED|All Treated Patients||302
294497|NCT00811720|709973|P1|STARTED|All Treated Patients||296
294498|NCT00811720|709972|P2|NOT COMPLETED|All Randomised Patients||4
294499|NCT00811720|709973|P1|NOT COMPLETED|All Randomised Patients||2
294500|NCT00811720|709972|P2|COMPLETED|All Randomised Patients||302
294501|NCT00811720|709973|P1|COMPLETED|All Randomised Patients||296
294502|NCT00811720|709972|P2|STARTED|All Randomised Patients||306
294503|NCT00811720|709973|P1|STARTED|All Randomised Patients||298
294504|NCT00811655|709991|P1|NOT COMPLETED|Overall Study||1
294505|NCT00811655|709991|P1|COMPLETED|Overall Study||5
294506|NCT00811655|709991|P1|STARTED|Overall Study||6
294507|NCT00811642|710003|P1|NOT COMPLETED|Overall Study||15
294508|NCT00811642|710003|P1|COMPLETED|Overall Study|The Per Protocol Set (PPS) includes the 47 participants who completed the study per protocol.|47
294509|NCT00811642|710003|P1|STARTED|Overall Study|63 participants were screened and enrolled; 62 participants from Safety Set (SS) started study drug.|62
294510|NCT00811590|710013|P1|NOT COMPLETED|Overall Study||0
294511|NCT00811590|710013|P1|COMPLETED|Overall Study||3
294512|NCT00811590|710013|P1|STARTED|Overall Study||3
294513|NCT00811577|710019|P2|NOT COMPLETED|Overall Study||1
294514|NCT00811577|710020|P1|NOT COMPLETED|Overall Study||10
294515|NCT00811577|710019|P2|COMPLETED|Overall Study||23
294516|NCT00811577|710020|P1|COMPLETED|Overall Study||116
294517|NCT00811577|710019|P2|STARTED|Overall Study||24
294518|NCT00811577|710020|P1|STARTED|Overall Study||126
294519|NCT00811564|710071|P2|NOT COMPLETED|Overall Study||2
294520|NCT00811564|710072|P1|NOT COMPLETED|Overall Study||9
294521|NCT00811564|710071|P2|COMPLETED|Overall Study||73
294522|NCT00811564|710072|P1|COMPLETED|Overall Study||64
294523|NCT00811564|710071|P2|STARTED|Overall Study||75
294524|NCT00811564|710072|P1|STARTED|Overall Study||73
294525|NCT00811473|710080|P2|NOT COMPLETED|Overall Study||26
294526|NCT00811473|710081|P1|NOT COMPLETED|Overall Study||23
294527|NCT00811473|710080|P2|COMPLETED|Overall Study||74
294528|NCT00811473|710081|P1|COMPLETED|Overall Study||70
294529|NCT00811473|710080|P2|STARTED|Overall Study||100
294530|NCT00811473|710081|P1|STARTED|Overall Study||93
294531|NCT00811434|710097|P2|NOT COMPLETED|Second Intervention||0
294532|NCT00811434|710098|P1|NOT COMPLETED|Second Intervention||0
294533|NCT00811434|710097|P2|COMPLETED|Second Intervention||5
294534|NCT00811434|710098|P1|COMPLETED|Second Intervention||4
294535|NCT00811434|710097|P2|STARTED|Second Intervention||5
294536|NCT00811434|710098|P1|STARTED|Second Intervention||4
294537|NCT00811434|710097|P2|NOT COMPLETED|Washout (1 Month)||0
294538|NCT00811434|710098|P1|NOT COMPLETED|Washout (1 Month)||0
294539|NCT00811434|710097|P2|COMPLETED|Washout (1 Month)||5
294540|NCT00811434|710098|P1|COMPLETED|Washout (1 Month)||4
294541|NCT00811434|710097|P2|STARTED|Washout (1 Month)||5
294542|NCT00811434|710098|P1|STARTED|Washout (1 Month)||4
294543|NCT00811434|710097|P2|NOT COMPLETED|First Intervention||0
294544|NCT00811434|710098|P1|NOT COMPLETED|First Intervention||3
294545|NCT00811434|710097|P2|COMPLETED|First Intervention||5
294546|NCT00811434|710098|P1|COMPLETED|First Intervention||4
294547|NCT00811434|710097|P2|STARTED|First Intervention||5
294548|NCT00811434|710098|P1|STARTED|First Intervention||7
294549|NCT00811395|710112|P6|NOT COMPLETED|Extension Treatment||2
294550|NCT00811395|710113|P5|NOT COMPLETED|Extension Treatment||0
294551|NCT00811395|710114|P4|NOT COMPLETED|Extension Treatment||3
294552|NCT00811395|710115|P3|NOT COMPLETED|Extension Treatment||3
294553|NCT00811395|710116|P2|NOT COMPLETED|Extension Treatment||6
294554|NCT00811395|710117|P1|NOT COMPLETED|Extension Treatment||2
294555|NCT00811395|710112|P6|COMPLETED|Extension Treatment|completed 48-week treatment|27
294556|NCT00811395|710113|P5|COMPLETED|Extension Treatment|completed 48-week treatment|30
294557|NCT00811395|710114|P4|COMPLETED|Extension Treatment|completed 48-week treatment|34
294558|NCT00811395|710115|P3|COMPLETED|Extension Treatment|completed 48-week treatment|24
294559|NCT00811395|710116|P2|COMPLETED|Extension Treatment|completed 48-week treatment|22
294560|NCT00811395|710117|P1|COMPLETED|Extension Treatment|completed 48-week treatment|29
294561|NCT00811395|710112|P6|STARTED|Extension Treatment|continued initial treatment|29
294562|NCT00811395|710113|P5|STARTED|Extension Treatment|continued initial treatment|30
294563|NCT00811395|710114|P4|STARTED|Extension Treatment|continued initial treatment|37
294564|NCT00811395|710115|P3|STARTED|Extension Treatment|continued initial treatment|27
294565|NCT00811395|710116|P2|STARTED|Extension Treatment|continued initial treatment|28
294566|NCT00811395|710117|P1|STARTED|Extension Treatment|continued initial treatment|31
294567|NCT00811395|710112|P6|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||6
294568|NCT00811395|710113|P5|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||5
294569|NCT00811395|710114|P4|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
294570|NCT00811395|710115|P3|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
294571|NCT00811395|710116|P2|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||4
294572|NCT00811395|710117|P1|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||3
294573|NCT00811395|710112|P6|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|35
294574|NCT00811395|710113|P5|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|37
294575|NCT00811395|710114|P4|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|38
294576|NCT00811395|710115|P3|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|36
294577|NCT00811395|710116|P2|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|33
294578|NCT00811395|710117|P1|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|38
294579|NCT00811395|710112|P6|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
294580|NCT00811395|710113|P5|STARTED|Initial Treatment (PDY6045 or PDY6046)||42
294581|NCT00811395|710114|P4|STARTED|Initial Treatment (PDY6045 or PDY6046)||40
294582|NCT00811395|710115|P3|STARTED|Initial Treatment (PDY6045 or PDY6046)||38
294583|NCT00811395|710116|P2|STARTED|Initial Treatment (PDY6045 or PDY6046)|One participant received 7 mg instead of 14 mg as per randomization|37
294584|NCT00811395|710117|P1|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
294585|NCT00811382|710181|P2|NOT COMPLETED|Overall Study||0
294586|NCT00811382|710182|P1|NOT COMPLETED|Overall Study||0
294587|NCT00811382|710181|P2|COMPLETED|Overall Study||75
294588|NCT00811382|710182|P1|COMPLETED|Overall Study||88
294589|NCT00811382|710181|P2|STARTED|Overall Study||75
294590|NCT00811382|710182|P1|STARTED|Overall Study||88
294591|NCT00811317|710194|P1|NOT COMPLETED|Overall Study||0
294592|NCT00811317|710194|P1|COMPLETED|Overall Study||11
294593|NCT00811317|710194|P1|STARTED|Overall Study||11
294594|NCT00811252|710223|P3|NOT COMPLETED|Overall Study||23
294595|NCT00811252|710224|P2|NOT COMPLETED|Overall Study||20
294596|NCT00811252|710225|P1|NOT COMPLETED|Overall Study||17
294597|NCT00811252|710223|P3|COMPLETED|Overall Study||128
294598|NCT00811252|710224|P2|COMPLETED|Overall Study||136
294599|NCT00811252|710225|P1|COMPLETED|Overall Study||128
294600|NCT00811252|710223|P3|STARTED|Overall Study||151
294601|NCT00811252|710224|P2|STARTED|Overall Study||156
294602|NCT00811252|710225|P1|STARTED|Overall Study||145
294603|NCT00811174|710269|P1|NOT COMPLETED|Overall Study||3
294604|NCT00811174|710269|P1|COMPLETED|Overall Study||2
294605|NCT00811174|710269|P1|STARTED|Overall Study||5
294606|NCT00811135|710280|P1|NOT COMPLETED|Overall Study||88
294607|NCT00811135|710280|P1|COMPLETED|Overall Study||0
294608|NCT00811135|710280|P1|STARTED|Overall Study||88
294609|NCT00811070|710298|P6|NOT COMPLETED|Overall Study||1
294610|NCT00811070|710299|P5|NOT COMPLETED|Overall Study||5
294611|NCT00811070|710300|P4|NOT COMPLETED|Overall Study||2
294612|NCT00811070|710301|P3|NOT COMPLETED|Overall Study||0
294613|NCT00811070|710302|P2|NOT COMPLETED|Overall Study||1
294614|NCT00811070|710303|P1|NOT COMPLETED|Overall Study||1
294615|NCT00811070|710298|P6|COMPLETED|Overall Study||10
294616|NCT00811070|710299|P5|COMPLETED|Overall Study||2
294617|NCT00811070|710300|P4|COMPLETED|Overall Study||26
294618|NCT00811070|710301|P3|COMPLETED|Overall Study||3
294619|NCT00811070|710302|P2|COMPLETED|Overall Study||6
294620|NCT00811070|710303|P1|COMPLETED|Overall Study||6
294621|NCT00811070|710298|P6|STARTED|Overall Study||11
294622|NCT00811070|710299|P5|STARTED|Overall Study||7
294623|NCT00811070|710300|P4|STARTED|Overall Study||28
294624|NCT00811070|710301|P3|STARTED|Overall Study||3
294625|NCT00811070|710302|P2|STARTED|Overall Study||7
294626|NCT00811070|710303|P1|STARTED|Overall Study||7
294627|NCT00811057|710363|P3|NOT COMPLETED|Overall Study||10
294628|NCT00811057|710364|P2|NOT COMPLETED|Overall Study||10
294629|NCT00811057|710365|P1|NOT COMPLETED|Overall Study||5
294630|NCT00811057|710363|P3|COMPLETED|Overall Study||87
294631|NCT00811057|710364|P2|COMPLETED|Overall Study||104
294632|NCT00811057|710365|P1|COMPLETED|Overall Study||85
294633|NCT00811057|710363|P3|STARTED|Overall Study||97
294634|NCT00811057|710364|P2|STARTED|Overall Study||114
294635|NCT00811057|710365|P1|STARTED|Overall Study||90
294636|NCT00811018|710376|P1|NOT COMPLETED|Overall Study||968
294637|NCT00811018|710376|P1|COMPLETED|Overall Study||224
294638|NCT00811018|710376|P1|STARTED|Overall Study||1192
294639|NCT00810901|710394|P2|NOT COMPLETED|Overall Study||58
294640|NCT00810901|710395|P1|NOT COMPLETED|Overall Study||88
294641|NCT00810901|710394|P2|COMPLETED|Overall Study||118
294642|NCT00810901|710395|P1|COMPLETED|Overall Study||165
294643|NCT00810901|710394|P2|6-month Follow-up|Overall Study||122
294644|NCT00810901|710395|P1|6-month Follow-up|Overall Study||181
294645|NCT00810901|710394|P2|1-month Follow up|Overall Study||146
294646|NCT00810901|710395|P1|1-month Follow up|Overall Study||242
294647|NCT00810901|710394|P2|STARTED|Overall Study||176
294648|NCT00810901|710395|P1|STARTED|Overall Study||253
294649|NCT00810888|710406|P3|NOT COMPLETED|Overall Study||0
294650|NCT00810888|710407|P2|NOT COMPLETED|Overall Study||0
294651|NCT00810888|710408|P1|NOT COMPLETED|Overall Study||0
294652|NCT00810888|710406|P3|COMPLETED|Overall Study||73
294653|NCT00810888|710407|P2|COMPLETED|Overall Study||9
294654|NCT00810888|710408|P1|COMPLETED|Overall Study||10
294655|NCT00810888|710406|P3|STARTED|Overall Study||73
294656|NCT00810888|710407|P2|STARTED|Overall Study||9
294657|NCT00810888|710408|P1|STARTED|Overall Study||10
294658|NCT00810810|710441|P4|NOT COMPLETED|Overall Study||13
294659|NCT00810810|710442|P3|NOT COMPLETED|Overall Study||11
294660|NCT00810810|710443|P2|NOT COMPLETED|Overall Study||11
294661|NCT00810810|710444|P1|NOT COMPLETED|Overall Study||0
294662|NCT00810810|710441|P4|COMPLETED|Overall Study||38
294663|NCT00810810|710442|P3|COMPLETED|Overall Study||45
294664|NCT00810810|710443|P2|COMPLETED|Overall Study||38
294665|NCT00810810|710444|P1|COMPLETED|Overall Study||124
294666|NCT00810810|710441|P4|STARTED|Overall Study||51
294667|NCT00810810|710442|P3|STARTED|Overall Study||56
294668|NCT00810810|710443|P2|STARTED|Overall Study||49
294669|NCT00810810|710444|P1|STARTED|Overall Study||124
294670|NCT00810771|710461|P3|NOT COMPLETED|Overall Study||0
294671|NCT00810771|710462|P2|NOT COMPLETED|Overall Study||0
294672|NCT00810771|710463|P1|NOT COMPLETED|Overall Study||0
294673|NCT00810771|710461|P3|COMPLETED|Overall Study||84
294674|NCT00810771|710462|P2|COMPLETED|Overall Study||234
294675|NCT00810771|710463|P1|COMPLETED|Overall Study||232
294676|NCT00810771|710461|P3|STARTED|Overall Study||84
294677|NCT00810771|710462|P2|STARTED|Overall Study||234
294678|NCT00810771|710463|P1|STARTED|Overall Study||232
294679|NCT00810719|710483|P1|NOT COMPLETED|Overall Study||0
294680|NCT00810719|710483|P1|COMPLETED|Overall Study||30
294681|NCT00810719|710483|P1|STARTED|Overall Study||30
294682|NCT00810693|710492|P3|NOT COMPLETED|Follow-up Period (FUP)||4
294683|NCT00810693|710493|P2|NOT COMPLETED|Follow-up Period (FUP)||3
294684|NCT00810693|710494|P1|NOT COMPLETED|Follow-up Period (FUP)||8
294685|NCT00810693|710492|P3|COMPLETED|Follow-up Period (FUP)||12
294686|NCT00810693|710493|P2|COMPLETED|Follow-up Period (FUP)||4
294687|NCT00810693|710494|P1|COMPLETED|Follow-up Period (FUP)||15
294688|NCT00810693|710492|P3|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|16
294689|NCT00810693|710493|P2|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|7
294690|NCT00810693|710494|P1|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|23
294691|NCT00810693|710492|P3|NOT COMPLETED|Treatment Period||16
294692|NCT00810693|710493|P2|NOT COMPLETED|Treatment Period||7
294693|NCT00810693|710494|P1|NOT COMPLETED|Treatment Period||17
294694|NCT00810693|710492|P3|COMPLETED|Treatment Period||111
294695|NCT00810693|710493|P2|COMPLETED|Treatment Period||57
294696|NCT00810693|710494|P1|COMPLETED|Treatment Period||237
294697|NCT00810693|710492|P3|Participants Received Treatment|Treatment Period||126
294698|NCT00810693|710493|P2|Participants Received Treatment|Treatment Period||63
294699|NCT00810693|710494|P1|Participants Received Treatment|Treatment Period||254
294700|NCT00810693|710492|P3|STARTED|Treatment Period|1 randomized but not treated|127
294701|NCT00810693|710493|P2|STARTED|Treatment Period|1 randomized but not treated|64
294702|NCT00810693|710494|P1|STARTED|Treatment Period||254
294703|NCT00810641|710526|P3|NOT COMPLETED|Overall Study||2
294704|NCT00810641|710527|P2|NOT COMPLETED|Overall Study||1
294705|NCT00810641|710528|P1|NOT COMPLETED|Overall Study||0
294706|NCT00810641|710526|P3|COMPLETED|Overall Study||49
294707|NCT00810641|710527|P2|COMPLETED|Overall Study||53
294708|NCT00810641|710528|P1|COMPLETED|Overall Study||52
294709|NCT00810641|710526|P3|STARTED|Overall Study||51
294710|NCT00810641|710527|P2|STARTED|Overall Study||54
294711|NCT00810641|710528|P1|STARTED|Overall Study||52
294712|NCT00810615|710538|P2|NOT COMPLETED|Overall Study||1
294713|NCT00810615|710539|P1|NOT COMPLETED|Overall Study||1
294714|NCT00810615|710538|P2|COMPLETED|Overall Study|One male withdrawal due to personal reasons.|24
294715|NCT00810615|710539|P1|COMPLETED|Overall Study|One male withdrawal due to personal reasons.|24
294716|NCT00810615|710538|P2|STARTED|Overall Study||25
294717|NCT00810615|710539|P1|STARTED|Overall Study||25
294718|NCT00810602|710589|P2|NOT COMPLETED|Overall Study||3
294719|NCT00810602|710590|P1|NOT COMPLETED|Overall Study||8
294720|NCT00810602|710589|P2|COMPLETED|Overall Study||31
294721|NCT00810602|710590|P1|COMPLETED|Overall Study||19
294722|NCT00810602|710589|P2|STARTED|Overall Study||34
294723|NCT00810602|710590|P1|STARTED|Overall Study||27
294724|NCT00810576|710597|P1|NOT COMPLETED|Overall Study||0
294725|NCT00810576|710597|P1|COMPLETED|Overall Study||1
294726|NCT00810576|710597|P1|STARTED|Overall Study||1
294727|NCT00810511|710603|P2|NOT COMPLETED|Overall Study||4
294728|NCT00810511|710604|P1|NOT COMPLETED|Overall Study||10
294729|NCT00810511|710603|P2|COMPLETED|Overall Study||102
294730|NCT00810511|710604|P1|COMPLETED|Overall Study||97
294731|NCT00810511|710603|P2|STARTED|Overall Study||106
294732|NCT00810511|710604|P1|STARTED|Overall Study||107
294733|NCT00810446|710610|P1|NOT COMPLETED|Overall Study||0
294734|NCT00810446|710610|P1|COMPLETED|Overall Study||72
294735|NCT00810446|710610|P1|STARTED|Overall Study||72
294736|NCT00810407|710622|P1|NOT COMPLETED|Overall Study||6
294737|NCT00810407|710622|P1|COMPLETED|Overall Study||588
294738|NCT00810407|710622|P1|STARTED|Overall Study||594
294739|NCT00810394|710634|P1|NOT COMPLETED|Overall Study||3
294740|NCT00810394|710634|P1|COMPLETED|Overall Study||47
294741|NCT00810394|710634|P1|Cycle 3 400mg Twice Daily|Overall Study||5
294742|NCT00810394|710634|P1|Cycle 3 800 mg Twice Daily|Overall Study||4
294743|NCT00810394|710634|P1|Cycle 2 400mg Once Daily|Overall Study||22
294744|NCT00810394|710634|P1|Cycle 2 600mg Twice Daily|Overall Study||13
294745|NCT00810394|710634|P1|STARTED|Overall Study||50
294746|NCT00810368|710642|P2|NOT COMPLETED|Overall Study||2
294747|NCT00810368|710643|P1|NOT COMPLETED|Overall Study||6
294748|NCT00810368|710642|P2|COMPLETED|Overall Study||13
294749|NCT00810368|710643|P1|COMPLETED|Overall Study||12
294750|NCT00810368|710642|P2|STARTED|Overall Study||15
294751|NCT00810368|710643|P1|STARTED|Overall Study||18
294752|NCT00810355|710664|P3|NOT COMPLETED|Overall Study||11
294753|NCT00810355|710665|P2|NOT COMPLETED|Overall Study||17
294754|NCT00810355|710666|P1|NOT COMPLETED|Overall Study||14
294755|NCT00810355|710664|P3|COMPLETED|Overall Study||14
294756|NCT00810355|710665|P2|COMPLETED|Overall Study||8
294757|NCT00810355|710666|P1|COMPLETED|Overall Study||11
294758|NCT00810355|710664|P3|STARTED|Overall Study||25
294759|NCT00810355|710665|P2|STARTED|Overall Study||25
294760|NCT00810355|710666|P1|STARTED|Overall Study||25
294761|NCT00810342|710682|P2|NOT COMPLETED|12-month Followup||11
294762|NCT00810342|710683|P1|NOT COMPLETED|12-month Followup||12
294763|NCT00810342|710682|P2|COMPLETED|12-month Followup||136
294764|NCT00810342|710683|P1|COMPLETED|12-month Followup||113
294765|NCT00810342|710682|P2|STARTED|12-month Followup||147
294766|NCT00810342|710683|P1|STARTED|12-month Followup||125
294767|NCT00810342|710682|P2|NOT COMPLETED|6-month Follow-up||8
294768|NCT00810342|710683|P1|NOT COMPLETED|6-month Follow-up||24
294769|NCT00810342|710682|P2|COMPLETED|6-month Follow-up||147
294770|NCT00810342|710683|P1|COMPLETED|6-month Follow-up||125
294771|NCT00810342|710682|P2|STARTED|6-month Follow-up||155
294772|NCT00810342|710683|P1|STARTED|6-month Follow-up||149
294773|NCT00810342|710682|P2|NOT COMPLETED|Month 1 Follow-up||2
294774|NCT00810342|710683|P1|NOT COMPLETED|Month 1 Follow-up||5
294775|NCT00810342|710682|P2|COMPLETED|Month 1 Follow-up||155
294776|NCT00810342|710683|P1|COMPLETED|Month 1 Follow-up||149
294777|NCT00810342|710682|P2|STARTED|Month 1 Follow-up||157
294778|NCT00810342|710683|P1|STARTED|Month 1 Follow-up||154
294779|NCT00810303|710691|P1|NOT COMPLETED|Ezetimibe and Efavirenz - Day 21-30||0
294780|NCT00810303|710691|P1|COMPLETED|Ezetimibe and Efavirenz - Day 21-30||12
294781|NCT00810303|710691|P1|STARTED|Ezetimibe and Efavirenz - Day 21-30||12
294782|NCT00810303|710691|P1|NOT COMPLETED|Ezetimibe and Efavirenz - Day 16-20||0
294783|NCT00810303|710691|P1|COMPLETED|Ezetimibe and Efavirenz - Day 16-20||12
294784|NCT00810303|710691|P1|STARTED|Ezetimibe and Efavirenz - Day 16-20||12
294785|NCT00810303|710691|P1|NOT COMPLETED|Ezetimibe Alone - Day 6-15||0
294786|NCT00810303|710691|P1|COMPLETED|Ezetimibe Alone - Day 6-15||12
294787|NCT00810303|710691|P1|STARTED|Ezetimibe Alone - Day 6-15||12
294788|NCT00810303|710691|P1|NOT COMPLETED|Efavirenz Alone - Day 1-5||0
294789|NCT00810303|710691|P1|COMPLETED|Efavirenz Alone - Day 1-5||12
294790|NCT00810303|710691|P1|STARTED|Efavirenz Alone - Day 1-5||12
294791|NCT00810277|710716|P1|NOT COMPLETED|Overall Study||1
294792|NCT00810277|710716|P1|COMPLETED|Overall Study||13
294793|NCT00810277|710716|P1|STARTED|Overall Study||14
294794|NCT00810264|710729|P1|NOT COMPLETED|Overall Study||1553
294795|NCT00810264|710729|P1|COMPLETED|Overall Study||946
294796|NCT00810264|710729|P1|STARTED|Overall Study||2499
294797|NCT00810199|710756|P2|NOT COMPLETED|Overall Study||82
294798|NCT00810199|710757|P1|NOT COMPLETED|Overall Study||59
294799|NCT00810199|710756|P2|COMPLETED|Overall Study|Completed=Completed Treatment|195
294800|NCT00810199|710757|P1|COMPLETED|Overall Study||220
294801|NCT00810199|710756|P2|Completed Week 104|Overall Study||201
294802|NCT00810199|710757|P1|Completed Week 104|Overall Study||222
294803|NCT00810199|710756|P2|Completed Week 52|Overall Study||229
294804|NCT00810199|710757|P1|Completed Week 52|Overall Study||243
294805|NCT00810199|710756|P2|Completed Week 24|Overall Study||250
294806|NCT00810199|710757|P1|Completed Week 24|Overall Study||259
294807|NCT00810199|710756|P2|Received Study Drug|Overall Study||276
294808|NCT00810199|710757|P1|Received Study Drug|Overall Study||277
294809|NCT00810199|710756|P2|STARTED|Overall Study||277
294810|NCT00810199|710757|P1|STARTED|Overall Study||279
294811|NCT00810108|710835|P2|NOT COMPLETED|Overall Study||0
294812|NCT00810108|710836|P1|NOT COMPLETED|Overall Study||1
294813|NCT00810108|710835|P2|COMPLETED|Overall Study||7
294814|NCT00810108|710836|P1|COMPLETED|Overall Study||5
294815|NCT00810108|710835|P2|STARTED|Overall Study||7
294816|NCT00810108|710836|P1|STARTED|Overall Study||6
294817|NCT00810095|710841|P1|NOT COMPLETED|Overall Study||0
294818|NCT00810095|710841|P1|COMPLETED|Overall Study||40
294819|NCT00810095|710841|P1|STARTED|Overall Study||40
294820|NCT00810082|710850|P2|NOT COMPLETED|Overall Study||4
294821|NCT00810082|710851|P1|NOT COMPLETED|Overall Study||0
294822|NCT00810082|710850|P2|COMPLETED|Overall Study||27
294823|NCT00810082|710851|P1|COMPLETED|Overall Study||34
294824|NCT00810082|710850|P2|STARTED|Overall Study||31
294825|NCT00810082|710851|P1|STARTED|Overall Study||34
294826|NCT00810069|710859|P3|NOT COMPLETED|Double-Blind Period II||72
294827|NCT00810069|710860|P2|NOT COMPLETED|Double-Blind Period II||56
294828|NCT00810069|710861|P1|NOT COMPLETED|Double-Blind Period II||0
294829|NCT00810069|710859|P3|COMPLETED|Double-Blind Period II||212
294830|NCT00810069|710860|P2|COMPLETED|Double-Blind Period II||226
294831|NCT00810069|710861|P1|COMPLETED|Double-Blind Period II||0
294832|NCT00810069|710859|P3|STARTED|Double-Blind Period II|At Week 8 - delayed intervention divided by response to treatment (nonresponders or responders).|284
294833|NCT00810069|710860|P2|STARTED|Double-Blind Period II||282
294834|NCT00810069|710861|P1|STARTED|Double-Blind Period II||0
294835|NCT00810069|710859|P3|NOT COMPLETED|Lead-in Period I||0
294836|NCT00810069|710860|P2|NOT COMPLETED|Lead-in Period I||0
294837|NCT00810069|710861|P1|NOT COMPLETED|Lead-in Period I||274
294838|NCT00810069|710859|P3|COMPLETED|Lead-in Period I||0
294839|NCT00810069|710860|P2|COMPLETED|Lead-in Period I||0
294840|NCT00810069|710861|P1|COMPLETED|Lead-in Period I||566
294841|NCT00810069|710859|P3|STARTED|Lead-in Period I||0
294842|NCT00810069|710860|P2|STARTED|Lead-in Period I||0
294843|NCT00810069|710861|P1|STARTED|Lead-in Period I||840
294844|NCT00810043|710906|P3|NOT COMPLETED|Overall Study||8
294845|NCT00810043|710907|P2|NOT COMPLETED|Overall Study||1
294846|NCT00810043|710908|P1|NOT COMPLETED|Overall Study||4
294847|NCT00810043|710906|P3|COMPLETED|Overall Study||0
294848|NCT00810043|710907|P2|COMPLETED|Overall Study||54
294849|NCT00810043|710908|P1|COMPLETED|Overall Study||53
294850|NCT00810043|710906|P3|STARTED|Overall Study||8
294851|NCT00810043|710907|P2|STARTED|Overall Study||55
294852|NCT00810043|710908|P1|STARTED|Overall Study||57
294853|NCT00809965|710930|P3|NOT COMPLETED|Overall Study||844
294854|NCT00809965|710931|P2|NOT COMPLETED|Overall Study||775
294855|NCT00809965|710932|P1|NOT COMPLETED|Overall Study||783
294856|NCT00809965|710930|P3|COMPLETED|Overall Study||4332
294857|NCT00809965|710931|P2|COMPLETED|Overall Study||4399
294858|NCT00809965|710932|P1|COMPLETED|Overall Study||4393
294859|NCT00809965|710930|P3|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5115
294860|NCT00809965|710931|P2|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5114
294861|NCT00809965|710932|P1|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5113
294862|NCT00809965|710930|P3|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5110
294863|NCT00809965|710931|P2|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5115
294864|NCT00809965|710932|P1|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5125
294865|NCT00809965|710930|P3|STARTED|Overall Study||5176
294866|NCT00809965|710931|P2|STARTED|Overall Study||5174
294867|NCT00809965|710932|P1|STARTED|Overall Study||5176
294868|NCT00809926|710954|P2|NOT COMPLETED|Overall Study||23
294869|NCT00809926|710955|P1|NOT COMPLETED|Overall Study||31
294870|NCT00809926|710954|P2|COMPLETED|Overall Study||196
294871|NCT00809926|710955|P1|COMPLETED|Overall Study||201
294872|NCT00809926|710954|P2|STARTED|Overall Study||219
294873|NCT00809926|710955|P1|STARTED|Overall Study||232
294874|NCT00809848|710984|P5|NOT COMPLETED|Overall Study||3
294875|NCT00809848|710985|P4|NOT COMPLETED|Overall Study||1
294876|NCT00809848|710986|P3|NOT COMPLETED|Overall Study||0
294877|NCT00809848|710987|P2|NOT COMPLETED|Overall Study||0
294878|NCT00809848|710988|P1|NOT COMPLETED|Overall Study||0
294879|NCT00809848|710984|P5|COMPLETED|Overall Study||34
294880|NCT00809848|710985|P4|COMPLETED|Overall Study||30
294881|NCT00809848|710986|P3|COMPLETED|Overall Study||34
294882|NCT00809848|710987|P2|COMPLETED|Overall Study||34
294883|NCT00809848|710988|P1|COMPLETED|Overall Study||36
294884|NCT00809848|710984|P5|STARTED|Overall Study||37
294885|NCT00809848|710985|P4|STARTED|Overall Study||31
294886|NCT00809848|710986|P3|STARTED|Overall Study||34
294887|NCT00809848|710987|P2|STARTED|Overall Study||34
294888|NCT00809848|710988|P1|STARTED|Overall Study||36
294889|NCT00809835|711009|P4|NOT COMPLETED|Overall Study||2
294890|NCT00809835|711010|P3|NOT COMPLETED|Overall Study||11
294891|NCT00809835|711011|P2|NOT COMPLETED|Overall Study||7
294892|NCT00809835|711012|P1|NOT COMPLETED|Overall Study||8
294893|NCT00809835|711009|P4|COMPLETED|Overall Study||25
294894|NCT00809835|711010|P3|COMPLETED|Overall Study||27
294895|NCT00809835|711011|P2|COMPLETED|Overall Study||20
294896|NCT00809835|711012|P1|COMPLETED|Overall Study||20
294897|NCT00809835|711009|P4|STARTED|Overall Study||27
294898|NCT00809835|711010|P3|STARTED|Overall Study||38
294899|NCT00809835|711011|P2|STARTED|Overall Study||27
294900|NCT00809835|711012|P1|STARTED|Overall Study||28
294901|NCT00809809|711032|P2|NOT COMPLETED|Overall Study||2
294902|NCT00809809|711033|P1|NOT COMPLETED|Overall Study||3
294903|NCT00809809|711032|P2|COMPLETED|Overall Study|2 dropped from the study when it was discovered they met the exclusion criteria|77
294904|NCT00809809|711033|P1|COMPLETED|Overall Study|3 dropped from the study when it was discovered they met the exclusion criteria|75
294905|NCT00809809|711032|P2|STARTED|Overall Study||79
294906|NCT00809809|711033|P1|STARTED|Overall Study||78
294907|NCT00809757|711042|P3|NOT COMPLETED|Overall Study||11
294908|NCT00809757|711043|P2|NOT COMPLETED|Overall Study||5
294909|NCT00809757|711044|P1|NOT COMPLETED|Overall Study||6
294910|NCT00809757|711042|P3|COMPLETED|Overall Study||53
294911|NCT00809757|711043|P2|COMPLETED|Overall Study||60
294912|NCT00809757|711044|P1|COMPLETED|Overall Study||62
294913|NCT00809757|711042|P3|STARTED|Overall Study||64
294914|NCT00809757|711043|P2|STARTED|Overall Study||65
294915|NCT00809757|711044|P1|STARTED|Overall Study||68
294916|NCT00809614|711129|P2|NOT COMPLETED|Overall Study||4
294917|NCT00809614|711130|P1|NOT COMPLETED|Overall Study||3
294918|NCT00809614|711129|P2|COMPLETED|Overall Study||10
294919|NCT00809614|711130|P1|COMPLETED|Overall Study||25
294920|NCT00809614|711129|P2|Pharmacodynamic (PD) Set|Overall Study||13
294921|NCT00809614|711130|P1|Pharmacodynamic (PD) Set|Overall Study||24
294922|NCT00809614|711129|P2|Pharmacokinetic Safety Set|Overall Study||14
294923|NCT00809614|711130|P1|Pharmacokinetic Safety Set|Overall Study||27
294924|NCT00809614|711129|P2|STARTED|Overall Study||14
294925|NCT00809614|711130|P1|STARTED|Overall Study||28
294926|NCT00809523|711160|P2|NOT COMPLETED|Overall Study||4
294927|NCT00809523|711161|P1|NOT COMPLETED|Overall Study||7
294928|NCT00809523|711160|P2|COMPLETED|Overall Study||48
294929|NCT00809523|711161|P1|COMPLETED|Overall Study||47
294930|NCT00809523|711160|P2|STARTED|Overall Study||52
294931|NCT00809523|711161|P1|STARTED|Overall Study||54
294932|NCT00809471|711174|P3|NOT COMPLETED|Overall Study||17
294933|NCT00809471|711175|P2|NOT COMPLETED|Overall Study||20
294934|NCT00809471|711176|P1|NOT COMPLETED|Overall Study||20
294935|NCT00809471|711174|P3|COMPLETED|Overall Study||114
294936|NCT00809471|711175|P2|COMPLETED|Overall Study||109
294937|NCT00809471|711176|P1|COMPLETED|Overall Study||110
294938|NCT00809471|711174|P3|STARTED|Overall Study||131
294939|NCT00809471|711175|P2|STARTED|Overall Study||129
294940|NCT00809471|711176|P1|STARTED|Overall Study||130
294941|NCT00809458|711192|P2|NOT COMPLETED|Overall Study||1
294942|NCT00809458|711193|P1|NOT COMPLETED|Overall Study||1
294943|NCT00809458|711192|P2|COMPLETED|Overall Study||5
294944|NCT00809458|711193|P1|COMPLETED|Overall Study||8
294945|NCT00809458|711192|P2|STARTED|Overall Study||6
294946|NCT00809458|711193|P1|STARTED|Overall Study||9
294947|NCT00809445|711206|P3|NOT COMPLETED|6 Month Follow-up||24
294948|NCT00809445|711207|P2|NOT COMPLETED|6 Month Follow-up||23
294949|NCT00809445|711208|P1|NOT COMPLETED|6 Month Follow-up||24
294950|NCT00809445|711206|P3|COMPLETED|6 Month Follow-up||395
294951|NCT00809445|711207|P2|COMPLETED|6 Month Follow-up||410
294952|NCT00809445|711208|P1|COMPLETED|6 Month Follow-up||405
294953|NCT00809445|711206|P3|STARTED|6 Month Follow-up||419
294954|NCT00809445|711207|P2|STARTED|6 Month Follow-up||433
294955|NCT00809445|711208|P1|STARTED|6 Month Follow-up||429
294956|NCT00809445|711206|P3|NOT COMPLETED|1 Month Follow-up||4
294957|NCT00809445|711207|P2|NOT COMPLETED|1 Month Follow-up||4
294958|NCT00809445|711208|P1|NOT COMPLETED|1 Month Follow-up||2
294959|NCT00809445|711206|P3|COMPLETED|1 Month Follow-up||415
294960|NCT00809445|711207|P2|COMPLETED|1 Month Follow-up||429
294961|NCT00809445|711208|P1|COMPLETED|1 Month Follow-up||427
294962|NCT00809445|711206|P3|STARTED|1 Month Follow-up||419
294963|NCT00809445|711207|P2|STARTED|1 Month Follow-up||433
294964|NCT00809445|711208|P1|STARTED|1 Month Follow-up||429
294965|NCT00809341|711227|P2|NOT COMPLETED|Overall Study||1
294966|NCT00809341|711228|P1|NOT COMPLETED|Overall Study||0
294967|NCT00809341|711227|P2|COMPLETED|Overall Study||4
294968|NCT00809341|711228|P1|COMPLETED|Overall Study||20
294969|NCT00809341|711227|P2|STARTED|Overall Study||5
294970|NCT00809341|711228|P1|STARTED|Overall Study||20
294971|NCT00809328|711236|P1|NOT COMPLETED|Overall Study||29
294972|NCT00809328|711236|P1|COMPLETED|Overall Study||73
294973|NCT00809328|711236|P1|STARTED|Overall Study||102
294974|NCT00809276|711244|P1|NOT COMPLETED|Overall Study||0
294975|NCT00809276|711244|P1|COMPLETED|Overall Study||92
294976|NCT00809276|711244|P1|STARTED|Overall Study||92
294977|NCT00809185|711248|P1|NOT COMPLETED|Overall Study||0
294978|NCT00809185|711248|P1|COMPLETED|Overall Study||7
294979|NCT00809185|711248|P1|STARTED|Overall Study||7
294980|NCT00809159|711258|P6|NOT COMPLETED|Part 1 and 2||3
294981|NCT00809159|711259|P5|NOT COMPLETED|Part 1 and 2||6
294982|NCT00809159|711260|P4|NOT COMPLETED|Part 1 and 2||5
294983|NCT00809159|711261|P3|NOT COMPLETED|Part 1 and 2||10
294984|NCT00809159|711262|P2|NOT COMPLETED|Part 1 and 2||0
294985|NCT00809159|711263|P1|NOT COMPLETED|Part 1 and 2||0
294986|NCT00809159|711258|P6|COMPLETED|Part 1 and 2||3
294987|NCT00809159|711259|P5|COMPLETED|Part 1 and 2||6
294988|NCT00809159|711260|P4|COMPLETED|Part 1 and 2||7
294989|NCT00809159|711261|P3|COMPLETED|Part 1 and 2||20
294990|NCT00809159|711262|P2|COMPLETED|Part 1 and 2||0
294991|NCT00809159|711263|P1|COMPLETED|Part 1 and 2||0
294992|NCT00809159|711258|P6|PD Analysis Set|Part 1 and 2||6
294993|NCT00809159|711259|P5|PD Analysis Set|Part 1 and 2||12
294994|NCT00809159|711260|P4|PD Analysis Set|Part 1 and 2||12
294995|NCT00809159|711261|P3|PD Analysis Set|Part 1 and 2||28
294996|NCT00809159|711262|P2|PD Analysis Set|Part 1 and 2||0
294997|NCT00809159|711263|P1|PD Analysis Set|Part 1 and 2||0
294998|NCT00809159|711258|P6|PK Analysis Set|Part 1 and 2||6
294999|NCT00809159|711259|P5|PK Analysis Set|Part 1 and 2||12
295000|NCT00809159|711260|P4|PK Analysis Set|Part 1 and 2||12
295001|NCT00809159|711261|P3|PK Analysis Set|Part 1 and 2||30
295002|NCT00809159|711262|P2|PK Analysis Set|Part 1 and 2||0
295003|NCT00809159|711263|P1|PK Analysis Set|Part 1 and 2||0
295004|NCT00809159|711258|P6|STARTED|Part 1 and 2||6
295005|NCT00809159|711259|P5|STARTED|Part 1 and 2||12
295006|NCT00809159|711260|P4|STARTED|Part 1 and 2||12
295007|NCT00809159|711261|P3|STARTED|Part 1 and 2||30
295008|NCT00809159|711262|P2|STARTED|Part 1 and 2||0
295009|NCT00809159|711263|P1|STARTED|Part 1 and 2||0
295010|NCT00809159|711258|P6|NOT COMPLETED|Part 1||0
295011|NCT00809159|711259|P5|NOT COMPLETED|Part 1||0
295012|NCT00809159|711260|P4|NOT COMPLETED|Part 1||0
295013|NCT00809159|711261|P3|NOT COMPLETED|Part 1||0
295014|NCT00809159|711262|P2|NOT COMPLETED|Part 1||3
295015|NCT00809159|711263|P1|NOT COMPLETED|Part 1||8
295016|NCT00809159|711258|P6|COMPLETED|Part 1||0
295017|NCT00809159|711259|P5|COMPLETED|Part 1||0
295018|NCT00809159|711260|P4|COMPLETED|Part 1||0
295019|NCT00809159|711261|P3|COMPLETED|Part 1||0
295020|NCT00809159|711262|P2|COMPLETED|Part 1||3
295021|NCT00809159|711263|P1|COMPLETED|Part 1||16
295022|NCT00809159|711258|P6|PD Analysis Set|Part 1||0
295023|NCT00809159|711259|P5|PD Analysis Set|Part 1||0
295024|NCT00809159|711260|P4|PD Analysis Set|Part 1||0
295025|NCT00809159|711261|P3|PD Analysis Set|Part 1||0
295026|NCT00809159|711262|P2|PD Analysis Set|Part 1||6
295027|NCT00809159|711263|P1|PD Analysis Set|Part 1||23
295028|NCT00809159|711258|P6|PK Analysis Set|Part 1||0
295029|NCT00809159|711259|P5|PK Analysis Set|Part 1||0
295030|NCT00809159|711260|P4|PK Analysis Set|Part 1||0
295031|NCT00809159|711261|P3|PK Analysis Set|Part 1||0
295032|NCT00809159|711262|P2|PK Analysis Set|Part 1||6
295033|NCT00809159|711263|P1|PK Analysis Set|Part 1||24
295034|NCT00809159|711258|P6|STARTED|Part 1||0
295035|NCT00809159|711259|P5|STARTED|Part 1||0
295036|NCT00809159|711260|P4|STARTED|Part 1||0
295037|NCT00809159|711261|P3|STARTED|Part 1||0
295038|NCT00809159|711262|P2|STARTED|Part 1||6
295039|NCT00809159|711263|P1|STARTED|Part 1||24
295040|NCT00809146|711329|P2|NOT COMPLETED|Overall Study||0
295041|NCT00809146|711330|P1|NOT COMPLETED|Overall Study||0
295042|NCT00809146|711329|P2|COMPLETED|Overall Study||445
295043|NCT00809146|711330|P1|COMPLETED|Overall Study||448
295044|NCT00809146|711329|P2|STARTED|Overall Study||445
295045|NCT00809146|711330|P1|STARTED|Overall Study||448
295046|NCT00809133|711368|P14|NOT COMPLETED|Overall Study||7
295047|NCT00809133|711369|P13|NOT COMPLETED|Overall Study||5
295048|NCT00809133|711370|P12|NOT COMPLETED|Overall Study||8
295049|NCT00809133|711371|P11|NOT COMPLETED|Overall Study||6
295050|NCT00809133|711372|P10|NOT COMPLETED|Overall Study||9
295051|NCT00809133|711373|P9|NOT COMPLETED|Overall Study||3
295052|NCT00809133|711374|P8|NOT COMPLETED|Overall Study||8
295053|NCT00809133|711375|P7|NOT COMPLETED|Overall Study||6
295054|NCT00809133|711376|P6|NOT COMPLETED|Overall Study||7
295055|NCT00809133|711377|P5|NOT COMPLETED|Overall Study||5
295056|NCT00809133|711378|P4|NOT COMPLETED|Overall Study||3
295057|NCT00809133|711379|P3|NOT COMPLETED|Overall Study||6
295058|NCT00809133|711380|P2|NOT COMPLETED|Overall Study||7
295059|NCT00809133|711381|P1|NOT COMPLETED|Overall Study||3
295060|NCT00809133|711368|P14|COMPLETED|Overall Study||0
295061|NCT00809133|711369|P13|COMPLETED|Overall Study||0
295062|NCT00809133|711370|P12|COMPLETED|Overall Study||0
295063|NCT00809133|711371|P11|COMPLETED|Overall Study||0
295064|NCT00809133|711372|P10|COMPLETED|Overall Study||0
295065|NCT00809133|711373|P9|COMPLETED|Overall Study||0
295066|NCT00809133|711374|P8|COMPLETED|Overall Study||0
295067|NCT00809133|711375|P7|COMPLETED|Overall Study||0
295068|NCT00809133|711376|P6|COMPLETED|Overall Study||0
295069|NCT00809133|711377|P5|COMPLETED|Overall Study||0
295070|NCT00809133|711378|P4|COMPLETED|Overall Study||0
295071|NCT00809133|711379|P3|COMPLETED|Overall Study||0
295072|NCT00809133|711380|P2|COMPLETED|Overall Study||0
295073|NCT00809133|711381|P1|COMPLETED|Overall Study||0
295074|NCT00809133|711368|P14|STARTED|Overall Study||7
295075|NCT00809133|711369|P13|STARTED|Overall Study||5
295076|NCT00809133|711370|P12|STARTED|Overall Study||8
295077|NCT00809133|711371|P11|STARTED|Overall Study||6
295078|NCT00809133|711372|P10|STARTED|Overall Study||9
295079|NCT00809133|711373|P9|STARTED|Overall Study||3
295080|NCT00809133|711374|P8|STARTED|Overall Study||8
295081|NCT00809133|711375|P7|STARTED|Overall Study||6
295082|NCT00809133|711376|P6|STARTED|Overall Study||7
295083|NCT00809133|711377|P5|STARTED|Overall Study||5
295084|NCT00809133|711378|P4|STARTED|Overall Study||3
295085|NCT00809133|711379|P3|STARTED|Overall Study||6
295086|NCT00809133|711380|P2|STARTED|Overall Study||7
295087|NCT00809133|711381|P1|STARTED|Overall Study||3
295088|NCT00809094|711535|P2|NOT COMPLETED|Overall Study||1
295089|NCT00809094|711536|P1|NOT COMPLETED|Overall Study||0
295090|NCT00809094|711535|P2|COMPLETED|Overall Study||33
295091|NCT00809094|711536|P1|COMPLETED|Overall Study||36
295092|NCT00809094|711535|P2|STARTED|Overall Study||34
295093|NCT00809094|711536|P1|STARTED|Overall Study||36
295094|NCT00809055|711556|P2|NOT COMPLETED|Overall Study||7
295095|NCT00809055|711557|P1|NOT COMPLETED|Overall Study||9
295096|NCT00809055|711556|P2|COMPLETED|Overall Study||30
295097|NCT00809055|711557|P1|COMPLETED|Overall Study||28
295098|NCT00809055|711556|P2|STARTED|Overall Study||37
295099|NCT00809055|711557|P1|STARTED|Overall Study||37
295100|NCT00808899|711581|P1|NOT COMPLETED|Overall Study||4
295101|NCT00808899|711581|P1|COMPLETED|Overall Study||0
295102|NCT00808899|711581|P1|STARTED|Overall Study||4
295103|NCT00808834|711585|P2|NOT COMPLETED|Period 2||0
295104|NCT00808834|711586|P1|NOT COMPLETED|Period 2||0
295105|NCT00808834|711585|P2|COMPLETED|Period 2||99
295106|NCT00808834|711586|P1|COMPLETED|Period 2||97
295107|NCT00808834|711585|P2|STARTED|Period 2||99
295108|NCT00808834|711586|P1|STARTED|Period 2||97
295109|NCT00808834|711585|P2|NOT COMPLETED|Period 1||0
295110|NCT00808834|711586|P1|NOT COMPLETED|Period 1||0
295111|NCT00808834|711585|P2|COMPLETED|Period 1||99
295112|NCT00808834|711586|P1|COMPLETED|Period 1||97
295113|NCT00808834|711585|P2|STARTED|Period 1||99
295114|NCT00808834|711586|P1|STARTED|Period 1||97
295115|NCT00808808|711595|P3|NOT COMPLETED|Overall Study||2557
295116|NCT00808808|711596|P2|NOT COMPLETED|Overall Study||2437
295117|NCT00808808|711597|P1|NOT COMPLETED|Overall Study||2817
295118|NCT00808808|711595|P3|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1830
295119|NCT00808808|711596|P2|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1320
295120|NCT00808808|711597|P1|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1261
295121|NCT00808808|711595|P3|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|2132
295122|NCT00808808|711596|P2|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1489
295123|NCT00808808|711597|P1|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1392
295124|NCT00808808|711595|P3|STARTED|Overall Study|Started includes all employees at participating sites.|4387
295125|NCT00808808|711596|P2|STARTED|Overall Study|Started includes all employees at participating sites|3757
295126|NCT00808808|711597|P1|STARTED|Overall Study|Started includes all employees at participating sites.|4078
295127|NCT00808769|711623|P2|NOT COMPLETED|Second Intervention||0
295128|NCT00808769|711624|P1|NOT COMPLETED|Second Intervention||0
295129|NCT00808769|711623|P2|COMPLETED|Second Intervention||15
295130|NCT00808769|711624|P1|COMPLETED|Second Intervention||15
295131|NCT00808769|711623|P2|STARTED|Second Intervention||15
295132|NCT00808769|711624|P1|STARTED|Second Intervention||15
295133|NCT00808769|711623|P2|NOT COMPLETED|First Intervention||0
295134|NCT00808769|711624|P1|NOT COMPLETED|First Intervention||0
295135|NCT00808769|711623|P2|COMPLETED|First Intervention||15
295136|NCT00808769|711624|P1|COMPLETED|First Intervention||15
295137|NCT00808769|711623|P2|STARTED|First Intervention||15
295138|NCT00808769|711624|P1|STARTED|First Intervention||15
295139|NCT00808665|711632|P2|NOT COMPLETED|Overall Study||3
295140|NCT00808665|711633|P1|NOT COMPLETED|Overall Study||6
295141|NCT00808665|711632|P2|COMPLETED|Overall Study||29
295142|NCT00808665|711633|P1|COMPLETED|Overall Study||25
295143|NCT00808665|711632|P2|Completed Post Operative Doses|Overall Study||29
295144|NCT00808665|711633|P1|Completed Post Operative Doses|Overall Study||25
295145|NCT00808665|711632|P2|Completed Intra-operative Dose|Overall Study||32
295146|NCT00808665|711633|P1|Completed Intra-operative Dose|Overall Study||26
295147|NCT00808665|711632|P2|Medication Started|Overall Study||32
295148|NCT00808665|711633|P1|Medication Started|Overall Study||30
295149|NCT00808665|711632|P2|STARTED|Overall Study||32
295150|NCT00808665|711633|P1|STARTED|Overall Study||31
295151|NCT00808639|711639|P1|NOT COMPLETED|Overall Study||1
295152|NCT00808639|711639|P1|COMPLETED|Overall Study|One patient went off treatment due to disease progression before surgery.|38
295153|NCT00808639|711639|P1|STARTED|Overall Study||39
295154|NCT00808509|711647|P2|NOT COMPLETED|Observation Phase||0
295155|NCT00808509|711648|P1|NOT COMPLETED|Observation Phase||0
295156|NCT00808509|711647|P2|COMPLETED|Observation Phase||15
295157|NCT00808509|711648|P1|COMPLETED|Observation Phase||16
295158|NCT00808509|711647|P2|STARTED|Observation Phase|The observation phase was open to all participants|15
295159|NCT00808509|711648|P1|STARTED|Observation Phase|The observation phase was open to all participants|16
295160|NCT00808509|711647|P2|NOT COMPLETED|Randomized Phase||5
295161|NCT00808509|711648|P1|NOT COMPLETED|Randomized Phase||2
295162|NCT00808509|711647|P2|COMPLETED|Randomized Phase|Includes participants who received rescue therapy & follow-up for 12 weeks|11
295163|NCT00808509|711648|P1|COMPLETED|Randomized Phase||15
295164|NCT00808509|711647|P2|Received Rescue Therapy|Randomized Phase||9
295165|NCT00808509|711648|P1|Received Rescue Therapy|Randomized Phase||0
295166|NCT00808509|711647|P2|STARTED|Randomized Phase||16
295167|NCT00808509|711648|P1|STARTED|Randomized Phase||17
295168|NCT00808483|711746|P2|NOT COMPLETED|From 5 Months to 12 Months||0
295169|NCT00808483|711747|P1|NOT COMPLETED|From 5 Months to 12 Months||1
295170|NCT00808483|711746|P2|COMPLETED|From 5 Months to 12 Months||32
295171|NCT00808483|711747|P1|COMPLETED|From 5 Months to 12 Months||32
295172|NCT00808483|711746|P2|STARTED|From 5 Months to 12 Months||32
295173|NCT00808483|711747|P1|STARTED|From 5 Months to 12 Months||33
295174|NCT00808483|711746|P2|NOT COMPLETED|From 3 to 5 Months After Surgery||1
295175|NCT00808483|711747|P1|NOT COMPLETED|From 3 to 5 Months After Surgery||2
295176|NCT00808483|711746|P2|COMPLETED|From 3 to 5 Months After Surgery||32
295177|NCT00808483|711747|P1|COMPLETED|From 3 to 5 Months After Surgery||33
295178|NCT00808483|711746|P2|STARTED|From 3 to 5 Months After Surgery||33
295179|NCT00808483|711747|P1|STARTED|From 3 to 5 Months After Surgery||35
295180|NCT00808470|711769|P2|NOT COMPLETED|Overall Study||0
295181|NCT00808470|711770|P1|NOT COMPLETED|Overall Study||2
295182|NCT00808470|711769|P2|COMPLETED|Overall Study||35
295183|NCT00808470|711770|P1|COMPLETED|Overall Study||35
295184|NCT00808470|711769|P2|STARTED|Overall Study||35
295185|NCT00808470|711770|P1|STARTED|Overall Study||37
295186|NCT00808444|711784|P2|NOT COMPLETED|Overall Study||1
295187|NCT00808444|711785|P1|NOT COMPLETED|Overall Study||1
295188|NCT00808444|711784|P2|COMPLETED|Overall Study||232
295189|NCT00808444|711785|P1|COMPLETED|Overall Study||232
295190|NCT00808444|711784|P2|STARTED|Overall Study||233
295191|NCT00808444|711785|P1|STARTED|Overall Study||233
295192|NCT00808405|711825|P2|NOT COMPLETED|Overall Study||0
295193|NCT00808405|711826|P1|NOT COMPLETED|Overall Study||0
295194|NCT00808405|711825|P2|COMPLETED|Overall Study||27
295195|NCT00808405|711826|P1|COMPLETED|Overall Study||61
295196|NCT00808405|711825|P2|STARTED|Overall Study||27
295197|NCT00808405|711826|P1|STARTED|Overall Study||61
295198|NCT00808340|711834|P6|NOT COMPLETED|Third Intervention||0
295199|NCT00808340|711835|P5|NOT COMPLETED|Third Intervention||0
295200|NCT00808340|711836|P4|NOT COMPLETED|Third Intervention||0
295201|NCT00808340|711837|P3|NOT COMPLETED|Third Intervention||0
295202|NCT00808340|711838|P2|NOT COMPLETED|Third Intervention||0
295203|NCT00808340|711839|P1|NOT COMPLETED|Third Intervention||0
295204|NCT00808340|711834|P6|COMPLETED|Third Intervention||6
295205|NCT00808340|711835|P5|COMPLETED|Third Intervention||5
295206|NCT00808340|711836|P4|COMPLETED|Third Intervention||3
295207|NCT00808340|711837|P3|COMPLETED|Third Intervention||7
295208|NCT00808340|711838|P2|COMPLETED|Third Intervention||9
295209|NCT00808340|711839|P1|COMPLETED|Third Intervention||4
295210|NCT00808340|711834|P6|STARTED|Third Intervention||6
295211|NCT00808340|711835|P5|STARTED|Third Intervention||5
295212|NCT00808340|711836|P4|STARTED|Third Intervention||3
295213|NCT00808340|711837|P3|STARTED|Third Intervention||7
295214|NCT00808340|711838|P2|STARTED|Third Intervention||9
295215|NCT00808340|711839|P1|STARTED|Third Intervention||4
295216|NCT00808340|711834|P6|NOT COMPLETED|Second Intervention||0
295217|NCT00808340|711835|P5|NOT COMPLETED|Second Intervention||0
295218|NCT00808340|711836|P4|NOT COMPLETED|Second Intervention||0
295219|NCT00808340|711837|P3|NOT COMPLETED|Second Intervention||0
295220|NCT00808340|711838|P2|NOT COMPLETED|Second Intervention||0
295221|NCT00808340|711839|P1|NOT COMPLETED|Second Intervention||0
295222|NCT00808340|711834|P6|COMPLETED|Second Intervention||6
295223|NCT00808340|711835|P5|COMPLETED|Second Intervention||5
295224|NCT00808340|711836|P4|COMPLETED|Second Intervention||3
295225|NCT00808340|711837|P3|COMPLETED|Second Intervention||7
295226|NCT00808340|711838|P2|COMPLETED|Second Intervention||9
295227|NCT00808340|711839|P1|COMPLETED|Second Intervention||4
295228|NCT00808340|711834|P6|STARTED|Second Intervention||6
295229|NCT00808340|711835|P5|STARTED|Second Intervention||5
295230|NCT00808340|711836|P4|STARTED|Second Intervention||3
295231|NCT00808340|711837|P3|STARTED|Second Intervention||7
295232|NCT00808340|711838|P2|STARTED|Second Intervention||9
295233|NCT00808340|711839|P1|STARTED|Second Intervention||4
295234|NCT00808340|711834|P6|NOT COMPLETED|First Intervention||0
295235|NCT00808340|711835|P5|NOT COMPLETED|First Intervention||0
295236|NCT00808340|711836|P4|NOT COMPLETED|First Intervention||0
295237|NCT00808340|711837|P3|NOT COMPLETED|First Intervention||0
295238|NCT00808340|711838|P2|NOT COMPLETED|First Intervention||0
295239|NCT00808340|711839|P1|NOT COMPLETED|First Intervention||0
295240|NCT00808340|711834|P6|COMPLETED|First Intervention||6
295241|NCT00808340|711835|P5|COMPLETED|First Intervention||5
295242|NCT00808340|711836|P4|COMPLETED|First Intervention||3
295243|NCT00808340|711837|P3|COMPLETED|First Intervention||7
295244|NCT00808340|711838|P2|COMPLETED|First Intervention||9
295245|NCT00808340|711839|P1|COMPLETED|First Intervention||4
295246|NCT00808340|711834|P6|STARTED|First Intervention||6
295247|NCT00808340|711835|P5|STARTED|First Intervention||5
295248|NCT00808340|711836|P4|STARTED|First Intervention||3
295249|NCT00808340|711837|P3|STARTED|First Intervention||7
295250|NCT00808340|711838|P2|STARTED|First Intervention||9
295251|NCT00808340|711839|P1|STARTED|First Intervention||4
295252|NCT00808249|711860|P4|NOT COMPLETED|Overall Study||16
295253|NCT00808249|711861|P3|NOT COMPLETED|Overall Study||22
295254|NCT00808249|711862|P2|NOT COMPLETED|Overall Study||15
295255|NCT00808249|711863|P1|NOT COMPLETED|Overall Study||17
295256|NCT00808249|711860|P4|COMPLETED|Overall Study||90
295257|NCT00808249|711861|P3|COMPLETED|Overall Study||83
295258|NCT00808249|711862|P2|COMPLETED|Overall Study||91
295259|NCT00808249|711863|P1|COMPLETED|Overall Study||90
295260|NCT00808249|711860|P4|STARTED|Overall Study||106
295261|NCT00808249|711861|P3|STARTED|Overall Study||105
295262|NCT00808249|711862|P2|STARTED|Overall Study||106
295263|NCT00808249|711863|P1|STARTED|Overall Study||107
295264|NCT00808236|711891|P2|NOT COMPLETED|Overall Study||91
295265|NCT00808236|711892|P1|NOT COMPLETED|Overall Study||82
295266|NCT00808236|711891|P2|COMPLETED|Overall Study||13
295267|NCT00808236|711892|P1|COMPLETED|Overall Study||14
295268|NCT00808236|711891|P2|Admitted to Hospital|Overall Study|Died during transport to hospital(1)|42
295269|NCT00808236|711892|P1|Admitted to Hospital|Overall Study|Died during transport to hospital(2); DNAR determination was made at hospital(1)|30
295270|NCT00808236|711891|P2|Achieved ROSC|Overall Study||43
295271|NCT00808236|711892|P1|Achieved ROSC|Overall Study||33
295272|NCT00808236|711891|P2|Included in Analysis|Overall Study|Crossed over & withdrawn (1); Lost to Follow-Up: taken to non-participating hospital (1)|99
295273|NCT00808236|711892|P1|Included in Analysis|Overall Study|Lost to Follow-Up: taken to non-participating hospital (1)|83
295274|NCT00808236|711891|P2|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: Terminal(1); Asphyxia(1), In-hospital(1)|101
295275|NCT00808236|711892|P1|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: DNAR(4); had pulse(2); CVA(2); Drug OD(2); On home oxygen(1); Unwitnessed(1)|84
295276|NCT00808236|711891|P2|STARTED|Overall Study||104
295277|NCT00808236|711892|P1|STARTED|Overall Study||96
295278|NCT00808132|711925|P5|NOT COMPLETED|Overall Study||100
295279|NCT00808132|711926|P4|NOT COMPLETED|Overall Study||69
295280|NCT00808132|711927|P3|NOT COMPLETED|Overall Study||54
295281|NCT00808132|711928|P2|NOT COMPLETED|Overall Study||88
295282|NCT00808132|711929|P1|NOT COMPLETED|Overall Study||98
295283|NCT00808132|711925|P5|COMPLETED|Overall Study||383
295284|NCT00808132|711926|P4|COMPLETED|Overall Study||159
295285|NCT00808132|711927|P3|COMPLETED|Overall Study||185
295286|NCT00808132|711928|P2|COMPLETED|Overall Study||393
295287|NCT00808132|711929|P1|COMPLETED|Overall Study||357
295288|NCT00808132|711925|P5|Treated|Overall Study||474
295289|NCT00808132|711926|P4|Treated|Overall Study||220
295290|NCT00808132|711927|P3|Treated|Overall Study||230
295291|NCT00808132|711928|P2|Treated|Overall Study||474
295292|NCT00808132|711929|P1|Treated|Overall Study||445
295293|NCT00808132|711925|P5|STARTED|Overall Study||483
295294|NCT00808132|711926|P4|STARTED|Overall Study||228
295295|NCT00808132|711927|P3|STARTED|Overall Study||239
295296|NCT00808132|711928|P2|STARTED|Overall Study||481
295297|NCT00808132|711929|P1|STARTED|Overall Study||455
295298|NCT00808080|712001|P1|NOT COMPLETED|Overall Study||6
295299|NCT00808080|712001|P1|COMPLETED|Overall Study||0
295300|NCT00808080|712001|P1|STARTED|Overall Study||6
295301|NCT00808067|712008|P2|NOT COMPLETED|Overall Study||518
295302|NCT00808067|712009|P1|NOT COMPLETED|Overall Study||481
295303|NCT00808067|712008|P2|COMPLETED|Overall Study||2438
295304|NCT00808067|712009|P1|COMPLETED|Overall Study||2446
295305|NCT00808067|712008|P2|STARTED|Overall Study|Number of patients which are treated.|2956
295306|NCT00808067|712009|P1|STARTED|Overall Study|Number of patients which are treated.|2927
295307|NCT00808028|712045|P4|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||23
295308|NCT00808028|712046|P3|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||29
295309|NCT00808028|712047|P2|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||0
295310|NCT00808028|712048|P1|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||11
295311|NCT00808028|712045|P4|COMPLETED|Stage 2 (Followed up to 48 Months )||128
295312|NCT00808028|712046|P3|COMPLETED|Stage 2 (Followed up to 48 Months )||141
295313|NCT00808028|712047|P2|COMPLETED|Stage 2 (Followed up to 48 Months )||0
295314|NCT00808028|712048|P1|COMPLETED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|69
295315|NCT00808028|712045|P4|STARTED|Stage 2 (Followed up to 48 Months )||151
295316|NCT00808028|712046|P3|STARTED|Stage 2 (Followed up to 48 Months )||170
295317|NCT00808028|712047|P2|STARTED|Stage 2 (Followed up to 48 Months )||0
295318|NCT00808028|712048|P1|STARTED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|80
295319|NCT00808028|712045|P4|NOT COMPLETED|Stage 1 (6 Months)||15
295320|NCT00808028|712046|P3|NOT COMPLETED|Stage 1 (6 Months)||7
295321|NCT00808028|712047|P2|NOT COMPLETED|Stage 1 (6 Months)||1
295322|NCT00808028|712048|P1|NOT COMPLETED|Stage 1 (6 Months)||5
295323|NCT00808028|712045|P4|COMPLETED|Stage 1 (6 Months)||183
295324|NCT00808028|712046|P3|COMPLETED|Stage 1 (6 Months)||191
295325|NCT00808028|712047|P2|COMPLETED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|21
295326|NCT00808028|712048|P1|COMPLETED|Stage 1 (6 Months)||116
295327|NCT00808028|712045|P4|STARTED|Stage 1 (6 Months)||198
295328|NCT00808028|712046|P3|STARTED|Stage 1 (6 Months)||198
295329|NCT00808028|712047|P2|STARTED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|22
295330|NCT00808028|712048|P1|STARTED|Stage 1 (6 Months)||121
295331|NCT00808015|712084|P1|NOT COMPLETED|Overall Study||344
295332|NCT00808015|712084|P1|COMPLETED|Overall Study||1033
295333|NCT00808015|712084|P1|Treated|Overall Study||1373
295334|NCT00808015|712084|P1|STARTED|Overall Study||1377
295335|NCT00807989|712098|P2|NOT COMPLETED|Overall Study||2
295336|NCT00807989|712099|P1|NOT COMPLETED|Overall Study||3
295337|NCT00807989|712098|P2|COMPLETED|Overall Study||98
295338|NCT00807989|712099|P1|COMPLETED|Overall Study||104
295339|NCT00807989|712098|P2|STARTED|Overall Study||100
295340|NCT00807989|712099|P1|STARTED|Overall Study||107
295341|NCT00807937|712113|P4|NOT COMPLETED|Overall Study||15
295342|NCT00807937|712114|P3|NOT COMPLETED|Overall Study||14
295343|NCT00807937|712115|P2|NOT COMPLETED|Overall Study||25
295344|NCT00807937|712116|P1|NOT COMPLETED|Overall Study||27
295345|NCT00807937|712113|P4|COMPLETED|Overall Study||77
295346|NCT00807937|712114|P3|COMPLETED|Overall Study||78
295347|NCT00807937|712115|P2|COMPLETED|Overall Study||67
295348|NCT00807937|712116|P1|COMPLETED|Overall Study||66
295349|NCT00807937|712113|P4|STARTED|Overall Study||92
295350|NCT00807937|712114|P3|STARTED|Overall Study||92
295351|NCT00807937|712115|P2|STARTED|Overall Study||92
295352|NCT00807937|712116|P1|STARTED|Overall Study||93
295353|NCT00807885|712151|P9|NOT COMPLETED|Overall Study||0
295354|NCT00807885|712152|P8|NOT COMPLETED|Overall Study||0
295355|NCT00807885|712153|P7|NOT COMPLETED|Overall Study||0
295356|NCT00807885|712154|P6|NOT COMPLETED|Overall Study||1
295357|NCT00807885|712155|P5|NOT COMPLETED|Overall Study||0
295358|NCT00807885|712156|P4|NOT COMPLETED|Overall Study||0
295359|NCT00807885|712157|P3|NOT COMPLETED|Overall Study||0
295360|NCT00807885|712158|P2|NOT COMPLETED|Overall Study||0
295361|NCT00807885|712159|P1|NOT COMPLETED|Overall Study||0
295362|NCT00807885|712151|P9|COMPLETED|Overall Study||11
295363|NCT00807885|712152|P8|COMPLETED|Overall Study||11
295364|NCT00807885|712153|P7|COMPLETED|Overall Study||12
295365|NCT00807885|712154|P6|COMPLETED|Overall Study|Subject completed treatment, but lost to follow-up|11
295366|NCT00807885|712155|P5|COMPLETED|Overall Study||12
295367|NCT00807885|712156|P4|COMPLETED|Overall Study||10
295368|NCT00807885|712157|P3|COMPLETED|Overall Study||11
295369|NCT00807885|712158|P2|COMPLETED|Overall Study||11
295370|NCT00807885|712159|P1|COMPLETED|Overall Study||10
295371|NCT00807885|712151|P9|STARTED|Overall Study||11
295372|NCT00807885|712152|P8|STARTED|Overall Study||11
295373|NCT00807885|712153|P7|STARTED|Overall Study||12
295374|NCT00807885|712154|P6|STARTED|Overall Study||12
295375|NCT00807885|712155|P5|STARTED|Overall Study||12
295376|NCT00807885|712156|P4|STARTED|Overall Study||10
295377|NCT00807885|712157|P3|STARTED|Overall Study||11
295378|NCT00807885|712158|P2|STARTED|Overall Study||11
295379|NCT00807885|712159|P1|STARTED|Overall Study||10
295380|NCT00807846|712208|P2|NOT COMPLETED|Overall Study||4
295381|NCT00807846|712209|P1|NOT COMPLETED|Overall Study||12
295382|NCT00807846|712208|P2|COMPLETED|Overall Study||94
295383|NCT00807846|712209|P1|COMPLETED|Overall Study||88
295384|NCT00807846|712208|P2|STARTED|Overall Study||98
295385|NCT00807846|712209|P1|STARTED|Overall Study||100
295386|NCT00807768|712243|P2|NOT COMPLETED|Overall Study||0
295387|NCT00807768|712244|P1|NOT COMPLETED|Overall Study||0
295388|NCT00807768|712243|P2|COMPLETED|Overall Study||300
295389|NCT00807768|712244|P1|COMPLETED|Overall Study||301
295390|NCT00807768|712243|P2|STARTED|Overall Study||300
295391|NCT00807768|712244|P1|STARTED|Overall Study||301
295392|NCT00807742|712262|P2|NOT COMPLETED|Overall Study||54
295393|NCT00807742|712263|P1|NOT COMPLETED|Overall Study||46
295394|NCT00807742|712262|P2|COMPLETED|Overall Study||114
295395|NCT00807742|712263|P1|COMPLETED|Overall Study||126
295396|NCT00807742|712262|P2|STARTED|Overall Study||168
295397|NCT00807742|712263|P1|STARTED|Overall Study||172
295398|NCT00807664|712309|P2|NOT COMPLETED|Overall Study||19
295399|NCT00807664|712310|P1|NOT COMPLETED|Overall Study||11
295400|NCT00807664|712309|P2|COMPLETED|Overall Study||75
295401|NCT00807664|712310|P1|COMPLETED|Overall Study||77
295402|NCT00807664|712309|P2|STARTED|Overall Study||94
295403|NCT00807664|712310|P1|STARTED|Overall Study||88
295404|NCT00807599|712322|P3|NOT COMPLETED|Overall Study||17
295405|NCT00807599|712323|P2|NOT COMPLETED|Overall Study||0
295406|NCT00807599|712324|P1|NOT COMPLETED|Overall Study||0
295407|NCT00807599|712322|P3|COMPLETED|Overall Study||0
295408|NCT00807599|712323|P2|COMPLETED|Overall Study||24
295409|NCT00807599|712324|P1|COMPLETED|Overall Study||26
295410|NCT00807599|712322|P3|STARTED|Overall Study||17
295411|NCT00807599|712323|P2|STARTED|Overall Study||24
295412|NCT00807599|712324|P1|STARTED|Overall Study||26
295413|NCT00807586|712338|P2|NOT COMPLETED|Overall Study||1
295414|NCT00807586|712339|P1|NOT COMPLETED|Overall Study||6
295415|NCT00807586|712338|P2|COMPLETED|Overall Study||58
295416|NCT00807586|712339|P1|COMPLETED|Overall Study||54
295417|NCT00807586|712338|P2|STARTED|Overall Study||59
295418|NCT00807586|712339|P1|STARTED|Overall Study||60
295419|NCT00807573|712351|P1|NOT COMPLETED|Overall Study||2
295420|NCT00807573|712351|P1|COMPLETED|Overall Study||42
295421|NCT00807573|712351|P1|STARTED|Overall Study||44
295422|NCT00807560|712357|P2|NOT COMPLETED|Overall Study||0
295423|NCT00807560|712358|P1|NOT COMPLETED|Overall Study||0
295424|NCT00807560|712357|P2|COMPLETED|Overall Study||39
295425|NCT00807560|712358|P1|COMPLETED|Overall Study||38
295426|NCT00807560|712357|P2|STARTED|Overall Study||39
295427|NCT00807560|712358|P1|STARTED|Overall Study||38
295428|NCT00807495|712397|P5|NOT COMPLETED|Overall Study||5
295429|NCT00807495|712398|P4|NOT COMPLETED|Overall Study||1
295430|NCT00807495|712399|P3|NOT COMPLETED|Overall Study||4
295431|NCT00807495|712400|P2|NOT COMPLETED|Overall Study||6
295432|NCT00807495|712401|P1|NOT COMPLETED|Overall Study||8
295433|NCT00807495|712397|P5|COMPLETED|Overall Study||2
295434|NCT00807495|712398|P4|COMPLETED|Overall Study||0
295435|NCT00807495|712399|P3|COMPLETED|Overall Study||1
295436|NCT00807495|712400|P2|COMPLETED|Overall Study||7
295437|NCT00807495|712401|P1|COMPLETED|Overall Study|Completed = participants who completed the study treatment to PD or symptomatic deterioration.|14
295438|NCT00807495|712397|P5|STARTED|Overall Study|An ATL participant had late on-study biopsy and was in DLBL, reducing ATL participants from 8 to 7.|7
295439|NCT00807495|712398|P4|STARTED|Overall Study||1
295440|NCT00807495|712399|P3|STARTED|Overall Study||5
295441|NCT00807495|712400|P2|STARTED|Overall Study||13
295442|NCT00807495|712401|P1|STARTED|Overall Study||22
295443|NCT00807456|712443|P1|NOT COMPLETED|Overall Study||0
295444|NCT00807456|712443|P1|COMPLETED|Overall Study||65
295445|NCT00807456|712443|P1|STARTED|Overall Study||65
295446|NCT00807365|712447|P1|NOT COMPLETED|Overall Study||5
295447|NCT00807365|712447|P1|COMPLETED|Overall Study||0
295448|NCT00807365|712447|P1|STARTED|Overall Study||5
295449|NCT00807248|712455|P4|NOT COMPLETED|Overall Study||14
295450|NCT00807248|712456|P3|NOT COMPLETED|Overall Study||18
295451|NCT00807248|712457|P2|NOT COMPLETED|Overall Study||12
295452|NCT00807248|712458|P1|NOT COMPLETED|Overall Study||21
295453|NCT00807248|712455|P4|COMPLETED|Overall Study||126
295454|NCT00807248|712456|P3|COMPLETED|Overall Study||121
295455|NCT00807248|712457|P2|COMPLETED|Overall Study||128
295456|NCT00807248|712458|P1|COMPLETED|Overall Study||50
295457|NCT00807248|712455|P4|STARTED|Overall Study||140
295458|NCT00807248|712456|P3|STARTED|Overall Study||139
295459|NCT00807248|712457|P2|STARTED|Overall Study||140
295460|NCT00807248|712458|P1|STARTED|Overall Study||71
295461|NCT00807235|712502|P2|NOT COMPLETED|Overall Study||0
295462|NCT00807235|712503|P1|NOT COMPLETED|Overall Study||1
295463|NCT00807235|712502|P2|COMPLETED|Overall Study||6
295464|NCT00807235|712503|P1|COMPLETED|Overall Study||10
295465|NCT00807235|712502|P2|STARTED|Overall Study||6
295466|NCT00807235|712503|P1|STARTED|Overall Study||11
295467|NCT00807209|712536|P3|NOT COMPLETED|Overall Study||0
295468|NCT00807209|712537|P2|NOT COMPLETED|Overall Study||0
295469|NCT00807209|712538|P1|NOT COMPLETED|Overall Study||0
295470|NCT00807209|712536|P3|COMPLETED|Overall Study||1
295471|NCT00807209|712537|P2|COMPLETED|Overall Study||1
295472|NCT00807209|712538|P1|COMPLETED|Overall Study||1
295473|NCT00807209|712536|P3|STARTED|Overall Study||1
295474|NCT00807209|712537|P2|STARTED|Overall Study||1
295475|NCT00807209|712538|P1|STARTED|Overall Study||1
295476|NCT00807092|712548|P2|NOT COMPLETED|Overall Study||4
295477|NCT00807092|712549|P1|NOT COMPLETED|Overall Study||1
295478|NCT00807092|712548|P2|COMPLETED|Overall Study||69
295479|NCT00807092|712549|P1|COMPLETED|Overall Study||71
295480|NCT00807092|712548|P2|Exposed to Drug|Overall Study||73
295481|NCT00807092|712549|P1|Exposed to Drug|Overall Study|Subject was randomised, but not exposed to any trial drug|71
295482|NCT00807092|712548|P2|STARTED|Overall Study||73
295483|NCT00807092|712549|P1|STARTED|Overall Study||72
295484|NCT00807040|712579|P2|NOT COMPLETED|Overall Study||41
295485|NCT00807040|712580|P1|NOT COMPLETED|Overall Study||36
295486|NCT00807040|712579|P2|COMPLETED|Overall Study||84
295487|NCT00807040|712580|P1|COMPLETED|Overall Study||90
295488|NCT00807040|712579|P2|STARTED|Overall Study||125
295489|NCT00807040|712580|P1|STARTED|Overall Study||126
295490|NCT00807014|712590|P2|NOT COMPLETED|Overall Study||27
295491|NCT00807014|712591|P1|NOT COMPLETED|Overall Study||27
295492|NCT00807014|712590|P2|COMPLETED|Overall Study||58
295493|NCT00807014|712591|P1|COMPLETED|Overall Study||56
295494|NCT00807014|712590|P2|STARTED|Overall Study||85
295495|NCT00807014|712591|P1|STARTED|Overall Study||83
295496|NCT00807001|712622|P5|NOT COMPLETED|Overall Study||0
295497|NCT00807001|712623|P4|NOT COMPLETED|Overall Study||0
295498|NCT00807001|712624|P3|NOT COMPLETED|Overall Study||0
295499|NCT00807001|712625|P2|NOT COMPLETED|Overall Study||1
295500|NCT00807001|712626|P1|NOT COMPLETED|Overall Study||0
295501|NCT00807001|712622|P5|COMPLETED|Overall Study||9
295502|NCT00807001|712623|P4|COMPLETED|Overall Study||8
295503|NCT00807001|712624|P3|COMPLETED|Overall Study||8
295504|NCT00807001|712625|P2|COMPLETED|Overall Study||7
295505|NCT00807001|712626|P1|COMPLETED|Overall Study||8
295506|NCT00807001|712622|P5|STARTED|Overall Study||9
295507|NCT00807001|712623|P4|STARTED|Overall Study||8
295508|NCT00807001|712624|P3|STARTED|Overall Study||8
295509|NCT00807001|712625|P2|STARTED|Overall Study||8
295510|NCT00807001|712626|P1|STARTED|Overall Study|For all groups, number of subjects who received at least one dose of study drug.|8
295511|NCT00806988|712645|P2|NOT COMPLETED|Overall Study||43
295512|NCT00806988|712646|P1|NOT COMPLETED|Overall Study||27
295513|NCT00806988|712645|P2|COMPLETED|Overall Study||108
295514|NCT00806988|712646|P1|COMPLETED|Overall Study||123
295515|NCT00806988|712645|P2|STARTED|Overall Study||151
295516|NCT00806988|712646|P1|STARTED|Overall Study||150
295517|NCT00806819|712656|P2|NOT COMPLETED|Overall Study||358
295518|NCT00806819|712657|P1|NOT COMPLETED|Overall Study||346
295519|NCT00806819|712656|P2|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|2
295520|NCT00806819|712657|P1|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|7
295521|NCT00806819|712656|P2|STARTED|Overall Study|randomised patients|360
295522|NCT00806819|712657|P1|STARTED|Overall Study|randomised patients|353
295523|NCT00806676|712692|P3|NOT COMPLETED|Overall Study||6
295524|NCT00806676|712693|P2|NOT COMPLETED|Overall Study||0
295525|NCT00806676|712694|P1|NOT COMPLETED|Overall Study||4
295526|NCT00806676|712692|P3|COMPLETED|Overall Study||23
295527|NCT00806676|712693|P2|COMPLETED|Overall Study||9
295528|NCT00806676|712694|P1|COMPLETED|Overall Study||25
295529|NCT00806676|712692|P3|STARTED|Overall Study||29
295530|NCT00806676|712693|P2|STARTED|Overall Study||9
295531|NCT00806676|712694|P1|STARTED|Overall Study||29
295532|NCT00806624|712726|P3|NOT COMPLETED|Overall Study||6
295533|NCT00806624|712727|P2|NOT COMPLETED|Overall Study||12
295534|NCT00806624|712728|P1|NOT COMPLETED|Overall Study||9
295535|NCT00806624|712726|P3|COMPLETED|Overall Study||69
295536|NCT00806624|712727|P2|COMPLETED|Overall Study||68
295537|NCT00806624|712728|P1|COMPLETED|Overall Study||70
295538|NCT00806624|712726|P3|STARTED|Overall Study||75
295539|NCT00806624|712727|P2|STARTED|Overall Study||80
295540|NCT00806624|712728|P1|STARTED|Overall Study||79
295541|NCT00806598|712736|P1|NOT COMPLETED|Overall Study||0
295542|NCT00806598|712736|P1|COMPLETED|Overall Study||48
295543|NCT00806598|712736|P1|STARTED|Overall Study||48
295544|NCT00806585|712745|P5|NOT COMPLETED|Overall Study||31
295545|NCT00806585|712746|P4|NOT COMPLETED|Overall Study||15
295546|NCT00806585|712747|P3|NOT COMPLETED|Overall Study||32
295547|NCT00806585|712748|P2|NOT COMPLETED|Overall Study||31
295548|NCT00806585|712749|P1|NOT COMPLETED|Overall Study||32
295549|NCT00806585|712745|P5|COMPLETED|Overall Study||106
295550|NCT00806585|712746|P4|COMPLETED|Overall Study||56
295551|NCT00806585|712747|P3|COMPLETED|Overall Study||109
295552|NCT00806585|712748|P2|COMPLETED|Overall Study||103
295553|NCT00806585|712749|P1|COMPLETED|Overall Study||105
295554|NCT00806585|712745|P5|STARTED|Overall Study||137
295555|NCT00806585|712746|P4|STARTED|Overall Study||71
295556|NCT00806585|712747|P3|STARTED|Overall Study||141
295557|NCT00806585|712748|P2|STARTED|Overall Study||134
295558|NCT00806585|712749|P1|STARTED|Overall Study||137
295559|NCT00806546|712781|P1|NOT COMPLETED|Overall Study||307
295560|NCT00806546|712781|P1|COMPLETED|Overall Study||207
295561|NCT00806546|712781|P1|STARTED|Overall Study|35 subjects were enrolled but did not treat for a total of 479 subjects in the safety population|514
295562|NCT00806494|712785|P1|NOT COMPLETED|Overall Study||80
295563|NCT00806494|712785|P1|COMPLETED|Overall Study||251
295564|NCT00806494|712785|P1|STARTED|Overall Study||331
295565|NCT00806442|712809|P2|NOT COMPLETED|Overall Study||7
295566|NCT00806442|712810|P1|NOT COMPLETED|Overall Study||4
295567|NCT00806442|712809|P2|COMPLETED|Overall Study||14
295568|NCT00806442|712810|P1|COMPLETED|Overall Study||14
295569|NCT00806442|712809|P2|Second Intervention (3 Wks)|Overall Study||14
295570|NCT00806442|712810|P1|Second Intervention (3 Wks)|Overall Study||15
295571|NCT00806442|712809|P2|Washout (3 Wks)|Overall Study||14
295572|NCT00806442|712810|P1|Washout (3 Wks)|Overall Study||15
295573|NCT00806442|712809|P2|First Intervention (3 Wks)|Overall Study||21
295574|NCT00806442|712810|P1|First Intervention (3 Wks)|Overall Study||18
295575|NCT00806442|712809|P2|STARTED|Overall Study||21
295576|NCT00806442|712810|P1|STARTED|Overall Study||18
295577|NCT00806416|712832|P4|NOT COMPLETED|Period 2 - Part II||0
295578|NCT00806416|712833|P3|NOT COMPLETED|Period 2 - Part II||0
295579|NCT00806416|712834|P2|NOT COMPLETED|Period 2 - Part II||0
295580|NCT00806416|712835|P1|NOT COMPLETED|Period 2 - Part II||0
295581|NCT00806416|712832|P4|COMPLETED|Period 2 - Part II||14
295582|NCT00806416|712833|P3|COMPLETED|Period 2 - Part II||14
295583|NCT00806416|712834|P2|COMPLETED|Period 2 - Part II||0
295584|NCT00806416|712835|P1|COMPLETED|Period 2 - Part II||0
295585|NCT00806416|712832|P4|STARTED|Period 2 - Part II||14
295586|NCT00806416|712833|P3|STARTED|Period 2 - Part II||14
295587|NCT00806416|712834|P2|STARTED|Period 2 - Part II||0
295588|NCT00806416|712835|P1|STARTED|Period 2 - Part II||0
295589|NCT00806416|712832|P4|NOT COMPLETED|Period 1 - Part II||2
295590|NCT00806416|712833|P3|NOT COMPLETED|Period 1 - Part II||0
295591|NCT00806416|712834|P2|NOT COMPLETED|Period 1 - Part II||0
295592|NCT00806416|712835|P1|NOT COMPLETED|Period 1 - Part II||0
295593|NCT00806416|712832|P4|COMPLETED|Period 1 - Part II||14
295594|NCT00806416|712833|P3|COMPLETED|Period 1 - Part II||14
295595|NCT00806416|712834|P2|COMPLETED|Period 1 - Part II||0
295596|NCT00806416|712835|P1|COMPLETED|Period 1 - Part II||0
295597|NCT00806416|712832|P4|STARTED|Period 1 - Part II||16
295598|NCT00806416|712833|P3|STARTED|Period 1 - Part II||14
295599|NCT00806416|712834|P2|STARTED|Period 1 - Part II||0
295600|NCT00806416|712835|P1|STARTED|Period 1 - Part II||0
295601|NCT00806416|712832|P4|NOT COMPLETED|Period 2 - Part I||0
295602|NCT00806416|712833|P3|NOT COMPLETED|Period 2 - Part I||0
295603|NCT00806416|712834|P2|NOT COMPLETED|Period 2 - Part I||0
295604|NCT00806416|712835|P1|NOT COMPLETED|Period 2 - Part I||0
295605|NCT00806416|712832|P4|COMPLETED|Period 2 - Part I||0
295606|NCT00806416|712833|P3|COMPLETED|Period 2 - Part I||0
295607|NCT00806416|712834|P2|COMPLETED|Period 2 - Part I||103
295608|NCT00806416|712835|P1|COMPLETED|Period 2 - Part I||104
295609|NCT00806416|712832|P4|STARTED|Period 2 - Part I||0
295610|NCT00806416|712833|P3|STARTED|Period 2 - Part I||0
295611|NCT00806416|712834|P2|STARTED|Period 2 - Part I||103
295612|NCT00806416|712835|P1|STARTED|Period 2 - Part I||104
295613|NCT00806416|712832|P4|NOT COMPLETED|Period 1 - Part I||0
295614|NCT00806416|712833|P3|NOT COMPLETED|Period 1 - Part I||0
295615|NCT00806416|712834|P2|NOT COMPLETED|Period 1 - Part I||4
295616|NCT00806416|712835|P1|NOT COMPLETED|Period 1 - Part I||3
295617|NCT00806416|712832|P4|COMPLETED|Period 1 - Part I||0
295618|NCT00806416|712833|P3|COMPLETED|Period 1 - Part I||0
295619|NCT00806416|712834|P2|COMPLETED|Period 1 - Part I||103
295620|NCT00806416|712835|P1|COMPLETED|Period 1 - Part I||104
295621|NCT00806416|712832|P4|STARTED|Period 1 - Part I||0
295622|NCT00806416|712833|P3|STARTED|Period 1 - Part I||0
295623|NCT00806416|712834|P2|STARTED|Period 1 - Part I||107
295624|NCT00806416|712835|P1|STARTED|Period 1 - Part I||107
295625|NCT00806403|712848|P2|NOT COMPLETED|Overall Study||3
295626|NCT00806403|712849|P1|NOT COMPLETED|Overall Study||4
295627|NCT00806403|712848|P2|COMPLETED|Overall Study||98
295628|NCT00806403|712849|P1|COMPLETED|Overall Study||100
295629|NCT00806403|712848|P2|STARTED|Overall Study||101
295630|NCT00806403|712849|P1|STARTED|Overall Study||104
295631|NCT00806390|712863|P2|NOT COMPLETED|Overall Study||0
295632|NCT00806390|712864|P1|NOT COMPLETED|Overall Study||0
295633|NCT00806390|712863|P2|COMPLETED|Overall Study||8
295634|NCT00806390|712864|P1|COMPLETED|Overall Study||7
295635|NCT00806390|712863|P2|STARTED|Overall Study||8
295636|NCT00806390|712864|P1|STARTED|Overall Study||7
295637|NCT00806351|712872|P2|NOT COMPLETED|Overall Study||4
295638|NCT00806351|712873|P1|NOT COMPLETED|Overall Study||5
295639|NCT00806351|712872|P2|COMPLETED|Overall Study||2
295640|NCT00806351|712873|P1|COMPLETED|Overall Study||10
295641|NCT00806351|712872|P2|STARTED|Overall Study||6
295642|NCT00806351|712873|P1|STARTED|Overall Study||15
295643|NCT00806260|712910|P6|NOT COMPLETED|Period 3||0
295644|NCT00806260|712911|P5|NOT COMPLETED|Period 3||0
295645|NCT00806260|712912|P4|NOT COMPLETED|Period 3||0
295646|NCT00806260|712913|P3|NOT COMPLETED|Period 3||1
295647|NCT00806260|712914|P2|NOT COMPLETED|Period 3||1
295648|NCT00806260|712915|P1|NOT COMPLETED|Period 3||1
295649|NCT00806260|712910|P6|COMPLETED|Period 3||0
295650|NCT00806260|712911|P5|COMPLETED|Period 3||0
295651|NCT00806260|712912|P4|COMPLETED|Period 3||12
295652|NCT00806260|712913|P3|COMPLETED|Period 3||5
295653|NCT00806260|712914|P2|COMPLETED|Period 3||7
295654|NCT00806260|712915|P1|COMPLETED|Period 3||12
295655|NCT00806260|712910|P6|STARTED|Period 3||0
295656|NCT00806260|712911|P5|STARTED|Period 3||0
295657|NCT00806260|712912|P4|STARTED|Period 3||12
295658|NCT00806260|712913|P3|STARTED|Period 3||6
295659|NCT00806260|712914|P2|STARTED|Period 3||8
295660|NCT00806260|712915|P1|STARTED|Period 3||13
295661|NCT00806260|712910|P6|NOT COMPLETED|Period 2||0
295662|NCT00806260|712911|P5|NOT COMPLETED|Period 2||0
295663|NCT00806260|712912|P4|NOT COMPLETED|Period 2||2
295664|NCT00806260|712913|P3|NOT COMPLETED|Period 2||2
295665|NCT00806260|712914|P2|NOT COMPLETED|Period 2||0
295666|NCT00806260|712915|P1|NOT COMPLETED|Period 2||2
295667|NCT00806260|712910|P6|COMPLETED|Period 2||0
295668|NCT00806260|712911|P5|COMPLETED|Period 2||0
295669|NCT00806260|712912|P4|COMPLETED|Period 2||12
295670|NCT00806260|712913|P3|COMPLETED|Period 2||6
295671|NCT00806260|712914|P2|COMPLETED|Period 2||8
295672|NCT00806260|712915|P1|COMPLETED|Period 2||13
295673|NCT00806260|712910|P6|STARTED|Period 2||0
295674|NCT00806260|712911|P5|STARTED|Period 2||0
295675|NCT00806260|712912|P4|STARTED|Period 2||14
295676|NCT00806260|712913|P3|STARTED|Period 2||8
295677|NCT00806260|712914|P2|STARTED|Period 2||8
295678|NCT00806260|712915|P1|STARTED|Period 2||15
295679|NCT00806260|712910|P6|NOT COMPLETED|Period 1 (1 Day)||0
295680|NCT00806260|712911|P5|NOT COMPLETED|Period 1 (1 Day)||3
295681|NCT00806260|712912|P4|NOT COMPLETED|Period 1 (1 Day)||0
295682|NCT00806260|712913|P3|NOT COMPLETED|Period 1 (1 Day)||0
295683|NCT00806260|712914|P2|NOT COMPLETED|Period 1 (1 Day)||0
295684|NCT00806260|712915|P1|NOT COMPLETED|Period 1 (1 Day)||0
295685|NCT00806260|712910|P6|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|17
295686|NCT00806260|712911|P5|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|15
295687|NCT00806260|712912|P4|COMPLETED|Period 1 (1 Day)||14
295688|NCT00806260|712913|P3|COMPLETED|Period 1 (1 Day)||8
295689|NCT00806260|712914|P2|COMPLETED|Period 1 (1 Day)||8
295690|NCT00806260|712915|P1|COMPLETED|Period 1 (1 Day)||15
295691|NCT00806260|712910|P6|STARTED|Period 1 (1 Day)||17
295692|NCT00806260|712911|P5|STARTED|Period 1 (1 Day)||18
295693|NCT00806260|712912|P4|STARTED|Period 1 (1 Day)||14
295694|NCT00806260|712913|P3|STARTED|Period 1 (1 Day)||8
295695|NCT00806260|712914|P2|STARTED|Period 1 (1 Day)||8
295696|NCT00806260|712915|P1|STARTED|Period 1 (1 Day)||15
295697|NCT00806234|712930|P3|NOT COMPLETED|Overall Study||12
295698|NCT00806234|712931|P2|NOT COMPLETED|Overall Study||12
295699|NCT00806234|712932|P1|NOT COMPLETED|Overall Study||13
295700|NCT00806234|712930|P3|COMPLETED|Overall Study||37
295701|NCT00806234|712931|P2|COMPLETED|Overall Study||19
295702|NCT00806234|712932|P1|COMPLETED|Overall Study||34
295703|NCT00806234|712930|P3|STARTED|Overall Study||49
295704|NCT00806234|712931|P2|STARTED|Overall Study||31
295705|NCT00806234|712932|P1|STARTED|Overall Study||47
295706|NCT00806221|712949|P1|NOT COMPLETED|Overall Study||2
295707|NCT00806221|712949|P1|COMPLETED|Overall Study||20
295708|NCT00806221|712949|P1|STARTED|Overall Study||22
295709|NCT00806195|712960|P4|NOT COMPLETED|Overall Study||106
295710|NCT00806195|712961|P3|NOT COMPLETED|Overall Study||270
295711|NCT00806195|712962|P2|NOT COMPLETED|Overall Study||162
295712|NCT00806195|712963|P1|NOT COMPLETED|Overall Study||514
295713|NCT00806195|712960|P4|COMPLETED|Overall Study||383
295714|NCT00806195|712961|P3|COMPLETED|Overall Study||1139
295715|NCT00806195|712962|P2|COMPLETED|Overall Study||1321
295716|NCT00806195|712963|P1|COMPLETED|Overall Study||3849
295717|NCT00806195|712960|P4|STARTED|Overall Study||489
295718|NCT00806195|712961|P3|STARTED|Overall Study||1409
295719|NCT00806195|712962|P2|STARTED|Overall Study||1483
295720|NCT00806195|712963|P1|STARTED|Overall Study||4363
295721|NCT00806078|712977|P2|NOT COMPLETED|Second Intervention||0
295722|NCT00806078|712978|P1|NOT COMPLETED|Second Intervention||0
295723|NCT00806078|712977|P2|COMPLETED|Second Intervention||9
295724|NCT00806078|712978|P1|COMPLETED|Second Intervention||9
295725|NCT00806078|712977|P2|STARTED|Second Intervention||9
295726|NCT00806078|712978|P1|STARTED|Second Intervention||9
295727|NCT00806078|712977|P2|NOT COMPLETED|7 Day Washout Period||0
295728|NCT00806078|712978|P1|NOT COMPLETED|7 Day Washout Period||0
295729|NCT00806078|712977|P2|COMPLETED|7 Day Washout Period||9
295730|NCT00806078|712978|P1|COMPLETED|7 Day Washout Period||9
295731|NCT00806078|712977|P2|STARTED|7 Day Washout Period||9
295732|NCT00806078|712978|P1|STARTED|7 Day Washout Period||9
295733|NCT00806078|712977|P2|NOT COMPLETED|First Intervention||0
295734|NCT00806078|712978|P1|NOT COMPLETED|First Intervention||0
295735|NCT00806078|712977|P2|COMPLETED|First Intervention||9
295736|NCT00806078|712978|P1|COMPLETED|First Intervention||9
295737|NCT00806078|712977|P2|STARTED|First Intervention||9
295738|NCT00806078|712978|P1|STARTED|First Intervention||9
295739|NCT00806026|712994|P6|NOT COMPLETED|Overall Study||32
295740|NCT00806026|712995|P5|NOT COMPLETED|Overall Study||30
295741|NCT00806026|712996|P4|NOT COMPLETED|Overall Study||29
295742|NCT00806026|712997|P3|NOT COMPLETED|Overall Study||93
295743|NCT00806026|712998|P2|NOT COMPLETED|Overall Study||101
295744|NCT00806026|712999|P1|NOT COMPLETED|Overall Study||92
295745|NCT00806026|712994|P6|COMPLETED|Overall Study||29
295746|NCT00806026|712995|P5|COMPLETED|Overall Study||29
295747|NCT00806026|712996|P4|COMPLETED|Overall Study||32
295748|NCT00806026|712997|P3|COMPLETED|Overall Study||89
295749|NCT00806026|712998|P2|COMPLETED|Overall Study||82
295750|NCT00806026|712999|P1|COMPLETED|Overall Study||93
295751|NCT00806026|712994|P6|Treated|Overall Study||61
295752|NCT00806026|712995|P5|Treated|Overall Study||59
295753|NCT00806026|712996|P4|Treated|Overall Study||59
295754|NCT00806026|712997|P3|Treated|Overall Study||180
295755|NCT00806026|712998|P2|Treated|Overall Study||178
295756|NCT00806026|712999|P1|Treated|Overall Study||182
295757|NCT00806026|712994|P6|STARTED|Overall Study||61
295758|NCT00806026|712995|P5|STARTED|Overall Study||59
295759|NCT00806026|712996|P4|STARTED|Overall Study||61
295760|NCT00806026|712997|P3|STARTED|Overall Study||182
295761|NCT00806026|712998|P2|STARTED|Overall Study||183
295762|NCT00806026|712999|P1|STARTED|Overall Study||185
295763|NCT00805961|713094|P1|NOT COMPLETED|Maintenance Treatment||34
295764|NCT00805961|713094|P1|COMPLETED|Maintenance Treatment||23
295765|NCT00805961|713094|P1|STARTED|Maintenance Treatment||57
295766|NCT00805961|713094|P1|NOT COMPLETED|Treatment-Free Interval||7
295767|NCT00805961|713094|P1|COMPLETED|Treatment-Free Interval||57
295768|NCT00805961|713094|P1|STARTED|Treatment-Free Interval||64
295769|NCT00805961|713094|P1|NOT COMPLETED|Modality Therapy||4
295770|NCT00805961|713094|P1|COMPLETED|Modality Therapy||64
295771|NCT00805961|713094|P1|STARTED|Modality Therapy||68
295772|NCT00805948|713102|P2|NOT COMPLETED|Overall Study||96
295773|NCT00805948|713103|P1|NOT COMPLETED|Overall Study||68
295774|NCT00805948|713102|P2|COMPLETED|Overall Study||99
295775|NCT00805948|713103|P1|COMPLETED|Overall Study||86
295776|NCT00805948|713102|P2|STARTED|Overall Study||195
295777|NCT00805948|713103|P1|STARTED|Overall Study||154
295778|NCT00805935|713118|P4|NOT COMPLETED|Overall Study||11
295779|NCT00805935|713119|P3|NOT COMPLETED|Overall Study||15
295780|NCT00805935|713120|P2|NOT COMPLETED|Overall Study||19
295781|NCT00805935|713121|P1|NOT COMPLETED|Overall Study||13
295782|NCT00805935|713118|P4|COMPLETED|Overall Study||19
295783|NCT00805935|713119|P3|COMPLETED|Overall Study||13
295784|NCT00805935|713120|P2|COMPLETED|Overall Study||8
295785|NCT00805935|713121|P1|COMPLETED|Overall Study||12
295786|NCT00805935|713118|P4|STARTED|Overall Study||30
295787|NCT00805935|713119|P3|STARTED|Overall Study||28
295788|NCT00805935|713120|P2|STARTED|Overall Study||27
295789|NCT00805935|713121|P1|STARTED|Overall Study||25
295790|NCT00805870|713175|P2|NOT COMPLETED|Overall Study||0
295791|NCT00805870|713176|P1|NOT COMPLETED|Overall Study||0
295792|NCT00805870|713175|P2|COMPLETED|Overall Study||10
295793|NCT00805870|713176|P1|COMPLETED|Overall Study||10
295794|NCT00805870|713175|P2|STARTED|Overall Study||10
295795|NCT00805870|713176|P1|STARTED|Overall Study||10
295796|NCT00805792|713188|P1|NOT COMPLETED|Overall Study||5
295797|NCT00805792|713188|P1|COMPLETED|Overall Study||28
295798|NCT00805792|713188|P1|STARTED|Overall Study||33
295799|NCT00805766|713196|P1|NOT COMPLETED|Increased Dose Period||13
295800|NCT00805766|713196|P1|COMPLETED|Increased Dose Period||26
295801|NCT00805766|713196|P1|STARTED|Increased Dose Period||39
295802|NCT00805766|713196|P1|NOT COMPLETED|Screening Period||6
295803|NCT00805766|713196|P1|COMPLETED|Screening Period||39
295804|NCT00805766|713196|P1|STARTED|Screening Period||45
295805|NCT00805740|713210|P2|NOT COMPLETED|Overall Study||4
295806|NCT00805740|713211|P1|NOT COMPLETED|Overall Study||11
295807|NCT00805740|713210|P2|COMPLETED|Overall Study||9
295808|NCT00805740|713211|P1|COMPLETED|Overall Study||17
295809|NCT00805740|713210|P2|Treated|Overall Study||13
295810|NCT00805740|713211|P1|Treated|Overall Study||26
295811|NCT00805740|713210|P2|STARTED|Overall Study||13
295812|NCT00805740|713211|P1|STARTED|Overall Study||28
295813|NCT00805675|713236|P3|NOT COMPLETED|Overall Study||1
295814|NCT00805675|713237|P2|NOT COMPLETED|Overall Study||0
295815|NCT00805675|713238|P1|NOT COMPLETED|Overall Study||0
295816|NCT00805675|713236|P3|COMPLETED|Overall Study||15
295817|NCT00805675|713237|P2|COMPLETED|Overall Study||14
295818|NCT00805675|713238|P1|COMPLETED|Overall Study||16
295819|NCT00805675|713236|P3|STARTED|Overall Study||16
295820|NCT00805675|713237|P2|STARTED|Overall Study||14
295821|NCT00805675|713238|P1|STARTED|Overall Study||16
295822|NCT00805545|713272|P2|NOT COMPLETED|Overall Study||3
295823|NCT00805545|713273|P1|NOT COMPLETED|Overall Study||6
295824|NCT00805545|713272|P2|COMPLETED|Overall Study||197
295825|NCT00805545|713273|P1|COMPLETED|Overall Study||194
295826|NCT00805545|713272|P2|STARTED|Overall Study||200
295827|NCT00805545|713273|P1|STARTED|Overall Study||200
295828|NCT00805532|713281|P2|NOT COMPLETED|Overall Study||1
295829|NCT00805532|713282|P1|NOT COMPLETED|Overall Study||0
295830|NCT00805532|713281|P2|COMPLETED|Overall Study||38
295831|NCT00805532|713282|P1|COMPLETED|Overall Study|We did intent-to-treat analyses so 42 participants' data were analyzed.|42
295832|NCT00805532|713281|P2|STARTED|Overall Study||39
295833|NCT00805532|713282|P1|STARTED|Overall Study||42
295834|NCT00805493|713299|P3|NOT COMPLETED|Overall Study||1
295835|NCT00805493|713300|P2|NOT COMPLETED|Overall Study||0
295836|NCT00805493|713301|P1|NOT COMPLETED|Overall Study||2
295837|NCT00805493|713299|P3|COMPLETED|Overall Study||0
295838|NCT00805493|713300|P2|COMPLETED|Overall Study||2
295839|NCT00805493|713301|P1|COMPLETED|Overall Study||1
295840|NCT00805493|713299|P3|STARTED|Overall Study||1
295841|NCT00805493|713300|P2|STARTED|Overall Study||2
295842|NCT00805493|713301|P1|STARTED|Overall Study||3
295843|NCT00805480|713316|P4|NOT COMPLETED|Overall Study||5
295844|NCT00805480|713317|P3|NOT COMPLETED|Overall Study||12
295845|NCT00805480|713318|P2|NOT COMPLETED|Overall Study||7
295846|NCT00805480|713319|P1|NOT COMPLETED|Overall Study||14
295847|NCT00805480|713316|P4|COMPLETED|Overall Study||5
295848|NCT00805480|713317|P3|COMPLETED|Overall Study||19
295849|NCT00805480|713318|P2|COMPLETED|Overall Study||22
295850|NCT00805480|713319|P1|COMPLETED|Overall Study||16
295851|NCT00805480|713316|P4|Pharmacodynamic Analysis Set|Overall Study||10
295852|NCT00805480|713317|P3|Pharmacodynamic Analysis Set|Overall Study||29
295853|NCT00805480|713318|P2|Pharmacodynamic Analysis Set|Overall Study||25
295854|NCT00805480|713319|P1|Pharmacodynamic Analysis Set|Overall Study||30
295855|NCT00805480|713316|P4|STARTED|Overall Study||10
295856|NCT00805480|713317|P3|STARTED|Overall Study||31
295857|NCT00805480|713318|P2|STARTED|Overall Study||29
295858|NCT00805480|713319|P1|STARTED|Overall Study||30
295859|NCT00805467|713348|P4|NOT COMPLETED|Overall Study||237
295860|NCT00805467|713349|P3|NOT COMPLETED|Overall Study||103
295861|NCT00805467|713350|P2|NOT COMPLETED|Overall Study||34
295862|NCT00805467|713351|P1|NOT COMPLETED|Overall Study||0
295863|NCT00805467|713348|P4|COMPLETED|Overall Study|Ongoing when study terminated|144
295864|NCT00805467|713349|P3|COMPLETED|Overall Study|Ongoing when study terminated|80
295865|NCT00805467|713350|P2|COMPLETED|Overall Study|Ongoing when study terminated|25
295866|NCT00805467|713351|P1|COMPLETED|Overall Study|Ongoing when study terminated|1
295867|NCT00805467|713348|P4|Enrolled But Did Not Receive Treatment|Overall Study||0
295868|NCT00805467|713349|P3|Enrolled But Did Not Receive Treatment|Overall Study||0
295869|NCT00805467|713350|P2|Enrolled But Did Not Receive Treatment|Overall Study||0
295870|NCT00805467|713351|P1|Enrolled But Did Not Receive Treatment|Overall Study||0
295871|NCT00805467|713348|P4|STARTED|Overall Study|Patients who received treatment|381
295872|NCT00805467|713349|P3|STARTED|Overall Study|Patients who received treatment|183
295873|NCT00805467|713350|P2|STARTED|Overall Study|Patients who received treatment|59
295874|NCT00805467|713351|P1|STARTED|Overall Study|Patients who received treatment|1
295875|NCT00805441|713371|P2|NOT COMPLETED|Overall Study||36
295876|NCT00805441|713372|P1|NOT COMPLETED|Overall Study||34
295877|NCT00805441|713371|P2|COMPLETED|Overall Study||60
295878|NCT00805441|713372|P1|COMPLETED|Overall Study||60
295879|NCT00805441|713371|P2|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|91
295880|NCT00805441|713372|P1|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|92
295881|NCT00805441|713371|P2|STARTED|Overall Study||96
295882|NCT00805441|713372|P1|STARTED|Overall Study||94
295883|NCT00805389|713407|P5|NOT COMPLETED|Overall Study||13
295884|NCT00805389|713408|P4|NOT COMPLETED|Overall Study||17
295885|NCT00805389|713409|P3|NOT COMPLETED|Overall Study||12
295886|NCT00805389|713410|P2|NOT COMPLETED|Overall Study||5
295887|NCT00805389|713411|P1|NOT COMPLETED|Overall Study||7
295888|NCT00805389|713407|P5|COMPLETED|Overall Study||129
295889|NCT00805389|713408|P4|COMPLETED|Overall Study||128
295890|NCT00805389|713409|P3|COMPLETED|Overall Study||129
295891|NCT00805389|713410|P2|COMPLETED|Overall Study||137
295892|NCT00805389|713411|P1|COMPLETED|Overall Study||136
295893|NCT00805389|713407|P5|STARTED|Overall Study||142
295894|NCT00805389|713408|P4|STARTED|Overall Study||145
295895|NCT00805389|713409|P3|STARTED|Overall Study||141
295896|NCT00805389|713410|P2|STARTED|Overall Study||142
295897|NCT00805389|713411|P1|STARTED|Overall Study||143
295898|NCT00805285|713658|P1|NOT COMPLETED|Overall Study||1
295899|NCT00805285|713658|P1|COMPLETED|Overall Study||0
295900|NCT00805285|713658|P1|STARTED|Overall Study||1
295901|NCT00805207|713675|P9|NOT COMPLETED|Overall Study||0
295902|NCT00805207|713676|P8|NOT COMPLETED|Overall Study||0
295903|NCT00805207|713677|P7|NOT COMPLETED|Overall Study||0
295904|NCT00805207|713678|P6|NOT COMPLETED|Overall Study||3
295905|NCT00805207|713679|P5|NOT COMPLETED|Overall Study||1
295906|NCT00805207|713680|P4|NOT COMPLETED|Overall Study||0
295907|NCT00805207|713681|P3|NOT COMPLETED|Overall Study||1
295908|NCT00805207|713682|P2|NOT COMPLETED|Overall Study||2
295909|NCT00805207|713683|P1|NOT COMPLETED|Overall Study||0
295910|NCT00805207|713675|P9|COMPLETED|Overall Study||6
295911|NCT00805207|713676|P8|COMPLETED|Overall Study||6
295912|NCT00805207|713677|P7|COMPLETED|Overall Study||6
295913|NCT00805207|713678|P6|COMPLETED|Overall Study||9
295914|NCT00805207|713679|P5|COMPLETED|Overall Study||2
295915|NCT00805207|713680|P4|COMPLETED|Overall Study||6
295916|NCT00805207|713681|P3|COMPLETED|Overall Study||11
295917|NCT00805207|713682|P2|COMPLETED|Overall Study||7
295918|NCT00805207|713683|P1|COMPLETED|Overall Study||1
295919|NCT00805207|713675|P9|STARTED|Overall Study||6
295920|NCT00805207|713676|P8|STARTED|Overall Study||6
295921|NCT00805207|713677|P7|STARTED|Overall Study||6
295922|NCT00805207|713678|P6|STARTED|Overall Study||12
295923|NCT00805207|713679|P5|STARTED|Overall Study||3
295924|NCT00805207|713680|P4|STARTED|Overall Study||6
295925|NCT00805207|713681|P3|STARTED|Overall Study||12
295926|NCT00805207|713682|P2|STARTED|Overall Study||9
295927|NCT00805207|713683|P1|STARTED|Overall Study||1
295928|NCT00805194|713741|P2|NOT COMPLETED|Overall Study||654
295929|NCT00805194|713742|P1|NOT COMPLETED|Overall Study||649
295930|NCT00805194|713741|P2|COMPLETED|Overall Study||5
295931|NCT00805194|713742|P1|COMPLETED|Overall Study||6
295932|NCT00805194|713741|P2|STARTED|Overall Study|randomised patients|659
295933|NCT00805194|713742|P1|STARTED|Overall Study|randomised patients|655
295934|NCT00805142|713776|P2|NOT COMPLETED|Maintenance Period||2
295935|NCT00805142|713777|P1|NOT COMPLETED|Maintenance Period||0
295936|NCT00805142|713776|P2|COMPLETED|Maintenance Period||30
295937|NCT00805142|713777|P1|COMPLETED|Maintenance Period||30
295938|NCT00805142|713776|P2|STARTED|Maintenance Period||32
295939|NCT00805142|713777|P1|STARTED|Maintenance Period||30
295940|NCT00805142|713776|P2|NOT COMPLETED|Titration Period||10
295941|NCT00805142|713777|P1|NOT COMPLETED|Titration Period||6
295942|NCT00805142|713776|P2|COMPLETED|Titration Period||32
295943|NCT00805142|713777|P1|COMPLETED|Titration Period||30
295944|NCT00805142|713776|P2|STARTED|Titration Period||42
295945|NCT00805142|713777|P1|STARTED|Titration Period||36
295946|NCT00805038|713803|P2|NOT COMPLETED|Overall Study||0
295947|NCT00805038|713804|P1|NOT COMPLETED|Overall Study||0
295948|NCT00805038|713803|P2|COMPLETED|Overall Study||92
295949|NCT00805038|713804|P1|COMPLETED|Overall Study||75
295950|NCT00805038|713803|P2|STARTED|Overall Study||92
295951|NCT00805038|713804|P1|STARTED|Overall Study||75
295952|NCT00805025|713810|P1|NOT COMPLETED|Overall Study||49
295953|NCT00805025|713810|P1|COMPLETED|Overall Study||82
295954|NCT00805025|713810|P1|Enrolled and Treated|Overall Study||89
295955|NCT00805025|713810|P1|STARTED|Overall Study||131
295956|NCT00804999|713820|P4|NOT COMPLETED|Overall Study||0
295957|NCT00804999|713821|P3|NOT COMPLETED|Overall Study||0
295958|NCT00804999|713822|P2|NOT COMPLETED|Overall Study||0
295959|NCT00804999|713823|P1|NOT COMPLETED|Overall Study||0
295960|NCT00804999|713820|P4|COMPLETED|Overall Study||10
295961|NCT00804999|713821|P3|COMPLETED|Overall Study||14
295962|NCT00804999|713822|P2|COMPLETED|Overall Study||12
295963|NCT00804999|713823|P1|COMPLETED|Overall Study||15
295964|NCT00804999|713820|P4|STARTED|Overall Study||10
295965|NCT00804999|713821|P3|STARTED|Overall Study||14
295966|NCT00804999|713822|P2|STARTED|Overall Study||12
295967|NCT00804999|713823|P1|STARTED|Overall Study||15
295968|NCT00804986|713839|P6|NOT COMPLETED|Overall Study||10
295969|NCT00804986|713840|P5|NOT COMPLETED|Overall Study||9
295970|NCT00804986|713841|P4|NOT COMPLETED|Overall Study||8
295971|NCT00804986|713842|P3|NOT COMPLETED|Overall Study||2
295972|NCT00804986|713843|P2|NOT COMPLETED|Overall Study||8
295973|NCT00804986|713844|P1|NOT COMPLETED|Overall Study||1
295974|NCT00804986|713839|P6|COMPLETED|Overall Study||31
295975|NCT00804986|713840|P5|COMPLETED|Overall Study||34
295976|NCT00804986|713841|P4|COMPLETED|Overall Study||34
295977|NCT00804986|713842|P3|COMPLETED|Overall Study||40
295978|NCT00804986|713843|P2|COMPLETED|Overall Study||35
295979|NCT00804986|713844|P1|COMPLETED|Overall Study||35
295980|NCT00804986|713839|P6|STARTED|Overall Study||41
295981|NCT00804986|713840|P5|STARTED|Overall Study||43
295982|NCT00804986|713841|P4|STARTED|Overall Study||42
295983|NCT00804986|713842|P3|STARTED|Overall Study||42
295984|NCT00804986|713843|P2|STARTED|Overall Study||43
295985|NCT00804986|713844|P1|STARTED|Overall Study||36
295986|NCT00804908|713939|P3|NOT COMPLETED|Overall Study||114
295987|NCT00804908|713940|P2|NOT COMPLETED|Overall Study||116
295988|NCT00804908|713941|P1|NOT COMPLETED|Overall Study||115
295989|NCT00804908|713939|P3|COMPLETED|Overall Study||1
295990|NCT00804908|713940|P2|COMPLETED|Overall Study||0
295991|NCT00804908|713941|P1|COMPLETED|Overall Study||0
295992|NCT00804908|713939|P3|STARTED|Overall Study||115
295993|NCT00804908|713940|P2|STARTED|Overall Study||116
295994|NCT00804908|713941|P1|STARTED|Overall Study||115
295995|NCT00804843|713972|P2|NOT COMPLETED|Overall Study||7
295996|NCT00804843|713973|P1|NOT COMPLETED|Overall Study||10
295997|NCT00804843|713972|P2|COMPLETED|Overall Study||43
295998|NCT00804843|713973|P1|COMPLETED|Overall Study||40
295999|NCT00804843|713972|P2|STARTED|Overall Study||50
296000|NCT00804843|713973|P1|STARTED|Overall Study||50
296001|NCT00804713|713983|P1|NOT COMPLETED|Overall Study||0
296002|NCT00804713|713983|P1|COMPLETED|Overall Study||1978
296003|NCT00804713|713983|P1|STARTED|Overall Study||1978
296004|NCT00804687|713991|P6|NOT COMPLETED|Period 5: Treatment Period||0
296005|NCT00804687|713992|P5|NOT COMPLETED|Period 5: Treatment Period||1
296006|NCT00804687|713993|P4|NOT COMPLETED|Period 5: Treatment Period||0
296007|NCT00804687|713994|P3|NOT COMPLETED|Period 5: Treatment Period||1
296008|NCT00804687|713995|P2|NOT COMPLETED|Period 5: Treatment Period||0
296009|NCT00804687|713996|P1|NOT COMPLETED|Period 5: Treatment Period||1
296010|NCT00804687|713991|P6|COMPLETED|Period 5: Treatment Period||8
296011|NCT00804687|713992|P5|COMPLETED|Period 5: Treatment Period||8
296012|NCT00804687|713993|P4|COMPLETED|Period 5: Treatment Period||8
296013|NCT00804687|713994|P3|COMPLETED|Period 5: Treatment Period||8
296014|NCT00804687|713995|P2|COMPLETED|Period 5: Treatment Period||9
296015|NCT00804687|713996|P1|COMPLETED|Period 5: Treatment Period||8
296016|NCT00804687|713991|P6|STARTED|Period 5: Treatment Period||8
296017|NCT00804687|713992|P5|STARTED|Period 5: Treatment Period||9
296018|NCT00804687|713993|P4|STARTED|Period 5: Treatment Period||8
296019|NCT00804687|713994|P3|STARTED|Period 5: Treatment Period||9
296020|NCT00804687|713995|P2|STARTED|Period 5: Treatment Period||9
296021|NCT00804687|713996|P1|STARTED|Period 5: Treatment Period||9
296022|NCT00804687|713991|P6|NOT COMPLETED|Period 4: Washout Period||0
296023|NCT00804687|713992|P5|NOT COMPLETED|Period 4: Washout Period||0
296024|NCT00804687|713993|P4|NOT COMPLETED|Period 4: Washout Period||0
296025|NCT00804687|713994|P3|NOT COMPLETED|Period 4: Washout Period||0
296026|NCT00804687|713995|P2|NOT COMPLETED|Period 4: Washout Period||0
296027|NCT00804687|713996|P1|NOT COMPLETED|Period 4: Washout Period||0
296028|NCT00804687|713991|P6|COMPLETED|Period 4: Washout Period||8
296029|NCT00804687|713992|P5|COMPLETED|Period 4: Washout Period||9
296030|NCT00804687|713993|P4|COMPLETED|Period 4: Washout Period||8
296031|NCT00804687|713994|P3|COMPLETED|Period 4: Washout Period||9
296032|NCT00804687|713995|P2|COMPLETED|Period 4: Washout Period||9
296033|NCT00804687|713996|P1|COMPLETED|Period 4: Washout Period||9
296034|NCT00804687|713991|P6|STARTED|Period 4: Washout Period||8
296035|NCT00804687|713992|P5|STARTED|Period 4: Washout Period||9
296036|NCT00804687|713993|P4|STARTED|Period 4: Washout Period||8
296037|NCT00804687|713994|P3|STARTED|Period 4: Washout Period||9
296038|NCT00804687|713995|P2|STARTED|Period 4: Washout Period||9
296039|NCT00804687|713996|P1|STARTED|Period 4: Washout Period||9
296040|NCT00804687|713991|P6|NOT COMPLETED|Period 3: Treatment Period||0
296041|NCT00804687|713992|P5|NOT COMPLETED|Period 3: Treatment Period||0
296042|NCT00804687|713993|P4|NOT COMPLETED|Period 3: Treatment Period||1
296043|NCT00804687|713994|P3|NOT COMPLETED|Period 3: Treatment Period||0
296044|NCT00804687|713995|P2|NOT COMPLETED|Period 3: Treatment Period||0
296045|NCT00804687|713996|P1|NOT COMPLETED|Period 3: Treatment Period||0
296046|NCT00804687|713991|P6|COMPLETED|Period 3: Treatment Period||8
296047|NCT00804687|713992|P5|COMPLETED|Period 3: Treatment Period||9
296048|NCT00804687|713993|P4|COMPLETED|Period 3: Treatment Period||8
296049|NCT00804687|713994|P3|COMPLETED|Period 3: Treatment Period||9
296050|NCT00804687|713995|P2|COMPLETED|Period 3: Treatment Period||9
296051|NCT00804687|713996|P1|COMPLETED|Period 3: Treatment Period||9
296052|NCT00804687|713991|P6|STARTED|Period 3: Treatment Period||8
296053|NCT00804687|713992|P5|STARTED|Period 3: Treatment Period||9
296054|NCT00804687|713993|P4|STARTED|Period 3: Treatment Period||9
296055|NCT00804687|713994|P3|STARTED|Period 3: Treatment Period||9
296056|NCT00804687|713995|P2|STARTED|Period 3: Treatment Period||9
296057|NCT00804687|713996|P1|STARTED|Period 3: Treatment Period||9
296058|NCT00804687|713991|P6|NOT COMPLETED|Period 2: Washout Period||0
296059|NCT00804687|713992|P5|NOT COMPLETED|Period 2: Washout Period||0
296060|NCT00804687|713993|P4|NOT COMPLETED|Period 2: Washout Period||0
296061|NCT00804687|713994|P3|NOT COMPLETED|Period 2: Washout Period||0
296062|NCT00804687|713995|P2|NOT COMPLETED|Period 2: Washout Period||0
296063|NCT00804687|713996|P1|NOT COMPLETED|Period 2: Washout Period||0
296064|NCT00804687|713991|P6|COMPLETED|Period 2: Washout Period||8
296065|NCT00804687|713992|P5|COMPLETED|Period 2: Washout Period||9
296066|NCT00804687|713993|P4|COMPLETED|Period 2: Washout Period||9
296067|NCT00804687|713994|P3|COMPLETED|Period 2: Washout Period||9
296068|NCT00804687|713995|P2|COMPLETED|Period 2: Washout Period||9
296069|NCT00804687|713996|P1|COMPLETED|Period 2: Washout Period||9
296070|NCT00804687|713991|P6|STARTED|Period 2: Washout Period||8
296071|NCT00804687|713992|P5|STARTED|Period 2: Washout Period||9
296072|NCT00804687|713993|P4|STARTED|Period 2: Washout Period||9
296073|NCT00804687|713994|P3|STARTED|Period 2: Washout Period||9
296074|NCT00804687|713995|P2|STARTED|Period 2: Washout Period||9
296075|NCT00804687|713996|P1|STARTED|Period 2: Washout Period||9
296076|NCT00804687|713991|P6|NOT COMPLETED|Period 1: Treatment Period||0
296077|NCT00804687|713992|P5|NOT COMPLETED|Period 1: Treatment Period||0
296078|NCT00804687|713993|P4|NOT COMPLETED|Period 1: Treatment Period||0
296079|NCT00804687|713994|P3|NOT COMPLETED|Period 1: Treatment Period||0
296080|NCT00804687|713995|P2|NOT COMPLETED|Period 1: Treatment Period||0
296081|NCT00804687|713996|P1|NOT COMPLETED|Period 1: Treatment Period||0
296082|NCT00804687|713991|P6|COMPLETED|Period 1: Treatment Period||8
296083|NCT00804687|713992|P5|COMPLETED|Period 1: Treatment Period||9
296084|NCT00804687|713993|P4|COMPLETED|Period 1: Treatment Period||9
296085|NCT00804687|713994|P3|COMPLETED|Period 1: Treatment Period||9
296086|NCT00804687|713995|P2|COMPLETED|Period 1: Treatment Period||9
296087|NCT00804687|713996|P1|COMPLETED|Period 1: Treatment Period||9
296088|NCT00804687|713991|P6|STARTED|Period 1: Treatment Period||8
296089|NCT00804687|713992|P5|STARTED|Period 1: Treatment Period||9
296090|NCT00804687|713993|P4|STARTED|Period 1: Treatment Period||9
296091|NCT00804687|713994|P3|STARTED|Period 1: Treatment Period||9
296092|NCT00804687|713995|P2|STARTED|Period 1: Treatment Period||9
296093|NCT00804687|713996|P1|STARTED|Period 1: Treatment Period||9
296094|NCT00804648|714013|P6|NOT COMPLETED|Third Invervention||0
296095|NCT00804648|714014|P5|NOT COMPLETED|Third Invervention||0
296096|NCT00804648|714015|P4|NOT COMPLETED|Third Invervention||0
296097|NCT00804648|714016|P3|NOT COMPLETED|Third Invervention||0
296098|NCT00804648|714017|P2|NOT COMPLETED|Third Invervention||0
296099|NCT00804648|714018|P1|NOT COMPLETED|Third Invervention||0
296100|NCT00804648|714013|P6|COMPLETED|Third Invervention||8
296101|NCT00804648|714014|P5|COMPLETED|Third Invervention||4
296102|NCT00804648|714015|P4|COMPLETED|Third Invervention||4
296103|NCT00804648|714016|P3|COMPLETED|Third Invervention||6
296104|NCT00804648|714017|P2|COMPLETED|Third Invervention||5
296105|NCT00804648|714018|P1|COMPLETED|Third Invervention||3
296106|NCT00804648|714013|P6|STARTED|Third Invervention||8
296107|NCT00804648|714014|P5|STARTED|Third Invervention||4
296108|NCT00804648|714015|P4|STARTED|Third Invervention||4
296109|NCT00804648|714016|P3|STARTED|Third Invervention||6
296110|NCT00804648|714017|P2|STARTED|Third Invervention||5
296111|NCT00804648|714018|P1|STARTED|Third Invervention||3
296112|NCT00804648|714013|P6|NOT COMPLETED|Second Intervention||0
296113|NCT00804648|714014|P5|NOT COMPLETED|Second Intervention||0
296114|NCT00804648|714015|P4|NOT COMPLETED|Second Intervention||0
296115|NCT00804648|714016|P3|NOT COMPLETED|Second Intervention||0
296116|NCT00804648|714017|P2|NOT COMPLETED|Second Intervention||0
296117|NCT00804648|714018|P1|NOT COMPLETED|Second Intervention||0
296118|NCT00804648|714013|P6|COMPLETED|Second Intervention||8
296119|NCT00804648|714014|P5|COMPLETED|Second Intervention||4
296120|NCT00804648|714015|P4|COMPLETED|Second Intervention||4
296121|NCT00804648|714016|P3|COMPLETED|Second Intervention||6
296122|NCT00804648|714017|P2|COMPLETED|Second Intervention||5
296123|NCT00804648|714018|P1|COMPLETED|Second Intervention||3
296124|NCT00804648|714013|P6|STARTED|Second Intervention||8
296125|NCT00804648|714014|P5|STARTED|Second Intervention||4
296126|NCT00804648|714015|P4|STARTED|Second Intervention||4
296127|NCT00804648|714016|P3|STARTED|Second Intervention||6
296128|NCT00804648|714017|P2|STARTED|Second Intervention||5
296129|NCT00804648|714018|P1|STARTED|Second Intervention||3
296130|NCT00804648|714013|P6|NOT COMPLETED|First Intervention||0
296131|NCT00804648|714014|P5|NOT COMPLETED|First Intervention||0
296132|NCT00804648|714015|P4|NOT COMPLETED|First Intervention||0
296133|NCT00804648|714016|P3|NOT COMPLETED|First Intervention||0
296134|NCT00804648|714017|P2|NOT COMPLETED|First Intervention||0
296135|NCT00804648|714018|P1|NOT COMPLETED|First Intervention||0
296136|NCT00804648|714013|P6|COMPLETED|First Intervention||8
296137|NCT00804648|714014|P5|COMPLETED|First Intervention||4
296138|NCT00804648|714015|P4|COMPLETED|First Intervention||4
296139|NCT00804648|714016|P3|COMPLETED|First Intervention||6
296140|NCT00804648|714017|P2|COMPLETED|First Intervention||5
296141|NCT00804648|714018|P1|COMPLETED|First Intervention||3
296142|NCT00804648|714013|P6|STARTED|First Intervention||8
296143|NCT00804648|714014|P5|STARTED|First Intervention||4
296144|NCT00804648|714015|P4|STARTED|First Intervention||4
296145|NCT00804648|714016|P3|STARTED|First Intervention||6
296146|NCT00804648|714017|P2|STARTED|First Intervention||5
296147|NCT00804648|714018|P1|STARTED|First Intervention||3
296148|NCT00804609|714061|P2|NOT COMPLETED|Overall Study||1
296149|NCT00804609|714062|P1|NOT COMPLETED|Overall Study||0
296150|NCT00804609|714061|P2|COMPLETED|Overall Study||14
296151|NCT00804609|714062|P1|COMPLETED|Overall Study||15
296152|NCT00804609|714061|P2|STARTED|Overall Study||15
296153|NCT00804609|714062|P1|STARTED|Overall Study||15
296154|NCT00804596|714068|P1|NOT COMPLETED|Overall Study||0
296155|NCT00804596|714068|P1|COMPLETED|Overall Study||74
296156|NCT00804596|714068|P1|STARTED|Overall Study||74
296157|NCT00804570|714075|P2|NOT COMPLETED|Overall Study||94
296158|NCT00804570|714076|P1|NOT COMPLETED|Overall Study||72
296159|NCT00804570|714075|P2|COMPLETED|Overall Study||94
296160|NCT00804570|714076|P1|COMPLETED|Overall Study||115
296161|NCT00804570|714075|P2|STARTED|Overall Study||188
296162|NCT00804570|714076|P1|STARTED|Overall Study||187
296163|NCT00804193|714135|P3|NOT COMPLETED|Overall Study||32
296164|NCT00804193|714136|P2|NOT COMPLETED|Overall Study||44
296165|NCT00804193|714137|P1|NOT COMPLETED|Overall Study||39
296166|NCT00804193|714135|P3|COMPLETED|Overall Study||77
296167|NCT00804193|714136|P2|COMPLETED|Overall Study||180
296168|NCT00804193|714137|P1|COMPLETED|Overall Study||181
296169|NCT00804193|714135|P3|STARTED|Overall Study||109
296170|NCT00804193|714136|P2|STARTED|Overall Study||224
296171|NCT00804193|714137|P1|STARTED|Overall Study||220
296172|NCT00804141|714151|P1|NOT COMPLETED|Overall Study||563
296173|NCT00804141|714151|P1|COMPLETED|Overall Study||477
296174|NCT00804141|714151|P1|Received at Least 1 Dose of Study Drug|Overall Study||1034
296175|NCT00804141|714151|P1|STARTED|Overall Study||1040
296176|NCT00803959|714158|P2|NOT COMPLETED|Overall Study||51
296177|NCT00803959|714159|P1|NOT COMPLETED|Overall Study||56
296178|NCT00803959|714158|P2|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=264).|264
296179|NCT00803959|714159|P1|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=259).|259
296180|NCT00803959|714158|P2|ITT Analysis With Primary Outcome Data|Overall Study||272
296181|NCT00803959|714159|P1|ITT Analysis With Primary Outcome Data|Overall Study||266
296182|NCT00803959|714158|P2|STARTED|Overall Study||315
296183|NCT00803959|714159|P1|STARTED|Overall Study||315
296184|NCT00803790|714191|P4|NOT COMPLETED|Period 2||1
296185|NCT00803790|714192|P3|NOT COMPLETED|Period 2||1
296186|NCT00803790|714193|P2|NOT COMPLETED|Period 2||0
296187|NCT00803790|714194|P1|NOT COMPLETED|Period 2||2
296188|NCT00803790|714191|P4|COMPLETED|Period 2||30
296189|NCT00803790|714192|P3|COMPLETED|Period 2||30
296190|NCT00803790|714193|P2|COMPLETED|Period 2||114
296191|NCT00803790|714194|P1|COMPLETED|Period 2||114
296192|NCT00803790|714191|P4|STARTED|Period 2||31
296193|NCT00803790|714192|P3|STARTED|Period 2||31
296194|NCT00803790|714193|P2|STARTED|Period 2||114
296195|NCT00803790|714194|P1|STARTED|Period 2||116
296196|NCT00803790|714191|P4|NOT COMPLETED|Period 1||4
296197|NCT00803790|714192|P3|NOT COMPLETED|Period 1||1
296198|NCT00803790|714193|P2|NOT COMPLETED|Period 1||12
296199|NCT00803790|714194|P1|NOT COMPLETED|Period 1||9
296200|NCT00803790|714191|P4|COMPLETED|Period 1||31
296201|NCT00803790|714192|P3|COMPLETED|Period 1||31
296202|NCT00803790|714193|P2|COMPLETED|Period 1||114
296203|NCT00803790|714194|P1|COMPLETED|Period 1||116
296204|NCT00803790|714191|P4|STARTED|Period 1||35
296205|NCT00803790|714192|P3|STARTED|Period 1||32
296206|NCT00803790|714193|P2|STARTED|Period 1||126
296207|NCT00803790|714194|P1|STARTED|Period 1||125
296208|NCT00803777|714205|P1|NOT COMPLETED|Overall Study||0
296209|NCT00803777|714205|P1|COMPLETED|Overall Study||147
296210|NCT00803777|714205|P1|STARTED|Overall Study||147
296211|NCT00803751|714215|P2|NOT COMPLETED|Overall Study||0
296212|NCT00803751|714216|P1|NOT COMPLETED|Overall Study||0
296213|NCT00803751|714215|P2|COMPLETED|Overall Study||23
296214|NCT00803751|714216|P1|COMPLETED|Overall Study||26
296215|NCT00803751|714215|P2|STARTED|Overall Study||23
296216|NCT00803751|714216|P1|STARTED|Overall Study||26
296217|NCT00803738|714234|P2|NOT COMPLETED|Overall Study||110
296218|NCT00803738|714235|P1|NOT COMPLETED|Overall Study||94
296219|NCT00803738|714234|P2|COMPLETED|Overall Study||176
296220|NCT00803738|714235|P1|COMPLETED|Overall Study||192
296221|NCT00803738|714234|P2|STARTED|Overall Study||286
296222|NCT00803738|714235|P1|STARTED|Overall Study||286
296223|NCT00803712|714247|P2|NOT COMPLETED|Overall Study||27
296224|NCT00803712|714248|P1|NOT COMPLETED|Overall Study||36
296225|NCT00803712|714247|P2|COMPLETED|Overall Study|128 participants randomized to the control group completed the study|128
296226|NCT00803712|714248|P1|COMPLETED|Overall Study|118 participants randomized to the cinacalcet group completed the study|118
296227|NCT00803712|714247|P2|Safety Analysis Set|Overall Study|Randomized to the control group|154
296228|NCT00803712|714248|P1|Safety Analysis Set|Overall Study|Rz'ed to cinacalcet and received at least 1 dose, or to control but received cinacalcet throughout|155
296229|NCT00803712|714247|P2|Full Analysis Set|Overall Study|151 participants randomized and had at least one PTH concentration available after study day 1.|151
296230|NCT00803712|714248|P1|Full Analysis Set|Overall Study|153 participants randomized and had at least one PTH concentration available after study day 1.|153
296231|NCT00803712|714247|P2|STARTED|Overall Study|155 participants were randomized to the control group|155
296232|NCT00803712|714248|P1|STARTED|Overall Study|154 participants were randomized to the cinacalcet group|154
296233|NCT00803686|714316|P4|NOT COMPLETED|Part 2, Period 3||0
296234|NCT00803686|714317|P3|NOT COMPLETED|Part 2, Period 3||0
296235|NCT00803686|714318|P2|NOT COMPLETED|Part 2, Period 3||0
296236|NCT00803686|714319|P1|NOT COMPLETED|Part 2, Period 3||0
296237|NCT00803686|714316|P4|COMPLETED|Part 2, Period 3|All who started this period completed|4
296238|NCT00803686|714317|P3|COMPLETED|Part 2, Period 3|All who started this period completed|5
296239|NCT00803686|714318|P2|COMPLETED|Part 2, Period 3|No subjects were treated in this period.|0
296240|NCT00803686|714319|P1|COMPLETED|Part 2, Period 3|No subjects were treated in this period|0
296241|NCT00803686|714316|P4|STARTED|Part 2, Period 3|Of the 6 eligible, 2 elected not to continue into Period 3.|4
296242|NCT00803686|714317|P3|STARTED|Part 2, Period 3|Of the 6 eligible, 1 elected not to continue into Period 3.|5
296243|NCT00803686|714318|P2|STARTED|Part 2, Period 3|No subjects were treated in this period.|0
296244|NCT00803686|714319|P1|STARTED|Part 2, Period 3|No subjects were treated in this period|0
296245|NCT00803686|714316|P4|NOT COMPLETED|Part 1, Period 2||0
296246|NCT00803686|714317|P3|NOT COMPLETED|Part 1, Period 2||0
296247|NCT00803686|714318|P2|NOT COMPLETED|Part 1, Period 2||0
296248|NCT00803686|714319|P1|NOT COMPLETED|Part 1, Period 2||0
296249|NCT00803686|714316|P4|COMPLETED|Part 1, Period 2|No subjects treated.|0
296250|NCT00803686|714317|P3|COMPLETED|Part 1, Period 2|No subjects treated.|0
296251|NCT00803686|714318|P2|COMPLETED|Part 1, Period 2||6
296252|NCT00803686|714319|P1|COMPLETED|Part 1, Period 2||6
296253|NCT00803686|714316|P4|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
296254|NCT00803686|714317|P3|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
296255|NCT00803686|714318|P2|STARTED|Part 1, Period 2||6
296256|NCT00803686|714319|P1|STARTED|Part 1, Period 2||6
296257|NCT00803686|714316|P4|NOT COMPLETED|Part 1, Period 1||0
296258|NCT00803686|714317|P3|NOT COMPLETED|Part 1, Period 1||0
296259|NCT00803686|714318|P2|NOT COMPLETED|Part 1, Period 1||0
296260|NCT00803686|714319|P1|NOT COMPLETED|Part 1, Period 1||0
296261|NCT00803686|714316|P4|COMPLETED|Part 1, Period 1||0
296262|NCT00803686|714317|P3|COMPLETED|Part 1, Period 1||0
296263|NCT00803686|714318|P2|COMPLETED|Part 1, Period 1||6
296264|NCT00803686|714319|P1|COMPLETED|Part 1, Period 1||6
296265|NCT00803686|714316|P4|STARTED|Part 1, Period 1||0
296266|NCT00803686|714317|P3|STARTED|Part 1, Period 1||0
296267|NCT00803686|714318|P2|STARTED|Part 1, Period 1||6
296268|NCT00803686|714319|P1|STARTED|Part 1, Period 1||6
296269|NCT00803647|714337|P1|NOT COMPLETED|Overall Study||0
296270|NCT00803647|714337|P1|COMPLETED|Overall Study||20
296271|NCT00803647|714337|P1|STARTED|Overall Study||20
296272|NCT00803634|714347|P2|NOT COMPLETED|Overall Study||5
296273|NCT00803634|714348|P1|NOT COMPLETED|Overall Study||6
296274|NCT00803634|714347|P2|COMPLETED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|48
296275|NCT00803634|714348|P1|COMPLETED|Overall Study|All patients dosed with clevidipine [Safety population]|45
296276|NCT00803634|714347|P2|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with SOC antihypertensive therapy and confirmed to have AHF [mITT population]|41
296277|NCT00803634|714348|P1|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with clevidipine and confirmed to have AHF [mITT population]|44
296278|NCT00803634|714347|P2|STARTED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|53
296279|NCT00803634|714348|P1|STARTED|Overall Study|All patients dosed with clevidipine [Safety population]|51
296280|NCT00803595|714377|P3|NOT COMPLETED|Overall Study||16
296281|NCT00803595|714378|P2|NOT COMPLETED|Overall Study||8
296282|NCT00803595|714379|P1|NOT COMPLETED|Overall Study||15
296283|NCT00803595|714377|P3|COMPLETED|Overall Study||322
296284|NCT00803595|714378|P2|COMPLETED|Overall Study||319
296285|NCT00803595|714379|P1|COMPLETED|Overall Study||322
296286|NCT00803595|714377|P3|STARTED|Overall Study||338
296287|NCT00803595|714378|P2|STARTED|Overall Study||327
296288|NCT00803595|714379|P1|STARTED|Overall Study||337
296289|NCT00803569|714390|P1|NOT COMPLETED|Overall Study||4
296290|NCT00803569|714390|P1|COMPLETED|Overall Study||9
296291|NCT00803569|714390|P1|STARTED|Overall Study||13
296292|NCT00803543|714400|P2|NOT COMPLETED|Overall Study||12
296293|NCT00803543|714401|P1|NOT COMPLETED|Overall Study||24
296294|NCT00803543|714400|P2|COMPLETED|Overall Study||22
296295|NCT00803543|714401|P1|COMPLETED|Overall Study||45
296296|NCT00803543|714400|P2|STARTED|Overall Study||34
296297|NCT00803543|714401|P1|STARTED|Overall Study||69
296298|NCT00803517|714415|P2|NOT COMPLETED|Overall Study||0
296299|NCT00803517|714416|P1|NOT COMPLETED|Overall Study||0
296300|NCT00803517|714415|P2|COMPLETED|Overall Study||12
296301|NCT00803517|714416|P1|COMPLETED|Overall Study||12
296302|NCT00803517|714415|P2|STARTED|Overall Study||12
296303|NCT00803517|714416|P1|STARTED|Overall Study||12
296304|NCT00803452|714424|P2|NOT COMPLETED|Overall Study||5
296305|NCT00803452|714425|P1|NOT COMPLETED|Overall Study||0
296306|NCT00803452|714424|P2|COMPLETED|Overall Study||17
296307|NCT00803452|714425|P1|COMPLETED|Overall Study||9
296308|NCT00803452|714424|P2|STARTED|Overall Study||22
296309|NCT00803452|714425|P1|STARTED|Overall Study||9
296310|NCT00803413|714435|P4|NOT COMPLETED|Overall Period||0
296311|NCT00803413|714436|P3|NOT COMPLETED|Overall Period||0
296312|NCT00803413|714437|P2|NOT COMPLETED|Overall Period||0
296313|NCT00803413|714438|P1|NOT COMPLETED|Overall Period||0
296314|NCT00803413|714435|P4|COMPLETED|Overall Period||30
296315|NCT00803413|714436|P3|COMPLETED|Overall Period||29
296316|NCT00803413|714437|P2|COMPLETED|Overall Period||32
296317|NCT00803413|714438|P1|COMPLETED|Overall Period||28
296318|NCT00803413|714435|P4|STARTED|Overall Period||30
296319|NCT00803413|714436|P3|STARTED|Overall Period||29
296320|NCT00803413|714437|P2|STARTED|Overall Period||32
296321|NCT00803413|714438|P1|STARTED|Overall Period||28
296322|NCT00803400|714450|P2|NOT COMPLETED|Overall Study||24
296323|NCT00803400|714451|P1|NOT COMPLETED|Overall Study||20
296324|NCT00803400|714450|P2|COMPLETED|Overall Study||51
296325|NCT00803400|714451|P1|COMPLETED|Overall Study||55
296326|NCT00803400|714450|P2|STARTED|Overall Study||75
296327|NCT00803400|714451|P1|STARTED|Overall Study||75
296328|NCT00803361|714463|P2|NOT COMPLETED|Overall Study||28
296329|NCT00803361|714464|P1|NOT COMPLETED|Overall Study||26
296330|NCT00803361|714463|P2|COMPLETED|Overall Study||74
296331|NCT00803361|714464|P1|COMPLETED|Overall Study||82
296332|NCT00803361|714463|P2|STARTED|Overall Study||102
296333|NCT00803361|714464|P1|STARTED|Overall Study||108
296334|NCT00803283|714484|P2|NOT COMPLETED|Overall Study||0
296335|NCT00803283|714485|P1|NOT COMPLETED|Overall Study||0
296336|NCT00803283|714484|P2|COMPLETED|Overall Study||1
296337|NCT00803283|714485|P1|COMPLETED|Overall Study||1
296338|NCT00803283|714484|P2|STARTED|Overall Study||1
296339|NCT00803283|714485|P1|STARTED|Overall Study||1
296340|NCT00803270|714511|P2|NOT COMPLETED|Overall Study||2
296341|NCT00803270|714512|P1|NOT COMPLETED|Overall Study||1
296342|NCT00803270|714511|P2|COMPLETED|Overall Study||12
296343|NCT00803270|714512|P1|COMPLETED|Overall Study||12
296344|NCT00803270|714511|P2|STARTED|Overall Study||14
296345|NCT00803270|714512|P1|STARTED|Overall Study||13
296346|NCT00803244|714522|P2|NOT COMPLETED|Overall Study||15
296347|NCT00803244|714523|P1|NOT COMPLETED|Overall Study||7
296348|NCT00803244|714522|P2|COMPLETED|Overall Study||178
296349|NCT00803244|714523|P1|COMPLETED|Overall Study||181
296350|NCT00803244|714522|P2|STARTED|Overall Study||193
296351|NCT00803244|714523|P1|STARTED|Overall Study||188
296352|NCT00803179|714531|P1|NOT COMPLETED|Overall Study||3
296353|NCT00803179|714531|P1|COMPLETED|Overall Study||2
296354|NCT00803179|714531|P1|STARTED|Overall Study||5
296355|NCT00803114|714537|P2|NOT COMPLETED|Overall Study||0
296356|NCT00803114|714538|P1|NOT COMPLETED|Overall Study||0
296357|NCT00803114|714537|P2|COMPLETED|Overall Study||115
296358|NCT00803114|714538|P1|COMPLETED|Overall Study||113
296359|NCT00803114|714537|P2|STARTED|Overall Study||115
296360|NCT00803114|714538|P1|STARTED|Overall Study||113
296361|NCT00803101|714550|P2|NOT COMPLETED|Overall Study||22
296362|NCT00803101|714551|P1|NOT COMPLETED|Overall Study||18
296363|NCT00803101|714550|P2|COMPLETED|Overall Study||66
296364|NCT00803101|714551|P1|COMPLETED|Overall Study||70
296365|NCT00803101|714550|P2|STARTED|Overall Study||88
296366|NCT00803101|714551|P1|STARTED|Overall Study||88
296367|NCT00803062|714573|P4|NOT COMPLETED|Overall Study||0
296368|NCT00803062|714574|P3|NOT COMPLETED|Overall Study||0
296369|NCT00803062|714575|P2|NOT COMPLETED|Overall Study||0
296370|NCT00803062|714576|P1|NOT COMPLETED|Overall Study||0
296371|NCT00803062|714573|P4|COMPLETED|Overall Study||112
296372|NCT00803062|714574|P3|COMPLETED|Overall Study||111
296373|NCT00803062|714575|P2|COMPLETED|Overall Study||115
296374|NCT00803062|714576|P1|COMPLETED|Overall Study||114
296375|NCT00803062|714573|P4|STARTED|Overall Study||112
296376|NCT00803062|714574|P3|STARTED|Overall Study||111
296377|NCT00803062|714575|P2|STARTED|Overall Study||115
296378|NCT00803062|714576|P1|STARTED|Overall Study||114
296379|NCT00803049|714602|P4|NOT COMPLETED|Overall Study||102
296380|NCT00803049|714603|P3|NOT COMPLETED|Overall Study||44
296381|NCT00803049|714604|P2|NOT COMPLETED|Overall Study||118
296382|NCT00803049|714605|P1|NOT COMPLETED|Overall Study||61
296383|NCT00803049|714602|P4|COMPLETED|Overall Study||151
296384|NCT00803049|714603|P3|COMPLETED|Overall Study||64
296385|NCT00803049|714604|P2|COMPLETED|Overall Study||134
296386|NCT00803049|714605|P1|COMPLETED|Overall Study||68
296387|NCT00803049|714602|P4|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|250
296388|NCT00803049|714603|P3|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|107
296389|NCT00803049|714604|P2|Safety Population|Overall Study|Included 1 participant from Placebo/Teriflunomide 14 mg and 1 from Teriflunomide14 mg/14 mg arm|254
296390|NCT00803049|714605|P1|Safety Population|Overall Study||129
296391|NCT00803049|714602|P4|Treated|Overall Study||251
296392|NCT00803049|714603|P3|Treated|Overall Study||108
296393|NCT00803049|714604|P2|Treated|Overall Study||252
296394|NCT00803049|714605|P1|Treated|Overall Study||129
296395|NCT00803049|714602|P4|STARTED|Overall Study|Randomized in extension study|253
296396|NCT00803049|714603|P3|STARTED|Overall Study|Randomized in extension study|108
296397|NCT00803049|714604|P2|STARTED|Overall Study|Randomized in extension study|252
296398|NCT00803049|714605|P1|STARTED|Overall Study|Randomized in extension study|129
296399|NCT00803023|714639|P4|NOT COMPLETED|Overall Study||8
296400|NCT00803023|714640|P3|NOT COMPLETED|Overall Study||11
296401|NCT00803023|714641|P2|NOT COMPLETED|Overall Study||8
296402|NCT00803023|714642|P1|NOT COMPLETED|Overall Study||5
296403|NCT00803023|714639|P4|COMPLETED|Overall Study||25
296404|NCT00803023|714640|P3|COMPLETED|Overall Study||20
296405|NCT00803023|714641|P2|COMPLETED|Overall Study||25
296406|NCT00803023|714642|P1|COMPLETED|Overall Study||27
296407|NCT00803023|714639|P4|STARTED|Overall Study||33
296408|NCT00803023|714640|P3|STARTED|Overall Study||31
296409|NCT00803023|714641|P2|STARTED|Overall Study||33
296410|NCT00803023|714642|P1|STARTED|Overall Study||32
296411|NCT00803010|714654|P2|NOT COMPLETED|Overall Study||0
296412|NCT00803010|714655|P1|NOT COMPLETED|Overall Study||0
296413|NCT00803010|714654|P2|COMPLETED|Overall Study||37
296414|NCT00803010|714655|P1|COMPLETED|Overall Study||37
296415|NCT00803010|714654|P2|STARTED|Overall Study||37
296416|NCT00803010|714655|P1|STARTED|Overall Study||37
296417|NCT00802997|714667|P2|NOT COMPLETED|6 Month to 9 Months||0
296418|NCT00802997|714668|P1|NOT COMPLETED|6 Month to 9 Months||2
296419|NCT00802997|714667|P2|COMPLETED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
296420|NCT00802997|714668|P1|COMPLETED|6 Month to 9 Months||25
296421|NCT00802997|714667|P2|STARTED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
296422|NCT00802997|714668|P1|STARTED|6 Month to 9 Months||27
296423|NCT00802997|714667|P2|NOT COMPLETED|3 Months to 6 Months||0
296424|NCT00802997|714668|P1|NOT COMPLETED|3 Months to 6 Months||7
296425|NCT00802997|714667|P2|COMPLETED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
296426|NCT00802997|714668|P1|COMPLETED|3 Months to 6 Months||27
296427|NCT00802997|714667|P2|STARTED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
296428|NCT00802997|714668|P1|STARTED|3 Months to 6 Months||34
296429|NCT00802997|714667|P2|NOT COMPLETED|Baseline to 3 Months||0
296430|NCT00802997|714668|P1|NOT COMPLETED|Baseline to 3 Months||0
296431|NCT00802997|714667|P2|COMPLETED|Baseline to 3 Months||17
296432|NCT00802997|714668|P1|COMPLETED|Baseline to 3 Months||34
296433|NCT00802997|714667|P2|STARTED|Baseline to 3 Months||17
296434|NCT00802997|714668|P1|STARTED|Baseline to 3 Months||34
296435|NCT00802945|714680|P2|NOT COMPLETED|Overall Study||35
296436|NCT00802945|714681|P1|NOT COMPLETED|Overall Study||35
296437|NCT00802945|714680|P2|COMPLETED|Overall Study||0
296438|NCT00802945|714681|P1|COMPLETED|Overall Study||0
296439|NCT00802945|714680|P2|STARTED|Overall Study||35
296440|NCT00802945|714681|P1|STARTED|Overall Study||35
296441|NCT00802919|714699|P2|NOT COMPLETED|Overall Study||1
296442|NCT00802919|714700|P1|NOT COMPLETED|Overall Study||3
296443|NCT00802919|714699|P2|COMPLETED|Overall Study||45
296444|NCT00802919|714700|P1|COMPLETED|Overall Study||42
296445|NCT00802919|714699|P2|STARTED|Overall Study||46
296446|NCT00802919|714700|P1|STARTED|Overall Study||45
296447|NCT00802893|714712|P1|NOT COMPLETED|Overall Study||3
296448|NCT00802893|714712|P1|COMPLETED|Overall Study||0
296449|NCT00802893|714712|P1|STARTED|Overall Study||3
296450|NCT00802880|714717|P1|NOT COMPLETED|Overall Study||0
296451|NCT00802880|714717|P1|COMPLETED|Overall Study||80
296452|NCT00802880|714717|P1|STARTED|Overall Study||80
296453|NCT00802867|714736|P1|NOT COMPLETED|Overall Study||13
296454|NCT00802867|714736|P1|COMPLETED|Overall Study||976
296455|NCT00802867|714736|P1|STARTED|Overall Study||989
296456|NCT00802854|714744|P1|NOT COMPLETED|Overall Study||0
296457|NCT00802854|714744|P1|COMPLETED|Overall Study||244
296458|NCT00802854|714744|P1|STARTED|Overall Study||244
296459|NCT00802841|714759|P2|NOT COMPLETED|Overall Study||95
296460|NCT00802841|714760|P1|NOT COMPLETED|Overall Study||96
296461|NCT00802841|714759|P2|COMPLETED|Overall Study||0
296462|NCT00802841|714760|P1|COMPLETED|Overall Study||0
296463|NCT00802841|714759|P2|Cross-over Set|Overall Study||56
296464|NCT00802841|714760|P1|Cross-over Set|Overall Study||13
296465|NCT00802841|714759|P2|Safety Set|Overall Study||93
296466|NCT00802841|714760|P1|Safety Set|Overall Study||96
296467|NCT00802841|714759|P2|Full Analysis Set|Overall Study||95
296468|NCT00802841|714760|P1|Full Analysis Set|Overall Study||96
296469|NCT00802841|714759|P2|STARTED|Overall Study||95
296470|NCT00802841|714760|P1|STARTED|Overall Study||96
296471|NCT00802737|714785|P3|NOT COMPLETED|Overall Study||1
296472|NCT00802737|714786|P2|NOT COMPLETED|Overall Study||11
296473|NCT00802737|714787|P1|NOT COMPLETED|Overall Study||17
296474|NCT00802737|714785|P3|COMPLETED|Overall Study||0
296475|NCT00802737|714786|P2|COMPLETED|Overall Study||0
296476|NCT00802737|714787|P1|COMPLETED|Overall Study||0
296477|NCT00802737|714785|P3|STARTED|Overall Study||1
296478|NCT00802737|714786|P2|STARTED|Overall Study||11
296479|NCT00802737|714787|P1|STARTED|Overall Study||17
296480|NCT00802685|714835|P2|NOT COMPLETED|Overall Study||0
296481|NCT00802685|714836|P1|NOT COMPLETED|Overall Study||0
296482|NCT00802685|714835|P2|COMPLETED|Overall Study||51
296483|NCT00802685|714836|P1|COMPLETED|Overall Study||54
296484|NCT00802685|714835|P2|STARTED|Overall Study||51
296485|NCT00802685|714836|P1|STARTED|Overall Study||54
296486|NCT00802672|714847|P3|NOT COMPLETED|Overall Study||34
296487|NCT00802672|714848|P2|NOT COMPLETED|Overall Study||52
296488|NCT00802672|714849|P1|NOT COMPLETED|Overall Study||68
296489|NCT00802672|714847|P3|COMPLETED|Overall Study||77
296490|NCT00802672|714848|P2|COMPLETED|Overall Study||174
296491|NCT00802672|714849|P1|COMPLETED|Overall Study||156
296492|NCT00802672|714847|P3|STARTED|Overall Study||111
296493|NCT00802672|714848|P2|STARTED|Overall Study||226
296494|NCT00802672|714849|P1|STARTED|Overall Study||224
296495|NCT00802659|714867|P4|NOT COMPLETED|Overall Study||0
296496|NCT00802659|714868|P3|NOT COMPLETED|Overall Study||0
296497|NCT00802659|714869|P2|NOT COMPLETED|Overall Study||1
296498|NCT00802659|714870|P1|NOT COMPLETED|Overall Study||0
296499|NCT00802659|714867|P4|COMPLETED|Overall Study||0
296500|NCT00802659|714868|P3|COMPLETED|Overall Study||0
296501|NCT00802659|714869|P2|COMPLETED|Overall Study||1
296502|NCT00802659|714870|P1|COMPLETED|Overall Study||0
296503|NCT00802659|714867|P4|STARTED|Overall Study||0
296504|NCT00802659|714868|P3|STARTED|Overall Study||0
296505|NCT00802659|714869|P2|STARTED|Overall Study||2
296506|NCT00802659|714870|P1|STARTED|Overall Study||0
296507|NCT00802633|714898|P2|NOT COMPLETED|Overall Study||0
296508|NCT00802633|714899|P1|NOT COMPLETED|Overall Study||0
296509|NCT00802633|714898|P2|COMPLETED|Overall Study||40
296510|NCT00802633|714899|P1|COMPLETED|Overall Study||40
296511|NCT00802633|714898|P2|STARTED|Overall Study||40
296512|NCT00802633|714899|P1|STARTED|Overall Study||40
296513|NCT00802529|714909|P2|NOT COMPLETED|Overall Study||1
296514|NCT00802529|714910|P1|NOT COMPLETED|Overall Study||0
296515|NCT00802529|714909|P2|COMPLETED|Overall Study||29
296516|NCT00802529|714910|P1|COMPLETED|Overall Study|2 patients crossed-over to gentamicin after steroids failed to control vertigo (as per protocol).|30
296517|NCT00802529|714909|P2|STARTED|Overall Study||30
296518|NCT00802529|714910|P1|STARTED|Overall Study||30
296519|NCT00802503|714922|P2|NOT COMPLETED|Overall Study||20
296520|NCT00802503|714923|P1|NOT COMPLETED|Overall Study||10
296521|NCT00802503|714922|P2|COMPLETED|Overall Study||133
296522|NCT00802503|714923|P1|COMPLETED|Overall Study||142
296523|NCT00802503|714922|P2|STARTED|Overall Study||153
296524|NCT00802503|714923|P1|STARTED|Overall Study||152
296525|NCT00802464|714949|P4|NOT COMPLETED|Month 8 - Month 14||0
296526|NCT00802464|714950|P3|NOT COMPLETED|Month 8 - Month 14||1
296527|NCT00802464|714951|P2|NOT COMPLETED|Month 8 - Month 14||2
296528|NCT00802464|714952|P1|NOT COMPLETED|Month 8 - Month 14||1
296529|NCT00802464|714949|P4|COMPLETED|Month 8 - Month 14||126
296530|NCT00802464|714950|P3|COMPLETED|Month 8 - Month 14||129
296531|NCT00802464|714951|P2|COMPLETED|Month 8 - Month 14||63
296532|NCT00802464|714952|P1|COMPLETED|Month 8 - Month 14||33
296533|NCT00802464|714949|P4|STARTED|Month 8 - Month 14||126
296534|NCT00802464|714950|P3|STARTED|Month 8 - Month 14||130
296535|NCT00802464|714951|P2|STARTED|Month 8 - Month 14||65
296536|NCT00802464|714952|P1|STARTED|Month 8 - Month 14||34
296537|NCT00802464|714949|P4|NOT COMPLETED|Month 0 - Month 8||9
296538|NCT00802464|714950|P3|NOT COMPLETED|Month 0 - Month 8||7
296539|NCT00802464|714951|P2|NOT COMPLETED|Month 0 - Month 8||3
296540|NCT00802464|714952|P1|NOT COMPLETED|Month 0 - Month 8||0
296541|NCT00802464|714949|P4|COMPLETED|Month 0 - Month 8||141
296542|NCT00802464|714950|P3|COMPLETED|Month 0 - Month 8||142
296543|NCT00802464|714951|P2|COMPLETED|Month 0 - Month 8||70
296544|NCT00802464|714952|P1|COMPLETED|Month 0 - Month 8||38
296545|NCT00802464|714949|P4|STARTED|Month 0 - Month 8||150
296546|NCT00802464|714950|P3|STARTED|Month 0 - Month 8||149
296547|NCT00802464|714951|P2|STARTED|Month 0 - Month 8||73
296548|NCT00802464|714952|P1|STARTED|Month 0 - Month 8||38
296549|NCT00802438|715038|P1|NOT COMPLETED|Overall Study||28
296550|NCT00802438|715038|P1|COMPLETED|Overall Study||10
296551|NCT00802438|715038|P1|STARTED|Overall Study||38
296552|NCT00802412|715045|P2|NOT COMPLETED|Overall Study||1
296553|NCT00802412|715046|P1|NOT COMPLETED|Overall Study||2
296554|NCT00802412|715045|P2|COMPLETED|Overall Study||66
296555|NCT00802412|715046|P1|COMPLETED|Overall Study||63
296556|NCT00802412|715045|P2|STARTED|Overall Study||67
296557|NCT00802412|715046|P1|STARTED|Overall Study||65
296558|NCT00802360|715058|P4|NOT COMPLETED|Overall Study||22
296559|NCT00802360|715059|P3|NOT COMPLETED|Overall Study||25
296560|NCT00802360|715060|P2|NOT COMPLETED|Overall Study||26
296561|NCT00802360|715061|P1|NOT COMPLETED|Overall Study||24
296562|NCT00802360|715058|P4|COMPLETED|Overall Study||17
296563|NCT00802360|715059|P3|COMPLETED|Overall Study||17
296564|NCT00802360|715060|P2|COMPLETED|Overall Study||16
296565|NCT00802360|715061|P1|COMPLETED|Overall Study||18
296566|NCT00802360|715058|P4|STARTED|Overall Study||39
296567|NCT00802360|715059|P3|STARTED|Overall Study||42
296568|NCT00802360|715060|P2|STARTED|Overall Study||42
296569|NCT00802360|715061|P1|STARTED|Overall Study||42
296570|NCT00802204|715103|P2|NOT COMPLETED|Overall Study||1
296571|NCT00802204|715104|P1|NOT COMPLETED|Overall Study||1
296572|NCT00802204|715103|P2|COMPLETED|Overall Study||18
296573|NCT00802204|715104|P1|COMPLETED|Overall Study||8
296574|NCT00802204|715103|P2|STARTED|Overall Study||19
296575|NCT00802204|715104|P1|STARTED|Overall Study||9
296576|NCT00802178|715128|P1|NOT COMPLETED|Overall Study||113
296577|NCT00802178|715128|P1|COMPLETED|Overall Study||2335
296578|NCT00802178|715128|P1|STARTED|Overall Study||2448
296579|NCT00802113|715137|P2|NOT COMPLETED|Overall Study||0
296580|NCT00802113|715138|P1|NOT COMPLETED|Overall Study||0
296581|NCT00802113|715137|P2|COMPLETED|Overall Study||17
296582|NCT00802113|715138|P1|COMPLETED|Overall Study||6
296583|NCT00802113|715137|P2|STARTED|Overall Study||17
296584|NCT00802113|715138|P1|STARTED|Overall Study||6
296585|NCT00802100|715159|P3|NOT COMPLETED|Overall Study||4
296586|NCT00802100|715160|P2|NOT COMPLETED|Overall Study||7
296587|NCT00802100|715161|P1|NOT COMPLETED|Overall Study||6
296588|NCT00802100|715159|P3|COMPLETED|Overall Study||2
296589|NCT00802100|715160|P2|COMPLETED|Overall Study||2
296590|NCT00802100|715161|P1|COMPLETED|Overall Study||0
296591|NCT00802100|715159|P3|STARTED|Overall Study||6
296592|NCT00802100|715160|P2|STARTED|Overall Study||9
296593|NCT00802100|715161|P1|STARTED|Overall Study||6
296594|NCT00802074|715176|P6|NOT COMPLETED|Overall Study||0
296595|NCT00802074|715177|P5|NOT COMPLETED|Overall Study||0
296596|NCT00802074|715178|P4|NOT COMPLETED|Overall Study||0
296597|NCT00802074|715179|P3|NOT COMPLETED|Overall Study||1
296598|NCT00802074|715180|P2|NOT COMPLETED|Overall Study||1
296599|NCT00802074|715181|P1|NOT COMPLETED|Overall Study||2
296600|NCT00802074|715176|P6|COMPLETED|Overall Study||7
296601|NCT00802074|715177|P5|COMPLETED|Overall Study||7
296602|NCT00802074|715178|P4|COMPLETED|Overall Study||7
296603|NCT00802074|715179|P3|COMPLETED|Overall Study||6
296604|NCT00802074|715180|P2|COMPLETED|Overall Study||7
296605|NCT00802074|715181|P1|COMPLETED|Overall Study||7
296606|NCT00802074|715176|P6|STARTED|Overall Study||7
296607|NCT00802074|715177|P5|STARTED|Overall Study||7
296608|NCT00802074|715178|P4|STARTED|Overall Study||7
296609|NCT00802074|715179|P3|STARTED|Overall Study||7
296610|NCT00802074|715180|P2|STARTED|Overall Study||8
296611|NCT00802074|715181|P1|STARTED|Overall Study||9
296612|NCT00801983|715215|P2|NOT COMPLETED|Period 2||1
296613|NCT00801983|715216|P1|NOT COMPLETED|Period 2||2
296614|NCT00801983|715215|P2|COMPLETED|Period 2||32
296615|NCT00801983|715216|P1|COMPLETED|Period 2||38
296616|NCT00801983|715215|P2|STARTED|Period 2||33
296617|NCT00801983|715216|P1|STARTED|Period 2||40
296618|NCT00801983|715215|P2|NOT COMPLETED|Period 1||8
296619|NCT00801983|715216|P1|NOT COMPLETED|Period 1||4
296620|NCT00801983|715215|P2|COMPLETED|Period 1||33
296621|NCT00801983|715216|P1|COMPLETED|Period 1||40
296622|NCT00801983|715215|P2|STARTED|Period 1||41
296623|NCT00801983|715216|P1|STARTED|Period 1||44
296624|NCT00801931|715222|P1|NOT COMPLETED|Overall Study||0
296625|NCT00801931|715222|P1|COMPLETED|Overall Study||1
296626|NCT00801931|715222|P1|STARTED|Overall Study||1
296627|NCT00801892|715231|P2|NOT COMPLETED|Sham Crossover Period||2
296628|NCT00801892|715232|P1|NOT COMPLETED|Sham Crossover Period||0
296629|NCT00801892|715231|P2|COMPLETED|Sham Crossover Period||5
296630|NCT00801892|715232|P1|COMPLETED|Sham Crossover Period||0
296631|NCT00801892|715231|P2|STARTED|Sham Crossover Period||7
296632|NCT00801892|715232|P1|STARTED|Sham Crossover Period||0
296633|NCT00801892|715231|P2|NOT COMPLETED|Main Study Period||1
296634|NCT00801892|715232|P1|NOT COMPLETED|Main Study Period||0
296635|NCT00801892|715231|P2|COMPLETED|Main Study Period||10
296636|NCT00801892|715232|P1|COMPLETED|Main Study Period||12
296637|NCT00801892|715231|P2|STARTED|Main Study Period||11
296638|NCT00801892|715232|P1|STARTED|Main Study Period||12
296639|NCT00801827|715248|P1|NOT COMPLETED|Overall Study||0
296640|NCT00801827|715248|P1|COMPLETED|Overall Study||5
296641|NCT00801827|715248|P1|STARTED|Overall Study|2 others consented but due to scheduling did not complete|5
296642|NCT00801801|715252|P1|NOT COMPLETED|Overall Study||0
296643|NCT00801801|715252|P1|COMPLETED|Overall Study||5
296644|NCT00801801|715252|P1|STARTED|Overall Study||5
296645|NCT00801684|715257|P1|NOT COMPLETED|Overall Study||0
296646|NCT00801684|715257|P1|COMPLETED|Overall Study||24
296647|NCT00801684|715257|P1|STARTED|Overall Study||24
296648|NCT00801632|715279|P1|NOT COMPLETED|Overall Study||1
296649|NCT00801632|715279|P1|COMPLETED|Overall Study||4
296650|NCT00801632|715279|P1|STARTED|Overall Study||5
296651|NCT00801398|715296|P6|NOT COMPLETED|Overall Study||3
296652|NCT00801398|715297|P5|NOT COMPLETED|Overall Study||7
296653|NCT00801398|715298|P4|NOT COMPLETED|Overall Study||6
296654|NCT00801398|715299|P3|NOT COMPLETED|Overall Study||7
296655|NCT00801398|715300|P2|NOT COMPLETED|Overall Study||9
296656|NCT00801398|715301|P1|NOT COMPLETED|Overall Study||6
296657|NCT00801398|715296|P6|COMPLETED|Overall Study||5
296658|NCT00801398|715297|P5|COMPLETED|Overall Study||1
296659|NCT00801398|715298|P4|COMPLETED|Overall Study||3
296660|NCT00801398|715299|P3|COMPLETED|Overall Study||4
296661|NCT00801398|715300|P2|COMPLETED|Overall Study||0
296662|NCT00801398|715301|P1|COMPLETED|Overall Study||7
296663|NCT00801398|715296|P6|STARTED|Overall Study||8
296664|NCT00801398|715297|P5|STARTED|Overall Study||8
296665|NCT00801398|715298|P4|STARTED|Overall Study||9
296666|NCT00801398|715299|P3|STARTED|Overall Study||11
296667|NCT00801398|715300|P2|STARTED|Overall Study||9
296668|NCT00801398|715301|P1|STARTED|Overall Study||13
296669|NCT00801242|715357|P1|NOT COMPLETED|Overall Study||52
296670|NCT00801242|715357|P1|COMPLETED|Overall Study|42, 10, and 0 participants withdrew during Cycles 1, 2, and 3 (i.e. 168 completed the trial).|168
296671|NCT00801242|715357|P1|Started Cycle 3|Overall Study||2
296672|NCT00801242|715357|P1|Started Cycle 2|Overall Study||35
296673|NCT00801242|715357|P1|FAS, Off-treatment Cycle 1|Overall Study|Completed 7 months induction period and were enrolled in the off-treatment period of cycle 1.|191
296674|NCT00801242|715357|P1|Full Analysis Set (FAS), Cycle 1|Overall Study|Randomized participants who received ≥1 dose and had ≥1 efficacy assessment.|213
296675|NCT00801242|715357|P1|Safety Analysis Set|Overall Study|Randomized participants who received ≥1 dose of degarelix.|216
296676|NCT00801242|715357|P1|STARTED|Overall Study|Randomized participants.|220
296677|NCT00801229|715370|P2|NOT COMPLETED|Received Study Drug/Placebo||4
296678|NCT00801229|715371|P1|NOT COMPLETED|Received Study Drug/Placebo||4
296679|NCT00801229|715370|P2|COMPLETED|Received Study Drug/Placebo||30
296680|NCT00801229|715371|P1|COMPLETED|Received Study Drug/Placebo||31
296681|NCT00801229|715370|P2|STARTED|Received Study Drug/Placebo||34
296682|NCT00801229|715371|P1|STARTED|Received Study Drug/Placebo||35
296683|NCT00801229|715370|P2|NOT COMPLETED|Signed Consent||3
296684|NCT00801229|715371|P1|NOT COMPLETED|Signed Consent||3
296685|NCT00801229|715370|P2|COMPLETED|Signed Consent||34
296686|NCT00801229|715371|P1|COMPLETED|Signed Consent||35
296687|NCT00801229|715370|P2|STARTED|Signed Consent||37
296688|NCT00801229|715371|P1|STARTED|Signed Consent||38
296689|NCT00801138|715381|P4|NOT COMPLETED|Overall Study||0
296690|NCT00801138|715382|P3|NOT COMPLETED|Overall Study||0
296691|NCT00801138|715383|P2|NOT COMPLETED|Overall Study||0
296692|NCT00801138|715384|P1|NOT COMPLETED|Overall Study||0
296693|NCT00801138|715381|P4|COMPLETED|Overall Study||54
296694|NCT00801138|715382|P3|COMPLETED|Overall Study||54
296695|NCT00801138|715383|P2|COMPLETED|Overall Study||56
296696|NCT00801138|715384|P1|COMPLETED|Overall Study||54
296697|NCT00801138|715381|P4|STARTED|Overall Study||54
296698|NCT00801138|715382|P3|STARTED|Overall Study||54
296699|NCT00801138|715383|P2|STARTED|Overall Study||56
296700|NCT00801138|715384|P1|STARTED|Overall Study||54
296701|NCT00801099|715406|P1|NOT COMPLETED|Overall Study||101
296702|NCT00801099|715406|P1|COMPLETED|Overall Study||175
296703|NCT00801099|715406|P1|STARTED|Overall Study||276
296704|NCT00800982|715412|P2|NOT COMPLETED|Overall Study||3
296705|NCT00800982|715413|P1|NOT COMPLETED|Overall Study||2
296706|NCT00800982|715412|P2|COMPLETED|Overall Study||12
296707|NCT00800982|715413|P1|COMPLETED|Overall Study||13
296708|NCT00800982|715412|P2|STARTED|Overall Study||15
296709|NCT00800982|715413|P1|STARTED|Overall Study||15
296710|NCT00800865|715421|P2|NOT COMPLETED|Overall Study||0
296711|NCT00800865|715422|P1|NOT COMPLETED|Overall Study||0
296712|NCT00800865|715421|P2|COMPLETED|Overall Study||16
296713|NCT00800865|715422|P1|COMPLETED|Overall Study||15
296714|NCT00800865|715421|P2|STARTED|Overall Study||16
296715|NCT00800865|715422|P1|STARTED|Overall Study||15
296716|NCT00800839|715430|P1|NOT COMPLETED|Overall Study||7
296717|NCT00800839|715430|P1|COMPLETED|Overall Study||49
296718|NCT00800839|715430|P1|STARTED|Overall Study||56
296719|NCT00800735|715439|P1|NOT COMPLETED|Overall Study||14
296720|NCT00800735|715439|P1|COMPLETED|Overall Study||16
296721|NCT00800735|715439|P1|STARTED|Overall Study||30
296722|NCT00800683|715445|P2|NOT COMPLETED|Overall Study||19
296723|NCT00800683|715446|P1|NOT COMPLETED|Overall Study||17
296724|NCT00800683|715445|P2|COMPLETED|Overall Study|Number who completed treatment|49
296725|NCT00800683|715446|P1|COMPLETED|Overall Study|Number who completed treatment|48
296726|NCT00800683|715445|P2|STARTED|Overall Study|Number who started treatment|68
296727|NCT00800683|715446|P1|STARTED|Overall Study|Number who started treatment|65
296728|NCT00800540|715492|P2|NOT COMPLETED|Period 2: 6 Weeks||1
296729|NCT00800540|715493|P1|NOT COMPLETED|Period 2: 6 Weeks||0
296730|NCT00800540|715492|P2|COMPLETED|Period 2: 6 Weeks||16
296731|NCT00800540|715493|P1|COMPLETED|Period 2: 6 Weeks||16
296732|NCT00800540|715492|P2|STARTED|Period 2: 6 Weeks||17
296733|NCT00800540|715493|P1|STARTED|Period 2: 6 Weeks||16
296734|NCT00800540|715492|P2|NOT COMPLETED|Washout: 4 Weeks||0
296735|NCT00800540|715493|P1|NOT COMPLETED|Washout: 4 Weeks||0
296736|NCT00800540|715492|P2|COMPLETED|Washout: 4 Weeks||17
296737|NCT00800540|715493|P1|COMPLETED|Washout: 4 Weeks||16
296738|NCT00800540|715492|P2|STARTED|Washout: 4 Weeks||17
296739|NCT00800540|715493|P1|STARTED|Washout: 4 Weeks||16
296740|NCT00800540|715492|P2|NOT COMPLETED|Period One: 6 Weeks||1
296741|NCT00800540|715493|P1|NOT COMPLETED|Period One: 6 Weeks||1
296742|NCT00800540|715492|P2|COMPLETED|Period One: 6 Weeks||17
296743|NCT00800540|715493|P1|COMPLETED|Period One: 6 Weeks||16
296744|NCT00800540|715492|P2|STARTED|Period One: 6 Weeks||18
296745|NCT00800540|715493|P1|STARTED|Period One: 6 Weeks||17
296746|NCT00800436|715528|P7|NOT COMPLETED|Overall Study||0
296747|NCT00800436|715529|P6|NOT COMPLETED|Overall Study||0
296748|NCT00800436|715530|P5|NOT COMPLETED|Overall Study||0
296749|NCT00800436|715531|P4|NOT COMPLETED|Overall Study||1
296750|NCT00800436|715532|P3|NOT COMPLETED|Overall Study||1
296751|NCT00800436|715533|P2|NOT COMPLETED|Overall Study||0
296752|NCT00800436|715534|P1|NOT COMPLETED|Overall Study||0
296753|NCT00800436|715528|P7|COMPLETED|Overall Study||20
296754|NCT00800436|715529|P6|COMPLETED|Overall Study||20
296755|NCT00800436|715530|P5|COMPLETED|Overall Study||6
296756|NCT00800436|715531|P4|COMPLETED|Overall Study||5
296757|NCT00800436|715532|P3|COMPLETED|Overall Study||5
296758|NCT00800436|715533|P2|COMPLETED|Overall Study||6
296759|NCT00800436|715534|P1|COMPLETED|Overall Study||6
296760|NCT00800436|715528|P7|STARTED|Overall Study||20
296761|NCT00800436|715529|P6|STARTED|Overall Study||20
296762|NCT00800436|715530|P5|STARTED|Overall Study||6
296763|NCT00800436|715531|P4|STARTED|Overall Study||6
296764|NCT00800436|715532|P3|STARTED|Overall Study||6
296765|NCT00800436|715533|P2|STARTED|Overall Study||6
296766|NCT00800436|715534|P1|STARTED|Overall Study||6
296767|NCT00800384|715580|P2|NOT COMPLETED|Overall Study||43
296768|NCT00800384|715581|P1|NOT COMPLETED|Overall Study||41
296769|NCT00800384|715580|P2|COMPLETED|Overall Study||1210
296770|NCT00800384|715581|P1|COMPLETED|Overall Study||1206
296771|NCT00800384|715580|P2|STARTED|Overall Study||1253
296772|NCT00800384|715581|P1|STARTED|Overall Study||1247
296773|NCT00800345|715589|P1|NOT COMPLETED|Overall Study||0
296774|NCT00800345|715589|P1|COMPLETED|Overall Study||33
296775|NCT00800345|715589|P1|STARTED|Overall Study||33
296776|NCT00800254|715596|P2|NOT COMPLETED|Overall Study||6
296777|NCT00800254|715597|P1|NOT COMPLETED|Overall Study||5
296778|NCT00800254|715596|P2|COMPLETED|Overall Study||25
296779|NCT00800254|715597|P1|COMPLETED|Overall Study||30
296780|NCT00800254|715596|P2|3.5 Weeks Post-operatively|Overall Study||31
296781|NCT00800254|715597|P1|3.5 Weeks Post-operatively|Overall Study||31
296782|NCT00800254|715596|P2|STARTED|Overall Study||31
296783|NCT00800254|715597|P1|STARTED|Overall Study||35
296784|NCT00800202|715619|P2|NOT COMPLETED|Overall Study||24
296785|NCT00800202|715620|P1|NOT COMPLETED|Overall Study||67
296786|NCT00800202|715619|P2|COMPLETED|Overall Study||0
296787|NCT00800202|715620|P1|COMPLETED|Overall Study||0
296788|NCT00800202|715619|P2|STARTED|Overall Study||24
296789|NCT00800202|715620|P1|STARTED|Overall Study||67
296790|NCT00799903|715640|P2|NOT COMPLETED|Overall Study||278
296791|NCT00799903|715641|P1|NOT COMPLETED|Overall Study||273
296792|NCT00799903|715640|P2|COMPLETED|Overall Study||7646
296793|NCT00799903|715641|P1|COMPLETED|Overall Study||7631
296794|NCT00799903|715640|P2|STARTED|Overall Study||7924
296795|NCT00799903|715641|P1|STARTED|Overall Study||7904
296796|NCT00799825|715661|P1|NOT COMPLETED|Overall Study||48
296797|NCT00799825|715661|P1|COMPLETED|Overall Study||296
296798|NCT00799825|715661|P1|STARTED|Overall Study||344
296799|NCT00799773|715669|P2|NOT COMPLETED|Overall Study||0
296800|NCT00799773|715670|P1|NOT COMPLETED|Overall Study||0
296801|NCT00799773|715669|P2|COMPLETED|Overall Study||1
296802|NCT00799773|715670|P1|COMPLETED|Overall Study||2
296803|NCT00799773|715669|P2|STARTED|Overall Study||1
296804|NCT00799773|715670|P1|STARTED|Overall Study||2
296805|NCT00799708|715701|P3|NOT COMPLETED|Overall Study||0
296806|NCT00799708|715702|P2|NOT COMPLETED|Overall Study||0
296807|NCT00799708|715703|P1|NOT COMPLETED|Overall Study||1
296808|NCT00799708|715701|P3|COMPLETED|Overall Study||11
296809|NCT00799708|715702|P2|COMPLETED|Overall Study||6
296810|NCT00799708|715703|P1|COMPLETED|Overall Study||9
296811|NCT00799708|715701|P3|STARTED|Overall Study||11
296812|NCT00799708|715702|P2|STARTED|Overall Study||6
296813|NCT00799708|715703|P1|STARTED|Overall Study||10
296814|NCT00799643|715715|P2|NOT COMPLETED|Overall Study||27
296815|NCT00799643|715716|P1|NOT COMPLETED|Overall Study||25
296816|NCT00799643|715715|P2|COMPLETED|Overall Study||119
296817|NCT00799643|715716|P1|COMPLETED|Overall Study||115
296818|NCT00799643|715715|P2|STARTED|Overall Study||146
296819|NCT00799643|715716|P1|STARTED|Overall Study||140
296820|NCT00799617|715726|P2|NOT COMPLETED|Anemia Trial||3
296821|NCT00799617|715727|P1|NOT COMPLETED|Anemia Trial||3
296822|NCT00799617|715726|P2|COMPLETED|Anemia Trial||32
296823|NCT00799617|715727|P1|COMPLETED|Anemia Trial||24
296824|NCT00799617|715726|P2|STARTED|Anemia Trial||35
296825|NCT00799617|715727|P1|STARTED|Anemia Trial||27
296826|NCT00799617|715726|P2|NOT COMPLETED|Cognitive Function Trial||1
296827|NCT00799617|715727|P1|NOT COMPLETED|Cognitive Function Trial||0
296828|NCT00799617|715726|P2|COMPLETED|Cognitive Function Trial||245
296829|NCT00799617|715727|P1|COMPLETED|Cognitive Function Trial||247
296830|NCT00799617|715726|P2|STARTED|Cognitive Function Trial||246
296831|NCT00799617|715727|P1|STARTED|Cognitive Function Trial||247
296832|NCT00799617|715726|P2|NOT COMPLETED|Bone Trial||16
296833|NCT00799617|715727|P1|NOT COMPLETED|Bone Trial||6
296834|NCT00799617|715726|P2|COMPLETED|Bone Trial||85
296835|NCT00799617|715727|P1|COMPLETED|Bone Trial||104
296836|NCT00799617|715726|P2|STARTED|Bone Trial||101
296837|NCT00799617|715727|P1|STARTED|Bone Trial||110
296838|NCT00799617|715726|P2|NOT COMPLETED|Cardiovascular Trial||17
296839|NCT00799617|715727|P1|NOT COMPLETED|Cardiovascular Trial||15
296840|NCT00799617|715726|P2|COMPLETED|Cardiovascular Trial||65
296841|NCT00799617|715727|P1|COMPLETED|Cardiovascular Trial||73
296842|NCT00799617|715726|P2|STARTED|Cardiovascular Trial||82
296843|NCT00799617|715727|P1|STARTED|Cardiovascular Trial||88
296844|NCT00799617|715726|P2|NOT COMPLETED|Vitality Trial||22
296845|NCT00799617|715727|P1|NOT COMPLETED|Vitality Trial||7
296846|NCT00799617|715726|P2|COMPLETED|Vitality Trial||216
296847|NCT00799617|715727|P1|COMPLETED|Vitality Trial||229
296848|NCT00799617|715726|P2|STARTED|Vitality Trial||238
296849|NCT00799617|715727|P1|STARTED|Vitality Trial||236
296850|NCT00799617|715726|P2|NOT COMPLETED|Physical Function Trial||11
296851|NCT00799617|715727|P1|NOT COMPLETED|Physical Function Trial||6
296852|NCT00799617|715726|P2|COMPLETED|Physical Function Trial||185
296853|NCT00799617|715727|P1|COMPLETED|Physical Function Trial||185
296854|NCT00799617|715726|P2|STARTED|Physical Function Trial||196
296855|NCT00799617|715727|P1|STARTED|Physical Function Trial||191
296856|NCT00799617|715726|P2|NOT COMPLETED|Sexual Funtion Trial||21
296857|NCT00799617|715727|P1|NOT COMPLETED|Sexual Funtion Trial||16
296858|NCT00799617|715726|P2|COMPLETED|Sexual Funtion Trial||215
296859|NCT00799617|715727|P1|COMPLETED|Sexual Funtion Trial||218
296860|NCT00799617|715726|P2|STARTED|Sexual Funtion Trial||236
296861|NCT00799617|715727|P1|STARTED|Sexual Funtion Trial||234
296862|NCT00799617|715726|P2|NOT COMPLETED|Main Testosterone Trial||21
296863|NCT00799617|715727|P1|NOT COMPLETED|Main Testosterone Trial||19
296864|NCT00799617|715726|P2|COMPLETED|Main Testosterone Trial||374
296865|NCT00799617|715727|P1|COMPLETED|Main Testosterone Trial|Participants qualified for 1 of the 3 main trials (sexual function, physical function, vitality).|376
296866|NCT00799617|715726|P2|STARTED|Main Testosterone Trial||395
296867|NCT00799617|715727|P1|STARTED|Main Testosterone Trial||395
296868|NCT00799604|715808|P3|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
296869|NCT00799604|715809|P2|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
296870|NCT00799604|715810|P1|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
296871|NCT00799604|715808|P3|COMPLETED|Bolus 2 (With Anesthesia)||3
296872|NCT00799604|715809|P2|COMPLETED|Bolus 2 (With Anesthesia)||12
296873|NCT00799604|715810|P1|COMPLETED|Bolus 2 (With Anesthesia)||6
296958|NCT00799422|715952|P3|NOT COMPLETED|First Week of Wear||1
296874|NCT00799604|715808|P3|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|3
296875|NCT00799604|715809|P2|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|12
296876|NCT00799604|715810|P1|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|6
296877|NCT00799604|715808|P3|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
296878|NCT00799604|715809|P2|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
296879|NCT00799604|715810|P1|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
296880|NCT00799604|715808|P3|COMPLETED|Bolus 1 (Pre-anesthesia)||10
296881|NCT00799604|715809|P2|COMPLETED|Bolus 1 (Pre-anesthesia)||10
296882|NCT00799604|715810|P1|COMPLETED|Bolus 1 (Pre-anesthesia)||10
296883|NCT00799604|715808|P3|STARTED|Bolus 1 (Pre-anesthesia)||10
296884|NCT00799604|715809|P2|STARTED|Bolus 1 (Pre-anesthesia)||10
296885|NCT00799604|715810|P1|STARTED|Bolus 1 (Pre-anesthesia)||10
296886|NCT00799591|715834|P1|NOT COMPLETED|Overall Study||66
296887|NCT00799591|715834|P1|COMPLETED|Overall Study||90
296888|NCT00799591|715834|P1|STARTED|Overall Study||156
296889|NCT00799578|715845|P1|NOT COMPLETED|Overall Study||2
296890|NCT00799578|715845|P1|COMPLETED|Overall Study||11
296891|NCT00799578|715845|P1|STARTED|Overall Study||13
296892|NCT00799487|715852|P3|NOT COMPLETED|Double-Blind Assessment Period||2
296893|NCT00799487|715853|P2|NOT COMPLETED|Double-Blind Assessment Period||1
296894|NCT00799487|715854|P1|NOT COMPLETED|Double-Blind Assessment Period||0
296895|NCT00799487|715852|P3|COMPLETED|Double-Blind Assessment Period||32
296896|NCT00799487|715853|P2|COMPLETED|Double-Blind Assessment Period||33
296897|NCT00799487|715854|P1|COMPLETED|Double-Blind Assessment Period||0
296898|NCT00799487|715852|P3|STARTED|Double-Blind Assessment Period||34
296899|NCT00799487|715853|P2|STARTED|Double-Blind Assessment Period||34
296900|NCT00799487|715854|P1|STARTED|Double-Blind Assessment Period||0
296901|NCT00799487|715852|P3|NOT COMPLETED|Dose Adjustment Period||0
296902|NCT00799487|715853|P2|NOT COMPLETED|Dose Adjustment Period||0
296903|NCT00799487|715854|P1|NOT COMPLETED|Dose Adjustment Period||21
296904|NCT00799487|715852|P3|COMPLETED|Dose Adjustment Period||34
296905|NCT00799487|715853|P2|COMPLETED|Dose Adjustment Period||34
296906|NCT00799487|715854|P1|COMPLETED|Dose Adjustment Period||0
296907|NCT00799487|715852|P3|STARTED|Dose Adjustment Period||34
296908|NCT00799487|715853|P2|STARTED|Dose Adjustment Period||34
296909|NCT00799487|715854|P1|STARTED|Dose Adjustment Period||21
296910|NCT00799474|715934|P1|NOT COMPLETED|Overall Study||0
296911|NCT00799474|715934|P1|COMPLETED|Overall Study||609
296912|NCT00799474|715934|P1|STARTED|Overall Study||609
296913|NCT00799435|715942|P2|NOT COMPLETED|Overall Study||0
296914|NCT00799435|715943|P1|NOT COMPLETED|Overall Study||0
296915|NCT00799435|715942|P2|COMPLETED|Overall Study||1
296916|NCT00799435|715943|P1|COMPLETED|Overall Study||1
296917|NCT00799435|715942|P2|STARTED|Overall Study||1
296918|NCT00799435|715943|P1|STARTED|Overall Study||1
296919|NCT00799422|715949|P6|NOT COMPLETED|Third Week of Wear||0
296920|NCT00799422|715950|P5|NOT COMPLETED|Third Week of Wear||0
296921|NCT00799422|715951|P4|NOT COMPLETED|Third Week of Wear||0
296922|NCT00799422|715952|P3|NOT COMPLETED|Third Week of Wear||0
296923|NCT00799422|715953|P2|NOT COMPLETED|Third Week of Wear||0
296924|NCT00799422|715954|P1|NOT COMPLETED|Third Week of Wear||0
296925|NCT00799422|715949|P6|COMPLETED|Third Week of Wear||4
296926|NCT00799422|715950|P5|COMPLETED|Third Week of Wear||4
296927|NCT00799422|715951|P4|COMPLETED|Third Week of Wear||3
296928|NCT00799422|715952|P3|COMPLETED|Third Week of Wear||3
296929|NCT00799422|715953|P2|COMPLETED|Third Week of Wear||4
296930|NCT00799422|715954|P1|COMPLETED|Third Week of Wear||4
296931|NCT00799422|715949|P6|STARTED|Third Week of Wear||4
296932|NCT00799422|715950|P5|STARTED|Third Week of Wear||4
296933|NCT00799422|715951|P4|STARTED|Third Week of Wear||3
296934|NCT00799422|715952|P3|STARTED|Third Week of Wear||3
296935|NCT00799422|715953|P2|STARTED|Third Week of Wear||4
296936|NCT00799422|715954|P1|STARTED|Third Week of Wear||4
296937|NCT00799422|715949|P6|NOT COMPLETED|Second Week of Wear||0
296938|NCT00799422|715950|P5|NOT COMPLETED|Second Week of Wear||0
296939|NCT00799422|715951|P4|NOT COMPLETED|Second Week of Wear||0
296940|NCT00799422|715952|P3|NOT COMPLETED|Second Week of Wear||0
296941|NCT00799422|715953|P2|NOT COMPLETED|Second Week of Wear||0
296942|NCT00799422|715954|P1|NOT COMPLETED|Second Week of Wear||0
296943|NCT00799422|715949|P6|COMPLETED|Second Week of Wear||4
296944|NCT00799422|715950|P5|COMPLETED|Second Week of Wear||4
296945|NCT00799422|715951|P4|COMPLETED|Second Week of Wear||3
296946|NCT00799422|715952|P3|COMPLETED|Second Week of Wear||3
296947|NCT00799422|715953|P2|COMPLETED|Second Week of Wear||4
296948|NCT00799422|715954|P1|COMPLETED|Second Week of Wear||4
296949|NCT00799422|715949|P6|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|4
296950|NCT00799422|715950|P5|STARTED|Second Week of Wear||4
296951|NCT00799422|715951|P4|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|3
296952|NCT00799422|715952|P3|STARTED|Second Week of Wear||3
296953|NCT00799422|715953|P2|STARTED|Second Week of Wear||4
296954|NCT00799422|715954|P1|STARTED|Second Week of Wear||4
296955|NCT00799422|715949|P6|NOT COMPLETED|First Week of Wear||0
296956|NCT00799422|715950|P5|NOT COMPLETED|First Week of Wear||0
296957|NCT00799422|715951|P4|NOT COMPLETED|First Week of Wear||1
296959|NCT00799422|715953|P2|NOT COMPLETED|First Week of Wear||0
296960|NCT00799422|715954|P1|NOT COMPLETED|First Week of Wear||0
296961|NCT00799422|715949|P6|COMPLETED|First Week of Wear||5
296962|NCT00799422|715950|P5|COMPLETED|First Week of Wear||4
296963|NCT00799422|715951|P4|COMPLETED|First Week of Wear||4
296964|NCT00799422|715952|P3|COMPLETED|First Week of Wear||3
296965|NCT00799422|715953|P2|COMPLETED|First Week of Wear||4
296966|NCT00799422|715954|P1|COMPLETED|First Week of Wear||4
296967|NCT00799422|715949|P6|STARTED|First Week of Wear||5
296968|NCT00799422|715950|P5|STARTED|First Week of Wear||4
296969|NCT00799422|715951|P4|STARTED|First Week of Wear||5
296970|NCT00799422|715952|P3|STARTED|First Week of Wear||4
296971|NCT00799422|715953|P2|STARTED|First Week of Wear||4
296972|NCT00799422|715954|P1|STARTED|First Week of Wear||4
296973|NCT00799409|715971|P3|NOT COMPLETED|Overall Study||0
296974|NCT00799409|715972|P2|NOT COMPLETED|Overall Study||0
296975|NCT00799409|715973|P1|NOT COMPLETED|Overall Study||7
296976|NCT00799409|715971|P3|COMPLETED|Overall Study||35
296977|NCT00799409|715972|P2|COMPLETED|Overall Study||36
296978|NCT00799409|715973|P1|COMPLETED|Overall Study||0
296979|NCT00799409|715971|P3|STARTED|Overall Study||35
296980|NCT00799409|715972|P2|STARTED|Overall Study||36
296981|NCT00799409|715973|P1|STARTED|Overall Study||7
296982|NCT00799396|716053|P1|NOT COMPLETED|Clopidogrel Plus Aspirin||6
296983|NCT00799396|716053|P1|COMPLETED|Clopidogrel Plus Aspirin||663
296984|NCT00799396|716053|P1|STARTED|Clopidogrel Plus Aspirin||669
296985|NCT00799396|716053|P1|NOT COMPLETED|Clopidogrel Treatment||13
296986|NCT00799396|716053|P1|COMPLETED|Clopidogrel Treatment||669
296987|NCT00799396|716053|P1|STARTED|Clopidogrel Treatment||682
296988|NCT00799383|716060|P2|NOT COMPLETED|Overall Study||6
296989|NCT00799383|716061|P1|NOT COMPLETED|Overall Study||3
296990|NCT00799383|716060|P2|COMPLETED|Overall Study||18
296991|NCT00799383|716061|P1|COMPLETED|Overall Study||20
296992|NCT00799383|716060|P2|STARTED|Overall Study||24
296993|NCT00799383|716061|P1|STARTED|Overall Study||23
296994|NCT00799292|716083|P2|NOT COMPLETED|Overall Study||0
296995|NCT00799292|716084|P1|NOT COMPLETED|Overall Study||0
296996|NCT00799292|716083|P2|COMPLETED|Overall Study||29
296997|NCT00799292|716084|P1|COMPLETED|Overall Study||29
296998|NCT00799292|716083|P2|STARTED|Overall Study||29
296999|NCT00799292|716084|P1|STARTED|Overall Study||29
297000|NCT00799266|716090|P2|NOT COMPLETED|Overall Study||1
297001|NCT00799266|716091|P1|NOT COMPLETED|Overall Study||3
297002|NCT00799266|716090|P2|COMPLETED|Overall Study||15
297003|NCT00799266|716091|P1|COMPLETED|Overall Study||15
297004|NCT00799266|716090|P2|Safety Set|Overall Study||16
297005|NCT00799266|716091|P1|Safety Set|Overall Study||18
297006|NCT00799266|716090|P2|Modified Intention-to-treat (MITT)|Overall Study||16
297007|NCT00799266|716091|P1|Modified Intention-to-treat (MITT)|Overall Study||17
297008|NCT00799266|716090|P2|STARTED|Overall Study||16
297009|NCT00799266|716091|P1|STARTED|Overall Study||18
297010|NCT00799227|716122|P1|NOT COMPLETED|Overall Study||3
297011|NCT00799227|716122|P1|COMPLETED|Overall Study||53
297012|NCT00799227|716122|P1|STARTED|Overall Study||56
297013|NCT00798967|716131|P2|NOT COMPLETED|Overall Study||4
297014|NCT00798967|716132|P1|NOT COMPLETED|Overall Study||4
297015|NCT00798967|716131|P2|COMPLETED|Overall Study||39
297016|NCT00798967|716132|P1|COMPLETED|Overall Study||39
297017|NCT00798967|716131|P2|Discontinued During Dosing Period|Overall Study||4
297018|NCT00798967|716132|P1|Discontinued During Dosing Period|Overall Study||4
297019|NCT00798967|716131|P2|STARTED|Overall Study||43
297020|NCT00798967|716132|P1|STARTED|Overall Study||43
297021|NCT00798889|716140|P1|NOT COMPLETED|Overall Study||314
297022|NCT00798889|716140|P1|COMPLETED|Overall Study||0
297023|NCT00798889|716140|P1|Treated|Overall Study||311
297024|NCT00798889|716140|P1|STARTED|Overall Study||314
297025|NCT00798759|716146|P2|NOT COMPLETED|Overall Study||13
297026|NCT00798759|716147|P1|NOT COMPLETED|Overall Study||8
297027|NCT00798759|716146|P2|COMPLETED|Overall Study||106
297028|NCT00798759|716147|P1|COMPLETED|Overall Study||109
297029|NCT00798759|716146|P2|STARTED|Overall Study||119
297030|NCT00798759|716147|P1|STARTED|Overall Study||117
297031|NCT00798720|716155|P1|NOT COMPLETED|Overall Study||0
297032|NCT00798720|716155|P1|COMPLETED|Overall Study||18
297033|NCT00798720|716155|P1|STARTED|Overall Study||18
297034|NCT00798707|716165|P3|NOT COMPLETED|Overall Study||22
297035|NCT00798707|716166|P2|NOT COMPLETED|Overall Study||33
297036|NCT00798707|716167|P1|NOT COMPLETED|Overall Study||26
297037|NCT00798707|716165|P3|COMPLETED|Overall Study||215
297038|NCT00798707|716166|P2|COMPLETED|Overall Study||204
297039|NCT00798707|716167|P1|COMPLETED|Overall Study||209
297040|NCT00798707|716165|P3|Treated|Overall Study||236
297041|NCT00798707|716166|P2|Treated|Overall Study||232
297042|NCT00798707|716167|P1|Treated|Overall Study||231
297043|NCT00798707|716165|P3|STARTED|Overall Study||237
297044|NCT00798707|716166|P2|STARTED|Overall Study||237
297045|NCT00798707|716167|P1|STARTED|Overall Study||235
297046|NCT00798694|716219|P2|NOT COMPLETED|Overall Study||1
297047|NCT00798694|716220|P1|NOT COMPLETED|Overall Study||2
297048|NCT00798694|716219|P2|COMPLETED|Overall Study||27
297049|NCT00798694|716220|P1|COMPLETED|Overall Study||28
297050|NCT00798694|716219|P2|STARTED|Overall Study||28
297051|NCT00798694|716220|P1|STARTED|Overall Study||30
297052|NCT00798655|716244|P1|NOT COMPLETED|Overall Study||2
297053|NCT00798655|716244|P1|COMPLETED|Overall Study||44
297054|NCT00798655|716244|P1|STARTED|Overall Study||46
297055|NCT00798603|716249|P1|NOT COMPLETED|Overall Study||35
297056|NCT00798603|716249|P1|COMPLETED|Overall Study||27
297057|NCT00798603|716249|P1|STARTED|Overall Study||62
297058|NCT00798590|716271|P2|NOT COMPLETED|Overall Study||8
297059|NCT00798590|716272|P1|NOT COMPLETED|Overall Study||11
297060|NCT00798590|716271|P2|COMPLETED|Overall Study||0
297061|NCT00798590|716272|P1|COMPLETED|Overall Study||0
297062|NCT00798590|716271|P2|STARTED|Overall Study||8
297063|NCT00798590|716272|P1|STARTED|Overall Study||11
297064|NCT00798577|716282|P2|NOT COMPLETED|Overall Study||0
297065|NCT00798577|716283|P1|NOT COMPLETED|Overall Study||0
297066|NCT00798577|716282|P2|COMPLETED|Overall Study||7
297067|NCT00798577|716283|P1|COMPLETED|Overall Study||17
297068|NCT00798577|716282|P2|STARTED|Overall Study||7
297069|NCT00798577|716283|P1|STARTED|Overall Study||17
297070|NCT00798486|716297|P1|NOT COMPLETED|Overall Study||0
297071|NCT00798486|716297|P1|COMPLETED|Overall Study||110
297072|NCT00798486|716297|P1|STARTED|Overall Study||110
297073|NCT00798434|716306|P2|NOT COMPLETED|Open-Label||32
297074|NCT00798434|716307|P1|NOT COMPLETED|Open-Label||42
297075|NCT00798434|716306|P2|COMPLETED|Open-Label||282
297076|NCT00798434|716307|P1|COMPLETED|Open-Label||299
297077|NCT00798434|716306|P2|Received Treatment|Open-Label||313
297078|NCT00798434|716307|P1|Received Treatment|Open-Label||341
297079|NCT00798434|716306|P2|STARTED|Open-Label||314
297080|NCT00798434|716307|P1|STARTED|Open-Label||341
297081|NCT00798434|716306|P2|NOT COMPLETED|Double-Blind||84
297082|NCT00798434|716307|P1|NOT COMPLETED|Double-Blind||55
297083|NCT00798434|716306|P2|COMPLETED|Double-Blind||314
297084|NCT00798434|716307|P1|COMPLETED|Double-Blind||341
297085|NCT00798434|716306|P2|Received Treatment|Double-Blind||392
297086|NCT00798434|716307|P1|Received Treatment|Double-Blind||393
297087|NCT00798434|716306|P2|STARTED|Double-Blind||398
297088|NCT00798434|716307|P1|STARTED|Double-Blind||396
297089|NCT00798369|716393|P6|NOT COMPLETED|Overall Study||3
297090|NCT00798369|716394|P5|NOT COMPLETED|Overall Study||1
297091|NCT00798369|716395|P4|NOT COMPLETED|Overall Study||1
297092|NCT00798369|716396|P3|NOT COMPLETED|Overall Study||2
297093|NCT00798369|716397|P2|NOT COMPLETED|Overall Study||1
297094|NCT00798369|716398|P1|NOT COMPLETED|Overall Study||1
297095|NCT00798369|716393|P6|COMPLETED|Overall Study||54
297096|NCT00798369|716394|P5|COMPLETED|Overall Study||27
297097|NCT00798369|716395|P4|COMPLETED|Overall Study||28
297098|NCT00798369|716396|P3|COMPLETED|Overall Study||27
297099|NCT00798369|716397|P2|COMPLETED|Overall Study||28
297100|NCT00798369|716398|P1|COMPLETED|Overall Study||27
297101|NCT00798369|716393|P6|STARTED|Overall Study||57
297102|NCT00798369|716394|P5|STARTED|Overall Study||28
297103|NCT00798369|716395|P4|STARTED|Overall Study||29
297104|NCT00798369|716396|P3|STARTED|Overall Study||29
297105|NCT00798369|716397|P2|STARTED|Overall Study||29
297106|NCT00798369|716398|P1|STARTED|Overall Study||28
297107|NCT00798317|716445|P2|NOT COMPLETED|Overall Study||7
297108|NCT00798317|716446|P1|NOT COMPLETED|Overall Study||10
297109|NCT00798317|716445|P2|COMPLETED|Overall Study||74
297110|NCT00798317|716446|P1|COMPLETED|Overall Study||235
297111|NCT00798317|716445|P2|STARTED|Overall Study||81
297112|NCT00798317|716446|P1|STARTED|Overall Study||245
297113|NCT00798304|716457|P3|NOT COMPLETED|Overall Study||10
297114|NCT00798304|716458|P2|NOT COMPLETED|Overall Study||22
297115|NCT00798304|716459|P1|NOT COMPLETED|Overall Study||14
297116|NCT00798304|716457|P3|COMPLETED|Overall Study||0
297117|NCT00798304|716458|P2|COMPLETED|Overall Study||0
297118|NCT00798304|716459|P1|COMPLETED|Overall Study||0
297119|NCT00798304|716457|P3|STARTED|Overall Study||10
297120|NCT00798304|716458|P2|STARTED|Overall Study||22
297121|NCT00798304|716459|P1|STARTED|Overall Study||14
297122|NCT00798174|716485|P2|NOT COMPLETED|Overall Study||3
297123|NCT00798174|716486|P1|NOT COMPLETED|Overall Study||4
297124|NCT00798174|716485|P2|COMPLETED|Overall Study||13
297125|NCT00798174|716486|P1|COMPLETED|Overall Study||12
297126|NCT00798174|716485|P2|STARTED|Overall Study||16
297127|NCT00798174|716486|P1|STARTED|Overall Study||16
297128|NCT00798161|716497|P7|NOT COMPLETED|Overall Study||10
297129|NCT00798161|716498|P6|NOT COMPLETED|Overall Study||11
297130|NCT00798161|716499|P5|NOT COMPLETED|Overall Study||16
297131|NCT00798161|716500|P4|NOT COMPLETED|Overall Study||21
297132|NCT00798161|716501|P3|NOT COMPLETED|Overall Study||21
297133|NCT00798161|716502|P2|NOT COMPLETED|Overall Study||17
297134|NCT00798161|716503|P1|NOT COMPLETED|Overall Study||18
297135|NCT00798161|716497|P7|COMPLETED|Overall Study||56
297136|NCT00798161|716498|P6|COMPLETED|Overall Study||132
297137|NCT00798161|716499|P5|COMPLETED|Overall Study||127
297138|NCT00798161|716500|P4|COMPLETED|Overall Study||121
297139|NCT00798161|716501|P3|COMPLETED|Overall Study||126
297140|NCT00798161|716502|P2|COMPLETED|Overall Study||127
297141|NCT00798161|716503|P1|COMPLETED|Overall Study||54
297142|NCT00798161|716497|P7|STARTED|Overall Study||66
297143|NCT00798161|716498|P6|STARTED|Overall Study||143
297144|NCT00798161|716499|P5|STARTED|Overall Study||143
297145|NCT00798161|716500|P4|STARTED|Overall Study||142
297146|NCT00798161|716501|P3|STARTED|Overall Study||147
297147|NCT00798161|716502|P2|STARTED|Overall Study||144
297148|NCT00798161|716503|P1|STARTED|Overall Study||72
297149|NCT00798135|716610|P1|NOT COMPLETED|Overall Study||13
297150|NCT00798135|716610|P1|COMPLETED|Overall Study||0
297151|NCT00798135|716610|P1|STARTED|Overall Study||13
297152|NCT00798096|716616|P1|NOT COMPLETED|Overall Study||2
297153|NCT00798096|716616|P1|COMPLETED|Overall Study|Completion of Study is defined as a minimum of 8 weeks of treatment or early disease progression|16
297154|NCT00798096|716616|P1|STARTED|Overall Study|Treatment with 200 mg bid, oral Fostamatanib until disease progression, toxicity or withdrawal|18
297155|NCT00798018|716627|P4|NOT COMPLETED|Overall Study||0
297156|NCT00798018|716628|P3|NOT COMPLETED|Overall Study||0
297157|NCT00798018|716629|P2|NOT COMPLETED|Overall Study||0
297158|NCT00798018|716630|P1|NOT COMPLETED|Overall Study||0
297159|NCT00798018|716627|P4|COMPLETED|Overall Study||25
297160|NCT00798018|716628|P3|COMPLETED|Overall Study||25
297161|NCT00798018|716629|P2|COMPLETED|Overall Study||25
297162|NCT00798018|716630|P1|COMPLETED|Overall Study||25
297163|NCT00798018|716627|P4|STARTED|Overall Study||25
297164|NCT00798018|716628|P3|STARTED|Overall Study||25
297165|NCT00798018|716629|P2|STARTED|Overall Study||25
297166|NCT00798018|716630|P1|STARTED|Overall Study||25
297167|NCT00797966|716644|P6|NOT COMPLETED|Phase A+||28
297168|NCT00797966|716645|P5|NOT COMPLETED|Phase A+||0
297169|NCT00797966|716646|P4|NOT COMPLETED|Phase A+||0
297170|NCT00797966|716647|P3|NOT COMPLETED|Phase A+||0
297171|NCT00797966|716648|P2|NOT COMPLETED|Phase A+||0
297172|NCT00797966|716649|P1|NOT COMPLETED|Phase A+||0
297173|NCT00797966|716644|P6|COMPLETED|Phase A+||207
297174|NCT00797966|716645|P5|COMPLETED|Phase A+||0
297175|NCT00797966|716646|P4|COMPLETED|Phase A+||0
297176|NCT00797966|716647|P3|COMPLETED|Phase A+||0
297177|NCT00797966|716648|P2|COMPLETED|Phase A+||0
297178|NCT00797966|716649|P1|COMPLETED|Phase A+||0
297179|NCT00797966|716644|P6|STARTED|Phase A+||235
297180|NCT00797966|716645|P5|STARTED|Phase A+||0
297181|NCT00797966|716646|P4|STARTED|Phase A+||0
297182|NCT00797966|716647|P3|STARTED|Phase A+||0
297183|NCT00797966|716648|P2|STARTED|Phase A+||0
297184|NCT00797966|716649|P1|STARTED|Phase A+||0
297185|NCT00797966|716644|P6|NOT COMPLETED|Phase B||0
297186|NCT00797966|716645|P5|NOT COMPLETED|Phase B||0
297187|NCT00797966|716646|P4|NOT COMPLETED|Phase B||16
297188|NCT00797966|716647|P3|NOT COMPLETED|Phase B||21
297189|NCT00797966|716648|P2|NOT COMPLETED|Phase B||18
297190|NCT00797966|716649|P1|NOT COMPLETED|Phase B||11
297191|NCT00797966|716644|P6|COMPLETED|Phase B||0
297192|NCT00797966|716645|P5|COMPLETED|Phase B||0
297193|NCT00797966|716646|P4|COMPLETED|Phase B||110
297194|NCT00797966|716647|P3|COMPLETED|Phase B||100
297195|NCT00797966|716648|P2|COMPLETED|Phase B||102
297196|NCT00797966|716649|P1|COMPLETED|Phase B||51
297197|NCT00797966|716644|P6|STARTED|Phase B||0
297198|NCT00797966|716645|P5|STARTED|Phase B||0
297199|NCT00797966|716646|P4|STARTED|Phase B|Randomized participants.|126
297200|NCT00797966|716647|P3|STARTED|Phase B|Randomized participants.|121
297201|NCT00797966|716648|P2|STARTED|Phase B|Randomized participants.|120
297202|NCT00797966|716649|P1|STARTED|Phase B|Randomized participants.|62
297203|NCT00797966|716644|P6|NOT COMPLETED|Phase A||0
297204|NCT00797966|716645|P5|NOT COMPLETED|Phase A||185
297205|NCT00797966|716646|P4|NOT COMPLETED|Phase A||0
297206|NCT00797966|716647|P3|NOT COMPLETED|Phase A||0
297207|NCT00797966|716648|P2|NOT COMPLETED|Phase A||0
297208|NCT00797966|716649|P1|NOT COMPLETED|Phase A||0
297209|NCT00797966|716644|P6|COMPLETED|Phase A||0
297210|NCT00797966|716645|P5|COMPLETED|Phase A||664
297211|NCT00797966|716646|P4|COMPLETED|Phase A||0
297212|NCT00797966|716647|P3|COMPLETED|Phase A||0
297213|NCT00797966|716648|P2|COMPLETED|Phase A||0
297214|NCT00797966|716649|P1|COMPLETED|Phase A||0
297215|NCT00797966|716644|P6|STARTED|Phase A||0
297216|NCT00797966|716645|P5|STARTED|Phase A|850 participants entered Phase A; 849 participants were treated.|849
297217|NCT00797966|716646|P4|STARTED|Phase A||0
297218|NCT00797966|716647|P3|STARTED|Phase A||0
297219|NCT00797966|716648|P2|STARTED|Phase A||0
297220|NCT00797966|716649|P1|STARTED|Phase A||0
297221|NCT00797862|716714|P3|NOT COMPLETED|Overall Study||86
297222|NCT00797862|716715|P2|NOT COMPLETED|Overall Study||68
297223|NCT00797862|716716|P1|NOT COMPLETED|Overall Study||124
297224|NCT00797862|716714|P3|COMPLETED|Overall Study||230
297225|NCT00797862|716715|P2|COMPLETED|Overall Study||250
297226|NCT00797862|716716|P1|COMPLETED|Overall Study||496
297227|NCT00797862|716714|P3|Entered Double-Blind Treatment (FAS)|Overall Study||315
297228|NCT00797862|716715|P2|Entered Double-Blind Treatment (FAS)|Overall Study||315
297229|NCT00797862|716716|P1|Entered Double-Blind Treatment (FAS)|Overall Study||617
297230|NCT00797862|716714|P3|STARTED|Overall Study|1 participant was mis-randomized and discontinued. Only 315 participants received study drug.|316
297231|NCT00797862|716715|P2|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 315 participants received study drug.|318
297232|NCT00797862|716716|P1|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 617 participants received study drug.|620
297233|NCT00797823|716745|P3|NOT COMPLETED|Second Period (Crossover)||0
297234|NCT00797823|716746|P2|NOT COMPLETED|Second Period (Crossover)||0
297235|NCT00797823|716747|P1|NOT COMPLETED|Second Period (Crossover)||0
297236|NCT00797823|716745|P3|COMPLETED|Second Period (Crossover)||0
297237|NCT00797823|716746|P2|COMPLETED|Second Period (Crossover)||4
297238|NCT00797823|716747|P1|COMPLETED|Second Period (Crossover)||3
297239|NCT00797823|716745|P3|STARTED|Second Period (Crossover)||0
297240|NCT00797823|716746|P2|STARTED|Second Period (Crossover)||4
297241|NCT00797823|716747|P1|STARTED|Second Period (Crossover)||3
297242|NCT00797823|716745|P3|NOT COMPLETED|First Period (Initial Randomization)||0
297243|NCT00797823|716746|P2|NOT COMPLETED|First Period (Initial Randomization)||0
297244|NCT00797823|716747|P1|NOT COMPLETED|First Period (Initial Randomization)||1
297245|NCT00797823|716745|P3|COMPLETED|First Period (Initial Randomization)||0
297246|NCT00797823|716746|P2|COMPLETED|First Period (Initial Randomization)||4
297247|NCT00797823|716747|P1|COMPLETED|First Period (Initial Randomization)||3
297248|NCT00797823|716745|P3|STARTED|First Period (Initial Randomization)|Pilot studies only performed during initial period.|0
297249|NCT00797823|716746|P2|STARTED|First Period (Initial Randomization)||4
297250|NCT00797823|716747|P1|STARTED|First Period (Initial Randomization)||4
297251|NCT00797823|716745|P3|NOT COMPLETED|Pilot Studies||0
297252|NCT00797823|716746|P2|NOT COMPLETED|Pilot Studies||0
297253|NCT00797823|716747|P1|NOT COMPLETED|Pilot Studies||0
297254|NCT00797823|716745|P3|COMPLETED|Pilot Studies||6
297255|NCT00797823|716746|P2|COMPLETED|Pilot Studies||0
297256|NCT00797823|716747|P1|COMPLETED|Pilot Studies||0
297257|NCT00797823|716745|P3|STARTED|Pilot Studies||6
297258|NCT00797823|716746|P2|STARTED|Pilot Studies|Not involved in pilot studies|0
297259|NCT00797823|716747|P1|STARTED|Pilot Studies|Not involved in pilot studies|0
297260|NCT00797797|716758|P2|NOT COMPLETED|Overall Study||43
297261|NCT00797797|716759|P1|NOT COMPLETED|Overall Study||55
297262|NCT00797797|716758|P2|COMPLETED|Overall Study||141
297263|NCT00797797|716759|P1|COMPLETED|Overall Study||123
297264|NCT00797797|716758|P2|STARTED|Overall Study||184
297265|NCT00797797|716759|P1|STARTED|Overall Study|Two patients took no background stable dose of pregabalin after randomization and are not included.|178
297266|NCT00797732|716769|P3|NOT COMPLETED|Overall Study||154
297267|NCT00797732|716770|P2|NOT COMPLETED|Overall Study||3
297268|NCT00797732|716771|P1|NOT COMPLETED|Overall Study||5
297269|NCT00797732|716769|P3|COMPLETED|Overall Study||0
297270|NCT00797732|716770|P2|COMPLETED|Overall Study||18
297271|NCT00797732|716771|P1|COMPLETED|Overall Study||16
297272|NCT00797732|716769|P3|Evaluable at 12 Months|Overall Study||0
297273|NCT00797732|716770|P2|Evaluable at 12 Months|Overall Study||18
297274|NCT00797732|716771|P1|Evaluable at 12 Months|Overall Study||17
297275|NCT00797732|716769|P3|Evaluable at 20 Weeks|Overall Study||0
297276|NCT00797732|716770|P2|Evaluable at 20 Weeks|Overall Study||18
297277|NCT00797732|716771|P1|Evaluable at 20 Weeks|Overall Study||17
297278|NCT00797732|716769|P3|Evaluable at Baseline|Overall Study||0
297279|NCT00797732|716770|P2|Evaluable at Baseline|Overall Study||18
297280|NCT00797732|716771|P1|Evaluable at Baseline|Overall Study||18
297281|NCT00797732|716769|P3|STARTED|Overall Study||154
297282|NCT00797732|716770|P2|STARTED|Overall Study||21
297283|NCT00797732|716771|P1|STARTED|Overall Study||21
297284|NCT00797667|716786|P3|NOT COMPLETED|Overall Study||127
297285|NCT00797667|716787|P2|NOT COMPLETED|Overall Study||259
297286|NCT00797667|716788|P1|NOT COMPLETED|Overall Study||260
297287|NCT00797667|716786|P3|COMPLETED|Overall Study||4
297288|NCT00797667|716787|P2|COMPLETED|Overall Study||5
297289|NCT00797667|716788|P1|COMPLETED|Overall Study||5
297290|NCT00797667|716786|P3|Treated|Overall Study||130
297291|NCT00797667|716787|P2|Treated|Overall Study||263
297292|NCT00797667|716788|P1|Treated|Overall Study||263
297293|NCT00797667|716786|P3|STARTED|Overall Study||131
297294|NCT00797667|716787|P2|STARTED|Overall Study||264
297295|NCT00797667|716788|P1|STARTED|Overall Study||265
297296|NCT00797563|716814|P1|NOT COMPLETED|Overall Study||1
297297|NCT00797563|716814|P1|COMPLETED|Overall Study||101
297298|NCT00797563|716814|P1|STARTED|Overall Study|number of subjects|102
297299|NCT00797511|716820|P1|NOT COMPLETED|Overall Study||1
297300|NCT00797511|716820|P1|COMPLETED|Overall Study||131
297301|NCT00797511|716820|P1|STARTED|Overall Study||132
297302|NCT00797459|716828|P1|NOT COMPLETED|Overall Study||0
297303|NCT00797459|716828|P1|COMPLETED|Overall Study||60
297304|NCT00797459|716828|P1|STARTED|Overall Study||60
297305|NCT00797316|716838|P2|NOT COMPLETED|Overall Study||32
297306|NCT00797316|716839|P1|NOT COMPLETED|Overall Study||23
297307|NCT00797316|716838|P2|COMPLETED|Overall Study||233
297308|NCT00797316|716839|P1|COMPLETED|Overall Study||244
297309|NCT00797316|716838|P2|STARTED|Overall Study||265
297310|NCT00797316|716839|P1|STARTED|Overall Study||267
297311|NCT00797277|716855|P2|NOT COMPLETED|Overall Study||0
297312|NCT00797277|716856|P1|NOT COMPLETED|Overall Study||0
297313|NCT00797277|716855|P2|COMPLETED|Overall Study||30
297314|NCT00797277|716856|P1|COMPLETED|Overall Study||37
297315|NCT00797277|716855|P2|STARTED|Overall Study||30
297316|NCT00797277|716856|P1|STARTED|Overall Study||37
297317|NCT00797225|716868|P8|NOT COMPLETED|Weeks 13 to 24||0
297318|NCT00797225|716869|P7|NOT COMPLETED|Weeks 13 to 24||2
297319|NCT00797225|716870|P6|NOT COMPLETED|Weeks 13 to 24||0
297320|NCT00797225|716871|P5|NOT COMPLETED|Weeks 13 to 24||1
297321|NCT00797225|716872|P4|NOT COMPLETED|Weeks 13 to 24||0
297322|NCT00797225|716873|P3|NOT COMPLETED|Weeks 13 to 24||2
297323|NCT00797225|716874|P2|NOT COMPLETED|Weeks 13 to 24||4
297324|NCT00797225|716875|P1|NOT COMPLETED|Weeks 13 to 24||0
297325|NCT00797225|716868|P8|COMPLETED|Weeks 13 to 24||22
297326|NCT00797225|716869|P7|COMPLETED|Weeks 13 to 24||20
297327|NCT00797225|716870|P6|COMPLETED|Weeks 13 to 24||21
297328|NCT00797225|716871|P5|COMPLETED|Weeks 13 to 24||19
297329|NCT00797225|716872|P4|COMPLETED|Weeks 13 to 24||0
297330|NCT00797225|716873|P3|COMPLETED|Weeks 13 to 24||41
297331|NCT00797225|716874|P2|COMPLETED|Weeks 13 to 24||38
297332|NCT00797225|716875|P1|COMPLETED|Weeks 13 to 24||0
297333|NCT00797225|716868|P8|STARTED|Weeks 13 to 24||22
297334|NCT00797225|716869|P7|STARTED|Weeks 13 to 24||22
297335|NCT00797225|716870|P6|STARTED|Weeks 13 to 24||21
297336|NCT00797225|716871|P5|STARTED|Weeks 13 to 24||20
297337|NCT00797225|716872|P4|STARTED|Weeks 13 to 24||0
297338|NCT00797225|716873|P3|STARTED|Weeks 13 to 24||43
297339|NCT00797225|716874|P2|STARTED|Weeks 13 to 24||42
297340|NCT00797225|716875|P1|STARTED|Weeks 13 to 24||0
297341|NCT00797225|716868|P8|NOT COMPLETED|Weeks 1 to 12||0
297342|NCT00797225|716869|P7|NOT COMPLETED|Weeks 1 to 12||0
297343|NCT00797225|716870|P6|NOT COMPLETED|Weeks 1 to 12||0
297344|NCT00797225|716871|P5|NOT COMPLETED|Weeks 1 to 12||0
297345|NCT00797225|716872|P4|NOT COMPLETED|Weeks 1 to 12||0
297346|NCT00797225|716873|P3|NOT COMPLETED|Weeks 1 to 12||1
297347|NCT00797225|716874|P2|NOT COMPLETED|Weeks 1 to 12||1
297348|NCT00797225|716875|P1|NOT COMPLETED|Weeks 1 to 12||2
297349|NCT00797225|716868|P8|COMPLETED|Weeks 1 to 12||0
297350|NCT00797225|716869|P7|COMPLETED|Weeks 1 to 12||0
297351|NCT00797225|716870|P6|COMPLETED|Weeks 1 to 12||0
297352|NCT00797225|716871|P5|COMPLETED|Weeks 1 to 12||0
297353|NCT00797225|716872|P4|COMPLETED|Weeks 1 to 12||44
297354|NCT00797225|716873|P3|COMPLETED|Weeks 1 to 12||43
297355|NCT00797225|716874|P2|COMPLETED|Weeks 1 to 12||42
297356|NCT00797225|716875|P1|COMPLETED|Weeks 1 to 12||41
297357|NCT00797225|716868|P8|Received Study Drug|Weeks 1 to 12||0
297358|NCT00797225|716869|P7|Received Study Drug|Weeks 1 to 12||0
297359|NCT00797225|716870|P6|Received Study Drug|Weeks 1 to 12||0
297360|NCT00797225|716871|P5|Received Study Drug|Weeks 1 to 12||0
297361|NCT00797225|716872|P4|Received Study Drug|Weeks 1 to 12||44
297362|NCT00797225|716873|P3|Received Study Drug|Weeks 1 to 12||44
297363|NCT00797225|716874|P2|Received Study Drug|Weeks 1 to 12||43
297364|NCT00797225|716875|P1|Received Study Drug|Weeks 1 to 12||43
297365|NCT00797225|716868|P8|STARTED|Weeks 1 to 12||0
297366|NCT00797225|716869|P7|STARTED|Weeks 1 to 12||0
297367|NCT00797225|716870|P6|STARTED|Weeks 1 to 12||0
297368|NCT00797225|716871|P5|STARTED|Weeks 1 to 12||0
297369|NCT00797225|716872|P4|STARTED|Weeks 1 to 12||44
297370|NCT00797225|716873|P3|STARTED|Weeks 1 to 12||44
297371|NCT00797225|716874|P2|STARTED|Weeks 1 to 12||43
297372|NCT00797225|716875|P1|STARTED|Weeks 1 to 12||43
297373|NCT00797212|716983|P1|NOT COMPLETED|Overall Study||0
297374|NCT00797212|716983|P1|COMPLETED|Overall Study||50
297375|NCT00797212|716983|P1|STARTED|Overall Study||50
297376|NCT00797108|716992|P3|NOT COMPLETED|Overall Study||6
297377|NCT00797108|716993|P2|NOT COMPLETED|Overall Study||2
297378|NCT00797108|716994|P1|NOT COMPLETED|Overall Study||4
297379|NCT00797108|716992|P3|COMPLETED|Overall Study||6
297380|NCT00797108|716993|P2|COMPLETED|Overall Study||9
297381|NCT00797108|716994|P1|COMPLETED|Overall Study||8
297382|NCT00797108|716992|P3|Treated|Overall Study||12
297383|NCT00797108|716993|P2|Treated|Overall Study||11
297384|NCT00797108|716994|P1|Treated|Overall Study||10
297385|NCT00797108|716992|P3|STARTED|Overall Study||12
297386|NCT00797108|716993|P2|STARTED|Overall Study||11
297387|NCT00797108|716994|P1|STARTED|Overall Study||12
297388|NCT00796991|717029|P3|NOT COMPLETED|Overall Study||14
297389|NCT00796991|717030|P2|NOT COMPLETED|Overall Study||12
297390|NCT00796991|717031|P1|NOT COMPLETED|Overall Study||15
297391|NCT00796991|717029|P3|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|6
297392|NCT00796991|717030|P2|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|7
297393|NCT00796991|717031|P1|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|5
297394|NCT00796991|717029|P3|STARTED|Overall Study||20
297395|NCT00796991|717030|P2|STARTED|Overall Study||19
297396|NCT00796991|717031|P1|STARTED|Overall Study||20
297397|NCT00796926|717131|P2|NOT COMPLETED|Overall Study||0
297398|NCT00796926|717132|P1|NOT COMPLETED|Overall Study||1
297399|NCT00796926|717131|P2|COMPLETED|Overall Study||15
297400|NCT00796926|717132|P1|COMPLETED|Overall Study||14
297401|NCT00796926|717131|P2|STARTED|Overall Study||15
297402|NCT00796926|717132|P1|STARTED|Overall Study||15
297403|NCT00796861|717138|P1|NOT COMPLETED|Overall Study||4
297404|NCT00796861|717138|P1|COMPLETED|Overall Study||0
297405|NCT00796861|717138|P1|STARTED|Overall Study||4
297406|NCT00796822|717144|P2|NOT COMPLETED|Overall Study||0
297407|NCT00796822|717145|P1|NOT COMPLETED|Overall Study||3
297408|NCT00796822|717144|P2|COMPLETED|Overall Study||13
297409|NCT00796822|717145|P1|COMPLETED|Overall Study||10
297410|NCT00796822|717144|P2|STARTED|Overall Study||13
297411|NCT00796822|717145|P1|STARTED|Overall Study||13
297412|NCT00796757|717153|P1|NOT COMPLETED|Overall Study||86
297413|NCT00796757|717153|P1|COMPLETED|Overall Study||60
297414|NCT00796757|717153|P1|STARTED|Overall Study||146
297415|NCT00796744|717168|P3|NOT COMPLETED|Overall Study||1
297416|NCT00796744|717169|P2|NOT COMPLETED|Overall Study||0
297417|NCT00796744|717170|P1|NOT COMPLETED|Overall Study||0
297418|NCT00796744|717168|P3|COMPLETED|Overall Study||27
297419|NCT00796744|717169|P2|COMPLETED|Overall Study||26
297420|NCT00796744|717170|P1|COMPLETED|Overall Study||24
297421|NCT00796744|717168|P3|STARTED|Overall Study||28
297422|NCT00796744|717169|P2|STARTED|Overall Study||26
297423|NCT00796744|717170|P1|STARTED|Overall Study||24
297424|NCT00796718|717187|P1|NOT COMPLETED|Overall Study||9
297425|NCT00796718|717187|P1|COMPLETED|Overall Study||53
297426|NCT00796718|717187|P1|STARTED|Overall Study||62
297427|NCT00796705|717198|P4|NOT COMPLETED|Overall Study||0
297428|NCT00796705|717199|P3|NOT COMPLETED|Overall Study||0
297429|NCT00796705|717200|P2|NOT COMPLETED|Overall Study||0
297430|NCT00796705|717201|P1|NOT COMPLETED|Overall Study||0
297431|NCT00796705|717198|P4|COMPLETED|Overall Study||2
297432|NCT00796705|717199|P3|COMPLETED|Overall Study||4
297433|NCT00796705|717200|P2|COMPLETED|Overall Study||4
297434|NCT00796705|717201|P1|COMPLETED|Overall Study||3
297435|NCT00796705|717198|P4|STARTED|Overall Study||2
297436|NCT00796705|717199|P3|STARTED|Overall Study||4
297437|NCT00796705|717200|P2|STARTED|Overall Study||4
297438|NCT00796705|717201|P1|STARTED|Overall Study||3
297439|NCT00796666|717239|P2|NOT COMPLETED|Overall Study||64
297440|NCT00796666|717240|P1|NOT COMPLETED|Overall Study||67
297441|NCT00796666|717239|P2|COMPLETED|Overall Study||0
297442|NCT00796666|717240|P1|COMPLETED|Overall Study||0
297443|NCT00796666|717239|P2|Randomized and Not Treated|Overall Study||0
297444|NCT00796666|717240|P1|Randomized and Not Treated|Overall Study||1
297445|NCT00796666|717239|P2|Treated|Overall Study||64
297446|NCT00796666|717240|P1|Treated|Overall Study||66
297447|NCT00796666|717239|P2|STARTED|Overall Study||64
297448|NCT00796666|717240|P1|STARTED|Overall Study||67
297449|NCT00796653|717274|P4|NOT COMPLETED|Overall Study||40
297450|NCT00796653|717275|P3|NOT COMPLETED|Overall Study||36
297451|NCT00796653|717276|P2|NOT COMPLETED|Overall Study||37
297452|NCT00796653|717277|P1|NOT COMPLETED|Overall Study||51
297453|NCT00796653|717274|P4|COMPLETED|Overall Study||193
297454|NCT00796653|717275|P3|COMPLETED|Overall Study||198
297455|NCT00796653|717276|P2|COMPLETED|Overall Study||195
297456|NCT00796653|717277|P1|COMPLETED|Overall Study||184
297457|NCT00796653|717274|P4|STARTED|Overall Study||233
297458|NCT00796653|717275|P3|STARTED|Overall Study||234
297459|NCT00796653|717276|P2|STARTED|Overall Study||232
297460|NCT00796653|717277|P1|STARTED|Overall Study||235
297461|NCT00796627|717545|P2|NOT COMPLETED|Overall Study||0
297462|NCT00796627|717546|P1|NOT COMPLETED|Overall Study||0
297463|NCT00796627|717545|P2|COMPLETED|Overall Study||31
297464|NCT00796627|717546|P1|COMPLETED|Overall Study||10
297465|NCT00796627|717545|P2|STARTED|Overall Study||31
297466|NCT00796627|717546|P1|STARTED|Overall Study||10
297467|NCT00796614|717562|P4|NOT COMPLETED|Overall Study||1
297468|NCT00796614|717563|P3|NOT COMPLETED|Overall Study||3
297469|NCT00796614|717564|P2|NOT COMPLETED|Overall Study||4
297470|NCT00796614|717565|P1|NOT COMPLETED|Overall Study||5
297471|NCT00796614|717562|P4|COMPLETED|Overall Study||40
297472|NCT00796614|717563|P3|COMPLETED|Overall Study||36
297473|NCT00796614|717564|P2|COMPLETED|Overall Study||36
297474|NCT00796614|717565|P1|COMPLETED|Overall Study||36
297475|NCT00796614|717562|P4|Not Treated|Overall Study||0
297476|NCT00796614|717563|P3|Not Treated|Overall Study||1
297477|NCT00796614|717564|P2|Not Treated|Overall Study||0
297478|NCT00796614|717565|P1|Not Treated|Overall Study||0
297479|NCT00796614|717562|P4|STARTED|Overall Study||41
297480|NCT00796614|717563|P3|STARTED|Overall Study||39
297481|NCT00796614|717564|P2|STARTED|Overall Study||40
297482|NCT00796614|717565|P1|STARTED|Overall Study||41
297483|NCT00796562|717607|P1|NOT COMPLETED|Overall Study||49
297484|NCT00796562|717607|P1|COMPLETED|Overall Study||47
297485|NCT00796562|717607|P1|STARTED|Overall Study||96
297486|NCT00796549|717616|P1|NOT COMPLETED|Overall Study||218
297487|NCT00796549|717616|P1|COMPLETED|Overall Study||0
297488|NCT00796549|717616|P1|Entered|Overall Study|entered and treated|69
297489|NCT00796549|717616|P1|STARTED|Overall Study|Excluding duplicate records for 5 patients who were screened twice|218
297490|NCT00796523|717633|P2|NOT COMPLETED|Overall Study||7
297491|NCT00796523|717634|P1|NOT COMPLETED|Overall Study||9
297492|NCT00796523|717633|P2|COMPLETED|Overall Study||17
297493|NCT00796523|717634|P1|COMPLETED|Overall Study||18
297494|NCT00796523|717633|P2|STARTED|Overall Study||24
297495|NCT00796523|717634|P1|STARTED|Overall Study||27
297496|NCT00796510|717644|P2|NOT COMPLETED|Overall Study||0
297497|NCT00796510|717645|P1|NOT COMPLETED|Overall Study||3
297498|NCT00796510|717644|P2|COMPLETED|Overall Study||0
297499|NCT00796510|717645|P1|COMPLETED|Overall Study||0
297500|NCT00796510|717644|P2|STARTED|Overall Study||0
297501|NCT00796510|717645|P1|STARTED|Overall Study||3
297502|NCT00796445|717657|P2|NOT COMPLETED|Overall Study||292
297503|NCT00796445|717658|P1|NOT COMPLETED|Overall Study||584
297504|NCT00796445|717657|P2|COMPLETED|Overall Study||158
297505|NCT00796445|717658|P1|COMPLETED|Overall Study||310
297506|NCT00796445|717657|P2|STARTED|Overall Study||450
297507|NCT00796445|717658|P1|STARTED|Overall Study||894
297508|NCT00796419|717710|P2|NOT COMPLETED|Overall Study||1
297509|NCT00796419|717711|P1|NOT COMPLETED|Overall Study||0
297510|NCT00796419|717710|P2|COMPLETED|Overall Study||13
297511|NCT00796419|717711|P1|COMPLETED|Overall Study||13
297512|NCT00796419|717710|P2|STARTED|Overall Study||14
297513|NCT00796419|717711|P1|STARTED|Overall Study||13
297514|NCT00796367|717724|P3|NOT COMPLETED|Overall Study||47
297515|NCT00796367|717725|P2|NOT COMPLETED|Overall Study||25
297516|NCT00796367|717726|P1|NOT COMPLETED|Overall Study||30
297517|NCT00796367|717724|P3|COMPLETED|Overall Study||248
297518|NCT00796367|717725|P2|COMPLETED|Overall Study||129
297519|NCT00796367|717726|P1|COMPLETED|Overall Study||197
297520|NCT00796367|717724|P3|STARTED|Overall Study||295
297521|NCT00796367|717725|P2|STARTED|Overall Study|one participant signed ICF but withdrew from study prior to first dosing in OB-305|154
297522|NCT00796367|717726|P1|STARTED|Overall Study||227
297523|NCT00796328|717737|P1|NOT COMPLETED|Overall Study||6
297524|NCT00796328|717737|P1|COMPLETED|Overall Study||40
297525|NCT00796328|717737|P1|STARTED|Overall Study||46
297526|NCT00796315|717741|P3|NOT COMPLETED|Overall Study||0
297527|NCT00796315|717742|P2|NOT COMPLETED|Overall Study||1
297528|NCT00796315|717743|P1|NOT COMPLETED|Overall Study||0
297529|NCT00796315|717741|P3|COMPLETED|Overall Study||15
297530|NCT00796315|717742|P2|COMPLETED|Overall Study||16
297531|NCT00796315|717743|P1|COMPLETED|Overall Study||9
297532|NCT00796315|717741|P3|STARTED|Overall Study||15
297533|NCT00796315|717742|P2|STARTED|Overall Study||17
297534|NCT00796315|717743|P1|STARTED|Overall Study||9
297535|NCT00796302|717756|P2|NOT COMPLETED|Overall Study||18
297536|NCT00796302|717757|P1|NOT COMPLETED|Overall Study||13
297537|NCT00796302|717756|P2|COMPLETED|Overall Study||66
297538|NCT00796302|717757|P1|COMPLETED|Overall Study||71
297539|NCT00796302|717756|P2|STARTED|Overall Study||84
297540|NCT00796302|717757|P1|STARTED|Overall Study||84
297541|NCT00796224|717771|P2|NOT COMPLETED|Overall Study||1
297542|NCT00796224|717772|P1|NOT COMPLETED|Overall Study||1
297543|NCT00796224|717771|P2|COMPLETED|Overall Study||18
297544|NCT00796224|717772|P1|COMPLETED|Overall Study||18
297545|NCT00796224|717771|P2|STARTED|Overall Study||19
297546|NCT00796224|717772|P1|STARTED|Overall Study||19
297547|NCT00796120|717792|P2|NOT COMPLETED|Overall Study||60
297548|NCT00796120|717793|P1|NOT COMPLETED|Overall Study||61
297549|NCT00796120|717792|P2|COMPLETED|Overall Study||0
297550|NCT00796120|717793|P1|COMPLETED|Overall Study||0
297551|NCT00796120|717792|P2|Treated|Overall Study||57
297552|NCT00796120|717793|P1|Treated|Overall Study||61
297553|NCT00796120|717792|P2|STARTED|Overall Study||60
297554|NCT00796120|717793|P1|STARTED|Overall Study||61
297555|NCT00796003|717809|P2|NOT COMPLETED|Overall Study||29
297556|NCT00796003|717810|P1|NOT COMPLETED|Overall Study||3
297557|NCT00796003|717809|P2|COMPLETED|Overall Study|Includes 2 participants from Phase I (20 mg/m2) group|7
297558|NCT00796003|717810|P1|COMPLETED|Overall Study||0
297559|NCT00796003|717809|P2|Treated|Overall Study|Number of participants treated|34
297560|NCT00796003|717810|P1|Treated|Overall Study|Number of participants treated|3
297561|NCT00796003|717809|P2|STARTED|Overall Study|Number of participants enrolled. Includes 6 participants from Phase I (20 mg/m2) group|36
297562|NCT00796003|717810|P1|STARTED|Overall Study|Number of participants enrolled|3
297563|NCT00795951|717831|P1|NOT COMPLETED|Overall Study||2
297564|NCT00795951|717831|P1|COMPLETED|Overall Study||100
297565|NCT00795951|717831|P1|STARTED|Overall Study||102
297566|NCT00795886|717868|P1|NOT COMPLETED|Overall Study||10
297567|NCT00795886|717868|P1|COMPLETED|Overall Study||53
297568|NCT00795886|717868|P1|STARTED|Overall Study||63
297569|NCT00795821|717876|P2|NOT COMPLETED|Taper Phase||0
297570|NCT00795821|717877|P1|NOT COMPLETED|Taper Phase||9
297571|NCT00795821|717876|P2|COMPLETED|Taper Phase|N=6 participants completed only Acute Taper Phase; N=0 participants entered Extension Taper Phase.|6
297572|NCT00795821|717877|P1|COMPLETED|Taper Phase|N=231 participants completed Taper Phases: N=3 from Acute Phase; N=228 from Extension Phase.|231
297573|NCT00795821|717876|P2|STARTED|Taper Phase|N=6 participants entered only Acute Taper Phase.|6
297574|NCT00795821|717877|P1|STARTED|Taper Phase|N=240 participants entered Taper Phases: N=4 from Acute Phase; N=236 from Extension Phase.|240
297575|NCT00795821|717876|P2|NOT COMPLETED|Long-term Extension Phase||92
297576|NCT00795821|717877|P1|NOT COMPLETED|Long-term Extension Phase||90
297577|NCT00795821|717876|P2|COMPLETED|Long-term Extension Phase||115
297578|NCT00795821|717877|P1|COMPLETED|Long-term Extension Phase||100
297579|NCT00795821|717876|P2|STARTED|Long-term Extension Phase|All placebo-treated participants received LY2216684 in the Long-term Extension Phase.|207
297580|NCT00795821|717877|P1|STARTED|Long-term Extension Phase||190
297581|NCT00795821|717876|P2|NOT COMPLETED|Acute Treatment Phase||31
297582|NCT00795821|717877|P1|NOT COMPLETED|Acute Treatment Phase||56
297583|NCT00795821|717876|P2|COMPLETED|Acute Treatment Phase|7 placebo-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|214
297584|NCT00795821|717877|P1|COMPLETED|Acute Treatment Phase|4 LY-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|194
297585|NCT00795821|717876|P2|STARTED|Acute Treatment Phase||245
297586|NCT00795821|717877|P1|STARTED|Acute Treatment Phase||250
297587|NCT00795769|717946|P1|NOT COMPLETED|Overall Study||0
297588|NCT00795769|717946|P1|COMPLETED|Overall Study||49
297589|NCT00795769|717946|P1|STARTED|Overall Study||49
297590|NCT00795717|717952|P2|NOT COMPLETED|Phase II||1
297591|NCT00795717|717953|P1|NOT COMPLETED|Phase II||0
297592|NCT00795717|717952|P2|COMPLETED|Phase II||18
297593|NCT00795717|717953|P1|COMPLETED|Phase II||18
297594|NCT00795717|717952|P2|STARTED|Phase II||19
297595|NCT00795717|717953|P1|STARTED|Phase II||18
297596|NCT00795717|717952|P2|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
297597|NCT00795717|717953|P1|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
297598|NCT00795717|717952|P2|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||19
297599|NCT00795717|717953|P1|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||18
297600|NCT00795717|717952|P2|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to placebo first|21
297601|NCT00795717|717953|P1|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to treatment first|20
297602|NCT00795704|717965|P2|NOT COMPLETED|Overall Study||3
297603|NCT00795704|717966|P1|NOT COMPLETED|Overall Study||4
297604|NCT00795704|717965|P2|COMPLETED|Overall Study||9
297605|NCT00795704|717966|P1|COMPLETED|Overall Study||8
297606|NCT00795704|717965|P2|STARTED|Overall Study||12
297607|NCT00795704|717966|P1|STARTED|Overall Study||12
297608|NCT00795639|717978|P2|NOT COMPLETED|Overall Study||26
297609|NCT00795639|717979|P1|NOT COMPLETED|Overall Study||21
297610|NCT00795639|717978|P2|COMPLETED|Overall Study||66
297611|NCT00795639|717979|P1|COMPLETED|Overall Study||70
297612|NCT00795639|717978|P2|Randomized and Not Treated|Overall Study||1
297613|NCT00795639|717979|P1|Randomized and Not Treated|Overall Study||0
297614|NCT00795639|717978|P2|STARTED|Overall Study||92
297615|NCT00795639|717979|P1|STARTED|Overall Study||91
297616|NCT00795600|717991|P2|NOT COMPLETED|Overall Study||4
297617|NCT00795600|717992|P1|NOT COMPLETED|Overall Study||4
297618|NCT00795600|717991|P2|COMPLETED|Overall Study||31
297619|NCT00795600|717992|P1|COMPLETED|Overall Study||21
297620|NCT00795600|717991|P2|Exposed to Drug|Overall Study||35
297621|NCT00795600|717992|P1|Exposed to Drug|Overall Study|1 patient did not take study medication because the patient withdrew consent|24
297622|NCT00795600|717991|P2|STARTED|Overall Study||35
297623|NCT00795600|717992|P1|STARTED|Overall Study||25
297624|NCT00795535|718112|P1|NOT COMPLETED|Overall Study||20
297625|NCT00795535|718112|P1|COMPLETED|Overall Study||75
297626|NCT00795535|718112|P1|STARTED|Overall Study||95
297627|NCT00795509|718119|P1|NOT COMPLETED|Overall Study||31
297628|NCT00795509|718119|P1|COMPLETED|Overall Study||343
297629|NCT00795509|718119|P1|STARTED|Overall Study||374
297630|NCT00795366|718126|P2|NOT COMPLETED|Overall Study||0
297631|NCT00795366|718127|P1|NOT COMPLETED|Overall Study||0
297632|NCT00795366|718126|P2|COMPLETED|Overall Study||54
297633|NCT00795366|718127|P1|COMPLETED|Overall Study||42
297634|NCT00795366|718126|P2|STARTED|Overall Study||54
297635|NCT00795366|718127|P1|STARTED|Overall Study||42
297636|NCT00795340|718135|P2|NOT COMPLETED|Overall Study||0
297637|NCT00795340|718136|P1|NOT COMPLETED|Overall Study||7
297638|NCT00795340|718135|P2|COMPLETED|Overall Study||153
297639|NCT00795340|718136|P1|COMPLETED|Overall Study||146
297640|NCT00795340|718135|P2|STARTED|Overall Study||153
297641|NCT00795340|718136|P1|STARTED|Overall Study||153
297642|NCT00795288|718148|P2|NOT COMPLETED|Overall Study||0
297643|NCT00795288|718149|P1|NOT COMPLETED|Overall Study||0
297644|NCT00795288|718148|P2|COMPLETED|Overall Study||21
297645|NCT00795288|718149|P1|COMPLETED|Overall Study||21
297646|NCT00795288|718148|P2|STARTED|Overall Study||21
297647|NCT00795288|718149|P1|STARTED|Overall Study||21
297648|NCT00795236|718161|P2|NOT COMPLETED|Overall Study||0
297649|NCT00795236|718162|P1|NOT COMPLETED|Overall Study||0
297650|NCT00795236|718161|P2|COMPLETED|Overall Study||0
297651|NCT00795236|718162|P1|COMPLETED|Overall Study|Unable to consistently obtain saliva DLMO in subjects and thus couldn't measure circadian period|0
297652|NCT00795236|718161|P2|STARTED|Overall Study||0
297653|NCT00795236|718162|P1|STARTED|Overall Study||0
297654|NCT00795210|718175|P3|NOT COMPLETED|Overall Study||2
297655|NCT00795210|718176|P2|NOT COMPLETED|Overall Study||1
297656|NCT00795210|718177|P1|NOT COMPLETED|Overall Study||0
297657|NCT00795210|718175|P3|COMPLETED|Overall Study||3
297658|NCT00795210|718176|P2|COMPLETED|Overall Study||11
297659|NCT00795210|718177|P1|COMPLETED|Overall Study||8
297660|NCT00795210|718175|P3|STARTED|Overall Study||5
297661|NCT00795210|718176|P2|STARTED|Overall Study||12
297662|NCT00795210|718177|P1|STARTED|Overall Study||8
297663|NCT00795184|718188|P2|NOT COMPLETED|Overall Study||13
297664|NCT00795184|718189|P1|NOT COMPLETED|Overall Study||8
297665|NCT00795184|718188|P2|COMPLETED|Overall Study|44 patients analysable, completed all 3 imaging procedures|44
297666|NCT00795184|718189|P1|COMPLETED|Overall Study|57 patients analysable, completed all 3 imaging procedures|57
297667|NCT00795184|718188|P2|STARTED|Overall Study||57
297668|NCT00795184|718189|P1|STARTED|Overall Study||65
297669|NCT00795145|718200|P7|NOT COMPLETED|Cohort 2||0
297670|NCT00795145|718201|P6|NOT COMPLETED|Cohort 2||0
297671|NCT00795145|718202|P5|NOT COMPLETED|Cohort 2||0
297672|NCT00795145|718203|P4|NOT COMPLETED|Cohort 2||0
297673|NCT00795145|718204|P3|NOT COMPLETED|Cohort 2||0
297674|NCT00795145|718205|P2|NOT COMPLETED|Cohort 2||0
297675|NCT00795145|718206|P1|NOT COMPLETED|Cohort 2||0
297676|NCT00795145|718200|P7|COMPLETED|Cohort 2||10
297677|NCT00795145|718201|P6|COMPLETED|Cohort 2||10
297678|NCT00795145|718202|P5|COMPLETED|Cohort 2||10
297679|NCT00795145|718203|P4|COMPLETED|Cohort 2||10
297680|NCT00795145|718204|P3|COMPLETED|Cohort 2||0
297681|NCT00795145|718205|P2|COMPLETED|Cohort 2||0
297682|NCT00795145|718206|P1|COMPLETED|Cohort 2||0
297683|NCT00795145|718200|P7|STARTED|Cohort 2||10
297684|NCT00795145|718201|P6|STARTED|Cohort 2||10
297685|NCT00795145|718202|P5|STARTED|Cohort 2||10
297686|NCT00795145|718203|P4|STARTED|Cohort 2||10
297687|NCT00795145|718204|P3|STARTED|Cohort 2||0
297688|NCT00795145|718205|P2|STARTED|Cohort 2||0
297689|NCT00795145|718206|P1|STARTED|Cohort 2||0
297690|NCT00795145|718200|P7|NOT COMPLETED|Cohort 1||0
297691|NCT00795145|718201|P6|NOT COMPLETED|Cohort 1||0
297692|NCT00795145|718202|P5|NOT COMPLETED|Cohort 1||0
297693|NCT00795145|718203|P4|NOT COMPLETED|Cohort 1||0
297694|NCT00795145|718204|P3|NOT COMPLETED|Cohort 1||0
297695|NCT00795145|718205|P2|NOT COMPLETED|Cohort 1||0
297696|NCT00795145|718206|P1|NOT COMPLETED|Cohort 1||0
297697|NCT00795145|718200|P7|COMPLETED|Cohort 1||0
297698|NCT00795145|718201|P6|COMPLETED|Cohort 1||0
297699|NCT00795145|718202|P5|COMPLETED|Cohort 1||0
297700|NCT00795145|718203|P4|COMPLETED|Cohort 1||0
297701|NCT00795145|718204|P3|COMPLETED|Cohort 1||3
297702|NCT00795145|718205|P2|COMPLETED|Cohort 1||3
297703|NCT00795145|718206|P1|COMPLETED|Cohort 1||3
297704|NCT00795145|718200|P7|STARTED|Cohort 1||0
297705|NCT00795145|718201|P6|STARTED|Cohort 1||0
297706|NCT00795145|718202|P5|STARTED|Cohort 1||0
297707|NCT00795145|718203|P4|STARTED|Cohort 1||0
297708|NCT00795145|718204|P3|STARTED|Cohort 1||3
297709|NCT00795145|718205|P2|STARTED|Cohort 1||3
297710|NCT00795145|718206|P1|STARTED|Cohort 1||3
297711|NCT00795132|718250|P1|NOT COMPLETED|Overall Study||3
297712|NCT00795132|718250|P1|COMPLETED|Overall Study||44
297713|NCT00795132|718250|P1|STARTED|Overall Study||47
297714|NCT00795002|718264|P2|NOT COMPLETED|Overall Study||0
297715|NCT00795002|718265|P1|NOT COMPLETED|Overall Study||0
297716|NCT00795002|718264|P2|COMPLETED|Overall Study||37
297717|NCT00795002|718265|P1|COMPLETED|Overall Study||37
297718|NCT00795002|718264|P2|STARTED|Overall Study||37
297719|NCT00795002|718265|P1|STARTED|Overall Study||37
297720|NCT00794963|718277|P2|NOT COMPLETED|Overall Study||4
297721|NCT00794963|718278|P1|NOT COMPLETED|Overall Study||1
297722|NCT00794963|718277|P2|COMPLETED|Overall Study||0
297723|NCT00794963|718278|P1|COMPLETED|Overall Study||3
297724|NCT00794963|718277|P2|STARTED|Overall Study||4
297725|NCT00794963|718278|P1|STARTED|Overall Study||4
297726|NCT00794950|718284|P1|NOT COMPLETED|Beginning Sunitinib Treatment||12
297727|NCT00794950|718284|P1|COMPLETED|Beginning Sunitinib Treatment||24
297728|NCT00794950|718284|P1|STARTED|Beginning Sunitinib Treatment||36
297729|NCT00794950|718284|P1|NOT COMPLETED|BCG Induction||7
297730|NCT00794950|718284|P1|COMPLETED|BCG Induction||36
297731|NCT00794950|718284|P1|STARTED|BCG Induction||43
297732|NCT00794924|718293|P2|NOT COMPLETED|Overall Study||70
297733|NCT00794924|718294|P1|NOT COMPLETED|Overall Study||60
297734|NCT00794924|718293|P2|COMPLETED|Overall Study||101
297735|NCT00794924|718294|P1|COMPLETED|Overall Study||114
297736|NCT00794924|718293|P2|STARTED|Overall Study|14 patients refused to start the study|171
297737|NCT00794924|718294|P1|STARTED|Overall Study|14 patients refused to start the study|174
297738|NCT00794820|718298|P1|NOT COMPLETED|Overall Study||16
297739|NCT00794820|718298|P1|COMPLETED|Overall Study||50
297740|NCT00794820|718298|P1|STARTED|Overall Study||66
297741|NCT00794677|718306|P2|NOT COMPLETED|Second Intervention||0
297742|NCT00794677|718307|P1|NOT COMPLETED|Second Intervention||0
297743|NCT00794677|718306|P2|COMPLETED|Second Intervention||13
297744|NCT00794677|718307|P1|COMPLETED|Second Intervention||11
297745|NCT00794677|718306|P2|STARTED|Second Intervention||13
297746|NCT00794677|718307|P1|STARTED|Second Intervention||11
297747|NCT00794677|718306|P2|NOT COMPLETED|First Intervention||0
297748|NCT00794677|718307|P1|NOT COMPLETED|First Intervention||2
297749|NCT00794677|718306|P2|COMPLETED|First Intervention||13
297750|NCT00794677|718307|P1|COMPLETED|First Intervention||11
297751|NCT00794677|718306|P2|STARTED|First Intervention||13
297752|NCT00794677|718307|P1|STARTED|First Intervention||13
297753|NCT00794664|718329|P2|NOT COMPLETED|Follow-up Period||5
297754|NCT00794664|718330|P1|NOT COMPLETED|Follow-up Period||1
297755|NCT00794664|718329|P2|COMPLETED|Follow-up Period||28
297756|NCT00794664|718330|P1|COMPLETED|Follow-up Period||15
297757|NCT00794664|718329|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|33
297758|NCT00794664|718330|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|16
297759|NCT00794664|718329|P2|NOT COMPLETED|Treatment Period||12
297760|NCT00794664|718330|P1|NOT COMPLETED|Treatment Period||1
297761|NCT00794664|718329|P2|COMPLETED|Treatment Period|6 participants enrolled in open-label extension study NCT00694109|27
297762|NCT00794664|718330|P1|COMPLETED|Treatment Period|3 participants enrolled in open-label extension study NCT00694109|18
297763|NCT00794664|718329|P2|STARTED|Treatment Period||39
297764|NCT00794664|718330|P1|STARTED|Treatment Period||19
297765|NCT00794573|718376|P2|NOT COMPLETED|Overall Study||45
297766|NCT00794573|718377|P1|NOT COMPLETED|Overall Study||38
297767|NCT00794573|718376|P2|COMPLETED|Overall Study||106
297768|NCT00794573|718377|P1|COMPLETED|Overall Study||113
297769|NCT00794573|718376|P2|STARTED|Overall Study||151
297770|NCT00794573|718377|P1|STARTED|Overall Study||151
297771|NCT00794560|718409|P4|NOT COMPLETED|Overall Study||4
297772|NCT00794560|718410|P3|NOT COMPLETED|Overall Study||4
297773|NCT00794560|718411|P2|NOT COMPLETED|Overall Study||4
297774|NCT00794560|718412|P1|NOT COMPLETED|Overall Study||3
297775|NCT00794560|718409|P4|COMPLETED|Overall Study||34
297776|NCT00794560|718410|P3|COMPLETED|Overall Study||40
297777|NCT00794560|718411|P2|COMPLETED|Overall Study||32
297778|NCT00794560|718412|P1|COMPLETED|Overall Study||33
297779|NCT00794560|718409|P4|STARTED|Overall Study||38
297780|NCT00794560|718410|P3|STARTED|Overall Study||44
297781|NCT00794560|718411|P2|STARTED|Overall Study||36
297782|NCT00794560|718412|P1|STARTED|Overall Study||36
297783|NCT00794547|718426|P2|NOT COMPLETED|Overall Study||0
297784|NCT00794547|718427|P1|NOT COMPLETED|Overall Study||0
297785|NCT00794547|718426|P2|COMPLETED|Overall Study||16
297786|NCT00794547|718427|P1|COMPLETED|Overall Study||18
297787|NCT00794547|718426|P2|STARTED|Overall Study||16
297788|NCT00794547|718427|P1|STARTED|Overall Study||18
297789|NCT00794508|718435|P1|NOT COMPLETED|Overall Study||0
297790|NCT00794508|718435|P1|COMPLETED|Overall Study||10
297791|NCT00794508|718435|P1|STARTED|Overall Study||10
297792|NCT00794469|718441|P1|NOT COMPLETED|Overall Study||0
297793|NCT00794469|718441|P1|COMPLETED|Overall Study||21
297794|NCT00794469|718441|P1|STARTED|Overall Study||21
297795|NCT00794365|718446|P1|NOT COMPLETED|Overall Study||79
297796|NCT00794365|718446|P1|COMPLETED|Overall Study||251
297797|NCT00794365|718446|P1|STARTED|Overall Study||330
297798|NCT00794313|718452|P3|NOT COMPLETED|Overall Study||0
297799|NCT00794313|718453|P2|NOT COMPLETED|Overall Study||0
297800|NCT00794313|718454|P1|NOT COMPLETED|Overall Study||0
297801|NCT00794313|718452|P3|COMPLETED|Overall Study||1
297802|NCT00794313|718453|P2|COMPLETED|Overall Study||1
297803|NCT00794313|718454|P1|COMPLETED|Overall Study||1
297804|NCT00794313|718452|P3|STARTED|Overall Study||1
297805|NCT00794313|718453|P2|STARTED|Overall Study||1
297806|NCT00794313|718454|P1|STARTED|Overall Study||1
297807|NCT00794196|718467|P2|NOT COMPLETED|Overall Study||23
297808|NCT00794196|718468|P1|NOT COMPLETED|Overall Study||5
297809|NCT00794196|718467|P2|COMPLETED|Overall Study||64
297810|NCT00794196|718468|P1|COMPLETED|Overall Study||87
297811|NCT00794196|718467|P2|STARTED|Overall Study||87
297812|NCT00794196|718468|P1|STARTED|Overall Study||92
297813|NCT00794170|718478|P2|NOT COMPLETED|Overall Study||3
297814|NCT00794170|718479|P1|NOT COMPLETED|Overall Study||7
297815|NCT00794170|718478|P2|COMPLETED|Overall Study||152
297816|NCT00794170|718479|P1|COMPLETED|Overall Study||150
297817|NCT00794170|718478|P2|STARTED|Overall Study||155
297818|NCT00794170|718479|P1|STARTED|Overall Study||157
297819|NCT00794157|718488|P3|NOT COMPLETED|Overall Study||19
297820|NCT00794157|718489|P2|NOT COMPLETED|Overall Study||10
297821|NCT00794157|718490|P1|NOT COMPLETED|Overall Study||10
297822|NCT00794157|718488|P3|COMPLETED|Overall Study||98
297823|NCT00794157|718489|P2|COMPLETED|Overall Study||106
297824|NCT00794157|718490|P1|COMPLETED|Overall Study||104
297825|NCT00794157|718488|P3|STARTED|Overall Study||117
297826|NCT00794157|718489|P2|STARTED|Overall Study||116
297827|NCT00794157|718490|P1|STARTED|Overall Study||114
297828|NCT00794144|718512|P2|NOT COMPLETED|Overall Study||3
297829|NCT00794144|718513|P1|NOT COMPLETED|Overall Study||3
297830|NCT00794144|718512|P2|COMPLETED|Overall Study||63
297831|NCT00794144|718513|P1|COMPLETED|Overall Study||63
297832|NCT00794144|718512|P2|STARTED|Overall Study||66
297833|NCT00794144|718513|P1|STARTED|Overall Study||66
297834|NCT00794118|718519|P1|NOT COMPLETED|Overall Study||27
297835|NCT00794118|718519|P1|COMPLETED|Overall Study||272
297836|NCT00794118|718519|P1|STARTED|Overall Study||299
297837|NCT00794040|718579|P2|NOT COMPLETED|Overall Study||5
297838|NCT00794040|718580|P1|NOT COMPLETED|Overall Study||3
297839|NCT00794040|718579|P2|COMPLETED|Overall Study||23
297840|NCT00794040|718580|P1|COMPLETED|Overall Study||22
297841|NCT00794040|718579|P2|STARTED|Overall Study||28
297842|NCT00794040|718580|P1|STARTED|Overall Study||25
297843|NCT00793910|718596|P2|NOT COMPLETED|Overall Study||7
297844|NCT00793910|718597|P1|NOT COMPLETED|Overall Study||5
297845|NCT00793910|718596|P2|COMPLETED|Overall Study||46
297846|NCT00793910|718597|P1|COMPLETED|Overall Study||48
297847|NCT00793910|718596|P2|STARTED|Overall Study||53
297848|NCT00793910|718597|P1|STARTED|Overall Study||53
297849|NCT00793871|718611|P1|NOT COMPLETED|Overall Study||60
297850|NCT00793871|718611|P1|COMPLETED|Overall Study||0
297851|NCT00793871|718611|P1|Received Treatment|Overall Study||59
297852|NCT00793871|718611|P1|STARTED|Overall Study||60
297853|NCT00793819|718625|P2|NOT COMPLETED|Overall Study||9
297854|NCT00793819|718626|P1|NOT COMPLETED|Overall Study||14
297855|NCT00793819|718625|P2|COMPLETED|Overall Study||89
297856|NCT00793819|718626|P1|COMPLETED|Overall Study||97
297857|NCT00793819|718625|P2|STARTED|Overall Study||98
297858|NCT00793819|718626|P1|STARTED|Overall Study||111
297859|NCT00793793|718644|P12|NOT COMPLETED|Overall Study||6
297860|NCT00793793|718645|P11|NOT COMPLETED|Overall Study||3
297861|NCT00793793|718646|P10|NOT COMPLETED|Overall Study||9
297862|NCT00793793|718647|P9|NOT COMPLETED|Overall Study||9
297863|NCT00793793|718648|P8|NOT COMPLETED|Overall Study||0
297864|NCT00793793|718649|P7|NOT COMPLETED|Overall Study||4
297865|NCT00793793|718650|P6|NOT COMPLETED|Overall Study||2
297866|NCT00793793|718651|P5|NOT COMPLETED|Overall Study||2
297867|NCT00793793|718652|P4|NOT COMPLETED|Overall Study||3
297868|NCT00793793|718653|P3|NOT COMPLETED|Overall Study||2
297869|NCT00793793|718654|P2|NOT COMPLETED|Overall Study||1
297870|NCT00793793|718655|P1|NOT COMPLETED|Overall Study||0
297871|NCT00793793|718644|P12|COMPLETED|Overall Study||1
297872|NCT00793793|718645|P11|COMPLETED|Overall Study||3
297873|NCT00793793|718646|P10|COMPLETED|Overall Study||6
297874|NCT00793793|718647|P9|COMPLETED|Overall Study||6
297875|NCT00793793|718648|P8|COMPLETED|Overall Study||6
297876|NCT00793793|718649|P7|COMPLETED|Overall Study||3
297877|NCT00793793|718650|P6|COMPLETED|Overall Study||4
297878|NCT00793793|718651|P5|COMPLETED|Overall Study||4
297879|NCT00793793|718652|P4|COMPLETED|Overall Study||4
297880|NCT00793793|718653|P3|COMPLETED|Overall Study||5
297881|NCT00793793|718654|P2|COMPLETED|Overall Study||5
297882|NCT00793793|718655|P1|COMPLETED|Overall Study||8
297883|NCT00793793|718644|P12|STARTED|Overall Study||7
297884|NCT00793793|718645|P11|STARTED|Overall Study||6
297885|NCT00793793|718646|P10|STARTED|Overall Study||15
297886|NCT00793793|718647|P9|STARTED|Overall Study||15
297887|NCT00793793|718648|P8|STARTED|Overall Study||6
297888|NCT00793793|718649|P7|STARTED|Overall Study||7
297889|NCT00793793|718650|P6|STARTED|Overall Study||6
297890|NCT00793793|718651|P5|STARTED|Overall Study||6
297891|NCT00793793|718652|P4|STARTED|Overall Study||7
297892|NCT00793793|718653|P3|STARTED|Overall Study||7
297893|NCT00793793|718654|P2|STARTED|Overall Study||6
297894|NCT00793793|718655|P1|STARTED|Overall Study||8
297895|NCT00793780|719030|P2|NOT COMPLETED|Overall Study||1
297896|NCT00793780|719031|P1|NOT COMPLETED|Overall Study||2
297897|NCT00793780|719030|P2|COMPLETED|Overall Study||11
297898|NCT00793780|719031|P1|COMPLETED|Overall Study||10
297899|NCT00793780|719030|P2|Collected Baseline Data|Overall Study||12
297900|NCT00793780|719031|P1|Collected Baseline Data|Overall Study||11
297901|NCT00793780|719030|P2|Randomization|Overall Study||12
297902|NCT00793780|719031|P1|Randomization|Overall Study||12
297903|NCT00793780|719030|P2|STARTED|Overall Study||12
297904|NCT00793780|719031|P1|STARTED|Overall Study||12
297905|NCT00793650|719049|P2|NOT COMPLETED|Overall Study||0
297906|NCT00793650|719050|P1|NOT COMPLETED|Overall Study||0
297907|NCT00793650|719049|P2|COMPLETED|Overall Study||20
297908|NCT00793650|719050|P1|COMPLETED|Overall Study||19
297909|NCT00793650|719049|P2|STARTED|Overall Study||20
297910|NCT00793650|719050|P1|STARTED|Overall Study||19
297911|NCT00793624|719062|P4|NOT COMPLETED|Overall Study||43
297912|NCT00793624|719063|P3|NOT COMPLETED|Overall Study||39
297913|NCT00793624|719064|P2|NOT COMPLETED|Overall Study||36
297914|NCT00793624|719065|P1|NOT COMPLETED|Overall Study||57
297915|NCT00793624|719062|P4|COMPLETED|Overall Study||184
297916|NCT00793624|719063|P3|COMPLETED|Overall Study||186
297917|NCT00793624|719064|P2|COMPLETED|Overall Study||191
297918|NCT00793624|719065|P1|COMPLETED|Overall Study||168
297919|NCT00793624|719062|P4|STARTED|Overall Study||227
297920|NCT00793624|719063|P3|STARTED|Overall Study||225
297921|NCT00793624|719064|P2|STARTED|Overall Study||227
297922|NCT00793624|719065|P1|STARTED|Overall Study||225
297923|NCT00793611|719333|P2|NOT COMPLETED|Overall Study||0
297924|NCT00793611|719334|P1|NOT COMPLETED|Overall Study||0
297925|NCT00793611|719333|P2|COMPLETED|Overall Study||10
297926|NCT00793611|719334|P1|COMPLETED|Overall Study||10
297927|NCT00793611|719333|P2|STARTED|Overall Study||10
297928|NCT00793611|719334|P1|STARTED|Overall Study||10
297929|NCT00793585|719346|P2|NOT COMPLETED|Overall Study||3
297930|NCT00793585|719347|P1|NOT COMPLETED|Overall Study||2
297931|NCT00793585|719346|P2|COMPLETED|Overall Study||18
297932|NCT00793585|719347|P1|COMPLETED|Overall Study||17
297933|NCT00793585|719346|P2|STARTED|Overall Study||21
297934|NCT00793585|719347|P1|STARTED|Overall Study||19
297935|NCT00793572|719355|P1|NOT COMPLETED|Overall Study||0
297936|NCT00793572|719355|P1|COMPLETED|Overall Study||32
297937|NCT00793572|719355|P1|STARTED|Overall Study||32
297938|NCT00793546|719366|P2|NOT COMPLETED|Overall Study||28
297939|NCT00793546|719367|P1|NOT COMPLETED|Overall Study||14
297940|NCT00793546|719366|P2|COMPLETED|Overall Study||0
297941|NCT00793546|719367|P1|COMPLETED|Overall Study||0
297942|NCT00793546|719366|P2|STARTED|Overall Study||28
297943|NCT00793546|719367|P1|STARTED|Overall Study||14
297944|NCT00793520|719397|P2|NOT COMPLETED|Placebo Crossover to Milnacipran||1
297945|NCT00793520|719398|P1|NOT COMPLETED|Placebo Crossover to Milnacipran||0
297946|NCT00793520|719397|P2|COMPLETED|Placebo Crossover to Milnacipran||0
297947|NCT00793520|719398|P1|COMPLETED|Placebo Crossover to Milnacipran||0
297948|NCT00793520|719397|P2|STARTED|Placebo Crossover to Milnacipran||1
297949|NCT00793520|719398|P1|STARTED|Placebo Crossover to Milnacipran||0
297950|NCT00793520|719397|P2|NOT COMPLETED|Milnacipran Crossover to Placebo||0
297951|NCT00793520|719398|P1|NOT COMPLETED|Milnacipran Crossover to Placebo||1
297952|NCT00793520|719397|P2|COMPLETED|Milnacipran Crossover to Placebo||0
297953|NCT00793520|719398|P1|COMPLETED|Milnacipran Crossover to Placebo||0
297954|NCT00793520|719397|P2|STARTED|Milnacipran Crossover to Placebo||0
297955|NCT00793520|719398|P1|STARTED|Milnacipran Crossover to Placebo||1
297956|NCT00793455|719408|P2|NOT COMPLETED|Overall Study||0
297957|NCT00793455|719409|P1|NOT COMPLETED|Overall Study||0
297958|NCT00793455|719408|P2|COMPLETED|Overall Study||314
297959|NCT00793455|719409|P1|COMPLETED|Overall Study||314
297960|NCT00793455|719408|P2|STARTED|Overall Study||314
297961|NCT00793455|719409|P1|STARTED|Overall Study||314
297962|NCT00793403|719417|P1|NOT COMPLETED|Overall Study||73
297963|NCT00793403|719417|P1|COMPLETED|Overall Study||220
297964|NCT00793403|719417|P1|STARTED|Overall Study||293
297965|NCT00793325|719464|P1|NOT COMPLETED|Overall Study||19
297966|NCT00793325|719464|P1|COMPLETED|Overall Study||890
297967|NCT00793325|719464|P1|STARTED|Overall Study||909
297968|NCT00793182|719490|P2|NOT COMPLETED|Overall Study||1
297969|NCT00793182|719491|P1|NOT COMPLETED|Overall Study||0
297970|NCT00793182|719490|P2|COMPLETED|Overall Study||3
297971|NCT00793182|719491|P1|COMPLETED|Overall Study||2
297972|NCT00793182|719490|P2|STARTED|Overall Study||4
297973|NCT00793182|719491|P1|STARTED|Overall Study||2
297974|NCT00793169|719497|P1|NOT COMPLETED|Overall Study||0
297975|NCT00793169|719497|P1|COMPLETED|Overall Study||19
297976|NCT00793169|719497|P1|STARTED|Overall Study||19
297977|NCT00793104|719501|P1|NOT COMPLETED|Overall Study||1
297978|NCT00793104|719501|P1|COMPLETED|Overall Study||9
297979|NCT00793104|719501|P1|STARTED|Overall Study||10
297980|NCT00792948|719509|P1|NOT COMPLETED|Overall Study||28
297981|NCT00792948|719509|P1|COMPLETED|Overall Study|Patients who completed induction/consolidation step|69
297982|NCT00792948|719509|P1|STARTED|Overall Study|Patients registered to induction/consolidation step|97
297983|NCT00792935|719520|P2|NOT COMPLETED|Overall Study||3
297984|NCT00792935|719521|P1|NOT COMPLETED|Overall Study||4
297985|NCT00792935|719520|P2|COMPLETED|Overall Study||68
297986|NCT00792935|719521|P1|COMPLETED|Overall Study||68
297987|NCT00792935|719520|P2|STARTED|Overall Study||71
297988|NCT00792935|719521|P1|STARTED|Overall Study||72
297989|NCT00792922|719533|P4|NOT COMPLETED|At 3 Years||0
297990|NCT00792922|719534|P3|NOT COMPLETED|At 3 Years||0
297991|NCT00792922|719535|P2|NOT COMPLETED|At 3 Years||0
297992|NCT00792922|719536|P1|NOT COMPLETED|At 3 Years||0
297993|NCT00792922|719533|P4|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
297994|NCT00792922|719534|P3|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
297995|NCT00792922|719535|P2|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
297996|NCT00792922|719536|P1|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
297997|NCT00792922|719533|P4|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
297998|NCT00792922|719534|P3|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
297999|NCT00792922|719535|P2|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
298000|NCT00792922|719536|P1|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
298001|NCT00792922|719533|P4|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
298002|NCT00792922|719534|P3|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
298003|NCT00792922|719535|P2|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
298004|NCT00792922|719536|P1|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
298005|NCT00792922|719533|P4|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
298006|NCT00792922|719534|P3|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
298007|NCT00792922|719535|P2|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
298008|NCT00792922|719536|P1|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
298009|NCT00792922|719533|P4|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|0
298010|NCT00792922|719534|P3|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|0
298011|NCT00792922|719535|P2|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|0
298012|NCT00792922|719536|P1|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|0
298013|NCT00792922|719533|P4|NOT COMPLETED|At Baseline||0
298014|NCT00792922|719534|P3|NOT COMPLETED|At Baseline||0
298015|NCT00792922|719535|P2|NOT COMPLETED|At Baseline||0
298016|NCT00792922|719536|P1|NOT COMPLETED|At Baseline||0
298017|NCT00792922|719533|P4|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
298018|NCT00792922|719534|P3|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
298019|NCT00792922|719535|P2|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
298020|NCT00792922|719536|P1|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
298021|NCT00792922|719533|P4|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
298022|NCT00792922|719534|P3|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
298023|NCT00792922|719535|P2|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
298024|NCT00792922|719536|P1|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
298025|NCT00792922|719533|P4|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
298026|NCT00792922|719534|P3|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
298027|NCT00792922|719535|P2|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
298028|NCT00792922|719536|P1|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
298029|NCT00792922|719533|P4|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
298030|NCT00792922|719534|P3|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
298031|NCT00792922|719535|P2|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
298032|NCT00792922|719536|P1|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
298033|NCT00792922|719533|P4|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
298034|NCT00792922|719534|P3|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
298035|NCT00792922|719535|P2|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
298036|NCT00792922|719536|P1|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
298037|NCT00792909|719553|P3|NOT COMPLETED|Overall Study||0
298038|NCT00792909|719554|P2|NOT COMPLETED|Overall Study||1
298039|NCT00792909|719555|P1|NOT COMPLETED|Overall Study||0
298040|NCT00792909|719553|P3|COMPLETED|Overall Study||62
298041|NCT00792909|719554|P2|COMPLETED|Overall Study||58
298042|NCT00792909|719555|P1|COMPLETED|Overall Study||51
298043|NCT00792909|719553|P3|STARTED|Overall Study||62
298044|NCT00792909|719554|P2|STARTED|Overall Study||59
298045|NCT00792909|719555|P1|STARTED|Overall Study||51
298046|NCT00792805|719611|P3|NOT COMPLETED|Overall Study||33
298047|NCT00792805|719612|P2|NOT COMPLETED|Overall Study||26
298048|NCT00792805|719613|P1|NOT COMPLETED|Overall Study||22
298049|NCT00792805|719611|P3|COMPLETED|Overall Study||154
298050|NCT00792805|719612|P2|COMPLETED|Overall Study||162
298051|NCT00792805|719613|P1|COMPLETED|Overall Study||166
298052|NCT00792805|719611|P3|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|186
298053|NCT00792805|719612|P2|Exposed to Study Medication or Placebo|Overall Study||188
298054|NCT00792805|719613|P1|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|187
298055|NCT00792805|719611|P3|STARTED|Overall Study||187
298056|NCT00792805|719612|P2|STARTED|Overall Study||188
298057|NCT00792805|719613|P1|STARTED|Overall Study||188
298058|NCT00792701|719623|P2|NOT COMPLETED|Overall Study||44
298059|NCT00792701|719624|P1|NOT COMPLETED|Overall Study||19
298060|NCT00792701|719623|P2|COMPLETED|Overall Study||22
298061|NCT00792701|719624|P1|COMPLETED|Overall Study||0
298062|NCT00792701|719623|P2|Eligible and Analyzable|Overall Study||44
298063|NCT00792701|719624|P1|Eligible and Analyzable|Overall Study||17
298064|NCT00792701|719623|P2|Eligible|Overall Study||63
298065|NCT00792701|719624|P1|Eligible|Overall Study||18
298066|NCT00792701|719623|P2|STARTED|Overall Study||66
298067|NCT00792701|719624|P1|STARTED|Overall Study||19
298068|NCT00792688|719638|P3|NOT COMPLETED|Overall Study||0
298069|NCT00792688|719639|P2|NOT COMPLETED|Overall Study||0
298070|NCT00792688|719640|P1|NOT COMPLETED|Overall Study||0
298071|NCT00792688|719638|P3|COMPLETED|Overall Study||9
298072|NCT00792688|719639|P2|COMPLETED|Overall Study||8
298073|NCT00792688|719640|P1|COMPLETED|Overall Study||9
298074|NCT00792688|719638|P3|STARTED|Overall Study||9
298075|NCT00792688|719639|P2|STARTED|Overall Study||8
298076|NCT00792688|719640|P1|STARTED|Overall Study||9
298077|NCT00792636|719654|P3|NOT COMPLETED|Overall Study||81
298078|NCT00792636|719655|P2|NOT COMPLETED|Overall Study||81
298079|NCT00792636|719656|P1|NOT COMPLETED|Overall Study||68
298080|NCT00792636|719654|P3|COMPLETED|Overall Study||55
298081|NCT00792636|719655|P2|COMPLETED|Overall Study||55
298082|NCT00792636|719656|P1|COMPLETED|Overall Study||67
298083|NCT00792636|719654|P3|STARTED|Overall Study||136
298084|NCT00792636|719655|P2|STARTED|Overall Study||136
298085|NCT00792636|719656|P1|STARTED|Overall Study||135
298086|NCT00792623|719693|P1|NOT COMPLETED|Overall Study||7
298087|NCT00792623|719693|P1|COMPLETED|Overall Study||22
298088|NCT00792623|719693|P1|STARTED|Overall Study||29
298089|NCT00792610|719706|P1|NOT COMPLETED|Overall Study||0
298090|NCT00792610|719706|P1|COMPLETED|Overall Study||127
298091|NCT00792610|719706|P1|Youths|Overall Study||127
298092|NCT00792610|719706|P1|STARTED|Overall Study||127
298093|NCT00792428|719712|P2|NOT COMPLETED|Overall Study||0
298094|NCT00792428|719713|P1|NOT COMPLETED|Overall Study||0
298095|NCT00792428|719712|P2|COMPLETED|Overall Study||10
298096|NCT00792428|719713|P1|COMPLETED|Overall Study||10
298097|NCT00792428|719712|P2|STARTED|Overall Study||10
298098|NCT00792428|719713|P1|STARTED|Overall Study||10
298099|NCT00792298|719721|P8|NOT COMPLETED|Treatment Period 2||2
298100|NCT00792298|719722|P7|NOT COMPLETED|Treatment Period 2||1
298101|NCT00792298|719723|P6|NOT COMPLETED|Treatment Period 2||0
298102|NCT00792298|719724|P5|NOT COMPLETED|Treatment Period 2||2
298103|NCT00792298|719725|P4|NOT COMPLETED|Treatment Period 2||2
298104|NCT00792298|719726|P3|NOT COMPLETED|Treatment Period 2||1
298105|NCT00792298|719727|P2|NOT COMPLETED|Treatment Period 2||1
298106|NCT00792298|719728|P1|NOT COMPLETED|Treatment Period 2||1
298107|NCT00792298|719721|P8|COMPLETED|Treatment Period 2||28
298108|NCT00792298|719722|P7|COMPLETED|Treatment Period 2||28
298109|NCT00792298|719723|P6|COMPLETED|Treatment Period 2||27
298110|NCT00792298|719724|P5|COMPLETED|Treatment Period 2||30
298111|NCT00792298|719725|P4|COMPLETED|Treatment Period 2||26
298112|NCT00792298|719726|P3|COMPLETED|Treatment Period 2||30
298113|NCT00792298|719727|P2|COMPLETED|Treatment Period 2||30
298114|NCT00792298|719728|P1|COMPLETED|Treatment Period 2||29
298115|NCT00792298|719721|P8|STARTED|Treatment Period 2||30
298116|NCT00792298|719722|P7|STARTED|Treatment Period 2||29
298117|NCT00792298|719723|P6|STARTED|Treatment Period 2||27
298118|NCT00792298|719724|P5|STARTED|Treatment Period 2||32
298119|NCT00792298|719725|P4|STARTED|Treatment Period 2||28
298120|NCT00792298|719726|P3|STARTED|Treatment Period 2||31
298121|NCT00792298|719727|P2|STARTED|Treatment Period 2||31
298122|NCT00792298|719728|P1|STARTED|Treatment Period 2||30
298123|NCT00792298|719721|P8|NOT COMPLETED|Washout||0
298124|NCT00792298|719722|P7|NOT COMPLETED|Washout||0
298125|NCT00792298|719723|P6|NOT COMPLETED|Washout||2
298126|NCT00792298|719724|P5|NOT COMPLETED|Washout||0
298127|NCT00792298|719725|P4|NOT COMPLETED|Washout||0
298128|NCT00792298|719726|P3|NOT COMPLETED|Washout||1
298129|NCT00792298|719727|P2|NOT COMPLETED|Washout||0
298130|NCT00792298|719728|P1|NOT COMPLETED|Washout||0
298131|NCT00792298|719721|P8|COMPLETED|Washout||30
298132|NCT00792298|719722|P7|COMPLETED|Washout||29
298133|NCT00792298|719723|P6|COMPLETED|Washout||27
298134|NCT00792298|719724|P5|COMPLETED|Washout||32
298135|NCT00792298|719725|P4|COMPLETED|Washout||28
298136|NCT00792298|719726|P3|COMPLETED|Washout||31
298137|NCT00792298|719727|P2|COMPLETED|Washout||31
298138|NCT00792298|719728|P1|COMPLETED|Washout||30
298139|NCT00792298|719721|P8|STARTED|Washout||30
298140|NCT00792298|719722|P7|STARTED|Washout|2 participants discontinued therapy during Period 1 but entered the Washout as allowed per protocol|29
298141|NCT00792298|719723|P6|STARTED|Washout||29
298142|NCT00792298|719724|P5|STARTED|Washout||32
298143|NCT00792298|719725|P4|STARTED|Washout||28
298144|NCT00792298|719726|P3|STARTED|Washout|1 participant discontinued therapy during Period 1 but entered the Washout as allowed per protocol|32
298145|NCT00792298|719727|P2|STARTED|Washout||31
298146|NCT00792298|719728|P1|STARTED|Washout||30
298147|NCT00792298|719721|P8|NOT COMPLETED|Treatment Period 1||1
298148|NCT00792298|719722|P7|NOT COMPLETED|Treatment Period 1||4
298149|NCT00792298|719723|P6|NOT COMPLETED|Treatment Period 1||3
298150|NCT00792298|719724|P5|NOT COMPLETED|Treatment Period 1||0
298151|NCT00792298|719725|P4|NOT COMPLETED|Treatment Period 1||4
298152|NCT00792298|719726|P3|NOT COMPLETED|Treatment Period 1||2
298153|NCT00792298|719727|P2|NOT COMPLETED|Treatment Period 1||1
298154|NCT00792298|719728|P1|NOT COMPLETED|Treatment Period 1||1
298155|NCT00792298|719721|P8|COMPLETED|Treatment Period 1||30
298156|NCT00792298|719722|P7|COMPLETED|Treatment Period 1||27
298157|NCT00792298|719723|P6|COMPLETED|Treatment Period 1||29
298158|NCT00792298|719724|P5|COMPLETED|Treatment Period 1||32
298159|NCT00792298|719725|P4|COMPLETED|Treatment Period 1||28
298160|NCT00792298|719726|P3|COMPLETED|Treatment Period 1||31
298161|NCT00792298|719727|P2|COMPLETED|Treatment Period 1||31
298162|NCT00792298|719728|P1|COMPLETED|Treatment Period 1||30
298163|NCT00792298|719721|P8|STARTED|Treatment Period 1||31
298164|NCT00792298|719722|P7|STARTED|Treatment Period 1||31
298165|NCT00792298|719723|P6|STARTED|Treatment Period 1||32
298166|NCT00792298|719724|P5|STARTED|Treatment Period 1||32
298167|NCT00792298|719725|P4|STARTED|Treatment Period 1||32
298168|NCT00792298|719726|P3|STARTED|Treatment Period 1||33
298169|NCT00792298|719727|P2|STARTED|Treatment Period 1||32
298170|NCT00792298|719728|P1|STARTED|Treatment Period 1||31
298171|NCT00792259|719758|P3|NOT COMPLETED|Overall Study||0
298172|NCT00792259|719759|P2|NOT COMPLETED|Overall Study||0
298173|NCT00792259|719760|P1|NOT COMPLETED|Overall Study||1
298174|NCT00792259|719758|P3|COMPLETED|Overall Study||13
298175|NCT00792259|719759|P2|COMPLETED|Overall Study||20
298176|NCT00792259|719760|P1|COMPLETED|Overall Study||14
298177|NCT00792259|719758|P3|STARTED|Overall Study||13
298178|NCT00792259|719759|P2|STARTED|Overall Study||20
298179|NCT00792259|719760|P1|STARTED|Overall Study||15
298180|NCT00792116|719770|P2|NOT COMPLETED|Overall Study||1
298181|NCT00792116|719771|P1|NOT COMPLETED|Overall Study||1
298182|NCT00792116|719770|P2|COMPLETED|Overall Study||54
298183|NCT00792116|719771|P1|COMPLETED|Overall Study||52
298184|NCT00792116|719770|P2|STARTED|Overall Study||55
298185|NCT00792116|719771|P1|STARTED|Overall Study||53
298186|NCT00792103|719781|P1|NOT COMPLETED|Overall Study||133
298187|NCT00792103|719781|P1|COMPLETED|Overall Study||65
298188|NCT00792103|719781|P1|STARTED|Overall Study|15 subjects were enrolled but did not treat for a total of 183 subjects in the safety population|198
298189|NCT00791999|719793|P4|NOT COMPLETED|Overall Study||52
298190|NCT00791999|719794|P3|NOT COMPLETED|Overall Study||20
298191|NCT00791999|719795|P2|NOT COMPLETED|Overall Study||16
298192|NCT00791999|719796|P1|NOT COMPLETED|Overall Study||21
298193|NCT00791999|719793|P4|COMPLETED|Overall Study||25
298194|NCT00791999|719794|P3|COMPLETED|Overall Study||65
298195|NCT00791999|719795|P2|COMPLETED|Overall Study||66
298196|NCT00791999|719796|P1|COMPLETED|Overall Study||51
298197|NCT00791999|719793|P4|STARTED|Overall Study||77
298198|NCT00791999|719794|P3|STARTED|Overall Study||85
298199|NCT00791999|719795|P2|STARTED|Overall Study||82
298200|NCT00791999|719796|P1|STARTED|Overall Study||72
298201|NCT00791973|719812|P2|NOT COMPLETED|Second Intervention (1 Week)||0
298202|NCT00791973|719813|P1|NOT COMPLETED|Second Intervention (1 Week)||0
298203|NCT00791973|719812|P2|COMPLETED|Second Intervention (1 Week)||7
298204|NCT00791973|719813|P1|COMPLETED|Second Intervention (1 Week)||8
298205|NCT00791973|719812|P2|STARTED|Second Intervention (1 Week)||7
298206|NCT00791973|719813|P1|STARTED|Second Intervention (1 Week)||8
298207|NCT00791973|719812|P2|NOT COMPLETED|Washout (1 Week)||0
298208|NCT00791973|719813|P1|NOT COMPLETED|Washout (1 Week)||0
298209|NCT00791973|719812|P2|COMPLETED|Washout (1 Week)||7
298210|NCT00791973|719813|P1|COMPLETED|Washout (1 Week)||8
298211|NCT00791973|719812|P2|STARTED|Washout (1 Week)||7
298212|NCT00791973|719813|P1|STARTED|Washout (1 Week)||8
298213|NCT00791973|719812|P2|NOT COMPLETED|First Intervention (1 Week)||0
298214|NCT00791973|719813|P1|NOT COMPLETED|First Intervention (1 Week)||0
298215|NCT00791973|719812|P2|COMPLETED|First Intervention (1 Week)||7
298216|NCT00791973|719813|P1|COMPLETED|First Intervention (1 Week)||8
298217|NCT00791973|719812|P2|STARTED|First Intervention (1 Week)||7
298218|NCT00791973|719813|P1|STARTED|First Intervention (1 Week)||8
298219|NCT00791934|719821|P1|NOT COMPLETED|Overall Study||15
298220|NCT00791934|719821|P1|COMPLETED|Overall Study|Follow-up extended to 1 yr. 13 subjects chose not to participate in the extension.|48
298221|NCT00791934|719821|P1|STARTED|Overall Study||63
298222|NCT00791921|719831|P2|NOT COMPLETED|Overall Study||96
298223|NCT00791921|719832|P1|NOT COMPLETED|Overall Study||34
298224|NCT00791921|719831|P2|COMPLETED|Overall Study||18
298225|NCT00791921|719832|P1|COMPLETED|Overall Study||82
298226|NCT00791921|719831|P2|STARTED|Overall Study||114
298227|NCT00791921|719832|P1|STARTED|Overall Study||116
298228|NCT00791908|719840|P1|NOT COMPLETED|Overall Study||0
298229|NCT00791908|719840|P1|COMPLETED|Overall Study||15
298230|NCT00791908|719840|P1|STARTED|Overall Study||15
298231|NCT00791843|719848|P1|NOT COMPLETED|Overall Study||0
298232|NCT00791843|719848|P1|COMPLETED|Overall Study|Data unavailable for the study|0
298233|NCT00791843|719848|P1|STARTED|Overall Study|Data unavailable for the study|0
298234|NCT00791817|719854|P2|NOT COMPLETED|2: Single Dose||0
298235|NCT00791817|719855|P1|NOT COMPLETED|2: Single Dose||0
298236|NCT00791817|719854|P2|COMPLETED|2: Single Dose||5
298237|NCT00791817|719855|P1|COMPLETED|2: Single Dose||5
298238|NCT00791817|719854|P2|STARTED|2: Single Dose||5
298239|NCT00791817|719855|P1|STARTED|2: Single Dose||5
298240|NCT00791817|719854|P2|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
298241|NCT00791817|719855|P1|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
298242|NCT00791817|719854|P2|COMPLETED|1: Single Dose Followed by Week Washout||5
298243|NCT00791817|719855|P1|COMPLETED|1: Single Dose Followed by Week Washout||5
298244|NCT00791817|719854|P2|STARTED|1: Single Dose Followed by Week Washout||5
298245|NCT00791817|719855|P1|STARTED|1: Single Dose Followed by Week Washout||5
298246|NCT00791778|719863|P2|NOT COMPLETED|Follow-up||1
298247|NCT00791778|719864|P1|NOT COMPLETED|Follow-up||5
298248|NCT00791778|719863|P2|COMPLETED|Follow-up|Includes 78 participants with study follow-up terminated by sponsor and 12 deaths|90
298249|NCT00791778|719864|P1|COMPLETED|Follow-up|Includes 79 participants with study follow-up terminated by sponsor and 16 deaths|95
298250|NCT00791778|719863|P2|STARTED|Follow-up||91
298251|NCT00791778|719864|P1|STARTED|Follow-up||100
298252|NCT00791778|719863|P2|NOT COMPLETED|Double-blind Treatment||48
298253|NCT00791778|719864|P1|NOT COMPLETED|Double-blind Treatment||77
298254|NCT00791778|719863|P2|COMPLETED|Double-blind Treatment|includes: 75 subjects with progression|75
298255|NCT00791778|719864|P1|COMPLETED|Double-blind Treatment|includes: 42 subjects with progression, 4 subjects transferred to a continuation study|46
298256|NCT00791778|719863|P2|STARTED|Double-blind Treatment||123
298257|NCT00791778|719864|P1|STARTED|Double-blind Treatment||123
298258|NCT00791765|719918|P2|NOT COMPLETED|Weeks 13 to 24||8
298259|NCT00791765|719919|P1|NOT COMPLETED|Weeks 13 to 24||5
298260|NCT00791765|719918|P2|COMPLETED|Weeks 13 to 24||49
298261|NCT00791765|719919|P1|COMPLETED|Weeks 13 to 24||49
298262|NCT00791765|719918|P2|STARTED|Weeks 13 to 24|1 participant discontinued due to an adverse event after completing 12 weeks.|57
298263|NCT00791765|719919|P1|STARTED|Weeks 13 to 24||54
298264|NCT00791765|719918|P2|NOT COMPLETED|Weeks 1 to 12||4
298265|NCT00791765|719919|P1|NOT COMPLETED|Weeks 1 to 12||8
298266|NCT00791765|719918|P2|COMPLETED|Weeks 1 to 12||58
298267|NCT00791765|719919|P1|COMPLETED|Weeks 1 to 12||54
298268|NCT00791765|719918|P2|Treated|Weeks 1 to 12||59
298269|NCT00791765|719919|P1|Treated|Weeks 1 to 12||62
298270|NCT00791765|719918|P2|STARTED|Weeks 1 to 12||62
298271|NCT00791765|719919|P1|STARTED|Weeks 1 to 12||62
298272|NCT00791700|719934|P4|NOT COMPLETED|Overall Study||18
298273|NCT00791700|719935|P3|NOT COMPLETED|Overall Study||4
298274|NCT00791700|719936|P2|NOT COMPLETED|Overall Study||5
298275|NCT00791700|719937|P1|NOT COMPLETED|Overall Study||4
298276|NCT00791700|719934|P4|COMPLETED|Overall Study|Two participants discontinued treatment after the lower bound (days 313 and 314) of Week 48 window.|25
298277|NCT00791700|719935|P3|COMPLETED|Overall Study||9
298278|NCT00791700|719936|P2|COMPLETED|Overall Study||26
298279|NCT00791700|719937|P1|COMPLETED|Overall Study||12
298280|NCT00791700|719934|P4|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|43
298281|NCT00791700|719935|P3|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|13
298282|NCT00791700|719936|P2|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|31
298283|NCT00791700|719937|P1|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|16
298284|NCT00791661|720025|P3|NOT COMPLETED|Period 3||0
298285|NCT00791661|720026|P2|NOT COMPLETED|Period 3||0
298286|NCT00791661|720027|P1|NOT COMPLETED|Period 3||0
298287|NCT00791661|720025|P3|COMPLETED|Period 3||6
298288|NCT00791661|720026|P2|COMPLETED|Period 3||8
298289|NCT00791661|720027|P1|COMPLETED|Period 3||8
298290|NCT00791661|720025|P3|Received Matching Placebo to MK-1006|Period 3||1
298291|NCT00791661|720026|P2|Received Matching Placebo to MK-1006|Period 3||2
298292|NCT00791661|720027|P1|Received Matching Placebo to MK-1006|Period 3||2
298293|NCT00791661|720025|P3|Received MK-1006|Period 3||5
298294|NCT00791661|720026|P2|Received MK-1006|Period 3||6
298295|NCT00791661|720027|P1|Received MK-1006|Period 3||6
298296|NCT00791661|720025|P3|STARTED|Period 3||6
298297|NCT00791661|720026|P2|STARTED|Period 3||8
298298|NCT00791661|720027|P1|STARTED|Period 3||8
298299|NCT00791661|720025|P3|NOT COMPLETED|7 Day Wash-out||0
298300|NCT00791661|720026|P2|NOT COMPLETED|7 Day Wash-out||0
298301|NCT00791661|720027|P1|NOT COMPLETED|7 Day Wash-out||0
298302|NCT00791661|720025|P3|COMPLETED|7 Day Wash-out||6
298303|NCT00791661|720026|P2|COMPLETED|7 Day Wash-out||8
298304|NCT00791661|720027|P1|COMPLETED|7 Day Wash-out||8
298305|NCT00791661|720025|P3|STARTED|7 Day Wash-out||6
298306|NCT00791661|720026|P2|STARTED|7 Day Wash-out||8
298307|NCT00791661|720027|P1|STARTED|7 Day Wash-out||8
298308|NCT00791661|720025|P3|NOT COMPLETED|Period 2||0
298309|NCT00791661|720026|P2|NOT COMPLETED|Period 2||0
298310|NCT00791661|720027|P1|NOT COMPLETED|Period 2||0
298311|NCT00791661|720025|P3|COMPLETED|Period 2||6
298312|NCT00791661|720026|P2|COMPLETED|Period 2||8
298313|NCT00791661|720027|P1|COMPLETED|Period 2||8
298314|NCT00791661|720025|P3|Received Matching Placebo to MK-1006|Period 2||2
298315|NCT00791661|720026|P2|Received Matching Placebo to MK-1006|Period 2||2
298316|NCT00791661|720027|P1|Received Matching Placebo to MK-1006|Period 2||2
298317|NCT00791661|720025|P3|Received MK-1006|Period 2||4
298318|NCT00791661|720026|P2|Received MK-1006|Period 2||6
298319|NCT00791661|720027|P1|Received MK-1006|Period 2||6
298320|NCT00791661|720025|P3|STARTED|Period 2||6
298321|NCT00791661|720026|P2|STARTED|Period 2||8
298322|NCT00791661|720027|P1|STARTED|Period 2||8
298323|NCT00791661|720025|P3|NOT COMPLETED|7 Day Wash-out||2
298324|NCT00791661|720026|P2|NOT COMPLETED|7 Day Wash-out||0
298325|NCT00791661|720027|P1|NOT COMPLETED|7 Day Wash-out||0
298326|NCT00791661|720025|P3|COMPLETED|7 Day Wash-out||6
298327|NCT00791661|720026|P2|COMPLETED|7 Day Wash-out||8
298328|NCT00791661|720027|P1|COMPLETED|7 Day Wash-out||8
298329|NCT00791661|720025|P3|STARTED|7 Day Wash-out||8
298330|NCT00791661|720026|P2|STARTED|7 Day Wash-out||8
298331|NCT00791661|720027|P1|STARTED|7 Day Wash-out||8
298332|NCT00791661|720025|P3|NOT COMPLETED|Period 1||0
298333|NCT00791661|720026|P2|NOT COMPLETED|Period 1||0
298334|NCT00791661|720027|P1|NOT COMPLETED|Period 1||0
298335|NCT00791661|720025|P3|COMPLETED|Period 1||8
298336|NCT00791661|720026|P2|COMPLETED|Period 1||8
298337|NCT00791661|720027|P1|COMPLETED|Period 1||8
298338|NCT00791661|720025|P3|Received Matching Placebo to MK-1006|Period 1||2
298339|NCT00791661|720026|P2|Received Matching Placebo to MK-1006|Period 1||2
298340|NCT00791661|720027|P1|Received Matching Placebo to MK-1006|Period 1||2
298341|NCT00791661|720025|P3|Received MK-1006|Period 1||6
298342|NCT00791661|720026|P2|Received MK-1006|Period 1||6
298343|NCT00791661|720027|P1|Received MK-1006|Period 1||6
298344|NCT00791661|720025|P3|STARTED|Period 1||8
298345|NCT00791661|720026|P2|STARTED|Period 1||8
298346|NCT00791661|720027|P1|STARTED|Period 1||8
298347|NCT00791648|720120|P2|NOT COMPLETED|Overall Study||2
298348|NCT00791648|720121|P1|NOT COMPLETED|Overall Study||0
298349|NCT00791648|720120|P2|COMPLETED|Overall Study||307
298350|NCT00791648|720121|P1|COMPLETED|Overall Study||308
298351|NCT00791648|720120|P2|STARTED|Overall Study||309
298352|NCT00791648|720121|P1|STARTED|Overall Study||308
298353|NCT00791557|720157|P1|NOT COMPLETED|Overall Study||1
298354|NCT00791557|720157|P1|COMPLETED|Overall Study||1
298355|NCT00791557|720157|P1|STARTED|Overall Study||2
298356|NCT00791518|720161|P1|NOT COMPLETED|Overall Study||93
298357|NCT00791518|720161|P1|COMPLETED|Overall Study||991
298358|NCT00791518|720161|P1|STARTED|Overall Study||1084
298359|NCT00791492|720189|P2|NOT COMPLETED|Overall Study||3
298360|NCT00791492|720190|P1|NOT COMPLETED|Overall Study||6
298361|NCT00791492|720189|P2|COMPLETED|Overall Study||38
298362|NCT00791492|720190|P1|COMPLETED|Overall Study||39
298363|NCT00791492|720189|P2|TREATED|Overall Study||41
298364|NCT00791492|720190|P1|TREATED|Overall Study||44
298365|NCT00791492|720189|P2|STARTED|Overall Study||41
298366|NCT00791492|720190|P1|STARTED|Overall Study||45
298367|NCT00791479|720238|P6|NOT COMPLETED|Overall Study||3
298368|NCT00791479|720239|P5|NOT COMPLETED|Overall Study||3
298369|NCT00791479|720240|P4|NOT COMPLETED|Overall Study||4
298370|NCT00791479|720241|P3|NOT COMPLETED|Overall Study||0
298371|NCT00791479|720242|P2|NOT COMPLETED|Overall Study||3
298372|NCT00791479|720243|P1|NOT COMPLETED|Overall Study||2
298373|NCT00791479|720238|P6|COMPLETED|Overall Study||29
298374|NCT00791479|720239|P5|COMPLETED|Overall Study||0
298375|NCT00791479|720240|P4|COMPLETED|Overall Study||25
298376|NCT00791479|720241|P3|COMPLETED|Overall Study||34
298377|NCT00791479|720242|P2|COMPLETED|Overall Study||31
298378|NCT00791479|720243|P1|COMPLETED|Overall Study||33
298379|NCT00791479|720238|P6|Received at Least One Dose of Study Drug|Overall Study||32
298380|NCT00791479|720239|P5|Received at Least One Dose of Study Drug|Overall Study||3
298381|NCT00791479|720240|P4|Received at Least One Dose of Study Drug|Overall Study||29
298382|NCT00791479|720241|P3|Received at Least One Dose of Study Drug|Overall Study||34
298383|NCT00791479|720242|P2|Received at Least One Dose of Study Drug|Overall Study||34
298384|NCT00791479|720243|P1|Received at Least One Dose of Study Drug|Overall Study||35
298385|NCT00791479|720238|P6|STARTED|Overall Study||32
298386|NCT00791479|720239|P5|STARTED|Overall Study|3mg LY2189265 discont. Replaced with 1.5mg dose based on dose finding Study H9X-MC-GBCF; NCT00734474|3
298387|NCT00791479|720240|P4|STARTED|Overall Study||29
298388|NCT00791479|720241|P3|STARTED|Overall Study||34
298389|NCT00791479|720242|P2|STARTED|Overall Study||34
298390|NCT00791479|720243|P1|STARTED|Overall Study||35
298391|NCT00791388|720342|P5|NOT COMPLETED|Period 4 - 400 mg Dose Group||4
298392|NCT00791388|720343|P4|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
298393|NCT00791388|720344|P3|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
298394|NCT00791388|720345|P2|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
298395|NCT00791388|720346|P1|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
298396|NCT00791388|720342|P5|COMPLETED|Period 4 - 400 mg Dose Group||4
298397|NCT00791388|720343|P4|COMPLETED|Period 4 - 400 mg Dose Group||0
298398|NCT00791388|720344|P3|COMPLETED|Period 4 - 400 mg Dose Group||0
298399|NCT00791388|720345|P2|COMPLETED|Period 4 - 400 mg Dose Group||0
298400|NCT00791388|720346|P1|COMPLETED|Period 4 - 400 mg Dose Group||4
298401|NCT00791388|720342|P5|STARTED|Period 4 - 400 mg Dose Group||8
298402|NCT00791388|720343|P4|STARTED|Period 4 - 400 mg Dose Group||0
298403|NCT00791388|720344|P3|STARTED|Period 4 - 400 mg Dose Group||0
298404|NCT00791388|720345|P2|STARTED|Period 4 - 400 mg Dose Group||0
298405|NCT00791388|720346|P1|STARTED|Period 4 - 400 mg Dose Group||4
298406|NCT00791388|720342|P5|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
298407|NCT00791388|720343|P4|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
298408|NCT00791388|720344|P3|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
298409|NCT00791388|720345|P2|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
298410|NCT00791388|720346|P1|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
298411|NCT00791388|720342|P5|COMPLETED|Period 3 - 200 mg Dose Group||0
298412|NCT00791388|720343|P4|COMPLETED|Period 3 - 200 mg Dose Group||8
298413|NCT00791388|720344|P3|COMPLETED|Period 3 - 200 mg Dose Group||0
298414|NCT00791388|720345|P2|COMPLETED|Period 3 - 200 mg Dose Group||0
298415|NCT00791388|720346|P1|COMPLETED|Period 3 - 200 mg Dose Group||3
298416|NCT00791388|720342|P5|STARTED|Period 3 - 200 mg Dose Group||0
298417|NCT00791388|720343|P4|STARTED|Period 3 - 200 mg Dose Group||8
298418|NCT00791388|720344|P3|STARTED|Period 3 - 200 mg Dose Group||0
298419|NCT00791388|720345|P2|STARTED|Period 3 - 200 mg Dose Group||0
298420|NCT00791388|720346|P1|STARTED|Period 3 - 200 mg Dose Group||3
298421|NCT00791388|720342|P5|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
298422|NCT00791388|720343|P4|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
298423|NCT00791388|720344|P3|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
298424|NCT00791388|720345|P2|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
298425|NCT00791388|720346|P1|NOT COMPLETED|Period 2 - 100 mg Dose Group||1
298426|NCT00791388|720342|P5|COMPLETED|Period 2 - 100 mg Dose Group||0
298427|NCT00791388|720343|P4|COMPLETED|Period 2 - 100 mg Dose Group||0
298428|NCT00791388|720344|P3|COMPLETED|Period 2 - 100 mg Dose Group||8
298429|NCT00791388|720345|P2|COMPLETED|Period 2 - 100 mg Dose Group||0
298430|NCT00791388|720346|P1|COMPLETED|Period 2 - 100 mg Dose Group||2
298431|NCT00791388|720342|P5|STARTED|Period 2 - 100 mg Dose Group||0
298432|NCT00791388|720343|P4|STARTED|Period 2 - 100 mg Dose Group||0
298433|NCT00791388|720344|P3|STARTED|Period 2 - 100 mg Dose Group||8
298434|NCT00791388|720345|P2|STARTED|Period 2 - 100 mg Dose Group||0
298435|NCT00791388|720346|P1|STARTED|Period 2 - 100 mg Dose Group||3
298436|NCT00791388|720342|P5|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
298437|NCT00791388|720343|P4|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
298438|NCT00791388|720344|P3|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
298439|NCT00791388|720345|P2|NOT COMPLETED|Period 1 - 50 mg Dose Group||1
298440|NCT00791388|720346|P1|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
298441|NCT00791388|720342|P5|COMPLETED|Period 1 - 50 mg Dose Group||0
298442|NCT00791388|720343|P4|COMPLETED|Period 1 - 50 mg Dose Group||0
298443|NCT00791388|720344|P3|COMPLETED|Period 1 - 50 mg Dose Group||0
298444|NCT00791388|720345|P2|COMPLETED|Period 1 - 50 mg Dose Group||7
298445|NCT00791388|720346|P1|COMPLETED|Period 1 - 50 mg Dose Group||3
298446|NCT00791388|720342|P5|STARTED|Period 1 - 50 mg Dose Group||0
298447|NCT00791388|720343|P4|STARTED|Period 1 - 50 mg Dose Group||0
298448|NCT00791388|720344|P3|STARTED|Period 1 - 50 mg Dose Group||0
298449|NCT00791388|720345|P2|STARTED|Period 1 - 50 mg Dose Group||8
298450|NCT00791388|720346|P1|STARTED|Period 1 - 50 mg Dose Group||3
298451|NCT00791336|720373|P1|NOT COMPLETED|Overall Study||0
298452|NCT00791336|720373|P1|COMPLETED|Overall Study||1
298453|NCT00791336|720373|P1|STARTED|Overall Study||1
298454|NCT00791323|720381|P2|NOT COMPLETED|Overall Study||0
298455|NCT00791323|720382|P1|NOT COMPLETED|Overall Study||0
298456|NCT00791323|720381|P2|COMPLETED|Overall Study||3
298457|NCT00791323|720382|P1|COMPLETED|Overall Study||6
298458|NCT00791323|720381|P2|STARTED|Overall Study||3
298459|NCT00791323|720382|P1|STARTED|Overall Study||6
298460|NCT00791258|720388|P1|NOT COMPLETED|Overall Study||263
298461|NCT00791258|720388|P1|COMPLETED|Overall Study||736
298462|NCT00791258|720388|P1|STARTED|Overall Study||999
298463|NCT00791128|720450|P1|NOT COMPLETED|Overall Study||9
298464|NCT00791128|720450|P1|COMPLETED|Overall Study||13
298465|NCT00791128|720450|P1|STARTED|Overall Study||22
298466|NCT00791102|720455|P2|NOT COMPLETED|Period 2||0
298467|NCT00791102|720456|P1|NOT COMPLETED|Period 2||0
298468|NCT00791102|720455|P2|COMPLETED|Period 2||10
298469|NCT00791102|720456|P1|COMPLETED|Period 2||10
298470|NCT00791102|720455|P2|STARTED|Period 2||10
298471|NCT00791102|720456|P1|STARTED|Period 2||10
298472|NCT00791102|720455|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
298473|NCT00791102|720456|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
298474|NCT00791102|720455|P2|COMPLETED|Washout Period of 2 Weeks||10
298475|NCT00791102|720456|P1|COMPLETED|Washout Period of 2 Weeks||10
298476|NCT00791102|720455|P2|STARTED|Washout Period of 2 Weeks||10
298477|NCT00791102|720456|P1|STARTED|Washout Period of 2 Weeks||10
298478|NCT00791102|720455|P2|NOT COMPLETED|Period 1||0
298479|NCT00791102|720456|P1|NOT COMPLETED|Period 1||0
298480|NCT00791102|720455|P2|COMPLETED|Period 1||10
298481|NCT00791102|720456|P1|COMPLETED|Period 1||10
298482|NCT00791102|720455|P2|STARTED|Period 1||10
298483|NCT00791102|720456|P1|STARTED|Period 1||10
298484|NCT00791089|720474|P2|NOT COMPLETED|Overall Study||6
298485|NCT00791089|720475|P1|NOT COMPLETED|Overall Study||6
298486|NCT00791089|720474|P2|COMPLETED|Overall Study||0
298487|NCT00791089|720475|P1|COMPLETED|Overall Study||0
298488|NCT00791089|720474|P2|Six-month Data Collected|Overall Study||5
298489|NCT00791089|720475|P1|Six-month Data Collected|Overall Study||6
298490|NCT00791089|720474|P2|Began Actually Taking Fish Oil or Placeb|Overall Study||5
298491|NCT00791089|720475|P1|Began Actually Taking Fish Oil or Placeb|Overall Study||6
298492|NCT00791089|720474|P2|STARTED|Overall Study||6
298493|NCT00791089|720475|P1|STARTED|Overall Study||6
298494|NCT00791076|720481|P1|NOT COMPLETED|Overall Study||8
298495|NCT00791076|720481|P1|COMPLETED|Overall Study||0
298496|NCT00791076|720481|P1|STARTED|Overall Study||8
298497|NCT00791037|720489|P1|NOT COMPLETED|Overall Study||0
298498|NCT00791037|720489|P1|COMPLETED|Overall Study||23
298499|NCT00791037|720489|P1|Skeletal or Bone-only Disease by FDG-PET|Overall Study||1
298500|NCT00791037|720489|P1|Primary Outcome|Overall Study||19
298501|NCT00791037|720489|P1|STARTED|Overall Study||23
298502|NCT00790933|720501|P5|NOT COMPLETED|Overall Study||276
298503|NCT00790933|720502|P4|NOT COMPLETED|Overall Study||14
298504|NCT00790933|720503|P3|NOT COMPLETED|Overall Study||269
298505|NCT00790933|720504|P2|NOT COMPLETED|Overall Study||480
298506|NCT00790933|720505|P1|NOT COMPLETED|Overall Study||438
298507|NCT00790933|720501|P5|COMPLETED|Overall Study||145
298508|NCT00790933|720502|P4|COMPLETED|Overall Study||23
298509|NCT00790933|720503|P3|COMPLETED|Overall Study||115
298510|NCT00790933|720504|P2|COMPLETED|Overall Study||246
298511|NCT00790933|720505|P1|COMPLETED|Overall Study||237
298512|NCT00790933|720501|P5|STARTED|Overall Study||421
298513|NCT00790933|720502|P4|STARTED|Overall Study||37
298514|NCT00790933|720503|P3|STARTED|Overall Study||384
298515|NCT00790933|720504|P2|STARTED|Overall Study||726
298516|NCT00790933|720505|P1|STARTED|Overall Study||675
298517|NCT00790907|721036|P3|NOT COMPLETED|Overall Study||339
298518|NCT00790907|721037|P2|NOT COMPLETED|Overall Study||340
298519|NCT00790907|721038|P1|NOT COMPLETED|Overall Study||455
298520|NCT00790907|721036|P3|COMPLETED|Overall Study||663
298521|NCT00790907|721037|P2|COMPLETED|Overall Study||684
298522|NCT00790907|721038|P1|COMPLETED|Overall Study||754
298523|NCT00790907|721036|P3|STARTED|Overall Study||1002
298524|NCT00790907|721037|P2|STARTED|Overall Study||1024
298525|NCT00790907|721038|P1|STARTED|Overall Study||1209
298526|NCT00790868|721061|P2|NOT COMPLETED|Overall Study||17
298527|NCT00790868|721062|P1|NOT COMPLETED|Overall Study||6
298528|NCT00790868|721061|P2|COMPLETED|Overall Study||75
298529|NCT00790868|721062|P1|COMPLETED|Overall Study||82
298530|NCT00790868|721061|P2|STARTED|Overall Study||92
298531|NCT00790868|721062|P1|STARTED|Overall Study||88
298532|NCT00790855|721076|P1|NOT COMPLETED|Overall Study||0
298533|NCT00790855|721076|P1|COMPLETED|Overall Study||25
298534|NCT00790855|721076|P1|STARTED|Overall Study||25
298535|NCT00790842|721084|P11|NOT COMPLETED|Expansion Cohort||0
298536|NCT00790842|721085|P10|NOT COMPLETED|Expansion Cohort||0
298537|NCT00790842|721086|P9|NOT COMPLETED|Expansion Cohort||0
298538|NCT00790842|721087|P8|NOT COMPLETED|Expansion Cohort||0
298539|NCT00790842|721088|P7|NOT COMPLETED|Expansion Cohort||1
298540|NCT00790842|721089|P6|NOT COMPLETED|Expansion Cohort||0
298541|NCT00790842|721090|P5|NOT COMPLETED|Expansion Cohort||0
298542|NCT00790842|721091|P4|NOT COMPLETED|Expansion Cohort||0
298543|NCT00790842|721092|P3|NOT COMPLETED|Expansion Cohort||7
298544|NCT00790842|721093|P2|NOT COMPLETED|Expansion Cohort||0
298545|NCT00790842|721094|P1|NOT COMPLETED|Expansion Cohort||0
298546|NCT00790842|721084|P11|COMPLETED|Expansion Cohort||0
298547|NCT00790842|721085|P10|COMPLETED|Expansion Cohort||0
298548|NCT00790842|721086|P9|COMPLETED|Expansion Cohort||0
298549|NCT00790842|721087|P8|COMPLETED|Expansion Cohort||0
298550|NCT00790842|721088|P7|COMPLETED|Expansion Cohort||1
298551|NCT00790842|721089|P6|COMPLETED|Expansion Cohort||0
298552|NCT00790842|721090|P5|COMPLETED|Expansion Cohort||0
298553|NCT00790842|721091|P4|COMPLETED|Expansion Cohort||0
298554|NCT00790842|721092|P3|COMPLETED|Expansion Cohort||7
298555|NCT00790842|721093|P2|COMPLETED|Expansion Cohort||0
298556|NCT00790842|721094|P1|COMPLETED|Expansion Cohort||0
298557|NCT00790842|721084|P11|Began Treatment|Expansion Cohort||0
298558|NCT00790842|721085|P10|Began Treatment|Expansion Cohort||0
298559|NCT00790842|721086|P9|Began Treatment|Expansion Cohort||0
298560|NCT00790842|721087|P8|Began Treatment|Expansion Cohort||0
298561|NCT00790842|721088|P7|Began Treatment|Expansion Cohort||2
298562|NCT00790842|721089|P6|Began Treatment|Expansion Cohort||0
298563|NCT00790842|721090|P5|Began Treatment|Expansion Cohort||0
298564|NCT00790842|721091|P4|Began Treatment|Expansion Cohort||0
298565|NCT00790842|721092|P3|Began Treatment|Expansion Cohort||14
298566|NCT00790842|721093|P2|Began Treatment|Expansion Cohort||0
298567|NCT00790842|721094|P1|Began Treatment|Expansion Cohort||0
298568|NCT00790842|721084|P11|STARTED|Expansion Cohort||0
298569|NCT00790842|721085|P10|STARTED|Expansion Cohort||0
298570|NCT00790842|721086|P9|STARTED|Expansion Cohort||0
298571|NCT00790842|721087|P8|STARTED|Expansion Cohort||0
298572|NCT00790842|721088|P7|STARTED|Expansion Cohort||2
298573|NCT00790842|721089|P6|STARTED|Expansion Cohort||0
298574|NCT00790842|721090|P5|STARTED|Expansion Cohort||0
298575|NCT00790842|721091|P4|STARTED|Expansion Cohort||0
298576|NCT00790842|721092|P3|STARTED|Expansion Cohort||14
298577|NCT00790842|721093|P2|STARTED|Expansion Cohort||0
298578|NCT00790842|721094|P1|STARTED|Expansion Cohort||0
298579|NCT00790842|721084|P11|NOT COMPLETED|Dose Level 4||2
298580|NCT00790842|721085|P10|NOT COMPLETED|Dose Level 4||0
298581|NCT00790842|721086|P9|NOT COMPLETED|Dose Level 4||0
298582|NCT00790842|721087|P8|NOT COMPLETED|Dose Level 4||0
298583|NCT00790842|721088|P7|NOT COMPLETED|Dose Level 4||2
298584|NCT00790842|721089|P6|NOT COMPLETED|Dose Level 4||0
298585|NCT00790842|721090|P5|NOT COMPLETED|Dose Level 4||0
298586|NCT00790842|721091|P4|NOT COMPLETED|Dose Level 4||0
298587|NCT00790842|721092|P3|NOT COMPLETED|Dose Level 4||0
298588|NCT00790842|721093|P2|NOT COMPLETED|Dose Level 4||0
298589|NCT00790842|721094|P1|NOT COMPLETED|Dose Level 4||0
298590|NCT00790842|721084|P11|COMPLETED|Dose Level 4||3
298591|NCT00790842|721085|P10|COMPLETED|Dose Level 4||0
298592|NCT00790842|721086|P9|COMPLETED|Dose Level 4||0
298593|NCT00790842|721087|P8|COMPLETED|Dose Level 4||0
298594|NCT00790842|721088|P7|COMPLETED|Dose Level 4||6
298595|NCT00790842|721089|P6|COMPLETED|Dose Level 4||0
298596|NCT00790842|721090|P5|COMPLETED|Dose Level 4||0
298597|NCT00790842|721091|P4|COMPLETED|Dose Level 4||0
298598|NCT00790842|721092|P3|COMPLETED|Dose Level 4||0
298599|NCT00790842|721093|P2|COMPLETED|Dose Level 4||0
298600|NCT00790842|721094|P1|COMPLETED|Dose Level 4||0
298601|NCT00790842|721084|P11|Began Treatment|Dose Level 4||5
298602|NCT00790842|721085|P10|Began Treatment|Dose Level 4||0
298603|NCT00790842|721086|P9|Began Treatment|Dose Level 4||0
298604|NCT00790842|721087|P8|Began Treatment|Dose Level 4||0
298605|NCT00790842|721088|P7|Began Treatment|Dose Level 4||8
298606|NCT00790842|721089|P6|Began Treatment|Dose Level 4||0
298607|NCT00790842|721090|P5|Began Treatment|Dose Level 4||0
298608|NCT00790842|721091|P4|Began Treatment|Dose Level 4||0
298609|NCT00790842|721092|P3|Began Treatment|Dose Level 4||0
298610|NCT00790842|721093|P2|Began Treatment|Dose Level 4||0
298611|NCT00790842|721094|P1|Began Treatment|Dose Level 4||0
298612|NCT00790842|721084|P11|STARTED|Dose Level 4||5
298613|NCT00790842|721085|P10|STARTED|Dose Level 4||0
298614|NCT00790842|721086|P9|STARTED|Dose Level 4||0
298615|NCT00790842|721087|P8|STARTED|Dose Level 4||0
298616|NCT00790842|721088|P7|STARTED|Dose Level 4||8
298617|NCT00790842|721089|P6|STARTED|Dose Level 4||0
298618|NCT00790842|721090|P5|STARTED|Dose Level 4||0
298619|NCT00790842|721091|P4|STARTED|Dose Level 4||0
298620|NCT00790842|721092|P3|STARTED|Dose Level 4||0
298621|NCT00790842|721093|P2|STARTED|Dose Level 4||0
298622|NCT00790842|721094|P1|STARTED|Dose Level 4||0
298623|NCT00790842|721084|P11|NOT COMPLETED|Dose Level 3||0
298624|NCT00790842|721085|P10|NOT COMPLETED|Dose Level 3||2
298625|NCT00790842|721086|P9|NOT COMPLETED|Dose Level 3||0
298626|NCT00790842|721087|P8|NOT COMPLETED|Dose Level 3||0
298627|NCT00790842|721088|P7|NOT COMPLETED|Dose Level 3||0
298628|NCT00790842|721089|P6|NOT COMPLETED|Dose Level 3||1
298629|NCT00790842|721090|P5|NOT COMPLETED|Dose Level 3||0
298630|NCT00790842|721091|P4|NOT COMPLETED|Dose Level 3||0
298631|NCT00790842|721092|P3|NOT COMPLETED|Dose Level 3||5
298632|NCT00790842|721093|P2|NOT COMPLETED|Dose Level 3||0
298633|NCT00790842|721094|P1|NOT COMPLETED|Dose Level 3||0
298634|NCT00790842|721084|P11|COMPLETED|Dose Level 3||0
298635|NCT00790842|721085|P10|COMPLETED|Dose Level 3||1
298636|NCT00790842|721086|P9|COMPLETED|Dose Level 3||0
298637|NCT00790842|721087|P8|COMPLETED|Dose Level 3||0
298638|NCT00790842|721088|P7|COMPLETED|Dose Level 3||0
298639|NCT00790842|721089|P6|COMPLETED|Dose Level 3||2
298640|NCT00790842|721090|P5|COMPLETED|Dose Level 3||0
298641|NCT00790842|721091|P4|COMPLETED|Dose Level 3||0
298642|NCT00790842|721092|P3|COMPLETED|Dose Level 3||2
298643|NCT00790842|721093|P2|COMPLETED|Dose Level 3||0
298644|NCT00790842|721094|P1|COMPLETED|Dose Level 3||0
298645|NCT00790842|721084|P11|Began Treatment|Dose Level 3||0
298646|NCT00790842|721085|P10|Began Treatment|Dose Level 3||3
298647|NCT00790842|721086|P9|Began Treatment|Dose Level 3||0
298648|NCT00790842|721087|P8|Began Treatment|Dose Level 3||0
298649|NCT00790842|721088|P7|Began Treatment|Dose Level 3||0
298650|NCT00790842|721089|P6|Began Treatment|Dose Level 3||3
298651|NCT00790842|721090|P5|Began Treatment|Dose Level 3||0
298652|NCT00790842|721091|P4|Began Treatment|Dose Level 3||0
298653|NCT00790842|721092|P3|Began Treatment|Dose Level 3||6
298654|NCT00790842|721093|P2|Began Treatment|Dose Level 3||0
298655|NCT00790842|721094|P1|Began Treatment|Dose Level 3||0
298656|NCT00790842|721084|P11|STARTED|Dose Level 3||0
298657|NCT00790842|721085|P10|STARTED|Dose Level 3||3
298658|NCT00790842|721086|P9|STARTED|Dose Level 3||0
298659|NCT00790842|721087|P8|STARTED|Dose Level 3||0
298660|NCT00790842|721088|P7|STARTED|Dose Level 3||0
298661|NCT00790842|721089|P6|STARTED|Dose Level 3||3
298662|NCT00790842|721090|P5|STARTED|Dose Level 3||0
298663|NCT00790842|721091|P4|STARTED|Dose Level 3||0
298664|NCT00790842|721092|P3|STARTED|Dose Level 3||7
298665|NCT00790842|721093|P2|STARTED|Dose Level 3||0
298666|NCT00790842|721094|P1|STARTED|Dose Level 3||0
298667|NCT00790842|721084|P11|NOT COMPLETED|Dose Level 2||0
298668|NCT00790842|721085|P10|NOT COMPLETED|Dose Level 2||0
298669|NCT00790842|721086|P9|NOT COMPLETED|Dose Level 2||2
298670|NCT00790842|721087|P8|NOT COMPLETED|Dose Level 2||0
298671|NCT00790842|721088|P7|NOT COMPLETED|Dose Level 2||0
298672|NCT00790842|721089|P6|NOT COMPLETED|Dose Level 2||0
298673|NCT00790842|721090|P5|NOT COMPLETED|Dose Level 2||1
298674|NCT00790842|721091|P4|NOT COMPLETED|Dose Level 2||0
298675|NCT00790842|721092|P3|NOT COMPLETED|Dose Level 2||0
298676|NCT00790842|721093|P2|NOT COMPLETED|Dose Level 2||3
298677|NCT00790842|721094|P1|NOT COMPLETED|Dose Level 2||0
298678|NCT00790842|721084|P11|COMPLETED|Dose Level 2||0
298679|NCT00790842|721085|P10|COMPLETED|Dose Level 2||0
298680|NCT00790842|721086|P9|COMPLETED|Dose Level 2||1
298681|NCT00790842|721087|P8|COMPLETED|Dose Level 2||0
298682|NCT00790842|721088|P7|COMPLETED|Dose Level 2||0
298683|NCT00790842|721089|P6|COMPLETED|Dose Level 2||0
298684|NCT00790842|721090|P5|COMPLETED|Dose Level 2||2
298685|NCT00790842|721091|P4|COMPLETED|Dose Level 2||0
298686|NCT00790842|721092|P3|COMPLETED|Dose Level 2||0
298687|NCT00790842|721093|P2|COMPLETED|Dose Level 2||0
298688|NCT00790842|721094|P1|COMPLETED|Dose Level 2||0
298689|NCT00790842|721084|P11|Began Treatment|Dose Level 2||0
298690|NCT00790842|721085|P10|Began Treatment|Dose Level 2||0
298691|NCT00790842|721086|P9|Began Treatment|Dose Level 2||3
298692|NCT00790842|721087|P8|Began Treatment|Dose Level 2||0
298693|NCT00790842|721088|P7|Began Treatment|Dose Level 2||0
298694|NCT00790842|721089|P6|Began Treatment|Dose Level 2||0
298695|NCT00790842|721090|P5|Began Treatment|Dose Level 2||3
298696|NCT00790842|721091|P4|Began Treatment|Dose Level 2||0
298697|NCT00790842|721092|P3|Began Treatment|Dose Level 2||0
298698|NCT00790842|721093|P2|Began Treatment|Dose Level 2||3
298699|NCT00790842|721094|P1|Began Treatment|Dose Level 2||0
298700|NCT00790842|721084|P11|STARTED|Dose Level 2||0
298701|NCT00790842|721085|P10|STARTED|Dose Level 2||0
298702|NCT00790842|721086|P9|STARTED|Dose Level 2||3
298703|NCT00790842|721087|P8|STARTED|Dose Level 2||0
298704|NCT00790842|721088|P7|STARTED|Dose Level 2||0
298705|NCT00790842|721089|P6|STARTED|Dose Level 2||0
298706|NCT00790842|721090|P5|STARTED|Dose Level 2||3
298707|NCT00790842|721091|P4|STARTED|Dose Level 2||0
298708|NCT00790842|721092|P3|STARTED|Dose Level 2||0
298709|NCT00790842|721093|P2|STARTED|Dose Level 2||3
298710|NCT00790842|721094|P1|STARTED|Dose Level 2||0
298711|NCT00790842|721084|P11|NOT COMPLETED|Dose Level 1||0
298712|NCT00790842|721085|P10|NOT COMPLETED|Dose Level 1||0
298713|NCT00790842|721086|P9|NOT COMPLETED|Dose Level 1||0
298714|NCT00790842|721087|P8|NOT COMPLETED|Dose Level 1||2
298715|NCT00790842|721088|P7|NOT COMPLETED|Dose Level 1||0
298716|NCT00790842|721089|P6|NOT COMPLETED|Dose Level 1||0
298717|NCT00790842|721090|P5|NOT COMPLETED|Dose Level 1||0
298718|NCT00790842|721091|P4|NOT COMPLETED|Dose Level 1||2
298719|NCT00790842|721092|P3|NOT COMPLETED|Dose Level 1||0
298720|NCT00790842|721093|P2|NOT COMPLETED|Dose Level 1||0
298721|NCT00790842|721094|P1|NOT COMPLETED|Dose Level 1||3
298722|NCT00790842|721084|P11|COMPLETED|Dose Level 1||0
298723|NCT00790842|721085|P10|COMPLETED|Dose Level 1||0
298724|NCT00790842|721086|P9|COMPLETED|Dose Level 1||0
298725|NCT00790842|721087|P8|COMPLETED|Dose Level 1||1
298726|NCT00790842|721088|P7|COMPLETED|Dose Level 1||0
298727|NCT00790842|721089|P6|COMPLETED|Dose Level 1||0
298728|NCT00790842|721090|P5|COMPLETED|Dose Level 1||0
298729|NCT00790842|721091|P4|COMPLETED|Dose Level 1||1
298730|NCT00790842|721092|P3|COMPLETED|Dose Level 1||0
298731|NCT00790842|721093|P2|COMPLETED|Dose Level 1||0
298732|NCT00790842|721094|P1|COMPLETED|Dose Level 1||3
298733|NCT00790842|721084|P11|Began Treatment|Dose Level 1||0
298734|NCT00790842|721085|P10|Began Treatment|Dose Level 1||0
298735|NCT00790842|721086|P9|Began Treatment|Dose Level 1||0
298736|NCT00790842|721087|P8|Began Treatment|Dose Level 1||3
298737|NCT00790842|721088|P7|Began Treatment|Dose Level 1||0
298738|NCT00790842|721089|P6|Began Treatment|Dose Level 1||0
298739|NCT00790842|721090|P5|Began Treatment|Dose Level 1||0
298740|NCT00790842|721091|P4|Began Treatment|Dose Level 1||3
298741|NCT00790842|721092|P3|Began Treatment|Dose Level 1||0
298742|NCT00790842|721093|P2|Began Treatment|Dose Level 1||0
298743|NCT00790842|721094|P1|Began Treatment|Dose Level 1||6
298744|NCT00790842|721084|P11|STARTED|Dose Level 1||0
298745|NCT00790842|721085|P10|STARTED|Dose Level 1||0
298746|NCT00790842|721086|P9|STARTED|Dose Level 1||0
298747|NCT00790842|721087|P8|STARTED|Dose Level 1||3
298748|NCT00790842|721088|P7|STARTED|Dose Level 1||0
298749|NCT00790842|721089|P6|STARTED|Dose Level 1||0
298750|NCT00790842|721090|P5|STARTED|Dose Level 1||0
298751|NCT00790842|721091|P4|STARTED|Dose Level 1||3
298752|NCT00790842|721092|P3|STARTED|Dose Level 1||0
298753|NCT00790842|721093|P2|STARTED|Dose Level 1||0
298754|NCT00790842|721094|P1|STARTED|Dose Level 1||6
298755|NCT00790803|721151|P1|NOT COMPLETED|Overall Study||0
298756|NCT00790803|721151|P1|COMPLETED|Overall Study||5
298757|NCT00790803|721151|P1|STARTED|Overall Study||5
298758|NCT00790790|721162|P3|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
298759|NCT00790790|721163|P2|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
298760|NCT00790790|721164|P1|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
298761|NCT00790790|721162|P3|COMPLETED|Study Period 3: 1-Week Washout Phase||26
298762|NCT00790790|721163|P2|COMPLETED|Study Period 3: 1-Week Washout Phase||31
298763|NCT00790790|721164|P1|COMPLETED|Study Period 3: 1-Week Washout Phase||37
298764|NCT00790790|721162|P3|STARTED|Study Period 3: 1-Week Washout Phase||27
298765|NCT00790790|721163|P2|STARTED|Study Period 3: 1-Week Washout Phase||32
298766|NCT00790790|721164|P1|STARTED|Study Period 3: 1-Week Washout Phase||37
298767|NCT00790790|721162|P3|NOT COMPLETED|Study Period 2: Therapy Phase||21
298768|NCT00790790|721163|P2|NOT COMPLETED|Study Period 2: Therapy Phase||18
298769|NCT00790790|721164|P1|NOT COMPLETED|Study Period 2: Therapy Phase||12
298770|NCT00790790|721162|P3|COMPLETED|Study Period 2: Therapy Phase||27
298771|NCT00790790|721163|P2|COMPLETED|Study Period 2: Therapy Phase||32
298772|NCT00790790|721164|P1|COMPLETED|Study Period 2: Therapy Phase||37
298773|NCT00790790|721162|P3|STARTED|Study Period 2: Therapy Phase||48
298774|NCT00790790|721163|P2|STARTED|Study Period 2: Therapy Phase||50
298775|NCT00790790|721164|P1|STARTED|Study Period 2: Therapy Phase||49
298776|NCT00790751|721241|P4|NOT COMPLETED|Overall Study||21
298777|NCT00790751|721242|P3|NOT COMPLETED|Overall Study||20
298778|NCT00790751|721243|P2|NOT COMPLETED|Overall Study||30
298779|NCT00790751|721244|P1|NOT COMPLETED|Overall Study||25
298780|NCT00790751|721241|P4|COMPLETED|Overall Study||141
298781|NCT00790751|721242|P3|COMPLETED|Overall Study||141
298782|NCT00790751|721243|P2|COMPLETED|Overall Study||131
298783|NCT00790751|721244|P1|COMPLETED|Overall Study||137
298784|NCT00790751|721241|P4|STARTED|Overall Study||162
298785|NCT00790751|721242|P3|STARTED|Overall Study||161
298786|NCT00790751|721243|P2|STARTED|Overall Study||161
298787|NCT00790751|721244|P1|STARTED|Overall Study||162
298788|NCT00790738|721264|P2|NOT COMPLETED|Overall Study||3
298789|NCT00790738|721265|P1|NOT COMPLETED|Overall Study||2
298790|NCT00790738|721264|P2|COMPLETED|Overall Study||3
298791|NCT00790738|721265|P1|COMPLETED|Overall Study||3
298792|NCT00790738|721264|P2|STARTED|Overall Study||6
298793|NCT00790738|721265|P1|STARTED|Overall Study||5
298794|NCT00790673|721279|P4|NOT COMPLETED|Overall Study||0
298795|NCT00790673|721280|P3|NOT COMPLETED|Overall Study||0
298796|NCT00790673|721281|P2|NOT COMPLETED|Overall Study||0
298797|NCT00790673|721282|P1|NOT COMPLETED|Overall Study||0
298798|NCT00790673|721279|P4|COMPLETED|Overall Study||8
298799|NCT00790673|721280|P3|COMPLETED|Overall Study||12
298800|NCT00790673|721281|P2|COMPLETED|Overall Study||6
298801|NCT00790673|721282|P1|COMPLETED|Overall Study||6
298802|NCT00790673|721279|P4|STARTED|Overall Study||8
298803|NCT00790673|721280|P3|STARTED|Overall Study||12
298804|NCT00790673|721281|P2|STARTED|Overall Study||6
298805|NCT00790673|721282|P1|STARTED|Overall Study||6
298806|NCT00790647|721292|P1|NOT COMPLETED|Overall Study||1
298807|NCT00790647|721292|P1|COMPLETED|Overall Study||9
298808|NCT00790647|721292|P1|STARTED|Overall Study||10
298809|NCT00790569|721302|P3|NOT COMPLETED|End of Study (12 Month Interview)||50
298810|NCT00790569|721303|P2|NOT COMPLETED|End of Study (12 Month Interview)||19
298811|NCT00790569|721304|P1|NOT COMPLETED|End of Study (12 Month Interview)||66
298812|NCT00790569|721302|P3|COMPLETED|End of Study (12 Month Interview)||83
298813|NCT00790569|721303|P2|COMPLETED|End of Study (12 Month Interview)||26
298814|NCT00790569|721304|P1|COMPLETED|End of Study (12 Month Interview)||71
298815|NCT00790569|721302|P3|STARTED|End of Study (12 Month Interview)||133
298816|NCT00790569|721303|P2|STARTED|End of Study (12 Month Interview)||45
298817|NCT00790569|721304|P1|STARTED|End of Study (12 Month Interview)||137
298818|NCT00790569|721302|P3|NOT COMPLETED|End of Treatment (6 Month Interview)||26
298819|NCT00790569|721303|P2|NOT COMPLETED|End of Treatment (6 Month Interview)||10
298820|NCT00790569|721304|P1|NOT COMPLETED|End of Treatment (6 Month Interview)||22
298821|NCT00790569|721302|P3|COMPLETED|End of Treatment (6 Month Interview)||107
298822|NCT00790569|721303|P2|COMPLETED|End of Treatment (6 Month Interview)||35
298823|NCT00790569|721304|P1|COMPLETED|End of Treatment (6 Month Interview)||115
298824|NCT00790569|721302|P3|STARTED|End of Treatment (6 Month Interview)||133
298825|NCT00790569|721303|P2|STARTED|End of Treatment (6 Month Interview)||45
298826|NCT00790569|721304|P1|STARTED|End of Treatment (6 Month Interview)||137
298827|NCT00790556|721345|P2|NOT COMPLETED|Treatment Period 2||0
298828|NCT00790556|721346|P1|NOT COMPLETED|Treatment Period 2||0
298829|NCT00790556|721345|P2|COMPLETED|Treatment Period 2||6
298830|NCT00790556|721346|P1|COMPLETED|Treatment Period 2||6
298831|NCT00790556|721345|P2|STARTED|Treatment Period 2||6
298832|NCT00790556|721346|P1|STARTED|Treatment Period 2||6
298833|NCT00790556|721345|P2|NOT COMPLETED|Washout After Period 1||0
298834|NCT00790556|721346|P1|NOT COMPLETED|Washout After Period 1||0
298835|NCT00790556|721345|P2|COMPLETED|Washout After Period 1||6
298836|NCT00790556|721346|P1|COMPLETED|Washout After Period 1||6
298837|NCT00790556|721345|P2|STARTED|Washout After Period 1||6
298838|NCT00790556|721346|P1|STARTED|Washout After Period 1||6
298839|NCT00790556|721345|P2|NOT COMPLETED|Treatment Period 1||0
298840|NCT00790556|721346|P1|NOT COMPLETED|Treatment Period 1||2
298841|NCT00790556|721345|P2|COMPLETED|Treatment Period 1||6
298842|NCT00790556|721346|P1|COMPLETED|Treatment Period 1||6
298843|NCT00790556|721345|P2|STARTED|Treatment Period 1||6
298844|NCT00790556|721346|P1|STARTED|Treatment Period 1||8
298845|NCT00790452|721358|P2|NOT COMPLETED|Overall Study||0
298846|NCT00790452|721359|P1|NOT COMPLETED|Overall Study||1
298847|NCT00790452|721358|P2|COMPLETED|Overall Study||0
298848|NCT00790452|721359|P1|COMPLETED|Overall Study||0
298849|NCT00790452|721358|P2|STARTED|Overall Study||0
298850|NCT00790452|721359|P1|STARTED|Overall Study||1
298851|NCT00790400|721367|P2|NOT COMPLETED|Everolimus Period (Core or Extension)||0
298852|NCT00790400|721368|P1|NOT COMPLETED|Everolimus Period (Core or Extension)||29
298853|NCT00790400|721367|P2|COMPLETED|Everolimus Period (Core or Extension)||0
298854|NCT00790400|721368|P1|COMPLETED|Everolimus Period (Core or Extension)|Treatment duration completed as per protocol|83
298855|NCT00790400|721367|P2|STARTED|Everolimus Period (Core or Extension)|"Placebo randomized patients who switched to Everolimus are reported in Everolimus arm."|0
298856|NCT00790400|721368|P1|STARTED|Everolimus Period (Core or Extension)|112 pts had Everolimus during core and/or extension (6 from placebo did not switch to Eve. in ext.)|112
298857|NCT00790400|721367|P2|NOT COMPLETED|Double-blind Period (Core Phase)||13
298858|NCT00790400|721368|P1|NOT COMPLETED|Double-blind Period (Core Phase)||7
298859|NCT00790400|721367|P2|COMPLETED|Double-blind Period (Core Phase)|Completed = 1st received Placebo in the Core phase, switched to Everolimus in Extension phase|26
298860|NCT00790400|721368|P1|COMPLETED|Double-blind Period (Core Phase)|Completed = Completed the Core phase & moved to Extension phase|72
298861|NCT00790400|721367|P2|STARTED|Double-blind Period (Core Phase)||39
298862|NCT00790400|721368|P1|STARTED|Double-blind Period (Core Phase)||79
298863|NCT00790335|721397|P2|NOT COMPLETED|Overall Study||112
298864|NCT00790335|721398|P1|NOT COMPLETED|Overall Study||80
298865|NCT00790335|721397|P2|COMPLETED|Overall Study||243
298866|NCT00790335|721398|P1|COMPLETED|Overall Study||257
298867|NCT00790335|721397|P2|STARTED|Overall Study||355
298868|NCT00790335|721398|P1|STARTED|Overall Study||337
298869|NCT00790296|721458|P2|NOT COMPLETED|Overall Study||2
298870|NCT00790296|721459|P1|NOT COMPLETED|Overall Study||1
298871|NCT00790296|721458|P2|COMPLETED|Overall Study||4
298872|NCT00790296|721459|P1|COMPLETED|Overall Study||4
298873|NCT00790296|721458|P2|STARTED|Overall Study||6
298874|NCT00790296|721459|P1|STARTED|Overall Study||5
298875|NCT00790270|721468|P3|NOT COMPLETED|Overall Study||0
298876|NCT00790270|721469|P2|NOT COMPLETED|Overall Study||0
298877|NCT00790270|721470|P1|NOT COMPLETED|Overall Study||0
298878|NCT00790270|721468|P3|COMPLETED|Overall Study||20
298879|NCT00790270|721469|P2|COMPLETED|Overall Study||20
298880|NCT00790270|721470|P1|COMPLETED|Overall Study||21
298881|NCT00790270|721468|P3|STARTED|Overall Study||20
298882|NCT00790270|721469|P2|STARTED|Overall Study||20
298883|NCT00790270|721470|P1|STARTED|Overall Study||21
298884|NCT00790218|721481|P3|NOT COMPLETED|Overall Study||0
298885|NCT00790218|721482|P2|NOT COMPLETED|Overall Study||0
298886|NCT00790218|721483|P1|NOT COMPLETED|Overall Study||1
298887|NCT00790218|721481|P3|COMPLETED|Overall Study||7
298888|NCT00790218|721482|P2|COMPLETED|Overall Study||6
298889|NCT00790218|721483|P1|COMPLETED|Overall Study||5
298890|NCT00790218|721481|P3|STARTED|Overall Study||7
298891|NCT00790218|721482|P2|STARTED|Overall Study||6
298892|NCT00790218|721483|P1|STARTED|Overall Study||6
298893|NCT00790205|721493|P2|NOT COMPLETED|Overall Study||434
298894|NCT00790205|721494|P1|NOT COMPLETED|Overall Study||360
298895|NCT00790205|721493|P2|COMPLETED|Overall Study||6905
298896|NCT00790205|721494|P1|COMPLETED|Overall Study||6972
298897|NCT00790205|721493|P2|Treated|Overall Study||7274
298898|NCT00790205|721494|P1|Treated|Overall Study||7266
298899|NCT00790205|721493|P2|STARTED|Overall Study||7339
298900|NCT00790205|721494|P1|STARTED|Overall Study||7332
298901|NCT00790192|721538|P4|NOT COMPLETED|Overall Study||48
298902|NCT00790192|721539|P3|NOT COMPLETED|Overall Study||23
298903|NCT00790192|721540|P2|NOT COMPLETED|Overall Study||28
298904|NCT00790192|721541|P1|NOT COMPLETED|Overall Study||36
298905|NCT00790192|721538|P4|COMPLETED|Overall Study||74
298906|NCT00790192|721539|P3|COMPLETED|Overall Study||97
298907|NCT00790192|721540|P2|COMPLETED|Overall Study||93
298908|NCT00790192|721541|P1|COMPLETED|Overall Study||89
298909|NCT00790192|721538|P4|STARTED|Overall Study||122
298910|NCT00790192|721539|P3|STARTED|Overall Study||120
298911|NCT00790192|721540|P2|STARTED|Overall Study||121
298912|NCT00790192|721541|P1|STARTED|Overall Study||125
298913|NCT00790088|721555|P1|NOT COMPLETED|Overall Study||39
298914|NCT00790088|721555|P1|COMPLETED|Overall Study||235
298915|NCT00790088|721555|P1|Eligible for Data Analysis|Overall Study|Number of participants minus 11 protocol violation|263
298916|NCT00790088|721555|P1|STARTED|Overall Study||274
298917|NCT00790062|721568|P3|NOT COMPLETED|Overall Study||0
298918|NCT00790062|721569|P2|NOT COMPLETED|Overall Study||0
298919|NCT00790062|721570|P1|NOT COMPLETED|Overall Study||0
298920|NCT00790062|721568|P3|COMPLETED|Overall Study||658
298921|NCT00790062|721569|P2|COMPLETED|Overall Study||481
298922|NCT00790062|721570|P1|COMPLETED|Overall Study||659
298923|NCT00790062|721568|P3|STARTED|Overall Study||658
298924|NCT00790062|721569|P2|STARTED|Overall Study||481
298925|NCT00790062|721570|P1|STARTED|Overall Study||659
298926|NCT00790036|721601|P2|NOT COMPLETED|Overall Study||121
298927|NCT00790036|721602|P1|NOT COMPLETED|Overall Study||195
298928|NCT00790036|721601|P2|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|249
298929|NCT00790036|721602|P1|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|177
298930|NCT00790036|721601|P2|Untreated Participants|Overall Study|not treated due to administrative problems and subject withdrawal of consent.|6
299022|NCT00789750|721971|P1|Dropped During run-in Period|Overall Study||6
298931|NCT00790036|721602|P1|Untreated Participants|Overall Study|not treated due to administrative problems, protocol deviation, and subject withdrawal of consent.|4
298932|NCT00790036|721601|P2|STARTED|Overall Study||370
298933|NCT00790036|721602|P1|STARTED|Overall Study||372
298934|NCT00790023|721616|P3|NOT COMPLETED|Overall Study||21
298935|NCT00790023|721617|P2|NOT COMPLETED|Overall Study||10
298936|NCT00790023|721618|P1|NOT COMPLETED|Overall Study||11
298937|NCT00790023|721616|P3|COMPLETED|Overall Study||214
298938|NCT00790023|721617|P2|COMPLETED|Overall Study||225
298939|NCT00790023|721618|P1|COMPLETED|Overall Study||226
298940|NCT00790023|721616|P3|STARTED|Overall Study||235
298941|NCT00790023|721617|P2|STARTED|Overall Study||235
298942|NCT00790023|721618|P1|STARTED|Overall Study||237
298943|NCT00789997|721708|P2|NOT COMPLETED|Overall Study||2
298944|NCT00789997|721709|P1|NOT COMPLETED|Overall Study||1
298945|NCT00789997|721708|P2|COMPLETED|Overall Study||38
298946|NCT00789997|721709|P1|COMPLETED|Overall Study||40
298947|NCT00789997|721708|P2|STARTED|Overall Study||40
298948|NCT00789997|721709|P1|STARTED|Overall Study||41
298949|NCT00789958|721717|P1|NOT COMPLETED|Overall Study||37
298950|NCT00789958|721717|P1|COMPLETED|Overall Study||68
298951|NCT00789958|721717|P1|Eligible and Analyzable|Overall Study||79
298952|NCT00789958|721717|P1|STARTED|Overall Study||105
298953|NCT00789880|721736|P6|NOT COMPLETED|Overall Study||0
298954|NCT00789880|721737|P5|NOT COMPLETED|Overall Study||3
298955|NCT00789880|721738|P4|NOT COMPLETED|Overall Study||1
298956|NCT00789880|721739|P3|NOT COMPLETED|Overall Study||0
298957|NCT00789880|721740|P2|NOT COMPLETED|Overall Study||1
298958|NCT00789880|721741|P1|NOT COMPLETED|Overall Study||1
298959|NCT00789880|721736|P6|COMPLETED|Overall Study||8
298960|NCT00789880|721737|P5|COMPLETED|Overall Study||15
298961|NCT00789880|721738|P4|COMPLETED|Overall Study||15
298962|NCT00789880|721739|P3|COMPLETED|Overall Study||8
298963|NCT00789880|721740|P2|COMPLETED|Overall Study||15
298964|NCT00789880|721741|P1|COMPLETED|Overall Study||15
298965|NCT00789880|721736|P6|STARTED|Overall Study||8
298966|NCT00789880|721737|P5|STARTED|Overall Study||18
298967|NCT00789880|721738|P4|STARTED|Overall Study||16
298968|NCT00789880|721739|P3|STARTED|Overall Study||8
298969|NCT00789880|721740|P2|STARTED|Overall Study||16
298970|NCT00789880|721741|P1|STARTED|Overall Study||16
298971|NCT00789854|721770|P3|NOT COMPLETED|Overall Study||47
298972|NCT00789854|721771|P2|NOT COMPLETED|Overall Study||35
298973|NCT00789854|721772|P1|NOT COMPLETED|Overall Study||49
298974|NCT00789854|721770|P3|COMPLETED|Overall Study||182
298975|NCT00789854|721771|P2|COMPLETED|Overall Study||196
298976|NCT00789854|721772|P1|COMPLETED|Overall Study||179
298977|NCT00789854|721770|P3|STARTED|Overall Study||229
298978|NCT00789854|721771|P2|STARTED|Overall Study||231
298979|NCT00789854|721772|P1|STARTED|Overall Study||228
298980|NCT00789828|721869|P2|NOT COMPLETED|Open-label Extension Period (4 Years)||0
298981|NCT00789828|721870|P1|NOT COMPLETED|Open-label Extension Period (4 Years)||29
298982|NCT00789828|721869|P2|COMPLETED|Open-label Extension Period (4 Years)||0
298983|NCT00789828|721870|P1|COMPLETED|Open-label Extension Period (4 Years)||82
298984|NCT00789828|721869|P2|STARTED|Open-label Extension Period (4 Years)|No participant received placebo.|0
298985|NCT00789828|721870|P1|STARTED|Open-label Extension Period (4 Years)|Of 117 participants only 111 completed the core period and continued in the extension period|111
298986|NCT00789828|721869|P2|NOT COMPLETED|Core Period (48 Weeks)||6
298987|NCT00789828|721870|P1|NOT COMPLETED|Core Period (48 Weeks)||0
298988|NCT00789828|721869|P2|COMPLETED|Core Period (48 Weeks)||33
298989|NCT00789828|721870|P1|COMPLETED|Core Period (48 Weeks)||78
298990|NCT00789828|721869|P2|STARTED|Core Period (48 Weeks)||39
298991|NCT00789828|721870|P1|STARTED|Core Period (48 Weeks)||78
298992|NCT00789815|721904|P2|NOT COMPLETED|Overall Study||1
298993|NCT00789815|721905|P1|NOT COMPLETED|Overall Study||7
298994|NCT00789815|721904|P2|COMPLETED|Overall Study||249
298995|NCT00789815|721905|P1|COMPLETED|Overall Study||243
298996|NCT00789815|721904|P2|STARTED|Overall Study||250
298997|NCT00789815|721905|P1|STARTED|Overall Study||250
298998|NCT00789802|721928|P3|NOT COMPLETED|Overall Study||6
298999|NCT00789802|721929|P2|NOT COMPLETED|Overall Study||7
299000|NCT00789802|721930|P1|NOT COMPLETED|Overall Study||10
299001|NCT00789802|721928|P3|COMPLETED|Overall Study||37
299002|NCT00789802|721929|P2|COMPLETED|Overall Study||35
299003|NCT00789802|721930|P1|COMPLETED|Overall Study||34
299004|NCT00789802|721928|P3|STARTED|Overall Study||43
299005|NCT00789802|721929|P2|STARTED|Overall Study||42
299006|NCT00789802|721930|P1|STARTED|Overall Study||44
299007|NCT00789776|721949|P2|NOT COMPLETED|Overall Study||1
299008|NCT00789776|721950|P1|NOT COMPLETED|Overall Study||0
299009|NCT00789776|721949|P2|COMPLETED|Overall Study||35
299010|NCT00789776|721950|P1|COMPLETED|Overall Study||5
299011|NCT00789776|721949|P2|STARTED|Overall Study||36
299012|NCT00789776|721950|P1|STARTED|Overall Study||5
299013|NCT00789750|721970|P2|NOT COMPLETED|Overall Study||60
299014|NCT00789750|721971|P1|NOT COMPLETED|Overall Study||59
299015|NCT00789750|721970|P2|COMPLETED|Overall Study||222
299016|NCT00789750|721971|P1|COMPLETED|Overall Study||221
299017|NCT00789750|721970|P2|Intent to Treat Set|Overall Study||276
299018|NCT00789750|721971|P1|Intent to Treat Set|Overall Study||271
299019|NCT00789750|721970|P2|Safety Set|Overall Study||277
299020|NCT00789750|721971|P1|Safety Set|Overall Study||274
299021|NCT00789750|721970|P2|Dropped During run-in Period|Overall Study||5
299023|NCT00789750|721970|P2|STARTED|Overall Study||282
299024|NCT00789750|721971|P1|STARTED|Overall Study||280
299025|NCT00789737|722015|P2|NOT COMPLETED|Overall Study||55
299026|NCT00789737|722016|P1|NOT COMPLETED|Overall Study||48
299027|NCT00789737|722015|P2|COMPLETED|Overall Study||126
299028|NCT00789737|722016|P1|COMPLETED|Overall Study||128
299029|NCT00789737|722015|P2|STARTED|Overall Study||181
299030|NCT00789737|722016|P1|STARTED|Overall Study||176
299031|NCT00789724|722048|P2|NOT COMPLETED|Overall Study||0
299032|NCT00789724|722049|P1|NOT COMPLETED|Overall Study||0
299033|NCT00789724|722048|P2|COMPLETED|Overall Study||5
299034|NCT00789724|722049|P1|COMPLETED|Overall Study||5
299035|NCT00789724|722048|P2|STARTED|Overall Study||5
299036|NCT00789724|722049|P1|STARTED|Overall Study||5
299037|NCT00789698|722059|P4|NOT COMPLETED|Overall Study||52
299038|NCT00789698|722060|P3|NOT COMPLETED|Overall Study||27
299039|NCT00789698|722061|P2|NOT COMPLETED|Overall Study||33
299040|NCT00789698|722062|P1|NOT COMPLETED|Overall Study||40
299041|NCT00789698|722059|P4|COMPLETED|Overall Study||33
299042|NCT00789698|722060|P3|COMPLETED|Overall Study||29
299043|NCT00789698|722061|P2|COMPLETED|Overall Study||46
299044|NCT00789698|722062|P1|COMPLETED|Overall Study||32
299045|NCT00789698|722059|P4|STARTED|Overall Study||85
299046|NCT00789698|722060|P3|STARTED|Overall Study||56
299047|NCT00789698|722061|P2|STARTED|Overall Study||79
299048|NCT00789698|722062|P1|STARTED|Overall Study||72
299049|NCT00789685|722076|P1|NOT COMPLETED|Overall Study||12
299050|NCT00789685|722076|P1|COMPLETED|Overall Study|Completed the study to Day 28|25
299051|NCT00789685|722076|P1|STARTED|Overall Study||37
299052|NCT00789672|722084|P2|NOT COMPLETED|Overall Study||0
299053|NCT00789672|722085|P1|NOT COMPLETED|Overall Study||0
299054|NCT00789672|722084|P2|COMPLETED|Overall Study||17
299055|NCT00789672|722085|P1|COMPLETED|Overall Study||16
299056|NCT00789672|722084|P2|STARTED|Overall Study||17
299057|NCT00789672|722085|P1|STARTED|Overall Study||16
299058|NCT00789581|722117|P2|NOT COMPLETED|Adjuvant Therapy||57
299059|NCT00789581|722118|P1|NOT COMPLETED|Adjuvant Therapy||40
299060|NCT00789581|722117|P2|COMPLETED|Adjuvant Therapy||234
299061|NCT00789581|722118|P1|COMPLETED|Adjuvant Therapy||255
299062|NCT00789581|722117|P2|STARTED|Adjuvant Therapy||291
299063|NCT00789581|722118|P1|STARTED|Adjuvant Therapy||295
299064|NCT00789581|722117|P2|NOT COMPLETED|AC Therapy||17
299065|NCT00789581|722118|P1|NOT COMPLETED|AC Therapy||11
299066|NCT00789581|722117|P2|COMPLETED|AC Therapy||291
299067|NCT00789581|722118|P1|COMPLETED|AC Therapy||295
299068|NCT00789581|722117|P2|STARTED|AC Therapy||308
299069|NCT00789581|722118|P1|STARTED|AC Therapy||306
299070|NCT00789555|722129|P3|NOT COMPLETED|Overall Study||159
299071|NCT00789555|722130|P2|NOT COMPLETED|Overall Study||139
299072|NCT00789555|722131|P1|NOT COMPLETED|Overall Study||159
299073|NCT00789555|722129|P3|COMPLETED|Overall Study||263
299074|NCT00789555|722130|P2|COMPLETED|Overall Study||278
299075|NCT00789555|722131|P1|COMPLETED|Overall Study||262
299076|NCT00789555|722129|P3|STARTED|Overall Study||422
299077|NCT00789555|722130|P2|STARTED|Overall Study||417
299078|NCT00789555|722131|P1|STARTED|Overall Study||421
299079|NCT00789529|722156|P2|NOT COMPLETED|Overall Study||1
299080|NCT00789529|722157|P1|NOT COMPLETED|Overall Study||1
299081|NCT00789529|722156|P2|COMPLETED|Overall Study||15
299082|NCT00789529|722157|P1|COMPLETED|Overall Study||15
299083|NCT00789529|722156|P2|STARTED|Overall Study||16
299084|NCT00789529|722157|P1|STARTED|Overall Study||16
299085|NCT00789477|722170|P5|NOT COMPLETED|Overall Study||7
299086|NCT00789477|722171|P4|NOT COMPLETED|Overall Study||10
299087|NCT00789477|722172|P3|NOT COMPLETED|Overall Study||11
299088|NCT00789477|722173|P2|NOT COMPLETED|Overall Study||6
299089|NCT00789477|722174|P1|NOT COMPLETED|Overall Study||11
299090|NCT00789477|722170|P5|COMPLETED|Overall Study||38
299091|NCT00789477|722171|P4|COMPLETED|Overall Study||34
299092|NCT00789477|722172|P3|COMPLETED|Overall Study||33
299093|NCT00789477|722173|P2|COMPLETED|Overall Study||38
299094|NCT00789477|722174|P1|COMPLETED|Overall Study||33
299095|NCT00789477|722170|P5|Participants Received Treatment|Overall Study|SAF|45
299096|NCT00789477|722171|P4|Participants Received Treatment|Overall Study|SAF|42
299097|NCT00789477|722172|P3|Participants Received Treatment|Overall Study|SAF|44
299098|NCT00789477|722173|P2|Participants Received Treatment|Overall Study|SAF|44
299099|NCT00789477|722174|P1|Participants Received Treatment|Overall Study|safety analysis set (SAF)|44
299100|NCT00789477|722170|P5|STARTED|Overall Study|randomized|45
299101|NCT00789477|722171|P4|STARTED|Overall Study|randomized|44
299102|NCT00789477|722172|P3|STARTED|Overall Study|randomized|44
299103|NCT00789477|722173|P2|STARTED|Overall Study|randomized|44
299104|NCT00789477|722174|P1|STARTED|Overall Study|randomized|44
299105|NCT00789438|722209|P3|NOT COMPLETED|Overall Study||0
299106|NCT00789438|722210|P2|NOT COMPLETED|Overall Study||0
299107|NCT00789438|722211|P1|NOT COMPLETED|Overall Study||0
299108|NCT00789438|722209|P3|COMPLETED|Overall Study||28
299109|NCT00789438|722210|P2|COMPLETED|Overall Study||20
299110|NCT00789438|722211|P1|COMPLETED|Overall Study||21
299111|NCT00789438|722209|P3|STARTED|Overall Study||28
299112|NCT00789438|722210|P2|STARTED|Overall Study||20
299113|NCT00789438|722211|P1|STARTED|Overall Study||21
299114|NCT00789373|722219|P3|NOT COMPLETED|Maintenance||180
299115|NCT00789373|722220|P2|NOT COMPLETED|Maintenance||359
299116|NCT00789373|722221|P1|NOT COMPLETED|Maintenance||0
299117|NCT00789373|722219|P3|COMPLETED|Maintenance||0
299118|NCT00789373|722220|P2|COMPLETED|Maintenance||0
299119|NCT00789373|722221|P1|COMPLETED|Maintenance||0
299120|NCT00789373|722219|P3|STARTED|Maintenance||180
299121|NCT00789373|722220|P2|STARTED|Maintenance||359
299122|NCT00789373|722221|P1|STARTED|Maintenance||0
299123|NCT00789373|722219|P3|NOT COMPLETED|Induction||0
299124|NCT00789373|722220|P2|NOT COMPLETED|Induction||0
299125|NCT00789373|722221|P1|NOT COMPLETED|Induction||399
299126|NCT00789373|722219|P3|COMPLETED|Induction||0
299127|NCT00789373|722220|P2|COMPLETED|Induction||0
299128|NCT00789373|722221|P1|COMPLETED|Induction|1 patient received maintenance therapy post-induction but was never randomized.|540
299129|NCT00789373|722219|P3|STARTED|Induction||0
299130|NCT00789373|722220|P2|STARTED|Induction||0
299131|NCT00789373|722221|P1|STARTED|Induction||939
299132|NCT00789360|722248|P2|NOT COMPLETED|Overall Study||1
299133|NCT00789360|722249|P1|NOT COMPLETED|Overall Study||3
299134|NCT00789360|722248|P2|COMPLETED|Overall Study||14
299135|NCT00789360|722249|P1|COMPLETED|Overall Study||12
299136|NCT00789360|722248|P2|STARTED|Overall Study||15
299137|NCT00789360|722249|P1|STARTED|Overall Study||15
299138|NCT00789321|722259|P2|NOT COMPLETED|Overall Study||1
299139|NCT00789321|722260|P1|NOT COMPLETED|Overall Study||0
299140|NCT00789321|722259|P2|COMPLETED|Overall Study||22
299141|NCT00789321|722260|P1|COMPLETED|Overall Study||24
299142|NCT00789321|722259|P2|STARTED|Overall Study||23
299143|NCT00789321|722260|P1|STARTED|Overall Study||24
299144|NCT00789256|722270|P2|NOT COMPLETED|Overall Study||0
299145|NCT00789256|722271|P1|NOT COMPLETED|Overall Study||0
299146|NCT00789256|722270|P2|COMPLETED|Overall Study||12
299147|NCT00789256|722271|P1|COMPLETED|Overall Study|Strata 1 had 5 responders and continued accrual, but the study was closed due to low accrual.|14
299148|NCT00789256|722270|P2|STARTED|Overall Study||12
299149|NCT00789256|722271|P1|STARTED|Overall Study||14
299150|NCT00789191|722282|P2|NOT COMPLETED|Overall Study||19
299151|NCT00789191|722283|P1|NOT COMPLETED|Overall Study||14
299152|NCT00789191|722282|P2|COMPLETED|Overall Study||92
299153|NCT00789191|722283|P1|COMPLETED|Overall Study||97
299154|NCT00789191|722282|P2|Exposed|Overall Study|1 non-compliance|110
299155|NCT00789191|722283|P1|Exposed|Overall Study|2 withdrew informed consent. 1 randomised by mistake. 1 non-compliance|107
299156|NCT00789191|722282|P2|STARTED|Overall Study||111
299157|NCT00789191|722283|P1|STARTED|Overall Study||111
299158|NCT00789113|722311|P1|NOT COMPLETED|Overall Study||0
299159|NCT00789113|722311|P1|COMPLETED|Overall Study||12
299160|NCT00789113|722311|P1|STARTED|Overall Study||12
299161|NCT00789074|722318|P2|NOT COMPLETED|Overall Study||13
299162|NCT00789074|722319|P1|NOT COMPLETED|Overall Study||11
299163|NCT00789074|722318|P2|COMPLETED|Overall Study||35
299164|NCT00789074|722319|P1|COMPLETED|Overall Study||42
299165|NCT00789074|722318|P2|STARTED|Overall Study||48
299166|NCT00789074|722319|P1|STARTED|Overall Study||53
299167|NCT00789035|722340|P5|NOT COMPLETED|Overall Study||6
299168|NCT00789035|722341|P4|NOT COMPLETED|Overall Study||1
299169|NCT00789035|722342|P3|NOT COMPLETED|Overall Study||1
299170|NCT00789035|722343|P2|NOT COMPLETED|Overall Study||7
299171|NCT00789035|722344|P1|NOT COMPLETED|Overall Study||6
299172|NCT00789035|722340|P5|COMPLETED|Overall Study||74
299173|NCT00789035|722341|P4|COMPLETED|Overall Study||81
299174|NCT00789035|722342|P3|COMPLETED|Overall Study||80
299175|NCT00789035|722343|P2|COMPLETED|Overall Study||74
299176|NCT00789035|722344|P1|COMPLETED|Overall Study||76
299177|NCT00789035|722340|P5|STARTED|Overall Study||80
299178|NCT00789035|722341|P4|STARTED|Overall Study||82
299179|NCT00789035|722342|P3|STARTED|Overall Study||81
299180|NCT00789035|722343|P2|STARTED|Overall Study||81
299181|NCT00789035|722344|P1|STARTED|Overall Study||82
299182|NCT00788957|722403|P6|NOT COMPLETED|Part 3||11
299183|NCT00788957|722404|P5|NOT COMPLETED|Part 3||9
299184|NCT00788957|722405|P4|NOT COMPLETED|Part 3||0
299185|NCT00788957|722406|P3|NOT COMPLETED|Part 3||0
299186|NCT00788957|722407|P2|NOT COMPLETED|Part 3||0
299187|NCT00788957|722408|P1|NOT COMPLETED|Part 3||0
299188|NCT00788957|722403|P6|COMPLETED|Part 3|Completed the safety follow-up visit|1
299189|NCT00788957|722404|P5|COMPLETED|Part 3|Completed the safety follow-up visit|4
299190|NCT00788957|722405|P4|COMPLETED|Part 3||0
299191|NCT00788957|722406|P3|COMPLETED|Part 3||0
299192|NCT00788957|722407|P2|COMPLETED|Part 3||0
299193|NCT00788957|722408|P1|COMPLETED|Part 3||0
299194|NCT00788957|722403|P6|STARTED|Part 3||12
299195|NCT00788957|722404|P5|STARTED|Part 3||13
299196|NCT00788957|722405|P4|STARTED|Part 3||0
299197|NCT00788957|722406|P3|STARTED|Part 3||0
299198|NCT00788957|722407|P2|STARTED|Part 3||0
299199|NCT00788957|722408|P1|STARTED|Part 3||0
299200|NCT00788957|722403|P6|NOT COMPLETED|Part 2||0
299201|NCT00788957|722404|P5|NOT COMPLETED|Part 2||0
299202|NCT00788957|722405|P4|NOT COMPLETED|Part 2||41
299203|NCT00788957|722406|P3|NOT COMPLETED|Part 2||44
299204|NCT00788957|722407|P2|NOT COMPLETED|Part 2||42
299205|NCT00788957|722408|P1|NOT COMPLETED|Part 2||0
299206|NCT00788957|722403|P6|COMPLETED|Part 2||0
299207|NCT00788957|722404|P5|COMPLETED|Part 2||0
299208|NCT00788957|722405|P4|COMPLETED|Part 2|Completed the safety follow-up visit|5
299209|NCT00788957|722406|P3|COMPLETED|Part 2|Completed the safety follow-up visit|4
299210|NCT00788957|722407|P2|COMPLETED|Part 2|Completed the safety follow-up visit at the end of the study|6
299211|NCT00788957|722408|P1|COMPLETED|Part 2||0
299212|NCT00788957|722403|P6|STARTED|Part 2||0
299213|NCT00788957|722404|P5|STARTED|Part 2||0
299214|NCT00788957|722405|P4|STARTED|Part 2||46
299215|NCT00788957|722406|P3|STARTED|Part 2||48
299216|NCT00788957|722407|P2|STARTED|Part 2||48
299217|NCT00788957|722408|P1|STARTED|Part 2||0
299218|NCT00788957|722403|P6|NOT COMPLETED|Part 1||0
299219|NCT00788957|722404|P5|NOT COMPLETED|Part 1||0
299220|NCT00788957|722405|P4|NOT COMPLETED|Part 1||0
299221|NCT00788957|722406|P3|NOT COMPLETED|Part 1||0
299222|NCT00788957|722407|P2|NOT COMPLETED|Part 1||0
299223|NCT00788957|722408|P1|NOT COMPLETED|Part 1||9
299224|NCT00788957|722403|P6|COMPLETED|Part 1||0
299225|NCT00788957|722404|P5|COMPLETED|Part 1||0
299226|NCT00788957|722405|P4|COMPLETED|Part 1||0
299227|NCT00788957|722406|P3|COMPLETED|Part 1||0
299228|NCT00788957|722407|P2|COMPLETED|Part 1||0
299229|NCT00788957|722408|P1|COMPLETED|Part 1|Completed the safety follow-up visit|2
299230|NCT00788957|722403|P6|STARTED|Part 1||0
299231|NCT00788957|722404|P5|STARTED|Part 1||0
299232|NCT00788957|722405|P4|STARTED|Part 1||0
299233|NCT00788957|722406|P3|STARTED|Part 1||0
299234|NCT00788957|722407|P2|STARTED|Part 1||0
299235|NCT00788957|722408|P1|STARTED|Part 1||11
299236|NCT00788892|722464|P2|NOT COMPLETED|Overall Study||23
299237|NCT00788892|722465|P1|NOT COMPLETED|Overall Study||49
299238|NCT00788892|722464|P2|COMPLETED|Overall Study||18
299239|NCT00788892|722465|P1|COMPLETED|Overall Study||36
299240|NCT00788892|722464|P2|STARTED|Overall Study||41
299241|NCT00788892|722465|P1|STARTED|Overall Study||85
299242|NCT00788827|722481|P1|NOT COMPLETED|Overall Study||2
299243|NCT00788827|722481|P1|COMPLETED|Overall Study||5
299244|NCT00788827|722481|P1|STARTED|Overall Study||7
299245|NCT00788775|722495|P2|NOT COMPLETED|Overall Study||8
299246|NCT00788775|722496|P1|NOT COMPLETED|Overall Study||10
299247|NCT00788775|722495|P2|COMPLETED|Overall Study||1
299248|NCT00788775|722496|P1|COMPLETED|Overall Study||1
299249|NCT00788775|722495|P2|Treated|Overall Study||8
299250|NCT00788775|722496|P1|Treated|Overall Study||11
299251|NCT00788775|722495|P2|STARTED|Overall Study||9
299252|NCT00788775|722496|P1|STARTED|Overall Study||11
299253|NCT00788710|722511|P3|NOT COMPLETED|Overall Study||6
299254|NCT00788710|722512|P2|NOT COMPLETED|Overall Study||8
299255|NCT00788710|722513|P1|NOT COMPLETED|Overall Study||5
299256|NCT00788710|722511|P3|COMPLETED|Overall Study||138
299257|NCT00788710|722512|P2|COMPLETED|Overall Study||134
299258|NCT00788710|722513|P1|COMPLETED|Overall Study||139
299259|NCT00788710|722511|P3|STARTED|Overall Study||144
299260|NCT00788710|722512|P2|STARTED|Overall Study||142
299261|NCT00788710|722513|P1|STARTED|Overall Study||144
299262|NCT00788697|722527|P1|NOT COMPLETED|Overall Study||109
299263|NCT00788697|722527|P1|COMPLETED|Overall Study||240
299264|NCT00788697|722527|P1|STARTED|Overall Study||349
299265|NCT00788593|722574|P3|NOT COMPLETED|Second Intervention Period||1
299266|NCT00788593|722575|P2|NOT COMPLETED|Second Intervention Period||1
299267|NCT00788593|722576|P1|NOT COMPLETED|Second Intervention Period||0
299268|NCT00788593|722574|P3|COMPLETED|Second Intervention Period||36
299269|NCT00788593|722575|P2|COMPLETED|Second Intervention Period||37
299270|NCT00788593|722576|P1|COMPLETED|Second Intervention Period||0
299271|NCT00788593|722574|P3|STARTED|Second Intervention Period||37
299272|NCT00788593|722575|P2|STARTED|Second Intervention Period||38
299273|NCT00788593|722576|P1|STARTED|Second Intervention Period||0
299274|NCT00788593|722574|P3|NOT COMPLETED|First Intervention Period||0
299275|NCT00788593|722575|P2|NOT COMPLETED|First Intervention Period||1
299276|NCT00788593|722576|P1|NOT COMPLETED|First Intervention Period||0
299277|NCT00788593|722574|P3|COMPLETED|First Intervention Period||37
299278|NCT00788593|722575|P2|COMPLETED|First Intervention Period||38
299279|NCT00788593|722576|P1|COMPLETED|First Intervention Period||0
299280|NCT00788593|722574|P3|STARTED|First Intervention Period||37
299281|NCT00788593|722575|P2|STARTED|First Intervention Period||39
299282|NCT00788593|722576|P1|STARTED|First Intervention Period||0
299283|NCT00788593|722574|P3|NOT COMPLETED|Placebo Run-in Phase||0
299284|NCT00788593|722575|P2|NOT COMPLETED|Placebo Run-in Phase||0
299285|NCT00788593|722576|P1|NOT COMPLETED|Placebo Run-in Phase||6
299286|NCT00788593|722574|P3|COMPLETED|Placebo Run-in Phase||0
299287|NCT00788593|722575|P2|COMPLETED|Placebo Run-in Phase||0
299288|NCT00788593|722576|P1|COMPLETED|Placebo Run-in Phase||76
299289|NCT00788593|722574|P3|STARTED|Placebo Run-in Phase||0
299290|NCT00788593|722575|P2|STARTED|Placebo Run-in Phase||0
299291|NCT00788593|722576|P1|STARTED|Placebo Run-in Phase||82
299292|NCT00788372|722593|P1|NOT COMPLETED|Period 2 (Week 4 to Week 52)||32
299293|NCT00788372|722593|P1|COMPLETED|Period 2 (Week 4 to Week 52)||79
299294|NCT00788372|722593|P1|STARTED|Period 2 (Week 4 to Week 52)||111
299295|NCT00788372|722593|P1|NOT COMPLETED|Period 1 (up to 4 Weeks)||31
299296|NCT00788372|722593|P1|COMPLETED|Period 1 (up to 4 Weeks)||111
299297|NCT00788372|722593|P1|STARTED|Period 1 (up to 4 Weeks)||142
299298|NCT00788255|722607|P1|NOT COMPLETED|Overall Study||0
299299|NCT00788255|722607|P1|COMPLETED|Overall Study||25
299300|NCT00788255|722607|P1|Oxytocin: 0 μU/mL|Overall Study||25
299301|NCT00788255|722607|P1|Oxytocin Infusion 3: 32.9μU/mL|Overall Study||25
299302|NCT00788255|722607|P1|Oxytocin Infusion 2: 30.1μU/mL|Overall Study||25
299303|NCT00788255|722607|P1|Oxytocin Infusion 1: 22.5 μU/mL|Overall Study||25
299304|NCT00788255|722607|P1|STARTED|Overall Study||25
299305|NCT00788151|722622|P2|NOT COMPLETED|Overall Study||10
299306|NCT00788151|722623|P1|NOT COMPLETED|Overall Study||14
299307|NCT00788151|722622|P2|COMPLETED|Overall Study||90
299308|NCT00788151|722623|P1|COMPLETED|Overall Study||186
299309|NCT00788151|722622|P2|Received Vaccination 3|Overall Study||90
299310|NCT00788151|722623|P1|Received Vaccination 3|Overall Study||186
299311|NCT00788151|722622|P2|Received Vaccination 2|Overall Study||92
299312|NCT00788151|722623|P1|Received Vaccination 2|Overall Study||188
299313|NCT00788151|722622|P2|Received Vaccination 1|Overall Study||99
299314|NCT00788151|722623|P1|Received Vaccination 1|Overall Study||199
299315|NCT00788151|722622|P2|STARTED|Overall Study||100
299316|NCT00788151|722623|P1|STARTED|Overall Study||200
299317|NCT00788073|722667|P2|NOT COMPLETED|Placebo Then STX209||1
299318|NCT00788073|722668|P1|NOT COMPLETED|Placebo Then STX209||2
299319|NCT00788073|722667|P2|COMPLETED|Placebo Then STX209||29
299320|NCT00788073|722668|P1|COMPLETED|Placebo Then STX209||27
299321|NCT00788073|722667|P2|STARTED|Placebo Then STX209||30
299322|NCT00788073|722668|P1|STARTED|Placebo Then STX209||29
299323|NCT00788073|722667|P2|NOT COMPLETED|STX209 Then Placebo||3
299324|NCT00788073|722668|P1|NOT COMPLETED|STX209 Then Placebo||1
299325|NCT00788073|722667|P2|COMPLETED|STX209 Then Placebo||30
299326|NCT00788073|722668|P1|COMPLETED|STX209 Then Placebo||29
299327|NCT00788073|722667|P2|STARTED|STX209 Then Placebo||33
299328|NCT00788073|722668|P1|STARTED|STX209 Then Placebo||30
299329|NCT00788008|722678|P2|NOT COMPLETED|Overall Study||0
299330|NCT00788008|722679|P1|NOT COMPLETED|Overall Study||0
299331|NCT00788008|722678|P2|COMPLETED|Overall Study||101
299332|NCT00788008|722679|P1|COMPLETED|Overall Study||98
299333|NCT00788008|722678|P2|STARTED|Overall Study||101
299334|NCT00788008|722679|P1|STARTED|Overall Study||98
299335|NCT00787943|722685|P1|NOT COMPLETED|Overall Study||0
299336|NCT00787943|722685|P1|COMPLETED|Overall Study||10
299337|NCT00787943|722685|P1|STARTED|Overall Study||10
299338|NCT00787930|722693|P1|NOT COMPLETED|Continuation Treatment -- up to 12 Month||3
299339|NCT00787930|722693|P1|COMPLETED|Continuation Treatment -- up to 12 Month||16
299340|NCT00787930|722693|P1|STARTED|Continuation Treatment -- up to 12 Month||19
299341|NCT00787930|722693|P1|NOT COMPLETED|Acute Treatment -- 3 Weeks||0
299342|NCT00787930|722693|P1|COMPLETED|Acute Treatment -- 3 Weeks||19
299343|NCT00787930|722693|P1|STARTED|Acute Treatment -- 3 Weeks||19
299344|NCT00787917|722708|P2|NOT COMPLETED|Open Label||0
299345|NCT00787917|722709|P1|NOT COMPLETED|Open Label||4
299346|NCT00787917|722708|P2|COMPLETED|Open Label||0
299347|NCT00787917|722709|P1|COMPLETED|Open Label||3
299348|NCT00787917|722708|P2|STARTED|Open Label|"Placebo was not an arm in open label treatment."|0
299349|NCT00787917|722709|P1|STARTED|Open Label||7
299350|NCT00787917|722708|P2|NOT COMPLETED|Blinded Treatment||2
299351|NCT00787917|722709|P1|NOT COMPLETED|Blinded Treatment||5
299352|NCT00787917|722708|P2|COMPLETED|Blinded Treatment||3
299353|NCT00787917|722709|P1|COMPLETED|Blinded Treatment||4
299354|NCT00787917|722708|P2|STARTED|Blinded Treatment||5
299355|NCT00787917|722709|P1|STARTED|Blinded Treatment||9
299356|NCT00787904|722728|P2|NOT COMPLETED|Overall Study||0
299357|NCT00787904|722729|P1|NOT COMPLETED|Overall Study||0
299358|NCT00787904|722728|P2|COMPLETED|Overall Study||13
299359|NCT00787904|722729|P1|COMPLETED|Overall Study||6
299360|NCT00787904|722728|P2|STARTED|Overall Study||13
299361|NCT00787904|722729|P1|STARTED|Overall Study||6
299362|NCT00787891|722739|P2|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
299363|NCT00787891|722740|P1|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
299364|NCT00787891|722739|P2|COMPLETED|Maintenance Double-blind Phase (Part 2)||24
299365|NCT00787891|722740|P1|COMPLETED|Maintenance Double-blind Phase (Part 2)||26
299366|NCT00787891|722739|P2|STARTED|Maintenance Double-blind Phase (Part 2)||31
299367|NCT00787891|722740|P1|STARTED|Maintenance Double-blind Phase (Part 2)||33
299368|NCT00787891|722739|P2|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||9
299369|NCT00787891|722740|P1|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||10
299370|NCT00787891|722739|P2|COMPLETED|Short-term Double-blind Phase (Part 1)||53
299371|NCT00787891|722740|P1|COMPLETED|Short-term Double-blind Phase (Part 1)||55
299372|NCT00787891|722739|P2|STARTED|Short-term Double-blind Phase (Part 1)||62
299373|NCT00787891|722740|P1|STARTED|Short-term Double-blind Phase (Part 1)||65
299374|NCT00787852|722760|P2|NOT COMPLETED|Overall Study||0
299375|NCT00787852|722761|P1|NOT COMPLETED|Overall Study||1
299376|NCT00787852|722760|P2|COMPLETED|Overall Study||5
299377|NCT00787852|722761|P1|COMPLETED|Overall Study|1 patient withdrew consent prior to starting|5
299378|NCT00787852|722760|P2|STARTED|Overall Study|The study was terminated prior to enrolled to group 2|5
299379|NCT00787852|722761|P1|STARTED|Overall Study||6
299380|NCT00787839|722767|P1|NOT COMPLETED|Overall Study||404
299381|NCT00787839|722767|P1|COMPLETED|Overall Study||1535
299382|NCT00787839|722767|P1|Complete GCT, OGTT, A1c, Demographics|Overall Study||1535
299383|NCT00787839|722767|P1|Completed GCT Screening|Overall Study||1876
299384|NCT00787839|722767|P1|Consented|Overall Study|consented|1939
299385|NCT00787839|722767|P1|STARTED|Overall Study||1939
299386|NCT00787800|722790|P2|NOT COMPLETED|Overall Study||7
299387|NCT00787800|722791|P1|NOT COMPLETED|Overall Study||3
299388|NCT00787800|722790|P2|COMPLETED|Overall Study||43
299389|NCT00787800|722791|P1|COMPLETED|Overall Study||47
299390|NCT00787800|722790|P2|STARTED|Overall Study||50
299391|NCT00787800|722791|P1|STARTED|Overall Study||50
299392|NCT00787787|722807|P1|NOT COMPLETED|Overall Study||7
299393|NCT00787787|722807|P1|COMPLETED|Overall Study||0
299394|NCT00787787|722807|P1|STARTED|Overall Study||7
299395|NCT00787761|722813|P1|NOT COMPLETED|Overall Study||0
299396|NCT00787761|722813|P1|COMPLETED|Overall Study||24
299397|NCT00787761|722813|P1|STARTED|Overall Study||24
299398|NCT00787644|722826|P2|NOT COMPLETED|Overall Study||2
299399|NCT00787644|722827|P1|NOT COMPLETED|Overall Study||2
299400|NCT00787644|722826|P2|COMPLETED|Overall Study||9
299401|NCT00787644|722827|P1|COMPLETED|Overall Study||10
299402|NCT00787644|722826|P2|STARTED|Overall Study||11
299403|NCT00787644|722827|P1|STARTED|Overall Study||12
299404|NCT00787618|722836|P3|NOT COMPLETED|Overall Study||0
299405|NCT00787618|722837|P2|NOT COMPLETED|Overall Study||0
299406|NCT00787618|722838|P1|NOT COMPLETED|Overall Study||0
299407|NCT00787618|722836|P3|COMPLETED|Overall Study||3
299408|NCT00787618|722837|P2|COMPLETED|Overall Study||0
299409|NCT00787618|722838|P1|COMPLETED|Overall Study||3
299410|NCT00787618|722836|P3|STARTED|Overall Study||3
299411|NCT00787618|722837|P2|STARTED|Overall Study||0
299412|NCT00787618|722838|P1|STARTED|Overall Study||3
299413|NCT00787605|722848|P2|NOT COMPLETED|Overall Study||56
299414|NCT00787605|722849|P1|NOT COMPLETED|Overall Study||46
299415|NCT00787605|722848|P2|COMPLETED|Overall Study||376
299416|NCT00787605|722849|P1|COMPLETED|Overall Study||382
299417|NCT00787605|722848|P2|STARTED|Overall Study||432
299418|NCT00787605|722849|P1|STARTED|Overall Study||428
299419|NCT00787566|722868|P3|NOT COMPLETED|Overall Study||0
299420|NCT00787566|722869|P2|NOT COMPLETED|Overall Study||1
299421|NCT00787566|722870|P1|NOT COMPLETED|Overall Study||0
299422|NCT00787566|722868|P3|COMPLETED|Overall Study||22
299423|NCT00787566|722869|P2|COMPLETED|Overall Study|1 patient withdrew from the study due to an AE related to chemotherapy agent administration.|24
299424|NCT00787566|722870|P1|COMPLETED|Overall Study||21
299425|NCT00787566|722868|P3|STARTED|Overall Study||22
299426|NCT00787566|722869|P2|STARTED|Overall Study||25
299427|NCT00787566|722870|P1|STARTED|Overall Study||21
299428|NCT00787527|722878|P1|NOT COMPLETED|Overall Study||3
299429|NCT00787527|722878|P1|COMPLETED|Overall Study||11
299430|NCT00787527|722878|P1|STARTED|Overall Study||14
299431|NCT00787332|722888|P2|NOT COMPLETED|Overall Study||0
299432|NCT00787332|722889|P1|NOT COMPLETED|Overall Study||0
299433|NCT00787332|722888|P2|COMPLETED|Overall Study||8
299434|NCT00787332|722889|P1|COMPLETED|Overall Study||8
299435|NCT00787332|722888|P2|STARTED|Overall Study||8
299436|NCT00787332|722889|P1|STARTED|Overall Study||8
299437|NCT00787319|722895|P1|NOT COMPLETED|Overall Study||63
299438|NCT00787319|722895|P1|COMPLETED|Overall Study||45
299439|NCT00787319|722895|P1|STARTED|Overall Study||108
299440|NCT00787267|722907|P1|NOT COMPLETED|Overall Study||12
299441|NCT00787267|722907|P1|COMPLETED|Overall Study|Received at least one dose of study drug|25
299442|NCT00787267|722907|P1|STARTED|Overall Study|Signed a consent form|37
299443|NCT00787254|722917|P2|NOT COMPLETED|Overall Study||82
299444|NCT00787254|722918|P1|NOT COMPLETED|Overall Study||76
299445|NCT00787254|722917|P2|COMPLETED|Overall Study||99
299446|NCT00787254|722918|P1|COMPLETED|Overall Study||109
299447|NCT00787254|722917|P2|STARTED|Overall Study||181
299448|NCT00787254|722918|P1|STARTED|Overall Study||185
299449|NCT00787241|723021|P3|NOT COMPLETED|Overall Study||0
299450|NCT00787241|723022|P2|NOT COMPLETED|Overall Study||0
299451|NCT00787241|723023|P1|NOT COMPLETED|Overall Study||0
299452|NCT00787241|723021|P3|COMPLETED|Overall Study||41
299453|NCT00787241|723022|P2|COMPLETED|Overall Study||143
299454|NCT00787241|723023|P1|COMPLETED|Overall Study||261
299455|NCT00787241|723021|P3|STARTED|Overall Study||41
299456|NCT00787241|723022|P2|STARTED|Overall Study||143
299457|NCT00787241|723023|P1|STARTED|Overall Study||261
299458|NCT00787202|723042|P5|NOT COMPLETED|Overall Study||4
299459|NCT00787202|723043|P4|NOT COMPLETED|Overall Study||2
299460|NCT00787202|723044|P3|NOT COMPLETED|Overall Study||7
299461|NCT00787202|723045|P2|NOT COMPLETED|Overall Study||11
299462|NCT00787202|723046|P1|NOT COMPLETED|Overall Study||14
299463|NCT00787202|723042|P5|COMPLETED|Overall Study||45
299464|NCT00787202|723043|P4|COMPLETED|Overall Study||31
299465|NCT00787202|723044|P3|COMPLETED|Overall Study||26
299466|NCT00787202|723045|P2|COMPLETED|Overall Study||20
299467|NCT00787202|723046|P1|COMPLETED|Overall Study||35
299468|NCT00787202|723042|P5|Treated|Overall Study||49
299469|NCT00787202|723043|P4|Treated|Overall Study||33
299470|NCT00787202|723044|P3|Treated|Overall Study||33
299471|NCT00787202|723045|P2|Treated|Overall Study||31
299472|NCT00787202|723046|P1|Treated|Overall Study||48
299473|NCT00787202|723042|P5|STARTED|Overall Study||49
299474|NCT00787202|723043|P4|STARTED|Overall Study||33
299475|NCT00787202|723044|P3|STARTED|Overall Study||33
299476|NCT00787202|723045|P2|STARTED|Overall Study||31
299477|NCT00787202|723046|P1|STARTED|Overall Study||49
299478|NCT00787189|723099|P2|NOT COMPLETED|Overall Study||2
299479|NCT00787189|723100|P1|NOT COMPLETED|Overall Study||2
299480|NCT00787189|723099|P2|COMPLETED|Overall Study|To study end point.|30
299481|NCT00787189|723100|P1|COMPLETED|Overall Study|To study end point.|30
299482|NCT00787189|723099|P2|STARTED|Overall Study||32
299483|NCT00787189|723100|P1|STARTED|Overall Study||32
299484|NCT00787150|723109|P3|NOT COMPLETED|Overall Study||5
299485|NCT00787150|723110|P2|NOT COMPLETED|Overall Study||7
299486|NCT00787150|723111|P1|NOT COMPLETED|Overall Study||9
299487|NCT00787150|723109|P3|COMPLETED|Overall Study||66
299488|NCT00787150|723110|P2|COMPLETED|Overall Study||65
299489|NCT00787150|723111|P1|COMPLETED|Overall Study||66
299490|NCT00787150|723109|P3|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|71
299491|NCT00787150|723110|P2|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|72
299492|NCT00787150|723111|P1|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|75
299493|NCT00787137|723156|P3|NOT COMPLETED|Overall Study||1
299494|NCT00787137|723157|P2|NOT COMPLETED|Overall Study||0
299495|NCT00787137|723158|P1|NOT COMPLETED|Overall Study||0
299496|NCT00787137|723156|P3|COMPLETED|Overall Study||4
299497|NCT00787137|723157|P2|COMPLETED|Overall Study||6
299498|NCT00787137|723158|P1|COMPLETED|Overall Study||6
299499|NCT00787137|723156|P3|STARTED|Overall Study||5
299500|NCT00787137|723157|P2|STARTED|Overall Study||6
299501|NCT00787137|723158|P1|STARTED|Overall Study||6
299502|NCT00787124|723180|P2|NOT COMPLETED|Overall Study||0
299503|NCT00787124|723181|P1|NOT COMPLETED|Overall Study||0
299504|NCT00787124|723180|P2|COMPLETED|Overall Study||4
299505|NCT00787124|723181|P1|COMPLETED|Overall Study||4
299506|NCT00787124|723180|P2|STARTED|Overall Study||4
299507|NCT00787124|723181|P1|STARTED|Overall Study||4
299508|NCT00787020|723191|P2|NOT COMPLETED|Overall Study||0
299509|NCT00787020|723192|P1|NOT COMPLETED|Overall Study||0
299510|NCT00787020|723191|P2|COMPLETED|Overall Study||13
299511|NCT00787020|723192|P1|COMPLETED|Overall Study||24
299512|NCT00787020|723191|P2|STARTED|Overall Study||13
299513|NCT00787020|723192|P1|STARTED|Overall Study||24
299514|NCT00786994|723206|P4|NOT COMPLETED|Overall Study||6
299515|NCT00786994|723207|P3|NOT COMPLETED|Overall Study||2
299516|NCT00786994|723208|P2|NOT COMPLETED|Overall Study||15
299517|NCT00786994|723209|P1|NOT COMPLETED|Overall Study||10
299518|NCT00786994|723206|P4|COMPLETED|Overall Study||22
299519|NCT00786994|723207|P3|COMPLETED|Overall Study||24
299520|NCT00786994|723208|P2|COMPLETED|Overall Study||39
299521|NCT00786994|723209|P1|COMPLETED|Overall Study||47
299522|NCT00786994|723206|P4|ITT|Overall Study||28
299523|NCT00786994|723207|P3|ITT|Overall Study||25
299524|NCT00786994|723208|P2|ITT|Overall Study||51
299525|NCT00786994|723209|P1|ITT|Overall Study||53
299526|NCT00786994|723206|P4|STARTED|Overall Study||28
299527|NCT00786994|723207|P3|STARTED|Overall Study||26
299528|NCT00786994|723208|P2|STARTED|Overall Study||54
299529|NCT00786994|723209|P1|STARTED|Overall Study||57
299530|NCT00786916|723221|P3|NOT COMPLETED|Overall Study||0
299531|NCT00786916|723222|P2|NOT COMPLETED|Overall Study||0
299532|NCT00786916|723223|P1|NOT COMPLETED|Overall Study||0
299533|NCT00786916|723221|P3|COMPLETED|Overall Study||34
299534|NCT00786916|723222|P2|COMPLETED|Overall Study||36
299535|NCT00786916|723223|P1|COMPLETED|Overall Study||39
299536|NCT00786916|723221|P3|STARTED|Overall Study||34
299537|NCT00786916|723222|P2|STARTED|Overall Study||36
299538|NCT00786916|723223|P1|STARTED|Overall Study||39
299539|NCT00786864|723233|P2|NOT COMPLETED|Overall Study||1
299540|NCT00786864|723234|P1|NOT COMPLETED|Overall Study||1
299541|NCT00786864|723233|P2|COMPLETED|Overall Study|1 child lost to study immediately post-intervention as she left the school|32
299542|NCT00786864|723234|P1|COMPLETED|Overall Study|1 child excluded at the 3 month follow-up, as he sustained a serious back injury|38
299543|NCT00786864|723233|P2|STARTED|Overall Study||33
299544|NCT00786864|723234|P1|STARTED|Overall Study||39
299545|NCT00786838|723246|P1|NOT COMPLETED|Overall Study||49
299546|NCT00786838|723246|P1|COMPLETED|Overall Study||26
299547|NCT00786838|723246|P1|STARTED|Overall Study||75
299548|NCT00786799|723273|P2|NOT COMPLETED|Overall Study||1
299549|NCT00786799|723274|P1|NOT COMPLETED|Overall Study||1
299550|NCT00786799|723273|P2|COMPLETED|Overall Study||12
299551|NCT00786799|723274|P1|COMPLETED|Overall Study||13
299552|NCT00786799|723273|P2|STARTED|Overall Study||13
299553|NCT00786799|723274|P1|STARTED|Overall Study||14
299554|NCT00786682|723285|P1|NOT COMPLETED|Overall Study||0
299555|NCT00786682|723285|P1|COMPLETED|Overall Study||11
299556|NCT00786682|723285|P1|STARTED|Overall Study||11
299557|NCT00786643|723293|P2|NOT COMPLETED|Overall Study||0
299558|NCT00786643|723294|P1|NOT COMPLETED|Overall Study||0
299559|NCT00786643|723293|P2|COMPLETED|Overall Study||28
299560|NCT00786643|723294|P1|COMPLETED|Overall Study||20
299561|NCT00786643|723293|P2|STARTED|Overall Study||28
299562|NCT00786643|723294|P1|STARTED|Overall Study||20
299563|NCT00786565|723304|P1|NOT COMPLETED|Post Surgery||2
299564|NCT00786565|723304|P1|COMPLETED|Post Surgery|67 Participants (134 eyes) completed the study.|67
299565|NCT00786565|723304|P1|STARTED|Post Surgery||69
299566|NCT00786565|723304|P1|NOT COMPLETED|Enrollment Prior to Surgery||6
299567|NCT00786565|723304|P1|COMPLETED|Enrollment Prior to Surgery|69 participants - Akreos Advanced Optic Lens in one eye and Akreos Adapt Lens in the fellow eye.|69
299568|NCT00786565|723304|P1|STARTED|Enrollment Prior to Surgery||75
299569|NCT00786487|723346|P4|NOT COMPLETED|Overall Study||0
299570|NCT00786487|723347|P3|NOT COMPLETED|Overall Study||0
299571|NCT00786487|723348|P2|NOT COMPLETED|Overall Study||0
299572|NCT00786487|723349|P1|NOT COMPLETED|Overall Study||0
299573|NCT00786487|723346|P4|COMPLETED|Overall Study||7
299574|NCT00786487|723347|P3|COMPLETED|Overall Study||9
299575|NCT00786487|723348|P2|COMPLETED|Overall Study||7
299576|NCT00786487|723349|P1|COMPLETED|Overall Study||10
299577|NCT00786487|723346|P4|STARTED|Overall Study||7
299578|NCT00786487|723347|P3|STARTED|Overall Study||9
299579|NCT00786487|723348|P2|STARTED|Overall Study||7
299580|NCT00786487|723349|P1|STARTED|Overall Study||10
299581|NCT00786474|723361|P2|NOT COMPLETED|Overall Study||43
299582|NCT00786474|723362|P1|NOT COMPLETED|Overall Study||37
299583|NCT00786474|723361|P2|COMPLETED|Overall Study||891
299584|NCT00786474|723362|P1|COMPLETED|Overall Study||913
299585|NCT00786474|723361|P2|STARTED|Overall Study||934
299586|NCT00786474|723362|P1|STARTED|Overall Study||950
299587|NCT00786422|723374|P1|NOT COMPLETED|Follow-up Period||3
299588|NCT00786422|723374|P1|COMPLETED|Follow-up Period||17
299589|NCT00786422|723374|P1|STARTED|Follow-up Period|Participants entered follow-up period. No reason documents for those not entering this period|20
299590|NCT00786422|723374|P1|NOT COMPLETED|Rivaroxaban Treatment||11
299591|NCT00786422|723374|P1|COMPLETED|Rivaroxaban Treatment||14
299592|NCT00786422|723374|P1|STARTED|Rivaroxaban Treatment||25
299593|NCT00786409|723390|P1|NOT COMPLETED|Overall Study||7
299594|NCT00786409|723390|P1|COMPLETED|Overall Study||20
299595|NCT00786409|723390|P1|STARTED|Overall Study||27
299596|NCT00786188|723407|P2|NOT COMPLETED|Overall Study||1
299597|NCT00786188|723408|P1|NOT COMPLETED|Overall Study||5
299598|NCT00786188|723407|P2|COMPLETED|Overall Study||51
299599|NCT00786188|723408|P1|COMPLETED|Overall Study||45
299600|NCT00786188|723407|P2|STARTED|Overall Study||52
299601|NCT00786188|723408|P1|STARTED|Overall Study||50
299602|NCT00786032|723434|P1|NOT COMPLETED|Overall Study||24
299603|NCT00786032|723434|P1|COMPLETED|Overall Study||3
299604|NCT00786032|723434|P1|Independent Users|Overall Study|All data analyses were based on the 14 independent users.|14
299605|NCT00786032|723434|P1|STARTED|Overall Study||27
299606|NCT00786019|723446|P2|NOT COMPLETED|Overall Study||10
299607|NCT00786019|723447|P1|NOT COMPLETED|Overall Study||5
299608|NCT00786019|723446|P2|COMPLETED|Overall Study||17
299609|NCT00786019|723447|P1|COMPLETED|Overall Study||15
299610|NCT00786019|723446|P2|STARTED|Overall Study||27
299611|NCT00786019|723447|P1|STARTED|Overall Study||20
299612|NCT00785980|723455|P1|NOT COMPLETED|Quinine Sulfate With Ciprofloxacin||0
299613|NCT00785980|723455|P1|COMPLETED|Quinine Sulfate With Ciprofloxacin||21
299614|NCT00785980|723455|P1|STARTED|Quinine Sulfate With Ciprofloxacin||21
299615|NCT00785980|723455|P1|NOT COMPLETED|Ciprofloxacin Alone||0
299616|NCT00785980|723455|P1|COMPLETED|Ciprofloxacin Alone||21
299617|NCT00785980|723455|P1|STARTED|Ciprofloxacin Alone||21
299618|NCT00785980|723455|P1|NOT COMPLETED|7 Day Washout Period||3
299619|NCT00785980|723455|P1|COMPLETED|7 Day Washout Period||21
299620|NCT00785980|723455|P1|STARTED|7 Day Washout Period||24
299621|NCT00785980|723455|P1|NOT COMPLETED|Quinine Sulfate Alone||0
299622|NCT00785980|723455|P1|COMPLETED|Quinine Sulfate Alone||24
299623|NCT00785980|723455|P1|STARTED|Quinine Sulfate Alone||24
299624|NCT00785928|723473|P7|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||5
299625|NCT00785928|723474|P6|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0
299626|NCT00785928|723475|P5|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2
299627|NCT00785928|723476|P4|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0
299628|NCT00785928|723477|P3|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2
299629|NCT00785928|723478|P2|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||3
299630|NCT00785928|723479|P1|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||1
299631|NCT00785928|723473|P7|COMPLETED|Follow-up Phases (Weeks 24-72)||9
299632|NCT00785928|723474|P6|COMPLETED|Follow-up Phases (Weeks 24-72)||0
299633|NCT00785928|723475|P5|COMPLETED|Follow-up Phases (Weeks 24-72)||4
299634|NCT00785928|723476|P4|COMPLETED|Follow-up Phases (Weeks 24-72)||4
299635|NCT00785928|723477|P3|COMPLETED|Follow-up Phases (Weeks 24-72)||4
299636|NCT00785928|723478|P2|COMPLETED|Follow-up Phases (Weeks 24-72)||5
299637|NCT00785928|723479|P1|COMPLETED|Follow-up Phases (Weeks 24-72)||7
299638|NCT00785928|723473|P7|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|14
299639|NCT00785928|723474|P6|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|0
299640|NCT00785928|723475|P5|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|6
299641|NCT00785928|723476|P4|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|4
299642|NCT00785928|723477|P3|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|6
299643|NCT00785928|723478|P2|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|8
299644|NCT00785928|723479|P1|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|8
299645|NCT00785928|723473|P7|NOT COMPLETED|Treatment Phase||3
299646|NCT00785928|723474|P6|NOT COMPLETED|Treatment Phase||0
299647|NCT00785928|723475|P5|NOT COMPLETED|Treatment Phase||2
299648|NCT00785928|723476|P4|NOT COMPLETED|Treatment Phase||0
299649|NCT00785928|723477|P3|NOT COMPLETED|Treatment Phase||3
299650|NCT00785928|723478|P2|NOT COMPLETED|Treatment Phase||5
299651|NCT00785928|723479|P1|NOT COMPLETED|Treatment Phase||3
299652|NCT00785928|723473|P7|COMPLETED|Treatment Phase||23
299653|NCT00785928|723474|P6|COMPLETED|Treatment Phase||13
299654|NCT00785928|723475|P5|COMPLETED|Treatment Phase||16
299655|NCT00785928|723476|P4|COMPLETED|Treatment Phase||15
299656|NCT00785928|723477|P3|COMPLETED|Treatment Phase||17
299657|NCT00785928|723478|P2|COMPLETED|Treatment Phase||25
299658|NCT00785928|723479|P1|COMPLETED|Treatment Phase||33
299659|NCT00785928|723473|P7|STARTED|Treatment Phase||26
299660|NCT00785928|723474|P6|STARTED|Treatment Phase||13
299661|NCT00785928|723475|P5|STARTED|Treatment Phase||18
299662|NCT00785928|723476|P4|STARTED|Treatment Phase||15
299663|NCT00785928|723477|P3|STARTED|Treatment Phase||20
299664|NCT00785928|723478|P2|STARTED|Treatment Phase||30
299665|NCT00785928|723479|P1|STARTED|Treatment Phase||36
299666|NCT00785798|723619|P1|NOT COMPLETED|Overall Study||1
299667|NCT00785798|723619|P1|COMPLETED|Overall Study||16
299668|NCT00785798|723619|P1|STARTED|Overall Study||17
299669|NCT00785785|723626|P2|NOT COMPLETED|Optional Extension Phase||125
299670|NCT00785785|723627|P1|NOT COMPLETED|Optional Extension Phase||39
299671|NCT00785785|723626|P2|COMPLETED|Optional Extension Phase||0
299672|NCT00785785|723627|P1|COMPLETED|Optional Extension Phase||0
299673|NCT00785785|723626|P2|STARTED|Optional Extension Phase|crossover extension phase was optional|125
299674|NCT00785785|723627|P1|STARTED|Optional Extension Phase|crossover extension phase was optional|39
299675|NCT00785785|723626|P2|NOT COMPLETED|Core Phase up to 36 Months||320
299676|NCT00785785|723627|P1|NOT COMPLETED|Core Phase up to 36 Months||324
299677|NCT00785785|723626|P2|COMPLETED|Core Phase up to 36 Months||0
299678|NCT00785785|723627|P1|COMPLETED|Core Phase up to 36 Months||0
299679|NCT00785785|723626|P2|STARTED|Core Phase up to 36 Months||320
299680|NCT00785785|723627|P1|STARTED|Core Phase up to 36 Months||324
299681|NCT00785772|723635|P1|NOT COMPLETED|Overall Study||0
299682|NCT00785772|723635|P1|COMPLETED|Overall Study||1
299683|NCT00785772|723635|P1|STARTED|Overall Study||1
299684|NCT00785707|723641|P1|NOT COMPLETED|Overall Study||7
299685|NCT00785707|723641|P1|COMPLETED|Overall Study||24
299686|NCT00785707|723641|P1|STARTED|Overall Study||31
299687|NCT00785629|723650|P4|NOT COMPLETED|Overall Study||16
299688|NCT00785629|723651|P3|NOT COMPLETED|Overall Study||10
299689|NCT00785629|723652|P2|NOT COMPLETED|Overall Study||5
299690|NCT00785629|723653|P1|NOT COMPLETED|Overall Study||8
299691|NCT00785629|723650|P4|COMPLETED|Overall Study|16 not completed|41
299692|NCT00785629|723651|P3|COMPLETED|Overall Study|10 not completed|18
299693|NCT00785629|723652|P2|COMPLETED|Overall Study|5 not completed|25
299694|NCT00785629|723653|P1|COMPLETED|Overall Study|8 not completed|22
299695|NCT00785629|723650|P4|STARTED|Overall Study||57
299696|NCT00785629|723651|P3|STARTED|Overall Study||28
299697|NCT00785629|723652|P2|STARTED|Overall Study||30
299698|NCT00785629|723653|P1|STARTED|Overall Study||30
299699|NCT00785577|723666|P5|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
299700|NCT00785577|723667|P4|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
299701|NCT00785577|723668|P3|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
299702|NCT00785577|723669|P2|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
299703|NCT00785577|723670|P1|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
299704|NCT00785577|723666|P5|COMPLETED|Study Period 3: 1-Week Washout Phase||26
299705|NCT00785577|723667|P4|COMPLETED|Study Period 3: 1-Week Washout Phase||35
299706|NCT00785577|723668|P3|COMPLETED|Study Period 3: 1-Week Washout Phase||25
299707|NCT00785577|723669|P2|COMPLETED|Study Period 3: 1-Week Washout Phase||36
299708|NCT00785577|723670|P1|COMPLETED|Study Period 3: 1-Week Washout Phase||78
299709|NCT00785577|723666|P5|STARTED|Study Period 3: 1-Week Washout Phase||27
299710|NCT00785577|723667|P4|STARTED|Study Period 3: 1-Week Washout Phase||36
299711|NCT00785577|723668|P3|STARTED|Study Period 3: 1-Week Washout Phase||25
299712|NCT00785577|723669|P2|STARTED|Study Period 3: 1-Week Washout Phase||36
299713|NCT00785577|723670|P1|STARTED|Study Period 3: 1-Week Washout Phase||78
299714|NCT00785577|723666|P5|NOT COMPLETED|Study Period 2: Therapy Phase||20
299715|NCT00785577|723667|P4|NOT COMPLETED|Study Period 2: Therapy Phase||13
299716|NCT00785577|723668|P3|NOT COMPLETED|Study Period 2: Therapy Phase||18
299717|NCT00785577|723669|P2|NOT COMPLETED|Study Period 2: Therapy Phase||9
299718|NCT00785577|723670|P1|NOT COMPLETED|Study Period 2: Therapy Phase||11
299719|NCT00785577|723666|P5|COMPLETED|Study Period 2: Therapy Phase||27
299720|NCT00785577|723667|P4|COMPLETED|Study Period 2: Therapy Phase||36
299721|NCT00785577|723668|P3|COMPLETED|Study Period 2: Therapy Phase||25
299722|NCT00785577|723669|P2|COMPLETED|Study Period 2: Therapy Phase||36
299723|NCT00785577|723670|P1|COMPLETED|Study Period 2: Therapy Phase||78
299724|NCT00785577|723666|P5|STARTED|Study Period 2: Therapy Phase||47
299725|NCT00785577|723667|P4|STARTED|Study Period 2: Therapy Phase||49
299726|NCT00785577|723668|P3|STARTED|Study Period 2: Therapy Phase||43
299727|NCT00785577|723669|P2|STARTED|Study Period 2: Therapy Phase||45
299728|NCT00785577|723670|P1|STARTED|Study Period 2: Therapy Phase||89
299729|NCT00785538|723810|P4|NOT COMPLETED|Treatment Period||1
299730|NCT00785538|723811|P3|NOT COMPLETED|Treatment Period||2
299731|NCT00785538|723812|P2|NOT COMPLETED|Treatment Period||2
299732|NCT00785538|723813|P1|NOT COMPLETED|Treatment Period||1
299733|NCT00785538|723810|P4|COMPLETED|Treatment Period||1
299734|NCT00785538|723811|P3|COMPLETED|Treatment Period||4
299735|NCT00785538|723812|P2|COMPLETED|Treatment Period||7
299736|NCT00785538|723813|P1|COMPLETED|Treatment Period||6
299737|NCT00785538|723810|P4|Received at Least 1 Dose of Study Drug|Treatment Period||2
299738|NCT00785538|723811|P3|Received at Least 1 Dose of Study Drug|Treatment Period||6
299739|NCT00785538|723812|P2|Received at Least 1 Dose of Study Drug|Treatment Period||9
299740|NCT00785538|723813|P1|Received at Least 1 Dose of Study Drug|Treatment Period||7
299741|NCT00785538|723810|P4|STARTED|Treatment Period||2
299742|NCT00785538|723811|P3|STARTED|Treatment Period||6
299743|NCT00785538|723812|P2|STARTED|Treatment Period||9
299744|NCT00785538|723813|P1|STARTED|Treatment Period||7
299745|NCT00785538|723810|P4|NOT COMPLETED|PK Period||0
299746|NCT00785538|723811|P3|NOT COMPLETED|PK Period||0
299747|NCT00785538|723812|P2|NOT COMPLETED|PK Period||0
299748|NCT00785538|723813|P1|NOT COMPLETED|PK Period||0
299749|NCT00785538|723810|P4|COMPLETED|PK Period||0
299750|NCT00785538|723811|P3|COMPLETED|PK Period||1
299751|NCT00785538|723812|P2|COMPLETED|PK Period||1
299752|NCT00785538|723813|P1|COMPLETED|PK Period||7
299753|NCT00785538|723810|P4|STARTED|PK Period||0
299754|NCT00785538|723811|P3|STARTED|PK Period||1
299755|NCT00785538|723812|P2|STARTED|PK Period||1
299756|NCT00785538|723813|P1|STARTED|PK Period||7
299757|NCT00785512|723861|P2|NOT COMPLETED|Overall Study||4
299758|NCT00785512|723862|P1|NOT COMPLETED|Overall Study||3
299759|NCT00785512|723861|P2|COMPLETED|Overall Study||101
299760|NCT00785512|723862|P1|COMPLETED|Overall Study||99
299761|NCT00785512|723861|P2|STARTED|Overall Study||105
299762|NCT00785512|723862|P1|STARTED|Overall Study||102
299763|NCT00785486|723871|P1|NOT COMPLETED|Midazolam With Qualaquin at Steady State||0
299764|NCT00785486|723871|P1|COMPLETED|Midazolam With Qualaquin at Steady State||23
299765|NCT00785486|723871|P1|STARTED|Midazolam With Qualaquin at Steady State||23
299766|NCT00785486|723871|P1|NOT COMPLETED|Qualaquin Alone at Steady State||0
299767|NCT00785486|723871|P1|COMPLETED|Qualaquin Alone at Steady State||23
299768|NCT00785486|723871|P1|STARTED|Qualaquin Alone at Steady State||23
299769|NCT00785486|723871|P1|NOT COMPLETED|3 Day Washout||0
299770|NCT00785486|723871|P1|COMPLETED|3 Day Washout||23
299771|NCT00785486|723871|P1|STARTED|3 Day Washout||23
299772|NCT00785486|723871|P1|NOT COMPLETED|Midazolam Alone||1
299773|NCT00785486|723871|P1|COMPLETED|Midazolam Alone|one participant withdrew for personal reasons after first midazolam dose|23
299774|NCT00785486|723871|P1|STARTED|Midazolam Alone||24
299775|NCT00785356|723895|P1|NOT COMPLETED|Overall Study||8
299776|NCT00785356|723895|P1|COMPLETED|Overall Study||0
299777|NCT00785356|723895|P1|STARTED|Overall Study||8
299778|NCT00785291|723906|P3|NOT COMPLETED|Overall Study||106
299779|NCT00785291|723907|P2|NOT COMPLETED|Overall Study||149
299780|NCT00785291|723908|P1|NOT COMPLETED|Overall Study||136
299781|NCT00785291|723906|P3|COMPLETED|Overall Study||139
299782|NCT00785291|723907|P2|COMPLETED|Overall Study||122
299783|NCT00785291|723908|P1|COMPLETED|Overall Study||147
299784|NCT00785291|723906|P3|STARTED|Overall Study||245
299785|NCT00785291|723907|P2|STARTED|Overall Study||271
299786|NCT00785291|723908|P1|STARTED|Overall Study||283
299787|NCT00785213|723928|P1|NOT COMPLETED|Rosiglitazone With Quinine Sulfate||1
299788|NCT00785213|723928|P1|COMPLETED|Rosiglitazone With Quinine Sulfate||18
299789|NCT00785213|723928|P1|STARTED|Rosiglitazone With Quinine Sulfate||19
299790|NCT00785213|723928|P1|NOT COMPLETED|Quinine Sulfate Alone||4
299791|NCT00785213|723928|P1|COMPLETED|Quinine Sulfate Alone||19
299792|NCT00785213|723928|P1|STARTED|Quinine Sulfate Alone||23
299793|NCT00785213|723928|P1|NOT COMPLETED|2 Day Washout Period||0
299794|NCT00785213|723928|P1|COMPLETED|2 Day Washout Period||23
299795|NCT00785213|723928|P1|STARTED|2 Day Washout Period||23
299796|NCT00785213|723928|P1|NOT COMPLETED|Rosiglitazone Alone||0
299797|NCT00785213|723928|P1|COMPLETED|Rosiglitazone Alone||23
299798|NCT00785213|723928|P1|STARTED|Rosiglitazone Alone||23
299799|NCT00785044|723939|P1|NOT COMPLETED|Overall Study||496
299800|NCT00785044|723939|P1|COMPLETED|Overall Study|Data for 471 participants (MBG313) combined with data from MBG311 and MBG312 for efficacy analysis|468
299801|NCT00785044|723939|P1|Enrolled Participants|Overall Study|Out of 964 from MBG311 and MBG312 HF participants, 471 enrolled into the extension MBG313 study.|471
299802|NCT00785044|723939|P1|STARTED|Overall Study|Eligible to participate in MBG313|964
299803|NCT00784979|723944|P1|NOT COMPLETED|Overall Study||6
299804|NCT00784979|723944|P1|COMPLETED|Overall Study||20
299805|NCT00784979|723944|P1|STARTED|Overall Study||26
299806|NCT00784927|723948|P1|NOT COMPLETED|Overall Study||3
299807|NCT00784927|723948|P1|COMPLETED|Overall Study||33
299808|NCT00784927|723948|P1|STARTED|Overall Study||36
299809|NCT00784875|723960|P4|NOT COMPLETED|Period D||1
299810|NCT00784875|723961|P3|NOT COMPLETED|Period D||6
299811|NCT00784875|723962|P2|NOT COMPLETED|Period D||4
299812|NCT00784875|723963|P1|NOT COMPLETED|Period D||5
299813|NCT00784875|723960|P4|COMPLETED|Period D||87
299814|NCT00784875|723961|P3|COMPLETED|Period D||88
299815|NCT00784875|723962|P2|COMPLETED|Period D||85
299816|NCT00784875|723963|P1|COMPLETED|Period D||86
299817|NCT00784875|723960|P4|STARTED|Period D||88
299818|NCT00784875|723961|P3|STARTED|Period D||94
299819|NCT00784875|723962|P2|STARTED|Period D||89
299820|NCT00784875|723963|P1|STARTED|Period D||91
299821|NCT00784875|723960|P4|NOT COMPLETED|Period C||7
299822|NCT00784875|723961|P3|NOT COMPLETED|Period C||13
299823|NCT00784875|723962|P2|NOT COMPLETED|Period C||6
299824|NCT00784875|723963|P1|NOT COMPLETED|Period C||7
299825|NCT00784875|723960|P4|COMPLETED|Period C||91
299826|NCT00784875|723961|P3|COMPLETED|Period C||84
299827|NCT00784875|723962|P2|COMPLETED|Period C||91
299828|NCT00784875|723963|P1|COMPLETED|Period C||96
299829|NCT00784875|723960|P4|STARTED|Period C||98
299830|NCT00784875|723961|P3|STARTED|Period C||97
299831|NCT00784875|723962|P2|STARTED|Period C||97
299832|NCT00784875|723963|P1|STARTED|Period C||103
299833|NCT00784875|723960|P4|NOT COMPLETED|Period B - Efficacy Endpoint||19
299834|NCT00784875|723961|P3|NOT COMPLETED|Period B - Efficacy Endpoint||21
299835|NCT00784875|723962|P2|NOT COMPLETED|Period B - Efficacy Endpoint||12
299836|NCT00784875|723963|P1|NOT COMPLETED|Period B - Efficacy Endpoint||14
299837|NCT00784875|723960|P4|COMPLETED|Period B - Efficacy Endpoint||98
299838|NCT00784875|723961|P3|COMPLETED|Period B - Efficacy Endpoint||96
299839|NCT00784875|723962|P2|COMPLETED|Period B - Efficacy Endpoint||101
299840|NCT00784875|723963|P1|COMPLETED|Period B - Efficacy Endpoint||100
299841|NCT00784875|723960|P4|Cohort 2|Period B - Efficacy Endpoint||101
299842|NCT00784875|723961|P3|Cohort 2|Period B - Efficacy Endpoint||102
299843|NCT00784875|723962|P2|Cohort 2|Period B - Efficacy Endpoint||102
299844|NCT00784875|723963|P1|Cohort 2|Period B - Efficacy Endpoint||102
299845|NCT00784875|723960|P4|STARTED|Period B - Efficacy Endpoint||117
299846|NCT00784875|723961|P3|STARTED|Period B - Efficacy Endpoint||117
299847|NCT00784875|723962|P2|STARTED|Period B - Efficacy Endpoint||113
299848|NCT00784875|723963|P1|STARTED|Period B - Efficacy Endpoint||114
299849|NCT00784875|723960|P4|NOT COMPLETED|Period A - Baseline||182
299850|NCT00784875|723961|P3|NOT COMPLETED|Period A - Baseline||0
299851|NCT00784875|723962|P2|NOT COMPLETED|Period A - Baseline||0
299852|NCT00784875|723963|P1|NOT COMPLETED|Period A - Baseline||0
299853|NCT00784875|723960|P4|COMPLETED|Period A - Baseline||461
299854|NCT00784875|723961|P3|COMPLETED|Period A - Baseline||0
299855|NCT00784875|723962|P2|COMPLETED|Period A - Baseline||0
299856|NCT00784875|723963|P1|COMPLETED|Period A - Baseline||0
299857|NCT00784875|723960|P4|STARTED|Period A - Baseline||643
299858|NCT00784875|723961|P3|STARTED|Period A - Baseline||0
299859|NCT00784875|723962|P2|STARTED|Period A - Baseline||0
299860|NCT00784875|723963|P1|STARTED|Period A - Baseline||0
299861|NCT00784849|724077|P1|NOT COMPLETED|Overall Study||0
299862|NCT00784849|724077|P1|COMPLETED|Overall Study||62
299863|NCT00784849|724077|P1|STARTED|Overall Study||62
299864|NCT00784836|724083|P1|NOT COMPLETED|Overall Study||3
299865|NCT00784836|724083|P1|COMPLETED|Overall Study|The study was terminated early by the Sponsor for business reason not related to safety.|0
299866|NCT00784836|724083|P1|STARTED|Overall Study||3
299867|NCT00784810|724090|P2|NOT COMPLETED|Overall Study||49
299868|NCT00784810|724091|P1|NOT COMPLETED|Overall Study||63
299869|NCT00784810|724090|P2|COMPLETED|Overall Study||74
299870|NCT00784810|724091|P1|COMPLETED|Overall Study||61
299871|NCT00784810|724090|P2|STARTED|Overall Study||123
299872|NCT00784810|724091|P1|STARTED|Overall Study||124
299873|NCT00784784|724101|P2|NOT COMPLETED|Overall Study||2
299874|NCT00784784|724102|P1|NOT COMPLETED|Overall Study||2
299875|NCT00784784|724101|P2|COMPLETED|Overall Study||40
299876|NCT00784784|724102|P1|COMPLETED|Overall Study||20
299877|NCT00784784|724101|P2|STARTED|Overall Study||42
299878|NCT00784784|724102|P1|STARTED|Overall Study||22
299879|NCT00784758|724112|P2|NOT COMPLETED|Overall Study||0
299880|NCT00784758|724113|P1|NOT COMPLETED|Overall Study||4
299881|NCT00784758|724112|P2|COMPLETED|Overall Study||39
299882|NCT00784758|724113|P1|COMPLETED|Overall Study||38
299883|NCT00784758|724112|P2|Completed Treatment|Overall Study||39
299884|NCT00784758|724113|P1|Completed Treatment|Overall Study||40
299885|NCT00784758|724112|P2|Began Treatment|Overall Study||39
299886|NCT00784758|724113|P1|Began Treatment|Overall Study||41
299887|NCT00784758|724112|P2|STARTED|Overall Study||39
299888|NCT00784758|724113|P1|STARTED|Overall Study||42
299889|NCT00784719|724162|P7|NOT COMPLETED|Overall Study||5
299890|NCT00784719|724163|P6|NOT COMPLETED|Overall Study||3
299891|NCT00784719|724164|P5|NOT COMPLETED|Overall Study||6
299892|NCT00784719|724165|P4|NOT COMPLETED|Overall Study||0
299893|NCT00784719|724166|P3|NOT COMPLETED|Overall Study||1
299894|NCT00784719|724167|P2|NOT COMPLETED|Overall Study||3
299895|NCT00784719|724168|P1|NOT COMPLETED|Overall Study||3
299896|NCT00784719|724162|P7|COMPLETED|Overall Study||42
299897|NCT00784719|724163|P6|COMPLETED|Overall Study||41
299898|NCT00784719|724164|P5|COMPLETED|Overall Study||42
299899|NCT00784719|724165|P4|COMPLETED|Overall Study||48
299900|NCT00784719|724166|P3|COMPLETED|Overall Study||46
299901|NCT00784719|724167|P2|COMPLETED|Overall Study||43
299902|NCT00784719|724168|P1|COMPLETED|Overall Study||44
299903|NCT00784719|724162|P7|STARTED|Overall Study||47
299904|NCT00784719|724163|P6|STARTED|Overall Study||44
299905|NCT00784719|724164|P5|STARTED|Overall Study||48
299906|NCT00784719|724165|P4|STARTED|Overall Study||48
299907|NCT00784719|724166|P3|STARTED|Overall Study||47
299908|NCT00784719|724167|P2|STARTED|Overall Study||46
299909|NCT00784719|724168|P1|STARTED|Overall Study||47
299910|NCT00784654|724338|P3|NOT COMPLETED|Randomized Withdrawal Period||63
299911|NCT00784654|724339|P2|NOT COMPLETED|Randomized Withdrawal Period||18
299912|NCT00784654|724340|P1|NOT COMPLETED|Randomized Withdrawal Period||0
299913|NCT00784654|724338|P3|COMPLETED|Randomized Withdrawal Period||16
299914|NCT00784654|724339|P2|COMPLETED|Randomized Withdrawal Period||60
299915|NCT00784654|724340|P1|COMPLETED|Randomized Withdrawal Period||0
299916|NCT00784654|724338|P3|STARTED|Randomized Withdrawal Period||79
299917|NCT00784654|724339|P2|STARTED|Randomized Withdrawal Period||78
299918|NCT00784654|724340|P1|STARTED|Randomized Withdrawal Period||0
299919|NCT00784654|724338|P3|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
299920|NCT00784654|724339|P2|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
299921|NCT00784654|724340|P1|NOT COMPLETED|Open-Label Period (Non-Randomized)||111
299922|NCT00784654|724338|P3|COMPLETED|Open-Label Period (Non-Randomized)||0
299923|NCT00784654|724339|P2|COMPLETED|Open-Label Period (Non-Randomized)||0
299924|NCT00784654|724340|P1|COMPLETED|Open-Label Period (Non-Randomized)||165
299925|NCT00784654|724338|P3|STARTED|Open-Label Period (Non-Randomized)||0
299926|NCT00784654|724339|P2|STARTED|Open-Label Period (Non-Randomized)||0
299927|NCT00784654|724340|P1|STARTED|Open-Label Period (Non-Randomized)||276
299928|NCT00784563|724375|P3|NOT COMPLETED|Year 3||3
299929|NCT00784563|724376|P2|NOT COMPLETED|Year 3||0
299930|NCT00784563|724377|P1|NOT COMPLETED|Year 3||0
299931|NCT00784563|724375|P3|COMPLETED|Year 3||14
299932|NCT00784563|724376|P2|COMPLETED|Year 3||0
299933|NCT00784563|724377|P1|COMPLETED|Year 3||0
299934|NCT00784563|724375|P3|STARTED|Year 3||17
299935|NCT00784563|724376|P2|STARTED|Year 3||0
299936|NCT00784563|724377|P1|STARTED|Year 3||0
299937|NCT00784563|724375|P3|NOT COMPLETED|Years 1 & 2||0
299938|NCT00784563|724376|P2|NOT COMPLETED|Years 1 & 2||5
299939|NCT00784563|724377|P1|NOT COMPLETED|Years 1 & 2||3
299940|NCT00784563|724375|P3|COMPLETED|Years 1 & 2||0
299941|NCT00784563|724376|P2|COMPLETED|Years 1 & 2||17
299942|NCT00784563|724377|P1|COMPLETED|Years 1 & 2||18
299943|NCT00784563|724375|P3|STARTED|Years 1 & 2||0
299944|NCT00784563|724376|P2|STARTED|Years 1 & 2||22
299945|NCT00784563|724377|P1|STARTED|Years 1 & 2||21
299946|NCT00784550|724395|P2|NOT COMPLETED|Overall Study||42
299947|NCT00784550|724396|P1|NOT COMPLETED|Overall Study||36
299948|NCT00784550|724395|P2|COMPLETED|Overall Study||127
299949|NCT00784550|724396|P1|COMPLETED|Overall Study||137
299950|NCT00784550|724395|P2|STARTED|Overall Study||169
299951|NCT00784550|724396|P1|STARTED|Overall Study||173
299952|NCT00784524|724412|P1|NOT COMPLETED|Overall Study||0
299953|NCT00784524|724412|P1|COMPLETED|Overall Study||14
299954|NCT00784524|724412|P1|STARTED|Overall Study||14
299955|NCT00784459|724422|P2|NOT COMPLETED|Overall Study||2
299956|NCT00784459|724423|P1|NOT COMPLETED|Overall Study||0
299957|NCT00784459|724422|P2|COMPLETED|Overall Study||11
299958|NCT00784459|724423|P1|COMPLETED|Overall Study||11
299959|NCT00784459|724422|P2|STARTED|Overall Study||13
299960|NCT00784459|724423|P1|STARTED|Overall Study||11
299961|NCT00784368|724434|P3|NOT COMPLETED|Overall Study||11
299962|NCT00784368|724435|P2|NOT COMPLETED|Overall Study||11
299963|NCT00784368|724436|P1|NOT COMPLETED|Overall Study||8
299964|NCT00784368|724434|P3|COMPLETED|Overall Study||12
299965|NCT00784368|724435|P2|COMPLETED|Overall Study||5
299966|NCT00784368|724436|P1|COMPLETED|Overall Study||8
299967|NCT00784368|724434|P3|STARTED|Overall Study||23
299968|NCT00784368|724435|P2|STARTED|Overall Study||16
299969|NCT00784368|724436|P1|STARTED|Overall Study||16
299970|NCT00784303|724472|P2|NOT COMPLETED|Overall Study||15
299971|NCT00784303|724473|P1|NOT COMPLETED|Overall Study||17
299972|NCT00784303|724472|P2|COMPLETED|Overall Study||44
299973|NCT00784303|724473|P1|COMPLETED|Overall Study||41
299974|NCT00784303|724472|P2|Discontinued Due to Disease Progression|Overall Study||15
299975|NCT00784303|724473|P1|Discontinued Due to Disease Progression|Overall Study||18
299976|NCT00784303|724472|P2|Continued Treatment in Extension Phase|Overall Study|Participants continued in extension phase at data cutoff date (11 April 2011)|29
299977|NCT00784303|724473|P1|Continued Treatment in Extension Phase|Overall Study|Participants continued in extension phase at data cutoff date (11 April 2011)|23
299978|NCT00784303|724472|P2|STARTED|Overall Study||59
299979|NCT00784303|724473|P1|STARTED|Overall Study||58
299980|NCT00784277|724512|P7|NOT COMPLETED|ER Treatment||15
299981|NCT00784277|724513|P6|NOT COMPLETED|ER Treatment||24
299982|NCT00784277|724514|P5|NOT COMPLETED|ER Treatment||9
299983|NCT00784277|724515|P4|NOT COMPLETED|ER Treatment||0
299984|NCT00784277|724516|P3|NOT COMPLETED|ER Treatment||0
299985|NCT00784277|724517|P2|NOT COMPLETED|ER Treatment||0
299986|NCT00784277|724518|P1|NOT COMPLETED|ER Treatment||0
299987|NCT00784277|724512|P7|COMPLETED|ER Treatment||76
299988|NCT00784277|724513|P6|COMPLETED|ER Treatment||226
299989|NCT00784277|724514|P5|COMPLETED|ER Treatment||113
299990|NCT00784277|724515|P4|COMPLETED|ER Treatment||0
299991|NCT00784277|724516|P3|COMPLETED|ER Treatment||0
299992|NCT00784277|724517|P2|COMPLETED|ER Treatment||0
299993|NCT00784277|724518|P1|COMPLETED|ER Treatment||0
299994|NCT00784277|724512|P7|STARTED|ER Treatment|9 participants who had completed IR treatment have not taken any ER treatment.|91
299995|NCT00784277|724513|P6|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|250
299996|NCT00784277|724514|P5|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|122
299997|NCT00784277|724515|P4|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
299998|NCT00784277|724516|P3|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
299999|NCT00784277|724517|P2|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
300000|NCT00784277|724518|P1|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
300001|NCT00784277|724512|P7|NOT COMPLETED|IR Treatment||0
300002|NCT00784277|724513|P6|NOT COMPLETED|IR Treatment||0
300003|NCT00784277|724514|P5|NOT COMPLETED|IR Treatment||0
300004|NCT00784277|724515|P4|NOT COMPLETED|IR Treatment||43
300005|NCT00784277|724516|P3|NOT COMPLETED|IR Treatment||28
300006|NCT00784277|724517|P2|NOT COMPLETED|IR Treatment||17
300007|NCT00784277|724518|P1|NOT COMPLETED|IR Treatment||16
300008|NCT00784277|724512|P7|COMPLETED|IR Treatment||0
300009|NCT00784277|724513|P6|COMPLETED|IR Treatment||0
300010|NCT00784277|724514|P5|COMPLETED|IR Treatment||0
300011|NCT00784277|724515|P4|COMPLETED|IR Treatment||100
300012|NCT00784277|724516|P3|COMPLETED|IR Treatment||126
300013|NCT00784277|724517|P2|COMPLETED|IR Treatment||134
300014|NCT00784277|724518|P1|COMPLETED|IR Treatment||132
300015|NCT00784277|724512|P7|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
300016|NCT00784277|724513|P6|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
300017|NCT00784277|724514|P5|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
300018|NCT00784277|724515|P4|STARTED|IR Treatment||143
300019|NCT00784277|724516|P3|STARTED|IR Treatment||154
300020|NCT00784277|724517|P2|STARTED|IR Treatment||151
300021|NCT00784277|724518|P1|STARTED|IR Treatment||148
300022|NCT00784238|724535|P1|NOT COMPLETED|Overall Study||119
300023|NCT00784238|724535|P1|COMPLETED|Overall Study||170
300024|NCT00784238|724535|P1|STARTED|Overall Study||289
300025|NCT00784225|724580|P4|NOT COMPLETED|Overall Study||0
300026|NCT00784225|724581|P3|NOT COMPLETED|Overall Study||0
300027|NCT00784225|724582|P2|NOT COMPLETED|Overall Study||0
300028|NCT00784225|724583|P1|NOT COMPLETED|Overall Study||0
300029|NCT00784225|724580|P4|COMPLETED|Overall Study||3374
300030|NCT00784225|724581|P3|COMPLETED|Overall Study||3369
300031|NCT00784225|724582|P2|COMPLETED|Overall Study||3357
300032|NCT00784225|724583|P1|COMPLETED|Overall Study||3375
300033|NCT00784225|724580|P4|STARTED|Overall Study||3374
300034|NCT00784225|724581|P3|STARTED|Overall Study||3369
300035|NCT00784225|724582|P2|STARTED|Overall Study||3357
300036|NCT00784225|724583|P1|STARTED|Overall Study||3375
300037|NCT00784147|724607|P2|NOT COMPLETED|Overall Study||9
300038|NCT00784147|724608|P1|NOT COMPLETED|Overall Study||8
300039|NCT00784147|724607|P2|COMPLETED|Overall Study||45
300040|NCT00784147|724608|P1|COMPLETED|Overall Study||51
300041|NCT00784147|724607|P2|STARTED|Overall Study||54
300042|NCT00784147|724608|P1|STARTED|Overall Study||59
300043|NCT00784134|724628|P2|NOT COMPLETED|Overall Study||6
300044|NCT00784134|724629|P1|NOT COMPLETED|Overall Study||3
300045|NCT00784134|724628|P2|COMPLETED|Overall Study||245
300046|NCT00784134|724629|P1|COMPLETED|Overall Study||246
300047|NCT00784134|724628|P2|STARTED|Overall Study||251
300048|NCT00784134|724629|P1|STARTED|Overall Study||249
300049|NCT00784095|724728|P3|NOT COMPLETED|Overall Study||1
300050|NCT00784095|724729|P2|NOT COMPLETED|Overall Study||1
300051|NCT00784095|724730|P1|NOT COMPLETED|Overall Study||0
300052|NCT00784095|724728|P3|COMPLETED|Overall Study||11
300053|NCT00784095|724729|P2|COMPLETED|Overall Study||11
300054|NCT00784095|724730|P1|COMPLETED|Overall Study||12
300055|NCT00784095|724728|P3|STARTED|Overall Study||12
300056|NCT00784095|724729|P2|STARTED|Overall Study||12
300057|NCT00784095|724730|P1|STARTED|Overall Study||12
300058|NCT00784043|724752|P2|NOT COMPLETED|Overall Study||6
300059|NCT00784043|724753|P1|NOT COMPLETED|Overall Study||31
300060|NCT00784043|724752|P2|COMPLETED|Overall Study||0
300061|NCT00784043|724753|P1|COMPLETED|Overall Study||0
300062|NCT00784043|724752|P2|STARTED|Overall Study||6
300063|NCT00784043|724753|P1|STARTED|Overall Study||31
300064|NCT00784030|724765|P2|NOT COMPLETED|Overall Study||0
300065|NCT00784030|724766|P1|NOT COMPLETED|Overall Study||0
300066|NCT00784030|724765|P2|COMPLETED|Overall Study||10
300067|NCT00784030|724766|P1|COMPLETED|Overall Study||13
300068|NCT00784030|724765|P2|STARTED|Overall Study||10
300069|NCT00784030|724766|P1|STARTED|Overall Study||13
300070|NCT00783965|724774|P2|NOT COMPLETED|Second Intervention (24 Months)||9
300071|NCT00783965|724775|P1|NOT COMPLETED|Second Intervention (24 Months)||0
300072|NCT00783965|724774|P2|COMPLETED|Second Intervention (24 Months)||16
300073|NCT00783965|724775|P1|COMPLETED|Second Intervention (24 Months)||2
300074|NCT00783965|724774|P2|STARTED|Second Intervention (24 Months)||25
300075|NCT00783965|724775|P1|STARTED|Second Intervention (24 Months)||2
300076|NCT00783965|724774|P2|NOT COMPLETED|First Intervention (12 Months)||4
300077|NCT00783965|724775|P1|NOT COMPLETED|First Intervention (12 Months)||3
300078|NCT00783965|724774|P2|COMPLETED|First Intervention (12 Months)||25
300079|NCT00783965|724775|P1|COMPLETED|First Intervention (12 Months)||2
300080|NCT00783965|724774|P2|STARTED|First Intervention (12 Months)||29
300081|NCT00783965|724775|P1|STARTED|First Intervention (12 Months)||5
300082|NCT00783952|724783|P1|NOT COMPLETED|Overall Study||0
300083|NCT00783952|724783|P1|COMPLETED|Overall Study||8
300084|NCT00783952|724783|P1|STARTED|Overall Study||8
300085|NCT00783835|724788|P1|NOT COMPLETED|Overall Study||10
300086|NCT00783835|724788|P1|COMPLETED|Overall Study||50
300087|NCT00783835|724788|P1|STARTED|Overall Study||60
300088|NCT00783796|724800|P1|NOT COMPLETED|Overall Study||6
300089|NCT00783796|724800|P1|COMPLETED|Overall Study||144
300090|NCT00783796|724800|P1|STARTED|Overall Study||150
300091|NCT00783718|724905|P7|NOT COMPLETED|Maintenance Phase||195
300092|NCT00783718|724906|P6|NOT COMPLETED|Maintenance Phase||41
300093|NCT00783718|724907|P5|NOT COMPLETED|Maintenance Phase||45
300094|NCT00783718|724908|P4|NOT COMPLETED|Maintenance Phase||78
300095|NCT00783718|724909|P3|NOT COMPLETED|Maintenance Phase||0
300096|NCT00783718|724910|P2|NOT COMPLETED|Maintenance Phase||0
300097|NCT00783718|724911|P1|NOT COMPLETED|Maintenance Phase||105
300098|NCT00783718|724905|P7|COMPLETED|Maintenance Phase||135
300099|NCT00783718|724906|P6|COMPLETED|Maintenance Phase||84
300100|NCT00783718|724907|P5|COMPLETED|Maintenance Phase||77
300101|NCT00783718|724908|P4|COMPLETED|Maintenance Phase||48
300102|NCT00783718|724909|P3|COMPLETED|Maintenance Phase||0
300103|NCT00783718|724910|P2|COMPLETED|Maintenance Phase||0
300104|NCT00783718|724911|P1|COMPLETED|Maintenance Phase||30
300105|NCT00783718|724905|P7|STARTED|Maintenance Phase||330
300106|NCT00783718|724906|P6|STARTED|Maintenance Phase||125
300107|NCT00783718|724907|P5|STARTED|Maintenance Phase||122
300108|NCT00783718|724908|P4|STARTED|Maintenance Phase||126
300109|NCT00783718|724909|P3|STARTED|Maintenance Phase||0
300110|NCT00783718|724910|P2|STARTED|Maintenance Phase||0
300111|NCT00783718|724911|P1|STARTED|Maintenance Phase||135
300112|NCT00783718|724905|P7|NOT COMPLETED|Induction Phase||0
300113|NCT00783718|724906|P6|NOT COMPLETED|Induction Phase||0
300114|NCT00783718|724907|P5|NOT COMPLETED|Induction Phase||0
300115|NCT00783718|724908|P4|NOT COMPLETED|Induction Phase||0
300116|NCT00783718|724909|P3|NOT COMPLETED|Induction Phase||36
300117|NCT00783718|724910|P2|NOT COMPLETED|Induction Phase||7
300118|NCT00783718|724911|P1|NOT COMPLETED|Induction Phase||14
300119|NCT00783718|724905|P7|COMPLETED|Induction Phase||0
300120|NCT00783718|724906|P6|COMPLETED|Induction Phase||0
300121|NCT00783718|724907|P5|COMPLETED|Induction Phase||0
300122|NCT00783718|724908|P4|COMPLETED|Induction Phase||0
300123|NCT00783718|724909|P3|COMPLETED|Induction Phase||485
300124|NCT00783718|724910|P2|COMPLETED|Induction Phase||218
300125|NCT00783718|724911|P1|COMPLETED|Induction Phase||135
300126|NCT00783718|724905|P7|STARTED|Induction Phase||0
300127|NCT00783718|724906|P6|STARTED|Induction Phase||0
300128|NCT00783718|724907|P5|STARTED|Induction Phase||0
300129|NCT00783718|724908|P4|STARTED|Induction Phase||0
300130|NCT00783718|724909|P3|STARTED|Induction Phase||521
300131|NCT00783718|724910|P2|STARTED|Induction Phase||225
300132|NCT00783718|724911|P1|STARTED|Induction Phase||149
300133|NCT00783705|724939|P2|NOT COMPLETED|Overall Study||5
300134|NCT00783705|724940|P1|NOT COMPLETED|Overall Study||6
300135|NCT00783705|724939|P2|COMPLETED|Overall Study||36
300136|NCT00783705|724940|P1|COMPLETED|Overall Study||38
300137|NCT00783705|724939|P2|STARTED|Overall Study||41
300138|NCT00783705|724940|P1|STARTED|Overall Study||44
300139|NCT00783692|724987|P7|NOT COMPLETED|Maintenance Phase||249
300140|NCT00783692|724988|P6|NOT COMPLETED|Maintenance Phase||72
300141|NCT00783692|724989|P5|NOT COMPLETED|Maintenance Phase||81
300142|NCT00783692|724990|P4|NOT COMPLETED|Maintenance Phase||89
300143|NCT00783692|724991|P3|NOT COMPLETED|Maintenance Phase||0
300144|NCT00783692|724992|P2|NOT COMPLETED|Maintenance Phase||0
300145|NCT00783692|724993|P1|NOT COMPLETED|Maintenance Phase||95
300146|NCT00783692|724987|P7|COMPLETED|Maintenance Phase||163
300147|NCT00783692|724988|P6|COMPLETED|Maintenance Phase||82
300148|NCT00783692|724989|P5|COMPLETED|Maintenance Phase||73
300149|NCT00783692|724990|P4|COMPLETED|Maintenance Phase||64
300150|NCT00783692|724991|P3|COMPLETED|Maintenance Phase||0
300151|NCT00783692|724992|P2|COMPLETED|Maintenance Phase||0
300152|NCT00783692|724993|P1|COMPLETED|Maintenance Phase||42
300153|NCT00783692|724987|P7|STARTED|Maintenance Phase||412
300154|NCT00783692|724988|P6|STARTED|Maintenance Phase||154
300155|NCT00783692|724989|P5|STARTED|Maintenance Phase||154
300156|NCT00783692|724990|P4|STARTED|Maintenance Phase||153
300157|NCT00783692|724991|P3|STARTED|Maintenance Phase||0
300158|NCT00783692|724992|P2|STARTED|Maintenance Phase||0
300159|NCT00783692|724993|P1|STARTED|Maintenance Phase||137
300160|NCT00783692|724987|P7|NOT COMPLETED|Induction Phase||0
300161|NCT00783692|724988|P6|NOT COMPLETED|Induction Phase||0
300162|NCT00783692|724989|P5|NOT COMPLETED|Induction Phase||0
300163|NCT00783692|724990|P4|NOT COMPLETED|Induction Phase||0
300164|NCT00783692|724991|P3|NOT COMPLETED|Induction Phase||74
300165|NCT00783692|724992|P2|NOT COMPLETED|Induction Phase||21
300166|NCT00783692|724993|P1|NOT COMPLETED|Induction Phase||11
300167|NCT00783692|724987|P7|COMPLETED|Induction Phase||0
300168|NCT00783692|724988|P6|COMPLETED|Induction Phase||0
300169|NCT00783692|724989|P5|COMPLETED|Induction Phase||0
300170|NCT00783692|724990|P4|COMPLETED|Induction Phase||0
300171|NCT00783692|724991|P3|COMPLETED|Induction Phase||674
300172|NCT00783692|724992|P2|COMPLETED|Induction Phase||199
300173|NCT00783692|724993|P1|COMPLETED|Induction Phase||137
300174|NCT00783692|724987|P7|Treated|Induction Phase||0
300175|NCT00783692|724988|P6|Treated|Induction Phase||0
300176|NCT00783692|724989|P5|Treated|Induction Phase||0
300177|NCT00783692|724990|P4|Treated|Induction Phase||0
300178|NCT00783692|724991|P3|Treated|Induction Phase||747
300179|NCT00783692|724992|P2|Treated|Induction Phase||220
300180|NCT00783692|724993|P1|Treated|Induction Phase||148
300181|NCT00783692|724987|P7|STARTED|Induction Phase||0
300182|NCT00783692|724988|P6|STARTED|Induction Phase||0
300183|NCT00783692|724989|P5|STARTED|Induction Phase||0
300184|NCT00783692|724990|P4|STARTED|Induction Phase||0
300185|NCT00783692|724991|P3|STARTED|Induction Phase||748
300186|NCT00783692|724992|P2|STARTED|Induction Phase||220
300187|NCT00783692|724993|P1|STARTED|Induction Phase||148
300188|NCT00783614|725020|P4|NOT COMPLETED|Overall Study||0
300189|NCT00783614|725021|P3|NOT COMPLETED|Overall Study||0
300190|NCT00783614|725022|P2|NOT COMPLETED|Overall Study||0
300191|NCT00783614|725023|P1|NOT COMPLETED|Overall Study||0
300192|NCT00783614|725020|P4|COMPLETED|Overall Study||5
300193|NCT00783614|725021|P3|COMPLETED|Overall Study||5
300194|NCT00783614|725022|P2|COMPLETED|Overall Study||6
300195|NCT00783614|725023|P1|COMPLETED|Overall Study||6
300196|NCT00783614|725020|P4|STARTED|Overall Study||5
300197|NCT00783614|725021|P3|STARTED|Overall Study||5
300198|NCT00783614|725022|P2|STARTED|Overall Study||6
300199|NCT00783614|725023|P1|STARTED|Overall Study||6
300200|NCT00783432|725039|P2|NOT COMPLETED|Overall Study||78
300201|NCT00783432|725040|P1|NOT COMPLETED|Overall Study||85
300202|NCT00783432|725039|P2|COMPLETED|Overall Study||354
300203|NCT00783432|725040|P1|COMPLETED|Overall Study||345
300204|NCT00783432|725039|P2|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|432
300205|NCT00783432|725040|P1|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|430
300206|NCT00783302|725050|P1|NOT COMPLETED|Overall Study||35
300207|NCT00783302|725050|P1|COMPLETED|Overall Study||850
300208|NCT00783302|725050|P1|STARTED|Overall Study||885
300209|NCT00783263|725072|P4|NOT COMPLETED|Overall Study||3
300210|NCT00783263|725073|P3|NOT COMPLETED|Overall Study||3
300211|NCT00783263|725074|P2|NOT COMPLETED|Overall Study||2
300212|NCT00783263|725075|P1|NOT COMPLETED|Overall Study||4
300213|NCT00783263|725072|P4|COMPLETED|Overall Study||118
300214|NCT00783263|725073|P3|COMPLETED|Overall Study||119
300215|NCT00783263|725074|P2|COMPLETED|Overall Study||96
300216|NCT00783263|725075|P1|COMPLETED|Overall Study||95
300217|NCT00783263|725072|P4|STARTED|Overall Study||121
300218|NCT00783263|725073|P3|STARTED|Overall Study||122
300219|NCT00783263|725074|P2|STARTED|Overall Study||98
300220|NCT00783263|725075|P1|STARTED|Overall Study||99
300221|NCT00783224|725105|P4|NOT COMPLETED|Overall Study||2
300222|NCT00783224|725106|P3|NOT COMPLETED|Overall Study||1
300223|NCT00783224|725107|P2|NOT COMPLETED|Overall Study||0
300224|NCT00783224|725108|P1|NOT COMPLETED|Overall Study||0
300225|NCT00783224|725105|P4|COMPLETED|Overall Study||140
300226|NCT00783224|725106|P3|COMPLETED|Overall Study||142
300227|NCT00783224|725107|P2|COMPLETED|Overall Study||34
300228|NCT00783224|725108|P1|COMPLETED|Overall Study||32
300229|NCT00783224|725105|P4|STARTED|Overall Study||142
300230|NCT00783224|725106|P3|STARTED|Overall Study||143
300231|NCT00783224|725107|P2|STARTED|Overall Study||34
300232|NCT00783224|725108|P1|STARTED|Overall Study||32
300233|NCT00783198|725120|P3|NOT COMPLETED|Overall Study||42
300234|NCT00783198|725121|P2|NOT COMPLETED|Overall Study||43
300235|NCT00783198|725122|P1|NOT COMPLETED|Overall Study||57
300236|NCT00783198|725120|P3|COMPLETED|Overall Study||146
300237|NCT00783198|725121|P2|COMPLETED|Overall Study||144
300238|NCT00783198|725122|P1|COMPLETED|Overall Study||133
300239|NCT00783198|725120|P3|STARTED|Overall Study||188
300240|NCT00783198|725121|P2|STARTED|Overall Study||187
300241|NCT00783198|725122|P1|STARTED|Overall Study||190
300242|NCT00783094|725145|P3|NOT COMPLETED|Open-Label Extension Period||30
300243|NCT00783094|725146|P2|NOT COMPLETED|Open-Label Extension Period||19
300244|NCT00783094|725147|P1|NOT COMPLETED|Open-Label Extension Period||22
300245|NCT00783094|725145|P3|COMPLETED|Open-Label Extension Period||101
300246|NCT00783094|725146|P2|COMPLETED|Open-Label Extension Period||109
300247|NCT00783094|725147|P1|COMPLETED|Open-Label Extension Period||113
300248|NCT00783094|725145|P3|STARTED|Open-Label Extension Period||131
300249|NCT00783094|725146|P2|STARTED|Open-Label Extension Period||128
300250|NCT00783094|725147|P1|STARTED|Open-Label Extension Period||135
300251|NCT00783094|725145|P3|NOT COMPLETED|Randomized Double-Blind Treatment Period||9
300252|NCT00783094|725146|P2|NOT COMPLETED|Randomized Double-Blind Treatment Period||12
300253|NCT00783094|725147|P1|NOT COMPLETED|Randomized Double-Blind Treatment Period||7
300254|NCT00783094|725145|P3|COMPLETED|Randomized Double-Blind Treatment Period||131
300255|NCT00783094|725146|P2|COMPLETED|Randomized Double-Blind Treatment Period||128
300256|NCT00783094|725147|P1|COMPLETED|Randomized Double-Blind Treatment Period||135
300257|NCT00783094|725145|P3|STARTED|Randomized Double-Blind Treatment Period||140
300258|NCT00783094|725146|P2|STARTED|Randomized Double-Blind Treatment Period||140
300259|NCT00783094|725147|P1|STARTED|Randomized Double-Blind Treatment Period||142
300260|NCT00782834|725223|P1|NOT COMPLETED|Treatment Phase||1
300261|NCT00782834|725223|P1|COMPLETED|Treatment Phase||13
300262|NCT00782834|725223|P1|STARTED|Treatment Phase||14
300263|NCT00782834|725223|P1|NOT COMPLETED|Screened Patients||1
300264|NCT00782834|725223|P1|COMPLETED|Screened Patients|1 pt ineligible d/t arrhythmia|14
300265|NCT00782834|725223|P1|STARTED|Screened Patients||15
300266|NCT00782821|725232|P4|NOT COMPLETED|Overall Study||2
300267|NCT00782821|725233|P3|NOT COMPLETED|Overall Study||1
300268|NCT00782821|725234|P2|NOT COMPLETED|Overall Study||0
300269|NCT00782821|725235|P1|NOT COMPLETED|Overall Study||0
300270|NCT00782821|725232|P4|COMPLETED|Overall Study||8
300271|NCT00782821|725233|P3|COMPLETED|Overall Study||9
300272|NCT00782821|725234|P2|COMPLETED|Overall Study||10
300273|NCT00782821|725235|P1|COMPLETED|Overall Study||10
300274|NCT00782821|725232|P4|STARTED|Overall Study||10
300275|NCT00782821|725233|P3|STARTED|Overall Study||10
300276|NCT00782821|725234|P2|STARTED|Overall Study||10
300277|NCT00782821|725235|P1|STARTED|Overall Study||10
300278|NCT00782795|725263|P2|NOT COMPLETED|Overall Study||2
300279|NCT00782795|725264|P1|NOT COMPLETED|Overall Study||1
300280|NCT00782795|725263|P2|COMPLETED|Overall Study||6
300281|NCT00782795|725264|P1|COMPLETED|Overall Study||16
300282|NCT00782795|725263|P2|24 Week Appointment|Overall Study||7
300283|NCT00782795|725264|P1|24 Week Appointment|Overall Study||16
300284|NCT00782795|725263|P2|6 Weeks (1st Apptment)|Overall Study||7
300285|NCT00782795|725264|P1|6 Weeks (1st Apptment)|Overall Study||16
300286|NCT00782795|725263|P2|STARTED|Overall Study||8
300287|NCT00782795|725264|P1|STARTED|Overall Study||17
300288|NCT00782756|725296|P1|NOT COMPLETED|Overall Study||0
300289|NCT00782756|725296|P1|COMPLETED|Overall Study||40
300290|NCT00782756|725296|P1|STARTED|Overall Study||40
300291|NCT00782717|725304|P2|NOT COMPLETED|Overall Study||28
300292|NCT00782717|725305|P1|NOT COMPLETED|Overall Study||15
300293|NCT00782717|725304|P2|COMPLETED|Overall Study||102
300294|NCT00782717|725305|P1|COMPLETED|Overall Study||118
300295|NCT00782717|725304|P2|STARTED|Overall Study||130
300296|NCT00782717|725305|P1|STARTED|Overall Study||133
300297|NCT00782639|725315|P2|NOT COMPLETED|Overall Study||0
300298|NCT00782639|725316|P1|NOT COMPLETED|Overall Study||0
300299|NCT00782639|725315|P2|COMPLETED|Overall Study|This study was terminated due to low enrollment.|11
300300|NCT00782639|725316|P1|COMPLETED|Overall Study|This study was terminated due to low enrollment.|12
300301|NCT00782639|725315|P2|STARTED|Overall Study||11
300302|NCT00782639|725316|P1|STARTED|Overall Study||12
300303|NCT00782626|725332|P1|NOT COMPLETED|Overall Study||7
300304|NCT00782626|725332|P1|COMPLETED|Overall Study||16
300305|NCT00782626|725332|P1|STARTED|Overall Study||23
300306|NCT00782509|725339|P3|NOT COMPLETED|Overall Study||36
300307|NCT00782509|725340|P2|NOT COMPLETED|Overall Study||24
300308|NCT00782509|725341|P1|NOT COMPLETED|Overall Study||41
300309|NCT00782509|725339|P3|COMPLETED|Overall Study||181
300310|NCT00782509|725340|P2|COMPLETED|Overall Study||185
300311|NCT00782509|725341|P1|COMPLETED|Overall Study||175
300312|NCT00782509|725339|P3|STARTED|Overall Study||217
300313|NCT00782509|725340|P2|STARTED|Overall Study||209
300314|NCT00782509|725341|P1|STARTED|Overall Study||216
300315|NCT00782496|725534|P2|NOT COMPLETED|Overall Study||15
300316|NCT00782496|725535|P1|NOT COMPLETED|Overall Study||14
300317|NCT00782496|725534|P2|COMPLETED|Overall Study||90
300318|NCT00782496|725535|P1|COMPLETED|Overall Study||92
300319|NCT00782496|725534|P2|STARTED|Overall Study||105
300320|NCT00782496|725535|P1|STARTED|Overall Study||106
300321|NCT00782483|725542|P1|NOT COMPLETED|Overall Study||6
300322|NCT00782483|725542|P1|COMPLETED|Overall Study||0
300323|NCT00782483|725542|P1|STARTED|Overall Study|6 subjects enrolled beginning on 04/27/2009 with last enrollment on 04/13/2010.|6
300324|NCT00782418|725546|P7|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
300325|NCT00782418|725547|P6|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
300326|NCT00782418|725548|P5|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
300327|NCT00782418|725549|P4|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
300328|NCT00782418|725550|P3|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
300329|NCT00782418|725551|P2|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
300330|NCT00782418|725552|P1|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
300331|NCT00782418|725546|P7|COMPLETED|Period 2 Procedure/Treatment Groups||4
300332|NCT00782418|725547|P6|COMPLETED|Period 2 Procedure/Treatment Groups||4
300333|NCT00782418|725548|P5|COMPLETED|Period 2 Procedure/Treatment Groups||3
300334|NCT00782418|725549|P4|COMPLETED|Period 2 Procedure/Treatment Groups||1
300335|NCT00782418|725550|P3|COMPLETED|Period 2 Procedure/Treatment Groups||4
300336|NCT00782418|725551|P2|COMPLETED|Period 2 Procedure/Treatment Groups||4
300337|NCT00782418|725552|P1|COMPLETED|Period 2 Procedure/Treatment Groups||3
300338|NCT00782418|725546|P7|STARTED|Period 2 Procedure/Treatment Groups||4
300339|NCT00782418|725547|P6|STARTED|Period 2 Procedure/Treatment Groups||4
300340|NCT00782418|725548|P5|STARTED|Period 2 Procedure/Treatment Groups||3
300341|NCT00782418|725549|P4|STARTED|Period 2 Procedure/Treatment Groups||1
300342|NCT00782418|725550|P3|STARTED|Period 2 Procedure/Treatment Groups||4
300343|NCT00782418|725551|P2|STARTED|Period 2 Procedure/Treatment Groups||4
300344|NCT00782418|725552|P1|STARTED|Period 2 Procedure/Treatment Groups||3
300345|NCT00782418|725546|P7|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
300346|NCT00782418|725547|P6|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
300347|NCT00782418|725548|P5|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
300348|NCT00782418|725549|P4|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
300349|NCT00782418|725550|P3|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
300350|NCT00782418|725551|P2|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
300351|NCT00782418|725552|P1|NOT COMPLETED|Period 1 Procedure/Treatment Groups||2
300352|NCT00782418|725546|P7|COMPLETED|Period 1 Procedure/Treatment Groups||4
300353|NCT00782418|725547|P6|COMPLETED|Period 1 Procedure/Treatment Groups||4
300354|NCT00782418|725548|P5|COMPLETED|Period 1 Procedure/Treatment Groups||4
300355|NCT00782418|725549|P4|COMPLETED|Period 1 Procedure/Treatment Groups||2
300356|NCT00782418|725550|P3|COMPLETED|Period 1 Procedure/Treatment Groups||4
300357|NCT00782418|725551|P2|COMPLETED|Period 1 Procedure/Treatment Groups||4
300358|NCT00782418|725552|P1|COMPLETED|Period 1 Procedure/Treatment Groups||1
300359|NCT00782418|725546|P7|STARTED|Period 1 Procedure/Treatment Groups||4
300360|NCT00782418|725547|P6|STARTED|Period 1 Procedure/Treatment Groups||5
300361|NCT00782418|725548|P5|STARTED|Period 1 Procedure/Treatment Groups||5
300362|NCT00782418|725549|P4|STARTED|Period 1 Procedure/Treatment Groups||2
300363|NCT00782418|725550|P3|STARTED|Period 1 Procedure/Treatment Groups||4
300364|NCT00782418|725551|P2|STARTED|Period 1 Procedure/Treatment Groups||4
300365|NCT00782418|725552|P1|STARTED|Period 1 Procedure/Treatment Groups||3
300366|NCT00782379|725572|P1|NOT COMPLETED|Overall Study||0
300367|NCT00782379|725572|P1|COMPLETED|Overall Study||20
300368|NCT00782379|725572|P1|STARTED|Overall Study||20
300369|NCT00782340|725589|P3|NOT COMPLETED|Randomized Double Blind||0
300370|NCT00782340|725590|P2|NOT COMPLETED|Randomized Double Blind||0
300371|NCT00782340|725591|P1|NOT COMPLETED|Randomized Double Blind||0
300372|NCT00782340|725589|P3|COMPLETED|Randomized Double Blind||80
300373|NCT00782340|725590|P2|COMPLETED|Randomized Double Blind||82
300374|NCT00782340|725591|P1|COMPLETED|Randomized Double Blind||0
300375|NCT00782340|725589|P3|STARTED|Randomized Double Blind||80
300376|NCT00782340|725590|P2|STARTED|Randomized Double Blind||82
300377|NCT00782340|725591|P1|STARTED|Randomized Double Blind||0
300378|NCT00782340|725589|P3|NOT COMPLETED|Open Label Titration||0
300379|NCT00782340|725590|P2|NOT COMPLETED|Open Label Titration||0
300380|NCT00782340|725591|P1|NOT COMPLETED|Open Label Titration||101
300381|NCT00782340|725589|P3|COMPLETED|Open Label Titration||0
300382|NCT00782340|725590|P2|COMPLETED|Open Label Titration||0
300383|NCT00782340|725591|P1|COMPLETED|Open Label Titration||162
300384|NCT00782340|725589|P3|STARTED|Open Label Titration||0
300385|NCT00782340|725590|P2|STARTED|Open Label Titration||0
300386|NCT00782340|725591|P1|STARTED|Open Label Titration||263
300387|NCT00782288|725617|P3|NOT COMPLETED|Overall Study||0
300388|NCT00782288|725618|P2|NOT COMPLETED|Overall Study||0
300389|NCT00782288|725619|P1|NOT COMPLETED|Overall Study||0
300390|NCT00782288|725617|P3|COMPLETED|Overall Study||8
300391|NCT00782288|725618|P2|COMPLETED|Overall Study||8
300392|NCT00782288|725619|P1|COMPLETED|Overall Study||8
300393|NCT00782288|725617|P3|STARTED|Overall Study||8
300394|NCT00782288|725618|P2|STARTED|Overall Study||8
300395|NCT00782288|725619|P1|STARTED|Overall Study||8
300396|NCT00782275|725661|P1|NOT COMPLETED|Overall Study||41
300397|NCT00782275|725661|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
300398|NCT00782275|725661|P1|Prior VEGFR Response Evaluable|Overall Study|One patient was unevaluable and therefore excluded from related subgroup analyses.|39
300399|NCT00782275|725661|P1|Treated|Overall Study||40
300400|NCT00782275|725661|P1|STARTED|Overall Study||41
300401|NCT00782210|725670|P3|NOT COMPLETED|Overall Study||35
300402|NCT00782210|725671|P2|NOT COMPLETED|Overall Study||35
300403|NCT00782210|725672|P1|NOT COMPLETED|Overall Study||50
300404|NCT00782210|725670|P3|COMPLETED|Overall Study||172
300405|NCT00782210|725671|P2|COMPLETED|Overall Study||173
300406|NCT00782210|725672|P1|COMPLETED|Overall Study||159
300407|NCT00782210|725670|P3|STARTED|Overall Study||207
300408|NCT00782210|725671|P2|STARTED|Overall Study||208
300409|NCT00782210|725672|P1|STARTED|Overall Study||209
300410|NCT00782184|725865|P2|NOT COMPLETED|Overall Study||5
300411|NCT00782184|725866|P1|NOT COMPLETED|Overall Study||4
300412|NCT00782184|725865|P2|COMPLETED|Overall Study||125
300413|NCT00782184|725866|P1|COMPLETED|Overall Study||116
300414|NCT00782184|725865|P2|STARTED|Overall Study||130
300415|NCT00782184|725866|P1|STARTED|Overall Study||120
300416|NCT00782171|725903|P2|NOT COMPLETED|Overall Study||19
300417|NCT00782171|725904|P1|NOT COMPLETED|Overall Study||22
300418|NCT00782171|725903|P2|COMPLETED|Overall Study||115
300419|NCT00782171|725904|P1|COMPLETED|Overall Study||124
300420|NCT00782171|725903|P2|Surgery (Baseline)|Overall Study||128
300421|NCT00782171|725904|P1|Surgery (Baseline)|Overall Study||138
300422|NCT00782171|725903|P2|1 Year|Overall Study||120
300423|NCT00782171|725904|P1|1 Year|Overall Study||131
300424|NCT00782171|725903|P2|20-23 Weeks|Overall Study||124
300425|NCT00782171|725904|P1|20-23 Weeks|Overall Study||135
300426|NCT00782171|725903|P2|STARTED|Overall Study||134
300427|NCT00782171|725904|P1|STARTED|Overall Study||146
300428|NCT00782067|725936|P1|NOT COMPLETED|Overall Study||116
300429|NCT00782067|725936|P1|COMPLETED|Overall Study||0
300430|NCT00782067|725936|P1|Primary Efficacy Population (PEP)|Overall Study||89
300431|NCT00782067|725936|P1|Safety Set (SS)|Overall Study||116
300432|NCT00782067|725936|P1|STARTED|Overall Study||116
300433|NCT00781963|725948|P2|NOT COMPLETED|Overall Study||2
300434|NCT00781963|725949|P1|NOT COMPLETED|Overall Study||17
300435|NCT00781963|725948|P2|COMPLETED|Overall Study||51
300436|NCT00781963|725949|P1|COMPLETED|Overall Study||89
300437|NCT00781963|725948|P2|STARTED|Overall Study||53
300438|NCT00781963|725949|P1|STARTED|Overall Study||106
300439|NCT00781950|725967|P2|NOT COMPLETED|Overall Study||13
300440|NCT00781950|725968|P1|NOT COMPLETED|Overall Study||11
300441|NCT00781950|725967|P2|COMPLETED|Overall Study||45
300442|NCT00781950|725968|P1|COMPLETED|Overall Study||41
300443|NCT00781950|725967|P2|STARTED|Overall Study||58
300444|NCT00781950|725968|P1|STARTED|Overall Study||52
300445|NCT00781937|725978|P2|NOT COMPLETED|Follow up Period (Week 56-68)||5
300446|NCT00781937|725979|P1|NOT COMPLETED|Follow up Period (Week 56-68)||6
300447|NCT00781937|725978|P2|COMPLETED|Follow up Period (Week 56-68)||141
300448|NCT00781937|725979|P1|COMPLETED|Follow up Period (Week 56-68)||153
300449|NCT00781937|725978|P2|STARTED|Follow up Period (Week 56-68)||146
300450|NCT00781937|725979|P1|STARTED|Follow up Period (Week 56-68)||159
300451|NCT00781937|725978|P2|NOT COMPLETED|Main Trial Period Through Week 56||64
300452|NCT00781937|725979|P1|NOT COMPLETED|Main Trial Period Through Week 56||53
300453|NCT00781937|725978|P2|COMPLETED|Main Trial Period Through Week 56||146
300454|NCT00781937|725979|P1|COMPLETED|Main Trial Period Through Week 56||159
300455|NCT00781937|725978|P2|STARTED|Main Trial Period Through Week 56||210
300456|NCT00781937|725979|P1|STARTED|Main Trial Period Through Week 56||212
300457|NCT00781911|726037|P2|NOT COMPLETED|Overall Study||8
300458|NCT00781911|726038|P1|NOT COMPLETED|Overall Study||6
300459|NCT00781911|726037|P2|COMPLETED|Overall Study||4
300460|NCT00781911|726038|P1|COMPLETED|Overall Study||25
300461|NCT00781911|726037|P2|Received at Least 1 Dose of Study Drug|Overall Study||12
300462|NCT00781911|726038|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
300463|NCT00781911|726037|P2|STARTED|Overall Study||12
300464|NCT00781911|726038|P1|STARTED|Overall Study||31
300465|NCT00781898|726066|P2|NOT COMPLETED|Overall Study||29
300466|NCT00781898|726067|P1|NOT COMPLETED|Overall Study||34
300467|NCT00781898|726066|P2|COMPLETED|Overall Study||126
300468|NCT00781898|726067|P1|COMPLETED|Overall Study||119
300469|NCT00781898|726066|P2|STARTED|Overall Study||155
300470|NCT00781898|726067|P1|STARTED|Overall Study||153
300471|NCT00781859|726075|P2|NOT COMPLETED|Overall Study||9
300472|NCT00781859|726076|P1|NOT COMPLETED|Overall Study||19
300473|NCT00781859|726075|P2|COMPLETED|Overall Study||98
300474|NCT00781859|726076|P1|COMPLETED|Overall Study||200
300475|NCT00781859|726075|P2|STARTED|Overall Study||107
300476|NCT00781859|726076|P1|STARTED|Overall Study||219
300477|NCT00781768|726086|P2|NOT COMPLETED|Overall Study||2
300478|NCT00781768|726087|P1|NOT COMPLETED|Overall Study||0
300479|NCT00781768|726086|P2|COMPLETED|Overall Study||90
300480|NCT00781768|726087|P1|COMPLETED|Overall Study||89
300481|NCT00781768|726086|P2|STARTED|Overall Study||92
300482|NCT00781768|726087|P1|STARTED|Overall Study||89
300483|NCT00781599|726095|P2|NOT COMPLETED|Overall Study||4
300484|NCT00781599|726096|P1|NOT COMPLETED|Overall Study||7
300485|NCT00781599|726095|P2|COMPLETED|Overall Study||32
300486|NCT00781599|726096|P1|COMPLETED|Overall Study||29
300487|NCT00781599|726095|P2|STARTED|Overall Study||36
300488|NCT00781599|726096|P1|STARTED|Overall Study||36
300489|NCT00781508|726110|P2|NOT COMPLETED|Overall Study||0
300490|NCT00781508|726111|P1|NOT COMPLETED|Overall Study||0
300491|NCT00781508|726110|P2|COMPLETED|Overall Study||5
300492|NCT00781508|726111|P1|COMPLETED|Overall Study||5
300493|NCT00781508|726110|P2|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
300494|NCT00781508|726111|P1|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
300495|NCT00781456|726121|P2|NOT COMPLETED|Overall Study||16
300496|NCT00781456|726122|P1|NOT COMPLETED|Overall Study||21
300497|NCT00781456|726121|P2|COMPLETED|Overall Study||35
300498|NCT00781456|726122|P1|COMPLETED|Overall Study||37
300499|NCT00781456|726121|P2|Received Study Drug|Overall Study||49
300500|NCT00781456|726122|P1|Received Study Drug|Overall Study||57
300501|NCT00781456|726121|P2|STARTED|Overall Study||51
300502|NCT00781456|726122|P1|STARTED|Overall Study||58
300503|NCT00781391|726145|P3|NOT COMPLETED|Overall Study||784
300504|NCT00781391|726146|P2|NOT COMPLETED|Overall Study||807
300505|NCT00781391|726147|P1|NOT COMPLETED|Overall Study||879
300506|NCT00781391|726145|P3|COMPLETED|Overall Study||6250
300507|NCT00781391|726146|P2|COMPLETED|Overall Study||6228
300508|NCT00781391|726147|P1|COMPLETED|Overall Study||6157
300509|NCT00781391|726145|P3|Per Protocol Analysis Set|Overall Study||6982
300510|NCT00781391|726146|P2|Per Protocol Analysis Set|Overall Study||6995
300511|NCT00781391|726147|P1|Per Protocol Analysis Set|Overall Study||6993
300512|NCT00781391|726145|P3|mITT Analysis Set (Received Drug)|Overall Study||7002
300513|NCT00781391|726146|P2|mITT Analysis Set (Received Drug)|Overall Study||7012
300514|NCT00781391|726147|P1|mITT Analysis Set (Received Drug)|Overall Study||7012
300515|NCT00781391|726145|P3|Safety Analysis Set (Received Drug)|Overall Study||7002
300516|NCT00781391|726146|P2|Safety Analysis Set (Received Drug)|Overall Study||7012
300517|NCT00781391|726147|P1|Safety Analysis Set (Received Drug)|Overall Study||7012
300518|NCT00781391|726145|P3|STARTED|Overall Study||7034
300519|NCT00781391|726146|P2|STARTED|Overall Study||7035
300520|NCT00781391|726147|P1|STARTED|Overall Study||7036
300521|NCT00781365|726181|P2|NOT COMPLETED|Overall Study||36
300522|NCT00781365|726182|P1|NOT COMPLETED|Overall Study||34
300523|NCT00781365|726181|P2|COMPLETED|Overall Study|completed both 6 and 12 month follow up|186
300524|NCT00781365|726182|P1|COMPLETED|Overall Study|completed both 6 and 12 month follow up|194
300525|NCT00781365|726181|P2|STARTED|Overall Study||222
300526|NCT00781365|726182|P1|STARTED|Overall Study||228
300527|NCT00781326|726192|P1|NOT COMPLETED|Phase 2||0
300528|NCT00781326|726192|P1|COMPLETED|Phase 2||0
300529|NCT00781326|726192|P1|STARTED|Phase 2|Study terminated prior to enrollment into Phase II|0
300530|NCT00781326|726192|P1|NOT COMPLETED|Phase I||4
300531|NCT00781326|726192|P1|COMPLETED|Phase I||2
300532|NCT00781326|726192|P1|STARTED|Phase I|Nine subjects consented; 3 did not meet eligibility criteria. 6 started antidepressant treatment.|6
300533|NCT00781274|726196|P1|NOT COMPLETED|Overall Study||2
300534|NCT00781274|726196|P1|COMPLETED|Overall Study||30
300535|NCT00781274|726196|P1|STARTED|Overall Study||32
300536|NCT00781079|726202|P2|NOT COMPLETED|Overall Study||17
300537|NCT00781079|726203|P1|NOT COMPLETED|Overall Study||27
300538|NCT00781079|726202|P2|COMPLETED|Overall Study||116
300539|NCT00781079|726203|P1|COMPLETED|Overall Study||122
300540|NCT00781079|726202|P2|STARTED|Overall Study||133
300541|NCT00781079|726203|P1|STARTED|Overall Study||149
300542|NCT00780962|726221|P2|NOT COMPLETED|Overall Study||27
300543|NCT00780962|726222|P1|NOT COMPLETED|Overall Study||15
300544|NCT00780962|726221|P2|COMPLETED|Overall Study||172
300545|NCT00780962|726222|P1|COMPLETED|Overall Study||185
300546|NCT00780962|726221|P2|Second Blood Draw (Outcome Measurement)|Overall Study||172
300547|NCT00780962|726222|P1|Second Blood Draw (Outcome Measurement)|Overall Study||185
300548|NCT00780962|726221|P2|STARTED|Overall Study||199
300549|NCT00780962|726222|P1|STARTED|Overall Study||200
300550|NCT00780910|726228|P1|NOT COMPLETED|Overall Study||2
300551|NCT00780910|726228|P1|COMPLETED|Overall Study||107
300552|NCT00780910|726228|P1|STARTED|Overall Study||109
300553|NCT00780741|726234|P2|NOT COMPLETED|Overall Study||10
300554|NCT00780741|726235|P1|NOT COMPLETED|Overall Study||7
300555|NCT00780741|726234|P2|COMPLETED|Overall Study|18 months of age (±4 weeks)|71
300556|NCT00780741|726235|P1|COMPLETED|Overall Study|18 months of age (±4 weeks)|75
300557|NCT00780741|726234|P2|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|67
300558|NCT00780741|726235|P1|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|73
300559|NCT00780741|726234|P2|STARTED|Overall Study|randomized|81
300560|NCT00780741|726235|P1|STARTED|Overall Study|randomized|82
300561|NCT00780715|726251|P4|NOT COMPLETED|Overall Study||0
300562|NCT00780715|726252|P3|NOT COMPLETED|Overall Study||0
300563|NCT00780715|726253|P2|NOT COMPLETED|Overall Study||0
300564|NCT00780715|726254|P1|NOT COMPLETED|Overall Study||0
300565|NCT00780715|726251|P4|COMPLETED|Overall Study||11
300566|NCT00780715|726252|P3|COMPLETED|Overall Study||6
300567|NCT00780715|726253|P2|COMPLETED|Overall Study||6
300568|NCT00780715|726254|P1|COMPLETED|Overall Study||6
300569|NCT00780715|726251|P4|STARTED|Overall Study||11
300570|NCT00780715|726252|P3|STARTED|Overall Study||6
300571|NCT00780715|726253|P2|STARTED|Overall Study||6
300572|NCT00780715|726254|P1|STARTED|Overall Study||6
300573|NCT00780676|726269|P5|NOT COMPLETED|Overall Study||0
300574|NCT00780676|726270|P4|NOT COMPLETED|Overall Study||0
300575|NCT00780676|726271|P3|NOT COMPLETED|Overall Study||0
300576|NCT00780676|726272|P2|NOT COMPLETED|Overall Study||0
300577|NCT00780676|726273|P1|NOT COMPLETED|Overall Study||0
300578|NCT00780676|726269|P5|COMPLETED|Overall Study||0
300579|NCT00780676|726270|P4|COMPLETED|Overall Study||0
300580|NCT00780676|726271|P3|COMPLETED|Overall Study||13
300581|NCT00780676|726272|P2|COMPLETED|Overall Study||8
300582|NCT00780676|726273|P1|COMPLETED|Overall Study||9
300583|NCT00780676|726269|P5|STARTED|Overall Study||0
300584|NCT00780676|726270|P4|STARTED|Overall Study||0
300585|NCT00780676|726271|P3|STARTED|Overall Study||13
300586|NCT00780676|726272|P2|STARTED|Overall Study||8
300587|NCT00780676|726273|P1|STARTED|Overall Study||9
300588|NCT00780572|726281|P2|NOT COMPLETED|Overall Study||0
300589|NCT00780572|726282|P1|NOT COMPLETED|Overall Study||0
300590|NCT00780572|726281|P2|COMPLETED|Overall Study||298
300591|NCT00780572|726282|P1|COMPLETED|Overall Study||297
300592|NCT00780572|726281|P2|STARTED|Overall Study||298
300593|NCT00780572|726282|P1|STARTED|Overall Study||297
300594|NCT00780559|726290|P2|NOT COMPLETED|Overall Study||7
300595|NCT00780559|726291|P1|NOT COMPLETED|Overall Study||3
300596|NCT00780559|726290|P2|COMPLETED|Overall Study||33
300597|NCT00780559|726291|P1|COMPLETED|Overall Study||29
300598|NCT00780559|726290|P2|STARTED|Overall Study||40
300599|NCT00780559|726291|P1|STARTED|Overall Study||32
300600|NCT00780494|726305|P1|NOT COMPLETED|Overall Study||0
300601|NCT00780494|726305|P1|COMPLETED|Overall Study||35
300602|NCT00780494|726305|P1|STARTED|Overall Study||35
300603|NCT00780481|726314|P1|NOT COMPLETED|Overall Study||0
300604|NCT00780481|726314|P1|COMPLETED|Overall Study||13
300605|NCT00780481|726314|P1|STARTED|Overall Study||13
300606|NCT00780455|726323|P2|NOT COMPLETED|Overall Study||0
300607|NCT00780455|726324|P1|NOT COMPLETED|Overall Study||0
300608|NCT00780455|726323|P2|COMPLETED|Overall Study||2
300609|NCT00780455|726324|P1|COMPLETED|Overall Study||2
300610|NCT00780455|726323|P2|STARTED|Overall Study||2
300611|NCT00780455|726324|P1|STARTED|Overall Study||2
300612|NCT00780442|726350|P2|NOT COMPLETED|Overall Study||0
300613|NCT00780442|726351|P1|NOT COMPLETED|Overall Study||0
300614|NCT00780442|726350|P2|COMPLETED|Overall Study||15
300615|NCT00780442|726351|P1|COMPLETED|Overall Study||12
300616|NCT00780442|726350|P2|STARTED|Overall Study||15
300617|NCT00780442|726351|P1|STARTED|Overall Study||12
300618|NCT00780416|726359|P2|NOT COMPLETED|Overall Study||9
300619|NCT00780416|726360|P1|NOT COMPLETED|Overall Study||12
300620|NCT00780416|726359|P2|COMPLETED|Overall Study||54
300621|NCT00780416|726360|P1|COMPLETED|Overall Study||114
300622|NCT00780416|726359|P2|STARTED|Overall Study||63
300623|NCT00780416|726360|P1|STARTED|Overall Study||126
300624|NCT00780403|726366|P2|NOT COMPLETED|Second Intervention||0
300625|NCT00780403|726367|P1|NOT COMPLETED|Second Intervention||0
300626|NCT00780403|726366|P2|COMPLETED|Second Intervention||111
300627|NCT00780403|726367|P1|COMPLETED|Second Intervention||109
300628|NCT00780403|726366|P2|STARTED|Second Intervention||111
300629|NCT00780403|726367|P1|STARTED|Second Intervention||109
300630|NCT00780403|726366|P2|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
300631|NCT00780403|726367|P1|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
300632|NCT00780403|726366|P2|COMPLETED|Interval Between Doses (8-10 Minutes)||111
300633|NCT00780403|726367|P1|COMPLETED|Interval Between Doses (8-10 Minutes)||109
300634|NCT00780403|726366|P2|STARTED|Interval Between Doses (8-10 Minutes)||111
300635|NCT00780403|726367|P1|STARTED|Interval Between Doses (8-10 Minutes)||109
300636|NCT00780403|726366|P2|NOT COMPLETED|First Intervention||0
300637|NCT00780403|726367|P1|NOT COMPLETED|First Intervention||0
300638|NCT00780403|726366|P2|COMPLETED|First Intervention||111
300639|NCT00780403|726367|P1|COMPLETED|First Intervention||109
300640|NCT00780403|726366|P2|STARTED|First Intervention||111
300641|NCT00780403|726367|P1|STARTED|First Intervention||109
300642|NCT00780338|726376|P2|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||5
300643|NCT00780338|726377|P1|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||13
300644|NCT00780338|726376|P2|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||159
300645|NCT00780338|726377|P1|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||156
300646|NCT00780338|726376|P2|STARTED|Mid to Post (1 Year; 2 Years in Total)||164
300647|NCT00780338|726377|P1|STARTED|Mid to Post (1 Year; 2 Years in Total)||169
300648|NCT00780338|726376|P2|NOT COMPLETED|Baseline to Mid (1 Year)||38
300649|NCT00780338|726377|P1|NOT COMPLETED|Baseline to Mid (1 Year)||5
300650|NCT00780338|726376|P2|COMPLETED|Baseline to Mid (1 Year)||164
300651|NCT00780338|726377|P1|COMPLETED|Baseline to Mid (1 Year)||169
300652|NCT00780338|726376|P2|STARTED|Baseline to Mid (1 Year)||202
300653|NCT00780338|726377|P1|STARTED|Baseline to Mid (1 Year)||174
300654|NCT00780273|726405|P1|NOT COMPLETED|Overall Study||2
300655|NCT00780273|726405|P1|COMPLETED|Overall Study||17
300656|NCT00780273|726405|P1|STARTED|Overall Study||19
300657|NCT00780234|726416|P2|NOT COMPLETED|Overall Study||8
300658|NCT00780234|726417|P1|NOT COMPLETED|Overall Study||8
300659|NCT00780234|726416|P2|COMPLETED|Overall Study||37
300660|NCT00780234|726417|P1|COMPLETED|Overall Study||39
300661|NCT00780234|726416|P2|STARTED|Overall Study||45
300662|NCT00780234|726417|P1|STARTED|Overall Study||47
300663|NCT00780208|726423|P1|NOT COMPLETED|Overall Study||6
300664|NCT00780208|726423|P1|COMPLETED|Overall Study||8
300665|NCT00780208|726423|P1|STARTED|Overall Study||14
300666|NCT00780143|726428|P1|NOT COMPLETED|Overall Study||3
300667|NCT00780143|726428|P1|COMPLETED|Overall Study||0
300668|NCT00780143|726428|P1|STARTED|Overall Study||3
300669|NCT00780026|726436|P2|NOT COMPLETED|Overall Study||0
300670|NCT00780026|726437|P1|NOT COMPLETED|Overall Study||0
300671|NCT00780026|726436|P2|COMPLETED|Overall Study||50
300672|NCT00780026|726437|P1|COMPLETED|Overall Study||50
300673|NCT00780026|726436|P2|STARTED|Overall Study||50
300674|NCT00780026|726437|P1|STARTED|Overall Study||50
300675|NCT00779909|726459|P4|NOT COMPLETED|Overall Study||1
300676|NCT00779909|726460|P3|NOT COMPLETED|Overall Study||0
300677|NCT00779909|726461|P2|NOT COMPLETED|Overall Study||1
300678|NCT00779909|726462|P1|NOT COMPLETED|Overall Study||1
300679|NCT00779909|726459|P4|COMPLETED|Overall Study||7
300680|NCT00779909|726460|P3|COMPLETED|Overall Study||8
300681|NCT00779909|726461|P2|COMPLETED|Overall Study||8
300682|NCT00779909|726462|P1|COMPLETED|Overall Study||9
300683|NCT00779909|726459|P4|STARTED|Overall Study||8
300684|NCT00779909|726460|P3|STARTED|Overall Study||8
300685|NCT00779909|726461|P2|STARTED|Overall Study||9
300686|NCT00779909|726462|P1|STARTED|Overall Study||10
300687|NCT00779870|726507|P3|NOT COMPLETED|Overall Study||0
300688|NCT00779870|726508|P2|NOT COMPLETED|Overall Study||0
300689|NCT00779870|726509|P1|NOT COMPLETED|Overall Study||0
300690|NCT00779870|726507|P3|COMPLETED|Overall Study||7
300691|NCT00779870|726508|P2|COMPLETED|Overall Study||6
300692|NCT00779870|726509|P1|COMPLETED|Overall Study||5
300693|NCT00779870|726507|P3|STARTED|Overall Study||7
300694|NCT00779870|726508|P2|STARTED|Overall Study||6
300695|NCT00779870|726509|P1|STARTED|Overall Study||5
300696|NCT00779857|726526|P1|NOT COMPLETED|Overall Study||6
300697|NCT00779857|726526|P1|COMPLETED|Overall Study|12 Month Post procedure, 64 subjects available for evaluation|64
300698|NCT00779857|726526|P1|3 Month Post Procedure|Overall Study|3 month follow-up, 65 of the subjects were available for evaluation.|65
300699|NCT00779857|726526|P1|30 Day Post Procedure|Overall Study|2 missed Visit|68
300700|NCT00779857|726526|P1|STARTED|Overall Study|70 patients treated|70
300701|NCT00779779|726531|P1|NOT COMPLETED|Overall Study||24
300702|NCT00779779|726531|P1|COMPLETED|Overall Study||498
300703|NCT00779779|726531|P1|STARTED|Overall Study||522
300704|NCT00779766|726540|P2|NOT COMPLETED|Month 72||189
300705|NCT00779766|726541|P1|NOT COMPLETED|Month 72||185
300706|NCT00779766|726540|P2|COMPLETED|Month 72||2158
300707|NCT00779766|726541|P1|COMPLETED|Month 72||2134
300708|NCT00779766|726540|P2|STARTED|Month 72||2347
300709|NCT00779766|726541|P1|STARTED|Month 72||2319
300710|NCT00779766|726540|P2|NOT COMPLETED|Month 48||168
300711|NCT00779766|726541|P1|NOT COMPLETED|Month 48||174
300712|NCT00779766|726540|P2|COMPLETED|Month 48||2559
300713|NCT00779766|726541|P1|COMPLETED|Month 48||2529
300714|NCT00779766|726540|P2|STARTED|Month 48||2727
300715|NCT00779766|726541|P1|STARTED|Month 48||2703
300716|NCT00779766|726540|P2|NOT COMPLETED|Month 24||332
300717|NCT00779766|726541|P1|NOT COMPLETED|Month 24||332
300718|NCT00779766|726540|P2|COMPLETED|Month 24||2693
300719|NCT00779766|726541|P1|COMPLETED|Month 24||2694
300720|NCT00779766|726540|P2|STARTED|Month 24||3025
300721|NCT00779766|726541|P1|STARTED|Month 24||3026
300722|NCT00779701|726625|P1|NOT COMPLETED|Overall Study||0
300723|NCT00779701|726625|P1|COMPLETED|Overall Study||27
300724|NCT00779701|726625|P1|STARTED|Overall Study||27
300725|NCT00779675|726629|P1|NOT COMPLETED|Extended Treatment Period||46
300726|NCT00779675|726629|P1|COMPLETED|Extended Treatment Period||147
300727|NCT00779675|726629|P1|STARTED|Extended Treatment Period|Clinical responders during the treatment period could enter the extended treatment period.|193
300728|NCT00779675|726629|P1|NOT COMPLETED|Treatment Period||332
300729|NCT00779675|726629|P1|COMPLETED|Treatment Period||328
300730|NCT00779675|726629|P1|STARTED|Treatment Period|One of the 660 participants did not receive study treatment.|660
300731|NCT00779584|726657|P9|NOT COMPLETED|Overall Study||2
300732|NCT00779584|726658|P8|NOT COMPLETED|Overall Study||3
300733|NCT00779584|726659|P7|NOT COMPLETED|Overall Study||8
300734|NCT00779584|726660|P6|NOT COMPLETED|Overall Study||6
300735|NCT00779584|726661|P5|NOT COMPLETED|Overall Study||7
300736|NCT00779584|726662|P4|NOT COMPLETED|Overall Study||6
300737|NCT00779584|726663|P3|NOT COMPLETED|Overall Study||7
300738|NCT00779584|726664|P2|NOT COMPLETED|Overall Study||3
300739|NCT00779584|726665|P1|NOT COMPLETED|Overall Study||3
300740|NCT00779584|726657|P9|COMPLETED|Overall Study||0
300741|NCT00779584|726658|P8|COMPLETED|Overall Study||0
300742|NCT00779584|726659|P7|COMPLETED|Overall Study||0
300743|NCT00779584|726660|P6|COMPLETED|Overall Study||0
300744|NCT00779584|726661|P5|COMPLETED|Overall Study||0
300745|NCT00779584|726662|P4|COMPLETED|Overall Study||0
300746|NCT00779584|726663|P3|COMPLETED|Overall Study||0
300747|NCT00779584|726664|P2|COMPLETED|Overall Study||0
300748|NCT00779584|726665|P1|COMPLETED|Overall Study||0
300749|NCT00779584|726657|P9|Treated|Overall Study||2
300750|NCT00779584|726658|P8|Treated|Overall Study||3
300751|NCT00779584|726659|P7|Treated|Overall Study||8
300752|NCT00779584|726660|P6|Treated|Overall Study||4
300753|NCT00779584|726661|P5|Treated|Overall Study||7
300754|NCT00779584|726662|P4|Treated|Overall Study||6
300755|NCT00779584|726663|P3|Treated|Overall Study||7
300756|NCT00779584|726664|P2|Treated|Overall Study||3
300757|NCT00779584|726665|P1|Treated|Overall Study||3
300758|NCT00779584|726657|P9|STARTED|Overall Study||2
300759|NCT00779584|726658|P8|STARTED|Overall Study||3
300760|NCT00779584|726659|P7|STARTED|Overall Study||8
300761|NCT00779584|726660|P6|STARTED|Overall Study||6
300762|NCT00779584|726661|P5|STARTED|Overall Study||7
300763|NCT00779584|726662|P4|STARTED|Overall Study||6
300764|NCT00779584|726663|P3|STARTED|Overall Study||7
300765|NCT00779584|726664|P2|STARTED|Overall Study||3
300766|NCT00779584|726665|P1|STARTED|Overall Study||3
300767|NCT00779558|726741|P2|NOT COMPLETED|Overall Study||7
300768|NCT00779558|726742|P1|NOT COMPLETED|Overall Study||4
300769|NCT00779558|726741|P2|COMPLETED|Overall Study||37
300770|NCT00779558|726742|P1|COMPLETED|Overall Study||53
300771|NCT00779558|726741|P2|STARTED|Overall Study||44
300772|NCT00779558|726742|P1|STARTED|Overall Study||57
300773|NCT00779506|726756|P1|NOT COMPLETED|Overall Study||29
300774|NCT00779506|726756|P1|COMPLETED|Overall Study||67
300775|NCT00779506|726756|P1|Withdrawal Treatment|Overall Study||27
300776|NCT00779506|726756|P1|Treatment Complete|Overall Study||67
300777|NCT00779506|726756|P1|MITT|Overall Study||89
300778|NCT00779506|726756|P1|Assigned|Overall Study||94
300779|NCT00779506|726756|P1|Screen Failed|Overall Study||2
300780|NCT00779506|726756|P1|Enrolled|Overall Study||96
300781|NCT00779506|726756|P1|STARTED|Overall Study||96
300782|NCT00779467|726770|P4|NOT COMPLETED|Overall Study||19
300783|NCT00779467|726771|P3|NOT COMPLETED|Overall Study||10
300784|NCT00779467|726772|P2|NOT COMPLETED|Overall Study||5
300785|NCT00779467|726773|P1|NOT COMPLETED|Overall Study||15
300786|NCT00779467|726770|P4|COMPLETED|Overall Study||35
300787|NCT00779467|726771|P3|COMPLETED|Overall Study||38
300788|NCT00779467|726772|P2|COMPLETED|Overall Study||40
300789|NCT00779467|726773|P1|COMPLETED|Overall Study||38
300790|NCT00779467|726770|P4|STARTED|Overall Study||54
300791|NCT00779467|726771|P3|STARTED|Overall Study||48
300792|NCT00779467|726772|P2|STARTED|Overall Study||45
300793|NCT00779467|726773|P1|STARTED|Overall Study||53
300794|NCT00779402|726813|P2|NOT COMPLETED|Long-term Follow-up||6
300795|NCT00779402|726814|P1|NOT COMPLETED|Long-term Follow-up||21
300796|NCT00779402|726813|P2|COMPLETED|Long-term Follow-up||7
300797|NCT00779402|726814|P1|COMPLETED|Long-term Follow-up||20
300798|NCT00779402|726813|P2|STARTED|Long-term Follow-up||13
300799|NCT00779402|726814|P1|STARTED|Long-term Follow-up||41
300800|NCT00779402|726813|P2|NOT COMPLETED|Surveillance Phase||31
300801|NCT00779402|726814|P1|NOT COMPLETED|Surveillance Phase||43
300802|NCT00779402|726813|P2|COMPLETED|Surveillance Phase||13
300803|NCT00779402|726814|P1|COMPLETED|Surveillance Phase||41
300804|NCT00779402|726813|P2|STARTED|Surveillance Phase||44
300805|NCT00779402|726814|P1|STARTED|Surveillance Phase||84
300806|NCT00779402|726813|P2|NOT COMPLETED|Treatment Phase 1||15
300807|NCT00779402|726814|P1|NOT COMPLETED|Treatment Phase 1||33
300808|NCT00779402|726813|P2|COMPLETED|Treatment Phase 1||44
300809|NCT00779402|726814|P1|COMPLETED|Treatment Phase 1||84
300810|NCT00779402|726813|P2|Received Booster Infusion|Treatment Phase 1||30
300811|NCT00779402|726814|P1|Received Booster Infusion|Treatment Phase 1||50
300812|NCT00779402|726813|P2|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||59
300813|NCT00779402|726814|P1|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||113
300814|NCT00779402|726813|P2|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||59
300815|NCT00779402|726814|P1|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||116
300816|NCT00779402|726813|P2|STARTED|Treatment Phase 1||59
300817|NCT00779402|726814|P1|STARTED|Treatment Phase 1||117
300818|NCT00779311|726827|P5|NOT COMPLETED|Overall Study||0
300819|NCT00779311|726828|P4|NOT COMPLETED|Overall Study||0
300820|NCT00779311|726829|P3|NOT COMPLETED|Overall Study||0
300821|NCT00779311|726830|P2|NOT COMPLETED|Overall Study||0
300822|NCT00779311|726831|P1|NOT COMPLETED|Overall Study||0
300823|NCT00779311|726827|P5|COMPLETED|Overall Study||0
300824|NCT00779311|726828|P4|COMPLETED|Overall Study||0
300825|NCT00779311|726829|P3|COMPLETED|Overall Study||0
300826|NCT00779311|726830|P2|COMPLETED|Overall Study||0
300827|NCT00779311|726831|P1|COMPLETED|Overall Study||8
300828|NCT00779311|726827|P5|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
300829|NCT00779311|726828|P4|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
300830|NCT00779311|726829|P3|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
300831|NCT00779311|726830|P2|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
300832|NCT00779311|726831|P1|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||6
300833|NCT00779311|726827|P5|STARTED|Overall Study||0
300834|NCT00779311|726828|P4|STARTED|Overall Study||0
300835|NCT00779311|726829|P3|STARTED|Overall Study||0
300836|NCT00779311|726830|P2|STARTED|Overall Study||0
300837|NCT00779311|726831|P1|STARTED|Overall Study|2 of 6 patients were not evaluable for DLT assessment and were replaced for a total of 8 enrolled.|8
300838|NCT00779285|726853|P1|NOT COMPLETED|Overall Study||0
300839|NCT00779285|726853|P1|COMPLETED|Overall Study||1
300840|NCT00779285|726853|P1|STARTED|Overall Study||1
300841|NCT00779259|726857|P1|NOT COMPLETED|Theophylline With Quinine||0
300842|NCT00779259|726857|P1|COMPLETED|Theophylline With Quinine||22
300843|NCT00779259|726857|P1|STARTED|Theophylline With Quinine||22
300844|NCT00779259|726857|P1|NOT COMPLETED|Quinine Alone||2
300845|NCT00779259|726857|P1|COMPLETED|Quinine Alone||22
300846|NCT00779259|726857|P1|STARTED|Quinine Alone||24
300847|NCT00779259|726857|P1|NOT COMPLETED|4 Day Washout Period||0
300848|NCT00779259|726857|P1|COMPLETED|4 Day Washout Period||24
300849|NCT00779259|726857|P1|STARTED|4 Day Washout Period||24
300850|NCT00779259|726857|P1|NOT COMPLETED|Theophylline Alone||0
300851|NCT00779259|726857|P1|COMPLETED|Theophylline Alone||24
300852|NCT00779259|726857|P1|STARTED|Theophylline Alone||24
300853|NCT00779246|726878|P2|NOT COMPLETED|Overall Study||53
300854|NCT00779246|726879|P1|NOT COMPLETED|Overall Study||33
300855|NCT00779246|726878|P2|COMPLETED|Overall Study||715
300856|NCT00779246|726879|P1|COMPLETED|Overall Study||717
300857|NCT00779246|726878|P2|STARTED|Overall Study||768
300858|NCT00779246|726879|P1|STARTED|Overall Study||750
300859|NCT00779155|726891|P2|NOT COMPLETED|Overall Study||0
300860|NCT00779155|726892|P1|NOT COMPLETED|Overall Study||0
300861|NCT00779155|726891|P2|COMPLETED|Overall Study||6
300862|NCT00779155|726892|P1|COMPLETED|Overall Study||6
300863|NCT00779155|726891|P2|STARTED|Overall Study||6
300864|NCT00779155|726892|P1|STARTED|Overall Study||6
300865|NCT00779142|726898|P1|NOT COMPLETED|Overall Study||3
300866|NCT00779142|726898|P1|COMPLETED|Overall Study|Only 2 patients were actually enrolled.|2
300867|NCT00779142|726898|P1|STARTED|Overall Study|5 patients signed consent and were screened.|5
300868|NCT00779116|726904|P2|NOT COMPLETED|Second Intervention||0
300869|NCT00779116|726905|P1|NOT COMPLETED|Second Intervention||0
300870|NCT00779116|726904|P2|COMPLETED|Second Intervention||108
300871|NCT00779116|726905|P1|COMPLETED|Second Intervention||109
300872|NCT00779116|726904|P2|STARTED|Second Intervention||108
300873|NCT00779116|726905|P1|STARTED|Second Intervention||109
300874|NCT00779116|726904|P2|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
300875|NCT00779116|726905|P1|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
300876|NCT00779116|726904|P2|COMPLETED|Interval Between Doses (8-10 Minutes)||108
300877|NCT00779116|726905|P1|COMPLETED|Interval Between Doses (8-10 Minutes)||109
300878|NCT00779116|726904|P2|STARTED|Interval Between Doses (8-10 Minutes)||108
300879|NCT00779116|726905|P1|STARTED|Interval Between Doses (8-10 Minutes)||109
300880|NCT00779116|726904|P2|NOT COMPLETED|First Intervention||0
300881|NCT00779116|726905|P1|NOT COMPLETED|First Intervention||0
300882|NCT00779116|726904|P2|COMPLETED|First Intervention||108
300883|NCT00779116|726905|P1|COMPLETED|First Intervention||109
300884|NCT00779116|726904|P2|STARTED|First Intervention||108
300885|NCT00779116|726905|P1|STARTED|First Intervention||109
300886|NCT00779038|726912|P1|NOT COMPLETED|Overall Study||13
300887|NCT00779038|726912|P1|COMPLETED|Overall Study||0
300888|NCT00779038|726912|P1|STARTED|Overall Study||13
300889|NCT00779025|726921|P1|NOT COMPLETED|Overall Study||1
300890|NCT00779025|726921|P1|COMPLETED|Overall Study||81
300891|NCT00779025|726921|P1|STARTED|Overall Study||82
300892|NCT00778999|726932|P2|NOT COMPLETED|Overall Study||34
300893|NCT00778999|726933|P1|NOT COMPLETED|Overall Study||28
300894|NCT00778999|726932|P2|COMPLETED|Overall Study||185
300895|NCT00778999|726933|P1|COMPLETED|Overall Study||195
300896|NCT00778999|726932|P2|STARTED|Overall Study||219
300897|NCT00778999|726933|P1|STARTED|Overall Study||223
300898|NCT00778921|726942|P3|NOT COMPLETED|Overall Study||28
300899|NCT00778921|726943|P2|NOT COMPLETED|Overall Study||19
300900|NCT00778921|726944|P1|NOT COMPLETED|Overall Study||18
300901|NCT00778921|726942|P3|COMPLETED|Overall Study||255
300902|NCT00778921|726943|P2|COMPLETED|Overall Study||266
300903|NCT00778921|726944|P1|COMPLETED|Overall Study||261
300904|NCT00778921|726942|P3|STARTED|Overall Study||283
300905|NCT00778921|726943|P2|STARTED|Overall Study||285
300906|NCT00778921|726944|P1|STARTED|Overall Study||279
300907|NCT00778895|726961|P3|NOT COMPLETED|ESFU Phase||2
300908|NCT00778895|726962|P2|NOT COMPLETED|ESFU Phase||12
300909|NCT00778895|726963|P1|NOT COMPLETED|ESFU Phase||11
300910|NCT00778895|726961|P3|COMPLETED|ESFU Phase||41
300911|NCT00778895|726962|P2|COMPLETED|ESFU Phase||155
300912|NCT00778895|726963|P1|COMPLETED|ESFU Phase||153
300913|NCT00778895|726961|P3|STARTED|ESFU Phase||43
300914|NCT00778895|726962|P2|STARTED|ESFU Phase||167
300915|NCT00778895|726963|P1|STARTED|ESFU Phase||164
300916|NCT00778895|726961|P3|NOT COMPLETED|Active Phase||0
300917|NCT00778895|726962|P2|NOT COMPLETED|Active Phase||6
300918|NCT00778895|726963|P1|NOT COMPLETED|Active Phase||7
300919|NCT00778895|726961|P3|COMPLETED|Active Phase||43
300920|NCT00778895|726962|P2|COMPLETED|Active Phase||161
300921|NCT00778895|726963|P1|COMPLETED|Active Phase||157
300922|NCT00778895|726961|P3|STARTED|Active Phase||43
300923|NCT00778895|726962|P2|STARTED|Active Phase||167
300924|NCT00778895|726963|P1|STARTED|Active Phase||164
300925|NCT00778869|727001|P1|NOT COMPLETED|Overall Study||0
300926|NCT00778869|727001|P1|COMPLETED|Overall Study||10
300927|NCT00778869|727001|P1|STARTED|Overall Study||10
300928|NCT00778830|727007|P2|NOT COMPLETED|Overall Study||1
300929|NCT00778830|727008|P1|NOT COMPLETED|Overall Study||0
300930|NCT00778830|727007|P2|COMPLETED|Overall Study||187
300931|NCT00778830|727008|P1|COMPLETED|Overall Study||101
300932|NCT00778830|727007|P2|STARTED|Overall Study||188
300933|NCT00778830|727008|P1|STARTED|Overall Study||101
300934|NCT00778817|727020|P1|NOT COMPLETED|Overall Study||4
300935|NCT00778817|727020|P1|COMPLETED|Overall Study||16
300936|NCT00778817|727020|P1|STARTED|Overall Study||20
300937|NCT00778648|727037|P2|NOT COMPLETED|Overall Study||5
300938|NCT00778648|727038|P1|NOT COMPLETED|Overall Study||9
300939|NCT00778648|727037|P2|COMPLETED|Overall Study||266
300940|NCT00778648|727038|P1|COMPLETED|Overall Study||263
300941|NCT00778648|727037|P2|STARTED|Overall Study||271
300942|NCT00778648|727038|P1|STARTED|Overall Study||272
300943|NCT00778622|727047|P3|NOT COMPLETED|Overall Study||15
300944|NCT00778622|727048|P2|NOT COMPLETED|Overall Study||15
300945|NCT00778622|727049|P1|NOT COMPLETED|Overall Study||16
300946|NCT00778622|727047|P3|COMPLETED|Overall Study||109
300947|NCT00778622|727048|P2|COMPLETED|Overall Study||107
300948|NCT00778622|727049|P1|COMPLETED|Overall Study||109
300949|NCT00778622|727047|P3|STARTED|Overall Study||124
300950|NCT00778622|727048|P2|STARTED|Overall Study||122
300951|NCT00778622|727049|P1|STARTED|Overall Study||125
300952|NCT00778375|727102|P1|NOT COMPLETED|Overall Study||3
300953|NCT00778375|727102|P1|COMPLETED|Overall Study||119
300954|NCT00778375|727102|P1|STARTED|Overall Study||122
300955|NCT00778336|727116|P4|NOT COMPLETED|3 Month Follow Up||0
300956|NCT00778336|727117|P3|NOT COMPLETED|3 Month Follow Up||5
300957|NCT00778336|727118|P2|NOT COMPLETED|3 Month Follow Up||23
300958|NCT00778336|727119|P1|NOT COMPLETED|3 Month Follow Up||23
300959|NCT00778336|727116|P4|COMPLETED|3 Month Follow Up||12
300960|NCT00778336|727117|P3|COMPLETED|3 Month Follow Up||65
300961|NCT00778336|727118|P2|COMPLETED|3 Month Follow Up||144
300962|NCT00778336|727119|P1|COMPLETED|3 Month Follow Up||169
300963|NCT00778336|727116|P4|STARTED|3 Month Follow Up||12
300964|NCT00778336|727117|P3|STARTED|3 Month Follow Up||70
300965|NCT00778336|727118|P2|STARTED|3 Month Follow Up||167
300966|NCT00778336|727119|P1|STARTED|3 Month Follow Up||192
300967|NCT00778336|727116|P4|NOT COMPLETED|Index Procedure-Discharge||0
300968|NCT00778336|727117|P3|NOT COMPLETED|Index Procedure-Discharge||2
300969|NCT00778336|727118|P2|NOT COMPLETED|Index Procedure-Discharge||3
300970|NCT00778336|727119|P1|NOT COMPLETED|Index Procedure-Discharge||6
300971|NCT00778336|727116|P4|COMPLETED|Index Procedure-Discharge||12
300972|NCT00778336|727117|P3|COMPLETED|Index Procedure-Discharge||70
300973|NCT00778336|727118|P2|COMPLETED|Index Procedure-Discharge||167
300974|NCT00778336|727119|P1|COMPLETED|Index Procedure-Discharge||192
300975|NCT00778336|727116|P4|STARTED|Index Procedure-Discharge||12
300976|NCT00778336|727117|P3|STARTED|Index Procedure-Discharge||72
300977|NCT00778336|727118|P2|STARTED|Index Procedure-Discharge||170
300978|NCT00778336|727119|P1|STARTED|Index Procedure-Discharge||198
300979|NCT00778310|727139|P2|NOT COMPLETED|Overall Study||0
300980|NCT00778310|727140|P1|NOT COMPLETED|Overall Study||0
300981|NCT00778310|727139|P2|COMPLETED|Overall Study||26
300982|NCT00778310|727140|P1|COMPLETED|Overall Study||17
300983|NCT00778310|727139|P2|Usable Data|Overall Study||21
300984|NCT00778310|727140|P1|Usable Data|Overall Study||14
300985|NCT00778310|727139|P2|STARTED|Overall Study||26
300986|NCT00778310|727140|P1|STARTED|Overall Study||17
300987|NCT00778258|727157|P9|NOT COMPLETED|Overall Study||4
300988|NCT00778258|727158|P8|NOT COMPLETED|Overall Study||15
300989|NCT00778258|727159|P7|NOT COMPLETED|Overall Study||15
300990|NCT00778258|727160|P6|NOT COMPLETED|Overall Study||10
300991|NCT00778258|727161|P5|NOT COMPLETED|Overall Study||0
300992|NCT00778258|727162|P4|NOT COMPLETED|Overall Study||3
300993|NCT00778258|727163|P3|NOT COMPLETED|Overall Study||10
300994|NCT00778258|727164|P2|NOT COMPLETED|Overall Study||2
300995|NCT00778258|727165|P1|NOT COMPLETED|Overall Study||7
300996|NCT00778258|727157|P9|COMPLETED|Overall Study||6
300997|NCT00778258|727158|P8|COMPLETED|Overall Study||26
300998|NCT00778258|727159|P7|COMPLETED|Overall Study||19
300999|NCT00778258|727160|P6|COMPLETED|Overall Study||13
301000|NCT00778258|727161|P5|COMPLETED|Overall Study||6
301001|NCT00778258|727162|P4|COMPLETED|Overall Study||12
301002|NCT00778258|727163|P3|COMPLETED|Overall Study||10
301003|NCT00778258|727164|P2|COMPLETED|Overall Study||3
301004|NCT00778258|727165|P1|COMPLETED|Overall Study||9
301005|NCT00778258|727157|P9|STARTED|Overall Study||10
301006|NCT00778258|727158|P8|STARTED|Overall Study||41
301007|NCT00778258|727159|P7|STARTED|Overall Study||34
301008|NCT00778258|727160|P6|STARTED|Overall Study||23
301009|NCT00778258|727161|P5|STARTED|Overall Study||6
301010|NCT00778258|727162|P4|STARTED|Overall Study||15
301011|NCT00778258|727163|P3|STARTED|Overall Study||20
301012|NCT00778258|727164|P2|STARTED|Overall Study||5
301013|NCT00778258|727165|P1|STARTED|Overall Study||16
301014|NCT00778167|727220|P3|NOT COMPLETED|Overall Study||0
301015|NCT00778167|727221|P2|NOT COMPLETED|Overall Study||0
301016|NCT00778167|727222|P1|NOT COMPLETED|Overall Study||0
301017|NCT00778167|727220|P3|COMPLETED|Overall Study||4
301018|NCT00778167|727221|P2|COMPLETED|Overall Study||8
301019|NCT00778167|727222|P1|COMPLETED|Overall Study||6
301020|NCT00778167|727220|P3|STARTED|Overall Study||4
301021|NCT00778167|727221|P2|STARTED|Overall Study||8
301022|NCT00778167|727222|P1|STARTED|Overall Study||6
301023|NCT00778102|727232|P2|NOT COMPLETED|Overall Study||22
301024|NCT00778102|727233|P1|NOT COMPLETED|Overall Study||21
301025|NCT00778102|727232|P2|COMPLETED|Overall Study||19
301026|NCT00778102|727233|P1|COMPLETED|Overall Study||18
301027|NCT00778102|727232|P2|STARTED|Overall Study||41
301028|NCT00778102|727233|P1|STARTED|Overall Study||39
301029|NCT00777946|727268|P3|NOT COMPLETED|Overall Study||16
301030|NCT00777946|727269|P2|NOT COMPLETED|Overall Study||6
301031|NCT00777946|727270|P1|NOT COMPLETED|Overall Study||21
301032|NCT00777946|727268|P3|COMPLETED|Overall Study||244
301033|NCT00777946|727269|P2|COMPLETED|Overall Study||271
301034|NCT00777946|727270|P1|COMPLETED|Overall Study||262
301035|NCT00777946|727268|P3|Safety & Full Analysis Sets|Overall Study||260
301036|NCT00777946|727269|P2|Safety & Full Analysis Sets|Overall Study||276
301037|NCT00777946|727270|P1|Safety & Full Analysis Sets|Overall Study||282
301038|NCT00777946|727268|P3|STARTED|Overall Study||260
301039|NCT00777946|727269|P2|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 5 mg group was randomized in error.|277
301040|NCT00777946|727270|P1|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 10 mg group was randomized in error.|283
301041|NCT00777855|727293|P2|NOT COMPLETED|Second Intervention||0
301042|NCT00777855|727294|P1|NOT COMPLETED|Second Intervention||0
301043|NCT00777855|727293|P2|COMPLETED|Second Intervention||5
301044|NCT00777855|727294|P1|COMPLETED|Second Intervention||5
301045|NCT00777855|727293|P2|STARTED|Second Intervention||5
301046|NCT00777855|727294|P1|STARTED|Second Intervention||5
301047|NCT00777855|727293|P2|NOT COMPLETED|Washout Period (>= 14 Days)||0
301048|NCT00777855|727294|P1|NOT COMPLETED|Washout Period (>= 14 Days)||0
301049|NCT00777855|727293|P2|COMPLETED|Washout Period (>= 14 Days)||5
301050|NCT00777855|727294|P1|COMPLETED|Washout Period (>= 14 Days)||5
301051|NCT00777855|727293|P2|STARTED|Washout Period (>= 14 Days)||5
301052|NCT00777855|727294|P1|STARTED|Washout Period (>= 14 Days)||5
301053|NCT00777855|727293|P2|NOT COMPLETED|First Intervention||0
301054|NCT00777855|727294|P1|NOT COMPLETED|First Intervention||0
301055|NCT00777855|727293|P2|COMPLETED|First Intervention||5
301056|NCT00777855|727294|P1|COMPLETED|First Intervention||5
301057|NCT00777855|727293|P2|STARTED|First Intervention||5
301058|NCT00777855|727294|P1|STARTED|First Intervention||5
301059|NCT00777803|727305|P2|NOT COMPLETED|Overall Study||7
301060|NCT00777803|727306|P1|NOT COMPLETED|Overall Study||15
301061|NCT00777803|727305|P2|COMPLETED|Overall Study||90
301062|NCT00777803|727306|P1|COMPLETED|Overall Study||269
301063|NCT00777803|727305|P2|STARTED|Overall Study||97
301064|NCT00777803|727306|P1|STARTED|Overall Study||284
301065|NCT00777790|727341|P3|NOT COMPLETED|Overall Study||0
301066|NCT00777790|727342|P2|NOT COMPLETED|Overall Study||0
301067|NCT00777790|727343|P1|NOT COMPLETED|Overall Study||0
301068|NCT00777790|727341|P3|COMPLETED|Overall Study||88
301069|NCT00777790|727342|P2|COMPLETED|Overall Study||77
301070|NCT00777790|727343|P1|COMPLETED|Overall Study||76
301071|NCT00777790|727341|P3|STARTED|Overall Study||88
301072|NCT00777790|727342|P2|STARTED|Overall Study||77
301073|NCT00777790|727343|P1|STARTED|Overall Study||76
301074|NCT00777764|727353|P2|NOT COMPLETED|Overall Study||1
301075|NCT00777764|727354|P1|NOT COMPLETED|Overall Study||0
301076|NCT00777764|727353|P2|COMPLETED|Overall Study||29
301077|NCT00777764|727354|P1|COMPLETED|Overall Study||30
301078|NCT00777764|727353|P2|STARTED|Overall Study||30
301079|NCT00777764|727354|P1|STARTED|Overall Study||30
301080|NCT00777634|727366|P2|NOT COMPLETED|Overall Study||1
301081|NCT00777634|727367|P1|NOT COMPLETED|Overall Study||5
301082|NCT00777634|727366|P2|COMPLETED|Overall Study||133
301083|NCT00777634|727367|P1|COMPLETED|Overall Study||129
301084|NCT00777634|727366|P2|STARTED|Overall Study||134
301085|NCT00777634|727367|P1|STARTED|Overall Study||134
301086|NCT00777608|727385|P2|NOT COMPLETED|Overall Study||6
301087|NCT00777608|727386|P1|NOT COMPLETED|Overall Study||4
301088|NCT00777608|727385|P2|COMPLETED|Overall Study||47
301089|NCT00777608|727386|P1|COMPLETED|Overall Study||49
301090|NCT00777608|727385|P2|STARTED|Overall Study||53
301091|NCT00777608|727386|P1|STARTED|Overall Study||53
301092|NCT00777556|727396|P1|NOT COMPLETED|Overall Study||66
301093|NCT00777556|727396|P1|COMPLETED|Overall Study|Completed all 3 follow-up visits|277
301094|NCT00777556|727396|P1|Used Product|Overall Study||297
301095|NCT00777556|727396|P1|Safety Population|Overall Study|Participants who used the product; two were given product in error (inappropriately self-selected)|299
301096|NCT00777556|727396|P1|Dispensed Product|Overall Study||307
301097|NCT00777556|727396|P1|STARTED|Overall Study|Enrolled; signed informed consent|343
301098|NCT00777491|727405|P2|NOT COMPLETED|Overall Study||2
301099|NCT00777491|727406|P1|NOT COMPLETED|Overall Study||2
301100|NCT00777491|727405|P2|COMPLETED|Overall Study||33
301101|NCT00777491|727406|P1|COMPLETED|Overall Study||33
301102|NCT00777491|727405|P2|Has 3 Year AUASI Data|Overall Study||6
301103|NCT00777491|727406|P1|Has 3 Year AUASI Data|Overall Study||6
301104|NCT00777491|727405|P2|Has Adverse Event Data (Late)|Overall Study||31
301105|NCT00777491|727406|P1|Has Adverse Event Data (Late)|Overall Study||32
301106|NCT00777491|727405|P2|Has Adverse Event Data (Treatment)|Overall Study||33
301107|NCT00777491|727406|P1|Has Adverse Event Data (Treatment)|Overall Study||33
301108|NCT00777491|727405|P2|Started Adjuvant Therapy|Overall Study||31
301109|NCT00777491|727406|P1|Started Adjuvant Therapy|Overall Study||32
301110|NCT00777491|727405|P2|Started Consolidation Therapy|Overall Study||25
301111|NCT00777491|727406|P1|Started Consolidation Therapy|Overall Study||29
301112|NCT00777491|727405|P2|Started Induction Therapy|Overall Study||33
301113|NCT00777491|727406|P1|Started Induction Therapy|Overall Study||33
301114|NCT00777491|727405|P2|Has 3-year Efficacy Data|Overall Study||25
301115|NCT00777491|727406|P1|Has 3-year Efficacy Data|Overall Study||27
301116|NCT00777491|727405|P2|Eligible|Overall Study||33
301117|NCT00777491|727406|P1|Eligible|Overall Study||33
301118|NCT00777491|727405|P2|STARTED|Overall Study||35
301119|NCT00777491|727406|P1|STARTED|Overall Study||35
301120|NCT00777335|727426|P2|NOT COMPLETED|Overall Study||0
301121|NCT00777335|727427|P1|NOT COMPLETED|Overall Study||0
301122|NCT00777335|727426|P2|COMPLETED|Overall Study||2
301123|NCT00777335|727427|P1|COMPLETED|Overall Study||2
301124|NCT00777335|727426|P2|STARTED|Overall Study||2
301125|NCT00777335|727427|P1|STARTED|Overall Study||2
301126|NCT00777296|727439|P4|NOT COMPLETED|Overall Study||1
301127|NCT00777296|727440|P3|NOT COMPLETED|Overall Study||2
301128|NCT00777296|727441|P2|NOT COMPLETED|Overall Study||1
301129|NCT00777296|727442|P1|NOT COMPLETED|Overall Study||1
301130|NCT00777296|727439|P4|COMPLETED|Overall Study||10
301131|NCT00777296|727440|P3|COMPLETED|Overall Study||21
301132|NCT00777296|727441|P2|COMPLETED|Overall Study||10
301133|NCT00777296|727442|P1|COMPLETED|Overall Study||20
301134|NCT00777296|727439|P4|STARTED|Overall Study||11
301135|NCT00777296|727440|P3|STARTED|Overall Study||23
301136|NCT00777296|727441|P2|STARTED|Overall Study||11
301137|NCT00777296|727442|P1|STARTED|Overall Study||21
301138|NCT00777257|727484|P3|NOT COMPLETED|Overall Study||9
301139|NCT00777257|727485|P2|NOT COMPLETED|Overall Study||12
301140|NCT00777257|727486|P1|NOT COMPLETED|Overall Study||11
301141|NCT00777257|727484|P3|COMPLETED|Overall Study||442
301142|NCT00777257|727485|P2|COMPLETED|Overall Study||438
301143|NCT00777257|727486|P1|COMPLETED|Overall Study||433
301144|NCT00777257|727484|P3|STARTED|Overall Study||451
301145|NCT00777257|727485|P2|STARTED|Overall Study||450
301146|NCT00777257|727486|P1|STARTED|Overall Study||444
301147|NCT00777205|727505|P2|NOT COMPLETED|Overall Study||71
301148|NCT00777205|727506|P1|NOT COMPLETED|Overall Study||31
301149|NCT00777205|727505|P2|COMPLETED|Overall Study||129
301150|NCT00777205|727506|P1|COMPLETED|Overall Study||212
301151|NCT00777205|727505|P2|Intervention Interruption|Overall Study|56 participants excluded from main analyses due to 2 mos interruption in study intervention|56
301152|NCT00777205|727506|P1|Intervention Interruption|Overall Study||0
301153|NCT00777205|727505|P2|STARTED|Overall Study||200
301154|NCT00777205|727506|P1|STARTED|Overall Study||243
301155|NCT00777179|727522|P2|NOT COMPLETED|Overall Study||0
301156|NCT00777179|727523|P1|NOT COMPLETED|Overall Study||0
301157|NCT00777179|727522|P2|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|42
301158|NCT00777179|727523|P1|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|75
301159|NCT00777179|727522|P2|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|42
301160|NCT00777179|727523|P1|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|75
301161|NCT00777153|727540|P3|NOT COMPLETED|Overall Study||37
301162|NCT00777153|727541|P2|NOT COMPLETED|Overall Study||83
301163|NCT00777153|727542|P1|NOT COMPLETED|Overall Study||90
301164|NCT00777153|727540|P3|COMPLETED|Overall Study||28
301165|NCT00777153|727541|P2|COMPLETED|Overall Study||46
301166|NCT00777153|727542|P1|COMPLETED|Overall Study||41
301167|NCT00777153|727540|P3|STARTED|Overall Study||65
301168|NCT00777153|727541|P2|STARTED|Overall Study||129
301169|NCT00777153|727542|P1|STARTED|Overall Study||131
301170|NCT00777101|727567|P2|NOT COMPLETED|Overall Study||51
301171|NCT00777101|727568|P1|NOT COMPLETED|Overall Study||62
301172|NCT00777101|727567|P2|COMPLETED|Overall Study||65
301173|NCT00777101|727568|P1|COMPLETED|Overall Study||55
301174|NCT00777101|727567|P2|Treated|Overall Study||115
301175|NCT00777101|727568|P1|Treated|Overall Study||116
301176|NCT00777101|727567|P2|STARTED|Overall Study||116
301177|NCT00777101|727568|P1|STARTED|Overall Study||117
301178|NCT00777088|727586|P1|NOT COMPLETED|Overall Study||1
301179|NCT00777088|727586|P1|COMPLETED|Overall Study||107
301180|NCT00777088|727586|P1|STARTED|Overall Study||108
301181|NCT00777062|727600|P2|NOT COMPLETED|Overall Study||5
301182|NCT00777062|727601|P1|NOT COMPLETED|Overall Study||3
301183|NCT00777062|727600|P2|COMPLETED|Overall Study||36
301184|NCT00777062|727601|P1|COMPLETED|Overall Study||36
301185|NCT00777062|727600|P2|STARTED|Overall Study||41
301186|NCT00777062|727601|P1|STARTED|Overall Study||39
301187|NCT00777049|727611|P2|NOT COMPLETED|Overall Study||1
301188|NCT00777049|727612|P1|NOT COMPLETED|Overall Study||1
301189|NCT00777049|727611|P2|COMPLETED|Overall Study||20
301190|NCT00777049|727612|P1|COMPLETED|Overall Study||32
301191|NCT00777049|727611|P2|STARTED|Overall Study||21
301192|NCT00777049|727612|P1|STARTED|Overall Study||33
301193|NCT00777036|727621|P3|NOT COMPLETED|Follow-Up||4
301194|NCT00777036|727622|P2|NOT COMPLETED|Follow-Up||8
301195|NCT00777036|727623|P1|NOT COMPLETED|Follow-Up||5
301196|NCT00777036|727621|P3|COMPLETED|Follow-Up|Completed = Still in Follow-up|19
301197|NCT00777036|727622|P2|COMPLETED|Follow-Up|Completed = Still in Follow-up|5
301198|NCT00777036|727623|P1|COMPLETED|Follow-Up|Completed = Still in Follow-up|9
301199|NCT00777036|727621|P3|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|23
301200|NCT00777036|727622|P2|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|13
301201|NCT00777036|727623|P1|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|14
301202|NCT00777036|727621|P3|NOT COMPLETED|On Treatment||23
301203|NCT00777036|727622|P2|NOT COMPLETED|On Treatment||16
301204|NCT00777036|727623|P1|NOT COMPLETED|On Treatment||15
301205|NCT00777036|727621|P3|COMPLETED|On Treatment|Completed = Still on treatment|61
301206|NCT00777036|727622|P2|COMPLETED|On Treatment|Completed = Still on treatment|1
301207|NCT00777036|727623|P1|COMPLETED|On Treatment|Completed = Still on treatment|14
301208|NCT00777036|727621|P3|STARTED|On Treatment||84
301209|NCT00777036|727622|P2|STARTED|On Treatment||17
301210|NCT00777036|727623|P1|STARTED|On Treatment||29
301211|NCT00777023|727719|P3|NOT COMPLETED|Overall Study||37
301212|NCT00777023|727720|P2|NOT COMPLETED|Overall Study||41
301213|NCT00777023|727721|P1|NOT COMPLETED|Overall Study||35
301214|NCT00777023|727719|P3|COMPLETED|Overall Study||146
301215|NCT00777023|727720|P2|COMPLETED|Overall Study||149
301216|NCT00777023|727721|P1|COMPLETED|Overall Study||151
301217|NCT00777023|727719|P3|STARTED|Overall Study|183 patients were randomized, and 183 received study treatment.|183
301218|NCT00777023|727720|P2|STARTED|Overall Study|190 patients were randomized, and 190 received study treatment.|190
301219|NCT00777023|727721|P1|STARTED|Overall Study|192 patients were randomized, but only 186 received study treatment.|186
301220|NCT00776997|727738|P1|NOT COMPLETED|Overall Study||2
301221|NCT00776997|727738|P1|COMPLETED|Overall Study|98 subjects evaluated at 12-months. Endpoint analysis based on all subjects treated (n=100)|98
301222|NCT00776997|727738|P1|STARTED|Overall Study||100
301223|NCT00776984|727747|P2|NOT COMPLETED|Overall Study||21
301224|NCT00776984|727748|P1|NOT COMPLETED|Overall Study||31
301225|NCT00776984|727747|P2|COMPLETED|Overall Study||198
301226|NCT00776984|727748|P1|COMPLETED|Overall Study||203
301227|NCT00776984|727747|P2|STARTED|Overall Study||219
301228|NCT00776984|727748|P1|STARTED|Overall Study||234
301229|NCT00776919|727822|P4|NOT COMPLETED|Overall Study||39
301230|NCT00776919|727823|P3|NOT COMPLETED|Overall Study||32
301231|NCT00776919|727824|P2|NOT COMPLETED|Overall Study||33
301232|NCT00776919|727825|P1|NOT COMPLETED|Overall Study||27
301233|NCT00776919|727822|P4|COMPLETED|Overall Study||293
301234|NCT00776919|727823|P3|COMPLETED|Overall Study||296
301235|NCT00776919|727824|P2|COMPLETED|Overall Study||295
301236|NCT00776919|727825|P1|COMPLETED|Overall Study||300
301237|NCT00776919|727822|P4|STARTED|Overall Study||332
301238|NCT00776919|727823|P3|STARTED|Overall Study||328
301239|NCT00776919|727824|P2|STARTED|Overall Study||328
301240|NCT00776919|727825|P1|STARTED|Overall Study||327
301241|NCT00776789|727889|P2|NOT COMPLETED|Overall Study||3
301242|NCT00776789|727890|P1|NOT COMPLETED|Overall Study||3
301243|NCT00776789|727889|P2|COMPLETED|Overall Study||18
301244|NCT00776789|727890|P1|COMPLETED|Overall Study||17
301245|NCT00776789|727889|P2|STARTED|Overall Study||21
301246|NCT00776789|727890|P1|STARTED|Overall Study||20
301247|NCT00776659|727902|P1|NOT COMPLETED|Overall Study||26
301248|NCT00776659|727902|P1|COMPLETED|Overall Study||13
301249|NCT00776659|727902|P1|STARTED|Overall Study||39
301250|NCT00776594|727914|P2|NOT COMPLETED|Overall Study||2
301251|NCT00776594|727915|P1|NOT COMPLETED|Overall Study||4
301252|NCT00776594|727914|P2|COMPLETED|Overall Study||34
301253|NCT00776594|727915|P1|COMPLETED|Overall Study||62
301254|NCT00776594|727914|P2|STARTED|Overall Study||36
301255|NCT00776594|727915|P1|STARTED|Overall Study||66
301256|NCT00776555|727929|P2|NOT COMPLETED|Overall Study||0
301257|NCT00776555|727930|P1|NOT COMPLETED|Overall Study||3
301258|NCT00776555|727929|P2|COMPLETED|Overall Study||0
301259|NCT00776555|727930|P1|COMPLETED|Overall Study||0
301260|NCT00776555|727929|P2|STARTED|Overall Study||0
301261|NCT00776555|727930|P1|STARTED|Overall Study||3
301262|NCT00776295|727940|P1|NOT COMPLETED|Overall Study||0
301263|NCT00776295|727940|P1|COMPLETED|Overall Study||2
301264|NCT00776295|727940|P1|STARTED|Overall Study||2
301265|NCT00776230|727948|P3|NOT COMPLETED|Overall Study||5
301266|NCT00776230|727949|P2|NOT COMPLETED|Overall Study||3
301267|NCT00776230|727950|P1|NOT COMPLETED|Overall Study||3
301268|NCT00776230|727948|P3|COMPLETED|Overall Study||97
301269|NCT00776230|727949|P2|COMPLETED|Overall Study||100
301270|NCT00776230|727950|P1|COMPLETED|Overall Study||96
301271|NCT00776230|727948|P3|Enrolled and Vaccinated at Day 0|Overall Study||102
301272|NCT00776230|727949|P2|Enrolled and Vaccinated at Day 0|Overall Study||103
301273|NCT00776230|727950|P1|Enrolled and Vaccinated at Day 0|Overall Study||98
301274|NCT00776230|727948|P3|STARTED|Overall Study||102
301275|NCT00776230|727949|P2|STARTED|Overall Study||103
301276|NCT00776230|727950|P1|STARTED|Overall Study||99
301277|NCT00776100|727960|P2|NOT COMPLETED|Overall Study||0
301278|NCT00776100|727961|P1|NOT COMPLETED|Overall Study||1
301279|NCT00776100|727960|P2|COMPLETED|Overall Study||1
301280|NCT00776100|727961|P1|COMPLETED|Overall Study||0
301281|NCT00776100|727960|P2|STARTED|Overall Study||1
301282|NCT00776100|727961|P1|STARTED|Overall Study||1
301283|NCT00776009|727983|P6|NOT COMPLETED|Period 3: Third Intervention||0
301284|NCT00776009|727984|P5|NOT COMPLETED|Period 3: Third Intervention||0
301285|NCT00776009|727985|P4|NOT COMPLETED|Period 3: Third Intervention||0
301286|NCT00776009|727986|P3|NOT COMPLETED|Period 3: Third Intervention||0
301287|NCT00776009|727987|P2|NOT COMPLETED|Period 3: Third Intervention||0
301288|NCT00776009|727988|P1|NOT COMPLETED|Period 3: Third Intervention||1
301289|NCT00776009|727983|P6|COMPLETED|Period 3: Third Intervention||26
301290|NCT00776009|727984|P5|COMPLETED|Period 3: Third Intervention||26
301291|NCT00776009|727985|P4|COMPLETED|Period 3: Third Intervention||27
301292|NCT00776009|727986|P3|COMPLETED|Period 3: Third Intervention||27
301293|NCT00776009|727987|P2|COMPLETED|Period 3: Third Intervention||27
301294|NCT00776009|727988|P1|COMPLETED|Period 3: Third Intervention||24
301295|NCT00776009|727983|P6|STARTED|Period 3: Third Intervention||26
301296|NCT00776009|727984|P5|STARTED|Period 3: Third Intervention||26
301297|NCT00776009|727985|P4|STARTED|Period 3: Third Intervention||27
301298|NCT00776009|727986|P3|STARTED|Period 3: Third Intervention||27
301299|NCT00776009|727987|P2|STARTED|Period 3: Third Intervention||27
301300|NCT00776009|727988|P1|STARTED|Period 3: Third Intervention||25
301301|NCT00776009|727983|P6|NOT COMPLETED|Period 2: Second Intervention||1
301302|NCT00776009|727984|P5|NOT COMPLETED|Period 2: Second Intervention||0
301303|NCT00776009|727985|P4|NOT COMPLETED|Period 2: Second Intervention||0
301304|NCT00776009|727986|P3|NOT COMPLETED|Period 2: Second Intervention||1
301305|NCT00776009|727987|P2|NOT COMPLETED|Period 2: Second Intervention||0
301306|NCT00776009|727988|P1|NOT COMPLETED|Period 2: Second Intervention||1
301307|NCT00776009|727983|P6|COMPLETED|Period 2: Second Intervention||26
301308|NCT00776009|727984|P5|COMPLETED|Period 2: Second Intervention||26
301309|NCT00776009|727985|P4|COMPLETED|Period 2: Second Intervention||27
301310|NCT00776009|727986|P3|COMPLETED|Period 2: Second Intervention||27
301311|NCT00776009|727987|P2|COMPLETED|Period 2: Second Intervention||27
301312|NCT00776009|727988|P1|COMPLETED|Period 2: Second Intervention||25
301313|NCT00776009|727983|P6|STARTED|Period 2: Second Intervention||27
301314|NCT00776009|727984|P5|STARTED|Period 2: Second Intervention||26
301315|NCT00776009|727985|P4|STARTED|Period 2: Second Intervention||27
301316|NCT00776009|727986|P3|STARTED|Period 2: Second Intervention||28
301317|NCT00776009|727987|P2|STARTED|Period 2: Second Intervention||27
301318|NCT00776009|727988|P1|STARTED|Period 2: Second Intervention||26
301319|NCT00776009|727983|P6|NOT COMPLETED|Period 1: First Intervention||0
301320|NCT00776009|727984|P5|NOT COMPLETED|Period 1: First Intervention||2
301321|NCT00776009|727985|P4|NOT COMPLETED|Period 1: First Intervention||0
301322|NCT00776009|727986|P3|NOT COMPLETED|Period 1: First Intervention||1
301323|NCT00776009|727987|P2|NOT COMPLETED|Period 1: First Intervention||1
301324|NCT00776009|727988|P1|NOT COMPLETED|Period 1: First Intervention||0
301325|NCT00776009|727983|P6|COMPLETED|Period 1: First Intervention||27
301326|NCT00776009|727984|P5|COMPLETED|Period 1: First Intervention||26
301327|NCT00776009|727985|P4|COMPLETED|Period 1: First Intervention||27
301328|NCT00776009|727986|P3|COMPLETED|Period 1: First Intervention||28
301329|NCT00776009|727987|P2|COMPLETED|Period 1: First Intervention||27
301330|NCT00776009|727988|P1|COMPLETED|Period 1: First Intervention||26
301331|NCT00776009|727983|P6|STARTED|Period 1: First Intervention||27
301332|NCT00776009|727984|P5|STARTED|Period 1: First Intervention||28
301333|NCT00776009|727985|P4|STARTED|Period 1: First Intervention||27
301334|NCT00776009|727986|P3|STARTED|Period 1: First Intervention||29
301335|NCT00776009|727987|P2|STARTED|Period 1: First Intervention||28
301336|NCT00776009|727988|P1|STARTED|Period 1: First Intervention||26
301337|NCT00775983|728010|P2|NOT COMPLETED|Overall Study||2
301338|NCT00775983|728011|P1|NOT COMPLETED|Overall Study||1
301339|NCT00775983|728010|P2|COMPLETED|Overall Study||34
301340|NCT00775983|728011|P1|COMPLETED|Overall Study||35
301341|NCT00775983|728010|P2|STARTED|Overall Study||36
301342|NCT00775983|728011|P1|STARTED|Overall Study||36
301343|NCT00775944|728023|P4|NOT COMPLETED|Overall Study||16
301344|NCT00775944|728024|P3|NOT COMPLETED|Overall Study||16
301345|NCT00775944|728025|P2|NOT COMPLETED|Overall Study||9
301346|NCT00775944|728026|P1|NOT COMPLETED|Overall Study||15
301347|NCT00775944|728023|P4|COMPLETED|Overall Study|16 participants withdrew consent|632
301348|NCT00775944|728024|P3|COMPLETED|Overall Study|16 participants withdrew consent|632
301349|NCT00775944|728025|P2|COMPLETED|Overall Study|9 participants withdrew consent|638
301350|NCT00775944|728026|P1|COMPLETED|Overall Study|15 participants withdrew consent|633
301351|NCT00775944|728023|P4|STARTED|Overall Study||648
301352|NCT00775944|728024|P3|STARTED|Overall Study||648
301353|NCT00775944|728025|P2|STARTED|Overall Study||647
301354|NCT00775944|728026|P1|STARTED|Overall Study||648
301355|NCT00775931|728054|P2|NOT COMPLETED|Overall Study||0
301356|NCT00775931|728055|P1|NOT COMPLETED|Overall Study||0
301357|NCT00775931|728054|P2|COMPLETED|Overall Study||1
301358|NCT00775931|728055|P1|COMPLETED|Overall Study||6
301359|NCT00775931|728054|P2|STARTED|Overall Study||1
301360|NCT00775931|728055|P1|STARTED|Overall Study||6
301361|NCT00775684|728070|P3|NOT COMPLETED|Overall Study||3
301362|NCT00775684|728071|P2|NOT COMPLETED|Overall Study||1
301363|NCT00775684|728072|P1|NOT COMPLETED|Overall Study||3
301364|NCT00775684|728070|P3|COMPLETED|Overall Study||14
301365|NCT00775684|728071|P2|COMPLETED|Overall Study||12
301366|NCT00775684|728072|P1|COMPLETED|Overall Study||14
301367|NCT00775684|728070|P3|STARTED|Overall Study||17
301368|NCT00775684|728071|P2|STARTED|Overall Study||13
301369|NCT00775684|728072|P1|STARTED|Overall Study||17
301370|NCT00775671|728094|P2|NOT COMPLETED|Overall Study||0
301371|NCT00775671|728095|P1|NOT COMPLETED|Overall Study||0
301372|NCT00775671|728094|P2|COMPLETED|Overall Study||23
301373|NCT00775671|728095|P1|COMPLETED|Overall Study||23
301374|NCT00775671|728094|P2|STARTED|Overall Study||23
301375|NCT00775671|728095|P1|STARTED|Overall Study||23
301376|NCT00775658|728103|P2|NOT COMPLETED|Second Intervention||0
301377|NCT00775658|728104|P1|NOT COMPLETED|Second Intervention||0
301378|NCT00775658|728103|P2|COMPLETED|Second Intervention||11
301379|NCT00775658|728104|P1|COMPLETED|Second Intervention||10
301380|NCT00775658|728103|P2|STARTED|Second Intervention||11
301381|NCT00775658|728104|P1|STARTED|Second Intervention||10
301382|NCT00775658|728103|P2|NOT COMPLETED|First Intervention||0
301383|NCT00775658|728104|P1|NOT COMPLETED|First Intervention||0
301384|NCT00775658|728103|P2|COMPLETED|First Intervention||11
301385|NCT00775658|728104|P1|COMPLETED|First Intervention||10
301386|NCT00775658|728103|P2|STARTED|First Intervention||11
301387|NCT00775658|728104|P1|STARTED|First Intervention||10
301388|NCT00775645|728114|P2|NOT COMPLETED|Overall Study||20
301389|NCT00775645|728115|P1|NOT COMPLETED|Overall Study||17
301390|NCT00775645|728114|P2|COMPLETED|Overall Study||181
301391|NCT00775645|728115|P1|COMPLETED|Overall Study||191
301392|NCT00775645|728114|P2|STARTED|Overall Study||201
301393|NCT00775645|728115|P1|STARTED|Overall Study||208
301394|NCT00775606|728137|P2|NOT COMPLETED|Overall Study||0
301395|NCT00775606|728138|P1|NOT COMPLETED|Overall Study||3
301396|NCT00775606|728137|P2|COMPLETED|Overall Study||5
301397|NCT00775606|728138|P1|COMPLETED|Overall Study||5
301398|NCT00775606|728137|P2|STARTED|Overall Study||5
301399|NCT00775606|728138|P1|STARTED|Overall Study||8
301400|NCT00775593|728148|P1|NOT COMPLETED|Overall Study||7
301401|NCT00775593|728148|P1|COMPLETED|Overall Study||53
301402|NCT00775593|728148|P1|STARTED|Overall Study||60
301403|NCT00775528|728155|P1|NOT COMPLETED|Overall Study||1
301404|NCT00775528|728155|P1|COMPLETED|Overall Study||18
301405|NCT00775528|728155|P1|STARTED|Overall Study|Started means number of patients who consented|19
301406|NCT00775463|728164|P2|NOT COMPLETED|Overall Study||13
301407|NCT00775463|728165|P1|NOT COMPLETED|Overall Study||11
301408|NCT00775463|728164|P2|COMPLETED|Overall Study||59
301409|NCT00775463|728165|P1|COMPLETED|Overall Study||65
301410|NCT00775463|728164|P2|STARTED|Overall Study||72
301411|NCT00775463|728165|P1|STARTED|Overall Study||76
301412|NCT00775450|728202|P5|NOT COMPLETED|Overall Study||2
301413|NCT00775450|728203|P4|NOT COMPLETED|Overall Study||0
301414|NCT00775450|728204|P3|NOT COMPLETED|Overall Study||0
301415|NCT00775450|728205|P2|NOT COMPLETED|Overall Study||0
301416|NCT00775450|728206|P1|NOT COMPLETED|Overall Study||3
301417|NCT00775450|728202|P5|COMPLETED|Overall Study||199
301418|NCT00775450|728203|P4|COMPLETED|Overall Study||108
301419|NCT00775450|728204|P3|COMPLETED|Overall Study||105
301420|NCT00775450|728205|P2|COMPLETED|Overall Study||98
301421|NCT00775450|728206|P1|COMPLETED|Overall Study||292
301422|NCT00775450|728202|P5|STARTED|Overall Study||201
301423|NCT00775450|728203|P4|STARTED|Overall Study||108
301424|NCT00775450|728204|P3|STARTED|Overall Study||105
301425|NCT00775450|728205|P2|STARTED|Overall Study||98
301426|NCT00775450|728206|P1|STARTED|Overall Study||295
301427|NCT00775437|728233|P1|NOT COMPLETED|Overall Study||6
301428|NCT00775437|728233|P1|COMPLETED|Overall Study||26
301429|NCT00775437|728233|P1|STARTED|Overall Study||32
301430|NCT00775411|728283|P1|NOT COMPLETED|Overall Study||1
301431|NCT00775411|728283|P1|COMPLETED|Overall Study||43
301432|NCT00775411|728283|P1|STARTED|Overall Study||44
301433|NCT00775346|728289|P1|NOT COMPLETED|Overall Study||0
301434|NCT00775346|728289|P1|COMPLETED|Overall Study||92
301435|NCT00775346|728289|P1|STARTED|Overall Study||92
301436|NCT00775229|728295|P2|NOT COMPLETED|Overall Study||2
301437|NCT00775229|728296|P1|NOT COMPLETED|Overall Study||5
301438|NCT00775229|728295|P2|COMPLETED|Overall Study||24
301439|NCT00775229|728296|P1|COMPLETED|Overall Study||20
301440|NCT00775229|728295|P2|STARTED|Overall Study||26
301441|NCT00775229|728296|P1|STARTED|Overall Study||25
301442|NCT00775203|728308|P2|NOT COMPLETED|Overall Study||43
301443|NCT00775203|728309|P1|NOT COMPLETED|Overall Study||62
301444|NCT00775203|728308|P2|COMPLETED|Overall Study||163
301445|NCT00775203|728309|P1|COMPLETED|Overall Study||144
301446|NCT00775203|728308|P2|Received Study Medication|Overall Study||204
301447|NCT00775203|728309|P1|Received Study Medication|Overall Study||202
301448|NCT00775203|728308|P2|STARTED|Overall Study||206
301449|NCT00775203|728309|P1|STARTED|Overall Study||206
301450|NCT00775190|728343|P2|NOT COMPLETED|Overall Study||5
301451|NCT00775190|728344|P1|NOT COMPLETED|Overall Study||4
301452|NCT00775190|728343|P2|COMPLETED|Overall Study||0
301453|NCT00775190|728344|P1|COMPLETED|Overall Study||3
301454|NCT00775190|728343|P2|STARTED|Overall Study||5
301455|NCT00775190|728344|P1|STARTED|Overall Study||7
301456|NCT00775138|728370|P4|NOT COMPLETED|Overall Study||2
301457|NCT00775138|728371|P3|NOT COMPLETED|Overall Study||3
301458|NCT00775138|728372|P2|NOT COMPLETED|Overall Study||0
301459|NCT00775138|728373|P1|NOT COMPLETED|Overall Study||0
301460|NCT00775138|728370|P4|COMPLETED|Overall Study||8
301461|NCT00775138|728371|P3|COMPLETED|Overall Study||17
301462|NCT00775138|728372|P2|COMPLETED|Overall Study||10
301463|NCT00775138|728373|P1|COMPLETED|Overall Study||24
301464|NCT00775138|728370|P4|STARTED|Overall Study||10
301465|NCT00775138|728371|P3|STARTED|Overall Study||20
301466|NCT00775138|728372|P2|STARTED|Overall Study||10
301467|NCT00775138|728373|P1|STARTED|Overall Study||24
301468|NCT00775021|728419|P2|NOT COMPLETED|Second Intervention||1
301469|NCT00775021|728420|P1|NOT COMPLETED|Second Intervention||0
301470|NCT00775021|728419|P2|COMPLETED|Second Intervention||59
301471|NCT00775021|728420|P1|COMPLETED|Second Intervention||62
301472|NCT00775021|728419|P2|STARTED|Second Intervention||60
301473|NCT00775021|728420|P1|STARTED|Second Intervention||62
301474|NCT00775021|728419|P2|NOT COMPLETED|First Intervention||0
301475|NCT00775021|728420|P1|NOT COMPLETED|First Intervention||1
301476|NCT00775021|728419|P2|COMPLETED|First Intervention||60
301477|NCT00775021|728420|P1|COMPLETED|First Intervention||62
301478|NCT00775021|728419|P2|STARTED|First Intervention||60
301479|NCT00775021|728420|P1|STARTED|First Intervention||63
301480|NCT00774995|728438|P4|NOT COMPLETED|Overall Study||0
301481|NCT00774995|728439|P3|NOT COMPLETED|Overall Study||1
301482|NCT00774995|728440|P2|NOT COMPLETED|Overall Study||0
301483|NCT00774995|728441|P1|NOT COMPLETED|Overall Study||0
301484|NCT00774995|728438|P4|COMPLETED|Overall Study||16
301485|NCT00774995|728439|P3|COMPLETED|Overall Study||7
301486|NCT00774995|728440|P2|COMPLETED|Overall Study||16
301487|NCT00774995|728441|P1|COMPLETED|Overall Study||9
301488|NCT00774995|728438|P4|STARTED|Overall Study||16
301489|NCT00774995|728439|P3|STARTED|Overall Study||8
301490|NCT00774995|728440|P2|STARTED|Overall Study||16
301491|NCT00774995|728441|P1|STARTED|Overall Study||9
301492|NCT00774930|728481|P2|NOT COMPLETED|LTOLE Phase||17
301493|NCT00774930|728482|P1|NOT COMPLETED|LTOLE Phase||15
301494|NCT00774930|728481|P2|COMPLETED|LTOLE Phase||8
301495|NCT00774930|728482|P1|COMPLETED|LTOLE Phase||17
301496|NCT00774930|728481|P2|STARTED|LTOLE Phase|20 subjects from IOL did not enter LTOLE (12 completed IOL, 8 did not complete IOL).|25
301497|NCT00774930|728482|P1|STARTED|LTOLE Phase|24 subjects from IOL did not enter LTOLE (11 completed IOL, 13 did not complete IOL).|32
301498|NCT00774930|728481|P2|NOT COMPLETED|IOL Phase||9
301499|NCT00774930|728482|P1|NOT COMPLETED|IOL Phase||13
301500|NCT00774930|728481|P2|COMPLETED|IOL Phase||37
301501|NCT00774930|728482|P1|COMPLETED|IOL Phase||43
301502|NCT00774930|728481|P2|STARTED|IOL Phase|Includes 1 subject listed as completing and withdrawing from the DB phase due to brain radiation|46
301503|NCT00774930|728482|P1|STARTED|IOL Phase||56
301504|NCT00774930|728481|P2|NOT COMPLETED|DB Phase||22
301505|NCT00774930|728482|P1|NOT COMPLETED|DB Phase||14
301506|NCT00774930|728481|P2|COMPLETED|DB Phase|had diary data at least up to day 21 after 4th dose, regardless of missing diary data before day 21.|34
301507|NCT00774930|728482|P1|COMPLETED|DB Phase|Received 4 DB study injections AND continued to IOL phase OR|45
301508|NCT00774930|728481|P2|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|56
301509|NCT00774930|728482|P1|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|59
301510|NCT00774852|728510|P2|NOT COMPLETED|Overall Study||41
301511|NCT00774852|728511|P1|NOT COMPLETED|Overall Study||45
301512|NCT00774852|728510|P2|COMPLETED|Overall Study||27
301513|NCT00774852|728511|P1|COMPLETED|Overall Study||24
301514|NCT00774852|728510|P2|STARTED|Overall Study||68
301515|NCT00774852|728511|P1|STARTED|Overall Study||69
301516|NCT00774800|728559|P1|NOT COMPLETED|Intervention 4||1
301517|NCT00774800|728559|P1|COMPLETED|Intervention 4||21
301518|NCT00774800|728559|P1|Received at Least One Dose of Study Drug|Intervention 4||21
301519|NCT00774800|728559|P1|STARTED|Intervention 4||22
301520|NCT00774800|728559|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
301521|NCT00774800|728559|P1|COMPLETED|Washout (3 to 10 Days)||22
301522|NCT00774800|728559|P1|STARTED|Washout (3 to 10 Days)||22
301523|NCT00774800|728559|P1|NOT COMPLETED|Intervention 3||0
301524|NCT00774800|728559|P1|COMPLETED|Intervention 3||22
301525|NCT00774800|728559|P1|Received at Least One Dose of Study Drug|Intervention 3||22
301526|NCT00774800|728559|P1|STARTED|Intervention 3||22
301527|NCT00774800|728559|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
301528|NCT00774800|728559|P1|COMPLETED|Washout (3 to 10 Days)||22
301529|NCT00774800|728559|P1|STARTED|Washout (3 to 10 Days)||22
301530|NCT00774800|728559|P1|NOT COMPLETED|Intervention 2||0
301531|NCT00774800|728559|P1|COMPLETED|Intervention 2||22
301532|NCT00774800|728559|P1|Received at Least One Dose of Study Drug|Intervention 2||22
301533|NCT00774800|728559|P1|STARTED|Intervention 2||22
301534|NCT00774800|728559|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
301535|NCT00774800|728559|P1|COMPLETED|Washout (3 to 10 Days)||22
301536|NCT00774800|728559|P1|STARTED|Washout (3 to 10 Days)||22
301537|NCT00774800|728559|P1|NOT COMPLETED|Intervention 1||0
301538|NCT00774800|728559|P1|COMPLETED|Intervention 1||22
301539|NCT00774800|728559|P1|Received at Least One Dose of Study Drug|Intervention 1||22
301540|NCT00774800|728559|P1|STARTED|Intervention 1||22
301541|NCT00774787|728581|P1|NOT COMPLETED|Overall Study||1
301542|NCT00774787|728581|P1|COMPLETED|Overall Study||26
301543|NCT00774787|728581|P1|STARTED|Overall Study||27
301544|NCT00774748|728588|P1|NOT COMPLETED|Overall Study||3
301545|NCT00774748|728588|P1|COMPLETED|Overall Study||18
301546|NCT00774748|728588|P1|STARTED|Overall Study||21
301547|NCT00774579|728598|P2|NOT COMPLETED|Overall Study||0
301548|NCT00774579|728599|P1|NOT COMPLETED|Overall Study||0
301549|NCT00774579|728598|P2|COMPLETED|Overall Study||9
301550|NCT00774579|728599|P1|COMPLETED|Overall Study||9
301551|NCT00774579|728598|P2|STARTED|Overall Study||9
301552|NCT00774579|728599|P1|STARTED|Overall Study||9
301553|NCT00774397|728614|P7|NOT COMPLETED|Overall Study||30
301554|NCT00774397|728615|P6|NOT COMPLETED|Overall Study||22
301555|NCT00774397|728616|P5|NOT COMPLETED|Overall Study||46
301556|NCT00774397|728617|P4|NOT COMPLETED|Overall Study||17
301557|NCT00774397|728618|P3|NOT COMPLETED|Overall Study||30
301558|NCT00774397|728619|P2|NOT COMPLETED|Overall Study||13
301559|NCT00774397|728620|P1|NOT COMPLETED|Overall Study||14
301560|NCT00774397|728614|P7|COMPLETED|Overall Study||41
301561|NCT00774397|728615|P6|COMPLETED|Overall Study||54
301562|NCT00774397|728616|P5|COMPLETED|Overall Study||97
301563|NCT00774397|728617|P4|COMPLETED|Overall Study||129
301564|NCT00774397|728618|P3|COMPLETED|Overall Study||113
301565|NCT00774397|728619|P2|COMPLETED|Overall Study||56
301566|NCT00774397|728620|P1|COMPLETED|Overall Study||57
301567|NCT00774397|728614|P7|STARTED|Overall Study||71
301568|NCT00774397|728615|P6|STARTED|Overall Study||76
301569|NCT00774397|728616|P5|STARTED|Overall Study||143
301570|NCT00774397|728617|P4|STARTED|Overall Study||146
301571|NCT00774397|728618|P3|STARTED|Overall Study||143
301572|NCT00774397|728619|P2|STARTED|Overall Study||69
301573|NCT00774397|728620|P1|STARTED|Overall Study||71
301574|NCT00774306|728856|P4|NOT COMPLETED|Overall Study||5
301575|NCT00774306|728857|P3|NOT COMPLETED|Overall Study||8
301576|NCT00774306|728858|P2|NOT COMPLETED|Overall Study||2
301577|NCT00774306|728859|P1|NOT COMPLETED|Overall Study||18
301578|NCT00774306|728856|P4|COMPLETED|Overall Study||2
301579|NCT00774306|728857|P3|COMPLETED|Overall Study||8
301580|NCT00774306|728858|P2|COMPLETED|Overall Study||3
301581|NCT00774306|728859|P1|COMPLETED|Overall Study||6
301582|NCT00774306|728856|P4|STARTED|Overall Study||7
301583|NCT00774306|728857|P3|STARTED|Overall Study||16
301584|NCT00774306|728858|P2|STARTED|Overall Study||5
301585|NCT00774306|728859|P1|STARTED|Overall Study||24
301586|NCT00774267|728873|P4|NOT COMPLETED|Overall Study||0
301587|NCT00774267|728874|P3|NOT COMPLETED|Overall Study||0
301588|NCT00774267|728875|P2|NOT COMPLETED|Overall Study||0
301589|NCT00774267|728876|P1|NOT COMPLETED|Overall Study||0
301590|NCT00774267|728873|P4|COMPLETED|Overall Study||135
301591|NCT00774267|728874|P3|COMPLETED|Overall Study||129
301592|NCT00774267|728875|P2|COMPLETED|Overall Study||111
301593|NCT00774267|728876|P1|COMPLETED|Overall Study||132
301594|NCT00774267|728873|P4|STARTED|Overall Study||135
301595|NCT00774267|728874|P3|STARTED|Overall Study||129
301596|NCT00774267|728875|P2|STARTED|Overall Study||111
301597|NCT00774267|728876|P1|STARTED|Overall Study||132
301598|NCT00774202|728888|P2|NOT COMPLETED|Overall Study||0
301599|NCT00774202|728889|P1|NOT COMPLETED|Overall Study||0
301600|NCT00774202|728888|P2|COMPLETED|Overall Study||8
301601|NCT00774202|728889|P1|COMPLETED|Overall Study||9
301602|NCT00774202|728888|P2|STARTED|Overall Study||8
301603|NCT00774202|728889|P1|STARTED|Overall Study||9
301604|NCT00774163|728901|P2|NOT COMPLETED|Overall Study||0
301605|NCT00774163|728902|P1|NOT COMPLETED|Overall Study||0
301606|NCT00774163|728901|P2|COMPLETED|Overall Study||15
301607|NCT00774163|728902|P1|COMPLETED|Overall Study||30
301608|NCT00774163|728901|P2|STARTED|Overall Study||15
301609|NCT00774163|728902|P1|STARTED|Overall Study||30
301610|NCT00774046|728940|P1|NOT COMPLETED|Autologous Transplant||0
301611|NCT00774046|728940|P1|COMPLETED|Autologous Transplant||4
301612|NCT00774046|728940|P1|STARTED|Autologous Transplant|2 patients died in remission and 1 relapsed without having received transplant|4
301613|NCT00774046|728940|P1|NOT COMPLETED|Stem Cell Mobilization||3
301614|NCT00774046|728940|P1|COMPLETED|Stem Cell Mobilization||7
301615|NCT00774046|728940|P1|STARTED|Stem Cell Mobilization|For mobilization, the patient must have had a CR and not been a candidate for allogeneic transplant|10
301616|NCT00774046|728940|P1|NOT COMPLETED|Induction Therapy||0
301617|NCT00774046|728940|P1|COMPLETED|Induction Therapy||32
301618|NCT00774046|728940|P1|STARTED|Induction Therapy||32
301619|NCT00774046|728940|P1|NOT COMPLETED|Enrollment||28
301620|NCT00774046|728940|P1|COMPLETED|Enrollment||32
301621|NCT00774046|728940|P1|STARTED|Enrollment||60
301622|NCT00774046|728940|P1|NOT COMPLETED|Screening||56
301623|NCT00774046|728940|P1|COMPLETED|Screening||60
301624|NCT00774046|728940|P1|STARTED|Screening||116
301625|NCT00773968|728950|P1|NOT COMPLETED|Overall Study||45
301626|NCT00773968|728950|P1|COMPLETED|Overall Study||95
301627|NCT00773968|728950|P1|Treated|Overall Study||111
301628|NCT00773968|728950|P1|STARTED|Overall Study||140
301629|NCT00773955|728959|P1|NOT COMPLETED|Overall Study||0
301630|NCT00773955|728959|P1|COMPLETED|Overall Study||15
301631|NCT00773955|728959|P1|STARTED|Overall Study||15
301632|NCT00773786|728966|P2|NOT COMPLETED|Second Intervention (1 Week)||0
301633|NCT00773786|728967|P1|NOT COMPLETED|Second Intervention (1 Week)||0
301634|NCT00773786|728966|P2|COMPLETED|Second Intervention (1 Week)||10
301635|NCT00773786|728967|P1|COMPLETED|Second Intervention (1 Week)||10
301636|NCT00773786|728966|P2|STARTED|Second Intervention (1 Week)||10
301637|NCT00773786|728967|P1|STARTED|Second Intervention (1 Week)||10
301638|NCT00773786|728966|P2|NOT COMPLETED|Washout (1 Week)||0
301639|NCT00773786|728967|P1|NOT COMPLETED|Washout (1 Week)||0
301640|NCT00773786|728966|P2|COMPLETED|Washout (1 Week)||10
301641|NCT00773786|728967|P1|COMPLETED|Washout (1 Week)||10
301642|NCT00773786|728966|P2|STARTED|Washout (1 Week)||10
301643|NCT00773786|728967|P1|STARTED|Washout (1 Week)||10
301644|NCT00773786|728966|P2|NOT COMPLETED|First Intervention (1 Week)||0
301645|NCT00773786|728967|P1|NOT COMPLETED|First Intervention (1 Week)||0
301646|NCT00773786|728966|P2|COMPLETED|First Intervention (1 Week)||10
301647|NCT00773786|728967|P1|COMPLETED|First Intervention (1 Week)||10
301648|NCT00773786|728966|P2|STARTED|First Intervention (1 Week)||10
301649|NCT00773786|728967|P1|STARTED|First Intervention (1 Week)||10
301650|NCT00773734|728981|P6|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
301651|NCT00773734|728982|P5|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
301652|NCT00773734|728983|P4|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
301653|NCT00773734|728984|P3|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
301654|NCT00773734|728985|P2|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
301655|NCT00773734|728986|P1|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
301656|NCT00773734|728981|P6|COMPLETED|LTE Period: Week 52 to 6 Years||0
301657|NCT00773734|728982|P5|COMPLETED|LTE Period: Week 52 to 6 Years||0
301658|NCT00773734|728983|P4|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|5
301659|NCT00773734|728984|P3|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|4
301660|NCT00773734|728985|P2|COMPLETED|LTE Period: Week 52 to 6 Years||0
301661|NCT00773734|728986|P1|COMPLETED|LTE Period: Week 52 to 6 Years||0
301662|NCT00773734|728981|P6|STARTED|LTE Period: Week 52 to 6 Years||0
301663|NCT00773734|728982|P5|STARTED|LTE Period: Week 52 to 6 Years||0
301664|NCT00773734|728983|P4|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|17
301665|NCT00773734|728984|P3|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|16
301666|NCT00773734|728985|P2|STARTED|LTE Period: Week 52 to 6 Years||0
301667|NCT00773734|728986|P1|STARTED|LTE Period: Week 52 to 6 Years||0
301668|NCT00773734|728981|P6|NOT COMPLETED|Extension: Active Treatment Week 24-52||8
301669|NCT00773734|728982|P5|NOT COMPLETED|Extension: Active Treatment Week 24-52||5
301670|NCT00773734|728983|P4|NOT COMPLETED|Extension: Active Treatment Week 24-52||10
301671|NCT00773734|728984|P3|NOT COMPLETED|Extension: Active Treatment Week 24-52||17
301672|NCT00773734|728985|P2|NOT COMPLETED|Extension: Active Treatment Week 24-52||13
301673|NCT00773734|728986|P1|NOT COMPLETED|Extension: Active Treatment Week 24-52||0
301674|NCT00773734|728981|P6|COMPLETED|Extension: Active Treatment Week 24-52||19
301675|NCT00773734|728982|P5|COMPLETED|Extension: Active Treatment Week 24-52||22
301676|NCT00773734|728983|P4|COMPLETED|Extension: Active Treatment Week 24-52||48
301677|NCT00773734|728984|P3|COMPLETED|Extension: Active Treatment Week 24-52||33
301678|NCT00773734|728985|P2|COMPLETED|Extension: Active Treatment Week 24-52|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|34
301679|NCT00773734|728986|P1|COMPLETED|Extension: Active Treatment Week 24-52||0
301680|NCT00773734|728981|P6|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
301681|NCT00773734|728982|P5|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
301682|NCT00773734|728983|P4|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
301683|NCT00773734|728984|P3|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
301684|NCT00773734|728985|P2|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||5
301685|NCT00773734|728986|P1|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||0
301686|NCT00773734|728981|P6|STARTED|Extension: Active Treatment Week 24-52||27
301687|NCT00773734|728982|P5|STARTED|Extension: Active Treatment Week 24-52||27
301688|NCT00773734|728983|P4|STARTED|Extension: Active Treatment Week 24-52||58
301689|NCT00773734|728984|P3|STARTED|Extension: Active Treatment Week 24-52||50
301690|NCT00773734|728985|P2|STARTED|Extension: Active Treatment Week 24-52||47
301691|NCT00773734|728986|P1|STARTED|Extension: Active Treatment Week 24-52||0
301692|NCT00773734|728981|P6|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||5
301693|NCT00773734|728982|P5|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||1
301694|NCT00773734|728983|P4|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||2
301695|NCT00773734|728984|P3|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||7
301696|NCT00773734|728985|P2|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||12
301697|NCT00773734|728986|P1|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||0
301698|NCT00773734|728981|P6|COMPLETED|Core: Active Treatment Phase Week 16-24||31
301699|NCT00773734|728982|P5|COMPLETED|Core: Active Treatment Phase Week 16-24||33
301700|NCT00773734|728983|P4|COMPLETED|Core: Active Treatment Phase Week 16-24||65
301701|NCT00773734|728984|P3|COMPLETED|Core: Active Treatment Phase Week 16-24||59
301702|NCT00773734|728985|P2|COMPLETED|Core: Active Treatment Phase Week 16-24||65
301703|NCT00773734|728986|P1|COMPLETED|Core: Active Treatment Phase Week 16-24||0
301704|NCT00773734|728981|P6|STARTED|Core: Active Treatment Phase Week 16-24||36
301705|NCT00773734|728982|P5|STARTED|Core: Active Treatment Phase Week 16-24||34
301788|NCT00773253|729697|P1|COMPLETED|First Intervention (Week 0-24)||5
301706|NCT00773734|728983|P4|STARTED|Core: Active Treatment Phase Week 16-24|3 participants elected not to continue from previous period|67
301707|NCT00773734|728984|P3|STARTED|Core: Active Treatment Phase Week 16-24||66
301708|NCT00773734|728985|P2|STARTED|Core: Active Treatment Phase Week 16-24|2 participants elected not to continue from previous period|77
301709|NCT00773734|728986|P1|STARTED|Core: Active Treatment Phase Week 16-24|Placebo participants were re-randomized at Week 16 to receive apremilast 20mg or 30mg PO BID.|0
301710|NCT00773734|728981|P6|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
301711|NCT00773734|728982|P5|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
301712|NCT00773734|728983|P4|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||18
301713|NCT00773734|728984|P3|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||21
301714|NCT00773734|728985|P2|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||10
301715|NCT00773734|728986|P1|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||16
301716|NCT00773734|728981|P6|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
301717|NCT00773734|728982|P5|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
301718|NCT00773734|728983|P4|COMPLETED|Core: Placebo Controlled Phase Week 0-16|3 participants completed placebo controlled phase but elected not to continue|70
301719|NCT00773734|728984|P3|COMPLETED|Core: Placebo Controlled Phase Week 0-16||66
301720|NCT00773734|728985|P2|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|79
301721|NCT00773734|728986|P1|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|72
301722|NCT00773734|728981|P6|STARTED|Core: Placebo Controlled Phase Week 0-16||0
301723|NCT00773734|728982|P5|STARTED|Core: Placebo Controlled Phase Week 0-16||0
301724|NCT00773734|728983|P4|STARTED|Core: Placebo Controlled Phase Week 0-16||88
301725|NCT00773734|728984|P3|STARTED|Core: Placebo Controlled Phase Week 0-16||87
301726|NCT00773734|728985|P2|STARTED|Core: Placebo Controlled Phase Week 0-16||89
301727|NCT00773734|728986|P1|STARTED|Core: Placebo Controlled Phase Week 0-16||88
301728|NCT00773604|729548|P1|NOT COMPLETED|Overall Study||0
301729|NCT00773604|729548|P1|COMPLETED|Overall Study||9
301730|NCT00773604|729548|P1|STARTED|Overall Study||9
301731|NCT00773513|729554|P2|NOT COMPLETED|Overall Study||1109
301732|NCT00773513|729555|P1|NOT COMPLETED|Overall Study||1101
301733|NCT00773513|729554|P2|COMPLETED|Overall Study||303
301734|NCT00773513|729555|P1|COMPLETED|Overall Study||312
301735|NCT00773513|729554|P2|Received Study Treatment|Overall Study||1409
301736|NCT00773513|729555|P1|Received Study Treatment|Overall Study||1409
301737|NCT00773513|729554|P2|STARTED|Overall Study||1412
301738|NCT00773513|729555|P1|STARTED|Overall Study||1413
301739|NCT00773474|729575|P1|NOT COMPLETED|Overall Study||0
301740|NCT00773474|729575|P1|COMPLETED|Overall Study||29
301741|NCT00773474|729575|P1|STARTED|Overall Study||29
301742|NCT00773461|729584|P2|NOT COMPLETED|Overall Study||4
301743|NCT00773461|729585|P1|NOT COMPLETED|Overall Study||5
301744|NCT00773461|729584|P2|COMPLETED|Overall Study||135
301745|NCT00773461|729585|P1|COMPLETED|Overall Study||65
301746|NCT00773461|729584|P2|STARTED|Overall Study||139
301747|NCT00773461|729585|P1|STARTED|Overall Study||70
301748|NCT00773422|729626|P3|NOT COMPLETED|Overall Study||0
301749|NCT00773422|729627|P2|NOT COMPLETED|Overall Study||0
301750|NCT00773422|729628|P1|NOT COMPLETED|Overall Study||0
301751|NCT00773422|729626|P3|COMPLETED|Overall Study||10
301752|NCT00773422|729627|P2|COMPLETED|Overall Study||9
301753|NCT00773422|729628|P1|COMPLETED|Overall Study||11
301754|NCT00773422|729626|P3|STARTED|Overall Study||10
301755|NCT00773422|729627|P2|STARTED|Overall Study||9
301756|NCT00773422|729628|P1|STARTED|Overall Study||11
301757|NCT00773383|729639|P1|NOT COMPLETED|Overall Study||31
301758|NCT00773383|729639|P1|COMPLETED|Overall Study|this includes at the time of clinical cut-off (2/23/2010) there were 4 patients ongoing|4
301759|NCT00773383|729639|P1|Received Study Drug|Overall Study||34
301760|NCT00773383|729639|P1|STARTED|Overall Study||35
301761|NCT00773370|729661|P2|NOT COMPLETED|Overall Study||10
301762|NCT00773370|729662|P1|NOT COMPLETED|Overall Study||18
301763|NCT00773370|729661|P2|COMPLETED|Overall Study||23
301764|NCT00773370|729662|P1|COMPLETED|Overall Study||25
301765|NCT00773370|729661|P2|STARTED|Overall Study||33
301766|NCT00773370|729662|P1|STARTED|Overall Study||43
301767|NCT00773279|729674|P2|NOT COMPLETED|Period 2||6
301768|NCT00773279|729675|P1|NOT COMPLETED|Period 2||3
301769|NCT00773279|729674|P2|COMPLETED|Period 2||111
301770|NCT00773279|729675|P1|COMPLETED|Period 2||111
301771|NCT00773279|729674|P2|STARTED|Period 2||117
301772|NCT00773279|729675|P1|STARTED|Period 2||114
301773|NCT00773279|729674|P2|NOT COMPLETED|Period 1||4
301774|NCT00773279|729675|P1|NOT COMPLETED|Period 1||7
301775|NCT00773279|729674|P2|COMPLETED|Period 1||117
301776|NCT00773279|729675|P1|COMPLETED|Period 1||114
301777|NCT00773279|729674|P2|STARTED|Period 1||121
301778|NCT00773279|729675|P1|STARTED|Period 1||121
301779|NCT00773253|729696|P2|NOT COMPLETED|Second Intervention (Week 24-48)||0
301780|NCT00773253|729697|P1|NOT COMPLETED|Second Intervention (Week 24-48)||0
301781|NCT00773253|729696|P2|COMPLETED|Second Intervention (Week 24-48)||4
301782|NCT00773253|729697|P1|COMPLETED|Second Intervention (Week 24-48)||5
301783|NCT00773253|729696|P2|STARTED|Second Intervention (Week 24-48)||4
301784|NCT00773253|729697|P1|STARTED|Second Intervention (Week 24-48)||5
301785|NCT00773253|729696|P2|NOT COMPLETED|First Intervention (Week 0-24)||1
301786|NCT00773253|729697|P1|NOT COMPLETED|First Intervention (Week 0-24)||0
301787|NCT00773253|729696|P2|COMPLETED|First Intervention (Week 0-24)||4
301789|NCT00773253|729696|P2|STARTED|First Intervention (Week 0-24)||5
301790|NCT00773253|729697|P1|STARTED|First Intervention (Week 0-24)||5
301791|NCT00773175|729705|P2|NOT COMPLETED|Overall Study||2
301792|NCT00773175|729706|P1|NOT COMPLETED|Overall Study||2
301793|NCT00773175|729705|P2|COMPLETED|Overall Study||73
301794|NCT00773175|729706|P1|COMPLETED|Overall Study||71
301795|NCT00773175|729705|P2|No Fluids Received|Overall Study||1
301796|NCT00773175|729706|P1|No Fluids Received|Overall Study||0
301797|NCT00773175|729705|P2|Initial Fluids Via Subcutaneous Rescue|Overall Study||15
301798|NCT00773175|729706|P1|Initial Fluids Via Subcutaneous Rescue|Overall Study||0
301799|NCT00773175|729705|P2|Initial Fluids Via Randomized Route|Overall Study||59
301800|NCT00773175|729706|P1|Initial Fluids Via Randomized Route|Overall Study||73
301801|NCT00773175|729705|P2|STARTED|Overall Study||75
301802|NCT00773175|729706|P1|STARTED|Overall Study||73
301803|NCT00773136|729798|P1|NOT COMPLETED|Overall Study||2
301804|NCT00773136|729798|P1|COMPLETED|Overall Study||19
301805|NCT00773136|729798|P1|STARTED|Overall Study||21
301806|NCT00773097|729803|P1|NOT COMPLETED|Overall Study||7
301807|NCT00773097|729803|P1|COMPLETED|Overall Study||39
301808|NCT00773097|729803|P1|STARTED|Overall Study||46
301809|NCT00772967|729809|P6|NOT COMPLETED|Crossover Treatment 3||0
301810|NCT00772967|729810|P5|NOT COMPLETED|Crossover Treatment 3||1
301811|NCT00772967|729811|P4|NOT COMPLETED|Crossover Treatment 3||0
301812|NCT00772967|729812|P3|NOT COMPLETED|Crossover Treatment 3||0
301813|NCT00772967|729813|P2|NOT COMPLETED|Crossover Treatment 3||0
301814|NCT00772967|729814|P1|NOT COMPLETED|Crossover Treatment 3||0
301815|NCT00772967|729809|P6|COMPLETED|Crossover Treatment 3||3
301816|NCT00772967|729810|P5|COMPLETED|Crossover Treatment 3||3
301817|NCT00772967|729811|P4|COMPLETED|Crossover Treatment 3||3
301818|NCT00772967|729812|P3|COMPLETED|Crossover Treatment 3||3
301819|NCT00772967|729813|P2|COMPLETED|Crossover Treatment 3||4
301820|NCT00772967|729814|P1|COMPLETED|Crossover Treatment 3||3
301821|NCT00772967|729809|P6|STARTED|Crossover Treatment 3||3
301822|NCT00772967|729810|P5|STARTED|Crossover Treatment 3||4
301823|NCT00772967|729811|P4|STARTED|Crossover Treatment 3||3
301824|NCT00772967|729812|P3|STARTED|Crossover Treatment 3||3
301825|NCT00772967|729813|P2|STARTED|Crossover Treatment 3||4
301826|NCT00772967|729814|P1|STARTED|Crossover Treatment 3||3
301827|NCT00772967|729809|P6|NOT COMPLETED|Break 2 (4-7 Days)||0
301828|NCT00772967|729810|P5|NOT COMPLETED|Break 2 (4-7 Days)||0
301829|NCT00772967|729811|P4|NOT COMPLETED|Break 2 (4-7 Days)||0
301830|NCT00772967|729812|P3|NOT COMPLETED|Break 2 (4-7 Days)||0
301831|NCT00772967|729813|P2|NOT COMPLETED|Break 2 (4-7 Days)||0
301832|NCT00772967|729814|P1|NOT COMPLETED|Break 2 (4-7 Days)||0
301833|NCT00772967|729809|P6|COMPLETED|Break 2 (4-7 Days)||3
301834|NCT00772967|729810|P5|COMPLETED|Break 2 (4-7 Days)||4
301835|NCT00772967|729811|P4|COMPLETED|Break 2 (4-7 Days)||3
301836|NCT00772967|729812|P3|COMPLETED|Break 2 (4-7 Days)||3
301837|NCT00772967|729813|P2|COMPLETED|Break 2 (4-7 Days)||4
301838|NCT00772967|729814|P1|COMPLETED|Break 2 (4-7 Days)||3
301839|NCT00772967|729809|P6|STARTED|Break 2 (4-7 Days)||3
301840|NCT00772967|729810|P5|STARTED|Break 2 (4-7 Days)||4
301841|NCT00772967|729811|P4|STARTED|Break 2 (4-7 Days)||3
301842|NCT00772967|729812|P3|STARTED|Break 2 (4-7 Days)||3
301843|NCT00772967|729813|P2|STARTED|Break 2 (4-7 Days)||4
301844|NCT00772967|729814|P1|STARTED|Break 2 (4-7 Days)||3
301845|NCT00772967|729809|P6|NOT COMPLETED|Crossover Treatment 2||0
301846|NCT00772967|729810|P5|NOT COMPLETED|Crossover Treatment 2||0
301847|NCT00772967|729811|P4|NOT COMPLETED|Crossover Treatment 2||0
301848|NCT00772967|729812|P3|NOT COMPLETED|Crossover Treatment 2||0
301849|NCT00772967|729813|P2|NOT COMPLETED|Crossover Treatment 2||0
301850|NCT00772967|729814|P1|NOT COMPLETED|Crossover Treatment 2||0
301851|NCT00772967|729809|P6|COMPLETED|Crossover Treatment 2||3
301852|NCT00772967|729810|P5|COMPLETED|Crossover Treatment 2||4
301853|NCT00772967|729811|P4|COMPLETED|Crossover Treatment 2||3
301854|NCT00772967|729812|P3|COMPLETED|Crossover Treatment 2||3
301855|NCT00772967|729813|P2|COMPLETED|Crossover Treatment 2||4
301856|NCT00772967|729814|P1|COMPLETED|Crossover Treatment 2||3
301857|NCT00772967|729809|P6|STARTED|Crossover Treatment 2||3
301858|NCT00772967|729810|P5|STARTED|Crossover Treatment 2||4
301859|NCT00772967|729811|P4|STARTED|Crossover Treatment 2||3
301860|NCT00772967|729812|P3|STARTED|Crossover Treatment 2||3
301861|NCT00772967|729813|P2|STARTED|Crossover Treatment 2||4
301862|NCT00772967|729814|P1|STARTED|Crossover Treatment 2||3
301863|NCT00772967|729809|P6|NOT COMPLETED|Break 1 (4-7 Days)||0
301864|NCT00772967|729810|P5|NOT COMPLETED|Break 1 (4-7 Days)||0
301865|NCT00772967|729811|P4|NOT COMPLETED|Break 1 (4-7 Days)||0
301866|NCT00772967|729812|P3|NOT COMPLETED|Break 1 (4-7 Days)||0
301867|NCT00772967|729813|P2|NOT COMPLETED|Break 1 (4-7 Days)||1
301868|NCT00772967|729814|P1|NOT COMPLETED|Break 1 (4-7 Days)||0
301869|NCT00772967|729809|P6|COMPLETED|Break 1 (4-7 Days)||3
301870|NCT00772967|729810|P5|COMPLETED|Break 1 (4-7 Days)||4
301871|NCT00772967|729811|P4|COMPLETED|Break 1 (4-7 Days)||3
301872|NCT00772967|729812|P3|COMPLETED|Break 1 (4-7 Days)||3
301873|NCT00772967|729813|P2|COMPLETED|Break 1 (4-7 Days)||4
301874|NCT00772967|729814|P1|COMPLETED|Break 1 (4-7 Days)||3
301875|NCT00772967|729809|P6|STARTED|Break 1 (4-7 Days)||3
301876|NCT00772967|729810|P5|STARTED|Break 1 (4-7 Days)||4
301877|NCT00772967|729811|P4|STARTED|Break 1 (4-7 Days)||3
301878|NCT00772967|729812|P3|STARTED|Break 1 (4-7 Days)||3
301879|NCT00772967|729813|P2|STARTED|Break 1 (4-7 Days)||5
301880|NCT00772967|729814|P1|STARTED|Break 1 (4-7 Days)||3
301881|NCT00772967|729809|P6|NOT COMPLETED|Crossover Treatment 1||0
301882|NCT00772967|729810|P5|NOT COMPLETED|Crossover Treatment 1||0
301883|NCT00772967|729811|P4|NOT COMPLETED|Crossover Treatment 1||1
301884|NCT00772967|729812|P3|NOT COMPLETED|Crossover Treatment 1||0
301885|NCT00772967|729813|P2|NOT COMPLETED|Crossover Treatment 1||0
301886|NCT00772967|729814|P1|NOT COMPLETED|Crossover Treatment 1||0
301887|NCT00772967|729809|P6|COMPLETED|Crossover Treatment 1||3
301888|NCT00772967|729810|P5|COMPLETED|Crossover Treatment 1||4
301889|NCT00772967|729811|P4|COMPLETED|Crossover Treatment 1|The withdrawal is not included in any outcomes; but is part of the Adverse Event group for placebo|3
301890|NCT00772967|729812|P3|COMPLETED|Crossover Treatment 1||3
301891|NCT00772967|729813|P2|COMPLETED|Crossover Treatment 1||5
301892|NCT00772967|729814|P1|COMPLETED|Crossover Treatment 1||3
301893|NCT00772967|729809|P6|STARTED|Crossover Treatment 1||3
301894|NCT00772967|729810|P5|STARTED|Crossover Treatment 1||4
301895|NCT00772967|729811|P4|STARTED|Crossover Treatment 1||4
301896|NCT00772967|729812|P3|STARTED|Crossover Treatment 1||3
301897|NCT00772967|729813|P2|STARTED|Crossover Treatment 1||5
301898|NCT00772967|729814|P1|STARTED|Crossover Treatment 1||3
301899|NCT00772954|729834|P3|NOT COMPLETED|Overall Study||1
301900|NCT00772954|729835|P2|NOT COMPLETED|Overall Study||0
301901|NCT00772954|729836|P1|NOT COMPLETED|Overall Study||0
301902|NCT00772954|729834|P3|COMPLETED|Overall Study||11
301903|NCT00772954|729835|P2|COMPLETED|Overall Study||12
301904|NCT00772954|729836|P1|COMPLETED|Overall Study||12
301905|NCT00772954|729834|P3|STARTED|Overall Study||12
301906|NCT00772954|729835|P2|STARTED|Overall Study||12
301907|NCT00772954|729836|P1|STARTED|Overall Study||12
301908|NCT00772941|729844|P1|NOT COMPLETED|Overall Study||682
301909|NCT00772941|729844|P1|COMPLETED|Overall Study||3257
301910|NCT00772941|729844|P1|STARTED|Overall Study||3939
301911|NCT00772928|729875|P2|NOT COMPLETED|Overall Study||41
301912|NCT00772928|729876|P1|NOT COMPLETED|Overall Study||44
301913|NCT00772928|729875|P2|COMPLETED|Overall Study||538
301914|NCT00772928|729876|P1|COMPLETED|Overall Study||543
301915|NCT00772928|729875|P2|STARTED|Overall Study||579
301916|NCT00772928|729876|P1|STARTED|Overall Study||587
301917|NCT00772915|729886|P1|NOT COMPLETED|Overall Study||15
301918|NCT00772915|729886|P1|COMPLETED|Overall Study||23
301919|NCT00772915|729886|P1|STARTED|Overall Study||38
301920|NCT00772889|729893|P3|NOT COMPLETED|Overall Study||16
301921|NCT00772889|729894|P2|NOT COMPLETED|Overall Study||18
301922|NCT00772889|729895|P1|NOT COMPLETED|Overall Study||22
301923|NCT00772889|729893|P3|COMPLETED|Overall Study||187
301924|NCT00772889|729894|P2|COMPLETED|Overall Study||375
301925|NCT00772889|729895|P1|COMPLETED|Overall Study||353
301926|NCT00772889|729893|P3|Completed at Day 21|Overall Study||203
301927|NCT00772889|729894|P2|Completed at Day 21|Overall Study||390
301928|NCT00772889|729895|P1|Completed at Day 21|Overall Study||374
301929|NCT00772889|729893|P3|STARTED|Overall Study||203
301930|NCT00772889|729894|P2|STARTED|Overall Study||393
301931|NCT00772889|729895|P1|STARTED|Overall Study||375
301932|NCT00772772|729948|P1|NOT COMPLETED|Overall Study||0
301933|NCT00772772|729948|P1|COMPLETED|Overall Study||12
301934|NCT00772772|729948|P1|STARTED|Overall Study||12
301935|NCT00772707|729953|P1|NOT COMPLETED|Overall Study||3
301936|NCT00772707|729953|P1|COMPLETED|Overall Study||111
301937|NCT00772707|729953|P1|STARTED|Overall Study||114
301938|NCT00772668|729958|P1|NOT COMPLETED|Overall Study||3
301939|NCT00772668|729958|P1|COMPLETED|Overall Study||0
301940|NCT00772668|729958|P1|STARTED|Overall Study||3
301941|NCT00772629|729967|P2|NOT COMPLETED|Overall Study||0
301942|NCT00772629|729968|P1|NOT COMPLETED|Overall Study||1
301943|NCT00772629|729967|P2|COMPLETED|Overall Study||1
301944|NCT00772629|729968|P1|COMPLETED|Overall Study||16
301945|NCT00772629|729967|P2|STARTED|Overall Study||1
301946|NCT00772629|729968|P1|STARTED|Overall Study||17
301947|NCT00772603|729977|P3|NOT COMPLETED|Overall Study||26
301948|NCT00772603|729978|P2|NOT COMPLETED|Overall Study||40
301949|NCT00772603|729979|P1|NOT COMPLETED|Overall Study||52
301950|NCT00772603|729977|P3|COMPLETED|Overall Study||95
301951|NCT00772603|729978|P2|COMPLETED|Overall Study||82
301952|NCT00772603|729979|P1|COMPLETED|Overall Study||71
301953|NCT00772603|729977|P3|STARTED|Overall Study||121
301954|NCT00772603|729978|P2|STARTED|Overall Study||122
301955|NCT00772603|729979|P1|STARTED|Overall Study||123
301956|NCT00772590|730003|P4|NOT COMPLETED|Overall Study||0
301957|NCT00772590|730004|P3|NOT COMPLETED|Overall Study||0
301958|NCT00772590|730005|P2|NOT COMPLETED|Overall Study||0
301959|NCT00772590|730006|P1|NOT COMPLETED|Overall Study||0
301960|NCT00772590|730003|P4|COMPLETED|Overall Study||17
301961|NCT00772590|730004|P3|COMPLETED|Overall Study||18
301962|NCT00772590|730005|P2|COMPLETED|Overall Study||19
301963|NCT00772590|730006|P1|COMPLETED|Overall Study||19
301964|NCT00772590|730003|P4|STARTED|Overall Study||17
301965|NCT00772590|730004|P3|STARTED|Overall Study||18
301966|NCT00772590|730005|P2|STARTED|Overall Study||19
301967|NCT00772590|730006|P1|STARTED|Overall Study||19
301968|NCT00772577|730018|P2|NOT COMPLETED|Overall Study||23
301969|NCT00772577|730019|P1|NOT COMPLETED|Overall Study||23
301970|NCT00772577|730018|P2|COMPLETED|Overall Study||170
301971|NCT00772577|730019|P1|COMPLETED|Overall Study||170
301972|NCT00772577|730018|P2|STARTED|Overall Study||193
301973|NCT00772577|730019|P1|STARTED|Overall Study||193
301974|NCT00772538|730035|P2|NOT COMPLETED|Overall Study||26
301975|NCT00772538|730036|P1|NOT COMPLETED|Overall Study||20
301976|NCT00772538|730035|P2|COMPLETED|Overall Study||211
301977|NCT00772538|730036|P1|COMPLETED|Overall Study||202
301978|NCT00772538|730035|P2|STARTED|Overall Study||237
301979|NCT00772538|730036|P1|STARTED|Overall Study||222
301980|NCT00772447|730108|P2|NOT COMPLETED|Overall Study||24
301981|NCT00772447|730109|P1|NOT COMPLETED|Overall Study||20
301982|NCT00772447|730108|P2|COMPLETED|Overall Study||110
301983|NCT00772447|730109|P1|COMPLETED|Overall Study||111
301984|NCT00772447|730108|P2|STARTED|Overall Study||134
301985|NCT00772447|730109|P1|STARTED|Overall Study||131
301986|NCT00772382|730137|P1|NOT COMPLETED|Overall Study||55
301987|NCT00772382|730137|P1|COMPLETED|Overall Study||61
301988|NCT00772382|730137|P1|STARTED|Overall Study||116
301989|NCT00772369|730142|P1|NOT COMPLETED|Overall Study||1
301990|NCT00772369|730142|P1|COMPLETED|Overall Study||3213
301991|NCT00772369|730142|P1|STARTED|Overall Study||3214
301992|NCT00772304|730147|P1|NOT COMPLETED|Overall Study||0
301993|NCT00772304|730147|P1|COMPLETED|Overall Study||102
301994|NCT00772304|730147|P1|STARTED|Overall Study||102
301995|NCT00772148|730153|P2|NOT COMPLETED|Maintenance Phase (Week 52)||5
301996|NCT00772148|730154|P1|NOT COMPLETED|Maintenance Phase (Week 52)||4
301997|NCT00772148|730153|P2|COMPLETED|Maintenance Phase (Week 52)||18
301998|NCT00772148|730154|P1|COMPLETED|Maintenance Phase (Week 52)||17
301999|NCT00772148|730153|P2|STARTED|Maintenance Phase (Week 52)||23
302000|NCT00772148|730154|P1|STARTED|Maintenance Phase (Week 52)||21
302001|NCT00772148|730153|P2|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||6
302002|NCT00772148|730154|P1|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||8
302003|NCT00772148|730153|P2|COMPLETED|Pharmacokinetic Phase (14 Days)||23
302004|NCT00772148|730154|P1|COMPLETED|Pharmacokinetic Phase (14 Days)||21
302005|NCT00772148|730153|P2|STARTED|Pharmacokinetic Phase (14 Days)||29
302006|NCT00772148|730154|P1|STARTED|Pharmacokinetic Phase (14 Days)||29
302007|NCT00772109|730174|P4|NOT COMPLETED|Overall Study||31
302008|NCT00772109|730175|P3|NOT COMPLETED|Overall Study||19
302009|NCT00772109|730176|P2|NOT COMPLETED|Overall Study||19
302010|NCT00772109|730177|P1|NOT COMPLETED|Overall Study||21
302011|NCT00772109|730174|P4|COMPLETED|Overall Study||1397
302012|NCT00772109|730175|P3|COMPLETED|Overall Study||936
302013|NCT00772109|730176|P2|COMPLETED|Overall Study||934
302014|NCT00772109|730177|P1|COMPLETED|Overall Study||935
302015|NCT00772109|730174|P4|STARTED|Overall Study||1428
302016|NCT00772109|730175|P3|STARTED|Overall Study||955
302017|NCT00772109|730176|P2|STARTED|Overall Study||953
302018|NCT00772109|730177|P1|STARTED|Overall Study||956
302019|NCT00772070|730201|P2|NOT COMPLETED|Overall Study||10
302020|NCT00772070|730202|P1|NOT COMPLETED|Overall Study||2
302021|NCT00772070|730201|P2|COMPLETED|Overall Study||61
302022|NCT00772070|730202|P1|COMPLETED|Overall Study|Two participants had vaccination errors, they were removed from analysis.|100
302023|NCT00772070|730201|P2|STARTED|Overall Study||71
302024|NCT00772070|730202|P1|STARTED|Overall Study||102
302025|NCT00772031|730214|P2|NOT COMPLETED|Overall Study||43
302026|NCT00772031|730215|P1|NOT COMPLETED|Overall Study||32
302027|NCT00772031|730214|P2|COMPLETED|Overall Study||52
302028|NCT00772031|730215|P1|COMPLETED|Overall Study||64
302029|NCT00772031|730214|P2|STARTED|Overall Study||95
302030|NCT00772031|730215|P1|STARTED|Overall Study||96
302031|NCT00772005|730241|P4|NOT COMPLETED|Overall Study||26
302032|NCT00772005|730242|P3|NOT COMPLETED|Overall Study||28
302033|NCT00772005|730243|P2|NOT COMPLETED|Overall Study||30
302034|NCT00772005|730244|P1|NOT COMPLETED|Overall Study||25
302035|NCT00772005|730241|P4|COMPLETED|Overall Study||46
302036|NCT00772005|730242|P3|COMPLETED|Overall Study||44
302037|NCT00772005|730243|P2|COMPLETED|Overall Study||40
302038|NCT00772005|730244|P1|COMPLETED|Overall Study||46
302039|NCT00772005|730241|P4|STARTED|Overall Study|Two patients withdrew before taking any study drug.|72
302040|NCT00772005|730242|P3|STARTED|Overall Study|One patient withdrew before taking any study drug.|72
302041|NCT00772005|730243|P2|STARTED|Overall Study|One patient withdrew before taking any study drug.|70
302042|NCT00772005|730244|P1|STARTED|Overall Study||71
302043|NCT00771953|730932|P2|NOT COMPLETED|Overall Study||10
302044|NCT00771953|730933|P1|NOT COMPLETED|Overall Study||10
302045|NCT00771953|730932|P2|COMPLETED|Overall Study||26
302046|NCT00771953|730933|P1|COMPLETED|Overall Study||26
302047|NCT00771953|730932|P2|STARTED|Overall Study||36
302048|NCT00771953|730933|P1|STARTED|Overall Study||36
302049|NCT00771927|730943|P2|NOT COMPLETED|Overall Study||237
302050|NCT00771927|730944|P1|NOT COMPLETED|Overall Study||255
302051|NCT00771927|730943|P2|COMPLETED|Overall Study||256
302052|NCT00771927|730944|P1|COMPLETED|Overall Study||256
302053|NCT00771927|730943|P2|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|493
302054|NCT00771927|730944|P1|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|511
302055|NCT00771914|730956|P4|NOT COMPLETED|Overall Study||2
302056|NCT00771914|730957|P3|NOT COMPLETED|Overall Study||0
302057|NCT00771914|730958|P2|NOT COMPLETED|Overall Study||0
302058|NCT00771914|730959|P1|NOT COMPLETED|Overall Study||0
302059|NCT00771914|730956|P4|COMPLETED|Overall Study||6
302060|NCT00771914|730957|P3|COMPLETED|Overall Study||6
302061|NCT00771914|730958|P2|COMPLETED|Overall Study||6
302062|NCT00771914|730959|P1|COMPLETED|Overall Study||7
302063|NCT00771914|730956|P4|STARTED|Overall Study||8
302064|NCT00771914|730957|P3|STARTED|Overall Study||6
302065|NCT00771914|730958|P2|STARTED|Overall Study||6
302066|NCT00771914|730959|P1|STARTED|Overall Study||7
302067|NCT00771901|730972|P3|NOT COMPLETED|Overall Study||4
302068|NCT00771901|730973|P2|NOT COMPLETED|Overall Study||0
302069|NCT00771901|730974|P1|NOT COMPLETED|Overall Study||0
302070|NCT00771901|730972|P3|COMPLETED|Overall Study||6
302071|NCT00771901|730973|P2|COMPLETED|Overall Study||10
302072|NCT00771901|730974|P1|COMPLETED|Overall Study||10
302073|NCT00771901|730972|P3|STARTED|Overall Study||10
302074|NCT00771901|730973|P2|STARTED|Overall Study||10
302075|NCT00771901|730974|P1|STARTED|Overall Study||10
302076|NCT00771875|730991|P3|NOT COMPLETED|Overall Study||0
302077|NCT00771875|730992|P2|NOT COMPLETED|Overall Study||1
302078|NCT00771875|730993|P1|NOT COMPLETED|Overall Study||0
302079|NCT00771875|730991|P3|COMPLETED|Overall Study||10
302080|NCT00771875|730992|P2|COMPLETED|Overall Study||9
302081|NCT00771875|730993|P1|COMPLETED|Overall Study||10
302082|NCT00771875|730991|P3|STARTED|Overall Study||10
302083|NCT00771875|730992|P2|STARTED|Overall Study||10
302084|NCT00771875|730993|P1|STARTED|Overall Study||10
302085|NCT00771849|731021|P2|NOT COMPLETED|Overall Study||4
302086|NCT00771849|731022|P1|NOT COMPLETED|Overall Study||2
302087|NCT00771849|731021|P2|COMPLETED|Overall Study||47
302088|NCT00771849|731022|P1|COMPLETED|Overall Study||50
302089|NCT00771849|731021|P2|STARTED|Overall Study|One subject was not vaccinated|51
302090|NCT00771849|731022|P1|STARTED|Overall Study||52
302091|NCT00771810|731033|P3|NOT COMPLETED|Overall Study||7
302092|NCT00771810|731034|P2|NOT COMPLETED|Overall Study||5
302093|NCT00771810|731035|P1|NOT COMPLETED|Overall Study||5
302094|NCT00771810|731033|P3|COMPLETED|Overall Study||6
302095|NCT00771810|731034|P2|COMPLETED|Overall Study||6
302096|NCT00771810|731035|P1|COMPLETED|Overall Study||5
302097|NCT00771810|731033|P3|STARTED|Overall Study||13
302098|NCT00771810|731034|P2|STARTED|Overall Study||11
302099|NCT00771810|731035|P1|STARTED|Overall Study||10
302100|NCT00771758|731073|P3|NOT COMPLETED|Overall Study||2
302101|NCT00771758|731074|P2|NOT COMPLETED|Overall Study||12
302102|NCT00771758|731075|P1|NOT COMPLETED|Overall Study||8
302103|NCT00771758|731073|P3|COMPLETED|Overall Study||19
302104|NCT00771758|731074|P2|COMPLETED|Overall Study||31
302105|NCT00771758|731075|P1|COMPLETED|Overall Study||36
302106|NCT00771758|731073|P3|STARTED|Overall Study||21
302107|NCT00771758|731074|P2|STARTED|Overall Study||43
302108|NCT00771758|731075|P1|STARTED|Overall Study||44
302109|NCT00771745|731225|P2|NOT COMPLETED|Overall Study||0
302110|NCT00771745|731226|P1|NOT COMPLETED|Overall Study||0
302111|NCT00771745|731225|P2|COMPLETED|Overall Study||5
302112|NCT00771745|731226|P1|COMPLETED|Overall Study||6
302113|NCT00771745|731225|P2|STARTED|Overall Study||5
302114|NCT00771745|731226|P1|STARTED|Overall Study||6
302115|NCT00771667|731236|P10|NOT COMPLETED|Maintenance Phase||17
302116|NCT00771667|731237|P9|NOT COMPLETED|Maintenance Phase||22
302117|NCT00771667|731238|P8|NOT COMPLETED|Maintenance Phase||5
302118|NCT00771667|731239|P7|NOT COMPLETED|Maintenance Phase||10
302119|NCT00771667|731240|P6|NOT COMPLETED|Maintenance Phase||7
302120|NCT00771667|731241|P5|NOT COMPLETED|Maintenance Phase||2
302121|NCT00771667|731242|P4|NOT COMPLETED|Maintenance Phase||0
302122|NCT00771667|731243|P3|NOT COMPLETED|Maintenance Phase||0
302123|NCT00771667|731244|P2|NOT COMPLETED|Maintenance Phase||0
302124|NCT00771667|731245|P1|NOT COMPLETED|Maintenance Phase||0
302125|NCT00771667|731236|P10|COMPLETED|Maintenance Phase||92
302126|NCT00771667|731237|P9|COMPLETED|Maintenance Phase||88
302127|NCT00771667|731238|P8|COMPLETED|Maintenance Phase||67
302128|NCT00771667|731239|P7|COMPLETED|Maintenance Phase||63
302129|NCT00771667|731240|P6|COMPLETED|Maintenance Phase||78
302130|NCT00771667|731241|P5|COMPLETED|Maintenance Phase||26
302131|NCT00771667|731242|P4|COMPLETED|Maintenance Phase||0
302132|NCT00771667|731243|P3|COMPLETED|Maintenance Phase||0
302133|NCT00771667|731244|P2|COMPLETED|Maintenance Phase||0
302134|NCT00771667|731245|P1|COMPLETED|Maintenance Phase||0
302135|NCT00771667|731236|P10|STARTED|Maintenance Phase||109
302136|NCT00771667|731237|P9|STARTED|Maintenance Phase||110
302137|NCT00771667|731238|P8|STARTED|Maintenance Phase||72
302138|NCT00771667|731239|P7|STARTED|Maintenance Phase||73
302139|NCT00771667|731240|P6|STARTED|Maintenance Phase||85
302140|NCT00771667|731241|P5|STARTED|Maintenance Phase||28
302141|NCT00771667|731242|P4|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
302142|NCT00771667|731243|P3|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
302143|NCT00771667|731244|P2|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
302144|NCT00771667|731245|P1|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
302145|NCT00771667|731236|P10|NOT COMPLETED|Induction Phase||0
302146|NCT00771667|731237|P9|NOT COMPLETED|Induction Phase||0
302147|NCT00771667|731238|P8|NOT COMPLETED|Induction Phase||0
302148|NCT00771667|731239|P7|NOT COMPLETED|Induction Phase||0
302149|NCT00771667|731240|P6|NOT COMPLETED|Induction Phase||0
302150|NCT00771667|731241|P5|NOT COMPLETED|Induction Phase||0
302151|NCT00771667|731242|P4|NOT COMPLETED|Induction Phase||8
302152|NCT00771667|731243|P3|NOT COMPLETED|Induction Phase||12
302153|NCT00771667|731244|P2|NOT COMPLETED|Induction Phase||10
302154|NCT00771667|731245|P1|NOT COMPLETED|Induction Phase||19
302155|NCT00771667|731236|P10|COMPLETED|Induction Phase||0
302156|NCT00771667|731237|P9|COMPLETED|Induction Phase||0
302157|NCT00771667|731238|P8|COMPLETED|Induction Phase||0
302158|NCT00771667|731239|P7|COMPLETED|Induction Phase||0
302159|NCT00771667|731240|P6|COMPLETED|Induction Phase||0
302160|NCT00771667|731241|P5|COMPLETED|Induction Phase||0
302161|NCT00771667|731242|P4|COMPLETED|Induction Phase||123
302162|NCT00771667|731243|P3|COMPLETED|Induction Phase||120
302163|NCT00771667|731244|P2|COMPLETED|Induction Phase||121
302164|NCT00771667|731245|P1|COMPLETED|Induction Phase||113
302165|NCT00771667|731236|P10|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
302166|NCT00771667|731237|P9|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
302167|NCT00771667|731238|P8|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
302168|NCT00771667|731239|P7|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
302169|NCT00771667|731240|P6|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
302170|NCT00771667|731241|P5|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
302171|NCT00771667|731242|P4|STARTED|Induction Phase||131
302172|NCT00771667|731243|P3|STARTED|Induction Phase||132
302173|NCT00771667|731244|P2|STARTED|Induction Phase||131
302174|NCT00771667|731245|P1|STARTED|Induction Phase||132
302175|NCT00771615|731290|P9|NOT COMPLETED|Overall Study||0
302176|NCT00771615|731291|P8|NOT COMPLETED|Overall Study||1
302177|NCT00771615|731292|P7|NOT COMPLETED|Overall Study||1
302178|NCT00771615|731293|P6|NOT COMPLETED|Overall Study||1
302179|NCT00771615|731294|P5|NOT COMPLETED|Overall Study||0
302180|NCT00771615|731295|P4|NOT COMPLETED|Overall Study||1
302181|NCT00771615|731296|P3|NOT COMPLETED|Overall Study||1
302182|NCT00771615|731297|P2|NOT COMPLETED|Overall Study||2
302183|NCT00771615|731298|P1|NOT COMPLETED|Overall Study||1
302184|NCT00771615|731290|P9|COMPLETED|Overall Study|Up to Day 364|41
302185|NCT00771615|731291|P8|COMPLETED|Overall Study|Up to Day 364|58
302186|NCT00771615|731292|P7|COMPLETED|Overall Study|Up to Day 364|45
302187|NCT00771615|731293|P6|COMPLETED|Overall Study|Up to Day 364|60
302188|NCT00771615|731294|P5|COMPLETED|Overall Study|Up to Day 364|40
302189|NCT00771615|731295|P4|COMPLETED|Overall Study|Up to Day 364|59
302190|NCT00771615|731296|P3|COMPLETED|Overall Study|Up to Day 364|40
302191|NCT00771615|731297|P2|COMPLETED|Overall Study|Up to Day 364|70
302192|NCT00771615|731298|P1|COMPLETED|Overall Study|Up to Day 364|48
302193|NCT00771615|731290|P9|STARTED|Overall Study||41
302194|NCT00771615|731291|P8|STARTED|Overall Study||59
302195|NCT00771615|731292|P7|STARTED|Overall Study||46
302196|NCT00771615|731293|P6|STARTED|Overall Study||61
302197|NCT00771615|731294|P5|STARTED|Overall Study||40
302198|NCT00771615|731295|P4|STARTED|Overall Study||60
302199|NCT00771615|731296|P3|STARTED|Overall Study||41
302200|NCT00771615|731297|P2|STARTED|Overall Study||72
302201|NCT00771615|731298|P1|STARTED|Overall Study||49
302202|NCT00771602|731492|P3|NOT COMPLETED|Overall Study||0
302203|NCT00771602|731493|P2|NOT COMPLETED|Overall Study||0
302204|NCT00771602|731494|P1|NOT COMPLETED|Overall Study||0
302205|NCT00771602|731492|P3|COMPLETED|Overall Study||0
302206|NCT00771602|731493|P2|COMPLETED|Overall Study||0
302207|NCT00771602|731494|P1|COMPLETED|Overall Study||1
302208|NCT00771602|731492|P3|STARTED|Overall Study||0
302209|NCT00771602|731493|P2|STARTED|Overall Study||0
302210|NCT00771602|731494|P1|STARTED|Overall Study||1
302211|NCT00771537|731518|P16|NOT COMPLETED|Overall Study||0
302212|NCT00771537|731519|P15|NOT COMPLETED|Overall Study||0
302213|NCT00771537|731520|P14|NOT COMPLETED|Overall Study||0
302214|NCT00771537|731521|P13|NOT COMPLETED|Overall Study||0
302215|NCT00771537|731522|P12|NOT COMPLETED|Overall Study||0
302216|NCT00771537|731523|P11|NOT COMPLETED|Overall Study||0
302217|NCT00771537|731524|P10|NOT COMPLETED|Overall Study||0
302218|NCT00771537|731525|P9|NOT COMPLETED|Overall Study||0
302219|NCT00771537|731526|P8|NOT COMPLETED|Overall Study||0
302220|NCT00771537|731527|P7|NOT COMPLETED|Overall Study||0
302221|NCT00771537|731528|P6|NOT COMPLETED|Overall Study||0
302222|NCT00771537|731529|P5|NOT COMPLETED|Overall Study||0
302223|NCT00771537|731530|P4|NOT COMPLETED|Overall Study||0
302224|NCT00771537|731531|P3|NOT COMPLETED|Overall Study||0
302225|NCT00771537|731532|P2|NOT COMPLETED|Overall Study||0
302226|NCT00771537|731533|P1|NOT COMPLETED|Overall Study||0
302227|NCT00771537|731518|P16|COMPLETED|Overall Study||122
302228|NCT00771537|731519|P15|COMPLETED|Overall Study||124
302229|NCT00771537|731520|P14|COMPLETED|Overall Study||124
302230|NCT00771537|731521|P13|COMPLETED|Overall Study||128
302231|NCT00771537|731522|P12|COMPLETED|Overall Study||137
302232|NCT00771537|731523|P11|COMPLETED|Overall Study||133
302233|NCT00771537|731524|P10|COMPLETED|Overall Study||119
302234|NCT00771537|731525|P9|COMPLETED|Overall Study||115
302235|NCT00771537|731526|P8|COMPLETED|Overall Study||132
302236|NCT00771537|731527|P7|COMPLETED|Overall Study||128
302237|NCT00771537|731528|P6|COMPLETED|Overall Study||118
302238|NCT00771537|731529|P5|COMPLETED|Overall Study||127
302239|NCT00771537|731530|P4|COMPLETED|Overall Study||114
302240|NCT00771537|731531|P3|COMPLETED|Overall Study||151
302241|NCT00771537|731532|P2|COMPLETED|Overall Study||124
302242|NCT00771537|731533|P1|COMPLETED|Overall Study||135
302243|NCT00771537|731518|P16|STARTED|Overall Study||122
302244|NCT00771537|731519|P15|STARTED|Overall Study||124
302245|NCT00771537|731520|P14|STARTED|Overall Study||124
302246|NCT00771537|731521|P13|STARTED|Overall Study||128
302247|NCT00771537|731522|P12|STARTED|Overall Study||137
302248|NCT00771537|731523|P11|STARTED|Overall Study||133
302249|NCT00771537|731524|P10|STARTED|Overall Study||119
302250|NCT00771537|731525|P9|STARTED|Overall Study||115
302251|NCT00771537|731526|P8|STARTED|Overall Study||132
302252|NCT00771537|731527|P7|STARTED|Overall Study||128
302253|NCT00771537|731528|P6|STARTED|Overall Study||118
302254|NCT00771537|731529|P5|STARTED|Overall Study||127
302255|NCT00771537|731530|P4|STARTED|Overall Study||114
302256|NCT00771537|731531|P3|STARTED|Overall Study||151
302257|NCT00771537|731532|P2|STARTED|Overall Study||124
302258|NCT00771537|731533|P1|STARTED|Overall Study||135
302259|NCT00771472|731559|P2|NOT COMPLETED|Overall Study||4
302260|NCT00771472|731560|P1|NOT COMPLETED|Overall Study||6
302261|NCT00771472|731559|P2|COMPLETED|Overall Study||0
302262|NCT00771472|731560|P1|COMPLETED|Overall Study||0
302263|NCT00771472|731559|P2|STARTED|Overall Study||4
302264|NCT00771472|731560|P1|STARTED|Overall Study||6
302265|NCT00771407|731571|P2|NOT COMPLETED|Overall Study||25
302266|NCT00771407|731572|P1|NOT COMPLETED|Overall Study||20
302267|NCT00771407|731571|P2|COMPLETED|Overall Study||35
302268|NCT00771407|731572|P1|COMPLETED|Overall Study||40
302269|NCT00771407|731571|P2|STARTED|Overall Study||60
302270|NCT00771407|731572|P1|STARTED|Overall Study||60
302271|NCT00771316|731580|P2|NOT COMPLETED|Overall Study||1
302272|NCT00771316|731581|P1|NOT COMPLETED|Overall Study||2
302273|NCT00771316|731580|P2|COMPLETED|Overall Study||1
302274|NCT00771316|731581|P1|COMPLETED|Overall Study||2
302275|NCT00771316|731580|P2|STARTED|Overall Study||2
302276|NCT00771316|731581|P1|STARTED|Overall Study||4
302277|NCT00771277|731591|P1|NOT COMPLETED|Overall Study||0
302278|NCT00771277|731591|P1|COMPLETED|Overall Study||6
302279|NCT00771277|731591|P1|STARTED|Overall Study||6
302280|NCT00771264|731599|P2|NOT COMPLETED|Overall Study||5
302281|NCT00771264|731600|P1|NOT COMPLETED|Overall Study||7
302282|NCT00771264|731599|P2|COMPLETED|Overall Study||105
302283|NCT00771264|731600|P1|COMPLETED|Overall Study||103
302284|NCT00771264|731599|P2|STARTED|Overall Study||110
302285|NCT00771264|731600|P1|STARTED|Overall Study||110
302286|NCT00771238|731608|P2|NOT COMPLETED|Overall Study||0
302287|NCT00771238|731609|P1|NOT COMPLETED|Overall Study||0
302288|NCT00771238|731608|P2|COMPLETED|Overall Study||21
302289|NCT00771238|731609|P1|COMPLETED|Overall Study||31
302290|NCT00771238|731608|P2|STARTED|Overall Study||21
302291|NCT00771238|731609|P1|STARTED|Overall Study||31
302292|NCT00771173|731619|P2|NOT COMPLETED|Overall Study||17
302293|NCT00771173|731620|P1|NOT COMPLETED|Overall Study||22
302294|NCT00771173|731619|P2|COMPLETED|Overall Study||112
302295|NCT00771173|731620|P1|COMPLETED|Overall Study||107
302296|NCT00771173|731619|P2|STARTED|Overall Study||129
302297|NCT00771173|731620|P1|STARTED|Overall Study||129
302298|NCT00771056|731626|P1|NOT COMPLETED|Overall Study||5
302299|NCT00771056|731626|P1|COMPLETED|Overall Study||18
302300|NCT00771056|731626|P1|STARTED|Overall Study||23
302301|NCT00770991|731633|P2|NOT COMPLETED|Overall Study||5
302302|NCT00770991|731634|P1|NOT COMPLETED|Overall Study||5
302303|NCT00770991|731633|P2|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
302304|NCT00770991|731634|P1|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
302305|NCT00770991|731633|P2|STARTED|Overall Study|We anticipated 26-30 subjects with FAP 18 year or olders would need to be enrolled to randomize 18|12
302306|NCT00770991|731634|P1|STARTED|Overall Study|34 participants enrolled (signed informed consent). 24 subjects were eligible to be randomized.|12
302307|NCT00770965|731650|P4|NOT COMPLETED|Excluded Set||13
302308|NCT00770965|731651|P3|NOT COMPLETED|Excluded Set||14
302309|NCT00770965|731652|P2|NOT COMPLETED|Excluded Set||13
302310|NCT00770965|731653|P1|NOT COMPLETED|Excluded Set||15
302311|NCT00770965|731650|P4|COMPLETED|Excluded Set||2
302312|NCT00770965|731651|P3|COMPLETED|Excluded Set||2
302313|NCT00770965|731652|P2|COMPLETED|Excluded Set||3
302314|NCT00770965|731653|P1|COMPLETED|Excluded Set||3
302315|NCT00770965|731650|P4|STARTED|Excluded Set||15
302316|NCT00770965|731651|P3|STARTED|Excluded Set||16
302317|NCT00770965|731652|P2|STARTED|Excluded Set||16
302318|NCT00770965|731653|P1|STARTED|Excluded Set||18
302319|NCT00770965|731650|P4|NOT COMPLETED|Safety Set||1
302320|NCT00770965|731651|P3|NOT COMPLETED|Safety Set||1
302321|NCT00770965|731652|P2|NOT COMPLETED|Safety Set||0
302322|NCT00770965|731653|P1|NOT COMPLETED|Safety Set||0
302323|NCT00770965|731650|P4|COMPLETED|Safety Set||4
302324|NCT00770965|731651|P3|COMPLETED|Safety Set||3
302325|NCT00770965|731652|P2|COMPLETED|Safety Set||4
302326|NCT00770965|731653|P1|COMPLETED|Safety Set||2
302327|NCT00770965|731650|P4|STARTED|Safety Set||5
302328|NCT00770965|731651|P3|STARTED|Safety Set||4
302329|NCT00770965|731652|P2|STARTED|Safety Set||4
302330|NCT00770965|731653|P1|STARTED|Safety Set||2
302331|NCT00770913|731674|P3|NOT COMPLETED|Overall Study||13
302332|NCT00770913|731675|P2|NOT COMPLETED|Overall Study||8
302333|NCT00770913|731676|P1|NOT COMPLETED|Overall Study||11
302334|NCT00770913|731674|P3|COMPLETED|Overall Study||100
302335|NCT00770913|731675|P2|COMPLETED|Overall Study||103
302336|NCT00770913|731676|P1|COMPLETED|Overall Study||102
302337|NCT00770913|731674|P3|STARTED|Overall Study||113
302338|NCT00770913|731675|P2|STARTED|Overall Study||111
302339|NCT00770913|731676|P1|STARTED|Overall Study||113
302340|NCT00770874|731686|P2|NOT COMPLETED|Overall Study||0
302341|NCT00770874|731687|P1|NOT COMPLETED|Overall Study||0
302342|NCT00770874|731686|P2|COMPLETED|Overall Study||176
302343|NCT00770874|731687|P1|COMPLETED|Overall Study||188
302344|NCT00770874|731686|P2|STARTED|Overall Study||176
302345|NCT00770874|731687|P1|STARTED|Overall Study||188
302346|NCT00770861|731697|P2|NOT COMPLETED|Overall Study||16
302347|NCT00770861|731698|P1|NOT COMPLETED|Overall Study||10
302348|NCT00770861|731697|P2|COMPLETED|Overall Study||120
302349|NCT00770861|731698|P1|COMPLETED|Overall Study||131
302350|NCT00770861|731697|P2|STARTED|Overall Study||136
302351|NCT00770861|731698|P1|STARTED|Overall Study||141
302352|NCT00770809|731709|P3|NOT COMPLETED|Overall Study||23
302353|NCT00770809|731710|P2|NOT COMPLETED|Overall Study||10
302354|NCT00770809|731711|P1|NOT COMPLETED|Overall Study||17
302355|NCT00770809|731709|P3|COMPLETED|Overall Study||44
302356|NCT00770809|731710|P2|COMPLETED|Overall Study||110
302357|NCT00770809|731711|P1|COMPLETED|Overall Study||101
302358|NCT00770809|731709|P3|STARTED|Overall Study||67
302359|NCT00770809|731710|P2|STARTED|Overall Study||120
302360|NCT00770809|731711|P1|STARTED|Overall Study||118
302361|NCT00770770|731721|P2|NOT COMPLETED|Overall Study||1
302362|NCT00770770|731722|P1|NOT COMPLETED|Overall Study||10
302363|NCT00770770|731721|P2|COMPLETED|Overall Study||5
302364|NCT00770770|731722|P1|COMPLETED|Overall Study||4
302365|NCT00770770|731721|P2|STARTED|Overall Study||6
302366|NCT00770770|731722|P1|STARTED|Overall Study||14
302367|NCT00770757|731728|P1|NOT COMPLETED|Overall Study||0
302368|NCT00770757|731728|P1|COMPLETED|Overall Study||13
302369|NCT00770757|731728|P1|STARTED|Overall Study||13
302370|NCT00770692|731740|P4|NOT COMPLETED|Overall Study||11
302371|NCT00770692|731741|P3|NOT COMPLETED|Overall Study||14
302372|NCT00770692|731742|P2|NOT COMPLETED|Overall Study||9
302373|NCT00770692|731743|P1|NOT COMPLETED|Overall Study||12
302374|NCT00770692|731740|P4|COMPLETED|Overall Study||66
302375|NCT00770692|731741|P3|COMPLETED|Overall Study||70
302376|NCT00770692|731742|P2|COMPLETED|Overall Study||74
302377|NCT00770692|731743|P1|COMPLETED|Overall Study||69
302378|NCT00770692|731740|P4|STARTED|Overall Study||77
302379|NCT00770692|731741|P3|STARTED|Overall Study||84
302380|NCT00770692|731742|P2|STARTED|Overall Study||83
302381|NCT00770692|731743|P1|STARTED|Overall Study|"1 participant whose compliance was unknown, was regarded as a treatment compliance unknown"|81
302382|NCT00770679|731769|P1|NOT COMPLETED|Overall Study||6
302383|NCT00770679|731769|P1|COMPLETED|Overall Study||10
302384|NCT00770679|731769|P1|STARTED|Overall Study||16
302385|NCT00770653|731777|P2|NOT COMPLETED|Overall Study||29
302386|NCT00770653|731778|P1|NOT COMPLETED|Overall Study||32
302387|NCT00770653|731777|P2|COMPLETED|Overall Study||121
302388|NCT00770653|731778|P1|COMPLETED|Overall Study||123
302389|NCT00770653|731777|P2|STARTED|Overall Study||150
302390|NCT00770653|731778|P1|STARTED|Overall Study||155
302391|NCT00770588|731848|P2|NOT COMPLETED|Overall Study||95
302392|NCT00770588|731849|P1|NOT COMPLETED|Overall Study||81
302393|NCT00770588|731848|P2|COMPLETED|Overall Study||53
302394|NCT00770588|731849|P1|COMPLETED|Overall Study||67
302395|NCT00770588|731848|P2|STARTED|Overall Study||148
302396|NCT00770588|731849|P1|STARTED|Overall Study||148
302397|NCT00770562|731865|P2|NOT COMPLETED|Overall Study||1
302398|NCT00770562|731866|P1|NOT COMPLETED|Overall Study||1
302399|NCT00770562|731865|P2|COMPLETED|Overall Study||49
302400|NCT00770562|731866|P1|COMPLETED|Overall Study||52
302401|NCT00770562|731865|P2|STARTED|Overall Study||50
302402|NCT00770562|731866|P1|STARTED|Overall Study||53
302403|NCT00770510|731877|P1|NOT COMPLETED|Overall Study||5
302404|NCT00770510|731877|P1|COMPLETED|Overall Study||67
302405|NCT00770510|731877|P1|STARTED|Overall Study||72
302406|NCT00770484|731916|P2|NOT COMPLETED|Overall Study||0
302407|NCT00770484|731917|P1|NOT COMPLETED|Overall Study||1
302408|NCT00770484|731916|P2|COMPLETED|Overall Study||4
302409|NCT00770484|731917|P1|COMPLETED|Overall Study||7
302410|NCT00770484|731916|P2|STARTED|Overall Study||4
302411|NCT00770484|731917|P1|STARTED|Overall Study||8
302412|NCT00770432|731925|P2|NOT COMPLETED|Overall Study||7
302413|NCT00770432|731926|P1|NOT COMPLETED|Overall Study||4
302414|NCT00770432|731925|P2|COMPLETED|Overall Study||94
302415|NCT00770432|731926|P1|COMPLETED|Overall Study||98
302416|NCT00770432|731925|P2|STARTED|Overall Study||101
302417|NCT00770432|731926|P1|STARTED|Overall Study||102
302418|NCT00770367|731934|P2|NOT COMPLETED|Second Intervention||0
302419|NCT00770367|731935|P1|NOT COMPLETED|Second Intervention||2
302420|NCT00770367|731934|P2|COMPLETED|Second Intervention||15
302421|NCT00770367|731935|P1|COMPLETED|Second Intervention||16
302422|NCT00770367|731934|P2|STARTED|Second Intervention||15
302423|NCT00770367|731935|P1|STARTED|Second Intervention||18
302424|NCT00770367|731934|P2|NOT COMPLETED|Washout Period of 4 Weeks||1
302425|NCT00770367|731935|P1|NOT COMPLETED|Washout Period of 4 Weeks||0
302426|NCT00770367|731934|P2|COMPLETED|Washout Period of 4 Weeks||15
302427|NCT00770367|731935|P1|COMPLETED|Washout Period of 4 Weeks||18
302428|NCT00770367|731934|P2|STARTED|Washout Period of 4 Weeks||16
302429|NCT00770367|731935|P1|STARTED|Washout Period of 4 Weeks||18
302430|NCT00770367|731934|P2|NOT COMPLETED|First Intervention||2
302431|NCT00770367|731935|P1|NOT COMPLETED|First Intervention||0
302432|NCT00770367|731934|P2|COMPLETED|First Intervention||16
302433|NCT00770367|731935|P1|COMPLETED|First Intervention||18
302434|NCT00770367|731934|P2|STARTED|First Intervention||18
302435|NCT00770367|731935|P1|STARTED|First Intervention||18
302436|NCT00770341|731946|P3|NOT COMPLETED|Overall Study||3
302437|NCT00770341|731947|P2|NOT COMPLETED|Overall Study||5
302438|NCT00770341|731948|P1|NOT COMPLETED|Overall Study||12
302439|NCT00770341|731946|P3|COMPLETED|Overall Study||8
302440|NCT00770341|731947|P2|COMPLETED|Overall Study||17
302441|NCT00770341|731948|P1|COMPLETED|Overall Study||77
302442|NCT00770341|731946|P3|STARTED|Overall Study|Number randomized|11
302443|NCT00770341|731947|P2|STARTED|Overall Study|Number randomized|22
302444|NCT00770341|731948|P1|STARTED|Overall Study|Number randomized|89
302445|NCT00770328|731974|P2|NOT COMPLETED|Overall Study||4
302446|NCT00770328|731975|P1|NOT COMPLETED|Overall Study||13
302447|NCT00770328|731974|P2|COMPLETED|Overall Study||11
302448|NCT00770328|731975|P1|COMPLETED|Overall Study||9
302449|NCT00770328|731974|P2|STARTED|Overall Study||15
302450|NCT00770328|731975|P1|STARTED|Overall Study||22
302451|NCT00770315|731991|P4|NOT COMPLETED|Overall Study||38
302452|NCT00770315|731992|P3|NOT COMPLETED|Overall Study||57
302453|NCT00770315|731993|P2|NOT COMPLETED|Overall Study||43
302454|NCT00770315|731994|P1|NOT COMPLETED|Overall Study||40
302455|NCT00770315|731991|P4|COMPLETED|Overall Study||160
302456|NCT00770315|731992|P3|COMPLETED|Overall Study||137
302457|NCT00770315|731993|P2|COMPLETED|Overall Study||152
302458|NCT00770315|731994|P1|COMPLETED|Overall Study||157
302459|NCT00770315|731991|P4|STARTED|Overall Study||198
302460|NCT00770315|731992|P3|STARTED|Overall Study||194
302461|NCT00770315|731993|P2|STARTED|Overall Study||195
302462|NCT00770315|731994|P1|STARTED|Overall Study||197
302463|NCT00770289|732020|P1|NOT COMPLETED|Overall Study||6
302464|NCT00770289|732020|P1|COMPLETED|Overall Study||845
302465|NCT00770289|732020|P1|STARTED|Overall Study||851
302466|NCT00770224|732029|P2|NOT COMPLETED|Step 2: Maintenance||30
302467|NCT00770224|732030|P1|NOT COMPLETED|Step 2: Maintenance||0
302468|NCT00770224|732029|P2|COMPLETED|Step 2: Maintenance||41
302469|NCT00770224|732030|P1|COMPLETED|Step 2: Maintenance||0
302470|NCT00770224|732029|P2|Eligible and Evaluable|Step 2: Maintenance||69
302471|NCT00770224|732030|P1|Eligible and Evaluable|Step 2: Maintenance||0
302472|NCT00770224|732029|P2|STARTED|Step 2: Maintenance||71
302473|NCT00770224|732030|P1|STARTED|Step 2: Maintenance||0
302474|NCT00770224|732029|P2|NOT COMPLETED|Step 1: Induction||0
302475|NCT00770224|732030|P1|NOT COMPLETED|Step 1: Induction||14
302476|NCT00770224|732029|P2|COMPLETED|Step 1: Induction||0
302477|NCT00770224|732030|P1|COMPLETED|Step 1: Induction||73
302478|NCT00770224|732029|P2|Eligible and Evaluable|Step 1: Induction||0
302479|NCT00770224|732030|P1|Eligible and Evaluable|Step 1: Induction||84
302480|NCT00770224|732029|P2|STARTED|Step 1: Induction||0
302481|NCT00770224|732030|P1|STARTED|Step 1: Induction||87
302482|NCT00770211|732042|P2|NOT COMPLETED|Overall Study||2
302483|NCT00770211|732043|P1|NOT COMPLETED|Overall Study||1
302484|NCT00770211|732042|P2|COMPLETED|Overall Study||87
302485|NCT00770211|732043|P1|COMPLETED|Overall Study||181
302486|NCT00770211|732042|P2|STARTED|Overall Study||89
302487|NCT00770211|732043|P1|STARTED|Overall Study||182
302488|NCT00770146|732059|P2|NOT COMPLETED|Follow-up Period||20
302489|NCT00770146|732060|P1|NOT COMPLETED|Follow-up Period||11
302490|NCT00770146|732059|P2|COMPLETED|Follow-up Period||85
302491|NCT00770146|732060|P1|COMPLETED|Follow-up Period||42
302492|NCT00770146|732059|P2|STARTED|Follow-up Period||105
302493|NCT00770146|732060|P1|STARTED|Follow-up Period||53
302494|NCT00770146|732059|P2|NOT COMPLETED|Treatment Period||45
302495|NCT00770146|732060|P1|NOT COMPLETED|Treatment Period||9
302496|NCT00770146|732059|P2|COMPLETED|Treatment Period||60
302497|NCT00770146|732060|P1|COMPLETED|Treatment Period||44
302498|NCT00770146|732059|P2|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|101
302499|NCT00770146|732060|P1|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|50
302500|NCT00770146|732059|P2|Treated|Treatment Period||105
302501|NCT00770146|732060|P1|Treated|Treatment Period||52
302502|NCT00770146|732059|P2|STARTED|Treatment Period||105
302503|NCT00770146|732060|P1|STARTED|Treatment Period||53
302504|NCT00770120|732104|P1|NOT COMPLETED|Overall Study||61
302505|NCT00770120|732104|P1|COMPLETED|Overall Study||0
302506|NCT00770120|732104|P1|Not Analyzable|Overall Study||1
302507|NCT00770120|732104|P1|Eligible|Overall Study||60
302508|NCT00770120|732104|P1|STARTED|Overall Study||61
302509|NCT00770029|732113|P2|NOT COMPLETED|Overall Study||3
302510|NCT00770029|732114|P1|NOT COMPLETED|Overall Study||6
302511|NCT00770029|732113|P2|COMPLETED|Overall Study||89
302512|NCT00770029|732114|P1|COMPLETED|Overall Study||178
302513|NCT00770029|732113|P2|STARTED|Overall Study||92
302514|NCT00770029|732114|P1|STARTED|Overall Study||184
302515|NCT00769860|732130|P2|NOT COMPLETED|Overall Study||0
302516|NCT00769860|732131|P1|NOT COMPLETED|Overall Study||2
302517|NCT00769860|732130|P2|COMPLETED|Overall Study||8
302518|NCT00769860|732131|P1|COMPLETED|Overall Study||14
302519|NCT00769860|732130|P2|Month 8|Overall Study||8
302520|NCT00769860|732131|P1|Month 8|Overall Study||14
302521|NCT00769860|732130|P2|Month 4|Overall Study||8
302522|NCT00769860|732131|P1|Month 4|Overall Study||16
302523|NCT00769860|732130|P2|STARTED|Overall Study||8
302524|NCT00769860|732131|P1|STARTED|Overall Study||16
302525|NCT00769704|732159|P2|NOT COMPLETED|Overall Study||199
302526|NCT00769704|732160|P1|NOT COMPLETED|Overall Study||111
302527|NCT00769704|732159|P2|COMPLETED|Overall Study||97
302528|NCT00769704|732160|P1|COMPLETED|Overall Study||30
302529|NCT00769704|732159|P2|Received Treatment|Overall Study||292
302530|NCT00769704|732160|P1|Received Treatment|Overall Study||127
302531|NCT00769704|732159|P2|Intent-to-treat Population|Overall Study|Participants who were randomized once to study treatment; excludes 1 participant randomized 3 times|295
302532|NCT00769704|732160|P1|Intent-to-treat Population|Overall Study|All participants who were randomized once to study treatment|141
302533|NCT00769704|732159|P2|STARTED|Overall Study||296
302534|NCT00769704|732160|P1|STARTED|Overall Study||141
302535|NCT00769652|732180|P2|NOT COMPLETED|Overall Study||0
302536|NCT00769652|732181|P1|NOT COMPLETED|Overall Study||0
302537|NCT00769652|732180|P2|COMPLETED|Overall Study||1
302538|NCT00769652|732181|P1|COMPLETED|Overall Study||6
302539|NCT00769652|732180|P2|STARTED|Overall Study||1
302540|NCT00769652|732181|P1|STARTED|Overall Study||6
302541|NCT00769600|732193|P2|NOT COMPLETED|Overall Study||0
302542|NCT00769600|732194|P1|NOT COMPLETED|Overall Study||0
302543|NCT00769600|732193|P2|COMPLETED|Overall Study||8
302544|NCT00769600|732194|P1|COMPLETED|Overall Study||15
302545|NCT00769600|732193|P2|STARTED|Overall Study||8
302546|NCT00769600|732194|P1|STARTED|Overall Study||15
302547|NCT00769561|732210|P2|NOT COMPLETED|Overall Study||5
302548|NCT00769561|732211|P1|NOT COMPLETED|Overall Study||3
302549|NCT00769561|732210|P2|COMPLETED|Overall Study||24
302550|NCT00769561|732211|P1|COMPLETED|Overall Study||26
302551|NCT00769561|732210|P2|STARTED|Overall Study||29
302552|NCT00769561|732211|P1|STARTED|Overall Study||29
302553|NCT00769483|732237|P6|NOT COMPLETED|Overall Study||0
302554|NCT00769483|732238|P5|NOT COMPLETED|Overall Study||1
302555|NCT00769483|732239|P4|NOT COMPLETED|Overall Study||0
302556|NCT00769483|732240|P3|NOT COMPLETED|Overall Study||0
302557|NCT00769483|732241|P2|NOT COMPLETED|Overall Study||1
302558|NCT00769483|732242|P1|NOT COMPLETED|Overall Study||0
302559|NCT00769483|732237|P6|COMPLETED|Overall Study||9
302560|NCT00769483|732238|P5|COMPLETED|Overall Study||15
302561|NCT00769483|732239|P4|COMPLETED|Overall Study||15
302562|NCT00769483|732240|P3|COMPLETED|Overall Study||15
302563|NCT00769483|732241|P2|COMPLETED|Overall Study||12
302564|NCT00769483|732242|P1|COMPLETED|Overall Study||9
302565|NCT00769483|732237|P6|STARTED|Overall Study||9
302566|NCT00769483|732238|P5|STARTED|Overall Study||16
302567|NCT00769483|732239|P4|STARTED|Overall Study||15
302568|NCT00769483|732240|P3|STARTED|Overall Study||15
302569|NCT00769483|732241|P2|STARTED|Overall Study||13
302570|NCT00769483|732242|P1|STARTED|Overall Study||9
302571|NCT00769392|732280|P1|NOT COMPLETED|Overall Study||4
302572|NCT00769392|732280|P1|COMPLETED|Overall Study||24
302573|NCT00769392|732280|P1|STARTED|Overall Study||28
302574|NCT00769314|732287|P2|NOT COMPLETED|Overall Study||13
302575|NCT00769314|732288|P1|NOT COMPLETED|Overall Study||17
302576|NCT00769314|732287|P2|COMPLETED|Overall Study||384
302577|NCT00769314|732288|P1|COMPLETED|Overall Study||361
302578|NCT00769314|732287|P2|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|397
302579|NCT00769314|732288|P1|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|378
302580|NCT00769184|732314|P2|NOT COMPLETED|No Treatment (6 Weeks)||1
302581|NCT00769184|732315|P1|NOT COMPLETED|No Treatment (6 Weeks)||1
302582|NCT00769184|732314|P2|COMPLETED|No Treatment (6 Weeks)||6
302583|NCT00769184|732315|P1|COMPLETED|No Treatment (6 Weeks)||5
302584|NCT00769184|732314|P2|STARTED|No Treatment (6 Weeks)||7
302585|NCT00769184|732315|P1|STARTED|No Treatment (6 Weeks)||6
302586|NCT00769184|732314|P2|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
302587|NCT00769184|732315|P1|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
302588|NCT00769184|732314|P2|COMPLETED|+LCD / +Placebo Only (4 Weeks)||7
302589|NCT00769184|732315|P1|COMPLETED|+LCD / +Placebo Only (4 Weeks)||6
302590|NCT00769184|732314|P2|STARTED|+LCD / +Placebo Only (4 Weeks)||7
302591|NCT00769184|732315|P1|STARTED|+LCD / +Placebo Only (4 Weeks)||6
302592|NCT00769184|732314|P2|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
302593|NCT00769184|732315|P1|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
302594|NCT00769184|732314|P2|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
302595|NCT00769184|732315|P1|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||6
302596|NCT00769184|732314|P2|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||8
302597|NCT00769184|732315|P1|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
302598|NCT00769132|732323|P4|NOT COMPLETED|Period 4||0
302599|NCT00769132|732324|P3|NOT COMPLETED|Period 4||0
302600|NCT00769132|732325|P2|NOT COMPLETED|Period 4||1
302601|NCT00769132|732326|P1|NOT COMPLETED|Period 4||0
302602|NCT00769132|732323|P4|COMPLETED|Period 4||5
302603|NCT00769132|732324|P3|COMPLETED|Period 4||6
302604|NCT00769132|732325|P2|COMPLETED|Period 4||5
302605|NCT00769132|732326|P1|COMPLETED|Period 4||5
302606|NCT00769132|732323|P4|STARTED|Period 4||5
302607|NCT00769132|732324|P3|STARTED|Period 4||6
302608|NCT00769132|732325|P2|STARTED|Period 4||6
302609|NCT00769132|732326|P1|STARTED|Period 4||5
302610|NCT00769132|732323|P4|NOT COMPLETED|Period 3||0
302611|NCT00769132|732324|P3|NOT COMPLETED|Period 3||0
302612|NCT00769132|732325|P2|NOT COMPLETED|Period 3||0
302613|NCT00769132|732326|P1|NOT COMPLETED|Period 3||1
302614|NCT00769132|732323|P4|COMPLETED|Period 3||5
302615|NCT00769132|732324|P3|COMPLETED|Period 3||6
302616|NCT00769132|732325|P2|COMPLETED|Period 3||6
302617|NCT00769132|732326|P1|COMPLETED|Period 3||5
302618|NCT00769132|732323|P4|STARTED|Period 3||5
302619|NCT00769132|732324|P3|STARTED|Period 3||6
302620|NCT00769132|732325|P2|STARTED|Period 3||6
302621|NCT00769132|732326|P1|STARTED|Period 3||6
302622|NCT00769132|732323|P4|NOT COMPLETED|Period 2||1
302623|NCT00769132|732324|P3|NOT COMPLETED|Period 2||0
302624|NCT00769132|732325|P2|NOT COMPLETED|Period 2||0
302625|NCT00769132|732326|P1|NOT COMPLETED|Period 2||0
302626|NCT00769132|732323|P4|COMPLETED|Period 2||5
302627|NCT00769132|732324|P3|COMPLETED|Period 2||6
302628|NCT00769132|732325|P2|COMPLETED|Period 2||6
302629|NCT00769132|732326|P1|COMPLETED|Period 2||6
302630|NCT00769132|732323|P4|STARTED|Period 2||6
302631|NCT00769132|732324|P3|STARTED|Period 2||6
302632|NCT00769132|732325|P2|STARTED|Period 2||6
302633|NCT00769132|732326|P1|STARTED|Period 2||6
302634|NCT00769132|732323|P4|NOT COMPLETED|Period 1||1
302635|NCT00769132|732324|P3|NOT COMPLETED|Period 1||0
302636|NCT00769132|732325|P2|NOT COMPLETED|Period 1||0
302637|NCT00769132|732326|P1|NOT COMPLETED|Period 1||1
302638|NCT00769132|732323|P4|COMPLETED|Period 1||6
302639|NCT00769132|732324|P3|COMPLETED|Period 1||6
302640|NCT00769132|732325|P2|COMPLETED|Period 1||6
302641|NCT00769132|732326|P1|COMPLETED|Period 1||6
302642|NCT00769132|732323|P4|STARTED|Period 1||7
302643|NCT00769132|732324|P3|STARTED|Period 1||6
302644|NCT00769132|732325|P2|STARTED|Period 1||6
302645|NCT00769132|732326|P1|STARTED|Period 1||7
302646|NCT00769119|732342|P2|NOT COMPLETED|Overall Study||3
302647|NCT00769119|732343|P1|NOT COMPLETED|Overall Study||2
302648|NCT00769119|732342|P2|COMPLETED|Overall Study||13
302649|NCT00769119|732343|P1|COMPLETED|Overall Study||20
302650|NCT00769119|732342|P2|STARTED|Overall Study||16
302651|NCT00769119|732343|P1|STARTED|Overall Study||22
302652|NCT00769067|732389|P2|NOT COMPLETED|Overall Study||94
302653|NCT00769067|732390|P1|NOT COMPLETED|Overall Study||94
302654|NCT00769067|732389|P2|COMPLETED|Overall Study||0
302655|NCT00769067|732390|P1|COMPLETED|Overall Study||0
302656|NCT00769067|732389|P2|Treated|Overall Study|One participant was not treated: refused treatment for reason other than an adverse event (AE).|93
302657|NCT00769067|732390|P1|Treated|Overall Study||94
302658|NCT00769067|732389|P2|STARTED|Overall Study||94
302659|NCT00769067|732390|P1|STARTED|Overall Study||94
302660|NCT00769015|732417|P2|NOT COMPLETED|Overall Study||16
302661|NCT00769015|732418|P1|NOT COMPLETED|Overall Study||9
302662|NCT00769015|732417|P2|COMPLETED|Overall Study||76
302663|NCT00769015|732418|P1|COMPLETED|Overall Study||87
302664|NCT00769015|732417|P2|STARTED|Overall Study||92
302665|NCT00769015|732418|P1|STARTED|Overall Study||96
302666|NCT00768989|732438|P2|NOT COMPLETED|On or After Week 36||27
302667|NCT00768989|732439|P1|NOT COMPLETED|On or After Week 36||51
302668|NCT00768989|732438|P2|COMPLETED|On or After Week 36||0
302669|NCT00768989|732439|P1|COMPLETED|On or After Week 36||0
302670|NCT00768989|732438|P2|STARTED|On or After Week 36||27
302671|NCT00768989|732439|P1|STARTED|On or After Week 36||51
302672|NCT00768989|732438|P2|NOT COMPLETED|Week 24 to Prior to Week 36||0
302673|NCT00768989|732439|P1|NOT COMPLETED|Week 24 to Prior to Week 36||8
302674|NCT00768989|732438|P2|COMPLETED|Week 24 to Prior to Week 36||27
302675|NCT00768989|732439|P1|COMPLETED|Week 24 to Prior to Week 36||51
302676|NCT00768989|732438|P2|STARTED|Week 24 to Prior to Week 36||27
302677|NCT00768989|732439|P1|STARTED|Week 24 to Prior to Week 36||59
302678|NCT00768989|732438|P2|NOT COMPLETED|Prior to Week 24||3
302679|NCT00768989|732439|P1|NOT COMPLETED|Prior to Week 24||4
302680|NCT00768989|732438|P2|COMPLETED|Prior to Week 24||27
302681|NCT00768989|732439|P1|COMPLETED|Prior to Week 24||59
302682|NCT00768989|732438|P2|STARTED|Prior to Week 24||30
302683|NCT00768989|732439|P1|STARTED|Prior to Week 24||63
302684|NCT00768898|732487|P1|NOT COMPLETED|Overall Study||2
302685|NCT00768898|732487|P1|COMPLETED|Overall Study||28
302686|NCT00768898|732487|P1|STARTED|Overall Study||30
302687|NCT00768755|732511|P4|NOT COMPLETED|Phase 2||57
302688|NCT00768755|732512|P3|NOT COMPLETED|Phase 2||58
302689|NCT00768755|732513|P2|NOT COMPLETED|Phase 2||55
302690|NCT00768755|732514|P1|NOT COMPLETED|Phase 2||0
302691|NCT00768755|732511|P4|COMPLETED|Phase 2||0
302692|NCT00768755|732512|P3|COMPLETED|Phase 2||0
302693|NCT00768755|732513|P2|COMPLETED|Phase 2||0
302694|NCT00768755|732514|P1|COMPLETED|Phase 2||0
302695|NCT00768755|732511|P4|Treated|Phase 2||55
302696|NCT00768755|732512|P3|Treated|Phase 2||58
302697|NCT00768755|732513|P2|Treated|Phase 2||55
302698|NCT00768755|732514|P1|Treated|Phase 2||0
302699|NCT00768755|732511|P4|STARTED|Phase 2||57
302700|NCT00768755|732512|P3|STARTED|Phase 2||58
302701|NCT00768755|732513|P2|STARTED|Phase 2||55
302702|NCT00768755|732514|P1|STARTED|Phase 2||0
302703|NCT00768755|732511|P4|NOT COMPLETED|Phase 1||0
302704|NCT00768755|732512|P3|NOT COMPLETED|Phase 1||0
302705|NCT00768755|732513|P2|NOT COMPLETED|Phase 1||0
302706|NCT00768755|732514|P1|NOT COMPLETED|Phase 1||10
302707|NCT00768755|732511|P4|COMPLETED|Phase 1||0
302708|NCT00768755|732512|P3|COMPLETED|Phase 1||0
302709|NCT00768755|732513|P2|COMPLETED|Phase 1||0
302710|NCT00768755|732514|P1|COMPLETED|Phase 1||0
302711|NCT00768755|732511|P4|STARTED|Phase 1||0
302712|NCT00768755|732512|P3|STARTED|Phase 1||0
302713|NCT00768755|732513|P2|STARTED|Phase 1||0
302714|NCT00768755|732514|P1|STARTED|Phase 1||10
302715|NCT00768716|732540|P2|NOT COMPLETED|Overall Study||0
302716|NCT00768716|732541|P1|NOT COMPLETED|Overall Study||0
302717|NCT00768716|732540|P2|COMPLETED|Overall Study||41
302718|NCT00768716|732541|P1|COMPLETED|Overall Study||54
302719|NCT00768716|732540|P2|STARTED|Overall Study||41
302720|NCT00768716|732541|P1|STARTED|Overall Study||54
302721|NCT00768651|732562|P1|NOT COMPLETED|Overall Study||1
302722|NCT00768651|732562|P1|COMPLETED|Overall Study||7
302723|NCT00768651|732562|P1|STARTED|Overall Study||8
302724|NCT00768599|732570|P3|NOT COMPLETED|Overall Study||12
302725|NCT00768599|732571|P2|NOT COMPLETED|Overall Study||16
302726|NCT00768599|732572|P1|NOT COMPLETED|Overall Study||11
302727|NCT00768599|732570|P3|COMPLETED|Overall Study||35
302728|NCT00768599|732571|P2|COMPLETED|Overall Study||27
302729|NCT00768599|732572|P1|COMPLETED|Overall Study||34
302730|NCT00768599|732570|P3|STARTED|Overall Study||47
302731|NCT00768599|732571|P2|STARTED|Overall Study||43
302732|NCT00768599|732572|P1|STARTED|Overall Study||45
302733|NCT00768560|732601|P6|NOT COMPLETED|Intervention Set 3||0
302734|NCT00768560|732602|P5|NOT COMPLETED|Intervention Set 3||0
302735|NCT00768560|732603|P4|NOT COMPLETED|Intervention Set 3||0
302736|NCT00768560|732604|P3|NOT COMPLETED|Intervention Set 3||0
302737|NCT00768560|732605|P2|NOT COMPLETED|Intervention Set 3||0
302738|NCT00768560|732606|P1|NOT COMPLETED|Intervention Set 3||0
302739|NCT00768560|732601|P6|COMPLETED|Intervention Set 3||6
302740|NCT00768560|732602|P5|COMPLETED|Intervention Set 3||6
302741|NCT00768560|732603|P4|COMPLETED|Intervention Set 3||6
302742|NCT00768560|732604|P3|COMPLETED|Intervention Set 3||6
302743|NCT00768560|732605|P2|COMPLETED|Intervention Set 3||5
302744|NCT00768560|732606|P1|COMPLETED|Intervention Set 3||5
302745|NCT00768560|732601|P6|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
302746|NCT00768560|732602|P5|STARTED|Intervention Set 3|40 mg BID for 2 weeks|6
302747|NCT00768560|732603|P4|STARTED|Intervention Set 3|80 mg OD for 2 weeks|6
302748|NCT00768560|732604|P3|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
302749|NCT00768560|732605|P2|STARTED|Intervention Set 3|40 mg BID for 2 weeks|5
302750|NCT00768560|732606|P1|STARTED|Intervention Set 3|80 mg OD for 2 weeks|5
302751|NCT00768560|732601|P6|NOT COMPLETED|Intervention Set 2||0
302752|NCT00768560|732602|P5|NOT COMPLETED|Intervention Set 2||0
302753|NCT00768560|732603|P4|NOT COMPLETED|Intervention Set 2||0
302754|NCT00768560|732604|P3|NOT COMPLETED|Intervention Set 2||0
302755|NCT00768560|732605|P2|NOT COMPLETED|Intervention Set 2||0
302756|NCT00768560|732606|P1|NOT COMPLETED|Intervention Set 2||0
302757|NCT00768560|732601|P6|COMPLETED|Intervention Set 2||6
302758|NCT00768560|732602|P5|COMPLETED|Intervention Set 2||6
302759|NCT00768560|732603|P4|COMPLETED|Intervention Set 2||6
302760|NCT00768560|732604|P3|COMPLETED|Intervention Set 2||6
302761|NCT00768560|732605|P2|COMPLETED|Intervention Set 2||5
302762|NCT00768560|732606|P1|COMPLETED|Intervention Set 2||5
302763|NCT00768560|732601|P6|STARTED|Intervention Set 2|40 mg BID for 2 weeks|6
302764|NCT00768560|732602|P5|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
302765|NCT00768560|732603|P4|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
302766|NCT00768560|732604|P3|STARTED|Intervention Set 2|80 mg OD for 2 weeks|6
302767|NCT00768560|732605|P2|STARTED|Intervention Set 2|80 mg OD for 2 weeks|5
302768|NCT00768560|732606|P1|STARTED|Intervention Set 2|40 mg BID for 2 weeks|5
302769|NCT00768560|732601|P6|NOT COMPLETED|Intervention Set 1||0
302770|NCT00768560|732602|P5|NOT COMPLETED|Intervention Set 1||0
302771|NCT00768560|732603|P4|NOT COMPLETED|Intervention Set 1||0
302772|NCT00768560|732604|P3|NOT COMPLETED|Intervention Set 1||0
302773|NCT00768560|732605|P2|NOT COMPLETED|Intervention Set 1||1
302774|NCT00768560|732606|P1|NOT COMPLETED|Intervention Set 1||0
302775|NCT00768560|732601|P6|COMPLETED|Intervention Set 1||6
302776|NCT00768560|732602|P5|COMPLETED|Intervention Set 1||6
302777|NCT00768560|732603|P4|COMPLETED|Intervention Set 1||6
302778|NCT00768560|732604|P3|COMPLETED|Intervention Set 1||6
302779|NCT00768560|732605|P2|COMPLETED|Intervention Set 1||5
302780|NCT00768560|732606|P1|COMPLETED|Intervention Set 1||5
302781|NCT00768560|732601|P6|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
302782|NCT00768560|732602|P5|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
302783|NCT00768560|732603|P4|Subjects Received Treatment|Intervention Set 1|40 mg BID for 2 weeks|6
302784|NCT00768560|732604|P3|Subjects Received Treatment|Intervention Set 1|40 mg twice daily (BID) for 2 weeks|6
302785|NCT00768560|732605|P2|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|6
302786|NCT00768560|732606|P1|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|5
302787|NCT00768560|732601|P6|STARTED|Intervention Set 1|3-period/treatment crossover|6
302788|NCT00768560|732602|P5|STARTED|Intervention Set 1|3-period/treatment crossover|6
302789|NCT00768560|732603|P4|STARTED|Intervention Set 1|3-period/treatment crossover|6
302790|NCT00768560|732604|P3|STARTED|Intervention Set 1|3-period/treatment crossover|6
302791|NCT00768560|732605|P2|STARTED|Intervention Set 1|3-period/treatment crossover|6
302792|NCT00768560|732606|P1|STARTED|Intervention Set 1|3-period/treatment crossover|5
302793|NCT00768521|732632|P2|NOT COMPLETED|Period 2||0
302794|NCT00768521|732633|P1|NOT COMPLETED|Period 2||0
302795|NCT00768521|732632|P2|COMPLETED|Period 2||11
302796|NCT00768521|732633|P1|COMPLETED|Period 2||9
302797|NCT00768521|732632|P2|STARTED|Period 2||11
302798|NCT00768521|732633|P1|STARTED|Period 2||9
302799|NCT00768521|732632|P2|NOT COMPLETED|Period 1||0
302800|NCT00768521|732633|P1|NOT COMPLETED|Period 1||0
302801|NCT00768521|732632|P2|COMPLETED|Period 1||11
302802|NCT00768521|732633|P1|COMPLETED|Period 1||9
302803|NCT00768521|732632|P2|STARTED|Period 1||11
302804|NCT00768521|732633|P1|STARTED|Period 1||9
302805|NCT00768469|732643|P2|NOT COMPLETED|Overall Study||7
302806|NCT00768469|732644|P1|NOT COMPLETED|Overall Study||3
302807|NCT00768469|732643|P2|COMPLETED|Overall Study||0
302808|NCT00768469|732644|P1|COMPLETED|Overall Study||0
302809|NCT00768469|732643|P2|STARTED|Overall Study||7
302810|NCT00768469|732644|P1|STARTED|Overall Study||3
302811|NCT00768430|732659|P2|NOT COMPLETED|7 Day Endpoint||3
302812|NCT00768430|732660|P1|NOT COMPLETED|7 Day Endpoint||2
302813|NCT00768430|732659|P2|COMPLETED|7 Day Endpoint||22
302814|NCT00768430|732660|P1|COMPLETED|7 Day Endpoint||45
302815|NCT00768430|732659|P2|STARTED|7 Day Endpoint||25
302816|NCT00768430|732660|P1|STARTED|7 Day Endpoint||47
302817|NCT00768430|732659|P2|NOT COMPLETED|24 Hour Endpoint||0
302818|NCT00768430|732660|P1|NOT COMPLETED|24 Hour Endpoint||1
302819|NCT00768430|732659|P2|COMPLETED|24 Hour Endpoint||25
302820|NCT00768430|732660|P1|COMPLETED|24 Hour Endpoint||47
302821|NCT00768430|732659|P2|STARTED|24 Hour Endpoint||25
302822|NCT00768430|732660|P1|STARTED|24 Hour Endpoint||48
302823|NCT00768300|732668|P2|NOT COMPLETED|Overall Study||163
302824|NCT00768300|732669|P1|NOT COMPLETED|Overall Study||329
302825|NCT00768300|732668|P2|COMPLETED|Overall Study||1
302826|NCT00768300|732669|P1|COMPLETED|Overall Study||1
302827|NCT00768300|732668|P2|Randomized and Treated|Overall Study||163
302828|NCT00768300|732669|P1|Randomized and Treated|Overall Study||329
302829|NCT00768300|732668|P2|STARTED|Overall Study||164
302830|NCT00768300|732669|P1|STARTED|Overall Study||330
302831|NCT00768287|732691|P6|NOT COMPLETED|Surgical Sub-study||0
302832|NCT00768287|732692|P5|NOT COMPLETED|Surgical Sub-study||0
302833|NCT00768287|732693|P4|NOT COMPLETED|Surgical Sub-study||0
302834|NCT00768287|732694|P3|NOT COMPLETED|Surgical Sub-study||0
302835|NCT00768287|732695|P2|NOT COMPLETED|Surgical Sub-study||0
302836|NCT00768287|732696|P1|NOT COMPLETED|Surgical Sub-study||0
302837|NCT00768287|732691|P6|COMPLETED|Surgical Sub-study||17
302838|NCT00768287|732692|P5|COMPLETED|Surgical Sub-study||0
302839|NCT00768287|732693|P4|COMPLETED|Surgical Sub-study||0
302840|NCT00768287|732694|P3|COMPLETED|Surgical Sub-study||0
302841|NCT00768287|732695|P2|COMPLETED|Surgical Sub-study||0
302842|NCT00768287|732696|P1|COMPLETED|Surgical Sub-study||0
302843|NCT00768287|732691|P6|STARTED|Surgical Sub-study|1 female subject was excluded from the efficacy analysis. She was included in the safety population.|17
302844|NCT00768287|732692|P5|STARTED|Surgical Sub-study||0
302845|NCT00768287|732693|P4|STARTED|Surgical Sub-study||0
302846|NCT00768287|732694|P3|STARTED|Surgical Sub-study||0
302847|NCT00768287|732695|P2|STARTED|Surgical Sub-study||0
302848|NCT00768287|732696|P1|STARTED|Surgical Sub-study||0
302849|NCT00768287|732691|P6|NOT COMPLETED|Treatment Study||0
302850|NCT00768287|732692|P5|NOT COMPLETED|Treatment Study||0
302851|NCT00768287|732693|P4|NOT COMPLETED|Treatment Study||0
302852|NCT00768287|732694|P3|NOT COMPLETED|Treatment Study||0
302853|NCT00768287|732695|P2|NOT COMPLETED|Treatment Study||0
302854|NCT00768287|732696|P1|NOT COMPLETED|Treatment Study||0
302855|NCT00768287|732691|P6|COMPLETED|Treatment Study||0
302856|NCT00768287|732692|P5|COMPLETED|Treatment Study||9
302857|NCT00768287|732693|P4|COMPLETED|Treatment Study||58
302858|NCT00768287|732694|P3|COMPLETED|Treatment Study||0
302859|NCT00768287|732695|P2|COMPLETED|Treatment Study||0
302860|NCT00768287|732696|P1|COMPLETED|Treatment Study||0
302861|NCT00768287|732691|P6|Treated|Treatment Study||0
302862|NCT00768287|732692|P5|Treated|Treatment Study|Subjects could switch treatment regimens. 3 subjects switched from Prophylaxis to On Demand.|12
302863|NCT00768287|732693|P4|Treated|Treatment Study|Subjects could switch treatment regimens. 3 subjects switched from On Demand to Prophylaxis.|61
302864|NCT00768287|732694|P3|Treated|Treatment Study||0
302865|NCT00768287|732695|P2|Treated|Treatment Study||0
302866|NCT00768287|732696|P1|Treated|Treatment Study||0
302867|NCT00768287|732691|P6|STARTED|Treatment Study||0
302868|NCT00768287|732692|P5|STARTED|Treatment Study|1 subject was not assigned a regimen at the start of the study.|9
302869|NCT00768287|732693|P4|STARTED|Treatment Study|1 subject was not assigned a regimen at the start of the study.|58
302870|NCT00768287|732694|P3|STARTED|Treatment Study||0
302871|NCT00768287|732695|P2|STARTED|Treatment Study||0
302872|NCT00768287|732696|P1|STARTED|Treatment Study||0
302873|NCT00768287|732691|P6|NOT COMPLETED|Repeat Pharmacokinetic Study||0
302874|NCT00768287|732692|P5|NOT COMPLETED|Repeat Pharmacokinetic Study||0
302875|NCT00768287|732693|P4|NOT COMPLETED|Repeat Pharmacokinetic Study||0
302876|NCT00768287|732694|P3|NOT COMPLETED|Repeat Pharmacokinetic Study||0
302877|NCT00768287|732695|P2|NOT COMPLETED|Repeat Pharmacokinetic Study||0
302878|NCT00768287|732696|P1|NOT COMPLETED|Repeat Pharmacokinetic Study||0
302879|NCT00768287|732691|P6|COMPLETED|Repeat Pharmacokinetic Study||0
302880|NCT00768287|732692|P5|COMPLETED|Repeat Pharmacokinetic Study||0
302881|NCT00768287|732693|P4|COMPLETED|Repeat Pharmacokinetic Study||0
302882|NCT00768287|732694|P3|COMPLETED|Repeat Pharmacokinetic Study||14
302883|NCT00768287|732695|P2|COMPLETED|Repeat Pharmacokinetic Study||0
302884|NCT00768287|732696|P1|COMPLETED|Repeat Pharmacokinetic Study||0
302885|NCT00768287|732691|P6|STARTED|Repeat Pharmacokinetic Study||0
302886|NCT00768287|732692|P5|STARTED|Repeat Pharmacokinetic Study||0
302887|NCT00768287|732693|P4|STARTED|Repeat Pharmacokinetic Study||0
302888|NCT00768287|732694|P3|STARTED|Repeat Pharmacokinetic Study|Eight subjects were part of the IB1001 first group; 6 were from the nonacog alfa first group.|14
302889|NCT00768287|732695|P2|STARTED|Repeat Pharmacokinetic Study||0
302890|NCT00768287|732696|P1|STARTED|Repeat Pharmacokinetic Study||0
302891|NCT00768287|732691|P6|NOT COMPLETED|Pharmacokinetic Study||0
302892|NCT00768287|732692|P5|NOT COMPLETED|Pharmacokinetic Study||0
302893|NCT00768287|732693|P4|NOT COMPLETED|Pharmacokinetic Study||0
302894|NCT00768287|732694|P3|NOT COMPLETED|Pharmacokinetic Study||0
302895|NCT00768287|732695|P2|NOT COMPLETED|Pharmacokinetic Study||0
302896|NCT00768287|732696|P1|NOT COMPLETED|Pharmacokinetic Study||0
302897|NCT00768287|732691|P6|COMPLETED|Pharmacokinetic Study||0
302898|NCT00768287|732692|P5|COMPLETED|Pharmacokinetic Study||0
302899|NCT00768287|732693|P4|COMPLETED|Pharmacokinetic Study||0
302900|NCT00768287|732694|P3|COMPLETED|Pharmacokinetic Study||0
302901|NCT00768287|732695|P2|COMPLETED|Pharmacokinetic Study||16
302902|NCT00768287|732696|P1|COMPLETED|Pharmacokinetic Study||16
302903|NCT00768287|732691|P6|STARTED|Pharmacokinetic Study||0
302904|NCT00768287|732692|P5|STARTED|Pharmacokinetic Study||0
302905|NCT00768287|732693|P4|STARTED|Pharmacokinetic Study||0
302906|NCT00768287|732694|P3|STARTED|Pharmacokinetic Study||0
302907|NCT00768287|732695|P2|STARTED|Pharmacokinetic Study||16
302908|NCT00768287|732696|P1|STARTED|Pharmacokinetic Study||16
302909|NCT00768261|732735|P4|NOT COMPLETED|Overall Study||0
302910|NCT00768261|732736|P3|NOT COMPLETED|Overall Study||25
302911|NCT00768261|732737|P2|NOT COMPLETED|Overall Study||0
302912|NCT00768261|732738|P1|NOT COMPLETED|Overall Study||0
302913|NCT00768261|732735|P4|COMPLETED|Overall Study||56
302914|NCT00768261|732736|P3|COMPLETED|Overall Study||14
302915|NCT00768261|732737|P2|COMPLETED|Overall Study||18
302916|NCT00768261|732738|P1|COMPLETED|Overall Study||14
302917|NCT00768261|732735|P4|STARTED|Overall Study||56
302918|NCT00768261|732736|P3|STARTED|Overall Study||39
302919|NCT00768261|732737|P2|STARTED|Overall Study||18
302920|NCT00768261|732738|P1|STARTED|Overall Study||14
302921|NCT00768248|732753|P2|NOT COMPLETED|Overall Study||1
302922|NCT00768248|732754|P1|NOT COMPLETED|Overall Study||1
302923|NCT00768248|732753|P2|COMPLETED|Overall Study||0
302924|NCT00768248|732754|P1|COMPLETED|Overall Study||0
302925|NCT00768248|732753|P2|STARTED|Overall Study||1
302926|NCT00768248|732754|P1|STARTED|Overall Study||1
302927|NCT00768222|732770|P2|NOT COMPLETED|Overall Study||4
302928|NCT00768222|732771|P1|NOT COMPLETED|Overall Study||4
302929|NCT00768222|732770|P2|COMPLETED|Overall Study||47
302930|NCT00768222|732771|P1|COMPLETED|Overall Study||46
302931|NCT00768222|732770|P2|STARTED|Overall Study||51
302932|NCT00768222|732771|P1|STARTED|Overall Study||50
302933|NCT00768144|732793|P1|NOT COMPLETED|Overall Study||36
302934|NCT00768144|732793|P1|COMPLETED|Overall Study||0
302935|NCT00768144|732793|P1|STARTED|Overall Study||36
302936|NCT00768118|732799|P1|NOT COMPLETED|Overall Study||0
302937|NCT00768118|732799|P1|COMPLETED|Overall Study||11
302938|NCT00768118|732799|P1|STARTED|Overall Study||11
302939|NCT00768066|732806|P3|NOT COMPLETED|Overall Study||0
302940|NCT00768066|732807|P2|NOT COMPLETED|Overall Study||3
302941|NCT00768066|732808|P1|NOT COMPLETED|Overall Study||3
302942|NCT00768066|732806|P3|COMPLETED|Overall Study||21
302943|NCT00768066|732807|P2|COMPLETED|Overall Study||19
302944|NCT00768066|732808|P1|COMPLETED|Overall Study||19
302945|NCT00768066|732806|P3|STARTED|Overall Study||21
302946|NCT00768066|732807|P2|STARTED|Overall Study||22
302947|NCT00768066|732808|P1|STARTED|Overall Study||22
302948|NCT00768053|732840|P1|NOT COMPLETED|Overall Study||11
302949|NCT00768053|732840|P1|COMPLETED|Overall Study||97
302950|NCT00768053|732840|P1|STARTED|Overall Study||108
302951|NCT00768040|732871|P2|NOT COMPLETED|Overall Study||3
302952|NCT00768040|732872|P1|NOT COMPLETED|Overall Study||4
302953|NCT00768040|732871|P2|COMPLETED|Overall Study||16
302954|NCT00768040|732872|P1|COMPLETED|Overall Study||16
302955|NCT00768040|732871|P2|STARTED|Overall Study||19
302956|NCT00768040|732872|P1|STARTED|Overall Study|"Started indicates randomized, safety and full analysis set."|20
302957|NCT00767819|732881|P3|NOT COMPLETED|Overall Study||0
302958|NCT00767819|732882|P2|NOT COMPLETED|Overall Study||19
302959|NCT00767819|732883|P1|NOT COMPLETED|Overall Study||25
302960|NCT00767819|732881|P3|COMPLETED|Overall Study||10
302961|NCT00767819|732882|P2|COMPLETED|Overall Study||5
302962|NCT00767819|732883|P1|COMPLETED|Overall Study||12
302963|NCT00767819|732881|P3|Safety Analysis Set (SAF)|Overall Study||10
302964|NCT00767819|732882|P2|Safety Analysis Set (SAF)|Overall Study||24
302965|NCT00767819|732883|P1|Safety Analysis Set (SAF)|Overall Study||37
302966|NCT00767819|732881|P3|Intent to Treat (ITT) Analysis Set|Overall Study||10
302967|NCT00767819|732882|P2|Intent to Treat (ITT) Analysis Set|Overall Study||24
302968|NCT00767819|732883|P1|Intent to Treat (ITT) Analysis Set|Overall Study||37
302969|NCT00767819|732881|P3|STARTED|Overall Study||10
302970|NCT00767819|732882|P2|STARTED|Overall Study||24
302971|NCT00767819|732883|P1|STARTED|Overall Study||37
302972|NCT00767806|732908|P2|NOT COMPLETED|Overall Study||47
302973|NCT00767806|732909|P1|NOT COMPLETED|Overall Study||51
302974|NCT00767806|732908|P2|COMPLETED|Overall Study||156
302975|NCT00767806|732909|P1|COMPLETED|Overall Study||147
302976|NCT00767806|732908|P2|STARTED|Overall Study||203
302977|NCT00767806|732909|P1|STARTED|Overall Study||198
302978|NCT00767767|732970|P5|NOT COMPLETED|Overall Study||0
302979|NCT00767767|732971|P4|NOT COMPLETED|Overall Study||0
302980|NCT00767767|732972|P3|NOT COMPLETED|Overall Study||0
302981|NCT00767767|732973|P2|NOT COMPLETED|Overall Study||0
302982|NCT00767767|732974|P1|NOT COMPLETED|Overall Study||0
302983|NCT00767767|732970|P5|COMPLETED|Overall Study||3
302984|NCT00767767|732971|P4|COMPLETED|Overall Study||3
302985|NCT00767767|732972|P3|COMPLETED|Overall Study||20
302986|NCT00767767|732973|P2|COMPLETED|Overall Study||20
302987|NCT00767767|732974|P1|COMPLETED|Overall Study||21
302988|NCT00767767|732970|P5|STARTED|Overall Study||3
302989|NCT00767767|732971|P4|STARTED|Overall Study||3
302990|NCT00767767|732972|P3|STARTED|Overall Study||20
302991|NCT00767767|732973|P2|STARTED|Overall Study||20
302992|NCT00767767|732974|P1|STARTED|Overall Study||21
302993|NCT00767676|732986|P1|NOT COMPLETED|Overall Study||54
302994|NCT00767676|732986|P1|COMPLETED|Overall Study||205
302995|NCT00767676|732986|P1|STARTED|Overall Study||259
302996|NCT00767624|732992|P2|NOT COMPLETED|Overall Study||17
302997|NCT00767624|732993|P1|NOT COMPLETED|Overall Study||24
302998|NCT00767624|732992|P2|COMPLETED|Overall Study||58
302999|NCT00767624|732993|P1|COMPLETED|Overall Study||51
303000|NCT00767624|732992|P2|STARTED|Overall Study||75
303001|NCT00767624|732993|P1|STARTED|Overall Study||75
303002|NCT00767572|733001|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
303003|NCT00767572|733001|P1|COMPLETED|Second Intervention (12 Weeks)||12
303004|NCT00767572|733001|P1|STARTED|Second Intervention (12 Weeks)||12
303005|NCT00767572|733001|P1|NOT COMPLETED|Washout (4 Weeks)||0
303006|NCT00767572|733001|P1|COMPLETED|Washout (4 Weeks)||12
303007|NCT00767572|733001|P1|STARTED|Washout (4 Weeks)||12
303008|NCT00767572|733001|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
303009|NCT00767572|733001|P1|COMPLETED|First Intervention (12 Weeks)||12
303010|NCT00767572|733001|P1|STARTED|First Intervention (12 Weeks)||12
303011|NCT00767520|733009|P2|NOT COMPLETED|Overall Study||17
303012|NCT00767520|733010|P1|NOT COMPLETED|Overall Study||11
303013|NCT00767520|733009|P2|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-56, study drug toxicity-2,AE-1,Death-1|61
303014|NCT00767520|733010|P1|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-50, study drug toxicity-10,AE-3,Death-2|68
303015|NCT00767520|733009|P2|STARTED|Overall Study||78
303016|NCT00767520|733010|P1|STARTED|Overall Study||79
303017|NCT00767507|733036|P4|NOT COMPLETED|Overall Study||3
303018|NCT00767507|733037|P3|NOT COMPLETED|Overall Study||0
303019|NCT00767507|733038|P2|NOT COMPLETED|Overall Study||0
303020|NCT00767507|733039|P1|NOT COMPLETED|Overall Study||0
303021|NCT00767507|733036|P4|COMPLETED|Overall Study||101
303022|NCT00767507|733037|P3|COMPLETED|Overall Study||106
303023|NCT00767507|733038|P2|COMPLETED|Overall Study||6
303024|NCT00767507|733039|P1|COMPLETED|Overall Study||5
303025|NCT00767507|733036|P4|STARTED|Overall Study||104
303026|NCT00767507|733037|P3|STARTED|Overall Study||106
303027|NCT00767507|733038|P2|STARTED|Overall Study||6
303028|NCT00767507|733039|P1|STARTED|Overall Study||5
303029|NCT00767455|733063|P1|NOT COMPLETED|Overall Study||19
303030|NCT00767455|733063|P1|COMPLETED|Overall Study||40
303031|NCT00767455|733063|P1|STARTED|Overall Study||59
303032|NCT00767364|733071|P2|NOT COMPLETED|Overall Study||0
303033|NCT00767364|733072|P1|NOT COMPLETED|Overall Study||0
303034|NCT00767364|733071|P2|COMPLETED|Overall Study||3
303035|NCT00767364|733072|P1|COMPLETED|Overall Study||5
303036|NCT00767364|733071|P2|STARTED|Overall Study||3
303037|NCT00767364|733072|P1|STARTED|Overall Study||5
303038|NCT00767338|733084|P4|NOT COMPLETED|Overall Study||0
303039|NCT00767338|733085|P3|NOT COMPLETED|Overall Study||0
303040|NCT00767338|733086|P2|NOT COMPLETED|Overall Study||2
303041|NCT00767338|733087|P1|NOT COMPLETED|Overall Study||1
303042|NCT00767338|733084|P4|COMPLETED|Overall Study||0
303043|NCT00767338|733085|P3|COMPLETED|Overall Study||0
303044|NCT00767338|733086|P2|COMPLETED|Overall Study||0
303045|NCT00767338|733087|P1|COMPLETED|Overall Study||0
303046|NCT00767338|733084|P4|STARTED|Overall Study||0
303047|NCT00767338|733085|P3|STARTED|Overall Study||0
303048|NCT00767338|733086|P2|STARTED|Overall Study||2
303049|NCT00767338|733087|P1|STARTED|Overall Study||1
303050|NCT00767325|733097|P1|NOT COMPLETED|Overall Study||15
303051|NCT00767325|733097|P1|COMPLETED|Overall Study||89
303052|NCT00767325|733097|P1|STARTED|Overall Study||104
303053|NCT00767104|733108|P2|NOT COMPLETED|Overall Study||2
303054|NCT00767104|733109|P1|NOT COMPLETED|Overall Study||1
303055|NCT00767104|733108|P2|COMPLETED|Overall Study||18
303056|NCT00767104|733109|P1|COMPLETED|Overall Study||19
303057|NCT00767104|733108|P2|STARTED|Overall Study||20
303058|NCT00767104|733109|P1|STARTED|Overall Study||20
303059|NCT00767039|733119|P2|NOT COMPLETED|Overall Study||2
303060|NCT00767039|733120|P1|NOT COMPLETED|Overall Study||5
303061|NCT00767039|733119|P2|COMPLETED|Overall Study||23
303062|NCT00767039|733120|P1|COMPLETED|Overall Study||22
303063|NCT00767039|733119|P2|STARTED|Overall Study||25
303064|NCT00767039|733120|P1|STARTED|Overall Study|Two early deaths and 3 late deaths occurred in this group|27
303065|NCT00767000|733151|P5|NOT COMPLETED|Optional 104-week Extension||4
303066|NCT00767000|733152|P4|NOT COMPLETED|Optional 104-week Extension||2
303067|NCT00767000|733153|P3|NOT COMPLETED|Optional 104-week Extension||7
303068|NCT00767000|733154|P2|NOT COMPLETED|Optional 104-week Extension||3
303069|NCT00767000|733155|P1|NOT COMPLETED|Optional 104-week Extension||7
303070|NCT00767000|733151|P5|COMPLETED|Optional 104-week Extension||0
303071|NCT00767000|733152|P4|COMPLETED|Optional 104-week Extension||0
303072|NCT00767000|733153|P3|COMPLETED|Optional 104-week Extension||0
303073|NCT00767000|733154|P2|COMPLETED|Optional 104-week Extension||0
303074|NCT00767000|733155|P1|COMPLETED|Optional 104-week Extension||0
303075|NCT00767000|733151|P5|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|4
303076|NCT00767000|733152|P4|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|2
303077|NCT00767000|733153|P3|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
303078|NCT00767000|733154|P2|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|3
303079|NCT00767000|733155|P1|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
303080|NCT00767000|733151|P5|NOT COMPLETED|54-week Study||224
303081|NCT00767000|733152|P4|NOT COMPLETED|54-week Study||225
303082|NCT00767000|733153|P3|NOT COMPLETED|54-week Study||109
303083|NCT00767000|733154|P2|NOT COMPLETED|54-week Study||113
303084|NCT00767000|733155|P1|NOT COMPLETED|54-week Study||108
303085|NCT00767000|733151|P5|COMPLETED|54-week Study||7
303086|NCT00767000|733152|P4|COMPLETED|54-week Study||4
303087|NCT00767000|733153|P3|COMPLETED|54-week Study||8
303088|NCT00767000|733154|P2|COMPLETED|54-week Study||4
303089|NCT00767000|733155|P1|COMPLETED|54-week Study||11
303090|NCT00767000|733151|P5|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|231
303091|NCT00767000|733152|P4|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|229
303092|NCT00767000|733153|P3|STARTED|54-week Study||117
303093|NCT00767000|733154|P2|STARTED|54-week Study||117
303094|NCT00767000|733155|P1|STARTED|54-week Study||119
303095|NCT00766831|733197|P1|NOT COMPLETED|Overall Study||115
303096|NCT00766831|733197|P1|COMPLETED|Overall Study||75
303097|NCT00766831|733197|P1|STARTED|Overall Study||190
303098|NCT00766753|733215|P2|NOT COMPLETED|Overall Study||0
303099|NCT00766753|733216|P1|NOT COMPLETED|Overall Study||0
303100|NCT00766753|733215|P2|COMPLETED|Overall Study||11
303101|NCT00766753|733216|P1|COMPLETED|Overall Study||11
303102|NCT00766753|733215|P2|Completed at Least Four Vaccines|Overall Study||9
303103|NCT00766753|733216|P1|Completed at Least Four Vaccines|Overall Study||10
303104|NCT00766753|733215|P2|Received at Least One Vaccine|Overall Study||11
303105|NCT00766753|733216|P1|Received at Least One Vaccine|Overall Study||11
303106|NCT00766753|733215|P2|STARTED|Overall Study||11
303107|NCT00766753|733216|P1|STARTED|Overall Study||11
303108|NCT00766675|733227|P1|NOT COMPLETED|Overall Study||40
303109|NCT00766675|733227|P1|COMPLETED|Overall Study||40
303110|NCT00766675|733227|P1|STARTED|Overall Study||80
303111|NCT00766649|733240|P1|NOT COMPLETED|Overall Study||10
303112|NCT00766649|733240|P1|COMPLETED|Overall Study||1
303113|NCT00766649|733240|P1|STARTED|Overall Study||11
303114|NCT00766636|733254|P2|NOT COMPLETED|Overall Study||2
303115|NCT00766636|733255|P1|NOT COMPLETED|Overall Study||3
303116|NCT00766636|733254|P2|COMPLETED|Overall Study||0
303117|NCT00766636|733255|P1|COMPLETED|Overall Study|Number that completed pre- and post-operative therapy as well as surgery.|0
303118|NCT00766636|733254|P2|STARTED|Overall Study||2
303119|NCT00766636|733255|P1|STARTED|Overall Study||3
303120|NCT00766597|733261|P1|NOT COMPLETED|Overall Study||9
303121|NCT00766597|733261|P1|COMPLETED|Overall Study|Treatment duration is 48 weeks plus 5 years of follow-up|0
303122|NCT00766597|733261|P1|Completed Week 48|Overall Study|Week 48 is the second primary time point of analysis|0
303123|NCT00766597|733261|P1|Completed Week 24|Overall Study|Week 24 is the first primary time point of analysis|1
303124|NCT00766597|733261|P1|Without CCR5-tropic Virus|Overall Study|Not evaluable participants, did not receive the study drug|5
303125|NCT00766597|733261|P1|With CCR5-tropic Virus|Overall Study|Evaluable participants, received the study drug|4
303126|NCT00766597|733261|P1|STARTED|Overall Study|Screened participants who were evaluated for co-receptor tropism|9
303127|NCT00766532|733273|P1|NOT COMPLETED|Overall Study||2
303128|NCT00766532|733273|P1|COMPLETED|Overall Study||10
303129|NCT00766532|733273|P1|STARTED|Overall Study||12
303130|NCT00766506|733279|P2|NOT COMPLETED|Overall Study||2
303131|NCT00766506|733280|P1|NOT COMPLETED|Overall Study||5
303132|NCT00766506|733279|P2|COMPLETED|Overall Study||48
303133|NCT00766506|733280|P1|COMPLETED|Overall Study||53
303134|NCT00766506|733279|P2|STARTED|Overall Study||50
303135|NCT00766506|733280|P1|STARTED|Overall Study||58
303136|NCT00766493|733304|P1|NOT COMPLETED|30 Days Post-Procedure||12
303137|NCT00766493|733304|P1|COMPLETED|30 Days Post-Procedure||238
303138|NCT00766493|733304|P1|STARTED|30 Days Post-Procedure||250
303139|NCT00766493|733304|P1|NOT COMPLETED|Pre-Discharge||0
303140|NCT00766493|733304|P1|COMPLETED|Pre-Discharge||250
303141|NCT00766493|733304|P1|STARTED|Pre-Discharge||250
303142|NCT00766467|733314|P2|NOT COMPLETED|Overall Study||8
303143|NCT00766467|733315|P1|NOT COMPLETED|Overall Study||11
303144|NCT00766467|733314|P2|COMPLETED|Overall Study||31
303145|NCT00766467|733315|P1|COMPLETED|Overall Study||31
303146|NCT00766467|733314|P2|Initiated Treatment|Overall Study||38
303147|NCT00766467|733315|P1|Initiated Treatment|Overall Study||39
303148|NCT00766467|733314|P2|STARTED|Overall Study||39
303149|NCT00766467|733315|P1|STARTED|Overall Study||42
303150|NCT00766415|733327|P2|NOT COMPLETED|Overall Study||1
303151|NCT00766415|733328|P1|NOT COMPLETED|Overall Study||0
303152|NCT00766415|733327|P2|COMPLETED|Overall Study||26
303153|NCT00766415|733328|P1|COMPLETED|Overall Study||25
303154|NCT00766415|733327|P2|STARTED|Overall Study||27
303155|NCT00766415|733328|P1|STARTED|Overall Study||25
303156|NCT00766376|733376|P1|NOT COMPLETED|Overall Study||27
303157|NCT00766376|733376|P1|COMPLETED|Overall Study||124
303158|NCT00766376|733376|P1|STARTED|Overall Study||151
303159|NCT00766363|733385|P4|NOT COMPLETED|Overall Study||0
303160|NCT00766363|733386|P3|NOT COMPLETED|Overall Study||0
303161|NCT00766363|733387|P2|NOT COMPLETED|Overall Study||1
303162|NCT00766363|733388|P1|NOT COMPLETED|Overall Study||1
303163|NCT00766363|733385|P4|COMPLETED|Overall Study||12
303164|NCT00766363|733386|P3|COMPLETED|Overall Study||12
303165|NCT00766363|733387|P2|COMPLETED|Overall Study||12
303166|NCT00766363|733388|P1|COMPLETED|Overall Study||11
303167|NCT00766363|733385|P4|PK POPULATION|Overall Study||13
303168|NCT00766363|733386|P3|PK POPULATION|Overall Study||10
303169|NCT00766363|733387|P2|PK POPULATION|Overall Study||13
303170|NCT00766363|733388|P1|PK POPULATION|Overall Study||12
303171|NCT00766363|733385|P4|SAFETY POPULATION|Overall Study|Increased by one subject who took placebo due to treatment assignment error.|13
303172|NCT00766363|733386|P3|SAFETY POPULATION|Overall Study|Decreased by one subject who took placebo instead due to treatment assignment error.|11
303173|NCT00766363|733387|P2|SAFETY POPULATION|Overall Study||13
303174|NCT00766363|733388|P1|SAFETY POPULATION|Overall Study||12
303175|NCT00766363|733385|P4|STARTED|Overall Study|Number randomized.|12
303176|NCT00766363|733386|P3|STARTED|Overall Study|Number randomized.|12
303177|NCT00766363|733387|P2|STARTED|Overall Study||13
303178|NCT00766363|733388|P1|STARTED|Overall Study||12
303179|NCT00766116|733425|P1|NOT COMPLETED|Overall Study||0
303180|NCT00766116|733425|P1|COMPLETED|Overall Study||50
303181|NCT00766116|733425|P1|STARTED|Overall Study||50
303182|NCT00766090|733434|P12|NOT COMPLETED|Treatment Period 3 (28 Days)||1
303183|NCT00766090|733435|P11|NOT COMPLETED|Treatment Period 3 (28 Days)||0
303184|NCT00766090|733436|P10|NOT COMPLETED|Treatment Period 3 (28 Days)||0
303185|NCT00766090|733437|P9|NOT COMPLETED|Treatment Period 3 (28 Days)||0
303186|NCT00766090|733438|P8|NOT COMPLETED|Treatment Period 3 (28 Days)||0
303187|NCT00766090|733439|P7|NOT COMPLETED|Treatment Period 3 (28 Days)||0
303188|NCT00766090|733440|P6|NOT COMPLETED|Treatment Period 3 (28 Days)||1
303189|NCT00766090|733441|P5|NOT COMPLETED|Treatment Period 3 (28 Days)||1
303190|NCT00766090|733442|P4|NOT COMPLETED|Treatment Period 3 (28 Days)||1
303191|NCT00766090|733443|P3|NOT COMPLETED|Treatment Period 3 (28 Days)||0
303192|NCT00766090|733444|P2|NOT COMPLETED|Treatment Period 3 (28 Days)||1
303193|NCT00766090|733445|P1|NOT COMPLETED|Treatment Period 3 (28 Days)||0
303194|NCT00766090|733434|P12|COMPLETED|Treatment Period 3 (28 Days)||6
303195|NCT00766090|733435|P11|COMPLETED|Treatment Period 3 (28 Days)||7
303196|NCT00766090|733436|P10|COMPLETED|Treatment Period 3 (28 Days)||8
303197|NCT00766090|733437|P9|COMPLETED|Treatment Period 3 (28 Days)||6
303198|NCT00766090|733438|P8|COMPLETED|Treatment Period 3 (28 Days)||8
303199|NCT00766090|733439|P7|COMPLETED|Treatment Period 3 (28 Days)||6
303200|NCT00766090|733440|P6|COMPLETED|Treatment Period 3 (28 Days)||22
303201|NCT00766090|733441|P5|COMPLETED|Treatment Period 3 (28 Days)||20
303202|NCT00766090|733442|P4|COMPLETED|Treatment Period 3 (28 Days)||24
303203|NCT00766090|733443|P3|COMPLETED|Treatment Period 3 (28 Days)||20
303204|NCT00766090|733444|P2|COMPLETED|Treatment Period 3 (28 Days)||26
303205|NCT00766090|733445|P1|COMPLETED|Treatment Period 3 (28 Days)||22
303206|NCT00766090|733434|P12|STARTED|Treatment Period 3 (28 Days)||7
303207|NCT00766090|733435|P11|STARTED|Treatment Period 3 (28 Days)||7
303208|NCT00766090|733436|P10|STARTED|Treatment Period 3 (28 Days)||8
303209|NCT00766090|733437|P9|STARTED|Treatment Period 3 (28 Days)||6
303210|NCT00766090|733438|P8|STARTED|Treatment Period 3 (28 Days)||8
303211|NCT00766090|733439|P7|STARTED|Treatment Period 3 (28 Days)||6
303212|NCT00766090|733440|P6|STARTED|Treatment Period 3 (28 Days)||23
303213|NCT00766090|733441|P5|STARTED|Treatment Period 3 (28 Days)||21
303214|NCT00766090|733442|P4|STARTED|Treatment Period 3 (28 Days)||25
303215|NCT00766090|733443|P3|STARTED|Treatment Period 3 (28 Days)||20
303216|NCT00766090|733444|P2|STARTED|Treatment Period 3 (28 Days)||27
303217|NCT00766090|733445|P1|STARTED|Treatment Period 3 (28 Days)||22
303218|NCT00766090|733434|P12|NOT COMPLETED|Washout Period 2 (14 Days)||0
303219|NCT00766090|733435|P11|NOT COMPLETED|Washout Period 2 (14 Days)||0
303220|NCT00766090|733436|P10|NOT COMPLETED|Washout Period 2 (14 Days)||0
303221|NCT00766090|733437|P9|NOT COMPLETED|Washout Period 2 (14 Days)||0
303222|NCT00766090|733438|P8|NOT COMPLETED|Washout Period 2 (14 Days)||0
303223|NCT00766090|733439|P7|NOT COMPLETED|Washout Period 2 (14 Days)||0
303224|NCT00766090|733440|P6|NOT COMPLETED|Washout Period 2 (14 Days)||0
303225|NCT00766090|733441|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
303226|NCT00766090|733442|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
303227|NCT00766090|733443|P3|NOT COMPLETED|Washout Period 2 (14 Days)||1
303228|NCT00766090|733444|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
303229|NCT00766090|733445|P1|NOT COMPLETED|Washout Period 2 (14 Days)||0
303230|NCT00766090|733434|P12|COMPLETED|Washout Period 2 (14 Days)||7
303231|NCT00766090|733435|P11|COMPLETED|Washout Period 2 (14 Days)||7
303232|NCT00766090|733436|P10|COMPLETED|Washout Period 2 (14 Days)||8
303233|NCT00766090|733437|P9|COMPLETED|Washout Period 2 (14 Days)||6
303234|NCT00766090|733438|P8|COMPLETED|Washout Period 2 (14 Days)||8
303235|NCT00766090|733439|P7|COMPLETED|Washout Period 2 (14 Days)||6
303236|NCT00766090|733440|P6|COMPLETED|Washout Period 2 (14 Days)||23
303237|NCT00766090|733441|P5|COMPLETED|Washout Period 2 (14 Days)||21
303238|NCT00766090|733442|P4|COMPLETED|Washout Period 2 (14 Days)||25
303239|NCT00766090|733443|P3|COMPLETED|Washout Period 2 (14 Days)||20
303240|NCT00766090|733444|P2|COMPLETED|Washout Period 2 (14 Days)||27
303241|NCT00766090|733445|P1|COMPLETED|Washout Period 2 (14 Days)||22
303242|NCT00766090|733434|P12|STARTED|Washout Period 2 (14 Days)||7
303243|NCT00766090|733435|P11|STARTED|Washout Period 2 (14 Days)||7
303244|NCT00766090|733436|P10|STARTED|Washout Period 2 (14 Days)||8
303245|NCT00766090|733437|P9|STARTED|Washout Period 2 (14 Days)||6
303246|NCT00766090|733438|P8|STARTED|Washout Period 2 (14 Days)||8
303247|NCT00766090|733439|P7|STARTED|Washout Period 2 (14 Days)||6
303248|NCT00766090|733440|P6|STARTED|Washout Period 2 (14 Days)||23
303249|NCT00766090|733441|P5|STARTED|Washout Period 2 (14 Days)||21
303250|NCT00766090|733442|P4|STARTED|Washout Period 2 (14 Days)||25
303251|NCT00766090|733443|P3|STARTED|Washout Period 2 (14 Days)||21
303252|NCT00766090|733444|P2|STARTED|Washout Period 2 (14 Days)||27
303253|NCT00766090|733445|P1|STARTED|Washout Period 2 (14 Days)||22
303254|NCT00766090|733434|P12|NOT COMPLETED|Treatment Period 2 (28 Days)||0
303255|NCT00766090|733435|P11|NOT COMPLETED|Treatment Period 2 (28 Days)||0
303256|NCT00766090|733436|P10|NOT COMPLETED|Treatment Period 2 (28 Days)||0
303257|NCT00766090|733437|P9|NOT COMPLETED|Treatment Period 2 (28 Days)||0
303258|NCT00766090|733438|P8|NOT COMPLETED|Treatment Period 2 (28 Days)||0
303259|NCT00766090|733439|P7|NOT COMPLETED|Treatment Period 2 (28 Days)||0
303260|NCT00766090|733440|P6|NOT COMPLETED|Treatment Period 2 (28 Days)||0
303261|NCT00766090|733441|P5|NOT COMPLETED|Treatment Period 2 (28 Days)||2
303262|NCT00766090|733442|P4|NOT COMPLETED|Treatment Period 2 (28 Days)||0
303263|NCT00766090|733443|P3|NOT COMPLETED|Treatment Period 2 (28 Days)||1
303264|NCT00766090|733444|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||0
303265|NCT00766090|733445|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
303266|NCT00766090|733434|P12|COMPLETED|Treatment Period 2 (28 Days)||7
303267|NCT00766090|733435|P11|COMPLETED|Treatment Period 2 (28 Days)||7
303268|NCT00766090|733436|P10|COMPLETED|Treatment Period 2 (28 Days)||8
303269|NCT00766090|733437|P9|COMPLETED|Treatment Period 2 (28 Days)||6
303270|NCT00766090|733438|P8|COMPLETED|Treatment Period 2 (28 Days)||8
303271|NCT00766090|733439|P7|COMPLETED|Treatment Period 2 (28 Days)||6
303272|NCT00766090|733440|P6|COMPLETED|Treatment Period 2 (28 Days)||23
303273|NCT00766090|733441|P5|COMPLETED|Treatment Period 2 (28 Days)||21
303274|NCT00766090|733442|P4|COMPLETED|Treatment Period 2 (28 Days)||25
303275|NCT00766090|733443|P3|COMPLETED|Treatment Period 2 (28 Days)||21
303276|NCT00766090|733444|P2|COMPLETED|Treatment Period 2 (28 Days)||27
303277|NCT00766090|733445|P1|COMPLETED|Treatment Period 2 (28 Days)||22
303278|NCT00766090|733434|P12|STARTED|Treatment Period 2 (28 Days)||7
303279|NCT00766090|733435|P11|STARTED|Treatment Period 2 (28 Days)||7
303280|NCT00766090|733436|P10|STARTED|Treatment Period 2 (28 Days)||8
303281|NCT00766090|733437|P9|STARTED|Treatment Period 2 (28 Days)||6
303282|NCT00766090|733438|P8|STARTED|Treatment Period 2 (28 Days)||8
303283|NCT00766090|733439|P7|STARTED|Treatment Period 2 (28 Days)||6
303284|NCT00766090|733440|P6|STARTED|Treatment Period 2 (28 Days)||23
303285|NCT00766090|733441|P5|STARTED|Treatment Period 2 (28 Days)||23
303286|NCT00766090|733442|P4|STARTED|Treatment Period 2 (28 Days)||25
303287|NCT00766090|733443|P3|STARTED|Treatment Period 2 (28 Days)||22
303288|NCT00766090|733444|P2|STARTED|Treatment Period 2 (28 Days)||27
303289|NCT00766090|733445|P1|STARTED|Treatment Period 2 (28 Days)||22
303290|NCT00766090|733434|P12|NOT COMPLETED|Washout Period 1 (14 Days)||0
303291|NCT00766090|733435|P11|NOT COMPLETED|Washout Period 1 (14 Days)||0
303292|NCT00766090|733436|P10|NOT COMPLETED|Washout Period 1 (14 Days)||0
303293|NCT00766090|733437|P9|NOT COMPLETED|Washout Period 1 (14 Days)||0
303294|NCT00766090|733438|P8|NOT COMPLETED|Washout Period 1 (14 Days)||0
303295|NCT00766090|733439|P7|NOT COMPLETED|Washout Period 1 (14 Days)||0
303296|NCT00766090|733440|P6|NOT COMPLETED|Washout Period 1 (14 Days)||0
303297|NCT00766090|733441|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
303298|NCT00766090|733442|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
303299|NCT00766090|733443|P3|NOT COMPLETED|Washout Period 1 (14 Days)||1
303300|NCT00766090|733444|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
303301|NCT00766090|733445|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
303302|NCT00766090|733434|P12|COMPLETED|Washout Period 1 (14 Days)||7
303303|NCT00766090|733435|P11|COMPLETED|Washout Period 1 (14 Days)||7
303304|NCT00766090|733436|P10|COMPLETED|Washout Period 1 (14 Days)||8
303305|NCT00766090|733437|P9|COMPLETED|Washout Period 1 (14 Days)||6
303306|NCT00766090|733438|P8|COMPLETED|Washout Period 1 (14 Days)||8
303307|NCT00766090|733439|P7|COMPLETED|Washout Period 1 (14 Days)||6
303308|NCT00766090|733440|P6|COMPLETED|Washout Period 1 (14 Days)||23
303309|NCT00766090|733441|P5|COMPLETED|Washout Period 1 (14 Days)||23
303310|NCT00766090|733442|P4|COMPLETED|Washout Period 1 (14 Days)||25
303311|NCT00766090|733443|P3|COMPLETED|Washout Period 1 (14 Days)||22
303312|NCT00766090|733444|P2|COMPLETED|Washout Period 1 (14 Days)||27
303313|NCT00766090|733445|P1|COMPLETED|Washout Period 1 (14 Days)||22
303314|NCT00766090|733434|P12|STARTED|Washout Period 1 (14 Days)||7
303315|NCT00766090|733435|P11|STARTED|Washout Period 1 (14 Days)||7
303316|NCT00766090|733436|P10|STARTED|Washout Period 1 (14 Days)||8
303317|NCT00766090|733437|P9|STARTED|Washout Period 1 (14 Days)||6
303318|NCT00766090|733438|P8|STARTED|Washout Period 1 (14 Days)||8
303319|NCT00766090|733439|P7|STARTED|Washout Period 1 (14 Days)||6
303320|NCT00766090|733440|P6|STARTED|Washout Period 1 (14 Days)||23
303321|NCT00766090|733441|P5|STARTED|Washout Period 1 (14 Days)||23
303322|NCT00766090|733442|P4|STARTED|Washout Period 1 (14 Days)||25
303323|NCT00766090|733443|P3|STARTED|Washout Period 1 (14 Days)||23
303324|NCT00766090|733444|P2|STARTED|Washout Period 1 (14 Days)||27
303325|NCT00766090|733445|P1|STARTED|Washout Period 1 (14 Days)||22
303326|NCT00766090|733434|P12|NOT COMPLETED|Treatment Period 1 (28 Days)||0
303327|NCT00766090|733435|P11|NOT COMPLETED|Treatment Period 1 (28 Days)||0
303328|NCT00766090|733436|P10|NOT COMPLETED|Treatment Period 1 (28 Days)||0
303329|NCT00766090|733437|P9|NOT COMPLETED|Treatment Period 1 (28 Days)||1
303330|NCT00766090|733438|P8|NOT COMPLETED|Treatment Period 1 (28 Days)||0
303331|NCT00766090|733439|P7|NOT COMPLETED|Treatment Period 1 (28 Days)||0
303332|NCT00766090|733440|P6|NOT COMPLETED|Treatment Period 1 (28 Days)||0
303333|NCT00766090|733441|P5|NOT COMPLETED|Treatment Period 1 (28 Days)||0
303334|NCT00766090|733442|P4|NOT COMPLETED|Treatment Period 1 (28 Days)||1
303335|NCT00766090|733443|P3|NOT COMPLETED|Treatment Period 1 (28 Days)||0
303336|NCT00766090|733444|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||0
303337|NCT00766090|733445|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||3
303338|NCT00766090|733434|P12|COMPLETED|Treatment Period 1 (28 Days)||7
303339|NCT00766090|733435|P11|COMPLETED|Treatment Period 1 (28 Days)||7
303340|NCT00766090|733436|P10|COMPLETED|Treatment Period 1 (28 Days)||8
303341|NCT00766090|733437|P9|COMPLETED|Treatment Period 1 (28 Days)||6
303342|NCT00766090|733438|P8|COMPLETED|Treatment Period 1 (28 Days)||8
303343|NCT00766090|733439|P7|COMPLETED|Treatment Period 1 (28 Days)||6
303344|NCT00766090|733440|P6|COMPLETED|Treatment Period 1 (28 Days)||23
303345|NCT00766090|733441|P5|COMPLETED|Treatment Period 1 (28 Days)||23
303346|NCT00766090|733442|P4|COMPLETED|Treatment Period 1 (28 Days)||25
303347|NCT00766090|733443|P3|COMPLETED|Treatment Period 1 (28 Days)||23
303348|NCT00766090|733444|P2|COMPLETED|Treatment Period 1 (28 Days)||27
303349|NCT00766090|733445|P1|COMPLETED|Treatment Period 1 (28 Days)||22
303350|NCT00766090|733434|P12|STARTED|Treatment Period 1 (28 Days)||7
303351|NCT00766090|733435|P11|STARTED|Treatment Period 1 (28 Days)||7
303352|NCT00766090|733436|P10|STARTED|Treatment Period 1 (28 Days)||8
303353|NCT00766090|733437|P9|STARTED|Treatment Period 1 (28 Days)||7
303354|NCT00766090|733438|P8|STARTED|Treatment Period 1 (28 Days)||8
303355|NCT00766090|733439|P7|STARTED|Treatment Period 1 (28 Days)||6
303356|NCT00766090|733440|P6|STARTED|Treatment Period 1 (28 Days)||23
303357|NCT00766090|733441|P5|STARTED|Treatment Period 1 (28 Days)||23
303358|NCT00766090|733442|P4|STARTED|Treatment Period 1 (28 Days)||26
303359|NCT00766090|733443|P3|STARTED|Treatment Period 1 (28 Days)||23
303360|NCT00766090|733444|P2|STARTED|Treatment Period 1 (28 Days)||27
303361|NCT00766090|733445|P1|STARTED|Treatment Period 1 (28 Days)||25
303362|NCT00766051|733486|P2|NOT COMPLETED|Overall Study||0
303363|NCT00766051|733487|P1|NOT COMPLETED|Overall Study||2
303364|NCT00766051|733486|P2|COMPLETED|Overall Study||10
303365|NCT00766051|733487|P1|COMPLETED|Overall Study||10
303366|NCT00766051|733486|P2|STARTED|Overall Study||10
303367|NCT00766051|733487|P1|STARTED|Overall Study||12
303368|NCT00766038|733499|P2|NOT COMPLETED|Overall Study||14
303369|NCT00766038|733500|P1|NOT COMPLETED|Overall Study||15
303370|NCT00766038|733499|P2|COMPLETED|Overall Study||18
303371|NCT00766038|733500|P1|COMPLETED|Overall Study||16
303372|NCT00766038|733499|P2|STARTED|Overall Study||32
303373|NCT00766038|733500|P1|STARTED|Overall Study||31
303374|NCT00765999|733516|P1|NOT COMPLETED|Overall Study||784
303375|NCT00765999|733516|P1|COMPLETED|Overall Study||770
303376|NCT00765999|733516|P1|STARTED|Overall Study||1554
303377|NCT00765947|733522|P1|NOT COMPLETED|Overall Study||24
303378|NCT00765947|733522|P1|COMPLETED|Overall Study||232
303379|NCT00765947|733522|P1|STARTED|Overall Study||256
303380|NCT00765895|733533|P2|NOT COMPLETED|Overall Study||0
303381|NCT00765895|733534|P1|NOT COMPLETED|Overall Study||0
303382|NCT00765895|733533|P2|COMPLETED|Overall Study||65
303383|NCT00765895|733534|P1|COMPLETED|Overall Study||65
303384|NCT00765895|733533|P2|STARTED|Overall Study||65
303385|NCT00765895|733534|P1|STARTED|Overall Study||65
303386|NCT00765882|733543|P3|NOT COMPLETED|Overall Study||36
303387|NCT00765882|733544|P2|NOT COMPLETED|Overall Study||40
303388|NCT00765882|733545|P1|NOT COMPLETED|Overall Study||24
303389|NCT00765882|733543|P3|COMPLETED|Overall Study||169
303390|NCT00765882|733544|P2|COMPLETED|Overall Study||173
303391|NCT00765882|733545|P1|COMPLETED|Overall Study||191
303392|NCT00765882|733543|P3|STARTED|Overall Study||205
303393|NCT00765882|733544|P2|STARTED|Overall Study||213
303394|NCT00765882|733545|P1|STARTED|Overall Study||215
303395|NCT00765843|733577|P3|NOT COMPLETED|Overall Study||3
303396|NCT00765843|733578|P2|NOT COMPLETED|Overall Study||4
303397|NCT00765843|733579|P1|NOT COMPLETED|Overall Study||1
303398|NCT00765843|733577|P3|COMPLETED|Overall Study||23
303399|NCT00765843|733578|P2|COMPLETED|Overall Study||21
303400|NCT00765843|733579|P1|COMPLETED|Overall Study||25
303401|NCT00765843|733577|P3|STARTED|Overall Study||26
303402|NCT00765843|733578|P2|STARTED|Overall Study||25
303403|NCT00765843|733579|P1|STARTED|Overall Study||26
303404|NCT00765817|733589|P2|NOT COMPLETED|Overall Study||22
303405|NCT00765817|733590|P1|NOT COMPLETED|Overall Study||26
303406|NCT00765817|733589|P2|COMPLETED|Overall Study||101
303407|NCT00765817|733590|P1|COMPLETED|Overall Study||112
303408|NCT00765817|733589|P2|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|123
303409|NCT00765817|733590|P1|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|138
303410|NCT00765765|733628|P1|NOT COMPLETED|Overall Study||0
303411|NCT00765765|733628|P1|COMPLETED|Overall Study||6
303412|NCT00765765|733628|P1|STARTED|Overall Study||6
303413|NCT00765726|733638|P1|NOT COMPLETED|Overall Study||9
303414|NCT00765726|733638|P1|COMPLETED|Overall Study||3
303415|NCT00765726|733638|P1|STARTED|Overall Study||12
303416|NCT00765674|733646|P4|NOT COMPLETED|Overall Study||25
303417|NCT00765674|733647|P3|NOT COMPLETED|Overall Study||17
303418|NCT00765674|733648|P2|NOT COMPLETED|Overall Study||22
303419|NCT00765674|733649|P1|NOT COMPLETED|Overall Study||21
303420|NCT00765674|733646|P4|COMPLETED|Overall Study||285
303421|NCT00765674|733647|P3|COMPLETED|Overall Study||279
303422|NCT00765674|733648|P2|COMPLETED|Overall Study||276
303423|NCT00765674|733649|P1|COMPLETED|Overall Study||266
303424|NCT00765674|733646|P4|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|310
303425|NCT00765674|733647|P3|STARTED|Overall Study||296
303426|NCT00765674|733648|P2|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|298
303427|NCT00765674|733649|P1|STARTED|Overall Study||287
303428|NCT00765661|733673|P2|NOT COMPLETED|Overall Study||0
303429|NCT00765661|733674|P1|NOT COMPLETED|Overall Study||0
303430|NCT00765661|733673|P2|COMPLETED|Overall Study||31
303431|NCT00765661|733674|P1|COMPLETED|Overall Study||32
303432|NCT00765661|733673|P2|STARTED|Overall Study||31
303433|NCT00765661|733674|P1|STARTED|Overall Study||32
303434|NCT00765648|733688|P2|NOT COMPLETED|Overall Study||2
303435|NCT00765648|733689|P1|NOT COMPLETED|Overall Study||1
303436|NCT00765648|733688|P2|COMPLETED|Overall Study||114
303437|NCT00765648|733689|P1|COMPLETED|Overall Study||109
303438|NCT00765648|733688|P2|STARTED|Overall Study||116
303439|NCT00765648|733689|P1|STARTED|Overall Study||110
303440|NCT00765570|733707|P2|NOT COMPLETED|Overall Study||0
303441|NCT00765570|733708|P1|NOT COMPLETED|Overall Study||2
303442|NCT00765570|733707|P2|COMPLETED|Overall Study||3
303443|NCT00765570|733708|P1|COMPLETED|Overall Study||7
303444|NCT00765570|733707|P2|STARTED|Overall Study||3
303445|NCT00765570|733708|P1|STARTED|Overall Study||9
303446|NCT00765388|733716|P2|NOT COMPLETED|Period 2||0
303447|NCT00765388|733717|P1|NOT COMPLETED|Period 2||0
303448|NCT00765388|733716|P2|COMPLETED|Period 2||6
303449|NCT00765388|733717|P1|COMPLETED|Period 2||15
303450|NCT00765388|733716|P2|STARTED|Period 2||6
303451|NCT00765388|733717|P1|STARTED|Period 2||15
303452|NCT00765388|733716|P2|NOT COMPLETED|Period 1||5
303453|NCT00765388|733717|P1|NOT COMPLETED|Period 1||1
303454|NCT00765388|733716|P2|COMPLETED|Period 1||6
303455|NCT00765388|733717|P1|COMPLETED|Period 1||15
303456|NCT00765388|733716|P2|STARTED|Period 1||11
303457|NCT00765388|733717|P1|STARTED|Period 1|A cross-over study|16
303458|NCT00765375|733745|P1|NOT COMPLETED|Overall Study||0
303459|NCT00765375|733745|P1|COMPLETED|Overall Study||5
303460|NCT00765375|733745|P1|STARTED|Overall Study||5
303461|NCT00765362|733751|P1|NOT COMPLETED|Overall Study||137
303462|NCT00765362|733751|P1|COMPLETED|Overall Study||282
303463|NCT00765362|733751|P1|STARTED|Overall Study||419
303464|NCT00765336|733759|P2|NOT COMPLETED|Overall Study||16
303465|NCT00765336|733760|P1|NOT COMPLETED|Overall Study||19
303466|NCT00765336|733759|P2|COMPLETED|Overall Study||73
303467|NCT00765336|733760|P1|COMPLETED|Overall Study||72
303468|NCT00765336|733759|P2|STARTED|Overall Study||89
303469|NCT00765336|733760|P1|STARTED|Overall Study||91
303470|NCT00765245|733768|P2|NOT COMPLETED|Overall Study||2
303471|NCT00765245|733769|P1|NOT COMPLETED|Overall Study||13
303472|NCT00765245|733768|P2|COMPLETED|Overall Study||20
303473|NCT00765245|733769|P1|COMPLETED|Overall Study||9
303474|NCT00765245|733768|P2|STARTED|Overall Study||22
303475|NCT00765245|733769|P1|STARTED|Overall Study||22
303476|NCT00765232|733781|P2|NOT COMPLETED|Overall Study||0
303477|NCT00765232|733782|P1|NOT COMPLETED|Overall Study||0
303478|NCT00765232|733781|P2|COMPLETED|Overall Study||54
303479|NCT00765232|733782|P1|COMPLETED|Overall Study||57
303480|NCT00765232|733781|P2|STARTED|Overall Study||54
303481|NCT00765232|733782|P1|STARTED|Overall Study||57
303482|NCT00765206|733790|P4|NOT COMPLETED|Second Intervention||0
303483|NCT00765206|733791|P3|NOT COMPLETED|Second Intervention||0
303484|NCT00765206|733792|P2|NOT COMPLETED|Second Intervention||0
303485|NCT00765206|733793|P1|NOT COMPLETED|Second Intervention||0
303486|NCT00765206|733790|P4|COMPLETED|Second Intervention||15
303487|NCT00765206|733791|P3|COMPLETED|Second Intervention||15
303488|NCT00765206|733792|P2|COMPLETED|Second Intervention||15
303489|NCT00765206|733793|P1|COMPLETED|Second Intervention||15
303490|NCT00765206|733790|P4|STARTED|Second Intervention||15
303491|NCT00765206|733791|P3|STARTED|Second Intervention||15
303492|NCT00765206|733792|P2|STARTED|Second Intervention||15
303493|NCT00765206|733793|P1|STARTED|Second Intervention||15
303494|NCT00765206|733790|P4|NOT COMPLETED|Washout Period of 14 Days||0
303495|NCT00765206|733791|P3|NOT COMPLETED|Washout Period of 14 Days||0
303496|NCT00765206|733792|P2|NOT COMPLETED|Washout Period of 14 Days||0
303497|NCT00765206|733793|P1|NOT COMPLETED|Washout Period of 14 Days||0
303498|NCT00765206|733790|P4|COMPLETED|Washout Period of 14 Days||15
303499|NCT00765206|733791|P3|COMPLETED|Washout Period of 14 Days||15
303500|NCT00765206|733792|P2|COMPLETED|Washout Period of 14 Days||15
303501|NCT00765206|733793|P1|COMPLETED|Washout Period of 14 Days||15
303502|NCT00765206|733790|P4|STARTED|Washout Period of 14 Days||15
303503|NCT00765206|733791|P3|STARTED|Washout Period of 14 Days||15
303504|NCT00765206|733792|P2|STARTED|Washout Period of 14 Days||15
303505|NCT00765206|733793|P1|STARTED|Washout Period of 14 Days||15
303506|NCT00765206|733790|P4|NOT COMPLETED|First Intervention||0
303507|NCT00765206|733791|P3|NOT COMPLETED|First Intervention||0
303508|NCT00765206|733792|P2|NOT COMPLETED|First Intervention||0
303509|NCT00765206|733793|P1|NOT COMPLETED|First Intervention||0
303510|NCT00765206|733790|P4|COMPLETED|First Intervention||15
303511|NCT00765206|733791|P3|COMPLETED|First Intervention||15
303512|NCT00765206|733792|P2|COMPLETED|First Intervention||15
303513|NCT00765206|733793|P1|COMPLETED|First Intervention||15
303514|NCT00765206|733790|P4|STARTED|First Intervention||15
303515|NCT00765206|733791|P3|STARTED|First Intervention||15
303516|NCT00765206|733792|P2|STARTED|First Intervention||15
303517|NCT00765206|733793|P1|STARTED|First Intervention||15
303518|NCT00765193|733799|P1|NOT COMPLETED|Full Body Examination||0
303519|NCT00765193|733799|P1|COMPLETED|Full Body Examination||14381
303520|NCT00765193|733799|P1|STARTED|Full Body Examination||14381
303521|NCT00765193|733799|P1|NOT COMPLETED|Problem Area Examination||0
303522|NCT00765193|733799|P1|COMPLETED|Problem Area Examination||14381
303523|NCT00765193|733799|P1|STARTED|Problem Area Examination||14381
303524|NCT00765128|733806|P2|NOT COMPLETED|Overall Study||0
303525|NCT00765128|733807|P1|NOT COMPLETED|Overall Study||0
303526|NCT00765128|733806|P2|COMPLETED|Overall Study||9
303527|NCT00765128|733807|P1|COMPLETED|Overall Study||8
303528|NCT00765128|733806|P2|STARTED|Overall Study||9
303529|NCT00765128|733807|P1|STARTED|Overall Study||8
303530|NCT00765102|733815|P1|NOT COMPLETED|Overall Study||31
303531|NCT00765102|733815|P1|COMPLETED|Overall Study|Completed 8 cycles of treatment|1
303532|NCT00765102|733815|P1|STARTED|Overall Study||32
303533|NCT00765076|733840|P3|NOT COMPLETED|Overall Study||1
303534|NCT00765076|733841|P2|NOT COMPLETED|Overall Study||0
303535|NCT00765076|733842|P1|NOT COMPLETED|Overall Study||1
303536|NCT00765076|733840|P3|COMPLETED|Overall Study||49
303537|NCT00765076|733841|P2|COMPLETED|Overall Study||73
303538|NCT00765076|733842|P1|COMPLETED|Overall Study||68
303539|NCT00765076|733840|P3|STARTED|Overall Study||50
303540|NCT00765076|733841|P2|STARTED|Overall Study||73
303541|NCT00765076|733842|P1|STARTED|Overall Study||69
303542|NCT00765063|733895|P1|NOT COMPLETED|Overall Study||32
303543|NCT00765063|733895|P1|COMPLETED|Overall Study||30
303544|NCT00765063|733895|P1|STARTED|Overall Study||62
303545|NCT00765037|733911|P1|NOT COMPLETED|Overall Study||6
303546|NCT00765037|733911|P1|COMPLETED|Overall Study|Subjects who came in for 1 year visit.|13
303547|NCT00765037|733911|P1|STARTED|Overall Study|Original number of eligible subjects who signed a consent form.|19
303548|NCT00764946|733918|P3|NOT COMPLETED|Overall Study||4
303549|NCT00764946|733919|P2|NOT COMPLETED|Overall Study||17
303550|NCT00764946|733920|P1|NOT COMPLETED|Overall Study||13
303551|NCT00764946|733918|P3|COMPLETED|Overall Study||18
303552|NCT00764946|733919|P2|COMPLETED|Overall Study||72
303553|NCT00764946|733920|P1|COMPLETED|Overall Study||85
303554|NCT00764946|733918|P3|TREATED|Overall Study||21
303555|NCT00764946|733919|P2|TREATED|Overall Study||88
303556|NCT00764946|733920|P1|TREATED|Overall Study||97
303557|NCT00764946|733918|P3|STARTED|Overall Study||22
303558|NCT00764946|733919|P2|STARTED|Overall Study||89
303559|NCT00764946|733920|P1|STARTED|Overall Study||98
303560|NCT00764881|733948|P2|NOT COMPLETED|Overall Study||10
303561|NCT00764881|733949|P1|NOT COMPLETED|Overall Study||16
303562|NCT00764881|733948|P2|COMPLETED|Overall Study||99
303563|NCT00764881|733949|P1|COMPLETED|Overall Study||92
303564|NCT00764881|733948|P2|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|107
303565|NCT00764881|733949|P1|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|106
303566|NCT00764881|733948|P2|STARTED|Overall Study||109
303567|NCT00764881|733949|P1|STARTED|Overall Study||108
303568|NCT00764868|734173|P1|NOT COMPLETED|Overall Study||113
303569|NCT00764868|734173|P1|COMPLETED|Overall Study||156
303570|NCT00764868|734173|P1|STARTED|Overall Study||269
303571|NCT00764790|734182|P3|NOT COMPLETED|Overall Study||30
303572|NCT00764790|734183|P2|NOT COMPLETED|Overall Study||41
303573|NCT00764790|734184|P1|NOT COMPLETED|Overall Study||38
303574|NCT00764790|734182|P3|COMPLETED|Overall Study||1074
303575|NCT00764790|734183|P2|COMPLETED|Overall Study||1065
303576|NCT00764790|734184|P1|COMPLETED|Overall Study||1069
303577|NCT00764790|734182|P3|STARTED|Overall Study||1104
303578|NCT00764790|734183|P2|STARTED|Overall Study||1106
303579|NCT00764790|734184|P1|STARTED|Overall Study||1107
303580|NCT00764751|734218|P2|NOT COMPLETED|Overall Study||1
303581|NCT00764751|734219|P1|NOT COMPLETED|Overall Study||2
303582|NCT00764751|734218|P2|COMPLETED|Overall Study||11
303583|NCT00764751|734219|P1|COMPLETED|Overall Study||37
303584|NCT00764751|734218|P2|STARTED|Overall Study||12
303585|NCT00764751|734219|P1|STARTED|Overall Study||39
303586|NCT00764699|734253|P1|NOT COMPLETED|Overall Study||3
303587|NCT00764699|734253|P1|COMPLETED|Overall Study||0
303588|NCT00764699|734253|P1|STARTED|Overall Study||3
303589|NCT00764673|734257|P1|NOT COMPLETED|Overall Study||12
303590|NCT00764673|734257|P1|COMPLETED|Overall Study||59
303591|NCT00764673|734257|P1|STARTED|Overall Study||71
303592|NCT00764660|734267|P2|NOT COMPLETED|Overall Study||11
303593|NCT00764660|734268|P1|NOT COMPLETED|Overall Study||22
303594|NCT00764660|734267|P2|COMPLETED|Overall Study||55
303595|NCT00764660|734268|P1|COMPLETED|Overall Study||53
303596|NCT00764660|734267|P2|STARTED|Overall Study||66
303597|NCT00764660|734268|P1|STARTED|Overall Study||75
303598|NCT00764517|734302|P2|NOT COMPLETED|Overall Study||14
303599|NCT00764517|734303|P1|NOT COMPLETED|Overall Study||15
303600|NCT00764517|734302|P2|COMPLETED|Overall Study||4
303601|NCT00764517|734303|P1|COMPLETED|Overall Study||24
303602|NCT00764517|734302|P2|STARTED|Overall Study||18
303603|NCT00764517|734303|P1|STARTED|Overall Study||39
303604|NCT00764504|734324|P3|NOT COMPLETED|Overall Study||103
303605|NCT00764504|734325|P2|NOT COMPLETED|Overall Study||70
303606|NCT00764504|734326|P1|NOT COMPLETED|Overall Study||66
303607|NCT00764504|734324|P3|COMPLETED|Overall Study||131
303608|NCT00764504|734325|P2|COMPLETED|Overall Study||71
303609|NCT00764504|734326|P1|COMPLETED|Overall Study||75
303610|NCT00764504|734324|P3|STARTED|Overall Study||234
303611|NCT00764504|734325|P2|STARTED|Overall Study||141
303612|NCT00764504|734326|P1|STARTED|Overall Study||141
303613|NCT00764478|734355|P3|NOT COMPLETED|Overall Study||8
303614|NCT00764478|734356|P2|NOT COMPLETED|Overall Study||22
303615|NCT00764478|734357|P1|NOT COMPLETED|Overall Study||15
303616|NCT00764478|734355|P3|COMPLETED|Overall Study||118
303617|NCT00764478|734356|P2|COMPLETED|Overall Study||97
303618|NCT00764478|734357|P1|COMPLETED|Overall Study||107
303619|NCT00764478|734355|P3|STARTED|Overall Study||126
303620|NCT00764478|734356|P2|STARTED|Overall Study||119
303621|NCT00764478|734357|P1|STARTED|Overall Study||122
303622|NCT00764465|734437|P6|NOT COMPLETED|Overall Study||1
303623|NCT00764465|734438|P5|NOT COMPLETED|Overall Study||1
303624|NCT00764465|734439|P4|NOT COMPLETED|Overall Study||1
303625|NCT00764465|734440|P3|NOT COMPLETED|Overall Study||1
303626|NCT00764465|734441|P2|NOT COMPLETED|Overall Study||1
303627|NCT00764465|734442|P1|NOT COMPLETED|Overall Study||2
303628|NCT00764465|734437|P6|COMPLETED|Overall Study||7
303629|NCT00764465|734438|P5|COMPLETED|Overall Study||6
303630|NCT00764465|734439|P4|COMPLETED|Overall Study||6
303631|NCT00764465|734440|P3|COMPLETED|Overall Study||6
303632|NCT00764465|734441|P2|COMPLETED|Overall Study||6
303633|NCT00764465|734442|P1|COMPLETED|Overall Study||7
303634|NCT00764465|734437|P6|STARTED|Overall Study||8
303635|NCT00764465|734438|P5|STARTED|Overall Study||7
303636|NCT00764465|734439|P4|STARTED|Overall Study||7
303637|NCT00764465|734440|P3|STARTED|Overall Study||7
303638|NCT00764465|734441|P2|STARTED|Overall Study||7
303639|NCT00764465|734442|P1|STARTED|Overall Study||9
303640|NCT00764361|734470|P2|NOT COMPLETED|Overall Study||4
303641|NCT00764361|734471|P1|NOT COMPLETED|Overall Study||2
303642|NCT00764361|734470|P2|COMPLETED|Overall Study||3
303643|NCT00764361|734471|P1|COMPLETED|Overall Study||6
303644|NCT00764361|734470|P2|STARTED|Overall Study||7
303645|NCT00764361|734471|P1|STARTED|Overall Study||8
303646|NCT00764322|734479|P1|NOT COMPLETED|Overall Study||20
303647|NCT00764322|734479|P1|COMPLETED|Overall Study||480
303648|NCT00764322|734479|P1|STARTED|Overall Study||500
303649|NCT00764309|734496|P1|NOT COMPLETED|Overall Study||0
303650|NCT00764309|734496|P1|COMPLETED|Overall Study|Completed=off study. Major Reasons for off study: AE-13; withdrawn by sponsor-10; Lack of efficacy-3|31
303651|NCT00764309|734496|P1|STARTED|Overall Study|Number of participants treated.|31
303652|NCT00763971|734506|P3|NOT COMPLETED|Overall Study||69
303653|NCT00763971|734507|P2|NOT COMPLETED|Overall Study||38
303654|NCT00763971|734508|P1|NOT COMPLETED|Overall Study||33
303655|NCT00763971|734506|P3|COMPLETED|Overall Study||42
303656|NCT00763971|734507|P2|COMPLETED|Overall Study||74
303657|NCT00763971|734508|P1|COMPLETED|Overall Study||80
303658|NCT00763971|734506|P3|STARTED|Overall Study||111
303659|NCT00763971|734507|P2|STARTED|Overall Study||112
303660|NCT00763971|734508|P1|STARTED|Overall Study||113
303661|NCT00763958|734539|P2|NOT COMPLETED|Overall Study||11
303662|NCT00763958|734540|P1|NOT COMPLETED|Overall Study||14
303663|NCT00763958|734539|P2|COMPLETED|Overall Study||5
303664|NCT00763958|734540|P1|COMPLETED|Overall Study||14
303665|NCT00763958|734539|P2|STARTED|Overall Study||16
303666|NCT00763958|734540|P1|STARTED|Overall Study||28
303667|NCT00763919|734550|P1|NOT COMPLETED|Overall Study||13
303668|NCT00763919|734550|P1|COMPLETED|Overall Study||30
303669|NCT00763919|734550|P1|STARTED|Overall Study||43
303670|NCT00763867|734578|P2|NOT COMPLETED|Overall Study||12
303671|NCT00763867|734579|P1|NOT COMPLETED|Overall Study||5
303672|NCT00763867|734578|P2|COMPLETED|Overall Study||101
303673|NCT00763867|734579|P1|COMPLETED|Overall Study||98
303674|NCT00763867|734578|P2|STARTED|Overall Study||113
303675|NCT00763867|734579|P1|STARTED|Overall Study||103
303676|NCT00763815|734675|P2|NOT COMPLETED|Overall Study||84
303677|NCT00763815|734676|P1|NOT COMPLETED|Overall Study||52
303678|NCT00763815|734675|P2|COMPLETED|Overall Study||239
303679|NCT00763815|734676|P1|COMPLETED|Overall Study||109
303680|NCT00763815|734675|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||320
303681|NCT00763815|734676|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|159
303682|NCT00763815|734675|P2|Treated/Safety Population|Overall Study||323
303683|NCT00763815|734676|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|161
303684|NCT00763815|734675|P2|STARTED|Overall Study||323
303685|NCT00763815|734676|P1|STARTED|Overall Study|Randomized.|161
303686|NCT00763750|734700|P1|NOT COMPLETED|Overall Study||0
303687|NCT00763750|734700|P1|COMPLETED|Overall Study||25
303688|NCT00763750|734700|P1|STARTED|Overall Study||25
303689|NCT00763698|734704|P1|NOT COMPLETED|Overall Study||10
303690|NCT00763698|734704|P1|COMPLETED|Overall Study||76
303691|NCT00763698|734704|P1|STARTED|Overall Study||86
303692|NCT00763490|734710|P1|NOT COMPLETED|Overall Study||0
303693|NCT00763490|734710|P1|COMPLETED|Overall Study||20
303694|NCT00763490|734710|P1|STARTED|Overall Study||20
303695|NCT00763451|734721|P4|NOT COMPLETED|Overall Study||30
303696|NCT00763451|734722|P3|NOT COMPLETED|Overall Study||40
303697|NCT00763451|734723|P2|NOT COMPLETED|Overall Study||22
303698|NCT00763451|734724|P1|NOT COMPLETED|Overall Study||13
303699|NCT00763451|734721|P4|COMPLETED|Overall Study||131
303700|NCT00763451|734722|P3|COMPLETED|Overall Study||121
303701|NCT00763451|734723|P2|COMPLETED|Overall Study||60
303702|NCT00763451|734724|P1|COMPLETED|Overall Study||67
303703|NCT00763451|734721|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||160
303704|NCT00763451|734722|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||160
303705|NCT00763451|734723|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||80
303706|NCT00763451|734724|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|79
303707|NCT00763451|734721|P4|Treated/Safety Population|Overall Study||161
303708|NCT00763451|734722|P3|Treated/Safety Population|Overall Study||161
303709|NCT00763451|734723|P2|Treated/Safety Population|Overall Study||81
303710|NCT00763451|734724|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|79
303711|NCT00763451|734721|P4|STARTED|Overall Study||161
303712|NCT00763451|734722|P3|STARTED|Overall Study||161
303713|NCT00763451|734723|P2|STARTED|Overall Study||82
303714|NCT00763451|734724|P1|STARTED|Overall Study|Randomized.|80
303715|NCT00763412|734758|P2|NOT COMPLETED|Overall Study||4
303716|NCT00763412|734759|P1|NOT COMPLETED|Overall Study||4
303717|NCT00763412|734758|P2|COMPLETED|Overall Study||4
303718|NCT00763412|734759|P1|COMPLETED|Overall Study||4
303719|NCT00763412|734758|P2|STARTED|Overall Study||8
303720|NCT00763412|734759|P1|STARTED|Overall Study||8
303721|NCT00763386|734783|P2|NOT COMPLETED|Overall Study||40
303722|NCT00763386|734784|P1|NOT COMPLETED|Overall Study||48
303723|NCT00763386|734783|P2|COMPLETED|Overall Study||127
303724|NCT00763386|734784|P1|COMPLETED|Overall Study||116
303725|NCT00763386|734783|P2|STARTED|Overall Study||167
303726|NCT00763386|734784|P1|STARTED|Overall Study||164
303727|NCT00763360|734795|P3|NOT COMPLETED|Overall Study||0
303728|NCT00763360|734796|P2|NOT COMPLETED|Overall Study||2
303729|NCT00763360|734797|P1|NOT COMPLETED|Overall Study||0
303730|NCT00763360|734795|P3|COMPLETED|Overall Study||63
303731|NCT00763360|734796|P2|COMPLETED|Overall Study||58
303732|NCT00763360|734797|P1|COMPLETED|Overall Study||61
303733|NCT00763360|734795|P3|STARTED|Overall Study||63
303734|NCT00763360|734796|P2|STARTED|Overall Study||60
303735|NCT00763360|734797|P1|STARTED|Overall Study||61
303736|NCT00763321|734817|P3|NOT COMPLETED|Double-blind Period||29
303737|NCT00763321|734818|P2|NOT COMPLETED|Double-blind Period||21
303738|NCT00763321|734819|P1|NOT COMPLETED|Double-blind Period||0
303739|NCT00763321|734817|P3|COMPLETED|Double-blind Period||84
303740|NCT00763321|734818|P2|COMPLETED|Double-blind Period||88
303741|NCT00763321|734819|P1|COMPLETED|Double-blind Period||0
303742|NCT00763321|734817|P3|STARTED|Double-blind Period||113
303743|NCT00763321|734818|P2|STARTED|Double-blind Period||109
303744|NCT00763321|734819|P1|STARTED|Double-blind Period||0
303745|NCT00763321|734817|P3|NOT COMPLETED|Open-label Period||0
303746|NCT00763321|734818|P2|NOT COMPLETED|Open-label Period||0
303747|NCT00763321|734819|P1|NOT COMPLETED|Open-label Period||63
303748|NCT00763321|734817|P3|COMPLETED|Open-label Period||0
303749|NCT00763321|734818|P2|COMPLETED|Open-label Period||0
303750|NCT00763321|734819|P1|COMPLETED|Open-label Period||222
303751|NCT00763321|734817|P3|STARTED|Open-label Period||0
303752|NCT00763321|734818|P2|STARTED|Open-label Period||0
303753|NCT00763321|734819|P1|STARTED|Open-label Period||285
303754|NCT00763282|734830|P2|NOT COMPLETED|Overall Study||34
303755|NCT00763282|734831|P1|NOT COMPLETED|Overall Study||32
303756|NCT00763282|734830|P2|COMPLETED|Overall Study||38
303757|NCT00763282|734831|P1|COMPLETED|Overall Study||40
303758|NCT00763282|734830|P2|STARTED|Overall Study||72
303759|NCT00763282|734831|P1|STARTED|Overall Study||72
303760|NCT00763269|734847|P2|NOT COMPLETED|Overall Study||13
303761|NCT00763269|734848|P1|NOT COMPLETED|Overall Study||12
303762|NCT00763269|734847|P2|COMPLETED|Overall Study||299
303763|NCT00763269|734848|P1|COMPLETED|Overall Study||302
303764|NCT00763269|734847|P2|STARTED|Overall Study||312
303765|NCT00763269|734848|P1|STARTED|Overall Study||314
303766|NCT00763256|734862|P2|NOT COMPLETED|Overall Study||10
303767|NCT00763256|734863|P1|NOT COMPLETED|Overall Study||7
303768|NCT00763256|734862|P2|COMPLETED|Overall Study||8
303769|NCT00763256|734863|P1|COMPLETED|Overall Study||8
303770|NCT00763256|734862|P2|STARTED|Overall Study||18
303771|NCT00763256|734863|P1|STARTED|Overall Study||15
303772|NCT00763243|734877|P1|NOT COMPLETED|6-Month Follow-Up Period||0
303773|NCT00763243|734877|P1|COMPLETED|6-Month Follow-Up Period||9
303774|NCT00763243|734877|P1|STARTED|6-Month Follow-Up Period||9
303775|NCT00763243|734877|P1|NOT COMPLETED|1-Month Follow-Up Period||0
303776|NCT00763243|734877|P1|COMPLETED|1-Month Follow-Up Period||9
303777|NCT00763243|734877|P1|STARTED|1-Month Follow-Up Period||9
303778|NCT00763243|734877|P1|NOT COMPLETED|Training Period||0
303779|NCT00763243|734877|P1|COMPLETED|Training Period||9
303780|NCT00763243|734877|P1|STARTED|Training Period||9
303781|NCT00763243|734877|P1|NOT COMPLETED|Waiting Period||0
303782|NCT00763243|734877|P1|COMPLETED|Waiting Period||9
303783|NCT00763243|734877|P1|STARTED|Waiting Period||9
303784|NCT00763139|734899|P2|NOT COMPLETED|Overall Study||3
303785|NCT00763139|734900|P1|NOT COMPLETED|Overall Study||5
303786|NCT00763139|734899|P2|COMPLETED|Overall Study||14
303787|NCT00763139|734900|P1|COMPLETED|Overall Study||12
303788|NCT00763139|734899|P2|STARTED|Overall Study||17
303789|NCT00763139|734900|P1|STARTED|Overall Study||17
303790|NCT00763061|734922|P2|NOT COMPLETED|Overall Study||13
303791|NCT00763061|734923|P1|NOT COMPLETED|Overall Study||5
303792|NCT00763061|734922|P2|COMPLETED|Overall Study||44
303793|NCT00763061|734923|P1|COMPLETED|Overall Study||49
303794|NCT00763061|734922|P2|STARTED|Overall Study||57
303795|NCT00763061|734923|P1|STARTED|Overall Study||54
303796|NCT00763048|734937|P2|NOT COMPLETED|Overall Study||0
303797|NCT00763048|734938|P1|NOT COMPLETED|Overall Study||0
303798|NCT00763048|734937|P2|COMPLETED|Overall Study||18
303799|NCT00763048|734938|P1|COMPLETED|Overall Study||21
303800|NCT00763048|734937|P2|STARTED|Overall Study||18
303801|NCT00763048|734938|P1|STARTED|Overall Study||21
303802|NCT00763035|734962|P2|NOT COMPLETED|Second Intervention||0
303803|NCT00763035|734963|P1|NOT COMPLETED|Second Intervention||3
303804|NCT00763035|734962|P2|COMPLETED|Second Intervention||3
303805|NCT00763035|734963|P1|COMPLETED|Second Intervention||6
303806|NCT00763035|734962|P2|STARTED|Second Intervention||3
303807|NCT00763035|734963|P1|STARTED|Second Intervention||9
303808|NCT00763035|734962|P2|NOT COMPLETED|First Intervention||1
303809|NCT00763035|734963|P1|NOT COMPLETED|First Intervention||1
303810|NCT00763035|734962|P2|COMPLETED|First Intervention||3
303811|NCT00763035|734963|P1|COMPLETED|First Intervention||9
303812|NCT00763035|734962|P2|STARTED|First Intervention||4
303813|NCT00763035|734963|P1|STARTED|First Intervention||10
303814|NCT00763009|734981|P1|NOT COMPLETED|Overall Study||1
303815|NCT00763009|734981|P1|COMPLETED|Overall Study||7
303816|NCT00763009|734981|P1|STARTED|Overall Study||8
303817|NCT00762996|734986|P4|NOT COMPLETED|Period Two||0
303818|NCT00762996|734987|P3|NOT COMPLETED|Period Two||0
303819|NCT00762996|734988|P2|NOT COMPLETED|Period Two||0
303820|NCT00762996|734989|P1|NOT COMPLETED|Period Two||0
303821|NCT00762996|734986|P4|COMPLETED|Period Two||16
303822|NCT00762996|734987|P3|COMPLETED|Period Two||13
303823|NCT00762996|734988|P2|COMPLETED|Period Two||16
303824|NCT00762996|734989|P1|COMPLETED|Period Two||15
303825|NCT00762996|734986|P4|STARTED|Period Two||16
303826|NCT00762996|734987|P3|STARTED|Period Two||13
303827|NCT00762996|734988|P2|STARTED|Period Two||16
303828|NCT00762996|734989|P1|STARTED|Period Two||15
303829|NCT00762996|734986|P4|NOT COMPLETED|Period One||1
303830|NCT00762996|734987|P3|NOT COMPLETED|Period One||4
303831|NCT00762996|734988|P2|NOT COMPLETED|Period One||0
303832|NCT00762996|734989|P1|NOT COMPLETED|Period One||0
303833|NCT00762996|734986|P4|COMPLETED|Period One||16
303834|NCT00762996|734987|P3|COMPLETED|Period One||13
303835|NCT00762996|734988|P2|COMPLETED|Period One||16
303836|NCT00762996|734989|P1|COMPLETED|Period One||15
303837|NCT00762996|734986|P4|STARTED|Period One||17
303838|NCT00762996|734987|P3|STARTED|Period One||17
303839|NCT00762996|734988|P2|STARTED|Period One||16
303840|NCT00762996|734989|P1|STARTED|Period One||15
303841|NCT00762970|735002|P3|NOT COMPLETED|Overall Study||1
303842|NCT00762970|735003|P2|NOT COMPLETED|Overall Study||9
303843|NCT00762970|735004|P1|NOT COMPLETED|Overall Study||12
303844|NCT00762970|735002|P3|COMPLETED|Overall Study||46
303845|NCT00762970|735003|P2|COMPLETED|Overall Study||35
303846|NCT00762970|735004|P1|COMPLETED|Overall Study||34
303847|NCT00762970|735002|P3|STARTED|Overall Study||47
303848|NCT00762970|735003|P2|STARTED|Overall Study||44
303849|NCT00762970|735004|P1|STARTED|Overall Study||46
303850|NCT00762931|735015|P1|NOT COMPLETED|Overall Study||2
303851|NCT00762931|735015|P1|COMPLETED|Overall Study||23
303852|NCT00762931|735015|P1|STARTED|Overall Study||25
303853|NCT00762892|735022|P2|NOT COMPLETED|Overall Study||6
303854|NCT00762892|735023|P1|NOT COMPLETED|Overall Study||5
303855|NCT00762892|735022|P2|COMPLETED|Overall Study||8
303856|NCT00762892|735023|P1|COMPLETED|Overall Study||9
303857|NCT00762892|735022|P2|STARTED|Overall Study||14
303858|NCT00762892|735023|P1|STARTED|Overall Study||14
303859|NCT00762853|735039|P2|NOT COMPLETED|Second Treatment Period||0
303860|NCT00762853|735040|P1|NOT COMPLETED|Second Treatment Period||0
303861|NCT00762853|735039|P2|COMPLETED|Second Treatment Period||10
303862|NCT00762853|735040|P1|COMPLETED|Second Treatment Period||10
303863|NCT00762853|735039|P2|STARTED|Second Treatment Period||10
303864|NCT00762853|735040|P1|STARTED|Second Treatment Period||10
303865|NCT00762853|735039|P2|NOT COMPLETED|1 Week Washout After Treatment 1||0
303866|NCT00762853|735040|P1|NOT COMPLETED|1 Week Washout After Treatment 1||0
303867|NCT00762853|735039|P2|COMPLETED|1 Week Washout After Treatment 1||10
303868|NCT00762853|735040|P1|COMPLETED|1 Week Washout After Treatment 1||10
303869|NCT00762853|735039|P2|STARTED|1 Week Washout After Treatment 1||10
303870|NCT00762853|735040|P1|STARTED|1 Week Washout After Treatment 1||10
303871|NCT00762853|735039|P2|NOT COMPLETED|First Treatment Period||0
303872|NCT00762853|735040|P1|NOT COMPLETED|First Treatment Period||0
303873|NCT00762853|735039|P2|COMPLETED|First Treatment Period||10
303874|NCT00762853|735040|P1|COMPLETED|First Treatment Period||10
303875|NCT00762853|735039|P2|STARTED|First Treatment Period||10
303876|NCT00762853|735040|P1|STARTED|First Treatment Period||10
303877|NCT00762788|735052|P6|NOT COMPLETED|Overall Study||21
303878|NCT00762788|735053|P5|NOT COMPLETED|Overall Study||13
303879|NCT00762788|735054|P4|NOT COMPLETED|Overall Study||26
303880|NCT00762788|735055|P3|NOT COMPLETED|Overall Study||21
303881|NCT00762788|735056|P2|NOT COMPLETED|Overall Study||37
303882|NCT00762788|735057|P1|NOT COMPLETED|Overall Study||26
303883|NCT00762788|735052|P6|COMPLETED|Overall Study||31
303884|NCT00762788|735053|P5|COMPLETED|Overall Study||30
303885|NCT00762788|735054|P4|COMPLETED|Overall Study||38
303886|NCT00762788|735055|P3|COMPLETED|Overall Study||21
303887|NCT00762788|735056|P2|COMPLETED|Overall Study||21
303888|NCT00762788|735057|P1|COMPLETED|Overall Study||29
303889|NCT00762788|735052|P6|STARTED|Overall Study||52
303890|NCT00762788|735053|P5|STARTED|Overall Study||43
303891|NCT00762788|735054|P4|STARTED|Overall Study||64
303892|NCT00762788|735055|P3|STARTED|Overall Study||42
303893|NCT00762788|735056|P2|STARTED|Overall Study||58
303894|NCT00762788|735057|P1|STARTED|Overall Study||55
303895|NCT00762762|735079|P2|NOT COMPLETED|Overall Study||10
303896|NCT00762762|735080|P1|NOT COMPLETED|Overall Study||8
303897|NCT00762762|735079|P2|COMPLETED|Overall Study||20
303898|NCT00762762|735080|P1|COMPLETED|Overall Study||22
303899|NCT00762762|735079|P2|STARTED|Overall Study||30
303900|NCT00762762|735080|P1|STARTED|Overall Study||30
303901|NCT00762723|735097|P3|NOT COMPLETED|Overall Study||3
303902|NCT00762723|735098|P2|NOT COMPLETED|Overall Study||5
303903|NCT00762723|735099|P1|NOT COMPLETED|Overall Study||5
303904|NCT00762723|735097|P3|COMPLETED|Overall Study||0
303905|NCT00762723|735098|P2|COMPLETED|Overall Study||6
303906|NCT00762723|735099|P1|COMPLETED|Overall Study||0
303907|NCT00762723|735097|P3|STARTED|Overall Study||3
303908|NCT00762723|735098|P2|STARTED|Overall Study||11
303909|NCT00762723|735099|P1|STARTED|Overall Study||5
303910|NCT00762645|735109|P2|NOT COMPLETED|Overall Study||2
303911|NCT00762645|735110|P1|NOT COMPLETED|Overall Study||4
303912|NCT00762645|735109|P2|COMPLETED|Overall Study||12
303913|NCT00762645|735110|P1|COMPLETED|Overall Study||12
303914|NCT00762645|735109|P2|STARTED|Overall Study||14
303915|NCT00762645|735110|P1|STARTED|Overall Study||16
303916|NCT00762619|735120|P2|NOT COMPLETED|Overall Study||0
303917|NCT00762619|735121|P1|NOT COMPLETED|Overall Study||0
303918|NCT00762619|735120|P2|COMPLETED|Overall Study||50
303919|NCT00762619|735121|P1|COMPLETED|Overall Study||55
303920|NCT00762619|735120|P2|STARTED|Overall Study||50
303921|NCT00762619|735121|P1|STARTED|Overall Study||55
303922|NCT00762606|735263|P2|NOT COMPLETED|Overall Study||13
303923|NCT00762606|735264|P1|NOT COMPLETED|Overall Study||18
303924|NCT00762606|735263|P2|COMPLETED|Overall Study||38
303925|NCT00762606|735264|P1|COMPLETED|Overall Study||37
303926|NCT00762606|735263|P2|STARTED|Overall Study||51
303927|NCT00762606|735264|P1|STARTED|Overall Study||55
303928|NCT00762528|735274|P2|NOT COMPLETED|Overall Study||0
303929|NCT00762528|735275|P1|NOT COMPLETED|Overall Study||0
303930|NCT00762528|735274|P2|COMPLETED|Overall Study||25
303931|NCT00762528|735275|P1|COMPLETED|Overall Study||24
303932|NCT00762528|735274|P2|STARTED|Overall Study||25
303933|NCT00762528|735275|P1|STARTED|Overall Study||24
303934|NCT00762515|735297|P2|NOT COMPLETED|Overall Study||0
303935|NCT00762515|735298|P1|NOT COMPLETED|Overall Study||0
303936|NCT00762515|735297|P2|COMPLETED|Overall Study||22
303937|NCT00762515|735298|P1|COMPLETED|Overall Study||22
303938|NCT00762515|735297|P2|STARTED|Overall Study||22
303939|NCT00762515|735298|P1|STARTED|Overall Study||22
303940|NCT00762502|735309|P3|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
303941|NCT00762502|735310|P2|NOT COMPLETED|Month 3 to Month 6 (Period 2)||1
303942|NCT00762502|735311|P1|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
303943|NCT00762502|735309|P3|COMPLETED|Month 3 to Month 6 (Period 2)||23
303944|NCT00762502|735310|P2|COMPLETED|Month 3 to Month 6 (Period 2)||4
303945|NCT00762502|735311|P1|COMPLETED|Month 3 to Month 6 (Period 2)||9
303946|NCT00762502|735309|P3|STARTED|Month 3 to Month 6 (Period 2)||23
303947|NCT00762502|735310|P2|STARTED|Month 3 to Month 6 (Period 2)||5
303948|NCT00762502|735311|P1|STARTED|Month 3 to Month 6 (Period 2)||9
303949|NCT00762502|735309|P3|NOT COMPLETED|Baseline to Month 3 (Period 1)||19
303950|NCT00762502|735310|P2|NOT COMPLETED|Baseline to Month 3 (Period 1)||6
303951|NCT00762502|735311|P1|NOT COMPLETED|Baseline to Month 3 (Period 1)||10
303952|NCT00762502|735309|P3|COMPLETED|Baseline to Month 3 (Period 1)||32
303953|NCT00762502|735310|P2|COMPLETED|Baseline to Month 3 (Period 1)||19
303954|NCT00762502|735311|P1|COMPLETED|Baseline to Month 3 (Period 1)||26
303955|NCT00762502|735309|P3|STARTED|Baseline to Month 3 (Period 1)||51
303956|NCT00762502|735310|P2|STARTED|Baseline to Month 3 (Period 1)||25
303957|NCT00762502|735311|P1|STARTED|Baseline to Month 3 (Period 1)||36
303958|NCT00762476|735325|P2|NOT COMPLETED|Overall Study||36
303959|NCT00762476|735326|P1|NOT COMPLETED|Overall Study||23
303960|NCT00762476|735325|P2|COMPLETED|Overall Study||169
303961|NCT00762476|735326|P1|COMPLETED|Overall Study||183
303962|NCT00762476|735325|P2|STARTED|Overall Study||205
303963|NCT00762476|735326|P1|STARTED|Overall Study||206
303964|NCT00762463|735338|P4|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||2
303965|NCT00762463|735339|P3|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||4
303966|NCT00762463|735340|P2|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||1
303967|NCT00762463|735341|P1|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||3
303968|NCT00762463|735338|P4|COMPLETED|Extension Phase (Week 6 to Week 12)||52
303969|NCT00762463|735339|P3|COMPLETED|Extension Phase (Week 6 to Week 12)||50
303970|NCT00762463|735340|P2|COMPLETED|Extension Phase (Week 6 to Week 12)||54
303971|NCT00762463|735341|P1|COMPLETED|Extension Phase (Week 6 to Week 12)||52
303972|NCT00762463|735338|P4|STARTED|Extension Phase (Week 6 to Week 12)||54
303973|NCT00762463|735339|P3|STARTED|Extension Phase (Week 6 to Week 12)||54
303974|NCT00762463|735340|P2|STARTED|Extension Phase (Week 6 to Week 12)||55
303975|NCT00762463|735341|P1|STARTED|Extension Phase (Week 6 to Week 12)||55
303976|NCT00762463|735338|P4|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
303977|NCT00762463|735339|P3|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
303978|NCT00762463|735340|P2|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||1
303979|NCT00762463|735341|P1|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||4
303980|NCT00762463|735338|P4|COMPLETED|Enrollment in Extension Phase (Week 6)||0
303981|NCT00762463|735339|P3|COMPLETED|Enrollment in Extension Phase (Week 6)||0
303982|NCT00762463|735340|P2|COMPLETED|Enrollment in Extension Phase (Week 6)||109
303983|NCT00762463|735341|P1|COMPLETED|Enrollment in Extension Phase (Week 6)||109
303984|NCT00762463|735338|P4|STARTED|Enrollment in Extension Phase (Week 6)||0
303985|NCT00762463|735339|P3|STARTED|Enrollment in Extension Phase (Week 6)||0
303986|NCT00762463|735340|P2|STARTED|Enrollment in Extension Phase (Week 6)||110
303987|NCT00762463|735341|P1|STARTED|Enrollment in Extension Phase (Week 6)||113
303988|NCT00762463|735338|P4|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
303989|NCT00762463|735339|P3|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
303990|NCT00762463|735340|P2|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||10
303991|NCT00762463|735341|P1|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||7
303992|NCT00762463|735338|P4|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
303993|NCT00762463|735339|P3|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
303994|NCT00762463|735340|P2|COMPLETED|Double-blind Phase (Baseline to Week 6)||110
303995|NCT00762463|735341|P1|COMPLETED|Double-blind Phase (Baseline to Week 6)||113
303996|NCT00762463|735338|P4|STARTED|Double-blind Phase (Baseline to Week 6)||0
303997|NCT00762463|735339|P3|STARTED|Double-blind Phase (Baseline to Week 6)||0
303998|NCT00762463|735340|P2|STARTED|Double-blind Phase (Baseline to Week 6)||120
303999|NCT00762463|735341|P1|STARTED|Double-blind Phase (Baseline to Week 6)||120
304000|NCT00762450|735426|P3|NOT COMPLETED|3rd Treatment Period||0
304001|NCT00762450|735427|P2|NOT COMPLETED|3rd Treatment Period||0
304002|NCT00762450|735428|P1|NOT COMPLETED|3rd Treatment Period||0
304003|NCT00762450|735426|P3|COMPLETED|3rd Treatment Period||2
304004|NCT00762450|735427|P2|COMPLETED|3rd Treatment Period||2
304005|NCT00762450|735428|P1|COMPLETED|3rd Treatment Period||2
304006|NCT00762450|735426|P3|STARTED|3rd Treatment Period||2
304007|NCT00762450|735427|P2|STARTED|3rd Treatment Period||2
304008|NCT00762450|735428|P1|STARTED|3rd Treatment Period||2
304009|NCT00762450|735426|P3|NOT COMPLETED|Washout After 2nd Treatment Period||0
304010|NCT00762450|735427|P2|NOT COMPLETED|Washout After 2nd Treatment Period||0
304011|NCT00762450|735428|P1|NOT COMPLETED|Washout After 2nd Treatment Period||0
304012|NCT00762450|735426|P3|COMPLETED|Washout After 2nd Treatment Period||2
304013|NCT00762450|735427|P2|COMPLETED|Washout After 2nd Treatment Period||2
304014|NCT00762450|735428|P1|COMPLETED|Washout After 2nd Treatment Period||2
304015|NCT00762450|735426|P3|STARTED|Washout After 2nd Treatment Period||2
304016|NCT00762450|735427|P2|STARTED|Washout After 2nd Treatment Period||2
304017|NCT00762450|735428|P1|STARTED|Washout After 2nd Treatment Period||2
304018|NCT00762450|735426|P3|NOT COMPLETED|2nd Treatment Period||0
304019|NCT00762450|735427|P2|NOT COMPLETED|2nd Treatment Period||0
304020|NCT00762450|735428|P1|NOT COMPLETED|2nd Treatment Period||0
304021|NCT00762450|735426|P3|COMPLETED|2nd Treatment Period||2
304022|NCT00762450|735427|P2|COMPLETED|2nd Treatment Period||2
304023|NCT00762450|735428|P1|COMPLETED|2nd Treatment Period||2
304024|NCT00762450|735426|P3|STARTED|2nd Treatment Period||2
304025|NCT00762450|735427|P2|STARTED|2nd Treatment Period||2
304026|NCT00762450|735428|P1|STARTED|2nd Treatment Period||2
304027|NCT00762450|735426|P3|NOT COMPLETED|Washout After 1st Treatment Period||0
304028|NCT00762450|735427|P2|NOT COMPLETED|Washout After 1st Treatment Period||0
304029|NCT00762450|735428|P1|NOT COMPLETED|Washout After 1st Treatment Period||0
304030|NCT00762450|735426|P3|COMPLETED|Washout After 1st Treatment Period||2
304031|NCT00762450|735427|P2|COMPLETED|Washout After 1st Treatment Period||2
304032|NCT00762450|735428|P1|COMPLETED|Washout After 1st Treatment Period||2
304033|NCT00762450|735426|P3|STARTED|Washout After 1st Treatment Period||2
304034|NCT00762450|735427|P2|STARTED|Washout After 1st Treatment Period||2
304035|NCT00762450|735428|P1|STARTED|Washout After 1st Treatment Period||2
304036|NCT00762450|735426|P3|NOT COMPLETED|1st Treatment Period||0
304037|NCT00762450|735427|P2|NOT COMPLETED|1st Treatment Period||0
304038|NCT00762450|735428|P1|NOT COMPLETED|1st Treatment Period||0
304039|NCT00762450|735426|P3|COMPLETED|1st Treatment Period||2
304040|NCT00762450|735427|P2|COMPLETED|1st Treatment Period||2
304041|NCT00762450|735428|P1|COMPLETED|1st Treatment Period||2
304042|NCT00762450|735426|P3|STARTED|1st Treatment Period||2
304043|NCT00762450|735427|P2|STARTED|1st Treatment Period||2
304044|NCT00762450|735428|P1|STARTED|1st Treatment Period||2
304045|NCT00762424|735438|P2|NOT COMPLETED|Overall Study||0
304046|NCT00762424|735439|P1|NOT COMPLETED|Overall Study||0
304047|NCT00762424|735438|P2|COMPLETED|Overall Study||25
304048|NCT00762424|735439|P1|COMPLETED|Overall Study||28
304049|NCT00762424|735438|P2|STARTED|Overall Study||25
304050|NCT00762424|735439|P1|STARTED|Overall Study||28
304051|NCT00762411|735447|P2|NOT COMPLETED|Safety Follow Up (SFU)-Optional||118
304052|NCT00762411|735448|P1|NOT COMPLETED|Safety Follow Up (SFU)-Optional||84
304053|NCT00762411|735447|P2|COMPLETED|Safety Follow Up (SFU)-Optional||312
304054|NCT00762411|735448|P1|COMPLETED|Safety Follow Up (SFU)-Optional||228
304055|NCT00762411|735447|P2|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|430
304056|NCT00762411|735448|P1|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|312
304057|NCT00762411|735447|P2|NOT COMPLETED|Delayed Start||26
304058|NCT00762411|735448|P1|NOT COMPLETED|Delayed Start||17
304059|NCT00762411|735447|P2|COMPLETED|Delayed Start||8
304060|NCT00762411|735448|P1|COMPLETED|Delayed Start||5
304061|NCT00762411|735447|P2|STARTED|Delayed Start||34
304062|NCT00762411|735448|P1|STARTED|Delayed Start||22
304063|NCT00762411|735447|P2|NOT COMPLETED|Initial Treatment||521
304064|NCT00762411|735448|P1|NOT COMPLETED|Initial Treatment||534
304065|NCT00762411|735447|P2|COMPLETED|Initial Treatment||34
304066|NCT00762411|735448|P1|COMPLETED|Initial Treatment||22
304067|NCT00762411|735447|P2|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who received at least 1 dose of study drug.|553
304068|NCT00762411|735448|P1|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants(pts) who received at least 1 dose of study drug.|555
304069|NCT00762411|735447|P2|STARTED|Initial Treatment||555
304070|NCT00762411|735448|P1|STARTED|Initial Treatment||556
304071|NCT00762385|735512|P2|NOT COMPLETED|Second Intervention||3
304072|NCT00762385|735513|P1|NOT COMPLETED|Second Intervention||3
304073|NCT00762385|735512|P2|COMPLETED|Second Intervention||39
304074|NCT00762385|735513|P1|COMPLETED|Second Intervention||46
304075|NCT00762385|735512|P2|STARTED|Second Intervention||42
304076|NCT00762385|735513|P1|STARTED|Second Intervention||49
304077|NCT00762385|735512|P2|NOT COMPLETED|First Intervention||4
304078|NCT00762385|735513|P1|NOT COMPLETED|First Intervention||2
304079|NCT00762385|735512|P2|COMPLETED|First Intervention||42
304080|NCT00762385|735513|P1|COMPLETED|First Intervention||49
304081|NCT00762385|735512|P2|STARTED|First Intervention||46
304082|NCT00762385|735513|P1|STARTED|First Intervention||51
304083|NCT00762372|735526|P3|NOT COMPLETED|Overall Study||0
304084|NCT00762372|735527|P2|NOT COMPLETED|Overall Study||0
304085|NCT00762372|735528|P1|NOT COMPLETED|Overall Study||1
304086|NCT00762372|735526|P3|COMPLETED|Overall Study||50
304087|NCT00762372|735527|P2|COMPLETED|Overall Study||55
304088|NCT00762372|735528|P1|COMPLETED|Overall Study||110
304089|NCT00762372|735526|P3|STARTED|Overall Study|N=53 enrolled but 3 participant's discontinued before start of study drug administration.|50
304090|NCT00762372|735527|P2|STARTED|Overall Study|N=57 enrolled but 2 participant's discontinued before start of study drug administration.|55
304091|NCT00762372|735528|P1|STARTED|Overall Study|N=114 enrolled but 3 participant's discontinued before start of study drug administration.|111
304092|NCT00762359|735604|P2|NOT COMPLETED|Overall Study||57
304093|NCT00762359|735605|P1|NOT COMPLETED|Overall Study||59
304094|NCT00762359|735604|P2|COMPLETED|Overall Study||178
304095|NCT00762359|735605|P1|COMPLETED|Overall Study||167
304096|NCT00762359|735604|P2|STARTED|Overall Study||235
304097|NCT00762359|735605|P1|STARTED|Overall Study||226
304098|NCT00762320|735705|P1|NOT COMPLETED|Overall Study||0
304099|NCT00762320|735705|P1|COMPLETED|Overall Study||8
304100|NCT00762320|735705|P1|STARTED|Overall Study||8
304101|NCT00762268|735722|P2|NOT COMPLETED|Overall Study||3
304102|NCT00762268|735723|P1|NOT COMPLETED|Overall Study||3
304103|NCT00762268|735722|P2|COMPLETED|Overall Study||8
304104|NCT00762268|735723|P1|COMPLETED|Overall Study||9
304105|NCT00762268|735722|P2|STARTED|Overall Study||11
304106|NCT00762268|735723|P1|STARTED|Overall Study||12
304107|NCT00762229|735735|P2|NOT COMPLETED|Overall Study||2
304108|NCT00762229|735736|P1|NOT COMPLETED|Overall Study||1
304109|NCT00762229|735735|P2|COMPLETED|Overall Study||22
304110|NCT00762229|735736|P1|COMPLETED|Overall Study||14
304111|NCT00762229|735735|P2|STARTED|Overall Study||24
304112|NCT00762229|735736|P1|STARTED|Overall Study||15
304113|NCT00762216|735744|P1|NOT COMPLETED|Overall Study||0
304114|NCT00762216|735744|P1|COMPLETED|Overall Study||71
304115|NCT00762216|735744|P1|STARTED|Overall Study||71
304116|NCT00762177|735752|P3|NOT COMPLETED|3rd Treatment Period||0
304117|NCT00762177|735753|P2|NOT COMPLETED|3rd Treatment Period||0
304118|NCT00762177|735754|P1|NOT COMPLETED|3rd Treatment Period||0
304119|NCT00762177|735752|P3|COMPLETED|3rd Treatment Period||8
304120|NCT00762177|735753|P2|COMPLETED|3rd Treatment Period||8
304121|NCT00762177|735754|P1|COMPLETED|3rd Treatment Period||8
304122|NCT00762177|735752|P3|STARTED|3rd Treatment Period||8
304123|NCT00762177|735753|P2|STARTED|3rd Treatment Period||8
304124|NCT00762177|735754|P1|STARTED|3rd Treatment Period||8
304125|NCT00762177|735752|P3|NOT COMPLETED|Washout After 2nd Treatment||0
304126|NCT00762177|735753|P2|NOT COMPLETED|Washout After 2nd Treatment||0
304127|NCT00762177|735754|P1|NOT COMPLETED|Washout After 2nd Treatment||0
304128|NCT00762177|735752|P3|COMPLETED|Washout After 2nd Treatment||8
304129|NCT00762177|735753|P2|COMPLETED|Washout After 2nd Treatment||8
304130|NCT00762177|735754|P1|COMPLETED|Washout After 2nd Treatment||8
304131|NCT00762177|735752|P3|STARTED|Washout After 2nd Treatment||8
304132|NCT00762177|735753|P2|STARTED|Washout After 2nd Treatment||8
304133|NCT00762177|735754|P1|STARTED|Washout After 2nd Treatment||8
304134|NCT00762177|735752|P3|NOT COMPLETED|2nd Treatment Period||0
304135|NCT00762177|735753|P2|NOT COMPLETED|2nd Treatment Period||0
304136|NCT00762177|735754|P1|NOT COMPLETED|2nd Treatment Period||0
304137|NCT00762177|735752|P3|COMPLETED|2nd Treatment Period||8
304138|NCT00762177|735753|P2|COMPLETED|2nd Treatment Period||8
304139|NCT00762177|735754|P1|COMPLETED|2nd Treatment Period||8
304140|NCT00762177|735752|P3|STARTED|2nd Treatment Period||8
304141|NCT00762177|735753|P2|STARTED|2nd Treatment Period||8
304142|NCT00762177|735754|P1|STARTED|2nd Treatment Period||8
304143|NCT00762177|735752|P3|NOT COMPLETED|Washout After 1st Treatment||0
304144|NCT00762177|735753|P2|NOT COMPLETED|Washout After 1st Treatment||0
304145|NCT00762177|735754|P1|NOT COMPLETED|Washout After 1st Treatment||0
304146|NCT00762177|735752|P3|COMPLETED|Washout After 1st Treatment||8
304147|NCT00762177|735753|P2|COMPLETED|Washout After 1st Treatment||8
304148|NCT00762177|735754|P1|COMPLETED|Washout After 1st Treatment||8
304149|NCT00762177|735752|P3|STARTED|Washout After 1st Treatment||8
304150|NCT00762177|735753|P2|STARTED|Washout After 1st Treatment||8
304151|NCT00762177|735754|P1|STARTED|Washout After 1st Treatment||8
304152|NCT00762177|735752|P3|NOT COMPLETED|1st Treatment Period||0
304153|NCT00762177|735753|P2|NOT COMPLETED|1st Treatment Period||0
304154|NCT00762177|735754|P1|NOT COMPLETED|1st Treatment Period||0
304155|NCT00762177|735752|P3|COMPLETED|1st Treatment Period||8
304156|NCT00762177|735753|P2|COMPLETED|1st Treatment Period||8
304157|NCT00762177|735754|P1|COMPLETED|1st Treatment Period||8
304158|NCT00762177|735752|P3|STARTED|1st Treatment Period||8
304159|NCT00762177|735753|P2|STARTED|1st Treatment Period||8
304160|NCT00762177|735754|P1|STARTED|1st Treatment Period||8
304161|NCT00762164|735833|P2|NOT COMPLETED|Overall Study||2
304162|NCT00762164|735834|P1|NOT COMPLETED|Overall Study||3
304163|NCT00762164|735833|P2|COMPLETED|Overall Study||15
304164|NCT00762164|735834|P1|COMPLETED|Overall Study||14
304165|NCT00762164|735833|P2|STARTED|Overall Study||17
304166|NCT00762164|735834|P1|STARTED|Overall Study||17
304167|NCT00762086|735844|P2|NOT COMPLETED|Overall Study||4
304168|NCT00762086|735845|P1|NOT COMPLETED|Overall Study||6
304169|NCT00762086|735844|P2|COMPLETED|Overall Study||24
304170|NCT00762086|735845|P1|COMPLETED|Overall Study||33
304171|NCT00762086|735844|P2|STARTED|Overall Study||28
304172|NCT00762086|735845|P1|STARTED|Overall Study||39
304173|NCT00762073|735855|P4|NOT COMPLETED|Overall Study||3
304174|NCT00762073|735856|P3|NOT COMPLETED|Overall Study||2
304175|NCT00762073|735857|P2|NOT COMPLETED|Overall Study||4
304176|NCT00762073|735858|P1|NOT COMPLETED|Overall Study||4
304177|NCT00762073|735855|P4|COMPLETED|Overall Study||17
304178|NCT00762073|735856|P3|COMPLETED|Overall Study|One participant was enrolled and randomized then withdrew consent and did not receive study drug.|18
304179|NCT00762073|735857|P2|COMPLETED|Overall Study||17
304180|NCT00762073|735858|P1|COMPLETED|Overall Study||17
304181|NCT00762073|735855|P4|STARTED|Overall Study||20
304182|NCT00762073|735856|P3|STARTED|Overall Study||20
304183|NCT00762073|735857|P2|STARTED|Overall Study||21
304184|NCT00762073|735858|P1|STARTED|Overall Study||21
304185|NCT00762034|735922|P2|NOT COMPLETED|Maintenance Period||298
304186|NCT00762034|735923|P1|NOT COMPLETED|Maintenance Period||294
304187|NCT00762034|735922|P2|COMPLETED|Maintenance Period||0
304188|NCT00762034|735923|P1|COMPLETED|Maintenance Period||0
304189|NCT00762034|735922|P2|Received at Least 1 Dose of Study Drug|Maintenance Period||298
304190|NCT00762034|735923|P1|Received at Least 1 Dose of Study Drug|Maintenance Period||294
304191|NCT00762034|735922|P2|STARTED|Maintenance Period||298
304192|NCT00762034|735923|P1|STARTED|Maintenance Period||294
304193|NCT00762034|735922|P2|NOT COMPLETED|Induction Period||169
304194|NCT00762034|735923|P1|NOT COMPLETED|Induction Period||178
304195|NCT00762034|735922|P2|COMPLETED|Induction Period||298
304196|NCT00762034|735923|P1|COMPLETED|Induction Period||294
304197|NCT00762034|735922|P2|Received at Least 1 Dose of Study Drug|Induction Period||443
304198|NCT00762034|735923|P1|Received at Least 1 Dose of Study Drug|Induction Period||442
304199|NCT00762034|735922|P2|STARTED|Induction Period||467
304200|NCT00762034|735923|P1|STARTED|Induction Period||472
304201|NCT00762021|735982|P2|NOT COMPLETED|Overall Study||8
304202|NCT00762021|735983|P1|NOT COMPLETED|Overall Study||8
304203|NCT00762021|735982|P2|COMPLETED|Overall Study||44
304204|NCT00762021|735983|P1|COMPLETED|Overall Study||44
304205|NCT00762021|735982|P2|STARTED|Overall Study||52
304206|NCT00762021|735983|P1|STARTED|Overall Study||52
304207|NCT00761969|735995|P2|NOT COMPLETED|Overall Study||140
304208|NCT00761969|735996|P1|NOT COMPLETED|Overall Study||200
304209|NCT00761969|735995|P2|COMPLETED|Overall Study||573
304210|NCT00761969|735996|P1|COMPLETED|Overall Study||542
304211|NCT00761969|735995|P2|STARTED|Overall Study||713
304212|NCT00761969|735996|P1|STARTED|Overall Study||742
304213|NCT00761956|736006|P2|NOT COMPLETED|Overall Study||54
304214|NCT00761956|736007|P1|NOT COMPLETED|Overall Study||35
304215|NCT00761956|736006|P2|COMPLETED|Overall Study||48
304216|NCT00761956|736007|P1|COMPLETED|Overall Study||52
304217|NCT00761956|736006|P2|STARTED|Overall Study||102
304218|NCT00761956|736007|P1|STARTED|Overall Study||87
304219|NCT00761930|736018|P3|NOT COMPLETED|Overall Study||0
304220|NCT00761930|736019|P2|NOT COMPLETED|Overall Study||0
304221|NCT00761930|736020|P1|NOT COMPLETED|Overall Study||0
304222|NCT00761930|736018|P3|COMPLETED|Overall Study||35
304223|NCT00761930|736019|P2|COMPLETED|Overall Study||34
304224|NCT00761930|736020|P1|COMPLETED|Overall Study||34
304225|NCT00761930|736018|P3|STARTED|Overall Study||35
304226|NCT00761930|736019|P2|STARTED|Overall Study||34
304227|NCT00761930|736020|P1|STARTED|Overall Study||34
304228|NCT00761891|736034|P1|NOT COMPLETED|Overall Study||10
304229|NCT00761891|736034|P1|COMPLETED|Overall Study||54
304230|NCT00761891|736034|P1|STARTED|Overall Study||64
304231|NCT00761865|736041|P2|NOT COMPLETED|Overall Study||7
304232|NCT00761865|736042|P1|NOT COMPLETED|Overall Study||8
304233|NCT00761865|736041|P2|COMPLETED|Overall Study||11
304234|NCT00761865|736042|P1|COMPLETED|Overall Study||8
304235|NCT00761865|736041|P2|STARTED|Overall Study||18
304236|NCT00761865|736042|P1|STARTED|Overall Study||16
304237|NCT00761813|736052|P2|NOT COMPLETED|Overall Study||14
304238|NCT00761813|736053|P1|NOT COMPLETED|Overall Study||15
304239|NCT00761813|736052|P2|COMPLETED|Overall Study||537
304240|NCT00761813|736053|P1|COMPLETED|Overall Study||542
304241|NCT00761813|736052|P2|STARTED|Overall Study||551
304242|NCT00761813|736053|P1|STARTED|Overall Study||557
304243|NCT00761774|736063|P1|NOT COMPLETED|Overall Study||79
304244|NCT00761774|736063|P1|COMPLETED|Overall Study||29
304245|NCT00761774|736063|P1|STARTED|Overall Study||108
304246|NCT00761761|736074|P2|NOT COMPLETED|Overall Study||1
304247|NCT00761761|736075|P1|NOT COMPLETED|Overall Study||6
304248|NCT00761761|736074|P2|COMPLETED|Overall Study||29
304249|NCT00761761|736075|P1|COMPLETED|Overall Study||24
304250|NCT00761761|736074|P2|STARTED|Overall Study||30
304251|NCT00761761|736075|P1|STARTED|Overall Study||30
304252|NCT00761748|736087|P2|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
304253|NCT00761748|736088|P1|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
304254|NCT00761748|736087|P2|COMPLETED|Second Intervention (21 +/- 3 Days)||7
304255|NCT00761748|736088|P1|COMPLETED|Second Intervention (21 +/- 3 Days)||17
304256|NCT00761748|736087|P2|STARTED|Second Intervention (21 +/- 3 Days)||7
304257|NCT00761748|736088|P1|STARTED|Second Intervention (21 +/- 3 Days)||17
304258|NCT00761748|736087|P2|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
304259|NCT00761748|736088|P1|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
304260|NCT00761748|736087|P2|COMPLETED|First Intervention (21 +/- 3 Days)||7
304261|NCT00761748|736088|P1|COMPLETED|First Intervention (21 +/- 3 Days)||17
304262|NCT00761748|736087|P2|STARTED|First Intervention (21 +/- 3 Days)||10
304263|NCT00761748|736088|P1|STARTED|First Intervention (21 +/- 3 Days)||20
304264|NCT00761735|736094|P1|NOT COMPLETED|Overall Study||14
304265|NCT00761735|736094|P1|COMPLETED|Overall Study||80
304266|NCT00761735|736094|P1|STARTED|Overall Study||94
304267|NCT00761631|736110|P6|NOT COMPLETED|Overall Study||5
304268|NCT00761631|736111|P5|NOT COMPLETED|Overall Study||22
304269|NCT00761631|736112|P4|NOT COMPLETED|Overall Study||3
304270|NCT00761631|736113|P3|NOT COMPLETED|Overall Study||16
304271|NCT00761631|736114|P2|NOT COMPLETED|Overall Study||7
304272|NCT00761631|736115|P1|NOT COMPLETED|Overall Study||15
304273|NCT00761631|736110|P6|COMPLETED|Overall Study||294
304274|NCT00761631|736111|P5|COMPLETED|Overall Study||277
304275|NCT00761631|736112|P4|COMPLETED|Overall Study||116
304276|NCT00761631|736113|P3|COMPLETED|Overall Study||160
304277|NCT00761631|736114|P2|COMPLETED|Overall Study||174
304278|NCT00761631|736115|P1|COMPLETED|Overall Study||111
304279|NCT00761631|736110|P6|Vaccinated Dose 2|Overall Study||0
304280|NCT00761631|736111|P5|Vaccinated Dose 2|Overall Study||0
304281|NCT00761631|736112|P4|Vaccinated Dose 2|Overall Study||0
304282|NCT00761631|736113|P3|Vaccinated Dose 2|Overall Study||165
304283|NCT00761631|736114|P2|Vaccinated Dose 2|Overall Study||0
304284|NCT00761631|736115|P1|Vaccinated Dose 2|Overall Study||112
304285|NCT00761631|736110|P6|Vaccinated Dose 1|Overall Study||298
304286|NCT00761631|736111|P5|Vaccinated Dose 1|Overall Study||294
304287|NCT00761631|736112|P4|Vaccinated Dose 1|Overall Study||118
304288|NCT00761631|736113|P3|Vaccinated Dose 1|Overall Study||175
304289|NCT00761631|736114|P2|Vaccinated Dose 1|Overall Study||179
304290|NCT00761631|736115|P1|Vaccinated Dose 1|Overall Study||124
304291|NCT00761631|736110|P6|STARTED|Overall Study||299
304292|NCT00761631|736111|P5|STARTED|Overall Study||299
304293|NCT00761631|736112|P4|STARTED|Overall Study||119
304294|NCT00761631|736113|P3|STARTED|Overall Study||176
304295|NCT00761631|736114|P2|STARTED|Overall Study||181
304296|NCT00761631|736115|P1|STARTED|Overall Study||126
304297|NCT00761605|736150|P1|NOT COMPLETED|Overall Study||141
304298|NCT00761605|736150|P1|COMPLETED|Overall Study||246
304299|NCT00761605|736150|P1|STARTED|Overall Study||387
304300|NCT00761592|736179|P2|NOT COMPLETED|Overall Study||1
304301|NCT00761592|736180|P1|NOT COMPLETED|Overall Study||1
304302|NCT00761592|736179|P2|COMPLETED|Overall Study||32
304303|NCT00761592|736180|P1|COMPLETED|Overall Study||31
304304|NCT00761592|736179|P2|STARTED|Overall Study||33
304305|NCT00761592|736180|P1|STARTED|Overall Study||32
304306|NCT00761579|736194|P1|NOT COMPLETED|Overall Study||92
304307|NCT00761579|736194|P1|COMPLETED|Overall Study||98
304308|NCT00761579|736194|P1|STARTED|Overall Study||190
304309|NCT00761527|736227|P1|NOT COMPLETED|Overall Study||22
304310|NCT00761527|736227|P1|COMPLETED|Overall Study||2958
304311|NCT00761527|736227|P1|Received One Dose of Study Medication|Overall Study||2978
304312|NCT00761527|736227|P1|STARTED|Overall Study||2980
304313|NCT00761514|736234|P1|NOT COMPLETED|Overall Study||7
304314|NCT00761514|736234|P1|COMPLETED|Overall Study||7
304315|NCT00761514|736234|P1|STARTED|Overall Study||14
304316|NCT00761462|736241|P2|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||51
304317|NCT00761462|736242|P1|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||154
304318|NCT00761462|736241|P2|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 2 year safety Follow-up.|456
304319|NCT00761462|736242|P1|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 5 year safety Follow-up.|333
304320|NCT00761462|736241|P2|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||507
304321|NCT00761462|736242|P1|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||485
304322|NCT00761462|736241|P2|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||507
304323|NCT00761462|736242|P1|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||487
304324|NCT00761462|736241|P2|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|507
304325|NCT00761462|736242|P1|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|487
304326|NCT00761462|736241|P2|NOT COMPLETED|Treatment||12
304327|NCT00761462|736242|P1|NOT COMPLETED|Treatment||23
304328|NCT00761462|736241|P2|COMPLETED|Treatment|Patients with confirmed intake of study drug|507
304329|NCT00761462|736242|P1|COMPLETED|Treatment|Patients with confirmed intake of study drug|487
304330|NCT00761462|736241|P2|STARTED|Treatment|Patients enrolled in study group|519
304331|NCT00761462|736242|P1|STARTED|Treatment|Patients enrolled in study group|510
304332|NCT00761345|736250|P1|NOT COMPLETED|Overall Study||3
304333|NCT00761345|736250|P1|COMPLETED|Overall Study||24
304334|NCT00761345|736250|P1|STARTED|Overall Study||27
304335|NCT00761319|736256|P2|NOT COMPLETED|Overall Study||34
304336|NCT00761319|736257|P1|NOT COMPLETED|Overall Study||48
304337|NCT00761319|736256|P2|COMPLETED|Overall Study||318
304338|NCT00761319|736257|P1|COMPLETED|Overall Study||305
304339|NCT00761319|736256|P2|STARTED|Overall Study||352
304340|NCT00761319|736257|P1|STARTED|Overall Study||353
304341|NCT00761306|736265|P1|NOT COMPLETED|Overall Study||20
304342|NCT00761306|736265|P1|COMPLETED|Overall Study||54
304343|NCT00761306|736265|P1|STARTED|Overall Study||74
304344|NCT00761280|736276|P2|NOT COMPLETED|First Dose to End of Study||11
304345|NCT00761280|736277|P1|NOT COMPLETED|First Dose to End of Study||12
304346|NCT00761280|736276|P2|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
304347|NCT00761280|736277|P1|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
304348|NCT00761280|736276|P2|STARTED|First Dose to End of Study||11
304349|NCT00761280|736277|P1|STARTED|First Dose to End of Study||12
304350|NCT00761280|736276|P2|NOT COMPLETED|Randomization to First Dose||2
304351|NCT00761280|736277|P1|NOT COMPLETED|Randomization to First Dose||2
304352|NCT00761280|736276|P2|COMPLETED|Randomization to First Dose||11
304353|NCT00761280|736277|P1|COMPLETED|Randomization to First Dose||12
304354|NCT00761280|736276|P2|First Dose of Study Drug / Chemotherapy|Randomization to First Dose|Safety population|11
304355|NCT00761280|736277|P1|First Dose of Study Drug / Chemotherapy|Randomization to First Dose||12
304356|NCT00761280|736276|P2|Catheter Surgery|Randomization to First Dose|Not applicable to control group|0
304357|NCT00761280|736277|P1|Catheter Surgery|Randomization to First Dose|Safety population|13
304358|NCT00761280|736276|P2|STARTED|Randomization to First Dose||13
304359|NCT00761280|736277|P1|STARTED|Randomization to First Dose||14
304360|NCT00761267|736308|P3|NOT COMPLETED|Overall Study||6
304361|NCT00761267|736309|P2|NOT COMPLETED|Overall Study||4
304362|NCT00761267|736310|P1|NOT COMPLETED|Overall Study||2
304363|NCT00761267|736308|P3|COMPLETED|Overall Study||24
304364|NCT00761267|736309|P2|COMPLETED|Overall Study||16
304365|NCT00761267|736310|P1|COMPLETED|Overall Study||18
304366|NCT00761267|736308|P3|Treated|Overall Study||30
304367|NCT00761267|736309|P2|Treated|Overall Study||19
304368|NCT00761267|736310|P1|Treated|Overall Study||19
304369|NCT00761267|736308|P3|STARTED|Overall Study||30
304370|NCT00761267|736309|P2|STARTED|Overall Study||20
304371|NCT00761267|736310|P1|STARTED|Overall Study||20
304372|NCT00761215|736361|P3|NOT COMPLETED|Overall Study||8
304373|NCT00761215|736362|P2|NOT COMPLETED|Overall Study||4
304374|NCT00761215|736363|P1|NOT COMPLETED|Overall Study||9
304375|NCT00761215|736361|P3|COMPLETED|Overall Study||56
304376|NCT00761215|736362|P2|COMPLETED|Overall Study||60
304377|NCT00761215|736363|P1|COMPLETED|Overall Study||55
304378|NCT00761215|736361|P3|STARTED|Overall Study||64
304379|NCT00761215|736362|P2|STARTED|Overall Study||64
304380|NCT00761215|736363|P1|STARTED|Overall Study||64
304381|NCT00761202|736388|P2|NOT COMPLETED|Overall Study||2
304382|NCT00761202|736389|P1|NOT COMPLETED|Overall Study||1
304383|NCT00761202|736388|P2|COMPLETED|Overall Study||26
304384|NCT00761202|736389|P1|COMPLETED|Overall Study||21
304385|NCT00761202|736388|P2|STARTED|Overall Study||28
304386|NCT00761202|736389|P1|STARTED|Overall Study||22
304387|NCT00761189|736405|P1|NOT COMPLETED|Overall Study||185
304388|NCT00761189|736405|P1|COMPLETED|Overall Study||306
304389|NCT00761189|736405|P1|STARTED|Overall Study||491
304390|NCT00761176|736422|P2|NOT COMPLETED|Overall Study||1
304391|NCT00761176|736423|P1|NOT COMPLETED|Overall Study||2
304392|NCT00761176|736422|P2|COMPLETED|Overall Study||3
304393|NCT00761176|736423|P1|COMPLETED|Overall Study||2
304394|NCT00761176|736422|P2|STARTED|Overall Study||4
304395|NCT00761176|736423|P1|STARTED|Overall Study||4
304396|NCT00761150|736432|P3|NOT COMPLETED|Double-blind Period||29
304397|NCT00761150|736433|P2|NOT COMPLETED|Double-blind Period||14
304398|NCT00761150|736434|P1|NOT COMPLETED|Double-blind Period||0
304399|NCT00761150|736432|P3|COMPLETED|Double-blind Period||89
304400|NCT00761150|736433|P2|COMPLETED|Double-blind Period||106
304401|NCT00761150|736434|P1|COMPLETED|Double-blind Period||0
304402|NCT00761150|736432|P3|STARTED|Double-blind Period||118
304403|NCT00761150|736433|P2|STARTED|Double-blind Period||120
304404|NCT00761150|736434|P1|STARTED|Double-blind Period||0
304405|NCT00761150|736432|P3|NOT COMPLETED|Open-label Period||0
304406|NCT00761150|736433|P2|NOT COMPLETED|Open-label Period||0
304407|NCT00761150|736434|P1|NOT COMPLETED|Open-label Period||70
304408|NCT00761150|736432|P3|COMPLETED|Open-label Period||0
304409|NCT00761150|736433|P2|COMPLETED|Open-label Period||0
304410|NCT00761150|736434|P1|COMPLETED|Open-label Period||238
304411|NCT00761150|736432|P3|STARTED|Open-label Period||0
304412|NCT00761150|736433|P2|STARTED|Open-label Period||0
304413|NCT00761150|736434|P1|STARTED|Open-label Period||308
304414|NCT00761137|736443|P1|NOT COMPLETED|Overall Study||0
304415|NCT00761137|736443|P1|COMPLETED|Overall Study||19
304416|NCT00761137|736443|P1|3 mg Tropicamide|Overall Study||19
304417|NCT00761137|736443|P1|1 mg Tropicamide|Overall Study||19
304418|NCT00761137|736443|P1|0.3 mg Tropicamide|Overall Study||19
304419|NCT00761137|736443|P1|Placebo|Overall Study||19
304420|NCT00761137|736443|P1|STARTED|Overall Study||19
304421|NCT00761007|736458|P4|NOT COMPLETED|Overall Study||7
304422|NCT00761007|736459|P3|NOT COMPLETED|Overall Study||18
304423|NCT00761007|736460|P2|NOT COMPLETED|Overall Study||11
304424|NCT00761007|736461|P1|NOT COMPLETED|Overall Study||13
304425|NCT00761007|736458|P4|COMPLETED|Overall Study||131
304426|NCT00761007|736459|P3|COMPLETED|Overall Study||121
304427|NCT00761007|736460|P2|COMPLETED|Overall Study||124
304428|NCT00761007|736461|P1|COMPLETED|Overall Study||129
304429|NCT00761007|736458|P4|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||136
304430|NCT00761007|736459|P3|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||135
304431|NCT00761007|736460|P2|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||133
304432|NCT00761007|736461|P1|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||140
304433|NCT00761007|736458|P4|Safety (>=1 Dose of Study Medication)|Overall Study||137
304434|NCT00761007|736459|P3|Safety (>=1 Dose of Study Medication)|Overall Study||139
304435|NCT00761007|736460|P2|Safety (>=1 Dose of Study Medication)|Overall Study||135
304436|NCT00761007|736461|P1|Safety (>=1 Dose of Study Medication)|Overall Study||140
304437|NCT00761007|736458|P4|STARTED|Overall Study||138
304438|NCT00761007|736459|P3|STARTED|Overall Study||139
304439|NCT00761007|736460|P2|STARTED|Overall Study||135
304440|NCT00761007|736461|P1|STARTED|Overall Study||142
304441|NCT00760877|736485|P2|NOT COMPLETED|Overall Study||26
304442|NCT00760877|736486|P1|NOT COMPLETED|Overall Study||45
304443|NCT00760877|736485|P2|COMPLETED|Overall Study||77
304444|NCT00760877|736486|P1|COMPLETED|Overall Study||59
304445|NCT00760877|736485|P2|Safety Set|Overall Study||103
304446|NCT00760877|736486|P1|Safety Set|Overall Study||101
304447|NCT00760877|736485|P2|Cross-over to Nilotinib|Overall Study||46
304448|NCT00760877|736486|P1|Cross-over to Nilotinib|Overall Study|Not applicable: cross-over occurred from imatinib to nilotinib only.|0
304449|NCT00760877|736485|P2|STARTED|Overall Study||103
304450|NCT00760877|736486|P1|STARTED|Overall Study||104
304451|NCT00760838|736504|P2|NOT COMPLETED|Overall Study||2
304452|NCT00760838|736505|P1|NOT COMPLETED|Overall Study||5
304453|NCT00760838|736504|P2|COMPLETED|Overall Study||53
304454|NCT00760838|736505|P1|COMPLETED|Overall Study||49
304455|NCT00760838|736504|P2|STARTED|Overall Study||55
304456|NCT00760838|736505|P1|STARTED|Overall Study||54
304457|NCT00760747|736523|P2|NOT COMPLETED|Study Period III||3
304458|NCT00760747|736524|P1|NOT COMPLETED|Study Period III||3
304459|NCT00760747|736523|P2|COMPLETED|Study Period III||38
304460|NCT00760747|736524|P1|COMPLETED|Study Period III||41
304461|NCT00760747|736523|P2|STARTED|Study Period III||41
304462|NCT00760747|736524|P1|STARTED|Study Period III||44
304463|NCT00760747|736523|P2|NOT COMPLETED|Study Period II||14
304464|NCT00760747|736524|P1|NOT COMPLETED|Study Period II||13
304465|NCT00760747|736523|P2|COMPLETED|Study Period II||41
304466|NCT00760747|736524|P1|COMPLETED|Study Period II||44
304467|NCT00760747|736523|P2|Received at Least One Dose of Study Drug|Study Period II||54
304468|NCT00760747|736524|P1|Received at Least One Dose of Study Drug|Study Period II||57
304469|NCT00760747|736523|P2|STARTED|Study Period II||55
304470|NCT00760747|736524|P1|STARTED|Study Period II||57
304471|NCT00760669|736552|P1|NOT COMPLETED|Overall Study||30
304472|NCT00760669|736552|P1|COMPLETED|Overall Study||1031
304473|NCT00760669|736552|P1|STARTED|Overall Study||1061
304474|NCT00760617|736569|P3|NOT COMPLETED|Overall Study||5
304475|NCT00760617|736570|P2|NOT COMPLETED|Overall Study||2
304476|NCT00760617|736571|P1|NOT COMPLETED|Overall Study||5
304477|NCT00760617|736569|P3|COMPLETED|Overall Study||111
304478|NCT00760617|736570|P2|COMPLETED|Overall Study||142
304479|NCT00760617|736571|P1|COMPLETED|Overall Study||261
304480|NCT00760617|736569|P3|STARTED|Overall Study||116
304481|NCT00760617|736570|P2|STARTED|Overall Study||144
304482|NCT00760617|736571|P1|STARTED|Overall Study||266
304483|NCT00760578|736646|P4|NOT COMPLETED|Overall Study||4
304484|NCT00760578|736647|P3|NOT COMPLETED|Overall Study||5
304485|NCT00760578|736648|P2|NOT COMPLETED|Overall Study||2
304486|NCT00760578|736649|P1|NOT COMPLETED|Overall Study||3
304487|NCT00760578|736646|P4|COMPLETED|Overall Study||18
304488|NCT00760578|736647|P3|COMPLETED|Overall Study||16
304489|NCT00760578|736648|P2|COMPLETED|Overall Study||19
304490|NCT00760578|736649|P1|COMPLETED|Overall Study||19
304491|NCT00760578|736646|P4|Entered Drug Treatment Period|Overall Study||22
304492|NCT00760578|736647|P3|Entered Drug Treatment Period|Overall Study||19
304493|NCT00760578|736648|P2|Entered Drug Treatment Period|Overall Study||20
304494|NCT00760578|736649|P1|Entered Drug Treatment Period|Overall Study||21
304495|NCT00760578|736646|P4|STARTED|Overall Study||22
304496|NCT00760578|736647|P3|STARTED|Overall Study||21
304497|NCT00760578|736648|P2|STARTED|Overall Study||21
304498|NCT00760578|736649|P1|STARTED|Overall Study||22
304499|NCT00760552|736685|P2|NOT COMPLETED|Overall Study||10
304500|NCT00760552|736686|P1|NOT COMPLETED|Overall Study||13
304501|NCT00760552|736685|P2|COMPLETED|Overall Study||52
304502|NCT00760552|736686|P1|COMPLETED|Overall Study||48
304503|NCT00760552|736685|P2|STARTED|Overall Study||62
304504|NCT00760552|736686|P1|STARTED|Overall Study||61
304505|NCT00760526|736694|P2|NOT COMPLETED|Overall Study||4
304506|NCT00760526|736695|P1|NOT COMPLETED|Overall Study||5
304507|NCT00760526|736694|P2|COMPLETED|Overall Study||68
304508|NCT00760526|736695|P1|COMPLETED|Overall Study||69
304509|NCT00760526|736694|P2|STARTED|Overall Study||72
304510|NCT00760526|736695|P1|STARTED|Overall Study||74
304511|NCT00760513|736722|P2|NOT COMPLETED|Overall Study||7
304512|NCT00760513|736723|P1|NOT COMPLETED|Overall Study||5
304513|NCT00760513|736722|P2|COMPLETED|Overall Study||45
304514|NCT00760513|736723|P1|COMPLETED|Overall Study||46
304515|NCT00760513|736722|P2|STARTED|Overall Study||52
304516|NCT00760513|736723|P1|STARTED|Overall Study||51
304517|NCT00760487|736733|P1|NOT COMPLETED|Overall Study||3
304518|NCT00760487|736733|P1|COMPLETED|Overall Study||117
304519|NCT00760487|736733|P1|STARTED|Overall Study||120
304520|NCT00760474|736739|P2|NOT COMPLETED|Period 2 (P2)||1
304521|NCT00760474|736740|P1|NOT COMPLETED|Period 2 (P2)||1
304522|NCT00760474|736739|P2|COMPLETED|Period 2 (P2)||11
304523|NCT00760474|736740|P1|COMPLETED|Period 2 (P2)||11
304524|NCT00760474|736739|P2|STARTED|Period 2 (P2)||12
304525|NCT00760474|736740|P1|STARTED|Period 2 (P2)||12
304526|NCT00760474|736739|P2|NOT COMPLETED|Placebo Washout Period||1
304527|NCT00760474|736740|P1|NOT COMPLETED|Placebo Washout Period||0
304528|NCT00760474|736739|P2|COMPLETED|Placebo Washout Period||12
304529|NCT00760474|736740|P1|COMPLETED|Placebo Washout Period||12
304530|NCT00760474|736739|P2|STARTED|Placebo Washout Period||13
304531|NCT00760474|736740|P1|STARTED|Placebo Washout Period||12
304532|NCT00760474|736739|P2|NOT COMPLETED|Period 1 (P1)||1
304533|NCT00760474|736740|P1|NOT COMPLETED|Period 1 (P1)||1
304534|NCT00760474|736739|P2|COMPLETED|Period 1 (P1)||13
304535|NCT00760474|736740|P1|COMPLETED|Period 1 (P1)||12
304536|NCT00760474|736739|P2|Overall Number of Unique Participants|Period 1 (P1)||13
304537|NCT00760474|736740|P1|Overall Number of Unique Participants|Period 1 (P1)||12
304538|NCT00760474|736739|P2|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|14
304539|NCT00760474|736740|P1|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|13
304540|NCT00760474|736739|P2|STARTED|Period 1 (P1)||14
304541|NCT00760474|736740|P1|STARTED|Period 1 (P1)||13
304542|NCT00760461|736776|P1|NOT COMPLETED|Overall Study||44
304543|NCT00760461|736776|P1|COMPLETED|Overall Study||0
304544|NCT00760461|736776|P1|STARTED|Overall Study||44
304545|NCT00760435|736782|P2|NOT COMPLETED|Overall Study||5
304546|NCT00760435|736783|P1|NOT COMPLETED|Overall Study||4
304547|NCT00760435|736782|P2|COMPLETED|Overall Study||93
304548|NCT00760435|736783|P1|COMPLETED|Overall Study||94
304549|NCT00760435|736782|P2|STARTED|Overall Study||98
304550|NCT00760435|736783|P1|STARTED|Overall Study||98
304551|NCT00760383|736797|P2|NOT COMPLETED|Overall Study||7
304552|NCT00760383|736798|P1|NOT COMPLETED|Overall Study||5
304553|NCT00760383|736797|P2|COMPLETED|Overall Study||12
304554|NCT00760383|736798|P1|COMPLETED|Overall Study||16
304555|NCT00760383|736797|P2|STARTED|Overall Study||19
304556|NCT00760383|736798|P1|STARTED|Overall Study||21
304557|NCT00760266|736810|P2|NOT COMPLETED|Overall Study||18
304558|NCT00760266|736811|P1|NOT COMPLETED|Overall Study||24
304559|NCT00760266|736810|P2|COMPLETED|Overall Study||205
304560|NCT00760266|736811|P1|COMPLETED|Overall Study||204
304561|NCT00760266|736810|P2|STARTED|Overall Study||223
304562|NCT00760266|736811|P1|STARTED|Overall Study||228
304563|NCT00760214|736828|P3|NOT COMPLETED|Overall Study||41
304564|NCT00760214|736829|P2|NOT COMPLETED|Overall Study||30
304565|NCT00760214|736830|P1|NOT COMPLETED|Overall Study||30
304566|NCT00760214|736828|P3|COMPLETED|Overall Study||255
304567|NCT00760214|736829|P2|COMPLETED|Overall Study||264
304568|NCT00760214|736830|P1|COMPLETED|Overall Study||265
304569|NCT00760214|736828|P3|STARTED|Overall Study||296
304570|NCT00760214|736829|P2|STARTED|Overall Study||294
304571|NCT00760214|736830|P1|STARTED|Overall Study||295
304572|NCT00760084|736871|P1|NOT COMPLETED|Overall Study||10
304573|NCT00760084|736871|P1|COMPLETED|Overall Study||0
304574|NCT00760084|736871|P1|STARTED|Overall Study||10
304575|NCT00760019|736877|P4|NOT COMPLETED|Overall Study||0
304576|NCT00760019|736878|P3|NOT COMPLETED|Overall Study||0
304577|NCT00760019|736879|P2|NOT COMPLETED|Overall Study||0
304578|NCT00760019|736880|P1|NOT COMPLETED|Overall Study||0
304579|NCT00760019|736877|P4|COMPLETED|Overall Study||14
304580|NCT00760019|736878|P3|COMPLETED|Overall Study||14
304581|NCT00760019|736879|P2|COMPLETED|Overall Study||15
304582|NCT00760019|736880|P1|COMPLETED|Overall Study||15
304583|NCT00760019|736877|P4|STARTED|Overall Study||14
304584|NCT00760019|736878|P3|STARTED|Overall Study||14
304585|NCT00760019|736879|P2|STARTED|Overall Study||15
304586|NCT00760019|736880|P1|STARTED|Overall Study||15
304587|NCT00760006|736888|P2|NOT COMPLETED|Overall Study||0
304588|NCT00760006|736889|P1|NOT COMPLETED|Overall Study||0
304589|NCT00760006|736888|P2|COMPLETED|Overall Study||138
304590|NCT00760006|736889|P1|COMPLETED|Overall Study||86
304591|NCT00760006|736888|P2|STARTED|Overall Study||138
304592|NCT00760006|736889|P1|STARTED|Overall Study||86
304593|NCT00759967|736895|P2|NOT COMPLETED|Second Intervention||0
304594|NCT00759967|736896|P1|NOT COMPLETED|Second Intervention||2
304595|NCT00759967|736895|P2|COMPLETED|Second Intervention||9
304596|NCT00759967|736896|P1|COMPLETED|Second Intervention||8
304597|NCT00759967|736895|P2|STARTED|Second Intervention||9
304598|NCT00759967|736896|P1|STARTED|Second Intervention||10
304599|NCT00759967|736895|P2|NOT COMPLETED|First Intervention||0
304600|NCT00759967|736896|P1|NOT COMPLETED|First Intervention||0
304601|NCT00759967|736895|P2|COMPLETED|First Intervention||9
304602|NCT00759967|736896|P1|COMPLETED|First Intervention||10
304603|NCT00759967|736895|P2|STARTED|First Intervention||9
304604|NCT00759967|736896|P1|STARTED|First Intervention||10
304605|NCT00759954|736914|P2|NOT COMPLETED|Overall Study||2
304606|NCT00759954|736915|P1|NOT COMPLETED|Overall Study||2
304607|NCT00759954|736914|P2|COMPLETED|Overall Study|Two participants (#202 and #228) did not enter Period 2.|16
304608|NCT00759954|736915|P1|COMPLETED|Overall Study|One participant(#225) did not enter Period 2 and one participant (#203)dropped out during Period 2|16
304609|NCT00759954|736914|P2|STARTED|Overall Study|All assigned participants entered trial|18
304610|NCT00759954|736915|P1|STARTED|Overall Study|All assigned participants entered trial|18
304611|NCT00759941|736929|P2|NOT COMPLETED|Overall Study||1
304612|NCT00759941|736930|P1|NOT COMPLETED|Overall Study||3
304613|NCT00759941|736929|P2|COMPLETED|Overall Study||43
304614|NCT00759941|736930|P1|COMPLETED|Overall Study||39
304615|NCT00759941|736929|P2|STARTED|Overall Study||44
304616|NCT00759941|736930|P1|STARTED|Overall Study||42
304617|NCT00759915|736944|P2|NOT COMPLETED|Overall Study||1
304618|NCT00759915|736945|P1|NOT COMPLETED|Overall Study||1
304619|NCT00759915|736944|P2|COMPLETED|Overall Study||17
304620|NCT00759915|736945|P1|COMPLETED|Overall Study||17
304621|NCT00759915|736944|P2|STARTED|Overall Study||18
304622|NCT00759915|736945|P1|STARTED|Overall Study||18
304623|NCT00759902|736959|P2|NOT COMPLETED|Overall Study||1
304624|NCT00759902|736960|P1|NOT COMPLETED|Overall Study||0
304625|NCT00759902|736959|P2|COMPLETED|Overall Study||17
304626|NCT00759902|736960|P1|COMPLETED|Overall Study||18
304627|NCT00759902|736959|P2|STARTED|Overall Study||18
304628|NCT00759902|736960|P1|STARTED|Overall Study||18
304629|NCT00759863|736974|P2|NOT COMPLETED|Overall Study||18
304630|NCT00759863|736975|P1|NOT COMPLETED|Overall Study||20
304631|NCT00759863|736974|P2|COMPLETED|Overall Study||80
304632|NCT00759863|736975|P1|COMPLETED|Overall Study||124
304633|NCT00759863|736974|P2|STARTED|Overall Study||98
304634|NCT00759863|736975|P1|STARTED|Overall Study||144
304635|NCT00759811|736987|P2|NOT COMPLETED|Overall Study||1
304636|NCT00759811|736988|P1|NOT COMPLETED|Overall Study||2
304637|NCT00759811|736987|P2|COMPLETED|Overall Study||24
304638|NCT00759811|736988|P1|COMPLETED|Overall Study||23
304639|NCT00759811|736987|P2|STARTED|Overall Study||25
304640|NCT00759811|736988|P1|STARTED|Overall Study||25
304641|NCT00759785|736996|P2|NOT COMPLETED|Overall Study||5
304642|NCT00759785|736997|P1|NOT COMPLETED|Overall Study||12
304643|NCT00759785|736996|P2|COMPLETED|Overall Study||17
304644|NCT00759785|736997|P1|COMPLETED|Overall Study||14
304645|NCT00759785|736996|P2|Treated|Overall Study||20
304646|NCT00759785|736997|P1|Treated|Overall Study||25
304647|NCT00759785|736996|P2|STARTED|Overall Study||22
304648|NCT00759785|736997|P1|STARTED|Overall Study||26
304649|NCT00759772|737011|P2|NOT COMPLETED|Overall Study||0
304650|NCT00759772|737012|P1|NOT COMPLETED|Overall Study||0
304651|NCT00759772|737011|P2|COMPLETED|Overall Study||11
304652|NCT00759772|737012|P1|COMPLETED|Overall Study||12
304653|NCT00759772|737011|P2|STARTED|Overall Study||11
304654|NCT00759772|737012|P1|STARTED|Overall Study||12
304655|NCT00759759|737020|P2|NOT COMPLETED|Overall Study||1
304656|NCT00759759|737021|P1|NOT COMPLETED|Overall Study||4
304657|NCT00759759|737020|P2|COMPLETED|Overall Study||17
304658|NCT00759759|737021|P1|COMPLETED|Overall Study||14
304659|NCT00759759|737020|P2|STARTED|Overall Study||18
304660|NCT00759759|737021|P1|STARTED|Overall Study||18
304661|NCT00759707|737033|P1|NOT COMPLETED|Overall Study||0
304662|NCT00759707|737033|P1|COMPLETED|Overall Study||19
304663|NCT00759707|737033|P1|STARTED|Overall Study||19
304664|NCT00759681|737039|P2|NOT COMPLETED|Overall Study||10
304665|NCT00759681|737040|P1|NOT COMPLETED|Overall Study||10
304666|NCT00759681|737039|P2|COMPLETED|Overall Study||100
304667|NCT00759681|737040|P1|COMPLETED|Overall Study||97
304668|NCT00759681|737039|P2|STARTED|Overall Study||110
304669|NCT00759681|737040|P1|STARTED|Overall Study||107
304670|NCT00759668|737050|P2|NOT COMPLETED|Overall Study||3
304671|NCT00759668|737051|P1|NOT COMPLETED|Overall Study||1
304672|NCT00759668|737050|P2|COMPLETED|Overall Study||15
304673|NCT00759668|737051|P1|COMPLETED|Overall Study||16
304674|NCT00759668|737050|P2|STARTED|Overall Study||18
304675|NCT00759668|737051|P1|STARTED|Overall Study||17
304676|NCT00759655|737067|P1|NOT COMPLETED|Overall Study||1
304677|NCT00759655|737067|P1|COMPLETED|Overall Study||0
304678|NCT00759655|737067|P1|STARTED|Overall Study||1
304679|NCT00759642|737078|P1|NOT COMPLETED|Overall Study||0
304680|NCT00759642|737078|P1|COMPLETED|Overall Study||33
304681|NCT00759642|737078|P1|STARTED|Overall Study||33
304682|NCT00759603|737082|P1|NOT COMPLETED|Overall Study||0
304683|NCT00759603|737082|P1|COMPLETED|Overall Study||59
304684|NCT00759603|737082|P1|STARTED|Overall Study||59
304685|NCT00759577|737086|P1|NOT COMPLETED|Overall Study||0
304686|NCT00759577|737086|P1|COMPLETED|Overall Study||36
304687|NCT00759577|737086|P1|STARTED|Overall Study||36
304688|NCT00759564|737095|P5|NOT COMPLETED|Second Intervention Period (4 Days)||0
304689|NCT00759564|737096|P4|NOT COMPLETED|Second Intervention Period (4 Days)||0
304690|NCT00759564|737097|P3|NOT COMPLETED|Second Intervention Period (4 Days)||0
304691|NCT00759564|737098|P2|NOT COMPLETED|Second Intervention Period (4 Days)||0
304692|NCT00759564|737099|P1|NOT COMPLETED|Second Intervention Period (4 Days)||0
304693|NCT00759564|737095|P5|COMPLETED|Second Intervention Period (4 Days)||3
304694|NCT00759564|737096|P4|COMPLETED|Second Intervention Period (4 Days)||1
304695|NCT00759564|737097|P3|COMPLETED|Second Intervention Period (4 Days)||8
304696|NCT00759564|737098|P2|COMPLETED|Second Intervention Period (4 Days)||8
304697|NCT00759564|737099|P1|COMPLETED|Second Intervention Period (4 Days)||8
304698|NCT00759564|737095|P5|STARTED|Second Intervention Period (4 Days)||3
304699|NCT00759564|737096|P4|STARTED|Second Intervention Period (4 Days)||1
304700|NCT00759564|737097|P3|STARTED|Second Intervention Period (4 Days)||8
304701|NCT00759564|737098|P2|STARTED|Second Intervention Period (4 Days)||8
304702|NCT00759564|737099|P1|STARTED|Second Intervention Period (4 Days)||8
304703|NCT00759564|737095|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||1
304704|NCT00759564|737096|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
304705|NCT00759564|737097|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
304706|NCT00759564|737098|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
304707|NCT00759564|737099|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
304708|NCT00759564|737095|P5|COMPLETED|Washout Period (at Least 14 Days)||3
304709|NCT00759564|737096|P4|COMPLETED|Washout Period (at Least 14 Days)||1
304710|NCT00759564|737097|P3|COMPLETED|Washout Period (at Least 14 Days)||8
304711|NCT00759564|737098|P2|COMPLETED|Washout Period (at Least 14 Days)||8
304712|NCT00759564|737099|P1|COMPLETED|Washout Period (at Least 14 Days)||8
304713|NCT00759564|737095|P5|STARTED|Washout Period (at Least 14 Days)||4
304714|NCT00759564|737096|P4|STARTED|Washout Period (at Least 14 Days)||1
304715|NCT00759564|737097|P3|STARTED|Washout Period (at Least 14 Days)||8
304716|NCT00759564|737098|P2|STARTED|Washout Period (at Least 14 Days)||8
304717|NCT00759564|737099|P1|STARTED|Washout Period (at Least 14 Days)||8
304718|NCT00759564|737095|P5|NOT COMPLETED|First Intervention Period (4 Days)||0
304719|NCT00759564|737096|P4|NOT COMPLETED|First Intervention Period (4 Days)||0
304720|NCT00759564|737097|P3|NOT COMPLETED|First Intervention Period (4 Days)||0
304721|NCT00759564|737098|P2|NOT COMPLETED|First Intervention Period (4 Days)||0
304722|NCT00759564|737099|P1|NOT COMPLETED|First Intervention Period (4 Days)||0
304723|NCT00759564|737095|P5|COMPLETED|First Intervention Period (4 Days)||4
304724|NCT00759564|737096|P4|COMPLETED|First Intervention Period (4 Days)||1
304725|NCT00759564|737097|P3|COMPLETED|First Intervention Period (4 Days)||8
304726|NCT00759564|737098|P2|COMPLETED|First Intervention Period (4 Days)||8
304727|NCT00759564|737099|P1|COMPLETED|First Intervention Period (4 Days)||8
304728|NCT00759564|737095|P5|STARTED|First Intervention Period (4 Days)||4
304729|NCT00759564|737096|P4|STARTED|First Intervention Period (4 Days)||1
304730|NCT00759564|737097|P3|STARTED|First Intervention Period (4 Days)||8
304731|NCT00759564|737098|P2|STARTED|First Intervention Period (4 Days)||8
304732|NCT00759564|737099|P1|STARTED|First Intervention Period (4 Days)||8
304733|NCT00759525|737239|P2|NOT COMPLETED|Second Intervention (14 Days)||0
304734|NCT00759525|737240|P1|NOT COMPLETED|Second Intervention (14 Days)||0
304735|NCT00759525|737239|P2|COMPLETED|Second Intervention (14 Days)||8
304736|NCT00759525|737240|P1|COMPLETED|Second Intervention (14 Days)||7
304737|NCT00759525|737239|P2|STARTED|Second Intervention (14 Days)||8
304738|NCT00759525|737240|P1|STARTED|Second Intervention (14 Days)||7
304739|NCT00759525|737239|P2|NOT COMPLETED|Washout (14 Days)||0
304740|NCT00759525|737240|P1|NOT COMPLETED|Washout (14 Days)||0
304741|NCT00759525|737239|P2|COMPLETED|Washout (14 Days)||8
304742|NCT00759525|737240|P1|COMPLETED|Washout (14 Days)||7
304743|NCT00759525|737239|P2|STARTED|Washout (14 Days)||8
304744|NCT00759525|737240|P1|STARTED|Washout (14 Days)||7
304745|NCT00759525|737239|P2|NOT COMPLETED|First Intervention (14 Days)||0
304746|NCT00759525|737240|P1|NOT COMPLETED|First Intervention (14 Days)||0
304747|NCT00759525|737239|P2|COMPLETED|First Intervention (14 Days)||8
304748|NCT00759525|737240|P1|COMPLETED|First Intervention (14 Days)||7
304749|NCT00759525|737239|P2|STARTED|First Intervention (14 Days)||8
304750|NCT00759525|737240|P1|STARTED|First Intervention (14 Days)||7
304751|NCT00759473|737251|P5|NOT COMPLETED|Overall Study||0
304752|NCT00759473|737252|P4|NOT COMPLETED|Overall Study||0
304753|NCT00759473|737253|P3|NOT COMPLETED|Overall Study||0
304754|NCT00759473|737254|P2|NOT COMPLETED|Overall Study||0
304755|NCT00759473|737255|P1|NOT COMPLETED|Overall Study||0
304756|NCT00759473|737251|P5|COMPLETED|Overall Study||24
304757|NCT00759473|737252|P4|COMPLETED|Overall Study||23
304758|NCT00759473|737253|P3|COMPLETED|Overall Study||12
304759|NCT00759473|737254|P2|COMPLETED|Overall Study||10
304760|NCT00759473|737255|P1|COMPLETED|Overall Study||10
304761|NCT00759473|737251|P5|STARTED|Overall Study||24
304762|NCT00759473|737252|P4|STARTED|Overall Study||23
304763|NCT00759473|737253|P3|STARTED|Overall Study||12
304764|NCT00759473|737254|P2|STARTED|Overall Study||10
304765|NCT00759473|737255|P1|STARTED|Overall Study||10
304766|NCT00759408|737267|P1|NOT COMPLETED|Overall Study||19
304767|NCT00759408|737267|P1|COMPLETED|Overall Study||19
304768|NCT00759408|737267|P1|STARTED|Overall Study||38
304769|NCT00759395|737276|P2|NOT COMPLETED|Overall Study||2
304770|NCT00759395|737277|P1|NOT COMPLETED|Overall Study||2
304771|NCT00759395|737276|P2|COMPLETED|Overall Study||7
304772|NCT00759395|737277|P1|COMPLETED|Overall Study||11
304773|NCT00759395|737276|P2|STARTED|Overall Study||9
304774|NCT00759395|737277|P1|STARTED|Overall Study||13
304775|NCT00759356|737293|P2|NOT COMPLETED|Overall Study||3
304776|NCT00759356|737294|P1|NOT COMPLETED|Overall Study||1
304777|NCT00759356|737293|P2|COMPLETED|Overall Study||15
304778|NCT00759356|737294|P1|COMPLETED|Overall Study||17
304779|NCT00759356|737293|P2|STARTED|Overall Study||18
304780|NCT00759356|737294|P1|STARTED|Overall Study||18
304781|NCT00759330|737310|P4|NOT COMPLETED|Overall Study||2
304782|NCT00759330|737311|P3|NOT COMPLETED|Overall Study||0
304783|NCT00759330|737312|P2|NOT COMPLETED|Overall Study||1
304784|NCT00759330|737313|P1|NOT COMPLETED|Overall Study||1
304785|NCT00759330|737310|P4|COMPLETED|Overall Study||41
304786|NCT00759330|737311|P3|COMPLETED|Overall Study||22
304787|NCT00759330|737312|P2|COMPLETED|Overall Study||41
304788|NCT00759330|737313|P1|COMPLETED|Overall Study||19
304789|NCT00759330|737310|P4|STARTED|Overall Study||43
304790|NCT00759330|737311|P3|STARTED|Overall Study||22
304791|NCT00759330|737312|P2|STARTED|Overall Study||42
304792|NCT00759330|737313|P1|STARTED|Overall Study||20
304793|NCT00759187|737362|P3|NOT COMPLETED|Overall Study||0
304794|NCT00759187|737363|P2|NOT COMPLETED|Overall Study||0
304795|NCT00759187|737364|P1|NOT COMPLETED|Overall Study||0
304796|NCT00759187|737362|P3|COMPLETED|Overall Study||9
304797|NCT00759187|737363|P2|COMPLETED|Overall Study||8
304798|NCT00759187|737364|P1|COMPLETED|Overall Study||8
304799|NCT00759187|737362|P3|STARTED|Overall Study||9
304800|NCT00759187|737363|P2|STARTED|Overall Study||8
304801|NCT00759187|737364|P1|STARTED|Overall Study||8
304802|NCT00759174|737374|P2|NOT COMPLETED|Overall Study||2
304803|NCT00759174|737375|P1|NOT COMPLETED|Overall Study||0
304804|NCT00759174|737374|P2|COMPLETED|Overall Study||595
304805|NCT00759174|737375|P1|COMPLETED|Overall Study||76
304806|NCT00759174|737374|P2|STARTED|Overall Study||597
304807|NCT00759174|737375|P1|STARTED|Overall Study||76
304808|NCT00759161|737384|P1|NOT COMPLETED|Overall Study||0
304809|NCT00759161|737384|P1|COMPLETED|Overall Study||35
304810|NCT00759161|737384|P1|STARTED|Overall Study||35
304811|NCT00759148|737399|P2|NOT COMPLETED|Overall Study||32
304812|NCT00759148|737400|P1|NOT COMPLETED|Overall Study||14
304813|NCT00759148|737399|P2|COMPLETED|Overall Study||554
304814|NCT00759148|737400|P1|COMPLETED|Overall Study||579
304815|NCT00759148|737399|P2|STARTED|Overall Study||586
304816|NCT00759148|737400|P1|STARTED|Overall Study||593
304817|NCT00759109|737410|P2|NOT COMPLETED|Overall Study||35
304818|NCT00759109|737411|P1|NOT COMPLETED|Overall Study||39
304819|NCT00759109|737410|P2|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|41
304820|NCT00759109|737411|P1|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|35
304821|NCT00759109|737410|P2|STARTED|Overall Study||76
304822|NCT00759109|737411|P1|STARTED|Overall Study||74
304823|NCT00759096|737427|P1|NOT COMPLETED|Overall Study||0
304824|NCT00759096|737427|P1|COMPLETED|Overall Study||30
304825|NCT00759096|737427|P1|STARTED|Overall Study||30
304826|NCT00759031|737433|P2|NOT COMPLETED|Second Intervention (1 Day)||0
304827|NCT00759031|737434|P1|NOT COMPLETED|Second Intervention (1 Day)||0
304828|NCT00759031|737433|P2|COMPLETED|Second Intervention (1 Day)||8
304829|NCT00759031|737434|P1|COMPLETED|Second Intervention (1 Day)||8
304830|NCT00759031|737433|P2|STARTED|Second Intervention (1 Day)||8
304831|NCT00759031|737434|P1|STARTED|Second Intervention (1 Day)||8
304832|NCT00759031|737433|P2|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
304833|NCT00759031|737434|P1|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
304834|NCT00759031|737433|P2|COMPLETED|Washout After 1st Intervention (1 Week)||8
304835|NCT00759031|737434|P1|COMPLETED|Washout After 1st Intervention (1 Week)||8
304836|NCT00759031|737433|P2|STARTED|Washout After 1st Intervention (1 Week)||8
304837|NCT00759031|737434|P1|STARTED|Washout After 1st Intervention (1 Week)||8
304838|NCT00759031|737433|P2|NOT COMPLETED|First Intervention (1 Day)||1
304839|NCT00759031|737434|P1|NOT COMPLETED|First Intervention (1 Day)||2
304840|NCT00759031|737433|P2|COMPLETED|First Intervention (1 Day)||8
304841|NCT00759031|737434|P1|COMPLETED|First Intervention (1 Day)||8
304842|NCT00759031|737433|P2|STARTED|First Intervention (1 Day)||9
304843|NCT00759031|737434|P1|STARTED|First Intervention (1 Day)||10
304844|NCT00758862|737440|P1|NOT COMPLETED|Overall Study||1
304845|NCT00758862|737440|P1|COMPLETED|Overall Study||19
304846|NCT00758862|737440|P1|STARTED|Overall Study||20
304847|NCT00758836|737460|P4|NOT COMPLETED|Overall Study||32
304848|NCT00758836|737461|P3|NOT COMPLETED|Overall Study||38
304849|NCT00758836|737462|P2|NOT COMPLETED|Overall Study||26
304850|NCT00758836|737463|P1|NOT COMPLETED|Overall Study||24
304851|NCT00758836|737460|P4|COMPLETED|Overall Study||138
304852|NCT00758836|737461|P3|COMPLETED|Overall Study||133
304853|NCT00758836|737462|P2|COMPLETED|Overall Study||145
304854|NCT00758836|737463|P1|COMPLETED|Overall Study||147
304855|NCT00758836|737460|P4|Treated|Overall Study||138
304856|NCT00758836|737461|P3|Treated|Overall Study||133
304857|NCT00758836|737462|P2|Treated|Overall Study||145
304858|NCT00758836|737463|P1|Treated|Overall Study||147
304859|NCT00758836|737460|P4|STARTED|Overall Study||170
304860|NCT00758836|737461|P3|STARTED|Overall Study||171
304861|NCT00758836|737462|P2|STARTED|Overall Study||171
304862|NCT00758836|737463|P1|STARTED|Overall Study||171
304863|NCT00758771|737487|P2|NOT COMPLETED|Overall Study||5
304864|NCT00758771|737488|P1|NOT COMPLETED|Overall Study||3
304865|NCT00758771|737487|P2|COMPLETED|Overall Study||15
304866|NCT00758771|737488|P1|COMPLETED|Overall Study||15
304867|NCT00758771|737487|P2|STARTED|Overall Study||20
304868|NCT00758771|737488|P1|STARTED|Overall Study||18
304869|NCT00758758|737502|P8|NOT COMPLETED|Overall Study||0
304870|NCT00758758|737503|P7|NOT COMPLETED|Overall Study||14
304871|NCT00758758|737504|P6|NOT COMPLETED|Overall Study||14
304872|NCT00758758|737505|P5|NOT COMPLETED|Overall Study||2
304873|NCT00758758|737506|P4|NOT COMPLETED|Overall Study||2
304874|NCT00758758|737507|P3|NOT COMPLETED|Overall Study||18
304875|NCT00758758|737508|P2|NOT COMPLETED|Overall Study||25
304876|NCT00758758|737509|P1|NOT COMPLETED|Overall Study||3
304877|NCT00758758|737502|P8|COMPLETED|Overall Study||0
304878|NCT00758758|737503|P7|COMPLETED|Overall Study||17
304879|NCT00758758|737504|P6|COMPLETED|Overall Study||36
304880|NCT00758758|737505|P5|COMPLETED|Overall Study||1
304881|NCT00758758|737506|P4|COMPLETED|Overall Study||4
304882|NCT00758758|737507|P3|COMPLETED|Overall Study||35
304883|NCT00758758|737508|P2|COMPLETED|Overall Study||49
304884|NCT00758758|737509|P1|COMPLETED|Overall Study||11
304885|NCT00758758|737502|P8|STARTED|Overall Study||0
304886|NCT00758758|737503|P7|STARTED|Overall Study||31
304887|NCT00758758|737504|P6|STARTED|Overall Study||50
304888|NCT00758758|737505|P5|STARTED|Overall Study||3
304889|NCT00758758|737506|P4|STARTED|Overall Study||6
304890|NCT00758758|737507|P3|STARTED|Overall Study||53
304891|NCT00758758|737508|P2|STARTED|Overall Study||74
304892|NCT00758758|737509|P1|STARTED|Overall Study||14
304893|NCT00758745|737537|P2|NOT COMPLETED|Overall Study||21
304894|NCT00758745|737538|P1|NOT COMPLETED|Overall Study||21
304895|NCT00758745|737537|P2|COMPLETED|Overall Study||60
304896|NCT00758745|737538|P1|COMPLETED|Overall Study||60
304897|NCT00758745|737537|P2|STARTED|Overall Study||81
304898|NCT00758745|737538|P1|STARTED|Overall Study||81
304899|NCT00758706|737546|P2|NOT COMPLETED|Overall Study||4
304900|NCT00758706|737547|P1|NOT COMPLETED|Overall Study||4
304901|NCT00758706|737546|P2|COMPLETED|Overall Study||25
304902|NCT00758706|737547|P1|COMPLETED|Overall Study||22
304903|NCT00758706|737546|P2|STARTED|Overall Study||29
304904|NCT00758706|737547|P1|STARTED|Overall Study||26
304905|NCT00758680|737583|P10|NOT COMPLETED|Overall Study||1
304906|NCT00758680|737584|P9|NOT COMPLETED|Overall Study||2
304907|NCT00758680|737585|P8|NOT COMPLETED|Overall Study||1
304908|NCT00758680|737586|P7|NOT COMPLETED|Overall Study||1
304909|NCT00758680|737587|P6|NOT COMPLETED|Overall Study||0
304910|NCT00758680|737588|P5|NOT COMPLETED|Overall Study||0
304911|NCT00758680|737589|P4|NOT COMPLETED|Overall Study||0
304912|NCT00758680|737590|P3|NOT COMPLETED|Overall Study||0
304913|NCT00758680|737591|P2|NOT COMPLETED|Overall Study||0
304914|NCT00758680|737592|P1|NOT COMPLETED|Overall Study||0
304915|NCT00758680|737583|P10|COMPLETED|Overall Study||28
304916|NCT00758680|737584|P9|COMPLETED|Overall Study||18
304917|NCT00758680|737585|P8|COMPLETED|Overall Study||19
304918|NCT00758680|737586|P7|COMPLETED|Overall Study||6
304919|NCT00758680|737587|P6|COMPLETED|Overall Study||6
304920|NCT00758680|737588|P5|COMPLETED|Overall Study||6
304921|NCT00758680|737589|P4|COMPLETED|Overall Study||6
304922|NCT00758680|737590|P3|COMPLETED|Overall Study||6
304923|NCT00758680|737591|P2|COMPLETED|Overall Study||6
304924|NCT00758680|737592|P1|COMPLETED|Overall Study||6
304925|NCT00758680|737583|P10|STARTED|Overall Study||29
304926|NCT00758680|737584|P9|STARTED|Overall Study||20
304927|NCT00758680|737585|P8|STARTED|Overall Study||20
304928|NCT00758680|737586|P7|STARTED|Overall Study||7
304929|NCT00758680|737587|P6|STARTED|Overall Study||6
304930|NCT00758680|737588|P5|STARTED|Overall Study||6
304931|NCT00758680|737589|P4|STARTED|Overall Study||6
304932|NCT00758680|737590|P3|STARTED|Overall Study||6
304933|NCT00758680|737591|P2|STARTED|Overall Study||6
304934|NCT00758680|737592|P1|STARTED|Overall Study||6
304935|NCT00758667|737634|P2|NOT COMPLETED|Overall Study||0
304936|NCT00758667|737635|P1|NOT COMPLETED|Overall Study||0
304937|NCT00758667|737634|P2|COMPLETED|Overall Study||11
304938|NCT00758667|737635|P1|COMPLETED|Overall Study||9
304939|NCT00758667|737634|P2|STARTED|Overall Study||11
304940|NCT00758667|737635|P1|STARTED|Overall Study||9
304941|NCT00758602|737645|P2|NOT COMPLETED|Overall Study||22
304942|NCT00758602|737646|P1|NOT COMPLETED|Overall Study||19
304943|NCT00758602|737645|P2|COMPLETED|Overall Study||84
304944|NCT00758602|737646|P1|COMPLETED|Overall Study||85
304945|NCT00758602|737645|P2|STARTED|Overall Study||106
304946|NCT00758602|737646|P1|STARTED|Overall Study||104
304947|NCT00758589|737672|P4|NOT COMPLETED|Overall Study||6
304948|NCT00758589|737673|P3|NOT COMPLETED|Overall Study||6
304949|NCT00758589|737674|P2|NOT COMPLETED|Overall Study||3
304950|NCT00758589|737675|P1|NOT COMPLETED|Overall Study||3
304951|NCT00758589|737672|P4|COMPLETED|Overall Study||85
304952|NCT00758589|737673|P3|COMPLETED|Overall Study||86
304953|NCT00758589|737674|P2|COMPLETED|Overall Study||87
304954|NCT00758589|737675|P1|COMPLETED|Overall Study||92
304955|NCT00758589|737672|P4|STARTED|Overall Study||91
304956|NCT00758589|737673|P3|STARTED|Overall Study||92
304957|NCT00758589|737674|P2|STARTED|Overall Study||90
304958|NCT00758589|737675|P1|STARTED|Overall Study||95
304959|NCT00758576|737741|P1|NOT COMPLETED|Overall Study||1
304960|NCT00758576|737741|P1|COMPLETED|Overall Study||63
304961|NCT00758576|737741|P1|STARTED|Overall Study||64
304962|NCT00758563|737749|P2|NOT COMPLETED|Overall Study||0
304963|NCT00758563|737750|P1|NOT COMPLETED|Overall Study||0
304964|NCT00758563|737749|P2|COMPLETED|Overall Study||8
304965|NCT00758563|737750|P1|COMPLETED|Overall Study||7
304966|NCT00758563|737749|P2|STARTED|Overall Study||8
304967|NCT00758563|737750|P1|STARTED|Overall Study||7
304968|NCT00758550|737756|P2|NOT COMPLETED|Overall Study||0
304969|NCT00758550|737757|P1|NOT COMPLETED|Overall Study||0
304970|NCT00758550|737756|P2|COMPLETED|Overall Study||30
304971|NCT00758550|737757|P1|COMPLETED|Overall Study||30
304972|NCT00758550|737756|P2|STARTED|Overall Study||30
304973|NCT00758550|737757|P1|STARTED|Overall Study||30
304974|NCT00758498|737768|P3|NOT COMPLETED|Overall Study||5
304975|NCT00758498|737769|P2|NOT COMPLETED|Overall Study||2
304976|NCT00758498|737770|P1|NOT COMPLETED|Overall Study||3
304977|NCT00758498|737768|P3|COMPLETED|Overall Study||137
304978|NCT00758498|737769|P2|COMPLETED|Overall Study||141
304979|NCT00758498|737770|P1|COMPLETED|Overall Study||139
304980|NCT00758498|737768|P3|STARTED|Overall Study||142
304981|NCT00758498|737769|P2|STARTED|Overall Study||143
304982|NCT00758498|737770|P1|STARTED|Overall Study||142
304983|NCT00758485|737855|P2|NOT COMPLETED|Overall Study||3
304984|NCT00758485|737856|P1|NOT COMPLETED|Overall Study||1
304985|NCT00758485|737855|P2|COMPLETED|Overall Study||67
304986|NCT00758485|737856|P1|COMPLETED|Overall Study||69
304987|NCT00758485|737855|P2|TREATED|Overall Study||68
304988|NCT00758485|737856|P1|TREATED|Overall Study||69
304989|NCT00758485|737855|P2|STARTED|Overall Study||70
304990|NCT00758485|737856|P1|STARTED|Overall Study||70
304991|NCT00758459|737868|P2|NOT COMPLETED|Overall Study||4
304992|NCT00758459|737869|P1|NOT COMPLETED|Overall Study||3
304993|NCT00758459|737868|P2|COMPLETED|Overall Study||35
304994|NCT00758459|737869|P1|COMPLETED|Overall Study||32
304995|NCT00758459|737868|P2|STARTED|Overall Study||39
304996|NCT00758459|737869|P1|STARTED|Overall Study||35
304997|NCT00758420|737903|P2|NOT COMPLETED|Overall Study||0
304998|NCT00758420|737904|P1|NOT COMPLETED|Overall Study||0
304999|NCT00758420|737903|P2|COMPLETED|Overall Study||38
305000|NCT00758420|737904|P1|COMPLETED|Overall Study||39
305001|NCT00758420|737903|P2|STARTED|Overall Study||38
305002|NCT00758420|737904|P1|STARTED|Overall Study||39
305003|NCT00758394|737914|P4|NOT COMPLETED|4th Intervention||0
305004|NCT00758394|737915|P3|NOT COMPLETED|4th Intervention||0
305005|NCT00758394|737916|P2|NOT COMPLETED|4th Intervention||0
305006|NCT00758394|737917|P1|NOT COMPLETED|4th Intervention||0
305007|NCT00758394|737914|P4|COMPLETED|4th Intervention||7
305008|NCT00758394|737915|P3|COMPLETED|4th Intervention||6
305009|NCT00758394|737916|P2|COMPLETED|4th Intervention||6
305010|NCT00758394|737917|P1|COMPLETED|4th Intervention||7
305011|NCT00758394|737914|P4|STARTED|4th Intervention||7
305012|NCT00758394|737915|P3|STARTED|4th Intervention||6
305013|NCT00758394|737916|P2|STARTED|4th Intervention||6
305014|NCT00758394|737917|P1|STARTED|4th Intervention||7
305015|NCT00758394|737914|P4|NOT COMPLETED|Washout After 3rd Intervention||0
305016|NCT00758394|737915|P3|NOT COMPLETED|Washout After 3rd Intervention||0
305017|NCT00758394|737916|P2|NOT COMPLETED|Washout After 3rd Intervention||0
305018|NCT00758394|737917|P1|NOT COMPLETED|Washout After 3rd Intervention||0
305019|NCT00758394|737914|P4|COMPLETED|Washout After 3rd Intervention||7
305020|NCT00758394|737915|P3|COMPLETED|Washout After 3rd Intervention||6
305021|NCT00758394|737916|P2|COMPLETED|Washout After 3rd Intervention||6
305022|NCT00758394|737917|P1|COMPLETED|Washout After 3rd Intervention||7
305023|NCT00758394|737914|P4|STARTED|Washout After 3rd Intervention||7
305024|NCT00758394|737915|P3|STARTED|Washout After 3rd Intervention||6
305025|NCT00758394|737916|P2|STARTED|Washout After 3rd Intervention||6
305026|NCT00758394|737917|P1|STARTED|Washout After 3rd Intervention||7
305027|NCT00758394|737914|P4|NOT COMPLETED|3rd Intervention||1
305028|NCT00758394|737915|P3|NOT COMPLETED|3rd Intervention||0
305029|NCT00758394|737916|P2|NOT COMPLETED|3rd Intervention||0
305030|NCT00758394|737917|P1|NOT COMPLETED|3rd Intervention||1
305031|NCT00758394|737914|P4|COMPLETED|3rd Intervention||7
305032|NCT00758394|737915|P3|COMPLETED|3rd Intervention||6
305033|NCT00758394|737916|P2|COMPLETED|3rd Intervention||6
305034|NCT00758394|737917|P1|COMPLETED|3rd Intervention||7
305035|NCT00758394|737914|P4|STARTED|3rd Intervention||8
305036|NCT00758394|737915|P3|STARTED|3rd Intervention||6
305037|NCT00758394|737916|P2|STARTED|3rd Intervention||6
305038|NCT00758394|737917|P1|STARTED|3rd Intervention||8
305039|NCT00758394|737914|P4|NOT COMPLETED|Washout After 2nd Intervention||0
305040|NCT00758394|737915|P3|NOT COMPLETED|Washout After 2nd Intervention||0
305041|NCT00758394|737916|P2|NOT COMPLETED|Washout After 2nd Intervention||0
305042|NCT00758394|737917|P1|NOT COMPLETED|Washout After 2nd Intervention||0
305043|NCT00758394|737914|P4|COMPLETED|Washout After 2nd Intervention||8
305044|NCT00758394|737915|P3|COMPLETED|Washout After 2nd Intervention||6
305045|NCT00758394|737916|P2|COMPLETED|Washout After 2nd Intervention||6
305046|NCT00758394|737917|P1|COMPLETED|Washout After 2nd Intervention||8
305047|NCT00758394|737914|P4|STARTED|Washout After 2nd Intervention||8
305048|NCT00758394|737915|P3|STARTED|Washout After 2nd Intervention||6
305049|NCT00758394|737916|P2|STARTED|Washout After 2nd Intervention||6
305050|NCT00758394|737917|P1|STARTED|Washout After 2nd Intervention||8
305051|NCT00758394|737914|P4|NOT COMPLETED|2nd Intervention Order||0
305052|NCT00758394|737915|P3|NOT COMPLETED|2nd Intervention Order||0
305053|NCT00758394|737916|P2|NOT COMPLETED|2nd Intervention Order||1
305054|NCT00758394|737917|P1|NOT COMPLETED|2nd Intervention Order||0
305055|NCT00758394|737914|P4|COMPLETED|2nd Intervention Order||8
305056|NCT00758394|737915|P3|COMPLETED|2nd Intervention Order||6
305057|NCT00758394|737916|P2|COMPLETED|2nd Intervention Order||6
305058|NCT00758394|737917|P1|COMPLETED|2nd Intervention Order||8
305059|NCT00758394|737914|P4|STARTED|2nd Intervention Order||8
305060|NCT00758394|737915|P3|STARTED|2nd Intervention Order||6
305061|NCT00758394|737916|P2|STARTED|2nd Intervention Order||7
305062|NCT00758394|737917|P1|STARTED|2nd Intervention Order||8
305063|NCT00758394|737914|P4|NOT COMPLETED|Washout After 1st Intervention||0
305064|NCT00758394|737915|P3|NOT COMPLETED|Washout After 1st Intervention||0
305065|NCT00758394|737916|P2|NOT COMPLETED|Washout After 1st Intervention||0
305066|NCT00758394|737917|P1|NOT COMPLETED|Washout After 1st Intervention||0
305067|NCT00758394|737914|P4|COMPLETED|Washout After 1st Intervention||8
305068|NCT00758394|737915|P3|COMPLETED|Washout After 1st Intervention||6
305069|NCT00758394|737916|P2|COMPLETED|Washout After 1st Intervention||7
305070|NCT00758394|737917|P1|COMPLETED|Washout After 1st Intervention||8
305071|NCT00758394|737914|P4|STARTED|Washout After 1st Intervention||8
305072|NCT00758394|737915|P3|STARTED|Washout After 1st Intervention||6
305073|NCT00758394|737916|P2|STARTED|Washout After 1st Intervention||7
305074|NCT00758394|737917|P1|STARTED|Washout After 1st Intervention||8
305075|NCT00758394|737914|P4|NOT COMPLETED|1st Intervention||0
305076|NCT00758394|737915|P3|NOT COMPLETED|1st Intervention||0
305077|NCT00758394|737916|P2|NOT COMPLETED|1st Intervention||0
305078|NCT00758394|737917|P1|NOT COMPLETED|1st Intervention||0
305079|NCT00758394|737914|P4|COMPLETED|1st Intervention||8
305080|NCT00758394|737915|P3|COMPLETED|1st Intervention||6
305081|NCT00758394|737916|P2|COMPLETED|1st Intervention||7
305082|NCT00758394|737917|P1|COMPLETED|1st Intervention||8
305083|NCT00758394|737914|P4|STARTED|1st Intervention||8
305084|NCT00758394|737915|P3|STARTED|1st Intervention||6
305085|NCT00758394|737916|P2|STARTED|1st Intervention||7
305086|NCT00758394|737917|P1|STARTED|1st Intervention||8
305087|NCT00758342|737929|P2|NOT COMPLETED|Overall Study||1
305088|NCT00758342|737930|P1|NOT COMPLETED|Overall Study||4
305089|NCT00758342|737929|P2|COMPLETED|Overall Study||17
305090|NCT00758342|737930|P1|COMPLETED|Overall Study||15
305091|NCT00758342|737929|P2|STARTED|Overall Study||18
305092|NCT00758342|737930|P1|STARTED|Overall Study||19
305093|NCT00758290|737938|P2|NOT COMPLETED|Overall Study||0
305094|NCT00758290|737939|P1|NOT COMPLETED|Overall Study||0
305095|NCT00758290|737938|P2|COMPLETED|Overall Study||12
305096|NCT00758290|737939|P1|COMPLETED|Overall Study||11
305097|NCT00758290|737938|P2|STARTED|Overall Study||12
305098|NCT00758290|737939|P1|STARTED|Overall Study||11
305099|NCT00758264|737946|P3|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
305100|NCT00758264|737947|P2|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
305101|NCT00758264|737948|P1|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
305102|NCT00758264|737946|P3|COMPLETED|Extended Safety Follow Up (ESFU) Phase||89
305103|NCT00758264|737947|P2|COMPLETED|Extended Safety Follow Up (ESFU) Phase||90
305104|NCT00758264|737948|P1|COMPLETED|Extended Safety Follow Up (ESFU) Phase||181
305105|NCT00758264|737946|P3|STARTED|Extended Safety Follow Up (ESFU) Phase||89
305191|NCT00757627|738212|P1|COMPLETED|Overall Study||419
305106|NCT00758264|737947|P2|STARTED|Extended Safety Follow Up (ESFU) Phase||90
305107|NCT00758264|737948|P1|STARTED|Extended Safety Follow Up (ESFU) Phase||181
305108|NCT00758264|737946|P3|NOT COMPLETED|Active Phase||5
305109|NCT00758264|737947|P2|NOT COMPLETED|Active Phase||0
305110|NCT00758264|737948|P1|NOT COMPLETED|Active Phase||1
305111|NCT00758264|737946|P3|COMPLETED|Active Phase||85
305112|NCT00758264|737947|P2|COMPLETED|Active Phase||91
305113|NCT00758264|737948|P1|COMPLETED|Active Phase||181
305114|NCT00758264|737946|P3|STARTED|Active Phase||90
305115|NCT00758264|737947|P2|STARTED|Active Phase||91
305116|NCT00758264|737948|P1|STARTED|Active Phase||182
305117|NCT00758160|738007|P1|NOT COMPLETED|Overall Study||66
305118|NCT00758160|738007|P1|COMPLETED|Overall Study||230
305119|NCT00758160|738007|P1|STARTED|Overall Study||296
305120|NCT00758069|738028|P3|NOT COMPLETED|Overall Study||1
305121|NCT00758069|738029|P2|NOT COMPLETED|Overall Study||0
305122|NCT00758069|738030|P1|NOT COMPLETED|Overall Study||1
305123|NCT00758069|738028|P3|COMPLETED|Overall Study||27
305124|NCT00758069|738029|P2|COMPLETED|Overall Study||25
305125|NCT00758069|738030|P1|COMPLETED|Overall Study||26
305126|NCT00758069|738028|P3|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|28
305127|NCT00758069|738029|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|25
305128|NCT00758069|738030|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|27
305129|NCT00758043|738045|P4|NOT COMPLETED|Overall Study||100
305130|NCT00758043|738046|P3|NOT COMPLETED|Overall Study||39
305131|NCT00758043|738047|P2|NOT COMPLETED|Overall Study||41
305132|NCT00758043|738048|P1|NOT COMPLETED|Overall Study||1
305133|NCT00758043|738045|P4|COMPLETED|Overall Study||0
305134|NCT00758043|738046|P3|COMPLETED|Overall Study||79
305135|NCT00758043|738047|P2|COMPLETED|Overall Study||119
305136|NCT00758043|738048|P1|COMPLETED|Overall Study||161
305137|NCT00758043|738045|P4|STARTED|Overall Study||100
305138|NCT00758043|738046|P3|STARTED|Overall Study||118
305139|NCT00758043|738047|P2|STARTED|Overall Study||160
305140|NCT00758043|738048|P1|STARTED|Overall Study||162
305141|NCT00757848|738076|P2|NOT COMPLETED|Overall Study||2
305142|NCT00757848|738077|P1|NOT COMPLETED|Overall Study||3
305143|NCT00757848|738076|P2|COMPLETED|Overall Study||27
305144|NCT00757848|738077|P1|COMPLETED|Overall Study||24
305145|NCT00757848|738076|P2|STARTED|Overall Study||29
305146|NCT00757848|738077|P1|STARTED|Overall Study||27
305147|NCT00757822|738123|P2|NOT COMPLETED|Overall Study||31
305148|NCT00757822|738124|P1|NOT COMPLETED|Overall Study||28
305149|NCT00757822|738123|P2|COMPLETED|Overall Study||57
305150|NCT00757822|738124|P1|COMPLETED|Overall Study||64
305151|NCT00757822|738123|P2|Data Lock, Unblinding Analysis|Overall Study||57
305152|NCT00757822|738124|P1|Data Lock, Unblinding Analysis|Overall Study||64
305153|NCT00757822|738123|P2|Withdrawn-protocol Deviation|Overall Study||8
305154|NCT00757822|738124|P1|Withdrawn-protocol Deviation|Overall Study||9
305155|NCT00757822|738123|P2|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk < 2|9
305156|NCT00757822|738124|P1|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk<2|12
305157|NCT00757822|738123|P2|Data Entry, QC Assessment|Overall Study||74
305158|NCT00757822|738124|P1|Data Entry, QC Assessment|Overall Study||85
305159|NCT00757822|738123|P2|2-6 wk Post-op Assessment|Overall Study||74
305160|NCT00757822|738124|P1|2-6 wk Post-op Assessment|Overall Study||85
305161|NCT00757822|738123|P2|24-48 hr Telephone Assessment|Overall Study||74
305162|NCT00757822|738124|P1|24-48 hr Telephone Assessment|Overall Study||85
305163|NCT00757822|738123|P2|DOS: Post-operative Assessments|Overall Study||74
305164|NCT00757822|738124|P1|DOS: Post-operative Assessments|Overall Study||85
305165|NCT00757822|738123|P2|Received Study Intervention|Overall Study||74
305166|NCT00757822|738124|P1|Received Study Intervention|Overall Study||85
305167|NCT00757822|738123|P2|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|11
305168|NCT00757822|738124|P1|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|6
305169|NCT00757822|738123|P2|Withdrawal by Subject-no Intervention|Overall Study||3
305170|NCT00757822|738124|P1|Withdrawal by Subject-no Intervention|Overall Study||1
305171|NCT00757822|738123|P2|Day of Surgery (DOS) Assessment|Overall Study||88
305172|NCT00757822|738124|P1|Day of Surgery (DOS) Assessment|Overall Study||92
305173|NCT00757822|738123|P2|STARTED|Overall Study||88
305174|NCT00757822|738124|P1|STARTED|Overall Study||92
305175|NCT00757783|738146|P2|NOT COMPLETED|Overall Study||6
305176|NCT00757783|738147|P1|NOT COMPLETED|Overall Study||5
305177|NCT00757783|738146|P2|COMPLETED|Overall Study||25
305178|NCT00757783|738147|P1|COMPLETED|Overall Study||29
305179|NCT00757783|738146|P2|STARTED|Overall Study||31
305180|NCT00757783|738147|P1|STARTED|Overall Study||34
305181|NCT00757705|738183|P1|NOT COMPLETED|Overall Study||121
305182|NCT00757705|738183|P1|COMPLETED|Overall Study||178
305183|NCT00757705|738183|P1|STARTED|Overall Study||299
305184|NCT00757666|738197|P2|NOT COMPLETED|Overall Study||23
305185|NCT00757666|738198|P1|NOT COMPLETED|Overall Study||22
305186|NCT00757666|738197|P2|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|11
305187|NCT00757666|738198|P1|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|12
305188|NCT00757666|738197|P2|STARTED|Overall Study||34
305189|NCT00757666|738198|P1|STARTED|Overall Study||34
305190|NCT00757627|738212|P1|NOT COMPLETED|Overall Study||81
305192|NCT00757627|738212|P1|STARTED|Overall Study||500
305193|NCT00757601|738225|P12|NOT COMPLETED|Period 5||0
305194|NCT00757601|738226|P11|NOT COMPLETED|Period 5||0
305195|NCT00757601|738227|P10|NOT COMPLETED|Period 5||0
305196|NCT00757601|738228|P9|NOT COMPLETED|Period 5||0
305197|NCT00757601|738229|P8|NOT COMPLETED|Period 5||0
305198|NCT00757601|738230|P7|NOT COMPLETED|Period 5||0
305199|NCT00757601|738231|P6|NOT COMPLETED|Period 5||0
305200|NCT00757601|738232|P5|NOT COMPLETED|Period 5||0
305201|NCT00757601|738233|P4|NOT COMPLETED|Period 5||0
305202|NCT00757601|738234|P3|NOT COMPLETED|Period 5||0
305203|NCT00757601|738235|P2|NOT COMPLETED|Period 5||0
305204|NCT00757601|738236|P1|NOT COMPLETED|Period 5||0
305205|NCT00757601|738225|P12|COMPLETED|Period 5||1
305206|NCT00757601|738226|P11|COMPLETED|Period 5||2
305207|NCT00757601|738227|P10|COMPLETED|Period 5||1
305208|NCT00757601|738228|P9|COMPLETED|Period 5||2
305209|NCT00757601|738229|P8|COMPLETED|Period 5||2
305210|NCT00757601|738230|P7|COMPLETED|Period 5||2
305211|NCT00757601|738231|P6|COMPLETED|Period 5||2
305212|NCT00757601|738232|P5|COMPLETED|Period 5||2
305213|NCT00757601|738233|P4|COMPLETED|Period 5||2
305214|NCT00757601|738234|P3|COMPLETED|Period 5||2
305215|NCT00757601|738235|P2|COMPLETED|Period 5||2
305216|NCT00757601|738236|P1|COMPLETED|Period 5||2
305217|NCT00757601|738225|P12|STARTED|Period 5||1
305218|NCT00757601|738226|P11|STARTED|Period 5||2
305219|NCT00757601|738227|P10|STARTED|Period 5||1
305220|NCT00757601|738228|P9|STARTED|Period 5||2
305221|NCT00757601|738229|P8|STARTED|Period 5||2
305222|NCT00757601|738230|P7|STARTED|Period 5||2
305223|NCT00757601|738231|P6|STARTED|Period 5||2
305224|NCT00757601|738232|P5|STARTED|Period 5||2
305225|NCT00757601|738233|P4|STARTED|Period 5||2
305226|NCT00757601|738234|P3|STARTED|Period 5||2
305227|NCT00757601|738235|P2|STARTED|Period 5||2
305228|NCT00757601|738236|P1|STARTED|Period 5||2
305229|NCT00757601|738225|P12|NOT COMPLETED|Period 4||1
305230|NCT00757601|738226|P11|NOT COMPLETED|Period 4||0
305231|NCT00757601|738227|P10|NOT COMPLETED|Period 4||1
305232|NCT00757601|738228|P9|NOT COMPLETED|Period 4||0
305233|NCT00757601|738229|P8|NOT COMPLETED|Period 4||0
305234|NCT00757601|738230|P7|NOT COMPLETED|Period 4||0
305235|NCT00757601|738231|P6|NOT COMPLETED|Period 4||0
305236|NCT00757601|738232|P5|NOT COMPLETED|Period 4||0
305237|NCT00757601|738233|P4|NOT COMPLETED|Period 4||0
305238|NCT00757601|738234|P3|NOT COMPLETED|Period 4||0
305239|NCT00757601|738235|P2|NOT COMPLETED|Period 4||0
305240|NCT00757601|738236|P1|NOT COMPLETED|Period 4||0
305241|NCT00757601|738225|P12|COMPLETED|Period 4|Replacement participant discontinued after receiving placebo to 230mg MK1006 and was not replaced|1
305242|NCT00757601|738226|P11|COMPLETED|Period 4||2
305243|NCT00757601|738227|P10|COMPLETED|Period 4|One participant discontinued after receiving the 230 mg dose of MK1006 and was not replaced|1
305244|NCT00757601|738228|P9|COMPLETED|Period 4||2
305245|NCT00757601|738229|P8|COMPLETED|Period 4||2
305246|NCT00757601|738230|P7|COMPLETED|Period 4||2
305247|NCT00757601|738231|P6|COMPLETED|Period 4||2
305248|NCT00757601|738232|P5|COMPLETED|Period 4||2
305249|NCT00757601|738233|P4|COMPLETED|Period 4||2
305250|NCT00757601|738234|P3|COMPLETED|Period 4||2
305251|NCT00757601|738235|P2|COMPLETED|Period 4||2
305252|NCT00757601|738236|P1|COMPLETED|Period 4||2
305253|NCT00757601|738225|P12|STARTED|Period 4||2
305254|NCT00757601|738226|P11|STARTED|Period 4||2
305255|NCT00757601|738227|P10|STARTED|Period 4||2
305256|NCT00757601|738228|P9|STARTED|Period 4||2
305257|NCT00757601|738229|P8|STARTED|Period 4||2
305258|NCT00757601|738230|P7|STARTED|Period 4||2
305259|NCT00757601|738231|P6|STARTED|Period 4||2
305260|NCT00757601|738232|P5|STARTED|Period 4||2
305261|NCT00757601|738233|P4|STARTED|Period 4||2
305262|NCT00757601|738234|P3|STARTED|Period 4||2
305263|NCT00757601|738235|P2|STARTED|Period 4||2
305264|NCT00757601|738236|P1|STARTED|Period 4||2
305265|NCT00757601|738225|P12|NOT COMPLETED|Period 3||0
305266|NCT00757601|738226|P11|NOT COMPLETED|Period 3||0
305267|NCT00757601|738227|P10|NOT COMPLETED|Period 3||0
305268|NCT00757601|738228|P9|NOT COMPLETED|Period 3||0
305269|NCT00757601|738229|P8|NOT COMPLETED|Period 3||0
305270|NCT00757601|738230|P7|NOT COMPLETED|Period 3||0
305271|NCT00757601|738231|P6|NOT COMPLETED|Period 3||0
305272|NCT00757601|738232|P5|NOT COMPLETED|Period 3||0
305273|NCT00757601|738233|P4|NOT COMPLETED|Period 3||0
305274|NCT00757601|738234|P3|NOT COMPLETED|Period 3||0
305275|NCT00757601|738235|P2|NOT COMPLETED|Period 3||0
305276|NCT00757601|738236|P1|NOT COMPLETED|Period 3||0
305277|NCT00757601|738225|P12|COMPLETED|Period 3||2
305278|NCT00757601|738226|P11|COMPLETED|Period 3||2
305279|NCT00757601|738227|P10|COMPLETED|Period 3||2
305280|NCT00757601|738228|P9|COMPLETED|Period 3||2
305281|NCT00757601|738229|P8|COMPLETED|Period 3||2
305282|NCT00757601|738230|P7|COMPLETED|Period 3||2
305283|NCT00757601|738231|P6|COMPLETED|Period 3||2
305284|NCT00757601|738232|P5|COMPLETED|Period 3||2
305285|NCT00757601|738233|P4|COMPLETED|Period 3||2
305286|NCT00757601|738234|P3|COMPLETED|Period 3||2
305287|NCT00757601|738235|P2|COMPLETED|Period 3||2
305288|NCT00757601|738236|P1|COMPLETED|Period 3||2
305289|NCT00757601|738225|P12|STARTED|Period 3||2
305290|NCT00757601|738226|P11|STARTED|Period 3||2
305291|NCT00757601|738227|P10|STARTED|Period 3||2
305292|NCT00757601|738228|P9|STARTED|Period 3||2
305293|NCT00757601|738229|P8|STARTED|Period 3||2
305294|NCT00757601|738230|P7|STARTED|Period 3||2
305295|NCT00757601|738231|P6|STARTED|Period 3||2
305296|NCT00757601|738232|P5|STARTED|Period 3||2
305297|NCT00757601|738233|P4|STARTED|Period 3||2
305298|NCT00757601|738234|P3|STARTED|Period 3||2
305299|NCT00757601|738235|P2|STARTED|Period 3||2
305300|NCT00757601|738236|P1|STARTED|Period 3||2
305301|NCT00757601|738225|P12|NOT COMPLETED|Period 2||1
305302|NCT00757601|738226|P11|NOT COMPLETED|Period 2||0
305303|NCT00757601|738227|P10|NOT COMPLETED|Period 2||0
305304|NCT00757601|738228|P9|NOT COMPLETED|Period 2||0
305305|NCT00757601|738229|P8|NOT COMPLETED|Period 2||0
305306|NCT00757601|738230|P7|NOT COMPLETED|Period 2||0
305307|NCT00757601|738231|P6|NOT COMPLETED|Period 2||0
305308|NCT00757601|738232|P5|NOT COMPLETED|Period 2||0
305309|NCT00757601|738233|P4|NOT COMPLETED|Period 2||0
305310|NCT00757601|738234|P3|NOT COMPLETED|Period 2||0
305311|NCT00757601|738235|P2|NOT COMPLETED|Period 2||0
305312|NCT00757601|738236|P1|NOT COMPLETED|Period 2||0
305313|NCT00757601|738225|P12|COMPLETED|Period 2|One participant discontinued the study after Period 2 and was replaced by another participant.|2
305314|NCT00757601|738226|P11|COMPLETED|Period 2||2
305315|NCT00757601|738227|P10|COMPLETED|Period 2||2
305316|NCT00757601|738228|P9|COMPLETED|Period 2||2
305317|NCT00757601|738229|P8|COMPLETED|Period 2||2
305318|NCT00757601|738230|P7|COMPLETED|Period 2||2
305319|NCT00757601|738231|P6|COMPLETED|Period 2||2
305320|NCT00757601|738232|P5|COMPLETED|Period 2||2
305321|NCT00757601|738233|P4|COMPLETED|Period 2||2
305322|NCT00757601|738234|P3|COMPLETED|Period 2||2
305323|NCT00757601|738235|P2|COMPLETED|Period 2||2
305324|NCT00757601|738236|P1|COMPLETED|Period 2||2
305325|NCT00757601|738225|P12|STARTED|Period 2||3
305326|NCT00757601|738226|P11|STARTED|Period 2||2
305327|NCT00757601|738227|P10|STARTED|Period 2||2
305328|NCT00757601|738228|P9|STARTED|Period 2||2
305329|NCT00757601|738229|P8|STARTED|Period 2||2
305330|NCT00757601|738230|P7|STARTED|Period 2||2
305331|NCT00757601|738231|P6|STARTED|Period 2||2
305332|NCT00757601|738232|P5|STARTED|Period 2||2
305333|NCT00757601|738233|P4|STARTED|Period 2||2
305334|NCT00757601|738234|P3|STARTED|Period 2||2
305335|NCT00757601|738235|P2|STARTED|Period 2||2
305336|NCT00757601|738236|P1|STARTED|Period 2||2
305337|NCT00757601|738225|P12|NOT COMPLETED|Period 1||0
305338|NCT00757601|738226|P11|NOT COMPLETED|Period 1||0
305339|NCT00757601|738227|P10|NOT COMPLETED|Period 1||0
305340|NCT00757601|738228|P9|NOT COMPLETED|Period 1||0
305341|NCT00757601|738229|P8|NOT COMPLETED|Period 1||0
305342|NCT00757601|738230|P7|NOT COMPLETED|Period 1||0
305343|NCT00757601|738231|P6|NOT COMPLETED|Period 1||0
305344|NCT00757601|738232|P5|NOT COMPLETED|Period 1||0
305345|NCT00757601|738233|P4|NOT COMPLETED|Period 1||0
305346|NCT00757601|738234|P3|NOT COMPLETED|Period 1||0
305347|NCT00757601|738235|P2|NOT COMPLETED|Period 1||0
305348|NCT00757601|738236|P1|NOT COMPLETED|Period 1||0
305349|NCT00757601|738225|P12|COMPLETED|Period 1||3
305350|NCT00757601|738226|P11|COMPLETED|Period 1||2
305351|NCT00757601|738227|P10|COMPLETED|Period 1||2
305352|NCT00757601|738228|P9|COMPLETED|Period 1||2
305353|NCT00757601|738229|P8|COMPLETED|Period 1||2
305354|NCT00757601|738230|P7|COMPLETED|Period 1||2
305355|NCT00757601|738231|P6|COMPLETED|Period 1||2
305356|NCT00757601|738232|P5|COMPLETED|Period 1||2
305357|NCT00757601|738233|P4|COMPLETED|Period 1||2
305358|NCT00757601|738234|P3|COMPLETED|Period 1||2
305359|NCT00757601|738235|P2|COMPLETED|Period 1||2
305360|NCT00757601|738236|P1|COMPLETED|Period 1||2
305361|NCT00757601|738225|P12|STARTED|Period 1||3
305362|NCT00757601|738226|P11|STARTED|Period 1||2
305363|NCT00757601|738227|P10|STARTED|Period 1||2
305364|NCT00757601|738228|P9|STARTED|Period 1||2
305365|NCT00757601|738229|P8|STARTED|Period 1||2
305366|NCT00757601|738230|P7|STARTED|Period 1||2
305367|NCT00757601|738231|P6|STARTED|Period 1||2
305368|NCT00757601|738232|P5|STARTED|Period 1||2
305369|NCT00757601|738233|P4|STARTED|Period 1||2
305370|NCT00757601|738234|P3|STARTED|Period 1||2
305371|NCT00757601|738235|P2|STARTED|Period 1||2
305372|NCT00757601|738236|P1|STARTED|Period 1||2
305373|NCT00757588|738347|P2|NOT COMPLETED|Period 2: Long-term (52-week) Phase||9
305374|NCT00757588|738348|P1|NOT COMPLETED|Period 2: Long-term (52-week) Phase||22
305375|NCT00757588|738347|P2|COMPLETED|Period 2: Long-term (52-week) Phase||125
305376|NCT00757588|738348|P1|COMPLETED|Period 2: Long-term (52-week) Phase||246
305377|NCT00757588|738347|P2|STARTED|Period 2: Long-term (52-week) Phase||134
305378|NCT00757588|738348|P1|STARTED|Period 2: Long-term (52-week) Phase|270 participants completed short-term phase; 2 of these did not enter long-term phase.|268
305379|NCT00757588|738347|P2|NOT COMPLETED|Period 1: Short-term (24-week) Phase||17
305380|NCT00757588|738348|P1|NOT COMPLETED|Period 1: Short-term (24-week) Phase||36
305381|NCT00757588|738347|P2|COMPLETED|Period 1: Short-term (24-week) Phase||134
305382|NCT00757588|738348|P1|COMPLETED|Period 1: Short-term (24-week) Phase|Does not include 2 who completed Period 1 but were erroneously reported in the CSR as noncompleters.|268
305383|NCT00757588|738347|P2|STARTED|Period 1: Short-term (24-week) Phase||151
305384|NCT00757588|738348|P1|STARTED|Period 1: Short-term (24-week) Phase||304
305385|NCT00757484|738380|P1|NOT COMPLETED|Overall Study||0
305386|NCT00757484|738380|P1|COMPLETED|Overall Study||491
305387|NCT00757484|738380|P1|STARTED|Overall Study||491
305388|NCT00757237|738389|P2|NOT COMPLETED|Overall Study||25
305389|NCT00757237|738390|P1|NOT COMPLETED|Overall Study||13
305390|NCT00757237|738389|P2|COMPLETED|Overall Study||111
305391|NCT00757237|738390|P1|COMPLETED|Overall Study||124
305392|NCT00757237|738389|P2|Treated|Overall Study||132
305393|NCT00757237|738390|P1|Treated|Overall Study||136
305394|NCT00757237|738389|P2|STARTED|Overall Study||136
305395|NCT00757237|738390|P1|STARTED|Overall Study||137
305396|NCT00757172|738418|P1|NOT COMPLETED|Overall Study||11
305397|NCT00757172|738418|P1|COMPLETED|Overall Study|Participants underwent surgery.|54
305398|NCT00757172|738418|P1|STARTED|Overall Study||65
305399|NCT00757003|738426|P1|NOT COMPLETED|Overall Study||49
305400|NCT00757003|738426|P1|COMPLETED|Overall Study||51
305401|NCT00757003|738426|P1|STARTED|Overall Study||100
305402|NCT00756977|738434|P2|NOT COMPLETED|Overall Study||11
305403|NCT00756977|738435|P1|NOT COMPLETED|Overall Study||21
305404|NCT00756977|738434|P2|COMPLETED|Overall Study||187
305405|NCT00756977|738435|P1|COMPLETED|Overall Study||175
305406|NCT00756977|738434|P2|STARTED|Overall Study||198
305407|NCT00756977|738435|P1|STARTED|Overall Study||196
305408|NCT00756964|738463|P2|NOT COMPLETED|Overall Study||0
305409|NCT00756964|738464|P1|NOT COMPLETED|Overall Study||0
305410|NCT00756964|738463|P2|COMPLETED|Overall Study||13
305411|NCT00756964|738464|P1|COMPLETED|Overall Study||13
305412|NCT00756964|738463|P2|STARTED|Overall Study||13
305413|NCT00756964|738464|P1|STARTED|Overall Study||13
305414|NCT00756938|738473|P4|NOT COMPLETED|Optional Extension||37
305415|NCT00756938|738474|P3|NOT COMPLETED|Optional Extension||0
305416|NCT00756938|738475|P2|NOT COMPLETED|Optional Extension||0
305417|NCT00756938|738476|P1|NOT COMPLETED|Optional Extension||0
305418|NCT00756938|738473|P4|COMPLETED|Optional Extension||53
305419|NCT00756938|738474|P3|COMPLETED|Optional Extension||0
305420|NCT00756938|738475|P2|COMPLETED|Optional Extension||0
305421|NCT00756938|738476|P1|COMPLETED|Optional Extension||0
305422|NCT00756938|738473|P4|STARTED|Optional Extension|7 participants who completed base study opted not to enter extension|90
305423|NCT00756938|738474|P3|STARTED|Optional Extension||0
305424|NCT00756938|738475|P2|STARTED|Optional Extension||0
305425|NCT00756938|738476|P1|STARTED|Optional Extension||0
305426|NCT00756938|738473|P4|NOT COMPLETED|12-week Base Study||0
305427|NCT00756938|738474|P3|NOT COMPLETED|12-week Base Study||2
305428|NCT00756938|738475|P2|NOT COMPLETED|12-week Base Study||0
305429|NCT00756938|738476|P1|NOT COMPLETED|12-week Base Study||2
305430|NCT00756938|738473|P4|COMPLETED|12-week Base Study||0
305431|NCT00756938|738474|P3|COMPLETED|12-week Base Study||32
305432|NCT00756938|738475|P2|COMPLETED|12-week Base Study||34
305433|NCT00756938|738476|P1|COMPLETED|12-week Base Study||31
305434|NCT00756938|738473|P4|STARTED|12-week Base Study||0
305435|NCT00756938|738474|P3|STARTED|12-week Base Study||34
305436|NCT00756938|738475|P2|STARTED|12-week Base Study||34
305437|NCT00756938|738476|P1|STARTED|12-week Base Study||33
305438|NCT00756886|738504|P2|NOT COMPLETED|Overall Study||7
305439|NCT00756886|738505|P1|NOT COMPLETED|Overall Study||11
305440|NCT00756886|738504|P2|COMPLETED|Overall Study||25
305441|NCT00756886|738505|P1|COMPLETED|Overall Study||30
305442|NCT00756886|738504|P2|STARTED|Overall Study||32
305443|NCT00756886|738505|P1|STARTED|Overall Study||41
305444|NCT00756730|738513|P2|NOT COMPLETED|Overall Study||2
305445|NCT00756730|738514|P1|NOT COMPLETED|Overall Study||0
305446|NCT00756730|738513|P2|COMPLETED|Overall Study||22
305447|NCT00756730|738514|P1|COMPLETED|Overall Study||25
305448|NCT00756730|738513|P2|STARTED|Overall Study||24
305449|NCT00756730|738514|P1|STARTED|Overall Study||25
305450|NCT00756717|738534|P1|NOT COMPLETED|Overall Study||2
305451|NCT00756717|738534|P1|COMPLETED|Overall Study||20
305452|NCT00756717|738534|P1|STARTED|Overall Study||22
305453|NCT00756678|738538|P1|NOT COMPLETED|Overall Study||1
305454|NCT00756678|738538|P1|COMPLETED|Overall Study||50
305455|NCT00756678|738538|P1|STARTED|Overall Study||51
305456|NCT00756613|738551|P2|NOT COMPLETED|Overall Study||70
305457|NCT00756613|738552|P1|NOT COMPLETED|Overall Study||86
305458|NCT00756613|738551|P2|COMPLETED|Overall Study||462
305459|NCT00756613|738552|P1|COMPLETED|Overall Study||426
305460|NCT00756613|738551|P2|STARTED|Overall Study||532
305461|NCT00756613|738552|P1|STARTED|Overall Study||512
305462|NCT00756574|738567|P2|NOT COMPLETED|Overall Study||11
305463|NCT00756574|738568|P1|NOT COMPLETED|Overall Study||13
305464|NCT00756574|738567|P2|COMPLETED|Overall Study||210
305465|NCT00756574|738568|P1|COMPLETED|Overall Study||212
305466|NCT00756574|738567|P2|STARTED|Overall Study||221
305467|NCT00756574|738568|P1|STARTED|Overall Study||225
305468|NCT00756561|738578|P1|NOT COMPLETED|Overall Study||0
305469|NCT00756561|738578|P1|COMPLETED|Overall Study||10
305470|NCT00756561|738578|P1|STARTED|Overall Study||10
305471|NCT00756548|738585|P2|NOT COMPLETED|Overall Study||0
305472|NCT00756548|738586|P1|NOT COMPLETED|Overall Study||2
305473|NCT00756548|738585|P2|COMPLETED|Overall Study||185
305474|NCT00756548|738586|P1|COMPLETED|Overall Study||184
305475|NCT00756548|738585|P2|STARTED|Overall Study||185
305476|NCT00756548|738586|P1|STARTED|Overall Study||186
305477|NCT00756470|738612|P1|NOT COMPLETED|Overall Study||5
305478|NCT00756470|738612|P1|COMPLETED|Overall Study||10
305479|NCT00756470|738612|P1|STARTED|Overall Study||15
305480|NCT00756457|738619|P2|NOT COMPLETED|Overall Study||2
305481|NCT00756457|738620|P1|NOT COMPLETED|Overall Study||1
305482|NCT00756457|738619|P2|COMPLETED|Overall Study|One participant moved overseas; the other participant resumed cancer treatment|17
305483|NCT00756457|738620|P1|COMPLETED|Overall Study|One participant in the Active treatment group decided to have surgery after the 2 week follow-up.|19
305484|NCT00756457|738619|P2|STARTED|Overall Study||19
305485|NCT00756457|738620|P1|STARTED|Overall Study||20
305486|NCT00756444|738650|P2|NOT COMPLETED|Overall Study||21
305487|NCT00756444|738651|P1|NOT COMPLETED|Overall Study||15
305488|NCT00756444|738650|P2|COMPLETED|Overall Study||13
305489|NCT00756444|738651|P1|COMPLETED|Overall Study||18
305490|NCT00756444|738650|P2|STARTED|Overall Study||34
305491|NCT00756444|738651|P1|STARTED|Overall Study||33
305492|NCT00756314|738662|P2|NOT COMPLETED|Overall Study||59
305493|NCT00756314|738663|P1|NOT COMPLETED|Overall Study||2
305494|NCT00756314|738662|P2|COMPLETED|Overall Study|"4 participants did not do the follow up, 55 discontinued and were analyzed by intention to treat"|64
305495|NCT00756314|738663|P1|COMPLETED|Overall Study|"2 participants discontinued the intervention and were analyzed by intention to treat analysis."|121
305496|NCT00756314|738662|P2|STARTED|Overall Study||123
305497|NCT00756314|738663|P1|STARTED|Overall Study||123
305498|NCT00756275|738679|P2|NOT COMPLETED|Overall Study||28
305499|NCT00756275|738680|P1|NOT COMPLETED|Overall Study||29
305500|NCT00756275|738679|P2|COMPLETED|Overall Study||49
305501|NCT00756275|738680|P1|COMPLETED|Overall Study||31
305502|NCT00756275|738679|P2|STARTED|Overall Study||77
305503|NCT00756275|738680|P1|STARTED|Overall Study||60
305504|NCT00756236|738707|P3|NOT COMPLETED|Overall Study||0
305505|NCT00756236|738708|P2|NOT COMPLETED|Overall Study||0
305506|NCT00756236|738709|P1|NOT COMPLETED|Overall Study||0
305507|NCT00756236|738707|P3|COMPLETED|Overall Study||20
305508|NCT00756236|738708|P2|COMPLETED|Overall Study||20
305509|NCT00756236|738709|P1|COMPLETED|Overall Study||20
305510|NCT00756236|738707|P3|STARTED|Overall Study||20
305511|NCT00756236|738708|P2|STARTED|Overall Study||20
305512|NCT00756236|738709|P1|STARTED|Overall Study||20
305513|NCT00756093|738717|P4|NOT COMPLETED|Fourth Intervention||0
305514|NCT00756093|738718|P3|NOT COMPLETED|Fourth Intervention||0
305515|NCT00756093|738719|P2|NOT COMPLETED|Fourth Intervention||0
305516|NCT00756093|738720|P1|NOT COMPLETED|Fourth Intervention||0
305517|NCT00756093|738717|P4|COMPLETED|Fourth Intervention||5
305518|NCT00756093|738718|P3|COMPLETED|Fourth Intervention||5
305519|NCT00756093|738719|P2|COMPLETED|Fourth Intervention||5
305520|NCT00756093|738720|P1|COMPLETED|Fourth Intervention||5
305521|NCT00756093|738717|P4|STARTED|Fourth Intervention||5
305522|NCT00756093|738718|P3|STARTED|Fourth Intervention||5
305523|NCT00756093|738719|P2|STARTED|Fourth Intervention||5
305524|NCT00756093|738720|P1|STARTED|Fourth Intervention||5
305525|NCT00756093|738717|P4|NOT COMPLETED|Third Intervention||0
305526|NCT00756093|738718|P3|NOT COMPLETED|Third Intervention||0
305527|NCT00756093|738719|P2|NOT COMPLETED|Third Intervention||0
305528|NCT00756093|738720|P1|NOT COMPLETED|Third Intervention||0
305529|NCT00756093|738717|P4|COMPLETED|Third Intervention||5
305530|NCT00756093|738718|P3|COMPLETED|Third Intervention||5
305531|NCT00756093|738719|P2|COMPLETED|Third Intervention||5
305532|NCT00756093|738720|P1|COMPLETED|Third Intervention||5
305533|NCT00756093|738717|P4|STARTED|Third Intervention||5
305534|NCT00756093|738718|P3|STARTED|Third Intervention||5
305535|NCT00756093|738719|P2|STARTED|Third Intervention||5
305536|NCT00756093|738720|P1|STARTED|Third Intervention||5
305537|NCT00756093|738717|P4|NOT COMPLETED|Second Intervention||0
305538|NCT00756093|738718|P3|NOT COMPLETED|Second Intervention||0
305539|NCT00756093|738719|P2|NOT COMPLETED|Second Intervention||0
305540|NCT00756093|738720|P1|NOT COMPLETED|Second Intervention||0
305541|NCT00756093|738717|P4|COMPLETED|Second Intervention||5
305542|NCT00756093|738718|P3|COMPLETED|Second Intervention||5
305543|NCT00756093|738719|P2|COMPLETED|Second Intervention||5
305544|NCT00756093|738720|P1|COMPLETED|Second Intervention||5
305545|NCT00756093|738717|P4|STARTED|Second Intervention||5
305546|NCT00756093|738718|P3|STARTED|Second Intervention||5
305547|NCT00756093|738719|P2|STARTED|Second Intervention||5
305548|NCT00756093|738720|P1|STARTED|Second Intervention||5
305549|NCT00756093|738717|P4|NOT COMPLETED|First Intervention||0
305550|NCT00756093|738718|P3|NOT COMPLETED|First Intervention||0
305551|NCT00756093|738719|P2|NOT COMPLETED|First Intervention||0
305552|NCT00756093|738720|P1|NOT COMPLETED|First Intervention||0
305553|NCT00756093|738717|P4|COMPLETED|First Intervention||5
305554|NCT00756093|738718|P3|COMPLETED|First Intervention||5
305555|NCT00756093|738719|P2|COMPLETED|First Intervention||5
305556|NCT00756093|738720|P1|COMPLETED|First Intervention||5
305557|NCT00756093|738717|P4|STARTED|First Intervention||5
305558|NCT00756093|738718|P3|STARTED|First Intervention||5
305559|NCT00756093|738719|P2|STARTED|First Intervention||5
305560|NCT00756093|738720|P1|STARTED|First Intervention||5
305561|NCT00756002|738732|P2|NOT COMPLETED|Placebo Run-out||0
305562|NCT00756002|738733|P1|NOT COMPLETED|Placebo Run-out||0
305563|NCT00756002|738732|P2|COMPLETED|Placebo Run-out||0
305564|NCT00756002|738733|P1|COMPLETED|Placebo Run-out||114
305565|NCT00756002|738732|P2|STARTED|Placebo Run-out||0
305566|NCT00756002|738733|P1|STARTED|Placebo Run-out||114
305567|NCT00756002|738732|P2|NOT COMPLETED|Double-Blind Treatment Period||15
305568|NCT00756002|738733|P1|NOT COMPLETED|Double-Blind Treatment Period||15
305569|NCT00756002|738732|P2|COMPLETED|Double-Blind Treatment Period||115
305570|NCT00756002|738733|P1|COMPLETED|Double-Blind Treatment Period||114
305571|NCT00756002|738732|P2|STARTED|Double-Blind Treatment Period||130
305572|NCT00756002|738733|P1|STARTED|Double-Blind Treatment Period||129
305573|NCT00756002|738732|P2|NOT COMPLETED|Placebo Run-in||0
305574|NCT00756002|738733|P1|NOT COMPLETED|Placebo Run-in||229
305575|NCT00756002|738732|P2|COMPLETED|Placebo Run-in||0
305576|NCT00756002|738733|P1|COMPLETED|Placebo Run-in||259
305577|NCT00756002|738732|P2|STARTED|Placebo Run-in||0
305578|NCT00756002|738733|P1|STARTED|Placebo Run-in||488
305579|NCT00755937|738827|P1|NOT COMPLETED|Observational Follow-up||148
305580|NCT00755937|738827|P1|COMPLETED|Observational Follow-up|Subjects followed until end of study/subjects for whom end of participation data were collected|244
305581|NCT00755937|738827|P1|STARTED|Observational Follow-up||392
305582|NCT00755937|738827|P1|NOT COMPLETED|Recruitment||164
305583|NCT00755937|738827|P1|COMPLETED|Recruitment|Subjects who had a baseline visit and at least 1 additional follow-up visit (analyzed population)|392
305584|NCT00755937|738827|P1|STARTED|Recruitment|Subjects registered in the program|556
305585|NCT00755911|738839|P2|NOT COMPLETED|Overall Study||0
305586|NCT00755911|738840|P1|NOT COMPLETED|Overall Study||0
305587|NCT00755911|738839|P2|COMPLETED|Overall Study||12
305588|NCT00755911|738840|P1|COMPLETED|Overall Study||12
305589|NCT00755911|738839|P2|STARTED|Overall Study||12
305590|NCT00755911|738840|P1|STARTED|Overall Study||12
305591|NCT00755846|738854|P6|NOT COMPLETED|Overall Study||14
305592|NCT00755846|738855|P5|NOT COMPLETED|Overall Study||17
305593|NCT00755846|738856|P4|NOT COMPLETED|Overall Study||13
305594|NCT00755846|738857|P3|NOT COMPLETED|Overall Study||12
305595|NCT00755846|738858|P2|NOT COMPLETED|Overall Study||17
305596|NCT00755846|738859|P1|NOT COMPLETED|Overall Study||25
305597|NCT00755846|738854|P6|COMPLETED|Overall Study||31
305598|NCT00755846|738855|P5|COMPLETED|Overall Study||27
305599|NCT00755846|738856|P4|COMPLETED|Overall Study||32
305600|NCT00755846|738857|P3|COMPLETED|Overall Study||32
305601|NCT00755846|738858|P2|COMPLETED|Overall Study||27
305602|NCT00755846|738859|P1|COMPLETED|Overall Study||18
305603|NCT00755846|738854|P6|STARTED|Overall Study||45
305604|NCT00755846|738855|P5|STARTED|Overall Study||44
305605|NCT00755846|738856|P4|STARTED|Overall Study||45
305606|NCT00755846|738857|P3|STARTED|Overall Study||44
305607|NCT00755846|738858|P2|STARTED|Overall Study||44
305608|NCT00755846|738859|P1|STARTED|Overall Study||43
305609|NCT00755807|738959|P2|NOT COMPLETED|Open-label Extension Phase||16
305610|NCT00755807|738960|P1|NOT COMPLETED|Open-label Extension Phase||18
305611|NCT00755807|738959|P2|COMPLETED|Open-label Extension Phase||93
305612|NCT00755807|738960|P1|COMPLETED|Open-label Extension Phase||82
305613|NCT00755807|738959|P2|STARTED|Open-label Extension Phase||109
305614|NCT00755807|738960|P1|STARTED|Open-label Extension Phase||100
305615|NCT00755807|738959|P2|NOT COMPLETED|Acute Phase||12
305616|NCT00755807|738960|P1|NOT COMPLETED|Acute Phase||18
305617|NCT00755807|738959|P2|COMPLETED|Acute Phase||109
305618|NCT00755807|738960|P1|COMPLETED|Acute Phase||100
305619|NCT00755807|738959|P2|STARTED|Acute Phase||121
305620|NCT00755807|738960|P1|STARTED|Acute Phase||118
305621|NCT00755755|739024|P3|NOT COMPLETED|Overall Study||3
305622|NCT00755755|739025|P2|NOT COMPLETED|Overall Study||8
305623|NCT00755755|739026|P1|NOT COMPLETED|Overall Study||6
305624|NCT00755755|739024|P3|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|45
305625|NCT00755755|739025|P2|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|90
305626|NCT00755755|739026|P1|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|89
305627|NCT00755755|739024|P3|STARTED|Overall Study|Safety population|48
305628|NCT00755755|739025|P2|STARTED|Overall Study|Safety population|98
305629|NCT00755755|739026|P1|STARTED|Overall Study|Safety population|95
305630|NCT00755716|739040|P3|NOT COMPLETED|Overall Study||3
305631|NCT00755716|739041|P2|NOT COMPLETED|Overall Study||8
305632|NCT00755716|739042|P1|NOT COMPLETED|Overall Study||8
305633|NCT00755716|739040|P3|COMPLETED|Overall Study||16
305634|NCT00755716|739041|P2|COMPLETED|Overall Study||11
305635|NCT00755716|739042|P1|COMPLETED|Overall Study||11
305636|NCT00755716|739040|P3|STARTED|Overall Study||19
305637|NCT00755716|739041|P2|STARTED|Overall Study||19
305638|NCT00755716|739042|P1|STARTED|Overall Study||19
305639|NCT00755417|739056|P3|NOT COMPLETED|Overall Study||42
305640|NCT00755417|739057|P2|NOT COMPLETED|Overall Study||55
305641|NCT00755417|739058|P1|NOT COMPLETED|Overall Study||62
305642|NCT00755417|739056|P3|COMPLETED|Overall Study||135
305643|NCT00755417|739057|P2|COMPLETED|Overall Study||126
305644|NCT00755417|739058|P1|COMPLETED|Overall Study||112
305645|NCT00755417|739056|P3|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|177
305646|NCT00755417|739057|P2|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|181
305647|NCT00755417|739058|P1|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|174
305648|NCT00755274|739077|P2|NOT COMPLETED|Overall Study||0
305649|NCT00755274|739078|P1|NOT COMPLETED|Overall Study||0
305650|NCT00755274|739077|P2|COMPLETED|Overall Study||8
305651|NCT00755274|739078|P1|COMPLETED|Overall Study||24
305652|NCT00755274|739077|P2|STARTED|Overall Study||8
305653|NCT00755274|739078|P1|STARTED|Overall Study||24
305654|NCT00755261|739098|P1|NOT COMPLETED|Overall Study||2
305655|NCT00755261|739098|P1|COMPLETED|Overall Study||4
305656|NCT00755261|739098|P1|STARTED|Overall Study||6
305657|NCT00755235|739104|P2|NOT COMPLETED|Overall Study||9
305658|NCT00755235|739105|P1|NOT COMPLETED|Overall Study||2
305659|NCT00755235|739104|P2|COMPLETED|Overall Study||93
305660|NCT00755235|739105|P1|COMPLETED|Overall Study||104
305661|NCT00755235|739104|P2|STARTED|Overall Study||102
305662|NCT00755235|739105|P1|STARTED|Overall Study||106
305663|NCT00755222|739115|P2|NOT COMPLETED|Overall Study||2
305664|NCT00755222|739116|P1|NOT COMPLETED|Overall Study||8
305665|NCT00755222|739115|P2|COMPLETED|Overall Study||34
305666|NCT00755222|739116|P1|COMPLETED|Overall Study||103
305667|NCT00755222|739115|P2|STARTED|Overall Study||36
305668|NCT00755222|739116|P1|STARTED|Overall Study||111
305669|NCT00755196|739130|P1|NOT COMPLETED|Overall Study||2
305670|NCT00755196|739130|P1|COMPLETED|Overall Study||28
305671|NCT00755196|739130|P1|STARTED|Overall Study||30
305672|NCT00755131|739137|P2|NOT COMPLETED|Overall Study||0
305673|NCT00755131|739138|P1|NOT COMPLETED|Overall Study||0
305674|NCT00755131|739137|P2|COMPLETED|Overall Study||38
305675|NCT00755131|739138|P1|COMPLETED|Overall Study||37
305676|NCT00755131|739137|P2|STARTED|Overall Study||38
305677|NCT00755131|739138|P1|STARTED|Overall Study||37
305678|NCT00755105|739151|P3|NOT COMPLETED|Overall Study||4
305679|NCT00755105|739152|P2|NOT COMPLETED|Overall Study||11
305680|NCT00755105|739153|P1|NOT COMPLETED|Overall Study||9
305681|NCT00755105|739151|P3|COMPLETED|Overall Study||5
305682|NCT00755105|739152|P2|COMPLETED|Overall Study||19
305683|NCT00755105|739153|P1|COMPLETED|Overall Study||29
305684|NCT00755105|739151|P3|STARTED|Overall Study||9
305685|NCT00755105|739152|P2|STARTED|Overall Study||30
305686|NCT00755105|739153|P1|STARTED|Overall Study||38
305687|NCT00755079|739163|P2|NOT COMPLETED|Overall Study||6
305688|NCT00755079|739164|P1|NOT COMPLETED|Overall Study||1
305689|NCT00755079|739163|P2|COMPLETED|Overall Study||16
305690|NCT00755079|739164|P1|COMPLETED|Overall Study||17
305691|NCT00755079|739163|P2|STARTED|Overall Study||22
305692|NCT00755079|739164|P1|STARTED|Overall Study||18
305693|NCT00755040|739174|P2|NOT COMPLETED|Overall Study||34
305694|NCT00755040|739175|P1|NOT COMPLETED|Overall Study||43
305695|NCT00755040|739174|P2|COMPLETED|Overall Study||47
305696|NCT00755040|739175|P1|COMPLETED|Overall Study||40
305697|NCT00755040|739174|P2|STARTED|Overall Study||81
305698|NCT00755040|739175|P1|STARTED|Overall Study||83
305699|NCT00754936|739183|P1|NOT COMPLETED|Overall Study||12
305700|NCT00754936|739183|P1|COMPLETED|Overall Study||59
305701|NCT00754936|739183|P1|STARTED|Overall Study||71
305702|NCT00754923|739188|P1|NOT COMPLETED|Overall Study||0
305703|NCT00754923|739188|P1|COMPLETED|Overall Study||11
305704|NCT00754923|739188|P1|STARTED|Overall Study||11
305705|NCT00754845|739197|P2|NOT COMPLETED|Overall Study||0
305706|NCT00754845|739198|P1|NOT COMPLETED|Overall Study||0
305707|NCT00754845|739197|P2|COMPLETED|Overall Study||959
305708|NCT00754845|739198|P1|COMPLETED|Overall Study||959
305709|NCT00754845|739197|P2|STARTED|Overall Study||959
305710|NCT00754845|739198|P1|STARTED|Overall Study||959
305711|NCT00754832|739210|P2|NOT COMPLETED|Second 6 Weeks Intervention||2
305712|NCT00754832|739211|P1|NOT COMPLETED|Second 6 Weeks Intervention||0
305713|NCT00754832|739210|P2|COMPLETED|Second 6 Weeks Intervention||24
305714|NCT00754832|739211|P1|COMPLETED|Second 6 Weeks Intervention||17
305715|NCT00754832|739210|P2|STARTED|Second 6 Weeks Intervention||26
305716|NCT00754832|739211|P1|STARTED|Second 6 Weeks Intervention||17
305717|NCT00754832|739210|P2|NOT COMPLETED|2 Weeks Washout||2
305718|NCT00754832|739211|P1|NOT COMPLETED|2 Weeks Washout||1
305719|NCT00754832|739210|P2|COMPLETED|2 Weeks Washout||26
305720|NCT00754832|739211|P1|COMPLETED|2 Weeks Washout||17
305721|NCT00754832|739210|P2|STARTED|2 Weeks Washout||28
305722|NCT00754832|739211|P1|STARTED|2 Weeks Washout||18
305723|NCT00754832|739210|P2|NOT COMPLETED|First 6 Weeks Intervention||2
305724|NCT00754832|739211|P1|NOT COMPLETED|First 6 Weeks Intervention||8
305725|NCT00754832|739210|P2|COMPLETED|First 6 Weeks Intervention||28
305726|NCT00754832|739211|P1|COMPLETED|First 6 Weeks Intervention||18
305727|NCT00754832|739210|P2|STARTED|First 6 Weeks Intervention||30
305728|NCT00754832|739211|P1|STARTED|First 6 Weeks Intervention||26
305729|NCT00754793|739223|P2|NOT COMPLETED|Overall Study||1
305730|NCT00754793|739224|P1|NOT COMPLETED|Overall Study||0
305731|NCT00754793|739223|P2|COMPLETED|Overall Study||1
305732|NCT00754793|739224|P1|COMPLETED|Overall Study||1
305733|NCT00754793|739223|P2|STARTED|Overall Study||2
305734|NCT00754793|739224|P1|STARTED|Overall Study||1
305735|NCT00754767|739232|P2|NOT COMPLETED|Overall Study||0
305736|NCT00754767|739233|P1|NOT COMPLETED|Overall Study||0
305737|NCT00754767|739232|P2|COMPLETED|Overall Study||0
305738|NCT00754767|739233|P1|COMPLETED|Overall Study||2
305739|NCT00754767|739232|P2|STARTED|Overall Study||0
305740|NCT00754767|739233|P1|STARTED|Overall Study||2
305741|NCT00754741|739242|P3|NOT COMPLETED|Overall Study||54
305742|NCT00754741|739243|P2|NOT COMPLETED|Overall Study||69
305743|NCT00754741|739244|P1|NOT COMPLETED|Overall Study||57
305744|NCT00754741|739242|P3|COMPLETED|Overall Study||502
305745|NCT00754741|739243|P2|COMPLETED|Overall Study||500
305746|NCT00754741|739244|P1|COMPLETED|Overall Study||510
305747|NCT00754741|739242|P3|STARTED|Overall Study||556
305748|NCT00754741|739243|P2|STARTED|Overall Study||569
305749|NCT00754741|739244|P1|STARTED|Overall Study||567
305750|NCT00754650|739291|P1|NOT COMPLETED|Overall Study||2
305751|NCT00754650|739291|P1|COMPLETED|Overall Study||0
305752|NCT00754650|739291|P1|STARTED|Overall Study||2
305753|NCT00754624|739296|P1|NOT COMPLETED|Overall Study||69
305754|NCT00754624|739296|P1|COMPLETED|Overall Study||160
305755|NCT00754624|739296|P1|STARTED|Overall Study||229
305756|NCT00754572|739306|P1|NOT COMPLETED|Overall Study||71
305757|NCT00754572|739306|P1|COMPLETED|Overall Study||347
305758|NCT00754572|739306|P1|STARTED|Overall Study||418
305759|NCT00754559|739333|P1|NOT COMPLETED|Overall Study||47
305760|NCT00754559|739333|P1|COMPLETED|Overall Study||239
305761|NCT00754559|739333|P1|STARTED|Overall Study||286
305762|NCT00754546|739357|P1|NOT COMPLETED|Overall Study||0
305763|NCT00754546|739357|P1|COMPLETED|Overall Study||20
305764|NCT00754546|739357|P1|STARTED|Overall Study||20
305765|NCT00754494|739374|P3|NOT COMPLETED|Overall Study||1
305766|NCT00754494|739375|P2|NOT COMPLETED|Overall Study||0
305767|NCT00754494|739376|P1|NOT COMPLETED|Overall Study||2
305768|NCT00754494|739374|P3|COMPLETED|Overall Study||14
305769|NCT00754494|739375|P2|COMPLETED|Overall Study||15
305770|NCT00754494|739376|P1|COMPLETED|Overall Study||13
305771|NCT00754494|739374|P3|STARTED|Overall Study||15
305772|NCT00754494|739375|P2|STARTED|Overall Study||15
305773|NCT00754494|739376|P1|STARTED|Overall Study||15
305774|NCT00754468|739422|P2|NOT COMPLETED|Overall Study||0
305775|NCT00754468|739423|P1|NOT COMPLETED|Overall Study||0
305776|NCT00754468|739422|P2|COMPLETED|Overall Study||3
305777|NCT00754468|739423|P1|COMPLETED|Overall Study||4
305778|NCT00754468|739422|P2|STARTED|Overall Study||3
305779|NCT00754468|739423|P1|STARTED|Overall Study||4
305780|NCT00754442|739433|P2|NOT COMPLETED|Overall Study||3
305781|NCT00754442|739434|P1|NOT COMPLETED|Overall Study||5
305782|NCT00754442|739433|P2|COMPLETED|Overall Study||6
305783|NCT00754442|739434|P1|COMPLETED|Overall Study||6
305784|NCT00754442|739433|P2|STARTED|Overall Study|patients 9|9
305785|NCT00754442|739434|P1|STARTED|Overall Study|controls 11|11
305786|NCT00754390|739441|P1|NOT COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||1
305787|NCT00754390|739441|P1|COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||10
305788|NCT00754390|739441|P1|STARTED|Ca/Phytate Test Meal 4 (Randomized)||11
305789|NCT00754390|739441|P1|NOT COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||1
305790|NCT00754390|739441|P1|COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||11
305791|NCT00754390|739441|P1|STARTED|Ca/Phytate Test Meal 3 (Randomized)||12
305792|NCT00754390|739441|P1|NOT COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||0
305793|NCT00754390|739441|P1|COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||12
305794|NCT00754390|739441|P1|STARTED|Ca/Phytate Test Meal 2 (Randomized)||12
305795|NCT00754390|739441|P1|NOT COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||5
305796|NCT00754390|739441|P1|COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||12
305797|NCT00754390|739441|P1|STARTED|Ca/Phytate Test Meal 1 (Randomized)||17
305798|NCT00754377|739450|P2|NOT COMPLETED|Overall Study||0
305799|NCT00754377|739451|P1|NOT COMPLETED|Overall Study||0
305800|NCT00754377|739450|P2|COMPLETED|Overall Study||42
305801|NCT00754377|739451|P1|COMPLETED|Overall Study||50
305802|NCT00754377|739450|P2|STARTED|Overall Study||42
305803|NCT00754377|739451|P1|STARTED|Overall Study||50
305804|NCT00754338|739463|P4|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
305805|NCT00754338|739464|P3|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
305806|NCT00754338|739465|P2|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
305807|NCT00754338|739466|P1|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
305808|NCT00754338|739463|P4|COMPLETED|Second Intervention for Phase1&Phase2||18
305809|NCT00754338|739464|P3|COMPLETED|Second Intervention for Phase1&Phase2||16
305810|NCT00754338|739465|P2|COMPLETED|Second Intervention for Phase1&Phase2||17
305811|NCT00754338|739466|P1|COMPLETED|Second Intervention for Phase1&Phase2||17
305812|NCT00754338|739463|P4|STARTED|Second Intervention for Phase1&Phase2||19
305813|NCT00754338|739464|P3|STARTED|Second Intervention for Phase1&Phase2||16
305814|NCT00754338|739465|P2|STARTED|Second Intervention for Phase1&Phase2||18
305815|NCT00754338|739466|P1|STARTED|Second Intervention for Phase1&Phase2||17
305816|NCT00754338|739463|P4|NOT COMPLETED|First Intervention for Phase1&Phase2||0
305817|NCT00754338|739464|P3|NOT COMPLETED|First Intervention for Phase1&Phase2||3
305818|NCT00754338|739465|P2|NOT COMPLETED|First Intervention for Phase1&Phase2||3
305819|NCT00754338|739466|P1|NOT COMPLETED|First Intervention for Phase1&Phase2||0
305820|NCT00754338|739463|P4|COMPLETED|First Intervention for Phase1&Phase2||19
305821|NCT00754338|739464|P3|COMPLETED|First Intervention for Phase1&Phase2||16
305822|NCT00754338|739465|P2|COMPLETED|First Intervention for Phase1&Phase2||18
305823|NCT00754338|739466|P1|COMPLETED|First Intervention for Phase1&Phase2||17
305824|NCT00754338|739463|P4|STARTED|First Intervention for Phase1&Phase2||19
305825|NCT00754338|739464|P3|STARTED|First Intervention for Phase1&Phase2||19
305826|NCT00754338|739465|P2|STARTED|First Intervention for Phase1&Phase2||21
305827|NCT00754338|739466|P1|STARTED|First Intervention for Phase1&Phase2||17
305828|NCT00754325|739498|P2|NOT COMPLETED|Progression and Cross-over||21
305829|NCT00754325|739499|P1|NOT COMPLETED|Progression and Cross-over||0
305830|NCT00754325|739498|P2|COMPLETED|Progression and Cross-over||0
305831|NCT00754325|739499|P1|COMPLETED|Progression and Cross-over||0
305832|NCT00754325|739498|P2|STARTED|Progression and Cross-over|Progressive disease participants in Arm 2 could add dasatinib (Arm 2b) at investigator discretion.|21
305833|NCT00754325|739499|P1|STARTED|Progression and Cross-over|Arm 1 participants with dasatinib-related toxicity stop dasatinib, continue fulvestrant (Arm 1b).|0
305834|NCT00754325|739498|P2|NOT COMPLETED|Initial Treatment||49
305835|NCT00754325|739499|P1|NOT COMPLETED|Initial Treatment||50
305836|NCT00754325|739498|P2|COMPLETED|Initial Treatment||0
305837|NCT00754325|739499|P1|COMPLETED|Initial Treatment||0
305838|NCT00754325|739498|P2|STARTED|Initial Treatment||49
305839|NCT00754325|739499|P1|STARTED|Initial Treatment||50
305840|NCT00754247|739521|P3|NOT COMPLETED|Overall Study||5
305841|NCT00754247|739522|P2|NOT COMPLETED|Overall Study||5
305842|NCT00754247|739523|P1|NOT COMPLETED|Overall Study||5
305843|NCT00754247|739521|P3|COMPLETED|Overall Study||5
305844|NCT00754247|739522|P2|COMPLETED|Overall Study||5
305845|NCT00754247|739523|P1|COMPLETED|Overall Study||5
305846|NCT00754247|739521|P3|STARTED|Overall Study||10
305847|NCT00754247|739522|P2|STARTED|Overall Study||10
305848|NCT00754247|739523|P1|STARTED|Overall Study||10
305849|NCT00754234|739552|P1|NOT COMPLETED|Overall Study||3
305850|NCT00754234|739552|P1|COMPLETED|Overall Study|2 participants did not receive the Day 1,4,5,6 menu and 1 did not receive the Day 2 menu|13
305851|NCT00754234|739552|P1|STARTED|Overall Study|7 Menus were consumed in randomized order|16
305852|NCT00754208|739556|P1|NOT COMPLETED|Overall Study||0
305853|NCT00754208|739556|P1|COMPLETED|Overall Study||7
305854|NCT00754208|739556|P1|STARTED|Overall Study||7
305855|NCT00754156|739565|P2|NOT COMPLETED|Overall Study||0
305856|NCT00754156|739566|P1|NOT COMPLETED|Overall Study||0
305857|NCT00754156|739565|P2|COMPLETED|Overall Study||6
305858|NCT00754156|739566|P1|COMPLETED|Overall Study||8
305859|NCT00754156|739565|P2|STARTED|Overall Study||6
305860|NCT00754156|739566|P1|STARTED|Overall Study||8
305861|NCT00754130|739590|P6|NOT COMPLETED|Period 2 (5 Days)||0
305862|NCT00754130|739591|P5|NOT COMPLETED|Period 2 (5 Days)||0
305863|NCT00754130|739592|P4|NOT COMPLETED|Period 2 (5 Days)||0
305864|NCT00754130|739593|P3|NOT COMPLETED|Period 2 (5 Days)||0
305865|NCT00754130|739594|P2|NOT COMPLETED|Period 2 (5 Days)||0
305866|NCT00754130|739595|P1|NOT COMPLETED|Period 2 (5 Days)||0
305867|NCT00754130|739590|P6|COMPLETED|Period 2 (5 Days)||4
305868|NCT00754130|739591|P5|COMPLETED|Period 2 (5 Days)||2
305869|NCT00754130|739592|P4|COMPLETED|Period 2 (5 Days)||2
305870|NCT00754130|739593|P3|COMPLETED|Period 2 (5 Days)||4
305871|NCT00754130|739594|P2|COMPLETED|Period 2 (5 Days)||2
305872|NCT00754130|739595|P1|COMPLETED|Period 2 (5 Days)||2
305873|NCT00754130|739590|P6|STARTED|Period 2 (5 Days)|One participant received MK-0941 35 mg starting with Dose 3 on Day 3.|4
305874|NCT00754130|739591|P5|STARTED|Period 2 (5 Days)||2
305875|NCT00754130|739592|P4|STARTED|Period 2 (5 Days)||2
305876|NCT00754130|739593|P3|STARTED|Period 2 (5 Days)||4
305877|NCT00754130|739594|P2|STARTED|Period 2 (5 Days)||2
305878|NCT00754130|739595|P1|STARTED|Period 2 (5 Days)|One participant received MK-0941 15 mg starting with Dose 2 on Day 2.|2
305879|NCT00754130|739590|P6|NOT COMPLETED|Washout Period (>=8 Days)||0
305880|NCT00754130|739591|P5|NOT COMPLETED|Washout Period (>=8 Days)||0
305881|NCT00754130|739592|P4|NOT COMPLETED|Washout Period (>=8 Days)||0
305882|NCT00754130|739593|P3|NOT COMPLETED|Washout Period (>=8 Days)||0
305883|NCT00754130|739594|P2|NOT COMPLETED|Washout Period (>=8 Days)||0
305884|NCT00754130|739595|P1|NOT COMPLETED|Washout Period (>=8 Days)||0
305885|NCT00754130|739590|P6|COMPLETED|Washout Period (>=8 Days)||4
305886|NCT00754130|739591|P5|COMPLETED|Washout Period (>=8 Days)||2
305887|NCT00754130|739592|P4|COMPLETED|Washout Period (>=8 Days)||2
305888|NCT00754130|739593|P3|COMPLETED|Washout Period (>=8 Days)||4
305889|NCT00754130|739594|P2|COMPLETED|Washout Period (>=8 Days)||2
305890|NCT00754130|739595|P1|COMPLETED|Washout Period (>=8 Days)||2
305891|NCT00754130|739590|P6|STARTED|Washout Period (>=8 Days)||4
305892|NCT00754130|739591|P5|STARTED|Washout Period (>=8 Days)||2
305893|NCT00754130|739592|P4|STARTED|Washout Period (>=8 Days)||2
305894|NCT00754130|739593|P3|STARTED|Washout Period (>=8 Days)||4
305895|NCT00754130|739594|P2|STARTED|Washout Period (>=8 Days)||2
305896|NCT00754130|739595|P1|STARTED|Washout Period (>=8 Days)||2
305897|NCT00754130|739590|P6|NOT COMPLETED|Period 1 (5 Days)||0
305898|NCT00754130|739591|P5|NOT COMPLETED|Period 1 (5 Days)||0
305899|NCT00754130|739592|P4|NOT COMPLETED|Period 1 (5 Days)||0
305900|NCT00754130|739593|P3|NOT COMPLETED|Period 1 (5 Days)||0
305901|NCT00754130|739594|P2|NOT COMPLETED|Period 1 (5 Days)||0
305902|NCT00754130|739595|P1|NOT COMPLETED|Period 1 (5 Days)||0
305903|NCT00754130|739590|P6|COMPLETED|Period 1 (5 Days)||4
305904|NCT00754130|739591|P5|COMPLETED|Period 1 (5 Days)||2
305905|NCT00754130|739592|P4|COMPLETED|Period 1 (5 Days)||2
305906|NCT00754130|739593|P3|COMPLETED|Period 1 (5 Days)||4
305907|NCT00754130|739594|P2|COMPLETED|Period 1 (5 Days)||2
305908|NCT00754130|739595|P1|COMPLETED|Period 1 (5 Days)||2
305909|NCT00754130|739590|P6|STARTED|Period 1 (5 Days)|One participant received MK-0941 10 mg in both Periods 1 and 2.|4
305910|NCT00754130|739591|P5|STARTED|Period 1 (5 Days)||2
305911|NCT00754130|739592|P4|STARTED|Period 1 (5 Days)||2
305912|NCT00754130|739593|P3|STARTED|Period 1 (5 Days)||4
305913|NCT00754130|739594|P2|STARTED|Period 1 (5 Days)||2
305914|NCT00754130|739595|P1|STARTED|Period 1 (5 Days)||2
305915|NCT00754065|739638|P2|NOT COMPLETED|Overall Study||80
305916|NCT00754065|739639|P1|NOT COMPLETED|Overall Study||81
305917|NCT00754065|739638|P2|COMPLETED|Overall Study||126
305918|NCT00754065|739639|P1|COMPLETED|Overall Study||122
305919|NCT00754065|739638|P2|Cycle 6|Overall Study||153
305920|NCT00754065|739639|P1|Cycle 6|Overall Study||141
305921|NCT00754065|739638|P2|Participants Received Treatment|Overall Study||204
305922|NCT00754065|739639|P1|Participants Received Treatment|Overall Study||191
305923|NCT00754065|739638|P2|STARTED|Overall Study||206
305924|NCT00754065|739639|P1|STARTED|Overall Study||203
305925|NCT00754052|739879|P2|NOT COMPLETED|Overall Study||3
305926|NCT00754052|739880|P1|NOT COMPLETED|Overall Study||5
305927|NCT00754052|739879|P2|COMPLETED|Overall Study||0
305928|NCT00754052|739880|P1|COMPLETED|Overall Study||0
305929|NCT00754052|739879|P2|STARTED|Overall Study||3
305930|NCT00754052|739880|P1|STARTED|Overall Study||5
305931|NCT00754013|739894|P2|NOT COMPLETED|Overall Study||5
305932|NCT00754013|739895|P1|NOT COMPLETED|Overall Study||4
305933|NCT00754013|739894|P2|COMPLETED|Overall Study||0
305934|NCT00754013|739895|P1|COMPLETED|Overall Study||0
305935|NCT00754013|739894|P2|STARTED|Overall Study||5
305936|NCT00754013|739895|P1|STARTED|Overall Study||4
305937|NCT00753948|739906|P3|NOT COMPLETED|Overall Study||0
305938|NCT00753948|739907|P2|NOT COMPLETED|Overall Study||0
305939|NCT00753948|739908|P1|NOT COMPLETED|Overall Study||0
305940|NCT00753948|739906|P3|COMPLETED|Overall Study||7
305941|NCT00753948|739907|P2|COMPLETED|Overall Study||7
305942|NCT00753948|739908|P1|COMPLETED|Overall Study||9
305943|NCT00753948|739906|P3|STARTED|Overall Study||7
305944|NCT00753948|739907|P2|STARTED|Overall Study||7
305945|NCT00753948|739908|P1|STARTED|Overall Study||9
305946|NCT00753935|739918|P2|NOT COMPLETED|Overall Study||0
305947|NCT00753935|739919|P1|NOT COMPLETED|Overall Study||0
305948|NCT00753935|739918|P2|COMPLETED|Overall Study||47
305949|NCT00753935|739919|P1|COMPLETED|Overall Study||45
305950|NCT00753935|739918|P2|STARTED|Overall Study||47
305951|NCT00753935|739919|P1|STARTED|Overall Study||45
305952|NCT00753922|739929|P4|NOT COMPLETED|Overall Study||23
305953|NCT00753922|739930|P3|NOT COMPLETED|Overall Study||63
305954|NCT00753922|739931|P2|NOT COMPLETED|Overall Study||94
305955|NCT00753922|739932|P1|NOT COMPLETED|Overall Study||246
305956|NCT00753922|739929|P4|COMPLETED|Overall Study||37
305957|NCT00753922|739930|P3|COMPLETED|Overall Study||82
305958|NCT00753922|739931|P2|COMPLETED|Overall Study||157
305959|NCT00753922|739932|P1|COMPLETED|Overall Study||306
305960|NCT00753922|739929|P4|STARTED|Overall Study||60
305961|NCT00753922|739930|P3|STARTED|Overall Study||145
305962|NCT00753922|739931|P2|STARTED|Overall Study||251
305963|NCT00753922|739932|P1|STARTED|Overall Study||552
305964|NCT00753896|739962|P1|NOT COMPLETED|Overall Study||16
305965|NCT00753896|739962|P1|COMPLETED|Overall Study||118
305966|NCT00753896|739962|P1|STARTED|Overall Study||134
305967|NCT00753766|739978|P2|NOT COMPLETED|Overall Study||0
305968|NCT00753766|739979|P1|NOT COMPLETED|Overall Study||1
305969|NCT00753766|739978|P2|COMPLETED|Overall Study||0
305970|NCT00753766|739979|P1|COMPLETED|Overall Study||0
305971|NCT00753766|739978|P2|STARTED|Overall Study||0
305972|NCT00753766|739979|P1|STARTED|Overall Study||1
305973|NCT00753714|740001|P2|NOT COMPLETED|Overall Study||62
305974|NCT00753714|740002|P1|NOT COMPLETED|Overall Study||60
305975|NCT00753714|740001|P2|COMPLETED|Overall Study||1
305976|NCT00753714|740002|P1|COMPLETED|Overall Study||1
305977|NCT00753714|740001|P2|STARTED|Overall Study||63
305978|NCT00753714|740002|P1|STARTED|Overall Study||61
305979|NCT00753688|740018|P2|NOT COMPLETED|Overall Study||246
305980|NCT00753688|740019|P1|NOT COMPLETED|Overall Study||123
305981|NCT00753688|740018|P2|COMPLETED|Overall Study||0
305982|NCT00753688|740019|P1|COMPLETED|Overall Study||0
305983|NCT00753688|740018|P2|Ongoing - in Follow-up|Overall Study||31
305984|NCT00753688|740019|P1|Ongoing - in Follow-up|Overall Study||15
305985|NCT00753688|740018|P2|STARTED|Overall Study||246
305986|NCT00753688|740019|P1|STARTED|Overall Study||123
305987|NCT00753675|740048|P3|NOT COMPLETED|Overall Study||56
305988|NCT00753675|740049|P2|NOT COMPLETED|Overall Study||59
305989|NCT00753675|740050|P1|NOT COMPLETED|Overall Study||59
305990|NCT00753675|740048|P3|COMPLETED|Overall Study||0
305991|NCT00753675|740049|P2|COMPLETED|Overall Study||0
305992|NCT00753675|740050|P1|COMPLETED|Overall Study||0
305993|NCT00753675|740048|P3|STARTED|Overall Study||56
305994|NCT00753675|740049|P2|STARTED|Overall Study||59
305995|NCT00753675|740050|P1|STARTED|Overall Study||59
305996|NCT00753649|740072|P2|NOT COMPLETED|Overall Study||0
305997|NCT00753649|740073|P1|NOT COMPLETED|Overall Study||7
305998|NCT00753649|740072|P2|COMPLETED|Overall Study||112
305999|NCT00753649|740073|P1|COMPLETED|Overall Study||105
306000|NCT00753649|740072|P2|STARTED|Overall Study||112
306001|NCT00753649|740073|P1|STARTED|Overall Study||112
306002|NCT00753636|740093|P1|NOT COMPLETED|Overall Study||6
306003|NCT00753636|740093|P1|COMPLETED|Overall Study||25
306004|NCT00753636|740093|P1|STARTED|Overall Study||31
306005|NCT00753623|740105|P2|NOT COMPLETED|Phase II (14 Days)||1
306006|NCT00753623|740106|P1|NOT COMPLETED|Phase II (14 Days)||0
306007|NCT00753623|740105|P2|COMPLETED|Phase II (14 Days)||7
306008|NCT00753623|740106|P1|COMPLETED|Phase II (14 Days)||8
306009|NCT00753623|740105|P2|STARTED|Phase II (14 Days)||8
306010|NCT00753623|740106|P1|STARTED|Phase II (14 Days)||8
306011|NCT00753623|740105|P2|NOT COMPLETED|Washout (7 Days)||0
306012|NCT00753623|740106|P1|NOT COMPLETED|Washout (7 Days)||1
306013|NCT00753623|740105|P2|COMPLETED|Washout (7 Days)||8
306014|NCT00753623|740106|P1|COMPLETED|Washout (7 Days)||8
306015|NCT00753623|740105|P2|STARTED|Washout (7 Days)||8
306016|NCT00753623|740106|P1|STARTED|Washout (7 Days)||9
306017|NCT00753623|740105|P2|NOT COMPLETED|Phase I (14 Days)||4
306018|NCT00753623|740106|P1|NOT COMPLETED|Phase I (14 Days)||2
306019|NCT00753623|740105|P2|COMPLETED|Phase I (14 Days)||8
306020|NCT00753623|740106|P1|COMPLETED|Phase I (14 Days)||9
306021|NCT00753623|740105|P2|STARTED|Phase I (14 Days)||12
306022|NCT00753623|740106|P1|STARTED|Phase I (14 Days)||11
306023|NCT00753545|740114|P2|NOT COMPLETED|Overall Study||118
306024|NCT00753545|740115|P1|NOT COMPLETED|Overall Study||108
306025|NCT00753545|740114|P2|COMPLETED|Overall Study|Patients completing the Study|11
306026|NCT00753545|740115|P1|COMPLETED|Overall Study|Patients completing the Study|28
306027|NCT00753545|740114|P2|STARTED|Overall Study|Patients randomized|129
306028|NCT00753545|740115|P1|STARTED|Overall Study|Patients randomized|136
306029|NCT00753519|740153|P2|NOT COMPLETED|Overall Study||2
306030|NCT00753519|740154|P1|NOT COMPLETED|Overall Study||0
306031|NCT00753519|740153|P2|COMPLETED|Overall Study||13
306032|NCT00753519|740154|P1|COMPLETED|Overall Study||13
306033|NCT00753519|740153|P2|STARTED|Overall Study||15
306034|NCT00753519|740154|P1|STARTED|Overall Study||13
306035|NCT00753506|740176|P2|NOT COMPLETED|Overall Study||2
306036|NCT00753506|740177|P1|NOT COMPLETED|Overall Study||7
306037|NCT00753506|740176|P2|COMPLETED|Overall Study||31
306038|NCT00753506|740177|P1|COMPLETED|Overall Study||26
306039|NCT00753506|740176|P2|STARTED|Overall Study||33
306040|NCT00753506|740177|P1|STARTED|Overall Study||33
306041|NCT00753454|740183|P1|NOT COMPLETED|Overall Study||14
306042|NCT00753454|740183|P1|COMPLETED|Overall Study||154
306043|NCT00753454|740183|P1|STARTED|Overall Study||168
306044|NCT00753415|740217|P10|NOT COMPLETED|Part B||1
306045|NCT00753415|740218|P9|NOT COMPLETED|Part B||3
306046|NCT00753415|740219|P8|NOT COMPLETED|Part B||1
306047|NCT00753415|740220|P7|NOT COMPLETED|Part B||0
306048|NCT00753415|740221|P6|NOT COMPLETED|Part B||0
306049|NCT00753415|740222|P5|NOT COMPLETED|Part B||0
306050|NCT00753415|740223|P4|NOT COMPLETED|Part B||0
306051|NCT00753415|740224|P3|NOT COMPLETED|Part B||0
306052|NCT00753415|740225|P2|NOT COMPLETED|Part B||0
306053|NCT00753415|740226|P1|NOT COMPLETED|Part B||0
306054|NCT00753415|740217|P10|COMPLETED|Part B||8
306055|NCT00753415|740218|P9|COMPLETED|Part B||6
306056|NCT00753415|740219|P8|COMPLETED|Part B||6
306057|NCT00753415|740220|P7|COMPLETED|Part B||2
306058|NCT00753415|740221|P6|COMPLETED|Part B||1
306059|NCT00753415|740222|P5|COMPLETED|Part B||0
306060|NCT00753415|740223|P4|COMPLETED|Part B||0
306061|NCT00753415|740224|P3|COMPLETED|Part B||0
306062|NCT00753415|740225|P2|COMPLETED|Part B||0
306063|NCT00753415|740226|P1|COMPLETED|Part B||0
306064|NCT00753415|740217|P10|STARTED|Part B|Of 10 eligible participants who completed Part A, 9 chose to enter Part B|9
306065|NCT00753415|740218|P9|STARTED|Part B|9 participants who completed Part A were eligible and enrolled in Part B|9
306066|NCT00753415|740219|P8|STARTED|Part B|Of 8 eligible participants who completed Part A, 7 chose to enter Part B|7
306067|NCT00753415|740220|P7|STARTED|Part B|Of 3 eligible participants who completed Part A, 2 chose to enter Part B|2
306068|NCT00753415|740221|P6|STARTED|Part B|Of 2 eligible participants who completed Part A, 1 chose to enter Part B|1
306069|NCT00753415|740222|P5|STARTED|Part B||0
306070|NCT00753415|740223|P4|STARTED|Part B||0
306071|NCT00753415|740224|P3|STARTED|Part B||0
306072|NCT00753415|740225|P2|STARTED|Part B||0
306073|NCT00753415|740226|P1|STARTED|Part B||0
306074|NCT00753415|740217|P10|NOT COMPLETED|Part A||0
306075|NCT00753415|740218|P9|NOT COMPLETED|Part A||0
306076|NCT00753415|740219|P8|NOT COMPLETED|Part A||0
306077|NCT00753415|740220|P7|NOT COMPLETED|Part A||0
306078|NCT00753415|740221|P6|NOT COMPLETED|Part A||0
306079|NCT00753415|740222|P5|NOT COMPLETED|Part A||0
306080|NCT00753415|740223|P4|NOT COMPLETED|Part A||2
306081|NCT00753415|740224|P3|NOT COMPLETED|Part A||2
306082|NCT00753415|740225|P2|NOT COMPLETED|Part A||0
306083|NCT00753415|740226|P1|NOT COMPLETED|Part A||1
306084|NCT00753415|740217|P10|COMPLETED|Part A||0
306085|NCT00753415|740218|P9|COMPLETED|Part A||0
306086|NCT00753415|740219|P8|COMPLETED|Part A||0
306087|NCT00753415|740220|P7|COMPLETED|Part A||0
306088|NCT00753415|740221|P6|COMPLETED|Part A||0
306089|NCT00753415|740222|P5|COMPLETED|Part A||10
306090|NCT00753415|740223|P4|COMPLETED|Part A||9
306091|NCT00753415|740224|P3|COMPLETED|Part A||8
306092|NCT00753415|740225|P2|COMPLETED|Part A||3
306093|NCT00753415|740226|P1|COMPLETED|Part A||2
306094|NCT00753415|740217|P10|STARTED|Part A||0
306095|NCT00753415|740218|P9|STARTED|Part A||0
306096|NCT00753415|740219|P8|STARTED|Part A||0
306097|NCT00753415|740220|P7|STARTED|Part A||0
306098|NCT00753415|740221|P6|STARTED|Part A||0
306099|NCT00753415|740222|P5|STARTED|Part A||10
306100|NCT00753415|740223|P4|STARTED|Part A||11
306101|NCT00753415|740224|P3|STARTED|Part A||10
306102|NCT00753415|740225|P2|STARTED|Part A||3
306103|NCT00753415|740226|P1|STARTED|Part A||3
306104|NCT00753363|740270|P2|NOT COMPLETED|Overall Study||39
306105|NCT00753363|740271|P1|NOT COMPLETED|Overall Study||40
306106|NCT00753363|740270|P2|COMPLETED|Overall Study||21
306107|NCT00753363|740271|P1|COMPLETED|Overall Study||19
306108|NCT00753363|740270|P2|STARTED|Overall Study||60
306109|NCT00753363|740271|P1|STARTED|Overall Study||59
306110|NCT00753337|740281|P1|NOT COMPLETED|Overall Study||0
306111|NCT00753337|740281|P1|COMPLETED|Overall Study||123
306112|NCT00753337|740281|P1|STARTED|Overall Study||123
306113|NCT00753298|740297|P2|NOT COMPLETED|Overall Study||4
306114|NCT00753298|740298|P1|NOT COMPLETED|Overall Study||8
306115|NCT00753298|740297|P2|COMPLETED|Overall Study||94
306116|NCT00753298|740298|P1|COMPLETED|Overall Study||89
306117|NCT00753298|740297|P2|STARTED|Overall Study||98
306118|NCT00753298|740298|P1|STARTED|Overall Study||97
306119|NCT00753272|740316|P2|NOT COMPLETED|Overall Study||4907
306120|NCT00753272|740317|P1|NOT COMPLETED|Overall Study||4982
306121|NCT00753272|740316|P2|COMPLETED|Overall Study||16895
306122|NCT00753272|740317|P1|COMPLETED|Overall Study||16911
306123|NCT00753272|740316|P2|STARTED|Overall Study||21802
306124|NCT00753272|740317|P1|STARTED|Overall Study||21893
306125|NCT00753220|740379|P1|NOT COMPLETED|Overall Study||5
306126|NCT00753220|740379|P1|COMPLETED|Overall Study||2
306127|NCT00753220|740379|P1|STARTED|Overall Study||7
306128|NCT00753142|740386|P3|NOT COMPLETED|Overall Study||0
306129|NCT00753142|740387|P2|NOT COMPLETED|Overall Study||0
306130|NCT00753142|740388|P1|NOT COMPLETED|Overall Study||0
306131|NCT00753142|740386|P3|COMPLETED|Overall Study||13
306132|NCT00753142|740387|P2|COMPLETED|Overall Study||7
306133|NCT00753142|740388|P1|COMPLETED|Overall Study||8
306134|NCT00753142|740386|P3|STARTED|Overall Study||13
306135|NCT00753142|740387|P2|STARTED|Overall Study||7
306136|NCT00753142|740388|P1|STARTED|Overall Study||8
306137|NCT00753012|740401|P2|NOT COMPLETED|Overall Study||1
306138|NCT00753012|740402|P1|NOT COMPLETED|Overall Study||8
306139|NCT00753012|740401|P2|COMPLETED|Overall Study||8
306140|NCT00753012|740402|P1|COMPLETED|Overall Study||7
306141|NCT00753012|740401|P2|STARTED|Overall Study||9
306142|NCT00753012|740402|P1|STARTED|Overall Study||15
306143|NCT00752986|740415|P3|NOT COMPLETED|Overall Study||2
306144|NCT00752986|740416|P2|NOT COMPLETED|Overall Study||1
306145|NCT00752986|740417|P1|NOT COMPLETED|Overall Study||5
306146|NCT00752986|740415|P3|COMPLETED|Overall Study||9
306147|NCT00752986|740416|P2|COMPLETED|Overall Study||11
306148|NCT00752986|740417|P1|COMPLETED|Overall Study||11
306149|NCT00752986|740415|P3|STARTED|Overall Study||11
306150|NCT00752986|740416|P2|STARTED|Overall Study||12
306151|NCT00752986|740417|P1|STARTED|Overall Study||16
306152|NCT00752973|740434|P1|NOT COMPLETED|Overall Study||0
306153|NCT00752973|740434|P1|COMPLETED|Overall Study||12
306154|NCT00752973|740434|P1|STARTED|Overall Study||12
306155|NCT00752908|740446|P2|NOT COMPLETED|Overall Study||0
306156|NCT00752908|740447|P1|NOT COMPLETED|Overall Study||0
306157|NCT00752908|740446|P2|COMPLETED|Overall Study||13
306158|NCT00752908|740447|P1|COMPLETED|Overall Study||14
306159|NCT00752908|740446|P2|STARTED|Overall Study||13
306160|NCT00752908|740447|P1|STARTED|Overall Study||14
306161|NCT00752895|740457|P2|NOT COMPLETED|Overall Study||3
306162|NCT00752895|740458|P1|NOT COMPLETED|Overall Study||8
306163|NCT00752895|740457|P2|COMPLETED|Overall Study||143
306164|NCT00752895|740458|P1|COMPLETED|Overall Study||139
306165|NCT00752895|740457|P2|STARTED|Overall Study||146
306166|NCT00752895|740458|P1|STARTED|Overall Study||147
306167|NCT00752791|740466|P1|NOT COMPLETED|Overall Study||16
306168|NCT00752791|740466|P1|COMPLETED|Overall Study||43
306169|NCT00752791|740466|P1|STARTED|Overall Study||59
306170|NCT00752726|740478|P2|NOT COMPLETED|Overall Study||13
306171|NCT00752726|740479|P1|NOT COMPLETED|Overall Study||11
306172|NCT00752726|740478|P2|COMPLETED|Overall Study||53
306173|NCT00752726|740479|P1|COMPLETED|Overall Study||54
306174|NCT00752726|740478|P2|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|61
306175|NCT00752726|740479|P1|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|62
306176|NCT00752726|740478|P2|Safety Population|Overall Study|2 participants were never dosed with the study medication.|64
306177|NCT00752726|740479|P1|Safety Population|Overall Study|2 participants were never dosed with the study medication.|63
306178|NCT00752726|740478|P2|STARTED|Overall Study||66
306179|NCT00752726|740479|P1|STARTED|Overall Study||65
306180|NCT00752622|740504|P1|NOT COMPLETED|Interventional Phase||8
306181|NCT00752622|740504|P1|COMPLETED|Interventional Phase|8 participants received at least 1 infusion of interventional treatment, but none completed trial|0
306182|NCT00752622|740504|P1|STARTED|Interventional Phase|5 participants randomized into increased dose group and 3 randomized into shortened interval group|8
306183|NCT00752622|740504|P1|NOT COMPLETED|Observational Phase||43
306184|NCT00752622|740504|P1|COMPLETED|Observational Phase|14 completed without loss of response 8 had loss of response & randomized into interventional phase|22
306185|NCT00752622|740504|P1|STARTED|Observational Phase||65
306186|NCT00752622|740504|P1|NOT COMPLETED|Induction Phase||35
306187|NCT00752622|740504|P1|COMPLETED|Induction Phase||65
306188|NCT00752622|740504|P1|STARTED|Induction Phase|The ELIG population comprised of 98 participants|100
306189|NCT00752609|740517|P2|NOT COMPLETED|Overall Study||2
306190|NCT00752609|740518|P1|NOT COMPLETED|Overall Study||9
306191|NCT00752609|740517|P2|COMPLETED|Overall Study||47
306192|NCT00752609|740518|P1|COMPLETED|Overall Study||44
306193|NCT00752609|740517|P2|Full Analysis Set|Overall Study||49
306194|NCT00752609|740518|P1|Full Analysis Set|Overall Study|One patient withdrew consent before receiving any study medication.|52
306195|NCT00752609|740517|P2|STARTED|Overall Study||49
306196|NCT00752609|740518|P1|STARTED|Overall Study||53
306197|NCT00752232|740544|P7|NOT COMPLETED|Overall Study||0
306198|NCT00752232|740545|P6|NOT COMPLETED|Overall Study||1
306199|NCT00752232|740546|P5|NOT COMPLETED|Overall Study||3
306200|NCT00752232|740547|P4|NOT COMPLETED|Overall Study||1
306201|NCT00752232|740548|P3|NOT COMPLETED|Overall Study||1
306202|NCT00752232|740549|P2|NOT COMPLETED|Overall Study||0
306203|NCT00752232|740550|P1|NOT COMPLETED|Overall Study||2
306204|NCT00752232|740544|P7|COMPLETED|Overall Study||4
306205|NCT00752232|740545|P6|COMPLETED|Overall Study||5
306206|NCT00752232|740546|P5|COMPLETED|Overall Study||3
306207|NCT00752232|740547|P4|COMPLETED|Overall Study||5
306208|NCT00752232|740548|P3|COMPLETED|Overall Study||5
306209|NCT00752232|740549|P2|COMPLETED|Overall Study||6
306210|NCT00752232|740550|P1|COMPLETED|Overall Study||4
306211|NCT00752232|740544|P7|STARTED|Overall Study||4
306212|NCT00752232|740545|P6|STARTED|Overall Study||6
306213|NCT00752232|740546|P5|STARTED|Overall Study||6
306214|NCT00752232|740547|P4|STARTED|Overall Study||6
306215|NCT00752232|740548|P3|STARTED|Overall Study||6
306216|NCT00752232|740549|P2|STARTED|Overall Study||6
306217|NCT00752232|740550|P1|STARTED|Overall Study||6
306218|NCT00752219|740624|P2|NOT COMPLETED|Overall Study||6
306219|NCT00752219|740625|P1|NOT COMPLETED|Overall Study||11
306220|NCT00752219|740624|P2|COMPLETED|Overall Study||96
306221|NCT00752219|740625|P1|COMPLETED|Overall Study||91
306222|NCT00752219|740624|P2|Treated|Overall Study||102
306223|NCT00752219|740625|P1|Treated|Overall Study||101
306224|NCT00752219|740624|P2|STARTED|Overall Study||102
306225|NCT00752219|740625|P1|STARTED|Overall Study||102
306226|NCT00752128|740649|P1|NOT COMPLETED|Overall Study||4
306227|NCT00752128|740649|P1|COMPLETED|Overall Study||2345
306228|NCT00752128|740649|P1|STARTED|Overall Study||2349
306229|NCT00752102|740656|P2|NOT COMPLETED|Overall Study||1
306230|NCT00752102|740657|P1|NOT COMPLETED|Overall Study||3
306231|NCT00752102|740656|P2|COMPLETED|Overall Study||21
306232|NCT00752102|740657|P1|COMPLETED|Overall Study||19
306233|NCT00752102|740656|P2|STARTED|Overall Study||22
306234|NCT00752102|740657|P1|STARTED|Overall Study||22
306235|NCT00752089|740663|P1|NOT COMPLETED|Overall Study||6
306236|NCT00752089|740663|P1|COMPLETED|Overall Study||14
306237|NCT00752089|740663|P1|Received Placebo|Overall Study||18
306238|NCT00752089|740663|P1|Received NaF|Overall Study||18
306239|NCT00752089|740663|P1|Received NaF/KNO3/ 0% Isopentane|Overall Study||17
306240|NCT00752089|740663|P1|Received NaF/ KNO3/ 2% Isopentane|Overall Study||19
306241|NCT00752089|740663|P1|STARTED|Overall Study||20
306242|NCT00751998|740677|P1|NOT COMPLETED|Overall Study||20
306243|NCT00751998|740677|P1|COMPLETED|Overall Study||277
306244|NCT00751998|740677|P1|STARTED|Overall Study||297
306245|NCT00751972|740683|P2|NOT COMPLETED|Overall Study||0
306246|NCT00751972|740684|P1|NOT COMPLETED|Overall Study||0
306247|NCT00751972|740683|P2|COMPLETED|Overall Study||499
306248|NCT00751972|740684|P1|COMPLETED|Overall Study||140
306249|NCT00751972|740683|P2|STARTED|Overall Study||499
306250|NCT00751972|740684|P1|STARTED|Overall Study||140
306251|NCT00751933|740696|P4|NOT COMPLETED|Overall Study||1
306252|NCT00751933|740697|P3|NOT COMPLETED|Overall Study||1
306253|NCT00751933|740698|P2|NOT COMPLETED|Overall Study||1
306254|NCT00751933|740699|P1|NOT COMPLETED|Overall Study||0
306255|NCT00751933|740696|P4|COMPLETED|Overall Study||0
306256|NCT00751933|740697|P3|COMPLETED|Overall Study||0
306257|NCT00751933|740698|P2|COMPLETED|Overall Study||0
306258|NCT00751933|740699|P1|COMPLETED|Overall Study||0
306259|NCT00751933|740696|P4|STARTED|Overall Study||1
306260|NCT00751933|740697|P3|STARTED|Overall Study||1
306261|NCT00751933|740698|P2|STARTED|Overall Study||1
306262|NCT00751933|740699|P1|STARTED|Overall Study||0
306263|NCT00751881|740707|P3|NOT COMPLETED|Extension Study Period||66
306264|NCT00751881|740708|P2|NOT COMPLETED|Extension Study Period||71
306265|NCT00751881|740709|P1|NOT COMPLETED|Extension Study Period||65
306266|NCT00751881|740707|P3|COMPLETED|Extension Study Period||167
306267|NCT00751881|740708|P2|COMPLETED|Extension Study Period||194
306268|NCT00751881|740709|P1|COMPLETED|Extension Study Period||188
306269|NCT00751881|740707|P3|STARTED|Extension Study Period|11 participants completed core treatment period but did not enter in extension treatment period.|233
306270|NCT00751881|740708|P2|STARTED|Extension Study Period|8 participants completed core treatment period but did not enter in extension treatment period.|265
306271|NCT00751881|740709|P1|STARTED|Extension Study Period|10 participants completed core treatment period but did not enter in extension treatment period.|253
306272|NCT00751881|740707|P3|NOT COMPLETED|Core Treatment Period||128
306273|NCT00751881|740708|P2|NOT COMPLETED|Core Treatment Period||135
306274|NCT00751881|740709|P1|NOT COMPLETED|Core Treatment Period||126
306275|NCT00751881|740707|P3|COMPLETED|Core Treatment Period||244
306276|NCT00751881|740708|P2|COMPLETED|Core Treatment Period||273
306277|NCT00751881|740709|P1|COMPLETED|Core Treatment Period||263
306278|NCT00751881|740707|P3|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 1 participant placebo (at least 1 dose)|370
306279|NCT00751881|740708|P2|Treated|Core Treatment Period|1 participant received placebo (at least 1 dose)|407
306280|NCT00751881|740709|P1|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 2 participants teriflunomide 14 mg (at least 1 dose)|388
306281|NCT00751881|740707|P3|STARTED|Core Treatment Period|Randomized|372
306282|NCT00751881|740708|P2|STARTED|Core Treatment Period|Randomized|408
306283|NCT00751881|740709|P1|STARTED|Core Treatment Period|Randomized|389
306284|NCT00751790|740756|P1|NOT COMPLETED|Overall Study||5
306285|NCT00751790|740756|P1|COMPLETED|Overall Study||115
306286|NCT00751790|740756|P1|STARTED|Overall Study||120
306287|NCT00751777|740762|P2|NOT COMPLETED|Overall Study||3
306288|NCT00751777|740763|P1|NOT COMPLETED|Overall Study||11
306289|NCT00751777|740762|P2|COMPLETED|Overall Study|Day 194: study completion for placebo group|36
306290|NCT00751777|740763|P1|COMPLETED|Overall Study|Day 380: study completion for LT group|70
306291|NCT00751777|740762|P2|STARTED|Overall Study||39
306292|NCT00751777|740763|P1|STARTED|Overall Study||81
306293|NCT00751634|740773|P1|NOT COMPLETED|Overall Study||0
306294|NCT00751634|740773|P1|COMPLETED|Overall Study||20
306295|NCT00751634|740773|P1|STARTED|Overall Study||20
306296|NCT00751621|740781|P1|NOT COMPLETED|Overall Study||4
306297|NCT00751621|740781|P1|COMPLETED|Overall Study||36
306298|NCT00751621|740781|P1|STARTED|Overall Study||40
306299|NCT00751530|740800|P2|NOT COMPLETED|Overall Study||0
306300|NCT00751530|740801|P1|NOT COMPLETED|Overall Study||0
306301|NCT00751530|740800|P2|COMPLETED|Overall Study||110
306302|NCT00751530|740801|P1|COMPLETED|Overall Study||332
306303|NCT00751530|740800|P2|STARTED|Overall Study||110
306304|NCT00751530|740801|P1|STARTED|Overall Study||332
306305|NCT00751400|740815|P1|NOT COMPLETED|Overall Study||10
306306|NCT00751400|740815|P1|COMPLETED|Overall Study||487
306307|NCT00751400|740815|P1|Subjects Provided Detailed Use Data|Overall Study||467
306308|NCT00751400|740815|P1|Subjects Consumed Drug|Overall Study||485
306309|NCT00751400|740815|P1|Subjects Provided Drug|Overall Study||497
306310|NCT00751400|740815|P1|STARTED|Overall Study||497
306311|NCT00751348|740830|P2|NOT COMPLETED|Overall Study||2
306312|NCT00751348|740831|P1|NOT COMPLETED|Overall Study||6
306313|NCT00751348|740830|P2|COMPLETED|Overall Study||159
306314|NCT00751348|740831|P1|COMPLETED|Overall Study||307
306315|NCT00751348|740830|P2|STARTED|Overall Study||161
306316|NCT00751348|740831|P1|STARTED|Overall Study||313
306317|NCT00751296|740853|P1|NOT COMPLETED|Overall Study||2
306318|NCT00751296|740853|P1|COMPLETED|Overall Study||25
306319|NCT00751296|740853|P1|STARTED|Overall Study|The start date of the study was 25 August 2006.|27
306320|NCT00751179|740860|P2|NOT COMPLETED|Overall Study||15
306321|NCT00751179|740861|P1|NOT COMPLETED|Overall Study||14
306322|NCT00751179|740860|P2|COMPLETED|Overall Study||70
306323|NCT00751179|740861|P1|COMPLETED|Overall Study||62
306324|NCT00751179|740860|P2|STARTED|Overall Study|5 of 85 randomized were not treated with succinylcholine|85
306325|NCT00751179|740861|P1|STARTED|Overall Study|10 of 76 randomized were not treated with sugammadex; 4 of these 10 received rocuronium only|76
306326|NCT00751140|740881|P1|NOT COMPLETED|Overall Study||1
306327|NCT00751140|740881|P1|COMPLETED|Overall Study||19
306328|NCT00751140|740881|P1|STARTED|Overall Study||20
306329|NCT00751114|740891|P2|NOT COMPLETED|Overall Study||32
306330|NCT00751114|740892|P1|NOT COMPLETED|Overall Study||38
306331|NCT00751114|740891|P2|COMPLETED|Overall Study||233
306332|NCT00751114|740892|P1|COMPLETED|Overall Study||212
306333|NCT00751114|740891|P2|mITT Population|Overall Study||253
306334|NCT00751114|740892|P1|mITT Population|Overall Study|modified Intent-To-Treat population: treated patients with at least 1 on-treatment efficacy measure|227
306335|NCT00751114|740891|P2|TREATED = Safety Population|Overall Study||264
306336|NCT00751114|740892|P1|TREATED = Safety Population|Overall Study|safety population: randomized patients who received at least one dose of investigational product|237
306337|NCT00751114|740891|P2|STARTED|Overall Study||265
306338|NCT00751114|740892|P1|STARTED|Overall Study|randomized|250
306339|NCT00751036|740917|P2|NOT COMPLETED|Overall Study||46
306340|NCT00751036|740918|P1|NOT COMPLETED|Overall Study||48
306341|NCT00751036|740917|P2|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
306342|NCT00751036|740918|P1|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
306343|NCT00751036|740917|P2|STARTED|Overall Study|Started = Treated|46
306344|NCT00751036|740918|P1|STARTED|Overall Study|Started = Treated|48
306345|NCT00751023|740932|P2|NOT COMPLETED|Overall Study||7
306346|NCT00751023|740933|P1|NOT COMPLETED|Overall Study||11
306347|NCT00751023|740932|P2|COMPLETED|Overall Study||13
306348|NCT00751023|740933|P1|COMPLETED|Overall Study||9
306349|NCT00751023|740932|P2|STARTED|Overall Study||20
306350|NCT00751023|740933|P1|STARTED|Overall Study||20
306351|NCT00750919|740953|P1|NOT COMPLETED|Overall Study||58
306352|NCT00750919|740953|P1|COMPLETED|Overall Study||126
306353|NCT00750919|740953|P1|STARTED|Overall Study||184
306354|NCT00750893|740961|P1|NOT COMPLETED|Overall Study||542
306355|NCT00750893|740961|P1|COMPLETED|Overall Study||2569
306356|NCT00750893|740961|P1|STARTED|Overall Study||3111
306357|NCT00750880|740976|P1|NOT COMPLETED|Overall Study||215
306358|NCT00750880|740976|P1|COMPLETED|Overall Study||1466
306359|NCT00750880|740976|P1|STARTED|Overall Study||1681
306360|NCT00750867|740999|P1|NOT COMPLETED|Overall Study||2
306361|NCT00750867|740999|P1|COMPLETED|Overall Study||7
306362|NCT00750867|740999|P1|STARTED|Overall Study||9
306363|NCT00750815|741006|P2|NOT COMPLETED|Overall Study||0
306364|NCT00750815|741007|P1|NOT COMPLETED|Overall Study||0
306365|NCT00750815|741006|P2|COMPLETED|Overall Study||46
306366|NCT00750815|741007|P1|COMPLETED|Overall Study||12
306367|NCT00750815|741006|P2|STARTED|Overall Study||46
306368|NCT00750815|741007|P1|STARTED|Overall Study||12
306369|NCT00750737|741020|P2|NOT COMPLETED|Overall Study||3
306370|NCT00750737|741021|P1|NOT COMPLETED|Overall Study||3
306371|NCT00750737|741020|P2|COMPLETED|Overall Study||19
306372|NCT00750737|741021|P1|COMPLETED|Overall Study||21
306373|NCT00750737|741020|P2|STARTED|Overall Study||22
306374|NCT00750737|741021|P1|STARTED|Overall Study||24
306375|NCT00750555|741029|P1|NOT COMPLETED|Overall Study||0
306376|NCT00750555|741029|P1|COMPLETED|Overall Study||0
306377|NCT00750555|741029|P1|STARTED|Overall Study||0
306378|NCT00750438|741036|P2|NOT COMPLETED|Overall Study||4
306379|NCT00750438|741037|P1|NOT COMPLETED|Overall Study||7
306380|NCT00750438|741036|P2|COMPLETED|Overall Study||25
306381|NCT00750438|741037|P1|COMPLETED|Overall Study||24
306382|NCT00750438|741036|P2|STARTED|Overall Study||29
306383|NCT00750438|741037|P1|STARTED|Overall Study||31
306384|NCT00750373|741053|P2|NOT COMPLETED|Overall Study||0
306385|NCT00750373|741054|P1|NOT COMPLETED|Overall Study||0
306386|NCT00750373|741053|P2|COMPLETED|Overall Study||37
306387|NCT00750373|741054|P1|COMPLETED|Overall Study||39
306388|NCT00750373|741053|P2|STARTED|Overall Study||37
306389|NCT00750373|741054|P1|STARTED|Overall Study||39
306390|NCT00750360|741066|P6|NOT COMPLETED|Overall Study||0
306391|NCT00750360|741067|P5|NOT COMPLETED|Overall Study||0
306392|NCT00750360|741068|P4|NOT COMPLETED|Overall Study||0
306393|NCT00750360|741069|P3|NOT COMPLETED|Overall Study||0
306394|NCT00750360|741070|P2|NOT COMPLETED|Overall Study||0
306395|NCT00750360|741071|P1|NOT COMPLETED|Overall Study||0
306396|NCT00750360|741066|P6|COMPLETED|Overall Study||71
306397|NCT00750360|741067|P5|COMPLETED|Overall Study||46
306398|NCT00750360|741068|P4|COMPLETED|Overall Study||79
306399|NCT00750360|741069|P3|COMPLETED|Overall Study||384
306400|NCT00750360|741070|P2|COMPLETED|Overall Study||1
306401|NCT00750360|741071|P1|COMPLETED|Overall Study||294
306402|NCT00750360|741066|P6|STARTED|Overall Study||71
306403|NCT00750360|741067|P5|STARTED|Overall Study||46
306404|NCT00750360|741068|P4|STARTED|Overall Study||79
306405|NCT00750360|741069|P3|STARTED|Overall Study||384
306406|NCT00750360|741070|P2|STARTED|Overall Study|"One subject enrolled in this group was not vaccinated and as such not included as STARTED."|1
306407|NCT00750360|741071|P1|STARTED|Overall Study|"Seven subjects enrolled in this group were not vaccinated and as such not included as STARTED."|294
306408|NCT00750308|741103|P12|NOT COMPLETED|Fourth Treatment||0
306409|NCT00750308|741104|P11|NOT COMPLETED|Fourth Treatment||0
306410|NCT00750308|741105|P10|NOT COMPLETED|Fourth Treatment||0
306411|NCT00750308|741106|P9|NOT COMPLETED|Fourth Treatment||0
306412|NCT00750308|741107|P8|NOT COMPLETED|Fourth Treatment||0
306413|NCT00750308|741108|P7|NOT COMPLETED|Fourth Treatment||0
306414|NCT00750308|741109|P6|NOT COMPLETED|Fourth Treatment||0
306415|NCT00750308|741110|P5|NOT COMPLETED|Fourth Treatment||0
306416|NCT00750308|741111|P4|NOT COMPLETED|Fourth Treatment||0
306417|NCT00750308|741112|P3|NOT COMPLETED|Fourth Treatment||0
306418|NCT00750308|741113|P2|NOT COMPLETED|Fourth Treatment||0
306419|NCT00750308|741114|P1|NOT COMPLETED|Fourth Treatment||0
306420|NCT00750308|741103|P12|COMPLETED|Fourth Treatment||1
306421|NCT00750308|741104|P11|COMPLETED|Fourth Treatment||1
306422|NCT00750308|741105|P10|COMPLETED|Fourth Treatment||2
306423|NCT00750308|741106|P9|COMPLETED|Fourth Treatment||1
306424|NCT00750308|741107|P8|COMPLETED|Fourth Treatment||2
306425|NCT00750308|741108|P7|COMPLETED|Fourth Treatment||2
306426|NCT00750308|741109|P6|COMPLETED|Fourth Treatment||2
306427|NCT00750308|741110|P5|COMPLETED|Fourth Treatment||1
306428|NCT00750308|741111|P4|COMPLETED|Fourth Treatment||1
306429|NCT00750308|741112|P3|COMPLETED|Fourth Treatment||2
306430|NCT00750308|741113|P2|COMPLETED|Fourth Treatment||1
306431|NCT00750308|741114|P1|COMPLETED|Fourth Treatment||2
306432|NCT00750308|741103|P12|STARTED|Fourth Treatment||1
306433|NCT00750308|741104|P11|STARTED|Fourth Treatment||1
306434|NCT00750308|741105|P10|STARTED|Fourth Treatment||2
306435|NCT00750308|741106|P9|STARTED|Fourth Treatment||1
306436|NCT00750308|741107|P8|STARTED|Fourth Treatment||2
306437|NCT00750308|741108|P7|STARTED|Fourth Treatment||2
306438|NCT00750308|741109|P6|STARTED|Fourth Treatment||2
306439|NCT00750308|741110|P5|STARTED|Fourth Treatment||1
306440|NCT00750308|741111|P4|STARTED|Fourth Treatment||1
306441|NCT00750308|741112|P3|STARTED|Fourth Treatment||2
306442|NCT00750308|741113|P2|STARTED|Fourth Treatment||1
306443|NCT00750308|741114|P1|STARTED|Fourth Treatment||2
306444|NCT00750308|741103|P12|NOT COMPLETED|Washout||0
306445|NCT00750308|741104|P11|NOT COMPLETED|Washout||0
306446|NCT00750308|741105|P10|NOT COMPLETED|Washout||0
306447|NCT00750308|741106|P9|NOT COMPLETED|Washout||0
306448|NCT00750308|741107|P8|NOT COMPLETED|Washout||0
306449|NCT00750308|741108|P7|NOT COMPLETED|Washout||0
306450|NCT00750308|741109|P6|NOT COMPLETED|Washout||0
306451|NCT00750308|741110|P5|NOT COMPLETED|Washout||0
306452|NCT00750308|741111|P4|NOT COMPLETED|Washout||0
306453|NCT00750308|741112|P3|NOT COMPLETED|Washout||0
306454|NCT00750308|741113|P2|NOT COMPLETED|Washout||0
306455|NCT00750308|741114|P1|NOT COMPLETED|Washout||0
306456|NCT00750308|741103|P12|COMPLETED|Washout||1
306457|NCT00750308|741104|P11|COMPLETED|Washout||1
306458|NCT00750308|741105|P10|COMPLETED|Washout||2
306459|NCT00750308|741106|P9|COMPLETED|Washout||1
306460|NCT00750308|741107|P8|COMPLETED|Washout||2
306461|NCT00750308|741108|P7|COMPLETED|Washout||2
306462|NCT00750308|741109|P6|COMPLETED|Washout||2
306463|NCT00750308|741110|P5|COMPLETED|Washout||1
306464|NCT00750308|741111|P4|COMPLETED|Washout||1
306465|NCT00750308|741112|P3|COMPLETED|Washout||2
306466|NCT00750308|741113|P2|COMPLETED|Washout||1
306467|NCT00750308|741114|P1|COMPLETED|Washout||2
306468|NCT00750308|741103|P12|STARTED|Washout||1
306469|NCT00750308|741104|P11|STARTED|Washout||1
306470|NCT00750308|741105|P10|STARTED|Washout||2
306471|NCT00750308|741106|P9|STARTED|Washout||1
306472|NCT00750308|741107|P8|STARTED|Washout||2
306473|NCT00750308|741108|P7|STARTED|Washout||2
306474|NCT00750308|741109|P6|STARTED|Washout||2
306475|NCT00750308|741110|P5|STARTED|Washout||1
306476|NCT00750308|741111|P4|STARTED|Washout||1
306477|NCT00750308|741112|P3|STARTED|Washout||2
306478|NCT00750308|741113|P2|STARTED|Washout||1
306479|NCT00750308|741114|P1|STARTED|Washout||2
306480|NCT00750308|741103|P12|NOT COMPLETED|Third Treatment||0
306481|NCT00750308|741104|P11|NOT COMPLETED|Third Treatment||0
306482|NCT00750308|741105|P10|NOT COMPLETED|Third Treatment||0
306483|NCT00750308|741106|P9|NOT COMPLETED|Third Treatment||0
306484|NCT00750308|741107|P8|NOT COMPLETED|Third Treatment||0
306485|NCT00750308|741108|P7|NOT COMPLETED|Third Treatment||0
306486|NCT00750308|741109|P6|NOT COMPLETED|Third Treatment||0
306487|NCT00750308|741110|P5|NOT COMPLETED|Third Treatment||0
306488|NCT00750308|741111|P4|NOT COMPLETED|Third Treatment||0
306489|NCT00750308|741112|P3|NOT COMPLETED|Third Treatment||0
306490|NCT00750308|741113|P2|NOT COMPLETED|Third Treatment||1
306491|NCT00750308|741114|P1|NOT COMPLETED|Third Treatment||0
306492|NCT00750308|741103|P12|COMPLETED|Third Treatment||1
306493|NCT00750308|741104|P11|COMPLETED|Third Treatment||1
306494|NCT00750308|741105|P10|COMPLETED|Third Treatment||2
306495|NCT00750308|741106|P9|COMPLETED|Third Treatment||1
306496|NCT00750308|741107|P8|COMPLETED|Third Treatment||2
306497|NCT00750308|741108|P7|COMPLETED|Third Treatment||2
306498|NCT00750308|741109|P6|COMPLETED|Third Treatment||2
306499|NCT00750308|741110|P5|COMPLETED|Third Treatment||1
306500|NCT00750308|741111|P4|COMPLETED|Third Treatment||1
306501|NCT00750308|741112|P3|COMPLETED|Third Treatment||2
306502|NCT00750308|741113|P2|COMPLETED|Third Treatment||1
306503|NCT00750308|741114|P1|COMPLETED|Third Treatment||2
306504|NCT00750308|741103|P12|STARTED|Third Treatment||1
306505|NCT00750308|741104|P11|STARTED|Third Treatment||1
306506|NCT00750308|741105|P10|STARTED|Third Treatment||2
306507|NCT00750308|741106|P9|STARTED|Third Treatment||1
306508|NCT00750308|741107|P8|STARTED|Third Treatment||2
306509|NCT00750308|741108|P7|STARTED|Third Treatment||2
306510|NCT00750308|741109|P6|STARTED|Third Treatment||2
306511|NCT00750308|741110|P5|STARTED|Third Treatment||1
306512|NCT00750308|741111|P4|STARTED|Third Treatment||1
306513|NCT00750308|741112|P3|STARTED|Third Treatment||2
306514|NCT00750308|741113|P2|STARTED|Third Treatment||2
306515|NCT00750308|741114|P1|STARTED|Third Treatment||2
306516|NCT00750308|741103|P12|NOT COMPLETED|Washout||0
306517|NCT00750308|741104|P11|NOT COMPLETED|Washout||0
306518|NCT00750308|741105|P10|NOT COMPLETED|Washout||0
306519|NCT00750308|741106|P9|NOT COMPLETED|Washout||0
306520|NCT00750308|741107|P8|NOT COMPLETED|Washout||0
306521|NCT00750308|741108|P7|NOT COMPLETED|Washout||0
306522|NCT00750308|741109|P6|NOT COMPLETED|Washout||0
306523|NCT00750308|741110|P5|NOT COMPLETED|Washout||0
306524|NCT00750308|741111|P4|NOT COMPLETED|Washout||0
306525|NCT00750308|741112|P3|NOT COMPLETED|Washout||0
306526|NCT00750308|741113|P2|NOT COMPLETED|Washout||0
306527|NCT00750308|741114|P1|NOT COMPLETED|Washout||0
306528|NCT00750308|741103|P12|COMPLETED|Washout||1
306529|NCT00750308|741104|P11|COMPLETED|Washout||1
306530|NCT00750308|741105|P10|COMPLETED|Washout||2
306531|NCT00750308|741106|P9|COMPLETED|Washout||1
306532|NCT00750308|741107|P8|COMPLETED|Washout||2
306533|NCT00750308|741108|P7|COMPLETED|Washout||2
306534|NCT00750308|741109|P6|COMPLETED|Washout||2
306535|NCT00750308|741110|P5|COMPLETED|Washout||1
306536|NCT00750308|741111|P4|COMPLETED|Washout||1
306537|NCT00750308|741112|P3|COMPLETED|Washout||2
306538|NCT00750308|741113|P2|COMPLETED|Washout||2
306539|NCT00750308|741114|P1|COMPLETED|Washout||2
306540|NCT00750308|741103|P12|STARTED|Washout||1
306541|NCT00750308|741104|P11|STARTED|Washout||1
306542|NCT00750308|741105|P10|STARTED|Washout||2
306543|NCT00750308|741106|P9|STARTED|Washout||1
306544|NCT00750308|741107|P8|STARTED|Washout||2
306545|NCT00750308|741108|P7|STARTED|Washout||2
306546|NCT00750308|741109|P6|STARTED|Washout||2
306547|NCT00750308|741110|P5|STARTED|Washout||1
306548|NCT00750308|741111|P4|STARTED|Washout||1
306549|NCT00750308|741112|P3|STARTED|Washout||2
306550|NCT00750308|741113|P2|STARTED|Washout||2
306551|NCT00750308|741114|P1|STARTED|Washout||2
306552|NCT00750308|741103|P12|NOT COMPLETED|Second Treatment||0
306553|NCT00750308|741104|P11|NOT COMPLETED|Second Treatment||0
306554|NCT00750308|741105|P10|NOT COMPLETED|Second Treatment||0
306555|NCT00750308|741106|P9|NOT COMPLETED|Second Treatment||1
306556|NCT00750308|741107|P8|NOT COMPLETED|Second Treatment||0
306557|NCT00750308|741108|P7|NOT COMPLETED|Second Treatment||0
306558|NCT00750308|741109|P6|NOT COMPLETED|Second Treatment||1
306559|NCT00750308|741110|P5|NOT COMPLETED|Second Treatment||1
306560|NCT00750308|741111|P4|NOT COMPLETED|Second Treatment||0
306561|NCT00750308|741112|P3|NOT COMPLETED|Second Treatment||0
306562|NCT00750308|741113|P2|NOT COMPLETED|Second Treatment||0
306563|NCT00750308|741114|P1|NOT COMPLETED|Second Treatment||0
306564|NCT00750308|741103|P12|COMPLETED|Second Treatment||1
306565|NCT00750308|741104|P11|COMPLETED|Second Treatment||1
306566|NCT00750308|741105|P10|COMPLETED|Second Treatment||2
306567|NCT00750308|741106|P9|COMPLETED|Second Treatment||1
306568|NCT00750308|741107|P8|COMPLETED|Second Treatment||2
306569|NCT00750308|741108|P7|COMPLETED|Second Treatment||2
306570|NCT00750308|741109|P6|COMPLETED|Second Treatment||2
306571|NCT00750308|741110|P5|COMPLETED|Second Treatment||1
306572|NCT00750308|741111|P4|COMPLETED|Second Treatment||1
306573|NCT00750308|741112|P3|COMPLETED|Second Treatment||2
306574|NCT00750308|741113|P2|COMPLETED|Second Treatment||2
306575|NCT00750308|741114|P1|COMPLETED|Second Treatment||2
306576|NCT00750308|741103|P12|STARTED|Second Treatment||1
306577|NCT00750308|741104|P11|STARTED|Second Treatment||1
306578|NCT00750308|741105|P10|STARTED|Second Treatment||2
306579|NCT00750308|741106|P9|STARTED|Second Treatment||2
306580|NCT00750308|741107|P8|STARTED|Second Treatment||2
306581|NCT00750308|741108|P7|STARTED|Second Treatment||2
306582|NCT00750308|741109|P6|STARTED|Second Treatment||3
306583|NCT00750308|741110|P5|STARTED|Second Treatment||2
306584|NCT00750308|741111|P4|STARTED|Second Treatment||1
306585|NCT00750308|741112|P3|STARTED|Second Treatment||2
306586|NCT00750308|741113|P2|STARTED|Second Treatment||2
306587|NCT00750308|741114|P1|STARTED|Second Treatment||2
306588|NCT00750308|741103|P12|NOT COMPLETED|Washout||0
306589|NCT00750308|741104|P11|NOT COMPLETED|Washout||0
306590|NCT00750308|741105|P10|NOT COMPLETED|Washout||0
306591|NCT00750308|741106|P9|NOT COMPLETED|Washout||0
306592|NCT00750308|741107|P8|NOT COMPLETED|Washout||0
306593|NCT00750308|741108|P7|NOT COMPLETED|Washout||0
306594|NCT00750308|741109|P6|NOT COMPLETED|Washout||0
306595|NCT00750308|741110|P5|NOT COMPLETED|Washout||0
306596|NCT00750308|741111|P4|NOT COMPLETED|Washout||0
306597|NCT00750308|741112|P3|NOT COMPLETED|Washout||0
306598|NCT00750308|741113|P2|NOT COMPLETED|Washout||0
306599|NCT00750308|741114|P1|NOT COMPLETED|Washout||0
306600|NCT00750308|741103|P12|COMPLETED|Washout||1
306601|NCT00750308|741104|P11|COMPLETED|Washout||1
306602|NCT00750308|741105|P10|COMPLETED|Washout||2
306603|NCT00750308|741106|P9|COMPLETED|Washout||2
306604|NCT00750308|741107|P8|COMPLETED|Washout||2
306605|NCT00750308|741108|P7|COMPLETED|Washout||2
306606|NCT00750308|741109|P6|COMPLETED|Washout||3
306607|NCT00750308|741110|P5|COMPLETED|Washout||2
306608|NCT00750308|741111|P4|COMPLETED|Washout||1
306609|NCT00750308|741112|P3|COMPLETED|Washout||2
306610|NCT00750308|741113|P2|COMPLETED|Washout||2
306611|NCT00750308|741114|P1|COMPLETED|Washout||2
306612|NCT00750308|741103|P12|STARTED|Washout||1
306613|NCT00750308|741104|P11|STARTED|Washout||1
306614|NCT00750308|741105|P10|STARTED|Washout||2
306615|NCT00750308|741106|P9|STARTED|Washout||2
306616|NCT00750308|741107|P8|STARTED|Washout||2
306617|NCT00750308|741108|P7|STARTED|Washout||2
306618|NCT00750308|741109|P6|STARTED|Washout||3
306619|NCT00750308|741110|P5|STARTED|Washout||2
306620|NCT00750308|741111|P4|STARTED|Washout||1
306621|NCT00750308|741112|P3|STARTED|Washout||2
306622|NCT00750308|741113|P2|STARTED|Washout||2
306623|NCT00750308|741114|P1|STARTED|Washout||2
306624|NCT00750308|741103|P12|NOT COMPLETED|First Treatment||1
306625|NCT00750308|741104|P11|NOT COMPLETED|First Treatment||1
306626|NCT00750308|741105|P10|NOT COMPLETED|First Treatment||0
306627|NCT00750308|741106|P9|NOT COMPLETED|First Treatment||0
306628|NCT00750308|741107|P8|NOT COMPLETED|First Treatment||1
306629|NCT00750308|741108|P7|NOT COMPLETED|First Treatment||0
306630|NCT00750308|741109|P6|NOT COMPLETED|First Treatment||0
306631|NCT00750308|741110|P5|NOT COMPLETED|First Treatment||0
306632|NCT00750308|741111|P4|NOT COMPLETED|First Treatment||1
306633|NCT00750308|741112|P3|NOT COMPLETED|First Treatment||0
306634|NCT00750308|741113|P2|NOT COMPLETED|First Treatment||1
306635|NCT00750308|741114|P1|NOT COMPLETED|First Treatment||0
306636|NCT00750308|741103|P12|COMPLETED|First Treatment||1
306637|NCT00750308|741104|P11|COMPLETED|First Treatment||1
306638|NCT00750308|741105|P10|COMPLETED|First Treatment||2
306639|NCT00750308|741106|P9|COMPLETED|First Treatment||2
306640|NCT00750308|741107|P8|COMPLETED|First Treatment||2
306641|NCT00750308|741108|P7|COMPLETED|First Treatment||2
306642|NCT00750308|741109|P6|COMPLETED|First Treatment||3
306643|NCT00750308|741110|P5|COMPLETED|First Treatment||2
306644|NCT00750308|741111|P4|COMPLETED|First Treatment||1
306645|NCT00750308|741112|P3|COMPLETED|First Treatment||2
306646|NCT00750308|741113|P2|COMPLETED|First Treatment||2
306647|NCT00750308|741114|P1|COMPLETED|First Treatment||2
306648|NCT00750308|741103|P12|STARTED|First Treatment||2
306649|NCT00750308|741104|P11|STARTED|First Treatment||2
306650|NCT00750308|741105|P10|STARTED|First Treatment||2
306651|NCT00750308|741106|P9|STARTED|First Treatment||2
306652|NCT00750308|741107|P8|STARTED|First Treatment||3
306653|NCT00750308|741108|P7|STARTED|First Treatment||2
306654|NCT00750308|741109|P6|STARTED|First Treatment||3
306655|NCT00750308|741110|P5|STARTED|First Treatment||2
306656|NCT00750308|741111|P4|STARTED|First Treatment||2
306657|NCT00750308|741112|P3|STARTED|First Treatment||2
306658|NCT00750308|741113|P2|STARTED|First Treatment||3
306659|NCT00750308|741114|P1|STARTED|First Treatment|One female withdrew due to muscle pain|2
306660|NCT00750282|741132|P4|NOT COMPLETED|Overall Study||1
306661|NCT00750282|741133|P3|NOT COMPLETED|Overall Study||1
306662|NCT00750282|741134|P2|NOT COMPLETED|Overall Study||1
306663|NCT00750282|741135|P1|NOT COMPLETED|Overall Study||0
306664|NCT00750282|741132|P4|COMPLETED|Overall Study||147
306665|NCT00750282|741133|P3|COMPLETED|Overall Study||125
306666|NCT00750282|741134|P2|COMPLETED|Overall Study||81
306667|NCT00750282|741135|P1|COMPLETED|Overall Study||69
306668|NCT00750282|741132|P4|STARTED|Overall Study||148
306669|NCT00750282|741133|P3|STARTED|Overall Study||126
306670|NCT00750282|741134|P2|STARTED|Overall Study||82
306671|NCT00750282|741135|P1|STARTED|Overall Study||69
306672|NCT00750269|741164|P5|NOT COMPLETED|Overall Study||10
306673|NCT00750269|741165|P4|NOT COMPLETED|Overall Study||5
306674|NCT00750269|741166|P3|NOT COMPLETED|Overall Study||4
306675|NCT00750269|741167|P2|NOT COMPLETED|Overall Study||1
306676|NCT00750269|741168|P1|NOT COMPLETED|Overall Study||0
306677|NCT00750269|741164|P5|COMPLETED|Overall Study||33
306678|NCT00750269|741165|P4|COMPLETED|Overall Study||38
306679|NCT00750269|741166|P3|COMPLETED|Overall Study||14
306680|NCT00750269|741167|P2|COMPLETED|Overall Study||7
306681|NCT00750269|741168|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|8
306682|NCT00750269|741164|P5|STARTED|Overall Study||43
306683|NCT00750269|741165|P4|STARTED|Overall Study||43
306684|NCT00750269|741166|P3|STARTED|Overall Study||18
306685|NCT00750269|741167|P2|STARTED|Overall Study||8
306686|NCT00750269|741168|P1|STARTED|Overall Study||8
306687|NCT00750204|741215|P2|NOT COMPLETED|Overall Study||1
306688|NCT00750204|741216|P1|NOT COMPLETED|Overall Study||1
306689|NCT00750204|741215|P2|COMPLETED|Overall Study||0
306690|NCT00750204|741216|P1|COMPLETED|Overall Study||0
306691|NCT00750204|741215|P2|STARTED|Overall Study||1
306692|NCT00750204|741216|P1|STARTED|Overall Study||1
306693|NCT00750191|741224|P2|NOT COMPLETED|Overall Study||10
306694|NCT00750191|741225|P1|NOT COMPLETED|Overall Study||5
306695|NCT00750191|741224|P2|COMPLETED|Overall Study||20
306696|NCT00750191|741225|P1|COMPLETED|Overall Study||22
306697|NCT00750191|741224|P2|STARTED|Overall Study||30
306698|NCT00750191|741225|P1|STARTED|Overall Study||27
306699|NCT00750165|741237|P1|NOT COMPLETED|Overall Study||11
306700|NCT00750165|741237|P1|COMPLETED|Overall Study||21
306701|NCT00750165|741237|P1|STARTED|Overall Study||32
306702|NCT00750152|741246|P2|NOT COMPLETED|Overall Study||27
306703|NCT00750152|741247|P1|NOT COMPLETED|Overall Study||22
306704|NCT00750152|741246|P2|COMPLETED|Overall Study||141
306705|NCT00750152|741247|P1|COMPLETED|Overall Study||144
306706|NCT00750152|741246|P2|STARTED|Overall Study||168
306707|NCT00750152|741247|P1|STARTED|Overall Study||166
306708|NCT00750139|741259|P4|NOT COMPLETED|Overall Study||46
306709|NCT00750139|741260|P3|NOT COMPLETED|Overall Study||101
306710|NCT00750139|741261|P2|NOT COMPLETED|Overall Study||59
306711|NCT00750139|741262|P1|NOT COMPLETED|Overall Study||89
306712|NCT00750139|741259|P4|COMPLETED|Overall Study||73
306713|NCT00750139|741260|P3|COMPLETED|Overall Study||135
306714|NCT00750139|741261|P2|COMPLETED|Overall Study||59
306715|NCT00750139|741262|P1|COMPLETED|Overall Study||145
306716|NCT00750139|741259|P4|STARTED|Overall Study||119
306717|NCT00750139|741260|P3|STARTED|Overall Study||236
306718|NCT00750139|741261|P2|STARTED|Overall Study||118
306719|NCT00750139|741262|P1|STARTED|Overall Study||234
306720|NCT00750061|741278|P2|NOT COMPLETED|Overall Study||2
306721|NCT00750061|741279|P1|NOT COMPLETED|Overall Study||2
306722|NCT00750061|741278|P2|COMPLETED|Overall Study||18
306723|NCT00750061|741279|P1|COMPLETED|Overall Study||18
306724|NCT00750061|741278|P2|STARTED|Overall Study||20
306725|NCT00750061|741279|P1|STARTED|Overall Study||20
306726|NCT00749996|741289|P2|NOT COMPLETED|Overall Study||13
306727|NCT00749996|741290|P1|NOT COMPLETED|Overall Study||18
306728|NCT00749996|741289|P2|COMPLETED|Overall Study||58
306729|NCT00749996|741290|P1|COMPLETED|Overall Study||57
306730|NCT00749996|741289|P2|24 Months Follow up|Overall Study|Withdrawn (n=3). Lost to follow-up (n=3)|58
306731|NCT00749996|741290|P1|24 Months Follow up|Overall Study|Withdrawn (n=5) Accidental death (n=1) Lost to follow up (n=7)|57
306732|NCT00749996|741289|P2|12 Months Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=4). Lost to follow-up (n=1)|60
306733|NCT00749996|741290|P1|12 Months Follow-up|Overall Study|Withdrawn(n=4). Visit not done (n=2)|68
306734|NCT00749996|741289|P2|6 Months Follow-up|Overall Study|Withdrawn (n=3). Visit not done (n=3)|63
306735|NCT00749996|741290|P1|6 Months Follow-up|Overall Study|Visit not done (n=3)|71
306736|NCT00749996|741289|P2|3 Months Follow-up|Overall Study|Visit not done (n=1)|68
306737|NCT00749996|741290|P1|3 Months Follow-up|Overall Study|Visit not done (n=2)|72
306738|NCT00749996|741289|P2|6 Weeks Follow-up|Overall Study|Withdrawn (n=2). Visit not done (n=2)|67
306739|NCT00749996|741290|P1|6 Weeks Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=2)|72
306740|NCT00749996|741289|P2|STARTED|Overall Study|5 pts were removed due to compliance issue. 1 pt was randomized but not treated (Non-eligible)|71
306741|NCT00749996|741290|P1|STARTED|Overall Study|4 pts were removed due to compliance issue. 2 pts were randomized but not treated (non-eligible)|75
306742|NCT00749957|741300|P2|NOT COMPLETED|Overall Study||0
306743|NCT00749957|741301|P1|NOT COMPLETED|Overall Study||0
306744|NCT00749957|741300|P2|COMPLETED|Overall Study||6
306745|NCT00749957|741301|P1|COMPLETED|Overall Study||6
306746|NCT00749957|741300|P2|STARTED|Overall Study||6
306747|NCT00749957|741301|P1|STARTED|Overall Study||6
306748|NCT00749944|741313|P2|NOT COMPLETED|Overall Study||1
306749|NCT00749944|741314|P1|NOT COMPLETED|Overall Study||5
306750|NCT00749944|741313|P2|COMPLETED|Overall Study||54
306751|NCT00749944|741314|P1|COMPLETED|Overall Study||50
306752|NCT00749944|741313|P2|STARTED|Overall Study||55
306753|NCT00749944|741314|P1|STARTED|Overall Study||55
306754|NCT00749931|741382|P3|NOT COMPLETED|Overall Study||0
306755|NCT00749931|741383|P2|NOT COMPLETED|Overall Study||0
306756|NCT00749931|741384|P1|NOT COMPLETED|Overall Study||0
306757|NCT00749931|741382|P3|COMPLETED|Overall Study||68
306758|NCT00749931|741383|P2|COMPLETED|Overall Study||298
306759|NCT00749931|741384|P1|COMPLETED|Overall Study||298
306760|NCT00749931|741382|P3|STARTED|Overall Study||68
306761|NCT00749931|741383|P2|STARTED|Overall Study||298
306762|NCT00749931|741384|P1|STARTED|Overall Study||298
306763|NCT00749879|741393|P1|NOT COMPLETED|Overall Study||0
306764|NCT00749879|741393|P1|COMPLETED|Overall Study||12
306765|NCT00749879|741393|P1|STARTED|Overall Study||12
306766|NCT00749775|741425|P1|NOT COMPLETED|Overall Study||107
306767|NCT00749775|741425|P1|COMPLETED|Overall Study||3210
306768|NCT00749775|741425|P1|STARTED|Overall Study||3317
306769|NCT00749684|741441|P1|NOT COMPLETED|Overall Study||82
306770|NCT00749684|741441|P1|COMPLETED|Overall Study||56
306771|NCT00749684|741441|P1|STARTED|Overall Study||138
306772|NCT00749671|741448|P2|NOT COMPLETED|Overall Study||0
306773|NCT00749671|741449|P1|NOT COMPLETED|Overall Study||0
306774|NCT00749671|741448|P2|COMPLETED|Overall Study||9
306775|NCT00749671|741449|P1|COMPLETED|Overall Study||11
306776|NCT00749671|741448|P2|STARTED|Overall Study||9
306777|NCT00749671|741449|P1|STARTED|Overall Study||11
306778|NCT00749606|741459|P2|NOT COMPLETED|Year 3 (Observation)||3
306779|NCT00749606|741460|P1|NOT COMPLETED|Year 3 (Observation)||0
306780|NCT00749606|741459|P2|COMPLETED|Year 3 (Observation)||69
306781|NCT00749606|741460|P1|COMPLETED|Year 3 (Observation)||63
306782|NCT00749606|741459|P2|STARTED|Year 3 (Observation)||72
306783|NCT00749606|741460|P1|STARTED|Year 3 (Observation)||63
306784|NCT00749606|741459|P2|NOT COMPLETED|Year 2||8
306785|NCT00749606|741460|P1|NOT COMPLETED|Year 2||11
306786|NCT00749606|741459|P2|COMPLETED|Year 2||72
306787|NCT00749606|741460|P1|COMPLETED|Year 2||63
306788|NCT00749606|741459|P2|STARTED|Year 2||80
306789|NCT00749606|741460|P1|STARTED|Year 2||74
306790|NCT00749606|741459|P2|NOT COMPLETED|Year 1||48
306791|NCT00749606|741460|P1|NOT COMPLETED|Year 1||55
306792|NCT00749606|741459|P2|COMPLETED|Year 1||80
306793|NCT00749606|741460|P1|COMPLETED|Year 1||74
306794|NCT00749606|741459|P2|STARTED|Year 1||128
306795|NCT00749606|741460|P1|STARTED|Year 1||129
306796|NCT00749580|741480|P2|NOT COMPLETED|Overall Study||9
306797|NCT00749580|741481|P1|NOT COMPLETED|Overall Study||4
306798|NCT00749580|741480|P2|COMPLETED|Overall Study||16
306799|NCT00749580|741481|P1|COMPLETED|Overall Study|December 2010|17
306800|NCT00749580|741480|P2|STARTED|Overall Study||25
306801|NCT00749580|741481|P1|STARTED|Overall Study|September 2008|21
306802|NCT00749515|741491|P2|NOT COMPLETED|Overall Study||0
306803|NCT00749515|741492|P1|NOT COMPLETED|Overall Study||0
306804|NCT00749515|741491|P2|COMPLETED|Overall Study||5
306805|NCT00749515|741492|P1|COMPLETED|Overall Study||10
306806|NCT00749515|741491|P2|STARTED|Overall Study||5
306807|NCT00749515|741492|P1|STARTED|Overall Study||10
306808|NCT00749476|741508|P1|NOT COMPLETED|Overall Study||0
306809|NCT00749476|741508|P1|COMPLETED|Overall Study||1
306810|NCT00749476|741508|P1|STARTED|Overall Study||1
306811|NCT00749463|741515|P3|NOT COMPLETED|Overall Study||1
306812|NCT00749463|741516|P2|NOT COMPLETED|Overall Study||4
306813|NCT00749463|741517|P1|NOT COMPLETED|Overall Study||1
306814|NCT00749463|741515|P3|COMPLETED|Overall Study||149
306815|NCT00749463|741516|P2|COMPLETED|Overall Study||60
306816|NCT00749463|741517|P1|COMPLETED|Overall Study||85
306817|NCT00749463|741515|P3|STARTED|Overall Study||150
306818|NCT00749463|741516|P2|STARTED|Overall Study||64
306819|NCT00749463|741517|P1|STARTED|Overall Study||86
306820|NCT00749398|741543|P1|NOT COMPLETED|Overall Study||53
306821|NCT00749398|741543|P1|COMPLETED|Overall Study||71
306822|NCT00749398|741543|P1|STARTED|Overall Study|Nine participants were excluded because they did not fulfill the inclusion criteria.|124
306823|NCT00749268|741561|P2|NOT COMPLETED|Overall Study||36
306824|NCT00749268|741562|P1|NOT COMPLETED|Overall Study||34
306825|NCT00749268|741561|P2|COMPLETED|Overall Study||74
306826|NCT00749268|741562|P1|COMPLETED|Overall Study||72
306827|NCT00749268|741561|P2|STARTED|Overall Study||110
306828|NCT00749268|741562|P1|STARTED|Overall Study||106
306829|NCT00749203|741586|P2|NOT COMPLETED|Second Infusion at 2 Weeks||2
306830|NCT00749203|741587|P1|NOT COMPLETED|Second Infusion at 2 Weeks||0
306831|NCT00749203|741586|P2|COMPLETED|Second Infusion at 2 Weeks||13
306832|NCT00749203|741587|P1|COMPLETED|Second Infusion at 2 Weeks||16
306833|NCT00749203|741586|P2|STARTED|Second Infusion at 2 Weeks||15
306834|NCT00749203|741587|P1|STARTED|Second Infusion at 2 Weeks|N=6 completed the study at 2 wks due to CAPS scores < 50, precluding 2nd infusion.|16
306835|NCT00749203|741586|P2|NOT COMPLETED|no Infusion at Week 1||4
306836|NCT00749203|741587|P1|NOT COMPLETED|no Infusion at Week 1||0
306837|NCT00749203|741586|P2|COMPLETED|no Infusion at Week 1||15
306838|NCT00749203|741587|P1|COMPLETED|no Infusion at Week 1||22
306839|NCT00749203|741586|P2|STARTED|no Infusion at Week 1||19
306840|NCT00749203|741587|P1|STARTED|no Infusion at Week 1||22
306841|NCT00749203|741586|P2|NOT COMPLETED|First Infusion Day 1||0
306842|NCT00749203|741587|P1|NOT COMPLETED|First Infusion Day 1||0
306843|NCT00749203|741586|P2|COMPLETED|First Infusion Day 1||19
306844|NCT00749203|741587|P1|COMPLETED|First Infusion Day 1||22
306845|NCT00749203|741586|P2|STARTED|First Infusion Day 1||19
306846|NCT00749203|741587|P1|STARTED|First Infusion Day 1||22
306847|NCT00749190|741608|P7|NOT COMPLETED|Overall Study||1
306848|NCT00749190|741609|P6|NOT COMPLETED|Overall Study||5
306849|NCT00749190|741610|P5|NOT COMPLETED|Overall Study||0
306850|NCT00749190|741611|P4|NOT COMPLETED|Overall Study||5
306851|NCT00749190|741612|P3|NOT COMPLETED|Overall Study||1
306852|NCT00749190|741613|P2|NOT COMPLETED|Overall Study||5
306853|NCT00749190|741614|P1|NOT COMPLETED|Overall Study||5
306854|NCT00749190|741608|P7|COMPLETED|Overall Study||70
306855|NCT00749190|741609|P6|COMPLETED|Overall Study||65
306856|NCT00749190|741610|P5|COMPLETED|Overall Study||70
306857|NCT00749190|741611|P4|COMPLETED|Overall Study||66
306858|NCT00749190|741612|P3|COMPLETED|Overall Study||70
306859|NCT00749190|741613|P2|COMPLETED|Overall Study||66
306860|NCT00749190|741614|P1|COMPLETED|Overall Study||66
306861|NCT00749190|741608|P7|STARTED|Overall Study||71
306862|NCT00749190|741609|P6|STARTED|Overall Study||70
306863|NCT00749190|741610|P5|STARTED|Overall Study||70
306864|NCT00749190|741611|P4|STARTED|Overall Study||71
306865|NCT00749190|741612|P3|STARTED|Overall Study||71
306866|NCT00749190|741613|P2|STARTED|Overall Study||71
306867|NCT00749190|741614|P1|STARTED|Overall Study||71
306868|NCT00749125|741693|P2|NOT COMPLETED|Overall Study||18
306869|NCT00749125|741694|P1|NOT COMPLETED|Overall Study||11
306870|NCT00749125|741693|P2|COMPLETED|Overall Study||34
306871|NCT00749125|741694|P1|COMPLETED|Overall Study||36
306872|NCT00749125|741693|P2|STARTED|Overall Study||52
306873|NCT00749125|741694|P1|STARTED|Overall Study||47
306874|NCT00749073|741700|P1|NOT COMPLETED|Overall Study||0
306875|NCT00749073|741700|P1|COMPLETED|Overall Study||10
306876|NCT00749073|741700|P1|STARTED|Overall Study||10
306877|NCT00748982|741708|P2|NOT COMPLETED|Overall Study||0
306878|NCT00748982|741709|P1|NOT COMPLETED|Overall Study||0
306879|NCT00748982|741708|P2|COMPLETED|Overall Study||4
306880|NCT00748982|741709|P1|COMPLETED|Overall Study||12
306881|NCT00748982|741708|P2|STARTED|Overall Study||4
306882|NCT00748982|741709|P1|STARTED|Overall Study||12
306883|NCT00748969|741723|P2|NOT COMPLETED|Overall Study||1
306884|NCT00748969|741724|P1|NOT COMPLETED|Overall Study||1
306885|NCT00748969|741723|P2|COMPLETED|Overall Study||0
306886|NCT00748969|741724|P1|COMPLETED|Overall Study||0
306887|NCT00748969|741723|P2|STARTED|Overall Study|Subject withdrew from study due to randomization to no treatment|1
306888|NCT00748969|741724|P1|STARTED|Overall Study|Subject withdrew from study due to worsening sleep apnea|1
306889|NCT00748956|741735|P3|NOT COMPLETED|Overall Study||0
306890|NCT00748956|741736|P2|NOT COMPLETED|Overall Study||0
306891|NCT00748956|741737|P1|NOT COMPLETED|Overall Study||0
306892|NCT00748956|741735|P3|COMPLETED|Overall Study||5
306893|NCT00748956|741736|P2|COMPLETED|Overall Study||5
306894|NCT00748956|741737|P1|COMPLETED|Overall Study||0
306895|NCT00748956|741735|P3|STARTED|Overall Study||5
306896|NCT00748956|741736|P2|STARTED|Overall Study||5
306897|NCT00748956|741737|P1|STARTED|Overall Study||0
306898|NCT00748865|741760|P2|NOT COMPLETED|Overall Study||0
306899|NCT00748865|741761|P1|NOT COMPLETED|Overall Study||0
306900|NCT00748865|741760|P2|COMPLETED|Overall Study||10
306901|NCT00748865|741761|P1|COMPLETED|Overall Study||10
306902|NCT00748865|741760|P2|STARTED|Overall Study||10
306903|NCT00748865|741761|P1|STARTED|Overall Study||10
306904|NCT00748826|741767|P1|NOT COMPLETED|Overall Study||301
306905|NCT00748826|741767|P1|COMPLETED|Overall Study||207
306906|NCT00748826|741767|P1|STARTED|Overall Study|Of 576 total enrolled, 68 out of scope participants were not used for analyses|508
306907|NCT00748709|741774|P1|NOT COMPLETED|Overall Study||20
306908|NCT00748709|741774|P1|COMPLETED|Overall Study||0
306909|NCT00748709|741774|P1|STARTED|Overall Study|Treated|20
306910|NCT00748657|741786|P1|NOT COMPLETED|Overall Study||0
306911|NCT00748657|741786|P1|COMPLETED|Overall Study||36
306912|NCT00748657|741786|P1|STARTED|Overall Study||36
306913|NCT00748579|741800|P2|NOT COMPLETED|Overall Study||0
306914|NCT00748579|741801|P1|NOT COMPLETED|Overall Study||0
306915|NCT00748579|741800|P2|COMPLETED|Overall Study||0
306916|NCT00748579|741801|P1|COMPLETED|Overall Study||2
306917|NCT00748579|741800|P2|STARTED|Overall Study||0
306918|NCT00748579|741801|P1|STARTED|Overall Study||2
306919|NCT00748566|741809|P1|NOT COMPLETED|Overall Study||112
306920|NCT00748566|741809|P1|COMPLETED|Overall Study||60
306921|NCT00748566|741809|P1|STARTED|Overall Study||172
306922|NCT00748553|741839|P2|NOT COMPLETED|Overall Study||1
306923|NCT00748553|741840|P1|NOT COMPLETED|Overall Study||3
306924|NCT00748553|741839|P2|COMPLETED|Overall Study||13
306925|NCT00748553|741840|P1|COMPLETED|Overall Study||13
306926|NCT00748553|741839|P2|STARTED|Overall Study||14
306927|NCT00748553|741840|P1|STARTED|Overall Study||16
306928|NCT00748540|741847|P1|NOT COMPLETED|Overall Study||1
306929|NCT00748540|741847|P1|COMPLETED|Overall Study||49
306930|NCT00748540|741847|P1|STARTED|Overall Study||50
306931|NCT00748410|741856|P2|NOT COMPLETED|Overall Study||0
306932|NCT00748410|741857|P1|NOT COMPLETED|Overall Study||0
306933|NCT00748410|741856|P2|COMPLETED|Overall Study||2
306934|NCT00748410|741857|P1|COMPLETED|Overall Study||1
306935|NCT00748410|741856|P2|STARTED|Overall Study||2
306936|NCT00748410|741857|P1|STARTED|Overall Study||1
306937|NCT00748241|741873|P1|NOT COMPLETED|Overall Study||8
306938|NCT00748241|741873|P1|COMPLETED|Overall Study||11
306939|NCT00748241|741873|P1|STARTED|Overall Study||19
306940|NCT00748189|741883|P2|NOT COMPLETED|Overall Study||212
306941|NCT00748189|741884|P1|NOT COMPLETED|Overall Study||216
306942|NCT00748189|741883|P2|COMPLETED|Overall Study||9
306943|NCT00748189|741884|P1|COMPLETED|Overall Study||10
306944|NCT00748189|741883|P2|STARTED|Overall Study||221
306945|NCT00748189|741884|P1|STARTED|Overall Study||226
306946|NCT00748098|741939|P2|NOT COMPLETED|Second Taper Period||0
306947|NCT00748098|741940|P1|NOT COMPLETED|Second Taper Period||0
306948|NCT00748098|741939|P2|COMPLETED|Second Taper Period||61
306949|NCT00748098|741940|P1|COMPLETED|Second Taper Period||53
306950|NCT00748098|741939|P2|STARTED|Second Taper Period||61
306951|NCT00748098|741940|P1|STARTED|Second Taper Period||53
306952|NCT00748098|741939|P2|NOT COMPLETED|Second Treatment Intervention Period||3
306953|NCT00748098|741940|P1|NOT COMPLETED|Second Treatment Intervention Period||6
306954|NCT00748098|741939|P2|COMPLETED|Second Treatment Intervention Period||61
306955|NCT00748098|741940|P1|COMPLETED|Second Treatment Intervention Period||53
306956|NCT00748098|741939|P2|STARTED|Second Treatment Intervention Period||64
306957|NCT00748098|741940|P1|STARTED|Second Treatment Intervention Period||59
306958|NCT00748098|741939|P2|NOT COMPLETED|1-Week Washout Period||1
306959|NCT00748098|741940|P1|NOT COMPLETED|1-Week Washout Period||2
306960|NCT00748098|741939|P2|COMPLETED|1-Week Washout Period||64
306961|NCT00748098|741940|P1|COMPLETED|1-Week Washout Period||59
306962|NCT00748098|741939|P2|STARTED|1-Week Washout Period||65
306963|NCT00748098|741940|P1|STARTED|1-Week Washout Period||61
306964|NCT00748098|741939|P2|NOT COMPLETED|First Taper Period||1
306965|NCT00748098|741940|P1|NOT COMPLETED|First Taper Period||3
306966|NCT00748098|741939|P2|COMPLETED|First Taper Period||65
306967|NCT00748098|741940|P1|COMPLETED|First Taper Period||61
306968|NCT00748098|741939|P2|STARTED|First Taper Period||66
306969|NCT00748098|741940|P1|STARTED|First Taper Period||64
306970|NCT00748098|741939|P2|NOT COMPLETED|First Treatment Intervention Period||1
306971|NCT00748098|741940|P1|NOT COMPLETED|First Treatment Intervention Period||5
306972|NCT00748098|741939|P2|COMPLETED|First Treatment Intervention Period||66
306973|NCT00748098|741940|P1|COMPLETED|First Treatment Intervention Period||64
306974|NCT00748098|741939|P2|STARTED|First Treatment Intervention Period||67
306975|NCT00748098|741940|P1|STARTED|First Treatment Intervention Period||69
306976|NCT00748085|742000|P1|NOT COMPLETED|Overall Study||0
306977|NCT00748085|742000|P1|COMPLETED|Overall Study|No analysis -study terminated for business reasons.|5
306978|NCT00748085|742000|P1|STARTED|Overall Study||5
306979|NCT00748072|742007|P2|NOT COMPLETED|Overall Study||0
306980|NCT00748072|742008|P1|NOT COMPLETED|Overall Study||0
306981|NCT00748072|742007|P2|COMPLETED|Overall Study||80
306982|NCT00748072|742008|P1|COMPLETED|Overall Study||82
306983|NCT00748072|742007|P2|STARTED|Overall Study||80
306984|NCT00748072|742008|P1|STARTED|Overall Study||82
306985|NCT00747916|742014|P1|NOT COMPLETED|Overall Study||0
306986|NCT00747916|742014|P1|COMPLETED|Overall Study||3
306987|NCT00747916|742014|P1|STARTED|Overall Study||3
306988|NCT00747812|742021|P2|NOT COMPLETED|Overall Study||3
306989|NCT00747812|742022|P1|NOT COMPLETED|Overall Study||5
306990|NCT00747812|742021|P2|COMPLETED|Overall Study||0
306991|NCT00747812|742022|P1|COMPLETED|Overall Study||0
306992|NCT00747812|742021|P2|STARTED|Overall Study|4 subjects were randomized to the Control Group; 1 was not implanted due to early enrollment closure|3
306993|NCT00747812|742022|P1|STARTED|Overall Study||5
306994|NCT00747747|742033|P3|NOT COMPLETED|Overall Study||0
306995|NCT00747747|742034|P2|NOT COMPLETED|Overall Study||0
306996|NCT00747747|742035|P1|NOT COMPLETED|Overall Study||0
306997|NCT00747747|742033|P3|COMPLETED|Overall Study|17 with acute episode + 4 with recurrent episode|21
306998|NCT00747747|742034|P2|COMPLETED|Overall Study|11 with acute episode + 3 with recurrent episode|14
306999|NCT00747747|742035|P1|COMPLETED|Overall Study|13 with acute episode + 1 with recurrent episode|14
307000|NCT00747747|742033|P3|STARTED|Overall Study||21
307001|NCT00747747|742034|P2|STARTED|Overall Study||14
307002|NCT00747747|742035|P1|STARTED|Overall Study||14
307003|NCT00747643|742060|P2|NOT COMPLETED|Overall Study||27
307004|NCT00747643|742061|P1|NOT COMPLETED|Overall Study||36
307005|NCT00747643|742060|P2|COMPLETED|Overall Study||54
307006|NCT00747643|742061|P1|COMPLETED|Overall Study||46
307007|NCT00747643|742060|P2|STARTED|Overall Study||81
307008|NCT00747643|742061|P1|STARTED|Overall Study||82
307009|NCT00747617|742075|P2|NOT COMPLETED|Overall Study||1
307010|NCT00747617|742076|P1|NOT COMPLETED|Overall Study||3
307011|NCT00747617|742075|P2|COMPLETED|Overall Study||11
307012|NCT00747617|742076|P1|COMPLETED|Overall Study||10
307013|NCT00747617|742075|P2|STARTED|Overall Study||12
307014|NCT00747617|742076|P1|STARTED|Overall Study||13
307015|NCT00747565|742086|P2|NOT COMPLETED|Overall Study||7
307016|NCT00747565|742087|P1|NOT COMPLETED|Overall Study||14
307017|NCT00747565|742086|P2|COMPLETED|Overall Study||116
307018|NCT00747565|742087|P1|COMPLETED|Overall Study|118 multifocal subjects in the original study plus 215 multifocal subejcts in the expansion study.|333
307019|NCT00747565|742086|P2|STARTED|Overall Study||123
307020|NCT00747565|742087|P1|STARTED|Overall Study|125 multifocal subjects in original study plus 222 multifocal subjects in the expansion study.|347
307021|NCT00747552|742095|P1|NOT COMPLETED|Overall Study||0
307022|NCT00747552|742095|P1|COMPLETED|Overall Study||30
307023|NCT00747552|742095|P1|STARTED|Overall Study|This number does not include the 2 who were enrolled but had no data collected on them.|30
307024|NCT00747474|742100|P12|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
307025|NCT00747474|742101|P11|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
307026|NCT00747474|742102|P10|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
307027|NCT00747474|742103|P9|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
307028|NCT00747474|742104|P8|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
307029|NCT00747474|742105|P7|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
307030|NCT00747474|742106|P6|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
307031|NCT00747474|742107|P5|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
307032|NCT00747474|742108|P4|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
307033|NCT00747474|742109|P3|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
307034|NCT00747474|742110|P2|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
307035|NCT00747474|742111|P1|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
307036|NCT00747474|742100|P12|COMPLETED|Cohort 12 (60 mg/m^2) Period||6
307037|NCT00747474|742101|P11|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
307038|NCT00747474|742102|P10|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
307039|NCT00747474|742103|P9|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
307040|NCT00747474|742104|P8|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
307041|NCT00747474|742105|P7|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
307042|NCT00747474|742106|P6|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
307043|NCT00747474|742107|P5|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
307044|NCT00747474|742108|P4|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
307045|NCT00747474|742109|P3|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
307046|NCT00747474|742110|P2|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
307047|NCT00747474|742111|P1|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
307048|NCT00747474|742100|P12|STARTED|Cohort 12 (60 mg/m^2) Period||6
307049|NCT00747474|742101|P11|STARTED|Cohort 12 (60 mg/m^2) Period||0
307050|NCT00747474|742102|P10|STARTED|Cohort 12 (60 mg/m^2) Period||0
307051|NCT00747474|742103|P9|STARTED|Cohort 12 (60 mg/m^2) Period||0
307052|NCT00747474|742104|P8|STARTED|Cohort 12 (60 mg/m^2) Period||0
307053|NCT00747474|742105|P7|STARTED|Cohort 12 (60 mg/m^2) Period||0
307054|NCT00747474|742106|P6|STARTED|Cohort 12 (60 mg/m^2) Period||0
307055|NCT00747474|742107|P5|STARTED|Cohort 12 (60 mg/m^2) Period||0
307056|NCT00747474|742108|P4|STARTED|Cohort 12 (60 mg/m^2) Period||0
307057|NCT00747474|742109|P3|STARTED|Cohort 12 (60 mg/m^2) Period||0
307058|NCT00747474|742110|P2|STARTED|Cohort 12 (60 mg/m^2) Period||0
307059|NCT00747474|742111|P1|STARTED|Cohort 12 (60 mg/m^2) Period||0
307060|NCT00747474|742100|P12|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
307061|NCT00747474|742101|P11|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
307062|NCT00747474|742102|P10|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
307063|NCT00747474|742103|P9|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
307064|NCT00747474|742104|P8|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
307065|NCT00747474|742105|P7|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
307066|NCT00747474|742106|P6|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
307067|NCT00747474|742107|P5|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
307068|NCT00747474|742108|P4|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
307069|NCT00747474|742109|P3|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
307070|NCT00747474|742110|P2|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
307071|NCT00747474|742111|P1|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
307072|NCT00747474|742100|P12|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
307073|NCT00747474|742101|P11|COMPLETED|Cohort 11 (50 mg/m^2) Period||5
307074|NCT00747474|742102|P10|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
307075|NCT00747474|742103|P9|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
307076|NCT00747474|742104|P8|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
307077|NCT00747474|742105|P7|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
307078|NCT00747474|742106|P6|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
307079|NCT00747474|742107|P5|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
307080|NCT00747474|742108|P4|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
307081|NCT00747474|742109|P3|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
307082|NCT00747474|742110|P2|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
307083|NCT00747474|742111|P1|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
307084|NCT00747474|742100|P12|STARTED|Cohort 11 (50 mg/m^2) Period||0
307085|NCT00747474|742101|P11|STARTED|Cohort 11 (50 mg/m^2) Period||5
307086|NCT00747474|742102|P10|STARTED|Cohort 11 (50 mg/m^2) Period||0
307087|NCT00747474|742103|P9|STARTED|Cohort 11 (50 mg/m^2) Period||0
307088|NCT00747474|742104|P8|STARTED|Cohort 11 (50 mg/m^2) Period||0
307089|NCT00747474|742105|P7|STARTED|Cohort 11 (50 mg/m^2) Period||0
307090|NCT00747474|742106|P6|STARTED|Cohort 11 (50 mg/m^2) Period||0
307091|NCT00747474|742107|P5|STARTED|Cohort 11 (50 mg/m^2) Period||0
307092|NCT00747474|742108|P4|STARTED|Cohort 11 (50 mg/m^2) Period||0
307093|NCT00747474|742109|P3|STARTED|Cohort 11 (50 mg/m^2) Period||0
307094|NCT00747474|742110|P2|STARTED|Cohort 11 (50 mg/m^2) Period||0
307095|NCT00747474|742111|P1|STARTED|Cohort 11 (50 mg/m^2) Period||0
307096|NCT00747474|742100|P12|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
307097|NCT00747474|742101|P11|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
307098|NCT00747474|742102|P10|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
307099|NCT00747474|742103|P9|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
307100|NCT00747474|742104|P8|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
307101|NCT00747474|742105|P7|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
307102|NCT00747474|742106|P6|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
307103|NCT00747474|742107|P5|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
307104|NCT00747474|742108|P4|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
307105|NCT00747474|742109|P3|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
307106|NCT00747474|742110|P2|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
307107|NCT00747474|742111|P1|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
307108|NCT00747474|742100|P12|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
307109|NCT00747474|742101|P11|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
307110|NCT00747474|742102|P10|COMPLETED|Cohort 10 (40 mg/m^2) Period||7
307111|NCT00747474|742103|P9|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
307112|NCT00747474|742104|P8|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
307113|NCT00747474|742105|P7|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
307114|NCT00747474|742106|P6|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
307115|NCT00747474|742107|P5|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
307116|NCT00747474|742108|P4|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
307117|NCT00747474|742109|P3|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
307118|NCT00747474|742110|P2|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
307119|NCT00747474|742111|P1|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
307120|NCT00747474|742100|P12|STARTED|Cohort 10 (40 mg/m^2) Period||0
307121|NCT00747474|742101|P11|STARTED|Cohort 10 (40 mg/m^2) Period||0
307122|NCT00747474|742102|P10|STARTED|Cohort 10 (40 mg/m^2) Period||7
307123|NCT00747474|742103|P9|STARTED|Cohort 10 (40 mg/m^2) Period||0
307124|NCT00747474|742104|P8|STARTED|Cohort 10 (40 mg/m^2) Period||0
307125|NCT00747474|742105|P7|STARTED|Cohort 10 (40 mg/m^2) Period||0
307126|NCT00747474|742106|P6|STARTED|Cohort 10 (40 mg/m^2) Period||0
307127|NCT00747474|742107|P5|STARTED|Cohort 10 (40 mg/m^2) Period||0
307128|NCT00747474|742108|P4|STARTED|Cohort 10 (40 mg/m^2) Period||0
307129|NCT00747474|742109|P3|STARTED|Cohort 10 (40 mg/m^2) Period||0
307130|NCT00747474|742110|P2|STARTED|Cohort 10 (40 mg/m^2) Period||0
307131|NCT00747474|742111|P1|STARTED|Cohort 10 (40 mg/m^2) Period||0
307132|NCT00747474|742100|P12|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
307133|NCT00747474|742101|P11|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
307134|NCT00747474|742102|P10|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
307135|NCT00747474|742103|P9|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
307136|NCT00747474|742104|P8|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
307137|NCT00747474|742105|P7|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
307138|NCT00747474|742106|P6|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
307139|NCT00747474|742107|P5|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
307140|NCT00747474|742108|P4|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
307141|NCT00747474|742109|P3|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
307142|NCT00747474|742110|P2|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
307143|NCT00747474|742111|P1|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
307144|NCT00747474|742100|P12|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
307145|NCT00747474|742101|P11|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
307146|NCT00747474|742102|P10|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
307147|NCT00747474|742103|P9|COMPLETED|Cohort 9 (35 mg/m^2) Period||4
307148|NCT00747474|742104|P8|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
307149|NCT00747474|742105|P7|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
307150|NCT00747474|742106|P6|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
307151|NCT00747474|742107|P5|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
307152|NCT00747474|742108|P4|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
307153|NCT00747474|742109|P3|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
307154|NCT00747474|742110|P2|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
307155|NCT00747474|742111|P1|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
307156|NCT00747474|742100|P12|STARTED|Cohort 9 (35 mg/m^2) Period||0
307157|NCT00747474|742101|P11|STARTED|Cohort 9 (35 mg/m^2) Period||0
307158|NCT00747474|742102|P10|STARTED|Cohort 9 (35 mg/m^2) Period||0
307159|NCT00747474|742103|P9|STARTED|Cohort 9 (35 mg/m^2) Period||4
307160|NCT00747474|742104|P8|STARTED|Cohort 9 (35 mg/m^2) Period||0
307161|NCT00747474|742105|P7|STARTED|Cohort 9 (35 mg/m^2) Period||0
307162|NCT00747474|742106|P6|STARTED|Cohort 9 (35 mg/m^2) Period||0
307163|NCT00747474|742107|P5|STARTED|Cohort 9 (35 mg/m^2) Period||0
307164|NCT00747474|742108|P4|STARTED|Cohort 9 (35 mg/m^2) Period||0
307165|NCT00747474|742109|P3|STARTED|Cohort 9 (35 mg/m^2) Period||0
307166|NCT00747474|742110|P2|STARTED|Cohort 9 (35 mg/m^2) Period||0
307167|NCT00747474|742111|P1|STARTED|Cohort 9 (35 mg/m^2) Period||0
307168|NCT00747474|742100|P12|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
307169|NCT00747474|742101|P11|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
307170|NCT00747474|742102|P10|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
307171|NCT00747474|742103|P9|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
307172|NCT00747474|742104|P8|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||1
307173|NCT00747474|742105|P7|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
307174|NCT00747474|742106|P6|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
307175|NCT00747474|742107|P5|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
307176|NCT00747474|742108|P4|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
307177|NCT00747474|742109|P3|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
307178|NCT00747474|742110|P2|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
307179|NCT00747474|742111|P1|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
307180|NCT00747474|742100|P12|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
307181|NCT00747474|742101|P11|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
307182|NCT00747474|742102|P10|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
307183|NCT00747474|742103|P9|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
307184|NCT00747474|742104|P8|COMPLETED|Cohort 8 (40 mg/m^2) Period||5
307185|NCT00747474|742105|P7|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
307186|NCT00747474|742106|P6|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
307187|NCT00747474|742107|P5|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
307188|NCT00747474|742108|P4|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
307189|NCT00747474|742109|P3|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
307190|NCT00747474|742110|P2|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
307191|NCT00747474|742111|P1|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
307192|NCT00747474|742100|P12|STARTED|Cohort 8 (40 mg/m^2) Period||0
307193|NCT00747474|742101|P11|STARTED|Cohort 8 (40 mg/m^2) Period||0
307194|NCT00747474|742102|P10|STARTED|Cohort 8 (40 mg/m^2) Period||0
307195|NCT00747474|742103|P9|STARTED|Cohort 8 (40 mg/m^2) Period||0
307196|NCT00747474|742104|P8|STARTED|Cohort 8 (40 mg/m^2) Period||6
307197|NCT00747474|742105|P7|STARTED|Cohort 8 (40 mg/m^2) Period||0
307198|NCT00747474|742106|P6|STARTED|Cohort 8 (40 mg/m^2) Period||0
307199|NCT00747474|742107|P5|STARTED|Cohort 8 (40 mg/m^2) Period||0
307200|NCT00747474|742108|P4|STARTED|Cohort 8 (40 mg/m^2) Period||0
307201|NCT00747474|742109|P3|STARTED|Cohort 8 (40 mg/m^2) Period||0
307202|NCT00747474|742110|P2|STARTED|Cohort 8 (40 mg/m^2) Period||0
307203|NCT00747474|742111|P1|STARTED|Cohort 8 (40 mg/m^2) Period||0
307204|NCT00747474|742100|P12|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
307205|NCT00747474|742101|P11|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
307206|NCT00747474|742102|P10|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
307207|NCT00747474|742103|P9|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
307208|NCT00747474|742104|P8|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
307209|NCT00747474|742105|P7|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
307210|NCT00747474|742106|P6|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
307211|NCT00747474|742107|P5|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
307212|NCT00747474|742108|P4|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
307213|NCT00747474|742109|P3|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
307214|NCT00747474|742110|P2|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
307215|NCT00747474|742111|P1|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
307216|NCT00747474|742100|P12|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
307217|NCT00747474|742101|P11|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
307218|NCT00747474|742102|P10|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
307219|NCT00747474|742103|P9|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
307220|NCT00747474|742104|P8|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
307221|NCT00747474|742105|P7|COMPLETED|Cohort 7 (30 mg/m^2) Period||4
307222|NCT00747474|742106|P6|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
307223|NCT00747474|742107|P5|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
307224|NCT00747474|742108|P4|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
307225|NCT00747474|742109|P3|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
307226|NCT00747474|742110|P2|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
307227|NCT00747474|742111|P1|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
307228|NCT00747474|742100|P12|STARTED|Cohort 7 (30 mg/m^2) Period||0
307229|NCT00747474|742101|P11|STARTED|Cohort 7 (30 mg/m^2) Period||0
307230|NCT00747474|742102|P10|STARTED|Cohort 7 (30 mg/m^2) Period||0
307231|NCT00747474|742103|P9|STARTED|Cohort 7 (30 mg/m^2) Period||0
307232|NCT00747474|742104|P8|STARTED|Cohort 7 (30 mg/m^2) Period||0
307233|NCT00747474|742105|P7|STARTED|Cohort 7 (30 mg/m^2) Period||4
307234|NCT00747474|742106|P6|STARTED|Cohort 7 (30 mg/m^2) Period||0
307235|NCT00747474|742107|P5|STARTED|Cohort 7 (30 mg/m^2) Period||0
307236|NCT00747474|742108|P4|STARTED|Cohort 7 (30 mg/m^2) Period||0
307237|NCT00747474|742109|P3|STARTED|Cohort 7 (30 mg/m^2) Period||0
307238|NCT00747474|742110|P2|STARTED|Cohort 7 (30 mg/m^2) Period||0
307239|NCT00747474|742111|P1|STARTED|Cohort 7 (30 mg/m^2) Period||0
307240|NCT00747474|742100|P12|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
307241|NCT00747474|742101|P11|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
307242|NCT00747474|742102|P10|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
307243|NCT00747474|742103|P9|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
307244|NCT00747474|742104|P8|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
307245|NCT00747474|742105|P7|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
307246|NCT00747474|742106|P6|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
307247|NCT00747474|742107|P5|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
307248|NCT00747474|742108|P4|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
307249|NCT00747474|742109|P3|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
307250|NCT00747474|742110|P2|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
307251|NCT00747474|742111|P1|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
307252|NCT00747474|742100|P12|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
307253|NCT00747474|742101|P11|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
307254|NCT00747474|742102|P10|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
307255|NCT00747474|742103|P9|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
307256|NCT00747474|742104|P8|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
307257|NCT00747474|742105|P7|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
307258|NCT00747474|742106|P6|COMPLETED|Cohort 6 (20 mg/m^2) Period||4
307259|NCT00747474|742107|P5|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
307260|NCT00747474|742108|P4|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
307261|NCT00747474|742109|P3|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
307262|NCT00747474|742110|P2|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
307263|NCT00747474|742111|P1|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
307264|NCT00747474|742100|P12|STARTED|Cohort 6 (20 mg/m^2) Period||0
307265|NCT00747474|742101|P11|STARTED|Cohort 6 (20 mg/m^2) Period||0
307266|NCT00747474|742102|P10|STARTED|Cohort 6 (20 mg/m^2) Period||0
307267|NCT00747474|742103|P9|STARTED|Cohort 6 (20 mg/m^2) Period||0
307268|NCT00747474|742104|P8|STARTED|Cohort 6 (20 mg/m^2) Period||0
307269|NCT00747474|742105|P7|STARTED|Cohort 6 (20 mg/m^2) Period||0
307270|NCT00747474|742106|P6|STARTED|Cohort 6 (20 mg/m^2) Period||4
307271|NCT00747474|742107|P5|STARTED|Cohort 6 (20 mg/m^2) Period||0
307272|NCT00747474|742108|P4|STARTED|Cohort 6 (20 mg/m^2) Period||0
307273|NCT00747474|742109|P3|STARTED|Cohort 6 (20 mg/m^2) Period||0
307274|NCT00747474|742110|P2|STARTED|Cohort 6 (20 mg/m^2) Period||0
307275|NCT00747474|742111|P1|STARTED|Cohort 6 (20 mg/m^2) Period||0
307276|NCT00747474|742100|P12|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
307277|NCT00747474|742101|P11|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
307278|NCT00747474|742102|P10|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
307279|NCT00747474|742103|P9|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
307280|NCT00747474|742104|P8|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
307281|NCT00747474|742105|P7|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
307282|NCT00747474|742106|P6|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
307283|NCT00747474|742107|P5|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
307284|NCT00747474|742108|P4|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
307285|NCT00747474|742109|P3|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
307286|NCT00747474|742110|P2|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
307287|NCT00747474|742111|P1|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
307288|NCT00747474|742100|P12|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
307289|NCT00747474|742101|P11|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
307290|NCT00747474|742102|P10|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
307291|NCT00747474|742103|P9|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
307292|NCT00747474|742104|P8|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
307293|NCT00747474|742105|P7|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
307294|NCT00747474|742106|P6|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
307295|NCT00747474|742107|P5|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||4
307296|NCT00747474|742108|P4|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
307297|NCT00747474|742109|P3|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
307298|NCT00747474|742110|P2|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
307299|NCT00747474|742111|P1|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
307300|NCT00747474|742100|P12|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
307301|NCT00747474|742101|P11|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
307302|NCT00747474|742102|P10|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
307303|NCT00747474|742103|P9|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
307304|NCT00747474|742104|P8|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
307305|NCT00747474|742105|P7|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
307306|NCT00747474|742106|P6|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
307307|NCT00747474|742107|P5|STARTED|Cohort 5 (13.5 mg/m^2) Period||4
307308|NCT00747474|742108|P4|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
307309|NCT00747474|742109|P3|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
307310|NCT00747474|742110|P2|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
307311|NCT00747474|742111|P1|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
307312|NCT00747474|742100|P12|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
307313|NCT00747474|742101|P11|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
307314|NCT00747474|742102|P10|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
307315|NCT00747474|742103|P9|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
307316|NCT00747474|742104|P8|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
307317|NCT00747474|742105|P7|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
307318|NCT00747474|742106|P6|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
307319|NCT00747474|742107|P5|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
307320|NCT00747474|742108|P4|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
307321|NCT00747474|742109|P3|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
307322|NCT00747474|742110|P2|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
307323|NCT00747474|742111|P1|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
307324|NCT00747474|742100|P12|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
307325|NCT00747474|742101|P11|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
307326|NCT00747474|742102|P10|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
307327|NCT00747474|742103|P9|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
307328|NCT00747474|742104|P8|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
307329|NCT00747474|742105|P7|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
307330|NCT00747474|742106|P6|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
307331|NCT00747474|742107|P5|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
307332|NCT00747474|742108|P4|COMPLETED|Cohort 4 (9 mg/m^2) Period||4
307333|NCT00747474|742109|P3|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
307334|NCT00747474|742110|P2|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
307335|NCT00747474|742111|P1|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
307336|NCT00747474|742100|P12|STARTED|Cohort 4 (9 mg/m^2) Period||0
307337|NCT00747474|742101|P11|STARTED|Cohort 4 (9 mg/m^2) Period||0
307338|NCT00747474|742102|P10|STARTED|Cohort 4 (9 mg/m^2) Period||0
307339|NCT00747474|742103|P9|STARTED|Cohort 4 (9 mg/m^2) Period||0
307340|NCT00747474|742104|P8|STARTED|Cohort 4 (9 mg/m^2) Period||0
307341|NCT00747474|742105|P7|STARTED|Cohort 4 (9 mg/m^2) Period||0
307342|NCT00747474|742106|P6|STARTED|Cohort 4 (9 mg/m^2) Period||0
307343|NCT00747474|742107|P5|STARTED|Cohort 4 (9 mg/m^2) Period||0
307344|NCT00747474|742108|P4|STARTED|Cohort 4 (9 mg/m^2) Period||4
307345|NCT00747474|742109|P3|STARTED|Cohort 4 (9 mg/m^2) Period||0
307346|NCT00747474|742110|P2|STARTED|Cohort 4 (9 mg/m^2) Period||0
307347|NCT00747474|742111|P1|STARTED|Cohort 4 (9 mg/m^2) Period||0
307348|NCT00747474|742100|P12|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
307349|NCT00747474|742101|P11|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
307350|NCT00747474|742102|P10|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
307351|NCT00747474|742103|P9|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
307352|NCT00747474|742104|P8|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
307353|NCT00747474|742105|P7|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
307354|NCT00747474|742106|P6|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
307355|NCT00747474|742107|P5|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
307356|NCT00747474|742108|P4|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
307357|NCT00747474|742109|P3|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
307358|NCT00747474|742110|P2|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
307359|NCT00747474|742111|P1|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
307360|NCT00747474|742100|P12|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
307361|NCT00747474|742101|P11|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
307362|NCT00747474|742102|P10|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
307363|NCT00747474|742103|P9|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
307364|NCT00747474|742104|P8|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
307365|NCT00747474|742105|P7|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
307366|NCT00747474|742106|P6|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
307367|NCT00747474|742107|P5|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
307368|NCT00747474|742108|P4|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
307369|NCT00747474|742109|P3|COMPLETED|Cohort 3 (6 mg/m^2) Period||3
307370|NCT00747474|742110|P2|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
307371|NCT00747474|742111|P1|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
307372|NCT00747474|742100|P12|STARTED|Cohort 3 (6 mg/m^2) Period||0
307373|NCT00747474|742101|P11|STARTED|Cohort 3 (6 mg/m^2) Period||0
307374|NCT00747474|742102|P10|STARTED|Cohort 3 (6 mg/m^2) Period||0
307375|NCT00747474|742103|P9|STARTED|Cohort 3 (6 mg/m^2) Period||0
307376|NCT00747474|742104|P8|STARTED|Cohort 3 (6 mg/m^2) Period||0
307377|NCT00747474|742105|P7|STARTED|Cohort 3 (6 mg/m^2) Period||0
307378|NCT00747474|742106|P6|STARTED|Cohort 3 (6 mg/m^2) Period||0
307379|NCT00747474|742107|P5|STARTED|Cohort 3 (6 mg/m^2) Period||0
307380|NCT00747474|742108|P4|STARTED|Cohort 3 (6 mg/m^2) Period||0
307381|NCT00747474|742109|P3|STARTED|Cohort 3 (6 mg/m^2) Period||3
307382|NCT00747474|742110|P2|STARTED|Cohort 3 (6 mg/m^2) Period||0
307383|NCT00747474|742111|P1|STARTED|Cohort 3 (6 mg/m^2) Period||0
307384|NCT00747474|742100|P12|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
307385|NCT00747474|742101|P11|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
307386|NCT00747474|742102|P10|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
307387|NCT00747474|742103|P9|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
307388|NCT00747474|742104|P8|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
307389|NCT00747474|742105|P7|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
307390|NCT00747474|742106|P6|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
307391|NCT00747474|742107|P5|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
307392|NCT00747474|742108|P4|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
307393|NCT00747474|742109|P3|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
307394|NCT00747474|742110|P2|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
307395|NCT00747474|742111|P1|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
307396|NCT00747474|742100|P12|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
307397|NCT00747474|742101|P11|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
307398|NCT00747474|742102|P10|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
307399|NCT00747474|742103|P9|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
307400|NCT00747474|742104|P8|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
307401|NCT00747474|742105|P7|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
307402|NCT00747474|742106|P6|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
307403|NCT00747474|742107|P5|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
307404|NCT00747474|742108|P4|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
307405|NCT00747474|742109|P3|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
307406|NCT00747474|742110|P2|COMPLETED|Cohort 2 (3 mg/m^2) Period||4
307407|NCT00747474|742111|P1|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
307408|NCT00747474|742100|P12|STARTED|Cohort 2 (3 mg/m^2) Period||0
307409|NCT00747474|742101|P11|STARTED|Cohort 2 (3 mg/m^2) Period||0
307410|NCT00747474|742102|P10|STARTED|Cohort 2 (3 mg/m^2) Period||0
307411|NCT00747474|742103|P9|STARTED|Cohort 2 (3 mg/m^2) Period||0
307412|NCT00747474|742104|P8|STARTED|Cohort 2 (3 mg/m^2) Period||0
307413|NCT00747474|742105|P7|STARTED|Cohort 2 (3 mg/m^2) Period||0
307414|NCT00747474|742106|P6|STARTED|Cohort 2 (3 mg/m^2) Period||0
307415|NCT00747474|742107|P5|STARTED|Cohort 2 (3 mg/m^2) Period||0
307416|NCT00747474|742108|P4|STARTED|Cohort 2 (3 mg/m^2) Period||0
307417|NCT00747474|742109|P3|STARTED|Cohort 2 (3 mg/m^2) Period||0
307418|NCT00747474|742110|P2|STARTED|Cohort 2 (3 mg/m^2) Period||4
307419|NCT00747474|742111|P1|STARTED|Cohort 2 (3 mg/m^2) Period||0
307420|NCT00747474|742100|P12|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
307421|NCT00747474|742101|P11|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
307422|NCT00747474|742102|P10|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
307423|NCT00747474|742103|P9|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
307424|NCT00747474|742104|P8|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
307425|NCT00747474|742105|P7|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
307426|NCT00747474|742106|P6|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
307427|NCT00747474|742107|P5|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
307428|NCT00747474|742108|P4|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
307429|NCT00747474|742109|P3|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
307430|NCT00747474|742110|P2|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
307431|NCT00747474|742111|P1|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
307432|NCT00747474|742100|P12|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
307433|NCT00747474|742101|P11|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
307434|NCT00747474|742102|P10|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
307435|NCT00747474|742103|P9|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
307436|NCT00747474|742104|P8|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
307437|NCT00747474|742105|P7|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
307438|NCT00747474|742106|P6|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
307439|NCT00747474|742107|P5|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
307440|NCT00747474|742108|P4|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
307441|NCT00747474|742109|P3|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
307442|NCT00747474|742110|P2|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
307443|NCT00747474|742111|P1|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||3
307444|NCT00747474|742100|P12|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
307445|NCT00747474|742101|P11|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
307446|NCT00747474|742102|P10|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
307447|NCT00747474|742103|P9|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
307448|NCT00747474|742104|P8|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
307449|NCT00747474|742105|P7|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
307450|NCT00747474|742106|P6|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
307451|NCT00747474|742107|P5|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
307452|NCT00747474|742108|P4|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
307453|NCT00747474|742109|P3|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
307454|NCT00747474|742110|P2|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
307455|NCT00747474|742111|P1|STARTED|Cohort 1 (1.5 mg/m^2) Period||3
307456|NCT00747461|742137|P1|NOT COMPLETED|Overall Study||5
307457|NCT00747461|742137|P1|COMPLETED|Overall Study||0
307458|NCT00747461|742137|P1|STARTED|Overall Study||5
307459|NCT00747435|742142|P1|NOT COMPLETED|Overall Study||6
307460|NCT00747435|742142|P1|COMPLETED|Overall Study||67
307461|NCT00747435|742142|P1|STARTED|Overall Study||73
307462|NCT00747344|742152|P4|NOT COMPLETED|After Controlled Period||1
307463|NCT00747344|742153|P3|NOT COMPLETED|After Controlled Period||0
307464|NCT00747344|742154|P2|NOT COMPLETED|After Controlled Period||0
307465|NCT00747344|742155|P1|NOT COMPLETED|After Controlled Period||0
307466|NCT00747344|742152|P4|COMPLETED|After Controlled Period||56
307467|NCT00747344|742153|P3|COMPLETED|After Controlled Period||55
307468|NCT00747344|742154|P2|COMPLETED|After Controlled Period||0
307469|NCT00747344|742155|P1|COMPLETED|After Controlled Period||0
307470|NCT00747344|742152|P4|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|57
307471|NCT00747344|742153|P3|STARTED|After Controlled Period||55
307472|NCT00747344|742154|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
307473|NCT00747344|742155|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
307474|NCT00747344|742152|P4|NOT COMPLETED|Controlled Period||0
307475|NCT00747344|742153|P3|NOT COMPLETED|Controlled Period||0
307476|NCT00747344|742154|P2|NOT COMPLETED|Controlled Period||4
307477|NCT00747344|742155|P1|NOT COMPLETED|Controlled Period||5
307478|NCT00747344|742152|P4|COMPLETED|Controlled Period||0
307479|NCT00747344|742153|P3|COMPLETED|Controlled Period||0
307480|NCT00747344|742154|P2|COMPLETED|Controlled Period||57
307481|NCT00747344|742155|P1|COMPLETED|Controlled Period||55
307482|NCT00747344|742152|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
307483|NCT00747344|742153|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
307484|NCT00747344|742154|P2|STARTED|Controlled Period||61
307485|NCT00747344|742155|P1|STARTED|Controlled Period||60
307486|NCT00747227|742169|P2|NOT COMPLETED|Overall Study||4
307487|NCT00747227|742170|P1|NOT COMPLETED|Overall Study||6
307488|NCT00747227|742169|P2|COMPLETED|Overall Study||120
307489|NCT00747227|742170|P1|COMPLETED|Overall Study||120
307490|NCT00747227|742169|P2|STARTED|Overall Study||124
307491|NCT00747227|742170|P1|STARTED|Overall Study||126
307492|NCT00747214|742184|P2|NOT COMPLETED|Overall Study||3
307493|NCT00747214|742185|P1|NOT COMPLETED|Overall Study||8
307494|NCT00747214|742184|P2|COMPLETED|Overall Study||29
307495|NCT00747214|742185|P1|COMPLETED|Overall Study||19
307496|NCT00747214|742184|P2|STARTED|Overall Study||32
307497|NCT00747214|742185|P1|STARTED|Overall Study||27
307498|NCT00747149|742199|P2|NOT COMPLETED|Overall Study||43
307499|NCT00747149|742200|P1|NOT COMPLETED|Overall Study||1
307500|NCT00747149|742199|P2|COMPLETED|Overall Study||401
307501|NCT00747149|742200|P1|COMPLETED|Overall Study||153
307502|NCT00747149|742199|P2|STARTED|Overall Study||444
307503|NCT00747149|742200|P1|STARTED|Overall Study||154
307504|NCT00747006|742215|P3|NOT COMPLETED|Overall Study||1
307505|NCT00747006|742216|P2|NOT COMPLETED|Overall Study||1
307506|NCT00747006|742217|P1|NOT COMPLETED|Overall Study||3
307507|NCT00747006|742215|P3|COMPLETED|Overall Study||2
307508|NCT00747006|742216|P2|COMPLETED|Overall Study||7
307509|NCT00747006|742217|P1|COMPLETED|Overall Study||4
307510|NCT00747006|742215|P3|STARTED|Overall Study||3
307511|NCT00747006|742216|P2|STARTED|Overall Study||8
307512|NCT00747006|742217|P1|STARTED|Overall Study||7
307513|NCT00746954|742283|P3|NOT COMPLETED|Overall Study||0
307514|NCT00746954|742284|P2|NOT COMPLETED|Overall Study||0
307515|NCT00746954|742285|P1|NOT COMPLETED|Overall Study||0
307516|NCT00746954|742283|P3|COMPLETED|Overall Study||2
307517|NCT00746954|742284|P2|COMPLETED|Overall Study||3
307518|NCT00746954|742285|P1|COMPLETED|Overall Study||3
307519|NCT00746954|742283|P3|STARTED|Overall Study||2
307520|NCT00746954|742284|P2|STARTED|Overall Study||3
307521|NCT00746954|742285|P1|STARTED|Overall Study||3
307522|NCT00746941|742295|P4|NOT COMPLETED|Overall Study||13
307523|NCT00746941|742296|P3|NOT COMPLETED|Overall Study||2
307524|NCT00746941|742297|P2|NOT COMPLETED|Overall Study||4
307525|NCT00746941|742298|P1|NOT COMPLETED|Overall Study||7
307526|NCT00746941|742295|P4|COMPLETED|Overall Study||7
307527|NCT00746941|742296|P3|COMPLETED|Overall Study||3
307528|NCT00746941|742297|P2|COMPLETED|Overall Study||1
307529|NCT00746941|742298|P1|COMPLETED|Overall Study||0
307530|NCT00746941|742295|P4|STARTED|Overall Study||20
307531|NCT00746941|742296|P3|STARTED|Overall Study||5
307532|NCT00746941|742297|P2|STARTED|Overall Study||5
307533|NCT00746941|742298|P1|STARTED|Overall Study||7
307534|NCT00746889|742326|P2|NOT COMPLETED|Overall Study||4
307535|NCT00746889|742327|P1|NOT COMPLETED|Overall Study||4
307536|NCT00746889|742326|P2|COMPLETED|Overall Study||35
307537|NCT00746889|742327|P1|COMPLETED|Overall Study||36
307538|NCT00746889|742326|P2|STARTED|Overall Study||39
307539|NCT00746889|742327|P1|STARTED|Overall Study||40
307540|NCT00746863|742337|P2|NOT COMPLETED|Overall Study||0
307541|NCT00746863|742338|P1|NOT COMPLETED|Overall Study||0
307542|NCT00746863|742337|P2|COMPLETED|Overall Study||21
307543|NCT00746863|742338|P1|COMPLETED|Overall Study||21
307544|NCT00746863|742337|P2|STARTED|Overall Study||21
307545|NCT00746863|742338|P1|STARTED|Overall Study||21
307546|NCT00746798|742356|P4|NOT COMPLETED|Overall Study||0
307547|NCT00746798|742357|P3|NOT COMPLETED|Overall Study||3
307548|NCT00746798|742358|P2|NOT COMPLETED|Overall Study||2
307549|NCT00746798|742359|P1|NOT COMPLETED|Overall Study||1
307550|NCT00746798|742356|P4|COMPLETED|Overall Study||120
307551|NCT00746798|742357|P3|COMPLETED|Overall Study||110
307552|NCT00746798|742358|P2|COMPLETED|Overall Study||122
307553|NCT00746798|742359|P1|COMPLETED|Overall Study||121
307554|NCT00746798|742356|P4|STARTED|Overall Study||120
307555|NCT00746798|742357|P3|STARTED|Overall Study||113
307556|NCT00746798|742358|P2|STARTED|Overall Study||124
307557|NCT00746798|742359|P1|STARTED|Overall Study||122
307558|NCT00746785|742384|P3|NOT COMPLETED|Overall Study||27
307559|NCT00746785|742385|P2|NOT COMPLETED|Overall Study||25
307560|NCT00746785|742386|P1|NOT COMPLETED|Overall Study||29
307561|NCT00746785|742384|P3|COMPLETED|Overall Study||13
307562|NCT00746785|742385|P2|COMPLETED|Overall Study||21
307563|NCT00746785|742386|P1|COMPLETED|Overall Study||14
307564|NCT00746785|742384|P3|STARTED|Overall Study||40
307565|NCT00746785|742385|P2|STARTED|Overall Study||46
307566|NCT00746785|742386|P1|STARTED|Overall Study||43
307567|NCT00746733|742394|P2|NOT COMPLETED|Fourth Intervention||0
307568|NCT00746733|742395|P1|NOT COMPLETED|Fourth Intervention||0
307569|NCT00746733|742394|P2|COMPLETED|Fourth Intervention||11
307570|NCT00746733|742395|P1|COMPLETED|Fourth Intervention||10
307571|NCT00746733|742394|P2|STARTED|Fourth Intervention||11
307572|NCT00746733|742395|P1|STARTED|Fourth Intervention||10
307573|NCT00746733|742394|P2|NOT COMPLETED|Third Intervention||1
307574|NCT00746733|742395|P1|NOT COMPLETED|Third Intervention||1
307575|NCT00746733|742394|P2|COMPLETED|Third Intervention||11
307576|NCT00746733|742395|P1|COMPLETED|Third Intervention||10
307577|NCT00746733|742394|P2|STARTED|Third Intervention||12
307578|NCT00746733|742395|P1|STARTED|Third Intervention||11
307579|NCT00746733|742394|P2|NOT COMPLETED|Second Intervention||0
307580|NCT00746733|742395|P1|NOT COMPLETED|Second Intervention||1
307581|NCT00746733|742394|P2|COMPLETED|Second Intervention||12
307582|NCT00746733|742395|P1|COMPLETED|Second Intervention||11
307583|NCT00746733|742394|P2|STARTED|Second Intervention||12
307584|NCT00746733|742395|P1|STARTED|Second Intervention||12
307585|NCT00746733|742394|P2|NOT COMPLETED|First Intervention||0
307586|NCT00746733|742395|P1|NOT COMPLETED|First Intervention||0
307587|NCT00746733|742394|P2|COMPLETED|First Intervention||12
307588|NCT00746733|742395|P1|COMPLETED|First Intervention||12
307589|NCT00746733|742394|P2|STARTED|First Intervention||12
307590|NCT00746733|742395|P1|STARTED|First Intervention||12
307591|NCT00746694|742455|P1|NOT COMPLETED|Overall Study||0
307592|NCT00746694|742455|P1|COMPLETED|Overall Study||154
307593|NCT00746694|742455|P1|STARTED|Overall Study||154
307594|NCT00746668|742460|P7|NOT COMPLETED|Overall Study||0
307595|NCT00746668|742461|P6|NOT COMPLETED|Overall Study||0
307596|NCT00746668|742462|P5|NOT COMPLETED|Overall Study||0
307597|NCT00746668|742463|P4|NOT COMPLETED|Overall Study||0
307598|NCT00746668|742464|P3|NOT COMPLETED|Overall Study||0
307599|NCT00746668|742465|P2|NOT COMPLETED|Overall Study||0
307600|NCT00746668|742466|P1|NOT COMPLETED|Overall Study||0
307601|NCT00746668|742460|P7|COMPLETED|Overall Study||5
307602|NCT00746668|742461|P6|COMPLETED|Overall Study||5
307603|NCT00746668|742462|P5|COMPLETED|Overall Study||5
307604|NCT00746668|742463|P4|COMPLETED|Overall Study||5
307605|NCT00746668|742464|P3|COMPLETED|Overall Study||5
307606|NCT00746668|742465|P2|COMPLETED|Overall Study||5
307607|NCT00746668|742466|P1|COMPLETED|Overall Study||6
307608|NCT00746668|742460|P7|STARTED|Overall Study||5
307609|NCT00746668|742461|P6|STARTED|Overall Study||5
307610|NCT00746668|742462|P5|STARTED|Overall Study||5
307611|NCT00746668|742463|P4|STARTED|Overall Study||5
307612|NCT00746668|742464|P3|STARTED|Overall Study||5
307613|NCT00746668|742465|P2|STARTED|Overall Study||5
307614|NCT00746668|742466|P1|STARTED|Overall Study||6
307615|NCT00746590|742479|P1|NOT COMPLETED|Overall Study||1
307616|NCT00746590|742479|P1|COMPLETED|Overall Study||0
307617|NCT00746590|742479|P1|STARTED|Overall Study||1
307618|NCT00746564|742483|P1|NOT COMPLETED|Overall Study||2
307619|NCT00746564|742483|P1|COMPLETED|Overall Study||73
307620|NCT00746564|742483|P1|STARTED|Overall Study||75
307621|NCT00746551|742498|P2|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
307622|NCT00746551|742499|P1|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
307623|NCT00746551|742498|P2|COMPLETED|At Delivery (GA of 39 Weeks)||25
307624|NCT00746551|742499|P1|COMPLETED|At Delivery (GA of 39 Weeks)||25
307625|NCT00746551|742498|P2|STARTED|At Delivery (GA of 39 Weeks)||40
307626|NCT00746551|742499|P1|STARTED|At Delivery (GA of 39 Weeks)||40
307627|NCT00746551|742498|P2|NOT COMPLETED|At Gestational Age of 36 Weeks||4
307628|NCT00746551|742499|P1|NOT COMPLETED|At Gestational Age of 36 Weeks||2
307629|NCT00746551|742498|P2|COMPLETED|At Gestational Age of 36 Weeks||36
307630|NCT00746551|742499|P1|COMPLETED|At Gestational Age of 36 Weeks||38
307631|NCT00746551|742498|P2|STARTED|At Gestational Age of 36 Weeks||40
307632|NCT00746551|742499|P1|STARTED|At Gestational Age of 36 Weeks||40
307633|NCT00746512|742511|P4|NOT COMPLETED|Overall Study||0
307634|NCT00746512|742512|P3|NOT COMPLETED|Overall Study||0
307635|NCT00746512|742513|P2|NOT COMPLETED|Overall Study||0
307636|NCT00746512|742514|P1|NOT COMPLETED|Overall Study||0
307637|NCT00746512|742511|P4|COMPLETED|Overall Study||9
307638|NCT00746512|742512|P3|COMPLETED|Overall Study||18
307639|NCT00746512|742513|P2|COMPLETED|Overall Study||10
307640|NCT00746512|742514|P1|COMPLETED|Overall Study||8
307641|NCT00746512|742511|P4|STARTED|Overall Study||9
307642|NCT00746512|742512|P3|STARTED|Overall Study||18
307643|NCT00746512|742513|P2|STARTED|Overall Study||10
307644|NCT00746512|742514|P1|STARTED|Overall Study||8
307645|NCT00746421|742530|P2|NOT COMPLETED|Overall Study||2
307646|NCT00746421|742531|P1|NOT COMPLETED|Overall Study||7
307647|NCT00746421|742530|P2|COMPLETED|Overall Study||9
307648|NCT00746421|742531|P1|COMPLETED|Overall Study||5
307649|NCT00746421|742530|P2|STARTED|Overall Study||11
307650|NCT00746421|742531|P1|STARTED|Overall Study||12
307651|NCT00746395|742541|P2|NOT COMPLETED|Overall Study||0
307652|NCT00746395|742542|P1|NOT COMPLETED|Overall Study||0
307653|NCT00746395|742541|P2|COMPLETED|Overall Study||20
307654|NCT00746395|742542|P1|COMPLETED|Overall Study||20
307655|NCT00746395|742541|P2|STARTED|Overall Study||20
307656|NCT00746395|742542|P1|STARTED|Overall Study||20
307657|NCT00746356|742550|P2|NOT COMPLETED|Overall Study||7
307658|NCT00746356|742551|P1|NOT COMPLETED|Overall Study||11
307659|NCT00746356|742550|P2|COMPLETED|Overall Study||40
307660|NCT00746356|742551|P1|COMPLETED|Overall Study||70
307661|NCT00746356|742550|P2|STARTED|Overall Study||47
307662|NCT00746356|742551|P1|STARTED|Overall Study||81
307663|NCT00746330|742563|P4|NOT COMPLETED|Period 4||0
307664|NCT00746330|742564|P3|NOT COMPLETED|Period 4||0
307665|NCT00746330|742565|P2|NOT COMPLETED|Period 4||0
307666|NCT00746330|742566|P1|NOT COMPLETED|Period 4||0
307667|NCT00746330|742563|P4|COMPLETED|Period 4||7
307668|NCT00746330|742564|P3|COMPLETED|Period 4||8
307669|NCT00746330|742565|P2|COMPLETED|Period 4||9
307670|NCT00746330|742566|P1|COMPLETED|Period 4||7
307671|NCT00746330|742563|P4|STARTED|Period 4||7
307672|NCT00746330|742564|P3|STARTED|Period 4||8
307673|NCT00746330|742565|P2|STARTED|Period 4||9
307674|NCT00746330|742566|P1|STARTED|Period 4||7
307675|NCT00746330|742563|P4|NOT COMPLETED|Period 3||0
307676|NCT00746330|742564|P3|NOT COMPLETED|Period 3||0
307677|NCT00746330|742565|P2|NOT COMPLETED|Period 3||0
307678|NCT00746330|742566|P1|NOT COMPLETED|Period 3||0
307679|NCT00746330|742563|P4|COMPLETED|Period 3||7
307680|NCT00746330|742564|P3|COMPLETED|Period 3||8
307681|NCT00746330|742565|P2|COMPLETED|Period 3||9
307682|NCT00746330|742566|P1|COMPLETED|Period 3||7
307683|NCT00746330|742563|P4|STARTED|Period 3||7
307684|NCT00746330|742564|P3|STARTED|Period 3||8
307685|NCT00746330|742565|P2|STARTED|Period 3||9
307686|NCT00746330|742566|P1|STARTED|Period 3||7
307687|NCT00746330|742563|P4|NOT COMPLETED|Period 2||0
307688|NCT00746330|742564|P3|NOT COMPLETED|Period 2||0
307689|NCT00746330|742565|P2|NOT COMPLETED|Period 2||0
307690|NCT00746330|742566|P1|NOT COMPLETED|Period 2||0
307691|NCT00746330|742563|P4|COMPLETED|Period 2||7
307692|NCT00746330|742564|P3|COMPLETED|Period 2||8
307693|NCT00746330|742565|P2|COMPLETED|Period 2||9
307694|NCT00746330|742566|P1|COMPLETED|Period 2||7
307695|NCT00746330|742563|P4|STARTED|Period 2||7
307696|NCT00746330|742564|P3|STARTED|Period 2||8
307697|NCT00746330|742565|P2|STARTED|Period 2||9
307698|NCT00746330|742566|P1|STARTED|Period 2||7
307699|NCT00746330|742563|P4|NOT COMPLETED|Period 1||0
307700|NCT00746330|742564|P3|NOT COMPLETED|Period 1||1
307701|NCT00746330|742565|P2|NOT COMPLETED|Period 1||0
307702|NCT00746330|742566|P1|NOT COMPLETED|Period 1||0
307703|NCT00746330|742563|P4|COMPLETED|Period 1||7
307704|NCT00746330|742564|P3|COMPLETED|Period 1||8
307705|NCT00746330|742565|P2|COMPLETED|Period 1||9
307706|NCT00746330|742566|P1|COMPLETED|Period 1||7
307707|NCT00746330|742563|P4|STARTED|Period 1||7
307708|NCT00746330|742564|P3|STARTED|Period 1||9
307709|NCT00746330|742565|P2|STARTED|Period 1||9
307710|NCT00746330|742566|P1|STARTED|Period 1||7
307711|NCT00746252|742596|P2|NOT COMPLETED|Overall Study||2
307712|NCT00746252|742597|P1|NOT COMPLETED|Overall Study||1
307713|NCT00746252|742596|P2|COMPLETED|Overall Study||0
307714|NCT00746252|742597|P1|COMPLETED|Overall Study||0
307715|NCT00746252|742596|P2|STARTED|Overall Study||2
307716|NCT00746252|742597|P1|STARTED|Overall Study||1
307717|NCT00746239|742603|P1|NOT COMPLETED|Overall Study||6
307718|NCT00746239|742603|P1|COMPLETED|Overall Study|11 subjects total were enrolled - 6 withdrew from study and 5 competed|5
307719|NCT00746239|742603|P1|STARTED|Overall Study||11
307720|NCT00746187|742610|P2|NOT COMPLETED|Overall Study||2
307721|NCT00746187|742611|P1|NOT COMPLETED|Overall Study||3
307722|NCT00746187|742610|P2|COMPLETED|Overall Study||16
307723|NCT00746187|742611|P1|COMPLETED|Overall Study||15
307724|NCT00746187|742610|P2|STARTED|Overall Study||18
307725|NCT00746187|742611|P1|STARTED|Overall Study||18
307726|NCT00746096|742619|P2|NOT COMPLETED|Overall Study||3
307727|NCT00746096|742620|P1|NOT COMPLETED|Overall Study||10
307728|NCT00746096|742619|P2|COMPLETED|Overall Study||54
307729|NCT00746096|742620|P1|COMPLETED|Overall Study||48
307730|NCT00746096|742619|P2|STARTED|Overall Study||57
307731|NCT00746096|742620|P1|STARTED|Overall Study||58
307732|NCT00746018|742628|P1|NOT COMPLETED|Overall Study||0
307733|NCT00746018|742628|P1|COMPLETED|Overall Study||39
307734|NCT00746018|742628|P1|STARTED|Overall Study||39
307735|NCT00745940|742634|P2|NOT COMPLETED|Overall Study||10
307736|NCT00745940|742635|P1|NOT COMPLETED|Overall Study||19
307737|NCT00745940|742634|P2|COMPLETED|Overall Study||38
307738|NCT00745940|742635|P1|COMPLETED|Overall Study||38
307739|NCT00745940|742634|P2|STARTED|Overall Study||48
307740|NCT00745940|742635|P1|STARTED|Overall Study||57
307741|NCT00745901|742651|P2|NOT COMPLETED|Overall Study||21
307742|NCT00745901|742652|P1|NOT COMPLETED|Overall Study||24
307743|NCT00745901|742651|P2|COMPLETED|Overall Study||156
307744|NCT00745901|742652|P1|COMPLETED|Overall Study||154
307745|NCT00745901|742651|P2|STARTED|Overall Study|Number of Patients Randomized|177
307746|NCT00745901|742652|P1|STARTED|Overall Study|Number of Patients Randomized|178
307747|NCT00745875|742698|P2|NOT COMPLETED|Overall Study||4
307748|NCT00745875|742699|P1|NOT COMPLETED|Overall Study||4
307749|NCT00745875|742698|P2|COMPLETED|Overall Study|Completed – Number of patients discontinued study treatment at data cut-off (17th January 2010)|26
307750|NCT00745875|742699|P1|COMPLETED|Overall Study|Completed – Number of patients discontinued study treatment at data cut-off (17th January 2010)|32
307751|NCT00745875|742698|P2|STARTED|Overall Study|Started – Number of patients randomised|30
307752|NCT00745875|742699|P1|STARTED|Overall Study|Started – Number of patients randomised|36
307753|NCT00745849|742707|P2|NOT COMPLETED|Second Intervention||1
307754|NCT00745849|742708|P1|NOT COMPLETED|Second Intervention||2
307755|NCT00745849|742707|P2|COMPLETED|Second Intervention||19
307756|NCT00745849|742708|P1|COMPLETED|Second Intervention||18
307757|NCT00745849|742707|P2|STARTED|Second Intervention||20
307758|NCT00745849|742708|P1|STARTED|Second Intervention||20
307759|NCT00745849|742707|P2|NOT COMPLETED|Washout Period||0
307760|NCT00745849|742708|P1|NOT COMPLETED|Washout Period||0
307761|NCT00745849|742707|P2|COMPLETED|Washout Period||20
307762|NCT00745849|742708|P1|COMPLETED|Washout Period||20
307763|NCT00745849|742707|P2|STARTED|Washout Period||20
307764|NCT00745849|742708|P1|STARTED|Washout Period||20
307765|NCT00745849|742707|P2|NOT COMPLETED|First Intervention||2
307766|NCT00745849|742708|P1|NOT COMPLETED|First Intervention||1
307767|NCT00745849|742707|P2|COMPLETED|First Intervention||20
307768|NCT00745849|742708|P1|COMPLETED|First Intervention||20
307769|NCT00745849|742707|P2|STARTED|First Intervention||22
307770|NCT00745849|742708|P1|STARTED|First Intervention||21
307771|NCT00745823|742716|P2|NOT COMPLETED|Overall Study||386
307772|NCT00745823|742717|P1|NOT COMPLETED|Overall Study||385
307773|NCT00745823|742716|P2|COMPLETED|Overall Study||3
307774|NCT00745823|742717|P1|COMPLETED|Overall Study||1
307775|NCT00745823|742716|P2|TREATED Week 0 - 96|Overall Study||388
307776|NCT00745823|742717|P1|TREATED Week 0 - 96|Overall Study||382
307777|NCT00745823|742716|P2|STARTED|Overall Study||389
307778|NCT00745823|742717|P1|STARTED|Overall Study||386
307779|NCT00745615|742745|P6|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||108
307780|NCT00745615|742746|P5|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||91
307781|NCT00745615|742747|P4|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
307782|NCT00745615|742748|P3|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
307783|NCT00745615|742749|P2|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
307784|NCT00745615|742750|P1|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
307785|NCT00745615|742745|P6|COMPLETED|Open-Label (up to Approx 10.5 Years)||5
307786|NCT00745615|742746|P5|COMPLETED|Open-Label (up to Approx 10.5 Years)||5
307787|NCT00745615|742747|P4|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
307788|NCT00745615|742748|P3|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
307789|NCT00745615|742749|P2|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
307790|NCT00745615|742750|P1|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
307791|NCT00745615|742745|P6|STARTED|Open-Label (up to Approx 10.5 Years)||113
307792|NCT00745615|742746|P5|STARTED|Open-Label (up to Approx 10.5 Years)||96
307793|NCT00745615|742747|P4|STARTED|Open-Label (up to Approx 10.5 Years)||0
307794|NCT00745615|742748|P3|STARTED|Open-Label (up to Approx 10.5 Years)||0
307795|NCT00745615|742749|P2|STARTED|Open-Label (up to Approx 10.5 Years)||0
307796|NCT00745615|742750|P1|STARTED|Open-Label (up to Approx 10.5 Years)||0
307797|NCT00745615|742745|P6|NOT COMPLETED|Double-Blind Extension (36 Weeks)||0
307798|NCT00745615|742746|P5|NOT COMPLETED|Double-Blind Extension (36 Weeks)||0
307799|NCT00745615|742747|P4|NOT COMPLETED|Double-Blind Extension (36 Weeks)||5
307800|NCT00745615|742748|P3|NOT COMPLETED|Double-Blind Extension (36 Weeks)||1
307801|NCT00745615|742749|P2|NOT COMPLETED|Double-Blind Extension (36 Weeks)||7
307802|NCT00745615|742750|P1|NOT COMPLETED|Double-Blind Extension (36 Weeks)||5
307803|NCT00745615|742745|P6|COMPLETED|Double-Blind Extension (36 Weeks)||0
307804|NCT00745615|742746|P5|COMPLETED|Double-Blind Extension (36 Weeks)||0
307805|NCT00745615|742747|P4|COMPLETED|Double-Blind Extension (36 Weeks)||39
307806|NCT00745615|742748|P3|COMPLETED|Double-Blind Extension (36 Weeks)||38
307807|NCT00745615|742749|P2|COMPLETED|Double-Blind Extension (36 Weeks)||87
307808|NCT00745615|742750|P1|COMPLETED|Double-Blind Extension (36 Weeks)||75
307809|NCT00745615|742745|P6|STARTED|Double-Blind Extension (36 Weeks)||0
307810|NCT00745615|742746|P5|STARTED|Double-Blind Extension (36 Weeks)||0
307811|NCT00745615|742747|P4|STARTED|Double-Blind Extension (36 Weeks)||44
307812|NCT00745615|742748|P3|STARTED|Double-Blind Extension (36 Weeks)||39
307813|NCT00745615|742749|P2|STARTED|Double-Blind Extension (36 Weeks)||94
307814|NCT00745615|742750|P1|STARTED|Double-Blind Extension (36 Weeks)||80
307815|NCT00745498|742799|P3|NOT COMPLETED|Overall Study||8
307816|NCT00745498|742800|P2|NOT COMPLETED|Overall Study||6
307817|NCT00745498|742801|P1|NOT COMPLETED|Overall Study||5
307818|NCT00745498|742799|P3|COMPLETED|Overall Study||34
307819|NCT00745498|742800|P2|COMPLETED|Overall Study||37
307820|NCT00745498|742801|P1|COMPLETED|Overall Study||36
307821|NCT00745498|742799|P3|STARTED|Overall Study||42
307822|NCT00745498|742800|P2|STARTED|Overall Study||43
307823|NCT00745498|742801|P1|STARTED|Overall Study||41
307824|NCT00745420|742815|P1|NOT COMPLETED|Overall Study||1
307825|NCT00745420|742815|P1|COMPLETED|Overall Study||29
307826|NCT00745420|742815|P1|STARTED|Overall Study||30
307827|NCT00745368|742832|P1|NOT COMPLETED|Overall Study||3
307828|NCT00745368|742832|P1|COMPLETED|Overall Study|3 male subjects were unable to provide a sample and are not included in the results|16
307829|NCT00745368|742832|P1|STARTED|Overall Study|Of the 28 subjects who enrolled, 19 participated in a study visit|19
307830|NCT00745290|742845|P2|NOT COMPLETED|Overall Study||0
307831|NCT00745290|742846|P1|NOT COMPLETED|Overall Study||0
307832|NCT00745290|742845|P2|COMPLETED|Overall Study||122
307833|NCT00745290|742846|P1|COMPLETED|Overall Study||123
307834|NCT00745290|742845|P2|STARTED|Overall Study||122
307835|NCT00745290|742846|P1|STARTED|Overall Study||123
307836|NCT00745251|742854|P2|NOT COMPLETED|Overall Study||3
307837|NCT00745251|742855|P1|NOT COMPLETED|Overall Study||2
307838|NCT00745251|742854|P2|COMPLETED|Overall Study||19
307839|NCT00745251|742855|P1|COMPLETED|Overall Study||21
307840|NCT00745251|742854|P2|STARTED|Overall Study||22
307841|NCT00745251|742855|P1|STARTED|Overall Study||23
307842|NCT00745121|742865|P2|NOT COMPLETED|Overall Study||2
307843|NCT00745121|742866|P1|NOT COMPLETED|Overall Study||9
307844|NCT00745121|742865|P2|COMPLETED|Overall Study||26
307845|NCT00745121|742866|P1|COMPLETED|Overall Study||11
307846|NCT00745121|742865|P2|STARTED|Overall Study||28
307847|NCT00745121|742866|P1|STARTED|Overall Study||20
307848|NCT00745095|742878|P6|NOT COMPLETED|Overall Study||123
307849|NCT00745095|742879|P5|NOT COMPLETED|Overall Study||122
307850|NCT00745095|742880|P4|NOT COMPLETED|Overall Study||3
307851|NCT00745095|742881|P3|NOT COMPLETED|Overall Study||3
307852|NCT00745095|742882|P2|NOT COMPLETED|Overall Study||2
307853|NCT00745095|742883|P1|NOT COMPLETED|Overall Study||1
307854|NCT00745095|742878|P6|COMPLETED|Overall Study||27
307855|NCT00745095|742879|P5|COMPLETED|Overall Study||28
307856|NCT00745095|742880|P4|COMPLETED|Overall Study||12
307857|NCT00745095|742881|P3|COMPLETED|Overall Study||12
307858|NCT00745095|742882|P2|COMPLETED|Overall Study||13
307859|NCT00745095|742883|P1|COMPLETED|Overall Study||14
307860|NCT00745095|742878|P6|STARTED|Overall Study||150
307861|NCT00745095|742879|P5|STARTED|Overall Study||150
307862|NCT00745095|742880|P4|STARTED|Overall Study||15
307863|NCT00745095|742881|P3|STARTED|Overall Study||15
307864|NCT00745095|742882|P2|STARTED|Overall Study||15
307865|NCT00745095|742883|P1|STARTED|Overall Study||15
307866|NCT00745030|742905|P2|NOT COMPLETED|Overall Study||0
307867|NCT00745030|742906|P1|NOT COMPLETED|Overall Study||0
307868|NCT00745030|742905|P2|COMPLETED|Overall Study||2
307869|NCT00745030|742906|P1|COMPLETED|Overall Study||1
307870|NCT00745030|742905|P2|STARTED|Overall Study||2
307871|NCT00745030|742906|P1|STARTED|Overall Study||1
307872|NCT00744978|742914|P2|NOT COMPLETED|Period 2||1
307873|NCT00744978|742915|P1|NOT COMPLETED|Period 2||0
307874|NCT00744978|742914|P2|COMPLETED|Period 2||28
307875|NCT00744978|742915|P1|COMPLETED|Period 2||26
307876|NCT00744978|742914|P2|STARTED|Period 2||29
307877|NCT00744978|742915|P1|STARTED|Period 2||26
307878|NCT00744978|742914|P2|NOT COMPLETED|Placebo Washout||0
307879|NCT00744978|742915|P1|NOT COMPLETED|Placebo Washout||0
307880|NCT00744978|742914|P2|COMPLETED|Placebo Washout||29
307881|NCT00744978|742915|P1|COMPLETED|Placebo Washout||26
307882|NCT00744978|742914|P2|STARTED|Placebo Washout||29
307883|NCT00744978|742915|P1|STARTED|Placebo Washout||26
307884|NCT00744978|742914|P2|NOT COMPLETED|Period 1||5
307885|NCT00744978|742915|P1|NOT COMPLETED|Period 1||6
307886|NCT00744978|742914|P2|COMPLETED|Period 1||29
307887|NCT00744978|742915|P1|COMPLETED|Period 1||26
307888|NCT00744978|742914|P2|Treated|Period 1||33
307889|NCT00744978|742915|P1|Treated|Period 1||31
307890|NCT00744978|742914|P2|STARTED|Period 1||34
307891|NCT00744978|742915|P1|STARTED|Period 1||32
307892|NCT00744939|742967|P1|NOT COMPLETED|Overall Study||91
307893|NCT00744939|742967|P1|COMPLETED|Overall Study||77
307894|NCT00744939|742967|P1|Treatment Received|Overall Study||141
307895|NCT00744939|742967|P1|STARTED|Overall Study||168
307896|NCT00744874|743003|P1|NOT COMPLETED|Overall Study||4
307897|NCT00744874|743003|P1|COMPLETED|Overall Study||51
307898|NCT00744874|743003|P1|STARTED|Overall Study||55
307899|NCT00744848|743021|P2|NOT COMPLETED|Overall Study||0
307900|NCT00744848|743022|P1|NOT COMPLETED|Overall Study||0
307901|NCT00744848|743021|P2|COMPLETED|Overall Study||101
307902|NCT00744848|743022|P1|COMPLETED|Overall Study||103
307903|NCT00744848|743021|P2|STARTED|Overall Study||101
307904|NCT00744848|743022|P1|STARTED|Overall Study||103
307905|NCT00744757|743028|P1|NOT COMPLETED|Overall Study||21
307906|NCT00744757|743028|P1|COMPLETED|Overall Study||16
307907|NCT00744757|743028|P1|STARTED|Overall Study||37
307908|NCT00744692|743041|P1|NOT COMPLETED|Overall Study||0
307909|NCT00744692|743041|P1|COMPLETED|Overall Study||22
307910|NCT00744692|743041|P1|STARTED|Overall Study||22
307911|NCT00744653|743053|P1|NOT COMPLETED|Overall Study||16
307912|NCT00744653|743053|P1|COMPLETED|Overall Study||1
307913|NCT00744653|743053|P1|STARTED|Overall Study||17
307914|NCT00744627|743061|P2|NOT COMPLETED|Overall Study||22
307915|NCT00744627|743062|P1|NOT COMPLETED|Overall Study||25
307916|NCT00744627|743061|P2|COMPLETED|Overall Study||128
307917|NCT00744627|743062|P1|COMPLETED|Overall Study||126
307918|NCT00744627|743061|P2|Treated|Overall Study||150
307919|NCT00744627|743062|P1|Treated|Overall Study||150
307920|NCT00744627|743061|P2|STARTED|Overall Study||150
307921|NCT00744627|743062|P1|STARTED|Overall Study||151
307922|NCT00744523|743118|P2|NOT COMPLETED|30 Days After the Procedure||5
307923|NCT00744523|743119|P1|NOT COMPLETED|30 Days After the Procedure||0
307924|NCT00744523|743118|P2|COMPLETED|30 Days After the Procedure||220
307925|NCT00744523|743119|P1|COMPLETED|30 Days After the Procedure||37
307926|NCT00744523|743118|P2|STARTED|30 Days After the Procedure||225
307927|NCT00744523|743119|P1|STARTED|30 Days After the Procedure||37
307928|NCT00744523|743118|P2|NOT COMPLETED|Procedure||0
307929|NCT00744523|743119|P1|NOT COMPLETED|Procedure||0
307930|NCT00744523|743118|P2|COMPLETED|Procedure||225
307931|NCT00744523|743119|P1|COMPLETED|Procedure||37
307932|NCT00744523|743118|P2|STARTED|Procedure||225
307933|NCT00744523|743119|P1|STARTED|Procedure||37
307934|NCT00744497|743139|P2|NOT COMPLETED|Overall Study||762
307935|NCT00744497|743140|P1|NOT COMPLETED|Overall Study||760
307936|NCT00744497|743139|P2|COMPLETED|Overall Study||0
307937|NCT00744497|743140|P1|COMPLETED|Overall Study||0
307938|NCT00744497|743139|P2|Received Treatment|Overall Study||761
307939|NCT00744497|743140|P1|Received Treatment|Overall Study||757
307940|NCT00744497|743139|P2|STARTED|Overall Study|Randomized|762
307941|NCT00744497|743140|P1|STARTED|Overall Study|Randomized|760
307942|NCT00744380|743176|P2|NOT COMPLETED|Overall Study||0
307943|NCT00744380|743177|P1|NOT COMPLETED|Overall Study||0
307944|NCT00744380|743176|P2|COMPLETED|Overall Study||11
307945|NCT00744380|743177|P1|COMPLETED|Overall Study||12
307946|NCT00744380|743176|P2|STARTED|Overall Study||11
307947|NCT00744380|743177|P1|STARTED|Overall Study||12
307948|NCT00744328|743200|P3|NOT COMPLETED|Overall Study||8
307949|NCT00744328|743201|P2|NOT COMPLETED|Overall Study||8
307950|NCT00744328|743202|P1|NOT COMPLETED|Overall Study||7
307951|NCT00744328|743200|P3|COMPLETED|Overall Study||21
307952|NCT00744328|743201|P2|COMPLETED|Overall Study||22
307953|NCT00744328|743202|P1|COMPLETED|Overall Study||19
307954|NCT00744328|743200|P3|STARTED|Overall Study||29
307955|NCT00744328|743201|P2|STARTED|Overall Study||30
307956|NCT00744328|743202|P1|STARTED|Overall Study||26
307957|NCT00744263|743215|P2|NOT COMPLETED|Overall Study||5320
307958|NCT00744263|743216|P1|NOT COMPLETED|Overall Study||5236
307959|NCT00744263|743215|P2|COMPLETED|Overall Study||36936
307960|NCT00744263|743216|P1|COMPLETED|Overall Study||37004
307961|NCT00744263|743215|P2|STARTED|Overall Study||42256
307962|NCT00744263|743216|P1|STARTED|Overall Study||42240
307963|NCT00744237|743239|P3|NOT COMPLETED|Overall Study||15
307964|NCT00744237|743240|P2|NOT COMPLETED|Overall Study||27
307965|NCT00744237|743241|P1|NOT COMPLETED|Overall Study||27
307966|NCT00744237|743239|P3|COMPLETED|Overall Study||59
307967|NCT00744237|743240|P2|COMPLETED|Overall Study||46
307968|NCT00744237|743241|P1|COMPLETED|Overall Study||56
307969|NCT00744237|743239|P3|STARTED|Overall Study||74
307970|NCT00744237|743240|P2|STARTED|Overall Study||73
307971|NCT00744237|743241|P1|STARTED|Overall Study||83
307972|NCT00744211|743255|P3|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
307973|NCT00744211|743256|P2|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
307974|NCT00744211|743257|P1|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
307975|NCT00744211|743255|P3|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
307976|NCT00744211|743256|P2|COMPLETED|24 Hours After Cardiopulmonary Bypass||9
307977|NCT00744211|743257|P1|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
307978|NCT00744211|743255|P3|STARTED|24 Hours After Cardiopulmonary Bypass||10
307979|NCT00744211|743256|P2|STARTED|24 Hours After Cardiopulmonary Bypass||9
307980|NCT00744211|743257|P1|STARTED|24 Hours After Cardiopulmonary Bypass||10
307981|NCT00744211|743255|P3|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
307982|NCT00744211|743256|P2|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
307983|NCT00744211|743257|P1|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
307984|NCT00744211|743255|P3|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
307985|NCT00744211|743256|P2|COMPLETED|12 Hours After Cardiopulmonary Bypass||9
307986|NCT00744211|743257|P1|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
307987|NCT00744211|743255|P3|STARTED|12 Hours After Cardiopulmonary Bypass||10
307988|NCT00744211|743256|P2|STARTED|12 Hours After Cardiopulmonary Bypass||9
307989|NCT00744211|743257|P1|STARTED|12 Hours After Cardiopulmonary Bypass||10
307990|NCT00744211|743255|P3|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
307991|NCT00744211|743256|P2|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
307992|NCT00744211|743257|P1|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
307993|NCT00744211|743255|P3|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
307994|NCT00744211|743256|P2|COMPLETED|6 Hours After Cardiopulmonary Bypass||9
307995|NCT00744211|743257|P1|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
307996|NCT00744211|743255|P3|STARTED|6 Hours After Cardiopulmonary Bypass||10
307997|NCT00744211|743256|P2|STARTED|6 Hours After Cardiopulmonary Bypass||9
307998|NCT00744211|743257|P1|STARTED|6 Hours After Cardiopulmonary Bypass||10
307999|NCT00744211|743255|P3|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
308000|NCT00744211|743256|P2|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
308001|NCT00744211|743257|P1|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
308002|NCT00744211|743255|P3|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
308003|NCT00744211|743256|P2|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||9
308004|NCT00744211|743257|P1|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
308005|NCT00744211|743255|P3|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
308006|NCT00744211|743256|P2|STARTED|0.5 Hours After Cardiopulmonary Bypass||9
308007|NCT00744211|743257|P1|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
308008|NCT00744211|743255|P3|NOT COMPLETED|Baseline||0
308009|NCT00744211|743256|P2|NOT COMPLETED|Baseline||0
308010|NCT00744211|743257|P1|NOT COMPLETED|Baseline||0
308011|NCT00744211|743255|P3|COMPLETED|Baseline||10
308012|NCT00744211|743256|P2|COMPLETED|Baseline||9
308013|NCT00744211|743257|P1|COMPLETED|Baseline||10
308014|NCT00744211|743255|P3|STARTED|Baseline||10
308015|NCT00744211|743256|P2|STARTED|Baseline||9
308016|NCT00744211|743257|P1|STARTED|Baseline||10
308017|NCT00744055|743275|P2|NOT COMPLETED|Overall Study||14
308018|NCT00744055|743276|P1|NOT COMPLETED|Overall Study||7
308019|NCT00744055|743275|P2|COMPLETED|Overall Study||32
308020|NCT00744055|743276|P1|COMPLETED|Overall Study||43
308021|NCT00744055|743275|P2|STARTED|Overall Study||46
308022|NCT00744055|743276|P1|STARTED|Overall Study||50
308023|NCT00744042|743284|P1|NOT COMPLETED|Overall Study||1
308024|NCT00744042|743284|P1|COMPLETED|Overall Study||10
308025|NCT00744042|743284|P1|STARTED|Overall Study||11
308026|NCT00743730|743300|P3|NOT COMPLETED|Overall Study||5
308027|NCT00743730|743301|P2|NOT COMPLETED|Overall Study||4
308028|NCT00743730|743302|P1|NOT COMPLETED|Overall Study||5
308029|NCT00743730|743300|P3|COMPLETED|Overall Study||28
308030|NCT00743730|743301|P2|COMPLETED|Overall Study||30
308031|NCT00743730|743302|P1|COMPLETED|Overall Study||22
308032|NCT00743730|743300|P3|STARTED|Overall Study||33
308033|NCT00743730|743301|P2|STARTED|Overall Study||34
308034|NCT00743730|743302|P1|STARTED|Overall Study||27
308035|NCT00743717|743318|P2|NOT COMPLETED|Overall Study||0
308036|NCT00743717|743319|P1|NOT COMPLETED|Overall Study||0
308037|NCT00743717|743318|P2|COMPLETED|Overall Study||2
308038|NCT00743717|743319|P1|COMPLETED|Overall Study||2
308039|NCT00743717|743318|P2|STARTED|Overall Study||2
308040|NCT00743717|743319|P1|STARTED|Overall Study||2
308041|NCT00743652|743330|P5|NOT COMPLETED|Overall Study||0
308042|NCT00743652|743331|P4|NOT COMPLETED|Overall Study||4
308043|NCT00743652|743332|P3|NOT COMPLETED|Overall Study||2
308044|NCT00743652|743333|P2|NOT COMPLETED|Overall Study||3
308045|NCT00743652|743334|P1|NOT COMPLETED|Overall Study||10
308046|NCT00743652|743330|P5|COMPLETED|Overall Study||79
308047|NCT00743652|743331|P4|COMPLETED|Overall Study||63
308048|NCT00743652|743332|P3|COMPLETED|Overall Study||23
308049|NCT00743652|743333|P2|COMPLETED|Overall Study||48
308050|NCT00743652|743334|P1|COMPLETED|Overall Study||141
308051|NCT00743652|743330|P5|Toddler Dose|Overall Study||0
308052|NCT00743652|743331|P4|Toddler Dose|Overall Study||0
308053|NCT00743652|743332|P3|Toddler Dose|Overall Study||16
308054|NCT00743652|743333|P2|Toddler Dose|Overall Study||23
308055|NCT00743652|743334|P1|Toddler Dose|Overall Study||15
308056|NCT00743652|743330|P5|Vaccinated Dose 3|Overall Study||0
308057|NCT00743652|743331|P4|Vaccinated Dose 3|Overall Study||0
308058|NCT00743652|743332|P3|Vaccinated Dose 3|Overall Study||0
308059|NCT00743652|743333|P2|Vaccinated Dose 3|Overall Study||0
308060|NCT00743652|743334|P1|Vaccinated Dose 3|Overall Study||74
308061|NCT00743652|743330|P5|Vaccinated Dose 2|Overall Study||0
308062|NCT00743652|743331|P4|Vaccinated Dose 2|Overall Study||49
308063|NCT00743652|743332|P3|Vaccinated Dose 2|Overall Study||0
308064|NCT00743652|743333|P2|Vaccinated Dose 2|Overall Study||41
308065|NCT00743652|743334|P1|Vaccinated Dose 2|Overall Study||112
308066|NCT00743652|743330|P5|Vaccinated Dose 1|Overall Study||79
308067|NCT00743652|743331|P4|Vaccinated Dose 1|Overall Study||66
308068|NCT00743652|743332|P3|Vaccinated Dose 1|Overall Study||25
308069|NCT00743652|743333|P2|Vaccinated Dose 1|Overall Study||51
308070|NCT00743652|743334|P1|Vaccinated Dose 1|Overall Study||151
308071|NCT00743652|743330|P5|STARTED|Overall Study||79
308072|NCT00743652|743331|P4|STARTED|Overall Study||67
308073|NCT00743652|743332|P3|STARTED|Overall Study||25
308074|NCT00743652|743333|P2|STARTED|Overall Study||51
308075|NCT00743652|743334|P1|STARTED|Overall Study||151
308076|NCT00743574|743409|P1|NOT COMPLETED|Overall Study||24
308077|NCT00743574|743409|P1|COMPLETED|Overall Study||12
308078|NCT00743574|743409|P1|Dropped Out After Initiating Trial|Overall Study||3
308079|NCT00743574|743409|P1|Further Exclusions|Overall Study||8
308080|NCT00743574|743409|P1|Dropped Out Before Eligibility Testing|Overall Study||13
308081|NCT00743574|743409|P1|STARTED|Overall Study||36
308082|NCT00743509|743418|P1|NOT COMPLETED|Overall Study||2
308083|NCT00743509|743418|P1|COMPLETED|Overall Study||47
308084|NCT00743509|743418|P1|STARTED|Overall Study||49
308085|NCT00743483|743423|P1|NOT COMPLETED|Treatment Period||1
308086|NCT00743483|743423|P1|COMPLETED|Treatment Period||13
308087|NCT00743483|743423|P1|STARTED|Treatment Period||14
308088|NCT00743483|743423|P1|NOT COMPLETED|Baseline Period||1
308089|NCT00743483|743423|P1|COMPLETED|Baseline Period||14
308090|NCT00743483|743423|P1|STARTED|Baseline Period||15
308091|NCT00743444|743427|P2|NOT COMPLETED|Second Intervention||0
308092|NCT00743444|743428|P1|NOT COMPLETED|Second Intervention||0
308093|NCT00743444|743427|P2|COMPLETED|Second Intervention||11
308094|NCT00743444|743428|P1|COMPLETED|Second Intervention||14
308095|NCT00743444|743427|P2|STARTED|Second Intervention||11
308096|NCT00743444|743428|P1|STARTED|Second Intervention||14
308097|NCT00743444|743427|P2|NOT COMPLETED|Washout Period||1
308098|NCT00743444|743428|P1|NOT COMPLETED|Washout Period||0
308099|NCT00743444|743427|P2|COMPLETED|Washout Period||11
308100|NCT00743444|743428|P1|COMPLETED|Washout Period||14
308101|NCT00743444|743427|P2|STARTED|Washout Period||12
308102|NCT00743444|743428|P1|STARTED|Washout Period||14
308103|NCT00743444|743427|P2|NOT COMPLETED|First Intervention||1
308104|NCT00743444|743428|P1|NOT COMPLETED|First Intervention||0
308105|NCT00743444|743427|P2|COMPLETED|First Intervention||12
308106|NCT00743444|743428|P1|COMPLETED|First Intervention||14
308107|NCT00743444|743427|P2|STARTED|First Intervention||13
308108|NCT00743444|743428|P1|STARTED|First Intervention||14
308109|NCT00743431|743437|P1|NOT COMPLETED|Overall Study||126
308110|NCT00743431|743437|P1|COMPLETED|Overall Study||98
308111|NCT00743431|743437|P1|STARTED|Overall Study||224
308112|NCT00743366|743441|P2|NOT COMPLETED|Intervention 2 (8 Days)||0
308113|NCT00743366|743442|P1|NOT COMPLETED|Intervention 2 (8 Days)||0
308114|NCT00743366|743441|P2|COMPLETED|Intervention 2 (8 Days)||7
308115|NCT00743366|743442|P1|COMPLETED|Intervention 2 (8 Days)||7
308116|NCT00743366|743441|P2|STARTED|Intervention 2 (8 Days)||7
308117|NCT00743366|743442|P1|STARTED|Intervention 2 (8 Days)||7
308118|NCT00743366|743441|P2|NOT COMPLETED|Intervention 1 (8 Days)||3
308119|NCT00743366|743442|P1|NOT COMPLETED|Intervention 1 (8 Days)||3
308120|NCT00743366|743441|P2|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
308121|NCT00743366|743442|P1|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
308122|NCT00743366|743441|P2|STARTED|Intervention 1 (8 Days)||10
308123|NCT00743366|743442|P1|STARTED|Intervention 1 (8 Days)||10
308124|NCT00743340|743448|P1|NOT COMPLETED|Overall Study||41
308125|NCT00743340|743448|P1|COMPLETED|Overall Study||9
308126|NCT00743340|743448|P1|STARTED|Overall Study||50
308127|NCT00743288|743452|P7|NOT COMPLETED|Overall Study||9
308128|NCT00743288|743453|P6|NOT COMPLETED|Overall Study||5
308129|NCT00743288|743454|P5|NOT COMPLETED|Overall Study||6
308130|NCT00743288|743455|P4|NOT COMPLETED|Overall Study||7
308131|NCT00743288|743456|P3|NOT COMPLETED|Overall Study||5
308132|NCT00743288|743457|P2|NOT COMPLETED|Overall Study||3
308133|NCT00743288|743458|P1|NOT COMPLETED|Overall Study||3
308134|NCT00743288|743452|P7|COMPLETED|Overall Study||0
308135|NCT00743288|743453|P6|COMPLETED|Overall Study||1
308136|NCT00743288|743454|P5|COMPLETED|Overall Study||0
308137|NCT00743288|743455|P4|COMPLETED|Overall Study||0
308138|NCT00743288|743456|P3|COMPLETED|Overall Study||1
308139|NCT00743288|743457|P2|COMPLETED|Overall Study||0
308140|NCT00743288|743458|P1|COMPLETED|Overall Study||0
308141|NCT00743288|743452|P7|STARTED|Overall Study|6 subjects were enrolled in phase 1 and 3 subjects were enrolled as part of the phase 2 expansion.|9
308142|NCT00743288|743453|P6|STARTED|Overall Study||6
308143|NCT00743288|743454|P5|STARTED|Overall Study||6
308144|NCT00743288|743455|P4|STARTED|Overall Study||7
308145|NCT00743288|743456|P3|STARTED|Overall Study||6
308146|NCT00743288|743457|P2|STARTED|Overall Study||3
308147|NCT00743288|743458|P1|STARTED|Overall Study||3
308148|NCT00743275|743472|P2|NOT COMPLETED|Overall Study||1
308149|NCT00743275|743473|P1|NOT COMPLETED|Overall Study||0
308150|NCT00743275|743472|P2|COMPLETED|Overall Study||60
308151|NCT00743275|743473|P1|COMPLETED|Overall Study||59
308152|NCT00743275|743472|P2|STARTED|Overall Study||61
308153|NCT00743275|743473|P1|STARTED|Overall Study||59
308154|NCT00743262|743485|P1|NOT COMPLETED|Overall Study||0
308155|NCT00743262|743485|P1|COMPLETED|Overall Study||15
308156|NCT00743262|743485|P1|STARTED|Overall Study||15
308157|NCT00743249|743493|P2|NOT COMPLETED|Overall Study||6
308158|NCT00743249|743494|P1|NOT COMPLETED|Overall Study||2
308159|NCT00743249|743493|P2|COMPLETED|Overall Study||24
308160|NCT00743249|743494|P1|COMPLETED|Overall Study||28
308161|NCT00743249|743493|P2|STARTED|Overall Study||30
308162|NCT00743249|743494|P1|STARTED|Overall Study||30
308163|NCT00743197|743504|P2|NOT COMPLETED|Overall Study||2
308164|NCT00743197|743505|P1|NOT COMPLETED|Overall Study||1
308165|NCT00743197|743504|P2|COMPLETED|Overall Study||0
308166|NCT00743197|743505|P1|COMPLETED|Overall Study||0
308167|NCT00743197|743504|P2|STARTED|Overall Study||2
308168|NCT00743197|743505|P1|STARTED|Overall Study||1
308169|NCT00743145|743511|P1|NOT COMPLETED|Overall Study||4
308170|NCT00743145|743511|P1|COMPLETED|Overall Study||19
308171|NCT00743145|743511|P1|STARTED|Overall Study||23
308172|NCT00743119|743525|P1|NOT COMPLETED|Overall Study||4
308173|NCT00743119|743525|P1|COMPLETED|Overall Study||30
308174|NCT00743119|743525|P1|STARTED|Overall Study||34
308175|NCT00743106|743539|P2|NOT COMPLETED|Overall Study||5
308176|NCT00743106|743540|P1|NOT COMPLETED|Overall Study||8
308177|NCT00743106|743539|P2|COMPLETED|Overall Study||43
308178|NCT00743106|743540|P1|COMPLETED|Overall Study||34
308179|NCT00743106|743539|P2|STARTED|Overall Study||48
308180|NCT00743106|743540|P1|STARTED|Overall Study||42
308181|NCT00743093|743550|P2|NOT COMPLETED|Extended Dosing Period||0
308182|NCT00743093|743551|P1|NOT COMPLETED|Extended Dosing Period||3
308183|NCT00743093|743550|P2|COMPLETED|Extended Dosing Period||1
308184|NCT00743093|743551|P1|COMPLETED|Extended Dosing Period||48
308185|NCT00743093|743550|P2|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|1
308186|NCT00743093|743551|P1|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|51
308187|NCT00743093|743550|P2|NOT COMPLETED|Base Study Period||5
308188|NCT00743093|743551|P1|NOT COMPLETED|Base Study Period||19
308189|NCT00743093|743550|P2|COMPLETED|Base Study Period||47
308190|NCT00743093|743551|P1|COMPLETED|Base Study Period||205
308191|NCT00743093|743550|P2|STARTED|Base Study Period||52
308192|NCT00743093|743551|P1|STARTED|Base Study Period||224
308193|NCT00742963|743559|P1|NOT COMPLETED|Overall Study||33
308194|NCT00742963|743559|P1|COMPLETED|Overall Study||68
308195|NCT00742963|743559|P1|Completed All Treatment Cycles|Overall Study||68
308196|NCT00742963|743559|P1|STARTED|Overall Study||101
308197|NCT00742924|743567|P4|NOT COMPLETED|Overall Study||6
308198|NCT00742924|743568|P3|NOT COMPLETED|Overall Study||4
308199|NCT00742924|743569|P2|NOT COMPLETED|Overall Study||2
308200|NCT00742924|743570|P1|NOT COMPLETED|Overall Study||5
308201|NCT00742924|743567|P4|COMPLETED|Overall Study||0
308202|NCT00742924|743568|P3|COMPLETED|Overall Study||2
308203|NCT00742924|743569|P2|COMPLETED|Overall Study||4
308204|NCT00742924|743570|P1|COMPLETED|Overall Study||1
308205|NCT00742924|743567|P4|STARTED|Overall Study||6
308206|NCT00742924|743568|P3|STARTED|Overall Study||6
308207|NCT00742924|743569|P2|STARTED|Overall Study||6
308208|NCT00742924|743570|P1|STARTED|Overall Study||6
308209|NCT00742885|743582|P2|NOT COMPLETED|Overall Study||0
308210|NCT00742885|743583|P1|NOT COMPLETED|Overall Study||1
308211|NCT00742885|743582|P2|COMPLETED|Overall Study|to Day 182|50
308212|NCT00742885|743583|P1|COMPLETED|Overall Study|to Day 182|49
308213|NCT00742885|743582|P2|STARTED|Overall Study||50
308214|NCT00742885|743583|P1|STARTED|Overall Study||50
308215|NCT00742872|743631|P2|NOT COMPLETED|Overall Study||8
308216|NCT00742872|743632|P1|NOT COMPLETED|Overall Study||12
308217|NCT00742872|743631|P2|COMPLETED|Overall Study||12
308218|NCT00742872|743632|P1|COMPLETED|Overall Study||9
308219|NCT00742872|743631|P2|STARTED|Overall Study||20
308220|NCT00742872|743632|P1|STARTED|Overall Study||21
308221|NCT00742859|743642|P4|NOT COMPLETED|Overall Study||8
308222|NCT00742859|743643|P3|NOT COMPLETED|Overall Study||11
308223|NCT00742859|743644|P2|NOT COMPLETED|Overall Study||12
308224|NCT00742859|743645|P1|NOT COMPLETED|Overall Study||11
308225|NCT00742859|743642|P4|COMPLETED|Overall Study||119
308226|NCT00742859|743643|P3|COMPLETED|Overall Study||116
308227|NCT00742859|743644|P2|COMPLETED|Overall Study||115
308228|NCT00742859|743645|P1|COMPLETED|Overall Study||116
308229|NCT00742859|743642|P4|STARTED|Overall Study||127
308230|NCT00742859|743643|P3|STARTED|Overall Study||127
308231|NCT00742859|743644|P2|STARTED|Overall Study||127
308232|NCT00742859|743645|P1|STARTED|Overall Study||127
308233|NCT00742781|743659|P1|NOT COMPLETED|Overall Study||3
308234|NCT00742781|743659|P1|COMPLETED|Overall Study||18
308235|NCT00742781|743659|P1|STARTED|Overall Study||21
308236|NCT00742625|743668|P1|NOT COMPLETED|Consolidation||21
308237|NCT00742625|743668|P1|COMPLETED|Consolidation||20
308238|NCT00742625|743668|P1|STARTED|Consolidation||41
308239|NCT00742625|743668|P1|NOT COMPLETED|Remission Induction||54
308240|NCT00742625|743668|P1|COMPLETED|Remission Induction||41
308241|NCT00742625|743668|P1|STARTED|Remission Induction||95
308242|NCT00742560|743682|P5|NOT COMPLETED|Overall Study||37
308243|NCT00742560|743683|P4|NOT COMPLETED|Overall Study||36
308244|NCT00742560|743684|P3|NOT COMPLETED|Overall Study||22
308245|NCT00742560|743685|P2|NOT COMPLETED|Overall Study||3
308246|NCT00742560|743686|P1|NOT COMPLETED|Overall Study||3
308247|NCT00742560|743682|P5|COMPLETED|Overall Study||0
308248|NCT00742560|743683|P4|COMPLETED|Overall Study||0
308249|NCT00742560|743684|P3|COMPLETED|Overall Study||0
308250|NCT00742560|743685|P2|COMPLETED|Overall Study||0
308251|NCT00742560|743686|P1|COMPLETED|Overall Study||0
308252|NCT00742560|743682|P5|STARTED|Overall Study||37
308253|NCT00742560|743683|P4|STARTED|Overall Study||36
308254|NCT00742560|743684|P3|STARTED|Overall Study||22
308255|NCT00742560|743685|P2|STARTED|Overall Study||3
308256|NCT00742560|743686|P1|STARTED|Overall Study||3
308257|NCT00742508|743760|P2|NOT COMPLETED|4-Week Exploratory Evaluation Period||1
308258|NCT00742508|743761|P1|NOT COMPLETED|4-Week Exploratory Evaluation Period||0
308259|NCT00742508|743760|P2|COMPLETED|4-Week Exploratory Evaluation Period||7
308260|NCT00742508|743761|P1|COMPLETED|4-Week Exploratory Evaluation Period||0
308261|NCT00742508|743760|P2|STARTED|4-Week Exploratory Evaluation Period||8
308262|NCT00742508|743761|P1|STARTED|4-Week Exploratory Evaluation Period||0
308263|NCT00742508|743760|P2|NOT COMPLETED|8-Week Primary Evaluation Period||11
308264|NCT00742508|743761|P1|NOT COMPLETED|8-Week Primary Evaluation Period||11
308265|NCT00742508|743760|P2|COMPLETED|8-Week Primary Evaluation Period||8
308266|NCT00742508|743761|P1|COMPLETED|8-Week Primary Evaluation Period||11
308267|NCT00742508|743760|P2|STARTED|8-Week Primary Evaluation Period||19
308268|NCT00742508|743761|P1|STARTED|8-Week Primary Evaluation Period||22
308269|NCT00742417|743825|P2|NOT COMPLETED|Maintenance II||0
308270|NCT00742417|743826|P1|NOT COMPLETED|Maintenance II||0
308271|NCT00742417|743825|P2|COMPLETED|Maintenance II||19
308272|NCT00742417|743826|P1|COMPLETED|Maintenance II||16
308273|NCT00742417|743825|P2|STARTED|Maintenance II||19
308274|NCT00742417|743826|P1|STARTED|Maintenance II||16
308275|NCT00742417|743825|P2|NOT COMPLETED|Maintenance I||0
308276|NCT00742417|743826|P1|NOT COMPLETED|Maintenance I||0
308277|NCT00742417|743825|P2|COMPLETED|Maintenance I||19
308278|NCT00742417|743826|P1|COMPLETED|Maintenance I||16
308279|NCT00742417|743825|P2|STARTED|Maintenance I||19
308280|NCT00742417|743826|P1|STARTED|Maintenance I||16
308281|NCT00742417|743825|P2|NOT COMPLETED|Intensive Period||1
308282|NCT00742417|743826|P1|NOT COMPLETED|Intensive Period||3
308283|NCT00742417|743825|P2|COMPLETED|Intensive Period|19 control patients completed all the 6 plasma exchange during the Intensive Period|19
308284|NCT00742417|743826|P1|COMPLETED|Intensive Period|16 patients completed all the 6 plasma exchange with Albutein 5% during the Intensive Period|16
308285|NCT00742417|743825|P2|STARTED|Intensive Period||20
308286|NCT00742417|743826|P1|STARTED|Intensive Period||19
308287|NCT00742417|743825|P2|NOT COMPLETED|Randomized||1
308288|NCT00742417|743826|P1|NOT COMPLETED|Randomized||2
308289|NCT00742417|743825|P2|COMPLETED|Randomized||20
308290|NCT00742417|743826|P1|COMPLETED|Randomized||19
308291|NCT00742417|743825|P2|STARTED|Randomized||21
308292|NCT00742417|743826|P1|STARTED|Randomized||21
308293|NCT00742391|743850|P2|NOT COMPLETED|Overall Study||1
308294|NCT00742391|743851|P1|NOT COMPLETED|Overall Study||4
308295|NCT00742391|743850|P2|COMPLETED|Overall Study||128
308296|NCT00742391|743851|P1|COMPLETED|Overall Study||122
308297|NCT00742391|743850|P2|STARTED|Overall Study||129
308298|NCT00742391|743851|P1|STARTED|Overall Study||126
308299|NCT00742326|743861|P2|NOT COMPLETED|Overall Study||1
308300|NCT00742326|743862|P1|NOT COMPLETED|Overall Study||0
308301|NCT00742326|743861|P2|COMPLETED|Overall Study||6
308302|NCT00742326|743862|P1|COMPLETED|Overall Study||6
308303|NCT00742326|743861|P2|STARTED|Overall Study||7
308304|NCT00742326|743862|P1|STARTED|Overall Study||6
308305|NCT00742313|743872|P2|NOT COMPLETED|Overall Study||0
308306|NCT00742313|743873|P1|NOT COMPLETED|Overall Study||1
308307|NCT00742313|743872|P2|COMPLETED|Overall Study||19
308308|NCT00742313|743873|P1|COMPLETED|Overall Study||24
308309|NCT00742313|743872|P2|STARTED|Overall Study||19
308310|NCT00742313|743873|P1|STARTED|Overall Study||25
308311|NCT00742274|743881|P2|NOT COMPLETED|Overall Study||3
308312|NCT00742274|743882|P1|NOT COMPLETED|Overall Study||3
308313|NCT00742274|743881|P2|COMPLETED|Overall Study||28
308314|NCT00742274|743882|P1|COMPLETED|Overall Study||27
308315|NCT00742274|743881|P2|STARTED|Overall Study||31
308316|NCT00742274|743882|P1|STARTED|Overall Study||30
308317|NCT00742235|743890|P2|NOT COMPLETED|Overall Study||31
308318|NCT00742235|743891|P1|NOT COMPLETED|Overall Study||0
308319|NCT00742235|743890|P2|COMPLETED|Overall Study||36
308320|NCT00742235|743891|P1|COMPLETED|Overall Study||32
308321|NCT00742235|743890|P2|STARTED|Overall Study||67
308322|NCT00742235|743891|P1|STARTED|Overall Study||32
308323|NCT00742209|743904|P5|NOT COMPLETED|Overall Study||25
308324|NCT00742209|743905|P4|NOT COMPLETED|Overall Study||37
308325|NCT00742209|743906|P3|NOT COMPLETED|Overall Study||46
308326|NCT00742209|743907|P2|NOT COMPLETED|Overall Study||18
308327|NCT00742209|743908|P1|NOT COMPLETED|Overall Study||34
308328|NCT00742209|743904|P5|COMPLETED|Overall Study||37
308329|NCT00742209|743905|P4|COMPLETED|Overall Study||97
308330|NCT00742209|743906|P3|COMPLETED|Overall Study||88
308331|NCT00742209|743907|P2|COMPLETED|Overall Study||49
308332|NCT00742209|743908|P1|COMPLETED|Overall Study||95
308333|NCT00742209|743904|P5|STARTED|Overall Study||62
308334|NCT00742209|743905|P4|STARTED|Overall Study||134
308335|NCT00742209|743906|P3|STARTED|Overall Study||134
308336|NCT00742209|743907|P2|STARTED|Overall Study||67
308337|NCT00742209|743908|P1|STARTED|Overall Study||129
308338|NCT00742183|744011|P2|NOT COMPLETED|Overall Study||12
308339|NCT00742183|744012|P1|NOT COMPLETED|Overall Study||9
308340|NCT00742183|744011|P2|COMPLETED|Overall Study||39
308341|NCT00742183|744012|P1|COMPLETED|Overall Study||40
308342|NCT00742183|744011|P2|STARTED|Overall Study||51
308343|NCT00742183|744012|P1|STARTED|Overall Study|50 subjects randomised, one of them did not receive any treatment.|49
308344|NCT00742170|744020|P2|NOT COMPLETED|Overall Study||5
308345|NCT00742170|744021|P1|NOT COMPLETED|Overall Study||2
308346|NCT00742170|744020|P2|COMPLETED|Overall Study||24
308347|NCT00742170|744021|P1|COMPLETED|Overall Study||24
308348|NCT00742170|744020|P2|STARTED|Overall Study||29
308349|NCT00742170|744021|P1|STARTED|Overall Study||26
308350|NCT00742079|744031|P2|NOT COMPLETED|Overall Study||1
308351|NCT00742079|744032|P1|NOT COMPLETED|Overall Study||0
308352|NCT00742079|744031|P2|COMPLETED|Overall Study||9
308353|NCT00742079|744032|P1|COMPLETED|Overall Study||11
308354|NCT00742079|744031|P2|Week 2 (Received Dose 2)|Overall Study||9
308355|NCT00742079|744032|P1|Week 2 (Received Dose 2)|Overall Study||11
308356|NCT00742079|744031|P2|Baseline/Week 1 (Received Dose 1)|Overall Study||9
308357|NCT00742079|744032|P1|Baseline/Week 1 (Received Dose 1)|Overall Study||11
308358|NCT00742079|744031|P2|STARTED|Overall Study||10
308359|NCT00742079|744032|P1|STARTED|Overall Study||11
308360|NCT00742053|744046|P1|NOT COMPLETED|Overall Study||0
308361|NCT00742053|744046|P1|COMPLETED|Overall Study||7
308362|NCT00742053|744046|P1|STARTED|Overall Study||7
308363|NCT00742001|744053|P3|NOT COMPLETED|Overall Study||1
308364|NCT00742001|744054|P2|NOT COMPLETED|Overall Study||0
308365|NCT00742001|744055|P1|NOT COMPLETED|Overall Study||0
308366|NCT00742001|744053|P3|COMPLETED|Overall Study||3
308367|NCT00742001|744054|P2|COMPLETED|Overall Study||4
308368|NCT00742001|744055|P1|COMPLETED|Overall Study||4
308369|NCT00742001|744053|P3|STARTED|Overall Study||4
308370|NCT00742001|744054|P2|STARTED|Overall Study||4
308371|NCT00742001|744055|P1|STARTED|Overall Study||4
308372|NCT00741988|744071|P2|NOT COMPLETED|Overall Study||4
308373|NCT00741988|744072|P1|NOT COMPLETED|Overall Study||4
308374|NCT00741988|744071|P2|COMPLETED|Overall Study||36
308375|NCT00741988|744072|P1|COMPLETED|Overall Study||38
308376|NCT00741988|744071|P2|STARTED|Overall Study||40
308377|NCT00741988|744072|P1|STARTED|Overall Study||42
308378|NCT00741936|744084|P2|NOT COMPLETED|Overall Study||8
308379|NCT00741936|744085|P1|NOT COMPLETED|Overall Study||9
308380|NCT00741936|744084|P2|COMPLETED|Overall Study||52
308381|NCT00741936|744085|P1|COMPLETED|Overall Study||51
308382|NCT00741936|744084|P2|STARTED|Overall Study||60
308383|NCT00741936|744085|P1|STARTED|Overall Study||60
308384|NCT00741858|744113|P2|NOT COMPLETED|Overall Study||0
308385|NCT00741858|744114|P1|NOT COMPLETED|Overall Study||0
308386|NCT00741858|744113|P2|COMPLETED|Overall Study||18
308387|NCT00741858|744114|P1|COMPLETED|Overall Study||16
308388|NCT00741858|744113|P2|STARTED|Overall Study||18
308389|NCT00741858|744114|P1|STARTED|Overall Study||16
308390|NCT00741819|744120|P1|NOT COMPLETED|Overall Study||8
308391|NCT00741819|744120|P1|COMPLETED|Overall Study||65
308392|NCT00741819|744120|P1|STARTED|Overall Study||73
308393|NCT00741611|744134|P3|NOT COMPLETED|Overall Study||3
308394|NCT00741611|744135|P2|NOT COMPLETED|Overall Study||2
308395|NCT00741611|744136|P1|NOT COMPLETED|Overall Study||0
308396|NCT00741611|744134|P3|COMPLETED|Overall Study||26
308397|NCT00741611|744135|P2|COMPLETED|Overall Study||1
308398|NCT00741611|744136|P1|COMPLETED|Overall Study||4
308399|NCT00741611|744134|P3|STARTED|Overall Study||29
308400|NCT00741611|744135|P2|STARTED|Overall Study||3
308401|NCT00741611|744136|P1|STARTED|Overall Study||4
308402|NCT00741598|744155|P2|NOT COMPLETED|Overall Study||9
308403|NCT00741598|744156|P1|NOT COMPLETED|Overall Study||9
308404|NCT00741598|744155|P2|COMPLETED|Overall Study||30
308405|NCT00741598|744156|P1|COMPLETED|Overall Study||24
308406|NCT00741598|744155|P2|STARTED|Overall Study||39
308407|NCT00741598|744156|P1|STARTED|Overall Study||33
308408|NCT00741468|744170|P1|NOT COMPLETED|Overall Study||0
308409|NCT00741468|744170|P1|COMPLETED|Overall Study||18
308410|NCT00741468|744170|P1|STARTED|Overall Study||18
308411|NCT00741390|744178|P4|NOT COMPLETED|Visit 2||1
308412|NCT00741390|744179|P3|NOT COMPLETED|Visit 2||1
308413|NCT00741390|744180|P2|NOT COMPLETED|Visit 2||0
308414|NCT00741390|744181|P1|NOT COMPLETED|Visit 2||0
308415|NCT00741390|744178|P4|COMPLETED|Visit 2||60
308416|NCT00741390|744179|P3|COMPLETED|Visit 2||54
308417|NCT00741390|744180|P2|COMPLETED|Visit 2||61
308418|NCT00741390|744181|P1|COMPLETED|Visit 2||59
308419|NCT00741390|744178|P4|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|61
308420|NCT00741390|744179|P3|STARTED|Visit 2||55
308421|NCT00741390|744180|P2|STARTED|Visit 2|2 subjects lost to follow-up between Visit 1 and Visit 2.|61
308422|NCT00741390|744181|P1|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|59
308423|NCT00741390|744178|P4|NOT COMPLETED|Visit 1||1
308424|NCT00741390|744179|P3|NOT COMPLETED|Visit 1||7
308425|NCT00741390|744180|P2|NOT COMPLETED|Visit 1||0
308426|NCT00741390|744181|P1|NOT COMPLETED|Visit 1||2
308427|NCT00741390|744178|P4|COMPLETED|Visit 1||62
308428|NCT00741390|744179|P3|COMPLETED|Visit 1||55
308429|NCT00741390|744180|P2|COMPLETED|Visit 1||63
308430|NCT00741390|744181|P1|COMPLETED|Visit 1||60
308431|NCT00741390|744178|P4|STARTED|Visit 1||63
308432|NCT00741390|744179|P3|STARTED|Visit 1||62
308433|NCT00741390|744180|P2|STARTED|Visit 1||63
308434|NCT00741390|744181|P1|STARTED|Visit 1||62
308435|NCT00741338|744202|P2|NOT COMPLETED|Overall Study||1
308436|NCT00741338|744203|P1|NOT COMPLETED|Overall Study||0
308437|NCT00741338|744202|P2|COMPLETED|Overall Study||2
308438|NCT00741338|744203|P1|COMPLETED|Overall Study||3
308439|NCT00741338|744202|P2|STARTED|Overall Study||3
308440|NCT00741338|744203|P1|STARTED|Overall Study||3
308441|NCT00741286|744213|P2|NOT COMPLETED|Overall Study||19
308442|NCT00741286|744214|P1|NOT COMPLETED|Overall Study||20
308443|NCT00741286|744213|P2|COMPLETED|Overall Study||81
308444|NCT00741286|744214|P1|COMPLETED|Overall Study||83
308445|NCT00741286|744213|P2|STARTED|Overall Study||100
308446|NCT00741286|744214|P1|STARTED|Overall Study||103
308447|NCT00741273|744224|P2|NOT COMPLETED|Overall Study||0
308448|NCT00741273|744225|P1|NOT COMPLETED|Overall Study||0
308449|NCT00741273|744224|P2|COMPLETED|Overall Study||8
308450|NCT00741273|744225|P1|COMPLETED|Overall Study||8
308451|NCT00741273|744224|P2|STARTED|Overall Study||8
308452|NCT00741273|744225|P1|STARTED|Overall Study||8
308453|NCT00741260|744248|P7|NOT COMPLETED|Overall Study||7
308454|NCT00741260|744249|P6|NOT COMPLETED|Overall Study||45
308455|NCT00741260|744250|P5|NOT COMPLETED|Overall Study||9
308456|NCT00741260|744251|P4|NOT COMPLETED|Overall Study||6
308457|NCT00741260|744252|P3|NOT COMPLETED|Overall Study||4
308458|NCT00741260|744253|P2|NOT COMPLETED|Overall Study||8
308459|NCT00741260|744254|P1|NOT COMPLETED|Overall Study||6
308460|NCT00741260|744248|P7|COMPLETED|Overall Study||0
308461|NCT00741260|744249|P6|COMPLETED|Overall Study||20
308462|NCT00741260|744250|P5|COMPLETED|Overall Study||0
308463|NCT00741260|744251|P4|COMPLETED|Overall Study||0
308464|NCT00741260|744252|P3|COMPLETED|Overall Study||0
308465|NCT00741260|744253|P2|COMPLETED|Overall Study||0
308466|NCT00741260|744254|P1|COMPLETED|Overall Study||0
308467|NCT00741260|744248|P7|STARTED|Overall Study||7
308468|NCT00741260|744249|P6|STARTED|Overall Study||65
308469|NCT00741260|744250|P5|STARTED|Overall Study||9
308470|NCT00741260|744251|P4|STARTED|Overall Study||6
308471|NCT00741260|744252|P3|STARTED|Overall Study||4
308472|NCT00741260|744253|P2|STARTED|Overall Study||8
308473|NCT00741260|744254|P1|STARTED|Overall Study||6
308474|NCT00741156|744281|P1|NOT COMPLETED|Overall Study||0
308475|NCT00741156|744281|P1|COMPLETED|Overall Study||12
308476|NCT00741156|744281|P1|STARTED|Overall Study||12
308477|NCT00741104|744296|P1|NOT COMPLETED|Overall Study||0
308478|NCT00741104|744296|P1|COMPLETED|Overall Study||363
308479|NCT00741104|744296|P1|STARTED|Overall Study||363
308480|NCT00741091|744303|P1|NOT COMPLETED|Overall Study||57
308481|NCT00741091|744303|P1|COMPLETED|Overall Study||1040
308482|NCT00741091|744303|P1|STARTED|Overall Study||1097
308483|NCT00741039|744313|P2|NOT COMPLETED|Overall Study||0
308484|NCT00741039|744314|P1|NOT COMPLETED|Overall Study||2
308485|NCT00741039|744313|P2|COMPLETED|Overall Study||25
308486|NCT00741039|744314|P1|COMPLETED|Overall Study||100
308487|NCT00741039|744313|P2|STARTED|Overall Study||25
308488|NCT00741039|744314|P1|STARTED|Overall Study||102
308489|NCT00741026|744320|P1|NOT COMPLETED|Overall Study||0
308490|NCT00741026|744320|P1|COMPLETED|Overall Study||15
308491|NCT00741026|744320|P1|STARTED|Overall Study||15
308492|NCT00741013|744351|P3|NOT COMPLETED|Overall Study||1
308493|NCT00741013|744352|P2|NOT COMPLETED|Overall Study||2
308494|NCT00741013|744353|P1|NOT COMPLETED|Overall Study||1
308495|NCT00741013|744351|P3|COMPLETED|Overall Study||6
308496|NCT00741013|744352|P2|COMPLETED|Overall Study||6
308497|NCT00741013|744353|P1|COMPLETED|Overall Study||6
308498|NCT00741013|744351|P3|STARTED|Overall Study||7
308499|NCT00741013|744352|P2|STARTED|Overall Study||8
308500|NCT00741013|744353|P1|STARTED|Overall Study||7
308501|NCT00740870|744364|P1|NOT COMPLETED|Overall Study||21
308502|NCT00740870|744364|P1|COMPLETED|Overall Study||150
308503|NCT00740870|744364|P1|STARTED|Overall Study||171
308504|NCT00740857|744379|P3|NOT COMPLETED|Overall Study||0
308505|NCT00740857|744380|P2|NOT COMPLETED|Overall Study||0
308506|NCT00740857|744381|P1|NOT COMPLETED|Overall Study||1
308507|NCT00740857|744379|P3|COMPLETED|Overall Study||90
308508|NCT00740857|744380|P2|COMPLETED|Overall Study||88
308509|NCT00740857|744381|P1|COMPLETED|Overall Study||32
308510|NCT00740857|744379|P3|STARTED|Overall Study||90
308511|NCT00740857|744380|P2|STARTED|Overall Study||88
308512|NCT00740857|744381|P1|STARTED|Overall Study||33
308513|NCT00740831|744413|P3|NOT COMPLETED|Overall Study||6
308514|NCT00740831|744414|P2|NOT COMPLETED|Overall Study||3
308515|NCT00740831|744415|P1|NOT COMPLETED|Overall Study||4
308516|NCT00740831|744413|P3|COMPLETED|Overall Study|Patients who completed part A (visit 6)|95
308517|NCT00740831|744414|P2|COMPLETED|Overall Study|Patients who completed part A (visit 6)|100
308518|NCT00740831|744415|P1|COMPLETED|Overall Study|Patients who completed part A (visit 6)|93
308519|NCT00740831|744413|P3|STARTED|Overall Study|Safety population|101
308520|NCT00740831|744414|P2|STARTED|Overall Study|Safety population|103
308521|NCT00740831|744415|P1|STARTED|Overall Study|Safety population|97
308522|NCT00740792|744436|P4|NOT COMPLETED|Overall Study||10
308523|NCT00740792|744437|P3|NOT COMPLETED|Overall Study||9
308524|NCT00740792|744438|P2|NOT COMPLETED|Overall Study||8
308525|NCT00740792|744439|P1|NOT COMPLETED|Overall Study||10
308526|NCT00740792|744436|P4|COMPLETED|Overall Study||190
308527|NCT00740792|744437|P3|COMPLETED|Overall Study||180
308528|NCT00740792|744438|P2|COMPLETED|Overall Study||186
308529|NCT00740792|744439|P1|COMPLETED|Overall Study||183
308530|NCT00740792|744436|P4|STARTED|Overall Study||200
308531|NCT00740792|744437|P3|STARTED|Overall Study||189
308532|NCT00740792|744438|P2|STARTED|Overall Study||194
308533|NCT00740792|744439|P1|STARTED|Overall Study||193
308534|NCT00740779|744460|P3|NOT COMPLETED|Overall Study||13
308535|NCT00740779|744461|P2|NOT COMPLETED|Overall Study||14
308536|NCT00740779|744462|P1|NOT COMPLETED|Overall Study||9
308537|NCT00740779|744460|P3|COMPLETED|Overall Study||41
308538|NCT00740779|744461|P2|COMPLETED|Overall Study||31
308539|NCT00740779|744462|P1|COMPLETED|Overall Study||43
308540|NCT00740779|744460|P3|STARTED|Overall Study||54
308541|NCT00740779|744461|P2|STARTED|Overall Study||45
308542|NCT00740779|744462|P1|STARTED|Overall Study||52
308543|NCT00740727|744470|P1|NOT COMPLETED|Overall Study||0
308544|NCT00740727|744470|P1|COMPLETED|Overall Study||18
308545|NCT00740727|744470|P1|STARTED|Overall Study||18
308546|NCT00740714|744479|P3|NOT COMPLETED|Overall Study||29
308547|NCT00740714|744480|P2|NOT COMPLETED|Overall Study||19
308548|NCT00740714|744481|P1|NOT COMPLETED|Overall Study||17
308549|NCT00740714|744479|P3|COMPLETED|Overall Study||174
308550|NCT00740714|744480|P2|COMPLETED|Overall Study||182
308551|NCT00740714|744481|P1|COMPLETED|Overall Study||179
308552|NCT00740714|744479|P3|Active Patients at Study Termination|Overall Study||33
308553|NCT00740714|744480|P2|Active Patients at Study Termination|Overall Study||12
308554|NCT00740714|744481|P1|Active Patients at Study Termination|Overall Study||24
308555|NCT00740714|744479|P3|Reaching Endpoint Before May 6, 2011|Overall Study||94
308556|NCT00740714|744480|P2|Reaching Endpoint Before May 6, 2011|Overall Study||87
308557|NCT00740714|744481|P1|Reaching Endpoint Before May 6, 2011|Overall Study||86
308558|NCT00740714|744479|P3|STARTED|Overall Study|Randomized throughout the recruitment period|203
308559|NCT00740714|744480|P2|STARTED|Overall Study|Randomized throughout the recruitment period|201
308560|NCT00740714|744481|P1|STARTED|Overall Study|Randomized throughout the recruitment period|196
308561|NCT00740636|744557|P2|NOT COMPLETED|Overall Study||4
308562|NCT00740636|744558|P1|NOT COMPLETED|Overall Study||2
308563|NCT00740636|744557|P2|COMPLETED|Overall Study||63
308564|NCT00740636|744558|P1|COMPLETED|Overall Study||23
308565|NCT00740636|744557|P2|STARTED|Overall Study||67
308566|NCT00740636|744558|P1|STARTED|Overall Study||25
308567|NCT00740597|744564|P1|NOT COMPLETED|Overall Study||1
308568|NCT00740597|744564|P1|COMPLETED|Overall Study||0
308569|NCT00740597|744564|P1|STARTED|Overall Study||1
308570|NCT00740584|744568|P1|NOT COMPLETED|Overall Study||1
308571|NCT00740584|744568|P1|COMPLETED|Overall Study||11
308572|NCT00740584|744568|P1|STARTED|Overall Study||12
308573|NCT00740480|744573|P1|NOT COMPLETED|Overall Study||2
308574|NCT00740480|744573|P1|COMPLETED|Overall Study||23
308575|NCT00740480|744573|P1|STARTED|Overall Study||25
308576|NCT00740376|744579|P2|NOT COMPLETED|Overall Study||3
308577|NCT00740376|744580|P1|NOT COMPLETED|Overall Study||3
308578|NCT00740376|744579|P2|COMPLETED|Overall Study||12
308579|NCT00740376|744580|P1|COMPLETED|Overall Study||19
308580|NCT00740376|744579|P2|STARTED|Overall Study||15
308581|NCT00740376|744580|P1|STARTED|Overall Study||22
308582|NCT00740220|744598|P1|NOT COMPLETED|Overall Study||9
308583|NCT00740220|744598|P1|COMPLETED|Overall Study||88
308584|NCT00740220|744598|P1|STARTED|Overall Study||97
308585|NCT00740207|744604|P2|NOT COMPLETED|Overall Study||0
308586|NCT00740207|744605|P1|NOT COMPLETED|Overall Study||0
308587|NCT00740207|744604|P2|COMPLETED|Overall Study||16
308588|NCT00740207|744605|P1|COMPLETED|Overall Study||17
308589|NCT00740207|744604|P2|STARTED|Overall Study||16
308590|NCT00740207|744605|P1|STARTED|Overall Study||17
308591|NCT00740181|744617|P1|NOT COMPLETED|Overall Study||0
308592|NCT00740181|744617|P1|COMPLETED|Overall Study||9
308593|NCT00740181|744617|P1|STARTED|Overall Study||9
308594|NCT00740051|744623|P2|NOT COMPLETED|Overall Study||32
308595|NCT00740051|744624|P1|NOT COMPLETED|Overall Study||18
308596|NCT00740051|744623|P2|COMPLETED|Overall Study||119
308597|NCT00740051|744624|P1|COMPLETED|Overall Study||58
308598|NCT00740051|744623|P2|STARTED|Overall Study||151
308599|NCT00740051|744624|P1|STARTED|Overall Study||76
308600|NCT00739999|744646|P2|NOT COMPLETED|Overall Study||0
308601|NCT00739999|744647|P1|NOT COMPLETED|Overall Study||0
308602|NCT00739999|744646|P2|COMPLETED|Overall Study||24
308603|NCT00739999|744647|P1|COMPLETED|Overall Study||15
308604|NCT00739999|744646|P2|STARTED|Overall Study||24
308605|NCT00739999|744647|P1|STARTED|Overall Study||15
308606|NCT00739973|744727|P9|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||14
308607|NCT00739973|744728|P8|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||10
308608|NCT00739973|744729|P7|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||13
308609|NCT00739973|744730|P6|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
308610|NCT00739973|744731|P5|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
308611|NCT00739973|744732|P4|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
308612|NCT00739973|744733|P3|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
308613|NCT00739973|744734|P2|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||20
308614|NCT00739973|744735|P1|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||30
308615|NCT00739973|744727|P9|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
308616|NCT00739973|744728|P8|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
308617|NCT00739973|744729|P7|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
308618|NCT00739973|744730|P6|COMPLETED|Double-blind:Randomized Period (8 Weeks)||169
308619|NCT00739973|744731|P5|COMPLETED|Double-blind:Randomized Period (8 Weeks)||162
308620|NCT00739973|744732|P4|COMPLETED|Double-blind:Randomized Period (8 Weeks)||173
308621|NCT00739973|744733|P3|COMPLETED|Double-blind:Randomized Period (8 Weeks)||184
308622|NCT00739973|744734|P2|COMPLETED|Double-blind:Randomized Period (8 Weeks)||175
308623|NCT00739973|744735|P1|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
308624|NCT00739973|744727|P9|STARTED|Double-blind:Randomized Period (8 Weeks)||184
308625|NCT00739973|744728|P8|STARTED|Double-blind:Randomized Period (8 Weeks)||178
308626|NCT00739973|744729|P7|STARTED|Double-blind:Randomized Period (8 Weeks)|2 pts. were mis-randomized, so discontinued from single-blind and were untreated in double-blind.|183
308627|NCT00739973|744730|P6|STARTED|Double-blind:Randomized Period (8 Weeks)||181
308628|NCT00739973|744731|P5|STARTED|Double-blind:Randomized Period (8 Weeks)||181
308629|NCT00739973|744732|P4|STARTED|Double-blind:Randomized Period (8 Weeks)||185
308630|NCT00739973|744733|P3|STARTED|Double-blind:Randomized Period (8 Weeks)||203
308631|NCT00739973|744734|P2|STARTED|Double-blind:Randomized Period (8 Weeks)|One pt. was mis-randomized, so discontinued from single-blind and was untreated in the double-blind.|195
308632|NCT00739973|744735|P1|STARTED|Double-blind:Randomized Period (8 Weeks)||198
308633|NCT00739973|744727|P9|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
308634|NCT00739973|744728|P8|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
308635|NCT00739973|744729|P7|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
308636|NCT00739973|744730|P6|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
308637|NCT00739973|744731|P5|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
308638|NCT00739973|744732|P4|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
308639|NCT00739973|744733|P3|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
308640|NCT00739973|744734|P2|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
308641|NCT00739973|744735|P1|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||1009
308642|NCT00739973|744727|P9|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
308643|NCT00739973|744728|P8|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
308644|NCT00739973|744729|P7|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
308645|NCT00739973|744730|P6|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
308646|NCT00739973|744731|P5|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
308647|NCT00739973|744732|P4|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
308648|NCT00739973|744733|P3|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
308649|NCT00739973|744734|P2|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
308650|NCT00739973|744735|P1|COMPLETED|Single-blind Period (2 to 4 Weeks)||1685
308651|NCT00739973|744727|P9|STARTED|Single-blind Period (2 to 4 Weeks)||0
308652|NCT00739973|744728|P8|STARTED|Single-blind Period (2 to 4 Weeks)||0
308653|NCT00739973|744729|P7|STARTED|Single-blind Period (2 to 4 Weeks)||0
308654|NCT00739973|744730|P6|STARTED|Single-blind Period (2 to 4 Weeks)||0
308655|NCT00739973|744731|P5|STARTED|Single-blind Period (2 to 4 Weeks)||0
308656|NCT00739973|744732|P4|STARTED|Single-blind Period (2 to 4 Weeks)||0
308657|NCT00739973|744733|P3|STARTED|Single-blind Period (2 to 4 Weeks)||0
308658|NCT00739973|744734|P2|STARTED|Single-blind Period (2 to 4 Weeks)||0
308659|NCT00739973|744735|P1|STARTED|Single-blind Period (2 to 4 Weeks)|In this period, participants were enrolled to only Placebo arm.|2694
308660|NCT00739934|744821|P1|NOT COMPLETED|Voriconazole Oral||3
308661|NCT00739934|744821|P1|COMPLETED|Voriconazole Oral||31
308662|NCT00739934|744821|P1|STARTED|Voriconazole Oral||34
308663|NCT00739934|744821|P1|NOT COMPLETED|Voriconazole IV||6
308664|NCT00739934|744821|P1|COMPLETED|Voriconazole IV||34
308665|NCT00739934|744821|P1|STARTED|Voriconazole IV||40
308666|NCT00739908|744843|P2|NOT COMPLETED|Overall Study||25
308667|NCT00739908|744844|P1|NOT COMPLETED|Overall Study||25
308668|NCT00739908|744843|P2|COMPLETED|Overall Study||118
308669|NCT00739908|744844|P1|COMPLETED|Overall Study||117
308670|NCT00739908|744843|P2|STARTED|Overall Study||143
308671|NCT00739908|744844|P1|STARTED|Overall Study||142
308672|NCT00739882|744864|P2|NOT COMPLETED|Open-label Period||5
308673|NCT00739882|744865|P1|NOT COMPLETED|Open-label Period||10
308674|NCT00739882|744864|P2|COMPLETED|Open-label Period||9
308675|NCT00739882|744865|P1|COMPLETED|Open-label Period||7
308676|NCT00739882|744864|P2|STARTED|Open-label Period||14
308677|NCT00739882|744865|P1|STARTED|Open-label Period||17
308678|NCT00739882|744864|P2|NOT COMPLETED|Double-blind Period||11
308679|NCT00739882|744865|P1|NOT COMPLETED|Double-blind Period||19
308680|NCT00739882|744864|P2|COMPLETED|Double-blind Period||14
308681|NCT00739882|744865|P1|COMPLETED|Double-blind Period||32
308682|NCT00739882|744864|P2|STARTED|Double-blind Period||25
308683|NCT00739882|744865|P1|STARTED|Double-blind Period||51
308684|NCT00739765|744886|P3|NOT COMPLETED|Overall Study||11
308685|NCT00739765|744887|P2|NOT COMPLETED|Overall Study||11
308686|NCT00739765|744888|P1|NOT COMPLETED|Overall Study||6
308687|NCT00739765|744886|P3|COMPLETED|Overall Study||21
308688|NCT00739765|744887|P2|COMPLETED|Overall Study||27
308689|NCT00739765|744888|P1|COMPLETED|Overall Study||34
308690|NCT00739765|744886|P3|STARTED|Overall Study||32
308691|NCT00739765|744887|P2|STARTED|Overall Study||38
308692|NCT00739765|744888|P1|STARTED|Overall Study||40
308693|NCT00739752|744905|P6|NOT COMPLETED|Overall Study||0
308694|NCT00739752|744906|P5|NOT COMPLETED|Overall Study||0
308695|NCT00739752|744907|P4|NOT COMPLETED|Overall Study||0
308696|NCT00739752|744908|P3|NOT COMPLETED|Overall Study||0
308697|NCT00739752|744909|P2|NOT COMPLETED|Overall Study||0
308698|NCT00739752|744910|P1|NOT COMPLETED|Overall Study||0
308699|NCT00739752|744905|P6|COMPLETED|Overall Study||293
308700|NCT00739752|744906|P5|COMPLETED|Overall Study||291
308701|NCT00739752|744907|P4|COMPLETED|Overall Study||288
308702|NCT00739752|744908|P3|COMPLETED|Overall Study||292
308703|NCT00739752|744909|P2|COMPLETED|Overall Study||284
308704|NCT00739752|744910|P1|COMPLETED|Overall Study||299
308705|NCT00739752|744905|P6|STARTED|Overall Study||293
308706|NCT00739752|744906|P5|STARTED|Overall Study||291
308707|NCT00739752|744907|P4|STARTED|Overall Study||288
308708|NCT00739752|744908|P3|STARTED|Overall Study||292
308709|NCT00739752|744909|P2|STARTED|Overall Study||284
308710|NCT00739752|744910|P1|STARTED|Overall Study||299
308711|NCT00739674|744926|P2|NOT COMPLETED|Overall Study||122
308712|NCT00739674|744927|P1|NOT COMPLETED|Overall Study||181
308713|NCT00739674|744926|P2|COMPLETED|Overall Study||335
308714|NCT00739674|744927|P1|COMPLETED|Overall Study||354
308715|NCT00739674|744926|P2|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|400
308716|NCT00739674|744927|P1|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|463
308717|NCT00739674|744926|P2|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|9
308718|NCT00739674|744927|P1|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|1
308719|NCT00739674|744926|P2|No Follow-up Data|Overall Study||18
308720|NCT00739674|744927|P1|No Follow-up Data|Overall Study||33
308721|NCT00739674|744926|P2|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|13
308722|NCT00739674|744927|P1|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|19
308723|NCT00739674|744926|P2|Screening Failures|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|17
308724|NCT00739674|744927|P1|Screening Failures|Overall Study||19
308725|NCT00739674|744926|P2|STARTED|Overall Study||457
308726|NCT00739674|744927|P1|STARTED|Overall Study||535
308727|NCT00739661|744955|P2|NOT COMPLETED|Overall Study||42
308728|NCT00739661|744956|P1|NOT COMPLETED|Overall Study||46
308729|NCT00739661|744955|P2|COMPLETED|Overall Study||10
308730|NCT00739661|744956|P1|COMPLETED|Overall Study||6
308731|NCT00739661|744955|P2|STARTED|Overall Study||52
308732|NCT00739661|744956|P1|STARTED|Overall Study||52
308733|NCT00739648|744968|P2|NOT COMPLETED|Overall Study||53
308734|NCT00739648|744969|P1|NOT COMPLETED|Overall Study||26
308735|NCT00739648|744968|P2|COMPLETED|Overall Study||161
308736|NCT00739648|744969|P1|COMPLETED|Overall Study||82
308737|NCT00739648|744968|P2|STARTED|Overall Study||214
308738|NCT00739648|744969|P1|STARTED|Overall Study||108
308739|NCT00739596|744983|P2|NOT COMPLETED|Overall Study||17
308740|NCT00739596|744984|P1|NOT COMPLETED|Overall Study||25
308741|NCT00739596|744983|P2|COMPLETED|Overall Study||149
308742|NCT00739596|744984|P1|COMPLETED|Overall Study||141
308743|NCT00739596|744983|P2|STARTED|Overall Study||166
308744|NCT00739596|744984|P1|STARTED|Overall Study||166
308745|NCT00739583|745000|P2|NOT COMPLETED|Overall Study||0
308746|NCT00739583|745001|P1|NOT COMPLETED|Overall Study||0
308747|NCT00739583|745000|P2|COMPLETED|Overall Study||10
308748|NCT00739583|745001|P1|COMPLETED|Overall Study||10
308749|NCT00739583|745000|P2|STARTED|Overall Study||10
308750|NCT00739583|745001|P1|STARTED|Overall Study||10
308751|NCT00739336|745013|P2|NOT COMPLETED|Overall Study||0
308752|NCT00739336|745014|P1|NOT COMPLETED|Overall Study||4
308753|NCT00739336|745013|P2|COMPLETED|Overall Study||24
308754|NCT00739336|745014|P1|COMPLETED|Overall Study||17
308755|NCT00739336|745013|P2|STARTED|Overall Study||24
308756|NCT00739336|745014|P1|STARTED|Overall Study||21
308757|NCT00739310|745026|P1|NOT COMPLETED|Overall Study||7
308758|NCT00739310|745026|P1|COMPLETED|Overall Study||22
308759|NCT00739310|745026|P1|STARTED|Overall Study||29
308760|NCT00739297|745031|P7|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
308761|NCT00739297|745032|P6|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
308762|NCT00739297|745033|P5|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
308763|NCT00739297|745034|P4|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
308764|NCT00739297|745035|P3|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
308765|NCT00739297|745036|P2|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
308766|NCT00739297|745037|P1|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
308767|NCT00739297|745031|P7|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||65
308768|NCT00739297|745032|P6|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
308769|NCT00739297|745033|P5|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||7
308770|NCT00739297|745034|P4|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||15
308771|NCT00739297|745035|P3|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
308772|NCT00739297|745036|P2|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||11
308773|NCT00739297|745037|P1|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||16
308774|NCT00739297|745031|P7|STARTED|Fourth Intervention(Visit 9 to Visit 10)||66
308775|NCT00739297|745032|P6|STARTED|Fourth Intervention(Visit 9 to Visit 10)||9
308776|NCT00739297|745033|P5|STARTED|Fourth Intervention(Visit 9 to Visit 10)||7
308777|NCT00739297|745034|P4|STARTED|Fourth Intervention(Visit 9 to Visit 10)||15
308778|NCT00739297|745035|P3|STARTED|Fourth Intervention(Visit 9 to Visit 10)||8
308779|NCT00739297|745036|P2|STARTED|Fourth Intervention(Visit 9 to Visit 10)||11
308780|NCT00739297|745037|P1|STARTED|Fourth Intervention(Visit 9 to Visit 10)||16
308781|NCT00739297|745031|P7|NOT COMPLETED|Third Washout Period of 4-7 Days||0
308782|NCT00739297|745032|P6|NOT COMPLETED|Third Washout Period of 4-7 Days||0
308783|NCT00739297|745033|P5|NOT COMPLETED|Third Washout Period of 4-7 Days||0
308784|NCT00739297|745034|P4|NOT COMPLETED|Third Washout Period of 4-7 Days||0
308785|NCT00739297|745035|P3|NOT COMPLETED|Third Washout Period of 4-7 Days||0
308786|NCT00739297|745036|P2|NOT COMPLETED|Third Washout Period of 4-7 Days||0
308787|NCT00739297|745037|P1|NOT COMPLETED|Third Washout Period of 4-7 Days||0
308788|NCT00739297|745031|P7|COMPLETED|Third Washout Period of 4-7 Days||66
308789|NCT00739297|745032|P6|COMPLETED|Third Washout Period of 4-7 Days||8
308790|NCT00739297|745033|P5|COMPLETED|Third Washout Period of 4-7 Days||6
308791|NCT00739297|745034|P4|COMPLETED|Third Washout Period of 4-7 Days||18
308792|NCT00739297|745035|P3|COMPLETED|Third Washout Period of 4-7 Days||6
308793|NCT00739297|745036|P2|COMPLETED|Third Washout Period of 4-7 Days||12
308794|NCT00739297|745037|P1|COMPLETED|Third Washout Period of 4-7 Days||16
308795|NCT00739297|745031|P7|STARTED|Third Washout Period of 4-7 Days||66
308796|NCT00739297|745032|P6|STARTED|Third Washout Period of 4-7 Days||8
308797|NCT00739297|745033|P5|STARTED|Third Washout Period of 4-7 Days||6
308798|NCT00739297|745034|P4|STARTED|Third Washout Period of 4-7 Days||18
308799|NCT00739297|745035|P3|STARTED|Third Washout Period of 4-7 Days||6
308800|NCT00739297|745036|P2|STARTED|Third Washout Period of 4-7 Days||12
308801|NCT00739297|745037|P1|STARTED|Third Washout Period of 4-7 Days||16
308802|NCT00739297|745031|P7|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
308803|NCT00739297|745032|P6|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
308804|NCT00739297|745033|P5|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
308805|NCT00739297|745034|P4|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
308806|NCT00739297|745035|P3|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
308807|NCT00739297|745036|P2|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
308808|NCT00739297|745037|P1|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
308809|NCT00739297|745031|P7|COMPLETED|Third Intervention (Visit 7 to Visit 8)||66
308810|NCT00739297|745032|P6|COMPLETED|Third Intervention (Visit 7 to Visit 8)||8
308811|NCT00739297|745033|P5|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
308812|NCT00739297|745034|P4|COMPLETED|Third Intervention (Visit 7 to Visit 8)||18
308813|NCT00739297|745035|P3|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
308814|NCT00739297|745036|P2|COMPLETED|Third Intervention (Visit 7 to Visit 8)||12
308815|NCT00739297|745037|P1|COMPLETED|Third Intervention (Visit 7 to Visit 8)||16
308816|NCT00739297|745031|P7|STARTED|Third Intervention (Visit 7 to Visit 8)||66
308817|NCT00739297|745032|P6|STARTED|Third Intervention (Visit 7 to Visit 8)||8
308818|NCT00739297|745033|P5|STARTED|Third Intervention (Visit 7 to Visit 8)||6
308819|NCT00739297|745034|P4|STARTED|Third Intervention (Visit 7 to Visit 8)||18
308820|NCT00739297|745035|P3|STARTED|Third Intervention (Visit 7 to Visit 8)||6
308821|NCT00739297|745036|P2|STARTED|Third Intervention (Visit 7 to Visit 8)||12
308822|NCT00739297|745037|P1|STARTED|Third Intervention (Visit 7 to Visit 8)||16
308823|NCT00739297|745031|P7|NOT COMPLETED|Second Washout Period of 4-7 Days||0
308824|NCT00739297|745032|P6|NOT COMPLETED|Second Washout Period of 4-7 Days||0
308825|NCT00739297|745033|P5|NOT COMPLETED|Second Washout Period of 4-7 Days||0
308826|NCT00739297|745034|P4|NOT COMPLETED|Second Washout Period of 4-7 Days||0
308827|NCT00739297|745035|P3|NOT COMPLETED|Second Washout Period of 4-7 Days||0
308828|NCT00739297|745036|P2|NOT COMPLETED|Second Washout Period of 4-7 Days||0
308829|NCT00739297|745037|P1|NOT COMPLETED|Second Washout Period of 4-7 Days||0
308830|NCT00739297|745031|P7|COMPLETED|Second Washout Period of 4-7 Days||66
308831|NCT00739297|745032|P6|COMPLETED|Second Washout Period of 4-7 Days||10
308832|NCT00739297|745033|P5|COMPLETED|Second Washout Period of 4-7 Days||6
308833|NCT00739297|745034|P4|COMPLETED|Second Washout Period of 4-7 Days||14
308834|NCT00739297|745035|P3|COMPLETED|Second Washout Period of 4-7 Days||10
308835|NCT00739297|745036|P2|COMPLETED|Second Washout Period of 4-7 Days||8
308836|NCT00739297|745037|P1|COMPLETED|Second Washout Period of 4-7 Days||18
308837|NCT00739297|745031|P7|STARTED|Second Washout Period of 4-7 Days||66
308838|NCT00739297|745032|P6|STARTED|Second Washout Period of 4-7 Days||10
308839|NCT00739297|745033|P5|STARTED|Second Washout Period of 4-7 Days||6
308840|NCT00739297|745034|P4|STARTED|Second Washout Period of 4-7 Days||14
308841|NCT00739297|745035|P3|STARTED|Second Washout Period of 4-7 Days||10
308842|NCT00739297|745036|P2|STARTED|Second Washout Period of 4-7 Days||8
308843|NCT00739297|745037|P1|STARTED|Second Washout Period of 4-7 Days||18
308844|NCT00739297|745031|P7|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
308845|NCT00739297|745032|P6|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
308846|NCT00739297|745033|P5|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
308847|NCT00739297|745034|P4|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
308848|NCT00739297|745035|P3|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
308849|NCT00739297|745036|P2|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
308850|NCT00739297|745037|P1|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
308851|NCT00739297|745031|P7|COMPLETED|Second Intervention (Visit 5 to Visit 6)||66
308852|NCT00739297|745032|P6|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
308853|NCT00739297|745033|P5|COMPLETED|Second Intervention (Visit 5 to Visit 6)||6
308854|NCT00739297|745034|P4|COMPLETED|Second Intervention (Visit 5 to Visit 6)||14
308855|NCT00739297|745035|P3|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
308856|NCT00739297|745036|P2|COMPLETED|Second Intervention (Visit 5 to Visit 6)||8
308857|NCT00739297|745037|P1|COMPLETED|Second Intervention (Visit 5 to Visit 6)||18
308858|NCT00739297|745031|P7|STARTED|Second Intervention (Visit 5 to Visit 6)||66
308859|NCT00739297|745032|P6|STARTED|Second Intervention (Visit 5 to Visit 6)||10
308860|NCT00739297|745033|P5|STARTED|Second Intervention (Visit 5 to Visit 6)||6
308861|NCT00739297|745034|P4|STARTED|Second Intervention (Visit 5 to Visit 6)||14
308862|NCT00739297|745035|P3|STARTED|Second Intervention (Visit 5 to Visit 6)||10
308863|NCT00739297|745036|P2|STARTED|Second Intervention (Visit 5 to Visit 6)||8
308864|NCT00739297|745037|P1|STARTED|Second Intervention (Visit 5 to Visit 6)||18
308865|NCT00739297|745031|P7|NOT COMPLETED|First Washout Period of 4-7 Days||2
308866|NCT00739297|745032|P6|NOT COMPLETED|First Washout Period of 4-7 Days||0
308867|NCT00739297|745033|P5|NOT COMPLETED|First Washout Period of 4-7 Days||0
308868|NCT00739297|745034|P4|NOT COMPLETED|First Washout Period of 4-7 Days||2
308869|NCT00739297|745035|P3|NOT COMPLETED|First Washout Period of 4-7 Days||0
308870|NCT00739297|745036|P2|NOT COMPLETED|First Washout Period of 4-7 Days||0
308871|NCT00739297|745037|P1|NOT COMPLETED|First Washout Period of 4-7 Days||0
308872|NCT00739297|745031|P7|COMPLETED|First Washout Period of 4-7 Days||66
308873|NCT00739297|745032|P6|COMPLETED|First Washout Period of 4-7 Days||9
308874|NCT00739297|745033|P5|COMPLETED|First Washout Period of 4-7 Days||6
308875|NCT00739297|745034|P4|COMPLETED|First Washout Period of 4-7 Days||17
308876|NCT00739297|745035|P3|COMPLETED|First Washout Period of 4-7 Days||6
308877|NCT00739297|745036|P2|COMPLETED|First Washout Period of 4-7 Days||11
308878|NCT00739297|745037|P1|COMPLETED|First Washout Period of 4-7 Days||17
308879|NCT00739297|745031|P7|STARTED|First Washout Period of 4-7 Days||68
308880|NCT00739297|745032|P6|STARTED|First Washout Period of 4-7 Days||9
308881|NCT00739297|745033|P5|STARTED|First Washout Period of 4-7 Days||6
308882|NCT00739297|745034|P4|STARTED|First Washout Period of 4-7 Days||19
308883|NCT00739297|745035|P3|STARTED|First Washout Period of 4-7 Days||6
308884|NCT00739297|745036|P2|STARTED|First Washout Period of 4-7 Days||11
308885|NCT00739297|745037|P1|STARTED|First Washout Period of 4-7 Days||17
308886|NCT00739297|745031|P7|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
308887|NCT00739297|745032|P6|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
308888|NCT00739297|745033|P5|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
308889|NCT00739297|745034|P4|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
308890|NCT00739297|745035|P3|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
308891|NCT00739297|745036|P2|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
308892|NCT00739297|745037|P1|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
308893|NCT00739297|745031|P7|COMPLETED|First Intervention (Visit 3 to Visit 4)||68
308894|NCT00739297|745032|P6|COMPLETED|First Intervention (Visit 3 to Visit 4)||9
308895|NCT00739297|745033|P5|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
308896|NCT00739297|745034|P4|COMPLETED|First Intervention (Visit 3 to Visit 4)||19
308897|NCT00739297|745035|P3|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
308898|NCT00739297|745036|P2|COMPLETED|First Intervention (Visit 3 to Visit 4)||11
308899|NCT00739297|745037|P1|COMPLETED|First Intervention (Visit 3 to Visit 4)||17
308900|NCT00739297|745031|P7|STARTED|First Intervention (Visit 3 to Visit 4)||68
308901|NCT00739297|745032|P6|STARTED|First Intervention (Visit 3 to Visit 4)||9
308902|NCT00739297|745033|P5|STARTED|First Intervention (Visit 3 to Visit 4)||6
308903|NCT00739297|745034|P4|STARTED|First Intervention (Visit 3 to Visit 4)||19
308904|NCT00739297|745035|P3|STARTED|First Intervention (Visit 3 to Visit 4)||6
308905|NCT00739297|745036|P2|STARTED|First Intervention (Visit 3 to Visit 4)||11
308906|NCT00739297|745037|P1|STARTED|First Intervention (Visit 3 to Visit 4)||17
308907|NCT00739102|745065|P1|NOT COMPLETED|Overall Study||15
308908|NCT00739102|745065|P1|COMPLETED|Overall Study|Completed 12-Month Follow-up|235
308909|NCT00739102|745065|P1|STARTED|Overall Study||250
308910|NCT00739063|745081|P1|NOT COMPLETED|Overall Study||8
308911|NCT00739063|745081|P1|COMPLETED|Overall Study||3
308912|NCT00739063|745081|P1|STARTED|Overall Study||11
308913|NCT00739050|745085|P2|NOT COMPLETED|Overall Study||0
308914|NCT00739050|745086|P1|NOT COMPLETED|Overall Study||1
308915|NCT00739050|745085|P2|COMPLETED|Overall Study||0
308916|NCT00739050|745086|P1|COMPLETED|Overall Study|These 3 patients completing treatment did not complete the required procedures during the trial.|3
308917|NCT00739050|745085|P2|STARTED|Overall Study||0
308918|NCT00739050|745086|P1|STARTED|Overall Study||4
308919|NCT00739024|745100|P2|NOT COMPLETED|Overall Study||0
308920|NCT00739024|745101|P1|NOT COMPLETED|Overall Study||0
308921|NCT00739024|745100|P2|COMPLETED|Overall Study||6
308922|NCT00739024|745101|P1|COMPLETED|Overall Study||7
308923|NCT00739024|745100|P2|STARTED|Overall Study||6
308924|NCT00739024|745101|P1|STARTED|Overall Study||7
308925|NCT00738972|745111|P4|NOT COMPLETED|Overall Study||1
308926|NCT00738972|745112|P3|NOT COMPLETED|Overall Study||0
308927|NCT00738972|745113|P2|NOT COMPLETED|Overall Study||0
308928|NCT00738972|745114|P1|NOT COMPLETED|Overall Study||0
308929|NCT00738972|745111|P4|COMPLETED|Overall Study||2
308930|NCT00738972|745112|P3|COMPLETED|Overall Study||3
308931|NCT00738972|745113|P2|COMPLETED|Overall Study||3
308932|NCT00738972|745114|P1|COMPLETED|Overall Study||3
308933|NCT00738972|745111|P4|STARTED|Overall Study||3
308934|NCT00738972|745112|P3|STARTED|Overall Study||3
308935|NCT00738972|745113|P2|STARTED|Overall Study||3
308936|NCT00738972|745114|P1|STARTED|Overall Study||3
308937|NCT00738894|745126|P2|NOT COMPLETED|Overall Study||33
308938|NCT00738894|745127|P1|NOT COMPLETED|Overall Study||39
308939|NCT00738894|745126|P2|COMPLETED|Overall Study||190
308940|NCT00738894|745127|P1|COMPLETED|Overall Study||402
308941|NCT00738894|745126|P2|STARTED|Overall Study||223
308942|NCT00738894|745127|P1|STARTED|Overall Study||441
308943|NCT00738881|745140|P2|NOT COMPLETED|Overall Study||2
308944|NCT00738881|745141|P1|NOT COMPLETED|Overall Study||0
308945|NCT00738881|745140|P2|COMPLETED|Overall Study||10
308946|NCT00738881|745141|P1|COMPLETED|Overall Study||11
308947|NCT00738881|745140|P2|STARTED|Overall Study||12
308948|NCT00738881|745141|P1|STARTED|Overall Study||11
308949|NCT00738699|745155|P2|NOT COMPLETED|Overall Study||140
308950|NCT00738699|745156|P1|NOT COMPLETED|Overall Study||275
308951|NCT00738699|745155|P2|COMPLETED|Overall Study||0
308952|NCT00738699|745156|P1|COMPLETED|Overall Study||0
308953|NCT00738699|745155|P2|Participants Treated|Overall Study||139
308954|NCT00738699|745156|P1|Participants Treated|Overall Study||273
308955|NCT00738699|745155|P2|Participants Not Treated|Overall Study||1
308956|NCT00738699|745156|P1|Participants Not Treated|Overall Study||2
308957|NCT00738699|745155|P2|STARTED|Overall Study||140
308958|NCT00738699|745156|P1|STARTED|Overall Study||275
308959|NCT00738673|745174|P2|NOT COMPLETED|Overall Study||11
308960|NCT00738673|745175|P1|NOT COMPLETED|Overall Study||24
308961|NCT00738673|745174|P2|COMPLETED|Overall Study||1
308962|NCT00738673|745175|P1|COMPLETED|Overall Study||1
308963|NCT00738673|745174|P2|Intent to Treat Population|Overall Study||12
308964|NCT00738673|745175|P1|Intent to Treat Population|Overall Study||24
308965|NCT00738673|745174|P2|STARTED|Overall Study||12
308966|NCT00738673|745175|P1|STARTED|Overall Study||25
308967|NCT00738543|745203|P1|NOT COMPLETED|Control||0
308968|NCT00738543|745203|P1|COMPLETED|Control||48
308969|NCT00738543|745203|P1|STARTED|Control||48
308970|NCT00738543|745203|P1|NOT COMPLETED|Sodium Hypochlorite||0
308971|NCT00738543|745203|P1|COMPLETED|Sodium Hypochlorite||48
308972|NCT00738543|745203|P1|STARTED|Sodium Hypochlorite||48
308973|NCT00738543|745203|P1|NOT COMPLETED|Povidone Iodine||0
308974|NCT00738543|745203|P1|COMPLETED|Povidone Iodine||48
308975|NCT00738543|745203|P1|STARTED|Povidone Iodine||48
308976|NCT00738530|745213|P2|NOT COMPLETED|Overall Study||238
308977|NCT00738530|745214|P1|NOT COMPLETED|Overall Study||234
308978|NCT00738530|745213|P2|COMPLETED|Overall Study||84
308979|NCT00738530|745214|P1|COMPLETED|Overall Study||93
308980|NCT00738530|745213|P2|Treated|Overall Study||316
308981|NCT00738530|745214|P1|Treated|Overall Study||325
308982|NCT00738530|745213|P2|STARTED|Overall Study||322
308983|NCT00738530|745214|P1|STARTED|Overall Study||327
308984|NCT00738426|745240|P2|NOT COMPLETED|Overall Study||3
308985|NCT00738426|745241|P1|NOT COMPLETED|Overall Study||2
308986|NCT00738426|745240|P2|COMPLETED|Overall Study||32
308987|NCT00738426|745241|P1|COMPLETED|Overall Study||35
308988|NCT00738426|745240|P2|STARTED|Overall Study||35
308989|NCT00738426|745241|P1|STARTED|Overall Study||37
308990|NCT00738400|745249|P2|NOT COMPLETED|Overall Study||7
308991|NCT00738400|745250|P1|NOT COMPLETED|Overall Study||4
308992|NCT00738400|745249|P2|COMPLETED|Overall Study||67
308993|NCT00738400|745250|P1|COMPLETED|Overall Study||72
308994|NCT00738400|745249|P2|ITT (Intent To Treatment) Population|Overall Study|No post-baseline efficacy measurement in 2 participants|70
308995|NCT00738400|745250|P1|ITT (Intent To Treatment) Population|Overall Study||75
308996|NCT00738400|745249|P2|Received Treatment, Safety Population|Overall Study|Two invalid participants (no evidence that these randomized participants took study medication).|72
308997|NCT00738400|745250|P1|Received Treatment, Safety Population|Overall Study|One invalid participant (no evidence that this randomized participant took study medication).|75
308998|NCT00738400|745249|P2|STARTED|Overall Study||74
308999|NCT00738400|745250|P1|STARTED|Overall Study||76
309000|NCT00738374|745271|P4|NOT COMPLETED|Maintenance Treatment/Observation Phase||12
309001|NCT00738374|745272|P3|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
309002|NCT00738374|745273|P2|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
309003|NCT00738374|745274|P1|NOT COMPLETED|Maintenance Treatment/Observation Phase||0
309004|NCT00738374|745271|P4|COMPLETED|Maintenance Treatment/Observation Phase||20
309005|NCT00738374|745272|P3|COMPLETED|Maintenance Treatment/Observation Phase||27
309006|NCT00738374|745273|P2|COMPLETED|Maintenance Treatment/Observation Phase||0
309007|NCT00738374|745274|P1|COMPLETED|Maintenance Treatment/Observation Phase||0
309008|NCT00738374|745271|P4|STARTED|Maintenance Treatment/Observation Phase||32
309009|NCT00738374|745272|P3|STARTED|Maintenance Treatment/Observation Phase||34
309010|NCT00738374|745273|P2|STARTED|Maintenance Treatment/Observation Phase||7
309011|NCT00738374|745274|P1|STARTED|Maintenance Treatment/Observation Phase|Participants were randomized to either maintenance therapy or observation at the end of induction.|0
309012|NCT00738374|745271|P4|NOT COMPLETED|Induction Treatment Phase||0
309013|NCT00738374|745272|P3|NOT COMPLETED|Induction Treatment Phase||0
309014|NCT00738374|745273|P2|NOT COMPLETED|Induction Treatment Phase||0
309015|NCT00738374|745274|P1|NOT COMPLETED|Induction Treatment Phase||24
309016|NCT00738374|745271|P4|COMPLETED|Induction Treatment Phase||0
309017|NCT00738374|745272|P3|COMPLETED|Induction Treatment Phase||0
309018|NCT00738374|745273|P2|COMPLETED|Induction Treatment Phase||0
309019|NCT00738374|745274|P1|COMPLETED|Induction Treatment Phase||73
309020|NCT00738374|745271|P4|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
309021|NCT00738374|745272|P3|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
309022|NCT00738374|745273|P2|STARTED|Induction Treatment Phase||0
309023|NCT00738374|745274|P1|STARTED|Induction Treatment Phase||97
309024|NCT00738361|745306|P1|NOT COMPLETED|Overall Study||0
309025|NCT00738361|745306|P1|COMPLETED|Overall Study||4
309026|NCT00738361|745306|P1|STARTED|Overall Study||4
309027|NCT00738283|745312|P1|NOT COMPLETED|Overall Study||4
309028|NCT00738283|745312|P1|COMPLETED|Overall Study||13
309029|NCT00738283|745312|P1|STARTED|Overall Study||17
309030|NCT00738062|745319|P3|NOT COMPLETED|Open-Label Extension||0
309031|NCT00738062|745320|P2|NOT COMPLETED|Open-Label Extension||0
309032|NCT00738062|745321|P1|NOT COMPLETED|Open-Label Extension||17
309033|NCT00738062|745319|P3|COMPLETED|Open-Label Extension||0
309034|NCT00738062|745320|P2|COMPLETED|Open-Label Extension||0
309035|NCT00738062|745321|P1|COMPLETED|Open-Label Extension||57
309036|NCT00738062|745319|P3|STARTED|Open-Label Extension||0
309037|NCT00738062|745320|P2|STARTED|Open-Label Extension||0
309038|NCT00738062|745321|P1|STARTED|Open-Label Extension|One patient completed double blind randomization but did not enter the open label extension|74
309039|NCT00738062|745319|P3|NOT COMPLETED|2 Week Randomized Withdrawal||0
309040|NCT00738062|745320|P2|NOT COMPLETED|2 Week Randomized Withdrawal||0
309041|NCT00738062|745321|P1|NOT COMPLETED|2 Week Randomized Withdrawal||0
309042|NCT00738062|745319|P3|COMPLETED|2 Week Randomized Withdrawal||37
309043|NCT00738062|745320|P2|COMPLETED|2 Week Randomized Withdrawal||38
309044|NCT00738062|745321|P1|COMPLETED|2 Week Randomized Withdrawal||0
309045|NCT00738062|745319|P3|STARTED|2 Week Randomized Withdrawal||37
309046|NCT00738062|745320|P2|STARTED|2 Week Randomized Withdrawal||38
309047|NCT00738062|745321|P1|STARTED|2 Week Randomized Withdrawal|Patients completing the open label titration phase were randomized to either Droxidopa or Placebo|0
309048|NCT00738062|745319|P3|NOT COMPLETED|Open Label Treatment||0
309049|NCT00738062|745320|P2|NOT COMPLETED|Open Label Treatment||0
309050|NCT00738062|745321|P1|NOT COMPLETED|Open Label Treatment||28
309051|NCT00738062|745319|P3|COMPLETED|Open Label Treatment||0
309052|NCT00738062|745320|P2|COMPLETED|Open Label Treatment||0
309053|NCT00738062|745321|P1|COMPLETED|Open Label Treatment||75
309054|NCT00738062|745319|P3|STARTED|Open Label Treatment||0
309055|NCT00738062|745320|P2|STARTED|Open Label Treatment||0
309056|NCT00738062|745321|P1|STARTED|Open Label Treatment||103
309057|NCT00738049|745348|P2|NOT COMPLETED|Washout||0
309058|NCT00738049|745349|P1|NOT COMPLETED|Washout||0
309059|NCT00738049|745348|P2|COMPLETED|Washout||7
309060|NCT00738049|745349|P1|COMPLETED|Washout||13
309061|NCT00738049|745348|P2|STARTED|Washout||7
309062|NCT00738049|745349|P1|STARTED|Washout||13
309063|NCT00738049|745348|P2|NOT COMPLETED|2nd Intervention(14 Days)||0
309064|NCT00738049|745349|P1|NOT COMPLETED|2nd Intervention(14 Days)||0
309065|NCT00738049|745348|P2|COMPLETED|2nd Intervention(14 Days)||7
309066|NCT00738049|745349|P1|COMPLETED|2nd Intervention(14 Days)||13
309067|NCT00738049|745348|P2|STARTED|2nd Intervention(14 Days)||7
309068|NCT00738049|745349|P1|STARTED|2nd Intervention(14 Days)||13
309069|NCT00738049|745348|P2|NOT COMPLETED|1st Intervention(14 Days)||0
309070|NCT00738049|745349|P1|NOT COMPLETED|1st Intervention(14 Days)||0
309071|NCT00738049|745348|P2|COMPLETED|1st Intervention(14 Days)||7
309072|NCT00738049|745349|P1|COMPLETED|1st Intervention(14 Days)||13
309073|NCT00738049|745348|P2|STARTED|1st Intervention(14 Days)||7
309074|NCT00738049|745349|P1|STARTED|1st Intervention(14 Days)||13
309075|NCT00738023|745363|P2|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
309076|NCT00738023|745364|P1|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
309077|NCT00738023|745363|P2|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
309078|NCT00738023|745364|P1|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||19
309079|NCT00738023|745363|P2|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||0
309080|NCT00738023|745364|P1|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||19
309081|NCT00738023|745363|P2|NOT COMPLETED|Saline Infusion||0
309082|NCT00738023|745364|P1|NOT COMPLETED|Saline Infusion||0
309083|NCT00738023|745363|P2|COMPLETED|Saline Infusion||0
309084|NCT00738023|745364|P1|COMPLETED|Saline Infusion||19
309085|NCT00738023|745363|P2|STARTED|Saline Infusion||0
309086|NCT00738023|745364|P1|STARTED|Saline Infusion||19
309087|NCT00738023|745363|P2|NOT COMPLETED|Intralipid Infusion||0
309088|NCT00738023|745364|P1|NOT COMPLETED|Intralipid Infusion||0
309089|NCT00738023|745363|P2|COMPLETED|Intralipid Infusion||13
309090|NCT00738023|745364|P1|COMPLETED|Intralipid Infusion||19
309091|NCT00738023|745363|P2|STARTED|Intralipid Infusion||13
309092|NCT00738023|745364|P1|STARTED|Intralipid Infusion||19
309093|NCT00737737|745374|P2|NOT COMPLETED|Overall Study||0
309094|NCT00737737|745375|P1|NOT COMPLETED|Overall Study||0
309095|NCT00737737|745374|P2|COMPLETED|Overall Study||2
309096|NCT00737737|745375|P1|COMPLETED|Overall Study||2
309097|NCT00737737|745374|P2|STARTED|Overall Study||2
309098|NCT00737737|745375|P1|STARTED|Overall Study||2
309099|NCT00737711|745383|P1|NOT COMPLETED|Overall Study||31
309100|NCT00737711|745383|P1|COMPLETED|Overall Study||158
309101|NCT00737711|745383|P1|STARTED|Overall Study||189
309102|NCT00737698|745417|P3|NOT COMPLETED|Overall Study||4
309103|NCT00737698|745418|P2|NOT COMPLETED|Overall Study||5
309104|NCT00737698|745419|P1|NOT COMPLETED|Overall Study||6
309105|NCT00737698|745417|P3|COMPLETED|Overall Study||17
309106|NCT00737698|745418|P2|COMPLETED|Overall Study||37
309107|NCT00737698|745419|P1|COMPLETED|Overall Study||17
309108|NCT00737698|745417|P3|STARTED|Overall Study||21
309109|NCT00737698|745418|P2|STARTED|Overall Study||42
309110|NCT00737698|745419|P1|STARTED|Overall Study||23
309111|NCT00737672|745429|P2|NOT COMPLETED|Overall Study||83
309112|NCT00737672|745430|P1|NOT COMPLETED|Overall Study||80
309113|NCT00737672|745429|P2|COMPLETED|Overall Study||65
309114|NCT00737672|745430|P1|COMPLETED|Overall Study||65
309115|NCT00737672|745429|P2|Per Protocol Population|Overall Study||138
309116|NCT00737672|745430|P1|Per Protocol Population|Overall Study||131
309117|NCT00737672|745429|P2|Exclusions Due to Protocol Deviations|Overall Study||10
309118|NCT00737672|745430|P1|Exclusions Due to Protocol Deviations|Overall Study||14
309119|NCT00737672|745429|P2|STARTED|Overall Study||148
309120|NCT00737672|745430|P1|STARTED|Overall Study||145
309121|NCT00737633|745468|P2|NOT COMPLETED|Overall Study||57
309122|NCT00737633|745469|P1|NOT COMPLETED|Overall Study||44
309123|NCT00737633|745468|P2|COMPLETED|Overall Study||0
309124|NCT00737633|745469|P1|COMPLETED|Overall Study||0
309125|NCT00737633|745468|P2|STARTED|Overall Study||57
309126|NCT00737633|745469|P1|STARTED|Overall Study||44
309127|NCT00737594|745480|P3|NOT COMPLETED|Overall Study||0
309128|NCT00737594|745481|P2|NOT COMPLETED|Overall Study||0
309129|NCT00737594|745482|P1|NOT COMPLETED|Overall Study||0
309130|NCT00737594|745480|P3|COMPLETED|Overall Study||0
309131|NCT00737594|745481|P2|COMPLETED|Overall Study||0
309132|NCT00737594|745482|P1|COMPLETED|Overall Study||0
309133|NCT00737594|745480|P3|STARTED|Overall Study||0
309134|NCT00737594|745481|P2|STARTED|Overall Study||0
309135|NCT00737594|745482|P1|STARTED|Overall Study||0
309136|NCT00737568|745492|P2|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||18
309137|NCT00737568|745493|P1|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||26
309138|NCT00737568|745492|P2|COMPLETED|Treatment-Free Follow-up (TFFU) Period||19
309139|NCT00737568|745493|P1|COMPLETED|Treatment-Free Follow-up (TFFU) Period||12
309140|NCT00737568|745492|P2|STARTED|Treatment-Free Follow-up (TFFU) Period|4 participants not completing the 240 week treatment period enrolled in the TFFU period.|37
309141|NCT00737568|745493|P1|STARTED|Treatment-Free Follow-up (TFFU) Period|1 participant not completing the 240 week treatment period enrolled in the TFFU period.|38
309142|NCT00737568|745492|P2|NOT COMPLETED|Treatment Period Through Week 240||21
309143|NCT00737568|745493|P1|NOT COMPLETED|Treatment Period Through Week 240||20
309144|NCT00737568|745492|P2|COMPLETED|Treatment Period Through Week 240||118
309145|NCT00737568|745493|P1|COMPLETED|Treatment Period Through Week 240||121
309146|NCT00737568|745492|P2|STARTED|Treatment Period Through Week 240||139
309147|NCT00737568|745493|P1|STARTED|Treatment Period Through Week 240||141
309148|NCT00737529|745523|P1|NOT COMPLETED|Overall Study||133
309149|NCT00737529|745523|P1|COMPLETED|Overall Study|Completed equals participants ongoing on treatment at the time of the data cut-off of 30 March 2017|1
309150|NCT00737529|745523|P1|STARTED|Overall Study||134
309151|NCT00737477|745537|P1|NOT COMPLETED|Overall Study||34
309152|NCT00737477|745537|P1|COMPLETED|Overall Study||62
309153|NCT00737477|745537|P1|STARTED|Overall Study||96
309154|NCT00737464|745553|P1|NOT COMPLETED|Overall Study||18
309155|NCT00737464|745553|P1|COMPLETED|Overall Study||114
309156|NCT00737464|745553|P1|STARTED|Overall Study||132
309157|NCT00737438|745574|P1|NOT COMPLETED|Overall Study||3
309158|NCT00737438|745574|P1|COMPLETED|Overall Study||20
309159|NCT00737438|745574|P1|STARTED|Overall Study||23
309160|NCT00737360|745578|P1|NOT COMPLETED|Overall Study||0
309161|NCT00737360|745578|P1|COMPLETED|Overall Study||27
309162|NCT00737360|745578|P1|STARTED|Overall Study||27
309163|NCT00737282|745587|P1|NOT COMPLETED|Overall Study||175
309164|NCT00737282|745587|P1|COMPLETED|Overall Study||0
309165|NCT00737282|745587|P1|STARTED|Overall Study||175
309166|NCT00737243|745593|P1|NOT COMPLETED|Overall Study||95
309167|NCT00737243|745593|P1|COMPLETED|Overall Study||194
309168|NCT00737243|745593|P1|Empiric CUP Therapy|Overall Study||29
309169|NCT00737243|745593|P1|Site Specific Therapy Less Responsive|Overall Study||79
309170|NCT00737243|745593|P1|Site Specific Therapy More Responsive|Overall Study||115
309171|NCT00737243|745593|P1|Not Treated|Overall Study|16 pts no longer met eligibility criteria; 13 came off study due to physician or pt preference.|29
309172|NCT00737243|745593|P1|Treated|Overall Study||223
309173|NCT00737243|745593|P1|Insufficient Tissue for Assay, Withdrawn|Overall Study||37
309174|NCT00737243|745593|P1|Successful Assay Performed|Overall Study||252
309175|NCT00737243|745593|P1|STARTED|Overall Study||289
309176|NCT00737204|745601|P2|NOT COMPLETED|Overall Study||6
309177|NCT00737204|745602|P1|NOT COMPLETED|Overall Study||0
309178|NCT00737204|745601|P2|COMPLETED|Overall Study||28
309179|NCT00737204|745602|P1|COMPLETED|Overall Study||36
309180|NCT00737204|745601|P2|STARTED|Overall Study||34
309181|NCT00737204|745602|P1|STARTED|Overall Study||36
309182|NCT00737178|745616|P2|NOT COMPLETED|Overall Study||9
309183|NCT00737178|745617|P1|NOT COMPLETED|Overall Study||5
309184|NCT00737178|745616|P2|COMPLETED|Overall Study||76
309185|NCT00737178|745617|P1|COMPLETED|Overall Study||66
309186|NCT00737178|745616|P2|STARTED|Overall Study||85
309187|NCT00737178|745617|P1|STARTED|Overall Study||71
309188|NCT00737100|745630|P3|NOT COMPLETED|Overall Study||7
309189|NCT00737100|745631|P2|NOT COMPLETED|Overall Study||7
309190|NCT00737100|745632|P1|NOT COMPLETED|Overall Study||7
309191|NCT00737100|745630|P3|COMPLETED|Overall Study||169
309192|NCT00737100|745631|P2|COMPLETED|Overall Study||159
309193|NCT00737100|745632|P1|COMPLETED|Overall Study||161
309194|NCT00737100|745630|P3|STARTED|Overall Study||176
309195|NCT00737100|745631|P2|STARTED|Overall Study||166
309196|NCT00737100|745632|P1|STARTED|Overall Study||168
309197|NCT00737061|745676|P1|NOT COMPLETED|1 Year Wearing Period||17
309198|NCT00737061|745676|P1|COMPLETED|1 Year Wearing Period||553
309199|NCT00737061|745676|P1|STARTED|1 Year Wearing Period||570
309200|NCT00737061|745676|P1|NOT COMPLETED|Waiting Period||75
309201|NCT00737061|745676|P1|COMPLETED|Waiting Period||570
309202|NCT00737061|745676|P1|STARTED|Waiting Period||645
309203|NCT00737048|745693|P3|NOT COMPLETED|Overall Study||4
309204|NCT00737048|745694|P2|NOT COMPLETED|Overall Study||6
309205|NCT00737048|745695|P1|NOT COMPLETED|Overall Study||3
309206|NCT00737048|745693|P3|COMPLETED|Overall Study||126
309207|NCT00737048|745694|P2|COMPLETED|Overall Study||60
309208|NCT00737048|745695|P1|COMPLETED|Overall Study||129
309209|NCT00737048|745693|P3|STARTED|Overall Study||130
309210|NCT00737048|745694|P2|STARTED|Overall Study||66
309211|NCT00737048|745695|P1|STARTED|Overall Study||132
309212|NCT00736996|745739|P3|NOT COMPLETED|Overall Study||2
309213|NCT00736996|745740|P2|NOT COMPLETED|Overall Study||9
309214|NCT00736996|745741|P1|NOT COMPLETED|Overall Study||1
309215|NCT00736996|745739|P3|COMPLETED|Overall Study||25
309216|NCT00736996|745740|P2|COMPLETED|Overall Study||17
309217|NCT00736996|745741|P1|COMPLETED|Overall Study||24
309218|NCT00736996|745739|P3|STARTED|Overall Study||27
309219|NCT00736996|745740|P2|STARTED|Overall Study||26
309220|NCT00736996|745741|P1|STARTED|Overall Study||25
309221|NCT00736957|745755|P1|NOT COMPLETED|Overall Study||122
309222|NCT00736957|745755|P1|COMPLETED|Overall Study||97
309223|NCT00736957|745755|P1|Treated|Overall Study||190
309224|NCT00736957|745755|P1|STARTED|Overall Study||219
309225|NCT00736944|745765|P1|NOT COMPLETED|Definitive Treatment||1
309226|NCT00736944|745765|P1|COMPLETED|Definitive Treatment||28
309227|NCT00736944|745765|P1|STARTED|Definitive Treatment||29
309228|NCT00736944|745765|P1|NOT COMPLETED|Induction||1
309229|NCT00736944|745765|P1|COMPLETED|Induction||29
309230|NCT00736944|745765|P1|STARTED|Induction||30
309231|NCT00736879|745796|P4|NOT COMPLETED|Follow up Period - No Drug Treatment||0
309232|NCT00736879|745797|P3|NOT COMPLETED|Follow up Period - No Drug Treatment||0
309233|NCT00736879|745798|P2|NOT COMPLETED|Follow up Period - No Drug Treatment||3
309234|NCT00736879|745799|P1|NOT COMPLETED|Follow up Period - No Drug Treatment||1
309235|NCT00736879|745796|P4|COMPLETED|Follow up Period - No Drug Treatment||62
309236|NCT00736879|745797|P3|COMPLETED|Follow up Period - No Drug Treatment||66
309237|NCT00736879|745798|P2|COMPLETED|Follow up Period - No Drug Treatment||67
309238|NCT00736879|745799|P1|COMPLETED|Follow up Period - No Drug Treatment||65
309239|NCT00736879|745796|P4|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|62
309240|NCT00736879|745797|P3|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
309241|NCT00736879|745798|P2|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|70
309242|NCT00736879|745799|P1|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
309243|NCT00736879|745796|P4|NOT COMPLETED|Double Blind Treatment Period||5
309244|NCT00736879|745797|P3|NOT COMPLETED|Double Blind Treatment Period||7
309245|NCT00736879|745798|P2|NOT COMPLETED|Double Blind Treatment Period||4
309246|NCT00736879|745799|P1|NOT COMPLETED|Double Blind Treatment Period||3
309247|NCT00736879|745796|P4|COMPLETED|Double Blind Treatment Period||63
309248|NCT00736879|745797|P3|COMPLETED|Double Blind Treatment Period||67
309249|NCT00736879|745798|P2|COMPLETED|Double Blind Treatment Period||68
309250|NCT00736879|745799|P1|COMPLETED|Double Blind Treatment Period||65
309251|NCT00736879|745796|P4|STARTED|Double Blind Treatment Period||68
309252|NCT00736879|745797|P3|STARTED|Double Blind Treatment Period||74
309253|NCT00736879|745798|P2|STARTED|Double Blind Treatment Period||72
309254|NCT00736879|745799|P1|STARTED|Double Blind Treatment Period||68
309255|NCT00736853|745853|P3|NOT COMPLETED|Double-Blind Period||48
309256|NCT00736853|745854|P2|NOT COMPLETED|Double-Blind Period||24
309257|NCT00736853|745855|P1|NOT COMPLETED|Double-Blind Period||0
309258|NCT00736853|745853|P3|COMPLETED|Double-Blind Period||45
309259|NCT00736853|745854|P2|COMPLETED|Double-Blind Period||70
309260|NCT00736853|745855|P1|COMPLETED|Double-Blind Period||0
309261|NCT00736853|745853|P3|STARTED|Double-Blind Period||93
309262|NCT00736853|745854|P2|STARTED|Double-Blind Period||94
309263|NCT00736853|745855|P1|STARTED|Double-Blind Period||0
309264|NCT00736853|745853|P3|NOT COMPLETED|Open-Label Period||0
309265|NCT00736853|745854|P2|NOT COMPLETED|Open-Label Period||0
309266|NCT00736853|745855|P1|NOT COMPLETED|Open-Label Period||132
309267|NCT00736853|745853|P3|COMPLETED|Open-Label Period||0
309268|NCT00736853|745854|P2|COMPLETED|Open-Label Period||0
309269|NCT00736853|745855|P1|COMPLETED|Open-Label Period||187
309270|NCT00736853|745853|P3|Treated|Open-Label Period||0
309271|NCT00736853|745854|P2|Treated|Open-Label Period||0
309272|NCT00736853|745855|P1|Treated|Open-Label Period||277
309273|NCT00736853|745853|P3|STARTED|Open-Label Period||0
309274|NCT00736853|745854|P2|STARTED|Open-Label Period||0
309275|NCT00736853|745855|P1|STARTED|Open-Label Period||319
309276|NCT00736840|745895|P1|NOT COMPLETED|Overall Study||13
309277|NCT00736840|745895|P1|COMPLETED|Overall Study|9 subjects-no biopsy results, 2-no breath test, 2 no biopsy results and no complete breath test|401
309278|NCT00736840|745895|P1|STARTED|Overall Study||414
309279|NCT00736723|745902|P2|NOT COMPLETED|Overall Study||3
309280|NCT00736723|745903|P1|NOT COMPLETED|Overall Study||4
309281|NCT00736723|745902|P2|COMPLETED|Overall Study||18
309282|NCT00736723|745903|P1|COMPLETED|Overall Study||26
309283|NCT00736723|745902|P2|STARTED|Overall Study||21
309284|NCT00736723|745903|P1|STARTED|Overall Study||30
309285|NCT00736645|745913|P4|NOT COMPLETED|Overall Study||0
309286|NCT00736645|745914|P3|NOT COMPLETED|Overall Study||0
309287|NCT00736645|745915|P2|NOT COMPLETED|Overall Study||2
309288|NCT00736645|745916|P1|NOT COMPLETED|Overall Study||0
309289|NCT00736645|745913|P4|COMPLETED|Overall Study||13
309290|NCT00736645|745914|P3|COMPLETED|Overall Study||14
309291|NCT00736645|745915|P2|COMPLETED|Overall Study||13
309292|NCT00736645|745916|P1|COMPLETED|Overall Study||13
309293|NCT00736645|745913|P4|STARTED|Overall Study||13
309294|NCT00736645|745914|P3|STARTED|Overall Study||14
309295|NCT00736645|745915|P2|STARTED|Overall Study||15
309296|NCT00736645|745916|P1|STARTED|Overall Study||13
309297|NCT00736580|745932|P2|NOT COMPLETED|Overall Study||0
309298|NCT00736580|745933|P1|NOT COMPLETED|Overall Study||0
309299|NCT00736580|745932|P2|COMPLETED|Overall Study||123
309300|NCT00736580|745933|P1|COMPLETED|Overall Study||117
309301|NCT00736580|745932|P2|STARTED|Overall Study||123
309302|NCT00736580|745933|P1|STARTED|Overall Study||117
309303|NCT00736502|745939|P1|NOT COMPLETED|Overall Study||65
309304|NCT00736502|745939|P1|COMPLETED|Overall Study||213
309305|NCT00736502|745939|P1|STARTED|Overall Study|Entered and treated.|278
309306|NCT00736489|745945|P6|NOT COMPLETED|Period 6||0
309307|NCT00736489|745946|P5|NOT COMPLETED|Period 6||0
309308|NCT00736489|745947|P4|NOT COMPLETED|Period 6||0
309309|NCT00736489|745948|P3|NOT COMPLETED|Period 6||0
309310|NCT00736489|745949|P2|NOT COMPLETED|Period 6||0
309311|NCT00736489|745950|P1|NOT COMPLETED|Period 6||0
309312|NCT00736489|745945|P6|COMPLETED|Period 6||5
309313|NCT00736489|745946|P5|COMPLETED|Period 6||7
309314|NCT00736489|745947|P4|COMPLETED|Period 6||7
309315|NCT00736489|745948|P3|COMPLETED|Period 6||6
309316|NCT00736489|745949|P2|COMPLETED|Period 6||5
309317|NCT00736489|745950|P1|COMPLETED|Period 6||5
309318|NCT00736489|745945|P6|STARTED|Period 6||5
309319|NCT00736489|745946|P5|STARTED|Period 6||7
309320|NCT00736489|745947|P4|STARTED|Period 6||7
309321|NCT00736489|745948|P3|STARTED|Period 6||6
309322|NCT00736489|745949|P2|STARTED|Period 6||5
309323|NCT00736489|745950|P1|STARTED|Period 6||5
309324|NCT00736489|745945|P6|NOT COMPLETED|Period 5||0
309325|NCT00736489|745946|P5|NOT COMPLETED|Period 5||0
309326|NCT00736489|745947|P4|NOT COMPLETED|Period 5||0
309327|NCT00736489|745948|P3|NOT COMPLETED|Period 5||0
309328|NCT00736489|745949|P2|NOT COMPLETED|Period 5||0
309329|NCT00736489|745950|P1|NOT COMPLETED|Period 5||0
309330|NCT00736489|745945|P6|COMPLETED|Period 5||5
309331|NCT00736489|745946|P5|COMPLETED|Period 5||7
309332|NCT00736489|745947|P4|COMPLETED|Period 5||7
309333|NCT00736489|745948|P3|COMPLETED|Period 5||6
309334|NCT00736489|745949|P2|COMPLETED|Period 5||5
309335|NCT00736489|745950|P1|COMPLETED|Period 5||5
309336|NCT00736489|745945|P6|STARTED|Period 5||5
309337|NCT00736489|745946|P5|STARTED|Period 5||7
309338|NCT00736489|745947|P4|STARTED|Period 5||7
309339|NCT00736489|745948|P3|STARTED|Period 5||6
309340|NCT00736489|745949|P2|STARTED|Period 5||5
309341|NCT00736489|745950|P1|STARTED|Period 5||5
309342|NCT00736489|745945|P6|NOT COMPLETED|Period 4||0
309343|NCT00736489|745946|P5|NOT COMPLETED|Period 4||0
309344|NCT00736489|745947|P4|NOT COMPLETED|Period 4||0
309345|NCT00736489|745948|P3|NOT COMPLETED|Period 4||0
309346|NCT00736489|745949|P2|NOT COMPLETED|Period 4||0
309347|NCT00736489|745950|P1|NOT COMPLETED|Period 4||0
309348|NCT00736489|745945|P6|COMPLETED|Period 4||5
309349|NCT00736489|745946|P5|COMPLETED|Period 4||7
309350|NCT00736489|745947|P4|COMPLETED|Period 4||7
309351|NCT00736489|745948|P3|COMPLETED|Period 4||6
309352|NCT00736489|745949|P2|COMPLETED|Period 4||5
309353|NCT00736489|745950|P1|COMPLETED|Period 4||5
309354|NCT00736489|745945|P6|STARTED|Period 4||5
309355|NCT00736489|745946|P5|STARTED|Period 4||7
309356|NCT00736489|745947|P4|STARTED|Period 4||7
309357|NCT00736489|745948|P3|STARTED|Period 4||6
309358|NCT00736489|745949|P2|STARTED|Period 4||5
309359|NCT00736489|745950|P1|STARTED|Period 4||5
309360|NCT00736489|745945|P6|NOT COMPLETED|Period 3||0
309361|NCT00736489|745946|P5|NOT COMPLETED|Period 3||0
309362|NCT00736489|745947|P4|NOT COMPLETED|Period 3||0
309363|NCT00736489|745948|P3|NOT COMPLETED|Period 3||0
309364|NCT00736489|745949|P2|NOT COMPLETED|Period 3||0
309365|NCT00736489|745950|P1|NOT COMPLETED|Period 3||0
309366|NCT00736489|745945|P6|COMPLETED|Period 3||5
309367|NCT00736489|745946|P5|COMPLETED|Period 3||7
309368|NCT00736489|745947|P4|COMPLETED|Period 3||7
309369|NCT00736489|745948|P3|COMPLETED|Period 3||6
309370|NCT00736489|745949|P2|COMPLETED|Period 3||5
309371|NCT00736489|745950|P1|COMPLETED|Period 3||5
309372|NCT00736489|745945|P6|STARTED|Period 3||5
309373|NCT00736489|745946|P5|STARTED|Period 3||7
309374|NCT00736489|745947|P4|STARTED|Period 3||7
309375|NCT00736489|745948|P3|STARTED|Period 3||6
309376|NCT00736489|745949|P2|STARTED|Period 3||5
309377|NCT00736489|745950|P1|STARTED|Period 3||5
309378|NCT00736489|745945|P6|NOT COMPLETED|Period 2||0
309379|NCT00736489|745946|P5|NOT COMPLETED|Period 2||0
309380|NCT00736489|745947|P4|NOT COMPLETED|Period 2||0
309381|NCT00736489|745948|P3|NOT COMPLETED|Period 2||0
309382|NCT00736489|745949|P2|NOT COMPLETED|Period 2||0
309383|NCT00736489|745950|P1|NOT COMPLETED|Period 2||0
309384|NCT00736489|745945|P6|COMPLETED|Period 2||5
309385|NCT00736489|745946|P5|COMPLETED|Period 2||7
309386|NCT00736489|745947|P4|COMPLETED|Period 2||7
309387|NCT00736489|745948|P3|COMPLETED|Period 2||6
309388|NCT00736489|745949|P2|COMPLETED|Period 2||5
309389|NCT00736489|745950|P1|COMPLETED|Period 2||5
309390|NCT00736489|745945|P6|STARTED|Period 2||5
309391|NCT00736489|745946|P5|STARTED|Period 2||7
309392|NCT00736489|745947|P4|STARTED|Period 2||7
309393|NCT00736489|745948|P3|STARTED|Period 2||6
309394|NCT00736489|745949|P2|STARTED|Period 2||5
309395|NCT00736489|745950|P1|STARTED|Period 2||5
309396|NCT00736489|745945|P6|NOT COMPLETED|Period 1||1
309397|NCT00736489|745946|P5|NOT COMPLETED|Period 1||0
309398|NCT00736489|745947|P4|NOT COMPLETED|Period 1||0
309399|NCT00736489|745948|P3|NOT COMPLETED|Period 1||0
309400|NCT00736489|745949|P2|NOT COMPLETED|Period 1||0
309401|NCT00736489|745950|P1|NOT COMPLETED|Period 1||1
309402|NCT00736489|745945|P6|COMPLETED|Period 1||5
309403|NCT00736489|745946|P5|COMPLETED|Period 1||7
309404|NCT00736489|745947|P4|COMPLETED|Period 1||7
309405|NCT00736489|745948|P3|COMPLETED|Period 1||6
309406|NCT00736489|745949|P2|COMPLETED|Period 1||5
309407|NCT00736489|745950|P1|COMPLETED|Period 1||5
309408|NCT00736489|745945|P6|STARTED|Period 1||6
309409|NCT00736489|745946|P5|STARTED|Period 1||7
309410|NCT00736489|745947|P4|STARTED|Period 1||7
309411|NCT00736489|745948|P3|STARTED|Period 1||6
309412|NCT00736489|745949|P2|STARTED|Period 1||5
309413|NCT00736489|745950|P1|STARTED|Period 1|Cross-over study|6
309414|NCT00736476|746104|P2|NOT COMPLETED|Overall Study||0
309415|NCT00736476|746105|P1|NOT COMPLETED|Overall Study||1
309416|NCT00736476|746104|P2|COMPLETED|Overall Study||27
309417|NCT00736476|746105|P1|COMPLETED|Overall Study||35
309418|NCT00736476|746104|P2|STARTED|Overall Study||27
309419|NCT00736476|746105|P1|STARTED|Overall Study||36
309420|NCT00736450|746125|P1|NOT COMPLETED|Overall Study||25
309421|NCT00736450|746125|P1|COMPLETED|Overall Study||12
309422|NCT00736450|746125|P1|STARTED|Overall Study||37
309423|NCT00736385|746133|P2|NOT COMPLETED|Overall Study||3
309424|NCT00736385|746134|P1|NOT COMPLETED|Overall Study||2
309425|NCT00736385|746133|P2|COMPLETED|Overall Study||2
309426|NCT00736385|746134|P1|COMPLETED|Overall Study||2
309427|NCT00736385|746133|P2|STARTED|Overall Study||5
309428|NCT00736385|746134|P1|STARTED|Overall Study||4
309429|NCT00736333|746146|P1|NOT COMPLETED|Overall Study||111
309430|NCT00736333|746146|P1|COMPLETED|Overall Study||56
309431|NCT00736333|746146|P1|STARTED|Overall Study||167
309432|NCT00736255|746157|P2|NOT COMPLETED|Overall Study||1
309433|NCT00736255|746158|P1|NOT COMPLETED|Overall Study||3
309434|NCT00736255|746157|P2|COMPLETED|Overall Study||14
309435|NCT00736255|746158|P1|COMPLETED|Overall Study||14
309436|NCT00736255|746157|P2|STARTED|Overall Study||15
309437|NCT00736255|746158|P1|STARTED|Overall Study||17
309438|NCT00736242|746176|P1|NOT COMPLETED|Overall Study||125
309439|NCT00736242|746176|P1|COMPLETED|Overall Study||107
309440|NCT00736242|746176|P1|Participants in Safety Analysis Set|Overall Study||229
309441|NCT00736242|746176|P1|STARTED|Overall Study||232
309442|NCT00736229|746190|P3|NOT COMPLETED|Overall Study||0
309443|NCT00736229|746191|P2|NOT COMPLETED|Overall Study||0
309444|NCT00736229|746192|P1|NOT COMPLETED|Overall Study||0
309445|NCT00736229|746190|P3|COMPLETED|Overall Study||84
309446|NCT00736229|746191|P2|COMPLETED|Overall Study||71
309447|NCT00736229|746192|P1|COMPLETED|Overall Study|All patients received bolus and fixed infusion of study drug, thus completed the study|40
309448|NCT00736229|746190|P3|STARTED|Overall Study|Historic Control|84
309449|NCT00736229|746191|P2|STARTED|Overall Study|Historic control|71
309450|NCT00736229|746192|P1|STARTED|Overall Study|Actively Enrolled|40
309451|NCT00736190|746205|P1|NOT COMPLETED|Overall Study||3
309452|NCT00736190|746205|P1|COMPLETED|Overall Study||87
309453|NCT00736190|746205|P1|STARTED|Overall Study||90
309454|NCT00736125|746220|P2|NOT COMPLETED|Overall Study||2
309455|NCT00736125|746221|P1|NOT COMPLETED|Overall Study||1
309456|NCT00736125|746220|P2|COMPLETED|Overall Study||8
309457|NCT00736125|746221|P1|COMPLETED|Overall Study||9
309458|NCT00736125|746220|P2|STARTED|Overall Study||10
309459|NCT00736125|746221|P1|STARTED|Overall Study||10
309460|NCT00736099|746235|P2|NOT COMPLETED|Overall Study||58
309461|NCT00736099|746236|P1|NOT COMPLETED|Overall Study||183
309462|NCT00736099|746235|P2|COMPLETED|Overall Study|Number who completed treatment.|531
309463|NCT00736099|746236|P1|COMPLETED|Overall Study|Number who completed treatment.|1349
309464|NCT00736099|746235|P2|STARTED|Overall Study|Number who started treatment.|589
309465|NCT00736099|746236|P1|STARTED|Overall Study|Number who started treatment.|1532
309466|NCT00736073|746334|P2|NOT COMPLETED|Overall Study||0
309467|NCT00736073|746335|P1|NOT COMPLETED|Overall Study||0
309468|NCT00736073|746334|P2|COMPLETED|Overall Study||39
309469|NCT00736073|746335|P1|COMPLETED|Overall Study||34
309470|NCT00736073|746334|P2|STARTED|Overall Study||39
309471|NCT00736073|746335|P1|STARTED|Overall Study||34
309472|NCT00736034|746345|P1|NOT COMPLETED|Overall Study||2
309473|NCT00736034|746345|P1|COMPLETED|Overall Study||16
309474|NCT00736034|746345|P1|STARTED|Overall Study||18
309475|NCT00735969|746349|P1|NOT COMPLETED|Overall Study||0
309476|NCT00735969|746349|P1|COMPLETED|Overall Study||21
309477|NCT00735969|746349|P1|STARTED|Overall Study||21
309478|NCT00735943|746353|P1|NOT COMPLETED|Overall Study||2
309479|NCT00735943|746353|P1|COMPLETED|Overall Study||20
309480|NCT00735943|746353|P1|STARTED|Overall Study||22
309481|NCT00735917|746370|P1|NOT COMPLETED|Overall Study||0
309482|NCT00735917|746370|P1|COMPLETED|Overall Study||19
309483|NCT00735917|746370|P1|STARTED|Overall Study||19
309484|NCT00735904|746378|P1|NOT COMPLETED|Overall Study||38
309485|NCT00735904|746378|P1|COMPLETED|Overall Study||0
309486|NCT00735904|746378|P1|STARTED|Overall Study||38
309487|NCT00735878|746388|P3|NOT COMPLETED|Phase II- Determined Dose||0
309488|NCT00735878|746389|P2|NOT COMPLETED|Phase II- Determined Dose||0
309489|NCT00735878|746390|P1|NOT COMPLETED|Phase II- Determined Dose||0
309490|NCT00735878|746388|P3|COMPLETED|Phase II- Determined Dose||0
309491|NCT00735878|746389|P2|COMPLETED|Phase II- Determined Dose||7
309492|NCT00735878|746390|P1|COMPLETED|Phase II- Determined Dose|Seven subjects completed therapy within the Phase II portion of the trial.|0
309493|NCT00735878|746388|P3|STARTED|Phase II- Determined Dose||0
309494|NCT00735878|746389|P2|STARTED|Phase II- Determined Dose||7
309495|NCT00735878|746390|P1|STARTED|Phase II- Determined Dose||0
309496|NCT00735878|746388|P3|NOT COMPLETED|Phase I- Dose Determination||1
309497|NCT00735878|746389|P2|NOT COMPLETED|Phase I- Dose Determination||0
309498|NCT00735878|746390|P1|NOT COMPLETED|Phase I- Dose Determination||0
309499|NCT00735878|746388|P3|COMPLETED|Phase I- Dose Determination||4
309500|NCT00735878|746389|P2|COMPLETED|Phase I- Dose Determination||7
309501|NCT00735878|746390|P1|COMPLETED|Phase I- Dose Determination|12 subjects received at least one cycle of treatment and were evaluable per the protocol.|1
309502|NCT00735878|746388|P3|STARTED|Phase I- Dose Determination||5
309503|NCT00735878|746389|P2|STARTED|Phase I- Dose Determination||7
309504|NCT00735878|746390|P1|STARTED|Phase I- Dose Determination|13 subjects enrolled. One subject withdrew consent prior to receiving therapy & was replaced.|1
309505|NCT00735839|746403|P2|NOT COMPLETED|Overall Study||0
309506|NCT00735839|746404|P1|NOT COMPLETED|Overall Study||0
309507|NCT00735839|746403|P2|COMPLETED|Overall Study||10
309508|NCT00735839|746404|P1|COMPLETED|Overall Study||30
309509|NCT00735839|746403|P2|STARTED|Overall Study||10
309510|NCT00735839|746404|P1|STARTED|Overall Study||30
309511|NCT00735826|746412|P1|NOT COMPLETED|Overall Study||0
309512|NCT00735826|746412|P1|COMPLETED|Overall Study||10
309513|NCT00735826|746412|P1|STARTED|Overall Study||10
309514|NCT00735787|746420|P2|NOT COMPLETED|Period 2||1
309515|NCT00735787|746421|P1|NOT COMPLETED|Period 2||5
309516|NCT00735787|746420|P2|COMPLETED|Period 2||40
309517|NCT00735787|746421|P1|COMPLETED|Period 2||13
309518|NCT00735787|746420|P2|STARTED|Period 2||41
309519|NCT00735787|746421|P1|STARTED|Period 2||18
309520|NCT00735787|746420|P2|NOT COMPLETED|Period 1||8
309521|NCT00735787|746421|P1|NOT COMPLETED|Period 1||6
309522|NCT00735787|746420|P2|COMPLETED|Period 1||41
309523|NCT00735787|746421|P1|COMPLETED|Period 1|Per visit window, 18 completed; 17 completed per subject case report form.|17
309524|NCT00735787|746420|P2|STARTED|Period 1||49
309525|NCT00735787|746421|P1|STARTED|Period 1||23
309526|NCT00735709|746469|P4|NOT COMPLETED|Overall Study||18
309527|NCT00735709|746470|P3|NOT COMPLETED|Overall Study||11
309528|NCT00735709|746471|P2|NOT COMPLETED|Overall Study||13
309529|NCT00735709|746472|P1|NOT COMPLETED|Overall Study||13
309530|NCT00735709|746469|P4|COMPLETED|Overall Study||122
309531|NCT00735709|746470|P3|COMPLETED|Overall Study||129
309532|NCT00735709|746471|P2|COMPLETED|Overall Study||127
309533|NCT00735709|746472|P1|COMPLETED|Overall Study||127
309534|NCT00735709|746469|P4|Treated|Overall Study||139
309535|NCT00735709|746470|P3|Treated|Overall Study||140
309536|NCT00735709|746471|P2|Treated|Overall Study||140
309537|NCT00735709|746472|P1|Treated|Overall Study||140
309538|NCT00735709|746469|P4|STARTED|Overall Study||140
309539|NCT00735709|746470|P3|STARTED|Overall Study||140
309540|NCT00735709|746471|P2|STARTED|Overall Study||140
309541|NCT00735709|746472|P1|STARTED|Overall Study||140
309542|NCT00735696|746582|P1|NOT COMPLETED|Overall Study||2
309543|NCT00735696|746582|P1|COMPLETED|Overall Study||39
309544|NCT00735696|746582|P1|Received Any Quantity of Study Drug|Overall Study||40
309545|NCT00735696|746582|P1|STARTED|Overall Study||41
309546|NCT00735670|746596|P2|NOT COMPLETED|Overall Study||5
309547|NCT00735670|746597|P1|NOT COMPLETED|Overall Study||4
309548|NCT00735670|746596|P2|COMPLETED|Overall Study||6
309549|NCT00735670|746597|P1|COMPLETED|Overall Study||6
309550|NCT00735670|746596|P2|STARTED|Overall Study||11
309551|NCT00735670|746597|P1|STARTED|Overall Study||10
309552|NCT00735644|746610|P5|NOT COMPLETED|Overall Study||0
309553|NCT00735644|746611|P4|NOT COMPLETED|Overall Study||1
309554|NCT00735644|746612|P3|NOT COMPLETED|Overall Study||1
309555|NCT00735644|746613|P2|NOT COMPLETED|Overall Study||2
309556|NCT00735644|746614|P1|NOT COMPLETED|Overall Study||0
309557|NCT00735644|746610|P5|COMPLETED|Overall Study||102
309558|NCT00735644|746611|P4|COMPLETED|Overall Study||198
309559|NCT00735644|746612|P3|COMPLETED|Overall Study||295
309560|NCT00735644|746613|P2|COMPLETED|Overall Study||298
309561|NCT00735644|746614|P1|COMPLETED|Overall Study||303
309562|NCT00735644|746610|P5|STARTED|Overall Study||102
309563|NCT00735644|746611|P4|STARTED|Overall Study||199
309564|NCT00735644|746612|P3|STARTED|Overall Study||296
309565|NCT00735644|746613|P2|STARTED|Overall Study||300
309566|NCT00735644|746614|P1|STARTED|Overall Study||303
309567|NCT00735618|746651|P1|NOT COMPLETED|Overall Study||0
309568|NCT00735618|746651|P1|COMPLETED|Overall Study||19
309569|NCT00735618|746651|P1|STARTED|Overall Study||19
309570|NCT00735553|746658|P1|NOT COMPLETED|Overall Study||77
309571|NCT00735553|746658|P1|COMPLETED|Overall Study||0
309572|NCT00735553|746658|P1|STARTED|Overall Study||77
309573|NCT00735475|746668|P2|NOT COMPLETED|Overall Study||11
309574|NCT00735475|746669|P1|NOT COMPLETED|Overall Study||8
309575|NCT00735475|746668|P2|COMPLETED|Overall Study||626
309576|NCT00735475|746669|P1|COMPLETED|Overall Study||623
309577|NCT00735475|746668|P2|STARTED|Overall Study||637
309578|NCT00735475|746669|P1|STARTED|Overall Study||631
309579|NCT00735462|746690|P3|NOT COMPLETED|Overall Study||28
309580|NCT00735462|746691|P2|NOT COMPLETED|Overall Study||55
309581|NCT00735462|746692|P1|NOT COMPLETED|Overall Study||63
309582|NCT00735462|746690|P3|COMPLETED|Overall Study||77
309583|NCT00735462|746691|P2|COMPLETED|Overall Study||149
309584|NCT00735462|746692|P1|COMPLETED|Overall Study||139
309585|NCT00735462|746690|P3|STARTED|Overall Study||105
309586|NCT00735462|746691|P2|STARTED|Overall Study||204
309587|NCT00735462|746692|P1|STARTED|Overall Study||202
309588|NCT00735449|746705|P2|NOT COMPLETED|Overall Study||6
309589|NCT00735449|746706|P1|NOT COMPLETED|Overall Study||7
309590|NCT00735449|746705|P2|COMPLETED|Overall Study||96
309591|NCT00735449|746706|P1|COMPLETED|Overall Study||95
309592|NCT00735449|746705|P2|STARTED|Overall Study||102
309593|NCT00735449|746706|P1|STARTED|Overall Study||102
309594|NCT00735436|746720|P1|NOT COMPLETED|Overall Study||0
309595|NCT00735436|746720|P1|COMPLETED|Overall Study||18
309596|NCT00735436|746720|P1|STARTED|Overall Study||18
309597|NCT00735397|746729|P1|NOT COMPLETED|Overall Study||1183
309598|NCT00735397|746729|P1|COMPLETED|Overall Study||35
309599|NCT00735397|746729|P1|STARTED|Overall Study||1218
309600|NCT00735371|746743|P4|NOT COMPLETED|Overall Study||10
309601|NCT00735371|746744|P3|NOT COMPLETED|Overall Study||11
309602|NCT00735371|746745|P2|NOT COMPLETED|Overall Study||13
309603|NCT00735371|746746|P1|NOT COMPLETED|Overall Study||15
309604|NCT00735371|746743|P4|COMPLETED|Overall Study||69
309605|NCT00735371|746744|P3|COMPLETED|Overall Study||67
309606|NCT00735371|746745|P2|COMPLETED|Overall Study||66
309607|NCT00735371|746746|P1|COMPLETED|Overall Study||63
309608|NCT00735371|746743|P4|STARTED|Overall Study||79
309609|NCT00735371|746744|P3|STARTED|Overall Study||78
309610|NCT00735371|746745|P2|STARTED|Overall Study||79
309611|NCT00735371|746746|P1|STARTED|Overall Study||78
309612|NCT00735306|746764|P1|NOT COMPLETED|Overall Study||0
309613|NCT00735306|746764|P1|COMPLETED|Overall Study||12
309614|NCT00735306|746764|P1|STARTED|Overall Study||12
309615|NCT00735254|746774|P4|NOT COMPLETED|Overall Study||0
309616|NCT00735254|746775|P3|NOT COMPLETED|Overall Study||1
309617|NCT00735254|746776|P2|NOT COMPLETED|Overall Study||1
309618|NCT00735254|746777|P1|NOT COMPLETED|Overall Study||1
309619|NCT00735254|746774|P4|COMPLETED|Overall Study||0
309620|NCT00735254|746775|P3|COMPLETED|Overall Study||0
309621|NCT00735254|746776|P2|COMPLETED|Overall Study||0
309622|NCT00735254|746777|P1|COMPLETED|Overall Study||0
309623|NCT00735254|746774|P4|STARTED|Overall Study||0
309624|NCT00735254|746775|P3|STARTED|Overall Study||1
309625|NCT00735254|746776|P2|STARTED|Overall Study||1
309626|NCT00735254|746777|P1|STARTED|Overall Study||1
309627|NCT00735072|746789|P2|NOT COMPLETED|Overall Study||1
309628|NCT00735072|746790|P1|NOT COMPLETED|Overall Study||1
309629|NCT00735072|746789|P2|COMPLETED|Overall Study||21
309630|NCT00735072|746790|P1|COMPLETED|Overall Study||22
309631|NCT00735072|746789|P2|STARTED|Overall Study||22
309632|NCT00735072|746790|P1|STARTED|Overall Study||23
309633|NCT00735007|746796|P1|NOT COMPLETED|Overall Study||5
309634|NCT00735007|746796|P1|COMPLETED|Overall Study||101
309635|NCT00735007|746796|P1|STARTED|Overall Study||106
309636|NCT00734994|746821|P1|NOT COMPLETED|Overall Study||1
309637|NCT00734994|746821|P1|COMPLETED|Overall Study||14
309638|NCT00734994|746821|P1|STARTED|Overall Study||15
309639|NCT00734968|746828|P2|NOT COMPLETED|Overall Study||1
309640|NCT00734968|746829|P1|NOT COMPLETED|Overall Study||1
309641|NCT00734968|746828|P2|COMPLETED|Overall Study||75
309642|NCT00734968|746829|P1|COMPLETED|Overall Study||76
309643|NCT00734968|746828|P2|STARTED|Overall Study||76
309644|NCT00734968|746829|P1|STARTED|Overall Study||77
309645|NCT00734929|746841|P2|NOT COMPLETED|Overall Study||5
309646|NCT00734929|746842|P1|NOT COMPLETED|Overall Study||6
309647|NCT00734929|746841|P2|COMPLETED|Overall Study||53
309648|NCT00734929|746842|P1|COMPLETED|Overall Study||51
309649|NCT00734929|746841|P2|STARTED|Overall Study||58
309650|NCT00734929|746842|P1|STARTED|Overall Study||57
309651|NCT00734903|746872|P2|NOT COMPLETED|Overall Study||1
309652|NCT00734903|746873|P1|NOT COMPLETED|Overall Study||3
309653|NCT00734903|746872|P2|COMPLETED|Overall Study||32
309654|NCT00734903|746873|P1|COMPLETED|Overall Study||30
309655|NCT00734903|746872|P2|Completed 3-month Followup|Overall Study||15
309656|NCT00734903|746873|P1|Completed 3-month Followup|Overall Study||14
309657|NCT00734903|746872|P2|Completed End of Treatment Assessment|Overall Study||23
309658|NCT00734903|746873|P1|Completed End of Treatment Assessment|Overall Study||21
309659|NCT00734903|746872|P2|STARTED|Overall Study||33
309660|NCT00734903|746873|P1|STARTED|Overall Study||33
309661|NCT00734851|746899|P1|NOT COMPLETED|Overall Study||21
309662|NCT00734851|746899|P1|COMPLETED|Overall Study||13
309663|NCT00734851|746899|P1|STARTED|Overall Study||34
309664|NCT00734799|746911|P2|NOT COMPLETED|Overall Study||4
309665|NCT00734799|746912|P1|NOT COMPLETED|Overall Study||0
309666|NCT00734799|746911|P2|COMPLETED|Overall Study||9
309667|NCT00734799|746912|P1|COMPLETED|Overall Study||9
309668|NCT00734799|746911|P2|STARTED|Overall Study||13
309669|NCT00734799|746912|P1|STARTED|Overall Study||9
309670|NCT00734747|746920|P1|NOT COMPLETED|6 Month Follow-up||3
309671|NCT00734747|746920|P1|COMPLETED|6 Month Follow-up||66
309672|NCT00734747|746920|P1|STARTED|6 Month Follow-up||69
309673|NCT00734747|746920|P1|NOT COMPLETED|SRS Procedure||3
309674|NCT00734747|746920|P1|COMPLETED|SRS Procedure||69
309675|NCT00734747|746920|P1|STARTED|SRS Procedure||72
309676|NCT00734734|746927|P1|NOT COMPLETED|Overall Study||0
309677|NCT00734734|746927|P1|COMPLETED|Overall Study||64
309678|NCT00734734|746927|P1|STARTED|Overall Study||64
309679|NCT00734656|746934|P4|NOT COMPLETED|Lab Session 4||1
309680|NCT00734656|746935|P3|NOT COMPLETED|Lab Session 4||0
309681|NCT00734656|746936|P2|NOT COMPLETED|Lab Session 4||0
309682|NCT00734656|746937|P1|NOT COMPLETED|Lab Session 4||0
309683|NCT00734656|746934|P4|COMPLETED|Lab Session 4||19
309684|NCT00734656|746935|P3|COMPLETED|Lab Session 4||16
309685|NCT00734656|746936|P2|COMPLETED|Lab Session 4||18
309686|NCT00734656|746937|P1|COMPLETED|Lab Session 4||20
309687|NCT00734656|746934|P4|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
309688|NCT00734656|746935|P3|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|16
309689|NCT00734656|746936|P2|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|18
309690|NCT00734656|746937|P1|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
309691|NCT00734656|746934|P4|NOT COMPLETED|Washout 3||1
309692|NCT00734656|746935|P3|NOT COMPLETED|Washout 3||0
309693|NCT00734656|746936|P2|NOT COMPLETED|Washout 3||0
309694|NCT00734656|746937|P1|NOT COMPLETED|Washout 3||1
309695|NCT00734656|746934|P4|COMPLETED|Washout 3||18
309696|NCT00734656|746935|P3|COMPLETED|Washout 3||20
309697|NCT00734656|746936|P2|COMPLETED|Washout 3||19
309698|NCT00734656|746937|P1|COMPLETED|Washout 3||17
309699|NCT00734656|746934|P4|STARTED|Washout 3||19
309700|NCT00734656|746935|P3|STARTED|Washout 3||20
309701|NCT00734656|746936|P2|STARTED|Washout 3||19
309702|NCT00734656|746937|P1|STARTED|Washout 3||18
309703|NCT00734656|746934|P4|NOT COMPLETED|Lab Session 3||0
309704|NCT00734656|746935|P3|NOT COMPLETED|Lab Session 3||0
309705|NCT00734656|746936|P2|NOT COMPLETED|Lab Session 3||0
309706|NCT00734656|746937|P1|NOT COMPLETED|Lab Session 3||0
309707|NCT00734656|746934|P4|COMPLETED|Lab Session 3||19
309708|NCT00734656|746935|P3|COMPLETED|Lab Session 3||20
309709|NCT00734656|746936|P2|COMPLETED|Lab Session 3||19
309710|NCT00734656|746937|P1|COMPLETED|Lab Session 3||18
309711|NCT00734656|746934|P4|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
309712|NCT00734656|746935|P3|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|20
309713|NCT00734656|746936|P2|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
309714|NCT00734656|746937|P1|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|18
309715|NCT00734656|746934|P4|NOT COMPLETED|Washout 2||0
309716|NCT00734656|746935|P3|NOT COMPLETED|Washout 2||1
309717|NCT00734656|746936|P2|NOT COMPLETED|Washout 2||1
309718|NCT00734656|746937|P1|NOT COMPLETED|Washout 2||1
309719|NCT00734656|746934|P4|COMPLETED|Washout 2||19
309720|NCT00734656|746935|P3|COMPLETED|Washout 2||20
309721|NCT00734656|746936|P2|COMPLETED|Washout 2||20
309722|NCT00734656|746937|P1|COMPLETED|Washout 2||17
309723|NCT00734656|746934|P4|STARTED|Washout 2||19
309724|NCT00734656|746935|P3|STARTED|Washout 2||21
309725|NCT00734656|746936|P2|STARTED|Washout 2||21
309726|NCT00734656|746937|P1|STARTED|Washout 2||18
309727|NCT00734656|746934|P4|NOT COMPLETED|Lab Session 2||1
309728|NCT00734656|746935|P3|NOT COMPLETED|Lab Session 2||0
309729|NCT00734656|746936|P2|NOT COMPLETED|Lab Session 2||0
309730|NCT00734656|746937|P1|NOT COMPLETED|Lab Session 2||1
309731|NCT00734656|746934|P4|COMPLETED|Lab Session 2||19
309732|NCT00734656|746935|P3|COMPLETED|Lab Session 2||21
309733|NCT00734656|746936|P2|COMPLETED|Lab Session 2||21
309734|NCT00734656|746937|P1|COMPLETED|Lab Session 2||18
309735|NCT00734656|746934|P4|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|20
309736|NCT00734656|746935|P3|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
309737|NCT00734656|746936|P2|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
309738|NCT00734656|746937|P1|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|19
309739|NCT00734656|746934|P4|NOT COMPLETED|Washout 1||3
309740|NCT00734656|746935|P3|NOT COMPLETED|Washout 1||2
309741|NCT00734656|746936|P2|NOT COMPLETED|Washout 1||5
309742|NCT00734656|746937|P1|NOT COMPLETED|Washout 1||1
309743|NCT00734656|746934|P4|COMPLETED|Washout 1||18
309744|NCT00734656|746935|P3|COMPLETED|Washout 1||24
309745|NCT00734656|746936|P2|COMPLETED|Washout 1||18
309746|NCT00734656|746937|P1|COMPLETED|Washout 1||21
309747|NCT00734656|746934|P4|STARTED|Washout 1||21
309748|NCT00734656|746935|P3|STARTED|Washout 1||26
309749|NCT00734656|746936|P2|STARTED|Washout 1||23
309750|NCT00734656|746937|P1|STARTED|Washout 1||22
309751|NCT00734656|746934|P4|NOT COMPLETED|Lab Session 1||0
309752|NCT00734656|746935|P3|NOT COMPLETED|Lab Session 1||0
309753|NCT00734656|746936|P2|NOT COMPLETED|Lab Session 1||0
309754|NCT00734656|746937|P1|NOT COMPLETED|Lab Session 1||2
309755|NCT00734656|746934|P4|COMPLETED|Lab Session 1||21
309756|NCT00734656|746935|P3|COMPLETED|Lab Session 1||26
309757|NCT00734656|746936|P2|COMPLETED|Lab Session 1||23
309758|NCT00734656|746937|P1|COMPLETED|Lab Session 1||22
309759|NCT00734656|746934|P4|STARTED|Lab Session 1||21
309760|NCT00734656|746935|P3|STARTED|Lab Session 1||26
309761|NCT00734656|746936|P2|STARTED|Lab Session 1||23
309762|NCT00734656|746937|P1|STARTED|Lab Session 1||24
309763|NCT00734630|746961|P2|NOT COMPLETED|Overall Study||33
309764|NCT00734630|746962|P1|NOT COMPLETED|Overall Study||29
309765|NCT00734630|746961|P2|COMPLETED|Overall Study||200
309766|NCT00734630|746962|P1|COMPLETED|Overall Study||229
309767|NCT00734630|746961|P2|STARTED|Overall Study||233
309768|NCT00734630|746962|P1|STARTED|Overall Study||258
309769|NCT00734617|746972|P2|NOT COMPLETED|Overall Study||102
309770|NCT00734617|746973|P1|NOT COMPLETED|Overall Study||107
309771|NCT00734617|746972|P2|COMPLETED|Overall Study||128
309772|NCT00734617|746973|P1|COMPLETED|Overall Study||142
309773|NCT00734617|746972|P2|STARTED|Overall Study||230
309774|NCT00734617|746973|P1|STARTED|Overall Study||249
309775|NCT00734604|746985|P6|NOT COMPLETED|Overall Study||6
309776|NCT00734604|746986|P5|NOT COMPLETED|Overall Study||8
309777|NCT00734604|746987|P4|NOT COMPLETED|Overall Study||9
309778|NCT00734604|746988|P3|NOT COMPLETED|Overall Study||6
309779|NCT00734604|746989|P2|NOT COMPLETED|Overall Study||12
309780|NCT00734604|746990|P1|NOT COMPLETED|Overall Study||3
309781|NCT00734604|746985|P6|COMPLETED|Overall Study||58
309782|NCT00734604|746986|P5|COMPLETED|Overall Study||55
309783|NCT00734604|746987|P4|COMPLETED|Overall Study||54
309784|NCT00734604|746988|P3|COMPLETED|Overall Study||57
309785|NCT00734604|746989|P2|COMPLETED|Overall Study||51
309786|NCT00734604|746990|P1|COMPLETED|Overall Study||59
309787|NCT00734604|746985|P6|STARTED|Overall Study||64
309788|NCT00734604|746986|P5|STARTED|Overall Study||63
309789|NCT00734604|746987|P4|STARTED|Overall Study||63
309790|NCT00734604|746988|P3|STARTED|Overall Study||63
309791|NCT00734604|746989|P2|STARTED|Overall Study||63
309792|NCT00734604|746990|P1|STARTED|Overall Study||62
309793|NCT00734591|747040|P2|NOT COMPLETED|Prospective Period||44
309794|NCT00734591|747041|P1|NOT COMPLETED|Prospective Period||51
309795|NCT00734591|747040|P2|COMPLETED|Prospective Period||1229
309796|NCT00734591|747041|P1|COMPLETED|Prospective Period||1307
309797|NCT00734591|747040|P2|STARTED|Prospective Period||1273
309798|NCT00734591|747041|P1|STARTED|Prospective Period||1358
309799|NCT00734591|747040|P2|NOT COMPLETED|Screening for Prospective Period||2291
309800|NCT00734591|747041|P1|NOT COMPLETED|Screening for Prospective Period||2517
309801|NCT00734591|747040|P2|COMPLETED|Screening for Prospective Period||1273
309802|NCT00734591|747041|P1|COMPLETED|Screening for Prospective Period||1358
309803|NCT00734591|747040|P2|STARTED|Screening for Prospective Period||3564
309804|NCT00734591|747041|P1|STARTED|Screening for Prospective Period||3875
309805|NCT00734591|747040|P2|NOT COMPLETED|Retrospective Period||0
309806|NCT00734591|747041|P1|NOT COMPLETED|Retrospective Period||0
309807|NCT00734591|747040|P2|COMPLETED|Retrospective Period||3564
309808|NCT00734591|747041|P1|COMPLETED|Retrospective Period||3875
309809|NCT00734591|747040|P2|STARTED|Retrospective Period||3564
309810|NCT00734591|747041|P1|STARTED|Retrospective Period||3875
309811|NCT00734578|747056|P3|NOT COMPLETED|Overall Study||25
309812|NCT00734578|747057|P2|NOT COMPLETED|Overall Study||25
309813|NCT00734578|747058|P1|NOT COMPLETED|Overall Study||33
309814|NCT00734578|747056|P3|COMPLETED|Overall Study||129
309815|NCT00734578|747057|P2|COMPLETED|Overall Study||128
309816|NCT00734578|747058|P1|COMPLETED|Overall Study||121
309817|NCT00734578|747056|P3|STARTED|Overall Study||154
309818|NCT00734578|747057|P2|STARTED|Overall Study||153
309819|NCT00734578|747058|P1|STARTED|Overall Study||154
309820|NCT00734539|747092|P2|NOT COMPLETED|Long Term Follow up||31
309821|NCT00734539|747093|P1|NOT COMPLETED|Long Term Follow up||34
309822|NCT00734539|747092|P2|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|107
309823|NCT00734539|747093|P1|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|118
309824|NCT00734539|747092|P2|STARTED|Long Term Follow up||138
309825|NCT00734539|747093|P1|STARTED|Long Term Follow up||152
309826|NCT00734539|747092|P2|NOT COMPLETED|Main Study||35
309827|NCT00734539|747093|P1|NOT COMPLETED|Main Study||37
309828|NCT00734539|747092|P2|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|138
309829|NCT00734539|747093|P1|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|152
309830|NCT00734539|747092|P2|STARTED|Main Study||173
309831|NCT00734539|747093|P1|STARTED|Main Study||189
309832|NCT00734500|747121|P1|NOT COMPLETED|Overall Study||1
309833|NCT00734500|747121|P1|COMPLETED|Overall Study||14
309834|NCT00734500|747121|P1|STARTED|Overall Study||15
309835|NCT00734474|747135|P9|NOT COMPLETED|Overall Study||82
309836|NCT00734474|747136|P8|NOT COMPLETED|Overall Study||129
309837|NCT00734474|747137|P7|NOT COMPLETED|Overall Study||24
309838|NCT00734474|747138|P6|NOT COMPLETED|Overall Study||25
309839|NCT00734474|747139|P5|NOT COMPLETED|Overall Study||118
309840|NCT00734474|747140|P4|NOT COMPLETED|Overall Study||10
309841|NCT00734474|747141|P3|NOT COMPLETED|Overall Study||112
309842|NCT00734474|747142|P2|NOT COMPLETED|Overall Study||30
309843|NCT00734474|747143|P1|NOT COMPLETED|Overall Study||15
309844|NCT00734474|747135|P9|COMPLETED|Overall Study||95
309845|NCT00734474|747136|P8|COMPLETED|Overall Study||186
309846|NCT00734474|747137|P7|COMPLETED|Overall Study||0
309847|NCT00734474|747138|P6|COMPLETED|Overall Study||0
309848|NCT00734474|747139|P5|COMPLETED|Overall Study||184
309849|NCT00734474|747140|P4|COMPLETED|Overall Study||0
309850|NCT00734474|747141|P3|COMPLETED|Overall Study||192
309851|NCT00734474|747142|P2|COMPLETED|Overall Study||0
309852|NCT00734474|747143|P1|COMPLETED|Overall Study||0
309853|NCT00734474|747135|P9|Completed 52-Week Visit|Overall Study||112
309854|NCT00734474|747136|P8|Completed 52-Week Visit|Overall Study||238
309855|NCT00734474|747137|P7|Completed 52-Week Visit|Overall Study||0
309856|NCT00734474|747138|P6|Completed 52-Week Visit|Overall Study||0
309857|NCT00734474|747139|P5|Completed 52-Week Visit|Overall Study||243
309858|NCT00734474|747140|P4|Completed 52-Week Visit|Overall Study||0
309859|NCT00734474|747141|P3|Completed 52-Week Visit|Overall Study||238
309860|NCT00734474|747142|P2|Completed 52-Week Visit|Overall Study||0
309861|NCT00734474|747143|P1|Completed 52-Week Visit|Overall Study||0
309862|NCT00734474|747135|P9|Completed 26-Week Visit|Overall Study||124
309863|NCT00734474|747136|P8|Completed 26-Week Visit|Overall Study||270
309864|NCT00734474|747137|P7|Completed 26-Week Visit|Overall Study||2
309865|NCT00734474|747138|P6|Completed 26-Week Visit|Overall Study||2
309866|NCT00734474|747139|P5|Completed 26-Week Visit|Overall Study||268
309867|NCT00734474|747140|P4|Completed 26-Week Visit|Overall Study||2
309868|NCT00734474|747141|P3|Completed 26-Week Visit|Overall Study||258
309869|NCT00734474|747142|P2|Completed 26-Week Visit|Overall Study||0
309870|NCT00734474|747143|P1|Completed 26-Week Visit|Overall Study||0
309871|NCT00734474|747135|P9|Entered Study After Dose Decision Point|Overall Study||139
309872|NCT00734474|747136|P8|Entered Study After Dose Decision Point|Overall Study||273
309873|NCT00734474|747137|P7|Entered Study After Dose Decision Point|Overall Study||0
309874|NCT00734474|747138|P6|Entered Study After Dose Decision Point|Overall Study||0
309875|NCT00734474|747139|P5|Entered Study After Dose Decision Point|Overall Study||281
309876|NCT00734474|747140|P4|Entered Study After Dose Decision Point|Overall Study||0
309877|NCT00734474|747141|P3|Entered Study After Dose Decision Point|Overall Study||279
309878|NCT00734474|747142|P2|Entered Study After Dose Decision Point|Overall Study||0
309879|NCT00734474|747143|P1|Entered Study After Dose Decision Point|Overall Study||0
309880|NCT00734474|747135|P9|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|34
309881|NCT00734474|747136|P8|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|42
309882|NCT00734474|747137|P7|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|23
309883|NCT00734474|747138|P6|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|21
309884|NCT00734474|747139|P5|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|21
309885|NCT00734474|747140|P4|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
309886|NCT00734474|747141|P3|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|24
309887|NCT00734474|747142|P2|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|25
309888|NCT00734474|747143|P1|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
309889|NCT00734474|747135|P9|Entered Study Before Dose Decision Point|Overall Study||38
309890|NCT00734474|747136|P8|Entered Study Before Dose Decision Point|Overall Study||42
309891|NCT00734474|747137|P7|Entered Study Before Dose Decision Point|Overall Study||24
309892|NCT00734474|747138|P6|Entered Study Before Dose Decision Point|Overall Study||25
309893|NCT00734474|747139|P5|Entered Study Before Dose Decision Point|Overall Study||21
309894|NCT00734474|747140|P4|Entered Study Before Dose Decision Point|Overall Study||10
309895|NCT00734474|747141|P3|Entered Study Before Dose Decision Point|Overall Study||25
309896|NCT00734474|747142|P2|Entered Study Before Dose Decision Point|Overall Study||30
309897|NCT00734474|747143|P1|Entered Study Before Dose Decision Point|Overall Study||15
309898|NCT00734474|747135|P9|Received at Least 1 Dose of Study Drug|Overall Study||177
309899|NCT00734474|747136|P8|Received at Least 1 Dose of Study Drug|Overall Study||315
309900|NCT00734474|747137|P7|Received at Least 1 Dose of Study Drug|Overall Study||24
309901|NCT00734474|747138|P6|Received at Least 1 Dose of Study Drug|Overall Study||25
309902|NCT00734474|747139|P5|Received at Least 1 Dose of Study Drug|Overall Study||302
309903|NCT00734474|747140|P4|Received at Least 1 Dose of Study Drug|Overall Study||10
309904|NCT00734474|747141|P3|Received at Least 1 Dose of Study Drug|Overall Study||304
309905|NCT00734474|747142|P2|Received at Least 1 Dose of Study Drug|Overall Study||30
309906|NCT00734474|747143|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
309907|NCT00734474|747135|P9|STARTED|Overall Study||177
309908|NCT00734474|747136|P8|STARTED|Overall Study||315
309909|NCT00734474|747137|P7|STARTED|Overall Study||24
309910|NCT00734474|747138|P6|STARTED|Overall Study||25
309911|NCT00734474|747139|P5|STARTED|Overall Study||302
309912|NCT00734474|747140|P4|STARTED|Overall Study||10
309913|NCT00734474|747141|P3|STARTED|Overall Study||304
309914|NCT00734474|747142|P2|STARTED|Overall Study||30
309915|NCT00734474|747143|P1|STARTED|Overall Study||15
309916|NCT00734409|747312|P2|NOT COMPLETED|Overall Study||0
309917|NCT00734409|747313|P1|NOT COMPLETED|Overall Study||0
309918|NCT00734409|747312|P2|COMPLETED|Overall Study||145
309919|NCT00734409|747313|P1|COMPLETED|Overall Study||155
309920|NCT00734409|747312|P2|STARTED|Overall Study||145
309921|NCT00734409|747313|P1|STARTED|Overall Study||155
309922|NCT00734344|747325|P2|NOT COMPLETED|Overall Study||0
309923|NCT00734344|747326|P1|NOT COMPLETED|Overall Study||0
309924|NCT00734344|747325|P2|COMPLETED|Overall Study||9
309925|NCT00734344|747326|P1|COMPLETED|Overall Study||9
309926|NCT00734344|747325|P2|STARTED|Overall Study||9
309927|NCT00734344|747326|P1|STARTED|Overall Study||9
309928|NCT00734305|747396|P7|NOT COMPLETED|Overall Study||0
309929|NCT00734305|747397|P6|NOT COMPLETED|Overall Study||0
309930|NCT00734305|747398|P5|NOT COMPLETED|Overall Study||0
309931|NCT00734305|747399|P4|NOT COMPLETED|Overall Study||0
309932|NCT00734305|747400|P3|NOT COMPLETED|Overall Study||0
309933|NCT00734305|747401|P2|NOT COMPLETED|Overall Study||0
309934|NCT00734305|747402|P1|NOT COMPLETED|Overall Study||1
309935|NCT00734305|747396|P7|COMPLETED|Overall Study||18
309936|NCT00734305|747397|P6|COMPLETED|Overall Study||4
309937|NCT00734305|747398|P5|COMPLETED|Overall Study||5
309938|NCT00734305|747399|P4|COMPLETED|Overall Study||3
309939|NCT00734305|747400|P3|COMPLETED|Overall Study||4
309940|NCT00734305|747401|P2|COMPLETED|Overall Study||3
309941|NCT00734305|747402|P1|COMPLETED|Overall Study|1 patient was enrolled but did not meet eligibility criteria at C1W1, and thus was never dosed|6
309942|NCT00734305|747396|P7|STARTED|Overall Study||18
309943|NCT00734305|747397|P6|STARTED|Overall Study||4
309944|NCT00734305|747398|P5|STARTED|Overall Study||5
309945|NCT00734305|747399|P4|STARTED|Overall Study||3
309946|NCT00734305|747400|P3|STARTED|Overall Study||4
309947|NCT00734305|747401|P2|STARTED|Overall Study||3
309948|NCT00734305|747402|P1|STARTED|Overall Study||7
309949|NCT00734214|747433|P2|NOT COMPLETED|Overall Study||4
309950|NCT00734214|747434|P1|NOT COMPLETED|Overall Study||4
309951|NCT00734214|747433|P2|COMPLETED|Overall Study||126
309952|NCT00734214|747434|P1|COMPLETED|Overall Study||124
309953|NCT00734214|747433|P2|STARTED|Overall Study||130
309954|NCT00734214|747434|P1|STARTED|Overall Study||128
309955|NCT00734162|747444|P4|NOT COMPLETED|Open-Label Phase||3
309956|NCT00734162|747445|P3|NOT COMPLETED|Open-Label Phase||1
309957|NCT00734162|747446|P2|NOT COMPLETED|Open-Label Phase||2
309958|NCT00734162|747447|P1|NOT COMPLETED|Open-Label Phase||3
309959|NCT00734162|747444|P4|COMPLETED|Open-Label Phase||36
309960|NCT00734162|747445|P3|COMPLETED|Open-Label Phase||12
309961|NCT00734162|747446|P2|COMPLETED|Open-Label Phase||39
309962|NCT00734162|747447|P1|COMPLETED|Open-Label Phase||7
309963|NCT00734162|747444|P4|STARTED|Open-Label Phase|2 participants switched to open-label treatment before completing double-blind period (elevated ALT)|39
309964|NCT00734162|747445|P3|STARTED|Open-Label Phase||13
309965|NCT00734162|747446|P2|STARTED|Open-Label Phase||41
309966|NCT00734162|747447|P1|STARTED|Open-Label Phase||10
309967|NCT00734162|747444|P4|NOT COMPLETED|Randomized Phase (Through Week 72)||4
309968|NCT00734162|747445|P3|NOT COMPLETED|Randomized Phase (Through Week 72)||0
309969|NCT00734162|747446|P2|NOT COMPLETED|Randomized Phase (Through Week 72)||1
309970|NCT00734162|747447|P1|NOT COMPLETED|Randomized Phase (Through Week 72)||0
309971|NCT00734162|747444|P4|COMPLETED|Randomized Phase (Through Week 72)||37
309972|NCT00734162|747445|P3|COMPLETED|Randomized Phase (Through Week 72)||13
309973|NCT00734162|747446|P2|COMPLETED|Randomized Phase (Through Week 72)||41
309974|NCT00734162|747447|P1|COMPLETED|Randomized Phase (Through Week 72)||10
309975|NCT00734162|747444|P4|STARTED|Randomized Phase (Through Week 72)||41
309976|NCT00734162|747445|P3|STARTED|Randomized Phase (Through Week 72)||13
309977|NCT00734162|747446|P2|STARTED|Randomized Phase (Through Week 72)||42
309978|NCT00734162|747447|P1|STARTED|Randomized Phase (Through Week 72)||10
309979|NCT00734149|747671|P1|NOT COMPLETED|Overall Study||1
309980|NCT00734149|747671|P1|COMPLETED|Overall Study||44
309981|NCT00734149|747671|P1|STARTED|Overall Study||45
309982|NCT00734097|747678|P1|NOT COMPLETED|Open Label||16
309983|NCT00734097|747678|P1|COMPLETED|Open Label|16 patients discontinued after randomization|301
309984|NCT00734097|747678|P1|Per Protocol|Open Label||301
309985|NCT00734097|747678|P1|Full Analysis|Open Label||311
309986|NCT00734097|747678|P1|Safety Analysis|Open Label||317
309987|NCT00734097|747678|P1|STARTED|Open Label|Full analysis performed in 311|317
309988|NCT00734097|747678|P1|NOT COMPLETED|Screening||20
309989|NCT00734097|747678|P1|COMPLETED|Screening|20 participants were screening failure.|317
309990|NCT00734097|747678|P1|STARTED|Screening||337
309991|NCT00734071|747695|P2|NOT COMPLETED|Overall Study||27
309992|NCT00734071|747696|P1|NOT COMPLETED|Overall Study||38
309993|NCT00734071|747695|P2|COMPLETED|Overall Study||125
309994|NCT00734071|747696|P1|COMPLETED|Overall Study||114
309995|NCT00734071|747695|P2|Treated|Overall Study||148
309996|NCT00734071|747696|P1|Treated|Overall Study||151
309997|NCT00734071|747695|P2|STARTED|Overall Study||152
309998|NCT00734071|747696|P1|STARTED|Overall Study||152
309999|NCT00734032|747754|P4|NOT COMPLETED|Overall Study||0
310000|NCT00734032|747755|P3|NOT COMPLETED|Overall Study||0
310001|NCT00734032|747756|P2|NOT COMPLETED|Overall Study||1
310002|NCT00734032|747757|P1|NOT COMPLETED|Overall Study||0
310003|NCT00734032|747754|P4|COMPLETED|Overall Study||26
310004|NCT00734032|747755|P3|COMPLETED|Overall Study||28
310005|NCT00734032|747756|P2|COMPLETED|Overall Study||27
310006|NCT00734032|747757|P1|COMPLETED|Overall Study||25
310007|NCT00734032|747754|P4|STARTED|Overall Study||26
310008|NCT00734032|747755|P3|STARTED|Overall Study||28
310009|NCT00734032|747756|P2|STARTED|Overall Study||28
310010|NCT00734032|747757|P1|STARTED|Overall Study||25
310011|NCT00733993|747777|P2|NOT COMPLETED|Overall Study||0
310012|NCT00733993|747778|P1|NOT COMPLETED|Overall Study||0
310013|NCT00733993|747777|P2|COMPLETED|Overall Study||10
310014|NCT00733993|747778|P1|COMPLETED|Overall Study||13
310015|NCT00733993|747777|P2|STARTED|Overall Study||10
310016|NCT00733993|747778|P1|STARTED|Overall Study||13
310017|NCT00733980|747813|P2|NOT COMPLETED|Overall Study||21
310018|NCT00733980|747814|P1|NOT COMPLETED|Overall Study||22
310019|NCT00733980|747813|P2|COMPLETED|Overall Study||55
310020|NCT00733980|747814|P1|COMPLETED|Overall Study||52
310021|NCT00733980|747813|P2|STARTED|Overall Study||76
310022|NCT00733980|747814|P1|STARTED|Overall Study||74
310023|NCT00733954|747858|P2|NOT COMPLETED|Overall Study||2
310024|NCT00733954|747859|P1|NOT COMPLETED|Overall Study||8
310025|NCT00733954|747858|P2|COMPLETED|Overall Study||123
310026|NCT00733954|747859|P1|COMPLETED|Overall Study||116
310027|NCT00733954|747858|P2|STARTED|Overall Study||125
310028|NCT00733954|747859|P1|STARTED|Overall Study||124
310029|NCT00733824|747906|P5|NOT COMPLETED|Phase II||0
310030|NCT00733824|747907|P4|NOT COMPLETED|Phase II||0
310031|NCT00733824|747908|P3|NOT COMPLETED|Phase II||0
310032|NCT00733824|747909|P2|NOT COMPLETED|Phase II||0
310033|NCT00733824|747910|P1|NOT COMPLETED|Phase II||0
310034|NCT00733824|747906|P5|COMPLETED|Phase II||36
310035|NCT00733824|747907|P4|COMPLETED|Phase II||0
310036|NCT00733824|747908|P3|COMPLETED|Phase II||0
310037|NCT00733824|747909|P2|COMPLETED|Phase II||0
310038|NCT00733824|747910|P1|COMPLETED|Phase II||0
310039|NCT00733824|747906|P5|STARTED|Phase II||36
310040|NCT00733824|747907|P4|STARTED|Phase II||0
310041|NCT00733824|747908|P3|STARTED|Phase II||0
310042|NCT00733824|747909|P2|STARTED|Phase II||0
310043|NCT00733824|747910|P1|STARTED|Phase II||0
310044|NCT00733824|747906|P5|NOT COMPLETED|Phase I||0
310045|NCT00733824|747907|P4|NOT COMPLETED|Phase I||0
310046|NCT00733824|747908|P3|NOT COMPLETED|Phase I||0
310047|NCT00733824|747909|P2|NOT COMPLETED|Phase I||0
310048|NCT00733824|747910|P1|NOT COMPLETED|Phase I||1
310049|NCT00733824|747906|P5|COMPLETED|Phase I||0
310050|NCT00733824|747907|P4|COMPLETED|Phase I||6
310051|NCT00733824|747908|P3|COMPLETED|Phase I||6
310052|NCT00733824|747909|P2|COMPLETED|Phase I||3
310053|NCT00733824|747910|P1|COMPLETED|Phase I||9
310054|NCT00733824|747906|P5|STARTED|Phase I||0
310055|NCT00733824|747907|P4|STARTED|Phase I||6
310056|NCT00733824|747908|P3|STARTED|Phase I||6
310057|NCT00733824|747909|P2|STARTED|Phase I||3
310058|NCT00733824|747910|P1|STARTED|Phase I||10
310059|NCT00733746|747929|P1|NOT COMPLETED|Overall Study||5
310060|NCT00733746|747929|P1|COMPLETED|Overall Study||114
310061|NCT00733746|747929|P1|STARTED|Overall Study||119
310062|NCT00733512|747937|P1|NOT COMPLETED|Overall Study||0
310063|NCT00733512|747937|P1|COMPLETED|Overall Study||146
310064|NCT00733512|747937|P1|STARTED|Overall Study||146
310065|NCT00733499|747944|P2|NOT COMPLETED|24 Months Follow-up||1
310066|NCT00733499|747945|P1|NOT COMPLETED|24 Months Follow-up||0
310067|NCT00733499|747944|P2|COMPLETED|24 Months Follow-up||95
310068|NCT00733499|747945|P1|COMPLETED|24 Months Follow-up||99
310069|NCT00733499|747944|P2|STARTED|24 Months Follow-up||96
310070|NCT00733499|747945|P1|STARTED|24 Months Follow-up||99
310071|NCT00733499|747944|P2|NOT COMPLETED|12 Months Follow-up||1
310072|NCT00733499|747945|P1|NOT COMPLETED|12 Months Follow-up||2
310073|NCT00733499|747944|P2|COMPLETED|12 Months Follow-up||96
310074|NCT00733499|747945|P1|COMPLETED|12 Months Follow-up||99
310075|NCT00733499|747944|P2|STARTED|12 Months Follow-up||97
310076|NCT00733499|747945|P1|STARTED|12 Months Follow-up||101
310077|NCT00733499|747944|P2|NOT COMPLETED|6 Months Follow-up||3
310078|NCT00733499|747945|P1|NOT COMPLETED|6 Months Follow-up||0
310079|NCT00733499|747944|P2|COMPLETED|6 Months Follow-up||97
310080|NCT00733499|747945|P1|COMPLETED|6 Months Follow-up||101
310081|NCT00733499|747944|P2|STARTED|6 Months Follow-up||100
310082|NCT00733499|747945|P1|STARTED|6 Months Follow-up||101
310083|NCT00733499|747944|P2|NOT COMPLETED|3 Months Follow-up||2
310084|NCT00733499|747945|P1|NOT COMPLETED|3 Months Follow-up||1
310085|NCT00733499|747944|P2|COMPLETED|3 Months Follow-up||100
310086|NCT00733499|747945|P1|COMPLETED|3 Months Follow-up||101
310087|NCT00733499|747944|P2|STARTED|3 Months Follow-up||102
310088|NCT00733499|747945|P1|STARTED|3 Months Follow-up||102
310089|NCT00733499|747944|P2|NOT COMPLETED|Pre-operative||1
310090|NCT00733499|747945|P1|NOT COMPLETED|Pre-operative||0
310091|NCT00733499|747944|P2|COMPLETED|Pre-operative||102
310092|NCT00733499|747945|P1|COMPLETED|Pre-operative||102
310093|NCT00733499|747944|P2|STARTED|Pre-operative||103
310094|NCT00733499|747945|P1|STARTED|Pre-operative||102
310095|NCT00733421|747953|P2|NOT COMPLETED|Overall Study||1
310096|NCT00733421|747954|P1|NOT COMPLETED|Overall Study||1
310097|NCT00733421|747953|P2|COMPLETED|Overall Study|All but one randomised patient|49
310098|NCT00733421|747954|P1|COMPLETED|Overall Study|All but one randomsied patient|49
310099|NCT00733421|747953|P2|STARTED|Overall Study|November 2008|50
310100|NCT00733421|747954|P1|STARTED|Overall Study|November 2008|50
310101|NCT00733408|747976|P1|NOT COMPLETED|Overall Study||4
310102|NCT00733408|747976|P1|COMPLETED|Overall Study||55
310103|NCT00733408|747976|P1|STARTED|Overall Study||59
310104|NCT00733369|747988|P2|NOT COMPLETED|Overall Study||9
310105|NCT00733369|747989|P1|NOT COMPLETED|Overall Study||10
310106|NCT00733369|747988|P2|COMPLETED|Overall Study||47
310107|NCT00733369|747989|P1|COMPLETED|Overall Study||40
310108|NCT00733369|747988|P2|STARTED|Overall Study||56
310109|NCT00733369|747989|P1|STARTED|Overall Study||50
310110|NCT00733356|748105|P1|NOT COMPLETED|Modified Lab School, Reading Evaluation||0
310111|NCT00733356|748105|P1|COMPLETED|Modified Lab School, Reading Evaluation||26
310112|NCT00733356|748105|P1|STARTED|Modified Lab School, Reading Evaluation||26
310113|NCT00733356|748105|P1|NOT COMPLETED|Vyvanse Dose Titration||2
310114|NCT00733356|748105|P1|COMPLETED|Vyvanse Dose Titration||26
310115|NCT00733356|748105|P1|STARTED|Vyvanse Dose Titration||28
310116|NCT00733330|748111|P2|NOT COMPLETED|Overall Study||4
310117|NCT00733330|748112|P1|NOT COMPLETED|Overall Study||2
310118|NCT00733330|748111|P2|COMPLETED|Overall Study||48
310119|NCT00733330|748112|P1|COMPLETED|Overall Study||30
310120|NCT00733330|748111|P2|STARTED|Overall Study||52
310121|NCT00733330|748112|P1|STARTED|Overall Study||32
310122|NCT00733304|748197|P3|NOT COMPLETED|Overall Study||5
310123|NCT00733304|748198|P2|NOT COMPLETED|Overall Study||3
310124|NCT00733304|748199|P1|NOT COMPLETED|Overall Study||7
310125|NCT00733304|748197|P3|COMPLETED|Overall Study||3
310126|NCT00733304|748198|P2|COMPLETED|Overall Study||12
310127|NCT00733304|748199|P1|COMPLETED|Overall Study||12
310128|NCT00733304|748197|P3|STARTED|Overall Study||8
310129|NCT00733304|748198|P2|STARTED|Overall Study||15
310130|NCT00733304|748199|P1|STARTED|Overall Study||19
310131|NCT00733291|748281|P4|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
310132|NCT00733291|748282|P3|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
310133|NCT00733291|748283|P2|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
310134|NCT00733291|748284|P1|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
310135|NCT00733291|748281|P4|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
310136|NCT00733291|748282|P3|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
310137|NCT00733291|748283|P2|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
310138|NCT00733291|748284|P1|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||12
310139|NCT00733291|748281|P4|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
310140|NCT00733291|748282|P3|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
310141|NCT00733291|748283|P2|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
310142|NCT00733291|748284|P1|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||12
310143|NCT00733291|748281|P4|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
310144|NCT00733291|748282|P3|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
310145|NCT00733291|748283|P2|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
310146|NCT00733291|748284|P1|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||1
310147|NCT00733291|748281|P4|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
310148|NCT00733291|748282|P3|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
310149|NCT00733291|748283|P2|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
310150|NCT00733291|748284|P1|COMPLETED|Washout Period, 3 Days (+/-1 Day)||12
310151|NCT00733291|748281|P4|STARTED|Washout Period, 3 Days (+/-1 Day)||17
310152|NCT00733291|748282|P3|STARTED|Washout Period, 3 Days (+/-1 Day)||17
310153|NCT00733291|748283|P2|STARTED|Washout Period, 3 Days (+/-1 Day)||17
310154|NCT00733291|748284|P1|STARTED|Washout Period, 3 Days (+/-1 Day)||13
310155|NCT00733291|748281|P4|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
310156|NCT00733291|748282|P3|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
310157|NCT00733291|748283|P2|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
310158|NCT00733291|748284|P1|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
310159|NCT00733291|748281|P4|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
310160|NCT00733291|748282|P3|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
310161|NCT00733291|748283|P2|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
310162|NCT00733291|748284|P1|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||13
310163|NCT00733291|748281|P4|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
310164|NCT00733291|748282|P3|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
310165|NCT00733291|748283|P2|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
310166|NCT00733291|748284|P1|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||13
310167|NCT00733278|748306|P1|NOT COMPLETED|Overall Study||0
310168|NCT00733278|748306|P1|COMPLETED|Overall Study||7
310169|NCT00733278|748306|P1|STARTED|Overall Study||7
310170|NCT00733226|748313|P2|NOT COMPLETED|Overall Study||0
310171|NCT00733226|748314|P1|NOT COMPLETED|Overall Study||5
310172|NCT00733226|748313|P2|COMPLETED|Overall Study||40
310173|NCT00733226|748314|P1|COMPLETED|Overall Study||35
310174|NCT00733226|748313|P2|STARTED|Overall Study||40
310175|NCT00733226|748314|P1|STARTED|Overall Study||40
310176|NCT00733135|748330|P1|NOT COMPLETED|Overall Study||2
310177|NCT00733135|748330|P1|COMPLETED|Overall Study||131
310178|NCT00733135|748330|P1|STARTED|Overall Study||133
310179|NCT00733096|748342|P3|NOT COMPLETED|Overall Study||0
310180|NCT00733096|748343|P2|NOT COMPLETED|Overall Study||0
310181|NCT00733096|748344|P1|NOT COMPLETED|Overall Study||0
310182|NCT00733096|748342|P3|COMPLETED|Overall Study||30
310183|NCT00733096|748343|P2|COMPLETED|Overall Study||26
310184|NCT00733096|748344|P1|COMPLETED|Overall Study||28
310185|NCT00733096|748342|P3|STARTED|Overall Study||30
310186|NCT00733096|748343|P2|STARTED|Overall Study||26
310187|NCT00733096|748344|P1|STARTED|Overall Study||28
310188|NCT00733005|748363|P2|NOT COMPLETED|Overall Study||3
310189|NCT00733005|748364|P1|NOT COMPLETED|Overall Study||2
310190|NCT00733005|748363|P2|COMPLETED|Overall Study||159
310191|NCT00733005|748364|P1|COMPLETED|Overall Study||160
310192|NCT00733005|748363|P2|STARTED|Overall Study||162
310193|NCT00733005|748364|P1|STARTED|Overall Study||162
310194|NCT00732992|748374|P2|NOT COMPLETED|Overall Study||6
310195|NCT00732992|748375|P1|NOT COMPLETED|Overall Study||6
310196|NCT00732992|748374|P2|COMPLETED|Overall Study||0
310197|NCT00732992|748375|P1|COMPLETED|Overall Study||0
310198|NCT00732992|748374|P2|STARTED|Overall Study||6
310199|NCT00732992|748375|P1|STARTED|Overall Study||6
310200|NCT00732940|748394|P2|NOT COMPLETED|Overall Study||3
310201|NCT00732940|748395|P1|NOT COMPLETED|Overall Study||2
310202|NCT00732940|748394|P2|COMPLETED|Overall Study||25
310203|NCT00732940|748395|P1|COMPLETED|Overall Study||26
310204|NCT00732940|748394|P2|STARTED|Overall Study||28
310205|NCT00732940|748395|P1|STARTED|Overall Study||28
310206|NCT00732901|748465|P2|NOT COMPLETED|Overall Study||0
310207|NCT00732901|748466|P1|NOT COMPLETED|Overall Study||0
310208|NCT00732901|748465|P2|COMPLETED|Overall Study||12
310209|NCT00732901|748466|P1|COMPLETED|Overall Study||11
310210|NCT00732901|748465|P2|STARTED|Overall Study||12
310211|NCT00732901|748466|P1|STARTED|Overall Study||11
310212|NCT00732875|748476|P1|NOT COMPLETED|Overall Study||35
310213|NCT00732875|748476|P1|COMPLETED|Overall Study|These participants continued treatment until trial was completed by Sponsor.|57
310214|NCT00732875|748476|P1|STARTED|Overall Study||92
310215|NCT00732758|748484|P2|NOT COMPLETED|Overall Study||16
310216|NCT00732758|748485|P1|NOT COMPLETED|Overall Study||8
310217|NCT00732758|748484|P2|COMPLETED|Overall Study||63
310218|NCT00732758|748485|P1|COMPLETED|Overall Study||70
310219|NCT00732758|748484|P2|STARTED|Overall Study||79
310220|NCT00732758|748485|P1|STARTED|Overall Study||78
310221|NCT00732680|748497|P1|NOT COMPLETED|Overall Study||0
310222|NCT00732680|748497|P1|COMPLETED|Overall Study||9
310223|NCT00732680|748497|P1|STARTED|Overall Study||9
310224|NCT00732654|748504|P3|NOT COMPLETED|Overall Study||0
310225|NCT00732654|748505|P2|NOT COMPLETED|Overall Study||1
310226|NCT00732654|748506|P1|NOT COMPLETED|Overall Study||0
310227|NCT00732654|748504|P3|COMPLETED|Overall Study||10
310228|NCT00732654|748505|P2|COMPLETED|Overall Study||9
310229|NCT00732654|748506|P1|COMPLETED|Overall Study||10
310230|NCT00732654|748504|P3|STARTED|Overall Study||10
310231|NCT00732654|748505|P2|STARTED|Overall Study||10
310232|NCT00732654|748506|P1|STARTED|Overall Study||10
310233|NCT00732641|748525|P2|NOT COMPLETED|Overall Study||112
310234|NCT00732641|748526|P1|NOT COMPLETED|Overall Study||106
310235|NCT00732641|748525|P2|COMPLETED|Overall Study||9
310236|NCT00732641|748526|P1|COMPLETED|Overall Study||17
310237|NCT00732641|748525|P2|STARTED|Overall Study||121
310238|NCT00732641|748526|P1|STARTED|Overall Study||123
310239|NCT00732615|748546|P2|NOT COMPLETED|Overall Study||5
310240|NCT00732615|748547|P1|NOT COMPLETED|Overall Study||7
310241|NCT00732615|748546|P2|COMPLETED|Overall Study||79
310242|NCT00732615|748547|P1|COMPLETED|Overall Study||33
310243|NCT00732615|748546|P2|STARTED|Overall Study||84
310244|NCT00732615|748547|P1|STARTED|Overall Study||40
310245|NCT00732498|748559|P1|NOT COMPLETED|Overall Study||6
310246|NCT00732498|748559|P1|COMPLETED|Overall Study||22
310247|NCT00732498|748559|P1|STARTED|Overall Study||28
310248|NCT00732472|748570|P4|NOT COMPLETED|Overall Study||3
310249|NCT00732472|748571|P3|NOT COMPLETED|Overall Study||1
310250|NCT00732472|748572|P2|NOT COMPLETED|Overall Study||3
310251|NCT00732472|748573|P1|NOT COMPLETED|Overall Study||0
310252|NCT00732472|748570|P4|COMPLETED|Overall Study||6
310253|NCT00732472|748571|P3|COMPLETED|Overall Study||9
310254|NCT00732472|748572|P2|COMPLETED|Overall Study||7
310255|NCT00732472|748573|P1|COMPLETED|Overall Study||9
310256|NCT00732472|748570|P4|STARTED|Overall Study||9
310257|NCT00732472|748571|P3|STARTED|Overall Study||10
310258|NCT00732472|748572|P2|STARTED|Overall Study|One par. (counted as 2 on outputs) was randomized/dosed with UMEC 250 µg on 2 separate occasions.|10
310259|NCT00732472|748573|P1|STARTED|Overall Study||9
310260|NCT00732381|748673|P2|NOT COMPLETED|Overall Study||1
310261|NCT00732381|748674|P1|NOT COMPLETED|Overall Study||2
310262|NCT00732381|748673|P2|COMPLETED|Overall Study||174
310263|NCT00732381|748674|P1|COMPLETED|Overall Study||174
310264|NCT00732381|748673|P2|STARTED|Overall Study||175
310265|NCT00732381|748674|P1|STARTED|Overall Study||176
310266|NCT00732303|748682|P1|NOT COMPLETED|Overall Study||2
310267|NCT00732303|748682|P1|COMPLETED|Overall Study||6
310268|NCT00732303|748682|P1|STARTED|Overall Study||8
310269|NCT00732251|748688|P1|NOT COMPLETED|Overall Study||7
310270|NCT00732251|748688|P1|COMPLETED|Overall Study||1
310271|NCT00732251|748688|P1|STARTED|Overall Study||8
310272|NCT00732238|748696|P2|NOT COMPLETED|Overall Study||1
310273|NCT00732238|748697|P1|NOT COMPLETED|Overall Study||5
310274|NCT00732238|748696|P2|COMPLETED|Overall Study||27
310275|NCT00732238|748697|P1|COMPLETED|Overall Study||28
310276|NCT00732238|748696|P2|STARTED|Overall Study||28
310277|NCT00732238|748697|P1|STARTED|Overall Study||33
310278|NCT00732225|748710|P5|NOT COMPLETED|Overall Study||6
310279|NCT00732225|748711|P4|NOT COMPLETED|Overall Study||4
310280|NCT00732225|748712|P3|NOT COMPLETED|Overall Study||3
310281|NCT00732225|748713|P2|NOT COMPLETED|Overall Study||8
310282|NCT00732225|748714|P1|NOT COMPLETED|Overall Study||11
310283|NCT00732225|748710|P5|COMPLETED|Overall Study|48 eyes of 48 patients|48
310284|NCT00732225|748711|P4|COMPLETED|Overall Study|29 eyes of 29 patients|29
310285|NCT00732225|748712|P3|COMPLETED|Overall Study|23 eyes of 23 patients|23
310286|NCT00732225|748713|P2|COMPLETED|Overall Study|33 eyes of 32 patients|32
310287|NCT00732225|748714|P1|COMPLETED|Overall Study|64 eyes of 60 patients|60
310288|NCT00732225|748710|P5|STARTED|Overall Study|55 eyes of 54 patients|54
310289|NCT00732225|748711|P4|STARTED|Overall Study|33 eyes of 33 patients|33
310290|NCT00732225|748712|P3|STARTED|Overall Study|26 eyes of 26 patients|26
310291|NCT00732225|748713|P2|STARTED|Overall Study|41 eyes of 40 patients|40
310292|NCT00732225|748714|P1|STARTED|Overall Study|76 eyes of 71 patients|71
310293|NCT00732212|748765|P2|NOT COMPLETED|Overall Study||0
310294|NCT00732212|748766|P1|NOT COMPLETED|Overall Study||0
310295|NCT00732212|748765|P2|COMPLETED|Overall Study||123
310296|NCT00732212|748766|P1|COMPLETED|Overall Study||112
310297|NCT00732212|748765|P2|Temporarily Suspended|Overall Study||50
310298|NCT00732212|748766|P1|Temporarily Suspended|Overall Study|Study was suspended for a 9 month period by the VA DMC because of slow enrollment, then restarted.|50
310299|NCT00732212|748765|P2|STARTED|Overall Study||123
310300|NCT00732212|748766|P1|STARTED|Overall Study||112
310301|NCT00732199|748798|P2|NOT COMPLETED|Overall Study||26
310302|NCT00732199|748799|P1|NOT COMPLETED|Overall Study||34
310303|NCT00732199|748798|P2|COMPLETED|Overall Study||16
310304|NCT00732199|748799|P1|COMPLETED|Overall Study||16
310305|NCT00732199|748798|P2|STARTED|Overall Study||42
310306|NCT00732199|748799|P1|STARTED|Overall Study||50
310307|NCT00732160|748814|P4|NOT COMPLETED|Overall Study||2
310308|NCT00732160|748815|P3|NOT COMPLETED|Overall Study||3
310309|NCT00732160|748816|P2|NOT COMPLETED|Overall Study||4
310310|NCT00732160|748817|P1|NOT COMPLETED|Overall Study||5
310311|NCT00732160|748814|P4|COMPLETED|Overall Study||3
310312|NCT00732160|748815|P3|COMPLETED|Overall Study||3
310313|NCT00732160|748816|P2|COMPLETED|Overall Study||1
310314|NCT00732160|748817|P1|COMPLETED|Overall Study||2
310315|NCT00732160|748814|P4|LS Aldosterone|Overall Study||5
310316|NCT00732160|748815|P3|LS Aldosterone|Overall Study||6
310317|NCT00732160|748816|P2|LS Aldosterone|Overall Study||1
310318|NCT00732160|748817|P1|LS Aldosterone|Overall Study||2
310319|NCT00732160|748814|P4|LS Vehicle|Overall Study||5
310320|NCT00732160|748815|P3|LS Vehicle|Overall Study||6
310321|NCT00732160|748816|P2|LS Vehicle|Overall Study||1
310322|NCT00732160|748817|P1|LS Vehicle|Overall Study||2
310323|NCT00732160|748814|P4|HS Aldosterone|Overall Study||3
310324|NCT00732160|748815|P3|HS Aldosterone|Overall Study||3
310325|NCT00732160|748816|P2|HS Aldosterone|Overall Study||5
310326|NCT00732160|748817|P1|HS Aldosterone|Overall Study||7
310327|NCT00732160|748814|P4|HS Vehicle|Overall Study||3
310328|NCT00732160|748815|P3|HS Vehicle|Overall Study||3
310329|NCT00732160|748816|P2|HS Vehicle|Overall Study||5
310330|NCT00732160|748817|P1|HS Vehicle|Overall Study||7
310331|NCT00732160|748814|P4|STARTED|Overall Study||5
310332|NCT00732160|748815|P3|STARTED|Overall Study||6
310333|NCT00732160|748816|P2|STARTED|Overall Study||5
310334|NCT00732160|748817|P1|STARTED|Overall Study||7
310335|NCT00732069|748831|P6|NOT COMPLETED|Third Study Drug||0
310336|NCT00732069|748832|P5|NOT COMPLETED|Third Study Drug||0
310337|NCT00732069|748833|P4|NOT COMPLETED|Third Study Drug||0
310338|NCT00732069|748834|P3|NOT COMPLETED|Third Study Drug||0
310339|NCT00732069|748835|P2|NOT COMPLETED|Third Study Drug||0
310340|NCT00732069|748836|P1|NOT COMPLETED|Third Study Drug||0
310341|NCT00732069|748831|P6|COMPLETED|Third Study Drug||2
310342|NCT00732069|748832|P5|COMPLETED|Third Study Drug||3
310343|NCT00732069|748833|P4|COMPLETED|Third Study Drug||2
310344|NCT00732069|748834|P3|COMPLETED|Third Study Drug||3
310345|NCT00732069|748835|P2|COMPLETED|Third Study Drug||3
310346|NCT00732069|748836|P1|COMPLETED|Third Study Drug||2
310347|NCT00732069|748831|P6|STARTED|Third Study Drug||2
310348|NCT00732069|748832|P5|STARTED|Third Study Drug||3
310349|NCT00732069|748833|P4|STARTED|Third Study Drug||2
310350|NCT00732069|748834|P3|STARTED|Third Study Drug||3
310351|NCT00732069|748835|P2|STARTED|Third Study Drug||3
310352|NCT00732069|748836|P1|STARTED|Third Study Drug||2
310353|NCT00732069|748831|P6|NOT COMPLETED|Washout After Second Study Drug||0
310354|NCT00732069|748832|P5|NOT COMPLETED|Washout After Second Study Drug||0
310355|NCT00732069|748833|P4|NOT COMPLETED|Washout After Second Study Drug||0
310356|NCT00732069|748834|P3|NOT COMPLETED|Washout After Second Study Drug||0
310357|NCT00732069|748835|P2|NOT COMPLETED|Washout After Second Study Drug||0
310358|NCT00732069|748836|P1|NOT COMPLETED|Washout After Second Study Drug||0
310359|NCT00732069|748831|P6|COMPLETED|Washout After Second Study Drug||2
310360|NCT00732069|748832|P5|COMPLETED|Washout After Second Study Drug||3
310361|NCT00732069|748833|P4|COMPLETED|Washout After Second Study Drug||2
310362|NCT00732069|748834|P3|COMPLETED|Washout After Second Study Drug||3
310363|NCT00732069|748835|P2|COMPLETED|Washout After Second Study Drug||3
310364|NCT00732069|748836|P1|COMPLETED|Washout After Second Study Drug||2
310365|NCT00732069|748831|P6|STARTED|Washout After Second Study Drug||2
310366|NCT00732069|748832|P5|STARTED|Washout After Second Study Drug||3
310367|NCT00732069|748833|P4|STARTED|Washout After Second Study Drug||2
310368|NCT00732069|748834|P3|STARTED|Washout After Second Study Drug||3
310369|NCT00732069|748835|P2|STARTED|Washout After Second Study Drug||3
310370|NCT00732069|748836|P1|STARTED|Washout After Second Study Drug||2
310371|NCT00732069|748831|P6|NOT COMPLETED|Second Study Drug||0
310372|NCT00732069|748832|P5|NOT COMPLETED|Second Study Drug||0
310373|NCT00732069|748833|P4|NOT COMPLETED|Second Study Drug||0
310374|NCT00732069|748834|P3|NOT COMPLETED|Second Study Drug||0
310375|NCT00732069|748835|P2|NOT COMPLETED|Second Study Drug||0
310376|NCT00732069|748836|P1|NOT COMPLETED|Second Study Drug||0
310377|NCT00732069|748831|P6|COMPLETED|Second Study Drug||2
310378|NCT00732069|748832|P5|COMPLETED|Second Study Drug||3
310379|NCT00732069|748833|P4|COMPLETED|Second Study Drug||2
310380|NCT00732069|748834|P3|COMPLETED|Second Study Drug||3
310381|NCT00732069|748835|P2|COMPLETED|Second Study Drug||3
310382|NCT00732069|748836|P1|COMPLETED|Second Study Drug||2
310383|NCT00732069|748831|P6|STARTED|Second Study Drug||2
310384|NCT00732069|748832|P5|STARTED|Second Study Drug||3
310385|NCT00732069|748833|P4|STARTED|Second Study Drug||2
310386|NCT00732069|748834|P3|STARTED|Second Study Drug||3
310387|NCT00732069|748835|P2|STARTED|Second Study Drug||3
310388|NCT00732069|748836|P1|STARTED|Second Study Drug||2
310389|NCT00732069|748831|P6|NOT COMPLETED|Washout After First Study Drug||0
310390|NCT00732069|748832|P5|NOT COMPLETED|Washout After First Study Drug||0
310391|NCT00732069|748833|P4|NOT COMPLETED|Washout After First Study Drug||0
310392|NCT00732069|748834|P3|NOT COMPLETED|Washout After First Study Drug||0
310393|NCT00732069|748835|P2|NOT COMPLETED|Washout After First Study Drug||0
310394|NCT00732069|748836|P1|NOT COMPLETED|Washout After First Study Drug||1
310395|NCT00732069|748831|P6|COMPLETED|Washout After First Study Drug||2
310396|NCT00732069|748832|P5|COMPLETED|Washout After First Study Drug||3
310397|NCT00732069|748833|P4|COMPLETED|Washout After First Study Drug||2
310398|NCT00732069|748834|P3|COMPLETED|Washout After First Study Drug||3
310399|NCT00732069|748835|P2|COMPLETED|Washout After First Study Drug||3
310400|NCT00732069|748836|P1|COMPLETED|Washout After First Study Drug||2
310401|NCT00732069|748831|P6|STARTED|Washout After First Study Drug||2
310402|NCT00732069|748832|P5|STARTED|Washout After First Study Drug||3
310403|NCT00732069|748833|P4|STARTED|Washout After First Study Drug||2
310404|NCT00732069|748834|P3|STARTED|Washout After First Study Drug||3
310405|NCT00732069|748835|P2|STARTED|Washout After First Study Drug||3
310406|NCT00732069|748836|P1|STARTED|Washout After First Study Drug||3
310407|NCT00732069|748831|P6|NOT COMPLETED|First Study Drug||0
310408|NCT00732069|748832|P5|NOT COMPLETED|First Study Drug||0
310409|NCT00732069|748833|P4|NOT COMPLETED|First Study Drug||0
310410|NCT00732069|748834|P3|NOT COMPLETED|First Study Drug||0
310411|NCT00732069|748835|P2|NOT COMPLETED|First Study Drug||0
310412|NCT00732069|748836|P1|NOT COMPLETED|First Study Drug||0
310413|NCT00732069|748831|P6|COMPLETED|First Study Drug||2
310414|NCT00732069|748832|P5|COMPLETED|First Study Drug||3
310415|NCT00732069|748833|P4|COMPLETED|First Study Drug||2
310416|NCT00732069|748834|P3|COMPLETED|First Study Drug||3
310417|NCT00732069|748835|P2|COMPLETED|First Study Drug||3
310418|NCT00732069|748836|P1|COMPLETED|First Study Drug||3
310419|NCT00732069|748831|P6|STARTED|First Study Drug||2
310420|NCT00732069|748832|P5|STARTED|First Study Drug||3
310421|NCT00732069|748833|P4|STARTED|First Study Drug||2
310422|NCT00732069|748834|P3|STARTED|First Study Drug||3
310423|NCT00732069|748835|P2|STARTED|First Study Drug||3
310424|NCT00732069|748836|P1|STARTED|First Study Drug||3
310425|NCT00732030|748847|P1|NOT COMPLETED|Overall Study||2
310426|NCT00732030|748847|P1|COMPLETED|Overall Study||24
310427|NCT00732030|748847|P1|STARTED|Overall Study||26
310428|NCT00731939|748854|P1|NOT COMPLETED|Overall Study||34
310429|NCT00731939|748854|P1|COMPLETED|Overall Study||90
310430|NCT00731939|748854|P1|STARTED|Overall Study||124
310431|NCT00731874|748904|P2|NOT COMPLETED|Overall Study||0
310432|NCT00731874|748905|P1|NOT COMPLETED|Overall Study||0
310433|NCT00731874|748904|P2|COMPLETED|Overall Study||13
310434|NCT00731874|748905|P1|COMPLETED|Overall Study||10
310435|NCT00731874|748904|P2|STARTED|Overall Study||13
310436|NCT00731874|748905|P1|STARTED|Overall Study||10
310437|NCT00731822|748931|P2|NOT COMPLETED|Overall Study||1
310438|NCT00731822|748932|P1|NOT COMPLETED|Overall Study||4
310439|NCT00731822|748931|P2|COMPLETED|Overall Study||39
310440|NCT00731822|748932|P1|COMPLETED|Overall Study||16
310441|NCT00731822|748931|P2|STARTED|Overall Study||40
310442|NCT00731822|748932|P1|STARTED|Overall Study||20
310443|NCT00731783|748946|P2|NOT COMPLETED|12 Month Follow-Up Visit||7
310444|NCT00731783|748947|P1|NOT COMPLETED|12 Month Follow-Up Visit||6
310445|NCT00731783|748946|P2|COMPLETED|12 Month Follow-Up Visit||58
310446|NCT00731783|748947|P1|COMPLETED|12 Month Follow-Up Visit||68
310447|NCT00731783|748946|P2|STARTED|12 Month Follow-Up Visit||65
310448|NCT00731783|748947|P1|STARTED|12 Month Follow-Up Visit||74
310449|NCT00731783|748946|P2|NOT COMPLETED|Six Month Follow-Up Visit||3
310450|NCT00731783|748947|P1|NOT COMPLETED|Six Month Follow-Up Visit||6
310451|NCT00731783|748946|P2|COMPLETED|Six Month Follow-Up Visit||64
310452|NCT00731783|748947|P1|COMPLETED|Six Month Follow-Up Visit||71
310453|NCT00731783|748946|P2|STARTED|Six Month Follow-Up Visit||67
310454|NCT00731783|748947|P1|STARTED|Six Month Follow-Up Visit||77
310455|NCT00731783|748946|P2|NOT COMPLETED|Three Month Follow-Up Visit||16
310456|NCT00731783|748947|P1|NOT COMPLETED|Three Month Follow-Up Visit||7
310457|NCT00731783|748946|P2|COMPLETED|Three Month Follow-Up Visit||57
310458|NCT00731783|748947|P1|COMPLETED|Three Month Follow-Up Visit||72
310459|NCT00731783|748946|P2|STARTED|Three Month Follow-Up Visit||73
310460|NCT00731783|748947|P1|STARTED|Three Month Follow-Up Visit||79
310461|NCT00731783|748946|P2|NOT COMPLETED|One Month Follow-Up Visit||22
310462|NCT00731783|748947|P1|NOT COMPLETED|One Month Follow-Up Visit||14
310463|NCT00731783|748946|P2|COMPLETED|One Month Follow-Up Visit||69
310464|NCT00731783|748947|P1|COMPLETED|One Month Follow-Up Visit||78
310465|NCT00731783|748946|P2|STARTED|One Month Follow-Up Visit||91
310466|NCT00731783|748947|P1|STARTED|One Month Follow-Up Visit||92
310467|NCT00731770|748969|P2|NOT COMPLETED|Overall Study||0
310468|NCT00731770|748970|P1|NOT COMPLETED|Overall Study||0
310469|NCT00731770|748969|P2|COMPLETED|Overall Study||5
310470|NCT00731770|748970|P1|COMPLETED|Overall Study||5
310471|NCT00731770|748969|P2|STARTED|Overall Study||5
310472|NCT00731770|748970|P1|STARTED|Overall Study||5
310473|NCT00731731|748981|P3|NOT COMPLETED|Overall Study||3
310474|NCT00731731|748982|P2|NOT COMPLETED|Overall Study||0
310475|NCT00731731|748983|P1|NOT COMPLETED|Overall Study||0
310476|NCT00731731|748981|P3|COMPLETED|Overall Study||107
310477|NCT00731731|748982|P2|COMPLETED|Overall Study||3
310478|NCT00731731|748983|P1|COMPLETED|Overall Study||12
310479|NCT00731731|748981|P3|STARTED|Overall Study||110
310480|NCT00731731|748982|P2|STARTED|Overall Study||3
310481|NCT00731731|748983|P1|STARTED|Overall Study||12
310482|NCT00731692|749001|P3|NOT COMPLETED|Extension Phase||301
310483|NCT00731692|749002|P2|NOT COMPLETED|Extension Phase||196
310484|NCT00731692|749003|P1|NOT COMPLETED|Extension Phase||74
310485|NCT00731692|749001|P3|COMPLETED|Extension Phase||0
310486|NCT00731692|749002|P2|COMPLETED|Extension Phase||0
310487|NCT00731692|749003|P1|COMPLETED|Extension Phase||0
310488|NCT00731692|749001|P3|STARTED|Extension Phase||301
310489|NCT00731692|749002|P2|STARTED|Extension Phase||196
310490|NCT00731692|749003|P1|STARTED|Extension Phase||74
310491|NCT00731692|749001|P3|NOT COMPLETED|Core Study (36 Months)||170
310492|NCT00731692|749002|P2|NOT COMPLETED|Core Study (36 Months)||116
310493|NCT00731692|749003|P1|NOT COMPLETED|Core Study (36 Months)||68
310494|NCT00731692|749001|P3|COMPLETED|Core Study (36 Months)||317
310495|NCT00731692|749002|P2|COMPLETED|Core Study (36 Months)||220
310496|NCT00731692|749003|P1|COMPLETED|Core Study (36 Months)||79
310497|NCT00731692|749001|P3|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
310498|NCT00731692|749002|P2|Post Protocol Amendment 5 Switch|Core Study (36 Months)|post protocol amendment 121 patients switch to 0.5 mg dose from 125mg dose|121
310499|NCT00731692|749003|P1|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
310500|NCT00731692|749001|P3|Pharmacokinetic Analysis Set|Core Study (36 Months)||0
310501|NCT00731692|749002|P2|Pharmacokinetic Analysis Set|Core Study (36 Months)||249
310502|NCT00731692|749003|P1|Pharmacokinetic Analysis Set|Core Study (36 Months)||102
310503|NCT00731692|749001|P3|Full Analysis Set (FAS)|Core Study (36 Months)||487
310504|NCT00731692|749002|P2|Full Analysis Set (FAS)|Core Study (36 Months)||336
310505|NCT00731692|749003|P1|Full Analysis Set (FAS)|Core Study (36 Months)||0
310506|NCT00731692|749001|P3|Safety Set (SAF)|Core Study (36 Months)||487
310507|NCT00731692|749002|P2|Safety Set (SAF)|Core Study (36 Months)||336
310508|NCT00731692|749003|P1|Safety Set (SAF)|Core Study (36 Months)||0
310509|NCT00731692|749001|P3|STARTED|Core Study (36 Months)||487
310510|NCT00731692|749002|P2|STARTED|Core Study (36 Months)||336
310511|NCT00731692|749003|P1|STARTED|Core Study (36 Months)||147
310512|NCT00731679|749049|P2|NOT COMPLETED|Overall Study||26
310513|NCT00731679|749050|P1|NOT COMPLETED|Overall Study||22
310514|NCT00731679|749049|P2|COMPLETED|Overall Study||283
310515|NCT00731679|749050|P1|COMPLETED|Overall Study||292
310516|NCT00731679|749049|P2|STARTED|Overall Study||309
310517|NCT00731679|749050|P1|STARTED|Overall Study||314
310518|NCT00731666|749058|P1|NOT COMPLETED|Overall Study||12
310519|NCT00731666|749058|P1|COMPLETED|Overall Study||28
310520|NCT00731666|749058|P1|STARTED|Overall Study||40
310521|NCT00731653|749064|P1|NOT COMPLETED|Overall Study||9
310522|NCT00731653|749064|P1|COMPLETED|Overall Study||72
310523|NCT00731653|749064|P1|STARTED|Overall Study||81
310524|NCT00731640|749070|P2|NOT COMPLETED|Overall Study||0
310525|NCT00731640|749071|P1|NOT COMPLETED|Overall Study||0
310526|NCT00731640|749070|P2|COMPLETED|Overall Study||32
310527|NCT00731640|749071|P1|COMPLETED|Overall Study||20
310528|NCT00731640|749070|P2|STARTED|Overall Study||32
310529|NCT00731640|749071|P1|STARTED|Overall Study||20
310530|NCT00731614|749085|P2|NOT COMPLETED|Overall Study||13
310531|NCT00731614|749086|P1|NOT COMPLETED|Overall Study||7
310532|NCT00731614|749085|P2|COMPLETED|Overall Study||18
310533|NCT00731614|749086|P1|COMPLETED|Overall Study||16
310534|NCT00731614|749085|P2|12 Weeks Posttreatment|Overall Study||23
310535|NCT00731614|749086|P1|12 Weeks Posttreatment|Overall Study||18
310536|NCT00731614|749085|P2|End of Treatment|Overall Study||24
310537|NCT00731614|749086|P1|End of Treatment|Overall Study||16
310538|NCT00731614|749085|P2|STARTED|Overall Study||31
310539|NCT00731614|749086|P1|STARTED|Overall Study||23
310540|NCT00731549|749094|P1|NOT COMPLETED|Overall Study||223
310541|NCT00731549|749094|P1|COMPLETED|Overall Study||858
310542|NCT00731549|749094|P1|STARTED|Overall Study||1081
310543|NCT00731484|749107|P1|NOT COMPLETED|Overall Study||0
310544|NCT00731484|749107|P1|COMPLETED|Overall Study||233
310545|NCT00731484|749107|P1|STARTED|Overall Study||233
310546|NCT00731341|749111|P1|NOT COMPLETED|Overall Study||0
310547|NCT00731341|749111|P1|COMPLETED|Overall Study||3
310548|NCT00731341|749111|P1|STARTED|Overall Study||3
310549|NCT00731211|749120|P1|NOT COMPLETED|Overall Study||0
310550|NCT00731211|749120|P1|COMPLETED|Overall Study||55
310551|NCT00731211|749120|P1|STARTED|Overall Study|2 patients ineligible (papillary histologic type-1 pt. Previous treatment with everolimus alone-1 pt|55
310552|NCT00731198|749127|P2|NOT COMPLETED|Overall Study||6
310553|NCT00731198|749128|P1|NOT COMPLETED|Overall Study||6
310554|NCT00731198|749127|P2|COMPLETED|Overall Study||319
310555|NCT00731198|749128|P1|COMPLETED|Overall Study||319
310556|NCT00731198|749127|P2|STARTED|Overall Study||325
310557|NCT00731198|749128|P1|STARTED|Overall Study||325
310558|NCT00731133|749134|P1|NOT COMPLETED|Overall Study||10
310559|NCT00731133|749134|P1|COMPLETED|Overall Study||5
310560|NCT00731133|749134|P1|STARTED|Overall Study||15
310561|NCT00731120|749142|P3|NOT COMPLETED|Overall Study||36
310562|NCT00731120|749143|P2|NOT COMPLETED|Overall Study||43
310563|NCT00731120|749144|P1|NOT COMPLETED|Overall Study||42
310564|NCT00731120|749142|P3|COMPLETED|Overall Study||116
310565|NCT00731120|749143|P2|COMPLETED|Overall Study||109
310566|NCT00731120|749144|P1|COMPLETED|Overall Study||111
310567|NCT00731120|749142|P3|Treated|Overall Study||152
310568|NCT00731120|749143|P2|Treated|Overall Study||151
310569|NCT00731120|749144|P1|Treated|Overall Study||153
310570|NCT00731120|749142|P3|STARTED|Overall Study||152
310571|NCT00731120|749143|P2|STARTED|Overall Study||152
310572|NCT00731120|749144|P1|STARTED|Overall Study||153
310573|NCT00731094|749181|P2|NOT COMPLETED|Overall Study||11
310574|NCT00731094|749182|P1|NOT COMPLETED|Overall Study||18
310575|NCT00731094|749181|P2|COMPLETED|Overall Study||105
310576|NCT00731094|749182|P1|COMPLETED|Overall Study||98
310577|NCT00731094|749181|P2|Month 6|Overall Study||107
310578|NCT00731094|749182|P1|Month 6|Overall Study||101
310579|NCT00731094|749181|P2|STARTED|Overall Study||116
310580|NCT00731094|749182|P1|STARTED|Overall Study||116
310581|NCT00731055|749252|P1|NOT COMPLETED|Overall Study||0
310582|NCT00731055|749252|P1|COMPLETED|Overall Study||16
310583|NCT00731055|749252|P1|Received Varenicline 2.0 mg|Overall Study||16
310584|NCT00731055|749252|P1|Received Varenicline 1.0 mg|Overall Study||16
310585|NCT00731055|749252|P1|Received Varenicline 0.5 mg|Overall Study||16
310586|NCT00731055|749252|P1|Received Placebo|Overall Study||16
310587|NCT00731055|749252|P1|STARTED|Overall Study|This is a within-subjects study design.|16
310588|NCT00731042|749261|P2|NOT COMPLETED|Second Intervention||2
310589|NCT00731042|749262|P1|NOT COMPLETED|Second Intervention||0
310590|NCT00731042|749261|P2|COMPLETED|Second Intervention|2 subjects did not met inclusion criteria for Period 2 Visual scoring skin condition|15
310591|NCT00731042|749262|P1|COMPLETED|Second Intervention||16
310592|NCT00731042|749261|P2|STARTED|Second Intervention||17
310593|NCT00731042|749262|P1|STARTED|Second Intervention||16
310594|NCT00731042|749261|P2|NOT COMPLETED|Wash-out||0
310595|NCT00731042|749262|P1|NOT COMPLETED|Wash-out||0
310596|NCT00731042|749261|P2|COMPLETED|Wash-out||17
310597|NCT00731042|749262|P1|COMPLETED|Wash-out||16
310598|NCT00731042|749261|P2|STARTED|Wash-out||17
310599|NCT00731042|749262|P1|STARTED|Wash-out||16
310600|NCT00731042|749261|P2|NOT COMPLETED|First Intervention||0
310601|NCT00731042|749262|P1|NOT COMPLETED|First Intervention||0
310602|NCT00731042|749261|P2|COMPLETED|First Intervention||17
310603|NCT00731042|749262|P1|COMPLETED|First Intervention||16
310604|NCT00731042|749261|P2|STARTED|First Intervention||17
310605|NCT00731042|749262|P1|STARTED|First Intervention||16
310606|NCT00730964|749268|P1|NOT COMPLETED|Overall Study||0
310607|NCT00730964|749268|P1|COMPLETED|Overall Study||1039
310608|NCT00730964|749268|P1|STARTED|Overall Study||1039
310609|NCT00730925|749273|P1|NOT COMPLETED|Overall Study||41
310610|NCT00730925|749273|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date|0
310611|NCT00730925|749273|P1|STARTED|Overall Study||41
310612|NCT00730912|749283|P3|NOT COMPLETED|Overall Study||1
310613|NCT00730912|749284|P2|NOT COMPLETED|Overall Study||0
310614|NCT00730912|749285|P1|NOT COMPLETED|Overall Study||0
310615|NCT00730912|749283|P3|COMPLETED|Overall Study||103
310616|NCT00730912|749284|P2|COMPLETED|Overall Study||104
310617|NCT00730912|749285|P1|COMPLETED|Overall Study||53
310618|NCT00730912|749283|P3|STARTED|Overall Study||104
310619|NCT00730912|749284|P2|STARTED|Overall Study||104
310620|NCT00730912|749285|P1|STARTED|Overall Study||53
310621|NCT00730886|749298|P2|NOT COMPLETED|Overall Study||0
310622|NCT00730886|749299|P1|NOT COMPLETED|Overall Study||2
310623|NCT00730886|749298|P2|COMPLETED|Overall Study|no subjects enrolled in this arm. Study enrollment terminated early.|0
310624|NCT00730886|749299|P1|COMPLETED|Overall Study||0
310625|NCT00730886|749298|P2|STARTED|Overall Study|no subjects enrolled in this arm. Study enrollment terminated early.|0
310626|NCT00730886|749299|P1|STARTED|Overall Study||2
310627|NCT00730847|749323|P1|NOT COMPLETED|Overall Study||131
310628|NCT00730847|749323|P1|COMPLETED|Overall Study||465
310629|NCT00730847|749323|P1|STARTED|Overall Study||596
310630|NCT00730756|749332|P2|NOT COMPLETED|Overall Study||5
310631|NCT00730756|749333|P1|NOT COMPLETED|Overall Study||4
310632|NCT00730756|749332|P2|COMPLETED|Overall Study||48
310633|NCT00730756|749333|P1|COMPLETED|Overall Study||45
310634|NCT00730756|749332|P2|STARTED|Overall Study||53
310635|NCT00730756|749333|P1|STARTED|Overall Study||49
310636|NCT00730730|749355|P1|NOT COMPLETED|Overall Study||0
310637|NCT00730730|749355|P1|COMPLETED|Overall Study||50
310638|NCT00730730|749355|P1|STARTED|Overall Study||50
310639|NCT00730691|749367|P5|NOT COMPLETED|Overall Study||50
310640|NCT00730691|749368|P4|NOT COMPLETED|Overall Study||45
310641|NCT00730691|749369|P3|NOT COMPLETED|Overall Study||39
310642|NCT00730691|749370|P2|NOT COMPLETED|Overall Study||36
310643|NCT00730691|749371|P1|NOT COMPLETED|Overall Study||36
310644|NCT00730691|749367|P5|COMPLETED|Overall Study||106
310645|NCT00730691|749368|P4|COMPLETED|Overall Study||111
310646|NCT00730691|749369|P3|COMPLETED|Overall Study||117
310647|NCT00730691|749370|P2|COMPLETED|Overall Study||120
310648|NCT00730691|749371|P1|COMPLETED|Overall Study||121
310649|NCT00730691|749367|P5|STARTED|Overall Study||156
310650|NCT00730691|749368|P4|STARTED|Overall Study||156
310651|NCT00730691|749369|P3|STARTED|Overall Study|One participant was randomized by error. Reason not completed is reported as Other.|156
310652|NCT00730691|749370|P2|STARTED|Overall Study||156
310653|NCT00730691|749371|P1|STARTED|Overall Study||157
310654|NCT00730639|749463|P5|NOT COMPLETED|Overall Study||131
310655|NCT00730639|749464|P4|NOT COMPLETED|Overall Study||54
310656|NCT00730639|749465|P3|NOT COMPLETED|Overall Study||86
310657|NCT00730639|749466|P2|NOT COMPLETED|Overall Study||18
310658|NCT00730639|749467|P1|NOT COMPLETED|Overall Study||17
310659|NCT00730639|749463|P5|COMPLETED|Overall Study||0
310660|NCT00730639|749464|P4|COMPLETED|Overall Study||0
310661|NCT00730639|749465|P3|COMPLETED|Overall Study||0
310662|NCT00730639|749466|P2|COMPLETED|Overall Study||0
310663|NCT00730639|749467|P1|COMPLETED|Overall Study||0
310664|NCT00730639|749463|P5|STARTED|Overall Study||131
310665|NCT00730639|749464|P4|STARTED|Overall Study||54
310666|NCT00730639|749465|P3|STARTED|Overall Study||86
310667|NCT00730639|749466|P2|STARTED|Overall Study||18
310668|NCT00730639|749467|P1|STARTED|Overall Study||17
310669|NCT00730483|749531|P1|NOT COMPLETED|Overall Study||7
310670|NCT00730483|749531|P1|COMPLETED|Overall Study||6
310671|NCT00730483|749531|P1|6 Months After First DEB-TACE|Overall Study||10
310672|NCT00730483|749531|P1|1 Month After First DEB-TACE|Overall Study||13
310673|NCT00730483|749531|P1|STARTED|Overall Study||13
310674|NCT00730405|749544|P5|NOT COMPLETED|Overall Study-follow-up Phase||22
310675|NCT00730405|749545|P4|NOT COMPLETED|Overall Study-follow-up Phase||17
310676|NCT00730405|749546|P3|NOT COMPLETED|Overall Study-follow-up Phase||23
310677|NCT00730405|749547|P2|NOT COMPLETED|Overall Study-follow-up Phase||21
310678|NCT00730405|749548|P1|NOT COMPLETED|Overall Study-follow-up Phase||21
310679|NCT00730405|749544|P5|COMPLETED|Overall Study-follow-up Phase||93
310680|NCT00730405|749545|P4|COMPLETED|Overall Study-follow-up Phase||100
310681|NCT00730405|749546|P3|COMPLETED|Overall Study-follow-up Phase||94
310682|NCT00730405|749547|P2|COMPLETED|Overall Study-follow-up Phase||96
310683|NCT00730405|749548|P1|COMPLETED|Overall Study-follow-up Phase||95
310684|NCT00730405|749544|P5|STARTED|Overall Study-follow-up Phase||115
310685|NCT00730405|749545|P4|STARTED|Overall Study-follow-up Phase||117
310686|NCT00730405|749546|P3|STARTED|Overall Study-follow-up Phase||117
310687|NCT00730405|749547|P2|STARTED|Overall Study-follow-up Phase||117
310688|NCT00730405|749548|P1|STARTED|Overall Study-follow-up Phase||116
310689|NCT00730405|749544|P5|NOT COMPLETED|Overall Study-Treatment Phase||20
310690|NCT00730405|749545|P4|NOT COMPLETED|Overall Study-Treatment Phase||19
310691|NCT00730405|749546|P3|NOT COMPLETED|Overall Study-Treatment Phase||21
310692|NCT00730405|749547|P2|NOT COMPLETED|Overall Study-Treatment Phase||21
310693|NCT00730405|749548|P1|NOT COMPLETED|Overall Study-Treatment Phase||19
310694|NCT00730405|749544|P5|COMPLETED|Overall Study-Treatment Phase||95
310695|NCT00730405|749545|P4|COMPLETED|Overall Study-Treatment Phase||98
310696|NCT00730405|749546|P3|COMPLETED|Overall Study-Treatment Phase||96
310697|NCT00730405|749547|P2|COMPLETED|Overall Study-Treatment Phase||96
310698|NCT00730405|749548|P1|COMPLETED|Overall Study-Treatment Phase||97
310699|NCT00730405|749544|P5|STARTED|Overall Study-Treatment Phase||115
310700|NCT00730405|749545|P4|STARTED|Overall Study-Treatment Phase||117
310701|NCT00730405|749546|P3|STARTED|Overall Study-Treatment Phase||117
310702|NCT00730405|749547|P2|STARTED|Overall Study-Treatment Phase||117
310703|NCT00730405|749548|P1|STARTED|Overall Study-Treatment Phase||116
310704|NCT00730353|749585|P1|NOT COMPLETED|Overall Study||0
310705|NCT00730353|749585|P1|COMPLETED|Overall Study||28
310706|NCT00730353|749585|P1|STARTED|Overall Study||28
310707|NCT00730327|749595|P2|NOT COMPLETED|Overall Study||37
310708|NCT00730327|749596|P1|NOT COMPLETED|Overall Study||27
310709|NCT00730327|749595|P2|COMPLETED|Overall Study||93
310710|NCT00730327|749596|P1|COMPLETED|Overall Study|Completed defined as subjects who completed the Week 52 follow-up visit.|98
310711|NCT00730327|749595|P2|Completed Week 26|Overall Study||99
310712|NCT00730327|749596|P1|Completed Week 26|Overall Study|Week 26 was halfway through the study, at which point the BIB group had their balloon removed.|125
310713|NCT00730327|749595|P2|STARTED|Overall Study||130
310714|NCT00730327|749596|P1|STARTED|Overall Study|Started is defined as subjects that began treatment.|125
310715|NCT00730275|749621|P4|NOT COMPLETED|Overall Study||1
310716|NCT00730275|749622|P3|NOT COMPLETED|Overall Study||0
310717|NCT00730275|749623|P2|NOT COMPLETED|Overall Study||0
310718|NCT00730275|749624|P1|NOT COMPLETED|Overall Study||0
310719|NCT00730275|749621|P4|COMPLETED|Overall Study||8
310720|NCT00730275|749622|P3|COMPLETED|Overall Study||8
310721|NCT00730275|749623|P2|COMPLETED|Overall Study||9
310722|NCT00730275|749624|P1|COMPLETED|Overall Study||9
310723|NCT00730275|749621|P4|STARTED|Overall Study||9
310724|NCT00730275|749622|P3|STARTED|Overall Study||8
310725|NCT00730275|749623|P2|STARTED|Overall Study||9
310726|NCT00730275|749624|P1|STARTED|Overall Study||9
310727|NCT00730236|749650|P1|NOT COMPLETED|Overall Study||6
310728|NCT00730236|749650|P1|COMPLETED|Overall Study||23
310729|NCT00730236|749650|P1|STARTED|Overall Study||29
310730|NCT00730171|749665|P1|NOT COMPLETED|Overall Study||771
310731|NCT00730171|749665|P1|COMPLETED|Overall Study||954
310732|NCT00730171|749665|P1|IBS-C Safety Population|Overall Study||1119
310733|NCT00730171|749665|P1|CC Safety Population|Overall Study||607
310734|NCT00730171|749665|P1|STARTED|Overall Study||1725
310735|NCT00730158|749675|P2|NOT COMPLETED|Overall Study||1
310736|NCT00730158|749676|P1|NOT COMPLETED|Overall Study||1
310737|NCT00730158|749675|P2|COMPLETED|Overall Study||15
310738|NCT00730158|749676|P1|COMPLETED|Overall Study||16
310739|NCT00730158|749675|P2|STARTED|Overall Study||16
310740|NCT00730158|749676|P1|STARTED|Overall Study||17
310741|NCT00730132|749714|P1|NOT COMPLETED|Overall Study||155
310742|NCT00730132|749714|P1|COMPLETED|Overall Study||557
310743|NCT00730132|749714|P1|STARTED|Overall Study||712
310744|NCT00730041|749732|P2|NOT COMPLETED|Overall Study||2
310745|NCT00730041|749733|P1|NOT COMPLETED|Overall Study||0
310746|NCT00730041|749732|P2|COMPLETED|Overall Study|One subject did not return for the final PSG or final visit, and one missed only the final visit.|23
310747|NCT00730041|749733|P1|COMPLETED|Overall Study||26
310748|NCT00730041|749732|P2|STARTED|Overall Study|4/25 (16.0%) female, 21/25 (84.0%) male|25
310749|NCT00730041|749733|P1|STARTED|Overall Study|4/26 (15.4%) female, 22/26 (84.6%) male|26
310750|NCT00730028|749756|P5|NOT COMPLETED|Overall Study||82
310751|NCT00730028|749757|P4|NOT COMPLETED|Overall Study||56
310752|NCT00730028|749758|P3|NOT COMPLETED|Overall Study||45
310753|NCT00730028|749759|P2|NOT COMPLETED|Overall Study||66
310754|NCT00730028|749760|P1|NOT COMPLETED|Overall Study||60
310755|NCT00730028|749756|P5|COMPLETED|Overall Study||175
310756|NCT00730028|749757|P4|COMPLETED|Overall Study||207
310757|NCT00730028|749758|P3|COMPLETED|Overall Study||221
310758|NCT00730028|749759|P2|COMPLETED|Overall Study||194
310759|NCT00730028|749760|P1|COMPLETED|Overall Study||204
310760|NCT00730028|749756|P5|STARTED|Overall Study||257
310761|NCT00730028|749757|P4|STARTED|Overall Study||263
310762|NCT00730028|749758|P3|STARTED|Overall Study||266
310763|NCT00730028|749759|P2|STARTED|Overall Study||260
310764|NCT00730028|749760|P1|STARTED|Overall Study||264
310765|NCT00730015|749810|P3|NOT COMPLETED|Overall Study||32
310766|NCT00730015|749811|P2|NOT COMPLETED|Overall Study||40
310767|NCT00730015|749812|P1|NOT COMPLETED|Overall Study||31
310768|NCT00730015|749810|P3|COMPLETED|Overall Study||177
310769|NCT00730015|749811|P2|COMPLETED|Overall Study||177
310770|NCT00730015|749812|P1|COMPLETED|Overall Study||186
310771|NCT00730015|749810|P3|STARTED|Overall Study||209
310772|NCT00730015|749811|P2|STARTED|Overall Study||217
310773|NCT00730015|749812|P1|STARTED|Overall Study||217
310774|NCT00729937|749852|P6|NOT COMPLETED|Overall Study||37
310775|NCT00729937|749853|P5|NOT COMPLETED|Overall Study||28
310776|NCT00729937|749854|P4|NOT COMPLETED|Overall Study||34
310777|NCT00729937|749855|P3|NOT COMPLETED|Overall Study||29
310778|NCT00729937|749856|P2|NOT COMPLETED|Overall Study||88
310779|NCT00729937|749857|P1|NOT COMPLETED|Overall Study||74
310780|NCT00729937|749852|P6|COMPLETED|Overall Study||214
310781|NCT00729937|749853|P5|COMPLETED|Overall Study||221
310782|NCT00729937|749854|P4|COMPLETED|Overall Study||215
310783|NCT00729937|749855|P3|COMPLETED|Overall Study||222
310784|NCT00729937|749856|P2|COMPLETED|Overall Study||548
310785|NCT00729937|749857|P1|COMPLETED|Overall Study||555
310786|NCT00729937|749852|P6|STARTED|Overall Study||251
310787|NCT00729937|749853|P5|STARTED|Overall Study||249
310788|NCT00729937|749854|P4|STARTED|Overall Study||249
310789|NCT00729937|749855|P3|STARTED|Overall Study||251
310790|NCT00729937|749856|P2|STARTED|Overall Study||636
310791|NCT00729937|749857|P1|STARTED|Overall Study||629
310792|NCT00729924|750051|P1|NOT COMPLETED|Overall Study||0
310793|NCT00729924|750051|P1|COMPLETED|Overall Study||40
310794|NCT00729924|750051|P1|STARTED|Overall Study||40
310795|NCT00729859|750061|P3|NOT COMPLETED|Overall Study||0
310796|NCT00729859|750062|P2|NOT COMPLETED|Overall Study||2
310797|NCT00729859|750063|P1|NOT COMPLETED|Overall Study||0
310798|NCT00729859|750061|P3|COMPLETED|Overall Study||8
310799|NCT00729859|750062|P2|COMPLETED|Overall Study||6
310800|NCT00729859|750063|P1|COMPLETED|Overall Study||8
310801|NCT00729859|750061|P3|STARTED|Overall Study||8
310802|NCT00729859|750062|P2|STARTED|Overall Study||8
310803|NCT00729859|750063|P1|STARTED|Overall Study||8
310804|NCT00729846|750100|P2|NOT COMPLETED|Overall Study||0
310805|NCT00729846|750101|P1|NOT COMPLETED|Overall Study||0
310806|NCT00729846|750100|P2|COMPLETED|Overall Study||11
310807|NCT00729846|750101|P1|COMPLETED|Overall Study||11
310808|NCT00729846|750100|P2|STARTED|Overall Study||11
310809|NCT00729846|750101|P1|STARTED|Overall Study||11
310810|NCT00729833|750107|P4|NOT COMPLETED|Overall Study||6
310811|NCT00729833|750108|P3|NOT COMPLETED|Overall Study||12
310812|NCT00729833|750109|P2|NOT COMPLETED|Overall Study||7
310813|NCT00729833|750110|P1|NOT COMPLETED|Overall Study||20
310814|NCT00729833|750107|P4|COMPLETED|Overall Study||0
310815|NCT00729833|750108|P3|COMPLETED|Overall Study||0
310816|NCT00729833|750109|P2|COMPLETED|Overall Study||0
310817|NCT00729833|750110|P1|COMPLETED|Overall Study||0
310818|NCT00729833|750107|P4|STARTED|Overall Study||6
310819|NCT00729833|750108|P3|STARTED|Overall Study||12
310820|NCT00729833|750109|P2|STARTED|Overall Study||7
310821|NCT00729833|750110|P1|STARTED|Overall Study||20
310822|NCT00729807|750149|P1|NOT COMPLETED|Overall Study||0
310823|NCT00729807|750149|P1|COMPLETED|Overall Study||6
310824|NCT00729807|750149|P1|STARTED|Overall Study||6
310825|NCT00729781|750159|P1|NOT COMPLETED|Long-term Follow-up Study||0
310826|NCT00729781|750159|P1|COMPLETED|Long-term Follow-up Study|All subjects completed the original study, but 3 did not consent to enroll in the follow-up study.|42
310827|NCT00729781|750159|P1|STARTED|Long-term Follow-up Study|Enrollment in the long-term follow-up required contact and a new Informed Consent.|42
310828|NCT00729781|750159|P1|NOT COMPLETED|Original Study||0
310829|NCT00729781|750159|P1|COMPLETED|Original Study||45
310830|NCT00729781|750159|P1|STARTED|Original Study||45
310831|NCT00729690|750168|P3|NOT COMPLETED|Overall Study||2
310832|NCT00729690|750169|P2|NOT COMPLETED|Overall Study||2
310833|NCT00729690|750170|P1|NOT COMPLETED|Overall Study||0
310834|NCT00729690|750168|P3|COMPLETED|Overall Study||14
310835|NCT00729690|750169|P2|COMPLETED|Overall Study||14
310836|NCT00729690|750170|P1|COMPLETED|Overall Study||16
310837|NCT00729690|750168|P3|STARTED|Overall Study||16
310838|NCT00729690|750169|P2|STARTED|Overall Study||16
310839|NCT00729690|750170|P1|STARTED|Overall Study||16
310840|NCT00729677|750187|P1|NOT COMPLETED|Overall Study||0
310841|NCT00729677|750187|P1|COMPLETED|Overall Study||64
310842|NCT00729677|750187|P1|STARTED|Overall Study||64
310843|NCT00729651|750200|P2|NOT COMPLETED|Overall Study||18
310844|NCT00729651|750201|P1|NOT COMPLETED|Overall Study||19
310845|NCT00729651|750200|P2|COMPLETED|Overall Study||152
310846|NCT00729651|750201|P1|COMPLETED|Overall Study||154
310847|NCT00729651|750200|P2|STARTED|Overall Study||170
310848|NCT00729651|750201|P1|STARTED|Overall Study||173
310849|NCT00729612|750213|P1|NOT COMPLETED|Overall Study||10
310850|NCT00729612|750213|P1|COMPLETED|Overall Study||53
310851|NCT00729612|750213|P1|Died After Cycle 2 Before Response Eval|Overall Study||1
310852|NCT00729612|750213|P1|Received Cycle 2|Overall Study||54
310853|NCT00729612|750213|P1|Did Not Receive Cycle 2|Overall Study||7
310854|NCT00729612|750213|P1|Received Cycle 1|Overall Study||62
310855|NCT00729612|750213|P1|Died Before Cycle 1|Overall Study||1
310856|NCT00729612|750213|P1|STARTED|Overall Study||63
310857|NCT00729586|750222|P2|NOT COMPLETED|Overall Study||1
310858|NCT00729586|750223|P1|NOT COMPLETED|Overall Study||1
310859|NCT00729586|750222|P2|COMPLETED|Overall Study|Eligible and treated patients|21
310860|NCT00729586|750223|P1|COMPLETED|Overall Study|Eligible and treated patients|50
310861|NCT00729586|750222|P2|STARTED|Overall Study||22
310862|NCT00729586|750223|P1|STARTED|Overall Study||51
310863|NCT00729560|750236|P1|NOT COMPLETED|Overall Study||3
310864|NCT00729560|750236|P1|COMPLETED|Overall Study||5
310865|NCT00729560|750236|P1|STARTED|Overall Study|Arm assignment can not be determined as study was ended prior to unblinding and no key found.|8
310866|NCT00729521|750243|P3|NOT COMPLETED|Overall Study||0
310867|NCT00729521|750244|P2|NOT COMPLETED|Overall Study||0
310868|NCT00729521|750245|P1|NOT COMPLETED|Overall Study||0
310869|NCT00729521|750243|P3|COMPLETED|Overall Study|Average annual population over 65 years old.|7701
310870|NCT00729521|750244|P2|COMPLETED|Overall Study|Average annual population over 65 years old.|14842
310871|NCT00729521|750245|P1|COMPLETED|Overall Study|Average annual population over 65 years old.|12494
310872|NCT00729521|750243|P3|STARTED|Overall Study|5 communities in Facilitative System with average annual pop. of 7,701 residents over 65 years.|7701
310873|NCT00729521|750244|P2|STARTED|Overall Study|Five communities with average annual population of 14,842 residents over 65 years old.|14842
310874|NCT00729521|750245|P1|STARTED|Overall Study|10 communities in Control with average annual population of 12,494 residents over 65 years old.|12494
310875|NCT00729482|750253|P1|NOT COMPLETED|Overall Study||0
310876|NCT00729482|750253|P1|COMPLETED|Overall Study||54
310877|NCT00729482|750253|P1|STARTED|Overall Study||54
310878|NCT00729469|750262|P2|NOT COMPLETED|Overall Study||47
310879|NCT00729469|750263|P1|NOT COMPLETED|Overall Study||53
310880|NCT00729469|750262|P2|COMPLETED|Overall Study||416
310881|NCT00729469|750263|P1|COMPLETED|Overall Study||403
310882|NCT00729469|750262|P2|STARTED|Overall Study||463
310883|NCT00729469|750263|P1|STARTED|Overall Study||456
310884|NCT00729430|750301|P2|NOT COMPLETED|Overall Study||50
310885|NCT00729430|750302|P1|NOT COMPLETED|Overall Study||47
310886|NCT00729430|750301|P2|COMPLETED|Overall Study||128
310887|NCT00729430|750302|P1|COMPLETED|Overall Study||133
310888|NCT00729430|750301|P2|STARTED|Overall Study||178
310889|NCT00729430|750302|P1|STARTED|Overall Study||180
310890|NCT00729378|750316|P2|NOT COMPLETED|36-months||6
310891|NCT00729378|750317|P1|NOT COMPLETED|36-months||15
310892|NCT00729378|750316|P2|COMPLETED|36-months||95
310893|NCT00729378|750317|P1|COMPLETED|36-months||105
310894|NCT00729378|750316|P2|STARTED|36-months||101
310895|NCT00729378|750317|P1|STARTED|36-months||120
310896|NCT00729378|750316|P2|NOT COMPLETED|24-months||51
310897|NCT00729378|750317|P1|NOT COMPLETED|24-months||72
310898|NCT00729378|750316|P2|COMPLETED|24-months||101
310899|NCT00729378|750317|P1|COMPLETED|24-months||120
310900|NCT00729378|750316|P2|STARTED|24-months||152
310901|NCT00729378|750317|P1|STARTED|24-months||192
310902|NCT00729378|750316|P2|NOT COMPLETED|12-months||65
310903|NCT00729378|750317|P1|NOT COMPLETED|12-months||100
310904|NCT00729378|750316|P2|COMPLETED|12-months||152
310905|NCT00729378|750317|P1|COMPLETED|12-months||192
310906|NCT00729378|750316|P2|STARTED|12-months||217
310907|NCT00729378|750317|P1|STARTED|12-months||292
310908|NCT00729378|750316|P2|NOT COMPLETED|Baseline||92
310909|NCT00729378|750317|P1|NOT COMPLETED|Baseline||138
310910|NCT00729378|750316|P2|COMPLETED|Baseline||217
310911|NCT00729378|750317|P1|COMPLETED|Baseline||292
310912|NCT00729378|750316|P2|STARTED|Baseline||309
310913|NCT00729378|750317|P1|STARTED|Baseline||430
310914|NCT00729365|750516|P3|NOT COMPLETED|Overall Study||7
310915|NCT00729365|750517|P2|NOT COMPLETED|Overall Study||6
310916|NCT00729365|750518|P1|NOT COMPLETED|Overall Study||33
310917|NCT00729365|750516|P3|COMPLETED|Overall Study|Study terminated|0
310918|NCT00729365|750517|P2|COMPLETED|Overall Study|Study Terminated|0
310919|NCT00729365|750518|P1|COMPLETED|Overall Study|Study terminated|0
310920|NCT00729365|750516|P3|STARTED|Overall Study||7
310921|NCT00729365|750517|P2|STARTED|Overall Study||6
310922|NCT00729365|750518|P1|STARTED|Overall Study||33
310923|NCT00729326|750531|P2|NOT COMPLETED|Overall Study||9
310924|NCT00729326|750532|P1|NOT COMPLETED|Overall Study||10
310925|NCT00729326|750531|P2|COMPLETED|Overall Study||33
310926|NCT00729326|750532|P1|COMPLETED|Overall Study||31
310927|NCT00729326|750531|P2|STARTED|Overall Study||42
310928|NCT00729326|750532|P1|STARTED|Overall Study||41
310929|NCT00729248|750574|P1|NOT COMPLETED|Overall Study||2
310930|NCT00729248|750574|P1|COMPLETED|Overall Study||10
310931|NCT00729248|750574|P1|STARTED|Overall Study||12
310932|NCT00729183|750581|P2|NOT COMPLETED|Overall Study||15
310933|NCT00729183|750582|P1|NOT COMPLETED|Overall Study||25
310934|NCT00729183|750581|P2|COMPLETED|Overall Study|Completed 24 month visit|90
310935|NCT00729183|750582|P1|COMPLETED|Overall Study|Completed 24 month visit|84
310936|NCT00729183|750581|P2|STARTED|Overall Study||105
310937|NCT00729183|750582|P1|STARTED|Overall Study||109
310938|NCT00729157|750614|P1|NOT COMPLETED|Overall Study||1
310939|NCT00729157|750614|P1|COMPLETED|Overall Study||40
310940|NCT00729157|750614|P1|STARTED|Overall Study||41
310941|NCT00729053|750626|P4|NOT COMPLETED|Overall Study||0
310942|NCT00729053|750627|P3|NOT COMPLETED|Overall Study||0
310943|NCT00729053|750628|P2|NOT COMPLETED|Overall Study||0
310944|NCT00729053|750629|P1|NOT COMPLETED|Overall Study||0
310945|NCT00729053|750626|P4|COMPLETED|Overall Study||23
310946|NCT00729053|750627|P3|COMPLETED|Overall Study||23
310947|NCT00729053|750628|P2|COMPLETED|Overall Study||23
310948|NCT00729053|750629|P1|COMPLETED|Overall Study||23
310949|NCT00729053|750626|P4|STARTED|Overall Study||23
310950|NCT00729053|750627|P3|STARTED|Overall Study||23
310951|NCT00729053|750628|P2|STARTED|Overall Study||23
310952|NCT00729053|750629|P1|STARTED|Overall Study||23
310953|NCT00728988|750657|P2|NOT COMPLETED|Overall Study||88
310954|NCT00728988|750658|P1|NOT COMPLETED|Overall Study||93
310955|NCT00728988|750657|P2|COMPLETED|Overall Study||164
310956|NCT00728988|750658|P1|COMPLETED|Overall Study||154
310957|NCT00728988|750657|P2|Full Analysis Set|Overall Study||172
310958|NCT00728988|750658|P1|Full Analysis Set|Overall Study||163
310959|NCT00728988|750657|P2|Treated|Overall Study||250
310960|NCT00728988|750658|P1|Treated|Overall Study||245
310961|NCT00728988|750657|P2|STARTED|Overall Study||252
310962|NCT00728988|750658|P1|STARTED|Overall Study||247
310963|NCT00728962|750676|P1|NOT COMPLETED|Two Year Post Placement Follow-up||3
310964|NCT00728962|750676|P1|COMPLETED|Two Year Post Placement Follow-up||59
310965|NCT00728962|750676|P1|STARTED|Two Year Post Placement Follow-up||62
310966|NCT00728962|750676|P1|NOT COMPLETED|One Year Post Placement Follow-up||0
310967|NCT00728962|750676|P1|COMPLETED|One Year Post Placement Follow-up||62
310968|NCT00728962|750676|P1|STARTED|One Year Post Placement Follow-up||62
310969|NCT00728962|750676|P1|NOT COMPLETED|Permanent Prosthesis Placement||3
310970|NCT00728962|750676|P1|COMPLETED|Permanent Prosthesis Placement||62
310971|NCT00728962|750676|P1|STARTED|Permanent Prosthesis Placement||65
310972|NCT00728962|750676|P1|NOT COMPLETED|Implant Placement Surgery||10
310973|NCT00728962|750676|P1|COMPLETED|Implant Placement Surgery||65
310974|NCT00728962|750676|P1|STARTED|Implant Placement Surgery||75
310975|NCT00728949|750682|P2|NOT COMPLETED|Overall Study||4
310976|NCT00728949|750683|P1|NOT COMPLETED|Overall Study||11
310977|NCT00728949|750682|P2|COMPLETED|Overall Study||27
310978|NCT00728949|750683|P1|COMPLETED|Overall Study||51
310979|NCT00728949|750682|P2|STARTED|Overall Study||31
310980|NCT00728949|750683|P1|STARTED|Overall Study||62
310981|NCT00728936|750708|P7|NOT COMPLETED|Overall Study||0
310982|NCT00728936|750709|P6|NOT COMPLETED|Overall Study||1
310983|NCT00728936|750710|P5|NOT COMPLETED|Overall Study||0
310984|NCT00728936|750711|P4|NOT COMPLETED|Overall Study||0
310985|NCT00728936|750712|P3|NOT COMPLETED|Overall Study||0
310986|NCT00728936|750713|P2|NOT COMPLETED|Overall Study||0
310987|NCT00728936|750714|P1|NOT COMPLETED|Overall Study||0
310988|NCT00728936|750708|P7|COMPLETED|Overall Study||7
310989|NCT00728936|750709|P6|COMPLETED|Overall Study||7
310990|NCT00728936|750710|P5|COMPLETED|Overall Study||8
310991|NCT00728936|750711|P4|COMPLETED|Overall Study||8
310992|NCT00728936|750712|P3|COMPLETED|Overall Study||9
310993|NCT00728936|750713|P2|COMPLETED|Overall Study||8
310994|NCT00728936|750714|P1|COMPLETED|Overall Study||10
310995|NCT00728936|750708|P7|STARTED|Overall Study||7
310996|NCT00728936|750709|P6|STARTED|Overall Study||8
310997|NCT00728936|750710|P5|STARTED|Overall Study||8
310998|NCT00728936|750711|P4|STARTED|Overall Study||8
310999|NCT00728936|750712|P3|STARTED|Overall Study||9
311000|NCT00728936|750713|P2|STARTED|Overall Study||8
311001|NCT00728936|750714|P1|STARTED|Overall Study||10
311002|NCT00728923|750730|P1|NOT COMPLETED|Overall Study||0
311003|NCT00728923|750730|P1|COMPLETED|Overall Study||9
311004|NCT00728923|750730|P1|STARTED|Overall Study||9
311005|NCT00728910|750735|P1|NOT COMPLETED|Atorvastatin+ABT335+ER Niacin||0
311006|NCT00728910|750735|P1|COMPLETED|Atorvastatin+ABT335+ER Niacin||22
311007|NCT00728910|750735|P1|STARTED|Atorvastatin+ABT335+ER Niacin||22
311008|NCT00728910|750735|P1|NOT COMPLETED|Atorvastatin+ABT335||0
311009|NCT00728910|750735|P1|COMPLETED|Atorvastatin+ABT335||22
311010|NCT00728910|750735|P1|STARTED|Atorvastatin+ABT335||22
311011|NCT00728910|750735|P1|NOT COMPLETED|Atorvastatin||3
311012|NCT00728910|750735|P1|COMPLETED|Atorvastatin||22
311013|NCT00728910|750735|P1|STARTED|Atorvastatin||25
311014|NCT00728884|750747|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
311015|NCT00728884|750747|P1|COMPLETED|Two Year Post Placement Follow-up||145
311016|NCT00728884|750747|P1|STARTED|Two Year Post Placement Follow-up||145
311017|NCT00728884|750747|P1|NOT COMPLETED|One Year Post Placement Follow-up||4
311018|NCT00728884|750747|P1|COMPLETED|One Year Post Placement Follow-up||145
311019|NCT00728884|750747|P1|STARTED|One Year Post Placement Follow-up||149
311020|NCT00728884|750747|P1|NOT COMPLETED|Permanent Prosthesis Placement||13
311021|NCT00728884|750747|P1|COMPLETED|Permanent Prosthesis Placement||149
311022|NCT00728884|750747|P1|STARTED|Permanent Prosthesis Placement||162
311023|NCT00728884|750747|P1|NOT COMPLETED|Implant Placement Surgery||0
311024|NCT00728884|750747|P1|COMPLETED|Implant Placement Surgery||162
311025|NCT00728884|750747|P1|STARTED|Implant Placement Surgery||162
311026|NCT00728845|750753|P2|NOT COMPLETED|Overall Study||0
311027|NCT00728845|750754|P1|NOT COMPLETED|Overall Study||0
311028|NCT00728845|750753|P2|COMPLETED|Overall Study||0
311029|NCT00728845|750754|P1|COMPLETED|Overall Study||8
311030|NCT00728845|750753|P2|STARTED|Overall Study||0
311031|NCT00728845|750754|P1|STARTED|Overall Study||8
311032|NCT00728819|750770|P2|NOT COMPLETED|Overall Study||29
311033|NCT00728819|750771|P1|NOT COMPLETED|Overall Study||36
311034|NCT00728819|750770|P2|COMPLETED|Overall Study||139
311035|NCT00728819|750771|P1|COMPLETED|Overall Study||135
311036|NCT00728819|750770|P2|STARTED|Overall Study||168
311037|NCT00728819|750771|P1|STARTED|Overall Study||171
311038|NCT00728754|750783|P2|NOT COMPLETED|Two Year Post Placement Follow-up||0
311039|NCT00728754|750784|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
311040|NCT00728754|750783|P2|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 68|28
311041|NCT00728754|750784|P1|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 65|24
311042|NCT00728754|750783|P2|STARTED|Two Year Post Placement Follow-up|individual control implant units is 68|28
311043|NCT00728754|750784|P1|STARTED|Two Year Post Placement Follow-up|individual test implant units is 65|24
311044|NCT00728754|750783|P2|NOT COMPLETED|One Year Post Placement Follow-up||0
311045|NCT00728754|750784|P1|NOT COMPLETED|One Year Post Placement Follow-up||1
311046|NCT00728754|750783|P2|COMPLETED|One Year Post Placement Follow-up|individual control implant units completed= 68|28
311047|NCT00728754|750784|P1|COMPLETED|One Year Post Placement Follow-up|individual test implant units completing is 65|24
311048|NCT00728754|750783|P2|STARTED|One Year Post Placement Follow-up|individual control implant units is 68|28
311049|NCT00728754|750784|P1|STARTED|One Year Post Placement Follow-up|individual test implant units is 66|25
311050|NCT00728754|750783|P2|NOT COMPLETED|Permanent Prosthesis Placement||4
311051|NCT00728754|750784|P1|NOT COMPLETED|Permanent Prosthesis Placement||4
311052|NCT00728754|750783|P2|COMPLETED|Permanent Prosthesis Placement|Individual control implant units completed = 68|28
311053|NCT00728754|750784|P1|COMPLETED|Permanent Prosthesis Placement|Individual test implant units completed = 66|25
311054|NCT00728754|750783|P2|STARTED|Permanent Prosthesis Placement|Individual control implant units is 78|32
311055|NCT00728754|750784|P1|STARTED|Permanent Prosthesis Placement|Individual test implant units is 75|29
311056|NCT00728754|750783|P2|NOT COMPLETED|Implant Placement Surgery||0
311057|NCT00728754|750784|P1|NOT COMPLETED|Implant Placement Surgery||0
311058|NCT00728754|750783|P2|COMPLETED|Implant Placement Surgery|Individual control implant units completed = 78|32
311059|NCT00728754|750784|P1|COMPLETED|Implant Placement Surgery|Individual test implant units completed = 75|29
311060|NCT00728754|750783|P2|STARTED|Implant Placement Surgery|Individual control implant units is 78|32
311061|NCT00728754|750784|P1|STARTED|Implant Placement Surgery|Individual test implant units is 75|29
311062|NCT00728728|750792|P2|NOT COMPLETED|Overall Study||12
311063|NCT00728728|750793|P1|NOT COMPLETED|Overall Study||4
311064|NCT00728728|750792|P2|COMPLETED|Overall Study||34
311065|NCT00728728|750793|P1|COMPLETED|Overall Study||38
311066|NCT00728728|750792|P2|STARTED|Overall Study||46
311067|NCT00728728|750793|P1|STARTED|Overall Study||42
311068|NCT00728689|750813|P2|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
311069|NCT00728689|750814|P1|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
311070|NCT00728689|750813|P2|COMPLETED|Second Intervention (Days 11 - 13)||6
311071|NCT00728689|750814|P1|COMPLETED|Second Intervention (Days 11 - 13)||5
311072|NCT00728689|750813|P2|STARTED|Second Intervention (Days 11 - 13)||6
311073|NCT00728689|750814|P1|STARTED|Second Intervention (Days 11 - 13)||5
311074|NCT00728689|750813|P2|NOT COMPLETED|Washout Period (Days 4 - 10)||0
311075|NCT00728689|750814|P1|NOT COMPLETED|Washout Period (Days 4 - 10)||1
311076|NCT00728689|750813|P2|COMPLETED|Washout Period (Days 4 - 10)||6
311077|NCT00728689|750814|P1|COMPLETED|Washout Period (Days 4 - 10)|Death in family during the Washout period. Completed First Intervention period with ST-246 Form I.|5
311078|NCT00728689|750813|P2|STARTED|Washout Period (Days 4 - 10)||6
311079|NCT00728689|750814|P1|STARTED|Washout Period (Days 4 - 10)||6
311080|NCT00728689|750813|P2|NOT COMPLETED|First Intervention (Days 1 - 3)||0
311081|NCT00728689|750814|P1|NOT COMPLETED|First Intervention (Days 1 - 3)||0
311082|NCT00728689|750813|P2|COMPLETED|First Intervention (Days 1 - 3)||6
311083|NCT00728689|750814|P1|COMPLETED|First Intervention (Days 1 - 3)||6
311084|NCT00728689|750813|P2|STARTED|First Intervention (Days 1 - 3)||6
311085|NCT00728689|750814|P1|STARTED|First Intervention (Days 1 - 3)||6
311086|NCT00728507|750832|P2|NOT COMPLETED|Overall Study||8
311087|NCT00728507|750833|P1|NOT COMPLETED|Overall Study||2
311088|NCT00728507|750832|P2|COMPLETED|Overall Study||51
311089|NCT00728507|750833|P1|COMPLETED|Overall Study||60
311090|NCT00728507|750832|P2|STARTED|Overall Study||59
311091|NCT00728507|750833|P1|STARTED|Overall Study||62
311092|NCT00728494|750843|P2|NOT COMPLETED|Overall Study||7
311093|NCT00728494|750844|P1|NOT COMPLETED|Overall Study||9
311094|NCT00728494|750843|P2|COMPLETED|Overall Study||32
311095|NCT00728494|750844|P1|COMPLETED|Overall Study||51
311096|NCT00728494|750843|P2|STARTED|Overall Study||39
311097|NCT00728494|750844|P1|STARTED|Overall Study||60
311098|NCT00728481|750862|P2|NOT COMPLETED|Overall Study||4
311099|NCT00728481|750863|P1|NOT COMPLETED|Overall Study||1
311100|NCT00728481|750862|P2|COMPLETED|Overall Study||28
311101|NCT00728481|750863|P1|COMPLETED|Overall Study||18
311102|NCT00728481|750862|P2|STARTED|Overall Study||32
311103|NCT00728481|750863|P1|STARTED|Overall Study||19
311104|NCT00728468|750879|P1|NOT COMPLETED|Overall Study||16
311105|NCT00728468|750879|P1|COMPLETED|Overall Study||0
311106|NCT00728468|750879|P1|Treated|Overall Study||15
311107|NCT00728468|750879|P1|STARTED|Overall Study||16
311108|NCT00728416|750903|P2|NOT COMPLETED|Overall Study||2
311109|NCT00728416|750904|P1|NOT COMPLETED|Overall Study||2
311110|NCT00728416|750903|P2|COMPLETED|Overall Study||163
311111|NCT00728416|750904|P1|COMPLETED|Overall Study||166
311112|NCT00728416|750903|P2|STARTED|Overall Study||165
311113|NCT00728416|750904|P1|STARTED|Overall Study||168
311114|NCT00728260|750912|P1|NOT COMPLETED|Overall Study||0
311115|NCT00728260|750912|P1|COMPLETED|Overall Study||1421
311116|NCT00728260|750912|P1|STARTED|Overall Study||1421
311117|NCT00728182|750920|P2|NOT COMPLETED|Overall Study||3
311118|NCT00728182|750921|P1|NOT COMPLETED|Overall Study||3
311119|NCT00728182|750920|P2|COMPLETED|Overall Study||90
311120|NCT00728182|750921|P1|COMPLETED|Overall Study||89
311121|NCT00728182|750920|P2|STARTED|Overall Study||93
311122|NCT00728182|750921|P1|STARTED|Overall Study||92
311123|NCT00728130|750949|P1|NOT COMPLETED|Overall Study||3
311124|NCT00728130|750949|P1|COMPLETED|Overall Study||19
311125|NCT00728130|750949|P1|STARTED|Overall Study||22
311126|NCT00727961|750954|P1|NOT COMPLETED|Overall Study||37
311127|NCT00727961|750954|P1|COMPLETED|Overall Study||21
311128|NCT00727961|750954|P1|STARTED|Overall Study||58
311129|NCT00727909|750964|P4|NOT COMPLETED|Overall Study||5
311130|NCT00727909|750965|P3|NOT COMPLETED|Overall Study||9
311131|NCT00727909|750966|P2|NOT COMPLETED|Overall Study||11
311132|NCT00727909|750967|P1|NOT COMPLETED|Overall Study||5
311133|NCT00727909|750964|P4|COMPLETED|Overall Study||70
311134|NCT00727909|750965|P3|COMPLETED|Overall Study||58
311135|NCT00727909|750966|P2|COMPLETED|Overall Study||61
311136|NCT00727909|750967|P1|COMPLETED|Overall Study||60
311137|NCT00727909|750964|P4|STARTED|Overall Study||75
311138|NCT00727909|750965|P3|STARTED|Overall Study||67
311139|NCT00727909|750966|P2|STARTED|Overall Study||72
311140|NCT00727909|750967|P1|STARTED|Overall Study||65
311141|NCT00727857|750974|P3|NOT COMPLETED|Overall Study||68
311142|NCT00727857|750975|P2|NOT COMPLETED|Overall Study||64
311143|NCT00727857|750976|P1|NOT COMPLETED|Overall Study||44
311144|NCT00727857|750974|P3|COMPLETED|Overall Study||142
311145|NCT00727857|750975|P2|COMPLETED|Overall Study||125
311146|NCT00727857|750976|P1|COMPLETED|Overall Study||157
311147|NCT00727857|750974|P3|STARTED|Overall Study||210
311148|NCT00727857|750975|P2|STARTED|Overall Study||189
311149|NCT00727857|750976|P1|STARTED|Overall Study||201
311150|NCT00727844|751064|P4|NOT COMPLETED|Second Randomization||0
311151|NCT00727844|751065|P3|NOT COMPLETED|Second Randomization||0
311152|NCT00727844|751066|P2|NOT COMPLETED|Second Randomization||0
311153|NCT00727844|751067|P1|NOT COMPLETED|Second Randomization||0
311154|NCT00727844|751064|P4|COMPLETED|Second Randomization||16
311155|NCT00727844|751065|P3|COMPLETED|Second Randomization||17
311156|NCT00727844|751066|P2|COMPLETED|Second Randomization||0
311157|NCT00727844|751067|P1|COMPLETED|Second Randomization||0
311158|NCT00727844|751064|P4|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|16
311159|NCT00727844|751065|P3|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|17
311160|NCT00727844|751066|P2|STARTED|Second Randomization||0
311161|NCT00727844|751067|P1|STARTED|Second Randomization||0
311162|NCT00727844|751064|P4|NOT COMPLETED|Initial Randomization||0
311163|NCT00727844|751065|P3|NOT COMPLETED|Initial Randomization||0
311164|NCT00727844|751066|P2|NOT COMPLETED|Initial Randomization||0
311165|NCT00727844|751067|P1|NOT COMPLETED|Initial Randomization||2
311166|NCT00727844|751064|P4|COMPLETED|Initial Randomization||0
311167|NCT00727844|751065|P3|COMPLETED|Initial Randomization||0
311168|NCT00727844|751066|P2|COMPLETED|Initial Randomization||20
311169|NCT00727844|751067|P1|COMPLETED|Initial Randomization||19
311170|NCT00727844|751064|P4|Included in MITT Analysis|Initial Randomization||0
311171|NCT00727844|751065|P3|Included in MITT Analysis|Initial Randomization||0
311172|NCT00727844|751066|P2|Included in MITT Analysis|Initial Randomization||20
311173|NCT00727844|751067|P1|Included in MITT Analysis|Initial Randomization||19
311174|NCT00727844|751064|P4|STARTED|Initial Randomization||0
311175|NCT00727844|751065|P3|STARTED|Initial Randomization||0
311176|NCT00727844|751066|P2|STARTED|Initial Randomization||20
311177|NCT00727844|751067|P1|STARTED|Initial Randomization|2 patients withdrawn before receiving any linezolid owing to baseline neuropathy|21
311178|NCT00727740|751074|P2|NOT COMPLETED|Overall Study||0
311179|NCT00727740|751075|P1|NOT COMPLETED|Overall Study||0
311180|NCT00727740|751074|P2|COMPLETED|Overall Study||61
311181|NCT00727740|751075|P1|COMPLETED|Overall Study||56
311182|NCT00727740|751074|P2|STARTED|Overall Study||61
311183|NCT00727740|751075|P1|STARTED|Overall Study||56
311184|NCT00727714|751081|P1|NOT COMPLETED|Overall Study||2
311185|NCT00727714|751081|P1|COMPLETED|Overall Study||93
311186|NCT00727714|751081|P1|STARTED|Overall Study||95
311187|NCT00727649|751091|P2|NOT COMPLETED|Second Intervention (4-weeks)||3
311188|NCT00727649|751092|P1|NOT COMPLETED|Second Intervention (4-weeks)||1
311189|NCT00727649|751091|P2|COMPLETED|Second Intervention (4-weeks)||34
311190|NCT00727649|751092|P1|COMPLETED|Second Intervention (4-weeks)||29
311191|NCT00727649|751091|P2|STARTED|Second Intervention (4-weeks)||37
311192|NCT00727649|751092|P1|STARTED|Second Intervention (4-weeks)||30
311193|NCT00727649|751091|P2|NOT COMPLETED|Wash-out (2-weeks)||3
311194|NCT00727649|751092|P1|NOT COMPLETED|Wash-out (2-weeks)||4
311195|NCT00727649|751091|P2|COMPLETED|Wash-out (2-weeks)||37
311196|NCT00727649|751092|P1|COMPLETED|Wash-out (2-weeks)||30
311197|NCT00727649|751091|P2|STARTED|Wash-out (2-weeks)||40
311198|NCT00727649|751092|P1|STARTED|Wash-out (2-weeks)||34
311199|NCT00727649|751091|P2|NOT COMPLETED|First Intervention (4-weeks)||3
311200|NCT00727649|751092|P1|NOT COMPLETED|First Intervention (4-weeks)||3
311201|NCT00727649|751091|P2|COMPLETED|First Intervention (4-weeks)||40
311202|NCT00727649|751092|P1|COMPLETED|First Intervention (4-weeks)||34
311203|NCT00727649|751091|P2|STARTED|First Intervention (4-weeks)||43
311204|NCT00727649|751092|P1|STARTED|First Intervention (4-weeks)||37
311205|NCT00727636|751106|P2|NOT COMPLETED|Overall Study||0
311206|NCT00727636|751107|P1|NOT COMPLETED|Overall Study||4
311207|NCT00727636|751106|P2|COMPLETED|Overall Study||15
311208|NCT00727636|751107|P1|COMPLETED|Overall Study||33
311209|NCT00727636|751106|P2|STARTED|Overall Study||15
311210|NCT00727636|751107|P1|STARTED|Overall Study||37
311211|NCT00727597|751121|P2|NOT COMPLETED|Overall Study||0
311212|NCT00727597|751122|P1|NOT COMPLETED|Overall Study||0
311213|NCT00727597|751121|P2|COMPLETED|Overall Study||50
311214|NCT00727597|751122|P1|COMPLETED|Overall Study||51
311215|NCT00727597|751121|P2|STARTED|Overall Study||50
311216|NCT00727597|751122|P1|STARTED|Overall Study||51
311217|NCT00727571|751134|P4|NOT COMPLETED|Overall Study||6
311218|NCT00727571|751135|P3|NOT COMPLETED|Overall Study||30
311219|NCT00727571|751136|P2|NOT COMPLETED|Overall Study||55
311220|NCT00727571|751137|P1|NOT COMPLETED|Overall Study||1
311221|NCT00727571|751134|P4|COMPLETED|Overall Study||163
311222|NCT00727571|751135|P3|COMPLETED|Overall Study||135
311223|NCT00727571|751136|P2|COMPLETED|Overall Study||173
311224|NCT00727571|751137|P1|COMPLETED|Overall Study||231
311225|NCT00727571|751134|P4|STARTED|Overall Study||169
311226|NCT00727571|751135|P3|STARTED|Overall Study||165
311227|NCT00727571|751136|P2|STARTED|Overall Study||228
311228|NCT00727571|751137|P1|STARTED|Overall Study||232
311229|NCT00727558|751164|P2|NOT COMPLETED|Overall Study||3
311230|NCT00727558|751165|P1|NOT COMPLETED|Overall Study||2
311231|NCT00727558|751164|P2|COMPLETED|Overall Study||118
311232|NCT00727558|751165|P1|COMPLETED|Overall Study||125
311233|NCT00727558|751164|P2|STARTED|Overall Study||121
311234|NCT00727558|751165|P1|STARTED|Overall Study||127
311235|NCT00727532|751183|P1|NOT COMPLETED|Overall Study||2
311236|NCT00727532|751183|P1|COMPLETED|Overall Study||7
311237|NCT00727532|751183|P1|STARTED|Overall Study||9
311238|NCT00727506|751195|P6|NOT COMPLETED|Overall Study||39
311239|NCT00727506|751196|P5|NOT COMPLETED|Overall Study||41
311240|NCT00727506|751197|P4|NOT COMPLETED|Overall Study||39
311241|NCT00727506|751198|P3|NOT COMPLETED|Overall Study||18
311242|NCT00727506|751199|P2|NOT COMPLETED|Overall Study||8
311243|NCT00727506|751200|P1|NOT COMPLETED|Overall Study||6
311244|NCT00727506|751195|P6|COMPLETED|Overall Study||0
311245|NCT00727506|751196|P5|COMPLETED|Overall Study||0
311246|NCT00727506|751197|P4|COMPLETED|Overall Study||0
311247|NCT00727506|751198|P3|COMPLETED|Overall Study||0
311248|NCT00727506|751199|P2|COMPLETED|Overall Study||0
311249|NCT00727506|751200|P1|COMPLETED|Overall Study||0
311250|NCT00727506|751195|P6|STARTED|Overall Study|Randomized|39
311251|NCT00727506|751196|P5|STARTED|Overall Study|Randomized|41
311252|NCT00727506|751197|P4|STARTED|Overall Study|Randomized|39
311253|NCT00727506|751198|P3|STARTED|Overall Study|Entered|18
311254|NCT00727506|751199|P2|STARTED|Overall Study|Entered|8
311255|NCT00727506|751200|P1|STARTED|Overall Study|Entered|6
311256|NCT00727441|751296|P3|NOT COMPLETED|Overall Study||25
311257|NCT00727441|751297|P2|NOT COMPLETED|Overall Study||22
311258|NCT00727441|751298|P1|NOT COMPLETED|Overall Study||18
311259|NCT00727441|751296|P3|COMPLETED|Overall Study||5
311260|NCT00727441|751297|P2|COMPLETED|Overall Study||6
311261|NCT00727441|751298|P1|COMPLETED|Overall Study||11
311262|NCT00727441|751296|P3|STARTED|Overall Study||30
311263|NCT00727441|751297|P2|STARTED|Overall Study||28
311264|NCT00727441|751298|P1|STARTED|Overall Study||29
311265|NCT00727415|751312|P1|NOT COMPLETED|Phase II||0
311266|NCT00727415|751312|P1|COMPLETED|Phase II||33
311267|NCT00727415|751312|P1|STARTED|Phase II||33
311268|NCT00727415|751312|P1|NOT COMPLETED|Phase I||2
311269|NCT00727415|751312|P1|COMPLETED|Phase I||7
311270|NCT00727415|751312|P1|STARTED|Phase I||9
311271|NCT00727402|751321|P1|NOT COMPLETED|Overall Study||116
311272|NCT00727402|751321|P1|COMPLETED|Overall Study||89
311273|NCT00727402|751321|P1|STARTED|Overall Study||205
311274|NCT00727337|751329|P4|NOT COMPLETED|Overall Study||9
311275|NCT00727337|751330|P3|NOT COMPLETED|Overall Study||10
311276|NCT00727337|751331|P2|NOT COMPLETED|Overall Study||10
311277|NCT00727337|751332|P1|NOT COMPLETED|Overall Study||7
311278|NCT00727337|751329|P4|COMPLETED|Overall Study||64
311279|NCT00727337|751330|P3|COMPLETED|Overall Study||63
311280|NCT00727337|751331|P2|COMPLETED|Overall Study||55
311281|NCT00727337|751332|P1|COMPLETED|Overall Study||61
311282|NCT00727337|751329|P4|STARTED|Overall Study||73
311283|NCT00727337|751330|P3|STARTED|Overall Study||73
311284|NCT00727337|751331|P2|STARTED|Overall Study||65
311285|NCT00727337|751332|P1|STARTED|Overall Study||68
311286|NCT00727311|751350|P1|NOT COMPLETED|Overall Study||1107
311287|NCT00727311|751350|P1|COMPLETED|Overall Study||1195
311288|NCT00727311|751350|P1|STARTED|Overall Study||2302
311289|NCT00727298|751357|P1|NOT COMPLETED|Overall Study||1257
311290|NCT00727298|751357|P1|COMPLETED|Overall Study||3228
311291|NCT00727298|751357|P1|STARTED|Overall Study||4485
311292|NCT00727272|751363|P3|NOT COMPLETED|Period III||0
311293|NCT00727272|751364|P2|NOT COMPLETED|Period III||0
311294|NCT00727272|751365|P1|NOT COMPLETED|Period III||0
311295|NCT00727272|751363|P3|COMPLETED|Period III||7
311296|NCT00727272|751364|P2|COMPLETED|Period III||9
311297|NCT00727272|751365|P1|COMPLETED|Period III||9
311298|NCT00727272|751363|P3|STARTED|Period III||7
311299|NCT00727272|751364|P2|STARTED|Period III||9
311300|NCT00727272|751365|P1|STARTED|Period III||9
311301|NCT00727272|751363|P3|NOT COMPLETED|Washout Period B||1
311302|NCT00727272|751364|P2|NOT COMPLETED|Washout Period B||0
311303|NCT00727272|751365|P1|NOT COMPLETED|Washout Period B||0
311304|NCT00727272|751363|P3|COMPLETED|Washout Period B|personal reasons|7
311305|NCT00727272|751364|P2|COMPLETED|Washout Period B||9
311306|NCT00727272|751365|P1|COMPLETED|Washout Period B||9
311307|NCT00727272|751363|P3|STARTED|Washout Period B||8
311308|NCT00727272|751364|P2|STARTED|Washout Period B||9
311309|NCT00727272|751365|P1|STARTED|Washout Period B||9
311310|NCT00727272|751363|P3|NOT COMPLETED|Period II||0
311311|NCT00727272|751364|P2|NOT COMPLETED|Period II||0
311312|NCT00727272|751365|P1|NOT COMPLETED|Period II||0
311313|NCT00727272|751363|P3|COMPLETED|Period II||8
311314|NCT00727272|751364|P2|COMPLETED|Period II||9
311315|NCT00727272|751365|P1|COMPLETED|Period II||9
311316|NCT00727272|751363|P3|STARTED|Period II||8
311317|NCT00727272|751364|P2|STARTED|Period II||9
311318|NCT00727272|751365|P1|STARTED|Period II||9
311319|NCT00727272|751363|P3|NOT COMPLETED|Washout Period A||1
311320|NCT00727272|751364|P2|NOT COMPLETED|Washout Period A||0
311321|NCT00727272|751365|P1|NOT COMPLETED|Washout Period A||0
311322|NCT00727272|751363|P3|COMPLETED|Washout Period A|positive pregnancy test - recorded as an adverse event|8
311323|NCT00727272|751364|P2|COMPLETED|Washout Period A||9
311324|NCT00727272|751365|P1|COMPLETED|Washout Period A||9
311325|NCT00727272|751363|P3|STARTED|Washout Period A||9
311326|NCT00727272|751364|P2|STARTED|Washout Period A||9
311327|NCT00727272|751365|P1|STARTED|Washout Period A||9
311328|NCT00727272|751363|P3|NOT COMPLETED|Period I||0
311329|NCT00727272|751364|P2|NOT COMPLETED|Period I||0
311330|NCT00727272|751365|P1|NOT COMPLETED|Period I||0
311331|NCT00727272|751363|P3|COMPLETED|Period I||9
311332|NCT00727272|751364|P2|COMPLETED|Period I||9
311333|NCT00727272|751365|P1|COMPLETED|Period I||9
311334|NCT00727272|751363|P3|STARTED|Period I||9
311335|NCT00727272|751364|P2|STARTED|Period I||9
311336|NCT00727272|751365|P1|STARTED|Period I||9
311337|NCT00727259|751382|P1|NOT COMPLETED|Overall Study||1055
311338|NCT00727259|751382|P1|COMPLETED|Overall Study||940
311339|NCT00727259|751382|P1|STARTED|Overall Study||1995
311340|NCT00727246|751391|P4|NOT COMPLETED|Overall Study||2
311341|NCT00727246|751392|P3|NOT COMPLETED|Overall Study||1
311342|NCT00727246|751393|P2|NOT COMPLETED|Overall Study||1
311343|NCT00727246|751394|P1|NOT COMPLETED|Overall Study||0
311344|NCT00727246|751391|P4|COMPLETED|Overall Study||3
311345|NCT00727246|751392|P3|COMPLETED|Overall Study||7
311346|NCT00727246|751393|P2|COMPLETED|Overall Study||2
311347|NCT00727246|751394|P1|COMPLETED|Overall Study||3
311348|NCT00727246|751391|P4|STARTED|Overall Study||5
311349|NCT00727246|751392|P3|STARTED|Overall Study||8
311350|NCT00727246|751393|P2|STARTED|Overall Study||3
311351|NCT00727246|751394|P1|STARTED|Overall Study||3
311352|NCT00727220|751410|P2|NOT COMPLETED|Overall Study||4
311353|NCT00727220|751411|P1|NOT COMPLETED|Overall Study||1
311354|NCT00727220|751410|P2|COMPLETED|Overall Study||17
311355|NCT00727220|751411|P1|COMPLETED|Overall Study||20
311356|NCT00727220|751410|P2|STARTED|Overall Study||21
311357|NCT00727220|751411|P1|STARTED|Overall Study||21
311358|NCT00727194|751417|P3|NOT COMPLETED|Treatment Period 2||0
311359|NCT00727194|751418|P2|NOT COMPLETED|Treatment Period 2||1
311360|NCT00727194|751419|P1|NOT COMPLETED|Treatment Period 2||0
311361|NCT00727194|751417|P3|COMPLETED|Treatment Period 2||0
311362|NCT00727194|751418|P2|COMPLETED|Treatment Period 2||5
311363|NCT00727194|751419|P1|COMPLETED|Treatment Period 2||6
311364|NCT00727194|751417|P3|STARTED|Treatment Period 2||0
311365|NCT00727194|751418|P2|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
311366|NCT00727194|751419|P1|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
311367|NCT00727194|751417|P3|NOT COMPLETED|Washout Period||0
311368|NCT00727194|751418|P2|NOT COMPLETED|Washout Period||0
311369|NCT00727194|751419|P1|NOT COMPLETED|Washout Period||0
311370|NCT00727194|751417|P3|COMPLETED|Washout Period||0
311371|NCT00727194|751418|P2|COMPLETED|Washout Period||7
311372|NCT00727194|751419|P1|COMPLETED|Washout Period||7
311373|NCT00727194|751417|P3|STARTED|Washout Period||0
311374|NCT00727194|751418|P2|STARTED|Washout Period||7
311375|NCT00727194|751419|P1|STARTED|Washout Period||7
311376|NCT00727194|751417|P3|NOT COMPLETED|Treatment Period 1||0
311377|NCT00727194|751418|P2|NOT COMPLETED|Treatment Period 1||0
311378|NCT00727194|751419|P1|NOT COMPLETED|Treatment Period 1||0
311379|NCT00727194|751417|P3|COMPLETED|Treatment Period 1||0
311380|NCT00727194|751418|P2|COMPLETED|Treatment Period 1||7
311381|NCT00727194|751419|P1|COMPLETED|Treatment Period 1||7
311382|NCT00727194|751417|P3|STARTED|Treatment Period 1||0
311383|NCT00727194|751418|P2|STARTED|Treatment Period 1||7
311384|NCT00727194|751419|P1|STARTED|Treatment Period 1||7
311385|NCT00727194|751417|P3|NOT COMPLETED|Screening Period||16
311386|NCT00727194|751418|P2|NOT COMPLETED|Screening Period||0
311387|NCT00727194|751419|P1|NOT COMPLETED|Screening Period||0
311388|NCT00727194|751417|P3|COMPLETED|Screening Period||0
311389|NCT00727194|751418|P2|COMPLETED|Screening Period||7
311390|NCT00727194|751419|P1|COMPLETED|Screening Period||7
311391|NCT00727194|751417|P3|STARTED|Screening Period||16
311392|NCT00727194|751418|P2|STARTED|Screening Period||7
311393|NCT00727194|751419|P1|STARTED|Screening Period||7
311394|NCT00727090|751455|P2|NOT COMPLETED|Overall Study||0
311395|NCT00727090|751456|P1|NOT COMPLETED|Overall Study||0
311396|NCT00727090|751455|P2|COMPLETED|Overall Study||3
311397|NCT00727090|751456|P1|COMPLETED|Overall Study||3
311398|NCT00727090|751455|P2|STARTED|Overall Study||3
311399|NCT00727090|751456|P1|STARTED|Overall Study||3
311400|NCT00727064|751474|P2|NOT COMPLETED|Overall Study||0
311401|NCT00727064|751475|P1|NOT COMPLETED|Overall Study||0
311402|NCT00727064|751474|P2|COMPLETED|Overall Study||7
311403|NCT00727064|751475|P1|COMPLETED|Overall Study||7
311404|NCT00727064|751474|P2|STARTED|Overall Study||7
311405|NCT00727064|751475|P1|STARTED|Overall Study||7
311406|NCT00727025|751491|P1|NOT COMPLETED|Overall Study||23
311407|NCT00727025|751491|P1|COMPLETED|Overall Study||51
311408|NCT00727025|751491|P1|STARTED|Overall Study||74
311409|NCT00726999|751503|P2|NOT COMPLETED|Overall Study||1
311410|NCT00726999|751504|P1|NOT COMPLETED|Overall Study||3
311411|NCT00726999|751503|P2|COMPLETED|Overall Study||30
311412|NCT00726999|751504|P1|COMPLETED|Overall Study||29
311413|NCT00726999|751503|P2|STARTED|Overall Study||31
311414|NCT00726999|751504|P1|STARTED|Overall Study||32
311415|NCT00726986|751516|P1|NOT COMPLETED|Maintenance Phase||3
311416|NCT00726986|751516|P1|COMPLETED|Maintenance Phase||0
311417|NCT00726986|751516|P1|STARTED|Maintenance Phase||3
311418|NCT00726986|751516|P1|NOT COMPLETED|Induction Phase||15
311419|NCT00726986|751516|P1|COMPLETED|Induction Phase||3
311420|NCT00726986|751516|P1|Maintance|Induction Phase||3
311421|NCT00726986|751516|P1|STARTED|Induction Phase||18
311422|NCT00726895|751523|P2|NOT COMPLETED|Second Intervention||0
311423|NCT00726895|751524|P1|NOT COMPLETED|Second Intervention||0
311424|NCT00726895|751523|P2|COMPLETED|Second Intervention||11
311425|NCT00726895|751524|P1|COMPLETED|Second Intervention||12
311426|NCT00726895|751523|P2|STARTED|Second Intervention||11
311427|NCT00726895|751524|P1|STARTED|Second Intervention||12
311428|NCT00726895|751523|P2|NOT COMPLETED|Washout Period of 7 Days||1
311429|NCT00726895|751524|P1|NOT COMPLETED|Washout Period of 7 Days||0
311430|NCT00726895|751523|P2|COMPLETED|Washout Period of 7 Days||11
311431|NCT00726895|751524|P1|COMPLETED|Washout Period of 7 Days||12
311432|NCT00726895|751523|P2|STARTED|Washout Period of 7 Days||12
311433|NCT00726895|751524|P1|STARTED|Washout Period of 7 Days||12
311434|NCT00726895|751523|P2|NOT COMPLETED|First Intervention||0
311435|NCT00726895|751524|P1|NOT COMPLETED|First Intervention||0
311436|NCT00726895|751523|P2|COMPLETED|First Intervention||12
311437|NCT00726895|751524|P1|COMPLETED|First Intervention||12
311438|NCT00726895|751523|P2|STARTED|First Intervention||12
311439|NCT00726895|751524|P1|STARTED|First Intervention||12
311440|NCT00726882|751537|P1|NOT COMPLETED|Overall Study||22
311441|NCT00726882|751537|P1|COMPLETED|Overall Study||13
311442|NCT00726882|751537|P1|Received ABT-333 in Study M10-351|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00696904/M10-351).|6
311443|NCT00726882|751537|P1|Received ABT-333 in Study M10-380|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00851890/M10-380).|22
311444|NCT00726882|751537|P1|STARTED|Overall Study||35
311445|NCT00726830|751545|P2|NOT COMPLETED|Overall Study||0
311446|NCT00726830|751546|P1|NOT COMPLETED|Overall Study||0
311447|NCT00726830|751545|P2|COMPLETED|Overall Study||0
311448|NCT00726830|751546|P1|COMPLETED|Overall Study||1
311449|NCT00726830|751545|P2|STARTED|Overall Study||0
311450|NCT00726830|751546|P1|STARTED|Overall Study||1
311451|NCT00726752|751552|P1|NOT COMPLETED|Overall Study||6
311452|NCT00726752|751552|P1|COMPLETED|Overall Study||0
311453|NCT00726752|751552|P1|STARTED|Overall Study||6
311454|NCT00726739|751568|P2|NOT COMPLETED|Overall Study||0
311455|NCT00726739|751569|P1|NOT COMPLETED|Overall Study||1
311456|NCT00726739|751568|P2|COMPLETED|Overall Study||10
311457|NCT00726739|751569|P1|COMPLETED|Overall Study|1 patient failed during screening due to brain metastasis.|10
311458|NCT00726739|751568|P2|STARTED|Overall Study||10
311459|NCT00726739|751569|P1|STARTED|Overall Study||11
311460|NCT00726713|751585|P2|NOT COMPLETED|Overall Study||7
311461|NCT00726713|751586|P1|NOT COMPLETED|Overall Study||7
311462|NCT00726713|751585|P2|COMPLETED|Overall Study||101
311463|NCT00726713|751586|P1|COMPLETED|Overall Study||99
311464|NCT00726713|751585|P2|STARTED|Overall Study||108
311465|NCT00726713|751586|P1|STARTED|Overall Study||106
311466|NCT00726661|751614|P2|NOT COMPLETED|Overall Study||418
311467|NCT00726661|751615|P1|NOT COMPLETED|Overall Study||814
311468|NCT00726661|751614|P2|COMPLETED|Overall Study||17
311469|NCT00726661|751615|P1|COMPLETED|Overall Study||18
311470|NCT00726661|751614|P2|STARTED|Overall Study||435
311471|NCT00726661|751615|P1|STARTED|Overall Study||832
311472|NCT00726622|751632|P2|NOT COMPLETED|Overall Study||3
311473|NCT00726622|751633|P1|NOT COMPLETED|Overall Study||18
311474|NCT00726622|751632|P2|COMPLETED|Overall Study||240
311475|NCT00726622|751633|P1|COMPLETED|Overall Study||225
311476|NCT00726622|751632|P2|STARTED|Overall Study||243
311477|NCT00726622|751633|P1|STARTED|Overall Study||243
311478|NCT00726609|751651|P1|NOT COMPLETED|Overall Study||98
311479|NCT00726609|751651|P1|COMPLETED|Overall Study|For 26 participants in the Missing category, it is unknown if they completed the study.|116
311480|NCT00726609|751651|P1|STARTED|Overall Study||214
311481|NCT00726557|751655|P1|NOT COMPLETED|Overall Study||128
311482|NCT00726557|751655|P1|COMPLETED|Overall Study|Completed is defined as those who finished the follow-up period.|118
311483|NCT00726557|751655|P1|STARTED|Overall Study||246
311484|NCT00726453|751662|P2|NOT COMPLETED|38 mm Length Group||3
311485|NCT00726453|751663|P1|NOT COMPLETED|38 mm Length Group||0
311486|NCT00726453|751662|P2|COMPLETED|38 mm Length Group|This sub-study completed the primary endpoint in March 2012 results not yet available.|111
311487|NCT00726453|751663|P1|COMPLETED|38 mm Length Group||0
311488|NCT00726453|751662|P2|STARTED|38 mm Length Group||114
311489|NCT00726453|751663|P1|STARTED|38 mm Length Group||0
311490|NCT00726453|751662|P2|NOT COMPLETED|Primary Enrollment Group||0
311491|NCT00726453|751663|P1|NOT COMPLETED|Primary Enrollment Group||31
311492|NCT00726453|751662|P2|COMPLETED|Primary Enrollment Group||0
311493|NCT00726453|751663|P1|COMPLETED|Primary Enrollment Group||1371
311494|NCT00726453|751662|P2|STARTED|Primary Enrollment Group||0
311495|NCT00726453|751663|P1|STARTED|Primary Enrollment Group||1402
311496|NCT00726414|751673|P2|NOT COMPLETED|Second Intervention||0
311497|NCT00726414|751674|P1|NOT COMPLETED|Second Intervention||0
311498|NCT00726414|751673|P2|COMPLETED|Second Intervention||11
311499|NCT00726414|751674|P1|COMPLETED|Second Intervention||11
311500|NCT00726414|751673|P2|STARTED|Second Intervention||11
311501|NCT00726414|751674|P1|STARTED|Second Intervention||11
311502|NCT00726414|751673|P2|NOT COMPLETED|Washout Period of 7 Days||0
311503|NCT00726414|751674|P1|NOT COMPLETED|Washout Period of 7 Days||0
311504|NCT00726414|751673|P2|COMPLETED|Washout Period of 7 Days||11
311505|NCT00726414|751674|P1|COMPLETED|Washout Period of 7 Days||11
311506|NCT00726414|751673|P2|STARTED|Washout Period of 7 Days||11
311507|NCT00726414|751674|P1|STARTED|Washout Period of 7 Days||11
311508|NCT00726414|751673|P2|NOT COMPLETED|First Intervention||0
311509|NCT00726414|751674|P1|NOT COMPLETED|First Intervention||0
311510|NCT00726414|751673|P2|COMPLETED|First Intervention||11
311511|NCT00726414|751674|P1|COMPLETED|First Intervention||11
311512|NCT00726414|751673|P2|STARTED|First Intervention||11
311513|NCT00726414|751674|P1|STARTED|First Intervention||11
311514|NCT00726375|751684|P1|NOT COMPLETED|Overall Study||0
311515|NCT00726375|751684|P1|COMPLETED|Overall Study||34
311516|NCT00726375|751684|P1|STARTED|Overall Study||34
311517|NCT00726323|751691|P2|NOT COMPLETED|Overall Study||31
311518|NCT00726323|751692|P1|NOT COMPLETED|Overall Study||37
311519|NCT00726323|751691|P2|COMPLETED|Overall Study||6
311520|NCT00726323|751692|P1|COMPLETED|Overall Study||0
311521|NCT00726323|751691|P2|STARTED|Overall Study||37
311522|NCT00726323|751692|P1|STARTED|Overall Study||37
311523|NCT00726232|751722|P8|NOT COMPLETED|Expansion Phase||38
311524|NCT00726232|751723|P7|NOT COMPLETED|Expansion Phase||24
311525|NCT00726232|751724|P6|NOT COMPLETED|Expansion Phase||0
311526|NCT00726232|751725|P5|NOT COMPLETED|Expansion Phase||0
311527|NCT00726232|751726|P4|NOT COMPLETED|Expansion Phase||0
311528|NCT00726232|751727|P3|NOT COMPLETED|Expansion Phase||0
311529|NCT00726232|751728|P2|NOT COMPLETED|Expansion Phase||0
311530|NCT00726232|751729|P1|NOT COMPLETED|Expansion Phase||0
311531|NCT00726232|751722|P8|COMPLETED|Expansion Phase||1
311532|NCT00726232|751723|P7|COMPLETED|Expansion Phase||10
311533|NCT00726232|751724|P6|COMPLETED|Expansion Phase||0
311534|NCT00726232|751725|P5|COMPLETED|Expansion Phase||0
311535|NCT00726232|751726|P4|COMPLETED|Expansion Phase||0
311536|NCT00726232|751727|P3|COMPLETED|Expansion Phase||0
311537|NCT00726232|751728|P2|COMPLETED|Expansion Phase||0
311538|NCT00726232|751729|P1|COMPLETED|Expansion Phase||0
311539|NCT00726232|751722|P8|ITT Participants|Expansion Phase||39
311540|NCT00726232|751723|P7|ITT Participants|Expansion Phase||34
311541|NCT00726232|751724|P6|ITT Participants|Expansion Phase||0
311542|NCT00726232|751725|P5|ITT Participants|Expansion Phase||0
311543|NCT00726232|751726|P4|ITT Participants|Expansion Phase||0
311544|NCT00726232|751727|P3|ITT Participants|Expansion Phase||0
311545|NCT00726232|751728|P2|ITT Participants|Expansion Phase||0
311546|NCT00726232|751729|P1|ITT Participants|Expansion Phase||0
311547|NCT00726232|751722|P8|Safety Evaluable Participants|Expansion Phase||39
311548|NCT00726232|751723|P7|Safety Evaluable Participants|Expansion Phase||34
311549|NCT00726232|751724|P6|Safety Evaluable Participants|Expansion Phase||0
311550|NCT00726232|751725|P5|Safety Evaluable Participants|Expansion Phase||0
311551|NCT00726232|751726|P4|Safety Evaluable Participants|Expansion Phase||0
311552|NCT00726232|751727|P3|Safety Evaluable Participants|Expansion Phase||0
311553|NCT00726232|751728|P2|Safety Evaluable Participants|Expansion Phase||0
311554|NCT00726232|751729|P1|Safety Evaluable Participants|Expansion Phase||0
311555|NCT00726232|751722|P8|STARTED|Expansion Phase||39
311556|NCT00726232|751723|P7|STARTED|Expansion Phase||34
311557|NCT00726232|751724|P6|STARTED|Expansion Phase||0
311558|NCT00726232|751725|P5|STARTED|Expansion Phase||0
311559|NCT00726232|751726|P4|STARTED|Expansion Phase||0
311560|NCT00726232|751727|P3|STARTED|Expansion Phase||0
311561|NCT00726232|751728|P2|STARTED|Expansion Phase||0
311562|NCT00726232|751729|P1|STARTED|Expansion Phase||0
311563|NCT00726232|751722|P8|NOT COMPLETED|Initial Phase (Dose-finding)||0
311564|NCT00726232|751723|P7|NOT COMPLETED|Initial Phase (Dose-finding)||0
311565|NCT00726232|751724|P6|NOT COMPLETED|Initial Phase (Dose-finding)||9
311566|NCT00726232|751725|P5|NOT COMPLETED|Initial Phase (Dose-finding)||21
311567|NCT00726232|751726|P4|NOT COMPLETED|Initial Phase (Dose-finding)||8
311568|NCT00726232|751727|P3|NOT COMPLETED|Initial Phase (Dose-finding)||5
311569|NCT00726232|751728|P2|NOT COMPLETED|Initial Phase (Dose-finding)||6
311570|NCT00726232|751729|P1|NOT COMPLETED|Initial Phase (Dose-finding)||13
311571|NCT00726232|751722|P8|COMPLETED|Initial Phase (Dose-finding)||0
311572|NCT00726232|751723|P7|COMPLETED|Initial Phase (Dose-finding)||0
311573|NCT00726232|751724|P6|COMPLETED|Initial Phase (Dose-finding)||0
311574|NCT00726232|751725|P5|COMPLETED|Initial Phase (Dose-finding)||1
311575|NCT00726232|751726|P4|COMPLETED|Initial Phase (Dose-finding)||0
311576|NCT00726232|751727|P3|COMPLETED|Initial Phase (Dose-finding)||2
311577|NCT00726232|751728|P2|COMPLETED|Initial Phase (Dose-finding)||2
311578|NCT00726232|751729|P1|COMPLETED|Initial Phase (Dose-finding)||6
311579|NCT00726232|751722|P8|ITT Participants|Initial Phase (Dose-finding)||0
311580|NCT00726232|751723|P7|ITT Participants|Initial Phase (Dose-finding)||0
311581|NCT00726232|751724|P6|ITT Participants|Initial Phase (Dose-finding)||9
311582|NCT00726232|751725|P5|ITT Participants|Initial Phase (Dose-finding)||22
311583|NCT00726232|751726|P4|ITT Participants|Initial Phase (Dose-finding)||8
311584|NCT00726232|751727|P3|ITT Participants|Initial Phase (Dose-finding)||7
311585|NCT00726232|751728|P2|ITT Participants|Initial Phase (Dose-finding)||8
311586|NCT00726232|751729|P1|ITT Participants|Initial Phase (Dose-finding)||19
311587|NCT00726232|751722|P8|Safety Evaluable Participants|Initial Phase (Dose-finding)||0
311588|NCT00726232|751723|P7|Safety Evaluable Participants|Initial Phase (Dose-finding)||0
311589|NCT00726232|751724|P6|Safety Evaluable Participants|Initial Phase (Dose-finding)||9
311590|NCT00726232|751725|P5|Safety Evaluable Participants|Initial Phase (Dose-finding)||22
311591|NCT00726232|751726|P4|Safety Evaluable Participants|Initial Phase (Dose-finding)||8
311592|NCT00726232|751727|P3|Safety Evaluable Participants|Initial Phase (Dose-finding)||7
311593|NCT00726232|751728|P2|Safety Evaluable Participants|Initial Phase (Dose-finding)||8
311594|NCT00726232|751729|P1|Safety Evaluable Participants|Initial Phase (Dose-finding)||19
311595|NCT00726232|751722|P8|STARTED|Initial Phase (Dose-finding)||0
311596|NCT00726232|751723|P7|STARTED|Initial Phase (Dose-finding)||0
311597|NCT00726232|751724|P6|STARTED|Initial Phase (Dose-finding)||9
311598|NCT00726232|751725|P5|STARTED|Initial Phase (Dose-finding)|The starting dose selected for the ET expansion cohort was 25 mg bid hence the sample size is larger|22
311599|NCT00726232|751726|P4|STARTED|Initial Phase (Dose-finding)||8
311600|NCT00726232|751727|P3|STARTED|Initial Phase (Dose-finding)||7
311601|NCT00726232|751728|P2|STARTED|Initial Phase (Dose-finding)||8
311602|NCT00726232|751729|P1|STARTED|Initial Phase (Dose-finding)|The starting dose selected for the PV expansion cohort was 10 mg bid hence the sample size is larger|19
311603|NCT00726180|751775|P1|NOT COMPLETED|Overall Study||0
311604|NCT00726180|751775|P1|COMPLETED|Overall Study||1
311605|NCT00726180|751775|P1|STARTED|Overall Study||1
311606|NCT00726063|751781|P2|NOT COMPLETED|Overall Study||7
311607|NCT00726063|751782|P1|NOT COMPLETED|Overall Study||9
311608|NCT00726063|751781|P2|COMPLETED|Overall Study|Number of implants = 239|112
311609|NCT00726063|751782|P1|COMPLETED|Overall Study|Number of implants =230|113
311610|NCT00726063|751781|P2|STARTED|Overall Study|Number of implants= 246|119
311611|NCT00726063|751782|P1|STARTED|Overall Study|Number of implants= 239|122
311612|NCT00726037|751788|P1|NOT COMPLETED|Overall Study||0
311613|NCT00726037|751788|P1|COMPLETED|Overall Study||7
311614|NCT00726037|751788|P1|STARTED|Overall Study||7
311615|NCT00725985|751796|P12|NOT COMPLETED|LTFU (No Cladribine Treatment)||14
311616|NCT00725985|751797|P11|NOT COMPLETED|LTFU (No Cladribine Treatment)||36
311617|NCT00725985|751798|P10|NOT COMPLETED|LTFU (No Cladribine Treatment)||34
311618|NCT00725985|751799|P9|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
311619|NCT00725985|751800|P8|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
311620|NCT00725985|751801|P7|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
311621|NCT00725985|751802|P6|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
311622|NCT00725985|751803|P5|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
311623|NCT00725985|751804|P4|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
311624|NCT00725985|751805|P3|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
311625|NCT00725985|751806|P2|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
311626|NCT00725985|751807|P1|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
311627|NCT00725985|751796|P12|COMPLETED|LTFU (No Cladribine Treatment)||0
311628|NCT00725985|751797|P11|COMPLETED|LTFU (No Cladribine Treatment)||0
311629|NCT00725985|751798|P10|COMPLETED|LTFU (No Cladribine Treatment)||0
311630|NCT00725985|751799|P9|COMPLETED|LTFU (No Cladribine Treatment)||0
311631|NCT00725985|751800|P8|COMPLETED|LTFU (No Cladribine Treatment)||0
311632|NCT00725985|751801|P7|COMPLETED|LTFU (No Cladribine Treatment)||0
311633|NCT00725985|751802|P6|COMPLETED|LTFU (No Cladribine Treatment)||0
311634|NCT00725985|751803|P5|COMPLETED|LTFU (No Cladribine Treatment)||0
311635|NCT00725985|751804|P4|COMPLETED|LTFU (No Cladribine Treatment)||0
311636|NCT00725985|751805|P3|COMPLETED|LTFU (No Cladribine Treatment)||0
311637|NCT00725985|751806|P2|COMPLETED|LTFU (No Cladribine Treatment)||0
311638|NCT00725985|751807|P1|COMPLETED|LTFU (No Cladribine Treatment)||0
311639|NCT00725985|751796|P12|STARTED|LTFU (No Cladribine Treatment)||14
311640|NCT00725985|751797|P11|STARTED|LTFU (No Cladribine Treatment)||36
311641|NCT00725985|751798|P10|STARTED|LTFU (No Cladribine Treatment)||34
311642|NCT00725985|751799|P9|STARTED|LTFU (No Cladribine Treatment)||0
311643|NCT00725985|751800|P8|STARTED|LTFU (No Cladribine Treatment)||0
311644|NCT00725985|751801|P7|STARTED|LTFU (No Cladribine Treatment)||0
311645|NCT00725985|751802|P6|STARTED|LTFU (No Cladribine Treatment)||0
311646|NCT00725985|751803|P5|STARTED|LTFU (No Cladribine Treatment)||0
311647|NCT00725985|751804|P4|STARTED|LTFU (No Cladribine Treatment)||0
311648|NCT00725985|751805|P3|STARTED|LTFU (No Cladribine Treatment)||0
311649|NCT00725985|751806|P2|STARTED|LTFU (No Cladribine Treatment)||0
311650|NCT00725985|751807|P1|STARTED|LTFU (No Cladribine Treatment)||0
311651|NCT00725985|751796|P12|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
311652|NCT00725985|751797|P11|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
311653|NCT00725985|751798|P10|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
311654|NCT00725985|751799|P9|NOT COMPLETED|LTFU (With Cladribine Treatment)||17
311655|NCT00725985|751800|P8|NOT COMPLETED|LTFU (With Cladribine Treatment)||9
311656|NCT00725985|751801|P7|NOT COMPLETED|LTFU (With Cladribine Treatment)||9
311657|NCT00725985|751802|P6|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
311658|NCT00725985|751803|P5|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
311659|NCT00725985|751804|P4|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
311660|NCT00725985|751805|P3|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
311661|NCT00725985|751806|P2|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
311662|NCT00725985|751807|P1|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
311663|NCT00725985|751796|P12|COMPLETED|LTFU (With Cladribine Treatment)||0
311664|NCT00725985|751797|P11|COMPLETED|LTFU (With Cladribine Treatment)||0
311665|NCT00725985|751798|P10|COMPLETED|LTFU (With Cladribine Treatment)||0
311666|NCT00725985|751799|P9|COMPLETED|LTFU (With Cladribine Treatment)||0
311667|NCT00725985|751800|P8|COMPLETED|LTFU (With Cladribine Treatment)||0
311668|NCT00725985|751801|P7|COMPLETED|LTFU (With Cladribine Treatment)||0
311669|NCT00725985|751802|P6|COMPLETED|LTFU (With Cladribine Treatment)||0
311670|NCT00725985|751803|P5|COMPLETED|LTFU (With Cladribine Treatment)||0
311671|NCT00725985|751804|P4|COMPLETED|LTFU (With Cladribine Treatment)||0
311672|NCT00725985|751805|P3|COMPLETED|LTFU (With Cladribine Treatment)||0
311673|NCT00725985|751806|P2|COMPLETED|LTFU (With Cladribine Treatment)||0
311674|NCT00725985|751807|P1|COMPLETED|LTFU (With Cladribine Treatment)||0
311675|NCT00725985|751796|P12|STARTED|LTFU (With Cladribine Treatment)||0
311676|NCT00725985|751797|P11|STARTED|LTFU (With Cladribine Treatment)||0
311677|NCT00725985|751798|P10|STARTED|LTFU (With Cladribine Treatment)||0
311678|NCT00725985|751799|P9|STARTED|LTFU (With Cladribine Treatment)||17
311679|NCT00725985|751800|P8|STARTED|LTFU (With Cladribine Treatment)||9
311680|NCT00725985|751801|P7|STARTED|LTFU (With Cladribine Treatment)||9
311681|NCT00725985|751802|P6|STARTED|LTFU (With Cladribine Treatment)||0
311682|NCT00725985|751803|P5|STARTED|LTFU (With Cladribine Treatment)||0
311683|NCT00725985|751804|P4|STARTED|LTFU (With Cladribine Treatment)||0
311684|NCT00725985|751805|P3|STARTED|LTFU (With Cladribine Treatment)||0
311685|NCT00725985|751806|P2|STARTED|LTFU (With Cladribine Treatment)||0
311686|NCT00725985|751807|P1|STARTED|LTFU (With Cladribine Treatment)||0
311687|NCT00725985|751796|P12|NOT COMPLETED|OLMP||0
311688|NCT00725985|751797|P11|NOT COMPLETED|OLMP||0
311689|NCT00725985|751798|P10|NOT COMPLETED|OLMP||0
311690|NCT00725985|751799|P9|NOT COMPLETED|OLMP||0
311691|NCT00725985|751800|P8|NOT COMPLETED|OLMP||0
311692|NCT00725985|751801|P7|NOT COMPLETED|OLMP||0
311693|NCT00725985|751802|P6|NOT COMPLETED|OLMP||53
311694|NCT00725985|751803|P5|NOT COMPLETED|OLMP||23
311695|NCT00725985|751804|P4|NOT COMPLETED|OLMP||18
311696|NCT00725985|751805|P3|NOT COMPLETED|OLMP||0
311697|NCT00725985|751806|P2|NOT COMPLETED|OLMP||0
311698|NCT00725985|751807|P1|NOT COMPLETED|OLMP||0
311699|NCT00725985|751796|P12|COMPLETED|OLMP||0
311700|NCT00725985|751797|P11|COMPLETED|OLMP||0
311701|NCT00725985|751798|P10|COMPLETED|OLMP||0
311702|NCT00725985|751799|P9|COMPLETED|OLMP||0
311703|NCT00725985|751800|P8|COMPLETED|OLMP||0
311704|NCT00725985|751801|P7|COMPLETED|OLMP||0
311705|NCT00725985|751802|P6|COMPLETED|OLMP||7
311706|NCT00725985|751803|P5|COMPLETED|OLMP||2
311707|NCT00725985|751804|P4|COMPLETED|OLMP||6
311708|NCT00725985|751805|P3|COMPLETED|OLMP||0
311709|NCT00725985|751806|P2|COMPLETED|OLMP||0
311710|NCT00725985|751807|P1|COMPLETED|OLMP||0
311711|NCT00725985|751796|P12|STARTED|OLMP||0
311712|NCT00725985|751797|P11|STARTED|OLMP||0
311713|NCT00725985|751798|P10|STARTED|OLMP||0
311714|NCT00725985|751799|P9|STARTED|OLMP||0
311715|NCT00725985|751800|P8|STARTED|OLMP||0
311716|NCT00725985|751801|P7|STARTED|OLMP||0
311717|NCT00725985|751802|P6|STARTED|OLMP||60
311718|NCT00725985|751803|P5|STARTED|OLMP||25
311719|NCT00725985|751804|P4|STARTED|OLMP||24
311720|NCT00725985|751805|P3|STARTED|OLMP||0
311721|NCT00725985|751806|P2|STARTED|OLMP||0
311722|NCT00725985|751807|P1|STARTED|OLMP||0
311723|NCT00725985|751796|P12|NOT COMPLETED|ITP (Up to 96 Weeks)||0
311724|NCT00725985|751797|P11|NOT COMPLETED|ITP (Up to 96 Weeks)||0
311725|NCT00725985|751798|P10|NOT COMPLETED|ITP (Up to 96 Weeks)||0
311726|NCT00725985|751799|P9|NOT COMPLETED|ITP (Up to 96 Weeks)||0
311727|NCT00725985|751800|P8|NOT COMPLETED|ITP (Up to 96 Weeks)||0
311728|NCT00725985|751801|P7|NOT COMPLETED|ITP (Up to 96 Weeks)||0
311729|NCT00725985|751802|P6|NOT COMPLETED|ITP (Up to 96 Weeks)||0
311730|NCT00725985|751803|P5|NOT COMPLETED|ITP (Up to 96 Weeks)||0
311731|NCT00725985|751804|P4|NOT COMPLETED|ITP (Up to 96 Weeks)||0
311732|NCT00725985|751805|P3|NOT COMPLETED|ITP (Up to 96 Weeks)||102
311733|NCT00725985|751806|P2|NOT COMPLETED|ITP (Up to 96 Weeks)||75
311734|NCT00725985|751807|P1|NOT COMPLETED|ITP (Up to 96 Weeks)||101
311735|NCT00725985|751796|P12|COMPLETED|ITP (Up to 96 Weeks)||0
311736|NCT00725985|751797|P11|COMPLETED|ITP (Up to 96 Weeks)||0
311737|NCT00725985|751798|P10|COMPLETED|ITP (Up to 96 Weeks)||0
311738|NCT00725985|751799|P9|COMPLETED|ITP (Up to 96 Weeks)||0
311739|NCT00725985|751800|P8|COMPLETED|ITP (Up to 96 Weeks)||0
311740|NCT00725985|751801|P7|COMPLETED|ITP (Up to 96 Weeks)||0
311741|NCT00725985|751802|P6|COMPLETED|ITP (Up to 96 Weeks)||0
311742|NCT00725985|751803|P5|COMPLETED|ITP (Up to 96 Weeks)||0
311743|NCT00725985|751804|P4|COMPLETED|ITP (Up to 96 Weeks)||0
311744|NCT00725985|751805|P3|COMPLETED|ITP (Up to 96 Weeks)||104
311745|NCT00725985|751806|P2|COMPLETED|ITP (Up to 96 Weeks)||131
311746|NCT00725985|751807|P1|COMPLETED|ITP (Up to 96 Weeks)||104
311747|NCT00725985|751796|P12|Treated|ITP (Up to 96 Weeks)||0
311748|NCT00725985|751797|P11|Treated|ITP (Up to 96 Weeks)||0
311749|NCT00725985|751798|P10|Treated|ITP (Up to 96 Weeks)||0
311750|NCT00725985|751799|P9|Treated|ITP (Up to 96 Weeks)||0
311751|NCT00725985|751800|P8|Treated|ITP (Up to 96 Weeks)||0
311752|NCT00725985|751801|P7|Treated|ITP (Up to 96 Weeks)||0
311753|NCT00725985|751802|P6|Treated|ITP (Up to 96 Weeks)||0
311754|NCT00725985|751803|P5|Treated|ITP (Up to 96 Weeks)||0
311755|NCT00725985|751804|P4|Treated|ITP (Up to 96 Weeks)||0
311756|NCT00725985|751805|P3|Treated|ITP (Up to 96 Weeks)||206
311757|NCT00725985|751806|P2|Treated|ITP (Up to 96 Weeks)||206
311758|NCT00725985|751807|P1|Treated|ITP (Up to 96 Weeks)||204
311759|NCT00725985|751796|P12|STARTED|ITP (Up to 96 Weeks)||0
311760|NCT00725985|751797|P11|STARTED|ITP (Up to 96 Weeks)||0
311761|NCT00725985|751798|P10|STARTED|ITP (Up to 96 Weeks)||0
311762|NCT00725985|751799|P9|STARTED|ITP (Up to 96 Weeks)||0
311763|NCT00725985|751800|P8|STARTED|ITP (Up to 96 Weeks)||0
311764|NCT00725985|751801|P7|STARTED|ITP (Up to 96 Weeks)||0
311765|NCT00725985|751802|P6|STARTED|ITP (Up to 96 Weeks)||0
311766|NCT00725985|751803|P5|STARTED|ITP (Up to 96 Weeks)||0
311767|NCT00725985|751804|P4|STARTED|ITP (Up to 96 Weeks)||0
311768|NCT00725985|751805|P3|STARTED|ITP (Up to 96 Weeks)||206
311769|NCT00725985|751806|P2|STARTED|ITP (Up to 96 Weeks)||206
311770|NCT00725985|751807|P1|STARTED|ITP (Up to 96 Weeks)||205
311771|NCT00725959|751835|P2|NOT COMPLETED|Overall Study||197
311772|NCT00725959|751836|P1|NOT COMPLETED|Overall Study||289
311773|NCT00725959|751835|P2|COMPLETED|Overall Study||439
311774|NCT00725959|751836|P1|COMPLETED|Overall Study||653
311775|NCT00725959|751835|P2|STARTED|Overall Study||636
311776|NCT00725959|751836|P1|STARTED|Overall Study||942
311777|NCT00725920|751844|P2|NOT COMPLETED|Overall Study||6
311778|NCT00725920|751845|P1|NOT COMPLETED|Overall Study||3
311779|NCT00725920|751844|P2|COMPLETED|Overall Study||12
311780|NCT00725920|751845|P1|COMPLETED|Overall Study||14
311781|NCT00725920|751844|P2|STARTED|Overall Study||18
311782|NCT00725920|751845|P1|STARTED|Overall Study||17
311783|NCT00725842|751851|P1|NOT COMPLETED|Overall Study||40
311784|NCT00725842|751851|P1|COMPLETED|Overall Study||57
311785|NCT00725842|751851|P1|Participants Eligible for Analysis|Overall Study||90
311786|NCT00725842|751851|P1|STARTED|Overall Study||97
311787|NCT00725764|751858|P1|NOT COMPLETED|Overall Study||14
311788|NCT00725764|751858|P1|COMPLETED|Overall Study||0
311789|NCT00725764|751858|P1|STARTED|Overall Study||14
311790|NCT00725751|751878|P2|NOT COMPLETED|Overall Study||108
311791|NCT00725751|751879|P1|NOT COMPLETED|Overall Study||34
311792|NCT00725751|751878|P2|COMPLETED|Overall Study||150
311793|NCT00725751|751879|P1|COMPLETED|Overall Study||56
311794|NCT00725751|751878|P2|STARTED|Overall Study||258
311795|NCT00725751|751879|P1|STARTED|Overall Study||90
311796|NCT00725725|751891|P3|NOT COMPLETED|Overall Study||5
311797|NCT00725725|751892|P2|NOT COMPLETED|Overall Study||4
311798|NCT00725725|751893|P1|NOT COMPLETED|Overall Study||4
311799|NCT00725725|751891|P3|COMPLETED|Overall Study||12
311800|NCT00725725|751892|P2|COMPLETED|Overall Study||11
311801|NCT00725725|751893|P1|COMPLETED|Overall Study||10
311802|NCT00725725|751891|P3|Treated|Overall Study||14
311803|NCT00725725|751892|P2|Treated|Overall Study||15
311804|NCT00725725|751893|P1|Treated|Overall Study||11
311805|NCT00725725|751891|P3|STARTED|Overall Study||17
311806|NCT00725725|751892|P2|STARTED|Overall Study||15
311807|NCT00725725|751893|P1|STARTED|Overall Study||14
311808|NCT00725712|751936|P2|NOT COMPLETED|Overall Study||26
311809|NCT00725712|751937|P1|NOT COMPLETED|Overall Study||48
311810|NCT00725712|751936|P2|COMPLETED|Overall Study||0
311811|NCT00725712|751937|P1|COMPLETED|Overall Study||0
311812|NCT00725712|751936|P2|STARTED|Overall Study||26
311813|NCT00725712|751937|P1|STARTED|Overall Study||48
311814|NCT00725621|751973|P1|NOT COMPLETED|Overall Study||271
311815|NCT00725621|751973|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|245
311816|NCT00725621|751973|P1|STARTED|Overall Study|Started was defined as the number of participants who received at least one infusion of Remicade.|516
311817|NCT00725608|751996|P1|NOT COMPLETED|Overall Study||167
311818|NCT00725608|751996|P1|COMPLETED|Overall Study|1 patient terminated treatment at day 368 and was counted as dropout|140
311819|NCT00725608|751996|P1|STARTED|Overall Study|339 patients enrolled, 32 non-eligible datasets excluded from final general and safety analysis|307
311820|NCT00725543|752002|P1|NOT COMPLETED|Overall Study||153
311821|NCT00725543|752002|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|205
311822|NCT00725543|752002|P1|STARTED|Overall Study||358
311823|NCT00725530|752011|P2|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
311824|NCT00725530|752012|P1|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
311825|NCT00725530|752011|P2|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
311826|NCT00725530|752012|P1|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
311827|NCT00725530|752011|P2|STARTED|Second Intervention, 7 Days (+0/-1)||27
311828|NCT00725530|752012|P1|STARTED|Second Intervention, 7 Days (+0/-1)||27
311829|NCT00725530|752011|P2|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
311830|NCT00725530|752012|P1|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
311831|NCT00725530|752011|P2|COMPLETED|First Intervention, 7 Days (+0/-1)||27
311832|NCT00725530|752012|P1|COMPLETED|First Intervention, 7 Days (+0/-1)||27
311833|NCT00725530|752011|P2|STARTED|First Intervention, 7 Days (+0/-1)||27
311834|NCT00725530|752012|P1|STARTED|First Intervention, 7 Days (+0/-1)||27
311835|NCT00725504|752018|P1|NOT COMPLETED|Overall Study||0
311836|NCT00725504|752018|P1|COMPLETED|Overall Study||71
311837|NCT00725504|752018|P1|STARTED|Overall Study||71
311838|NCT00725491|752027|P2|NOT COMPLETED|Overall Study||18
311839|NCT00725491|752028|P1|NOT COMPLETED|Overall Study||9
311840|NCT00725491|752027|P2|COMPLETED|Overall Study||102
311841|NCT00725491|752028|P1|COMPLETED|Overall Study||104
311842|NCT00725491|752027|P2|STARTED|Overall Study|Intent-to-Treat Group|120
311843|NCT00725491|752028|P1|STARTED|Overall Study|Intent-to-Treat Group|113
311844|NCT00725452|752034|P1|NOT COMPLETED|Overall Study||11
311845|NCT00725452|752034|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Infliximab infusions.|15
311846|NCT00725452|752034|P1|STARTED|Overall Study||26
311847|NCT00725361|752043|P1|NOT COMPLETED|Overall Study||4
311848|NCT00725361|752043|P1|COMPLETED|Overall Study||16
311849|NCT00725361|752043|P1|STARTED|Overall Study||20
311850|NCT00725322|752053|P2|NOT COMPLETED|Second Injection Visit||0
311851|NCT00725322|752054|P1|NOT COMPLETED|Second Injection Visit||0
311852|NCT00725322|752053|P2|COMPLETED|Second Injection Visit||14
311853|NCT00725322|752054|P1|COMPLETED|Second Injection Visit||13
311854|NCT00725322|752053|P2|STARTED|Second Injection Visit||14
311855|NCT00725322|752054|P1|STARTED|Second Injection Visit||13
311856|NCT00725322|752053|P2|NOT COMPLETED|Washout (28 Days)||1
311857|NCT00725322|752054|P1|NOT COMPLETED|Washout (28 Days)||2
311858|NCT00725322|752053|P2|COMPLETED|Washout (28 Days)||14
311859|NCT00725322|752054|P1|COMPLETED|Washout (28 Days)||13
311860|NCT00725322|752053|P2|STARTED|Washout (28 Days)||15
311861|NCT00725322|752054|P1|STARTED|Washout (28 Days)||15
311862|NCT00725322|752053|P2|NOT COMPLETED|First Injection Visit||0
311863|NCT00725322|752054|P1|NOT COMPLETED|First Injection Visit||0
311864|NCT00725322|752053|P2|COMPLETED|First Injection Visit||15
311865|NCT00725322|752054|P1|COMPLETED|First Injection Visit||15
311866|NCT00725322|752053|P2|STARTED|First Injection Visit||15
311867|NCT00725322|752054|P1|STARTED|First Injection Visit||15
311868|NCT00725296|752062|P1|NOT COMPLETED|Overall Study||62
311869|NCT00725296|752062|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive infusions.|101
311870|NCT00725296|752062|P1|STARTED|Overall Study|163 of the 178 enrolled participants received at least one dose of Infliximab.|163
311871|NCT00725283|752071|P1|NOT COMPLETED|Overall Study||24
311872|NCT00725283|752071|P1|COMPLETED|Overall Study||10
311873|NCT00725283|752071|P1|STARTED|Overall Study||34
311874|NCT00725270|752083|P2|NOT COMPLETED|Overall Study||0
311875|NCT00725270|752084|P1|NOT COMPLETED|Overall Study||0
311876|NCT00725270|752083|P2|COMPLETED|Overall Study||7
311877|NCT00725270|752084|P1|COMPLETED|Overall Study||5
311878|NCT00725270|752083|P2|STARTED|Overall Study||7
311879|NCT00725270|752084|P1|STARTED|Overall Study||5
311880|NCT00725205|752092|P1|NOT COMPLETED|Overall Study||87
311881|NCT00725205|752092|P1|COMPLETED|Overall Study||207
311882|NCT00725205|752092|P1|STARTED|Overall Study||294
311883|NCT00725153|752098|P2|NOT COMPLETED|Period Two, 10 Hours of Wear||0
311884|NCT00725153|752099|P1|NOT COMPLETED|Period Two, 10 Hours of Wear||0
311885|NCT00725153|752098|P2|COMPLETED|Period Two, 10 Hours of Wear||28
311886|NCT00725153|752099|P1|COMPLETED|Period Two, 10 Hours of Wear||27
311887|NCT00725153|752098|P2|STARTED|Period Two, 10 Hours of Wear||28
311888|NCT00725153|752099|P1|STARTED|Period Two, 10 Hours of Wear||27
311889|NCT00725153|752098|P2|NOT COMPLETED|Period One, 10 Hours of Wear||0
311890|NCT00725153|752099|P1|NOT COMPLETED|Period One, 10 Hours of Wear||0
311891|NCT00725153|752098|P2|COMPLETED|Period One, 10 Hours of Wear||28
311892|NCT00725153|752099|P1|COMPLETED|Period One, 10 Hours of Wear||27
311893|NCT00725153|752098|P2|STARTED|Period One, 10 Hours of Wear||28
311894|NCT00725153|752099|P1|STARTED|Period One, 10 Hours of Wear||27
311895|NCT00725101|752105|P1|NOT COMPLETED|Overall Study||495
311896|NCT00725101|752105|P1|COMPLETED|Overall Study||1205
311897|NCT00725101|752105|P1|STARTED|Overall Study||1700
311898|NCT00725075|752128|P3|NOT COMPLETED|Overall Study||9
311899|NCT00725075|752129|P2|NOT COMPLETED|Overall Study||8
311900|NCT00725075|752130|P1|NOT COMPLETED|Overall Study||11
311901|NCT00725075|752128|P3|COMPLETED|Overall Study||61
311902|NCT00725075|752129|P2|COMPLETED|Overall Study||65
311903|NCT00725075|752130|P1|COMPLETED|Overall Study||61
311904|NCT00725075|752128|P3|Treated|Overall Study||70
311905|NCT00725075|752129|P2|Treated|Overall Study||73
311906|NCT00725075|752130|P1|Treated|Overall Study||71
311907|NCT00725075|752128|P3|STARTED|Overall Study||70
311908|NCT00725075|752129|P2|STARTED|Overall Study||73
311909|NCT00725075|752130|P1|STARTED|Overall Study||72
311910|NCT00725049|752176|P2|NOT COMPLETED|Overall Study||0
311911|NCT00725049|752177|P1|NOT COMPLETED|Overall Study||0
311912|NCT00725049|752176|P2|COMPLETED|Overall Study||20
311913|NCT00725049|752177|P1|COMPLETED|Overall Study||17
311914|NCT00725049|752176|P2|STARTED|Overall Study||20
311915|NCT00725049|752177|P1|STARTED|Overall Study||17
311916|NCT00725010|752183|P1|NOT COMPLETED|Overall Study||25
311917|NCT00725010|752183|P1|COMPLETED|Overall Study||25
311918|NCT00725010|752183|P1|STARTED|Overall Study|Only in 50 of 64 participants the documentation of therapy and follow-up was received and evaluated.|50
311919|NCT00724984|752197|P6|NOT COMPLETED|Overall Study||5
311920|NCT00724984|752198|P5|NOT COMPLETED|Overall Study||4
311921|NCT00724984|752199|P4|NOT COMPLETED|Overall Study||2
311922|NCT00724984|752200|P3|NOT COMPLETED|Overall Study||0
311923|NCT00724984|752201|P2|NOT COMPLETED|Overall Study||1
311924|NCT00724984|752202|P1|NOT COMPLETED|Overall Study||1
311925|NCT00724984|752197|P6|COMPLETED|Overall Study||9
311926|NCT00724984|752198|P5|COMPLETED|Overall Study||12
311927|NCT00724984|752199|P4|COMPLETED|Overall Study||7
311928|NCT00724984|752200|P3|COMPLETED|Overall Study||3
311929|NCT00724984|752201|P2|COMPLETED|Overall Study||7
311930|NCT00724984|752202|P1|COMPLETED|Overall Study||4
311931|NCT00724984|752197|P6|STARTED|Overall Study||14
311932|NCT00724984|752198|P5|STARTED|Overall Study||16
311933|NCT00724984|752199|P4|STARTED|Overall Study||9
311934|NCT00724984|752200|P3|STARTED|Overall Study||3
311935|NCT00724984|752201|P2|STARTED|Overall Study||8
311936|NCT00724984|752202|P1|STARTED|Overall Study||5
311937|NCT00724971|752216|P1|NOT COMPLETED|Overall Study||6
311938|NCT00724971|752216|P1|COMPLETED|Overall Study||4
311939|NCT00724971|752216|P1|STARTED|Overall Study||10
311940|NCT00724958|752231|P1|NOT COMPLETED|Overall Study||182
311941|NCT00724958|752231|P1|COMPLETED|Overall Study||166
311942|NCT00724958|752231|P1|STARTED|Overall Study||348
311943|NCT00724945|752240|P2|NOT COMPLETED|Period 2||0
311944|NCT00724945|752241|P1|NOT COMPLETED|Period 2||4
311945|NCT00724945|752240|P2|COMPLETED|Period 2||54
311946|NCT00724945|752241|P1|COMPLETED|Period 2||51
311947|NCT00724945|752240|P2|STARTED|Period 2||54
311948|NCT00724945|752241|P1|STARTED|Period 2||55
311949|NCT00724945|752240|P2|NOT COMPLETED|Period 1||1
311950|NCT00724945|752241|P1|NOT COMPLETED|Period 1||3
311951|NCT00724945|752240|P2|COMPLETED|Period 1||54
311952|NCT00724945|752241|P1|COMPLETED|Period 1||55
311953|NCT00724945|752240|P2|STARTED|Period 1||55
311954|NCT00724945|752241|P1|STARTED|Period 1||58
311955|NCT00724932|752253|P2|NOT COMPLETED|Overall Study||3
311956|NCT00724932|752254|P1|NOT COMPLETED|Overall Study||5
311957|NCT00724932|752253|P2|COMPLETED|Overall Study||67
311958|NCT00724932|752254|P1|COMPLETED|Overall Study||65
311959|NCT00724932|752253|P2|STARTED|Overall Study||70
311960|NCT00724932|752254|P1|STARTED|Overall Study||70
311961|NCT00724893|752325|P2|NOT COMPLETED|Overall Study||458
311962|NCT00724893|752326|P1|NOT COMPLETED|Overall Study||364
311963|NCT00724893|752325|P2|COMPLETED|Overall Study||670
311964|NCT00724893|752326|P1|COMPLETED|Overall Study||938
311965|NCT00724893|752325|P2|STARTED|Overall Study||1128
311966|NCT00724893|752326|P1|STARTED|Overall Study||1302
311967|NCT00724867|752394|P1|NOT COMPLETED|Overall Study||128
311968|NCT00724867|752394|P1|COMPLETED|Overall Study||140
311969|NCT00724867|752394|P1|STARTED|Overall Study||268
311970|NCT00724854|752434|P2|NOT COMPLETED|Overall Study||31
311971|NCT00724854|752435|P1|NOT COMPLETED|Overall Study||403
311972|NCT00724854|752434|P2|COMPLETED|Overall Study||41
311973|NCT00724854|752435|P1|COMPLETED|Overall Study||607
312062|NCT00724152|752634|P3|COMPLETED|Two-arm Study Period||0
311974|NCT00724854|752434|P2|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|72
311975|NCT00724854|752435|P1|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|1010
311976|NCT00724815|752452|P2|NOT COMPLETED|Overall Study||39
311977|NCT00724815|752453|P1|NOT COMPLETED|Overall Study||43
311978|NCT00724815|752452|P2|COMPLETED|Overall Study||226
311979|NCT00724815|752453|P1|COMPLETED|Overall Study||222
311980|NCT00724815|752452|P2|STARTED|Overall Study|subjects randomized|265
311981|NCT00724815|752453|P1|STARTED|Overall Study|subjects randomized|265
311982|NCT00724750|752467|P2|NOT COMPLETED|Overall Study||0
311983|NCT00724750|752468|P1|NOT COMPLETED|Overall Study||0
311984|NCT00724750|752467|P2|COMPLETED|Overall Study||42
311985|NCT00724750|752468|P1|COMPLETED|Overall Study||45
311986|NCT00724750|752467|P2|STARTED|Overall Study||42
311987|NCT00724750|752468|P1|STARTED|Overall Study||45
311988|NCT00724711|752486|P2|NOT COMPLETED|Overall Study||17
311989|NCT00724711|752487|P1|NOT COMPLETED|Overall Study||17
311990|NCT00724711|752486|P2|COMPLETED|Overall Study||139
311991|NCT00724711|752487|P1|COMPLETED|Overall Study||138
311992|NCT00724711|752486|P2|STARTED|Overall Study||156
311993|NCT00724711|752487|P1|STARTED|Overall Study||155
311994|NCT00724698|752519|P1|NOT COMPLETED|Overall Study||90
311995|NCT00724698|752519|P1|COMPLETED|Overall Study||2921
311996|NCT00724698|752519|P1|STARTED|Overall Study||3011
311997|NCT00724594|752526|P4|NOT COMPLETED|Overall Study||1
311998|NCT00724594|752527|P3|NOT COMPLETED|Overall Study||0
311999|NCT00724594|752528|P2|NOT COMPLETED|Overall Study||0
312000|NCT00724594|752529|P1|NOT COMPLETED|Overall Study||0
312001|NCT00724594|752526|P4|COMPLETED|Overall Study||10
312002|NCT00724594|752527|P3|COMPLETED|Overall Study||11
312003|NCT00724594|752528|P2|COMPLETED|Overall Study||12
312004|NCT00724594|752529|P1|COMPLETED|Overall Study||12
312005|NCT00724594|752526|P4|STARTED|Overall Study||11
312006|NCT00724594|752527|P3|STARTED|Overall Study||11
312007|NCT00724594|752528|P2|STARTED|Overall Study||12
312008|NCT00724594|752529|P1|STARTED|Overall Study||12
312009|NCT00724568|752564|P2|NOT COMPLETED|Overall Study||0
312010|NCT00724568|752565|P1|NOT COMPLETED|Overall Study||0
312011|NCT00724568|752564|P2|COMPLETED|Overall Study||32
312012|NCT00724568|752565|P1|COMPLETED|Overall Study||42
312013|NCT00724568|752564|P2|STARTED|Overall Study||32
312014|NCT00724568|752565|P1|STARTED|Overall Study||42
312015|NCT00724503|752572|P2|NOT COMPLETED|Overall Study||220
312016|NCT00724503|752573|P1|NOT COMPLETED|Overall Study||210
312017|NCT00724503|752572|P2|COMPLETED|Overall Study||43
312018|NCT00724503|752573|P1|COMPLETED|Overall Study||57
312019|NCT00724503|752572|P2|STARTED|Overall Study||263
312020|NCT00724503|752573|P1|STARTED|Overall Study||267
312021|NCT00724477|752581|P1|NOT COMPLETED|Overall Study||0
312022|NCT00724477|752581|P1|COMPLETED|Overall Study||1663
312023|NCT00724477|752581|P1|STARTED|Overall Study|This safety population (SAF)analysed consisted of all patients who took at least one tablet of INEGY|1663
312024|NCT00724464|752585|P1|NOT COMPLETED|Overall Study||23
312025|NCT00724464|752585|P1|COMPLETED|Overall Study||309
312026|NCT00724464|752585|P1|STARTED|Overall Study||332
312027|NCT00724451|752597|P1|NOT COMPLETED|Overall Study||802
312028|NCT00724451|752597|P1|COMPLETED|Overall Study|Completed defined as participants who completed anti-viral treatment.|326
312029|NCT00724451|752597|P1|Received Antiviral Treatment|Overall Study||500
312030|NCT00724451|752597|P1|STARTED|Overall Study||1128
312031|NCT00724373|752603|P1|NOT COMPLETED|Overall Study||171
312032|NCT00724373|752603|P1|COMPLETED|Overall Study||271
312033|NCT00724373|752603|P1|STARTED|Overall Study||442
312034|NCT00724347|752607|P1|NOT COMPLETED|Overall Study||2
312035|NCT00724347|752607|P1|COMPLETED|Overall Study||16
312036|NCT00724347|752607|P1|Baseline Testing|Overall Study||18
312037|NCT00724347|752607|P1|STARTED|Overall Study|Training was the final step in the program, once the outcome tests had been developed.|18
312038|NCT00724308|752613|P2|NOT COMPLETED|Overall Study||97
312039|NCT00724308|752614|P1|NOT COMPLETED|Overall Study||80
312040|NCT00724308|752613|P2|COMPLETED|Overall Study||210
312041|NCT00724308|752614|P1|COMPLETED|Overall Study||190
312042|NCT00724308|752613|P2|STARTED|Overall Study||307
312043|NCT00724308|752614|P1|STARTED|Overall Study||270
312044|NCT00724282|752620|P1|NOT COMPLETED|Overall Study||4
312045|NCT00724282|752620|P1|COMPLETED|Overall Study||16
312046|NCT00724282|752620|P1|STARTED|Overall Study||20
312047|NCT00724243|752624|P1|NOT COMPLETED|Overall Study||15
312048|NCT00724243|752624|P1|COMPLETED|Overall Study||18
312049|NCT00724243|752624|P1|STARTED|Overall Study||33
312050|NCT00724152|752634|P3|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
312051|NCT00724152|752635|P2|NOT COMPLETED|Three-arm Study Period (+Standard Care)||2
312052|NCT00724152|752636|P1|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
312053|NCT00724152|752634|P3|COMPLETED|Three-arm Study Period (+Standard Care)||1
312054|NCT00724152|752635|P2|COMPLETED|Three-arm Study Period (+Standard Care)||0
312055|NCT00724152|752636|P1|COMPLETED|Three-arm Study Period (+Standard Care)||3
312056|NCT00724152|752634|P3|STARTED|Three-arm Study Period (+Standard Care)|3-group randomization began|2
312057|NCT00724152|752635|P2|STARTED|Three-arm Study Period (+Standard Care)||2
312058|NCT00724152|752636|P1|STARTED|Three-arm Study Period (+Standard Care)||4
312059|NCT00724152|752634|P3|NOT COMPLETED|Two-arm Study Period||0
312060|NCT00724152|752635|P2|NOT COMPLETED|Two-arm Study Period||2
312061|NCT00724152|752636|P1|NOT COMPLETED|Two-arm Study Period||3
312063|NCT00724152|752635|P2|COMPLETED|Two-arm Study Period||9
312064|NCT00724152|752636|P1|COMPLETED|Two-arm Study Period||11
312065|NCT00724152|752634|P3|STARTED|Two-arm Study Period|Standard Care arm was added later (Period 2)|0
312066|NCT00724152|752635|P2|STARTED|Two-arm Study Period||11
312067|NCT00724152|752636|P1|STARTED|Two-arm Study Period||14
312068|NCT00724126|752653|P2|NOT COMPLETED|Overall Study||15
312069|NCT00724126|752654|P1|NOT COMPLETED|Overall Study||19
312070|NCT00724126|752653|P2|COMPLETED|Overall Study||301
312071|NCT00724126|752654|P1|COMPLETED|Overall Study||302
312072|NCT00724126|752653|P2|STARTED|Overall Study||316
312073|NCT00724126|752654|P1|STARTED|Overall Study||321
312074|NCT00724061|752662|P1|NOT COMPLETED|Maintenance Therapy||0
312075|NCT00724061|752662|P1|COMPLETED|Maintenance Therapy||2
312076|NCT00724061|752662|P1|STARTED|Maintenance Therapy||2
312077|NCT00724061|752662|P1|NOT COMPLETED|Dose Escalation Phase||5
312078|NCT00724061|752662|P1|COMPLETED|Dose Escalation Phase||2
312079|NCT00724061|752662|P1|STARTED|Dose Escalation Phase||7
312080|NCT00724009|752669|P1|NOT COMPLETED|Overall Study||0
312081|NCT00724009|752669|P1|COMPLETED|Overall Study|One patient underwent conditioning but died 1 day before stem cell infusion due to sepsis.|29
312082|NCT00724009|752669|P1|STARTED|Overall Study||29
312083|NCT00723957|752682|P2|NOT COMPLETED|Overall Study||53
312084|NCT00723957|752683|P1|NOT COMPLETED|Overall Study||51
312085|NCT00723957|752682|P2|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|46
312086|NCT00723957|752683|P1|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|47
312087|NCT00723957|752682|P2|STARTED|Overall Study|Randomized|99
312088|NCT00723957|752683|P1|STARTED|Overall Study|Randomized|98
312089|NCT00723944|752707|P2|NOT COMPLETED|Two Year Post Placement Follow-up||0
312090|NCT00723944|752708|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
312091|NCT00723944|752707|P2|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 108|37
312092|NCT00723944|752708|P1|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 130|48
312093|NCT00723944|752707|P2|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 108|37
312094|NCT00723944|752708|P1|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 130|48
312095|NCT00723944|752707|P2|NOT COMPLETED|One Year Post Placement Follow-up||4
312096|NCT00723944|752708|P1|NOT COMPLETED|One Year Post Placement Follow-up||1
312097|NCT00723944|752707|P2|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 108|37
312098|NCT00723944|752708|P1|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 130|48
312099|NCT00723944|752707|P2|STARTED|One Year Post Placement Follow-up|number of individual implant units is 112|41
312100|NCT00723944|752708|P1|STARTED|One Year Post Placement Follow-up|number of individual implant units is 134|49
312101|NCT00723944|752707|P2|NOT COMPLETED|Permanent Prosthesis Placement||9
312102|NCT00723944|752708|P1|NOT COMPLETED|Permanent Prosthesis Placement||3
312103|NCT00723944|752707|P2|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 112|41
312104|NCT00723944|752708|P1|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 134|49
312105|NCT00723944|752707|P2|STARTED|Permanent Prosthesis Placement|number of individual implant units is 138|50
312106|NCT00723944|752708|P1|STARTED|Permanent Prosthesis Placement|number of individual implant units is 148|52
312107|NCT00723944|752707|P2|NOT COMPLETED|Implant Placement Surgery||0
312108|NCT00723944|752708|P1|NOT COMPLETED|Implant Placement Surgery||0
312109|NCT00723944|752707|P2|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 138|50
312110|NCT00723944|752708|P1|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 148|52
312111|NCT00723944|752707|P2|STARTED|Implant Placement Surgery|number of individual implant units is 138|50
312112|NCT00723944|752708|P1|STARTED|Implant Placement Surgery|number of individual implant units is 148|52
312113|NCT00723931|752714|P1|NOT COMPLETED|Overall Study||0
312114|NCT00723931|752714|P1|COMPLETED|Overall Study||1267
312115|NCT00723931|752714|P1|STARTED|Overall Study||1267
312116|NCT00723892|752721|P2|NOT COMPLETED|Overall Study||87
312117|NCT00723892|752722|P1|NOT COMPLETED|Overall Study||107
312118|NCT00723892|752721|P2|COMPLETED|Overall Study||168
312119|NCT00723892|752722|P1|COMPLETED|Overall Study||206
312120|NCT00723892|752721|P2|STARTED|Overall Study||255
312121|NCT00723892|752722|P1|STARTED|Overall Study||313
312122|NCT00723840|752729|P1|NOT COMPLETED|Overall Study||82
312123|NCT00723840|752729|P1|COMPLETED|Overall Study||163
312124|NCT00723840|752729|P1|STARTED|Overall Study||245
312125|NCT00723827|752740|P1|NOT COMPLETED|Overall Study||0
312126|NCT00723827|752740|P1|COMPLETED|Overall Study||682
312127|NCT00723827|752740|P1|STARTED|Overall Study||682
312128|NCT00723801|752750|P2|NOT COMPLETED|Overall Study||3
312129|NCT00723801|752751|P1|NOT COMPLETED|Overall Study||3
312130|NCT00723801|752750|P2|COMPLETED|Overall Study||17
312131|NCT00723801|752751|P1|COMPLETED|Overall Study||17
312132|NCT00723801|752750|P2|STARTED|Overall Study||20
312133|NCT00723801|752751|P1|STARTED|Overall Study||20
312134|NCT00723788|752759|P1|NOT COMPLETED|Overall Study||0
312135|NCT00723788|752759|P1|COMPLETED|Overall Study||21
312136|NCT00723788|752759|P1|STARTED|Overall Study||21
312137|NCT00723749|752765|P1|NOT COMPLETED|Overall Study||163
312138|NCT00723749|752765|P1|COMPLETED|Overall Study||182
312139|NCT00723749|752765|P1|STARTED|Overall Study|384 patients were enrolled, 36 non-eligible datasets were excluded from analysis|345
312140|NCT00723736|752772|P1|NOT COMPLETED|Overall Study||1
312141|NCT00723736|752772|P1|COMPLETED|Overall Study|Subject's caregiver did not wish to continue, reasons unrelated.|99
312142|NCT00723736|752772|P1|STARTED|Overall Study||100
312143|NCT00723710|752776|P1|NOT COMPLETED|Overall Study||174
312144|NCT00723710|752776|P1|COMPLETED|Overall Study||120
312145|NCT00723710|752776|P1|STARTED|Overall Study||294
312146|NCT00723697|752780|P1|NOT COMPLETED|Overall Study||18
312147|NCT00723697|752780|P1|COMPLETED|Overall Study||1289
312148|NCT00723697|752780|P1|STARTED|Overall Study||1307
312149|NCT00723645|752788|P1|NOT COMPLETED|Visit 3 (Week 72 Post-treatment)||0
312150|NCT00723645|752788|P1|COMPLETED|Visit 3 (Week 72 Post-treatment)||187
312151|NCT00723645|752788|P1|STARTED|Visit 3 (Week 72 Post-treatment)|61 discontinued before V3; 26 lost to followup, 34 HCV RNA+ at Wk 24,1 death,1 HCV RNA not available|187
312152|NCT00723645|752788|P1|NOT COMPLETED|Visit 2 (Week 24 Post-treatment)||0
312153|NCT00723645|752788|P1|COMPLETED|Visit 2 (Week 24 Post-treatment)||248
312154|NCT00723645|752788|P1|STARTED|Visit 2 (Week 24 Post-treatment)|10 discontinued before Visit 2; 7 lost to follow-up and 3 were HCV RNA+ before Wk 24|248
312155|NCT00723645|752788|P1|NOT COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||0
312156|NCT00723645|752788|P1|COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||258
312157|NCT00723645|752788|P1|STARTED|Visit 1 (≤4 Weeks Post-treatment)||258
312158|NCT00723632|752793|P1|NOT COMPLETED|Overall Study||203
312159|NCT00723632|752793|P1|COMPLETED|Overall Study|Completed initial exam form and >= 1 follow up visit form; end of treatment and SVR status recorded|698
312160|NCT00723632|752793|P1|STARTED|Overall Study||901
312161|NCT00723606|752801|P2|NOT COMPLETED|Overall Study||7
312162|NCT00723606|752802|P1|NOT COMPLETED|Overall Study||4
312163|NCT00723606|752801|P2|COMPLETED|Overall Study||180
312164|NCT00723606|752802|P1|COMPLETED|Overall Study||185
312165|NCT00723606|752801|P2|STARTED|Overall Study||187
312166|NCT00723606|752802|P1|STARTED|Overall Study||189
312167|NCT00723580|752818|P1|NOT COMPLETED|Overall Study||0
312168|NCT00723580|752818|P1|COMPLETED|Overall Study|Completion of repeated Measurements|1
312169|NCT00723580|752818|P1|Baseline Measurements|Overall Study|Actigraphic, Psychometric and Observational Baseline Data Collected.|1
312170|NCT00723580|752818|P1|STARTED|Overall Study|Study was extended with continued repeated measurements.|1
312171|NCT00723554|752822|P1|NOT COMPLETED|Overall Study||29
312172|NCT00723554|752822|P1|COMPLETED|Overall Study||34
312173|NCT00723554|752822|P1|STARTED|Overall Study||63
312174|NCT00723528|752872|P7|NOT COMPLETED|Period 2: After Controlled Period||4
312175|NCT00723528|752873|P6|NOT COMPLETED|Period 2: After Controlled Period||6
312176|NCT00723528|752874|P5|NOT COMPLETED|Period 2: After Controlled Period||2
312177|NCT00723528|752875|P4|NOT COMPLETED|Period 2: After Controlled Period||1
312178|NCT00723528|752876|P3|NOT COMPLETED|Period 2: After Controlled Period||0
312179|NCT00723528|752877|P2|NOT COMPLETED|Period 2: After Controlled Period||0
312180|NCT00723528|752878|P1|NOT COMPLETED|Period 2: After Controlled Period||0
312181|NCT00723528|752872|P7|COMPLETED|Period 2: After Controlled Period||54
312182|NCT00723528|752873|P6|COMPLETED|Period 2: After Controlled Period||58
312183|NCT00723528|752874|P5|COMPLETED|Period 2: After Controlled Period||11
312184|NCT00723528|752875|P4|COMPLETED|Period 2: After Controlled Period||14
312185|NCT00723528|752876|P3|COMPLETED|Period 2: After Controlled Period||0
312186|NCT00723528|752877|P2|COMPLETED|Period 2: After Controlled Period||0
312187|NCT00723528|752878|P1|COMPLETED|Period 2: After Controlled Period||0
312188|NCT00723528|752872|P7|STARTED|Period 2: After Controlled Period||58
312189|NCT00723528|752873|P6|STARTED|Period 2: After Controlled Period||64
312190|NCT00723528|752874|P5|STARTED|Period 2: After Controlled Period||13
312191|NCT00723528|752875|P4|STARTED|Period 2: After Controlled Period||15
312192|NCT00723528|752876|P3|STARTED|Period 2: After Controlled Period||0
312193|NCT00723528|752877|P2|STARTED|Period 2: After Controlled Period||0
312194|NCT00723528|752878|P1|STARTED|Period 2: After Controlled Period||0
312195|NCT00723528|752872|P7|NOT COMPLETED|Period 1: Controlled Period (CP)||0
312196|NCT00723528|752873|P6|NOT COMPLETED|Period 1: Controlled Period (CP)||0
312197|NCT00723528|752874|P5|NOT COMPLETED|Period 1: Controlled Period (CP)||0
312198|NCT00723528|752875|P4|NOT COMPLETED|Period 1: Controlled Period (CP)||0
312199|NCT00723528|752876|P3|NOT COMPLETED|Period 1: Controlled Period (CP)||4
312200|NCT00723528|752877|P2|NOT COMPLETED|Period 1: Controlled Period (CP)||0
312201|NCT00723528|752878|P1|NOT COMPLETED|Period 1: Controlled Period (CP)||4
312202|NCT00723528|752872|P7|COMPLETED|Period 1: Controlled Period (CP)||0
312203|NCT00723528|752873|P6|COMPLETED|Period 1: Controlled Period (CP)||0
312204|NCT00723528|752874|P5|COMPLETED|Period 1: Controlled Period (CP)||0
312205|NCT00723528|752875|P4|COMPLETED|Period 1: Controlled Period (CP)||0
312206|NCT00723528|752876|P3|COMPLETED|Period 1: Controlled Period (CP)||58
312207|NCT00723528|752877|P2|COMPLETED|Period 1: Controlled Period (CP)||64
312208|NCT00723528|752878|P1|COMPLETED|Period 1: Controlled Period (CP)||28
312209|NCT00723528|752872|P7|STARTED|Period 1: Controlled Period (CP)||0
312210|NCT00723528|752873|P6|STARTED|Period 1: Controlled Period (CP)||0
312211|NCT00723528|752874|P5|STARTED|Period 1: Controlled Period (CP)||0
312212|NCT00723528|752875|P4|STARTED|Period 1: Controlled Period (CP)||0
312213|NCT00723528|752876|P3|STARTED|Period 1: Controlled Period (CP)||62
312214|NCT00723528|752877|P2|STARTED|Period 1: Controlled Period (CP)||64
312215|NCT00723528|752878|P1|STARTED|Period 1: Controlled Period (CP)||32
312216|NCT00723489|752940|P4|NOT COMPLETED|Overall Study||3
312217|NCT00723489|752941|P3|NOT COMPLETED|Overall Study||0
312218|NCT00723489|752942|P2|NOT COMPLETED|Overall Study||4
312219|NCT00723489|752943|P1|NOT COMPLETED|Overall Study||1
312220|NCT00723489|752940|P4|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
312221|NCT00723489|752941|P3|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|19
312222|NCT00723489|752942|P2|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|15
312223|NCT00723489|752943|P1|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
312224|NCT00723489|752940|P4|STARTED|Overall Study||23
312225|NCT00723489|752941|P3|STARTED|Overall Study||19
312226|NCT00723489|752942|P2|STARTED|Overall Study||19
312227|NCT00723489|752943|P1|STARTED|Overall Study||21
312228|NCT00723450|752971|P3|NOT COMPLETED|Randomized Phase||67
312229|NCT00723450|752972|P2|NOT COMPLETED|Randomized Phase||65
312230|NCT00723450|752973|P1|NOT COMPLETED|Randomized Phase||0
312231|NCT00723450|752971|P3|COMPLETED|Randomized Phase||20
312232|NCT00723450|752972|P2|COMPLETED|Randomized Phase||21
312233|NCT00723450|752973|P1|COMPLETED|Randomized Phase||0
312234|NCT00723450|752971|P3|STARTED|Randomized Phase||87
312235|NCT00723450|752972|P2|STARTED|Randomized Phase||86
312236|NCT00723450|752973|P1|STARTED|Randomized Phase||0
312237|NCT00723450|752971|P3|NOT COMPLETED|Open-Label Phase||0
312238|NCT00723450|752972|P2|NOT COMPLETED|Open-Label Phase||0
312239|NCT00723450|752973|P1|NOT COMPLETED|Open-Label Phase||125
312240|NCT00723450|752971|P3|COMPLETED|Open-Label Phase||0
312241|NCT00723450|752972|P2|COMPLETED|Open-Label Phase||0
312242|NCT00723450|752973|P1|COMPLETED|Open-Label Phase||173
312243|NCT00723450|752971|P3|STARTED|Open-Label Phase||0
312244|NCT00723450|752972|P2|STARTED|Open-Label Phase||0
312245|NCT00723450|752973|P1|STARTED|Open-Label Phase||298
312246|NCT00723398|753019|P5|NOT COMPLETED|Overall Study||9
312247|NCT00723398|753020|P4|NOT COMPLETED|Overall Study||5
312248|NCT00723398|753021|P3|NOT COMPLETED|Overall Study||17
312249|NCT00723398|753022|P2|NOT COMPLETED|Overall Study||15
312250|NCT00723398|753023|P1|NOT COMPLETED|Overall Study||6
312251|NCT00723398|753019|P5|COMPLETED|Overall Study||44
312252|NCT00723398|753020|P4|COMPLETED|Overall Study||49
312253|NCT00723398|753021|P3|COMPLETED|Overall Study||36
312254|NCT00723398|753022|P2|COMPLETED|Overall Study||38
312255|NCT00723398|753023|P1|COMPLETED|Overall Study||47
312256|NCT00723398|753019|P5|STARTED|Overall Study||53
312257|NCT00723398|753020|P4|STARTED|Overall Study||54
312258|NCT00723398|753021|P3|STARTED|Overall Study||53
312259|NCT00723398|753022|P2|STARTED|Overall Study||53
312260|NCT00723398|753023|P1|STARTED|Overall Study||53
312261|NCT00723294|753085|P1|NOT COMPLETED|Overall Study||13
312262|NCT00723294|753085|P1|COMPLETED|Overall Study||86
312263|NCT00723294|753085|P1|STARTED|Overall Study||99
312264|NCT00723255|753090|P1|NOT COMPLETED|Overall Study||4
312265|NCT00723255|753090|P1|COMPLETED|Overall Study|Eligible and treated patients|49
312266|NCT00723255|753090|P1|STARTED|Overall Study||53
312267|NCT00723229|753117|P2|NOT COMPLETED|Second Intervention||0
312268|NCT00723229|753118|P1|NOT COMPLETED|Second Intervention||0
312269|NCT00723229|753117|P2|COMPLETED|Second Intervention||20
312270|NCT00723229|753118|P1|COMPLETED|Second Intervention||18
312271|NCT00723229|753117|P2|STARTED|Second Intervention||20
312272|NCT00723229|753118|P1|STARTED|Second Intervention||18
312273|NCT00723229|753117|P2|NOT COMPLETED|First Intervention||3
312274|NCT00723229|753118|P1|NOT COMPLETED|First Intervention||7
312275|NCT00723229|753117|P2|COMPLETED|First Intervention||20
312276|NCT00723229|753118|P1|COMPLETED|First Intervention||18
312277|NCT00723229|753117|P2|STARTED|First Intervention||23
312278|NCT00723229|753118|P1|STARTED|First Intervention||25
312279|NCT00723203|753130|P1|NOT COMPLETED|Overall Study||3
312280|NCT00723203|753130|P1|COMPLETED|Overall Study||13
312281|NCT00723203|753130|P1|STARTED|Overall Study||16
312282|NCT00723190|753134|P1|NOT COMPLETED|Overall Study||142
312283|NCT00723190|753134|P1|COMPLETED|Overall Study|53 participants completed 6-month protocol and 108 participants completed 12-month protocol|161
312284|NCT00723190|753134|P1|SAFETY POPULATION|Overall Study||301
312285|NCT00723190|753134|P1|STARTED|Overall Study|Study CLON-301 (168 participants) and Study CLON-302 (135 participants)|303
312286|NCT00723177|753152|P3|NOT COMPLETED|Overall Study||5
312287|NCT00723177|753153|P2|NOT COMPLETED|Overall Study||4
312288|NCT00723177|753154|P1|NOT COMPLETED|Overall Study||5
312289|NCT00723177|753152|P3|COMPLETED|Overall Study||10
312290|NCT00723177|753153|P2|COMPLETED|Overall Study||10
312291|NCT00723177|753154|P1|COMPLETED|Overall Study||10
312292|NCT00723177|753152|P3|STARTED|Overall Study||15
312293|NCT00723177|753153|P2|STARTED|Overall Study||14
312294|NCT00723177|753154|P1|STARTED|Overall Study||15
312295|NCT00723125|753167|P2|NOT COMPLETED|Overall Study||6
312296|NCT00723125|753168|P1|NOT COMPLETED|Overall Study||18
312297|NCT00723125|753167|P2|COMPLETED|Overall Study||21
312298|NCT00723125|753168|P1|COMPLETED|Overall Study||15
312299|NCT00723125|753167|P2|STARTED|Overall Study|27 evaluable Neo-adjuvant Of 27 patients neo-adjuvant, 24 DDAC Of 24 DDAC, 21 Avastin post-op|27
312300|NCT00723125|753168|P1|STARTED|Overall Study|33 pts Neo-adjuvant, 28 evaluable,DDAC: Of 28 pts,27 treated DDAC Avastin:Of 27,15 Avastin post-op|33
312301|NCT00723099|753178|P1|NOT COMPLETED|Overall Study||1
312302|NCT00723099|753178|P1|COMPLETED|Overall Study||72
312303|NCT00723099|753178|P1|STARTED|Overall Study||73
312304|NCT00723073|753192|P2|NOT COMPLETED|Overall Study||0
312305|NCT00723073|753193|P1|NOT COMPLETED|Overall Study||0
312306|NCT00723073|753192|P2|COMPLETED|Overall Study||174
312307|NCT00723073|753193|P1|COMPLETED|Overall Study||149
312308|NCT00723073|753192|P2|STARTED|Overall Study||174
312309|NCT00723073|753193|P1|STARTED|Overall Study||149
312310|NCT00723021|753217|P5|NOT COMPLETED|Intervention Period 5||0
312311|NCT00723021|753218|P4|NOT COMPLETED|Intervention Period 5||0
312312|NCT00723021|753219|P3|NOT COMPLETED|Intervention Period 5||0
312313|NCT00723021|753220|P2|NOT COMPLETED|Intervention Period 5||0
312314|NCT00723021|753221|P1|NOT COMPLETED|Intervention Period 5||0
312315|NCT00723021|753217|P5|COMPLETED|Intervention Period 5||2
312316|NCT00723021|753218|P4|COMPLETED|Intervention Period 5||3
312317|NCT00723021|753219|P3|COMPLETED|Intervention Period 5||3
312318|NCT00723021|753220|P2|COMPLETED|Intervention Period 5||3
312319|NCT00723021|753221|P1|COMPLETED|Intervention Period 5||3
312320|NCT00723021|753217|P5|STARTED|Intervention Period 5||2
312321|NCT00723021|753218|P4|STARTED|Intervention Period 5||3
312322|NCT00723021|753219|P3|STARTED|Intervention Period 5||3
312323|NCT00723021|753220|P2|STARTED|Intervention Period 5||3
312324|NCT00723021|753221|P1|STARTED|Intervention Period 5||3
312325|NCT00723021|753217|P5|NOT COMPLETED|Intervention Period 4||1
312326|NCT00723021|753218|P4|NOT COMPLETED|Intervention Period 4||0
312327|NCT00723021|753219|P3|NOT COMPLETED|Intervention Period 4||0
312328|NCT00723021|753220|P2|NOT COMPLETED|Intervention Period 4||0
312329|NCT00723021|753221|P1|NOT COMPLETED|Intervention Period 4||0
312330|NCT00723021|753217|P5|COMPLETED|Intervention Period 4||2
312331|NCT00723021|753218|P4|COMPLETED|Intervention Period 4||3
312332|NCT00723021|753219|P3|COMPLETED|Intervention Period 4||3
312333|NCT00723021|753220|P2|COMPLETED|Intervention Period 4||3
312334|NCT00723021|753221|P1|COMPLETED|Intervention Period 4||3
312335|NCT00723021|753217|P5|STARTED|Intervention Period 4||3
312336|NCT00723021|753218|P4|STARTED|Intervention Period 4||3
312337|NCT00723021|753219|P3|STARTED|Intervention Period 4||3
312338|NCT00723021|753220|P2|STARTED|Intervention Period 4||3
312339|NCT00723021|753221|P1|STARTED|Intervention Period 4||3
312340|NCT00723021|753217|P5|NOT COMPLETED|Intervention Period 3||0
312341|NCT00723021|753218|P4|NOT COMPLETED|Intervention Period 3||0
312342|NCT00723021|753219|P3|NOT COMPLETED|Intervention Period 3||0
312343|NCT00723021|753220|P2|NOT COMPLETED|Intervention Period 3||0
312344|NCT00723021|753221|P1|NOT COMPLETED|Intervention Period 3||0
312345|NCT00723021|753217|P5|COMPLETED|Intervention Period 3||3
312346|NCT00723021|753218|P4|COMPLETED|Intervention Period 3||3
312347|NCT00723021|753219|P3|COMPLETED|Intervention Period 3||3
312348|NCT00723021|753220|P2|COMPLETED|Intervention Period 3||3
312349|NCT00723021|753221|P1|COMPLETED|Intervention Period 3||3
312350|NCT00723021|753217|P5|STARTED|Intervention Period 3||3
312351|NCT00723021|753218|P4|STARTED|Intervention Period 3||3
312352|NCT00723021|753219|P3|STARTED|Intervention Period 3||3
312353|NCT00723021|753220|P2|STARTED|Intervention Period 3||3
312354|NCT00723021|753221|P1|STARTED|Intervention Period 3||3
312355|NCT00723021|753217|P5|NOT COMPLETED|Intervention Period 2||0
312356|NCT00723021|753218|P4|NOT COMPLETED|Intervention Period 2||0
312357|NCT00723021|753219|P3|NOT COMPLETED|Intervention Period 2||0
312358|NCT00723021|753220|P2|NOT COMPLETED|Intervention Period 2||0
312359|NCT00723021|753221|P1|NOT COMPLETED|Intervention Period 2||0
312360|NCT00723021|753217|P5|COMPLETED|Intervention Period 2||3
312361|NCT00723021|753218|P4|COMPLETED|Intervention Period 2||3
312362|NCT00723021|753219|P3|COMPLETED|Intervention Period 2||3
312363|NCT00723021|753220|P2|COMPLETED|Intervention Period 2||3
312364|NCT00723021|753221|P1|COMPLETED|Intervention Period 2||3
312365|NCT00723021|753217|P5|STARTED|Intervention Period 2||3
312366|NCT00723021|753218|P4|STARTED|Intervention Period 2||3
312367|NCT00723021|753219|P3|STARTED|Intervention Period 2||3
312368|NCT00723021|753220|P2|STARTED|Intervention Period 2||3
312369|NCT00723021|753221|P1|STARTED|Intervention Period 2||3
312370|NCT00723021|753217|P5|NOT COMPLETED|Intervention Period 1||0
312371|NCT00723021|753218|P4|NOT COMPLETED|Intervention Period 1||0
312372|NCT00723021|753219|P3|NOT COMPLETED|Intervention Period 1||0
312373|NCT00723021|753220|P2|NOT COMPLETED|Intervention Period 1||0
312374|NCT00723021|753221|P1|NOT COMPLETED|Intervention Period 1||0
312375|NCT00723021|753217|P5|COMPLETED|Intervention Period 1||3
312376|NCT00723021|753218|P4|COMPLETED|Intervention Period 1||3
312377|NCT00723021|753219|P3|COMPLETED|Intervention Period 1||3
312378|NCT00723021|753220|P2|COMPLETED|Intervention Period 1||3
312379|NCT00723021|753221|P1|COMPLETED|Intervention Period 1||3
312380|NCT00723021|753217|P5|STARTED|Intervention Period 1||3
312381|NCT00723021|753218|P4|STARTED|Intervention Period 1||3
312382|NCT00723021|753219|P3|STARTED|Intervention Period 1||3
312383|NCT00723021|753220|P2|STARTED|Intervention Period 1||3
312384|NCT00723021|753221|P1|STARTED|Intervention Period 1||3
312385|NCT00723008|753275|P2|NOT COMPLETED|4-Week Unblinded Treatment||1
312386|NCT00723008|753276|P1|NOT COMPLETED|4-Week Unblinded Treatment||1
312387|NCT00723008|753275|P2|COMPLETED|4-Week Unblinded Treatment||3
312388|NCT00723008|753276|P1|COMPLETED|4-Week Unblinded Treatment||4
312389|NCT00723008|753275|P2|STARTED|4-Week Unblinded Treatment||4
312390|NCT00723008|753276|P1|STARTED|4-Week Unblinded Treatment||5
312391|NCT00723008|753275|P2|NOT COMPLETED|4-Week Double Blinded||5
312392|NCT00723008|753276|P1|NOT COMPLETED|4-Week Double Blinded||5
312393|NCT00723008|753275|P2|COMPLETED|4-Week Double Blinded||4
312394|NCT00723008|753276|P1|COMPLETED|4-Week Double Blinded||5
312395|NCT00723008|753275|P2|STARTED|4-Week Double Blinded||9
312396|NCT00723008|753276|P1|STARTED|4-Week Double Blinded||10
312397|NCT00723008|753275|P2|NOT COMPLETED|Enrollment||0
312398|NCT00723008|753276|P1|NOT COMPLETED|Enrollment||1
312399|NCT00723008|753275|P2|COMPLETED|Enrollment||9
312400|NCT00723008|753276|P1|COMPLETED|Enrollment||10
312401|NCT00723008|753275|P2|STARTED|Enrollment||9
312402|NCT00723008|753276|P1|STARTED|Enrollment||11
312403|NCT00722865|753298|P1|NOT COMPLETED|Overall Study||2
312404|NCT00722865|753298|P1|COMPLETED|Overall Study||23
312405|NCT00722865|753298|P1|STARTED|Overall Study||25
312406|NCT00722800|753308|P2|NOT COMPLETED|Overall Study||0
312407|NCT00722800|753309|P1|NOT COMPLETED|Overall Study||2
312408|NCT00722800|753308|P2|COMPLETED|Overall Study||2
312409|NCT00722800|753309|P1|COMPLETED|Overall Study||0
312410|NCT00722800|753308|P2|STARTED|Overall Study||2
312411|NCT00722800|753309|P1|STARTED|Overall Study||2
312412|NCT00722761|753321|P2|NOT COMPLETED|Overall Study||6
312413|NCT00722761|753322|P1|NOT COMPLETED|Overall Study||6
312414|NCT00722761|753321|P2|COMPLETED|Overall Study||8
312415|NCT00722761|753322|P1|COMPLETED|Overall Study||10
312416|NCT00722761|753321|P2|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||10
312417|NCT00722761|753322|P1|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||15
312418|NCT00722761|753321|P2|STARTED|Overall Study||14
312419|NCT00722761|753322|P1|STARTED|Overall Study||16
312420|NCT00722722|753333|P3|NOT COMPLETED|Overall Study||0
312421|NCT00722722|753334|P2|NOT COMPLETED|Overall Study||0
312422|NCT00722722|753335|P1|NOT COMPLETED|Overall Study||0
312423|NCT00722722|753333|P3|COMPLETED|Overall Study||10
312424|NCT00722722|753334|P2|COMPLETED|Overall Study||5
312425|NCT00722722|753335|P1|COMPLETED|Overall Study||3
312426|NCT00722722|753333|P3|STARTED|Overall Study||10
312427|NCT00722722|753334|P2|STARTED|Overall Study||5
312428|NCT00722722|753335|P1|STARTED|Overall Study||3
312429|NCT00722566|753345|P2|NOT COMPLETED|Overall Study||35
312430|NCT00722566|753346|P1|NOT COMPLETED|Overall Study||67
312431|NCT00722566|753345|P2|COMPLETED|Overall Study|Completed 8 cycles|39
312432|NCT00722566|753346|P1|COMPLETED|Overall Study|Completed 8 cycles|81
312433|NCT00722566|753345|P2|STARTED|Overall Study||74
312434|NCT00722566|753346|P1|STARTED|Overall Study|One patient randomized and not dosed|148
312435|NCT00722553|753354|P1|NOT COMPLETED|Overall Study||0
312436|NCT00722553|753354|P1|COMPLETED|Overall Study||30
312437|NCT00722553|753354|P1|STARTED|Overall Study||30
312438|NCT00722436|753364|P2|NOT COMPLETED|Overall Study||0
312439|NCT00722436|753365|P1|NOT COMPLETED|Overall Study||0
312440|NCT00722436|753364|P2|COMPLETED|Overall Study||11
312441|NCT00722436|753365|P1|COMPLETED|Overall Study||9
312442|NCT00722436|753364|P2|STARTED|Overall Study||11
312443|NCT00722436|753365|P1|STARTED|Overall Study||9
312444|NCT00722423|753379|P2|NOT COMPLETED|Overall Study||1
312445|NCT00722423|753380|P1|NOT COMPLETED|Overall Study||0
312446|NCT00722423|753379|P2|COMPLETED|Overall Study||181
312447|NCT00722423|753380|P1|COMPLETED|Overall Study||182
312448|NCT00722423|753379|P2|STARTED|Overall Study||182
312449|NCT00722423|753380|P1|STARTED|Overall Study||182
312450|NCT00722371|753395|P7|NOT COMPLETED|Overall Study||51
312451|NCT00722371|753396|P6|NOT COMPLETED|Overall Study||53
312452|NCT00722371|753397|P5|NOT COMPLETED|Overall Study||48
312453|NCT00722371|753398|P4|NOT COMPLETED|Overall Study||63
312454|NCT00722371|753399|P3|NOT COMPLETED|Overall Study||65
312455|NCT00722371|753400|P2|NOT COMPLETED|Overall Study||72
312456|NCT00722371|753401|P1|NOT COMPLETED|Overall Study||56
312457|NCT00722371|753395|P7|COMPLETED|Overall Study||179
312458|NCT00722371|753396|P6|COMPLETED|Overall Study||178
312459|NCT00722371|753397|P5|COMPLETED|Overall Study||182
312460|NCT00722371|753398|P4|COMPLETED|Overall Study||167
312461|NCT00722371|753399|P3|COMPLETED|Overall Study||168
312462|NCT00722371|753400|P2|COMPLETED|Overall Study||158
312463|NCT00722371|753401|P1|COMPLETED|Overall Study||175
312464|NCT00722371|753395|P7|STARTED|Overall Study||230
312465|NCT00722371|753396|P6|STARTED|Overall Study||231
312466|NCT00722371|753397|P5|STARTED|Overall Study||230
312467|NCT00722371|753398|P4|STARTED|Overall Study||230
312468|NCT00722371|753399|P3|STARTED|Overall Study||233
312469|NCT00722371|753400|P2|STARTED|Overall Study||230
312470|NCT00722371|753401|P1|STARTED|Overall Study||231
312471|NCT00722137|753454|P2|NOT COMPLETED|Overall Study||48
312472|NCT00722137|753455|P1|NOT COMPLETED|Overall Study||45
312473|NCT00722137|753454|P2|COMPLETED|Overall Study||195
312474|NCT00722137|753455|P1|COMPLETED|Overall Study||199
312475|NCT00722137|753454|P2|STARTED|Overall Study||243
312476|NCT00722137|753455|P1|STARTED|Overall Study||244
312477|NCT00722124|753484|P3|NOT COMPLETED|Overall Study||20
312478|NCT00722124|753485|P2|NOT COMPLETED|Overall Study||14
312479|NCT00722124|753486|P1|NOT COMPLETED|Overall Study||17
312480|NCT00722124|753484|P3|COMPLETED|Overall Study||20
312481|NCT00722124|753485|P2|COMPLETED|Overall Study||26
312482|NCT00722124|753486|P1|COMPLETED|Overall Study||23
312483|NCT00722124|753484|P3|STARTED|Overall Study||40
312484|NCT00722124|753485|P2|STARTED|Overall Study||40
312485|NCT00722124|753486|P1|STARTED|Overall Study||40
312486|NCT00722111|753496|P2|NOT COMPLETED|Overall Study||0
312487|NCT00722111|753497|P1|NOT COMPLETED|Overall Study||0
312488|NCT00722111|753496|P2|COMPLETED|Overall Study||72
312489|NCT00722111|753497|P1|COMPLETED|Overall Study||11
312490|NCT00722111|753496|P2|STARTED|Overall Study||72
312491|NCT00722111|753497|P1|STARTED|Overall Study||11
312492|NCT00722072|753504|P1|NOT COMPLETED|Overall Study||3
312493|NCT00722072|753504|P1|COMPLETED|Overall Study||9
312494|NCT00722072|753504|P1|STARTED|Overall Study||12
312495|NCT00722020|753514|P2|NOT COMPLETED|Overall Study||0
312496|NCT00722020|753515|P1|NOT COMPLETED|Overall Study||0
312497|NCT00722020|753514|P2|COMPLETED|Overall Study||24
312498|NCT00722020|753515|P1|COMPLETED|Overall Study||19
312499|NCT00722020|753514|P2|STARTED|Overall Study||24
312500|NCT00722020|753515|P1|STARTED|Overall Study||19
312501|NCT00722007|753523|P1|NOT COMPLETED|Overall Study||30
312502|NCT00722007|753523|P1|COMPLETED|Overall Study||117
312503|NCT00722007|753523|P1|STARTED|Overall Study||147
312504|NCT00721968|753533|P2|NOT COMPLETED|Overall Study||0
312505|NCT00721968|753534|P1|NOT COMPLETED|Overall Study||2
312506|NCT00721968|753533|P2|COMPLETED|Overall Study||17
312507|NCT00721968|753534|P1|COMPLETED|Overall Study||25
312508|NCT00721968|753533|P2|STARTED|Overall Study||17
312509|NCT00721968|753534|P1|STARTED|Overall Study||27
312510|NCT00721955|753545|P3|NOT COMPLETED|Overall Study||2
312511|NCT00721955|753546|P2|NOT COMPLETED|Overall Study||0
312512|NCT00721955|753547|P1|NOT COMPLETED|Overall Study||0
312513|NCT00721955|753545|P3|COMPLETED|Overall Study||103
312514|NCT00721955|753546|P2|COMPLETED|Overall Study||104
312515|NCT00721955|753547|P1|COMPLETED|Overall Study||105
312516|NCT00721955|753545|P3|STARTED|Overall Study||105
312517|NCT00721955|753546|P2|STARTED|Overall Study||104
312518|NCT00721955|753547|P1|STARTED|Overall Study||105
312519|NCT00721799|753561|P1|NOT COMPLETED|Overall Study||8
312520|NCT00721799|753561|P1|COMPLETED|Overall Study||25
312521|NCT00721799|753561|P1|Received FLT PET Scan #2|Overall Study||25
312522|NCT00721799|753561|P1|Recieved FLT PET Scan 1|Overall Study||26
312523|NCT00721799|753561|P1|STARTED|Overall Study||33
312524|NCT00721734|753601|P5|NOT COMPLETED|Overall Study||6
312525|NCT00721734|753602|P4|NOT COMPLETED|Overall Study||6
312526|NCT00721734|753603|P3|NOT COMPLETED|Overall Study||8
312527|NCT00721734|753604|P2|NOT COMPLETED|Overall Study||12
312528|NCT00721734|753605|P1|NOT COMPLETED|Overall Study||8
312529|NCT00721734|753601|P5|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
312530|NCT00721734|753602|P4|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
312531|NCT00721734|753603|P3|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
312532|NCT00721734|753604|P2|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|0
312533|NCT00721734|753605|P1|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|4
312534|NCT00721734|753601|P5|STARTED|Overall Study||8
312535|NCT00721734|753602|P4|STARTED|Overall Study||8
312536|NCT00721734|753603|P3|STARTED|Overall Study||10
312537|NCT00721734|753604|P2|STARTED|Overall Study||12
312538|NCT00721734|753605|P1|STARTED|Overall Study||12
312539|NCT00721630|753717|P1|NOT COMPLETED|Overall Study||1
312540|NCT00721630|753717|P1|COMPLETED|Overall Study||23
312541|NCT00721630|753717|P1|STARTED|Overall Study||24
312542|NCT00721617|753722|P1|NOT COMPLETED|8 Hours Into Intralipid/Dextrose||0
312543|NCT00721617|753722|P1|COMPLETED|8 Hours Into Intralipid/Dextrose||12
312544|NCT00721617|753722|P1|STARTED|8 Hours Into Intralipid/Dextrose||12
312545|NCT00721617|753722|P1|NOT COMPLETED|4 Hours Into Intralipid/Dextrose||0
312546|NCT00721617|753722|P1|COMPLETED|4 Hours Into Intralipid/Dextrose||12
312547|NCT00721617|753722|P1|STARTED|4 Hours Into Intralipid/Dextrose||12
312548|NCT00721617|753722|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||0
312549|NCT00721617|753722|P1|COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||12
312550|NCT00721617|753722|P1|STARTED|0 Hour (Baseline) of Intralipid/Dextrose||12
312551|NCT00721617|753722|P1|NOT COMPLETED|8 Hours Into Dextrose Infusion||0
312552|NCT00721617|753722|P1|COMPLETED|8 Hours Into Dextrose Infusion||12
312553|NCT00721617|753722|P1|STARTED|8 Hours Into Dextrose Infusion||12
312554|NCT00721617|753722|P1|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
312555|NCT00721617|753722|P1|COMPLETED|4 Hours Into Dextrose Infusion||12
312556|NCT00721617|753722|P1|STARTED|4 Hours Into Dextrose Infusion||12
312557|NCT00721617|753722|P1|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
312558|NCT00721617|753722|P1|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
312559|NCT00721617|753722|P1|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
312560|NCT00721617|753722|P1|NOT COMPLETED|8 Hours Into Intralipid Infusion||0
312561|NCT00721617|753722|P1|COMPLETED|8 Hours Into Intralipid Infusion||12
312562|NCT00721617|753722|P1|STARTED|8 Hours Into Intralipid Infusion||12
312563|NCT00721617|753722|P1|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
312564|NCT00721617|753722|P1|COMPLETED|4 Hours Into Intralipid Infusion||12
312565|NCT00721617|753722|P1|STARTED|4 Hours Into Intralipid Infusion||12
312566|NCT00721617|753722|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
312567|NCT00721617|753722|P1|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
312568|NCT00721617|753722|P1|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
312569|NCT00721617|753722|P1|NOT COMPLETED|8 Hours Into Saline Infusion||0
312570|NCT00721617|753722|P1|COMPLETED|8 Hours Into Saline Infusion||12
312571|NCT00721617|753722|P1|STARTED|8 Hours Into Saline Infusion||12
312572|NCT00721617|753722|P1|NOT COMPLETED|4 Hours Into Saline Infusion||0
312573|NCT00721617|753722|P1|COMPLETED|4 Hours Into Saline Infusion||12
312574|NCT00721617|753722|P1|STARTED|4 Hours Into Saline Infusion||12
312575|NCT00721617|753722|P1|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
312576|NCT00721617|753722|P1|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
312577|NCT00721617|753722|P1|STARTED|0 Hour (Baseline) of Saline Infusion||12
312578|NCT00721578|753746|P2|NOT COMPLETED|Overall Study||2
312579|NCT00721578|753747|P1|NOT COMPLETED|Overall Study||2
312580|NCT00721578|753746|P2|COMPLETED|Overall Study||9
312581|NCT00721578|753747|P1|COMPLETED|Overall Study||10
312582|NCT00721578|753746|P2|STARTED|Overall Study||11
312583|NCT00721578|753747|P1|STARTED|Overall Study||12
312584|NCT00721539|753759|P1|NOT COMPLETED|Overall Study||0
312585|NCT00721539|753759|P1|COMPLETED|Overall Study||9
312586|NCT00721539|753759|P1|STARTED|Overall Study||9
312587|NCT00721513|753766|P1|NOT COMPLETED|Overall Study||0
312588|NCT00721513|753766|P1|COMPLETED|Overall Study||20
312589|NCT00721513|753766|P1|STARTED|Overall Study||20
312590|NCT00721500|753778|P4|NOT COMPLETED|Period Three||0
312591|NCT00721500|753779|P3|NOT COMPLETED|Period Three||0
312592|NCT00721500|753780|P2|NOT COMPLETED|Period Three||0
312593|NCT00721500|753781|P1|NOT COMPLETED|Period Three||0
312594|NCT00721500|753778|P4|COMPLETED|Period Three||6
312595|NCT00721500|753779|P3|COMPLETED|Period Three||6
312596|NCT00721500|753780|P2|COMPLETED|Period Three||7
312597|NCT00721500|753781|P1|COMPLETED|Period Three||6
312598|NCT00721500|753778|P4|STARTED|Period Three||6
312599|NCT00721500|753779|P3|STARTED|Period Three||6
312600|NCT00721500|753780|P2|STARTED|Period Three||7
312601|NCT00721500|753781|P1|STARTED|Period Three||6
312602|NCT00721500|753778|P4|NOT COMPLETED|Period Two||0
312603|NCT00721500|753779|P3|NOT COMPLETED|Period Two||0
312604|NCT00721500|753780|P2|NOT COMPLETED|Period Two||0
312605|NCT00721500|753781|P1|NOT COMPLETED|Period Two||0
312606|NCT00721500|753778|P4|COMPLETED|Period Two||6
312607|NCT00721500|753779|P3|COMPLETED|Period Two||6
312608|NCT00721500|753780|P2|COMPLETED|Period Two||7
312609|NCT00721500|753781|P1|COMPLETED|Period Two||6
312610|NCT00721500|753778|P4|STARTED|Period Two||6
312611|NCT00721500|753779|P3|STARTED|Period Two||6
312612|NCT00721500|753780|P2|STARTED|Period Two||7
312613|NCT00721500|753781|P1|STARTED|Period Two||6
312614|NCT00721500|753778|P4|NOT COMPLETED|Period One||0
312615|NCT00721500|753779|P3|NOT COMPLETED|Period One||0
312616|NCT00721500|753780|P2|NOT COMPLETED|Period One||0
312617|NCT00721500|753781|P1|NOT COMPLETED|Period One||0
312618|NCT00721500|753778|P4|COMPLETED|Period One||6
312619|NCT00721500|753779|P3|COMPLETED|Period One||6
312620|NCT00721500|753780|P2|COMPLETED|Period One||7
312621|NCT00721500|753781|P1|COMPLETED|Period One||6
312622|NCT00721500|753778|P4|STARTED|Period One||6
312623|NCT00721500|753779|P3|STARTED|Period One||6
312624|NCT00721500|753780|P2|STARTED|Period One||7
312625|NCT00721500|753781|P1|STARTED|Period One||6
312626|NCT00721409|753802|P3|NOT COMPLETED|Overall Study||79
312627|NCT00721409|753803|P2|NOT COMPLETED|Overall Study||82
312628|NCT00721409|753804|P1|NOT COMPLETED|Overall Study||12
312629|NCT00721409|753802|P3|COMPLETED|Overall Study||2
312630|NCT00721409|753803|P2|COMPLETED|Overall Study||2
312631|NCT00721409|753804|P1|COMPLETED|Overall Study||0
312632|NCT00721409|753802|P3|Treated|Overall Study||77
312633|NCT00721409|753803|P2|Treated|Overall Study||83
312634|NCT00721409|753804|P1|Treated|Overall Study||12
312635|NCT00721409|753802|P3|STARTED|Overall Study||81
312636|NCT00721409|753803|P2|STARTED|Overall Study||84
312637|NCT00721409|753804|P1|STARTED|Overall Study||12
312638|NCT00721396|753931|P4|NOT COMPLETED|Overall Study||10
312639|NCT00721396|753932|P3|NOT COMPLETED|Overall Study||10
312640|NCT00721396|753933|P2|NOT COMPLETED|Overall Study||36
312641|NCT00721396|753934|P1|NOT COMPLETED|Overall Study||30
312642|NCT00721396|753931|P4|COMPLETED|Overall Study||302
312643|NCT00721396|753932|P3|COMPLETED|Overall Study||308
312644|NCT00721396|753933|P2|COMPLETED|Overall Study||592
312645|NCT00721396|753934|P1|COMPLETED|Overall Study||597
312646|NCT00721396|753931|P4|STARTED|Overall Study||312
312647|NCT00721396|753932|P3|STARTED|Overall Study||318
312648|NCT00721396|753933|P2|STARTED|Overall Study||628
312649|NCT00721396|753934|P1|STARTED|Overall Study||627
312650|NCT00721357|753972|P2|NOT COMPLETED|Overall Study||0
312651|NCT00721357|753973|P1|NOT COMPLETED|Overall Study||0
312652|NCT00721357|753972|P2|COMPLETED|Overall Study||15
312653|NCT00721357|753973|P1|COMPLETED|Overall Study||15
312654|NCT00721357|753972|P2|STARTED|Overall Study||15
312655|NCT00721357|753973|P1|STARTED|Overall Study||15
312656|NCT00721279|753985|P2|NOT COMPLETED|Overall Study||24
312657|NCT00721279|753986|P1|NOT COMPLETED|Overall Study||36
312658|NCT00721279|753985|P2|COMPLETED|Overall Study||73
312659|NCT00721279|753986|P1|COMPLETED|Overall Study||416
312660|NCT00721279|753985|P2|STARTED|Overall Study||97
312661|NCT00721279|753986|P1|STARTED|Overall Study||452
312662|NCT00721253|754000|P3|NOT COMPLETED|Overall Study||0
312663|NCT00721253|754001|P2|NOT COMPLETED|Overall Study||0
312664|NCT00721253|754002|P1|NOT COMPLETED|Overall Study||0
312665|NCT00721253|754000|P3|COMPLETED|Overall Study||0
312666|NCT00721253|754001|P2|COMPLETED|Overall Study||22
312667|NCT00721253|754002|P1|COMPLETED|Overall Study||20
312668|NCT00721253|754000|P3|STARTED|Overall Study|There were no subjects that were implanted with the Tecnis lens.|0
312669|NCT00721253|754001|P2|STARTED|Overall Study||22
312670|NCT00721253|754002|P1|STARTED|Overall Study||20
312671|NCT00721227|754014|P2|NOT COMPLETED|Overall Study||0
312672|NCT00721227|754015|P1|NOT COMPLETED|Overall Study||4
312673|NCT00721227|754014|P2|COMPLETED|Overall Study||6
312766|NCT00720499|754311|P2|COMPLETED|Treatment Period 1 (4 Weeks)||70
312674|NCT00721227|754015|P1|COMPLETED|Overall Study|3 subjects lost to follow up; 1 subject did not complete due to noncompliance of scheduled visits.|5
312675|NCT00721227|754014|P2|STARTED|Overall Study||6
312676|NCT00721227|754015|P1|STARTED|Overall Study||9
312677|NCT00721214|754025|P1|NOT COMPLETED|Overall Study||4
312678|NCT00721214|754025|P1|COMPLETED|Overall Study||12
312679|NCT00721214|754025|P1|STARTED|Overall Study||16
312680|NCT00721188|754036|P1|NOT COMPLETED|Overall Study||0
312681|NCT00721188|754036|P1|COMPLETED|Overall Study||11
312682|NCT00721188|754036|P1|STARTED|Overall Study||11
312683|NCT00721175|754053|P2|NOT COMPLETED|Overall Study||0
312684|NCT00721175|754054|P1|NOT COMPLETED|Overall Study||0
312685|NCT00721175|754053|P2|COMPLETED|Overall Study||54
312686|NCT00721175|754054|P1|COMPLETED|Overall Study||54
312687|NCT00721175|754053|P2|STARTED|Overall Study||54
312688|NCT00721175|754054|P1|STARTED|Overall Study||54
312689|NCT00721162|754066|P1|NOT COMPLETED|Overall Study||0
312690|NCT00721162|754066|P1|COMPLETED|Overall Study||60
312691|NCT00721162|754066|P1|Received Any Amount of Study Drug|Overall Study||60
312692|NCT00721162|754066|P1|STARTED|Overall Study||60
312693|NCT00721149|754075|P1|NOT COMPLETED|Overall Study||1
312694|NCT00721149|754075|P1|COMPLETED|Overall Study||9
312695|NCT00721149|754075|P1|STARTED|Overall Study|Enrollment was stopped after 10 subjects entered the trial.|10
312696|NCT00721136|754088|P4|NOT COMPLETED|Overall Study||0
312697|NCT00721136|754089|P3|NOT COMPLETED|Overall Study||0
312698|NCT00721136|754090|P2|NOT COMPLETED|Overall Study||0
312699|NCT00721136|754091|P1|NOT COMPLETED|Overall Study||0
312700|NCT00721136|754088|P4|COMPLETED|Overall Study||8
312701|NCT00721136|754089|P3|COMPLETED|Overall Study||8
312702|NCT00721136|754090|P2|COMPLETED|Overall Study||42
312703|NCT00721136|754091|P1|COMPLETED|Overall Study||42
312704|NCT00721136|754088|P4|STARTED|Overall Study||8
312705|NCT00721136|754089|P3|STARTED|Overall Study||8
312706|NCT00721136|754090|P2|STARTED|Overall Study||42
312707|NCT00721136|754091|P1|STARTED|Overall Study||42
312708|NCT00721123|754109|P1|NOT COMPLETED|Overall Study||183
312709|NCT00721123|754109|P1|COMPLETED|Overall Study||355
312710|NCT00721123|754109|P1|STARTED|Overall Study||538
312711|NCT00721110|754187|P4|NOT COMPLETED|Overall Study||0
312712|NCT00721110|754188|P3|NOT COMPLETED|Overall Study||1
312713|NCT00721110|754189|P2|NOT COMPLETED|Overall Study||0
312714|NCT00721110|754190|P1|NOT COMPLETED|Overall Study||1
312715|NCT00721110|754187|P4|COMPLETED|Overall Study||16
312716|NCT00721110|754188|P3|COMPLETED|Overall Study||15
312717|NCT00721110|754189|P2|COMPLETED|Overall Study||16
312718|NCT00721110|754190|P1|COMPLETED|Overall Study||15
312719|NCT00721110|754187|P4|STARTED|Overall Study||16
312720|NCT00721110|754188|P3|STARTED|Overall Study||16
312721|NCT00721110|754189|P2|STARTED|Overall Study||16
312722|NCT00721110|754190|P1|STARTED|Overall Study||16
312723|NCT00720941|754218|P2|NOT COMPLETED|Overall Study||415
312724|NCT00720941|754219|P1|NOT COMPLETED|Overall Study||413
312725|NCT00720941|754218|P2|COMPLETED|Overall Study||138
312726|NCT00720941|754219|P1|COMPLETED|Overall Study||144
312727|NCT00720941|754218|P2|Ongoing|Overall Study||23
312728|NCT00720941|754219|P1|Ongoing|Overall Study||34
312729|NCT00720941|754218|P2|STARTED|Overall Study||553
312730|NCT00720941|754219|P1|STARTED|Overall Study||557
312731|NCT00720876|754259|P1|NOT COMPLETED|Overall Study||2
312732|NCT00720876|754259|P1|COMPLETED|Overall Study||28
312733|NCT00720876|754259|P1|STARTED|Overall Study||30
312734|NCT00720798|754265|P1|NOT COMPLETED|Overall Study||756
312735|NCT00720798|754265|P1|COMPLETED|Overall Study||1311
312736|NCT00720798|754265|P1|STARTED|Overall Study||2067
312737|NCT00720759|754288|P4|NOT COMPLETED|Overall Study||0
312738|NCT00720759|754289|P3|NOT COMPLETED|Overall Study||1
312739|NCT00720759|754290|P2|NOT COMPLETED|Overall Study||1
312740|NCT00720759|754291|P1|NOT COMPLETED|Overall Study||0
312741|NCT00720759|754288|P4|COMPLETED|Overall Study||6
312742|NCT00720759|754289|P3|COMPLETED|Overall Study||5
312743|NCT00720759|754290|P2|COMPLETED|Overall Study||5
312744|NCT00720759|754291|P1|COMPLETED|Overall Study||6
312745|NCT00720759|754288|P4|STARTED|Overall Study||6
312746|NCT00720759|754289|P3|STARTED|Overall Study||6
312747|NCT00720759|754290|P2|STARTED|Overall Study||6
312748|NCT00720759|754291|P1|STARTED|Overall Study||6
312749|NCT00720629|754301|P1|NOT COMPLETED|Overall Study||0
312750|NCT00720629|754301|P1|COMPLETED|Overall Study||8
312751|NCT00720629|754301|P1|STARTED|Overall Study||8
312752|NCT00720499|754311|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||3
312753|NCT00720499|754312|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||2
312754|NCT00720499|754311|P2|COMPLETED|Treatment Period 2 (4 Weeks)||67
312755|NCT00720499|754312|P1|COMPLETED|Treatment Period 2 (4 Weeks)||64
312756|NCT00720499|754311|P2|STARTED|Treatment Period 2 (4 Weeks)||70
312757|NCT00720499|754312|P1|STARTED|Treatment Period 2 (4 Weeks)||66
312758|NCT00720499|754311|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
312759|NCT00720499|754312|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
312760|NCT00720499|754311|P2|COMPLETED|Washout Period (2 Weeks)||70
312761|NCT00720499|754312|P1|COMPLETED|Washout Period (2 Weeks)||66
312762|NCT00720499|754311|P2|STARTED|Washout Period (2 Weeks)||70
312763|NCT00720499|754312|P1|STARTED|Washout Period (2 Weeks)||66
312764|NCT00720499|754311|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||2
312765|NCT00720499|754312|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||3
312767|NCT00720499|754312|P1|COMPLETED|Treatment Period 1 (4 Weeks)||66
312768|NCT00720499|754311|P2|STARTED|Treatment Period 1 (4 Weeks)||72
312769|NCT00720499|754312|P1|STARTED|Treatment Period 1 (4 Weeks)||69
312770|NCT00720473|754376|P2|NOT COMPLETED|Overall Study||8
312771|NCT00720473|754377|P1|NOT COMPLETED|Overall Study||30
312772|NCT00720473|754376|P2|COMPLETED|Overall Study||16
312773|NCT00720473|754377|P1|COMPLETED|Overall Study||15
312774|NCT00720473|754376|P2|STARTED|Overall Study||24
312775|NCT00720473|754377|P1|STARTED|Overall Study||45
312776|NCT00720434|754405|P4|NOT COMPLETED|Open-Label Period (Week 5-72)||4
312777|NCT00720434|754406|P3|NOT COMPLETED|Open-Label Period (Week 5-72)||4
312778|NCT00720434|754407|P2|NOT COMPLETED|Open-Label Period (Week 5-72)||3
312779|NCT00720434|754408|P1|NOT COMPLETED|Open-Label Period (Week 5-72)||6
312780|NCT00720434|754405|P4|COMPLETED|Open-Label Period (Week 5-72)||4
312781|NCT00720434|754406|P3|COMPLETED|Open-Label Period (Week 5-72)||4
312782|NCT00720434|754407|P2|COMPLETED|Open-Label Period (Week 5-72)||5
312783|NCT00720434|754408|P1|COMPLETED|Open-Label Period (Week 5-72)||4
312784|NCT00720434|754405|P4|STARTED|Open-Label Period (Week 5-72)||8
312785|NCT00720434|754406|P3|STARTED|Open-Label Period (Week 5-72)||8
312786|NCT00720434|754407|P2|STARTED|Open-Label Period (Week 5-72)||8
312787|NCT00720434|754408|P1|STARTED|Open-Label Period (Week 5-72)||10
312788|NCT00720434|754405|P4|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
312789|NCT00720434|754406|P3|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
312790|NCT00720434|754407|P2|NOT COMPLETED|Double-Blind Period (Week 1-4)||1
312791|NCT00720434|754408|P1|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
312792|NCT00720434|754405|P4|COMPLETED|Double-Blind Period (Week 1-4)||8
312793|NCT00720434|754406|P3|COMPLETED|Double-Blind Period (Week 1-4)||8
312794|NCT00720434|754407|P2|COMPLETED|Double-Blind Period (Week 1-4)||8
312795|NCT00720434|754408|P1|COMPLETED|Double-Blind Period (Week 1-4)||10
312796|NCT00720434|754405|P4|STARTED|Double-Blind Period (Week 1-4)||8
312797|NCT00720434|754406|P3|STARTED|Double-Blind Period (Week 1-4)||8
312798|NCT00720434|754407|P2|STARTED|Double-Blind Period (Week 1-4)||9
312799|NCT00720434|754408|P1|STARTED|Double-Blind Period (Week 1-4)||10
312800|NCT00720382|754432|P2|NOT COMPLETED|Overall Study||59
312801|NCT00720382|754433|P1|NOT COMPLETED|Overall Study||176
312802|NCT00720382|754432|P2|COMPLETED|Overall Study||178
312803|NCT00720382|754433|P1|COMPLETED|Overall Study||290
312804|NCT00720382|754432|P2|STARTED|Overall Study||237
312805|NCT00720382|754433|P1|STARTED|Overall Study||466
312806|NCT00720369|754443|P2|NOT COMPLETED|Overall Study||0
312807|NCT00720369|754444|P1|NOT COMPLETED|Overall Study||1
312808|NCT00720369|754443|P2|COMPLETED|Overall Study||8
312809|NCT00720369|754444|P1|COMPLETED|Overall Study|one subject discontinued due to an adverse event.|10
312810|NCT00720369|754443|P2|STARTED|Overall Study||8
312811|NCT00720369|754444|P1|STARTED|Overall Study||11
312812|NCT00720356|754452|P1|NOT COMPLETED|Follow up Until Death||5
312813|NCT00720356|754452|P1|COMPLETED|Follow up Until Death||43
312814|NCT00720356|754452|P1|STARTED|Follow up Until Death|All patients that are treated on study go into the follow up period|48
312815|NCT00720356|754452|P1|NOT COMPLETED|Went on to be Treated Cycle 3||2
312816|NCT00720356|754452|P1|COMPLETED|Went on to be Treated Cycle 3||44
312817|NCT00720356|754452|P1|STARTED|Went on to be Treated Cycle 3||46
312818|NCT00720356|754452|P1|NOT COMPLETED|Reached 1st Response/2 Cycles||2
312819|NCT00720356|754452|P1|COMPLETED|Reached 1st Response/2 Cycles||46
312820|NCT00720356|754452|P1|STARTED|Reached 1st Response/2 Cycles||48
312821|NCT00720356|754452|P1|NOT COMPLETED|Registration to Study||67
312822|NCT00720356|754452|P1|COMPLETED|Registration to Study||48
312823|NCT00720356|754452|P1|Completed Registration Step 2|Registration to Study||48
312824|NCT00720356|754452|P1|Completed Registration Step 1|Registration to Study||115
312825|NCT00720356|754452|P1|STARTED|Registration to Study||115
312826|NCT00720343|754466|P1|NOT COMPLETED|Overall Study||6
312827|NCT00720343|754466|P1|COMPLETED|Overall Study|3 removed by physician. 3 unable to be determined; Columbia will never have access to this data.|48
312828|NCT00720343|754466|P1|STARTED|Overall Study||54
312829|NCT00720330|754475|P3|NOT COMPLETED|Overall Study||0
312830|NCT00720330|754476|P2|NOT COMPLETED|Overall Study||0
312831|NCT00720330|754477|P1|NOT COMPLETED|Overall Study||0
312832|NCT00720330|754475|P3|COMPLETED|Overall Study||3
312833|NCT00720330|754476|P2|COMPLETED|Overall Study||4
312834|NCT00720330|754477|P1|COMPLETED|Overall Study||5
312835|NCT00720330|754475|P3|STARTED|Overall Study||3
312836|NCT00720330|754476|P2|STARTED|Overall Study||4
312837|NCT00720330|754477|P1|STARTED|Overall Study||5
312838|NCT00720278|754500|P3|NOT COMPLETED|Overall Study||6
312839|NCT00720278|754501|P2|NOT COMPLETED|Overall Study||4
312840|NCT00720278|754502|P1|NOT COMPLETED|Overall Study||7
312841|NCT00720278|754500|P3|COMPLETED|Overall Study||172
312842|NCT00720278|754501|P2|COMPLETED|Overall Study||166
312843|NCT00720278|754502|P1|COMPLETED|Overall Study||171
312844|NCT00720278|754500|P3|STARTED|Overall Study|1 subject was randomized in error|178
312845|NCT00720278|754501|P2|STARTED|Overall Study|1 subject was randomized in error|170
312846|NCT00720278|754502|P1|STARTED|Overall Study|1 subject was randomized in error|178
312847|NCT00720226|754524|P2|NOT COMPLETED|Overall Study||4
312848|NCT00720226|754525|P1|NOT COMPLETED|Overall Study||7
312849|NCT00720226|754524|P2|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|48
312850|NCT00720226|754525|P1|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|47
312851|NCT00720226|754524|P2|STARTED|Overall Study||52
312852|NCT00720226|754525|P1|STARTED|Overall Study||54
312853|NCT00720213|754533|P3|NOT COMPLETED|Treatment Period||0
312854|NCT00720213|754534|P2|NOT COMPLETED|Treatment Period||0
312855|NCT00720213|754535|P1|NOT COMPLETED|Treatment Period||0
312856|NCT00720213|754533|P3|COMPLETED|Treatment Period||17
312857|NCT00720213|754534|P2|COMPLETED|Treatment Period||20
312858|NCT00720213|754535|P1|COMPLETED|Treatment Period||0
312859|NCT00720213|754533|P3|STARTED|Treatment Period||17
312860|NCT00720213|754534|P2|STARTED|Treatment Period||20
312861|NCT00720213|754535|P1|STARTED|Treatment Period||0
312862|NCT00720213|754533|P3|NOT COMPLETED|Screening Phase With Diagnostic PSG||0
312863|NCT00720213|754534|P2|NOT COMPLETED|Screening Phase With Diagnostic PSG||0
312864|NCT00720213|754535|P1|NOT COMPLETED|Screening Phase With Diagnostic PSG||7
312865|NCT00720213|754533|P3|COMPLETED|Screening Phase With Diagnostic PSG||0
312866|NCT00720213|754534|P2|COMPLETED|Screening Phase With Diagnostic PSG||0
312867|NCT00720213|754535|P1|COMPLETED|Screening Phase With Diagnostic PSG||37
312868|NCT00720213|754533|P3|STARTED|Screening Phase With Diagnostic PSG||0
312869|NCT00720213|754534|P2|STARTED|Screening Phase With Diagnostic PSG||0
312870|NCT00720213|754535|P1|STARTED|Screening Phase With Diagnostic PSG||44
312871|NCT00720122|754573|P1|NOT COMPLETED|Overall Study||9
312872|NCT00720122|754573|P1|COMPLETED|Overall Study||19
312873|NCT00720122|754573|P1|STARTED|Overall Study||28
312874|NCT00720109|754577|P3|NOT COMPLETED|Risk Stratification Period||8
312875|NCT00720109|754578|P2|NOT COMPLETED|Risk Stratification Period||15
312876|NCT00720109|754579|P1|NOT COMPLETED|Risk Stratification Period||0
312877|NCT00720109|754577|P3|COMPLETED|Risk Stratification Period||1
312878|NCT00720109|754578|P2|COMPLETED|Risk Stratification Period||33
312879|NCT00720109|754579|P1|COMPLETED|Risk Stratification Period||0
312880|NCT00720109|754577|P3|STARTED|Risk Stratification Period||9
312881|NCT00720109|754578|P2|STARTED|Risk Stratification Period||48
312882|NCT00720109|754579|P1|STARTED|Risk Stratification Period||0
312883|NCT00720109|754577|P3|NOT COMPLETED|Induction Period||0
312884|NCT00720109|754578|P2|NOT COMPLETED|Induction Period||0
312885|NCT00720109|754579|P1|NOT COMPLETED|Induction Period||6
312886|NCT00720109|754577|P3|COMPLETED|Induction Period||0
312887|NCT00720109|754578|P2|COMPLETED|Induction Period||0
312888|NCT00720109|754579|P1|COMPLETED|Induction Period||57
312889|NCT00720109|754577|P3|STARTED|Induction Period||0
312890|NCT00720109|754578|P2|STARTED|Induction Period||0
312891|NCT00720109|754579|P1|STARTED|Induction Period||63
312892|NCT00720096|754599|P2|NOT COMPLETED|Overall Study||2
312893|NCT00720096|754600|P1|NOT COMPLETED|Overall Study||0
312894|NCT00720096|754599|P2|COMPLETED|Overall Study||0
312895|NCT00720096|754600|P1|COMPLETED|Overall Study||2
312896|NCT00720096|754599|P2|STARTED|Overall Study||2
312897|NCT00720096|754600|P1|STARTED|Overall Study||2
312898|NCT00720083|754612|P2|NOT COMPLETED|Overall Study||2
312899|NCT00720083|754613|P1|NOT COMPLETED|Overall Study||1
312900|NCT00720083|754612|P2|COMPLETED|Overall Study||13
312901|NCT00720083|754613|P1|COMPLETED|Overall Study|Subjects with data for the primary analysis are considered to have completed the study.|16
312902|NCT00720083|754612|P2|STARTED|Overall Study||15
312903|NCT00720083|754613|P1|STARTED|Overall Study||17
312904|NCT00720057|754621|P2|NOT COMPLETED|Overall Study||3
312905|NCT00720057|754622|P1|NOT COMPLETED|Overall Study||1
312906|NCT00720057|754621|P2|COMPLETED|Overall Study||156
312907|NCT00720057|754622|P1|COMPLETED|Overall Study||152
312908|NCT00720057|754621|P2|STARTED|Overall Study||159
312909|NCT00720057|754622|P1|STARTED|Overall Study||153
312910|NCT00719953|754638|P1|NOT COMPLETED|Overall Study||4
312911|NCT00719953|754638|P1|COMPLETED|Overall Study||26
312912|NCT00719953|754638|P1|STARTED|Overall Study||30
312913|NCT00719914|754644|P2|NOT COMPLETED|Overall Study||0
312914|NCT00719914|754645|P1|NOT COMPLETED|Overall Study||0
312915|NCT00719914|754644|P2|COMPLETED|Overall Study||7
312916|NCT00719914|754645|P1|COMPLETED|Overall Study||10
312917|NCT00719914|754644|P2|STARTED|Overall Study||7
312918|NCT00719914|754645|P1|STARTED|Overall Study||10
312919|NCT00719901|754651|P1|NOT COMPLETED|Overall Study||11
312920|NCT00719901|754651|P1|COMPLETED|Overall Study||0
312921|NCT00719901|754651|P1|STARTED|Overall Study||11
312922|NCT00719862|754663|P2|NOT COMPLETED|Overall Study||6
312923|NCT00719862|754664|P1|NOT COMPLETED|Overall Study||8
312924|NCT00719862|754663|P2|COMPLETED|Overall Study||233
312925|NCT00719862|754664|P1|COMPLETED|Overall Study||234
312926|NCT00719862|754663|P2|STARTED|Overall Study|1 subject was randomized in error|239
312927|NCT00719862|754664|P1|STARTED|Overall Study||242
312928|NCT00719849|754682|P2|NOT COMPLETED|Overall Study||1
312929|NCT00719849|754683|P1|NOT COMPLETED|Overall Study||0
312930|NCT00719849|754682|P2|COMPLETED|Overall Study||8
312931|NCT00719849|754683|P1|COMPLETED|Overall Study||4
312932|NCT00719849|754682|P2|STARTED|Overall Study||9
312933|NCT00719849|754683|P1|STARTED|Overall Study||4
312934|NCT00719810|754722|P3|NOT COMPLETED|Overall Study||8
312935|NCT00719810|754723|P2|NOT COMPLETED|Overall Study||4
312936|NCT00719810|754724|P1|NOT COMPLETED|Overall Study||3
312937|NCT00719810|754722|P3|COMPLETED|Overall Study||42
312938|NCT00719810|754723|P2|COMPLETED|Overall Study||47
312939|NCT00719810|754724|P1|COMPLETED|Overall Study||46
312940|NCT00719810|754722|P3|STARTED|Overall Study||50
312941|NCT00719810|754723|P2|STARTED|Overall Study||51
312942|NCT00719810|754724|P1|STARTED|Overall Study||49
312943|NCT00719732|754735|P1|NOT COMPLETED|Overall Study||22
312944|NCT00719732|754735|P1|COMPLETED|Overall Study||196
312945|NCT00719732|754735|P1|STARTED|Overall Study||218
312946|NCT00719706|754741|P2|NOT COMPLETED|Overall Study||6
312947|NCT00719706|754742|P1|NOT COMPLETED|Overall Study||9
312948|NCT00719706|754741|P2|COMPLETED|Overall Study||14
312949|NCT00719706|754742|P1|COMPLETED|Overall Study||11
312950|NCT00719706|754741|P2|STARTED|Overall Study||20
312951|NCT00719706|754742|P1|STARTED|Overall Study||20
312952|NCT00719680|754756|P1|NOT COMPLETED|Overall Study||5
312953|NCT00719680|754756|P1|COMPLETED|Overall Study||16
312954|NCT00719680|754756|P1|STARTED|Overall Study||21
312955|NCT00719615|754779|P3|NOT COMPLETED|Overall Study||0
312956|NCT00719615|754780|P2|NOT COMPLETED|Overall Study||0
312957|NCT00719615|754781|P1|NOT COMPLETED|Overall Study||0
312958|NCT00719615|754779|P3|COMPLETED|Overall Study||24
312959|NCT00719615|754780|P2|COMPLETED|Overall Study||45
312960|NCT00719615|754781|P1|COMPLETED|Overall Study||42
312961|NCT00719615|754779|P3|STARTED|Overall Study||24
312962|NCT00719615|754780|P2|STARTED|Overall Study||45
312963|NCT00719615|754781|P1|STARTED|Overall Study||42
312964|NCT00719576|754791|P2|NOT COMPLETED|Overall Study||5
312965|NCT00719576|754792|P1|NOT COMPLETED|Overall Study||2
312966|NCT00719576|754791|P2|COMPLETED|Overall Study||67
312967|NCT00719576|754792|P1|COMPLETED|Overall Study||70
312968|NCT00719576|754791|P2|STARTED|Overall Study||72
312969|NCT00719576|754792|P1|STARTED|Overall Study||72
312970|NCT00719563|754812|P2|NOT COMPLETED|Overall Study||42
312971|NCT00719563|754813|P1|NOT COMPLETED|Overall Study||38
312972|NCT00719563|754812|P2|COMPLETED|Overall Study||128
312973|NCT00719563|754813|P1|COMPLETED|Overall Study||133
312974|NCT00719563|754812|P2|STARTED|Overall Study||170
312975|NCT00719563|754813|P1|STARTED|Overall Study||171
312976|NCT00719537|754845|P2|NOT COMPLETED|Overall Study||1
312977|NCT00719537|754846|P1|NOT COMPLETED|Overall Study||1
312978|NCT00719537|754845|P2|COMPLETED|Overall Study||0
312979|NCT00719537|754846|P1|COMPLETED|Overall Study||1
312980|NCT00719537|754845|P2|STARTED|Overall Study||1
312981|NCT00719537|754846|P1|STARTED|Overall Study||2
312982|NCT00719472|754852|P1|NOT COMPLETED|Received Cycle 2 Treatment||68
312983|NCT00719472|754852|P1|COMPLETED|Received Cycle 2 Treatment||304
312984|NCT00719472|754852|P1|STARTED|Received Cycle 2 Treatment||372
312985|NCT00719472|754852|P1|NOT COMPLETED|Received Cycle 1 Treatment||53
312986|NCT00719472|754852|P1|COMPLETED|Received Cycle 1 Treatment||372
312987|NCT00719472|754852|P1|STARTED|Received Cycle 1 Treatment||425
312988|NCT00719472|754852|P1|NOT COMPLETED|Enrolled in Study||26
312989|NCT00719472|754852|P1|COMPLETED|Enrolled in Study||425
312990|NCT00719472|754852|P1|STARTED|Enrolled in Study||451
312991|NCT00719355|754863|P2|NOT COMPLETED|Overall Study||13
312992|NCT00719355|754864|P1|NOT COMPLETED|Overall Study||18
312993|NCT00719355|754863|P2|COMPLETED|Overall Study||39
312994|NCT00719355|754864|P1|COMPLETED|Overall Study||33
312995|NCT00719355|754863|P2|Completed 32 Weeks|Overall Study||39
312996|NCT00719355|754864|P1|Completed 32 Weeks|Overall Study||33
312997|NCT00719355|754863|P2|Completed 24 Weeks|Overall Study||43
312998|NCT00719355|754864|P1|Completed 24 Weeks|Overall Study||34
312999|NCT00719355|754863|P2|Completed 12 Weeks|Overall Study||46
313000|NCT00719355|754864|P1|Completed 12 Weeks|Overall Study||43
313001|NCT00719355|754863|P2|Completed 6 Weeks|Overall Study||48
313002|NCT00719355|754864|P1|Completed 6 Weeks|Overall Study||49
313003|NCT00719355|754863|P2|STARTED|Overall Study||52
313004|NCT00719355|754864|P1|STARTED|Overall Study||51
313005|NCT00719329|754875|P3|NOT COMPLETED|Overall Study||1
313006|NCT00719329|754876|P2|NOT COMPLETED|Overall Study||2
313007|NCT00719329|754877|P1|NOT COMPLETED|Overall Study||0
313008|NCT00719329|754875|P3|COMPLETED|Overall Study||646
313009|NCT00719329|754876|P2|COMPLETED|Overall Study||569
313010|NCT00719329|754877|P1|COMPLETED|Overall Study||705
313011|NCT00719329|754875|P3|Day 7 Swab|Overall Study||561
313012|NCT00719329|754876|P2|Day 7 Swab|Overall Study||467
313013|NCT00719329|754877|P1|Day 7 Swab|Overall Study||593
313014|NCT00719329|754875|P3|Day 3 Swab|Overall Study||578
313015|NCT00719329|754876|P2|Day 3 Swab|Overall Study||501
313016|NCT00719329|754877|P1|Day 3 Swab|Overall Study||614
313017|NCT00719329|754875|P3|Day 1 Swab|Overall Study||646
313018|NCT00719329|754876|P2|Day 1 Swab|Overall Study||569
313019|NCT00719329|754877|P1|Day 1 Swab|Overall Study||705
313020|NCT00719329|754875|P3|STARTED|Overall Study||647
313021|NCT00719329|754876|P2|STARTED|Overall Study||571
313022|NCT00719329|754877|P1|STARTED|Overall Study||705
313023|NCT00719264|754893|P2|NOT COMPLETED|Overall Study||183
313024|NCT00719264|754894|P1|NOT COMPLETED|Overall Study||182
313025|NCT00719264|754893|P2|COMPLETED|Overall Study||0
313026|NCT00719264|754894|P1|COMPLETED|Overall Study||0
313027|NCT00719264|754893|P2|Safety Set|Overall Study||181
313028|NCT00719264|754894|P1|Safety Set|Overall Study||180
313029|NCT00719264|754893|P2|Full Analysis Set|Overall Study||183
313030|NCT00719264|754894|P1|Full Analysis Set|Overall Study||182
313031|NCT00719264|754893|P2|STARTED|Overall Study||183
313032|NCT00719264|754894|P1|STARTED|Overall Study||182
313033|NCT00719212|754913|P1|NOT COMPLETED|Overall Study||44
313034|NCT00719212|754913|P1|COMPLETED|Overall Study||17
313035|NCT00719212|754913|P1|STARTED|Overall Study||61
313036|NCT00719186|754925|P2|NOT COMPLETED|Overall Study||0
313037|NCT00719186|754926|P1|NOT COMPLETED|Overall Study||0
313038|NCT00719186|754925|P2|COMPLETED|Overall Study||374
313039|NCT00719186|754926|P1|COMPLETED|Overall Study||376
313040|NCT00719186|754925|P2|STARTED|Overall Study||374
313041|NCT00719186|754926|P1|STARTED|Overall Study||376
313042|NCT00719160|754940|P2|NOT COMPLETED|Overall Study||0
313043|NCT00719160|754941|P1|NOT COMPLETED|Overall Study||0
313044|NCT00719160|754940|P2|COMPLETED|Overall Study||6
313045|NCT00719160|754941|P1|COMPLETED|Overall Study||6
313046|NCT00719160|754940|P2|STARTED|Overall Study||6
313047|NCT00719160|754941|P1|STARTED|Overall Study||6
313048|NCT00719134|754948|P1|NOT COMPLETED|Overall Study||10
313049|NCT00719134|754948|P1|COMPLETED|Overall Study||66
313050|NCT00719134|754948|P1|STARTED|Overall Study||76
313051|NCT00719043|754961|P7|NOT COMPLETED|Overall Study||28
313052|NCT00719043|754962|P6|NOT COMPLETED|Overall Study||34
313053|NCT00719043|754963|P5|NOT COMPLETED|Overall Study||27
313054|NCT00719043|754964|P4|NOT COMPLETED|Overall Study||23
313055|NCT00719043|754965|P3|NOT COMPLETED|Overall Study||20
313056|NCT00719043|754966|P2|NOT COMPLETED|Overall Study||25
313057|NCT00719043|754967|P1|NOT COMPLETED|Overall Study||32
313058|NCT00719043|754961|P7|COMPLETED|Overall Study|Up to Day 909|92
313059|NCT00719043|754962|P6|COMPLETED|Overall Study|Up to Day 909|86
313060|NCT00719043|754963|P5|COMPLETED|Overall Study|Up to Day 909|95
313061|NCT00719043|754964|P4|COMPLETED|Overall Study|Up to Day 909|96
313062|NCT00719043|754965|P3|COMPLETED|Overall Study|Up to Day 909|99
313063|NCT00719043|754966|P2|COMPLETED|Overall Study|Up to Day 909|96
313064|NCT00719043|754967|P1|COMPLETED|Overall Study|Up to Day 909|88
313065|NCT00719043|754961|P7|STARTED|Overall Study||120
313066|NCT00719043|754962|P6|STARTED|Overall Study||120
313067|NCT00719043|754963|P5|STARTED|Overall Study||122
313068|NCT00719043|754964|P4|STARTED|Overall Study||119
313069|NCT00719043|754965|P3|STARTED|Overall Study||119
313070|NCT00719043|754966|P2|STARTED|Overall Study||121
313071|NCT00719043|754967|P1|STARTED|Overall Study||120
313072|NCT00718887|755091|P2|NOT COMPLETED|Overall Study||9
313073|NCT00718887|755092|P1|NOT COMPLETED|Overall Study||5
313074|NCT00718887|755091|P2|COMPLETED|Overall Study||68
313075|NCT00718887|755092|P1|COMPLETED|Overall Study|Continued in study after 48 weeks|84
313076|NCT00718887|755091|P2|STARTED|Overall Study|Participants who received treatment.|77
313077|NCT00718887|755092|P1|STARTED|Overall Study|Participants who received treatment.|89
313078|NCT00718861|755116|P2|NOT COMPLETED|Overall Study||18
313079|NCT00718861|755117|P1|NOT COMPLETED|Overall Study||21
313080|NCT00718861|755116|P2|COMPLETED|Overall Study||77
313081|NCT00718861|755117|P1|COMPLETED|Overall Study||74
313082|NCT00718861|755116|P2|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|69
313083|NCT00718861|755117|P1|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|67
313084|NCT00718861|755116|P2|Safety Set|Overall Study||95
313085|NCT00718861|755117|P1|Safety Set|Overall Study|3 patients randomized but never received study drug|92
313086|NCT00718861|755116|P2|STARTED|Overall Study||95
313087|NCT00718861|755117|P1|STARTED|Overall Study|"Started indicates Randomized and Intent-to Treat (ITT) population"|95
313088|NCT00718809|755145|P2|NOT COMPLETED|Overall Study||9
313089|NCT00718809|755146|P1|NOT COMPLETED|Overall Study||12
313090|NCT00718809|755145|P2|COMPLETED|Overall Study||0
313091|NCT00718809|755146|P1|COMPLETED|Overall Study||0
313092|NCT00718809|755145|P2|STARTED|Overall Study||9
313093|NCT00718809|755146|P1|STARTED|Overall Study||12
313094|NCT00718770|755160|P1|NOT COMPLETED|Overall Study||8
313095|NCT00718770|755160|P1|COMPLETED|Overall Study||2
313096|NCT00718770|755160|P1|STARTED|Overall Study||10
313097|NCT00718718|755171|P10|NOT COMPLETED|Week 12 to End of Study||0
313098|NCT00718718|755172|P9|NOT COMPLETED|Week 12 to End of Study||1
313099|NCT00718718|755173|P8|NOT COMPLETED|Week 12 to End of Study||1
313100|NCT00718718|755174|P7|NOT COMPLETED|Week 12 to End of Study||2
313101|NCT00718718|755175|P6|NOT COMPLETED|Week 12 to End of Study||3
313102|NCT00718718|755176|P5|NOT COMPLETED|Week 12 to End of Study||0
313103|NCT00718718|755177|P4|NOT COMPLETED|Week 12 to End of Study||1
313104|NCT00718718|755178|P3|NOT COMPLETED|Week 12 to End of Study||0
313105|NCT00718718|755179|P2|NOT COMPLETED|Week 12 to End of Study||1
313106|NCT00718718|755180|P1|NOT COMPLETED|Week 12 to End of Study||0
313107|NCT00718718|755171|P10|COMPLETED|Week 12 to End of Study||31
313108|NCT00718718|755172|P9|COMPLETED|Week 12 to End of Study||27
313109|NCT00718718|755173|P8|COMPLETED|Week 12 to End of Study||27
313110|NCT00718718|755174|P7|COMPLETED|Week 12 to End of Study||27
313111|NCT00718718|755175|P6|COMPLETED|Week 12 to End of Study||24
313112|NCT00718718|755176|P5|COMPLETED|Week 12 to End of Study||0
313113|NCT00718718|755177|P4|COMPLETED|Week 12 to End of Study||15
313114|NCT00718718|755178|P3|COMPLETED|Week 12 to End of Study||0
313115|NCT00718718|755179|P2|COMPLETED|Week 12 to End of Study||17
313116|NCT00718718|755180|P1|COMPLETED|Week 12 to End of Study||0
313117|NCT00718718|755171|P10|Treated|Week 12 to End of Study||31
313118|NCT00718718|755172|P9|Treated|Week 12 to End of Study||28
313119|NCT00718718|755173|P8|Treated|Week 12 to End of Study||28
313120|NCT00718718|755174|P7|Treated|Week 12 to End of Study||29
313121|NCT00718718|755175|P6|Treated|Week 12 to End of Study||26
313122|NCT00718718|755176|P5|Treated|Week 12 to End of Study||0
313123|NCT00718718|755177|P4|Treated|Week 12 to End of Study||16
313124|NCT00718718|755178|P3|Treated|Week 12 to End of Study||0
313125|NCT00718718|755179|P2|Treated|Week 12 to End of Study||18
313126|NCT00718718|755180|P1|Treated|Week 12 to End of Study||0
313127|NCT00718718|755171|P10|STARTED|Week 12 to End of Study||31
313128|NCT00718718|755172|P9|STARTED|Week 12 to End of Study||28
313129|NCT00718718|755173|P8|STARTED|Week 12 to End of Study||28
313130|NCT00718718|755174|P7|STARTED|Week 12 to End of Study||29
313131|NCT00718718|755175|P6|STARTED|Week 12 to End of Study||27
313132|NCT00718718|755176|P5|STARTED|Week 12 to End of Study||0
313133|NCT00718718|755177|P4|STARTED|Week 12 to End of Study||16
313134|NCT00718718|755178|P3|STARTED|Week 12 to End of Study||0
313135|NCT00718718|755179|P2|STARTED|Week 12 to End of Study||18
313136|NCT00718718|755180|P1|STARTED|Week 12 to End of Study||0
313137|NCT00718718|755171|P10|NOT COMPLETED|Prior to Week 12||0
313138|NCT00718718|755172|P9|NOT COMPLETED|Prior to Week 12||2
313139|NCT00718718|755173|P8|NOT COMPLETED|Prior to Week 12||2
313140|NCT00718718|755174|P7|NOT COMPLETED|Prior to Week 12||1
313141|NCT00718718|755175|P6|NOT COMPLETED|Prior to Week 12||0
313142|NCT00718718|755176|P5|NOT COMPLETED|Prior to Week 12||3
313143|NCT00718718|755177|P4|NOT COMPLETED|Prior to Week 12||0
313144|NCT00718718|755178|P3|NOT COMPLETED|Prior to Week 12||1
313145|NCT00718718|755179|P2|NOT COMPLETED|Prior to Week 12||0
313146|NCT00718718|755180|P1|NOT COMPLETED|Prior to Week 12||1
313147|NCT00718718|755171|P10|COMPLETED|Prior to Week 12||31
313148|NCT00718718|755172|P9|COMPLETED|Prior to Week 12||28
313149|NCT00718718|755173|P8|COMPLETED|Prior to Week 12||28
313150|NCT00718718|755174|P7|COMPLETED|Prior to Week 12||29
313151|NCT00718718|755175|P6|COMPLETED|Prior to Week 12||0
313152|NCT00718718|755176|P5|COMPLETED|Prior to Week 12||27
313153|NCT00718718|755177|P4|COMPLETED|Prior to Week 12||0
313154|NCT00718718|755178|P3|COMPLETED|Prior to Week 12||16
313155|NCT00718718|755179|P2|COMPLETED|Prior to Week 12||0
313156|NCT00718718|755180|P1|COMPLETED|Prior to Week 12||18
313157|NCT00718718|755171|P10|STARTED|Prior to Week 12||31
313158|NCT00718718|755172|P9|STARTED|Prior to Week 12||30
313159|NCT00718718|755173|P8|STARTED|Prior to Week 12||30
313160|NCT00718718|755174|P7|STARTED|Prior to Week 12||30
313161|NCT00718718|755175|P6|STARTED|Prior to Week 12||0
313162|NCT00718718|755176|P5|STARTED|Prior to Week 12||30
313163|NCT00718718|755177|P4|STARTED|Prior to Week 12||0
313164|NCT00718718|755178|P3|STARTED|Prior to Week 12||17
313165|NCT00718718|755179|P2|STARTED|Prior to Week 12||0
313166|NCT00718718|755180|P1|STARTED|Prior to Week 12||19
313167|NCT00718666|755223|P3|NOT COMPLETED|Booster Phase Year 5||6
313168|NCT00718666|755224|P2|NOT COMPLETED|Booster Phase Year 5||0
313169|NCT00718666|755225|P1|NOT COMPLETED|Booster Phase Year 5||2
313170|NCT00718666|755223|P3|COMPLETED|Booster Phase Year 5||94
313171|NCT00718666|755224|P2|COMPLETED|Booster Phase Year 5||46
313172|NCT00718666|755225|P1|COMPLETED|Booster Phase Year 5||36
313173|NCT00718666|755223|P3|STARTED|Booster Phase Year 5||100
313174|NCT00718666|755224|P2|STARTED|Booster Phase Year 5||46
313175|NCT00718666|755225|P1|STARTED|Booster Phase Year 5||38
313176|NCT00718666|755223|P3|NOT COMPLETED|Persistence Phase Year 5||0
313177|NCT00718666|755224|P2|NOT COMPLETED|Persistence Phase Year 5||0
313178|NCT00718666|755225|P1|NOT COMPLETED|Persistence Phase Year 5||0
313179|NCT00718666|755223|P3|COMPLETED|Persistence Phase Year 5|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
313180|NCT00718666|755224|P2|COMPLETED|Persistence Phase Year 5||82
313181|NCT00718666|755225|P1|COMPLETED|Persistence Phase Year 5||70
313182|NCT00718666|755223|P3|STARTED|Persistence Phase Year 5||0
313183|NCT00718666|755224|P2|STARTED|Persistence Phase Year 5||82
313184|NCT00718666|755225|P1|STARTED|Persistence Phase Year 5||70
313185|NCT00718666|755223|P3|NOT COMPLETED|Persistence Phase Year 3||0
313186|NCT00718666|755224|P2|NOT COMPLETED|Persistence Phase Year 3||0
313187|NCT00718666|755225|P1|NOT COMPLETED|Persistence Phase Year 3||0
313188|NCT00718666|755223|P3|COMPLETED|Persistence Phase Year 3|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
313189|NCT00718666|755224|P2|COMPLETED|Persistence Phase Year 3||104
313190|NCT00718666|755225|P1|COMPLETED|Persistence Phase Year 3||98
313191|NCT00718666|755223|P3|STARTED|Persistence Phase Year 3||0
313192|NCT00718666|755224|P2|STARTED|Persistence Phase Year 3||104
313193|NCT00718666|755225|P1|STARTED|Persistence Phase Year 3||98
313194|NCT00718666|755223|P3|NOT COMPLETED|Persistence Phase Year 1||0
313195|NCT00718666|755224|P2|NOT COMPLETED|Persistence Phase Year 1||0
313196|NCT00718666|755225|P1|NOT COMPLETED|Persistence Phase Year 1||0
313197|NCT00718666|755223|P3|COMPLETED|Persistence Phase Year 1|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
313198|NCT00718666|755224|P2|COMPLETED|Persistence Phase Year 1||130
313199|NCT00718666|755225|P1|COMPLETED|Persistence Phase Year 1||118
313200|NCT00718666|755223|P3|STARTED|Persistence Phase Year 1||0
313201|NCT00718666|755224|P2|STARTED|Persistence Phase Year 1||130
313202|NCT00718666|755225|P1|STARTED|Persistence Phase Year 1||118
313203|NCT00718640|755309|P1|NOT COMPLETED|Overall Study||7
313204|NCT00718640|755309|P1|COMPLETED|Overall Study||3
313205|NCT00718640|755309|P1|STARTED|Overall Study||10
313206|NCT00718549|755321|P3|NOT COMPLETED|Maintenance/ Observation Phase||30
313207|NCT00718549|755322|P2|NOT COMPLETED|Maintenance/ Observation Phase||28
313208|NCT00718549|755323|P1|NOT COMPLETED|Maintenance/ Observation Phase||0
313209|NCT00718549|755321|P3|COMPLETED|Maintenance/ Observation Phase||3
313210|NCT00718549|755322|P2|COMPLETED|Maintenance/ Observation Phase||5
313211|NCT00718549|755323|P1|COMPLETED|Maintenance/ Observation Phase||0
313212|NCT00718549|755321|P3|STARTED|Maintenance/ Observation Phase||33
313213|NCT00718549|755322|P2|STARTED|Maintenance/ Observation Phase||33
313214|NCT00718549|755323|P1|STARTED|Maintenance/ Observation Phase||0
313215|NCT00718549|755321|P3|NOT COMPLETED|Induction Phase||0
313216|NCT00718549|755322|P2|NOT COMPLETED|Induction Phase||0
313217|NCT00718549|755323|P1|NOT COMPLETED|Induction Phase||62
313218|NCT00718549|755321|P3|COMPLETED|Induction Phase||0
313219|NCT00718549|755322|P2|COMPLETED|Induction Phase||0
313220|NCT00718549|755323|P1|COMPLETED|Induction Phase||66
313221|NCT00718549|755321|P3|STARTED|Induction Phase||0
313222|NCT00718549|755322|P2|STARTED|Induction Phase||0
313223|NCT00718549|755323|P1|STARTED|Induction Phase||128
313224|NCT00718523|755348|P2|NOT COMPLETED|Overall Study||24
313225|NCT00718523|755349|P1|NOT COMPLETED|Overall Study||18
313226|NCT00718523|755348|P2|COMPLETED|Overall Study||62
313227|NCT00718523|755349|P1|COMPLETED|Overall Study||66
313228|NCT00718523|755348|P2|STARTED|Overall Study||86
313229|NCT00718523|755349|P1|STARTED|Overall Study||84
313230|NCT00718510|755361|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
313231|NCT00718510|755362|P1|NOT COMPLETED|Second Intervention (3 Weeks)||1
313232|NCT00718510|755361|P2|COMPLETED|Second Intervention (3 Weeks)||7
313233|NCT00718510|755362|P1|COMPLETED|Second Intervention (3 Weeks)||6
313234|NCT00718510|755361|P2|STARTED|Second Intervention (3 Weeks)||7
313235|NCT00718510|755362|P1|STARTED|Second Intervention (3 Weeks)||7
313236|NCT00718510|755361|P2|NOT COMPLETED|Washout (5 Days)||0
313237|NCT00718510|755362|P1|NOT COMPLETED|Washout (5 Days)||0
313238|NCT00718510|755361|P2|COMPLETED|Washout (5 Days)||7
313239|NCT00718510|755362|P1|COMPLETED|Washout (5 Days)||7
313240|NCT00718510|755361|P2|STARTED|Washout (5 Days)||7
313241|NCT00718510|755362|P1|STARTED|Washout (5 Days)||7
313242|NCT00718510|755361|P2|NOT COMPLETED|First Intervention (3 Weeks)||1
313243|NCT00718510|755362|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
313244|NCT00718510|755361|P2|COMPLETED|First Intervention (3 Weeks)||7
313245|NCT00718510|755362|P1|COMPLETED|First Intervention (3 Weeks)||7
313246|NCT00718510|755361|P2|Received Intervention|First Intervention (3 Weeks)||7
313247|NCT00718510|755362|P1|Received Intervention|First Intervention (3 Weeks)||7
313248|NCT00718510|755361|P2|STARTED|First Intervention (3 Weeks)||8
313249|NCT00718510|755362|P1|STARTED|First Intervention (3 Weeks)||7
313250|NCT00718328|755374|P2|NOT COMPLETED|Overall Study||0
313251|NCT00718328|755375|P1|NOT COMPLETED|Overall Study||1
313252|NCT00718328|755374|P2|COMPLETED|Overall Study|Terminated due to poor enrollment|0
313253|NCT00718328|755375|P1|COMPLETED|Overall Study|Prematurely terminated due to poor enrollment|0
313254|NCT00718328|755374|P2|STARTED|Overall Study||0
313255|NCT00718328|755375|P1|STARTED|Overall Study||1
313256|NCT00718315|755384|P3|NOT COMPLETED|Overall Study||21
313257|NCT00718315|755385|P2|NOT COMPLETED|Overall Study||22
313258|NCT00718315|755386|P1|NOT COMPLETED|Overall Study||19
313259|NCT00718315|755384|P3|COMPLETED|Overall Study||46
313260|NCT00718315|755385|P2|COMPLETED|Overall Study||45
313261|NCT00718315|755386|P1|COMPLETED|Overall Study||48
313262|NCT00718315|755384|P3|STARTED|Overall Study||67
313263|NCT00718315|755385|P2|STARTED|Overall Study||67
313264|NCT00718315|755386|P1|STARTED|Overall Study||67
313265|NCT00718302|755420|P2|NOT COMPLETED|Overall Study||0
313266|NCT00718302|755421|P1|NOT COMPLETED|Overall Study||0
313267|NCT00718302|755420|P2|COMPLETED|Overall Study||114
313268|NCT00718302|755421|P1|COMPLETED|Overall Study||119
313269|NCT00718302|755420|P2|STARTED|Overall Study||114
313270|NCT00718302|755421|P1|STARTED|Overall Study||119
313271|NCT00718237|755437|P2|NOT COMPLETED|Overall Study||15
313272|NCT00718237|755438|P1|NOT COMPLETED|Overall Study||13
313273|NCT00718237|755437|P2|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|366
313274|NCT00718237|755438|P1|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|368
313275|NCT00718237|755437|P2|Vaccinated at Visit 3|Overall Study||369
313276|NCT00718237|755438|P1|Vaccinated at Visit 3|Overall Study||371
313277|NCT00718237|755437|P2|Vaccinated at Visit 2|Overall Study||374
313278|NCT00718237|755438|P1|Vaccinated at Visit 2|Overall Study||373
313279|NCT00718237|755437|P2|Vaccinated at Visit 1|Overall Study||381
313280|NCT00718237|755438|P1|Vaccinated at Visit 1|Overall Study||380
313281|NCT00718237|755437|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
313282|NCT00718237|755438|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
313283|NCT00718159|755455|P7|NOT COMPLETED|Overall Study||1
313284|NCT00718159|755456|P6|NOT COMPLETED|Overall Study||1
313285|NCT00718159|755457|P5|NOT COMPLETED|Overall Study||8
313286|NCT00718159|755458|P4|NOT COMPLETED|Overall Study||4
313287|NCT00718159|755459|P3|NOT COMPLETED|Overall Study||3
313288|NCT00718159|755460|P2|NOT COMPLETED|Overall Study||3
313289|NCT00718159|755461|P1|NOT COMPLETED|Overall Study||3
313290|NCT00718159|755455|P7|COMPLETED|Overall Study||0
313291|NCT00718159|755456|P6|COMPLETED|Overall Study||0
313292|NCT00718159|755457|P5|COMPLETED|Overall Study||0
313293|NCT00718159|755458|P4|COMPLETED|Overall Study||0
313294|NCT00718159|755459|P3|COMPLETED|Overall Study||0
313295|NCT00718159|755460|P2|COMPLETED|Overall Study||0
313296|NCT00718159|755461|P1|COMPLETED|Overall Study||0
313297|NCT00718159|755455|P7|Received at Least 1 Dose of Study Drug|Overall Study||1
313298|NCT00718159|755456|P6|Received at Least 1 Dose of Study Drug|Overall Study||1
313299|NCT00718159|755457|P5|Received at Least 1 Dose of Study Drug|Overall Study||8
313300|NCT00718159|755458|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
313301|NCT00718159|755459|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
313302|NCT00718159|755460|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
313303|NCT00718159|755461|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
313304|NCT00718159|755455|P7|STARTED|Overall Study||1
313305|NCT00718159|755456|P6|STARTED|Overall Study||1
313306|NCT00718159|755457|P5|STARTED|Overall Study||8
313307|NCT00718159|755458|P4|STARTED|Overall Study||4
313308|NCT00718159|755459|P3|STARTED|Overall Study||3
313309|NCT00718159|755460|P2|STARTED|Overall Study||3
313310|NCT00718159|755461|P1|STARTED|Overall Study||3
313311|NCT00718120|755487|P2|NOT COMPLETED|Overall Study||0
313312|NCT00718120|755488|P1|NOT COMPLETED|Overall Study||0
313313|NCT00718120|755487|P2|COMPLETED|Overall Study||55
313314|NCT00718120|755488|P1|COMPLETED|Overall Study||55
313315|NCT00718120|755487|P2|STARTED|Overall Study||55
313316|NCT00718120|755488|P1|STARTED|Overall Study||55
313317|NCT00718094|755508|P2|NOT COMPLETED|Overall Study||0
313318|NCT00718094|755509|P1|NOT COMPLETED|Overall Study||0
313319|NCT00718094|755508|P2|COMPLETED|Overall Study||5
313320|NCT00718094|755509|P1|COMPLETED|Overall Study||15
313321|NCT00718094|755508|P2|STARTED|Overall Study||5
313322|NCT00718094|755509|P1|STARTED|Overall Study||15
313323|NCT00718081|755518|P3|NOT COMPLETED|Overall Study||21
313324|NCT00718081|755519|P2|NOT COMPLETED|Overall Study||4
313325|NCT00718081|755520|P1|NOT COMPLETED|Overall Study||7
313326|NCT00718081|755518|P3|COMPLETED|Overall Study||9
313327|NCT00718081|755519|P2|COMPLETED|Overall Study||25
313328|NCT00718081|755520|P1|COMPLETED|Overall Study||22
313329|NCT00718081|755518|P3|STARTED|Overall Study||30
313330|NCT00718081|755519|P2|STARTED|Overall Study||29
313331|NCT00718081|755520|P1|STARTED|Overall Study||29
313332|NCT00718042|755537|P6|NOT COMPLETED|Donor Follow-up||0
313333|NCT00718042|755538|P5|NOT COMPLETED|Donor Follow-up||19
313334|NCT00718042|755539|P4|NOT COMPLETED|Donor Follow-up||0
313335|NCT00718042|755540|P3|NOT COMPLETED|Donor Follow-up||0
313336|NCT00718042|755541|P2|NOT COMPLETED|Donor Follow-up||0
313337|NCT00718042|755542|P1|NOT COMPLETED|Donor Follow-up||13
313338|NCT00718042|755537|P6|COMPLETED|Donor Follow-up||0
313339|NCT00718042|755538|P5|COMPLETED|Donor Follow-up||24
313340|NCT00718042|755539|P4|COMPLETED|Donor Follow-up||0
313341|NCT00718042|755540|P3|COMPLETED|Donor Follow-up||0
313342|NCT00718042|755541|P2|COMPLETED|Donor Follow-up||0
313343|NCT00718042|755542|P1|COMPLETED|Donor Follow-up||23
313344|NCT00718042|755537|P6|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
313345|NCT00718042|755538|P5|STARTED|Donor Follow-up||43
313346|NCT00718042|755539|P4|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
313347|NCT00718042|755540|P3|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
313348|NCT00718042|755541|P2|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
313349|NCT00718042|755542|P1|STARTED|Donor Follow-up||36
313350|NCT00718042|755537|P6|NOT COMPLETED|ESA Chagas Testing||0
313351|NCT00718042|755538|P5|NOT COMPLETED|ESA Chagas Testing||0
313352|NCT00718042|755539|P4|NOT COMPLETED|ESA Chagas Testing||0
313353|NCT00718042|755540|P3|NOT COMPLETED|ESA Chagas Testing||0
313354|NCT00718042|755541|P2|NOT COMPLETED|ESA Chagas Testing||0
313355|NCT00718042|755542|P1|NOT COMPLETED|ESA Chagas Testing||0
313356|NCT00718042|755537|P6|COMPLETED|ESA Chagas Testing||330
313357|NCT00718042|755538|P5|COMPLETED|ESA Chagas Testing||43
313358|NCT00718042|755539|P4|COMPLETED|ESA Chagas Testing||110
313359|NCT00718042|755540|P3|COMPLETED|ESA Chagas Testing||524
313360|NCT00718042|755541|P2|COMPLETED|ESA Chagas Testing||287
313361|NCT00718042|755542|P1|COMPLETED|ESA Chagas Testing||36
313362|NCT00718042|755537|P6|STARTED|ESA Chagas Testing|Specimens only tested with ESA Chagas|330
313363|NCT00718042|755538|P5|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|43
313364|NCT00718042|755539|P4|STARTED|ESA Chagas Testing||110
313365|NCT00718042|755540|P3|STARTED|ESA Chagas Testing||524
313366|NCT00718042|755541|P2|STARTED|ESA Chagas Testing||287
313367|NCT00718042|755542|P1|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|36
313368|NCT00718042|755537|P6|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
313369|NCT00718042|755538|P5|NOT COMPLETED|ABBOTT PRISM Chagas Testing||38
313370|NCT00718042|755539|P4|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
313371|NCT00718042|755540|P3|NOT COMPLETED|ABBOTT PRISM Chagas Testing||1
313372|NCT00718042|755541|P2|NOT COMPLETED|ABBOTT PRISM Chagas Testing||2
313373|NCT00718042|755542|P1|NOT COMPLETED|ABBOTT PRISM Chagas Testing||64
313374|NCT00718042|755537|P6|COMPLETED|ABBOTT PRISM Chagas Testing||0
313375|NCT00718042|755538|P5|COMPLETED|ABBOTT PRISM Chagas Testing||25511
313376|NCT00718042|755539|P4|COMPLETED|ABBOTT PRISM Chagas Testing||110
313377|NCT00718042|755540|P3|COMPLETED|ABBOTT PRISM Chagas Testing||524
313378|NCT00718042|755541|P2|COMPLETED|ABBOTT PRISM Chagas Testing||287
313379|NCT00718042|755542|P1|COMPLETED|ABBOTT PRISM Chagas Testing||16249
313380|NCT00718042|755537|P6|STARTED|ABBOTT PRISM Chagas Testing|Specimens not screened with PRISM Chagas assay per protocol.|0
313381|NCT00718042|755538|P5|STARTED|ABBOTT PRISM Chagas Testing||25549
313382|NCT00718042|755539|P4|STARTED|ABBOTT PRISM Chagas Testing||110
313383|NCT00718042|755540|P3|STARTED|ABBOTT PRISM Chagas Testing||525
313384|NCT00718042|755541|P2|STARTED|ABBOTT PRISM Chagas Testing||289
313385|NCT00718042|755542|P1|STARTED|ABBOTT PRISM Chagas Testing||16313
313386|NCT00717977|755554|P1|NOT COMPLETED|Overall Study||0
313387|NCT00717977|755554|P1|COMPLETED|Overall Study||74
313388|NCT00717977|755554|P1|STARTED|Overall Study||74
313389|NCT00717912|755582|P6|NOT COMPLETED|Overall Study||0
313390|NCT00717912|755583|P5|NOT COMPLETED|Overall Study||0
313391|NCT00717912|755584|P4|NOT COMPLETED|Overall Study||0
313392|NCT00717912|755585|P3|NOT COMPLETED|Overall Study||0
313393|NCT00717912|755586|P2|NOT COMPLETED|Overall Study||0
313394|NCT00717912|755587|P1|NOT COMPLETED|Overall Study||0
313395|NCT00717912|755582|P6|COMPLETED|Overall Study||1
313396|NCT00717912|755583|P5|COMPLETED|Overall Study||1
313397|NCT00717912|755584|P4|COMPLETED|Overall Study||1
313398|NCT00717912|755585|P3|COMPLETED|Overall Study||1
313399|NCT00717912|755586|P2|COMPLETED|Overall Study||1
313400|NCT00717912|755587|P1|COMPLETED|Overall Study||1
313401|NCT00717912|755582|P6|STARTED|Overall Study||1
313402|NCT00717912|755583|P5|STARTED|Overall Study||1
313403|NCT00717912|755584|P4|STARTED|Overall Study||1
313404|NCT00717912|755585|P3|STARTED|Overall Study||1
313405|NCT00717912|755586|P2|STARTED|Overall Study||1
313406|NCT00717912|755587|P1|STARTED|Overall Study||1
313407|NCT00717886|755598|P1|NOT COMPLETED|Overall Study||4
313408|NCT00717886|755598|P1|COMPLETED|Overall Study||9
313409|NCT00717886|755598|P1|STARTED|Overall Study||13
313410|NCT00717873|755604|P2|NOT COMPLETED|Overall Study||0
313411|NCT00717873|755605|P1|NOT COMPLETED|Overall Study||0
313412|NCT00717873|755604|P2|COMPLETED|Overall Study||59
313413|NCT00717873|755605|P1|COMPLETED|Overall Study||46
313414|NCT00717873|755604|P2|STARTED|Overall Study||59
313415|NCT00717873|755605|P1|STARTED|Overall Study||46
313416|NCT00717860|755613|P2|NOT COMPLETED|Overall Study||28
313417|NCT00717860|755614|P1|NOT COMPLETED|Overall Study||27
313418|NCT00717860|755613|P2|COMPLETED|Overall Study||32
313419|NCT00717860|755614|P1|COMPLETED|Overall Study||34
313420|NCT00717860|755613|P2|STARTED|Overall Study||60
313421|NCT00717860|755614|P1|STARTED|Overall Study||61
313422|NCT00717756|755624|P1|NOT COMPLETED|Overall Study||1
313423|NCT00717756|755624|P1|COMPLETED|Overall Study||40
313424|NCT00717756|755624|P1|STARTED|Overall Study||41
313425|NCT00717574|755630|P2|NOT COMPLETED|Overall Study||2
313426|NCT00717574|755631|P1|NOT COMPLETED|Overall Study||2
313427|NCT00717574|755630|P2|COMPLETED|Overall Study||14
313428|NCT00717574|755631|P1|COMPLETED|Overall Study||14
313429|NCT00717574|755630|P2|STARTED|Overall Study||16
313430|NCT00717574|755631|P1|STARTED|Overall Study||16
313431|NCT00717522|755637|P1|NOT COMPLETED|Overall Study||7
313432|NCT00717522|755637|P1|COMPLETED|Overall Study||0
313433|NCT00717522|755637|P1|STARTED|Overall Study||7
313434|NCT00717418|755646|P4|NOT COMPLETED|1-Year Follow-Up||4
313435|NCT00717418|755647|P3|NOT COMPLETED|1-Year Follow-Up||434
313436|NCT00717418|755648|P2|NOT COMPLETED|1-Year Follow-Up||51
313437|NCT00717418|755649|P1|NOT COMPLETED|1-Year Follow-Up||147
313438|NCT00717418|755646|P4|COMPLETED|1-Year Follow-Up||0
313439|NCT00717418|755647|P3|COMPLETED|1-Year Follow-Up||74
313440|NCT00717418|755648|P2|COMPLETED|1-Year Follow-Up||23
313441|NCT00717418|755649|P1|COMPLETED|1-Year Follow-Up||33
313442|NCT00717418|755646|P4|STARTED|1-Year Follow-Up||4
313443|NCT00717418|755647|P3|STARTED|1-Year Follow-Up||508
313444|NCT00717418|755648|P2|STARTED|1-Year Follow-Up||74
313445|NCT00717418|755649|P1|STARTED|1-Year Follow-Up||180
313446|NCT00717418|755646|P4|NOT COMPLETED|Baseline||15
313447|NCT00717418|755647|P3|NOT COMPLETED|Baseline||0
313448|NCT00717418|755648|P2|NOT COMPLETED|Baseline||0
313449|NCT00717418|755649|P1|NOT COMPLETED|Baseline||0
313450|NCT00717418|755646|P4|COMPLETED|Baseline||4
313451|NCT00717418|755647|P3|COMPLETED|Baseline||508
313452|NCT00717418|755648|P2|COMPLETED|Baseline||74
313453|NCT00717418|755649|P1|COMPLETED|Baseline||180
313454|NCT00717418|755646|P4|STARTED|Baseline||19
313455|NCT00717418|755647|P3|STARTED|Baseline||508
313456|NCT00717418|755648|P2|STARTED|Baseline||74
313457|NCT00717418|755649|P1|STARTED|Baseline||180
313458|NCT00717405|755654|P1|NOT COMPLETED|Overall Study||0
313459|NCT00717405|755654|P1|COMPLETED|Overall Study||52
313460|NCT00717405|755654|P1|STARTED|Overall Study||52
313461|NCT00717366|755673|P2|NOT COMPLETED|Extension Period (52 Weeks)||16
313462|NCT00717366|755674|P1|NOT COMPLETED|Extension Period (52 Weeks)||4
313463|NCT00717366|755673|P2|COMPLETED|Extension Period (52 Weeks)||12
313464|NCT00717366|755674|P1|COMPLETED|Extension Period (52 Weeks)||5
313465|NCT00717366|755673|P2|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||28
313466|NCT00717366|755674|P1|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||8
313467|NCT00717366|755673|P2|STARTED|Extension Period (52 Weeks)||28
313468|NCT00717366|755674|P1|STARTED|Extension Period (52 Weeks)||9
313469|NCT00717366|755673|P2|NOT COMPLETED|Core Study Period (20 Weeks)||13
313470|NCT00717366|755674|P1|NOT COMPLETED|Core Study Period (20 Weeks)||4
313471|NCT00717366|755673|P2|COMPLETED|Core Study Period (20 Weeks)||35
313472|NCT00717366|755674|P1|COMPLETED|Core Study Period (20 Weeks)||12
313473|NCT00717366|755673|P2|STARTED|Core Study Period (20 Weeks)||48
313474|NCT00717366|755674|P1|STARTED|Core Study Period (20 Weeks)||16
313475|NCT00717314|755698|P2|NOT COMPLETED|Overall Study||10
313476|NCT00717314|755699|P1|NOT COMPLETED|Overall Study||6
313477|NCT00717314|755698|P2|COMPLETED|Overall Study||34
313478|NCT00717314|755699|P1|COMPLETED|Overall Study||37
313479|NCT00717314|755698|P2|STARTED|Overall Study||44
313480|NCT00717314|755699|P1|STARTED|Overall Study||43
313481|NCT00717288|755720|P3|NOT COMPLETED|Overall Study||0
313482|NCT00717288|755721|P2|NOT COMPLETED|Overall Study||0
313483|NCT00717288|755722|P1|NOT COMPLETED|Overall Study||0
313484|NCT00717288|755720|P3|COMPLETED|Overall Study||25
313485|NCT00717288|755721|P2|COMPLETED|Overall Study||29
313486|NCT00717288|755722|P1|COMPLETED|Overall Study||28
313487|NCT00717288|755720|P3|STARTED|Overall Study||25
313488|NCT00717288|755721|P2|STARTED|Overall Study||29
313489|NCT00717288|755722|P1|STARTED|Overall Study||28
313490|NCT00717275|755736|P1|NOT COMPLETED|Overall Study||3
313491|NCT00717275|755736|P1|COMPLETED|Overall Study||0
313492|NCT00717275|755736|P1|STARTED|Overall Study||3
313493|NCT00717249|755742|P2|NOT COMPLETED|Overall Study||15
313494|NCT00717249|755743|P1|NOT COMPLETED|Overall Study||22
313495|NCT00717249|755742|P2|COMPLETED|Overall Study||150
313496|NCT00717249|755743|P1|COMPLETED|Overall Study||304
313497|NCT00717249|755742|P2|STARTED|Overall Study||165
313498|NCT00717249|755743|P1|STARTED|Overall Study||326
313499|NCT00717236|755757|P2|NOT COMPLETED|Open-Label Period||21
313500|NCT00717236|755758|P1|NOT COMPLETED|Open-Label Period||125
313501|NCT00717236|755757|P2|COMPLETED|Open-Label Period||163
313502|NCT00717236|755758|P1|COMPLETED|Open-Label Period||646
313503|NCT00717236|755757|P2|STARTED|Open-Label Period||184
313504|NCT00717236|755758|P1|STARTED|Open-Label Period||771
313505|NCT00717236|755757|P2|NOT COMPLETED|Double-Blind Period||28
313506|NCT00717236|755758|P1|NOT COMPLETED|Double-Blind Period||80
313507|NCT00717236|755757|P2|COMPLETED|Double-Blind Period||184
313508|NCT00717236|755758|P1|COMPLETED|Double-Blind Period||771
313509|NCT00717236|755757|P2|STARTED|Double-Blind Period||212
313510|NCT00717236|755758|P1|STARTED|Double-Blind Period||851
313511|NCT00717197|755827|P1|NOT COMPLETED|Overall Study||7
313512|NCT00717197|755827|P1|COMPLETED|Overall Study||23
313513|NCT00717197|755827|P1|STARTED|Overall Study||30
313514|NCT00717093|755833|P2|NOT COMPLETED|Overall Study||48
313515|NCT00717093|755834|P1|NOT COMPLETED|Overall Study||44
313516|NCT00717093|755833|P2|COMPLETED|Overall Study||170
313517|NCT00717093|755834|P1|COMPLETED|Overall Study||170
313518|NCT00717093|755833|P2|Received Treatment|Overall Study||218
313519|NCT00717093|755834|P1|Received Treatment|Overall Study||213
313520|NCT00717093|755833|P2|STARTED|Overall Study||218
313521|NCT00717093|755834|P1|STARTED|Overall Study||214
313522|NCT00717067|755851|P5|NOT COMPLETED|Part 2: End Stage Renal Disease||0
313523|NCT00717067|755852|P4|NOT COMPLETED|Part 2: End Stage Renal Disease||0
313524|NCT00717067|755853|P3|NOT COMPLETED|Part 2: End Stage Renal Disease||0
313525|NCT00717067|755854|P2|NOT COMPLETED|Part 2: End Stage Renal Disease||0
313526|NCT00717067|755855|P1|NOT COMPLETED|Part 2: End Stage Renal Disease||0
313527|NCT00717067|755851|P5|COMPLETED|Part 2: End Stage Renal Disease||6
313528|NCT00717067|755852|P4|COMPLETED|Part 2: End Stage Renal Disease||0
313529|NCT00717067|755853|P3|COMPLETED|Part 2: End Stage Renal Disease||0
313530|NCT00717067|755854|P2|COMPLETED|Part 2: End Stage Renal Disease||0
313531|NCT00717067|755855|P1|COMPLETED|Part 2: End Stage Renal Disease||0
313532|NCT00717067|755851|P5|STARTED|Part 2: End Stage Renal Disease||6
313533|NCT00717067|755852|P4|STARTED|Part 2: End Stage Renal Disease||0
313534|NCT00717067|755853|P3|STARTED|Part 2: End Stage Renal Disease||0
313535|NCT00717067|755854|P2|STARTED|Part 2: End Stage Renal Disease||0
313536|NCT00717067|755855|P1|STARTED|Part 2: End Stage Renal Disease||0
313537|NCT00717067|755851|P5|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
313538|NCT00717067|755852|P4|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
313539|NCT00717067|755853|P3|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
313540|NCT00717067|755854|P2|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
313541|NCT00717067|755855|P1|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
313542|NCT00717067|755851|P5|COMPLETED|Part 1b: Severe Renal Impairment||0
313543|NCT00717067|755852|P4|COMPLETED|Part 1b: Severe Renal Impairment||6
313544|NCT00717067|755853|P3|COMPLETED|Part 1b: Severe Renal Impairment||0
313545|NCT00717067|755854|P2|COMPLETED|Part 1b: Severe Renal Impairment||0
313546|NCT00717067|755855|P1|COMPLETED|Part 1b: Severe Renal Impairment||0
313547|NCT00717067|755851|P5|STARTED|Part 1b: Severe Renal Impairment||0
313548|NCT00717067|755852|P4|STARTED|Part 1b: Severe Renal Impairment||6
313549|NCT00717067|755853|P3|STARTED|Part 1b: Severe Renal Impairment||0
313550|NCT00717067|755854|P2|STARTED|Part 1b: Severe Renal Impairment||0
313551|NCT00717067|755855|P1|STARTED|Part 1b: Severe Renal Impairment||0
313552|NCT00717067|755851|P5|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
313553|NCT00717067|755852|P4|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
313554|NCT00717067|755853|P3|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||1
313555|NCT00717067|755854|P2|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
313556|NCT00717067|755855|P1|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
313557|NCT00717067|755851|P5|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
313558|NCT00717067|755852|P4|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
313559|NCT00717067|755853|P3|COMPLETED|Part 1a: Normal/Mild/Moderate Group||5
313560|NCT00717067|755854|P2|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
313656|NCT00716742|756079|P3|STARTED|Baseline||365
313561|NCT00717067|755855|P1|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
313562|NCT00717067|755851|P5|STARTED|Part 1a: Normal/Mild/Moderate Group||0
313563|NCT00717067|755852|P4|STARTED|Part 1a: Normal/Mild/Moderate Group||0
313564|NCT00717067|755853|P3|STARTED|Part 1a: Normal/Mild/Moderate Group||6
313565|NCT00717067|755854|P2|STARTED|Part 1a: Normal/Mild/Moderate Group||6
313566|NCT00717067|755855|P1|STARTED|Part 1a: Normal/Mild/Moderate Group||6
313567|NCT00717054|755939|P2|NOT COMPLETED|Overall Study||0
313568|NCT00717054|755940|P1|NOT COMPLETED|Overall Study||0
313569|NCT00717054|755939|P2|COMPLETED|Overall Study||57
313570|NCT00717054|755940|P1|COMPLETED|Overall Study||58
313571|NCT00717054|755939|P2|STARTED|Overall Study||57
313572|NCT00717054|755940|P1|STARTED|Overall Study||58
313573|NCT00717041|755952|P1|NOT COMPLETED|Overall Study||0
313574|NCT00717041|755952|P1|COMPLETED|Overall Study||1206
313575|NCT00717041|755952|P1|STARTED|Overall Study||1206
313576|NCT00716976|755962|P2|NOT COMPLETED|Overall Study||9
313577|NCT00716976|755963|P1|NOT COMPLETED|Overall Study||20
313578|NCT00716976|755962|P2|COMPLETED|Overall Study||57
313579|NCT00716976|755963|P1|COMPLETED|Overall Study||45
313580|NCT00716976|755962|P2|STARTED|Overall Study||66
313581|NCT00716976|755963|P1|STARTED|Overall Study||65
313582|NCT00716963|755985|P6|NOT COMPLETED|Overall Study||0
313583|NCT00716963|755986|P5|NOT COMPLETED|Overall Study||0
313584|NCT00716963|755987|P4|NOT COMPLETED|Overall Study||0
313585|NCT00716963|755988|P3|NOT COMPLETED|Overall Study||0
313586|NCT00716963|755989|P2|NOT COMPLETED|Overall Study||0
313587|NCT00716963|755990|P1|NOT COMPLETED|Overall Study||1
313588|NCT00716963|755985|P6|COMPLETED|Overall Study||1
313589|NCT00716963|755986|P5|COMPLETED|Overall Study||1
313590|NCT00716963|755987|P4|COMPLETED|Overall Study||1
313591|NCT00716963|755988|P3|COMPLETED|Overall Study||1
313592|NCT00716963|755989|P2|COMPLETED|Overall Study||1
313593|NCT00716963|755990|P1|COMPLETED|Overall Study||1
313594|NCT00716963|755985|P6|STARTED|Overall Study||1
313595|NCT00716963|755986|P5|STARTED|Overall Study||1
313596|NCT00716963|755987|P4|STARTED|Overall Study||1
313597|NCT00716963|755988|P3|STARTED|Overall Study||1
313598|NCT00716963|755989|P2|STARTED|Overall Study||1
313599|NCT00716963|755990|P1|STARTED|Overall Study||2
313600|NCT00716859|756003|P2|NOT COMPLETED|Overall Study||5
313601|NCT00716859|756004|P1|NOT COMPLETED|Overall Study||9
313602|NCT00716859|756003|P2|COMPLETED|Overall Study||64
313603|NCT00716859|756004|P1|COMPLETED|Overall Study||61
313604|NCT00716859|756003|P2|Received Treatment|Overall Study||68
313605|NCT00716859|756004|P1|Received Treatment|Overall Study||69
313606|NCT00716859|756003|P2|STARTED|Overall Study||69
313607|NCT00716859|756004|P1|STARTED|Overall Study||70
313608|NCT00716820|756028|P1|NOT COMPLETED|Overall Study||0
313609|NCT00716820|756028|P1|COMPLETED|Overall Study||472
313610|NCT00716820|756028|P1|STARTED|Overall Study||472
313611|NCT00716807|756063|P4|NOT COMPLETED|Overall Study||0
313612|NCT00716807|756064|P3|NOT COMPLETED|Overall Study||0
313613|NCT00716807|756065|P2|NOT COMPLETED|Overall Study||0
313614|NCT00716807|756066|P1|NOT COMPLETED|Overall Study||0
313615|NCT00716807|756063|P4|COMPLETED|Overall Study||15
313616|NCT00716807|756064|P3|COMPLETED|Overall Study||18
313617|NCT00716807|756065|P2|COMPLETED|Overall Study||5
313618|NCT00716807|756066|P1|COMPLETED|Overall Study||8
313619|NCT00716807|756063|P4|STARTED|Overall Study||15
313620|NCT00716807|756064|P3|STARTED|Overall Study||18
313621|NCT00716807|756065|P2|STARTED|Overall Study||5
313622|NCT00716807|756066|P1|STARTED|Overall Study||8
313623|NCT00716742|756079|P3|NOT COMPLETED|3 Year Follow-up||21
313624|NCT00716742|756080|P2|NOT COMPLETED|3 Year Follow-up||32
313625|NCT00716742|756081|P1|NOT COMPLETED|3 Year Follow-up||30
313626|NCT00716742|756079|P3|COMPLETED|3 Year Follow-up||29
313627|NCT00716742|756080|P2|COMPLETED|3 Year Follow-up||35
313628|NCT00716742|756081|P1|COMPLETED|3 Year Follow-up||26
313629|NCT00716742|756079|P3|STARTED|3 Year Follow-up||50
313630|NCT00716742|756080|P2|STARTED|3 Year Follow-up||67
313631|NCT00716742|756081|P1|STARTED|3 Year Follow-up||56
313632|NCT00716742|756079|P3|NOT COMPLETED|2 Year Follow-up||102
313633|NCT00716742|756080|P2|NOT COMPLETED|2 Year Follow-up||96
313634|NCT00716742|756081|P1|NOT COMPLETED|2 Year Follow-up||104
313635|NCT00716742|756079|P3|COMPLETED|2 Year Follow-up||50
313636|NCT00716742|756080|P2|COMPLETED|2 Year Follow-up||67
313637|NCT00716742|756081|P1|COMPLETED|2 Year Follow-up||56
313638|NCT00716742|756079|P3|STARTED|2 Year Follow-up||152
313639|NCT00716742|756080|P2|STARTED|2 Year Follow-up||163
313640|NCT00716742|756081|P1|STARTED|2 Year Follow-up||160
313641|NCT00716742|756079|P3|NOT COMPLETED|1 Year Follow-up||200
313642|NCT00716742|756080|P2|NOT COMPLETED|1 Year Follow-up||193
313643|NCT00716742|756081|P1|NOT COMPLETED|1 Year Follow-up||187
313644|NCT00716742|756079|P3|COMPLETED|1 Year Follow-up||152
313645|NCT00716742|756080|P2|COMPLETED|1 Year Follow-up||163
313646|NCT00716742|756081|P1|COMPLETED|1 Year Follow-up||160
313647|NCT00716742|756079|P3|STARTED|1 Year Follow-up||352
313648|NCT00716742|756080|P2|STARTED|1 Year Follow-up||356
313649|NCT00716742|756081|P1|STARTED|1 Year Follow-up||347
313650|NCT00716742|756079|P3|NOT COMPLETED|Baseline||13
313651|NCT00716742|756080|P2|NOT COMPLETED|Baseline||14
313652|NCT00716742|756081|P1|NOT COMPLETED|Baseline||17
313653|NCT00716742|756079|P3|COMPLETED|Baseline||352
313654|NCT00716742|756080|P2|COMPLETED|Baseline||356
313655|NCT00716742|756081|P1|COMPLETED|Baseline||347
313657|NCT00716742|756080|P2|STARTED|Baseline||370
313658|NCT00716742|756081|P1|STARTED|Baseline||364
313659|NCT00716625|756089|P1|NOT COMPLETED|Overall Study||1
313660|NCT00716625|756089|P1|COMPLETED|Overall Study||1673
313661|NCT00716625|756089|P1|STARTED|Overall Study||1674
313662|NCT00716482|756114|P1|NOT COMPLETED|Overall Study||119
313663|NCT00716482|756114|P1|COMPLETED|Overall Study||1562
313664|NCT00716482|756114|P1|STARTED|Overall Study||1681
313665|NCT00716456|756127|P3|NOT COMPLETED|Overall Study||0
313666|NCT00716456|756128|P2|NOT COMPLETED|Overall Study||2
313667|NCT00716456|756129|P1|NOT COMPLETED|Overall Study||0
313668|NCT00716456|756127|P3|COMPLETED|Overall Study||13
313669|NCT00716456|756128|P2|COMPLETED|Overall Study||3
313670|NCT00716456|756129|P1|COMPLETED|Overall Study||3
313671|NCT00716456|756127|P3|STARTED|Overall Study||13
313672|NCT00716456|756128|P2|STARTED|Overall Study||5
313673|NCT00716456|756129|P1|STARTED|Overall Study||3
313674|NCT00716443|756137|P1|NOT COMPLETED|Overall Study||0
313675|NCT00716443|756137|P1|COMPLETED|Overall Study||51
313676|NCT00716443|756137|P1|STARTED|Overall Study||51
313677|NCT00716417|756180|P10|NOT COMPLETED|Overall Study||3
313678|NCT00716417|756181|P9|NOT COMPLETED|Overall Study||5
313679|NCT00716417|756182|P8|NOT COMPLETED|Overall Study||3
313680|NCT00716417|756183|P7|NOT COMPLETED|Overall Study||7
313681|NCT00716417|756184|P6|NOT COMPLETED|Overall Study||3
313682|NCT00716417|756185|P5|NOT COMPLETED|Overall Study||1
313683|NCT00716417|756186|P4|NOT COMPLETED|Overall Study||11
313684|NCT00716417|756187|P3|NOT COMPLETED|Overall Study||5
313685|NCT00716417|756188|P2|NOT COMPLETED|Overall Study||6
313686|NCT00716417|756189|P1|NOT COMPLETED|Overall Study||3
313687|NCT00716417|756180|P10|COMPLETED|Overall Study||0
313688|NCT00716417|756181|P9|COMPLETED|Overall Study||0
313689|NCT00716417|756182|P8|COMPLETED|Overall Study||0
313690|NCT00716417|756183|P7|COMPLETED|Overall Study||0
313691|NCT00716417|756184|P6|COMPLETED|Overall Study||0
313692|NCT00716417|756185|P5|COMPLETED|Overall Study||0
313693|NCT00716417|756186|P4|COMPLETED|Overall Study||0
313694|NCT00716417|756187|P3|COMPLETED|Overall Study||0
313695|NCT00716417|756188|P2|COMPLETED|Overall Study||0
313696|NCT00716417|756189|P1|COMPLETED|Overall Study||0
313697|NCT00716417|756180|P10|STARTED|Overall Study||3
313698|NCT00716417|756181|P9|STARTED|Overall Study||5
313699|NCT00716417|756182|P8|STARTED|Overall Study||3
313700|NCT00716417|756183|P7|STARTED|Overall Study||7
313701|NCT00716417|756184|P6|STARTED|Overall Study||3
313702|NCT00716417|756185|P5|STARTED|Overall Study||1
313703|NCT00716417|756186|P4|STARTED|Overall Study||11
313704|NCT00716417|756187|P3|STARTED|Overall Study||5
313705|NCT00716417|756188|P2|STARTED|Overall Study||6
313706|NCT00716417|756189|P1|STARTED|Overall Study||3
313707|NCT00716274|756236|P6|NOT COMPLETED|Study Period III (16-Weeks)||0
313708|NCT00716274|756237|P5|NOT COMPLETED|Study Period III (16-Weeks)||3
313709|NCT00716274|756238|P4|NOT COMPLETED|Study Period III (16-Weeks)||1
313710|NCT00716274|756239|P3|NOT COMPLETED|Study Period III (16-Weeks)||2
313711|NCT00716274|756240|P2|NOT COMPLETED|Study Period III (16-Weeks)||0
313712|NCT00716274|756241|P1|NOT COMPLETED|Study Period III (16-Weeks)||0
313713|NCT00716274|756236|P6|COMPLETED|Study Period III (16-Weeks)||19
313714|NCT00716274|756237|P5|COMPLETED|Study Period III (16-Weeks)||32
313715|NCT00716274|756238|P4|COMPLETED|Study Period III (16-Weeks)||17
313716|NCT00716274|756239|P3|COMPLETED|Study Period III (16-Weeks)||16
313717|NCT00716274|756240|P2|COMPLETED|Study Period III (16-Weeks)||0
313718|NCT00716274|756241|P1|COMPLETED|Study Period III (16-Weeks)||0
313719|NCT00716274|756236|P6|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|19
313720|NCT00716274|756237|P5|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|35
313721|NCT00716274|756238|P4|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
313722|NCT00716274|756239|P3|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
313723|NCT00716274|756240|P2|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
313724|NCT00716274|756241|P1|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
313725|NCT00716274|756236|P6|NOT COMPLETED|Study Period II (16-Weeks)||2
313726|NCT00716274|756237|P5|NOT COMPLETED|Study Period II (16-Weeks)||0
313727|NCT00716274|756238|P4|NOT COMPLETED|Study Period II (16-Weeks)||0
313728|NCT00716274|756239|P3|NOT COMPLETED|Study Period II (16-Weeks)||0
313729|NCT00716274|756240|P2|NOT COMPLETED|Study Period II (16-Weeks)||9
313730|NCT00716274|756241|P1|NOT COMPLETED|Study Period II (16-Weeks)||9
313731|NCT00716274|756236|P6|COMPLETED|Study Period II (16-Weeks)||19
313732|NCT00716274|756237|P5|COMPLETED|Study Period II (16-Weeks)||0
313733|NCT00716274|756238|P4|COMPLETED|Study Period II (16-Weeks)||0
313734|NCT00716274|756239|P3|COMPLETED|Study Period II (16-Weeks)||0
313735|NCT00716274|756240|P2|COMPLETED|Study Period II (16-Weeks)||35
313736|NCT00716274|756241|P1|COMPLETED|Study Period II (16-Weeks)||36
313737|NCT00716274|756236|P6|STARTED|Study Period II (16-Weeks)||21
313738|NCT00716274|756237|P5|STARTED|Study Period II (16-Weeks)||0
313739|NCT00716274|756238|P4|STARTED|Study Period II (16-Weeks)||0
313740|NCT00716274|756239|P3|STARTED|Study Period II (16-Weeks)||0
313741|NCT00716274|756240|P2|STARTED|Study Period II (16-Weeks)||44
313742|NCT00716274|756241|P1|STARTED|Study Period II (16-Weeks)||45
313743|NCT00716144|756375|P4|NOT COMPLETED|Overall Study||12
313744|NCT00716144|756376|P3|NOT COMPLETED|Overall Study||12
313745|NCT00716144|756377|P2|NOT COMPLETED|Overall Study||7
313746|NCT00716144|756378|P1|NOT COMPLETED|Overall Study||9
313747|NCT00716144|756375|P4|COMPLETED|Overall Study||33
313748|NCT00716144|756376|P3|COMPLETED|Overall Study||33
313749|NCT00716144|756377|P2|COMPLETED|Overall Study||38
313750|NCT00716144|756378|P1|COMPLETED|Overall Study||32
313751|NCT00716144|756375|P4|STARTED|Overall Study||45
313752|NCT00716144|756376|P3|STARTED|Overall Study||45
313753|NCT00716144|756377|P2|STARTED|Overall Study||45
313754|NCT00716144|756378|P1|STARTED|Overall Study||41
313755|NCT00716092|756403|P3|NOT COMPLETED|Overall Study||0
313756|NCT00716092|756404|P2|NOT COMPLETED|Overall Study||1
313757|NCT00716092|756405|P1|NOT COMPLETED|Overall Study||2
313758|NCT00716092|756403|P3|COMPLETED|Overall Study||41
313759|NCT00716092|756404|P2|COMPLETED|Overall Study||39
313760|NCT00716092|756405|P1|COMPLETED|Overall Study||38
313761|NCT00716092|756403|P3|STARTED|Overall Study||41
313762|NCT00716092|756404|P2|STARTED|Overall Study||40
313763|NCT00716092|756405|P1|STARTED|Overall Study||40
313764|NCT00716079|756436|P2|NOT COMPLETED|Overall Study||15
313765|NCT00716079|756437|P1|NOT COMPLETED|Overall Study||9
313766|NCT00716079|756436|P2|COMPLETED|Overall Study||1421
313767|NCT00716079|756437|P1|COMPLETED|Overall Study||1394
313768|NCT00716079|756436|P2|STARTED|Overall Study||1436
313769|NCT00716079|756437|P1|STARTED|Overall Study||1403
313770|NCT00715962|756447|P2|NOT COMPLETED|Overall Study||2
313771|NCT00715962|756448|P1|NOT COMPLETED|Overall Study||6
313772|NCT00715962|756447|P2|COMPLETED|Overall Study||48
313773|NCT00715962|756448|P1|COMPLETED|Overall Study||44
313774|NCT00715962|756447|P2|STARTED|Overall Study||50
313775|NCT00715962|756448|P1|STARTED|Overall Study||50
313776|NCT00715949|756458|P1|NOT COMPLETED|Overall Study||4
313777|NCT00715949|756458|P1|COMPLETED|Overall Study|116 patients completed first test|116
313778|NCT00715949|756458|P1|STARTED|Overall Study|4 dropped because could not finish first test|120
313779|NCT00715910|756466|P6|NOT COMPLETED|Booster and ESFU Phase||13
313780|NCT00715910|756467|P5|NOT COMPLETED|Booster and ESFU Phase||2
313781|NCT00715910|756468|P4|NOT COMPLETED|Booster and ESFU Phase||11
313782|NCT00715910|756469|P3|NOT COMPLETED|Booster and ESFU Phase||0
313783|NCT00715910|756470|P2|NOT COMPLETED|Booster and ESFU Phase||0
313784|NCT00715910|756471|P1|NOT COMPLETED|Booster and ESFU Phase||0
313785|NCT00715910|756466|P6|COMPLETED|Booster and ESFU Phase||88
313786|NCT00715910|756467|P5|COMPLETED|Booster and ESFU Phase||36
313787|NCT00715910|756468|P4|COMPLETED|Booster and ESFU Phase||172
313788|NCT00715910|756469|P3|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
313789|NCT00715910|756470|P2|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
313790|NCT00715910|756471|P1|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
313791|NCT00715910|756466|P6|STARTED|Booster and ESFU Phase||101
313792|NCT00715910|756467|P5|STARTED|Booster and ESFU Phase||38
313793|NCT00715910|756468|P4|STARTED|Booster and ESFU Phase||183
313794|NCT00715910|756469|P3|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
313795|NCT00715910|756470|P2|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
313796|NCT00715910|756471|P1|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
313797|NCT00715910|756466|P6|NOT COMPLETED|Year 5||0
313798|NCT00715910|756467|P5|NOT COMPLETED|Year 5||0
313799|NCT00715910|756468|P4|NOT COMPLETED|Year 5||0
313800|NCT00715910|756469|P3|NOT COMPLETED|Year 5||0
313801|NCT00715910|756470|P2|NOT COMPLETED|Year 5||0
313802|NCT00715910|756471|P1|NOT COMPLETED|Year 5||0
313803|NCT00715910|756466|P6|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
313804|NCT00715910|756467|P5|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
313805|NCT00715910|756468|P4|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
313806|NCT00715910|756469|P3|COMPLETED|Year 5||38
313807|NCT00715910|756470|P2|COMPLETED|Year 5||56
313808|NCT00715910|756471|P1|COMPLETED|Year 5||218
313809|NCT00715910|756466|P6|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
313810|NCT00715910|756467|P5|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
313811|NCT00715910|756468|P4|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
313812|NCT00715910|756469|P3|STARTED|Year 5||38
313813|NCT00715910|756470|P2|STARTED|Year 5||56
313814|NCT00715910|756471|P1|STARTED|Year 5||218
313815|NCT00715910|756466|P6|NOT COMPLETED|Year 3||0
313816|NCT00715910|756467|P5|NOT COMPLETED|Year 3||0
313817|NCT00715910|756468|P4|NOT COMPLETED|Year 3||0
313818|NCT00715910|756469|P3|NOT COMPLETED|Year 3||0
313819|NCT00715910|756470|P2|NOT COMPLETED|Year 3||0
313820|NCT00715910|756471|P1|NOT COMPLETED|Year 3||0
313821|NCT00715910|756466|P6|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
313822|NCT00715910|756467|P5|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
313823|NCT00715910|756468|P4|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
313824|NCT00715910|756469|P3|COMPLETED|Year 3||56
313825|NCT00715910|756470|P2|COMPLETED|Year 3||86
313826|NCT00715910|756471|P1|COMPLETED|Year 3||345
313827|NCT00715910|756466|P6|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
313828|NCT00715910|756467|P5|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
313829|NCT00715910|756468|P4|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
313830|NCT00715910|756469|P3|STARTED|Year 3||56
313831|NCT00715910|756470|P2|STARTED|Year 3||86
313832|NCT00715910|756471|P1|STARTED|Year 3||345
313833|NCT00715910|756466|P6|NOT COMPLETED|Year 1||0
313834|NCT00715910|756467|P5|NOT COMPLETED|Year 1||0
313835|NCT00715910|756468|P4|NOT COMPLETED|Year 1||0
313836|NCT00715910|756469|P3|NOT COMPLETED|Year 1||0
313837|NCT00715910|756470|P2|NOT COMPLETED|Year 1||0
313838|NCT00715910|756471|P1|NOT COMPLETED|Year 1||0
313839|NCT00715910|756466|P6|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
313840|NCT00715910|756467|P5|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
313841|NCT00715910|756468|P4|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
313842|NCT00715910|756469|P3|COMPLETED|Year 1||68
313843|NCT00715910|756470|P2|COMPLETED|Year 1||147
313844|NCT00715910|756471|P1|COMPLETED|Year 1||433
313845|NCT00715910|756466|P6|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
313846|NCT00715910|756467|P5|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
313847|NCT00715910|756468|P4|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
313848|NCT00715910|756469|P3|STARTED|Year 1||68
313849|NCT00715910|756470|P2|STARTED|Year 1||147
313850|NCT00715910|756471|P1|STARTED|Year 1||433
313851|NCT00715884|756547|P2|NOT COMPLETED|Overall Study||1
313852|NCT00715884|756548|P1|NOT COMPLETED|Overall Study||8
313853|NCT00715884|756547|P2|COMPLETED|Overall Study||225
313854|NCT00715884|756548|P1|COMPLETED|Overall Study||444
313855|NCT00715884|756547|P2|STARTED|Overall Study||226
313856|NCT00715884|756548|P1|STARTED|Overall Study||452
313857|NCT00715793|756590|P2|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||2
313858|NCT00715793|756591|P1|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
313859|NCT00715793|756590|P2|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||27
313860|NCT00715793|756591|P1|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
313861|NCT00715793|756590|P2|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||29
313862|NCT00715793|756591|P1|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
313863|NCT00715793|756590|P2|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||0
313864|NCT00715793|756591|P1|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||1
313865|NCT00715793|756590|P2|COMPLETED|Phase 1 RP2D DAC + TMZ||6
313866|NCT00715793|756591|P1|COMPLETED|Phase 1 RP2D DAC + TMZ||3
313867|NCT00715793|756590|P2|STARTED|Phase 1 RP2D DAC + TMZ||6
313868|NCT00715793|756591|P1|STARTED|Phase 1 RP2D DAC + TMZ||4
313869|NCT00715754|756603|P1|NOT COMPLETED|Overall Study||0
313870|NCT00715754|756603|P1|COMPLETED|Overall Study||47
313871|NCT00715754|756603|P1|STARTED|Overall Study||47
313872|NCT00715741|756613|P4|NOT COMPLETED|Overall Study||0
313873|NCT00715741|756614|P3|NOT COMPLETED|Overall Study||0
313874|NCT00715741|756615|P2|NOT COMPLETED|Overall Study||0
313875|NCT00715741|756616|P1|NOT COMPLETED|Overall Study||0
313876|NCT00715741|756613|P4|COMPLETED|Overall Study||25
313877|NCT00715741|756614|P3|COMPLETED|Overall Study||25
313878|NCT00715741|756615|P2|COMPLETED|Overall Study||25
313879|NCT00715741|756616|P1|COMPLETED|Overall Study||25
313880|NCT00715741|756613|P4|STARTED|Overall Study||25
313881|NCT00715741|756614|P3|STARTED|Overall Study||25
313882|NCT00715741|756615|P2|STARTED|Overall Study||25
313883|NCT00715741|756616|P1|STARTED|Overall Study||25
313884|NCT00715728|756640|P2|NOT COMPLETED|Overall Study||0
313885|NCT00715728|756641|P1|NOT COMPLETED|Overall Study||0
313886|NCT00715728|756640|P2|COMPLETED|Overall Study||14
313887|NCT00715728|756641|P1|COMPLETED|Overall Study||14
313888|NCT00715728|756640|P2|STARTED|Overall Study||14
313889|NCT00715728|756641|P1|STARTED|Overall Study||14
313890|NCT00715676|756652|P3|NOT COMPLETED|Overall Study||32
313891|NCT00715676|756653|P2|NOT COMPLETED|Overall Study||11
313892|NCT00715676|756654|P1|NOT COMPLETED|Overall Study||6
313893|NCT00715676|756652|P3|COMPLETED|Overall Study||21
313894|NCT00715676|756653|P2|COMPLETED|Overall Study||43
313895|NCT00715676|756654|P1|COMPLETED|Overall Study||43
313896|NCT00715676|756652|P3|STARTED|Overall Study||53
313897|NCT00715676|756653|P2|STARTED|Overall Study||54
313898|NCT00715676|756654|P1|STARTED|Overall Study|1 additional subject was enrolled in the placebo group but discontinued before taking any study drug|49
313899|NCT00715650|756682|P2|NOT COMPLETED|Follow-up||5
313900|NCT00715650|756683|P1|NOT COMPLETED|Follow-up||13
313901|NCT00715650|756682|P2|COMPLETED|Follow-up||37
313902|NCT00715650|756683|P1|COMPLETED|Follow-up||29
313903|NCT00715650|756682|P2|Completed Month 6 Follow-up|Follow-up||37
313904|NCT00715650|756683|P1|Completed Month 6 Follow-up|Follow-up||29
313905|NCT00715650|756682|P2|Completed Month 3 Follow-up|Follow-up||40
313906|NCT00715650|756683|P1|Completed Month 3 Follow-up|Follow-up||35
313907|NCT00715650|756682|P2|Completed Month 1 Follow-up|Follow-up||38
313908|NCT00715650|756683|P1|Completed Month 1 Follow-up|Follow-up||40
313909|NCT00715650|756682|P2|STARTED|Follow-up||42
313910|NCT00715650|756683|P1|STARTED|Follow-up||42
313911|NCT00715650|756682|P2|NOT COMPLETED|Intervention||3
313912|NCT00715650|756683|P1|NOT COMPLETED|Intervention||5
313913|NCT00715650|756682|P2|COMPLETED|Intervention||42
313914|NCT00715650|756683|P1|COMPLETED|Intervention||42
313915|NCT00715650|756682|P2|Attended ≥ 3 Sessions|Intervention||17
313916|NCT00715650|756683|P1|Attended ≥ 3 Sessions|Intervention||23
313917|NCT00715650|756682|P2|Attended ≥ 2 Sessions|Intervention||33
313918|NCT00715650|756683|P1|Attended ≥ 2 Sessions|Intervention||36
313919|NCT00715650|756682|P2|Received Any Session|Intervention||38
313920|NCT00715650|756683|P1|Received Any Session|Intervention||39
313921|NCT00715650|756682|P2|STARTED|Intervention||45
313922|NCT00715650|756683|P1|STARTED|Intervention||47
313923|NCT00715624|756697|P2|NOT COMPLETED|Overall Study||116
313924|NCT00715624|756698|P1|NOT COMPLETED|Overall Study||52
313925|NCT00715624|756697|P2|COMPLETED|Overall Study||213
313926|NCT00715624|756698|P1|COMPLETED|Overall Study||115
313927|NCT00715624|756697|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||327
313928|NCT00715624|756698|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|166
313929|NCT00715624|756697|P2|Treated/Safety Population|Overall Study||328
313930|NCT00715624|756698|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|167
313931|NCT00715624|756697|P2|STARTED|Overall Study||329
313932|NCT00715624|756698|P1|STARTED|Overall Study|Randomized|167
313933|NCT00715559|756726|P1|NOT COMPLETED|Overall Study||1
313934|NCT00715559|756726|P1|COMPLETED|Overall Study||2
313935|NCT00715559|756726|P1|STARTED|Overall Study||3
313936|NCT00715520|756736|P3|NOT COMPLETED|Overall Study||2
313937|NCT00715520|756737|P2|NOT COMPLETED|Overall Study||1
313938|NCT00715520|756738|P1|NOT COMPLETED|Overall Study||10
313939|NCT00715520|756736|P3|COMPLETED|Overall Study||1
313940|NCT00715520|756737|P2|COMPLETED|Overall Study||9
313941|NCT00715520|756738|P1|COMPLETED|Overall Study||10
313942|NCT00715520|756736|P3|STARTED|Overall Study||3
313943|NCT00715520|756737|P2|STARTED|Overall Study||10
313944|NCT00715520|756738|P1|STARTED|Overall Study||20
313945|NCT00715429|756753|P2|NOT COMPLETED|Overall Study||1
313946|NCT00715429|756754|P1|NOT COMPLETED|Overall Study||0
313947|NCT00715429|756753|P2|COMPLETED|Overall Study||6
313948|NCT00715429|756754|P1|COMPLETED|Overall Study||7
313949|NCT00715429|756753|P2|STARTED|Overall Study||7
313950|NCT00715429|756754|P1|STARTED|Overall Study||7
313951|NCT00715403|756769|P7|NOT COMPLETED|Overall Study||1
313952|NCT00715403|756770|P6|NOT COMPLETED|Overall Study||19
313953|NCT00715403|756771|P5|NOT COMPLETED|Overall Study||6
313954|NCT00715403|756772|P4|NOT COMPLETED|Overall Study||9
313955|NCT00715403|756773|P3|NOT COMPLETED|Overall Study||4
313956|NCT00715403|756774|P2|NOT COMPLETED|Overall Study||1
313957|NCT00715403|756775|P1|NOT COMPLETED|Overall Study||1
313958|NCT00715403|756769|P7|COMPLETED|Overall Study||0
313959|NCT00715403|756770|P6|COMPLETED|Overall Study||0
313960|NCT00715403|756771|P5|COMPLETED|Overall Study||0
313961|NCT00715403|756772|P4|COMPLETED|Overall Study||0
313962|NCT00715403|756773|P3|COMPLETED|Overall Study||0
313963|NCT00715403|756774|P2|COMPLETED|Overall Study||0
313964|NCT00715403|756775|P1|COMPLETED|Overall Study||0
313965|NCT00715403|756769|P7|STARTED|Overall Study||1
313966|NCT00715403|756770|P6|STARTED|Overall Study||19
313967|NCT00715403|756771|P5|STARTED|Overall Study||6
313968|NCT00715403|756772|P4|STARTED|Overall Study||9
313969|NCT00715403|756773|P3|STARTED|Overall Study||4
313970|NCT00715403|756774|P2|STARTED|Overall Study||1
313971|NCT00715403|756775|P1|STARTED|Overall Study||1
313972|NCT00715390|756910|P1|NOT COMPLETED|Overall Study||0
313973|NCT00715390|756910|P1|COMPLETED|Overall Study|These were broken down to different types of dysrhythymia.|234
313974|NCT00715390|756910|P1|Eligible|Overall Study||234
313975|NCT00715390|756910|P1|STARTED|Overall Study|114,209 Anesthetic records were screened to identify 234 records.|234
313976|NCT00715299|756914|P1|NOT COMPLETED|Overall Study||6
313977|NCT00715299|756914|P1|COMPLETED|Overall Study||30
313978|NCT00715299|756914|P1|STARTED|Overall Study|A total of 38 participants were consented to the study, but only 36 made it to day one of testing.|36
313979|NCT00715208|756920|P2|NOT COMPLETED|Overall Study||9
313980|NCT00715208|756921|P1|NOT COMPLETED|Overall Study||1
313981|NCT00715208|756920|P2|COMPLETED|Overall Study||39
313982|NCT00715208|756921|P1|COMPLETED|Overall Study||6
313983|NCT00715208|756920|P2|STARTED|Overall Study||48
313984|NCT00715208|756921|P1|STARTED|Overall Study||7
313985|NCT00715117|756937|P2|NOT COMPLETED|Overall Study||1
313986|NCT00715117|756938|P1|NOT COMPLETED|Overall Study||0
313987|NCT00715117|756937|P2|COMPLETED|Overall Study|One subject flared and was rescued with steroids|5
313988|NCT00715117|756938|P1|COMPLETED|Overall Study||6
313989|NCT00715117|756937|P2|Completion fo 8 Week Study|Overall Study||6
313990|NCT00715117|756938|P1|Completion fo 8 Week Study|Overall Study||6
313991|NCT00715117|756937|P2|STARTED|Overall Study||6
313992|NCT00715117|756938|P1|STARTED|Overall Study||6
313993|NCT00715104|756952|P3|NOT COMPLETED|Overall Study||0
313994|NCT00715104|756953|P2|NOT COMPLETED|Overall Study||0
313995|NCT00715104|756954|P1|NOT COMPLETED|Overall Study||0
313996|NCT00715104|756952|P3|COMPLETED|Overall Study||8
313997|NCT00715104|756953|P2|COMPLETED|Overall Study||16
313998|NCT00715104|756954|P1|COMPLETED|Overall Study||18
313999|NCT00715104|756952|P3|STARTED|Overall Study||8
314000|NCT00715104|756953|P2|STARTED|Overall Study||16
314001|NCT00715104|756954|P1|STARTED|Overall Study||18
314002|NCT00715078|757006|P3|NOT COMPLETED|Overall Study||38
314003|NCT00715078|757007|P2|NOT COMPLETED|Overall Study||36
314004|NCT00715078|757008|P1|NOT COMPLETED|Overall Study||30
314005|NCT00715078|757006|P3|COMPLETED|Overall Study||3
314006|NCT00715078|757007|P2|COMPLETED|Overall Study||4
314007|NCT00715078|757008|P1|COMPLETED|Overall Study||11
314008|NCT00715078|757006|P3|Received ≥ 1 Leukapheresis|Overall Study||40
314009|NCT00715078|757007|P2|Received ≥ 1 Leukapheresis|Overall Study||40
314010|NCT00715078|757008|P1|Received ≥ 1 Leukapheresis|Overall Study||40
314011|NCT00715078|757006|P3|Received ≥ 1 Study Infusion|Overall Study||39
314012|NCT00715078|757007|P2|Received ≥ 1 Study Infusion|Overall Study||40
314013|NCT00715078|757008|P1|Received ≥ 1 Study Infusion|Overall Study||40
314014|NCT00715078|757006|P3|STARTED|Overall Study||41
314015|NCT00715078|757007|P2|STARTED|Overall Study||40
314016|NCT00715078|757008|P1|STARTED|Overall Study||41
314017|NCT00715026|757016|P1|NOT COMPLETED|Overall Study||10
314018|NCT00715026|757016|P1|COMPLETED|Overall Study|20 unilateral subjects and 1 bilateral|21
314019|NCT00715026|757016|P1|Subjects That Received Surgery|Overall Study|24 unilateral subjects and 1 bilateral|25
314020|NCT00715026|757016|P1|STARTED|Overall Study|30 unilateral subjects and 1 bilateral|31
314021|NCT00714948|757021|P1|NOT COMPLETED|Overall Study||2
314022|NCT00714948|757021|P1|COMPLETED|Overall Study||0
314023|NCT00714948|757021|P1|STARTED|Overall Study||2
314024|NCT00714870|757027|P2|NOT COMPLETED|Overall Study||5
314025|NCT00714870|757028|P1|NOT COMPLETED|Overall Study||27
314026|NCT00714870|757027|P2|COMPLETED|Overall Study||22
314027|NCT00714870|757028|P1|COMPLETED|Overall Study||22
314028|NCT00714870|757027|P2|STARTED|Overall Study||27
314029|NCT00714870|757028|P1|STARTED|Overall Study||49
314030|NCT00714792|757036|P2|NOT COMPLETED|Overall Study||0
314031|NCT00714792|757037|P1|NOT COMPLETED|Overall Study||0
314032|NCT00714792|757036|P2|COMPLETED|Overall Study||8
314033|NCT00714792|757037|P1|COMPLETED|Overall Study||10
314034|NCT00714792|757036|P2|STARTED|Overall Study||8
314035|NCT00714792|757037|P1|STARTED|Overall Study||10
314036|NCT00714753|757043|P1|NOT COMPLETED|Overall Study||0
314037|NCT00714753|757043|P1|COMPLETED|Overall Study||5
314038|NCT00714753|757043|P1|External Beam Radiotherapy (EBRT)|Overall Study||1
314039|NCT00714753|757043|P1|HDR Brachytherapy|Overall Study||5
314040|NCT00714753|757043|P1|STARTED|Overall Study||5
314041|NCT00714714|757052|P1|NOT COMPLETED|Overall Study||1
314042|NCT00714714|757052|P1|COMPLETED|Overall Study||24
314043|NCT00714714|757052|P1|STARTED|Overall Study||25
314044|NCT00714688|757061|P3|NOT COMPLETED|Overall Study||37
314045|NCT00714688|757062|P2|NOT COMPLETED|Overall Study||35
314046|NCT00714688|757063|P1|NOT COMPLETED|Overall Study||29
314047|NCT00714688|757061|P3|COMPLETED|Overall Study||55
314048|NCT00714688|757062|P2|COMPLETED|Overall Study||55
314049|NCT00714688|757063|P1|COMPLETED|Overall Study||68
314050|NCT00714688|757061|P3|STARTED|Overall Study||92
314051|NCT00714688|757062|P2|STARTED|Overall Study||90
314052|NCT00714688|757063|P1|STARTED|Overall Study||97
314053|NCT00714571|757086|P6|NOT COMPLETED|Stage 2||0
314054|NCT00714571|757087|P5|NOT COMPLETED|Stage 2||0
314055|NCT00714571|757088|P4|NOT COMPLETED|Stage 2||0
314056|NCT00714571|757089|P3|NOT COMPLETED|Stage 2||0
314057|NCT00714571|757090|P2|NOT COMPLETED|Stage 2||0
314058|NCT00714571|757091|P1|NOT COMPLETED|Stage 2||0
314059|NCT00714571|757086|P6|COMPLETED|Stage 2||15
314060|NCT00714571|757087|P5|COMPLETED|Stage 2||15
314061|NCT00714571|757088|P4|COMPLETED|Stage 2||0
314062|NCT00714571|757089|P3|COMPLETED|Stage 2||0
314063|NCT00714571|757090|P2|COMPLETED|Stage 2||0
314064|NCT00714571|757091|P1|COMPLETED|Stage 2||0
314065|NCT00714571|757086|P6|STARTED|Stage 2||15
314066|NCT00714571|757087|P5|STARTED|Stage 2||15
314067|NCT00714571|757088|P4|STARTED|Stage 2||0
314068|NCT00714571|757089|P3|STARTED|Stage 2||0
314069|NCT00714571|757090|P2|STARTED|Stage 2||0
314070|NCT00714571|757091|P1|STARTED|Stage 2||0
314071|NCT00714571|757086|P6|NOT COMPLETED|Stage 1||0
314072|NCT00714571|757087|P5|NOT COMPLETED|Stage 1||0
314073|NCT00714571|757088|P4|NOT COMPLETED|Stage 1||0
314074|NCT00714571|757089|P3|NOT COMPLETED|Stage 1||1
314075|NCT00714571|757090|P2|NOT COMPLETED|Stage 1||0
314076|NCT00714571|757091|P1|NOT COMPLETED|Stage 1||0
314077|NCT00714571|757086|P6|COMPLETED|Stage 1||0
314078|NCT00714571|757087|P5|COMPLETED|Stage 1||0
314079|NCT00714571|757088|P4|COMPLETED|Stage 1||14
314080|NCT00714571|757089|P3|COMPLETED|Stage 1||10
314081|NCT00714571|757090|P2|COMPLETED|Stage 1||15
314082|NCT00714571|757091|P1|COMPLETED|Stage 1|1 patient excluded who completed training but did not disclose ongoing chemotherapy for cancer|12
314083|NCT00714571|757086|P6|STARTED|Stage 1||0
314084|NCT00714571|757087|P5|STARTED|Stage 1||0
314085|NCT00714571|757088|P4|STARTED|Stage 1||14
314086|NCT00714571|757089|P3|STARTED|Stage 1||11
314087|NCT00714571|757090|P2|STARTED|Stage 1|11 allocated to intervention, but 1 withdrew before the first intervention session|15
314088|NCT00714571|757091|P1|STARTED|Stage 1||12
314089|NCT00714493|757105|P1|NOT COMPLETED|Overall Study||49
314090|NCT00714493|757105|P1|COMPLETED|Overall Study||154
314091|NCT00714493|757105|P1|STARTED|Overall Study||203
314092|NCT00714415|757117|P2|NOT COMPLETED|Overall Study||0
314093|NCT00714415|757118|P1|NOT COMPLETED|Overall Study||2
314094|NCT00714415|757117|P2|COMPLETED|Overall Study||55
314095|NCT00714415|757118|P1|COMPLETED|Overall Study||23
314096|NCT00714415|757117|P2|STARTED|Overall Study||55
314097|NCT00714415|757118|P1|STARTED|Overall Study||25
314098|NCT00714389|757150|P1|NOT COMPLETED|Overall Study||0
314099|NCT00714389|757150|P1|COMPLETED|Overall Study||12
314100|NCT00714389|757150|P1|STARTED|Overall Study||12
314101|NCT00714311|757157|P2|NOT COMPLETED|Overall Study||22
314102|NCT00714311|757158|P1|NOT COMPLETED|Overall Study||13
314103|NCT00714311|757157|P2|COMPLETED|Overall Study||30
314104|NCT00714311|757158|P1|COMPLETED|Overall Study||39
314105|NCT00714311|757157|P2|STARTED|Overall Study||52
314106|NCT00714311|757158|P1|STARTED|Overall Study||52
314107|NCT00714285|757168|P4|NOT COMPLETED|Overall Study||1
314108|NCT00714285|757169|P3|NOT COMPLETED|Overall Study||0
314109|NCT00714285|757170|P2|NOT COMPLETED|Overall Study||3
314110|NCT00714285|757171|P1|NOT COMPLETED|Overall Study||0
314111|NCT00714285|757168|P4|COMPLETED|Overall Study|Completed upto Day 180|104
314112|NCT00714285|757169|P3|COMPLETED|Overall Study|Completed upto Day 180|105
314113|NCT00714285|757170|P2|COMPLETED|Overall Study|Completed upto Day 180|102
314114|NCT00714285|757171|P1|COMPLETED|Overall Study|Completed upto Day 180|105
314115|NCT00714285|757168|P4|STARTED|Overall Study||105
314116|NCT00714285|757169|P3|STARTED|Overall Study||105
314117|NCT00714285|757170|P2|STARTED|Overall Study||105
314118|NCT00714285|757171|P1|STARTED|Overall Study||105
314119|NCT00714259|757221|P1|NOT COMPLETED|Overall Study||2
314120|NCT00714259|757221|P1|COMPLETED|Overall Study||3
314121|NCT00714259|757221|P1|STARTED|Overall Study||5
314122|NCT00714233|757235|P4|NOT COMPLETED|Overall Study||4
314123|NCT00714233|757236|P3|NOT COMPLETED|Overall Study||1
314124|NCT00714233|757237|P2|NOT COMPLETED|Overall Study||1
314125|NCT00714233|757238|P1|NOT COMPLETED|Overall Study||4
314126|NCT00714233|757235|P4|COMPLETED|Overall Study||6
314127|NCT00714233|757236|P3|COMPLETED|Overall Study||10
314128|NCT00714233|757237|P2|COMPLETED|Overall Study||10
314129|NCT00714233|757238|P1|COMPLETED|Overall Study||6
314130|NCT00714233|757235|P4|STARTED|Overall Study||10
314131|NCT00714233|757236|P3|STARTED|Overall Study||11
314132|NCT00714233|757237|P2|STARTED|Overall Study||11
314133|NCT00714233|757238|P1|STARTED|Overall Study||10
314134|NCT00714168|757267|P2|NOT COMPLETED|Overall Study||59
314135|NCT00714168|757268|P1|NOT COMPLETED|Overall Study||44
314136|NCT00714168|757267|P2|COMPLETED|Overall Study||139
314137|NCT00714168|757268|P1|COMPLETED|Overall Study||121
314138|NCT00714168|757267|P2|STARTED|Overall Study||198
314139|NCT00714168|757268|P1|STARTED|Overall Study||165
314140|NCT00714051|757284|P2|NOT COMPLETED|Overall Study||1
314141|NCT00714051|757285|P1|NOT COMPLETED|Overall Study||1
314142|NCT00714051|757284|P2|COMPLETED|Overall Study||27
314143|NCT00714051|757285|P1|COMPLETED|Overall Study||26
314144|NCT00714051|757284|P2|STARTED|Overall Study||28
314145|NCT00714051|757285|P1|STARTED|Overall Study||27
314146|NCT00713830|757293|P2|NOT COMPLETED|Overall Study||177
314147|NCT00713830|757294|P1|NOT COMPLETED|Overall Study||82
314148|NCT00713830|757293|P2|COMPLETED|Overall Study||396
314149|NCT00713830|757294|P1|COMPLETED|Overall Study||204
314150|NCT00713830|757293|P2|Subgroup for Standardized Meal Test|Overall Study||313
314151|NCT00713830|757294|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal challenge test was performed.|155
314152|NCT00713830|757293|P2|Safety Population|Overall Study|1 patient randomized to placebo received Lixisenatide (at least one dose)|574
314153|NCT00713830|757294|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|285
314154|NCT00713830|757293|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||570
314155|NCT00713830|757294|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|286
314156|NCT00713830|757293|P2|STARTED|Overall Study||573
314157|NCT00713830|757294|P1|STARTED|Overall Study|Randomized.|286
314158|NCT00713817|757332|P2|NOT COMPLETED|Overall Study||0
314159|NCT00713817|757333|P1|NOT COMPLETED|Overall Study||0
314160|NCT00713817|757332|P2|COMPLETED|Overall Study||9
314161|NCT00713817|757333|P1|COMPLETED|Overall Study||10
314162|NCT00713817|757332|P2|STARTED|Overall Study||9
314163|NCT00713817|757333|P1|STARTED|Overall Study||10
314164|NCT00713700|757351|P1|NOT COMPLETED|Overall Study||4
314165|NCT00713700|757351|P1|COMPLETED|Overall Study||188
314166|NCT00713700|757351|P1|STARTED|Overall Study||192
314167|NCT00713661|757360|P4|NOT COMPLETED|Overall Study||0
314168|NCT00713661|757361|P3|NOT COMPLETED|Overall Study||0
314169|NCT00713661|757362|P2|NOT COMPLETED|Overall Study||0
314170|NCT00713661|757363|P1|NOT COMPLETED|Overall Study||0
314171|NCT00713661|757360|P4|COMPLETED|Overall Study||5
314172|NCT00713661|757361|P3|COMPLETED|Overall Study||4
314173|NCT00713661|757362|P2|COMPLETED|Overall Study||9
314174|NCT00713661|757363|P1|COMPLETED|Overall Study||7
314175|NCT00713661|757360|P4|STARTED|Overall Study||5
314176|NCT00713661|757361|P3|STARTED|Overall Study||4
314177|NCT00713661|757362|P2|STARTED|Overall Study||9
314178|NCT00713661|757363|P1|STARTED|Overall Study||7
314179|NCT00713648|757377|P1|NOT COMPLETED|Overall Study||8
314180|NCT00713648|757377|P1|COMPLETED|Overall Study||33
314181|NCT00713648|757377|P1|STARTED|Overall Study||41
314182|NCT00713609|757390|P6|NOT COMPLETED|Overall Study||8
314183|NCT00713609|757391|P5|NOT COMPLETED|Overall Study||19
314184|NCT00713609|757392|P4|NOT COMPLETED|Overall Study||9
314185|NCT00713609|757393|P3|NOT COMPLETED|Overall Study||15
314186|NCT00713609|757394|P2|NOT COMPLETED|Overall Study||15
314187|NCT00713609|757395|P1|NOT COMPLETED|Overall Study||21
314188|NCT00713609|757390|P6|COMPLETED|Overall Study||47
314189|NCT00713609|757391|P5|COMPLETED|Overall Study||87
314190|NCT00713609|757392|P4|COMPLETED|Overall Study||99
314191|NCT00713609|757393|P3|COMPLETED|Overall Study||92
314192|NCT00713609|757394|P2|COMPLETED|Overall Study||90
314193|NCT00713609|757395|P1|COMPLETED|Overall Study||85
314194|NCT00713609|757390|P6|STARTED|Overall Study||55
314195|NCT00713609|757391|P5|STARTED|Overall Study||106
314196|NCT00713609|757392|P4|STARTED|Overall Study||108
314197|NCT00713609|757393|P3|STARTED|Overall Study||107
314198|NCT00713609|757394|P2|STARTED|Overall Study||105
314199|NCT00713609|757395|P1|STARTED|Overall Study||106
314200|NCT00713596|757430|P3|NOT COMPLETED|Overall Study||2
314201|NCT00713596|757431|P2|NOT COMPLETED|Overall Study||3
314202|NCT00713596|757432|P1|NOT COMPLETED|Overall Study||2
314203|NCT00713596|757430|P3|COMPLETED|Overall Study||6
314204|NCT00713596|757431|P2|COMPLETED|Overall Study||5
314205|NCT00713596|757432|P1|COMPLETED|Overall Study||7
314206|NCT00713596|757430|P3|STARTED|Overall Study||8
314207|NCT00713596|757431|P2|STARTED|Overall Study||8
314208|NCT00713596|757432|P1|STARTED|Overall Study||9
314209|NCT00713583|757445|P2|NOT COMPLETED|Overall Study||0
314210|NCT00713583|757446|P1|NOT COMPLETED|Overall Study||0
314211|NCT00713583|757445|P2|COMPLETED|Overall Study||40
314212|NCT00713583|757446|P1|COMPLETED|Overall Study||45
314213|NCT00713583|757445|P2|STARTED|Overall Study||40
314214|NCT00713583|757446|P1|STARTED|Overall Study||45
314215|NCT00713544|757458|P6|NOT COMPLETED|Overall Study||9
314216|NCT00713544|757459|P5|NOT COMPLETED|Overall Study||8
314217|NCT00713544|757460|P4|NOT COMPLETED|Overall Study||10
314218|NCT00713544|757461|P3|NOT COMPLETED|Overall Study||11
314219|NCT00713544|757462|P2|NOT COMPLETED|Overall Study||6
314220|NCT00713544|757463|P1|NOT COMPLETED|Overall Study||7
314221|NCT00713544|757458|P6|COMPLETED|Overall Study||67
314222|NCT00713544|757459|P5|COMPLETED|Overall Study||57
314223|NCT00713544|757460|P4|COMPLETED|Overall Study||66
314224|NCT00713544|757461|P3|COMPLETED|Overall Study||41
314225|NCT00713544|757462|P2|COMPLETED|Overall Study||46
314226|NCT00713544|757463|P1|COMPLETED|Overall Study||45
314227|NCT00713544|757458|P6|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|76
314228|NCT00713544|757459|P5|STARTED|Overall Study||65
314229|NCT00713544|757460|P4|STARTED|Overall Study||76
314230|NCT00713544|757461|P3|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|52
314231|NCT00713544|757462|P2|STARTED|Overall Study||52
314232|NCT00713544|757463|P1|STARTED|Overall Study||52
314233|NCT00713479|757501|P2|NOT COMPLETED|Next Medication Condition||0
314234|NCT00713479|757502|P1|NOT COMPLETED|Next Medication Condition||0
314235|NCT00713479|757501|P2|COMPLETED|Next Medication Condition||6
314236|NCT00713479|757502|P1|COMPLETED|Next Medication Condition||2
314237|NCT00713479|757501|P2|STARTED|Next Medication Condition||6
314238|NCT00713479|757502|P1|STARTED|Next Medication Condition||2
314239|NCT00713479|757501|P2|NOT COMPLETED|Washout||0
314240|NCT00713479|757502|P1|NOT COMPLETED|Washout||0
314241|NCT00713479|757501|P2|COMPLETED|Washout||6
314242|NCT00713479|757502|P1|COMPLETED|Washout||2
314243|NCT00713479|757501|P2|STARTED|Washout||6
314244|NCT00713479|757502|P1|STARTED|Washout||2
314245|NCT00713479|757501|P2|NOT COMPLETED|First Medication Condition||0
314246|NCT00713479|757502|P1|NOT COMPLETED|First Medication Condition||4
314247|NCT00713479|757501|P2|COMPLETED|First Medication Condition||6
314248|NCT00713479|757502|P1|COMPLETED|First Medication Condition||2
314249|NCT00713479|757501|P2|STARTED|First Medication Condition||6
314250|NCT00713479|757502|P1|STARTED|First Medication Condition||6
314251|NCT00713349|757514|P1|NOT COMPLETED|Overall Study||1
314252|NCT00713349|757514|P1|COMPLETED|Overall Study||24
314253|NCT00713349|757514|P1|STARTED|Overall Study||25
314254|NCT00713323|757520|P1|NOT COMPLETED|Overall Study||146
314255|NCT00713323|757520|P1|COMPLETED|Overall Study||234
314256|NCT00713323|757520|P1|STARTED|Overall Study||380
314257|NCT00713310|757533|P2|NOT COMPLETED|Overall Study||6
314258|NCT00713310|757534|P1|NOT COMPLETED|Overall Study||5
314259|NCT00713310|757533|P2|COMPLETED|Overall Study||36
314260|NCT00713310|757534|P1|COMPLETED|Overall Study||36
314261|NCT00713310|757533|P2|mITT Population|Overall Study|1 subject randomized to high dose not dosed so not included in the mITT population.|41
314262|NCT00713310|757534|P1|mITT Population|Overall Study||41
314263|NCT00713310|757533|P2|STARTED|Overall Study||42
314264|NCT00713310|757534|P1|STARTED|Overall Study||41
314265|NCT00713258|757544|P2|NOT COMPLETED|Overall Study||6
314266|NCT00713258|757545|P1|NOT COMPLETED|Overall Study||5
314267|NCT00713258|757544|P2|COMPLETED|Overall Study||28
314268|NCT00713258|757545|P1|COMPLETED|Overall Study||36
314269|NCT00713258|757544|P2|STARTED|Overall Study||34
314270|NCT00713258|757545|P1|STARTED|Overall Study||41
314271|NCT00713219|757553|P1|NOT COMPLETED|Overall Study||2
314272|NCT00713219|757553|P1|COMPLETED|Overall Study||12
314273|NCT00713219|757553|P1|STARTED|Overall Study||14
314274|NCT00713206|757559|P2|NOT COMPLETED|Overall Study||3
314275|NCT00713206|757560|P1|NOT COMPLETED|Overall Study||7
314276|NCT00713206|757559|P2|COMPLETED|Overall Study||27
314277|NCT00713206|757560|P1|COMPLETED|Overall Study||55
314278|NCT00713206|757559|P2|STARTED|Overall Study||30
314279|NCT00713206|757560|P1|STARTED|Overall Study||62
314280|NCT00712985|757566|P1|NOT COMPLETED|Overall Study||5
314281|NCT00712985|757566|P1|COMPLETED|Overall Study||13
314282|NCT00712985|757566|P1|STARTED|Overall Study||18
314283|NCT00712959|757572|P2|NOT COMPLETED|Overall Study||3
314284|NCT00712959|757573|P1|NOT COMPLETED|Overall Study||19
314285|NCT00712959|757572|P2|COMPLETED|Overall Study||404
314286|NCT00712959|757573|P1|COMPLETED|Overall Study||342
314287|NCT00712959|757572|P2|STARTED|Overall Study||407
314288|NCT00712959|757573|P1|STARTED|Overall Study||361
314289|NCT00712933|757591|P1|NOT COMPLETED|Overall Study||367
314290|NCT00712933|757591|P1|COMPLETED|Overall Study||368
314291|NCT00712933|757591|P1|STARTED|Overall Study||735
314292|NCT00712920|757621|P3|NOT COMPLETED|Overall Study||12
314293|NCT00712920|757622|P2|NOT COMPLETED|Overall Study||17
314294|NCT00712920|757623|P1|NOT COMPLETED|Overall Study||17
314295|NCT00712920|757621|P3|COMPLETED|Overall Study||180
314296|NCT00712920|757622|P2|COMPLETED|Overall Study||180
314297|NCT00712920|757623|P1|COMPLETED|Overall Study||175
314298|NCT00712920|757621|P3|STARTED|Overall Study||192
314299|NCT00712920|757622|P2|STARTED|Overall Study|3 subjects were randomized in error|197
314300|NCT00712920|757623|P1|STARTED|Overall Study||192
314301|NCT00712725|757651|P8|NOT COMPLETED|Overall Study||11
314302|NCT00712725|757652|P7|NOT COMPLETED|Overall Study||22
314303|NCT00712725|757653|P6|NOT COMPLETED|Overall Study||16
314304|NCT00712725|757654|P5|NOT COMPLETED|Overall Study||19
314305|NCT00712725|757655|P4|NOT COMPLETED|Overall Study||17
314306|NCT00712725|757656|P3|NOT COMPLETED|Overall Study||10
314307|NCT00712725|757657|P2|NOT COMPLETED|Overall Study||6
314308|NCT00712725|757658|P1|NOT COMPLETED|Overall Study||29
314309|NCT00712725|757651|P8|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|63
314310|NCT00712725|757652|P7|COMPLETED|Overall Study|One patient received study drug. The remaining patients discontinued prior to receiving study drug.|61
314311|NCT00712725|757653|P6|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|68
314312|NCT00712725|757654|P5|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
314313|NCT00712725|757655|P4|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
314314|NCT00712725|757656|P3|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|47
314315|NCT00712725|757657|P2|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|33
314316|NCT00712725|757658|P1|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|140
314317|NCT00712725|757651|P8|STARTED|Overall Study||74
314318|NCT00712725|757652|P7|STARTED|Overall Study||83
314319|NCT00712725|757653|P6|STARTED|Overall Study||84
314320|NCT00712725|757654|P5|STARTED|Overall Study||86
314321|NCT00712725|757655|P4|STARTED|Overall Study||84
314322|NCT00712725|757656|P3|STARTED|Overall Study||57
314323|NCT00712725|757657|P2|STARTED|Overall Study||39
314324|NCT00712725|757658|P1|STARTED|Overall Study||169
314325|NCT00712673|757719|P4|NOT COMPLETED|Overall Study||70
314326|NCT00712673|757720|P3|NOT COMPLETED|Overall Study||57
314327|NCT00712673|757721|P2|NOT COMPLETED|Overall Study||21
314328|NCT00712673|757722|P1|NOT COMPLETED|Overall Study||21
314329|NCT00712673|757719|P4|COMPLETED|Overall Study||185
314330|NCT00712673|757720|P3|COMPLETED|Overall Study||198
314331|NCT00712673|757721|P2|COMPLETED|Overall Study||64
314332|NCT00712673|757722|P1|COMPLETED|Overall Study||64
314333|NCT00712673|757719|P4|Subgroup for Standardized Meal Test|Overall Study||0
314334|NCT00712673|757720|P3|Subgroup for Standardized Meal Test|Overall Study||255
314335|NCT00712673|757721|P2|Subgroup for Standardized Meal Test|Overall Study||0
314336|NCT00712673|757722|P1|Subgroup for Standardized Meal Test|Overall Study|Patients from morning injection arms where standardized meal test was performed.|85
314337|NCT00712673|757719|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||255
314338|NCT00712673|757720|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||255
314339|NCT00712673|757721|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||85
314340|NCT00712673|757722|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|85
314341|NCT00712673|757719|P4|Safety Population|Overall Study||255
314342|NCT00712673|757720|P3|Safety Population|Overall Study||255
314343|NCT00712673|757721|P2|Safety Population|Overall Study||85
314344|NCT00712673|757722|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|85
314345|NCT00712673|757719|P4|STARTED|Overall Study||255
314346|NCT00712673|757720|P3|STARTED|Overall Study||255
314347|NCT00712673|757721|P2|STARTED|Overall Study||85
314348|NCT00712673|757722|P1|STARTED|Overall Study|Randomized.|85
314349|NCT00712543|757786|P2|NOT COMPLETED|Day 8-14||2
314350|NCT00712543|757787|P1|NOT COMPLETED|Day 8-14||0
314351|NCT00712543|757786|P2|COMPLETED|Day 8-14||25
314352|NCT00712543|757787|P1|COMPLETED|Day 8-14||23
314353|NCT00712543|757786|P2|STARTED|Day 8-14||27
314354|NCT00712543|757787|P1|STARTED|Day 8-14||23
314355|NCT00712543|757786|P2|NOT COMPLETED|Day 1-7||0
314356|NCT00712543|757787|P1|NOT COMPLETED|Day 1-7||0
314357|NCT00712543|757786|P2|COMPLETED|Day 1-7||27
314358|NCT00712543|757787|P1|COMPLETED|Day 1-7||23
314359|NCT00712543|757786|P2|STARTED|Day 1-7||27
314360|NCT00712543|757787|P1|STARTED|Day 1-7||23
314361|NCT00712530|757796|P3|NOT COMPLETED|Overall Study||0
314362|NCT00712530|757797|P2|NOT COMPLETED|Overall Study||0
314363|NCT00712530|757798|P1|NOT COMPLETED|Overall Study||0
314364|NCT00712530|757796|P3|COMPLETED|Overall Study||3
314365|NCT00712530|757797|P2|COMPLETED|Overall Study||3
314366|NCT00712530|757798|P1|COMPLETED|Overall Study||3
314367|NCT00712530|757796|P3|STARTED|Overall Study|Screened 4 patients, but one failed to meet entry criteria due to a history of bleeding and diabetes|3
314368|NCT00712530|757797|P2|STARTED|Overall Study||3
314369|NCT00712530|757798|P1|STARTED|Overall Study||3
314370|NCT00712348|757821|P1|NOT COMPLETED|Overall Study||1
314371|NCT00712348|757821|P1|COMPLETED|Overall Study||30
314372|NCT00712348|757821|P1|STARTED|Overall Study||31
314373|NCT00712335|757833|P5|NOT COMPLETED|Overall Study||0
314374|NCT00712335|757834|P4|NOT COMPLETED|Overall Study||5
314375|NCT00712335|757835|P3|NOT COMPLETED|Overall Study||5
314376|NCT00712335|757836|P2|NOT COMPLETED|Overall Study||17
314377|NCT00712335|757837|P1|NOT COMPLETED|Overall Study||3
314378|NCT00712335|757833|P5|COMPLETED|Overall Study||30
314379|NCT00712335|757834|P4|COMPLETED|Overall Study||19
314380|NCT00712335|757835|P3|COMPLETED|Overall Study||6
314381|NCT00712335|757836|P2|COMPLETED|Overall Study||15
314382|NCT00712335|757837|P1|COMPLETED|Overall Study||5
314383|NCT00712335|757833|P5|STARTED|Overall Study||30
314384|NCT00712335|757834|P4|STARTED|Overall Study||24
314385|NCT00712335|757835|P3|STARTED|Overall Study||11
314386|NCT00712335|757836|P2|STARTED|Overall Study||32
314387|NCT00712335|757837|P1|STARTED|Overall Study||8
314388|NCT00712270|757882|P1|NOT COMPLETED|Overall Study||14
314389|NCT00712270|757882|P1|COMPLETED|Overall Study||7
314390|NCT00712270|757882|P1|STARTED|Overall Study||21
314391|NCT00712244|757895|P4|NOT COMPLETED|Overall Study||1
314392|NCT00712244|757896|P3|NOT COMPLETED|Overall Study||2
314393|NCT00712244|757897|P2|NOT COMPLETED|Overall Study||1
314394|NCT00712244|757898|P1|NOT COMPLETED|Overall Study||4
314395|NCT00712244|757895|P4|COMPLETED|Overall Study||26
314396|NCT00712244|757896|P3|COMPLETED|Overall Study||25
314397|NCT00712244|757897|P2|COMPLETED|Overall Study||28
314398|NCT00712244|757898|P1|COMPLETED|Overall Study||25
314399|NCT00712244|757895|P4|STARTED|Overall Study||27
314400|NCT00712244|757896|P3|STARTED|Overall Study||27
314401|NCT00712244|757897|P2|STARTED|Overall Study||29
314402|NCT00712244|757898|P1|STARTED|Overall Study||29
314403|NCT00712179|757940|P1|NOT COMPLETED|Overall Study||12
314404|NCT00712179|757940|P1|COMPLETED|Overall Study|Data from 4 subjects was excluded due to noise in recorded EMG signal, so 33 subjects were analysed.|37
314405|NCT00712179|757940|P1|STARTED|Overall Study||49
314406|NCT00712166|757946|P2|NOT COMPLETED|Overall Study||1
314407|NCT00712166|757947|P1|NOT COMPLETED|Overall Study||0
314408|NCT00712166|757946|P2|COMPLETED|Overall Study||75
314409|NCT00712166|757947|P1|COMPLETED|Overall Study||81
314410|NCT00712166|757946|P2|STARTED|Overall Study||76
314411|NCT00712166|757947|P1|STARTED|Overall Study||81
314412|NCT00712075|757974|P3|NOT COMPLETED|Overall Study||11
314413|NCT00712075|757975|P2|NOT COMPLETED|Overall Study||4
314414|NCT00712075|757976|P1|NOT COMPLETED|Overall Study||5
314415|NCT00712075|757974|P3|COMPLETED|Overall Study||14
314416|NCT00712075|757975|P2|COMPLETED|Overall Study||26
314417|NCT00712075|757976|P1|COMPLETED|Overall Study||17
314418|NCT00712075|757974|P3|STARTED|Overall Study||25
314419|NCT00712075|757975|P2|STARTED|Overall Study||30
314420|NCT00712075|757976|P1|STARTED|Overall Study||22
314421|NCT00712010|757990|P1|NOT COMPLETED|7th and Last Protein Testing (1 Day)||0
314422|NCT00712010|757990|P1|COMPLETED|7th and Last Protein Testing (1 Day)||23
314423|NCT00712010|757990|P1|STARTED|7th and Last Protein Testing (1 Day)||23
314424|NCT00712010|757990|P1|NOT COMPLETED|Washout (7 Days)||0
314425|NCT00712010|757990|P1|COMPLETED|Washout (7 Days)||23
314426|NCT00712010|757990|P1|STARTED|Washout (7 Days)||23
314427|NCT00712010|757990|P1|NOT COMPLETED|6th Protein Testing (1 Day)||0
314428|NCT00712010|757990|P1|COMPLETED|6th Protein Testing (1 Day)||23
314429|NCT00712010|757990|P1|STARTED|6th Protein Testing (1 Day)||23
314430|NCT00712010|757990|P1|NOT COMPLETED|Washout (7 Days)||0
314431|NCT00712010|757990|P1|COMPLETED|Washout (7 Days)||23
314432|NCT00712010|757990|P1|STARTED|Washout (7 Days)||23
314433|NCT00712010|757990|P1|NOT COMPLETED|5th Protein Testing (1 Day)||0
314434|NCT00712010|757990|P1|COMPLETED|5th Protein Testing (1 Day)||23
314435|NCT00712010|757990|P1|STARTED|5th Protein Testing (1 Day)||23
314436|NCT00712010|757990|P1|NOT COMPLETED|Washout (7 Days)||1
314437|NCT00712010|757990|P1|COMPLETED|Washout (7 Days)||23
314438|NCT00712010|757990|P1|STARTED|Washout (7 Days)||24
314439|NCT00712010|757990|P1|NOT COMPLETED|4th Protein Testing (1 Day)||0
314440|NCT00712010|757990|P1|COMPLETED|4th Protein Testing (1 Day)||24
314441|NCT00712010|757990|P1|STARTED|4th Protein Testing (1 Day)||24
314442|NCT00712010|757990|P1|NOT COMPLETED|Washout (7 Days)||0
314443|NCT00712010|757990|P1|COMPLETED|Washout (7 Days)||24
314444|NCT00712010|757990|P1|STARTED|Washout (7 Days)||24
314445|NCT00712010|757990|P1|NOT COMPLETED|3rd Protein Testing (1 Day)||0
314446|NCT00712010|757990|P1|COMPLETED|3rd Protein Testing (1 Day)||24
314447|NCT00712010|757990|P1|STARTED|3rd Protein Testing (1 Day)||24
314448|NCT00712010|757990|P1|NOT COMPLETED|Washout (7 Days)||0
314449|NCT00712010|757990|P1|COMPLETED|Washout (7 Days)||24
314450|NCT00712010|757990|P1|STARTED|Washout (7 Days)||24
314451|NCT00712010|757990|P1|NOT COMPLETED|2nd Protein Testing (1 Day)||0
314452|NCT00712010|757990|P1|COMPLETED|2nd Protein Testing (1 Day)||24
314453|NCT00712010|757990|P1|STARTED|2nd Protein Testing (1 Day)||24
314454|NCT00712010|757990|P1|NOT COMPLETED|Washout (7 Days)||0
314455|NCT00712010|757990|P1|COMPLETED|Washout (7 Days)||24
314456|NCT00712010|757990|P1|STARTED|Washout (7 Days)||24
314457|NCT00712010|757990|P1|NOT COMPLETED|1st Protein Testing (1 Day)||0
314458|NCT00712010|757990|P1|COMPLETED|1st Protein Testing (1 Day)||24
314459|NCT00712010|757990|P1|STARTED|1st Protein Testing (1 Day)|1 subject withdrew his consent form before to starting the 1st intervention|24
314460|NCT00711997|758015|P2|NOT COMPLETED|Overall Study||0
314461|NCT00711997|758016|P1|NOT COMPLETED|Overall Study||0
314462|NCT00711997|758015|P2|COMPLETED|Overall Study||6
314463|NCT00711997|758016|P1|COMPLETED|Overall Study||3
314464|NCT00711997|758015|P2|STARTED|Overall Study||6
314465|NCT00711997|758016|P1|STARTED|Overall Study||3
314466|NCT00711971|758029|P3|NOT COMPLETED|Overall Study||1
314467|NCT00711971|758030|P2|NOT COMPLETED|Overall Study||4
314468|NCT00711971|758031|P1|NOT COMPLETED|Overall Study||3
314469|NCT00711971|758029|P3|COMPLETED|Overall Study||41
314470|NCT00711971|758030|P2|COMPLETED|Overall Study||38
314471|NCT00711971|758031|P1|COMPLETED|Overall Study||39
314472|NCT00711971|758029|P3|STARTED|Overall Study||42
314473|NCT00711971|758030|P2|STARTED|Overall Study||42
314474|NCT00711971|758031|P1|STARTED|Overall Study||42
314475|NCT00711958|758065|P2|NOT COMPLETED|Overall Study||23
314476|NCT00711958|758066|P1|NOT COMPLETED|Overall Study||33
314477|NCT00711958|758065|P2|COMPLETED|Overall Study||17
314478|NCT00711958|758066|P1|COMPLETED|Overall Study||41
314479|NCT00711958|758065|P2|STARTED|Overall Study||40
314480|NCT00711958|758066|P1|STARTED|Overall Study||74
314481|NCT00711880|758074|P2|NOT COMPLETED|Overall Study||7
314482|NCT00711880|758075|P1|NOT COMPLETED|Overall Study||13
314483|NCT00711880|758074|P2|COMPLETED|Overall Study||55
314484|NCT00711880|758075|P1|COMPLETED|Overall Study||50
314485|NCT00711880|758074|P2|STARTED|Overall Study||62
314486|NCT00711880|758075|P1|STARTED|Overall Study||63
314487|NCT00711867|758113|P2|NOT COMPLETED|Overall Study||4
314488|NCT00711867|758114|P1|NOT COMPLETED|Overall Study||5
314489|NCT00711867|758113|P2|COMPLETED|Overall Study|3 received additional warming. 1 missing primary measure.|21
314490|NCT00711867|758114|P1|COMPLETED|Overall Study|2 received additional warming. 3 missing primary measure.|25
314491|NCT00711867|758113|P2|STARTED|Overall Study||25
314492|NCT00711867|758114|P1|STARTED|Overall Study||30
314493|NCT00711828|758120|P1|NOT COMPLETED|Overall Study||0
314494|NCT00711828|758120|P1|COMPLETED|Overall Study||21
314495|NCT00711828|758120|P1|STARTED|Overall Study||21
314496|NCT00711802|758137|P8|NOT COMPLETED|Overall Study||2
314497|NCT00711802|758138|P7|NOT COMPLETED|Overall Study||5
314498|NCT00711802|758139|P6|NOT COMPLETED|Overall Study||8
314499|NCT00711802|758140|P5|NOT COMPLETED|Overall Study||14
314500|NCT00711802|758141|P4|NOT COMPLETED|Overall Study||3
314501|NCT00711802|758142|P3|NOT COMPLETED|Overall Study||6
314502|NCT00711802|758143|P2|NOT COMPLETED|Overall Study||6
314503|NCT00711802|758144|P1|NOT COMPLETED|Overall Study||2
314504|NCT00711802|758137|P8|COMPLETED|Overall Study||13
314505|NCT00711802|758138|P7|COMPLETED|Overall Study||25
314506|NCT00711802|758139|P6|COMPLETED|Overall Study||34
314507|NCT00711802|758140|P5|COMPLETED|Overall Study||69
314508|NCT00711802|758141|P4|COMPLETED|Overall Study||35
314509|NCT00711802|758142|P3|COMPLETED|Overall Study||69
314510|NCT00711802|758143|P2|COMPLETED|Overall Study||32
314511|NCT00711802|758144|P1|COMPLETED|Overall Study||73
314512|NCT00711802|758137|P8|Received at Least 1 Dose of Study Drug|Overall Study||15
314513|NCT00711802|758138|P7|Received at Least 1 Dose of Study Drug|Overall Study||30
314514|NCT00711802|758139|P6|Received at Least 1 Dose of Study Drug|Overall Study||42
314515|NCT00711802|758140|P5|Received at Least 1 Dose of Study Drug|Overall Study||81
314516|NCT00711802|758141|P4|Received at Least 1 Dose of Study Drug|Overall Study||38
314517|NCT00711802|758142|P3|Received at Least 1 Dose of Study Drug|Overall Study||73
314518|NCT00711802|758143|P2|Received at Least 1 Dose of Study Drug|Overall Study||37
314519|NCT00711802|758144|P1|Received at Least 1 Dose of Study Drug|Overall Study||73
314520|NCT00711802|758137|P8|STARTED|Overall Study||15
314521|NCT00711802|758138|P7|STARTED|Overall Study||30
314522|NCT00711802|758139|P6|STARTED|Overall Study||42
314523|NCT00711802|758140|P5|STARTED|Overall Study||83
314524|NCT00711802|758141|P4|STARTED|Overall Study||38
314525|NCT00711802|758142|P3|STARTED|Overall Study||75
314526|NCT00711802|758143|P2|STARTED|Overall Study||38
314527|NCT00711802|758144|P1|STARTED|Overall Study||75
314528|NCT00711711|758176|P2|NOT COMPLETED|Overall Study||6
314529|NCT00711711|758177|P1|NOT COMPLETED|Overall Study||1
314530|NCT00711711|758176|P2|COMPLETED|Overall Study||24
314531|NCT00711711|758177|P1|COMPLETED|Overall Study||29
314532|NCT00711711|758176|P2|Seventh Postsurgical Day|Overall Study||27
314533|NCT00711711|758177|P1|Seventh Postsurgical Day|Overall Study||29
314534|NCT00711711|758176|P2|Second Postsurgical Day|Overall Study||30
314535|NCT00711711|758177|P1|Second Postsurgical Day|Overall Study||30
314536|NCT00711711|758176|P2|STARTED|Overall Study||30
314537|NCT00711711|758177|P1|STARTED|Overall Study||30
314538|NCT00711646|758187|P2|NOT COMPLETED|Overall Study||3
314539|NCT00711646|758188|P1|NOT COMPLETED|Overall Study||12
314540|NCT00711646|758187|P2|COMPLETED|Overall Study||62
314541|NCT00711646|758188|P1|COMPLETED|Overall Study||112
314542|NCT00711646|758187|P2|STARTED|Overall Study||65
314543|NCT00711646|758188|P1|STARTED|Overall Study||124
314544|NCT00711594|758210|P4|NOT COMPLETED|Overall Study||62
314545|NCT00711594|758211|P3|NOT COMPLETED|Overall Study||6
314546|NCT00711594|758212|P2|NOT COMPLETED|Overall Study||3
314547|NCT00711594|758213|P1|NOT COMPLETED|Overall Study||3
314548|NCT00711594|758210|P4|COMPLETED|Overall Study||0
314549|NCT00711594|758211|P3|COMPLETED|Overall Study||0
314550|NCT00711594|758212|P2|COMPLETED|Overall Study||0
314551|NCT00711594|758213|P1|COMPLETED|Overall Study||0
314552|NCT00711594|758210|P4|STARTED|Overall Study||62
314553|NCT00711594|758211|P3|STARTED|Overall Study||6
314554|NCT00711594|758212|P2|STARTED|Overall Study||3
314555|NCT00711594|758213|P1|STARTED|Overall Study||3
314556|NCT00711555|758250|P1|NOT COMPLETED|Overall Study||3
314557|NCT00711555|758250|P1|COMPLETED|Overall Study||19
314558|NCT00711555|758250|P1|STARTED|Overall Study||22
314559|NCT00711529|758259|P2|NOT COMPLETED|Overall Study||6
314560|NCT00711529|758260|P1|NOT COMPLETED|Overall Study||4
314561|NCT00711529|758259|P2|COMPLETED|Overall Study||8
314562|NCT00711529|758260|P1|COMPLETED|Overall Study|2 women lost their hot flash diary, so only 7 patients were evaluable for primary endpoint.|9
314563|NCT00711529|758259|P2|STARTED|Overall Study||14
314564|NCT00711529|758260|P1|STARTED|Overall Study||13
314565|NCT00711516|758284|P2|NOT COMPLETED|Overall Study||3
314566|NCT00711516|758285|P1|NOT COMPLETED|Overall Study||1
314567|NCT00711516|758284|P2|COMPLETED|Overall Study||16
314568|NCT00711516|758285|P1|COMPLETED|Overall Study||20
314569|NCT00711516|758284|P2|STARTED|Overall Study||19
314570|NCT00711516|758285|P1|STARTED|Overall Study||21
314571|NCT00711490|758379|P1|NOT COMPLETED|Overall Study||0
314572|NCT00711490|758379|P1|COMPLETED|Overall Study||5
314573|NCT00711490|758379|P1|STARTED|Overall Study||5
314574|NCT00711477|758392|P2|NOT COMPLETED|Overall Study||3
314575|NCT00711477|758393|P1|NOT COMPLETED|Overall Study||3
314576|NCT00711477|758392|P2|COMPLETED|Overall Study||20
314577|NCT00711477|758393|P1|COMPLETED|Overall Study||20
314578|NCT00711477|758392|P2|STARTED|Overall Study||23
314579|NCT00711477|758393|P1|STARTED|Overall Study||23
314580|NCT00711464|758421|P1|NOT COMPLETED|Overall Study||0
314581|NCT00711464|758421|P1|COMPLETED|Overall Study||29
314582|NCT00711464|758421|P1|STARTED|Overall Study||29
314583|NCT00711425|758439|P1|NOT COMPLETED|Overall Study||4
314584|NCT00711425|758439|P1|COMPLETED|Overall Study||41
314585|NCT00711425|758439|P1|STARTED|Overall Study|Implant placement in 45 patients. Implant loading (baseline) in 44 patients.|45
314586|NCT00711412|758445|P1|NOT COMPLETED|Survival Follow up Until Death||12
314587|NCT00711412|758445|P1|COMPLETED|Survival Follow up Until Death||26
314588|NCT00711412|758445|P1|STARTED|Survival Follow up Until Death|All patients that received treatment went into follow up period.|38
314589|NCT00711412|758445|P1|NOT COMPLETED|Evaluation for Response and Surgery||6
314590|NCT00711412|758445|P1|COMPLETED|Evaluation for Response and Surgery||28
314591|NCT00711412|758445|P1|STARTED|Evaluation for Response and Surgery|1 patient only completed 2 cycles of therapy was evaluated and eligible for surgical resection.|34
314592|NCT00711412|758445|P1|NOT COMPLETED|Combination Treatment||1
314593|NCT00711412|758445|P1|COMPLETED|Combination Treatment||33
314594|NCT00711412|758445|P1|STARTED|Combination Treatment||34
314595|NCT00711412|758445|P1|NOT COMPLETED|Evaluated for Combination Treatment||6
314596|NCT00711412|758445|P1|COMPLETED|Evaluated for Combination Treatment||34
314597|NCT00711412|758445|P1|STARTED|Evaluated for Combination Treatment||40
314598|NCT00711412|758445|P1|NOT COMPLETED|Induction Treatment||4
314599|NCT00711412|758445|P1|COMPLETED|Induction Treatment||40
314600|NCT00711412|758445|P1|Started Induction Treatment|Induction Treatment||43
314601|NCT00711412|758445|P1|Registered to Study|Induction Treatment||44
314602|NCT00711412|758445|P1|STARTED|Induction Treatment||44
314603|NCT00711347|758459|P2|NOT COMPLETED|Overall Study||0
314604|NCT00711347|758460|P1|NOT COMPLETED|Overall Study||0
314605|NCT00711347|758459|P2|COMPLETED|Overall Study||14
314606|NCT00711347|758460|P1|COMPLETED|Overall Study||14
314607|NCT00711347|758459|P2|STARTED|Overall Study||14
314608|NCT00711347|758460|P1|STARTED|Overall Study||14
314609|NCT00711269|758480|P4|NOT COMPLETED|Overall Study||14
314610|NCT00711269|758481|P3|NOT COMPLETED|Overall Study||50
314611|NCT00711269|758482|P2|NOT COMPLETED|Overall Study||48
314612|NCT00711269|758483|P1|NOT COMPLETED|Overall Study||44
314613|NCT00711269|758480|P4|COMPLETED|Overall Study||51
314614|NCT00711269|758481|P3|COMPLETED|Overall Study||83
314615|NCT00711269|758482|P2|COMPLETED|Overall Study||83
314616|NCT00711269|758483|P1|COMPLETED|Overall Study||87
314617|NCT00711269|758480|P4|STARTED|Overall Study||65
314618|NCT00711269|758481|P3|STARTED|Overall Study||133
314619|NCT00711269|758482|P2|STARTED|Overall Study||131
314620|NCT00711269|758483|P1|STARTED|Overall Study||131
314621|NCT00711243|758523|P6|NOT COMPLETED|Follow up Every 3 Months Until Death||2
314622|NCT00711243|758524|P5|NOT COMPLETED|Follow up Every 3 Months Until Death||0
314623|NCT00711243|758525|P4|NOT COMPLETED|Follow up Every 3 Months Until Death||0
314624|NCT00711243|758526|P3|NOT COMPLETED|Follow up Every 3 Months Until Death||0
314625|NCT00711243|758527|P2|NOT COMPLETED|Follow up Every 3 Months Until Death||0
314626|NCT00711243|758528|P1|NOT COMPLETED|Follow up Every 3 Months Until Death||0
314627|NCT00711243|758523|P6|COMPLETED|Follow up Every 3 Months Until Death||37
314628|NCT00711243|758524|P5|COMPLETED|Follow up Every 3 Months Until Death||3
314629|NCT00711243|758525|P4|COMPLETED|Follow up Every 3 Months Until Death||3
314630|NCT00711243|758526|P3|COMPLETED|Follow up Every 3 Months Until Death||3
314631|NCT00711243|758527|P2|COMPLETED|Follow up Every 3 Months Until Death||3
314632|NCT00711243|758528|P1|COMPLETED|Follow up Every 3 Months Until Death||3
314633|NCT00711243|758523|P6|STARTED|Follow up Every 3 Months Until Death|4 patients died whilst on study and 1 patient did not get treated on study|39
314634|NCT00711243|758524|P5|STARTED|Follow up Every 3 Months Until Death||3
314635|NCT00711243|758525|P4|STARTED|Follow up Every 3 Months Until Death||3
314636|NCT00711243|758526|P3|STARTED|Follow up Every 3 Months Until Death||3
314637|NCT00711243|758527|P2|STARTED|Follow up Every 3 Months Until Death||3
314638|NCT00711243|758528|P1|STARTED|Follow up Every 3 Months Until Death||3
314639|NCT00711243|758523|P6|NOT COMPLETED|Treated Cycle 5 After First Response||4
314640|NCT00711243|758524|P5|NOT COMPLETED|Treated Cycle 5 After First Response||1
314641|NCT00711243|758525|P4|NOT COMPLETED|Treated Cycle 5 After First Response||0
314642|NCT00711243|758526|P3|NOT COMPLETED|Treated Cycle 5 After First Response||0
314643|NCT00711243|758527|P2|NOT COMPLETED|Treated Cycle 5 After First Response||2
314644|NCT00711243|758528|P1|NOT COMPLETED|Treated Cycle 5 After First Response||1
314645|NCT00711243|758523|P6|COMPLETED|Treated Cycle 5 After First Response||37
314646|NCT00711243|758524|P5|COMPLETED|Treated Cycle 5 After First Response||2
314647|NCT00711243|758525|P4|COMPLETED|Treated Cycle 5 After First Response||2
314648|NCT00711243|758526|P3|COMPLETED|Treated Cycle 5 After First Response||3
314649|NCT00711243|758527|P2|COMPLETED|Treated Cycle 5 After First Response||1
314650|NCT00711243|758528|P1|COMPLETED|Treated Cycle 5 After First Response||2
314651|NCT00711243|758523|P6|STARTED|Treated Cycle 5 After First Response||41
314652|NCT00711243|758524|P5|STARTED|Treated Cycle 5 After First Response||3
314653|NCT00711243|758525|P4|STARTED|Treated Cycle 5 After First Response||2
314654|NCT00711243|758526|P3|STARTED|Treated Cycle 5 After First Response||3
314655|NCT00711243|758527|P2|STARTED|Treated Cycle 5 After First Response||3
314656|NCT00711243|758528|P1|STARTED|Treated Cycle 5 After First Response||3
314657|NCT00711243|758523|P6|NOT COMPLETED|Reached First Response/4 Cycles||2
314658|NCT00711243|758524|P5|NOT COMPLETED|Reached First Response/4 Cycles||0
314659|NCT00711243|758525|P4|NOT COMPLETED|Reached First Response/4 Cycles||1
314660|NCT00711243|758526|P3|NOT COMPLETED|Reached First Response/4 Cycles||0
314661|NCT00711243|758527|P2|NOT COMPLETED|Reached First Response/4 Cycles||0
314662|NCT00711243|758528|P1|NOT COMPLETED|Reached First Response/4 Cycles||0
314663|NCT00711243|758523|P6|COMPLETED|Reached First Response/4 Cycles||41
314664|NCT00711243|758524|P5|COMPLETED|Reached First Response/4 Cycles||3
314665|NCT00711243|758525|P4|COMPLETED|Reached First Response/4 Cycles||2
314666|NCT00711243|758526|P3|COMPLETED|Reached First Response/4 Cycles||3
314667|NCT00711243|758527|P2|COMPLETED|Reached First Response/4 Cycles||3
314668|NCT00711243|758528|P1|COMPLETED|Reached First Response/4 Cycles||3
314669|NCT00711243|758523|P6|STARTED|Reached First Response/4 Cycles||43
314670|NCT00711243|758524|P5|STARTED|Reached First Response/4 Cycles||3
314671|NCT00711243|758525|P4|STARTED|Reached First Response/4 Cycles||3
314672|NCT00711243|758526|P3|STARTED|Reached First Response/4 Cycles||3
314673|NCT00711243|758527|P2|STARTED|Reached First Response/4 Cycles||3
314674|NCT00711243|758528|P1|STARTED|Reached First Response/4 Cycles||3
314675|NCT00711243|758523|P6|NOT COMPLETED|Registed and Started Treatment||1
314676|NCT00711243|758524|P5|NOT COMPLETED|Registed and Started Treatment||0
314677|NCT00711243|758525|P4|NOT COMPLETED|Registed and Started Treatment||0
314678|NCT00711243|758526|P3|NOT COMPLETED|Registed and Started Treatment||0
314679|NCT00711243|758527|P2|NOT COMPLETED|Registed and Started Treatment||0
314680|NCT00711243|758528|P1|NOT COMPLETED|Registed and Started Treatment||0
314681|NCT00711243|758523|P6|COMPLETED|Registed and Started Treatment||43
314682|NCT00711243|758524|P5|COMPLETED|Registed and Started Treatment||3
314683|NCT00711243|758525|P4|COMPLETED|Registed and Started Treatment||3
314684|NCT00711243|758526|P3|COMPLETED|Registed and Started Treatment||3
314685|NCT00711243|758527|P2|COMPLETED|Registed and Started Treatment||3
314686|NCT00711243|758528|P1|COMPLETED|Registed and Started Treatment||3
314687|NCT00711243|758523|P6|Started Treatment|Registed and Started Treatment||43
314688|NCT00711243|758524|P5|Started Treatment|Registed and Started Treatment||3
314689|NCT00711243|758525|P4|Started Treatment|Registed and Started Treatment||3
314690|NCT00711243|758526|P3|Started Treatment|Registed and Started Treatment||3
314691|NCT00711243|758527|P2|Started Treatment|Registed and Started Treatment||3
314692|NCT00711243|758528|P1|Started Treatment|Registed and Started Treatment||3
314693|NCT00711243|758523|P6|Registered to Study|Registed and Started Treatment||44
314694|NCT00711243|758524|P5|Registered to Study|Registed and Started Treatment||3
314695|NCT00711243|758525|P4|Registered to Study|Registed and Started Treatment||3
314696|NCT00711243|758526|P3|Registered to Study|Registed and Started Treatment||3
314697|NCT00711243|758527|P2|Registered to Study|Registed and Started Treatment||3
314698|NCT00711243|758528|P1|Registered to Study|Registed and Started Treatment||3
314699|NCT00711243|758523|P6|STARTED|Registed and Started Treatment||44
314700|NCT00711243|758524|P5|STARTED|Registed and Started Treatment||3
314701|NCT00711243|758525|P4|STARTED|Registed and Started Treatment||3
314702|NCT00711243|758526|P3|STARTED|Registed and Started Treatment||3
314703|NCT00711243|758527|P2|STARTED|Registed and Started Treatment||3
314704|NCT00711243|758528|P1|STARTED|Registed and Started Treatment||3
314705|NCT00711191|758551|P3|NOT COMPLETED|Overall Study||12
314706|NCT00711191|758552|P2|NOT COMPLETED|Overall Study||5
314707|NCT00711191|758553|P1|NOT COMPLETED|Overall Study||3
314708|NCT00711191|758551|P3|COMPLETED|Overall Study||1
314709|NCT00711191|758552|P2|COMPLETED|Overall Study||1
314710|NCT00711191|758553|P1|COMPLETED|Overall Study||0
314711|NCT00711191|758551|P3|STARTED|Overall Study||13
314712|NCT00711191|758552|P2|STARTED|Overall Study||6
314713|NCT00711191|758553|P1|STARTED|Overall Study||3
314714|NCT00711113|758590|P1|NOT COMPLETED|Overall Study||11
314715|NCT00711113|758590|P1|COMPLETED|Overall Study||36
314716|NCT00711113|758590|P1|STARTED|Overall Study||47
314717|NCT00711100|758596|P1|NOT COMPLETED|Overall Study||13
314718|NCT00711100|758596|P1|COMPLETED|Overall Study||91
314719|NCT00711100|758596|P1|STARTED|Overall Study||104
314720|NCT00711087|758614|P2|NOT COMPLETED|Overall Study||0
314721|NCT00711087|758615|P1|NOT COMPLETED|Overall Study||1
314722|NCT00711087|758614|P2|COMPLETED|Overall Study||0
314723|NCT00711087|758615|P1|COMPLETED|Overall Study||0
314724|NCT00711087|758614|P2|STARTED|Overall Study||0
314725|NCT00711087|758615|P1|STARTED|Overall Study||1
314726|NCT00711022|758621|P1|NOT COMPLETED|Overall Study||11
314727|NCT00711022|758621|P1|COMPLETED|Overall Study||40
314728|NCT00711022|758621|P1|STARTED|Overall Study||51
314729|NCT00711009|758627|P2|NOT COMPLETED|Overall Study||19
314730|NCT00711009|758628|P1|NOT COMPLETED|Overall Study||15
314731|NCT00711009|758627|P2|COMPLETED|Overall Study||82
314732|NCT00711009|758628|P1|COMPLETED|Overall Study||90
314733|NCT00711009|758627|P2|STARTED|Overall Study||101
314734|NCT00711009|758628|P1|STARTED|Overall Study||105
314735|NCT00710996|758799|P3|NOT COMPLETED|Overall Study||0
314736|NCT00710996|758800|P2|NOT COMPLETED|Overall Study||4
314737|NCT00710996|758801|P1|NOT COMPLETED|Overall Study||1
314738|NCT00710996|758799|P3|COMPLETED|Overall Study||21
314739|NCT00710996|758800|P2|COMPLETED|Overall Study||16
314740|NCT00710996|758801|P1|COMPLETED|Overall Study||16
314741|NCT00710996|758799|P3|STARTED|Overall Study||21
314742|NCT00710996|758800|P2|STARTED|Overall Study||20
314743|NCT00710996|758801|P1|STARTED|Overall Study||17
314744|NCT00710970|758809|P1|NOT COMPLETED|Overall Study||10
314745|NCT00710970|758809|P1|COMPLETED|Overall Study||18
314746|NCT00710970|758809|P1|STARTED|Overall Study||28
314747|NCT00710944|758816|P3|NOT COMPLETED|Overall Study||2
314748|NCT00710944|758817|P2|NOT COMPLETED|Overall Study||9
314749|NCT00710944|758818|P1|NOT COMPLETED|Overall Study||10
314750|NCT00710944|758816|P3|COMPLETED|Overall Study||17
314751|NCT00710944|758817|P2|COMPLETED|Overall Study||49
314752|NCT00710944|758818|P1|COMPLETED|Overall Study||45
314753|NCT00710944|758816|P3|STARTED|Overall Study||19
314754|NCT00710944|758817|P2|STARTED|Overall Study||58
314755|NCT00710944|758818|P1|STARTED|Overall Study||55
314756|NCT00710931|758826|P1|NOT COMPLETED|Overall Study||5
314757|NCT00710931|758826|P1|COMPLETED|Overall Study||29
314758|NCT00710931|758826|P1|STARTED|Overall Study||34
314759|NCT00710905|758830|P1|NOT COMPLETED|Overall Study||16
314760|NCT00710905|758830|P1|COMPLETED|Overall Study||34
314761|NCT00710905|758830|P1|STARTED|Overall Study||50
314762|NCT00710879|758836|P2|NOT COMPLETED|Overall Study||4
314763|NCT00710879|758837|P1|NOT COMPLETED|Overall Study||2
314764|NCT00710879|758836|P2|COMPLETED|Overall Study||113
314765|NCT00710879|758837|P1|COMPLETED|Overall Study||58
314766|NCT00710879|758836|P2|STARTED|Overall Study||117
314767|NCT00710879|758837|P1|STARTED|Overall Study||60
314768|NCT00710866|758849|P2|NOT COMPLETED|Overall Study||6
314769|NCT00710866|758850|P1|NOT COMPLETED|Overall Study||9
314770|NCT00710866|758849|P2|COMPLETED|Overall Study||128
314771|NCT00710866|758850|P1|COMPLETED|Overall Study||124
314772|NCT00710866|758849|P2|STARTED|Overall Study||134
314773|NCT00710866|758850|P1|STARTED|Overall Study||133
314774|NCT00710840|758872|P2|NOT COMPLETED|Overall Study||3
314775|NCT00710840|758873|P1|NOT COMPLETED|Overall Study||0
314776|NCT00710840|758872|P2|COMPLETED|Overall Study||19
314777|NCT00710840|758873|P1|COMPLETED|Overall Study||22
314778|NCT00710840|758872|P2|STARTED|Overall Study||22
314779|NCT00710840|758873|P1|STARTED|Overall Study||22
314780|NCT00710814|758887|P2|NOT COMPLETED|Overall Study||3
314781|NCT00710814|758888|P1|NOT COMPLETED|Overall Study||1
314782|NCT00710814|758887|P2|COMPLETED|Overall Study||13
314783|NCT00710814|758888|P1|COMPLETED|Overall Study||14
314784|NCT00710814|758887|P2|STARTED|Overall Study||16
314785|NCT00710814|758888|P1|STARTED|Overall Study||15
314786|NCT00710762|758896|P2|NOT COMPLETED|Overall Study||40
314787|NCT00710762|758897|P1|NOT COMPLETED|Overall Study||39
314788|NCT00710762|758896|P2|COMPLETED|Overall Study||0
314789|NCT00710762|758897|P1|COMPLETED|Overall Study||5
314790|NCT00710762|758896|P2|STARTED|Overall Study||40
314791|NCT00710762|758897|P1|STARTED|Overall Study||44
314792|NCT00710749|758913|P2|NOT COMPLETED|Second Intervention||0
314793|NCT00710749|758914|P1|NOT COMPLETED|Second Intervention||0
314794|NCT00710749|758913|P2|COMPLETED|Second Intervention||30
314795|NCT00710749|758914|P1|COMPLETED|Second Intervention||29
314796|NCT00710749|758913|P2|STARTED|Second Intervention||30
314797|NCT00710749|758914|P1|STARTED|Second Intervention||29
314798|NCT00710749|758913|P2|NOT COMPLETED|First Intervention||0
314799|NCT00710749|758914|P1|NOT COMPLETED|First Intervention||1
314800|NCT00710749|758913|P2|COMPLETED|First Intervention||30
314801|NCT00710749|758914|P1|COMPLETED|First Intervention||29
314802|NCT00710749|758913|P2|STARTED|First Intervention||30
314803|NCT00710749|758914|P1|STARTED|First Intervention||30
314804|NCT00710749|758913|P2|NOT COMPLETED|Clinic Baseline Recording||0
314805|NCT00710749|758914|P1|NOT COMPLETED|Clinic Baseline Recording||0
314806|NCT00710749|758913|P2|COMPLETED|Clinic Baseline Recording||30
314807|NCT00710749|758914|P1|COMPLETED|Clinic Baseline Recording||30
314808|NCT00710749|758913|P2|STARTED|Clinic Baseline Recording||30
314809|NCT00710749|758914|P1|STARTED|Clinic Baseline Recording||30
314810|NCT00710684|758925|P3|NOT COMPLETED|Overall Study||64
314811|NCT00710684|758926|P2|NOT COMPLETED|Overall Study||74
314812|NCT00710684|758927|P1|NOT COMPLETED|Overall Study||74
314813|NCT00710684|758925|P3|COMPLETED|Overall Study||172
314814|NCT00710684|758926|P2|COMPLETED|Overall Study||147
314815|NCT00710684|758927|P1|COMPLETED|Overall Study||151
314816|NCT00710684|758925|P3|STARTED|Overall Study||236
314817|NCT00710684|758926|P2|STARTED|Overall Study||221
314818|NCT00710684|758927|P1|STARTED|Overall Study||225
314819|NCT00710606|758984|P2|NOT COMPLETED|Overall Study||2
314820|NCT00710606|758985|P1|NOT COMPLETED|Overall Study||0
314821|NCT00710606|758984|P2|COMPLETED|Overall Study||18
314822|NCT00710606|758985|P1|COMPLETED|Overall Study||20
314823|NCT00710606|758984|P2|STARTED|Overall Study||20
314824|NCT00710606|758985|P1|STARTED|Overall Study||20
314825|NCT00710593|758997|P2|NOT COMPLETED|Overall Study||5
314826|NCT00710593|758998|P1|NOT COMPLETED|Overall Study||15
314827|NCT00710593|758997|P2|COMPLETED|Overall Study|25 completed study and vaccine. 2 did not receive all vaccine, but completed all study visits.|25
314828|NCT00710593|758998|P1|COMPLETED|Overall Study|54 completed study and vaccine. 6 did not receive all vaccine, but completed all study visits.|54
314829|NCT00710593|758997|P2|STARTED|Overall Study||30
314830|NCT00710593|758998|P1|STARTED|Overall Study||69
314831|NCT00710554|759041|P2|NOT COMPLETED|Overall Study||24
314832|NCT00710554|759042|P1|NOT COMPLETED|Overall Study||49
314833|NCT00710554|759041|P2|COMPLETED|Overall Study||94
314834|NCT00710554|759042|P1|COMPLETED|Overall Study||79
314835|NCT00710554|759041|P2|STARTED|Overall Study||118
314836|NCT00710554|759042|P1|STARTED|Overall Study||128
314837|NCT00710424|759070|P2|NOT COMPLETED|Overall Study||23
314838|NCT00710424|759071|P1|NOT COMPLETED|Overall Study||44
314839|NCT00710424|759070|P2|COMPLETED|Overall Study||125
314840|NCT00710424|759071|P1|COMPLETED|Overall Study||105
314841|NCT00710424|759070|P2|STARTED|Overall Study||148
314842|NCT00710424|759071|P1|STARTED|Overall Study||149
314843|NCT00710385|759095|P1|NOT COMPLETED|Overall Study||5
314844|NCT00710385|759095|P1|COMPLETED|Overall Study||12
314845|NCT00710385|759095|P1|STARTED|Overall Study|19 participants signed consent for the study 2 withdrew before any study procedures were initiated.|17
314846|NCT00710203|759112|P1|NOT COMPLETED|Overall Study||0
314847|NCT00710203|759112|P1|COMPLETED|Overall Study||10
314848|NCT00710203|759112|P1|STARTED|Overall Study||10
314849|NCT00710034|759140|P2|NOT COMPLETED|Completed 12 Weeks of Treatment||11
314850|NCT00710034|759141|P1|NOT COMPLETED|Completed 12 Weeks of Treatment||13
314851|NCT00710034|759140|P2|COMPLETED|Completed 12 Weeks of Treatment||138
314852|NCT00710034|759141|P1|COMPLETED|Completed 12 Weeks of Treatment||141
314853|NCT00710034|759140|P2|STARTED|Completed 12 Weeks of Treatment||149
314854|NCT00710034|759141|P1|STARTED|Completed 12 Weeks of Treatment||154
314855|NCT00710034|759140|P2|NOT COMPLETED|Completed 6 Weeks of Treatment||47
314856|NCT00710034|759141|P1|NOT COMPLETED|Completed 6 Weeks of Treatment||41
314857|NCT00710034|759140|P2|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=149|149
314858|NCT00710034|759141|P1|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=154|154
314859|NCT00710034|759140|P2|STARTED|Completed 6 Weeks of Treatment||196
314860|NCT00710034|759141|P1|STARTED|Completed 6 Weeks of Treatment||195
314861|NCT00710021|759158|P3|NOT COMPLETED|Overall Study||1
314862|NCT00710021|759159|P2|NOT COMPLETED|Overall Study||3
314863|NCT00710021|759160|P1|NOT COMPLETED|Overall Study||1
314864|NCT00710021|759158|P3|COMPLETED|Overall Study||18
314865|NCT00710021|759159|P2|COMPLETED|Overall Study||16
314866|NCT00710021|759160|P1|COMPLETED|Overall Study||18
314867|NCT00710021|759158|P3|Modified Intent-to-Treat (mITT)|Overall Study|1 subject who did not take study drug was excluded from mITT|18
314868|NCT00710021|759159|P2|Modified Intent-to-Treat (mITT)|Overall Study|2 subjects who did not take study drug were excluded from mITT|17
314869|NCT00710021|759160|P1|Modified Intent-to-Treat (mITT)|Overall Study||19
314870|NCT00710021|759158|P3|STARTED|Overall Study||19
314871|NCT00710021|759159|P2|STARTED|Overall Study||19
314872|NCT00710021|759160|P1|STARTED|Overall Study||19
314873|NCT00709995|759275|P2|NOT COMPLETED|Overall Study||5
314874|NCT00709995|759276|P1|NOT COMPLETED|Overall Study||5
314875|NCT00709995|759275|P2|COMPLETED|Overall Study||1
314876|NCT00709995|759276|P1|COMPLETED|Overall Study||6
314877|NCT00709995|759275|P2|Progressive Disease|Overall Study||1
314878|NCT00709995|759276|P1|Progressive Disease|Overall Study||6
314879|NCT00709995|759275|P2|STARTED|Overall Study||6
314880|NCT00709995|759276|P1|STARTED|Overall Study||11
314881|NCT00709956|759294|P2|NOT COMPLETED|Overall Study||4
314882|NCT00709956|759295|P1|NOT COMPLETED|Overall Study||3
314883|NCT00709956|759294|P2|COMPLETED|Overall Study||33
314884|NCT00709956|759295|P1|COMPLETED|Overall Study||30
314885|NCT00709956|759294|P2|Double-blind Crossover-period|Overall Study|Days 2 and 3|33
314886|NCT00709956|759295|P1|Double-blind Crossover-period|Overall Study|Days 2 and 3|31
314887|NCT00709956|759294|P2|STARTED|Overall Study|Day 1 Single-blind placebo run-in|37
314888|NCT00709956|759295|P1|STARTED|Overall Study|Day 1 Single-blind placebo run-in|33
314889|NCT00709891|759303|P1|NOT COMPLETED|Longitudinal Follow-up Phase||4982
314890|NCT00709891|759303|P1|COMPLETED|Longitudinal Follow-up Phase||5020
314891|NCT00709891|759303|P1|STARTED|Longitudinal Follow-up Phase|Only participants who met study criteria in the Baseline phase started the Follow-up phase.|10002
314892|NCT00709891|759303|P1|NOT COMPLETED|Baseline, Cross-sectional Phase||1450
314893|NCT00709891|759303|P1|COMPLETED|Baseline, Cross-sectional Phase||45758
314894|NCT00709891|759303|P1|STARTED|Baseline, Cross-sectional Phase||47208
314895|NCT00709878|759312|P4|NOT COMPLETED|Overall Study||0
314896|NCT00709878|759313|P3|NOT COMPLETED|Overall Study||0
314897|NCT00709878|759314|P2|NOT COMPLETED|Overall Study||0
314898|NCT00709878|759315|P1|NOT COMPLETED|Overall Study||0
314899|NCT00709878|759312|P4|COMPLETED|Overall Study||8
314900|NCT00709878|759313|P3|COMPLETED|Overall Study||8
314901|NCT00709878|759314|P2|COMPLETED|Overall Study||8
314902|NCT00709878|759315|P1|COMPLETED|Overall Study||8
314903|NCT00709878|759312|P4|STARTED|Overall Study||8
314904|NCT00709878|759313|P3|STARTED|Overall Study||8
314905|NCT00709878|759314|P2|STARTED|Overall Study||8
314906|NCT00709878|759315|P1|STARTED|Overall Study||8
314907|NCT00709852|759325|P2|NOT COMPLETED|Period 2||2
314908|NCT00709852|759326|P1|NOT COMPLETED|Period 2||9
314909|NCT00709852|759325|P2|COMPLETED|Period 2||169
314910|NCT00709852|759326|P1|COMPLETED|Period 2||211
314911|NCT00709852|759325|P2|STARTED|Period 2||171
314912|NCT00709852|759326|P1|STARTED|Period 2||220
314913|NCT00709852|759325|P2|NOT COMPLETED|Period 1||3
314914|NCT00709852|759326|P1|NOT COMPLETED|Period 1||8
314915|NCT00709852|759325|P2|COMPLETED|Period 1||171
314916|NCT00709852|759326|P1|COMPLETED|Period 1||220
314917|NCT00709852|759325|P2|STARTED|Period 1||174
314918|NCT00709852|759326|P1|STARTED|Period 1||228
314919|NCT00709826|759481|P2|NOT COMPLETED|Overall Study||1
314920|NCT00709826|759482|P1|NOT COMPLETED|Overall Study||2
314921|NCT00709826|759481|P2|COMPLETED|Overall Study||38
314922|NCT00709826|759482|P1|COMPLETED|Overall Study||68
314923|NCT00709826|759481|P2|STARTED|Overall Study||39
314924|NCT00709826|759482|P1|STARTED|Overall Study||70
314925|NCT00709761|759490|P1|NOT COMPLETED|Overall Study||27
314926|NCT00709761|759490|P1|COMPLETED|Overall Study||33
314927|NCT00709761|759490|P1|STARTED|Overall Study||60
314928|NCT00709735|759501|P2|NOT COMPLETED|Overall Study||2
314929|NCT00709735|759502|P1|NOT COMPLETED|Overall Study||3
314930|NCT00709735|759501|P2|COMPLETED|Overall Study||10
314931|NCT00709735|759502|P1|COMPLETED|Overall Study||8
314932|NCT00709735|759501|P2|STARTED|Overall Study||12
314933|NCT00709735|759502|P1|STARTED|Overall Study||11
314934|NCT00709722|759510|P1|NOT COMPLETED|Overall Study||1
314935|NCT00709722|759510|P1|COMPLETED|Overall Study||20
314936|NCT00709722|759510|P1|STARTED|Overall Study||21
314937|NCT00709696|759518|P2|NOT COMPLETED|Overall Study||0
314938|NCT00709696|759519|P1|NOT COMPLETED|Overall Study||0
314939|NCT00709696|759518|P2|COMPLETED|Overall Study||3
314940|NCT00709696|759519|P1|COMPLETED|Overall Study||4
314941|NCT00709696|759518|P2|STARTED|Overall Study||3
314942|NCT00709696|759519|P1|STARTED|Overall Study||4
314943|NCT00709618|759525|P1|NOT COMPLETED|Overall Study||30
314944|NCT00709618|759525|P1|COMPLETED|Overall Study||14
314945|NCT00709618|759525|P1|STARTED|Overall Study||44
314946|NCT00709592|759537|P2|NOT COMPLETED|Overall Study||1
314947|NCT00709592|759538|P1|NOT COMPLETED|Overall Study||0
314948|NCT00709592|759537|P2|COMPLETED|Overall Study||22
314949|NCT00709592|759538|P1|COMPLETED|Overall Study||19
314950|NCT00709592|759537|P2|STARTED|Overall Study||23
314951|NCT00709592|759538|P1|STARTED|Overall Study||19
314952|NCT00709319|759560|P1|NOT COMPLETED|Overall Study||6
314953|NCT00709319|759560|P1|COMPLETED|Overall Study||81
314954|NCT00709319|759560|P1|STARTED|Overall Study||87
314955|NCT00709306|759572|P4|NOT COMPLETED|Overall Study||10
314956|NCT00709306|759573|P3|NOT COMPLETED|Overall Study||10
314957|NCT00709306|759574|P2|NOT COMPLETED|Overall Study||14
314958|NCT00709306|759575|P1|NOT COMPLETED|Overall Study||9
314959|NCT00709306|759572|P4|COMPLETED|Overall Study||37
314960|NCT00709306|759573|P3|COMPLETED|Overall Study||48
314961|NCT00709306|759574|P2|COMPLETED|Overall Study||30
314962|NCT00709306|759575|P1|COMPLETED|Overall Study||39
314963|NCT00709306|759572|P4|STARTED|Overall Study||47
314964|NCT00709306|759573|P3|STARTED|Overall Study||58
314965|NCT00709306|759574|P2|STARTED|Overall Study||44
314966|NCT00709306|759575|P1|STARTED|Overall Study||48
314967|NCT00709228|759589|P1|NOT COMPLETED|Overall Study||332
314968|NCT00709228|759589|P1|COMPLETED|Overall Study|Number completed is defined as participants who completed the follow-up period.|164
314969|NCT00709228|759589|P1|STARTED|Overall Study||496
314970|NCT00709202|759595|P2|NOT COMPLETED|Overall Study||6
314971|NCT00709202|759596|P1|NOT COMPLETED|Overall Study||6
314972|NCT00709202|759595|P2|COMPLETED|Overall Study||15
314973|NCT00709202|759596|P1|COMPLETED|Overall Study||13
314974|NCT00709202|759595|P2|STARTED|Overall Study||21
314975|NCT00709202|759596|P1|STARTED|Overall Study||19
314976|NCT00709124|759624|P2|NOT COMPLETED|Overall Study||1
314977|NCT00709124|759625|P1|NOT COMPLETED|Overall Study||4
314978|NCT00709124|759624|P2|COMPLETED|Overall Study||17
314979|NCT00709124|759625|P1|COMPLETED|Overall Study||12
314980|NCT00709124|759624|P2|STARTED|Overall Study||18
314981|NCT00709124|759625|P1|STARTED|Overall Study||16
314982|NCT00709111|759659|P1|NOT COMPLETED|Overall Study||2
314983|NCT00709111|759659|P1|COMPLETED|Overall Study||32
314984|NCT00709111|759659|P1|Week 22/24|Overall Study||33
314985|NCT00709111|759659|P1|STARTED|Overall Study||34
314986|NCT00709098|759700|P3|NOT COMPLETED|Open-label Period||14
314987|NCT00709098|759701|P2|NOT COMPLETED|Open-label Period||0
314988|NCT00709098|759702|P1|NOT COMPLETED|Open-label Period||0
314989|NCT00709098|759700|P3|COMPLETED|Open-label Period||18
314990|NCT00709098|759701|P2|COMPLETED|Open-label Period||0
314991|NCT00709098|759702|P1|COMPLETED|Open-label Period||0
314992|NCT00709098|759700|P3|STARTED|Open-label Period|The open-label period was only made available to patients in US centers|32
314993|NCT00709098|759701|P2|STARTED|Open-label Period||0
314994|NCT00709098|759702|P1|STARTED|Open-label Period||0
314995|NCT00709098|759700|P3|NOT COMPLETED|Double-blind Period||0
314996|NCT00709098|759701|P2|NOT COMPLETED|Double-blind Period||8
314997|NCT00709098|759702|P1|NOT COMPLETED|Double-blind Period||6
314998|NCT00709098|759700|P3|COMPLETED|Double-blind Period||0
314999|NCT00709098|759701|P2|COMPLETED|Double-blind Period||16
315000|NCT00709098|759702|P1|COMPLETED|Double-blind Period||19
315001|NCT00709098|759700|P3|STARTED|Double-blind Period||0
315002|NCT00709098|759701|P2|STARTED|Double-blind Period||24
315003|NCT00709098|759702|P1|STARTED|Double-blind Period||25
315004|NCT00709059|759721|P1|NOT COMPLETED|Overall Study||94
315005|NCT00709059|759721|P1|COMPLETED|Overall Study||444
315006|NCT00709059|759721|P1|STARTED|Overall Study||538
315007|NCT00708942|759730|P5|NOT COMPLETED|Overall Study||1
315008|NCT00708942|759731|P4|NOT COMPLETED|Overall Study||0
315009|NCT00708942|759732|P3|NOT COMPLETED|Overall Study||2
315010|NCT00708942|759733|P2|NOT COMPLETED|Overall Study||1
315011|NCT00708942|759734|P1|NOT COMPLETED|Overall Study||7
315012|NCT00708942|759730|P5|COMPLETED|Overall Study||2
315013|NCT00708942|759731|P4|COMPLETED|Overall Study||10
315014|NCT00708942|759732|P3|COMPLETED|Overall Study||9
315015|NCT00708942|759733|P2|COMPLETED|Overall Study||11
315016|NCT00708942|759734|P1|COMPLETED|Overall Study||40
315017|NCT00708942|759730|P5|STARTED|Overall Study||3
315018|NCT00708942|759731|P4|STARTED|Overall Study||10
315019|NCT00708942|759732|P3|STARTED|Overall Study||11
315020|NCT00708942|759733|P2|STARTED|Overall Study||12
315021|NCT00708942|759734|P1|STARTED|Overall Study||47
315022|NCT00708877|759756|P1|NOT COMPLETED|Overall Study||0
315023|NCT00708877|759756|P1|COMPLETED|Overall Study||5
315024|NCT00708877|759756|P1|STARTED|Overall Study||5
315025|NCT00708851|759760|P1|NOT COMPLETED|Overall Study||0
315026|NCT00708851|759760|P1|COMPLETED|Overall Study||12
315027|NCT00708851|759760|P1|STARTED|Overall Study||12
315028|NCT00708734|759768|P1|NOT COMPLETED|Overall Study||7
315029|NCT00708734|759768|P1|COMPLETED|Overall Study|Ten subjects enrolled, three completed the intervention and all follow up sessions.|3
315030|NCT00708734|759768|P1|STARTED|Overall Study|94 subjects were screened, 45 did not meet criteria, and 39 declined participation after screening.|10
315031|NCT00708721|759772|P4|NOT COMPLETED|Overall Study||0
315032|NCT00708721|759773|P3|NOT COMPLETED|Overall Study||0
315033|NCT00708721|759774|P2|NOT COMPLETED|Overall Study||0
315034|NCT00708721|759775|P1|NOT COMPLETED|Overall Study||0
315035|NCT00708721|759772|P4|COMPLETED|Overall Study||2
315036|NCT00708721|759773|P3|COMPLETED|Overall Study||3
315037|NCT00708721|759774|P2|COMPLETED|Overall Study||4
315038|NCT00708721|759775|P1|COMPLETED|Overall Study||2
315039|NCT00708721|759772|P4|STARTED|Overall Study||2
315040|NCT00708721|759773|P3|STARTED|Overall Study||3
315041|NCT00708721|759774|P2|STARTED|Overall Study||4
315042|NCT00708721|759775|P1|STARTED|Overall Study||2
315043|NCT00708708|759788|P1|NOT COMPLETED|Overall Study||742
315044|NCT00708708|759788|P1|COMPLETED|Overall Study|Included participants completed total observation period and participants with planned study end.|213
315045|NCT00708708|759788|P1|STARTED|Overall Study||955
315046|NCT00708682|759836|P1|NOT COMPLETED|Toddler Dose||8
315047|NCT00708682|759836|P1|COMPLETED|Toddler Dose||183
315048|NCT00708682|759836|P1|STARTED|Toddler Dose||191
315049|NCT00708682|759836|P1|NOT COMPLETED|After Infant Series||1
315050|NCT00708682|759836|P1|COMPLETED|After Infant Series||191
315051|NCT00708682|759836|P1|STARTED|After Infant Series||192
315052|NCT00708682|759836|P1|NOT COMPLETED|Infant Series||33
315053|NCT00708682|759836|P1|COMPLETED|Infant Series||192
315054|NCT00708682|759836|P1|Vaccinated Dose 3|Infant Series||194
315055|NCT00708682|759836|P1|Vaccinated Dose 2|Infant Series||214
315056|NCT00708682|759836|P1|Vaccinated Dose 1|Infant Series||223
315057|NCT00708682|759836|P1|STARTED|Infant Series||225
315058|NCT00708643|759857|P2|NOT COMPLETED|Overall Study||1
315059|NCT00708643|759858|P1|NOT COMPLETED|Overall Study||0
315060|NCT00708643|759857|P2|COMPLETED|Overall Study||39
315061|NCT00708643|759858|P1|COMPLETED|Overall Study||40
315062|NCT00708643|759857|P2|STARTED|Overall Study||40
315063|NCT00708643|759858|P1|STARTED|Overall Study||40
315064|NCT00708552|759878|P4|NOT COMPLETED|Overall Study||21
315065|NCT00708552|759879|P3|NOT COMPLETED|Overall Study||15
315066|NCT00708552|759880|P2|NOT COMPLETED|Overall Study||18
315067|NCT00708552|759881|P1|NOT COMPLETED|Overall Study||27
315068|NCT00708552|759878|P4|COMPLETED|Overall Study||130
315069|NCT00708552|759879|P3|COMPLETED|Overall Study||118
315070|NCT00708552|759880|P2|COMPLETED|Overall Study||127
315071|NCT00708552|759881|P1|COMPLETED|Overall Study||118
315072|NCT00708552|759878|P4|STARTED|Overall Study||151
315073|NCT00708552|759879|P3|STARTED|Overall Study||133
315074|NCT00708552|759880|P2|STARTED|Overall Study||145
315075|NCT00708552|759881|P1|STARTED|Overall Study||145
315076|NCT00708526|760031|P2|NOT COMPLETED|Return of Cognitive Function||0
315077|NCT00708526|760032|P1|NOT COMPLETED|Return of Cognitive Function||0
315078|NCT00708526|760031|P2|COMPLETED|Return of Cognitive Function||11
315079|NCT00708526|760032|P1|COMPLETED|Return of Cognitive Function||11
315080|NCT00708526|760031|P2|STARTED|Return of Cognitive Function||11
315081|NCT00708526|760032|P1|STARTED|Return of Cognitive Function||11
315082|NCT00708526|760031|P2|NOT COMPLETED|Wake up After Anesthesia||0
315083|NCT00708526|760032|P1|NOT COMPLETED|Wake up After Anesthesia||0
315084|NCT00708526|760031|P2|COMPLETED|Wake up After Anesthesia||11
315085|NCT00708526|760032|P1|COMPLETED|Wake up After Anesthesia||11
315086|NCT00708526|760031|P2|STARTED|Wake up After Anesthesia||11
315087|NCT00708526|760032|P1|STARTED|Wake up After Anesthesia||11
315088|NCT00708500|760043|P3|NOT COMPLETED|FOLLOWUP||15
315089|NCT00708500|760044|P2|NOT COMPLETED|FOLLOWUP||15
315090|NCT00708500|760045|P1|NOT COMPLETED|FOLLOWUP||40
315091|NCT00708500|760043|P3|COMPLETED|FOLLOWUP||143
315092|NCT00708500|760044|P2|COMPLETED|FOLLOWUP||136
315093|NCT00708500|760045|P1|COMPLETED|FOLLOWUP||37
315094|NCT00708500|760043|P3|STARTED|FOLLOWUP||158
315095|NCT00708500|760044|P2|STARTED|FOLLOWUP||151
315096|NCT00708500|760045|P1|STARTED|FOLLOWUP||77
315097|NCT00708500|760043|P3|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
315098|NCT00708500|760044|P2|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||52
315099|NCT00708500|760045|P1|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
315100|NCT00708500|760043|P3|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||105
315101|NCT00708500|760044|P2|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||104
315102|NCT00708500|760045|P1|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||23
315103|NCT00708500|760043|P3|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||160
315104|NCT00708500|760044|P2|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||156
315105|NCT00708500|760045|P1|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||78
315106|NCT00708500|760043|P3|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
315107|NCT00708500|760044|P2|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||6
315108|NCT00708500|760045|P1|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
315109|NCT00708500|760043|P3|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||160
315110|NCT00708500|760044|P2|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||156
315111|NCT00708500|760045|P1|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||78
315112|NCT00708500|760043|P3|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||161
315113|NCT00708500|760044|P2|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
315114|NCT00708500|760045|P1|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
315115|NCT00708500|760043|P3|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
315116|NCT00708500|760044|P2|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
315117|NCT00708500|760045|P1|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
315118|NCT00708461|760064|P2|NOT COMPLETED|Overall Study||200
315119|NCT00708461|760065|P1|NOT COMPLETED|Overall Study||141
315120|NCT00708461|760064|P2|COMPLETED|Overall Study||795
315121|NCT00708461|760065|P1|COMPLETED|Overall Study||611
315122|NCT00708461|760064|P2|STARTED|Overall Study||995
315123|NCT00708461|760065|P1|STARTED|Overall Study||752
315124|NCT00708435|760073|P2|NOT COMPLETED|Overall Study||17
315125|NCT00708435|760074|P1|NOT COMPLETED|Overall Study||25
315126|NCT00708435|760073|P2|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|92
315127|NCT00708435|760074|P1|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|82
315128|NCT00708435|760073|P2|STARTED|Overall Study||109
315129|NCT00708435|760074|P1|STARTED|Overall Study||107
315130|NCT00708422|760101|P2|NOT COMPLETED|Overall Study||1
315131|NCT00708422|760102|P1|NOT COMPLETED|Overall Study||4
315132|NCT00708422|760101|P2|COMPLETED|Overall Study||114
315133|NCT00708422|760102|P1|COMPLETED|Overall Study||112
315134|NCT00708422|760101|P2|STARTED|Overall Study||115
315135|NCT00708422|760102|P1|STARTED|Overall Study||116
315136|NCT00708305|760110|P4|NOT COMPLETED|Period 4||0
315137|NCT00708305|760111|P3|NOT COMPLETED|Period 4||0
315138|NCT00708305|760112|P2|NOT COMPLETED|Period 4||0
315139|NCT00708305|760113|P1|NOT COMPLETED|Period 4||0
315140|NCT00708305|760110|P4|COMPLETED|Period 4||14
315141|NCT00708305|760111|P3|COMPLETED|Period 4||14
315142|NCT00708305|760112|P2|COMPLETED|Period 4||14
315143|NCT00708305|760113|P1|COMPLETED|Period 4||12
315144|NCT00708305|760110|P4|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
315145|NCT00708305|760111|P3|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
315146|NCT00708305|760112|P2|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
315147|NCT00708305|760113|P1|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
315148|NCT00708305|760110|P4|NOT COMPLETED|Period 3||0
315149|NCT00708305|760111|P3|NOT COMPLETED|Period 3||0
315150|NCT00708305|760112|P2|NOT COMPLETED|Period 3||2
315151|NCT00708305|760113|P1|NOT COMPLETED|Period 3||1
315152|NCT00708305|760110|P4|COMPLETED|Period 3||14
315153|NCT00708305|760111|P3|COMPLETED|Period 3||14
315154|NCT00708305|760112|P2|COMPLETED|Period 3||12
315155|NCT00708305|760113|P1|COMPLETED|Period 3||14
315156|NCT00708305|760110|P4|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
315157|NCT00708305|760111|P3|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
315158|NCT00708305|760112|P2|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
315159|NCT00708305|760113|P1|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|15
315160|NCT00708305|760110|P4|NOT COMPLETED|Period 2||1
315161|NCT00708305|760111|P3|NOT COMPLETED|Period 2||0
315162|NCT00708305|760112|P2|NOT COMPLETED|Period 2||2
315163|NCT00708305|760113|P1|NOT COMPLETED|Period 2||1
315164|NCT00708305|760110|P4|COMPLETED|Period 2||14
315165|NCT00708305|760111|P3|COMPLETED|Period 2||16
315166|NCT00708305|760112|P2|COMPLETED|Period 2||13
315167|NCT00708305|760113|P1|COMPLETED|Period 2||14
315168|NCT00708305|760110|P4|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
315169|NCT00708305|760111|P3|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|16
315170|NCT00708305|760112|P2|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
315171|NCT00708305|760113|P1|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
315172|NCT00708305|760110|P4|NOT COMPLETED|Period 1||2
315173|NCT00708305|760111|P3|NOT COMPLETED|Period 1||1
315174|NCT00708305|760112|P2|NOT COMPLETED|Period 1||0
315175|NCT00708305|760113|P1|NOT COMPLETED|Period 1||1
315176|NCT00708305|760110|P4|COMPLETED|Period 1||14
315177|NCT00708305|760111|P3|COMPLETED|Period 1||16
315178|NCT00708305|760112|P2|COMPLETED|Period 1||16
315179|NCT00708305|760113|P1|COMPLETED|Period 1||15
315180|NCT00708305|760110|P4|STARTED|Period 1||16
315181|NCT00708305|760111|P3|STARTED|Period 1||17
315182|NCT00708305|760112|P2|STARTED|Period 1||16
315183|NCT00708305|760113|P1|STARTED|Period 1||16
315184|NCT00708227|760149|P4|NOT COMPLETED|Overall Study||3
315185|NCT00708227|760150|P3|NOT COMPLETED|Overall Study||1
315186|NCT00708227|760151|P2|NOT COMPLETED|Overall Study||5
315187|NCT00708227|760152|P1|NOT COMPLETED|Overall Study||1
315188|NCT00708227|760149|P4|COMPLETED|Overall Study||22
315189|NCT00708227|760150|P3|COMPLETED|Overall Study||17
315190|NCT00708227|760151|P2|COMPLETED|Overall Study||21
315191|NCT00708227|760152|P1|COMPLETED|Overall Study||18
315192|NCT00708227|760149|P4|STARTED|Overall Study||25
315193|NCT00708227|760150|P3|STARTED|Overall Study||18
315194|NCT00708227|760151|P2|STARTED|Overall Study||26
315195|NCT00708227|760152|P1|STARTED|Overall Study||19
315196|NCT00708214|760185|P3|NOT COMPLETED|Overall Study||8
315197|NCT00708214|760186|P2|NOT COMPLETED|Overall Study||13
315198|NCT00708214|760187|P1|NOT COMPLETED|Overall Study||7
315199|NCT00708214|760185|P3|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
315200|NCT00708214|760186|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
315201|NCT00708214|760187|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
315202|NCT00708214|760185|P3|STARTED|Overall Study||8
315203|NCT00708214|760186|P2|STARTED|Overall Study||13
315204|NCT00708214|760187|P1|STARTED|Overall Study||7
315205|NCT00708201|760230|P2|NOT COMPLETED|Overall Study||6
315206|NCT00708201|760231|P1|NOT COMPLETED|Overall Study||7
315207|NCT00708201|760230|P2|COMPLETED|Overall Study||137
315208|NCT00708201|760231|P1|COMPLETED|Overall Study||130
315209|NCT00708201|760230|P2|Received at Least 1 Dose of Study Drug|Overall Study||137
315210|NCT00708201|760231|P1|Received at Least 1 Dose of Study Drug|Overall Study||130
315211|NCT00708201|760230|P2|STARTED|Overall Study||143
315212|NCT00708201|760231|P1|STARTED|Overall Study||137
315213|NCT00708175|760255|P2|NOT COMPLETED|Overall Study||21
315214|NCT00708175|760256|P1|NOT COMPLETED|Overall Study||18
315215|NCT00708175|760255|P2|COMPLETED|Overall Study||57
315216|NCT00708175|760256|P1|COMPLETED|Overall Study||60
315217|NCT00708175|760255|P2|STARTED|Overall Study||78
315218|NCT00708175|760256|P1|STARTED|Overall Study||78
315219|NCT00708162|760272|P2|NOT COMPLETED|Open-Label Phase||30
315220|NCT00708162|760273|P1|NOT COMPLETED|Open-Label Phase||44
315221|NCT00708162|760272|P2|COMPLETED|Open-Label Phase||121
315222|NCT00708162|760273|P1|COMPLETED|Open-Label Phase||152
315223|NCT00708162|760272|P2|STARTED|Open-Label Phase|58 participants completing the Randomized Phase did not continue to the Open-Label Phase.|151
315224|NCT00708162|760273|P1|STARTED|Open-Label Phase|9 participants completing the Randomized Phase did not continue to the Open-Label Phase.|196
315225|NCT00708162|760272|P2|NOT COMPLETED|Randomized Phase||154
315226|NCT00708162|760273|P1|NOT COMPLETED|Randomized Phase||156
315227|NCT00708162|760272|P2|COMPLETED|Randomized Phase||209
315228|NCT00708162|760273|P1|COMPLETED|Randomized Phase||205
315229|NCT00708162|760272|P2|Randomized and Treated|Randomized Phase||358
315230|NCT00708162|760273|P1|Randomized and Treated|Randomized Phase||354
315231|NCT00708162|760272|P2|STARTED|Randomized Phase||363
315232|NCT00708162|760273|P1|STARTED|Randomized Phase||361
315233|NCT00708123|760314|P5|NOT COMPLETED|Period 5||0
315234|NCT00708123|760315|P4|NOT COMPLETED|Period 5||0
315235|NCT00708123|760316|P3|NOT COMPLETED|Period 5||0
315236|NCT00708123|760317|P2|NOT COMPLETED|Period 5||0
315237|NCT00708123|760318|P1|NOT COMPLETED|Period 5||0
315238|NCT00708123|760314|P5|COMPLETED|Period 5||10
315239|NCT00708123|760315|P4|COMPLETED|Period 5||11
315240|NCT00708123|760316|P3|COMPLETED|Period 5||11
315241|NCT00708123|760317|P2|COMPLETED|Period 5||10
315242|NCT00708123|760318|P1|COMPLETED|Period 5||10
315243|NCT00708123|760314|P5|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
315244|NCT00708123|760315|P4|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
315245|NCT00708123|760316|P3|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
315246|NCT00708123|760317|P2|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
315247|NCT00708123|760318|P1|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
315248|NCT00708123|760314|P5|NOT COMPLETED|Period 4||0
315249|NCT00708123|760315|P4|NOT COMPLETED|Period 4||0
315250|NCT00708123|760316|P3|NOT COMPLETED|Period 4||0
315251|NCT00708123|760317|P2|NOT COMPLETED|Period 4||1
315252|NCT00708123|760318|P1|NOT COMPLETED|Period 4||0
315253|NCT00708123|760314|P5|COMPLETED|Period 4||11
315254|NCT00708123|760315|P4|COMPLETED|Period 4||10
315255|NCT00708123|760316|P3|COMPLETED|Period 4||10
315256|NCT00708123|760317|P2|COMPLETED|Period 4||11
315257|NCT00708123|760318|P1|COMPLETED|Period 4||10
315258|NCT00708123|760314|P5|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|11
315259|NCT00708123|760315|P4|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
315260|NCT00708123|760316|P3|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
315261|NCT00708123|760317|P2|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
315262|NCT00708123|760318|P1|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
315263|NCT00708123|760314|P5|NOT COMPLETED|Period 3||0
315264|NCT00708123|760315|P4|NOT COMPLETED|Period 3||1
315265|NCT00708123|760316|P3|NOT COMPLETED|Period 3||1
315266|NCT00708123|760317|P2|NOT COMPLETED|Period 3||0
315267|NCT00708123|760318|P1|NOT COMPLETED|Period 3||0
315268|NCT00708123|760314|P5|COMPLETED|Period 3||10
315269|NCT00708123|760315|P4|COMPLETED|Period 3||11
315270|NCT00708123|760316|P3|COMPLETED|Period 3||10
315271|NCT00708123|760317|P2|COMPLETED|Period 3||10
315272|NCT00708123|760318|P1|COMPLETED|Period 3||12
315273|NCT00708123|760314|P5|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
315274|NCT00708123|760315|P4|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
315275|NCT00708123|760316|P3|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|11
315276|NCT00708123|760317|P2|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
315277|NCT00708123|760318|P1|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
315278|NCT00708123|760314|P5|NOT COMPLETED|Period 2||0
315279|NCT00708123|760315|P4|NOT COMPLETED|Period 2||1
315280|NCT00708123|760316|P3|NOT COMPLETED|Period 2||0
315281|NCT00708123|760317|P2|NOT COMPLETED|Period 2||0
315282|NCT00708123|760318|P1|NOT COMPLETED|Period 2||1
315283|NCT00708123|760314|P5|COMPLETED|Period 2||11
315284|NCT00708123|760315|P4|COMPLETED|Period 2||10
315285|NCT00708123|760316|P3|COMPLETED|Period 2||12
315286|NCT00708123|760317|P2|COMPLETED|Period 2||12
315287|NCT00708123|760318|P1|COMPLETED|Period 2||10
315288|NCT00708123|760314|P5|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
315289|NCT00708123|760315|P4|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
315290|NCT00708123|760316|P3|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
315291|NCT00708123|760317|P2|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
315292|NCT00708123|760318|P1|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
315293|NCT00708123|760314|P5|NOT COMPLETED|Period 1||0
315294|NCT00708123|760315|P4|NOT COMPLETED|Period 1||1
315295|NCT00708123|760316|P3|NOT COMPLETED|Period 1||1
315296|NCT00708123|760317|P2|NOT COMPLETED|Period 1||1
315297|NCT00708123|760318|P1|NOT COMPLETED|Period 1||0
315298|NCT00708123|760314|P5|COMPLETED|Period 1||12
315299|NCT00708123|760315|P4|COMPLETED|Period 1||11
315300|NCT00708123|760316|P3|COMPLETED|Period 1||11
315301|NCT00708123|760317|P2|COMPLETED|Period 1||11
315302|NCT00708123|760318|P1|COMPLETED|Period 1||12
315303|NCT00708123|760314|P5|STARTED|Period 1||12
315304|NCT00708123|760315|P4|STARTED|Period 1||12
315305|NCT00708123|760316|P3|STARTED|Period 1||12
315306|NCT00708123|760317|P2|STARTED|Period 1||12
315307|NCT00708123|760318|P1|STARTED|Period 1||12
315308|NCT00708110|760342|P4|NOT COMPLETED|Overall Study||0
315309|NCT00708110|760343|P3|NOT COMPLETED|Overall Study||0
315310|NCT00708110|760344|P2|NOT COMPLETED|Overall Study||0
315311|NCT00708110|760345|P1|NOT COMPLETED|Overall Study||0
315312|NCT00708110|760342|P4|COMPLETED|Overall Study||10
315313|NCT00708110|760343|P3|COMPLETED|Overall Study||9
315314|NCT00708110|760344|P2|COMPLETED|Overall Study||9
315315|NCT00708110|760345|P1|COMPLETED|Overall Study||7
315316|NCT00708110|760342|P4|STARTED|Overall Study||10
315317|NCT00708110|760343|P3|STARTED|Overall Study||9
315318|NCT00708110|760344|P2|STARTED|Overall Study||9
315319|NCT00708110|760345|P1|STARTED|Overall Study||7
315320|NCT00708097|760451|P5|NOT COMPLETED|Period 5||0
315321|NCT00708097|760452|P4|NOT COMPLETED|Period 5||0
315322|NCT00708097|760453|P3|NOT COMPLETED|Period 5||0
315323|NCT00708097|760454|P2|NOT COMPLETED|Period 5||0
315324|NCT00708097|760455|P1|NOT COMPLETED|Period 5||0
315325|NCT00708097|760451|P5|COMPLETED|Period 5||12
315326|NCT00708097|760452|P4|COMPLETED|Period 5||10
315327|NCT00708097|760453|P3|COMPLETED|Period 5||11
315328|NCT00708097|760454|P2|COMPLETED|Period 5||9
315329|NCT00708097|760455|P1|COMPLETED|Period 5||8
315330|NCT00708097|760451|P5|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|12
315331|NCT00708097|760452|P4|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|10
315332|NCT00708097|760453|P3|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|11
315333|NCT00708097|760454|P2|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|9
315334|NCT00708097|760455|P1|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|8
315335|NCT00708097|760451|P5|NOT COMPLETED|Period 4||0
315336|NCT00708097|760452|P4|NOT COMPLETED|Period 4||0
315337|NCT00708097|760453|P3|NOT COMPLETED|Period 4||0
315338|NCT00708097|760454|P2|NOT COMPLETED|Period 4||0
315339|NCT00708097|760455|P1|NOT COMPLETED|Period 4||0
315340|NCT00708097|760451|P5|COMPLETED|Period 4||8
315341|NCT00708097|760452|P4|COMPLETED|Period 4||11
315342|NCT00708097|760453|P3|COMPLETED|Period 4||10
315343|NCT00708097|760454|P2|COMPLETED|Period 4||9
315344|NCT00708097|760455|P1|COMPLETED|Period 4||12
315345|NCT00708097|760451|P5|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|8
315346|NCT00708097|760452|P4|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|11
315347|NCT00708097|760453|P3|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|10
315348|NCT00708097|760454|P2|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|9
315349|NCT00708097|760455|P1|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|12
315350|NCT00708097|760451|P5|NOT COMPLETED|Period 3||0
315351|NCT00708097|760452|P4|NOT COMPLETED|Period 3||0
315352|NCT00708097|760453|P3|NOT COMPLETED|Period 3||0
315353|NCT00708097|760454|P2|NOT COMPLETED|Period 3||0
315354|NCT00708097|760455|P1|NOT COMPLETED|Period 3||0
315355|NCT00708097|760451|P5|COMPLETED|Period 3||10
315356|NCT00708097|760452|P4|COMPLETED|Period 3||10
315357|NCT00708097|760453|P3|COMPLETED|Period 3||10
315358|NCT00708097|760454|P2|COMPLETED|Period 3||11
315359|NCT00708097|760455|P1|COMPLETED|Period 3||9
315360|NCT00708097|760451|P5|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
315361|NCT00708097|760452|P4|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
315362|NCT00708097|760453|P3|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
315363|NCT00708097|760454|P2|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|11
315364|NCT00708097|760455|P1|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|9
315365|NCT00708097|760451|P5|NOT COMPLETED|Period 2||0
315366|NCT00708097|760452|P4|NOT COMPLETED|Period 2||1
315367|NCT00708097|760453|P3|NOT COMPLETED|Period 2||1
315368|NCT00708097|760454|P2|NOT COMPLETED|Period 2||1
315369|NCT00708097|760455|P1|NOT COMPLETED|Period 2||0
315370|NCT00708097|760451|P5|COMPLETED|Period 2||10
315371|NCT00708097|760452|P4|COMPLETED|Period 2||10
315372|NCT00708097|760453|P3|COMPLETED|Period 2||9
315373|NCT00708097|760454|P2|COMPLETED|Period 2||11
315374|NCT00708097|760455|P1|COMPLETED|Period 2||10
315375|NCT00708097|760451|P5|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
315376|NCT00708097|760452|P4|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|11
315377|NCT00708097|760453|P3|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
315378|NCT00708097|760454|P2|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|12
315379|NCT00708097|760455|P1|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
315380|NCT00708097|760451|P5|NOT COMPLETED|Period 1||1
315381|NCT00708097|760452|P4|NOT COMPLETED|Period 1||2
315382|NCT00708097|760453|P3|NOT COMPLETED|Period 1||0
315383|NCT00708097|760454|P2|NOT COMPLETED|Period 1||1
315384|NCT00708097|760455|P1|NOT COMPLETED|Period 1||0
315385|NCT00708097|760451|P5|COMPLETED|Period 1||10
315386|NCT00708097|760452|P4|COMPLETED|Period 1||9
315387|NCT00708097|760453|P3|COMPLETED|Period 1||12
315388|NCT00708097|760454|P2|COMPLETED|Period 1||11
315389|NCT00708097|760455|P1|COMPLETED|Period 1||11
315390|NCT00708097|760451|P5|STARTED|Period 1||11
315391|NCT00708097|760452|P4|STARTED|Period 1||11
315392|NCT00708097|760453|P3|STARTED|Period 1||12
315393|NCT00708097|760454|P2|STARTED|Period 1||12
315394|NCT00708097|760455|P1|STARTED|Period 1||11
315395|NCT00708071|760485|P1|NOT COMPLETED|Overall Study||0
315396|NCT00708071|760485|P1|COMPLETED|Overall Study||45
315397|NCT00708071|760485|P1|STARTED|Overall Study|Randomized and treated|45
315398|NCT00708032|760565|P2|NOT COMPLETED|Overall Study||16
315399|NCT00708032|760566|P1|NOT COMPLETED|Overall Study||10
315400|NCT00708032|760565|P2|COMPLETED|Overall Study||22
315401|NCT00708032|760566|P1|COMPLETED|Overall Study||26
315402|NCT00708032|760565|P2|STARTED|Overall Study||38
315403|NCT00708032|760566|P1|STARTED|Overall Study||36
315404|NCT00708019|760582|P2|NOT COMPLETED|Overall Study||15
315405|NCT00708019|760583|P1|NOT COMPLETED|Overall Study||15
315406|NCT00708019|760582|P2|COMPLETED|Overall Study||78
315407|NCT00708019|760583|P1|COMPLETED|Overall Study||77
315408|NCT00708019|760582|P2|STARTED|Overall Study||93
315409|NCT00708019|760583|P1|STARTED|Overall Study||92
315410|NCT00707993|760593|P2|NOT COMPLETED|Overall Study||94
315411|NCT00707993|760594|P1|NOT COMPLETED|Overall Study||89
315412|NCT00707993|760593|P2|COMPLETED|Overall Study||125
315413|NCT00707993|760594|P1|COMPLETED|Overall Study||133
315414|NCT00707993|760593|P2|STARTED|Overall Study||219
315415|NCT00707993|760594|P1|STARTED|Overall Study||222
315416|NCT00707980|760636|P1|NOT COMPLETED|Overall Study||310
315417|NCT00707980|760636|P1|COMPLETED|Overall Study||526
315418|NCT00707980|760636|P1|Received Treatment|Overall Study||834
315419|NCT00707980|760636|P1|STARTED|Overall Study||836
315420|NCT00707967|760654|P3|NOT COMPLETED|Overall Study||0
315421|NCT00707967|760655|P2|NOT COMPLETED|Overall Study||0
315422|NCT00707967|760656|P1|NOT COMPLETED|Overall Study||0
315423|NCT00707967|760654|P3|COMPLETED|Overall Study||7
315424|NCT00707967|760655|P2|COMPLETED|Overall Study||8
315425|NCT00707967|760656|P1|COMPLETED|Overall Study||22
315426|NCT00707967|760654|P3|STARTED|Overall Study||7
315427|NCT00707967|760655|P2|STARTED|Overall Study||8
315428|NCT00707967|760656|P1|STARTED|Overall Study||22
315429|NCT00707954|760720|P5|NOT COMPLETED|Overall Study||1
315430|NCT00707954|760721|P4|NOT COMPLETED|Overall Study||0
315431|NCT00707954|760722|P3|NOT COMPLETED|Overall Study||0
315432|NCT00707954|760723|P2|NOT COMPLETED|Overall Study||0
315433|NCT00707954|760724|P1|NOT COMPLETED|Overall Study||0
315434|NCT00707954|760720|P5|COMPLETED|Overall Study||9
315435|NCT00707954|760721|P4|COMPLETED|Overall Study||13
315436|NCT00707954|760722|P3|COMPLETED|Overall Study||14
315437|NCT00707954|760723|P2|COMPLETED|Overall Study||12
315438|NCT00707954|760724|P1|COMPLETED|Overall Study||12
315439|NCT00707954|760720|P5|STARTED|Overall Study||10
315440|NCT00707954|760721|P4|STARTED|Overall Study||13
315441|NCT00707954|760722|P3|STARTED|Overall Study||14
315442|NCT00707954|760723|P2|STARTED|Overall Study||12
315443|NCT00707954|760724|P1|STARTED|Overall Study||12
315444|NCT00707915|760736|P1|NOT COMPLETED|Overall Study||0
315445|NCT00707915|760736|P1|COMPLETED|Overall Study||30
315446|NCT00707915|760736|P1|Effects of Discontinuing Benzodiazepine|Overall Study||30
315447|NCT00707915|760736|P1|STARTED|Overall Study||30
315448|NCT00707863|760747|P2|NOT COMPLETED|Overall Study||3
315449|NCT00707863|760748|P1|NOT COMPLETED|Overall Study||0
315450|NCT00707863|760747|P2|COMPLETED|Overall Study||8
315451|NCT00707863|760748|P1|COMPLETED|Overall Study||6
315452|NCT00707863|760747|P2|STARTED|Overall Study||11
315453|NCT00707863|760748|P1|STARTED|Overall Study||6
315454|NCT00707759|760756|P2|NOT COMPLETED|Overall Study||2
315455|NCT00707759|760757|P1|NOT COMPLETED|Overall Study||2
315456|NCT00707759|760756|P2|COMPLETED|Overall Study||12
315457|NCT00707759|760757|P1|COMPLETED|Overall Study||12
315458|NCT00707759|760756|P2|STARTED|Overall Study||14
315459|NCT00707759|760757|P1|STARTED|Overall Study||14
315460|NCT00707746|760765|P2|NOT COMPLETED|Follow-up Period||0
315461|NCT00707746|760766|P1|NOT COMPLETED|Follow-up Period||0
315462|NCT00707746|760765|P2|COMPLETED|Follow-up Period||21
315463|NCT00707746|760766|P1|COMPLETED|Follow-up Period||12
315464|NCT00707746|760765|P2|STARTED|Follow-up Period||21
315465|NCT00707746|760766|P1|STARTED|Follow-up Period||12
315466|NCT00707746|760765|P2|NOT COMPLETED|Treatment Period||5
315467|NCT00707746|760766|P1|NOT COMPLETED|Treatment Period||2
315468|NCT00707746|760765|P2|COMPLETED|Treatment Period||17
315469|NCT00707746|760766|P1|COMPLETED|Treatment Period||10
315470|NCT00707746|760765|P2|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|21
315471|NCT00707746|760766|P1|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|12
315472|NCT00707746|760765|P2|STARTED|Treatment Period||22
315473|NCT00707746|760766|P1|STARTED|Treatment Period||12
315474|NCT00707655|760814|P2|NOT COMPLETED|Overall Study||2
315475|NCT00707655|760815|P1|NOT COMPLETED|Overall Study||0
315476|NCT00707655|760814|P2|COMPLETED|Overall Study||3
315477|NCT00707655|760815|P1|COMPLETED|Overall Study||3
315478|NCT00707655|760814|P2|STARTED|Overall Study||5
315479|NCT00707655|760815|P1|STARTED|Overall Study||3
315480|NCT00707577|760827|P2|NOT COMPLETED|Overall Study||38
315481|NCT00707577|760828|P1|NOT COMPLETED|Overall Study||54
315482|NCT00707577|760827|P2|COMPLETED|Overall Study||118
315483|NCT00707577|760828|P1|COMPLETED|Overall Study||120
315484|NCT00707577|760827|P2|STARTED|Overall Study||156
315485|NCT00707577|760828|P1|STARTED|Overall Study||174
315486|NCT00707486|760834|P1|NOT COMPLETED|Overall Study||1
315487|NCT00707486|760834|P1|COMPLETED|Overall Study||71
315488|NCT00707486|760834|P1|STARTED|Overall Study||72
315489|NCT00707447|760845|P2|NOT COMPLETED|Overall Study||8
315490|NCT00707447|760846|P1|NOT COMPLETED|Overall Study||8
315491|NCT00707447|760845|P2|COMPLETED|Overall Study||85
315492|NCT00707447|760846|P1|COMPLETED|Overall Study||81
315493|NCT00707447|760845|P2|STARTED|Overall Study||93
315494|NCT00707447|760846|P1|STARTED|Overall Study||89
315495|NCT00707343|760870|P1|NOT COMPLETED|Overall Study||0
315496|NCT00707343|760870|P1|COMPLETED|Overall Study||15
315497|NCT00707343|760870|P1|STARTED|Overall Study||15
315498|NCT00707239|760877|P3|NOT COMPLETED|Overall Study||14
315499|NCT00707239|760878|P2|NOT COMPLETED|Overall Study||11
315500|NCT00707239|760879|P1|NOT COMPLETED|Overall Study||19
315501|NCT00707239|760877|P3|COMPLETED|Overall Study||21
315502|NCT00707239|760878|P2|COMPLETED|Overall Study||25
315503|NCT00707239|760879|P1|COMPLETED|Overall Study||18
315504|NCT00707239|760877|P3|Treated|Overall Study||34
315505|NCT00707239|760878|P2|Treated|Overall Study||35
315506|NCT00707239|760879|P1|Treated|Overall Study||36
315507|NCT00707239|760877|P3|STARTED|Overall Study||35
315508|NCT00707239|760878|P2|STARTED|Overall Study||36
315509|NCT00707239|760879|P1|STARTED|Overall Study||37
315510|NCT00707174|760927|P2|NOT COMPLETED|Overall Study||7
315511|NCT00707174|760928|P1|NOT COMPLETED|Overall Study||5
315512|NCT00707174|760927|P2|COMPLETED|Overall Study||37
315513|NCT00707174|760928|P1|COMPLETED|Overall Study||41
315514|NCT00707174|760927|P2|STARTED|Overall Study||44
315515|NCT00707174|760928|P1|STARTED|Overall Study||46
315516|NCT00707161|760934|P1|NOT COMPLETED|Overall Study||6
315517|NCT00707161|760934|P1|COMPLETED|Overall Study||0
315518|NCT00707161|760934|P1|STARTED|Overall Study|3 deceased (1-Huntsman Cancer Institute, 2- LDS Hospital).|6
315519|NCT00707057|760940|P2|NOT COMPLETED|Overall Study||4
315520|NCT00707057|760941|P1|NOT COMPLETED|Overall Study||8
315521|NCT00707057|760940|P2|COMPLETED|Overall Study||83
315522|NCT00707057|760941|P1|COMPLETED|Overall Study||161
315523|NCT00707057|760940|P2|STARTED|Overall Study||87
315524|NCT00707057|760941|P1|STARTED|Overall Study||169
315525|NCT00707031|760975|P2|NOT COMPLETED|Overall Study||99
315526|NCT00707031|760976|P1|NOT COMPLETED|Overall Study||104
315527|NCT00707031|760975|P2|COMPLETED|Overall Study||220
315528|NCT00707031|760976|P1|COMPLETED|Overall Study||216
315529|NCT00707031|760975|P2|Modified Intent-to-Treat Population|Overall Study||315
315530|NCT00707031|760976|P1|Modified Intent-to-Treat Population|Overall Study|All patients who received at least 1 dose;had baseline;at least 1 post-baseline efficacy assessment.|315
315531|NCT00707031|760975|P2|Treated/Safety Population|Overall Study||316
315532|NCT00707031|760976|P1|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|318
315533|NCT00707031|760975|P2|STARTED|Overall Study||319
315534|NCT00707031|760976|P1|STARTED|Overall Study|Randomized|320
315535|NCT00706992|761005|P7|NOT COMPLETED|Overall Study||3
315536|NCT00706992|761006|P6|NOT COMPLETED|Overall Study||2
315537|NCT00706992|761007|P5|NOT COMPLETED|Overall Study||4
315538|NCT00706992|761008|P4|NOT COMPLETED|Overall Study||2
315539|NCT00706992|761009|P3|NOT COMPLETED|Overall Study||6
315540|NCT00706992|761010|P2|NOT COMPLETED|Overall Study||5
315541|NCT00706992|761011|P1|NOT COMPLETED|Overall Study||5
315542|NCT00706992|761005|P7|COMPLETED|Overall Study||3
315543|NCT00706992|761006|P6|COMPLETED|Overall Study||3
315544|NCT00706992|761007|P5|COMPLETED|Overall Study||2
315545|NCT00706992|761008|P4|COMPLETED|Overall Study||6
315546|NCT00706992|761009|P3|COMPLETED|Overall Study||3
315547|NCT00706992|761010|P2|COMPLETED|Overall Study||3
315548|NCT00706992|761011|P1|COMPLETED|Overall Study||3
315549|NCT00706992|761005|P7|STARTED|Overall Study||6
315550|NCT00706992|761006|P6|STARTED|Overall Study||5
315551|NCT00706992|761007|P5|STARTED|Overall Study||6
315552|NCT00706992|761008|P4|STARTED|Overall Study||8
315553|NCT00706992|761009|P3|STARTED|Overall Study||9
315554|NCT00706992|761010|P2|STARTED|Overall Study||8
315555|NCT00706992|761011|P1|STARTED|Overall Study||8
315556|NCT00706979|761030|P2|NOT COMPLETED|Overall Study||0
315557|NCT00706979|761031|P1|NOT COMPLETED|Overall Study||0
315558|NCT00706979|761030|P2|COMPLETED|Overall Study||423
315559|NCT00706979|761031|P1|COMPLETED|Overall Study||426
315560|NCT00706979|761030|P2|STARTED|Overall Study||423
315561|NCT00706979|761031|P1|STARTED|Overall Study||426
315562|NCT00706966|761043|P1|NOT COMPLETED|Overall Study||1
315563|NCT00706966|761043|P1|COMPLETED|Overall Study||9
315564|NCT00706966|761043|P1|STARTED|Overall Study||10
315565|NCT00706914|761079|P3|NOT COMPLETED|Overall Study||1
315566|NCT00706914|761080|P2|NOT COMPLETED|Overall Study||4
315567|NCT00706914|761081|P1|NOT COMPLETED|Overall Study||6
315568|NCT00706914|761079|P3|COMPLETED|Overall Study||30
315569|NCT00706914|761080|P2|COMPLETED|Overall Study||58
315570|NCT00706914|761081|P1|COMPLETED|Overall Study||57
315571|NCT00706914|761079|P3|STARTED|Overall Study||31
315572|NCT00706914|761080|P2|STARTED|Overall Study||62
315573|NCT00706914|761081|P1|STARTED|Overall Study||63
315574|NCT00706901|761104|P3|NOT COMPLETED|Overall Study||8
315575|NCT00706901|761105|P2|NOT COMPLETED|Overall Study||5
315576|NCT00706901|761106|P1|NOT COMPLETED|Overall Study||8
315577|NCT00706901|761104|P3|COMPLETED|Overall Study||51
315578|NCT00706901|761105|P2|COMPLETED|Overall Study||57
315579|NCT00706901|761106|P1|COMPLETED|Overall Study||51
315580|NCT00706901|761104|P3|STARTED|Overall Study||59
315581|NCT00706901|761105|P2|STARTED|Overall Study||62
315582|NCT00706901|761106|P1|STARTED|Overall Study||59
315583|NCT00706849|761131|P2|NOT COMPLETED|Follow-up Period||3
315584|NCT00706849|761132|P1|NOT COMPLETED|Follow-up Period||0
315585|NCT00706849|761131|P2|COMPLETED|Follow-up Period||25
315586|NCT00706849|761132|P1|COMPLETED|Follow-up Period||3
315587|NCT00706849|761131|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|28
315588|NCT00706849|761132|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|3
315589|NCT00706849|761131|P2|NOT COMPLETED|Treatment Period||10
315590|NCT00706849|761132|P1|NOT COMPLETED|Treatment Period||0
315591|NCT00706849|761131|P2|COMPLETED|Treatment Period|55 patients entered the open-label extension study (301012-CS6; NCT00694109).|73
315592|NCT00706849|761132|P1|COMPLETED|Treatment Period|38 patients entered the open-label extension study (301012-CS6; NCT00694109).|41
315593|NCT00706849|761131|P2|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement.|82
315594|NCT00706849|761132|P1|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|41
315595|NCT00706849|761131|P2|STARTED|Treatment Period||83
315596|NCT00706849|761132|P1|STARTED|Treatment Period||41
315597|NCT00706836|761176|P1|NOT COMPLETED|Overall Study||0
315598|NCT00706836|761176|P1|COMPLETED|Overall Study||16
315599|NCT00706836|761176|P1|STARTED|Overall Study||16
315600|NCT00706823|761186|P2|NOT COMPLETED|Overall Study||0
315601|NCT00706823|761187|P1|NOT COMPLETED|Overall Study||0
315602|NCT00706823|761186|P2|COMPLETED|Overall Study||25
315603|NCT00706823|761187|P1|COMPLETED|Overall Study||25
315604|NCT00706823|761186|P2|STARTED|Overall Study||25
315605|NCT00706823|761187|P1|STARTED|Overall Study||25
315606|NCT00706810|761203|P1|NOT COMPLETED|Overall Study||1
315607|NCT00706810|761203|P1|COMPLETED|Overall Study||7
315608|NCT00706810|761203|P1|STARTED|Overall Study||8
315609|NCT00706797|761210|P2|NOT COMPLETED|Overall Study||71
315610|NCT00706797|761211|P1|NOT COMPLETED|Overall Study||69
315611|NCT00706797|761210|P2|COMPLETED|Overall Study||0
315612|NCT00706797|761211|P1|COMPLETED|Overall Study||1
315613|NCT00706797|761210|P2|Safety Population|Overall Study||71
315614|NCT00706797|761211|P1|Safety Population|Overall Study|Safety population=all randomly assigned subjects who had at least 1 dose of study treatment.|63
315615|NCT00706797|761210|P2|STARTED|Overall Study||71
315616|NCT00706797|761211|P1|STARTED|Overall Study||70
315617|NCT00706784|761253|P2|NOT COMPLETED|Overall Study||0
315618|NCT00706784|761254|P1|NOT COMPLETED|Overall Study||0
315619|NCT00706784|761253|P2|COMPLETED|Overall Study||3
315620|NCT00706784|761254|P1|COMPLETED|Overall Study||3
315621|NCT00706784|761253|P2|STARTED|Overall Study||3
315622|NCT00706784|761254|P1|STARTED|Overall Study||3
315623|NCT00706719|761263|P3|NOT COMPLETED|Overall Study||4
315624|NCT00706719|761264|P2|NOT COMPLETED|Overall Study||1
315625|NCT00706719|761265|P1|NOT COMPLETED|Overall Study||0
315626|NCT00706719|761263|P3|COMPLETED|Overall Study||1
315627|NCT00706719|761264|P2|COMPLETED|Overall Study||6
315628|NCT00706719|761265|P1|COMPLETED|Overall Study||5
315629|NCT00706719|761263|P3|STARTED|Overall Study||5
315630|NCT00706719|761264|P2|STARTED|Overall Study||7
315631|NCT00706719|761265|P1|STARTED|Overall Study||5
315632|NCT00706706|761280|P1|NOT COMPLETED|Overall Study||105
315633|NCT00706706|761280|P1|COMPLETED|Overall Study||0
315634|NCT00706706|761280|P1|STARTED|Overall Study||105
315635|NCT00706654|761290|P4|NOT COMPLETED|Depot Maintenance Phase||70
315636|NCT00706654|761291|P3|NOT COMPLETED|Depot Maintenance Phase||88
315637|NCT00706654|761292|P2|NOT COMPLETED|Depot Maintenance Phase||69
315638|NCT00706654|761293|P1|NOT COMPLETED|Depot Maintenance Phase||0
315639|NCT00706654|761290|P4|COMPLETED|Depot Maintenance Phase||61
315640|NCT00706654|761291|P3|COMPLETED|Depot Maintenance Phase||178
315641|NCT00706654|761292|P2|COMPLETED|Depot Maintenance Phase||196
315642|NCT00706654|761293|P1|COMPLETED|Depot Maintenance Phase||0
315643|NCT00706654|761290|P4|STARTED|Depot Maintenance Phase||131
315644|NCT00706654|761291|P3|STARTED|Depot Maintenance Phase||266
315645|NCT00706654|761292|P2|STARTED|Depot Maintenance Phase||265
315646|NCT00706654|761293|P1|STARTED|Depot Maintenance Phase|Patients were randomized into the 3 aripiprazole treatment groups in this phase of the study.|0
315647|NCT00706654|761290|P4|NOT COMPLETED|Oral Stabilization Phase||0
315648|NCT00706654|761291|P3|NOT COMPLETED|Oral Stabilization Phase||0
315649|NCT00706654|761292|P2|NOT COMPLETED|Oral Stabilization Phase||0
315650|NCT00706654|761293|P1|NOT COMPLETED|Oral Stabilization Phase||180
315651|NCT00706654|761290|P4|COMPLETED|Oral Stabilization Phase||0
315652|NCT00706654|761291|P3|COMPLETED|Oral Stabilization Phase||0
315653|NCT00706654|761292|P2|COMPLETED|Oral Stabilization Phase||0
315654|NCT00706654|761293|P1|COMPLETED|Oral Stabilization Phase||662
315655|NCT00706654|761290|P4|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
315656|NCT00706654|761291|P3|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
315657|NCT00706654|761292|P2|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
315658|NCT00706654|761293|P1|STARTED|Oral Stabilization Phase|228 of the 842 patients who started this phase enrolled directly into this phase of the study.|842
315659|NCT00706654|761290|P4|NOT COMPLETED|Conversion Phase||0
315660|NCT00706654|761291|P3|NOT COMPLETED|Conversion Phase||0
315661|NCT00706654|761292|P2|NOT COMPLETED|Conversion Phase||0
315662|NCT00706654|761293|P1|NOT COMPLETED|Conversion Phase||95
315663|NCT00706654|761290|P4|COMPLETED|Conversion Phase||0
315664|NCT00706654|761291|P3|COMPLETED|Conversion Phase||0
315665|NCT00706654|761292|P2|COMPLETED|Conversion Phase||0
315666|NCT00706654|761293|P1|COMPLETED|Conversion Phase||614
315667|NCT00706654|761290|P4|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
315668|NCT00706654|761291|P3|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
315669|NCT00706654|761292|P2|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
315670|NCT00706654|761293|P1|STARTED|Conversion Phase||709
315671|NCT00706641|761312|P1|NOT COMPLETED|Radical Cystectomy||1
315672|NCT00706641|761312|P1|COMPLETED|Radical Cystectomy||22
315673|NCT00706641|761312|P1|STARTED|Radical Cystectomy||23
315674|NCT00706641|761312|P1|NOT COMPLETED|Dasatinib Administration||2
315675|NCT00706641|761312|P1|COMPLETED|Dasatinib Administration||23
315676|NCT00706641|761312|P1|Toxicity Evaluation|Dasatinib Administration||24
315677|NCT00706641|761312|P1|STARTED|Dasatinib Administration||25
315678|NCT00706628|761326|P4|NOT COMPLETED|Overall Study||3
315679|NCT00706628|761327|P3|NOT COMPLETED|Overall Study||16
315680|NCT00706628|761328|P2|NOT COMPLETED|Overall Study||21
315681|NCT00706628|761329|P1|NOT COMPLETED|Overall Study||47
315682|NCT00706628|761326|P4|COMPLETED|Overall Study||0
315683|NCT00706628|761327|P3|COMPLETED|Overall Study||0
315684|NCT00706628|761328|P2|COMPLETED|Overall Study||0
315685|NCT00706628|761329|P1|COMPLETED|Overall Study||0
315686|NCT00706628|761326|P4|STARTED|Overall Study||3
315687|NCT00706628|761327|P3|STARTED|Overall Study||16
315688|NCT00706628|761328|P2|STARTED|Overall Study||21
315689|NCT00706628|761329|P1|STARTED|Overall Study||47
315690|NCT00706589|761379|P2|NOT COMPLETED|Overall Study||4
315691|NCT00706589|761380|P1|NOT COMPLETED|Overall Study||3
315692|NCT00706589|761379|P2|COMPLETED|Overall Study||25
315693|NCT00706589|761380|P1|COMPLETED|Overall Study||29
315694|NCT00706589|761379|P2|STARTED|Overall Study||29
315695|NCT00706589|761380|P1|STARTED|Overall Study||32
315696|NCT00706563|761388|P2|NOT COMPLETED|Overall Study||0
315697|NCT00706563|761389|P1|NOT COMPLETED|Overall Study||0
315698|NCT00706563|761388|P2|COMPLETED|Overall Study||59
315699|NCT00706563|761389|P1|COMPLETED|Overall Study||61
315700|NCT00706563|761388|P2|STARTED|Overall Study||59
315701|NCT00706563|761389|P1|STARTED|Overall Study||61
315702|NCT00706550|761413|P2|NOT COMPLETED|Overall Study||28
315703|NCT00706550|761414|P1|NOT COMPLETED|Overall Study||7
315704|NCT00706550|761413|P2|COMPLETED|Overall Study||36
315705|NCT00706550|761414|P1|COMPLETED|Overall Study||36
315706|NCT00706550|761413|P2|STARTED|Overall Study||64
315707|NCT00706550|761414|P1|STARTED|Overall Study||43
315708|NCT00706485|761430|P1|NOT COMPLETED|Overall Study||0
315709|NCT00706485|761430|P1|COMPLETED|Overall Study||5
315710|NCT00706485|761430|P1|STARTED|Overall Study||5
315711|NCT00706446|761442|P6|NOT COMPLETED|Overall Study||38
315712|NCT00706446|761443|P5|NOT COMPLETED|Overall Study||44
315713|NCT00706446|761444|P4|NOT COMPLETED|Overall Study||22
315714|NCT00706446|761445|P3|NOT COMPLETED|Overall Study||37
315715|NCT00706446|761446|P2|NOT COMPLETED|Overall Study||49
315716|NCT00706446|761447|P1|NOT COMPLETED|Overall Study||26
315717|NCT00706446|761442|P6|COMPLETED|Overall Study||7
315718|NCT00706446|761443|P5|COMPLETED|Overall Study||10
315719|NCT00706446|761444|P4|COMPLETED|Overall Study||4
315720|NCT00706446|761445|P3|COMPLETED|Overall Study||7
315721|NCT00706446|761446|P2|COMPLETED|Overall Study||8
315722|NCT00706446|761447|P1|COMPLETED|Overall Study||3
315723|NCT00706446|761442|P6|STARTED|Overall Study||45
315724|NCT00706446|761443|P5|STARTED|Overall Study||54
315725|NCT00706446|761444|P4|STARTED|Overall Study||26
315726|NCT00706446|761445|P3|STARTED|Overall Study||44
315727|NCT00706446|761446|P2|STARTED|Overall Study||57
315728|NCT00706446|761447|P1|STARTED|Overall Study||29
315729|NCT00706433|761489|P4|NOT COMPLETED|Overall Study||2
315730|NCT00706433|761490|P3|NOT COMPLETED|Overall Study||10
315731|NCT00706433|761491|P2|NOT COMPLETED|Overall Study||3
315732|NCT00706433|761492|P1|NOT COMPLETED|Overall Study||5
315733|NCT00706433|761489|P4|COMPLETED|Overall Study||64
315734|NCT00706433|761490|P3|COMPLETED|Overall Study||57
315735|NCT00706433|761491|P2|COMPLETED|Overall Study||62
315736|NCT00706433|761492|P1|COMPLETED|Overall Study||63
315737|NCT00706433|761489|P4|STARTED|Overall Study||66
315738|NCT00706433|761490|P3|STARTED|Overall Study||67
315739|NCT00706433|761491|P2|STARTED|Overall Study||65
315740|NCT00706433|761492|P1|STARTED|Overall Study||68
315741|NCT00706407|761808|P1|NOT COMPLETED|Overall Study||9
315742|NCT00706407|761808|P1|COMPLETED|Overall Study||33
315743|NCT00706407|761808|P1|STARTED|Overall Study||42
315744|NCT00706355|761819|P4|NOT COMPLETED|Period 4: PF-04217903 150 mg||4
315745|NCT00706355|761820|P3|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
315746|NCT00706355|761821|P2|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
315747|NCT00706355|761822|P1|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
315748|NCT00706355|761819|P4|COMPLETED|Period 4: PF-04217903 150 mg||0
315749|NCT00706355|761820|P3|COMPLETED|Period 4: PF-04217903 150 mg||0
315750|NCT00706355|761821|P2|COMPLETED|Period 4: PF-04217903 150 mg||0
315751|NCT00706355|761822|P1|COMPLETED|Period 4: PF-04217903 150 mg||0
315752|NCT00706355|761819|P4|STARTED|Period 4: PF-04217903 150 mg||4
315753|NCT00706355|761820|P3|STARTED|Period 4: PF-04217903 150 mg||0
315754|NCT00706355|761821|P2|STARTED|Period 4: PF-04217903 150 mg||0
315755|NCT00706355|761822|P1|STARTED|Period 4: PF-04217903 150 mg||0
315756|NCT00706355|761819|P4|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
315757|NCT00706355|761820|P3|NOT COMPLETED|Period 3: PF-04217903 200 mg||2
315758|NCT00706355|761821|P2|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
315759|NCT00706355|761822|P1|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
315760|NCT00706355|761819|P4|COMPLETED|Period 3: PF-04217903 200 mg||0
315761|NCT00706355|761820|P3|COMPLETED|Period 3: PF-04217903 200 mg||0
315762|NCT00706355|761821|P2|COMPLETED|Period 3: PF-04217903 200 mg||0
315763|NCT00706355|761822|P1|COMPLETED|Period 3: PF-04217903 200 mg||0
315764|NCT00706355|761819|P4|STARTED|Period 3: PF-04217903 200 mg||0
315765|NCT00706355|761820|P3|STARTED|Period 3: PF-04217903 200 mg||2
315766|NCT00706355|761821|P2|STARTED|Period 3: PF-04217903 200 mg||0
315767|NCT00706355|761822|P1|STARTED|Period 3: PF-04217903 200 mg||0
315768|NCT00706355|761819|P4|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
315769|NCT00706355|761820|P3|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
315770|NCT00706355|761821|P2|NOT COMPLETED|Period 2: PF-04217903 100 mg||7
315771|NCT00706355|761822|P1|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
315772|NCT00706355|761819|P4|COMPLETED|Period 2: PF-04217903 100 mg||0
315773|NCT00706355|761820|P3|COMPLETED|Period 2: PF-04217903 100 mg||0
315774|NCT00706355|761821|P2|COMPLETED|Period 2: PF-04217903 100 mg||0
315775|NCT00706355|761822|P1|COMPLETED|Period 2: PF-04217903 100 mg||0
315776|NCT00706355|761819|P4|STARTED|Period 2: PF-04217903 100 mg||0
315777|NCT00706355|761820|P3|STARTED|Period 2: PF-04217903 100 mg||0
315778|NCT00706355|761821|P2|STARTED|Period 2: PF-04217903 100 mg||7
315779|NCT00706355|761822|P1|STARTED|Period 2: PF-04217903 100 mg||0
315780|NCT00706355|761819|P4|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
315781|NCT00706355|761820|P3|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
315782|NCT00706355|761821|P2|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
315783|NCT00706355|761822|P1|NOT COMPLETED|Period 1: PF-04217903 50 mg||3
315784|NCT00706355|761819|P4|COMPLETED|Period 1: PF-04217903 50 mg||0
315785|NCT00706355|761820|P3|COMPLETED|Period 1: PF-04217903 50 mg||0
315786|NCT00706355|761821|P2|COMPLETED|Period 1: PF-04217903 50 mg||0
315787|NCT00706355|761822|P1|COMPLETED|Period 1: PF-04217903 50 mg||0
315788|NCT00706355|761819|P4|STARTED|Period 1: PF-04217903 50 mg||0
315789|NCT00706355|761820|P3|STARTED|Period 1: PF-04217903 50 mg||0
315790|NCT00706355|761821|P2|STARTED|Period 1: PF-04217903 50 mg||0
315791|NCT00706355|761822|P1|STARTED|Period 1: PF-04217903 50 mg||3
315792|NCT00706342|761874|P1|NOT COMPLETED|Overall Study||18
315793|NCT00706342|761874|P1|COMPLETED|Overall Study||0
315794|NCT00706342|761874|P1|STARTED|Overall Study||18
315795|NCT00706329|761883|P1|NOT COMPLETED|Overall Study||0
315796|NCT00706329|761883|P1|COMPLETED|Overall Study||25
315797|NCT00706329|761883|P1|STARTED|Overall Study||25
315798|NCT00706238|761887|P1|NOT COMPLETED|Overall Study||5
315799|NCT00706238|761887|P1|COMPLETED|Overall Study||0
315800|NCT00706238|761887|P1|STARTED|Overall Study||5
315801|NCT00706134|761904|P4|NOT COMPLETED|Overall Study||11
315802|NCT00706134|761905|P3|NOT COMPLETED|Overall Study||6
315803|NCT00706134|761906|P2|NOT COMPLETED|Overall Study||19
315804|NCT00706134|761907|P1|NOT COMPLETED|Overall Study||20
315805|NCT00706134|761904|P4|COMPLETED|Overall Study||175
315806|NCT00706134|761905|P3|COMPLETED|Overall Study||183
315807|NCT00706134|761906|P2|COMPLETED|Overall Study||173
315808|NCT00706134|761907|P1|COMPLETED|Overall Study||169
315809|NCT00706134|761904|P4|Entered Double-blind Period|Overall Study||186
315810|NCT00706134|761905|P3|Entered Double-blind Period|Overall Study||189
315811|NCT00706134|761906|P2|Entered Double-blind Period|Overall Study||192
315812|NCT00706134|761907|P1|Entered Double-blind Period|Overall Study||187
315813|NCT00706134|761904|P4|STARTED|Overall Study||186
315814|NCT00706134|761905|P3|STARTED|Overall Study||189
315815|NCT00706134|761906|P2|STARTED|Overall Study||192
315816|NCT00706134|761907|P1|STARTED|Overall Study||189
315817|NCT00706121|761941|P4|NOT COMPLETED|Overall Study||352
315818|NCT00706121|761942|P3|NOT COMPLETED|Overall Study||404
315819|NCT00706121|761943|P2|NOT COMPLETED|Overall Study||396
315820|NCT00706121|761944|P1|NOT COMPLETED|Overall Study||396
315821|NCT00706121|761941|P4|COMPLETED|Overall Study||1577
315822|NCT00706121|761942|P3|COMPLETED|Overall Study||1626
315823|NCT00706121|761943|P2|COMPLETED|Overall Study||1700
315824|NCT00706121|761944|P1|COMPLETED|Overall Study||1643
315825|NCT00706121|761941|P4|STARTED|Overall Study||1929
315826|NCT00706121|761942|P3|STARTED|Overall Study||2030
315827|NCT00706121|761943|P2|STARTED|Overall Study||2096
315828|NCT00706121|761944|P1|STARTED|Overall Study||2039
315829|NCT00706095|761973|P3|NOT COMPLETED|Overall Study||5
315830|NCT00706095|761974|P2|NOT COMPLETED|Overall Study||7
315831|NCT00706095|761975|P1|NOT COMPLETED|Overall Study||6
315832|NCT00706095|761973|P3|COMPLETED|Overall Study||0
315833|NCT00706095|761974|P2|COMPLETED|Overall Study||0
315834|NCT00706095|761975|P1|COMPLETED|Overall Study||0
315835|NCT00706095|761973|P3|STARTED|Overall Study||5
315836|NCT00706095|761974|P2|STARTED|Overall Study||7
315837|NCT00706095|761975|P1|STARTED|Overall Study||6
315838|NCT00706030|761993|P4|NOT COMPLETED|Overall Study||16
315839|NCT00706030|761994|P3|NOT COMPLETED|Overall Study||60
315840|NCT00706030|761995|P2|NOT COMPLETED|Overall Study||6
315841|NCT00706030|761996|P1|NOT COMPLETED|Overall Study||6
315842|NCT00706030|761993|P4|COMPLETED|Overall Study||0
315843|NCT00706030|761994|P3|COMPLETED|Overall Study||4
315844|NCT00706030|761995|P2|COMPLETED|Overall Study||0
315845|NCT00706030|761996|P1|COMPLETED|Overall Study||0
315846|NCT00706030|761993|P4|Treated|Overall Study||15
315847|NCT00706030|761994|P3|Treated|Overall Study||64
315848|NCT00706030|761995|P2|Treated|Overall Study||6
315849|NCT00706030|761996|P1|Treated|Overall Study||6
315850|NCT00706030|761993|P4|STARTED|Overall Study||16
315851|NCT00706030|761994|P3|STARTED|Overall Study||64
315852|NCT00706030|761995|P2|STARTED|Overall Study||6
315853|NCT00706030|761996|P1|STARTED|Overall Study||6
315854|NCT00706004|762011|P1|NOT COMPLETED|Overall Study||2
315855|NCT00706004|762011|P1|COMPLETED|Overall Study||7
315856|NCT00706004|762011|P1|STARTED|Overall Study||9
315857|NCT00705939|762039|P3|NOT COMPLETED|Overall Study||4
315858|NCT00705939|762040|P2|NOT COMPLETED|Overall Study||2
315859|NCT00705939|762041|P1|NOT COMPLETED|Overall Study||0
315860|NCT00705939|762039|P3|COMPLETED|Overall Study||14
315861|NCT00705939|762040|P2|COMPLETED|Overall Study||12
315862|NCT00705939|762041|P1|COMPLETED|Overall Study||12
315863|NCT00705939|762039|P3|STARTED|Overall Study|1 subject enrolled but not treated in this protocol.|18
315864|NCT00705939|762040|P2|STARTED|Overall Study||14
315865|NCT00705939|762041|P1|STARTED|Overall Study||12
315866|NCT00705874|762071|P7|NOT COMPLETED|Overall Study||0
315867|NCT00705874|762072|P6|NOT COMPLETED|Overall Study||4
315868|NCT00705874|762073|P5|NOT COMPLETED|Overall Study||12
315869|NCT00705874|762074|P4|NOT COMPLETED|Overall Study||1
315870|NCT00705874|762075|P3|NOT COMPLETED|Overall Study||2
315871|NCT00705874|762076|P2|NOT COMPLETED|Overall Study||1
315872|NCT00705874|762077|P1|NOT COMPLETED|Overall Study||2
315873|NCT00705874|762071|P7|COMPLETED|Overall Study||3
315874|NCT00705874|762072|P6|COMPLETED|Overall Study||28
315875|NCT00705874|762073|P5|COMPLETED|Overall Study||36
315876|NCT00705874|762074|P4|COMPLETED|Overall Study||33
315877|NCT00705874|762075|P3|COMPLETED|Overall Study||32
315878|NCT00705874|762076|P2|COMPLETED|Overall Study||8
315879|NCT00705874|762077|P1|COMPLETED|Overall Study||10
315880|NCT00705874|762071|P7|STARTED|Overall Study||3
315881|NCT00705874|762072|P6|STARTED|Overall Study||32
315882|NCT00705874|762073|P5|STARTED|Overall Study||48
315883|NCT00705874|762074|P4|STARTED|Overall Study||34
315884|NCT00705874|762075|P3|STARTED|Overall Study||34
315885|NCT00705874|762076|P2|STARTED|Overall Study||9
315886|NCT00705874|762077|P1|STARTED|Overall Study||12
315887|NCT00705783|762095|P3|NOT COMPLETED|Depot Maintenance Phase||131
315888|NCT00705783|762096|P2|NOT COMPLETED|Depot Maintenance Phase||246
315889|NCT00705783|762097|P1|NOT COMPLETED|Depot Maintenance Phase||0
315890|NCT00705783|762095|P3|COMPLETED|Depot Maintenance Phase||3
315891|NCT00705783|762096|P2|COMPLETED|Depot Maintenance Phase||23
315892|NCT00705783|762097|P1|COMPLETED|Depot Maintenance Phase||0
315893|NCT00705783|762095|P3|STARTED|Depot Maintenance Phase||134
315894|NCT00705783|762096|P2|STARTED|Depot Maintenance Phase||269
315895|NCT00705783|762097|P1|STARTED|Depot Maintenance Phase|Patients were randomized into the aripiprazole and placebo depot groups in this phase of the study.|0
315896|NCT00705783|762095|P3|NOT COMPLETED|Depot Stabilization Phase||0
315897|NCT00705783|762096|P2|NOT COMPLETED|Depot Stabilization Phase||0
315898|NCT00705783|762097|P1|NOT COMPLETED|Depot Stabilization Phase||173
315899|NCT00705783|762095|P3|COMPLETED|Depot Stabilization Phase||0
315900|NCT00705783|762096|P2|COMPLETED|Depot Stabilization Phase||0
315901|NCT00705783|762097|P1|COMPLETED|Depot Stabilization Phase||403
315902|NCT00705783|762095|P3|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
315903|NCT00705783|762096|P2|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
315904|NCT00705783|762097|P1|STARTED|Depot Stabilization Phase||576
315905|NCT00705783|762095|P3|NOT COMPLETED|Oral Stabilization Phase||0
315906|NCT00705783|762096|P2|NOT COMPLETED|Oral Stabilization Phase||0
315907|NCT00705783|762097|P1|NOT COMPLETED|Oral Stabilization Phase||134
315908|NCT00705783|762095|P3|COMPLETED|Oral Stabilization Phase||0
315909|NCT00705783|762096|P2|COMPLETED|Oral Stabilization Phase||0
315910|NCT00705783|762097|P1|COMPLETED|Oral Stabilization Phase||576
315911|NCT00705783|762095|P3|Received Study Medication|Oral Stabilization Phase||0
315912|NCT00705783|762096|P2|Received Study Medication|Oral Stabilization Phase||0
315913|NCT00705783|762097|P1|Received Study Medication|Oral Stabilization Phase||709
315914|NCT00705783|762095|P3|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
315915|NCT00705783|762096|P2|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
315916|NCT00705783|762097|P1|STARTED|Oral Stabilization Phase|210 of the 710 patients who started this phase enrolled in this study directly into this phase.|710
315917|NCT00705783|762095|P3|NOT COMPLETED|Conversion Phase||0
315918|NCT00705783|762096|P2|NOT COMPLETED|Conversion Phase||0
315919|NCT00705783|762097|P1|NOT COMPLETED|Conversion Phase||133
315920|NCT00705783|762095|P3|COMPLETED|Conversion Phase||0
315921|NCT00705783|762096|P2|COMPLETED|Conversion Phase||0
315922|NCT00705783|762097|P1|COMPLETED|Conversion Phase||500
315923|NCT00705783|762095|P3|Received Study Medication|Conversion Phase||0
315924|NCT00705783|762096|P2|Received Study Medication|Conversion Phase||0
315925|NCT00705783|762097|P1|Received Study Medication|Conversion Phase||632
315926|NCT00705783|762095|P3|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
315927|NCT00705783|762096|P2|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
315928|NCT00705783|762097|P1|STARTED|Conversion Phase||633
315929|NCT00705757|762127|P3|NOT COMPLETED|Overall Study||11
315930|NCT00705757|762128|P2|NOT COMPLETED|Overall Study||8
315931|NCT00705757|762129|P1|NOT COMPLETED|Overall Study||13
315932|NCT00705757|762127|P3|COMPLETED|Overall Study||17
315933|NCT00705757|762128|P2|COMPLETED|Overall Study||21
315934|NCT00705757|762129|P1|COMPLETED|Overall Study||19
315935|NCT00705757|762127|P3|STARTED|Overall Study||28
315936|NCT00705757|762128|P2|STARTED|Overall Study||29
315937|NCT00705757|762129|P1|STARTED|Overall Study||32
315938|NCT00705718|762139|P2|NOT COMPLETED|Overall Study||22
315939|NCT00705718|762140|P1|NOT COMPLETED|Overall Study||7
315940|NCT00705718|762139|P2|COMPLETED|Overall Study||128
315941|NCT00705718|762140|P1|COMPLETED|Overall Study||37
315942|NCT00705718|762139|P2|12 Month Follow up|Overall Study|4 Deaths, 12 Subjects Not due for next visit, 4 Subjects Missed Visit|128
315943|NCT00705718|762140|P1|12 Month Follow up|Overall Study|2 Deaths|37
315944|NCT00705718|762139|P2|6 Month Follow up|Overall Study|2 Deaths, 5 Subjects Missed Visit|143
315945|NCT00705718|762140|P1|6 Month Follow up|Overall Study|3 Deaths|40
315946|NCT00705718|762139|P2|1 Month Follow up|Overall Study|1 Subject Missed Visit|149
315947|NCT00705718|762140|P1|1 Month Follow up|Overall Study|1 Death|43
315948|NCT00705718|762139|P2|STARTED|Overall Study||150
315949|NCT00705718|762140|P1|STARTED|Overall Study||44
315950|NCT00705679|762161|P5|NOT COMPLETED|Overall Study||69
315951|NCT00705679|762162|P4|NOT COMPLETED|Overall Study||80
315952|NCT00705679|762163|P3|NOT COMPLETED|Overall Study||115
315953|NCT00705679|762164|P2|NOT COMPLETED|Overall Study||139
315954|NCT00705679|762165|P1|NOT COMPLETED|Overall Study||65
315955|NCT00705679|762161|P5|COMPLETED|Overall Study||934
315956|NCT00705679|762162|P4|COMPLETED|Overall Study||927
315957|NCT00705679|762163|P3|COMPLETED|Overall Study||894
315958|NCT00705679|762164|P2|COMPLETED|Overall Study||864
315959|NCT00705679|762165|P1|COMPLETED|Overall Study||942
315960|NCT00705679|762161|P5|STARTED|Overall Study||1003
315961|NCT00705679|762162|P4|STARTED|Overall Study||1007
315962|NCT00705679|762163|P3|STARTED|Overall Study||1009
315963|NCT00705679|762164|P2|STARTED|Overall Study||1003
315964|NCT00705679|762165|P1|STARTED|Overall Study||1007
315965|NCT00705666|762200|P1|NOT COMPLETED|Overall Study||339
315966|NCT00705666|762200|P1|COMPLETED|Overall Study||450
315967|NCT00705666|762200|P1|STARTED|Overall Study||789
315968|NCT00705653|762204|P1|NOT COMPLETED|Overall Study||0
315969|NCT00705653|762204|P1|COMPLETED|Overall Study||46
315970|NCT00705653|762204|P1|STARTED|Overall Study||46
315971|NCT00705614|762211|P2|NOT COMPLETED|Switch to Remicade||49
315972|NCT00705614|762212|P1|NOT COMPLETED|Switch to Remicade||0
315973|NCT00705614|762211|P2|COMPLETED|Switch to Remicade||249
315974|NCT00705614|762212|P1|COMPLETED|Switch to Remicade||0
315975|NCT00705614|762211|P2|STARTED|Switch to Remicade||298
315976|NCT00705614|762212|P1|STARTED|Switch to Remicade||0
315977|NCT00705614|762211|P2|NOT COMPLETED|Initial Intervention||321
315978|NCT00705614|762212|P1|NOT COMPLETED|Initial Intervention||518
315979|NCT00705614|762211|P2|COMPLETED|Initial Intervention||800
315980|NCT00705614|762212|P1|COMPLETED|Initial Intervention||1023
315981|NCT00705614|762211|P2|STARTED|Initial Intervention||1121
315982|NCT00705614|762212|P1|STARTED|Initial Intervention||1541
315983|NCT00705575|762261|P2|NOT COMPLETED|Overall Study||46
315984|NCT00705575|762262|P1|NOT COMPLETED|Overall Study||23
315985|NCT00705575|762261|P2|COMPLETED|Overall Study||293
315986|NCT00705575|762262|P1|COMPLETED|Overall Study||326
315987|NCT00705575|762261|P2|STARTED|Overall Study||339
315988|NCT00705575|762262|P1|STARTED|Overall Study||349
315989|NCT00705536|762276|P4|NOT COMPLETED|Completed Study||0
315990|NCT00705536|762277|P3|NOT COMPLETED|Completed Study||0
315991|NCT00705536|762278|P2|NOT COMPLETED|Completed Study||0
315992|NCT00705536|762279|P1|NOT COMPLETED|Completed Study||0
315993|NCT00705536|762276|P4|COMPLETED|Completed Study||6
315994|NCT00705536|762277|P3|COMPLETED|Completed Study||7
315995|NCT00705536|762278|P2|COMPLETED|Completed Study||6
315996|NCT00705536|762279|P1|COMPLETED|Completed Study||6
315997|NCT00705536|762276|P4|STARTED|Completed Study||6
315998|NCT00705536|762277|P3|STARTED|Completed Study||7
315999|NCT00705536|762278|P2|STARTED|Completed Study||6
316000|NCT00705536|762279|P1|STARTED|Completed Study||6
316001|NCT00705536|762276|P4|NOT COMPLETED|Start Period 2||0
316002|NCT00705536|762277|P3|NOT COMPLETED|Start Period 2||0
316003|NCT00705536|762278|P2|NOT COMPLETED|Start Period 2||0
316004|NCT00705536|762279|P1|NOT COMPLETED|Start Period 2||0
316005|NCT00705536|762276|P4|COMPLETED|Start Period 2||6
316006|NCT00705536|762277|P3|COMPLETED|Start Period 2||7
316007|NCT00705536|762278|P2|COMPLETED|Start Period 2||6
316008|NCT00705536|762279|P1|COMPLETED|Start Period 2||6
316009|NCT00705536|762276|P4|STARTED|Start Period 2||6
316010|NCT00705536|762277|P3|STARTED|Start Period 2||7
316011|NCT00705536|762278|P2|STARTED|Start Period 2||6
316012|NCT00705536|762279|P1|STARTED|Start Period 2||6
316013|NCT00705536|762276|P4|NOT COMPLETED|Washout Period of at Least 6 Days||0
316014|NCT00705536|762277|P3|NOT COMPLETED|Washout Period of at Least 6 Days||0
316015|NCT00705536|762278|P2|NOT COMPLETED|Washout Period of at Least 6 Days||0
316016|NCT00705536|762279|P1|NOT COMPLETED|Washout Period of at Least 6 Days||0
316017|NCT00705536|762276|P4|COMPLETED|Washout Period of at Least 6 Days||6
316018|NCT00705536|762277|P3|COMPLETED|Washout Period of at Least 6 Days||7
316019|NCT00705536|762278|P2|COMPLETED|Washout Period of at Least 6 Days||6
316020|NCT00705536|762279|P1|COMPLETED|Washout Period of at Least 6 Days||6
316021|NCT00705536|762276|P4|STARTED|Washout Period of at Least 6 Days||6
316022|NCT00705536|762277|P3|STARTED|Washout Period of at Least 6 Days||7
316023|NCT00705536|762278|P2|STARTED|Washout Period of at Least 6 Days||6
316024|NCT00705536|762279|P1|STARTED|Washout Period of at Least 6 Days||6
316025|NCT00705536|762276|P4|NOT COMPLETED|Start Period 1||1
316026|NCT00705536|762277|P3|NOT COMPLETED|Start Period 1||0
316027|NCT00705536|762278|P2|NOT COMPLETED|Start Period 1||0
316028|NCT00705536|762279|P1|NOT COMPLETED|Start Period 1||0
316029|NCT00705536|762276|P4|COMPLETED|Start Period 1||6
316030|NCT00705536|762277|P3|COMPLETED|Start Period 1||7
316031|NCT00705536|762278|P2|COMPLETED|Start Period 1||6
316032|NCT00705536|762279|P1|COMPLETED|Start Period 1||6
316033|NCT00705536|762276|P4|Received at Least 1 Dose of Study Drug|Start Period 1||7
316034|NCT00705536|762277|P3|Received at Least 1 Dose of Study Drug|Start Period 1||7
316035|NCT00705536|762278|P2|Received at Least 1 Dose of Study Drug|Start Period 1||6
316036|NCT00705536|762279|P1|Received at Least 1 Dose of Study Drug|Start Period 1||6
316037|NCT00705536|762276|P4|STARTED|Start Period 1||7
316038|NCT00705536|762277|P3|STARTED|Start Period 1||7
316039|NCT00705536|762278|P2|STARTED|Start Period 1||6
316040|NCT00705536|762279|P1|STARTED|Start Period 1||6
316041|NCT00705523|762340|P2|NOT COMPLETED|Overall Study||3
316042|NCT00705523|762341|P1|NOT COMPLETED|Overall Study||2
316043|NCT00705523|762340|P2|COMPLETED|Overall Study||18
316044|NCT00705523|762341|P1|COMPLETED|Overall Study||17
316045|NCT00705523|762340|P2|STARTED|Overall Study||21
316046|NCT00705523|762341|P1|STARTED|Overall Study||19
316047|NCT00705484|762351|P2|NOT COMPLETED|Overall Study||408
316048|NCT00705484|762352|P1|NOT COMPLETED|Overall Study||382
316049|NCT00705484|762351|P2|COMPLETED|Overall Study||772
316050|NCT00705484|762352|P1|COMPLETED|Overall Study||677
316051|NCT00705484|762351|P2|Follow-up Period|Overall Study|Switched From Standard Therapy to Remicade|296
316052|NCT00705484|762352|P1|Follow-up Period|Overall Study||1059
316053|NCT00705484|762351|P2|STARTED|Overall Study|Number Enrolled|1180
316054|NCT00705484|762352|P1|STARTED|Overall Study|Number Enrolled|1059
316055|NCT00705432|762366|P6|NOT COMPLETED|Follow-up Period (Upto Week 72)||7
316056|NCT00705432|762367|P5|NOT COMPLETED|Follow-up Period (Upto Week 72)||6
316057|NCT00705432|762368|P4|NOT COMPLETED|Follow-up Period (Upto Week 72)||14
316058|NCT00705432|762369|P3|NOT COMPLETED|Follow-up Period (Upto Week 72)||25
316059|NCT00705432|762370|P2|NOT COMPLETED|Follow-up Period (Upto Week 72)||43
316060|NCT00705432|762371|P1|NOT COMPLETED|Follow-up Period (Upto Week 72)||71
316061|NCT00705432|762366|P6|COMPLETED|Follow-up Period (Upto Week 72)||46
316062|NCT00705432|762367|P5|COMPLETED|Follow-up Period (Upto Week 72)||38
316063|NCT00705432|762368|P4|COMPLETED|Follow-up Period (Upto Week 72)||28
316064|NCT00705432|762369|P3|COMPLETED|Follow-up Period (Upto Week 72)||266
316065|NCT00705432|762370|P2|COMPLETED|Follow-up Period (Upto Week 72)||252
316066|NCT00705432|762371|P1|COMPLETED|Follow-up Period (Upto Week 72)||207
316067|NCT00705432|762366|P6|STARTED|Follow-up Period (Upto Week 72)||53
316068|NCT00705432|762367|P5|STARTED|Follow-up Period (Upto Week 72)||44
316069|NCT00705432|762368|P4|STARTED|Follow-up Period (Upto Week 72)||42
316070|NCT00705432|762369|P3|STARTED|Follow-up Period (Upto Week 72)||291
316071|NCT00705432|762370|P2|STARTED|Follow-up Period (Upto Week 72)||295
316072|NCT00705432|762371|P1|STARTED|Follow-up Period (Upto Week 72)||278
316073|NCT00705432|762366|P6|NOT COMPLETED|Treatment Period||30
316074|NCT00705432|762367|P5|NOT COMPLETED|Treatment Period||28
316075|NCT00705432|762368|P4|NOT COMPLETED|Treatment Period||41
316076|NCT00705432|762369|P3|NOT COMPLETED|Treatment Period||121
316077|NCT00705432|762370|P2|NOT COMPLETED|Treatment Period||111
316078|NCT00705432|762371|P1|NOT COMPLETED|Treatment Period||163
316079|NCT00705432|762366|P6|COMPLETED|Treatment Period||25
316080|NCT00705432|762367|P5|COMPLETED|Treatment Period||24
316081|NCT00705432|762368|P4|COMPLETED|Treatment Period||11
316082|NCT00705432|762369|P3|COMPLETED|Treatment Period||190
316083|NCT00705432|762370|P2|COMPLETED|Treatment Period||205
316084|NCT00705432|762371|P1|COMPLETED|Treatment Period||148
316085|NCT00705432|762366|P6|STARTED BOCEPREVIR/PLACEBO|Treatment Period||55
316086|NCT00705432|762367|P5|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
316087|NCT00705432|762368|P4|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
316088|NCT00705432|762369|P3|STARTED BOCEPREVIR/PLACEBO|Treatment Period||299
316089|NCT00705432|762370|P2|STARTED BOCEPREVIR/PLACEBO|Treatment Period||303
316090|NCT00705432|762371|P1|STARTED BOCEPREVIR/PLACEBO|Treatment Period||297
316091|NCT00705432|762366|P6|STARTED|Treatment Period||55
316092|NCT00705432|762367|P5|STARTED|Treatment Period||52
316093|NCT00705432|762368|P4|STARTED|Treatment Period||52
316094|NCT00705432|762369|P3|STARTED|Treatment Period||311
316095|NCT00705432|762370|P2|STARTED|Treatment Period||316
316096|NCT00705432|762371|P1|STARTED|Treatment Period||311
316097|NCT00705406|762408|P2|NOT COMPLETED|Overall Study||5
316098|NCT00705406|762409|P1|NOT COMPLETED|Overall Study||4
316099|NCT00705406|762408|P2|COMPLETED|Overall Study||197
316100|NCT00705406|762409|P1|COMPLETED|Overall Study||199
316101|NCT00705406|762408|P2|STARTED|Overall Study||202
316102|NCT00705406|762409|P1|STARTED|Overall Study||203
316103|NCT00705367|762433|P2|NOT COMPLETED|Long-term Extension Period||0
316104|NCT00705367|762434|P1|NOT COMPLETED|Long-term Extension Period||9
316105|NCT00705367|762433|P2|COMPLETED|Long-term Extension Period||0
316106|NCT00705367|762434|P1|COMPLETED|Long-term Extension Period||0
316107|NCT00705367|762433|P2|STARTED|Long-term Extension Period||0
316108|NCT00705367|762434|P1|STARTED|Long-term Extension Period||9
316109|NCT00705367|762433|P2|NOT COMPLETED|Short-term Period||0
316110|NCT00705367|762434|P1|NOT COMPLETED|Short-term Period||0
316111|NCT00705367|762433|P2|COMPLETED|Short-term Period||3
316112|NCT00705367|762434|P1|COMPLETED|Short-term Period||6
316113|NCT00705367|762433|P2|STARTED|Short-term Period||3
316114|NCT00705367|762434|P1|STARTED|Short-term Period||6
316115|NCT00705341|762461|P4|NOT COMPLETED|Phase 2: Trial||4
316116|NCT00705341|762462|P3|NOT COMPLETED|Phase 2: Trial||7
316117|NCT00705341|762463|P2|NOT COMPLETED|Phase 2: Trial||0
316118|NCT00705341|762464|P1|NOT COMPLETED|Phase 2: Trial||0
316119|NCT00705341|762461|P4|COMPLETED|Phase 2: Trial||28
316120|NCT00705341|762462|P3|COMPLETED|Phase 2: Trial||23
316121|NCT00705341|762463|P2|COMPLETED|Phase 2: Trial||0
316122|NCT00705341|762464|P1|COMPLETED|Phase 2: Trial||0
316123|NCT00705341|762461|P4|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|32
316124|NCT00705341|762462|P3|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|30
316125|NCT00705341|762463|P2|STARTED|Phase 2: Trial||0
316126|NCT00705341|762464|P1|STARTED|Phase 2: Trial||0
316127|NCT00705341|762461|P4|NOT COMPLETED|Phase 1:Control Challenge||0
316128|NCT00705341|762462|P3|NOT COMPLETED|Phase 1:Control Challenge||0
316129|NCT00705341|762463|P2|NOT COMPLETED|Phase 1:Control Challenge||0
316130|NCT00705341|762464|P1|NOT COMPLETED|Phase 1:Control Challenge||0
316131|NCT00705341|762461|P4|COMPLETED|Phase 1:Control Challenge||0
316132|NCT00705341|762462|P3|COMPLETED|Phase 1:Control Challenge||0
316133|NCT00705341|762463|P2|COMPLETED|Phase 1:Control Challenge|Nonasthmatic controls did not advance to phase 2 due to design of study|93
316134|NCT00705341|762464|P1|COMPLETED|Phase 1:Control Challenge|If participants in this group met criteria, they were randomized into phase 2|126
316135|NCT00705341|762461|P4|STARTED|Phase 1:Control Challenge||0
316136|NCT00705341|762462|P3|STARTED|Phase 1:Control Challenge||0
316137|NCT00705341|762463|P2|STARTED|Phase 1:Control Challenge||93
316138|NCT00705341|762464|P1|STARTED|Phase 1:Control Challenge||126
316139|NCT00705289|762472|P1|NOT COMPLETED|Overall Study||131
316140|NCT00705289|762472|P1|COMPLETED|Overall Study||597
316141|NCT00705289|762472|P1|STARTED|Overall Study||728
316142|NCT00705263|762496|P1|NOT COMPLETED|Overall Study||2
316143|NCT00705263|762496|P1|COMPLETED|Overall Study||108
316144|NCT00705263|762496|P1|STARTED|Overall Study|113 patients started the treatment; however, data were available for only 110 patients.|110
316145|NCT00705250|762500|P1|NOT COMPLETED|Overall Study||2
316146|NCT00705250|762500|P1|COMPLETED|Overall Study||34
316147|NCT00705250|762500|P1|STARTED|Overall Study||36
316148|NCT00705224|762504|P1|NOT COMPLETED|Overall Study||11
316149|NCT00705224|762504|P1|COMPLETED|Overall Study||239
316150|NCT00705224|762504|P1|STARTED|Overall Study||250
316151|NCT00705159|762520|P4|NOT COMPLETED|Overall Study||4
316152|NCT00705159|762521|P3|NOT COMPLETED|Overall Study||5
316153|NCT00705159|762522|P2|NOT COMPLETED|Overall Study||2
316154|NCT00705159|762523|P1|NOT COMPLETED|Overall Study||0
316155|NCT00705159|762520|P4|COMPLETED|Overall Study||30
316156|NCT00705159|762521|P3|COMPLETED|Overall Study||29
316157|NCT00705159|762522|P2|COMPLETED|Overall Study||33
316158|NCT00705159|762523|P1|COMPLETED|Overall Study||34
316159|NCT00705159|762520|P4|STARTED|Overall Study||34
316160|NCT00705159|762521|P3|STARTED|Overall Study||34
316161|NCT00705159|762522|P2|STARTED|Overall Study||35
316162|NCT00705159|762523|P1|STARTED|Overall Study||34
316163|NCT00705146|762543|P2|NOT COMPLETED|Overall Study||1
316164|NCT00705146|762544|P1|NOT COMPLETED|Overall Study||1
316165|NCT00705146|762543|P2|COMPLETED|Overall Study||23
316166|NCT00705146|762544|P1|COMPLETED|Overall Study||31
316167|NCT00705146|762543|P2|STARTED|Overall Study||24
316168|NCT00705146|762544|P1|STARTED|Overall Study||32
316169|NCT00705107|762552|P1|NOT COMPLETED|Overall Study||49
316170|NCT00705107|762552|P1|COMPLETED|Overall Study||218
316171|NCT00705107|762552|P1|STARTED|Overall Study||267
316172|NCT00705081|762559|P2|NOT COMPLETED|Overall Study||0
316173|NCT00705081|762560|P1|NOT COMPLETED|Overall Study||0
316174|NCT00705081|762559|P2|COMPLETED|Overall Study||198
316175|NCT00705081|762560|P1|COMPLETED|Overall Study||255
316176|NCT00705081|762559|P2|STARTED|Overall Study||198
316177|NCT00705081|762560|P1|STARTED|Overall Study||255
316178|NCT00705016|762573|P3|NOT COMPLETED|Overall Study||58
316179|NCT00705016|762574|P2|NOT COMPLETED|Overall Study||58
316180|NCT00705016|762575|P1|NOT COMPLETED|Overall Study||60
316181|NCT00705016|762573|P3|COMPLETED|Overall Study||4
316182|NCT00705016|762574|P2|COMPLETED|Overall Study||2
316183|NCT00705016|762575|P1|COMPLETED|Overall Study||2
316184|NCT00705016|762573|P3|STARTED|Overall Study||62
316185|NCT00705016|762574|P2|STARTED|Overall Study||60
316186|NCT00705016|762575|P1|STARTED|Overall Study||62
316187|NCT00705003|762604|P3|NOT COMPLETED|Treated||3
316188|NCT00705003|762605|P2|NOT COMPLETED|Treated||6
316189|NCT00705003|762606|P1|NOT COMPLETED|Treated||13
316190|NCT00705003|762604|P3|COMPLETED|Treated||30
316191|NCT00705003|762605|P2|COMPLETED|Treated||28
316192|NCT00705003|762606|P1|COMPLETED|Treated||54
316193|NCT00705003|762604|P3|STARTED|Treated||33
316194|NCT00705003|762605|P2|STARTED|Treated||34
316195|NCT00705003|762606|P1|STARTED|Treated||67
316196|NCT00705003|762604|P3|NOT COMPLETED|Enrolled||1
316197|NCT00705003|762605|P2|NOT COMPLETED|Enrolled||3
316198|NCT00705003|762606|P1|NOT COMPLETED|Enrolled||4
316199|NCT00705003|762604|P3|COMPLETED|Enrolled||33
316200|NCT00705003|762605|P2|COMPLETED|Enrolled||34
316201|NCT00705003|762606|P1|COMPLETED|Enrolled||67
316202|NCT00705003|762604|P3|STARTED|Enrolled||34
316203|NCT00705003|762605|P2|STARTED|Enrolled||37
316204|NCT00705003|762606|P1|STARTED|Enrolled||71
316205|NCT00704964|762626|P1|NOT COMPLETED|Overall Study||328
316206|NCT00704964|762626|P1|COMPLETED|Overall Study|Number of participants who completed therapy as scheduled.|418
316207|NCT00704964|762626|P1|STARTED|Overall Study|Number of participants who took at least one dose of study medication.|746
316208|NCT00704938|762633|P2|NOT COMPLETED|Overall Study||0
316209|NCT00704938|762634|P1|NOT COMPLETED|Overall Study||0
316210|NCT00704938|762633|P2|COMPLETED|Overall Study||1
316211|NCT00704938|762634|P1|COMPLETED|Overall Study||2
316212|NCT00704938|762633|P2|STARTED|Overall Study||1
316213|NCT00704938|762634|P1|STARTED|Overall Study||2
316214|NCT00704912|762645|P3|NOT COMPLETED|Overall Study||7
316215|NCT00704912|762646|P2|NOT COMPLETED|Overall Study||4
316216|NCT00704912|762647|P1|NOT COMPLETED|Overall Study||6
316217|NCT00704912|762645|P3|COMPLETED|Overall Study||43
316218|NCT00704912|762646|P2|COMPLETED|Overall Study||45
316219|NCT00704912|762647|P1|COMPLETED|Overall Study||44
316220|NCT00704912|762645|P3|STARTED|Overall Study||50
316221|NCT00704912|762646|P2|STARTED|Overall Study||49
316222|NCT00704912|762647|P1|STARTED|Overall Study||50
316223|NCT00704847|762666|P2|NOT COMPLETED|Overall Study||170
316224|NCT00704847|762667|P1|NOT COMPLETED|Overall Study||221
316225|NCT00704847|762666|P2|COMPLETED|Overall Study||339
316226|NCT00704847|762667|P1|COMPLETED|Overall Study||300
316227|NCT00704847|762666|P2|STARTED|Overall Study||509
316228|NCT00704847|762667|P1|STARTED|Overall Study||521
316229|NCT00704808|762687|P1|NOT COMPLETED|Overall Study||131
316230|NCT00704808|762687|P1|COMPLETED|Overall Study||49
316231|NCT00704808|762687|P1|STARTED|Overall Study||180
316232|NCT00704769|762691|P1|NOT COMPLETED|Overall Study||0
316233|NCT00704769|762691|P1|COMPLETED|Overall Study||591
316234|NCT00704769|762691|P1|STARTED|Overall Study||591
316235|NCT00704730|762698|P2|NOT COMPLETED|Overall Study||96
316236|NCT00704730|762699|P1|NOT COMPLETED|Overall Study||121
316237|NCT00704730|762698|P2|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|15
316238|NCT00704730|762699|P1|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|98
316239|NCT00704730|762698|P2|STARTED|Overall Study|Randomized|111
316240|NCT00704730|762699|P1|STARTED|Overall Study|Randomized|219
316241|NCT00704717|762715|P1|NOT COMPLETED|Overall Study||0
316242|NCT00704717|762715|P1|COMPLETED|Overall Study||185
316243|NCT00704717|762715|P1|STARTED|Overall Study||185
316244|NCT00704535|762719|P1|NOT COMPLETED|Overall Study||146
316245|NCT00704535|762719|P1|COMPLETED|Overall Study||3959
316246|NCT00704535|762719|P1|STARTED|Overall Study||4105
316247|NCT00704522|762732|P2|NOT COMPLETED|Overall Study||45
316248|NCT00704522|762733|P1|NOT COMPLETED|Overall Study||183
316249|NCT00704522|762732|P2|COMPLETED|Overall Study||75
316250|NCT00704522|762733|P1|COMPLETED|Overall Study||298
316251|NCT00704522|762732|P2|STARTED|Overall Study||120
316252|NCT00704522|762733|P1|STARTED|Overall Study||481
316253|NCT00704496|762742|P2|NOT COMPLETED|Overall Study||0
316254|NCT00704496|762743|P1|NOT COMPLETED|Overall Study||0
316255|NCT00704496|762742|P2|COMPLETED|Overall Study||0
316256|NCT00704496|762743|P1|COMPLETED|Overall Study||0
316257|NCT00704496|762742|P2|STARTED|Overall Study||0
316258|NCT00704496|762743|P1|STARTED|Overall Study||0
316259|NCT00704418|762753|P2|NOT COMPLETED|Overall Study||6
316260|NCT00704418|762754|P1|NOT COMPLETED|Overall Study||5
316261|NCT00704418|762753|P2|COMPLETED|Overall Study||72
316262|NCT00704418|762754|P1|COMPLETED|Overall Study||73
316263|NCT00704418|762753|P2|STARTED|Overall Study||78
316264|NCT00704418|762754|P1|STARTED|Overall Study||78
316265|NCT00704405|762767|P5|NOT COMPLETED|Overall Study (C Population)||0
316266|NCT00704405|762768|P4|NOT COMPLETED|Overall Study (C Population)||1
316267|NCT00704405|762769|P3|NOT COMPLETED|Overall Study (C Population)||1
316268|NCT00704405|762770|P2|NOT COMPLETED|Overall Study (C Population)||3
316269|NCT00704405|762771|P1|NOT COMPLETED|Overall Study (C Population)||1
316270|NCT00704405|762767|P5|COMPLETED|Overall Study (C Population)||14
316271|NCT00704405|762768|P4|COMPLETED|Overall Study (C Population)||14
316272|NCT00704405|762769|P3|COMPLETED|Overall Study (C Population)||14
316273|NCT00704405|762770|P2|COMPLETED|Overall Study (C Population)||11
316274|NCT00704405|762771|P1|COMPLETED|Overall Study (C Population)||15
316275|NCT00704405|762767|P5|STARTED|Overall Study (C Population)||14
316276|NCT00704405|762768|P4|STARTED|Overall Study (C Population)||15
316277|NCT00704405|762769|P3|STARTED|Overall Study (C Population)||15
316278|NCT00704405|762770|P2|STARTED|Overall Study (C Population)||14
316279|NCT00704405|762771|P1|STARTED|Overall Study (C Population)||16
316280|NCT00704405|762767|P5|NOT COMPLETED|Overall Study (NC Population)||5
316281|NCT00704405|762768|P4|NOT COMPLETED|Overall Study (NC Population)||4
316282|NCT00704405|762769|P3|NOT COMPLETED|Overall Study (NC Population)||3
316283|NCT00704405|762770|P2|NOT COMPLETED|Overall Study (NC Population)||4
316284|NCT00704405|762771|P1|NOT COMPLETED|Overall Study (NC Population)||5
316285|NCT00704405|762767|P5|COMPLETED|Overall Study (NC Population)||37
316286|NCT00704405|762768|P4|COMPLETED|Overall Study (NC Population)||38
316287|NCT00704405|762769|P3|COMPLETED|Overall Study (NC Population)||38
316288|NCT00704405|762770|P2|COMPLETED|Overall Study (NC Population)||40
316289|NCT00704405|762771|P1|COMPLETED|Overall Study (NC Population)||37
316290|NCT00704405|762767|P5|STARTED|Overall Study (NC Population)||42
316291|NCT00704405|762768|P4|STARTED|Overall Study (NC Population)||42
316292|NCT00704405|762769|P3|STARTED|Overall Study (NC Population)||41
316293|NCT00704405|762770|P2|STARTED|Overall Study (NC Population)||44
316294|NCT00704405|762771|P1|STARTED|Overall Study (NC Population)||42
316295|NCT00704379|762801|P2|NOT COMPLETED|Overall Study||7
316296|NCT00704379|762802|P1|NOT COMPLETED|Overall Study||7
316297|NCT00704379|762801|P2|COMPLETED|Overall Study||41
316298|NCT00704379|762802|P1|COMPLETED|Overall Study||39
316299|NCT00704379|762801|P2|STARTED|Overall Study||48
316300|NCT00704379|762802|P1|STARTED|Overall Study||46
316301|NCT00704353|762820|P2|NOT COMPLETED|Overall Study||114
316302|NCT00704353|762821|P1|NOT COMPLETED|Overall Study||98
316303|NCT00704353|762820|P2|COMPLETED|Overall Study||255
316304|NCT00704353|762821|P1|COMPLETED|Overall Study||268
316305|NCT00704353|762820|P2|STARTED|Overall Study||369
316306|NCT00704353|762821|P1|STARTED|Overall Study||366
316307|NCT00704340|762829|P2|NOT COMPLETED|Overall Study||2
316308|NCT00704340|762830|P1|NOT COMPLETED|Overall Study||2
316309|NCT00704340|762829|P2|COMPLETED|Overall Study||115
316310|NCT00704340|762830|P1|COMPLETED|Overall Study||118
316311|NCT00704340|762829|P2|STARTED|Overall Study||117
316312|NCT00704340|762830|P1|STARTED|Overall Study||120
316313|NCT00704184|762845|P5|NOT COMPLETED|Open-Label Treatment||3
316314|NCT00704184|762846|P4|NOT COMPLETED|Open-Label Treatment||5
316315|NCT00704184|762847|P3|NOT COMPLETED|Open-Label Treatment||4
316316|NCT00704184|762848|P2|NOT COMPLETED|Open-Label Treatment||2
316317|NCT00704184|762849|P1|NOT COMPLETED|Open-Label Treatment||1
316318|NCT00704184|762845|P5|COMPLETED|Open-Label Treatment||16
316319|NCT00704184|762846|P4|COMPLETED|Open-Label Treatment||13
316320|NCT00704184|762847|P3|COMPLETED|Open-Label Treatment||16
316321|NCT00704184|762848|P2|COMPLETED|Open-Label Treatment||16
316322|NCT00704184|762849|P1|COMPLETED|Open-Label Treatment||18
316323|NCT00704184|762845|P5|STARTED|Open-Label Treatment||19
316324|NCT00704184|762846|P4|STARTED|Open-Label Treatment||18
316325|NCT00704184|762847|P3|STARTED|Open-Label Treatment||20
316326|NCT00704184|762848|P2|STARTED|Open-Label Treatment||18
316327|NCT00704184|762849|P1|STARTED|Open-Label Treatment||19
316328|NCT00704184|762845|P5|NOT COMPLETED|Double-Blind Treatment||0
316329|NCT00704184|762846|P4|NOT COMPLETED|Double-Blind Treatment||0
316330|NCT00704184|762847|P3|NOT COMPLETED|Double-Blind Treatment||0
316331|NCT00704184|762848|P2|NOT COMPLETED|Double-Blind Treatment||0
316332|NCT00704184|762849|P1|NOT COMPLETED|Double-Blind Treatment||1
316333|NCT00704184|762845|P5|COMPLETED|Double-Blind Treatment||19
316334|NCT00704184|762846|P4|COMPLETED|Double-Blind Treatment||18
316335|NCT00704184|762847|P3|COMPLETED|Double-Blind Treatment||20
316336|NCT00704184|762848|P2|COMPLETED|Double-Blind Treatment||18
316337|NCT00704184|762849|P1|COMPLETED|Double-Blind Treatment||19
316338|NCT00704184|762845|P5|Treated|Double-Blind Treatment||19
316339|NCT00704184|762846|P4|Treated|Double-Blind Treatment||18
316340|NCT00704184|762847|P3|Treated|Double-Blind Treatment||20
316341|NCT00704184|762848|P2|Treated|Double-Blind Treatment||18
316342|NCT00704184|762849|P1|Treated|Double-Blind Treatment|One participant was randomized to placebo but withdrew prior to receiving study medication.|19
316343|NCT00704184|762845|P5|STARTED|Double-Blind Treatment||19
316344|NCT00704184|762846|P4|STARTED|Double-Blind Treatment||18
316345|NCT00704184|762847|P3|STARTED|Double-Blind Treatment||20
316346|NCT00704184|762848|P2|STARTED|Double-Blind Treatment||18
316347|NCT00704184|762849|P1|STARTED|Double-Blind Treatment||20
316348|NCT00704171|762888|P2|NOT COMPLETED|Overall Study||0
316349|NCT00704171|762889|P1|NOT COMPLETED|Overall Study||1
316350|NCT00704171|762888|P2|COMPLETED|Overall Study|All control subjects completed the study.|59
316351|NCT00704171|762889|P1|COMPLETED|Overall Study|One subject withdrew consent prior to study completion. No reason given.|61
316352|NCT00704171|762888|P2|STARTED|Overall Study||59
316353|NCT00704171|762889|P1|STARTED|Overall Study||62
316354|NCT00704132|762907|P2|NOT COMPLETED|Overall Study||2
316355|NCT00704132|762908|P1|NOT COMPLETED|Overall Study||1
316356|NCT00704132|762907|P2|COMPLETED|Overall Study||22
316357|NCT00704132|762908|P1|COMPLETED|Overall Study||25
316358|NCT00704132|762907|P2|STARTED|Overall Study||24
316359|NCT00704132|762908|P1|STARTED|Overall Study||26
316360|NCT00704028|762916|P2|NOT COMPLETED|Overall Study||21
316361|NCT00704028|762917|P1|NOT COMPLETED|Overall Study||12
316362|NCT00704028|762916|P2|COMPLETED|Overall Study||57
316363|NCT00704028|762917|P1|COMPLETED|Overall Study||70
316364|NCT00704028|762916|P2|STARTED|Overall Study|A subject randomized to iron dextran never received study drug and was d/c due to subject request.|78
316365|NCT00704028|762917|P1|STARTED|Overall Study||82
316366|NCT00703976|762925|P2|NOT COMPLETED|Overall Study||0
316367|NCT00703976|762926|P1|NOT COMPLETED|Overall Study||0
316368|NCT00703976|762925|P2|COMPLETED|Overall Study||41
316369|NCT00703976|762926|P1|COMPLETED|Overall Study||37
316370|NCT00703976|762925|P2|STARTED|Overall Study||41
316371|NCT00703976|762926|P1|STARTED|Overall Study||37
316372|NCT00703963|762936|P2|NOT COMPLETED|Overall Study||14
316373|NCT00703963|762937|P1|NOT COMPLETED|Overall Study||7
316374|NCT00703963|762936|P2|COMPLETED|Overall Study||86
316375|NCT00703963|762937|P1|COMPLETED|Overall Study||93
316376|NCT00703963|762936|P2|STARTED|Overall Study||100
316377|NCT00703963|762937|P1|STARTED|Overall Study||100
316378|NCT00703937|762949|P2|NOT COMPLETED|Overall Study||93
316379|NCT00703937|762950|P1|NOT COMPLETED|Overall Study||65
316380|NCT00703937|762949|P2|COMPLETED|Overall Study||267
316381|NCT00703937|762950|P1|COMPLETED|Overall Study||278
316382|NCT00703937|762949|P2|STARTED|Overall Study||360
316383|NCT00703937|762950|P1|STARTED|Overall Study||343
316384|NCT00703924|762958|P2|NOT COMPLETED|Overall Study||1
316385|NCT00703924|762959|P1|NOT COMPLETED|Overall Study||1
316386|NCT00703924|762958|P2|COMPLETED|Overall Study||41
316387|NCT00703924|762959|P1|COMPLETED|Overall Study||49
316388|NCT00703924|762958|P2|STARTED|Overall Study||42
316389|NCT00703924|762959|P1|STARTED|Overall Study||50
316390|NCT00703911|762975|P1|NOT COMPLETED|Overall Study||10
316391|NCT00703911|762975|P1|COMPLETED|Overall Study||92
316392|NCT00703911|762975|P1|STARTED|Overall Study||102
316393|NCT00703885|763003|P1|NOT COMPLETED|Overall Study||0
316394|NCT00703885|763003|P1|COMPLETED|Overall Study||16
316395|NCT00703885|763003|P1|STARTED|Overall Study||16
316396|NCT00703846|763008|P1|NOT COMPLETED|Overall Study||137
316397|NCT00703846|763008|P1|COMPLETED|Overall Study||363
316398|NCT00703846|763008|P1|STARTED|Overall Study||500
316399|NCT00703820|763024|P2|NOT COMPLETED|Overall Study||34
316400|NCT00703820|763025|P1|NOT COMPLETED|Overall Study||35
316401|NCT00703820|763024|P2|COMPLETED|Overall Study||95
316402|NCT00703820|763025|P1|COMPLETED|Overall Study||98
316403|NCT00703820|763024|P2|STARTED|Overall Study||129
316404|NCT00703820|763025|P1|STARTED|Overall Study||133
316405|NCT00703781|763034|P2|NOT COMPLETED|Overall Study||2
316406|NCT00703781|763035|P1|NOT COMPLETED|Overall Study||2
316407|NCT00703781|763034|P2|COMPLETED|Overall Study||61
316408|NCT00703781|763035|P1|COMPLETED|Overall Study||61
316409|NCT00703781|763034|P2|STARTED|Overall Study||63
316410|NCT00703781|763035|P1|STARTED|Overall Study||63
316411|NCT00703729|763045|P2|NOT COMPLETED|Overall Study||3
316412|NCT00703729|763046|P1|NOT COMPLETED|Overall Study||0
316413|NCT00703729|763045|P2|COMPLETED|Overall Study||21
316414|NCT00703729|763046|P1|COMPLETED|Overall Study||25
316415|NCT00703729|763045|P2|STARTED|Overall Study||24
316416|NCT00703729|763046|P1|STARTED|Overall Study||25
316417|NCT00703677|763080|P1|NOT COMPLETED|Overall Study||3
316418|NCT00703677|763080|P1|COMPLETED|Overall Study||14
316419|NCT00703677|763080|P1|STARTED|Overall Study||17
316420|NCT00703664|763096|P3|NOT COMPLETED|Overall Study||0
316421|NCT00703664|763097|P2|NOT COMPLETED|Overall Study||0
316422|NCT00703664|763098|P1|NOT COMPLETED|Overall Study||0
316423|NCT00703664|763096|P3|COMPLETED|Overall Study||39
316424|NCT00703664|763097|P2|COMPLETED|Overall Study||4
316425|NCT00703664|763098|P1|COMPLETED|Overall Study||22
316426|NCT00703664|763096|P3|STARTED|Overall Study||39
316427|NCT00703664|763097|P2|STARTED|Overall Study||4
316428|NCT00703664|763098|P1|STARTED|Overall Study||22
316429|NCT00703534|763120|P2|NOT COMPLETED|Overall Study||25
316430|NCT00703534|763121|P1|NOT COMPLETED|Overall Study||30
316431|NCT00703534|763120|P2|COMPLETED|Overall Study||218
316432|NCT00703534|763121|P1|COMPLETED|Overall Study||205
316433|NCT00703534|763120|P2|STARTED|Overall Study||243
316434|NCT00703534|763121|P1|STARTED|Overall Study||235
316435|NCT00703508|763127|P1|NOT COMPLETED|Overall Study||0
316436|NCT00703508|763127|P1|COMPLETED|Overall Study||26
316437|NCT00703508|763127|P1|STARTED|Overall Study||26
316438|NCT00703391|763141|P2|NOT COMPLETED|Overall Study||0
316439|NCT00703391|763142|P1|NOT COMPLETED|Overall Study||0
316440|NCT00703391|763141|P2|COMPLETED|Overall Study||6
316441|NCT00703391|763142|P1|COMPLETED|Overall Study||12
316442|NCT00703391|763141|P2|STARTED|Overall Study||6
316443|NCT00703391|763142|P1|STARTED|Overall Study||12
316444|NCT00703339|763186|P1|NOT COMPLETED|Overall Study||0
316445|NCT00703339|763186|P1|COMPLETED|Overall Study||1
316446|NCT00703339|763186|P1|STARTED|Overall Study||1
316447|NCT00703326|763193|P2|NOT COMPLETED|Overall Study||225
316448|NCT00703326|763194|P1|NOT COMPLETED|Overall Study||447
316449|NCT00703326|763193|P2|COMPLETED|Overall Study||160
316450|NCT00703326|763194|P1|COMPLETED|Overall Study||312
316451|NCT00703326|763193|P2|Received at Least 1 Dose of Study Drug|Overall Study||382
316452|NCT00703326|763194|P1|Received at Least 1 Dose of Study Drug|Overall Study||752
316453|NCT00703326|763193|P2|STARTED|Overall Study||385
316454|NCT00703326|763194|P1|STARTED|Overall Study||759
316455|NCT00703261|763216|P2|NOT COMPLETED|Overall Study||6
316456|NCT00703261|763217|P1|NOT COMPLETED|Overall Study||6
316457|NCT00703261|763216|P2|COMPLETED|Overall Study||35
316458|NCT00703261|763217|P1|COMPLETED|Overall Study||36
316459|NCT00703261|763216|P2|STARTED|Overall Study||41
316460|NCT00703261|763217|P1|STARTED|Overall Study||42
316461|NCT00703157|763226|P2|NOT COMPLETED|Overall Study||2
316462|NCT00703157|763227|P1|NOT COMPLETED|Overall Study||4
316463|NCT00703157|763226|P2|COMPLETED|Overall Study||24
316464|NCT00703157|763227|P1|COMPLETED|Overall Study||22
316465|NCT00703157|763226|P2|24 Months FU|Overall Study||24
316466|NCT00703157|763227|P1|24 Months FU|Overall Study||22
316467|NCT00703157|763226|P2|6 Months FU|Overall Study||25
316468|NCT00703157|763227|P1|6 Months FU|Overall Study||25
316469|NCT00703157|763226|P2|STARTED|Overall Study||26
316470|NCT00703157|763227|P1|STARTED|Overall Study||26
316471|NCT00703118|763261|P3|NOT COMPLETED|Overall Study||22
316472|NCT00703118|763262|P2|NOT COMPLETED|Overall Study||16
316473|NCT00703118|763263|P1|NOT COMPLETED|Overall Study||21
316474|NCT00703118|763261|P3|COMPLETED|Overall Study||110
316475|NCT00703118|763262|P2|COMPLETED|Overall Study||248
316476|NCT00703118|763263|P1|COMPLETED|Overall Study||245
316477|NCT00703118|763261|P3|STARTED|Overall Study||132
316478|NCT00703118|763262|P2|STARTED|Overall Study||264
316479|NCT00703118|763263|P1|STARTED|Overall Study||266
316480|NCT00703092|763294|P1|NOT COMPLETED|Overall Study||2
316481|NCT00703092|763294|P1|COMPLETED|Overall Study||0
316482|NCT00703092|763294|P1|STARTED|Overall Study||2
316483|NCT00703053|763308|P9|NOT COMPLETED|Overall Study||1
316484|NCT00703053|763309|P8|NOT COMPLETED|Overall Study||6
316485|NCT00703053|763310|P7|NOT COMPLETED|Overall Study||7
316486|NCT00703053|763311|P6|NOT COMPLETED|Overall Study||6
316487|NCT00703053|763312|P5|NOT COMPLETED|Overall Study||1
316488|NCT00703053|763313|P4|NOT COMPLETED|Overall Study||3
316489|NCT00703053|763314|P3|NOT COMPLETED|Overall Study||3
316490|NCT00703053|763315|P2|NOT COMPLETED|Overall Study||2
316491|NCT00703053|763316|P1|NOT COMPLETED|Overall Study||1
316492|NCT00703053|763308|P9|COMPLETED|Overall Study||102
316493|NCT00703053|763309|P8|COMPLETED|Overall Study||91
316494|NCT00703053|763310|P7|COMPLETED|Overall Study||45
316495|NCT00703053|763311|P6|COMPLETED|Overall Study||43
316496|NCT00703053|763312|P5|COMPLETED|Overall Study||50
316497|NCT00703053|763313|P4|COMPLETED|Overall Study||46
316498|NCT00703053|763314|P3|COMPLETED|Overall Study||48
316499|NCT00703053|763315|P2|COMPLETED|Overall Study||24
316500|NCT00703053|763316|P1|COMPLETED|Overall Study||26
316501|NCT00703053|763308|P9|STARTED|Overall Study||103
316502|NCT00703053|763309|P8|STARTED|Overall Study||97
316503|NCT00703053|763310|P7|STARTED|Overall Study||52
316504|NCT00703053|763311|P6|STARTED|Overall Study||49
316505|NCT00703053|763312|P5|STARTED|Overall Study||51
316506|NCT00703053|763313|P4|STARTED|Overall Study||49
316507|NCT00703053|763314|P3|STARTED|Overall Study||51
316508|NCT00703053|763315|P2|STARTED|Overall Study||26
316509|NCT00703053|763316|P1|STARTED|Overall Study||27
316510|NCT00703014|763502|P4|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||42
316511|NCT00703014|763503|P3|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||47
316512|NCT00703014|763504|P2|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
316513|NCT00703014|763505|P1|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
316514|NCT00703014|763502|P4|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|284
316515|NCT00703014|763503|P3|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|305
316516|NCT00703014|763504|P2|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
316517|NCT00703014|763505|P1|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
316518|NCT00703014|763502|P4|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|315
316519|NCT00703014|763503|P3|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|344
316520|NCT00703014|763504|P2|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
316521|NCT00703014|763505|P1|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
316522|NCT00703014|763502|P4|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|326
316523|NCT00703014|763503|P3|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|352
316524|NCT00703014|763504|P2|STARTED|Fetuses/Infants Follow Up Trial P05712||0
316525|NCT00703014|763505|P1|STARTED|Fetuses/Infants Follow Up Trial P05712||0
316526|NCT00703014|763502|P4|NOT COMPLETED|Mothers Follow Up Trial P05712||0
316527|NCT00703014|763503|P3|NOT COMPLETED|Mothers Follow Up Trial P05712||0
316528|NCT00703014|763504|P2|NOT COMPLETED|Mothers Follow Up Trial P05712||32
316529|NCT00703014|763505|P1|NOT COMPLETED|Mothers Follow Up Trial P05712||33
316530|NCT00703014|763502|P4|COMPLETED|Mothers Follow Up Trial P05712||0
316531|NCT00703014|763503|P3|COMPLETED|Mothers Follow Up Trial P05712||0
316532|NCT00703014|763504|P2|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|235
316533|NCT00703014|763505|P1|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|241
316534|NCT00703014|763502|P4|STARTED|Mothers Follow Up Trial P05712||0
316535|NCT00703014|763503|P3|STARTED|Mothers Follow Up Trial P05712||0
316536|NCT00703014|763504|P2|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|267
316537|NCT00703014|763505|P1|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|274
316538|NCT00703014|763502|P4|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
316539|NCT00703014|763503|P3|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
316540|NCT00703014|763504|P2|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||466
316541|NCT00703014|763505|P1|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||462
316542|NCT00703014|763502|P4|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
316543|NCT00703014|763503|P3|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
316544|NCT00703014|763504|P2|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|286
316545|NCT00703014|763505|P1|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|295
316546|NCT00703014|763502|P4|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
316547|NCT00703014|763503|P3|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
316548|NCT00703014|763504|P2|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|704
316549|NCT00703014|763505|P1|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|672
316550|NCT00703014|763502|P4|Treated|Mothers Base Trial P05787 (NCT00696800)||0
316551|NCT00703014|763503|P3|Treated|Mothers Base Trial P05787 (NCT00696800)||0
316552|NCT00703014|763504|P2|Treated|Mothers Base Trial P05787 (NCT00696800)|ITT group in Base Trial P05787 (NCT006968000)|750
316553|NCT00703014|763505|P1|Treated|Mothers Base Trial P05787 (NCT00696800)|Intent-To-Treat (ITT) group in Base Trial P05787 (NCT00696800)|756
316554|NCT00703014|763502|P4|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
316555|NCT00703014|763503|P3|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
316556|NCT00703014|763504|P2|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|752
316557|NCT00703014|763505|P1|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|757
316558|NCT00702962|763525|P2|NOT COMPLETED|Overall Study||1
316559|NCT00702962|763526|P1|NOT COMPLETED|Overall Study||1
316560|NCT00702962|763525|P2|COMPLETED|Overall Study|Two completed all required cycles. One experienced progressive disease after 2 cycles|2
316561|NCT00702962|763526|P1|COMPLETED|Overall Study|The one participant off treatment after 2 doses due to concurrent health disorder.|0
316562|NCT00702962|763525|P2|STARTED|Overall Study|Three treated. Milestone not met as Phase I closed prematurely as NCI research established the MTD.|3
316563|NCT00702962|763526|P1|STARTED|Overall Study|One initiated treatment. Milestones not achieved due to premature closing due to low accrual.|1
316564|NCT00702949|763537|P3|NOT COMPLETED|Overall Study||8
316565|NCT00702949|763538|P2|NOT COMPLETED|Overall Study||9
316566|NCT00702949|763539|P1|NOT COMPLETED|Overall Study||5
316567|NCT00702949|763537|P3|COMPLETED|Overall Study||54
316568|NCT00702949|763538|P2|COMPLETED|Overall Study||57
316569|NCT00702949|763539|P1|COMPLETED|Overall Study||58
316570|NCT00702949|763537|P3|Evaluable for Primary Endpoint|Overall Study||51
316571|NCT00702949|763538|P2|Evaluable for Primary Endpoint|Overall Study||56
316572|NCT00702949|763539|P1|Evaluable for Primary Endpoint|Overall Study||56
316573|NCT00702949|763537|P3|STARTED|Overall Study||62
316574|NCT00702949|763538|P2|STARTED|Overall Study||66
316575|NCT00702949|763539|P1|STARTED|Overall Study||63
316576|NCT00702923|763564|P1|NOT COMPLETED|Overall Study||1
316577|NCT00702923|763564|P1|COMPLETED|Overall Study||11
316578|NCT00702923|763564|P1|STARTED|Overall Study||12
316579|NCT00702884|763573|P1|NOT COMPLETED|Overall Study||0
316580|NCT00702884|763573|P1|COMPLETED|Overall Study||25
316581|NCT00702884|763573|P1|STARTED|Overall Study||25
316582|NCT00702845|763587|P2|NOT COMPLETED|Overall Study||8
316583|NCT00702845|763588|P1|NOT COMPLETED|Overall Study||22
316584|NCT00702845|763587|P2|COMPLETED|Overall Study||121
316585|NCT00702845|763588|P1|COMPLETED|Overall Study||246
316586|NCT00702845|763587|P2|Randomized|Overall Study||128
316587|NCT00702845|763588|P1|Randomized|Overall Study||268
316588|NCT00702845|763587|P2|STARTED|Overall Study|Includes one treated participant who was not randomized|129
316589|NCT00702845|763588|P1|STARTED|Overall Study||268
316590|NCT00702780|763628|P2|NOT COMPLETED|Overall Study||8
316591|NCT00702780|763629|P1|NOT COMPLETED|Overall Study||9
316592|NCT00702780|763628|P2|COMPLETED|Overall Study||29
316593|NCT00702780|763629|P1|COMPLETED|Overall Study||28
316594|NCT00702780|763628|P2|STARTED|Overall Study||37
316595|NCT00702780|763629|P1|STARTED|Overall Study||37
316596|NCT00702754|763637|P1|NOT COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||24
316597|NCT00702754|763637|P1|COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||329
316598|NCT00702754|763637|P1|STARTED|MYOBLOC Treatment Session 8 (App 84 Wks)||353
316599|NCT00702754|763637|P1|NOT COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||24
316600|NCT00702754|763637|P1|COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||353
316601|NCT00702754|763637|P1|STARTED|MYOBLOC Treatment Session 7 (App 72 Wks)||377
316602|NCT00702754|763637|P1|NOT COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||19
316603|NCT00702754|763637|P1|COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||377
316604|NCT00702754|763637|P1|STARTED|MYOBLOC Treatment Session 6 (App 60 Wks)||396
316605|NCT00702754|763637|P1|NOT COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||32
316606|NCT00702754|763637|P1|COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||396
316607|NCT00702754|763637|P1|STARTED|MYOBLOC Treatment Session 5 (App 48 Wks)||428
316608|NCT00702754|763637|P1|NOT COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||22
316609|NCT00702754|763637|P1|COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||428
316610|NCT00702754|763637|P1|STARTED|MYOBLOC Treatment Session 4 (App 36 Wks)||450
316611|NCT00702754|763637|P1|NOT COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||25
316612|NCT00702754|763637|P1|COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||450
316613|NCT00702754|763637|P1|STARTED|MYOBLOC Treatment Session 3 (App 24 Wks)||475
316614|NCT00702754|763637|P1|NOT COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||20
316615|NCT00702754|763637|P1|COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||475
316616|NCT00702754|763637|P1|STARTED|MYOBLOC Treatment Session 2 (App 12 Wks)||495
316617|NCT00702754|763637|P1|NOT COMPLETED|MYOBLOC Treatment Session 1 (Time 0)||7
316618|NCT00702754|763637|P1|COMPLETED|MYOBLOC Treatment Session 1 (Time 0)|Approximately 70% of subjects completed at least 2 years of treatment.|495
316619|NCT00702754|763637|P1|STARTED|MYOBLOC Treatment Session 1 (Time 0)||502
316620|NCT00702715|763650|P2|NOT COMPLETED|Overall Study||0
316621|NCT00702715|763651|P1|NOT COMPLETED|Overall Study||1
316622|NCT00702715|763650|P2|COMPLETED|Overall Study||33
316623|NCT00702715|763651|P1|COMPLETED|Overall Study||34
316624|NCT00702715|763650|P2|STARTED|Overall Study|One subject was enrolled but did not start study|33
316625|NCT00702715|763651|P1|STARTED|Overall Study||35
316626|NCT00702702|763664|P1|NOT COMPLETED|Overall Study||56
316627|NCT00702702|763664|P1|COMPLETED|Overall Study||0
316628|NCT00702702|763664|P1|STARTED|Overall Study||56
316629|NCT00702689|763672|P1|NOT COMPLETED|Overall Study||6
316630|NCT00702689|763672|P1|COMPLETED|Overall Study||14
316631|NCT00702689|763672|P1|STARTED|Overall Study||20
316632|NCT00702650|763683|P1|NOT COMPLETED|Overall Study||20
316633|NCT00702650|763683|P1|COMPLETED|Overall Study||135
316634|NCT00702650|763683|P1|STARTED|Overall Study||155
316635|NCT00702624|763703|P4|NOT COMPLETED|Fetuses/Infant Follow-up||0
316636|NCT00702624|763704|P3|NOT COMPLETED|Fetuses/Infant Follow-up||10
316637|NCT00702624|763705|P2|NOT COMPLETED|Fetuses/Infant Follow-up||0
316638|NCT00702624|763706|P1|NOT COMPLETED|Fetuses/Infant Follow-up||0
316639|NCT00702624|763703|P4|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|55
316640|NCT00702624|763704|P3|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|78
316641|NCT00702624|763705|P2|COMPLETED|Fetuses/Infant Follow-up||0
316642|NCT00702624|763706|P1|COMPLETED|Fetuses/Infant Follow-up||0
316643|NCT00702624|763703|P4|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy.|55
316644|NCT00702624|763704|P3|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy|80
316645|NCT00702624|763705|P2|Live Born Infants|Fetuses/Infant Follow-up||0
316646|NCT00702624|763706|P1|Live Born Infants|Fetuses/Infant Follow-up||0
316647|NCT00702624|763703|P4|STARTED|Fetuses/Infant Follow-up||55
316648|NCT00702624|763704|P3|STARTED|Fetuses/Infant Follow-up||88
316649|NCT00702624|763705|P2|STARTED|Fetuses/Infant Follow-up||0
316650|NCT00702624|763706|P1|STARTED|Fetuses/Infant Follow-up||0
316651|NCT00702624|763703|P4|NOT COMPLETED|Expectant Mother Follow-up||0
316652|NCT00702624|763704|P3|NOT COMPLETED|Expectant Mother Follow-up||0
316653|NCT00702624|763705|P2|NOT COMPLETED|Expectant Mother Follow-up||0
316654|NCT00702624|763706|P1|NOT COMPLETED|Expectant Mother Follow-up||7
316655|NCT00702624|763703|P4|COMPLETED|Expectant Mother Follow-up||0
316656|NCT00702624|763704|P3|COMPLETED|Expectant Mother Follow-up||0
316657|NCT00702624|763705|P2|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|45
316658|NCT00702624|763706|P1|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|61
316659|NCT00702624|763703|P4|STARTED|Expectant Mother Follow-up||0
316660|NCT00702624|763704|P3|STARTED|Expectant Mother Follow-up||0
316661|NCT00702624|763705|P2|STARTED|Expectant Mother Follow-up||45
316662|NCT00702624|763706|P1|STARTED|Expectant Mother Follow-up||68
316663|NCT00702624|763703|P4|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
316664|NCT00702624|763704|P3|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
316665|NCT00702624|763705|P2|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
316666|NCT00702624|763706|P1|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
316667|NCT00702624|763703|P4|COMPLETED|Base Study P05690 (NCT00702845)||0
316668|NCT00702624|763704|P3|COMPLETED|Base Study P05690 (NCT00702845)||0
316669|NCT00702624|763705|P2|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
316670|NCT00702624|763706|P1|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
316671|NCT00702624|763703|P4|STARTED|Base Study P05690 (NCT00702845)||0
316672|NCT00702624|763704|P3|STARTED|Base Study P05690 (NCT00702845)||0
316673|NCT00702624|763705|P2|STARTED|Base Study P05690 (NCT00702845)||128
316674|NCT00702624|763706|P1|STARTED|Base Study P05690 (NCT00702845)||268
316675|NCT00702546|763724|P2|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||1
316676|NCT00702546|763725|P1|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||5
316677|NCT00702546|763724|P2|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|24
316678|NCT00702546|763725|P1|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|72
316679|NCT00702546|763724|P2|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|25
316680|NCT00702546|763725|P1|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|77
316681|NCT00702546|763724|P2|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
316682|NCT00702546|763725|P1|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
316683|NCT00702546|763724|P2|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
316684|NCT00702546|763725|P1|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
316685|NCT00702546|763724|P2|STARTED|Base Study P05690 (NCT00702845)||128
316686|NCT00702546|763725|P1|STARTED|Base Study P05690 (NCT00702845)||268
316687|NCT00702520|763745|P4|NOT COMPLETED|Follow-up Study P05783||0
316688|NCT00702520|763746|P3|NOT COMPLETED|Follow-up Study P05783||0
316689|NCT00702520|763747|P2|NOT COMPLETED|Follow-up Study P05783||0
316690|NCT00702520|763748|P1|NOT COMPLETED|Follow-up Study P05783||0
316691|NCT00702520|763745|P4|COMPLETED|Follow-up Study P05783||11
316692|NCT00702520|763746|P3|COMPLETED|Follow-up Study P05783||8
316693|NCT00702520|763747|P2|COMPLETED|Follow-up Study P05783||8
316694|NCT00702520|763748|P1|COMPLETED|Follow-up Study P05783||7
316769|NCT00702403|763801|P1|Ineligible for Study Drug|From Consent to Engraftment||17
316695|NCT00702520|763745|P4|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 150 ug.|11
316696|NCT00702520|763746|P3|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 100 ug.|8
316697|NCT00702520|763747|P2|STARTED|Follow-up Study P05783||8
316698|NCT00702520|763748|P1|STARTED|Follow-up Study P05783||7
316699|NCT00702520|763745|P4|NOT COMPLETED|Base Study P05788 - Follow-Up||0
316700|NCT00702520|763746|P3|NOT COMPLETED|Base Study P05788 - Follow-Up||0
316701|NCT00702520|763747|P2|NOT COMPLETED|Base Study P05788 - Follow-Up||10
316702|NCT00702520|763748|P1|NOT COMPLETED|Base Study P05788 - Follow-Up||15
316703|NCT00702520|763745|P4|COMPLETED|Base Study P05788 - Follow-Up||0
316704|NCT00702520|763746|P3|COMPLETED|Base Study P05788 - Follow-Up||0
316705|NCT00702520|763747|P2|COMPLETED|Base Study P05788 - Follow-Up||8
316706|NCT00702520|763748|P1|COMPLETED|Base Study P05788 - Follow-Up||7
316707|NCT00702520|763745|P4|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
316708|NCT00702520|763746|P3|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
316709|NCT00702520|763747|P2|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||8
316710|NCT00702520|763748|P1|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||7
316711|NCT00702520|763745|P4|STARTED|Base Study P05788 - Follow-Up||0
316712|NCT00702520|763746|P3|STARTED|Base Study P05788 - Follow-Up||0
316713|NCT00702520|763747|P2|STARTED|Base Study P05788 - Follow-Up||18
316714|NCT00702520|763748|P1|STARTED|Base Study P05788 - Follow-Up||22
316715|NCT00702520|763745|P4|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
316716|NCT00702520|763746|P3|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
316717|NCT00702520|763747|P2|NOT COMPLETED|Base Study P05788 - Embryo Transfer||6
316718|NCT00702520|763748|P1|NOT COMPLETED|Base Study P05788 - Embryo Transfer||3
316719|NCT00702520|763745|P4|COMPLETED|Base Study P05788 - Embryo Transfer||0
316720|NCT00702520|763746|P3|COMPLETED|Base Study P05788 - Embryo Transfer||0
316721|NCT00702520|763747|P2|COMPLETED|Base Study P05788 - Embryo Transfer||18
316722|NCT00702520|763748|P1|COMPLETED|Base Study P05788 - Embryo Transfer||22
316723|NCT00702520|763745|P4|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
316724|NCT00702520|763746|P3|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
316725|NCT00702520|763747|P2|Embryo Transfer|Base Study P05788 - Embryo Transfer||18
316726|NCT00702520|763748|P1|Embryo Transfer|Base Study P05788 - Embryo Transfer||22
316727|NCT00702520|763745|P4|STARTED|Base Study P05788 - Embryo Transfer||0
316728|NCT00702520|763746|P3|STARTED|Base Study P05788 - Embryo Transfer||0
316729|NCT00702520|763747|P2|STARTED|Base Study P05788 - Embryo Transfer||24
316730|NCT00702520|763748|P1|STARTED|Base Study P05788 - Embryo Transfer||25
316731|NCT00702520|763745|P4|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
316732|NCT00702520|763746|P3|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
316733|NCT00702520|763747|P2|NOT COMPLETED|Base Study P05788 - Assigned Treatment||1
316734|NCT00702520|763748|P1|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
316735|NCT00702520|763745|P4|COMPLETED|Base Study P05788 - Assigned Treatment||0
316736|NCT00702520|763746|P3|COMPLETED|Base Study P05788 - Assigned Treatment||0
316737|NCT00702520|763747|P2|COMPLETED|Base Study P05788 - Assigned Treatment||24
316738|NCT00702520|763748|P1|COMPLETED|Base Study P05788 - Assigned Treatment||25
316739|NCT00702520|763745|P4|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
316740|NCT00702520|763746|P3|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
316741|NCT00702520|763747|P2|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||24
316742|NCT00702520|763748|P1|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||25
316743|NCT00702520|763745|P4|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
316744|NCT00702520|763746|P3|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
316745|NCT00702520|763747|P2|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||24
316746|NCT00702520|763748|P1|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||25
316747|NCT00702520|763745|P4|STARTED|Base Study P05788 - Assigned Treatment||0
316748|NCT00702520|763746|P3|STARTED|Base Study P05788 - Assigned Treatment||0
316749|NCT00702520|763747|P2|STARTED|Base Study P05788 - Assigned Treatment||25
316750|NCT00702520|763748|P1|STARTED|Base Study P05788 - Assigned Treatment||25
316751|NCT00702507|763764|P1|NOT COMPLETED|Follow-up Phase||27
316752|NCT00702507|763764|P1|COMPLETED|Follow-up Phase||132
316753|NCT00702507|763764|P1|STARTED|Follow-up Phase||159
316754|NCT00702507|763764|P1|NOT COMPLETED|Initial Treatment Phase||41
316755|NCT00702507|763764|P1|COMPLETED|Initial Treatment Phase||159
316756|NCT00702507|763764|P1|STARTED|Initial Treatment Phase||200
316757|NCT00702468|763778|P2|NOT COMPLETED|Overall Study||16
316758|NCT00702468|763779|P1|NOT COMPLETED|Overall Study||3
316759|NCT00702468|763778|P2|COMPLETED|Overall Study||2
316760|NCT00702468|763779|P1|COMPLETED|Overall Study||15
316761|NCT00702468|763778|P2|STARTED|Overall Study||18
316762|NCT00702468|763779|P1|STARTED|Overall Study||18
316763|NCT00702403|763801|P1|NOT COMPLETED|From Engraftment to Study Completion||27
316764|NCT00702403|763801|P1|COMPLETED|From Engraftment to Study Completion||13
316765|NCT00702403|763801|P1|Patient Drop-outs|From Engraftment to Study Completion||27
316766|NCT00702403|763801|P1|STARTED|From Engraftment to Study Completion||40
316767|NCT00702403|763801|P1|NOT COMPLETED|From Consent to Engraftment||17
316768|NCT00702403|763801|P1|COMPLETED|From Consent to Engraftment|40 of 57 originally consented subjects remained eligible at engraftment (= the 2nd ITT population)|40
316770|NCT00702403|763801|P1|STARTED|From Consent to Engraftment|"57 agreed to participate and completed informed consent (= the 1st intention to treat population)"|57
316771|NCT00702377|763811|P2|NOT COMPLETED|Overall Study||3
316772|NCT00702377|763812|P1|NOT COMPLETED|Overall Study||1
316773|NCT00702377|763811|P2|COMPLETED|Overall Study||53
316774|NCT00702377|763812|P1|COMPLETED|Overall Study||52
316775|NCT00702377|763811|P2|STARTED|Overall Study||56
316776|NCT00702377|763812|P1|STARTED|Overall Study||53
316777|NCT00702364|763824|P2|NOT COMPLETED|Overall Study||4
316778|NCT00702364|763825|P1|NOT COMPLETED|Overall Study||2
316779|NCT00702364|763824|P2|COMPLETED|Overall Study||25
316780|NCT00702364|763825|P1|COMPLETED|Overall Study||24
316781|NCT00702364|763824|P2|STARTED|Overall Study||29
316782|NCT00702364|763825|P1|STARTED|Overall Study||26
316783|NCT00702338|763837|P3|NOT COMPLETED|Follow-up Study: Infant FU||2
316784|NCT00702338|763838|P2|NOT COMPLETED|Follow-up Study: Infant FU||0
316785|NCT00702338|763839|P1|NOT COMPLETED|Follow-up Study: Infant FU||0
316786|NCT00702338|763837|P3|COMPLETED|Follow-up Study: Infant FU||0
316787|NCT00702338|763838|P2|COMPLETED|Follow-up Study: Infant FU||0
316788|NCT00702338|763839|P1|COMPLETED|Follow-up Study: Infant FU||0
316789|NCT00702338|763837|P3|STARTED|Follow-up Study: Infant FU|Participants died on day of delivery, did not complete follow-up visit at 4-12 weeks postpartum.|2
316790|NCT00702338|763838|P2|STARTED|Follow-up Study: Infant FU||0
316791|NCT00702338|763839|P1|STARTED|Follow-up Study: Infant FU||0
316792|NCT00702338|763837|P3|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
316793|NCT00702338|763838|P2|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||1
316794|NCT00702338|763839|P1|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
316795|NCT00702338|763837|P3|COMPLETED|Follow-up Study: Expectant Mothers FU||0
316796|NCT00702338|763838|P2|COMPLETED|Follow-up Study: Expectant Mothers FU|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|0
316797|NCT00702338|763839|P1|COMPLETED|Follow-up Study: Expectant Mothers FU||0
316798|NCT00702338|763837|P3|STARTED|Follow-up Study: Expectant Mothers FU||0
316799|NCT00702338|763838|P2|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|1
316800|NCT00702338|763839|P1|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|0
316801|NCT00702338|763837|P3|NOT COMPLETED|Base Study (NCT00697255)||0
316802|NCT00702338|763838|P2|NOT COMPLETED|Base Study (NCT00697255)||2
316803|NCT00702338|763839|P1|NOT COMPLETED|Base Study (NCT00697255)||3
316804|NCT00702338|763837|P3|COMPLETED|Base Study (NCT00697255)||0
316805|NCT00702338|763838|P2|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|1
316806|NCT00702338|763839|P1|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|2
316807|NCT00702338|763837|P3|STARTED|Base Study (NCT00697255)||0
316808|NCT00702338|763838|P2|STARTED|Base Study (NCT00697255)||3
316809|NCT00702338|763839|P1|STARTED|Base Study (NCT00697255)||5
316810|NCT00702325|763855|P2|NOT COMPLETED|Overall Study||53
316811|NCT00702325|763856|P1|NOT COMPLETED|Overall Study||38
316812|NCT00702325|763855|P2|COMPLETED|Overall Study|Completed participants based on randomized population (155) minus discontinued participants (53).|102
316813|NCT00702325|763856|P1|COMPLETED|Overall Study|Completed participants based on randomized population (156) minus discontinued participants (38).|118
316814|NCT00702325|763855|P2|STARTED|Overall Study|Randomized|155
316815|NCT00702325|763856|P1|STARTED|Overall Study|Randomized|156
316816|NCT00702299|763908|P1|NOT COMPLETED|Overall Study||0
316817|NCT00702299|763908|P1|COMPLETED|Overall Study||15
316818|NCT00702299|763908|P1|STARTED|Overall Study||15
316819|NCT00702273|763921|P2|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||29
316820|NCT00702273|763922|P1|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||20
316821|NCT00702273|763921|P2|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|147
316822|NCT00702273|763922|P1|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|148
316823|NCT00702273|763921|P2|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study, who had at least one embryo thawed for a FTET cycle|176
316824|NCT00702273|763922|P1|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study,who had at least one embryo thawed for a FTET cycle.|168
316825|NCT00702273|763921|P2|NOT COMPLETED|Base Study P05787 (NCT00696800)||48
316826|NCT00702273|763922|P1|NOT COMPLETED|Base Study P05787 (NCT00696800)||85
316827|NCT00702273|763921|P2|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|704
316828|NCT00702273|763922|P1|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|672
316829|NCT00702273|763921|P2|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|750
316830|NCT00702273|763922|P1|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|756
316831|NCT00702273|763921|P2|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|752
316832|NCT00702273|763922|P1|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|757
316833|NCT00702234|763940|P2|NOT COMPLETED|Follow-up Study: Fetuses/Infants||27
316834|NCT00702234|763941|P1|NOT COMPLETED|Follow-up Study: Fetuses/Infants||0
316835|NCT00702234|763940|P2|COMPLETED|Follow-up Study: Fetuses/Infants|All 288 who completed were live born infants|288
316836|NCT00702234|763941|P1|COMPLETED|Follow-up Study: Fetuses/Infants||0
316837|NCT00702234|763940|P2|Live Born Infants|Follow-up Study: Fetuses/Infants|Of the 11 that were not live born infants, outcome is known for 8 (fetus was lost) and unknown for 3|304
316838|NCT00702234|763941|P1|Live Born Infants|Follow-up Study: Fetuses/Infants||0
316839|NCT00702234|763940|P2|STARTED|Follow-up Study: Fetuses/Infants|Fetuses present 10 weeks after fresh ET and/or at enrollment of expectant mother in follow-up study|315
316840|NCT00702234|763941|P1|STARTED|Follow-up Study: Fetuses/Infants||0
316841|NCT00702234|763940|P2|NOT COMPLETED|Follow-up Study: Expectant Mothers||0
316842|NCT00702234|763941|P1|NOT COMPLETED|Follow-up Study: Expectant Mothers||22
316843|NCT00702234|763940|P2|COMPLETED|Follow-up Study: Expectant Mothers||0
316844|NCT00702234|763941|P1|COMPLETED|Follow-up Study: Expectant Mothers||246
316845|NCT00702234|763940|P2|STARTED|Follow-up Study: Expectant Mothers||0
316846|NCT00702234|763941|P1|STARTED|Follow-up Study: Expectant Mothers|"A participant could enter follow-up study without meeting definition for Completion of base study"|268
316847|NCT00702234|763940|P2|NOT COMPLETED|Base Study (NCT00696878)||0
316848|NCT00702234|763941|P1|NOT COMPLETED|Base Study (NCT00696878)||504
316849|NCT00702234|763940|P2|COMPLETED|Base Study (NCT00696878)||0
316850|NCT00702234|763941|P1|COMPLETED|Base Study (NCT00696878)||178
316851|NCT00702234|763940|P2|STARTED|Base Study (NCT00696878)||0
316852|NCT00702234|763941|P1|STARTED|Base Study (NCT00696878)||682
316853|NCT00702221|763952|P2|NOT COMPLETED|Overall Study||3
316854|NCT00702221|763953|P1|NOT COMPLETED|Overall Study||4
316855|NCT00702221|763952|P2|COMPLETED|Overall Study||7
316856|NCT00702221|763953|P1|COMPLETED|Overall Study||6
316857|NCT00702221|763952|P2|STARTED|Overall Study||10
316858|NCT00702221|763953|P1|STARTED|Overall Study||10
316859|NCT00702208|763959|P1|NOT COMPLETED|Overall Study||31
316860|NCT00702208|763959|P1|COMPLETED|Overall Study||167
316861|NCT00702208|763959|P1|STARTED|Overall Study||198
316862|NCT00702143|763968|P3|NOT COMPLETED|Overall Study||1
316863|NCT00702143|763969|P2|NOT COMPLETED|Overall Study||0
316864|NCT00702143|763970|P1|NOT COMPLETED|Overall Study||0
316865|NCT00702143|763968|P3|COMPLETED|Overall Study||78
316866|NCT00702143|763969|P2|COMPLETED|Overall Study||60
316867|NCT00702143|763970|P1|COMPLETED|Overall Study||45
316868|NCT00702143|763968|P3|STARTED|Overall Study||79
316869|NCT00702143|763969|P2|STARTED|Overall Study||60
316870|NCT00702143|763970|P1|STARTED|Overall Study||45
316871|NCT00701935|763984|P2|NOT COMPLETED|Overall Study||11
316872|NCT00701935|763985|P1|NOT COMPLETED|Overall Study||16
316873|NCT00701935|763984|P2|COMPLETED|Overall Study||26
316874|NCT00701935|763985|P1|COMPLETED|Overall Study||27
316875|NCT00701935|763984|P2|STARTED|Overall Study||37
316876|NCT00701935|763985|P1|STARTED|Overall Study||43
316877|NCT00701805|764019|P4|NOT COMPLETED|Overall Study||4
316878|NCT00701805|764020|P3|NOT COMPLETED|Overall Study||7
316879|NCT00701805|764021|P2|NOT COMPLETED|Overall Study||4
316880|NCT00701805|764022|P1|NOT COMPLETED|Overall Study||3
316881|NCT00701805|764019|P4|COMPLETED|Overall Study||22
316882|NCT00701805|764020|P3|COMPLETED|Overall Study||16
316883|NCT00701805|764021|P2|COMPLETED|Overall Study||25
316884|NCT00701805|764022|P1|COMPLETED|Overall Study||23
316885|NCT00701805|764019|P4|STARTED|Overall Study||26
316886|NCT00701805|764020|P3|STARTED|Overall Study||23
316887|NCT00701805|764021|P2|STARTED|Overall Study||29
316888|NCT00701805|764022|P1|STARTED|Overall Study||26
316889|NCT00701779|764072|P1|NOT COMPLETED|Overall Study||9
316890|NCT00701779|764072|P1|COMPLETED|Overall Study||54
316891|NCT00701779|764072|P1|12 Month|Overall Study||54
316892|NCT00701779|764072|P1|9 Month|Overall Study||56
316893|NCT00701779|764072|P1|6 Month|Overall Study||58
316894|NCT00701779|764072|P1|3 Month|Overall Study||60
316895|NCT00701779|764072|P1|STARTED|Overall Study||63
316896|NCT00701727|764084|P2|NOT COMPLETED|Second Treatment Period||0
316897|NCT00701727|764085|P1|NOT COMPLETED|Second Treatment Period||2
316898|NCT00701727|764084|P2|COMPLETED|Second Treatment Period||13
316899|NCT00701727|764085|P1|COMPLETED|Second Treatment Period||13
316900|NCT00701727|764084|P2|STARTED|Second Treatment Period||13
316901|NCT00701727|764085|P1|STARTED|Second Treatment Period||15
316902|NCT00701727|764084|P2|NOT COMPLETED|First Treatment Period||2
316903|NCT00701727|764085|P1|NOT COMPLETED|First Treatment Period||1
316904|NCT00701727|764084|P2|COMPLETED|First Treatment Period||13
316905|NCT00701727|764085|P1|COMPLETED|First Treatment Period||15
316906|NCT00701727|764084|P2|STARTED|First Treatment Period||15
316907|NCT00701727|764085|P1|STARTED|First Treatment Period||16
316908|NCT00701714|764105|P2|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
316909|NCT00701714|764106|P1|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
316910|NCT00701714|764105|P2|COMPLETED|Safety Follow-up Period (6 Months)||112
316911|NCT00701714|764106|P1|COMPLETED|Safety Follow-up Period (6 Months)||144
316912|NCT00701714|764105|P2|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|119
316913|NCT00701714|764106|P1|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|151
316914|NCT00701714|764105|P2|NOT COMPLETED|Treatment Period (up to 1 Year)||134
316915|NCT00701714|764106|P1|NOT COMPLETED|Treatment Period (up to 1 Year)||137
316916|NCT00701714|764105|P2|COMPLETED|Treatment Period (up to 1 Year)||29
316917|NCT00701714|764106|P1|COMPLETED|Treatment Period (up to 1 Year)||37
316918|NCT00701714|764105|P2|STARTED|Treatment Period (up to 1 Year)||163
316919|NCT00701714|764106|P1|STARTED|Treatment Period (up to 1 Year)||174
316920|NCT00701675|764121|P3|NOT COMPLETED|Overall Study||7
316921|NCT00701675|764122|P2|NOT COMPLETED|Overall Study||8
316922|NCT00701675|764123|P1|NOT COMPLETED|Overall Study||4
316923|NCT00701675|764121|P3|COMPLETED|Overall Study||7
316924|NCT00701675|764122|P2|COMPLETED|Overall Study||6
316925|NCT00701675|764123|P1|COMPLETED|Overall Study||10
316926|NCT00701675|764121|P3|STARTED|Overall Study||14
316927|NCT00701675|764122|P2|STARTED|Overall Study||14
316928|NCT00701675|764123|P1|STARTED|Overall Study||14
316929|NCT00701662|764131|P1|NOT COMPLETED|Overall Study||1
316930|NCT00701662|764131|P1|COMPLETED|Overall Study||7
316931|NCT00701662|764131|P1|STARTED|Overall Study||8
316932|NCT00701636|764150|P2|NOT COMPLETED|Overall Study||0
316933|NCT00701636|764151|P1|NOT COMPLETED|Overall Study||0
316934|NCT00701636|764150|P2|COMPLETED|Overall Study||15
316935|NCT00701636|764151|P1|COMPLETED|Overall Study||15
316936|NCT00701636|764150|P2|STARTED|Overall Study||15
316937|NCT00701636|764151|P1|STARTED|Overall Study||15
316938|NCT00701558|764156|P1|NOT COMPLETED|Overall Study||15
316939|NCT00701558|764156|P1|COMPLETED|Overall Study||4
316940|NCT00701558|764156|P1|STARTED|Overall Study||19
316941|NCT00701441|764164|P2|NOT COMPLETED|Overall Study||4
316942|NCT00701441|764165|P1|NOT COMPLETED|Overall Study||0
316943|NCT00701441|764164|P2|COMPLETED|Overall Study||12
316944|NCT00701441|764165|P1|COMPLETED|Overall Study||9
316945|NCT00701441|764164|P2|STARTED|Overall Study||16
316946|NCT00701441|764165|P1|STARTED|Overall Study||9
316947|NCT00701415|764177|P2|NOT COMPLETED|Overall Study||1
316948|NCT00701415|764178|P1|NOT COMPLETED|Overall Study||1
316949|NCT00701415|764177|P2|COMPLETED|Overall Study||14
316950|NCT00701415|764178|P1|COMPLETED|Overall Study||15
316951|NCT00701415|764177|P2|STARTED|Overall Study||15
316952|NCT00701415|764178|P1|STARTED|Overall Study||16
316953|NCT00701389|764188|P4|NOT COMPLETED|Period 4||0
316954|NCT00701389|764189|P3|NOT COMPLETED|Period 4||0
316955|NCT00701389|764190|P2|NOT COMPLETED|Period 4||0
316956|NCT00701389|764191|P1|NOT COMPLETED|Period 4||0
316957|NCT00701389|764188|P4|COMPLETED|Period 4||6
316958|NCT00701389|764189|P3|COMPLETED|Period 4||6
316959|NCT00701389|764190|P2|COMPLETED|Period 4||6
316960|NCT00701389|764191|P1|COMPLETED|Period 4||6
316961|NCT00701389|764188|P4|STARTED|Period 4||6
316962|NCT00701389|764189|P3|STARTED|Period 4||6
316963|NCT00701389|764190|P2|STARTED|Period 4||6
316964|NCT00701389|764191|P1|STARTED|Period 4||6
316965|NCT00701389|764188|P4|NOT COMPLETED|Period 3||0
316966|NCT00701389|764189|P3|NOT COMPLETED|Period 3||0
316967|NCT00701389|764190|P2|NOT COMPLETED|Period 3||0
316968|NCT00701389|764191|P1|NOT COMPLETED|Period 3||0
316969|NCT00701389|764188|P4|COMPLETED|Period 3||6
316970|NCT00701389|764189|P3|COMPLETED|Period 3||6
316971|NCT00701389|764190|P2|COMPLETED|Period 3||6
316972|NCT00701389|764191|P1|COMPLETED|Period 3||6
316973|NCT00701389|764188|P4|STARTED|Period 3||6
316974|NCT00701389|764189|P3|STARTED|Period 3||6
316975|NCT00701389|764190|P2|STARTED|Period 3||6
316976|NCT00701389|764191|P1|STARTED|Period 3||6
316977|NCT00701389|764188|P4|NOT COMPLETED|Period 2||0
316978|NCT00701389|764189|P3|NOT COMPLETED|Period 2||0
316979|NCT00701389|764190|P2|NOT COMPLETED|Period 2||0
316980|NCT00701389|764191|P1|NOT COMPLETED|Period 2||0
316981|NCT00701389|764188|P4|COMPLETED|Period 2||6
316982|NCT00701389|764189|P3|COMPLETED|Period 2||6
316983|NCT00701389|764190|P2|COMPLETED|Period 2||6
316984|NCT00701389|764191|P1|COMPLETED|Period 2||6
316985|NCT00701389|764188|P4|STARTED|Period 2||6
316986|NCT00701389|764189|P3|STARTED|Period 2||6
316987|NCT00701389|764190|P2|STARTED|Period 2||6
316988|NCT00701389|764191|P1|STARTED|Period 2||6
316989|NCT00701389|764188|P4|NOT COMPLETED|Period 1||0
316990|NCT00701389|764189|P3|NOT COMPLETED|Period 1||0
316991|NCT00701389|764190|P2|NOT COMPLETED|Period 1||0
316992|NCT00701389|764191|P1|NOT COMPLETED|Period 1||0
316993|NCT00701389|764188|P4|COMPLETED|Period 1||6
316994|NCT00701389|764189|P3|COMPLETED|Period 1||6
316995|NCT00701389|764190|P2|COMPLETED|Period 1||6
316996|NCT00701389|764191|P1|COMPLETED|Period 1||6
316997|NCT00701389|764188|P4|STARTED|Period 1||6
316998|NCT00701389|764189|P3|STARTED|Period 1||6
316999|NCT00701389|764190|P2|STARTED|Period 1||6
317000|NCT00701389|764191|P1|STARTED|Period 1||6
317001|NCT00701363|764213|P4|NOT COMPLETED|Treatment Phase 2||0
317002|NCT00701363|764214|P3|NOT COMPLETED|Treatment Phase 2||2
317003|NCT00701363|764215|P2|NOT COMPLETED|Treatment Phase 2||0
317004|NCT00701363|764216|P1|NOT COMPLETED|Treatment Phase 2||0
317005|NCT00701363|764213|P4|COMPLETED|Treatment Phase 2||26
317006|NCT00701363|764214|P3|COMPLETED|Treatment Phase 2||68
317007|NCT00701363|764215|P2|COMPLETED|Treatment Phase 2||13
317008|NCT00701363|764216|P1|COMPLETED|Treatment Phase 2||0
317009|NCT00701363|764213|P4|STARTED|Treatment Phase 2||26
317010|NCT00701363|764214|P3|STARTED|Treatment Phase 2||70
317011|NCT00701363|764215|P2|STARTED|Treatment Phase 2||13
317012|NCT00701363|764216|P1|STARTED|Treatment Phase 2||0
317013|NCT00701363|764213|P4|NOT COMPLETED|Treatment Phase 1||0
317014|NCT00701363|764214|P3|NOT COMPLETED|Treatment Phase 1||0
317015|NCT00701363|764215|P2|NOT COMPLETED|Treatment Phase 1||0
317016|NCT00701363|764216|P1|NOT COMPLETED|Treatment Phase 1||15
317017|NCT00701363|764213|P4|COMPLETED|Treatment Phase 1||0
317018|NCT00701363|764214|P3|COMPLETED|Treatment Phase 1||0
317019|NCT00701363|764215|P2|COMPLETED|Treatment Phase 1||0
317020|NCT00701363|764216|P1|COMPLETED|Treatment Phase 1||109
317021|NCT00701363|764213|P4|STARTED|Treatment Phase 1||0
317022|NCT00701363|764214|P3|STARTED|Treatment Phase 1||0
317023|NCT00701363|764215|P2|STARTED|Treatment Phase 1||0
317024|NCT00701363|764216|P1|STARTED|Treatment Phase 1||124
317025|NCT00701363|764213|P4|NOT COMPLETED|Screening (Pre-assignment) Phase||0
317026|NCT00701363|764214|P3|NOT COMPLETED|Screening (Pre-assignment) Phase||0
317027|NCT00701363|764215|P2|NOT COMPLETED|Screening (Pre-assignment) Phase||0
317028|NCT00701363|764216|P1|NOT COMPLETED|Screening (Pre-assignment) Phase||4
317029|NCT00701363|764213|P4|COMPLETED|Screening (Pre-assignment) Phase||0
317030|NCT00701363|764214|P3|COMPLETED|Screening (Pre-assignment) Phase||0
317031|NCT00701363|764215|P2|COMPLETED|Screening (Pre-assignment) Phase||0
317032|NCT00701363|764216|P1|COMPLETED|Screening (Pre-assignment) Phase||124
317033|NCT00701363|764213|P4|STARTED|Screening (Pre-assignment) Phase||0
317034|NCT00701363|764214|P3|STARTED|Screening (Pre-assignment) Phase||0
317035|NCT00701363|764215|P2|STARTED|Screening (Pre-assignment) Phase||0
317036|NCT00701363|764216|P1|STARTED|Screening (Pre-assignment) Phase||128
317037|NCT00701311|764256|P1|NOT COMPLETED|Overall Study||8
317038|NCT00701311|764256|P1|COMPLETED|Overall Study|Eight subjects did not complete full period of treatment but their data was included in analysis.|9
317039|NCT00701311|764256|P1|STARTED|Overall Study||17
317040|NCT00701129|764260|P1|NOT COMPLETED|Overall Study||2
317041|NCT00701129|764260|P1|COMPLETED|Overall Study||2
317042|NCT00701129|764260|P1|Full Analysis Set (FAS)|Overall Study|All enrolled patients who signed informed consent, received at least 1 dose of alglucosidase alfa.|4
317043|NCT00701129|764260|P1|STARTED|Overall Study||4
317044|NCT00701103|764282|P11|NOT COMPLETED|Overall Study||11
317045|NCT00701103|764283|P10|NOT COMPLETED|Overall Study||11
317046|NCT00701103|764284|P9|NOT COMPLETED|Overall Study||9
317047|NCT00701103|764285|P8|NOT COMPLETED|Overall Study||7
317048|NCT00701103|764286|P7|NOT COMPLETED|Overall Study||8
317049|NCT00701103|764287|P6|NOT COMPLETED|Overall Study||6
317050|NCT00701103|764288|P5|NOT COMPLETED|Overall Study||6
317051|NCT00701103|764289|P4|NOT COMPLETED|Overall Study||6
317052|NCT00701103|764290|P3|NOT COMPLETED|Overall Study||8
317053|NCT00701103|764291|P2|NOT COMPLETED|Overall Study||3
317054|NCT00701103|764292|P1|NOT COMPLETED|Overall Study||5
317055|NCT00701103|764282|P11|COMPLETED|Overall Study||0
317056|NCT00701103|764283|P10|COMPLETED|Overall Study||0
317057|NCT00701103|764284|P9|COMPLETED|Overall Study||0
317058|NCT00701103|764285|P8|COMPLETED|Overall Study||0
317059|NCT00701103|764286|P7|COMPLETED|Overall Study||0
317060|NCT00701103|764287|P6|COMPLETED|Overall Study||0
317061|NCT00701103|764288|P5|COMPLETED|Overall Study||0
317062|NCT00701103|764289|P4|COMPLETED|Overall Study||0
317063|NCT00701103|764290|P3|COMPLETED|Overall Study||0
317064|NCT00701103|764291|P2|COMPLETED|Overall Study||0
317065|NCT00701103|764292|P1|COMPLETED|Overall Study||0
317066|NCT00701103|764282|P11|STARTED|Overall Study||11
317067|NCT00701103|764283|P10|STARTED|Overall Study||11
317068|NCT00701103|764284|P9|STARTED|Overall Study||9
317069|NCT00701103|764285|P8|STARTED|Overall Study||7
317070|NCT00701103|764286|P7|STARTED|Overall Study||8
317071|NCT00701103|764287|P6|STARTED|Overall Study||6
317072|NCT00701103|764288|P5|STARTED|Overall Study||6
317073|NCT00701103|764289|P4|STARTED|Overall Study||6
317074|NCT00701103|764290|P3|STARTED|Overall Study||8
317075|NCT00701103|764291|P2|STARTED|Overall Study||3
317076|NCT00701103|764292|P1|STARTED|Overall Study||5
317077|NCT00701090|764398|P2|NOT COMPLETED|Overall Study||51
317078|NCT00701090|764399|P1|NOT COMPLETED|Overall Study||48
317079|NCT00701090|764398|P2|COMPLETED|Overall Study||468
317080|NCT00701090|764399|P1|COMPLETED|Overall Study||468
317081|NCT00701090|764398|P2|STARTED|Overall Study||519
317082|NCT00701090|764399|P1|STARTED|Overall Study||516
317083|NCT00701064|764417|P2|NOT COMPLETED|Overall Study||4
317084|NCT00701064|764418|P1|NOT COMPLETED|Overall Study||4
317085|NCT00701064|764417|P2|COMPLETED|Overall Study||32
317086|NCT00701064|764418|P1|COMPLETED|Overall Study||31
317087|NCT00701064|764417|P2|STARTED|Overall Study||36
317088|NCT00701064|764418|P1|STARTED|Overall Study||35
317089|NCT00701051|764430|P3|NOT COMPLETED|Detraining Intervention (Optional)||0
317090|NCT00701051|764431|P2|NOT COMPLETED|Detraining Intervention (Optional)||0
317091|NCT00701051|764432|P1|NOT COMPLETED|Detraining Intervention (Optional)||0
317092|NCT00701051|764430|P3|COMPLETED|Detraining Intervention (Optional)||6
317093|NCT00701051|764431|P2|COMPLETED|Detraining Intervention (Optional)||6
317094|NCT00701051|764432|P1|COMPLETED|Detraining Intervention (Optional)||0
317095|NCT00701051|764430|P3|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
317096|NCT00701051|764431|P2|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
317097|NCT00701051|764432|P1|STARTED|Detraining Intervention (Optional)||0
317098|NCT00701051|764430|P3|NOT COMPLETED|Exercise Intervention||3
317099|NCT00701051|764431|P2|NOT COMPLETED|Exercise Intervention||5
317100|NCT00701051|764432|P1|NOT COMPLETED|Exercise Intervention||0
317101|NCT00701051|764430|P3|COMPLETED|Exercise Intervention||9
317102|NCT00701051|764431|P2|COMPLETED|Exercise Intervention||14
317103|NCT00701051|764432|P1|COMPLETED|Exercise Intervention||0
317104|NCT00701051|764430|P3|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|12
317105|NCT00701051|764431|P2|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|19
317106|NCT00701051|764432|P1|STARTED|Exercise Intervention|Participants assigned to Normal or Impaired glucose tolerance arm after screening.|0
317107|NCT00701051|764430|P3|NOT COMPLETED|Screening||0
317108|NCT00701051|764431|P2|NOT COMPLETED|Screening||0
317109|NCT00701051|764432|P1|NOT COMPLETED|Screening||59
317110|NCT00701051|764430|P3|COMPLETED|Screening||0
317111|NCT00701051|764431|P2|COMPLETED|Screening||0
317112|NCT00701051|764432|P1|COMPLETED|Screening|Arm assignment not known until baseline testing; both arms included in this number|31
317113|NCT00701051|764430|P3|STARTED|Screening||0
317114|NCT00701051|764431|P2|STARTED|Screening||0
317115|NCT00701051|764432|P1|STARTED|Screening|Arm assignment not known until baseline testing; both arms included in this number|90
317116|NCT00701038|764450|P2|NOT COMPLETED|Overall Study||4
317117|NCT00701038|764451|P1|NOT COMPLETED|Overall Study||4
317118|NCT00701038|764450|P2|COMPLETED|Overall Study||23
317119|NCT00701038|764451|P1|COMPLETED|Overall Study||23
317120|NCT00701038|764450|P2|STARTED|Overall Study||27
317121|NCT00701038|764451|P1|STARTED|Overall Study||27
317122|NCT00700999|764459|P2|NOT COMPLETED|Overall Study||9
317123|NCT00700999|764460|P1|NOT COMPLETED|Overall Study||15
317124|NCT00700999|764459|P2|COMPLETED|Overall Study||20
317125|NCT00700999|764460|P1|COMPLETED|Overall Study||21
317126|NCT00700999|764459|P2|Second MRI Scan|Overall Study||18
317127|NCT00700999|764460|P1|Second MRI Scan|Overall Study||19
317128|NCT00700999|764459|P2|First MRI Scan|Overall Study||22
317129|NCT00700999|764460|P1|First MRI Scan|Overall Study||29
317130|NCT00700999|764459|P2|STARTED|Overall Study||29
317131|NCT00700999|764460|P1|STARTED|Overall Study||36
317132|NCT00700973|764468|P2|NOT COMPLETED|Overall Study||7
317133|NCT00700973|764469|P1|NOT COMPLETED|Overall Study||8
317134|NCT00700973|764468|P2|COMPLETED|Overall Study||63
317135|NCT00700973|764469|P1|COMPLETED|Overall Study||63
317136|NCT00700973|764468|P2|STARTED|Overall Study||70
317137|NCT00700973|764469|P1|STARTED|Overall Study||71
317138|NCT00700817|764480|P5|NOT COMPLETED|Week 52-78 (Extension Period 2)||5
317139|NCT00700817|764481|P4|NOT COMPLETED|Week 52-78 (Extension Period 2)||8
317140|NCT00700817|764482|P3|NOT COMPLETED|Week 52-78 (Extension Period 2)||0
317141|NCT00700817|764483|P2|NOT COMPLETED|Week 52-78 (Extension Period 2)||15
317142|NCT00700817|764484|P1|NOT COMPLETED|Week 52-78 (Extension Period 2)||10
317143|NCT00700817|764480|P5|COMPLETED|Week 52-78 (Extension Period 2)||63
317144|NCT00700817|764481|P4|COMPLETED|Week 52-78 (Extension Period 2)||59
317145|NCT00700817|764482|P3|COMPLETED|Week 52-78 (Extension Period 2)||0
317146|NCT00700817|764483|P2|COMPLETED|Week 52-78 (Extension Period 2)||135
317147|NCT00700817|764484|P1|COMPLETED|Week 52-78 (Extension Period 2)||124
317148|NCT00700817|764480|P5|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|68
317149|NCT00700817|764481|P4|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|67
317150|NCT00700817|764482|P3|STARTED|Week 52-78 (Extension Period 2)|Re-randomised to lira 1.2 or 1.8 mg|0
317151|NCT00700817|764483|P2|STARTED|Week 52-78 (Extension Period 2)||150
317152|NCT00700817|764484|P1|STARTED|Week 52-78 (Extension Period 2)|Subject withdrew before entry to extension period 2|134
317153|NCT00700817|764480|P5|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
317154|NCT00700817|764481|P4|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
317155|NCT00700817|764482|P3|NOT COMPLETED|Week 26-52 (Extension Period 1)||15
317156|NCT00700817|764483|P2|NOT COMPLETED|Week 26-52 (Extension Period 1)||26
317157|NCT00700817|764484|P1|NOT COMPLETED|Week 26-52 (Extension Period 1)||20
317158|NCT00700817|764480|P5|COMPLETED|Week 26-52 (Extension Period 1)||0
317159|NCT00700817|764481|P4|COMPLETED|Week 26-52 (Extension Period 1)||0
317160|NCT00700817|764482|P3|COMPLETED|Week 26-52 (Extension Period 1)||151
317161|NCT00700817|764483|P2|COMPLETED|Week 26-52 (Extension Period 1)||150
317162|NCT00700817|764484|P1|COMPLETED|Week 26-52 (Extension Period 1)||135
317163|NCT00700817|764480|P5|STARTED|Week 26-52 (Extension Period 1)||0
317164|NCT00700817|764481|P4|STARTED|Week 26-52 (Extension Period 1)||0
317165|NCT00700817|764482|P3|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|166
317166|NCT00700817|764483|P2|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|176
317167|NCT00700817|764484|P1|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|155
317168|NCT00700817|764480|P5|NOT COMPLETED|Week 0-26 (Main Period)||0
317169|NCT00700817|764481|P4|NOT COMPLETED|Week 0-26 (Main Period)||0
317170|NCT00700817|764482|P3|NOT COMPLETED|Week 0-26 (Main Period)||25
317171|NCT00700817|764483|P2|NOT COMPLETED|Week 0-26 (Main Period)||30
317172|NCT00700817|764484|P1|NOT COMPLETED|Week 0-26 (Main Period)||56
317173|NCT00700817|764480|P5|COMPLETED|Week 0-26 (Main Period)||0
317174|NCT00700817|764481|P4|COMPLETED|Week 0-26 (Main Period)||0
317175|NCT00700817|764482|P3|COMPLETED|Week 0-26 (Main Period)||194
317176|NCT00700817|764483|P2|COMPLETED|Week 0-26 (Main Period)||191
317177|NCT00700817|764484|P1|COMPLETED|Week 0-26 (Main Period)||169
317178|NCT00700817|764480|P5|Exposed|Week 0-26 (Main Period)||0
317179|NCT00700817|764481|P4|Exposed|Week 0-26 (Main Period)||0
317180|NCT00700817|764482|P3|Exposed|Week 0-26 (Main Period)||219
317181|NCT00700817|764483|P2|Exposed|Week 0-26 (Main Period)|3 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|218
317269|NCT00700427|764997|P1|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
317182|NCT00700817|764484|P1|Exposed|Week 0-26 (Main Period)|4 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|221
317183|NCT00700817|764480|P5|STARTED|Week 0-26 (Main Period)||0
317184|NCT00700817|764481|P4|STARTED|Week 0-26 (Main Period)||0
317185|NCT00700817|764482|P3|STARTED|Week 0-26 (Main Period)|Randomised|219
317186|NCT00700817|764483|P2|STARTED|Week 0-26 (Main Period)|Randomised|221
317187|NCT00700817|764484|P1|STARTED|Week 0-26 (Main Period)|Randomised|225
317188|NCT00700804|764866|P2|NOT COMPLETED|Overall Study||4
317189|NCT00700804|764867|P1|NOT COMPLETED|Overall Study||3
317190|NCT00700804|764866|P2|COMPLETED|Overall Study||13
317191|NCT00700804|764867|P1|COMPLETED|Overall Study||14
317192|NCT00700804|764866|P2|STARTED|Overall Study||17
317193|NCT00700804|764867|P1|STARTED|Overall Study||17
317194|NCT00700752|764875|P2|NOT COMPLETED|Second Intervention||0
317195|NCT00700752|764876|P1|NOT COMPLETED|Second Intervention||0
317196|NCT00700752|764875|P2|COMPLETED|Second Intervention||18
317197|NCT00700752|764876|P1|COMPLETED|Second Intervention||20
317198|NCT00700752|764875|P2|STARTED|Second Intervention||18
317199|NCT00700752|764876|P1|STARTED|Second Intervention||20
317200|NCT00700752|764875|P2|NOT COMPLETED|First Intervention||2
317201|NCT00700752|764876|P1|NOT COMPLETED|First Intervention||0
317202|NCT00700752|764875|P2|COMPLETED|First Intervention||18
317203|NCT00700752|764876|P1|COMPLETED|First Intervention||20
317204|NCT00700752|764875|P2|STARTED|First Intervention||20
317205|NCT00700752|764876|P1|STARTED|First Intervention||20
317206|NCT00700739|764884|P2|NOT COMPLETED|Overall Study||4
317207|NCT00700739|764885|P1|NOT COMPLETED|Overall Study||4
317208|NCT00700739|764884|P2|COMPLETED|Overall Study||12
317209|NCT00700739|764885|P1|COMPLETED|Overall Study||18
317210|NCT00700739|764884|P2|STARTED|Overall Study||16
317211|NCT00700739|764885|P1|STARTED|Overall Study||22
317212|NCT00700713|764924|P3|NOT COMPLETED|Overall Study||2
317213|NCT00700713|764925|P2|NOT COMPLETED|Overall Study||0
317214|NCT00700713|764926|P1|NOT COMPLETED|Overall Study||1
317215|NCT00700713|764924|P3|COMPLETED|Overall Study||65
317216|NCT00700713|764925|P2|COMPLETED|Overall Study||66
317217|NCT00700713|764926|P1|COMPLETED|Overall Study||47
317218|NCT00700713|764924|P3|STARTED|Overall Study||67
317219|NCT00700713|764925|P2|STARTED|Overall Study||66
317220|NCT00700713|764926|P1|STARTED|Overall Study||48
317221|NCT00700635|764943|P3|NOT COMPLETED|Overall Study||1
317222|NCT00700635|764944|P2|NOT COMPLETED|Overall Study||8
317223|NCT00700635|764945|P1|NOT COMPLETED|Overall Study||11
317224|NCT00700635|764943|P3|COMPLETED|Overall Study||110
317225|NCT00700635|764944|P2|COMPLETED|Overall Study||103
317226|NCT00700635|764945|P1|COMPLETED|Overall Study||100
317227|NCT00700635|764943|P3|STARTED|Overall Study||111
317228|NCT00700635|764944|P2|STARTED|Overall Study||111
317229|NCT00700635|764945|P1|STARTED|Overall Study||111
317230|NCT00700622|764967|P2|NOT COMPLETED|Overall Study||5
317231|NCT00700622|764968|P1|NOT COMPLETED|Overall Study||13
317232|NCT00700622|764967|P2|COMPLETED|Overall Study||60
317233|NCT00700622|764968|P1|COMPLETED|Overall Study||52
317234|NCT00700622|764967|P2|STARTED|Overall Study||65
317235|NCT00700622|764968|P1|STARTED|Overall Study||65
317236|NCT00700570|764976|P2|NOT COMPLETED|Overall Study||26
317237|NCT00700570|764977|P1|NOT COMPLETED|Overall Study||11
317238|NCT00700570|764976|P2|COMPLETED|Overall Study||0
317239|NCT00700570|764977|P1|COMPLETED|Overall Study||8
317240|NCT00700570|764976|P2|STARTED|Overall Study||26
317241|NCT00700570|764977|P1|STARTED|Overall Study||19
317242|NCT00700440|764989|P1|NOT COMPLETED|Overall Study||0
317243|NCT00700440|764989|P1|COMPLETED|Overall Study||100
317244|NCT00700440|764989|P1|STARTED|Overall Study||100
317245|NCT00700427|764993|P5|NOT COMPLETED|Study Period 4 (Open-Label Extension)||84
317246|NCT00700427|764994|P4|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
317247|NCT00700427|764995|P3|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
317248|NCT00700427|764996|P2|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
317249|NCT00700427|764997|P1|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
317250|NCT00700427|764993|P5|COMPLETED|Study Period 4 (Open-Label Extension)||96
317251|NCT00700427|764994|P4|COMPLETED|Study Period 4 (Open-Label Extension)||0
317252|NCT00700427|764995|P3|COMPLETED|Study Period 4 (Open-Label Extension)||0
317253|NCT00700427|764996|P2|COMPLETED|Study Period 4 (Open-Label Extension)||0
317254|NCT00700427|764997|P1|COMPLETED|Study Period 4 (Open-Label Extension)||0
317255|NCT00700427|764993|P5|STARTED|Study Period 4 (Open-Label Extension)||180
317256|NCT00700427|764994|P4|STARTED|Study Period 4 (Open-Label Extension)||0
317257|NCT00700427|764995|P3|STARTED|Study Period 4 (Open-Label Extension)||0
317258|NCT00700427|764996|P2|STARTED|Study Period 4 (Open-Label Extension)||0
317259|NCT00700427|764997|P1|STARTED|Study Period 4 (Open-Label Extension)||0
317260|NCT00700427|764993|P5|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
317261|NCT00700427|764994|P4|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||93
317262|NCT00700427|764995|P3|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||82
317263|NCT00700427|764996|P2|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
317264|NCT00700427|764997|P1|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
317265|NCT00700427|764993|P5|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
317266|NCT00700427|764994|P4|COMPLETED|Study Period 3B (Randomized Withdrawal)||165
317267|NCT00700427|764995|P3|COMPLETED|Study Period 3B (Randomized Withdrawal)||184
317268|NCT00700427|764996|P2|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
317270|NCT00700427|764993|P5|STARTED|Study Period 3B (Randomized Withdrawal)||0
317271|NCT00700427|764994|P4|STARTED|Study Period 3B (Randomized Withdrawal)||258
317272|NCT00700427|764995|P3|STARTED|Study Period 3B (Randomized Withdrawal)||266
317273|NCT00700427|764996|P2|STARTED|Study Period 3B (Randomized Withdrawal)||0
317274|NCT00700427|764997|P1|STARTED|Study Period 3B (Randomized Withdrawal)||0
317275|NCT00700427|764993|P5|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
317276|NCT00700427|764994|P4|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
317277|NCT00700427|764995|P3|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
317278|NCT00700427|764996|P2|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||481
317279|NCT00700427|764997|P1|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
317280|NCT00700427|764993|P5|COMPLETED|Study Period 3A (Blinded Maintenance)||0
317281|NCT00700427|764994|P4|COMPLETED|Study Period 3A (Blinded Maintenance)||0
317282|NCT00700427|764995|P3|COMPLETED|Study Period 3A (Blinded Maintenance)||0
317283|NCT00700427|764996|P2|COMPLETED|Study Period 3A (Blinded Maintenance)||524
317284|NCT00700427|764997|P1|COMPLETED|Study Period 3A (Blinded Maintenance)||0
317285|NCT00700427|764993|P5|STARTED|Study Period 3A (Blinded Maintenance)||0
317286|NCT00700427|764994|P4|STARTED|Study Period 3A (Blinded Maintenance)||0
317287|NCT00700427|764995|P3|STARTED|Study Period 3A (Blinded Maintenance)||0
317288|NCT00700427|764996|P2|STARTED|Study Period 3A (Blinded Maintenance)||1005
317289|NCT00700427|764997|P1|STARTED|Study Period 3A (Blinded Maintenance)||0
317290|NCT00700427|764993|P5|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
317291|NCT00700427|764994|P4|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
317292|NCT00700427|764995|P3|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
317293|NCT00700427|764996|P2|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
317294|NCT00700427|764997|P1|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||1011
317295|NCT00700427|764993|P5|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
317296|NCT00700427|764994|P4|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
317297|NCT00700427|764995|P3|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
317298|NCT00700427|764996|P2|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
317299|NCT00700427|764997|P1|COMPLETED|Study Period 2 (Open-Label Acute Trx)|One participant was mistakenly recorded as completed. The reason for discontinuation is unknown.|1006
317300|NCT00700427|764993|P5|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
317301|NCT00700427|764994|P4|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
317302|NCT00700427|764995|P3|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
317303|NCT00700427|764996|P2|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
317304|NCT00700427|764997|P1|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||2011
317305|NCT00700427|764993|P5|STARTED|Study Period 2 (Open-Label Acute Trx)||0
317306|NCT00700427|764994|P4|STARTED|Study Period 2 (Open-Label Acute Trx)||0
317307|NCT00700427|764995|P3|STARTED|Study Period 2 (Open-Label Acute Trx)||0
317308|NCT00700427|764996|P2|STARTED|Study Period 2 (Open-Label Acute Trx)||0
317309|NCT00700427|764997|P1|STARTED|Study Period 2 (Open-Label Acute Trx)||2017
317310|NCT00700401|765019|P1|NOT COMPLETED|Overall Study||94
317311|NCT00700401|765019|P1|COMPLETED|Overall Study||168
317312|NCT00700401|765019|P1|STARTED|Overall Study||262
317313|NCT00700375|765032|P2|NOT COMPLETED|Overall Study||0
317314|NCT00700375|765033|P1|NOT COMPLETED|Overall Study||0
317315|NCT00700375|765032|P2|COMPLETED|Overall Study||29
317316|NCT00700375|765033|P1|COMPLETED|Overall Study||30
317317|NCT00700375|765032|P2|2 Days After Creatinine Mesurement|Overall Study||29
317318|NCT00700375|765033|P1|2 Days After Creatinine Mesurement|Overall Study||30
317319|NCT00700375|765032|P2|STARTED|Overall Study||29
317320|NCT00700375|765033|P1|STARTED|Overall Study||30
317321|NCT00700310|765043|P4|NOT COMPLETED|Overall Study||26
317322|NCT00700310|765044|P3|NOT COMPLETED|Overall Study||16
317323|NCT00700310|765045|P2|NOT COMPLETED|Overall Study||26
317324|NCT00700310|765046|P1|NOT COMPLETED|Overall Study||21
317325|NCT00700310|765043|P4|COMPLETED|Overall Study||145
317326|NCT00700310|765044|P3|COMPLETED|Overall Study||158
317327|NCT00700310|765045|P2|COMPLETED|Overall Study||154
317328|NCT00700310|765046|P1|COMPLETED|Overall Study||166
317329|NCT00700310|765043|P4|STARTED|Overall Study||171
317330|NCT00700310|765044|P3|STARTED|Overall Study||174
317331|NCT00700310|765045|P2|STARTED|Overall Study||180
317332|NCT00700310|765046|P1|STARTED|Overall Study||187
317333|NCT00700271|765066|P2|NOT COMPLETED|Overall Study||12
317334|NCT00700271|765067|P1|NOT COMPLETED|Overall Study||14
317335|NCT00700271|765066|P2|COMPLETED|Overall Study||256
317336|NCT00700271|765067|P1|COMPLETED|Overall Study||264
317337|NCT00700271|765066|P2|STARTED|Overall Study||268
317338|NCT00700271|765067|P1|STARTED|Overall Study||278
317339|NCT00700180|765095|P2|NOT COMPLETED|Overall Study||149
317340|NCT00700180|765096|P1|NOT COMPLETED|Overall Study||154
317341|NCT00700180|765095|P2|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
317342|NCT00700180|765096|P1|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
317343|NCT00700180|765095|P2|STARTED|Overall Study||149
317344|NCT00700180|765096|P1|STARTED|Overall Study||154
317345|NCT00700141|765118|P1|NOT COMPLETED|Overall Study||0
317346|NCT00700141|765118|P1|COMPLETED|Overall Study||482
317347|NCT00700141|765118|P1|STARTED|Overall Study||482
317348|NCT00700115|765125|P2|NOT COMPLETED|Overall Study||1
317349|NCT00700115|765126|P1|NOT COMPLETED|Overall Study||1
317350|NCT00700115|765125|P2|COMPLETED|Overall Study||19
317351|NCT00700115|765126|P1|COMPLETED|Overall Study||39
317352|NCT00700115|765125|P2|STARTED|Overall Study||20
317353|NCT00700115|765126|P1|STARTED|Overall Study||40
317354|NCT00700102|765136|P2|NOT COMPLETED|Overall Study||395
317355|NCT00700102|765137|P1|NOT COMPLETED|Overall Study||402
317356|NCT00700102|765136|P2|COMPLETED|Overall Study||14
317357|NCT00700102|765137|P1|COMPLETED|Overall Study||9
317358|NCT00700102|765136|P2|Received at Least One Dose|Overall Study||403
317359|NCT00700102|765137|P1|Received at Least One Dose|Overall Study||407
317360|NCT00700102|765136|P2|Intention to Treat|Overall Study||409
317361|NCT00700102|765137|P1|Intention to Treat|Overall Study||410
317362|NCT00700102|765136|P2|STARTED|Overall Study||409
317363|NCT00700102|765137|P1|STARTED|Overall Study||411
317364|NCT00700063|765161|P8|NOT COMPLETED|Overall Study||0
317365|NCT00700063|765162|P7|NOT COMPLETED|Overall Study||0
317366|NCT00700063|765163|P6|NOT COMPLETED|Overall Study||0
317367|NCT00700063|765164|P5|NOT COMPLETED|Overall Study||2
317368|NCT00700063|765165|P4|NOT COMPLETED|Overall Study||2
317369|NCT00700063|765166|P3|NOT COMPLETED|Overall Study||0
317370|NCT00700063|765167|P2|NOT COMPLETED|Overall Study||0
317371|NCT00700063|765168|P1|NOT COMPLETED|Overall Study||1
317372|NCT00700063|765161|P8|COMPLETED|Overall Study||33
317373|NCT00700063|765162|P7|COMPLETED|Overall Study||32
317374|NCT00700063|765163|P6|COMPLETED|Overall Study||34
317375|NCT00700063|765164|P5|COMPLETED|Overall Study||31
317376|NCT00700063|765165|P4|COMPLETED|Overall Study||31
317377|NCT00700063|765166|P3|COMPLETED|Overall Study||33
317378|NCT00700063|765167|P2|COMPLETED|Overall Study||34
317379|NCT00700063|765168|P1|COMPLETED|Overall Study||32
317380|NCT00700063|765161|P8|STARTED|Overall Study||33
317381|NCT00700063|765162|P7|STARTED|Overall Study||32
317382|NCT00700063|765163|P6|STARTED|Overall Study||34
317383|NCT00700063|765164|P5|STARTED|Overall Study||33
317384|NCT00700063|765165|P4|STARTED|Overall Study||33
317385|NCT00700063|765166|P3|STARTED|Overall Study||33
317386|NCT00700063|765167|P2|STARTED|Overall Study||34
317387|NCT00700063|765168|P1|STARTED|Overall Study||33
317388|NCT00700011|765276|P2|NOT COMPLETED|Overall Study||1
317389|NCT00700011|765277|P1|NOT COMPLETED|Overall Study||0
317390|NCT00700011|765276|P2|COMPLETED|Overall Study||1
317391|NCT00700011|765277|P1|COMPLETED|Overall Study||8
317392|NCT00700011|765276|P2|STARTED|Overall Study||2
317393|NCT00700011|765277|P1|STARTED|Overall Study||8
317394|NCT00699998|765293|P4|NOT COMPLETED|Overall Study||82
317395|NCT00699998|765294|P3|NOT COMPLETED|Overall Study||206
317396|NCT00699998|765295|P2|NOT COMPLETED|Overall Study||86
317397|NCT00699998|765296|P1|NOT COMPLETED|Overall Study||199
317398|NCT00699998|765293|P4|COMPLETED|Overall Study||958
317399|NCT00699998|765294|P3|COMPLETED|Overall Study||3417
317400|NCT00699998|765295|P2|COMPLETED|Overall Study||957
317401|NCT00699998|765296|P1|COMPLETED|Overall Study||3421
317402|NCT00699998|765293|P4|Received at Least 1 Dose of Study Drug|Overall Study||1027
317403|NCT00699998|765294|P3|Received at Least 1 Dose of Study Drug|Overall Study||3590
317404|NCT00699998|765295|P2|Received at Least 1 Dose of Study Drug|Overall Study||1033
317405|NCT00699998|765296|P1|Received at Least 1 Dose of Study Drug|Overall Study||3590
317406|NCT00699998|765293|P4|STARTED|Overall Study||1040
317407|NCT00699998|765294|P3|STARTED|Overall Study||3623
317408|NCT00699998|765295|P2|STARTED|Overall Study||1043
317409|NCT00699998|765296|P1|STARTED|Overall Study||3620
317410|NCT00699972|765341|P3|NOT COMPLETED|Overall Study||35
317411|NCT00699972|765342|P2|NOT COMPLETED|Overall Study||19
317412|NCT00699972|765343|P1|NOT COMPLETED|Overall Study||16
317413|NCT00699972|765341|P3|COMPLETED|Overall Study||100
317414|NCT00699972|765342|P2|COMPLETED|Overall Study||114
317415|NCT00699972|765343|P1|COMPLETED|Overall Study||106
317416|NCT00699972|765341|P3|STARTED|Overall Study||135
317417|NCT00699972|765342|P2|STARTED|Overall Study||133
317418|NCT00699972|765343|P1|STARTED|Overall Study||122
317419|NCT00699907|765360|P3|NOT COMPLETED|Overall Study||8
317420|NCT00699907|765361|P2|NOT COMPLETED|Overall Study||10
317421|NCT00699907|765362|P1|NOT COMPLETED|Overall Study||2
317422|NCT00699907|765360|P3|COMPLETED|Overall Study||48
317423|NCT00699907|765361|P2|COMPLETED|Overall Study||47
317424|NCT00699907|765362|P1|COMPLETED|Overall Study||12
317425|NCT00699907|765360|P3|STARTED|Overall Study||56
317426|NCT00699907|765361|P2|STARTED|Overall Study||57
317427|NCT00699907|765362|P1|STARTED|Overall Study||14
317428|NCT00699842|765397|P3|NOT COMPLETED|Overall Study||0
317429|NCT00699842|765398|P2|NOT COMPLETED|Overall Study||1
317430|NCT00699842|765399|P1|NOT COMPLETED|Overall Study||0
317431|NCT00699842|765397|P3|COMPLETED|Overall Study||0
317432|NCT00699842|765398|P2|COMPLETED|Overall Study||4
317433|NCT00699842|765399|P1|COMPLETED|Overall Study||3
317434|NCT00699842|765397|P3|STARTED|Overall Study||0
317435|NCT00699842|765398|P2|STARTED|Overall Study||5
317436|NCT00699842|765399|P1|STARTED|Overall Study||3
317437|NCT00699816|765412|P2|NOT COMPLETED|Overall Study||3
317438|NCT00699816|765413|P1|NOT COMPLETED|Overall Study||1
317439|NCT00699816|765412|P2|COMPLETED|Overall Study||112
317440|NCT00699816|765413|P1|COMPLETED|Overall Study||114
317441|NCT00699816|765412|P2|STARTED|Overall Study||115
317442|NCT00699816|765413|P1|STARTED|Overall Study||115
317443|NCT00699751|765431|P2|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||9
317444|NCT00699751|765432|P1|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||0
317445|NCT00699751|765431|P2|COMPLETED|Period 2:Switched From Placebo to Xofigo|Completed all 6 injections|17
317446|NCT00699751|765432|P1|COMPLETED|Period 2:Switched From Placebo to Xofigo||0
317447|NCT00699751|765431|P2|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
317448|NCT00699751|765432|P1|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
317449|NCT00699751|765431|P2|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||15
317450|NCT00699751|765432|P1|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
317451|NCT00699751|765431|P2|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||24
317452|NCT00699751|765432|P1|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||0
317453|NCT00699751|765431|P2|STARTED|Period 2:Switched From Placebo to Xofigo|Participants in the placebo group switched to Xofigo treatment|26
317454|NCT00699751|765432|P1|STARTED|Period 2:Switched From Placebo to Xofigo||0
317455|NCT00699751|765431|P2|NOT COMPLETED|Period 1: Without/Before Drug Switch||162
317456|NCT00699751|765432|P1|NOT COMPLETED|Period 1: Without/Before Drug Switch||225
317457|NCT00699751|765431|P2|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|145
317458|NCT00699751|765432|P1|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|389
317459|NCT00699751|765431|P2|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||12
317460|NCT00699751|765432|P1|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||49
317461|NCT00699751|765431|P2|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|168
317462|NCT00699751|765432|P1|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|407
317463|NCT00699751|765431|P2|Participants Received Treatment|Period 1: Without/Before Drug Switch||301
317464|NCT00699751|765432|P1|Participants Received Treatment|Period 1: Without/Before Drug Switch||600
317465|NCT00699751|765431|P2|STARTED|Period 1: Without/Before Drug Switch||307
317466|NCT00699751|765432|P1|STARTED|Period 1: Without/Before Drug Switch||614
317467|NCT00699699|765517|P1|NOT COMPLETED|Overall Study||57
317468|NCT00699699|765517|P1|COMPLETED|Overall Study||1223
317469|NCT00699699|765517|P1|STARTED|Overall Study||1280
317470|NCT00699660|765526|P2|NOT COMPLETED|Overall Study||8
317471|NCT00699660|765527|P1|NOT COMPLETED|Overall Study||14
317472|NCT00699660|765526|P2|COMPLETED|Overall Study||208
317473|NCT00699660|765527|P1|COMPLETED|Overall Study||176
317474|NCT00699660|765526|P2|STARTED|Overall Study||216
317475|NCT00699660|765527|P1|STARTED|Overall Study||190
317476|NCT00699608|765539|P6|NOT COMPLETED|Third Intervention||0
317477|NCT00699608|765540|P5|NOT COMPLETED|Third Intervention||0
317478|NCT00699608|765541|P4|NOT COMPLETED|Third Intervention||0
317479|NCT00699608|765542|P3|NOT COMPLETED|Third Intervention||0
317480|NCT00699608|765543|P2|NOT COMPLETED|Third Intervention||0
317481|NCT00699608|765544|P1|NOT COMPLETED|Third Intervention||0
317482|NCT00699608|765539|P6|COMPLETED|Third Intervention||15
317483|NCT00699608|765540|P5|COMPLETED|Third Intervention||14
317484|NCT00699608|765541|P4|COMPLETED|Third Intervention||14
317485|NCT00699608|765542|P3|COMPLETED|Third Intervention||13
317486|NCT00699608|765543|P2|COMPLETED|Third Intervention||15
317487|NCT00699608|765544|P1|COMPLETED|Third Intervention||16
317488|NCT00699608|765539|P6|STARTED|Third Intervention||15
317489|NCT00699608|765540|P5|STARTED|Third Intervention||14
317490|NCT00699608|765541|P4|STARTED|Third Intervention||14
317491|NCT00699608|765542|P3|STARTED|Third Intervention||13
317492|NCT00699608|765543|P2|STARTED|Third Intervention||15
317493|NCT00699608|765544|P1|STARTED|Third Intervention||16
317494|NCT00699608|765539|P6|NOT COMPLETED|Second 4-14 Day Washout Period||0
317495|NCT00699608|765540|P5|NOT COMPLETED|Second 4-14 Day Washout Period||0
317496|NCT00699608|765541|P4|NOT COMPLETED|Second 4-14 Day Washout Period||0
317497|NCT00699608|765542|P3|NOT COMPLETED|Second 4-14 Day Washout Period||0
317498|NCT00699608|765543|P2|NOT COMPLETED|Second 4-14 Day Washout Period||0
317499|NCT00699608|765544|P1|NOT COMPLETED|Second 4-14 Day Washout Period||0
317500|NCT00699608|765539|P6|COMPLETED|Second 4-14 Day Washout Period||15
317501|NCT00699608|765540|P5|COMPLETED|Second 4-14 Day Washout Period||14
317502|NCT00699608|765541|P4|COMPLETED|Second 4-14 Day Washout Period||14
317503|NCT00699608|765542|P3|COMPLETED|Second 4-14 Day Washout Period||13
317504|NCT00699608|765543|P2|COMPLETED|Second 4-14 Day Washout Period||15
317505|NCT00699608|765544|P1|COMPLETED|Second 4-14 Day Washout Period||16
317506|NCT00699608|765539|P6|STARTED|Second 4-14 Day Washout Period||15
317507|NCT00699608|765540|P5|STARTED|Second 4-14 Day Washout Period||14
317508|NCT00699608|765541|P4|STARTED|Second 4-14 Day Washout Period||14
317509|NCT00699608|765542|P3|STARTED|Second 4-14 Day Washout Period||13
317510|NCT00699608|765543|P2|STARTED|Second 4-14 Day Washout Period||15
317511|NCT00699608|765544|P1|STARTED|Second 4-14 Day Washout Period||16
317512|NCT00699608|765539|P6|NOT COMPLETED|Second Intervention||0
317513|NCT00699608|765540|P5|NOT COMPLETED|Second Intervention||0
317514|NCT00699608|765541|P4|NOT COMPLETED|Second Intervention||1
317515|NCT00699608|765542|P3|NOT COMPLETED|Second Intervention||1
317516|NCT00699608|765543|P2|NOT COMPLETED|Second Intervention||0
317517|NCT00699608|765544|P1|NOT COMPLETED|Second Intervention||0
317518|NCT00699608|765539|P6|COMPLETED|Second Intervention||15
317519|NCT00699608|765540|P5|COMPLETED|Second Intervention||14
317520|NCT00699608|765541|P4|COMPLETED|Second Intervention||14
317521|NCT00699608|765542|P3|COMPLETED|Second Intervention||13
317522|NCT00699608|765543|P2|COMPLETED|Second Intervention||15
317523|NCT00699608|765544|P1|COMPLETED|Second Intervention||16
317524|NCT00699608|765539|P6|STARTED|Second Intervention||15
317525|NCT00699608|765540|P5|STARTED|Second Intervention||14
317526|NCT00699608|765541|P4|STARTED|Second Intervention||15
317527|NCT00699608|765542|P3|STARTED|Second Intervention||14
317528|NCT00699608|765543|P2|STARTED|Second Intervention||15
317529|NCT00699608|765544|P1|STARTED|Second Intervention||16
317530|NCT00699608|765539|P6|NOT COMPLETED|First 4-14 Day Washout Period||0
317531|NCT00699608|765540|P5|NOT COMPLETED|First 4-14 Day Washout Period||0
317532|NCT00699608|765541|P4|NOT COMPLETED|First 4-14 Day Washout Period||0
317533|NCT00699608|765542|P3|NOT COMPLETED|First 4-14 Day Washout Period||0
317534|NCT00699608|765543|P2|NOT COMPLETED|First 4-14 Day Washout Period||0
317535|NCT00699608|765544|P1|NOT COMPLETED|First 4-14 Day Washout Period||0
317536|NCT00699608|765539|P6|COMPLETED|First 4-14 Day Washout Period||15
317537|NCT00699608|765540|P5|COMPLETED|First 4-14 Day Washout Period||14
317538|NCT00699608|765541|P4|COMPLETED|First 4-14 Day Washout Period||15
317539|NCT00699608|765542|P3|COMPLETED|First 4-14 Day Washout Period||14
317540|NCT00699608|765543|P2|COMPLETED|First 4-14 Day Washout Period||15
317541|NCT00699608|765544|P1|COMPLETED|First 4-14 Day Washout Period||16
317542|NCT00699608|765539|P6|STARTED|First 4-14 Day Washout Period||15
317543|NCT00699608|765540|P5|STARTED|First 4-14 Day Washout Period||14
317544|NCT00699608|765541|P4|STARTED|First 4-14 Day Washout Period||15
317545|NCT00699608|765542|P3|STARTED|First 4-14 Day Washout Period||14
317546|NCT00699608|765543|P2|STARTED|First 4-14 Day Washout Period||15
317547|NCT00699608|765544|P1|STARTED|First 4-14 Day Washout Period||16
317548|NCT00699608|765539|P6|NOT COMPLETED|First Intervention||0
317549|NCT00699608|765540|P5|NOT COMPLETED|First Intervention||1
317550|NCT00699608|765541|P4|NOT COMPLETED|First Intervention||0
317551|NCT00699608|765542|P3|NOT COMPLETED|First Intervention||1
317552|NCT00699608|765543|P2|NOT COMPLETED|First Intervention||0
317553|NCT00699608|765544|P1|NOT COMPLETED|First Intervention||0
317554|NCT00699608|765539|P6|COMPLETED|First Intervention||15
317555|NCT00699608|765540|P5|COMPLETED|First Intervention||14
317556|NCT00699608|765541|P4|COMPLETED|First Intervention||15
317557|NCT00699608|765542|P3|COMPLETED|First Intervention||14
317558|NCT00699608|765543|P2|COMPLETED|First Intervention||15
317559|NCT00699608|765544|P1|COMPLETED|First Intervention||16
317560|NCT00699608|765539|P6|STARTED|First Intervention||15
317561|NCT00699608|765540|P5|STARTED|First Intervention||15
317562|NCT00699608|765541|P4|STARTED|First Intervention||15
317563|NCT00699608|765542|P3|STARTED|First Intervention||15
317564|NCT00699608|765543|P2|STARTED|First Intervention||15
317565|NCT00699608|765544|P1|STARTED|First Intervention||16
317566|NCT00699582|765597|P3|NOT COMPLETED|Overall Study||28
317567|NCT00699582|765598|P2|NOT COMPLETED|Overall Study||22
317568|NCT00699582|765599|P1|NOT COMPLETED|Overall Study||18
317569|NCT00699582|765597|P3|COMPLETED|Overall Study||93
317570|NCT00699582|765598|P2|COMPLETED|Overall Study||108
317571|NCT00699582|765599|P1|COMPLETED|Overall Study||120
317572|NCT00699582|765597|P3|STARTED|Overall Study||121
317573|NCT00699582|765598|P2|STARTED|Overall Study||130
317574|NCT00699582|765599|P1|STARTED|Overall Study||138
317575|NCT00699556|765613|P2|NOT COMPLETED|Second Intervention (1 Day)||0
317576|NCT00699556|765614|P1|NOT COMPLETED|Second Intervention (1 Day)||0
317577|NCT00699556|765613|P2|COMPLETED|Second Intervention (1 Day)||11
317578|NCT00699556|765614|P1|COMPLETED|Second Intervention (1 Day)||11
317579|NCT00699556|765613|P2|STARTED|Second Intervention (1 Day)||11
317580|NCT00699556|765614|P1|STARTED|Second Intervention (1 Day)||11
317581|NCT00699556|765613|P2|NOT COMPLETED|First Intervention (1 Day)||0
317582|NCT00699556|765614|P1|NOT COMPLETED|First Intervention (1 Day)||0
317583|NCT00699556|765613|P2|COMPLETED|First Intervention (1 Day)||11
317584|NCT00699556|765614|P1|COMPLETED|First Intervention (1 Day)||11
317585|NCT00699556|765613|P2|STARTED|First Intervention (1 Day)||11
317586|NCT00699556|765614|P1|STARTED|First Intervention (1 Day)||11
317587|NCT00699491|765628|P6|NOT COMPLETED|Overall Study||0
317588|NCT00699491|765629|P5|NOT COMPLETED|Overall Study||0
317589|NCT00699491|765630|P4|NOT COMPLETED|Overall Study||0
317590|NCT00699491|765631|P3|NOT COMPLETED|Overall Study||0
317591|NCT00699491|765632|P2|NOT COMPLETED|Overall Study||0
317592|NCT00699491|765633|P1|NOT COMPLETED|Overall Study||0
317593|NCT00699491|765628|P6|COMPLETED|Overall Study||22
317594|NCT00699491|765629|P5|COMPLETED|Overall Study||8
317595|NCT00699491|765630|P4|COMPLETED|Overall Study||6
317596|NCT00699491|765631|P3|COMPLETED|Overall Study||7
317597|NCT00699491|765632|P2|COMPLETED|Overall Study||2
317598|NCT00699491|765633|P1|COMPLETED|Overall Study||3
317599|NCT00699491|765628|P6|STARTED|Overall Study||22
317600|NCT00699491|765629|P5|STARTED|Overall Study||8
317601|NCT00699491|765630|P4|STARTED|Overall Study||6
317602|NCT00699491|765631|P3|STARTED|Overall Study||7
317603|NCT00699491|765632|P2|STARTED|Overall Study||2
317604|NCT00699491|765633|P1|STARTED|Overall Study||3
317605|NCT00699413|765654|P2|NOT COMPLETED|Overall Study||4
317606|NCT00699413|765655|P1|NOT COMPLETED|Overall Study||4
317607|NCT00699413|765654|P2|COMPLETED|Overall Study||0
317608|NCT00699413|765655|P1|COMPLETED|Overall Study||0
317609|NCT00699413|765654|P2|STARTED|Overall Study||4
317610|NCT00699413|765655|P1|STARTED|Overall Study||4
317611|NCT00699400|765670|P6|NOT COMPLETED|Overall Study||11
317612|NCT00699400|765671|P5|NOT COMPLETED|Overall Study||0
317613|NCT00699400|765672|P4|NOT COMPLETED|Overall Study||0
317614|NCT00699400|765673|P3|NOT COMPLETED|Overall Study||0
317615|NCT00699400|765674|P2|NOT COMPLETED|Overall Study||0
317616|NCT00699400|765675|P1|NOT COMPLETED|Overall Study||0
317617|NCT00699400|765670|P6|COMPLETED|Overall Study||0
317618|NCT00699400|765671|P5|COMPLETED|Overall Study||4
317619|NCT00699400|765672|P4|COMPLETED|Overall Study||6
317620|NCT00699400|765673|P3|COMPLETED|Overall Study||138
317621|NCT00699400|765674|P2|COMPLETED|Overall Study||3
317622|NCT00699400|765675|P1|COMPLETED|Overall Study||42
317623|NCT00699400|765670|P6|STARTED|Overall Study||11
317624|NCT00699400|765671|P5|STARTED|Overall Study||4
317625|NCT00699400|765672|P4|STARTED|Overall Study||6
317626|NCT00699400|765673|P3|STARTED|Overall Study||138
317627|NCT00699400|765674|P2|STARTED|Overall Study||3
317628|NCT00699400|765675|P1|STARTED|Overall Study||42
317629|NCT00699374|765709|P2|NOT COMPLETED|Overall Study||544
317630|NCT00699374|765710|P1|NOT COMPLETED|Overall Study||530
317631|NCT00699374|765709|P2|COMPLETED|Overall Study||0
317632|NCT00699374|765710|P1|COMPLETED|Overall Study||0
317633|NCT00699374|765709|P2|Treated|Overall Study||542
317634|NCT00699374|765710|P1|Treated|Overall Study||526
317635|NCT00699374|765709|P2|STARTED|Overall Study||544
317636|NCT00699374|765710|P1|STARTED|Overall Study||530
317637|NCT00699348|765722|P1|NOT COMPLETED|Overall Study||90
317638|NCT00699348|765722|P1|COMPLETED|Overall Study||261
317639|NCT00699348|765722|P1|STARTED|Overall Study||351
317640|NCT00699335|765731|P1|NOT COMPLETED|Overall Study||228
317641|NCT00699335|765731|P1|COMPLETED|Overall Study||5080
317642|NCT00699335|765731|P1|STARTED|Overall Study||5308
317643|NCT00699283|765764|P2|NOT COMPLETED|Overall Study||8
317644|NCT00699283|765765|P1|NOT COMPLETED|Overall Study||33
317645|NCT00699283|765764|P2|COMPLETED|Overall Study||7
317646|NCT00699283|765765|P1|COMPLETED|Overall Study||14
317647|NCT00699283|765764|P2|STARTED|Overall Study||15
317648|NCT00699283|765765|P1|STARTED|Overall Study||47
317649|NCT00699218|765770|P1|NOT COMPLETED|Overall Study||0
317650|NCT00699218|765770|P1|COMPLETED|Overall Study||15
317651|NCT00699218|765770|P1|STARTED|Overall Study||15
317652|NCT00699192|765778|P3|NOT COMPLETED|Overall Study||11
317653|NCT00699192|765779|P2|NOT COMPLETED|Overall Study||12
317654|NCT00699192|765780|P1|NOT COMPLETED|Overall Study||16
317655|NCT00699192|765778|P3|COMPLETED|Overall Study||261
317656|NCT00699192|765779|P2|COMPLETED|Overall Study||260
317657|NCT00699192|765780|P1|COMPLETED|Overall Study||259
317658|NCT00699192|765778|P3|STARTED|Overall Study||272
317659|NCT00699192|765779|P2|STARTED|Overall Study||272
317660|NCT00699192|765780|P1|STARTED|Overall Study||275
317661|NCT00699153|765802|P2|NOT COMPLETED|Overall Study||2
317662|NCT00699153|765803|P1|NOT COMPLETED|Overall Study||3
317663|NCT00699153|765802|P2|COMPLETED|Overall Study||200
317664|NCT00699153|765803|P1|COMPLETED|Overall Study||200
317665|NCT00699153|765802|P2|STARTED|Overall Study|Intent to treat population|202
317666|NCT00699153|765803|P1|STARTED|Overall Study|Intent to treat population|203
317667|NCT00699140|765815|P1|NOT COMPLETED|Overall Study||0
317668|NCT00699140|765815|P1|COMPLETED|Overall Study||18
317669|NCT00699140|765815|P1|STARTED|Overall Study||18
317670|NCT00699010|765829|P2|NOT COMPLETED|Overall Study||0
317671|NCT00699010|765830|P1|NOT COMPLETED|Overall Study||0
317672|NCT00699010|765829|P2|COMPLETED|Overall Study||15
317673|NCT00699010|765830|P1|COMPLETED|Overall Study||15
317674|NCT00699010|765829|P2|STARTED|Overall Study||15
317675|NCT00699010|765830|P1|STARTED|Overall Study||15
317676|NCT00698932|765838|P2|NOT COMPLETED|Overall Study||36
317677|NCT00698932|765839|P1|NOT COMPLETED|Overall Study||22
317678|NCT00698932|765838|P2|COMPLETED|Overall Study|Completed 24 Weeks of treatment|248
317679|NCT00698932|765839|P1|COMPLETED|Overall Study|Completed 24 Weeks of treatment|262
317680|NCT00698932|765838|P2|STARTED|Overall Study|Randomized and treated|284
317681|NCT00698932|765839|P1|STARTED|Overall Study|Randomized and treated|284
317682|NCT00698867|765855|P1|NOT COMPLETED|Overall Study||91
317683|NCT00698867|765855|P1|COMPLETED|Overall Study||27
317684|NCT00698867|765855|P1|Subjects With 4 Year Data|Overall Study||34
317685|NCT00698867|765855|P1|Subjects With 3 Year Data|Overall Study||35
317686|NCT00698867|765855|P1|Subjects With 2 Year Data|Overall Study||55
317687|NCT00698867|765855|P1|Subjects With 1 Year Data|Overall Study||68
317688|NCT00698867|765855|P1|STARTED|Overall Study||118
317689|NCT00698841|765865|P1|NOT COMPLETED|Overall Study||18
317690|NCT00698841|765865|P1|COMPLETED|Overall Study||33
317691|NCT00698841|765865|P1|STARTED|Overall Study||51
317692|NCT00698815|765879|P3|NOT COMPLETED|Overall Study||10
317693|NCT00698815|765880|P2|NOT COMPLETED|Overall Study||14
317694|NCT00698815|765881|P1|NOT COMPLETED|Overall Study||10
317695|NCT00698815|765879|P3|COMPLETED|Overall Study||31
317696|NCT00698815|765880|P2|COMPLETED|Overall Study||33
317697|NCT00698815|765881|P1|COMPLETED|Overall Study||32
317698|NCT00698815|765879|P3|STARTED|Overall Study||41
317699|NCT00698815|765880|P2|STARTED|Overall Study||47
317700|NCT00698815|765881|P1|STARTED|Overall Study||42
317701|NCT00698685|765898|P1|NOT COMPLETED|Overall Study||2
317702|NCT00698685|765898|P1|COMPLETED|Overall Study||12
317703|NCT00698685|765898|P1|STARTED|Overall Study||14
317704|NCT00698646|765906|P3|NOT COMPLETED|Overall Study||29
317705|NCT00698646|765907|P2|NOT COMPLETED|Overall Study||31
317706|NCT00698646|765908|P1|NOT COMPLETED|Overall Study||36
317707|NCT00698646|765906|P3|COMPLETED|Overall Study||99
317708|NCT00698646|765907|P2|COMPLETED|Overall Study||97
317709|NCT00698646|765908|P1|COMPLETED|Overall Study||92
317710|NCT00698646|765906|P3|STARTED|Overall Study||128
317711|NCT00698646|765907|P2|STARTED|Overall Study||128
317712|NCT00698646|765908|P1|STARTED|Overall Study||128
317713|NCT00698581|765933|P2|NOT COMPLETED|Overall Study||12
317714|NCT00698581|765934|P1|NOT COMPLETED|Overall Study||45
317715|NCT00698581|765933|P2|COMPLETED|Overall Study||8
317716|NCT00698581|765934|P1|COMPLETED|Overall Study||23
317717|NCT00698581|765933|P2|STARTED|Overall Study||20
317718|NCT00698581|765934|P1|STARTED|Overall Study||68
317719|NCT00698516|765945|P1|NOT COMPLETED|Overall Study||5
317720|NCT00698516|765945|P1|COMPLETED|Overall Study||45
317721|NCT00698516|765945|P1|STARTED|Overall Study||50
317722|NCT00698451|765963|P1|NOT COMPLETED|Overall Study||39
317723|NCT00698451|765963|P1|COMPLETED|Overall Study||15
317724|NCT00698451|765963|P1|STARTED|Overall Study||54
317725|NCT00698204|765970|P2|NOT COMPLETED|Overall Study||0
317726|NCT00698204|765971|P1|NOT COMPLETED|Overall Study||1
317727|NCT00698204|765970|P2|COMPLETED|Overall Study||20
317728|NCT00698204|765971|P1|COMPLETED|Overall Study||19
317729|NCT00698204|765970|P2|STARTED|Overall Study||20
317730|NCT00698204|765971|P1|STARTED|Overall Study||20
317731|NCT00698139|765982|P3|NOT COMPLETED|Overall Study||0
317732|NCT00698139|765983|P2|NOT COMPLETED|Overall Study||0
317733|NCT00698139|765984|P1|NOT COMPLETED|Overall Study||0
317734|NCT00698139|765982|P3|COMPLETED|Overall Study||1
317735|NCT00698139|765983|P2|COMPLETED|Overall Study||1
317736|NCT00698139|765984|P1|COMPLETED|Overall Study||1
317737|NCT00698139|765982|P3|2nd Visit|Overall Study|1 subject in the Intervention Group did not have a 2nd visit (per design).|0
317738|NCT00698139|765983|P2|2nd Visit|Overall Study||1
317739|NCT00698139|765984|P1|2nd Visit|Overall Study||1
317740|NCT00698139|765982|P3|STARTED|Overall Study||1
317741|NCT00698139|765983|P2|STARTED|Overall Study||1
317742|NCT00698139|765984|P1|STARTED|Overall Study||1
317743|NCT00698035|766000|P2|NOT COMPLETED|Overall Study||2
317744|NCT00698035|766001|P1|NOT COMPLETED|Overall Study||4
317745|NCT00698035|766000|P2|COMPLETED|Overall Study||34
317746|NCT00698035|766001|P1|COMPLETED|Overall Study||35
317747|NCT00698035|766000|P2|STARTED|Overall Study||36
317748|NCT00698035|766001|P1|STARTED|Overall Study||39
317749|NCT00698022|766021|P3|NOT COMPLETED|Overall Study||2
317750|NCT00698022|766022|P2|NOT COMPLETED|Overall Study||10
317751|NCT00698022|766023|P1|NOT COMPLETED|Overall Study||16
317752|NCT00698022|766021|P3|COMPLETED|Overall Study||14
317753|NCT00698022|766022|P2|COMPLETED|Overall Study||20
317754|NCT00698022|766023|P1|COMPLETED|Overall Study||14
317755|NCT00698022|766021|P3|STARTED|Overall Study||16
317756|NCT00698022|766022|P2|STARTED|Overall Study||30
317757|NCT00698022|766023|P1|STARTED|Overall Study||30
317758|NCT00698009|766031|P1|NOT COMPLETED|Overall Study||1
317759|NCT00698009|766031|P1|COMPLETED|Overall Study||0
317760|NCT00698009|766031|P1|STARTED|Overall Study||1
317761|NCT00697827|766037|P2|NOT COMPLETED|Overall Study||1
317762|NCT00697827|766038|P1|NOT COMPLETED|Overall Study||2
317763|NCT00697827|766037|P2|COMPLETED|Overall Study||15
317764|NCT00697827|766038|P1|COMPLETED|Overall Study||26
317765|NCT00697827|766037|P2|STARTED|Overall Study||16
317766|NCT00697827|766038|P1|STARTED|Overall Study||28
317767|NCT00697801|766049|P3|NOT COMPLETED|Overall Study||24
317768|NCT00697801|766050|P2|NOT COMPLETED|Overall Study||12
317769|NCT00697801|766051|P1|NOT COMPLETED|Overall Study||12
317770|NCT00697801|766049|P3|COMPLETED|Overall Study||45
317771|NCT00697801|766050|P2|COMPLETED|Overall Study||58
317772|NCT00697801|766051|P1|COMPLETED|Overall Study||57
317773|NCT00697801|766049|P3|STARTED|Overall Study||69
317774|NCT00697801|766050|P2|STARTED|Overall Study||70
317775|NCT00697801|766051|P1|STARTED|Overall Study||69
317776|NCT00697788|766065|P8|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
317777|NCT00697788|766066|P7|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
317778|NCT00697788|766067|P6|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
317779|NCT00697788|766068|P5|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
317780|NCT00697788|766069|P4|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
317781|NCT00697788|766070|P3|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
317782|NCT00697788|766071|P2|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
317783|NCT00697788|766072|P1|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
317784|NCT00697788|766065|P8|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
317785|NCT00697788|766066|P7|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
317786|NCT00697788|766067|P6|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
317787|NCT00697788|766068|P5|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
317788|NCT00697788|766069|P4|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
317789|NCT00697788|766070|P3|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
317790|NCT00697788|766071|P2|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
317791|NCT00697788|766072|P1|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
317792|NCT00697788|766065|P8|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
317793|NCT00697788|766066|P7|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
317794|NCT00697788|766067|P6|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
318108|NCT00696709|766613|P2|COMPLETED|Overall Study||60
317795|NCT00697788|766068|P5|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
317796|NCT00697788|766069|P4|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
317797|NCT00697788|766070|P3|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
317798|NCT00697788|766071|P2|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
317799|NCT00697788|766072|P1|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
317800|NCT00697788|766065|P8|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
317801|NCT00697788|766066|P7|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
317802|NCT00697788|766067|P6|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
317803|NCT00697788|766068|P5|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
317804|NCT00697788|766069|P4|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
317805|NCT00697788|766070|P3|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
317806|NCT00697788|766071|P2|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
317807|NCT00697788|766072|P1|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
317808|NCT00697788|766065|P8|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
317809|NCT00697788|766066|P7|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
317810|NCT00697788|766067|P6|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
317811|NCT00697788|766068|P5|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
317812|NCT00697788|766069|P4|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
317813|NCT00697788|766070|P3|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
317814|NCT00697788|766071|P2|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
317815|NCT00697788|766072|P1|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
317816|NCT00697788|766065|P8|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
317817|NCT00697788|766066|P7|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
317818|NCT00697788|766067|P6|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
317819|NCT00697788|766068|P5|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
317820|NCT00697788|766069|P4|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
317821|NCT00697788|766070|P3|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
317822|NCT00697788|766071|P2|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
317823|NCT00697788|766072|P1|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
317824|NCT00697788|766065|P8|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
317825|NCT00697788|766066|P7|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
317826|NCT00697788|766067|P6|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
317827|NCT00697788|766068|P5|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
317828|NCT00697788|766069|P4|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
317829|NCT00697788|766070|P3|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
317830|NCT00697788|766071|P2|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
317831|NCT00697788|766072|P1|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
317832|NCT00697788|766065|P8|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
317833|NCT00697788|766066|P7|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
317834|NCT00697788|766067|P6|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
317835|NCT00697788|766068|P5|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
317836|NCT00697788|766069|P4|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
317837|NCT00697788|766070|P3|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
317838|NCT00697788|766071|P2|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
317839|NCT00697788|766072|P1|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
317840|NCT00697788|766065|P8|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
317841|NCT00697788|766066|P7|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
317842|NCT00697788|766067|P6|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
317843|NCT00697788|766068|P5|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
317844|NCT00697788|766069|P4|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
317845|NCT00697788|766070|P3|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
317846|NCT00697788|766071|P2|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
317847|NCT00697788|766072|P1|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
317848|NCT00697788|766065|P8|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
317849|NCT00697788|766066|P7|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
317850|NCT00697788|766067|P6|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
317851|NCT00697788|766068|P5|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||1
317852|NCT00697788|766069|P4|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
317853|NCT00697788|766070|P3|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
317854|NCT00697788|766071|P2|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
317855|NCT00697788|766072|P1|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
317856|NCT00697788|766065|P8|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
317857|NCT00697788|766066|P7|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
317858|NCT00697788|766067|P6|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
317859|NCT00697788|766068|P5|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||2
317860|NCT00697788|766069|P4|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
317861|NCT00697788|766070|P3|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
317862|NCT00697788|766071|P2|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
317863|NCT00697788|766072|P1|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
317864|NCT00697788|766065|P8|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
317865|NCT00697788|766066|P7|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
317866|NCT00697788|766067|P6|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
317867|NCT00697788|766068|P5|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||3
317868|NCT00697788|766069|P4|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
317869|NCT00697788|766070|P3|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
317870|NCT00697788|766071|P2|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
317871|NCT00697788|766072|P1|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
317872|NCT00697788|766065|P8|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
317873|NCT00697788|766066|P7|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
317874|NCT00697788|766067|P6|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
317875|NCT00697788|766068|P5|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
317876|NCT00697788|766069|P4|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
317877|NCT00697788|766070|P3|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
317878|NCT00697788|766071|P2|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
317879|NCT00697788|766072|P1|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
317880|NCT00697788|766065|P8|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
317881|NCT00697788|766066|P7|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
317882|NCT00697788|766067|P6|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
317883|NCT00697788|766068|P5|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
317884|NCT00697788|766069|P4|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
317885|NCT00697788|766070|P3|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
317886|NCT00697788|766071|P2|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
317887|NCT00697788|766072|P1|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
317888|NCT00697788|766065|P8|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
317889|NCT00697788|766066|P7|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
317890|NCT00697788|766067|P6|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
317891|NCT00697788|766068|P5|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
317892|NCT00697788|766069|P4|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
317893|NCT00697788|766070|P3|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
317894|NCT00697788|766071|P2|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
317895|NCT00697788|766072|P1|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
317896|NCT00697788|766065|P8|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
317897|NCT00697788|766066|P7|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
317898|NCT00697788|766067|P6|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
317899|NCT00697788|766068|P5|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
317900|NCT00697788|766069|P4|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
317901|NCT00697788|766070|P3|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
317902|NCT00697788|766071|P2|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
317903|NCT00697788|766072|P1|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
317904|NCT00697788|766065|P8|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
317905|NCT00697788|766066|P7|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
317906|NCT00697788|766067|P6|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
317907|NCT00697788|766068|P5|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
317908|NCT00697788|766069|P4|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
317909|NCT00697788|766070|P3|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||3
317910|NCT00697788|766071|P2|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
317911|NCT00697788|766072|P1|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
317912|NCT00697788|766065|P8|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
317913|NCT00697788|766066|P7|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
317914|NCT00697788|766067|P6|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
317915|NCT00697788|766068|P5|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
317916|NCT00697788|766069|P4|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
317917|NCT00697788|766070|P3|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion|2 participants did not begin this infusion due to hypotension (MAP<50)|3
317918|NCT00697788|766071|P2|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
317919|NCT00697788|766072|P1|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
317920|NCT00697788|766065|P8|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
317921|NCT00697788|766066|P7|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
317922|NCT00697788|766067|P6|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
317923|NCT00697788|766068|P5|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
317924|NCT00697788|766069|P4|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
317925|NCT00697788|766070|P3|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
317926|NCT00697788|766071|P2|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||2
317927|NCT00697788|766072|P1|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
317928|NCT00697788|766065|P8|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
317929|NCT00697788|766066|P7|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
317930|NCT00697788|766067|P6|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
317931|NCT00697788|766068|P5|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
317932|NCT00697788|766069|P4|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
317933|NCT00697788|766070|P3|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
317934|NCT00697788|766071|P2|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||5
317935|NCT00697788|766072|P1|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
317936|NCT00697788|766065|P8|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
317937|NCT00697788|766066|P7|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
317938|NCT00697788|766067|P6|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
317939|NCT00697788|766068|P5|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
317940|NCT00697788|766069|P4|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
317941|NCT00697788|766070|P3|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
317942|NCT00697788|766071|P2|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion|1 participant did not begin infusion due to hypotension (MAP<50)|7
317943|NCT00697788|766072|P1|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
317944|NCT00697788|766065|P8|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
317945|NCT00697788|766066|P7|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
317946|NCT00697788|766067|P6|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
317947|NCT00697788|766068|P5|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
317948|NCT00697788|766069|P4|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
317949|NCT00697788|766070|P3|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
317950|NCT00697788|766071|P2|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
317951|NCT00697788|766072|P1|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
317952|NCT00697788|766065|P8|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
317953|NCT00697788|766066|P7|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
317954|NCT00697788|766067|P6|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
317955|NCT00697788|766068|P5|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
317956|NCT00697788|766069|P4|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
317957|NCT00697788|766070|P3|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
317958|NCT00697788|766071|P2|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
317959|NCT00697788|766072|P1|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||8
317960|NCT00697788|766065|P8|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
317961|NCT00697788|766066|P7|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
317962|NCT00697788|766067|P6|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
317963|NCT00697788|766068|P5|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
317964|NCT00697788|766069|P4|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
317965|NCT00697788|766070|P3|STARTED|Dexmedetomidine Bolus 1 mcg/kg|2 participants did not begin the ascending (1.0 mcg/kg/hr) due to MAP<50|0
317966|NCT00697788|766071|P2|STARTED|Dexmedetomidine Bolus 1 mcg/kg|One participant did not begin infusion due to hypotension (mean pressure <50)|0
317967|NCT00697788|766072|P1|STARTED|Dexmedetomidine Bolus 1 mcg/kg||8
317968|NCT00697697|766116|P2|NOT COMPLETED|Overall Study||54
317969|NCT00697697|766117|P1|NOT COMPLETED|Overall Study||49
317970|NCT00697697|766116|P2|COMPLETED|Overall Study||44
317971|NCT00697697|766117|P1|COMPLETED|Overall Study||45
317972|NCT00697697|766116|P2|STARTED|Overall Study||98
317973|NCT00697697|766117|P1|STARTED|Overall Study||94
317974|NCT00697619|766127|P2|NOT COMPLETED|Overall Study||8
317975|NCT00697619|766128|P1|NOT COMPLETED|Overall Study||6
317976|NCT00697619|766127|P2|COMPLETED|Overall Study||22
317977|NCT00697619|766128|P1|COMPLETED|Overall Study||24
317978|NCT00697619|766127|P2|STARTED|Overall Study||30
317979|NCT00697619|766128|P1|STARTED|Overall Study||30
317980|NCT00697593|766134|P1|NOT COMPLETED|Overall Study||19
317981|NCT00697593|766134|P1|COMPLETED|Overall Study||51
317982|NCT00697593|766134|P1|STARTED|Overall Study||70
317983|NCT00697541|766167|P2|NOT COMPLETED|Overall Study||1
317984|NCT00697541|766168|P1|NOT COMPLETED|Overall Study||2
317985|NCT00697541|766167|P2|COMPLETED|Overall Study||9
317986|NCT00697541|766168|P1|COMPLETED|Overall Study||8
317987|NCT00697541|766167|P2|STARTED|Overall Study||10
317988|NCT00697541|766168|P1|STARTED|Overall Study||10
317989|NCT00697515|766178|P2|NOT COMPLETED|Second Intervention (Crossover Period)||1
317990|NCT00697515|766179|P1|NOT COMPLETED|Second Intervention (Crossover Period)||1
317991|NCT00697515|766178|P2|COMPLETED|Second Intervention (Crossover Period)||51
317992|NCT00697515|766179|P1|COMPLETED|Second Intervention (Crossover Period)||52
317993|NCT00697515|766178|P2|STARTED|Second Intervention (Crossover Period)||52
317994|NCT00697515|766179|P1|STARTED|Second Intervention (Crossover Period)||53
317995|NCT00697515|766178|P2|NOT COMPLETED|First Intervention (Crossover Period)||12
317996|NCT00697515|766179|P1|NOT COMPLETED|First Intervention (Crossover Period)||10
317997|NCT00697515|766178|P2|COMPLETED|First Intervention (Crossover Period)||52
317998|NCT00697515|766179|P1|COMPLETED|First Intervention (Crossover Period)||53
317999|NCT00697515|766178|P2|STARTED|First Intervention (Crossover Period)||64
318000|NCT00697515|766179|P1|STARTED|First Intervention (Crossover Period)||63
318001|NCT00697515|766178|P2|NOT COMPLETED|Dose Optimization Period||0
318002|NCT00697515|766179|P1|NOT COMPLETED|Dose Optimization Period||15
318003|NCT00697515|766178|P2|COMPLETED|Dose Optimization Period||0
318004|NCT00697515|766179|P1|COMPLETED|Dose Optimization Period||127
318005|NCT00697515|766178|P2|STARTED|Dose Optimization Period||0
318006|NCT00697515|766179|P1|STARTED|Dose Optimization Period||142
318007|NCT00697463|766207|P1|NOT COMPLETED|Overall Study||1
318008|NCT00697463|766207|P1|COMPLETED|Overall Study||21
318009|NCT00697463|766207|P1|STARTED|Overall Study||22
318010|NCT00697346|766214|P3|NOT COMPLETED|Overall Study||1
318011|NCT00697346|766215|P2|NOT COMPLETED|Overall Study||26
318012|NCT00697346|766216|P1|NOT COMPLETED|Overall Study||28
318013|NCT00697346|766214|P3|COMPLETED|Overall Study|1 participant was ongoing as of primary completion date 27 Dec 2011 and has now completed.|1
318014|NCT00697346|766215|P2|COMPLETED|Overall Study|2 participants were ongoing as of primary completion date 27 Dec 2011 and have now completed.|2
318015|NCT00697346|766216|P1|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0
318016|NCT00697346|766214|P3|STARTED|Overall Study||2
318017|NCT00697346|766215|P2|STARTED|Overall Study||28
318018|NCT00697346|766216|P1|STARTED|Overall Study||28
318019|NCT00697255|766324|P2|NOT COMPLETED|Stage 1b||2
318020|NCT00697255|766325|P1|NOT COMPLETED|Stage 1b||0
318109|NCT00696709|766614|P1|COMPLETED|Overall Study||62
318021|NCT00697255|766324|P2|COMPLETED|Stage 1b|Participants who completed 1b received hCG bolus injection and did not proceed further in the trial|1
318022|NCT00697255|766325|P1|COMPLETED|Stage 1b||0
318023|NCT00697255|766324|P2|STARTED|Stage 1b|After enrollment in Stage 1a completed, a new cohort of participants enrolled in Stage 1b.|3
318024|NCT00697255|766325|P1|STARTED|Stage 1b||0
318025|NCT00697255|766324|P2|NOT COMPLETED|Stage 1a||0
318026|NCT00697255|766325|P1|NOT COMPLETED|Stage 1a||3
318027|NCT00697255|766324|P2|COMPLETED|Stage 1a||0
318028|NCT00697255|766325|P1|COMPLETED|Stage 1a|Participants who completed 1a received hCG bolus injection and did not proceed further in the trial|2
318029|NCT00697255|766324|P2|STARTED|Stage 1a||0
318030|NCT00697255|766325|P1|STARTED|Stage 1a||5
318031|NCT00697190|766341|P2|NOT COMPLETED|Second Intervention||0
318032|NCT00697190|766342|P1|NOT COMPLETED|Second Intervention||0
318033|NCT00697190|766341|P2|COMPLETED|Second Intervention||20
318034|NCT00697190|766342|P1|COMPLETED|Second Intervention||18
318035|NCT00697190|766341|P2|STARTED|Second Intervention||20
318036|NCT00697190|766342|P1|STARTED|Second Intervention|one subject moved away between the first period and second period.|18
318037|NCT00697190|766341|P2|NOT COMPLETED|First Intervention||0
318038|NCT00697190|766342|P1|NOT COMPLETED|First Intervention||0
318039|NCT00697190|766341|P2|COMPLETED|First Intervention||20
318040|NCT00697190|766342|P1|COMPLETED|First Intervention||19
318041|NCT00697190|766341|P2|STARTED|First Intervention||20
318042|NCT00697190|766342|P1|STARTED|First Intervention||19
318043|NCT00697112|766376|P1|NOT COMPLETED|Overall Study||10
318044|NCT00697112|766376|P1|COMPLETED|Overall Study||43
318045|NCT00697112|766376|P1|Met the Inclusion Criteria|Overall Study||52
318046|NCT00697112|766376|P1|STARTED|Overall Study||53
318047|NCT00697073|766400|P1|NOT COMPLETED|Overall Study||9
318048|NCT00697073|766400|P1|COMPLETED|Overall Study||59
318049|NCT00697073|766400|P1|STARTED|Overall Study||68
318050|NCT00696878|766404|P1|NOT COMPLETED|Overall Study||504
318051|NCT00696878|766404|P1|COMPLETED|Overall Study||178
318052|NCT00696878|766404|P1|STARTED|Overall Study||682
318053|NCT00696800|766478|P2|NOT COMPLETED|Overall Study||48
318054|NCT00696800|766479|P1|NOT COMPLETED|Overall Study||85
318055|NCT00696800|766478|P2|COMPLETED|Overall Study|Participants who had embryos transferred|704
318056|NCT00696800|766479|P1|COMPLETED|Overall Study|Participants who had embryos transferred|672
318057|NCT00696800|766478|P2|Treated (ITT)|Overall Study|The ITT group|750
318058|NCT00696800|766479|P1|Treated (ITT)|Overall Study|The ITT group|756
318059|NCT00696800|766478|P2|STARTED|Overall Study||752
318060|NCT00696800|766479|P1|STARTED|Overall Study||757
318061|NCT00696787|766532|P3|NOT COMPLETED|Overall Study||26
318062|NCT00696787|766533|P2|NOT COMPLETED|Overall Study||20
318063|NCT00696787|766534|P1|NOT COMPLETED|Overall Study||15
318064|NCT00696787|766532|P3|COMPLETED|Overall Study||17
318065|NCT00696787|766533|P2|COMPLETED|Overall Study||22
318066|NCT00696787|766534|P1|COMPLETED|Overall Study||25
318067|NCT00696787|766532|P3|STARTED|Overall Study||43
318068|NCT00696787|766533|P2|STARTED|Overall Study||42
318069|NCT00696787|766534|P1|STARTED|Overall Study||40
318070|NCT00696774|766548|P3|NOT COMPLETED|Period III||0
318071|NCT00696774|766549|P2|NOT COMPLETED|Period III||7
318072|NCT00696774|766550|P1|NOT COMPLETED|Period III||7
318073|NCT00696774|766548|P3|COMPLETED|Period III||0
318074|NCT00696774|766549|P2|COMPLETED|Period III|82 participants were reported at Week 8; 81 completed Week 8 as 1 participant decided to withdraw.|81
318075|NCT00696774|766550|P1|COMPLETED|Period III||106
318076|NCT00696774|766548|P3|STARTED|Period III||0
318077|NCT00696774|766549|P2|STARTED|Period III|91 reported at Week 4; 88 start Period 3 (1 adverse event, 1 protocol violation, 1 lack of efficacy)|88
318078|NCT00696774|766550|P1|STARTED|Period III|115 reported at Week 4; 113 started Period 3 (1 lost to follow-up and 1 protocol violation).|113
318079|NCT00696774|766548|P3|NOT COMPLETED|Period II||36
318080|NCT00696774|766549|P2|NOT COMPLETED|Period II||0
318081|NCT00696774|766550|P1|NOT COMPLETED|Period II||0
318082|NCT00696774|766548|P3|COMPLETED|Period II||0
318083|NCT00696774|766549|P2|COMPLETED|Period II||91
318084|NCT00696774|766550|P1|COMPLETED|Period II||115
318085|NCT00696774|766548|P3|STARTED|Period II|1 participant did not receive study drug and was not included in the safety analyses.|36
318086|NCT00696774|766549|P2|STARTED|Period II||91
318087|NCT00696774|766550|P1|STARTED|Period II||115
318088|NCT00696761|766588|P4|NOT COMPLETED|Overall Study||10
318089|NCT00696761|766589|P3|NOT COMPLETED|Overall Study||11
318090|NCT00696761|766590|P2|NOT COMPLETED|Overall Study||26
318091|NCT00696761|766591|P1|NOT COMPLETED|Overall Study||20
318092|NCT00696761|766588|P4|COMPLETED|Overall Study||44
318093|NCT00696761|766589|P3|COMPLETED|Overall Study||30
318094|NCT00696761|766590|P2|COMPLETED|Overall Study||50
318095|NCT00696761|766591|P1|COMPLETED|Overall Study||41
318096|NCT00696761|766588|P4|STARTED|Overall Study||54
318097|NCT00696761|766589|P3|STARTED|Overall Study||41
318098|NCT00696761|766590|P2|STARTED|Overall Study||76
318099|NCT00696761|766591|P1|STARTED|Overall Study||61
318100|NCT00696709|766610|P5|NOT COMPLETED|Overall Study||3
318101|NCT00696709|766611|P4|NOT COMPLETED|Overall Study||5
318102|NCT00696709|766612|P3|NOT COMPLETED|Overall Study||1
318103|NCT00696709|766613|P2|NOT COMPLETED|Overall Study||3
318104|NCT00696709|766614|P1|NOT COMPLETED|Overall Study||3
318105|NCT00696709|766610|P5|COMPLETED|Overall Study||62
318106|NCT00696709|766611|P4|COMPLETED|Overall Study||59
318107|NCT00696709|766612|P3|COMPLETED|Overall Study||32
318110|NCT00696709|766610|P5|Vaccination 4 (~Day 90)|Overall Study||63
318111|NCT00696709|766611|P4|Vaccination 4 (~Day 90)|Overall Study||59
318112|NCT00696709|766612|P3|Vaccination 4 (~Day 90)|Overall Study||32
318113|NCT00696709|766613|P2|Vaccination 4 (~Day 90)|Overall Study||60
318114|NCT00696709|766614|P1|Vaccination 4 (~Day 90)|Overall Study||62
318115|NCT00696709|766610|P5|Vaccination 3 (~Day 60)|Overall Study||63
318116|NCT00696709|766611|P4|Vaccination 3 (~Day 60)|Overall Study||59
318117|NCT00696709|766612|P3|Vaccination 3 (~Day 60)|Overall Study||32
318118|NCT00696709|766613|P2|Vaccination 3 (~Day 60)|Overall Study||60
318119|NCT00696709|766614|P1|Vaccination 3 (~Day 60)|Overall Study||64
318120|NCT00696709|766610|P5|Vaccination 2 (~Day 30)|Overall Study||64
318121|NCT00696709|766611|P4|Vaccination 2 (~Day 30)|Overall Study||61
318122|NCT00696709|766612|P3|Vaccination 2 (~Day 30)|Overall Study||32
318123|NCT00696709|766613|P2|Vaccination 2 (~Day 30)|Overall Study||60
318124|NCT00696709|766614|P1|Vaccination 2 (~Day 30)|Overall Study||64
318125|NCT00696709|766610|P5|Vaccination 1 (Day 1)|Overall Study||65
318126|NCT00696709|766611|P4|Vaccination 1 (Day 1)|Overall Study||64
318127|NCT00696709|766612|P3|Vaccination 1 (Day 1)|Overall Study||32
318128|NCT00696709|766613|P2|Vaccination 1 (Day 1)|Overall Study||63
318129|NCT00696709|766614|P1|Vaccination 1 (Day 1)|Overall Study||65
318130|NCT00696709|766610|P5|STARTED|Overall Study||65
318131|NCT00696709|766611|P4|STARTED|Overall Study||64
318132|NCT00696709|766612|P3|STARTED|Overall Study||33
318133|NCT00696709|766613|P2|STARTED|Overall Study||63
318134|NCT00696709|766614|P1|STARTED|Overall Study||65
318135|NCT00696696|766650|P1|NOT COMPLETED|Overall Study||18
318136|NCT00696696|766650|P1|COMPLETED|Overall Study|number of patients off treatment due to progression of disease only|26
318137|NCT00696696|766650|P1|STARTED|Overall Study||44
318138|NCT00696657|766665|P9|NOT COMPLETED|Overall Study||9
318139|NCT00696657|766666|P8|NOT COMPLETED|Overall Study||3
318140|NCT00696657|766667|P7|NOT COMPLETED|Overall Study||15
318141|NCT00696657|766668|P6|NOT COMPLETED|Overall Study||12
318142|NCT00696657|766669|P5|NOT COMPLETED|Overall Study||10
318143|NCT00696657|766670|P4|NOT COMPLETED|Overall Study||11
318144|NCT00696657|766671|P3|NOT COMPLETED|Overall Study||8
318145|NCT00696657|766672|P2|NOT COMPLETED|Overall Study||5
318146|NCT00696657|766673|P1|NOT COMPLETED|Overall Study||1
318147|NCT00696657|766665|P9|COMPLETED|Overall Study||41
318148|NCT00696657|766666|P8|COMPLETED|Overall Study||42
318149|NCT00696657|766667|P7|COMPLETED|Overall Study||30
318150|NCT00696657|766668|P6|COMPLETED|Overall Study||33
318151|NCT00696657|766669|P5|COMPLETED|Overall Study||34
318152|NCT00696657|766670|P4|COMPLETED|Overall Study||38
318153|NCT00696657|766671|P3|COMPLETED|Overall Study||36
318154|NCT00696657|766672|P2|COMPLETED|Overall Study||42
318155|NCT00696657|766673|P1|COMPLETED|Overall Study||45
318156|NCT00696657|766665|P9|EXPOSED|Overall Study||50
318157|NCT00696657|766666|P8|EXPOSED|Overall Study||45
318158|NCT00696657|766667|P7|EXPOSED|Overall Study||45
318159|NCT00696657|766668|P6|EXPOSED|Overall Study||43
318160|NCT00696657|766669|P5|EXPOSED|Overall Study||44
318161|NCT00696657|766670|P4|EXPOSED|Overall Study||48
318162|NCT00696657|766671|P3|EXPOSED|Overall Study||43
318163|NCT00696657|766672|P2|EXPOSED|Overall Study||47
318164|NCT00696657|766673|P1|EXPOSED|Overall Study||46
318165|NCT00696657|766665|P9|STARTED|Overall Study||50
318166|NCT00696657|766666|P8|STARTED|Overall Study||45
318167|NCT00696657|766667|P7|STARTED|Overall Study||45
318168|NCT00696657|766668|P6|STARTED|Overall Study||45
318169|NCT00696657|766669|P5|STARTED|Overall Study||44
318170|NCT00696657|766670|P4|STARTED|Overall Study||49
318171|NCT00696657|766671|P3|STARTED|Overall Study||44
318172|NCT00696657|766672|P2|STARTED|Overall Study||47
318173|NCT00696657|766673|P1|STARTED|Overall Study||46
318174|NCT00696618|767000|P3|NOT COMPLETED|Overall Study||0
318175|NCT00696618|767001|P2|NOT COMPLETED|Overall Study||0
318176|NCT00696618|767002|P1|NOT COMPLETED|Overall Study||0
318177|NCT00696618|767000|P3|COMPLETED|Overall Study||3
318178|NCT00696618|767001|P2|COMPLETED|Overall Study||3
318179|NCT00696618|767002|P1|COMPLETED|Overall Study||3
318180|NCT00696618|767000|P3|STARTED|Overall Study||3
318181|NCT00696618|767001|P2|STARTED|Overall Study||3
318182|NCT00696618|767002|P1|STARTED|Overall Study||3
318183|NCT00696488|767016|P1|NOT COMPLETED|Overall Study||0
318184|NCT00696488|767016|P1|COMPLETED|Overall Study||20
318185|NCT00696488|767016|P1|STARTED|Overall Study||20
318186|NCT00696449|767024|P4|NOT COMPLETED|Overall Study||3
318187|NCT00696449|767025|P3|NOT COMPLETED|Overall Study||1
318188|NCT00696449|767026|P2|NOT COMPLETED|Overall Study||6
318189|NCT00696449|767027|P1|NOT COMPLETED|Overall Study||3
318190|NCT00696449|767024|P4|COMPLETED|Overall Study||13
318191|NCT00696449|767025|P3|COMPLETED|Overall Study||14
318192|NCT00696449|767026|P2|COMPLETED|Overall Study||9
318193|NCT00696449|767027|P1|COMPLETED|Overall Study||12
318194|NCT00696449|767024|P4|STARTED|Overall Study||16
318195|NCT00696449|767025|P3|STARTED|Overall Study||15
318196|NCT00696449|767026|P2|STARTED|Overall Study||15
318197|NCT00696449|767027|P1|STARTED|Overall Study||15
318198|NCT00696436|767042|P5|NOT COMPLETED|Overall Study||13
318199|NCT00696436|767043|P4|NOT COMPLETED|Overall Study||22
318200|NCT00696436|767044|P3|NOT COMPLETED|Overall Study||28
318201|NCT00696436|767045|P2|NOT COMPLETED|Overall Study||30
318202|NCT00696436|767046|P1|NOT COMPLETED|Overall Study||23
318203|NCT00696436|767042|P5|COMPLETED|Overall Study||141
318204|NCT00696436|767043|P4|COMPLETED|Overall Study||268
318205|NCT00696436|767044|P3|COMPLETED|Overall Study||254
318206|NCT00696436|767045|P2|COMPLETED|Overall Study||255
318207|NCT00696436|767046|P1|COMPLETED|Overall Study||257
318208|NCT00696436|767042|P5|STARTED|Overall Study|Randomized participants only.|154
318209|NCT00696436|767043|P4|STARTED|Overall Study|Randomized participants only.|290
318210|NCT00696436|767044|P3|STARTED|Overall Study|Randomized participants only.|282
318211|NCT00696436|767045|P2|STARTED|Overall Study|Randomized participants only. One participant treated but not randomized and is not included.|285
318212|NCT00696436|767046|P1|STARTED|Overall Study|Randomized participants only.|280
318213|NCT00696423|767130|P2|NOT COMPLETED|Overall Study||5
318214|NCT00696423|767131|P1|NOT COMPLETED|Overall Study||0
318215|NCT00696423|767130|P2|COMPLETED|Overall Study||218
318216|NCT00696423|767131|P1|COMPLETED|Overall Study||244
318217|NCT00696423|767130|P2|STARTED|Overall Study||223
318218|NCT00696423|767131|P1|STARTED|Overall Study||244
318219|NCT00696410|767163|P2|NOT COMPLETED|Overall Study||0
318220|NCT00696410|767164|P1|NOT COMPLETED|Overall Study||13
318221|NCT00696410|767163|P2|COMPLETED|Overall Study||10
318222|NCT00696410|767164|P1|COMPLETED|Overall Study||25
318223|NCT00696410|767163|P2|STARTED|Overall Study||10
318224|NCT00696410|767164|P1|STARTED|Overall Study||38
318225|NCT00696384|767178|P3|NOT COMPLETED|Double Blind Phase||6
318226|NCT00696384|767179|P2|NOT COMPLETED|Double Blind Phase||11
318227|NCT00696384|767180|P1|NOT COMPLETED|Double Blind Phase||0
318228|NCT00696384|767178|P3|COMPLETED|Double Blind Phase||145
318229|NCT00696384|767179|P2|COMPLETED|Double Blind Phase||137
318230|NCT00696384|767180|P1|COMPLETED|Double Blind Phase||0
318231|NCT00696384|767178|P3|STARTED|Double Blind Phase||151
318232|NCT00696384|767179|P2|STARTED|Double Blind Phase||148
318233|NCT00696384|767180|P1|STARTED|Double Blind Phase||0
318234|NCT00696384|767178|P3|NOT COMPLETED|Open Label Phase||0
318235|NCT00696384|767179|P2|NOT COMPLETED|Open Label Phase||0
318236|NCT00696384|767180|P1|NOT COMPLETED|Open Label Phase||119
318237|NCT00696384|767178|P3|COMPLETED|Open Label Phase||0
318238|NCT00696384|767179|P2|COMPLETED|Open Label Phase||0
318239|NCT00696384|767180|P1|COMPLETED|Open Label Phase||299
318240|NCT00696384|767178|P3|STARTED|Open Label Phase||0
318241|NCT00696384|767179|P2|STARTED|Open Label Phase||0
318242|NCT00696384|767180|P1|STARTED|Open Label Phase||418
318243|NCT00696293|767194|P1|NOT COMPLETED|Overall Study||2
318244|NCT00696293|767194|P1|COMPLETED|Overall Study||28
318245|NCT00696293|767194|P1|STARTED|Overall Study||30
318246|NCT00696241|767204|P5|NOT COMPLETED|Overall Study||12
318247|NCT00696241|767205|P4|NOT COMPLETED|Overall Study||14
318248|NCT00696241|767206|P3|NOT COMPLETED|Overall Study||24
318249|NCT00696241|767207|P2|NOT COMPLETED|Overall Study||22
318250|NCT00696241|767208|P1|NOT COMPLETED|Overall Study||24
318251|NCT00696241|767204|P5|COMPLETED|Overall Study||130
318252|NCT00696241|767205|P4|COMPLETED|Overall Study||268
318253|NCT00696241|767206|P3|COMPLETED|Overall Study||261
318254|NCT00696241|767207|P2|COMPLETED|Overall Study||261
318255|NCT00696241|767208|P1|COMPLETED|Overall Study||259
318256|NCT00696241|767204|P5|STARTED|Overall Study||142
318257|NCT00696241|767205|P4|STARTED|Overall Study||282
318258|NCT00696241|767206|P3|STARTED|Overall Study||285
318259|NCT00696241|767207|P2|STARTED|Overall Study||283
318260|NCT00696241|767208|P1|STARTED|Overall Study||283
318261|NCT00696137|767290|P1|NOT COMPLETED|Overall Study||2
318262|NCT00696137|767290|P1|COMPLETED|Overall Study||3
318263|NCT00696137|767290|P1|STARTED|Overall Study||5
318264|NCT00696072|767296|P2|NOT COMPLETED|Overall Study||63
318265|NCT00696072|767297|P1|NOT COMPLETED|Overall Study||57
318266|NCT00696072|767296|P2|COMPLETED|Overall Study||0
318267|NCT00696072|767297|P1|COMPLETED|Overall Study||0
318268|NCT00696072|767296|P2|STARTED|Overall Study||63
318269|NCT00696072|767297|P1|STARTED|Overall Study||57
318270|NCT00696020|767318|P4|NOT COMPLETED|Overall Study||4
318271|NCT00696020|767319|P3|NOT COMPLETED|Overall Study||3
318272|NCT00696020|767320|P2|NOT COMPLETED|Overall Study||2
318273|NCT00696020|767321|P1|NOT COMPLETED|Overall Study||4
318274|NCT00696020|767318|P4|COMPLETED|Overall Study||84
318275|NCT00696020|767319|P3|COMPLETED|Overall Study||90
318276|NCT00696020|767320|P2|COMPLETED|Overall Study||87
318277|NCT00696020|767321|P1|COMPLETED|Overall Study||86
318278|NCT00696020|767318|P4|STARTED|Overall Study||88
318279|NCT00696020|767319|P3|STARTED|Overall Study||93
318280|NCT00696020|767320|P2|STARTED|Overall Study||89
318281|NCT00696020|767321|P1|STARTED|Overall Study||90
318282|NCT00695955|767429|P1|NOT COMPLETED|Cohort 2||104
318283|NCT00695955|767429|P1|COMPLETED|Cohort 2||203
318284|NCT00695955|767429|P1|STARTED|Cohort 2||307
318285|NCT00695955|767429|P1|NOT COMPLETED|Cohort 1||102
318286|NCT00695955|767429|P1|COMPLETED|Cohort 1||260
318287|NCT00695955|767429|P1|STARTED|Cohort 1||362
318288|NCT00695903|767441|P2|NOT COMPLETED|Had Test of Cure (TOC) Assessment||1
318289|NCT00695903|767442|P1|NOT COMPLETED|Had Test of Cure (TOC) Assessment||2
318290|NCT00695903|767441|P2|COMPLETED|Had Test of Cure (TOC) Assessment||3
318291|NCT00695903|767442|P1|COMPLETED|Had Test of Cure (TOC) Assessment||5
318292|NCT00695903|767441|P2|STARTED|Had Test of Cure (TOC) Assessment||4
318293|NCT00695903|767442|P1|STARTED|Had Test of Cure (TOC) Assessment||7
318294|NCT00695903|767441|P2|NOT COMPLETED|Had End of Therapy (EOT) Assessment||15
318295|NCT00695903|767442|P1|NOT COMPLETED|Had End of Therapy (EOT) Assessment||12
318296|NCT00695903|767441|P2|COMPLETED|Had End of Therapy (EOT) Assessment||4
318297|NCT00695903|767442|P1|COMPLETED|Had End of Therapy (EOT) Assessment||7
318298|NCT00695903|767441|P2|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||6
318299|NCT00695903|767442|P1|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||9
318300|NCT00695903|767441|P2|STARTED|Had End of Therapy (EOT) Assessment||19
318301|NCT00695903|767442|P1|STARTED|Had End of Therapy (EOT) Assessment||19
318302|NCT00695864|767454|P1|NOT COMPLETED|Ondansetron||5
318303|NCT00695864|767454|P1|COMPLETED|Ondansetron||9
318304|NCT00695864|767454|P1|STARTED|Ondansetron||14
318305|NCT00695864|767454|P1|NOT COMPLETED|Placebo||5
318306|NCT00695864|767454|P1|COMPLETED|Placebo||9
318307|NCT00695864|767454|P1|STARTED|Placebo||14
318308|NCT00695669|767464|P4|NOT COMPLETED|Overall Study||4
318309|NCT00695669|767465|P3|NOT COMPLETED|Overall Study||3
318310|NCT00695669|767466|P2|NOT COMPLETED|Overall Study||4
318311|NCT00695669|767467|P1|NOT COMPLETED|Overall Study||4
318312|NCT00695669|767464|P4|COMPLETED|Overall Study||74
318313|NCT00695669|767465|P3|COMPLETED|Overall Study||75
318314|NCT00695669|767466|P2|COMPLETED|Overall Study||74
318315|NCT00695669|767467|P1|COMPLETED|Overall Study||74
318316|NCT00695669|767464|P4|STARTED|Overall Study||78
318317|NCT00695669|767465|P3|STARTED|Overall Study||78
318318|NCT00695669|767466|P2|STARTED|Overall Study||78
318319|NCT00695669|767467|P1|STARTED|Overall Study||78
318320|NCT00695578|767543|P2|NOT COMPLETED|Overall Study||0
318321|NCT00695578|767544|P1|NOT COMPLETED|Overall Study||0
318322|NCT00695578|767543|P2|COMPLETED|Overall Study||10
318323|NCT00695578|767544|P1|COMPLETED|Overall Study||10
318324|NCT00695578|767543|P2|STARTED|Overall Study||10
318325|NCT00695578|767544|P1|STARTED|Overall Study||10
318326|NCT00695565|767552|P2|NOT COMPLETED|Overall Study||9
318327|NCT00695565|767553|P1|NOT COMPLETED|Overall Study||13
318328|NCT00695565|767552|P2|COMPLETED|Overall Study||81
318329|NCT00695565|767553|P1|COMPLETED|Overall Study||77
318330|NCT00695565|767552|P2|STARTED|Overall Study||90
318331|NCT00695565|767553|P1|STARTED|Overall Study||90
318332|NCT00695500|767587|P2|NOT COMPLETED|Overall Study||5
318333|NCT00695500|767588|P1|NOT COMPLETED|Overall Study||3
318334|NCT00695500|767587|P2|COMPLETED|Overall Study||17
318335|NCT00695500|767588|P1|COMPLETED|Overall Study||21
318336|NCT00695500|767587|P2|STARTED|Overall Study||22
318337|NCT00695500|767588|P1|STARTED|Overall Study||24
318338|NCT00695435|767598|P3|NOT COMPLETED|Overall Study||0
318339|NCT00695435|767599|P2|NOT COMPLETED|Overall Study||0
318340|NCT00695435|767600|P1|NOT COMPLETED|Overall Study||0
318341|NCT00695435|767598|P3|COMPLETED|Overall Study||7
318342|NCT00695435|767599|P2|COMPLETED|Overall Study||7
318343|NCT00695435|767600|P1|COMPLETED|Overall Study||7
318344|NCT00695435|767598|P3|STARTED|Overall Study||7
318345|NCT00695435|767599|P2|STARTED|Overall Study||7
318346|NCT00695435|767600|P1|STARTED|Overall Study||7
318347|NCT00695409|767611|P1|NOT COMPLETED|Overall Study||0
318348|NCT00695409|767611|P1|COMPLETED|Overall Study||122
318349|NCT00695409|767611|P1|STARTED|Overall Study||122
318350|NCT00695396|767626|P3|NOT COMPLETED|Overall Study||8
318351|NCT00695396|767627|P2|NOT COMPLETED|Overall Study||8
318352|NCT00695396|767628|P1|NOT COMPLETED|Overall Study||7
318353|NCT00695396|767626|P3|COMPLETED|Overall Study||1
318354|NCT00695396|767627|P2|COMPLETED|Overall Study||0
318355|NCT00695396|767628|P1|COMPLETED|Overall Study||1
318356|NCT00695396|767626|P3|STARTED|Overall Study||9
318357|NCT00695396|767627|P2|STARTED|Overall Study||8
318358|NCT00695396|767628|P1|STARTED|Overall Study||8
318359|NCT00695318|767644|P2|NOT COMPLETED|Overall Study||1
318360|NCT00695318|767645|P1|NOT COMPLETED|Overall Study||5
318361|NCT00695318|767644|P2|COMPLETED|Overall Study||6
318362|NCT00695318|767645|P1|COMPLETED|Overall Study||5
318363|NCT00695318|767644|P2|STARTED|Overall Study||7
318364|NCT00695318|767645|P1|STARTED|Overall Study||10
318365|NCT00695292|767656|P1|NOT COMPLETED|Overall Study||0
318366|NCT00695292|767656|P1|COMPLETED|Overall Study||37
318367|NCT00695292|767656|P1|STARTED|Overall Study||37
318368|NCT00695188|767663|P2|NOT COMPLETED|Overall Study||0
318369|NCT00695188|767664|P1|NOT COMPLETED|Overall Study||0
318370|NCT00695188|767663|P2|COMPLETED|Overall Study||9
318371|NCT00695188|767664|P1|COMPLETED|Overall Study||10
318372|NCT00695188|767663|P2|STARTED|Overall Study||9
318373|NCT00695188|767664|P1|STARTED|Overall Study||10
318374|NCT00695136|767670|P1|NOT COMPLETED|Overall Study||2
318375|NCT00695136|767670|P1|COMPLETED|Overall Study||5
318376|NCT00695136|767670|P1|STARTED|Overall Study|7|7
318377|NCT00695097|767676|P2|NOT COMPLETED|Overall Study||0
318378|NCT00695097|767677|P1|NOT COMPLETED|Overall Study||1
318379|NCT00695097|767676|P2|COMPLETED|Overall Study||5
318380|NCT00695097|767677|P1|COMPLETED|Overall Study||9
318381|NCT00695097|767676|P2|STARTED|Overall Study||5
318382|NCT00695097|767677|P1|STARTED|Overall Study||10
318383|NCT00695019|767686|P3|NOT COMPLETED|Overall Study||10
318384|NCT00695019|767687|P2|NOT COMPLETED|Overall Study||14
318385|NCT00695019|767688|P1|NOT COMPLETED|Overall Study||13
318386|NCT00695019|767686|P3|COMPLETED|Overall Study||47
318387|NCT00695019|767687|P2|COMPLETED|Overall Study||39
318388|NCT00695019|767688|P1|COMPLETED|Overall Study||46
318389|NCT00695019|767686|P3|STARTED|Overall Study||57
318390|NCT00695019|767687|P2|STARTED|Overall Study||53
318391|NCT00695019|767688|P1|STARTED|Overall Study||59
318392|NCT00694707|767722|P5|NOT COMPLETED|Overall Study||40
318393|NCT00694707|767723|P4|NOT COMPLETED|Overall Study||50
318394|NCT00694707|767724|P3|NOT COMPLETED|Overall Study||51
318395|NCT00694707|767725|P2|NOT COMPLETED|Overall Study||55
318396|NCT00694707|767726|P1|NOT COMPLETED|Overall Study||72
318397|NCT00694707|767722|P5|COMPLETED|Overall Study||101
318398|NCT00694707|767723|P4|COMPLETED|Overall Study||98
318399|NCT00694707|767724|P3|COMPLETED|Overall Study||96
318400|NCT00694707|767725|P2|COMPLETED|Overall Study||90
318401|NCT00694707|767726|P1|COMPLETED|Overall Study||79
318402|NCT00694707|767722|P5|STARTED|Overall Study||141
318403|NCT00694707|767723|P4|STARTED|Overall Study||148
318404|NCT00694707|767724|P3|STARTED|Overall Study||147
318405|NCT00694707|767725|P2|STARTED|Overall Study||145
318406|NCT00694707|767726|P1|STARTED|Overall Study||151
318407|NCT00694603|767743|P1|NOT COMPLETED|Overall Study||0
318408|NCT00694603|767743|P1|COMPLETED|Overall Study||18
318409|NCT00694603|767743|P1|STARTED|Overall Study||18
318410|NCT00694564|767748|P1|NOT COMPLETED|Overall Study||2
318411|NCT00694564|767748|P1|COMPLETED|Overall Study||6
318412|NCT00694564|767748|P1|STARTED|Overall Study||8
318413|NCT00694551|767755|P3|NOT COMPLETED|Overall Study||1
318414|NCT00694551|767756|P2|NOT COMPLETED|Overall Study||0
318415|NCT00694551|767757|P1|NOT COMPLETED|Overall Study||1
318416|NCT00694551|767755|P3|COMPLETED|Overall Study||8
318417|NCT00694551|767756|P2|COMPLETED|Overall Study||10
318418|NCT00694551|767757|P1|COMPLETED|Overall Study||9
318419|NCT00694551|767755|P3|STARTED|Overall Study||9
318420|NCT00694551|767756|P2|STARTED|Overall Study||10
318421|NCT00694551|767757|P1|STARTED|Overall Study||10
318422|NCT00694473|767771|P1|NOT COMPLETED|Overall Study||7
318423|NCT00694473|767771|P1|COMPLETED|Overall Study|Dec 2010|69
318424|NCT00694473|767771|P1|STARTED|Overall Study|Aug 2008|76
318425|NCT00694369|767786|P5|NOT COMPLETED|Overall Study||6
318426|NCT00694369|767787|P4|NOT COMPLETED|Overall Study||3
318427|NCT00694369|767788|P3|NOT COMPLETED|Overall Study||2
318428|NCT00694369|767789|P2|NOT COMPLETED|Overall Study||3
318429|NCT00694369|767790|P1|NOT COMPLETED|Overall Study||1
318430|NCT00694369|767786|P5|COMPLETED|Overall Study||56
318431|NCT00694369|767787|P4|COMPLETED|Overall Study||189
318432|NCT00694369|767788|P3|COMPLETED|Overall Study||95
318433|NCT00694369|767789|P2|COMPLETED|Overall Study||188
318434|NCT00694369|767790|P1|COMPLETED|Overall Study||45
318435|NCT00694369|767786|P5|STARTED|Overall Study||62
318436|NCT00694369|767787|P4|STARTED|Overall Study||192
318437|NCT00694369|767788|P3|STARTED|Overall Study||97
318438|NCT00694369|767789|P2|STARTED|Overall Study||191
318439|NCT00694369|767790|P1|STARTED|Overall Study||46
318440|NCT00694356|767810|P3|NOT COMPLETED|Overall Study||6
318441|NCT00694356|767811|P2|NOT COMPLETED|Overall Study||6
318442|NCT00694356|767812|P1|NOT COMPLETED|Overall Study||3
318443|NCT00694356|767810|P3|COMPLETED|Overall Study||0
318444|NCT00694356|767811|P2|COMPLETED|Overall Study||0
318445|NCT00694356|767812|P1|COMPLETED|Overall Study||0
318446|NCT00694356|767810|P3|STARTED|Overall Study||6
318447|NCT00694356|767811|P2|STARTED|Overall Study||6
318448|NCT00694356|767812|P1|STARTED|Overall Study||3
318449|NCT00694304|767847|P1|NOT COMPLETED|Overall Study||207
318450|NCT00694304|767847|P1|COMPLETED|Overall Study||328
318451|NCT00694304|767847|P1|STARTED|Overall Study||535
318452|NCT00694161|767860|P1|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||3
318453|NCT00694161|767860|P1|COMPLETED|Part 2 (After Week 6 up to Month 12)||32
318454|NCT00694161|767860|P1|STARTED|Part 2 (After Week 6 up to Month 12)||35
318455|NCT00694161|767860|P1|NOT COMPLETED|Part 1 (up to Week 6)||0
318456|NCT00694161|767860|P1|COMPLETED|Part 1 (up to Week 6)||35
318457|NCT00694161|767860|P1|STARTED|Part 1 (up to Week 6)||35
318458|NCT00694122|767899|P2|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
318459|NCT00694122|767900|P1|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
318460|NCT00694122|767899|P2|COMPLETED|Second Intervention (3-4 Weeks)||5
318461|NCT00694122|767900|P1|COMPLETED|Second Intervention (3-4 Weeks)||10
318462|NCT00694122|767899|P2|STARTED|Second Intervention (3-4 Weeks)||5
318463|NCT00694122|767900|P1|STARTED|Second Intervention (3-4 Weeks)||10
318464|NCT00694122|767899|P2|NOT COMPLETED|Washout (1 Day)||0
318465|NCT00694122|767900|P1|NOT COMPLETED|Washout (1 Day)||0
318466|NCT00694122|767899|P2|COMPLETED|Washout (1 Day)||5
318467|NCT00694122|767900|P1|COMPLETED|Washout (1 Day)||10
318468|NCT00694122|767899|P2|STARTED|Washout (1 Day)||5
318469|NCT00694122|767900|P1|STARTED|Washout (1 Day)||10
318470|NCT00694122|767899|P2|NOT COMPLETED|First Intervention (3-4 Weeks)||2
318471|NCT00694122|767900|P1|NOT COMPLETED|First Intervention (3-4 Weeks)||10
318472|NCT00694122|767899|P2|COMPLETED|First Intervention (3-4 Weeks)||5
318473|NCT00694122|767900|P1|COMPLETED|First Intervention (3-4 Weeks)||10
318474|NCT00694122|767899|P2|STARTED|First Intervention (3-4 Weeks)|Started on NPH then on Lantus.|7
318475|NCT00694122|767900|P1|STARTED|First Intervention (3-4 Weeks)|Started Lantus then on NPH.|20
318476|NCT00694109|767916|P1|NOT COMPLETED|Overall Study||117
318477|NCT00694109|767916|P1|COMPLETED|Overall Study||25
318478|NCT00694109|767916|P1|Completed Consented Length of Treatment|Overall Study||60
318479|NCT00694109|767916|P1|Consented 2 Years Additional Treatment|Overall Study||42
318480|NCT00694109|767916|P1|Treated|Overall Study||141
318481|NCT00694109|767916|P1|STARTED|Overall Study|This does not include 2 patients from phase 2 trial with very different treatment experience.|142
318482|NCT00694096|767940|P1|NOT COMPLETED|Overall Study||5
318483|NCT00694096|767940|P1|COMPLETED|Overall Study||20
318484|NCT00694096|767940|P1|STARTED|Overall Study||25
318485|NCT00694070|767946|P1|NOT COMPLETED|Overall Study||0
318486|NCT00694070|767946|P1|COMPLETED|Overall Study||51
318487|NCT00694070|767946|P1|STARTED|Overall Study||51
318488|NCT00694018|767954|P2|NOT COMPLETED|Overall Study||9
318489|NCT00694018|767955|P1|NOT COMPLETED|Overall Study||13
318490|NCT00694018|767954|P2|COMPLETED|Overall Study||102
318491|NCT00694018|767955|P1|COMPLETED|Overall Study||105
318492|NCT00694018|767954|P2|6 Months|Overall Study||101
318493|NCT00694018|767955|P1|6 Months|Overall Study||106
318494|NCT00694018|767954|P2|STARTED|Overall Study||111
318495|NCT00694018|767955|P1|STARTED|Overall Study||118
318496|NCT00693992|767963|P2|NOT COMPLETED|Overall Study||0
318497|NCT00693992|767964|P1|NOT COMPLETED|Overall Study||0
318498|NCT00693992|767963|P2|COMPLETED|Overall Study||104
318499|NCT00693992|767964|P1|COMPLETED|Overall Study||106
318500|NCT00693992|767963|P2|STARTED|Overall Study||104
318501|NCT00693992|767964|P1|STARTED|Overall Study||106
318502|NCT00693784|767980|P1|NOT COMPLETED|Overall Study||4
318503|NCT00693784|767980|P1|COMPLETED|Overall Study||11
318504|NCT00693784|767980|P1|104-week Extended Follow-up|Overall Study||11
318505|NCT00693784|767980|P1|52-week Extended Follow-up|Overall Study||13
318506|NCT00693784|767980|P1|26-Week Primary Endpoint|Overall Study||15
318507|NCT00693784|767980|P1|STARTED|Overall Study||15
318508|NCT00693719|767986|P1|NOT COMPLETED|Overall Study||0
318509|NCT00693719|767986|P1|COMPLETED|Overall Study||31
318510|NCT00693719|767986|P1|STARTED|Overall Study||31
318511|NCT00693706|767993|P2|NOT COMPLETED|Overall Study||1
318512|NCT00693706|767994|P1|NOT COMPLETED|Overall Study||0
318513|NCT00693706|767993|P2|COMPLETED|Overall Study||98
318514|NCT00693706|767994|P1|COMPLETED|Overall Study||101
318515|NCT00693706|767993|P2|STARTED|Overall Study||99
318516|NCT00693706|767994|P1|STARTED|Overall Study||101
318517|NCT00693693|768021|P3|NOT COMPLETED|Overall Study||2
318518|NCT00693693|768022|P2|NOT COMPLETED|Overall Study||1
318519|NCT00693693|768023|P1|NOT COMPLETED|Overall Study||1
318520|NCT00693693|768021|P3|COMPLETED|Overall Study||7
318521|NCT00693693|768022|P2|COMPLETED|Overall Study||8
318522|NCT00693693|768023|P1|COMPLETED|Overall Study||6
318523|NCT00693693|768021|P3|STARTED|Overall Study||9
318524|NCT00693693|768022|P2|STARTED|Overall Study||9
318525|NCT00693693|768023|P1|STARTED|Overall Study||7
318526|NCT00693654|768033|P2|NOT COMPLETED|Overall Study||0
318527|NCT00693654|768034|P1|NOT COMPLETED|Overall Study||0
318528|NCT00693654|768033|P2|COMPLETED|Overall Study||14
318529|NCT00693654|768034|P1|COMPLETED|Overall Study||14
318530|NCT00693654|768033|P2|STARTED|Overall Study||14
318531|NCT00693654|768034|P1|STARTED|Overall Study||14
318532|NCT00693628|768044|P2|NOT COMPLETED|Overall Study||0
318533|NCT00693628|768045|P1|NOT COMPLETED|Overall Study||0
318534|NCT00693628|768044|P2|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment.|0
318535|NCT00693628|768045|P1|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment|0
318536|NCT00693628|768044|P2|STARTED|Overall Study|No data is available indicating to which group patients were assigned .|0
318537|NCT00693628|768045|P1|STARTED|Overall Study|No data is available indicating to which group patients were assigned.|0
318538|NCT00693498|768053|P2|NOT COMPLETED|Overall Study||0
318539|NCT00693498|768054|P1|NOT COMPLETED|Overall Study||0
318540|NCT00693498|768053|P2|COMPLETED|Overall Study||81
318541|NCT00693498|768054|P1|COMPLETED|Overall Study||81
318542|NCT00693498|768053|P2|STARTED|Overall Study||81
318543|NCT00693498|768054|P1|STARTED|Overall Study||81
318544|NCT00693485|768065|P3|NOT COMPLETED|Overall Study||0
318545|NCT00693485|768066|P2|NOT COMPLETED|Overall Study||2
318546|NCT00693485|768067|P1|NOT COMPLETED|Overall Study||0
318547|NCT00693485|768065|P3|COMPLETED|Overall Study||24
318548|NCT00693485|768066|P2|COMPLETED|Overall Study||19
318549|NCT00693485|768067|P1|COMPLETED|Overall Study||25
318550|NCT00693485|768065|P3|STARTED|Overall Study||24
318551|NCT00693485|768066|P2|STARTED|Overall Study||21
318552|NCT00693485|768067|P1|STARTED|Overall Study||25
318553|NCT00693472|768082|P4|NOT COMPLETED|Part 2||2
318554|NCT00693472|768083|P3|NOT COMPLETED|Part 2||2
318555|NCT00693472|768084|P2|NOT COMPLETED|Part 2||0
318556|NCT00693472|768085|P1|NOT COMPLETED|Part 2||0
318557|NCT00693472|768082|P4|COMPLETED|Part 2||4
318558|NCT00693472|768083|P3|COMPLETED|Part 2||6
318559|NCT00693472|768084|P2|COMPLETED|Part 2||0
318560|NCT00693472|768085|P1|COMPLETED|Part 2||0
318561|NCT00693472|768082|P4|STARTED|Part 2||6
318562|NCT00693472|768083|P3|STARTED|Part 2||8
318563|NCT00693472|768084|P2|STARTED|Part 2||0
318564|NCT00693472|768085|P1|STARTED|Part 2||0
318565|NCT00693472|768082|P4|NOT COMPLETED|Part 1||0
318566|NCT00693472|768083|P3|NOT COMPLETED|Part 1||0
318567|NCT00693472|768084|P2|NOT COMPLETED|Part 1||4
318568|NCT00693472|768085|P1|NOT COMPLETED|Part 1||6
318569|NCT00693472|768082|P4|COMPLETED|Part 1||0
318570|NCT00693472|768083|P3|COMPLETED|Part 1||0
318571|NCT00693472|768084|P2|COMPLETED|Part 1||9
318572|NCT00693472|768085|P1|COMPLETED|Part 1||13
318573|NCT00693472|768082|P4|STARTED|Part 1||0
318574|NCT00693472|768083|P3|STARTED|Part 1||0
318575|NCT00693472|768084|P2|STARTED|Part 1||13
318576|NCT00693472|768085|P1|STARTED|Part 1||19
318577|NCT00693420|768105|P2|NOT COMPLETED|Overall Study||15
318578|NCT00693420|768106|P1|NOT COMPLETED|Overall Study||6
318579|NCT00693420|768105|P2|COMPLETED|Overall Study||126
318580|NCT00693420|768106|P1|COMPLETED|Overall Study||131
318581|NCT00693420|768105|P2|STARTED|Overall Study||141
318582|NCT00693420|768106|P1|STARTED|Overall Study||137
318583|NCT00693303|768130|P1|NOT COMPLETED|Overall Study||0
318584|NCT00693303|768130|P1|COMPLETED|Overall Study||21
318585|NCT00693303|768130|P1|STARTED|Overall Study||21
318586|NCT00693238|768136|P2|NOT COMPLETED|Overall Study||0
318587|NCT00693238|768137|P1|NOT COMPLETED|Overall Study||0
318588|NCT00693238|768136|P2|COMPLETED|Overall Study||106
318589|NCT00693238|768137|P1|COMPLETED|Overall Study||122
318590|NCT00693238|768136|P2|STARTED|Overall Study||106
318591|NCT00693238|768137|P1|STARTED|Overall Study||122
318592|NCT00693225|768145|P2|NOT COMPLETED|Overall Study||5
318593|NCT00693225|768146|P1|NOT COMPLETED|Overall Study||2
318594|NCT00693225|768145|P2|COMPLETED|Overall Study||43
318595|NCT00693225|768146|P1|COMPLETED|Overall Study||41
318596|NCT00693225|768145|P2|STARTED|Overall Study||48
318597|NCT00693225|768146|P1|STARTED|Overall Study||43
318598|NCT00693160|768158|P2|NOT COMPLETED|Overall Study||0
318599|NCT00693160|768159|P1|NOT COMPLETED|Overall Study||0
318600|NCT00693160|768158|P2|COMPLETED|Overall Study||16
318601|NCT00693160|768159|P1|COMPLETED|Overall Study||14
318602|NCT00693160|768158|P2|STARTED|Overall Study||16
318603|NCT00693160|768159|P1|STARTED|Overall Study||14
318604|NCT00693017|768169|P2|NOT COMPLETED|Overall Study||2
318605|NCT00693017|768170|P1|NOT COMPLETED|Overall Study||2
318606|NCT00693017|768169|P2|COMPLETED|Overall Study||0
318607|NCT00693017|768170|P1|COMPLETED|Overall Study||0
318608|NCT00693017|768169|P2|STARTED|Overall Study||2
318609|NCT00693017|768170|P1|STARTED|Overall Study||2
318610|NCT00692913|768180|P2|NOT COMPLETED|Overall Study||30
318611|NCT00692913|768181|P1|NOT COMPLETED|Overall Study||29
318612|NCT00692913|768180|P2|COMPLETED|Overall Study||228
318613|NCT00692913|768181|P1|COMPLETED|Overall Study||228
318614|NCT00692913|768180|P2|STARTED|Overall Study||258
318615|NCT00692913|768181|P1|STARTED|Overall Study||257
318616|NCT00692770|768203|P2|NOT COMPLETED|Overall Study||558
318617|NCT00692770|768204|P1|NOT COMPLETED|Overall Study||556
318618|NCT00692770|768203|P2|COMPLETED|Overall Study||0
318619|NCT00692770|768204|P1|COMPLETED|Overall Study||0
318620|NCT00692770|768203|P2|Participants Received Treatment|Overall Study||554
318621|NCT00692770|768204|P1|Participants Received Treatment|Overall Study||553
318622|NCT00692770|768203|P2|STARTED|Overall Study||558
318623|NCT00692770|768204|P1|STARTED|Overall Study||556
318624|NCT00692692|768228|P2|NOT COMPLETED|Overall Study||0
318625|NCT00692692|768229|P1|NOT COMPLETED|Overall Study||0
318626|NCT00692692|768228|P2|COMPLETED|Overall Study||16
318627|NCT00692692|768229|P1|COMPLETED|Overall Study||20
318628|NCT00692692|768228|P2|STARTED|Overall Study||16
318629|NCT00692692|768229|P1|STARTED|Overall Study||20
318630|NCT00692419|768239|P2|NOT COMPLETED|Overall Study||18
318631|NCT00692419|768240|P1|NOT COMPLETED|Overall Study||16
318632|NCT00692419|768239|P2|COMPLETED|Overall Study||102
318633|NCT00692419|768240|P1|COMPLETED|Overall Study||84
318634|NCT00692419|768239|P2|STARTED|Overall Study||120
318635|NCT00692419|768240|P1|STARTED|Overall Study||100
318636|NCT00692406|768250|P1|NOT COMPLETED|Overall Study||57
318637|NCT00692406|768250|P1|COMPLETED|Overall Study|This group quit smoking before their second scan.|23
318638|NCT00692406|768250|P1|STARTED|Overall Study|Initially this group was assigned to quit smoking before the second scan.|80
318639|NCT00692341|768264|P3|NOT COMPLETED|Overall Study||0
318640|NCT00692341|768265|P2|NOT COMPLETED|Overall Study||0
318641|NCT00692341|768266|P1|NOT COMPLETED|Overall Study||0
318642|NCT00692341|768264|P3|COMPLETED|Overall Study||8
318643|NCT00692341|768265|P2|COMPLETED|Overall Study||8
318644|NCT00692341|768266|P1|COMPLETED|Overall Study||8
318645|NCT00692341|768264|P3|STARTED|Overall Study||8
318646|NCT00692341|768265|P2|STARTED|Overall Study||8
318647|NCT00692341|768266|P1|STARTED|Overall Study||8
318648|NCT00692237|768312|P2|NOT COMPLETED|Overall Study||4
318649|NCT00692237|768313|P1|NOT COMPLETED|Overall Study||1
318650|NCT00692237|768312|P2|COMPLETED|Overall Study||25
318651|NCT00692237|768313|P1|COMPLETED|Overall Study||29
318652|NCT00692237|768312|P2|STARTED|Overall Study||29
318653|NCT00692237|768313|P1|STARTED|Overall Study||30
318654|NCT00692211|768323|P2|NOT COMPLETED|Overall Study||0
318655|NCT00692211|768324|P1|NOT COMPLETED|Overall Study||0
318656|NCT00692211|768323|P2|COMPLETED|Overall Study||202
318657|NCT00692211|768324|P1|COMPLETED|Overall Study||202
318658|NCT00692211|768323|P2|STARTED|Overall Study||202
318659|NCT00692211|768324|P1|STARTED|Overall Study||202
318660|NCT00692198|768332|P2|NOT COMPLETED|Overall Study||0
318661|NCT00692198|768333|P1|NOT COMPLETED|Overall Study||0
318662|NCT00692198|768332|P2|COMPLETED|Overall Study||370
318663|NCT00692198|768333|P1|COMPLETED|Overall Study||368
318664|NCT00692198|768332|P2|STARTED|Overall Study||370
318665|NCT00692198|768333|P1|STARTED|Overall Study||368
318666|NCT00692185|768368|P2|NOT COMPLETED|Overall Study||3
318667|NCT00692185|768369|P1|NOT COMPLETED|Overall Study||3
318668|NCT00692185|768368|P2|COMPLETED|Overall Study||9
318669|NCT00692185|768369|P1|COMPLETED|Overall Study||8
318670|NCT00692185|768368|P2|STARTED|Overall Study||12
318671|NCT00692185|768369|P1|STARTED|Overall Study||11
318672|NCT00692094|768381|P4|NOT COMPLETED|Overall Study||0
318673|NCT00692094|768382|P3|NOT COMPLETED|Overall Study||0
318674|NCT00692094|768383|P2|NOT COMPLETED|Overall Study||0
318675|NCT00692094|768384|P1|NOT COMPLETED|Overall Study||0
318676|NCT00692094|768381|P4|COMPLETED|Overall Study||0
318677|NCT00692094|768382|P3|COMPLETED|Overall Study||0
318678|NCT00692094|768383|P2|COMPLETED|Overall Study||0
318679|NCT00692094|768384|P1|COMPLETED|Overall Study||0
318680|NCT00692094|768381|P4|STARTED|Overall Study||0
318681|NCT00692094|768382|P3|STARTED|Overall Study||0
318682|NCT00692094|768383|P2|STARTED|Overall Study||0
318683|NCT00692094|768384|P1|STARTED|Overall Study||0
318684|NCT00692003|768400|P2|NOT COMPLETED|Overall Study||1
318685|NCT00692003|768401|P1|NOT COMPLETED|Overall Study||5
318686|NCT00692003|768400|P2|COMPLETED|Overall Study||0
318687|NCT00692003|768401|P1|COMPLETED|Overall Study||0
318688|NCT00692003|768400|P2|STARTED|Overall Study||1
318689|NCT00692003|768401|P1|STARTED|Overall Study||5
318690|NCT00691938|768416|P7|NOT COMPLETED|Overall Study||0
318691|NCT00691938|768417|P6|NOT COMPLETED|Overall Study||0
318692|NCT00691938|768418|P5|NOT COMPLETED|Overall Study||0
318693|NCT00691938|768419|P4|NOT COMPLETED|Overall Study||0
318694|NCT00691938|768420|P3|NOT COMPLETED|Overall Study||0
318695|NCT00691938|768421|P2|NOT COMPLETED|Overall Study||0
318696|NCT00691938|768422|P1|NOT COMPLETED|Overall Study||1
318697|NCT00691938|768416|P7|COMPLETED|Overall Study||14
318698|NCT00691938|768417|P6|COMPLETED|Overall Study||6
318699|NCT00691938|768418|P5|COMPLETED|Overall Study||10
318700|NCT00691938|768419|P4|COMPLETED|Overall Study||8
318701|NCT00691938|768420|P3|COMPLETED|Overall Study||6
318702|NCT00691938|768421|P2|COMPLETED|Overall Study||3
318703|NCT00691938|768422|P1|COMPLETED|Overall Study||4
318704|NCT00691938|768416|P7|STARTED|Overall Study||14
318705|NCT00691938|768417|P6|STARTED|Overall Study||6
318706|NCT00691938|768418|P5|STARTED|Overall Study||10
318707|NCT00691938|768419|P4|STARTED|Overall Study||8
318708|NCT00691938|768420|P3|STARTED|Overall Study||6
318709|NCT00691938|768421|P2|STARTED|Overall Study||3
318710|NCT00691938|768422|P1|STARTED|Overall Study||5
318711|NCT00691808|768446|P3|NOT COMPLETED|Overall Study||0
318712|NCT00691808|768447|P2|NOT COMPLETED|Overall Study||1
318713|NCT00691808|768448|P1|NOT COMPLETED|Overall Study||0
318714|NCT00691808|768446|P3|COMPLETED|Overall Study||32
318715|NCT00691808|768447|P2|COMPLETED|Overall Study||35
318716|NCT00691808|768448|P1|COMPLETED|Overall Study||35
318717|NCT00691808|768446|P3|STARTED|Overall Study||32
318718|NCT00691808|768447|P2|STARTED|Overall Study||36
318719|NCT00691808|768448|P1|STARTED|Overall Study||35
318720|NCT00691704|768489|P1|NOT COMPLETED|Two Years of Maintenance Therapy||13
318721|NCT00691704|768489|P1|COMPLETED|Two Years of Maintenance Therapy||3
318722|NCT00691704|768489|P1|STARTED|Two Years of Maintenance Therapy||16
318723|NCT00691704|768489|P1|NOT COMPLETED|Induction Therapy||2
318724|NCT00691704|768489|P1|COMPLETED|Induction Therapy||16
318725|NCT00691704|768489|P1|STARTED|Induction Therapy||18
318726|NCT00691665|768499|P2|NOT COMPLETED|Overall Study||0
318727|NCT00691665|768500|P1|NOT COMPLETED|Overall Study||0
318728|NCT00691665|768499|P2|COMPLETED|Overall Study||65
318729|NCT00691665|768500|P1|COMPLETED|Overall Study||65
318730|NCT00691665|768499|P2|STARTED|Overall Study||65
318731|NCT00691665|768500|P1|STARTED|Overall Study||65
318732|NCT00691652|768512|P1|NOT COMPLETED|Overall Study||1
318733|NCT00691652|768512|P1|COMPLETED|Overall Study||1
318734|NCT00691652|768512|P1|STARTED|Overall Study||2
318735|NCT00691574|768524|P2|NOT COMPLETED|Overall Study||0
318736|NCT00691574|768525|P1|NOT COMPLETED|Overall Study||0
318737|NCT00691574|768524|P2|COMPLETED|Overall Study||0
318738|NCT00691574|768525|P1|COMPLETED|Overall Study||0
318739|NCT00691574|768524|P2|STARTED|Overall Study||0
318740|NCT00691574|768525|P1|STARTED|Overall Study||0
318741|NCT00691483|768537|P2|NOT COMPLETED|Overall Study||25
318742|NCT00691483|768538|P1|NOT COMPLETED|Overall Study||68
318743|NCT00691483|768537|P2|COMPLETED|Overall Study||141
318744|NCT00691483|768538|P1|COMPLETED|Overall Study|Completed refers to completion of the study.|425
318745|NCT00691483|768537|P2|Received Treatment|Overall Study||165
318746|NCT00691483|768538|P1|Received Treatment|Overall Study||486
318747|NCT00691483|768537|P2|STARTED|Overall Study||166
318748|NCT00691483|768538|P1|STARTED|Overall Study||493
318749|NCT00691444|768557|P3|NOT COMPLETED|Overall Study||0
318750|NCT00691444|768558|P2|NOT COMPLETED|Overall Study||0
318751|NCT00691444|768559|P1|NOT COMPLETED|Overall Study||0
318752|NCT00691444|768557|P3|COMPLETED|Overall Study||0
318753|NCT00691444|768558|P2|COMPLETED|Overall Study||0
318754|NCT00691444|768559|P1|COMPLETED|Overall Study||0
318755|NCT00691444|768557|P3|STARTED|Overall Study||0
318756|NCT00691444|768558|P2|STARTED|Overall Study||0
318757|NCT00691444|768559|P1|STARTED|Overall Study||0
318758|NCT00691327|768572|P2|NOT COMPLETED|Overall Study||2508
318759|NCT00691327|768573|P1|NOT COMPLETED|Overall Study||2841
318760|NCT00691327|768572|P2|COMPLETED|Overall Study||36766
318761|NCT00691327|768573|P1|COMPLETED|Overall Study||42214
318762|NCT00691327|768572|P2|STARTED|Overall Study||39274
318763|NCT00691327|768573|P1|STARTED|Overall Study||45055
318764|NCT00691301|768581|P1|NOT COMPLETED|Overall Study||54
318765|NCT00691301|768581|P1|COMPLETED|Overall Study||1
318766|NCT00691301|768581|P1|STARTED|Overall Study||55
318767|NCT00691210|768601|P8|NOT COMPLETED|Overall Study||0
318768|NCT00691210|768602|P7|NOT COMPLETED|Overall Study||0
318769|NCT00691210|768603|P6|NOT COMPLETED|Overall Study||1
318770|NCT00691210|768604|P5|NOT COMPLETED|Overall Study||0
318771|NCT00691210|768605|P4|NOT COMPLETED|Overall Study||3
318772|NCT00691210|768606|P3|NOT COMPLETED|Overall Study||0
318773|NCT00691210|768607|P2|NOT COMPLETED|Overall Study||0
318774|NCT00691210|768608|P1|NOT COMPLETED|Overall Study||0
318775|NCT00691210|768601|P8|COMPLETED|Overall Study||0
318776|NCT00691210|768602|P7|COMPLETED|Overall Study||6
318777|NCT00691210|768603|P6|COMPLETED|Overall Study||6
318778|NCT00691210|768604|P5|COMPLETED|Overall Study||5
318779|NCT00691210|768605|P4|COMPLETED|Overall Study||6
318780|NCT00691210|768606|P3|COMPLETED|Overall Study||3
318781|NCT00691210|768607|P2|COMPLETED|Overall Study||5
318782|NCT00691210|768608|P1|COMPLETED|Overall Study||3
318783|NCT00691210|768601|P8|STARTED|Overall Study||0
318784|NCT00691210|768602|P7|STARTED|Overall Study||6
318785|NCT00691210|768603|P6|STARTED|Overall Study||7
318786|NCT00691210|768604|P5|STARTED|Overall Study||5
318787|NCT00691210|768605|P4|STARTED|Overall Study||9
318788|NCT00691210|768606|P3|STARTED|Overall Study||3
318789|NCT00691210|768607|P2|STARTED|Overall Study||5
318790|NCT00691210|768608|P1|STARTED|Overall Study||3
318791|NCT00691197|768628|P2|NOT COMPLETED|Overall Study||5
318792|NCT00691197|768629|P1|NOT COMPLETED|Overall Study||11
318793|NCT00691197|768628|P2|COMPLETED|Overall Study||75
318794|NCT00691197|768629|P1|COMPLETED|Overall Study||155
318795|NCT00691197|768628|P2|STARTED|Overall Study||80
318796|NCT00691197|768629|P1|STARTED|Overall Study||166
318797|NCT00691132|768643|P2|NOT COMPLETED|Overall Study||13
318798|NCT00691132|768644|P1|NOT COMPLETED|Overall Study||12
318799|NCT00691132|768643|P2|COMPLETED|Overall Study|45 completed, but 4 excluded b/c urinary measures indicated they did not smoke study cigarettes.|41
318800|NCT00691132|768644|P1|COMPLETED|Overall Study||41
318801|NCT00691132|768643|P2|STARTED|Overall Study|107 total randomized. Approximately 1/2 per arm.|54
318802|NCT00691132|768644|P1|STARTED|Overall Study||53
318803|NCT00691093|768663|P1|NOT COMPLETED|Overall Study||7
318804|NCT00691093|768663|P1|COMPLETED|Overall Study||816
318805|NCT00691093|768663|P1|STARTED|Overall Study||823
318806|NCT00691054|768697|P1|NOT COMPLETED|Overall Study||1
318807|NCT00691054|768697|P1|COMPLETED|Overall Study||19
318808|NCT00691054|768697|P1|STARTED|Overall Study||20
318809|NCT00691028|768709|P4|NOT COMPLETED|Double-blind Period||0
318810|NCT00691028|768710|P3|NOT COMPLETED|Double-blind Period||9
318811|NCT00691028|768711|P2|NOT COMPLETED|Double-blind Period||13
318812|NCT00691028|768712|P1|NOT COMPLETED|Double-blind Period||13
318813|NCT00691028|768709|P4|COMPLETED|Double-blind Period||0
318814|NCT00691028|768710|P3|COMPLETED|Double-blind Period||95
318815|NCT00691028|768711|P2|COMPLETED|Double-blind Period||91
318816|NCT00691028|768712|P1|COMPLETED|Double-blind Period||86
318817|NCT00691028|768709|P4|STARTED|Double-blind Period||0
318818|NCT00691028|768710|P3|STARTED|Double-blind Period||104
318819|NCT00691028|768711|P2|STARTED|Double-blind Period||104
318820|NCT00691028|768712|P1|STARTED|Double-blind Period||99
318821|NCT00691028|768709|P4|NOT COMPLETED|Open-label Period||20
318822|NCT00691028|768710|P3|NOT COMPLETED|Open-label Period||0
318823|NCT00691028|768711|P2|NOT COMPLETED|Open-label Period||0
318824|NCT00691028|768712|P1|NOT COMPLETED|Open-label Period||0
318825|NCT00691028|768709|P4|COMPLETED|Open-label Period||307
318826|NCT00691028|768710|P3|COMPLETED|Open-label Period||0
318827|NCT00691028|768711|P2|COMPLETED|Open-label Period||0
318828|NCT00691028|768712|P1|COMPLETED|Open-label Period||0
318829|NCT00691028|768709|P4|STARTED|Open-label Period||327
318830|NCT00691028|768710|P3|STARTED|Open-label Period||0
318831|NCT00691028|768711|P2|STARTED|Open-label Period||0
318832|NCT00691028|768712|P1|STARTED|Open-label Period||0
318833|NCT00691015|768745|P1|NOT COMPLETED|Overall Study||1
318834|NCT00691015|768745|P1|COMPLETED|Overall Study||47
318835|NCT00691015|768745|P1|STARTED|Overall Study||48
318836|NCT00690924|768756|P1|NOT COMPLETED|Overall Study||0
318837|NCT00690924|768756|P1|COMPLETED|Overall Study||16
318838|NCT00690924|768756|P1|STARTED|Overall Study||16
318839|NCT00690898|768760|P1|NOT COMPLETED|TREATMENT||26
318840|NCT00690898|768760|P1|COMPLETED|TREATMENT||64
318841|NCT00690898|768760|P1|STARTED|TREATMENT|Total number of patients treated.|90
318842|NCT00690898|768760|P1|NOT COMPLETED|SCREENING||18
318843|NCT00690898|768760|P1|COMPLETED|SCREENING|Number of patients included in the study.|90
318844|NCT00690898|768760|P1|STARTED|SCREENING|Total of patients screened for the study.|108
318845|NCT00690833|768774|P1|NOT COMPLETED|Overall Study||2
318846|NCT00690833|768774|P1|COMPLETED|Overall Study||39
318847|NCT00690833|768774|P1|STARTED|Overall Study||41
318848|NCT00690820|768780|P2|NOT COMPLETED|Period 2||0
318849|NCT00690820|768781|P1|NOT COMPLETED|Period 2||0
318850|NCT00690820|768780|P2|COMPLETED|Period 2||8
318851|NCT00690820|768781|P1|COMPLETED|Period 2||8
318852|NCT00690820|768780|P2|STARTED|Period 2||8
318853|NCT00690820|768781|P1|STARTED|Period 2||8
318854|NCT00690820|768780|P2|NOT COMPLETED|Period 1||1
318855|NCT00690820|768781|P1|NOT COMPLETED|Period 1||0
318856|NCT00690820|768780|P2|COMPLETED|Period 1||8
318857|NCT00690820|768781|P1|COMPLETED|Period 1||8
318858|NCT00690820|768780|P2|STARTED|Period 1||9
318859|NCT00690820|768781|P1|STARTED|Period 1||8
318860|NCT00690794|768803|P2|NOT COMPLETED|Overall Study||35
318861|NCT00690794|768804|P1|NOT COMPLETED|Overall Study||21
318862|NCT00690794|768803|P2|COMPLETED|Overall Study||328
318863|NCT00690794|768804|P1|COMPLETED|Overall Study||342
318864|NCT00690794|768803|P2|STARTED|Overall Study||363
318865|NCT00690794|768804|P1|STARTED|Overall Study||363
318866|NCT00690755|768819|P7|NOT COMPLETED|Overall Study||0
318867|NCT00690755|768820|P6|NOT COMPLETED|Overall Study||4
318868|NCT00690755|768821|P5|NOT COMPLETED|Overall Study||0
318869|NCT00690755|768822|P4|NOT COMPLETED|Overall Study||5
318870|NCT00690755|768823|P3|NOT COMPLETED|Overall Study||46
318871|NCT00690755|768824|P2|NOT COMPLETED|Overall Study||0
318872|NCT00690755|768825|P1|NOT COMPLETED|Overall Study||2
318873|NCT00690755|768819|P7|COMPLETED|Overall Study||0
318874|NCT00690755|768820|P6|COMPLETED|Overall Study||6
318875|NCT00690755|768821|P5|COMPLETED|Overall Study||0
318876|NCT00690755|768822|P4|COMPLETED|Overall Study||15
318877|NCT00690755|768823|P3|COMPLETED|Overall Study||51
318878|NCT00690755|768824|P2|COMPLETED|Overall Study||0
318879|NCT00690755|768825|P1|COMPLETED|Overall Study|Patient recruitment ended on 12/31/2010|28
318880|NCT00690755|768819|P7|STARTED|Overall Study||0
318881|NCT00690755|768820|P6|STARTED|Overall Study||10
318882|NCT00690755|768821|P5|STARTED|Overall Study||0
318883|NCT00690755|768822|P4|STARTED|Overall Study||20
318884|NCT00690755|768823|P3|STARTED|Overall Study||97
318885|NCT00690755|768824|P2|STARTED|Overall Study||0
318886|NCT00690755|768825|P1|STARTED|Overall Study||30
318887|NCT00690612|768841|P1|NOT COMPLETED|Overall Study||3
318888|NCT00690612|768841|P1|COMPLETED|Overall Study||32
318889|NCT00690612|768841|P1|STARTED|Overall Study||35
318890|NCT00690573|768846|P1|NOT COMPLETED|Overall Study||9
318891|NCT00690573|768846|P1|COMPLETED|Overall Study||16
318892|NCT00690573|768846|P1|STARTED|Overall Study||25
318893|NCT00690495|768856|P2|NOT COMPLETED|Overall Study||0
318894|NCT00690495|768857|P1|NOT COMPLETED|Overall Study||0
318895|NCT00690495|768856|P2|COMPLETED|Overall Study||50
318896|NCT00690495|768857|P1|COMPLETED|Overall Study||50
318897|NCT00690495|768856|P2|Primary Endpoint|Overall Study||50
318898|NCT00690495|768857|P1|Primary Endpoint|Overall Study||50
318899|NCT00690495|768856|P2|STARTED|Overall Study||50
318900|NCT00690495|768857|P1|STARTED|Overall Study||50
318901|NCT00690482|768865|P2|NOT COMPLETED|Overall Study||3
318902|NCT00690482|768866|P1|NOT COMPLETED|Overall Study||4
318903|NCT00690482|768865|P2|COMPLETED|Overall Study||54
318904|NCT00690482|768866|P1|COMPLETED|Overall Study||57
318905|NCT00690482|768865|P2|STARTED|Overall Study||57
318906|NCT00690482|768866|P1|STARTED|Overall Study||61
318907|NCT00690443|768900|P2|NOT COMPLETED|Overall Study||2
318908|NCT00690443|768901|P1|NOT COMPLETED|Overall Study||1
318909|NCT00690443|768900|P2|COMPLETED|Overall Study||19
318910|NCT00690443|768901|P1|COMPLETED|Overall Study||22
318911|NCT00690443|768900|P2|STARTED|Overall Study||21
318912|NCT00690443|768901|P1|STARTED|Overall Study||23
318913|NCT00690430|768911|P3|NOT COMPLETED|Extension Phase||13
318914|NCT00690430|768912|P2|NOT COMPLETED|Extension Phase||5
318915|NCT00690430|768913|P1|NOT COMPLETED|Extension Phase||18
318916|NCT00690430|768911|P3|COMPLETED|Extension Phase||2
318917|NCT00690430|768912|P2|COMPLETED|Extension Phase||1
318918|NCT00690430|768913|P1|COMPLETED|Extension Phase||2
318919|NCT00690430|768911|P3|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|15
318920|NCT00690430|768912|P2|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|6
318921|NCT00690430|768913|P1|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|20
318922|NCT00690430|768911|P3|NOT COMPLETED|Core Phase||0
318923|NCT00690430|768912|P2|NOT COMPLETED|Core Phase||23
318924|NCT00690430|768913|P1|NOT COMPLETED|Core Phase||18
318925|NCT00690430|768911|P3|COMPLETED|Core Phase||0
318926|NCT00690430|768912|P2|COMPLETED|Core Phase||34
318927|NCT00690430|768913|P1|COMPLETED|Core Phase||35
318928|NCT00690430|768911|P3|STARTED|Core Phase|This arm belongs to Extension Phase.|0
318929|NCT00690430|768912|P2|STARTED|Core Phase||57
318930|NCT00690430|768913|P1|STARTED|Core Phase|"Started indicates Full Analysis Set (FAS) and Safety Set."|53
318931|NCT00690378|768942|P2|NOT COMPLETED|Overall Study||14
318932|NCT00690378|768943|P1|NOT COMPLETED|Overall Study||20
318933|NCT00690378|768942|P2|COMPLETED|Overall Study|Up to LFU visit|54
318934|NCT00690378|768943|P1|COMPLETED|Overall Study|Up to Late follow up (LFU) visit|49
318935|NCT00690378|768942|P2|Treated|Overall Study||67
318936|NCT00690378|768943|P1|Treated|Overall Study||68
318937|NCT00690378|768942|P2|STARTED|Overall Study|Randomized|68
318938|NCT00690378|768943|P1|STARTED|Overall Study|Randomized|69
318939|NCT00690339|768991|P4|NOT COMPLETED|Overall Study||25
318940|NCT00690339|768992|P3|NOT COMPLETED|Overall Study||57
318941|NCT00690339|768993|P2|NOT COMPLETED|Overall Study||81
318942|NCT00690339|768994|P1|NOT COMPLETED|Overall Study||117
318943|NCT00690339|768991|P4|COMPLETED|Overall Study||43
318944|NCT00690339|768992|P3|COMPLETED|Overall Study||99
318945|NCT00690339|768993|P2|COMPLETED|Overall Study||144
318946|NCT00690339|768994|P1|COMPLETED|Overall Study||375
318947|NCT00690339|768991|P4|STARTED|Overall Study||68
318948|NCT00690339|768992|P3|STARTED|Overall Study||156
318949|NCT00690339|768993|P2|STARTED|Overall Study||225
318950|NCT00690339|768994|P1|STARTED|Overall Study||492
318951|NCT00690274|769010|P2|NOT COMPLETED|Overall Study||8
318952|NCT00690274|769011|P1|NOT COMPLETED|Overall Study||6
318953|NCT00690274|769010|P2|COMPLETED|Overall Study||15
318954|NCT00690274|769011|P1|COMPLETED|Overall Study||23
318955|NCT00690274|769010|P2|STARTED|Overall Study||23
318956|NCT00690274|769011|P1|STARTED|Overall Study||29
318957|NCT00690235|769021|P2|NOT COMPLETED|Overall Study||4
318958|NCT00690235|769022|P1|NOT COMPLETED|Overall Study||5
318959|NCT00690235|769021|P2|COMPLETED|Overall Study||12
318960|NCT00690235|769022|P1|COMPLETED|Overall Study||12
318961|NCT00690235|769021|P2|STARTED|Overall Study||16
318962|NCT00690235|769022|P1|STARTED|Overall Study||17
318963|NCT00690040|769030|P2|NOT COMPLETED|Overall Study||0
318964|NCT00690040|769031|P1|NOT COMPLETED|Overall Study||0
318965|NCT00690040|769030|P2|COMPLETED|Overall Study||148
318966|NCT00690040|769031|P1|COMPLETED|Overall Study||145
318967|NCT00690040|769030|P2|STARTED|Overall Study||148
318968|NCT00690040|769031|P1|STARTED|Overall Study||145
318969|NCT00689936|769040|P3|NOT COMPLETED|Long-Term Follow Up Phase||144
318970|NCT00689936|769041|P2|NOT COMPLETED|Long-Term Follow Up Phase||188
318971|NCT00689936|769042|P1|NOT COMPLETED|Long-Term Follow Up Phase||127
318972|NCT00689936|769040|P3|COMPLETED|Long-Term Follow Up Phase||315
318973|NCT00689936|769041|P2|COMPLETED|Long-Term Follow Up Phase||275
318974|NCT00689936|769042|P1|COMPLETED|Long-Term Follow Up Phase||255
318975|NCT00689936|769040|P3|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|459
318976|NCT00689936|769041|P2|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|463
318977|NCT00689936|769042|P1|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|382
318978|NCT00689936|769040|P3|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
318979|NCT00689936|769041|P2|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
318980|NCT00689936|769042|P1|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
318981|NCT00689936|769040|P3|COMPLETED|Progression Free Survival-PFS-Follow-Up||273
318982|NCT00689936|769041|P2|COMPLETED|Progression Free Survival-PFS-Follow-Up||300
318983|NCT00689936|769042|P1|COMPLETED|Progression Free Survival-PFS-Follow-Up||87
318984|NCT00689936|769040|P3|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 12 cycles MPT and did not experience progressive disease.|273
318985|NCT00689936|769041|P2|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 18 cycles (Rd18) and did not experience progressive disease.|300
318986|NCT00689936|769042|P1|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who discontinued treatment for reasons other than progressive disease.|87
318987|NCT00689936|769040|P3|NOT COMPLETED|Active Treatment Phase||547
318988|NCT00689936|769041|P2|NOT COMPLETED|Active Treatment Phase||541
318989|NCT00689936|769042|P1|NOT COMPLETED|Active Treatment Phase||535
318990|NCT00689936|769040|P3|COMPLETED|Active Treatment Phase||0
318991|NCT00689936|769041|P2|COMPLETED|Active Treatment Phase||0
318992|NCT00689936|769042|P1|COMPLETED|Active Treatment Phase||0
318993|NCT00689936|769040|P3|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|6
318994|NCT00689936|769041|P2|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|1
318995|NCT00689936|769042|P1|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|3
318996|NCT00689936|769040|P3|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|541
318997|NCT00689936|769041|P2|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|540
318998|NCT00689936|769042|P1|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|532
318999|NCT00689936|769040|P3|STARTED|Active Treatment Phase||547
319000|NCT00689936|769041|P2|STARTED|Active Treatment Phase||541
319001|NCT00689936|769042|P1|STARTED|Active Treatment Phase||535
319002|NCT00689884|769182|P1|NOT COMPLETED|Overall Study||0
319003|NCT00689884|769182|P1|COMPLETED|Overall Study||7
319004|NCT00689884|769182|P1|STARTED|Overall Study||7
319005|NCT00689871|769191|P4|NOT COMPLETED|Overall Study||7
319006|NCT00689871|769192|P3|NOT COMPLETED|Overall Study||73
319007|NCT00689871|769193|P2|NOT COMPLETED|Overall Study||52
319008|NCT00689871|769194|P1|NOT COMPLETED|Overall Study||175
319009|NCT00689871|769191|P4|COMPLETED|Overall Study|4 Patients discontinued|8
319010|NCT00689871|769192|P3|COMPLETED|Overall Study|28 Patients discontinued|74
319011|NCT00689871|769193|P2|COMPLETED|Overall Study|35 Patients discontinued|46
319012|NCT00689871|769194|P1|COMPLETED|Overall Study|35 Patients discontinued|280
319013|NCT00689871|769191|P4|STARTED|Overall Study|25 Implants|15
319014|NCT00689871|769192|P3|STARTED|Overall Study|288 Implants|147
319015|NCT00689871|769193|P2|STARTED|Overall Study|127 Implants|98
319016|NCT00689871|769194|P1|STARTED|Overall Study|908 Implants|455
319017|NCT00689819|769210|P2|NOT COMPLETED|Overall Study||15
319018|NCT00689819|769211|P1|NOT COMPLETED|Overall Study||20
319019|NCT00689819|769210|P2|COMPLETED|Overall Study||43
319020|NCT00689819|769211|P1|COMPLETED|Overall Study||45
319021|NCT00689819|769210|P2|STARTED|Overall Study||58
319022|NCT00689819|769211|P1|STARTED|Overall Study||65
319023|NCT00689793|769221|P2|NOT COMPLETED|Overall Study||5
319024|NCT00689793|769222|P1|NOT COMPLETED|Overall Study||4
319025|NCT00689793|769221|P2|COMPLETED|Overall Study||71
319026|NCT00689793|769222|P1|COMPLETED|Overall Study||74
319027|NCT00689793|769221|P2|STARTED|Overall Study||76
319028|NCT00689793|769222|P1|STARTED|Overall Study||78
319029|NCT00689728|769241|P3|NOT COMPLETED|Optional Follow-Up||6
319030|NCT00689728|769242|P2|NOT COMPLETED|Optional Follow-Up||6
319031|NCT00689728|769243|P1|NOT COMPLETED|Optional Follow-Up||3
319032|NCT00689728|769241|P3|COMPLETED|Optional Follow-Up||4
319033|NCT00689728|769242|P2|COMPLETED|Optional Follow-Up||5
319034|NCT00689728|769243|P1|COMPLETED|Optional Follow-Up||6
319035|NCT00689728|769241|P3|STARTED|Optional Follow-Up|19 participants who completed the rescue period did not enter the optional follow-up period.|10
319036|NCT00689728|769242|P2|STARTED|Optional Follow-Up|13 participants who completed the rescue period did not enter the optional follow-up period.|11
319037|NCT00689728|769243|P1|STARTED|Optional Follow-Up|21 participants who completed the rescue period did not enter the optional follow-up period.|9
319038|NCT00689728|769241|P3|NOT COMPLETED|Rescue||1
319039|NCT00689728|769242|P2|NOT COMPLETED|Rescue||2
319040|NCT00689728|769243|P1|NOT COMPLETED|Rescue||1
319041|NCT00689728|769241|P3|COMPLETED|Rescue||29
319042|NCT00689728|769242|P2|COMPLETED|Rescue||24
319043|NCT00689728|769243|P1|COMPLETED|Rescue||30
319044|NCT00689728|769241|P3|STARTED|Rescue||30
319045|NCT00689728|769242|P2|STARTED|Rescue||26
319046|NCT00689728|769243|P1|STARTED|Rescue||31
319047|NCT00689728|769241|P3|NOT COMPLETED|Double-Blind Treatment||5
319048|NCT00689728|769242|P2|NOT COMPLETED|Double-Blind Treatment||4
319049|NCT00689728|769243|P1|NOT COMPLETED|Double-Blind Treatment||4
319050|NCT00689728|769241|P3|COMPLETED|Double-Blind Treatment||30
319051|NCT00689728|769242|P2|COMPLETED|Double-Blind Treatment||26
319052|NCT00689728|769243|P1|COMPLETED|Double-Blind Treatment||31
319053|NCT00689728|769241|P3|STARTED|Double-Blind Treatment||35
319054|NCT00689728|769242|P2|STARTED|Double-Blind Treatment||30
319055|NCT00689728|769243|P1|STARTED|Double-Blind Treatment||35
319056|NCT00689611|769326|P2|NOT COMPLETED|Overall Study||46
319057|NCT00689611|769327|P1|NOT COMPLETED|Overall Study||41
319058|NCT00689611|769326|P2|COMPLETED|Overall Study||146
319059|NCT00689611|769327|P1|COMPLETED|Overall Study||159
319060|NCT00689611|769326|P2|STARTED|Overall Study||192
319061|NCT00689611|769327|P1|STARTED|Overall Study||200
319062|NCT00689481|769337|P2|NOT COMPLETED|Overall Study||14
319063|NCT00689481|769338|P1|NOT COMPLETED|Overall Study||24
319064|NCT00689481|769337|P2|COMPLETED|Overall Study||95
319065|NCT00689481|769338|P1|COMPLETED|Overall Study||190
319066|NCT00689481|769337|P2|STARTED|Overall Study||109
319067|NCT00689481|769338|P1|STARTED|Overall Study||214
319068|NCT00689390|769356|P2|NOT COMPLETED|Overall Study||10
319069|NCT00689390|769357|P1|NOT COMPLETED|Overall Study||426
319070|NCT00689390|769356|P2|COMPLETED|Overall Study||37
319071|NCT00689390|769357|P1|COMPLETED|Overall Study||1481
319072|NCT00689390|769356|P2|STARTED|Overall Study||47
319073|NCT00689390|769357|P1|STARTED|Overall Study||1907
319074|NCT00689351|769375|P2|NOT COMPLETED|Toddler Dose||0
319075|NCT00689351|769376|P1|NOT COMPLETED|Toddler Dose||0
319076|NCT00689351|769375|P2|COMPLETED|Toddler Dose||88
319077|NCT00689351|769376|P1|COMPLETED|Toddler Dose||84
319078|NCT00689351|769375|P2|STARTED|Toddler Dose||88
319079|NCT00689351|769376|P1|STARTED|Toddler Dose||84
319080|NCT00689351|769375|P2|NOT COMPLETED|After Infant Series||0
319081|NCT00689351|769376|P1|NOT COMPLETED|After Infant Series||1
319082|NCT00689351|769375|P2|COMPLETED|After Infant Series||88
319083|NCT00689351|769376|P1|COMPLETED|After Infant Series||84
319084|NCT00689351|769375|P2|STARTED|After Infant Series||88
319085|NCT00689351|769376|P1|STARTED|After Infant Series||85
319086|NCT00689351|769375|P2|NOT COMPLETED|Infant Series of Dosing||1
319087|NCT00689351|769376|P1|NOT COMPLETED|Infant Series of Dosing||6
319088|NCT00689351|769375|P2|COMPLETED|Infant Series of Dosing||88
319089|NCT00689351|769376|P1|COMPLETED|Infant Series of Dosing||85
319090|NCT00689351|769375|P2|Vaccinated Dose 3|Infant Series of Dosing||88
319091|NCT00689351|769376|P1|Vaccinated Dose 3|Infant Series of Dosing||85
319092|NCT00689351|769375|P2|Vaccinated Dose 2|Infant Series of Dosing||88
319093|NCT00689351|769376|P1|Vaccinated Dose 2|Infant Series of Dosing||86
319094|NCT00689351|769375|P2|Vaccinated Dose 1|Infant Series of Dosing||89
319095|NCT00689351|769376|P1|Vaccinated Dose 1|Infant Series of Dosing||88
319096|NCT00689351|769375|P2|STARTED|Infant Series of Dosing||89
319097|NCT00689351|769376|P1|STARTED|Infant Series of Dosing||91
319098|NCT00689338|769408|P1|NOT COMPLETED|Overall Study||143
319099|NCT00689338|769408|P1|COMPLETED|Overall Study||73
319100|NCT00689338|769408|P1|STARTED|Overall Study||216
319101|NCT00689299|769421|P3|NOT COMPLETED|Overall Study||5
319102|NCT00689299|769422|P2|NOT COMPLETED|Overall Study||3
319103|NCT00689299|769423|P1|NOT COMPLETED|Overall Study||7
319104|NCT00689299|769421|P3|COMPLETED|Overall Study||49
319105|NCT00689299|769422|P2|COMPLETED|Overall Study||54
319106|NCT00689299|769423|P1|COMPLETED|Overall Study||51
319107|NCT00689299|769421|P3|STARTED|Overall Study||54
319108|NCT00689299|769422|P2|STARTED|Overall Study||57
319109|NCT00689299|769423|P1|STARTED|Overall Study||58
319110|NCT00689260|769433|P2|NOT COMPLETED|Overall Study||0
319111|NCT00689260|769434|P1|NOT COMPLETED|Overall Study||2
319112|NCT00689260|769433|P2|COMPLETED|Overall Study||21
319113|NCT00689260|769434|P1|COMPLETED|Overall Study||19
319114|NCT00689260|769433|P2|STARTED|Overall Study||21
319115|NCT00689260|769434|P1|STARTED|Overall Study||21
319116|NCT00689221|769452|P2|NOT COMPLETED|Overall Study||36
319117|NCT00689221|769453|P1|NOT COMPLETED|Overall Study||39
319118|NCT00689221|769452|P2|COMPLETED|Overall Study||237
319119|NCT00689221|769453|P1|COMPLETED|Overall Study||233
319120|NCT00689221|769452|P2|STARTED|Overall Study||273
319121|NCT00689221|769453|P1|STARTED|Overall Study||272
319122|NCT00689117|769482|P4|NOT COMPLETED|Overall Study||31
319123|NCT00689117|769483|P3|NOT COMPLETED|Overall Study||59
319124|NCT00689117|769484|P2|NOT COMPLETED|Overall Study||51
319125|NCT00689117|769485|P1|NOT COMPLETED|Overall Study||62
319126|NCT00689117|769482|P4|COMPLETED|Overall Study||211
319127|NCT00689117|769483|P3|COMPLETED|Overall Study||405
319128|NCT00689117|769484|P2|COMPLETED|Overall Study||416
319129|NCT00689117|769485|P1|COMPLETED|Overall Study||414
319130|NCT00689117|769482|P4|STARTED|Overall Study||242
319131|NCT00689117|769483|P3|STARTED|Overall Study||464
319132|NCT00689117|769484|P2|STARTED|Overall Study||467
319133|NCT00689117|769485|P1|STARTED|Overall Study||476
319134|NCT00689104|769515|P4|NOT COMPLETED|Overall Study||50
319135|NCT00689104|769516|P3|NOT COMPLETED|Overall Study||45
319136|NCT00689104|769517|P2|NOT COMPLETED|Overall Study||57
319137|NCT00689104|769518|P1|NOT COMPLETED|Overall Study||44
319138|NCT00689104|769515|P4|COMPLETED|Overall Study||445
319139|NCT00689104|769516|P3|COMPLETED|Overall Study||453
319140|NCT00689104|769517|P2|COMPLETED|Overall Study||440
319141|NCT00689104|769518|P1|COMPLETED|Overall Study||453
319142|NCT00689104|769515|P4|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|300
319143|NCT00689104|769516|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|281
319144|NCT00689104|769517|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|293
319145|NCT00689104|769518|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|291
319146|NCT00689104|769515|P4|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|475
319147|NCT00689104|769516|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|478
319148|NCT00689104|769517|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|473
319149|NCT00689104|769518|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|480
319150|NCT00689104|769515|P4|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|495
319151|NCT00689104|769516|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|496
319152|NCT00689104|769517|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|493
319153|NCT00689104|769518|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|494
319154|NCT00689104|769515|P4|STARTED|Overall Study||495
319155|NCT00689104|769516|P3|STARTED|Overall Study||498
319156|NCT00689104|769517|P2|STARTED|Overall Study||497
319157|NCT00689104|769518|P1|STARTED|Overall Study||497
319158|NCT00689091|769650|P2|NOT COMPLETED|Overall Study||1394
319159|NCT00689091|769651|P1|NOT COMPLETED|Overall Study||1371
319160|NCT00689091|769650|P2|COMPLETED|Overall Study||9376
319161|NCT00689091|769651|P1|COMPLETED|Overall Study||9460
319162|NCT00689091|769650|P2|STARTED|Overall Study||10770
319163|NCT00689091|769651|P1|STARTED|Overall Study||10831
319164|NCT00689078|769673|P4|NOT COMPLETED|Overall Study||1
319165|NCT00689078|769674|P3|NOT COMPLETED|Overall Study||1
319166|NCT00689078|769675|P2|NOT COMPLETED|Overall Study||2
319167|NCT00689078|769676|P1|NOT COMPLETED|Overall Study||0
319168|NCT00689078|769673|P4|COMPLETED|Overall Study||8
319169|NCT00689078|769674|P3|COMPLETED|Overall Study||8
319170|NCT00689078|769675|P2|COMPLETED|Overall Study||7
319171|NCT00689078|769676|P1|COMPLETED|Overall Study||9
319172|NCT00689078|769673|P4|STARTED|Overall Study||9
319173|NCT00689078|769674|P3|STARTED|Overall Study||9
319174|NCT00689078|769675|P2|STARTED|Overall Study||9
319175|NCT00689078|769676|P1|STARTED|Overall Study||9
319176|NCT00689052|769724|P2|NOT COMPLETED|Overall Study||30
319177|NCT00689052|769725|P1|NOT COMPLETED|Overall Study||31
319178|NCT00689052|769724|P2|COMPLETED|Overall Study||0
319179|NCT00689052|769725|P1|COMPLETED|Overall Study||0
319180|NCT00689052|769724|P2|STARTED|Overall Study||30
319181|NCT00689052|769725|P1|STARTED|Overall Study||31
319182|NCT00689026|769757|P2|NOT COMPLETED|Overall Study||6
319183|NCT00689026|769758|P1|NOT COMPLETED|Overall Study||13
319184|NCT00689026|769757|P2|COMPLETED|Overall Study||24
319185|NCT00689026|769758|P1|COMPLETED|Overall Study||17
319186|NCT00689026|769757|P2|STARTED|Overall Study||30
319187|NCT00689026|769758|P1|STARTED|Overall Study||30
319188|NCT00688935|769764|P1|NOT COMPLETED|Overall Study||0
319189|NCT00688935|769764|P1|COMPLETED|Overall Study||0
319190|NCT00688935|769764|P1|STARTED|Overall Study||0
319191|NCT00688870|769771|P2|NOT COMPLETED|Toddler Dose||0
319192|NCT00688870|769772|P1|NOT COMPLETED|Toddler Dose||0
319193|NCT00688870|769771|P2|COMPLETED|Toddler Dose||84
319194|NCT00688870|769772|P1|COMPLETED|Toddler Dose||80
319195|NCT00688870|769771|P2|STARTED|Toddler Dose||84
319196|NCT00688870|769772|P1|STARTED|Toddler Dose||80
319197|NCT00688870|769771|P2|NOT COMPLETED|After Infant Series||0
319198|NCT00688870|769772|P1|NOT COMPLETED|After Infant Series||0
319199|NCT00688870|769771|P2|COMPLETED|After Infant Series||84
319200|NCT00688870|769772|P1|COMPLETED|After Infant Series||80
319201|NCT00688870|769771|P2|STARTED|After Infant Series||84
319202|NCT00688870|769772|P1|STARTED|After Infant Series||80
319203|NCT00688870|769771|P2|NOT COMPLETED|Infant Series||0
319204|NCT00688870|769772|P1|NOT COMPLETED|Infant Series||4
319205|NCT00688870|769771|P2|COMPLETED|Infant Series||84
319206|NCT00688870|769772|P1|COMPLETED|Infant Series||80
319207|NCT00688870|769771|P2|Vaccinated Dose 3|Infant Series||84
319208|NCT00688870|769772|P1|Vaccinated Dose 3|Infant Series||80
319209|NCT00688870|769771|P2|Vaccinated Dose 2|Infant Series||84
319210|NCT00688870|769772|P1|Vaccinated Dose 2|Infant Series||80
319211|NCT00688870|769771|P2|Vaccinated Dose 1|Infant Series||84
319212|NCT00688870|769772|P1|Vaccinated Dose 1|Infant Series||83
319213|NCT00688870|769771|P2|STARTED|Infant Series||84
319214|NCT00688870|769772|P1|STARTED|Infant Series||84
319215|NCT00688844|769804|P1|NOT COMPLETED|Overall Study||10
319216|NCT00688844|769804|P1|COMPLETED|Overall Study||48
319217|NCT00688844|769804|P1|STARTED|Overall Study||58
319218|NCT00688753|769814|P1|NOT COMPLETED|Overall Study||92
319219|NCT00688753|769814|P1|COMPLETED|Overall Study||0
319220|NCT00688753|769814|P1|STARTED|Overall Study||92
319221|NCT00688740|769825|P2|NOT COMPLETED|Overall Study||35
319222|NCT00688740|769826|P1|NOT COMPLETED|Overall Study||66
319223|NCT00688740|769825|P2|COMPLETED|Overall Study||711
319224|NCT00688740|769826|P1|COMPLETED|Overall Study||679
319225|NCT00688740|769825|P2|STARTED|Overall Study||746
319226|NCT00688740|769826|P1|STARTED|Overall Study||745
319227|NCT00688701|769839|P4|NOT COMPLETED|Overall Study||11
319228|NCT00688701|769840|P3|NOT COMPLETED|Overall Study||10
319229|NCT00688701|769841|P2|NOT COMPLETED|Overall Study||5
319230|NCT00688701|769842|P1|NOT COMPLETED|Overall Study||4
319231|NCT00688701|769839|P4|COMPLETED|Overall Study||108
319232|NCT00688701|769840|P3|COMPLETED|Overall Study||110
319233|NCT00688701|769841|P2|COMPLETED|Overall Study||56
319234|NCT00688701|769842|P1|COMPLETED|Overall Study||57
319235|NCT00688701|769839|P4|Subgroup for Standardized Meal Test|Overall Study||65
319236|NCT00688701|769840|P3|Subgroup for Standardized Meal Test|Overall Study||60
319237|NCT00688701|769841|P2|Subgroup for Standardized Meal Test|Overall Study||35
319238|NCT00688701|769842|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|27
319239|NCT00688701|769839|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||118
319240|NCT00688701|769840|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||120
319241|NCT00688701|769841|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||60
319242|NCT00688701|769842|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|61
319243|NCT00688701|769839|P4|Treated/Safety Population|Overall Study||119
319244|NCT00688701|769840|P3|Treated/Safety Population|Overall Study||120
319245|NCT00688701|769841|P2|Treated/Safety Population|Overall Study||61
319246|NCT00688701|769842|P1|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|61
319247|NCT00688701|769839|P4|STARTED|Overall Study||119
319248|NCT00688701|769840|P3|STARTED|Overall Study||120
319249|NCT00688701|769841|P2|STARTED|Overall Study||61
319250|NCT00688701|769842|P1|STARTED|Overall Study|Randomized|61
319251|NCT00688688|769883|P3|NOT COMPLETED|Overall Study||192
319252|NCT00688688|769884|P2|NOT COMPLETED|Overall Study||179
319253|NCT00688688|769885|P1|NOT COMPLETED|Overall Study||186
319254|NCT00688688|769883|P3|COMPLETED|Overall Study||621
319255|NCT00688688|769884|P2|COMPLETED|Overall Study||645
319256|NCT00688688|769885|P1|COMPLETED|Overall Study||629
319257|NCT00688688|769883|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|488
319258|NCT00688688|769884|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|483
319259|NCT00688688|769885|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|479
319260|NCT00688688|769883|P3|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|791
319261|NCT00688688|769884|P2|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|802
319262|NCT00688688|769885|P1|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|789
319263|NCT00688688|769883|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
319264|NCT00688688|769884|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|820
319265|NCT00688688|769885|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
319266|NCT00688688|769883|P3|STARTED|Overall Study||813
319267|NCT00688688|769884|P2|STARTED|Overall Study||824
319268|NCT00688688|769885|P1|STARTED|Overall Study||815
319269|NCT00688662|769976|P2|NOT COMPLETED|Overall Study||18
319270|NCT00688662|769977|P1|NOT COMPLETED|Overall Study||23
319271|NCT00688662|769976|P2|COMPLETED|Overall Study||55
319272|NCT00688662|769977|P1|COMPLETED|Overall Study||118
319273|NCT00688662|769976|P2|STARTED|Overall Study||73
319274|NCT00688662|769977|P1|STARTED|Overall Study||141
319275|NCT00688636|769987|P2|NOT COMPLETED|Overall Study||1
319276|NCT00688636|769988|P1|NOT COMPLETED|Overall Study||2
319277|NCT00688636|769987|P2|COMPLETED|Overall Study||12
319278|NCT00688636|769988|P1|COMPLETED|Overall Study||9
319279|NCT00688636|769987|P2|STARTED|Overall Study||13
319280|NCT00688636|769988|P1|STARTED|Overall Study||11
319281|NCT00688623|770002|P1|NOT COMPLETED|Overall Study||55
319282|NCT00688623|770002|P1|COMPLETED|Overall Study||18
319283|NCT00688623|770002|P1|Per Protocol (PP)|Overall Study|no major protocol deviation and 50% of planned dose of 8 weeks or d/c due to disease progression|60
319284|NCT00688623|770002|P1|Safety Analysis Set|Overall Study|received at least one dose of study drug and had at least one post-baseline safety assessment|73
319285|NCT00688623|770002|P1|STARTED|Overall Study|Intent to treat (ITT)|73
319286|NCT00688597|770016|P3|NOT COMPLETED|Overall Study||0
319287|NCT00688597|770017|P2|NOT COMPLETED|Overall Study||0
319288|NCT00688597|770018|P1|NOT COMPLETED|Overall Study||3
319289|NCT00688597|770016|P3|COMPLETED|Overall Study||0
319290|NCT00688597|770017|P2|COMPLETED|Overall Study||0
319291|NCT00688597|770018|P1|COMPLETED|Overall Study||0
319292|NCT00688597|770016|P3|Received at Least 1 Dose of Study Drug|Overall Study||0
319293|NCT00688597|770017|P2|Received at Least 1 Dose of Study Drug|Overall Study||0
319294|NCT00688597|770018|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
319295|NCT00688597|770016|P3|STARTED|Overall Study||0
319296|NCT00688597|770017|P2|STARTED|Overall Study||0
319297|NCT00688597|770018|P1|STARTED|Overall Study||3
319298|NCT00688545|770031|P2|NOT COMPLETED|Overall Study||15
319299|NCT00688545|770032|P1|NOT COMPLETED|Overall Study||5
319300|NCT00688545|770031|P2|COMPLETED|Overall Study||204
319301|NCT00688545|770032|P1|COMPLETED|Overall Study||50
319302|NCT00688545|770031|P2|Switched Treatment at Least Once|Overall Study||13
319303|NCT00688545|770032|P1|Switched Treatment at Least Once|Overall Study||6
319304|NCT00688545|770031|P2|STARTED|Overall Study||219
319305|NCT00688545|770032|P1|STARTED|Overall Study||55
319306|NCT00688519|770042|P2|NOT COMPLETED|Overall Study||15
319307|NCT00688519|770043|P1|NOT COMPLETED|Overall Study||19
319308|NCT00688519|770042|P2|COMPLETED|Overall Study||98
319309|NCT00688519|770043|P1|COMPLETED|Overall Study||204
319310|NCT00688519|770042|P2|STARTED|Overall Study||113
319311|NCT00688519|770043|P1|STARTED|Overall Study||223
319312|NCT00688467|770061|P2|NOT COMPLETED|Treatment Period 2||2
319313|NCT00688467|770062|P1|NOT COMPLETED|Treatment Period 2||0
319314|NCT00688467|770061|P2|COMPLETED|Treatment Period 2||6
319315|NCT00688467|770062|P1|COMPLETED|Treatment Period 2||7
319316|NCT00688467|770061|P2|STARTED|Treatment Period 2||8
319317|NCT00688467|770062|P1|STARTED|Treatment Period 2||7
319318|NCT00688467|770061|P2|NOT COMPLETED|Treatment Period 1||2
319319|NCT00688467|770062|P1|NOT COMPLETED|Treatment Period 1||2
319320|NCT00688467|770061|P2|COMPLETED|Treatment Period 1||8
319321|NCT00688467|770062|P1|COMPLETED|Treatment Period 1||7
319322|NCT00688467|770061|P2|STARTED|Treatment Period 1||10
319323|NCT00688467|770062|P1|STARTED|Treatment Period 1||9
319324|NCT00688324|770092|P1|NOT COMPLETED|Overall Study||8
319325|NCT00688324|770092|P1|COMPLETED|Overall Study||28
319326|NCT00688324|770092|P1|STARTED|Overall Study||36
319327|NCT00688259|770137|P2|NOT COMPLETED|Overall Study||8
319328|NCT00688259|770138|P1|NOT COMPLETED|Overall Study||7
319329|NCT00688259|770137|P2|COMPLETED|Overall Study||36
319330|NCT00688259|770138|P1|COMPLETED|Overall Study||37
319331|NCT00688259|770137|P2|End to Active Treatment,|Overall Study||37
319332|NCT00688259|770138|P1|End to Active Treatment,|Overall Study||37
319333|NCT00688259|770137|P2|STARTED|Overall Study||44
319334|NCT00688259|770138|P1|STARTED|Overall Study||44
319335|NCT00688155|770158|P4|NOT COMPLETED|Overall Study||1
319336|NCT00688155|770159|P3|NOT COMPLETED|Overall Study||1
319337|NCT00688155|770160|P2|NOT COMPLETED|Overall Study||2
319338|NCT00688155|770161|P1|NOT COMPLETED|Overall Study||2
319339|NCT00688155|770158|P4|COMPLETED|Overall Study||17
319340|NCT00688155|770159|P3|COMPLETED|Overall Study||18
319341|NCT00688155|770160|P2|COMPLETED|Overall Study||16
319342|NCT00688155|770161|P1|COMPLETED|Overall Study||16
319343|NCT00688155|770158|P4|STARTED|Overall Study||18
319344|NCT00688155|770159|P3|STARTED|Overall Study||19
319345|NCT00688155|770160|P2|STARTED|Overall Study||18
319346|NCT00688155|770161|P1|STARTED|Overall Study||18
319347|NCT00688103|770181|P2|NOT COMPLETED|Overall Study||13
319348|NCT00688103|770182|P1|NOT COMPLETED|Overall Study||30
319349|NCT00688103|770181|P2|COMPLETED|Overall Study||64
319350|NCT00688103|770182|P1|COMPLETED|Overall Study||44
319351|NCT00688103|770181|P2|Actually Treated|Overall Study||76
319352|NCT00688103|770182|P1|Actually Treated|Overall Study||71
319353|NCT00688103|770181|P2|STARTED|Overall Study||77
319354|NCT00688103|770182|P1|STARTED|Overall Study||74
319355|NCT00688064|770194|P2|NOT COMPLETED|Overall Study||26
319356|NCT00688064|770195|P1|NOT COMPLETED|Overall Study||21
319357|NCT00688064|770194|P2|COMPLETED|Overall Study||201
319358|NCT00688064|770195|P1|COMPLETED|Overall Study||211
319359|NCT00688064|770194|P2|STARTED|Overall Study||227
319360|NCT00688064|770195|P1|STARTED|Overall Study||232
319361|NCT00687973|770211|P2|NOT COMPLETED|Overall Study||38
319362|NCT00687973|770212|P1|NOT COMPLETED|Overall Study||24
319363|NCT00687973|770211|P2|COMPLETED|Overall Study||162
319364|NCT00687973|770212|P1|COMPLETED|Overall Study||169
319365|NCT00687973|770211|P2|STARTED|Overall Study||200
319366|NCT00687973|770212|P1|STARTED|Overall Study||193
319367|NCT00687908|770241|P2|NOT COMPLETED|Overall Study||42
319368|NCT00687908|770242|P1|NOT COMPLETED|Overall Study||18
319369|NCT00687908|770241|P2|COMPLETED|Overall Study||78
319370|NCT00687908|770242|P1|COMPLETED|Overall Study||105
319371|NCT00687908|770241|P2|STARTED|Overall Study||120
319372|NCT00687908|770242|P1|STARTED|Overall Study||123
319373|NCT00687856|770256|P1|NOT COMPLETED|Overall Study||0
319374|NCT00687856|770256|P1|COMPLETED|Overall Study||211
319375|NCT00687856|770256|P1|STARTED|Overall Study||211
319376|NCT00687830|770262|P2|NOT COMPLETED|Overall Study||0
319377|NCT00687830|770263|P1|NOT COMPLETED|Overall Study||0
319378|NCT00687830|770262|P2|COMPLETED|Overall Study||68
319379|NCT00687830|770263|P1|COMPLETED|Overall Study||68
319380|NCT00687830|770262|P2|STARTED|Overall Study||68
319381|NCT00687830|770263|P1|STARTED|Overall Study||68
319382|NCT00687804|770274|P3|NOT COMPLETED|Open-Label Extension Study||11
319383|NCT00687804|770275|P2|NOT COMPLETED|Open-Label Extension Study||11
319384|NCT00687804|770276|P1|NOT COMPLETED|Open-Label Extension Study||10
319385|NCT00687804|770274|P3|COMPLETED|Open-Label Extension Study||63
319386|NCT00687804|770275|P2|COMPLETED|Open-Label Extension Study||72
319387|NCT00687804|770276|P1|COMPLETED|Open-Label Extension Study||73
319388|NCT00687804|770274|P3|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||15
319389|NCT00687804|770275|P2|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||21
319390|NCT00687804|770276|P1|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||16
319391|NCT00687804|770274|P3|STARTED|Open-Label Extension Study||74
319392|NCT00687804|770275|P2|STARTED|Open-Label Extension Study||83
319393|NCT00687804|770276|P1|STARTED|Open-Label Extension Study||83
319394|NCT00687804|770274|P3|NOT COMPLETED|Core Study||13
319395|NCT00687804|770275|P2|NOT COMPLETED|Core Study||15
319396|NCT00687804|770276|P1|NOT COMPLETED|Core Study||14
319397|NCT00687804|770274|P3|COMPLETED|Core Study||98
319398|NCT00687804|770275|P2|COMPLETED|Core Study||103
319399|NCT00687804|770276|P1|COMPLETED|Core Study||102
319400|NCT00687804|770274|P3|STARTED|Core Study||111
319401|NCT00687804|770275|P2|STARTED|Core Study||118
319402|NCT00687804|770276|P1|STARTED|Core Study||116
319403|NCT00687713|770321|P2|NOT COMPLETED|Overall Study||40
319404|NCT00687713|770322|P1|NOT COMPLETED|Overall Study||32
319405|NCT00687713|770321|P2|COMPLETED|Overall Study||64
319406|NCT00687713|770322|P1|COMPLETED|Overall Study||68
319407|NCT00687713|770321|P2|STARTED|Overall Study||104
319408|NCT00687713|770322|P1|STARTED|Overall Study||100
319409|NCT00687674|770330|P1|NOT COMPLETED|Overall Study||2
319410|NCT00687674|770330|P1|COMPLETED|Overall Study||11
319411|NCT00687674|770330|P1|STARTED|Overall Study||13
319412|NCT00687609|770337|P1|NOT COMPLETED|Overall Study||3
319413|NCT00687609|770337|P1|COMPLETED|Overall Study||4
319414|NCT00687609|770337|P1|STARTED|Overall Study||7
319415|NCT00687544|770351|P1|NOT COMPLETED|Overall Study||11
319416|NCT00687544|770351|P1|COMPLETED|Overall Study||0
319417|NCT00687544|770351|P1|STARTED|Overall Study||11
319418|NCT00687531|770360|P1|NOT COMPLETED|Overall Study||135
319419|NCT00687531|770360|P1|COMPLETED|Overall Study||250
319420|NCT00687531|770360|P1|RECEIVED TREATMENT|Overall Study||281
319421|NCT00687531|770360|P1|STARTED|Overall Study|Completed screening procedures|385
319422|NCT00687453|770376|P2|NOT COMPLETED|Overall Study||6
319423|NCT00687453|770377|P1|NOT COMPLETED|Overall Study||3
319424|NCT00687453|770376|P2|COMPLETED|Overall Study||7
319425|NCT00687453|770377|P1|COMPLETED|Overall Study||8
319426|NCT00687453|770376|P2|STARTED|Overall Study||13
319427|NCT00687453|770377|P1|STARTED|Overall Study||11
319428|NCT00687440|770383|P1|NOT COMPLETED|Overall Study||12
319429|NCT00687440|770383|P1|COMPLETED|Overall Study||15
319430|NCT00687440|770383|P1|STARTED|Overall Study|Number of screened participants|27
319431|NCT00687401|770387|P1|NOT COMPLETED|Overall Study||30
319432|NCT00687401|770387|P1|COMPLETED|Overall Study||129
319433|NCT00687401|770387|P1|STARTED|Overall Study|215 participants enrolled in the study, of which 56 failed screening and did not receive study drug.|159
319434|NCT00687362|770392|P1|NOT COMPLETED|Overall Study||3
319435|NCT00687362|770392|P1|COMPLETED|Overall Study|Completed protocol at Week 24|19
319436|NCT00687362|770392|P1|STARTED|Overall Study||22
319437|NCT00687323|770396|P1|NOT COMPLETED|Overall Study||180
319438|NCT00687323|770396|P1|COMPLETED|Overall Study|Number of participants alive at one year|15
319439|NCT00687323|770396|P1|Received Treatment|Overall Study||47
319440|NCT00687323|770396|P1|STARTED|Overall Study|Number of screened participants|195
319441|NCT00687297|770412|P2|NOT COMPLETED|Maintenance||1
319442|NCT00687297|770413|P1|NOT COMPLETED|Maintenance||3
319443|NCT00687297|770412|P2|COMPLETED|Maintenance||25
319444|NCT00687297|770413|P1|COMPLETED|Maintenance||29
319445|NCT00687297|770412|P2|STARTED|Maintenance||26
319446|NCT00687297|770413|P1|STARTED|Maintenance||32
319447|NCT00687297|770412|P2|NOT COMPLETED|Induction||55
319448|NCT00687297|770413|P1|NOT COMPLETED|Induction||45
319449|NCT00687297|770412|P2|COMPLETED|Induction||26
319450|NCT00687297|770413|P1|COMPLETED|Induction||32
319451|NCT00687297|770412|P2|STARTED|Induction||81
319452|NCT00687297|770413|P1|STARTED|Induction||77
319453|NCT00687297|770412|P2|NOT COMPLETED|Randomization||1
319454|NCT00687297|770413|P1|NOT COMPLETED|Randomization||3
319455|NCT00687297|770412|P2|COMPLETED|Randomization||81
319456|NCT00687297|770413|P1|COMPLETED|Randomization||77
319457|NCT00687297|770412|P2|STARTED|Randomization||82
319458|NCT00687297|770413|P1|STARTED|Randomization||80
319459|NCT00687271|770427|P4|NOT COMPLETED|Overall Study||0
319460|NCT00687271|770428|P3|NOT COMPLETED|Overall Study||5
319461|NCT00687271|770429|P2|NOT COMPLETED|Overall Study||6
319462|NCT00687271|770430|P1|NOT COMPLETED|Overall Study||3
319463|NCT00687271|770427|P4|COMPLETED|Overall Study||48
319464|NCT00687271|770428|P3|COMPLETED|Overall Study||91
319465|NCT00687271|770429|P2|COMPLETED|Overall Study||90
319466|NCT00687271|770430|P1|COMPLETED|Overall Study||91
319467|NCT00687271|770427|P4|Treated|Overall Study||48
319468|NCT00687271|770428|P3|Treated|Overall Study||96
319469|NCT00687271|770429|P2|Treated|Overall Study||95
319470|NCT00687271|770430|P1|Treated|Overall Study||94
319471|NCT00687271|770427|P4|STARTED|Overall Study||48
319472|NCT00687271|770428|P3|STARTED|Overall Study||96
319473|NCT00687271|770429|P2|STARTED|Overall Study||96
319474|NCT00687271|770430|P1|STARTED|Overall Study||94
319475|NCT00687219|770468|P1|NOT COMPLETED|Overall Study||51
319476|NCT00687219|770468|P1|COMPLETED|Overall Study||51
319477|NCT00687219|770468|P1|STARTED|Overall Study||102
319478|NCT00687193|770480|P6|NOT COMPLETED|Overall Study||4
319479|NCT00687193|770481|P5|NOT COMPLETED|Overall Study||2
319480|NCT00687193|770482|P4|NOT COMPLETED|Overall Study||4
319481|NCT00687193|770483|P3|NOT COMPLETED|Overall Study||2
319482|NCT00687193|770484|P2|NOT COMPLETED|Overall Study||4
319483|NCT00687193|770485|P1|NOT COMPLETED|Overall Study||2
319484|NCT00687193|770480|P6|COMPLETED|Overall Study||48
319485|NCT00687193|770481|P5|COMPLETED|Overall Study||52
319486|NCT00687193|770482|P4|COMPLETED|Overall Study||49
319487|NCT00687193|770483|P3|COMPLETED|Overall Study||50
319488|NCT00687193|770484|P2|COMPLETED|Overall Study||49
319489|NCT00687193|770485|P1|COMPLETED|Overall Study||51
319490|NCT00687193|770480|P6|STARTED|Overall Study|One participant withdrew after randomization but prior to treatment.|52
319491|NCT00687193|770481|P5|STARTED|Overall Study||54
319492|NCT00687193|770482|P4|STARTED|Overall Study||53
319493|NCT00687193|770483|P3|STARTED|Overall Study||52
319494|NCT00687193|770484|P2|STARTED|Overall Study||53
319495|NCT00687193|770485|P1|STARTED|Overall Study||53
319496|NCT00687167|770649|P2|NOT COMPLETED|Second Intervention||0
319497|NCT00687167|770650|P1|NOT COMPLETED|Second Intervention||0
319498|NCT00687167|770649|P2|COMPLETED|Second Intervention||17
319499|NCT00687167|770650|P1|COMPLETED|Second Intervention||17
319500|NCT00687167|770649|P2|STARTED|Second Intervention||17
319501|NCT00687167|770650|P1|STARTED|Second Intervention||17
319502|NCT00687167|770649|P2|NOT COMPLETED|Washout Period of 28 Days||0
319503|NCT00687167|770650|P1|NOT COMPLETED|Washout Period of 28 Days||0
319504|NCT00687167|770649|P2|COMPLETED|Washout Period of 28 Days||17
319505|NCT00687167|770650|P1|COMPLETED|Washout Period of 28 Days||17
319506|NCT00687167|770649|P2|STARTED|Washout Period of 28 Days||17
319507|NCT00687167|770650|P1|STARTED|Washout Period of 28 Days||17
319508|NCT00687167|770649|P2|NOT COMPLETED|First Intervention||0
319509|NCT00687167|770650|P1|NOT COMPLETED|First Intervention||0
319510|NCT00687167|770649|P2|COMPLETED|First Intervention||17
319511|NCT00687167|770650|P1|COMPLETED|First Intervention||17
319512|NCT00687167|770649|P2|STARTED|First Intervention||17
319513|NCT00687167|770650|P1|STARTED|First Intervention||17
319514|NCT00687102|770660|P2|NOT COMPLETED|Overall Study||0
319515|NCT00687102|770661|P1|NOT COMPLETED|Overall Study||0
319516|NCT00687102|770660|P2|COMPLETED|Overall Study||765
319517|NCT00687102|770661|P1|COMPLETED|Overall Study||733
319518|NCT00687102|770660|P2|STARTED|Overall Study||765
319519|NCT00687102|770661|P1|STARTED|Overall Study||733
319520|NCT00687076|770683|P2|NOT COMPLETED|Overall Study||30
319521|NCT00687076|770684|P1|NOT COMPLETED|Overall Study||32
319522|NCT00687076|770683|P2|COMPLETED|Overall Study||21
319523|NCT00687076|770684|P1|COMPLETED|Overall Study||19
319524|NCT00687076|770683|P2|STARTED|Overall Study||51
319525|NCT00687076|770684|P1|STARTED|Overall Study||51
319526|NCT00686998|770695|P3|NOT COMPLETED|Overall Study||4
319527|NCT00686998|770696|P2|NOT COMPLETED|Overall Study||8
319528|NCT00686998|770697|P1|NOT COMPLETED|Overall Study||13
319529|NCT00686998|770695|P3|COMPLETED|Overall Study||18
319530|NCT00686998|770696|P2|COMPLETED|Overall Study||33
319531|NCT00686998|770697|P1|COMPLETED|Overall Study||30
319532|NCT00686998|770695|P3|Completed Scheduled Treatment|Overall Study||18
319533|NCT00686998|770696|P2|Completed Scheduled Treatment|Overall Study||33
319534|NCT00686998|770697|P1|Completed Scheduled Treatment|Overall Study||30
319535|NCT00686998|770695|P3|Eligible for Efficacy Analysis|Overall Study||21
319536|NCT00686998|770696|P2|Eligible for Efficacy Analysis|Overall Study||39
319537|NCT00686998|770697|P1|Eligible for Efficacy Analysis|Overall Study||42
319538|NCT00686998|770695|P3|Received Treatment|Overall Study||22
319539|NCT00686998|770696|P2|Received Treatment|Overall Study||41
319540|NCT00686998|770697|P1|Received Treatment|Overall Study||43
319541|NCT00686998|770695|P3|Randomized|Overall Study||22
319542|NCT00686998|770696|P2|Randomized|Overall Study||41
319543|NCT00686998|770697|P1|Randomized|Overall Study||43
319544|NCT00686998|770695|P3|STARTED|Overall Study|Randomized & received study medication|22
319545|NCT00686998|770696|P2|STARTED|Overall Study|Randomized & received study medication|41
319546|NCT00686998|770697|P1|STARTED|Overall Study|Randomized & received study medication|43
319547|NCT00686972|770705|P1|NOT COMPLETED|Overall Study||51
319548|NCT00686972|770705|P1|COMPLETED|Overall Study||0
319549|NCT00686972|770705|P1|STARTED|Overall Study||51
319550|NCT00686959|770711|P2|NOT COMPLETED|Overall Study||117
319551|NCT00686959|770712|P1|NOT COMPLETED|Overall Study||124
319552|NCT00686959|770711|P2|COMPLETED|Overall Study|Study completion includes death due to any cause.|180
319553|NCT00686959|770712|P1|COMPLETED|Overall Study|Study completion includes death due to any cause|177
319554|NCT00686959|770711|P2|Entered Consolidation Phase|Overall Study||202
319555|NCT00686959|770712|P1|Entered Consolidation Phase|Overall Study||229
319556|NCT00686959|770711|P2|Received at Least One Dose of Study Drug|Overall Study||272
319557|NCT00686959|770712|P1|Received at Least One Dose of Study Drug|Overall Study||283
319558|NCT00686959|770711|P2|STARTED|Overall Study||297
319559|NCT00686959|770712|P1|STARTED|Overall Study||301
319560|NCT00686920|770732|P2|NOT COMPLETED|Overall Study||36
319561|NCT00686920|770733|P1|NOT COMPLETED|Overall Study||132
319562|NCT00686920|770732|P2|COMPLETED|Overall Study||34
319563|NCT00686920|770733|P1|COMPLETED|Overall Study||120
319564|NCT00686920|770732|P2|Received At Least 1 Dose Of Study Drug|Overall Study||70
319565|NCT00686920|770733|P1|Received At Least 1 Dose Of Study Drug|Overall Study||252
319566|NCT00686920|770732|P2|STARTED|Overall Study||70
319567|NCT00686920|770733|P1|STARTED|Overall Study||252
319568|NCT00686894|770745|P1|NOT COMPLETED|Overall Study||6
319569|NCT00686894|770745|P1|COMPLETED|Overall Study||1
319570|NCT00686894|770745|P1|STARTED|Overall Study||7
319571|NCT00686881|770751|P2|NOT COMPLETED|Overall Study||81
319572|NCT00686881|770752|P1|NOT COMPLETED|Overall Study||82
319573|NCT00686881|770751|P2|COMPLETED|Overall Study||53
319574|NCT00686881|770752|P1|COMPLETED|Overall Study||45
319575|NCT00686881|770751|P2|STARTED|Overall Study|After randomization, 6 participants withdrew consent and did not receive study drug.|134
319576|NCT00686881|770752|P1|STARTED|Overall Study|After randomization, 2 participants withdrew consent and did not receive study drug.|127
319577|NCT00686855|770764|P2|NOT COMPLETED|Overall Study||1
319578|NCT00686855|770765|P1|NOT COMPLETED|Overall Study||1
319579|NCT00686855|770764|P2|COMPLETED|Overall Study||17
319580|NCT00686855|770765|P1|COMPLETED|Overall Study||27
319581|NCT00686855|770764|P2|STARTED|Overall Study||18
319582|NCT00686855|770765|P1|STARTED|Overall Study||28
319583|NCT00686842|770771|P1|NOT COMPLETED|Overall Study||0
319584|NCT00686842|770771|P1|COMPLETED|Overall Study||17
319585|NCT00686842|770771|P1|STARTED|Overall Study||17
319586|NCT00686803|770778|P3|NOT COMPLETED|Overall Study||0
319587|NCT00686803|770779|P2|NOT COMPLETED|Overall Study||0
319588|NCT00686803|770780|P1|NOT COMPLETED|Overall Study||0
319589|NCT00686803|770778|P3|COMPLETED|Overall Study||3
319590|NCT00686803|770779|P2|COMPLETED|Overall Study||12
319591|NCT00686803|770780|P1|COMPLETED|Overall Study||6
319592|NCT00686803|770778|P3|STARTED|Overall Study||3
319593|NCT00686803|770779|P2|STARTED|Overall Study||12
319594|NCT00686803|770780|P1|STARTED|Overall Study||6
319595|NCT00686790|770791|P1|NOT COMPLETED|Overall Study||16
319596|NCT00686790|770791|P1|COMPLETED|Overall Study||32
319597|NCT00686790|770791|P1|STARTED|Overall Study||48
319598|NCT00686777|770799|P1|NOT COMPLETED|Overall Study||10
319599|NCT00686777|770799|P1|COMPLETED|Overall Study|Of 10 noncompleters, 6 had AEs including 4 meeting protocol prespecified AE discontinuance criteria.|65
319600|NCT00686777|770799|P1|Completed 24 Weeks of Follow-up|Overall Study||70
319601|NCT00686777|770799|P1|Included in Follow-up (All Treated)|Overall Study||75
319602|NCT00686777|770799|P1|Completed 48 Weeks of Treatment|Overall Study||65
319603|NCT00686777|770799|P1|Completed 24 Weeks of Treatment|Overall Study||69
319604|NCT00686777|770799|P1|STARTED|Overall Study||75
319605|NCT00686725|770807|P2|NOT COMPLETED|Overall Study||42
319606|NCT00686725|770808|P1|NOT COMPLETED|Overall Study||46
319607|NCT00686725|770807|P2|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|10
319608|NCT00686725|770808|P1|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|1
319609|NCT00686725|770807|P2|STARTED|Overall Study||52
319610|NCT00686725|770808|P1|STARTED|Overall Study||47
319611|NCT00686712|770833|P3|NOT COMPLETED|Overall Study||13
319612|NCT00686712|770834|P2|NOT COMPLETED|Overall Study||11
319613|NCT00686712|770835|P1|NOT COMPLETED|Overall Study||10
319614|NCT00686712|770833|P3|COMPLETED|Overall Study||17
319615|NCT00686712|770834|P2|COMPLETED|Overall Study||14
319616|NCT00686712|770835|P1|COMPLETED|Overall Study||20
319617|NCT00686712|770833|P3|STARTED|Overall Study||30
319618|NCT00686712|770834|P2|STARTED|Overall Study||25
319619|NCT00686712|770835|P1|STARTED|Overall Study||30
319620|NCT00686699|770863|P2|NOT COMPLETED|Treatment Period 2||0
319621|NCT00686699|770864|P1|NOT COMPLETED|Treatment Period 2||0
319622|NCT00686699|770863|P2|COMPLETED|Treatment Period 2||5
319623|NCT00686699|770864|P1|COMPLETED|Treatment Period 2||4
319624|NCT00686699|770863|P2|STARTED|Treatment Period 2||5
319625|NCT00686699|770864|P1|STARTED|Treatment Period 2||4
319626|NCT00686699|770863|P2|NOT COMPLETED|Treatment Period 1||2
319627|NCT00686699|770864|P1|NOT COMPLETED|Treatment Period 1||0
319628|NCT00686699|770863|P2|COMPLETED|Treatment Period 1||5
319629|NCT00686699|770864|P1|COMPLETED|Treatment Period 1||4
319630|NCT00686699|770863|P2|STARTED|Treatment Period 1||7
319631|NCT00686699|770864|P1|STARTED|Treatment Period 1||4
319632|NCT00686686|770888|P1|NOT COMPLETED|Overall Study||6
319633|NCT00686686|770888|P1|COMPLETED|Overall Study||17
319634|NCT00686686|770888|P1|STARTED|Overall Study||23
319635|NCT00686647|770896|P1|NOT COMPLETED|Overall Study||2
319636|NCT00686647|770896|P1|COMPLETED|Overall Study||91
319637|NCT00686647|770896|P1|STARTED|Overall Study||93
319638|NCT00686634|770902|P1|NOT COMPLETED|Overall Study||6
319639|NCT00686634|770902|P1|COMPLETED|Overall Study||102
319640|NCT00686634|770902|P1|STARTED|Overall Study||108
319641|NCT00686595|770909|P1|NOT COMPLETED|Overall Study||7
319642|NCT00686595|770909|P1|COMPLETED|Overall Study||31
319643|NCT00686595|770909|P1|STARTED|Overall Study||38
319644|NCT00686582|770937|P3|NOT COMPLETED|Overall Study||0
319645|NCT00686582|770938|P2|NOT COMPLETED|Overall Study||14
319646|NCT00686582|770939|P1|NOT COMPLETED|Overall Study||18
319647|NCT00686582|770937|P3|COMPLETED|Overall Study||121
319648|NCT00686582|770938|P2|COMPLETED|Overall Study||77
319649|NCT00686582|770939|P1|COMPLETED|Overall Study||74
319650|NCT00686582|770937|P3|Booster Vaccination|Overall Study||0
319651|NCT00686582|770938|P2|Booster Vaccination|Overall Study||77
319652|NCT00686582|770939|P1|Booster Vaccination|Overall Study||75
319653|NCT00686582|770937|P3|STARTED|Overall Study||121
319654|NCT00686582|770938|P2|STARTED|Overall Study||91
319655|NCT00686582|770939|P1|STARTED|Overall Study||92
319656|NCT00686543|770969|P4|NOT COMPLETED|Overall Study||3
319657|NCT00686543|770970|P3|NOT COMPLETED|Overall Study||5
319658|NCT00686543|770971|P2|NOT COMPLETED|Overall Study||1
319659|NCT00686543|770972|P1|NOT COMPLETED|Overall Study||14
319660|NCT00686543|770969|P4|COMPLETED|Overall Study||17
319661|NCT00686543|770970|P3|COMPLETED|Overall Study||15
319662|NCT00686543|770971|P2|COMPLETED|Overall Study||20
319663|NCT00686543|770972|P1|COMPLETED|Overall Study||0
319664|NCT00686543|770969|P4|STARTED|Overall Study||20
319665|NCT00686543|770970|P3|STARTED|Overall Study||20
319666|NCT00686543|770971|P2|STARTED|Overall Study||21
319667|NCT00686543|770972|P1|STARTED|Overall Study||14
319668|NCT00686517|770993|P3|NOT COMPLETED|Follow-up||10
319669|NCT00686517|770994|P2|NOT COMPLETED|Follow-up||10
319670|NCT00686517|770995|P1|NOT COMPLETED|Follow-up||8
319671|NCT00686517|770993|P3|COMPLETED|Follow-up||29
319672|NCT00686517|770994|P2|COMPLETED|Follow-up||28
319673|NCT00686517|770995|P1|COMPLETED|Follow-up||29
319674|NCT00686517|770993|P3|STARTED|Follow-up||39
319675|NCT00686517|770994|P2|STARTED|Follow-up||38
319676|NCT00686517|770995|P1|STARTED|Follow-up||37
319677|NCT00686517|770993|P3|NOT COMPLETED|Treatment||1
319678|NCT00686517|770994|P2|NOT COMPLETED|Treatment||3
319679|NCT00686517|770995|P1|NOT COMPLETED|Treatment||6
319680|NCT00686517|770993|P3|COMPLETED|Treatment||42
319681|NCT00686517|770994|P2|COMPLETED|Treatment||40
319682|NCT00686517|770995|P1|COMPLETED|Treatment||38
319683|NCT00686517|770993|P3|Completed Final Treatment Visit|Treatment|Included 1 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
319684|NCT00686517|770994|P2|Completed Final Treatment Visit|Treatment|Included 3 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
319685|NCT00686517|770995|P1|Completed Final Treatment Visit|Treatment|Included 6 that discontinued the treatment before completion,but performed the Final Treatment Visit|44
319686|NCT00686517|770993|P3|STARTED|Treatment||43
319687|NCT00686517|770994|P2|STARTED|Treatment||43
319688|NCT00686517|770995|P1|STARTED|Treatment||44
319689|NCT00686374|771018|P1|NOT COMPLETED|Overall Study||61
319690|NCT00686374|771018|P1|COMPLETED|Overall Study||39
319691|NCT00686374|771018|P1|STARTED|Overall Study||100
319692|NCT00686335|771029|P1|NOT COMPLETED|Treatment Period||0
319693|NCT00686335|771029|P1|COMPLETED|Treatment Period||7
319694|NCT00686335|771029|P1|STARTED|Treatment Period||7
319695|NCT00686335|771029|P1|NOT COMPLETED|Run-in Period||5
319696|NCT00686335|771029|P1|COMPLETED|Run-in Period||7
319697|NCT00686335|771029|P1|STARTED|Run-in Period||12
319698|NCT00686257|771037|P2|NOT COMPLETED|Overall Study||0
319699|NCT00686257|771038|P1|NOT COMPLETED|Overall Study||0
319700|NCT00686257|771037|P2|COMPLETED|Overall Study||31
319701|NCT00686257|771038|P1|COMPLETED|Overall Study||29
319702|NCT00686257|771037|P2|STARTED|Overall Study||31
319703|NCT00686257|771038|P1|STARTED|Overall Study||29
319704|NCT00686231|771061|P3|NOT COMPLETED|Overall Study||0
319705|NCT00686231|771062|P2|NOT COMPLETED|Overall Study||0
319706|NCT00686231|771063|P1|NOT COMPLETED|Overall Study||0
319707|NCT00686231|771061|P3|COMPLETED|Overall Study||20
319708|NCT00686231|771062|P2|COMPLETED|Overall Study||20
319709|NCT00686231|771063|P1|COMPLETED|Overall Study||20
319710|NCT00686231|771061|P3|STARTED|Overall Study||20
319711|NCT00686231|771062|P2|STARTED|Overall Study||20
319712|NCT00686231|771063|P1|STARTED|Overall Study||20
319713|NCT00686205|771073|P2|NOT COMPLETED|Overall Study||981
319714|NCT00686205|771074|P1|NOT COMPLETED|Overall Study||6007
319715|NCT00686205|771073|P2|COMPLETED|Overall Study||1524
319716|NCT00686205|771074|P1|COMPLETED|Overall Study||15599
319717|NCT00686205|771073|P2|STARTED|Overall Study||2505
319718|NCT00686205|771074|P1|STARTED|Overall Study||21606
319719|NCT00686166|771080|P1|NOT COMPLETED|Overall Study||20
319720|NCT00686166|771080|P1|COMPLETED|Overall Study||63
319721|NCT00686166|771080|P1|Eligible and Began Protocol Therapy|Overall Study||74
319722|NCT00686166|771080|P1|Eligible|Overall Study||78
319723|NCT00686166|771080|P1|STARTED|Overall Study||83
319724|NCT00686127|771092|P2|NOT COMPLETED|Overall Study||6
319725|NCT00686127|771093|P1|NOT COMPLETED|Overall Study||14
319726|NCT00686127|771092|P2|COMPLETED|Overall Study||1
319727|NCT00686127|771093|P1|COMPLETED|Overall Study|Patients withdrew from the study because they did not like wearing the patch.|0
319728|NCT00686127|771092|P2|STARTED|Overall Study||7
319729|NCT00686127|771093|P1|STARTED|Overall Study||14
319730|NCT00686075|771109|P10|NOT COMPLETED|Overall Study||10
319731|NCT00686075|771110|P9|NOT COMPLETED|Overall Study||6
319732|NCT00686075|771111|P8|NOT COMPLETED|Overall Study||2
319733|NCT00686075|771112|P7|NOT COMPLETED|Overall Study||0
319734|NCT00686075|771113|P6|NOT COMPLETED|Overall Study||3
319735|NCT00686075|771114|P5|NOT COMPLETED|Overall Study||4
319736|NCT00686075|771115|P4|NOT COMPLETED|Overall Study||9
319737|NCT00686075|771116|P3|NOT COMPLETED|Overall Study||6
319738|NCT00686075|771117|P2|NOT COMPLETED|Overall Study||10
319739|NCT00686075|771118|P1|NOT COMPLETED|Overall Study||8
319740|NCT00686075|771109|P10|COMPLETED|Overall Study||69
319741|NCT00686075|771110|P9|COMPLETED|Overall Study||75
319742|NCT00686075|771111|P8|COMPLETED|Overall Study||76
319743|NCT00686075|771112|P7|COMPLETED|Overall Study||82
319744|NCT00686075|771113|P6|COMPLETED|Overall Study||37
319745|NCT00686075|771114|P5|COMPLETED|Overall Study||36
319746|NCT00686075|771115|P4|COMPLETED|Overall Study||71
319747|NCT00686075|771116|P3|COMPLETED|Overall Study||74
319748|NCT00686075|771117|P2|COMPLETED|Overall Study||71
319749|NCT00686075|771118|P1|COMPLETED|Overall Study||71
319750|NCT00686075|771109|P10|Treated|Overall Study||78
319751|NCT00686075|771110|P9|Treated|Overall Study||80
319752|NCT00686075|771111|P8|Treated|Overall Study||77
319753|NCT00686075|771112|P7|Treated|Overall Study||82
319754|NCT00686075|771113|P6|Treated|Overall Study||40
319755|NCT00686075|771114|P5|Treated|Overall Study||40
319756|NCT00686075|771115|P4|Treated|Overall Study||80
319757|NCT00686075|771116|P3|Treated|Overall Study||80
319758|NCT00686075|771117|P2|Treated|Overall Study||79
319759|NCT00686075|771118|P1|Treated|Overall Study||78
319760|NCT00686075|771109|P10|STARTED|Overall Study||79
319761|NCT00686075|771110|P9|STARTED|Overall Study||81
319762|NCT00686075|771111|P8|STARTED|Overall Study||78
319763|NCT00686075|771112|P7|STARTED|Overall Study||82
319764|NCT00686075|771113|P6|STARTED|Overall Study||40
319765|NCT00686075|771114|P5|STARTED|Overall Study||40
319766|NCT00686075|771115|P4|STARTED|Overall Study||80
319767|NCT00686075|771116|P3|STARTED|Overall Study||80
319768|NCT00686075|771117|P2|STARTED|Overall Study||81
319769|NCT00686075|771118|P1|STARTED|Overall Study||79
319770|NCT00686036|771312|P2|NOT COMPLETED|Overall Study||6
319771|NCT00686036|771313|P1|NOT COMPLETED|Overall Study||9
319772|NCT00686036|771312|P2|COMPLETED|Overall Study||2
319773|NCT00686036|771313|P1|COMPLETED|Overall Study||0
319774|NCT00686036|771312|P2|STARTED|Overall Study||8
319775|NCT00686036|771313|P1|STARTED|Overall Study||9
319776|NCT00685945|771325|P1|NOT COMPLETED|Sildenafil + L-NMMA + Bradykinin||0
319777|NCT00685945|771325|P1|COMPLETED|Sildenafil + L-NMMA + Bradykinin||12
319778|NCT00685945|771325|P1|STARTED|Sildenafil + L-NMMA + Bradykinin||12
319779|NCT00685945|771325|P1|NOT COMPLETED|Isosorbide + L-NMMA + Bradykinin||0
319780|NCT00685945|771325|P1|COMPLETED|Isosorbide + L-NMMA + Bradykinin||11
319781|NCT00685945|771325|P1|STARTED|Isosorbide + L-NMMA + Bradykinin||11
319782|NCT00685945|771325|P1|NOT COMPLETED|L-NMMA + Bradykinin||1
319783|NCT00685945|771325|P1|COMPLETED|L-NMMA + Bradykinin||23
319784|NCT00685945|771325|P1|STARTED|L-NMMA + Bradykinin||24
319785|NCT00685945|771325|P1|NOT COMPLETED|Control (Bradykinin Infusion)||0
319786|NCT00685945|771325|P1|COMPLETED|Control (Bradykinin Infusion)||24
319787|NCT00685945|771325|P1|STARTED|Control (Bradykinin Infusion)|A total of 24 subjects received an infusion of bradykinin|24
319788|NCT00685932|771342|P2|NOT COMPLETED|Overall Study||20
319789|NCT00685932|771343|P1|NOT COMPLETED|Overall Study||21
319790|NCT00685932|771342|P2|COMPLETED|Overall Study||58
319791|NCT00685932|771343|P1|COMPLETED|Overall Study||55
319792|NCT00685932|771342|P2|STARTED|Overall Study||78
319793|NCT00685932|771343|P1|STARTED|Overall Study||76
319794|NCT00685880|771353|P2|NOT COMPLETED|Overall Study||0
319795|NCT00685880|771354|P1|NOT COMPLETED|Overall Study||0
319796|NCT00685880|771353|P2|COMPLETED|Overall Study||2
319797|NCT00685880|771354|P1|COMPLETED|Overall Study||0
319798|NCT00685880|771353|P2|STARTED|Overall Study||2
319799|NCT00685880|771354|P1|STARTED|Overall Study||0
319800|NCT00685802|771360|P2|NOT COMPLETED|Second Intervention||0
319801|NCT00685802|771361|P1|NOT COMPLETED|Second Intervention||0
319802|NCT00685802|771360|P2|COMPLETED|Second Intervention||15
319803|NCT00685802|771361|P1|COMPLETED|Second Intervention||14
319804|NCT00685802|771360|P2|STARTED|Second Intervention||15
319805|NCT00685802|771361|P1|STARTED|Second Intervention||14
319806|NCT00685802|771360|P2|NOT COMPLETED|Washout Period of 7 Days||1
319807|NCT00685802|771361|P1|NOT COMPLETED|Washout Period of 7 Days||2
319808|NCT00685802|771360|P2|COMPLETED|Washout Period of 7 Days||15
319809|NCT00685802|771361|P1|COMPLETED|Washout Period of 7 Days||14
319810|NCT00685802|771360|P2|STARTED|Washout Period of 7 Days||16
319811|NCT00685802|771361|P1|STARTED|Washout Period of 7 Days||16
319812|NCT00685802|771360|P2|NOT COMPLETED|First Intervention||0
319813|NCT00685802|771361|P1|NOT COMPLETED|First Intervention||0
319814|NCT00685802|771360|P2|COMPLETED|First Intervention||16
319815|NCT00685802|771361|P1|COMPLETED|First Intervention||16
319816|NCT00685802|771360|P2|STARTED|First Intervention||16
319817|NCT00685802|771361|P1|STARTED|First Intervention||16
319818|NCT00685763|771371|P1|NOT COMPLETED|Overall Study||2
319819|NCT00685763|771371|P1|COMPLETED|Overall Study||11
319820|NCT00685763|771371|P1|STARTED|Overall Study||13
319821|NCT00685750|771382|P7|NOT COMPLETED|Overall Study||1
319822|NCT00685750|771383|P6|NOT COMPLETED|Overall Study||0
319823|NCT00685750|771384|P5|NOT COMPLETED|Overall Study||0
319824|NCT00685750|771385|P4|NOT COMPLETED|Overall Study||0
319825|NCT00685750|771386|P3|NOT COMPLETED|Overall Study||2
319826|NCT00685750|771387|P2|NOT COMPLETED|Overall Study||0
319827|NCT00685750|771388|P1|NOT COMPLETED|Overall Study||0
319828|NCT00685750|771382|P7|COMPLETED|Overall Study||9
319829|NCT00685750|771383|P6|COMPLETED|Overall Study||20
319830|NCT00685750|771384|P5|COMPLETED|Overall Study||15
319831|NCT00685750|771385|P4|COMPLETED|Overall Study||2
319832|NCT00685750|771386|P3|COMPLETED|Overall Study||19
319833|NCT00685750|771387|P2|COMPLETED|Overall Study||3
319834|NCT00685750|771388|P1|COMPLETED|Overall Study||17
319835|NCT00685750|771382|P7|STARTED|Overall Study||10
319836|NCT00685750|771383|P6|STARTED|Overall Study||20
319837|NCT00685750|771384|P5|STARTED|Overall Study||15
319838|NCT00685750|771385|P4|STARTED|Overall Study||2
319839|NCT00685750|771386|P3|STARTED|Overall Study||21
319840|NCT00685750|771387|P2|STARTED|Overall Study||3
319841|NCT00685750|771388|P1|STARTED|Overall Study||17
319842|NCT00685698|771416|P1|NOT COMPLETED|Overall Study||13
319843|NCT00685698|771416|P1|COMPLETED|Overall Study||25
319844|NCT00685698|771416|P1|STARTED|Overall Study||38
319845|NCT00685685|771451|P2|NOT COMPLETED|Second Intervention||0
319846|NCT00685685|771452|P1|NOT COMPLETED|Second Intervention||0
319847|NCT00685685|771451|P2|COMPLETED|Second Intervention||26
319848|NCT00685685|771452|P1|COMPLETED|Second Intervention||25
319849|NCT00685685|771451|P2|STARTED|Second Intervention||26
319850|NCT00685685|771452|P1|STARTED|Second Intervention||25
319851|NCT00685685|771451|P2|NOT COMPLETED|Washout Period of 7 Days||1
319852|NCT00685685|771452|P1|NOT COMPLETED|Washout Period of 7 Days||2
319853|NCT00685685|771451|P2|COMPLETED|Washout Period of 7 Days||26
319854|NCT00685685|771452|P1|COMPLETED|Washout Period of 7 Days||25
319855|NCT00685685|771451|P2|STARTED|Washout Period of 7 Days||27
319856|NCT00685685|771452|P1|STARTED|Washout Period of 7 Days||27
319857|NCT00685685|771451|P2|NOT COMPLETED|First Intervention||0
319858|NCT00685685|771452|P1|NOT COMPLETED|First Intervention||0
319859|NCT00685685|771451|P2|COMPLETED|First Intervention||27
319860|NCT00685685|771452|P1|COMPLETED|First Intervention||27
319861|NCT00685685|771451|P2|STARTED|First Intervention||27
319862|NCT00685685|771452|P1|STARTED|First Intervention||27
319863|NCT00685659|771465|P3|NOT COMPLETED|Overall Study||15
319864|NCT00685659|771466|P2|NOT COMPLETED|Overall Study||25
319865|NCT00685659|771467|P1|NOT COMPLETED|Overall Study||31
319866|NCT00685659|771465|P3|COMPLETED|Overall Study||92
319867|NCT00685659|771466|P2|COMPLETED|Overall Study||81
319868|NCT00685659|771467|P1|COMPLETED|Overall Study||77
319869|NCT00685659|771465|P3|STARTED|Overall Study||107
319870|NCT00685659|771466|P2|STARTED|Overall Study||106
319871|NCT00685659|771467|P1|STARTED|Overall Study||108
319872|NCT00685516|771565|P3|NOT COMPLETED|Overall Study||7
319873|NCT00685516|771566|P2|NOT COMPLETED|Overall Study||5
319874|NCT00685516|771567|P1|NOT COMPLETED|Overall Study||8
319875|NCT00685516|771565|P3|COMPLETED|Overall Study||26
319876|NCT00685516|771566|P2|COMPLETED|Overall Study||33
319877|NCT00685516|771567|P1|COMPLETED|Overall Study||34
319878|NCT00685516|771565|P3|STARTED|Overall Study||33
319879|NCT00685516|771566|P2|STARTED|Overall Study||38
319880|NCT00685516|771567|P1|STARTED|Overall Study||42
319881|NCT00685477|771584|P6|NOT COMPLETED|Overall Study||0
319882|NCT00685477|771585|P5|NOT COMPLETED|Overall Study||0
319883|NCT00685477|771586|P4|NOT COMPLETED|Overall Study||0
319884|NCT00685477|771587|P3|NOT COMPLETED|Overall Study||0
319885|NCT00685477|771588|P2|NOT COMPLETED|Overall Study||0
319886|NCT00685477|771589|P1|NOT COMPLETED|Overall Study||0
319887|NCT00685477|771584|P6|COMPLETED|Overall Study||10
319888|NCT00685477|771585|P5|COMPLETED|Overall Study||10
319889|NCT00685477|771586|P4|COMPLETED|Overall Study||10
319890|NCT00685477|771587|P3|COMPLETED|Overall Study||10
319891|NCT00685477|771588|P2|COMPLETED|Overall Study||10
319892|NCT00685477|771589|P1|COMPLETED|Overall Study||10
319893|NCT00685477|771584|P6|STARTED|Overall Study||10
319894|NCT00685477|771585|P5|STARTED|Overall Study||10
319895|NCT00685477|771586|P4|STARTED|Overall Study||10
319896|NCT00685477|771587|P3|STARTED|Overall Study||10
319897|NCT00685477|771588|P2|STARTED|Overall Study||10
319898|NCT00685477|771589|P1|STARTED|Overall Study||10
319899|NCT00685399|771605|P8|NOT COMPLETED|Extension||0
319900|NCT00685399|771606|P7|NOT COMPLETED|Extension||0
319901|NCT00685399|771607|P6|NOT COMPLETED|Extension||0
319902|NCT00685399|771608|P5|NOT COMPLETED|Extension||0
319903|NCT00685399|771609|P4|NOT COMPLETED|Extension||7
319904|NCT00685399|771610|P3|NOT COMPLETED|Extension||0
319905|NCT00685399|771611|P2|NOT COMPLETED|Extension||0
319906|NCT00685399|771612|P1|NOT COMPLETED|Extension||0
319907|NCT00685399|771605|P8|COMPLETED|Extension||0
319908|NCT00685399|771606|P7|COMPLETED|Extension||0
319909|NCT00685399|771607|P6|COMPLETED|Extension||0
319910|NCT00685399|771608|P5|COMPLETED|Extension||0
319911|NCT00685399|771609|P4|COMPLETED|Extension||21
319912|NCT00685399|771610|P3|COMPLETED|Extension||0
319913|NCT00685399|771611|P2|COMPLETED|Extension||0
319914|NCT00685399|771612|P1|COMPLETED|Extension||0
319915|NCT00685399|771605|P8|STARTED|Extension||0
319916|NCT00685399|771606|P7|STARTED|Extension||0
319917|NCT00685399|771607|P6|STARTED|Extension||0
319918|NCT00685399|771608|P5|STARTED|Extension||0
319919|NCT00685399|771609|P4|STARTED|Extension||28
319920|NCT00685399|771610|P3|STARTED|Extension||0
319921|NCT00685399|771611|P2|STARTED|Extension||0
319922|NCT00685399|771612|P1|STARTED|Extension||0
319923|NCT00685399|771605|P8|NOT COMPLETED|Treatment Period 2||2
319924|NCT00685399|771606|P7|NOT COMPLETED|Treatment Period 2||0
319925|NCT00685399|771607|P6|NOT COMPLETED|Treatment Period 2||2
319926|NCT00685399|771608|P5|NOT COMPLETED|Treatment Period 2||0
319927|NCT00685399|771609|P4|NOT COMPLETED|Treatment Period 2||0
319928|NCT00685399|771610|P3|NOT COMPLETED|Treatment Period 2||3
319929|NCT00685399|771611|P2|NOT COMPLETED|Treatment Period 2||12
319930|NCT00685399|771612|P1|NOT COMPLETED|Treatment Period 2||0
319931|NCT00685399|771605|P8|COMPLETED|Treatment Period 2||10
319932|NCT00685399|771606|P7|COMPLETED|Treatment Period 2||13
319933|NCT00685399|771607|P6|COMPLETED|Treatment Period 2||10
319934|NCT00685399|771608|P5|COMPLETED|Treatment Period 2||4
319935|NCT00685399|771609|P4|COMPLETED|Treatment Period 2|in extension period only|0
319936|NCT00685399|771610|P3|COMPLETED|Treatment Period 2||2
319937|NCT00685399|771611|P2|COMPLETED|Treatment Period 2||2
319938|NCT00685399|771612|P1|COMPLETED|Treatment Period 2||0
319939|NCT00685399|771605|P8|STARTED|Treatment Period 2||12
319940|NCT00685399|771606|P7|STARTED|Treatment Period 2||13
319941|NCT00685399|771607|P6|STARTED|Treatment Period 2||12
319942|NCT00685399|771608|P5|STARTED|Treatment Period 2||4
319943|NCT00685399|771609|P4|STARTED|Treatment Period 2|in extension period only|0
319944|NCT00685399|771610|P3|STARTED|Treatment Period 2||5
319945|NCT00685399|771611|P2|STARTED|Treatment Period 2||14
319946|NCT00685399|771612|P1|STARTED|Treatment Period 2||0
319947|NCT00685399|771605|P8|NOT COMPLETED|Treatment Period 1||0
319948|NCT00685399|771606|P7|NOT COMPLETED|Treatment Period 1||0
319949|NCT00685399|771607|P6|NOT COMPLETED|Treatment Period 1||0
319950|NCT00685399|771608|P5|NOT COMPLETED|Treatment Period 1||0
319951|NCT00685399|771609|P4|NOT COMPLETED|Treatment Period 1||0
319952|NCT00685399|771610|P3|NOT COMPLETED|Treatment Period 1||0
319953|NCT00685399|771611|P2|NOT COMPLETED|Treatment Period 1||0
319954|NCT00685399|771612|P1|NOT COMPLETED|Treatment Period 1||6
319955|NCT00685399|771605|P8|COMPLETED|Treatment Period 1||0
319956|NCT00685399|771606|P7|COMPLETED|Treatment Period 1||0
319957|NCT00685399|771607|P6|COMPLETED|Treatment Period 1||0
319958|NCT00685399|771608|P5|COMPLETED|Treatment Period 1||0
319959|NCT00685399|771609|P4|COMPLETED|Treatment Period 1||0
319960|NCT00685399|771610|P3|COMPLETED|Treatment Period 1||0
319961|NCT00685399|771611|P2|COMPLETED|Treatment Period 1||0
319962|NCT00685399|771612|P1|COMPLETED|Treatment Period 1||10
319963|NCT00685399|771605|P8|STARTED|Treatment Period 1||0
319964|NCT00685399|771606|P7|STARTED|Treatment Period 1||0
319965|NCT00685399|771607|P6|STARTED|Treatment Period 1||0
319966|NCT00685399|771608|P5|STARTED|Treatment Period 1||0
319967|NCT00685399|771609|P4|STARTED|Treatment Period 1||0
319968|NCT00685399|771610|P3|STARTED|Treatment Period 1||0
319969|NCT00685399|771611|P2|STARTED|Treatment Period 1||0
319970|NCT00685399|771612|P1|STARTED|Treatment Period 1||16
319971|NCT00685373|771645|P1|NOT COMPLETED|Overall Study||15
319972|NCT00685373|771645|P1|COMPLETED|Overall Study||151
319973|NCT00685373|771645|P1|STARTED|Overall Study||166
319974|NCT00685334|771654|P2|NOT COMPLETED|Overall Study||7
319975|NCT00685334|771655|P1|NOT COMPLETED|Overall Study||10
319976|NCT00685334|771654|P2|COMPLETED|Overall Study||3
319977|NCT00685334|771655|P1|COMPLETED|Overall Study||2
319978|NCT00685334|771654|P2|STARTED|Overall Study||10
319979|NCT00685334|771655|P1|STARTED|Overall Study||12
319980|NCT00685295|771665|P2|NOT COMPLETED|Overall Study||0
319981|NCT00685295|771666|P1|NOT COMPLETED|Overall Study||0
319982|NCT00685295|771665|P2|COMPLETED|Overall Study||30
319983|NCT00685295|771666|P1|COMPLETED|Overall Study||30
319984|NCT00685295|771665|P2|STARTED|Overall Study||30
319985|NCT00685295|771666|P1|STARTED|Overall Study||30
319986|NCT00685178|771680|P4|NOT COMPLETED|Overall Study||14
319987|NCT00685178|771681|P3|NOT COMPLETED|Overall Study||12
319988|NCT00685178|771682|P2|NOT COMPLETED|Overall Study||19
319989|NCT00685178|771683|P1|NOT COMPLETED|Overall Study||13
319990|NCT00685178|771680|P4|COMPLETED|Overall Study||33
319991|NCT00685178|771681|P3|COMPLETED|Overall Study||27
319992|NCT00685178|771682|P2|COMPLETED|Overall Study||26
319993|NCT00685178|771683|P1|COMPLETED|Overall Study||27
319994|NCT00685178|771680|P4|STARTED|Overall Study||47
319995|NCT00685178|771681|P3|STARTED|Overall Study||39
319996|NCT00685178|771682|P2|STARTED|Overall Study||45
319997|NCT00685178|771683|P1|STARTED|Overall Study||40
319998|NCT00685165|771697|P2|NOT COMPLETED|Second Intervention||0
319999|NCT00685165|771698|P1|NOT COMPLETED|Second Intervention||0
320000|NCT00685165|771697|P2|COMPLETED|Second Intervention||11
320001|NCT00685165|771698|P1|COMPLETED|Second Intervention||10
320002|NCT00685165|771697|P2|STARTED|Second Intervention||11
320003|NCT00685165|771698|P1|STARTED|Second Intervention||10
320004|NCT00685165|771697|P2|NOT COMPLETED|Washout Period of 14 Days||0
320005|NCT00685165|771698|P1|NOT COMPLETED|Washout Period of 14 Days||1
320006|NCT00685165|771697|P2|COMPLETED|Washout Period of 14 Days||11
320007|NCT00685165|771698|P1|COMPLETED|Washout Period of 14 Days|adverse event- possible upper respiratory infection|10
320008|NCT00685165|771697|P2|STARTED|Washout Period of 14 Days||11
320009|NCT00685165|771698|P1|STARTED|Washout Period of 14 Days||11
320010|NCT00685165|771697|P2|NOT COMPLETED|First Intervention||0
320011|NCT00685165|771698|P1|NOT COMPLETED|First Intervention||0
320012|NCT00685165|771697|P2|COMPLETED|First Intervention||11
320013|NCT00685165|771698|P1|COMPLETED|First Intervention||11
320014|NCT00685165|771697|P2|STARTED|First Intervention||11
320015|NCT00685165|771698|P1|STARTED|First Intervention||11
320016|NCT00685139|771708|P2|NOT COMPLETED|Second Intervention||0
320017|NCT00685139|771709|P1|NOT COMPLETED|Second Intervention||0
320018|NCT00685139|771708|P2|COMPLETED|Second Intervention||17
320019|NCT00685139|771709|P1|COMPLETED|Second Intervention||17
320020|NCT00685139|771708|P2|STARTED|Second Intervention||17
320021|NCT00685139|771709|P1|STARTED|Second Intervention||17
320022|NCT00685139|771708|P2|NOT COMPLETED|Washout Period of 28 Days||0
320023|NCT00685139|771709|P1|NOT COMPLETED|Washout Period of 28 Days||0
320024|NCT00685139|771708|P2|COMPLETED|Washout Period of 28 Days||17
320025|NCT00685139|771709|P1|COMPLETED|Washout Period of 28 Days||17
320026|NCT00685139|771708|P2|STARTED|Washout Period of 28 Days||17
320027|NCT00685139|771709|P1|STARTED|Washout Period of 28 Days||17
320028|NCT00685139|771708|P2|NOT COMPLETED|First Intervention||0
320029|NCT00685139|771709|P1|NOT COMPLETED|First Intervention||0
320030|NCT00685139|771708|P2|COMPLETED|First Intervention||17
320031|NCT00685139|771709|P1|COMPLETED|First Intervention||17
320032|NCT00685139|771708|P2|STARTED|First Intervention||17
320033|NCT00685139|771709|P1|STARTED|First Intervention||17
320034|NCT00685035|771717|P2|NOT COMPLETED|Period 3: 2nd Intervention||0
320035|NCT00685035|771718|P1|NOT COMPLETED|Period 3: 2nd Intervention||0
320036|NCT00685035|771717|P2|COMPLETED|Period 3: 2nd Intervention||8
320037|NCT00685035|771718|P1|COMPLETED|Period 3: 2nd Intervention||8
320038|NCT00685035|771717|P2|STARTED|Period 3: 2nd Intervention||8
320039|NCT00685035|771718|P1|STARTED|Period 3: 2nd Intervention||8
320040|NCT00685035|771717|P2|NOT COMPLETED|Period 2: 2-day Washout||0
320041|NCT00685035|771718|P1|NOT COMPLETED|Period 2: 2-day Washout||0
320042|NCT00685035|771717|P2|COMPLETED|Period 2: 2-day Washout||8
320043|NCT00685035|771718|P1|COMPLETED|Period 2: 2-day Washout||8
320044|NCT00685035|771717|P2|STARTED|Period 2: 2-day Washout||8
320045|NCT00685035|771718|P1|STARTED|Period 2: 2-day Washout||8
320046|NCT00685035|771717|P2|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||0
320047|NCT00685035|771718|P1|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||1
320048|NCT00685035|771717|P2|COMPLETED|Period 1: First Intervention: 30 Minutes||8
320049|NCT00685035|771718|P1|COMPLETED|Period 1: First Intervention: 30 Minutes||8
320050|NCT00685035|771717|P2|STARTED|Period 1: First Intervention: 30 Minutes||8
320051|NCT00685035|771718|P1|STARTED|Period 1: First Intervention: 30 Minutes||9
320052|NCT00684996|771742|P1|NOT COMPLETED|Overall Study||5
320053|NCT00684996|771742|P1|COMPLETED|Overall Study||0
320054|NCT00684996|771742|P1|Eligible|Overall Study||5
320055|NCT00684996|771742|P1|STARTED|Overall Study||5
320056|NCT00684983|771757|P2|NOT COMPLETED|Overall Study||0
320057|NCT00684983|771758|P1|NOT COMPLETED|Overall Study||0
320058|NCT00684983|771757|P2|COMPLETED|Overall Study|One major violation patient in Arm B is included in the primary analysis per protocol.|45
320059|NCT00684983|771758|P1|COMPLETED|Overall Study||19
320060|NCT00684983|771757|P2|STARTED|Overall Study||45
320061|NCT00684983|771758|P1|STARTED|Overall Study||19
320062|NCT00684814|771774|P2|NOT COMPLETED|Second Intervention||0
320063|NCT00684814|771775|P1|NOT COMPLETED|Second Intervention||1
320064|NCT00684814|771774|P2|COMPLETED|Second Intervention||15
320065|NCT00684814|771775|P1|COMPLETED|Second Intervention||16
320066|NCT00684814|771774|P2|STARTED|Second Intervention||15
320067|NCT00684814|771775|P1|STARTED|Second Intervention||17
320068|NCT00684814|771774|P2|NOT COMPLETED|Washout Period of 7 Days||4
320069|NCT00684814|771775|P1|NOT COMPLETED|Washout Period of 7 Days||2
320070|NCT00684814|771774|P2|COMPLETED|Washout Period of 7 Days||15
320071|NCT00684814|771775|P1|COMPLETED|Washout Period of 7 Days||17
320072|NCT00684814|771774|P2|STARTED|Washout Period of 7 Days||19
320073|NCT00684814|771775|P1|STARTED|Washout Period of 7 Days||19
320074|NCT00684814|771774|P2|NOT COMPLETED|First Intervention||0
320075|NCT00684814|771775|P1|NOT COMPLETED|First Intervention||0
320076|NCT00684814|771774|P2|COMPLETED|First Intervention||19
320077|NCT00684814|771775|P1|COMPLETED|First Intervention||19
320078|NCT00684814|771774|P2|STARTED|First Intervention||19
320079|NCT00684814|771775|P1|STARTED|First Intervention||19
320080|NCT00684788|771787|P2|NOT COMPLETED|Overall Study||0
320081|NCT00684788|771788|P1|NOT COMPLETED|Overall Study||0
320082|NCT00684788|771787|P2|COMPLETED|Overall Study||18
320083|NCT00684788|771788|P1|COMPLETED|Overall Study||17
320084|NCT00684788|771787|P2|STARTED|Overall Study||18
320085|NCT00684788|771788|P1|STARTED|Overall Study||17
320086|NCT00684775|771808|P2|NOT COMPLETED|Overall Study||0
320087|NCT00684775|771809|P1|NOT COMPLETED|Overall Study||0
320088|NCT00684775|771808|P2|COMPLETED|Overall Study||19
320089|NCT00684775|771809|P1|COMPLETED|Overall Study||19
320090|NCT00684775|771808|P2|STARTED|Overall Study||19
320091|NCT00684775|771809|P1|STARTED|Overall Study||19
320092|NCT00684762|771827|P2|NOT COMPLETED|Second Intervention||0
320093|NCT00684762|771828|P1|NOT COMPLETED|Second Intervention||0
320094|NCT00684762|771827|P2|COMPLETED|Second Intervention||14
320095|NCT00684762|771828|P1|COMPLETED|Second Intervention||14
320096|NCT00684762|771827|P2|STARTED|Second Intervention||14
320097|NCT00684762|771828|P1|STARTED|Second Intervention||14
320098|NCT00684762|771827|P2|NOT COMPLETED|Washout Period of 7 Days||2
320099|NCT00684762|771828|P1|NOT COMPLETED|Washout Period of 7 Days||2
320100|NCT00684762|771827|P2|COMPLETED|Washout Period of 7 Days||14
320101|NCT00684762|771828|P1|COMPLETED|Washout Period of 7 Days||14
320102|NCT00684762|771827|P2|STARTED|Washout Period of 7 Days||16
320103|NCT00684762|771828|P1|STARTED|Washout Period of 7 Days||16
320104|NCT00684762|771827|P2|NOT COMPLETED|First Intervention||0
320105|NCT00684762|771828|P1|NOT COMPLETED|First Intervention||0
320106|NCT00684762|771827|P2|COMPLETED|First Intervention||16
320107|NCT00684762|771828|P1|COMPLETED|First Intervention||16
320108|NCT00684762|771827|P2|STARTED|First Intervention||16
320109|NCT00684762|771828|P1|STARTED|First Intervention||16
320110|NCT00684749|771838|P1|NOT COMPLETED|Overall Study||0
320111|NCT00684749|771838|P1|COMPLETED|Overall Study||142
320112|NCT00684749|771838|P1|STARTED|Overall Study||142
320113|NCT00684723|771842|P2|NOT COMPLETED|Second Intervention||0
320114|NCT00684723|771843|P1|NOT COMPLETED|Second Intervention||0
320115|NCT00684723|771842|P2|COMPLETED|Second Intervention||27
320116|NCT00684723|771843|P1|COMPLETED|Second Intervention||27
320117|NCT00684723|771842|P2|STARTED|Second Intervention||27
320118|NCT00684723|771843|P1|STARTED|Second Intervention||27
320119|NCT00684723|771842|P2|NOT COMPLETED|Washout Period of 7 Days||0
320120|NCT00684723|771843|P1|NOT COMPLETED|Washout Period of 7 Days||0
320121|NCT00684723|771842|P2|COMPLETED|Washout Period of 7 Days||27
320122|NCT00684723|771843|P1|COMPLETED|Washout Period of 7 Days||27
320123|NCT00684723|771842|P2|STARTED|Washout Period of 7 Days||27
320124|NCT00684723|771843|P1|STARTED|Washout Period of 7 Days||27
320125|NCT00684723|771842|P2|NOT COMPLETED|First Intervention||0
320126|NCT00684723|771843|P1|NOT COMPLETED|First Intervention||0
320127|NCT00684723|771842|P2|COMPLETED|First Intervention||27
320128|NCT00684723|771843|P1|COMPLETED|First Intervention||27
320129|NCT00684723|771842|P2|STARTED|First Intervention||27
320130|NCT00684723|771843|P1|STARTED|First Intervention||27
320131|NCT00684671|771856|P3|NOT COMPLETED|Overall Study||0
320132|NCT00684671|771857|P2|NOT COMPLETED|Overall Study||0
320133|NCT00684671|771858|P1|NOT COMPLETED|Overall Study||3
320134|NCT00684671|771856|P3|COMPLETED|Overall Study||164
320135|NCT00684671|771857|P2|COMPLETED|Overall Study||170
320136|NCT00684671|771858|P1|COMPLETED|Overall Study||169
320137|NCT00684671|771856|P3|STARTED|Overall Study||164
320138|NCT00684671|771857|P2|STARTED|Overall Study||170
320139|NCT00684671|771858|P1|STARTED|Overall Study||172
320140|NCT00684645|771887|P1|NOT COMPLETED|Overall Study||114
320141|NCT00684645|771887|P1|COMPLETED|Overall Study||72
320142|NCT00684645|771887|P1|STARTED|Overall Study||186
320143|NCT00684593|771907|P2|NOT COMPLETED|Overall Study||2
320144|NCT00684593|771908|P1|NOT COMPLETED|Overall Study||0
320145|NCT00684593|771907|P2|COMPLETED|Overall Study||8
320146|NCT00684593|771908|P1|COMPLETED|Overall Study||21
320147|NCT00684593|771907|P2|STARTED|Overall Study||10
320148|NCT00684593|771908|P1|STARTED|Overall Study||21
320149|NCT00684567|771920|P1|NOT COMPLETED|Monotherapy Period||14
320150|NCT00684567|771920|P1|COMPLETED|Monotherapy Period||9
320151|NCT00684567|771920|P1|STARTED|Monotherapy Period|5 subjects completed radiotherapy combined therapy phase but did not proceed to monotherapy phase.|23
320152|NCT00684567|771920|P1|NOT COMPLETED|Concomitant Radiotherapy Period||2
320153|NCT00684567|771920|P1|COMPLETED|Concomitant Radiotherapy Period||28
320154|NCT00684567|771920|P1|STARTED|Concomitant Radiotherapy Period||30
320155|NCT00684554|771930|P2|NOT COMPLETED|Overall Study||0
320156|NCT00684554|771931|P1|NOT COMPLETED|Overall Study||0
320157|NCT00684554|771930|P2|COMPLETED|Overall Study||10
320158|NCT00684554|771931|P1|COMPLETED|Overall Study||10
320159|NCT00684554|771930|P2|STARTED|Overall Study||10
320160|NCT00684554|771931|P1|STARTED|Overall Study||10
320161|NCT00684541|771941|P2|NOT COMPLETED|Overall Study||3
320162|NCT00684541|771942|P1|NOT COMPLETED|Overall Study||3
320163|NCT00684541|771941|P2|COMPLETED|Overall Study||23
320164|NCT00684541|771942|P1|COMPLETED|Overall Study||20
320165|NCT00684541|771941|P2|STARTED|Overall Study||26
320166|NCT00684541|771942|P1|STARTED|Overall Study||23
320167|NCT00684515|771953|P3|NOT COMPLETED|Overall Study||1
320168|NCT00684515|771954|P2|NOT COMPLETED|Overall Study||3
320169|NCT00684515|771955|P1|NOT COMPLETED|Overall Study||4
320170|NCT00684515|771953|P3|COMPLETED|Overall Study||27
320171|NCT00684515|771954|P2|COMPLETED|Overall Study||26
320172|NCT00684515|771955|P1|COMPLETED|Overall Study||29
320173|NCT00684515|771953|P3|STARTED|Overall Study||28
320174|NCT00684515|771954|P2|STARTED|Overall Study||29
320175|NCT00684515|771955|P1|STARTED|Overall Study||33
320176|NCT00684424|771978|P1|NOT COMPLETED|Overall Study||5
320177|NCT00684424|771978|P1|COMPLETED|Overall Study||194
320178|NCT00684424|771978|P1|STARTED|Overall Study||199
320179|NCT00684411|771993|P1|NOT COMPLETED|Overall Study||12
320180|NCT00684411|771993|P1|COMPLETED|Overall Study||0
320181|NCT00684411|771993|P1|Disease Evaluable|Overall Study||11
320182|NCT00684411|771993|P1|STARTED|Overall Study||12
320183|NCT00684320|772001|P2|NOT COMPLETED|Overall Study||0
320184|NCT00684320|772002|P1|NOT COMPLETED|Overall Study||4
320185|NCT00684320|772001|P2|COMPLETED|Overall Study||22
320186|NCT00684320|772002|P1|COMPLETED|Overall Study||22
320187|NCT00684320|772001|P2|STARTED|Overall Study||22
320188|NCT00684320|772002|P1|STARTED|Overall Study||26
320189|NCT00684307|772015|P5|NOT COMPLETED|Overall Study||25
320190|NCT00684307|772016|P4|NOT COMPLETED|Overall Study||32
320191|NCT00684307|772017|P3|NOT COMPLETED|Overall Study||28
320192|NCT00684307|772018|P2|NOT COMPLETED|Overall Study||22
320193|NCT00684307|772019|P1|NOT COMPLETED|Overall Study||24
320194|NCT00684307|772015|P5|COMPLETED|Overall Study||293
320195|NCT00684307|772016|P4|COMPLETED|Overall Study||128
320196|NCT00684307|772017|P3|COMPLETED|Overall Study||128
320197|NCT00684307|772018|P2|COMPLETED|Overall Study||129
320198|NCT00684307|772019|P1|COMPLETED|Overall Study||140
320199|NCT00684307|772015|P5|On Treatment Period Completed|Overall Study||293
320200|NCT00684307|772016|P4|On Treatment Period Completed|Overall Study||128
320201|NCT00684307|772017|P3|On Treatment Period Completed|Overall Study||128
320202|NCT00684307|772018|P2|On Treatment Period Completed|Overall Study||129
320203|NCT00684307|772019|P1|On Treatment Period Completed|Overall Study|Patients who completed treatment|140
320204|NCT00684307|772015|P5|On Treatment Period Started|Overall Study||318
320205|NCT00684307|772016|P4|On Treatment Period Started|Overall Study||160
320206|NCT00684307|772017|P3|On Treatment Period Started|Overall Study||156
320207|NCT00684307|772018|P2|On Treatment Period Started|Overall Study||151
320208|NCT00684307|772019|P1|On Treatment Period Started|Overall Study||164
320209|NCT00684307|772015|P5|STARTED|Overall Study||318
320210|NCT00684307|772016|P4|STARTED|Overall Study||160
320211|NCT00684307|772017|P3|STARTED|Overall Study||156
320212|NCT00684307|772018|P2|STARTED|Overall Study||151
320213|NCT00684307|772019|P1|STARTED|Overall Study|Patients who received treatment|164
320214|NCT00684255|772086|P1|NOT COMPLETED|Overall Study||0
320215|NCT00684255|772086|P1|COMPLETED|Overall Study||1
320216|NCT00684255|772086|P1|STARTED|Overall Study||1
320217|NCT00684242|772091|P1|NOT COMPLETED|Overall Study||0
320218|NCT00684242|772091|P1|COMPLETED|Overall Study||3
320219|NCT00684242|772091|P1|STARTED|Overall Study||3
320220|NCT00684203|772101|P6|NOT COMPLETED|Overall Study||0
320221|NCT00684203|772102|P5|NOT COMPLETED|Overall Study||0
320222|NCT00684203|772103|P4|NOT COMPLETED|Overall Study||0
320223|NCT00684203|772104|P3|NOT COMPLETED|Overall Study||9
320224|NCT00684203|772105|P2|NOT COMPLETED|Overall Study||8
320225|NCT00684203|772106|P1|NOT COMPLETED|Overall Study||9
320226|NCT00684203|772101|P6|COMPLETED|Overall Study||2
320227|NCT00684203|772102|P5|COMPLETED|Overall Study||17
320228|NCT00684203|772103|P4|COMPLETED|Overall Study||6
320229|NCT00684203|772104|P3|COMPLETED|Overall Study||12
320230|NCT00684203|772105|P2|COMPLETED|Overall Study||23
320231|NCT00684203|772106|P1|COMPLETED|Overall Study||31
320232|NCT00684203|772101|P6|STARTED|Overall Study||2
320233|NCT00684203|772102|P5|STARTED|Overall Study||17
320234|NCT00684203|772103|P4|STARTED|Overall Study||6
320235|NCT00684203|772104|P3|STARTED|Overall Study||21
320236|NCT00684203|772105|P2|STARTED|Overall Study||31
320237|NCT00684203|772106|P1|STARTED|Overall Study||40
320238|NCT00684177|772167|P2|NOT COMPLETED|Overall Study||23
320239|NCT00684177|772168|P1|NOT COMPLETED|Overall Study||21
320240|NCT00684177|772167|P2|COMPLETED|Overall Study||141
320241|NCT00684177|772168|P1|COMPLETED|Overall Study||322
320242|NCT00684177|772167|P2|STARTED|Overall Study||164
320243|NCT00684177|772168|P1|STARTED|Overall Study||343
320244|NCT00684138|772186|P2|NOT COMPLETED|Overall Study||8
320245|NCT00684138|772187|P1|NOT COMPLETED|Overall Study||3
320246|NCT00684138|772186|P2|COMPLETED|Overall Study||131
320247|NCT00684138|772187|P1|COMPLETED|Overall Study||138
320248|NCT00684138|772186|P2|STARTED|Overall Study||139
320249|NCT00684138|772187|P1|STARTED|Overall Study||141
320250|NCT00684073|772203|P1|NOT COMPLETED|Treatment (Days 1 Through 5)||1
320251|NCT00684073|772203|P1|COMPLETED|Treatment (Days 1 Through 5)|number of subjects who had a Day 5 visit (and therefore completed study)|52
320252|NCT00684073|772203|P1|STARTED|Treatment (Days 1 Through 5)|number of subjects who had a Day 1 visit|53
320253|NCT00684073|772203|P1|NOT COMPLETED|Selection||7
320254|NCT00684073|772203|P1|COMPLETED|Selection|number of subjects who had a Day 1 visit|53
320255|NCT00684073|772203|P1|STARTED|Selection||60
320256|NCT00684060|772213|P2|NOT COMPLETED|Overall Study||3
320257|NCT00684060|772214|P1|NOT COMPLETED|Overall Study||3
320258|NCT00684060|772213|P2|COMPLETED|Overall Study||26
320259|NCT00684060|772214|P1|COMPLETED|Overall Study||55
320260|NCT00684060|772213|P2|STARTED|Overall Study||29
320261|NCT00684060|772214|P1|STARTED|Overall Study||58
320262|NCT00684047|772237|P3|NOT COMPLETED|Overall Study||5
320263|NCT00684047|772238|P2|NOT COMPLETED|Overall Study||16
320264|NCT00684047|772239|P1|NOT COMPLETED|Overall Study||13
320265|NCT00684047|772237|P3|COMPLETED|Overall Study||52
320266|NCT00684047|772238|P2|COMPLETED|Overall Study||94
320267|NCT00684047|772239|P1|COMPLETED|Overall Study||59
320268|NCT00684047|772237|P3|STARTED|Overall Study||57
320269|NCT00684047|772238|P2|STARTED|Overall Study||110
320270|NCT00684047|772239|P1|STARTED|Overall Study||72
320271|NCT00684021|772253|P4|NOT COMPLETED|Overall Study||2
320272|NCT00684021|772254|P3|NOT COMPLETED|Overall Study||2
320273|NCT00684021|772255|P2|NOT COMPLETED|Overall Study||2
320274|NCT00684021|772256|P1|NOT COMPLETED|Overall Study||2
320275|NCT00684021|772253|P4|COMPLETED|Overall Study||15
320276|NCT00684021|772254|P3|COMPLETED|Overall Study||34
320277|NCT00684021|772255|P2|COMPLETED|Overall Study||22
320278|NCT00684021|772256|P1|COMPLETED|Overall Study||41
320279|NCT00684021|772253|P4|STARTED|Overall Study||17
320280|NCT00684021|772254|P3|STARTED|Overall Study||36
320281|NCT00684021|772255|P2|STARTED|Overall Study||24
320282|NCT00684021|772256|P1|STARTED|Overall Study||43
320283|NCT00683930|772297|P3|NOT COMPLETED|Overall Study||9
320284|NCT00683930|772298|P2|NOT COMPLETED|Overall Study||3
320285|NCT00683930|772299|P1|NOT COMPLETED|Overall Study||7
320286|NCT00683930|772297|P3|COMPLETED|Overall Study||28
320287|NCT00683930|772298|P2|COMPLETED|Overall Study||18
320288|NCT00683930|772299|P1|COMPLETED|Overall Study||29
320289|NCT00683930|772297|P3|STARTED|Overall Study||37
320290|NCT00683930|772298|P2|STARTED|Overall Study|One subject not included: no study drug dispensed.|21
320291|NCT00683930|772299|P1|STARTED|Overall Study|One subject not included: no study drug dispensed.|36
320292|NCT00683917|772317|P1|NOT COMPLETED|Overall Study||10
320293|NCT00683917|772317|P1|COMPLETED|Overall Study||0
320294|NCT00683917|772317|P1|STARTED|Overall Study||10
320295|NCT00683904|772327|P2|NOT COMPLETED|Dose Level 2||2
320296|NCT00683904|772328|P1|NOT COMPLETED|Dose Level 2||0
320297|NCT00683904|772327|P2|COMPLETED|Dose Level 2||4
320298|NCT00683904|772328|P1|COMPLETED|Dose Level 2||0
320299|NCT00683904|772327|P2|STARTED|Dose Level 2||6
320300|NCT00683904|772328|P1|STARTED|Dose Level 2||0
320301|NCT00683904|772327|P2|NOT COMPLETED|Dose Level 1||0
320302|NCT00683904|772328|P1|NOT COMPLETED|Dose Level 1||3
320303|NCT00683904|772327|P2|COMPLETED|Dose Level 1||0
320304|NCT00683904|772328|P1|COMPLETED|Dose Level 1||3
320305|NCT00683904|772327|P2|STARTED|Dose Level 1||0
320306|NCT00683904|772328|P1|STARTED|Dose Level 1||6
320307|NCT00683878|772364|P3|NOT COMPLETED|Overall Study||14
320308|NCT00683878|772365|P2|NOT COMPLETED|Overall Study||16
320309|NCT00683878|772366|P1|NOT COMPLETED|Overall Study||23
320310|NCT00683878|772364|P3|COMPLETED|Overall Study||126
320311|NCT00683878|772365|P2|COMPLETED|Overall Study||125
320312|NCT00683878|772366|P1|COMPLETED|Overall Study||116
320313|NCT00683878|772364|P3|STARTED|Overall Study||140
320314|NCT00683878|772365|P2|STARTED|Overall Study||141
320315|NCT00683878|772366|P1|STARTED|Overall Study||139
320316|NCT00683852|772394|P3|NOT COMPLETED|30-Day Phase 2 Period||9
320317|NCT00683852|772395|P2|NOT COMPLETED|30-Day Phase 2 Period||5
320318|NCT00683852|772396|P1|NOT COMPLETED|30-Day Phase 2 Period||6
320319|NCT00683852|772394|P3|COMPLETED|30-Day Phase 2 Period||75
320320|NCT00683852|772395|P2|COMPLETED|30-Day Phase 2 Period||78
320321|NCT00683852|772396|P1|COMPLETED|30-Day Phase 2 Period||48
320322|NCT00683852|772394|P3|STARTED|30-Day Phase 2 Period||84
320323|NCT00683852|772395|P2|STARTED|30-Day Phase 2 Period||83
320324|NCT00683852|772396|P1|STARTED|30-Day Phase 2 Period||54
320325|NCT00683852|772394|P3|NOT COMPLETED|30-Day Phase 1 Period||1
320326|NCT00683852|772395|P2|NOT COMPLETED|30-Day Phase 1 Period||1
320327|NCT00683852|772396|P1|NOT COMPLETED|30-Day Phase 1 Period||2
320328|NCT00683852|772394|P3|COMPLETED|30-Day Phase 1 Period||84
320329|NCT00683852|772395|P2|COMPLETED|30-Day Phase 1 Period||83
320330|NCT00683852|772396|P1|COMPLETED|30-Day Phase 1 Period||54
320331|NCT00683852|772394|P3|STARTED|30-Day Phase 1 Period||85
320332|NCT00683852|772395|P2|STARTED|30-Day Phase 1 Period||84
320333|NCT00683852|772396|P1|STARTED|30-Day Phase 1 Period||56
320334|NCT00683826|772430|P1|NOT COMPLETED|Overall Study||1
320335|NCT00683826|772430|P1|COMPLETED|Overall Study||7
320336|NCT00683826|772430|P1|4g Leucine|Overall Study||7
320337|NCT00683826|772430|P1|8g Leucine|Overall Study||8
320338|NCT00683826|772430|P1|0g Leucine|Overall Study||8
320339|NCT00683826|772430|P1|STARTED|Overall Study||8
320340|NCT00683800|772440|P2|NOT COMPLETED|Overall Study||366
320341|NCT00683800|772441|P1|NOT COMPLETED|Overall Study||432
320342|NCT00683800|772440|P2|COMPLETED|Overall Study||719
320343|NCT00683800|772441|P1|COMPLETED|Overall Study||669
320344|NCT00683800|772440|P2|Treated|Overall Study||1052
320345|NCT00683800|772441|P1|Treated|Overall Study||1066
320346|NCT00683800|772440|P2|STARTED|Overall Study||1085
320347|NCT00683800|772441|P1|STARTED|Overall Study||1101
320348|NCT00683787|772508|P3|NOT COMPLETED|Overall Study||2
320349|NCT00683787|772509|P2|NOT COMPLETED|Overall Study||3
320350|NCT00683787|772510|P1|NOT COMPLETED|Overall Study||3
320351|NCT00683787|772508|P3|COMPLETED|Overall Study||0
320352|NCT00683787|772509|P2|COMPLETED|Overall Study||0
320353|NCT00683787|772510|P1|COMPLETED|Overall Study||0
320354|NCT00683787|772508|P3|STARTED|Overall Study||2
320355|NCT00683787|772509|P2|STARTED|Overall Study||3
320356|NCT00683787|772510|P1|STARTED|Overall Study||3
320357|NCT00683774|772529|P2|NOT COMPLETED|Overall Study||1
320358|NCT00683774|772530|P1|NOT COMPLETED|Overall Study||3
320359|NCT00683774|772529|P2|COMPLETED|Overall Study||9
320360|NCT00683774|772530|P1|COMPLETED|Overall Study||8
320361|NCT00683774|772529|P2|STARTED|Overall Study||10
320362|NCT00683774|772530|P1|STARTED|Overall Study||11
320363|NCT00683696|772540|P2|NOT COMPLETED|Overall Study||405
320364|NCT00683696|772541|P1|NOT COMPLETED|Overall Study||404
320365|NCT00683696|772540|P2|COMPLETED|Overall Study||0
320366|NCT00683696|772541|P1|COMPLETED|Overall Study||0
320367|NCT00683696|772540|P2|STARTED|Overall Study||405
320368|NCT00683696|772541|P1|STARTED|Overall Study||404
320369|NCT00683657|772560|P2|NOT COMPLETED|Overall Study||1
320370|NCT00683657|772561|P1|NOT COMPLETED|Overall Study||1
320371|NCT00683657|772560|P2|COMPLETED|Overall Study||46
320372|NCT00683657|772561|P1|COMPLETED|Overall Study||45
320373|NCT00683657|772560|P2|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|47
320465|NCT00683020|772770|P2|NOT COMPLETED|Overall Study||55
320374|NCT00683657|772561|P1|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|46
320375|NCT00683657|772560|P2|STARTED|Overall Study||47
320376|NCT00683657|772561|P1|STARTED|Overall Study||46
320377|NCT00683644|772577|P2|NOT COMPLETED|Overall Study||14
320378|NCT00683644|772578|P1|NOT COMPLETED|Overall Study||13
320379|NCT00683644|772577|P2|COMPLETED|Overall Study||44
320380|NCT00683644|772578|P1|COMPLETED|Overall Study||45
320381|NCT00683644|772577|P2|STARTED|Overall Study||58
320382|NCT00683644|772578|P1|STARTED|Overall Study||58
320383|NCT00683618|772591|P3|NOT COMPLETED|Extension Treatment Period||0
320384|NCT00683618|772592|P2|NOT COMPLETED|Extension Treatment Period||0
320385|NCT00683618|772593|P1|NOT COMPLETED|Extension Treatment Period||3
320386|NCT00683618|772591|P3|COMPLETED|Extension Treatment Period||0
320387|NCT00683618|772592|P2|COMPLETED|Extension Treatment Period||23
320388|NCT00683618|772593|P1|COMPLETED|Extension Treatment Period||33
320389|NCT00683618|772591|P3|STARTED|Extension Treatment Period||0
320390|NCT00683618|772592|P2|STARTED|Extension Treatment Period||23
320391|NCT00683618|772593|P1|STARTED|Extension Treatment Period||36
320392|NCT00683618|772591|P3|NOT COMPLETED|Randomised Treatment Period||6
320393|NCT00683618|772592|P2|NOT COMPLETED|Randomised Treatment Period||2
320394|NCT00683618|772593|P1|NOT COMPLETED|Randomised Treatment Period||6
320395|NCT00683618|772591|P3|COMPLETED|Randomised Treatment Period||140
320396|NCT00683618|772592|P2|COMPLETED|Randomised Treatment Period||143
320397|NCT00683618|772593|P1|COMPLETED|Randomised Treatment Period||139
320398|NCT00683618|772591|P3|STARTED|Randomised Treatment Period||146
320399|NCT00683618|772592|P2|STARTED|Randomised Treatment Period||145
320400|NCT00683618|772593|P1|STARTED|Randomised Treatment Period||145
320401|NCT00683592|772643|P2|NOT COMPLETED|Overall Study||46
320402|NCT00683592|772644|P1|NOT COMPLETED|Overall Study||47
320403|NCT00683592|772643|P2|COMPLETED|Overall Study||195
320404|NCT00683592|772644|P1|COMPLETED|Overall Study||193
320405|NCT00683592|772643|P2|Safety Population|Overall Study||233
320406|NCT00683592|772644|P1|Safety Population|Overall Study||235
320407|NCT00683592|772643|P2|Intent to Treat Population|Overall Study||232
320408|NCT00683592|772644|P1|Intent to Treat Population|Overall Study||231
320409|NCT00683592|772643|P2|STARTED|Overall Study||241
320410|NCT00683592|772644|P1|STARTED|Overall Study||240
320411|NCT00683475|772662|P2|NOT COMPLETED|Overall Study||3
320412|NCT00683475|772663|P1|NOT COMPLETED|Overall Study||4
320413|NCT00683475|772662|P2|COMPLETED|Overall Study||66
320414|NCT00683475|772663|P1|COMPLETED|Overall Study||65
320415|NCT00683475|772662|P2|Received Any Quantity of Study Drug|Overall Study||66
320416|NCT00683475|772663|P1|Received Any Quantity of Study Drug|Overall Study||66
320417|NCT00683475|772662|P2|STARTED|Overall Study||69
320418|NCT00683475|772663|P1|STARTED|Overall Study||69
320419|NCT00683449|772698|P5|NOT COMPLETED|Overall Study||0
320420|NCT00683449|772699|P4|NOT COMPLETED|Overall Study||0
320421|NCT00683449|772700|P3|NOT COMPLETED|Overall Study||0
320422|NCT00683449|772701|P2|NOT COMPLETED|Overall Study||1
320423|NCT00683449|772702|P1|NOT COMPLETED|Overall Study||0
320424|NCT00683449|772698|P5|COMPLETED|Overall Study||2
320425|NCT00683449|772699|P4|COMPLETED|Overall Study||6
320426|NCT00683449|772700|P3|COMPLETED|Overall Study||3
320427|NCT00683449|772701|P2|COMPLETED|Overall Study||12
320428|NCT00683449|772702|P1|COMPLETED|Overall Study||5
320429|NCT00683449|772698|P5|STARTED|Overall Study||2
320430|NCT00683449|772699|P4|STARTED|Overall Study||6
320431|NCT00683449|772700|P3|STARTED|Overall Study||3
320432|NCT00683449|772701|P2|STARTED|Overall Study||13
320433|NCT00683449|772702|P1|STARTED|Overall Study||5
320434|NCT00683410|772724|P1|NOT COMPLETED|Overall Study||0
320435|NCT00683410|772724|P1|COMPLETED|Overall Study||3366
320436|NCT00683410|772724|P1|Vaccinated Dose 4|Overall Study||175
320437|NCT00683410|772724|P1|Vaccinated Dose 3|Overall Study||817
320438|NCT00683410|772724|P1|Vaccinated Dose 2|Overall Study||1623
320439|NCT00683410|772724|P1|Vaccinated Dose 1|Overall Study||3240
320440|NCT00683410|772724|P1|STARTED|Overall Study||3366
320441|NCT00683384|772728|P1|NOT COMPLETED|Overall Study||2
320442|NCT00683384|772728|P1|COMPLETED|Overall Study||91
320443|NCT00683384|772728|P1|STARTED|Overall Study||93
320444|NCT00683332|772732|P1|NOT COMPLETED|Overall Study||0
320445|NCT00683332|772732|P1|COMPLETED|Overall Study||621
320446|NCT00683332|772732|P1|STARTED|Overall Study||621
320447|NCT00683293|772738|P2|NOT COMPLETED|Overall Study||3
320448|NCT00683293|772739|P1|NOT COMPLETED|Overall Study||2
320449|NCT00683293|772738|P2|COMPLETED|Overall Study||47
320450|NCT00683293|772739|P1|COMPLETED|Overall Study||48
320451|NCT00683293|772738|P2|STARTED|Overall Study||50
320452|NCT00683293|772739|P1|STARTED|Overall Study||50
320453|NCT00683163|772749|P2|NOT COMPLETED|Overall Study||0
320454|NCT00683163|772750|P1|NOT COMPLETED|Overall Study||0
320455|NCT00683163|772749|P2|COMPLETED|Overall Study||22
320456|NCT00683163|772750|P1|COMPLETED|Overall Study||22
320457|NCT00683163|772749|P2|STARTED|Overall Study||22
320458|NCT00683163|772750|P1|STARTED|Overall Study||22
320459|NCT00683085|772758|P1|NOT COMPLETED|Overall Study||0
320460|NCT00683085|772758|P1|COMPLETED|Overall Study||2
320461|NCT00683085|772758|P1|STARTED|Overall Study||2
320462|NCT00683046|772763|P1|NOT COMPLETED|Overall Study||0
320463|NCT00683046|772763|P1|COMPLETED|Overall Study||204
320464|NCT00683046|772763|P1|STARTED|Overall Study||204
320466|NCT00683020|772771|P1|NOT COMPLETED|Overall Study||55
320467|NCT00683020|772770|P2|COMPLETED|Overall Study||125
320468|NCT00683020|772771|P1|COMPLETED|Overall Study||127
320469|NCT00683020|772770|P2|STARTED|Overall Study||180
320470|NCT00683020|772771|P1|STARTED|Overall Study||182
320471|NCT00682929|772802|P3|NOT COMPLETED|Overall Study||2
320472|NCT00682929|772803|P2|NOT COMPLETED|Overall Study||5
320473|NCT00682929|772804|P1|NOT COMPLETED|Overall Study||6
320474|NCT00682929|772802|P3|COMPLETED|Overall Study||12
320475|NCT00682929|772803|P2|COMPLETED|Overall Study||9
320476|NCT00682929|772804|P1|COMPLETED|Overall Study||7
320477|NCT00682929|772802|P3|STARTED|Overall Study||14
320478|NCT00682929|772803|P2|STARTED|Overall Study||14
320479|NCT00682929|772804|P1|STARTED|Overall Study||13
320480|NCT00682890|772973|P2|NOT COMPLETED|Overall Study||2
320481|NCT00682890|772974|P1|NOT COMPLETED|Overall Study||2
320482|NCT00682890|772973|P2|COMPLETED|Overall Study||9
320483|NCT00682890|772974|P1|COMPLETED|Overall Study||10
320484|NCT00682890|772973|P2|STARTED|Overall Study||11
320485|NCT00682890|772974|P1|STARTED|Overall Study||12
320486|NCT00682851|772984|P2|NOT COMPLETED|Overall Study||0
320487|NCT00682851|772985|P1|NOT COMPLETED|Overall Study||0
320488|NCT00682851|772984|P2|COMPLETED|Overall Study||268
320489|NCT00682851|772985|P1|COMPLETED|Overall Study||251
320490|NCT00682851|772984|P2|STARTED|Overall Study||268
320491|NCT00682851|772985|P1|STARTED|Overall Study||251
320492|NCT00682838|773001|P4|NOT COMPLETED|Overall Study||0
320493|NCT00682838|773002|P3|NOT COMPLETED|Overall Study||0
320494|NCT00682838|773003|P2|NOT COMPLETED|Overall Study||0
320495|NCT00682838|773004|P1|NOT COMPLETED|Overall Study||0
320496|NCT00682838|773001|P4|COMPLETED|Overall Study||73
320497|NCT00682838|773002|P3|COMPLETED|Overall Study||75
320498|NCT00682838|773003|P2|COMPLETED|Overall Study||67
320499|NCT00682838|773004|P1|COMPLETED|Overall Study||65
320500|NCT00682838|773001|P4|STARTED|Overall Study||73
320501|NCT00682838|773002|P3|STARTED|Overall Study||75
320502|NCT00682838|773003|P2|STARTED|Overall Study||67
320503|NCT00682838|773004|P1|STARTED|Overall Study||65
320504|NCT00682786|773016|P2|NOT COMPLETED|Overall Study||3
320505|NCT00682786|773017|P1|NOT COMPLETED|Overall Study||2
320506|NCT00682786|773016|P2|COMPLETED|Overall Study||34
320507|NCT00682786|773017|P1|COMPLETED|Overall Study||96
320508|NCT00682786|773016|P2|STARTED|Overall Study||37
320509|NCT00682786|773017|P1|STARTED|Overall Study||98
320510|NCT00682734|773054|P3|NOT COMPLETED|48 Hour Follow-up||11
320511|NCT00682734|773055|P2|NOT COMPLETED|48 Hour Follow-up||6
320512|NCT00682734|773056|P1|NOT COMPLETED|48 Hour Follow-up||6
320513|NCT00682734|773054|P3|COMPLETED|48 Hour Follow-up||106
320514|NCT00682734|773055|P2|COMPLETED|48 Hour Follow-up||111
320515|NCT00682734|773056|P1|COMPLETED|48 Hour Follow-up||107
320516|NCT00682734|773054|P3|STARTED|48 Hour Follow-up||117
320517|NCT00682734|773055|P2|STARTED|48 Hour Follow-up||117
320518|NCT00682734|773056|P1|STARTED|48 Hour Follow-up||113
320519|NCT00682734|773054|P3|NOT COMPLETED|Emergency Department Portion||1
320520|NCT00682734|773055|P2|NOT COMPLETED|Emergency Department Portion||1
320521|NCT00682734|773056|P1|NOT COMPLETED|Emergency Department Portion||0
320522|NCT00682734|773054|P3|COMPLETED|Emergency Department Portion||117
320523|NCT00682734|773055|P2|COMPLETED|Emergency Department Portion||117
320524|NCT00682734|773056|P1|COMPLETED|Emergency Department Portion||113
320525|NCT00682734|773054|P3|STARTED|Emergency Department Portion||118
320526|NCT00682734|773055|P2|STARTED|Emergency Department Portion||118
320527|NCT00682734|773056|P1|STARTED|Emergency Department Portion||113
320528|NCT00682643|773066|P2|NOT COMPLETED|Overall Study||169
320529|NCT00682643|773067|P1|NOT COMPLETED|Overall Study||78
320530|NCT00682643|773066|P2|COMPLETED|Overall Study||199
320531|NCT00682643|773067|P1|COMPLETED|Overall Study||104
320532|NCT00682643|773066|P2|STARTED|Overall Study||368
320533|NCT00682643|773067|P1|STARTED|Overall Study||182
320534|NCT00682565|773102|P3|NOT COMPLETED|Overall Study||0
320535|NCT00682565|773103|P2|NOT COMPLETED|Overall Study||3
320536|NCT00682565|773104|P1|NOT COMPLETED|Overall Study||1
320537|NCT00682565|773102|P3|COMPLETED|Overall Study||29
320538|NCT00682565|773103|P2|COMPLETED|Overall Study||32
320539|NCT00682565|773104|P1|COMPLETED|Overall Study||30
320540|NCT00682565|773102|P3|STARTED|Overall Study||29
320541|NCT00682565|773103|P2|STARTED|Overall Study||35
320542|NCT00682565|773104|P1|STARTED|Overall Study||31
320543|NCT00682539|773128|P3|NOT COMPLETED|Ranibizumab vs Triamcinolone||8
320544|NCT00682539|773129|P2|NOT COMPLETED|Ranibizumab vs Triamcinolone||3
320545|NCT00682539|773130|P1|NOT COMPLETED|Ranibizumab vs Triamcinolone||0
320546|NCT00682539|773128|P3|COMPLETED|Ranibizumab vs Triamcinolone||10
320547|NCT00682539|773129|P2|COMPLETED|Ranibizumab vs Triamcinolone||15
320548|NCT00682539|773130|P1|COMPLETED|Ranibizumab vs Triamcinolone||0
320549|NCT00682539|773128|P3|STARTED|Ranibizumab vs Triamcinolone|Both periods recruited independently following the same criteria.|18
320550|NCT00682539|773129|P2|STARTED|Ranibizumab vs Triamcinolone|None of the patients of the 1st period was included in the second period.|18
320551|NCT00682539|773130|P1|STARTED|Ranibizumab vs Triamcinolone|Two independent periods.|0
320552|NCT00682539|773128|P3|NOT COMPLETED|Bevacizumab vs Triamcinolone||0
320553|NCT00682539|773129|P2|NOT COMPLETED|Bevacizumab vs Triamcinolone||1
320554|NCT00682539|773130|P1|NOT COMPLETED|Bevacizumab vs Triamcinolone||3
320555|NCT00682539|773128|P3|COMPLETED|Bevacizumab vs Triamcinolone||0
320556|NCT00682539|773129|P2|COMPLETED|Bevacizumab vs Triamcinolone||15
320557|NCT00682539|773130|P1|COMPLETED|Bevacizumab vs Triamcinolone||15
320558|NCT00682539|773128|P3|STARTED|Bevacizumab vs Triamcinolone||0
320559|NCT00682539|773129|P2|STARTED|Bevacizumab vs Triamcinolone||16
320560|NCT00682539|773130|P1|STARTED|Bevacizumab vs Triamcinolone||18
320561|NCT00682461|773143|P2|NOT COMPLETED|Overall Study||31
320562|NCT00682461|773144|P1|NOT COMPLETED|Overall Study||25
320563|NCT00682461|773143|P2|COMPLETED|Overall Study||69
320564|NCT00682461|773144|P1|COMPLETED|Overall Study||75
320565|NCT00682461|773143|P2|STARTED|Overall Study||100
320566|NCT00682461|773144|P1|STARTED|Overall Study||100
320567|NCT00682435|773158|P1|NOT COMPLETED|Overall Study||7
320568|NCT00682435|773158|P1|COMPLETED|Overall Study||223
320569|NCT00682435|773158|P1|Sufficient Data to Carry Out Analysis|Overall Study||223
320570|NCT00682435|773158|P1|Ensured Enrolled Only Once|Overall Study||228
320571|NCT00682435|773158|P1|STARTED|Overall Study||230
320572|NCT00682357|773168|P3|NOT COMPLETED|Overall Study||0
320573|NCT00682357|773169|P2|NOT COMPLETED|Overall Study||0
320574|NCT00682357|773170|P1|NOT COMPLETED|Overall Study||0
320575|NCT00682357|773168|P3|COMPLETED|Overall Study||5
320576|NCT00682357|773169|P2|COMPLETED|Overall Study||10
320577|NCT00682357|773170|P1|COMPLETED|Overall Study||10
320578|NCT00682357|773168|P3|STARTED|Overall Study||5
320579|NCT00682357|773169|P2|STARTED|Overall Study||10
320580|NCT00682357|773170|P1|STARTED|Overall Study||10
320581|NCT00681889|773187|P1|NOT COMPLETED|Overall Study||0
320582|NCT00681889|773187|P1|COMPLETED|Overall Study||9
320583|NCT00681889|773187|P1|STARTED|Overall Study||9
320584|NCT00681863|773191|P1|NOT COMPLETED|Overall Study||23
320585|NCT00681863|773191|P1|COMPLETED|Overall Study||22
320586|NCT00681863|773191|P1|STARTED|Overall Study||45
320587|NCT00681824|773239|P3|NOT COMPLETED|Overall Study||1
320588|NCT00681824|773240|P2|NOT COMPLETED|Overall Study||1
320589|NCT00681824|773241|P1|NOT COMPLETED|Overall Study||1
320590|NCT00681824|773239|P3|COMPLETED|Overall Study||33
320591|NCT00681824|773240|P2|COMPLETED|Overall Study||12
320592|NCT00681824|773241|P1|COMPLETED|Overall Study||27
320593|NCT00681824|773239|P3|STARTED|Overall Study||34
320594|NCT00681824|773240|P2|STARTED|Overall Study||13
320595|NCT00681824|773241|P1|STARTED|Overall Study||28
320596|NCT00681811|773259|P2|NOT COMPLETED|Overall Study||4
320597|NCT00681811|773260|P1|NOT COMPLETED|Overall Study||3
320598|NCT00681811|773259|P2|COMPLETED|Overall Study||1
320599|NCT00681811|773260|P1|COMPLETED|Overall Study||3
320600|NCT00681811|773259|P2|STARTED|Overall Study||5
320601|NCT00681811|773260|P1|STARTED|Overall Study||6
320602|NCT00681668|773288|P1|NOT COMPLETED|Overall Study||2
320603|NCT00681668|773288|P1|COMPLETED|Overall Study||3
320604|NCT00681668|773288|P1|STARTED|Overall Study||5
320605|NCT00681629|773297|P2|NOT COMPLETED|Overall Study||2
320606|NCT00681629|773298|P1|NOT COMPLETED|Overall Study||5
320607|NCT00681629|773297|P2|COMPLETED|Overall Study||0
320608|NCT00681629|773298|P1|COMPLETED|Overall Study||0
320609|NCT00681629|773297|P2|STARTED|Overall Study|It was planned to recruit 100 patient|2
320610|NCT00681629|773298|P1|STARTED|Overall Study|It was planned to recruit 100 patient|5
320611|NCT00681590|773344|P2|NOT COMPLETED|Overall Study||12
320612|NCT00681590|773345|P1|NOT COMPLETED|Overall Study||2
320613|NCT00681590|773344|P2|COMPLETED|Overall Study||59
320614|NCT00681590|773345|P1|COMPLETED|Overall Study||32
320615|NCT00681590|773344|P2|STARTED|Overall Study||71
320616|NCT00681590|773345|P1|STARTED|Overall Study||34
320617|NCT00681564|773355|P2|NOT COMPLETED|Overall Study||8
320618|NCT00681564|773356|P1|NOT COMPLETED|Overall Study||6
320619|NCT00681564|773355|P2|COMPLETED|Overall Study||47
320620|NCT00681564|773356|P1|COMPLETED|Overall Study||41
320621|NCT00681564|773355|P2|STARTED|Overall Study||55
320622|NCT00681564|773356|P1|STARTED|Overall Study||47
320623|NCT00681538|773386|P2|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||2
320624|NCT00681538|773387|P1|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||15
320625|NCT00681538|773386|P2|COMPLETED|Phase B- Responders;12 Week Double-blind||115
320626|NCT00681538|773387|P1|COMPLETED|Phase B- Responders;12 Week Double-blind||109
320627|NCT00681538|773386|P2|STARTED|Phase B- Responders;12 Week Double-blind||117
320628|NCT00681538|773387|P1|STARTED|Phase B- Responders;12 Week Double-blind||124
320629|NCT00681538|773386|P2|NOT COMPLETED|Phase A- 4 Weeks Single Blind||0
320630|NCT00681538|773387|P1|NOT COMPLETED|Phase A- 4 Weeks Single Blind||34
320631|NCT00681538|773386|P2|COMPLETED|Phase A- 4 Weeks Single Blind||0
320632|NCT00681538|773387|P1|COMPLETED|Phase A- 4 Weeks Single Blind||538
320633|NCT00681538|773386|P2|STARTED|Phase A- 4 Weeks Single Blind||0
320634|NCT00681538|773387|P1|STARTED|Phase A- 4 Weeks Single Blind||572
320635|NCT00681473|773417|P1|NOT COMPLETED|Overall Study||0
320636|NCT00681473|773417|P1|COMPLETED|Overall Study|All 20 patients completed RT and tolerated treatment well.|20
320637|NCT00681473|773417|P1|STARTED|Overall Study|20 patients with WHO Grade 2 Glioma were enrolled.|20
320638|NCT00681291|773425|P2|NOT COMPLETED|Overall Study||27
320639|NCT00681291|773426|P1|NOT COMPLETED|Overall Study||13
320640|NCT00681291|773425|P2|COMPLETED|Overall Study||57
320641|NCT00681291|773426|P1|COMPLETED|Overall Study||75
320642|NCT00681291|773425|P2|STARTED|Overall Study||84
320643|NCT00681291|773426|P1|STARTED|Overall Study||88
320644|NCT00681265|773438|P1|NOT COMPLETED|Overall Study||0
320645|NCT00681265|773438|P1|COMPLETED|Overall Study||16
320646|NCT00681265|773438|P1|STARTED|Overall Study||16
320647|NCT00681187|773448|P2|NOT COMPLETED|Overall Study||2
320648|NCT00681187|773449|P1|NOT COMPLETED|Overall Study||1
320649|NCT00681187|773448|P2|COMPLETED|Overall Study||13
320650|NCT00681187|773449|P1|COMPLETED|Overall Study||10
320651|NCT00681187|773448|P2|STARTED|Overall Study||15
320652|NCT00681187|773449|P1|STARTED|Overall Study||11
320653|NCT00681109|773484|P3|NOT COMPLETED|Overall Study||0
320654|NCT00681109|773485|P2|NOT COMPLETED|Overall Study||6
320655|NCT00681109|773486|P1|NOT COMPLETED|Overall Study||2
320656|NCT00681109|773484|P3|COMPLETED|Overall Study||15
320657|NCT00681109|773485|P2|COMPLETED|Overall Study||24
320658|NCT00681109|773486|P1|COMPLETED|Overall Study||28
320659|NCT00681109|773484|P3|STARTED|Overall Study||15
320660|NCT00681109|773485|P2|STARTED|Overall Study||30
320661|NCT00681109|773486|P1|STARTED|Overall Study||30
320662|NCT00681083|773503|P2|NOT COMPLETED|Night 2 (Crossover of Night 1)||0
320663|NCT00681083|773504|P1|NOT COMPLETED|Night 2 (Crossover of Night 1)||0
320664|NCT00681083|773503|P2|COMPLETED|Night 2 (Crossover of Night 1)||10
320665|NCT00681083|773504|P1|COMPLETED|Night 2 (Crossover of Night 1)||10
320666|NCT00681083|773503|P2|STARTED|Night 2 (Crossover of Night 1)||10
320667|NCT00681083|773504|P1|STARTED|Night 2 (Crossover of Night 1)||10
320668|NCT00681083|773503|P2|NOT COMPLETED|Night 1||3
320669|NCT00681083|773504|P1|NOT COMPLETED|Night 1||3
320670|NCT00681083|773503|P2|COMPLETED|Night 1|20 in total completed study. 10 randomized to arm 1 and arm 2 then crossed over to other arm.|10
320671|NCT00681083|773504|P1|COMPLETED|Night 1|20 in total completed study. 10 randomized to arm 1 and arm 2 then crossed over to other arm.|10
320672|NCT00681083|773503|P2|STARTED|Night 1|26 participants were initially consented (this is the total for the study).|13
320673|NCT00681083|773504|P1|STARTED|Night 1|26 participants were initially consented (this is the total for the study).|13
320674|NCT00681044|773512|P1|NOT COMPLETED|Overall Study||0
320675|NCT00681044|773512|P1|COMPLETED|Overall Study||4
320676|NCT00681044|773512|P1|STARTED|Overall Study||4
320677|NCT00681031|773520|P1|NOT COMPLETED|Overall Study||0
320678|NCT00681031|773520|P1|COMPLETED|Overall Study||96
320679|NCT00681031|773520|P1|STARTED|Overall Study||96
320680|NCT00680992|773527|P3|NOT COMPLETED|Overall Study||12
320681|NCT00680992|773528|P2|NOT COMPLETED|Overall Study||252
320682|NCT00680992|773529|P1|NOT COMPLETED|Overall Study||268
320683|NCT00680992|773527|P3|COMPLETED|Overall Study||0
320684|NCT00680992|773528|P2|COMPLETED|Overall Study||0
320685|NCT00680992|773529|P1|COMPLETED|Overall Study||0
320686|NCT00680992|773527|P3|Efficacy Analysis Set|Overall Study||11
320687|NCT00680992|773528|P2|Efficacy Analysis Set|Overall Study||242
320688|NCT00680992|773529|P1|Efficacy Analysis Set|Overall Study||260
320689|NCT00680992|773527|P3|Safety Analysis Set|Overall Study||12
320690|NCT00680992|773528|P2|Safety Analysis Set|Overall Study||249
320691|NCT00680992|773529|P1|Safety Analysis Set|Overall Study||265
320692|NCT00680992|773527|P3|STARTED|Overall Study||12
320693|NCT00680992|773528|P2|STARTED|Overall Study||252
320694|NCT00680992|773529|P1|STARTED|Overall Study||268
320695|NCT00680953|773545|P3|NOT COMPLETED|Overall Study||47
320696|NCT00680953|773546|P2|NOT COMPLETED|Overall Study||95
320697|NCT00680953|773547|P1|NOT COMPLETED|Overall Study||86
320698|NCT00680953|773545|P3|COMPLETED|Overall Study||204
320699|NCT00680953|773546|P2|COMPLETED|Overall Study||416
320700|NCT00680953|773547|P1|COMPLETED|Overall Study||414
320701|NCT00680953|773545|P3|STARTED|Overall Study||251
320702|NCT00680953|773546|P2|STARTED|Overall Study||511
320703|NCT00680953|773547|P1|STARTED|Overall Study||500
320704|NCT00680914|773563|P2|NOT COMPLETED|Overall Study||4
320705|NCT00680914|773564|P1|NOT COMPLETED|Overall Study||10
320706|NCT00680914|773563|P2|COMPLETED|Overall Study||125
320707|NCT00680914|773564|P1|COMPLETED|Overall Study||364
320708|NCT00680914|773563|P2|STARTED|Overall Study||129
320709|NCT00680914|773564|P1|STARTED|Overall Study||374
320710|NCT00680901|773598|P2|NOT COMPLETED|Overall Study||76
320711|NCT00680901|773599|P1|NOT COMPLETED|Overall Study||73
320712|NCT00680901|773598|P2|COMPLETED|Overall Study||197
320713|NCT00680901|773599|P1|COMPLETED|Overall Study||199
320714|NCT00680901|773598|P2|Ongoing: In Follow Up|Overall Study||41
320715|NCT00680901|773599|P1|Ongoing: In Follow Up|Overall Study||45
320716|NCT00680901|773598|P2|Ongoing: On Study Treatment|Overall Study||13
320717|NCT00680901|773599|P1|Ongoing: On Study Treatment|Overall Study||16
320718|NCT00680901|773598|P2|STARTED|Overall Study||273
320719|NCT00680901|773599|P1|STARTED|Overall Study||272
320720|NCT00680862|773631|P1|NOT COMPLETED|Overall Study||0
320721|NCT00680862|773631|P1|COMPLETED|Overall Study||25
320722|NCT00680862|773631|P1|STARTED|Overall Study||25
320723|NCT00680836|773637|P2|NOT COMPLETED|Overall Study||2
320724|NCT00680836|773638|P1|NOT COMPLETED|Overall Study||8
320725|NCT00680836|773637|P2|COMPLETED|Overall Study||25
320726|NCT00680836|773638|P1|COMPLETED|Overall Study||19
320727|NCT00680836|773637|P2|STARTED|Overall Study||27
320728|NCT00680836|773638|P1|STARTED|Overall Study||27
320729|NCT00680823|773657|P3|NOT COMPLETED|Overall Study||0
320730|NCT00680823|773658|P2|NOT COMPLETED|Overall Study||0
320731|NCT00680823|773659|P1|NOT COMPLETED|Overall Study||0
320732|NCT00680823|773657|P3|COMPLETED|Overall Study||50
320733|NCT00680823|773658|P2|COMPLETED|Overall Study||50
320734|NCT00680823|773659|P1|COMPLETED|Overall Study||50
320735|NCT00680823|773657|P3|STARTED|Overall Study||50
320736|NCT00680823|773658|P2|STARTED|Overall Study||50
320737|NCT00680823|773659|P1|STARTED|Overall Study||50
320738|NCT00680797|773677|P4|NOT COMPLETED|Overall Study||0
320739|NCT00680797|773678|P3|NOT COMPLETED|Overall Study||0
320740|NCT00680797|773679|P2|NOT COMPLETED|Overall Study||0
320741|NCT00680797|773680|P1|NOT COMPLETED|Overall Study||0
320742|NCT00680797|773677|P4|COMPLETED|Overall Study||8
320743|NCT00680797|773678|P3|COMPLETED|Overall Study||8
320744|NCT00680797|773679|P2|COMPLETED|Overall Study||8
320745|NCT00680797|773680|P1|COMPLETED|Overall Study||9
320746|NCT00680797|773677|P4|STARTED|Overall Study||8
320747|NCT00680797|773678|P3|STARTED|Overall Study||8
320748|NCT00680797|773679|P2|STARTED|Overall Study||8
320749|NCT00680797|773680|P1|STARTED|Overall Study||9
320750|NCT00680771|773692|P2|NOT COMPLETED|Overall Study||2
320751|NCT00680771|773693|P1|NOT COMPLETED|Overall Study||6
320752|NCT00680771|773692|P2|COMPLETED|Overall Study||11
320753|NCT00680771|773693|P1|COMPLETED|Overall Study||9
320754|NCT00680771|773692|P2|STARTED|Overall Study||13
320755|NCT00680771|773693|P1|STARTED|Overall Study||15
320756|NCT00680745|773703|P4|NOT COMPLETED|Overall Study||13
320757|NCT00680745|773704|P3|NOT COMPLETED|Overall Study||10
320758|NCT00680745|773705|P2|NOT COMPLETED|Overall Study||13
320759|NCT00680745|773706|P1|NOT COMPLETED|Overall Study||14
320760|NCT00680745|773703|P4|COMPLETED|Overall Study||133
320761|NCT00680745|773704|P3|COMPLETED|Overall Study||141
320762|NCT00680745|773705|P2|COMPLETED|Overall Study||132
320763|NCT00680745|773706|P1|COMPLETED|Overall Study||140
320764|NCT00680745|773703|P4|STARTED|Overall Study|Safety Analysis Set|146
320765|NCT00680745|773704|P3|STARTED|Overall Study|Safety Analysis Set|151
320766|NCT00680745|773705|P2|STARTED|Overall Study|Safety Analysis Set|145
320767|NCT00680745|773706|P1|STARTED|Overall Study|Safety Analysis Set|154
320768|NCT00680706|773738|P2|NOT COMPLETED|Overall Study||5
320769|NCT00680706|773739|P1|NOT COMPLETED|Overall Study||7
320770|NCT00680706|773738|P2|COMPLETED|Overall Study||55
320771|NCT00680706|773739|P1|COMPLETED|Overall Study||63
320772|NCT00680706|773738|P2|STARTED|Overall Study||60
320773|NCT00680706|773739|P1|STARTED|Overall Study||70
320774|NCT00680628|773749|P2|NOT COMPLETED|Overall Study||0
320775|NCT00680628|773750|P1|NOT COMPLETED|Overall Study||0
320776|NCT00680628|773749|P2|COMPLETED|Overall Study||40
320777|NCT00680628|773750|P1|COMPLETED|Overall Study||43
320778|NCT00680628|773749|P2|STARTED|Overall Study||40
320779|NCT00680628|773750|P1|STARTED|Overall Study||43
320780|NCT00680524|773760|P1|NOT COMPLETED|Overall Study||3
320781|NCT00680524|773760|P1|COMPLETED|Overall Study||17
320782|NCT00680524|773760|P1|STARTED|Overall Study||20
320783|NCT00680459|773766|P2|NOT COMPLETED|Overall Study||0
320784|NCT00680459|773767|P1|NOT COMPLETED|Overall Study||0
320785|NCT00680459|773766|P2|COMPLETED|Overall Study||6
320786|NCT00680459|773767|P1|COMPLETED|Overall Study||7
320787|NCT00680459|773766|P2|STARTED|Overall Study||6
320788|NCT00680459|773767|P1|STARTED|Overall Study||7
320789|NCT00680407|773780|P3|NOT COMPLETED|Overall Study||3
320790|NCT00680407|773781|P2|NOT COMPLETED|Overall Study||5
320791|NCT00680407|773782|P1|NOT COMPLETED|Overall Study||8
320792|NCT00680407|773780|P3|COMPLETED|Overall Study||22
320793|NCT00680407|773781|P2|COMPLETED|Overall Study||22
320794|NCT00680407|773782|P1|COMPLETED|Overall Study||18
320795|NCT00680407|773780|P3|STARTED|Overall Study||25
320796|NCT00680407|773781|P2|STARTED|Overall Study||27
320797|NCT00680407|773782|P1|STARTED|Overall Study||26
320798|NCT00680368|773796|P1|NOT COMPLETED|Overall Study||15
320799|NCT00680368|773796|P1|COMPLETED|Overall Study|15 residents excluded because their attending physician was not participating in the study|97
320800|NCT00680368|773796|P1|STARTED|Overall Study||112
320801|NCT00680316|773804|P2|NOT COMPLETED|Overall Study||0
320802|NCT00680316|773805|P1|NOT COMPLETED|Overall Study||0
320803|NCT00680316|773804|P2|COMPLETED|Overall Study||2
320804|NCT00680316|773805|P1|COMPLETED|Overall Study||1
320805|NCT00680316|773804|P2|STARTED|Overall Study||2
320806|NCT00680316|773805|P1|STARTED|Overall Study||1
320807|NCT00680225|773817|P1|NOT COMPLETED|Overall Study||2
320808|NCT00680225|773817|P1|COMPLETED|Overall Study||8
320809|NCT00680225|773817|P1|STARTED|Overall Study||10
320810|NCT00680186|773824|P2|NOT COMPLETED|Overall Study||116
320811|NCT00680186|773825|P1|NOT COMPLETED|Overall Study||125
320812|NCT00680186|773824|P2|COMPLETED|Overall Study|Completed planned observation time.|1172
320813|NCT00680186|773825|P1|COMPLETED|Overall Study|Completed planned observation time.|1155
320814|NCT00680186|773824|P2|STARTED|Overall Study|Started treatment.|1288
320815|NCT00680186|773825|P1|STARTED|Overall Study|Started treatment.|1280
320816|NCT00680121|773851|P2|NOT COMPLETED|Overall Study||23
320817|NCT00680121|773852|P1|NOT COMPLETED|Overall Study||27
320818|NCT00680121|773851|P2|COMPLETED|Overall Study||37
320819|NCT00680121|773852|P1|COMPLETED|Overall Study||33
320820|NCT00680121|773851|P2|STARTED|Overall Study||60
320821|NCT00680121|773852|P1|STARTED|Overall Study||60
320822|NCT00680056|773866|P2|NOT COMPLETED|Second Intervention||1
320823|NCT00680056|773867|P1|NOT COMPLETED|Second Intervention||3
320824|NCT00680056|773866|P2|COMPLETED|Second Intervention||14
320825|NCT00680056|773867|P1|COMPLETED|Second Intervention||12
320826|NCT00680056|773866|P2|STARTED|Second Intervention||15
320827|NCT00680056|773867|P1|STARTED|Second Intervention||15
320828|NCT00680056|773866|P2|NOT COMPLETED|Washout Period of One Week||0
320829|NCT00680056|773867|P1|NOT COMPLETED|Washout Period of One Week||0
320830|NCT00680056|773866|P2|COMPLETED|Washout Period of One Week||15
320831|NCT00680056|773867|P1|COMPLETED|Washout Period of One Week||15
320832|NCT00680056|773866|P2|STARTED|Washout Period of One Week||15
320833|NCT00680056|773867|P1|STARTED|Washout Period of One Week||15
320834|NCT00680056|773866|P2|NOT COMPLETED|First Intervention||2
320835|NCT00680056|773867|P1|NOT COMPLETED|First Intervention||1
320836|NCT00680056|773866|P2|COMPLETED|First Intervention||15
320837|NCT00680056|773867|P1|COMPLETED|First Intervention||15
320838|NCT00680056|773866|P2|STARTED|First Intervention||17
320839|NCT00680056|773867|P1|STARTED|First Intervention||16
320840|NCT00680043|773878|P3|NOT COMPLETED|Overall Study||4
320841|NCT00680043|773879|P2|NOT COMPLETED|Overall Study||1
320842|NCT00680043|773880|P1|NOT COMPLETED|Overall Study||2
320843|NCT00680043|773878|P3|COMPLETED|Overall Study||34
320844|NCT00680043|773879|P2|COMPLETED|Overall Study||36
320845|NCT00680043|773880|P1|COMPLETED|Overall Study||37
320846|NCT00680043|773878|P3|STARTED|Overall Study||38
320847|NCT00680043|773879|P2|STARTED|Overall Study||37
320848|NCT00680043|773880|P1|STARTED|Overall Study||39
320849|NCT00680017|773896|P2|NOT COMPLETED|Overall Study||12
320850|NCT00680017|773897|P1|NOT COMPLETED|Overall Study||17
320851|NCT00680017|773896|P2|COMPLETED|Overall Study||128
320852|NCT00680017|773897|P1|COMPLETED|Overall Study||123
320853|NCT00680017|773896|P2|STARTED|Overall Study||140
320854|NCT00680017|773897|P1|STARTED|Overall Study||140
320855|NCT00679952|773907|P2|NOT COMPLETED|Overall Study||0
320856|NCT00679952|773908|P1|NOT COMPLETED|Overall Study||0
320857|NCT00679952|773907|P2|COMPLETED|Overall Study||82
320858|NCT00679952|773908|P1|COMPLETED|Overall Study||86
320859|NCT00679952|773907|P2|STARTED|Overall Study||82
320860|NCT00679952|773908|P1|STARTED|Overall Study||86
320861|NCT00679939|773916|P2|NOT COMPLETED|24-Week Open-Label (OL) Period||4
320862|NCT00679939|773917|P1|NOT COMPLETED|24-Week Open-Label (OL) Period||7
320863|NCT00679939|773916|P2|COMPLETED|24-Week Open-Label (OL) Period||80
320864|NCT00679939|773917|P1|COMPLETED|24-Week Open-Label (OL) Period||69
320865|NCT00679939|773916|P2|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|84
320866|NCT00679939|773917|P1|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|76
320867|NCT00679939|773916|P2|NOT COMPLETED|52-Week Double-Blind (DB) Period||27
320868|NCT00679939|773917|P1|NOT COMPLETED|52-Week Double-Blind (DB) Period||37
320869|NCT00679939|773916|P2|COMPLETED|52-Week Double-Blind (DB) Period||85
320870|NCT00679939|773917|P1|COMPLETED|52-Week Double-Blind (DB) Period||77
320871|NCT00679939|773916|P2|STARTED|52-Week Double-Blind (DB) Period||112
320872|NCT00679939|773917|P1|STARTED|52-Week Double-Blind (DB) Period||114
320873|NCT00679913|774068|P2|NOT COMPLETED|Overall Study||13
320874|NCT00679913|774069|P1|NOT COMPLETED|Overall Study||18
320875|NCT00679913|774068|P2|COMPLETED|Overall Study||86
320876|NCT00679913|774069|P1|COMPLETED|Overall Study||83
320877|NCT00679913|774068|P2|STARTED|Overall Study||99
320878|NCT00679913|774069|P1|STARTED|Overall Study||101
320879|NCT00679783|774084|P7|NOT COMPLETED|Overall Study||1
320880|NCT00679783|774085|P6|NOT COMPLETED|Overall Study||0
320881|NCT00679783|774086|P5|NOT COMPLETED|Overall Study||1
320882|NCT00679783|774087|P4|NOT COMPLETED|Overall Study||20
320883|NCT00679783|774088|P3|NOT COMPLETED|Overall Study||1
320884|NCT00679783|774089|P2|NOT COMPLETED|Overall Study||3
320885|NCT00679783|774090|P1|NOT COMPLETED|Overall Study||2
320886|NCT00679783|774084|P7|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|15
320887|NCT00679783|774085|P6|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|5
320888|NCT00679783|774086|P5|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|4
320889|NCT00679783|774087|P4|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|25
320890|NCT00679783|774088|P3|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
320891|NCT00679783|774089|P2|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|10
320892|NCT00679783|774090|P1|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
320893|NCT00679783|774084|P7|STARTED|Overall Study|Gave Informed consent and passed screening|16
320894|NCT00679783|774085|P6|STARTED|Overall Study|Gave Informed consent and passed screening|5
320895|NCT00679783|774086|P5|STARTED|Overall Study|Gave Informed consent and passed screening|5
320896|NCT00679783|774087|P4|STARTED|Overall Study|Gave Informed consent and passed screening|45
320897|NCT00679783|774088|P3|STARTED|Overall Study|Gave Informed consent and passed screening|3
320898|NCT00679783|774089|P2|STARTED|Overall Study|Gave Informed consent and passed screening|13
320899|NCT00679783|774090|P1|STARTED|Overall Study|Gave Informed consent and passed screening|4
320900|NCT00679627|774143|P2|NOT COMPLETED|Overall Study||685
320901|NCT00679627|774144|P1|NOT COMPLETED|Overall Study||699
320902|NCT00679627|774143|P2|COMPLETED|Overall Study||339
320903|NCT00679627|774144|P1|COMPLETED|Overall Study||322
320904|NCT00679627|774143|P2|STARTED|Overall Study||1024
320905|NCT00679627|774144|P1|STARTED|Overall Study||1021
320906|NCT00679549|774168|P2|NOT COMPLETED|Overall Study||9
320907|NCT00679549|774169|P1|NOT COMPLETED|Overall Study||6
320908|NCT00679549|774168|P2|COMPLETED|Overall Study|4 dropouts in the control arm; 5 missing echocardiograms in the control arm|66
320909|NCT00679549|774169|P1|COMPLETED|Overall Study||69
320910|NCT00679549|774168|P2|STARTED|Overall Study||75
320911|NCT00679549|774169|P1|STARTED|Overall Study||75
320912|NCT00679432|774179|P4|NOT COMPLETED|Overall Study||32
320913|NCT00679432|774180|P3|NOT COMPLETED|Overall Study||53
320914|NCT00679432|774181|P2|NOT COMPLETED|Overall Study||38
320915|NCT00679432|774182|P1|NOT COMPLETED|Overall Study||37
320916|NCT00679432|774179|P4|COMPLETED|Overall Study||95
320917|NCT00679432|774180|P3|COMPLETED|Overall Study||76
320918|NCT00679432|774181|P2|COMPLETED|Overall Study||89
320919|NCT00679432|774182|P1|COMPLETED|Overall Study||89
320920|NCT00679432|774179|P4|STARTED|Overall Study||127
320921|NCT00679432|774180|P3|STARTED|Overall Study||129
320922|NCT00679432|774181|P2|STARTED|Overall Study||127
320923|NCT00679432|774182|P1|STARTED|Overall Study||126
320924|NCT00679380|774204|P4|NOT COMPLETED|Overall Study||28
320925|NCT00679380|774205|P3|NOT COMPLETED|Overall Study||35
320926|NCT00679380|774206|P2|NOT COMPLETED|Overall Study||33
320927|NCT00679380|774207|P1|NOT COMPLETED|Overall Study||42
320928|NCT00679380|774204|P4|COMPLETED|Overall Study||61
320929|NCT00679380|774205|P3|COMPLETED|Overall Study||68
320930|NCT00679380|774206|P2|COMPLETED|Overall Study||76
320931|NCT00679380|774207|P1|COMPLETED|Overall Study||67
320932|NCT00679380|774204|P4|STARTED|Overall Study||89
320933|NCT00679380|774205|P3|STARTED|Overall Study||103
320934|NCT00679380|774206|P2|STARTED|Overall Study||109
320935|NCT00679380|774207|P1|STARTED|Overall Study||109
320936|NCT00679367|774225|P1|NOT COMPLETED|Overall Study||12
320937|NCT00679367|774225|P1|COMPLETED|Overall Study||4
320938|NCT00679367|774225|P1|STARTED|Overall Study||16
320939|NCT00679354|774231|P1|NOT COMPLETED|Overall Study||30
320940|NCT00679354|774231|P1|COMPLETED|Overall Study||0
320941|NCT00679354|774231|P1|STARTED|Overall Study||30
320942|NCT00679341|774249|P2|NOT COMPLETED|Overall Study||51
320943|NCT00679341|774250|P1|NOT COMPLETED|Overall Study||53
320944|NCT00679341|774249|P2|COMPLETED|Overall Study||19
320945|NCT00679341|774250|P1|COMPLETED|Overall Study||14
320946|NCT00679341|774249|P2|STARTED|Overall Study||70
320947|NCT00679341|774250|P1|STARTED|Overall Study||67
320948|NCT00679302|774270|P2|NOT COMPLETED|Overall Study||4
320949|NCT00679302|774271|P1|NOT COMPLETED|Overall Study||8
320950|NCT00679302|774270|P2|COMPLETED|Overall Study||73
320951|NCT00679302|774271|P1|COMPLETED|Overall Study||76
320952|NCT00679302|774270|P2|STARTED|Overall Study||77
320953|NCT00679302|774271|P1|STARTED|Overall Study||84
320954|NCT00679289|774282|P3|NOT COMPLETED|Overall Study||23
320955|NCT00679289|774283|P2|NOT COMPLETED|Overall Study||6
320956|NCT00679289|774284|P1|NOT COMPLETED|Overall Study||5
320957|NCT00679289|774282|P3|COMPLETED|Overall Study||1
320958|NCT00679289|774283|P2|COMPLETED|Overall Study||0
320959|NCT00679289|774284|P1|COMPLETED|Overall Study||1
320960|NCT00679289|774282|P3|STARTED|Overall Study||24
320961|NCT00679289|774283|P2|STARTED|Overall Study||6
320962|NCT00679289|774284|P1|STARTED|Overall Study||6
320963|NCT00679263|774306|P3|NOT COMPLETED|Visit 2/Dose 1||0
320964|NCT00679263|774307|P2|NOT COMPLETED|Visit 2/Dose 1||1
320965|NCT00679263|774308|P1|NOT COMPLETED|Visit 2/Dose 1||2
320966|NCT00679263|774306|P3|COMPLETED|Visit 2/Dose 1||11
320967|NCT00679263|774307|P2|COMPLETED|Visit 2/Dose 1||5
320968|NCT00679263|774308|P1|COMPLETED|Visit 2/Dose 1||9
320969|NCT00679263|774306|P3|STARTED|Visit 2/Dose 1||11
320970|NCT00679263|774307|P2|STARTED|Visit 2/Dose 1||6
320971|NCT00679263|774308|P1|STARTED|Visit 2/Dose 1||11
320972|NCT00679263|774306|P3|NOT COMPLETED|Visit 3/Dose 2||0
320973|NCT00679263|774307|P2|NOT COMPLETED|Visit 3/Dose 2||5
320974|NCT00679263|774308|P1|NOT COMPLETED|Visit 3/Dose 2||1
320975|NCT00679263|774306|P3|COMPLETED|Visit 3/Dose 2||11
320976|NCT00679263|774307|P2|COMPLETED|Visit 3/Dose 2||6
320977|NCT00679263|774308|P1|COMPLETED|Visit 3/Dose 2||9
320978|NCT00679263|774306|P3|STARTED|Visit 3/Dose 2||11
320979|NCT00679263|774307|P2|STARTED|Visit 3/Dose 2||11
320980|NCT00679263|774308|P1|STARTED|Visit 3/Dose 2||10
320981|NCT00679211|774319|P1|NOT COMPLETED|Overall Study||110
320982|NCT00679211|774319|P1|COMPLETED|Overall Study||0
320983|NCT00679211|774319|P1|STARTED|Overall Study||110
320984|NCT00679172|774336|P5|NOT COMPLETED|Overall Study||0
320985|NCT00679172|774337|P4|NOT COMPLETED|Overall Study||1
320986|NCT00679172|774338|P3|NOT COMPLETED|Overall Study||1
320987|NCT00679172|774339|P2|NOT COMPLETED|Overall Study||1
320988|NCT00679172|774340|P1|NOT COMPLETED|Overall Study||1
320989|NCT00679172|774336|P5|COMPLETED|Overall Study||37
320990|NCT00679172|774337|P4|COMPLETED|Overall Study||38
320991|NCT00679172|774338|P3|COMPLETED|Overall Study||35
320992|NCT00679172|774339|P2|COMPLETED|Overall Study||37
320993|NCT00679172|774340|P1|COMPLETED|Overall Study||36
320994|NCT00679172|774336|P5|STARTED|Overall Study||37
320995|NCT00679172|774337|P4|STARTED|Overall Study||39
320996|NCT00679172|774338|P3|STARTED|Overall Study||36
320997|NCT00679172|774339|P2|STARTED|Overall Study||38
320998|NCT00679172|774340|P1|STARTED|Overall Study||37
320999|NCT00679081|774403|P1|NOT COMPLETED|Overall Study||1
321000|NCT00679081|774403|P1|COMPLETED|Overall Study||14
321001|NCT00679081|774403|P1|STARTED|Overall Study|Study design was within-subject control.|15
321002|NCT00679055|774413|P2|NOT COMPLETED|Overall Study||5
321003|NCT00679055|774414|P1|NOT COMPLETED|Overall Study||2
321004|NCT00679055|774413|P2|COMPLETED|Overall Study||1
321005|NCT00679055|774414|P1|COMPLETED|Overall Study||6
321006|NCT00679055|774413|P2|STARTED|Overall Study||6
321007|NCT00679055|774414|P1|STARTED|Overall Study||8
321008|NCT00679029|774424|P1|NOT COMPLETED|Overall Study||5
321009|NCT00679029|774424|P1|COMPLETED|Overall Study||10
321010|NCT00679029|774424|P1|STARTED|Overall Study||15
321011|NCT00678899|774431|P1|NOT COMPLETED|Overall Study||1
321012|NCT00678899|774431|P1|COMPLETED|Overall Study||49
321013|NCT00678899|774431|P1|STARTED|Overall Study||50
321014|NCT00678886|774440|P4|NOT COMPLETED|Overall Study||9
321015|NCT00678886|774441|P3|NOT COMPLETED|Overall Study||9
321016|NCT00678886|774442|P2|NOT COMPLETED|Overall Study||0
321017|NCT00678886|774443|P1|NOT COMPLETED|Overall Study||0
321018|NCT00678886|774440|P4|COMPLETED|Overall Study||153
321019|NCT00678886|774441|P3|COMPLETED|Overall Study||72
321020|NCT00678886|774442|P2|COMPLETED|Overall Study||19
321021|NCT00678886|774443|P1|COMPLETED|Overall Study||10
321022|NCT00678886|774440|P4|STARTED|Overall Study||162
321023|NCT00678886|774441|P3|STARTED|Overall Study||81
321024|NCT00678886|774442|P2|STARTED|Overall Study||19
321025|NCT00678886|774443|P1|STARTED|Overall Study||10
321026|NCT00678834|774490|P3|NOT COMPLETED|Overall Study||9
321027|NCT00678834|774491|P2|NOT COMPLETED|Overall Study||0
321028|NCT00678834|774492|P1|NOT COMPLETED|Overall Study||16
321029|NCT00678834|774490|P3|COMPLETED|Overall Study||16
321030|NCT00678834|774491|P2|COMPLETED|Overall Study||15
321031|NCT00678834|774492|P1|COMPLETED|Overall Study||24
321032|NCT00678834|774490|P3|STARTED|Overall Study||25
321033|NCT00678834|774491|P2|STARTED|Overall Study||15
321034|NCT00678834|774492|P1|STARTED|Overall Study||40
321035|NCT00678795|774512|P2|NOT COMPLETED|Overall Study||6
321036|NCT00678795|774513|P1|NOT COMPLETED|Overall Study||11
321037|NCT00678795|774512|P2|COMPLETED|Overall Study||62
321038|NCT00678795|774513|P1|COMPLETED|Overall Study||56
321039|NCT00678795|774512|P2|STARTED|Overall Study||68
321040|NCT00678795|774513|P1|STARTED|Overall Study||67
321041|NCT00678691|774535|P2|NOT COMPLETED|Overall Study||4
321042|NCT00678691|774536|P1|NOT COMPLETED|Overall Study||6
321043|NCT00678691|774535|P2|COMPLETED|Overall Study||24
321044|NCT00678691|774536|P1|COMPLETED|Overall Study||21
321045|NCT00678691|774535|P2|STARTED|Overall Study||28
321046|NCT00678691|774536|P1|STARTED|Overall Study||27
321047|NCT00678652|774546|P4|NOT COMPLETED|Overall Study||0
321048|NCT00678652|774547|P3|NOT COMPLETED|Overall Study||1
321049|NCT00678652|774548|P2|NOT COMPLETED|Overall Study||0
321050|NCT00678652|774549|P1|NOT COMPLETED|Overall Study||3
321051|NCT00678652|774546|P4|COMPLETED|Overall Study||9
321052|NCT00678652|774547|P3|COMPLETED|Overall Study||8
321053|NCT00678652|774548|P2|COMPLETED|Overall Study||9
321054|NCT00678652|774549|P1|COMPLETED|Overall Study||6
321055|NCT00678652|774546|P4|STARTED|Overall Study||9
321056|NCT00678652|774547|P3|STARTED|Overall Study||9
321057|NCT00678652|774548|P2|STARTED|Overall Study||9
321058|NCT00678652|774549|P1|STARTED|Overall Study||9
321059|NCT00678639|774573|P2|NOT COMPLETED|Overall Study||0
321060|NCT00678639|774574|P1|NOT COMPLETED|Overall Study||2
321061|NCT00678639|774573|P2|COMPLETED|Overall Study||57
321062|NCT00678639|774574|P1|COMPLETED|Overall Study||51
321063|NCT00678639|774573|P2|Hospital Discharge|Overall Study||57
321064|NCT00678639|774574|P1|Hospital Discharge|Overall Study||53
321065|NCT00678639|774573|P2|STARTED|Overall Study||57
321066|NCT00678639|774574|P1|STARTED|Overall Study||53
321067|NCT00678587|774589|P2|NOT COMPLETED|Overall Study||18
321068|NCT00678587|774590|P1|NOT COMPLETED|Overall Study||20
321069|NCT00678587|774589|P2|COMPLETED|Overall Study||127
321070|NCT00678587|774590|P1|COMPLETED|Overall Study||127
321071|NCT00678587|774589|P2|STARTED|Overall Study||145
321072|NCT00678587|774590|P1|STARTED|Overall Study||147
321073|NCT00678574|774624|P2|NOT COMPLETED|Overall Study||0
321074|NCT00678574|774625|P1|NOT COMPLETED|Overall Study||0
321075|NCT00678574|774624|P2|COMPLETED|Overall Study||27
321076|NCT00678574|774625|P1|COMPLETED|Overall Study||18
321077|NCT00678574|774624|P2|STARTED|Overall Study||27
321078|NCT00678574|774625|P1|STARTED|Overall Study||18
321079|NCT00678535|774633|P2|NOT COMPLETED|Overall Study||98
321080|NCT00678535|774634|P1|NOT COMPLETED|Overall Study||93
321081|NCT00678535|774633|P2|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|351
321082|NCT00678535|774634|P1|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|362
321083|NCT00678535|774633|P2|STARTED|Overall Study|ITT population|449
321084|NCT00678535|774634|P1|STARTED|Overall Study|ITT population|455
321085|NCT00678470|774650|P1|NOT COMPLETED|Overall Study||4
321086|NCT00678470|774650|P1|COMPLETED|Overall Study||14
321087|NCT00678470|774650|P1|STARTED|Overall Study||18
321088|NCT00678444|774656|P2|NOT COMPLETED|Overall Study||0
321089|NCT00678444|774657|P1|NOT COMPLETED|Overall Study||0
321090|NCT00678444|774656|P2|COMPLETED|Overall Study||99
321091|NCT00678444|774657|P1|COMPLETED|Overall Study||100
321092|NCT00678444|774656|P2|STARTED|Overall Study||99
321093|NCT00678444|774657|P1|STARTED|Overall Study||100
321094|NCT00678418|774667|P2|NOT COMPLETED|Part B (Open Label)||0
321095|NCT00678418|774668|P1|NOT COMPLETED|Part B (Open Label)||43
321096|NCT00678418|774667|P2|COMPLETED|Part B (Open Label)||0
321097|NCT00678418|774668|P1|COMPLETED|Part B (Open Label)||71
321098|NCT00678418|774667|P2|STARTED|Part B (Open Label)||0
321099|NCT00678418|774668|P1|STARTED|Part B (Open Label)|All participants who received placebo in Part A were switched to open-label VIVITROL in Part B.|114
321100|NCT00678418|774667|P2|NOT COMPLETED|Part A (Double Blind)||77
321101|NCT00678418|774668|P1|NOT COMPLETED|Part A (Double Blind)||59
321102|NCT00678418|774667|P2|COMPLETED|Part A (Double Blind)||47
321103|NCT00678418|774668|P1|COMPLETED|Part A (Double Blind)||67
321104|NCT00678418|774667|P2|STARTED|Part A (Double Blind)||124
321105|NCT00678418|774668|P1|STARTED|Part A (Double Blind)||126
321106|NCT00678392|774684|P2|NOT COMPLETED|Overall Study||362
321107|NCT00678392|774685|P1|NOT COMPLETED|Overall Study||361
321108|NCT00678392|774684|P2|COMPLETED|Overall Study||0
321109|NCT00678392|774685|P1|COMPLETED|Overall Study||0
321110|NCT00678392|774684|P2|Treated|Overall Study||355
321111|NCT00678392|774685|P1|Treated|Overall Study||359
321112|NCT00678392|774684|P2|STARTED|Overall Study||362
321113|NCT00678392|774685|P1|STARTED|Overall Study||361
321114|NCT00678379|774720|P3|NOT COMPLETED|Overall Study||4
321115|NCT00678379|774721|P2|NOT COMPLETED|Overall Study||3
321116|NCT00678379|774722|P1|NOT COMPLETED|Overall Study||6
321117|NCT00678379|774720|P3|COMPLETED|Overall Study||36
321118|NCT00678379|774721|P2|COMPLETED|Overall Study||37
321119|NCT00678379|774722|P1|COMPLETED|Overall Study||34
321120|NCT00678379|774720|P3|STARTED|Overall Study||40
321121|NCT00678379|774721|P2|STARTED|Overall Study||40
321122|NCT00678379|774722|P1|STARTED|Overall Study||40
321123|NCT00678301|774750|P2|NOT COMPLETED|Overall Study||2
321124|NCT00678301|774751|P1|NOT COMPLETED|Overall Study||8
321125|NCT00678301|774750|P2|COMPLETED|Overall Study||116
321126|NCT00678301|774751|P1|COMPLETED|Overall Study||231
321127|NCT00678301|774750|P2|STARTED|Overall Study||118
321128|NCT00678301|774751|P1|STARTED|Overall Study||239
321129|NCT00678288|774809|P2|NOT COMPLETED|Overall Study||6
321130|NCT00678288|774810|P1|NOT COMPLETED|Overall Study||10
321131|NCT00678288|774809|P2|COMPLETED|Overall Study||0
321132|NCT00678288|774810|P1|COMPLETED|Overall Study||0
321133|NCT00678288|774809|P2|STARTED|Overall Study||6
321134|NCT00678288|774810|P1|STARTED|Overall Study||10
321135|NCT00678249|774827|P3|NOT COMPLETED|Overall Study||0
321136|NCT00678249|774828|P2|NOT COMPLETED|Overall Study||0
321137|NCT00678249|774829|P1|NOT COMPLETED|Overall Study||0
321138|NCT00678249|774827|P3|COMPLETED|Overall Study||37
321139|NCT00678249|774828|P2|COMPLETED|Overall Study||93
321140|NCT00678249|774829|P1|COMPLETED|Overall Study||97
321141|NCT00678249|774827|P3|STARTED|Overall Study||37
321142|NCT00678249|774828|P2|STARTED|Overall Study||93
321143|NCT00678249|774829|P1|STARTED|Overall Study||97
321144|NCT00678210|774865|P4|NOT COMPLETED|Overall Study||20
321145|NCT00678210|774866|P3|NOT COMPLETED|Overall Study||6
321146|NCT00678210|774867|P2|NOT COMPLETED|Overall Study||11
321147|NCT00678210|774868|P1|NOT COMPLETED|Overall Study||11
321148|NCT00678210|774865|P4|COMPLETED|Overall Study||30
321149|NCT00678210|774866|P3|COMPLETED|Overall Study||43
321150|NCT00678210|774867|P2|COMPLETED|Overall Study||38
321151|NCT00678210|774868|P1|COMPLETED|Overall Study||38
321152|NCT00678210|774865|P4|STARTED|Overall Study||50
321153|NCT00678210|774866|P3|STARTED|Overall Study||49
321154|NCT00678210|774867|P2|STARTED|Overall Study||49
321155|NCT00678210|774868|P1|STARTED|Overall Study||49
321156|NCT00678080|774904|P2|NOT COMPLETED|Overall Study||1
321157|NCT00678080|774905|P1|NOT COMPLETED|Overall Study||3
321158|NCT00678080|774904|P2|COMPLETED|Overall Study||13
321159|NCT00678080|774905|P1|COMPLETED|Overall Study||8
321160|NCT00678080|774904|P2|STARTED|Overall Study||14
321161|NCT00678080|774905|P1|STARTED|Overall Study||11
321162|NCT00678041|774931|P2|NOT COMPLETED|Overall Study||5
321163|NCT00678041|774932|P1|NOT COMPLETED|Overall Study||5
321164|NCT00678041|774931|P2|COMPLETED|Overall Study||0
321165|NCT00678041|774932|P1|COMPLETED|Overall Study||0
321166|NCT00678041|774931|P2|STARTED|Overall Study||5
321167|NCT00678041|774932|P1|STARTED|Overall Study||5
321168|NCT00678015|774944|P1|NOT COMPLETED|Overall Study||0
321169|NCT00678015|774944|P1|COMPLETED|Overall Study||12
321170|NCT00678015|774944|P1|STARTED|Overall Study||12
321171|NCT00677924|774953|P2|NOT COMPLETED|Overall Study||0
321172|NCT00677924|774954|P1|NOT COMPLETED|Overall Study||0
321173|NCT00677924|774953|P2|COMPLETED|Overall Study||6
321174|NCT00677924|774954|P1|COMPLETED|Overall Study||3
321175|NCT00677924|774953|P2|STARTED|Overall Study||6
321176|NCT00677924|774954|P1|STARTED|Overall Study||3
321177|NCT00677898|774964|P2|NOT COMPLETED|Overall Study||18
321178|NCT00677898|774965|P1|NOT COMPLETED|Overall Study||20
321179|NCT00677898|774964|P2|COMPLETED|Overall Study||102
321180|NCT00677898|774965|P1|COMPLETED|Overall Study||99
321181|NCT00677898|774964|P2|STARTED|Overall Study||120
321182|NCT00677898|774965|P1|STARTED|Overall Study||119
321183|NCT00677833|774985|P4|NOT COMPLETED|Overall Study||3
321184|NCT00677833|774986|P3|NOT COMPLETED|Overall Study||2
321185|NCT00677833|774987|P2|NOT COMPLETED|Overall Study||0
321186|NCT00677833|774988|P1|NOT COMPLETED|Overall Study||4
321187|NCT00677833|774985|P4|COMPLETED|Overall Study||128
321188|NCT00677833|774986|P3|COMPLETED|Overall Study||122
321189|NCT00677833|774987|P2|COMPLETED|Overall Study||51
321190|NCT00677833|774988|P1|COMPLETED|Overall Study||51
321191|NCT00677833|774985|P4|STARTED|Overall Study||131
321192|NCT00677833|774986|P3|STARTED|Overall Study||124
321193|NCT00677833|774987|P2|STARTED|Overall Study||51
321194|NCT00677833|774988|P1|STARTED|Overall Study||55
321195|NCT00677820|775038|P2|NOT COMPLETED|Overall Study||0
321196|NCT00677820|775039|P1|NOT COMPLETED|Overall Study||1
321197|NCT00677820|775038|P2|COMPLETED|Overall Study||60
321198|NCT00677820|775039|P1|COMPLETED|Overall Study||239
321199|NCT00677820|775038|P2|STARTED|Overall Study||60
321200|NCT00677820|775039|P1|STARTED|Overall Study||240
321201|NCT00677807|775060|P3|NOT COMPLETED|Overall Study||20
321202|NCT00677807|775061|P2|NOT COMPLETED|Overall Study||11
321203|NCT00677807|775062|P1|NOT COMPLETED|Overall Study||18
321204|NCT00677807|775060|P3|COMPLETED|Overall Study||105
321205|NCT00677807|775061|P2|COMPLETED|Overall Study||135
321206|NCT00677807|775062|P1|COMPLETED|Overall Study||126
321207|NCT00677807|775060|P3|Safety/ITT: Received Study Drug|Overall Study|One patient did not take study medication.|124
321208|NCT00677807|775061|P2|Safety/ITT: Received Study Drug|Overall Study||146
321209|NCT00677807|775062|P1|Safety/ITT: Received Study Drug|Overall Study||144
321210|NCT00677807|775060|P3|STARTED|Overall Study||125
321211|NCT00677807|775061|P2|STARTED|Overall Study||146
321212|NCT00677807|775062|P1|STARTED|Overall Study||144
321213|NCT00677690|775093|P2|NOT COMPLETED|Overall Study||0
321214|NCT00677690|775094|P1|NOT COMPLETED|Overall Study||0
321215|NCT00677690|775093|P2|COMPLETED|Overall Study||41
321216|NCT00677690|775094|P1|COMPLETED|Overall Study||42
321217|NCT00677690|775093|P2|STARTED|Overall Study||41
321218|NCT00677690|775094|P1|STARTED|Overall Study||42
321219|NCT00677534|775108|P1|NOT COMPLETED|After Paricalcitol Restart (Weeks 13-14)||0
321220|NCT00677534|775108|P1|COMPLETED|After Paricalcitol Restart (Weeks 13-14)||7
321221|NCT00677534|775108|P1|STARTED|After Paricalcitol Restart (Weeks 13-14)||7
321222|NCT00677534|775108|P1|NOT COMPLETED|Cholecalciferol (Weeks 5-12)||0
321223|NCT00677534|775108|P1|COMPLETED|Cholecalciferol (Weeks 5-12)||7
321224|NCT00677534|775108|P1|STARTED|Cholecalciferol (Weeks 5-12)||7
321225|NCT00677534|775108|P1|NOT COMPLETED|Washout (Weeks 1-4)||3
321226|NCT00677534|775108|P1|COMPLETED|Washout (Weeks 1-4)||7
321227|NCT00677534|775108|P1|STARTED|Washout (Weeks 1-4)||10
321228|NCT00677365|775116|P4|NOT COMPLETED|Overall Study||3
321229|NCT00677365|775117|P3|NOT COMPLETED|Overall Study||2
321230|NCT00677365|775118|P2|NOT COMPLETED|Overall Study||1
321231|NCT00677365|775119|P1|NOT COMPLETED|Overall Study||2
321232|NCT00677365|775116|P4|COMPLETED|Overall Study||36
321233|NCT00677365|775117|P3|COMPLETED|Overall Study||35
321234|NCT00677365|775118|P2|COMPLETED|Overall Study||37
321235|NCT00677365|775119|P1|COMPLETED|Overall Study||35
321236|NCT00677365|775116|P4|STARTED|Overall Study||39
321237|NCT00677365|775117|P3|STARTED|Overall Study||37
321238|NCT00677365|775118|P2|STARTED|Overall Study||38
321239|NCT00677365|775119|P1|STARTED|Overall Study||37
321240|NCT00677352|775151|P2|NOT COMPLETED|Tapering Phase||10
321241|NCT00677352|775152|P1|NOT COMPLETED|Tapering Phase||6
321242|NCT00677352|775151|P2|COMPLETED|Tapering Phase||112
321243|NCT00677352|775152|P1|COMPLETED|Tapering Phase||126
321244|NCT00677352|775151|P2|STARTED|Tapering Phase||122
321245|NCT00677352|775152|P1|STARTED|Tapering Phase||132
321246|NCT00677352|775151|P2|NOT COMPLETED|Treatment Phase||42
321247|NCT00677352|775152|P1|NOT COMPLETED|Treatment Phase||25
321248|NCT00677352|775151|P2|COMPLETED|Treatment Phase||122
321249|NCT00677352|775152|P1|COMPLETED|Treatment Phase||132
321250|NCT00677352|775151|P2|STARTED|Treatment Phase|2 subjects were not teated, therefore 162 subjects were treated with paroxetine.|164
321251|NCT00677352|775152|P1|STARTED|Treatment Phase|All 157 subjects were treated with Sertraline.|157
321252|NCT00677235|775172|P2|NOT COMPLETED|Overall Study||38
321253|NCT00677235|775173|P1|NOT COMPLETED|Overall Study||41
321254|NCT00677235|775172|P2|COMPLETED|Overall Study||94
321255|NCT00677235|775173|P1|COMPLETED|Overall Study||97
321256|NCT00677235|775172|P2|STARTED|Overall Study||132
321257|NCT00677235|775173|P1|STARTED|Overall Study||138
321258|NCT00677092|775213|P1|NOT COMPLETED|Overall Study||6
321259|NCT00677092|775213|P1|COMPLETED|Overall Study||6
321260|NCT00677092|775213|P1|Received Study Treatment|Overall Study||11
321261|NCT00677092|775213|P1|STARTED|Overall Study||12
321262|NCT00677040|775222|P1|NOT COMPLETED|Overall Study||0
321263|NCT00677040|775222|P1|COMPLETED|Overall Study||20
321264|NCT00677040|775222|P1|STARTED|Overall Study||20
321265|NCT00677014|775230|P3|NOT COMPLETED|Overall Study||49
321266|NCT00677014|775231|P2|NOT COMPLETED|Overall Study||41
321267|NCT00677014|775232|P1|NOT COMPLETED|Overall Study||44
321268|NCT00677014|775230|P3|COMPLETED|Overall Study||283
321269|NCT00677014|775231|P2|COMPLETED|Overall Study||282
321270|NCT00677014|775232|P1|COMPLETED|Overall Study||281
321271|NCT00677014|775230|P3|STARTED|Overall Study||332
321272|NCT00677014|775231|P2|STARTED|Overall Study||323
321273|NCT00677014|775232|P1|STARTED|Overall Study||325
321274|NCT00676897|775242|P2|NOT COMPLETED|Overall Study||0
321275|NCT00676897|775243|P1|NOT COMPLETED|Overall Study||0
321276|NCT00676897|775242|P2|COMPLETED|Overall Study||10
321277|NCT00676897|775243|P1|COMPLETED|Overall Study||8
321278|NCT00676897|775242|P2|STARTED|Overall Study||10
321279|NCT00676897|775243|P1|STARTED|Overall Study||8
321280|NCT00676806|775253|P2|NOT COMPLETED|Overall Study||0
321281|NCT00676806|775254|P1|NOT COMPLETED|Overall Study||0
321282|NCT00676806|775253|P2|COMPLETED|Overall Study||3
321283|NCT00676806|775254|P1|COMPLETED|Overall Study||3
321284|NCT00676806|775253|P2|STARTED|Overall Study||3
321285|NCT00676806|775254|P1|STARTED|Overall Study||3
321286|NCT00676793|775270|P1|NOT COMPLETED|Overall Study||13
321287|NCT00676793|775270|P1|COMPLETED|Overall Study||19
321288|NCT00676793|775270|P1|STARTED|Overall Study||32
321289|NCT00676780|775275|P1|NOT COMPLETED|Overall Study||7
321290|NCT00676780|775275|P1|COMPLETED|Overall Study||26
321291|NCT00676780|775275|P1|STARTED|Overall Study||33
321292|NCT00676715|775285|P4|NOT COMPLETED|Overall Study||40
321293|NCT00676715|775286|P3|NOT COMPLETED|Overall Study||41
321294|NCT00676715|775287|P2|NOT COMPLETED|Overall Study||47
321295|NCT00676715|775288|P1|NOT COMPLETED|Overall Study||40
321296|NCT00676715|775285|P4|COMPLETED|Overall Study||14
321297|NCT00676715|775286|P3|COMPLETED|Overall Study||14
321298|NCT00676715|775287|P2|COMPLETED|Overall Study||8
321299|NCT00676715|775288|P1|COMPLETED|Overall Study||14
321300|NCT00676715|775285|P4|STARTED|Overall Study||54
321301|NCT00676715|775286|P3|STARTED|Overall Study||55
321302|NCT00676715|775287|P2|STARTED|Overall Study||55
321303|NCT00676715|775288|P1|STARTED|Overall Study||54
321304|NCT00676689|775318|P1|NOT COMPLETED|Overall Study||61
321305|NCT00676689|775318|P1|COMPLETED|Overall Study||20
321306|NCT00676689|775318|P1|1 Year Follow-up|Overall Study||64
321307|NCT00676689|775318|P1|30 Day Follow-up|Overall Study||78
321308|NCT00676689|775318|P1|Procedure|Overall Study|Two enrolled patients did not meet eligibility criteria and did not undergo the study procedure.|79
321309|NCT00676689|775318|P1|STARTED|Overall Study||81
321310|NCT00676676|775324|P1|NOT COMPLETED|Overall Study||0
321311|NCT00676676|775324|P1|COMPLETED|Overall Study||9
321312|NCT00676676|775324|P1|STARTED|Overall Study||9
321313|NCT00676663|775330|P2|NOT COMPLETED|Overall Study||38
321314|NCT00676663|775331|P1|NOT COMPLETED|Overall Study||45
321315|NCT00676663|775330|P2|COMPLETED|Overall Study||26
321316|NCT00676663|775331|P1|COMPLETED|Overall Study||21
321317|NCT00676663|775330|P2|STARTED|Overall Study||64
321318|NCT00676663|775331|P1|STARTED|Overall Study||66
321319|NCT00676650|775347|P2|NOT COMPLETED|Overall Study||289
321320|NCT00676650|775348|P1|NOT COMPLETED|Overall Study||584
321321|NCT00676650|775347|P2|COMPLETED|Overall Study||0
321322|NCT00676650|775348|P1|COMPLETED|Overall Study||0
321323|NCT00676650|775347|P2|Treated|Overall Study||285
321324|NCT00676650|775348|P1|Treated|Overall Study||581
321325|NCT00676650|775347|P2|STARTED|Overall Study||289
321326|NCT00676650|775348|P1|STARTED|Overall Study||584
321327|NCT00676585|775368|P2|NOT COMPLETED|Overall Study||0
321328|NCT00676585|775369|P1|NOT COMPLETED|Overall Study||0
321329|NCT00676585|775368|P2|COMPLETED|Overall Study||25
321330|NCT00676585|775369|P1|COMPLETED|Overall Study||25
321331|NCT00676585|775368|P2|STARTED|Overall Study||25
321332|NCT00676585|775369|P1|STARTED|Overall Study||25
321333|NCT00676572|775381|P2|NOT COMPLETED|Overall Study||0
321334|NCT00676572|775382|P1|NOT COMPLETED|Overall Study||0
321335|NCT00676572|775381|P2|COMPLETED|Overall Study||6
321336|NCT00676572|775382|P1|COMPLETED|Overall Study||6
321337|NCT00676572|775381|P2|STARTED|Overall Study||6
321338|NCT00676572|775382|P1|STARTED|Overall Study||6
321339|NCT00676520|775390|P1|NOT COMPLETED|Overall Study||731
321340|NCT00676520|775390|P1|COMPLETED|Overall Study||7309
321341|NCT00676520|775390|P1|STARTED|Overall Study||8040
321342|NCT00676494|775447|P1|NOT COMPLETED|Overall Study||14
321343|NCT00676494|775447|P1|COMPLETED|Overall Study||158
321344|NCT00676494|775447|P1|STARTED|Overall Study||172
321345|NCT00676455|775453|P1|NOT COMPLETED|Overall Study||0
321346|NCT00676455|775453|P1|COMPLETED|Overall Study||14
321347|NCT00676455|775453|P1|STARTED|Overall Study||14
321348|NCT00676403|775464|P6|NOT COMPLETED|Overall Study||5
321349|NCT00676403|775465|P5|NOT COMPLETED|Overall Study||1
321350|NCT00676403|775466|P4|NOT COMPLETED|Overall Study||5
321351|NCT00676403|775467|P3|NOT COMPLETED|Overall Study||1
321352|NCT00676403|775468|P2|NOT COMPLETED|Overall Study||2
321353|NCT00676403|775469|P1|NOT COMPLETED|Overall Study||2
321354|NCT00676403|775464|P6|COMPLETED|Overall Study||18
321355|NCT00676403|775465|P5|COMPLETED|Overall Study||23
321356|NCT00676403|775466|P4|COMPLETED|Overall Study||17
321357|NCT00676403|775467|P3|COMPLETED|Overall Study||22
321358|NCT00676403|775468|P2|COMPLETED|Overall Study||20
321359|NCT00676403|775469|P1|COMPLETED|Overall Study||21
321360|NCT00676403|775464|P6|STARTED|Overall Study||23
321361|NCT00676403|775465|P5|STARTED|Overall Study||24
321362|NCT00676403|775466|P4|STARTED|Overall Study||22
321363|NCT00676403|775467|P3|STARTED|Overall Study||23
321364|NCT00676403|775468|P2|STARTED|Overall Study||22
321365|NCT00676403|775469|P1|STARTED|Overall Study||23
321366|NCT00676364|775599|P2|NOT COMPLETED|Overall Study||0
321367|NCT00676364|775600|P1|NOT COMPLETED|Overall Study||0
321368|NCT00676364|775599|P2|COMPLETED|Overall Study||57
321369|NCT00676364|775600|P1|COMPLETED|Overall Study||57
321370|NCT00676364|775599|P2|STARTED|Overall Study||57
321371|NCT00676364|775600|P1|STARTED|Overall Study||57
321372|NCT00676338|775612|P4|NOT COMPLETED|Overall Study||23
321373|NCT00676338|775613|P3|NOT COMPLETED|Overall Study||30
321374|NCT00676338|775614|P2|NOT COMPLETED|Overall Study||33
321375|NCT00676338|775615|P1|NOT COMPLETED|Overall Study||38
321376|NCT00676338|775612|P4|COMPLETED|Overall Study||140
321377|NCT00676338|775613|P3|COMPLETED|Overall Study||133
321378|NCT00676338|775614|P2|COMPLETED|Overall Study||213
321379|NCT00676338|775615|P1|COMPLETED|Overall Study||210
321380|NCT00676338|775612|P4|STARTED|Overall Study||163
321381|NCT00676338|775613|P3|STARTED|Overall Study||163
321382|NCT00676338|775614|P2|STARTED|Overall Study||246
321383|NCT00676338|775615|P1|STARTED|Overall Study||248
321384|NCT00676208|775667|P2|NOT COMPLETED|Overall Study||6
321385|NCT00676208|775668|P1|NOT COMPLETED|Overall Study||2
321386|NCT00676208|775667|P2|COMPLETED|Overall Study||13
321387|NCT00676208|775668|P1|COMPLETED|Overall Study||12
321388|NCT00676208|775667|P2|STARTED|Overall Study||19
321389|NCT00676208|775668|P1|STARTED|Overall Study||14
321390|NCT00676195|775676|P1|NOT COMPLETED|Overall Study||3
321391|NCT00676195|775676|P1|COMPLETED|Overall Study||21
321392|NCT00676195|775676|P1|STARTED|Overall Study||24
321393|NCT00676182|775686|P1|NOT COMPLETED|Overall Study||0
321394|NCT00676182|775686|P1|COMPLETED|Overall Study||75
321395|NCT00676182|775686|P1|STARTED|Overall Study||75
321396|NCT00676143|775701|P2|NOT COMPLETED|Overall Study||260
321397|NCT00676143|775702|P1|NOT COMPLETED|Overall Study||156
321398|NCT00676143|775701|P2|COMPLETED|Overall Study||398
321399|NCT00676143|775702|P1|COMPLETED|Overall Study||285
321400|NCT00676143|775701|P2|Treated|Overall Study||654
321401|NCT00676143|775702|P1|Treated|Overall Study||439
321402|NCT00676143|775701|P2|STARTED|Overall Study||658
321403|NCT00676143|775702|P1|STARTED|Overall Study||441
321404|NCT00676130|775742|P2|NOT COMPLETED|Overall Study||4
321405|NCT00676130|775743|P1|NOT COMPLETED|Overall Study||3
321406|NCT00676130|775742|P2|COMPLETED|Overall Study||73
321407|NCT00676130|775743|P1|COMPLETED|Overall Study||73
321408|NCT00676130|775742|P2|STARTED|Overall Study||77
321409|NCT00676130|775743|P1|STARTED|Overall Study||76
321410|NCT00676091|775753|P2|NOT COMPLETED|Toddler Dose||0
321411|NCT00676091|775754|P1|NOT COMPLETED|Toddler Dose||3
321412|NCT00676091|775753|P2|COMPLETED|Toddler Dose||156
321413|NCT00676091|775754|P1|COMPLETED|Toddler Dose||153
321414|NCT00676091|775753|P2|STARTED|Toddler Dose||156
321415|NCT00676091|775754|P1|STARTED|Toddler Dose||156
321416|NCT00676091|775753|P2|NOT COMPLETED|After Infant Series||3
321417|NCT00676091|775754|P1|NOT COMPLETED|After Infant Series||1
321418|NCT00676091|775753|P2|COMPLETED|After Infant Series||156
321419|NCT00676091|775754|P1|COMPLETED|After Infant Series||156
321420|NCT00676091|775753|P2|STARTED|After Infant Series||159
321421|NCT00676091|775754|P1|STARTED|After Infant Series||157
321422|NCT00676091|775753|P2|NOT COMPLETED|Infant Series||18
321423|NCT00676091|775754|P1|NOT COMPLETED|Infant Series||20
321424|NCT00676091|775753|P2|COMPLETED|Infant Series||159
321425|NCT00676091|775754|P1|COMPLETED|Infant Series||157
321426|NCT00676091|775753|P2|Vaccinated Dose 3|Infant Series||161
321427|NCT00676091|775754|P1|Vaccinated Dose 3|Infant Series||158
321428|NCT00676091|775753|P2|Vaccinated Dose 2|Infant Series||162
321429|NCT00676091|775754|P1|Vaccinated Dose 2|Infant Series||159
321430|NCT00676091|775753|P2|Vaccinated Dose 1|Infant Series||162
321431|NCT00676091|775754|P1|Vaccinated Dose 1|Infant Series||163
321432|NCT00676091|775753|P2|STARTED|Infant Series||177
321433|NCT00676091|775754|P1|STARTED|Infant Series||177
321434|NCT00676065|775789|P3|NOT COMPLETED|Overall Study||0
321435|NCT00676065|775790|P2|NOT COMPLETED|Overall Study||0
321436|NCT00676065|775791|P1|NOT COMPLETED|Overall Study||0
321437|NCT00676065|775789|P3|COMPLETED|Overall Study||26341
321438|NCT00676065|775790|P2|COMPLETED|Overall Study||15428
321439|NCT00676065|775791|P1|COMPLETED|Overall Study||16534
321440|NCT00676065|775789|P3|STARTED|Overall Study||26341
321441|NCT00676065|775790|P2|STARTED|Overall Study||15428
321442|NCT00676065|775791|P1|STARTED|Overall Study||16534
321443|NCT00676052|775811|P6|NOT COMPLETED|Overall Study||6
321444|NCT00676052|775812|P5|NOT COMPLETED|Overall Study||6
321445|NCT00676052|775813|P4|NOT COMPLETED|Overall Study||5
321446|NCT00676052|775814|P3|NOT COMPLETED|Overall Study||6
321447|NCT00676052|775815|P2|NOT COMPLETED|Overall Study||7
321448|NCT00676052|775816|P1|NOT COMPLETED|Overall Study||9
321449|NCT00676052|775811|P6|COMPLETED|Overall Study||91
321450|NCT00676052|775812|P5|COMPLETED|Overall Study||89
321451|NCT00676052|775813|P4|COMPLETED|Overall Study||92
321452|NCT00676052|775814|P3|COMPLETED|Overall Study||90
321453|NCT00676052|775815|P2|COMPLETED|Overall Study||88
321454|NCT00676052|775816|P1|COMPLETED|Overall Study||87
321455|NCT00676052|775811|P6|STARTED|Overall Study||97
321456|NCT00676052|775812|P5|STARTED|Overall Study||95
321457|NCT00676052|775813|P4|STARTED|Overall Study||97
321458|NCT00676052|775814|P3|STARTED|Overall Study||96
321459|NCT00676052|775815|P2|STARTED|Overall Study||95
321460|NCT00676052|775816|P1|STARTED|Overall Study||96
321461|NCT00676026|775848|P1|NOT COMPLETED|Overall Study||0
321462|NCT00676026|775848|P1|COMPLETED|Overall Study||8
321463|NCT00676026|775848|P1|STARTED|Overall Study||8
321464|NCT00675987|775854|P2|NOT COMPLETED|Overall Study||0
321465|NCT00675987|775855|P1|NOT COMPLETED|Overall Study||0
321466|NCT00675987|775854|P2|COMPLETED|Overall Study||27
321467|NCT00675987|775855|P1|COMPLETED|Overall Study||26
321468|NCT00675987|775854|P2|STARTED|Overall Study||27
321469|NCT00675987|775855|P1|STARTED|Overall Study||26
321470|NCT00675948|775879|P2|NOT COMPLETED|Overall Study||3
321471|NCT00675948|775880|P1|NOT COMPLETED|Overall Study||39
321472|NCT00675948|775879|P2|COMPLETED|Overall Study||1
321473|NCT00675948|775880|P1|COMPLETED|Overall Study||0
321474|NCT00675948|775879|P2|STARTED|Overall Study||4
321475|NCT00675948|775880|P1|STARTED|Overall Study||39
321476|NCT00675922|775890|P1|NOT COMPLETED|Overall Study||0
321477|NCT00675922|775890|P1|COMPLETED|Overall Study||98
321478|NCT00675922|775890|P1|STARTED|Overall Study||98
321479|NCT00675909|775898|P3|NOT COMPLETED|Overall Study||0
321480|NCT00675909|775899|P2|NOT COMPLETED|Overall Study||0
321481|NCT00675909|775900|P1|NOT COMPLETED|Overall Study||0
321482|NCT00675909|775898|P3|COMPLETED|Overall Study||60
321483|NCT00675909|775899|P2|COMPLETED|Overall Study||60
321484|NCT00675909|775900|P1|COMPLETED|Overall Study||60
321485|NCT00675909|775898|P3|STARTED|Overall Study||60
321486|NCT00675909|775899|P2|STARTED|Overall Study||60
321487|NCT00675909|775900|P1|STARTED|Overall Study||60
321488|NCT00675792|775922|P2|NOT COMPLETED|Overall Study||0
321489|NCT00675792|775923|P1|NOT COMPLETED|Overall Study||0
321490|NCT00675792|775922|P2|COMPLETED|Overall Study||49
321491|NCT00675792|775923|P1|COMPLETED|Overall Study||51
321492|NCT00675792|775922|P2|STARTED|Overall Study||49
321493|NCT00675792|775923|P1|STARTED|Overall Study||51
321494|NCT00675766|775943|P4|NOT COMPLETED|Overall Study||26
321495|NCT00675766|775944|P3|NOT COMPLETED|Overall Study||21
321496|NCT00675766|775945|P2|NOT COMPLETED|Overall Study||5
321497|NCT00675766|775946|P1|NOT COMPLETED|Overall Study||6
321498|NCT00675766|775943|P4|COMPLETED|Overall Study||11
321499|NCT00675766|775944|P3|COMPLETED|Overall Study||29
321500|NCT00675766|775945|P2|COMPLETED|Overall Study||25
321501|NCT00675766|775946|P1|COMPLETED|Overall Study||100
321502|NCT00675766|775943|P4|Year 3|Overall Study||11
321503|NCT00675766|775944|P3|Year 3|Overall Study||29
321504|NCT00675766|775945|P2|Year 3|Overall Study||25
321505|NCT00675766|775946|P1|Year 3|Overall Study||100
321506|NCT00675766|775943|P4|Year 2|Overall Study||20
321507|NCT00675766|775944|P3|Year 2|Overall Study||34
321508|NCT00675766|775945|P2|Year 2|Overall Study||28
321509|NCT00675766|775946|P1|Year 2|Overall Study||105
321510|NCT00675766|775943|P4|STARTED|Overall Study||37
321511|NCT00675766|775944|P3|STARTED|Overall Study||50
321512|NCT00675766|775945|P2|STARTED|Overall Study||30
321513|NCT00675766|775946|P1|STARTED|Overall Study||106
321514|NCT00675597|775956|P1|NOT COMPLETED|Overall Study||3
321515|NCT00675597|775956|P1|COMPLETED|Overall Study||23
321516|NCT00675597|775956|P1|STARTED|Overall Study||26
321517|NCT00675584|775962|P2|NOT COMPLETED|Overall Study||26
321518|NCT00675584|775963|P1|NOT COMPLETED|Overall Study||39
321519|NCT00675584|775962|P2|COMPLETED|Overall Study||113
321520|NCT00675584|775963|P1|COMPLETED|Overall Study||100
321521|NCT00675584|775962|P2|STARTED|Overall Study||139
321522|NCT00675584|775963|P1|STARTED|Overall Study||139
321523|NCT00675558|775992|P3|NOT COMPLETED|Second Operation||0
321524|NCT00675558|775993|P2|NOT COMPLETED|Second Operation||0
321525|NCT00675558|775994|P1|NOT COMPLETED|Second Operation||0
321526|NCT00675558|775992|P3|COMPLETED|Second Operation||10
321527|NCT00675558|775993|P2|COMPLETED|Second Operation||0
321528|NCT00675558|775994|P1|COMPLETED|Second Operation||0
321529|NCT00675558|775992|P3|STARTED|Second Operation|As predicted, only 10 SMO patients medically required a second operation, and thus met study goals.|10
321530|NCT00675558|775993|P2|STARTED|Second Operation|No medical reason, and none for the goals of the study, for MO pts to have a second procedure .|0
321531|NCT00675558|775994|P1|STARTED|Second Operation|No medical reason, and no study-related reason for non-obese pts to have a second procedure.|0
321532|NCT00675558|775992|P3|NOT COMPLETED|Surgery||0
321533|NCT00675558|775993|P2|NOT COMPLETED|Surgery||0
321534|NCT00675558|775994|P1|NOT COMPLETED|Surgery||0
321535|NCT00675558|775992|P3|COMPLETED|Surgery||30
321536|NCT00675558|775993|P2|COMPLETED|Surgery||10
321537|NCT00675558|775994|P1|COMPLETED|Surgery||10
321538|NCT00675558|775992|P3|STARTED|Surgery||30
321539|NCT00675558|775993|P2|STARTED|Surgery||10
321540|NCT00675558|775994|P1|STARTED|Surgery||10
321541|NCT00675506|776010|P2|NOT COMPLETED|Overall Study||12
321542|NCT00675506|776011|P1|NOT COMPLETED|Overall Study||12
321543|NCT00675506|776010|P2|COMPLETED|Overall Study||17
321544|NCT00675506|776011|P1|COMPLETED|Overall Study||19
321545|NCT00675506|776010|P2|Received Intervention|Overall Study||29
321546|NCT00675506|776011|P1|Received Intervention|Overall Study|Two subjects did not start treatment: 1) disclosed cancer history, 2) declined participation.|29
321547|NCT00675506|776010|P2|STARTED|Overall Study||29
321548|NCT00675506|776011|P1|STARTED|Overall Study||31
321549|NCT00675441|776027|P1|NOT COMPLETED|Overall Study||3
321550|NCT00675441|776027|P1|COMPLETED|Overall Study||2
321551|NCT00675441|776027|P1|STARTED|Overall Study||5
321552|NCT00675428|776033|P2|NOT COMPLETED|Overall Study||3
321553|NCT00675428|776034|P1|NOT COMPLETED|Overall Study||3
321554|NCT00675428|776033|P2|COMPLETED|Overall Study||0
321555|NCT00675428|776034|P1|COMPLETED|Overall Study||0
321556|NCT00675428|776033|P2|STARTED|Overall Study||3
321557|NCT00675428|776034|P1|STARTED|Overall Study||3
321558|NCT00675415|776054|P2|NOT COMPLETED|Overall Study||8
321559|NCT00675415|776055|P1|NOT COMPLETED|Overall Study||8
321560|NCT00675415|776054|P2|COMPLETED|Overall Study||123
321561|NCT00675415|776055|P1|COMPLETED|Overall Study||124
321562|NCT00675415|776054|P2|STARTED|Overall Study||131
321563|NCT00675415|776055|P1|STARTED|Overall Study||132
321564|NCT00675259|776067|P1|NOT COMPLETED|Overall Study||14
321565|NCT00675259|776067|P1|COMPLETED|Overall Study||19
321566|NCT00675259|776067|P1|STARTED|Overall Study||33
321567|NCT00675103|776076|P1|NOT COMPLETED|Overall Study||3
321568|NCT00675103|776076|P1|COMPLETED|Overall Study||4
321569|NCT00675103|776076|P1|STARTED|Overall Study||7
321570|NCT00674986|776083|P2|NOT COMPLETED|Overall Study||81
321571|NCT00674986|776084|P1|NOT COMPLETED|Overall Study||43
321572|NCT00674986|776083|P2|COMPLETED|Overall Study||188
321573|NCT00674986|776084|P1|COMPLETED|Overall Study||187
321574|NCT00674986|776083|P2|Intent to Treat Population|Overall Study||256
321575|NCT00674986|776084|P1|Intent to Treat Population|Overall Study||227
321576|NCT00674986|776083|P2|STARTED|Overall Study||269
321577|NCT00674986|776084|P1|STARTED|Overall Study||230
321578|NCT00674973|776105|P2|NOT COMPLETED|Overall Study||102
321579|NCT00674973|776106|P1|NOT COMPLETED|Overall Study||100
321580|NCT00674973|776105|P2|COMPLETED|Overall Study|Completed double-blind treatment.|2
321581|NCT00674973|776106|P1|COMPLETED|Overall Study|Completed double-blind treatment.|3
321582|NCT00674973|776105|P2|Switch to Open-Label Erlotinib|Overall Study||0
321583|NCT00674973|776106|P1|Switch to Open-Label Erlotinib|Overall Study|Participants with PD were given opportunity to switch.|57
321584|NCT00674973|776105|P2|STARTED|Overall Study||104
321585|NCT00674973|776106|P1|STARTED|Overall Study||103
321586|NCT00674817|776120|P1|NOT COMPLETED|Period 6||0
321587|NCT00674817|776120|P1|COMPLETED|Period 6||38
321588|NCT00674817|776120|P1|STARTED|Period 6||38
321589|NCT00674817|776120|P1|NOT COMPLETED|Period 5||0
321590|NCT00674817|776120|P1|COMPLETED|Period 5||38
321591|NCT00674817|776120|P1|STARTED|Period 5||38
321592|NCT00674817|776120|P1|NOT COMPLETED|Period 4||1
321593|NCT00674817|776120|P1|COMPLETED|Period 4||38
321594|NCT00674817|776120|P1|STARTED|Period 4||39
321595|NCT00674817|776120|P1|NOT COMPLETED|Period 3||2
321596|NCT00674817|776120|P1|COMPLETED|Period 3||39
321597|NCT00674817|776120|P1|STARTED|Period 3||41
321598|NCT00674817|776120|P1|NOT COMPLETED|Period 2||0
321599|NCT00674817|776120|P1|COMPLETED|Period 2||41
321600|NCT00674817|776120|P1|STARTED|Period 2||41
321601|NCT00674817|776120|P1|NOT COMPLETED|Period 1||3
321602|NCT00674817|776120|P1|COMPLETED|Period 1||41
321603|NCT00674817|776120|P1|STARTED|Period 1||44
321604|NCT00674765|776268|P2|NOT COMPLETED|Overall Study||29
321605|NCT00674765|776269|P1|NOT COMPLETED|Overall Study||36
321606|NCT00674765|776268|P2|COMPLETED|Overall Study||46
321607|NCT00674765|776269|P1|COMPLETED|Overall Study||45
321608|NCT00674765|776268|P2|STARTED|Overall Study||75
321609|NCT00674765|776269|P1|STARTED|Overall Study||81
321610|NCT00674739|776278|P3|NOT COMPLETED|Overall Study||32
321611|NCT00674739|776279|P2|NOT COMPLETED|Overall Study||59
321612|NCT00674739|776280|P1|NOT COMPLETED|Overall Study||57
321613|NCT00674739|776278|P3|COMPLETED|Overall Study||65
321614|NCT00674739|776279|P2|COMPLETED|Overall Study||136
321615|NCT00674739|776280|P1|COMPLETED|Overall Study||121
321616|NCT00674739|776278|P3|STARTED|Overall Study||97
321617|NCT00674739|776279|P2|STARTED|Overall Study||195
321618|NCT00674739|776280|P1|STARTED|Overall Study||178
321619|NCT00674700|776297|P3|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
321620|NCT00674700|776298|P2|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
321621|NCT00674700|776299|P1|NOT COMPLETED|Year 2 Follow-up Without Treatment||6
321622|NCT00674700|776297|P3|COMPLETED|Year 2 Follow-up Without Treatment||141
321623|NCT00674700|776298|P2|COMPLETED|Year 2 Follow-up Without Treatment||123
321624|NCT00674700|776299|P1|COMPLETED|Year 2 Follow-up Without Treatment||133
321625|NCT00674700|776297|P3|STARTED|Year 2 Follow-up Without Treatment||153
321626|NCT00674700|776298|P2|STARTED|Year 2 Follow-up Without Treatment||135
321627|NCT00674700|776299|P1|STARTED|Year 2 Follow-up Without Treatment||139
321628|NCT00674700|776297|P3|NOT COMPLETED|Year 1||17
321629|NCT00674700|776298|P2|NOT COMPLETED|Year 1||34
321630|NCT00674700|776299|P1|NOT COMPLETED|Year 1||31
321631|NCT00674700|776297|P3|COMPLETED|Year 1||153
321632|NCT00674700|776298|P2|COMPLETED|Year 1||135
321633|NCT00674700|776299|P1|COMPLETED|Year 1||139
321634|NCT00674700|776297|P3|STARTED|Year 1||170
321635|NCT00674700|776298|P2|STARTED|Year 1||169
321636|NCT00674700|776299|P1|STARTED|Year 1||170
321637|NCT00674661|776312|P2|NOT COMPLETED|Overall Study||15
321638|NCT00674661|776313|P1|NOT COMPLETED|Overall Study||11
321639|NCT00674661|776312|P2|COMPLETED|Overall Study||48
321640|NCT00674661|776313|P1|COMPLETED|Overall Study||56
321641|NCT00674661|776312|P2|STARTED|Overall Study||63
321642|NCT00674661|776313|P1|STARTED|Overall Study||67
321643|NCT00674622|776322|P3|NOT COMPLETED|Overall Study||0
321644|NCT00674622|776323|P2|NOT COMPLETED|Overall Study||4
321645|NCT00674622|776324|P1|NOT COMPLETED|Overall Study||1
321646|NCT00674622|776322|P3|COMPLETED|Overall Study||22
321647|NCT00674622|776323|P2|COMPLETED|Overall Study||18
321648|NCT00674622|776324|P1|COMPLETED|Overall Study||21
321649|NCT00674622|776322|P3|STARTED|Overall Study||22
321650|NCT00674622|776323|P2|STARTED|Overall Study||22
321651|NCT00674622|776324|P1|STARTED|Overall Study||22
321652|NCT00674609|776347|P3|NOT COMPLETED|Overall Study||8
321653|NCT00674609|776348|P2|NOT COMPLETED|Overall Study||13
321654|NCT00674609|776349|P1|NOT COMPLETED|Overall Study||12
321655|NCT00674609|776347|P3|COMPLETED|Overall Study||51
321656|NCT00674609|776348|P2|COMPLETED|Overall Study||45
321657|NCT00674609|776349|P1|COMPLETED|Overall Study||48
321658|NCT00674609|776347|P3|STARTED|Overall Study||59
321659|NCT00674609|776348|P2|STARTED|Overall Study||58
321660|NCT00674609|776349|P1|STARTED|Overall Study||60
321661|NCT00674583|776383|P2|NOT COMPLETED|Overall Study||0
321662|NCT00674583|776384|P1|NOT COMPLETED|Overall Study||0
321663|NCT00674583|776383|P2|COMPLETED|Overall Study||103
321664|NCT00674583|776384|P1|COMPLETED|Overall Study||311
321665|NCT00674583|776383|P2|STARTED|Overall Study||103
321666|NCT00674583|776384|P1|STARTED|Overall Study||311
321667|NCT00674570|776411|P3|NOT COMPLETED|Overall Study||0
321668|NCT00674570|776412|P2|NOT COMPLETED|Overall Study||2
321669|NCT00674570|776413|P1|NOT COMPLETED|Overall Study||0
321670|NCT00674570|776411|P3|COMPLETED|Overall Study||35
321671|NCT00674570|776412|P2|COMPLETED|Overall Study||32
321672|NCT00674570|776413|P1|COMPLETED|Overall Study||37
321673|NCT00674570|776411|P3|STARTED|Overall Study||35
321674|NCT00674570|776412|P2|STARTED|Overall Study||34
321675|NCT00674570|776413|P1|STARTED|Overall Study||37
321676|NCT00674492|776421|P1|NOT COMPLETED|Overall Study||0
321677|NCT00674492|776421|P1|COMPLETED|Overall Study||21
321678|NCT00674492|776421|P1|STARTED|Overall Study||21
321679|NCT00674466|776428|P3|NOT COMPLETED|Overall Study||9
321680|NCT00674466|776429|P2|NOT COMPLETED|Overall Study||8
321681|NCT00674466|776430|P1|NOT COMPLETED|Overall Study||7
321682|NCT00674466|776428|P3|COMPLETED|Overall Study||21
321683|NCT00674466|776429|P2|COMPLETED|Overall Study||22
321684|NCT00674466|776430|P1|COMPLETED|Overall Study||23
321685|NCT00674466|776428|P3|STARTED|Overall Study||30
321686|NCT00674466|776429|P2|STARTED|Overall Study||30
321687|NCT00674466|776430|P1|STARTED|Overall Study||30
321688|NCT00674362|776446|P2|NOT COMPLETED|Open Label||0
321689|NCT00674362|776447|P1|NOT COMPLETED|Open Label||2
321690|NCT00674362|776446|P2|COMPLETED|Open Label||7
321691|NCT00674362|776447|P1|COMPLETED|Open Label||18
321692|NCT00674362|776446|P2|STARTED|Open Label||7
321693|NCT00674362|776447|P1|STARTED|Open Label||20
321694|NCT00674362|776446|P2|NOT COMPLETED|Double Blind||18
321695|NCT00674362|776447|P1|NOT COMPLETED|Double Blind||12
321696|NCT00674362|776446|P2|COMPLETED|Double Blind||80
321697|NCT00674362|776447|P1|COMPLETED|Double Blind||84
321698|NCT00674362|776446|P2|STARTED|Double Blind||98
321699|NCT00674362|776447|P1|STARTED|Double Blind||96
321700|NCT00674323|776515|P3|NOT COMPLETED|Overall Study||0
321701|NCT00674323|776516|P2|NOT COMPLETED|Overall Study||1
321702|NCT00674323|776517|P1|NOT COMPLETED|Overall Study||1
321703|NCT00674323|776515|P3|COMPLETED|Overall Study||21
321704|NCT00674323|776516|P2|COMPLETED|Overall Study||20
321705|NCT00674323|776517|P1|COMPLETED|Overall Study||18
321706|NCT00674323|776515|P3|STARTED|Overall Study||21
321707|NCT00674323|776516|P2|STARTED|Overall Study||21
321708|NCT00674323|776517|P1|STARTED|Overall Study||19
321709|NCT00674297|776534|P4|NOT COMPLETED|Overall Study||3
321710|NCT00674297|776535|P3|NOT COMPLETED|Overall Study||4
321711|NCT00674297|776536|P2|NOT COMPLETED|Overall Study||0
321712|NCT00674297|776537|P1|NOT COMPLETED|Overall Study||10
321713|NCT00674297|776534|P4|COMPLETED|Overall Study||4
321714|NCT00674297|776535|P3|COMPLETED|Overall Study||5
321715|NCT00674297|776536|P2|COMPLETED|Overall Study||7
321716|NCT00674297|776537|P1|COMPLETED|Overall Study||8
321717|NCT00674297|776534|P4|STARTED|Overall Study||7
321718|NCT00674297|776535|P3|STARTED|Overall Study||9
321719|NCT00674297|776536|P2|STARTED|Overall Study||7
321720|NCT00674297|776537|P1|STARTED|Overall Study||18
321721|NCT00674219|776554|P2|NOT COMPLETED|Overall Study||0
321722|NCT00674219|776555|P1|NOT COMPLETED|Overall Study||0
321723|NCT00674219|776554|P2|COMPLETED|Overall Study||7
321724|NCT00674219|776555|P1|COMPLETED|Overall Study||10
321725|NCT00674219|776554|P2|STARTED|Overall Study||7
321726|NCT00674219|776555|P1|STARTED|Overall Study||10
321727|NCT00674206|776561|P1|NOT COMPLETED|Overall Study||0
321728|NCT00674206|776561|P1|COMPLETED|Overall Study||6
321729|NCT00674206|776561|P1|STARTED|Overall Study||6
321730|NCT00674154|776568|P2|NOT COMPLETED|Overall Study||3
321731|NCT00674154|776569|P1|NOT COMPLETED|Overall Study||3
321732|NCT00674154|776568|P2|COMPLETED|Overall Study||20
321733|NCT00674154|776569|P1|COMPLETED|Overall Study||20
321734|NCT00674154|776568|P2|STARTED|Overall Study||23
321735|NCT00674154|776569|P1|STARTED|Overall Study||23
321736|NCT00674128|776577|P2|NOT COMPLETED|Overall Study||23
321737|NCT00674128|776578|P1|NOT COMPLETED|Overall Study||25
321738|NCT00674128|776577|P2|COMPLETED|Overall Study||21
321739|NCT00674128|776578|P1|COMPLETED|Overall Study||25
321740|NCT00674128|776577|P2|STARTED|Overall Study||44
321741|NCT00674128|776578|P1|STARTED|Overall Study||50
321742|NCT00674115|776584|P4|NOT COMPLETED|Third Intervention||0
321743|NCT00674115|776585|P3|NOT COMPLETED|Third Intervention||0
321744|NCT00674115|776586|P2|NOT COMPLETED|Third Intervention||0
321745|NCT00674115|776587|P1|NOT COMPLETED|Third Intervention||0
321746|NCT00674115|776584|P4|COMPLETED|Third Intervention||0
321747|NCT00674115|776585|P3|COMPLETED|Third Intervention||0
321748|NCT00674115|776586|P2|COMPLETED|Third Intervention||16
321749|NCT00674115|776587|P1|COMPLETED|Third Intervention||14
321750|NCT00674115|776584|P4|STARTED|Third Intervention||0
321751|NCT00674115|776585|P3|STARTED|Third Intervention||0
321752|NCT00674115|776586|P2|STARTED|Third Intervention||16
321753|NCT00674115|776587|P1|STARTED|Third Intervention||14
321754|NCT00674115|776584|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
321755|NCT00674115|776585|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
321756|NCT00674115|776586|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
321757|NCT00674115|776587|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
321758|NCT00674115|776584|P4|COMPLETED|Washout Period of 2 Weeks||0
321759|NCT00674115|776585|P3|COMPLETED|Washout Period of 2 Weeks||0
321760|NCT00674115|776586|P2|COMPLETED|Washout Period of 2 Weeks||16
321761|NCT00674115|776587|P1|COMPLETED|Washout Period of 2 Weeks||14
321762|NCT00674115|776584|P4|STARTED|Washout Period of 2 Weeks||0
321763|NCT00674115|776585|P3|STARTED|Washout Period of 2 Weeks||0
321764|NCT00674115|776586|P2|STARTED|Washout Period of 2 Weeks||16
321765|NCT00674115|776587|P1|STARTED|Washout Period of 2 Weeks||14
321766|NCT00674115|776584|P4|NOT COMPLETED|Second Intervention||0
321767|NCT00674115|776585|P3|NOT COMPLETED|Second Intervention||0
321768|NCT00674115|776586|P2|NOT COMPLETED|Second Intervention||0
321769|NCT00674115|776587|P1|NOT COMPLETED|Second Intervention||0
321770|NCT00674115|776584|P4|COMPLETED|Second Intervention||16
321771|NCT00674115|776585|P3|COMPLETED|Second Intervention||14
321772|NCT00674115|776586|P2|COMPLETED|Second Intervention||16
321773|NCT00674115|776587|P1|COMPLETED|Second Intervention||14
321774|NCT00674115|776584|P4|STARTED|Second Intervention||16
321775|NCT00674115|776585|P3|STARTED|Second Intervention||14
321776|NCT00674115|776586|P2|STARTED|Second Intervention||16
321777|NCT00674115|776587|P1|STARTED|Second Intervention||14
321778|NCT00674115|776584|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
321779|NCT00674115|776585|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
321780|NCT00674115|776586|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
321781|NCT00674115|776587|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
321782|NCT00674115|776584|P4|COMPLETED|Washout Period of 2 Weeks||16
321783|NCT00674115|776585|P3|COMPLETED|Washout Period of 2 Weeks||14
321784|NCT00674115|776586|P2|COMPLETED|Washout Period of 2 Weeks||16
321785|NCT00674115|776587|P1|COMPLETED|Washout Period of 2 Weeks||14
321786|NCT00674115|776584|P4|STARTED|Washout Period of 2 Weeks||16
321787|NCT00674115|776585|P3|STARTED|Washout Period of 2 Weeks||14
321788|NCT00674115|776586|P2|STARTED|Washout Period of 2 Weeks||16
321789|NCT00674115|776587|P1|STARTED|Washout Period of 2 Weeks||14
321790|NCT00674115|776584|P4|NOT COMPLETED|First Intervention||0
321791|NCT00674115|776585|P3|NOT COMPLETED|First Intervention||0
321792|NCT00674115|776586|P2|NOT COMPLETED|First Intervention||0
321793|NCT00674115|776587|P1|NOT COMPLETED|First Intervention||0
321794|NCT00674115|776584|P4|COMPLETED|First Intervention||16
321795|NCT00674115|776585|P3|COMPLETED|First Intervention||14
321796|NCT00674115|776586|P2|COMPLETED|First Intervention||16
321797|NCT00674115|776587|P1|COMPLETED|First Intervention||14
321798|NCT00674115|776584|P4|STARTED|First Intervention||16
321799|NCT00674115|776585|P3|STARTED|First Intervention||14
321800|NCT00674115|776586|P2|STARTED|First Intervention||16
321801|NCT00674115|776587|P1|STARTED|First Intervention||14
321802|NCT00673959|776596|P2|NOT COMPLETED|Overall Study||0
321803|NCT00673959|776597|P1|NOT COMPLETED|Overall Study||0
321804|NCT00673959|776596|P2|COMPLETED|Overall Study||10
321805|NCT00673959|776597|P1|COMPLETED|Overall Study||10
321806|NCT00673959|776596|P2|STARTED|Overall Study||10
321807|NCT00673959|776597|P1|STARTED|Overall Study||10
321808|NCT00673933|776603|P1|NOT COMPLETED|Overall Study||3
321809|NCT00673933|776603|P1|COMPLETED|Overall Study||17
321810|NCT00673933|776603|P1|STARTED|Overall Study||20
321811|NCT00673894|776621|P2|NOT COMPLETED|Second Intervention 4 Weeks||0
321812|NCT00673894|776622|P1|NOT COMPLETED|Second Intervention 4 Weeks||0
321813|NCT00673894|776621|P2|COMPLETED|Second Intervention 4 Weeks||7
321814|NCT00673894|776622|P1|COMPLETED|Second Intervention 4 Weeks||6
321815|NCT00673894|776621|P2|STARTED|Second Intervention 4 Weeks||7
321816|NCT00673894|776622|P1|STARTED|Second Intervention 4 Weeks||6
321817|NCT00673894|776621|P2|NOT COMPLETED|Washout 4-6 Weeks||0
321818|NCT00673894|776622|P1|NOT COMPLETED|Washout 4-6 Weeks||0
321819|NCT00673894|776621|P2|COMPLETED|Washout 4-6 Weeks||7
321820|NCT00673894|776622|P1|COMPLETED|Washout 4-6 Weeks||6
321821|NCT00673894|776621|P2|STARTED|Washout 4-6 Weeks||7
321822|NCT00673894|776622|P1|STARTED|Washout 4-6 Weeks||6
321823|NCT00673894|776621|P2|NOT COMPLETED|First Intervention 4 Weeks||0
321824|NCT00673894|776622|P1|NOT COMPLETED|First Intervention 4 Weeks||2
321825|NCT00673894|776621|P2|COMPLETED|First Intervention 4 Weeks||7
321826|NCT00673894|776622|P1|COMPLETED|First Intervention 4 Weeks||6
321827|NCT00673894|776621|P2|STARTED|First Intervention 4 Weeks||7
321828|NCT00673894|776622|P1|STARTED|First Intervention 4 Weeks||8
321829|NCT00673881|776630|P1|NOT COMPLETED|Overall Study||1
321830|NCT00673881|776630|P1|COMPLETED|Overall Study||24
321831|NCT00673881|776630|P1|STARTED|Overall Study||25
321832|NCT00673855|776637|P2|NOT COMPLETED|Second Intervention||0
321833|NCT00673855|776638|P1|NOT COMPLETED|Second Intervention||0
321834|NCT00673855|776637|P2|COMPLETED|Second Intervention||10
321835|NCT00673855|776638|P1|COMPLETED|Second Intervention||10
321836|NCT00673855|776637|P2|STARTED|Second Intervention||10
321837|NCT00673855|776638|P1|STARTED|Second Intervention||10
321838|NCT00673855|776637|P2|NOT COMPLETED|First Intervention||0
321839|NCT00673855|776638|P1|NOT COMPLETED|First Intervention||0
321840|NCT00673855|776637|P2|COMPLETED|First Intervention||10
321841|NCT00673855|776638|P1|COMPLETED|First Intervention||10
321842|NCT00673855|776637|P2|STARTED|First Intervention||10
321843|NCT00673855|776638|P1|STARTED|First Intervention||10
321844|NCT00673816|776644|P1|NOT COMPLETED|Overall Study||2
321845|NCT00673816|776644|P1|COMPLETED|Overall Study||0
321846|NCT00673816|776644|P1|STARTED|Overall Study||2
321847|NCT00673764|776651|P2|NOT COMPLETED|Overall Study||0
321848|NCT00673764|776652|P1|NOT COMPLETED|Overall Study||0
321849|NCT00673764|776651|P2|COMPLETED|Overall Study||24
321850|NCT00673764|776652|P1|COMPLETED|Overall Study||24
321851|NCT00673764|776651|P2|STARTED|Overall Study||24
321852|NCT00673764|776652|P1|STARTED|Overall Study||24
321853|NCT00673738|776660|P1|NOT COMPLETED|Overall Study||0
321854|NCT00673738|776660|P1|COMPLETED|Overall Study||27
321855|NCT00673738|776660|P1|STARTED|Overall Study||27
321856|NCT00673712|776668|P2|NOT COMPLETED|Overall Study||0
321857|NCT00673712|776669|P1|NOT COMPLETED|Overall Study||0
321858|NCT00673712|776668|P2|COMPLETED|Overall Study||326
321859|NCT00673712|776669|P1|COMPLETED|Overall Study||321
321860|NCT00673712|776668|P2|STARTED|Overall Study||326
321861|NCT00673712|776669|P1|STARTED|Overall Study||321
321862|NCT00673673|776679|P1|NOT COMPLETED|Overall Study||36
321863|NCT00673673|776679|P1|COMPLETED|Overall Study||3
321864|NCT00673673|776679|P1|STARTED|Overall Study||39
321865|NCT00673660|776685|P1|NOT COMPLETED|Overall Study||107
321866|NCT00673660|776685|P1|COMPLETED|Overall Study||268
321867|NCT00673660|776685|P1|STARTED|Overall Study||375
321868|NCT00673595|776698|P2|NOT COMPLETED|Overall Study||0
321869|NCT00673595|776699|P1|NOT COMPLETED|Overall Study||0
321870|NCT00673595|776698|P2|COMPLETED|Overall Study||11
321871|NCT00673595|776699|P1|COMPLETED|Overall Study||8
321872|NCT00673595|776698|P2|STARTED|Overall Study||11
321873|NCT00673595|776699|P1|STARTED|Overall Study||8
321874|NCT00673465|776707|P12|NOT COMPLETED|Part 2 (India)||0
321875|NCT00673465|776708|P11|NOT COMPLETED|Part 2 (India)||0
321876|NCT00673465|776709|P10|NOT COMPLETED|Part 2 (India)||0
321877|NCT00673465|776710|P9|NOT COMPLETED|Part 2 (India)||0
321878|NCT00673465|776711|P8|NOT COMPLETED|Part 2 (India)||0
321879|NCT00673465|776712|P7|NOT COMPLETED|Part 2 (India)||0
321880|NCT00673465|776713|P6|NOT COMPLETED|Part 2 (India)||0
321881|NCT00673465|776714|P5|NOT COMPLETED|Part 2 (India)||0
321882|NCT00673465|776715|P4|NOT COMPLETED|Part 2 (India)||0
321883|NCT00673465|776716|P3|NOT COMPLETED|Part 2 (India)||0
321884|NCT00673465|776717|P2|NOT COMPLETED|Part 2 (India)||0
321885|NCT00673465|776718|P1|NOT COMPLETED|Part 2 (India)||0
321886|NCT00673465|776707|P12|COMPLETED|Part 2 (India)||0
321887|NCT00673465|776708|P11|COMPLETED|Part 2 (India)||0
321888|NCT00673465|776709|P10|COMPLETED|Part 2 (India)||0
321889|NCT00673465|776710|P9|COMPLETED|Part 2 (India)||0
321890|NCT00673465|776711|P8|COMPLETED|Part 2 (India)||0
321891|NCT00673465|776712|P7|COMPLETED|Part 2 (India)||0
321892|NCT00673465|776713|P6|COMPLETED|Part 2 (India)||0
321893|NCT00673465|776714|P5|COMPLETED|Part 2 (India)||0
321894|NCT00673465|776715|P4|COMPLETED|Part 2 (India)||0
321895|NCT00673465|776716|P3|COMPLETED|Part 2 (India)||0
321896|NCT00673465|776717|P2|COMPLETED|Part 2 (India)||0
321897|NCT00673465|776718|P1|COMPLETED|Part 2 (India)||0
321898|NCT00673465|776707|P12|STARTED|Part 2 (India)||0
321899|NCT00673465|776708|P11|STARTED|Part 2 (India)||0
321900|NCT00673465|776709|P10|STARTED|Part 2 (India)||0
321901|NCT00673465|776710|P9|STARTED|Part 2 (India)||0
321902|NCT00673465|776711|P8|STARTED|Part 2 (India)||0
321903|NCT00673465|776712|P7|STARTED|Part 2 (India)||0
321904|NCT00673465|776713|P6|STARTED|Part 2 (India)||0
321905|NCT00673465|776714|P5|STARTED|Part 2 (India)||0
321906|NCT00673465|776715|P4|STARTED|Part 2 (India)||0
321907|NCT00673465|776716|P3|STARTED|Part 2 (India)||0
321908|NCT00673465|776717|P2|STARTED|Part 2 (India)||0
321909|NCT00673465|776718|P1|STARTED|Part 2 (India)||0
321910|NCT00673465|776707|P12|NOT COMPLETED|Part 1/Period 3 (United States)||0
321911|NCT00673465|776708|P11|NOT COMPLETED|Part 1/Period 3 (United States)||0
321912|NCT00673465|776709|P10|NOT COMPLETED|Part 1/Period 3 (United States)||0
321913|NCT00673465|776710|P9|NOT COMPLETED|Part 1/Period 3 (United States)||0
321914|NCT00673465|776711|P8|NOT COMPLETED|Part 1/Period 3 (United States)||0
321915|NCT00673465|776712|P7|NOT COMPLETED|Part 1/Period 3 (United States)||0
321916|NCT00673465|776713|P6|NOT COMPLETED|Part 1/Period 3 (United States)||0
321917|NCT00673465|776714|P5|NOT COMPLETED|Part 1/Period 3 (United States)||0
321918|NCT00673465|776715|P4|NOT COMPLETED|Part 1/Period 3 (United States)||0
321919|NCT00673465|776716|P3|NOT COMPLETED|Part 1/Period 3 (United States)||0
321920|NCT00673465|776717|P2|NOT COMPLETED|Part 1/Period 3 (United States)||0
321921|NCT00673465|776718|P1|NOT COMPLETED|Part 1/Period 3 (United States)||0
321922|NCT00673465|776707|P12|COMPLETED|Part 1/Period 3 (United States)||0
321923|NCT00673465|776708|P11|COMPLETED|Part 1/Period 3 (United States)||0
321924|NCT00673465|776709|P10|COMPLETED|Part 1/Period 3 (United States)||0
321925|NCT00673465|776710|P9|COMPLETED|Part 1/Period 3 (United States)||0
321926|NCT00673465|776711|P8|COMPLETED|Part 1/Period 3 (United States)||0
321927|NCT00673465|776712|P7|COMPLETED|Part 1/Period 3 (United States)||0
321928|NCT00673465|776713|P6|COMPLETED|Part 1/Period 3 (United States)||1
321929|NCT00673465|776714|P5|COMPLETED|Part 1/Period 3 (United States)||1
321930|NCT00673465|776715|P4|COMPLETED|Part 1/Period 3 (United States)||3
321931|NCT00673465|776716|P3|COMPLETED|Part 1/Period 3 (United States)||3
321932|NCT00673465|776717|P2|COMPLETED|Part 1/Period 3 (United States)||3
321933|NCT00673465|776718|P1|COMPLETED|Part 1/Period 3 (United States)||3
321934|NCT00673465|776707|P12|STARTED|Part 1/Period 3 (United States)||0
321935|NCT00673465|776708|P11|STARTED|Part 1/Period 3 (United States)||0
321936|NCT00673465|776709|P10|STARTED|Part 1/Period 3 (United States)||0
321937|NCT00673465|776710|P9|STARTED|Part 1/Period 3 (United States)||0
321938|NCT00673465|776711|P8|STARTED|Part 1/Period 3 (United States)||0
321939|NCT00673465|776712|P7|STARTED|Part 1/Period 3 (United States)||0
321940|NCT00673465|776713|P6|STARTED|Part 1/Period 3 (United States)||1
321941|NCT00673465|776714|P5|STARTED|Part 1/Period 3 (United States)||1
321942|NCT00673465|776715|P4|STARTED|Part 1/Period 3 (United States)||3
321943|NCT00673465|776716|P3|STARTED|Part 1/Period 3 (United States)||3
321944|NCT00673465|776717|P2|STARTED|Part 1/Period 3 (United States)||3
321945|NCT00673465|776718|P1|STARTED|Part 1/Period 3 (United States)||3
321946|NCT00673465|776707|P12|NOT COMPLETED|Part 1/Period 2 (United States)||0
321947|NCT00673465|776708|P11|NOT COMPLETED|Part 1/Period 2 (United States)||0
321948|NCT00673465|776709|P10|NOT COMPLETED|Part 1/Period 2 (United States)||0
321949|NCT00673465|776710|P9|NOT COMPLETED|Part 1/Period 2 (United States)||0
321950|NCT00673465|776711|P8|NOT COMPLETED|Part 1/Period 2 (United States)||0
321951|NCT00673465|776712|P7|NOT COMPLETED|Part 1/Period 2 (United States)||0
321952|NCT00673465|776713|P6|NOT COMPLETED|Part 1/Period 2 (United States)||0
321953|NCT00673465|776714|P5|NOT COMPLETED|Part 1/Period 2 (United States)||1
321954|NCT00673465|776715|P4|NOT COMPLETED|Part 1/Period 2 (United States)||0
321955|NCT00673465|776716|P3|NOT COMPLETED|Part 1/Period 2 (United States)||0
321956|NCT00673465|776717|P2|NOT COMPLETED|Part 1/Period 2 (United States)||0
321957|NCT00673465|776718|P1|NOT COMPLETED|Part 1/Period 2 (United States)||0
321958|NCT00673465|776707|P12|COMPLETED|Part 1/Period 2 (United States)||0
321959|NCT00673465|776708|P11|COMPLETED|Part 1/Period 2 (United States)||0
321960|NCT00673465|776709|P10|COMPLETED|Part 1/Period 2 (United States)||0
321961|NCT00673465|776710|P9|COMPLETED|Part 1/Period 2 (United States)||0
321962|NCT00673465|776711|P8|COMPLETED|Part 1/Period 2 (United States)||0
321963|NCT00673465|776712|P7|COMPLETED|Part 1/Period 2 (United States)||0
321964|NCT00673465|776713|P6|COMPLETED|Part 1/Period 2 (United States)||1
321965|NCT00673465|776714|P5|COMPLETED|Part 1/Period 2 (United States)||1
321966|NCT00673465|776715|P4|COMPLETED|Part 1/Period 2 (United States)||3
321967|NCT00673465|776716|P3|COMPLETED|Part 1/Period 2 (United States)||3
321968|NCT00673465|776717|P2|COMPLETED|Part 1/Period 2 (United States)||3
321969|NCT00673465|776718|P1|COMPLETED|Part 1/Period 2 (United States)||3
321970|NCT00673465|776707|P12|STARTED|Part 1/Period 2 (United States)||0
321971|NCT00673465|776708|P11|STARTED|Part 1/Period 2 (United States)||0
321972|NCT00673465|776709|P10|STARTED|Part 1/Period 2 (United States)||0
321973|NCT00673465|776710|P9|STARTED|Part 1/Period 2 (United States)||0
321974|NCT00673465|776711|P8|STARTED|Part 1/Period 2 (United States)||0
321975|NCT00673465|776712|P7|STARTED|Part 1/Period 2 (United States)||0
321976|NCT00673465|776713|P6|STARTED|Part 1/Period 2 (United States)||1
321977|NCT00673465|776714|P5|STARTED|Part 1/Period 2 (United States)||2
321978|NCT00673465|776715|P4|STARTED|Part 1/Period 2 (United States)||3
321979|NCT00673465|776716|P3|STARTED|Part 1/Period 2 (United States)||3
321980|NCT00673465|776717|P2|STARTED|Part 1/Period 2 (United States)||3
321981|NCT00673465|776718|P1|STARTED|Part 1/Period 2 (United States)||3
321982|NCT00673465|776707|P12|NOT COMPLETED|Part 1/Period 1 (United States)||0
321983|NCT00673465|776708|P11|NOT COMPLETED|Part 1/Period 1 (United States)||0
321984|NCT00673465|776709|P10|NOT COMPLETED|Part 1/Period 1 (United States)||0
321985|NCT00673465|776710|P9|NOT COMPLETED|Part 1/Period 1 (United States)||0
321986|NCT00673465|776711|P8|NOT COMPLETED|Part 1/Period 1 (United States)||0
321987|NCT00673465|776712|P7|NOT COMPLETED|Part 1/Period 1 (United States)||0
321988|NCT00673465|776713|P6|NOT COMPLETED|Part 1/Period 1 (United States)||1
321989|NCT00673465|776714|P5|NOT COMPLETED|Part 1/Period 1 (United States)||1
321990|NCT00673465|776715|P4|NOT COMPLETED|Part 1/Period 1 (United States)||0
321991|NCT00673465|776716|P3|NOT COMPLETED|Part 1/Period 1 (United States)||0
321992|NCT00673465|776717|P2|NOT COMPLETED|Part 1/Period 1 (United States)||0
321993|NCT00673465|776718|P1|NOT COMPLETED|Part 1/Period 1 (United States)||0
321994|NCT00673465|776707|P12|COMPLETED|Part 1/Period 1 (United States)||0
321995|NCT00673465|776708|P11|COMPLETED|Part 1/Period 1 (United States)||0
321996|NCT00673465|776709|P10|COMPLETED|Part 1/Period 1 (United States)||0
321997|NCT00673465|776710|P9|COMPLETED|Part 1/Period 1 (United States)||0
321998|NCT00673465|776711|P8|COMPLETED|Part 1/Period 1 (United States)||0
321999|NCT00673465|776712|P7|COMPLETED|Part 1/Period 1 (United States)||0
322000|NCT00673465|776713|P6|COMPLETED|Part 1/Period 1 (United States)||1
322001|NCT00673465|776714|P5|COMPLETED|Part 1/Period 1 (United States)||2
322002|NCT00673465|776715|P4|COMPLETED|Part 1/Period 1 (United States)||3
322003|NCT00673465|776716|P3|COMPLETED|Part 1/Period 1 (United States)||3
322004|NCT00673465|776717|P2|COMPLETED|Part 1/Period 1 (United States)||3
322005|NCT00673465|776718|P1|COMPLETED|Part 1/Period 1 (United States)||3
322006|NCT00673465|776707|P12|STARTED|Part 1/Period 1 (United States)||0
322007|NCT00673465|776708|P11|STARTED|Part 1/Period 1 (United States)||0
322008|NCT00673465|776709|P10|STARTED|Part 1/Period 1 (United States)||0
322009|NCT00673465|776710|P9|STARTED|Part 1/Period 1 (United States)||0
322010|NCT00673465|776711|P8|STARTED|Part 1/Period 1 (United States)||0
322011|NCT00673465|776712|P7|STARTED|Part 1/Period 1 (United States)||0
322012|NCT00673465|776713|P6|STARTED|Part 1/Period 1 (United States)||2
322013|NCT00673465|776714|P5|STARTED|Part 1/Period 1 (United States)||3
322014|NCT00673465|776715|P4|STARTED|Part 1/Period 1 (United States)||3
322015|NCT00673465|776716|P3|STARTED|Part 1/Period 1 (United States)||3
322016|NCT00673465|776717|P2|STARTED|Part 1/Period 1 (United States)||3
322017|NCT00673465|776718|P1|STARTED|Part 1/Period 1 (United States)||3
322018|NCT00673452|776767|P2|NOT COMPLETED|Continuation Double-Blind Phase||34
322019|NCT00673452|776768|P1|NOT COMPLETED|Continuation Double-Blind Phase||25
322020|NCT00673452|776767|P2|COMPLETED|Continuation Double-Blind Phase||153
322021|NCT00673452|776768|P1|COMPLETED|Continuation Double-Blind Phase||151
322022|NCT00673452|776767|P2|STARTED|Continuation Double-Blind Phase|Patients on placebo in acute phase received 60 mg duloxetine during the continuation phase.|187
322023|NCT00673452|776768|P1|STARTED|Continuation Double-Blind Phase||176
322024|NCT00673452|776767|P2|NOT COMPLETED|Acute Double-Blind Phase||80
322025|NCT00673452|776768|P1|NOT COMPLETED|Acute Double-Blind Phase||87
322026|NCT00673452|776767|P2|COMPLETED|Acute Double-Blind Phase||187
322027|NCT00673452|776768|P1|COMPLETED|Acute Double-Blind Phase||176
322028|NCT00673452|776767|P2|STARTED|Acute Double-Blind Phase||267
322029|NCT00673452|776768|P1|STARTED|Acute Double-Blind Phase||263
322030|NCT00673439|776802|P1|NOT COMPLETED|Overall Study||0
322031|NCT00673439|776802|P1|COMPLETED|Overall Study||3
322032|NCT00673439|776802|P1|STARTED|Overall Study||3
322033|NCT00673400|776807|P1|NOT COMPLETED|Overall Study||0
322034|NCT00673400|776807|P1|COMPLETED|Overall Study||52
322035|NCT00673400|776807|P1|STARTED|Overall Study||52
322036|NCT00673387|776832|P8|NOT COMPLETED|Overall Study||35
322037|NCT00673387|776833|P7|NOT COMPLETED|Overall Study||30
322038|NCT00673387|776834|P6|NOT COMPLETED|Overall Study||34
322039|NCT00673387|776835|P5|NOT COMPLETED|Overall Study||30
322040|NCT00673387|776836|P4|NOT COMPLETED|Overall Study||26
322041|NCT00673387|776837|P3|NOT COMPLETED|Overall Study||31
322042|NCT00673387|776838|P2|NOT COMPLETED|Overall Study||23
322043|NCT00673387|776839|P1|NOT COMPLETED|Overall Study||29
322044|NCT00673387|776832|P8|COMPLETED|Overall Study||40
322045|NCT00673387|776833|P7|COMPLETED|Overall Study||48
322046|NCT00673387|776834|P6|COMPLETED|Overall Study||44
322047|NCT00673387|776835|P5|COMPLETED|Overall Study||48
322048|NCT00673387|776836|P4|COMPLETED|Overall Study||49
322049|NCT00673387|776837|P3|COMPLETED|Overall Study||41
322050|NCT00673387|776838|P2|COMPLETED|Overall Study||54
322051|NCT00673387|776839|P1|COMPLETED|Overall Study||46
322052|NCT00673387|776832|P8|STARTED|Overall Study||75
322053|NCT00673387|776833|P7|STARTED|Overall Study||78
322054|NCT00673387|776834|P6|STARTED|Overall Study||78
322055|NCT00673387|776835|P5|STARTED|Overall Study||78
322056|NCT00673387|776836|P4|STARTED|Overall Study||75
322057|NCT00673387|776837|P3|STARTED|Overall Study||72
322058|NCT00673387|776838|P2|STARTED|Overall Study||77
322059|NCT00673387|776839|P1|STARTED|Overall Study||75
322060|NCT00673361|777055|P1|NOT COMPLETED|Overall Study||2
322061|NCT00673361|777055|P1|COMPLETED|Overall Study||7
322062|NCT00673361|777055|P1|STARTED|Overall Study||9
322063|NCT00673257|777059|P1|NOT COMPLETED|Overall Study||5
322064|NCT00673257|777059|P1|COMPLETED|Overall Study||102
322065|NCT00673257|777059|P1|STARTED|Overall Study||107
322066|NCT00673231|777068|P4|NOT COMPLETED|Overall Study||18
322067|NCT00673231|777069|P3|NOT COMPLETED|Overall Study||26
322068|NCT00673231|777070|P2|NOT COMPLETED|Overall Study||22
322069|NCT00673231|777071|P1|NOT COMPLETED|Overall Study||29
322070|NCT00673231|777068|P4|COMPLETED|Overall Study||178
322071|NCT00673231|777069|P3|COMPLETED|Overall Study||186
322072|NCT00673231|777070|P2|COMPLETED|Overall Study||180
322073|NCT00673231|777071|P1|COMPLETED|Overall Study||168
322074|NCT00673231|777068|P4|STARTED|Overall Study|Of the 196 randomized participants only 194 were included in the full analysis set|196
322075|NCT00673231|777069|P3|STARTED|Overall Study|Of the 212 randomized participants only 211 were included in the full analysis set|212
322076|NCT00673231|777070|P2|STARTED|Overall Study|All 202 were included in the full analysis set|202
322077|NCT00673231|777071|P1|STARTED|Overall Study|Of the 197 randomized participants only 193 were included in the full analysis set|197
322078|NCT00673179|777103|P2|NOT COMPLETED|Overall Study||0
322079|NCT00673179|777104|P1|NOT COMPLETED|Overall Study||3
322080|NCT00673179|777103|P2|COMPLETED|Overall Study||0
322081|NCT00673179|777104|P1|COMPLETED|Overall Study||4
322082|NCT00673179|777103|P2|STARTED|Overall Study||0
322083|NCT00673179|777104|P1|STARTED|Overall Study||7
322084|NCT00673153|777110|P1|NOT COMPLETED|Overall Study||1
322085|NCT00673153|777110|P1|COMPLETED|Overall Study||30
322086|NCT00673153|777110|P1|STARTED|Overall Study||31
322087|NCT00673127|777118|P1|NOT COMPLETED|Overall Study||0
322088|NCT00673127|777118|P1|COMPLETED|Overall Study||57
322089|NCT00673127|777118|P1|STARTED|Overall Study||57
322090|NCT00673114|777123|P1|NOT COMPLETED|Overall Study||0
322091|NCT00673114|777123|P1|COMPLETED|Overall Study||3
322092|NCT00673114|777123|P1|STARTED|Overall Study||3
322093|NCT00673075|777136|P2|NOT COMPLETED|Overall Study||7
322094|NCT00673075|777137|P1|NOT COMPLETED|Overall Study||9
322095|NCT00673075|777136|P2|COMPLETED|Overall Study||11
322096|NCT00673075|777137|P1|COMPLETED|Overall Study||12
322097|NCT00673075|777136|P2|STARTED|Overall Study||18
322098|NCT00673075|777137|P1|STARTED|Overall Study||21
322099|NCT00673049|777153|P4|NOT COMPLETED|After Progression on Erlotinib||83
322100|NCT00673049|777154|P3|NOT COMPLETED|After Progression on Erlotinib||0
322101|NCT00673049|777155|P2|NOT COMPLETED|After Progression on Erlotinib||0
322102|NCT00673049|777156|P1|NOT COMPLETED|After Progression on Erlotinib||0
322103|NCT00673049|777153|P4|COMPLETED|After Progression on Erlotinib||0
322104|NCT00673049|777154|P3|COMPLETED|After Progression on Erlotinib||0
322105|NCT00673049|777155|P2|COMPLETED|After Progression on Erlotinib||0
322106|NCT00673049|777156|P1|COMPLETED|After Progression on Erlotinib||0
322107|NCT00673049|777153|P4|STARTED|After Progression on Erlotinib||83
322108|NCT00673049|777154|P3|STARTED|After Progression on Erlotinib||0
322109|NCT00673049|777155|P2|STARTED|After Progression on Erlotinib||0
322110|NCT00673049|777156|P1|STARTED|After Progression on Erlotinib||0
322111|NCT00673049|777153|P4|NOT COMPLETED|Before Progression on Erlotinib||0
322112|NCT00673049|777154|P3|NOT COMPLETED|Before Progression on Erlotinib||1
322113|NCT00673049|777155|P2|NOT COMPLETED|Before Progression on Erlotinib||290
322114|NCT00673049|777156|P1|NOT COMPLETED|Before Progression on Erlotinib||292
322115|NCT00673049|777153|P4|COMPLETED|Before Progression on Erlotinib||0
322116|NCT00673049|777154|P3|COMPLETED|Before Progression on Erlotinib||0
322117|NCT00673049|777155|P2|COMPLETED|Before Progression on Erlotinib||0
322118|NCT00673049|777156|P1|COMPLETED|Before Progression on Erlotinib||0
322119|NCT00673049|777153|P4|Treated|Before Progression on Erlotinib||0
322120|NCT00673049|777154|P3|Treated|Before Progression on Erlotinib||1
322121|NCT00673049|777155|P2|Treated|Before Progression on Erlotinib||289
322122|NCT00673049|777156|P1|Treated|Before Progression on Erlotinib||289
322123|NCT00673049|777153|P4|STARTED|Before Progression on Erlotinib|Participants treated with erlo alone who subsequently received figi upon disease progression.|0
322124|NCT00673049|777154|P3|STARTED|Before Progression on Erlotinib||1
322125|NCT00673049|777155|P2|STARTED|Before Progression on Erlotinib||290
322126|NCT00673049|777156|P1|STARTED|Before Progression on Erlotinib||292
322127|NCT00672984|777180|P3|NOT COMPLETED|Third Intervention||1
322128|NCT00672984|777181|P2|NOT COMPLETED|Third Intervention||0
322129|NCT00672984|777182|P1|NOT COMPLETED|Third Intervention||1
322130|NCT00672984|777180|P3|COMPLETED|Third Intervention||23
322131|NCT00672984|777181|P2|COMPLETED|Third Intervention||17
322132|NCT00672984|777182|P1|COMPLETED|Third Intervention||21
322133|NCT00672984|777180|P3|STARTED|Third Intervention||24
322134|NCT00672984|777181|P2|STARTED|Third Intervention||17
322135|NCT00672984|777182|P1|STARTED|Third Intervention||22
322136|NCT00672984|777180|P3|NOT COMPLETED|Second Intervention||1
322137|NCT00672984|777181|P2|NOT COMPLETED|Second Intervention||6
322138|NCT00672984|777182|P1|NOT COMPLETED|Second Intervention||0
322139|NCT00672984|777180|P3|COMPLETED|Second Intervention||24
322140|NCT00672984|777181|P2|COMPLETED|Second Intervention||17
322141|NCT00672984|777182|P1|COMPLETED|Second Intervention||22
322142|NCT00672984|777180|P3|STARTED|Second Intervention||25
322143|NCT00672984|777181|P2|STARTED|Second Intervention||23
322144|NCT00672984|777182|P1|STARTED|Second Intervention||22
322145|NCT00672984|777180|P3|NOT COMPLETED|First Intervention||2
322146|NCT00672984|777181|P2|NOT COMPLETED|First Intervention||2
322147|NCT00672984|777182|P1|NOT COMPLETED|First Intervention||9
322148|NCT00672984|777180|P3|COMPLETED|First Intervention||25
322149|NCT00672984|777181|P2|COMPLETED|First Intervention||23
322150|NCT00672984|777182|P1|COMPLETED|First Intervention||22
322151|NCT00672984|777180|P3|STARTED|First Intervention||27
322152|NCT00672984|777181|P2|STARTED|First Intervention||25
322153|NCT00672984|777182|P1|STARTED|First Intervention||31
322154|NCT00672958|777233|P2|NOT COMPLETED|Overall Study||56
322155|NCT00672958|777234|P1|NOT COMPLETED|Overall Study||64
322156|NCT00672958|777233|P2|COMPLETED|Overall Study||244
322157|NCT00672958|777234|P1|COMPLETED|Overall Study||236
322158|NCT00672958|777233|P2|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|292
322159|NCT00672958|777234|P1|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|286
322160|NCT00672958|777233|P2|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|299
322161|NCT00672958|777234|P1|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|298
322162|NCT00672958|777233|P2|STARTED|Overall Study||300
322163|NCT00672958|777234|P1|STARTED|Overall Study||300
322164|NCT00672932|777266|P2|NOT COMPLETED|Overall Study||0
322165|NCT00672932|777267|P1|NOT COMPLETED|Overall Study||0
322166|NCT00672932|777266|P2|COMPLETED|Overall Study||9
322167|NCT00672932|777267|P1|COMPLETED|Overall Study||9
322168|NCT00672932|777266|P2|Rolled Over to Raltegravir|Overall Study|6 subjects randomized to no drug later rolled over to receive raltegravir|6
322169|NCT00672932|777267|P1|Rolled Over to Raltegravir|Overall Study||0
322170|NCT00672932|777266|P2|Provided Analyzable Blood and CSF Sample|Overall Study||9
322171|NCT00672932|777267|P1|Provided Analyzable Blood and CSF Sample|Overall Study|one subject was censored when pharmacological study showed no drug in plasma or CSF|8
322172|NCT00672932|777266|P2|Completed Initial 12-week Assignment|Overall Study||9
322173|NCT00672932|777267|P1|Completed Initial 12-week Assignment|Overall Study||9
322174|NCT00672932|777266|P2|STARTED|Overall Study||9
322175|NCT00672932|777267|P1|STARTED|Overall Study||9
322176|NCT00672854|777277|P2|NOT COMPLETED|Overall Study||0
322177|NCT00672854|777278|P1|NOT COMPLETED|Overall Study||0
322178|NCT00672854|777277|P2|COMPLETED|Overall Study||51
322179|NCT00672854|777278|P1|COMPLETED|Overall Study||49
322180|NCT00672854|777277|P2|STARTED|Overall Study||51
322181|NCT00672854|777278|P1|STARTED|Overall Study||49
322182|NCT00672841|777300|P2|NOT COMPLETED|Overall Study||15
322183|NCT00672841|777301|P1|NOT COMPLETED|Overall Study||1
322184|NCT00672841|777300|P2|COMPLETED|Overall Study||32
322185|NCT00672841|777301|P1|COMPLETED|Overall Study||16
322186|NCT00672841|777300|P2|STARTED|Overall Study||47
322187|NCT00672841|777301|P1|STARTED|Overall Study||17
322188|NCT00672737|777313|P1|NOT COMPLETED|Overall Study||8
322189|NCT00672737|777313|P1|COMPLETED|Overall Study||48
322190|NCT00672737|777313|P1|STARTED|Overall Study||56
322191|NCT00672646|777323|P3|NOT COMPLETED|Overall Study||3
322192|NCT00672646|777324|P2|NOT COMPLETED|Overall Study||1
322193|NCT00672646|777325|P1|NOT COMPLETED|Overall Study||0
322194|NCT00672646|777323|P3|COMPLETED|Overall Study||37
322195|NCT00672646|777324|P2|COMPLETED|Overall Study||22
322196|NCT00672646|777325|P1|COMPLETED|Overall Study||40
322197|NCT00672646|777323|P3|STARTED|Overall Study||40
322198|NCT00672646|777324|P2|STARTED|Overall Study||23
322199|NCT00672646|777325|P1|STARTED|Overall Study||40
322200|NCT00672633|777350|P2|NOT COMPLETED|Overall Study||1
322201|NCT00672633|777351|P1|NOT COMPLETED|Overall Study||0
322202|NCT00672633|777350|P2|COMPLETED|Overall Study||12
322203|NCT00672633|777351|P1|COMPLETED|Overall Study||12
322204|NCT00672633|777350|P2|STARTED|Overall Study||13
322205|NCT00672633|777351|P1|STARTED|Overall Study||12
322206|NCT00672620|777365|P4|NOT COMPLETED|Overall Study||42
322207|NCT00672620|777366|P3|NOT COMPLETED|Overall Study||31
322208|NCT00672620|777367|P2|NOT COMPLETED|Overall Study||54
322209|NCT00672620|777368|P1|NOT COMPLETED|Overall Study||33
322210|NCT00672620|777365|P4|COMPLETED|Overall Study||110
322211|NCT00672620|777366|P3|COMPLETED|Overall Study||122
322212|NCT00672620|777367|P2|COMPLETED|Overall Study||99
322213|NCT00672620|777368|P1|COMPLETED|Overall Study||120
322214|NCT00672620|777365|P4|Treated|Overall Study||150
322215|NCT00672620|777366|P3|Treated|Overall Study||153
322216|NCT00672620|777367|P2|Treated|Overall Study||149
322217|NCT00672620|777368|P1|Treated|Overall Study||151
322218|NCT00672620|777365|P4|STARTED|Overall Study||152
322219|NCT00672620|777366|P3|STARTED|Overall Study||153
322220|NCT00672620|777367|P2|STARTED|Overall Study||153
322221|NCT00672620|777368|P1|STARTED|Overall Study||153
322222|NCT00672594|777422|P1|NOT COMPLETED|Overall Study||3
322223|NCT00672594|777422|P1|COMPLETED|Overall Study||27
322224|NCT00672594|777422|P1|STARTED|Overall Study||30
322225|NCT00672555|777433|P1|NOT COMPLETED|Overall Study||6
322226|NCT00672555|777433|P1|COMPLETED|Overall Study|All patients were seen at 3 weeks in the outpatient clinic.|64
322227|NCT00672555|777433|P1|STARTED|Overall Study||70
322228|NCT00672490|777444|P2|NOT COMPLETED|Overall Study||32
322229|NCT00672490|777445|P1|NOT COMPLETED|Overall Study||24
322230|NCT00672490|777444|P2|COMPLETED|Overall Study||157
322231|NCT00672490|777445|P1|COMPLETED|Overall Study||163
322232|NCT00672490|777444|P2|STARTED|Overall Study||189
322233|NCT00672490|777445|P1|STARTED|Overall Study||187
322234|NCT00672477|777469|P2|NOT COMPLETED|Overall Study||26
322235|NCT00672477|777470|P1|NOT COMPLETED|Overall Study||27
322236|NCT00672477|777469|P2|COMPLETED|Overall Study||88
322237|NCT00672477|777470|P1|COMPLETED|Overall Study|One subject had missing data as reason for study termination - not counted as early termination.|89
322238|NCT00672477|777469|P2|STARTED|Overall Study|117 subjects were randomized to this group, but only 114 subjects received study drug.|114
322239|NCT00672477|777470|P1|STARTED|Overall Study|120 subjects were randomized to this group, but only 116 subjects received study drug.|116
322240|NCT00672451|777480|P2|NOT COMPLETED|Overall Study||0
322241|NCT00672451|777481|P1|NOT COMPLETED|Overall Study||0
322242|NCT00672451|777480|P2|COMPLETED|Overall Study||2
322243|NCT00672451|777481|P1|COMPLETED|Overall Study||1
322244|NCT00672451|777480|P2|STARTED|Overall Study||2
322245|NCT00672451|777481|P1|STARTED|Overall Study||1
322246|NCT00672438|777491|P2|NOT COMPLETED|Infusion 2||0
322247|NCT00672438|777492|P1|NOT COMPLETED|Infusion 2||0
322248|NCT00672438|777491|P2|COMPLETED|Infusion 2||118
322249|NCT00672438|777492|P1|COMPLETED|Infusion 2||119
322250|NCT00672438|777491|P2|STARTED|Infusion 2||118
322251|NCT00672438|777492|P1|STARTED|Infusion 2||119
322252|NCT00672438|777491|P2|NOT COMPLETED|Washout||0
322253|NCT00672438|777492|P1|NOT COMPLETED|Washout||0
322254|NCT00672438|777491|P2|COMPLETED|Washout||118
322255|NCT00672438|777492|P1|COMPLETED|Washout||119
322256|NCT00672438|777491|P2|STARTED|Washout||118
322257|NCT00672438|777492|P1|STARTED|Washout||119
322258|NCT00672438|777491|P2|NOT COMPLETED|Infusion 1||0
322259|NCT00672438|777492|P1|NOT COMPLETED|Infusion 1||0
322260|NCT00672438|777491|P2|COMPLETED|Infusion 1||118
322261|NCT00672438|777492|P1|COMPLETED|Infusion 1||119
322262|NCT00672438|777491|P2|STARTED|Infusion 1||118
322263|NCT00672438|777492|P1|STARTED|Infusion 1||119
322264|NCT00672256|777523|P1|NOT COMPLETED|Overall Study||44
322265|NCT00672256|777523|P1|COMPLETED|Overall Study||18
322266|NCT00672256|777523|P1|STARTED|Overall Study|January 2007|62
322267|NCT00672243|777530|P1|NOT COMPLETED|Overall Study||0
322268|NCT00672243|777530|P1|COMPLETED|Overall Study||32
322269|NCT00672243|777530|P1|STARTED|Overall Study||32
322270|NCT00672204|777538|P1|NOT COMPLETED|Overall Study||20
322271|NCT00672204|777538|P1|COMPLETED|Overall Study||3
322272|NCT00672204|777538|P1|STARTED|Overall Study||23
322273|NCT00672178|777542|P1|NOT COMPLETED|Overall Study||0
322274|NCT00672178|777542|P1|COMPLETED|Overall Study||1
322275|NCT00672178|777542|P1|STARTED|Overall Study||1
322276|NCT00672139|777548|P2|NOT COMPLETED|Overall Study||45
322277|NCT00672139|777549|P1|NOT COMPLETED|Overall Study||30
322278|NCT00672139|777548|P2|COMPLETED|Overall Study||47
322279|NCT00672139|777549|P1|COMPLETED|Overall Study||27
322280|NCT00672139|777548|P2|STARTED|Overall Study|Four of 96 enrolled subjects did not receive study drug.|92
322281|NCT00672139|777549|P1|STARTED|Overall Study|Three of 60 enrolled subjects did not receive study drug.|57
322282|NCT00672100|777558|P3|NOT COMPLETED|Overall Study||0
322283|NCT00672100|777559|P2|NOT COMPLETED|Overall Study||0
322284|NCT00672100|777560|P1|NOT COMPLETED|Overall Study||0
322285|NCT00672100|777558|P3|COMPLETED|Overall Study||12
322286|NCT00672100|777559|P2|COMPLETED|Overall Study||12
322287|NCT00672100|777560|P1|COMPLETED|Overall Study||12
322288|NCT00672100|777558|P3|PACU (Within 8 Hours)|Overall Study||12
322289|NCT00672100|777559|P2|PACU (Within 8 Hours)|Overall Study||12
322290|NCT00672100|777560|P1|PACU (Within 8 Hours)|Overall Study||12
322291|NCT00672100|777558|P3|STARTED|Overall Study||12
322292|NCT00672100|777559|P2|STARTED|Overall Study||12
322293|NCT00672100|777560|P1|STARTED|Overall Study||12
322294|NCT00671970|777577|P2|NOT COMPLETED|Overall Study||0
322295|NCT00671970|777578|P1|NOT COMPLETED|Overall Study||0
322296|NCT00671970|777577|P2|COMPLETED|Overall Study||25
322297|NCT00671970|777578|P1|COMPLETED|Overall Study||32
322298|NCT00671970|777577|P2|STARTED|Overall Study||25
322299|NCT00671970|777578|P1|STARTED|Overall Study||32
322300|NCT00671931|777606|P5|NOT COMPLETED|Overall Study||1
322301|NCT00671931|777607|P4|NOT COMPLETED|Overall Study||2
322302|NCT00671931|777608|P3|NOT COMPLETED|Overall Study||0
322303|NCT00671931|777609|P2|NOT COMPLETED|Overall Study||0
322304|NCT00671931|777610|P1|NOT COMPLETED|Overall Study||1
322305|NCT00671931|777606|P5|COMPLETED|Overall Study|Low heart rate requiring treatment|7
322306|NCT00671931|777607|P4|COMPLETED|Overall Study|Prepositioning - Neuromonitoring required|8
322307|NCT00671931|777608|P3|COMPLETED|Overall Study|all completed|9
322308|NCT00671931|777609|P2|COMPLETED|Overall Study|All completed|8
322309|NCT00671931|777610|P1|COMPLETED|Overall Study|Nueromonitoring equipment falure|8
322310|NCT00671931|777606|P5|STARTED|Overall Study||8
322311|NCT00671931|777607|P4|STARTED|Overall Study||10
322312|NCT00671931|777608|P3|STARTED|Overall Study||9
322313|NCT00671931|777609|P2|STARTED|Overall Study||8
322314|NCT00671931|777610|P1|STARTED|Overall Study||9
322315|NCT00671918|777622|P1|NOT COMPLETED|Overall Study||17
322316|NCT00671918|777622|P1|COMPLETED|Overall Study||169
322317|NCT00671918|777622|P1|STARTED|Overall Study||186
322318|NCT00671879|777630|P3|NOT COMPLETED|Overall Study||6
322319|NCT00671879|777631|P2|NOT COMPLETED|Overall Study||4
322320|NCT00671879|777632|P1|NOT COMPLETED|Overall Study||0
322321|NCT00671879|777630|P3|COMPLETED|Overall Study||274
322322|NCT00671879|777631|P2|COMPLETED|Overall Study||275
322323|NCT00671879|777632|P1|COMPLETED|Overall Study||281
322324|NCT00671879|777630|P3|STARTED|Overall Study||280
322325|NCT00671879|777631|P2|STARTED|Overall Study||279
322326|NCT00671879|777632|P1|STARTED|Overall Study||281
322327|NCT00671853|777645|P2|NOT COMPLETED|Overall Study||27
322328|NCT00671853|777646|P1|NOT COMPLETED|Overall Study||20
322329|NCT00671853|777645|P2|COMPLETED|Overall Study||18
322330|NCT00671853|777646|P1|COMPLETED|Overall Study||26
322331|NCT00671853|777645|P2|STARTED|Overall Study||45
322332|NCT00671853|777646|P1|STARTED|Overall Study||46
322333|NCT00671788|777662|P1|NOT COMPLETED|Overall Study||14
322334|NCT00671788|777662|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|21
322335|NCT00671788|777662|P1|STARTED|Overall Study||35
322336|NCT00671749|777669|P1|NOT COMPLETED|Overall Study||8
322337|NCT00671749|777669|P1|COMPLETED|Overall Study||92
322338|NCT00671749|777669|P1|STARTED|Overall Study||100
322339|NCT00671723|777682|P3|NOT COMPLETED|Overall Study||0
322340|NCT00671723|777683|P2|NOT COMPLETED|Overall Study||0
322341|NCT00671723|777684|P1|NOT COMPLETED|Overall Study||0
322342|NCT00671723|777682|P3|COMPLETED|Overall Study||11
322343|NCT00671723|777683|P2|COMPLETED|Overall Study||11
322344|NCT00671723|777684|P1|COMPLETED|Overall Study||11
322345|NCT00671723|777682|P3|STARTED|Overall Study||11
322346|NCT00671723|777683|P2|STARTED|Overall Study||11
322347|NCT00671723|777684|P1|STARTED|Overall Study||11
322348|NCT00671671|777697|P2|NOT COMPLETED|Overall Study||0
322349|NCT00671671|777698|P1|NOT COMPLETED|Overall Study||0
322350|NCT00671671|777697|P2|COMPLETED|Overall Study||10
322351|NCT00671671|777698|P1|COMPLETED|Overall Study||10
322352|NCT00671671|777697|P2|STARTED|Overall Study||10
322353|NCT00671671|777698|P1|STARTED|Overall Study||10
322354|NCT00671606|777724|P1|NOT COMPLETED|Overall Study||0
322355|NCT00671606|777724|P1|COMPLETED|Overall Study||5
322356|NCT00671606|777724|P1|STARTED|Overall Study||5
322357|NCT00671554|777728|P1|NOT COMPLETED|Overall Study||3
322358|NCT00671554|777728|P1|COMPLETED|Overall Study||0
322359|NCT00671554|777728|P1|STARTED|Overall Study||3
322360|NCT00671528|777736|P3|NOT COMPLETED|Overall Study||0
322361|NCT00671528|777737|P2|NOT COMPLETED|Overall Study||0
322362|NCT00671528|777738|P1|NOT COMPLETED|Overall Study||0
322363|NCT00671528|777736|P3|COMPLETED|Overall Study||1
322364|NCT00671528|777737|P2|COMPLETED|Overall Study||1
322365|NCT00671528|777738|P1|COMPLETED|Overall Study||1
322366|NCT00671528|777736|P3|STARTED|Overall Study||1
322367|NCT00671528|777737|P2|STARTED|Overall Study||1
322368|NCT00671528|777738|P1|STARTED|Overall Study||1
322369|NCT00671515|777749|P1|NOT COMPLETED|Phase 2||4
322370|NCT00671515|777749|P1|COMPLETED|Phase 2||9
322371|NCT00671515|777749|P1|STARTED|Phase 2||13
322372|NCT00671515|777749|P1|NOT COMPLETED|Phase 1||3
322373|NCT00671515|777749|P1|COMPLETED|Phase 1||20
322374|NCT00671515|777749|P1|STARTED|Phase 1||23
322375|NCT00671502|777757|P3|NOT COMPLETED|Overall Study||27
322376|NCT00671502|777758|P2|NOT COMPLETED|Overall Study||39
322377|NCT00671502|777759|P1|NOT COMPLETED|Overall Study||39
322378|NCT00671502|777757|P3|COMPLETED|Overall Study||252
322379|NCT00671502|777758|P2|COMPLETED|Overall Study||241
322380|NCT00671502|777759|P1|COMPLETED|Overall Study||242
322381|NCT00671502|777757|P3|STARTED|Overall Study||279
322382|NCT00671502|777758|P2|STARTED|Overall Study||280
322383|NCT00671502|777759|P1|STARTED|Overall Study||281
322384|NCT00671437|777767|P1|NOT COMPLETED|Overall Study||15
322385|NCT00671437|777767|P1|COMPLETED|Overall Study||27
322386|NCT00671437|777767|P1|STARTED|Overall Study||42
322387|NCT00671177|777788|P2|NOT COMPLETED|Overall Study||1
322388|NCT00671177|777789|P1|NOT COMPLETED|Overall Study||2
322389|NCT00671177|777788|P2|COMPLETED|Overall Study||114
322390|NCT00671177|777789|P1|COMPLETED|Overall Study||112
322391|NCT00671177|777788|P2|STARTED|Overall Study||115
322392|NCT00671177|777789|P1|STARTED|Overall Study||114
322393|NCT00671060|777801|P2|NOT COMPLETED|Overall Study||1
322394|NCT00671060|777802|P1|NOT COMPLETED|Overall Study||1
322395|NCT00671060|777801|P2|COMPLETED|Overall Study|1 woman was withdrawn from the study due to preeclampsia.|75
322396|NCT00671060|777802|P1|COMPLETED|Overall Study|1 woman completed study but was excluded from analysis because gestational age <14 weeks.|76
322397|NCT00671060|777801|P2|STARTED|Overall Study||76
322398|NCT00671060|777802|P1|STARTED|Overall Study||77
322399|NCT00671034|777811|P3|NOT COMPLETED|Overall Study||24
322400|NCT00671034|777812|P2|NOT COMPLETED|Overall Study||20
322401|NCT00671034|777813|P1|NOT COMPLETED|Overall Study||39
322402|NCT00671034|777811|P3|COMPLETED|Overall Study||31
322403|NCT00671034|777812|P2|COMPLETED|Overall Study||22
322404|NCT00671034|777813|P1|COMPLETED|Overall Study||30
322405|NCT00671034|777811|P3|STARTED|Overall Study||55
322406|NCT00671034|777812|P2|STARTED|Overall Study||42
322407|NCT00671034|777813|P1|STARTED|Overall Study||69
322408|NCT00670982|777850|P2|NOT COMPLETED|Overall Study||0
322409|NCT00670982|777851|P1|NOT COMPLETED|Overall Study||0
322410|NCT00670982|777850|P2|COMPLETED|Overall Study||7
322411|NCT00670982|777851|P1|COMPLETED|Overall Study||22
322412|NCT00670982|777850|P2|STARTED|Overall Study||7
322413|NCT00670982|777851|P1|STARTED|Overall Study||22
322414|NCT00670956|777860|P1|NOT COMPLETED|Overall Study||0
322415|NCT00670956|777860|P1|COMPLETED|Overall Study||1
322416|NCT00670956|777860|P1|STARTED|Overall Study||1
322417|NCT00670930|777868|P2|NOT COMPLETED|Overall Study||1
322418|NCT00670930|777869|P1|NOT COMPLETED|Overall Study||1
322419|NCT00670930|777868|P2|COMPLETED|Overall Study||12
322420|NCT00670930|777869|P1|COMPLETED|Overall Study||22
322421|NCT00670930|777868|P2|Intent to Treat (ITT) Population|Overall Study||12
322422|NCT00670930|777869|P1|Intent to Treat (ITT) Population|Overall Study||23
322423|NCT00670930|777868|P2|STARTED|Overall Study||13
322424|NCT00670930|777869|P1|STARTED|Overall Study|"Started indicates Randomized and Safety populaiton"|23
322425|NCT00670800|777885|P2|NOT COMPLETED|Overall Study||2
322426|NCT00670800|777886|P1|NOT COMPLETED|Overall Study||0
322427|NCT00670800|777885|P2|COMPLETED|Overall Study|Two controls were found to have insulin resistance and were excluded from analysis.|5
322428|NCT00670800|777886|P1|COMPLETED|Overall Study||7
322429|NCT00670800|777885|P2|STARTED|Overall Study||7
322430|NCT00670800|777886|P1|STARTED|Overall Study||7
322431|NCT00670774|777902|P1|NOT COMPLETED|Overall Study||0
322432|NCT00670774|777902|P1|COMPLETED|Overall Study||26
322433|NCT00670774|777902|P1|STARTED|Overall Study||26
322434|NCT00670748|777917|P4|NOT COMPLETED|Overall Study||1
322435|NCT00670748|777918|P3|NOT COMPLETED|Overall Study||2
322436|NCT00670748|777919|P2|NOT COMPLETED|Overall Study||2
322437|NCT00670748|777920|P1|NOT COMPLETED|Overall Study||3
322438|NCT00670748|777917|P4|COMPLETED|Overall Study||4
322439|NCT00670748|777918|P3|COMPLETED|Overall Study||5
322440|NCT00670748|777919|P2|COMPLETED|Overall Study||14
322441|NCT00670748|777920|P1|COMPLETED|Overall Study||14
322442|NCT00670748|777917|P4|STARTED|Overall Study||5
322443|NCT00670748|777918|P3|STARTED|Overall Study||7
322444|NCT00670748|777919|P2|STARTED|Overall Study||16
322445|NCT00670748|777920|P1|STARTED|Overall Study||17
322446|NCT00670709|777940|P2|NOT COMPLETED|Overall Study||0
322447|NCT00670709|777941|P1|NOT COMPLETED|Overall Study||0
322448|NCT00670709|777940|P2|COMPLETED|Overall Study||15
322449|NCT00670709|777941|P1|COMPLETED|Overall Study||27
322450|NCT00670709|777940|P2|STARTED|Overall Study||15
322451|NCT00670709|777941|P1|STARTED|Overall Study||27
322452|NCT00670631|777949|P1|NOT COMPLETED|Overall Study||0
322453|NCT00670631|777949|P1|COMPLETED|Overall Study||0
322454|NCT00670631|777949|P1|STARTED|Overall Study||0
322455|NCT00670540|777955|P1|NOT COMPLETED|Overall Study||3325
322456|NCT00670540|777955|P1|COMPLETED|Overall Study|total recruited for the follow up|4931
322457|NCT00670540|777955|P1|STARTED|Overall Study||8256
322458|NCT00670488|777975|P10|NOT COMPLETED|Overall Study||2
322459|NCT00670488|777976|P9|NOT COMPLETED|Overall Study||3
322460|NCT00670488|777977|P8|NOT COMPLETED|Overall Study||3
322461|NCT00670488|777978|P7|NOT COMPLETED|Overall Study||17
322462|NCT00670488|777979|P6|NOT COMPLETED|Overall Study||5
322463|NCT00670488|777980|P5|NOT COMPLETED|Overall Study||3
322464|NCT00670488|777981|P4|NOT COMPLETED|Overall Study||7
322465|NCT00670488|777982|P3|NOT COMPLETED|Overall Study||3
322466|NCT00670488|777983|P2|NOT COMPLETED|Overall Study||58
322467|NCT00670488|777984|P1|NOT COMPLETED|Overall Study||3
322468|NCT00670488|777975|P10|COMPLETED|Overall Study||0
322469|NCT00670488|777976|P9|COMPLETED|Overall Study||0
322470|NCT00670488|777977|P8|COMPLETED|Overall Study||0
322471|NCT00670488|777978|P7|COMPLETED|Overall Study||0
322472|NCT00670488|777979|P6|COMPLETED|Overall Study||0
322473|NCT00670488|777980|P5|COMPLETED|Overall Study||0
322474|NCT00670488|777981|P4|COMPLETED|Overall Study||0
322475|NCT00670488|777982|P3|COMPLETED|Overall Study||0
322476|NCT00670488|777983|P2|COMPLETED|Overall Study||0
322477|NCT00670488|777984|P1|COMPLETED|Overall Study||0
322478|NCT00670488|777975|P10|STARTED|Overall Study||2
322479|NCT00670488|777976|P9|STARTED|Overall Study||3
322480|NCT00670488|777977|P8|STARTED|Overall Study||3
322481|NCT00670488|777978|P7|STARTED|Overall Study||17
322482|NCT00670488|777979|P6|STARTED|Overall Study||5
322483|NCT00670488|777980|P5|STARTED|Overall Study||3
322484|NCT00670488|777981|P4|STARTED|Overall Study||7
322485|NCT00670488|777982|P3|STARTED|Overall Study||3
322486|NCT00670488|777983|P2|STARTED|Overall Study||58
322487|NCT00670488|777984|P1|STARTED|Overall Study||3
322488|NCT00670462|778138|P2|NOT COMPLETED|Overall Study||31
322489|NCT00670462|778139|P1|NOT COMPLETED|Overall Study||30
322490|NCT00670462|778138|P2|COMPLETED|Overall Study||76
322491|NCT00670462|778139|P1|COMPLETED|Overall Study||76
322492|NCT00670462|778138|P2|STARTED|Overall Study||107
322493|NCT00670462|778139|P1|STARTED|Overall Study||106
322494|NCT00670449|778171|P4|NOT COMPLETED|Overall Study||8
322495|NCT00670449|778172|P3|NOT COMPLETED|Overall Study||9
322496|NCT00670449|778173|P2|NOT COMPLETED|Overall Study||10
322497|NCT00670449|778174|P1|NOT COMPLETED|Overall Study||9
322498|NCT00670449|778171|P4|COMPLETED|Overall Study||15
322499|NCT00670449|778172|P3|COMPLETED|Overall Study||18
322500|NCT00670449|778173|P2|COMPLETED|Overall Study||36
322501|NCT00670449|778174|P1|COMPLETED|Overall Study||38
322502|NCT00670449|778171|P4|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|17
322503|NCT00670449|778172|P3|Switched to 0.5mg (Open Label)|Overall Study||23
322504|NCT00670449|778173|P2|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|41
322505|NCT00670449|778174|P1|Switched to 0.5mg (Open Label)|Overall Study||45
322506|NCT00670449|778171|P4|STARTED|Overall Study||23
322507|NCT00670449|778172|P3|STARTED|Overall Study||27
322508|NCT00670449|778173|P2|STARTED|Overall Study||46
322509|NCT00670449|778174|P1|STARTED|Overall Study||47
322510|NCT00670306|778198|P1|NOT COMPLETED|Overall Study||55
322511|NCT00670306|778198|P1|COMPLETED|Overall Study||473
322512|NCT00670306|778198|P1|STARTED|Overall Study||528
322513|NCT00670267|778202|P1|NOT COMPLETED|Overall Study||1
322514|NCT00670267|778202|P1|COMPLETED|Overall Study||9
322515|NCT00670267|778202|P1|STARTED|Overall Study||10
322516|NCT00670241|778213|P3|NOT COMPLETED|Overall Study||27
322517|NCT00670241|778214|P2|NOT COMPLETED|Overall Study||21
322518|NCT00670241|778215|P1|NOT COMPLETED|Overall Study||12
322519|NCT00670241|778213|P3|COMPLETED|Overall Study||64
322520|NCT00670241|778214|P2|COMPLETED|Overall Study||163
322521|NCT00670241|778215|P1|COMPLETED|Overall Study||171
322522|NCT00670241|778213|P3|STARTED|Overall Study||91
322523|NCT00670241|778214|P2|STARTED|Overall Study||184
322524|NCT00670241|778215|P1|STARTED|Overall Study||183
322525|NCT00670228|778237|P2|NOT COMPLETED|Overall Study||3
322526|NCT00670228|778238|P1|NOT COMPLETED|Overall Study||5
322527|NCT00670228|778237|P2|COMPLETED|Overall Study||12
322528|NCT00670228|778238|P1|COMPLETED|Overall Study||13
322529|NCT00670228|778237|P2|STARTED|Overall Study||15
322530|NCT00670228|778238|P1|STARTED|Overall Study||18
322531|NCT00670202|778252|P2|NOT COMPLETED|Overall Study||0
322532|NCT00670202|778253|P1|NOT COMPLETED|Overall Study||0
322533|NCT00670202|778252|P2|COMPLETED|Overall Study||0
322534|NCT00670202|778253|P1|COMPLETED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
322535|NCT00670202|778252|P2|STARTED|Overall Study||0
322536|NCT00670202|778253|P1|STARTED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
322537|NCT00670111|778262|P3|NOT COMPLETED|Six Months to Twelve Months||0
322538|NCT00670111|778263|P2|NOT COMPLETED|Six Months to Twelve Months||0
322539|NCT00670111|778264|P1|NOT COMPLETED|Six Months to Twelve Months||0
322540|NCT00670111|778262|P3|COMPLETED|Six Months to Twelve Months||0
322541|NCT00670111|778263|P2|COMPLETED|Six Months to Twelve Months||8
322542|NCT00670111|778264|P1|COMPLETED|Six Months to Twelve Months||4
322543|NCT00670111|778262|P3|STARTED|Six Months to Twelve Months||0
322544|NCT00670111|778263|P2|STARTED|Six Months to Twelve Months||8
322545|NCT00670111|778264|P1|STARTED|Six Months to Twelve Months||4
322546|NCT00670111|778262|P3|NOT COMPLETED|One Month to Six Months||0
322547|NCT00670111|778263|P2|NOT COMPLETED|One Month to Six Months||0
322548|NCT00670111|778264|P1|NOT COMPLETED|One Month to Six Months||0
322549|NCT00670111|778262|P3|COMPLETED|One Month to Six Months||0
322550|NCT00670111|778263|P2|COMPLETED|One Month to Six Months|8 patients in this group completed the 1 month visit; 4 had data eligible for endpoint analysis.|8
322551|NCT00670111|778264|P1|COMPLETED|One Month to Six Months|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
322552|NCT00670111|778262|P3|STARTED|One Month to Six Months||0
322553|NCT00670111|778263|P2|STARTED|One Month to Six Months||8
322554|NCT00670111|778264|P1|STARTED|One Month to Six Months||4
322555|NCT00670111|778262|P3|NOT COMPLETED|One Month Period B||0
322556|NCT00670111|778263|P2|NOT COMPLETED|One Month Period B||0
322557|NCT00670111|778264|P1|NOT COMPLETED|One Month Period B||0
322558|NCT00670111|778262|P3|COMPLETED|One Month Period B||0
322559|NCT00670111|778263|P2|COMPLETED|One Month Period B|8 patients in this group completed the 1 month visit; 6 had data eligible for endpoint analysis.|8
322560|NCT00670111|778264|P1|COMPLETED|One Month Period B|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
322561|NCT00670111|778262|P3|STARTED|One Month Period B||0
322562|NCT00670111|778263|P2|STARTED|One Month Period B||8
322563|NCT00670111|778264|P1|STARTED|One Month Period B||4
322564|NCT00670111|778262|P3|NOT COMPLETED|One Month Period A||0
322565|NCT00670111|778263|P2|NOT COMPLETED|One Month Period A||0
322566|NCT00670111|778264|P1|NOT COMPLETED|One Month Period A||0
322567|NCT00670111|778262|P3|COMPLETED|One Month Period A||0
322568|NCT00670111|778263|P2|COMPLETED|One Month Period A||8
322569|NCT00670111|778264|P1|COMPLETED|One Month Period A||4
322570|NCT00670111|778262|P3|STARTED|One Month Period A||0
322571|NCT00670111|778263|P2|STARTED|One Month Period A||8
322572|NCT00670111|778264|P1|STARTED|One Month Period A||4
322573|NCT00670111|778262|P3|NOT COMPLETED|Enrollment to One Month||19
322574|NCT00670111|778263|P2|NOT COMPLETED|Enrollment to One Month||0
322575|NCT00670111|778264|P1|NOT COMPLETED|Enrollment to One Month||1
322576|NCT00670111|778262|P3|COMPLETED|Enrollment to One Month||0
322577|NCT00670111|778263|P2|COMPLETED|Enrollment to One Month||8
322578|NCT00670111|778264|P1|COMPLETED|Enrollment to One Month||4
322579|NCT00670111|778262|P3|STARTED|Enrollment to One Month||19
322580|NCT00670111|778263|P2|STARTED|Enrollment to One Month||8
322581|NCT00670111|778264|P1|STARTED|Enrollment to One Month||5
322582|NCT00670046|778274|P2|NOT COMPLETED|Overall Study||2
322583|NCT00670046|778275|P1|NOT COMPLETED|Overall Study||1
322584|NCT00670046|778274|P2|COMPLETED|Overall Study||6
322585|NCT00670046|778275|P1|COMPLETED|Overall Study||6
322586|NCT00670046|778274|P2|STARTED|Overall Study||8
322587|NCT00670046|778275|P1|STARTED|Overall Study||7
322588|NCT00670007|778289|P1|NOT COMPLETED|Overall Study||9
322589|NCT00670007|778289|P1|COMPLETED|Overall Study||131
322590|NCT00670007|778289|P1|STARTED|Overall Study||140
322591|NCT00669955|778316|P2|NOT COMPLETED|Overall Study||27
322592|NCT00669955|778317|P1|NOT COMPLETED|Overall Study||14
322593|NCT00669955|778316|P2|COMPLETED|Overall Study||195
322594|NCT00669955|778317|P1|COMPLETED|Overall Study||204
322595|NCT00669955|778316|P2|STARTED|Overall Study||222
322596|NCT00669955|778317|P1|STARTED|Overall Study|216 patients received study drug. 2 patients were dispensed study drug but did not take it|218
322597|NCT00669942|778347|P12|NOT COMPLETED|Healthy Volunteers||0
322598|NCT00669942|778348|P11|NOT COMPLETED|Healthy Volunteers||1
322599|NCT00669942|778349|P10|NOT COMPLETED|Healthy Volunteers||0
322600|NCT00669942|778350|P9|NOT COMPLETED|Healthy Volunteers||0
322601|NCT00669942|778351|P8|NOT COMPLETED|Healthy Volunteers||0
322602|NCT00669942|778352|P7|NOT COMPLETED|Healthy Volunteers||0
322603|NCT00669942|778353|P6|NOT COMPLETED|Healthy Volunteers||0
322604|NCT00669942|778354|P5|NOT COMPLETED|Healthy Volunteers||0
322605|NCT00669942|778355|P4|NOT COMPLETED|Healthy Volunteers||0
322606|NCT00669942|778356|P3|NOT COMPLETED|Healthy Volunteers||0
322607|NCT00669942|778357|P2|NOT COMPLETED|Healthy Volunteers||0
322608|NCT00669942|778358|P1|NOT COMPLETED|Healthy Volunteers||0
322609|NCT00669942|778347|P12|COMPLETED|Healthy Volunteers||2
322610|NCT00669942|778348|P11|COMPLETED|Healthy Volunteers||2
322611|NCT00669942|778349|P10|COMPLETED|Healthy Volunteers||3
322612|NCT00669942|778350|P9|COMPLETED|Healthy Volunteers||0
322613|NCT00669942|778351|P8|COMPLETED|Healthy Volunteers||0
322614|NCT00669942|778352|P7|COMPLETED|Healthy Volunteers||0
322615|NCT00669942|778353|P6|COMPLETED|Healthy Volunteers||0
322616|NCT00669942|778354|P5|COMPLETED|Healthy Volunteers||0
322617|NCT00669942|778355|P4|COMPLETED|Healthy Volunteers||0
322618|NCT00669942|778356|P3|COMPLETED|Healthy Volunteers||0
322619|NCT00669942|778357|P2|COMPLETED|Healthy Volunteers||0
322620|NCT00669942|778358|P1|COMPLETED|Healthy Volunteers||0
322621|NCT00669942|778347|P12|STARTED|Healthy Volunteers||2
322622|NCT00669942|778348|P11|STARTED|Healthy Volunteers||3
322623|NCT00669942|778349|P10|STARTED|Healthy Volunteers||3
322624|NCT00669942|778350|P9|STARTED|Healthy Volunteers||0
322625|NCT00669942|778351|P8|STARTED|Healthy Volunteers||0
322626|NCT00669942|778352|P7|STARTED|Healthy Volunteers||0
322627|NCT00669942|778353|P6|STARTED|Healthy Volunteers||0
322628|NCT00669942|778354|P5|STARTED|Healthy Volunteers||0
322629|NCT00669942|778355|P4|STARTED|Healthy Volunteers||0
322630|NCT00669942|778356|P3|STARTED|Healthy Volunteers||0
322631|NCT00669942|778357|P2|STARTED|Healthy Volunteers||0
322632|NCT00669942|778358|P1|STARTED|Healthy Volunteers||0
322633|NCT00669942|778347|P12|NOT COMPLETED|Parts 2 and 3||0
322634|NCT00669942|778348|P11|NOT COMPLETED|Parts 2 and 3||0
322635|NCT00669942|778349|P10|NOT COMPLETED|Parts 2 and 3||0
322636|NCT00669942|778350|P9|NOT COMPLETED|Parts 2 and 3||3
322637|NCT00669942|778351|P8|NOT COMPLETED|Parts 2 and 3||2
322638|NCT00669942|778352|P7|NOT COMPLETED|Parts 2 and 3||0
322639|NCT00669942|778353|P6|NOT COMPLETED|Parts 2 and 3||2
322640|NCT00669942|778354|P5|NOT COMPLETED|Parts 2 and 3||0
322641|NCT00669942|778355|P4|NOT COMPLETED|Parts 2 and 3||0
322642|NCT00669942|778356|P3|NOT COMPLETED|Parts 2 and 3||0
322643|NCT00669942|778357|P2|NOT COMPLETED|Parts 2 and 3||0
322644|NCT00669942|778358|P1|NOT COMPLETED|Parts 2 and 3||0
322645|NCT00669942|778347|P12|COMPLETED|Parts 2 and 3||0
322646|NCT00669942|778348|P11|COMPLETED|Parts 2 and 3||0
322647|NCT00669942|778349|P10|COMPLETED|Parts 2 and 3||0
322648|NCT00669942|778350|P9|COMPLETED|Parts 2 and 3||23
322649|NCT00669942|778351|P8|COMPLETED|Parts 2 and 3||24
322650|NCT00669942|778352|P7|COMPLETED|Parts 2 and 3||6
322651|NCT00669942|778353|P6|COMPLETED|Parts 2 and 3||4
322652|NCT00669942|778354|P5|COMPLETED|Parts 2 and 3||0
322653|NCT00669942|778355|P4|COMPLETED|Parts 2 and 3||0
322654|NCT00669942|778356|P3|COMPLETED|Parts 2 and 3||0
322655|NCT00669942|778357|P2|COMPLETED|Parts 2 and 3||0
322656|NCT00669942|778358|P1|COMPLETED|Parts 2 and 3||0
322657|NCT00669942|778347|P12|STARTED|Parts 2 and 3||0
322658|NCT00669942|778348|P11|STARTED|Parts 2 and 3||0
322659|NCT00669942|778349|P10|STARTED|Parts 2 and 3||0
322660|NCT00669942|778350|P9|STARTED|Parts 2 and 3||26
322661|NCT00669942|778351|P8|STARTED|Parts 2 and 3||26
322662|NCT00669942|778352|P7|STARTED|Parts 2 and 3||6
322663|NCT00669942|778353|P6|STARTED|Parts 2 and 3||6
322664|NCT00669942|778354|P5|STARTED|Parts 2 and 3||0
322665|NCT00669942|778355|P4|STARTED|Parts 2 and 3||0
322666|NCT00669942|778356|P3|STARTED|Parts 2 and 3||0
322667|NCT00669942|778357|P2|STARTED|Parts 2 and 3||0
322668|NCT00669942|778358|P1|STARTED|Parts 2 and 3||0
322669|NCT00669942|778347|P12|NOT COMPLETED|Part 1||0
322670|NCT00669942|778348|P11|NOT COMPLETED|Part 1||0
322671|NCT00669942|778349|P10|NOT COMPLETED|Part 1||0
322672|NCT00669942|778350|P9|NOT COMPLETED|Part 1||0
322673|NCT00669942|778351|P8|NOT COMPLETED|Part 1||0
322674|NCT00669942|778352|P7|NOT COMPLETED|Part 1||0
322675|NCT00669942|778353|P6|NOT COMPLETED|Part 1||0
322676|NCT00669942|778354|P5|NOT COMPLETED|Part 1||0
322677|NCT00669942|778355|P4|NOT COMPLETED|Part 1||0
322678|NCT00669942|778356|P3|NOT COMPLETED|Part 1||0
322679|NCT00669942|778357|P2|NOT COMPLETED|Part 1||0
322680|NCT00669942|778358|P1|NOT COMPLETED|Part 1||0
322681|NCT00669942|778347|P12|COMPLETED|Part 1||0
322682|NCT00669942|778348|P11|COMPLETED|Part 1||0
322683|NCT00669942|778349|P10|COMPLETED|Part 1||0
322684|NCT00669942|778350|P9|COMPLETED|Part 1||0
322685|NCT00669942|778351|P8|COMPLETED|Part 1||0
322686|NCT00669942|778352|P7|COMPLETED|Part 1||0
322687|NCT00669942|778353|P6|COMPLETED|Part 1||0
322688|NCT00669942|778354|P5|COMPLETED|Part 1||8
322689|NCT00669942|778355|P4|COMPLETED|Part 1||6
322690|NCT00669942|778356|P3|COMPLETED|Part 1||6
322691|NCT00669942|778357|P2|COMPLETED|Part 1||6
322692|NCT00669942|778358|P1|COMPLETED|Part 1||6
322693|NCT00669942|778347|P12|STARTED|Part 1||0
322694|NCT00669942|778348|P11|STARTED|Part 1||0
322695|NCT00669942|778349|P10|STARTED|Part 1||0
322696|NCT00669942|778350|P9|STARTED|Part 1||0
322697|NCT00669942|778351|P8|STARTED|Part 1||0
322698|NCT00669942|778352|P7|STARTED|Part 1||0
322699|NCT00669942|778353|P6|STARTED|Part 1||0
322700|NCT00669942|778354|P5|STARTED|Part 1||8
322701|NCT00669942|778355|P4|STARTED|Part 1||6
322702|NCT00669942|778356|P3|STARTED|Part 1||6
322703|NCT00669942|778357|P2|STARTED|Part 1||6
322704|NCT00669942|778358|P1|STARTED|Part 1||6
322705|NCT00669916|778422|P2|NOT COMPLETED|Overall Study||0
322706|NCT00669916|778423|P1|NOT COMPLETED|Overall Study||0
322707|NCT00669916|778422|P2|COMPLETED|Overall Study||18
322708|NCT00669916|778423|P1|COMPLETED|Overall Study||18
322709|NCT00669916|778422|P2|STARTED|Overall Study||18
322710|NCT00669916|778423|P1|STARTED|Overall Study||18
322711|NCT00669903|778441|P4|NOT COMPLETED|Overall Study||4
322712|NCT00669903|778442|P3|NOT COMPLETED|Overall Study||5
322713|NCT00669903|778443|P2|NOT COMPLETED|Overall Study||5
322714|NCT00669903|778444|P1|NOT COMPLETED|Overall Study||1
322715|NCT00669903|778441|P4|COMPLETED|Overall Study||18
322716|NCT00669903|778442|P3|COMPLETED|Overall Study||13
322717|NCT00669903|778443|P2|COMPLETED|Overall Study||32
322718|NCT00669903|778444|P1|COMPLETED|Overall Study||22
322719|NCT00669903|778441|P4|Completed Treatment Period|Overall Study||19
322720|NCT00669903|778442|P3|Completed Treatment Period|Overall Study||13
322721|NCT00669903|778443|P2|Completed Treatment Period|Overall Study||33
322722|NCT00669903|778444|P1|Completed Treatment Period|Overall Study||23
322723|NCT00669903|778441|P4|STARTED|Overall Study||22
322724|NCT00669903|778442|P3|STARTED|Overall Study||18
322725|NCT00669903|778443|P2|STARTED|Overall Study||37
322726|NCT00669903|778444|P1|STARTED|Overall Study||23
322727|NCT00669877|778474|P1|NOT COMPLETED|Overall Study||4
322728|NCT00669877|778474|P1|COMPLETED|Overall Study||52
322729|NCT00669877|778474|P1|STARTED|Overall Study||56
322730|NCT00669864|778479|P1|NOT COMPLETED|Overall Study||9
322731|NCT00669864|778479|P1|COMPLETED|Overall Study||284
322732|NCT00669864|778479|P1|STARTED|Overall Study||293
322733|NCT00669682|778488|P1|NOT COMPLETED|Overall Study||0
322734|NCT00669682|778488|P1|COMPLETED|Overall Study||9
322735|NCT00669682|778488|P1|STARTED|Overall Study||9
322736|NCT00669669|778493|P1|NOT COMPLETED|Overall Study||1
322737|NCT00669669|778493|P1|COMPLETED|Overall Study||11
322738|NCT00669669|778493|P1|STARTED|Overall Study||12
322739|NCT00669617|778498|P5|NOT COMPLETED|Period 5||0
322740|NCT00669617|778499|P4|NOT COMPLETED|Period 5||0
322741|NCT00669617|778500|P3|NOT COMPLETED|Period 5||0
322742|NCT00669617|778501|P2|NOT COMPLETED|Period 5||0
322743|NCT00669617|778502|P1|NOT COMPLETED|Period 5||0
322744|NCT00669617|778498|P5|COMPLETED|Period 5||17
322745|NCT00669617|778499|P4|COMPLETED|Period 5||18
322746|NCT00669617|778500|P3|COMPLETED|Period 5||17
322747|NCT00669617|778501|P2|COMPLETED|Period 5||17
322748|NCT00669617|778502|P1|COMPLETED|Period 5||17
322749|NCT00669617|778498|P5|STARTED|Period 5||17
322750|NCT00669617|778499|P4|STARTED|Period 5||18
322751|NCT00669617|778500|P3|STARTED|Period 5||17
322752|NCT00669617|778501|P2|STARTED|Period 5||17
322753|NCT00669617|778502|P1|STARTED|Period 5||17
322754|NCT00669617|778498|P5|NOT COMPLETED|Period 4||0
322755|NCT00669617|778499|P4|NOT COMPLETED|Period 4||0
322756|NCT00669617|778500|P3|NOT COMPLETED|Period 4||0
322757|NCT00669617|778501|P2|NOT COMPLETED|Period 4||0
322758|NCT00669617|778502|P1|NOT COMPLETED|Period 4||0
322759|NCT00669617|778498|P5|COMPLETED|Period 4||17
322760|NCT00669617|778499|P4|COMPLETED|Period 4||18
322761|NCT00669617|778500|P3|COMPLETED|Period 4||17
322762|NCT00669617|778501|P2|COMPLETED|Period 4||17
322763|NCT00669617|778502|P1|COMPLETED|Period 4||17
322764|NCT00669617|778498|P5|STARTED|Period 4||17
322765|NCT00669617|778499|P4|STARTED|Period 4||18
322766|NCT00669617|778500|P3|STARTED|Period 4||17
322767|NCT00669617|778501|P2|STARTED|Period 4||17
322768|NCT00669617|778502|P1|STARTED|Period 4||17
322769|NCT00669617|778498|P5|NOT COMPLETED|Period 3||0
322770|NCT00669617|778499|P4|NOT COMPLETED|Period 3||0
322771|NCT00669617|778500|P3|NOT COMPLETED|Period 3||0
322772|NCT00669617|778501|P2|NOT COMPLETED|Period 3||0
322773|NCT00669617|778502|P1|NOT COMPLETED|Period 3||1
322774|NCT00669617|778498|P5|COMPLETED|Period 3||17
322775|NCT00669617|778499|P4|COMPLETED|Period 3||18
322776|NCT00669617|778500|P3|COMPLETED|Period 3||17
322777|NCT00669617|778501|P2|COMPLETED|Period 3||17
322778|NCT00669617|778502|P1|COMPLETED|Period 3||17
322779|NCT00669617|778498|P5|STARTED|Period 3||17
322780|NCT00669617|778499|P4|STARTED|Period 3||18
322781|NCT00669617|778500|P3|STARTED|Period 3||17
322782|NCT00669617|778501|P2|STARTED|Period 3||17
322783|NCT00669617|778502|P1|STARTED|Period 3||18
322784|NCT00669617|778498|P5|NOT COMPLETED|Period 2||0
322785|NCT00669617|778499|P4|NOT COMPLETED|Period 2||0
322786|NCT00669617|778500|P3|NOT COMPLETED|Period 2||0
322787|NCT00669617|778501|P2|NOT COMPLETED|Period 2||0
322788|NCT00669617|778502|P1|NOT COMPLETED|Period 2||0
322789|NCT00669617|778498|P5|COMPLETED|Period 2||17
322790|NCT00669617|778499|P4|COMPLETED|Period 2||18
322791|NCT00669617|778500|P3|COMPLETED|Period 2||17
322792|NCT00669617|778501|P2|COMPLETED|Period 2||17
322793|NCT00669617|778502|P1|COMPLETED|Period 2||18
322794|NCT00669617|778498|P5|STARTED|Period 2||17
322795|NCT00669617|778499|P4|STARTED|Period 2||18
322796|NCT00669617|778500|P3|STARTED|Period 2||17
322797|NCT00669617|778501|P2|STARTED|Period 2||17
322798|NCT00669617|778502|P1|STARTED|Period 2||18
322799|NCT00669617|778498|P5|NOT COMPLETED|Period 1||1
322800|NCT00669617|778499|P4|NOT COMPLETED|Period 1||0
322801|NCT00669617|778500|P3|NOT COMPLETED|Period 1||1
322802|NCT00669617|778501|P2|NOT COMPLETED|Period 1||0
322803|NCT00669617|778502|P1|NOT COMPLETED|Period 1||0
322804|NCT00669617|778498|P5|COMPLETED|Period 1||17
322805|NCT00669617|778499|P4|COMPLETED|Period 1||18
322806|NCT00669617|778500|P3|COMPLETED|Period 1||17
322807|NCT00669617|778501|P2|COMPLETED|Period 1||17
322808|NCT00669617|778502|P1|COMPLETED|Period 1||18
322809|NCT00669617|778498|P5|STARTED|Period 1||18
322810|NCT00669617|778499|P4|STARTED|Period 1||18
322811|NCT00669617|778500|P3|STARTED|Period 1||18
322812|NCT00669617|778501|P2|STARTED|Period 1||17
322813|NCT00669617|778502|P1|STARTED|Period 1||18
322814|NCT00669578|778516|P2|NOT COMPLETED|Overall Study||0
322815|NCT00669578|778517|P1|NOT COMPLETED|Overall Study||0
322816|NCT00669578|778516|P2|COMPLETED|Overall Study||65
322817|NCT00669578|778517|P1|COMPLETED|Overall Study||12
322818|NCT00669578|778516|P2|STARTED|Overall Study||65
322819|NCT00669578|778517|P1|STARTED|Overall Study||12
322820|NCT00669552|778530|P1|NOT COMPLETED|Overall Study||0
322821|NCT00669552|778530|P1|COMPLETED|Overall Study||11
322822|NCT00669552|778530|P1|STARTED|Overall Study||11
322823|NCT00669539|778536|P2|NOT COMPLETED|Overall Study||9
322824|NCT00669539|778537|P1|NOT COMPLETED|Overall Study||8
322825|NCT00669539|778536|P2|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|43
322826|NCT00669539|778537|P1|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|86
322827|NCT00669539|778536|P2|STARTED|Overall Study||52
322828|NCT00669539|778537|P1|STARTED|Overall Study||94
322829|NCT00669461|778543|P1|NOT COMPLETED|Overall Study||0
322830|NCT00669461|778543|P1|COMPLETED|Overall Study||1
322831|NCT00669461|778543|P1|STARTED|Overall Study||1
322832|NCT00669396|778550|P2|NOT COMPLETED|Overall Study||12
322833|NCT00669396|778551|P1|NOT COMPLETED|Overall Study||10
322834|NCT00669396|778550|P2|COMPLETED|Overall Study||22
322835|NCT00669396|778551|P1|COMPLETED|Overall Study||13
322836|NCT00669396|778550|P2|STARTED|Overall Study||34
322837|NCT00669396|778551|P1|STARTED|Overall Study||23
322838|NCT00669383|778565|P2|NOT COMPLETED|Overall Study||0
322839|NCT00669383|778566|P1|NOT COMPLETED|Overall Study||0
322840|NCT00669383|778565|P2|COMPLETED|Overall Study||41
322841|NCT00669383|778566|P1|COMPLETED|Overall Study||44
322842|NCT00669383|778565|P2|STARTED|Overall Study||41
322843|NCT00669383|778566|P1|STARTED|Overall Study||44
322844|NCT00669331|778578|P2|NOT COMPLETED|Blinded Treatment Period||39
322845|NCT00669331|778579|P1|NOT COMPLETED|Blinded Treatment Period||42
322846|NCT00669331|778578|P2|COMPLETED|Blinded Treatment Period||189
322847|NCT00669331|778579|P1|COMPLETED|Blinded Treatment Period||191
322848|NCT00669331|778578|P2|STARTED|Blinded Treatment Period||228
322849|NCT00669331|778579|P1|STARTED|Blinded Treatment Period||233
322850|NCT00669331|778578|P2|NOT COMPLETED|Randomisation to First Dose||13
322851|NCT00669331|778579|P1|NOT COMPLETED|Randomisation to First Dose||11
322852|NCT00669331|778578|P2|COMPLETED|Randomisation to First Dose||228
322853|NCT00669331|778579|P1|COMPLETED|Randomisation to First Dose||233
322854|NCT00669331|778578|P2|STARTED|Randomisation to First Dose||241
322855|NCT00669331|778579|P1|STARTED|Randomisation to First Dose||244
322856|NCT00669318|778621|P1|NOT COMPLETED|Overall Study||2
322857|NCT00669318|778621|P1|COMPLETED|Overall Study||39
322858|NCT00669318|778621|P1|STARTED|Overall Study||41
322859|NCT00669279|778631|P2|NOT COMPLETED|Overall Study||0
322860|NCT00669279|778632|P1|NOT COMPLETED|Overall Study||0
322861|NCT00669279|778631|P2|COMPLETED|Overall Study||19
322862|NCT00669279|778632|P1|COMPLETED|Overall Study||22
322863|NCT00669279|778631|P2|STARTED|Overall Study||19
322864|NCT00669279|778632|P1|STARTED|Overall Study||22
322865|NCT00669240|778638|P1|NOT COMPLETED|Overall Study||165
322866|NCT00669240|778638|P1|COMPLETED|Overall Study||402
322867|NCT00669240|778638|P1|Received Treatment|Overall Study||551
322868|NCT00669240|778638|P1|Assigned to Treatment|Overall Study||566
322869|NCT00669240|778638|P1|STARTED|Overall Study||567
322870|NCT00669214|778654|P2|NOT COMPLETED|Open-Label Treatment Period (Week 24)||9
322871|NCT00669214|778655|P1|NOT COMPLETED|Open-Label Treatment Period (Week 24)||4
322872|NCT00669214|778654|P2|COMPLETED|Open-Label Treatment Period (Week 24)||46
322873|NCT00669214|778655|P1|COMPLETED|Open-Label Treatment Period (Week 24)||18
322874|NCT00669214|778654|P2|STARTED|Open-Label Treatment Period (Week 24)||55
322875|NCT00669214|778655|P1|STARTED|Open-Label Treatment Period (Week 24)||22
322876|NCT00669214|778654|P2|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||7
322877|NCT00669214|778655|P1|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||5
322878|NCT00669214|778654|P2|COMPLETED|Double-Blind Treatment Period (Week 12)||55
322879|NCT00669214|778655|P1|COMPLETED|Double-Blind Treatment Period (Week 12)||22
322880|NCT00669214|778654|P2|STARTED|Double-Blind Treatment Period (Week 12)||62
322881|NCT00669214|778655|P1|STARTED|Double-Blind Treatment Period (Week 12)||27
322882|NCT00669162|778687|P1|NOT COMPLETED|Overall Study||1
322883|NCT00669162|778687|P1|COMPLETED|Overall Study||26
322884|NCT00669162|778687|P1|STARTED|Overall Study||27
322885|NCT00669110|778693|P2|NOT COMPLETED|Overall Study||13
322886|NCT00669110|778694|P1|NOT COMPLETED|Overall Study||8
322887|NCT00669110|778693|P2|COMPLETED|Overall Study||7
322888|NCT00669110|778694|P1|COMPLETED|Overall Study||12
322889|NCT00669110|778693|P2|STARTED|Overall Study||20
322890|NCT00669110|778694|P1|STARTED|Overall Study||20
322891|NCT00669071|778730|P1|NOT COMPLETED|Overall Study||4
322892|NCT00669071|778730|P1|COMPLETED|Overall Study||52
322893|NCT00669071|778730|P1|STARTED|Overall Study||56
322894|NCT00669032|778751|P2|NOT COMPLETED|Overall Study||59
322895|NCT00669032|778752|P1|NOT COMPLETED|Overall Study||44
322896|NCT00669032|778751|P2|COMPLETED|Overall Study||94
322897|NCT00669032|778752|P1|COMPLETED|Overall Study||109
322898|NCT00669032|778751|P2|STARTED|Overall Study||153
322899|NCT00669032|778752|P1|STARTED|Overall Study||153
322900|NCT00669019|778780|P1|NOT COMPLETED|Overall Study||0
322901|NCT00669019|778780|P1|COMPLETED|Overall Study||23
322902|NCT00669019|778780|P1|STARTED|Overall Study||23
322903|NCT00668902|778788|P3|NOT COMPLETED|Overall Study||0
322904|NCT00668902|778789|P2|NOT COMPLETED|Overall Study||0
322905|NCT00668902|778790|P1|NOT COMPLETED|Overall Study||0
322906|NCT00668902|778788|P3|COMPLETED|Overall Study||5
322907|NCT00668902|778789|P2|COMPLETED|Overall Study||10
322908|NCT00668902|778790|P1|COMPLETED|Overall Study||10
322909|NCT00668902|778788|P3|STARTED|Overall Study||5
322910|NCT00668902|778789|P2|STARTED|Overall Study||10
322911|NCT00668902|778790|P1|STARTED|Overall Study||10
322912|NCT00668863|778798|P1|NOT COMPLETED|Overall Study||71
322913|NCT00668863|778798|P1|COMPLETED|Overall Study||0
322914|NCT00668863|778798|P1|STARTED|Overall Study||71
322915|NCT00668811|778817|P1|NOT COMPLETED|Overall Study||0
322916|NCT00668811|778817|P1|COMPLETED|Overall Study||23
322917|NCT00668811|778817|P1|STARTED|Overall Study||23
322918|NCT00668785|778822|P1|NOT COMPLETED|Overall Study||0
322919|NCT00668785|778822|P1|COMPLETED|Overall Study||6
322920|NCT00668785|778822|P1|STARTED|Overall Study||6
322921|NCT00668746|778830|P2|NOT COMPLETED|Overall Study||1
322922|NCT00668746|778831|P1|NOT COMPLETED|Overall Study||2
322923|NCT00668746|778830|P2|COMPLETED|Overall Study||11
322924|NCT00668746|778831|P1|COMPLETED|Overall Study||21
322925|NCT00668746|778830|P2|STARTED|Overall Study||12
322926|NCT00668746|778831|P1|STARTED|Overall Study||23
322927|NCT00668733|778851|P2|NOT COMPLETED|Overall Study||7
322928|NCT00668733|778852|P1|NOT COMPLETED|Overall Study||2
322929|NCT00668733|778851|P2|COMPLETED|Overall Study||83
322930|NCT00668733|778852|P1|COMPLETED|Overall Study||87
322931|NCT00668733|778851|P2|STARTED|Overall Study||90
322932|NCT00668733|778852|P1|STARTED|Overall Study||89
322933|NCT00668564|778858|P1|NOT COMPLETED|Overall Study||0
322934|NCT00668564|778858|P1|COMPLETED|Overall Study||18
322935|NCT00668564|778858|P1|STARTED|Overall Study||18
322936|NCT00668525|778866|P3|NOT COMPLETED|Overall Study||53
322937|NCT00668525|778867|P2|NOT COMPLETED|Overall Study||93
322938|NCT00668525|778868|P1|NOT COMPLETED|Overall Study||77
322939|NCT00668525|778866|P3|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|167
322940|NCT00668525|778867|P2|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|239
322941|NCT00668525|778868|P1|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|248
322942|NCT00668525|778866|P3|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|220
322943|NCT00668525|778867|P2|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|332
322944|NCT00668525|778868|P1|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|325
322945|NCT00668434|778881|P2|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||11
322946|NCT00668434|778882|P1|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||22
322947|NCT00668434|778881|P2|COMPLETED|Secondary Outcome Time Point (52 Weeks)||77
322948|NCT00668434|778882|P1|COMPLETED|Secondary Outcome Time Point (52 Weeks)||157
322949|NCT00668434|778881|P2|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|88
322950|NCT00668434|778882|P1|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|179
322951|NCT00668434|778881|P2|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||0
322952|NCT00668434|778882|P1|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||2
322953|NCT00668434|778881|P2|COMPLETED|Primary Outcome Time Point (3 Weeks)||88
322954|NCT00668434|778882|P1|COMPLETED|Primary Outcome Time Point (3 Weeks)||179
322955|NCT00668434|778881|P2|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|88
322956|NCT00668434|778882|P1|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|181
322957|NCT00668395|778897|P3|NOT COMPLETED|Overall Study||1
322958|NCT00668395|778898|P2|NOT COMPLETED|Overall Study||6
322959|NCT00668395|778899|P1|NOT COMPLETED|Overall Study||6
322960|NCT00668395|778897|P3|COMPLETED|Overall Study||5
322961|NCT00668395|778898|P2|COMPLETED|Overall Study||16
322962|NCT00668395|778899|P1|COMPLETED|Overall Study||39
322963|NCT00668395|778897|P3|STARTED|Overall Study||6
322964|NCT00668395|778898|P2|STARTED|Overall Study||22
322965|NCT00668395|778899|P1|STARTED|Overall Study||45
322966|NCT00668382|778907|P1|NOT COMPLETED|Overall Study||0
322967|NCT00668382|778907|P1|COMPLETED|Overall Study||11
322968|NCT00668382|778907|P1|STARTED|Overall Study|beginning of trial|11
322969|NCT00668317|778911|P1|NOT COMPLETED|Overall Study||2
322970|NCT00668317|778911|P1|COMPLETED|Overall Study||3
322971|NCT00668317|778911|P1|STARTED|Overall Study||5
322972|NCT00668265|778917|P2|NOT COMPLETED|Overall Study||5
322973|NCT00668265|778918|P1|NOT COMPLETED|Overall Study||9
322974|NCT00668265|778917|P2|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
322975|NCT00668265|778918|P1|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
322976|NCT00668265|778917|P2|STARTED|Overall Study||5
322977|NCT00668265|778918|P1|STARTED|Overall Study||9
322978|NCT00668200|778926|P1|NOT COMPLETED|Overall Study||3
322979|NCT00668200|778926|P1|COMPLETED|Overall Study||77
322980|NCT00668200|778926|P1|Intent to Treat (ITT)|Overall Study||80
322981|NCT00668200|778926|P1|Safety Population|Overall Study|1 patient was not included in the ITT patient was enrolled in error|81
322982|NCT00668200|778926|P1|STARTED|Overall Study||80
322983|NCT00668148|778932|P1|NOT COMPLETED|Overall Study||10
322984|NCT00668148|778932|P1|COMPLETED|Overall Study||103
322985|NCT00668148|778932|P1|Received at Least 1 Dose of Study Drug|Overall Study||111
322986|NCT00668148|778932|P1|STARTED|Overall Study||113
322987|NCT00667992|778971|P2|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
322988|NCT00667992|778972|P1|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
322989|NCT00667992|778971|P2|COMPLETED|Forth Intervention 400 Mcg Twice Daily||35
322990|NCT00667992|778972|P1|COMPLETED|Forth Intervention 400 Mcg Twice Daily||33
322991|NCT00667992|778971|P2|STARTED|Forth Intervention 400 Mcg Twice Daily||35
322992|NCT00667992|778972|P1|STARTED|Forth Intervention 400 Mcg Twice Daily||33
322993|NCT00667992|778971|P2|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
322994|NCT00667992|778972|P1|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
322995|NCT00667992|778971|P2|COMPLETED|Third Intervention 100 Mcg Twice Daily||35
322996|NCT00667992|778972|P1|COMPLETED|Third Intervention 100 Mcg Twice Daily||33
322997|NCT00667992|778971|P2|STARTED|Third Intervention 100 Mcg Twice Daily||36
322998|NCT00667992|778972|P1|STARTED|Third Intervention 100 Mcg Twice Daily||34
322999|NCT00667992|778971|P2|NOT COMPLETED|Wash-out||5
323000|NCT00667992|778972|P1|NOT COMPLETED|Wash-out||7
323001|NCT00667992|778971|P2|COMPLETED|Wash-out||36
323002|NCT00667992|778972|P1|COMPLETED|Wash-out||34
323003|NCT00667992|778971|P2|STARTED|Wash-out||41
323004|NCT00667992|778972|P1|STARTED|Wash-out||41
323005|NCT00667992|778971|P2|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||4
323006|NCT00667992|778972|P1|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||3
323007|NCT00667992|778971|P2|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
323008|NCT00667992|778972|P1|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
323009|NCT00667992|778971|P2|STARTED|Second Intervention 400 Mcg Twice Daily||45
323010|NCT00667992|778972|P1|STARTED|Second Intervention 400 Mcg Twice Daily||44
323098|NCT00667615|779174|P1|STARTED|Overall Study||30
323011|NCT00667992|778971|P2|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
323012|NCT00667992|778972|P1|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
323013|NCT00667992|778971|P2|COMPLETED|First Intervention 100 Mcg Twice Daily||45
323014|NCT00667992|778972|P1|COMPLETED|First Intervention 100 Mcg Twice Daily||44
323015|NCT00667992|778971|P2|STARTED|First Intervention 100 Mcg Twice Daily||50
323016|NCT00667992|778972|P1|STARTED|First Intervention 100 Mcg Twice Daily||49
323017|NCT00667875|779029|P3|NOT COMPLETED|Overall Study||13
323018|NCT00667875|779030|P2|NOT COMPLETED|Overall Study||11
323019|NCT00667875|779031|P1|NOT COMPLETED|Overall Study||10
323020|NCT00667875|779029|P3|COMPLETED|Overall Study||8
323021|NCT00667875|779030|P2|COMPLETED|Overall Study||10
323022|NCT00667875|779031|P1|COMPLETED|Overall Study|Subjects who dropped out during treatment are considered completed if they provide end of study data|13
323023|NCT00667875|779029|P3|Subjects Included in Analysisd|Overall Study||19
323024|NCT00667875|779030|P2|Subjects Included in Analysisd|Overall Study||21
323025|NCT00667875|779031|P1|Subjects Included in Analysisd|Overall Study||20
323026|NCT00667875|779029|P3|STARTED|Overall Study|2 subjects had no data following randomization and were excluded from the analysis.|21
323027|NCT00667875|779030|P2|STARTED|Overall Study||21
323028|NCT00667875|779031|P1|STARTED|Overall Study|3 subjects had no data after randomization and were excluded from analysis|23
323029|NCT00667849|779050|P2|NOT COMPLETED|Overall Study||121
323030|NCT00667849|779051|P1|NOT COMPLETED|Overall Study||108
323031|NCT00667849|779050|P2|COMPLETED|Overall Study||130
323032|NCT00667849|779051|P1|COMPLETED|Overall Study||142
323033|NCT00667849|779050|P2|STARTED|Overall Study||251
323034|NCT00667849|779051|P1|STARTED|Overall Study||250
323035|NCT00667810|779065|P4|NOT COMPLETED|Overall Study||2
323036|NCT00667810|779066|P3|NOT COMPLETED|Overall Study||222
323037|NCT00667810|779067|P2|NOT COMPLETED|Overall Study||170
323038|NCT00667810|779068|P1|NOT COMPLETED|Overall Study||167
323039|NCT00667810|779065|P4|COMPLETED|Overall Study||9
323040|NCT00667810|779066|P3|COMPLETED|Overall Study||124
323041|NCT00667810|779067|P2|COMPLETED|Overall Study||94
323042|NCT00667810|779068|P1|COMPLETED|Overall Study||102
323043|NCT00667810|779065|P4|Treated|Overall Study||11
323044|NCT00667810|779066|P3|Treated|Overall Study||344
323045|NCT00667810|779067|P2|Treated|Overall Study||263
323046|NCT00667810|779068|P1|Treated|Overall Study||267
323047|NCT00667810|779065|P4|STARTED|Overall Study||11
323048|NCT00667810|779066|P3|STARTED|Overall Study||346
323049|NCT00667810|779067|P2|STARTED|Overall Study||264
323050|NCT00667810|779068|P1|STARTED|Overall Study||269
323051|NCT00667745|779127|P2|NOT COMPLETED|Overall Study||21
323052|NCT00667745|779128|P1|NOT COMPLETED|Overall Study||25
323053|NCT00667745|779127|P2|COMPLETED|Overall Study||121
323054|NCT00667745|779128|P1|COMPLETED|Overall Study||116
323055|NCT00667745|779127|P2|STARTED|Overall Study||142
323056|NCT00667745|779128|P1|STARTED|Overall Study||141
323057|NCT00667732|779144|P3|NOT COMPLETED|Extension (26 Weeks)||0
323058|NCT00667732|779145|P2|NOT COMPLETED|Extension (26 Weeks)||0
323059|NCT00667732|779146|P1|NOT COMPLETED|Extension (26 Weeks)||0
323060|NCT00667732|779144|P3|COMPLETED|Extension (26 Weeks)||17
323061|NCT00667732|779145|P2|COMPLETED|Extension (26 Weeks)||14
323062|NCT00667732|779146|P1|COMPLETED|Extension (26 Weeks)||0
323063|NCT00667732|779144|P3|STARTED|Extension (26 Weeks)||17
323064|NCT00667732|779145|P2|STARTED|Extension (26 Weeks)||14
323065|NCT00667732|779146|P1|STARTED|Extension (26 Weeks)||0
323066|NCT00667732|779144|P3|NOT COMPLETED|Randomization (24 Weeks)||0
323067|NCT00667732|779145|P2|NOT COMPLETED|Randomization (24 Weeks)||1
323068|NCT00667732|779146|P1|NOT COMPLETED|Randomization (24 Weeks)||0
323069|NCT00667732|779144|P3|COMPLETED|Randomization (24 Weeks)||17
323070|NCT00667732|779145|P2|COMPLETED|Randomization (24 Weeks)||16
323071|NCT00667732|779146|P1|COMPLETED|Randomization (24 Weeks)||0
323072|NCT00667732|779144|P3|Participants Enrolled in Substudy|Randomization (24 Weeks)||9
323073|NCT00667732|779145|P2|Participants Enrolled in Substudy|Randomization (24 Weeks)||11
323074|NCT00667732|779146|P1|Participants Enrolled in Substudy|Randomization (24 Weeks)||0
323075|NCT00667732|779144|P3|STARTED|Randomization (24 Weeks)||17
323076|NCT00667732|779145|P2|STARTED|Randomization (24 Weeks)||17
323077|NCT00667732|779146|P1|STARTED|Randomization (24 Weeks)||0
323078|NCT00667732|779144|P3|NOT COMPLETED|Run -In (8 Weeks)||0
323079|NCT00667732|779145|P2|NOT COMPLETED|Run -In (8 Weeks)||0
323080|NCT00667732|779146|P1|NOT COMPLETED|Run -In (8 Weeks)||7
323081|NCT00667732|779144|P3|COMPLETED|Run -In (8 Weeks)||0
323082|NCT00667732|779145|P2|COMPLETED|Run -In (8 Weeks)||0
323083|NCT00667732|779146|P1|COMPLETED|Run -In (8 Weeks)||34
323084|NCT00667732|779144|P3|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
323085|NCT00667732|779145|P2|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
323086|NCT00667732|779146|P1|Participants Enrolled in Substudy|Run -In (8 Weeks)||20
323087|NCT00667732|779144|P3|STARTED|Run -In (8 Weeks)||0
323088|NCT00667732|779145|P2|STARTED|Run -In (8 Weeks)||0
323089|NCT00667732|779146|P1|STARTED|Run -In (8 Weeks)||41
323090|NCT00667693|779159|P2|NOT COMPLETED|Overall Study||2
323091|NCT00667693|779160|P1|NOT COMPLETED|Overall Study||0
323092|NCT00667693|779159|P2|COMPLETED|Overall Study||50
323093|NCT00667693|779160|P1|COMPLETED|Overall Study||49
323094|NCT00667693|779159|P2|STARTED|Overall Study||52
323095|NCT00667693|779160|P1|STARTED|Overall Study||49
323096|NCT00667615|779174|P1|NOT COMPLETED|Overall Study||0
323097|NCT00667615|779174|P1|COMPLETED|Overall Study||30
323099|NCT00667602|779182|P3|NOT COMPLETED|Overall Study||18
323100|NCT00667602|779183|P2|NOT COMPLETED|Overall Study||15
323101|NCT00667602|779184|P1|NOT COMPLETED|Overall Study||8
323102|NCT00667602|779182|P3|COMPLETED|Overall Study||197
323103|NCT00667602|779183|P2|COMPLETED|Overall Study||213
323104|NCT00667602|779184|P1|COMPLETED|Overall Study||211
323105|NCT00667602|779182|P3|STARTED|Overall Study||215
323106|NCT00667602|779183|P2|STARTED|Overall Study||228
323107|NCT00667602|779184|P1|STARTED|Overall Study||219
323108|NCT00667589|779234|P4|NOT COMPLETED|Overall Study||1
323109|NCT00667589|779235|P3|NOT COMPLETED|Overall Study||3
323110|NCT00667589|779236|P2|NOT COMPLETED|Overall Study||0
323111|NCT00667589|779237|P1|NOT COMPLETED|Overall Study||1
323112|NCT00667589|779234|P4|COMPLETED|Overall Study||1
323113|NCT00667589|779235|P3|COMPLETED|Overall Study||0
323114|NCT00667589|779236|P2|COMPLETED|Overall Study||0
323115|NCT00667589|779237|P1|COMPLETED|Overall Study||0
323116|NCT00667589|779234|P4|STARTED|Overall Study||2
323117|NCT00667589|779235|P3|STARTED|Overall Study||3
323118|NCT00667589|779236|P2|STARTED|Overall Study||0
323119|NCT00667589|779237|P1|STARTED|Overall Study||1
323120|NCT00667576|779252|P5|NOT COMPLETED|Overall Study||1
323121|NCT00667576|779253|P4|NOT COMPLETED|Overall Study||4
323122|NCT00667576|779254|P3|NOT COMPLETED|Overall Study||2
323123|NCT00667576|779255|P2|NOT COMPLETED|Overall Study||1
323124|NCT00667576|779256|P1|NOT COMPLETED|Overall Study||2
323125|NCT00667576|779252|P5|COMPLETED|Overall Study||29
323126|NCT00667576|779253|P4|COMPLETED|Overall Study||27
323127|NCT00667576|779254|P3|COMPLETED|Overall Study||29
323128|NCT00667576|779255|P2|COMPLETED|Overall Study||30
323129|NCT00667576|779256|P1|COMPLETED|Overall Study||28
323130|NCT00667576|779252|P5|STARTED|Overall Study||30
323131|NCT00667576|779253|P4|STARTED|Overall Study||31
323132|NCT00667576|779254|P3|STARTED|Overall Study||31
323133|NCT00667576|779255|P2|STARTED|Overall Study||31
323134|NCT00667576|779256|P1|STARTED|Overall Study||30
323135|NCT00667563|779303|P1|NOT COMPLETED|Overall Study||24
323136|NCT00667563|779303|P1|COMPLETED|Overall Study||126
323137|NCT00667563|779303|P1|STARTED|Overall Study||150
323138|NCT00667511|779313|P1|NOT COMPLETED|Intervention 2: Home NHD||4
323139|NCT00667511|779313|P1|COMPLETED|Intervention 2: Home NHD||39
323140|NCT00667511|779313|P1|STARTED|Intervention 2: Home NHD||43
323141|NCT00667511|779313|P1|NOT COMPLETED|Training/Transition Period||8
323142|NCT00667511|779313|P1|COMPLETED|Training/Transition Period||43
323143|NCT00667511|779313|P1|STARTED|Training/Transition Period||51
323144|NCT00667511|779313|P1|NOT COMPLETED|Intervention 1: Home DHD||7
323145|NCT00667511|779313|P1|COMPLETED|Intervention 1: Home DHD||51
323146|NCT00667511|779313|P1|STARTED|Intervention 1: Home DHD||58
323147|NCT00667459|779323|P2|NOT COMPLETED|Overall Study||45
323148|NCT00667459|779324|P1|NOT COMPLETED|Overall Study||8
323149|NCT00667459|779323|P2|COMPLETED|Overall Study||220
323150|NCT00667459|779324|P1|COMPLETED|Overall Study||272
323151|NCT00667459|779323|P2|STARTED|Overall Study||265
323152|NCT00667459|779324|P1|STARTED|Overall Study||280
323153|NCT00667446|779366|P2|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||1
323154|NCT00667446|779367|P1|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||0
323155|NCT00667446|779366|P2|COMPLETED|Safety Follow-up Period (12 Weeks)||25
323156|NCT00667446|779367|P1|COMPLETED|Safety Follow-up Period (12 Weeks)||28
323157|NCT00667446|779366|P2|STARTED|Safety Follow-up Period (12 Weeks)||26
323158|NCT00667446|779367|P1|STARTED|Safety Follow-up Period (12 Weeks)||28
323159|NCT00667446|779366|P2|NOT COMPLETED|Treatment Period (36 Months)||25
323160|NCT00667446|779367|P1|NOT COMPLETED|Treatment Period (36 Months)||23
323161|NCT00667446|779366|P2|COMPLETED|Treatment Period (36 Months)||13
323162|NCT00667446|779367|P1|COMPLETED|Treatment Period (36 Months)||11
323163|NCT00667446|779366|P2|STARTED|Treatment Period (36 Months)||38
323164|NCT00667446|779367|P1|STARTED|Treatment Period (36 Months)||34
323165|NCT00667420|779389|P1|NOT COMPLETED|Overall Study||10
323166|NCT00667420|779389|P1|COMPLETED|Overall Study||7
323167|NCT00667420|779389|P1|Completion of Surgery/Re-staging|Overall Study||11
323168|NCT00667420|779389|P1|Completion of Pre-operative EOX-P|Overall Study||15
323169|NCT00667420|779389|P1|STARTED|Overall Study||17
323170|NCT00667394|779399|P2|NOT COMPLETED|Overall Study||0
323171|NCT00667394|779400|P1|NOT COMPLETED|Overall Study||4
323172|NCT00667394|779399|P2|COMPLETED|Overall Study||1
323173|NCT00667394|779400|P1|COMPLETED|Overall Study||37
323174|NCT00667394|779399|P2|STARTED|Overall Study||1
323175|NCT00667394|779400|P1|STARTED|Overall Study||41
323176|NCT00667381|779410|P2|NOT COMPLETED|Overall Study||0
323177|NCT00667381|779411|P1|NOT COMPLETED|Overall Study||0
323178|NCT00667381|779410|P2|COMPLETED|Overall Study||503
323179|NCT00667381|779411|P1|COMPLETED|Overall Study||501
323180|NCT00667381|779410|P2|STARTED|Overall Study||503
323181|NCT00667381|779411|P1|STARTED|Overall Study||501
323182|NCT00667368|779427|P2|NOT COMPLETED|Overall Study||172
323183|NCT00667368|779428|P1|NOT COMPLETED|Overall Study||200
323184|NCT00667368|779427|P2|COMPLETED|Overall Study||511
323185|NCT00667368|779428|P1|COMPLETED|Overall Study||482
323186|NCT00667368|779427|P2|STARTED|Overall Study||683
323187|NCT00667368|779428|P1|STARTED|Overall Study||682
323188|NCT00667355|779436|P1|NOT COMPLETED|Overall Study||11
323189|NCT00667355|779436|P1|COMPLETED|Overall Study||30
323190|NCT00667355|779436|P1|STARTED|Overall Study||41
323191|NCT00667342|779461|P3|NOT COMPLETED|Overall Study||9
323192|NCT00667342|779462|P2|NOT COMPLETED|Overall Study||0
323193|NCT00667342|779463|P1|NOT COMPLETED|Overall Study||14
323194|NCT00667342|779461|P3|COMPLETED|Overall Study||3
323195|NCT00667342|779462|P2|COMPLETED|Overall Study||0
323196|NCT00667342|779463|P1|COMPLETED|Overall Study||17
323197|NCT00667342|779461|P3|STARTED|Overall Study||12
323198|NCT00667342|779462|P2|STARTED|Overall Study||0
323199|NCT00667342|779463|P1|STARTED|Overall Study||31
323200|NCT00667277|779501|P1|NOT COMPLETED|Overall Study||2
323201|NCT00667277|779501|P1|COMPLETED|Overall Study||11
323202|NCT00667277|779501|P1|STARTED|Overall Study||13
323203|NCT00667251|779508|P2|NOT COMPLETED|Overall Study||95
323204|NCT00667251|779509|P1|NOT COMPLETED|Overall Study||70
323205|NCT00667251|779508|P2|COMPLETED|Overall Study||231
323206|NCT00667251|779509|P1|COMPLETED|Overall Study||256
323207|NCT00667251|779508|P2|Not Started|Overall Study||1
323208|NCT00667251|779509|P1|Not Started|Overall Study||4
323209|NCT00667251|779508|P2|Monotherapy|Overall Study||232
323210|NCT00667251|779509|P1|Monotherapy|Overall Study||225
323211|NCT00667251|779508|P2|Combination Rx|Overall Study||325
323212|NCT00667251|779509|P1|Combination Rx|Overall Study||322
323213|NCT00667251|779508|P2|STARTED|Overall Study||326
323214|NCT00667251|779509|P1|STARTED|Overall Study||326
323215|NCT00667225|779535|P2|NOT COMPLETED|Overall Study||1
323216|NCT00667225|779536|P1|NOT COMPLETED|Overall Study||1
323217|NCT00667225|779535|P2|COMPLETED|Overall Study||12
323218|NCT00667225|779536|P1|COMPLETED|Overall Study||15
323219|NCT00667225|779535|P2|STARTED|Overall Study||13
323220|NCT00667225|779536|P1|STARTED|Overall Study||16
323221|NCT00667186|779546|P2|NOT COMPLETED|Overall Study||0
323222|NCT00667186|779547|P1|NOT COMPLETED|Overall Study||0
323223|NCT00667186|779546|P2|COMPLETED|Overall Study||4880
323224|NCT00667186|779547|P1|COMPLETED|Overall Study||4692
323225|NCT00667186|779546|P2|STARTED|Overall Study||4880
323226|NCT00667186|779547|P1|STARTED|Overall Study||4692
323227|NCT00667095|779557|P2|NOT COMPLETED|Overall Study||1
323228|NCT00667095|779558|P1|NOT COMPLETED|Overall Study||0
323229|NCT00667095|779557|P2|COMPLETED|Overall Study||9
323230|NCT00667095|779558|P1|COMPLETED|Overall Study||11
323231|NCT00667095|779557|P2|STARTED|Overall Study||10
323232|NCT00667095|779558|P1|STARTED|Overall Study||11
323233|NCT00667017|779574|P1|NOT COMPLETED|Overall Study||1
323234|NCT00667017|779574|P1|COMPLETED|Overall Study||0
323235|NCT00667017|779574|P1|STARTED|Overall Study||1
323236|NCT00666978|779580|P2|NOT COMPLETED|Overall Study||83
323237|NCT00666978|779581|P1|NOT COMPLETED|Overall Study||78
323238|NCT00666978|779580|P2|COMPLETED|Overall Study||187
323239|NCT00666978|779581|P1|COMPLETED|Overall Study||192
323240|NCT00666978|779580|P2|STARTED|Overall Study||270
323241|NCT00666978|779581|P1|STARTED|Overall Study||270
323242|NCT00666965|779594|P4|NOT COMPLETED|Overall Study||15
323243|NCT00666965|779595|P3|NOT COMPLETED|Overall Study||2
323244|NCT00666965|779596|P2|NOT COMPLETED|Overall Study||4
323245|NCT00666965|779597|P1|NOT COMPLETED|Overall Study||3
323246|NCT00666965|779594|P4|COMPLETED|Overall Study||42
323247|NCT00666965|779595|P3|COMPLETED|Overall Study||56
323248|NCT00666965|779596|P2|COMPLETED|Overall Study||53
323249|NCT00666965|779597|P1|COMPLETED|Overall Study||55
323250|NCT00666965|779594|P4|STARTED|Overall Study||57
323251|NCT00666965|779595|P3|STARTED|Overall Study||58
323252|NCT00666965|779596|P2|STARTED|Overall Study||57
323253|NCT00666965|779597|P1|STARTED|Overall Study||58
323254|NCT00666926|779627|P16|NOT COMPLETED|Overall Study||8
323255|NCT00666926|779628|P15|NOT COMPLETED|Overall Study||7
323256|NCT00666926|779629|P14|NOT COMPLETED|Overall Study||4
323257|NCT00666926|779630|P13|NOT COMPLETED|Overall Study||3
323258|NCT00666926|779631|P12|NOT COMPLETED|Overall Study||33
323259|NCT00666926|779632|P11|NOT COMPLETED|Overall Study||6
323260|NCT00666926|779633|P10|NOT COMPLETED|Overall Study||10
323261|NCT00666926|779634|P9|NOT COMPLETED|Overall Study||3
323262|NCT00666926|779635|P8|NOT COMPLETED|Overall Study||1
323263|NCT00666926|779636|P7|NOT COMPLETED|Overall Study||4
323264|NCT00666926|779637|P6|NOT COMPLETED|Overall Study||4
323265|NCT00666926|779638|P5|NOT COMPLETED|Overall Study||3
323266|NCT00666926|779639|P4|NOT COMPLETED|Overall Study||4
323267|NCT00666926|779640|P3|NOT COMPLETED|Overall Study||3
323268|NCT00666926|779641|P2|NOT COMPLETED|Overall Study||4
323269|NCT00666926|779642|P1|NOT COMPLETED|Overall Study||2
323270|NCT00666926|779627|P16|COMPLETED|Overall Study||0
323271|NCT00666926|779628|P15|COMPLETED|Overall Study||0
323272|NCT00666926|779629|P14|COMPLETED|Overall Study||0
323273|NCT00666926|779630|P13|COMPLETED|Overall Study||0
323274|NCT00666926|779631|P12|COMPLETED|Overall Study||0
323275|NCT00666926|779632|P11|COMPLETED|Overall Study||0
323276|NCT00666926|779633|P10|COMPLETED|Overall Study||0
323277|NCT00666926|779634|P9|COMPLETED|Overall Study||0
323278|NCT00666926|779635|P8|COMPLETED|Overall Study||0
323279|NCT00666926|779636|P7|COMPLETED|Overall Study||0
323280|NCT00666926|779637|P6|COMPLETED|Overall Study||0
323281|NCT00666926|779638|P5|COMPLETED|Overall Study||0
323282|NCT00666926|779639|P4|COMPLETED|Overall Study||0
323283|NCT00666926|779640|P3|COMPLETED|Overall Study||0
323284|NCT00666926|779641|P2|COMPLETED|Overall Study||0
323285|NCT00666926|779642|P1|COMPLETED|Overall Study||0
323286|NCT00666926|779627|P16|STARTED|Overall Study||8
323287|NCT00666926|779628|P15|STARTED|Overall Study||7
323288|NCT00666926|779629|P14|STARTED|Overall Study||4
323289|NCT00666926|779630|P13|STARTED|Overall Study||3
323290|NCT00666926|779631|P12|STARTED|Overall Study||33
323291|NCT00666926|779632|P11|STARTED|Overall Study||6
323292|NCT00666926|779633|P10|STARTED|Overall Study||10
323293|NCT00666926|779634|P9|STARTED|Overall Study||3
323294|NCT00666926|779635|P8|STARTED|Overall Study||1
323295|NCT00666926|779636|P7|STARTED|Overall Study||4
323296|NCT00666926|779637|P6|STARTED|Overall Study||4
323297|NCT00666926|779638|P5|STARTED|Overall Study||3
323298|NCT00666926|779639|P4|STARTED|Overall Study||4
323299|NCT00666926|779640|P3|STARTED|Overall Study||3
323300|NCT00666926|779641|P2|STARTED|Overall Study||4
323301|NCT00666926|779642|P1|STARTED|Overall Study||2
323302|NCT00666848|779936|P3|NOT COMPLETED|Overall Study||0
323303|NCT00666848|779937|P2|NOT COMPLETED|Overall Study||0
323304|NCT00666848|779938|P1|NOT COMPLETED|Overall Study||0
323305|NCT00666848|779936|P3|COMPLETED|Overall Study|finished Aim 3|7
323306|NCT00666848|779937|P2|COMPLETED|Overall Study|finished Aim 1|9
323307|NCT00666848|779938|P1|COMPLETED|Overall Study|finished Aim 2|8
323308|NCT00666848|779936|P3|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|7
323309|NCT00666848|779937|P2|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|9
323310|NCT00666848|779938|P1|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|8
323311|NCT00666835|779951|P2|NOT COMPLETED|Overall Study||22
323312|NCT00666835|779952|P1|NOT COMPLETED|Overall Study||53
323313|NCT00666835|779951|P2|COMPLETED|Overall Study||142
323314|NCT00666835|779952|P1|COMPLETED|Overall Study||261
323315|NCT00666835|779951|P2|STARTED|Overall Study||164
323316|NCT00666835|779952|P1|STARTED|Overall Study||314
323317|NCT00666757|779962|P2|NOT COMPLETED|Overall Study||97
323318|NCT00666757|779963|P1|NOT COMPLETED|Overall Study||100
323319|NCT00666757|779962|P2|COMPLETED|Overall Study||281
323320|NCT00666757|779963|P1|COMPLETED|Overall Study||272
323321|NCT00666757|779962|P2|STARTED|Overall Study||378
323322|NCT00666757|779963|P1|STARTED|Overall Study||372
323323|NCT00666718|780022|P2|NOT COMPLETED|Overall Study||18
323324|NCT00666718|780023|P1|NOT COMPLETED|Overall Study||12
323325|NCT00666718|780022|P2|COMPLETED|Overall Study||169
323326|NCT00666718|780023|P1|COMPLETED|Overall Study||175
323327|NCT00666718|780022|P2|STARTED|Overall Study||187
323328|NCT00666718|780023|P1|STARTED|Overall Study||187
323329|NCT00666705|780049|P1|NOT COMPLETED|Overall Study||1
323330|NCT00666705|780049|P1|COMPLETED|Overall Study||17
323331|NCT00666705|780049|P1|Raltegravir + Maraviroc (Days 12 - 14)|Overall Study|400 mg Raltegravir every 12 hours plus 300 mg Maraviroc every 12 hours (AM doses only on Day 14)|17
323332|NCT00666705|780049|P1|Maraviroc Alone (Days 6 - 11)|Overall Study|300 mg Maraviroc every 12 hours|18
323333|NCT00666705|780049|P1|Washout (Days 4 - 5)|Overall Study||18
323334|NCT00666705|780049|P1|Raltegravir Alone (Days 1 - 3)|Overall Study|400 mg Raltegravir every 12 hours (AM dose on Day 3)|18
323335|NCT00666705|780049|P1|STARTED|Overall Study||18
323336|NCT00666679|780068|P2|NOT COMPLETED|Second Intervention||1
323337|NCT00666679|780069|P1|NOT COMPLETED|Second Intervention||1
323338|NCT00666679|780068|P2|COMPLETED|Second Intervention||64
323339|NCT00666679|780069|P1|COMPLETED|Second Intervention||61
323340|NCT00666679|780068|P2|STARTED|Second Intervention||65
323341|NCT00666679|780069|P1|STARTED|Second Intervention||62
323342|NCT00666679|780068|P2|NOT COMPLETED|Washout Period of 1 Week||2
323343|NCT00666679|780069|P1|NOT COMPLETED|Washout Period of 1 Week||0
323344|NCT00666679|780068|P2|COMPLETED|Washout Period of 1 Week||65
323345|NCT00666679|780069|P1|COMPLETED|Washout Period of 1 Week||62
323346|NCT00666679|780068|P2|STARTED|Washout Period of 1 Week||67
323347|NCT00666679|780069|P1|STARTED|Washout Period of 1 Week||62
323348|NCT00666679|780068|P2|NOT COMPLETED|First Intervention||1
323349|NCT00666679|780069|P1|NOT COMPLETED|First Intervention||4
323350|NCT00666679|780068|P2|COMPLETED|First Intervention||67
323351|NCT00666679|780069|P1|COMPLETED|First Intervention||62
323352|NCT00666679|780068|P2|STARTED|First Intervention||68
323353|NCT00666679|780069|P1|STARTED|First Intervention||66
323354|NCT00666666|780089|P1|NOT COMPLETED|Overall Study||0
323355|NCT00666666|780089|P1|COMPLETED|Overall Study||55
323356|NCT00666666|780089|P1|STARTED|Overall Study||55
323357|NCT00666588|780099|P4|NOT COMPLETED|Overall Study||2
323358|NCT00666588|780100|P3|NOT COMPLETED|Overall Study||0
323359|NCT00666588|780101|P2|NOT COMPLETED|Overall Study||0
323360|NCT00666588|780102|P1|NOT COMPLETED|Overall Study||4
323361|NCT00666588|780099|P4|COMPLETED|Overall Study||20
323362|NCT00666588|780100|P3|COMPLETED|Overall Study||6
323363|NCT00666588|780101|P2|COMPLETED|Overall Study||6
323364|NCT00666588|780102|P1|COMPLETED|Overall Study||14
323365|NCT00666588|780099|P4|STARTED|Overall Study||22
323366|NCT00666588|780100|P3|STARTED|Overall Study||6
323367|NCT00666588|780101|P2|STARTED|Overall Study||6
323368|NCT00666588|780102|P1|STARTED|Overall Study||18
323369|NCT00666562|780135|P3|NOT COMPLETED|Overall Study||0
323370|NCT00666562|780136|P2|NOT COMPLETED|Overall Study||2
323371|NCT00666562|780137|P1|NOT COMPLETED|Overall Study||0
323372|NCT00666562|780135|P3|COMPLETED|Overall Study||10
323373|NCT00666562|780136|P2|COMPLETED|Overall Study||8
323374|NCT00666562|780137|P1|COMPLETED|Overall Study||11
323375|NCT00666562|780135|P3|STARTED|Overall Study||10
323376|NCT00666562|780136|P2|STARTED|Overall Study||10
323377|NCT00666562|780137|P1|STARTED|Overall Study||11
323378|NCT00666536|780184|P2|NOT COMPLETED|Overall Study||37
323379|NCT00666536|780185|P1|NOT COMPLETED|Overall Study||33
323380|NCT00666536|780184|P2|COMPLETED|Overall Study||322
323381|NCT00666536|780185|P1|COMPLETED|Overall Study||336
323382|NCT00666536|780184|P2|STARTED|Overall Study||359
323383|NCT00666536|780185|P1|STARTED|Overall Study||369
323384|NCT00666458|780203|P2|NOT COMPLETED|Overall Study||24
323385|NCT00666458|780204|P1|NOT COMPLETED|Overall Study||38
323386|NCT00666458|780203|P2|COMPLETED|Overall Study|Completed 18 weeks of treatment|374
323387|NCT00666458|780204|P1|COMPLETED|Overall Study|Completed 18 weeks of treatment|365
323388|NCT00666458|780203|P2|STARTED|Overall Study|Randomized and treated|398
323389|NCT00666458|780204|P1|STARTED|Overall Study|Randomized and treated|403
323390|NCT00666406|780216|P2|NOT COMPLETED|Second PK Infusion||0
323391|NCT00666406|780217|P1|NOT COMPLETED|Second PK Infusion||0
323392|NCT00666406|780216|P2|COMPLETED|Second PK Infusion||3
323393|NCT00666406|780217|P1|COMPLETED|Second PK Infusion||6
323394|NCT00666406|780216|P2|STARTED|Second PK Infusion||3
323395|NCT00666406|780217|P1|STARTED|Second PK Infusion||6
323396|NCT00666406|780216|P2|NOT COMPLETED|First PK Infusion||0
323397|NCT00666406|780217|P1|NOT COMPLETED|First PK Infusion||0
323398|NCT00666406|780216|P2|COMPLETED|First PK Infusion||3
323399|NCT00666406|780217|P1|COMPLETED|First PK Infusion||6
323400|NCT00666406|780216|P2|STARTED|First PK Infusion||3
323401|NCT00666406|780217|P1|STARTED|First PK Infusion||6
323402|NCT00666328|780292|P1|NOT COMPLETED|Overall Study||5
323403|NCT00666328|780292|P1|COMPLETED|Overall Study|30/35 completed the study within the Safety population; 28/33 completed within the mITT population.|30
323404|NCT00666328|780292|P1|Modified Intent To Treat (mITT)|Overall Study|mITT population: participants dosed and in whom all inclusion and no exclusion criteria were met|33
323405|NCT00666328|780292|P1|STARTED|Overall Study|Safety population: participants dosed with study drug (primary population for Safety analyses)|35
323406|NCT00666276|780305|P1|NOT COMPLETED|Overall Study||34
323407|NCT00666276|780305|P1|COMPLETED|Overall Study||970
323408|NCT00666276|780305|P1|STARTED|Overall Study||1004
323409|NCT00666263|780329|P2|NOT COMPLETED|End of Study Visit||0
323410|NCT00666263|780330|P1|NOT COMPLETED|End of Study Visit||0
323411|NCT00666263|780329|P2|COMPLETED|End of Study Visit||22
323412|NCT00666263|780330|P1|COMPLETED|End of Study Visit||22
323413|NCT00666263|780329|P2|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
323414|NCT00666263|780330|P1|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
323415|NCT00666263|780329|P2|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||1
323416|NCT00666263|780330|P1|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||0
323417|NCT00666263|780329|P2|COMPLETED|Study Part 5 (Stabilization Phase 3)||20
323418|NCT00666263|780330|P1|COMPLETED|Study Part 5 (Stabilization Phase 3)||21
323419|NCT00666263|780329|P2|STARTED|Study Part 5 (Stabilization Phase 3)||21
323420|NCT00666263|780330|P1|STARTED|Study Part 5 (Stabilization Phase 3)||21
323421|NCT00666263|780329|P2|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||0
323422|NCT00666263|780330|P1|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||1
323423|NCT00666263|780329|P2|COMPLETED|Study Part 4 (Cross-over Period 2)||21
323424|NCT00666263|780330|P1|COMPLETED|Study Part 4 (Cross-over Period 2)||21
323425|NCT00666263|780329|P2|STARTED|Study Part 4 (Cross-over Period 2)||21
323426|NCT00666263|780330|P1|STARTED|Study Part 4 (Cross-over Period 2)||22
323427|NCT00666263|780329|P2|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
323428|NCT00666263|780330|P1|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
323429|NCT00666263|780329|P2|COMPLETED|Study Part 3 (Stabilization Phase 2)||21
323430|NCT00666263|780330|P1|COMPLETED|Study Part 3 (Stabilization Phase 2)||22
323431|NCT00666263|780329|P2|STARTED|Study Part 3 (Stabilization Phase 2)||21
323432|NCT00666263|780330|P1|STARTED|Study Part 3 (Stabilization Phase 2)||22
323433|NCT00666263|780329|P2|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
323434|NCT00666263|780330|P1|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
323435|NCT00666263|780329|P2|COMPLETED|Study Part 2 (Cross-over Period 1)||21
323436|NCT00666263|780330|P1|COMPLETED|Study Part 2 (Cross-over Period 1)||22
323437|NCT00666263|780329|P2|STARTED|Study Part 2 (Cross-over Period 1)||21
323438|NCT00666263|780330|P1|STARTED|Study Part 2 (Cross-over Period 1)||22
323439|NCT00666263|780329|P2|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||1
323440|NCT00666263|780330|P1|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||0
323441|NCT00666263|780329|P2|COMPLETED|Study Part 1 (Stabilization Phase 1)||21
323442|NCT00666263|780330|P1|COMPLETED|Study Part 1 (Stabilization Phase 1)||22
323443|NCT00666263|780329|P2|STARTED|Study Part 1 (Stabilization Phase 1)||22
323444|NCT00666263|780330|P1|STARTED|Study Part 1 (Stabilization Phase 1)||22
323445|NCT00666224|780474|P2|NOT COMPLETED|Open-Label||85
323446|NCT00666224|780475|P1|NOT COMPLETED|Open-Label||35
323447|NCT00666224|780474|P2|COMPLETED|Open-Label||126
323448|NCT00666224|780475|P1|COMPLETED|Open-Label||163
323449|NCT00666224|780474|P2|STARTED|Open-Label||211
323450|NCT00666224|780475|P1|STARTED|Open-Label|454 participants took at least one dose of GA including 45 who didn't continue into the OL.|198
323451|NCT00666224|780474|P2|NOT COMPLETED|Double-Blind||27
323452|NCT00666224|780475|P1|NOT COMPLETED|Double-Blind||45
323453|NCT00666224|780474|P2|COMPLETED|Double-Blind|55 completed 3 years treatment, 109 converted to CDMS, 47 switched to OL as per DMC|211
323454|NCT00666224|780475|P1|COMPLETED|Double-Blind|78 completed 3 years treatment, 66 converted to CDMS, 54 switched to OL as per DMC|198
323455|NCT00666224|780474|P2|STARTED|Double-Blind||238
323456|NCT00666224|780475|P1|STARTED|Double-Blind||243
323457|NCT00666211|780494|P2|NOT COMPLETED|Overall Study||38
323458|NCT00666211|780495|P1|NOT COMPLETED|Overall Study||20
323459|NCT00666211|780494|P2|COMPLETED|Overall Study||18
323460|NCT00666211|780495|P1|COMPLETED|Overall Study||22
323461|NCT00666211|780494|P2|STARTED|Overall Study||56
323462|NCT00666211|780495|P1|STARTED|Overall Study||42
323463|NCT00666198|780513|P1|NOT COMPLETED|Overall Study||33
323464|NCT00666198|780513|P1|COMPLETED|Overall Study||3304
323465|NCT00666198|780513|P1|STARTED|Overall Study||3337
323466|NCT00666029|780528|P2|NOT COMPLETED|Overall Study||0
323467|NCT00666029|780529|P1|NOT COMPLETED|Overall Study||1
323468|NCT00666029|780528|P2|COMPLETED|Overall Study||20
323469|NCT00666029|780529|P1|COMPLETED|Overall Study||19
323470|NCT00666029|780528|P2|STARTED|Overall Study||20
323471|NCT00666029|780529|P1|STARTED|Overall Study||20
323472|NCT00665925|780541|P4|NOT COMPLETED|Overall Study||21
323473|NCT00665925|780542|P3|NOT COMPLETED|Overall Study||26
323474|NCT00665925|780543|P2|NOT COMPLETED|Overall Study||17
323475|NCT00665925|780544|P1|NOT COMPLETED|Overall Study||15
323476|NCT00665925|780541|P4|COMPLETED|Overall Study|Participants completed the study|131
323477|NCT00665925|780542|P3|COMPLETED|Overall Study|Participants completed the study|126
323478|NCT00665925|780543|P2|COMPLETED|Overall Study|Participants completed the study|59
323479|NCT00665925|780544|P1|COMPLETED|Overall Study|Participants completed the study|62
323480|NCT00665925|780541|P4|STARTED|Overall Study|Participants randomized|152
323481|NCT00665925|780542|P3|STARTED|Overall Study|Participants randomized|152
323482|NCT00665925|780543|P2|STARTED|Overall Study|Participants randomized|76
323483|NCT00665925|780544|P1|STARTED|Overall Study|Participants randomized|77
323484|NCT00665847|780955|P1|NOT COMPLETED|Overall Study||25
323485|NCT00665847|780955|P1|COMPLETED|Overall Study||76
323486|NCT00665847|780955|P1|STARTED|Overall Study||101
323487|NCT00665704|780967|P1|NOT COMPLETED|Overall Study||0
323488|NCT00665704|780967|P1|COMPLETED|Overall Study||9
323489|NCT00665704|780967|P1|STARTED|Overall Study||9
323490|NCT00665652|780972|P1|NOT COMPLETED|Overall Study||6
323491|NCT00665652|780972|P1|COMPLETED|Overall Study||2
323492|NCT00665652|780972|P1|STARTED|Overall Study||8
323493|NCT00665626|780978|P2|NOT COMPLETED|Overall Study||22
323494|NCT00665626|780979|P1|NOT COMPLETED|Overall Study||10
323495|NCT00665626|780978|P2|COMPLETED|Overall Study|Participants completed the study|124
323496|NCT00665626|780979|P1|COMPLETED|Overall Study|Participants completed the study|63
323497|NCT00665626|780978|P2|STARTED|Overall Study|Participants randomized|146
323498|NCT00665626|780979|P1|STARTED|Overall Study|Participants randomized|73
323499|NCT00665470|781047|P2|NOT COMPLETED|Overall Study||0
323500|NCT00665470|781048|P1|NOT COMPLETED|Overall Study||0
323501|NCT00665470|781047|P2|COMPLETED|Overall Study||0
323502|NCT00665470|781048|P1|COMPLETED|Overall Study||10
323503|NCT00665470|781047|P2|STARTED|Overall Study||0
323504|NCT00665470|781048|P1|STARTED|Overall Study||10
323505|NCT00665457|781056|P1|NOT COMPLETED|Overall Study||0
323506|NCT00665457|781056|P1|COMPLETED|Overall Study||3
323507|NCT00665457|781056|P1|STARTED|Overall Study||3
323508|NCT00665444|781061|P1|NOT COMPLETED|Overall Study||2
323509|NCT00665444|781061|P1|COMPLETED|Overall Study||1
323510|NCT00665444|781061|P1|STARTED|Overall Study||3
323511|NCT00665431|781073|P3|NOT COMPLETED|Overall Study||24
323512|NCT00665431|781074|P2|NOT COMPLETED|Overall Study||57
323513|NCT00665431|781075|P1|NOT COMPLETED|Overall Study||40
323514|NCT00665431|781073|P3|COMPLETED|Overall Study||98
323515|NCT00665431|781074|P2|COMPLETED|Overall Study||188
323516|NCT00665431|781075|P1|COMPLETED|Overall Study||203
323517|NCT00665431|781073|P3|STARTED|Overall Study|Safety population|122
323518|NCT00665431|781074|P2|STARTED|Overall Study|Safety population|245
323519|NCT00665431|781075|P1|STARTED|Overall Study|Safety population|243
323520|NCT00665366|781118|P2|NOT COMPLETED|Overall Study||59
323521|NCT00665366|781119|P1|NOT COMPLETED|Overall Study||58
323522|NCT00665366|781118|P2|COMPLETED|Overall Study||122
323523|NCT00665366|781119|P1|COMPLETED|Overall Study||131
323524|NCT00665366|781118|P2|STARTED|Overall Study|Participants randomized|181
323525|NCT00665366|781119|P1|STARTED|Overall Study|Participants randomized|189
323526|NCT00665353|781147|P1|NOT COMPLETED|Study Step 2||14
323527|NCT00665353|781147|P1|COMPLETED|Study Step 2||2
323528|NCT00665353|781147|P1|STARTED|Study Step 2||16
323529|NCT00665353|781147|P1|NOT COMPLETED|Study Step 1||3
323530|NCT00665353|781147|P1|COMPLETED|Study Step 1||16
323531|NCT00665353|781147|P1|STARTED|Study Step 1||19
323532|NCT00665132|781157|P1|NOT COMPLETED|Overall Study||0
323533|NCT00665132|781157|P1|COMPLETED|Overall Study||10
323534|NCT00665132|781157|P1|STARTED|Overall Study||10
323535|NCT00665002|781164|P1|NOT COMPLETED|Overall Study||12
323536|NCT00665002|781164|P1|COMPLETED|Overall Study||4
323537|NCT00665002|781164|P1|STARTED|Overall Study||16
323538|NCT00664755|781171|P2|NOT COMPLETED|Overall Study||0
323539|NCT00664755|781172|P1|NOT COMPLETED|Overall Study||0
323540|NCT00664755|781171|P2|COMPLETED|Overall Study||73
323541|NCT00664755|781172|P1|COMPLETED|Overall Study||67
323542|NCT00664755|781171|P2|STARTED|Overall Study||73
323543|NCT00664755|781172|P1|STARTED|Overall Study||67
323544|NCT00664742|781178|P1|NOT COMPLETED|Overall Study||126
323545|NCT00664742|781178|P1|COMPLETED|Overall Study||481
323546|NCT00664742|781178|P1|STARTED|Overall Study||607
323547|NCT00664560|781186|P3|NOT COMPLETED|Overall Study||19
323548|NCT00664560|781187|P2|NOT COMPLETED|Overall Study||35
323549|NCT00664560|781188|P1|NOT COMPLETED|Overall Study||39
323550|NCT00664560|781186|P3|COMPLETED|Overall Study||105
323551|NCT00664560|781187|P2|COMPLETED|Overall Study||208
323552|NCT00664560|781188|P1|COMPLETED|Overall Study||208
323553|NCT00664560|781186|P3|STARTED|Overall Study|Safety Population|124
323554|NCT00664560|781187|P2|STARTED|Overall Study|Safety Population|243
323555|NCT00664560|781188|P1|STARTED|Overall Study|Safety Population|247
323556|NCT00664534|781231|P2|NOT COMPLETED|Overall Study||33
323557|NCT00664534|781232|P1|NOT COMPLETED|Overall Study||41
323558|NCT00664534|781231|P2|COMPLETED|Overall Study||138
323559|NCT00664534|781232|P1|COMPLETED|Overall Study||132
323560|NCT00664534|781231|P2|STARTED|Overall Study||171
323561|NCT00664534|781232|P1|STARTED|Overall Study||173
323562|NCT00664521|781260|P2|NOT COMPLETED|Overall Study||1
323563|NCT00664521|781261|P1|NOT COMPLETED|Overall Study||6
323564|NCT00664521|781260|P2|COMPLETED|Overall Study||8
323565|NCT00664521|781261|P1|COMPLETED|Overall Study||12
323566|NCT00664521|781260|P2|STARTED|Overall Study||9
323567|NCT00664521|781261|P1|STARTED|Overall Study||18
323568|NCT00664430|781281|P1|NOT COMPLETED|Overall Study||13
323569|NCT00664430|781281|P1|COMPLETED|Overall Study|Study terminated early due to low enrollment rate.|0
323570|NCT00664430|781281|P1|STARTED|Overall Study||13
323571|NCT00664326|781287|P1|NOT COMPLETED|Overall Study||24
323572|NCT00664326|781287|P1|COMPLETED|Overall Study||25
323573|NCT00664326|781287|P1|STARTED|Overall Study||49
323574|NCT00664209|781306|P1|NOT COMPLETED|Study Treatment Period||6
323575|NCT00664209|781306|P1|COMPLETED|Study Treatment Period||0
323576|NCT00664209|781306|P1|STARTED|Study Treatment Period||6
323577|NCT00664209|781306|P1|NOT COMPLETED|Motor Fluctuations Screen||7
323578|NCT00664209|781306|P1|COMPLETED|Motor Fluctuations Screen||6
323579|NCT00664209|781306|P1|STARTED|Motor Fluctuations Screen||13
323580|NCT00664105|781314|P1|NOT COMPLETED|Overall Study||24
323581|NCT00664105|781314|P1|COMPLETED|Overall Study||39
323582|NCT00664105|781314|P1|STARTED|Overall Study||63
323583|NCT00664066|781321|P1|NOT COMPLETED|Overall Study||3
323584|NCT00664066|781321|P1|COMPLETED|Overall Study||0
323585|NCT00664066|781321|P1|STARTED|Overall Study||3
323586|NCT00663962|781327|P2|NOT COMPLETED|Overall Study||0
323587|NCT00663962|781328|P1|NOT COMPLETED|Overall Study||1
323588|NCT00663962|781327|P2|COMPLETED|Overall Study||8
323589|NCT00663962|781328|P1|COMPLETED|Overall Study|1 patient excluded for somnolence and unblinded--in 300mg group|6
323590|NCT00663962|781327|P2|STARTED|Overall Study||8
323591|NCT00663962|781328|P1|STARTED|Overall Study||7
323592|NCT00663923|781334|P1|NOT COMPLETED|Overall Study||2
323593|NCT00663923|781334|P1|COMPLETED|Overall Study||48
323594|NCT00663923|781334|P1|STARTED|Overall Study||50
323595|NCT00663858|781351|P3|NOT COMPLETED|Overall Study||20
323596|NCT00663858|781352|P2|NOT COMPLETED|Overall Study||10
323597|NCT00663858|781353|P1|NOT COMPLETED|Overall Study||34
323598|NCT00663858|781351|P3|COMPLETED|Overall Study||82
323599|NCT00663858|781352|P2|COMPLETED|Overall Study||96
323600|NCT00663858|781353|P1|COMPLETED|Overall Study||178
323601|NCT00663858|781351|P3|STARTED|Overall Study||102
323602|NCT00663858|781352|P2|STARTED|Overall Study||106
323603|NCT00663858|781353|P1|STARTED|Overall Study||212
323604|NCT00663819|781363|P2|NOT COMPLETED|Overall Study||0
323605|NCT00663819|781364|P1|NOT COMPLETED|Overall Study||0
323606|NCT00663819|781363|P2|COMPLETED|Overall Study||135
323607|NCT00663819|781364|P1|COMPLETED|Overall Study||123
323608|NCT00663819|781363|P2|STARTED|Overall Study||135
323609|NCT00663819|781364|P1|STARTED|Overall Study||123
323610|NCT00663793|781378|P2|NOT COMPLETED|Overall Study||0
323611|NCT00663793|781379|P1|NOT COMPLETED|Overall Study||0
323612|NCT00663793|781378|P2|COMPLETED|Overall Study||8
323613|NCT00663793|781379|P1|COMPLETED|Overall Study||8
323614|NCT00663793|781378|P2|STARTED|Overall Study||8
323615|NCT00663793|781379|P1|STARTED|Overall Study||8
323616|NCT00663702|781391|P2|NOT COMPLETED|Overall Study||10
323617|NCT00663702|781392|P1|NOT COMPLETED|Overall Study||18
323618|NCT00663702|781391|P2|COMPLETED|Overall Study||61
323619|NCT00663702|781392|P1|COMPLETED|Overall Study||34
323620|NCT00663702|781391|P2|STARTED|Overall Study||71
323621|NCT00663702|781392|P1|STARTED|Overall Study||52
323622|NCT00663403|781415|P1|NOT COMPLETED|Overall Study||0
323623|NCT00663403|781415|P1|COMPLETED|Overall Study||8
323624|NCT00663403|781415|P1|STARTED|Overall Study||8
323625|NCT00663260|781428|P3|NOT COMPLETED|Overall Study||16
323626|NCT00663260|781429|P2|NOT COMPLETED|Overall Study||11
323627|NCT00663260|781430|P1|NOT COMPLETED|Overall Study||21
323628|NCT00663260|781428|P3|COMPLETED|Overall Study||69
323629|NCT00663260|781429|P2|COMPLETED|Overall Study||72
323630|NCT00663260|781430|P1|COMPLETED|Overall Study||63
323631|NCT00663260|781428|P3|STARTED|Overall Study||85
323632|NCT00663260|781429|P2|STARTED|Overall Study||83
323633|NCT00663260|781430|P1|STARTED|Overall Study||84
323634|NCT00663234|781444|P1|NOT COMPLETED|Overall Study||1
323635|NCT00663234|781444|P1|COMPLETED|Overall Study||27
323636|NCT00663234|781444|P1|Dose Increased to 20 mg at Week 8|Overall Study||10
323637|NCT00663234|781444|P1|STARTED|Overall Study||28
323638|NCT00663208|781477|P7|NOT COMPLETED|Follow-up Period||1
323639|NCT00663208|781478|P6|NOT COMPLETED|Follow-up Period||0
323640|NCT00663208|781479|P5|NOT COMPLETED|Follow-up Period||0
323641|NCT00663208|781480|P4|NOT COMPLETED|Follow-up Period||2
323642|NCT00663208|781481|P3|NOT COMPLETED|Follow-up Period||3
323643|NCT00663208|781482|P2|NOT COMPLETED|Follow-up Period||0
323644|NCT00663208|781483|P1|NOT COMPLETED|Follow-up Period||3
323645|NCT00663208|781477|P7|COMPLETED|Follow-up Period||5
323646|NCT00663208|781478|P6|COMPLETED|Follow-up Period||4
323647|NCT00663208|781479|P5|COMPLETED|Follow-up Period||4
323648|NCT00663208|781480|P4|COMPLETED|Follow-up Period||2
323649|NCT00663208|781481|P3|COMPLETED|Follow-up Period||1
323650|NCT00663208|781482|P2|COMPLETED|Follow-up Period||3
323651|NCT00663208|781483|P1|COMPLETED|Follow-up Period||1
323652|NCT00663208|781477|P7|STARTED|Follow-up Period||6
323653|NCT00663208|781478|P6|STARTED|Follow-up Period||4
323654|NCT00663208|781479|P5|STARTED|Follow-up Period||4
323655|NCT00663208|781480|P4|STARTED|Follow-up Period||4
323656|NCT00663208|781481|P3|STARTED|Follow-up Period||4
323657|NCT00663208|781482|P2|STARTED|Follow-up Period||3
323658|NCT00663208|781483|P1|STARTED|Follow-up Period||4
323659|NCT00663208|781477|P7|NOT COMPLETED|Treatment Period||0
323660|NCT00663208|781478|P6|NOT COMPLETED|Treatment Period||0
323661|NCT00663208|781479|P5|NOT COMPLETED|Treatment Period||0
323662|NCT00663208|781480|P4|NOT COMPLETED|Treatment Period||0
323663|NCT00663208|781481|P3|NOT COMPLETED|Treatment Period||0
323664|NCT00663208|781482|P2|NOT COMPLETED|Treatment Period||1
323665|NCT00663208|781483|P1|NOT COMPLETED|Treatment Period||0
323666|NCT00663208|781477|P7|COMPLETED|Treatment Period||6
323667|NCT00663208|781478|P6|COMPLETED|Treatment Period||4
323668|NCT00663208|781479|P5|COMPLETED|Treatment Period||4
323669|NCT00663208|781480|P4|COMPLETED|Treatment Period||4
323670|NCT00663208|781481|P3|COMPLETED|Treatment Period||4
323671|NCT00663208|781482|P2|COMPLETED|Treatment Period||3
323672|NCT00663208|781483|P1|COMPLETED|Treatment Period||4
323673|NCT00663208|781477|P7|STARTED|Treatment Period||6
323674|NCT00663208|781478|P6|STARTED|Treatment Period||4
323675|NCT00663208|781479|P5|STARTED|Treatment Period||4
323676|NCT00663208|781480|P4|STARTED|Treatment Period||4
323677|NCT00663208|781481|P3|STARTED|Treatment Period||4
323678|NCT00663208|781482|P2|STARTED|Treatment Period||4
323679|NCT00663208|781483|P1|STARTED|Treatment Period||4
323680|NCT00663169|781635|P2|NOT COMPLETED|Overall Study||0
323681|NCT00663169|781636|P1|NOT COMPLETED|Overall Study||0
323682|NCT00663169|781635|P2|COMPLETED|Overall Study||3
323683|NCT00663169|781636|P1|COMPLETED|Overall Study||3
323684|NCT00663169|781635|P2|STARTED|Overall Study||3
323685|NCT00663169|781636|P1|STARTED|Overall Study||3
323686|NCT00663117|781661|P2|NOT COMPLETED|Overall Study||0
323687|NCT00663117|781662|P1|NOT COMPLETED|Overall Study||1
323688|NCT00663117|781661|P2|COMPLETED|Overall Study||20
323689|NCT00663117|781662|P1|COMPLETED|Overall Study|One patient in placebo flared and was unblinded and crossed over to active drug|19
323690|NCT00663117|781661|P2|STARTED|Overall Study||20
323691|NCT00663117|781662|P1|STARTED|Overall Study||20
323692|NCT00663052|781676|P2|NOT COMPLETED|Overall Study||10
323693|NCT00663052|781677|P1|NOT COMPLETED|Overall Study||12
323694|NCT00663052|781676|P2|COMPLETED|Overall Study||127
323695|NCT00663052|781677|P1|COMPLETED|Overall Study||124
323696|NCT00663052|781676|P2|STARTED|Overall Study||137
323697|NCT00663052|781677|P1|STARTED|Overall Study||136
323698|NCT00663039|781757|P2|NOT COMPLETED|Overall Study||4
323699|NCT00663039|781758|P1|NOT COMPLETED|Overall Study||4
323700|NCT00663039|781757|P2|COMPLETED|Overall Study||9
323701|NCT00663039|781758|P1|COMPLETED|Overall Study||10
323702|NCT00663039|781757|P2|STARTED|Overall Study||13
323703|NCT00663039|781758|P1|STARTED|Overall Study||14
323704|NCT00663026|781783|P3|NOT COMPLETED|Overall Study||4
323705|NCT00663026|781784|P2|NOT COMPLETED|Overall Study||6
323706|NCT00663026|781785|P1|NOT COMPLETED|Overall Study||2
323707|NCT00663026|781783|P3|COMPLETED|Overall Study||27
323708|NCT00663026|781784|P2|COMPLETED|Overall Study||23
323709|NCT00663026|781785|P1|COMPLETED|Overall Study||17
323710|NCT00663026|781783|P3|STARTED|Overall Study||31
323711|NCT00663026|781784|P2|STARTED|Overall Study||29
323712|NCT00663026|781785|P1|STARTED|Overall Study||19
323713|NCT00662909|781808|P3|NOT COMPLETED|Overall Study||53
323714|NCT00662909|781809|P2|NOT COMPLETED|Overall Study||59
323715|NCT00662909|781810|P1|NOT COMPLETED|Overall Study||69
323716|NCT00662909|781808|P3|COMPLETED|Overall Study||380
323717|NCT00662909|781809|P2|COMPLETED|Overall Study||383
323718|NCT00662909|781810|P1|COMPLETED|Overall Study||385
323719|NCT00662909|781808|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|296
323720|NCT00662909|781809|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|312
323721|NCT00662909|781810|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|325
323722|NCT00662909|781808|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|412
323723|NCT00662909|781809|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|425
323724|NCT00662909|781810|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|433
323807|NCT00662649|782009|P1|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||31
323725|NCT00662909|781808|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
323726|NCT00662909|781809|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|442
323727|NCT00662909|781810|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|453
323728|NCT00662909|781808|P3|STARTED|Overall Study||433
323729|NCT00662909|781809|P2|STARTED|Overall Study||442
323730|NCT00662909|781810|P1|STARTED|Overall Study||454
323731|NCT00662857|781908|P2|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
323732|NCT00662857|781909|P1|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
323733|NCT00662857|781908|P2|COMPLETED|Lispro Dosing Period (1 Day)||14
323734|NCT00662857|781909|P1|COMPLETED|Lispro Dosing Period (1 Day)||12
323735|NCT00662857|781908|P2|STARTED|Lispro Dosing Period (1 Day)||14
323736|NCT00662857|781909|P1|STARTED|Lispro Dosing Period (1 Day)||12
323737|NCT00662857|781908|P2|NOT COMPLETED|Washout 2 (3 - 14 Days)||0
323738|NCT00662857|781909|P1|NOT COMPLETED|Washout 2 (3 - 14 Days)||1
323739|NCT00662857|781908|P2|COMPLETED|Washout 2 (3 - 14 Days)||14
323740|NCT00662857|781909|P1|COMPLETED|Washout 2 (3 - 14 Days)||12
323741|NCT00662857|781908|P2|STARTED|Washout 2 (3 - 14 Days)||14
323742|NCT00662857|781909|P1|STARTED|Washout 2 (3 - 14 Days)||13
323743|NCT00662857|781908|P2|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
323744|NCT00662857|781909|P1|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
323745|NCT00662857|781908|P2|COMPLETED|TI Dosing Period 2 (1 Day)||14
323746|NCT00662857|781909|P1|COMPLETED|TI Dosing Period 2 (1 Day)||13
323747|NCT00662857|781908|P2|STARTED|TI Dosing Period 2 (1 Day)||14
323748|NCT00662857|781909|P1|STARTED|TI Dosing Period 2 (1 Day)||13
323749|NCT00662857|781908|P2|NOT COMPLETED|Washout 1 (3 - 14 Days)||2
323750|NCT00662857|781909|P1|NOT COMPLETED|Washout 1 (3 - 14 Days)||0
323751|NCT00662857|781908|P2|COMPLETED|Washout 1 (3 - 14 Days)||14
323752|NCT00662857|781909|P1|COMPLETED|Washout 1 (3 - 14 Days)||13
323753|NCT00662857|781908|P2|STARTED|Washout 1 (3 - 14 Days)||16
323754|NCT00662857|781909|P1|STARTED|Washout 1 (3 - 14 Days)||13
323755|NCT00662857|781908|P2|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
323756|NCT00662857|781909|P1|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
323757|NCT00662857|781908|P2|COMPLETED|TI Dosing Period 1 (1 Day)||16
323758|NCT00662857|781909|P1|COMPLETED|TI Dosing Period 1 (1 Day)||13
323759|NCT00662857|781908|P2|STARTED|TI Dosing Period 1 (1 Day)||16
323760|NCT00662857|781909|P1|STARTED|TI Dosing Period 1 (1 Day)||13
323761|NCT00662831|781924|P2|NOT COMPLETED|Overall Study||59
323762|NCT00662831|781925|P1|NOT COMPLETED|Overall Study||106
323763|NCT00662831|781924|P2|COMPLETED|Overall Study||33
323764|NCT00662831|781925|P1|COMPLETED|Overall Study||78
323765|NCT00662831|781924|P2|STARTED|Overall Study||92
323766|NCT00662831|781925|P1|STARTED|Overall Study||184
323767|NCT00662818|781965|P2|NOT COMPLETED|Period 2 (6 Weeks)||12
323768|NCT00662818|781966|P1|NOT COMPLETED|Period 2 (6 Weeks)||13
323769|NCT00662818|781965|P2|COMPLETED|Period 2 (6 Weeks)||41
323770|NCT00662818|781966|P1|COMPLETED|Period 2 (6 Weeks)||38
323771|NCT00662818|781965|P2|STARTED|Period 2 (6 Weeks)||53
323772|NCT00662818|781966|P1|STARTED|Period 2 (6 Weeks)||51
323773|NCT00662818|781965|P2|NOT COMPLETED|Wash-Out (14 Days)||5
323774|NCT00662818|781966|P1|NOT COMPLETED|Wash-Out (14 Days)||5
323775|NCT00662818|781965|P2|COMPLETED|Wash-Out (14 Days)||53
323776|NCT00662818|781966|P1|COMPLETED|Wash-Out (14 Days)||51
323777|NCT00662818|781965|P2|STARTED|Wash-Out (14 Days)||58
323778|NCT00662818|781966|P1|STARTED|Wash-Out (14 Days)||56
323779|NCT00662818|781965|P2|NOT COMPLETED|Period 1 (6 Weeks)||23
323780|NCT00662818|781966|P1|NOT COMPLETED|Period 1 (6 Weeks)||28
323781|NCT00662818|781965|P2|COMPLETED|Period 1 (6 Weeks)||58
323782|NCT00662818|781966|P1|COMPLETED|Period 1 (6 Weeks)||56
323783|NCT00662818|781965|P2|Treated|Period 1 (6 Weeks)||58
323784|NCT00662818|781966|P1|Treated|Period 1 (6 Weeks)||56
323785|NCT00662818|781965|P2|STARTED|Period 1 (6 Weeks)||81
323786|NCT00662818|781966|P1|STARTED|Period 1 (6 Weeks)||84
323787|NCT00662675|781990|P2|NOT COMPLETED|Overall Study||0
323788|NCT00662675|781991|P1|NOT COMPLETED|Overall Study||0
323789|NCT00662675|781990|P2|COMPLETED|Overall Study||20
323790|NCT00662675|781991|P1|COMPLETED|Overall Study||20
323791|NCT00662675|781990|P2|STARTED|Overall Study||20
323792|NCT00662675|781991|P1|STARTED|Overall Study||20
323793|NCT00662649|782005|P5|NOT COMPLETED|Extension Study (Month 24 to 60)||29
323794|NCT00662649|782006|P4|NOT COMPLETED|Extension Study (Month 24 to 60)||33
323795|NCT00662649|782007|P3|NOT COMPLETED|Extension Study (Month 24 to 60)||0
323796|NCT00662649|782008|P2|NOT COMPLETED|Extension Study (Month 24 to 60)||41
323797|NCT00662649|782009|P1|NOT COMPLETED|Extension Study (Month 24 to 60)||44
323798|NCT00662649|782005|P5|COMPLETED|Extension Study (Month 24 to 60)||126
323799|NCT00662649|782006|P4|COMPLETED|Extension Study (Month 24 to 60)||112
323800|NCT00662649|782007|P3|COMPLETED|Extension Study (Month 24 to 60)||0
323801|NCT00662649|782008|P2|COMPLETED|Extension Study (Month 24 to 60)||290
323802|NCT00662649|782009|P1|COMPLETED|Extension Study (Month 24 to 60)|"completed refers to patients that completed extension study in different time points."|245
323803|NCT00662649|782005|P5|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||13
323804|NCT00662649|782006|P4|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||11
323805|NCT00662649|782007|P3|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||0
323806|NCT00662649|782008|P2|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||32
323808|NCT00662649|782005|P5|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||67
323809|NCT00662649|782006|P4|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||58
323810|NCT00662649|782007|P3|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||0
323811|NCT00662649|782008|P2|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||152
323812|NCT00662649|782009|P1|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||125
323813|NCT00662649|782005|P5|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||136
323814|NCT00662649|782006|P4|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||120
323815|NCT00662649|782007|P3|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||0
323816|NCT00662649|782008|P2|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||301
323817|NCT00662649|782009|P1|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||254
323818|NCT00662649|782005|P5|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||145
323819|NCT00662649|782006|P4|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||130
323820|NCT00662649|782007|P3|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||0
323821|NCT00662649|782008|P2|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||311
323822|NCT00662649|782009|P1|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||270
323823|NCT00662649|782005|P5|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||152
323824|NCT00662649|782006|P4|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||136
323825|NCT00662649|782007|P3|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||0
323826|NCT00662649|782008|P2|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||324
323827|NCT00662649|782009|P1|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||276
323828|NCT00662649|782005|P5|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||155
323829|NCT00662649|782006|P4|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||145
323830|NCT00662649|782007|P3|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||0
323831|NCT00662649|782008|P2|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||331
323832|NCT00662649|782009|P1|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||289
323833|NCT00662649|782005|P5|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||154
323834|NCT00662649|782006|P4|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||145
323835|NCT00662649|782007|P3|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||0
323836|NCT00662649|782008|P2|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||330
323837|NCT00662649|782009|P1|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||287
323838|NCT00662649|782005|P5|STARTED|Extension Study (Month 24 to 60)||155
323839|NCT00662649|782006|P4|STARTED|Extension Study (Month 24 to 60)||145
323840|NCT00662649|782007|P3|STARTED|Extension Study (Month 24 to 60)|This reporting group is used only for core study|0
323841|NCT00662649|782008|P2|STARTED|Extension Study (Month 24 to 60)||331
323842|NCT00662649|782009|P1|STARTED|Extension Study (Month 24 to 60)||289
323843|NCT00662649|782005|P5|NOT COMPLETED|Core Study (24 Months)||0
323844|NCT00662649|782006|P4|NOT COMPLETED|Core Study (24 Months)||0
323845|NCT00662649|782007|P3|NOT COMPLETED|Core Study (24 Months)||86
323846|NCT00662649|782008|P2|NOT COMPLETED|Core Study (24 Months)||56
323847|NCT00662649|782009|P1|NOT COMPLETED|Core Study (24 Months)||97
323848|NCT00662649|782005|P5|COMPLETED|Core Study (24 Months)||0
323849|NCT00662649|782006|P4|COMPLETED|Core Study (24 Months)||0
323850|NCT00662649|782007|P3|COMPLETED|Core Study (24 Months)||332
323851|NCT00662649|782008|P2|COMPLETED|Core Study (24 Months)||369
323852|NCT00662649|782009|P1|COMPLETED|Core Study (24 Months)||332
323853|NCT00662649|782005|P5|Intent to Treat (ITT)|Core Study (24 Months)||0
323854|NCT00662649|782006|P4|Intent to Treat (ITT)|Core Study (24 Months)||0
323855|NCT00662649|782007|P3|Intent to Treat (ITT)|Core Study (24 Months)||418
323856|NCT00662649|782008|P2|Intent to Treat (ITT)|Core Study (24 Months)||425
323857|NCT00662649|782009|P1|Intent to Treat (ITT)|Core Study (24 Months)||429
323858|NCT00662649|782005|P5|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
323859|NCT00662649|782006|P4|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
323860|NCT00662649|782007|P3|STARTED|Core Study (24 Months)||418
323861|NCT00662649|782008|P2|STARTED|Core Study (24 Months)||425
323862|NCT00662649|782009|P1|STARTED|Core Study (24 Months)||429
323863|NCT00662558|782049|P2|NOT COMPLETED|Overall Study||110
323864|NCT00662558|782050|P1|NOT COMPLETED|Overall Study||56
323865|NCT00662558|782049|P2|COMPLETED|Overall Study||294
323866|NCT00662558|782050|P1|COMPLETED|Overall Study||342
323867|NCT00662558|782049|P2|Received Treatment|Overall Study||396
323868|NCT00662558|782050|P1|Received Treatment|Overall Study||396
323869|NCT00662558|782049|P2|STARTED|Overall Study||404
323870|NCT00662558|782050|P1|STARTED|Overall Study||398
323871|NCT00662545|782084|P2|NOT COMPLETED|Overall Study||0
323872|NCT00662545|782085|P1|NOT COMPLETED|Overall Study||0
323873|NCT00662545|782084|P2|COMPLETED|Overall Study||5
323874|NCT00662545|782085|P1|COMPLETED|Overall Study||5
323875|NCT00662545|782084|P2|STARTED|Overall Study||5
323876|NCT00662545|782085|P1|STARTED|Overall Study||5
323877|NCT00662532|782101|P2|NOT COMPLETED|Overall Study||2
323878|NCT00662532|782102|P1|NOT COMPLETED|Overall Study||0
323879|NCT00662532|782101|P2|COMPLETED|Overall Study||20
323880|NCT00662532|782102|P1|COMPLETED|Overall Study||22
323881|NCT00662532|782101|P2|STARTED|Overall Study||22
323882|NCT00662532|782102|P1|STARTED|Overall Study||22
323883|NCT00662389|782112|P1|NOT COMPLETED|Overall Study||0
323884|NCT00662389|782112|P1|COMPLETED|Overall Study||4
323885|NCT00662389|782112|P1|STARTED|Overall Study||4
323886|NCT00662363|782117|P2|NOT COMPLETED|Overall Study||10
323887|NCT00662363|782118|P1|NOT COMPLETED|Overall Study||11
323888|NCT00662363|782117|P2|COMPLETED|Overall Study|one subject died before receiving any study med 2 subjects withdrew before taking any study med|22
323889|NCT00662363|782118|P1|COMPLETED|Overall Study|1 subject withdrew before taking any study medication|21
323890|NCT00662363|782117|P2|STARTED|Overall Study||32
323891|NCT00662363|782118|P1|STARTED|Overall Study||32
323892|NCT00662311|782129|P3|NOT COMPLETED|Overall Study||0
323893|NCT00662311|782130|P2|NOT COMPLETED|Overall Study||0
323894|NCT00662311|782131|P1|NOT COMPLETED|Overall Study||1
323895|NCT00662311|782129|P3|COMPLETED|Overall Study||0
323896|NCT00662311|782130|P2|COMPLETED|Overall Study||0
323897|NCT00662311|782131|P1|COMPLETED|Overall Study||4
323898|NCT00662311|782129|P3|STARTED|Overall Study||0
323899|NCT00662311|782130|P2|STARTED|Overall Study||0
323900|NCT00662311|782131|P1|STARTED|Overall Study||5
323901|NCT00662298|782154|P1|NOT COMPLETED|Overall Study||0
323902|NCT00662298|782154|P1|COMPLETED|Overall Study||5
323903|NCT00662298|782154|P1|STARTED|Overall Study||5
323904|NCT00662259|782166|P2|NOT COMPLETED|Overall Study||0
323905|NCT00662259|782167|P1|NOT COMPLETED|Overall Study||2
323906|NCT00662259|782166|P2|COMPLETED|Overall Study||11
323907|NCT00662259|782167|P1|COMPLETED|Overall Study||19
323908|NCT00662259|782166|P2|STARTED|Overall Study||11
323909|NCT00662259|782167|P1|STARTED|Overall Study||21
323910|NCT00662207|782181|P1|NOT COMPLETED|Overall Study||0
323911|NCT00662207|782181|P1|COMPLETED|Overall Study||3
323912|NCT00662207|782181|P1|STARTED|Overall Study||3
323913|NCT00662155|782192|P4|NOT COMPLETED|Overall Study||4
323914|NCT00662155|782193|P3|NOT COMPLETED|Overall Study||7
323915|NCT00662155|782194|P2|NOT COMPLETED|Overall Study||5
323916|NCT00662155|782195|P1|NOT COMPLETED|Overall Study||3
323917|NCT00662155|782192|P4|COMPLETED|Overall Study||14
323918|NCT00662155|782193|P3|COMPLETED|Overall Study||13
323919|NCT00662155|782194|P2|COMPLETED|Overall Study||15
323920|NCT00662155|782195|P1|COMPLETED|Overall Study||13
323921|NCT00662155|782192|P4|STARTED|Overall Study||18
323922|NCT00662155|782193|P3|STARTED|Overall Study||20
323923|NCT00662155|782194|P2|STARTED|Overall Study||20
323924|NCT00662155|782195|P1|STARTED|Overall Study||16
323925|NCT00662129|782209|P1|NOT COMPLETED|Overall Study||3
323926|NCT00662129|782209|P1|COMPLETED|Overall Study||47
323927|NCT00662129|782209|P1|STARTED|Overall Study||50
323928|NCT00662038|782219|P1|NOT COMPLETED|Overall Study||631
323929|NCT00662038|782219|P1|COMPLETED|Overall Study||427
323930|NCT00662038|782219|P1|STARTED|Overall Study||1058
323931|NCT00662025|782223|P1|NOT COMPLETED|Overall Study||63
323932|NCT00662025|782223|P1|COMPLETED|Overall Study||0
323933|NCT00662025|782223|P1|STARTED|Overall Study|All 63 participants were included in Full Analysis Set population.|63
323934|NCT00662012|782243|P1|NOT COMPLETED|Overall Study||87
323935|NCT00662012|782243|P1|COMPLETED|Overall Study||327
323936|NCT00662012|782243|P1|STARTED|Overall Study||414
323937|NCT00661999|782251|P3|NOT COMPLETED|Overall Study||57
323938|NCT00661999|782252|P2|NOT COMPLETED|Overall Study||50
323939|NCT00661999|782253|P1|NOT COMPLETED|Overall Study||59
323940|NCT00661999|782251|P3|COMPLETED|Overall Study||106
323941|NCT00661999|782252|P2|COMPLETED|Overall Study||113
323942|NCT00661999|782253|P1|COMPLETED|Overall Study||105
323943|NCT00661999|782251|P3|STARTED|Overall Study||163
323944|NCT00661999|782252|P2|STARTED|Overall Study||163
323945|NCT00661999|782253|P1|STARTED|Overall Study||164
323946|NCT00661960|782309|P3|NOT COMPLETED|Overall Study||1
323947|NCT00661960|782310|P2|NOT COMPLETED|Overall Study||3
323948|NCT00661960|782311|P1|NOT COMPLETED|Overall Study||0
323949|NCT00661960|782309|P3|COMPLETED|Overall Study||9
323950|NCT00661960|782310|P2|COMPLETED|Overall Study||7
323951|NCT00661960|782311|P1|COMPLETED|Overall Study||5
323952|NCT00661960|782309|P3|STARTED|Overall Study||10
323953|NCT00661960|782310|P2|STARTED|Overall Study||10
323954|NCT00661960|782311|P1|STARTED|Overall Study||5
323955|NCT00661895|782321|P2|NOT COMPLETED|Overall Study||0
323956|NCT00661895|782322|P1|NOT COMPLETED|Overall Study||0
323957|NCT00661895|782321|P2|COMPLETED|Overall Study||50
323958|NCT00661895|782322|P1|COMPLETED|Overall Study||49
323959|NCT00661895|782321|P2|STARTED|Overall Study||50
323960|NCT00661895|782322|P1|STARTED|Overall Study||49
323961|NCT00661830|782330|P2|NOT COMPLETED|Overall Study||42
323962|NCT00661830|782331|P1|NOT COMPLETED|Overall Study||40
323963|NCT00661830|782330|P2|COMPLETED|Overall Study||6
323964|NCT00661830|782331|P1|COMPLETED|Overall Study||9
323965|NCT00661830|782330|P2|STARTED|Overall Study||48
323966|NCT00661830|782331|P1|STARTED|Overall Study||49
323967|NCT00661778|782343|P1|NOT COMPLETED|Overall Study||50
323968|NCT00661778|782343|P1|COMPLETED|Overall Study||0
323969|NCT00661778|782343|P1|STARTED|Overall Study||50
323970|NCT00661726|782350|P1|NOT COMPLETED|Overall Study||1
323971|NCT00661726|782350|P1|COMPLETED|Overall Study||5
323972|NCT00661726|782350|P1|STARTED|Overall Study||6
323973|NCT00661713|782373|P8|NOT COMPLETED|Overall Study||11
323974|NCT00661713|782374|P7|NOT COMPLETED|Overall Study||64
323975|NCT00661713|782375|P6|NOT COMPLETED|Overall Study||37
323976|NCT00661713|782376|P5|NOT COMPLETED|Overall Study||20
323977|NCT00661713|782377|P4|NOT COMPLETED|Overall Study||28
323978|NCT00661713|782378|P3|NOT COMPLETED|Overall Study||17
323979|NCT00661713|782379|P2|NOT COMPLETED|Overall Study||39
323980|NCT00661713|782380|P1|NOT COMPLETED|Overall Study||16
323981|NCT00661713|782373|P8|COMPLETED|Overall Study||117
323982|NCT00661713|782374|P7|COMPLETED|Overall Study||309
323983|NCT00661713|782375|P6|COMPLETED|Overall Study||216
323984|NCT00661713|782376|P5|COMPLETED|Overall Study||107
323985|NCT00661713|782377|P4|COMPLETED|Overall Study||219
323986|NCT00661713|782378|P3|COMPLETED|Overall Study||111
323987|NCT00661713|782379|P2|COMPLETED|Overall Study||208
323988|NCT00661713|782380|P1|COMPLETED|Overall Study||112
323989|NCT00661713|782373|P8|STARTED|Overall Study||128
323990|NCT00661713|782374|P7|STARTED|Overall Study||373
323991|NCT00661713|782375|P6|STARTED|Overall Study||253
323992|NCT00661713|782376|P5|STARTED|Overall Study||127
323993|NCT00661713|782377|P4|STARTED|Overall Study||247
323994|NCT00661713|782378|P3|STARTED|Overall Study||128
323995|NCT00661713|782379|P2|STARTED|Overall Study||247
323996|NCT00661713|782380|P1|STARTED|Overall Study||128
323997|NCT00661687|782472|P1|NOT COMPLETED|Overall Study||15
323998|NCT00661687|782472|P1|COMPLETED|Overall Study|Number indicates number of subjects successfully completing study.|189
323999|NCT00661687|782472|P1|STARTED|Overall Study|Contralateral study design, numbers indicate number of subjects.|204
324000|NCT00661674|782482|P6|NOT COMPLETED|Overall Study||0
324001|NCT00661674|782483|P5|NOT COMPLETED|Overall Study||0
324002|NCT00661674|782484|P4|NOT COMPLETED|Overall Study||0
324003|NCT00661674|782485|P3|NOT COMPLETED|Overall Study||0
324004|NCT00661674|782486|P2|NOT COMPLETED|Overall Study||0
324005|NCT00661674|782487|P1|NOT COMPLETED|Overall Study||0
324006|NCT00661674|782482|P6|COMPLETED|Overall Study|Participant 9 completed sequence 6|1
324007|NCT00661674|782483|P5|COMPLETED|Overall Study|Participants 6 & 8 completed sequence 5|2
324008|NCT00661674|782484|P4|COMPLETED|Overall Study|Participant 5 completed sequence 4|1
324009|NCT00661674|782485|P3|COMPLETED|Overall Study|Participants 4 & 7 completed sequence 3|2
324010|NCT00661674|782486|P2|COMPLETED|Overall Study|Participants 2 & 3 completed sequence 2|2
324011|NCT00661674|782487|P1|COMPLETED|Overall Study|Participants 1 & 10 completed sequence 1|2
324012|NCT00661674|782482|P6|STARTED|Overall Study|Participant 9 was assigned to sequence 6|1
324013|NCT00661674|782483|P5|STARTED|Overall Study|Participants 6 & 8 were assigned to sequence 5|2
324014|NCT00661674|782484|P4|STARTED|Overall Study|Participant 5 was assigned to sequence 4|1
324015|NCT00661674|782485|P3|STARTED|Overall Study|Participants 4 & 7 were assigned to sequence 3|2
324016|NCT00661674|782486|P2|STARTED|Overall Study|Participants 2 & 3 were assigned to sequence 2|2
324017|NCT00661674|782487|P1|STARTED|Overall Study|Participants 1 & 10 were assigned to sequence 1|2
324018|NCT00661661|782500|P2|NOT COMPLETED|Overall Study||39
324019|NCT00661661|782501|P1|NOT COMPLETED|Overall Study||140
324020|NCT00661661|782500|P2|COMPLETED|Overall Study||66
324021|NCT00661661|782501|P1|COMPLETED|Overall Study||242
324022|NCT00661661|782500|P2|STARTED|Overall Study||105
324023|NCT00661661|782501|P1|STARTED|Overall Study||382
324024|NCT00661622|782577|P2|NOT COMPLETED|Overall Study||0
324025|NCT00661622|782578|P1|NOT COMPLETED|Overall Study||1
324026|NCT00661622|782577|P2|COMPLETED|Overall Study||27
324027|NCT00661622|782578|P1|COMPLETED|Overall Study||25
324028|NCT00661622|782577|P2|STARTED|Overall Study||27
324029|NCT00661622|782578|P1|STARTED|Overall Study||26
324030|NCT00661609|782592|P1|NOT COMPLETED|Overall Study||41
324031|NCT00661609|782592|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
324032|NCT00661609|782592|P1|STARTED|Overall Study|All dosed patients|41
324033|NCT00661583|782602|P3|NOT COMPLETED|Overall Study||0
324034|NCT00661583|782603|P2|NOT COMPLETED|Overall Study||0
324035|NCT00661583|782604|P1|NOT COMPLETED|Overall Study||0
324036|NCT00661583|782602|P3|COMPLETED|Overall Study||10
324037|NCT00661583|782603|P2|COMPLETED|Overall Study||10
324038|NCT00661583|782604|P1|COMPLETED|Overall Study||10
324039|NCT00661583|782602|P3|STARTED|Overall Study||10
324040|NCT00661583|782603|P2|STARTED|Overall Study||10
324041|NCT00661583|782604|P1|STARTED|Overall Study||10
324042|NCT00661570|782621|P1|NOT COMPLETED|Overall Study||0
324043|NCT00661570|782621|P1|COMPLETED|Overall Study||26
324044|NCT00661570|782621|P1|STARTED|Overall Study||26
324045|NCT00661557|782630|P2|NOT COMPLETED|Overall Study||0
324046|NCT00661557|782631|P1|NOT COMPLETED|Overall Study||9
324047|NCT00661557|782630|P2|COMPLETED|Overall Study||79
324048|NCT00661557|782631|P1|COMPLETED|Overall Study||183
324049|NCT00661557|782630|P2|STARTED|Overall Study||79
324050|NCT00661557|782631|P1|STARTED|Overall Study||192
324051|NCT00661544|782655|P1|NOT COMPLETED|Overall Study||0
324052|NCT00661544|782655|P1|COMPLETED|Overall Study||48
324053|NCT00661544|782655|P1|STARTED|Overall Study||48
324054|NCT00661531|782659|P1|NOT COMPLETED|Overall Study||3
324055|NCT00661531|782659|P1|COMPLETED|Overall Study||8
324056|NCT00661531|782659|P1|STARTED|Overall Study||11
324057|NCT00661505|782664|P1|NOT COMPLETED|Overall Study||30
324058|NCT00661505|782664|P1|COMPLETED|Overall Study||102
324059|NCT00661505|782664|P1|STARTED|Overall Study||132
324060|NCT00661492|782692|P2|NOT COMPLETED|Overall Study||29
324061|NCT00661492|782693|P1|NOT COMPLETED|Overall Study||68
324062|NCT00661492|782692|P2|COMPLETED|Overall Study||11
324063|NCT00661492|782693|P1|COMPLETED|Overall Study||7
324064|NCT00661492|782692|P2|STARTED|Overall Study||40
324065|NCT00661492|782693|P1|STARTED|Overall Study||75
324066|NCT00661479|782717|P4|NOT COMPLETED|Overall Study||0
324067|NCT00661479|782718|P3|NOT COMPLETED|Overall Study||0
324068|NCT00661479|782719|P2|NOT COMPLETED|Overall Study||0
324069|NCT00661479|782720|P1|NOT COMPLETED|Overall Study||0
324070|NCT00661479|782717|P4|COMPLETED|Overall Study||3
324071|NCT00661479|782718|P3|COMPLETED|Overall Study||3
324072|NCT00661479|782719|P2|COMPLETED|Overall Study||3
324073|NCT00661479|782720|P1|COMPLETED|Overall Study||12
324074|NCT00661479|782717|P4|STARTED|Overall Study||3
324075|NCT00661479|782718|P3|STARTED|Overall Study||3
324076|NCT00661479|782719|P2|STARTED|Overall Study||3
324077|NCT00661479|782720|P1|STARTED|Overall Study||12
324078|NCT00661453|782733|P1|NOT COMPLETED|Overall Study||13
324079|NCT00661453|782733|P1|COMPLETED|Overall Study||25
324080|NCT00661453|782733|P1|STARTED|Overall Study||38
324081|NCT00661427|782739|P2|NOT COMPLETED|Overall Study||7
324082|NCT00661427|782740|P1|NOT COMPLETED|Overall Study||5
324083|NCT00661427|782739|P2|COMPLETED|Overall Study||19
324084|NCT00661427|782740|P1|COMPLETED|Overall Study||30
324085|NCT00661427|782739|P2|STARTED|Overall Study||26
324086|NCT00661427|782740|P1|STARTED|Overall Study||35
324087|NCT00661388|782748|P1|NOT COMPLETED|Overall Study||24
324088|NCT00661388|782748|P1|COMPLETED|Overall Study||51
324089|NCT00661388|782748|P1|STARTED|Overall Study||75
324090|NCT00661362|782771|P2|NOT COMPLETED|Overall Study||40
324091|NCT00661362|782772|P1|NOT COMPLETED|Overall Study||29
324092|NCT00661362|782771|P2|COMPLETED|Overall Study|Completed 24 Weeks of treatment|247
324093|NCT00661362|782772|P1|COMPLETED|Overall Study|Completed 24 Weeks of treatment|254
324094|NCT00661362|782771|P2|STARTED|Overall Study|Randomized and treated|287
324095|NCT00661362|782772|P1|STARTED|Overall Study|Randomized and treated|283
324096|NCT00661271|782790|P2|NOT COMPLETED|Overall Study||25
324097|NCT00661271|782791|P1|NOT COMPLETED|Overall Study||28
324098|NCT00661271|782790|P2|COMPLETED|Overall Study||20
324099|NCT00661271|782791|P1|COMPLETED|Overall Study||20
324100|NCT00661271|782790|P2|STARTED|Overall Study||45
324101|NCT00661271|782791|P1|STARTED|Overall Study||48
324102|NCT00661258|782801|P2|NOT COMPLETED|Overall Study||1
324103|NCT00661258|782802|P1|NOT COMPLETED|Overall Study||3
324104|NCT00661258|782801|P2|COMPLETED|Overall Study||33
324105|NCT00661258|782802|P1|COMPLETED|Overall Study||31
324106|NCT00661258|782801|P2|STARTED|Overall Study||34
324107|NCT00661258|782802|P1|STARTED|Overall Study||34
324108|NCT00661193|782812|P2|NOT COMPLETED|Overall Study||26
324109|NCT00661193|782813|P1|NOT COMPLETED|Overall Study||33
324110|NCT00661193|782812|P2|COMPLETED|Overall Study||0
324111|NCT00661193|782813|P1|COMPLETED|Overall Study||0
324112|NCT00661193|782812|P2|STARTED|Overall Study||26
324113|NCT00661193|782813|P1|STARTED|Overall Study||33
324114|NCT00661141|782824|P6|NOT COMPLETED|Overall Study||0
324115|NCT00661141|782825|P5|NOT COMPLETED|Overall Study||0
324116|NCT00661141|782826|P4|NOT COMPLETED|Overall Study||0
324117|NCT00661141|782827|P3|NOT COMPLETED|Overall Study||0
324118|NCT00661141|782828|P2|NOT COMPLETED|Overall Study||0
324119|NCT00661141|782829|P1|NOT COMPLETED|Overall Study||0
324120|NCT00661141|782824|P6|COMPLETED|Overall Study||4
324121|NCT00661141|782825|P5|COMPLETED|Overall Study||4
324122|NCT00661141|782826|P4|COMPLETED|Overall Study||4
324123|NCT00661141|782827|P3|COMPLETED|Overall Study||4
324124|NCT00661141|782828|P2|COMPLETED|Overall Study||8
324125|NCT00661141|782829|P1|COMPLETED|Overall Study||8
324126|NCT00661141|782824|P6|Administered 30 Minutes After Ethanol|Overall Study||0
324127|NCT00661141|782825|P5|Administered 30 Minutes After Ethanol|Overall Study||0
324128|NCT00661141|782826|P4|Administered 30 Minutes After Ethanol|Overall Study||2
324129|NCT00661141|782827|P3|Administered 30 Minutes After Ethanol|Overall Study||2
324130|NCT00661141|782828|P2|Administered 30 Minutes After Ethanol|Overall Study||2
324131|NCT00661141|782829|P1|Administered 30 Minutes After Ethanol|Overall Study||2
324132|NCT00661141|782824|P6|Administered 30 Minutes Prior to Ethanol|Overall Study||4
324133|NCT00661141|782825|P5|Administered 30 Minutes Prior to Ethanol|Overall Study||4
324134|NCT00661141|782826|P4|Administered 30 Minutes Prior to Ethanol|Overall Study||2
324135|NCT00661141|782827|P3|Administered 30 Minutes Prior to Ethanol|Overall Study||2
324136|NCT00661141|782828|P2|Administered 30 Minutes Prior to Ethanol|Overall Study||6
324137|NCT00661141|782829|P1|Administered 30 Minutes Prior to Ethanol|Overall Study||6
324138|NCT00661141|782824|P6|STARTED|Overall Study||4
324139|NCT00661141|782825|P5|STARTED|Overall Study||4
324140|NCT00661141|782826|P4|STARTED|Overall Study||4
324141|NCT00661141|782827|P3|STARTED|Overall Study||4
324142|NCT00661141|782828|P2|STARTED|Overall Study||8
324143|NCT00661141|782829|P1|STARTED|Overall Study||8
324144|NCT00661089|783038|P2|NOT COMPLETED|Overall Study||2
324145|NCT00661089|783039|P1|NOT COMPLETED|Overall Study||0
324146|NCT00661089|783038|P2|COMPLETED|Overall Study||9
324147|NCT00661089|783039|P1|COMPLETED|Overall Study||10
324148|NCT00661089|783038|P2|STARTED|Overall Study||11
324149|NCT00661089|783039|P1|STARTED|Overall Study||10
324150|NCT00661037|783049|P2|NOT COMPLETED|Overall Study||257
324151|NCT00661037|783050|P1|NOT COMPLETED|Overall Study||154
324152|NCT00661037|783049|P2|COMPLETED|Overall Study||1027
324153|NCT00661037|783050|P1|COMPLETED|Overall Study||682
324154|NCT00661037|783049|P2|Deaths|Overall Study||188
324155|NCT00661037|783050|P1|Deaths|Overall Study||108
324156|NCT00661037|783049|P2|Witdrawn|Overall Study||68
324157|NCT00661037|783050|P1|Witdrawn|Overall Study||47
324158|NCT00661037|783049|P2|STARTED|Overall Study||1284
324159|NCT00661037|783050|P1|STARTED|Overall Study||836
324160|NCT00660985|783062|P2|NOT COMPLETED|Overall Study||0
324161|NCT00660985|783063|P1|NOT COMPLETED|Overall Study||1
324162|NCT00660985|783062|P2|COMPLETED|Overall Study||25
324163|NCT00660985|783063|P1|COMPLETED|Overall Study||25
324164|NCT00660985|783062|P2|STARTED|Overall Study||25
324165|NCT00660985|783063|P1|STARTED|Overall Study||26
324166|NCT00660907|783087|P2|NOT COMPLETED|Overall Study||94
324167|NCT00660907|783088|P1|NOT COMPLETED|Overall Study||84
324168|NCT00660907|783087|P2|COMPLETED|Overall Study||314
324169|NCT00660907|783088|P1|COMPLETED|Overall Study||322
324170|NCT00660907|783087|P2|STARTED|Overall Study|Of the 408 randomized participants only 401 were included in the full analysis set.|408
324171|NCT00660907|783088|P1|STARTED|Overall Study|Of the 406 randomized participants only 400 were included in the full analysis set.|406
324172|NCT00660829|783102|P2|NOT COMPLETED|Overall Study||19
324173|NCT00660829|783103|P1|NOT COMPLETED|Overall Study||18
324174|NCT00660829|783102|P2|COMPLETED|Overall Study||249
324175|NCT00660829|783103|P1|COMPLETED|Overall Study||250
324176|NCT00660829|783102|P2|STARTED|Overall Study|2 subjects were randomized in error|268
324177|NCT00660829|783103|P1|STARTED|Overall Study|2 subjects were randomized in error|268
324178|NCT00660816|783121|P2|NOT COMPLETED|Overall Study||19
324179|NCT00660816|783122|P1|NOT COMPLETED|Overall Study||20
324180|NCT00660816|783121|P2|COMPLETED|Overall Study||3
324181|NCT00660816|783122|P1|COMPLETED|Overall Study||4
324182|NCT00660816|783121|P2|STARTED|Overall Study||22
324183|NCT00660816|783122|P1|STARTED|Overall Study||24
324184|NCT00660699|783134|P1|NOT COMPLETED|Overall Study||2
324185|NCT00660699|783134|P1|COMPLETED|Overall Study||48
324186|NCT00660699|783134|P1|STARTED|Overall Study||50
324187|NCT00660660|783150|P2|NOT COMPLETED|Overall Study||9
324188|NCT00660660|783151|P1|NOT COMPLETED|Overall Study||5
324189|NCT00660660|783150|P2|COMPLETED|Overall Study|Number of completed patients is based on randomized population (133) minus withdrawals (9).|124
324190|NCT00660660|783151|P1|COMPLETED|Overall Study|Number of completed patients is based on randomized population (143) minus withdrawals (5).|138
324191|NCT00660660|783150|P2|Met Criteria for MITT Population|Overall Study||125
324192|NCT00660660|783151|P1|Met Criteria for MITT Population|Overall Study||137
324193|NCT00660660|783150|P2|STARTED|Overall Study|Randomized|133
324194|NCT00660660|783151|P1|STARTED|Overall Study|Randomized|143
324195|NCT00660595|783251|P2|NOT COMPLETED|Overall Study||9
324196|NCT00660595|783252|P1|NOT COMPLETED|Overall Study||18
324197|NCT00660595|783251|P2|COMPLETED|Overall Study|One of the two was lost to follow-up|1
324198|NCT00660595|783252|P1|COMPLETED|Overall Study||1
324199|NCT00660595|783251|P2|STARTED|Overall Study||10
324200|NCT00660595|783252|P1|STARTED|Overall Study||19
324201|NCT00660543|783264|P1|NOT COMPLETED|Overall Study||0
324202|NCT00660543|783264|P1|COMPLETED|Overall Study||14
324203|NCT00660543|783264|P1|STARTED|Overall Study||14
324204|NCT00660517|783277|P4|NOT COMPLETED|Overall Study||7
324205|NCT00660517|783278|P3|NOT COMPLETED|Overall Study||7
324206|NCT00660517|783279|P2|NOT COMPLETED|Overall Study||8
324207|NCT00660517|783280|P1|NOT COMPLETED|Overall Study||8
324208|NCT00660517|783277|P4|COMPLETED|Overall Study||144
324209|NCT00660517|783278|P3|COMPLETED|Overall Study||144
324210|NCT00660517|783279|P2|COMPLETED|Overall Study||144
324211|NCT00660517|783280|P1|COMPLETED|Overall Study||145
324212|NCT00660517|783277|P4|STARTED|Overall Study||151
324213|NCT00660517|783278|P3|STARTED|Overall Study||151
324214|NCT00660517|783279|P2|STARTED|Overall Study||152
324215|NCT00660517|783280|P1|STARTED|Overall Study||153
324216|NCT00660504|783300|P2|NOT COMPLETED|Overall Study||1
324217|NCT00660504|783301|P1|NOT COMPLETED|Overall Study||0
324218|NCT00660504|783300|P2|COMPLETED|Overall Study||150
324219|NCT00660504|783301|P1|COMPLETED|Overall Study||149
324220|NCT00660504|783300|P2|STARTED|Overall Study||151
324221|NCT00660504|783301|P1|STARTED|Overall Study||149
324222|NCT00660400|783313|P1|NOT COMPLETED|Overall Study||4
324223|NCT00660400|783313|P1|COMPLETED|Overall Study||21
324224|NCT00660400|783313|P1|STARTED|Overall Study||25
324225|NCT00660387|783322|P2|NOT COMPLETED|Overall Study||3
324226|NCT00660387|783323|P1|NOT COMPLETED|Overall Study||2
324227|NCT00660387|783322|P2|COMPLETED|Overall Study||31
324228|NCT00660387|783323|P1|COMPLETED|Overall Study||35
324229|NCT00660387|783322|P2|STARTED|Overall Study||34
324230|NCT00660387|783323|P1|STARTED|Overall Study||37
324231|NCT00660348|783377|P2|NOT COMPLETED|Overall Study||0
324232|NCT00660348|783378|P1|NOT COMPLETED|Overall Study||1
324233|NCT00660348|783377|P2|COMPLETED|Overall Study||0
324234|NCT00660348|783378|P1|COMPLETED|Overall Study||0
324235|NCT00660348|783377|P2|STARTED|Overall Study||0
324236|NCT00660348|783378|P1|STARTED|Overall Study||1
324237|NCT00660309|783386|P2|NOT COMPLETED|Overall Study||3
324238|NCT00660309|783387|P1|NOT COMPLETED|Overall Study||2
324239|NCT00660309|783386|P2|COMPLETED|Overall Study||19
324240|NCT00660309|783387|P1|COMPLETED|Overall Study||21
324241|NCT00660309|783386|P2|Pharmacodynamic Analysis Set|Overall Study||20
324242|NCT00660309|783387|P1|Pharmacodynamic Analysis Set|Overall Study||22
324243|NCT00660309|783386|P2|Treated With Aliskiren or Irbesartan|Overall Study||21
324244|NCT00660309|783387|P1|Treated With Aliskiren or Irbesartan|Overall Study||22
324245|NCT00660309|783386|P2|STARTED|Overall Study|Represents participants who received one dose of Captopril.|22
324246|NCT00660309|783387|P1|STARTED|Overall Study|Represents participants who received one dose of Captopril.|23
324247|NCT00660192|783428|P2|NOT COMPLETED|Overall Study||3
324248|NCT00660192|783429|P1|NOT COMPLETED|Overall Study||2
324249|NCT00660192|783428|P2|COMPLETED|Overall Study||10
324250|NCT00660192|783429|P1|COMPLETED|Overall Study||10
324251|NCT00660192|783428|P2|STARTED|Overall Study||13
324252|NCT00660192|783429|P1|STARTED|Overall Study||12
324253|NCT00660179|783440|P3|NOT COMPLETED|Overall Study||41
324254|NCT00660179|783441|P2|NOT COMPLETED|Overall Study||58
324255|NCT00660179|783442|P1|NOT COMPLETED|Overall Study||56
324256|NCT00660179|783440|P3|COMPLETED|Overall Study||201
324257|NCT00660179|783441|P2|COMPLETED|Overall Study||192
324258|NCT00660179|783442|P1|COMPLETED|Overall Study||194
324259|NCT00660179|783440|P3|STARTED|Overall Study||242
324260|NCT00660179|783441|P2|STARTED|Overall Study||250
324261|NCT00660179|783442|P1|STARTED|Overall Study||250
324262|NCT00660075|783476|P2|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
324263|NCT00660075|783477|P1|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
324264|NCT00660075|783476|P2|COMPLETED|Second Intervention (Week 11 to Week 16||18
324265|NCT00660075|783477|P1|COMPLETED|Second Intervention (Week 11 to Week 16||18
324266|NCT00660075|783476|P2|STARTED|Second Intervention (Week 11 to Week 16||18
324267|NCT00660075|783477|P1|STARTED|Second Intervention (Week 11 to Week 16||18
324268|NCT00660075|783476|P2|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
324269|NCT00660075|783477|P1|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
324270|NCT00660075|783476|P2|COMPLETED|Washout Period (Week 7 to Week 10)||18
324271|NCT00660075|783477|P1|COMPLETED|Washout Period (Week 7 to Week 10)||18
324272|NCT00660075|783476|P2|STARTED|Washout Period (Week 7 to Week 10)||18
324273|NCT00660075|783477|P1|STARTED|Washout Period (Week 7 to Week 10)||18
324274|NCT00660075|783476|P2|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
324275|NCT00660075|783477|P1|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
324276|NCT00660075|783476|P2|COMPLETED|First Intervention (Week 1 to Week 6)||18
324277|NCT00660075|783477|P1|COMPLETED|First Intervention (Week 1 to Week 6)||18
324278|NCT00660075|783476|P2|STARTED|First Intervention (Week 1 to Week 6)||18
324279|NCT00660075|783477|P1|STARTED|First Intervention (Week 1 to Week 6)||18
324280|NCT00660049|783483|P1|NOT COMPLETED|Overall Study||6
324281|NCT00660049|783483|P1|COMPLETED|Overall Study||6
324282|NCT00660049|783483|P1|STARTED|Overall Study||12
324283|NCT00660023|783487|P1|NOT COMPLETED|Overall Study||29
324284|NCT00660023|783487|P1|COMPLETED|Overall Study||95
324285|NCT00660023|783487|P1|Treated|Overall Study||114
324286|NCT00660023|783487|P1|STARTED|Overall Study||124
324287|NCT00660010|783498|P1|NOT COMPLETED|Overall Study||9
324288|NCT00660010|783498|P1|COMPLETED|Overall Study||46
324289|NCT00660010|783498|P1|STARTED|Overall Study||55
324290|NCT00659984|783512|P1|NOT COMPLETED|Overall Study||1
324291|NCT00659984|783512|P1|COMPLETED|Overall Study||14
324292|NCT00659984|783512|P1|STARTED|Overall Study||15
324293|NCT00659945|783525|P2|NOT COMPLETED|Overall Study||0
324294|NCT00659945|783526|P1|NOT COMPLETED|Overall Study||0
324295|NCT00659945|783525|P2|COMPLETED|Overall Study||75
324296|NCT00659945|783526|P1|COMPLETED|Overall Study||75
324297|NCT00659945|783525|P2|STARTED|Overall Study||75
324298|NCT00659945|783526|P1|STARTED|Overall Study||75
324299|NCT00659880|783532|P1|NOT COMPLETED|Overall Study||5
324300|NCT00659880|783532|P1|COMPLETED|Overall Study|60 months|4
324301|NCT00659880|783532|P1|24 Months|Overall Study||6
324302|NCT00659880|783532|P1|12 Months|Overall Study||7
324303|NCT00659880|783532|P1|6 Months|Overall Study||9
324304|NCT00659880|783532|P1|6 Weeks|Overall Study||9
324305|NCT00659880|783532|P1|STARTED|Overall Study||9
324306|NCT00659815|783539|P2|NOT COMPLETED|Overall Study||4
324307|NCT00659815|783540|P1|NOT COMPLETED|Overall Study||4
324308|NCT00659815|783539|P2|COMPLETED|Overall Study||147
324309|NCT00659815|783540|P1|COMPLETED|Overall Study||153
324310|NCT00659815|783539|P2|STARTED|Overall Study||151
324311|NCT00659815|783540|P1|STARTED|Overall Study||157
324312|NCT00659789|783552|P2|NOT COMPLETED|Overall Study||7
324313|NCT00659789|783553|P1|NOT COMPLETED|Overall Study||7
324314|NCT00659789|783552|P2|COMPLETED|Overall Study||36
324315|NCT00659789|783553|P1|COMPLETED|Overall Study||86
324316|NCT00659789|783552|P2|STARTED|Overall Study||43
324317|NCT00659789|783553|P1|STARTED|Overall Study||93
324318|NCT00659737|783571|P2|NOT COMPLETED|Overall Study||0
324319|NCT00659737|783572|P1|NOT COMPLETED|Overall Study||0
324320|NCT00659737|783571|P2|COMPLETED|Overall Study||58
324321|NCT00659737|783572|P1|COMPLETED|Overall Study||57
324322|NCT00659737|783571|P2|STARTED|Overall Study||58
324323|NCT00659737|783572|P1|STARTED|Overall Study||57
324324|NCT00659724|783578|P1|NOT COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||0
324325|NCT00659724|783578|P1|COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||33
324326|NCT00659724|783578|P1|STARTED|Weeks 3-4: Assessment of HD-C4 Big||33
324327|NCT00659724|783578|P1|NOT COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||0
324328|NCT00659724|783578|P1|COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||33
324329|NCT00659724|783578|P1|STARTED|Weeks 1-2: Assessment of 180NR or 200NR||33
324330|NCT00659633|783596|P1|NOT COMPLETED|Overall Study||0
324331|NCT00659633|783596|P1|COMPLETED|Overall Study||10
324332|NCT00659633|783596|P1|STARTED|Overall Study||10
324333|NCT00659607|783600|P1|NOT COMPLETED|Overall Study||316
324334|NCT00659607|783600|P1|COMPLETED|Overall Study||3616
324335|NCT00659607|783600|P1|STARTED|Overall Study||3932
324336|NCT00659581|783618|P1|NOT COMPLETED|Overall Study||8582
324337|NCT00659581|783618|P1|COMPLETED|Overall Study||12412
324338|NCT00659581|783618|P1|STARTED|Overall Study||20994
324339|NCT00659529|783630|P1|NOT COMPLETED|Overall Study||16
324340|NCT00659529|783630|P1|COMPLETED|Overall Study|4 patients withdrew as a result of side effects. 3 subjects were withdrawn by the investigator.|20
324341|NCT00659529|783630|P1|Received at Least One Dose of Study Drug|Overall Study|Received at least one dose of study drug|27
324342|NCT00659529|783630|P1|STARTED|Overall Study|There were 9 screen failures (subjects who did not meet inclusion/exclusion criteria)|36
324343|NCT00659490|783637|P3|NOT COMPLETED|Overall Study||1
324344|NCT00659490|783638|P2|NOT COMPLETED|Overall Study||0
324345|NCT00659490|783639|P1|NOT COMPLETED|Overall Study||2
324346|NCT00659490|783637|P3|COMPLETED|Overall Study||30
324347|NCT00659490|783638|P2|COMPLETED|Overall Study||59
324348|NCT00659490|783639|P1|COMPLETED|Overall Study||59
324349|NCT00659490|783637|P3|STARTED|Overall Study||31
324350|NCT00659490|783638|P2|STARTED|Overall Study||59
324351|NCT00659490|783639|P1|STARTED|Overall Study||61
324352|NCT00659438|783712|P2|NOT COMPLETED|Overall Study||8
324353|NCT00659438|783713|P1|NOT COMPLETED|Overall Study||14
324354|NCT00659438|783712|P2|COMPLETED|Overall Study||40
324355|NCT00659438|783713|P1|COMPLETED|Overall Study||33
324356|NCT00659438|783712|P2|Safety Analysis Set|Overall Study||47
324357|NCT00659438|783713|P1|Safety Analysis Set|Overall Study|One patient randomized to placebo was accounted in vandetanib group as he mistakenly received drug|48
324358|NCT00659438|783712|P2|Secondary Analysis Set|Overall Study||48
324359|NCT00659438|783713|P1|Secondary Analysis Set|Overall Study||47
324360|NCT00659438|783712|P2|Assessable Set : Primary Analysis|Overall Study||45
324361|NCT00659438|783713|P1|Assessable Set : Primary Analysis|Overall Study||44
324362|NCT00659438|783712|P2|STARTED|Overall Study||48
324363|NCT00659438|783713|P1|STARTED|Overall Study||47
324364|NCT00659425|783745|P10|NOT COMPLETED|Overall Study||13
324365|NCT00659425|783746|P9|NOT COMPLETED|Overall Study||6
324366|NCT00659425|783747|P8|NOT COMPLETED|Overall Study||11
324367|NCT00659425|783748|P7|NOT COMPLETED|Overall Study||8
324368|NCT00659425|783749|P6|NOT COMPLETED|Overall Study||4
324369|NCT00659425|783750|P5|NOT COMPLETED|Overall Study||4
324370|NCT00659425|783751|P4|NOT COMPLETED|Overall Study||4
324371|NCT00659425|783752|P3|NOT COMPLETED|Overall Study||1
324372|NCT00659425|783753|P2|NOT COMPLETED|Overall Study||1
324373|NCT00659425|783754|P1|NOT COMPLETED|Overall Study||1
324374|NCT00659425|783745|P10|COMPLETED|Overall Study||1
324375|NCT00659425|783746|P9|COMPLETED|Overall Study||0
324376|NCT00659425|783747|P8|COMPLETED|Overall Study||0
324377|NCT00659425|783748|P7|COMPLETED|Overall Study||0
324378|NCT00659425|783749|P6|COMPLETED|Overall Study||1
324379|NCT00659425|783750|P5|COMPLETED|Overall Study||0
324380|NCT00659425|783751|P4|COMPLETED|Overall Study||0
324381|NCT00659425|783752|P3|COMPLETED|Overall Study||0
324382|NCT00659425|783753|P2|COMPLETED|Overall Study||0
324383|NCT00659425|783754|P1|COMPLETED|Overall Study||0
324384|NCT00659425|783745|P10|STARTED|Overall Study||14
324385|NCT00659425|783746|P9|STARTED|Overall Study||6
324386|NCT00659425|783747|P8|STARTED|Overall Study||11
324387|NCT00659425|783748|P7|STARTED|Overall Study||8
324388|NCT00659425|783749|P6|STARTED|Overall Study||5
324389|NCT00659425|783750|P5|STARTED|Overall Study||4
324390|NCT00659425|783751|P4|STARTED|Overall Study||4
324391|NCT00659425|783752|P3|STARTED|Overall Study||1
324392|NCT00659425|783753|P2|STARTED|Overall Study||1
324393|NCT00659425|783754|P1|STARTED|Overall Study||1
324394|NCT00659373|783985|P2|NOT COMPLETED|Overall Study||7
324395|NCT00659373|783986|P1|NOT COMPLETED|Overall Study||5
324396|NCT00659373|783985|P2|COMPLETED|Overall Study||54
324397|NCT00659373|783986|P1|COMPLETED|Overall Study||20
324398|NCT00659373|783985|P2|STARTED|Overall Study||61
324399|NCT00659373|783986|P1|STARTED|Overall Study||25
324400|NCT00659360|783992|P1|NOT COMPLETED|Overall Study||0
324401|NCT00659360|783992|P1|COMPLETED|Overall Study||17
324402|NCT00659360|783992|P1|STARTED|Overall Study||17
324403|NCT00659334|784008|P7|NOT COMPLETED|Overall Study||1
324404|NCT00659334|784009|P6|NOT COMPLETED|Overall Study||0
324405|NCT00659334|784010|P5|NOT COMPLETED|Overall Study||0
324406|NCT00659334|784011|P4|NOT COMPLETED|Overall Study||0
324407|NCT00659334|784012|P3|NOT COMPLETED|Overall Study||0
324408|NCT00659334|784013|P2|NOT COMPLETED|Overall Study||5
324409|NCT00659334|784014|P1|NOT COMPLETED|Overall Study||8
324410|NCT00659334|784008|P7|COMPLETED|Overall Study|1 screen failure|20
324411|NCT00659334|784009|P6|COMPLETED|Overall Study||0
324412|NCT00659334|784010|P5|COMPLETED|Overall Study||1
324413|NCT00659334|784011|P4|COMPLETED|Overall Study||2
324414|NCT00659334|784012|P3|COMPLETED|Overall Study||5
324415|NCT00659334|784013|P2|COMPLETED|Overall Study|5 Screen failures|36
324416|NCT00659334|784014|P1|COMPLETED|Overall Study|8 Screen failures|38
324417|NCT00659334|784008|P7|STARTED|Overall Study||21
324418|NCT00659334|784009|P6|STARTED|Overall Study||0
324419|NCT00659334|784010|P5|STARTED|Overall Study||1
324420|NCT00659334|784011|P4|STARTED|Overall Study||2
324421|NCT00659334|784012|P3|STARTED|Overall Study||5
324422|NCT00659334|784013|P2|STARTED|Overall Study||41
324423|NCT00659334|784014|P1|STARTED|Overall Study||46
324424|NCT00659295|784032|P2|NOT COMPLETED|Overall Study||5603
324425|NCT00659295|784033|P1|NOT COMPLETED|Overall Study||2708
324426|NCT00659295|784032|P2|COMPLETED|Overall Study||32038
324427|NCT00659295|784033|P1|COMPLETED|Overall Study||10821
324428|NCT00659295|784032|P2|STARTED|Overall Study||37641
324429|NCT00659295|784033|P1|STARTED|Overall Study||13529
324430|NCT00659269|784041|P2|NOT COMPLETED|Overall Study||1
324431|NCT00659269|784042|P1|NOT COMPLETED|Overall Study||1
324432|NCT00659269|784041|P2|COMPLETED|Overall Study||161
324433|NCT00659269|784042|P1|COMPLETED|Overall Study||156
324434|NCT00659269|784041|P2|Group 3 (Taxanes)|Overall Study||97
324435|NCT00659269|784042|P1|Group 3 (Taxanes)|Overall Study||92
324436|NCT00659269|784041|P2|Group 2 (Vinca Alkaloids)|Overall Study||12
324437|NCT00659269|784042|P1|Group 2 (Vinca Alkaloids)|Overall Study||12
324438|NCT00659269|784041|P2|Group 1 (Heavy Metals)|Overall Study||52
324439|NCT00659269|784042|P1|Group 1 (Heavy Metals)|Overall Study||52
324440|NCT00659269|784041|P2|STARTED|Overall Study||162
324441|NCT00659269|784042|P1|STARTED|Overall Study||157
324442|NCT00659230|784072|P2|NOT COMPLETED|Overall Study||12
324443|NCT00659230|784073|P1|NOT COMPLETED|Overall Study||9
324444|NCT00659230|784072|P2|COMPLETED|Overall Study||37
324445|NCT00659230|784073|P1|COMPLETED|Overall Study||42
324446|NCT00659230|784072|P2|STARTED|Overall Study|3 did not return post-randomization, 4 lost source documents, thus 7 excluded from results analysis|49
324447|NCT00659230|784073|P1|STARTED|Overall Study|2 did not return post-randomization, 5 lost source documents, thus 7 excluded from results analysis|51
324448|NCT00659165|784087|P2|NOT COMPLETED|Overall Study||0
324449|NCT00659165|784088|P1|NOT COMPLETED|Overall Study||0
324450|NCT00659165|784087|P2|COMPLETED|Overall Study||5
324451|NCT00659165|784088|P1|COMPLETED|Overall Study||5
324452|NCT00659165|784087|P2|STARTED|Overall Study||5
324453|NCT00659165|784088|P1|STARTED|Overall Study||5
324454|NCT00659061|784096|P2|NOT COMPLETED|Overall Study||15
324455|NCT00659061|784097|P1|NOT COMPLETED|Overall Study||21
324456|NCT00659061|784096|P2|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
324457|NCT00659061|784097|P1|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
324458|NCT00659061|784096|P2|STARTED|Overall Study||302
324459|NCT00659061|784097|P1|STARTED|Overall Study||308
324460|NCT00658996|784115|P2|NOT COMPLETED|Second Intervention||1
324461|NCT00658996|784116|P1|NOT COMPLETED|Second Intervention||1
324462|NCT00658996|784115|P2|COMPLETED|Second Intervention||104
324463|NCT00658996|784116|P1|COMPLETED|Second Intervention||105
324464|NCT00658996|784115|P2|STARTED|Second Intervention||105
324465|NCT00658996|784116|P1|STARTED|Second Intervention||106
324466|NCT00658996|784115|P2|NOT COMPLETED|Crossover Period||1
324467|NCT00658996|784116|P1|NOT COMPLETED|Crossover Period||2
324468|NCT00658996|784115|P2|COMPLETED|Crossover Period||105
324469|NCT00658996|784116|P1|COMPLETED|Crossover Period||106
324470|NCT00658996|784115|P2|STARTED|Crossover Period||106
324471|NCT00658996|784116|P1|STARTED|Crossover Period||108
324472|NCT00658996|784115|P2|NOT COMPLETED|First Intervention||1
324473|NCT00658996|784116|P1|NOT COMPLETED|First Intervention||1
324474|NCT00658996|784115|P2|COMPLETED|First Intervention||106
324475|NCT00658996|784116|P1|COMPLETED|First Intervention||108
324476|NCT00658996|784115|P2|STARTED|First Intervention||107
324477|NCT00658996|784116|P1|STARTED|First Intervention||109
324478|NCT00658879|784126|P1|NOT COMPLETED|Overall Study||1
324479|NCT00658879|784126|P1|COMPLETED|Overall Study||250
324480|NCT00658879|784126|P1|STARTED|Overall Study||251
324481|NCT00658814|784143|P2|NOT COMPLETED|Maintenance Therapy||1
324482|NCT00658814|784144|P1|NOT COMPLETED|Maintenance Therapy||3
324483|NCT00658814|784143|P2|COMPLETED|Maintenance Therapy||7
324484|NCT00658814|784144|P1|COMPLETED|Maintenance Therapy||17
324485|NCT00658814|784143|P2|Eligible|Maintenance Therapy||8
324486|NCT00658814|784144|P1|Eligible|Maintenance Therapy||19
324487|NCT00658814|784143|P2|STARTED|Maintenance Therapy||8
324488|NCT00658814|784144|P1|STARTED|Maintenance Therapy||20
324489|NCT00658814|784143|P2|NOT COMPLETED|Consolidation Therapy||3
324490|NCT00658814|784144|P1|NOT COMPLETED|Consolidation Therapy||2
324491|NCT00658814|784143|P2|COMPLETED|Consolidation Therapy||10
324492|NCT00658814|784144|P1|COMPLETED|Consolidation Therapy||22
324493|NCT00658814|784143|P2|Eligible|Consolidation Therapy||11
324494|NCT00658814|784144|P1|Eligible|Consolidation Therapy||22
324495|NCT00658814|784143|P2|STARTED|Consolidation Therapy||13
324496|NCT00658814|784144|P1|STARTED|Consolidation Therapy||24
324497|NCT00658814|784143|P2|NOT COMPLETED|Remission Induction Chemotherapy||18
324498|NCT00658814|784144|P1|NOT COMPLETED|Remission Induction Chemotherapy||8
324499|NCT00658814|784143|P2|COMPLETED|Remission Induction Chemotherapy||41
324500|NCT00658814|784144|P1|COMPLETED|Remission Induction Chemotherapy||75
324501|NCT00658814|784143|P2|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||54
324502|NCT00658814|784144|P1|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||79
324503|NCT00658814|784143|P2|Eligible|Remission Induction Chemotherapy||57
324504|NCT00658814|784144|P1|Eligible|Remission Induction Chemotherapy||82
324505|NCT00658814|784143|P2|STARTED|Remission Induction Chemotherapy||59
324506|NCT00658814|784144|P1|STARTED|Remission Induction Chemotherapy||83
324507|NCT00658788|784158|P1|NOT COMPLETED|Overall Study||74
324508|NCT00658788|784158|P1|COMPLETED|Overall Study||231
324509|NCT00658788|784158|P1|STARTED|Overall Study||305
324510|NCT00658775|784213|P2|NOT COMPLETED|Overall Study||43
324511|NCT00658775|784214|P1|NOT COMPLETED|Overall Study||42
324512|NCT00658775|784213|P2|COMPLETED|Overall Study||485
324513|NCT00658775|784214|P1|COMPLETED|Overall Study||495
324514|NCT00658775|784213|P2|STARTED|Overall Study|Treated|528
324515|NCT00658775|784214|P1|STARTED|Overall Study|Treated|537
324516|NCT00658736|784226|P2|NOT COMPLETED|Overall Study||2
324517|NCT00658736|784227|P1|NOT COMPLETED|Overall Study||6
324518|NCT00658736|784226|P2|COMPLETED|Overall Study||19
324519|NCT00658736|784227|P1|COMPLETED|Overall Study||13
324520|NCT00658736|784226|P2|STARTED|Overall Study||21
324521|NCT00658736|784227|P1|STARTED|Overall Study||19
324522|NCT00658723|784237|P3|NOT COMPLETED|Overall Study||7
324523|NCT00658723|784238|P2|NOT COMPLETED|Overall Study||4
324524|NCT00658723|784239|P1|NOT COMPLETED|Overall Study||4
324525|NCT00658723|784237|P3|COMPLETED|Overall Study||44
324526|NCT00658723|784238|P2|COMPLETED|Overall Study||26
324527|NCT00658723|784239|P1|COMPLETED|Overall Study||56
324528|NCT00658723|784237|P3|STARTED|Overall Study||51
324529|NCT00658723|784238|P2|STARTED|Overall Study||30
324530|NCT00658723|784239|P1|STARTED|Overall Study||60
324531|NCT00658697|784266|P1|NOT COMPLETED|Overall Study||0
324532|NCT00658697|784266|P1|COMPLETED|Overall Study||41
324533|NCT00658697|784266|P1|STARTED|Overall Study||41
324534|NCT00658684|784277|P4|NOT COMPLETED|Overall Study||1
324535|NCT00658684|784278|P3|NOT COMPLETED|Overall Study||3
324536|NCT00658684|784279|P2|NOT COMPLETED|Overall Study||15
324537|NCT00658684|784280|P1|NOT COMPLETED|Overall Study||19
324538|NCT00658684|784277|P4|COMPLETED|Overall Study||27
324539|NCT00658684|784278|P3|COMPLETED|Overall Study||22
324540|NCT00658684|784279|P2|COMPLETED|Overall Study||84
324541|NCT00658684|784280|P1|COMPLETED|Overall Study||133
324542|NCT00658684|784277|P4|STARTED|Overall Study||28
324543|NCT00658684|784278|P3|STARTED|Overall Study||25
324544|NCT00658684|784279|P2|STARTED|Overall Study||99
324545|NCT00658684|784280|P1|STARTED|Overall Study||152
324546|NCT00658658|784335|P5|NOT COMPLETED|Overall Study||5
324547|NCT00658658|784336|P4|NOT COMPLETED|Overall Study||2
324548|NCT00658658|784337|P3|NOT COMPLETED|Overall Study||0
324549|NCT00658658|784338|P2|NOT COMPLETED|Overall Study||2
324550|NCT00658658|784339|P1|NOT COMPLETED|Overall Study||5
324551|NCT00658658|784335|P5|COMPLETED|Overall Study||3
324552|NCT00658658|784336|P4|COMPLETED|Overall Study||4
324553|NCT00658658|784337|P3|COMPLETED|Overall Study||4
324554|NCT00658658|784338|P2|COMPLETED|Overall Study||5
324555|NCT00658658|784339|P1|COMPLETED|Overall Study||1
324556|NCT00658658|784335|P5|STARTED|Overall Study||8
324557|NCT00658658|784336|P4|STARTED|Overall Study||6
324558|NCT00658658|784337|P3|STARTED|Overall Study||4
324559|NCT00658658|784338|P2|STARTED|Overall Study||7
324560|NCT00658658|784339|P1|STARTED|Overall Study||6
324561|NCT00658632|784398|P2|NOT COMPLETED|Overall Study||65
324562|NCT00658632|784399|P1|NOT COMPLETED|Overall Study||64
324563|NCT00658632|784398|P2|COMPLETED|Overall Study||633
324564|NCT00658632|784399|P1|COMPLETED|Overall Study||618
324565|NCT00658632|784398|P2|STARTED|Overall Study|Treated|698
324566|NCT00658632|784399|P1|STARTED|Overall Study|Treated|682
324567|NCT00658619|784414|P5|NOT COMPLETED|Overall Study||2
324568|NCT00658619|784415|P4|NOT COMPLETED|Overall Study||12
324569|NCT00658619|784416|P3|NOT COMPLETED|Overall Study||10
324570|NCT00658619|784417|P2|NOT COMPLETED|Overall Study||1
324571|NCT00658619|784418|P1|NOT COMPLETED|Overall Study||0
324572|NCT00658619|784414|P5|COMPLETED|Overall Study||21
324573|NCT00658619|784415|P4|COMPLETED|Overall Study||37
324574|NCT00658619|784416|P3|COMPLETED|Overall Study||31
324575|NCT00658619|784417|P2|COMPLETED|Overall Study||2
324576|NCT00658619|784418|P1|COMPLETED|Overall Study||3
324577|NCT00658619|784414|P5|STARTED|Overall Study||23
324578|NCT00658619|784415|P4|STARTED|Overall Study||49
324579|NCT00658619|784416|P3|STARTED|Overall Study||41
324580|NCT00658619|784417|P2|STARTED|Overall Study||3
324581|NCT00658619|784418|P1|STARTED|Overall Study||3
324582|NCT00658606|784440|P2|NOT COMPLETED|Overall Study||23
324583|NCT00658606|784441|P1|NOT COMPLETED|Overall Study||16
324584|NCT00658606|784440|P2|COMPLETED|Overall Study|Represents patients who completed follow-up|26
324585|NCT00658606|784441|P1|COMPLETED|Overall Study|Represents patients who completed follow-up|33
324586|NCT00658606|784440|P2|Completed Treatment|Overall Study||44
324587|NCT00658606|784441|P1|Completed Treatment|Overall Study||42
324588|NCT00658606|784440|P2|STARTED|Overall Study||49
324589|NCT00658606|784441|P1|STARTED|Overall Study||49
324590|NCT00658567|784470|P3|NOT COMPLETED|Overall Study||6
324591|NCT00658567|784471|P2|NOT COMPLETED|Overall Study||4
324592|NCT00658567|784472|P1|NOT COMPLETED|Overall Study||8
324593|NCT00658567|784470|P3|COMPLETED|Overall Study||35
324594|NCT00658567|784471|P2|COMPLETED|Overall Study||38
324595|NCT00658567|784472|P1|COMPLETED|Overall Study||32
324596|NCT00658567|784470|P3|STARTED|Overall Study||41
324597|NCT00658567|784471|P2|STARTED|Overall Study||42
324598|NCT00658567|784472|P1|STARTED|Overall Study||40
324599|NCT00658541|784483|P2|NOT COMPLETED|Second Intervention||0
324600|NCT00658541|784484|P1|NOT COMPLETED|Second Intervention||0
324601|NCT00658541|784483|P2|COMPLETED|Second Intervention||17
324602|NCT00658541|784484|P1|COMPLETED|Second Intervention||18
324603|NCT00658541|784483|P2|STARTED|Second Intervention||17
324604|NCT00658541|784484|P1|STARTED|Second Intervention||18
324605|NCT00658541|784483|P2|NOT COMPLETED|Washout Period of 7 Days||2
324606|NCT00658541|784484|P1|NOT COMPLETED|Washout Period of 7 Days||1
324607|NCT00658541|784483|P2|COMPLETED|Washout Period of 7 Days||17
324608|NCT00658541|784484|P1|COMPLETED|Washout Period of 7 Days||18
324609|NCT00658541|784483|P2|STARTED|Washout Period of 7 Days||19
324610|NCT00658541|784484|P1|STARTED|Washout Period of 7 Days||19
324611|NCT00658541|784483|P2|NOT COMPLETED|First Intervention||0
324612|NCT00658541|784484|P1|NOT COMPLETED|First Intervention||0
324613|NCT00658541|784483|P2|COMPLETED|First Intervention||19
324614|NCT00658541|784484|P1|COMPLETED|First Intervention||19
324615|NCT00658541|784483|P2|STARTED|First Intervention||19
324616|NCT00658541|784484|P1|STARTED|First Intervention||19
324617|NCT00658528|784496|P2|NOT COMPLETED|Overall Study||45
324618|NCT00658528|784497|P1|NOT COMPLETED|Overall Study||40
324619|NCT00658528|784496|P2|COMPLETED|Overall Study||479
324620|NCT00658528|784497|P1|COMPLETED|Overall Study||491
324621|NCT00658528|784496|P2|STARTED|Overall Study|Treated|524
324622|NCT00658528|784497|P1|STARTED|Overall Study|Treated|531
324623|NCT00658411|784507|P1|NOT COMPLETED|Overall Study||0
324624|NCT00658411|784507|P1|COMPLETED|Overall Study||5
324625|NCT00658411|784507|P1|STARTED|Overall Study||5
324626|NCT00658385|784515|P1|NOT COMPLETED|Overall Study||0
324627|NCT00658385|784515|P1|COMPLETED|Overall Study||5
324628|NCT00658385|784515|P1|STARTED|Overall Study||5
324629|NCT00658359|784522|P3|NOT COMPLETED|Overall Study||46
324630|NCT00658359|784523|P2|NOT COMPLETED|Overall Study||45
324631|NCT00658359|784524|P1|NOT COMPLETED|Overall Study||28
324632|NCT00658359|784522|P3|COMPLETED|Overall Study||8
324633|NCT00658359|784523|P2|COMPLETED|Overall Study||15
324634|NCT00658359|784524|P1|COMPLETED|Overall Study||36
324635|NCT00658359|784522|P3|STARTED|Overall Study||54
324636|NCT00658359|784523|P2|STARTED|Overall Study||60
324637|NCT00658359|784524|P1|STARTED|Overall Study||64
324638|NCT00658333|784612|P2|NOT COMPLETED|Overall Study||1
324639|NCT00658333|784613|P1|NOT COMPLETED|Overall Study||2
324640|NCT00658333|784612|P2|COMPLETED|Overall Study||14
324641|NCT00658333|784613|P1|COMPLETED|Overall Study||13
324642|NCT00658333|784612|P2|STARTED|Overall Study||15
324643|NCT00658333|784613|P1|STARTED|Overall Study||15
324644|NCT00658320|784623|P2|NOT COMPLETED|Extension Study: After Month 24||0
324645|NCT00658320|784624|P1|NOT COMPLETED|Extension Study: After Month 24||2
324646|NCT00658320|784623|P2|COMPLETED|Extension Study: After Month 24||0
324647|NCT00658320|784624|P1|COMPLETED|Extension Study: After Month 24||42
324648|NCT00658320|784623|P2|STARTED|Extension Study: After Month 24||0
324649|NCT00658320|784624|P1|STARTED|Extension Study: After Month 24||44
324650|NCT00658320|784623|P2|NOT COMPLETED|Extension Study: Month 12 to Month 24||7
324651|NCT00658320|784624|P1|NOT COMPLETED|Extension Study: Month 12 to Month 24||6
324652|NCT00658320|784623|P2|COMPLETED|Extension Study: Month 12 to Month 24||50
324653|NCT00658320|784624|P1|COMPLETED|Extension Study: Month 12 to Month 24||47
324654|NCT00658320|784623|P2|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
324655|NCT00658320|784624|P1|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
324656|NCT00658320|784623|P2|STARTED|Extension Study: Month 12 to Month 24||57
324657|NCT00658320|784624|P1|STARTED|Extension Study: Month 12 to Month 24||53
324658|NCT00658320|784623|P2|NOT COMPLETED|Core Study: 12 Months||3
324659|NCT00658320|784624|P1|NOT COMPLETED|Core Study: 12 Months||5
324660|NCT00658320|784623|P2|COMPLETED|Core Study: 12 Months||58
324661|NCT00658320|784624|P1|COMPLETED|Core Study: 12 Months||56
324662|NCT00658320|784623|P2|STARTED|Core Study: 12 Months||61
324663|NCT00658320|784624|P1|STARTED|Core Study: 12 Months||61
324664|NCT00658138|784647|P1|NOT COMPLETED|Overall Study||21
324665|NCT00658138|784647|P1|COMPLETED|Overall Study||40
324666|NCT00658138|784647|P1|STARTED|Overall Study||61
324667|NCT00658112|784652|P1|NOT COMPLETED|Overall Study||9
324668|NCT00658112|784652|P1|COMPLETED|Overall Study||11
324669|NCT00658112|784652|P1|STARTED|Overall Study||20
324670|NCT00657917|784656|P1|NOT COMPLETED|Overall Study||0
324671|NCT00657917|784656|P1|COMPLETED|Overall Study||1
324672|NCT00657917|784656|P1|STARTED|Overall Study||1
324673|NCT00657709|784667|P5|NOT COMPLETED|Overall Study||33
324674|NCT00657709|784668|P4|NOT COMPLETED|Overall Study||14
324675|NCT00657709|784669|P3|NOT COMPLETED|Overall Study||28
324676|NCT00657709|784670|P2|NOT COMPLETED|Overall Study||33
324677|NCT00657709|784671|P1|NOT COMPLETED|Overall Study||23
324678|NCT00657709|784667|P5|COMPLETED|Overall Study||457
324679|NCT00657709|784668|P4|COMPLETED|Overall Study||645
324680|NCT00657709|784669|P3|COMPLETED|Overall Study||792
324681|NCT00657709|784670|P2|COMPLETED|Overall Study||795
324682|NCT00657709|784671|P1|COMPLETED|Overall Study||810
324683|NCT00657709|784667|P5|STARTED|Overall Study||490
324684|NCT00657709|784668|P4|STARTED|Overall Study||659
324685|NCT00657709|784669|P3|STARTED|Overall Study||820
324686|NCT00657709|784670|P2|STARTED|Overall Study||828
324687|NCT00657709|784671|P1|STARTED|Overall Study||833
324688|NCT00657657|784712|P1|NOT COMPLETED|Overall Study||0
324689|NCT00657657|784712|P1|COMPLETED|Overall Study||29
324690|NCT00657657|784712|P1|STARTED|Overall Study||29
324691|NCT00657618|784720|P1|NOT COMPLETED|Overall Study||43
324692|NCT00657618|784720|P1|COMPLETED|Overall Study||34
324693|NCT00657618|784720|P1|STARTED|Overall Study||77
324694|NCT00657553|784727|P2|NOT COMPLETED|Overall Study||5
324695|NCT00657553|784728|P1|NOT COMPLETED|Overall Study||5
324696|NCT00657553|784727|P2|COMPLETED|Overall Study||0
324697|NCT00657553|784728|P1|COMPLETED|Overall Study||0
324698|NCT00657553|784727|P2|STARTED|Overall Study||5
324699|NCT00657553|784728|P1|STARTED|Overall Study||5
324700|NCT00657540|784736|P2|NOT COMPLETED|Overall Study||4
324701|NCT00657540|784737|P1|NOT COMPLETED|Overall Study||1
324702|NCT00657540|784736|P2|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|27
324703|NCT00657540|784737|P1|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|28
324704|NCT00657540|784736|P2|STARTED|Overall Study||31
324705|NCT00657540|784737|P1|STARTED|Overall Study||29
324706|NCT00657371|784751|P1|NOT COMPLETED|Overall Study||39
324707|NCT00657371|784751|P1|COMPLETED|Overall Study||249
324708|NCT00657371|784751|P1|STARTED|Overall Study||288
324709|NCT00657358|784756|P1|NOT COMPLETED|Overall Study||6
324710|NCT00657358|784756|P1|COMPLETED|Overall Study||16
324711|NCT00657358|784756|P1|STARTED|Overall Study||22
324712|NCT00657280|784764|P1|NOT COMPLETED|Overall Study||0
324713|NCT00657280|784764|P1|COMPLETED|Overall Study||16
324714|NCT00657280|784764|P1|STARTED|Overall Study||16
324715|NCT00657267|784768|P1|NOT COMPLETED|Overall Study||54
324716|NCT00657267|784768|P1|COMPLETED|Overall Study||4
324717|NCT00657267|784768|P1|STARTED|Overall Study||58
324718|NCT00657150|784778|P2|NOT COMPLETED|Treatment||97
324719|NCT00657150|784779|P1|NOT COMPLETED|Treatment||107
324720|NCT00657150|784778|P2|COMPLETED|Treatment||906
324721|NCT00657150|784779|P1|COMPLETED|Treatment||903
324722|NCT00657150|784778|P2|STARTED|Treatment||1003
324723|NCT00657150|784779|P1|STARTED|Treatment||1010
324724|NCT00657150|784778|P2|NOT COMPLETED|Overall Study||93
324725|NCT00657150|784779|P1|NOT COMPLETED|Overall Study||115
324726|NCT00657150|784778|P2|COMPLETED|Overall Study||910
324727|NCT00657150|784779|P1|COMPLETED|Overall Study||895
324728|NCT00657150|784778|P2|STARTED|Overall Study||1003
324729|NCT00657150|784779|P1|STARTED|Overall Study||1010
324730|NCT00657046|784810|P3|NOT COMPLETED|Overall Study||2
324731|NCT00657046|784811|P2|NOT COMPLETED|Overall Study||3
324732|NCT00657046|784812|P1|NOT COMPLETED|Overall Study||4
324733|NCT00657046|784810|P3|COMPLETED|Overall Study||21
324734|NCT00657046|784811|P2|COMPLETED|Overall Study||29
324735|NCT00657046|784812|P1|COMPLETED|Overall Study||26
324736|NCT00657046|784810|P3|Had Visits up to Visit 18|Overall Study||23
324737|NCT00657046|784811|P2|Had Visits up to Visit 18|Overall Study||30
324738|NCT00657046|784812|P1|Had Visits up to Visit 18|Overall Study||28
324739|NCT00657046|784810|P3|Had at Least 1 Post Baseline Visit|Overall Study||23
324740|NCT00657046|784811|P2|Had at Least 1 Post Baseline Visit|Overall Study||31
324741|NCT00657046|784812|P1|Had at Least 1 Post Baseline Visit|Overall Study||30
324742|NCT00657046|784810|P3|STARTED|Overall Study||23
324743|NCT00657046|784811|P2|STARTED|Overall Study||32
324744|NCT00657046|784812|P1|STARTED|Overall Study||30
324745|NCT00657020|784844|P2|NOT COMPLETED|PERIOD 2||0
324746|NCT00657020|784845|P1|NOT COMPLETED|PERIOD 2||0
324747|NCT00657020|784844|P2|COMPLETED|PERIOD 2||11
324748|NCT00657020|784845|P1|COMPLETED|PERIOD 2||11
324749|NCT00657020|784844|P2|STARTED|PERIOD 2||11
324750|NCT00657020|784845|P1|STARTED|PERIOD 2||11
324751|NCT00657020|784844|P2|NOT COMPLETED|PERIOD 1||1
324752|NCT00657020|784845|P1|NOT COMPLETED|PERIOD 1||0
324753|NCT00657020|784844|P2|COMPLETED|PERIOD 1||11
324754|NCT00657020|784845|P1|COMPLETED|PERIOD 1||11
324755|NCT00657020|784844|P2|STARTED|PERIOD 1||12
324756|NCT00657020|784845|P1|STARTED|PERIOD 1||11
324757|NCT00656968|784875|P2|NOT COMPLETED|Overall Study||0
324758|NCT00656968|784876|P1|NOT COMPLETED|Overall Study||0
324759|NCT00656968|784875|P2|COMPLETED|Overall Study||117
324760|NCT00656968|784876|P1|COMPLETED|Overall Study||115
324761|NCT00656968|784875|P2|STARTED|Overall Study||117
324762|NCT00656968|784876|P1|STARTED|Overall Study||115
324763|NCT00656916|784886|P2|NOT COMPLETED|Overall Study||0
324764|NCT00656916|784887|P1|NOT COMPLETED|Overall Study||0
324765|NCT00656916|784886|P2|COMPLETED|Overall Study||0
324766|NCT00656916|784887|P1|COMPLETED|Overall Study||1
324767|NCT00656916|784886|P2|STARTED|Overall Study||0
324768|NCT00656916|784887|P1|STARTED|Overall Study||1
324769|NCT00656851|784895|P2|NOT COMPLETED|Overall Study||4
324770|NCT00656851|784896|P1|NOT COMPLETED|Overall Study||0
324771|NCT00656851|784895|P2|COMPLETED|Overall Study||8
324772|NCT00656851|784896|P1|COMPLETED|Overall Study||12
324773|NCT00656851|784895|P2|STARTED|Overall Study||12
324774|NCT00656851|784896|P1|STARTED|Overall Study||12
324775|NCT00656799|784918|P1|NOT COMPLETED|Overall Study||2
324776|NCT00656799|784918|P1|COMPLETED|Overall Study||4
324777|NCT00656799|784918|P1|STARTED|Overall Study||6
324778|NCT00656669|784940|P1|NOT COMPLETED|AC (Cycles 6-9)||2
324779|NCT00656669|784940|P1|COMPLETED|AC (Cycles 6-9)||15
324780|NCT00656669|784940|P1|STARTED|AC (Cycles 6-9)||17
324781|NCT00656669|784940|P1|NOT COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||6
324782|NCT00656669|784940|P1|COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||17
324783|NCT00656669|784940|P1|STARTED|Paclitaxel/Sunitinib (Cycles 2-5)||23
324784|NCT00656669|784940|P1|NOT COMPLETED|Single Agent Sunitinib (Cycle 1)||0
324785|NCT00656669|784940|P1|COMPLETED|Single Agent Sunitinib (Cycle 1)||23
324786|NCT00656669|784940|P1|STARTED|Single Agent Sunitinib (Cycle 1)||23
324787|NCT00656656|784949|P1|NOT COMPLETED|Overall Study||0
324788|NCT00656656|784949|P1|COMPLETED|Overall Study||23
324789|NCT00656656|784949|P1|STARTED|Overall Study||23
324790|NCT00656630|784957|P3|NOT COMPLETED|Overall Study||2
324791|NCT00656630|784958|P2|NOT COMPLETED|Overall Study||2
324792|NCT00656630|784959|P1|NOT COMPLETED|Overall Study||2
324793|NCT00656630|784957|P3|COMPLETED|Overall Study||17
324794|NCT00656630|784958|P2|COMPLETED|Overall Study||25
324795|NCT00656630|784959|P1|COMPLETED|Overall Study||20
324796|NCT00656630|784957|P3|STARTED|Overall Study||19
324797|NCT00656630|784958|P2|STARTED|Overall Study||27
324798|NCT00656630|784959|P1|STARTED|Overall Study||22
324799|NCT00656617|784979|P1|NOT COMPLETED|Overall Study||7
324800|NCT00656617|784979|P1|COMPLETED|Overall Study||99
324801|NCT00656617|784979|P1|Induction Phase|Overall Study|Induction phase following determination of safe combination Vorinostat with Idarubicin.|103
324802|NCT00656617|784979|P1|Run-in Induction Phase|Overall Study|Initial run-in: Vorinostat induction dose 500 mg orally three times daily for 3 days.|3
324803|NCT00656617|784979|P1|STARTED|Overall Study||106
324804|NCT00656513|784988|P3|NOT COMPLETED|Overall Study||22
324805|NCT00656513|784989|P2|NOT COMPLETED|Overall Study||30
324806|NCT00656513|784990|P1|NOT COMPLETED|Overall Study||4
324807|NCT00656513|784988|P3|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|53
324808|NCT00656513|784989|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|43
324809|NCT00656513|784990|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
324810|NCT00656513|784988|P3|STARTED|Overall Study||75
324811|NCT00656513|784989|P2|STARTED|Overall Study||73
324812|NCT00656513|784990|P1|STARTED|Overall Study||48
324813|NCT00656487|785012|P3|NOT COMPLETED|Overall Study||0
324814|NCT00656487|785013|P2|NOT COMPLETED|Overall Study||4
324815|NCT00656487|785014|P1|NOT COMPLETED|Overall Study||2
324816|NCT00656487|785012|P3|COMPLETED|Overall Study||20
324817|NCT00656487|785013|P2|COMPLETED|Overall Study||19
324818|NCT00656487|785014|P1|COMPLETED|Overall Study||21
324819|NCT00656487|785012|P3|STARTED|Overall Study||20
324820|NCT00656487|785013|P2|STARTED|Overall Study||23
324821|NCT00656487|785014|P1|STARTED|Overall Study||23
324822|NCT00656474|785037|P1|NOT COMPLETED|Overall Study||1
324823|NCT00656474|785037|P1|COMPLETED|Overall Study||11
324824|NCT00656474|785037|P1|STARTED|Overall Study||12
324825|NCT00656448|785046|P2|NOT COMPLETED|Overall Study||0
324826|NCT00656448|785047|P1|NOT COMPLETED|Overall Study||0
324827|NCT00656448|785046|P2|COMPLETED|Overall Study||25
324828|NCT00656448|785047|P1|COMPLETED|Overall Study||25
324829|NCT00656448|785046|P2|STARTED|Overall Study||25
324830|NCT00656448|785047|P1|STARTED|Overall Study||25
324831|NCT00656370|785055|P1|NOT COMPLETED|Overall Study||10
324832|NCT00656370|785055|P1|COMPLETED|Overall Study|15 subjects were randomized and completed stage 1 (received both NS and LR).|15
324833|NCT00656370|785055|P1|STARTED|Overall Study|25 subjects were assessed for eligibility and signed an Informed Consent Form.|25
324834|NCT00656305|785071|P2|NOT COMPLETED|Overall Study||7
324835|NCT00656305|785072|P1|NOT COMPLETED|Overall Study||22
324836|NCT00656305|785071|P2|COMPLETED|Overall Study||21
324837|NCT00656305|785072|P1|COMPLETED|Overall Study||65
324838|NCT00656305|785071|P2|STARTED|Overall Study||28
324839|NCT00656305|785072|P1|STARTED|Overall Study||87
324840|NCT00656292|785084|P2|NOT COMPLETED|Overall Study||5
324841|NCT00656292|785085|P1|NOT COMPLETED|Overall Study||3
324842|NCT00656292|785084|P2|COMPLETED|Overall Study||24
324843|NCT00656292|785085|P1|COMPLETED|Overall Study||29
324844|NCT00656292|785084|P2|STARTED|Overall Study||29
324845|NCT00656292|785085|P1|STARTED|Overall Study||32
324846|NCT00656201|785103|P2|NOT COMPLETED|Overall Study||32
324847|NCT00656201|785104|P1|NOT COMPLETED|Overall Study||29
324848|NCT00656201|785103|P2|COMPLETED|Overall Study||201
324849|NCT00656201|785104|P1|COMPLETED|Overall Study||206
324850|NCT00656201|785103|P2|STARTED|Overall Study||233
324851|NCT00656201|785104|P1|STARTED|Overall Study||235
324852|NCT00656175|785112|P2|NOT COMPLETED|Overall Study||1
324853|NCT00656175|785113|P1|NOT COMPLETED|Overall Study||1
324854|NCT00656175|785112|P2|COMPLETED|Overall Study||20
324855|NCT00656175|785113|P1|COMPLETED|Overall Study||17
324856|NCT00656175|785112|P2|STARTED|Overall Study||21
324857|NCT00656175|785113|P1|STARTED|Overall Study||18
324858|NCT00656136|785121|P2|NOT COMPLETED|Overall Study||390
324859|NCT00656136|785122|P1|NOT COMPLETED|Overall Study||195
324860|NCT00656136|785121|P2|COMPLETED|Overall Study||0
324861|NCT00656136|785122|P1|COMPLETED|Overall Study||0
324862|NCT00656136|785121|P2|STARTED|Overall Study|Randomised patients.|390
324863|NCT00656136|785122|P1|STARTED|Overall Study|Randomised patients.|195
324864|NCT00656084|785132|P1|NOT COMPLETED|Overall Study||7
324865|NCT00656084|785132|P1|COMPLETED|Overall Study||9
324866|NCT00656084|785132|P1|STARTED|Overall Study||16
324867|NCT00656058|785139|P1|NOT COMPLETED|Overall Study||6
324868|NCT00656058|785139|P1|COMPLETED|Overall Study||19
324869|NCT00656058|785139|P1|STARTED|Overall Study||25
324870|NCT00656019|785152|P4|NOT COMPLETED|Overall Study||0
324871|NCT00656019|785153|P3|NOT COMPLETED|Overall Study||0
324872|NCT00656019|785154|P2|NOT COMPLETED|Overall Study||1
324873|NCT00656019|785155|P1|NOT COMPLETED|Overall Study||14
324874|NCT00656019|785152|P4|COMPLETED|Overall Study||4
324875|NCT00656019|785153|P3|COMPLETED|Overall Study||11
324876|NCT00656019|785154|P2|COMPLETED|Overall Study||18
324877|NCT00656019|785155|P1|COMPLETED|Overall Study||15
324878|NCT00656019|785152|P4|STARTED|Overall Study||4
324879|NCT00656019|785153|P3|STARTED|Overall Study||11
324880|NCT00656019|785154|P2|STARTED|Overall Study||19
324881|NCT00656019|785155|P1|STARTED|Overall Study||29
324882|NCT00655928|785167|P2|NOT COMPLETED|Overall Study||2
324883|NCT00655928|785168|P1|NOT COMPLETED|Overall Study||3
324884|NCT00655928|785167|P2|COMPLETED|Overall Study||24
324885|NCT00655928|785168|P1|COMPLETED|Overall Study||23
324886|NCT00655928|785167|P2|STARTED|Overall Study||26
324887|NCT00655928|785168|P1|STARTED|Overall Study||26
324888|NCT00655889|785174|P1|NOT COMPLETED|Overall Study||2
324889|NCT00655889|785174|P1|COMPLETED|Overall Study||11
324890|NCT00655889|785174|P1|STARTED|Overall Study||13
324891|NCT00655876|785181|P2|NOT COMPLETED|Overall Study||7
324892|NCT00655876|785182|P1|NOT COMPLETED|Overall Study||9
324893|NCT00655876|785181|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|169
324894|NCT00655876|785182|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|159
324895|NCT00655876|785181|P2|STARTED|Overall Study||176
324896|NCT00655876|785182|P1|STARTED|Overall Study||168
324897|NCT00655863|785201|P3|NOT COMPLETED|Overall Study||1
324898|NCT00655863|785202|P2|NOT COMPLETED|Overall Study||0
324899|NCT00655863|785203|P1|NOT COMPLETED|Overall Study||0
324900|NCT00655863|785201|P3|COMPLETED|Overall Study||21
324901|NCT00655863|785202|P2|COMPLETED|Overall Study||25
324902|NCT00655863|785203|P1|COMPLETED|Overall Study||24
324903|NCT00655863|785201|P3|STARTED|Overall Study||22
324904|NCT00655863|785202|P2|STARTED|Overall Study||25
324905|NCT00655863|785203|P1|STARTED|Overall Study||24
324906|NCT00655850|785262|P1|NOT COMPLETED|Overall Study||3
324907|NCT00655850|785262|P1|COMPLETED|Overall Study||36
324908|NCT00655850|785262|P1|STARTED|Overall Study||39
324909|NCT00655824|785269|P1|NOT COMPLETED|Overall Study||84
324910|NCT00655824|785269|P1|COMPLETED|Overall Study||8
324911|NCT00655824|785269|P1|STARTED|Overall Study||92
324912|NCT00655811|785303|P1|NOT COMPLETED|Overall Study||0
324913|NCT00655811|785303|P1|COMPLETED|Overall Study||40
324914|NCT00655811|785303|P1|STARTED|Overall Study||40
324915|NCT00655746|785317|P1|NOT COMPLETED|Overall Study||1
324916|NCT00655746|785317|P1|COMPLETED|Overall Study||13
324917|NCT00655746|785317|P1|STARTED|Overall Study||14
324918|NCT00655733|785336|P2|NOT COMPLETED|Overall Study||8
324919|NCT00655733|785337|P1|NOT COMPLETED|Overall Study||7
324920|NCT00655733|785336|P2|COMPLETED|Overall Study||42
324921|NCT00655733|785337|P1|COMPLETED|Overall Study||44
324922|NCT00655733|785336|P2|STARTED|Overall Study||50
324923|NCT00655733|785337|P1|STARTED|Overall Study||51
324924|NCT00655707|785343|P1|NOT COMPLETED|Overall Study||0
324925|NCT00655707|785343|P1|COMPLETED|Overall Study||5
324926|NCT00655707|785343|P1|STARTED|Overall Study||5
324927|NCT00655668|785348|P1|NOT COMPLETED|Overall Study||54
324928|NCT00655668|785348|P1|COMPLETED|Overall Study|Participants dosed up to 24 months, disease progression or unacceptable adverse events developed.|0
324929|NCT00655668|785348|P1|STARTED|Overall Study|Planned enrollment: 80 participants|54
324930|NCT00655642|785360|P4|NOT COMPLETED|Overall Study||2
324931|NCT00655642|785361|P3|NOT COMPLETED|Overall Study||2
324932|NCT00655642|785362|P2|NOT COMPLETED|Overall Study||3
324933|NCT00655642|785363|P1|NOT COMPLETED|Overall Study||1
324934|NCT00655642|785360|P4|COMPLETED|Overall Study|1 patient's initial Visual analog scale (VAS)<40; 1 patient was withdrawn by treating physician|39
324935|NCT00655642|785361|P3|COMPLETED|Overall Study|1 patient left the ED prior to receiving drug; 1 patient's nausea resolved prior to receiving drug|43
324936|NCT00655642|785362|P2|COMPLETED|Overall Study|1 patient given drug orally rather than intravenous(iv);1 patient refused iv; 1 pt lost to follow-up|40
324937|NCT00655642|785363|P1|COMPLETED|Overall Study|1 patient withdrawn by treating physician after consent|41
324938|NCT00655642|785360|P4|STARTED|Overall Study||41
324939|NCT00655642|785361|P3|STARTED|Overall Study||45
324940|NCT00655642|785362|P2|STARTED|Overall Study||43
324941|NCT00655642|785363|P1|STARTED|Overall Study||42
324942|NCT00655629|785375|P2|NOT COMPLETED|Overall Study||23
324943|NCT00655629|785376|P1|NOT COMPLETED|Overall Study||21
324944|NCT00655629|785375|P2|COMPLETED|Overall Study||144
324945|NCT00655629|785376|P1|COMPLETED|Overall Study||151
324946|NCT00655629|785375|P2|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion.(safety population)|166
324947|NCT00655629|785376|P1|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion. (safety population)|171
324948|NCT00655629|785375|P2|STARTED|Overall Study||167
324949|NCT00655629|785376|P1|STARTED|Overall Study||172
324950|NCT00655564|785412|P1|NOT COMPLETED|Overall Study||3
324951|NCT00655564|785412|P1|COMPLETED|Overall Study||12
324952|NCT00655564|785412|P1|STARTED|Overall Study||15
324953|NCT00655551|785420|P3|NOT COMPLETED|Period 4 (up to 7 Days)||0
324954|NCT00655551|785421|P2|NOT COMPLETED|Period 4 (up to 7 Days)||2
324955|NCT00655551|785422|P1|NOT COMPLETED|Period 4 (up to 7 Days)||0
324956|NCT00655551|785420|P3|COMPLETED|Period 4 (up to 7 Days)||0
324957|NCT00655551|785421|P2|COMPLETED|Period 4 (up to 7 Days)||23
324958|NCT00655551|785422|P1|COMPLETED|Period 4 (up to 7 Days)||0
324959|NCT00655551|785420|P3|STARTED|Period 4 (up to 7 Days)||0
324960|NCT00655551|785421|P2|STARTED|Period 4 (up to 7 Days)||25
324961|NCT00655551|785422|P1|STARTED|Period 4 (up to 7 Days)||0
324962|NCT00655551|785420|P3|NOT COMPLETED|Period 3 (up to 7 Days)||4
324963|NCT00655551|785421|P2|NOT COMPLETED|Period 3 (up to 7 Days)||0
324964|NCT00655551|785422|P1|NOT COMPLETED|Period 3 (up to 7 Days)||0
324965|NCT00655551|785420|P3|COMPLETED|Period 3 (up to 7 Days)||21
324966|NCT00655551|785421|P2|COMPLETED|Period 3 (up to 7 Days)||0
324967|NCT00655551|785422|P1|COMPLETED|Period 3 (up to 7 Days)||0
324968|NCT00655551|785420|P3|STARTED|Period 3 (up to 7 Days)||25
324969|NCT00655551|785421|P2|STARTED|Period 3 (up to 7 Days)||0
324970|NCT00655551|785422|P1|STARTED|Period 3 (up to 7 Days)||0
324971|NCT00655551|785420|P3|NOT COMPLETED|Period 2 (up to 7 Days)||0
324972|NCT00655551|785421|P2|NOT COMPLETED|Period 2 (up to 7 Days)||1
324973|NCT00655551|785422|P1|NOT COMPLETED|Period 2 (up to 7 Days)||0
324974|NCT00655551|785420|P3|COMPLETED|Period 2 (up to 7 Days)||0
324975|NCT00655551|785421|P2|COMPLETED|Period 2 (up to 7 Days)||24
324976|NCT00655551|785422|P1|COMPLETED|Period 2 (up to 7 Days)||0
324977|NCT00655551|785420|P3|STARTED|Period 2 (up to 7 Days)||0
324978|NCT00655551|785421|P2|STARTED|Period 2 (up to 7 Days)||25
324979|NCT00655551|785422|P1|STARTED|Period 2 (up to 7 Days)||0
324980|NCT00655551|785420|P3|NOT COMPLETED|Period 1 (up to 7 Days)||0
324981|NCT00655551|785421|P2|NOT COMPLETED|Period 1 (up to 7 Days)||0
324982|NCT00655551|785422|P1|NOT COMPLETED|Period 1 (up to 7 Days)||0
324983|NCT00655551|785420|P3|COMPLETED|Period 1 (up to 7 Days)||0
324984|NCT00655551|785421|P2|COMPLETED|Period 1 (up to 7 Days)||0
324985|NCT00655551|785422|P1|COMPLETED|Period 1 (up to 7 Days)||25
324986|NCT00655551|785420|P3|STARTED|Period 1 (up to 7 Days)||0
324987|NCT00655551|785421|P2|STARTED|Period 1 (up to 7 Days)||0
324988|NCT00655551|785422|P1|STARTED|Period 1 (up to 7 Days)||25
324989|NCT00655551|785420|P3|NOT COMPLETED|All Periods Combined||4
324990|NCT00655551|785421|P2|NOT COMPLETED|All Periods Combined||3
324991|NCT00655551|785422|P1|NOT COMPLETED|All Periods Combined||0
324992|NCT00655551|785420|P3|COMPLETED|All Periods Combined||21
324993|NCT00655551|785421|P2|COMPLETED|All Periods Combined||47
324994|NCT00655551|785422|P1|COMPLETED|All Periods Combined||25
324995|NCT00655551|785420|P3|STARTED|All Periods Combined||25
324996|NCT00655551|785421|P2|STARTED|All Periods Combined||50
324997|NCT00655551|785422|P1|STARTED|All Periods Combined||25
324998|NCT00655486|785436|P1|NOT COMPLETED|Overall Study||28
324999|NCT00655486|785436|P1|COMPLETED|Overall Study||69
325000|NCT00655486|785436|P1|STARTED|Overall Study||97
325001|NCT00655356|785443|P2|NOT COMPLETED|Overall Study||10
325002|NCT00655356|785444|P1|NOT COMPLETED|Overall Study||17
325003|NCT00655356|785443|P2|COMPLETED|Overall Study||98
325004|NCT00655356|785444|P1|COMPLETED|Overall Study||93
325005|NCT00655356|785443|P2|STARTED|Overall Study||108
325006|NCT00655356|785444|P1|STARTED|Overall Study||110
325007|NCT00655083|785458|P2|NOT COMPLETED|Overall Study||0
325008|NCT00655083|785459|P1|NOT COMPLETED|Overall Study||0
325009|NCT00655083|785458|P2|COMPLETED|Overall Study||8
325010|NCT00655083|785459|P1|COMPLETED|Overall Study||12
325011|NCT00655083|785458|P2|STARTED|Overall Study||8
325012|NCT00655083|785459|P1|STARTED|Overall Study||12
325013|NCT00654992|785473|P2|NOT COMPLETED|Overall Study||0
325014|NCT00654992|785474|P1|NOT COMPLETED|Overall Study||0
325015|NCT00654992|785473|P2|COMPLETED|Overall Study||35
325016|NCT00654992|785474|P1|COMPLETED|Overall Study||36
325017|NCT00654992|785473|P2|STARTED|Overall Study||35
325018|NCT00654992|785474|P1|STARTED|Overall Study||36
325019|NCT00654953|785483|P3|NOT COMPLETED|Overall Study||22
325020|NCT00654953|785484|P2|NOT COMPLETED|Overall Study||28
325021|NCT00654953|785485|P1|NOT COMPLETED|Overall Study||30
325022|NCT00654953|785483|P3|COMPLETED|Overall Study||8
325023|NCT00654953|785484|P2|COMPLETED|Overall Study||8
325024|NCT00654953|785485|P1|COMPLETED|Overall Study||6
325025|NCT00654953|785483|P3|STARTED|Overall Study||30
325026|NCT00654953|785484|P2|STARTED|Overall Study||36
325027|NCT00654953|785485|P1|STARTED|Overall Study||36
325028|NCT00654940|785495|P2|NOT COMPLETED|Period 2||0
325029|NCT00654940|785496|P1|NOT COMPLETED|Period 2||0
325030|NCT00654940|785495|P2|COMPLETED|Period 2||11
325031|NCT00654940|785496|P1|COMPLETED|Period 2||12
325032|NCT00654940|785495|P2|STARTED|Period 2||11
325033|NCT00654940|785496|P1|STARTED|Period 2||12
325034|NCT00654940|785495|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
325035|NCT00654940|785496|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
325036|NCT00654940|785495|P2|COMPLETED|Washout Period of 2 Weeks||11
325037|NCT00654940|785496|P1|COMPLETED|Washout Period of 2 Weeks||12
325038|NCT00654940|785495|P2|STARTED|Washout Period of 2 Weeks||11
325039|NCT00654940|785496|P1|STARTED|Washout Period of 2 Weeks||12
325040|NCT00654940|785495|P2|NOT COMPLETED|Period 1||1
325041|NCT00654940|785496|P1|NOT COMPLETED|Period 1||1
325042|NCT00654940|785495|P2|COMPLETED|Period 1||11
325043|NCT00654940|785496|P1|COMPLETED|Period 1||12
325044|NCT00654940|785495|P2|Received Study Treatment|Period 1||12
325045|NCT00654940|785496|P1|Received Study Treatment|Period 1||12
325046|NCT00654940|785495|P2|STARTED|Period 1|Assigned to study treatment.|12
325047|NCT00654940|785496|P1|STARTED|Period 1|Assigned to study treatment.|13
325048|NCT00654927|785508|P1|NOT COMPLETED|Overall Study||107
325049|NCT00654927|785508|P1|COMPLETED|Overall Study||70
325050|NCT00654927|785508|P1|STARTED|Overall Study||177
325051|NCT00654901|785520|P4|NOT COMPLETED|Overall Study||0
325052|NCT00654901|785521|P3|NOT COMPLETED|Overall Study||2
325053|NCT00654901|785522|P2|NOT COMPLETED|Overall Study||0
325054|NCT00654901|785523|P1|NOT COMPLETED|Overall Study||4
325055|NCT00654901|785520|P4|COMPLETED|Overall Study||113
325056|NCT00654901|785521|P3|COMPLETED|Overall Study||250
325057|NCT00654901|785522|P2|COMPLETED|Overall Study||262
325058|NCT00654901|785523|P1|COMPLETED|Overall Study||250
325059|NCT00654901|785520|P4|STARTED|Overall Study||113
325060|NCT00654901|785521|P3|STARTED|Overall Study||252
325061|NCT00654901|785522|P2|STARTED|Overall Study||262
325062|NCT00654901|785523|P1|STARTED|Overall Study||254
325063|NCT00654875|785543|P2|NOT COMPLETED|Overall Study||17
325064|NCT00654875|785544|P1|NOT COMPLETED|Overall Study||17
325065|NCT00654875|785543|P2|COMPLETED|Overall Study||147
325066|NCT00654875|785544|P1|COMPLETED|Overall Study||147
325067|NCT00654875|785543|P2|STARTED|Overall Study||164
325068|NCT00654875|785544|P1|STARTED|Overall Study||164
325069|NCT00654836|785562|P1|NOT COMPLETED|Overall Study||0
325070|NCT00654836|785562|P1|COMPLETED|Overall Study||32
325071|NCT00654836|785562|P1|STARTED|Overall Study||32
325072|NCT00654784|785570|P2|NOT COMPLETED|Overall Study||0
325073|NCT00654784|785571|P1|NOT COMPLETED|Overall Study||0
325074|NCT00654784|785570|P2|COMPLETED|Overall Study||8
325075|NCT00654784|785571|P1|COMPLETED|Overall Study||13
325076|NCT00654784|785570|P2|STARTED|Overall Study||8
325077|NCT00654784|785571|P1|STARTED|Overall Study||13
325078|NCT00654745|785577|P1|NOT COMPLETED|Overall Study||43
325079|NCT00654745|785577|P1|COMPLETED|Overall Study||164
325080|NCT00654745|785577|P1|STARTED|Overall Study|This is single group study in which subjects were titrated to the next of 7 arms if BP goal not met.|207
325081|NCT00654654|785615|P1|NOT COMPLETED|Overall Study||7
325082|NCT00654654|785615|P1|COMPLETED|Overall Study||43
325083|NCT00654654|785615|P1|STARTED|Overall Study||50
325084|NCT00654641|785622|P2|NOT COMPLETED|Overall Study||3
325085|NCT00654641|785623|P1|NOT COMPLETED|Overall Study||2
325086|NCT00654641|785622|P2|COMPLETED|Overall Study||23
325087|NCT00654641|785623|P1|COMPLETED|Overall Study||26
325088|NCT00654641|785622|P2|STARTED|Overall Study||26
325089|NCT00654641|785623|P1|STARTED|Overall Study||28
325090|NCT00654628|785629|P1|NOT COMPLETED|6 –Week Extension Period (Single Site)||5
325091|NCT00654628|785629|P1|COMPLETED|6 –Week Extension Period (Single Site)||55
325092|NCT00654628|785629|P1|STARTED|6 –Week Extension Period (Single Site)|Subjects who completed the first 6-week period and participated in the second 6-week study period.|60
325093|NCT00654628|785629|P1|NOT COMPLETED|6-week Active Treatment Period||21
325094|NCT00654628|785629|P1|COMPLETED|6-week Active Treatment Period||152
325095|NCT00654628|785629|P1|STARTED|6-week Active Treatment Period||173
325096|NCT00654615|785646|P2|NOT COMPLETED|Overall Study||7
325097|NCT00654615|785647|P1|NOT COMPLETED|Overall Study||8
325098|NCT00654615|785646|P2|COMPLETED|Overall Study||23
325099|NCT00654615|785647|P1|COMPLETED|Overall Study||22
325100|NCT00654615|785646|P2|STARTED|Overall Study||30
325101|NCT00654615|785647|P1|STARTED|Overall Study||30
325102|NCT00654511|785659|P4|NOT COMPLETED|Overall Study||0
325103|NCT00654511|785660|P3|NOT COMPLETED|Overall Study||0
325104|NCT00654511|785661|P2|NOT COMPLETED|Overall Study||0
325105|NCT00654511|785662|P1|NOT COMPLETED|Overall Study||0
325106|NCT00654511|785659|P4|COMPLETED|Overall Study||25
325107|NCT00654511|785660|P3|COMPLETED|Overall Study||25
325108|NCT00654511|785661|P2|COMPLETED|Overall Study||25
325109|NCT00654511|785662|P1|COMPLETED|Overall Study||26
325110|NCT00654511|785659|P4|STARTED|Overall Study||25
325111|NCT00654511|785660|P3|STARTED|Overall Study||25
325112|NCT00654511|785661|P2|STARTED|Overall Study||25
325113|NCT00654511|785662|P1|STARTED|Overall Study||26
325114|NCT00654498|785678|P2|NOT COMPLETED|Overall Study||12
325115|NCT00654498|785679|P1|NOT COMPLETED|Overall Study||14
325116|NCT00654498|785678|P2|COMPLETED|Overall Study||91
325117|NCT00654498|785679|P1|COMPLETED|Overall Study||189
325118|NCT00654498|785678|P2|STARTED|Overall Study||103
325119|NCT00654498|785679|P1|STARTED|Overall Study||203
325120|NCT00654420|785711|P4|NOT COMPLETED|Phase II||38
325121|NCT00654420|785712|P3|NOT COMPLETED|Phase II||37
325122|NCT00654420|785713|P2|NOT COMPLETED|Phase II||0
325123|NCT00654420|785714|P1|NOT COMPLETED|Phase II||0
325124|NCT00654420|785711|P4|COMPLETED|Phase II||0
325125|NCT00654420|785712|P3|COMPLETED|Phase II||0
325126|NCT00654420|785713|P2|COMPLETED|Phase II||0
325127|NCT00654420|785714|P1|COMPLETED|Phase II||0
325128|NCT00654420|785711|P4|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|38
325129|NCT00654420|785712|P3|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|37
325130|NCT00654420|785713|P2|STARTED|Phase II||0
325131|NCT00654420|785714|P1|STARTED|Phase II||0
325132|NCT00654420|785711|P4|NOT COMPLETED|Phase I (Dose Escalation)||0
325133|NCT00654420|785712|P3|NOT COMPLETED|Phase I (Dose Escalation)||0
325134|NCT00654420|785713|P2|NOT COMPLETED|Phase I (Dose Escalation)||16
325135|NCT00654420|785714|P1|NOT COMPLETED|Phase I (Dose Escalation)||4
325136|NCT00654420|785711|P4|COMPLETED|Phase I (Dose Escalation)||0
325137|NCT00654420|785712|P3|COMPLETED|Phase I (Dose Escalation)||0
325138|NCT00654420|785713|P2|COMPLETED|Phase I (Dose Escalation)||0
325139|NCT00654420|785714|P1|COMPLETED|Phase I (Dose Escalation)||0
325140|NCT00654420|785711|P4|STARTED|Phase I (Dose Escalation)||0
325141|NCT00654420|785712|P3|STARTED|Phase I (Dose Escalation)||0
325142|NCT00654420|785713|P2|STARTED|Phase I (Dose Escalation)||16
325143|NCT00654420|785714|P1|STARTED|Phase I (Dose Escalation)||4
325144|NCT00654381|785740|P6|NOT COMPLETED|Extension Stage||3
325145|NCT00654381|785741|P5|NOT COMPLETED|Extension Stage||3
325146|NCT00654381|785742|P4|NOT COMPLETED|Extension Stage||9
325147|NCT00654381|785743|P3|NOT COMPLETED|Extension Stage||11
325148|NCT00654381|785744|P2|NOT COMPLETED|Extension Stage||2
325149|NCT00654381|785745|P1|NOT COMPLETED|Extension Stage||1
325150|NCT00654381|785740|P6|COMPLETED|Extension Stage||73
325151|NCT00654381|785741|P5|COMPLETED|Extension Stage||68
325152|NCT00654381|785742|P4|COMPLETED|Extension Stage||142
325153|NCT00654381|785743|P3|COMPLETED|Extension Stage||142
325154|NCT00654381|785744|P2|COMPLETED|Extension Stage||36
325155|NCT00654381|785745|P1|COMPLETED|Extension Stage||33
325156|NCT00654381|785740|P6|STARTED|Extension Stage||76
325157|NCT00654381|785741|P5|STARTED|Extension Stage||71
325158|NCT00654381|785742|P4|STARTED|Extension Stage||151
325159|NCT00654381|785743|P3|STARTED|Extension Stage||153
325160|NCT00654381|785744|P2|STARTED|Extension Stage||38
325161|NCT00654381|785745|P1|STARTED|Extension Stage||34
325162|NCT00654381|785740|P6|NOT COMPLETED|2nd Stage||3
325163|NCT00654381|785741|P5|NOT COMPLETED|2nd Stage||8
325164|NCT00654381|785742|P4|NOT COMPLETED|2nd Stage||4
325165|NCT00654381|785743|P3|NOT COMPLETED|2nd Stage||3
325166|NCT00654381|785744|P2|NOT COMPLETED|2nd Stage||0
325167|NCT00654381|785745|P1|NOT COMPLETED|2nd Stage||2
325168|NCT00654381|785740|P6|COMPLETED|2nd Stage||76
325169|NCT00654381|785741|P5|COMPLETED|2nd Stage||71
325170|NCT00654381|785742|P4|COMPLETED|2nd Stage||151
325171|NCT00654381|785743|P3|COMPLETED|2nd Stage||153
325172|NCT00654381|785744|P2|COMPLETED|2nd Stage||38
325173|NCT00654381|785745|P1|COMPLETED|2nd Stage||34
325174|NCT00654381|785740|P6|STARTED|2nd Stage||79
325175|NCT00654381|785741|P5|STARTED|2nd Stage||79
325176|NCT00654381|785742|P4|STARTED|2nd Stage||155
325177|NCT00654381|785743|P3|STARTED|2nd Stage||156
325178|NCT00654381|785744|P2|STARTED|2nd Stage||38
325179|NCT00654381|785745|P1|STARTED|2nd Stage||36
325180|NCT00654381|785740|P6|NOT COMPLETED|1st Stage||2
325181|NCT00654381|785741|P5|NOT COMPLETED|1st Stage||2
325182|NCT00654381|785742|P4|NOT COMPLETED|1st Stage||5
325183|NCT00654381|785743|P3|NOT COMPLETED|1st Stage||3
325184|NCT00654381|785744|P2|NOT COMPLETED|1st Stage||3
325185|NCT00654381|785745|P1|NOT COMPLETED|1st Stage||3
325186|NCT00654381|785740|P6|COMPLETED|1st Stage||79
325187|NCT00654381|785741|P5|COMPLETED|1st Stage||79
325188|NCT00654381|785742|P4|COMPLETED|1st Stage||155
325189|NCT00654381|785743|P3|COMPLETED|1st Stage||156
325190|NCT00654381|785744|P2|COMPLETED|1st Stage||38
325191|NCT00654381|785745|P1|COMPLETED|1st Stage||36
325192|NCT00654381|785740|P6|STARTED|1st Stage||81
325193|NCT00654381|785741|P5|STARTED|1st Stage||81
325194|NCT00654381|785742|P4|STARTED|1st Stage||160
325195|NCT00654381|785743|P3|STARTED|1st Stage||159
325196|NCT00654381|785744|P2|STARTED|1st Stage||41
325197|NCT00654381|785745|P1|STARTED|1st Stage||39
325198|NCT00654368|785782|P3|NOT COMPLETED|Overall Study||32
325199|NCT00654368|785783|P2|NOT COMPLETED|Overall Study||48
325200|NCT00654368|785784|P1|NOT COMPLETED|Overall Study||53
325201|NCT00654368|785782|P3|COMPLETED|Overall Study||75
325202|NCT00654368|785783|P2|COMPLETED|Overall Study||50
325203|NCT00654368|785784|P1|COMPLETED|Overall Study||0
325204|NCT00654368|785782|P3|STARTED|Overall Study||107
325205|NCT00654368|785783|P2|STARTED|Overall Study||98
325206|NCT00654368|785784|P1|STARTED|Overall Study||53
325207|NCT00654355|785817|P2|NOT COMPLETED|Overall Study||2
325208|NCT00654355|785818|P1|NOT COMPLETED|Overall Study||2
325209|NCT00654355|785817|P2|COMPLETED|Overall Study||13
325210|NCT00654355|785818|P1|COMPLETED|Overall Study||13
325211|NCT00654355|785817|P2|STARTED|Overall Study||15
325212|NCT00654355|785818|P1|STARTED|Overall Study||15
325213|NCT00654329|785832|P4|NOT COMPLETED|Overall Study||0
325214|NCT00654329|785833|P3|NOT COMPLETED|Overall Study||0
325215|NCT00654329|785834|P2|NOT COMPLETED|Overall Study||0
325216|NCT00654329|785835|P1|NOT COMPLETED|Overall Study||0
325217|NCT00654329|785832|P4|COMPLETED|Overall Study||27
325218|NCT00654329|785833|P3|COMPLETED|Overall Study||23
325219|NCT00654329|785834|P2|COMPLETED|Overall Study||28
325220|NCT00654329|785835|P1|COMPLETED|Overall Study||23
325221|NCT00654329|785832|P4|STARTED|Overall Study||27
325222|NCT00654329|785833|P3|STARTED|Overall Study||23
325223|NCT00654329|785834|P2|STARTED|Overall Study||28
325224|NCT00654329|785835|P1|STARTED|Overall Study||23
325225|NCT00654238|785849|P1|NOT COMPLETED|Overall Study||4
325226|NCT00654238|785849|P1|COMPLETED|Overall Study||55
325227|NCT00654238|785849|P1|STARTED|Overall Study||59
325228|NCT00654186|785854|P1|NOT COMPLETED|Overall Study||5
325229|NCT00654186|785854|P1|COMPLETED|Overall Study||27
325230|NCT00654186|785854|P1|STARTED|Overall Study||32
325231|NCT00654147|785862|P2|NOT COMPLETED|Overall Study||4
325232|NCT00654147|785863|P1|NOT COMPLETED|Overall Study||2
325233|NCT00654147|785862|P2|COMPLETED|Overall Study||19
325234|NCT00654147|785863|P1|COMPLETED|Overall Study||19
325235|NCT00654147|785862|P2|STARTED|Overall Study||23
325236|NCT00654147|785863|P1|STARTED|Overall Study||21
325237|NCT00654095|785879|P1|NOT COMPLETED|Overall Study||32
325238|NCT00654095|785879|P1|COMPLETED|Overall Study||114
325239|NCT00654095|785879|P1|STARTED|Overall Study||146
325240|NCT00654069|785886|P3|NOT COMPLETED|Overall Study||18
325241|NCT00654069|785887|P2|NOT COMPLETED|Overall Study||11
325242|NCT00654069|785888|P1|NOT COMPLETED|Overall Study||17
325243|NCT00654069|785886|P3|COMPLETED|Overall Study||116
325244|NCT00654069|785887|P2|COMPLETED|Overall Study||124
325245|NCT00654069|785888|P1|COMPLETED|Overall Study||119
325246|NCT00654069|785886|P3|STARTED|Overall Study||134
325247|NCT00654069|785887|P2|STARTED|Overall Study||135
325248|NCT00654069|785888|P1|STARTED|Overall Study||136
325249|NCT00654030|785896|P1|NOT COMPLETED|Overall Study||1
325250|NCT00654030|785896|P1|COMPLETED|Overall Study||11
325251|NCT00654030|785896|P1|STARTED|Overall Study||12
325252|NCT00654004|785902|P2|NOT COMPLETED|Overall Study||0
325253|NCT00654004|785903|P1|NOT COMPLETED|Overall Study||1
325254|NCT00654004|785902|P2|COMPLETED|Overall Study||12
325255|NCT00654004|785903|P1|COMPLETED|Overall Study||13
325256|NCT00654004|785902|P2|STARTED|Overall Study||12
325257|NCT00654004|785903|P1|STARTED|Overall Study||14
325258|NCT00653991|785919|P2|NOT COMPLETED|6 Month Follow-up||141
325259|NCT00653991|785920|P1|NOT COMPLETED|6 Month Follow-up||133
325260|NCT00653991|785919|P2|COMPLETED|6 Month Follow-up||350
325261|NCT00653991|785920|P1|COMPLETED|6 Month Follow-up||311
325262|NCT00653991|785919|P2|STARTED|6 Month Follow-up|Completion of 3 month follow-up was not required for 6-month eligibility.|491
325263|NCT00653991|785920|P1|STARTED|6 Month Follow-up|Completion of 3 month follow-up was not required for 6-month eligibility.|444
325264|NCT00653991|785919|P2|NOT COMPLETED|3 Month Follow-up||157
325265|NCT00653991|785920|P1|NOT COMPLETED|3 Month Follow-up||150
325266|NCT00653991|785919|P2|COMPLETED|3 Month Follow-up||334
325267|NCT00653991|785920|P1|COMPLETED|3 Month Follow-up||294
325268|NCT00653991|785919|P2|STARTED|3 Month Follow-up||491
325269|NCT00653991|785920|P1|STARTED|3 Month Follow-up||444
325270|NCT00653939|785932|P2|NOT COMPLETED|Overall Study||15
325271|NCT00653939|785933|P1|NOT COMPLETED|Overall Study||12
325272|NCT00653939|785932|P2|COMPLETED|Overall Study||17
325273|NCT00653939|785933|P1|COMPLETED|Overall Study||19
325274|NCT00653939|785932|P2|STARTED|Overall Study|1 patient randomized did not receive treatment due to acute renal failure.|32
325275|NCT00653939|785933|P1|STARTED|Overall Study|2 patients randomized did not receive treatment due to brain metastasis or consent withdrawal.|31
325276|NCT00653861|785949|P1|NOT COMPLETED|Overall Study||0
325277|NCT00653861|785949|P1|COMPLETED|Overall Study||72
325278|NCT00653861|785949|P1|STARTED|Overall Study||72
325279|NCT00653523|785958|P1|NOT COMPLETED|Overall Study||19
325280|NCT00653523|785958|P1|COMPLETED|Overall Study||132
325281|NCT00653523|785958|P1|STARTED|Overall Study||151
325282|NCT00653328|785962|P1|NOT COMPLETED|Overall Study||15
325283|NCT00653328|785962|P1|COMPLETED|Overall Study||0
325284|NCT00653328|785962|P1|STARTED|Overall Study||15
325285|NCT00653263|785969|P1|NOT COMPLETED|Overall Study||2
325286|NCT00653263|785969|P1|COMPLETED|Overall Study||6
325287|NCT00653263|785969|P1|STARTED|Overall Study|1 dropped out of treatment and the other had untreated hypertension|8
325288|NCT00653224|785977|P2|NOT COMPLETED|Overall Study||7
325289|NCT00653224|785978|P1|NOT COMPLETED|Overall Study||7
325290|NCT00653224|785977|P2|COMPLETED|Overall Study||280
325291|NCT00653224|785978|P1|COMPLETED|Overall Study||286
325292|NCT00653224|785977|P2|STARTED|Overall Study||287
325293|NCT00653224|785978|P1|STARTED|Overall Study||293
325294|NCT00653159|786164|P2|NOT COMPLETED|Overall Study||3
325295|NCT00653159|786165|P1|NOT COMPLETED|Overall Study||5
325296|NCT00653159|786164|P2|COMPLETED|Overall Study||9
325297|NCT00653159|786165|P1|COMPLETED|Overall Study||6
325298|NCT00653159|786164|P2|STARTED|Overall Study||12
325299|NCT00653159|786165|P1|STARTED|Overall Study||11
325300|NCT00653133|786181|P2|NOT COMPLETED|Overall Study||0
325301|NCT00653133|786182|P1|NOT COMPLETED|Overall Study||0
325302|NCT00653133|786181|P2|COMPLETED|Overall Study||497
325303|NCT00653133|786182|P1|COMPLETED|Overall Study||1324
325304|NCT00653133|786181|P2|STARTED|Overall Study||497
325305|NCT00653133|786182|P1|STARTED|Overall Study||1324
325306|NCT00653068|786192|P1|NOT COMPLETED|Overall Study||50
325307|NCT00653068|786192|P1|COMPLETED|Overall Study||20
325308|NCT00653068|786192|P1|STARTED|Overall Study||70
325309|NCT00652951|786206|P3|NOT COMPLETED|Booster Phase||0
325310|NCT00652951|786207|P2|NOT COMPLETED|Booster Phase||1
325311|NCT00652951|786208|P1|NOT COMPLETED|Booster Phase||1
325312|NCT00652951|786206|P3|COMPLETED|Booster Phase||258
325313|NCT00652951|786207|P2|COMPLETED|Booster Phase||258
325314|NCT00652951|786208|P1|COMPLETED|Booster Phase||256
325315|NCT00652951|786206|P3|STARTED|Booster Phase||258
325316|NCT00652951|786207|P2|STARTED|Booster Phase||259
325317|NCT00652951|786208|P1|STARTED|Booster Phase||257
325318|NCT00652951|786206|P3|NOT COMPLETED|Primary Phase||0
325319|NCT00652951|786207|P2|NOT COMPLETED|Primary Phase||0
325320|NCT00652951|786208|P1|NOT COMPLETED|Primary Phase||0
325321|NCT00652951|786206|P3|COMPLETED|Primary Phase||260
325322|NCT00652951|786207|P2|COMPLETED|Primary Phase||260
325323|NCT00652951|786208|P1|COMPLETED|Primary Phase||260
325324|NCT00652951|786206|P3|STARTED|Primary Phase||260
325325|NCT00652951|786207|P2|STARTED|Primary Phase||260
325326|NCT00652951|786208|P1|STARTED|Primary Phase||260
325327|NCT00652938|786345|P3|NOT COMPLETED|Overall Study||5
325328|NCT00652938|786346|P2|NOT COMPLETED|Overall Study||7
325329|NCT00652938|786347|P1|NOT COMPLETED|Overall Study||1
325330|NCT00652938|786345|P3|COMPLETED|Overall Study||242
325331|NCT00652938|786346|P2|COMPLETED|Overall Study||240
325332|NCT00652938|786347|P1|COMPLETED|Overall Study||246
325333|NCT00652938|786345|P3|STARTED|Overall Study||247
325334|NCT00652938|786346|P2|STARTED|Overall Study||247
325335|NCT00652938|786347|P1|STARTED|Overall Study||247
325336|NCT00652899|786412|P1|NOT COMPLETED|Overall Study||2
325337|NCT00652899|786412|P1|COMPLETED|Overall Study||12
325338|NCT00652899|786412|P1|STARTED|Overall Study||14
325339|NCT00652834|786422|P1|NOT COMPLETED|Overall Study||5
325340|NCT00652834|786422|P1|COMPLETED|Overall Study|3 subjects withdrew after completing baseline questionnaire. 2 did not complete 30-day visit.|18
325341|NCT00652834|786422|P1|STARTED|Overall Study||23
325342|NCT00652743|786429|P3|NOT COMPLETED|Months 42-48||0
325343|NCT00652743|786430|P2|NOT COMPLETED|Months 42-48||0
325344|NCT00652743|786431|P1|NOT COMPLETED|Months 42-48||0
325345|NCT00652743|786429|P3|COMPLETED|Months 42-48||367
325346|NCT00652743|786430|P2|COMPLETED|Months 42-48||170
325347|NCT00652743|786431|P1|COMPLETED|Months 42-48||196
325348|NCT00652743|786429|P3|STARTED|Months 42-48||367
325349|NCT00652743|786430|P2|STARTED|Months 42-48||170
325350|NCT00652743|786431|P1|STARTED|Months 42-48||196
325351|NCT00652743|786429|P3|NOT COMPLETED|Months 36-42||9
325352|NCT00652743|786430|P2|NOT COMPLETED|Months 36-42||5
325353|NCT00652743|786431|P1|NOT COMPLETED|Months 36-42||6
325354|NCT00652743|786429|P3|COMPLETED|Months 36-42||381
325355|NCT00652743|786430|P2|COMPLETED|Months 36-42||180
325356|NCT00652743|786431|P1|COMPLETED|Months 36-42||210
325357|NCT00652743|786429|P3|STARTED|Months 36-42||390
325358|NCT00652743|786430|P2|STARTED|Months 36-42||185
325359|NCT00652743|786431|P1|STARTED|Months 36-42||216
325360|NCT00652743|786429|P3|NOT COMPLETED|Months 24-30||11
325361|NCT00652743|786430|P2|NOT COMPLETED|Months 24-30||1
325362|NCT00652743|786431|P1|NOT COMPLETED|Months 24-30||5
325363|NCT00652743|786429|P3|COMPLETED|Months 24-30||422
325364|NCT00652743|786430|P2|COMPLETED|Months 24-30||185
325365|NCT00652743|786431|P1|COMPLETED|Months 24-30||207
325366|NCT00652743|786429|P3|STARTED|Months 24-30||433
325367|NCT00652743|786430|P2|STARTED|Months 24-30||186
325368|NCT00652743|786431|P1|STARTED|Months 24-30||212
325369|NCT00652743|786429|P3|NOT COMPLETED|Months 12-18||7
325370|NCT00652743|786430|P2|NOT COMPLETED|Months 12-18||2
325371|NCT00652743|786431|P1|NOT COMPLETED|Months 12-18||1
325372|NCT00652743|786429|P3|COMPLETED|Months 12-18||430
325373|NCT00652743|786430|P2|COMPLETED|Months 12-18||186
325374|NCT00652743|786431|P1|COMPLETED|Months 12-18||218
325375|NCT00652743|786429|P3|STARTED|Months 12-18||437
325376|NCT00652743|786430|P2|STARTED|Months 12-18||188
325377|NCT00652743|786431|P1|STARTED|Months 12-18||219
325378|NCT00652626|786513|P7|NOT COMPLETED|Extension Phase||3
325379|NCT00652626|786514|P6|NOT COMPLETED|Extension Phase||12
325380|NCT00652626|786515|P5|NOT COMPLETED|Extension Phase||0
325381|NCT00652626|786516|P4|NOT COMPLETED|Extension Phase||0
325382|NCT00652626|786517|P3|NOT COMPLETED|Extension Phase||0
325383|NCT00652626|786518|P2|NOT COMPLETED|Extension Phase||0
325384|NCT00652626|786519|P1|NOT COMPLETED|Extension Phase||0
325385|NCT00652626|786513|P7|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|1
325386|NCT00652626|786514|P6|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|2
325387|NCT00652626|786515|P5|COMPLETED|Extension Phase||0
325388|NCT00652626|786516|P4|COMPLETED|Extension Phase||0
325389|NCT00652626|786517|P3|COMPLETED|Extension Phase||0
325390|NCT00652626|786518|P2|COMPLETED|Extension Phase||0
325391|NCT00652626|786519|P1|COMPLETED|Extension Phase||0
325392|NCT00652626|786513|P7|STARTED|Extension Phase||4
325393|NCT00652626|786514|P6|STARTED|Extension Phase||14
325394|NCT00652626|786515|P5|STARTED|Extension Phase||0
325395|NCT00652626|786516|P4|STARTED|Extension Phase||0
325396|NCT00652626|786517|P3|STARTED|Extension Phase||0
325397|NCT00652626|786518|P2|STARTED|Extension Phase||0
325398|NCT00652626|786519|P1|STARTED|Extension Phase||0
325399|NCT00652626|786513|P7|NOT COMPLETED|Initial Treatment Phase||0
325400|NCT00652626|786514|P6|NOT COMPLETED|Initial Treatment Phase||0
325401|NCT00652626|786515|P5|NOT COMPLETED|Initial Treatment Phase||3
325402|NCT00652626|786516|P4|NOT COMPLETED|Initial Treatment Phase||1
325403|NCT00652626|786517|P3|NOT COMPLETED|Initial Treatment Phase||1
325404|NCT00652626|786518|P2|NOT COMPLETED|Initial Treatment Phase||0
325405|NCT00652626|786519|P1|NOT COMPLETED|Initial Treatment Phase||0
325406|NCT00652626|786513|P7|COMPLETED|Initial Treatment Phase||0
325407|NCT00652626|786514|P6|COMPLETED|Initial Treatment Phase||0
325408|NCT00652626|786515|P5|COMPLETED|Initial Treatment Phase||5
325409|NCT00652626|786516|P4|COMPLETED|Initial Treatment Phase||5
325410|NCT00652626|786517|P3|COMPLETED|Initial Treatment Phase||6
325411|NCT00652626|786518|P2|COMPLETED|Initial Treatment Phase||5
325412|NCT00652626|786519|P1|COMPLETED|Initial Treatment Phase||5
325413|NCT00652626|786513|P7|Received Study Drug|Initial Treatment Phase||0
325414|NCT00652626|786514|P6|Received Study Drug|Initial Treatment Phase||0
325415|NCT00652626|786515|P5|Received Study Drug|Initial Treatment Phase||6
325416|NCT00652626|786516|P4|Received Study Drug|Initial Treatment Phase||5
325417|NCT00652626|786517|P3|Received Study Drug|Initial Treatment Phase||6
325418|NCT00652626|786518|P2|Received Study Drug|Initial Treatment Phase||5
325419|NCT00652626|786519|P1|Received Study Drug|Initial Treatment Phase||5
325420|NCT00652626|786513|P7|STARTED|Initial Treatment Phase||0
325421|NCT00652626|786514|P6|STARTED|Initial Treatment Phase||0
325422|NCT00652626|786515|P5|STARTED|Initial Treatment Phase||8
325423|NCT00652626|786516|P4|STARTED|Initial Treatment Phase||6
325424|NCT00652626|786517|P3|STARTED|Initial Treatment Phase||7
325425|NCT00652626|786518|P2|STARTED|Initial Treatment Phase||5
325426|NCT00652626|786519|P1|STARTED|Initial Treatment Phase||5
325427|NCT00652366|786588|P5|NOT COMPLETED|Overall Study||36
325428|NCT00652366|786589|P4|NOT COMPLETED|Overall Study||179
325429|NCT00652366|786590|P3|NOT COMPLETED|Overall Study||71
325430|NCT00652366|786591|P2|NOT COMPLETED|Overall Study||75
325431|NCT00652366|786592|P1|NOT COMPLETED|Overall Study||106
325432|NCT00652366|786588|P5|COMPLETED|Overall Study||0
325433|NCT00652366|786589|P4|COMPLETED|Overall Study||0
325434|NCT00652366|786590|P3|COMPLETED|Overall Study||0
325435|NCT00652366|786591|P2|COMPLETED|Overall Study||0
325436|NCT00652366|786592|P1|COMPLETED|Overall Study||0
325437|NCT00652366|786588|P5|STARTED|Overall Study||36
325438|NCT00652366|786589|P4|STARTED|Overall Study||179
325439|NCT00652366|786590|P3|STARTED|Overall Study||71
325440|NCT00652366|786591|P2|STARTED|Overall Study||75
325441|NCT00652366|786592|P1|STARTED|Overall Study||106
325442|NCT00652340|786627|P2|NOT COMPLETED|Overall Study||3
325443|NCT00652340|786628|P1|NOT COMPLETED|Overall Study||4
325444|NCT00652340|786627|P2|COMPLETED|Overall Study|3 patients remained on study at database lock.|39
325445|NCT00652340|786628|P1|COMPLETED|Overall Study|4 patients remained on study at database lock.|74
325446|NCT00652340|786627|P2|STARTED|Overall Study||42
325447|NCT00652340|786628|P1|STARTED|Overall Study||78
325448|NCT00652327|786638|P2|NOT COMPLETED|Overall Study||5
325449|NCT00652327|786639|P1|NOT COMPLETED|Overall Study||0
325450|NCT00652327|786638|P2|COMPLETED|Overall Study||36
325451|NCT00652327|786639|P1|COMPLETED|Overall Study||42
325452|NCT00652327|786638|P2|STARTED|Overall Study|Participants who recieved randomized treatment assignment to double the dose of ongoing statin|41
325453|NCT00652327|786639|P1|STARTED|Overall Study|Participants who recieved randomized treatment assignment to ezetimibe and ongoing statin|42
325454|NCT00652314|786647|P2|NOT COMPLETED|Overall Study||9
325455|NCT00652314|786648|P1|NOT COMPLETED|Overall Study||9
325456|NCT00652314|786647|P2|COMPLETED|Overall Study||26
325457|NCT00652314|786648|P1|COMPLETED|Overall Study||53
325458|NCT00652314|786647|P2|STARTED|Overall Study||35
325459|NCT00652314|786648|P1|STARTED|Overall Study||62
325460|NCT00652145|786664|P2|NOT COMPLETED|Overall Study||0
325461|NCT00652145|786665|P1|NOT COMPLETED|Overall Study||0
325462|NCT00652145|786664|P2|COMPLETED|Overall Study||26
325463|NCT00652145|786665|P1|COMPLETED|Overall Study||26
325464|NCT00652145|786664|P2|STARTED|Overall Study||26
325465|NCT00652145|786665|P1|STARTED|Overall Study||26
325466|NCT00652093|786681|P6|NOT COMPLETED|Overall Study||0
325467|NCT00652093|786682|P5|NOT COMPLETED|Overall Study||2
325468|NCT00652093|786683|P4|NOT COMPLETED|Overall Study||0
325469|NCT00652093|786684|P3|NOT COMPLETED|Overall Study||1
325470|NCT00652093|786685|P2|NOT COMPLETED|Overall Study||0
325471|NCT00652093|786686|P1|NOT COMPLETED|Overall Study||0
325472|NCT00652093|786681|P6|COMPLETED|Overall Study||4
325473|NCT00652093|786682|P5|COMPLETED|Overall Study||2
325474|NCT00652093|786683|P4|COMPLETED|Overall Study||4
325475|NCT00652093|786684|P3|COMPLETED|Overall Study||3
325476|NCT00652093|786685|P2|COMPLETED|Overall Study||4
325477|NCT00652093|786686|P1|COMPLETED|Overall Study||4
325478|NCT00652093|786681|P6|STARTED|Overall Study||4
325479|NCT00652093|786682|P5|STARTED|Overall Study||4
325480|NCT00652093|786683|P4|STARTED|Overall Study||4
325481|NCT00652093|786684|P3|STARTED|Overall Study||4
325482|NCT00652093|786685|P2|STARTED|Overall Study||4
325483|NCT00652093|786686|P1|STARTED|Overall Study||4
325484|NCT00652080|786766|P1|NOT COMPLETED|Overall Study||4
325485|NCT00652080|786766|P1|COMPLETED|Overall Study||31
325486|NCT00652080|786766|P1|STARTED|Overall Study||35
325487|NCT00652028|786776|P4|NOT COMPLETED|Overall Study||0
325488|NCT00652028|786777|P3|NOT COMPLETED|Overall Study||1
325489|NCT00652028|786778|P2|NOT COMPLETED|Overall Study||1
325490|NCT00652028|786779|P1|NOT COMPLETED|Overall Study||1
325491|NCT00652028|786776|P4|COMPLETED|Overall Study||14
325492|NCT00652028|786777|P3|COMPLETED|Overall Study||14
325493|NCT00652028|786778|P2|COMPLETED|Overall Study||13
325494|NCT00652028|786779|P1|COMPLETED|Overall Study||15
325495|NCT00652028|786776|P4|STARTED|Overall Study||14
325496|NCT00652028|786777|P3|STARTED|Overall Study||15
325497|NCT00652028|786778|P2|STARTED|Overall Study||14
325498|NCT00652028|786779|P1|STARTED|Overall Study||16
325499|NCT00651924|786823|P2|NOT COMPLETED|Overall Study||7
325500|NCT00651924|786824|P1|NOT COMPLETED|Overall Study||0
325501|NCT00651924|786823|P2|COMPLETED|Overall Study||2
325502|NCT00651924|786824|P1|COMPLETED|Overall Study||18
325503|NCT00651924|786823|P2|STARTED|Overall Study||9
325504|NCT00651924|786824|P1|STARTED|Overall Study||18
325505|NCT00651820|786830|P1|NOT COMPLETED|Overall Study||2
325506|NCT00651820|786830|P1|COMPLETED|Overall Study||26
325507|NCT00651820|786830|P1|STARTED|Overall Study||28
325508|NCT00651794|786840|P3|NOT COMPLETED|Overall Study||21
325509|NCT00651794|786841|P2|NOT COMPLETED|Overall Study||22
325510|NCT00651794|786842|P1|NOT COMPLETED|Overall Study||21
325511|NCT00651794|786840|P3|COMPLETED|Overall Study||10
325512|NCT00651794|786841|P2|COMPLETED|Overall Study||9
325513|NCT00651794|786842|P1|COMPLETED|Overall Study||15
325514|NCT00651794|786840|P3|STARTED|Overall Study||31
325515|NCT00651794|786841|P2|STARTED|Overall Study||31
325516|NCT00651794|786842|P1|STARTED|Overall Study||36
325517|NCT00651755|786862|P2|NOT COMPLETED|Cycle 2 (Second 21 Days)||1
325518|NCT00651755|786863|P1|NOT COMPLETED|Cycle 2 (Second 21 Days)||0
325519|NCT00651755|786862|P2|COMPLETED|Cycle 2 (Second 21 Days)||8
325520|NCT00651755|786863|P1|COMPLETED|Cycle 2 (Second 21 Days)||10
325521|NCT00651755|786862|P2|STARTED|Cycle 2 (Second 21 Days)||9
325522|NCT00651755|786863|P1|STARTED|Cycle 2 (Second 21 Days)||10
325523|NCT00651755|786862|P2|NOT COMPLETED|Cycle 1 (First 21 Days)||0
325524|NCT00651755|786863|P1|NOT COMPLETED|Cycle 1 (First 21 Days)||1
325525|NCT00651755|786862|P2|COMPLETED|Cycle 1 (First 21 Days)||9
325526|NCT00651755|786863|P1|COMPLETED|Cycle 1 (First 21 Days)||10
325527|NCT00651755|786862|P2|STARTED|Cycle 1 (First 21 Days)||9
325528|NCT00651755|786863|P1|STARTED|Cycle 1 (First 21 Days)||11
325529|NCT00651664|786889|P10|NOT COMPLETED|Overall Study||7
325530|NCT00651664|786890|P9|NOT COMPLETED|Overall Study||7
325531|NCT00651664|786891|P8|NOT COMPLETED|Overall Study||7
325532|NCT00651664|786892|P7|NOT COMPLETED|Overall Study||6
325533|NCT00651664|786893|P6|NOT COMPLETED|Overall Study||3
325534|NCT00651664|786894|P5|NOT COMPLETED|Overall Study||6
325535|NCT00651664|786895|P4|NOT COMPLETED|Overall Study||14
325536|NCT00651664|786896|P3|NOT COMPLETED|Overall Study||3
325537|NCT00651664|786897|P2|NOT COMPLETED|Overall Study||3
325538|NCT00651664|786898|P1|NOT COMPLETED|Overall Study||3
325539|NCT00651664|786889|P10|COMPLETED|Overall Study||0
325540|NCT00651664|786890|P9|COMPLETED|Overall Study||0
325541|NCT00651664|786891|P8|COMPLETED|Overall Study||0
325542|NCT00651664|786892|P7|COMPLETED|Overall Study||0
325543|NCT00651664|786893|P6|COMPLETED|Overall Study||0
325544|NCT00651664|786894|P5|COMPLETED|Overall Study||0
325545|NCT00651664|786895|P4|COMPLETED|Overall Study||0
325546|NCT00651664|786896|P3|COMPLETED|Overall Study||0
325547|NCT00651664|786897|P2|COMPLETED|Overall Study||0
325548|NCT00651664|786898|P1|COMPLETED|Overall Study||0
325549|NCT00651664|786889|P10|STARTED|Overall Study||7
325550|NCT00651664|786890|P9|STARTED|Overall Study||7
325551|NCT00651664|786891|P8|STARTED|Overall Study||7
325552|NCT00651664|786892|P7|STARTED|Overall Study||6
325553|NCT00651664|786893|P6|STARTED|Overall Study||3
325554|NCT00651664|786894|P5|STARTED|Overall Study||6
325555|NCT00651664|786895|P4|STARTED|Overall Study||14
325556|NCT00651664|786896|P3|STARTED|Overall Study||3
325557|NCT00651664|786897|P2|STARTED|Overall Study||3
325558|NCT00651664|786898|P1|STARTED|Overall Study||3
325559|NCT00651625|787024|P2|NOT COMPLETED|Overall Study||0
325560|NCT00651625|787025|P1|NOT COMPLETED|Overall Study||0
325561|NCT00651625|787024|P2|COMPLETED|Overall Study||218
325562|NCT00651625|787025|P1|COMPLETED|Overall Study||219
325563|NCT00651625|787024|P2|STARTED|Overall Study||218
325564|NCT00651625|787025|P1|STARTED|Overall Study||219
325565|NCT00651573|787039|P2|NOT COMPLETED|Overall Study||3
325566|NCT00651573|787040|P1|NOT COMPLETED|Overall Study||2
325567|NCT00651573|787039|P2|COMPLETED|Overall Study||354
325568|NCT00651573|787040|P1|COMPLETED|Overall Study||363
325569|NCT00651573|787039|P2|STARTED|Overall Study||357
325570|NCT00651573|787040|P1|STARTED|Overall Study||365
325571|NCT00651482|787056|P1|NOT COMPLETED|Overall Study||0
325572|NCT00651482|787056|P1|COMPLETED|Overall Study||10
325573|NCT00651482|787056|P1|STARTED|Overall Study||10
325574|NCT00651313|787070|P2|NOT COMPLETED|Overall Study||6
325575|NCT00651313|787071|P1|NOT COMPLETED|Overall Study||6
325576|NCT00651313|787070|P2|COMPLETED|Overall Study||37
325577|NCT00651313|787071|P1|COMPLETED|Overall Study||35
325578|NCT00651313|787070|P2|STARTED|Overall Study||43
325579|NCT00651313|787071|P1|STARTED|Overall Study||41
325580|NCT00651261|787079|P2|NOT COMPLETED|Overall Study||306
325581|NCT00651261|787080|P1|NOT COMPLETED|Overall Study||291
325582|NCT00651261|787079|P2|COMPLETED|Overall Study||51
325583|NCT00651261|787080|P1|COMPLETED|Overall Study||69
325584|NCT00651261|787079|P2|STARTED|Overall Study||357
325585|NCT00651261|787080|P1|STARTED|Overall Study||360
325586|NCT00651183|787096|P2|NOT COMPLETED|Overall Study||10
325587|NCT00651183|787097|P1|NOT COMPLETED|Overall Study||20
325588|NCT00651183|787096|P2|COMPLETED|Overall Study|"other reasons. No explanation was required to be given by the physicians"|87
325589|NCT00651183|787097|P1|COMPLETED|Overall Study|Case Report Form (CRF) listed reasons for early termination, of which one was|169
325590|NCT00651183|787096|P2|STARTED|Overall Study||97
325591|NCT00651183|787097|P1|STARTED|Overall Study|"For one patient the information was not given, therefore, the patient was listed missing"|189
325592|NCT00651157|787109|P1|NOT COMPLETED|Overall Study||2
325593|NCT00651157|787109|P1|COMPLETED|Overall Study||21
325594|NCT00651157|787109|P1|STARTED|Overall Study||23
325595|NCT00651118|787119|P4|NOT COMPLETED|Overall Study||7
325596|NCT00651118|787120|P3|NOT COMPLETED|Overall Study||11
325597|NCT00651118|787121|P2|NOT COMPLETED|Overall Study||7
325598|NCT00651118|787122|P1|NOT COMPLETED|Overall Study||9
325599|NCT00651118|787119|P4|COMPLETED|Overall Study||203
325600|NCT00651118|787120|P3|COMPLETED|Overall Study||197
325601|NCT00651118|787121|P2|COMPLETED|Overall Study||200
325602|NCT00651118|787122|P1|COMPLETED|Overall Study||198
325603|NCT00651118|787119|P4|STARTED|Overall Study||210
325604|NCT00651118|787120|P3|STARTED|Overall Study||208
325605|NCT00651118|787121|P2|STARTED|Overall Study||207
325606|NCT00651118|787122|P1|STARTED|Overall Study||207
325607|NCT00651040|787142|P2|NOT COMPLETED|Overall Study||1
325608|NCT00651040|787143|P1|NOT COMPLETED|Overall Study||3
325609|NCT00651040|787142|P2|COMPLETED|Overall Study||14
325610|NCT00651040|787143|P1|COMPLETED|Overall Study||13
325611|NCT00651040|787142|P2|STARTED|Overall Study||15
325612|NCT00651040|787143|P1|STARTED|Overall Study||16
325613|NCT00650936|787149|P1|NOT COMPLETED|Overall Study||70
325614|NCT00650936|787149|P1|COMPLETED|Overall Study||930
325615|NCT00650936|787149|P1|STARTED|Overall Study||1000
325616|NCT00650858|787158|P3|NOT COMPLETED|Overall Study||0
325617|NCT00650858|787159|P2|NOT COMPLETED|Overall Study||0
325618|NCT00650858|787160|P1|NOT COMPLETED|Overall Study||0
325619|NCT00650858|787158|P3|COMPLETED|Overall Study||36
325620|NCT00650858|787159|P2|COMPLETED|Overall Study||8
325621|NCT00650858|787160|P1|COMPLETED|Overall Study||8
325622|NCT00650858|787158|P3|STARTED|Overall Study||36
325623|NCT00650858|787159|P2|STARTED|Overall Study||8
325624|NCT00650858|787160|P1|STARTED|Overall Study||8
325625|NCT00650845|787191|P2|NOT COMPLETED|Overall Study||13
325626|NCT00650845|787192|P1|NOT COMPLETED|Overall Study||5
325627|NCT00650845|787191|P2|COMPLETED|Overall Study||44
325628|NCT00650845|787192|P1|COMPLETED|Overall Study||70
325629|NCT00650845|787191|P2|STARTED|Overall Study||57
325630|NCT00650845|787192|P1|STARTED|Overall Study||75
325631|NCT00650806|787212|P4|NOT COMPLETED|Overall Study||26
325632|NCT00650806|787213|P3|NOT COMPLETED|Overall Study||29
325633|NCT00650806|787214|P2|NOT COMPLETED|Overall Study||21
325634|NCT00650806|787215|P1|NOT COMPLETED|Overall Study||18
325635|NCT00650806|787212|P4|COMPLETED|Overall Study||70
325636|NCT00650806|787213|P3|COMPLETED|Overall Study||64
325637|NCT00650806|787214|P2|COMPLETED|Overall Study||77
325638|NCT00650806|787215|P1|COMPLETED|Overall Study||71
325639|NCT00650806|787212|P4|STARTED|Overall Study||96
325640|NCT00650806|787213|P3|STARTED|Overall Study||93
325641|NCT00650806|787214|P2|STARTED|Overall Study||98
325642|NCT00650806|787215|P1|STARTED|Overall Study||89
325643|NCT00650767|787257|P4|NOT COMPLETED|Overall Study||11
325644|NCT00650767|787258|P3|NOT COMPLETED|Overall Study||14
325645|NCT00650767|787259|P2|NOT COMPLETED|Overall Study||9
325646|NCT00650767|787260|P1|NOT COMPLETED|Overall Study||5
325647|NCT00650767|787257|P4|COMPLETED|Overall Study||39
325648|NCT00650767|787258|P3|COMPLETED|Overall Study||36
325649|NCT00650767|787259|P2|COMPLETED|Overall Study||41
325650|NCT00650767|787260|P1|COMPLETED|Overall Study||46
325651|NCT00650767|787257|P4|STARTED|Overall Study||50
325652|NCT00650767|787258|P3|STARTED|Overall Study||50
325653|NCT00650767|787259|P2|STARTED|Overall Study||50
325654|NCT00650767|787260|P1|STARTED|Overall Study||51
325655|NCT00650585|787764|P2|NOT COMPLETED|Overall Study||1477
325656|NCT00650585|787765|P1|NOT COMPLETED|Overall Study||1797
325657|NCT00650585|787764|P2|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2513
325658|NCT00650585|787765|P1|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2551
325659|NCT00650585|787764|P2|STARTED|Overall Study||3990
325660|NCT00650585|787765|P1|STARTED|Overall Study||4348
325661|NCT00650546|787785|P1|NOT COMPLETED|Overall Study||0
325662|NCT00650546|787785|P1|COMPLETED|Overall Study||8
325663|NCT00650546|787785|P1|STARTED|Overall Study||8
325664|NCT00650260|787792|P2|NOT COMPLETED|Overall Study||0
325665|NCT00650260|787793|P1|NOT COMPLETED|Overall Study||0
325666|NCT00650260|787792|P2|COMPLETED|Overall Study||21
325667|NCT00650260|787793|P1|COMPLETED|Overall Study||21
325668|NCT00650260|787792|P2|STARTED|Overall Study||21
325669|NCT00650260|787793|P1|STARTED|Overall Study||21
325670|NCT00650104|787809|P1|NOT COMPLETED|Overall Study||41
325671|NCT00650104|787809|P1|COMPLETED|Overall Study||42
325672|NCT00650104|787809|P1|STARTED|Overall Study||83
325673|NCT00650091|787824|P3|NOT COMPLETED|Amended Study Design||0
325674|NCT00650091|787825|P2|NOT COMPLETED|Amended Study Design||20
325675|NCT00650091|787826|P1|NOT COMPLETED|Amended Study Design||23
325676|NCT00650091|787824|P3|COMPLETED|Amended Study Design||0
325677|NCT00650091|787825|P2|COMPLETED|Amended Study Design||111
325678|NCT00650091|787826|P1|COMPLETED|Amended Study Design||110
325679|NCT00650091|787824|P3|STARTED|Amended Study Design|Study Drug was discontinued for all subjects due to safety concerns.|0
325680|NCT00650091|787825|P2|STARTED|Amended Study Design||131
325681|NCT00650091|787826|P1|STARTED|Amended Study Design||133
325682|NCT00650091|787824|P3|NOT COMPLETED|Initial Study Design - Interim Analysis||0
325683|NCT00650091|787825|P2|NOT COMPLETED|Initial Study Design - Interim Analysis||0
325684|NCT00650091|787826|P1|NOT COMPLETED|Initial Study Design - Interim Analysis||0
325685|NCT00650091|787824|P3|COMPLETED|Initial Study Design - Interim Analysis||77
325686|NCT00650091|787825|P2|COMPLETED|Initial Study Design - Interim Analysis||78
325687|NCT00650091|787826|P1|COMPLETED|Initial Study Design - Interim Analysis||81
325688|NCT00650091|787824|P3|STARTED|Initial Study Design - Interim Analysis||77
325689|NCT00650091|787825|P2|STARTED|Initial Study Design - Interim Analysis||78
325690|NCT00650091|787826|P1|STARTED|Initial Study Design - Interim Analysis||81
325691|NCT00650078|787846|P2|NOT COMPLETED|Overall Study||13
325692|NCT00650078|787847|P1|NOT COMPLETED|Overall Study||14
325693|NCT00650078|787846|P2|COMPLETED|Overall Study||106
325694|NCT00650078|787847|P1|COMPLETED|Overall Study||217
325695|NCT00650078|787846|P2|STARTED|Overall Study||119
325696|NCT00650078|787847|P1|STARTED|Overall Study||231
325697|NCT00649961|787855|P1|NOT COMPLETED|Overall Study||0
325698|NCT00649961|787855|P1|COMPLETED|Overall Study||18
325699|NCT00649961|787855|P1|STARTED|Overall Study||18
325700|NCT00649792|787859|P1|NOT COMPLETED|Overall Study||68
325701|NCT00649792|787859|P1|COMPLETED|Overall Study||146
325702|NCT00649792|787859|P1|STARTED|Overall Study||214
325703|NCT00649428|787869|P2|NOT COMPLETED|Overall Study||15
325704|NCT00649428|787870|P1|NOT COMPLETED|Overall Study||20
325705|NCT00649428|787869|P2|COMPLETED|Overall Study||88
325706|NCT00649428|787870|P1|COMPLETED|Overall Study||80
325707|NCT00649428|787869|P2|STARTED|Overall Study||103
325708|NCT00649428|787870|P1|STARTED|Overall Study||100
325709|NCT00649389|787886|P4|NOT COMPLETED|Overall Study||111
325710|NCT00649389|787887|P3|NOT COMPLETED|Overall Study||88
325711|NCT00649389|787888|P2|NOT COMPLETED|Overall Study||106
325712|NCT00649389|787889|P1|NOT COMPLETED|Overall Study||71
325713|NCT00649389|787886|P4|COMPLETED|Overall Study||516
325714|NCT00649389|787887|P3|COMPLETED|Overall Study||512
325715|NCT00649389|787888|P2|COMPLETED|Overall Study||531
325716|NCT00649389|787889|P1|COMPLETED|Overall Study||557
325717|NCT00649389|787886|P4|STARTED|Overall Study||627
325718|NCT00649389|787887|P3|STARTED|Overall Study||600
325719|NCT00649389|787888|P2|STARTED|Overall Study||637
325720|NCT00649389|787889|P1|STARTED|Overall Study||628
325721|NCT00649220|787911|P1|NOT COMPLETED|Overall Study||3
325722|NCT00649220|787911|P1|COMPLETED|Overall Study||16
325723|NCT00649220|787911|P1|STARTED|Overall Study||19
325724|NCT00648908|787922|P1|NOT COMPLETED|Overall Study||115
325725|NCT00648908|787922|P1|COMPLETED|Overall Study||154
325726|NCT00648908|787922|P1|STARTED|Overall Study||269
325727|NCT00648895|787932|P2|NOT COMPLETED|Overall Study||1
325728|NCT00648895|787933|P1|NOT COMPLETED|Overall Study||0
325729|NCT00648895|787932|P2|COMPLETED|Overall Study||5
325730|NCT00648895|787933|P1|COMPLETED|Overall Study||6
325731|NCT00648895|787932|P2|STARTED|Overall Study||6
325732|NCT00648895|787933|P1|STARTED|Overall Study||6
325733|NCT00648739|787939|P7|NOT COMPLETED|Overall Study||1
325734|NCT00648739|787940|P6|NOT COMPLETED|Overall Study||5
325735|NCT00648739|787941|P5|NOT COMPLETED|Overall Study||2
325736|NCT00648739|787942|P4|NOT COMPLETED|Overall Study||2
325737|NCT00648739|787943|P3|NOT COMPLETED|Overall Study||3
325738|NCT00648739|787944|P2|NOT COMPLETED|Overall Study||2
325739|NCT00648739|787945|P1|NOT COMPLETED|Overall Study||2
325740|NCT00648739|787939|P7|COMPLETED|Overall Study||0
325741|NCT00648739|787940|P6|COMPLETED|Overall Study||2
325742|NCT00648739|787941|P5|COMPLETED|Overall Study||1
325743|NCT00648739|787942|P4|COMPLETED|Overall Study||1
325744|NCT00648739|787943|P3|COMPLETED|Overall Study||0
325745|NCT00648739|787944|P2|COMPLETED|Overall Study||3
325746|NCT00648739|787945|P1|COMPLETED|Overall Study||2
325747|NCT00648739|787939|P7|Received at Least 1 Dose of Study Drug|Overall Study||1
325748|NCT00648739|787940|P6|Received at Least 1 Dose of Study Drug|Overall Study||7
325749|NCT00648739|787941|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
325750|NCT00648739|787942|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
325751|NCT00648739|787943|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
325752|NCT00648739|787944|P2|Received at Least 1 Dose of Study Drug|Overall Study||5
325753|NCT00648739|787945|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
325754|NCT00648739|787939|P7|STARTED|Overall Study||1
325755|NCT00648739|787940|P6|STARTED|Overall Study||7
325756|NCT00648739|787941|P5|STARTED|Overall Study||3
325757|NCT00648739|787942|P4|STARTED|Overall Study||3
325758|NCT00648739|787943|P3|STARTED|Overall Study||3
325759|NCT00648739|787944|P2|STARTED|Overall Study||5
325760|NCT00648739|787945|P1|STARTED|Overall Study||4
325761|NCT00648648|788011|P28|NOT COMPLETED|Overall Study||12
325762|NCT00648648|788012|P27|NOT COMPLETED|Overall Study||26
325763|NCT00648648|788013|P26|NOT COMPLETED|Overall Study||4
325764|NCT00648648|788014|P25|NOT COMPLETED|Overall Study||4
325765|NCT00648648|788015|P24|NOT COMPLETED|Overall Study||4
325766|NCT00648648|788016|P23|NOT COMPLETED|Overall Study||14
325767|NCT00648648|788017|P22|NOT COMPLETED|Overall Study||10
325768|NCT00648648|788018|P21|NOT COMPLETED|Overall Study||6
325769|NCT00648648|788019|P20|NOT COMPLETED|Overall Study||7
325770|NCT00648648|788020|P19|NOT COMPLETED|Overall Study||5
325771|NCT00648648|788021|P18|NOT COMPLETED|Overall Study||6
325772|NCT00648648|788022|P17|NOT COMPLETED|Overall Study||14
325773|NCT00648648|788023|P16|NOT COMPLETED|Overall Study||11
325774|NCT00648648|788024|P15|NOT COMPLETED|Overall Study||4
325775|NCT00648648|788025|P14|NOT COMPLETED|Overall Study||5
325776|NCT00648648|788026|P13|NOT COMPLETED|Overall Study||6
325777|NCT00648648|788027|P12|NOT COMPLETED|Overall Study||13
325778|NCT00648648|788028|P11|NOT COMPLETED|Overall Study||6
325779|NCT00648648|788029|P10|NOT COMPLETED|Overall Study||10
325780|NCT00648648|788030|P9|NOT COMPLETED|Overall Study||3
325781|NCT00648648|788031|P8|NOT COMPLETED|Overall Study||1
325782|NCT00648648|788032|P7|NOT COMPLETED|Overall Study||10
325783|NCT00648648|788033|P6|NOT COMPLETED|Overall Study||1
325784|NCT00648648|788034|P5|NOT COMPLETED|Overall Study||9
325785|NCT00648648|788035|P4|NOT COMPLETED|Overall Study||4
325786|NCT00648648|788036|P3|NOT COMPLETED|Overall Study||0
325787|NCT00648648|788037|P2|NOT COMPLETED|Overall Study||0
325788|NCT00648648|788038|P1|NOT COMPLETED|Overall Study||0
325789|NCT00648648|788011|P28|COMPLETED|Overall Study||0
325790|NCT00648648|788012|P27|COMPLETED|Overall Study||0
325791|NCT00648648|788013|P26|COMPLETED|Overall Study||0
325792|NCT00648648|788014|P25|COMPLETED|Overall Study||0
325793|NCT00648648|788015|P24|COMPLETED|Overall Study||0
325794|NCT00648648|788016|P23|COMPLETED|Overall Study||0
325795|NCT00648648|788017|P22|COMPLETED|Overall Study||0
325796|NCT00648648|788018|P21|COMPLETED|Overall Study||0
325797|NCT00648648|788019|P20|COMPLETED|Overall Study||0
325798|NCT00648648|788020|P19|COMPLETED|Overall Study||0
325799|NCT00648648|788021|P18|COMPLETED|Overall Study||0
325800|NCT00648648|788022|P17|COMPLETED|Overall Study||2
325801|NCT00648648|788023|P16|COMPLETED|Overall Study||0
325802|NCT00648648|788024|P15|COMPLETED|Overall Study||0
325803|NCT00648648|788025|P14|COMPLETED|Overall Study||0
325804|NCT00648648|788026|P13|COMPLETED|Overall Study||0
325805|NCT00648648|788027|P12|COMPLETED|Overall Study||0
325806|NCT00648648|788028|P11|COMPLETED|Overall Study||0
325807|NCT00648648|788029|P10|COMPLETED|Overall Study||0
325808|NCT00648648|788030|P9|COMPLETED|Overall Study||0
325809|NCT00648648|788031|P8|COMPLETED|Overall Study||0
325810|NCT00648648|788032|P7|COMPLETED|Overall Study||0
325811|NCT00648648|788033|P6|COMPLETED|Overall Study||0
325812|NCT00648648|788034|P5|COMPLETED|Overall Study||0
325813|NCT00648648|788035|P4|COMPLETED|Overall Study||0
325814|NCT00648648|788036|P3|COMPLETED|Overall Study||3
325815|NCT00648648|788037|P2|COMPLETED|Overall Study||3
325816|NCT00648648|788038|P1|COMPLETED|Overall Study||3
325817|NCT00648648|788011|P28|Treated|Overall Study||12
325818|NCT00648648|788012|P27|Treated|Overall Study||26
325819|NCT00648648|788013|P26|Treated|Overall Study||4
325820|NCT00648648|788014|P25|Treated|Overall Study||4
325821|NCT00648648|788015|P24|Treated|Overall Study||4
325822|NCT00648648|788016|P23|Treated|Overall Study||14
325823|NCT00648648|788017|P22|Treated|Overall Study||10
325824|NCT00648648|788018|P21|Treated|Overall Study||6
325825|NCT00648648|788019|P20|Treated|Overall Study||7
325826|NCT00648648|788020|P19|Treated|Overall Study||4
325827|NCT00648648|788021|P18|Treated|Overall Study||6
325828|NCT00648648|788022|P17|Treated|Overall Study||16
325829|NCT00648648|788023|P16|Treated|Overall Study||11
325830|NCT00648648|788024|P15|Treated|Overall Study||4
325831|NCT00648648|788025|P14|Treated|Overall Study||5
325832|NCT00648648|788026|P13|Treated|Overall Study||6
325833|NCT00648648|788027|P12|Treated|Overall Study||13
325834|NCT00648648|788028|P11|Treated|Overall Study||6
325835|NCT00648648|788029|P10|Treated|Overall Study|Does not include one treated participant who was excluded from analysis.|9
325836|NCT00648648|788030|P9|Treated|Overall Study|Does not include one Part 1 participant who was treated in this arm.|3
325837|NCT00648648|788031|P8|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|1
325838|NCT00648648|788032|P7|Treated|Overall Study|Does not include one treated participant who was excluded from analysis.|9
325839|NCT00648648|788033|P6|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|1
325840|NCT00648648|788034|P5|Treated|Overall Study||8
325841|NCT00648648|788035|P4|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|4
325842|NCT00648648|788036|P3|Treated|Overall Study||3
325843|NCT00648648|788037|P2|Treated|Overall Study||3
325844|NCT00648648|788038|P1|Treated|Overall Study||3
325845|NCT00648648|788011|P28|STARTED|Overall Study||12
325846|NCT00648648|788012|P27|STARTED|Overall Study||26
325847|NCT00648648|788013|P26|STARTED|Overall Study||4
325848|NCT00648648|788014|P25|STARTED|Overall Study||4
325849|NCT00648648|788015|P24|STARTED|Overall Study||4
325850|NCT00648648|788016|P23|STARTED|Overall Study||14
325851|NCT00648648|788017|P22|STARTED|Overall Study||10
325852|NCT00648648|788018|P21|STARTED|Overall Study||6
325853|NCT00648648|788019|P20|STARTED|Overall Study||7
325854|NCT00648648|788020|P19|STARTED|Overall Study||5
325855|NCT00648648|788021|P18|STARTED|Overall Study||6
325856|NCT00648648|788022|P17|STARTED|Overall Study||16
325857|NCT00648648|788023|P16|STARTED|Overall Study||11
325858|NCT00648648|788024|P15|STARTED|Overall Study||4
325859|NCT00648648|788025|P14|STARTED|Overall Study||5
325860|NCT00648648|788026|P13|STARTED|Overall Study||6
325861|NCT00648648|788027|P12|STARTED|Overall Study||13
325862|NCT00648648|788028|P11|STARTED|Overall Study||6
325863|NCT00648648|788029|P10|STARTED|Overall Study||10
325864|NCT00648648|788030|P9|STARTED|Overall Study|Does not include one Part 1 participant who was randomized to this arm.|3
325865|NCT00648648|788031|P8|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|1
325866|NCT00648648|788032|P7|STARTED|Overall Study|Does not include one Part 1 participant who was randomized to this arm.|10
325867|NCT00648648|788033|P6|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|1
325868|NCT00648648|788034|P5|STARTED|Overall Study||9
325869|NCT00648648|788035|P4|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|4
325870|NCT00648648|788036|P3|STARTED|Overall Study||3
325871|NCT00648648|788037|P2|STARTED|Overall Study||3
325872|NCT00648648|788038|P1|STARTED|Overall Study||3
325873|NCT00648167|788264|P1|NOT COMPLETED|Overall Study||7
325874|NCT00648167|788264|P1|COMPLETED|Overall Study||48
325875|NCT00648167|788264|P1|Start Dose 6 g/Day|Overall Study||21
325876|NCT00648167|788264|P1|Start Dose 4.5 g/Day|Overall Study||34
325877|NCT00648167|788264|P1|STARTED|Overall Study||55
325878|NCT00648115|788271|P3|NOT COMPLETED|Overall Study||0
325879|NCT00648115|788272|P2|NOT COMPLETED|Overall Study||0
325880|NCT00648115|788273|P1|NOT COMPLETED|Overall Study||0
325881|NCT00648115|788271|P3|COMPLETED|Overall Study||27
325882|NCT00648115|788272|P2|COMPLETED|Overall Study||42
325883|NCT00648115|788273|P1|COMPLETED|Overall Study||42
325884|NCT00648115|788271|P3|STARTED|Overall Study||27
325885|NCT00648115|788272|P2|STARTED|Overall Study||42
325886|NCT00648115|788273|P1|STARTED|Overall Study||42
325887|NCT00648037|788284|P1|NOT COMPLETED|Overall Study||16
325888|NCT00648037|788284|P1|COMPLETED|Overall Study||10
325889|NCT00648037|788284|P1|STARTED|Overall Study||26
325890|NCT00647998|788290|P2|NOT COMPLETED|Overall Study||0
325891|NCT00647998|788291|P1|NOT COMPLETED|Overall Study||0
325892|NCT00647998|788290|P2|COMPLETED|Overall Study||9
325893|NCT00647998|788291|P1|COMPLETED|Overall Study||9
325894|NCT00647998|788290|P2|STARTED|Overall Study||9
325895|NCT00647998|788291|P1|STARTED|Overall Study||9
325896|NCT00647699|788303|P2|NOT COMPLETED|Overall Study||12
325897|NCT00647699|788304|P1|NOT COMPLETED|Overall Study||8
325898|NCT00647699|788303|P2|COMPLETED|Overall Study||62
325899|NCT00647699|788304|P1|COMPLETED|Overall Study||65
325900|NCT00647699|788303|P2|STARTED|Overall Study||74
325901|NCT00647699|788304|P1|STARTED|Overall Study||73
325902|NCT00647556|788312|P2|NOT COMPLETED|Overall Study||2
325903|NCT00647556|788313|P1|NOT COMPLETED|Overall Study||3
325904|NCT00647556|788312|P2|COMPLETED|Overall Study||13
325905|NCT00647556|788313|P1|COMPLETED|Overall Study||12
325906|NCT00647556|788312|P2|STARTED|Overall Study||15
325907|NCT00647556|788313|P1|STARTED|Overall Study||15
325908|NCT00647426|788327|P1|NOT COMPLETED|Overall Study||2
325909|NCT00647426|788327|P1|COMPLETED|Overall Study||5
325910|NCT00647426|788327|P1|STARTED|Overall Study||7
325911|NCT00647400|788336|P2|NOT COMPLETED|Overall Study||13
325912|NCT00647400|788337|P1|NOT COMPLETED|Overall Study||22
325913|NCT00647400|788336|P2|COMPLETED|Overall Study||45
325914|NCT00647400|788337|P1|COMPLETED|Overall Study||67
325915|NCT00647400|788336|P2|STARTED|Overall Study||58
325916|NCT00647400|788337|P1|STARTED|Overall Study||89
325917|NCT00647270|788350|P3|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||7
325918|NCT00647270|788351|P2|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||9
325919|NCT00647270|788352|P1|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||3
325920|NCT00647270|788350|P3|COMPLETED|Period 2, Placebo Switched to Adalimumab||175
325921|NCT00647270|788351|P2|COMPLETED|Period 2, Placebo Switched to Adalimumab||137
325922|NCT00647270|788352|P1|COMPLETED|Period 2, Placebo Switched to Adalimumab||45
325923|NCT00647270|788350|P3|STARTED|Period 2, Placebo Switched to Adalimumab||182
325924|NCT00647270|788351|P2|STARTED|Period 2, Placebo Switched to Adalimumab||146
325925|NCT00647270|788352|P1|STARTED|Period 2, Placebo Switched to Adalimumab|Placebo subjects in Period 1 received adalimumab 40 mg eow in Period 2|48
325926|NCT00647270|788350|P3|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||23
325927|NCT00647270|788351|P2|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||13
325928|NCT00647270|788352|P1|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||8
325929|NCT00647270|788350|P3|COMPLETED|Period 1, Placebo-control (12 Weeks)||182
325930|NCT00647270|788351|P2|COMPLETED|Period 1, Placebo-control (12 Weeks)||146
325931|NCT00647270|788352|P1|COMPLETED|Period 1, Placebo-control (12 Weeks)||48
325932|NCT00647270|788350|P3|STARTED|Period 1, Placebo-control (12 Weeks)||205
325933|NCT00647270|788351|P2|STARTED|Period 1, Placebo-control (12 Weeks)||159
325934|NCT00647270|788352|P1|STARTED|Period 1, Placebo-control (12 Weeks)|Placebo subjects in Period 1 received adalimumab 40 mg every other week in Period 2.|56
325935|NCT00646958|788378|P3|NOT COMPLETED|Overall Study||9
325936|NCT00646958|788379|P2|NOT COMPLETED|Overall Study||9
325937|NCT00646958|788380|P1|NOT COMPLETED|Overall Study||11
325938|NCT00646958|788378|P3|COMPLETED|Overall Study||40
325939|NCT00646958|788379|P2|COMPLETED|Overall Study||41
325940|NCT00646958|788380|P1|COMPLETED|Overall Study||40
325941|NCT00646958|788378|P3|STARTED|Overall Study|No. Participants Randomized|49
325942|NCT00646958|788379|P2|STARTED|Overall Study|No. Participants Randomized|50
325943|NCT00646958|788380|P1|STARTED|Overall Study|Number (No.) Participants Randomized|51
325944|NCT00646776|788393|P2|NOT COMPLETED|Overall Study||13
325945|NCT00646776|788394|P1|NOT COMPLETED|Overall Study||1
325946|NCT00646776|788393|P2|COMPLETED|Overall Study||5
325947|NCT00646776|788394|P1|COMPLETED|Overall Study||14
325948|NCT00646776|788393|P2|STARTED|Overall Study|Treated on Day 1|18
325949|NCT00646776|788394|P1|STARTED|Overall Study|Treated on Day 1|15
325950|NCT00646763|788443|P2|NOT COMPLETED|Overall Study||0
325951|NCT00646763|788444|P1|NOT COMPLETED|Overall Study||0
325952|NCT00646763|788443|P2|COMPLETED|Overall Study||17
325953|NCT00646763|788444|P1|COMPLETED|Overall Study||18
325954|NCT00646763|788443|P2|STARTED|Overall Study||17
325955|NCT00646763|788444|P1|STARTED|Overall Study||18
325956|NCT00646646|788458|P4|NOT COMPLETED|Overall Study||0
325957|NCT00646646|788459|P3|NOT COMPLETED|Overall Study||0
325958|NCT00646646|788460|P2|NOT COMPLETED|Overall Study||0
325959|NCT00646646|788461|P1|NOT COMPLETED|Overall Study||0
325960|NCT00646646|788458|P4|COMPLETED|Overall Study||20
325961|NCT00646646|788459|P3|COMPLETED|Overall Study||15
325962|NCT00646646|788460|P2|COMPLETED|Overall Study||15
325963|NCT00646646|788461|P1|COMPLETED|Overall Study||15
325964|NCT00646646|788458|P4|STARTED|Overall Study||20
325965|NCT00646646|788459|P3|STARTED|Overall Study||15
325966|NCT00646646|788460|P2|STARTED|Overall Study||15
325967|NCT00646646|788461|P1|STARTED|Overall Study||15
325968|NCT00646581|788473|P2|NOT COMPLETED|Overall Study||0
325969|NCT00646581|788474|P1|NOT COMPLETED|Overall Study||0
325970|NCT00646581|788473|P2|COMPLETED|Overall Study||15
325971|NCT00646581|788474|P1|COMPLETED|Overall Study||15
325972|NCT00646581|788473|P2|STARTED|Overall Study||15
325973|NCT00646581|788474|P1|STARTED|Overall Study||15
325974|NCT00646399|788492|P2|NOT COMPLETED|Overall Study||74
325975|NCT00646399|788493|P1|NOT COMPLETED|Overall Study||83
325976|NCT00646399|788492|P2|COMPLETED|Overall Study||713
325977|NCT00646399|788493|P1|COMPLETED|Overall Study||709
325978|NCT00646399|788492|P2|STARTED|Overall Study||787
325979|NCT00646399|788493|P1|STARTED|Overall Study||792
325980|NCT00646282|788501|P2|NOT COMPLETED|Overall Study||4
325981|NCT00646282|788502|P1|NOT COMPLETED|Overall Study||4
325982|NCT00646282|788501|P2|COMPLETED|Overall Study||0
325983|NCT00646282|788502|P1|COMPLETED|Overall Study||0
325984|NCT00646282|788501|P2|STARTED|Overall Study||4
325985|NCT00646282|788502|P1|STARTED|Overall Study||4
325986|NCT00646113|788508|P1|NOT COMPLETED|Overall Study||8
325987|NCT00646113|788508|P1|COMPLETED|Overall Study||61
325988|NCT00646113|788508|P1|STARTED|Overall Study|3 of the 72 enrolled participants were excluded before surgery.|69
325989|NCT00646048|788512|P1|NOT COMPLETED|Overall Study||16
325990|NCT00646048|788512|P1|COMPLETED|Overall Study||27
325991|NCT00646048|788512|P1|STARTED|Overall Study||43
325992|NCT00645970|788520|P2|NOT COMPLETED|Overall Study||186
325993|NCT00645970|788521|P1|NOT COMPLETED|Overall Study||109
325994|NCT00645970|788520|P2|COMPLETED|Overall Study||32
325995|NCT00645970|788521|P1|COMPLETED|Overall Study||32
325996|NCT00645970|788520|P2|1 Year|Overall Study||42
325997|NCT00645970|788521|P1|1 Year|Overall Study||37
325998|NCT00645970|788520|P2|6 Months|Overall Study||97
325999|NCT00645970|788521|P1|6 Months|Overall Study||58
326000|NCT00645970|788520|P2|STARTED|Overall Study||218
326001|NCT00645970|788521|P1|STARTED|Overall Study||141
326002|NCT00645944|788529|P2|NOT COMPLETED|Received Medication||3
326003|NCT00645944|788530|P1|NOT COMPLETED|Received Medication||6
326004|NCT00645944|788529|P2|COMPLETED|Received Medication||14
326005|NCT00645944|788530|P1|COMPLETED|Received Medication||13
326006|NCT00645944|788529|P2|STARTED|Received Medication||17
326007|NCT00645944|788530|P1|STARTED|Received Medication||19
326008|NCT00645944|788529|P2|NOT COMPLETED|Randomized||2
326009|NCT00645944|788530|P1|NOT COMPLETED|Randomized||1
326010|NCT00645944|788529|P2|COMPLETED|Randomized||17
326011|NCT00645944|788530|P1|COMPLETED|Randomized||19
326012|NCT00645944|788529|P2|STARTED|Randomized||19
326013|NCT00645944|788530|P1|STARTED|Randomized||20
326014|NCT00645853|788538|P2|NOT COMPLETED|Overall Study||57
326015|NCT00645853|788539|P1|NOT COMPLETED|Overall Study||92
326016|NCT00645853|788538|P2|COMPLETED|Overall Study||178
326017|NCT00645853|788539|P1|COMPLETED|Overall Study||196
326018|NCT00645853|788538|P2|AZ Study Closure in Hungary|Overall Study||40
326019|NCT00645853|788539|P1|AZ Study Closure in Hungary|Overall Study||60
326020|NCT00645853|788538|P2|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|178
326021|NCT00645853|788539|P1|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|196
326022|NCT00645853|788538|P2|No of Patients After Dose Switch|Overall Study|No changes for VKA patients|188
326023|NCT00645853|788539|P1|No of Patients After Dose Switch|Overall Study|All patients in the AZD0837 arm switched from their initial doses, to a general dose of 300 mg od|209
326024|NCT00645853|788538|P2|STARTED|Overall Study||235
326025|NCT00645853|788539|P1|STARTED|Overall Study||288
326026|NCT00645840|788557|P1|NOT COMPLETED|Overall Study||3
326027|NCT00645840|788557|P1|COMPLETED|Overall Study||12
326028|NCT00645840|788557|P1|STARTED|Overall Study||15
326029|NCT00645827|788564|P2|NOT COMPLETED|Overall Study||0
326030|NCT00645827|788565|P1|NOT COMPLETED|Overall Study||0
326031|NCT00645827|788564|P2|COMPLETED|Overall Study||17
326032|NCT00645827|788565|P1|COMPLETED|Overall Study||14
326033|NCT00645827|788564|P2|STARTED|Overall Study||17
326034|NCT00645827|788565|P1|STARTED|Overall Study||14
326035|NCT00645788|788575|P4|NOT COMPLETED|Overall Study||14
326036|NCT00645788|788576|P3|NOT COMPLETED|Overall Study||18
326037|NCT00645788|788577|P2|NOT COMPLETED|Overall Study||27
326038|NCT00645788|788578|P1|NOT COMPLETED|Overall Study||20
326039|NCT00645788|788575|P4|COMPLETED|Overall Study||21
326040|NCT00645788|788576|P3|COMPLETED|Overall Study||47
326041|NCT00645788|788577|P2|COMPLETED|Overall Study||67
326042|NCT00645788|788578|P1|COMPLETED|Overall Study||74
326043|NCT00645788|788575|P4|Participants Receive Treatment|Overall Study||35
326044|NCT00645788|788576|P3|Participants Receive Treatment|Overall Study||65
326045|NCT00645788|788577|P2|Participants Receive Treatment|Overall Study||93
326046|NCT00645788|788578|P1|Participants Receive Treatment|Overall Study||93
326047|NCT00645788|788575|P4|STARTED|Overall Study||35
326048|NCT00645788|788576|P3|STARTED|Overall Study||65
326049|NCT00645788|788577|P2|STARTED|Overall Study||94
326050|NCT00645788|788578|P1|STARTED|Overall Study||94
326051|NCT00645762|788628|P1|NOT COMPLETED|Overall Study||4
326052|NCT00645762|788628|P1|COMPLETED|Overall Study||67
326053|NCT00645762|788628|P1|STARTED|Overall Study||71
326054|NCT00645710|788637|P3|NOT COMPLETED|Overall Study||0
326055|NCT00645710|788638|P2|NOT COMPLETED|Overall Study||0
326056|NCT00645710|788639|P1|NOT COMPLETED|Overall Study||0
326057|NCT00645710|788637|P3|COMPLETED|Overall Study||10
326058|NCT00645710|788638|P2|COMPLETED|Overall Study||3
326059|NCT00645710|788639|P1|COMPLETED|Overall Study||3
326060|NCT00645710|788637|P3|STARTED|Overall Study||10
326061|NCT00645710|788638|P2|STARTED|Overall Study||3
326062|NCT00645710|788639|P1|STARTED|Overall Study||3
326063|NCT00645671|788656|P2|NOT COMPLETED|Overall Study||6
326064|NCT00645671|788657|P1|NOT COMPLETED|Overall Study||1
326065|NCT00645671|788656|P2|COMPLETED|Overall Study||193
326066|NCT00645671|788657|P1|COMPLETED|Overall Study||200
326067|NCT00645671|788656|P2|STARTED|Overall Study||199
326068|NCT00645671|788657|P1|STARTED|Overall Study||201
326069|NCT00645593|788671|P2|NOT COMPLETED|Overall Study||0
326070|NCT00645593|788672|P1|NOT COMPLETED|Overall Study||1
326071|NCT00645593|788671|P2|COMPLETED|Overall Study||60
326072|NCT00645593|788672|P1|COMPLETED|Overall Study||28
326073|NCT00645593|788671|P2|STARTED|Overall Study||60
326074|NCT00645593|788672|P1|STARTED|Overall Study||29
326075|NCT00645567|788684|P1|NOT COMPLETED|Overall Study||1
326076|NCT00645567|788684|P1|COMPLETED|Overall Study|One individual provided consent & was dropped due to an unrelated injury to his hand at his home.|4
326077|NCT00645567|788684|P1|STARTED|Overall Study||5
326078|NCT00645528|788692|P1|NOT COMPLETED|Overall Study||7
326079|NCT00645528|788692|P1|COMPLETED|Overall Study||32
326080|NCT00645528|788692|P1|STARTED|Overall Study||39
326081|NCT00645450|788703|P2|NOT COMPLETED|Overall Study||0
326082|NCT00645450|788704|P1|NOT COMPLETED|Overall Study||0
326083|NCT00645450|788703|P2|COMPLETED|Overall Study||4
326084|NCT00645450|788704|P1|COMPLETED|Overall Study||5
326085|NCT00645450|788703|P2|STARTED|Overall Study||4
326086|NCT00645450|788704|P1|STARTED|Overall Study||5
326087|NCT00645411|788714|P4|NOT COMPLETED|Overall Study||103
326088|NCT00645411|788715|P3|NOT COMPLETED|Overall Study||151
326089|NCT00645411|788716|P2|NOT COMPLETED|Overall Study||6
326090|NCT00645411|788717|P1|NOT COMPLETED|Overall Study||13
326091|NCT00645411|788714|P4|COMPLETED|Overall Study||919
326092|NCT00645411|788715|P3|COMPLETED|Overall Study||1457
326093|NCT00645411|788716|P2|COMPLETED|Overall Study||312
326094|NCT00645411|788717|P1|COMPLETED|Overall Study||643
326095|NCT00645411|788714|P4|STARTED|Overall Study||1022
326096|NCT00645411|788715|P3|STARTED|Overall Study||1608
326097|NCT00645411|788716|P2|STARTED|Overall Study||318
326098|NCT00645411|788717|P1|STARTED|Overall Study||656
326099|NCT00645359|788749|P1|NOT COMPLETED|Overall Study||0
326100|NCT00645359|788749|P1|COMPLETED|Overall Study||9
326101|NCT00645359|788749|P1|STARTED|Overall Study||9
326102|NCT00645333|788754|P1|NOT COMPLETED|Overall Study||0
326103|NCT00645333|788754|P1|COMPLETED|Overall Study||30
326104|NCT00645333|788754|P1|STARTED|Overall Study||30
326105|NCT00645164|788759|P1|NOT COMPLETED|Overall Study||7
326106|NCT00645164|788759|P1|COMPLETED|Overall Study||52
326107|NCT00645164|788759|P1|STARTED|Overall Study||59
326108|NCT00645099|788765|P2|NOT COMPLETED|Overall Study||42
326109|NCT00645099|788766|P1|NOT COMPLETED|Overall Study||71
326110|NCT00645099|788765|P2|COMPLETED|Overall Study||178
326111|NCT00645099|788766|P1|COMPLETED|Overall Study||168
326112|NCT00645099|788765|P2|STARTED|Overall Study||220
326113|NCT00645099|788766|P1|STARTED|Overall Study||239
326114|NCT00645047|788810|P2|NOT COMPLETED|Overall Study||39
326115|NCT00645047|788811|P1|NOT COMPLETED|Overall Study||43
326116|NCT00645047|788810|P2|COMPLETED|Overall Study||65
326117|NCT00645047|788811|P1|COMPLETED|Overall Study|6 month follow up|60
326118|NCT00645047|788810|P2|Post|Overall Study||80
326119|NCT00645047|788811|P1|Post|Overall Study||74
326120|NCT00645047|788810|P2|STARTED|Overall Study||104
326121|NCT00645047|788811|P1|STARTED|Overall Study||103
326122|NCT00644995|788835|P2|NOT COMPLETED|Overall Study||4
326123|NCT00644995|788836|P1|NOT COMPLETED|Overall Study||2
326124|NCT00644995|788835|P2|COMPLETED|Overall Study||23
326125|NCT00644995|788836|P1|COMPLETED|Overall Study|Completed 6 month assessment|23
326126|NCT00644995|788835|P2|Completed 4 Month Assessment|Overall Study||24
326127|NCT00644995|788836|P1|Completed 4 Month Assessment|Overall Study||23
326128|NCT00644995|788835|P2|STARTED|Overall Study||27
326129|NCT00644995|788836|P1|STARTED|Overall Study||25
326130|NCT00644969|788856|P2|NOT COMPLETED|Post Treatment Phase||3
326131|NCT00644969|788857|P1|NOT COMPLETED|Post Treatment Phase||10
326132|NCT00644969|788856|P2|COMPLETED|Post Treatment Phase||37
326133|NCT00644969|788857|P1|COMPLETED|Post Treatment Phase||61
326134|NCT00644969|788856|P2|STARTED|Post Treatment Phase||40
326135|NCT00644969|788857|P1|STARTED|Post Treatment Phase||71
326136|NCT00644969|788856|P2|NOT COMPLETED|Treatment Phase||3
326137|NCT00644969|788857|P1|NOT COMPLETED|Treatment Phase||14
326138|NCT00644969|788856|P2|COMPLETED|Treatment Phase||40
326139|NCT00644969|788857|P1|COMPLETED|Treatment Phase||71
326140|NCT00644969|788856|P2|STARTED|Treatment Phase||43
326141|NCT00644969|788857|P1|STARTED|Treatment Phase||85
326142|NCT00644917|788903|P1|NOT COMPLETED|Overall Study||2
326143|NCT00644917|788903|P1|COMPLETED|Overall Study||36
326144|NCT00644917|788903|P1|STARTED|Overall Study||38
326145|NCT00644787|788911|P3|NOT COMPLETED|Period 2: Double Blind Phase||7
326146|NCT00644787|788912|P2|NOT COMPLETED|Period 2: Double Blind Phase||9
326147|NCT00644787|788913|P1|NOT COMPLETED|Period 2: Double Blind Phase||0
326148|NCT00644787|788911|P3|COMPLETED|Period 2: Double Blind Phase||55
326149|NCT00644787|788912|P2|COMPLETED|Period 2: Double Blind Phase||49
326150|NCT00644787|788913|P1|COMPLETED|Period 2: Double Blind Phase||0
326151|NCT00644787|788911|P3|STARTED|Period 2: Double Blind Phase||62
326152|NCT00644787|788912|P2|STARTED|Period 2: Double Blind Phase||58
326153|NCT00644787|788913|P1|STARTED|Period 2: Double Blind Phase||0
326154|NCT00644787|788911|P3|NOT COMPLETED|Period 1: Titration Phase||0
326155|NCT00644787|788912|P2|NOT COMPLETED|Period 1: Titration Phase||0
326156|NCT00644787|788913|P1|NOT COMPLETED|Period 1: Titration Phase||27
326157|NCT00644787|788911|P3|COMPLETED|Period 1: Titration Phase||0
326158|NCT00644787|788912|P2|COMPLETED|Period 1: Titration Phase||0
326159|NCT00644787|788913|P1|COMPLETED|Period 1: Titration Phase||129
326160|NCT00644787|788911|P3|STARTED|Period 1: Titration Phase||0
326161|NCT00644787|788912|P2|STARTED|Period 1: Titration Phase||0
326162|NCT00644787|788913|P1|STARTED|Period 1: Titration Phase||156
326163|NCT00644657|788941|P1|NOT COMPLETED|Overall Study||0
326164|NCT00644657|788941|P1|COMPLETED|Overall Study||27
326165|NCT00644657|788941|P1|STARTED|Overall Study||27
326166|NCT00644592|788948|P2|NOT COMPLETED|Overall Study||0
326167|NCT00644592|788949|P1|NOT COMPLETED|Overall Study||0
326168|NCT00644592|788948|P2|COMPLETED|Overall Study||6
326169|NCT00644592|788949|P1|COMPLETED|Overall Study||5
326170|NCT00644592|788948|P2|STARTED|Overall Study||6
326171|NCT00644592|788949|P1|STARTED|Overall Study||5
326172|NCT00644423|788957|P2|NOT COMPLETED|Overall Study||1
326173|NCT00644423|788958|P1|NOT COMPLETED|Overall Study||1
326174|NCT00644423|788957|P2|COMPLETED|Overall Study||4
326175|NCT00644423|788958|P1|COMPLETED|Overall Study||5
326176|NCT00644423|788957|P2|STARTED|Overall Study||5
326177|NCT00644423|788958|P1|STARTED|Overall Study||6
326178|NCT00644358|788976|P1|NOT COMPLETED|Overall Study||362
326179|NCT00644358|788976|P1|COMPLETED|Overall Study||254
326180|NCT00644358|788976|P1|STARTED|Overall Study||616
326181|NCT00644332|788983|P1|NOT COMPLETED|Overall Study||21
326182|NCT00644332|788983|P1|COMPLETED|Overall Study||150
326183|NCT00644332|788983|P1|STARTED|Overall Study|172 patients were enrolled; one withdrew consent prior to starting treatment|171
326184|NCT00644280|788998|P2|NOT COMPLETED|Overall Study||0
326185|NCT00644280|788999|P1|NOT COMPLETED|Overall Study||0
326186|NCT00644280|788998|P2|COMPLETED|Overall Study||5
326187|NCT00644280|788999|P1|COMPLETED|Overall Study||6
326188|NCT00644280|788998|P2|STARTED|Overall Study||5
326189|NCT00644280|788999|P1|STARTED|Overall Study||6
326190|NCT00644228|789009|P2|NOT COMPLETED|Maintenance||135
326191|NCT00644228|789010|P1|NOT COMPLETED|Maintenance||143
326192|NCT00644228|789009|P2|COMPLETED|Maintenance||0
326193|NCT00644228|789010|P1|COMPLETED|Maintenance||0
326194|NCT00644228|789009|P2|STARTED|Maintenance|2 patients who completed induction did not continue on to maintenance due to other (2).|135
326195|NCT00644228|789010|P1|STARTED|Maintenance|3 patients who completed induction did not continue on to maintenance due to refusal (1), other (2).|143
326196|NCT00644228|789009|P2|NOT COMPLETED|Induction Therapy||105
326197|NCT00644228|789010|P1|NOT COMPLETED|Induction Therapy||83
326198|NCT00644228|789009|P2|COMPLETED|Induction Therapy||137
326199|NCT00644228|789010|P1|COMPLETED|Induction Therapy||146
326200|NCT00644228|789009|P2|STARTED|Induction Therapy||242
326201|NCT00644228|789010|P1|STARTED|Induction Therapy||229
326202|NCT00644228|789009|P2|NOT COMPLETED|Randomization & Eligibility||22
326203|NCT00644228|789010|P1|NOT COMPLETED|Randomization & Eligibility||32
326204|NCT00644228|789009|P2|COMPLETED|Randomization & Eligibility||242
326205|NCT00644228|789010|P1|COMPLETED|Randomization & Eligibility||229
326206|NCT00644228|789009|P2|Eligible and Analyzable|Randomization & Eligibility||242
326207|NCT00644228|789010|P1|Eligible and Analyzable|Randomization & Eligibility||229
326208|NCT00644228|789009|P2|STARTED|Randomization & Eligibility||264
326209|NCT00644228|789010|P1|STARTED|Randomization & Eligibility||261
326210|NCT00644189|789020|P4|NOT COMPLETED|Phase II||0
326211|NCT00644189|789021|P3|NOT COMPLETED|Phase II||0
326212|NCT00644189|789022|P2|NOT COMPLETED|Phase II||0
326213|NCT00644189|789023|P1|NOT COMPLETED|Phase II||0
326214|NCT00644189|789020|P4|COMPLETED|Phase II||50
326215|NCT00644189|789021|P3|COMPLETED|Phase II||0
326216|NCT00644189|789022|P2|COMPLETED|Phase II||0
326217|NCT00644189|789023|P1|COMPLETED|Phase II||0
326218|NCT00644189|789020|P4|Completed All 6 Cycles of Treatment|Phase II||19
326219|NCT00644189|789021|P3|Completed All 6 Cycles of Treatment|Phase II||0
326220|NCT00644189|789022|P2|Completed All 6 Cycles of Treatment|Phase II||0
326221|NCT00644189|789023|P1|Completed All 6 Cycles of Treatment|Phase II||0
326222|NCT00644189|789020|P4|STARTED|Phase II|Additional participants were added to the phase I sample at the phase II 3mg dose level|50
326223|NCT00644189|789021|P3|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
326224|NCT00644189|789022|P2|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
326225|NCT00644189|789023|P1|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
326226|NCT00644189|789020|P4|NOT COMPLETED|Phase I||0
326227|NCT00644189|789021|P3|NOT COMPLETED|Phase I||0
326228|NCT00644189|789022|P2|NOT COMPLETED|Phase I||0
326229|NCT00644189|789023|P1|NOT COMPLETED|Phase I||0
326230|NCT00644189|789020|P4|COMPLETED|Phase I||18
326231|NCT00644189|789021|P3|COMPLETED|Phase I||6
326232|NCT00644189|789022|P2|COMPLETED|Phase I||3
326233|NCT00644189|789023|P1|COMPLETED|Phase I||3
326234|NCT00644189|789020|P4|STARTED|Phase I||18
326235|NCT00644189|789021|P3|STARTED|Phase I||6
326236|NCT00644189|789022|P2|STARTED|Phase I||3
326237|NCT00644189|789023|P1|STARTED|Phase I||3
326238|NCT00644059|789039|P3|NOT COMPLETED|Overall Study||65
326239|NCT00644059|789040|P2|NOT COMPLETED|Overall Study||123
326240|NCT00644059|789041|P1|NOT COMPLETED|Overall Study||124
326241|NCT00644059|789039|P3|COMPLETED|Overall Study||969
326242|NCT00644059|789040|P2|COMPLETED|Overall Study||1726
326243|NCT00644059|789041|P1|COMPLETED|Overall Study||1895
326244|NCT00644059|789039|P3|STARTED|Overall Study||1034
326245|NCT00644059|789040|P2|STARTED|Overall Study||1849
326246|NCT00644059|789041|P1|STARTED|Overall Study||2019
326247|NCT00643916|789131|P6|NOT COMPLETED|Overall Study||1
326248|NCT00643916|789132|P5|NOT COMPLETED|Overall Study||2
326249|NCT00643916|789133|P4|NOT COMPLETED|Overall Study||2
326250|NCT00643916|789134|P3|NOT COMPLETED|Overall Study||6
326251|NCT00643916|789135|P2|NOT COMPLETED|Overall Study||6
326252|NCT00643916|789136|P1|NOT COMPLETED|Overall Study||4
326253|NCT00643916|789131|P6|COMPLETED|Overall Study||66
326254|NCT00643916|789132|P5|COMPLETED|Overall Study||57
326255|NCT00643916|789133|P4|COMPLETED|Overall Study||60
326256|NCT00643916|789134|P3|COMPLETED|Overall Study||62
326257|NCT00643916|789135|P2|COMPLETED|Overall Study||61
326258|NCT00643916|789136|P1|COMPLETED|Overall Study||51
326259|NCT00643916|789131|P6|STARTED|Overall Study||67
326260|NCT00643916|789132|P5|STARTED|Overall Study||59
326261|NCT00643916|789133|P4|STARTED|Overall Study||62
326262|NCT00643916|789134|P3|STARTED|Overall Study||68
326263|NCT00643916|789135|P2|STARTED|Overall Study||67
326264|NCT00643916|789136|P1|STARTED|Overall Study||55
326265|NCT00643864|789156|P1|NOT COMPLETED|Post-test Assessment||0
326266|NCT00643864|789156|P1|COMPLETED|Post-test Assessment||3
326267|NCT00643864|789156|P1|STARTED|Post-test Assessment||3
326268|NCT00643864|789156|P1|NOT COMPLETED|Pre-test Assessment||0
326269|NCT00643864|789156|P1|COMPLETED|Pre-test Assessment||3
326270|NCT00643864|789156|P1|STARTED|Pre-test Assessment||3
326271|NCT00643851|789165|P3|NOT COMPLETED|Overall Study||30
326272|NCT00643851|789166|P2|NOT COMPLETED|Overall Study||33
326273|NCT00643851|789167|P1|NOT COMPLETED|Overall Study||17
326274|NCT00643851|789165|P3|COMPLETED|Overall Study||171
326275|NCT00643851|789166|P2|COMPLETED|Overall Study||170
326276|NCT00643851|789167|P1|COMPLETED|Overall Study||177
326277|NCT00643851|789165|P3|STARTED|Overall Study||201
326278|NCT00643851|789166|P2|STARTED|Overall Study||203
326279|NCT00643851|789167|P1|STARTED|Overall Study||194
326280|NCT00643760|789195|P5|NOT COMPLETED|Overall Study||19
326281|NCT00643760|789196|P4|NOT COMPLETED|Overall Study||38
326282|NCT00643760|789197|P3|NOT COMPLETED|Overall Study||19
326283|NCT00643760|789198|P2|NOT COMPLETED|Overall Study||15
326284|NCT00643760|789199|P1|NOT COMPLETED|Overall Study||30
326285|NCT00643760|789195|P5|COMPLETED|Overall Study||47
326286|NCT00643760|789196|P4|COMPLETED|Overall Study||79
326287|NCT00643760|789197|P3|COMPLETED|Overall Study||37
326288|NCT00643760|789198|P2|COMPLETED|Overall Study||47
326289|NCT00643760|789199|P1|COMPLETED|Overall Study||90
326290|NCT00643760|789195|P5|ITT Population|Overall Study||66
326291|NCT00643760|789196|P4|ITT Population|Overall Study||116
326292|NCT00643760|789197|P3|ITT Population|Overall Study||56
326293|NCT00643760|789198|P2|ITT Population|Overall Study||62
326294|NCT00643760|789199|P1|ITT Population|Overall Study||120
326295|NCT00643760|789195|P5|Safety Population/Treated With Drug|Overall Study||66
326296|NCT00643760|789196|P4|Safety Population/Treated With Drug|Overall Study||116
326297|NCT00643760|789197|P3|Safety Population/Treated With Drug|Overall Study||56
326298|NCT00643760|789198|P2|Safety Population/Treated With Drug|Overall Study||62
326299|NCT00643760|789199|P1|Safety Population/Treated With Drug|Overall Study||120
326300|NCT00643760|789195|P5|STARTED|Overall Study||66
326301|NCT00643760|789196|P4|STARTED|Overall Study||117
326302|NCT00643760|789197|P3|STARTED|Overall Study||56
326303|NCT00643760|789198|P2|STARTED|Overall Study||62
326304|NCT00643760|789199|P1|STARTED|Overall Study||120
326305|NCT00643682|789303|P2|NOT COMPLETED|Overall Study||509
326306|NCT00643682|789304|P1|NOT COMPLETED|Overall Study||522
326307|NCT00643682|789303|P2|COMPLETED|Overall Study||492
326308|NCT00643682|789304|P1|COMPLETED|Overall Study||477
326309|NCT00643682|789303|P2|STARTED|Overall Study||1001
326310|NCT00643682|789304|P1|STARTED|Overall Study||999
326311|NCT00643604|789316|P1|NOT COMPLETED|Overall Study||1
326312|NCT00643604|789316|P1|COMPLETED|Overall Study||6
326313|NCT00643604|789316|P1|STARTED|Overall Study||7
326314|NCT00643578|789333|P2|NOT COMPLETED|Overall Study||0
326315|NCT00643578|789334|P1|NOT COMPLETED|Overall Study||2
326316|NCT00643578|789333|P2|COMPLETED|Overall Study||6
326317|NCT00643578|789334|P1|COMPLETED|Overall Study||4
326318|NCT00643578|789333|P2|STARTED|Overall Study||6
326319|NCT00643578|789334|P1|STARTED|Overall Study||6
326320|NCT00643565|789344|P2|NOT COMPLETED|Overall Study||67
326321|NCT00643565|789345|P1|NOT COMPLETED|Overall Study||73
326322|NCT00643565|789344|P2|COMPLETED|Overall Study||7
326323|NCT00643565|789345|P1|COMPLETED|Overall Study||7
326324|NCT00643565|789344|P2|STARTED|Overall Study||74
326325|NCT00643565|789345|P1|STARTED|Overall Study||80
326326|NCT00643487|789367|P1|NOT COMPLETED|Overall Study||3
326327|NCT00643487|789367|P1|COMPLETED|Overall Study||5
326328|NCT00643487|789367|P1|STARTED|Overall Study||8
326329|NCT00643448|789374|P3|NOT COMPLETED|Overall Study||6
326330|NCT00643448|789375|P2|NOT COMPLETED|Overall Study||5
326331|NCT00643448|789376|P1|NOT COMPLETED|Overall Study||4
326332|NCT00643448|789374|P3|COMPLETED|Overall Study||16
326333|NCT00643448|789375|P2|COMPLETED|Overall Study||17
326334|NCT00643448|789376|P1|COMPLETED|Overall Study||17
326335|NCT00643448|789374|P3|STARTED|Overall Study||22
326336|NCT00643448|789375|P2|STARTED|Overall Study||22
326337|NCT00643448|789376|P1|STARTED|Overall Study||21
326338|NCT00643279|789393|P2|NOT COMPLETED|Overall Study||13
326339|NCT00643279|789394|P1|NOT COMPLETED|Overall Study||16
326340|NCT00643279|789393|P2|COMPLETED|Overall Study||127
326341|NCT00643279|789394|P1|COMPLETED|Overall Study||118
326342|NCT00643279|789393|P2|STARTED|Overall Study||140
326343|NCT00643279|789394|P1|STARTED|Overall Study||134
326344|NCT00643201|789416|P2|NOT COMPLETED|Completed Study Follow Up||79
326345|NCT00643201|789417|P1|NOT COMPLETED|Completed Study Follow Up||70
326346|NCT00643201|789416|P2|COMPLETED|Completed Study Follow Up|Of 79 who did not complete follow up: 3 completed treatment, 76 discontinued treatment|2560
326347|NCT00643201|789417|P1|COMPLETED|Completed Study Follow Up|Of 70 who did not complete follow up: 7 completed treatment; 63 discontinued treatment|2547
326348|NCT00643201|789416|P2|STARTED|Completed Study Follow Up||2639
326349|NCT00643201|789417|P1|STARTED|Completed Study Follow Up||2617
326350|NCT00643201|789416|P2|NOT COMPLETED|Randomized, Completed 6 Months of Study||413
326351|NCT00643201|789417|P1|NOT COMPLETED|Randomized, Completed 6 Months of Study||377
326352|NCT00643201|789416|P2|COMPLETED|Randomized, Completed 6 Months of Study||2291
326353|NCT00643201|789417|P1|COMPLETED|Randomized, Completed 6 Months of Study||2314
326354|NCT00643201|789416|P2|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2704
326355|NCT00643201|789417|P1|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2691
326356|NCT00643162|789465|P2|NOT COMPLETED|Overall Study||1
326357|NCT00643162|789466|P1|NOT COMPLETED|Overall Study||1
326358|NCT00643162|789465|P2|COMPLETED|Overall Study||4
326359|NCT00643162|789466|P1|COMPLETED|Overall Study||6
326360|NCT00643162|789465|P2|STARTED|Overall Study||5
326361|NCT00643162|789466|P1|STARTED|Overall Study||7
326362|NCT00643123|789478|P2|NOT COMPLETED|Overall Study||1
326363|NCT00643123|789479|P1|NOT COMPLETED|Overall Study||5
326364|NCT00643123|789478|P2|COMPLETED|Overall Study||11
326365|NCT00643123|789479|P1|COMPLETED|Overall Study||10
326366|NCT00643123|789478|P2|STARTED|Overall Study||12
326367|NCT00643123|789479|P1|STARTED|Overall Study||15
326368|NCT00643097|789490|P3|NOT COMPLETED|Overall Study||0
326369|NCT00643097|789491|P2|NOT COMPLETED|Overall Study||0
326370|NCT00643097|789492|P1|NOT COMPLETED|Overall Study||0
326371|NCT00643097|789490|P3|COMPLETED|Overall Study||10
326372|NCT00643097|789491|P2|COMPLETED|Overall Study||12
326373|NCT00643097|789492|P1|COMPLETED|Overall Study||18
326374|NCT00643097|789490|P3|STARTED|Overall Study||10
326375|NCT00643097|789491|P2|STARTED|Overall Study||12
326376|NCT00643097|789492|P1|STARTED|Overall Study||18
326377|NCT00643006|789511|P2|NOT COMPLETED|Overall Study||4
326378|NCT00643006|789512|P1|NOT COMPLETED|Overall Study||5
326379|NCT00643006|789511|P2|COMPLETED|Overall Study||29
326380|NCT00643006|789512|P1|COMPLETED|Overall Study||29
326381|NCT00643006|789511|P2|STARTED|Overall Study||33
326382|NCT00643006|789512|P1|STARTED|Overall Study||34
326383|NCT00642993|789522|P2|NOT COMPLETED|Overall Study||16
326384|NCT00642993|789523|P1|NOT COMPLETED|Overall Study||106
326385|NCT00642993|789522|P2|COMPLETED|Overall Study||118
326386|NCT00642993|789523|P1|COMPLETED|Overall Study||161
326387|NCT00642993|789522|P2|STARTED|Overall Study||134
326388|NCT00642993|789523|P1|STARTED|Overall Study||267
326389|NCT00642902|789541|P4|NOT COMPLETED|Overall Study||40
326390|NCT00642902|789542|P3|NOT COMPLETED|Overall Study||43
326391|NCT00642902|789543|P2|NOT COMPLETED|Overall Study||42
326392|NCT00642902|789544|P1|NOT COMPLETED|Overall Study||40
326393|NCT00642902|789541|P4|COMPLETED|Overall Study||25
326394|NCT00642902|789542|P3|COMPLETED|Overall Study||21
326395|NCT00642902|789543|P2|COMPLETED|Overall Study||21
326396|NCT00642902|789544|P1|COMPLETED|Overall Study||23
326397|NCT00642902|789541|P4|Treated|Overall Study||65
326398|NCT00642902|789542|P3|Treated|Overall Study||63
326399|NCT00642902|789543|P2|Treated|Overall Study||63
326400|NCT00642902|789544|P1|Treated|Overall Study||63
326401|NCT00642902|789541|P4|STARTED|Overall Study||65
326402|NCT00642902|789542|P3|STARTED|Overall Study||64
326403|NCT00642902|789543|P2|STARTED|Overall Study||63
326404|NCT00642902|789544|P1|STARTED|Overall Study||63
326405|NCT00642850|789566|P1|NOT COMPLETED|Overall Study||33
326406|NCT00642850|789566|P1|COMPLETED|Overall Study||155
326407|NCT00642850|789566|P1|STARTED|Overall Study||188
326408|NCT00642811|789582|P6|NOT COMPLETED|Overall Study||1
326409|NCT00642811|789583|P5|NOT COMPLETED|Overall Study||1
326410|NCT00642811|789584|P4|NOT COMPLETED|Overall Study||1
326411|NCT00642811|789585|P3|NOT COMPLETED|Overall Study||0
326412|NCT00642811|789586|P2|NOT COMPLETED|Overall Study||4
326413|NCT00642811|789587|P1|NOT COMPLETED|Overall Study||3
326414|NCT00642811|789582|P6|COMPLETED|Overall Study||13
326415|NCT00642811|789583|P5|COMPLETED|Overall Study||13
326416|NCT00642811|789584|P4|COMPLETED|Overall Study||15
326417|NCT00642811|789585|P3|COMPLETED|Overall Study||13
326418|NCT00642811|789586|P2|COMPLETED|Overall Study||17
326419|NCT00642811|789587|P1|COMPLETED|Overall Study||17
326420|NCT00642811|789582|P6|STARTED|Overall Study||14
326421|NCT00642811|789583|P5|STARTED|Overall Study||14
326422|NCT00642811|789584|P4|STARTED|Overall Study||16
326423|NCT00642811|789585|P3|STARTED|Overall Study||13
326424|NCT00642811|789586|P2|STARTED|Overall Study||21
326425|NCT00642811|789587|P1|STARTED|Overall Study||20
326426|NCT00642772|789609|P1|NOT COMPLETED|Overall Study||10
326427|NCT00642772|789609|P1|COMPLETED|Overall Study||14
326428|NCT00642772|789609|P1|STARTED|Overall Study||24
326429|NCT00642759|789613|P1|NOT COMPLETED|Overall Study||1
326430|NCT00642759|789613|P1|COMPLETED|Overall Study||35
326431|NCT00642759|789613|P1|STARTED|Overall Study||36
326432|NCT00642746|789622|P2|NOT COMPLETED|Overall Study||0
326433|NCT00642746|789623|P1|NOT COMPLETED|Overall Study||1
326434|NCT00642746|789622|P2|COMPLETED|Overall Study||1
326435|NCT00642746|789623|P1|COMPLETED|Overall Study||9
326436|NCT00642746|789622|P2|STARTED|Overall Study||1
326437|NCT00642746|789623|P1|STARTED|Overall Study||10
326438|NCT00642707|789637|P4|NOT COMPLETED|Overall Study||2
326439|NCT00642707|789638|P3|NOT COMPLETED|Overall Study||0
326440|NCT00642707|789639|P2|NOT COMPLETED|Overall Study||0
326441|NCT00642707|789640|P1|NOT COMPLETED|Overall Study||1
326442|NCT00642707|789637|P4|COMPLETED|Overall Study||8
326443|NCT00642707|789638|P3|COMPLETED|Overall Study||12
326444|NCT00642707|789639|P2|COMPLETED|Overall Study||11
326445|NCT00642707|789640|P1|COMPLETED|Overall Study||10
326446|NCT00642707|789637|P4|STARTED|Overall Study||10
326447|NCT00642707|789638|P3|STARTED|Overall Study||12
326448|NCT00642707|789639|P2|STARTED|Overall Study||11
326449|NCT00642707|789640|P1|STARTED|Overall Study||11
326450|NCT00642694|789652|P2|NOT COMPLETED|Overall Study||4
326451|NCT00642694|789653|P1|NOT COMPLETED|Overall Study||6
326452|NCT00642694|789652|P2|COMPLETED|Overall Study||11
326453|NCT00642694|789653|P1|COMPLETED|Overall Study||8
326454|NCT00642694|789652|P2|STARTED|Overall Study||15
326455|NCT00642694|789653|P1|STARTED|Overall Study||14
326456|NCT00642668|789675|P1|NOT COMPLETED|Overall Study||14
326457|NCT00642668|789675|P1|COMPLETED|Overall Study||21
326458|NCT00642668|789675|P1|STARTED|Overall Study||35
326459|NCT00642642|789683|P1|NOT COMPLETED|Treatment & Follow Up||17
326460|NCT00642642|789683|P1|COMPLETED|Treatment & Follow Up||92
326461|NCT00642642|789683|P1|STARTED|Treatment & Follow Up||109
326462|NCT00642642|789683|P1|NOT COMPLETED|Biopsy & Product Manufacture||13
326463|NCT00642642|789683|P1|COMPLETED|Biopsy & Product Manufacture|Patients biopsied and for whom study product could be produced are considered completed|109
326464|NCT00642642|789683|P1|STARTED|Biopsy & Product Manufacture||122
326465|NCT00642616|789700|P4|NOT COMPLETED|Overall Study||7
326466|NCT00642616|789701|P3|NOT COMPLETED|Overall Study||9
326467|NCT00642616|789702|P2|NOT COMPLETED|Overall Study||7
326468|NCT00642616|789703|P1|NOT COMPLETED|Overall Study||9
326469|NCT00642616|789700|P4|COMPLETED|Overall Study||1
326470|NCT00642616|789701|P3|COMPLETED|Overall Study||0
326471|NCT00642616|789702|P2|COMPLETED|Overall Study||1
326472|NCT00642616|789703|P1|COMPLETED|Overall Study||0
326473|NCT00642616|789700|P4|STARTED|Overall Study||8
326474|NCT00642616|789701|P3|STARTED|Overall Study||9
326475|NCT00642616|789702|P2|STARTED|Overall Study||8
326476|NCT00642616|789703|P1|STARTED|Overall Study||9
326477|NCT00642603|789727|P2|NOT COMPLETED|Overall Study||18
326478|NCT00642603|789728|P1|NOT COMPLETED|Overall Study||21
326479|NCT00642603|789727|P2|COMPLETED|Overall Study||2
326480|NCT00642603|789728|P1|COMPLETED|Overall Study||0
326481|NCT00642603|789727|P2|Safety Population|Overall Study||20
326482|NCT00642603|789728|P1|Safety Population|Overall Study||19
326483|NCT00642603|789727|P2|STARTED|Overall Study||20
326484|NCT00642603|789728|P1|STARTED|Overall Study||21
326485|NCT00642473|789736|P2|NOT COMPLETED|Overall Study||11
326486|NCT00642473|789737|P1|NOT COMPLETED|Overall Study||4
326487|NCT00642473|789736|P2|COMPLETED|Overall Study||5
326488|NCT00642473|789737|P1|COMPLETED|Overall Study||14
326489|NCT00642473|789736|P2|STARTED|Overall Study||16
326490|NCT00642473|789737|P1|STARTED|Overall Study||18
326491|NCT00642460|789751|P6|NOT COMPLETED|Part III: Open-Label Up to Week 260||21
326492|NCT00642460|789752|P5|NOT COMPLETED|Part III: Open-Label Up to Week 260||25
326493|NCT00642460|789753|P4|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
326494|NCT00642460|789754|P3|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
326495|NCT00642460|789755|P2|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
326496|NCT00642460|789756|P1|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
326497|NCT00642460|789751|P6|COMPLETED|Part III: Open-Label Up to Week 260||38
326498|NCT00642460|789752|P5|COMPLETED|Part III: Open-Label Up to Week 260||28
326499|NCT00642460|789753|P4|COMPLETED|Part III: Open-Label Up to Week 260||0
326500|NCT00642460|789754|P3|COMPLETED|Part III: Open-Label Up to Week 260||0
326501|NCT00642460|789755|P2|COMPLETED|Part III: Open-Label Up to Week 260||0
326502|NCT00642460|789756|P1|COMPLETED|Part III: Open-Label Up to Week 260||0
326503|NCT00642460|789751|P6|STARTED|Part III: Open-Label Up to Week 260||59
326504|NCT00642460|789752|P5|STARTED|Part III: Open-Label Up to Week 260||53
326505|NCT00642460|789753|P4|STARTED|Part III: Open-Label Up to Week 260||0
326506|NCT00642460|789754|P3|STARTED|Part III: Open-Label Up to Week 260||0
326507|NCT00642460|789755|P2|STARTED|Part III: Open-Label Up to Week 260||0
326508|NCT00642460|789756|P1|STARTED|Part III: Open-Label Up to Week 260||0
326509|NCT00642460|789751|P6|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
326510|NCT00642460|789752|P5|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
326511|NCT00642460|789753|P4|NOT COMPLETED|Part II: Open-Label Up to Week 92||3
326512|NCT00642460|789754|P3|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
326513|NCT00642460|789755|P2|NOT COMPLETED|Part II: Open-Label Up to Week 92||8
326514|NCT00642460|789756|P1|NOT COMPLETED|Part II: Open-Label Up to Week 92||9
326515|NCT00642460|789751|P6|COMPLETED|Part II: Open-Label Up to Week 92||0
326516|NCT00642460|789752|P5|COMPLETED|Part II: Open-Label Up to Week 92||0
326517|NCT00642460|789753|P4|COMPLETED|Part II: Open-Label Up to Week 92||17
326518|NCT00642460|789754|P3|COMPLETED|Part II: Open-Label Up to Week 92||0
326519|NCT00642460|789755|P2|COMPLETED|Part II: Open-Label Up to Week 92||32
326520|NCT00642460|789756|P1|COMPLETED|Part II: Open-Label Up to Week 92||43
326521|NCT00642460|789751|P6|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
326522|NCT00642460|789752|P5|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
326523|NCT00642460|789753|P4|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||20
326524|NCT00642460|789754|P3|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
326525|NCT00642460|789755|P2|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||40
326526|NCT00642460|789756|P1|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||52
326527|NCT00642460|789751|P6|STARTED|Part II: Open-Label Up to Week 92||0
326528|NCT00642460|789752|P5|STARTED|Part II: Open-Label Up to Week 92||0
326529|NCT00642460|789753|P4|STARTED|Part II: Open-Label Up to Week 92|19 Participants switched from 12 mg/kg to 8 mg/kg and 1 Participant switched from 8mg/kg to 12 mg/kg|20
326530|NCT00642460|789754|P3|STARTED|Part II: Open-Label Up to Week 92|Placebo group received open-label Tocilizumab 8 mg/kg or 12 mg/kg based on body weight in Part II.|0
326531|NCT00642460|789755|P2|STARTED|Part II: Open-Label Up to Week 92||40
326532|NCT00642460|789756|P1|STARTED|Part II: Open-Label Up to Week 92|Includes Participants who received Open-Label in Part II or Open-Label escape therapy in Part I.|52
326533|NCT00642460|789751|P6|NOT COMPLETED|Part I: 12 Week Double-Blind||0
326534|NCT00642460|789752|P5|NOT COMPLETED|Part I: 12 Week Double-Blind||0
326535|NCT00642460|789753|P4|NOT COMPLETED|Part I: 12 Week Double-Blind||0
326536|NCT00642460|789754|P3|NOT COMPLETED|Part I: 12 Week Double-Blind||1
326537|NCT00642460|789755|P2|NOT COMPLETED|Part I: 12 Week Double-Blind||1
326538|NCT00642460|789756|P1|NOT COMPLETED|Part I: 12 Week Double-Blind||1
326539|NCT00642460|789751|P6|COMPLETED|Part I: 12 Week Double-Blind||0
326540|NCT00642460|789752|P5|COMPLETED|Part I: 12 Week Double-Blind||0
326541|NCT00642460|789753|P4|COMPLETED|Part I: 12 Week Double-Blind||0
326542|NCT00642460|789754|P3|COMPLETED|Part I: 12 Week Double-Blind||36
326543|NCT00642460|789755|P2|COMPLETED|Part I: 12 Week Double-Blind||37
326544|NCT00642460|789756|P1|COMPLETED|Part I: 12 Week Double-Blind||36
326545|NCT00642460|789751|P6|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
326546|NCT00642460|789752|P5|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
326547|NCT00642460|789753|P4|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
326548|NCT00642460|789754|P3|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
326549|NCT00642460|789755|P2|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||38
326550|NCT00642460|789756|P1|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
326551|NCT00642460|789751|P6|STARTED|Part I: 12 Week Double-Blind||0
326552|NCT00642460|789752|P5|STARTED|Part I: 12 Week Double-Blind||0
326553|NCT00642460|789753|P4|STARTED|Part I: 12 Week Double-Blind||0
326554|NCT00642460|789754|P3|STARTED|Part I: 12 Week Double-Blind||37
326555|NCT00642460|789755|P2|STARTED|Part I: 12 Week Double-Blind||38
326556|NCT00642460|789756|P1|STARTED|Part I: 12 Week Double-Blind||37
326557|NCT00642382|789822|P2|NOT COMPLETED|Overall Study||0
326558|NCT00642382|789823|P1|NOT COMPLETED|Overall Study||0
326559|NCT00642382|789822|P2|COMPLETED|Overall Study||0
326560|NCT00642382|789823|P1|COMPLETED|Overall Study||0
326561|NCT00642382|789822|P2|STARTED|Overall Study||0
326562|NCT00642382|789823|P1|STARTED|Overall Study||0
326563|NCT00642369|789831|P2|NOT COMPLETED|Overall Study||6
326564|NCT00642369|789832|P1|NOT COMPLETED|Overall Study||5
326565|NCT00642369|789831|P2|COMPLETED|Overall Study||24
326566|NCT00642369|789832|P1|COMPLETED|Overall Study||25
326567|NCT00642369|789831|P2|STARTED|Overall Study||30
326568|NCT00642369|789832|P1|STARTED|Overall Study||30
326569|NCT00642356|789842|P2|NOT COMPLETED|Overall Study||3
326570|NCT00642356|789843|P1|NOT COMPLETED|Overall Study||2
326571|NCT00642356|789842|P2|COMPLETED|Overall Study||4
326572|NCT00642356|789843|P1|COMPLETED|Overall Study||5
326573|NCT00642356|789842|P2|STARTED|Overall Study||7
326574|NCT00642356|789843|P1|STARTED|Overall Study||7
326575|NCT00642304|789851|P1|NOT COMPLETED|Overall Study||6
326576|NCT00642304|789851|P1|COMPLETED|Overall Study||14
326577|NCT00642304|789851|P1|STARTED|Overall Study||20
326578|NCT00642278|789867|P7|NOT COMPLETED|Overall Study||5
326579|NCT00642278|789868|P6|NOT COMPLETED|Overall Study||7
326580|NCT00642278|789869|P5|NOT COMPLETED|Overall Study||8
326581|NCT00642278|789870|P4|NOT COMPLETED|Overall Study||9
326582|NCT00642278|789871|P3|NOT COMPLETED|Overall Study||5
326583|NCT00642278|789872|P2|NOT COMPLETED|Overall Study||5
326584|NCT00642278|789873|P1|NOT COMPLETED|Overall Study||10
326585|NCT00642278|789867|P7|COMPLETED|Overall Study||60
326586|NCT00642278|789868|P6|COMPLETED|Overall Study||57
326587|NCT00642278|789869|P5|COMPLETED|Overall Study||56
326588|NCT00642278|789870|P4|COMPLETED|Overall Study||56
326589|NCT00642278|789871|P3|COMPLETED|Overall Study||59
326590|NCT00642278|789872|P2|COMPLETED|Overall Study||59
326591|NCT00642278|789873|P1|COMPLETED|Overall Study||55
326592|NCT00642278|789867|P7|STARTED|Overall Study||65
326593|NCT00642278|789868|P6|STARTED|Overall Study||64
326594|NCT00642278|789869|P5|STARTED|Overall Study||64
326595|NCT00642278|789870|P4|STARTED|Overall Study||65
326596|NCT00642278|789871|P3|STARTED|Overall Study||64
326597|NCT00642278|789872|P2|STARTED|Overall Study||64
326598|NCT00642278|789873|P1|STARTED|Overall Study||65
326599|NCT00642174|789926|P2|NOT COMPLETED|Period 2 - Crossover Drug||0
326600|NCT00642174|789927|P1|NOT COMPLETED|Period 2 - Crossover Drug||0
326601|NCT00642174|789926|P2|COMPLETED|Period 2 - Crossover Drug||16
326602|NCT00642174|789927|P1|COMPLETED|Period 2 - Crossover Drug||18
326603|NCT00642174|789926|P2|STARTED|Period 2 - Crossover Drug||16
326604|NCT00642174|789927|P1|STARTED|Period 2 - Crossover Drug||18
326605|NCT00642174|789926|P2|NOT COMPLETED|Period 1 - Initial Drug||1
326606|NCT00642174|789927|P1|NOT COMPLETED|Period 1 - Initial Drug||0
326607|NCT00642174|789926|P2|COMPLETED|Period 1 - Initial Drug||16
326608|NCT00642174|789927|P1|COMPLETED|Period 1 - Initial Drug||18
326609|NCT00642174|789926|P2|STARTED|Period 1 - Initial Drug||17
326610|NCT00642174|789927|P1|STARTED|Period 1 - Initial Drug||18
326611|NCT00642018|789943|P2|NOT COMPLETED|Overall Study||79
326612|NCT00642018|789944|P1|NOT COMPLETED|Overall Study||28
326613|NCT00642018|789943|P2|COMPLETED|Overall Study|Participants who completed 10 cycles of treatment.|23
326614|NCT00642018|789944|P1|COMPLETED|Overall Study|Participants who completed 10 cycles of treatment.|24
326615|NCT00642018|789943|P2|Received at Least One Dose of Study Drug|Overall Study||98
326616|NCT00642018|789944|P1|Received at Least One Dose of Study Drug|Overall Study||51
326617|NCT00642018|789943|P2|STARTED|Overall Study||102
326618|NCT00642018|789944|P1|STARTED|Overall Study||52
326619|NCT00641862|789974|P2|NOT COMPLETED|Overall Study||38
326620|NCT00641862|789975|P1|NOT COMPLETED|Overall Study||44
326621|NCT00641862|789974|P2|COMPLETED|Overall Study||145
326622|NCT00641862|789975|P1|COMPLETED|Overall Study||139
326623|NCT00641862|789974|P2|STARTED|Overall Study||183
326624|NCT00641862|789975|P1|STARTED|Overall Study||183
326625|NCT00641797|789993|P2|NOT COMPLETED|Overall Study||0
326626|NCT00641797|789994|P1|NOT COMPLETED|Overall Study||0
326627|NCT00641797|789993|P2|COMPLETED|Overall Study||15
326628|NCT00641797|789994|P1|COMPLETED|Overall Study||11
326629|NCT00641797|789993|P2|STARTED|Overall Study||15
326630|NCT00641797|789994|P1|STARTED|Overall Study||11
326631|NCT00641745|790002|P2|NOT COMPLETED|Overall Study||113
326632|NCT00641745|790003|P1|NOT COMPLETED|Overall Study||280
326633|NCT00641745|790002|P2|COMPLETED|Overall Study||89
326634|NCT00641745|790003|P1|COMPLETED|Overall Study||147
326635|NCT00641745|790002|P2|STARTED|Overall Study||202
326636|NCT00641745|790003|P1|STARTED|Overall Study||427
326637|NCT00641719|790011|P2|NOT COMPLETED|Overall Study||37
326638|NCT00641719|790012|P1|NOT COMPLETED|Overall Study||30
326639|NCT00641719|790011|P2|COMPLETED|Overall Study|1 participant discontinued during taper phase, not during treatment phase.|92
326640|NCT00641719|790012|P1|COMPLETED|Overall Study||99
326641|NCT00641719|790011|P2|STARTED|Overall Study||129
326642|NCT00641719|790012|P1|STARTED|Overall Study||129
326643|NCT00641706|790036|P2|NOT COMPLETED|Overall Study||3
326644|NCT00641706|790037|P1|NOT COMPLETED|Overall Study||9
326645|NCT00641706|790036|P2|COMPLETED|Overall Study||4
326646|NCT00641706|790037|P1|COMPLETED|Overall Study||28
326647|NCT00641706|790036|P2|STARTED|Overall Study||7
326648|NCT00641706|790037|P1|STARTED|Overall Study||37
326649|NCT00641667|790049|P1|NOT COMPLETED|Overall Study||6
326650|NCT00641667|790049|P1|COMPLETED|Overall Study||60
326651|NCT00641667|790049|P1|STARTED|Overall Study||66
326652|NCT00641641|790059|P1|NOT COMPLETED|Overall Study||0
326653|NCT00641641|790059|P1|COMPLETED|Overall Study||16
326654|NCT00641641|790059|P1|STARTED|Overall Study||16
326655|NCT00641563|790063|P2|NOT COMPLETED|Infusion 2||0
326656|NCT00641563|790064|P1|NOT COMPLETED|Infusion 2||0
326657|NCT00641563|790063|P2|COMPLETED|Infusion 2||5
326658|NCT00641563|790064|P1|COMPLETED|Infusion 2||5
326659|NCT00641563|790063|P2|STARTED|Infusion 2||5
326660|NCT00641563|790064|P1|STARTED|Infusion 2||5
326661|NCT00641563|790063|P2|NOT COMPLETED|Infusion 1||0
326662|NCT00641563|790064|P1|NOT COMPLETED|Infusion 1||0
326663|NCT00641563|790063|P2|COMPLETED|Infusion 1||5
326664|NCT00641563|790064|P1|COMPLETED|Infusion 1||5
326665|NCT00641563|790063|P2|STARTED|Infusion 1||5
326666|NCT00641563|790064|P1|STARTED|Infusion 1||5
326667|NCT00641537|790077|P8|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
326668|NCT00641537|790078|P7|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
326669|NCT00641537|790079|P6|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
326670|NCT00641537|790080|P5|NOT COMPLETED|24-Week Supplemental Follow-up Period||5
326671|NCT00641537|790081|P4|NOT COMPLETED|24-Week Supplemental Follow-up Period||4
326672|NCT00641537|790082|P3|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
326673|NCT00641537|790083|P2|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
326674|NCT00641537|790084|P1|NOT COMPLETED|24-Week Supplemental Follow-up Period||0
326675|NCT00641537|790077|P8|COMPLETED|24-Week Supplemental Follow-up Period||10
326676|NCT00641537|790078|P7|COMPLETED|24-Week Supplemental Follow-up Period||8
326677|NCT00641537|790079|P6|COMPLETED|24-Week Supplemental Follow-up Period||14
326678|NCT00641537|790080|P5|COMPLETED|24-Week Supplemental Follow-up Period||193
326679|NCT00641537|790081|P4|COMPLETED|24-Week Supplemental Follow-up Period||147
326680|NCT00641537|790082|P3|COMPLETED|24-Week Supplemental Follow-up Period||140
326681|NCT00641537|790083|P2|COMPLETED|24-Week Supplemental Follow-up Period||66
326682|NCT00641537|790084|P1|COMPLETED|24-Week Supplemental Follow-up Period||75
326683|NCT00641537|790077|P8|STARTED|24-Week Supplemental Follow-up Period||11
326684|NCT00641537|790078|P7|STARTED|24-Week Supplemental Follow-up Period||9
326685|NCT00641537|790079|P6|STARTED|24-Week Supplemental Follow-up Period||15
326686|NCT00641537|790080|P5|STARTED|24-Week Supplemental Follow-up Period||198
326687|NCT00641537|790081|P4|STARTED|24-Week Supplemental Follow-up Period||151
326688|NCT00641537|790082|P3|STARTED|24-Week Supplemental Follow-up Period||143
326689|NCT00641537|790083|P2|STARTED|24-Week Supplemental Follow-up Period||69
326690|NCT00641537|790084|P1|STARTED|24-Week Supplemental Follow-up Period||75
326691|NCT00641537|790077|P8|NOT COMPLETED|96-week Period||6
326692|NCT00641537|790078|P7|NOT COMPLETED|96-week Period||5
326693|NCT00641537|790079|P6|NOT COMPLETED|96-week Period||7
326694|NCT00641537|790080|P5|NOT COMPLETED|96-week Period||18
326695|NCT00641537|790081|P4|NOT COMPLETED|96-week Period||12
326696|NCT00641537|790082|P3|NOT COMPLETED|96-week Period||20
326697|NCT00641537|790083|P2|NOT COMPLETED|96-week Period||10
326698|NCT00641537|790084|P1|NOT COMPLETED|96-week Period||9
326699|NCT00641537|790077|P8|COMPLETED|96-week Period||16
326700|NCT00641537|790078|P7|COMPLETED|96-week Period||12
326701|NCT00641537|790079|P6|COMPLETED|96-week Period||15
326702|NCT00641537|790080|P5|COMPLETED|96-week Period||226
326703|NCT00641537|790081|P4|COMPLETED|96-week Period||174
326704|NCT00641537|790082|P3|COMPLETED|96-week Period||166
326705|NCT00641537|790083|P2|COMPLETED|96-week Period||82
326706|NCT00641537|790084|P1|COMPLETED|96-week Period||89
326707|NCT00641537|790077|P8|STARTED|96-week Period||22
326708|NCT00641537|790078|P7|STARTED|96-week Period||17
326709|NCT00641537|790079|P6|STARTED|96-week Period||22
326710|NCT00641537|790080|P5|STARTED|96-week Period||244
326711|NCT00641537|790081|P4|STARTED|96-week Period||186
326712|NCT00641537|790082|P3|STARTED|96-week Period||186
326713|NCT00641537|790083|P2|STARTED|96-week Period||92
326714|NCT00641537|790084|P1|STARTED|96-week Period||98
326715|NCT00641147|790139|P2|NOT COMPLETED|Completed 16 Months.||0
326716|NCT00641147|790140|P1|NOT COMPLETED|Completed 16 Months.||2
326717|NCT00641147|790139|P2|COMPLETED|Completed 16 Months.||19
326718|NCT00641147|790140|P1|COMPLETED|Completed 16 Months.||13
326719|NCT00641147|790139|P2|STARTED|Completed 16 Months.||19
326720|NCT00641147|790140|P1|STARTED|Completed 16 Months.||15
326721|NCT00641147|790139|P2|NOT COMPLETED|Completed 12 Months.||2
326722|NCT00641147|790140|P1|NOT COMPLETED|Completed 12 Months.||1
326723|NCT00641147|790139|P2|COMPLETED|Completed 12 Months.||19
326724|NCT00641147|790140|P1|COMPLETED|Completed 12 Months.||15
326725|NCT00641147|790139|P2|STARTED|Completed 12 Months.||21
326726|NCT00641147|790140|P1|STARTED|Completed 12 Months.||16
326727|NCT00641147|790139|P2|NOT COMPLETED|Completed 8 Months.||2
326728|NCT00641147|790140|P1|NOT COMPLETED|Completed 8 Months.||3
326729|NCT00641147|790139|P2|COMPLETED|Completed 8 Months.||21
326730|NCT00641147|790140|P1|COMPLETED|Completed 8 Months.||16
326731|NCT00641147|790139|P2|STARTED|Completed 8 Months.||23
326732|NCT00641147|790140|P1|STARTED|Completed 8 Months.||19
326733|NCT00641147|790139|P2|NOT COMPLETED|Completed 4 Months.||0
326734|NCT00641147|790140|P1|NOT COMPLETED|Completed 4 Months.||2
326735|NCT00641147|790139|P2|COMPLETED|Completed 4 Months.||23
326736|NCT00641147|790140|P1|COMPLETED|Completed 4 Months.||19
326737|NCT00641147|790139|P2|STARTED|Completed 4 Months.||23
326738|NCT00641147|790140|P1|STARTED|Completed 4 Months.||21
326739|NCT00641056|790184|P2|NOT COMPLETED|Overall Study||25
326740|NCT00641056|790185|P1|NOT COMPLETED|Overall Study||29
326741|NCT00641056|790184|P2|COMPLETED|Overall Study||209
326742|NCT00641056|790185|P1|COMPLETED|Overall Study||204
326743|NCT00641056|790184|P2|Intent to Treat (ITT)|Overall Study||223
326744|NCT00641056|790185|P1|Intent to Treat (ITT)|Overall Study||233
326745|NCT00641056|790184|P2|STARTED|Overall Study||234
326746|NCT00641056|790185|P1|STARTED|Overall Study||233
326747|NCT00641043|790213|P2|NOT COMPLETED|Overall Study||15
326748|NCT00641043|790214|P1|NOT COMPLETED|Overall Study||19
326749|NCT00641043|790213|P2|COMPLETED|Overall Study|number who completed treatment|244
326750|NCT00641043|790214|P1|COMPLETED|Overall Study|number who completed treatment|111
326751|NCT00641043|790213|P2|STARTED|Overall Study|number who started treatment|259
326752|NCT00641043|790214|P1|STARTED|Overall Study|number who started treatment|130
326753|NCT00640978|790244|P1|NOT COMPLETED|Overall Study||0
326754|NCT00640978|790244|P1|COMPLETED|Overall Study||15
326755|NCT00640978|790244|P1|STARTED|Overall Study||15
326756|NCT00640926|790251|P3|NOT COMPLETED|Overall Study||8
326757|NCT00640926|790252|P2|NOT COMPLETED|Overall Study||6
326758|NCT00640926|790253|P1|NOT COMPLETED|Overall Study||8
326759|NCT00640926|790251|P3|COMPLETED|Overall Study||45
326760|NCT00640926|790252|P2|COMPLETED|Overall Study||46
326761|NCT00640926|790253|P1|COMPLETED|Overall Study||45
326762|NCT00640926|790251|P3|STARTED|Overall Study||53
326763|NCT00640926|790252|P2|STARTED|Overall Study||52
326764|NCT00640926|790253|P1|STARTED|Overall Study||53
326765|NCT00640835|790266|P2|NOT COMPLETED|Overall Study||57
326766|NCT00640835|790267|P1|NOT COMPLETED|Overall Study||76
326767|NCT00640835|790266|P2|COMPLETED|Overall Study||131
326768|NCT00640835|790267|P1|COMPLETED|Overall Study||118
326769|NCT00640835|790266|P2|STARTED|Overall Study||188
326770|NCT00640835|790267|P1|STARTED|Overall Study||194
326771|NCT00640822|790278|P3|NOT COMPLETED|Overall Study||25
326772|NCT00640822|790279|P2|NOT COMPLETED|Overall Study||59
326773|NCT00640822|790280|P1|NOT COMPLETED|Overall Study||43
326774|NCT00640822|790278|P3|COMPLETED|Overall Study||77
326775|NCT00640822|790279|P2|COMPLETED|Overall Study||258
326776|NCT00640822|790280|P1|COMPLETED|Overall Study||279
326777|NCT00640822|790278|P3|STARTED|Overall Study||102
326778|NCT00640822|790279|P2|STARTED|Overall Study||317
326779|NCT00640822|790280|P1|STARTED|Overall Study||322
326780|NCT00640653|790293|P5|NOT COMPLETED|Overall Study||5
326781|NCT00640653|790294|P4|NOT COMPLETED|Overall Study||2
326782|NCT00640653|790295|P3|NOT COMPLETED|Overall Study||0
326783|NCT00640653|790296|P2|NOT COMPLETED|Overall Study||3
326784|NCT00640653|790297|P1|NOT COMPLETED|Overall Study||3
326785|NCT00640653|790293|P5|COMPLETED|Overall Study||129
326786|NCT00640653|790294|P4|COMPLETED|Overall Study||132
326787|NCT00640653|790295|P3|COMPLETED|Overall Study||129
326788|NCT00640653|790296|P2|COMPLETED|Overall Study||131
326789|NCT00640653|790297|P1|COMPLETED|Overall Study||128
326790|NCT00640653|790293|P5|Followed-up at 24 mo|Overall Study||112
326791|NCT00640653|790294|P4|Followed-up at 24 mo|Overall Study||112
326792|NCT00640653|790295|P3|Followed-up at 24 mo|Overall Study||105
326793|NCT00640653|790296|P2|Followed-up at 24 mo|Overall Study||116
326794|NCT00640653|790297|P1|Followed-up at 24 mo|Overall Study||114
326795|NCT00640653|790293|P5|Followed-up at 18 mo|Overall Study||117
326796|NCT00640653|790294|P4|Followed-up at 18 mo|Overall Study||117
326797|NCT00640653|790295|P3|Followed-up at 18 mo|Overall Study||113
326798|NCT00640653|790296|P2|Followed-up at 18 mo|Overall Study||112
326799|NCT00640653|790297|P1|Followed-up at 18 mo|Overall Study||118
326800|NCT00640653|790293|P5|Followed-up at 12 mo|Overall Study||116
326801|NCT00640653|790294|P4|Followed-up at 12 mo|Overall Study||122
326802|NCT00640653|790295|P3|Followed-up at 12 mo|Overall Study||115
326803|NCT00640653|790296|P2|Followed-up at 12 mo|Overall Study||121
326804|NCT00640653|790297|P1|Followed-up at 12 mo|Overall Study||124
326805|NCT00640653|790293|P5|Followed-up at 6 mo|Overall Study||125
326806|NCT00640653|790294|P4|Followed-up at 6 mo|Overall Study||130
326807|NCT00640653|790295|P3|Followed-up at 6 mo|Overall Study||124
326808|NCT00640653|790296|P2|Followed-up at 6 mo|Overall Study||130
326809|NCT00640653|790297|P1|Followed-up at 6 mo|Overall Study||127
326810|NCT00640653|790293|P5|Followed-up at 3 mo|Overall Study||126
326811|NCT00640653|790294|P4|Followed-up at 3 mo|Overall Study||129
326812|NCT00640653|790295|P3|Followed-up at 3 mo|Overall Study||125
326813|NCT00640653|790296|P2|Followed-up at 3 mo|Overall Study||127
326814|NCT00640653|790297|P1|Followed-up at 3 mo|Overall Study||126
326815|NCT00640653|790293|P5|STARTED|Overall Study||134
326816|NCT00640653|790294|P4|STARTED|Overall Study||134
326817|NCT00640653|790295|P3|STARTED|Overall Study||129
326818|NCT00640653|790296|P2|STARTED|Overall Study||134
326819|NCT00640653|790297|P1|STARTED|Overall Study||131
326820|NCT00640614|790331|P2|NOT COMPLETED|Overall Study||0
326821|NCT00640614|790332|P1|NOT COMPLETED|Overall Study||1
326822|NCT00640614|790331|P2|COMPLETED|Overall Study||110
326823|NCT00640614|790332|P1|COMPLETED|Overall Study||124
326824|NCT00640614|790331|P2|STARTED|Overall Study||110
326825|NCT00640614|790332|P1|STARTED|Overall Study||125
326826|NCT00640601|790374|P1|NOT COMPLETED|Overall Study||112
326827|NCT00640601|790374|P1|COMPLETED|Overall Study||183
326828|NCT00640601|790374|P1|STARTED|Overall Study|331 patients enrolled and 295 patients started investigational product (IP)|295
326829|NCT00640562|790390|P2|NOT COMPLETED|Overall Study||26
326830|NCT00640562|790391|P1|NOT COMPLETED|Overall Study||18
326831|NCT00640562|790390|P2|COMPLETED|Overall Study||81
326832|NCT00640562|790391|P1|COMPLETED|Overall Study||91
326833|NCT00640562|790390|P2|STARTED|Overall Study||107
326834|NCT00640562|790391|P1|STARTED|Overall Study||109
326835|NCT00640510|790419|P2|NOT COMPLETED|Overall Study||2
326836|NCT00640510|790420|P1|NOT COMPLETED|Overall Study||1
326837|NCT00640510|790419|P2|COMPLETED|Overall Study||15
326838|NCT00640510|790420|P1|COMPLETED|Overall Study||16
326839|NCT00640510|790419|P2|STARTED|Overall Study|One patient randomized to placebo discontinued prior to receiving study drug.|17
326840|NCT00640510|790420|P1|STARTED|Overall Study||17
326841|NCT00640393|790432|P3|NOT COMPLETED|Part 2||3
326842|NCT00640393|790433|P2|NOT COMPLETED|Part 2||10
326843|NCT00640393|790434|P1|NOT COMPLETED|Part 2||0
326844|NCT00640393|790432|P3|COMPLETED|Part 2|Per protocol analysis of 27 to 29 participants that were compliant depending on evaluation or visit|35
326845|NCT00640393|790433|P2|COMPLETED|Part 2|Per Protocol analysis is of 7 participants that were compliant to protocol|27
326846|NCT00640393|790434|P1|COMPLETED|Part 2||0
326847|NCT00640393|790432|P3|STARTED|Part 2||38
326848|NCT00640393|790433|P2|STARTED|Part 2||37
326849|NCT00640393|790434|P1|STARTED|Part 2||0
326850|NCT00640393|790432|P3|NOT COMPLETED|Randomization||0
326851|NCT00640393|790433|P2|NOT COMPLETED|Randomization||0
326852|NCT00640393|790434|P1|NOT COMPLETED|Randomization||19
326853|NCT00640393|790432|P3|COMPLETED|Randomization||0
326854|NCT00640393|790433|P2|COMPLETED|Randomization||0
326855|NCT00640393|790434|P1|COMPLETED|Randomization||75
326856|NCT00640393|790432|P3|STARTED|Randomization||0
326857|NCT00640393|790433|P2|STARTED|Randomization||0
326858|NCT00640393|790434|P1|STARTED|Randomization||94
326859|NCT00640393|790432|P3|NOT COMPLETED|Part 1||0
326860|NCT00640393|790433|P2|NOT COMPLETED|Part 1||0
326861|NCT00640393|790434|P1|NOT COMPLETED|Part 1||5
326862|NCT00640393|790432|P3|COMPLETED|Part 1||0
326863|NCT00640393|790433|P2|COMPLETED|Part 1||0
326864|NCT00640393|790434|P1|COMPLETED|Part 1||94
326865|NCT00640393|790432|P3|STARTED|Part 1||0
326866|NCT00640393|790433|P2|STARTED|Part 1||0
326867|NCT00640393|790434|P1|STARTED|Part 1||99
326868|NCT00640341|790499|P3|NOT COMPLETED|Overall Study||7
326869|NCT00640341|790500|P2|NOT COMPLETED|Overall Study||5
326870|NCT00640341|790501|P1|NOT COMPLETED|Overall Study||21
326871|NCT00640341|790499|P3|COMPLETED|Overall Study||163
326872|NCT00640341|790500|P2|COMPLETED|Overall Study||165
326873|NCT00640341|790501|P1|COMPLETED|Overall Study||149
326874|NCT00640341|790499|P3|Eligible Participants at Baseline|Overall Study||168
326875|NCT00640341|790500|P2|Eligible Participants at Baseline|Overall Study||167
326876|NCT00640341|790501|P1|Eligible Participants at Baseline|Overall Study||165
326877|NCT00640341|790499|P3|STARTED|Overall Study||170
326878|NCT00640341|790500|P2|STARTED|Overall Study||170
326879|NCT00640341|790501|P1|STARTED|Overall Study|All Starting participants were dispensed lenses|170
326880|NCT00640328|790521|P6|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
326881|NCT00640328|790522|P5|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
326882|NCT00640328|790523|P4|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
326883|NCT00640328|790524|P3|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
326884|NCT00640328|790525|P2|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
326885|NCT00640328|790526|P1|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
326886|NCT00640328|790521|P6|COMPLETED|IFUP (Week 48 to Individual Termination)||4
326887|NCT00640328|790522|P5|COMPLETED|IFUP (Week 48 to Individual Termination)||4
326888|NCT00640328|790523|P4|COMPLETED|IFUP (Week 48 to Individual Termination)||3
326889|NCT00640328|790524|P3|COMPLETED|IFUP (Week 48 to Individual Termination)||6
326890|NCT00640328|790525|P2|COMPLETED|IFUP (Week 48 to Individual Termination)||10
326891|NCT00640328|790526|P1|COMPLETED|IFUP (Week 48 to Individual Termination)||8
326892|NCT00640328|790521|P6|STARTED|IFUP (Week 48 to Individual Termination)||4
326893|NCT00640328|790522|P5|STARTED|IFUP (Week 48 to Individual Termination)||4
326894|NCT00640328|790523|P4|STARTED|IFUP (Week 48 to Individual Termination)||4
326895|NCT00640328|790524|P3|STARTED|IFUP (Week 48 to Individual Termination)||7
326896|NCT00640328|790525|P2|STARTED|IFUP (Week 48 to Individual Termination)||11
326897|NCT00640328|790526|P1|STARTED|IFUP (Week 48 to Individual Termination)||8
326898|NCT00640328|790521|P6|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
326899|NCT00640328|790522|P5|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||1
326900|NCT00640328|790523|P4|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
326901|NCT00640328|790524|P3|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
326902|NCT00640328|790525|P2|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
326903|NCT00640328|790526|P1|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
326904|NCT00640328|790521|P6|COMPLETED|Second Treatment Period (Weeks 24-48)||4
326905|NCT00640328|790522|P5|COMPLETED|Second Treatment Period (Weeks 24-48)||3
326906|NCT00640328|790523|P4|COMPLETED|Second Treatment Period (Weeks 24-48)||4
326907|NCT00640328|790524|P3|COMPLETED|Second Treatment Period (Weeks 24-48)||7
326908|NCT00640328|790525|P2|COMPLETED|Second Treatment Period (Weeks 24-48)||10
326909|NCT00640328|790526|P1|COMPLETED|Second Treatment Period (Weeks 24-48)||8
326910|NCT00640328|790521|P6|STARTED|Second Treatment Period (Weeks 24-48)||4
326911|NCT00640328|790522|P5|STARTED|Second Treatment Period (Weeks 24-48)||4
326912|NCT00640328|790523|P4|STARTED|Second Treatment Period (Weeks 24-48)||4
326913|NCT00640328|790524|P3|STARTED|Second Treatment Period (Weeks 24-48)||7
326914|NCT00640328|790525|P2|STARTED|Second Treatment Period (Weeks 24-48)||10
326915|NCT00640328|790526|P1|STARTED|Second Treatment Period (Weeks 24-48)||8
326916|NCT00640328|790521|P6|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
326917|NCT00640328|790522|P5|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
326918|NCT00640328|790523|P4|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
326919|NCT00640328|790524|P3|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
326920|NCT00640328|790525|P2|NOT COMPLETED|First Treatment Period (Weeks 0-24)||1
326921|NCT00640328|790526|P1|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
326922|NCT00640328|790521|P6|COMPLETED|First Treatment Period (Weeks 0-24)||4
326923|NCT00640328|790522|P5|COMPLETED|First Treatment Period (Weeks 0-24)||4
326924|NCT00640328|790523|P4|COMPLETED|First Treatment Period (Weeks 0-24)||4
326925|NCT00640328|790524|P3|COMPLETED|First Treatment Period (Weeks 0-24)||7
326926|NCT00640328|790525|P2|COMPLETED|First Treatment Period (Weeks 0-24)||10
326927|NCT00640328|790526|P1|COMPLETED|First Treatment Period (Weeks 0-24)||8
326928|NCT00640328|790521|P6|STARTED|First Treatment Period (Weeks 0-24)||4
326929|NCT00640328|790522|P5|STARTED|First Treatment Period (Weeks 0-24)||4
326930|NCT00640328|790523|P4|STARTED|First Treatment Period (Weeks 0-24)||4
326931|NCT00640328|790524|P3|STARTED|First Treatment Period (Weeks 0-24)||7
326932|NCT00640328|790525|P2|STARTED|First Treatment Period (Weeks 0-24)||11
326933|NCT00640328|790526|P1|STARTED|First Treatment Period (Weeks 0-24)||8
326934|NCT00640315|790692|P2|NOT COMPLETED|Overall Study||1
326935|NCT00640315|790693|P1|NOT COMPLETED|Overall Study||0
326936|NCT00640315|790692|P2|COMPLETED|Overall Study||12
326937|NCT00640315|790693|P1|COMPLETED|Overall Study||10
326938|NCT00640315|790692|P2|Participants Received Treatment|Overall Study||13
326939|NCT00640315|790693|P1|Participants Received Treatment|Overall Study||10
326940|NCT00640315|790692|P2|STARTED|Overall Study||13
326941|NCT00640315|790693|P1|STARTED|Overall Study||10
326942|NCT00640289|790819|P1|NOT COMPLETED|Overall Study||13
326943|NCT00640289|790819|P1|COMPLETED|Overall Study||59
326944|NCT00640289|790819|P1|STARTED|Overall Study||72
326945|NCT00640250|790824|P1|NOT COMPLETED|Overall Study||0
326946|NCT00640250|790824|P1|COMPLETED|Overall Study||48
326947|NCT00640250|790824|P1|STARTED|Overall Study||48
326948|NCT00640224|790931|P4|NOT COMPLETED|Overall Study||0
326949|NCT00640224|790932|P3|NOT COMPLETED|Overall Study||0
326950|NCT00640224|790933|P2|NOT COMPLETED|Overall Study||3
326951|NCT00640224|790934|P1|NOT COMPLETED|Overall Study||6
326952|NCT00640224|790931|P4|COMPLETED|Overall Study||0
326953|NCT00640224|790932|P3|COMPLETED|Overall Study||0
326954|NCT00640224|790933|P2|COMPLETED|Overall Study||20
326955|NCT00640224|790934|P1|COMPLETED|Overall Study||17
326956|NCT00640224|790931|P4|STARTED|Overall Study||0
326957|NCT00640224|790932|P3|STARTED|Overall Study||0
326958|NCT00640224|790933|P2|STARTED|Overall Study||23
326959|NCT00640224|790934|P1|STARTED|Overall Study||23
326960|NCT00640146|791034|P2|NOT COMPLETED|Overall Study||6
326961|NCT00640146|791035|P1|NOT COMPLETED|Overall Study||4
326962|NCT00640146|791034|P2|COMPLETED|Overall Study||12
326963|NCT00640146|791035|P1|COMPLETED|Overall Study||15
326964|NCT00640146|791034|P2|Received at Least 1 Dose of Study Drug|Overall Study||15
326965|NCT00640146|791035|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
326966|NCT00640146|791034|P2|STARTED|Overall Study||18
326967|NCT00640146|791035|P1|STARTED|Overall Study||19
326968|NCT00640133|791047|P2|NOT COMPLETED|Open Label Phase (Month 4-12)||0
326969|NCT00640133|791048|P1|NOT COMPLETED|Open Label Phase (Month 4-12)||3
326970|NCT00640133|791047|P2|COMPLETED|Open Label Phase (Month 4-12)||0
326971|NCT00640133|791048|P1|COMPLETED|Open Label Phase (Month 4-12)||24
326972|NCT00640133|791047|P2|STARTED|Open Label Phase (Month 4-12)||0
326973|NCT00640133|791048|P1|STARTED|Open Label Phase (Month 4-12)||27
326974|NCT00640133|791047|P2|NOT COMPLETED|Randomization Phase (Baseline-Month 3)||0
326975|NCT00640133|791048|P1|NOT COMPLETED|Randomization Phase (Baseline-Month 3)||0
326976|NCT00640133|791047|P2|COMPLETED|Randomization Phase (Baseline-Month 3)||12
326977|NCT00640133|791048|P1|COMPLETED|Randomization Phase (Baseline-Month 3)||15
326978|NCT00640133|791047|P2|STARTED|Randomization Phase (Baseline-Month 3)||12
326979|NCT00640133|791048|P1|STARTED|Randomization Phase (Baseline-Month 3)||15
326980|NCT00640042|791068|P1|NOT COMPLETED|Treatment||926
326981|NCT00640042|791068|P1|COMPLETED|Treatment||561
326982|NCT00640042|791068|P1|STARTED|Treatment||1487
326983|NCT00640042|791068|P1|NOT COMPLETED|Enrollment||83
326984|NCT00640042|791068|P1|COMPLETED|Enrollment|Number of patients with evidence of study drug receipt|1487
326985|NCT00640042|791068|P1|STARTED|Enrollment|Number of patients with evidence of prescription card receipt|1570
326986|NCT00640016|791084|P4|NOT COMPLETED|Overall Study||3
326987|NCT00640016|791085|P3|NOT COMPLETED|Overall Study||3
326988|NCT00640016|791086|P2|NOT COMPLETED|Overall Study||2
326989|NCT00640016|791087|P1|NOT COMPLETED|Overall Study||2
326990|NCT00640016|791084|P4|COMPLETED|Overall Study||1
326991|NCT00640016|791085|P3|COMPLETED|Overall Study||1
326992|NCT00640016|791086|P2|COMPLETED|Overall Study||1
326993|NCT00640016|791087|P1|COMPLETED|Overall Study||1
326994|NCT00640016|791084|P4|Treated|Overall Study||4
326995|NCT00640016|791085|P3|Treated|Overall Study||4
326996|NCT00640016|791086|P2|Treated|Overall Study||2
326997|NCT00640016|791087|P1|Treated|Overall Study||3
326998|NCT00640016|791084|P4|STARTED|Overall Study||4
326999|NCT00640016|791085|P3|STARTED|Overall Study||4
327000|NCT00640016|791086|P2|STARTED|Overall Study||3
327001|NCT00640016|791087|P1|STARTED|Overall Study||3
327002|NCT00639860|791131|P1|NOT COMPLETED|Overall Study||0
327003|NCT00639860|791131|P1|COMPLETED|Overall Study||10
327004|NCT00639860|791131|P1|STARTED|Overall Study||10
327005|NCT00639769|791139|P1|NOT COMPLETED|Overall Study||40
327006|NCT00639769|791139|P1|COMPLETED|Overall Study||0
327007|NCT00639769|791139|P1|STARTED|Overall Study||40
327008|NCT00639717|791144|P1|NOT COMPLETED|Overall Study||0
327009|NCT00639717|791144|P1|COMPLETED|Overall Study||48
327010|NCT00639717|791144|P1|STARTED|Overall Study||48
327011|NCT00639678|791156|P4|NOT COMPLETED|Overall Study||0
327012|NCT00639678|791157|P3|NOT COMPLETED|Overall Study||11
327013|NCT00639678|791158|P2|NOT COMPLETED|Overall Study||1
327014|NCT00639678|791159|P1|NOT COMPLETED|Overall Study||4
327015|NCT00639678|791156|P4|COMPLETED|Overall Study||23
327016|NCT00639678|791157|P3|COMPLETED|Overall Study||206
327017|NCT00639678|791158|P2|COMPLETED|Overall Study||5
327018|NCT00639678|791159|P1|COMPLETED|Overall Study||70
327019|NCT00639678|791156|P4|STARTED|Overall Study||23
327020|NCT00639678|791157|P3|STARTED|Overall Study||217
327021|NCT00639678|791158|P2|STARTED|Overall Study||6
327022|NCT00639678|791159|P1|STARTED|Overall Study||74
327023|NCT00639626|791219|P1|NOT COMPLETED|Overall Study||0
327024|NCT00639626|791219|P1|COMPLETED|Overall Study||0
327025|NCT00639626|791219|P1|STARTED|Overall Study||0
327026|NCT00639509|791224|P1|NOT COMPLETED|Overall Study||1
327027|NCT00639509|791224|P1|COMPLETED|Overall Study||23
327028|NCT00639509|791224|P1|STARTED|Overall Study||24
327029|NCT00639457|791232|P2|NOT COMPLETED|Overall Study||3
327030|NCT00639457|791233|P1|NOT COMPLETED|Overall Study||2
327031|NCT00639457|791232|P2|COMPLETED|Overall Study||19
327032|NCT00639457|791233|P1|COMPLETED|Overall Study||20
327033|NCT00639457|791232|P2|STARTED|Overall Study||22
327034|NCT00639457|791233|P1|STARTED|Overall Study||22
327035|NCT00639418|791271|P4|NOT COMPLETED|Overall Study||0
327036|NCT00639418|791272|P3|NOT COMPLETED|Overall Study||0
327037|NCT00639418|791273|P2|NOT COMPLETED|Overall Study||0
327038|NCT00639418|791274|P1|NOT COMPLETED|Overall Study||0
327039|NCT00639418|791271|P4|COMPLETED|Overall Study||46930
327040|NCT00639418|791272|P3|COMPLETED|Overall Study||36496
327041|NCT00639418|791273|P2|COMPLETED|Overall Study||35967
327042|NCT00639418|791274|P1|COMPLETED|Overall Study||28101
327043|NCT00639418|791271|P4|STARTED|Overall Study||46930
327044|NCT00639418|791272|P3|STARTED|Overall Study||36496
327045|NCT00639418|791273|P2|STARTED|Overall Study||35967
327046|NCT00639418|791274|P1|STARTED|Overall Study||28101
327047|NCT00639379|791292|P2|NOT COMPLETED|Period 2 - 2 Weeks||0
327048|NCT00639379|791293|P1|NOT COMPLETED|Period 2 - 2 Weeks||0
327049|NCT00639379|791292|P2|COMPLETED|Period 2 - 2 Weeks||45
327050|NCT00639379|791293|P1|COMPLETED|Period 2 - 2 Weeks||39
327051|NCT00639379|791292|P2|STARTED|Period 2 - 2 Weeks||45
327052|NCT00639379|791293|P1|STARTED|Period 2 - 2 Weeks||39
327053|NCT00639379|791292|P2|NOT COMPLETED|Period 1 - 2 Weeks||0
327054|NCT00639379|791293|P1|NOT COMPLETED|Period 1 - 2 Weeks||5
327055|NCT00639379|791292|P2|COMPLETED|Period 1 - 2 Weeks||45
327056|NCT00639379|791293|P1|COMPLETED|Period 1 - 2 Weeks||39
327057|NCT00639379|791292|P2|STARTED|Period 1 - 2 Weeks||45
327058|NCT00639379|791293|P1|STARTED|Period 1 - 2 Weeks||44
327059|NCT00639223|791309|P2|NOT COMPLETED|Overall Study||2
327060|NCT00639223|791310|P1|NOT COMPLETED|Overall Study||0
327061|NCT00639223|791309|P2|COMPLETED|Overall Study||19
327062|NCT00639223|791310|P1|COMPLETED|Overall Study||22
327063|NCT00639223|791309|P2|STARTED|Overall Study||21
327064|NCT00639223|791310|P1|STARTED|Overall Study||22
327065|NCT00639158|791320|P2|NOT COMPLETED|Overall Study||30
327066|NCT00639158|791321|P1|NOT COMPLETED|Overall Study||26
327067|NCT00639158|791320|P2|COMPLETED|Overall Study|30 subjects prematurely discontinued treatment|240
327068|NCT00639158|791321|P1|COMPLETED|Overall Study|26 subjects prematurely discontinued treatment.|246
327069|NCT00639158|791320|P2|STARTED|Overall Study|1 subject was randomized but not treated because of an abnormal ECG that precluded treatment.|270
327070|NCT00639158|791321|P1|STARTED|Overall Study|All randomized subjects were treated.|272
327071|NCT00639093|791343|P2|NOT COMPLETED|Overall Study||0
327072|NCT00639093|791344|P1|NOT COMPLETED|Overall Study||0
327073|NCT00639093|791343|P2|COMPLETED|Overall Study|46|46
327074|NCT00639093|791344|P1|COMPLETED|Overall Study|45|45
327075|NCT00639093|791343|P2|STARTED|Overall Study|46|46
327076|NCT00639093|791344|P1|STARTED|Overall Study|45|45
327077|NCT00639002|791350|P1|NOT COMPLETED|Overall Study||13
327078|NCT00639002|791350|P1|COMPLETED|Overall Study||0
327079|NCT00639002|791350|P1|Received Ruxolitinib + Dexamethasone|Overall Study||7
327080|NCT00639002|791350|P1|Received Ruxolitinib|Overall Study||13
327081|NCT00639002|791350|P1|STARTED|Overall Study||13
327082|NCT00638989|791359|P3|NOT COMPLETED|Overall Study||1
327083|NCT00638989|791360|P2|NOT COMPLETED|Overall Study||0
327084|NCT00638989|791361|P1|NOT COMPLETED|Overall Study||0
327085|NCT00638989|791359|P3|COMPLETED|Overall Study||9
327086|NCT00638989|791360|P2|COMPLETED|Overall Study||10
327087|NCT00638989|791361|P1|COMPLETED|Overall Study||10
327088|NCT00638989|791359|P3|STARTED|Overall Study||10
327089|NCT00638989|791360|P2|STARTED|Overall Study||10
327090|NCT00638989|791361|P1|STARTED|Overall Study||10
327091|NCT00638963|791401|P2|NOT COMPLETED|Overall Study||0
327092|NCT00638963|791402|P1|NOT COMPLETED|Overall Study||1
327093|NCT00638963|791401|P2|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|3
327094|NCT00638963|791402|P1|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|2
327095|NCT00638963|791401|P2|STARTED|Overall Study|Received randomized treatment assignment|3
327096|NCT00638963|791402|P1|STARTED|Overall Study|Received randomized treatment assignment|3
327097|NCT00638937|791421|P1|NOT COMPLETED|Overall Study||0
327098|NCT00638937|791421|P1|COMPLETED|Overall Study||37
327099|NCT00638937|791421|P1|STARTED|Overall Study||37
327100|NCT00638924|791432|P1|NOT COMPLETED|Overall Study||0
327101|NCT00638924|791432|P1|COMPLETED|Overall Study||40
327102|NCT00638924|791432|P1|2 Months|Overall Study||40
327103|NCT00638924|791432|P1|STARTED|Overall Study||40
327104|NCT00638885|791437|P1|NOT COMPLETED|Overall Study||0
327105|NCT00638885|791437|P1|COMPLETED|Overall Study||142
327106|NCT00638885|791437|P1|STARTED|Overall Study||142
327107|NCT00638846|791443|P2|NOT COMPLETED|Overall Study||6
327108|NCT00638846|791444|P1|NOT COMPLETED|Overall Study||4
327109|NCT00638846|791443|P2|COMPLETED|Overall Study||133
327110|NCT00638846|791444|P1|COMPLETED|Overall Study||133
327111|NCT00638846|791443|P2|STARTED|Overall Study||139
327112|NCT00638846|791444|P1|STARTED|Overall Study||137
327113|NCT00638820|791460|P1|NOT COMPLETED|Overall Study||0
327114|NCT00638820|791460|P1|COMPLETED|Overall Study||3
327115|NCT00638820|791460|P1|STARTED|Overall Study||3
327116|NCT00638716|791470|P3|NOT COMPLETED|Overall Study||12
327117|NCT00638716|791471|P2|NOT COMPLETED|Overall Study||15
327118|NCT00638716|791472|P1|NOT COMPLETED|Overall Study||7
327119|NCT00638716|791470|P3|COMPLETED|Overall Study||46
327120|NCT00638716|791471|P2|COMPLETED|Overall Study||37
327121|NCT00638716|791472|P1|COMPLETED|Overall Study||43
327122|NCT00638716|791470|P3|STARTED|Overall Study||58
327123|NCT00638716|791471|P2|STARTED|Overall Study||52
327124|NCT00638716|791472|P1|STARTED|Overall Study||50
327125|NCT00638690|791488|P2|NOT COMPLETED|Overall Study||342
327126|NCT00638690|791489|P1|NOT COMPLETED|Overall Study||681
327127|NCT00638690|791488|P2|COMPLETED|Overall Study||56
327128|NCT00638690|791489|P1|COMPLETED|Overall Study||116
327129|NCT00638690|791488|P2|STARTED|Overall Study||398
327130|NCT00638690|791489|P1|STARTED|Overall Study||797
327131|NCT00638651|791502|P1|NOT COMPLETED|Overall Study||0
327132|NCT00638651|791502|P1|COMPLETED|Overall Study||3
327133|NCT00638651|791502|P1|STARTED|Overall Study||3
327134|NCT00638508|791509|P2|NOT COMPLETED|Overall Study||2
327135|NCT00638508|791510|P1|NOT COMPLETED|Overall Study||5
327136|NCT00638508|791509|P2|COMPLETED|Overall Study||30
327137|NCT00638508|791510|P1|COMPLETED|Overall Study||30
327138|NCT00638508|791509|P2|STARTED|Overall Study||32
327139|NCT00638508|791510|P1|STARTED|Overall Study||35
327140|NCT00638456|791556|P2|NOT COMPLETED|Overall Study||2
327141|NCT00638456|791557|P1|NOT COMPLETED|Overall Study||6
327142|NCT00638456|791556|P2|COMPLETED|Overall Study||9
327143|NCT00638456|791557|P1|COMPLETED|Overall Study||15
327144|NCT00638456|791556|P2|STARTED|Overall Study||11
327145|NCT00638456|791557|P1|STARTED|Overall Study||21
327146|NCT00638443|791567|P2|NOT COMPLETED|Second Intervention||0
327147|NCT00638443|791568|P1|NOT COMPLETED|Second Intervention||0
327148|NCT00638443|791567|P2|COMPLETED|Second Intervention||14
327149|NCT00638443|791568|P1|COMPLETED|Second Intervention||12
327150|NCT00638443|791567|P2|STARTED|Second Intervention||14
327151|NCT00638443|791568|P1|STARTED|Second Intervention||12
327152|NCT00638443|791567|P2|NOT COMPLETED|Washout||0
327153|NCT00638443|791568|P1|NOT COMPLETED|Washout||0
327154|NCT00638443|791567|P2|COMPLETED|Washout||14
327155|NCT00638443|791568|P1|COMPLETED|Washout||12
327156|NCT00638443|791567|P2|STARTED|Washout||14
327157|NCT00638443|791568|P1|STARTED|Washout||12
327158|NCT00638443|791567|P2|NOT COMPLETED|First Intervention||1
327159|NCT00638443|791568|P1|NOT COMPLETED|First Intervention||2
327160|NCT00638443|791567|P2|COMPLETED|First Intervention||14
327161|NCT00638443|791568|P1|COMPLETED|First Intervention||12
327162|NCT00638443|791567|P2|STARTED|First Intervention||15
327163|NCT00638443|791568|P1|STARTED|First Intervention||14
327164|NCT00638404|791598|P2|NOT COMPLETED|Overall Study||0
327165|NCT00638404|791599|P1|NOT COMPLETED|Overall Study||8
327166|NCT00638404|791598|P2|COMPLETED|Overall Study||100
327167|NCT00638404|791599|P1|COMPLETED|Overall Study||192
327168|NCT00638404|791598|P2|STARTED|Overall Study||100
327169|NCT00638404|791599|P1|STARTED|Overall Study||200
327170|NCT00638378|791611|P1|NOT COMPLETED|Overall Study||22
327171|NCT00638378|791611|P1|COMPLETED|Overall Study||0
327172|NCT00638378|791611|P1|STARTED|Overall Study||22
327173|NCT00638365|791621|P3|NOT COMPLETED|Overall Study||0
327174|NCT00638365|791622|P2|NOT COMPLETED|Overall Study||0
327175|NCT00638365|791623|P1|NOT COMPLETED|Overall Study||0
327176|NCT00638365|791621|P3|COMPLETED|Overall Study||8
327177|NCT00638365|791622|P2|COMPLETED|Overall Study||10
327178|NCT00638365|791623|P1|COMPLETED|Overall Study||9
327179|NCT00638365|791621|P3|STARTED|Overall Study||8
327180|NCT00638365|791622|P2|STARTED|Overall Study||10
327181|NCT00638365|791623|P1|STARTED|Overall Study||9
327182|NCT00638274|791633|P2|NOT COMPLETED|Overall Study||5
327183|NCT00638274|791634|P1|NOT COMPLETED|Overall Study||6
327184|NCT00638274|791633|P2|COMPLETED|Overall Study||172
327185|NCT00638274|791634|P1|COMPLETED|Overall Study||173
327186|NCT00638274|791633|P2|STARTED|Overall Study||177
327187|NCT00638274|791634|P1|STARTED|Overall Study||179
327188|NCT00638235|791651|P9|NOT COMPLETED|Overall Study||18
327189|NCT00638235|791652|P8|NOT COMPLETED|Overall Study||1
327190|NCT00638235|791653|P7|NOT COMPLETED|Overall Study||0
327191|NCT00638235|791654|P6|NOT COMPLETED|Overall Study||26
327192|NCT00638235|791655|P5|NOT COMPLETED|Overall Study||13
327193|NCT00638235|791656|P4|NOT COMPLETED|Overall Study||10
327194|NCT00638235|791657|P3|NOT COMPLETED|Overall Study||18
327195|NCT00638235|791658|P2|NOT COMPLETED|Overall Study||3
327196|NCT00638235|791659|P1|NOT COMPLETED|Overall Study||31
327197|NCT00638235|791651|P9|COMPLETED|Overall Study||124
327198|NCT00638235|791652|P8|COMPLETED|Overall Study|Ph-VI ended after 12M b/c next generation of Elevate Anterior was already under trial in Phase VII|34
327199|NCT00638235|791653|P7|COMPLETED|Overall Study||23
327200|NCT00638235|791654|P6|COMPLETED|Overall Study||113
327201|NCT00638235|791655|P5|COMPLETED|Overall Study||42
327202|NCT00638235|791656|P4|COMPLETED|Overall Study||46
327203|NCT00638235|791657|P3|COMPLETED|Overall Study|Ph-II ended before all subjects had 24M b/c Perigee next generation was already under trial P-III/IV|63
327204|NCT00638235|791658|P2|COMPLETED|Overall Study||23
327205|NCT00638235|791659|P1|COMPLETED|Overall Study||110
327206|NCT00638235|791651|P9|STARTED|Overall Study||142
327207|NCT00638235|791652|P8|STARTED|Overall Study||35
327208|NCT00638235|791653|P7|STARTED|Overall Study||23
327209|NCT00638235|791654|P6|STARTED|Overall Study||139
327210|NCT00638235|791655|P5|STARTED|Overall Study||55
327211|NCT00638235|791656|P4|STARTED|Overall Study||56
327212|NCT00638235|791657|P3|STARTED|Overall Study||81
327213|NCT00638235|791658|P2|STARTED|Overall Study||26
327214|NCT00638235|791659|P1|STARTED|Overall Study||141
327215|NCT00638222|792060|P3|NOT COMPLETED|Overall Study||0
327216|NCT00638222|792061|P2|NOT COMPLETED|Overall Study||0
327217|NCT00638222|792062|P1|NOT COMPLETED|Overall Study||0
327218|NCT00638222|792060|P3|COMPLETED|Overall Study||6
327219|NCT00638222|792061|P2|COMPLETED|Overall Study||0
327220|NCT00638222|792062|P1|COMPLETED|Overall Study||0
327221|NCT00638222|792060|P3|STARTED|Overall Study||6
327222|NCT00638222|792061|P2|STARTED|Overall Study||0
327223|NCT00638222|792062|P1|STARTED|Overall Study||0
327224|NCT00638183|792069|P1|NOT COMPLETED|Overall Study||119
327225|NCT00638183|792069|P1|COMPLETED|Overall Study||266
327226|NCT00638183|792069|P1|STARTED|Overall Study||385
327227|NCT00638157|792078|P2|NOT COMPLETED|Overall Study||4
327228|NCT00638157|792079|P1|NOT COMPLETED|Overall Study||7
327229|NCT00638157|792078|P2|COMPLETED|Overall Study|4 subjects completed study drug in this arm|8
327230|NCT00638157|792079|P1|COMPLETED|Overall Study|4 subjects completed study drug in this arm|5
327231|NCT00638157|792078|P2|Treated|Overall Study||12
327232|NCT00638157|792079|P1|Treated|Overall Study||10
327233|NCT00638157|792078|P2|STARTED|Overall Study||12
327234|NCT00638157|792079|P1|STARTED|Overall Study||12
327235|NCT00638027|792089|P2|NOT COMPLETED|Overall Study||2
327236|NCT00638027|792090|P1|NOT COMPLETED|Overall Study||0
327237|NCT00638027|792089|P2|COMPLETED|Overall Study|all 10 included in analyses|8
327238|NCT00638027|792090|P1|COMPLETED|Overall Study||11
327239|NCT00638027|792089|P2|STARTED|Overall Study||10
327240|NCT00638027|792090|P1|STARTED|Overall Study||11
327241|NCT00638014|792102|P2|NOT COMPLETED|Overall Study||0
327242|NCT00638014|792103|P1|NOT COMPLETED|Overall Study||0
327243|NCT00638014|792102|P2|COMPLETED|Overall Study||28
327244|NCT00638014|792103|P1|COMPLETED|Overall Study||23
327245|NCT00638014|792102|P2|STARTED|Overall Study||28
327246|NCT00638014|792103|P1|STARTED|Overall Study||23
327247|NCT00637923|792113|P2|NOT COMPLETED|Overall Study||19
327248|NCT00637923|792114|P1|NOT COMPLETED|Overall Study||30
327249|NCT00637923|792113|P2|COMPLETED|Overall Study||18
327250|NCT00637923|792114|P1|COMPLETED|Overall Study||45
327251|NCT00637923|792113|P2|STARTED|Overall Study||37
327252|NCT00637923|792114|P1|STARTED|Overall Study||75
327253|NCT00637806|792137|P4|NOT COMPLETED|Extension Phase||1
327254|NCT00637806|792138|P3|NOT COMPLETED|Extension Phase||0
327255|NCT00637806|792139|P2|NOT COMPLETED|Extension Phase||0
327256|NCT00637806|792140|P1|NOT COMPLETED|Extension Phase||0
327257|NCT00637806|792137|P4|COMPLETED|Extension Phase||0
327258|NCT00637806|792138|P3|COMPLETED|Extension Phase||0
327259|NCT00637806|792139|P2|COMPLETED|Extension Phase||0
327260|NCT00637806|792140|P1|COMPLETED|Extension Phase||0
327261|NCT00637806|792137|P4|STARTED|Extension Phase||1
327262|NCT00637806|792138|P3|STARTED|Extension Phase||0
327263|NCT00637806|792139|P2|STARTED|Extension Phase||0
327264|NCT00637806|792140|P1|STARTED|Extension Phase||0
327265|NCT00637806|792137|P4|NOT COMPLETED|Double-blind Phase||0
327266|NCT00637806|792138|P3|NOT COMPLETED|Double-blind Phase||1
327267|NCT00637806|792139|P2|NOT COMPLETED|Double-blind Phase||0
327268|NCT00637806|792140|P1|NOT COMPLETED|Double-blind Phase||2
327269|NCT00637806|792137|P4|COMPLETED|Double-blind Phase||0
327270|NCT00637806|792138|P3|COMPLETED|Double-blind Phase||1
327271|NCT00637806|792139|P2|COMPLETED|Double-blind Phase||0
327272|NCT00637806|792140|P1|COMPLETED|Double-blind Phase||0
327273|NCT00637806|792137|P4|STARTED|Double-blind Phase||0
327274|NCT00637806|792138|P3|STARTED|Double-blind Phase||2
327275|NCT00637806|792139|P2|STARTED|Double-blind Phase||0
327276|NCT00637806|792140|P1|STARTED|Double-blind Phase||2
327277|NCT00637780|792158|P1|NOT COMPLETED|Overall Study||0
327278|NCT00637780|792158|P1|COMPLETED|Overall Study||2
327279|NCT00637780|792158|P1|STARTED|Overall Study||2
327280|NCT00637728|792175|P3|NOT COMPLETED|Extension Phase||0
327281|NCT00637728|792176|P2|NOT COMPLETED|Extension Phase||0
327282|NCT00637728|792177|P1|NOT COMPLETED|Extension Phase||0
327283|NCT00637728|792175|P3|COMPLETED|Extension Phase||0
327284|NCT00637728|792176|P2|COMPLETED|Extension Phase||0
327285|NCT00637728|792177|P1|COMPLETED|Extension Phase||0
327286|NCT00637728|792175|P3|STARTED|Extension Phase||0
327287|NCT00637728|792176|P2|STARTED|Extension Phase||0
327288|NCT00637728|792177|P1|STARTED|Extension Phase||0
327289|NCT00637728|792175|P3|NOT COMPLETED|Double-blind Phase||0
327290|NCT00637728|792176|P2|NOT COMPLETED|Double-blind Phase||1
327291|NCT00637728|792177|P1|NOT COMPLETED|Double-blind Phase||4
327292|NCT00637728|792175|P3|COMPLETED|Double-blind Phase||0
327293|NCT00637728|792176|P2|COMPLETED|Double-blind Phase||0
327294|NCT00637728|792177|P1|COMPLETED|Double-blind Phase||0
327295|NCT00637728|792175|P3|STARTED|Double-blind Phase||0
327296|NCT00637728|792176|P2|STARTED|Double-blind Phase||1
327297|NCT00637728|792177|P1|STARTED|Double-blind Phase||4
327298|NCT00637572|792192|P2|NOT COMPLETED|Overall Study||7
327299|NCT00637572|792193|P1|NOT COMPLETED|Overall Study||3
327300|NCT00637572|792192|P2|COMPLETED|Overall Study||24
327301|NCT00637572|792193|P1|COMPLETED|Overall Study||29
327302|NCT00637572|792192|P2|STARTED|Overall Study||31
327303|NCT00637572|792193|P1|STARTED|Overall Study||32
327304|NCT00637494|792221|P2|NOT COMPLETED|Overall Study||43
327305|NCT00637494|792222|P1|NOT COMPLETED|Overall Study||32
327306|NCT00637494|792221|P2|COMPLETED|Overall Study||108
327307|NCT00637494|792222|P1|COMPLETED|Overall Study||109
327308|NCT00637494|792221|P2|STARTED|Overall Study||151
327309|NCT00637494|792222|P1|STARTED|Overall Study||141
327310|NCT00637416|792232|P2|NOT COMPLETED|Overall Study||2
327311|NCT00637416|792233|P1|NOT COMPLETED|Overall Study||1
327312|NCT00637416|792232|P2|COMPLETED|Overall Study||3
327313|NCT00637416|792233|P1|COMPLETED|Overall Study||3
327314|NCT00637416|792232|P2|STARTED|Overall Study||5
327315|NCT00637416|792233|P1|STARTED|Overall Study||4
327316|NCT00637377|792243|P4|NOT COMPLETED|Overall Study||29
327317|NCT00637377|792244|P3|NOT COMPLETED|Overall Study||37
327318|NCT00637377|792245|P2|NOT COMPLETED|Overall Study||32
327319|NCT00637377|792246|P1|NOT COMPLETED|Overall Study||27
327320|NCT00637377|792243|P4|COMPLETED|Overall Study||284
327321|NCT00637377|792244|P3|COMPLETED|Overall Study||274
327322|NCT00637377|792245|P2|COMPLETED|Overall Study||281
327323|NCT00637377|792246|P1|COMPLETED|Overall Study||276
327324|NCT00637377|792243|P4|Participants Treated (FAS)|Overall Study||306
327325|NCT00637377|792244|P3|Participants Treated (FAS)|Overall Study||296
327326|NCT00637377|792245|P2|Participants Treated (FAS)|Overall Study||309
327327|NCT00637377|792246|P1|Participants Treated (FAS)|Overall Study||291
327328|NCT00637377|792243|P4|Participants Received Treatment|Overall Study|safety population|307
327329|NCT00637377|792244|P3|Participants Received Treatment|Overall Study|safety population|297
327330|NCT00637377|792245|P2|Participants Received Treatment|Overall Study|safety population|309
327331|NCT00637377|792246|P1|Participants Received Treatment|Overall Study|safety population|291
327332|NCT00637377|792243|P4|STARTED|Overall Study||313
327333|NCT00637377|792244|P3|STARTED|Overall Study||311
327334|NCT00637377|792245|P2|STARTED|Overall Study||313
327335|NCT00637377|792246|P1|STARTED|Overall Study||303
327336|NCT00637312|792274|P2|NOT COMPLETED|Overall Study||17
327337|NCT00637312|792275|P1|NOT COMPLETED|Overall Study||42
327338|NCT00637312|792274|P2|COMPLETED|Overall Study||19
327339|NCT00637312|792275|P1|COMPLETED|Overall Study||30
327340|NCT00637312|792274|P2|STARTED|Overall Study||36
327341|NCT00637312|792275|P1|STARTED|Overall Study||72
327342|NCT00637299|792283|P2|NOT COMPLETED|Overall Study||0
327343|NCT00637299|792284|P1|NOT COMPLETED|Overall Study||0
327344|NCT00637299|792283|P2|COMPLETED|Overall Study||10
327345|NCT00637299|792284|P1|COMPLETED|Overall Study||10
327346|NCT00637299|792283|P2|STARTED|Overall Study||10
327347|NCT00637299|792284|P1|STARTED|Overall Study||10
327348|NCT00637273|792295|P3|NOT COMPLETED|Overall Study||41
327349|NCT00637273|792296|P2|NOT COMPLETED|Overall Study||28
327350|NCT00637273|792297|P1|NOT COMPLETED|Overall Study||43
327351|NCT00637273|792295|P3|COMPLETED|Overall Study||131
327352|NCT00637273|792296|P2|COMPLETED|Overall Study||144
327353|NCT00637273|792297|P1|COMPLETED|Overall Study||127
327354|NCT00637273|792295|P3|Intent to Treat (ITT)|Overall Study||165
327355|NCT00637273|792296|P2|Intent to Treat (ITT)|Overall Study||166
327356|NCT00637273|792297|P1|Intent to Treat (ITT)|Overall Study||160
327357|NCT00637273|792295|P3|STARTED|Overall Study||172
327358|NCT00637273|792296|P2|STARTED|Overall Study||172
327359|NCT00637273|792297|P1|STARTED|Overall Study||170
327360|NCT00637247|792340|P2|NOT COMPLETED|Overall Study||0
327361|NCT00637247|792341|P1|NOT COMPLETED|Overall Study||0
327362|NCT00637247|792340|P2|COMPLETED|Overall Study||70
327363|NCT00637247|792341|P1|COMPLETED|Overall Study||72
327364|NCT00637247|792340|P2|STARTED|Overall Study||70
327365|NCT00637247|792341|P1|STARTED|Overall Study||72
327366|NCT00637195|792355|P2|NOT COMPLETED|Overall Study||1
327367|NCT00637195|792356|P1|NOT COMPLETED|Overall Study||3
327368|NCT00637195|792355|P2|COMPLETED|Overall Study||75
327369|NCT00637195|792356|P1|COMPLETED|Overall Study||73
327370|NCT00637195|792355|P2|STARTED|Overall Study||76
327371|NCT00637195|792356|P1|STARTED|Overall Study||76
327372|NCT00637156|792392|P2|NOT COMPLETED|Overall Study||24
327373|NCT00637156|792393|P1|NOT COMPLETED|Overall Study||10
327374|NCT00637156|792392|P2|COMPLETED|Overall Study||164
327375|NCT00637156|792393|P1|COMPLETED|Overall Study||199
327376|NCT00637156|792392|P2|STARTED|Overall Study||188
327377|NCT00637156|792393|P1|STARTED|Overall Study||209
327378|NCT00637000|792435|P2|NOT COMPLETED|Overall Study||3
327379|NCT00637000|792436|P1|NOT COMPLETED|Overall Study||4
327380|NCT00637000|792435|P2|COMPLETED|Overall Study||15
327381|NCT00637000|792436|P1|COMPLETED|Overall Study||16
327382|NCT00637000|792435|P2|Evaluable|Overall Study||16
327383|NCT00637000|792436|P1|Evaluable|Overall Study||18
327384|NCT00637000|792435|P2|STARTED|Overall Study|Randomized and treated|18
327385|NCT00637000|792436|P1|STARTED|Overall Study|Randomized and treated|20
327386|NCT00636987|792476|P1|NOT COMPLETED|Overall Study||189
327387|NCT00636987|792476|P1|COMPLETED|Overall Study||108
327388|NCT00636987|792476|P1|STARTED|Overall Study||297
327389|NCT00636961|792486|P2|NOT COMPLETED|Period 2||0
327390|NCT00636961|792487|P1|NOT COMPLETED|Period 2||1
327391|NCT00636961|792486|P2|COMPLETED|Period 2||12
327392|NCT00636961|792487|P1|COMPLETED|Period 2||12
327393|NCT00636961|792486|P2|STARTED|Period 2||12
327394|NCT00636961|792487|P1|STARTED|Period 2||13
327395|NCT00636961|792486|P2|NOT COMPLETED|Period 1||1
327396|NCT00636961|792487|P1|NOT COMPLETED|Period 1||1
327397|NCT00636961|792486|P2|COMPLETED|Period 1||12
327398|NCT00636961|792487|P1|COMPLETED|Period 1||13
327399|NCT00636961|792486|P2|STARTED|Period 1||13
327400|NCT00636961|792487|P1|STARTED|Period 1||14
327401|NCT00636818|792501|P1|NOT COMPLETED|Overall Study||11
327402|NCT00636818|792501|P1|COMPLETED|Overall Study||34
327403|NCT00636818|792501|P1|Received at Least One Dose of Study Drug|Overall Study|One patient was lost to follow up and did not receive any study drug.|44
327404|NCT00636818|792501|P1|STARTED|Overall Study||45
327405|NCT00636805|792516|P1|NOT COMPLETED|Overall Study||0
327406|NCT00636805|792516|P1|COMPLETED|Overall Study||63
327407|NCT00636805|792516|P1|STARTED|Overall Study||63
327408|NCT00636792|792526|P1|NOT COMPLETED|Overall Study||33
327409|NCT00636792|792526|P1|COMPLETED|Overall Study||40
327410|NCT00636792|792526|P1|STARTED|Overall Study||73
327411|NCT00636701|792533|P2|NOT COMPLETED|Overall Study||0
327412|NCT00636701|792534|P1|NOT COMPLETED|Overall Study||0
327413|NCT00636701|792533|P2|COMPLETED|Overall Study||2
327414|NCT00636701|792534|P1|COMPLETED|Overall Study||2
327415|NCT00636701|792533|P2|STARTED|Overall Study||2
327416|NCT00636701|792534|P1|STARTED|Overall Study||2
327417|NCT00636675|792542|P2|NOT COMPLETED|Overall Study||41
327418|NCT00636675|792543|P1|NOT COMPLETED|Overall Study||140
327419|NCT00636675|792542|P2|COMPLETED|Overall Study||734
327420|NCT00636675|792543|P1|COMPLETED|Overall Study||811
327421|NCT00636675|792542|P2|STARTED|Overall Study||775
327422|NCT00636675|792543|P1|STARTED|Overall Study||951
327423|NCT00636649|792555|P2|NOT COMPLETED|Overall Study||0
327424|NCT00636649|792556|P1|NOT COMPLETED|Overall Study||0
327425|NCT00636649|792555|P2|COMPLETED|Overall Study||20
327426|NCT00636649|792556|P1|COMPLETED|Overall Study||20
327427|NCT00636649|792555|P2|STARTED|Overall Study||20
327428|NCT00636649|792556|P1|STARTED|Overall Study||20
327429|NCT00636636|792586|P2|NOT COMPLETED|Overall Study||39
327430|NCT00636636|792587|P1|NOT COMPLETED|Overall Study||36
327431|NCT00636636|792586|P2|COMPLETED|Overall Study||192
327432|NCT00636636|792587|P1|COMPLETED|Overall Study||185
327433|NCT00636636|792586|P2|379|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
327434|NCT00636636|792587|P1|379|Overall Study||186
327435|NCT00636636|792586|P2|Safety & Efficacy of Gabapentin ER|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
327436|NCT00636636|792587|P1|Safety & Efficacy of Gabapentin ER|Overall Study||186
327437|NCT00636636|792586|P2|STARTED|Overall Study||231
327438|NCT00636636|792587|P1|STARTED|Overall Study||221
327439|NCT00636610|792603|P2|NOT COMPLETED|Overall Study||83
327440|NCT00636610|792604|P1|NOT COMPLETED|Overall Study||92
327441|NCT00636610|792603|P2|COMPLETED|Overall Study||18
327442|NCT00636610|792604|P1|COMPLETED|Overall Study||6
327443|NCT00636610|792603|P2|STARTED|Overall Study||101
327444|NCT00636610|792604|P1|STARTED|Overall Study||98
327445|NCT00636506|792614|P1|NOT COMPLETED|Overall Study||16
327446|NCT00636506|792614|P1|COMPLETED|Overall Study||60
327447|NCT00636506|792614|P1|STARTED|Overall Study||76
327448|NCT00636441|792661|P7|NOT COMPLETED|Overall Study||18
327449|NCT00636441|792662|P6|NOT COMPLETED|Overall Study||1
327450|NCT00636441|792663|P5|NOT COMPLETED|Overall Study||0
327451|NCT00636441|792664|P4|NOT COMPLETED|Overall Study||0
327452|NCT00636441|792665|P3|NOT COMPLETED|Overall Study||1
327453|NCT00636441|792666|P2|NOT COMPLETED|Overall Study||1
327454|NCT00636441|792667|P1|NOT COMPLETED|Overall Study||0
327455|NCT00636441|792661|P7|COMPLETED|Overall Study||0
327456|NCT00636441|792662|P6|COMPLETED|Overall Study||6
327457|NCT00636441|792663|P5|COMPLETED|Overall Study||6
327458|NCT00636441|792664|P4|COMPLETED|Overall Study||6
327459|NCT00636441|792665|P3|COMPLETED|Overall Study||5
327460|NCT00636441|792666|P2|COMPLETED|Overall Study||6
327461|NCT00636441|792667|P1|COMPLETED|Overall Study||6
327462|NCT00636441|792661|P7|Assigned Treatment|Overall Study|This is a late determined ineligibility.|1
327463|NCT00636441|792662|P6|Assigned Treatment|Overall Study||7
327464|NCT00636441|792663|P5|Assigned Treatment|Overall Study||6
327465|NCT00636441|792664|P4|Assigned Treatment|Overall Study||6
327466|NCT00636441|792665|P3|Assigned Treatment|Overall Study||6
327467|NCT00636441|792666|P2|Assigned Treatment|Overall Study||7
327468|NCT00636441|792667|P1|Assigned Treatment|Overall Study||6
327469|NCT00636441|792661|P7|STARTED|Overall Study||18
327470|NCT00636441|792662|P6|STARTED|Overall Study||7
327471|NCT00636441|792663|P5|STARTED|Overall Study||6
327472|NCT00636441|792664|P4|STARTED|Overall Study||6
327473|NCT00636441|792665|P3|STARTED|Overall Study||6
327474|NCT00636441|792666|P2|STARTED|Overall Study||7
327475|NCT00636441|792667|P1|STARTED|Overall Study||6
327476|NCT00636389|792696|P2|NOT COMPLETED|Period 2 - 1 Week||0
327477|NCT00636389|792697|P1|NOT COMPLETED|Period 2 - 1 Week||0
327478|NCT00636389|792696|P2|COMPLETED|Period 2 - 1 Week||5
327479|NCT00636389|792697|P1|COMPLETED|Period 2 - 1 Week||7
327480|NCT00636389|792696|P2|STARTED|Period 2 - 1 Week||5
327481|NCT00636389|792697|P1|STARTED|Period 2 - 1 Week||7
327482|NCT00636389|792696|P2|NOT COMPLETED|Period 1 - 1 Week||0
327483|NCT00636389|792697|P1|NOT COMPLETED|Period 1 - 1 Week||0
327484|NCT00636389|792696|P2|COMPLETED|Period 1 - 1 Week||5
327485|NCT00636389|792697|P1|COMPLETED|Period 1 - 1 Week||7
327486|NCT00636389|792696|P2|STARTED|Period 1 - 1 Week||5
327487|NCT00636389|792697|P1|STARTED|Period 1 - 1 Week||7
327488|NCT00636363|792710|P3|NOT COMPLETED|Overall Study||18
327489|NCT00636363|792711|P2|NOT COMPLETED|Overall Study||20
327490|NCT00636363|792712|P1|NOT COMPLETED|Overall Study||13
327491|NCT00636363|792710|P3|COMPLETED|Overall Study||163
327492|NCT00636363|792711|P2|COMPLETED|Overall Study||156
327493|NCT00636363|792712|P1|COMPLETED|Overall Study||165
327494|NCT00636363|792710|P3|STARTED|Overall Study||181
327495|NCT00636363|792711|P2|STARTED|Overall Study||176
327496|NCT00636363|792712|P1|STARTED|Overall Study||178
327497|NCT00636220|792726|P1|NOT COMPLETED|Overall Study||0
327498|NCT00636220|792726|P1|COMPLETED|Overall Study||101
327499|NCT00636220|792726|P1|STARTED|Overall Study||101
327500|NCT00636207|792733|P7|NOT COMPLETED|Overall Study||0
327501|NCT00636207|792734|P6|NOT COMPLETED|Overall Study||0
327502|NCT00636207|792735|P5|NOT COMPLETED|Overall Study||1
327503|NCT00636207|792736|P4|NOT COMPLETED|Overall Study||0
327504|NCT00636207|792737|P3|NOT COMPLETED|Overall Study||0
327505|NCT00636207|792738|P2|NOT COMPLETED|Overall Study||1
327506|NCT00636207|792739|P1|NOT COMPLETED|Overall Study||1
327507|NCT00636207|792733|P7|COMPLETED|Overall Study||3
327508|NCT00636207|792734|P6|COMPLETED|Overall Study||1
327509|NCT00636207|792735|P5|COMPLETED|Overall Study||8
327510|NCT00636207|792736|P4|COMPLETED|Overall Study||6
327511|NCT00636207|792737|P3|COMPLETED|Overall Study||18
327512|NCT00636207|792738|P2|COMPLETED|Overall Study||7
327513|NCT00636207|792739|P1|COMPLETED|Overall Study||0
327514|NCT00636207|792733|P7|STARTED|Overall Study||3
327515|NCT00636207|792734|P6|STARTED|Overall Study||1
327516|NCT00636207|792735|P5|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|9
327517|NCT00636207|792736|P4|STARTED|Overall Study||6
327518|NCT00636207|792737|P3|STARTED|Overall Study||18
327519|NCT00636207|792738|P2|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|8
327520|NCT00636207|792739|P1|STARTED|Overall Study|One participant discontinued after completing Period 2. Doses in Periods 1 and 2 were Montelukast.|1
327521|NCT00636194|792803|P2|NOT COMPLETED|Overall Study||0
327522|NCT00636194|792804|P1|NOT COMPLETED|Overall Study||3
327523|NCT00636194|792803|P2|COMPLETED|Overall Study||175
327524|NCT00636194|792804|P1|COMPLETED|Overall Study||172
327525|NCT00636194|792803|P2|STARTED|Overall Study||175
327526|NCT00636194|792804|P1|STARTED|Overall Study||175
327527|NCT00636181|792817|P3|NOT COMPLETED|Overall Study||10
327528|NCT00636181|792818|P2|NOT COMPLETED|Overall Study||6
327529|NCT00636181|792819|P1|NOT COMPLETED|Overall Study||8
327530|NCT00636181|792817|P3|COMPLETED|Overall Study||47
327531|NCT00636181|792818|P2|COMPLETED|Overall Study||47
327532|NCT00636181|792819|P1|COMPLETED|Overall Study||46
327533|NCT00636181|792817|P3|STARTED|Overall Study||57
327534|NCT00636181|792818|P2|STARTED|Overall Study||53
327535|NCT00636181|792819|P1|STARTED|Overall Study||54
327536|NCT00636168|792847|P2|NOT COMPLETED|Treated With Study Drug||411
327537|NCT00636168|792848|P1|NOT COMPLETED|Treated With Study Drug||447
327538|NCT00636168|792847|P2|COMPLETED|Treated With Study Drug||63
327539|NCT00636168|792848|P1|COMPLETED|Treated With Study Drug||24
327540|NCT00636168|792847|P2|STARTED|Treated With Study Drug||474
327541|NCT00636168|792848|P1|STARTED|Treated With Study Drug||471
327542|NCT00636168|792847|P2|NOT COMPLETED|Randomized to Study Drug||2
327543|NCT00636168|792848|P1|NOT COMPLETED|Randomized to Study Drug||4
327544|NCT00636168|792847|P2|COMPLETED|Randomized to Study Drug||474
327545|NCT00636168|792848|P1|COMPLETED|Randomized to Study Drug||471
327546|NCT00636168|792847|P2|STARTED|Randomized to Study Drug||476
327547|NCT00636168|792848|P1|STARTED|Randomized to Study Drug||475
327548|NCT00636155|792868|P1|NOT COMPLETED|Overall Study||18
327549|NCT00636155|792868|P1|COMPLETED|Overall Study|Completed maximum 6 cycles of treatment|2
327550|NCT00636155|792868|P1|STARTED|Overall Study||20
327551|NCT00636077|792874|P4|NOT COMPLETED|Week 4||0
327552|NCT00636077|792875|P3|NOT COMPLETED|Week 4||0
327553|NCT00636077|792876|P2|NOT COMPLETED|Week 4||0
327554|NCT00636077|792877|P1|NOT COMPLETED|Week 4||0
327555|NCT00636077|792874|P4|COMPLETED|Week 4||3
327556|NCT00636077|792875|P3|COMPLETED|Week 4||3
327557|NCT00636077|792876|P2|COMPLETED|Week 4||3
327558|NCT00636077|792877|P1|COMPLETED|Week 4||3
327559|NCT00636077|792874|P4|STARTED|Week 4||3
327560|NCT00636077|792875|P3|STARTED|Week 4||3
327561|NCT00636077|792876|P2|STARTED|Week 4||3
327562|NCT00636077|792877|P1|STARTED|Week 4||3
327563|NCT00636077|792874|P4|NOT COMPLETED|Week 3||0
327564|NCT00636077|792875|P3|NOT COMPLETED|Week 3||0
327565|NCT00636077|792876|P2|NOT COMPLETED|Week 3||0
327566|NCT00636077|792877|P1|NOT COMPLETED|Week 3||0
327567|NCT00636077|792874|P4|COMPLETED|Week 3||3
327568|NCT00636077|792875|P3|COMPLETED|Week 3||3
327569|NCT00636077|792876|P2|COMPLETED|Week 3||3
327570|NCT00636077|792877|P1|COMPLETED|Week 3||3
327571|NCT00636077|792874|P4|STARTED|Week 3||3
327572|NCT00636077|792875|P3|STARTED|Week 3||3
327573|NCT00636077|792876|P2|STARTED|Week 3||3
327574|NCT00636077|792877|P1|STARTED|Week 3||3
327575|NCT00636077|792874|P4|NOT COMPLETED|Week 2||0
327576|NCT00636077|792875|P3|NOT COMPLETED|Week 2||0
327577|NCT00636077|792876|P2|NOT COMPLETED|Week 2||0
327578|NCT00636077|792877|P1|NOT COMPLETED|Week 2||0
327579|NCT00636077|792874|P4|COMPLETED|Week 2||3
327580|NCT00636077|792875|P3|COMPLETED|Week 2||3
327581|NCT00636077|792876|P2|COMPLETED|Week 2||3
327582|NCT00636077|792877|P1|COMPLETED|Week 2||3
327583|NCT00636077|792874|P4|STARTED|Week 2||3
327584|NCT00636077|792875|P3|STARTED|Week 2||3
327585|NCT00636077|792876|P2|STARTED|Week 2||3
327586|NCT00636077|792877|P1|STARTED|Week 2||3
327587|NCT00636077|792874|P4|NOT COMPLETED|Week 1||0
327588|NCT00636077|792875|P3|NOT COMPLETED|Week 1||0
327589|NCT00636077|792876|P2|NOT COMPLETED|Week 1||0
327590|NCT00636077|792877|P1|NOT COMPLETED|Week 1||0
327591|NCT00636077|792874|P4|COMPLETED|Week 1||3
327592|NCT00636077|792875|P3|COMPLETED|Week 1||3
327593|NCT00636077|792876|P2|COMPLETED|Week 1||3
327594|NCT00636077|792877|P1|COMPLETED|Week 1||3
327595|NCT00636077|792874|P4|STARTED|Week 1||3
327596|NCT00636077|792875|P3|STARTED|Week 1||3
327597|NCT00636077|792876|P2|STARTED|Week 1||3
327598|NCT00636077|792877|P1|STARTED|Week 1||3
327599|NCT00635999|792910|P3|NOT COMPLETED|Overall Study||1
327600|NCT00635999|792911|P2|NOT COMPLETED|Overall Study||2
327601|NCT00635999|792912|P1|NOT COMPLETED|Overall Study||4
327602|NCT00635999|792910|P3|COMPLETED|Overall Study||23
327603|NCT00635999|792911|P2|COMPLETED|Overall Study||23
327604|NCT00635999|792912|P1|COMPLETED|Overall Study||23
327605|NCT00635999|792910|P3|STARTED|Overall Study||24
327606|NCT00635999|792911|P2|STARTED|Overall Study||25
327607|NCT00635999|792912|P1|STARTED|Overall Study||27
327608|NCT00635882|792929|P6|NOT COMPLETED|Overall Study||0
327609|NCT00635882|792930|P5|NOT COMPLETED|Overall Study||0
327610|NCT00635882|792931|P4|NOT COMPLETED|Overall Study||0
327611|NCT00635882|792932|P3|NOT COMPLETED|Overall Study||0
327612|NCT00635882|792933|P2|NOT COMPLETED|Overall Study||0
327613|NCT00635882|792934|P1|NOT COMPLETED|Overall Study||1
327614|NCT00635882|792929|P6|COMPLETED|Overall Study||13
327615|NCT00635882|792930|P5|COMPLETED|Overall Study||16
327616|NCT00635882|792931|P4|COMPLETED|Overall Study||15
327617|NCT00635882|792932|P3|COMPLETED|Overall Study||12
327618|NCT00635882|792933|P2|COMPLETED|Overall Study||17
327619|NCT00635882|792934|P1|COMPLETED|Overall Study||19
327620|NCT00635882|792929|P6|STARTED|Overall Study||13
327621|NCT00635882|792930|P5|STARTED|Overall Study||16
327622|NCT00635882|792931|P4|STARTED|Overall Study||15
327623|NCT00635882|792932|P3|STARTED|Overall Study||12
327624|NCT00635882|792933|P2|STARTED|Overall Study||17
327625|NCT00635882|792934|P1|STARTED|Overall Study||20
327626|NCT00635830|792998|P2|NOT COMPLETED|Overall Study||0
327627|NCT00635830|792999|P1|NOT COMPLETED|Overall Study||0
327628|NCT00635830|792998|P2|COMPLETED|Overall Study||20
327629|NCT00635830|792999|P1|COMPLETED|Overall Study||20
327630|NCT00635830|792998|P2|STARTED|Overall Study||20
327631|NCT00635830|792999|P1|STARTED|Overall Study||20
327632|NCT00635817|793009|P4|NOT COMPLETED|Overall Study||0
327633|NCT00635817|793010|P3|NOT COMPLETED|Overall Study||2
327634|NCT00635817|793011|P2|NOT COMPLETED|Overall Study||2
327635|NCT00635817|793012|P1|NOT COMPLETED|Overall Study||6
327636|NCT00635817|793009|P4|COMPLETED|Overall Study||21
327637|NCT00635817|793010|P3|COMPLETED|Overall Study||19
327638|NCT00635817|793011|P2|COMPLETED|Overall Study||19
327639|NCT00635817|793012|P1|COMPLETED|Overall Study||15
327640|NCT00635817|793009|P4|STARTED|Overall Study||21
327641|NCT00635817|793010|P3|STARTED|Overall Study||21
327642|NCT00635817|793011|P2|STARTED|Overall Study||21
327643|NCT00635817|793012|P1|STARTED|Overall Study||21
327644|NCT00635804|793064|P8|NOT COMPLETED|Overall Study||0
327645|NCT00635804|793065|P7|NOT COMPLETED|Overall Study||0
327646|NCT00635804|793066|P6|NOT COMPLETED|Overall Study||1
327647|NCT00635804|793067|P5|NOT COMPLETED|Overall Study||0
327648|NCT00635804|793068|P4|NOT COMPLETED|Overall Study||0
327649|NCT00635804|793069|P3|NOT COMPLETED|Overall Study||0
327650|NCT00635804|793070|P2|NOT COMPLETED|Overall Study||0
327651|NCT00635804|793071|P1|NOT COMPLETED|Overall Study||1
327652|NCT00635804|793064|P8|COMPLETED|Overall Study||14
327653|NCT00635804|793065|P7|COMPLETED|Overall Study||3
327654|NCT00635804|793066|P6|COMPLETED|Overall Study||11
327655|NCT00635804|793067|P5|COMPLETED|Overall Study||6
327656|NCT00635804|793068|P4|COMPLETED|Overall Study||6
327657|NCT00635804|793069|P3|COMPLETED|Overall Study||6
327658|NCT00635804|793070|P2|COMPLETED|Overall Study||6
327659|NCT00635804|793071|P1|COMPLETED|Overall Study||6
327660|NCT00635804|793064|P8|STARTED|Overall Study||14
327661|NCT00635804|793065|P7|STARTED|Overall Study||3
327662|NCT00635804|793066|P6|STARTED|Overall Study||12
327663|NCT00635804|793067|P5|STARTED|Overall Study||6
327664|NCT00635804|793068|P4|STARTED|Overall Study||6
327665|NCT00635804|793069|P3|STARTED|Overall Study||6
327666|NCT00635804|793070|P2|STARTED|Overall Study||6
327667|NCT00635804|793071|P1|STARTED|Overall Study||7
327668|NCT00635778|793175|P7|NOT COMPLETED|Overall Study||6
327669|NCT00635778|793176|P6|NOT COMPLETED|Overall Study||21
327670|NCT00635778|793177|P5|NOT COMPLETED|Overall Study||8
327671|NCT00635778|793178|P4|NOT COMPLETED|Overall Study||8
327672|NCT00635778|793179|P3|NOT COMPLETED|Overall Study||3
327673|NCT00635778|793180|P2|NOT COMPLETED|Overall Study||3
327674|NCT00635778|793181|P1|NOT COMPLETED|Overall Study||1
327675|NCT00635778|793175|P7|COMPLETED|Overall Study||0
327676|NCT00635778|793176|P6|COMPLETED|Overall Study||0
327677|NCT00635778|793177|P5|COMPLETED|Overall Study||0
327678|NCT00635778|793178|P4|COMPLETED|Overall Study||0
327679|NCT00635778|793179|P3|COMPLETED|Overall Study||0
327680|NCT00635778|793180|P2|COMPLETED|Overall Study||0
327681|NCT00635778|793181|P1|COMPLETED|Overall Study||0
327682|NCT00635778|793175|P7|STARTED|Overall Study||6
327683|NCT00635778|793176|P6|STARTED|Overall Study||21
327684|NCT00635778|793177|P5|STARTED|Overall Study||8
327685|NCT00635778|793178|P4|STARTED|Overall Study||8
327686|NCT00635778|793179|P3|STARTED|Overall Study||3
327687|NCT00635778|793180|P2|STARTED|Overall Study||3
327688|NCT00635778|793181|P1|STARTED|Overall Study||1
327689|NCT00635739|793234|P2|NOT COMPLETED|Overall Study||2
327690|NCT00635739|793235|P1|NOT COMPLETED|Overall Study||3
327691|NCT00635739|793234|P2|COMPLETED|Overall Study||36
327692|NCT00635739|793235|P1|COMPLETED|Overall Study||39
327693|NCT00635739|793234|P2|STARTED|Overall Study||38
327694|NCT00635739|793235|P1|STARTED|Overall Study||42
327695|NCT00635700|793245|P2|NOT COMPLETED|Overall Study||14
327696|NCT00635700|793246|P1|NOT COMPLETED|Overall Study||15
327697|NCT00635700|793245|P2|COMPLETED|Overall Study||13
327698|NCT00635700|793246|P1|COMPLETED|Overall Study||9
327699|NCT00635700|793245|P2|STARTED|Overall Study||27
327700|NCT00635700|793246|P1|STARTED|Overall Study||24
327701|NCT00635661|793252|P1|NOT COMPLETED|Overall Study||4
327702|NCT00635661|793252|P1|COMPLETED|Overall Study||30
327703|NCT00635661|793252|P1|STARTED|Overall Study||34
327704|NCT00635648|793256|P1|NOT COMPLETED|Overall Study||37
327705|NCT00635648|793256|P1|COMPLETED|Overall Study||26
327706|NCT00635648|793256|P1|STARTED|Overall Study||63
327707|NCT00635609|793265|P2|NOT COMPLETED|Overall Study||3
327708|NCT00635609|793266|P1|NOT COMPLETED|Overall Study||7
327709|NCT00635609|793265|P2|COMPLETED|Overall Study||42
327710|NCT00635609|793266|P1|COMPLETED|Overall Study||41
327711|NCT00635609|793265|P2|STARTED|Overall Study||45
327712|NCT00635609|793266|P1|STARTED|Overall Study||48
327713|NCT00635570|793278|P2|NOT COMPLETED|Overall Study||11
327714|NCT00635570|793279|P1|NOT COMPLETED|Overall Study||15
327715|NCT00635570|793278|P2|COMPLETED|Overall Study||126
327716|NCT00635570|793279|P1|COMPLETED|Overall Study||121
327717|NCT00635570|793278|P2|STARTED|Overall Study||137
327718|NCT00635570|793279|P1|STARTED|Overall Study||136
327719|NCT00635492|793293|P2|NOT COMPLETED|Overall Study||282
327720|NCT00635492|793294|P1|NOT COMPLETED|Overall Study||279
327721|NCT00635492|793293|P2|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|992
327722|NCT00635492|793294|P1|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|835
327723|NCT00635492|793293|P2|STARTED|Overall Study|This population consists of the analysis population.|1274
327724|NCT00635492|793294|P1|STARTED|Overall Study|This population consists of the analysis population.|1114
327725|NCT00635479|793340|P2|NOT COMPLETED|Overall Study||18
327726|NCT00635479|793341|P1|NOT COMPLETED|Overall Study||6
327727|NCT00635479|793340|P2|COMPLETED|Overall Study||42
327728|NCT00635479|793341|P1|COMPLETED|Overall Study||49
327729|NCT00635479|793340|P2|STARTED|Overall Study||60
327730|NCT00635479|793341|P1|STARTED|Overall Study||55
327731|NCT00635453|793349|P2|NOT COMPLETED|Overall Study||174
327732|NCT00635453|793350|P1|NOT COMPLETED|Overall Study||154
327733|NCT00635453|793349|P2|COMPLETED|Overall Study||181
327734|NCT00635453|793350|P1|COMPLETED|Overall Study||206
327735|NCT00635453|793349|P2|3 Years Assessment|Overall Study||204
327736|NCT00635453|793350|P1|3 Years Assessment|Overall Study||246
327737|NCT00635453|793349|P2|12 Months Assessment|Overall Study||260
327738|NCT00635453|793350|P1|12 Months Assessment|Overall Study||285
327739|NCT00635453|793349|P2|6 Months Assessment|Overall Study||311
327740|NCT00635453|793350|P1|6 Months Assessment|Overall Study||322
327741|NCT00635453|793349|P2|STARTED|Overall Study||355
327742|NCT00635453|793350|P1|STARTED|Overall Study||360
327743|NCT00635427|793367|P5|NOT COMPLETED|Overall Study||8
327744|NCT00635427|793368|P4|NOT COMPLETED|Overall Study||9
327745|NCT00635427|793369|P3|NOT COMPLETED|Overall Study||11
327746|NCT00635427|793370|P2|NOT COMPLETED|Overall Study||6
327747|NCT00635427|793371|P1|NOT COMPLETED|Overall Study||12
327748|NCT00635427|793367|P5|COMPLETED|Overall Study||30
327749|NCT00635427|793368|P4|COMPLETED|Overall Study||7
327750|NCT00635427|793369|P3|COMPLETED|Overall Study||5
327751|NCT00635427|793370|P2|COMPLETED|Overall Study||6
327752|NCT00635427|793371|P1|COMPLETED|Overall Study||1
327753|NCT00635427|793367|P5|STARTED|Overall Study||38
327754|NCT00635427|793368|P4|STARTED|Overall Study||16
327755|NCT00635427|793369|P3|STARTED|Overall Study||16
327756|NCT00635427|793370|P2|STARTED|Overall Study|11 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|12
327757|NCT00635427|793371|P1|STARTED|Overall Study|12 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|13
327758|NCT00635362|793393|P2|NOT COMPLETED|Overall Study||8
327759|NCT00635362|793394|P1|NOT COMPLETED|Overall Study||13
327760|NCT00635362|793393|P2|COMPLETED|Overall Study||12
327761|NCT00635362|793394|P1|COMPLETED|Overall Study||9
327762|NCT00635362|793393|P2|STARTED|Overall Study||20
327763|NCT00635362|793394|P1|STARTED|Overall Study||22
327764|NCT00635349|793410|P2|NOT COMPLETED|Overall Study||48
327765|NCT00635349|793411|P1|NOT COMPLETED|Overall Study||44
327766|NCT00635349|793410|P2|COMPLETED|Overall Study||19
327767|NCT00635349|793411|P1|COMPLETED|Overall Study||29
327768|NCT00635349|793410|P2|STARTED|Overall Study||67
327769|NCT00635349|793411|P1|STARTED|Overall Study||73
327770|NCT00635232|793434|P5|NOT COMPLETED|Overall Study||8
327771|NCT00635232|793435|P4|NOT COMPLETED|Overall Study||10
327772|NCT00635232|793436|P3|NOT COMPLETED|Overall Study||3
327773|NCT00635232|793437|P2|NOT COMPLETED|Overall Study||20
327774|NCT00635232|793438|P1|NOT COMPLETED|Overall Study||14
327775|NCT00635232|793434|P5|COMPLETED|Overall Study||20
327776|NCT00635232|793435|P4|COMPLETED|Overall Study||48
327777|NCT00635232|793436|P3|COMPLETED|Overall Study||55
327778|NCT00635232|793437|P2|COMPLETED|Overall Study||39
327779|NCT00635232|793438|P1|COMPLETED|Overall Study||44
327780|NCT00635232|793434|P5|STARTED|Overall Study||28
327781|NCT00635232|793435|P4|STARTED|Overall Study||58
327782|NCT00635232|793436|P3|STARTED|Overall Study||58
327783|NCT00635232|793437|P2|STARTED|Overall Study||59
327784|NCT00635232|793438|P1|STARTED|Overall Study||58
327785|NCT00635219|793465|P5|NOT COMPLETED|Overall Study||42
327786|NCT00635219|793466|P4|NOT COMPLETED|Overall Study||34
327787|NCT00635219|793467|P3|NOT COMPLETED|Overall Study||35
327788|NCT00635219|793468|P2|NOT COMPLETED|Overall Study||25
327789|NCT00635219|793469|P1|NOT COMPLETED|Overall Study||25
327790|NCT00635219|793465|P5|COMPLETED|Overall Study||113
327791|NCT00635219|793466|P4|COMPLETED|Overall Study||117
327792|NCT00635219|793467|P3|COMPLETED|Overall Study||122
327793|NCT00635219|793468|P2|COMPLETED|Overall Study||130
327794|NCT00635219|793469|P1|COMPLETED|Overall Study||123
327795|NCT00635219|793465|P5|STARTED|Overall Study||155
327796|NCT00635219|793466|P4|STARTED|Overall Study||151
327797|NCT00635219|793467|P3|STARTED|Overall Study||157
327798|NCT00635219|793468|P2|STARTED|Overall Study||155
327799|NCT00635219|793469|P1|STARTED|Overall Study||148
327800|NCT00635167|793526|P1|NOT COMPLETED|Overall Study||0
327801|NCT00635167|793526|P1|COMPLETED|Overall Study||1
327802|NCT00635167|793526|P1|STARTED|Overall Study||1
327803|NCT00635154|793532|P1|NOT COMPLETED|Overall Study||33
327804|NCT00635154|793532|P1|COMPLETED|Overall Study||21
327805|NCT00635154|793532|P1|STARTED|Overall Study||54
327806|NCT00635128|793544|P2|NOT COMPLETED|Overall Study||0
327807|NCT00635128|793545|P1|NOT COMPLETED|Overall Study||0
327808|NCT00635128|793544|P2|COMPLETED|Overall Study||64
327809|NCT00635128|793545|P1|COMPLETED|Overall Study||351
327810|NCT00635128|793544|P2|STARTED|Overall Study||64
327811|NCT00635128|793545|P1|STARTED|Overall Study||351
327812|NCT00635102|793575|P2|NOT COMPLETED|Overall Study||8
327813|NCT00635102|793576|P1|NOT COMPLETED|Overall Study||7
327814|NCT00635102|793575|P2|COMPLETED|Overall Study||22
327815|NCT00635102|793576|P1|COMPLETED|Overall Study||20
327816|NCT00635102|793575|P2|STARTED|Overall Study||30
327817|NCT00635102|793576|P1|STARTED|Overall Study||27
327818|NCT00635089|793670|P1|NOT COMPLETED|Overall Study||78
327819|NCT00635089|793670|P1|COMPLETED|Overall Study|Participants who had not withdrawn at the time of study termination.|112
327820|NCT00635089|793670|P1|Completed >/= 16 Weeks of Study|Overall Study||181
327821|NCT00635089|793670|P1|STARTED|Overall Study||190
327822|NCT00635050|793697|P1|NOT COMPLETED|Overall Study||1
327823|NCT00635050|793697|P1|COMPLETED|Overall Study|Followup through 10 years planned.|31
327824|NCT00635050|793697|P1|STARTED|Overall Study|No patient received regimen B due to grade 3 toxicity in the third patient treated on regimen A.|32
327825|NCT00635024|793704|P1|NOT COMPLETED|Overall Study||1
327826|NCT00635024|793704|P1|COMPLETED|Overall Study||0
327827|NCT00635024|793704|P1|STARTED|Overall Study||1
327828|NCT00634933|793715|P5|NOT COMPLETED|Part B: Week 24 to Week 52||10
327829|NCT00634933|793716|P4|NOT COMPLETED|Part B: Week 24 to Week 52||6
327830|NCT00634933|793717|P3|NOT COMPLETED|Part B: Week 24 to Week 52||22
327831|NCT00634933|793718|P2|NOT COMPLETED|Part B: Week 24 to Week 52||14
327832|NCT00634933|793719|P1|NOT COMPLETED|Part B: Week 24 to Week 52||0
327833|NCT00634933|793715|P5|COMPLETED|Part B: Week 24 to Week 52||22
327834|NCT00634933|793716|P4|COMPLETED|Part B: Week 24 to Week 52||25
327835|NCT00634933|793717|P3|COMPLETED|Part B: Week 24 to Week 52||33
327836|NCT00634933|793718|P2|COMPLETED|Part B: Week 24 to Week 52||42
327837|NCT00634933|793719|P1|COMPLETED|Part B: Week 24 to Week 52||0
327838|NCT00634933|793715|P5|STARTED|Part B: Week 24 to Week 52||32
327839|NCT00634933|793716|P4|STARTED|Part B: Week 24 to Week 52||31
327840|NCT00634933|793717|P3|STARTED|Part B: Week 24 to Week 52||55
327841|NCT00634933|793718|P2|STARTED|Part B: Week 24 to Week 52||56
327842|NCT00634933|793719|P1|STARTED|Part B: Week 24 to Week 52||0
327843|NCT00634933|793715|P5|NOT COMPLETED|Between Part A and Part B||0
327844|NCT00634933|793716|P4|NOT COMPLETED|Between Part A and Part B||0
327845|NCT00634933|793717|P3|NOT COMPLETED|Between Part A and Part B||0
327846|NCT00634933|793718|P2|NOT COMPLETED|Between Part A and Part B||1
327847|NCT00634933|793719|P1|NOT COMPLETED|Between Part A and Part B||0
327848|NCT00634933|793715|P5|COMPLETED|Between Part A and Part B||32
327849|NCT00634933|793716|P4|COMPLETED|Between Part A and Part B||31
327850|NCT00634933|793717|P3|COMPLETED|Between Part A and Part B||55
327851|NCT00634933|793718|P2|COMPLETED|Between Part A and Part B||56
327852|NCT00634933|793719|P1|COMPLETED|Between Part A and Part B||0
327853|NCT00634933|793715|P5|STARTED|Between Part A and Part B||32
327854|NCT00634933|793716|P4|STARTED|Between Part A and Part B||31
327855|NCT00634933|793717|P3|STARTED|Between Part A and Part B||55
327856|NCT00634933|793718|P2|STARTED|Between Part A and Part B||57
327857|NCT00634933|793719|P1|STARTED|Between Part A and Part B||0
327858|NCT00634933|793715|P5|NOT COMPLETED|Part A: Baseline to Week 24||0
327859|NCT00634933|793716|P4|NOT COMPLETED|Part A: Baseline to Week 24||0
327860|NCT00634933|793717|P3|NOT COMPLETED|Part A: Baseline to Week 24||18
327861|NCT00634933|793718|P2|NOT COMPLETED|Part A: Baseline to Week 24||18
327862|NCT00634933|793719|P1|NOT COMPLETED|Part A: Baseline to Week 24||11
327863|NCT00634933|793715|P5|COMPLETED|Part A: Baseline to Week 24||0
327864|NCT00634933|793716|P4|COMPLETED|Part A: Baseline to Week 24||0
327865|NCT00634933|793717|P3|COMPLETED|Part A: Baseline to Week 24||55
327866|NCT00634933|793718|P2|COMPLETED|Part A: Baseline to Week 24||57
327867|NCT00634933|793719|P1|COMPLETED|Part A: Baseline to Week 24||63
327868|NCT00634933|793715|P5|STARTED|Part A: Baseline to Week 24||0
327869|NCT00634933|793716|P4|STARTED|Part A: Baseline to Week 24||0
327870|NCT00634933|793717|P3|STARTED|Part A: Baseline to Week 24||73
327871|NCT00634933|793718|P2|STARTED|Part A: Baseline to Week 24||75
327872|NCT00634933|793719|P1|STARTED|Part A: Baseline to Week 24||74
327873|NCT00634920|793788|P3|NOT COMPLETED|Period 2 - Post-Randomization||0
327874|NCT00634920|793789|P2|NOT COMPLETED|Period 2 - Post-Randomization||32
327875|NCT00634920|793790|P1|NOT COMPLETED|Period 2 - Post-Randomization||61
327876|NCT00634920|793788|P3|COMPLETED|Period 2 - Post-Randomization||0
327877|NCT00634920|793789|P2|COMPLETED|Period 2 - Post-Randomization||68
327878|NCT00634920|793790|P1|COMPLETED|Period 2 - Post-Randomization||43
327879|NCT00634920|793788|P3|Full Analysis Set (FAS)|Period 2 - Post-Randomization||0
327880|NCT00634920|793789|P2|Full Analysis Set (FAS)|Period 2 - Post-Randomization||90
327881|NCT00634920|793790|P1|Full Analysis Set (FAS)|Period 2 - Post-Randomization||92
327882|NCT00634920|793788|P3|STARTED|Period 2 - Post-Randomization|This group included patients who had renal TX but did not qualify for randomization at Visit 2.|0
327883|NCT00634920|793789|P2|STARTED|Period 2 - Post-Randomization||100
327884|NCT00634920|793790|P1|STARTED|Period 2 - Post-Randomization|2 patients randomized in this group did not receive at least one dose of study drug.|104
327885|NCT00634920|793788|P3|NOT COMPLETED|Period 1 - Pre-Randomization||137
327886|NCT00634920|793789|P2|NOT COMPLETED|Period 1 - Pre-Randomization||0
327887|NCT00634920|793790|P1|NOT COMPLETED|Period 1 - Pre-Randomization||0
327888|NCT00634920|793788|P3|COMPLETED|Period 1 - Pre-Randomization|Total number of patients who became randomized|204
327889|NCT00634920|793789|P2|COMPLETED|Period 1 - Pre-Randomization||0
327890|NCT00634920|793790|P1|COMPLETED|Period 1 - Pre-Randomization||0
327891|NCT00634920|793788|P3|STARTED|Period 1 - Pre-Randomization|Total number of Enrolled patients|341
327892|NCT00634920|793789|P2|STARTED|Period 1 - Pre-Randomization||0
327893|NCT00634920|793790|P1|STARTED|Period 1 - Pre-Randomization||0
327894|NCT00634907|793834|P2|NOT COMPLETED|Overall Study||17
327895|NCT00634907|793835|P1|NOT COMPLETED|Overall Study||17
327896|NCT00634907|793834|P2|COMPLETED|Overall Study||115
327897|NCT00634907|793835|P1|COMPLETED|Overall Study||114
327898|NCT00634907|793834|P2|STARTED|Overall Study||132
327899|NCT00634907|793835|P1|STARTED|Overall Study||131
327900|NCT00634842|793859|P2|NOT COMPLETED|Overall Study||18
327901|NCT00634842|793860|P1|NOT COMPLETED|Overall Study||15
327902|NCT00634842|793859|P2|COMPLETED|Overall Study||104
327903|NCT00634842|793860|P1|COMPLETED|Overall Study||107
327904|NCT00634842|793859|P2|STARTED|Overall Study||122
327905|NCT00634842|793860|P1|STARTED|Overall Study||122
327906|NCT00634751|793876|P4|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
327907|NCT00634751|793877|P3|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
327908|NCT00634751|793878|P2|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
327909|NCT00634751|793879|P1|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
327910|NCT00634751|793876|P4|COMPLETED|Pancreatic and Bilial Tract Cancer||7
327911|NCT00634751|793877|P3|COMPLETED|Pancreatic and Bilial Tract Cancer||23
327912|NCT00634751|793878|P2|COMPLETED|Pancreatic and Bilial Tract Cancer||0
327913|NCT00634751|793879|P1|COMPLETED|Pancreatic and Bilial Tract Cancer||0
327914|NCT00634751|793876|P4|STARTED|Pancreatic and Bilial Tract Cancer||8
327915|NCT00634751|793877|P3|STARTED|Pancreatic and Bilial Tract Cancer||24
327916|NCT00634751|793878|P2|STARTED|Pancreatic and Bilial Tract Cancer||0
327917|NCT00634751|793879|P1|STARTED|Pancreatic and Bilial Tract Cancer||0
327918|NCT00634751|793876|P4|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
327919|NCT00634751|793877|P3|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
327920|NCT00634751|793878|P2|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||1
327921|NCT00634751|793879|P1|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
327922|NCT00634751|793876|P4|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
327923|NCT00634751|793877|P3|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
327924|NCT00634751|793878|P2|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||6
327925|NCT00634751|793879|P1|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
327926|NCT00634751|793876|P4|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
327927|NCT00634751|793877|P3|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
327928|NCT00634751|793878|P2|STARTED|Phase I: 400mg Sorafenib BID+2DOC||7
327929|NCT00634751|793879|P1|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
327930|NCT00634751|793876|P4|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
327931|NCT00634751|793877|P3|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
327932|NCT00634751|793878|P2|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
327933|NCT00634751|793879|P1|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||1
327934|NCT00634751|793876|P4|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
327935|NCT00634751|793877|P3|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
327936|NCT00634751|793878|P2|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
327937|NCT00634751|793879|P1|COMPLETED|Phase I: 200mg Sorafenib+2DOC||8
327938|NCT00634751|793876|P4|STARTED|Phase I: 200mg Sorafenib+2DOC||0
327939|NCT00634751|793877|P3|STARTED|Phase I: 200mg Sorafenib+2DOC||0
327940|NCT00634751|793878|P2|STARTED|Phase I: 200mg Sorafenib+2DOC||0
327941|NCT00634751|793879|P1|STARTED|Phase I: 200mg Sorafenib+2DOC||9
327942|NCT00634647|793897|P1|NOT COMPLETED|Overall Study||7
327943|NCT00634647|793897|P1|COMPLETED|Overall Study||17
327944|NCT00634647|793897|P1|STARTED|Overall Study||24
327945|NCT00634621|793903|P1|NOT COMPLETED|Overall Study||0
327946|NCT00634621|793903|P1|COMPLETED|Overall Study||283
327947|NCT00634621|793903|P1|STARTED|Overall Study||283
327948|NCT00634582|793911|P1|NOT COMPLETED|Overall Study||0
327949|NCT00634582|793911|P1|COMPLETED|Overall Study||2
327950|NCT00634582|793911|P1|STARTED|Overall Study||2
327951|NCT00634569|793917|P2|NOT COMPLETED|Overall Study||5
327952|NCT00634569|793918|P1|NOT COMPLETED|Overall Study||0
327953|NCT00634569|793917|P2|COMPLETED|Overall Study||5
327954|NCT00634569|793918|P1|COMPLETED|Overall Study||14
327955|NCT00634569|793917|P2|STARTED|Overall Study||10
327956|NCT00634569|793918|P1|STARTED|Overall Study||14
327957|NCT00634543|793932|P2|NOT COMPLETED|Overall Study||21
327958|NCT00634543|793933|P1|NOT COMPLETED|Overall Study||19
327959|NCT00634543|793932|P2|COMPLETED|Overall Study||63
327960|NCT00634543|793933|P1|COMPLETED|Overall Study||59
327961|NCT00634543|793932|P2|Treated|Overall Study||80
327962|NCT00634543|793933|P1|Treated|Overall Study||76
327963|NCT00634543|793932|P2|STARTED|Overall Study||84
327964|NCT00634543|793933|P1|STARTED|Overall Study||78
327965|NCT00634504|793951|P2|NOT COMPLETED|Overall Study||0
327966|NCT00634504|793952|P1|NOT COMPLETED|Overall Study||1
327967|NCT00634504|793951|P2|COMPLETED|Overall Study||9
327968|NCT00634504|793952|P1|COMPLETED|Overall Study||10
327969|NCT00634504|793951|P2|STARTED|Overall Study||9
327970|NCT00634504|793952|P1|STARTED|Overall Study||11
327971|NCT00634322|793961|P3|NOT COMPLETED|Overall Study||0
327972|NCT00634322|793962|P2|NOT COMPLETED|Overall Study||0
327973|NCT00634322|793963|P1|NOT COMPLETED|Overall Study||0
327974|NCT00634322|793961|P3|COMPLETED|Overall Study||5
327975|NCT00634322|793962|P2|COMPLETED|Overall Study||1
327976|NCT00634322|793963|P1|COMPLETED|Overall Study||1
327977|NCT00634322|793961|P3|STARTED|Overall Study||5
327978|NCT00634322|793962|P2|STARTED|Overall Study||1
327979|NCT00634322|793963|P1|STARTED|Overall Study||1
327980|NCT00634270|793973|P2|NOT COMPLETED|Overall Study||1
327981|NCT00634270|793974|P1|NOT COMPLETED|Overall Study||3
327982|NCT00634270|793973|P2|COMPLETED|Overall Study||12
327983|NCT00634270|793974|P1|COMPLETED|Overall Study||46
327984|NCT00634270|793973|P2|STARTED|Overall Study||13
327985|NCT00634270|793974|P1|STARTED|Overall Study|February 12, 2008|49
327986|NCT00634244|794003|P3|NOT COMPLETED|Overall Study||0
327987|NCT00634244|794004|P2|NOT COMPLETED|Overall Study||13
327988|NCT00634244|794005|P1|NOT COMPLETED|Overall Study||1
327989|NCT00634244|794003|P3|COMPLETED|Overall Study||20
327990|NCT00634244|794004|P2|COMPLETED|Overall Study||24
327991|NCT00634244|794005|P1|COMPLETED|Overall Study||34
327992|NCT00634244|794003|P3|Eligible and Treated|Overall Study||20
327993|NCT00634244|794004|P2|Eligible and Treated|Overall Study||36
327994|NCT00634244|794005|P1|Eligible and Treated|Overall Study||35
327995|NCT00634244|794003|P3|STARTED|Overall Study||20
327996|NCT00634244|794004|P2|STARTED|Overall Study||37
327997|NCT00634244|794005|P1|STARTED|Overall Study||35
327998|NCT00634179|794016|P1|NOT COMPLETED|Phase II: Maintenance||1
327999|NCT00634179|794016|P1|COMPLETED|Phase II: Maintenance||29
328000|NCT00634179|794016|P1|STARTED|Phase II: Maintenance||30
328001|NCT00634179|794016|P1|NOT COMPLETED|Phase I: Induction||0
328002|NCT00634179|794016|P1|COMPLETED|Phase I: Induction||19
328003|NCT00634179|794016|P1|STARTED|Phase I: Induction||19
328004|NCT00634166|794025|P2|NOT COMPLETED|Overall Study||60
328005|NCT00634166|794026|P1|NOT COMPLETED|Overall Study||60
328006|NCT00634166|794025|P2|COMPLETED|Overall Study||78
328007|NCT00634166|794026|P1|COMPLETED|Overall Study||22
328008|NCT00634166|794025|P2|STARTED|Overall Study||138
328009|NCT00634166|794026|P1|STARTED|Overall Study||82
328010|NCT00634114|794035|P3|NOT COMPLETED|Overall Study||39
328011|NCT00634114|794036|P2|NOT COMPLETED|Overall Study||35
328012|NCT00634114|794037|P1|NOT COMPLETED|Overall Study||28
328013|NCT00634114|794035|P3|COMPLETED|Overall Study|Completed|148
328014|NCT00634114|794036|P2|COMPLETED|Overall Study|Completed|154
328015|NCT00634114|794037|P1|COMPLETED|Overall Study|Completed|160
328016|NCT00634114|794035|P3|STARTED|Overall Study|Randomised|187
328017|NCT00634114|794036|P2|STARTED|Overall Study|Randomised|189
328018|NCT00634114|794037|P1|STARTED|Overall Study|Randomised|188
328019|NCT00634088|794055|P4|NOT COMPLETED|Time Period 4: Triplet Combination||0
328020|NCT00634088|794056|P3|NOT COMPLETED|Time Period 4: Triplet Combination||0
328021|NCT00634088|794057|P2|NOT COMPLETED|Time Period 4: Triplet Combination||0
328022|NCT00634088|794058|P1|NOT COMPLETED|Time Period 4: Triplet Combination||0
328023|NCT00634088|794055|P4|COMPLETED|Time Period 4: Triplet Combination||0
328024|NCT00634088|794056|P3|COMPLETED|Time Period 4: Triplet Combination||0
328025|NCT00634088|794057|P2|COMPLETED|Time Period 4: Triplet Combination||0
328026|NCT00634088|794058|P1|COMPLETED|Time Period 4: Triplet Combination||0
328027|NCT00634088|794055|P4|STARTED|Time Period 4: Triplet Combination||0
328028|NCT00634088|794056|P3|STARTED|Time Period 4: Triplet Combination||0
328029|NCT00634088|794057|P2|STARTED|Time Period 4: Triplet Combination||0
328030|NCT00634088|794058|P1|STARTED|Time Period 4: Triplet Combination||0
328031|NCT00634088|794055|P4|NOT COMPLETED|Time Period 3: Dose Level 3||0
328032|NCT00634088|794056|P3|NOT COMPLETED|Time Period 3: Dose Level 3||1
328033|NCT00634088|794057|P2|NOT COMPLETED|Time Period 3: Dose Level 3||0
328034|NCT00634088|794058|P1|NOT COMPLETED|Time Period 3: Dose Level 3||0
328035|NCT00634088|794055|P4|COMPLETED|Time Period 3: Dose Level 3||0
328036|NCT00634088|794056|P3|COMPLETED|Time Period 3: Dose Level 3||0
328037|NCT00634088|794057|P2|COMPLETED|Time Period 3: Dose Level 3||0
328038|NCT00634088|794058|P1|COMPLETED|Time Period 3: Dose Level 3||0
328039|NCT00634088|794055|P4|STARTED|Time Period 3: Dose Level 3||0
328040|NCT00634088|794056|P3|STARTED|Time Period 3: Dose Level 3||1
328041|NCT00634088|794057|P2|STARTED|Time Period 3: Dose Level 3||0
328042|NCT00634088|794058|P1|STARTED|Time Period 3: Dose Level 3||0
328043|NCT00634088|794055|P4|NOT COMPLETED|Time Period 2: Dose Level 2||0
328044|NCT00634088|794056|P3|NOT COMPLETED|Time Period 2: Dose Level 2||0
328045|NCT00634088|794057|P2|NOT COMPLETED|Time Period 2: Dose Level 2||3
328046|NCT00634088|794058|P1|NOT COMPLETED|Time Period 2: Dose Level 2||0
328047|NCT00634088|794055|P4|COMPLETED|Time Period 2: Dose Level 2||0
328048|NCT00634088|794056|P3|COMPLETED|Time Period 2: Dose Level 2||0
328049|NCT00634088|794057|P2|COMPLETED|Time Period 2: Dose Level 2||0
328050|NCT00634088|794058|P1|COMPLETED|Time Period 2: Dose Level 2||0
328051|NCT00634088|794055|P4|STARTED|Time Period 2: Dose Level 2||0
328052|NCT00634088|794056|P3|STARTED|Time Period 2: Dose Level 2||0
328053|NCT00634088|794057|P2|STARTED|Time Period 2: Dose Level 2||3
328054|NCT00634088|794058|P1|STARTED|Time Period 2: Dose Level 2||0
328055|NCT00634088|794055|P4|NOT COMPLETED|Time Period 1: Dose Level 1||0
328056|NCT00634088|794056|P3|NOT COMPLETED|Time Period 1: Dose Level 1||0
328057|NCT00634088|794057|P2|NOT COMPLETED|Time Period 1: Dose Level 1||0
328058|NCT00634088|794058|P1|NOT COMPLETED|Time Period 1: Dose Level 1||6
328059|NCT00634088|794055|P4|COMPLETED|Time Period 1: Dose Level 1||0
328060|NCT00634088|794056|P3|COMPLETED|Time Period 1: Dose Level 1||0
328061|NCT00634088|794057|P2|COMPLETED|Time Period 1: Dose Level 1||0
328062|NCT00634088|794058|P1|COMPLETED|Time Period 1: Dose Level 1||0
328063|NCT00634088|794055|P4|STARTED|Time Period 1: Dose Level 1||0
328064|NCT00634088|794056|P3|STARTED|Time Period 1: Dose Level 1||0
328065|NCT00634088|794057|P2|STARTED|Time Period 1: Dose Level 1||0
328066|NCT00634088|794058|P1|STARTED|Time Period 1: Dose Level 1||6
328067|NCT00634049|794109|P1|NOT COMPLETED|Overall Study||3
328068|NCT00634049|794109|P1|COMPLETED|Overall Study||146
328069|NCT00634049|794109|P1|STARTED|Overall Study||149
328070|NCT00634036|794188|P2|NOT COMPLETED|Overall Study||2
328071|NCT00634036|794189|P1|NOT COMPLETED|Overall Study||2
328072|NCT00634036|794188|P2|COMPLETED|Overall Study||9
328073|NCT00634036|794189|P1|COMPLETED|Overall Study||10
328074|NCT00634036|794188|P2|STARTED|Overall Study||11
328075|NCT00634036|794189|P1|STARTED|Overall Study||12
328076|NCT00634010|794203|P2|NOT COMPLETED|Overall Study||14
328077|NCT00634010|794204|P1|NOT COMPLETED|Overall Study||10
328078|NCT00634010|794203|P2|COMPLETED|Overall Study||4
328079|NCT00634010|794204|P1|COMPLETED|Overall Study||8
328080|NCT00634010|794203|P2|STARTED|Overall Study||18
328081|NCT00634010|794204|P1|STARTED|Overall Study||18
328082|NCT00633984|794212|P2|NOT COMPLETED|Overall Study||13
328083|NCT00633984|794213|P1|NOT COMPLETED|Overall Study||9
328084|NCT00633984|794212|P2|COMPLETED|Overall Study||69
328085|NCT00633984|794213|P1|COMPLETED|Overall Study||78
328086|NCT00633984|794212|P2|STARTED|Overall Study||82
328087|NCT00633984|794213|P1|STARTED|Overall Study||87
328088|NCT00633945|794221|P1|NOT COMPLETED|Overall Study||2
328089|NCT00633945|794221|P1|COMPLETED|Overall Study||3
328090|NCT00633945|794221|P1|STARTED|Overall Study||5
328091|NCT00633932|794237|P3|NOT COMPLETED|Overall Study||11
328092|NCT00633932|794238|P2|NOT COMPLETED|Overall Study||14
328093|NCT00633932|794239|P1|NOT COMPLETED|Overall Study||12
328094|NCT00633932|794237|P3|COMPLETED|Overall Study||180
328095|NCT00633932|794238|P2|COMPLETED|Overall Study||176
328096|NCT00633932|794239|P1|COMPLETED|Overall Study||179
328097|NCT00633932|794237|P3|STARTED|Overall Study|Randomised|191
328098|NCT00633932|794238|P2|STARTED|Overall Study|Randomised|190
328099|NCT00633932|794239|P1|STARTED|Overall Study|Randomised|191
328100|NCT00633919|794252|P2|NOT COMPLETED|Overall Study||22
328101|NCT00633919|794253|P1|NOT COMPLETED|Overall Study||27
328102|NCT00633919|794252|P2|COMPLETED|Overall Study||39
328103|NCT00633919|794253|P1|COMPLETED|Overall Study||36
328104|NCT00633919|794252|P2|STARTED|Overall Study||61
328105|NCT00633919|794253|P1|STARTED|Overall Study||63
328106|NCT00633893|794270|P3|NOT COMPLETED|Overall Study||188
328107|NCT00633893|794271|P2|NOT COMPLETED|Overall Study||129
328108|NCT00633893|794272|P1|NOT COMPLETED|Overall Study||114
328109|NCT00633893|794270|P3|COMPLETED|Overall Study||641
328110|NCT00633893|794271|P2|COMPLETED|Overall Study||684
328111|NCT00633893|794272|P1|COMPLETED|Overall Study||726
328112|NCT00633893|794270|P3|STARTED|Overall Study|3 participants were randomized to placebo but not treated.|829
328113|NCT00633893|794271|P2|STARTED|Overall Study|2 participants were randomized to 5 mg study drug but not treated.|813
328114|NCT00633893|794272|P1|STARTED|Overall Study||840
328115|NCT00633880|794346|P3|NOT COMPLETED|Randomized Double Blind||0
328116|NCT00633880|794347|P2|NOT COMPLETED|Randomized Double Blind||0
328117|NCT00633880|794348|P1|NOT COMPLETED|Randomized Double Blind||0
328118|NCT00633880|794346|P3|COMPLETED|Randomized Double Blind||51
328119|NCT00633880|794347|P2|COMPLETED|Randomized Double Blind||50
328120|NCT00633880|794348|P1|COMPLETED|Randomized Double Blind||0
328121|NCT00633880|794346|P3|STARTED|Randomized Double Blind||51
328122|NCT00633880|794347|P2|STARTED|Randomized Double Blind||50
328123|NCT00633880|794348|P1|STARTED|Randomized Double Blind||0
328124|NCT00633880|794346|P3|NOT COMPLETED|Open Label Titration||0
328125|NCT00633880|794347|P2|NOT COMPLETED|Open Label Titration||0
328126|NCT00633880|794348|P1|NOT COMPLETED|Open Label Titration||80
328127|NCT00633880|794346|P3|COMPLETED|Open Label Titration||0
328128|NCT00633880|794347|P2|COMPLETED|Open Label Titration||0
328129|NCT00633880|794348|P1|COMPLETED|Open Label Titration||101
328130|NCT00633880|794346|P3|STARTED|Open Label Titration||0
328131|NCT00633880|794347|P2|STARTED|Open Label Titration||0
328132|NCT00633880|794348|P1|STARTED|Open Label Titration||181
328133|NCT00633867|794377|P2|NOT COMPLETED|Overall Study||0
328134|NCT00633867|794378|P1|NOT COMPLETED|Overall Study||0
328135|NCT00633867|794377|P2|COMPLETED|Overall Study||60
328136|NCT00633867|794378|P1|COMPLETED|Overall Study||60
328137|NCT00633867|794377|P2|STARTED|Overall Study||60
328138|NCT00633867|794378|P1|STARTED|Overall Study||60
328139|NCT00633750|794384|P1|NOT COMPLETED|Overall Study||5
328140|NCT00633750|794384|P1|COMPLETED|Overall Study||42
328141|NCT00633750|794384|P1|STARTED|Overall Study||47
328142|NCT00633594|794393|P3|NOT COMPLETED|Overall Study||10
328143|NCT00633594|794394|P2|NOT COMPLETED|Overall Study||5
328144|NCT00633594|794395|P1|NOT COMPLETED|Overall Study||0
328145|NCT00633594|794393|P3|COMPLETED|Overall Study||16
328146|NCT00633594|794394|P2|COMPLETED|Overall Study||3
328147|NCT00633594|794395|P1|COMPLETED|Overall Study||5
328148|NCT00633594|794393|P3|STARTED|Overall Study||26
328149|NCT00633594|794394|P2|STARTED|Overall Study||8
328150|NCT00633594|794395|P1|STARTED|Overall Study||5
328151|NCT00633477|794424|P2|NOT COMPLETED|Overall Study||0
328152|NCT00633477|794425|P1|NOT COMPLETED|Overall Study||2
328153|NCT00633477|794424|P2|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|11
328154|NCT00633477|794425|P1|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|5
328155|NCT00633477|794424|P2|Completed Study Through Day 28|Overall Study||8
328156|NCT00633477|794425|P1|Completed Study Through Day 28|Overall Study||4
328157|NCT00633477|794424|P2|Prematurely Discontinued Study Drug|Overall Study||0
328158|NCT00633477|794425|P1|Prematurely Discontinued Study Drug|Overall Study||1
328159|NCT00633477|794424|P2|Randomized But Not Treated|Overall Study||0
328160|NCT00633477|794425|P1|Randomized But Not Treated|Overall Study||1
328161|NCT00633477|794424|P2|STARTED|Overall Study||11
328162|NCT00633477|794425|P1|STARTED|Overall Study|Seven subjects were randomized, however, one was not treated.|7
328163|NCT00633464|794441|P2|NOT COMPLETED|Overall Study||2
328164|NCT00633464|794442|P1|NOT COMPLETED|Overall Study||0
328165|NCT00633464|794441|P2|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-25,study drug toxicity-4,subject request-3|37
328166|NCT00633464|794442|P1|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-27,study drug toxicity-7,max clinical benefit-3|40
328167|NCT00633464|794441|P2|Treated|Overall Study||37
328168|NCT00633464|794442|P1|Treated|Overall Study||40
328169|NCT00633464|794441|P2|STARTED|Overall Study||39
328170|NCT00633464|794442|P1|STARTED|Overall Study||40
328171|NCT00633399|794464|P2|NOT COMPLETED|Overall Study||15
328172|NCT00633399|794465|P1|NOT COMPLETED|Overall Study||22
328173|NCT00633399|794464|P2|COMPLETED|Overall Study||53
328174|NCT00633399|794465|P1|COMPLETED|Overall Study||49
328175|NCT00633399|794464|P2|STARTED|Overall Study||68
328176|NCT00633399|794465|P1|STARTED|Overall Study||71
328177|NCT00633360|794477|P2|NOT COMPLETED|Overall Study||3
328178|NCT00633360|794478|P1|NOT COMPLETED|Overall Study||4
328179|NCT00633360|794477|P2|COMPLETED|Overall Study||13
328180|NCT00633360|794478|P1|COMPLETED|Overall Study||12
328181|NCT00633360|794477|P2|STARTED|Overall Study||16
328182|NCT00633360|794478|P1|STARTED|Overall Study||16
328183|NCT00633256|794488|P2|NOT COMPLETED|Overall Study||3
328184|NCT00633256|794489|P1|NOT COMPLETED|Overall Study||4
328185|NCT00633256|794488|P2|COMPLETED|Overall Study||10
328186|NCT00633256|794489|P1|COMPLETED|Overall Study||8
328187|NCT00633256|794488|P2|STARTED|Overall Study||13
328188|NCT00633256|794489|P1|STARTED|Overall Study||12
328189|NCT00633243|794501|P2|NOT COMPLETED|Overall Study||7
328190|NCT00633243|794502|P1|NOT COMPLETED|Overall Study||1
328191|NCT00633243|794501|P2|COMPLETED|Overall Study||2
328192|NCT00633243|794502|P1|COMPLETED|Overall Study||11
328193|NCT00633243|794501|P2|STARTED|Overall Study||9
328194|NCT00633243|794502|P1|STARTED|Overall Study||12
328195|NCT00633217|794510|P2|NOT COMPLETED|Overall Study||23
328196|NCT00633217|794511|P1|NOT COMPLETED|Overall Study||15
328197|NCT00633217|794510|P2|COMPLETED|Overall Study||103
328198|NCT00633217|794511|P1|COMPLETED|Overall Study||106
328199|NCT00633217|794510|P2|STARTED|Overall Study||126
328200|NCT00633217|794511|P1|STARTED|Overall Study||121
328201|NCT00633152|794523|P2|NOT COMPLETED|Overall Study||6
328202|NCT00633152|794524|P1|NOT COMPLETED|Overall Study||14
328203|NCT00633152|794523|P2|COMPLETED|Overall Study||41
328204|NCT00633152|794524|P1|COMPLETED|Overall Study||89
328205|NCT00633152|794523|P2|Clinically Evaluable Population|Overall Study||39
328206|NCT00633152|794524|P1|Clinically Evaluable Population|Overall Study||86
328207|NCT00633152|794523|P2|MITT and Safety Population|Overall Study||45
328208|NCT00633152|794524|P1|MITT and Safety Population|Overall Study||98
328209|NCT00633152|794523|P2|STARTED|Overall Study||47
328210|NCT00633152|794524|P1|STARTED|Overall Study||103
328211|NCT00633139|794535|P3|NOT COMPLETED|Overall Study||1
328212|NCT00633139|794536|P2|NOT COMPLETED|Overall Study||1
328213|NCT00633139|794537|P1|NOT COMPLETED|Overall Study||0
328214|NCT00633139|794535|P3|COMPLETED|Overall Study||3
328215|NCT00633139|794536|P2|COMPLETED|Overall Study||4
328216|NCT00633139|794537|P1|COMPLETED|Overall Study||4
328217|NCT00633139|794535|P3|STARTED|Overall Study||4
328218|NCT00633139|794536|P2|STARTED|Overall Study||5
328219|NCT00633139|794537|P1|STARTED|Overall Study||4
328220|NCT00633126|794551|P1|NOT COMPLETED|Overall Study||1
328221|NCT00633126|794551|P1|COMPLETED|Overall Study||8
328222|NCT00633126|794551|P1|STARTED|Overall Study||9
328223|NCT00633087|794556|P1|NOT COMPLETED|Overall Study||0
328224|NCT00633087|794556|P1|COMPLETED|Overall Study||12
328225|NCT00633087|794556|P1|STARTED|Overall Study||12
328226|NCT00633074|794565|P2|NOT COMPLETED|Overall Study||0
328227|NCT00633074|794566|P1|NOT COMPLETED|Overall Study||1
328228|NCT00633074|794565|P2|COMPLETED|Overall Study||360
328229|NCT00633074|794566|P1|COMPLETED|Overall Study||359
328230|NCT00633074|794565|P2|STARTED|Overall Study||360
328231|NCT00633074|794566|P1|STARTED|Overall Study||360
328232|NCT00633061|794596|P2|NOT COMPLETED|Overall Study||0
328233|NCT00633061|794597|P1|NOT COMPLETED|Overall Study||86
328234|NCT00633061|794596|P2|COMPLETED|Overall Study||0
328235|NCT00633061|794597|P1|COMPLETED|Overall Study||50
328236|NCT00633061|794596|P2|Had Prior Thrombosis Identified|Overall Study||0
328237|NCT00633061|794597|P1|Had Prior Thrombosis Identified|Overall Study||25
328238|NCT00633061|794596|P2|Met Criteria for Imaging|Overall Study||0
328239|NCT00633061|794597|P1|Met Criteria for Imaging|Overall Study||25
328240|NCT00633061|794596|P2|STARTED|Overall Study||0
328241|NCT00633061|794597|P1|STARTED|Overall Study|Study was on hold for 2 months for continuing review|136
328242|NCT00633022|794608|P3|NOT COMPLETED|Overall Study||5
328243|NCT00633022|794609|P2|NOT COMPLETED|Overall Study||1
328244|NCT00633022|794610|P1|NOT COMPLETED|Overall Study||1
328245|NCT00633022|794608|P3|COMPLETED|Overall Study||27
328246|NCT00633022|794609|P2|COMPLETED|Overall Study||32
328247|NCT00633022|794610|P1|COMPLETED|Overall Study||33
328248|NCT00633022|794608|P3|STARTED|Overall Study||32
328249|NCT00633022|794609|P2|STARTED|Overall Study||33
328250|NCT00633022|794610|P1|STARTED|Overall Study||34
328251|NCT00633009|794648|P3|NOT COMPLETED|Overall Study||1
328252|NCT00633009|794649|P2|NOT COMPLETED|Overall Study||4
328253|NCT00633009|794650|P1|NOT COMPLETED|Overall Study||4
328254|NCT00633009|794648|P3|COMPLETED|Overall Study||10
328255|NCT00633009|794649|P2|COMPLETED|Overall Study||23
328256|NCT00633009|794650|P1|COMPLETED|Overall Study||8
328257|NCT00633009|794648|P3|STARTED|Overall Study||11
328258|NCT00633009|794649|P2|STARTED|Overall Study||27
328259|NCT00633009|794650|P1|STARTED|Overall Study||12
328260|NCT00632970|794663|P2|NOT COMPLETED|Overall Study||0
328261|NCT00632970|794664|P1|NOT COMPLETED|Overall Study||0
328262|NCT00632970|794663|P2|COMPLETED|Overall Study||3
328263|NCT00632970|794664|P1|COMPLETED|Overall Study||3
328264|NCT00632970|794663|P2|STARTED|Overall Study||3
328265|NCT00632970|794664|P1|STARTED|Overall Study||3
328266|NCT00632931|794672|P3|NOT COMPLETED|Part 2||24
328267|NCT00632931|794673|P2|NOT COMPLETED|Part 2||0
328268|NCT00632931|794674|P1|NOT COMPLETED|Part 2||0
328269|NCT00632931|794672|P3|COMPLETED|Part 2||0
328270|NCT00632931|794673|P2|COMPLETED|Part 2||0
328271|NCT00632931|794674|P1|COMPLETED|Part 2||0
328272|NCT00632931|794672|P3|STARTED|Part 2||24
328273|NCT00632931|794673|P2|STARTED|Part 2||0
328274|NCT00632931|794674|P1|STARTED|Part 2||0
328275|NCT00632931|794672|P3|NOT COMPLETED|Post-Part 1 Washout||0
328276|NCT00632931|794673|P2|NOT COMPLETED|Post-Part 1 Washout||0
328277|NCT00632931|794674|P1|NOT COMPLETED|Post-Part 1 Washout||0
328278|NCT00632931|794672|P3|COMPLETED|Post-Part 1 Washout||0
328279|NCT00632931|794673|P2|COMPLETED|Post-Part 1 Washout||12
328280|NCT00632931|794674|P1|COMPLETED|Post-Part 1 Washout||12
328281|NCT00632931|794672|P3|STARTED|Post-Part 1 Washout||0
328282|NCT00632931|794673|P2|STARTED|Post-Part 1 Washout||12
328283|NCT00632931|794674|P1|STARTED|Post-Part 1 Washout|1 patient who did not complete Period 1 was subsequently enrolled into Post Part 1|12
328284|NCT00632931|794672|P3|NOT COMPLETED|Part 1, Period 2||0
328285|NCT00632931|794673|P2|NOT COMPLETED|Part 1, Period 2||0
328286|NCT00632931|794674|P1|NOT COMPLETED|Part 1, Period 2||0
328287|NCT00632931|794672|P3|COMPLETED|Part 1, Period 2||0
328288|NCT00632931|794673|P2|COMPLETED|Part 1, Period 2||12
328289|NCT00632931|794674|P1|COMPLETED|Part 1, Period 2||11
328290|NCT00632931|794672|P3|STARTED|Part 1, Period 2||0
328291|NCT00632931|794673|P2|STARTED|Part 1, Period 2||12
328292|NCT00632931|794674|P1|STARTED|Part 1, Period 2||11
328293|NCT00632931|794672|P3|NOT COMPLETED|Part 1, Washout||0
328294|NCT00632931|794673|P2|NOT COMPLETED|Part 1, Washout||0
328295|NCT00632931|794674|P1|NOT COMPLETED|Part 1, Washout||0
328296|NCT00632931|794672|P3|COMPLETED|Part 1, Washout||0
328297|NCT00632931|794673|P2|COMPLETED|Part 1, Washout||12
328298|NCT00632931|794674|P1|COMPLETED|Part 1, Washout||11
328299|NCT00632931|794672|P3|STARTED|Part 1, Washout||0
328300|NCT00632931|794673|P2|STARTED|Part 1, Washout||12
328301|NCT00632931|794674|P1|STARTED|Part 1, Washout||11
328302|NCT00632931|794672|P3|NOT COMPLETED|Part 1, Period 1||0
328303|NCT00632931|794673|P2|NOT COMPLETED|Part 1, Period 1||0
328304|NCT00632931|794674|P1|NOT COMPLETED|Part 1, Period 1||2
328305|NCT00632931|794672|P3|COMPLETED|Part 1, Period 1||0
328306|NCT00632931|794673|P2|COMPLETED|Part 1, Period 1||12
328307|NCT00632931|794674|P1|COMPLETED|Part 1, Period 1||11
328308|NCT00632931|794672|P3|STARTED|Part 1, Period 1||0
328309|NCT00632931|794673|P2|STARTED|Part 1, Period 1||12
328310|NCT00632931|794674|P1|STARTED|Part 1, Period 1||13
328311|NCT00632814|794696|P3|NOT COMPLETED|Overall Study||0
328312|NCT00632814|794697|P2|NOT COMPLETED|Overall Study||0
328313|NCT00632814|794698|P1|NOT COMPLETED|Overall Study||0
328314|NCT00632814|794696|P3|COMPLETED|Overall Study||8
328315|NCT00632814|794697|P2|COMPLETED|Overall Study||13
328316|NCT00632814|794698|P1|COMPLETED|Overall Study||11
328317|NCT00632814|794696|P3|STARTED|Overall Study||8
328318|NCT00632814|794697|P2|STARTED|Overall Study||13
328319|NCT00632814|794698|P1|STARTED|Overall Study||11
328320|NCT00632749|794744|P14|NOT COMPLETED|Overall Study||6
328321|NCT00632749|794745|P13|NOT COMPLETED|Overall Study||3
328322|NCT00632749|794746|P12|NOT COMPLETED|Overall Study||4
328323|NCT00632749|794747|P11|NOT COMPLETED|Overall Study||7
328324|NCT00632749|794748|P10|NOT COMPLETED|Overall Study||3
328325|NCT00632749|794749|P9|NOT COMPLETED|Overall Study||5
328326|NCT00632749|794750|P8|NOT COMPLETED|Overall Study||4
328327|NCT00632749|794751|P7|NOT COMPLETED|Overall Study||5
328328|NCT00632749|794752|P6|NOT COMPLETED|Overall Study||8
328329|NCT00632749|794753|P5|NOT COMPLETED|Overall Study||7
328330|NCT00632749|794754|P4|NOT COMPLETED|Overall Study||4
328331|NCT00632749|794755|P3|NOT COMPLETED|Overall Study||3
328332|NCT00632749|794756|P2|NOT COMPLETED|Overall Study||5
328333|NCT00632749|794757|P1|NOT COMPLETED|Overall Study||4
328334|NCT00632749|794744|P14|COMPLETED|Overall Study||0
328335|NCT00632749|794745|P13|COMPLETED|Overall Study||0
328336|NCT00632749|794746|P12|COMPLETED|Overall Study||0
328337|NCT00632749|794747|P11|COMPLETED|Overall Study||0
328338|NCT00632749|794748|P10|COMPLETED|Overall Study||0
328339|NCT00632749|794749|P9|COMPLETED|Overall Study||0
328340|NCT00632749|794750|P8|COMPLETED|Overall Study||0
328341|NCT00632749|794751|P7|COMPLETED|Overall Study||0
328342|NCT00632749|794752|P6|COMPLETED|Overall Study||0
328343|NCT00632749|794753|P5|COMPLETED|Overall Study||0
328344|NCT00632749|794754|P4|COMPLETED|Overall Study||0
328345|NCT00632749|794755|P3|COMPLETED|Overall Study||0
328346|NCT00632749|794756|P2|COMPLETED|Overall Study||0
328347|NCT00632749|794757|P1|COMPLETED|Overall Study||0
328348|NCT00632749|794744|P14|Not Treated|Overall Study||0
328349|NCT00632749|794745|P13|Not Treated|Overall Study||0
328350|NCT00632749|794746|P12|Not Treated|Overall Study||0
328351|NCT00632749|794747|P11|Not Treated|Overall Study||0
328352|NCT00632749|794748|P10|Not Treated|Overall Study||0
328353|NCT00632749|794749|P9|Not Treated|Overall Study||0
328354|NCT00632749|794750|P8|Not Treated|Overall Study||0
328355|NCT00632749|794751|P7|Not Treated|Overall Study||1
328356|NCT00632749|794752|P6|Not Treated|Overall Study||1
328357|NCT00632749|794753|P5|Not Treated|Overall Study||0
328358|NCT00632749|794754|P4|Not Treated|Overall Study||0
328359|NCT00632749|794755|P3|Not Treated|Overall Study||0
328360|NCT00632749|794756|P2|Not Treated|Overall Study||2
328361|NCT00632749|794757|P1|Not Treated|Overall Study||0
328362|NCT00632749|794744|P14|Treated|Overall Study||6
328363|NCT00632749|794745|P13|Treated|Overall Study||3
328364|NCT00632749|794746|P12|Treated|Overall Study||4
328365|NCT00632749|794747|P11|Treated|Overall Study||7
328366|NCT00632749|794748|P10|Treated|Overall Study||3
328367|NCT00632749|794749|P9|Treated|Overall Study||5
328368|NCT00632749|794750|P8|Treated|Overall Study||4
328369|NCT00632749|794751|P7|Treated|Overall Study||4
328370|NCT00632749|794752|P6|Treated|Overall Study||7
328371|NCT00632749|794753|P5|Treated|Overall Study||7
328372|NCT00632749|794754|P4|Treated|Overall Study||4
328373|NCT00632749|794755|P3|Treated|Overall Study||3
328374|NCT00632749|794756|P2|Treated|Overall Study||3
328375|NCT00632749|794757|P1|Treated|Overall Study||4
328376|NCT00632749|794744|P14|STARTED|Overall Study||6
328377|NCT00632749|794745|P13|STARTED|Overall Study||3
328378|NCT00632749|794746|P12|STARTED|Overall Study||4
328379|NCT00632749|794747|P11|STARTED|Overall Study||7
328380|NCT00632749|794748|P10|STARTED|Overall Study||3
328381|NCT00632749|794749|P9|STARTED|Overall Study||5
328382|NCT00632749|794750|P8|STARTED|Overall Study||4
328383|NCT00632749|794751|P7|STARTED|Overall Study||5
328384|NCT00632749|794752|P6|STARTED|Overall Study||8
328385|NCT00632749|794753|P5|STARTED|Overall Study||7
328386|NCT00632749|794754|P4|STARTED|Overall Study||4
328387|NCT00632749|794755|P3|STARTED|Overall Study||3
328388|NCT00632749|794756|P2|STARTED|Overall Study||5
328389|NCT00632749|794757|P1|STARTED|Overall Study||4
328390|NCT00632736|795051|P1|NOT COMPLETED|Overall Study||268
328391|NCT00632736|795051|P1|COMPLETED|Overall Study||151
328392|NCT00632736|795051|P1|STARTED|Overall Study||419
328393|NCT00632632|795058|P2|NOT COMPLETED|Overall Study||3
328394|NCT00632632|795059|P1|NOT COMPLETED|Overall Study||0
328395|NCT00632632|795058|P2|COMPLETED|Overall Study||9
328396|NCT00632632|795059|P1|COMPLETED|Overall Study||13
328397|NCT00632632|795058|P2|STARTED|Overall Study||12
328398|NCT00632632|795059|P1|STARTED|Overall Study||13
328399|NCT00632619|795071|P2|NOT COMPLETED|Overall Study||4
328400|NCT00632619|795072|P1|NOT COMPLETED|Overall Study||8
328401|NCT00632619|795071|P2|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10~nd cohort completed follow up 7/18/11"|31
328402|NCT00632619|795072|P1|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10~nd cohort completed follow up 7/18/11"|25
328403|NCT00632619|795071|P2|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|35
328404|NCT00632619|795072|P1|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|33
328405|NCT00632541|795086|P1|NOT COMPLETED|Overall Study||7
328406|NCT00632541|795086|P1|COMPLETED|Overall Study||11
328407|NCT00632541|795086|P1|STARTED|Overall Study|18 subjects were accrued to the study|18
328408|NCT00632502|795095|P2|NOT COMPLETED|Overall Study||1
328409|NCT00632502|795096|P1|NOT COMPLETED|Overall Study||3
328410|NCT00632502|795095|P2|COMPLETED|Overall Study||11
328411|NCT00632502|795096|P1|COMPLETED|Overall Study||22
328412|NCT00632502|795095|P2|Completed Treatment|Overall Study||9
328413|NCT00632502|795096|P1|Completed Treatment|Overall Study||19
328414|NCT00632502|795095|P2|Treated|Overall Study||12
328415|NCT00632502|795096|P1|Treated|Overall Study||22
328416|NCT00632502|795095|P2|STARTED|Overall Study||12
328417|NCT00632502|795096|P1|STARTED|Overall Study||25
328418|NCT00632489|795124|P3|NOT COMPLETED|Overall Study||0
328419|NCT00632489|795125|P2|NOT COMPLETED|Overall Study||5
328420|NCT00632489|795126|P1|NOT COMPLETED|Overall Study||15
328421|NCT00632489|795124|P3|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
328422|NCT00632489|795125|P2|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
328423|NCT00632489|795126|P1|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
328424|NCT00632489|795124|P3|STARTED|Overall Study||0
328425|NCT00632489|795125|P2|STARTED|Overall Study||5
328426|NCT00632489|795126|P1|STARTED|Overall Study||15
328427|NCT00632463|795140|P3|NOT COMPLETED|Overall Study||0
328428|NCT00632463|795141|P2|NOT COMPLETED|Overall Study||1
328429|NCT00632463|795142|P1|NOT COMPLETED|Overall Study||0
328430|NCT00632463|795140|P3|COMPLETED|Overall Study||7
328431|NCT00632463|795141|P2|COMPLETED|Overall Study||6
328432|NCT00632463|795142|P1|COMPLETED|Overall Study||7
328433|NCT00632463|795140|P3|STARTED|Overall Study||7
328434|NCT00632463|795141|P2|STARTED|Overall Study||7
328435|NCT00632463|795142|P1|STARTED|Overall Study||7
328436|NCT00632424|795159|P1|NOT COMPLETED|Overall Study||18
328437|NCT00632424|795159|P1|COMPLETED|Overall Study||0
328438|NCT00632424|795159|P1|STARTED|Overall Study||18
328439|NCT00632411|795183|P2|NOT COMPLETED|Overall Study||176
328440|NCT00632411|795184|P1|NOT COMPLETED|Overall Study||160
328441|NCT00632411|795183|P2|COMPLETED|Overall Study||473
328442|NCT00632411|795184|P1|COMPLETED|Overall Study||489
328443|NCT00632411|795183|P2|STARTED|Overall Study||649
328444|NCT00632411|795184|P1|STARTED|Overall Study||649
328445|NCT00632281|795190|P1|NOT COMPLETED|Overall Study||0
328446|NCT00632281|795190|P1|COMPLETED|Overall Study||38
328447|NCT00632281|795190|P1|STARTED|Overall Study||38
328448|NCT00632229|795197|P2|NOT COMPLETED|Overall Study||6
328449|NCT00632229|795198|P1|NOT COMPLETED|Overall Study||6
328450|NCT00632229|795197|P2|COMPLETED|Overall Study||11
328451|NCT00632229|795198|P1|COMPLETED|Overall Study||11
328452|NCT00632229|795197|P2|STARTED|Overall Study||17
328453|NCT00632229|795198|P1|STARTED|Overall Study||17
328454|NCT00632203|795208|P2|NOT COMPLETED|Overall Study||0
328455|NCT00632203|795209|P1|NOT COMPLETED|Overall Study||1
328456|NCT00632203|795208|P2|COMPLETED|Overall Study||27
328457|NCT00632203|795209|P1|COMPLETED|Overall Study||25
328458|NCT00632203|795208|P2|STARTED|Overall Study||27
328459|NCT00632203|795209|P1|STARTED|Overall Study||26
328460|NCT00632125|795227|P1|NOT COMPLETED|Overall Study||302
328461|NCT00632125|795227|P1|COMPLETED|Overall Study||1393
328462|NCT00632125|795227|P1|STARTED|Overall Study|1,698 patients were enrolled but 3 patients did not receive any study medication.|1695
328463|NCT00632099|795233|P2|NOT COMPLETED|Overall Study||3
328464|NCT00632099|795234|P1|NOT COMPLETED|Overall Study||3
328465|NCT00632099|795233|P2|COMPLETED|Overall Study||8
328466|NCT00632099|795234|P1|COMPLETED|Overall Study||7
328467|NCT00632099|795233|P2|STARTED|Overall Study||11
328468|NCT00632099|795234|P1|STARTED|Overall Study||10
328469|NCT00632021|795242|P2|NOT COMPLETED|Overall Study||7
328470|NCT00632021|795243|P1|NOT COMPLETED|Overall Study||4
328471|NCT00632021|795242|P2|COMPLETED|Overall Study||423
328472|NCT00632021|795243|P1|COMPLETED|Overall Study||428
328473|NCT00632021|795242|P2|STARTED|Overall Study||430
328474|NCT00632021|795243|P1|STARTED|Overall Study||432
328475|NCT00631969|795253|P2|NOT COMPLETED|Overall Study||21
328476|NCT00631969|795254|P1|NOT COMPLETED|Overall Study||15
328477|NCT00631969|795253|P2|COMPLETED|Overall Study||155
328478|NCT00631969|795254|P1|COMPLETED|Overall Study||171
328479|NCT00631969|795253|P2|Received Treatment|Overall Study|safety population|174
328480|NCT00631969|795254|P1|Received Treatment|Overall Study|safety population|184
328481|NCT00631969|795253|P2|STARTED|Overall Study||176
328482|NCT00631969|795254|P1|STARTED|Overall Study||186
328483|NCT00631917|795300|P2|NOT COMPLETED|Overall Study||108
328484|NCT00631917|795301|P1|NOT COMPLETED|Overall Study||88
328485|NCT00631917|795300|P2|COMPLETED|Overall Study||291
328486|NCT00631917|795301|P1|COMPLETED|Overall Study||287
328487|NCT00631917|795300|P2|STARTED|Overall Study||399
328488|NCT00631917|795301|P1|STARTED|Overall Study||375
328489|NCT00631748|795317|P2|NOT COMPLETED|Overall Study||22
328490|NCT00631748|795318|P1|NOT COMPLETED|Overall Study||18
328491|NCT00631748|795317|P2|COMPLETED|Overall Study|9 participants completed the double-blind portion of the study; 5 participants completed follow-up.|9
328492|NCT00631748|795318|P1|COMPLETED|Overall Study|11 participants completed the double-blind portion of the study; 8 participants completed follow-up.|11
328493|NCT00631748|795317|P2|STARTED|Overall Study||31
328494|NCT00631748|795318|P1|STARTED|Overall Study||29
328495|NCT00631696|795328|P2|NOT COMPLETED|Overall Study||40
328496|NCT00631696|795329|P1|NOT COMPLETED|Overall Study||37
328497|NCT00631696|795328|P2|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|70
328498|NCT00631696|795329|P1|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|75
328499|NCT00631696|795328|P2|Ongoing at Database Release 18Oct2011|Overall Study||0
328500|NCT00631696|795329|P1|Ongoing at Database Release 18Oct2011|Overall Study|Completed Tx at time of database release 18Oct2011; included in all analyses.|2
328501|NCT00631696|795328|P2|Received Study Treatment (Tx)|Overall Study||109
328502|NCT00631696|795329|P1|Received Study Treatment (Tx)|Overall Study||111
328503|NCT00631696|795328|P2|STARTED|Overall Study||110
328504|NCT00631696|795329|P1|STARTED|Overall Study||112
328505|NCT00631670|795355|P2|NOT COMPLETED|Overall Study||0
328506|NCT00631670|795356|P1|NOT COMPLETED|Overall Study||0
328507|NCT00631670|795355|P2|COMPLETED|Overall Study||0
328508|NCT00631670|795356|P1|COMPLETED|Overall Study||21
328509|NCT00631670|795355|P2|STARTED|Overall Study||0
328510|NCT00631670|795356|P1|STARTED|Overall Study||21
328511|NCT00631657|795372|P3|NOT COMPLETED|7-Day Discontinuation Period||1
328512|NCT00631657|795373|P2|NOT COMPLETED|7-Day Discontinuation Period||1
328513|NCT00631657|795374|P1|NOT COMPLETED|7-Day Discontinuation Period||2
328514|NCT00631657|795372|P3|COMPLETED|7-Day Discontinuation Period||65
328515|NCT00631657|795373|P2|COMPLETED|7-Day Discontinuation Period||136
328516|NCT00631657|795374|P1|COMPLETED|7-Day Discontinuation Period||65
328517|NCT00631657|795372|P3|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|65
328518|NCT00631657|795373|P2|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|136
328519|NCT00631657|795374|P1|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|66
328520|NCT00631657|795372|P3|STARTED|7-Day Discontinuation Period||66
328521|NCT00631657|795373|P2|STARTED|7-Day Discontinuation Period||137
328522|NCT00631657|795374|P1|STARTED|7-Day Discontinuation Period|One participant was radomized in the Discont. Period, without completing the Treatment Period.|67
328523|NCT00631657|795372|P3|NOT COMPLETED|6-Month Treatment Period||50
328524|NCT00631657|795373|P2|NOT COMPLETED|6-Month Treatment Period||0
328525|NCT00631657|795374|P1|NOT COMPLETED|6-Month Treatment Period||141
328526|NCT00631657|795372|P3|COMPLETED|6-Month Treatment Period||66
328527|NCT00631657|795373|P2|COMPLETED|6-Month Treatment Period||0
328528|NCT00631657|795374|P1|COMPLETED|6-Month Treatment Period||203
328529|NCT00631657|795372|P3|Treated|6-Month Treatment Period|One randomized participant was not treated during the 6-month Treatment Period.|115
328530|NCT00631657|795373|P2|Treated|6-Month Treatment Period||0
328531|NCT00631657|795374|P1|Treated|6-Month Treatment Period|Two randomized participants were not treated during the 6-month Treatment Period.|342
328532|NCT00631657|795372|P3|STARTED|6-Month Treatment Period||116
328533|NCT00631657|795373|P2|STARTED|6-Month Treatment Period||0
328534|NCT00631657|795374|P1|STARTED|6-Month Treatment Period||344
328535|NCT00631566|795404|P3|NOT COMPLETED|Overall Study||0
328536|NCT00631566|795405|P2|NOT COMPLETED|Overall Study||4
328537|NCT00631566|795406|P1|NOT COMPLETED|Overall Study||2
328538|NCT00631566|795404|P3|COMPLETED|Overall Study||501
328539|NCT00631566|795405|P2|COMPLETED|Overall Study||24
328540|NCT00631566|795406|P1|COMPLETED|Overall Study||19
328541|NCT00631566|795404|P3|STARTED|Overall Study||501
328542|NCT00631566|795405|P2|STARTED|Overall Study||28
328543|NCT00631566|795406|P1|STARTED|Overall Study||21
328544|NCT00631540|795423|P1|NOT COMPLETED|Overall Study||14
328545|NCT00631540|795423|P1|COMPLETED|Overall Study||86
328546|NCT00631540|795423|P1|STARTED|Overall Study||100
328547|NCT00631488|795435|P3|NOT COMPLETED|Overall Study||2
328548|NCT00631488|795436|P2|NOT COMPLETED|Overall Study||2
328549|NCT00631488|795437|P1|NOT COMPLETED|Overall Study||4
328550|NCT00631488|795435|P3|COMPLETED|Overall Study||47
328551|NCT00631488|795436|P2|COMPLETED|Overall Study||47
328552|NCT00631488|795437|P1|COMPLETED|Overall Study||44
328553|NCT00631488|795435|P3|Completed Post-Treatment Period|Overall Study||47
328554|NCT00631488|795436|P2|Completed Post-Treatment Period|Overall Study||47
328555|NCT00631488|795437|P1|Completed Post-Treatment Period|Overall Study||44
328556|NCT00631488|795435|P3|STARTED|Overall Study||49
328557|NCT00631488|795436|P2|STARTED|Overall Study||49
328558|NCT00631488|795437|P1|STARTED|Overall Study||48
328559|NCT00631475|795457|P1|NOT COMPLETED|Overall Study||45
328560|NCT00631475|795457|P1|COMPLETED|Overall Study||83
328561|NCT00631475|795457|P1|STARTED|Overall Study||128
328562|NCT00631449|795467|P2|NOT COMPLETED|Overall Study||0
328563|NCT00631449|795468|P1|NOT COMPLETED|Overall Study||0
328564|NCT00631449|795467|P2|COMPLETED|Overall Study||15
328565|NCT00631449|795468|P1|COMPLETED|Overall Study||15
328566|NCT00631449|795467|P2|STARTED|Overall Study||15
328567|NCT00631449|795468|P1|STARTED|Overall Study||15
328568|NCT00631410|795476|P2|NOT COMPLETED|Overall Study||6
328569|NCT00631410|795477|P1|NOT COMPLETED|Overall Study||6
328570|NCT00631410|795476|P2|COMPLETED|Overall Study||0
328571|NCT00631410|795477|P1|COMPLETED|Overall Study||0
328572|NCT00631410|795476|P2|STARTED|Overall Study||6
328573|NCT00631410|795477|P1|STARTED|Overall Study||6
328574|NCT00631371|795496|P2|NOT COMPLETED|Overall Study||391
328575|NCT00631371|795497|P1|NOT COMPLETED|Overall Study||400
328576|NCT00631371|795496|P2|COMPLETED|Overall Study||0
328577|NCT00631371|795497|P1|COMPLETED|Overall Study||0
328578|NCT00631371|795496|P2|Treated|Overall Study||391
328579|NCT00631371|795497|P1|Treated|Overall Study||393
328580|NCT00631371|795496|P2|STARTED|Overall Study||391
328581|NCT00631371|795497|P1|STARTED|Overall Study||400
328582|NCT00631358|795511|P2|NOT COMPLETED|Overall Study||2
328583|NCT00631358|795512|P1|NOT COMPLETED|Overall Study||6
328584|NCT00631358|795511|P2|COMPLETED|Overall Study||45
328585|NCT00631358|795512|P1|COMPLETED|Overall Study||44
328586|NCT00631358|795511|P2|STARTED|Overall Study||47
328587|NCT00631358|795512|P1|STARTED|Overall Study||50
328588|NCT00631189|795530|P4|NOT COMPLETED|Treatment Phase||7
328589|NCT00631189|795531|P3|NOT COMPLETED|Treatment Phase||11
328590|NCT00631189|795532|P2|NOT COMPLETED|Treatment Phase||7
328591|NCT00631189|795533|P1|NOT COMPLETED|Treatment Phase||0
328592|NCT00631189|795530|P4|COMPLETED|Treatment Phase||103
328593|NCT00631189|795531|P3|COMPLETED|Treatment Phase||92
328594|NCT00631189|795532|P2|COMPLETED|Treatment Phase||97
328595|NCT00631189|795533|P1|COMPLETED|Treatment Phase||0
328596|NCT00631189|795530|P4|STARTED|Treatment Phase||110
328597|NCT00631189|795531|P3|STARTED|Treatment Phase||103
328598|NCT00631189|795532|P2|STARTED|Treatment Phase||104
328599|NCT00631189|795533|P1|STARTED|Treatment Phase||0
328600|NCT00631189|795530|P4|NOT COMPLETED|Initial Phase||0
328601|NCT00631189|795531|P3|NOT COMPLETED|Initial Phase||0
328602|NCT00631189|795532|P2|NOT COMPLETED|Initial Phase||0
328603|NCT00631189|795533|P1|NOT COMPLETED|Initial Phase||351
328604|NCT00631189|795530|P4|COMPLETED|Initial Phase||0
328605|NCT00631189|795531|P3|COMPLETED|Initial Phase||0
328606|NCT00631189|795532|P2|COMPLETED|Initial Phase||0
328607|NCT00631189|795533|P1|COMPLETED|Initial Phase||317
328608|NCT00631189|795530|P4|STARTED|Initial Phase||0
328609|NCT00631189|795531|P3|STARTED|Initial Phase||0
328610|NCT00631189|795532|P2|STARTED|Initial Phase||0
328611|NCT00631189|795533|P1|STARTED|Initial Phase||668
328612|NCT00631137|795577|P2|NOT COMPLETED|Overall Study||0
328613|NCT00631137|795578|P1|NOT COMPLETED|Overall Study||1
328614|NCT00631137|795577|P2|COMPLETED|Overall Study||0
328615|NCT00631137|795578|P1|COMPLETED|Overall Study||0
328616|NCT00631137|795577|P2|STARTED|Overall Study||0
328617|NCT00631137|795578|P1|STARTED|Overall Study||1
328618|NCT00631020|795596|P1|NOT COMPLETED|Overall Study||8
328619|NCT00631020|795596|P1|COMPLETED|Overall Study||26
328620|NCT00631020|795596|P1|STARTED|Overall Study||34
328621|NCT00631007|795611|P6|NOT COMPLETED|Overall Study||15
328622|NCT00631007|795612|P5|NOT COMPLETED|Overall Study||12
328623|NCT00631007|795613|P4|NOT COMPLETED|Overall Study||9
328624|NCT00631007|795614|P3|NOT COMPLETED|Overall Study||10
328625|NCT00631007|795615|P2|NOT COMPLETED|Overall Study||11
328626|NCT00631007|795616|P1|NOT COMPLETED|Overall Study||11
328627|NCT00631007|795611|P6|COMPLETED|Overall Study||46
328628|NCT00631007|795612|P5|COMPLETED|Overall Study||48
328629|NCT00631007|795613|P4|COMPLETED|Overall Study||53
328630|NCT00631007|795614|P3|COMPLETED|Overall Study||53
328631|NCT00631007|795615|P2|COMPLETED|Overall Study||50
328632|NCT00631007|795616|P1|COMPLETED|Overall Study||49
328633|NCT00631007|795611|P6|STARTED|Overall Study||61
328634|NCT00631007|795612|P5|STARTED|Overall Study||60
328635|NCT00631007|795613|P4|STARTED|Overall Study||62
328636|NCT00631007|795614|P3|STARTED|Overall Study||63
328637|NCT00631007|795615|P2|STARTED|Overall Study||61
328638|NCT00631007|795616|P1|STARTED|Overall Study||60
328639|NCT00630994|795636|P1|NOT COMPLETED|Overall Study||4
328640|NCT00630994|795636|P1|COMPLETED|Overall Study||0
328641|NCT00630994|795636|P1|STARTED|Overall Study||4
328642|NCT00630955|795647|P3|NOT COMPLETED|Overall Study||12
328643|NCT00630955|795648|P2|NOT COMPLETED|Overall Study||6
328644|NCT00630955|795649|P1|NOT COMPLETED|Overall Study||3
328645|NCT00630955|795647|P3|COMPLETED|Overall Study||28
328646|NCT00630955|795648|P2|COMPLETED|Overall Study||31
328647|NCT00630955|795649|P1|COMPLETED|Overall Study||31
328648|NCT00630955|795647|P3|STARTED|Overall Study||40
328649|NCT00630955|795648|P2|STARTED|Overall Study||37
328650|NCT00630955|795649|P1|STARTED|Overall Study||34
328651|NCT00630916|795666|P1|NOT COMPLETED|Overall Study||210
328652|NCT00630916|795666|P1|COMPLETED|Overall Study|The number of patients that were active (i.e. not drop out) at the end of the study.|546
328653|NCT00630916|795666|P1|Study Cohort|Overall Study|Enrolled but did not receive device via physician decision, protocol violation, or lack of efficacy.|699
328654|NCT00630916|795666|P1|STARTED|Overall Study|Total patients enrolled (i.e. consented) to participate in the study.|756
328655|NCT00630877|795676|P3|NOT COMPLETED|Overall Study||10
328656|NCT00630877|795677|P2|NOT COMPLETED|Overall Study||15
328657|NCT00630877|795678|P1|NOT COMPLETED|Overall Study||19
328658|NCT00630877|795676|P3|COMPLETED|Overall Study||80
328659|NCT00630877|795677|P2|COMPLETED|Overall Study||75
328660|NCT00630877|795678|P1|COMPLETED|Overall Study||72
328661|NCT00630877|795676|P3|STARTED|Overall Study||90
328662|NCT00630877|795677|P2|STARTED|Overall Study||90
328663|NCT00630877|795678|P1|STARTED|Overall Study|For all arms, started means treated.|91
328664|NCT00630864|795696|P1|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||2
328665|NCT00630864|795696|P1|COMPLETED|Part 2 (After Week 6 up to Month 12)||18
328666|NCT00630864|795696|P1|STARTED|Part 2 (After Week 6 up to Month 12)||20
328667|NCT00630864|795696|P1|NOT COMPLETED|Part 1 (up to Week 6)||1
328668|NCT00630864|795696|P1|COMPLETED|Part 1 (up to Week 6)||20
328669|NCT00630864|795696|P1|STARTED|Part 1 (up to Week 6)||21
328670|NCT00630838|795735|P2|NOT COMPLETED|Overall Study||2
328671|NCT00630838|795736|P1|NOT COMPLETED|Overall Study||0
328672|NCT00630838|795735|P2|COMPLETED|Overall Study||28
328673|NCT00630838|795736|P1|COMPLETED|Overall Study||32
328674|NCT00630838|795735|P2|STARTED|Overall Study||30
328675|NCT00630838|795736|P1|STARTED|Overall Study||32
328676|NCT00630825|795748|P4|NOT COMPLETED|Overall Study||6
328677|NCT00630825|795749|P3|NOT COMPLETED|Overall Study||8
328678|NCT00630825|795750|P2|NOT COMPLETED|Overall Study||7
328679|NCT00630825|795751|P1|NOT COMPLETED|Overall Study||9
328680|NCT00630825|795748|P4|COMPLETED|Overall Study||60
328681|NCT00630825|795749|P3|COMPLETED|Overall Study||58
328682|NCT00630825|795750|P2|COMPLETED|Overall Study||58
328683|NCT00630825|795751|P1|COMPLETED|Overall Study||56
328684|NCT00630825|795748|P4|Received at Least One Dose of Study Drug|Overall Study||66
328685|NCT00630825|795749|P3|Received at Least One Dose of Study Drug|Overall Study||66
328686|NCT00630825|795750|P2|Received at Least One Dose of Study Drug|Overall Study||65
328687|NCT00630825|795751|P1|Received at Least One Dose of Study Drug|Overall Study||65
328688|NCT00630825|795748|P4|STARTED|Overall Study||66
328689|NCT00630825|795749|P3|STARTED|Overall Study||66
328690|NCT00630825|795750|P2|STARTED|Overall Study||65
328691|NCT00630825|795751|P1|STARTED|Overall Study||65
328692|NCT00630786|795823|P3|NOT COMPLETED|Overall Study||2
328693|NCT00630786|795824|P2|NOT COMPLETED|Overall Study||2
328694|NCT00630786|795825|P1|NOT COMPLETED|Overall Study||1
328695|NCT00630786|795823|P3|COMPLETED|Overall Study|Completed study defined as participant death|7
328696|NCT00630786|795824|P2|COMPLETED|Overall Study|Completed study defined as participant death|23
328697|NCT00630786|795825|P1|COMPLETED|Overall Study|Completed study defined as participant death|18
328698|NCT00630786|795823|P3|Received Study Medication|Overall Study||8
328699|NCT00630786|795824|P2|Received Study Medication|Overall Study||25
328700|NCT00630786|795825|P1|Received Study Medication|Overall Study||19
328701|NCT00630786|795823|P3|STARTED|Overall Study|All patients were enrolled in Part 2.|9
328702|NCT00630786|795824|P2|STARTED|Overall Study|Includes 3 patients enrolled in Part 1 and 22 patients enrolled in Part 2.|25
328703|NCT00630786|795825|P1|STARTED|Overall Study|Includes 2 patients enrolled in Part 1 and 17 patients enrolled in Part 2.|19
328704|NCT00630747|795844|P1|NOT COMPLETED|Overall Study||9
328705|NCT00630747|795844|P1|COMPLETED|Overall Study||85
328706|NCT00630747|795844|P1|Participants Treated in Phase I of Study|Overall Study||94
328707|NCT00630747|795844|P1|STARTED|Overall Study||94
328708|NCT00630734|795856|P3|NOT COMPLETED|Overall Study||1
328709|NCT00630734|795857|P2|NOT COMPLETED|Overall Study||1
328710|NCT00630734|795858|P1|NOT COMPLETED|Overall Study||2
328711|NCT00630734|795856|P3|COMPLETED|Overall Study||7
328712|NCT00630734|795857|P2|COMPLETED|Overall Study||12
328713|NCT00630734|795858|P1|COMPLETED|Overall Study||9
328714|NCT00630734|795856|P3|STARTED|Overall Study||8
328715|NCT00630734|795857|P2|STARTED|Overall Study||13
328716|NCT00630734|795858|P1|STARTED|Overall Study||11
328717|NCT00630539|795897|P4|NOT COMPLETED|Overall Study||3
328718|NCT00630539|795898|P3|NOT COMPLETED|Overall Study||1
328719|NCT00630539|795899|P2|NOT COMPLETED|Overall Study||4
328720|NCT00630539|795900|P1|NOT COMPLETED|Overall Study||1
328721|NCT00630539|795897|P4|COMPLETED|Overall Study||27
328722|NCT00630539|795898|P3|COMPLETED|Overall Study||28
328723|NCT00630539|795899|P2|COMPLETED|Overall Study||29
328724|NCT00630539|795900|P1|COMPLETED|Overall Study||33
328725|NCT00630539|795897|P4|STARTED|Overall Study||30
328726|NCT00630539|795898|P3|STARTED|Overall Study||29
328727|NCT00630539|795899|P2|STARTED|Overall Study||33
328728|NCT00630539|795900|P1|STARTED|Overall Study||34
328729|NCT00630487|795956|P2|NOT COMPLETED|Overall Study||0
328730|NCT00630487|795957|P1|NOT COMPLETED|Overall Study||0
328731|NCT00630487|795956|P2|COMPLETED|Overall Study||0
328732|NCT00630487|795957|P1|COMPLETED|Overall Study||0
328733|NCT00630487|795956|P2|STARTED|Overall Study||0
328734|NCT00630487|795957|P1|STARTED|Overall Study||0
328735|NCT00630409|795991|P1|NOT COMPLETED|Overall Study||1
328736|NCT00630409|795991|P1|COMPLETED|Overall Study||4
328737|NCT00630409|795991|P1|STARTED|Overall Study||5
328738|NCT00630396|795996|P1|NOT COMPLETED|Overall Study||7
328739|NCT00630396|795996|P1|COMPLETED|Overall Study||53
328740|NCT00630396|795996|P1|STARTED|Overall Study||60
328741|NCT00630344|796002|P1|NOT COMPLETED|Overall Study||36
328742|NCT00630344|796002|P1|COMPLETED|Overall Study||0
328743|NCT00630344|796002|P1|STARTED|Overall Study||36
328744|NCT00630331|796014|P3|NOT COMPLETED|Overall Study||188
328745|NCT00630331|796015|P2|NOT COMPLETED|Overall Study||166
328746|NCT00630331|796016|P1|NOT COMPLETED|Overall Study||206
328747|NCT00630331|796014|P3|COMPLETED|Overall Study||3712
328748|NCT00630331|796015|P2|COMPLETED|Overall Study||3510
328749|NCT00630331|796016|P1|COMPLETED|Overall Study||3622
328750|NCT00630331|796014|P3|STARTED|Overall Study||3900
328751|NCT00630331|796015|P2|STARTED|Overall Study||3676
328752|NCT00630331|796016|P1|STARTED|Overall Study||3828
328753|NCT00630305|796057|P1|NOT COMPLETED|Overall Study||2
328754|NCT00630305|796057|P1|COMPLETED|Overall Study||35
328755|NCT00630305|796057|P1|STARTED|Overall Study||37
328756|NCT00630292|796079|P1|NOT COMPLETED|Overall Study||1
328757|NCT00630292|796079|P1|COMPLETED|Overall Study||5
328758|NCT00630292|796079|P1|STARTED|Overall Study||6
328759|NCT00630058|796085|P2|NOT COMPLETED|Overall Study||4
328760|NCT00630058|796086|P1|NOT COMPLETED|Overall Study||4
328761|NCT00630058|796085|P2|COMPLETED|Overall Study||6
328762|NCT00630058|796086|P1|COMPLETED|Overall Study||6
328763|NCT00630058|796085|P2|STARTED|Overall Study||10
328764|NCT00630058|796086|P1|STARTED|Overall Study||10
328765|NCT00629850|796104|P2|NOT COMPLETED|Overall Study||0
328766|NCT00629850|796105|P1|NOT COMPLETED|Overall Study||0
328767|NCT00629850|796104|P2|COMPLETED|Overall Study||0
328768|NCT00629850|796105|P1|COMPLETED|Overall Study||1
328769|NCT00629850|796104|P2|STARTED|Overall Study||0
328770|NCT00629850|796105|P1|STARTED|Overall Study||1
328771|NCT00629772|796117|P2|NOT COMPLETED|Second Intervention Week 14 - Week 26||2
328772|NCT00629772|796118|P1|NOT COMPLETED|Second Intervention Week 14 - Week 26||1
328773|NCT00629772|796117|P2|COMPLETED|Second Intervention Week 14 - Week 26||10
328774|NCT00629772|796118|P1|COMPLETED|Second Intervention Week 14 - Week 26||11
328775|NCT00629772|796117|P2|STARTED|Second Intervention Week 14 - Week 26||12
328776|NCT00629772|796118|P1|STARTED|Second Intervention Week 14 - Week 26|Patient withdrew at Week 14 and therefore never received infliximab.|12
328777|NCT00629772|796117|P2|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
328778|NCT00629772|796118|P1|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
328779|NCT00629772|796117|P2|COMPLETED|First Intervention - Day 0 - Week 14||12
328780|NCT00629772|796118|P1|COMPLETED|First Intervention - Day 0 - Week 14||12
328781|NCT00629772|796117|P2|STARTED|First Intervention - Day 0 - Week 14||12
328782|NCT00629772|796118|P1|STARTED|First Intervention - Day 0 - Week 14||12
328783|NCT00629707|796138|P2|NOT COMPLETED|Overall Study||2
328784|NCT00629707|796139|P1|NOT COMPLETED|Overall Study||0
328785|NCT00629707|796138|P2|COMPLETED|Overall Study||8
328786|NCT00629707|796139|P1|COMPLETED|Overall Study||10
328787|NCT00629707|796138|P2|STARTED|Overall Study||10
328788|NCT00629707|796139|P1|STARTED|Overall Study||10
328789|NCT00629525|796145|P1|NOT COMPLETED|Overall Study||3
328790|NCT00629525|796145|P1|COMPLETED|Overall Study||32
328791|NCT00629525|796145|P1|STARTED|Overall Study||35
328792|NCT00629499|796153|P1|NOT COMPLETED|Overall Study||0
328793|NCT00629499|796153|P1|COMPLETED|Overall Study||63
328794|NCT00629499|796153|P1|STARTED|Overall Study||63
328795|NCT00629265|796159|P2|NOT COMPLETED|Overall Study||20
328796|NCT00629265|796160|P1|NOT COMPLETED|Overall Study||32
328797|NCT00629265|796159|P2|COMPLETED|Overall Study||34
328798|NCT00629265|796160|P1|COMPLETED|Overall Study||84
328799|NCT00629265|796159|P2|STARTED|Overall Study||54
328800|NCT00629265|796160|P1|STARTED|Overall Study||116
328801|NCT00629239|796170|P2|NOT COMPLETED|Overall Study||4
328802|NCT00629239|796171|P1|NOT COMPLETED|Overall Study||8
328803|NCT00629239|796170|P2|COMPLETED|Overall Study||28
328804|NCT00629239|796171|P1|COMPLETED|Overall Study||26
328805|NCT00629239|796170|P2|STARTED|Overall Study||32
328806|NCT00629239|796171|P1|STARTED|Overall Study||34
328807|NCT00629122|796205|P2|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
328808|NCT00629122|796206|P1|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
328809|NCT00629122|796205|P2|COMPLETED|Third Period: Day 6-8 (Oral)||3
328810|NCT00629122|796206|P1|COMPLETED|Third Period: Day 6-8 (Oral)||2
328811|NCT00629122|796205|P2|STARTED|Third Period: Day 6-8 (Oral)||3
328812|NCT00629122|796206|P1|STARTED|Third Period: Day 6-8 (Oral)||2
328813|NCT00629122|796205|P2|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
328814|NCT00629122|796206|P1|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
328815|NCT00629122|796205|P2|COMPLETED|Second Period: Day 3-5 (Washout)||3
328816|NCT00629122|796206|P1|COMPLETED|Second Period: Day 3-5 (Washout)||2
328817|NCT00629122|796205|P2|STARTED|Second Period: Day 3-5 (Washout)||3
328818|NCT00629122|796206|P1|STARTED|Second Period: Day 3-5 (Washout)||2
328819|NCT00629122|796205|P2|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
328820|NCT00629122|796206|P1|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
328821|NCT00629122|796205|P2|COMPLETED|First Period: Day 1- 3 (Sublingual)||3
328822|NCT00629122|796206|P1|COMPLETED|First Period: Day 1- 3 (Sublingual)||2
328823|NCT00629122|796205|P2|STARTED|First Period: Day 1- 3 (Sublingual)||3
328824|NCT00629122|796206|P1|STARTED|First Period: Day 1- 3 (Sublingual)||2
328825|NCT00629018|796224|P2|NOT COMPLETED|Overall Study||0
328826|NCT00629018|796225|P1|NOT COMPLETED|Overall Study||0
328827|NCT00629018|796224|P2|COMPLETED|Overall Study||55
328828|NCT00629018|796225|P1|COMPLETED|Overall Study||55
328829|NCT00629018|796224|P2|STARTED|Overall Study||55
328830|NCT00629018|796225|P1|STARTED|Overall Study||55
328831|NCT00628927|796235|P2|NOT COMPLETED|Overall Study||0
328832|NCT00628927|796236|P1|NOT COMPLETED|Overall Study||8
328833|NCT00628927|796235|P2|COMPLETED|Overall Study||30
328834|NCT00628927|796236|P1|COMPLETED|Overall Study||175
328835|NCT00628927|796235|P2|STARTED|Overall Study||30
328836|NCT00628927|796236|P1|STARTED|Overall Study||183
328837|NCT00628901|796249|P2|NOT COMPLETED|Overall Study||1
328838|NCT00628901|796250|P1|NOT COMPLETED|Overall Study||3
328839|NCT00628901|796249|P2|COMPLETED|Overall Study||29
328840|NCT00628901|796250|P1|COMPLETED|Overall Study||27
328841|NCT00628901|796249|P2|STARTED|Overall Study||30
328842|NCT00628901|796250|P1|STARTED|Overall Study||30
328843|NCT00628862|796281|P3|NOT COMPLETED|Overall Study||22
328844|NCT00628862|796282|P2|NOT COMPLETED|Overall Study||17
328845|NCT00628862|796283|P1|NOT COMPLETED|Overall Study||11
328846|NCT00628862|796281|P3|COMPLETED|Overall Study|randomised patients|186
328847|NCT00628862|796282|P2|COMPLETED|Overall Study|randomised patients|182
328848|NCT00628862|796283|P1|COMPLETED|Overall Study|randomised patients|195
328849|NCT00628862|796281|P3|STARTED|Overall Study|randomised patients|208
328850|NCT00628862|796282|P2|STARTED|Overall Study|randomised patients|199
328851|NCT00628862|796283|P1|STARTED|Overall Study|randomised patients|206
328852|NCT00628758|796329|P2|NOT COMPLETED|Overall Study||42
328853|NCT00628758|796330|P1|NOT COMPLETED|Overall Study||44
328854|NCT00628758|796329|P2|COMPLETED|Overall Study||179
328855|NCT00628758|796330|P1|COMPLETED|Overall Study||165
328856|NCT00628758|796329|P2|STARTED|Overall Study||221
328857|NCT00628758|796330|P1|STARTED|Overall Study||209
328858|NCT00628628|796344|P2|NOT COMPLETED|Overall Study||0
328859|NCT00628628|796345|P1|NOT COMPLETED|Overall Study||0
328860|NCT00628628|796344|P2|COMPLETED|Overall Study||40
328861|NCT00628628|796345|P1|COMPLETED|Overall Study||40
328862|NCT00628628|796344|P2|STARTED|Overall Study||40
328863|NCT00628628|796345|P1|STARTED|Overall Study||40
328864|NCT00628589|796354|P3|NOT COMPLETED|Overall Study||3
328865|NCT00628589|796355|P2|NOT COMPLETED|Overall Study||2
328866|NCT00628589|796356|P1|NOT COMPLETED|Overall Study||1
328867|NCT00628589|796354|P3|COMPLETED|Overall Study||110
328868|NCT00628589|796355|P2|COMPLETED|Overall Study||114
328869|NCT00628589|796356|P1|COMPLETED|Overall Study||114
328870|NCT00628589|796354|P3|STARTED|Overall Study||113
328871|NCT00628589|796355|P2|STARTED|Overall Study||116
328872|NCT00628589|796356|P1|STARTED|Overall Study||115
328873|NCT00628498|796370|P1|NOT COMPLETED|Overall Study||52
328874|NCT00628498|796370|P1|COMPLETED|Overall Study||1154
328875|NCT00628498|796370|P1|STARTED|Overall Study||1206
328876|NCT00628446|796374|P1|NOT COMPLETED|Overall Study||7
328877|NCT00628446|796374|P1|COMPLETED|Overall Study||38
328878|NCT00628446|796374|P1|STARTED|Overall Study||45
328879|NCT00628407|796379|P1|NOT COMPLETED|Overall Study||0
328880|NCT00628407|796379|P1|COMPLETED|Overall Study||13
328881|NCT00628407|796379|P1|STARTED|Overall Study||13
328882|NCT00628355|796385|P2|NOT COMPLETED|Overall Study||1
328883|NCT00628355|796386|P1|NOT COMPLETED|Overall Study||1
328884|NCT00628355|796385|P2|COMPLETED|Overall Study||14
328885|NCT00628355|796386|P1|COMPLETED|Overall Study||14
328886|NCT00628355|796385|P2|STARTED|Overall Study||15
328887|NCT00628355|796386|P1|STARTED|Overall Study||15
328888|NCT00628251|796397|P3|NOT COMPLETED|Cross-over/ Continuation of Olaparib||17
328889|NCT00628251|796398|P2|NOT COMPLETED|Cross-over/ Continuation of Olaparib||26
328890|NCT00628251|796399|P1|NOT COMPLETED|Cross-over/ Continuation of Olaparib||27
328891|NCT00628251|796397|P3|COMPLETED|Cross-over/ Continuation of Olaparib|Patients ongoing crossover treatment|8
328892|NCT00628251|796398|P2|COMPLETED|Cross-over/ Continuation of Olaparib|Ongoing initial study treatment at primary data cut-off|6
328893|NCT00628251|796399|P1|COMPLETED|Cross-over/ Continuation of Olaparib|Ongoing initial study treatment at primary data cut-off|5
328894|NCT00628251|796397|P3|STARTED|Cross-over/ Continuation of Olaparib|Patients who crossed over from Liposomal doxorubicin to Olaparib 400 mg bd|25
328895|NCT00628251|796398|P2|STARTED|Cross-over/ Continuation of Olaparib|Patients who received treatment|32
328896|NCT00628251|796399|P1|STARTED|Cross-over/ Continuation of Olaparib|Patients who received treatment|32
328897|NCT00628251|796397|P3|NOT COMPLETED|Randomised Part||8
328898|NCT00628251|796398|P2|NOT COMPLETED|Randomised Part||0
328899|NCT00628251|796399|P1|NOT COMPLETED|Randomised Part||0
328900|NCT00628251|796397|P3|COMPLETED|Randomised Part|Patients who received olaparib (crossed over). 1 of 33 did not receive Liposomal Doxorubicin.|25
328901|NCT00628251|796398|P2|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
328902|NCT00628251|796399|P1|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
328903|NCT00628251|796397|P3|STARTED|Randomised Part|Patients randomised|33
328904|NCT00628251|796398|P2|STARTED|Randomised Part|Patients randomised|32
328905|NCT00628251|796399|P1|STARTED|Randomised Part|Patients randomised|32
328906|NCT00628212|796442|P4|NOT COMPLETED|Overall Study||5
328907|NCT00628212|796443|P3|NOT COMPLETED|Overall Study||3
328908|NCT00628212|796444|P2|NOT COMPLETED|Overall Study||1
328909|NCT00628212|796445|P1|NOT COMPLETED|Overall Study||3
328910|NCT00628212|796442|P4|COMPLETED|Overall Study||76
328911|NCT00628212|796443|P3|COMPLETED|Overall Study||76
328912|NCT00628212|796444|P2|COMPLETED|Overall Study||83
328913|NCT00628212|796445|P1|COMPLETED|Overall Study||77
328914|NCT00628212|796442|P4|STARTED|Overall Study||81
328915|NCT00628212|796443|P3|STARTED|Overall Study||79
328916|NCT00628212|796444|P2|STARTED|Overall Study||84
328917|NCT00628212|796445|P1|STARTED|Overall Study||80
328918|NCT00628147|796469|P2|NOT COMPLETED|Overall Study||1
328919|NCT00628147|796470|P1|NOT COMPLETED|Overall Study||7
328920|NCT00628147|796469|P2|COMPLETED|Overall Study||141
328921|NCT00628147|796470|P1|COMPLETED|Overall Study||135
328922|NCT00628147|796469|P2|STARTED|Overall Study||142
328923|NCT00628147|796470|P1|STARTED|Overall Study||142
328924|NCT00628134|796482|P2|NOT COMPLETED|Overall Study||0
328925|NCT00628134|796483|P1|NOT COMPLETED|Overall Study||0
328926|NCT00628134|796482|P2|COMPLETED|Overall Study||4
328927|NCT00628134|796483|P1|COMPLETED|Overall Study||4
328928|NCT00628134|796482|P2|STARTED|Overall Study||4
328929|NCT00628134|796483|P1|STARTED|Overall Study||4
328930|NCT00628108|796493|P2|NOT COMPLETED|Overall Study||3
328931|NCT00628108|796494|P1|NOT COMPLETED|Overall Study||1
328932|NCT00628108|796493|P2|COMPLETED|Overall Study||43
328933|NCT00628108|796494|P1|COMPLETED|Overall Study||22
328934|NCT00628108|796493|P2|Safety Population|Overall Study|Subjects in the Safety Population were analyzed as treated.|45
328935|NCT00628108|796494|P1|Safety Population|Overall Study||24
328936|NCT00628108|796493|P2|STARTED|Overall Study|One subject was randomized to levocetirizine but received placebo.|46
328937|NCT00628108|796494|P1|STARTED|Overall Study||23
328938|NCT00628030|796526|P2|NOT COMPLETED|Post to 6 Month Follow-up||30
328939|NCT00628030|796527|P1|NOT COMPLETED|Post to 6 Month Follow-up||32
328940|NCT00628030|796526|P2|COMPLETED|Post to 6 Month Follow-up||33
328941|NCT00628030|796527|P1|COMPLETED|Post to 6 Month Follow-up||27
328942|NCT00628030|796526|P2|STARTED|Post to 6 Month Follow-up||63
328943|NCT00628030|796527|P1|STARTED|Post to 6 Month Follow-up||59
328944|NCT00628030|796526|P2|NOT COMPLETED|Baseline to Post-Assessment||29
328945|NCT00628030|796527|P1|NOT COMPLETED|Baseline to Post-Assessment||33
328946|NCT00628030|796526|P2|COMPLETED|Baseline to Post-Assessment||63
328947|NCT00628030|796527|P1|COMPLETED|Baseline to Post-Assessment||59
328948|NCT00628030|796526|P2|STARTED|Baseline to Post-Assessment||92
328949|NCT00628030|796527|P1|STARTED|Baseline to Post-Assessment||92
328950|NCT00627978|796543|P2|NOT COMPLETED|Overall Study||0
328951|NCT00627978|796544|P1|NOT COMPLETED|Overall Study||0
328952|NCT00627978|796543|P2|COMPLETED|Overall Study||5
328953|NCT00627978|796544|P1|COMPLETED|Overall Study||10
328954|NCT00627978|796543|P2|STARTED|Overall Study||5
328955|NCT00627978|796544|P1|STARTED|Overall Study||10
328956|NCT00627926|796553|P3|NOT COMPLETED|Overall Study||95
328957|NCT00627926|796554|P2|NOT COMPLETED|Overall Study||104
328958|NCT00627926|796555|P1|NOT COMPLETED|Overall Study||159
328959|NCT00627926|796553|P3|COMPLETED|Overall Study||268
328960|NCT00627926|796554|P2|COMPLETED|Overall Study||260
328961|NCT00627926|796555|P1|COMPLETED|Overall Study||202
328962|NCT00627926|796553|P3|STARTED|Overall Study||363
328963|NCT00627926|796554|P2|STARTED|Overall Study||364
328964|NCT00627926|796555|P1|STARTED|Overall Study||361
328965|NCT00627861|796599|P1|NOT COMPLETED|Overall Study||0
328966|NCT00627861|796599|P1|COMPLETED|Overall Study||1
328967|NCT00627861|796599|P1|STARTED|Overall Study||1
328968|NCT00627705|796607|P2|NOT COMPLETED|Overall Study||6
328969|NCT00627705|796608|P1|NOT COMPLETED|Overall Study||2
328970|NCT00627705|796607|P2|COMPLETED|Overall Study||12
328971|NCT00627705|796608|P1|COMPLETED|Overall Study||13
328972|NCT00627705|796607|P2|STARTED|Overall Study||18
328973|NCT00627705|796608|P1|STARTED|Overall Study||15
328974|NCT00627679|796628|P4|NOT COMPLETED|Overall Study||0
328975|NCT00627679|796629|P3|NOT COMPLETED|Overall Study||0
328976|NCT00627679|796630|P2|NOT COMPLETED|Overall Study||0
328977|NCT00627679|796631|P1|NOT COMPLETED|Overall Study||0
328978|NCT00627679|796628|P4|COMPLETED|Overall Study||4
328979|NCT00627679|796629|P3|COMPLETED|Overall Study||4
328980|NCT00627679|796630|P2|COMPLETED|Overall Study||4
328981|NCT00627679|796631|P1|COMPLETED|Overall Study||4
328982|NCT00627679|796628|P4|STARTED|Overall Study||4
328983|NCT00627679|796629|P3|STARTED|Overall Study||4
328984|NCT00627679|796630|P2|STARTED|Overall Study||4
328985|NCT00627679|796631|P1|STARTED|Overall Study||4
328986|NCT00627523|796659|P2|NOT COMPLETED|Overall Study||2
328987|NCT00627523|796660|P1|NOT COMPLETED|Overall Study||2
328988|NCT00627523|796659|P2|COMPLETED|Overall Study||20
328989|NCT00627523|796660|P1|COMPLETED|Overall Study||19
328990|NCT00627523|796659|P2|STARTED|Overall Study||22
328991|NCT00627523|796660|P1|STARTED|Overall Study|22 assigned to Genotropin and 21 in Control; 1 did not take Genotropin, so considered as Control.|21
328992|NCT00627497|796688|P4|NOT COMPLETED|Overall Study||0
328993|NCT00627497|796689|P3|NOT COMPLETED|Overall Study||0
328994|NCT00627497|796690|P2|NOT COMPLETED|Overall Study||1
328995|NCT00627497|796691|P1|NOT COMPLETED|Overall Study||1
328996|NCT00627497|796688|P4|COMPLETED|Overall Study||2
328997|NCT00627497|796689|P3|COMPLETED|Overall Study||4
328998|NCT00627497|796690|P2|COMPLETED|Overall Study||11
328999|NCT00627497|796691|P1|COMPLETED|Overall Study||13
329000|NCT00627497|796688|P4|STARTED|Overall Study||2
329001|NCT00627497|796689|P3|STARTED|Overall Study||4
329002|NCT00627497|796690|P2|STARTED|Overall Study||12
329003|NCT00627497|796691|P1|STARTED|Overall Study||14
329004|NCT00627458|796752|P3|NOT COMPLETED|Overall Study||6
329005|NCT00627458|796753|P2|NOT COMPLETED|Overall Study||7
329006|NCT00627458|796754|P1|NOT COMPLETED|Overall Study||4
329007|NCT00627458|796752|P3|COMPLETED|Overall Study||133
329008|NCT00627458|796753|P2|COMPLETED|Overall Study||130
329009|NCT00627458|796754|P1|COMPLETED|Overall Study||123
329010|NCT00627458|796752|P3|STARTED|Overall Study||139
329011|NCT00627458|796753|P2|STARTED|Overall Study||137
329012|NCT00627458|796754|P1|STARTED|Overall Study||127
329013|NCT00627445|796829|P2|NOT COMPLETED|Overall Study||12
329014|NCT00627445|796830|P1|NOT COMPLETED|Overall Study||9
329015|NCT00627445|796829|P2|COMPLETED|Overall Study||210
329016|NCT00627445|796830|P1|COMPLETED|Overall Study||210
329017|NCT00627445|796829|P2|Exposed to Study Drug|Overall Study||222
329018|NCT00627445|796830|P1|Exposed to Study Drug|Overall Study||219
329019|NCT00627445|796829|P2|STARTED|Overall Study||222
329020|NCT00627445|796830|P1|STARTED|Overall Study||219
329021|NCT00627406|796854|P4|NOT COMPLETED|Overall Study||0
329022|NCT00627406|796855|P3|NOT COMPLETED|Overall Study||0
329023|NCT00627406|796856|P2|NOT COMPLETED|Overall Study||0
329024|NCT00627406|796857|P1|NOT COMPLETED|Overall Study||0
329025|NCT00627406|796854|P4|COMPLETED|Overall Study||141
329026|NCT00627406|796855|P3|COMPLETED|Overall Study||125
329027|NCT00627406|796856|P2|COMPLETED|Overall Study||58
329028|NCT00627406|796857|P1|COMPLETED|Overall Study||60
329029|NCT00627406|796854|P4|STARTED|Overall Study||141
329030|NCT00627406|796855|P3|STARTED|Overall Study||125
329031|NCT00627406|796856|P2|STARTED|Overall Study||58
329032|NCT00627406|796857|P1|STARTED|Overall Study||60
329033|NCT00627393|796873|P2|NOT COMPLETED|Per-Protocol Analysis||13
329034|NCT00627393|796874|P1|NOT COMPLETED|Per-Protocol Analysis||10
329035|NCT00627393|796873|P2|COMPLETED|Per-Protocol Analysis||35
329036|NCT00627393|796874|P1|COMPLETED|Per-Protocol Analysis||39
329037|NCT00627393|796873|P2|STARTED|Per-Protocol Analysis||48
329038|NCT00627393|796874|P1|STARTED|Per-Protocol Analysis||49
329039|NCT00627393|796873|P2|NOT COMPLETED|Intention-To-Treat Analysis||8
329040|NCT00627393|796874|P1|NOT COMPLETED|Intention-To-Treat Analysis||9
329041|NCT00627393|796873|P2|COMPLETED|Intention-To-Treat Analysis||48
329042|NCT00627393|796874|P1|COMPLETED|Intention-To-Treat Analysis||49
329043|NCT00627393|796873|P2|STARTED|Intention-To-Treat Analysis||56
329044|NCT00627393|796874|P1|STARTED|Intention-To-Treat Analysis||58
329045|NCT00627367|796895|P2|NOT COMPLETED|Overall Study||0
329046|NCT00627367|796896|P1|NOT COMPLETED|Overall Study||0
329047|NCT00627367|796895|P2|COMPLETED|Overall Study||112
329048|NCT00627367|796896|P1|COMPLETED|Overall Study||112
329049|NCT00627367|796895|P2|STARTED|Overall Study||112
329050|NCT00627367|796896|P1|STARTED|Overall Study||112
329051|NCT00627094|796910|P2|NOT COMPLETED|Overall Study||15
329052|NCT00627094|796911|P1|NOT COMPLETED|Overall Study||12
329053|NCT00627094|796910|P2|COMPLETED|Overall Study||45
329054|NCT00627094|796911|P1|COMPLETED|Overall Study||48
329055|NCT00627094|796910|P2|STARTED|Overall Study||60
329056|NCT00627094|796911|P1|STARTED|Overall Study||60
329057|NCT00627042|796923|P1|NOT COMPLETED|Overall Study||2
329058|NCT00627042|796923|P1|COMPLETED|Overall Study||40
329059|NCT00627042|796923|P1|Received at Least 1 Dose of Study Drug|Overall Study||42
329060|NCT00627042|796923|P1|STARTED|Overall Study||42
329061|NCT00627016|796935|P2|NOT COMPLETED|Overall Study||6
329062|NCT00627016|796936|P1|NOT COMPLETED|Overall Study||6
329063|NCT00627016|796935|P2|COMPLETED|Overall Study||146
329064|NCT00627016|796936|P1|COMPLETED|Overall Study||147
329065|NCT00627016|796935|P2|STARTED|Overall Study||152
329066|NCT00627016|796936|P1|STARTED|Overall Study||153
329067|NCT00626925|796948|P2|NOT COMPLETED|Overall Study||9
329068|NCT00626925|796949|P1|NOT COMPLETED|Overall Study||12
329069|NCT00626925|796948|P2|COMPLETED|Overall Study||62
329070|NCT00626925|796949|P1|COMPLETED|Overall Study||55
329071|NCT00626925|796948|P2|STARTED|Overall Study||71
329072|NCT00626925|796949|P1|STARTED|Overall Study||67
329073|NCT00626912|796983|P2|NOT COMPLETED|Overall Study||10
329074|NCT00626912|796984|P1|NOT COMPLETED|Overall Study||2
329075|NCT00626912|796983|P2|COMPLETED|Overall Study||215
329076|NCT00626912|796984|P1|COMPLETED|Overall Study||220
329077|NCT00626912|796983|P2|STARTED|Overall Study||225
329078|NCT00626912|796984|P1|STARTED|Overall Study||222
329079|NCT00626821|796996|P1|NOT COMPLETED|Overall Study||221
329080|NCT00626821|796996|P1|COMPLETED|Overall Study||2796
329081|NCT00626821|796996|P1|Quality of Life|Overall Study|Attended both visit 1 and visit 2|2672
329082|NCT00626821|796996|P1|STARTED|Overall Study||3017
329083|NCT00626808|797004|P4|NOT COMPLETED|Overall Study||0
329084|NCT00626808|797005|P3|NOT COMPLETED|Overall Study||0
329085|NCT00626808|797006|P2|NOT COMPLETED|Overall Study||0
329086|NCT00626808|797007|P1|NOT COMPLETED|Overall Study||0
329087|NCT00626808|797004|P4|COMPLETED|Overall Study||2906
329088|NCT00626808|797005|P3|COMPLETED|Overall Study||30011
329089|NCT00626808|797006|P2|COMPLETED|Overall Study||34316
329090|NCT00626808|797007|P1|COMPLETED|Overall Study||254464
329091|NCT00626808|797004|P4|STARTED|Overall Study||2906
329092|NCT00626808|797005|P3|STARTED|Overall Study||30011
329093|NCT00626808|797006|P2|STARTED|Overall Study||34316
329094|NCT00626808|797007|P1|STARTED|Overall Study||254464
329095|NCT00626795|797076|P3|NOT COMPLETED|Blinded Treatment||9
329096|NCT00626795|797077|P2|NOT COMPLETED|Blinded Treatment||5
329097|NCT00626795|797078|P1|NOT COMPLETED|Blinded Treatment||10
329098|NCT00626795|797076|P3|COMPLETED|Blinded Treatment||196
329099|NCT00626795|797077|P2|COMPLETED|Blinded Treatment||200
329100|NCT00626795|797078|P1|COMPLETED|Blinded Treatment||194
329101|NCT00626795|797076|P3|STARTED|Blinded Treatment||205
329102|NCT00626795|797077|P2|STARTED|Blinded Treatment||205
329103|NCT00626795|797078|P1|STARTED|Blinded Treatment||204
329104|NCT00626795|797076|P3|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0
329105|NCT00626795|797077|P2|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||1
329106|NCT00626795|797078|P1|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0
329107|NCT00626795|797076|P3|COMPLETED|Open-label TD1414 Cream TID Treatment||0
329108|NCT00626795|797077|P2|COMPLETED|Open-label TD1414 Cream TID Treatment||64
329109|NCT00626795|797078|P1|COMPLETED|Open-label TD1414 Cream TID Treatment||0
329110|NCT00626795|797076|P3|STARTED|Open-label TD1414 Cream TID Treatment||0
329111|NCT00626795|797077|P2|STARTED|Open-label TD1414 Cream TID Treatment||65
329112|NCT00626795|797078|P1|STARTED|Open-label TD1414 Cream TID Treatment||0
329113|NCT00626782|797107|P2|NOT COMPLETED|Overall Study||0
329114|NCT00626782|797108|P1|NOT COMPLETED|Overall Study||0
329115|NCT00626782|797107|P2|COMPLETED|Overall Study||12
329116|NCT00626782|797108|P1|COMPLETED|Overall Study||12
329117|NCT00626782|797107|P2|STARTED|Overall Study||12
329118|NCT00626782|797108|P1|STARTED|Overall Study||12
329119|NCT00626743|797118|P2|NOT COMPLETED|Treatment Period 2||0
329120|NCT00626743|797119|P1|NOT COMPLETED|Treatment Period 2||0
329121|NCT00626743|797118|P2|COMPLETED|Treatment Period 2||6
329122|NCT00626743|797119|P1|COMPLETED|Treatment Period 2||6
329123|NCT00626743|797118|P2|STARTED|Treatment Period 2||6
329124|NCT00626743|797119|P1|STARTED|Treatment Period 2||6
329125|NCT00626743|797118|P2|NOT COMPLETED|Wash-out Period of 6 Days||0
329126|NCT00626743|797119|P1|NOT COMPLETED|Wash-out Period of 6 Days||0
329127|NCT00626743|797118|P2|COMPLETED|Wash-out Period of 6 Days||6
329128|NCT00626743|797119|P1|COMPLETED|Wash-out Period of 6 Days||6
329129|NCT00626743|797118|P2|STARTED|Wash-out Period of 6 Days||6
329130|NCT00626743|797119|P1|STARTED|Wash-out Period of 6 Days||6
329131|NCT00626743|797118|P2|NOT COMPLETED|Treatment Period 1||1
329132|NCT00626743|797119|P1|NOT COMPLETED|Treatment Period 1||0
329133|NCT00626743|797118|P2|COMPLETED|Treatment Period 1||6
329134|NCT00626743|797119|P1|COMPLETED|Treatment Period 1||6
329135|NCT00626743|797118|P2|STARTED|Treatment Period 1||7
329136|NCT00626743|797119|P1|STARTED|Treatment Period 1||6
329137|NCT00626639|797129|P2|NOT COMPLETED|Overall Study||2
329138|NCT00626639|797130|P1|NOT COMPLETED|Overall Study||2
329139|NCT00626639|797129|P2|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|1
329140|NCT00626639|797130|P1|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|0
329141|NCT00626639|797129|P2|STARTED|Overall Study||3
329142|NCT00626639|797130|P1|STARTED|Overall Study||2
329143|NCT00626626|797150|P2|NOT COMPLETED|Overall Study||0
329144|NCT00626626|797151|P1|NOT COMPLETED|Overall Study||0
329145|NCT00626626|797150|P2|COMPLETED|Overall Study||3
329146|NCT00626626|797151|P1|COMPLETED|Overall Study||5
329147|NCT00626626|797150|P2|STARTED|Overall Study||3
329148|NCT00626626|797151|P1|STARTED|Overall Study||5
329149|NCT00626574|797163|P2|NOT COMPLETED|Overall Study||0
329150|NCT00626574|797164|P1|NOT COMPLETED|Overall Study||0
329151|NCT00626574|797163|P2|COMPLETED|Overall Study||1
329152|NCT00626574|797164|P1|COMPLETED|Overall Study||2
329153|NCT00626574|797163|P2|STARTED|Overall Study||1
329154|NCT00626574|797164|P1|STARTED|Overall Study||2
329155|NCT00626561|797176|P1|NOT COMPLETED|Overall Study||4
329156|NCT00626561|797176|P1|COMPLETED|Overall Study||0
329157|NCT00626561|797176|P1|STARTED|Overall Study||4
329158|NCT00626548|797182|P2|NOT COMPLETED|Overall Study||716
329159|NCT00626548|797183|P1|NOT COMPLETED|Overall Study||705
329160|NCT00626548|797182|P2|COMPLETED|Overall Study||0
329161|NCT00626548|797183|P1|COMPLETED|Overall Study||0
329162|NCT00626548|797182|P2|Patients Received Treatment|Overall Study||712
329163|NCT00626548|797183|P1|Patients Received Treatment|Overall Study||703
329164|NCT00626548|797182|P2|STARTED|Overall Study||716
329165|NCT00626548|797183|P1|STARTED|Overall Study||705
329166|NCT00626522|797197|P6|NOT COMPLETED|Overall Study||2
329167|NCT00626522|797198|P5|NOT COMPLETED|Overall Study||7
329168|NCT00626522|797199|P4|NOT COMPLETED|Overall Study||2
329169|NCT00626522|797200|P3|NOT COMPLETED|Overall Study||8
329170|NCT00626522|797201|P2|NOT COMPLETED|Overall Study||7
329171|NCT00626522|797202|P1|NOT COMPLETED|Overall Study||6
329172|NCT00626522|797197|P6|COMPLETED|Overall Study||57
329173|NCT00626522|797198|P5|COMPLETED|Overall Study||58
329174|NCT00626522|797199|P4|COMPLETED|Overall Study||74
329175|NCT00626522|797200|P3|COMPLETED|Overall Study||117
329176|NCT00626522|797201|P2|COMPLETED|Overall Study||113
329177|NCT00626522|797202|P1|COMPLETED|Overall Study||115
329178|NCT00626522|797197|P6|STARTED|Overall Study||59
329179|NCT00626522|797198|P5|STARTED|Overall Study||65
329180|NCT00626522|797199|P4|STARTED|Overall Study||76
329181|NCT00626522|797200|P3|STARTED|Overall Study||125
329182|NCT00626522|797201|P2|STARTED|Overall Study||120
329183|NCT00626522|797202|P1|STARTED|Overall Study||121
329184|NCT00626444|797240|P1|NOT COMPLETED|Overall Study||0
329185|NCT00626444|797240|P1|COMPLETED|Overall Study||2
329186|NCT00626444|797240|P1|STARTED|Overall Study||2
329187|NCT00626431|797247|P2|NOT COMPLETED|Overall Study||45
329188|NCT00626431|797248|P1|NOT COMPLETED|Overall Study||17
329189|NCT00626431|797247|P2|COMPLETED|Overall Study||114
329190|NCT00626431|797248|P1|COMPLETED|Overall Study||134
329191|NCT00626431|797247|P2|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|159
329192|NCT00626431|797248|P1|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|151
329193|NCT00626405|797265|P2|NOT COMPLETED|Overall Study||1
329194|NCT00626405|797266|P1|NOT COMPLETED|Overall Study||1
329195|NCT00626405|797265|P2|COMPLETED|Overall Study||51
329196|NCT00626405|797266|P1|COMPLETED|Overall Study||42
329197|NCT00626405|797265|P2|STARTED|Overall Study||52
329198|NCT00626405|797266|P1|STARTED|Overall Study||43
329199|NCT00626392|797282|P6|NOT COMPLETED|Coadministration Period||6
329200|NCT00626392|797283|P5|NOT COMPLETED|Coadministration Period||5
329201|NCT00626392|797284|P4|NOT COMPLETED|Coadministration Period||7
329202|NCT00626392|797285|P3|NOT COMPLETED|Coadministration Period||10
329203|NCT00626392|797286|P2|NOT COMPLETED|Coadministration Period||5
329204|NCT00626392|797287|P1|NOT COMPLETED|Coadministration Period||4
329205|NCT00626392|797282|P6|COMPLETED|Coadministration Period||38
329206|NCT00626392|797283|P5|COMPLETED|Coadministration Period||36
329207|NCT00626392|797284|P4|COMPLETED|Coadministration Period||36
329208|NCT00626392|797285|P3|COMPLETED|Coadministration Period||31
329209|NCT00626392|797286|P2|COMPLETED|Coadministration Period||38
329210|NCT00626392|797287|P1|COMPLETED|Coadministration Period||40
329211|NCT00626392|797282|P6|STARTED|Coadministration Period||44
329212|NCT00626392|797283|P5|STARTED|Coadministration Period||41
329213|NCT00626392|797284|P4|STARTED|Coadministration Period||43
329214|NCT00626392|797285|P3|STARTED|Coadministration Period||41
329215|NCT00626392|797286|P2|STARTED|Coadministration Period||43
329216|NCT00626392|797287|P1|STARTED|Coadministration Period||44
329217|NCT00626392|797282|P6|NOT COMPLETED|Run-in Period||1
329218|NCT00626392|797283|P5|NOT COMPLETED|Run-in Period||4
329219|NCT00626392|797284|P4|NOT COMPLETED|Run-in Period||1
329220|NCT00626392|797285|P3|NOT COMPLETED|Run-in Period||3
329221|NCT00626392|797286|P2|NOT COMPLETED|Run-in Period||1
329222|NCT00626392|797287|P1|NOT COMPLETED|Run-in Period||1
329223|NCT00626392|797282|P6|COMPLETED|Run-in Period||44
329224|NCT00626392|797283|P5|COMPLETED|Run-in Period||41
329225|NCT00626392|797284|P4|COMPLETED|Run-in Period||43
329226|NCT00626392|797285|P3|COMPLETED|Run-in Period||41
329227|NCT00626392|797286|P2|COMPLETED|Run-in Period||43
329228|NCT00626392|797287|P1|COMPLETED|Run-in Period||44
329229|NCT00626392|797282|P6|STARTED|Run-in Period||45
329230|NCT00626392|797283|P5|STARTED|Run-in Period||45
329231|NCT00626392|797284|P4|STARTED|Run-in Period||44
329232|NCT00626392|797285|P3|STARTED|Run-in Period||44
329233|NCT00626392|797286|P2|STARTED|Run-in Period||44
329234|NCT00626392|797287|P1|STARTED|Run-in Period||45
329235|NCT00626366|797301|P2|NOT COMPLETED|Overall Study||0
329236|NCT00626366|797302|P1|NOT COMPLETED|Overall Study||0
329237|NCT00626366|797301|P2|COMPLETED|Overall Study||9
329238|NCT00626366|797302|P1|COMPLETED|Overall Study||9
329239|NCT00626366|797301|P2|STARTED|Overall Study||9
329240|NCT00626366|797302|P1|STARTED|Overall Study||9
329241|NCT00626340|797308|P1|NOT COMPLETED|Overall Study||0
329242|NCT00626340|797308|P1|COMPLETED|Overall Study||18
329243|NCT00626340|797308|P1|STARTED|Overall Study||18
329244|NCT00626327|797315|P3|NOT COMPLETED|Overall Study||88
329245|NCT00626327|797316|P2|NOT COMPLETED|Overall Study||59
329246|NCT00626327|797317|P1|NOT COMPLETED|Overall Study||78
329247|NCT00626327|797315|P3|COMPLETED|Overall Study||422
329248|NCT00626327|797316|P2|COMPLETED|Overall Study||557
329249|NCT00626327|797317|P1|COMPLETED|Overall Study||426
329250|NCT00626327|797315|P3|STARTED|Overall Study||510
329251|NCT00626327|797316|P2|STARTED|Overall Study||616
329252|NCT00626327|797317|P1|STARTED|Overall Study||504
329253|NCT00626275|797343|P8|NOT COMPLETED|Part B||1
329254|NCT00626275|797344|P7|NOT COMPLETED|Part B||1
329255|NCT00626275|797345|P6|NOT COMPLETED|Part B||0
329256|NCT00626275|797346|P5|NOT COMPLETED|Part B||0
329257|NCT00626275|797347|P4|NOT COMPLETED|Part B||0
329258|NCT00626275|797348|P3|NOT COMPLETED|Part B||0
329259|NCT00626275|797349|P2|NOT COMPLETED|Part B||0
329260|NCT00626275|797350|P1|NOT COMPLETED|Part B||0
329261|NCT00626275|797343|P8|COMPLETED|Part B||23
329262|NCT00626275|797344|P7|COMPLETED|Part B||19
329263|NCT00626275|797345|P6|COMPLETED|Part B||0
329264|NCT00626275|797346|P5|COMPLETED|Part B||0
329265|NCT00626275|797347|P4|COMPLETED|Part B||0
329266|NCT00626275|797348|P3|COMPLETED|Part B||0
329267|NCT00626275|797349|P2|COMPLETED|Part B||0
329268|NCT00626275|797350|P1|COMPLETED|Part B||0
329269|NCT00626275|797343|P8|STARTED|Part B||24
329270|NCT00626275|797344|P7|STARTED|Part B||20
329271|NCT00626275|797345|P6|STARTED|Part B||0
329272|NCT00626275|797346|P5|STARTED|Part B||0
329273|NCT00626275|797347|P4|STARTED|Part B||0
329274|NCT00626275|797348|P3|STARTED|Part B||0
329275|NCT00626275|797349|P2|STARTED|Part B||0
329276|NCT00626275|797350|P1|STARTED|Part B||0
329277|NCT00626275|797343|P8|NOT COMPLETED|Re-randomization Period for Part B||0
329278|NCT00626275|797344|P7|NOT COMPLETED|Re-randomization Period for Part B||0
329279|NCT00626275|797345|P6|NOT COMPLETED|Re-randomization Period for Part B||0
329280|NCT00626275|797346|P5|NOT COMPLETED|Re-randomization Period for Part B||0
329281|NCT00626275|797347|P4|NOT COMPLETED|Re-randomization Period for Part B||0
329282|NCT00626275|797348|P3|NOT COMPLETED|Re-randomization Period for Part B||0
329283|NCT00626275|797349|P2|NOT COMPLETED|Re-randomization Period for Part B||0
329284|NCT00626275|797350|P1|NOT COMPLETED|Re-randomization Period for Part B||0
329285|NCT00626275|797343|P8|COMPLETED|Re-randomization Period for Part B||24
329286|NCT00626275|797344|P7|COMPLETED|Re-randomization Period for Part B||20
329287|NCT00626275|797345|P6|COMPLETED|Re-randomization Period for Part B||0
329288|NCT00626275|797346|P5|COMPLETED|Re-randomization Period for Part B||0
329289|NCT00626275|797347|P4|COMPLETED|Re-randomization Period for Part B||0
329290|NCT00626275|797348|P3|COMPLETED|Re-randomization Period for Part B||0
329291|NCT00626275|797349|P2|COMPLETED|Re-randomization Period for Part B||0
329292|NCT00626275|797350|P1|COMPLETED|Re-randomization Period for Part B||0
329293|NCT00626275|797343|P8|STARTED|Re-randomization Period for Part B||24
329294|NCT00626275|797344|P7|STARTED|Re-randomization Period for Part B||20
329295|NCT00626275|797345|P6|STARTED|Re-randomization Period for Part B||0
329296|NCT00626275|797346|P5|STARTED|Re-randomization Period for Part B||0
329297|NCT00626275|797347|P4|STARTED|Re-randomization Period for Part B||0
329298|NCT00626275|797348|P3|STARTED|Re-randomization Period for Part B||0
329299|NCT00626275|797349|P2|STARTED|Re-randomization Period for Part B||0
329300|NCT00626275|797350|P1|STARTED|Re-randomization Period for Part B||0
329301|NCT00626275|797343|P8|NOT COMPLETED|Part A - Treatment Period 3||0
329302|NCT00626275|797344|P7|NOT COMPLETED|Part A - Treatment Period 3||0
329303|NCT00626275|797345|P6|NOT COMPLETED|Part A - Treatment Period 3||0
329304|NCT00626275|797346|P5|NOT COMPLETED|Part A - Treatment Period 3||0
329305|NCT00626275|797347|P4|NOT COMPLETED|Part A - Treatment Period 3||0
329306|NCT00626275|797348|P3|NOT COMPLETED|Part A - Treatment Period 3||0
329307|NCT00626275|797349|P2|NOT COMPLETED|Part A - Treatment Period 3||0
329308|NCT00626275|797350|P1|NOT COMPLETED|Part A - Treatment Period 3||0
329309|NCT00626275|797343|P8|COMPLETED|Part A - Treatment Period 3||0
329310|NCT00626275|797344|P7|COMPLETED|Part A - Treatment Period 3||0
329311|NCT00626275|797345|P6|COMPLETED|Part A - Treatment Period 3||8
329312|NCT00626275|797346|P5|COMPLETED|Part A - Treatment Period 3||9
329313|NCT00626275|797347|P4|COMPLETED|Part A - Treatment Period 3||8
329314|NCT00626275|797348|P3|COMPLETED|Part A - Treatment Period 3||6
329315|NCT00626275|797349|P2|COMPLETED|Part A - Treatment Period 3||7
329316|NCT00626275|797350|P1|COMPLETED|Part A - Treatment Period 3||6
329317|NCT00626275|797343|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
329318|NCT00626275|797344|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
329319|NCT00626275|797345|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
329320|NCT00626275|797346|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||9
329321|NCT00626275|797347|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
329322|NCT00626275|797348|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
329323|NCT00626275|797349|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||7
329324|NCT00626275|797350|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
329325|NCT00626275|797343|P8|STARTED|Part A - Treatment Period 3||0
329326|NCT00626275|797344|P7|STARTED|Part A - Treatment Period 3||0
329327|NCT00626275|797345|P6|STARTED|Part A - Treatment Period 3||8
329328|NCT00626275|797346|P5|STARTED|Part A - Treatment Period 3||9
329329|NCT00626275|797347|P4|STARTED|Part A - Treatment Period 3||8
329330|NCT00626275|797348|P3|STARTED|Part A - Treatment Period 3||6
329331|NCT00626275|797349|P2|STARTED|Part A - Treatment Period 3||7
329332|NCT00626275|797350|P1|STARTED|Part A - Treatment Period 3||6
329333|NCT00626275|797343|P8|NOT COMPLETED|Part A - Washout Period 2||0
329334|NCT00626275|797344|P7|NOT COMPLETED|Part A - Washout Period 2||0
329335|NCT00626275|797345|P6|NOT COMPLETED|Part A - Washout Period 2||0
329336|NCT00626275|797346|P5|NOT COMPLETED|Part A - Washout Period 2||0
329337|NCT00626275|797347|P4|NOT COMPLETED|Part A - Washout Period 2||0
329338|NCT00626275|797348|P3|NOT COMPLETED|Part A - Washout Period 2||0
329339|NCT00626275|797349|P2|NOT COMPLETED|Part A - Washout Period 2||0
329340|NCT00626275|797350|P1|NOT COMPLETED|Part A - Washout Period 2||0
329341|NCT00626275|797343|P8|COMPLETED|Part A - Washout Period 2||0
329342|NCT00626275|797344|P7|COMPLETED|Part A - Washout Period 2||0
329343|NCT00626275|797345|P6|COMPLETED|Part A - Washout Period 2||8
329344|NCT00626275|797346|P5|COMPLETED|Part A - Washout Period 2||9
329345|NCT00626275|797347|P4|COMPLETED|Part A - Washout Period 2||8
329346|NCT00626275|797348|P3|COMPLETED|Part A - Washout Period 2||6
329347|NCT00626275|797349|P2|COMPLETED|Part A - Washout Period 2||7
329348|NCT00626275|797350|P1|COMPLETED|Part A - Washout Period 2||6
329349|NCT00626275|797343|P8|STARTED|Part A - Washout Period 2||0
329350|NCT00626275|797344|P7|STARTED|Part A - Washout Period 2||0
329351|NCT00626275|797345|P6|STARTED|Part A - Washout Period 2||8
329352|NCT00626275|797346|P5|STARTED|Part A - Washout Period 2||9
329353|NCT00626275|797347|P4|STARTED|Part A - Washout Period 2||8
329354|NCT00626275|797348|P3|STARTED|Part A - Washout Period 2||6
329355|NCT00626275|797349|P2|STARTED|Part A - Washout Period 2||7
329356|NCT00626275|797350|P1|STARTED|Part A - Washout Period 2||6
329357|NCT00626275|797343|P8|NOT COMPLETED|Part A - Treatment Period 2||0
329358|NCT00626275|797344|P7|NOT COMPLETED|Part A - Treatment Period 2||0
329359|NCT00626275|797345|P6|NOT COMPLETED|Part A - Treatment Period 2||0
329360|NCT00626275|797346|P5|NOT COMPLETED|Part A - Treatment Period 2||0
329361|NCT00626275|797347|P4|NOT COMPLETED|Part A - Treatment Period 2||0
329362|NCT00626275|797348|P3|NOT COMPLETED|Part A - Treatment Period 2||0
329363|NCT00626275|797349|P2|NOT COMPLETED|Part A - Treatment Period 2||0
329364|NCT00626275|797350|P1|NOT COMPLETED|Part A - Treatment Period 2||0
329365|NCT00626275|797343|P8|COMPLETED|Part A - Treatment Period 2||0
329366|NCT00626275|797344|P7|COMPLETED|Part A - Treatment Period 2||0
329367|NCT00626275|797345|P6|COMPLETED|Part A - Treatment Period 2||8
329368|NCT00626275|797346|P5|COMPLETED|Part A - Treatment Period 2||9
329369|NCT00626275|797347|P4|COMPLETED|Part A - Treatment Period 2||8
329370|NCT00626275|797348|P3|COMPLETED|Part A - Treatment Period 2||6
329371|NCT00626275|797349|P2|COMPLETED|Part A - Treatment Period 2||7
329372|NCT00626275|797350|P1|COMPLETED|Part A - Treatment Period 2||6
329373|NCT00626275|797343|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
329374|NCT00626275|797344|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
329375|NCT00626275|797345|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
329376|NCT00626275|797346|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||9
329377|NCT00626275|797347|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
329378|NCT00626275|797348|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
329379|NCT00626275|797349|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||7
329380|NCT00626275|797350|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
329381|NCT00626275|797343|P8|STARTED|Part A - Treatment Period 2||0
329382|NCT00626275|797344|P7|STARTED|Part A - Treatment Period 2||0
329383|NCT00626275|797345|P6|STARTED|Part A - Treatment Period 2||8
329384|NCT00626275|797346|P5|STARTED|Part A - Treatment Period 2||9
329385|NCT00626275|797347|P4|STARTED|Part A - Treatment Period 2||8
329386|NCT00626275|797348|P3|STARTED|Part A - Treatment Period 2||6
329387|NCT00626275|797349|P2|STARTED|Part A - Treatment Period 2||7
329388|NCT00626275|797350|P1|STARTED|Part A - Treatment Period 2||6
329389|NCT00626275|797343|P8|NOT COMPLETED|Part A - Washout Period 1||0
329390|NCT00626275|797344|P7|NOT COMPLETED|Part A - Washout Period 1||0
329391|NCT00626275|797345|P6|NOT COMPLETED|Part A - Washout Period 1||0
329392|NCT00626275|797346|P5|NOT COMPLETED|Part A - Washout Period 1||0
329393|NCT00626275|797347|P4|NOT COMPLETED|Part A - Washout Period 1||0
329394|NCT00626275|797348|P3|NOT COMPLETED|Part A - Washout Period 1||0
329395|NCT00626275|797349|P2|NOT COMPLETED|Part A - Washout Period 1||0
329396|NCT00626275|797350|P1|NOT COMPLETED|Part A - Washout Period 1||0
329397|NCT00626275|797343|P8|COMPLETED|Part A - Washout Period 1||0
329398|NCT00626275|797344|P7|COMPLETED|Part A - Washout Period 1||0
329399|NCT00626275|797345|P6|COMPLETED|Part A - Washout Period 1||8
329400|NCT00626275|797346|P5|COMPLETED|Part A - Washout Period 1||9
329401|NCT00626275|797347|P4|COMPLETED|Part A - Washout Period 1||8
329402|NCT00626275|797348|P3|COMPLETED|Part A - Washout Period 1||6
329403|NCT00626275|797349|P2|COMPLETED|Part A - Washout Period 1||7
329404|NCT00626275|797350|P1|COMPLETED|Part A - Washout Period 1||6
329405|NCT00626275|797343|P8|STARTED|Part A - Washout Period 1||0
329406|NCT00626275|797344|P7|STARTED|Part A - Washout Period 1||0
329407|NCT00626275|797345|P6|STARTED|Part A - Washout Period 1||8
329408|NCT00626275|797346|P5|STARTED|Part A - Washout Period 1||9
329409|NCT00626275|797347|P4|STARTED|Part A - Washout Period 1||8
329410|NCT00626275|797348|P3|STARTED|Part A - Washout Period 1||6
329411|NCT00626275|797349|P2|STARTED|Part A - Washout Period 1||7
329412|NCT00626275|797350|P1|STARTED|Part A - Washout Period 1||6
329413|NCT00626275|797343|P8|NOT COMPLETED|Part A - Treatment Period 1||0
329414|NCT00626275|797344|P7|NOT COMPLETED|Part A - Treatment Period 1||0
329415|NCT00626275|797345|P6|NOT COMPLETED|Part A - Treatment Period 1||0
329416|NCT00626275|797346|P5|NOT COMPLETED|Part A - Treatment Period 1||0
329417|NCT00626275|797347|P4|NOT COMPLETED|Part A - Treatment Period 1||0
329418|NCT00626275|797348|P3|NOT COMPLETED|Part A - Treatment Period 1||1
329419|NCT00626275|797349|P2|NOT COMPLETED|Part A - Treatment Period 1||0
329420|NCT00626275|797350|P1|NOT COMPLETED|Part A - Treatment Period 1||1
329421|NCT00626275|797343|P8|COMPLETED|Part A - Treatment Period 1||0
329422|NCT00626275|797344|P7|COMPLETED|Part A - Treatment Period 1||0
329423|NCT00626275|797345|P6|COMPLETED|Part A - Treatment Period 1||8
329424|NCT00626275|797346|P5|COMPLETED|Part A - Treatment Period 1||9
329425|NCT00626275|797347|P4|COMPLETED|Part A - Treatment Period 1||8
329426|NCT00626275|797348|P3|COMPLETED|Part A - Treatment Period 1||6
329427|NCT00626275|797349|P2|COMPLETED|Part A - Treatment Period 1||7
329428|NCT00626275|797350|P1|COMPLETED|Part A - Treatment Period 1||6
329429|NCT00626275|797343|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
329430|NCT00626275|797344|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
329431|NCT00626275|797345|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
329432|NCT00626275|797346|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||9
329433|NCT00626275|797347|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
329434|NCT00626275|797348|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
329435|NCT00626275|797349|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
329436|NCT00626275|797350|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
329437|NCT00626275|797343|P8|STARTED|Part A - Treatment Period 1||0
329438|NCT00626275|797344|P7|STARTED|Part A - Treatment Period 1||0
329439|NCT00626275|797345|P6|STARTED|Part A - Treatment Period 1||8
329440|NCT00626275|797346|P5|STARTED|Part A - Treatment Period 1||9
329441|NCT00626275|797347|P4|STARTED|Part A - Treatment Period 1||8
329442|NCT00626275|797348|P3|STARTED|Part A - Treatment Period 1||7
329443|NCT00626275|797349|P2|STARTED|Part A - Treatment Period 1||7
329444|NCT00626275|797350|P1|STARTED|Part A - Treatment Period 1||7
329445|NCT00626210|797390|P1|NOT COMPLETED|Overall Study||0
329446|NCT00626210|797390|P1|COMPLETED|Overall Study||2
329447|NCT00626210|797390|P1|STARTED|Overall Study||2
329448|NCT00626093|797394|P1|NOT COMPLETED|Overall Study||23
329449|NCT00626093|797394|P1|COMPLETED|Overall Study||54
329450|NCT00626093|797394|P1|STARTED|Overall Study||77
329451|NCT00626028|797401|P2|NOT COMPLETED|Treatment 3 10 Minute Dose NO or O2||0
329452|NCT00626028|797402|P1|NOT COMPLETED|Treatment 3 10 Minute Dose NO or O2||0
329453|NCT00626028|797401|P2|COMPLETED|Treatment 3 10 Minute Dose NO or O2||59
329454|NCT00626028|797402|P1|COMPLETED|Treatment 3 10 Minute Dose NO or O2||62
329455|NCT00626028|797401|P2|STARTED|Treatment 3 10 Minute Dose NO or O2||59
329456|NCT00626028|797402|P1|STARTED|Treatment 3 10 Minute Dose NO or O2||62
329457|NCT00626028|797401|P2|NOT COMPLETED|Washout Period of 10 Minutes||0
329458|NCT00626028|797402|P1|NOT COMPLETED|Washout Period of 10 Minutes||0
329459|NCT00626028|797401|P2|COMPLETED|Washout Period of 10 Minutes||59
329460|NCT00626028|797402|P1|COMPLETED|Washout Period of 10 Minutes||62
329461|NCT00626028|797401|P2|STARTED|Washout Period of 10 Minutes||59
329462|NCT00626028|797402|P1|STARTED|Washout Period of 10 Minutes||62
329463|NCT00626028|797401|P2|NOT COMPLETED|Treatment 2 10 Minute Dose NO Plus O2||0
329464|NCT00626028|797402|P1|NOT COMPLETED|Treatment 2 10 Minute Dose NO Plus O2||0
329465|NCT00626028|797401|P2|COMPLETED|Treatment 2 10 Minute Dose NO Plus O2||59
329466|NCT00626028|797402|P1|COMPLETED|Treatment 2 10 Minute Dose NO Plus O2||62
329467|NCT00626028|797401|P2|STARTED|Treatment 2 10 Minute Dose NO Plus O2||59
329468|NCT00626028|797402|P1|STARTED|Treatment 2 10 Minute Dose NO Plus O2||62
329469|NCT00626028|797401|P2|NOT COMPLETED|Treatment 1 NO First, O2 Last||9
329470|NCT00626028|797402|P1|NOT COMPLETED|Treatment 1 NO First, O2 Last||6
329471|NCT00626028|797401|P2|COMPLETED|Treatment 1 NO First, O2 Last||59
329472|NCT00626028|797402|P1|COMPLETED|Treatment 1 NO First, O2 Last||62
329473|NCT00626028|797401|P2|STARTED|Treatment 1 NO First, O2 Last||68
329474|NCT00626028|797402|P1|STARTED|Treatment 1 NO First, O2 Last||68
329475|NCT00625989|797412|P2|NOT COMPLETED|Overall Study||0
329476|NCT00625989|797413|P1|NOT COMPLETED|Overall Study||0
329477|NCT00625989|797412|P2|COMPLETED|Overall Study||6
329478|NCT00625989|797413|P1|COMPLETED|Overall Study||6
329479|NCT00625989|797412|P2|STARTED|Overall Study||6
329480|NCT00625989|797413|P1|STARTED|Overall Study||6
329481|NCT00625872|797422|P2|NOT COMPLETED|Overall Study||6
329482|NCT00625872|797423|P1|NOT COMPLETED|Overall Study||4
329483|NCT00625872|797422|P2|COMPLETED|Overall Study||5
329484|NCT00625872|797423|P1|COMPLETED|Overall Study||8
329485|NCT00625872|797422|P2|Treated|Overall Study||10
329486|NCT00625872|797423|P1|Treated|Overall Study||12
329487|NCT00625872|797422|P2|STARTED|Overall Study||11
329488|NCT00625872|797423|P1|STARTED|Overall Study||12
329489|NCT00625820|797533|P1|NOT COMPLETED|Overall Study||1
329490|NCT00625820|797533|P1|COMPLETED|Overall Study||16
329491|NCT00625820|797533|P1|STARTED|Overall Study||17
329492|NCT00625807|797541|P2|NOT COMPLETED|Overall Study||8
329493|NCT00625807|797542|P1|NOT COMPLETED|Overall Study||2
329494|NCT00625807|797541|P2|COMPLETED|Overall Study||20
329495|NCT00625807|797542|P1|COMPLETED|Overall Study||20
329496|NCT00625807|797541|P2|STARTED|Overall Study||28
329497|NCT00625807|797542|P1|STARTED|Overall Study||22
329498|NCT00625742|797558|P1|NOT COMPLETED|Overall Study||12
329499|NCT00625742|797558|P1|COMPLETED|Overall Study||3
329500|NCT00625742|797558|P1|STARTED|Overall Study||15
329501|NCT00625729|797563|P1|NOT COMPLETED|Overall Study||0
329502|NCT00625729|797563|P1|COMPLETED|Overall Study||6
329503|NCT00625729|797563|P1|STARTED|Overall Study||6
329504|NCT00625586|797572|P1|NOT COMPLETED|Overall Study||1
329505|NCT00625586|797572|P1|COMPLETED|Overall Study||1
329506|NCT00625586|797572|P1|STARTED|Overall Study||2
329507|NCT00625443|797585|P3|NOT COMPLETED|Overall Study||5
329508|NCT00625443|797586|P2|NOT COMPLETED|Overall Study||11
329509|NCT00625443|797587|P1|NOT COMPLETED|Overall Study||2
329510|NCT00625443|797585|P3|COMPLETED|Overall Study||10
329511|NCT00625443|797586|P2|COMPLETED|Overall Study||15
329512|NCT00625443|797587|P1|COMPLETED|Overall Study||10
329513|NCT00625443|797585|P3|STARTED|Overall Study||15
329514|NCT00625443|797586|P2|STARTED|Overall Study||26
329515|NCT00625443|797587|P1|STARTED|Overall Study||12
329516|NCT00625404|797617|P2|NOT COMPLETED|Overall Study||173
329517|NCT00625404|797618|P1|NOT COMPLETED|Overall Study||207
329518|NCT00625404|797617|P2|COMPLETED|Overall Study||885
329519|NCT00625404|797618|P1|COMPLETED|Overall Study||855
329520|NCT00625404|797617|P2|STARTED|Overall Study||1058
329521|NCT00625404|797618|P1|STARTED|Overall Study||1062
329522|NCT00625391|797650|P4|NOT COMPLETED|Overall Study||1
329523|NCT00625391|797651|P3|NOT COMPLETED|Overall Study||5
329524|NCT00625391|797652|P2|NOT COMPLETED|Overall Study||8
329525|NCT00625391|797653|P1|NOT COMPLETED|Overall Study||7
329526|NCT00625391|797650|P4|COMPLETED|Overall Study||37
329527|NCT00625391|797651|P3|COMPLETED|Overall Study||37
329528|NCT00625391|797652|P2|COMPLETED|Overall Study||39
329529|NCT00625391|797653|P1|COMPLETED|Overall Study||37
329530|NCT00625391|797650|P4|STARTED|Overall Study||38
329531|NCT00625391|797651|P3|STARTED|Overall Study||42
329532|NCT00625391|797652|P2|STARTED|Overall Study||47
329533|NCT00625391|797653|P1|STARTED|Overall Study||44
329534|NCT00625365|797667|P1|NOT COMPLETED|Overall Study||7
329535|NCT00625365|797667|P1|COMPLETED|Overall Study|Participants who were analyzed for safety|1053
329536|NCT00625365|797667|P1|STARTED|Overall Study||1060
329537|NCT00625183|797673|P1|NOT COMPLETED|Overall Study||1
329538|NCT00625183|797673|P1|COMPLETED|Overall Study||4
329539|NCT00625183|797673|P1|STARTED|Overall Study||5
329540|NCT00625131|797684|P3|NOT COMPLETED|Overall Study||5
329541|NCT00625131|797685|P2|NOT COMPLETED|Overall Study||2
329542|NCT00625131|797686|P1|NOT COMPLETED|Overall Study||4
329543|NCT00625131|797684|P3|COMPLETED|Overall Study||0
329544|NCT00625131|797685|P2|COMPLETED|Overall Study||42
329545|NCT00625131|797686|P1|COMPLETED|Overall Study||34
329546|NCT00625131|797684|P3|STARTED|Overall Study|These participants were not included in any analyses.|5
329547|NCT00625131|797685|P2|STARTED|Overall Study||44
329548|NCT00625131|797686|P1|STARTED|Overall Study||38
329549|NCT00624923|797698|P2|NOT COMPLETED|Overall Study||23
329550|NCT00624923|797699|P1|NOT COMPLETED|Overall Study||38
329551|NCT00624923|797698|P2|COMPLETED|Overall Study||101
329552|NCT00624923|797699|P1|COMPLETED|Overall Study||89
329553|NCT00624923|797698|P2|STARTED|Overall Study||124
329554|NCT00624923|797699|P1|STARTED|Overall Study||127
329555|NCT00624832|797715|P4|NOT COMPLETED|Overall Study||1
329556|NCT00624832|797716|P3|NOT COMPLETED|Overall Study||0
329557|NCT00624832|797717|P2|NOT COMPLETED|Overall Study||1
329558|NCT00624832|797718|P1|NOT COMPLETED|Overall Study||2
329559|NCT00624832|797715|P4|COMPLETED|Overall Study||15
329560|NCT00624832|797716|P3|COMPLETED|Overall Study||10
329561|NCT00624832|797717|P2|COMPLETED|Overall Study||15
329562|NCT00624832|797718|P1|COMPLETED|Overall Study||16
329563|NCT00624832|797715|P4|STARTED|Overall Study||16
329564|NCT00624832|797716|P3|STARTED|Overall Study||10
329565|NCT00624832|797717|P2|STARTED|Overall Study||16
329566|NCT00624832|797718|P1|STARTED|Overall Study||18
329567|NCT00624806|797732|P2|NOT COMPLETED|Overall Study||0
329568|NCT00624806|797733|P1|NOT COMPLETED|Overall Study||0
329569|NCT00624806|797732|P2|COMPLETED|Overall Study||8
329570|NCT00624806|797733|P1|COMPLETED|Overall Study||10
329571|NCT00624806|797732|P2|STARTED|Overall Study||8
329572|NCT00624806|797733|P1|STARTED|Overall Study||10
329573|NCT00624780|797749|P6|NOT COMPLETED|Follow-up (Week 26)||0
329574|NCT00624780|797750|P5|NOT COMPLETED|Follow-up (Week 26)||2
329575|NCT00624780|797751|P4|NOT COMPLETED|Follow-up (Week 26)||0
329576|NCT00624780|797752|P3|NOT COMPLETED|Follow-up (Week 26)||2
329577|NCT00624780|797753|P2|NOT COMPLETED|Follow-up (Week 26)||1
329578|NCT00624780|797754|P1|NOT COMPLETED|Follow-up (Week 26)||2
329579|NCT00624780|797749|P6|COMPLETED|Follow-up (Week 26)||29
329580|NCT00624780|797750|P5|COMPLETED|Follow-up (Week 26)||93
329581|NCT00624780|797751|P4|COMPLETED|Follow-up (Week 26)||26
329582|NCT00624780|797752|P3|COMPLETED|Follow-up (Week 26)||89
329583|NCT00624780|797753|P2|COMPLETED|Follow-up (Week 26)||27
329584|NCT00624780|797754|P1|COMPLETED|Follow-up (Week 26)||102
329585|NCT00624780|797749|P6|STARTED|Follow-up (Week 26)||29
329586|NCT00624780|797750|P5|STARTED|Follow-up (Week 26)||95
329587|NCT00624780|797751|P4|STARTED|Follow-up (Week 26)||26
329588|NCT00624780|797752|P3|STARTED|Follow-up (Week 26)||91
329589|NCT00624780|797753|P2|STARTED|Follow-up (Week 26)||28
329590|NCT00624780|797754|P1|STARTED|Follow-up (Week 26)||104
329591|NCT00624780|797749|P6|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
329592|NCT00624780|797750|P5|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
329593|NCT00624780|797751|P4|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
329594|NCT00624780|797752|P3|NOT COMPLETED|Treatment Discontinuation (Week 25)||3
329595|NCT00624780|797753|P2|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
329596|NCT00624780|797754|P1|NOT COMPLETED|Treatment Discontinuation (Week 25)||2
329597|NCT00624780|797749|P6|COMPLETED|Treatment Discontinuation (Week 25)||29
329598|NCT00624780|797750|P5|COMPLETED|Treatment Discontinuation (Week 25)||95
329599|NCT00624780|797751|P4|COMPLETED|Treatment Discontinuation (Week 25)||26
329600|NCT00624780|797752|P3|COMPLETED|Treatment Discontinuation (Week 25)||91
329601|NCT00624780|797753|P2|COMPLETED|Treatment Discontinuation (Week 25)||28
329602|NCT00624780|797754|P1|COMPLETED|Treatment Discontinuation (Week 25)||104
329603|NCT00624780|797749|P6|STARTED|Treatment Discontinuation (Week 25)||30
329604|NCT00624780|797750|P5|STARTED|Treatment Discontinuation (Week 25)||95
329605|NCT00624780|797751|P4|STARTED|Treatment Discontinuation (Week 25)||27
329606|NCT00624780|797752|P3|STARTED|Treatment Discontinuation (Week 25)||94
329607|NCT00624780|797753|P2|STARTED|Treatment Discontinuation (Week 25)||28
329608|NCT00624780|797754|P1|STARTED|Treatment Discontinuation (Week 25)||106
329609|NCT00624780|797749|P6|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||9
329610|NCT00624780|797750|P5|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||19
329611|NCT00624780|797751|P4|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
329612|NCT00624780|797752|P3|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||18
329613|NCT00624780|797753|P2|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
329614|NCT00624780|797754|P1|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||15
329615|NCT00624780|797749|P6|COMPLETED|Fixed Dosing (Week 13 to Week 24)||30
329616|NCT00624780|797750|P5|COMPLETED|Fixed Dosing (Week 13 to Week 24)||95
329617|NCT00624780|797751|P4|COMPLETED|Fixed Dosing (Week 13 to Week 24)||27
329618|NCT00624780|797752|P3|COMPLETED|Fixed Dosing (Week 13 to Week 24)||94
329619|NCT00624780|797753|P2|COMPLETED|Fixed Dosing (Week 13 to Week 24)||28
329620|NCT00624780|797754|P1|COMPLETED|Fixed Dosing (Week 13 to Week 24)||106
329621|NCT00624780|797749|P6|STARTED|Fixed Dosing (Week 13 to Week 24)||39
329622|NCT00624780|797750|P5|STARTED|Fixed Dosing (Week 13 to Week 24)||114
329623|NCT00624780|797751|P4|STARTED|Fixed Dosing (Week 13 to Week 24)||38
329624|NCT00624780|797752|P3|STARTED|Fixed Dosing (Week 13 to Week 24)||112
329625|NCT00624780|797753|P2|STARTED|Fixed Dosing (Week 13 to Week 24)||39
329626|NCT00624780|797754|P1|STARTED|Fixed Dosing (Week 13 to Week 24)||121
329627|NCT00624780|797749|P6|NOT COMPLETED|Treatment Optimization (Up to Week 12)||11
329628|NCT00624780|797750|P5|NOT COMPLETED|Treatment Optimization (Up to Week 12)||39
329629|NCT00624780|797751|P4|NOT COMPLETED|Treatment Optimization (Up to Week 12)||14
329630|NCT00624780|797752|P3|NOT COMPLETED|Treatment Optimization (Up to Week 12)||42
329631|NCT00624780|797753|P2|NOT COMPLETED|Treatment Optimization (Up to Week 12)||13
329632|NCT00624780|797754|P1|NOT COMPLETED|Treatment Optimization (Up to Week 12)||33
329633|NCT00624780|797749|P6|COMPLETED|Treatment Optimization (Up to Week 12)||39
329634|NCT00624780|797750|P5|COMPLETED|Treatment Optimization (Up to Week 12)||114
329635|NCT00624780|797751|P4|COMPLETED|Treatment Optimization (Up to Week 12)||38
329636|NCT00624780|797752|P3|COMPLETED|Treatment Optimization (Up to Week 12)||112
329637|NCT00624780|797753|P2|COMPLETED|Treatment Optimization (Up to Week 12)||39
329638|NCT00624780|797754|P1|COMPLETED|Treatment Optimization (Up to Week 12)||121
329639|NCT00624780|797749|P6|STARTED|Treatment Optimization (Up to Week 12)||50
329640|NCT00624780|797750|P5|STARTED|Treatment Optimization (Up to Week 12)||153
329641|NCT00624780|797751|P4|STARTED|Treatment Optimization (Up to Week 12)||52
329642|NCT00624780|797752|P3|STARTED|Treatment Optimization (Up to Week 12)||154
329643|NCT00624780|797753|P2|STARTED|Treatment Optimization (Up to Week 12)||52
329644|NCT00624780|797754|P1|STARTED|Treatment Optimization (Up to Week 12)||154
329645|NCT00624650|797938|P2|NOT COMPLETED|Overall Study||1
329646|NCT00624650|797939|P1|NOT COMPLETED|Overall Study||1
329647|NCT00624650|797938|P2|COMPLETED|Overall Study||15
329648|NCT00624650|797939|P1|COMPLETED|Overall Study||16
329649|NCT00624650|797938|P2|STARTED|Overall Study||16
329650|NCT00624650|797939|P1|STARTED|Overall Study||17
329651|NCT00624585|797945|P1|NOT COMPLETED|Overall Study||12
329652|NCT00624585|797945|P1|COMPLETED|Overall Study||6
329653|NCT00624585|797945|P1|STARTED|Overall Study||18
329654|NCT00624559|797956|P4|NOT COMPLETED|Overall Study||0
329655|NCT00624559|797957|P3|NOT COMPLETED|Overall Study||0
329656|NCT00624559|797958|P2|NOT COMPLETED|Overall Study||0
329657|NCT00624559|797959|P1|NOT COMPLETED|Overall Study||0
329658|NCT00624559|797956|P4|COMPLETED|Overall Study||3
329659|NCT00624559|797957|P3|COMPLETED|Overall Study||3
329660|NCT00624559|797958|P2|COMPLETED|Overall Study||3
329661|NCT00624559|797959|P1|COMPLETED|Overall Study||3
329662|NCT00624559|797956|P4|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
329663|NCT00624559|797957|P3|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
329664|NCT00624559|797958|P2|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
329665|NCT00624559|797959|P1|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
329666|NCT00624520|797975|P2|NOT COMPLETED|Overall Study||8
329667|NCT00624520|797976|P1|NOT COMPLETED|Overall Study||12
329668|NCT00624520|797975|P2|COMPLETED|Overall Study||39
329669|NCT00624520|797976|P1|COMPLETED|Overall Study||44
329670|NCT00624520|797975|P2|STARTED|Overall Study||47
329671|NCT00624520|797976|P1|STARTED|Overall Study||56
329672|NCT00624468|798003|P4|NOT COMPLETED|Safety Follow-up (SFU) Period||3
329673|NCT00624468|798004|P3|NOT COMPLETED|Safety Follow-up (SFU) Period||2
329674|NCT00624468|798005|P2|NOT COMPLETED|Safety Follow-up (SFU) Period||0
329675|NCT00624468|798006|P1|NOT COMPLETED|Safety Follow-up (SFU) Period||0
329676|NCT00624468|798003|P4|COMPLETED|Safety Follow-up (SFU) Period||11
329677|NCT00624468|798004|P3|COMPLETED|Safety Follow-up (SFU) Period||11
329678|NCT00624468|798005|P2|COMPLETED|Safety Follow-up (SFU) Period||0
329679|NCT00624468|798006|P1|COMPLETED|Safety Follow-up (SFU) Period||0
329680|NCT00624468|798003|P4|STARTED|Safety Follow-up (SFU) Period||14
329681|NCT00624468|798004|P3|STARTED|Safety Follow-up (SFU) Period||13
329682|NCT00624468|798005|P2|STARTED|Safety Follow-up (SFU) Period||0
329683|NCT00624468|798006|P1|STARTED|Safety Follow-up (SFU) Period||0
329684|NCT00624468|798003|P4|NOT COMPLETED|Double-blind Period||0
329685|NCT00624468|798004|P3|NOT COMPLETED|Double-blind Period||0
329686|NCT00624468|798005|P2|NOT COMPLETED|Double-blind Period||13
329687|NCT00624468|798006|P1|NOT COMPLETED|Double-blind Period||14
329688|NCT00624468|798003|P4|COMPLETED|Double-blind Period||0
329689|NCT00624468|798004|P3|COMPLETED|Double-blind Period||0
329690|NCT00624468|798005|P2|COMPLETED|Double-blind Period||4
329691|NCT00624468|798006|P1|COMPLETED|Double-blind Period||3
329692|NCT00624468|798003|P4|STARTED|Double-blind Period||0
329693|NCT00624468|798004|P3|STARTED|Double-blind Period||0
329694|NCT00624468|798005|P2|STARTED|Double-blind Period||17
329695|NCT00624468|798006|P1|STARTED|Double-blind Period||17
329696|NCT00624442|798037|P5|NOT COMPLETED|Overall Study||2
329697|NCT00624442|798038|P4|NOT COMPLETED|Overall Study||0
329698|NCT00624442|798039|P3|NOT COMPLETED|Overall Study||2
329699|NCT00624442|798040|P2|NOT COMPLETED|Overall Study||1
329700|NCT00624442|798041|P1|NOT COMPLETED|Overall Study||0
329701|NCT00624442|798037|P5|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
329702|NCT00624442|798038|P4|COMPLETED|Overall Study||8
329703|NCT00624442|798039|P3|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
329704|NCT00624442|798040|P2|COMPLETED|Overall Study|One patient was discontinued after inadvertant overdose.|8
329705|NCT00624442|798041|P1|COMPLETED|Overall Study||8
329706|NCT00624442|798037|P5|STARTED|Overall Study||10
329707|NCT00624442|798038|P4|STARTED|Overall Study||8
329708|NCT00624442|798039|P3|STARTED|Overall Study||10
329709|NCT00624442|798040|P2|STARTED|Overall Study||9
329710|NCT00624442|798041|P1|STARTED|Overall Study||8
329711|NCT00624416|798067|P1|NOT COMPLETED|Overall Study||0
329712|NCT00624416|798067|P1|COMPLETED|Overall Study||10
329713|NCT00624416|798067|P1|STARTED|Overall Study||10
329714|NCT00624377|798073|P1|NOT COMPLETED|Overall Study||644
329715|NCT00624377|798073|P1|COMPLETED|Overall Study||1387
329716|NCT00624377|798073|P1|STARTED|Overall Study||2031
329717|NCT00624338|798087|P3|NOT COMPLETED|Overall Study||46
329718|NCT00624338|798088|P2|NOT COMPLETED|Overall Study||83
329719|NCT00624338|798089|P1|NOT COMPLETED|Overall Study||47
329720|NCT00624338|798087|P3|COMPLETED|Overall Study||111
329721|NCT00624338|798088|P2|COMPLETED|Overall Study||62
329722|NCT00624338|798089|P1|COMPLETED|Overall Study||112
329723|NCT00624338|798087|P3|Treated|Overall Study||154
329724|NCT00624338|798088|P2|Treated|Overall Study||144
329725|NCT00624338|798089|P1|Treated|Overall Study||157
329726|NCT00624338|798087|P3|STARTED|Overall Study||157
329727|NCT00624338|798088|P2|STARTED|Overall Study||145
329728|NCT00624338|798089|P1|STARTED|Overall Study||159
329729|NCT00624286|798111|P2|NOT COMPLETED|Overall Study||27
329730|NCT00624286|798112|P1|NOT COMPLETED|Overall Study||25
329731|NCT00624286|798111|P2|COMPLETED|Overall Study||178
329732|NCT00624286|798112|P1|COMPLETED|Overall Study||186
329733|NCT00624286|798111|P2|STARTED|Overall Study||205
329734|NCT00624286|798112|P1|STARTED|Overall Study||211
329735|NCT00624234|798126|P6|NOT COMPLETED|Overall Study||0
329736|NCT00624234|798127|P5|NOT COMPLETED|Overall Study||0
329737|NCT00624234|798128|P4|NOT COMPLETED|Overall Study||0
329738|NCT00624234|798129|P3|NOT COMPLETED|Overall Study||0
329739|NCT00624234|798130|P2|NOT COMPLETED|Overall Study||0
329740|NCT00624234|798131|P1|NOT COMPLETED|Overall Study||0
329741|NCT00624234|798126|P6|COMPLETED|Overall Study||14
329742|NCT00624234|798127|P5|COMPLETED|Overall Study||18
329743|NCT00624234|798128|P4|COMPLETED|Overall Study||14
329744|NCT00624234|798129|P3|COMPLETED|Overall Study||26
329745|NCT00624234|798130|P2|COMPLETED|Overall Study||9
329746|NCT00624234|798131|P1|COMPLETED|Overall Study||8
329747|NCT00624234|798126|P6|STARTED|Overall Study||14
329748|NCT00624234|798127|P5|STARTED|Overall Study||18
329749|NCT00624234|798128|P4|STARTED|Overall Study||14
329750|NCT00624234|798129|P3|STARTED|Overall Study||26
329751|NCT00624234|798130|P2|STARTED|Overall Study||9
329752|NCT00624234|798131|P1|STARTED|Overall Study||8
329753|NCT00624221|798147|P2|NOT COMPLETED|Overall Study||0
329754|NCT00624221|798148|P1|NOT COMPLETED|Overall Study||0
329755|NCT00624221|798147|P2|COMPLETED|Overall Study||20
329756|NCT00624221|798148|P1|COMPLETED|Overall Study||20
329757|NCT00624221|798147|P2|STARTED|Overall Study||20
329758|NCT00624221|798148|P1|STARTED|Overall Study||20
329759|NCT00624195|798156|P2|NOT COMPLETED|Overall Study||7
329760|NCT00624195|798157|P1|NOT COMPLETED|Overall Study||3
329761|NCT00624195|798156|P2|COMPLETED|Overall Study||23
329762|NCT00624195|798157|P1|COMPLETED|Overall Study||26
329763|NCT00624195|798156|P2|STARTED|Overall Study||30
329764|NCT00624195|798157|P1|STARTED|Overall Study||29
329765|NCT00624065|798165|P2|NOT COMPLETED|Overall Study||24
329766|NCT00624065|798166|P1|NOT COMPLETED|Overall Study||19
329767|NCT00624065|798165|P2|COMPLETED|Overall Study||192
329768|NCT00624065|798166|P1|COMPLETED|Overall Study||197
329769|NCT00624065|798165|P2|STARTED|Overall Study||216
329770|NCT00624065|798166|P1|STARTED|Overall Study||216
329771|NCT00624052|798178|P4|NOT COMPLETED|Overall Study||4
329772|NCT00624052|798179|P3|NOT COMPLETED|Overall Study||3
329773|NCT00624052|798180|P2|NOT COMPLETED|Overall Study||14
329774|NCT00624052|798181|P1|NOT COMPLETED|Overall Study||15
329775|NCT00624052|798178|P4|COMPLETED|Overall Study||88
329776|NCT00624052|798179|P3|COMPLETED|Overall Study||88
329777|NCT00624052|798180|P2|COMPLETED|Overall Study||422
329778|NCT00624052|798181|P1|COMPLETED|Overall Study||204
329779|NCT00624052|798178|P4|STARTED|Overall Study||92
329780|NCT00624052|798179|P3|STARTED|Overall Study||91
329781|NCT00624052|798180|P2|STARTED|Overall Study||436
329782|NCT00624052|798181|P1|STARTED|Overall Study||219
329783|NCT00624013|798232|P2|NOT COMPLETED|Overall Study||6
329784|NCT00624013|798233|P1|NOT COMPLETED|Overall Study||8
329785|NCT00624013|798232|P2|COMPLETED|Overall Study||39
329786|NCT00624013|798233|P1|COMPLETED|Overall Study||36
329787|NCT00624013|798232|P2|STARTED|Overall Study||45
329788|NCT00624013|798233|P1|STARTED|Overall Study||44
329789|NCT00623974|798245|P4|NOT COMPLETED|Overall Study||0
329790|NCT00623974|798246|P3|NOT COMPLETED|Overall Study||0
329791|NCT00623974|798247|P2|NOT COMPLETED|Overall Study||0
329792|NCT00623974|798248|P1|NOT COMPLETED|Overall Study||0
329793|NCT00623974|798245|P4|COMPLETED|Overall Study||0
329794|NCT00623974|798246|P3|COMPLETED|Overall Study||0
329795|NCT00623974|798247|P2|COMPLETED|Overall Study||0
329796|NCT00623974|798248|P1|COMPLETED|Overall Study||0
329797|NCT00623974|798245|P4|STARTED|Overall Study||0
329798|NCT00623974|798246|P3|STARTED|Overall Study||0
329799|NCT00623974|798247|P2|STARTED|Overall Study||0
329800|NCT00623974|798248|P1|STARTED|Overall Study||0
329801|NCT00623935|798258|P1|NOT COMPLETED|Overall Study||2
329802|NCT00623935|798258|P1|COMPLETED|Overall Study||54
329803|NCT00623935|798258|P1|STARTED|Overall Study||56
329804|NCT00623831|798265|P2|NOT COMPLETED|Overall Study||1
329805|NCT00623831|798266|P1|NOT COMPLETED|Overall Study||1
329806|NCT00623831|798265|P2|COMPLETED|Overall Study||3
329807|NCT00623831|798266|P1|COMPLETED|Overall Study||12
329808|NCT00623831|798265|P2|STARTED|Overall Study||4
329809|NCT00623831|798266|P1|STARTED|Overall Study||13
329810|NCT00623805|798278|P2|NOT COMPLETED|Overall Study||22
329811|NCT00623805|798279|P1|NOT COMPLETED|Overall Study||20
329812|NCT00623805|798278|P2|COMPLETED|Overall Study||39
329813|NCT00623805|798279|P1|COMPLETED|Overall Study||42
329814|NCT00623805|798278|P2|STARTED|Overall Study||61
329815|NCT00623805|798279|P1|STARTED|Overall Study||62
329816|NCT00623779|798296|P3|NOT COMPLETED|Overall Study||1
329817|NCT00623779|798297|P2|NOT COMPLETED|Overall Study||3
329818|NCT00623779|798298|P1|NOT COMPLETED|Overall Study||3
329819|NCT00623779|798296|P3|COMPLETED|Overall Study||44
329820|NCT00623779|798297|P2|COMPLETED|Overall Study||39
329821|NCT00623779|798298|P1|COMPLETED|Overall Study||38
329822|NCT00623779|798296|P3|STARTED|Overall Study||45
329823|NCT00623779|798297|P2|STARTED|Overall Study||42
329824|NCT00623779|798298|P1|STARTED|Overall Study||41
329907|NCT00623480|798570|P1|COMPLETED|Overall Study||35
329825|NCT00623766|798347|P2|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||2
329826|NCT00623766|798348|P1|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||10
329827|NCT00623766|798347|P2|COMPLETED|Maintenance Phase (Week 24 to Year 2)||0
329828|NCT00623766|798348|P1|COMPLETED|Maintenance Phase (Week 24 to Year 2)|Inadvertently not noted as discontinued (disease progression); data collection error at site closure|1
329829|NCT00623766|798347|P2|STARTED|Maintenance Phase (Week 24 to Year 2)||2
329830|NCT00623766|798348|P1|STARTED|Maintenance Phase (Week 24 to Year 2)||11
329831|NCT00623766|798347|P2|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||16
329832|NCT00623766|798348|P1|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||36
329833|NCT00623766|798347|P2|COMPLETED|Induction Phase (Day 1 to Week 24)|3 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|5
329834|NCT00623766|798348|P1|COMPLETED|Induction Phase (Day 1 to Week 24)|4 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|15
329835|NCT00623766|798347|P2|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|21
329836|NCT00623766|798348|P1|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|51
329837|NCT00623727|798372|P2|NOT COMPLETED|Open Label Extension Period||0
329838|NCT00623727|798373|P1|NOT COMPLETED|Open Label Extension Period||0
329839|NCT00623727|798372|P2|COMPLETED|Open Label Extension Period||0
329840|NCT00623727|798373|P1|COMPLETED|Open Label Extension Period||20
329841|NCT00623727|798372|P2|STARTED|Open Label Extension Period||0
329842|NCT00623727|798373|P1|STARTED|Open Label Extension Period|10 participants of each group entered open-label extension period after completion of DB study|20
329843|NCT00623727|798372|P2|NOT COMPLETED|Open Label Follow-up||8
329844|NCT00623727|798373|P1|NOT COMPLETED|Open Label Follow-up||0
329845|NCT00623727|798372|P2|COMPLETED|Open Label Follow-up||18
329846|NCT00623727|798373|P1|COMPLETED|Open Label Follow-up||0
329847|NCT00623727|798372|P2|STARTED|Open Label Follow-up|13 Participants from each group after DB period terminated entered open label follow up.|26
329848|NCT00623727|798373|P1|STARTED|Open Label Follow-up||0
329849|NCT00623727|798372|P2|NOT COMPLETED|Double Blind (DB)||32
329850|NCT00623727|798373|P1|NOT COMPLETED|Double Blind (DB)||36
329851|NCT00623727|798372|P2|COMPLETED|Double Blind (DB)||41
329852|NCT00623727|798373|P1|COMPLETED|Double Blind (DB)||34
329853|NCT00623727|798372|P2|Participants Received Treatment|Double Blind (DB)||72
329854|NCT00623727|798373|P1|Participants Received Treatment|Double Blind (DB)||67
329855|NCT00623727|798372|P2|STARTED|Double Blind (DB)|only 72 participants are applicable for baseline characteristic evaluation|73
329856|NCT00623727|798373|P1|STARTED|Double Blind (DB)|only 67 participants are applicable for baseline characteristic evaluation|70
329857|NCT00623714|798393|P2|NOT COMPLETED|Period 2||0
329858|NCT00623714|798394|P1|NOT COMPLETED|Period 2||0
329859|NCT00623714|798393|P2|COMPLETED|Period 2||7
329860|NCT00623714|798394|P1|COMPLETED|Period 2||6
329861|NCT00623714|798393|P2|STARTED|Period 2||7
329862|NCT00623714|798394|P1|STARTED|Period 2||6
329863|NCT00623714|798393|P2|NOT COMPLETED|Period 1||0
329864|NCT00623714|798394|P1|NOT COMPLETED|Period 1||0
329865|NCT00623714|798393|P2|COMPLETED|Period 1||7
329866|NCT00623714|798394|P1|COMPLETED|Period 1||6
329867|NCT00623714|798393|P2|STARTED|Period 1||7
329868|NCT00623714|798394|P1|STARTED|Period 1||6
329869|NCT00623636|798404|P2|NOT COMPLETED|Open Label||412
329870|NCT00623636|798405|P1|NOT COMPLETED|Open Label||0
329871|NCT00623636|798404|P2|COMPLETED|Open Label||263
329872|NCT00623636|798405|P1|COMPLETED|Open Label||0
329873|NCT00623636|798404|P2|STARTED|Open Label|Includes eligible Placebo and MAP0004 patients from the double-blind period.|675
329874|NCT00623636|798405|P1|STARTED|Open Label|Eligible double-blind placebo patients received MAP0004 in the open-label period.|0
329875|NCT00623636|798404|P2|NOT COMPLETED|Double Blind||28
329876|NCT00623636|798405|P1|NOT COMPLETED|Double Blind||33
329877|NCT00623636|798404|P2|COMPLETED|Double Blind||422
329878|NCT00623636|798405|P1|COMPLETED|Double Blind||419
329879|NCT00623636|798404|P2|STARTED|Double Blind||450
329880|NCT00623636|798405|P1|STARTED|Double Blind||452
329881|NCT00623623|798428|P2|NOT COMPLETED|Overall Study||1
329882|NCT00623623|798429|P1|NOT COMPLETED|Overall Study||1
329883|NCT00623623|798428|P2|COMPLETED|Overall Study||948
329884|NCT00623623|798429|P1|COMPLETED|Overall Study||949
329885|NCT00623623|798428|P2|STARTED|Overall Study||949
329886|NCT00623623|798429|P1|STARTED|Overall Study||950
329887|NCT00623597|798485|P2|NOT COMPLETED|Overall Study||0
329888|NCT00623597|798486|P1|NOT COMPLETED|Overall Study||1
329889|NCT00623597|798485|P2|COMPLETED|Overall Study||13
329890|NCT00623597|798486|P1|COMPLETED|Overall Study||4
329891|NCT00623597|798485|P2|STARTED|Overall Study||13
329892|NCT00623597|798486|P1|STARTED|Overall Study||5
329893|NCT00623545|798549|P1|NOT COMPLETED|Overall Study||10
329894|NCT00623545|798549|P1|COMPLETED|Overall Study||18
329895|NCT00623545|798549|P1|STARTED|Overall Study||28
329896|NCT00623506|798556|P2|NOT COMPLETED|Overall Study||4
329897|NCT00623506|798557|P1|NOT COMPLETED|Overall Study||4
329898|NCT00623506|798556|P2|COMPLETED|Overall Study||11
329899|NCT00623506|798557|P1|COMPLETED|Overall Study||11
329900|NCT00623506|798556|P2|Week 4|Overall Study||11
329901|NCT00623506|798557|P1|Week 4|Overall Study||11
329902|NCT00623506|798556|P2|STARTED|Overall Study||15
329903|NCT00623506|798557|P1|STARTED|Overall Study||15
329904|NCT00623480|798569|P2|NOT COMPLETED|Overall Study||7
329905|NCT00623480|798570|P1|NOT COMPLETED|Overall Study||7
329906|NCT00623480|798569|P2|COMPLETED|Overall Study||35
329908|NCT00623480|798569|P2|STARTED|Overall Study||42
329909|NCT00623480|798570|P1|STARTED|Overall Study||42
329910|NCT00623467|798582|P1|NOT COMPLETED|Overall Study||7
329911|NCT00623467|798582|P1|COMPLETED|Overall Study||336
329912|NCT00623467|798582|P1|STARTED|Overall Study||343
329913|NCT00623441|798646|P1|NOT COMPLETED|Overall Study||0
329914|NCT00623441|798646|P1|COMPLETED|Overall Study|12 months follow-up compliance was 94.2%|8314
329915|NCT00623441|798646|P1|STARTED|Overall Study||8314
329916|NCT00623428|798652|P2|NOT COMPLETED|Follow-up Period||15
329917|NCT00623428|798653|P1|NOT COMPLETED|Follow-up Period||29
329918|NCT00623428|798652|P2|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 24 weeks of follow-up|78
329919|NCT00623428|798653|P1|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 48 weeks of follow-up|66
329920|NCT00623428|798652|P2|STARTED|Follow-up Period||93
329921|NCT00623428|798653|P1|STARTED|Follow-up Period||95
329922|NCT00623428|798652|P2|NOT COMPLETED|Treatment Period||27
329923|NCT00623428|798653|P1|NOT COMPLETED|Treatment Period||0
329924|NCT00623428|798652|P2|COMPLETED|Treatment Period|Patients who completed 48 weeks of treatment|66
329925|NCT00623428|798653|P1|COMPLETED|Treatment Period|Patients who completed 24 weeks of treatment|95
329926|NCT00623428|798652|P2|STARTED|Treatment Period||93
329927|NCT00623428|798653|P1|STARTED|Treatment Period||95
329928|NCT00623233|798671|P1|NOT COMPLETED|Overall Study||24
329929|NCT00623233|798671|P1|COMPLETED|Overall Study|Included those who discontinued due to PD or death and those who achieved complete response (CR).|28
329930|NCT00623233|798671|P1|STARTED|Overall Study||52
329931|NCT00623194|798678|P1|NOT COMPLETED|Overall Study||5
329932|NCT00623194|798678|P1|COMPLETED|Overall Study||141
329933|NCT00623194|798678|P1|STARTED|Overall Study||146
329934|NCT00623181|798700|P2|NOT COMPLETED|Overall Study||0
329935|NCT00623181|798701|P1|NOT COMPLETED|Overall Study||0
329936|NCT00623181|798700|P2|COMPLETED|Overall Study||54
329937|NCT00623181|798701|P1|COMPLETED|Overall Study||56
329938|NCT00623181|798700|P2|STARTED|Overall Study||54
329939|NCT00623181|798701|P1|STARTED|Overall Study||56
329940|NCT00623103|798715|P2|NOT COMPLETED|Overall Study||113
329941|NCT00623103|798716|P1|NOT COMPLETED|Overall Study||111
329942|NCT00623103|798715|P2|COMPLETED|Overall Study||175
329943|NCT00623103|798716|P1|COMPLETED|Overall Study||184
329944|NCT00623103|798715|P2|Safety Set: Received Study Drug|Overall Study||288
329945|NCT00623103|798716|P1|Safety Set: Received Study Drug|Overall Study|One randomized participant did not receive study drug and was not included in the Safety set.|294
329946|NCT00623103|798715|P2|STARTED|Overall Study||288
329947|NCT00623103|798716|P1|STARTED|Overall Study||295
329948|NCT00623012|798736|P1|NOT COMPLETED|Overall Study||0
329949|NCT00623012|798736|P1|COMPLETED|Overall Study||2
329950|NCT00623012|798736|P1|STARTED|Overall Study||2
329951|NCT00622908|798744|P2|NOT COMPLETED|Overall Study||10
329952|NCT00622908|798745|P1|NOT COMPLETED|Overall Study||3
329953|NCT00622908|798744|P2|COMPLETED|Overall Study||122
329954|NCT00622908|798745|P1|COMPLETED|Overall Study||134
329955|NCT00622908|798744|P2|STARTED|Overall Study|Intent to treat population|132
329956|NCT00622908|798745|P1|STARTED|Overall Study|Intent to treat population|137
329957|NCT00622895|798757|P1|NOT COMPLETED|Overall Study||0
329958|NCT00622895|798757|P1|COMPLETED|Overall Study||3
329959|NCT00622895|798757|P1|STARTED|Overall Study||3
329960|NCT00622869|798775|P3|NOT COMPLETED|Overall Study||39
329961|NCT00622869|798776|P2|NOT COMPLETED|Overall Study||57
329962|NCT00622869|798777|P1|NOT COMPLETED|Overall Study||43
329963|NCT00622869|798775|P3|COMPLETED|Overall Study||204
329964|NCT00622869|798776|P2|COMPLETED|Overall Study||174
329965|NCT00622869|798777|P1|COMPLETED|Overall Study||202
329966|NCT00622869|798775|P3|STARTED|Overall Study||243
329967|NCT00622869|798776|P2|STARTED|Overall Study||231
329968|NCT00622869|798777|P1|STARTED|Overall Study||245
329969|NCT00622739|798796|P2|NOT COMPLETED|Overall Study||6
329970|NCT00622739|798797|P1|NOT COMPLETED|Overall Study||2
329971|NCT00622739|798796|P2|COMPLETED|Overall Study||9
329972|NCT00622739|798797|P1|COMPLETED|Overall Study||11
329973|NCT00622739|798796|P2|STARTED|Overall Study||15
329974|NCT00622739|798797|P1|STARTED|Overall Study||13
329975|NCT00622726|798815|P2|NOT COMPLETED|August, 2010 to April, 2013||5
329976|NCT00622726|798816|P1|NOT COMPLETED|August, 2010 to April, 2013||1
329977|NCT00622726|798815|P2|COMPLETED|August, 2010 to April, 2013||68
329978|NCT00622726|798816|P1|COMPLETED|August, 2010 to April, 2013||69
329979|NCT00622726|798815|P2|STARTED|August, 2010 to April, 2013||73
329980|NCT00622726|798816|P1|STARTED|August, 2010 to April, 2013||70
329981|NCT00622726|798815|P2|NOT COMPLETED|March, 2008 to August, 2010||2
329982|NCT00622726|798816|P1|NOT COMPLETED|March, 2008 to August, 2010||5
329983|NCT00622726|798815|P2|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|73
329984|NCT00622726|798816|P1|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|70
329985|NCT00622726|798815|P2|STARTED|March, 2008 to August, 2010||75
329986|NCT00622726|798816|P1|STARTED|March, 2008 to August, 2010||75
329987|NCT00622713|798826|P1|NOT COMPLETED|Overall Study||59
329988|NCT00622713|798826|P1|COMPLETED|Overall Study||169
329989|NCT00622713|798826|P1|Intent to Treat (ITT) Population|Overall Study||218
329990|NCT00622713|798826|P1|Exposed to Study Drug|Overall Study||226
329991|NCT00622713|798826|P1|STARTED|Overall Study||228
329992|NCT00622700|798837|P7|NOT COMPLETED|Extension Treatment Period||30
329993|NCT00622700|798838|P6|NOT COMPLETED|Extension Treatment Period||17
329994|NCT00622700|798839|P5|NOT COMPLETED|Extension Treatment Period||39
329995|NCT00622700|798840|P4|NOT COMPLETED|Extension Treatment Period||21
329996|NCT00622700|798841|P3|NOT COMPLETED|Extension Treatment Period||0
329997|NCT00622700|798842|P2|NOT COMPLETED|Extension Treatment Period||0
329998|NCT00622700|798843|P1|NOT COMPLETED|Extension Treatment Period||0
329999|NCT00622700|798837|P7|COMPLETED|Extension Treatment Period||120
330000|NCT00622700|798838|P6|COMPLETED|Extension Treatment Period||50
330001|NCT00622700|798839|P5|COMPLETED|Extension Treatment Period||103
330002|NCT00622700|798840|P4|COMPLETED|Extension Treatment Period||43
330003|NCT00622700|798841|P3|COMPLETED|Extension Treatment Period||0
330004|NCT00622700|798842|P2|COMPLETED|Extension Treatment Period||0
330005|NCT00622700|798843|P1|COMPLETED|Extension Treatment Period||0
330006|NCT00622700|798837|P7|STARTED|Extension Treatment Period|13 participants completed core treatment period but did not enter in extension treatment period.|150
330007|NCT00622700|798838|P6|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|67
330008|NCT00622700|798839|P5|STARTED|Extension Treatment Period|8 participants completed core treatment period but did not enter in extension treatment period.|142
330009|NCT00622700|798840|P4|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|64
330010|NCT00622700|798841|P3|STARTED|Extension Treatment Period||0
330011|NCT00622700|798842|P2|STARTED|Extension Treatment Period||0
330012|NCT00622700|798843|P1|STARTED|Extension Treatment Period|Participants were re-randomized in a 1:1 ratio to either teriflunomide 7 mg or 14 mg treatment arm.|0
330013|NCT00622700|798837|P7|NOT COMPLETED|Core Treatment Period||0
330014|NCT00622700|798838|P6|NOT COMPLETED|Core Treatment Period||0
330015|NCT00622700|798839|P5|NOT COMPLETED|Core Treatment Period||0
330016|NCT00622700|798840|P4|NOT COMPLETED|Core Treatment Period||0
330017|NCT00622700|798841|P3|NOT COMPLETED|Core Treatment Period||53
330018|NCT00622700|798842|P2|NOT COMPLETED|Core Treatment Period||55
330019|NCT00622700|798843|P1|NOT COMPLETED|Core Treatment Period||56
330020|NCT00622700|798837|P7|COMPLETED|Core Treatment Period||0
330021|NCT00622700|798838|P6|COMPLETED|Core Treatment Period||0
330022|NCT00622700|798839|P5|COMPLETED|Core Treatment Period||0
330023|NCT00622700|798840|P4|COMPLETED|Core Treatment Period||0
330024|NCT00622700|798841|P3|COMPLETED|Core Treatment Period||163
330025|NCT00622700|798842|P2|COMPLETED|Core Treatment Period||150
330026|NCT00622700|798843|P1|COMPLETED|Core Treatment Period||141
330027|NCT00622700|798837|P7|Treated|Core Treatment Period||0
330028|NCT00622700|798838|P6|Treated|Core Treatment Period||0
330029|NCT00622700|798839|P5|Treated|Core Treatment Period||0
330030|NCT00622700|798840|P4|Treated|Core Treatment Period||0
330031|NCT00622700|798841|P3|Treated|Core Treatment Period||214
330032|NCT00622700|798842|P2|Treated|Core Treatment Period||203
330033|NCT00622700|798843|P1|Treated|Core Treatment Period||197
330034|NCT00622700|798837|P7|STARTED|Core Treatment Period||0
330035|NCT00622700|798838|P6|STARTED|Core Treatment Period||0
330036|NCT00622700|798839|P5|STARTED|Core Treatment Period||0
330037|NCT00622700|798840|P4|STARTED|Core Treatment Period||0
330038|NCT00622700|798841|P3|STARTED|Core Treatment Period||216
330039|NCT00622700|798842|P2|STARTED|Core Treatment Period||205
330040|NCT00622700|798843|P1|STARTED|Core Treatment Period||197
330041|NCT00622635|798902|P6|NOT COMPLETED|Treatment Period 3||0
330042|NCT00622635|798903|P5|NOT COMPLETED|Treatment Period 3||0
330043|NCT00622635|798904|P4|NOT COMPLETED|Treatment Period 3||3
330044|NCT00622635|798905|P3|NOT COMPLETED|Treatment Period 3||0
330045|NCT00622635|798906|P2|NOT COMPLETED|Treatment Period 3||0
330046|NCT00622635|798907|P1|NOT COMPLETED|Treatment Period 3||0
330047|NCT00622635|798902|P6|COMPLETED|Treatment Period 3||10
330048|NCT00622635|798903|P5|COMPLETED|Treatment Period 3||9
330049|NCT00622635|798904|P4|COMPLETED|Treatment Period 3||10
330050|NCT00622635|798905|P3|COMPLETED|Treatment Period 3||10
330051|NCT00622635|798906|P2|COMPLETED|Treatment Period 3||10
330052|NCT00622635|798907|P1|COMPLETED|Treatment Period 3||12
330053|NCT00622635|798902|P6|STARTED|Treatment Period 3||10
330054|NCT00622635|798903|P5|STARTED|Treatment Period 3||9
330055|NCT00622635|798904|P4|STARTED|Treatment Period 3||13
330056|NCT00622635|798905|P3|STARTED|Treatment Period 3||10
330057|NCT00622635|798906|P2|STARTED|Treatment Period 3||10
330058|NCT00622635|798907|P1|STARTED|Treatment Period 3||12
330059|NCT00622635|798902|P6|NOT COMPLETED|Treatment Period 2||0
330060|NCT00622635|798903|P5|NOT COMPLETED|Treatment Period 2||0
330061|NCT00622635|798904|P4|NOT COMPLETED|Treatment Period 2||0
330062|NCT00622635|798905|P3|NOT COMPLETED|Treatment Period 2||0
330063|NCT00622635|798906|P2|NOT COMPLETED|Treatment Period 2||0
330064|NCT00622635|798907|P1|NOT COMPLETED|Treatment Period 2||1
330065|NCT00622635|798902|P6|COMPLETED|Treatment Period 2||10
330066|NCT00622635|798903|P5|COMPLETED|Treatment Period 2||9
330067|NCT00622635|798904|P4|COMPLETED|Treatment Period 2||13
330068|NCT00622635|798905|P3|COMPLETED|Treatment Period 2||10
330069|NCT00622635|798906|P2|COMPLETED|Treatment Period 2||10
330070|NCT00622635|798907|P1|COMPLETED|Treatment Period 2||12
330071|NCT00622635|798902|P6|STARTED|Treatment Period 2||10
330072|NCT00622635|798903|P5|STARTED|Treatment Period 2||9
330073|NCT00622635|798904|P4|STARTED|Treatment Period 2||13
330074|NCT00622635|798905|P3|STARTED|Treatment Period 2||10
330075|NCT00622635|798906|P2|STARTED|Treatment Period 2||10
330076|NCT00622635|798907|P1|STARTED|Treatment Period 2||13
330077|NCT00622635|798902|P6|NOT COMPLETED|Treatment Period 1||0
330078|NCT00622635|798903|P5|NOT COMPLETED|Treatment Period 1||1
330079|NCT00622635|798904|P4|NOT COMPLETED|Treatment Period 1||0
330080|NCT00622635|798905|P3|NOT COMPLETED|Treatment Period 1||1
330081|NCT00622635|798906|P2|NOT COMPLETED|Treatment Period 1||1
330082|NCT00622635|798907|P1|NOT COMPLETED|Treatment Period 1||0
330083|NCT00622635|798902|P6|COMPLETED|Treatment Period 1||10
330084|NCT00622635|798903|P5|COMPLETED|Treatment Period 1||9
330085|NCT00622635|798904|P4|COMPLETED|Treatment Period 1||13
330086|NCT00622635|798905|P3|COMPLETED|Treatment Period 1||10
330087|NCT00622635|798906|P2|COMPLETED|Treatment Period 1||10
330088|NCT00622635|798907|P1|COMPLETED|Treatment Period 1||13
330089|NCT00622635|798902|P6|STARTED|Treatment Period 1||10
330090|NCT00622635|798903|P5|STARTED|Treatment Period 1||10
330091|NCT00622635|798904|P4|STARTED|Treatment Period 1||13
330092|NCT00622635|798905|P3|STARTED|Treatment Period 1||11
330093|NCT00622635|798906|P2|STARTED|Treatment Period 1||11
330094|NCT00622635|798907|P1|STARTED|Treatment Period 1||13
330095|NCT00622544|798972|P1|NOT COMPLETED|Overall Study||9
330096|NCT00622544|798972|P1|COMPLETED|Overall Study|35|35
330097|NCT00622544|798972|P1|STARTED|Overall Study||44
330098|NCT00622518|798979|P2|NOT COMPLETED|Overall Study||0
330099|NCT00622518|798980|P1|NOT COMPLETED|Overall Study||0
330100|NCT00622518|798979|P2|COMPLETED|Overall Study||60
330101|NCT00622518|798980|P1|COMPLETED|Overall Study||59
330102|NCT00622518|798979|P2|STARTED|Overall Study||60
330103|NCT00622518|798980|P1|STARTED|Overall Study||59
330104|NCT00622440|798990|P2|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||1
330105|NCT00622440|798991|P1|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||0
330106|NCT00622440|798990|P2|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||27
330107|NCT00622440|798991|P1|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||28
330108|NCT00622440|798990|P2|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
330109|NCT00622440|798991|P1|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
330110|NCT00622440|798990|P2|NOT COMPLETED|Week 12 - Week 48 (Treatment)||6
330111|NCT00622440|798991|P1|NOT COMPLETED|Week 12 - Week 48 (Treatment)||3
330112|NCT00622440|798990|P2|COMPLETED|Week 12 - Week 48 (Treatment)||28
330113|NCT00622440|798991|P1|COMPLETED|Week 12 - Week 48 (Treatment)||28
330114|NCT00622440|798990|P2|STARTED|Week 12 - Week 48 (Treatment)||34
330115|NCT00622440|798991|P1|STARTED|Week 12 - Week 48 (Treatment)||31
330116|NCT00622440|798990|P2|NOT COMPLETED|Baseline - Week 12 (Treatment)||1
330117|NCT00622440|798991|P1|NOT COMPLETED|Baseline - Week 12 (Treatment)||4
330118|NCT00622440|798990|P2|COMPLETED|Baseline - Week 12 (Treatment)||34
330119|NCT00622440|798991|P1|COMPLETED|Baseline - Week 12 (Treatment)||31
330120|NCT00622440|798990|P2|STARTED|Baseline - Week 12 (Treatment)||35
330121|NCT00622440|798991|P1|STARTED|Baseline - Week 12 (Treatment)||35
330122|NCT00622427|799005|P2|NOT COMPLETED|Overall Study||0
330123|NCT00622427|799006|P1|NOT COMPLETED|Overall Study||0
330124|NCT00622427|799005|P2|COMPLETED|Overall Study|each subject received 2 weeks of placebo, then 2 weeks of Ramelteon after a two week wash out period|16
330125|NCT00622427|799006|P1|COMPLETED|Overall Study|each subject received 2 weeks of Ramelteon, then 2 weeks of placebo after a two week wash out period|16
330126|NCT00622427|799005|P2|STARTED|Overall Study||16
330127|NCT00622427|799006|P1|STARTED|Overall Study||16
330128|NCT00622401|799017|P3|NOT COMPLETED|Overall Study||0
330129|NCT00622401|799018|P2|NOT COMPLETED|Overall Study||2
330130|NCT00622401|799019|P1|NOT COMPLETED|Overall Study||3
330131|NCT00622401|799017|P3|COMPLETED|Overall Study||0
330132|NCT00622401|799018|P2|COMPLETED|Overall Study||0
330133|NCT00622401|799019|P1|COMPLETED|Overall Study||3
330134|NCT00622401|799017|P3|STARTED|Overall Study|Never Opened|0
330135|NCT00622401|799018|P2|STARTED|Overall Study||2
330136|NCT00622401|799019|P1|STARTED|Overall Study||6
330137|NCT00622388|799026|P1|NOT COMPLETED|Overall Study||72
330138|NCT00622388|799026|P1|COMPLETED|Overall Study||9
330139|NCT00622388|799026|P1|STARTED|Overall Study||81
330140|NCT00622336|799044|P1|NOT COMPLETED|Extension Phase||21
330141|NCT00622336|799044|P1|COMPLETED|Extension Phase||0
330142|NCT00622336|799044|P1|STARTED|Extension Phase||21
330143|NCT00622336|799044|P1|NOT COMPLETED|Treatment Phase||309
330144|NCT00622336|799044|P1|COMPLETED|Treatment Phase|Completed = those who completed the treatment phase and were ongoing in the extension study|21
330145|NCT00622336|799044|P1|Safety Population|Treatment Phase||330
330146|NCT00622336|799044|P1|STARTED|Treatment Phase||330
330147|NCT00622284|799055|P2|NOT COMPLETED|Overall Study||171
330148|NCT00622284|799056|P1|NOT COMPLETED|Overall Study||189
330149|NCT00622284|799055|P2|COMPLETED|Overall Study|Number who completed treatment.|604
330150|NCT00622284|799056|P1|COMPLETED|Overall Study|Number who completed treatment.|587
330151|NCT00622284|799055|P2|STARTED|Overall Study|Number who started treatment.|775
330152|NCT00622284|799056|P1|STARTED|Overall Study|Number who started treatment. One patient in the Linagliptin group was randomized but not treated.|776
330153|NCT00622180|799118|P2|NOT COMPLETED|Overall Study||2
330154|NCT00622180|799119|P1|NOT COMPLETED|Overall Study||1
330155|NCT00622180|799118|P2|COMPLETED|Overall Study||5
330156|NCT00622180|799119|P1|COMPLETED|Overall Study||5
330157|NCT00622180|799118|P2|STARTED|Overall Study||7
330158|NCT00622180|799119|P1|STARTED|Overall Study||6
330159|NCT00622167|799125|P1|NOT COMPLETED|Overall Study||20
330160|NCT00622167|799125|P1|COMPLETED|Overall Study||4
330161|NCT00622167|799125|P1|STARTED|Overall Study||24
330162|NCT00621985|799129|P1|NOT COMPLETED|Dexamethasone Admission||1
330163|NCT00621985|799129|P1|COMPLETED|Dexamethasone Admission||4
330164|NCT00621985|799129|P1|STARTED|Dexamethasone Admission||5
330165|NCT00621985|799129|P1|NOT COMPLETED|Hydrocortisone Admission||0
330166|NCT00621985|799129|P1|COMPLETED|Hydrocortisone Admission||5
330167|NCT00621985|799129|P1|STARTED|Hydrocortisone Admission||5
330168|NCT00621959|799137|P2|NOT COMPLETED|Overall Study||9
330169|NCT00621959|799138|P1|NOT COMPLETED|Overall Study||7
330170|NCT00621959|799137|P2|COMPLETED|Overall Study||292
330171|NCT00621959|799138|P1|COMPLETED|Overall Study||288
330172|NCT00621959|799137|P2|STARTED|Overall Study||301
330173|NCT00621959|799138|P1|STARTED|Overall Study|In all 791 subjects have been screened and 596 have been randomized|295
330174|NCT00621946|799148|P2|NOT COMPLETED|Overall Study||1
330175|NCT00621946|799149|P1|NOT COMPLETED|Overall Study||0
330176|NCT00621946|799148|P2|COMPLETED|Overall Study||12
330177|NCT00621946|799149|P1|COMPLETED|Overall Study||13
330178|NCT00621946|799148|P2|STARTED|Overall Study||13
330179|NCT00621946|799149|P1|STARTED|Overall Study||13
330180|NCT00621933|799165|P1|NOT COMPLETED|Overall Study||0
330181|NCT00621933|799165|P1|COMPLETED|Overall Study||399
330182|NCT00621933|799165|P1|STARTED|Overall Study||399
330183|NCT00621855|799177|P5|NOT COMPLETED|Overall Study||55
330184|NCT00621855|799178|P4|NOT COMPLETED|Overall Study||67
330185|NCT00621855|799179|P3|NOT COMPLETED|Overall Study||81
330186|NCT00621855|799180|P2|NOT COMPLETED|Overall Study||61
330187|NCT00621855|799181|P1|NOT COMPLETED|Overall Study||76
330188|NCT00621855|799177|P5|COMPLETED|Overall Study|Completed means completed treatment|318
330189|NCT00621855|799178|P4|COMPLETED|Overall Study|Completed means completed treatment|284
330190|NCT00621855|799179|P3|COMPLETED|Overall Study|Completed means completed treatment|330
330191|NCT00621855|799180|P2|COMPLETED|Overall Study|Completed means completed treatment|310
330192|NCT00621855|799181|P1|COMPLETED|Overall Study|Completed means completed treatment|296
330193|NCT00621855|799177|P5|STARTED|Overall Study|Started means randomised to treatment|373
330194|NCT00621855|799178|P4|STARTED|Overall Study|Started means randomised to treatment|351
330195|NCT00621855|799179|P3|STARTED|Overall Study|Started means randomised to treatment|411
330196|NCT00621855|799180|P2|STARTED|Overall Study|Started means randomised to treatment|371
330197|NCT00621855|799181|P1|STARTED|Overall Study|Started means randomised to treatment|372
330198|NCT00621842|799223|P1|NOT COMPLETED|Overall Study||19
330199|NCT00621842|799223|P1|COMPLETED|Overall Study||38
330200|NCT00621842|799223|P1|STARTED|Overall Study||57
330201|NCT00621777|799240|P2|NOT COMPLETED|Randomized Phase||19
330202|NCT00621777|799241|P1|NOT COMPLETED|Randomized Phase||7
330203|NCT00621777|799240|P2|COMPLETED|Randomized Phase||28
330204|NCT00621777|799241|P1|COMPLETED|Randomized Phase||33
330205|NCT00621777|799240|P2|STARTED|Randomized Phase||47
330206|NCT00621777|799241|P1|STARTED|Randomized Phase|87 open phase participants were continuously abstinent for at least 14 days and were randomized|40
330207|NCT00621777|799240|P2|NOT COMPLETED|Open Phase||0
330208|NCT00621777|799241|P1|NOT COMPLETED|Open Phase||116
330209|NCT00621777|799240|P2|COMPLETED|Open Phase||0
330210|NCT00621777|799241|P1|COMPLETED|Open Phase||87
330211|NCT00621777|799240|P2|STARTED|Open Phase|During this open label phase, all study participants received varenicline|0
330212|NCT00621777|799241|P1|STARTED|Open Phase||203
330213|NCT00621764|799256|P4|NOT COMPLETED|Overall Study||1
330214|NCT00621764|799257|P3|NOT COMPLETED|Overall Study||0
330215|NCT00621764|799258|P2|NOT COMPLETED|Overall Study||0
330216|NCT00621764|799259|P1|NOT COMPLETED|Overall Study||0
330217|NCT00621764|799256|P4|COMPLETED|Overall Study||98
330218|NCT00621764|799257|P3|COMPLETED|Overall Study||101
330219|NCT00621764|799258|P2|COMPLETED|Overall Study||50
330220|NCT00621764|799259|P1|COMPLETED|Overall Study||50
330221|NCT00621764|799256|P4|STARTED|Overall Study||99
330222|NCT00621764|799257|P3|STARTED|Overall Study||101
330223|NCT00621764|799258|P2|STARTED|Overall Study||50
330224|NCT00621764|799259|P1|STARTED|Overall Study||50
330225|NCT00621686|799291|P2|NOT COMPLETED|Overall Study||0
330226|NCT00621686|799292|P1|NOT COMPLETED|Overall Study||0
330227|NCT00621686|799291|P2|COMPLETED|Overall Study||35
330228|NCT00621686|799292|P1|COMPLETED|Overall Study||19
330229|NCT00621686|799291|P2|STARTED|Overall Study||35
330230|NCT00621686|799292|P1|STARTED|Overall Study||19
330231|NCT00621621|799305|P2|NOT COMPLETED|Overall Study||0
330232|NCT00621621|799306|P1|NOT COMPLETED|Overall Study||30
330233|NCT00621621|799305|P2|COMPLETED|Overall Study||705
330234|NCT00621621|799306|P1|COMPLETED|Overall Study|Treated with the experimental catheter|75
330235|NCT00621621|799305|P2|STARTED|Overall Study||705
330236|NCT00621621|799306|P1|STARTED|Overall Study|Date of Post- Approval Study protocol approval|105
330237|NCT00621582|799314|P1|NOT COMPLETED|Overall Study||106
330238|NCT00621582|799314|P1|COMPLETED|Overall Study||4812
330239|NCT00621582|799314|P1|STARTED|Overall Study||4918
330240|NCT00621543|799321|P1|NOT COMPLETED|Overall Study||23
330241|NCT00621543|799321|P1|COMPLETED|Overall Study||97
330242|NCT00621543|799321|P1|STARTED|Overall Study||120
330243|NCT00621530|799328|P2|NOT COMPLETED|Overall Study||3
330244|NCT00621530|799329|P1|NOT COMPLETED|Overall Study||2
330245|NCT00621530|799328|P2|COMPLETED|Overall Study||29
330246|NCT00621530|799329|P1|COMPLETED|Overall Study||28
330247|NCT00621530|799328|P2|STARTED|Overall Study||32
330248|NCT00621530|799329|P1|STARTED|Overall Study||30
330249|NCT00621517|799345|P2|NOT COMPLETED|Overall Study||7
330250|NCT00621517|799346|P1|NOT COMPLETED|Overall Study||7
330251|NCT00621517|799345|P2|COMPLETED|Overall Study||24
330252|NCT00621517|799346|P1|COMPLETED|Overall Study||22
330253|NCT00621517|799345|P2|STARTED|Overall Study||31
330254|NCT00621517|799346|P1|STARTED|Overall Study||29
330255|NCT00621504|799358|P2|NOT COMPLETED|Overall Study||25
330256|NCT00621504|799359|P1|NOT COMPLETED|Overall Study||26
330257|NCT00621504|799358|P2|COMPLETED|Overall Study||282
330258|NCT00621504|799359|P1|COMPLETED|Overall Study||273
330259|NCT00621504|799358|P2|STARTED|Overall Study||307
330260|NCT00621504|799359|P1|STARTED|Overall Study||299
330261|NCT00621348|799368|P3|NOT COMPLETED|Overall Study||0
330262|NCT00621348|799369|P2|NOT COMPLETED|Overall Study||0
330263|NCT00621348|799370|P1|NOT COMPLETED|Overall Study||0
330264|NCT00621348|799368|P3|COMPLETED|Overall Study||56
330265|NCT00621348|799369|P2|COMPLETED|Overall Study||53
330266|NCT00621348|799370|P1|COMPLETED|Overall Study||58
330267|NCT00621348|799368|P3|STARTED|Overall Study||56
330268|NCT00621348|799369|P2|STARTED|Overall Study||53
330269|NCT00621348|799370|P1|STARTED|Overall Study||58
330270|NCT00621322|799393|P6|NOT COMPLETED|Overall Study||4
330271|NCT00621322|799394|P5|NOT COMPLETED|Overall Study||1
330272|NCT00621322|799395|P4|NOT COMPLETED|Overall Study||3
330273|NCT00621322|799396|P3|NOT COMPLETED|Overall Study||2
330274|NCT00621322|799397|P2|NOT COMPLETED|Overall Study||0
330275|NCT00621322|799398|P1|NOT COMPLETED|Overall Study||1
330276|NCT00621322|799393|P6|COMPLETED|Overall Study||36
330277|NCT00621322|799394|P5|COMPLETED|Overall Study||39
330278|NCT00621322|799395|P4|COMPLETED|Overall Study||37
330279|NCT00621322|799396|P3|COMPLETED|Overall Study||38
330280|NCT00621322|799397|P2|COMPLETED|Overall Study||10
330281|NCT00621322|799398|P1|COMPLETED|Overall Study||9
330282|NCT00621322|799393|P6|STARTED|Overall Study||40
330283|NCT00621322|799394|P5|STARTED|Overall Study||40
330284|NCT00621322|799395|P4|STARTED|Overall Study||40
330285|NCT00621322|799396|P3|STARTED|Overall Study||40
330286|NCT00621322|799397|P2|STARTED|Overall Study||10
330287|NCT00621322|799398|P1|STARTED|Overall Study||10
330288|NCT00621309|799478|P6|NOT COMPLETED|Overall Study||1
330289|NCT00621309|799479|P5|NOT COMPLETED|Overall Study||1
330290|NCT00621309|799480|P4|NOT COMPLETED|Overall Study||1
330291|NCT00621309|799481|P3|NOT COMPLETED|Overall Study||1
330292|NCT00621309|799482|P2|NOT COMPLETED|Overall Study||0
330293|NCT00621309|799483|P1|NOT COMPLETED|Overall Study||2
330294|NCT00621309|799478|P6|COMPLETED|Overall Study||3
330295|NCT00621309|799479|P5|COMPLETED|Overall Study||3
330296|NCT00621309|799480|P4|COMPLETED|Overall Study||5
330297|NCT00621309|799481|P3|COMPLETED|Overall Study||4
330298|NCT00621309|799482|P2|COMPLETED|Overall Study||4
330299|NCT00621309|799483|P1|COMPLETED|Overall Study||4
330300|NCT00621309|799478|P6|STARTED|Overall Study||4
330301|NCT00621309|799479|P5|STARTED|Overall Study||4
330302|NCT00621309|799480|P4|STARTED|Overall Study||6
330303|NCT00621309|799481|P3|STARTED|Overall Study||5
330304|NCT00621309|799482|P2|STARTED|Overall Study||4
330305|NCT00621309|799483|P1|STARTED|Overall Study||6
330306|NCT00621296|799489|P1|NOT COMPLETED|Overall Study||14
330307|NCT00621296|799489|P1|COMPLETED|Overall Study||1
330308|NCT00621296|799489|P1|STARTED|Overall Study||15
330309|NCT00621257|799498|P5|NOT COMPLETED|Overall Study||9
330310|NCT00621257|799499|P4|NOT COMPLETED|Overall Study||6
330311|NCT00621257|799500|P3|NOT COMPLETED|Overall Study||3
330312|NCT00621257|799501|P2|NOT COMPLETED|Overall Study||3
330313|NCT00621257|799502|P1|NOT COMPLETED|Overall Study||4
330314|NCT00621257|799498|P5|COMPLETED|Overall Study||22
330315|NCT00621257|799499|P4|COMPLETED|Overall Study||26
330316|NCT00621257|799500|P3|COMPLETED|Overall Study||20
330317|NCT00621257|799501|P2|COMPLETED|Overall Study||21
330318|NCT00621257|799502|P1|COMPLETED|Overall Study||20
330319|NCT00621257|799498|P5|STARTED|Overall Study||31
330320|NCT00621257|799499|P4|STARTED|Overall Study||32
330321|NCT00621257|799500|P3|STARTED|Overall Study||23
330322|NCT00621257|799501|P2|STARTED|Overall Study||24
330323|NCT00621257|799502|P1|STARTED|Overall Study||24
330324|NCT00621244|799518|P4|NOT COMPLETED|Overall Study||23
330325|NCT00621244|799519|P3|NOT COMPLETED|Overall Study||33
330326|NCT00621244|799520|P2|NOT COMPLETED|Overall Study||34
330327|NCT00621244|799521|P1|NOT COMPLETED|Overall Study||86
330328|NCT00621244|799518|P4|COMPLETED|Overall Study||0
330329|NCT00621244|799519|P3|COMPLETED|Overall Study||0
330330|NCT00621244|799520|P2|COMPLETED|Overall Study||0
330331|NCT00621244|799521|P1|COMPLETED|Overall Study||0
330332|NCT00621244|799518|P4|STARTED|Overall Study||23
330333|NCT00621244|799519|P3|STARTED|Overall Study||33
330334|NCT00621244|799520|P2|STARTED|Overall Study||34
330335|NCT00621244|799521|P1|STARTED|Overall Study||86
330336|NCT00621192|799625|P4|NOT COMPLETED|Overall Study||3
330337|NCT00621192|799626|P3|NOT COMPLETED|Overall Study||5
330338|NCT00621192|799627|P2|NOT COMPLETED|Overall Study||9
330339|NCT00621192|799628|P1|NOT COMPLETED|Overall Study||4
330340|NCT00621192|799625|P4|COMPLETED|Overall Study||24
330341|NCT00621192|799626|P3|COMPLETED|Overall Study||26
330342|NCT00621192|799627|P2|COMPLETED|Overall Study||94
330343|NCT00621192|799628|P1|COMPLETED|Overall Study||35
330344|NCT00621192|799625|P4|Efficacy Population|Overall Study||27
330345|NCT00621192|799626|P3|Efficacy Population|Overall Study||28
330346|NCT00621192|799627|P2|Efficacy Population|Overall Study||101
330347|NCT00621192|799628|P1|Efficacy Population|Overall Study||39
330348|NCT00621192|799625|P4|Safety Population|Overall Study||27
330349|NCT00621192|799626|P3|Safety Population|Overall Study||31
330350|NCT00621192|799627|P2|Safety Population|Overall Study||103
330351|NCT00621192|799628|P1|Safety Population|Overall Study||39
330352|NCT00621192|799625|P4|STARTED|Overall Study||27
330353|NCT00621192|799626|P3|STARTED|Overall Study||31
330354|NCT00621192|799627|P2|STARTED|Overall Study||103
330355|NCT00621192|799628|P1|STARTED|Overall Study||39
330356|NCT00621153|799652|P2|NOT COMPLETED|Overall Study||15
330357|NCT00621153|799653|P1|NOT COMPLETED|Overall Study||20
330358|NCT00621153|799652|P2|COMPLETED|Overall Study|completed|101
330359|NCT00621153|799653|P1|COMPLETED|Overall Study|completed|97
330360|NCT00621153|799652|P2|Discontinued|Overall Study||15
330361|NCT00621153|799653|P1|Discontinued|Overall Study||20
330362|NCT00621153|799652|P2|STARTED|Overall Study|randomised|116
330363|NCT00621153|799653|P1|STARTED|Overall Study|randomised|117
330364|NCT00621140|799661|P2|NOT COMPLETED|Overall Study||18
330365|NCT00621140|799662|P1|NOT COMPLETED|Overall Study||15
330366|NCT00621140|799661|P2|COMPLETED|Overall Study|number who completed treatment|318
330367|NCT00621140|799662|P1|COMPLETED|Overall Study|number who completed treatment|152
330368|NCT00621140|799661|P2|STARTED|Overall Study|number who started treatment|336
330369|NCT00621140|799662|P1|STARTED|Overall Study|number who started treatment|167
330370|NCT00621049|799696|P2|NOT COMPLETED|Maintenance Treatment||0
330371|NCT00621049|799697|P1|NOT COMPLETED|Maintenance Treatment||15
330372|NCT00621049|799696|P2|COMPLETED|Maintenance Treatment||0
330373|NCT00621049|799697|P1|COMPLETED|Maintenance Treatment||34
330374|NCT00621049|799696|P2|STARTED|Maintenance Treatment|Per protocol, only the Docetaxel/Carboplatin/Bevacizumab/Erlotinib arm enters maintenance therapy|0
330375|NCT00621049|799697|P1|STARTED|Maintenance Treatment|3 patients came off study between the end of adjuvant therapy and the start of maintenance|49
330376|NCT00621049|799696|P2|NOT COMPLETED|Adjuvant Treatment||10
330377|NCT00621049|799697|P1|NOT COMPLETED|Adjuvant Treatment||3
330378|NCT00621049|799696|P2|COMPLETED|Adjuvant Treatment||47
330379|NCT00621049|799697|P1|COMPLETED|Adjuvant Treatment||52
330380|NCT00621049|799696|P2|STARTED|Adjuvant Treatment||57
330381|NCT00621049|799697|P1|STARTED|Adjuvant Treatment||55
330382|NCT00621023|799709|P1|NOT COMPLETED|Overall Study||6
330383|NCT00621023|799709|P1|COMPLETED|Overall Study|Completed is defined as 5 years of follow up.|0
330384|NCT00621023|799709|P1|STARTED|Overall Study||6
330385|NCT00620945|799715|P1|NOT COMPLETED|Overall Study||0
330386|NCT00620945|799715|P1|COMPLETED|Overall Study||87
330387|NCT00620945|799715|P1|STARTED|Overall Study|Total number in the study|87
330388|NCT00620854|799726|P6|NOT COMPLETED|Period 3||0
330389|NCT00620854|799727|P5|NOT COMPLETED|Period 3||0
330390|NCT00620854|799728|P4|NOT COMPLETED|Period 3||0
330391|NCT00620854|799729|P3|NOT COMPLETED|Period 3||0
330392|NCT00620854|799730|P2|NOT COMPLETED|Period 3||0
330393|NCT00620854|799731|P1|NOT COMPLETED|Period 3||0
330394|NCT00620854|799726|P6|COMPLETED|Period 3||4
330395|NCT00620854|799727|P5|COMPLETED|Period 3||4
330396|NCT00620854|799728|P4|COMPLETED|Period 3||3
330397|NCT00620854|799729|P3|COMPLETED|Period 3||3
330398|NCT00620854|799730|P2|COMPLETED|Period 3||4
330399|NCT00620854|799731|P1|COMPLETED|Period 3||4
330400|NCT00620854|799726|P6|STARTED|Period 3||4
330401|NCT00620854|799727|P5|STARTED|Period 3||4
330402|NCT00620854|799728|P4|STARTED|Period 3||3
330403|NCT00620854|799729|P3|STARTED|Period 3||3
330404|NCT00620854|799730|P2|STARTED|Period 3||4
330405|NCT00620854|799731|P1|STARTED|Period 3||4
330406|NCT00620854|799726|P6|NOT COMPLETED|Washout 2||0
330407|NCT00620854|799727|P5|NOT COMPLETED|Washout 2||0
330408|NCT00620854|799728|P4|NOT COMPLETED|Washout 2||0
330409|NCT00620854|799729|P3|NOT COMPLETED|Washout 2||0
330410|NCT00620854|799730|P2|NOT COMPLETED|Washout 2||0
330411|NCT00620854|799731|P1|NOT COMPLETED|Washout 2||0
330412|NCT00620854|799726|P6|COMPLETED|Washout 2||4
330413|NCT00620854|799727|P5|COMPLETED|Washout 2||4
330414|NCT00620854|799728|P4|COMPLETED|Washout 2||3
330415|NCT00620854|799729|P3|COMPLETED|Washout 2||3
330416|NCT00620854|799730|P2|COMPLETED|Washout 2||4
330417|NCT00620854|799731|P1|COMPLETED|Washout 2||4
330418|NCT00620854|799726|P6|STARTED|Washout 2||4
330419|NCT00620854|799727|P5|STARTED|Washout 2||4
330420|NCT00620854|799728|P4|STARTED|Washout 2||3
330421|NCT00620854|799729|P3|STARTED|Washout 2||3
330422|NCT00620854|799730|P2|STARTED|Washout 2||4
330423|NCT00620854|799731|P1|STARTED|Washout 2||4
330424|NCT00620854|799726|P6|NOT COMPLETED|Period 2||0
330425|NCT00620854|799727|P5|NOT COMPLETED|Period 2||0
330426|NCT00620854|799728|P4|NOT COMPLETED|Period 2||0
330427|NCT00620854|799729|P3|NOT COMPLETED|Period 2||0
330428|NCT00620854|799730|P2|NOT COMPLETED|Period 2||0
330429|NCT00620854|799731|P1|NOT COMPLETED|Period 2||0
330430|NCT00620854|799726|P6|COMPLETED|Period 2||4
330431|NCT00620854|799727|P5|COMPLETED|Period 2||4
330432|NCT00620854|799728|P4|COMPLETED|Period 2||3
330433|NCT00620854|799729|P3|COMPLETED|Period 2||3
330434|NCT00620854|799730|P2|COMPLETED|Period 2||4
330435|NCT00620854|799731|P1|COMPLETED|Period 2||4
330436|NCT00620854|799726|P6|STARTED|Period 2||4
330437|NCT00620854|799727|P5|STARTED|Period 2||4
330438|NCT00620854|799728|P4|STARTED|Period 2||3
330439|NCT00620854|799729|P3|STARTED|Period 2||3
330440|NCT00620854|799730|P2|STARTED|Period 2||4
330441|NCT00620854|799731|P1|STARTED|Period 2||4
330442|NCT00620854|799726|P6|NOT COMPLETED|Washout 1||0
330443|NCT00620854|799727|P5|NOT COMPLETED|Washout 1||0
330444|NCT00620854|799728|P4|NOT COMPLETED|Washout 1||1
330445|NCT00620854|799729|P3|NOT COMPLETED|Washout 1||1
330446|NCT00620854|799730|P2|NOT COMPLETED|Washout 1||0
330447|NCT00620854|799731|P1|NOT COMPLETED|Washout 1||0
330448|NCT00620854|799726|P6|COMPLETED|Washout 1||4
330449|NCT00620854|799727|P5|COMPLETED|Washout 1||4
330450|NCT00620854|799728|P4|COMPLETED|Washout 1||3
330451|NCT00620854|799729|P3|COMPLETED|Washout 1||3
330452|NCT00620854|799730|P2|COMPLETED|Washout 1||4
330453|NCT00620854|799731|P1|COMPLETED|Washout 1||4
330454|NCT00620854|799726|P6|STARTED|Washout 1||4
330455|NCT00620854|799727|P5|STARTED|Washout 1||4
330456|NCT00620854|799728|P4|STARTED|Washout 1||4
330457|NCT00620854|799729|P3|STARTED|Washout 1||4
330458|NCT00620854|799730|P2|STARTED|Washout 1||4
330459|NCT00620854|799731|P1|STARTED|Washout 1||4
330460|NCT00620854|799726|P6|NOT COMPLETED|Period 1||0
330461|NCT00620854|799727|P5|NOT COMPLETED|Period 1||0
330462|NCT00620854|799728|P4|NOT COMPLETED|Period 1||0
330463|NCT00620854|799729|P3|NOT COMPLETED|Period 1||0
330464|NCT00620854|799730|P2|NOT COMPLETED|Period 1||0
330465|NCT00620854|799731|P1|NOT COMPLETED|Period 1||0
330466|NCT00620854|799726|P6|COMPLETED|Period 1||4
330467|NCT00620854|799727|P5|COMPLETED|Period 1||4
330468|NCT00620854|799728|P4|COMPLETED|Period 1||4
330469|NCT00620854|799729|P3|COMPLETED|Period 1||4
330470|NCT00620854|799730|P2|COMPLETED|Period 1||4
330471|NCT00620854|799731|P1|COMPLETED|Period 1||4
330472|NCT00620854|799726|P6|STARTED|Period 1||4
330473|NCT00620854|799727|P5|STARTED|Period 1||4
330474|NCT00620854|799728|P4|STARTED|Period 1||4
330475|NCT00620854|799729|P3|STARTED|Period 1||4
330476|NCT00620854|799730|P2|STARTED|Period 1||4
330477|NCT00620854|799731|P1|STARTED|Period 1||4
330478|NCT00620828|799744|P2|NOT COMPLETED|Overall Study||0
330479|NCT00620828|799745|P1|NOT COMPLETED|Overall Study||0
330480|NCT00620828|799744|P2|COMPLETED|Overall Study||35
330481|NCT00620828|799745|P1|COMPLETED|Overall Study||32
330482|NCT00620828|799744|P2|Number of Subjects Enrolled = 67|Overall Study||35
330483|NCT00620828|799745|P1|Number of Subjects Enrolled = 67|Overall Study||32
330484|NCT00620828|799744|P2|STARTED|Overall Study||35
330485|NCT00620828|799745|P1|STARTED|Overall Study||32
330486|NCT00620815|799762|P3|NOT COMPLETED|Overall Study||7
330487|NCT00620815|799763|P2|NOT COMPLETED|Overall Study||11
330488|NCT00620815|799764|P1|NOT COMPLETED|Overall Study||4
330489|NCT00620815|799762|P3|COMPLETED|Overall Study||192
330490|NCT00620815|799763|P2|COMPLETED|Overall Study||192
330491|NCT00620815|799764|P1|COMPLETED|Overall Study||195
330492|NCT00620815|799762|P3|STARTED|Overall Study||199
330493|NCT00620815|799763|P2|STARTED|Overall Study||203
330494|NCT00620815|799764|P1|STARTED|Overall Study||199
330495|NCT00620776|799804|P2|NOT COMPLETED|Overall Study||16
330496|NCT00620776|799805|P1|NOT COMPLETED|Overall Study||12
330497|NCT00620776|799804|P2|COMPLETED|Overall Study|24 out of 35 attended the week 24 (last) assessment.|24
330498|NCT00620776|799805|P1|COMPLETED|Overall Study|17 out of 26 attended the week 24 (last) assessment.|17
330499|NCT00620776|799804|P2|Received at Least One Session/Dose|Overall Study|35 out of 40 that consented to receive medication alone received at least one dose of medication.|35
330500|NCT00620776|799805|P1|Received at Least One Session/Dose|Overall Study|26 out of 29 that consented to the combined treatment option received at least one session of CBT.|26
330501|NCT00620776|799804|P2|STARTED|Overall Study|All 40 patients that were randomly assigned to not be offered CBT consented to this option.|40
330502|NCT00620776|799805|P1|STARTED|Overall Study|29 patients (of the 77 that were randomly assigned to add on CBT) consented to this option.|29
330503|NCT00620763|799833|P2|NOT COMPLETED|Period: Second Intervention||0
330504|NCT00620763|799834|P1|NOT COMPLETED|Period: Second Intervention||1
330505|NCT00620763|799833|P2|COMPLETED|Period: Second Intervention||7
330506|NCT00620763|799834|P1|COMPLETED|Period: Second Intervention||9
330507|NCT00620763|799833|P2|STARTED|Period: Second Intervention||7
330508|NCT00620763|799834|P1|STARTED|Period: Second Intervention||10
330509|NCT00620763|799833|P2|NOT COMPLETED|Period: Washout Period of 1 Week||0
330510|NCT00620763|799834|P1|NOT COMPLETED|Period: Washout Period of 1 Week||0
330511|NCT00620763|799833|P2|COMPLETED|Period: Washout Period of 1 Week||7
330512|NCT00620763|799834|P1|COMPLETED|Period: Washout Period of 1 Week||10
330513|NCT00620763|799833|P2|STARTED|Period: Washout Period of 1 Week||7
330514|NCT00620763|799834|P1|STARTED|Period: Washout Period of 1 Week||10
330515|NCT00620763|799833|P2|NOT COMPLETED|Period: First Intervention||5
330516|NCT00620763|799834|P1|NOT COMPLETED|Period: First Intervention||0
330517|NCT00620763|799833|P2|COMPLETED|Period: First Intervention||7
330518|NCT00620763|799834|P1|COMPLETED|Period: First Intervention||10
330519|NCT00620763|799833|P2|STARTED|Period: First Intervention||12
330520|NCT00620763|799834|P1|STARTED|Period: First Intervention||10
330521|NCT00620750|799840|P1|NOT COMPLETED|Overall Study||25
330522|NCT00620750|799840|P1|COMPLETED|Overall Study||40
330523|NCT00620750|799840|P1|STARTED|Overall Study||65
330524|NCT00620711|799844|P1|NOT COMPLETED|Overall Study||0
330525|NCT00620711|799844|P1|COMPLETED|Overall Study||4
330526|NCT00620711|799844|P1|STARTED|Overall Study||4
330527|NCT00620698|799849|P1|NOT COMPLETED|Overall Study||29
330528|NCT00620698|799849|P1|COMPLETED|Overall Study||60
330529|NCT00620698|799849|P1|STARTED|Overall Study||89
330530|NCT00620659|799855|P6|NOT COMPLETED|Treatment Period 3||0
330531|NCT00620659|799856|P5|NOT COMPLETED|Treatment Period 3||0
330532|NCT00620659|799857|P4|NOT COMPLETED|Treatment Period 3||1
330533|NCT00620659|799858|P3|NOT COMPLETED|Treatment Period 3||0
330534|NCT00620659|799859|P2|NOT COMPLETED|Treatment Period 3||2
330535|NCT00620659|799860|P1|NOT COMPLETED|Treatment Period 3||0
330536|NCT00620659|799855|P6|COMPLETED|Treatment Period 3||20
330537|NCT00620659|799856|P5|COMPLETED|Treatment Period 3||15
330538|NCT00620659|799857|P4|COMPLETED|Treatment Period 3||17
330539|NCT00620659|799858|P3|COMPLETED|Treatment Period 3||19
330540|NCT00620659|799859|P2|COMPLETED|Treatment Period 3||16
330541|NCT00620659|799860|P1|COMPLETED|Treatment Period 3||16
330542|NCT00620659|799855|P6|STARTED|Treatment Period 3||20
330543|NCT00620659|799856|P5|STARTED|Treatment Period 3||15
330544|NCT00620659|799857|P4|STARTED|Treatment Period 3||18
330545|NCT00620659|799858|P3|STARTED|Treatment Period 3||19
330546|NCT00620659|799859|P2|STARTED|Treatment Period 3||18
330547|NCT00620659|799860|P1|STARTED|Treatment Period 3||16
330548|NCT00620659|799855|P6|NOT COMPLETED|Placebo Washout Period 2||0
330549|NCT00620659|799856|P5|NOT COMPLETED|Placebo Washout Period 2||0
330550|NCT00620659|799857|P4|NOT COMPLETED|Placebo Washout Period 2||0
330551|NCT00620659|799858|P3|NOT COMPLETED|Placebo Washout Period 2||0
330552|NCT00620659|799859|P2|NOT COMPLETED|Placebo Washout Period 2||0
330553|NCT00620659|799860|P1|NOT COMPLETED|Placebo Washout Period 2||2
330554|NCT00620659|799855|P6|COMPLETED|Placebo Washout Period 2||20
330555|NCT00620659|799856|P5|COMPLETED|Placebo Washout Period 2||15
330556|NCT00620659|799857|P4|COMPLETED|Placebo Washout Period 2||18
330557|NCT00620659|799858|P3|COMPLETED|Placebo Washout Period 2||19
330558|NCT00620659|799859|P2|COMPLETED|Placebo Washout Period 2||18
330559|NCT00620659|799860|P1|COMPLETED|Placebo Washout Period 2||16
330560|NCT00620659|799855|P6|STARTED|Placebo Washout Period 2||20
330561|NCT00620659|799856|P5|STARTED|Placebo Washout Period 2||15
330562|NCT00620659|799857|P4|STARTED|Placebo Washout Period 2||18
330563|NCT00620659|799858|P3|STARTED|Placebo Washout Period 2||19
330564|NCT00620659|799859|P2|STARTED|Placebo Washout Period 2||18
330565|NCT00620659|799860|P1|STARTED|Placebo Washout Period 2||18
330566|NCT00620659|799855|P6|NOT COMPLETED|Treatment Period 2||0
330567|NCT00620659|799856|P5|NOT COMPLETED|Treatment Period 2||5
330568|NCT00620659|799857|P4|NOT COMPLETED|Treatment Period 2||0
330569|NCT00620659|799858|P3|NOT COMPLETED|Treatment Period 2||1
330570|NCT00620659|799859|P2|NOT COMPLETED|Treatment Period 2||3
330571|NCT00620659|799860|P1|NOT COMPLETED|Treatment Period 2||0
330572|NCT00620659|799855|P6|COMPLETED|Treatment Period 2||20
330573|NCT00620659|799856|P5|COMPLETED|Treatment Period 2||15
330574|NCT00620659|799857|P4|COMPLETED|Treatment Period 2||18
330575|NCT00620659|799858|P3|COMPLETED|Treatment Period 2||19
330576|NCT00620659|799859|P2|COMPLETED|Treatment Period 2||18
330577|NCT00620659|799860|P1|COMPLETED|Treatment Period 2||18
330578|NCT00620659|799855|P6|STARTED|Treatment Period 2||20
330579|NCT00620659|799856|P5|STARTED|Treatment Period 2||20
330580|NCT00620659|799857|P4|STARTED|Treatment Period 2||18
330581|NCT00620659|799858|P3|STARTED|Treatment Period 2||20
330582|NCT00620659|799859|P2|STARTED|Treatment Period 2||21
330583|NCT00620659|799860|P1|STARTED|Treatment Period 2||18
330584|NCT00620659|799855|P6|NOT COMPLETED|Placebo Washout Period 1||0
330585|NCT00620659|799856|P5|NOT COMPLETED|Placebo Washout Period 1||0
330586|NCT00620659|799857|P4|NOT COMPLETED|Placebo Washout Period 1||1
330587|NCT00620659|799858|P3|NOT COMPLETED|Placebo Washout Period 1||0
330588|NCT00620659|799859|P2|NOT COMPLETED|Placebo Washout Period 1||0
330589|NCT00620659|799860|P1|NOT COMPLETED|Placebo Washout Period 1||0
330590|NCT00620659|799855|P6|COMPLETED|Placebo Washout Period 1||20
330591|NCT00620659|799856|P5|COMPLETED|Placebo Washout Period 1||20
330592|NCT00620659|799857|P4|COMPLETED|Placebo Washout Period 1||18
330593|NCT00620659|799858|P3|COMPLETED|Placebo Washout Period 1||20
330594|NCT00620659|799859|P2|COMPLETED|Placebo Washout Period 1||21
330595|NCT00620659|799860|P1|COMPLETED|Placebo Washout Period 1||18
330596|NCT00620659|799855|P6|STARTED|Placebo Washout Period 1||20
330597|NCT00620659|799856|P5|STARTED|Placebo Washout Period 1||20
330598|NCT00620659|799857|P4|STARTED|Placebo Washout Period 1||19
330599|NCT00620659|799858|P3|STARTED|Placebo Washout Period 1||20
330600|NCT00620659|799859|P2|STARTED|Placebo Washout Period 1||21
330601|NCT00620659|799860|P1|STARTED|Placebo Washout Period 1||18
330602|NCT00620659|799855|P6|NOT COMPLETED|Treatment Period 1||0
330603|NCT00620659|799856|P5|NOT COMPLETED|Treatment Period 1||1
330604|NCT00620659|799857|P4|NOT COMPLETED|Treatment Period 1||3
330605|NCT00620659|799858|P3|NOT COMPLETED|Treatment Period 1||1
330606|NCT00620659|799859|P2|NOT COMPLETED|Treatment Period 1||0
330607|NCT00620659|799860|P1|NOT COMPLETED|Treatment Period 1||3
330608|NCT00620659|799855|P6|COMPLETED|Treatment Period 1||20
330609|NCT00620659|799856|P5|COMPLETED|Treatment Period 1||20
330610|NCT00620659|799857|P4|COMPLETED|Treatment Period 1|1 patient discontinued from MK0249, but continued in following periods, & completed the study|18
330611|NCT00620659|799858|P3|COMPLETED|Treatment Period 1||20
330612|NCT00620659|799859|P2|COMPLETED|Treatment Period 1||21
330613|NCT00620659|799860|P1|COMPLETED|Treatment Period 1||18
330614|NCT00620659|799855|P6|STARTED|Treatment Period 1||20
330615|NCT00620659|799856|P5|STARTED|Treatment Period 1||21
330616|NCT00620659|799857|P4|STARTED|Treatment Period 1||21
330617|NCT00620659|799858|P3|STARTED|Treatment Period 1||21
330618|NCT00620659|799859|P2|STARTED|Treatment Period 1||21
330619|NCT00620659|799860|P1|STARTED|Treatment Period 1||21
330620|NCT00620555|799878|P1|NOT COMPLETED|Overall Study||21
330621|NCT00620555|799878|P1|COMPLETED|Overall Study||44
330622|NCT00620555|799878|P1|STARTED|Overall Study||65
330623|NCT00620542|799887|P4|NOT COMPLETED|Part B (2 Year Core Study)||144
330624|NCT00620542|799888|P3|NOT COMPLETED|Part B (2 Year Core Study)||148
330625|NCT00620542|799889|P2|NOT COMPLETED|Part B (2 Year Core Study)||0
330626|NCT00620542|799890|P1|NOT COMPLETED|Part B (2 Year Core Study)||0
330627|NCT00620542|799887|P4|COMPLETED|Part B (2 Year Core Study)||547
330628|NCT00620542|799888|P3|COMPLETED|Part B (2 Year Core Study)||546
330629|NCT00620542|799889|P2|COMPLETED|Part B (2 Year Core Study)||0
330630|NCT00620542|799890|P1|COMPLETED|Part B (2 Year Core Study)||0
330631|NCT00620542|799887|P4|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|519
330632|NCT00620542|799888|P3|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|520
330633|NCT00620542|799889|P2|Intent-to-treat Population|Part B (2 Year Core Study)||0
330634|NCT00620542|799890|P1|Intent-to-treat Population|Part B (2 Year Core Study)||0
330635|NCT00620542|799887|P4|Received Treatment|Part B (2 Year Core Study)||689
330636|NCT00620542|799888|P3|Received Treatment|Part B (2 Year Core Study)||691
330637|NCT00620542|799889|P2|Received Treatment|Part B (2 Year Core Study)||0
330638|NCT00620542|799890|P1|Received Treatment|Part B (2 Year Core Study)||0
330639|NCT00620542|799887|P4|STARTED|Part B (2 Year Core Study)|Of 691 patients randomized, N=689 received treatment.|691
330640|NCT00620542|799888|P3|STARTED|Part B (2 Year Core Study)|Of 694 patients randomized, N=691 received treatment.|694
330641|NCT00620542|799889|P2|STARTED|Part B (2 Year Core Study)||0
330642|NCT00620542|799890|P1|STARTED|Part B (2 Year Core Study)||0
330643|NCT00620542|799887|P4|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
330644|NCT00620542|799888|P3|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
330645|NCT00620542|799889|P2|NOT COMPLETED|Part A (Run-in - 2 Weeks)||476
330646|NCT00620542|799890|P1|NOT COMPLETED|Part A (Run-in - 2 Weeks)||472
330647|NCT00620542|799887|P4|COMPLETED|Part A (Run-in - 2 Weeks)||0
330648|NCT00620542|799888|P3|COMPLETED|Part A (Run-in - 2 Weeks)||0
330649|NCT00620542|799889|P2|COMPLETED|Part A (Run-in - 2 Weeks)||690
330650|NCT00620542|799890|P1|COMPLETED|Part A (Run-in - 2 Weeks)||695
330651|NCT00620542|799887|P4|Received Treatment|Part A (Run-in - 2 Weeks)||0
330652|NCT00620542|799888|P3|Received Treatment|Part A (Run-in - 2 Weeks)||0
330653|NCT00620542|799889|P2|Received Treatment|Part A (Run-in - 2 Weeks)||795
330654|NCT00620542|799890|P1|Received Treatment|Part A (Run-in - 2 Weeks)||783
330655|NCT00620542|799887|P4|STARTED|Part A (Run-in - 2 Weeks)||0
330656|NCT00620542|799888|P3|STARTED|Part A (Run-in - 2 Weeks)||0
330657|NCT00620542|799889|P2|STARTED|Part A (Run-in - 2 Weeks)|Of 1166 randomized, N=795 received treatment.|1166
330658|NCT00620542|799890|P1|STARTED|Part A (Run-in - 2 Weeks)|Of 1167 randomized, N=783 received treatment.|1167
330659|NCT00620503|799928|P6|NOT COMPLETED|Follow-up (up to 14 Days)||0
330660|NCT00620503|799929|P5|NOT COMPLETED|Follow-up (up to 14 Days)||0
330661|NCT00620503|799930|P4|NOT COMPLETED|Follow-up (up to 14 Days)||0
330662|NCT00620503|799931|P3|NOT COMPLETED|Follow-up (up to 14 Days)||0
330663|NCT00620503|799932|P2|NOT COMPLETED|Follow-up (up to 14 Days)||0
330664|NCT00620503|799933|P1|NOT COMPLETED|Follow-up (up to 14 Days)||0
330665|NCT00620503|799928|P6|COMPLETED|Follow-up (up to 14 Days)||2
330666|NCT00620503|799929|P5|COMPLETED|Follow-up (up to 14 Days)||2
330667|NCT00620503|799930|P4|COMPLETED|Follow-up (up to 14 Days)||2
330668|NCT00620503|799931|P3|COMPLETED|Follow-up (up to 14 Days)||2
330669|NCT00620503|799932|P2|COMPLETED|Follow-up (up to 14 Days)||2
330670|NCT00620503|799933|P1|COMPLETED|Follow-up (up to 14 Days)||2
330671|NCT00620503|799928|P6|STARTED|Follow-up (up to 14 Days)||2
330672|NCT00620503|799929|P5|STARTED|Follow-up (up to 14 Days)||2
330673|NCT00620503|799930|P4|STARTED|Follow-up (up to 14 Days)||2
330674|NCT00620503|799931|P3|STARTED|Follow-up (up to 14 Days)||2
330675|NCT00620503|799932|P2|STARTED|Follow-up (up to 14 Days)||2
330676|NCT00620503|799933|P1|STARTED|Follow-up (up to 14 Days)||2
330677|NCT00620503|799928|P6|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
330678|NCT00620503|799929|P5|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
330679|NCT00620503|799930|P4|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
330680|NCT00620503|799931|P3|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
330681|NCT00620503|799932|P2|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
330682|NCT00620503|799933|P1|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
330683|NCT00620503|799928|P6|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
330684|NCT00620503|799929|P5|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
330685|NCT00620503|799930|P4|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
330686|NCT00620503|799931|P3|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
330687|NCT00620503|799932|P2|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
330688|NCT00620503|799933|P1|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
330689|NCT00620503|799928|P6|STARTED|Treatment Period 3 (TP3) (7 Days)||2
330690|NCT00620503|799929|P5|STARTED|Treatment Period 3 (TP3) (7 Days)||2
330691|NCT00620503|799930|P4|STARTED|Treatment Period 3 (TP3) (7 Days)||2
330692|NCT00620503|799931|P3|STARTED|Treatment Period 3 (TP3) (7 Days)||2
330693|NCT00620503|799932|P2|STARTED|Treatment Period 3 (TP3) (7 Days)||2
330694|NCT00620503|799933|P1|STARTED|Treatment Period 3 (TP3) (7 Days)||2
330695|NCT00620503|799928|P6|NOT COMPLETED|Washout (at Least 1 Day)||0
330696|NCT00620503|799929|P5|NOT COMPLETED|Washout (at Least 1 Day)||0
330697|NCT00620503|799930|P4|NOT COMPLETED|Washout (at Least 1 Day)||0
330698|NCT00620503|799931|P3|NOT COMPLETED|Washout (at Least 1 Day)||0
330699|NCT00620503|799932|P2|NOT COMPLETED|Washout (at Least 1 Day)||0
330700|NCT00620503|799933|P1|NOT COMPLETED|Washout (at Least 1 Day)||0
330701|NCT00620503|799928|P6|COMPLETED|Washout (at Least 1 Day)||2
330702|NCT00620503|799929|P5|COMPLETED|Washout (at Least 1 Day)||2
330703|NCT00620503|799930|P4|COMPLETED|Washout (at Least 1 Day)||2
330704|NCT00620503|799931|P3|COMPLETED|Washout (at Least 1 Day)||2
330705|NCT00620503|799932|P2|COMPLETED|Washout (at Least 1 Day)||2
330706|NCT00620503|799933|P1|COMPLETED|Washout (at Least 1 Day)||2
330707|NCT00620503|799928|P6|STARTED|Washout (at Least 1 Day)||2
330708|NCT00620503|799929|P5|STARTED|Washout (at Least 1 Day)||2
330709|NCT00620503|799930|P4|STARTED|Washout (at Least 1 Day)||2
330710|NCT00620503|799931|P3|STARTED|Washout (at Least 1 Day)||2
330711|NCT00620503|799932|P2|STARTED|Washout (at Least 1 Day)||2
330712|NCT00620503|799933|P1|STARTED|Washout (at Least 1 Day)||2
330713|NCT00620503|799928|P6|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
330714|NCT00620503|799929|P5|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
330715|NCT00620503|799930|P4|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
330716|NCT00620503|799931|P3|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
330717|NCT00620503|799932|P2|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
330718|NCT00620503|799933|P1|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
330719|NCT00620503|799928|P6|COMPLETED|Treatment Period 2 (TP2) (7days)||2
330720|NCT00620503|799929|P5|COMPLETED|Treatment Period 2 (TP2) (7days)||2
330721|NCT00620503|799930|P4|COMPLETED|Treatment Period 2 (TP2) (7days)||2
330722|NCT00620503|799931|P3|COMPLETED|Treatment Period 2 (TP2) (7days)||2
330723|NCT00620503|799932|P2|COMPLETED|Treatment Period 2 (TP2) (7days)||2
330724|NCT00620503|799933|P1|COMPLETED|Treatment Period 2 (TP2) (7days)||2
330725|NCT00620503|799928|P6|STARTED|Treatment Period 2 (TP2) (7days)||2
330726|NCT00620503|799929|P5|STARTED|Treatment Period 2 (TP2) (7days)||2
330727|NCT00620503|799930|P4|STARTED|Treatment Period 2 (TP2) (7days)||2
330728|NCT00620503|799931|P3|STARTED|Treatment Period 2 (TP2) (7days)||2
330729|NCT00620503|799932|P2|STARTED|Treatment Period 2 (TP2) (7days)||2
330730|NCT00620503|799933|P1|STARTED|Treatment Period 2 (TP2) (7days)||2
330731|NCT00620503|799928|P6|NOT COMPLETED|Washout (at Least 1 Day)||0
330732|NCT00620503|799929|P5|NOT COMPLETED|Washout (at Least 1 Day)||0
330733|NCT00620503|799930|P4|NOT COMPLETED|Washout (at Least 1 Day)||0
330734|NCT00620503|799931|P3|NOT COMPLETED|Washout (at Least 1 Day)||0
330735|NCT00620503|799932|P2|NOT COMPLETED|Washout (at Least 1 Day)||0
330736|NCT00620503|799933|P1|NOT COMPLETED|Washout (at Least 1 Day)||0
330737|NCT00620503|799928|P6|COMPLETED|Washout (at Least 1 Day)||2
330738|NCT00620503|799929|P5|COMPLETED|Washout (at Least 1 Day)||2
330739|NCT00620503|799930|P4|COMPLETED|Washout (at Least 1 Day)||2
330740|NCT00620503|799931|P3|COMPLETED|Washout (at Least 1 Day)||2
330741|NCT00620503|799932|P2|COMPLETED|Washout (at Least 1 Day)||2
330742|NCT00620503|799933|P1|COMPLETED|Washout (at Least 1 Day)||2
330743|NCT00620503|799928|P6|STARTED|Washout (at Least 1 Day)||2
330744|NCT00620503|799929|P5|STARTED|Washout (at Least 1 Day)||2
330745|NCT00620503|799930|P4|STARTED|Washout (at Least 1 Day)||2
330746|NCT00620503|799931|P3|STARTED|Washout (at Least 1 Day)||2
330747|NCT00620503|799932|P2|STARTED|Washout (at Least 1 Day)||2
330748|NCT00620503|799933|P1|STARTED|Washout (at Least 1 Day)||2
330749|NCT00620503|799928|P6|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
330750|NCT00620503|799929|P5|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
330751|NCT00620503|799930|P4|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
330752|NCT00620503|799931|P3|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
330753|NCT00620503|799932|P2|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
330754|NCT00620503|799933|P1|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
330755|NCT00620503|799928|P6|COMPLETED|Treatment Period 1 (TP1) (7days)||2
330756|NCT00620503|799929|P5|COMPLETED|Treatment Period 1 (TP1) (7days)||2
330757|NCT00620503|799930|P4|COMPLETED|Treatment Period 1 (TP1) (7days)||2
330758|NCT00620503|799931|P3|COMPLETED|Treatment Period 1 (TP1) (7days)||2
330759|NCT00620503|799932|P2|COMPLETED|Treatment Period 1 (TP1) (7days)||2
330760|NCT00620503|799933|P1|COMPLETED|Treatment Period 1 (TP1) (7days)||2
330761|NCT00620503|799928|P6|STARTED|Treatment Period 1 (TP1) (7days)||2
330762|NCT00620503|799929|P5|STARTED|Treatment Period 1 (TP1) (7days)||2
330763|NCT00620503|799930|P4|STARTED|Treatment Period 1 (TP1) (7days)||2
330764|NCT00620503|799931|P3|STARTED|Treatment Period 1 (TP1) (7days)||2
330765|NCT00620503|799932|P2|STARTED|Treatment Period 1 (TP1) (7days)||2
330766|NCT00620503|799933|P1|STARTED|Treatment Period 1 (TP1) (7days)||2
330767|NCT00620503|799928|P6|NOT COMPLETED|Screening (up to 21 Days)||0
330768|NCT00620503|799929|P5|NOT COMPLETED|Screening (up to 21 Days)||0
330769|NCT00620503|799930|P4|NOT COMPLETED|Screening (up to 21 Days)||0
330770|NCT00620503|799931|P3|NOT COMPLETED|Screening (up to 21 Days)||0
330771|NCT00620503|799932|P2|NOT COMPLETED|Screening (up to 21 Days)||0
330772|NCT00620503|799933|P1|NOT COMPLETED|Screening (up to 21 Days)||0
330773|NCT00620503|799928|P6|COMPLETED|Screening (up to 21 Days)||2
330774|NCT00620503|799929|P5|COMPLETED|Screening (up to 21 Days)||2
330775|NCT00620503|799930|P4|COMPLETED|Screening (up to 21 Days)||2
330776|NCT00620503|799931|P3|COMPLETED|Screening (up to 21 Days)||2
330777|NCT00620503|799932|P2|COMPLETED|Screening (up to 21 Days)||2
330778|NCT00620503|799933|P1|COMPLETED|Screening (up to 21 Days)||2
330779|NCT00620503|799928|P6|STARTED|Screening (up to 21 Days)||2
330780|NCT00620503|799929|P5|STARTED|Screening (up to 21 Days)||2
330781|NCT00620503|799930|P4|STARTED|Screening (up to 21 Days)||2
330782|NCT00620503|799931|P3|STARTED|Screening (up to 21 Days)||2
330783|NCT00620503|799932|P2|STARTED|Screening (up to 21 Days)||2
330784|NCT00620503|799933|P1|STARTED|Screening (up to 21 Days)||2
330785|NCT00620464|799955|P2|NOT COMPLETED|Overall Study||24
330786|NCT00620464|799956|P1|NOT COMPLETED|Overall Study||20
330787|NCT00620464|799955|P2|COMPLETED|Overall Study||32
330788|NCT00620464|799956|P1|COMPLETED|Overall Study||32
330789|NCT00620464|799955|P2|STARTED|Overall Study||56
330790|NCT00620464|799956|P1|STARTED|Overall Study||52
330791|NCT00620425|799964|P1|NOT COMPLETED|Overall Study||0
330792|NCT00620425|799964|P1|COMPLETED|Overall Study||18
330793|NCT00620425|799964|P1|STARTED|Overall Study||18
330794|NCT00620373|799975|P1|NOT COMPLETED|Overall Study||33
330795|NCT00620373|799975|P1|COMPLETED|Overall Study||936
330796|NCT00620373|799975|P1|STARTED|Overall Study||969
330797|NCT00620321|799993|P2|NOT COMPLETED|Overall Study||16
330798|NCT00620321|799994|P1|NOT COMPLETED|Overall Study||8
330799|NCT00620321|799993|P2|COMPLETED|Overall Study||0
330800|NCT00620321|799994|P1|COMPLETED|Overall Study||0
330801|NCT00620321|799993|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
330802|NCT00620321|799994|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
330803|NCT00620321|799993|P2|STARTED|Overall Study||16
330804|NCT00620321|799994|P1|STARTED|Overall Study||8
330805|NCT00620282|800013|P3|NOT COMPLETED|Overall Study||1
330806|NCT00620282|800014|P2|NOT COMPLETED|Overall Study||2
330807|NCT00620282|800015|P1|NOT COMPLETED|Overall Study||0
330808|NCT00620282|800013|P3|COMPLETED|Overall Study||16
330809|NCT00620282|800014|P2|COMPLETED|Overall Study||14
330810|NCT00620282|800015|P1|COMPLETED|Overall Study||16
330811|NCT00620282|800013|P3|STARTED|Overall Study||17
330812|NCT00620282|800014|P2|STARTED|Overall Study||16
330813|NCT00620282|800015|P1|STARTED|Overall Study||16
330814|NCT00620126|800064|P2|NOT COMPLETED|Overall Study||5
330815|NCT00620126|800065|P1|NOT COMPLETED|Overall Study||11
330816|NCT00620126|800064|P2|COMPLETED|Overall Study||17
330817|NCT00620126|800065|P1|COMPLETED|Overall Study||14
330818|NCT00620126|800064|P2|STARTED|Overall Study||22
330819|NCT00620126|800065|P1|STARTED|Overall Study||25
330820|NCT00620113|800079|P4|NOT COMPLETED|Overall Study||10
330821|NCT00620113|800080|P3|NOT COMPLETED|Overall Study||5
330822|NCT00620113|800081|P2|NOT COMPLETED|Overall Study||7
330823|NCT00620113|800082|P1|NOT COMPLETED|Overall Study||13
330824|NCT00620113|800079|P4|COMPLETED|Overall Study||59
330825|NCT00620113|800080|P3|COMPLETED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|66
330826|NCT00620113|800081|P2|COMPLETED|Overall Study||67
330827|NCT00620113|800082|P1|COMPLETED|Overall Study||60
330828|NCT00620113|800079|P4|Efficacy/Safety Population|Overall Study||69
330829|NCT00620113|800080|P3|Efficacy/Safety Population|Overall Study||70
330830|NCT00620113|800081|P2|Efficacy/Safety Population|Overall Study||74
330831|NCT00620113|800082|P1|Efficacy/Safety Population|Overall Study||73
330832|NCT00620113|800079|P4|STARTED|Overall Study||69
330833|NCT00620113|800080|P3|STARTED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|71
330834|NCT00620113|800081|P2|STARTED|Overall Study||74
330835|NCT00620113|800082|P1|STARTED|Overall Study||73
330836|NCT00620074|800132|P1|NOT COMPLETED|Overall Study||1
330837|NCT00620074|800132|P1|COMPLETED|Overall Study||5
330838|NCT00620074|800132|P1|STARTED|Overall Study||6
330839|NCT00620035|800140|P1|NOT COMPLETED|Overall Study||145
330840|NCT00620035|800140|P1|COMPLETED|Overall Study||156
330841|NCT00620035|800140|P1|STARTED|Overall Study||301
330842|NCT00620022|800150|P2|NOT COMPLETED|Treatment Period 2||2
330843|NCT00620022|800151|P1|NOT COMPLETED|Treatment Period 2||2
330844|NCT00620022|800150|P2|COMPLETED|Treatment Period 2||35
330845|NCT00620022|800151|P1|COMPLETED|Treatment Period 2||39
330846|NCT00620022|800150|P2|STARTED|Treatment Period 2||37
330847|NCT00620022|800151|P1|STARTED|Treatment Period 2||41
330848|NCT00620022|800150|P2|NOT COMPLETED|Treatment Period 1||6
330849|NCT00620022|800151|P1|NOT COMPLETED|Treatment Period 1||5
330850|NCT00620022|800150|P2|COMPLETED|Treatment Period 1||37
330851|NCT00620022|800151|P1|COMPLETED|Treatment Period 1||41
330852|NCT00620022|800150|P2|STARTED|Treatment Period 1|Of 44 randomized patients, 1 patient discontinued before receiving any study treatment.|43
330853|NCT00620022|800151|P1|STARTED|Treatment Period 1||46
330854|NCT00619983|800163|P4|NOT COMPLETED|Gabapentin Alone||0
330855|NCT00619983|800164|P3|NOT COMPLETED|Gabapentin Alone||0
330856|NCT00619983|800165|P2|NOT COMPLETED|Gabapentin Alone||0
330857|NCT00619983|800166|P1|NOT COMPLETED|Gabapentin Alone||0
330858|NCT00619983|800163|P4|COMPLETED|Gabapentin Alone||3
330859|NCT00619983|800164|P3|COMPLETED|Gabapentin Alone||4
330860|NCT00619983|800165|P2|COMPLETED|Gabapentin Alone||4
330861|NCT00619983|800166|P1|COMPLETED|Gabapentin Alone||3
330862|NCT00619983|800163|P4|STARTED|Gabapentin Alone||3
330863|NCT00619983|800164|P3|STARTED|Gabapentin Alone||4
330864|NCT00619983|800165|P2|STARTED|Gabapentin Alone||4
330865|NCT00619983|800166|P1|STARTED|Gabapentin Alone||3
330866|NCT00619983|800163|P4|NOT COMPLETED|Test Drug Plus Gabapentin||0
330867|NCT00619983|800164|P3|NOT COMPLETED|Test Drug Plus Gabapentin||0
330868|NCT00619983|800165|P2|NOT COMPLETED|Test Drug Plus Gabapentin||0
330869|NCT00619983|800166|P1|NOT COMPLETED|Test Drug Plus Gabapentin||0
330870|NCT00619983|800163|P4|COMPLETED|Test Drug Plus Gabapentin||3
330871|NCT00619983|800164|P3|COMPLETED|Test Drug Plus Gabapentin||4
330872|NCT00619983|800165|P2|COMPLETED|Test Drug Plus Gabapentin||4
330873|NCT00619983|800166|P1|COMPLETED|Test Drug Plus Gabapentin||3
330874|NCT00619983|800163|P4|STARTED|Test Drug Plus Gabapentin||3
330875|NCT00619983|800164|P3|STARTED|Test Drug Plus Gabapentin||4
330876|NCT00619983|800165|P2|STARTED|Test Drug Plus Gabapentin||4
330877|NCT00619983|800166|P1|STARTED|Test Drug Plus Gabapentin||3
330878|NCT00619983|800163|P4|NOT COMPLETED|Test Drug Alone||3
330879|NCT00619983|800164|P3|NOT COMPLETED|Test Drug Alone||2
330880|NCT00619983|800165|P2|NOT COMPLETED|Test Drug Alone||1
330881|NCT00619983|800166|P1|NOT COMPLETED|Test Drug Alone||2
330882|NCT00619983|800163|P4|COMPLETED|Test Drug Alone||3
330883|NCT00619983|800164|P3|COMPLETED|Test Drug Alone||4
330884|NCT00619983|800165|P2|COMPLETED|Test Drug Alone||4
330885|NCT00619983|800166|P1|COMPLETED|Test Drug Alone||3
330886|NCT00619983|800163|P4|STARTED|Test Drug Alone||6
330887|NCT00619983|800164|P3|STARTED|Test Drug Alone||6
330888|NCT00619983|800165|P2|STARTED|Test Drug Alone||5
330889|NCT00619983|800166|P1|STARTED|Test Drug Alone||5
330890|NCT00619970|800179|P3|NOT COMPLETED|Overall Study||2
330891|NCT00619970|800180|P2|NOT COMPLETED|Overall Study||3
330892|NCT00619970|800181|P1|NOT COMPLETED|Overall Study||0
330893|NCT00619970|800179|P3|COMPLETED|Overall Study||24
330894|NCT00619970|800180|P2|COMPLETED|Overall Study||46
330895|NCT00619970|800181|P1|COMPLETED|Overall Study||40
330896|NCT00619970|800179|P3|STARTED|Overall Study||26
330897|NCT00619970|800180|P2|STARTED|Overall Study||49
330898|NCT00619970|800181|P1|STARTED|Overall Study||40
330899|NCT00619957|800193|P2|NOT COMPLETED|Month 48 Open-Label||17
330900|NCT00619957|800194|P1|NOT COMPLETED|Month 48 Open-Label||12
330901|NCT00619957|800193|P2|COMPLETED|Month 48 Open-Label||134
330902|NCT00619957|800194|P1|COMPLETED|Month 48 Open-Label||55
330903|NCT00619957|800193|P2|STARTED|Month 48 Open-Label||151
330904|NCT00619957|800194|P1|STARTED|Month 48 Open-Label||67
330905|NCT00619957|800193|P2|NOT COMPLETED|Month 24 Double-Blind||17
330906|NCT00619957|800194|P1|NOT COMPLETED|Month 24 Double-Blind||18
330907|NCT00619957|800193|P2|COMPLETED|Month 24 Double-Blind||175
330908|NCT00619957|800194|P1|COMPLETED|Month 24 Double-Blind||75
330909|NCT00619957|800193|P2|Intent to Treat (ITT Population)|Month 24 Double-Blind|One subject did not take any study medication.|191
330910|NCT00619957|800194|P1|Intent to Treat (ITT Population)|Month 24 Double-Blind||93
330911|NCT00619957|800193|P2|STARTED|Month 24 Double-Blind||192
330912|NCT00619957|800194|P1|STARTED|Month 24 Double-Blind||93
330913|NCT00619918|800276|P2|NOT COMPLETED|Overall Study||22
330914|NCT00619918|800277|P1|NOT COMPLETED|Overall Study||20
330915|NCT00619918|800276|P2|COMPLETED|Overall Study||195
330916|NCT00619918|800277|P1|COMPLETED|Overall Study||210
330917|NCT00619918|800276|P2|STARTED|Overall Study||217
330918|NCT00619918|800277|P1|STARTED|Overall Study||230
330919|NCT00619892|800287|P2|NOT COMPLETED|Overall Study||2
330920|NCT00619892|800288|P1|NOT COMPLETED|Overall Study||3
330921|NCT00619892|800287|P2|COMPLETED|Overall Study||11
330922|NCT00619892|800288|P1|COMPLETED|Overall Study||10
330923|NCT00619892|800287|P2|STARTED|Overall Study||13
330924|NCT00619892|800288|P1|STARTED|Overall Study||13
330925|NCT00619866|800299|P5|NOT COMPLETED|Weeks 13 - 24||2
330926|NCT00619866|800300|P4|NOT COMPLETED|Weeks 13 - 24||4
330927|NCT00619866|800301|P3|NOT COMPLETED|Weeks 13 - 24||5
330928|NCT00619866|800302|P2|NOT COMPLETED|Weeks 13 - 24||7
330929|NCT00619866|800303|P1|NOT COMPLETED|Weeks 13 - 24||0
330930|NCT00619866|800299|P5|COMPLETED|Weeks 13 - 24||18
330931|NCT00619866|800300|P4|COMPLETED|Weeks 13 - 24||14
330932|NCT00619866|800301|P3|COMPLETED|Weeks 13 - 24||37
330933|NCT00619866|800302|P2|COMPLETED|Weeks 13 - 24||38
330934|NCT00619866|800303|P1|COMPLETED|Weeks 13 - 24||0
330935|NCT00619866|800299|P5|STARTED|Weeks 13 - 24||20
330936|NCT00619866|800300|P4|STARTED|Weeks 13 - 24||18
330937|NCT00619866|800301|P3|STARTED|Weeks 13 - 24||42
330938|NCT00619866|800302|P2|STARTED|Weeks 13 - 24||45
330939|NCT00619866|800303|P1|STARTED|Weeks 13 - 24||0
330940|NCT00619866|800299|P5|NOT COMPLETED|Weeks 1 - 12||0
330941|NCT00619866|800300|P4|NOT COMPLETED|Weeks 1 - 12||0
330942|NCT00619866|800301|P3|NOT COMPLETED|Weeks 1 - 12||10
330943|NCT00619866|800302|P2|NOT COMPLETED|Weeks 1 - 12||6
330944|NCT00619866|800303|P1|NOT COMPLETED|Weeks 1 - 12||14
330945|NCT00619866|800299|P5|COMPLETED|Weeks 1 - 12||0
330946|NCT00619866|800300|P4|COMPLETED|Weeks 1 - 12||0
330947|NCT00619866|800301|P3|COMPLETED|Weeks 1 - 12||42
330948|NCT00619866|800302|P2|COMPLETED|Weeks 1 - 12||45
330949|NCT00619866|800303|P1|COMPLETED|Weeks 1 - 12||38
330950|NCT00619866|800299|P5|STARTED|Weeks 1 - 12||0
330951|NCT00619866|800300|P4|STARTED|Weeks 1 - 12||0
330952|NCT00619866|800301|P3|STARTED|Weeks 1 - 12||52
330953|NCT00619866|800302|P2|STARTED|Weeks 1 - 12||51
330954|NCT00619866|800303|P1|STARTED|Weeks 1 - 12||52
330955|NCT00619827|800390|P2|NOT COMPLETED|Overall Study||4
330956|NCT00619827|800391|P1|NOT COMPLETED|Overall Study||3
330957|NCT00619827|800390|P2|COMPLETED|Overall Study||40
330958|NCT00619827|800391|P1|COMPLETED|Overall Study||42
330959|NCT00619827|800390|P2|STARTED|Overall Study||44
330960|NCT00619827|800391|P1|STARTED|Overall Study||45
330961|NCT00619801|800399|P2|NOT COMPLETED|Overall Study||3
330962|NCT00619801|800400|P1|NOT COMPLETED|Overall Study||1
330963|NCT00619801|800399|P2|COMPLETED|Overall Study||111
330964|NCT00619801|800400|P1|COMPLETED|Overall Study||58
330965|NCT00619801|800399|P2|Safety Population|Overall Study||114
330966|NCT00619801|800400|P1|Safety Population|Overall Study||59
330967|NCT00619801|800399|P2|STARTED|Overall Study||114
330968|NCT00619801|800400|P1|STARTED|Overall Study||59
330969|NCT00619762|800430|P1|NOT COMPLETED|Overall Study||3
330970|NCT00619762|800430|P1|COMPLETED|Overall Study|(25 breasts) last patient visit 11/09/2009|14
330971|NCT00619762|800430|P1|STARTED|Overall Study|(29 breasts) First patient implanted 10/23/2007|17
330972|NCT00619723|800437|P2|NOT COMPLETED|Overall Study||6
330973|NCT00619723|800438|P1|NOT COMPLETED|Overall Study||2
330974|NCT00619723|800437|P2|COMPLETED|Overall Study||61
330975|NCT00619723|800438|P1|COMPLETED|Overall Study||61
330976|NCT00619723|800437|P2|STARTED|Overall Study||67
330977|NCT00619723|800438|P1|STARTED|Overall Study||63
330978|NCT00619684|800448|P1|NOT COMPLETED|Overall Study||0
330979|NCT00619684|800448|P1|COMPLETED|Overall Study||18
330980|NCT00619684|800448|P1|STARTED|Overall Study||18
330981|NCT00619645|800457|P1|NOT COMPLETED|Overall Study||1
330982|NCT00619645|800457|P1|COMPLETED|Overall Study||7
330983|NCT00619645|800457|P1|STARTED|Overall Study||8
330984|NCT00619619|800471|P8|NOT COMPLETED|Overall Study||3
330985|NCT00619619|800472|P7|NOT COMPLETED|Overall Study||1
330986|NCT00619619|800473|P6|NOT COMPLETED|Overall Study||0
330987|NCT00619619|800474|P5|NOT COMPLETED|Overall Study||2
330988|NCT00619619|800475|P4|NOT COMPLETED|Overall Study||1
330989|NCT00619619|800476|P3|NOT COMPLETED|Overall Study||1
330990|NCT00619619|800477|P2|NOT COMPLETED|Overall Study||0
330991|NCT00619619|800478|P1|NOT COMPLETED|Overall Study||0
330992|NCT00619619|800471|P8|COMPLETED|Overall Study||5
330993|NCT00619619|800472|P7|COMPLETED|Overall Study||7
330994|NCT00619619|800473|P6|COMPLETED|Overall Study||7
330995|NCT00619619|800474|P5|COMPLETED|Overall Study||5
330996|NCT00619619|800475|P4|COMPLETED|Overall Study||6
330997|NCT00619619|800476|P3|COMPLETED|Overall Study||8
330998|NCT00619619|800477|P2|COMPLETED|Overall Study||7
330999|NCT00619619|800478|P1|COMPLETED|Overall Study|Completed=conclusion of Test Article (treatment) phase for all treatment groups in 3151A6-2000.|6
331000|NCT00619619|800471|P8|Entered the Extension Study|Overall Study||7
331001|NCT00619619|800472|P7|Entered the Extension Study|Overall Study||6
331002|NCT00619619|800473|P6|Entered the Extension Study|Overall Study||6
331003|NCT00619619|800474|P5|Entered the Extension Study|Overall Study||7
331004|NCT00619619|800475|P4|Entered the Extension Study|Overall Study||3
331005|NCT00619619|800476|P3|Entered the Extension Study|Overall Study||8
331006|NCT00619619|800477|P2|Entered the Extension Study|Overall Study||5
331007|NCT00619619|800478|P1|Entered the Extension Study|Overall Study|Extension study: 3151A6-2001 (NCT00669110)|6
331008|NCT00619619|800471|P8|STARTED|Overall Study||8
331009|NCT00619619|800472|P7|STARTED|Overall Study||8
331010|NCT00619619|800473|P6|STARTED|Overall Study||7
331011|NCT00619619|800474|P5|STARTED|Overall Study||7
331012|NCT00619619|800475|P4|STARTED|Overall Study||7
331013|NCT00619619|800476|P3|STARTED|Overall Study||9
331014|NCT00619619|800477|P2|STARTED|Overall Study||7
331015|NCT00619619|800478|P1|STARTED|Overall Study||6
331016|NCT00619515|800563|P1|NOT COMPLETED|Overall Study||73
331017|NCT00619515|800563|P1|COMPLETED|Overall Study||0
331018|NCT00619515|800563|P1|STARTED|Overall Study||73
331019|NCT00619502|800577|P2|NOT COMPLETED|Overall Study||10
331020|NCT00619502|800578|P1|NOT COMPLETED|Overall Study||8
331021|NCT00619502|800577|P2|COMPLETED|Overall Study||114
331022|NCT00619502|800578|P1|COMPLETED|Overall Study||122
331023|NCT00619502|800577|P2|STARTED|Overall Study||124
331024|NCT00619502|800578|P1|STARTED|Overall Study||130
331025|NCT00619489|800590|P2|NOT COMPLETED|Overall Study||34
331026|NCT00619489|800591|P1|NOT COMPLETED|Overall Study||23
331027|NCT00619489|800590|P2|COMPLETED|Overall Study||1
331028|NCT00619489|800591|P1|COMPLETED|Overall Study||14
331029|NCT00619489|800590|P2|STARTED|Overall Study||35
331030|NCT00619489|800591|P1|STARTED|Overall Study||37
331031|NCT00619476|800613|P4|NOT COMPLETED|Overall Study||34
331032|NCT00619476|800614|P3|NOT COMPLETED|Overall Study||24
331033|NCT00619476|800615|P2|NOT COMPLETED|Overall Study||22
331034|NCT00619476|800616|P1|NOT COMPLETED|Overall Study||31
331035|NCT00619476|800613|P4|COMPLETED|Overall Study||56
331036|NCT00619476|800614|P3|COMPLETED|Overall Study||60
331037|NCT00619476|800615|P2|COMPLETED|Overall Study||85
331038|NCT00619476|800616|P1|COMPLETED|Overall Study||64
331039|NCT00619476|800613|P4|Safety Population|Overall Study||87
331040|NCT00619476|800614|P3|Safety Population|Overall Study||82
331041|NCT00619476|800615|P2|Safety Population|Overall Study||107
331042|NCT00619476|800616|P1|Safety Population|Overall Study||95
331043|NCT00619476|800613|P4|Intent-to-Treat Population|Overall Study||87
331044|NCT00619476|800614|P3|Intent-to-Treat Population|Overall Study||82
331045|NCT00619476|800615|P2|Intent-to-Treat Population|Overall Study||107
331046|NCT00619476|800616|P1|Intent-to-Treat Population|Overall Study||95
331047|NCT00619476|800613|P4|STARTED|Overall Study||90
331048|NCT00619476|800614|P3|STARTED|Overall Study||84
331049|NCT00619476|800615|P2|STARTED|Overall Study||107
331050|NCT00619476|800616|P1|STARTED|Overall Study||95
331051|NCT00619385|800701|P3|NOT COMPLETED|Overall Study||4
331052|NCT00619385|800702|P2|NOT COMPLETED|Overall Study||2
331053|NCT00619385|800703|P1|NOT COMPLETED|Overall Study||1
331054|NCT00619385|800701|P3|COMPLETED|Overall Study||6
331055|NCT00619385|800702|P2|COMPLETED|Overall Study||6
331056|NCT00619385|800703|P1|COMPLETED|Overall Study||6
331057|NCT00619385|800701|P3|STARTED|Overall Study||10
331058|NCT00619385|800702|P2|STARTED|Overall Study||8
331059|NCT00619385|800703|P1|STARTED|Overall Study||7
331060|NCT00619359|800718|P2|NOT COMPLETED|Overall Study||81
331061|NCT00619359|800719|P1|NOT COMPLETED|Overall Study||67
331062|NCT00619359|800718|P2|COMPLETED|Overall Study||1094
331063|NCT00619359|800719|P1|COMPLETED|Overall Study||1080
331064|NCT00619359|800718|P2|STARTED|Overall Study||1175
331065|NCT00619359|800719|P1|STARTED|Overall Study||1147
331066|NCT00619307|800731|P2|NOT COMPLETED|Overall Study||4
331067|NCT00619307|800732|P1|NOT COMPLETED|Overall Study||4
331068|NCT00619307|800731|P2|COMPLETED|Overall Study||53
331069|NCT00619307|800732|P1|COMPLETED|Overall Study||56
331070|NCT00619307|800731|P2|STARTED|Overall Study||57
331071|NCT00619307|800732|P1|STARTED|Overall Study||60
331072|NCT00619255|800748|P2|NOT COMPLETED|Overall Study||0
331073|NCT00619255|800749|P1|NOT COMPLETED|Overall Study||2
331074|NCT00619255|800748|P2|COMPLETED|Overall Study||61
331075|NCT00619255|800749|P1|COMPLETED|Overall Study||57
331076|NCT00619255|800748|P2|STARTED|Overall Study||61
331077|NCT00619255|800749|P1|STARTED|Overall Study||59
331078|NCT00619242|800763|P1|NOT COMPLETED|Overall Study||0
331079|NCT00619242|800763|P1|COMPLETED|Overall Study||3
331080|NCT00619242|800763|P1|STARTED|Overall Study||3
331081|NCT00619229|800769|P2|NOT COMPLETED|Overall Study||2
331082|NCT00619229|800770|P1|NOT COMPLETED|Overall Study||4
331083|NCT00619229|800769|P2|COMPLETED|Overall Study||16
331084|NCT00619229|800770|P1|COMPLETED|Overall Study||14
331085|NCT00619229|800769|P2|Full Analysis Set (FAS)|Overall Study||17
331086|NCT00619229|800770|P1|Full Analysis Set (FAS)|Overall Study||16
331087|NCT00619229|800769|P2|STARTED|Overall Study||18
331088|NCT00619229|800770|P1|STARTED|Overall Study||18
331089|NCT00619190|800798|P2|NOT COMPLETED|Overall Study||0
331090|NCT00619190|800799|P1|NOT COMPLETED|Overall Study||1
331091|NCT00619190|800798|P2|COMPLETED|Overall Study||9
331092|NCT00619190|800799|P1|COMPLETED|Overall Study||20
331093|NCT00619190|800798|P2|STARTED|Overall Study||9
331094|NCT00619190|800799|P1|STARTED|Overall Study||21
331095|NCT00619177|800809|P1|NOT COMPLETED|Overall Study||508
331096|NCT00619177|800809|P1|COMPLETED|Overall Study|"Due to some missing termination information, the number of completed may be larger than 3061."|3061
331097|NCT00619177|800809|P1|STARTED|Overall Study|treated set = 3569 (treated with Movalis)|3569
331098|NCT00619151|800819|P2|NOT COMPLETED|Overall Study||0
331099|NCT00619151|800820|P1|NOT COMPLETED|Overall Study||1
331100|NCT00619151|800819|P2|COMPLETED|Overall Study||0
331101|NCT00619151|800820|P1|COMPLETED|Overall Study||1
331102|NCT00619151|800819|P2|STARTED|Overall Study||0
331103|NCT00619151|800820|P1|STARTED|Overall Study||2
331104|NCT00619112|800830|P2|NOT COMPLETED|Overall Study||2
331105|NCT00619112|800831|P1|NOT COMPLETED|Overall Study||1
331106|NCT00619112|800830|P2|COMPLETED|Overall Study|Data from patients who didn't complete study was still included in the final analysis.|18
331107|NCT00619112|800831|P1|COMPLETED|Overall Study|Data from patient who didn't complete study was still included in the final analysis.|39
331108|NCT00619112|800830|P2|STARTED|Overall Study||20
331109|NCT00619112|800831|P1|STARTED|Overall Study||40
331110|NCT00619099|800852|P2|NOT COMPLETED|Overall Study||19
331111|NCT00619099|800853|P1|NOT COMPLETED|Overall Study||33
331112|NCT00619099|800852|P2|COMPLETED|Overall Study||4
331113|NCT00619099|800853|P1|COMPLETED|Overall Study||11
331114|NCT00619099|800852|P2|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|22
331115|NCT00619099|800853|P1|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|43
331116|NCT00619099|800852|P2|STARTED|Overall Study|All randomized subjects|23
331117|NCT00619099|800853|P1|STARTED|Overall Study|All randomized subjects|44
331118|NCT00619073|800859|P2|NOT COMPLETED|Second Intervention - 60 Days||0
331119|NCT00619073|800860|P1|NOT COMPLETED|Second Intervention - 60 Days||0
331120|NCT00619073|800859|P2|COMPLETED|Second Intervention - 60 Days||8
331121|NCT00619073|800860|P1|COMPLETED|Second Intervention - 60 Days||8
331122|NCT00619073|800859|P2|STARTED|Second Intervention - 60 Days||8
331123|NCT00619073|800860|P1|STARTED|Second Intervention - 60 Days||8
331124|NCT00619073|800859|P2|NOT COMPLETED|Washout Period (30 Days)||0
331125|NCT00619073|800860|P1|NOT COMPLETED|Washout Period (30 Days)||0
331126|NCT00619073|800859|P2|COMPLETED|Washout Period (30 Days)||8
331127|NCT00619073|800860|P1|COMPLETED|Washout Period (30 Days)||8
331128|NCT00619073|800859|P2|STARTED|Washout Period (30 Days)||8
331129|NCT00619073|800860|P1|STARTED|Washout Period (30 Days)||8
331130|NCT00619073|800859|P2|NOT COMPLETED|First Intervention - 60 Days||0
331131|NCT00619073|800860|P1|NOT COMPLETED|First Intervention - 60 Days||0
331132|NCT00619073|800859|P2|COMPLETED|First Intervention - 60 Days||8
331133|NCT00619073|800860|P1|COMPLETED|First Intervention - 60 Days||8
331134|NCT00619073|800859|P2|STARTED|First Intervention - 60 Days||8
331135|NCT00619073|800860|P1|STARTED|First Intervention - 60 Days||8
331136|NCT00619060|800866|P2|NOT COMPLETED|Overall Study||0
331137|NCT00619060|800867|P1|NOT COMPLETED|Overall Study||0
331138|NCT00619060|800866|P2|COMPLETED|Overall Study||12
331139|NCT00619060|800867|P1|COMPLETED|Overall Study||10
331140|NCT00619060|800866|P2|STARTED|Overall Study||12
331141|NCT00619060|800867|P1|STARTED|Overall Study||10
331142|NCT00618995|800875|P4|NOT COMPLETED|Period 4||0
331143|NCT00618995|800876|P3|NOT COMPLETED|Period 4||0
331144|NCT00618995|800877|P2|NOT COMPLETED|Period 4||0
331145|NCT00618995|800878|P1|NOT COMPLETED|Period 4||1
331146|NCT00618995|800875|P4|COMPLETED|Period 4||6
331147|NCT00618995|800876|P3|COMPLETED|Period 4||4
331148|NCT00618995|800877|P2|COMPLETED|Period 4||6
331149|NCT00618995|800878|P1|COMPLETED|Period 4||5
331150|NCT00618995|800875|P4|STARTED|Period 4||6
331151|NCT00618995|800876|P3|STARTED|Period 4||4
331152|NCT00618995|800877|P2|STARTED|Period 4||6
331153|NCT00618995|800878|P1|STARTED|Period 4||6
331154|NCT00618995|800875|P4|NOT COMPLETED|Period 3||0
331155|NCT00618995|800876|P3|NOT COMPLETED|Period 3||0
331156|NCT00618995|800877|P2|NOT COMPLETED|Period 3||0
331157|NCT00618995|800878|P1|NOT COMPLETED|Period 3||0
331158|NCT00618995|800875|P4|COMPLETED|Period 3||6
331159|NCT00618995|800876|P3|COMPLETED|Period 3||4
331160|NCT00618995|800877|P2|COMPLETED|Period 3||6
331161|NCT00618995|800878|P1|COMPLETED|Period 3||6
331162|NCT00618995|800875|P4|STARTED|Period 3||6
331163|NCT00618995|800876|P3|STARTED|Period 3||4
331164|NCT00618995|800877|P2|STARTED|Period 3||6
331165|NCT00618995|800878|P1|STARTED|Period 3||6
331166|NCT00618995|800875|P4|NOT COMPLETED|Period 2||0
331167|NCT00618995|800876|P3|NOT COMPLETED|Period 2||1
331168|NCT00618995|800877|P2|NOT COMPLETED|Period 2||0
331169|NCT00618995|800878|P1|NOT COMPLETED|Period 2||0
331170|NCT00618995|800875|P4|COMPLETED|Period 2||6
331171|NCT00618995|800876|P3|COMPLETED|Period 2||4
331172|NCT00618995|800877|P2|COMPLETED|Period 2||6
331173|NCT00618995|800878|P1|COMPLETED|Period 2||6
331174|NCT00618995|800875|P4|STARTED|Period 2||6
331175|NCT00618995|800876|P3|STARTED|Period 2||5
331176|NCT00618995|800877|P2|STARTED|Period 2||6
331177|NCT00618995|800878|P1|STARTED|Period 2||6
331178|NCT00618995|800875|P4|NOT COMPLETED|Period 1||0
331179|NCT00618995|800876|P3|NOT COMPLETED|Period 1||2
331180|NCT00618995|800877|P2|NOT COMPLETED|Period 1||1
331181|NCT00618995|800878|P1|NOT COMPLETED|Period 1||0
331182|NCT00618995|800875|P4|COMPLETED|Period 1||6
331183|NCT00618995|800876|P3|COMPLETED|Period 1||5
331184|NCT00618995|800877|P2|COMPLETED|Period 1||6
331185|NCT00618995|800878|P1|COMPLETED|Period 1||6
331186|NCT00618995|800875|P4|STARTED|Period 1||6
331187|NCT00618995|800876|P3|STARTED|Period 1||7
331188|NCT00618995|800877|P2|STARTED|Period 1||7
331189|NCT00618995|800878|P1|STARTED|Period 1||6
331190|NCT00618982|800892|P1|NOT COMPLETED|Overall Study||50
331191|NCT00618982|800892|P1|COMPLETED|Overall Study||33
331192|NCT00618982|800892|P1|STARTED|Overall Study||83
331193|NCT00618956|800915|P2|NOT COMPLETED|Overall Study||50
331194|NCT00618956|800916|P1|NOT COMPLETED|Overall Study||25
331195|NCT00618956|800915|P2|COMPLETED|Overall Study||160
331196|NCT00618956|800916|P1|COMPLETED|Overall Study||86
331197|NCT00618956|800915|P2|STARTED|Overall Study||210
331198|NCT00618956|800916|P1|STARTED|Overall Study||111
331199|NCT00618839|800932|P1|NOT COMPLETED|Overall Study||0
331200|NCT00618839|800932|P1|COMPLETED|Overall Study||15
331201|NCT00618839|800932|P1|STARTED|Overall Study||15
331202|NCT00618826|800941|P1|NOT COMPLETED|Overall Study||1
331203|NCT00618826|800941|P1|COMPLETED|Overall Study||13
331204|NCT00618826|800941|P1|STARTED|Overall Study||14
331205|NCT00618813|800946|P1|NOT COMPLETED|Overall Study||4
331206|NCT00618813|800946|P1|COMPLETED|Overall Study||31
331207|NCT00618813|800946|P1|Completed Week 29 to Week 37 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|33
331208|NCT00618813|800946|P1|Completed Week 23 to Week 28 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
331209|NCT00618813|800946|P1|Completed Week 13 to Week 22 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
331210|NCT00618813|800946|P1|Completed Enrollment - Week 12 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|35
331211|NCT00618813|800946|P1|STARTED|Overall Study||35
331212|NCT00618787|800956|P2|NOT COMPLETED|Overall Study||2
331213|NCT00618787|800957|P1|NOT COMPLETED|Overall Study||3
331214|NCT00618787|800956|P2|COMPLETED|Overall Study||21
331215|NCT00618787|800957|P1|COMPLETED|Overall Study||19
331216|NCT00618787|800956|P2|STARTED|Overall Study||23
331217|NCT00618787|800957|P1|STARTED|Overall Study||22
331218|NCT00618774|800965|P2|NOT COMPLETED|Overall Study||3
331219|NCT00618774|800966|P1|NOT COMPLETED|Overall Study||6
331220|NCT00618774|800965|P2|COMPLETED|Overall Study||45
331221|NCT00618774|800966|P1|COMPLETED|Overall Study||205
331222|NCT00618774|800965|P2|STARTED|Overall Study||48
331223|NCT00618774|800966|P1|STARTED|Overall Study||211
331224|NCT00618748|800999|P3|NOT COMPLETED|Overall Study||14
331225|NCT00618748|801000|P2|NOT COMPLETED|Overall Study||5
331226|NCT00618748|801001|P1|NOT COMPLETED|Overall Study||11
331227|NCT00618748|800999|P3|COMPLETED|Overall Study||6
331228|NCT00618748|801000|P2|COMPLETED|Overall Study||20
331229|NCT00618748|801001|P1|COMPLETED|Overall Study||45
331230|NCT00618748|800999|P3|STARTED|Overall Study||20
331231|NCT00618748|801000|P2|STARTED|Overall Study||25
331232|NCT00618748|801001|P1|STARTED|Overall Study||56
331233|NCT00618722|801046|P4|NOT COMPLETED|Overall Study||4
331234|NCT00618722|801047|P3|NOT COMPLETED|Overall Study||3
331235|NCT00618722|801048|P2|NOT COMPLETED|Overall Study||2
331236|NCT00618722|801049|P1|NOT COMPLETED|Overall Study||3
331237|NCT00618722|801046|P4|COMPLETED|Overall Study||18
331238|NCT00618722|801047|P3|COMPLETED|Overall Study||19
331239|NCT00618722|801048|P2|COMPLETED|Overall Study||18
331240|NCT00618722|801049|P1|COMPLETED|Overall Study||18
331241|NCT00618722|801046|P4|Received Treatment|Overall Study||22
331242|NCT00618722|801047|P3|Received Treatment|Overall Study||22
331243|NCT00618722|801048|P2|Received Treatment|Overall Study||20
331244|NCT00618722|801049|P1|Received Treatment|Overall Study||20
331245|NCT00618722|801046|P4|STARTED|Overall Study||22
331246|NCT00618722|801047|P3|STARTED|Overall Study||22
331247|NCT00618722|801048|P2|STARTED|Overall Study||20
331248|NCT00618722|801049|P1|STARTED|Overall Study||21
331249|NCT00618618|801087|P4|NOT COMPLETED|Overall Study||1
331250|NCT00618618|801088|P3|NOT COMPLETED|Overall Study||3
331251|NCT00618618|801089|P2|NOT COMPLETED|Overall Study||3
331252|NCT00618618|801090|P1|NOT COMPLETED|Overall Study||4
331253|NCT00618618|801087|P4|COMPLETED|Overall Study||13
331254|NCT00618618|801088|P3|COMPLETED|Overall Study||18
331255|NCT00618618|801089|P2|COMPLETED|Overall Study||11
331256|NCT00618618|801090|P1|COMPLETED|Overall Study||20
331257|NCT00618618|801087|P4|Received Treatment|Overall Study||14
331258|NCT00618618|801088|P3|Received Treatment|Overall Study||20
331259|NCT00618618|801089|P2|Received Treatment|Overall Study||13
331260|NCT00618618|801090|P1|Received Treatment|Overall Study||24
331261|NCT00618618|801087|P4|STARTED|Overall Study||14
331262|NCT00618618|801088|P3|STARTED|Overall Study||21
331263|NCT00618618|801089|P2|STARTED|Overall Study||14
331264|NCT00618618|801090|P1|STARTED|Overall Study||24
331265|NCT00618540|801136|P1|NOT COMPLETED|Overall Study||0
331266|NCT00618540|801136|P1|COMPLETED|Overall Study||1
331267|NCT00618540|801136|P1|STARTED|Overall Study||1
331268|NCT00618514|801149|P3|NOT COMPLETED|Overall Study||4
331269|NCT00618514|801150|P2|NOT COMPLETED|Overall Study||12
331270|NCT00618514|801151|P1|NOT COMPLETED|Overall Study||11
331271|NCT00618514|801149|P3|COMPLETED|Overall Study||12
331272|NCT00618514|801150|P2|COMPLETED|Overall Study||26
331273|NCT00618514|801151|P1|COMPLETED|Overall Study||25
331274|NCT00618514|801149|P3|STARTED|Overall Study||16
331275|NCT00618514|801150|P2|STARTED|Overall Study||38
331276|NCT00618514|801151|P1|STARTED|Overall Study||36
331277|NCT00618449|801171|P2|NOT COMPLETED|Overall Study||110
331278|NCT00618449|801172|P1|NOT COMPLETED|Overall Study||98
331279|NCT00618449|801171|P2|COMPLETED|Overall Study||558
331280|NCT00618449|801172|P1|COMPLETED|Overall Study||581
331281|NCT00618449|801171|P2|1-year, Post-treatment|Overall Study||558
331282|NCT00618449|801172|P1|1-year, Post-treatment|Overall Study||581
331283|NCT00618449|801171|P2|1-month, Post-treatment|Overall Study||656
331284|NCT00618449|801172|P1|1-month, Post-treatment|Overall Study||666
331285|NCT00618449|801171|P2|STARTED|Overall Study||668
331286|NCT00618449|801172|P1|STARTED|Overall Study||679
331287|NCT00618436|801180|P2|NOT COMPLETED|Overall Study||0
331288|NCT00618436|801181|P1|NOT COMPLETED|Overall Study||0
331289|NCT00618436|801180|P2|COMPLETED|Overall Study||18
331290|NCT00618436|801181|P1|COMPLETED|Overall Study||34
331291|NCT00618436|801180|P2|STARTED|Overall Study||18
331292|NCT00618436|801181|P1|STARTED|Overall Study||34
331293|NCT00618410|801191|P2|NOT COMPLETED|Second Intervention||0
331294|NCT00618410|801192|P1|NOT COMPLETED|Second Intervention||0
331295|NCT00618410|801191|P2|COMPLETED|Second Intervention||5
331296|NCT00618410|801192|P1|COMPLETED|Second Intervention||7
331297|NCT00618410|801191|P2|STARTED|Second Intervention||5
331298|NCT00618410|801192|P1|STARTED|Second Intervention||7
331299|NCT00618410|801191|P2|NOT COMPLETED|Washout Period (2 Weeks)||1
331300|NCT00618410|801192|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
331301|NCT00618410|801191|P2|COMPLETED|Washout Period (2 Weeks)||5
331302|NCT00618410|801192|P1|COMPLETED|Washout Period (2 Weeks)||7
331303|NCT00618410|801191|P2|STARTED|Washout Period (2 Weeks)||6
331304|NCT00618410|801192|P1|STARTED|Washout Period (2 Weeks)||7
331305|NCT00618410|801191|P2|NOT COMPLETED|First Intervention||0
331306|NCT00618410|801192|P1|NOT COMPLETED|First Intervention||0
331307|NCT00618410|801191|P2|COMPLETED|First Intervention||6
331308|NCT00618410|801192|P1|COMPLETED|First Intervention||7
331309|NCT00618410|801191|P2|STARTED|First Intervention||6
331310|NCT00618410|801192|P1|STARTED|First Intervention||7
331311|NCT00618371|801208|P1|NOT COMPLETED|Overall Study||2
331312|NCT00618371|801208|P1|COMPLETED|Overall Study||10
331313|NCT00618371|801208|P1|STARTED|Overall Study||12
331314|NCT00618332|801215|P2|NOT COMPLETED|Overall Study||0
331315|NCT00618332|801216|P1|NOT COMPLETED|Overall Study||0
331316|NCT00618332|801215|P2|COMPLETED|Overall Study||20
331317|NCT00618332|801216|P1|COMPLETED|Overall Study||20
331318|NCT00618332|801215|P2|STARTED|Overall Study||20
331319|NCT00618332|801216|P1|STARTED|Overall Study||20
331320|NCT00618072|801241|P3|NOT COMPLETED|Overall Study||4
331321|NCT00618072|801242|P2|NOT COMPLETED|Overall Study||1
331322|NCT00618072|801243|P1|NOT COMPLETED|Overall Study||2
331323|NCT00618072|801241|P3|COMPLETED|Overall Study||11
331324|NCT00618072|801242|P2|COMPLETED|Overall Study||14
331325|NCT00618072|801243|P1|COMPLETED|Overall Study||14
331326|NCT00618072|801241|P3|STARTED|Overall Study||15
331327|NCT00618072|801242|P2|STARTED|Overall Study||15
331328|NCT00618072|801243|P1|STARTED|Overall Study||16
331329|NCT00617981|801277|P2|NOT COMPLETED|Overall Study||102
331330|NCT00617981|801278|P1|NOT COMPLETED|Overall Study||110
331331|NCT00617981|801277|P2|COMPLETED|Overall Study||245
331332|NCT00617981|801278|P1|COMPLETED|Overall Study||244
331333|NCT00617981|801277|P2|STARTED|Overall Study||347
331334|NCT00617981|801278|P1|STARTED|Overall Study||354
331335|NCT00617942|801286|P2|NOT COMPLETED|Overall Study||4
331336|NCT00617942|801287|P1|NOT COMPLETED|Overall Study||8
331337|NCT00617942|801286|P2|COMPLETED|Overall Study||19
331338|NCT00617942|801287|P1|COMPLETED|Overall Study||29
331339|NCT00617942|801286|P2|STARTED|Overall Study||23
331340|NCT00617942|801287|P1|STARTED|Overall Study||37
331341|NCT00617929|801299|P1|NOT COMPLETED|Overall Study||1
331342|NCT00617929|801299|P1|COMPLETED|Overall Study||11
331343|NCT00617929|801299|P1|STARTED|Overall Study||12
331344|NCT00617903|801311|P2|NOT COMPLETED|Overall Study||7
331345|NCT00617903|801312|P1|NOT COMPLETED|Overall Study||3
331346|NCT00617903|801311|P2|COMPLETED|Overall Study||35
331347|NCT00617903|801312|P1|COMPLETED|Overall Study||38
331348|NCT00617903|801311|P2|STARTED|Overall Study||42
331349|NCT00617903|801312|P1|STARTED|Overall Study||41
331350|NCT00617890|801358|P4|NOT COMPLETED|Overall Study||115
331351|NCT00617890|801359|P3|NOT COMPLETED|Overall Study||35
331352|NCT00617890|801360|P2|NOT COMPLETED|Overall Study||28
331353|NCT00617890|801361|P1|NOT COMPLETED|Overall Study||31
331354|NCT00617890|801358|P4|COMPLETED|Overall Study||1
331355|NCT00617890|801359|P3|COMPLETED|Overall Study||0
331356|NCT00617890|801360|P2|COMPLETED|Overall Study||5
331357|NCT00617890|801361|P1|COMPLETED|Overall Study||4
331358|NCT00617890|801358|P4|Received Treatment|Overall Study||115
331359|NCT00617890|801359|P3|Received Treatment|Overall Study||34
331360|NCT00617890|801360|P2|Received Treatment|Overall Study||33
331361|NCT00617890|801361|P1|Received Treatment|Overall Study||34
331362|NCT00617890|801358|P4|STARTED|Overall Study||116
331363|NCT00617890|801359|P3|STARTED|Overall Study||35
331364|NCT00617890|801360|P2|STARTED|Overall Study||33
331365|NCT00617890|801361|P1|STARTED|Overall Study||35
331366|NCT00617851|801397|P4|NOT COMPLETED|Overall Study||25
331367|NCT00617851|801398|P3|NOT COMPLETED|Overall Study||45
331368|NCT00617851|801399|P2|NOT COMPLETED|Overall Study||40
331369|NCT00617851|801400|P1|NOT COMPLETED|Overall Study||47
331370|NCT00617851|801397|P4|COMPLETED|Overall Study||192
331371|NCT00617851|801398|P3|COMPLETED|Overall Study||384
331372|NCT00617851|801399|P2|COMPLETED|Overall Study||391
331373|NCT00617851|801400|P1|COMPLETED|Overall Study||383
331374|NCT00617851|801397|P4|STARTED|Overall Study||217
331375|NCT00617851|801398|P3|STARTED|Overall Study||429
331376|NCT00617851|801399|P2|STARTED|Overall Study||431
331377|NCT00617851|801400|P1|STARTED|Overall Study||430
331378|NCT00617773|801438|P1|NOT COMPLETED|Overall Study||24
331379|NCT00617773|801438|P1|COMPLETED|Overall Study|Patients COMPLETED were evaluated as having no disease progression at the end of cycle 3.|7
331380|NCT00617773|801438|P1|STARTED|Overall Study||31
331381|NCT00617734|801455|P2|NOT COMPLETED|Overall Study||6
331382|NCT00617734|801456|P1|NOT COMPLETED|Overall Study||8
331383|NCT00617734|801455|P2|COMPLETED|Overall Study||42
331384|NCT00617734|801456|P1|COMPLETED|Overall Study||41
331385|NCT00617734|801455|P2|Received at Least 1 Dose of Study Drug|Overall Study||44
331386|NCT00617734|801456|P1|Received at Least 1 Dose of Study Drug|Overall Study||47
331387|NCT00617734|801455|P2|STARTED|Overall Study||48
331388|NCT00617734|801456|P1|STARTED|Overall Study||49
331389|NCT00617708|801477|P3|NOT COMPLETED|Overall Study||64
331390|NCT00617708|801478|P2|NOT COMPLETED|Overall Study||60
331391|NCT00617708|801479|P1|NOT COMPLETED|Overall Study||10
331392|NCT00617708|801477|P3|COMPLETED|Overall Study||0
331393|NCT00617708|801478|P2|COMPLETED|Overall Study||0
331394|NCT00617708|801479|P1|COMPLETED|Overall Study||0
331395|NCT00617708|801477|P3|Eligible and Began Protocol Therapy|Overall Study||59
331396|NCT00617708|801478|P2|Eligible and Began Protocol Therapy|Overall Study||57
331397|NCT00617708|801479|P1|Eligible and Began Protocol Therapy|Overall Study||9
331398|NCT00617708|801477|P3|STARTED|Overall Study||64
331399|NCT00617708|801478|P2|STARTED|Overall Study||60
331400|NCT00617708|801479|P1|STARTED|Overall Study||10
331401|NCT00617669|801496|P2|NOT COMPLETED|Overall Study||451
331402|NCT00617669|801497|P1|NOT COMPLETED|Overall Study||430
331403|NCT00617669|801496|P2|COMPLETED|Overall Study|Patients receiving placebo at data cut-off|77
331404|NCT00617669|801497|P1|COMPLETED|Overall Study|Patients receiving ZD4054 10 mg at data cut-off|94
331405|NCT00617669|801496|P2|Patients Who Received IP|Overall Study||525
331406|NCT00617669|801497|P1|Patients Who Received IP|Overall Study||522
331407|NCT00617669|801496|P2|STARTED|Overall Study||528
331408|NCT00617669|801497|P1|STARTED|Overall Study||524
331409|NCT00617604|801519|P2|NOT COMPLETED|Overall Study||20
331410|NCT00617604|801520|P1|NOT COMPLETED|Overall Study||18
331411|NCT00617604|801519|P2|COMPLETED|Overall Study|Completed Month 6 assessment|88
331412|NCT00617604|801520|P1|COMPLETED|Overall Study|Completed Month 6 assessment|92
331413|NCT00617604|801519|P2|Completed 12 Weeks of Treatment|Overall Study||83
331414|NCT00617604|801520|P1|Completed 12 Weeks of Treatment|Overall Study||89
331415|NCT00617604|801519|P2|Received Treatment|Overall Study||105
331416|NCT00617604|801520|P1|Received Treatment|Overall Study||107
331417|NCT00617604|801519|P2|STARTED|Overall Study||108
331418|NCT00617604|801520|P1|STARTED|Overall Study||110
331419|NCT00617591|801564|P1|NOT COMPLETED|Overall Study||10
331420|NCT00617591|801564|P1|COMPLETED|Overall Study||47
331421|NCT00617591|801564|P1|STARTED|Overall Study||57
331422|NCT00617539|801572|P1|NOT COMPLETED|Overall Study||0
331423|NCT00617539|801572|P1|COMPLETED|Overall Study||30
331424|NCT00617539|801572|P1|STARTED|Overall Study||30
331425|NCT00617461|801580|P2|NOT COMPLETED|6-Day Down-Titration Period||2
331426|NCT00617461|801581|P1|NOT COMPLETED|6-Day Down-Titration Period||2
331427|NCT00617461|801580|P2|COMPLETED|6-Day Down-Titration Period||35
331428|NCT00617461|801581|P1|COMPLETED|6-Day Down-Titration Period||39
331429|NCT00617461|801580|P2|STARTED|6-Day Down-Titration Period||37
331430|NCT00617461|801581|P1|STARTED|6-Day Down-Titration Period||41
331431|NCT00617461|801580|P2|NOT COMPLETED|Second Treatment Intervention Period||4
331432|NCT00617461|801581|P1|NOT COMPLETED|Second Treatment Intervention Period||0
331433|NCT00617461|801580|P2|COMPLETED|Second Treatment Intervention Period||37
331434|NCT00617461|801581|P1|COMPLETED|Second Treatment Intervention Period||41
331435|NCT00617461|801580|P2|STARTED|Second Treatment Intervention Period||41
331436|NCT00617461|801581|P1|STARTED|Second Treatment Intervention Period||41
331437|NCT00617461|801580|P2|NOT COMPLETED|4-Day Crossover Period||0
331438|NCT00617461|801581|P1|NOT COMPLETED|4-Day Crossover Period||1
331439|NCT00617461|801580|P2|COMPLETED|4-Day Crossover Period||40
331440|NCT00617461|801581|P1|COMPLETED|4-Day Crossover Period||41
331441|NCT00617461|801580|P2|STARTED|4-Day Crossover Period|One 3600:1200 participant skipped the Crossover period, going directly to second Treatment Period.|40
331442|NCT00617461|801581|P1|STARTED|4-Day Crossover Period||42
331443|NCT00617461|801580|P2|NOT COMPLETED|First Treatment Intervention Period||3
331444|NCT00617461|801581|P1|NOT COMPLETED|First Treatment Intervention Period||10
331445|NCT00617461|801580|P2|COMPLETED|First Treatment Intervention Period||41
331446|NCT00617461|801581|P1|COMPLETED|First Treatment Intervention Period||42
331447|NCT00617461|801580|P2|STARTED|First Treatment Intervention Period||44
331448|NCT00617461|801581|P1|STARTED|First Treatment Intervention Period|2 par. (1 withdrawal due to inv. discretion, 1 withdrawal by subject) did not take study drug.|52
331449|NCT00617409|801637|P3|NOT COMPLETED|Overall Study||27
331450|NCT00617409|801638|P2|NOT COMPLETED|Overall Study||18
331451|NCT00617409|801639|P1|NOT COMPLETED|Overall Study||16
331452|NCT00617409|801637|P3|COMPLETED|Overall Study||4
331453|NCT00617409|801638|P2|COMPLETED|Overall Study||2
331454|NCT00617409|801639|P1|COMPLETED|Overall Study||2
331455|NCT00617409|801637|P3|STARTED|Overall Study||31
331456|NCT00617409|801638|P2|STARTED|Overall Study||20
331457|NCT00617409|801639|P1|STARTED|Overall Study||18
331458|NCT00617396|801650|P1|NOT COMPLETED|Overall Study||0
331459|NCT00617396|801650|P1|COMPLETED|Overall Study||25
331460|NCT00617396|801650|P1|STARTED|Overall Study||25
331461|NCT00617357|801654|P1|NOT COMPLETED|Overall Study||16
331462|NCT00617357|801654|P1|COMPLETED|Overall Study|67 subjects completed study; 7 completed early, 60 completed 24 month visit|67
331463|NCT00617357|801654|P1|STARTED|Overall Study|83 subjects enrolled, 80 subjects received Strattice reinforcement of hernia repair|83
331464|NCT00617344|801667|P3|NOT COMPLETED|Overall Study||8
331465|NCT00617344|801668|P2|NOT COMPLETED|Overall Study||22
331466|NCT00617344|801669|P1|NOT COMPLETED|Overall Study||25
331467|NCT00617344|801667|P3|COMPLETED|Overall Study||45
331468|NCT00617344|801668|P2|COMPLETED|Overall Study||81
331469|NCT00617344|801669|P1|COMPLETED|Overall Study||79
331470|NCT00617344|801667|P3|Received Vaccination 3|Overall Study||45
331471|NCT00617344|801668|P2|Received Vaccination 3|Overall Study||81
331472|NCT00617344|801669|P1|Received Vaccination 3|Overall Study||79
331473|NCT00617344|801667|P3|Received Vaccination 2|Overall Study||46
331474|NCT00617344|801668|P2|Received Vaccination 2|Overall Study||85
331475|NCT00617344|801669|P1|Received Vaccination 2|Overall Study||86
331476|NCT00617344|801667|P3|Received Vaccination 1|Overall Study||53
331477|NCT00617344|801668|P2|Received Vaccination 1|Overall Study||103
331478|NCT00617344|801669|P1|Received Vaccination 1|Overall Study||104
331479|NCT00617344|801667|P3|STARTED|Overall Study||53
331480|NCT00617344|801668|P2|STARTED|Overall Study||103
331481|NCT00617344|801669|P1|STARTED|Overall Study||104
331482|NCT00617305|801697|P3|NOT COMPLETED|Overall Study||1
331483|NCT00617305|801698|P2|NOT COMPLETED|Overall Study||0
331484|NCT00617305|801699|P1|NOT COMPLETED|Overall Study||8
331485|NCT00617305|801697|P3|COMPLETED|Overall Study||0
331486|NCT00617305|801698|P2|COMPLETED|Overall Study||4
331487|NCT00617305|801699|P1|COMPLETED|Overall Study||25
331488|NCT00617305|801697|P3|Completed 24-week Primary Analysis|Overall Study||0
331489|NCT00617305|801698|P2|Completed 24-week Primary Analysis|Overall Study||4
331490|NCT00617305|801699|P1|Completed 24-week Primary Analysis|Overall Study||31
331491|NCT00617305|801697|P3|STARTED|Overall Study||1
331492|NCT00617305|801698|P2|STARTED|Overall Study||4
331493|NCT00617305|801699|P1|STARTED|Overall Study||33
331494|NCT00617279|801755|P2|NOT COMPLETED|Overall Study||17
331495|NCT00617279|801756|P1|NOT COMPLETED|Overall Study||14
331496|NCT00617279|801755|P2|COMPLETED|Overall Study||0
331497|NCT00617279|801756|P1|COMPLETED|Overall Study||0
331498|NCT00617279|801755|P2|STARTED|Overall Study||17
331499|NCT00617279|801756|P1|STARTED|Overall Study||14
331500|NCT00617240|801812|P2|NOT COMPLETED|Overall Study||0
331501|NCT00617240|801813|P1|NOT COMPLETED|Overall Study||1
331502|NCT00617240|801812|P2|COMPLETED|Overall Study||4
331503|NCT00617240|801813|P1|COMPLETED|Overall Study||4
331504|NCT00617240|801812|P2|STARTED|Overall Study||4
331505|NCT00617240|801813|P1|STARTED|Overall Study||5
331506|NCT00617201|801833|P2|NOT COMPLETED|Overall Study||13
331507|NCT00617201|801834|P1|NOT COMPLETED|Overall Study||9
331508|NCT00617201|801833|P2|COMPLETED|Overall Study||12
331509|NCT00617201|801834|P1|COMPLETED|Overall Study||16
331510|NCT00617201|801833|P2|STARTED|Overall Study||25
331511|NCT00617201|801834|P1|STARTED|Overall Study||25
331512|NCT00617188|801842|P1|NOT COMPLETED|Overall Study||0
331513|NCT00617188|801842|P1|COMPLETED|Overall Study||26
331514|NCT00617188|801842|P1|STARTED|Overall Study||26
331515|NCT00617175|801853|P2|NOT COMPLETED|Overall Study||0
331516|NCT00617175|801854|P1|NOT COMPLETED|Overall Study||0
331517|NCT00617175|801853|P2|COMPLETED|Overall Study||948
331518|NCT00617175|801854|P1|COMPLETED|Overall Study||954
331519|NCT00617175|801853|P2|STARTED|Overall Study||948
331520|NCT00617175|801854|P1|STARTED|Overall Study||954
331521|NCT00617123|801862|P2|NOT COMPLETED|Study Treatment Period||16
331522|NCT00617123|801863|P1|NOT COMPLETED|Study Treatment Period||17
331523|NCT00617123|801862|P2|COMPLETED|Study Treatment Period||79
331524|NCT00617123|801863|P1|COMPLETED|Study Treatment Period||81
331525|NCT00617123|801862|P2|Treated|Study Treatment Period||95
331526|NCT00617123|801863|P1|Treated|Study Treatment Period|1 participant was not treated|97
331527|NCT00617123|801862|P2|STARTED|Study Treatment Period||95
331528|NCT00617123|801863|P1|STARTED|Study Treatment Period||98
331529|NCT00617123|801862|P2|NOT COMPLETED|Referral Screening Period||26
331530|NCT00617123|801863|P1|NOT COMPLETED|Referral Screening Period||39
331531|NCT00617123|801862|P2|COMPLETED|Referral Screening Period||95
331532|NCT00617123|801863|P1|COMPLETED|Referral Screening Period||98
331533|NCT00617123|801862|P2|STARTED|Referral Screening Period||121
331534|NCT00617123|801863|P1|STARTED|Referral Screening Period||137
331535|NCT00617097|801879|P2|NOT COMPLETED|Overall Study||0
331536|NCT00617097|801880|P1|NOT COMPLETED|Overall Study||0
331537|NCT00617097|801879|P2|COMPLETED|Overall Study||25
331538|NCT00617097|801880|P1|COMPLETED|Overall Study||25
331539|NCT00617097|801879|P2|STARTED|Overall Study||25
331540|NCT00617097|801880|P1|STARTED|Overall Study||25
331541|NCT00617084|801894|P2|NOT COMPLETED|Overall Study||26
331542|NCT00617084|801895|P1|NOT COMPLETED|Overall Study||21
331543|NCT00617084|801894|P2|COMPLETED|Overall Study||1126
331544|NCT00617084|801895|P1|COMPLETED|Overall Study||1119
331545|NCT00617084|801894|P2|STARTED|Overall Study||1152
331546|NCT00617084|801895|P1|STARTED|Overall Study||1140
331547|NCT00617058|801906|P3|NOT COMPLETED|Overall Study||0
331548|NCT00617058|801907|P2|NOT COMPLETED|Overall Study||0
331549|NCT00617058|801908|P1|NOT COMPLETED|Overall Study||0
331550|NCT00617058|801906|P3|COMPLETED|Overall Study||0
331551|NCT00617058|801907|P2|COMPLETED|Overall Study||0
331552|NCT00617058|801908|P1|COMPLETED|Overall Study||1
331553|NCT00617058|801906|P3|STARTED|Overall Study||0
331554|NCT00617058|801907|P2|STARTED|Overall Study||0
331555|NCT00617058|801908|P1|STARTED|Overall Study||1
331556|NCT00616967|801948|P3|NOT COMPLETED|Overall Study||1
331557|NCT00616967|801949|P2|NOT COMPLETED|Overall Study||0
331558|NCT00616967|801950|P1|NOT COMPLETED|Overall Study||0
331559|NCT00616967|801948|P3|COMPLETED|Overall Study||30
331560|NCT00616967|801949|P2|COMPLETED|Overall Study||31
331561|NCT00616967|801950|P1|COMPLETED|Overall Study||6
331562|NCT00616967|801948|P3|STARTED|Overall Study||31
331563|NCT00616967|801949|P2|STARTED|Overall Study||31
331564|NCT00616967|801950|P1|STARTED|Overall Study||6
331565|NCT00616941|801962|P3|NOT COMPLETED|Overall Study||6
331566|NCT00616941|801963|P2|NOT COMPLETED|Overall Study||5
331567|NCT00616941|801964|P1|NOT COMPLETED|Overall Study||1
331568|NCT00616941|801962|P3|COMPLETED|Overall Study||5
331569|NCT00616941|801963|P2|COMPLETED|Overall Study||8
331570|NCT00616941|801964|P1|COMPLETED|Overall Study||3
331571|NCT00616941|801962|P3|STARTED|Overall Study||11
331572|NCT00616941|801963|P2|STARTED|Overall Study||13
331573|NCT00616941|801964|P1|STARTED|Overall Study||4
331574|NCT00616928|801991|P4|NOT COMPLETED|Overall Study||7
331575|NCT00616928|801992|P3|NOT COMPLETED|Overall Study||17
331576|NCT00616928|801993|P2|NOT COMPLETED|Overall Study||18
331577|NCT00616928|801994|P1|NOT COMPLETED|Overall Study||62
331578|NCT00616928|801991|P4|COMPLETED|Overall Study||364
331579|NCT00616928|801992|P3|COMPLETED|Overall Study||1101
331580|NCT00616928|801993|P2|COMPLETED|Overall Study||750
331581|NCT00616928|801994|P1|COMPLETED|Overall Study||2242
331582|NCT00616928|801991|P4|STARTED|Overall Study||371
331583|NCT00616928|801992|P3|STARTED|Overall Study||1118
331584|NCT00616928|801993|P2|STARTED|Overall Study||768
331585|NCT00616928|801994|P1|STARTED|Overall Study||2304
331586|NCT00616902|802058|P2|NOT COMPLETED|Overall Study||6
331587|NCT00616902|802059|P1|NOT COMPLETED|Overall Study||6
331588|NCT00616902|802058|P2|COMPLETED|Overall Study||0
331589|NCT00616902|802059|P1|COMPLETED|Overall Study||0
331590|NCT00616902|802058|P2|STARTED|Overall Study||6
331591|NCT00616902|802059|P1|STARTED|Overall Study||6
331592|NCT00616772|802085|P2|NOT COMPLETED|Overall Study||102
331593|NCT00616772|802086|P1|NOT COMPLETED|Overall Study||115
331594|NCT00616772|802085|P2|COMPLETED|Overall Study||240
331595|NCT00616772|802086|P1|COMPLETED|Overall Study||225
331596|NCT00616772|802085|P2|Treated|Overall Study||339
331597|NCT00616772|802086|P1|Treated|Overall Study||337
331598|NCT00616772|802085|P2|STARTED|Overall Study||342
331599|NCT00616772|802086|P1|STARTED|Overall Study||340
331600|NCT00616759|802102|P2|NOT COMPLETED|Overall Study||2
331601|NCT00616759|802103|P1|NOT COMPLETED|Overall Study||3
331602|NCT00616759|802102|P2|COMPLETED|Overall Study||8
331603|NCT00616759|802103|P1|COMPLETED|Overall Study||7
331604|NCT00616759|802102|P2|STARTED|Overall Study||10
331605|NCT00616759|802103|P1|STARTED|Overall Study||10
331606|NCT00616655|802112|P3|NOT COMPLETED|Overall Study||48
331607|NCT00616655|802113|P2|NOT COMPLETED|Overall Study||41
331608|NCT00616655|802114|P1|NOT COMPLETED|Overall Study||35
331609|NCT00616655|802112|P3|COMPLETED|Overall Study||103
331610|NCT00616655|802113|P2|COMPLETED|Overall Study||112
331611|NCT00616655|802114|P1|COMPLETED|Overall Study||117
331612|NCT00616655|802112|P3|STARTED|Overall Study||151
331613|NCT00616655|802113|P2|STARTED|Overall Study||153
331614|NCT00616655|802114|P1|STARTED|Overall Study||152
331615|NCT00616642|802154|P2|NOT COMPLETED|Overall Study||1
331616|NCT00616642|802155|P1|NOT COMPLETED|Overall Study||0
331617|NCT00616642|802154|P2|COMPLETED|Overall Study||0
331618|NCT00616642|802155|P1|COMPLETED|Overall Study||0
331619|NCT00616642|802154|P2|STARTED|Overall Study||1
331620|NCT00616642|802155|P1|STARTED|Overall Study||0
331621|NCT00616629|802166|P5|NOT COMPLETED|Overall Study||0
331622|NCT00616629|802167|P4|NOT COMPLETED|Overall Study||0
331623|NCT00616629|802168|P3|NOT COMPLETED|Overall Study||1
331624|NCT00616629|802169|P2|NOT COMPLETED|Overall Study||2
331625|NCT00616629|802170|P1|NOT COMPLETED|Overall Study||2
331626|NCT00616629|802166|P5|COMPLETED|Overall Study||12
331627|NCT00616629|802167|P4|COMPLETED|Overall Study||2
331628|NCT00616629|802168|P3|COMPLETED|Overall Study||13
331629|NCT00616629|802169|P2|COMPLETED|Overall Study||12
331630|NCT00616629|802170|P1|COMPLETED|Overall Study||11
331631|NCT00616629|802166|P5|STARTED|Overall Study||12
331632|NCT00616629|802167|P4|STARTED|Overall Study||2
331633|NCT00616629|802168|P3|STARTED|Overall Study|One patient never received study drug|14
331634|NCT00616629|802169|P2|STARTED|Overall Study|Two patients never received study drug|14
331635|NCT00616629|802170|P1|STARTED|Overall Study|Two patients never received study drug|13
331636|NCT00616603|802215|P3|NOT COMPLETED|Overall Study||2
331637|NCT00616603|802216|P2|NOT COMPLETED|Overall Study||0
331638|NCT00616603|802217|P1|NOT COMPLETED|Overall Study||2
331639|NCT00616603|802215|P3|COMPLETED|Overall Study||13
331640|NCT00616603|802216|P2|COMPLETED|Overall Study||14
331641|NCT00616603|802217|P1|COMPLETED|Overall Study||12
331642|NCT00616603|802215|P3|STARTED|Overall Study||15
331643|NCT00616603|802216|P2|STARTED|Overall Study||14
331644|NCT00616603|802217|P1|STARTED|Overall Study||14
331645|NCT00616577|802228|P3|NOT COMPLETED|Overall Study||0
331646|NCT00616577|802229|P2|NOT COMPLETED|Overall Study||0
331647|NCT00616577|802230|P1|NOT COMPLETED|Overall Study||0
331648|NCT00616577|802228|P3|COMPLETED|Overall Study||7
331649|NCT00616577|802229|P2|COMPLETED|Overall Study||9
331650|NCT00616577|802230|P1|COMPLETED|Overall Study||6
331651|NCT00616577|802228|P3|STARTED|Overall Study||7
331652|NCT00616577|802229|P2|STARTED|Overall Study||9
331653|NCT00616577|802230|P1|STARTED|Overall Study||6
331654|NCT00616434|802240|P2|NOT COMPLETED|Overall Study||8
331655|NCT00616434|802241|P1|NOT COMPLETED|Overall Study||6
331656|NCT00616434|802240|P2|COMPLETED|Overall Study||53
331657|NCT00616434|802241|P1|COMPLETED|Overall Study||56
331658|NCT00616434|802240|P2|STARTED|Overall Study||61
331659|NCT00616434|802241|P1|STARTED|Overall Study||62
331660|NCT00616421|802254|P3|NOT COMPLETED|Overall Study||41
331661|NCT00616421|802255|P2|NOT COMPLETED|Overall Study||38
331662|NCT00616421|802256|P1|NOT COMPLETED|Overall Study||26
331663|NCT00616421|802254|P3|COMPLETED|Overall Study||1229
331664|NCT00616421|802255|P2|COMPLETED|Overall Study||1240
331665|NCT00616421|802256|P1|COMPLETED|Overall Study||333
331666|NCT00616421|802254|P3|STARTED|Overall Study||1270
331667|NCT00616421|802255|P2|STARTED|Overall Study||1278
331668|NCT00616421|802256|P1|STARTED|Overall Study||359
331669|NCT00616343|802293|P1|NOT COMPLETED|Overall Study||0
331670|NCT00616343|802293|P1|COMPLETED|Overall Study||9
331671|NCT00616343|802293|P1|STARTED|Overall Study||9
331672|NCT00616239|802297|P1|NOT COMPLETED|Overall Study||2
331673|NCT00616239|802297|P1|COMPLETED|Overall Study||18
331674|NCT00616239|802297|P1|STARTED|Overall Study||20
331675|NCT00616200|802301|P1|NOT COMPLETED|Four Week Very Low Carbohydrate Diet||3
331676|NCT00616200|802301|P1|COMPLETED|Four Week Very Low Carbohydrate Diet||13
331677|NCT00616200|802301|P1|STARTED|Four Week Very Low Carbohydrate Diet||16
331678|NCT00616200|802301|P1|NOT COMPLETED|Two Week Standard Diet||1
331679|NCT00616200|802301|P1|COMPLETED|Two Week Standard Diet||16
331680|NCT00616200|802301|P1|STARTED|Two Week Standard Diet||17
331681|NCT00616122|802307|P1|NOT COMPLETED|Overall Study||7
331682|NCT00616122|802307|P1|COMPLETED|Overall Study||25
331683|NCT00616122|802307|P1|STARTED|Overall Study||32
331684|NCT00616109|802314|P1|NOT COMPLETED|Overall Study||0
331685|NCT00616109|802314|P1|COMPLETED|Overall Study||16
331686|NCT00616109|802314|P1|STARTED|Overall Study||16
331687|NCT00616018|802321|P1|NOT COMPLETED|Overall Study||3
331688|NCT00616018|802321|P1|COMPLETED|Overall Study||24
331689|NCT00616018|802321|P1|STARTED|Overall Study||27
331690|NCT00615992|802326|P1|NOT COMPLETED|Overall Study||67
331691|NCT00615992|802326|P1|COMPLETED|Overall Study||687
331692|NCT00615992|802326|P1|STARTED|Overall Study||754
331693|NCT00615927|802337|P2|NOT COMPLETED|Overall Study||0
331694|NCT00615927|802338|P1|NOT COMPLETED|Overall Study||0
331695|NCT00615927|802337|P2|COMPLETED|Overall Study||32
331696|NCT00615927|802338|P1|COMPLETED|Overall Study||32
331697|NCT00615927|802337|P2|STARTED|Overall Study||32
331698|NCT00615927|802338|P1|STARTED|Overall Study||32
331699|NCT00615914|802352|P1|NOT COMPLETED|Overall Study||637
331700|NCT00615914|802352|P1|COMPLETED|Overall Study||1008
331701|NCT00615914|802352|P1|STARTED|Overall Study|The number of patients enrolled|1645
331702|NCT00615901|802359|P1|NOT COMPLETED|Overall Study||9
331703|NCT00615901|802359|P1|COMPLETED|Overall Study||29
331704|NCT00615901|802359|P1|STARTED|Overall Study||38
331705|NCT00615836|802367|P5|NOT COMPLETED|Extension Study (FE992026 CS31)||0
331706|NCT00615836|802368|P4|NOT COMPLETED|Extension Study (FE992026 CS31)||84
331707|NCT00615836|802369|P3|NOT COMPLETED|Extension Study (FE992026 CS31)||73
331708|NCT00615836|802370|P2|NOT COMPLETED|Extension Study (FE992026 CS31)||86
331709|NCT00615836|802371|P1|NOT COMPLETED|Extension Study (FE992026 CS31)||141
331710|NCT00615836|802367|P5|COMPLETED|Extension Study (FE992026 CS31)||0
331711|NCT00615836|802368|P4|COMPLETED|Extension Study (FE992026 CS31)||53
331712|NCT00615836|802369|P3|COMPLETED|Extension Study (FE992026 CS31)||59
331713|NCT00615836|802370|P2|COMPLETED|Extension Study (FE992026 CS31)||58
331714|NCT00615836|802371|P1|COMPLETED|Extension Study (FE992026 CS31)||0
331715|NCT00615836|802367|P5|STARTED|Extension Study (FE992026 CS31)||0
331716|NCT00615836|802368|P4|STARTED|Extension Study (FE992026 CS31)||137
331717|NCT00615836|802369|P3|STARTED|Extension Study (FE992026 CS31)||132
331718|NCT00615836|802370|P2|STARTED|Extension Study (FE992026 CS31)||144
331719|NCT00615836|802371|P1|STARTED|Extension Study (FE992026 CS31)||141
331720|NCT00615836|802367|P5|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||15
331721|NCT00615836|802368|P4|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||25
331722|NCT00615836|802369|P3|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||20
331723|NCT00615836|802370|P2|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||10
331724|NCT00615836|802371|P1|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||19
331725|NCT00615836|802367|P5|COMPLETED|Part I of Core Study (FE992026 CS29)||145
331726|NCT00615836|802368|P4|COMPLETED|Part I of Core Study (FE992026 CS29)||135
331727|NCT00615836|802369|P3|COMPLETED|Part I of Core Study (FE992026 CS29)||138
331728|NCT00615836|802370|P2|COMPLETED|Part I of Core Study (FE992026 CS29)||148
331729|NCT00615836|802371|P1|COMPLETED|Part I of Core Study (FE992026 CS29)||144
331730|NCT00615836|802367|P5|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|156
331731|NCT00615836|802368|P4|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|146
331732|NCT00615836|802369|P3|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|148
331733|NCT00615836|802370|P2|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|152
331734|NCT00615836|802371|P1|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|155
331735|NCT00615836|802367|P5|STARTED|Part I of Core Study (FE992026 CS29)||160
331736|NCT00615836|802368|P4|STARTED|Part I of Core Study (FE992026 CS29)||160
331737|NCT00615836|802369|P3|STARTED|Part I of Core Study (FE992026 CS29)||158
331738|NCT00615836|802370|P2|STARTED|Part I of Core Study (FE992026 CS29)||158
331739|NCT00615836|802371|P1|STARTED|Part I of Core Study (FE992026 CS29)||163
331740|NCT00615719|802431|P1|NOT COMPLETED|Overall Study||5
331741|NCT00615719|802431|P1|COMPLETED|Overall Study||30
331742|NCT00615719|802431|P1|STARTED|Overall Study||35
331743|NCT00615589|802435|P1|NOT COMPLETED|Overall Study||0
331744|NCT00615589|802435|P1|COMPLETED|Overall Study||22
331745|NCT00615589|802435|P1|STARTED|Overall Study||22
331746|NCT00615550|802445|P2|NOT COMPLETED|Overall Study||1
331747|NCT00615550|802446|P1|NOT COMPLETED|Overall Study||6
331748|NCT00615550|802445|P2|COMPLETED|Overall Study||235
331749|NCT00615550|802446|P1|COMPLETED|Overall Study||223
331750|NCT00615550|802445|P2|STARTED|Overall Study||236
331751|NCT00615550|802446|P1|STARTED|Overall Study||229
331752|NCT00615472|802462|P2|NOT COMPLETED|Overall Study||0
331753|NCT00615472|802463|P1|NOT COMPLETED|Overall Study||0
331754|NCT00615472|802462|P2|COMPLETED|Overall Study||28
331755|NCT00615472|802463|P1|COMPLETED|Overall Study||30
331756|NCT00615472|802462|P2|STARTED|Overall Study||28
331757|NCT00615472|802463|P1|STARTED|Overall Study||30
331758|NCT00615459|802469|P4|NOT COMPLETED|Period III||0
331759|NCT00615459|802470|P3|NOT COMPLETED|Period III||1
331760|NCT00615459|802471|P2|NOT COMPLETED|Period III||3
331761|NCT00615459|802472|P1|NOT COMPLETED|Period III||0
331762|NCT00615459|802469|P4|COMPLETED|Period III||41
331763|NCT00615459|802470|P3|COMPLETED|Period III||39
331764|NCT00615459|802471|P2|COMPLETED|Period III||37
331765|NCT00615459|802472|P1|COMPLETED|Period III||36
331766|NCT00615459|802469|P4|STARTED|Period III||41
331767|NCT00615459|802470|P3|STARTED|Period III||40
331768|NCT00615459|802471|P2|STARTED|Period III||40
331769|NCT00615459|802472|P1|STARTED|Period III||36
331770|NCT00615459|802469|P4|NOT COMPLETED|Period II||1
331771|NCT00615459|802470|P3|NOT COMPLETED|Period II||0
331772|NCT00615459|802471|P2|NOT COMPLETED|Period II||0
331773|NCT00615459|802472|P1|NOT COMPLETED|Period II||1
331774|NCT00615459|802469|P4|COMPLETED|Period II||41
331775|NCT00615459|802470|P3|COMPLETED|Period II||40
331776|NCT00615459|802471|P2|COMPLETED|Period II||40
331777|NCT00615459|802472|P1|COMPLETED|Period II||36
331778|NCT00615459|802469|P4|STARTED|Period II||42
331779|NCT00615459|802470|P3|STARTED|Period II||40
331780|NCT00615459|802471|P2|STARTED|Period II||40
331781|NCT00615459|802472|P1|STARTED|Period II||37
331782|NCT00615459|802469|P4|NOT COMPLETED|Period I||1
331783|NCT00615459|802470|P3|NOT COMPLETED|Period I||2
331784|NCT00615459|802471|P2|NOT COMPLETED|Period I||1
331785|NCT00615459|802472|P1|NOT COMPLETED|Period I||4
331786|NCT00615459|802469|P4|COMPLETED|Period I||42
331787|NCT00615459|802470|P3|COMPLETED|Period I||40
331788|NCT00615459|802471|P2|COMPLETED|Period I||40
331789|NCT00615459|802472|P1|COMPLETED|Period I||37
331790|NCT00615459|802469|P4|STARTED|Period I||43
331791|NCT00615459|802470|P3|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|42
331792|NCT00615459|802471|P2|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|41
331793|NCT00615459|802472|P1|STARTED|Period I||41
331794|NCT00615433|802490|P4|NOT COMPLETED|Overall Study||45
331795|NCT00615433|802491|P3|NOT COMPLETED|Overall Study||39
331796|NCT00615433|802492|P2|NOT COMPLETED|Overall Study||53
331797|NCT00615433|802493|P1|NOT COMPLETED|Overall Study||43
331798|NCT00615433|802490|P4|COMPLETED|Overall Study||71
331799|NCT00615433|802491|P3|COMPLETED|Overall Study||84
331800|NCT00615433|802492|P2|COMPLETED|Overall Study||66
331801|NCT00615433|802493|P1|COMPLETED|Overall Study||77
331802|NCT00615433|802490|P4|STARTED|Overall Study||116
331803|NCT00615433|802491|P3|STARTED|Overall Study||123
331804|NCT00615433|802492|P2|STARTED|Overall Study||119
331805|NCT00615433|802493|P1|STARTED|Overall Study||120
331806|NCT00615420|802509|P2|NOT COMPLETED|Overall Study||27
331807|NCT00615420|802510|P1|NOT COMPLETED|Overall Study||31
331808|NCT00615420|802509|P2|COMPLETED|Overall Study||25
331809|NCT00615420|802510|P1|COMPLETED|Overall Study||23
331810|NCT00615420|802509|P2|STARTED|Overall Study||52
331811|NCT00615420|802510|P1|STARTED|Overall Study||54
331812|NCT00615290|802518|P1|NOT COMPLETED|Overall Study||8
331813|NCT00615290|802518|P1|COMPLETED|Overall Study||34
331814|NCT00615290|802518|P1|STARTED|Overall Study||42
331815|NCT00615264|802532|P2|NOT COMPLETED|Overall Study||52
331816|NCT00615264|802533|P1|NOT COMPLETED|Overall Study||50
331817|NCT00615264|802532|P2|COMPLETED|Overall Study||180
331818|NCT00615264|802533|P1|COMPLETED|Overall Study||175
331819|NCT00615264|802532|P2|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||213
331820|NCT00615264|802533|P1|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||209
331821|NCT00615264|802532|P2|Received at Least One Dose (ITT)|Overall Study||231
331822|NCT00615264|802533|P1|Received at Least One Dose (ITT)|Overall Study||225
331823|NCT00615264|802532|P2|STARTED|Overall Study||232
331824|NCT00615264|802533|P1|STARTED|Overall Study||225
331825|NCT00615199|802545|P4|NOT COMPLETED|Overall Study||2
331826|NCT00615199|802546|P3|NOT COMPLETED|Overall Study||1
331827|NCT00615199|802547|P2|NOT COMPLETED|Overall Study||2
331828|NCT00615199|802548|P1|NOT COMPLETED|Overall Study||8
331829|NCT00615199|802545|P4|COMPLETED|Overall Study||33
331830|NCT00615199|802546|P3|COMPLETED|Overall Study||33
331831|NCT00615199|802547|P2|COMPLETED|Overall Study||34
331832|NCT00615199|802548|P1|COMPLETED|Overall Study||26
331833|NCT00615199|802545|P4|STARTED|Overall Study||35
331834|NCT00615199|802546|P3|STARTED|Overall Study||34
331835|NCT00615199|802547|P2|STARTED|Overall Study||36
331836|NCT00615199|802548|P1|STARTED|Overall Study||34
331837|NCT00615108|802582|P1|NOT COMPLETED|Overall Study||507
331838|NCT00615108|802582|P1|COMPLETED|Overall Study||2641
331839|NCT00615108|802582|P1|STARTED|Overall Study||3148
331840|NCT00615069|802597|P1|NOT COMPLETED|Overall Study||16
331841|NCT00615069|802597|P1|COMPLETED|Overall Study||19
331842|NCT00615069|802597|P1|STARTED|Overall Study||35
331843|NCT00615056|802606|P4|NOT COMPLETED|Overall Study||35
331844|NCT00615056|802607|P3|NOT COMPLETED|Overall Study||36
331845|NCT00615056|802608|P2|NOT COMPLETED|Overall Study||51
331846|NCT00615056|802609|P1|NOT COMPLETED|Overall Study||49
331847|NCT00615056|802606|P4|COMPLETED|Overall Study||0
331848|NCT00615056|802607|P3|COMPLETED|Overall Study||0
331849|NCT00615056|802608|P2|COMPLETED|Overall Study||0
331850|NCT00615056|802609|P1|COMPLETED|Overall Study||0
331851|NCT00615056|802606|P4|Treated|Overall Study||35
331852|NCT00615056|802607|P3|Treated|Overall Study||36
331853|NCT00615056|802608|P2|Treated|Overall Study||51
331854|NCT00615056|802609|P1|Treated|Overall Study||46
331855|NCT00615056|802606|P4|STARTED|Overall Study||35
331856|NCT00615056|802607|P3|STARTED|Overall Study||36
331857|NCT00615056|802608|P2|STARTED|Overall Study||51
331858|NCT00615056|802609|P1|STARTED|Overall Study||49
331859|NCT00615030|802639|P12|NOT COMPLETED|Period III||0
331860|NCT00615030|802640|P11|NOT COMPLETED|Period III||0
331861|NCT00615030|802641|P10|NOT COMPLETED|Period III||0
331862|NCT00615030|802642|P9|NOT COMPLETED|Period III||0
331863|NCT00615030|802643|P8|NOT COMPLETED|Period III||0
331864|NCT00615030|802644|P7|NOT COMPLETED|Period III||0
331865|NCT00615030|802645|P6|NOT COMPLETED|Period III||0
331866|NCT00615030|802646|P5|NOT COMPLETED|Period III||0
331867|NCT00615030|802647|P4|NOT COMPLETED|Period III||1
331868|NCT00615030|802648|P3|NOT COMPLETED|Period III||0
331869|NCT00615030|802649|P2|NOT COMPLETED|Period III||0
331870|NCT00615030|802650|P1|NOT COMPLETED|Period III||1
331871|NCT00615030|802639|P12|COMPLETED|Period III||6
331872|NCT00615030|802640|P11|COMPLETED|Period III||7
331873|NCT00615030|802641|P10|COMPLETED|Period III||8
331874|NCT00615030|802642|P9|COMPLETED|Period III||7
331875|NCT00615030|802643|P8|COMPLETED|Period III||7
331876|NCT00615030|802644|P7|COMPLETED|Period III||6
331877|NCT00615030|802645|P6|COMPLETED|Period III||5
331878|NCT00615030|802646|P5|COMPLETED|Period III||8
331879|NCT00615030|802647|P4|COMPLETED|Period III||6
331880|NCT00615030|802648|P3|COMPLETED|Period III||8
331881|NCT00615030|802649|P2|COMPLETED|Period III||8
331882|NCT00615030|802650|P1|COMPLETED|Period III||7
331883|NCT00615030|802639|P12|STARTED|Period III||6
331884|NCT00615030|802640|P11|STARTED|Period III||7
331885|NCT00615030|802641|P10|STARTED|Period III||8
331886|NCT00615030|802642|P9|STARTED|Period III||7
331887|NCT00615030|802643|P8|STARTED|Period III||7
331888|NCT00615030|802644|P7|STARTED|Period III||6
331889|NCT00615030|802645|P6|STARTED|Period III||5
331890|NCT00615030|802646|P5|STARTED|Period III||8
331891|NCT00615030|802647|P4|STARTED|Period III||7
331892|NCT00615030|802648|P3|STARTED|Period III||8
331893|NCT00615030|802649|P2|STARTED|Period III||8
331894|NCT00615030|802650|P1|STARTED|Period III||8
331895|NCT00615030|802639|P12|NOT COMPLETED|Period II||0
331896|NCT00615030|802640|P11|NOT COMPLETED|Period II||0
331897|NCT00615030|802641|P10|NOT COMPLETED|Period II||0
331898|NCT00615030|802642|P9|NOT COMPLETED|Period II||1
331899|NCT00615030|802643|P8|NOT COMPLETED|Period II||0
331900|NCT00615030|802644|P7|NOT COMPLETED|Period II||1
331901|NCT00615030|802645|P6|NOT COMPLETED|Period II||0
331902|NCT00615030|802646|P5|NOT COMPLETED|Period II||0
331903|NCT00615030|802647|P4|NOT COMPLETED|Period II||1
331904|NCT00615030|802648|P3|NOT COMPLETED|Period II||1
331905|NCT00615030|802649|P2|NOT COMPLETED|Period II||0
331906|NCT00615030|802650|P1|NOT COMPLETED|Period II||0
331907|NCT00615030|802639|P12|COMPLETED|Period II||6
331908|NCT00615030|802640|P11|COMPLETED|Period II||7
331909|NCT00615030|802641|P10|COMPLETED|Period II||8
331910|NCT00615030|802642|P9|COMPLETED|Period II||7
331911|NCT00615030|802643|P8|COMPLETED|Period II||7
331912|NCT00615030|802644|P7|COMPLETED|Period II||6
331913|NCT00615030|802645|P6|COMPLETED|Period II||5
331914|NCT00615030|802646|P5|COMPLETED|Period II||8
331915|NCT00615030|802647|P4|COMPLETED|Period II||7
331916|NCT00615030|802648|P3|COMPLETED|Period II||8
331917|NCT00615030|802649|P2|COMPLETED|Period II||8
331918|NCT00615030|802650|P1|COMPLETED|Period II||8
331919|NCT00615030|802639|P12|STARTED|Period II||6
331920|NCT00615030|802640|P11|STARTED|Period II||7
331921|NCT00615030|802641|P10|STARTED|Period II||8
331922|NCT00615030|802642|P9|STARTED|Period II||8
331923|NCT00615030|802643|P8|STARTED|Period II||7
331924|NCT00615030|802644|P7|STARTED|Period II||7
331925|NCT00615030|802645|P6|STARTED|Period II||5
331926|NCT00615030|802646|P5|STARTED|Period II||8
331927|NCT00615030|802647|P4|STARTED|Period II||8
331928|NCT00615030|802648|P3|STARTED|Period II||9
331929|NCT00615030|802649|P2|STARTED|Period II||8
331930|NCT00615030|802650|P1|STARTED|Period II||8
331931|NCT00615030|802639|P12|NOT COMPLETED|Period I||1
331932|NCT00615030|802640|P11|NOT COMPLETED|Period I||1
331933|NCT00615030|802641|P10|NOT COMPLETED|Period I||0
331934|NCT00615030|802642|P9|NOT COMPLETED|Period I||1
331935|NCT00615030|802643|P8|NOT COMPLETED|Period I||0
331936|NCT00615030|802644|P7|NOT COMPLETED|Period I||0
331937|NCT00615030|802645|P6|NOT COMPLETED|Period I||1
331938|NCT00615030|802646|P5|NOT COMPLETED|Period I||1
331939|NCT00615030|802647|P4|NOT COMPLETED|Period I||0
331940|NCT00615030|802648|P3|NOT COMPLETED|Period I||0
331941|NCT00615030|802649|P2|NOT COMPLETED|Period I||0
331942|NCT00615030|802650|P1|NOT COMPLETED|Period I||1
331943|NCT00615030|802639|P12|COMPLETED|Period I||6
331944|NCT00615030|802640|P11|COMPLETED|Period I||7
331945|NCT00615030|802641|P10|COMPLETED|Period I||8
331946|NCT00615030|802642|P9|COMPLETED|Period I||8
331947|NCT00615030|802643|P8|COMPLETED|Period I||7
331948|NCT00615030|802644|P7|COMPLETED|Period I||7
331949|NCT00615030|802645|P6|COMPLETED|Period I||5
331950|NCT00615030|802646|P5|COMPLETED|Period I||8
331951|NCT00615030|802647|P4|COMPLETED|Period I||8
331952|NCT00615030|802648|P3|COMPLETED|Period I||9
331953|NCT00615030|802649|P2|COMPLETED|Period I||8
331954|NCT00615030|802650|P1|COMPLETED|Period I||8
331955|NCT00615030|802639|P12|STARTED|Period I||7
331956|NCT00615030|802640|P11|STARTED|Period I||8
331957|NCT00615030|802641|P10|STARTED|Period I||8
331958|NCT00615030|802642|P9|STARTED|Period I||9
331959|NCT00615030|802643|P8|STARTED|Period I||7
331960|NCT00615030|802644|P7|STARTED|Period I||7
331961|NCT00615030|802645|P6|STARTED|Period I|1 randomized patient in this sequence dropped out before exposure to study drug in Period I.|6
331962|NCT00615030|802646|P5|STARTED|Period I||9
331963|NCT00615030|802647|P4|STARTED|Period I||8
331964|NCT00615030|802648|P3|STARTED|Period I||9
331965|NCT00615030|802649|P2|STARTED|Period I||8
331966|NCT00615030|802650|P1|STARTED|Period I||9
331967|NCT00615017|802670|P6|NOT COMPLETED|Overall Study||3
331968|NCT00615017|802671|P5|NOT COMPLETED|Overall Study||1
331969|NCT00615017|802672|P4|NOT COMPLETED|Overall Study||1
331970|NCT00615017|802673|P3|NOT COMPLETED|Overall Study||5
331971|NCT00615017|802674|P2|NOT COMPLETED|Overall Study||1
331972|NCT00615017|802675|P1|NOT COMPLETED|Overall Study||0
331973|NCT00615017|802670|P6|COMPLETED|Overall Study|Patient completed the study drug|20
331974|NCT00615017|802671|P5|COMPLETED|Overall Study|Patient completed the study drug|7
331975|NCT00615017|802672|P4|COMPLETED|Overall Study|Patient completed the study drug|9
331976|NCT00615017|802673|P3|COMPLETED|Overall Study|Patient completed the study drug|7
331977|NCT00615017|802674|P2|COMPLETED|Overall Study|Patient completed the study drug|8
331978|NCT00615017|802675|P1|COMPLETED|Overall Study|Patient completed the study drug|8
331979|NCT00615017|802670|P6|STARTED|Overall Study|Patients received treatment|23
331980|NCT00615017|802671|P5|STARTED|Overall Study|Patients received treatment|8
331981|NCT00615017|802672|P4|STARTED|Overall Study|Patients received treatment|10
331982|NCT00615017|802673|P3|STARTED|Overall Study|Patients received treatment|12
331983|NCT00615017|802674|P2|STARTED|Overall Study|Patients received treatment|9
331984|NCT00615017|802675|P1|STARTED|Overall Study|Patients received treatment|8
331985|NCT00614991|802833|P6|NOT COMPLETED|Overall Study||0
331986|NCT00614991|802834|P5|NOT COMPLETED|Overall Study||1
331987|NCT00614991|802835|P4|NOT COMPLETED|Overall Study||0
331988|NCT00614991|802836|P3|NOT COMPLETED|Overall Study||0
331989|NCT00614991|802837|P2|NOT COMPLETED|Overall Study||3
331990|NCT00614991|802838|P1|NOT COMPLETED|Overall Study||3
331991|NCT00614991|802833|P6|COMPLETED|Overall Study||6
331992|NCT00614991|802834|P5|COMPLETED|Overall Study||6
331993|NCT00614991|802835|P4|COMPLETED|Overall Study||7
331994|NCT00614991|802836|P3|COMPLETED|Overall Study||7
331995|NCT00614991|802837|P2|COMPLETED|Overall Study||6
331996|NCT00614991|802838|P1|COMPLETED|Overall Study||5
331997|NCT00614991|802833|P6|STARTED|Overall Study||6
331998|NCT00614991|802834|P5|STARTED|Overall Study||7
331999|NCT00614991|802835|P4|STARTED|Overall Study||7
332000|NCT00614991|802836|P3|STARTED|Overall Study||7
332001|NCT00614991|802837|P2|STARTED|Overall Study||9
332002|NCT00614991|802838|P1|STARTED|Overall Study||8
332003|NCT00614939|802872|P2|NOT COMPLETED|Overall Study||43
332004|NCT00614939|802873|P1|NOT COMPLETED|Overall Study||35
332005|NCT00614939|802872|P2|COMPLETED|Overall Study|Completed 52 weeks of treatment|42
332006|NCT00614939|802873|P1|COMPLETED|Overall Study|Completed 52 weeks of treatment|50
332007|NCT00614939|802872|P2|STARTED|Overall Study|Randomized and treated|85
332008|NCT00614939|802873|P1|STARTED|Overall Study|Randomized and treated|85
332009|NCT00614926|802907|P2|NOT COMPLETED|Overall Study||0
332010|NCT00614926|802908|P1|NOT COMPLETED|Overall Study||4
332011|NCT00614926|802907|P2|COMPLETED|Overall Study||7
332012|NCT00614926|802908|P1|COMPLETED|Overall Study||21
332013|NCT00614926|802907|P2|STARTED|Overall Study||7
332014|NCT00614926|802908|P1|STARTED|Overall Study||25
332015|NCT00614913|802916|P1|NOT COMPLETED|Overall Study||0
332016|NCT00614913|802916|P1|COMPLETED|Overall Study||76
332017|NCT00614913|802916|P1|STARTED|Overall Study||76
332018|NCT00614874|802921|P1|NOT COMPLETED|Overall Study||2
332019|NCT00614874|802921|P1|COMPLETED|Overall Study||14
332020|NCT00614874|802921|P1|STARTED|Overall Study||16
332021|NCT00614822|802928|P1|NOT COMPLETED|Overall Study||3
332022|NCT00614822|802928|P1|COMPLETED|Overall Study||47
332023|NCT00614822|802928|P1|STARTED|Overall Study||50
332024|NCT00614744|802937|P2|NOT COMPLETED|Overall Study||6
332025|NCT00614744|802938|P1|NOT COMPLETED|Overall Study||5
332026|NCT00614744|802937|P2|COMPLETED|Overall Study||79
332027|NCT00614744|802938|P1|COMPLETED|Overall Study||78
332028|NCT00614744|802937|P2|STARTED|Overall Study||85
332029|NCT00614744|802938|P1|STARTED|Overall Study||83
332030|NCT00614614|802964|P5|NOT COMPLETED|Booster Vaccination Phase||13
332031|NCT00614614|802965|P4|NOT COMPLETED|Booster Vaccination Phase||19
332032|NCT00614614|802966|P3|NOT COMPLETED|Booster Vaccination Phase||27
332033|NCT00614614|802967|P2|NOT COMPLETED|Booster Vaccination Phase||6
332034|NCT00614614|802968|P1|NOT COMPLETED|Booster Vaccination Phase||0
332035|NCT00614614|802964|P5|COMPLETED|Booster Vaccination Phase||396
332036|NCT00614614|802965|P4|COMPLETED|Booster Vaccination Phase||210
332037|NCT00614614|802966|P3|COMPLETED|Booster Vaccination Phase||405
332038|NCT00614614|802967|P2|COMPLETED|Booster Vaccination Phase||227
332039|NCT00614614|802968|P1|COMPLETED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
332040|NCT00614614|802964|P5|STARTED|Booster Vaccination Phase||409
332041|NCT00614614|802965|P4|STARTED|Booster Vaccination Phase||229
332042|NCT00614614|802966|P3|STARTED|Booster Vaccination Phase||432
332043|NCT00614614|802967|P2|STARTED|Booster Vaccination Phase||233
332044|NCT00614614|802968|P1|STARTED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
332045|NCT00614614|802964|P5|NOT COMPLETED|Primary Vaccination Phase||0
332046|NCT00614614|802965|P4|NOT COMPLETED|Primary Vaccination Phase||0
332047|NCT00614614|802966|P3|NOT COMPLETED|Primary Vaccination Phase||0
332048|NCT00614614|802967|P2|NOT COMPLETED|Primary Vaccination Phase||17
332049|NCT00614614|802968|P1|NOT COMPLETED|Primary Vaccination Phase||90
332050|NCT00614614|802964|P5|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
332051|NCT00614614|802965|P4|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
332052|NCT00614614|802966|P3|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
332053|NCT00614614|802967|P2|COMPLETED|Primary Vaccination Phase||265
332054|NCT00614614|802968|P1|COMPLETED|Primary Vaccination Phase||1182
332055|NCT00614614|802964|P5|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
332056|NCT00614614|802965|P4|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
332057|NCT00614614|802966|P3|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
332058|NCT00614614|802967|P2|STARTED|Primary Vaccination Phase||282
332059|NCT00614614|802968|P1|STARTED|Primary Vaccination Phase||1272
332060|NCT00614575|803091|P1|NOT COMPLETED|Overall Study||228
332061|NCT00614575|803091|P1|COMPLETED|Overall Study||861
332062|NCT00614575|803091|P1|STARTED|Overall Study|The number of patients enrolled.|1089
332063|NCT00614523|803102|P2|NOT COMPLETED|Overall Study||131
332064|NCT00614523|803103|P1|NOT COMPLETED|Overall Study||63
332065|NCT00614523|803102|P2|COMPLETED|Overall Study||36
332066|NCT00614523|803103|P1|COMPLETED|Overall Study||20
332067|NCT00614523|803102|P2|STARTED|Overall Study||167
332068|NCT00614523|803103|P1|STARTED|Overall Study||83
332069|NCT00614484|803127|P1|NOT COMPLETED|Overall Study||0
332070|NCT00614484|803127|P1|COMPLETED|Overall Study||28
332071|NCT00614484|803127|P1|STARTED|Overall Study||28
332072|NCT00614458|803132|P1|NOT COMPLETED|Overall Study||0
332073|NCT00614458|803132|P1|COMPLETED|Overall Study||6
332074|NCT00614458|803132|P1|STARTED|Overall Study||6
332075|NCT00614445|803138|P2|NOT COMPLETED|Overall Study||49
332076|NCT00614445|803139|P1|NOT COMPLETED|Overall Study||28
332077|NCT00614445|803138|P2|COMPLETED|Overall Study||91
332078|NCT00614445|803139|P1|COMPLETED|Overall Study||112
332079|NCT00614445|803138|P2|STARTED|Overall Study||140
332080|NCT00614445|803139|P1|STARTED|Overall Study||140
332081|NCT00614432|803147|P2|NOT COMPLETED|Overall Study||0
332082|NCT00614432|803148|P1|NOT COMPLETED|Overall Study||0
332083|NCT00614432|803147|P2|COMPLETED|Overall Study||6
332084|NCT00614432|803148|P1|COMPLETED|Overall Study||4
332085|NCT00614432|803147|P2|STARTED|Overall Study||6
332086|NCT00614432|803148|P1|STARTED|Overall Study||4
332087|NCT00614406|803156|P2|NOT COMPLETED|Overall Study||0
332088|NCT00614406|803157|P1|NOT COMPLETED|Overall Study||0
332089|NCT00614406|803156|P2|COMPLETED|Overall Study||4
332090|NCT00614406|803157|P1|COMPLETED|Overall Study||7
332091|NCT00614406|803156|P2|STARTED|Overall Study||4
332092|NCT00614406|803157|P1|STARTED|Overall Study||7
332093|NCT00614393|803168|P5|NOT COMPLETED|Overall Study||180
332094|NCT00614393|803169|P4|NOT COMPLETED|Overall Study||180
332095|NCT00614393|803170|P3|NOT COMPLETED|Overall Study||10
332096|NCT00614393|803171|P2|NOT COMPLETED|Overall Study||8
332097|NCT00614393|803172|P1|NOT COMPLETED|Overall Study||180
332098|NCT00614393|803168|P5|COMPLETED|Overall Study||0
332099|NCT00614393|803169|P4|COMPLETED|Overall Study||0
332100|NCT00614393|803170|P3|COMPLETED|Overall Study||0
332101|NCT00614393|803171|P2|COMPLETED|Overall Study||0
332102|NCT00614393|803172|P1|COMPLETED|Overall Study||0
332103|NCT00614393|803168|P5|Treated|Overall Study||178
332104|NCT00614393|803169|P4|Treated|Overall Study||180
332105|NCT00614393|803170|P3|Treated|Overall Study||10
332106|NCT00614393|803171|P2|Treated|Overall Study||8
332107|NCT00614393|803172|P1|Treated|Overall Study||180
332108|NCT00614393|803168|P5|STARTED|Overall Study||180
332109|NCT00614393|803169|P4|STARTED|Overall Study||180
332110|NCT00614393|803170|P3|STARTED|Overall Study||10
332111|NCT00614393|803171|P2|STARTED|Overall Study||8
332112|NCT00614393|803172|P1|STARTED|Overall Study||180
332113|NCT00614380|803218|P4|NOT COMPLETED|Overall Study||2
332114|NCT00614380|803219|P3|NOT COMPLETED|Overall Study||1
332115|NCT00614380|803220|P2|NOT COMPLETED|Overall Study||8
332116|NCT00614380|803221|P1|NOT COMPLETED|Overall Study||35
332117|NCT00614380|803218|P4|COMPLETED|Overall Study||179
332118|NCT00614380|803219|P3|COMPLETED|Overall Study||24
332119|NCT00614380|803220|P2|COMPLETED|Overall Study||198
332120|NCT00614380|803221|P1|COMPLETED|Overall Study||529
332121|NCT00614380|803218|P4|STARTED|Overall Study||181
332122|NCT00614380|803219|P3|STARTED|Overall Study||25
332123|NCT00614380|803220|P2|STARTED|Overall Study||206
332124|NCT00614380|803221|P1|STARTED|Overall Study||564
332125|NCT00614315|803270|P1|NOT COMPLETED|Overall Study||0
332126|NCT00614315|803270|P1|COMPLETED|Overall Study||30
332127|NCT00614315|803270|P1|STARTED|Overall Study||30
332128|NCT00614198|803277|P2|NOT COMPLETED|Stage 2||12
332129|NCT00614198|803278|P1|NOT COMPLETED|Stage 2||8
332130|NCT00614198|803277|P2|COMPLETED|Stage 2||17
332131|NCT00614198|803278|P1|COMPLETED|Stage 2||18
332132|NCT00614198|803277|P2|STARTED|Stage 2|Reallocated to gluten- and casein-free dietary intervention|29
332133|NCT00614198|803278|P1|STARTED|Stage 2||26
332134|NCT00614198|803277|P2|NOT COMPLETED|Stage 1||5
332135|NCT00614198|803278|P1|NOT COMPLETED|Stage 1||12
332136|NCT00614198|803277|P2|COMPLETED|Stage 1||29
332137|NCT00614198|803278|P1|COMPLETED|Stage 1||26
332138|NCT00614198|803277|P2|STARTED|Stage 1||34
332139|NCT00614198|803278|P1|STARTED|Stage 1||38
332140|NCT00614120|803288|P4|NOT COMPLETED|Overall Study||16
332141|NCT00614120|803289|P3|NOT COMPLETED|Overall Study||59
332142|NCT00614120|803290|P2|NOT COMPLETED|Overall Study||46
332143|NCT00614120|803291|P1|NOT COMPLETED|Overall Study||29
332144|NCT00614120|803288|P4|COMPLETED|Overall Study||215
332145|NCT00614120|803289|P3|COMPLETED|Overall Study||175
332146|NCT00614120|803290|P2|COMPLETED|Overall Study||187
332147|NCT00614120|803291|P1|COMPLETED|Overall Study||202
332148|NCT00614120|803288|P4|Exposed to Study Drug|Overall Study||231
332149|NCT00614120|803289|P3|Exposed to Study Drug|Overall Study|Subject withdrew before exposure to study products, and thus not included in full analysis set.|233
332150|NCT00614120|803290|P2|Exposed to Study Drug|Overall Study||233
332151|NCT00614120|803291|P1|Exposed to Study Drug|Overall Study||231
332152|NCT00614120|803288|P4|STARTED|Overall Study|Randomised|231
332153|NCT00614120|803289|P3|STARTED|Overall Study|Randomised|234
332154|NCT00614120|803290|P2|STARTED|Overall Study|Randomised|233
332155|NCT00614120|803291|P1|STARTED|Overall Study|Randomised|231
332156|NCT00614055|803332|P3|NOT COMPLETED|Overall Study||5
332157|NCT00614055|803333|P2|NOT COMPLETED|Overall Study||6
332158|NCT00614055|803334|P1|NOT COMPLETED|Overall Study||4
332159|NCT00614055|803332|P3|COMPLETED|Overall Study||55
332160|NCT00614055|803333|P2|COMPLETED|Overall Study||53
332161|NCT00614055|803334|P1|COMPLETED|Overall Study||55
332162|NCT00614055|803332|P3|Exposed|Overall Study||60
332163|NCT00614055|803333|P2|Exposed|Overall Study||59
332164|NCT00614055|803334|P1|Exposed|Overall Study||59
332165|NCT00614055|803332|P3|STARTED|Overall Study||60
332166|NCT00614055|803333|P2|STARTED|Overall Study||59
332167|NCT00614055|803334|P1|STARTED|Overall Study||59
332168|NCT00613951|803381|P3|NOT COMPLETED|Overall Study||5
332169|NCT00613951|803382|P2|NOT COMPLETED|Overall Study||5
332170|NCT00613951|803383|P1|NOT COMPLETED|Overall Study||7
332171|NCT00613951|803381|P3|COMPLETED|Overall Study||57
332172|NCT00613951|803382|P2|COMPLETED|Overall Study||54
332173|NCT00613951|803383|P1|COMPLETED|Overall Study||54
332174|NCT00613951|803381|P3|Exposed|Overall Study||62
332175|NCT00613951|803382|P2|Exposed|Overall Study||59
332176|NCT00613951|803383|P1|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|60
332177|NCT00613951|803381|P3|STARTED|Overall Study||62
332178|NCT00613951|803382|P2|STARTED|Overall Study||59
332179|NCT00613951|803383|P1|STARTED|Overall Study||61
332180|NCT00613938|803428|P4|NOT COMPLETED|Overall Study||26
332181|NCT00613938|803429|P3|NOT COMPLETED|Overall Study||23
332182|NCT00613938|803430|P2|NOT COMPLETED|Overall Study||28
332183|NCT00613938|803431|P1|NOT COMPLETED|Overall Study||20
332184|NCT00613938|803428|P4|COMPLETED|Overall Study||253
332185|NCT00613938|803429|P3|COMPLETED|Overall Study||255
332186|NCT00613938|803430|P2|COMPLETED|Overall Study||247
332187|NCT00613938|803431|P1|COMPLETED|Overall Study||49
332188|NCT00613938|803428|P4|STARTED|Overall Study|one patient did not have a valid baseline score therefore excluded from above|279
332189|NCT00613938|803429|P3|STARTED|Overall Study||278
332190|NCT00613938|803430|P2|STARTED|Overall Study||275
332191|NCT00613938|803431|P1|STARTED|Overall Study||69
332192|NCT00613925|803463|P2|NOT COMPLETED|Overall Study||1
332193|NCT00613925|803464|P1|NOT COMPLETED|Overall Study||0
332194|NCT00613925|803463|P2|COMPLETED|Overall Study||32
332195|NCT00613925|803464|P1|COMPLETED|Overall Study||37
332196|NCT00613925|803463|P2|STARTED|Overall Study||33
332197|NCT00613925|803464|P1|STARTED|Overall Study||37
332198|NCT00613821|803474|P2|NOT COMPLETED|Overall Study||1
332199|NCT00613821|803475|P1|NOT COMPLETED|Overall Study||2
332200|NCT00613821|803474|P2|COMPLETED|Overall Study||39
332201|NCT00613821|803475|P1|COMPLETED|Overall Study||38
332202|NCT00613821|803474|P2|STARTED|Overall Study||40
332203|NCT00613821|803475|P1|STARTED|Overall Study||40
332204|NCT00613730|803481|P1|NOT COMPLETED|Overall Study||3
332205|NCT00613730|803481|P1|COMPLETED|Overall Study||0
332206|NCT00613730|803481|P1|STARTED|Overall Study||3
332207|NCT00613626|803490|P3|NOT COMPLETED|Overall Study||0
332208|NCT00613626|803491|P2|NOT COMPLETED|Overall Study||1
332209|NCT00613626|803492|P1|NOT COMPLETED|Overall Study||0
332210|NCT00613626|803490|P3|COMPLETED|Overall Study||7
332211|NCT00613626|803491|P2|COMPLETED|Overall Study||33
332212|NCT00613626|803492|P1|COMPLETED|Overall Study||33
332213|NCT00613626|803490|P3|1st Dose ZD6474|Overall Study||7
332214|NCT00613626|803491|P2|1st Dose ZD6474|Overall Study||34
332215|NCT00613626|803492|P1|1st Dose ZD6474|Overall Study||33
332216|NCT00613626|803490|P3|STARTED|Overall Study|These participants provided the toxicity data to determine if ZD6474+Etopiside+Cisplatin was safe.|7
332217|NCT00613626|803491|P2|STARTED|Overall Study||34
332218|NCT00613626|803492|P1|STARTED|Overall Study||33
332219|NCT00613574|803508|P1|NOT COMPLETED|Overall Study||6
332220|NCT00613574|803508|P1|COMPLETED|Overall Study||401
332221|NCT00613574|803508|P1|STARTED|Overall Study||407
332222|NCT00613509|803520|P2|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
332223|NCT00613509|803521|P1|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
332224|NCT00613509|803520|P2|COMPLETED|Cycle 2 (Group 2 = Crossover)||4
332225|NCT00613509|803521|P1|COMPLETED|Cycle 2 (Group 2 = Crossover)||11
332226|NCT00613509|803520|P2|STARTED|Cycle 2 (Group 2 = Crossover)||4
332227|NCT00613509|803521|P1|STARTED|Cycle 2 (Group 2 = Crossover)||11
332228|NCT00613509|803520|P2|NOT COMPLETED|Cycle 1||8
332229|NCT00613509|803521|P1|NOT COMPLETED|Cycle 1||5
332230|NCT00613509|803520|P2|COMPLETED|Cycle 1|Completion of Cycle 1. 12 participants were deemed evaluable|4
332231|NCT00613509|803521|P1|COMPLETED|Cycle 1|Completion of Cycle 1. 9 participants were deemed evaluable|6
332232|NCT00613509|803520|P2|STARTED|Cycle 1||12
332233|NCT00613509|803521|P1|STARTED|Cycle 1||11
332234|NCT00613405|803545|P2|NOT COMPLETED|Overall Study||0
332235|NCT00613405|803546|P1|NOT COMPLETED|Overall Study||0
332236|NCT00613405|803545|P2|COMPLETED|Overall Study||42
332237|NCT00613405|803546|P1|COMPLETED|Overall Study||45
332238|NCT00613405|803545|P2|STARTED|Overall Study||42
332239|NCT00613405|803546|P1|STARTED|Overall Study||45
332240|NCT00613379|803555|P3|NOT COMPLETED|Overall Study||0
332241|NCT00613379|803556|P2|NOT COMPLETED|Overall Study||0
332242|NCT00613379|803557|P1|NOT COMPLETED|Overall Study||0
332243|NCT00613379|803555|P3|COMPLETED|Overall Study||11
332244|NCT00613379|803556|P2|COMPLETED|Overall Study||10
332245|NCT00613379|803557|P1|COMPLETED|Overall Study||10
332246|NCT00613379|803555|P3|STARTED|Overall Study||11
332247|NCT00613379|803556|P2|STARTED|Overall Study||10
332248|NCT00613379|803557|P1|STARTED|Overall Study||10
332249|NCT00613366|803567|P2|NOT COMPLETED|Overall Study||2
332250|NCT00613366|803568|P1|NOT COMPLETED|Overall Study||3
332251|NCT00613366|803567|P2|COMPLETED|Overall Study||18
332252|NCT00613366|803568|P1|COMPLETED|Overall Study||17
332253|NCT00613366|803567|P2|STARTED|Overall Study||20
332254|NCT00613366|803568|P1|STARTED|Overall Study||20
332255|NCT00613327|803576|P1|NOT COMPLETED|Overall Study||101
332256|NCT00613327|803576|P1|COMPLETED|Overall Study||244
332257|NCT00613327|803576|P1|STARTED|Overall Study||345
332258|NCT00613314|803595|P1|NOT COMPLETED|Overall Study||155
332259|NCT00613314|803595|P1|COMPLETED|Overall Study||15113
332260|NCT00613314|803595|P1|STARTED|Overall Study||15268
332261|NCT00613301|803603|P1|NOT COMPLETED|Overall Study||228
332262|NCT00613301|803603|P1|COMPLETED|Overall Study||188
332263|NCT00613301|803603|P1|STARTED|Overall Study||416
332264|NCT00613106|803612|P2|NOT COMPLETED|Overall Study||9
332265|NCT00613106|803613|P1|NOT COMPLETED|Overall Study||20
332266|NCT00613106|803612|P2|COMPLETED|Overall Study||38
332267|NCT00613106|803613|P1|COMPLETED|Overall Study||112
332268|NCT00613106|803612|P2|STARTED|Overall Study||47
332269|NCT00613106|803613|P1|STARTED|Overall Study||132
332270|NCT00613080|803619|P1|NOT COMPLETED|Overall Study||11
332271|NCT00613080|803619|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|68
332272|NCT00613080|803619|P1|STARTED|Overall Study||79
332273|NCT00613028|803633|P2|NOT COMPLETED|Overall Study||1
332274|NCT00613028|803634|P1|NOT COMPLETED|Overall Study||0
332275|NCT00613028|803633|P2|COMPLETED|Overall Study||12
332276|NCT00613028|803634|P1|COMPLETED|Overall Study||10
332277|NCT00613028|803633|P2|STARTED|Overall Study||13
332278|NCT00613028|803634|P1|STARTED|Overall Study||10
332279|NCT00613015|803654|P6|NOT COMPLETED|Overall Study||3
332280|NCT00613015|803655|P5|NOT COMPLETED|Overall Study||2
332281|NCT00613015|803656|P4|NOT COMPLETED|Overall Study||3
332282|NCT00613015|803657|P3|NOT COMPLETED|Overall Study||3
332283|NCT00613015|803658|P2|NOT COMPLETED|Overall Study||1
332284|NCT00613015|803659|P1|NOT COMPLETED|Overall Study||0
332285|NCT00613015|803654|P6|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|16
332286|NCT00613015|803655|P5|COMPLETED|Overall Study|Two participants did not complete one-week follow-up visit.|13
332287|NCT00613015|803656|P4|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|21
332288|NCT00613015|803657|P3|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|23
332289|NCT00613015|803658|P2|COMPLETED|Overall Study|One participant did not complete the one-week follow-up visit.|11
332290|NCT00613015|803659|P1|COMPLETED|Overall Study||13
332291|NCT00613015|803654|P6|STARTED|Overall Study||19
332292|NCT00613015|803655|P5|STARTED|Overall Study||15
332293|NCT00613015|803656|P4|STARTED|Overall Study||24
332294|NCT00613015|803657|P3|STARTED|Overall Study||26
332295|NCT00613015|803658|P2|STARTED|Overall Study||12
332296|NCT00613015|803659|P1|STARTED|Overall Study||13
332297|NCT00612924|803681|P2|NOT COMPLETED|Overall Study||9
332298|NCT00612924|803682|P1|NOT COMPLETED|Overall Study||7
332299|NCT00612924|803681|P2|COMPLETED|Overall Study||85
332300|NCT00612924|803682|P1|COMPLETED|Overall Study||94
332301|NCT00612924|803681|P2|STARTED|Overall Study||94
332302|NCT00612924|803682|P1|STARTED|Overall Study||101
332303|NCT00612807|803695|P2|NOT COMPLETED|Overall Study||0
332304|NCT00612807|803696|P1|NOT COMPLETED|Overall Study||2
332305|NCT00612807|803695|P2|COMPLETED|Overall Study||28
332306|NCT00612807|803696|P1|COMPLETED|Overall Study||12
332307|NCT00612807|803695|P2|STARTED|Overall Study||28
332308|NCT00612807|803696|P1|STARTED|Overall Study||14
332309|NCT00612768|803704|P1|NOT COMPLETED|Overall Study||0
332310|NCT00612768|803704|P1|COMPLETED|Overall Study||50
332311|NCT00612768|803704|P1|STARTED|Overall Study||50
332312|NCT00612690|803731|P2|NOT COMPLETED|Overall Study||118
332313|NCT00612690|803732|P1|NOT COMPLETED|Overall Study||115
332314|NCT00612690|803731|P2|COMPLETED|Overall Study||89
332315|NCT00612690|803732|P1|COMPLETED|Overall Study||160
332316|NCT00612690|803731|P2|STARTED|Overall Study||207
332317|NCT00612690|803732|P1|STARTED|Overall Study||275
332318|NCT00612677|803740|P1|NOT COMPLETED|Overall Study||1
332319|NCT00612677|803740|P1|COMPLETED|Overall Study||0
332320|NCT00612677|803740|P1|STARTED|Overall Study||1
332321|NCT00612573|803750|P4|NOT COMPLETED|Overall Study||13
332322|NCT00612573|803751|P3|NOT COMPLETED|Overall Study||9
332323|NCT00612573|803752|P2|NOT COMPLETED|Overall Study||14
332324|NCT00612573|803753|P1|NOT COMPLETED|Overall Study||12
332325|NCT00612573|803750|P4|COMPLETED|Overall Study||54
332326|NCT00612573|803751|P3|COMPLETED|Overall Study||52
332327|NCT00612573|803752|P2|COMPLETED|Overall Study||51
332328|NCT00612573|803753|P1|COMPLETED|Overall Study||52
332329|NCT00612573|803750|P4|STARTED|Overall Study||67
332330|NCT00612573|803751|P3|STARTED|Overall Study||61
332331|NCT00612573|803752|P2|STARTED|Overall Study||65
332332|NCT00612573|803753|P1|STARTED|Overall Study||64
332333|NCT00612560|803779|P4|NOT COMPLETED|Overall Study||0
332334|NCT00612560|803780|P3|NOT COMPLETED|Overall Study||0
332335|NCT00612560|803781|P2|NOT COMPLETED|Overall Study||0
332336|NCT00612560|803782|P1|NOT COMPLETED|Overall Study||0
332337|NCT00612560|803779|P4|COMPLETED|Overall Study||6
332338|NCT00612560|803780|P3|COMPLETED|Overall Study||8
332339|NCT00612560|803781|P2|COMPLETED|Overall Study||7
332340|NCT00612560|803782|P1|COMPLETED|Overall Study||7
332341|NCT00612560|803779|P4|STARTED|Overall Study||6
332342|NCT00612560|803780|P3|STARTED|Overall Study||8
332343|NCT00612560|803781|P2|STARTED|Overall Study||7
332344|NCT00612560|803782|P1|STARTED|Overall Study||7
332345|NCT00612534|803808|P4|NOT COMPLETED|Overall Study||17
332346|NCT00612534|803809|P3|NOT COMPLETED|Overall Study||7
332347|NCT00612534|803810|P2|NOT COMPLETED|Overall Study||17
332348|NCT00612534|803811|P1|NOT COMPLETED|Overall Study||13
332349|NCT00612534|803808|P4|COMPLETED|Overall Study||7
332350|NCT00612534|803809|P3|COMPLETED|Overall Study||13
332351|NCT00612534|803810|P2|COMPLETED|Overall Study||9
332352|NCT00612534|803811|P1|COMPLETED|Overall Study||11
332353|NCT00612534|803808|P4|STARTED|Overall Study||24
332354|NCT00612534|803809|P3|STARTED|Overall Study||20
332355|NCT00612534|803810|P2|STARTED|Overall Study||26
332356|NCT00612534|803811|P1|STARTED|Overall Study||24
332357|NCT00612508|803823|P2|NOT COMPLETED|Overall Study||4
332358|NCT00612508|803824|P1|NOT COMPLETED|Overall Study||3
332359|NCT00612508|803823|P2|COMPLETED|Overall Study|6 nuvaring users returned for the 84 day biopsy|3
332360|NCT00612508|803824|P1|COMPLETED|Overall Study|5 desogen users returned for the 84 day biopsy|4
332361|NCT00612508|803823|P2|STARTED|Overall Study||7
332362|NCT00612508|803824|P1|STARTED|Overall Study||7
332363|NCT00612456|803835|P3|NOT COMPLETED|Overall Study||0
332364|NCT00612456|803836|P2|NOT COMPLETED|Overall Study||2
332365|NCT00612456|803837|P1|NOT COMPLETED|Overall Study||2
332366|NCT00612456|803835|P3|COMPLETED|Overall Study||16
332367|NCT00612456|803836|P2|COMPLETED|Overall Study||25
332368|NCT00612456|803837|P1|COMPLETED|Overall Study||25
332369|NCT00612456|803835|P3|STARTED|Overall Study||16
332370|NCT00612456|803836|P2|STARTED|Overall Study||27
332371|NCT00612456|803837|P1|STARTED|Overall Study||27
332372|NCT00612430|803883|P2|NOT COMPLETED|Overall Study||0
332373|NCT00612430|803884|P1|NOT COMPLETED|Overall Study||0
332374|NCT00612430|803883|P2|COMPLETED|Overall Study||27
332375|NCT00612430|803884|P1|COMPLETED|Overall Study||32
332376|NCT00612430|803883|P2|STARTED|Overall Study||27
332377|NCT00612430|803884|P1|STARTED|Overall Study||32
332378|NCT00612352|803900|P2|NOT COMPLETED|Overall Study||6
332379|NCT00612352|803901|P1|NOT COMPLETED|Overall Study||9
332380|NCT00612352|803900|P2|COMPLETED|Overall Study||109
332381|NCT00612352|803901|P1|COMPLETED|Overall Study||56
332382|NCT00612352|803900|P2|Placebo|Overall Study||4
332383|NCT00612352|803901|P1|Placebo|Overall Study||4
332384|NCT00612352|803900|P2|40%mg|Overall Study||0
332385|NCT00612352|803901|P1|40%mg|Overall Study||1
332386|NCT00612352|803900|P2|100%mg|Overall Study||1
332387|NCT00612352|803901|P1|100%mg|Overall Study||2
332388|NCT00612352|803900|P2|Placebo & 100%mg|Overall Study||0
332389|NCT00612352|803901|P1|Placebo & 100%mg|Overall Study||1
332390|NCT00612352|803900|P2|40%mg & 100%mg|Overall Study||1
332391|NCT00612352|803901|P1|40%mg & 100%mg|Overall Study||1
332392|NCT00612352|803900|P2|STARTED|Overall Study||115
332393|NCT00612352|803901|P1|STARTED|Overall Study||65
332394|NCT00612339|804015|P1|NOT COMPLETED|Overall Study||0
332395|NCT00612339|804015|P1|COMPLETED|Overall Study||41
332396|NCT00612339|804015|P1|STARTED|Overall Study||41
332397|NCT00612313|804021|P2|NOT COMPLETED|Overall Study||13
332398|NCT00612313|804022|P1|NOT COMPLETED|Overall Study||17
332399|NCT00612313|804021|P2|COMPLETED|Overall Study||62
332400|NCT00612313|804022|P1|COMPLETED|Overall Study||52
332401|NCT00612313|804021|P2|STARTED|Overall Study||75
332402|NCT00612313|804022|P1|STARTED|Overall Study||69
332403|NCT00612235|804042|P4|NOT COMPLETED|Overall Study||0
332404|NCT00612235|804043|P3|NOT COMPLETED|Overall Study||0
332405|NCT00612235|804044|P2|NOT COMPLETED|Overall Study||0
332406|NCT00612235|804045|P1|NOT COMPLETED|Overall Study||0
332407|NCT00612235|804042|P4|COMPLETED|Overall Study||20
332408|NCT00612235|804043|P3|COMPLETED|Overall Study||20
332409|NCT00612235|804044|P2|COMPLETED|Overall Study||20
332410|NCT00612235|804045|P1|COMPLETED|Overall Study||20
332411|NCT00612235|804042|P4|STARTED|Overall Study||20
332412|NCT00612235|804043|P3|STARTED|Overall Study||20
332413|NCT00612235|804044|P2|STARTED|Overall Study||20
332414|NCT00612235|804045|P1|STARTED|Overall Study||20
332415|NCT00612222|804056|P1|NOT COMPLETED|Overall Study||0
332416|NCT00612222|804056|P1|COMPLETED|Overall Study||4
332417|NCT00612222|804056|P1|STARTED|Overall Study||4
332418|NCT00612105|804064|P2|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||0
332419|NCT00612105|804065|P1|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||1
332420|NCT00612105|804064|P2|COMPLETED|Period Title 3: 3-Week Taper Phase||58
332421|NCT00612105|804065|P1|COMPLETED|Period Title 3: 3-Week Taper Phase||85
332422|NCT00612105|804064|P2|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|58
332423|NCT00612105|804065|P1|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|86
332424|NCT00612105|804064|P2|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||2
332425|NCT00612105|804065|P1|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||11
332426|NCT00612105|804064|P2|COMPLETED|Period Title 2: 4-Week Maintenance Phase||55
332427|NCT00612105|804065|P1|COMPLETED|Period Title 2: 4-Week Maintenance Phase||78
332428|NCT00612105|804064|P2|STARTED|Period Title 2: 4-Week Maintenance Phase||57
332429|NCT00612105|804065|P1|STARTED|Period Title 2: 4-Week Maintenance Phase||89
332430|NCT00612105|804064|P2|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||5
332431|NCT00612105|804065|P1|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||36
332432|NCT00612105|804064|P2|COMPLETED|Period Title 1: 6-Week Titration Phase||57
332433|NCT00612105|804065|P1|COMPLETED|Period Title 1: 6-Week Titration Phase||89
332434|NCT00612105|804064|P2|STARTED|Period Title 1: 6-Week Titration Phase||62
332435|NCT00612105|804065|P1|STARTED|Period Title 1: 6-Week Titration Phase||125
332436|NCT00612066|804115|P1|NOT COMPLETED|Overall Study||1
332437|NCT00612066|804115|P1|COMPLETED|Overall Study||1
332438|NCT00612066|804115|P1|STARTED|Overall Study||2
332439|NCT00612040|804122|P3|NOT COMPLETED|Overall Study||7
332440|NCT00612040|804123|P2|NOT COMPLETED|Overall Study||7
332441|NCT00612040|804124|P1|NOT COMPLETED|Overall Study||5
332442|NCT00612040|804122|P3|COMPLETED|Overall Study||52
332443|NCT00612040|804123|P2|COMPLETED|Overall Study||52
332444|NCT00612040|804124|P1|COMPLETED|Overall Study||55
332445|NCT00612040|804122|P3|Exposed|Overall Study||59
332446|NCT00612040|804123|P2|Exposed|Overall Study||59
332447|NCT00612040|804124|P1|Exposed|Overall Study||60
332448|NCT00612040|804122|P3|STARTED|Overall Study||59
332449|NCT00612040|804123|P2|STARTED|Overall Study||59
332450|NCT00612040|804124|P1|STARTED|Overall Study||60
332451|NCT00611923|804170|P2|NOT COMPLETED|Overall Study||2
332452|NCT00611923|804171|P1|NOT COMPLETED|Overall Study||2
332453|NCT00611923|804170|P2|COMPLETED|Overall Study||11
332454|NCT00611923|804171|P1|COMPLETED|Overall Study||10
332455|NCT00611923|804170|P2|STARTED|Overall Study||13
332456|NCT00611923|804171|P1|STARTED|Overall Study||12
332457|NCT00611897|804183|P2|NOT COMPLETED|Day 2: Crossover Treatment||0
332458|NCT00611897|804184|P1|NOT COMPLETED|Day 2: Crossover Treatment||0
332459|NCT00611897|804183|P2|COMPLETED|Day 2: Crossover Treatment||8
332460|NCT00611897|804184|P1|COMPLETED|Day 2: Crossover Treatment||8
332461|NCT00611897|804183|P2|STARTED|Day 2: Crossover Treatment||8
332462|NCT00611897|804184|P1|STARTED|Day 2: Crossover Treatment||8
332463|NCT00611897|804183|P2|NOT COMPLETED|Day 1: Initial Treatment||0
332464|NCT00611897|804184|P1|NOT COMPLETED|Day 1: Initial Treatment||0
332465|NCT00611897|804183|P2|COMPLETED|Day 1: Initial Treatment||8
332466|NCT00611897|804184|P1|COMPLETED|Day 1: Initial Treatment||8
332467|NCT00611897|804183|P2|STARTED|Day 1: Initial Treatment||8
332468|NCT00611897|804184|P1|STARTED|Day 1: Initial Treatment||8
332469|NCT00611884|804212|P4|NOT COMPLETED|Overall Study||6
332470|NCT00611884|804213|P3|NOT COMPLETED|Overall Study||4
332471|NCT00611884|804214|P2|NOT COMPLETED|Overall Study||9
332472|NCT00611884|804215|P1|NOT COMPLETED|Overall Study||9
332473|NCT00611884|804212|P4|COMPLETED|Overall Study||56
332474|NCT00611884|804213|P3|COMPLETED|Overall Study||58
332475|NCT00611884|804214|P2|COMPLETED|Overall Study||51
332476|NCT00611884|804215|P1|COMPLETED|Overall Study||52
332477|NCT00611884|804212|P4|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
332478|NCT00611884|804213|P3|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
332479|NCT00611884|804214|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|59
332480|NCT00611884|804215|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|58
332481|NCT00611884|804212|P4|STARTED|Overall Study||62
332482|NCT00611884|804213|P3|STARTED|Overall Study||62
332483|NCT00611884|804214|P2|STARTED|Overall Study||60
332484|NCT00611884|804215|P1|STARTED|Overall Study||61
332485|NCT00611858|804269|P1|NOT COMPLETED|Overall Study||4
332486|NCT00611858|804269|P1|COMPLETED|Overall Study||9
332487|NCT00611858|804269|P1|STARTED|Overall Study||13
332488|NCT00611806|804281|P2|NOT COMPLETED|Overall Study||3
332489|NCT00611806|804282|P1|NOT COMPLETED|Overall Study||16
332490|NCT00611806|804281|P2|COMPLETED|Overall Study||43
332491|NCT00611806|804282|P1|COMPLETED|Overall Study||78
332492|NCT00611806|804281|P2|STARTED|Overall Study||46
332493|NCT00611806|804282|P1|STARTED|Overall Study||94
332494|NCT00611767|804296|P2|NOT COMPLETED|Overall Study||2
332495|NCT00611767|804297|P1|NOT COMPLETED|Overall Study||9
332496|NCT00611767|804296|P2|COMPLETED|Overall Study||22
332497|NCT00611767|804297|P1|COMPLETED|Overall Study||40
332498|NCT00611767|804296|P2|Placebo Test Day|Overall Study||1
332499|NCT00611767|804297|P1|Placebo Test Day|Overall Study||6
332500|NCT00611767|804296|P2|Thiopental Test Day|Overall Study||1
332501|NCT00611767|804297|P1|Thiopental Test Day|Overall Study||3
332502|NCT00611767|804296|P2|STARTED|Overall Study||24
332503|NCT00611767|804297|P1|STARTED|Overall Study||49
332504|NCT00611715|804459|P2|NOT COMPLETED|Overall Study||6
332505|NCT00611715|804460|P1|NOT COMPLETED|Overall Study||41
332506|NCT00611715|804459|P2|COMPLETED|Overall Study||0
332507|NCT00611715|804460|P1|COMPLETED|Overall Study|"2 pts in Arm 1 remain on-tx. They are not accounted for in off-tx reasonor completed data fields"|1
332508|NCT00611715|804459|P2|STARTED|Overall Study||6
332509|NCT00611715|804460|P1|STARTED|Overall Study||42
332510|NCT00611624|804472|P1|NOT COMPLETED|Overall Study||0
332511|NCT00611624|804472|P1|COMPLETED|Overall Study||28
332512|NCT00611624|804472|P1|STARTED|Overall Study||28
332513|NCT00611559|804480|P3|NOT COMPLETED|Overall Study||1
332514|NCT00611559|804481|P2|NOT COMPLETED|Overall Study||1
332515|NCT00611559|804482|P1|NOT COMPLETED|Overall Study||1
332516|NCT00611559|804480|P3|COMPLETED|Overall Study||56
332517|NCT00611559|804481|P2|COMPLETED|Overall Study||114
332518|NCT00611559|804482|P1|COMPLETED|Overall Study||110
332519|NCT00611559|804480|P3|STARTED|Overall Study||57
332520|NCT00611559|804481|P2|STARTED|Overall Study||115
332521|NCT00611559|804482|P1|STARTED|Overall Study||111
332522|NCT00611533|804541|P2|NOT COMPLETED|Second Intervention (6 Weeks)||2
332523|NCT00611533|804542|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
332524|NCT00611533|804541|P2|COMPLETED|Second Intervention (6 Weeks)||4
332525|NCT00611533|804542|P1|COMPLETED|Second Intervention (6 Weeks)||8
332526|NCT00611533|804541|P2|STARTED|Second Intervention (6 Weeks)||6
332527|NCT00611533|804542|P1|STARTED|Second Intervention (6 Weeks)||8
332528|NCT00611533|804541|P2|NOT COMPLETED|First Intervention (6 Weeks)||2
332529|NCT00611533|804542|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
332530|NCT00611533|804541|P2|COMPLETED|First Intervention (6 Weeks)||6
332531|NCT00611533|804542|P1|COMPLETED|First Intervention (6 Weeks)||8
332532|NCT00611533|804541|P2|STARTED|First Intervention (6 Weeks)||8
332533|NCT00611533|804542|P1|STARTED|First Intervention (6 Weeks)||8
332534|NCT00611468|804561|P4|NOT COMPLETED|Overall Study||0
332535|NCT00611468|804562|P3|NOT COMPLETED|Overall Study||0
332536|NCT00611468|804563|P2|NOT COMPLETED|Overall Study||1
332537|NCT00611468|804564|P1|NOT COMPLETED|Overall Study||0
332538|NCT00611468|804561|P4|COMPLETED|Overall Study||13
332539|NCT00611468|804562|P3|COMPLETED|Overall Study||6
332540|NCT00611468|804563|P2|COMPLETED|Overall Study|One subject did not complete Cycle 1 of treatment and was replaced.|6
332541|NCT00611468|804564|P1|COMPLETED|Overall Study||3
332542|NCT00611468|804561|P4|STARTED|Overall Study||13
332543|NCT00611468|804562|P3|STARTED|Overall Study||6
332544|NCT00611468|804563|P2|STARTED|Overall Study||7
332545|NCT00611468|804564|P1|STARTED|Overall Study||3
332546|NCT00611455|804576|P3|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||211
332547|NCT00611455|804577|P2|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
332548|NCT00611455|804578|P1|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
332549|NCT00611455|804576|P3|COMPLETED|Follow-up Period (Approximately 2 Years)||49
332550|NCT00611455|804577|P2|COMPLETED|Follow-up Period (Approximately 2 Years)||0
332551|NCT00611455|804578|P1|COMPLETED|Follow-up Period (Approximately 2 Years)||0
332552|NCT00611455|804576|P3|STARTED|Follow-up Period (Approximately 2 Years)|These participants received at least one infusion of placebo or ofatumumab.|260
332553|NCT00611455|804577|P2|STARTED|Follow-up Period (Approximately 2 Years)||0
332554|NCT00611455|804578|P1|STARTED|Follow-up Period (Approximately 2 Years)||0
332555|NCT00611455|804576|P3|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
332556|NCT00611455|804577|P2|NOT COMPLETED|OL Treatment Period (120 Weeks)||179
332557|NCT00611455|804578|P1|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
332558|NCT00611455|804576|P3|COMPLETED|OL Treatment Period (120 Weeks)||0
332559|NCT00611455|804577|P2|COMPLETED|OL Treatment Period (120 Weeks)||52
332560|NCT00611455|804578|P1|COMPLETED|OL Treatment Period (120 Weeks)||0
332561|NCT00611455|804576|P3|STARTED|OL Treatment Period (120 Weeks)||0
332562|NCT00611455|804577|P2|STARTED|OL Treatment Period (120 Weeks)|118 participants received OFA during the DB Period; 113 received placebo during the DB Period.|231
332563|NCT00611455|804578|P1|STARTED|OL Treatment Period (120 Weeks)||0
332564|NCT00611455|804576|P3|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
332565|NCT00611455|804577|P2|NOT COMPLETED|DB Treatment Period (24 Weeks)||14
332566|NCT00611455|804578|P1|NOT COMPLETED|DB Treatment Period (24 Weeks)||13
332567|NCT00611455|804576|P3|COMPLETED|DB Treatment Period (24 Weeks)||0
332568|NCT00611455|804577|P2|COMPLETED|DB Treatment Period (24 Weeks)||117
332569|NCT00611455|804578|P1|COMPLETED|DB Treatment Period (24 Weeks)||121
332570|NCT00611455|804576|P3|STARTED|DB Treatment Period (24 Weeks)||0
332571|NCT00611455|804577|P2|STARTED|DB Treatment Period (24 Weeks)||131
332572|NCT00611455|804578|P1|STARTED|DB Treatment Period (24 Weeks)||134
332573|NCT00611442|804706|P2|NOT COMPLETED|Overall Study||2
332574|NCT00611442|804707|P1|NOT COMPLETED|Overall Study||1
332575|NCT00611442|804706|P2|COMPLETED|Overall Study||94
332576|NCT00611442|804707|P1|COMPLETED|Overall Study||94
332577|NCT00611442|804706|P2|STARTED|Overall Study||96
332578|NCT00611442|804707|P1|STARTED|Overall Study||95
332579|NCT00611403|804721|P2|NOT COMPLETED|Post Treatment Extension Phase||1
332580|NCT00611403|804722|P1|NOT COMPLETED|Post Treatment Extension Phase||4
332581|NCT00611403|804721|P2|COMPLETED|Post Treatment Extension Phase||24
332582|NCT00611403|804722|P1|COMPLETED|Post Treatment Extension Phase||22
332583|NCT00611403|804721|P2|STARTED|Post Treatment Extension Phase|25 of 69 pts who received ENDURA® in the Treatment Phase entered the Post Treatment Extension Phase|25
332584|NCT00611403|804722|P1|STARTED|Post Treatment Extension Phase|26 of 68 pts who received RESTASIS® in the Treatment Phase entered the Post Treatment Ext. Phase|26
332585|NCT00611403|804721|P2|NOT COMPLETED|Treatment Phase||11
332586|NCT00611403|804722|P1|NOT COMPLETED|Treatment Phase||6
332587|NCT00611403|804721|P2|COMPLETED|Treatment Phase||58
332588|NCT00611403|804722|P1|COMPLETED|Treatment Phase||62
332589|NCT00611403|804721|P2|STARTED|Treatment Phase||69
332590|NCT00611403|804722|P1|STARTED|Treatment Phase||68
332591|NCT00611351|804732|P1|NOT COMPLETED|Overall Study||2
332592|NCT00611351|804732|P1|COMPLETED|Overall Study||3
332593|NCT00611351|804732|P1|STARTED|Overall Study||5
332594|NCT00611325|804741|P2|NOT COMPLETED|Overall Study||0
332595|NCT00611325|804742|P1|NOT COMPLETED|Overall Study||0
332596|NCT00611325|804741|P2|COMPLETED|Overall Study||28
332597|NCT00611325|804742|P1|COMPLETED|Overall Study||28
332598|NCT00611325|804741|P2|STARTED|Overall Study||28
332599|NCT00611325|804742|P1|STARTED|Overall Study||28
332600|NCT00611247|804758|P2|NOT COMPLETED|Overall Study||21
332601|NCT00611247|804759|P1|NOT COMPLETED|Overall Study||2
332602|NCT00611247|804758|P2|COMPLETED|Overall Study||10
332603|NCT00611247|804759|P1|COMPLETED|Overall Study||3
332604|NCT00611247|804758|P2|STARTED|Overall Study||31
332605|NCT00611247|804759|P1|STARTED|Overall Study||5
332606|NCT00611130|804771|P2|NOT COMPLETED|Overall Study||47
332607|NCT00611130|804772|P1|NOT COMPLETED|Overall Study||49
332608|NCT00611130|804771|P2|COMPLETED|Overall Study||47
332609|NCT00611130|804772|P1|COMPLETED|Overall Study||43
332610|NCT00611130|804771|P2|Completed 12 Week Treatment Phase|Overall Study||64
332611|NCT00611130|804772|P1|Completed 12 Week Treatment Phase|Overall Study||61
332612|NCT00611130|804771|P2|STARTED|Overall Study||94
332613|NCT00611130|804772|P1|STARTED|Overall Study||92
332614|NCT00611026|804782|P3|NOT COMPLETED|Double-blind Treatment Period||98
332615|NCT00611026|804783|P2|NOT COMPLETED|Double-blind Treatment Period||88
332616|NCT00611026|804784|P1|NOT COMPLETED|Double-blind Treatment Period||47
332617|NCT00611026|804782|P3|COMPLETED|Double-blind Treatment Period||862
332618|NCT00611026|804783|P2|COMPLETED|Double-blind Treatment Period||885
332619|NCT00611026|804784|P1|COMPLETED|Double-blind Treatment Period||431
332620|NCT00611026|804782|P3|STARTED|Double-blind Treatment Period||960
332621|NCT00611026|804783|P2|STARTED|Double-blind Treatment Period||973
332622|NCT00611026|804784|P1|STARTED|Double-blind Treatment Period||478
332623|NCT00611026|804782|P3|NOT COMPLETED|Randomized to Double-blind Treatment||3
332624|NCT00611026|804783|P2|NOT COMPLETED|Randomized to Double-blind Treatment||1
332625|NCT00611026|804784|P1|NOT COMPLETED|Randomized to Double-blind Treatment||2
332626|NCT00611026|804782|P3|COMPLETED|Randomized to Double-blind Treatment||960
332627|NCT00611026|804783|P2|COMPLETED|Randomized to Double-blind Treatment||973
332628|NCT00611026|804784|P1|COMPLETED|Randomized to Double-blind Treatment||478
332629|NCT00611026|804782|P3|STARTED|Randomized to Double-blind Treatment||963
332630|NCT00611026|804783|P2|STARTED|Randomized to Double-blind Treatment||974
332631|NCT00611026|804784|P1|STARTED|Randomized to Double-blind Treatment||480
332632|NCT00610987|804850|P2|NOT COMPLETED|Overall Study||0
332633|NCT00610987|804851|P1|NOT COMPLETED|Overall Study||0
332634|NCT00610987|804850|P2|COMPLETED|Overall Study||71
332635|NCT00610987|804851|P1|COMPLETED|Overall Study||75
332636|NCT00610987|804850|P2|STARTED|Overall Study||71
332637|NCT00610987|804851|P1|STARTED|Overall Study||75
332638|NCT00610883|804857|P1|NOT COMPLETED|Overall Study||0
332639|NCT00610883|804857|P1|COMPLETED|Overall Study||17
332640|NCT00610883|804857|P1|STARTED|Overall Study||17
332641|NCT00610857|804861|P1|NOT COMPLETED|Overall Study||2
332642|NCT00610857|804861|P1|COMPLETED|Overall Study||35
332643|NCT00610857|804861|P1|STARTED|Overall Study||37
332644|NCT00610740|804868|P1|NOT COMPLETED|Overall Study||0
332645|NCT00610740|804868|P1|COMPLETED|Overall Study||18
332646|NCT00610740|804868|P1|STARTED|Overall Study||18
332647|NCT00610727|804880|P6|NOT COMPLETED|Overall Study||0
332648|NCT00610727|804881|P5|NOT COMPLETED|Overall Study||0
332649|NCT00610727|804882|P4|NOT COMPLETED|Overall Study||0
332650|NCT00610727|804883|P3|NOT COMPLETED|Overall Study||0
332651|NCT00610727|804884|P2|NOT COMPLETED|Overall Study||0
332652|NCT00610727|804885|P1|NOT COMPLETED|Overall Study||0
332653|NCT00610727|804880|P6|COMPLETED|Overall Study||8
332654|NCT00610727|804881|P5|COMPLETED|Overall Study||8
332655|NCT00610727|804882|P4|COMPLETED|Overall Study||8
332656|NCT00610727|804883|P3|COMPLETED|Overall Study||8
332657|NCT00610727|804884|P2|COMPLETED|Overall Study||8
332658|NCT00610727|804885|P1|COMPLETED|Overall Study||14
332659|NCT00610727|804880|P6|STARTED|Overall Study||8
332660|NCT00610727|804881|P5|STARTED|Overall Study||8
332661|NCT00610727|804882|P4|STARTED|Overall Study||8
332662|NCT00610727|804883|P3|STARTED|Overall Study||8
332663|NCT00610727|804884|P2|STARTED|Overall Study||8
332664|NCT00610727|804885|P1|STARTED|Overall Study||14
332665|NCT00610714|804905|P2|NOT COMPLETED|Overall Study||24
332666|NCT00610714|804906|P1|NOT COMPLETED|Overall Study||26
332667|NCT00610714|804905|P2|COMPLETED|Overall Study||82
332668|NCT00610714|804906|P1|COMPLETED|Overall Study||79
332669|NCT00610714|804905|P2|STARTED|Overall Study||106
332670|NCT00610714|804906|P1|STARTED|Overall Study||105
332671|NCT00610701|804918|P2|NOT COMPLETED|Overall Study||11
332672|NCT00610701|804919|P1|NOT COMPLETED|Overall Study||10
332673|NCT00610701|804918|P2|COMPLETED|Overall Study||9
332674|NCT00610701|804919|P1|COMPLETED|Overall Study||5
332675|NCT00610701|804918|P2|STARTED|Overall Study||20
332676|NCT00610701|804919|P1|STARTED|Overall Study||15
332677|NCT00610688|804928|P3|NOT COMPLETED|Overall Study||8
332678|NCT00610688|804929|P2|NOT COMPLETED|Overall Study||13
332679|NCT00610688|804930|P1|NOT COMPLETED|Overall Study||9
332680|NCT00610688|804928|P3|COMPLETED|Overall Study||55
332681|NCT00610688|804929|P2|COMPLETED|Overall Study||52
332682|NCT00610688|804930|P1|COMPLETED|Overall Study||55
332683|NCT00610688|804928|P3|STARTED|Overall Study||63
332684|NCT00610688|804929|P2|STARTED|Overall Study||65
332685|NCT00610688|804930|P1|STARTED|Overall Study||64
332686|NCT00610675|804944|P1|NOT COMPLETED|Overall Study||220
332687|NCT00610675|804944|P1|COMPLETED|Overall Study||126
332688|NCT00610675|804944|P1|Treated|Overall Study||342
332689|NCT00610675|804944|P1|STARTED|Overall Study||346
332690|NCT00610649|804966|P11|NOT COMPLETED|Overall Study||1
332691|NCT00610649|804967|P10|NOT COMPLETED|Overall Study||1
332692|NCT00610649|804968|P9|NOT COMPLETED|Overall Study||0
332693|NCT00610649|804969|P8|NOT COMPLETED|Overall Study||0
332694|NCT00610649|804970|P7|NOT COMPLETED|Overall Study||0
332695|NCT00610649|804971|P6|NOT COMPLETED|Overall Study||0
332696|NCT00610649|804972|P5|NOT COMPLETED|Overall Study||0
332697|NCT00610649|804973|P4|NOT COMPLETED|Overall Study||0
332698|NCT00610649|804974|P3|NOT COMPLETED|Overall Study||0
332699|NCT00610649|804975|P2|NOT COMPLETED|Overall Study||1
332700|NCT00610649|804976|P1|NOT COMPLETED|Overall Study||1
332701|NCT00610649|804966|P11|COMPLETED|Overall Study||9
332702|NCT00610649|804967|P10|COMPLETED|Overall Study||9
332703|NCT00610649|804968|P9|COMPLETED|Overall Study||10
332704|NCT00610649|804969|P8|COMPLETED|Overall Study||2
332705|NCT00610649|804970|P7|COMPLETED|Overall Study||4
332706|NCT00610649|804971|P6|COMPLETED|Overall Study||2
332707|NCT00610649|804972|P5|COMPLETED|Overall Study||4
332708|NCT00610649|804973|P4|COMPLETED|Overall Study||2
332709|NCT00610649|804974|P3|COMPLETED|Overall Study||4
332710|NCT00610649|804975|P2|COMPLETED|Overall Study||1
332711|NCT00610649|804976|P1|COMPLETED|Overall Study||3
332712|NCT00610649|804966|P11|STARTED|Overall Study||10
332713|NCT00610649|804967|P10|STARTED|Overall Study||10
332714|NCT00610649|804968|P9|STARTED|Overall Study||10
332715|NCT00610649|804969|P8|STARTED|Overall Study||2
332716|NCT00610649|804970|P7|STARTED|Overall Study||4
332717|NCT00610649|804971|P6|STARTED|Overall Study||2
332718|NCT00610649|804972|P5|STARTED|Overall Study||4
332719|NCT00610649|804973|P4|STARTED|Overall Study||2
332720|NCT00610649|804974|P3|STARTED|Overall Study||4
332721|NCT00610649|804975|P2|STARTED|Overall Study||2
332722|NCT00610649|804976|P1|STARTED|Overall Study||4
332723|NCT00610558|805033|P3|NOT COMPLETED|Overall Study||6
332724|NCT00610558|805034|P2|NOT COMPLETED|Overall Study||6
332725|NCT00610558|805035|P1|NOT COMPLETED|Overall Study||5
332726|NCT00610558|805033|P3|COMPLETED|Overall Study||14
332727|NCT00610558|805034|P2|COMPLETED|Overall Study||14
332728|NCT00610558|805035|P1|COMPLETED|Overall Study||15
332729|NCT00610558|805033|P3|STARTED|Overall Study||20
332730|NCT00610558|805034|P2|STARTED|Overall Study||20
332731|NCT00610558|805035|P1|STARTED|Overall Study||20
332732|NCT00610532|805043|P1|NOT COMPLETED|Intravenous Phenytoin Plus Probenecid||0
332733|NCT00610532|805043|P1|COMPLETED|Intravenous Phenytoin Plus Probenecid||7
332734|NCT00610532|805043|P1|STARTED|Intravenous Phenytoin Plus Probenecid|one participant dropped out between periods|7
332735|NCT00610532|805043|P1|NOT COMPLETED|Intravenous Phenytoin Alone||0
332736|NCT00610532|805043|P1|COMPLETED|Intravenous Phenytoin Alone||8
332737|NCT00610532|805043|P1|STARTED|Intravenous Phenytoin Alone||8
332738|NCT00610441|805053|P4|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
332739|NCT00610441|805054|P3|NOT COMPLETED|Treatment Period 2 - 3 Weeks||0
332740|NCT00610441|805055|P2|NOT COMPLETED|Treatment Period 2 - 3 Weeks||1
332741|NCT00610441|805056|P1|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
332742|NCT00610441|805053|P4|COMPLETED|Treatment Period 2 - 3 Weeks||14
332743|NCT00610441|805054|P3|COMPLETED|Treatment Period 2 - 3 Weeks||9
332744|NCT00610441|805055|P2|COMPLETED|Treatment Period 2 - 3 Weeks||12
332745|NCT00610441|805056|P1|COMPLETED|Treatment Period 2 - 3 Weeks||10
332746|NCT00610441|805053|P4|STARTED|Treatment Period 2 - 3 Weeks||16
332747|NCT00610441|805054|P3|STARTED|Treatment Period 2 - 3 Weeks||9
332748|NCT00610441|805055|P2|STARTED|Treatment Period 2 - 3 Weeks||13
332749|NCT00610441|805056|P1|STARTED|Treatment Period 2 - 3 Weeks||12
332750|NCT00610441|805053|P4|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
332751|NCT00610441|805054|P3|NOT COMPLETED|Placebo Washout Period - 2 Weeks||2
332752|NCT00610441|805055|P2|NOT COMPLETED|Placebo Washout Period - 2 Weeks||1
332753|NCT00610441|805056|P1|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
332754|NCT00610441|805053|P4|COMPLETED|Placebo Washout Period - 2 Weeks||16
332755|NCT00610441|805054|P3|COMPLETED|Placebo Washout Period - 2 Weeks||9
332756|NCT00610441|805055|P2|COMPLETED|Placebo Washout Period - 2 Weeks||13
332757|NCT00610441|805056|P1|COMPLETED|Placebo Washout Period - 2 Weeks||12
332758|NCT00610441|805053|P4|STARTED|Placebo Washout Period - 2 Weeks||16
332759|NCT00610441|805054|P3|STARTED|Placebo Washout Period - 2 Weeks||11
332760|NCT00610441|805055|P2|STARTED|Placebo Washout Period - 2 Weeks||14
332761|NCT00610441|805056|P1|STARTED|Placebo Washout Period - 2 Weeks||12
332762|NCT00610441|805053|P4|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
332763|NCT00610441|805054|P3|NOT COMPLETED|Treatment Period 1 - 3 Weeks||7
332764|NCT00610441|805055|P2|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
332765|NCT00610441|805056|P1|NOT COMPLETED|Treatment Period 1 - 3 Weeks||3
332766|NCT00610441|805053|P4|COMPLETED|Treatment Period 1 - 3 Weeks||16
332767|NCT00610441|805054|P3|COMPLETED|Treatment Period 1 - 3 Weeks||11
332768|NCT00610441|805055|P2|COMPLETED|Treatment Period 1 - 3 Weeks||14
332769|NCT00610441|805056|P1|COMPLETED|Treatment Period 1 - 3 Weeks||12
332770|NCT00610441|805053|P4|STARTED|Treatment Period 1 - 3 Weeks||18
332771|NCT00610441|805054|P3|STARTED|Treatment Period 1 - 3 Weeks||18
332772|NCT00610441|805055|P2|STARTED|Treatment Period 1 - 3 Weeks||16
332773|NCT00610441|805056|P1|STARTED|Treatment Period 1 - 3 Weeks||15
332774|NCT00610428|805150|P3|NOT COMPLETED|Overall Study||2
332775|NCT00610428|805151|P2|NOT COMPLETED|Overall Study||1
332776|NCT00610428|805152|P1|NOT COMPLETED|Overall Study||0
332777|NCT00610428|805150|P3|COMPLETED|Overall Study||25
332778|NCT00610428|805151|P2|COMPLETED|Overall Study||23
332779|NCT00610428|805152|P1|COMPLETED|Overall Study||24
332780|NCT00610428|805150|P3|STARTED|Overall Study||27
332781|NCT00610428|805151|P2|STARTED|Overall Study||24
332782|NCT00610428|805152|P1|STARTED|Overall Study||24
332783|NCT00610363|805165|P2|NOT COMPLETED|Overall Study||3
332784|NCT00610363|805166|P1|NOT COMPLETED|Overall Study||11
332785|NCT00610363|805165|P2|COMPLETED|Overall Study||38
332786|NCT00610363|805166|P1|COMPLETED|Overall Study||31
332787|NCT00610363|805165|P2|STARTED|Overall Study||41
332788|NCT00610363|805166|P1|STARTED|Overall Study||42
332789|NCT00610311|805184|P1|NOT COMPLETED|Overall Study||0
332790|NCT00610311|805184|P1|COMPLETED|Overall Study||3
332791|NCT00610311|805184|P1|STARTED|Overall Study||3
332792|NCT00610207|805191|P1|NOT COMPLETED|Overall Study||3
332793|NCT00610207|805191|P1|COMPLETED|Overall Study||18
332794|NCT00610207|805191|P1|STARTED|Overall Study||21
332795|NCT00610168|805198|P2|NOT COMPLETED|Overall Study||0
332796|NCT00610168|805199|P1|NOT COMPLETED|Overall Study||2
332797|NCT00610168|805198|P2|COMPLETED|Overall Study||7
332798|NCT00610168|805199|P1|COMPLETED|Overall Study||73
332799|NCT00610168|805198|P2|STARTED|Overall Study||7
332800|NCT00610168|805199|P1|STARTED|Overall Study||75
332801|NCT00610155|805218|P6|NOT COMPLETED|Period 3||0
332802|NCT00610155|805219|P5|NOT COMPLETED|Period 3||0
332803|NCT00610155|805220|P4|NOT COMPLETED|Period 3||0
332804|NCT00610155|805221|P3|NOT COMPLETED|Period 3||0
332805|NCT00610155|805222|P2|NOT COMPLETED|Period 3||0
332806|NCT00610155|805223|P1|NOT COMPLETED|Period 3||1
332807|NCT00610155|805218|P6|COMPLETED|Period 3||1
332808|NCT00610155|805219|P5|COMPLETED|Period 3||3
332809|NCT00610155|805220|P4|COMPLETED|Period 3||3
332810|NCT00610155|805221|P3|COMPLETED|Period 3||3
332811|NCT00610155|805222|P2|COMPLETED|Period 3||3
332812|NCT00610155|805223|P1|COMPLETED|Period 3||3
332813|NCT00610155|805218|P6|STARTED|Period 3||1
332814|NCT00610155|805219|P5|STARTED|Period 3||3
332815|NCT00610155|805220|P4|STARTED|Period 3||3
332816|NCT00610155|805221|P3|STARTED|Period 3||3
332817|NCT00610155|805222|P2|STARTED|Period 3||3
332818|NCT00610155|805223|P1|STARTED|Period 3||4
332819|NCT00610155|805218|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
332820|NCT00610155|805219|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
332821|NCT00610155|805220|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
332822|NCT00610155|805221|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
332823|NCT00610155|805222|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
332824|NCT00610155|805223|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
332825|NCT00610155|805218|P6|COMPLETED|Washout Period 2 (7 Days)||1
332826|NCT00610155|805219|P5|COMPLETED|Washout Period 2 (7 Days)||3
332827|NCT00610155|805220|P4|COMPLETED|Washout Period 2 (7 Days)||3
332828|NCT00610155|805221|P3|COMPLETED|Washout Period 2 (7 Days)||3
332829|NCT00610155|805222|P2|COMPLETED|Washout Period 2 (7 Days)||3
332830|NCT00610155|805223|P1|COMPLETED|Washout Period 2 (7 Days)||4
332831|NCT00610155|805218|P6|STARTED|Washout Period 2 (7 Days)||1
332832|NCT00610155|805219|P5|STARTED|Washout Period 2 (7 Days)||3
332833|NCT00610155|805220|P4|STARTED|Washout Period 2 (7 Days)||3
332834|NCT00610155|805221|P3|STARTED|Washout Period 2 (7 Days)||3
332835|NCT00610155|805222|P2|STARTED|Washout Period 2 (7 Days)||3
332836|NCT00610155|805223|P1|STARTED|Washout Period 2 (7 Days)||4
332837|NCT00610155|805218|P6|NOT COMPLETED|Period 2||0
332838|NCT00610155|805219|P5|NOT COMPLETED|Period 2||0
332839|NCT00610155|805220|P4|NOT COMPLETED|Period 2||0
332840|NCT00610155|805221|P3|NOT COMPLETED|Period 2||0
332841|NCT00610155|805222|P2|NOT COMPLETED|Period 2||0
332842|NCT00610155|805223|P1|NOT COMPLETED|Period 2||0
332843|NCT00610155|805218|P6|COMPLETED|Period 2||1
332844|NCT00610155|805219|P5|COMPLETED|Period 2||3
332845|NCT00610155|805220|P4|COMPLETED|Period 2||3
332846|NCT00610155|805221|P3|COMPLETED|Period 2||3
332847|NCT00610155|805222|P2|COMPLETED|Period 2||3
332848|NCT00610155|805223|P1|COMPLETED|Period 2||4
332849|NCT00610155|805218|P6|STARTED|Period 2||1
332850|NCT00610155|805219|P5|STARTED|Period 2||3
332851|NCT00610155|805220|P4|STARTED|Period 2||3
332852|NCT00610155|805221|P3|STARTED|Period 2||3
332853|NCT00610155|805222|P2|STARTED|Period 2||3
332854|NCT00610155|805223|P1|STARTED|Period 2||4
332855|NCT00610155|805218|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
332856|NCT00610155|805219|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
332857|NCT00610155|805220|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
332858|NCT00610155|805221|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
332859|NCT00610155|805222|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
332860|NCT00610155|805223|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
332861|NCT00610155|805218|P6|COMPLETED|Washout Period 1 (7 Days)||1
332862|NCT00610155|805219|P5|COMPLETED|Washout Period 1 (7 Days)||3
332863|NCT00610155|805220|P4|COMPLETED|Washout Period 1 (7 Days)||3
332864|NCT00610155|805221|P3|COMPLETED|Washout Period 1 (7 Days)||3
332865|NCT00610155|805222|P2|COMPLETED|Washout Period 1 (7 Days)||3
332866|NCT00610155|805223|P1|COMPLETED|Washout Period 1 (7 Days)||4
332867|NCT00610155|805218|P6|STARTED|Washout Period 1 (7 Days)||1
332868|NCT00610155|805219|P5|STARTED|Washout Period 1 (7 Days)||3
332869|NCT00610155|805220|P4|STARTED|Washout Period 1 (7 Days)||3
332870|NCT00610155|805221|P3|STARTED|Washout Period 1 (7 Days)||3
332871|NCT00610155|805222|P2|STARTED|Washout Period 1 (7 Days)||3
332872|NCT00610155|805223|P1|STARTED|Washout Period 1 (7 Days)||4
332873|NCT00610155|805218|P6|NOT COMPLETED|Period 1||0
332874|NCT00610155|805219|P5|NOT COMPLETED|Period 1||0
332875|NCT00610155|805220|P4|NOT COMPLETED|Period 1||0
332876|NCT00610155|805221|P3|NOT COMPLETED|Period 1||1
332877|NCT00610155|805222|P2|NOT COMPLETED|Period 1||0
332878|NCT00610155|805223|P1|NOT COMPLETED|Period 1||0
332879|NCT00610155|805218|P6|COMPLETED|Period 1||1
332880|NCT00610155|805219|P5|COMPLETED|Period 1||3
332881|NCT00610155|805220|P4|COMPLETED|Period 1||3
332882|NCT00610155|805221|P3|COMPLETED|Period 1||3
332883|NCT00610155|805222|P2|COMPLETED|Period 1||3
332884|NCT00610155|805223|P1|COMPLETED|Period 1||4
332885|NCT00610155|805218|P6|STARTED|Period 1||1
332886|NCT00610155|805219|P5|STARTED|Period 1||3
332887|NCT00610155|805220|P4|STARTED|Period 1||3
332888|NCT00610155|805221|P3|STARTED|Period 1||4
332889|NCT00610155|805222|P2|STARTED|Period 1||3
332890|NCT00610155|805223|P1|STARTED|Period 1||4
332891|NCT00610129|805270|P1|NOT COMPLETED|Overall Study||3
332892|NCT00610129|805270|P1|COMPLETED|Overall Study||25
332893|NCT00610129|805270|P1|STARTED|Overall Study||28
332894|NCT00609986|805276|P2|NOT COMPLETED|Overall Study||3
332895|NCT00609986|805277|P1|NOT COMPLETED|Overall Study||8
332896|NCT00609986|805276|P2|COMPLETED|Overall Study||49
332897|NCT00609986|805277|P1|COMPLETED|Overall Study||44
332898|NCT00609986|805276|P2|Received Transplant|Overall Study||49
332899|NCT00609986|805277|P1|Received Transplant|Overall Study||44
332900|NCT00609986|805276|P2|STARTED|Overall Study||52
332901|NCT00609986|805277|P1|STARTED|Overall Study||52
332902|NCT00609973|805291|P2|NOT COMPLETED|Overall Study||6
332903|NCT00609973|805292|P1|NOT COMPLETED|Overall Study||8
332904|NCT00609973|805291|P2|COMPLETED|Overall Study||10
332905|NCT00609973|805292|P1|COMPLETED|Overall Study||9
332906|NCT00609973|805291|P2|STARTED|Overall Study||16
332907|NCT00609973|805292|P1|STARTED|Overall Study||17
332908|NCT00609947|805300|P1|NOT COMPLETED|Overall Study||1
332909|NCT00609947|805300|P1|COMPLETED|Overall Study|One death due to automobile accident.|240
332910|NCT00609947|805300|P1|STARTED|Overall Study||241
332911|NCT00609869|805305|P1|NOT COMPLETED|Overall Study||11
332912|NCT00609869|805305|P1|COMPLETED|Overall Study||18
332913|NCT00609869|805305|P1|STARTED|Overall Study||29
332914|NCT00609804|805313|P2|NOT COMPLETED|Overall Study||28
332915|NCT00609804|805314|P1|NOT COMPLETED|Overall Study||25
332916|NCT00609804|805313|P2|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
332917|NCT00609804|805314|P1|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
332918|NCT00609804|805313|P2|STARTED|Overall Study||28
332919|NCT00609804|805314|P1|STARTED|Overall Study||25
332920|NCT00609765|805324|P1|NOT COMPLETED|Overall Study||1
332921|NCT00609765|805324|P1|COMPLETED|Overall Study||0
332922|NCT00609765|805324|P1|STARTED|Overall Study||1
332923|NCT00609739|805329|P1|NOT COMPLETED|Overall Study||0
332924|NCT00609739|805329|P1|COMPLETED|Overall Study||1
332925|NCT00609739|805329|P1|STARTED|Overall Study||1
332926|NCT00609674|805338|P2|NOT COMPLETED|Overall Study||7
332927|NCT00609674|805339|P1|NOT COMPLETED|Overall Study||7
332928|NCT00609674|805338|P2|COMPLETED|Overall Study||153
332929|NCT00609674|805339|P1|COMPLETED|Overall Study||148
332930|NCT00609674|805338|P2|STARTED|Overall Study||160
332931|NCT00609674|805339|P1|STARTED|Overall Study||155
332932|NCT00609622|805375|P2|NOT COMPLETED|Overall Study||95
332933|NCT00609622|805376|P1|NOT COMPLETED|Overall Study||96
332934|NCT00609622|805375|P2|COMPLETED|Overall Study||0
332935|NCT00609622|805376|P1|COMPLETED|Overall Study||0
332936|NCT00609622|805375|P2|STARTED|Overall Study||95
332937|NCT00609622|805376|P1|STARTED|Overall Study||96
332938|NCT00609609|805398|P2|NOT COMPLETED|Overall Study||2
332939|NCT00609609|805399|P1|NOT COMPLETED|Overall Study||6
332940|NCT00609609|805398|P2|COMPLETED|Overall Study||49
332941|NCT00609609|805399|P1|COMPLETED|Overall Study||24
332942|NCT00609609|805398|P2|STARTED|Overall Study||51
332943|NCT00609609|805399|P1|STARTED|Overall Study||30
332944|NCT00609518|805411|P2|NOT COMPLETED|Overall Study||40
332945|NCT00609518|805412|P1|NOT COMPLETED|Overall Study||43
332946|NCT00609518|805411|P2|COMPLETED|Overall Study||17
332947|NCT00609518|805412|P1|COMPLETED|Overall Study||11
332948|NCT00609518|805411|P2|Completed 6 Treatment Cycles|Overall Study||22
332949|NCT00609518|805412|P1|Completed 6 Treatment Cycles|Overall Study||19
332950|NCT00609518|805411|P2|STARTED|Overall Study||57
332951|NCT00609518|805412|P1|STARTED|Overall Study||54
332952|NCT00609492|805427|P3|NOT COMPLETED|Overall Study||7
332953|NCT00609492|805428|P2|NOT COMPLETED|Overall Study||3
332954|NCT00609492|805429|P1|NOT COMPLETED|Overall Study||1
332955|NCT00609492|805427|P3|COMPLETED|Overall Study||122
332956|NCT00609492|805428|P2|COMPLETED|Overall Study||69
332957|NCT00609492|805429|P1|COMPLETED|Overall Study||43
332958|NCT00609492|805427|P3|STARTED|Overall Study||129
332959|NCT00609492|805428|P2|STARTED|Overall Study||72
332960|NCT00609492|805429|P1|STARTED|Overall Study||44
332961|NCT00609466|805514|P3|NOT COMPLETED|Overall Study||4
332962|NCT00609466|805515|P2|NOT COMPLETED|Overall Study||6
332963|NCT00609466|805516|P1|NOT COMPLETED|Overall Study||2
332964|NCT00609466|805514|P3|COMPLETED|Overall Study||95
332965|NCT00609466|805515|P2|COMPLETED|Overall Study||90
332966|NCT00609466|805516|P1|COMPLETED|Overall Study||94
332967|NCT00609466|805514|P3|STARTED|Overall Study||99
332968|NCT00609466|805515|P2|STARTED|Overall Study||96
332969|NCT00609466|805516|P1|STARTED|Overall Study||96
332970|NCT00609362|805544|P2|NOT COMPLETED|Overall Study||1
332971|NCT00609362|805545|P1|NOT COMPLETED|Overall Study||3
332972|NCT00609362|805544|P2|COMPLETED|Overall Study||27
332973|NCT00609362|805545|P1|COMPLETED|Overall Study||26
332974|NCT00609362|805544|P2|STARTED|Overall Study||28
332975|NCT00609362|805545|P1|STARTED|Overall Study||29
332976|NCT00609336|805555|P1|NOT COMPLETED|Overall Study||13
332977|NCT00609336|805555|P1|COMPLETED|Overall Study||22
332978|NCT00609336|805555|P1|Surgery|Overall Study||22
332979|NCT00609336|805555|P1|STARTED|Overall Study||35
332980|NCT00609271|805569|P2|NOT COMPLETED|Overall Study||13
332981|NCT00609271|805570|P1|NOT COMPLETED|Overall Study||16
332982|NCT00609271|805569|P2|COMPLETED|Overall Study||60
332983|NCT00609271|805570|P1|COMPLETED|Overall Study||59
332984|NCT00609271|805569|P2|STARTED|Overall Study||73
332985|NCT00609271|805570|P1|STARTED|Overall Study||75
332986|NCT00609245|805606|P1|NOT COMPLETED|Overall Study||1
332987|NCT00609245|805606|P1|COMPLETED|Overall Study||12
332988|NCT00609245|805606|P1|STARTED|Overall Study||13
332989|NCT00609167|805614|P2|NOT COMPLETED|Overall Study||7
332990|NCT00609167|805615|P1|NOT COMPLETED|Overall Study||8
332991|NCT00609167|805614|P2|COMPLETED|Overall Study||23
332992|NCT00609167|805615|P1|COMPLETED|Overall Study||25
332993|NCT00609167|805614|P2|STARTED|Overall Study||30
332994|NCT00609167|805615|P1|STARTED|Overall Study||33
332995|NCT00609128|805637|P1|NOT COMPLETED|Overall Study||0
332996|NCT00609128|805637|P1|COMPLETED|Overall Study||21
332997|NCT00609128|805637|P1|STARTED|Overall Study||21
332998|NCT00608985|805646|P4|NOT COMPLETED|Overall Study||9
332999|NCT00608985|805647|P3|NOT COMPLETED|Overall Study||6
333000|NCT00608985|805648|P2|NOT COMPLETED|Overall Study||13
333001|NCT00608985|805649|P1|NOT COMPLETED|Overall Study||16
333002|NCT00608985|805646|P4|COMPLETED|Overall Study|Completed follow-up|159
333003|NCT00608985|805647|P3|COMPLETED|Overall Study|Completed follow-up|170
333004|NCT00608985|805648|P2|COMPLETED|Overall Study|Completed follow-up|173
333005|NCT00608985|805649|P1|COMPLETED|Overall Study|Completed follow-up|161
333006|NCT00608985|805646|P4|Completed Double-blind Treatment|Overall Study||161
333007|NCT00608985|805647|P3|Completed Double-blind Treatment|Overall Study||171
333008|NCT00608985|805648|P2|Completed Double-blind Treatment|Overall Study||174
333009|NCT00608985|805649|P1|Completed Double-blind Treatment|Overall Study||163
333010|NCT00608985|805646|P4|STARTED|Overall Study|Randomized and started double-blind treatment|168
333011|NCT00608985|805647|P3|STARTED|Overall Study|Randomized and started double-blind treatment|176
333012|NCT00608985|805648|P2|STARTED|Overall Study|Randomized and started double-blind treatment|186
333013|NCT00608985|805649|P1|STARTED|Overall Study|Randomized and started double-blind treatment|177
333014|NCT00608959|805681|P1|NOT COMPLETED|Part 2||0
333015|NCT00608959|805681|P1|COMPLETED|Part 2||25
333016|NCT00608959|805681|P1|STARTED|Part 2|20 Part 1 subjects also participated in Part 2.Five more subjects were enrolled for a total of 25.|25
333017|NCT00608959|805681|P1|NOT COMPLETED|Part 1||1
333018|NCT00608959|805681|P1|COMPLETED|Part 1||24
333019|NCT00608959|805681|P1|STARTED|Part 1|25 subjects each participated in Parts 1 and 2 .A total of 20 subjects participated in both parts.|25
333020|NCT00608907|805694|P3|NOT COMPLETED|Overall Study||1
333021|NCT00608907|805695|P2|NOT COMPLETED|Overall Study||0
333022|NCT00608907|805696|P1|NOT COMPLETED|Overall Study||12
333023|NCT00608907|805694|P3|COMPLETED|Overall Study||17
333024|NCT00608907|805695|P2|COMPLETED|Overall Study||13
333025|NCT00608907|805696|P1|COMPLETED|Overall Study||18
333026|NCT00608907|805694|P3|STARTED|Overall Study||18
333027|NCT00608907|805695|P2|STARTED|Overall Study||13
333028|NCT00608907|805696|P1|STARTED|Overall Study||30
333029|NCT00608881|805706|P2|NOT COMPLETED|Overall Study||66
333030|NCT00608881|805707|P1|NOT COMPLETED|Overall Study||79
333031|NCT00608881|805706|P2|COMPLETED|Overall Study||240
333032|NCT00608881|805707|P1|COMPLETED|Overall Study||224
333033|NCT00608881|805706|P2|STARTED|Overall Study||306
333034|NCT00608881|805707|P1|STARTED|Overall Study||303
333035|NCT00608868|805741|P1|NOT COMPLETED|Overall Study||15
333036|NCT00608868|805741|P1|COMPLETED|Overall Study||141
333037|NCT00608868|805741|P1|Per Protocol (PP) Population|Overall Study||121
333038|NCT00608868|805741|P1|Intention to Treat (ITT) Population|Overall Study|8 patients who had no target lesion and 8 who had no tumor assessment after baseline were excluded|138
333039|NCT00608868|805741|P1|Treatment Completed|Overall Study||141
333040|NCT00608868|805741|P1|Safety Population|Overall Study|2 patients who received no study treatment were excluded|154
333041|NCT00608868|805741|P1|Enrolled|Overall Study||156
333042|NCT00608868|805741|P1|STARTED|Overall Study||156
333043|NCT00608842|805752|P4|NOT COMPLETED|Overall Study||1
333044|NCT00608842|805753|P3|NOT COMPLETED|Overall Study||2
333045|NCT00608842|805754|P2|NOT COMPLETED|Overall Study||1
333046|NCT00608842|805755|P1|NOT COMPLETED|Overall Study||1
333047|NCT00608842|805752|P4|COMPLETED|Overall Study||16
333048|NCT00608842|805753|P3|COMPLETED|Overall Study||13
333049|NCT00608842|805754|P2|COMPLETED|Overall Study||14
333050|NCT00608842|805755|P1|COMPLETED|Overall Study||14
333051|NCT00608842|805752|P4|STARTED|Overall Study||17
333052|NCT00608842|805753|P3|STARTED|Overall Study||15
333053|NCT00608842|805754|P2|STARTED|Overall Study||15
333054|NCT00608842|805755|P1|STARTED|Overall Study||15
333055|NCT00608829|805789|P1|NOT COMPLETED|Overall Study||15
333056|NCT00608829|805789|P1|COMPLETED|Overall Study||8
333057|NCT00608829|805789|P1|STARTED|Overall Study||23
333058|NCT00608777|805793|P1|NOT COMPLETED|Overall Study||0
333059|NCT00608777|805793|P1|COMPLETED|Overall Study||6
333060|NCT00608777|805793|P1|STARTED|Overall Study||6
333061|NCT00608634|805800|P3|NOT COMPLETED|Overall Study||1
333062|NCT00608634|805801|P2|NOT COMPLETED|Overall Study||1
333063|NCT00608634|805802|P1|NOT COMPLETED|Overall Study||2
333064|NCT00608634|805800|P3|COMPLETED|Overall Study||27
333065|NCT00608634|805801|P2|COMPLETED|Overall Study||26
333066|NCT00608634|805802|P1|COMPLETED|Overall Study||26
333067|NCT00608634|805800|P3|STARTED|Overall Study||28
333068|NCT00608634|805801|P2|STARTED|Overall Study||27
333069|NCT00608634|805802|P1|STARTED|Overall Study||28
333070|NCT00608582|805815|P2|NOT COMPLETED|Overall Study||4
333071|NCT00608582|805816|P1|NOT COMPLETED|Overall Study||4
333072|NCT00608582|805815|P2|COMPLETED|Overall Study||7
333073|NCT00608582|805816|P1|COMPLETED|Overall Study||10
333074|NCT00608582|805815|P2|STARTED|Overall Study||11
333075|NCT00608582|805816|P1|STARTED|Overall Study||14
333076|NCT00608569|805826|P2|NOT COMPLETED|Overall Study||9
333077|NCT00608569|805827|P1|NOT COMPLETED|Overall Study||10
333078|NCT00608569|805826|P2|COMPLETED|Overall Study||119
333079|NCT00608569|805827|P1|COMPLETED|Overall Study||119
333080|NCT00608569|805826|P2|STARTED|Overall Study||128
333081|NCT00608569|805827|P1|STARTED|Overall Study||129
333082|NCT00608543|805847|P1|NOT COMPLETED|Overall Study||4
333083|NCT00608543|805847|P1|COMPLETED|Overall Study||13
333084|NCT00608543|805847|P1|STARTED|Overall Study||17
333085|NCT00608530|805860|P4|NOT COMPLETED|Study 2 Nurse-delivered Treatments||7
333086|NCT00608530|805861|P3|NOT COMPLETED|Study 2 Nurse-delivered Treatments||12
333087|NCT00608530|805862|P2|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
333088|NCT00608530|805863|P1|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
333089|NCT00608530|805860|P4|COMPLETED|Study 2 Nurse-delivered Treatments||27
333090|NCT00608530|805861|P3|COMPLETED|Study 2 Nurse-delivered Treatments||21
333091|NCT00608530|805862|P2|COMPLETED|Study 2 Nurse-delivered Treatments||0
333092|NCT00608530|805863|P1|COMPLETED|Study 2 Nurse-delivered Treatments||0
333093|NCT00608530|805860|P4|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||31
333094|NCT00608530|805861|P3|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||30
333095|NCT00608530|805862|P2|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
333096|NCT00608530|805863|P1|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
333097|NCT00608530|805860|P4|STARTED|Study 2 Nurse-delivered Treatments||34
333098|NCT00608530|805861|P3|STARTED|Study 2 Nurse-delivered Treatments||33
333099|NCT00608530|805862|P2|STARTED|Study 2 Nurse-delivered Treatments||0
333100|NCT00608530|805863|P1|STARTED|Study 2 Nurse-delivered Treatments||0
333101|NCT00608530|805860|P4|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
333102|NCT00608530|805861|P3|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
333103|NCT00608530|805862|P2|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||5
333104|NCT00608530|805863|P1|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||11
333105|NCT00608530|805860|P4|COMPLETED|Study 1 Psychologist-delivered Treatment||0
333106|NCT00608530|805861|P3|COMPLETED|Study 1 Psychologist-delivered Treatment||0
333107|NCT00608530|805862|P2|COMPLETED|Study 1 Psychologist-delivered Treatment||28
333108|NCT00608530|805863|P1|COMPLETED|Study 1 Psychologist-delivered Treatment||22
333109|NCT00608530|805860|P4|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
333110|NCT00608530|805861|P3|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
333111|NCT00608530|805862|P2|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||31
333112|NCT00608530|805863|P1|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||28
333113|NCT00608530|805860|P4|STARTED|Study 1 Psychologist-delivered Treatment||0
333114|NCT00608530|805861|P3|STARTED|Study 1 Psychologist-delivered Treatment||0
333115|NCT00608530|805862|P2|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
333116|NCT00608530|805863|P1|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
333117|NCT00608517|805884|P3|NOT COMPLETED|Overall Study||0
333118|NCT00608517|805885|P2|NOT COMPLETED|Overall Study||0
333119|NCT00608517|805886|P1|NOT COMPLETED|Overall Study||1
333120|NCT00608517|805884|P3|COMPLETED|Overall Study||1
333121|NCT00608517|805885|P2|COMPLETED|Overall Study||3
333122|NCT00608517|805886|P1|COMPLETED|Overall Study||1
333123|NCT00608517|805884|P3|STARTED|Overall Study||1
333124|NCT00608517|805885|P2|STARTED|Overall Study||3
333125|NCT00608517|805886|P1|STARTED|Overall Study||2
333126|NCT00608491|805914|P2|NOT COMPLETED|Overall Study||22
333127|NCT00608491|805915|P1|NOT COMPLETED|Overall Study||21
333128|NCT00608491|805914|P2|COMPLETED|Overall Study||72
333129|NCT00608491|805915|P1|COMPLETED|Overall Study||73
333130|NCT00608491|805914|P2|STARTED|Overall Study||94
333131|NCT00608491|805915|P1|STARTED|Overall Study||94
333132|NCT00608465|806059|P1|NOT COMPLETED|Overall Study||0
333133|NCT00608465|806059|P1|COMPLETED|Overall Study||4
333134|NCT00608465|806059|P1|STARTED|Overall Study||4
333135|NCT00608426|806066|P2|NOT COMPLETED|Overall Study||905
333136|NCT00608426|806067|P1|NOT COMPLETED|Overall Study||836
333137|NCT00608426|806066|P2|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1614
333138|NCT00608426|806067|P1|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1768
333139|NCT00608426|806066|P2|STARTED|Overall Study||2519
333140|NCT00608426|806067|P1|STARTED|Overall Study||2604
333141|NCT00608322|806079|P2|NOT COMPLETED|Overall Study||1
333142|NCT00608322|806080|P1|NOT COMPLETED|Overall Study||2
333143|NCT00608322|806079|P2|COMPLETED|Overall Study||22
333144|NCT00608322|806080|P1|COMPLETED|Overall Study||24
333145|NCT00608322|806079|P2|STARTED|Overall Study||23
333146|NCT00608322|806080|P1|STARTED|Overall Study||26
333147|NCT00608244|806086|P1|NOT COMPLETED|Overall Study||2
333148|NCT00608244|806086|P1|COMPLETED|Overall Study||57
333149|NCT00608244|806086|P1|STARTED|Overall Study||59
333150|NCT00608205|806097|P2|NOT COMPLETED|Overall Study||3
333151|NCT00608205|806098|P1|NOT COMPLETED|Overall Study||3
333152|NCT00608205|806097|P2|COMPLETED|Overall Study||31
333153|NCT00608205|806098|P1|COMPLETED|Overall Study||32
333154|NCT00608205|806097|P2|STARTED|Overall Study||34
333155|NCT00608205|806098|P1|STARTED|Overall Study||35
333156|NCT00608140|806188|P2|NOT COMPLETED|Overall Study||1
333157|NCT00608140|806189|P1|NOT COMPLETED|Overall Study||1
333158|NCT00608140|806188|P2|COMPLETED|Overall Study|Study ended early due to low enrollment|0
333159|NCT00608140|806189|P1|COMPLETED|Overall Study|Study ended early due to low enrollment|0
333160|NCT00608140|806188|P2|STARTED|Overall Study||1
333161|NCT00608140|806189|P1|STARTED|Overall Study||1
333162|NCT00608023|806215|P3|NOT COMPLETED|Overall Study||14
333163|NCT00608023|806216|P2|NOT COMPLETED|Overall Study||22
333164|NCT00608023|806217|P1|NOT COMPLETED|Overall Study||12
333165|NCT00608023|806215|P3|COMPLETED|Overall Study||72
333166|NCT00608023|806216|P2|COMPLETED|Overall Study||63
333167|NCT00608023|806217|P1|COMPLETED|Overall Study||80
333168|NCT00608023|806215|P3|STARTED|Overall Study||86
333169|NCT00608023|806216|P2|STARTED|Overall Study||85
333170|NCT00608023|806217|P1|STARTED|Overall Study||92
333171|NCT00607997|806241|P4|NOT COMPLETED|Overall Study||16
333172|NCT00607997|806242|P3|NOT COMPLETED|Overall Study||24
333173|NCT00607997|806243|P2|NOT COMPLETED|Overall Study||27
333174|NCT00607997|806244|P1|NOT COMPLETED|Overall Study||27
333175|NCT00607997|806241|P4|COMPLETED|Overall Study||4
333176|NCT00607997|806242|P3|COMPLETED|Overall Study||5
333177|NCT00607997|806243|P2|COMPLETED|Overall Study||8
333178|NCT00607997|806244|P1|COMPLETED|Overall Study||2
333179|NCT00607997|806241|P4|STARTED|Overall Study||20
333180|NCT00607997|806242|P3|STARTED|Overall Study||29
333181|NCT00607997|806243|P2|STARTED|Overall Study||35
333182|NCT00607997|806244|P1|STARTED|Overall Study||29
333183|NCT00607919|806302|P2|NOT COMPLETED|Open-Label Phase||12
333184|NCT00607919|806303|P1|NOT COMPLETED|Open-Label Phase||10
333185|NCT00607919|806302|P2|COMPLETED|Open-Label Phase||59
333186|NCT00607919|806303|P1|COMPLETED|Open-Label Phase||74
333187|NCT00607919|806302|P2|STARTED|Open-Label Phase||71
333188|NCT00607919|806303|P1|STARTED|Open-Label Phase||84
333189|NCT00607919|806302|P2|NOT COMPLETED|Acute Phase||16
333190|NCT00607919|806303|P1|NOT COMPLETED|Acute Phase||34
333191|NCT00607919|806302|P2|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|73
333192|NCT00607919|806303|P1|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|86
333193|NCT00607919|806302|P2|STARTED|Acute Phase||89
333194|NCT00607919|806303|P1|STARTED|Acute Phase||120
333195|NCT00607893|806361|P2|NOT COMPLETED|Overall Study||4
333196|NCT00607893|806362|P1|NOT COMPLETED|Overall Study||6
333197|NCT00607893|806361|P2|COMPLETED|Overall Study||72
333198|NCT00607893|806362|P1|COMPLETED|Overall Study||71
333199|NCT00607893|806361|P2|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|29
333200|NCT00607893|806362|P1|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|0
333201|NCT00607893|806361|P2|Completed 8 Week Visit|Overall Study||72
333202|NCT00607893|806362|P1|Completed 8 Week Visit|Overall Study||71
333203|NCT00607893|806361|P2|Completed Baseline Visit|Overall Study||75
333204|NCT00607893|806362|P1|Completed Baseline Visit|Overall Study||74
333205|NCT00607893|806361|P2|STARTED|Overall Study||76
333206|NCT00607893|806362|P1|STARTED|Overall Study||77
333207|NCT00607880|806390|P2|NOT COMPLETED|Overall Study||0
333208|NCT00607880|806391|P1|NOT COMPLETED|Overall Study||1
333209|NCT00607880|806390|P2|COMPLETED|Overall Study||50
333210|NCT00607880|806391|P1|COMPLETED|Overall Study||49
333211|NCT00607880|806390|P2|STARTED|Overall Study||50
333212|NCT00607880|806391|P1|STARTED|Overall Study||50
333213|NCT00607867|806405|P2|NOT COMPLETED|Overall Study||0
333214|NCT00607867|806406|P1|NOT COMPLETED|Overall Study||0
333215|NCT00607867|806405|P2|COMPLETED|Overall Study||7
333216|NCT00607867|806406|P1|COMPLETED|Overall Study||7
333217|NCT00607867|806405|P2|STARTED|Overall Study||7
333218|NCT00607867|806406|P1|STARTED|Overall Study||7
333219|NCT00607815|806424|P2|NOT COMPLETED|Overall Study||11
333220|NCT00607815|806425|P1|NOT COMPLETED|Overall Study||23
333221|NCT00607815|806424|P2|COMPLETED|Overall Study||25
333222|NCT00607815|806425|P1|COMPLETED|Overall Study||20
333223|NCT00607815|806424|P2|STARTED|Overall Study||36
333224|NCT00607815|806425|P1|STARTED|Overall Study||43
333225|NCT00607789|806441|P2|NOT COMPLETED|Overall Study||6
333226|NCT00607789|806442|P1|NOT COMPLETED|Overall Study||7
333227|NCT00607789|806441|P2|COMPLETED|Overall Study||14
333228|NCT00607789|806442|P1|COMPLETED|Overall Study||13
333229|NCT00607789|806441|P2|STARTED|Overall Study||20
333230|NCT00607789|806442|P1|STARTED|Overall Study|20 participants were randomized in each group|20
333231|NCT00607724|806457|P7|NOT COMPLETED|Stage 2: Expanded Cohort||11
333232|NCT00607724|806458|P6|NOT COMPLETED|Stage 2: Expanded Cohort||12
333233|NCT00607724|806459|P5|NOT COMPLETED|Stage 2: Expanded Cohort||9
333234|NCT00607724|806460|P4|NOT COMPLETED|Stage 2: Expanded Cohort||5
333235|NCT00607724|806461|P3|NOT COMPLETED|Stage 2: Expanded Cohort||0
333236|NCT00607724|806462|P2|NOT COMPLETED|Stage 2: Expanded Cohort||0
333237|NCT00607724|806463|P1|NOT COMPLETED|Stage 2: Expanded Cohort||0
333238|NCT00607724|806457|P7|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered ‘completers’.|5
333239|NCT00607724|806458|P6|COMPLETED|Stage 2: Expanded Cohort||0
333240|NCT00607724|806459|P5|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered ‘completers’.|5
333241|NCT00607724|806460|P4|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered ‘completers’.|1
333242|NCT00607724|806461|P3|COMPLETED|Stage 2: Expanded Cohort||0
333243|NCT00607724|806462|P2|COMPLETED|Stage 2: Expanded Cohort||0
333244|NCT00607724|806463|P1|COMPLETED|Stage 2: Expanded Cohort||0
333245|NCT00607724|806457|P7|STARTED|Stage 2: Expanded Cohort||16
333246|NCT00607724|806458|P6|STARTED|Stage 2: Expanded Cohort||12
333247|NCT00607724|806459|P5|STARTED|Stage 2: Expanded Cohort||14
333248|NCT00607724|806460|P4|STARTED|Stage 2: Expanded Cohort||6
333249|NCT00607724|806461|P3|STARTED|Stage 2: Expanded Cohort||0
333250|NCT00607724|806462|P2|STARTED|Stage 2: Expanded Cohort||0
333251|NCT00607724|806463|P1|STARTED|Stage 2: Expanded Cohort||0
333252|NCT00607724|806457|P7|NOT COMPLETED|Stage 1: Dose Escalation||0
333253|NCT00607724|806458|P6|NOT COMPLETED|Stage 1: Dose Escalation||0
333254|NCT00607724|806459|P5|NOT COMPLETED|Stage 1: Dose Escalation||0
333255|NCT00607724|806460|P4|NOT COMPLETED|Stage 1: Dose Escalation||0
333256|NCT00607724|806461|P3|NOT COMPLETED|Stage 1: Dose Escalation||4
333257|NCT00607724|806462|P2|NOT COMPLETED|Stage 1: Dose Escalation||8
333258|NCT00607724|806463|P1|NOT COMPLETED|Stage 1: Dose Escalation||7
333259|NCT00607724|806457|P7|COMPLETED|Stage 1: Dose Escalation||0
333260|NCT00607724|806458|P6|COMPLETED|Stage 1: Dose Escalation||0
333261|NCT00607724|806459|P5|COMPLETED|Stage 1: Dose Escalation||0
333262|NCT00607724|806460|P4|COMPLETED|Stage 1: Dose Escalation||0
333263|NCT00607724|806461|P3|COMPLETED|Stage 1: Dose Escalation||0
333264|NCT00607724|806462|P2|COMPLETED|Stage 1: Dose Escalation|Participants still on treatment at time of study closure were considered ‘completers’.|1
333265|NCT00607724|806463|P1|COMPLETED|Stage 1: Dose Escalation||0
333266|NCT00607724|806457|P7|STARTED|Stage 1: Dose Escalation||0
333267|NCT00607724|806458|P6|STARTED|Stage 1: Dose Escalation||0
333268|NCT00607724|806459|P5|STARTED|Stage 1: Dose Escalation||0
333269|NCT00607724|806460|P4|STARTED|Stage 1: Dose Escalation||0
333270|NCT00607724|806461|P3|STARTED|Stage 1: Dose Escalation||4
333271|NCT00607724|806462|P2|STARTED|Stage 1: Dose Escalation||9
333272|NCT00607724|806463|P1|STARTED|Stage 1: Dose Escalation||7
333273|NCT00607672|806542|P3|NOT COMPLETED|Overall Study||5
333274|NCT00607672|806543|P2|NOT COMPLETED|Overall Study||3
333275|NCT00607672|806544|P1|NOT COMPLETED|Overall Study||4
333276|NCT00607672|806542|P3|COMPLETED|Overall Study||22
333277|NCT00607672|806543|P2|COMPLETED|Overall Study||24
333278|NCT00607672|806544|P1|COMPLETED|Overall Study||28
333279|NCT00607672|806542|P3|STARTED|Overall Study||27
333280|NCT00607672|806543|P2|STARTED|Overall Study||27
333281|NCT00607672|806544|P1|STARTED|Overall Study||32
333282|NCT00607620|806590|P2|NOT COMPLETED|Overall Study||0
333283|NCT00607620|806591|P1|NOT COMPLETED|Overall Study||0
333284|NCT00607620|806590|P2|COMPLETED|Overall Study||469
333285|NCT00607620|806591|P1|COMPLETED|Overall Study||409
333286|NCT00607620|806590|P2|STARTED|Overall Study||469
333287|NCT00607620|806591|P1|STARTED|Overall Study||409
333288|NCT00607594|806605|P1|NOT COMPLETED|Overall Study||0
333289|NCT00607594|806605|P1|COMPLETED|Overall Study||21
333290|NCT00607594|806605|P1|STARTED|Overall Study||21
333291|NCT00607477|806619|P2|NOT COMPLETED|Overall Study||0
333292|NCT00607477|806620|P1|NOT COMPLETED|Overall Study||0
333293|NCT00607477|806619|P2|COMPLETED|Overall Study||2
333294|NCT00607477|806620|P1|COMPLETED|Overall Study||0
333295|NCT00607477|806619|P2|STARTED|Overall Study||2
333296|NCT00607477|806620|P1|STARTED|Overall Study||0
333297|NCT00607386|806626|P1|NOT COMPLETED|Overall Study||1
333298|NCT00607386|806626|P1|COMPLETED|Overall Study||27
333299|NCT00607386|806626|P1|STARTED|Overall Study||28
333300|NCT00607373|806641|P2|NOT COMPLETED|Follow-up Period||5
333301|NCT00607373|806642|P1|NOT COMPLETED|Follow-up Period||1
333302|NCT00607373|806641|P2|COMPLETED|Follow-up Period||6
333303|NCT00607373|806642|P1|COMPLETED|Follow-up Period||0
333304|NCT00607373|806641|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|11
333397|NCT00607048|806808|P2|STARTED|Overall Study||6
333305|NCT00607373|806642|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|1
333306|NCT00607373|806641|P2|NOT COMPLETED|Treatment Period||6
333307|NCT00607373|806642|P1|NOT COMPLETED|Treatment Period||0
333308|NCT00607373|806641|P2|COMPLETED|Treatment Period|23 enrolled in open-label extension study NCT00694109|28
333309|NCT00607373|806642|P1|COMPLETED|Treatment Period|16 enrolled in open-label extension study NCT00694109|17
333310|NCT00607373|806641|P2|STARTED|Treatment Period||34
333311|NCT00607373|806642|P1|STARTED|Treatment Period||17
333312|NCT00607321|806686|P1|NOT COMPLETED|Overall Study||0
333313|NCT00607321|806686|P1|COMPLETED|Overall Study||60
333314|NCT00607321|806686|P1|STARTED|Overall Study||60
333315|NCT00607269|806696|P2|NOT COMPLETED|Overall Study||0
333316|NCT00607269|806697|P1|NOT COMPLETED|Overall Study||0
333317|NCT00607269|806696|P2|COMPLETED|Overall Study||64
333318|NCT00607269|806697|P1|COMPLETED|Overall Study||67
333319|NCT00607269|806696|P2|STARTED|Overall Study||64
333320|NCT00607269|806697|P1|STARTED|Overall Study||67
333321|NCT00607243|806711|P2|NOT COMPLETED|Telephone Safety Assessment Period||2
333322|NCT00607243|806712|P1|NOT COMPLETED|Telephone Safety Assessment Period||5
333323|NCT00607243|806711|P2|COMPLETED|Telephone Safety Assessment Period|40 Available for 3 months 39 Available for 6 months|39
333324|NCT00607243|806712|P1|COMPLETED|Telephone Safety Assessment Period|80 Available for 3 months 77 Available for 6 months|77
333325|NCT00607243|806711|P2|STARTED|Telephone Safety Assessment Period||41
333326|NCT00607243|806712|P1|STARTED|Telephone Safety Assessment Period||82
333327|NCT00607243|806711|P2|NOT COMPLETED|Initial Post-vaccination Period||0
333328|NCT00607243|806712|P1|NOT COMPLETED|Initial Post-vaccination Period||0
333329|NCT00607243|806711|P2|COMPLETED|Initial Post-vaccination Period||41
333330|NCT00607243|806712|P1|COMPLETED|Initial Post-vaccination Period||82
333331|NCT00607243|806711|P2|STARTED|Initial Post-vaccination Period||41
333332|NCT00607243|806712|P1|STARTED|Initial Post-vaccination Period||82
333333|NCT00607126|806720|P2|NOT COMPLETED|Overall Study||0
333334|NCT00607126|806721|P1|NOT COMPLETED|Overall Study||0
333335|NCT00607126|806720|P2|COMPLETED|Overall Study||19
333336|NCT00607126|806721|P1|COMPLETED|Overall Study||17
333337|NCT00607126|806720|P2|STARTED|Overall Study||19
333338|NCT00607126|806721|P1|STARTED|Overall Study||17
333339|NCT00607113|806735|P2|NOT COMPLETED|Overall Study||0
333340|NCT00607113|806736|P1|NOT COMPLETED|Overall Study||0
333341|NCT00607113|806735|P2|COMPLETED|Overall Study||20
333342|NCT00607113|806736|P1|COMPLETED|Overall Study||19
333343|NCT00607113|806735|P2|STARTED|Overall Study||20
333344|NCT00607113|806736|P1|STARTED|Overall Study||19
333345|NCT00607087|806744|P3|NOT COMPLETED|Period 3||0
333346|NCT00607087|806745|P2|NOT COMPLETED|Period 3||2
333347|NCT00607087|806746|P1|NOT COMPLETED|Period 3||2
333348|NCT00607087|806744|P3|COMPLETED|Period 3||84
333349|NCT00607087|806745|P2|COMPLETED|Period 3||84
333350|NCT00607087|806746|P1|COMPLETED|Period 3||84
333351|NCT00607087|806744|P3|STARTED|Period 3||84
333352|NCT00607087|806745|P2|STARTED|Period 3||86
333353|NCT00607087|806746|P1|STARTED|Period 3||86
333354|NCT00607087|806744|P3|NOT COMPLETED|Period 2||5
333355|NCT00607087|806745|P2|NOT COMPLETED|Period 2||3
333356|NCT00607087|806746|P1|NOT COMPLETED|Period 2||1
333357|NCT00607087|806744|P3|COMPLETED|Period 2||84
333358|NCT00607087|806745|P2|COMPLETED|Period 2||86
333359|NCT00607087|806746|P1|COMPLETED|Period 2||86
333360|NCT00607087|806744|P3|STARTED|Period 2||89
333361|NCT00607087|806745|P2|STARTED|Period 2||89
333362|NCT00607087|806746|P1|STARTED|Period 2||87
333363|NCT00607087|806744|P3|NOT COMPLETED|Period 1||5
333364|NCT00607087|806745|P2|NOT COMPLETED|Period 1||6
333365|NCT00607087|806746|P1|NOT COMPLETED|Period 1||12
333366|NCT00607087|806744|P3|COMPLETED|Period 1||89
333367|NCT00607087|806745|P2|COMPLETED|Period 1||89
333368|NCT00607087|806746|P1|COMPLETED|Period 1||87
333369|NCT00607087|806744|P3|STARTED|Period 1||94
333370|NCT00607087|806745|P2|STARTED|Period 1||95
333371|NCT00607087|806746|P1|STARTED|Period 1||99
333372|NCT00607087|806744|P3|NOT COMPLETED|Overall Study||10
333373|NCT00607087|806745|P2|NOT COMPLETED|Overall Study||11
333374|NCT00607087|806746|P1|NOT COMPLETED|Overall Study||15
333375|NCT00607087|806744|P3|COMPLETED|Overall Study||84
333376|NCT00607087|806745|P2|COMPLETED|Overall Study||84
333377|NCT00607087|806746|P1|COMPLETED|Overall Study||84
333378|NCT00607087|806744|P3|STARTED|Overall Study||94
333379|NCT00607087|806745|P2|STARTED|Overall Study||95
333380|NCT00607087|806746|P1|STARTED|Overall Study||99
333381|NCT00607048|806804|P6|NOT COMPLETED|Overall Study||5
333382|NCT00607048|806805|P5|NOT COMPLETED|Overall Study||6
333383|NCT00607048|806806|P4|NOT COMPLETED|Overall Study||3
333384|NCT00607048|806807|P3|NOT COMPLETED|Overall Study||4
333385|NCT00607048|806808|P2|NOT COMPLETED|Overall Study||4
333386|NCT00607048|806809|P1|NOT COMPLETED|Overall Study||3
333387|NCT00607048|806804|P6|COMPLETED|Overall Study||2
333388|NCT00607048|806805|P5|COMPLETED|Overall Study||0
333389|NCT00607048|806806|P4|COMPLETED|Overall Study||0
333390|NCT00607048|806807|P3|COMPLETED|Overall Study||3
333391|NCT00607048|806808|P2|COMPLETED|Overall Study||2
333392|NCT00607048|806809|P1|COMPLETED|Overall Study||0
333393|NCT00607048|806804|P6|STARTED|Overall Study||7
333394|NCT00607048|806805|P5|STARTED|Overall Study||6
333395|NCT00607048|806806|P4|STARTED|Overall Study||3
333396|NCT00607048|806807|P3|STARTED|Overall Study||7
333398|NCT00607048|806809|P1|STARTED|Overall Study||3
333399|NCT00607022|806894|P3|NOT COMPLETED|Overall Study||0
333400|NCT00607022|806895|P2|NOT COMPLETED|Overall Study||0
333401|NCT00607022|806896|P1|NOT COMPLETED|Overall Study||1
333402|NCT00607022|806894|P3|COMPLETED|Overall Study||19
333403|NCT00607022|806895|P2|COMPLETED|Overall Study||15
333404|NCT00607022|806896|P1|COMPLETED|Overall Study||6
333405|NCT00607022|806894|P3|STARTED|Overall Study||19
333406|NCT00607022|806895|P2|STARTED|Overall Study||15
333407|NCT00607022|806896|P1|STARTED|Overall Study||7
333408|NCT00606944|806906|P2|NOT COMPLETED|Overall Study||0
333409|NCT00606944|806907|P1|NOT COMPLETED|Overall Study||0
333410|NCT00606944|806906|P2|COMPLETED|Overall Study||100
333411|NCT00606944|806907|P1|COMPLETED|Overall Study||98
333412|NCT00606944|806906|P2|STARTED|Overall Study||100
333413|NCT00606944|806907|P1|STARTED|Overall Study||98
333414|NCT00606931|806913|P1|NOT COMPLETED|Overall Study||3
333415|NCT00606931|806913|P1|COMPLETED|Overall Study||19
333416|NCT00606931|806913|P1|STARTED|Overall Study||22
333417|NCT00606905|806921|P2|NOT COMPLETED|Overall Study||15
333418|NCT00606905|806922|P1|NOT COMPLETED|Overall Study||15
333419|NCT00606905|806921|P2|COMPLETED|Overall Study||24
333420|NCT00606905|806922|P1|COMPLETED|Overall Study||23
333421|NCT00606905|806921|P2|Pregnancy|Overall Study||33
333422|NCT00606905|806922|P1|Pregnancy|Overall Study||29
333423|NCT00606905|806921|P2|STARTED|Overall Study||39
333424|NCT00606905|806922|P1|STARTED|Overall Study||38
333425|NCT00606892|806928|P2|NOT COMPLETED|Second Intervention||0
333426|NCT00606892|806929|P1|NOT COMPLETED|Second Intervention||0
333427|NCT00606892|806928|P2|COMPLETED|Second Intervention||4
333428|NCT00606892|806929|P1|COMPLETED|Second Intervention||8
333429|NCT00606892|806928|P2|STARTED|Second Intervention||4
333430|NCT00606892|806929|P1|STARTED|Second Intervention||8
333431|NCT00606892|806928|P2|NOT COMPLETED|Washout Period||0
333432|NCT00606892|806929|P1|NOT COMPLETED|Washout Period||0
333433|NCT00606892|806928|P2|COMPLETED|Washout Period||4
333434|NCT00606892|806929|P1|COMPLETED|Washout Period||8
333435|NCT00606892|806928|P2|STARTED|Washout Period||4
333436|NCT00606892|806929|P1|STARTED|Washout Period||8
333437|NCT00606892|806928|P2|NOT COMPLETED|First Intervention||4
333438|NCT00606892|806929|P1|NOT COMPLETED|First Intervention||1
333439|NCT00606892|806928|P2|COMPLETED|First Intervention||4
333440|NCT00606892|806929|P1|COMPLETED|First Intervention||8
333441|NCT00606892|806928|P2|STARTED|First Intervention||8
333442|NCT00606892|806929|P1|STARTED|First Intervention||9
333443|NCT00606892|806928|P2|NOT COMPLETED|Adaptation||0
333444|NCT00606892|806929|P1|NOT COMPLETED|Adaptation||0
333445|NCT00606892|806928|P2|COMPLETED|Adaptation||8
333446|NCT00606892|806929|P1|COMPLETED|Adaptation||9
333447|NCT00606892|806928|P2|STARTED|Adaptation||8
333448|NCT00606892|806929|P1|STARTED|Adaptation||9
333449|NCT00606801|806963|P2|NOT COMPLETED|Intervention||3
333450|NCT00606801|806964|P1|NOT COMPLETED|Intervention||3
333451|NCT00606801|806963|P2|COMPLETED|Intervention||14
333452|NCT00606801|806964|P1|COMPLETED|Intervention||14
333453|NCT00606801|806963|P2|STARTED|Intervention||17
333454|NCT00606801|806964|P1|STARTED|Intervention||17
333455|NCT00606801|806963|P2|NOT COMPLETED|Adaptation||0
333456|NCT00606801|806964|P1|NOT COMPLETED|Adaptation||0
333457|NCT00606801|806963|P2|COMPLETED|Adaptation||17
333458|NCT00606801|806964|P1|COMPLETED|Adaptation||17
333459|NCT00606801|806963|P2|STARTED|Adaptation||17
333460|NCT00606801|806964|P1|STARTED|Adaptation||17
333461|NCT00606684|806992|P7|NOT COMPLETED|Double-Blind Treatment Period||8
333462|NCT00606684|806993|P6|NOT COMPLETED|Double-Blind Treatment Period||9
333463|NCT00606684|806994|P5|NOT COMPLETED|Double-Blind Treatment Period||9
333464|NCT00606684|806995|P4|NOT COMPLETED|Double-Blind Treatment Period||10
333465|NCT00606684|806996|P3|NOT COMPLETED|Double-Blind Treatment Period||11
333466|NCT00606684|806997|P2|NOT COMPLETED|Double-Blind Treatment Period||16
333467|NCT00606684|806998|P1|NOT COMPLETED|Double-Blind Treatment Period||0
333468|NCT00606684|806992|P7|COMPLETED|Double-Blind Treatment Period||91
333469|NCT00606684|806993|P6|COMPLETED|Double-Blind Treatment Period||92
333470|NCT00606684|806994|P5|COMPLETED|Double-Blind Treatment Period||92
333471|NCT00606684|806995|P4|COMPLETED|Double-Blind Treatment Period||91
333472|NCT00606684|806996|P3|COMPLETED|Double-Blind Treatment Period||88
333473|NCT00606684|806997|P2|COMPLETED|Double-Blind Treatment Period||85
333474|NCT00606684|806998|P1|COMPLETED|Double-Blind Treatment Period||0
333475|NCT00606684|806992|P7|STARTED|Double-Blind Treatment Period||99
333476|NCT00606684|806993|P6|STARTED|Double-Blind Treatment Period||101
333477|NCT00606684|806994|P5|STARTED|Double-Blind Treatment Period||101
333478|NCT00606684|806995|P4|STARTED|Double-Blind Treatment Period||101
333479|NCT00606684|806996|P3|STARTED|Double-Blind Treatment Period||99
333480|NCT00606684|806997|P2|STARTED|Double-Blind Treatment Period||101
333481|NCT00606684|806998|P1|STARTED|Double-Blind Treatment Period||0
333482|NCT00606684|806992|P7|NOT COMPLETED|2-week Single-Blind Run-in Period||0
333483|NCT00606684|806993|P6|NOT COMPLETED|2-week Single-Blind Run-in Period||0
333484|NCT00606684|806994|P5|NOT COMPLETED|2-week Single-Blind Run-in Period||0
333485|NCT00606684|806995|P4|NOT COMPLETED|2-week Single-Blind Run-in Period||0
333486|NCT00606684|806996|P3|NOT COMPLETED|2-week Single-Blind Run-in Period||0
333487|NCT00606684|806997|P2|NOT COMPLETED|2-week Single-Blind Run-in Period||0
333488|NCT00606684|806998|P1|NOT COMPLETED|2-week Single-Blind Run-in Period||246
333489|NCT00606684|806992|P7|COMPLETED|2-week Single-Blind Run-in Period||0
333490|NCT00606684|806993|P6|COMPLETED|2-week Single-Blind Run-in Period||0
333491|NCT00606684|806994|P5|COMPLETED|2-week Single-Blind Run-in Period||0
333492|NCT00606684|806995|P4|COMPLETED|2-week Single-Blind Run-in Period||0
333493|NCT00606684|806996|P3|COMPLETED|2-week Single-Blind Run-in Period||0
333494|NCT00606684|806997|P2|COMPLETED|2-week Single-Blind Run-in Period||0
333495|NCT00606684|806998|P1|COMPLETED|2-week Single-Blind Run-in Period||605
333496|NCT00606684|806992|P7|STARTED|2-week Single-Blind Run-in Period||0
333497|NCT00606684|806993|P6|STARTED|2-week Single-Blind Run-in Period||0
333498|NCT00606684|806994|P5|STARTED|2-week Single-Blind Run-in Period||0
333499|NCT00606684|806995|P4|STARTED|2-week Single-Blind Run-in Period||0
333500|NCT00606684|806996|P3|STARTED|2-week Single-Blind Run-in Period||0
333501|NCT00606684|806997|P2|STARTED|2-week Single-Blind Run-in Period||0
333502|NCT00606684|806998|P1|STARTED|2-week Single-Blind Run-in Period||851
333503|NCT00606632|807030|P1|NOT COMPLETED|Overall Study||22
333504|NCT00606632|807030|P1|COMPLETED|Overall Study||204
333505|NCT00606632|807030|P1|STARTED|Overall Study||226
333506|NCT00606593|807043|P10|NOT COMPLETED|Overall Study||0
333507|NCT00606593|807044|P9|NOT COMPLETED|Overall Study||1
333508|NCT00606593|807045|P8|NOT COMPLETED|Overall Study||2
333509|NCT00606593|807046|P7|NOT COMPLETED|Overall Study||1
333510|NCT00606593|807047|P6|NOT COMPLETED|Overall Study||0
333511|NCT00606593|807048|P5|NOT COMPLETED|Overall Study||1
333512|NCT00606593|807049|P4|NOT COMPLETED|Overall Study||1
333513|NCT00606593|807050|P3|NOT COMPLETED|Overall Study||2
333514|NCT00606593|807051|P2|NOT COMPLETED|Overall Study||0
333515|NCT00606593|807052|P1|NOT COMPLETED|Overall Study||1
333516|NCT00606593|807043|P10|COMPLETED|Overall Study||11
333517|NCT00606593|807044|P9|COMPLETED|Overall Study||11
333518|NCT00606593|807045|P8|COMPLETED|Overall Study||9
333519|NCT00606593|807046|P7|COMPLETED|Overall Study||10
333520|NCT00606593|807047|P6|COMPLETED|Overall Study||11
333521|NCT00606593|807048|P5|COMPLETED|Overall Study||11
333522|NCT00606593|807049|P4|COMPLETED|Overall Study||10
333523|NCT00606593|807050|P3|COMPLETED|Overall Study||9
333524|NCT00606593|807051|P2|COMPLETED|Overall Study||11
333525|NCT00606593|807052|P1|COMPLETED|Overall Study||10
333526|NCT00606593|807043|P10|5th Double-blind Treatment|Overall Study||11
333527|NCT00606593|807044|P9|5th Double-blind Treatment|Overall Study||11
333528|NCT00606593|807045|P8|5th Double-blind Treatment|Overall Study||9
333529|NCT00606593|807046|P7|5th Double-blind Treatment|Overall Study||10
333530|NCT00606593|807047|P6|5th Double-blind Treatment|Overall Study||11
333531|NCT00606593|807048|P5|5th Double-blind Treatment|Overall Study||11
333532|NCT00606593|807049|P4|5th Double-blind Treatment|Overall Study||10
333533|NCT00606593|807050|P3|5th Double-blind Treatment|Overall Study||9
333534|NCT00606593|807051|P2|5th Double-blind Treatment|Overall Study||11
333535|NCT00606593|807052|P1|5th Double-blind Treatment|Overall Study||10
333536|NCT00606593|807043|P10|4th Double-blind Treatment|Overall Study||11
333537|NCT00606593|807044|P9|4th Double-blind Treatment|Overall Study||11
333538|NCT00606593|807045|P8|4th Double-blind Treatment|Overall Study||9
333539|NCT00606593|807046|P7|4th Double-blind Treatment|Overall Study||10
333540|NCT00606593|807047|P6|4th Double-blind Treatment|Overall Study||11
333541|NCT00606593|807048|P5|4th Double-blind Treatment|Overall Study||11
333542|NCT00606593|807049|P4|4th Double-blind Treatment|Overall Study||10
333543|NCT00606593|807050|P3|4th Double-blind Treatment|Overall Study||10
333544|NCT00606593|807051|P2|4th Double-blind Treatment|Overall Study||11
333545|NCT00606593|807052|P1|4th Double-blind Treatment|Overall Study||10
333546|NCT00606593|807043|P10|3rd Double-blind Treatment|Overall Study||11
333547|NCT00606593|807044|P9|3rd Double-blind Treatment|Overall Study||12
333548|NCT00606593|807045|P8|3rd Double-blind Treatment|Overall Study||9
333549|NCT00606593|807046|P7|3rd Double-blind Treatment|Overall Study||10
333550|NCT00606593|807047|P6|3rd Double-blind Treatment|Overall Study||11
333551|NCT00606593|807048|P5|3rd Double-blind Treatment|Overall Study||11
333552|NCT00606593|807049|P4|3rd Double-blind Treatment|Overall Study||10
333553|NCT00606593|807050|P3|3rd Double-blind Treatment|Overall Study||10
333554|NCT00606593|807051|P2|3rd Double-blind Treatment|Overall Study||11
333555|NCT00606593|807052|P1|3rd Double-blind Treatment|Overall Study||11
333556|NCT00606593|807043|P10|2nd Double-blind Treatment|Overall Study||11
333557|NCT00606593|807044|P9|2nd Double-blind Treatment|Overall Study||12
333558|NCT00606593|807045|P8|2nd Double-blind Treatment|Overall Study||9
333559|NCT00606593|807046|P7|2nd Double-blind Treatment|Overall Study||10
333560|NCT00606593|807047|P6|2nd Double-blind Treatment|Overall Study||11
333561|NCT00606593|807048|P5|2nd Double-blind Treatment|Overall Study||12
333562|NCT00606593|807049|P4|2nd Double-blind Treatment|Overall Study||10
333563|NCT00606593|807050|P3|2nd Double-blind Treatment|Overall Study||11
333564|NCT00606593|807051|P2|2nd Double-blind Treatment|Overall Study||11
333565|NCT00606593|807052|P1|2nd Double-blind Treatment|Overall Study||11
333566|NCT00606593|807043|P10|1st Double-blind Treatment|Overall Study||11
333567|NCT00606593|807044|P9|1st Double-blind Treatment|Overall Study||12
333568|NCT00606593|807045|P8|1st Double-blind Treatment|Overall Study||11
333569|NCT00606593|807046|P7|1st Double-blind Treatment|Overall Study||11
333570|NCT00606593|807047|P6|1st Double-blind Treatment|Overall Study||11
333571|NCT00606593|807048|P5|1st Double-blind Treatment|Overall Study||12
333572|NCT00606593|807049|P4|1st Double-blind Treatment|Overall Study||11
333573|NCT00606593|807050|P3|1st Double-blind Treatment|Overall Study||11
333574|NCT00606593|807051|P2|1st Double-blind Treatment|Overall Study||11
333575|NCT00606593|807052|P1|1st Double-blind Treatment|Overall Study||11
333576|NCT00606593|807043|P10|STARTED|Overall Study|Randomized participants|11
333577|NCT00606593|807044|P9|STARTED|Overall Study|Randomized participants|12
333578|NCT00606593|807045|P8|STARTED|Overall Study|Randomized participants. One participant actually received the treatment sequence 200/P/100/ 50/25|11
333579|NCT00606593|807046|P7|STARTED|Overall Study|Randomized participants|11
333580|NCT00606593|807047|P6|STARTED|Overall Study|Randomized participants|11
333581|NCT00606593|807048|P5|STARTED|Overall Study|Randomized participants|12
333582|NCT00606593|807049|P4|STARTED|Overall Study|Randomized participants|11
333583|NCT00606593|807050|P3|STARTED|Overall Study|Randomized participants|11
333584|NCT00606593|807051|P2|STARTED|Overall Study|Randomized participants|11
333585|NCT00606593|807052|P1|STARTED|Overall Study|Randomized participants|11
333586|NCT00606580|807073|P3|NOT COMPLETED|Overall Study||22
333587|NCT00606580|807074|P2|NOT COMPLETED|Overall Study||3
333588|NCT00606580|807075|P1|NOT COMPLETED|Overall Study||2
333589|NCT00606580|807073|P3|COMPLETED|Overall Study||103
333590|NCT00606580|807074|P2|COMPLETED|Overall Study||122
333591|NCT00606580|807075|P1|COMPLETED|Overall Study||123
333592|NCT00606580|807073|P3|STARTED|Overall Study||125
333593|NCT00606580|807074|P2|STARTED|Overall Study||125
333594|NCT00606580|807075|P1|STARTED|Overall Study||125
333595|NCT00606554|807118|P2|NOT COMPLETED|Overall Study||0
333596|NCT00606554|807119|P1|NOT COMPLETED|Overall Study||0
333597|NCT00606554|807118|P2|COMPLETED|Overall Study||18
333598|NCT00606554|807119|P1|COMPLETED|Overall Study||15
333599|NCT00606554|807118|P2|STARTED|Overall Study||18
333600|NCT00606554|807119|P1|STARTED|Overall Study||15
333601|NCT00606502|807141|P2|NOT COMPLETED|Treatment||3
333602|NCT00606502|807142|P1|NOT COMPLETED|Treatment||0
333603|NCT00606502|807141|P2|COMPLETED|Treatment||98
333604|NCT00606502|807142|P1|COMPLETED|Treatment||97
333605|NCT00606502|807141|P2|STARTED|Treatment||101
333606|NCT00606502|807142|P1|STARTED|Treatment||97
333607|NCT00606502|807141|P2|NOT COMPLETED|Randomization||0
333608|NCT00606502|807142|P1|NOT COMPLETED|Randomization||3
333609|NCT00606502|807141|P2|COMPLETED|Randomization||101
333610|NCT00606502|807142|P1|COMPLETED|Randomization||97
333611|NCT00606502|807141|P2|STARTED|Randomization||101
333612|NCT00606502|807142|P1|STARTED|Randomization||100
333613|NCT00606489|807156|P2|NOT COMPLETED|Overall Study||0
333614|NCT00606489|807157|P1|NOT COMPLETED|Overall Study||0
333615|NCT00606489|807156|P2|COMPLETED|Overall Study||40
333616|NCT00606489|807157|P1|COMPLETED|Overall Study||21
333617|NCT00606489|807156|P2|STARTED|Overall Study||40
333618|NCT00606489|807157|P1|STARTED|Overall Study||21
333619|NCT00606320|807163|P1|NOT COMPLETED|Overall Study||37
333620|NCT00606320|807163|P1|COMPLETED|Overall Study||22
333621|NCT00606320|807163|P1|STARTED|Overall Study||59
333622|NCT00606281|807170|P2|NOT COMPLETED|Overall Study||66
333623|NCT00606281|807171|P1|NOT COMPLETED|Overall Study||56
333624|NCT00606281|807170|P2|COMPLETED|Overall Study||64
333625|NCT00606281|807171|P1|COMPLETED|Overall Study||72
333626|NCT00606281|807170|P2|STARTED|Overall Study||130
333627|NCT00606281|807171|P1|STARTED|Overall Study||128
333628|NCT00606229|807179|P1|NOT COMPLETED|Overall Study||22
333629|NCT00606229|807179|P1|COMPLETED|Overall Study||19
333630|NCT00606229|807179|P1|STARTED|Overall Study||41
333631|NCT00606177|807186|P2|NOT COMPLETED|Overall Study||25
333632|NCT00606177|807187|P1|NOT COMPLETED|Overall Study||27
333633|NCT00606177|807186|P2|COMPLETED|Overall Study||19
333634|NCT00606177|807187|P1|COMPLETED|Overall Study||28
333635|NCT00606177|807186|P2|STARTED|Overall Study||44
333636|NCT00606177|807187|P1|STARTED|Overall Study||55
333637|NCT00606138|807197|P2|NOT COMPLETED|Overall Study||0
333638|NCT00606138|807198|P1|NOT COMPLETED|Overall Study||0
333639|NCT00606138|807197|P2|COMPLETED|Overall Study||2
333640|NCT00606138|807198|P1|COMPLETED|Overall Study||6
333641|NCT00606138|807197|P2|STARTED|Overall Study||2
333642|NCT00606138|807198|P1|STARTED|Overall Study||6
333643|NCT00606086|807214|P2|NOT COMPLETED|Overall Study||15
333644|NCT00606086|807215|P1|NOT COMPLETED|Overall Study||12
333645|NCT00606086|807214|P2|COMPLETED|Overall Study||53
333646|NCT00606086|807215|P1|COMPLETED|Overall Study||60
333647|NCT00606086|807214|P2|STARTED|Overall Study||68
333648|NCT00606086|807215|P1|STARTED|Overall Study||72
333649|NCT00606034|807221|P1|NOT COMPLETED|Overall Study||1
333650|NCT00606034|807221|P1|COMPLETED|Overall Study||20
333651|NCT00606034|807221|P1|STARTED|Overall Study||21
333652|NCT00606021|807229|P3|NOT COMPLETED|Maintenance Phase||17
333653|NCT00606021|807230|P2|NOT COMPLETED|Maintenance Phase||23
333654|NCT00606021|807231|P1|NOT COMPLETED|Maintenance Phase||0
333655|NCT00606021|807229|P3|COMPLETED|Maintenance Phase||10
333656|NCT00606021|807230|P2|COMPLETED|Maintenance Phase||5
333657|NCT00606021|807231|P1|COMPLETED|Maintenance Phase||0
333658|NCT00606021|807229|P3|STARTED|Maintenance Phase||27
333659|NCT00606021|807230|P2|STARTED|Maintenance Phase||28
333660|NCT00606021|807231|P1|STARTED|Maintenance Phase||0
333661|NCT00606021|807229|P3|NOT COMPLETED|Induction Phase||0
333662|NCT00606021|807230|P2|NOT COMPLETED|Induction Phase||0
333663|NCT00606021|807231|P1|NOT COMPLETED|Induction Phase||87
333664|NCT00606021|807229|P3|COMPLETED|Induction Phase||0
333665|NCT00606021|807230|P2|COMPLETED|Induction Phase||0
333666|NCT00606021|807231|P1|COMPLETED|Induction Phase||19
333667|NCT00606021|807229|P3|STARTED|Induction Phase||0
333668|NCT00606021|807230|P2|STARTED|Induction Phase||0
333669|NCT00606021|807231|P1|STARTED|Induction Phase||106
333670|NCT00606008|807249|P1|NOT COMPLETED|Overall Study||5
333671|NCT00606008|807249|P1|COMPLETED|Overall Study||25
333672|NCT00606008|807249|P1|STARTED|Overall Study||30
333673|NCT00605917|807263|P1|NOT COMPLETED|Overall Study||79
333674|NCT00605917|807263|P1|COMPLETED|Overall Study||908
333675|NCT00605917|807263|P1|STARTED|Overall Study||987
333676|NCT00605904|807304|P2|NOT COMPLETED|Infusion Sessions||3
333677|NCT00605904|807305|P1|NOT COMPLETED|Infusion Sessions||1
333678|NCT00605904|807304|P2|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|13
333679|NCT00605904|807305|P1|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|12
333680|NCT00605904|807304|P2|Yohimbine Infusion|Infusion Sessions|Milestones (infusions) were not received in the same order for each subjects so are not consecutive.|15
333681|NCT00605904|807305|P1|Yohimbine Infusion|Infusion Sessions||12
333682|NCT00605904|807304|P2|mCPP Infusion|Infusion Sessions||13
333683|NCT00605904|807305|P1|mCPP Infusion|Infusion Sessions||12
333684|NCT00605904|807304|P2|Saline Infusion|Infusion Sessions||14
333685|NCT00605904|807305|P1|Saline Infusion|Infusion Sessions||13
333686|NCT00605904|807304|P2|STARTED|Infusion Sessions||16
333687|NCT00605904|807305|P1|STARTED|Infusion Sessions||13
333688|NCT00605904|807304|P2|NOT COMPLETED|Baseline Data Collection and Dosing||5
333689|NCT00605904|807305|P1|NOT COMPLETED|Baseline Data Collection and Dosing||0
333690|NCT00605904|807304|P2|COMPLETED|Baseline Data Collection and Dosing||16
333691|NCT00605904|807305|P1|COMPLETED|Baseline Data Collection and Dosing||13
333692|NCT00605904|807304|P2|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|21
333693|NCT00605904|807305|P1|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|13
333694|NCT00605865|807315|P1|NOT COMPLETED|Overall Study||115
333695|NCT00605865|807315|P1|COMPLETED|Overall Study||2157
333696|NCT00605865|807315|P1|STARTED|Overall Study||2272
333697|NCT00605839|807357|P3|NOT COMPLETED|Overall Study||0
333698|NCT00605839|807358|P2|NOT COMPLETED|Overall Study||0
333699|NCT00605839|807359|P1|NOT COMPLETED|Overall Study||1
333700|NCT00605839|807357|P3|COMPLETED|Overall Study||28
333701|NCT00605839|807358|P2|COMPLETED|Overall Study||37
333702|NCT00605839|807359|P1|COMPLETED|Overall Study|One patient would not keep to the text messaging constraints and had to be removed.|39
333703|NCT00605839|807357|P3|STARTED|Overall Study||28
333704|NCT00605839|807358|P2|STARTED|Overall Study||37
333705|NCT00605839|807359|P1|STARTED|Overall Study||40
333706|NCT00605813|807367|P1|NOT COMPLETED|Overall Study||25
333707|NCT00605813|807367|P1|COMPLETED|Overall Study||517
333708|NCT00605813|807367|P1|STARTED|Overall Study||542
333709|NCT00605722|807380|P1|NOT COMPLETED|Overall Study||51
333710|NCT00605722|807380|P1|COMPLETED|Overall Study|Completed=Completed Treatment.|0
333711|NCT00605722|807380|P1|STARTED|Overall Study||51
333712|NCT00605696|807392|P2|NOT COMPLETED|Overall Study||0
333713|NCT00605696|807393|P1|NOT COMPLETED|Overall Study||0
333714|NCT00605696|807392|P2|COMPLETED|Overall Study||11
333715|NCT00605696|807393|P1|COMPLETED|Overall Study||7
333716|NCT00605696|807392|P2|STARTED|Overall Study||11
333717|NCT00605696|807393|P1|STARTED|Overall Study||7
333718|NCT00605657|807401|P1|NOT COMPLETED|Overall Study||2
333719|NCT00605657|807401|P1|COMPLETED|Overall Study||3
333720|NCT00605657|807401|P1|STARTED|Overall Study||5
333721|NCT00605566|807406|P1|NOT COMPLETED|Overall Study||3
333722|NCT00605566|807406|P1|COMPLETED|Overall Study||19
333723|NCT00605566|807406|P1|STARTED|Overall Study||22
333724|NCT00605540|807414|P1|NOT COMPLETED|Overall Study||38
333725|NCT00605540|807414|P1|COMPLETED|Overall Study||95
333726|NCT00605540|807414|P1|STARTED|Overall Study||133
333727|NCT00605475|807432|P10|NOT COMPLETED|Overall Study||2
333728|NCT00605475|807433|P9|NOT COMPLETED|Overall Study||2
333729|NCT00605475|807434|P8|NOT COMPLETED|Overall Study||0
333730|NCT00605475|807435|P7|NOT COMPLETED|Overall Study||1
333731|NCT00605475|807436|P6|NOT COMPLETED|Overall Study||2
333732|NCT00605475|807437|P5|NOT COMPLETED|Overall Study||1
333733|NCT00605475|807438|P4|NOT COMPLETED|Overall Study||0
333734|NCT00605475|807439|P3|NOT COMPLETED|Overall Study||0
333735|NCT00605475|807440|P2|NOT COMPLETED|Overall Study||0
333736|NCT00605475|807441|P1|NOT COMPLETED|Overall Study||0
333737|NCT00605475|807432|P10|COMPLETED|Overall Study||8
333738|NCT00605475|807433|P9|COMPLETED|Overall Study||18
333739|NCT00605475|807434|P8|COMPLETED|Overall Study||24
333740|NCT00605475|807435|P7|COMPLETED|Overall Study||22
333741|NCT00605475|807436|P6|COMPLETED|Overall Study||22
333742|NCT00605475|807437|P5|COMPLETED|Overall Study||24
333743|NCT00605475|807438|P4|COMPLETED|Overall Study||45
333744|NCT00605475|807439|P3|COMPLETED|Overall Study||45
333745|NCT00605475|807440|P2|COMPLETED|Overall Study||5
333746|NCT00605475|807441|P1|COMPLETED|Overall Study||10
333747|NCT00605475|807432|P10|STARTED|Overall Study||10
333748|NCT00605475|807433|P9|STARTED|Overall Study||20
333749|NCT00605475|807434|P8|STARTED|Overall Study||24
333750|NCT00605475|807435|P7|STARTED|Overall Study||23
333751|NCT00605475|807436|P6|STARTED|Overall Study||24
333752|NCT00605475|807437|P5|STARTED|Overall Study||25
333753|NCT00605475|807438|P4|STARTED|Overall Study||45
333754|NCT00605475|807439|P3|STARTED|Overall Study||45
333755|NCT00605475|807440|P2|STARTED|Overall Study||5
333756|NCT00605475|807441|P1|STARTED|Overall Study||10
333757|NCT00605423|807565|P2|NOT COMPLETED|Overall Study||0
333758|NCT00605423|807566|P1|NOT COMPLETED|Overall Study||0
333759|NCT00605423|807565|P2|COMPLETED|Overall Study||2
333760|NCT00605423|807566|P1|COMPLETED|Overall Study||4
333761|NCT00605423|807565|P2|STARTED|Overall Study||2
333762|NCT00605423|807566|P1|STARTED|Overall Study||4
333763|NCT00605384|807578|P2|NOT COMPLETED|Overall Study||1
333764|NCT00605384|807579|P1|NOT COMPLETED|Overall Study||1
333765|NCT00605384|807578|P2|COMPLETED|Overall Study|study terminated early|0
333766|NCT00605384|807579|P1|COMPLETED|Overall Study|study terminated early|0
333767|NCT00605384|807578|P2|STARTED|Overall Study||1
333768|NCT00605384|807579|P1|STARTED|Overall Study||1
333769|NCT00605358|807609|P2|NOT COMPLETED|Overall Study||0
333770|NCT00605358|807610|P1|NOT COMPLETED|Overall Study||0
333771|NCT00605358|807609|P2|COMPLETED|Overall Study||80
333772|NCT00605358|807610|P1|COMPLETED|Overall Study||81
333773|NCT00605358|807609|P2|STARTED|Overall Study||80
333774|NCT00605358|807610|P1|STARTED|Overall Study||81
333775|NCT00605345|807618|P2|NOT COMPLETED|Overall Study||3
333776|NCT00605345|807619|P1|NOT COMPLETED|Overall Study||1
333777|NCT00605345|807618|P2|COMPLETED|Overall Study||22
333778|NCT00605345|807619|P1|COMPLETED|Overall Study||45
333779|NCT00605345|807618|P2|STARTED|Overall Study||25
333780|NCT00605345|807619|P1|STARTED|Overall Study||46
333781|NCT00605319|807635|P1|NOT COMPLETED|Overall Study||6
333782|NCT00605319|807635|P1|COMPLETED|Overall Study||11
333783|NCT00605319|807635|P1|STARTED|Overall Study||17
333784|NCT00605306|807647|P2|NOT COMPLETED|Overall Study||1
333785|NCT00605306|807648|P1|NOT COMPLETED|Overall Study||0
333786|NCT00605306|807647|P2|COMPLETED|Overall Study||13
333787|NCT00605306|807648|P1|COMPLETED|Overall Study||14
333788|NCT00605306|807647|P2|STARTED|Overall Study||14
333789|NCT00605306|807648|P1|STARTED|Overall Study||14
333790|NCT00605293|807662|P2|NOT COMPLETED|Overall Study||5
333791|NCT00605293|807663|P1|NOT COMPLETED|Overall Study||17
333792|NCT00605293|807662|P2|COMPLETED|Overall Study||31
333793|NCT00605293|807663|P1|COMPLETED|Overall Study||48
333794|NCT00605293|807662|P2|STARTED|Overall Study||36
333795|NCT00605293|807663|P1|STARTED|Overall Study||65
333796|NCT00605280|807683|P4|NOT COMPLETED|Year 3 Extension||9
333797|NCT00605280|807684|P3|NOT COMPLETED|Year 3 Extension||0
333798|NCT00605280|807685|P2|NOT COMPLETED|Year 3 Extension||0
333799|NCT00605280|807686|P1|NOT COMPLETED|Year 3 Extension||8
333800|NCT00605280|807683|P4|COMPLETED|Year 3 Extension||45
333801|NCT00605280|807684|P3|COMPLETED|Year 3 Extension||0
333802|NCT00605280|807685|P2|COMPLETED|Year 3 Extension||0
333803|NCT00605280|807686|P1|COMPLETED|Year 3 Extension||38
333804|NCT00605280|807683|P4|Received 0.3 mg Treatment|Year 3 Extension||54
333805|NCT00605280|807684|P3|Received 0.3 mg Treatment|Year 3 Extension||0
333806|NCT00605280|807685|P2|Received 0.3 mg Treatment|Year 3 Extension||0
333807|NCT00605280|807686|P1|Received 0.3 mg Treatment|Year 3 Extension||46
333808|NCT00605280|807683|P4|STARTED|Year 3 Extension||54
333809|NCT00605280|807684|P3|STARTED|Year 3 Extension||0
333810|NCT00605280|807685|P2|STARTED|Year 3 Extension||0
333811|NCT00605280|807686|P1|STARTED|Year 3 Extension||46
333812|NCT00605280|807683|P4|NOT COMPLETED|Year 2||22
333813|NCT00605280|807684|P3|NOT COMPLETED|Year 2||6
333814|NCT00605280|807685|P2|NOT COMPLETED|Year 2||6
333815|NCT00605280|807686|P1|NOT COMPLETED|Year 2||24
333816|NCT00605280|807683|P4|COMPLETED|Year 2||102
333817|NCT00605280|807684|P3|COMPLETED|Year 2||0
333818|NCT00605280|807685|P2|COMPLETED|Year 2||5
333819|NCT00605280|807686|P1|COMPLETED|Year 2||102
333820|NCT00605280|807683|P4|Received 0.3 mg Treatment|Year 2||0
333821|NCT00605280|807684|P3|Received 0.3 mg Treatment|Year 2||2
333822|NCT00605280|807685|P2|Received 0.3 mg Treatment|Year 2||3
333823|NCT00605280|807686|P1|Received 0.3 mg Treatment|Year 2||126
333824|NCT00605280|807683|P4|STARTED|Year 2||124
333825|NCT00605280|807684|P3|STARTED|Year 2||6
333826|NCT00605280|807685|P2|STARTED|Year 2||11
333827|NCT00605280|807686|P1|STARTED|Year 2||126
333828|NCT00605280|807683|P4|NOT COMPLETED|Year 1||19
333829|NCT00605280|807684|P3|NOT COMPLETED|Year 1||1
333830|NCT00605280|807685|P2|NOT COMPLETED|Year 1||11
333831|NCT00605280|807686|P1|NOT COMPLETED|Year 1||19
333832|NCT00605280|807683|P4|COMPLETED|Year 1||124
333833|NCT00605280|807684|P3|COMPLETED|Year 1||6
333834|NCT00605280|807685|P2|COMPLETED|Year 1||11
333835|NCT00605280|807686|P1|COMPLETED|Year 1||126
333836|NCT00605280|807683|P4|Received 0.3 mg Treatment|Year 1||0
333837|NCT00605280|807684|P3|Received 0.3 mg Treatment|Year 1||3
333838|NCT00605280|807685|P2|Received 0.3 mg Treatment|Year 1||13
333839|NCT00605280|807686|P1|Received 0.3 mg Treatment|Year 1||144
333840|NCT00605280|807683|P4|STARTED|Year 1||143
333841|NCT00605280|807684|P3|STARTED|Year 1||7
333842|NCT00605280|807685|P2|STARTED|Year 1||22
333843|NCT00605280|807686|P1|STARTED|Year 1||145
333844|NCT00605267|807720|P2|NOT COMPLETED|Overall Study||9
333845|NCT00605267|807721|P1|NOT COMPLETED|Overall Study||3
333846|NCT00605267|807720|P2|COMPLETED|Overall Study|Breast surgery performed|90
333847|NCT00605267|807721|P1|COMPLETED|Overall Study|Breast surgery performed|95
333848|NCT00605267|807720|P2|STARTED|Overall Study||99
333849|NCT00605267|807721|P1|STARTED|Overall Study||98
333850|NCT00605202|807759|P2|NOT COMPLETED|Second Intervention||0
333851|NCT00605202|807760|P1|NOT COMPLETED|Second Intervention||0
333852|NCT00605202|807759|P2|COMPLETED|Second Intervention||5
333853|NCT00605202|807760|P1|COMPLETED|Second Intervention||5
333854|NCT00605202|807759|P2|STARTED|Second Intervention||5
333855|NCT00605202|807760|P1|STARTED|Second Intervention||5
333856|NCT00605202|807759|P2|NOT COMPLETED|Washout Period of 3 Weeks||0
333857|NCT00605202|807760|P1|NOT COMPLETED|Washout Period of 3 Weeks||0
333858|NCT00605202|807759|P2|COMPLETED|Washout Period of 3 Weeks||5
333859|NCT00605202|807760|P1|COMPLETED|Washout Period of 3 Weeks||5
333860|NCT00605202|807759|P2|STARTED|Washout Period of 3 Weeks||5
333861|NCT00605202|807760|P1|STARTED|Washout Period of 3 Weeks||5
333862|NCT00605202|807759|P2|NOT COMPLETED|First Intervention||0
333863|NCT00605202|807760|P1|NOT COMPLETED|First Intervention||0
333864|NCT00605202|807759|P2|COMPLETED|First Intervention||5
333865|NCT00605202|807760|P1|COMPLETED|First Intervention||5
333866|NCT00605202|807759|P2|STARTED|First Intervention||5
333867|NCT00605202|807760|P1|STARTED|First Intervention||5
333868|NCT00605189|807769|P3|NOT COMPLETED|Overall Study||0
333869|NCT00605189|807770|P2|NOT COMPLETED|Overall Study||2
333870|NCT00605189|807771|P1|NOT COMPLETED|Overall Study||3
333871|NCT00605189|807769|P3|COMPLETED|Overall Study||9
333872|NCT00605189|807770|P2|COMPLETED|Overall Study||19
333873|NCT00605189|807771|P1|COMPLETED|Overall Study||17
333874|NCT00605189|807769|P3|STARTED|Overall Study||9
333875|NCT00605189|807770|P2|STARTED|Overall Study||21
333876|NCT00605189|807771|P1|STARTED|Overall Study||20
333877|NCT00605176|807782|P3|NOT COMPLETED|Overall Study||9
333878|NCT00605176|807783|P2|NOT COMPLETED|Overall Study||6
333879|NCT00605176|807784|P1|NOT COMPLETED|Overall Study||11
333880|NCT00605176|807782|P3|COMPLETED|Overall Study||150
333881|NCT00605176|807783|P2|COMPLETED|Overall Study||154
333882|NCT00605176|807784|P1|COMPLETED|Overall Study||149
333883|NCT00605176|807782|P3|STARTED|Overall Study||159
333884|NCT00605176|807783|P2|STARTED|Overall Study||160
333885|NCT00605176|807784|P1|STARTED|Overall Study||160
333886|NCT00605150|807801|P1|NOT COMPLETED|Overall Study||1
333887|NCT00605150|807801|P1|COMPLETED|Overall Study||10
333888|NCT00605150|807801|P1|STARTED|Overall Study|11 started|11
333889|NCT00605085|807808|P2|NOT COMPLETED|Overall Study||25
333890|NCT00605085|807809|P1|NOT COMPLETED|Overall Study||50
333891|NCT00605085|807808|P2|COMPLETED|Overall Study||638
333892|NCT00605085|807809|P1|COMPLETED|Overall Study||1962
333893|NCT00605085|807808|P2|STARTED|Overall Study||663
333894|NCT00605085|807809|P1|STARTED|Overall Study||2012
333895|NCT00605072|807818|P3|NOT COMPLETED|Overall Study||4
333896|NCT00605072|807819|P2|NOT COMPLETED|Overall Study||11
333897|NCT00605072|807820|P1|NOT COMPLETED|Overall Study||7
333898|NCT00605072|807818|P3|COMPLETED|Overall Study||11
333899|NCT00605072|807819|P2|COMPLETED|Overall Study||9
333900|NCT00605072|807820|P1|COMPLETED|Overall Study||11
333901|NCT00605072|807818|P3|STARTED|Overall Study||15
333902|NCT00605072|807819|P2|STARTED|Overall Study||20
333903|NCT00605072|807820|P1|STARTED|Overall Study||18
333904|NCT00605033|807842|P2|NOT COMPLETED|Overall Study||8
333905|NCT00605033|807843|P1|NOT COMPLETED|Overall Study||7
333906|NCT00605033|807842|P2|COMPLETED|Overall Study||90
333907|NCT00605033|807843|P1|COMPLETED|Overall Study||136
333908|NCT00605033|807842|P2|STARTED|Overall Study|One participant was randomized but withdrew before taking any study medication (treated n=97).|98
333909|NCT00605033|807843|P1|STARTED|Overall Study||143
333910|NCT00604968|807849|P1|NOT COMPLETED|Overall Study||0
333911|NCT00604968|807849|P1|COMPLETED|Overall Study|Due to the nature of study, all subjects receiving drug were considered to have completed.|25
333912|NCT00604968|807849|P1|STARTED|Overall Study||25
333913|NCT00604890|807866|P4|NOT COMPLETED|Overall Study||4
333914|NCT00604890|807867|P3|NOT COMPLETED|Overall Study||1
333915|NCT00604890|807868|P2|NOT COMPLETED|Overall Study||0
333916|NCT00604890|807869|P1|NOT COMPLETED|Overall Study||3
333917|NCT00604890|807866|P4|COMPLETED|Overall Study||42
333918|NCT00604890|807867|P3|COMPLETED|Overall Study||47
333919|NCT00604890|807868|P2|COMPLETED|Overall Study||45
333920|NCT00604890|807869|P1|COMPLETED|Overall Study||44
333921|NCT00604890|807866|P4|STARTED|Overall Study||46
333922|NCT00604890|807867|P3|STARTED|Overall Study||48
333923|NCT00604890|807868|P2|STARTED|Overall Study||45
333924|NCT00604890|807869|P1|STARTED|Overall Study||47
333925|NCT00604825|807887|P4|NOT COMPLETED|Overall Study||11
333926|NCT00604825|807888|P3|NOT COMPLETED|Overall Study||16
333927|NCT00604825|807889|P2|NOT COMPLETED|Overall Study||15
333928|NCT00604825|807890|P1|NOT COMPLETED|Overall Study||9
333929|NCT00604825|807887|P4|COMPLETED|Overall Study||79
333930|NCT00604825|807888|P3|COMPLETED|Overall Study||73
333931|NCT00604825|807889|P2|COMPLETED|Overall Study||72
333932|NCT00604825|807890|P1|COMPLETED|Overall Study||81
333933|NCT00604825|807887|P4|STARTED|Overall Study||90
333934|NCT00604825|807888|P3|STARTED|Overall Study||89
333935|NCT00604825|807889|P2|STARTED|Overall Study||87
333936|NCT00604825|807890|P1|STARTED|Overall Study||90
333937|NCT00604812|808091|P6|NOT COMPLETED|Overall Study||0
333938|NCT00604812|808092|P5|NOT COMPLETED|Overall Study||0
333939|NCT00604812|808093|P4|NOT COMPLETED|Overall Study||0
333940|NCT00604812|808094|P3|NOT COMPLETED|Overall Study||0
333941|NCT00604812|808095|P2|NOT COMPLETED|Overall Study||0
333942|NCT00604812|808096|P1|NOT COMPLETED|Overall Study||0
333943|NCT00604812|808091|P6|COMPLETED|Overall Study||1
333944|NCT00604812|808092|P5|COMPLETED|Overall Study||5
333945|NCT00604812|808093|P4|COMPLETED|Overall Study||3
333946|NCT00604812|808094|P3|COMPLETED|Overall Study||10
333947|NCT00604812|808095|P2|COMPLETED|Overall Study||3
333948|NCT00604812|808096|P1|COMPLETED|Overall Study||9
333949|NCT00604812|808091|P6|STARTED|Overall Study||1
333950|NCT00604812|808092|P5|STARTED|Overall Study||5
333951|NCT00604812|808093|P4|STARTED|Overall Study||3
333952|NCT00604812|808094|P3|STARTED|Overall Study||10
333953|NCT00604812|808095|P2|STARTED|Overall Study||3
333954|NCT00604812|808096|P1|STARTED|Overall Study||9
333955|NCT00604786|808118|P2|NOT COMPLETED|Overall Study||0
333956|NCT00604786|808119|P1|NOT COMPLETED|Overall Study||2
333957|NCT00604786|808118|P2|COMPLETED|Overall Study||4
333958|NCT00604786|808119|P1|COMPLETED|Overall Study||12
333959|NCT00604786|808118|P2|STARTED|Overall Study||4
333960|NCT00604786|808119|P1|STARTED|Overall Study||14
333961|NCT00604721|808125|P1|NOT COMPLETED|Overall Study||2
333962|NCT00604721|808125|P1|COMPLETED|Overall Study|2 patients failed to complete a full cycle of therapy.|17
333963|NCT00604721|808125|P1|STARTED|Overall Study||19
333964|NCT00604708|808133|P2|NOT COMPLETED|Overall Study||40
333965|NCT00604708|808134|P1|NOT COMPLETED|Overall Study||31
333966|NCT00604708|808133|P2|COMPLETED|Overall Study||397
333967|NCT00604708|808134|P1|COMPLETED|Overall Study||399
333968|NCT00604708|808133|P2|STARTED|Overall Study||437
333969|NCT00604708|808134|P1|STARTED|Overall Study||430
333970|NCT00604695|808144|P2|NOT COMPLETED|Overall Study||4
333971|NCT00604695|808145|P1|NOT COMPLETED|Overall Study||0
333972|NCT00604695|808144|P2|COMPLETED|Overall Study||16
333973|NCT00604695|808145|P1|COMPLETED|Overall Study||20
333974|NCT00604695|808144|P2|STARTED|Overall Study||20
333975|NCT00604695|808145|P1|STARTED|Overall Study||20
333976|NCT00604669|808167|P1|NOT COMPLETED|Overall Study||7
333977|NCT00604669|808167|P1|COMPLETED|Overall Study||163
333978|NCT00604669|808167|P1|STARTED|Overall Study||170
333979|NCT00604565|808173|P2|NOT COMPLETED|Overall Study||3
333980|NCT00604565|808174|P1|NOT COMPLETED|Overall Study||0
333981|NCT00604565|808173|P2|COMPLETED|Overall Study||4
333982|NCT00604565|808174|P1|COMPLETED|Overall Study||4
333983|NCT00604565|808173|P2|STARTED|Overall Study||7
333984|NCT00604565|808174|P1|STARTED|Overall Study||4
333985|NCT00604552|808184|P2|NOT COMPLETED|Overall Study||0
333986|NCT00604552|808185|P1|NOT COMPLETED|Overall Study||0
333987|NCT00604552|808184|P2|COMPLETED|Overall Study||160
333988|NCT00604552|808185|P1|COMPLETED|Overall Study||189
333989|NCT00604552|808184|P2|STARTED|Overall Study||160
333990|NCT00604552|808185|P1|STARTED|Overall Study||189
333991|NCT00604500|808193|P1|NOT COMPLETED|Overall Study||11
333992|NCT00604500|808193|P1|COMPLETED|Overall Study|There were 233 participants who took at least 90% of the labeled actuations (Completer Population).|261
333993|NCT00604500|808193|P1|STARTED|Overall Study||272
333994|NCT00604461|808200|P1|NOT COMPLETED|Overall Study||1
333995|NCT00604461|808200|P1|COMPLETED|Overall Study|Death within 30 days of treatment occurred in 1 patient.|12
333996|NCT00604461|808200|P1|STARTED|Overall Study||13
333997|NCT00604383|808207|P2|NOT COMPLETED|Overall Study||84
333998|NCT00604383|808208|P1|NOT COMPLETED|Overall Study||87
333999|NCT00604383|808207|P2|COMPLETED|Overall Study||256
334000|NCT00604383|808208|P1|COMPLETED|Overall Study||258
334001|NCT00604383|808207|P2|Received Extended Treatment|Overall Study||141
334002|NCT00604383|808208|P1|Received Extended Treatment|Overall Study||136
334003|NCT00604383|808207|P2|Received at Least 1 Dose of Study Drug|Overall Study||340
334004|NCT00604383|808208|P1|Received at Least 1 Dose of Study Drug|Overall Study||345
334005|NCT00604383|808207|P2|STARTED|Overall Study||340
334006|NCT00604383|808208|P1|STARTED|Overall Study||345
334007|NCT00604279|808224|P2|NOT COMPLETED|Overall Study||38
334008|NCT00604279|808225|P1|NOT COMPLETED|Overall Study||64
334009|NCT00604279|808224|P2|COMPLETED|Overall Study||185
334010|NCT00604279|808225|P1|COMPLETED|Overall Study||165
334011|NCT00604279|808224|P2|STARTED|Overall Study||223
334012|NCT00604279|808225|P1|STARTED|Overall Study||229
334013|NCT00604214|808241|P2|NOT COMPLETED|Day 91 to Day 180||32
334014|NCT00604214|808242|P1|NOT COMPLETED|Day 91 to Day 180||26
334015|NCT00604214|808241|P2|COMPLETED|Day 91 to Day 180||521
334016|NCT00604214|808242|P1|COMPLETED|Day 91 to Day 180||529
334017|NCT00604214|808241|P2|STARTED|Day 91 to Day 180||553
334018|NCT00604214|808242|P1|STARTED|Day 91 to Day 180||555
334019|NCT00604214|808241|P2|NOT COMPLETED|Day 29 to Day 90||79
334020|NCT00604214|808242|P1|NOT COMPLETED|Day 29 to Day 90||68
334021|NCT00604214|808241|P2|COMPLETED|Day 29 to Day 90||553
334022|NCT00604214|808242|P1|COMPLETED|Day 29 to Day 90||555
334023|NCT00604214|808241|P2|STARTED|Day 29 to Day 90||632
334024|NCT00604214|808242|P1|STARTED|Day 29 to Day 90||623
334025|NCT00604214|808241|P2|NOT COMPLETED|Baseline to Day 28||213
334026|NCT00604214|808242|P1|NOT COMPLETED|Baseline to Day 28||228
334027|NCT00604214|808241|P2|COMPLETED|Baseline to Day 28||632
334028|NCT00604214|808242|P1|COMPLETED|Baseline to Day 28||623
334029|NCT00604214|808241|P2|Received Study Drug|Baseline to Day 28||833
334030|NCT00604214|808242|P1|Received Study Drug|Baseline to Day 28||833
334031|NCT00604214|808241|P2|STARTED|Baseline to Day 28||845
334032|NCT00604214|808242|P1|STARTED|Baseline to Day 28||851
334033|NCT00604188|808274|P2|NOT COMPLETED|Overall Study||25
334034|NCT00604188|808275|P1|NOT COMPLETED|Overall Study||27
334035|NCT00604188|808274|P2|COMPLETED|Overall Study||70
334036|NCT00604188|808275|P1|COMPLETED|Overall Study||66
334037|NCT00604188|808274|P2|STARTED|Overall Study|The ITT population for Subutex-to-Suboxone Induction is 94 participants|95
334038|NCT00604188|808275|P1|STARTED|Overall Study||93
334039|NCT00604175|808298|P3|NOT COMPLETED|Week 29 Through Week 72||4
334040|NCT00604175|808299|P2|NOT COMPLETED|Week 29 Through Week 72||7
334041|NCT00604175|808300|P1|NOT COMPLETED|Week 29 Through Week 72||12
334042|NCT00604175|808298|P3|COMPLETED|Week 29 Through Week 72||89
334043|NCT00604175|808299|P2|COMPLETED|Week 29 Through Week 72||85
334044|NCT00604175|808300|P1|COMPLETED|Week 29 Through Week 72||108
334045|NCT00604175|808298|P3|STARTED|Week 29 Through Week 72||93
334046|NCT00604175|808299|P2|STARTED|Week 29 Through Week 72||92
334047|NCT00604175|808300|P1|STARTED|Week 29 Through Week 72||120
334048|NCT00604175|808298|P3|NOT COMPLETED|Entry Through Week 28||1
334049|NCT00604175|808299|P2|NOT COMPLETED|Entry Through Week 28||3
334050|NCT00604175|808300|P1|NOT COMPLETED|Entry Through Week 28||10
334051|NCT00604175|808298|P3|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|93
334052|NCT00604175|808299|P2|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|92
334053|NCT00604175|808300|P1|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|120
334054|NCT00604175|808298|P3|STARTED|Entry Through Week 28||94
334055|NCT00604175|808299|P2|STARTED|Entry Through Week 28||95
334056|NCT00604175|808300|P1|STARTED|Entry Through Week 28||130
334057|NCT00604162|808353|P1|NOT COMPLETED|Overall Study||4
334058|NCT00604162|808353|P1|COMPLETED|Overall Study||328
334059|NCT00604162|808353|P1|STARTED|Overall Study||332
334060|NCT00604045|808366|P2|NOT COMPLETED|Overall Study||1
334061|NCT00604045|808367|P1|NOT COMPLETED|Overall Study||1
334062|NCT00604045|808366|P2|COMPLETED|Overall Study||9
334063|NCT00604045|808367|P1|COMPLETED|Overall Study||14
334064|NCT00604045|808366|P2|STARTED|Overall Study||10
334065|NCT00604045|808367|P1|STARTED|Overall Study||15
334066|NCT00604019|808375|P2|NOT COMPLETED|Overall Study||0
334067|NCT00604019|808376|P1|NOT COMPLETED|Overall Study||0
334068|NCT00604019|808375|P2|COMPLETED|Overall Study||118
334069|NCT00604019|808376|P1|COMPLETED|Overall Study||134
334070|NCT00604019|808375|P2|STARTED|Overall Study||118
334071|NCT00604019|808376|P1|STARTED|Overall Study||134
334072|NCT00603993|808382|P1|NOT COMPLETED|Overall Study||20
334073|NCT00603993|808382|P1|COMPLETED|Overall Study||68
334074|NCT00603993|808382|P1|STARTED|Overall Study||88
334075|NCT00603915|808395|P1|NOT COMPLETED|Overall Study||1
334076|NCT00603915|808395|P1|COMPLETED|Overall Study||19
334077|NCT00603915|808395|P1|STARTED|Overall Study||20
334078|NCT00603902|808403|P3|NOT COMPLETED|Overall Study||769
334079|NCT00603902|808404|P2|NOT COMPLETED|Overall Study||686
334080|NCT00603902|808405|P1|NOT COMPLETED|Overall Study||329
334081|NCT00603902|808403|P3|COMPLETED|Overall Study||834
334082|NCT00603902|808404|P2|COMPLETED|Overall Study||917
334083|NCT00603902|808405|P1|COMPLETED|Overall Study||473
334084|NCT00603902|808403|P3|STARTED|Overall Study||1603
334085|NCT00603902|808404|P2|STARTED|Overall Study||1603
334086|NCT00603902|808405|P1|STARTED|Overall Study||802
334087|NCT00603889|808416|P1|NOT COMPLETED|Overall Study||0
334088|NCT00603889|808416|P1|COMPLETED|Overall Study||12
334089|NCT00603889|808416|P1|STARTED|Overall Study||12
334090|NCT00603837|808425|P2|NOT COMPLETED|Overall Study||0
334091|NCT00603837|808426|P1|NOT COMPLETED|Overall Study||3
334092|NCT00603837|808425|P2|COMPLETED|Overall Study||19
334093|NCT00603837|808426|P1|COMPLETED|Overall Study||17
334094|NCT00603837|808425|P2|STARTED|Overall Study||19
334095|NCT00603837|808426|P1|STARTED|Overall Study||20
334096|NCT00603798|808435|P3|NOT COMPLETED|Overall Study||10
334097|NCT00603798|808436|P2|NOT COMPLETED|Overall Study||7
334098|NCT00603798|808437|P1|NOT COMPLETED|Overall Study||10
334099|NCT00603798|808435|P3|COMPLETED|Overall Study||154
334100|NCT00603798|808436|P2|COMPLETED|Overall Study||157
334101|NCT00603798|808437|P1|COMPLETED|Overall Study||152
334102|NCT00603798|808435|P3|STARTED|Overall Study||164
334103|NCT00603798|808436|P2|STARTED|Overall Study||164
334104|NCT00603798|808437|P1|STARTED|Overall Study||162
334105|NCT00603746|808460|P6|NOT COMPLETED|Overall Study||13
334106|NCT00603746|808461|P5|NOT COMPLETED|Overall Study||17
334107|NCT00603746|808462|P4|NOT COMPLETED|Overall Study||13
334108|NCT00603746|808463|P3|NOT COMPLETED|Overall Study||8
334109|NCT00603746|808464|P2|NOT COMPLETED|Overall Study||18
334110|NCT00603746|808465|P1|NOT COMPLETED|Overall Study||38
334111|NCT00603746|808460|P6|COMPLETED|Overall Study||97
334112|NCT00603746|808461|P5|COMPLETED|Overall Study||85
334113|NCT00603746|808462|P4|COMPLETED|Overall Study||94
334114|NCT00603746|808463|P3|COMPLETED|Overall Study||93
334115|NCT00603746|808464|P2|COMPLETED|Overall Study||81
334116|NCT00603746|808465|P1|COMPLETED|Overall Study||65
334117|NCT00603746|808460|P6|STARTED|Overall Study||110
334118|NCT00603746|808461|P5|STARTED|Overall Study||102
334119|NCT00603746|808462|P4|STARTED|Overall Study||107
334120|NCT00603746|808463|P3|STARTED|Overall Study||101
334121|NCT00603746|808464|P2|STARTED|Overall Study||99
334122|NCT00603746|808465|P1|STARTED|Overall Study||103
334123|NCT00603733|808613|P2|NOT COMPLETED|Maintenance Phase ITT||16
334124|NCT00603733|808614|P1|NOT COMPLETED|Maintenance Phase ITT||10
334125|NCT00603733|808613|P2|COMPLETED|Maintenance Phase ITT||66
334126|NCT00603733|808614|P1|COMPLETED|Maintenance Phase ITT||61
334127|NCT00603733|808613|P2|STARTED|Maintenance Phase ITT||82
334128|NCT00603733|808614|P1|STARTED|Maintenance Phase ITT|Note:82 subjects randomized at Active phase & 71 at Run-In phase progressed to the maintenance phase|71
334129|NCT00603733|808613|P2|NOT COMPLETED|Run-In Phase - 4 Weeks||13
334130|NCT00603733|808614|P1|NOT COMPLETED|Run-In Phase - 4 Weeks||14
334131|NCT00603733|808613|P2|COMPLETED|Run-In Phase - 4 Weeks||36
334132|NCT00603733|808614|P1|COMPLETED|Run-In Phase - 4 Weeks||35
334133|NCT00603733|808613|P2|STARTED|Run-In Phase - 4 Weeks||49
334134|NCT00603733|808614|P1|STARTED|Run-In Phase - 4 Weeks|Note: Of the 98 subjects randomized at Run-In, 71 progressed into the maintenance phase.|49
334135|NCT00603733|808613|P2|NOT COMPLETED|Active Phase ITT||17
334136|NCT00603733|808614|P1|NOT COMPLETED|Active Phase ITT||11
334137|NCT00603733|808613|P2|COMPLETED|Active Phase ITT||78
334138|NCT00603733|808614|P1|COMPLETED|Active Phase ITT||84
334139|NCT00603733|808613|P2|STARTED|Active Phase ITT||95
334140|NCT00603733|808614|P1|STARTED|Active Phase ITT|Note: a total of 190 new participants were enrolled and randomized in the Active Phase|95
334141|NCT00603720|808629|P5|NOT COMPLETED|Overall Study||0
334142|NCT00603720|808630|P4|NOT COMPLETED|Overall Study||0
334143|NCT00603720|808631|P3|NOT COMPLETED|Overall Study||0
334144|NCT00603720|808632|P2|NOT COMPLETED|Overall Study||0
334145|NCT00603720|808633|P1|NOT COMPLETED|Overall Study||0
334146|NCT00603720|808629|P5|COMPLETED|Overall Study||12
334147|NCT00603720|808630|P4|COMPLETED|Overall Study||10
334148|NCT00603720|808631|P3|COMPLETED|Overall Study||12
334149|NCT00603720|808632|P2|COMPLETED|Overall Study||10
334150|NCT00603720|808633|P1|COMPLETED|Overall Study||10
334151|NCT00603720|808629|P5|STARTED|Overall Study||12
334152|NCT00603720|808630|P4|STARTED|Overall Study||10
334153|NCT00603720|808631|P3|STARTED|Overall Study||12
334154|NCT00603720|808632|P2|STARTED|Overall Study||10
334155|NCT00603720|808633|P1|STARTED|Overall Study||10
334156|NCT00603642|808647|P2|NOT COMPLETED|Overall Study||0
334157|NCT00603642|808648|P1|NOT COMPLETED|Overall Study||0
334158|NCT00603642|808647|P2|COMPLETED|Overall Study||22
334159|NCT00603642|808648|P1|COMPLETED|Overall Study||12
334160|NCT00603642|808647|P2|STARTED|Overall Study||22
334161|NCT00603642|808648|P1|STARTED|Overall Study||12
334162|NCT00603590|808664|P2|NOT COMPLETED|Overall Study||51
334163|NCT00603590|808665|P1|NOT COMPLETED|Overall Study||76
334164|NCT00603590|808664|P2|COMPLETED|Overall Study||183
334165|NCT00603590|808665|P1|COMPLETED|Overall Study||165
334166|NCT00603590|808664|P2|Eight Months|Overall Study||194
334167|NCT00603590|808665|P1|Eight Months|Overall Study||178
334168|NCT00603590|808664|P2|Four Months|Overall Study||200
334169|NCT00603590|808665|P1|Four Months|Overall Study||187
334170|NCT00603590|808664|P2|One Month|Overall Study||212
334171|NCT00603590|808665|P1|One Month|Overall Study||204
334172|NCT00603590|808664|P2|STARTED|Overall Study||234
334173|NCT00603590|808665|P1|STARTED|Overall Study||241
334174|NCT00603564|808677|P2|NOT COMPLETED|Overall Study||0
334175|NCT00603564|808678|P1|NOT COMPLETED|Overall Study||0
334176|NCT00603564|808677|P2|COMPLETED|Overall Study|February 2008|27
334177|NCT00603564|808678|P1|COMPLETED|Overall Study|February 2008|20
334178|NCT00603564|808677|P2|STARTED|Overall Study|January 2006|27
334179|NCT00603564|808678|P1|STARTED|Overall Study|January 2006|20
334180|NCT00603538|808689|P3|NOT COMPLETED|Overall Study||2
334181|NCT00603538|808690|P2|NOT COMPLETED|Overall Study||4
334182|NCT00603538|808691|P1|NOT COMPLETED|Overall Study||3
334183|NCT00603538|808689|P3|COMPLETED|Overall Study||4
334184|NCT00603538|808690|P2|COMPLETED|Overall Study||3
334185|NCT00603538|808691|P1|COMPLETED|Overall Study||3
334186|NCT00603538|808689|P3|STARTED|Overall Study||6
334187|NCT00603538|808690|P2|STARTED|Overall Study|Including one participant who discontinued from the study prior to CP-751,871 administration.|7
334188|NCT00603538|808691|P1|STARTED|Overall Study||6
334189|NCT00603525|808731|P3|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||111
334190|NCT00603525|808732|P2|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
334191|NCT00603525|808733|P1|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
334192|NCT00603525|808731|P3|COMPLETED|Follow-up Period (Approximately 2 Years)||13
334193|NCT00603525|808732|P2|COMPLETED|Follow-up Period (Approximately 2 Years)||0
334194|NCT00603525|808733|P1|COMPLETED|Follow-up Period (Approximately 2 Years)||0
334195|NCT00603525|808731|P3|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)|As par. were not on active drug during the Follow-up Period, withdrawal reasons were not collected.|111
334196|NCT00603525|808732|P2|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
334197|NCT00603525|808733|P1|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
334198|NCT00603525|808731|P3|STARTED|Follow-up Period (Approximately 2 Years)|124 participants (par) completing/withdrawing from the DB or OL Periods attended >=1 follow-up visit|124
334199|NCT00603525|808732|P2|STARTED|Follow-up Period (Approximately 2 Years)||0
334200|NCT00603525|808733|P1|STARTED|Follow-up Period (Approximately 2 Years)||0
334201|NCT00603525|808731|P3|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
334202|NCT00603525|808732|P2|NOT COMPLETED|OL Treatment Period (120 Weeks)||112
334203|NCT00603525|808733|P1|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
334204|NCT00603525|808731|P3|COMPLETED|OL Treatment Period (120 Weeks)||0
334205|NCT00603525|808732|P2|COMPLETED|OL Treatment Period (120 Weeks)||13
334206|NCT00603525|808733|P1|COMPLETED|OL Treatment Period (120 Weeks)||0
334207|NCT00603525|808731|P3|STARTED|OL Treatment Period (120 Weeks)||0
334208|NCT00603525|808732|P2|STARTED|OL Treatment Period (120 Weeks)|61 participants received OFA during the DB Period; 64 received placebo during the DB Period.|125
334209|NCT00603525|808733|P1|STARTED|OL Treatment Period (120 Weeks)||0
334210|NCT00603525|808731|P3|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
334211|NCT00603525|808732|P2|NOT COMPLETED|DB Treatment Period (24 Weeks)||22
334212|NCT00603525|808733|P1|NOT COMPLETED|DB Treatment Period (24 Weeks)||17
334213|NCT00603525|808731|P3|COMPLETED|DB Treatment Period (24 Weeks)||0
334214|NCT00603525|808732|P2|COMPLETED|DB Treatment Period (24 Weeks)||63
334215|NCT00603525|808733|P1|COMPLETED|DB Treatment Period (24 Weeks)||67
334216|NCT00603525|808731|P3|STARTED|DB Treatment Period (24 Weeks)||0
334217|NCT00603525|808732|P2|STARTED|DB Treatment Period (24 Weeks)||85
334218|NCT00603525|808733|P1|STARTED|DB Treatment Period (24 Weeks)||84
334219|NCT00603512|808865|P5|NOT COMPLETED|Overall Study||5
334220|NCT00603512|808866|P4|NOT COMPLETED|Overall Study||7
334221|NCT00603512|808867|P3|NOT COMPLETED|Overall Study||5
334222|NCT00603512|808868|P2|NOT COMPLETED|Overall Study||5
334223|NCT00603512|808869|P1|NOT COMPLETED|Overall Study||2
334224|NCT00603512|808865|P5|COMPLETED|Overall Study||23
334225|NCT00603512|808866|P4|COMPLETED|Overall Study||21
334226|NCT00603512|808867|P3|COMPLETED|Overall Study||23
334227|NCT00603512|808868|P2|COMPLETED|Overall Study||23
334228|NCT00603512|808869|P1|COMPLETED|Overall Study||26
334229|NCT00603512|808865|P5|Treated|Overall Study||28
334230|NCT00603512|808866|P4|Treated|Overall Study||26
334231|NCT00603512|808867|P3|Treated|Overall Study||27
334232|NCT00603512|808868|P2|Treated|Overall Study||27
334233|NCT00603512|808869|P1|Treated|Overall Study||28
334234|NCT00603512|808865|P5|STARTED|Overall Study||28
334235|NCT00603512|808866|P4|STARTED|Overall Study||28
334236|NCT00603512|808867|P3|STARTED|Overall Study||28
334237|NCT00603512|808868|P2|STARTED|Overall Study||28
334238|NCT00603512|808869|P1|STARTED|Overall Study||28
334239|NCT00603473|809011|P1|NOT COMPLETED|Overall Study||9
334240|NCT00603473|809011|P1|COMPLETED|Overall Study||80
334241|NCT00603473|809011|P1|STARTED|Overall Study||89
334242|NCT00603447|809024|P7|NOT COMPLETED|Overall Study||24
334243|NCT00603447|809025|P6|NOT COMPLETED|Overall Study||2
334244|NCT00603447|809026|P5|NOT COMPLETED|Overall Study||5
334245|NCT00603447|809027|P4|NOT COMPLETED|Overall Study||2
334246|NCT00603447|809028|P3|NOT COMPLETED|Overall Study||2
334247|NCT00603447|809029|P2|NOT COMPLETED|Overall Study||3
334248|NCT00603447|809030|P1|NOT COMPLETED|Overall Study||0
334249|NCT00603447|809024|P7|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|20
334250|NCT00603447|809025|P6|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
334251|NCT00603447|809026|P5|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|1
334252|NCT00603447|809027|P4|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|4
334253|NCT00603447|809028|P3|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
334254|NCT00603447|809029|P2|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|3
334255|NCT00603447|809030|P1|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
334256|NCT00603447|809024|P7|STARTED|Overall Study||44
334257|NCT00603447|809025|P6|STARTED|Overall Study||8
334258|NCT00603447|809026|P5|STARTED|Overall Study||6
334259|NCT00603447|809027|P4|STARTED|Overall Study||6
334260|NCT00603447|809028|P3|STARTED|Overall Study||8
334261|NCT00603447|809029|P2|STARTED|Overall Study||6
334262|NCT00603447|809030|P1|STARTED|Overall Study||6
334263|NCT00603408|809052|P1|NOT COMPLETED|Overall Study||0
334264|NCT00603408|809052|P1|COMPLETED|Overall Study||5
334265|NCT00603408|809052|P1|STARTED|Overall Study||5
334266|NCT00603382|809069|P6|NOT COMPLETED|Overall Study||18
334267|NCT00603382|809070|P5|NOT COMPLETED|Overall Study||9
334268|NCT00603382|809071|P4|NOT COMPLETED|Overall Study||12
334269|NCT00603382|809072|P3|NOT COMPLETED|Overall Study||9
334270|NCT00603382|809073|P2|NOT COMPLETED|Overall Study||14
334271|NCT00603382|809074|P1|NOT COMPLETED|Overall Study||18
334272|NCT00603382|809069|P6|COMPLETED|Overall Study||84
334273|NCT00603382|809070|P5|COMPLETED|Overall Study||86
334274|NCT00603382|809071|P4|COMPLETED|Overall Study||98
334275|NCT00603382|809072|P3|COMPLETED|Overall Study||91
334276|NCT00603382|809073|P2|COMPLETED|Overall Study||83
334277|NCT00603382|809074|P1|COMPLETED|Overall Study||76
334278|NCT00603382|809069|P6|STARTED|Overall Study||102
334279|NCT00603382|809070|P5|STARTED|Overall Study||95
334280|NCT00603382|809071|P4|STARTED|Overall Study||110
334281|NCT00603382|809072|P3|STARTED|Overall Study||100
334282|NCT00603382|809073|P2|STARTED|Overall Study||97
334283|NCT00603382|809074|P1|STARTED|Overall Study||94
334284|NCT00603304|809222|P2|NOT COMPLETED|Overall Study||31
334285|NCT00603304|809223|P1|NOT COMPLETED|Overall Study||32
334286|NCT00603304|809222|P2|COMPLETED|Overall Study||155
334287|NCT00603304|809223|P1|COMPLETED|Overall Study||151
334288|NCT00603304|809222|P2|STARTED|Overall Study||186
334289|NCT00603304|809223|P1|STARTED|Overall Study||183
334290|NCT00603291|809260|P3|NOT COMPLETED|Overall Study||96
334291|NCT00603291|809261|P2|NOT COMPLETED|Overall Study||87
334292|NCT00603291|809262|P1|NOT COMPLETED|Overall Study||20
334293|NCT00603291|809260|P3|COMPLETED|Overall Study||157
334294|NCT00603291|809261|P2|COMPLETED|Overall Study||169
334295|NCT00603291|809262|P1|COMPLETED|Overall Study||75
334296|NCT00603291|809260|P3|STARTED|Overall Study||253
334297|NCT00603291|809261|P2|STARTED|Overall Study||256
334298|NCT00603291|809262|P1|STARTED|Overall Study||95
334299|NCT00603278|809279|P6|NOT COMPLETED|Overall Study||19
334300|NCT00603278|809280|P5|NOT COMPLETED|Overall Study||13
334301|NCT00603278|809281|P4|NOT COMPLETED|Overall Study||11
334302|NCT00603278|809282|P3|NOT COMPLETED|Overall Study||14
334303|NCT00603278|809283|P2|NOT COMPLETED|Overall Study||17
334304|NCT00603278|809284|P1|NOT COMPLETED|Overall Study||41
334305|NCT00603278|809279|P6|COMPLETED|Overall Study||81
334306|NCT00603278|809280|P5|COMPLETED|Overall Study||86
334307|NCT00603278|809281|P4|COMPLETED|Overall Study||92
334308|NCT00603278|809282|P3|COMPLETED|Overall Study||87
334309|NCT00603278|809283|P2|COMPLETED|Overall Study||88
334310|NCT00603278|809284|P1|COMPLETED|Overall Study||66
334311|NCT00603278|809279|P6|STARTED|Overall Study||100
334312|NCT00603278|809280|P5|STARTED|Overall Study||99
334313|NCT00603278|809281|P4|STARTED|Overall Study||103
334314|NCT00603278|809282|P3|STARTED|Overall Study||101
334315|NCT00603278|809283|P2|STARTED|Overall Study||105
334316|NCT00603278|809284|P1|STARTED|Overall Study||107
334317|NCT00603265|809433|P3|NOT COMPLETED|Overall Study||5
334318|NCT00603265|809434|P2|NOT COMPLETED|Overall Study||16
334319|NCT00603265|809435|P1|NOT COMPLETED|Overall Study||7
334320|NCT00603265|809433|P3|COMPLETED|Overall Study||67
334321|NCT00603265|809434|P2|COMPLETED|Overall Study||62
334322|NCT00603265|809435|P1|COMPLETED|Overall Study||69
334323|NCT00603265|809433|P3|Received at Least 1 Dose of Study Drug|Overall Study||72
334324|NCT00603265|809434|P2|Received at Least 1 Dose of Study Drug|Overall Study||78
334325|NCT00603265|809435|P1|Received at Least 1 Dose of Study Drug|Overall Study||75
334326|NCT00603265|809433|P3|STARTED|Overall Study||72
334327|NCT00603265|809434|P2|STARTED|Overall Study||78
334328|NCT00603265|809435|P1|STARTED|Overall Study|1 participant was randomized in error and did not receive study medication|76
334329|NCT00603239|809463|P2|NOT COMPLETED|Overall Study||4
334330|NCT00603239|809464|P1|NOT COMPLETED|Overall Study||15
334331|NCT00603239|809463|P2|COMPLETED|Overall Study||50
334332|NCT00603239|809464|P1|COMPLETED|Overall Study||96
334333|NCT00603239|809463|P2|STARTED|Overall Study||54
334334|NCT00603239|809464|P1|STARTED|Overall Study||111
334335|NCT00603187|809490|P1|NOT COMPLETED|Overall Study||0
334336|NCT00603187|809490|P1|COMPLETED|Overall Study||4
334337|NCT00603187|809490|P1|STARTED|Overall Study||4
334338|NCT00603044|809498|P2|NOT COMPLETED|Overall Study||0
334339|NCT00603044|809499|P1|NOT COMPLETED|Overall Study||0
334340|NCT00603044|809498|P2|COMPLETED|Overall Study||13
334341|NCT00603044|809499|P1|COMPLETED|Overall Study||11
334342|NCT00603044|809498|P2|STARTED|Overall Study||13
334343|NCT00603044|809499|P1|STARTED|Overall Study||11
334344|NCT00603018|809515|P1|NOT COMPLETED|Overall Study||0
334345|NCT00603018|809515|P1|COMPLETED|Overall Study||23
334346|NCT00603018|809515|P1|STARTED|Overall Study||23
334347|NCT00602979|809525|P5|NOT COMPLETED|Overall Study||3
334348|NCT00602979|809526|P4|NOT COMPLETED|Overall Study||3
334349|NCT00602979|809527|P3|NOT COMPLETED|Overall Study||3
334350|NCT00602979|809528|P2|NOT COMPLETED|Overall Study||3
334351|NCT00602979|809529|P1|NOT COMPLETED|Overall Study||3
334352|NCT00602979|809525|P5|COMPLETED|Overall Study||45
334353|NCT00602979|809526|P4|COMPLETED|Overall Study||45
334354|NCT00602979|809527|P3|COMPLETED|Overall Study||45
334355|NCT00602979|809528|P2|COMPLETED|Overall Study||45
334356|NCT00602979|809529|P1|COMPLETED|Overall Study||45
334357|NCT00602979|809525|P5|STARTED|Overall Study||48
334358|NCT00602979|809526|P4|STARTED|Overall Study||48
334359|NCT00602979|809527|P3|STARTED|Overall Study||48
334360|NCT00602979|809528|P2|STARTED|Overall Study||48
334361|NCT00602979|809529|P1|STARTED|Overall Study||48
334362|NCT00602953|809546|P5|NOT COMPLETED|Overall Study||0
334363|NCT00602953|809547|P4|NOT COMPLETED|Overall Study||0
334364|NCT00602953|809548|P3|NOT COMPLETED|Overall Study||0
334365|NCT00602953|809549|P2|NOT COMPLETED|Overall Study||0
334366|NCT00602953|809550|P1|NOT COMPLETED|Overall Study||0
334367|NCT00602953|809546|P5|COMPLETED|Overall Study||0
334368|NCT00602953|809547|P4|COMPLETED|Overall Study||13
334369|NCT00602953|809548|P3|COMPLETED|Overall Study||47
334370|NCT00602953|809549|P2|COMPLETED|Overall Study||26
334371|NCT00602953|809550|P1|COMPLETED|Overall Study||15
334372|NCT00602953|809546|P5|STARTED|Overall Study||0
334373|NCT00602953|809547|P4|STARTED|Overall Study||13
334374|NCT00602953|809548|P3|STARTED|Overall Study||47
334375|NCT00602953|809549|P2|STARTED|Overall Study||26
334376|NCT00602953|809550|P1|STARTED|Overall Study||15
334377|NCT00602927|809579|P2|NOT COMPLETED|Period 3: 13 Days||3
334378|NCT00602927|809580|P1|NOT COMPLETED|Period 3: 13 Days||2
334379|NCT00602927|809579|P2|COMPLETED|Period 3: 13 Days||9
334380|NCT00602927|809580|P1|COMPLETED|Period 3: 13 Days||13
334381|NCT00602927|809579|P2|STARTED|Period 3: 13 Days||12
334382|NCT00602927|809580|P1|STARTED|Period 3: 13 Days||15
334383|NCT00602927|809579|P2|NOT COMPLETED|Period 2: 14 Days||2
334384|NCT00602927|809580|P1|NOT COMPLETED|Period 2: 14 Days||0
334385|NCT00602927|809579|P2|COMPLETED|Period 2: 14 Days||12
334386|NCT00602927|809580|P1|COMPLETED|Period 2: 14 Days||15
334387|NCT00602927|809579|P2|STARTED|Period 2: 14 Days||14
334388|NCT00602927|809580|P1|STARTED|Period 2: 14 Days||15
334389|NCT00602927|809579|P2|NOT COMPLETED|Period 1: 13 Days||5
334390|NCT00602927|809580|P1|NOT COMPLETED|Period 1: 13 Days||4
334391|NCT00602927|809579|P2|COMPLETED|Period 1: 13 Days||14
334392|NCT00602927|809580|P1|COMPLETED|Period 1: 13 Days||15
334393|NCT00602927|809579|P2|STARTED|Period 1: 13 Days||19
334394|NCT00602927|809580|P1|STARTED|Period 1: 13 Days||19
334395|NCT00602836|809588|P1|NOT COMPLETED|Overall Study||5
334396|NCT00602836|809588|P1|COMPLETED|Overall Study||39
334397|NCT00602836|809588|P1|STARTED|Overall Study||44
334398|NCT00602797|809592|P1|NOT COMPLETED|Overall Study||1
334399|NCT00602797|809592|P1|COMPLETED|Overall Study||19
334400|NCT00602797|809592|P1|STARTED|Overall Study||20
334401|NCT00602771|809600|P2|NOT COMPLETED|Overall Study||0
334402|NCT00602771|809601|P1|NOT COMPLETED|Overall Study||1
334403|NCT00602771|809600|P2|COMPLETED|Overall Study||21
334404|NCT00602771|809601|P1|COMPLETED|Overall Study||62
334405|NCT00602771|809600|P2|STARTED|Overall Study||21
334406|NCT00602771|809601|P1|STARTED|Overall Study||63
334407|NCT00602667|809610|P3|NOT COMPLETED|Overall Study||63
334408|NCT00602667|809611|P2|NOT COMPLETED|Overall Study||81
334409|NCT00602667|809612|P1|NOT COMPLETED|Overall Study||19
334410|NCT00602667|809610|P3|COMPLETED|Overall Study||14
334411|NCT00602667|809611|P2|COMPLETED|Overall Study||75
334412|NCT00602667|809612|P1|COMPLETED|Overall Study||38
334413|NCT00602667|809610|P3|STARTED|Overall Study||77
334414|NCT00602667|809611|P2|STARTED|Overall Study||156
334415|NCT00602667|809612|P1|STARTED|Overall Study||57
334416|NCT00602641|809790|P2|NOT COMPLETED|Overall Study||152
334417|NCT00602641|809791|P1|NOT COMPLETED|Overall Study||154
334418|NCT00602641|809790|P2|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
334419|NCT00602641|809791|P1|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
334420|NCT00602641|809790|P2|Started Protocol Therapy|Overall Study||150
334421|NCT00602641|809791|P1|Started Protocol Therapy|Overall Study||148
334422|NCT00602641|809790|P2|STARTED|Overall Study||152
334423|NCT00602641|809791|P1|STARTED|Overall Study||154
334424|NCT00602537|809805|P2|NOT COMPLETED|Follow Up Study Comparison||3
334425|NCT00602537|809806|P1|NOT COMPLETED|Follow Up Study Comparison||11
334426|NCT00602537|809805|P2|COMPLETED|Follow Up Study Comparison||14
334427|NCT00602537|809806|P1|COMPLETED|Follow Up Study Comparison||31
334428|NCT00602537|809805|P2|STARTED|Follow Up Study Comparison||17
334429|NCT00602537|809806|P1|STARTED|Follow Up Study Comparison||42
334430|NCT00602537|809805|P2|NOT COMPLETED|12 Week Double Blind Comparison||47
334431|NCT00602537|809806|P1|NOT COMPLETED|12 Week Double Blind Comparison||23
334432|NCT00602537|809805|P2|COMPLETED|12 Week Double Blind Comparison||17
334433|NCT00602537|809806|P1|COMPLETED|12 Week Double Blind Comparison||42
334434|NCT00602537|809805|P2|Responded|12 Week Double Blind Comparison||22
334435|NCT00602537|809806|P1|Responded|12 Week Double Blind Comparison||44
334436|NCT00602537|809805|P2|STARTED|12 Week Double Blind Comparison||64
334437|NCT00602537|809806|P1|STARTED|12 Week Double Blind Comparison||65
334438|NCT00602472|809816|P2|NOT COMPLETED|Overall Study||58
334439|NCT00602472|809817|P1|NOT COMPLETED|Overall Study||21
334440|NCT00602472|809816|P2|COMPLETED|Overall Study|number who completed treatment|734
334441|NCT00602472|809817|P1|COMPLETED|Overall Study|number who completed treatment|242
334442|NCT00602472|809816|P2|STARTED|Overall Study|3 randomised patients never took medication.|792
334443|NCT00602472|809817|P1|STARTED|Overall Study|3 randomised patients never took medication.|263
334444|NCT00602459|809851|P4|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
334445|NCT00602459|809852|P3|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
334446|NCT00602459|809853|P2|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
334447|NCT00602459|809854|P1|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
334448|NCT00602459|809851|P4|COMPLETED|Re-assignment After Del(11q22.3) Testing||31
334449|NCT00602459|809852|P3|COMPLETED|Re-assignment After Del(11q22.3) Testing||137
334450|NCT00602459|809853|P2|COMPLETED|Re-assignment After Del(11q22.3) Testing||109
334451|NCT00602459|809854|P1|COMPLETED|Re-assignment After Del(11q22.3) Testing||123
334452|NCT00602459|809851|P4|STARTED|Re-assignment After Del(11q22.3) Testing||31
334453|NCT00602459|809852|P3|STARTED|Re-assignment After Del(11q22.3) Testing||137
334454|NCT00602459|809853|P2|STARTED|Re-assignment After Del(11q22.3) Testing||109
334455|NCT00602459|809854|P1|STARTED|Re-assignment After Del(11q22.3) Testing||123
334456|NCT00602459|809851|P4|NOT COMPLETED|Initial Registration/Randomization||0
334457|NCT00602459|809852|P3|NOT COMPLETED|Initial Registration/Randomization||3
334458|NCT00602459|809853|P2|NOT COMPLETED|Initial Registration/Randomization||10
334459|NCT00602459|809854|P1|NOT COMPLETED|Initial Registration/Randomization||5
334460|NCT00602459|809851|P4|COMPLETED|Initial Registration/Randomization||0
334461|NCT00602459|809852|P3|COMPLETED|Initial Registration/Randomization||137
334462|NCT00602459|809853|P2|COMPLETED|Initial Registration/Randomization||130
334463|NCT00602459|809854|P1|COMPLETED|Initial Registration/Randomization||133
334464|NCT00602459|809851|P4|STARTED|Initial Registration/Randomization||0
334465|NCT00602459|809852|P3|STARTED|Initial Registration/Randomization||140
334466|NCT00602459|809853|P2|STARTED|Initial Registration/Randomization||140
334467|NCT00602459|809854|P1|STARTED|Initial Registration/Randomization||138
334468|NCT00602446|809875|P1|NOT COMPLETED|Overall Study||0
334469|NCT00602446|809875|P1|COMPLETED|Overall Study||3
334470|NCT00602446|809875|P1|STARTED|Overall Study||3
334471|NCT00602420|809882|P2|NOT COMPLETED|Overall Study||24
334472|NCT00602420|809883|P1|NOT COMPLETED|Overall Study||25
334473|NCT00602420|809882|P2|COMPLETED|Overall Study||229
334474|NCT00602420|809883|P1|COMPLETED|Overall Study||232
334475|NCT00602420|809882|P2|STARTED|Overall Study||253
334476|NCT00602420|809883|P1|STARTED|Overall Study||257
334477|NCT00602355|809892|P3|NOT COMPLETED|Overall Study||10
334478|NCT00602355|809893|P2|NOT COMPLETED|Overall Study||18
334479|NCT00602355|809894|P1|NOT COMPLETED|Overall Study||9
334480|NCT00602355|809892|P3|COMPLETED|Overall Study||43
334481|NCT00602355|809893|P2|COMPLETED|Overall Study||38
334482|NCT00602355|809894|P1|COMPLETED|Overall Study||44
334483|NCT00602355|809892|P3|STARTED|Overall Study||53
334484|NCT00602355|809893|P2|STARTED|Overall Study||56
334485|NCT00602355|809894|P1|STARTED|Overall Study||53
334486|NCT00602290|809917|P3|NOT COMPLETED|Overall Study||1
334487|NCT00602290|809918|P2|NOT COMPLETED|Overall Study||2
334488|NCT00602290|809919|P1|NOT COMPLETED|Overall Study||2
334489|NCT00602290|809917|P3|COMPLETED|Overall Study||46
334490|NCT00602290|809918|P2|COMPLETED|Overall Study||46
334491|NCT00602290|809919|P1|COMPLETED|Overall Study||46
334492|NCT00602290|809917|P3|STARTED|Overall Study||47
334493|NCT00602290|809918|P2|STARTED|Overall Study||48
334494|NCT00602290|809919|P1|STARTED|Overall Study||48
334495|NCT00602225|809930|P1|NOT COMPLETED|Overall Study||0
334496|NCT00602225|809930|P1|COMPLETED|Overall Study||50
334497|NCT00602225|809930|P1|STARTED|Overall Study||50
334498|NCT00602043|809943|P1|NOT COMPLETED|Overall Study||5
334499|NCT00602043|809943|P1|COMPLETED|Overall Study||15
334500|NCT00602043|809943|P1|STARTED|Overall Study||20
334501|NCT00601965|809957|P4|NOT COMPLETED|Overall Study||1
334502|NCT00601965|809958|P3|NOT COMPLETED|Overall Study||0
334503|NCT00601965|809959|P2|NOT COMPLETED|Overall Study||2
334504|NCT00601965|809960|P1|NOT COMPLETED|Overall Study||0
334505|NCT00601965|809957|P4|COMPLETED|Overall Study||17
334506|NCT00601965|809958|P3|COMPLETED|Overall Study||19
334507|NCT00601965|809959|P2|COMPLETED|Overall Study||16
334508|NCT00601965|809960|P1|COMPLETED|Overall Study||18
334509|NCT00601965|809957|P4|STARTED|Overall Study||18
334510|NCT00601965|809958|P3|STARTED|Overall Study||19
334511|NCT00601965|809959|P2|STARTED|Overall Study||18
334512|NCT00601965|809960|P1|STARTED|Overall Study||18
334513|NCT00601952|809976|P2|NOT COMPLETED|Overall Study||0
334514|NCT00601952|809977|P1|NOT COMPLETED|Overall Study||2
334515|NCT00601952|809976|P2|COMPLETED|Overall Study||17
334516|NCT00601952|809977|P1|COMPLETED|Overall Study||12
334517|NCT00601952|809976|P2|STARTED|Overall Study||17
334518|NCT00601952|809977|P1|STARTED|Overall Study||14
334519|NCT00601926|809983|P1|NOT COMPLETED|Overall Study||0
334520|NCT00601926|809983|P1|COMPLETED|Overall Study||5
334521|NCT00601926|809983|P1|STARTED|Overall Study||5
334522|NCT00601900|809991|P2|NOT COMPLETED|Overall Study||3
334523|NCT00601900|809992|P1|NOT COMPLETED|Overall Study||0
334524|NCT00601900|809991|P2|COMPLETED|Overall Study||196
334525|NCT00601900|809992|P1|COMPLETED|Overall Study||195
334526|NCT00601900|809991|P2|STARTED|Overall Study||199
334527|NCT00601900|809992|P1|STARTED|Overall Study||195
334528|NCT00601835|810008|P2|NOT COMPLETED|Overall Study||14
334529|NCT00601835|810009|P1|NOT COMPLETED|Overall Study||60
334530|NCT00601835|810008|P2|COMPLETED|Overall Study||686
334531|NCT00601835|810009|P1|COMPLETED|Overall Study||2890
334532|NCT00601835|810008|P2|STARTED|Overall Study||700
334533|NCT00601835|810009|P1|STARTED|Overall Study||2950
334534|NCT00601796|810019|P1|NOT COMPLETED|Overall Study||0
334535|NCT00601796|810019|P1|COMPLETED|Overall Study||24
334536|NCT00601796|810019|P1|STARTED|Overall Study||24
334537|NCT00601731|810038|P4|NOT COMPLETED|Overall Study||1
334538|NCT00601731|810039|P3|NOT COMPLETED|Overall Study||15
334539|NCT00601731|810040|P2|NOT COMPLETED|Overall Study||0
334540|NCT00601731|810041|P1|NOT COMPLETED|Overall Study||23
334541|NCT00601731|810038|P4|COMPLETED|Overall Study||29
334542|NCT00601731|810039|P3|COMPLETED|Overall Study||151
334543|NCT00601731|810040|P2|COMPLETED|Overall Study||43
334544|NCT00601731|810041|P1|COMPLETED|Overall Study||120
334545|NCT00601731|810038|P4|STARTED|Overall Study||30
334546|NCT00601731|810039|P3|STARTED|Overall Study||166
334547|NCT00601731|810040|P2|STARTED|Overall Study||43
334548|NCT00601731|810041|P1|STARTED|Overall Study||143
334549|NCT00601718|810091|P1|NOT COMPLETED|Overall Study||0
334550|NCT00601718|810091|P1|COMPLETED|Overall Study||29
334551|NCT00601718|810091|P1|STARTED|Overall Study||29
334552|NCT00601705|810098|P1|NOT COMPLETED|Overall Study||1
334553|NCT00601705|810098|P1|COMPLETED|Overall Study||60
334554|NCT00601705|810098|P1|STARTED|Overall Study||61
334555|NCT00601640|810110|P3|NOT COMPLETED|Overall Study||10
334556|NCT00601640|810111|P2|NOT COMPLETED|Overall Study||5
334557|NCT00601640|810112|P1|NOT COMPLETED|Overall Study||5
334558|NCT00601640|810110|P3|COMPLETED|Overall Study||42
334559|NCT00601640|810111|P2|COMPLETED|Overall Study||47
334560|NCT00601640|810112|P1|COMPLETED|Overall Study||47
334561|NCT00601640|810110|P3|STARTED|Overall Study||52
334562|NCT00601640|810111|P2|STARTED|Overall Study||52
334563|NCT00601640|810112|P1|STARTED|Overall Study||52
334564|NCT00601627|810126|P1|NOT COMPLETED|Overall Study||0
334565|NCT00601627|810126|P1|COMPLETED|Overall Study||51
334566|NCT00601627|810126|P1|STARTED|Overall Study||51
334567|NCT00601523|810137|P2|NOT COMPLETED|Overall Study||26
334568|NCT00601523|810138|P1|NOT COMPLETED|Overall Study||77
334569|NCT00601523|810137|P2|COMPLETED|Overall Study||117
334570|NCT00601523|810138|P1|COMPLETED|Overall Study||291
334571|NCT00601523|810137|P2|STARTED|Overall Study||143
334572|NCT00601523|810138|P1|STARTED|Overall Study||368
334573|NCT00601458|810173|P3|NOT COMPLETED|Overall Study||2
334574|NCT00601458|810174|P2|NOT COMPLETED|Overall Study||5
334575|NCT00601458|810175|P1|NOT COMPLETED|Overall Study||4
334576|NCT00601458|810173|P3|COMPLETED|Overall Study||28
334577|NCT00601458|810174|P2|COMPLETED|Overall Study||29
334578|NCT00601458|810175|P1|COMPLETED|Overall Study||32
334579|NCT00601458|810173|P3|STARTED|Overall Study||30
334580|NCT00601458|810174|P2|STARTED|Overall Study||34
334581|NCT00601458|810175|P1|STARTED|Overall Study||36
334582|NCT00601419|810186|P1|NOT COMPLETED|Overall Study||4
334583|NCT00601419|810186|P1|COMPLETED|Overall Study||226
334584|NCT00601419|810186|P1|STARTED|Overall Study||230
334585|NCT00601367|810210|P1|NOT COMPLETED|Overall Study||187
334586|NCT00601367|810210|P1|COMPLETED|Overall Study||293
334587|NCT00601367|810210|P1|STARTED|Overall Study||480
334588|NCT00601354|810216|P2|NOT COMPLETED|Overall Study||5
334589|NCT00601354|810217|P1|NOT COMPLETED|Overall Study||4
334590|NCT00601354|810216|P2|COMPLETED|Overall Study||4
334591|NCT00601354|810217|P1|COMPLETED|Overall Study||4
334592|NCT00601354|810216|P2|STARTED|Overall Study||9
334593|NCT00601354|810217|P1|STARTED|Overall Study||8
334594|NCT00601250|810229|P2|NOT COMPLETED|Overall Study||39
334595|NCT00601250|810230|P1|NOT COMPLETED|Overall Study||14
334596|NCT00601250|810229|P2|COMPLETED|Overall Study|number who completed treatment|484
334597|NCT00601250|810230|P1|COMPLETED|Overall Study|number who completed treatment|163
334598|NCT00601250|810229|P2|STARTED|Overall Study|number who started treatment. One additional patient was randomised but not treated.|523
334599|NCT00601250|810230|P1|STARTED|Overall Study|number who started treatment|177
334600|NCT00601172|810266|P2|NOT COMPLETED|Overall Study||127
334601|NCT00601172|810267|P1|NOT COMPLETED|Overall Study||141
334602|NCT00601172|810266|P2|COMPLETED|Overall Study||228
334603|NCT00601172|810267|P1|COMPLETED|Overall Study||214
334604|NCT00601172|810266|P2|STARTED|Overall Study||355
334605|NCT00601172|810267|P1|STARTED|Overall Study||355
334606|NCT00601146|810316|P1|NOT COMPLETED|Overall Study||161
334607|NCT00601146|810316|P1|COMPLETED|Overall Study||39
334608|NCT00601146|810316|P1|STARTED|Overall Study||200
334609|NCT00601107|810324|P4|NOT COMPLETED|Overall Study||12
334610|NCT00601107|810325|P3|NOT COMPLETED|Overall Study||12
334611|NCT00601107|810326|P2|NOT COMPLETED|Overall Study||9
334612|NCT00601107|810327|P1|NOT COMPLETED|Overall Study||13
334613|NCT00601107|810324|P4|COMPLETED|Overall Study||13
334614|NCT00601107|810325|P3|COMPLETED|Overall Study||16
334615|NCT00601107|810326|P2|COMPLETED|Overall Study||22
334616|NCT00601107|810327|P1|COMPLETED|Overall Study||14
334617|NCT00601107|810324|P4|Treated|Overall Study||25
334618|NCT00601107|810325|P3|Treated|Overall Study||28
334619|NCT00601107|810326|P2|Treated|Overall Study||31
334620|NCT00601107|810327|P1|Treated|Overall Study||27
334621|NCT00601107|810324|P4|STARTED|Overall Study||25
334622|NCT00601107|810325|P3|STARTED|Overall Study||28
334623|NCT00601107|810326|P2|STARTED|Overall Study||31
334624|NCT00601107|810327|P1|STARTED|Overall Study|Randomized.|27
334625|NCT00600938|810347|P4|NOT COMPLETED|Extension Study||1
334626|NCT00600938|810348|P3|NOT COMPLETED|Extension Study||9
334627|NCT00600938|810349|P2|NOT COMPLETED|Extension Study||5
334628|NCT00600938|810350|P1|NOT COMPLETED|Extension Study||9
334629|NCT00600938|810347|P4|COMPLETED|Extension Study||0
334630|NCT00600938|810348|P3|COMPLETED|Extension Study||33
334631|NCT00600938|810349|P2|COMPLETED|Extension Study||24
334632|NCT00600938|810350|P1|COMPLETED|Extension Study||65
334633|NCT00600938|810347|P4|Extension Safety Set|Extension Study||1
334634|NCT00600938|810348|P3|Extension Safety Set|Extension Study||42
334635|NCT00600938|810349|P2|Extension Safety Set|Extension Study||29
334636|NCT00600938|810350|P1|Extension Safety Set|Extension Study|1 patient did not receive drug in the ext. phase but received drug in the core phase|73
334637|NCT00600938|810347|P4|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|1
334638|NCT00600938|810348|P3|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|42
334639|NCT00600938|810349|P2|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|29
334640|NCT00600938|810350|P1|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|74
334641|NCT00600938|810347|P4|NOT COMPLETED|Core Study||0
334642|NCT00600938|810348|P3|NOT COMPLETED|Core Study||0
334643|NCT00600938|810349|P2|NOT COMPLETED|Core Study||21
334644|NCT00600938|810350|P1|NOT COMPLETED|Core Study||16
334645|NCT00600938|810347|P4|COMPLETED|Core Study||0
334646|NCT00600938|810348|P3|COMPLETED|Core Study||0
334647|NCT00600938|810349|P2|COMPLETED|Core Study||78
334648|NCT00600938|810350|P1|COMPLETED|Core Study||82
334649|NCT00600938|810347|P4|Per Protocol Set (PPS)|Core Study||0
334650|NCT00600938|810348|P3|Per Protocol Set (PPS)|Core Study||0
334651|NCT00600938|810349|P2|Per Protocol Set (PPS)|Core Study||81
334652|NCT00600938|810350|P1|Per Protocol Set (PPS)|Core Study||91
334653|NCT00600938|810347|P4|Core Safety Set|Core Study||0
334654|NCT00600938|810348|P3|Core Safety Set|Core Study||0
334655|NCT00600938|810349|P2|Core Safety Set|Core Study||91
334656|NCT00600938|810350|P1|Core Safety Set|Core Study||96
334657|NCT00600938|810347|P4|STARTED|Core Study||0
334658|NCT00600938|810348|P3|STARTED|Core Study||0
334659|NCT00600938|810349|P2|STARTED|Core Study||99
334660|NCT00600938|810350|P1|STARTED|Core Study||98
334661|NCT00600886|810414|P2|NOT COMPLETED|Extension - After Crossover (CAS)||13
334662|NCT00600886|810415|P1|NOT COMPLETED|Extension - After Crossover (CAS)||62
334663|NCT00600886|810414|P2|COMPLETED|Extension - After Crossover (CAS)|Completed the study|25
334664|NCT00600886|810415|P1|COMPLETED|Extension - After Crossover (CAS)|Completed after month 26: transferred to a roll-over protocol or commercial supply of Pas.LAR|19
334665|NCT00600886|810414|P2|Discontinued After M26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|0
334666|NCT00600886|810415|P1|Discontinued After M26|Extension - After Crossover (CAS)||31
334667|NCT00600886|810414|P2|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||13
334668|NCT00600886|810415|P1|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||31
334669|NCT00600886|810414|P2|Completed After Month 26|Extension - After Crossover (CAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in study after M26|0
334670|NCT00600886|810415|P1|Completed After Month 26|Extension - After Crossover (CAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|19
334671|NCT00600886|810414|P2|Completed Study at Month 26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|25
334672|NCT00600886|810415|P1|Completed Study at Month 26|Extension - After Crossover (CAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
334673|NCT00600886|810414|P2|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Octreotide LAR|38
334674|NCT00600886|810415|P1|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Pasireotide LAR|81
334675|NCT00600886|810414|P2|NOT COMPLETED|Extension - Same Treatment (FAS)||11
334676|NCT00600886|810415|P1|NOT COMPLETED|Extension - Same Treatment (FAS)||46
334677|NCT00600886|810414|P2|COMPLETED|Extension - Same Treatment (FAS)|Completed = completed the study|35
334678|NCT00600886|810415|P1|COMPLETED|Extension - Same Treatment (FAS)|Completed= completed after M26, switched to commercial pasireotide LAR or entered roll-over protocol|28
334679|NCT00600886|810414|P2|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||10
334680|NCT00600886|810415|P1|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||23
334681|NCT00600886|810414|P2|Discontinued After Month 26|Extension - Same Treatment (FAS)|Received treatment and discontinued after M26: Recorded as protocol deviation|1
334682|NCT00600886|810415|P1|Discontinued After Month 26|Extension - Same Treatment (FAS)||23
334683|NCT00600886|810414|P2|Completed Study After Month 26|Extension - Same Treatment (FAS)|Received treatment and completed after M26: Recorded as protocol deviation|4
334684|NCT00600886|810415|P1|Completed Study After Month 26|Extension - Same Treatment (FAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|28
334685|NCT00600886|810414|P2|Completed Study at Month 26|Extension - Same Treatment (FAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in the study after M26|31
334686|NCT00600886|810415|P1|Completed Study at Month 26|Extension - Same Treatment (FAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
334687|NCT00600886|810414|P2|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Octreotide LAR|46
334688|NCT00600886|810415|P1|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Pasireotide LAR|74
334689|NCT00600886|810414|P2|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||26
334690|NCT00600886|810415|P1|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||35
334691|NCT00600886|810414|P2|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|156
334692|NCT00600886|810415|P1|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|141
334693|NCT00600886|810414|P2|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||46
334694|NCT00600886|810415|P1|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||74
334695|NCT00600886|810414|P2|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||81
334696|NCT00600886|810415|P1|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||38
334697|NCT00600886|810414|P2|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
334698|NCT00600886|810415|P1|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
334699|NCT00600886|810414|P2|STARTED|Core Phase - Full Analysis Set (FAS)||182
334700|NCT00600886|810415|P1|STARTED|Core Phase - Full Analysis Set (FAS)||176
334701|NCT00600821|810479|P2|NOT COMPLETED|Overall Study||60
334702|NCT00600821|810480|P1|NOT COMPLETED|Overall Study||58
334703|NCT00600821|810479|P2|COMPLETED|Overall Study||0
334704|NCT00600821|810480|P1|COMPLETED|Overall Study||0
334705|NCT00600821|810479|P2|Treated|Overall Study||59
334706|NCT00600821|810480|P1|Treated|Overall Study||58
334707|NCT00600821|810479|P2|STARTED|Overall Study||60
334708|NCT00600821|810480|P1|STARTED|Overall Study||58
334709|NCT00600756|810508|P2|NOT COMPLETED|Overall Study Analysis After 12 Months||176
334710|NCT00600756|810509|P1|NOT COMPLETED|Overall Study Analysis After 12 Months||183
334711|NCT00600756|810508|P2|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|227
334799|NCT00600119|810725|P3|COMPLETED|Double-blind Treatment Period||27
334712|NCT00600756|810509|P1|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|212
334713|NCT00600756|810508|P2|ITT Analysis|Overall Study Analysis After 12 Months||392
334714|NCT00600756|810509|P1|ITT Analysis|Overall Study Analysis After 12 Months||379
334715|NCT00600756|810508|P2|Safety Analysis|Overall Study Analysis After 12 Months||402
334716|NCT00600756|810509|P1|Safety Analysis|Overall Study Analysis After 12 Months||391
334717|NCT00600756|810508|P2|Randomized Analysis|Overall Study Analysis After 12 Months||403
334718|NCT00600756|810509|P1|Randomized Analysis|Overall Study Analysis After 12 Months||395
334719|NCT00600756|810508|P2|STARTED|Overall Study Analysis After 12 Months||403
334720|NCT00600756|810509|P1|STARTED|Overall Study Analysis After 12 Months||395
334721|NCT00600756|810508|P2|NOT COMPLETED|Analysis After 6 Months||120
334722|NCT00600756|810509|P1|NOT COMPLETED|Analysis After 6 Months||131
334723|NCT00600756|810508|P2|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|283
334724|NCT00600756|810509|P1|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|264
334725|NCT00600756|810508|P2|STARTED|Analysis After 6 Months||403
334726|NCT00600756|810509|P1|STARTED|Analysis After 6 Months||395
334727|NCT00600743|810579|P4|NOT COMPLETED|Overall Study||0
334728|NCT00600743|810580|P3|NOT COMPLETED|Overall Study||0
334729|NCT00600743|810581|P2|NOT COMPLETED|Overall Study||0
334730|NCT00600743|810582|P1|NOT COMPLETED|Overall Study||0
334731|NCT00600743|810579|P4|COMPLETED|Overall Study||7
334732|NCT00600743|810580|P3|COMPLETED|Overall Study||8
334733|NCT00600743|810581|P2|COMPLETED|Overall Study||4
334734|NCT00600743|810582|P1|COMPLETED|Overall Study||4
334735|NCT00600743|810579|P4|STARTED|Overall Study||7
334736|NCT00600743|810580|P3|STARTED|Overall Study||8
334737|NCT00600743|810581|P2|STARTED|Overall Study||4
334738|NCT00600743|810582|P1|STARTED|Overall Study||4
334739|NCT00600704|810611|P2|NOT COMPLETED|Overall Study||0
334740|NCT00600704|810612|P1|NOT COMPLETED|Overall Study||0
334741|NCT00600704|810611|P2|COMPLETED|Overall Study||92
334742|NCT00600704|810612|P1|COMPLETED|Overall Study||100
334743|NCT00600704|810611|P2|STARTED|Overall Study||92
334744|NCT00600704|810612|P1|STARTED|Overall Study||100
334745|NCT00600613|810618|P1|NOT COMPLETED|Overall Study||1
334746|NCT00600613|810618|P1|COMPLETED|Overall Study||5
334747|NCT00600613|810618|P1|STARTED|Overall Study||6
334748|NCT00600353|810624|P2|NOT COMPLETED|Overall Study||1
334749|NCT00600353|810625|P1|NOT COMPLETED|Overall Study||1
334750|NCT00600353|810624|P2|COMPLETED|Overall Study||9
334751|NCT00600353|810625|P1|COMPLETED|Overall Study||9
334752|NCT00600353|810624|P2|STARTED|Overall Study||10
334753|NCT00600353|810625|P1|STARTED|Overall Study||10
334754|NCT00600171|810643|P6|NOT COMPLETED|Overall Study||5
334755|NCT00600171|810644|P5|NOT COMPLETED|Overall Study||8
334756|NCT00600171|810645|P4|NOT COMPLETED|Overall Study||12
334757|NCT00600171|810646|P3|NOT COMPLETED|Overall Study||10
334758|NCT00600171|810647|P2|NOT COMPLETED|Overall Study||17
334759|NCT00600171|810648|P1|NOT COMPLETED|Overall Study||16
334760|NCT00600171|810643|P6|COMPLETED|Overall Study||97
334761|NCT00600171|810644|P5|COMPLETED|Overall Study||93
334762|NCT00600171|810645|P4|COMPLETED|Overall Study||88
334763|NCT00600171|810646|P3|COMPLETED|Overall Study||91
334764|NCT00600171|810647|P2|COMPLETED|Overall Study||84
334765|NCT00600171|810648|P1|COMPLETED|Overall Study||86
334766|NCT00600171|810643|P6|STARTED|Overall Study||102
334767|NCT00600171|810644|P5|STARTED|Overall Study||101
334768|NCT00600171|810645|P4|STARTED|Overall Study||100
334769|NCT00600171|810646|P3|STARTED|Overall Study||101
334770|NCT00600171|810647|P2|STARTED|Overall Study||101
334771|NCT00600171|810648|P1|STARTED|Overall Study||102
334772|NCT00600119|810722|P6|NOT COMPLETED|Follow-up Period||1
334773|NCT00600119|810723|P5|NOT COMPLETED|Follow-up Period||0
334774|NCT00600119|810724|P4|NOT COMPLETED|Follow-up Period||0
334775|NCT00600119|810725|P3|NOT COMPLETED|Follow-up Period||0
334776|NCT00600119|810726|P2|NOT COMPLETED|Follow-up Period||0
334777|NCT00600119|810727|P1|NOT COMPLETED|Follow-up Period||1
334778|NCT00600119|810722|P6|COMPLETED|Follow-up Period||20
334779|NCT00600119|810723|P5|COMPLETED|Follow-up Period||31
334780|NCT00600119|810724|P4|COMPLETED|Follow-up Period||28
334781|NCT00600119|810725|P3|COMPLETED|Follow-up Period||27
334782|NCT00600119|810726|P2|COMPLETED|Follow-up Period||28
334783|NCT00600119|810727|P1|COMPLETED|Follow-up Period||26
334784|NCT00600119|810722|P6|STARTED|Follow-up Period||21
334785|NCT00600119|810723|P5|STARTED|Follow-up Period||31
334786|NCT00600119|810724|P4|STARTED|Follow-up Period||28
334787|NCT00600119|810725|P3|STARTED|Follow-up Period||27
334788|NCT00600119|810726|P2|STARTED|Follow-up Period||28
334789|NCT00600119|810727|P1|STARTED|Follow-up Period||27
334790|NCT00600119|810722|P6|NOT COMPLETED|Double-blind Treatment Period||14
334791|NCT00600119|810723|P5|NOT COMPLETED|Double-blind Treatment Period||6
334792|NCT00600119|810724|P4|NOT COMPLETED|Double-blind Treatment Period||2
334793|NCT00600119|810725|P3|NOT COMPLETED|Double-blind Treatment Period||0
334794|NCT00600119|810726|P2|NOT COMPLETED|Double-blind Treatment Period||5
334795|NCT00600119|810727|P1|NOT COMPLETED|Double-blind Treatment Period||5
334796|NCT00600119|810722|P6|COMPLETED|Double-blind Treatment Period||21
334797|NCT00600119|810723|P5|COMPLETED|Double-blind Treatment Period||31
334798|NCT00600119|810724|P4|COMPLETED|Double-blind Treatment Period||28
334800|NCT00600119|810726|P2|COMPLETED|Double-blind Treatment Period||28
334801|NCT00600119|810727|P1|COMPLETED|Double-blind Treatment Period||27
334802|NCT00600119|810722|P6|STARTED|Double-blind Treatment Period||35
334803|NCT00600119|810723|P5|STARTED|Double-blind Treatment Period||37
334804|NCT00600119|810724|P4|STARTED|Double-blind Treatment Period||30
334805|NCT00600119|810725|P3|STARTED|Double-blind Treatment Period||27
334806|NCT00600119|810726|P2|STARTED|Double-blind Treatment Period||33
334807|NCT00600119|810727|P1|STARTED|Double-blind Treatment Period||32
334808|NCT00600119|810722|P6|NOT COMPLETED|Single-blind Placebo run-in Period||2
334809|NCT00600119|810723|P5|NOT COMPLETED|Single-blind Placebo run-in Period||2
334810|NCT00600119|810724|P4|NOT COMPLETED|Single-blind Placebo run-in Period||1
334811|NCT00600119|810725|P3|NOT COMPLETED|Single-blind Placebo run-in Period||2
334812|NCT00600119|810726|P2|NOT COMPLETED|Single-blind Placebo run-in Period||2
334813|NCT00600119|810727|P1|NOT COMPLETED|Single-blind Placebo run-in Period||4
334814|NCT00600119|810722|P6|COMPLETED|Single-blind Placebo run-in Period||35
334815|NCT00600119|810723|P5|COMPLETED|Single-blind Placebo run-in Period||37
334816|NCT00600119|810724|P4|COMPLETED|Single-blind Placebo run-in Period||30
334817|NCT00600119|810725|P3|COMPLETED|Single-blind Placebo run-in Period||27
334818|NCT00600119|810726|P2|COMPLETED|Single-blind Placebo run-in Period||33
334819|NCT00600119|810727|P1|COMPLETED|Single-blind Placebo run-in Period||32
334820|NCT00600119|810722|P6|STARTED|Single-blind Placebo run-in Period||37
334821|NCT00600119|810723|P5|STARTED|Single-blind Placebo run-in Period||39
334822|NCT00600119|810724|P4|STARTED|Single-blind Placebo run-in Period||31
334823|NCT00600119|810725|P3|STARTED|Single-blind Placebo run-in Period||29
334824|NCT00600119|810726|P2|STARTED|Single-blind Placebo run-in Period||35
334825|NCT00600119|810727|P1|STARTED|Single-blind Placebo run-in Period||36
334826|NCT00600106|810761|P2|NOT COMPLETED|Overall Study||1
334827|NCT00600106|810762|P1|NOT COMPLETED|Overall Study||1
334828|NCT00600106|810761|P2|COMPLETED|Overall Study||18
334829|NCT00600106|810762|P1|COMPLETED|Overall Study||17
334830|NCT00600106|810761|P2|STARTED|Overall Study||19
334831|NCT00600106|810762|P1|STARTED|Overall Study||18
334832|NCT00600080|810794|P2|NOT COMPLETED|Period 2: One-week to Two-weeks||0
334833|NCT00600080|810795|P1|NOT COMPLETED|Period 2: One-week to Two-weeks||0
334834|NCT00600080|810794|P2|COMPLETED|Period 2: One-week to Two-weeks||32
334835|NCT00600080|810795|P1|COMPLETED|Period 2: One-week to Two-weeks||28
334836|NCT00600080|810794|P2|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|32
334837|NCT00600080|810795|P1|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|28
334838|NCT00600080|810794|P2|NOT COMPLETED|Period 1: Baseline to One-week||0
334839|NCT00600080|810795|P1|NOT COMPLETED|Period 1: Baseline to One-week||0
334840|NCT00600080|810794|P2|COMPLETED|Period 1: Baseline to One-week||32
334841|NCT00600080|810795|P1|COMPLETED|Period 1: Baseline to One-week||28
334842|NCT00600080|810794|P2|STARTED|Period 1: Baseline to One-week||32
334843|NCT00600080|810795|P1|STARTED|Period 1: Baseline to One-week||28
334844|NCT00600067|810809|P2|NOT COMPLETED|Overall Study||7
334845|NCT00600067|810810|P1|NOT COMPLETED|Overall Study||3
334846|NCT00600067|810809|P2|COMPLETED|Overall Study||68
334847|NCT00600067|810810|P1|COMPLETED|Overall Study||52
334848|NCT00600067|810809|P2|STARTED|Overall Study||75
334849|NCT00600067|810810|P1|STARTED|Overall Study||55
334850|NCT00600028|810820|P2|NOT COMPLETED|Second Intervention (12 Weeks)||2
334851|NCT00600028|810821|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
334852|NCT00600028|810820|P2|COMPLETED|Second Intervention (12 Weeks)||8
334853|NCT00600028|810821|P1|COMPLETED|Second Intervention (12 Weeks)||12
334854|NCT00600028|810820|P2|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|10
334855|NCT00600028|810821|P1|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|12
334856|NCT00600028|810820|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
334857|NCT00600028|810821|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
334858|NCT00600028|810820|P2|COMPLETED|First Intervention (12 Weeks)||10
334859|NCT00600028|810821|P1|COMPLETED|First Intervention (12 Weeks)||12
334860|NCT00600028|810820|P2|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|11
334861|NCT00600028|810821|P1|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|13
334862|NCT00600015|810835|P2|NOT COMPLETED|Overall Study||35
334863|NCT00600015|810836|P1|NOT COMPLETED|Overall Study||60
334864|NCT00600015|810835|P2|COMPLETED|Overall Study|Completed >=2 cycles|20
334865|NCT00600015|810836|P1|COMPLETED|Overall Study|Completed >=2 cycles|51
334866|NCT00600015|810835|P2|STARTED|Overall Study||55
334867|NCT00600015|810836|P1|STARTED|Overall Study||111
334868|NCT00599924|810851|P7|NOT COMPLETED|Overall Study||5
334869|NCT00599924|810852|P6|NOT COMPLETED|Overall Study||4
334870|NCT00599924|810853|P5|NOT COMPLETED|Overall Study||6
334871|NCT00599924|810854|P4|NOT COMPLETED|Overall Study||8
334872|NCT00599924|810855|P3|NOT COMPLETED|Overall Study||2
334873|NCT00599924|810856|P2|NOT COMPLETED|Overall Study||5
334874|NCT00599924|810857|P1|NOT COMPLETED|Overall Study||3
334875|NCT00599924|810851|P7|COMPLETED|Overall Study||3
334876|NCT00599924|810852|P6|COMPLETED|Overall Study||2
334877|NCT00599924|810853|P5|COMPLETED|Overall Study||3
334878|NCT00599924|810854|P4|COMPLETED|Overall Study||4
334879|NCT00599924|810855|P3|COMPLETED|Overall Study||3
334880|NCT00599924|810856|P2|COMPLETED|Overall Study||4
334881|NCT00599924|810857|P1|COMPLETED|Overall Study||1
334882|NCT00599924|810851|P7|STARTED|Overall Study||8
334883|NCT00599924|810852|P6|STARTED|Overall Study||6
334884|NCT00599924|810853|P5|STARTED|Overall Study||9
334885|NCT00599924|810854|P4|STARTED|Overall Study||12
334886|NCT00599924|810855|P3|STARTED|Overall Study||5
334887|NCT00599924|810856|P2|STARTED|Overall Study||9
334888|NCT00599924|810857|P1|STARTED|Overall Study||4
334889|NCT00599872|810944|P2|NOT COMPLETED|Overall Study||33
334890|NCT00599872|810945|P1|NOT COMPLETED|Overall Study||49
334891|NCT00599872|810944|P2|COMPLETED|Overall Study||181
334892|NCT00599872|810945|P1|COMPLETED|Overall Study||167
334893|NCT00599872|810944|P2|STARTED|Overall Study||214
334894|NCT00599872|810945|P1|STARTED|Overall Study||216
334895|NCT00599755|810961|P1|NOT COMPLETED|Overall Study||19
334896|NCT00599755|810961|P1|COMPLETED|Overall Study||49
334897|NCT00599755|810961|P1|STARTED|Overall Study||68
334898|NCT00599521|810972|P2|NOT COMPLETED|Overall Study||69
334899|NCT00599521|810973|P1|NOT COMPLETED|Overall Study||60
334900|NCT00599521|810972|P2|COMPLETED|Overall Study||462
334901|NCT00599521|810973|P1|COMPLETED|Overall Study||475
334902|NCT00599521|810972|P2|STARTED|Overall Study||531
334903|NCT00599521|810973|P1|STARTED|Overall Study||535
334904|NCT00599339|810987|P1|NOT COMPLETED|Overall Study||664
334905|NCT00599339|810987|P1|COMPLETED|Overall Study||1531
334906|NCT00599339|810987|P1|Safety Set|Overall Study||2179
334907|NCT00599339|810987|P1|STARTED|Overall Study||2195
334908|NCT00599326|811089|P1|NOT COMPLETED|Overall Study||2
334909|NCT00599326|811089|P1|COMPLETED|Overall Study||8
334910|NCT00599326|811089|P1|STARTED|Overall Study||10
334911|NCT00599313|811094|P1|NOT COMPLETED|Overall Study||36
334912|NCT00599313|811094|P1|COMPLETED|Overall Study||0
334913|NCT00599313|811094|P1|STARTED|Overall Study||36
334914|NCT00599248|811105|P4|NOT COMPLETED|Overall Study||0
334915|NCT00599248|811106|P3|NOT COMPLETED|Overall Study||0
334916|NCT00599248|811107|P2|NOT COMPLETED|Overall Study||0
334917|NCT00599248|811108|P1|NOT COMPLETED|Overall Study||0
334918|NCT00599248|811105|P4|COMPLETED|Overall Study||3
334919|NCT00599248|811106|P3|COMPLETED|Overall Study||3
334920|NCT00599248|811107|P2|COMPLETED|Overall Study||3
334921|NCT00599248|811108|P1|COMPLETED|Overall Study||3
334922|NCT00599248|811105|P4|STARTED|Overall Study||3
334923|NCT00599248|811106|P3|STARTED|Overall Study||3
334924|NCT00599248|811107|P2|STARTED|Overall Study||3
334925|NCT00599248|811108|P1|STARTED|Overall Study||3
334926|NCT00599196|811136|P1|NOT COMPLETED|Overall Study||381
334927|NCT00599196|811136|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
334928|NCT00599196|811136|P1|STARTED|Overall Study||381
334929|NCT00599131|811142|P1|NOT COMPLETED|Overall Study||0
334930|NCT00599131|811142|P1|COMPLETED|Overall Study||4
334931|NCT00599131|811142|P1|STARTED|Overall Study||4
334932|NCT00599053|811152|P2|NOT COMPLETED|Overall Study||0
334933|NCT00599053|811153|P1|NOT COMPLETED|Overall Study||0
334934|NCT00599053|811152|P2|COMPLETED|Overall Study||2
334935|NCT00599053|811153|P1|COMPLETED|Overall Study||5
334936|NCT00599053|811152|P2|STARTED|Overall Study||2
334937|NCT00599053|811153|P1|STARTED|Overall Study||5
334938|NCT00599027|811167|P2|NOT COMPLETED|Overall Study||3
334939|NCT00599027|811168|P1|NOT COMPLETED|Overall Study||1
334940|NCT00599027|811167|P2|COMPLETED|Overall Study||22
334941|NCT00599027|811168|P1|COMPLETED|Overall Study||25
334942|NCT00599027|811167|P2|STARTED|Overall Study||25
334943|NCT00599027|811168|P1|STARTED|Overall Study||26
334944|NCT00599014|811174|P1|NOT COMPLETED|Overall Study||0
334945|NCT00599014|811174|P1|COMPLETED|Overall Study||335
334946|NCT00599014|811174|P1|STARTED|Overall Study||335
334947|NCT00598871|811181|P2|NOT COMPLETED|Overall Study||1
334948|NCT00598871|811182|P1|NOT COMPLETED|Overall Study||0
334949|NCT00598871|811181|P2|COMPLETED|Overall Study||8
334950|NCT00598871|811182|P1|COMPLETED|Overall Study||3
334951|NCT00598871|811181|P2|STARTED|Overall Study||9
334952|NCT00598871|811182|P1|STARTED|Overall Study||3
334953|NCT00598832|811192|P2|NOT COMPLETED|Overall Study||82
334954|NCT00598832|811193|P1|NOT COMPLETED|Overall Study||62
334955|NCT00598832|811192|P2|COMPLETED|Overall Study||460
334956|NCT00598832|811193|P1|COMPLETED|Overall Study||471
334957|NCT00598832|811192|P2|STARTED|Overall Study||542
334958|NCT00598832|811193|P1|STARTED|Overall Study||533
334959|NCT00598819|811207|P1|NOT COMPLETED|Overall Study||0
334960|NCT00598819|811207|P1|COMPLETED|Overall Study||14
334961|NCT00598819|811207|P1|STARTED|Overall Study||14
334962|NCT00598806|811217|P2|NOT COMPLETED|Overall Study||64
334963|NCT00598806|811218|P1|NOT COMPLETED|Overall Study||73
334964|NCT00598806|811217|P2|COMPLETED|Overall Study||346
334965|NCT00598806|811218|P1|COMPLETED|Overall Study||329
334966|NCT00598806|811217|P2|STARTED|Overall Study||410
334967|NCT00598806|811218|P1|STARTED|Overall Study||402
334968|NCT00598702|811246|P8|NOT COMPLETED|Overall Study||0
334969|NCT00598702|811247|P7|NOT COMPLETED|Overall Study||1
334970|NCT00598702|811248|P6|NOT COMPLETED|Overall Study||12
334971|NCT00598702|811249|P5|NOT COMPLETED|Overall Study||3
334972|NCT00598702|811250|P4|NOT COMPLETED|Overall Study||8
334973|NCT00598702|811251|P3|NOT COMPLETED|Overall Study||2
334974|NCT00598702|811252|P2|NOT COMPLETED|Overall Study||2
334975|NCT00598702|811253|P1|NOT COMPLETED|Overall Study||0
334976|NCT00598702|811246|P8|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|4
334977|NCT00598702|811247|P7|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|0
334978|NCT00598702|811248|P6|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|30
334979|NCT00598702|811249|P5|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|6
334980|NCT00598702|811250|P4|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|25
334981|NCT00598702|811251|P3|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|5
334982|NCT00598702|811252|P2|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
334983|NCT00598702|811253|P1|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
334984|NCT00598702|811246|P8|STARTED|Overall Study||4
334985|NCT00598702|811247|P7|STARTED|Overall Study||1
334986|NCT00598702|811248|P6|STARTED|Overall Study||42
334987|NCT00598702|811249|P5|STARTED|Overall Study||9
334988|NCT00598702|811250|P4|STARTED|Overall Study||33
334989|NCT00598702|811251|P3|STARTED|Overall Study||7
334990|NCT00598702|811252|P2|STARTED|Overall Study||3
334991|NCT00598702|811253|P1|STARTED|Overall Study||1
334992|NCT00598689|811297|P2|NOT COMPLETED|Overall Study||0
334993|NCT00598689|811298|P1|NOT COMPLETED|Overall Study||0
334994|NCT00598689|811297|P2|COMPLETED|Overall Study||40
334995|NCT00598689|811298|P1|COMPLETED|Overall Study||40
334996|NCT00598689|811297|P2|STARTED|Overall Study||40
334997|NCT00598689|811298|P1|STARTED|Overall Study||40
334998|NCT00598663|811310|P2|NOT COMPLETED|Second Intervention (6 Months)||1
334999|NCT00598663|811311|P1|NOT COMPLETED|Second Intervention (6 Months)||4
335000|NCT00598663|811310|P2|COMPLETED|Second Intervention (6 Months)||69
335001|NCT00598663|811311|P1|COMPLETED|Second Intervention (6 Months)||69
335002|NCT00598663|811310|P2|STARTED|Second Intervention (6 Months)||70
335003|NCT00598663|811311|P1|STARTED|Second Intervention (6 Months)||73
335004|NCT00598663|811310|P2|NOT COMPLETED|Washout (4 Months)||1
335005|NCT00598663|811311|P1|NOT COMPLETED|Washout (4 Months)||0
335006|NCT00598663|811310|P2|COMPLETED|Washout (4 Months)||70
335007|NCT00598663|811311|P1|COMPLETED|Washout (4 Months)||73
335008|NCT00598663|811310|P2|STARTED|Washout (4 Months)||71
335009|NCT00598663|811311|P1|STARTED|Washout (4 Months)||73
335010|NCT00598663|811310|P2|NOT COMPLETED|First Intervention (6 Months)||6
335011|NCT00598663|811311|P1|NOT COMPLETED|First Intervention (6 Months)||3
335012|NCT00598663|811310|P2|COMPLETED|First Intervention (6 Months)||71
335013|NCT00598663|811311|P1|COMPLETED|First Intervention (6 Months)||73
335014|NCT00598663|811310|P2|STARTED|First Intervention (6 Months)||77
335015|NCT00598663|811311|P1|STARTED|First Intervention (6 Months)||76
335016|NCT00598650|811329|P1|NOT COMPLETED|Overall Study||27
335017|NCT00598650|811329|P1|COMPLETED|Overall Study|5 subjects withdrew for multiple reasons|81
335018|NCT00598650|811329|P1|STARTED|Overall Study||108
335019|NCT00598585|811338|P2|NOT COMPLETED|Overall Study||0
335020|NCT00598585|811339|P1|NOT COMPLETED|Overall Study||1
335021|NCT00598585|811338|P2|COMPLETED|Overall Study||6
335022|NCT00598585|811339|P1|COMPLETED|Overall Study||5
335023|NCT00598585|811338|P2|STARTED|Overall Study||6
335024|NCT00598585|811339|P1|STARTED|Overall Study||6
335025|NCT00598559|811348|P3|NOT COMPLETED|Overall Study||3
335026|NCT00598559|811349|P2|NOT COMPLETED|Overall Study||28
335027|NCT00598559|811350|P1|NOT COMPLETED|Overall Study||27
335028|NCT00598559|811348|P3|COMPLETED|Overall Study|Subjects completed 5 days of treatment|27
335029|NCT00598559|811349|P2|COMPLETED|Overall Study|Subjects completed 5 days of treatment|63
335030|NCT00598559|811350|P1|COMPLETED|Overall Study|Subjects completed 5 days of treatment|65
335031|NCT00598559|811348|P3|STARTED|Overall Study||30
335032|NCT00598559|811349|P2|STARTED|Overall Study||91
335033|NCT00598559|811350|P1|STARTED|Overall Study||92
335034|NCT00598507|811367|P1|NOT COMPLETED|Overall Study||0
335035|NCT00598507|811367|P1|COMPLETED|Overall Study||35
335036|NCT00598507|811367|P1|STARTED|Overall Study||35
335037|NCT00598442|811377|P3|NOT COMPLETED|Overall Study||24
335038|NCT00598442|811378|P2|NOT COMPLETED|Overall Study||39
335039|NCT00598442|811379|P1|NOT COMPLETED|Overall Study||43
335040|NCT00598442|811377|P3|COMPLETED|Overall Study||139
335041|NCT00598442|811378|P2|COMPLETED|Overall Study||124
335042|NCT00598442|811379|P1|COMPLETED|Overall Study||124
335043|NCT00598442|811377|P3|STARTED|Overall Study||163
335044|NCT00598442|811378|P2|STARTED|Overall Study||163
335045|NCT00598442|811379|P1|STARTED|Overall Study||167
335046|NCT00598273|811396|P3|NOT COMPLETED|Overall Study||39
335047|NCT00598273|811397|P2|NOT COMPLETED|Overall Study||38
335048|NCT00598273|811398|P1|NOT COMPLETED|Overall Study||41
335049|NCT00598273|811396|P3|COMPLETED|Overall Study||125
335050|NCT00598273|811397|P2|COMPLETED|Overall Study||127
335051|NCT00598273|811398|P1|COMPLETED|Overall Study||120
335052|NCT00598273|811396|P3|STARTED|Overall Study||164
335053|NCT00598273|811397|P2|STARTED|Overall Study||165
335054|NCT00598273|811398|P1|STARTED|Overall Study||161
335055|NCT00598078|811412|P2|NOT COMPLETED|Period 3 (Day 3)||0
335056|NCT00598078|811413|P1|NOT COMPLETED|Period 3 (Day 3)||0
335057|NCT00598078|811412|P2|COMPLETED|Period 3 (Day 3)||10
335058|NCT00598078|811413|P1|COMPLETED|Period 3 (Day 3)||9
335059|NCT00598078|811412|P2|STARTED|Period 3 (Day 3)||10
335060|NCT00598078|811413|P1|STARTED|Period 3 (Day 3)||9
335061|NCT00598078|811412|P2|NOT COMPLETED|Period 2 (Day 2)||0
335062|NCT00598078|811413|P1|NOT COMPLETED|Period 2 (Day 2)||1
335063|NCT00598078|811412|P2|COMPLETED|Period 2 (Day 2)||10
335064|NCT00598078|811413|P1|COMPLETED|Period 2 (Day 2)||9
335065|NCT00598078|811412|P2|STARTED|Period 2 (Day 2)||10
335066|NCT00598078|811413|P1|STARTED|Period 2 (Day 2)||10
335067|NCT00598078|811412|P2|NOT COMPLETED|Period 1 (Day 1)||0
335068|NCT00598078|811413|P1|NOT COMPLETED|Period 1 (Day 1)||0
335069|NCT00598078|811412|P2|COMPLETED|Period 1 (Day 1)||10
335070|NCT00598078|811413|P1|COMPLETED|Period 1 (Day 1)||10
335071|NCT00598078|811412|P2|STARTED|Period 1 (Day 1)||10
335072|NCT00598078|811413|P1|STARTED|Period 1 (Day 1)||10
335073|NCT00597909|811424|P3|NOT COMPLETED|Overall Study||0
335074|NCT00597909|811425|P2|NOT COMPLETED|Overall Study||0
335075|NCT00597909|811426|P1|NOT COMPLETED|Overall Study||0
335076|NCT00597909|811424|P3|COMPLETED|Overall Study||0
335077|NCT00597909|811425|P2|COMPLETED|Overall Study||0
335078|NCT00597909|811426|P1|COMPLETED|Overall Study||0
335079|NCT00597909|811424|P3|STARTED|Overall Study||0
335080|NCT00597909|811425|P2|STARTED|Overall Study||0
335081|NCT00597909|811426|P1|STARTED|Overall Study||0
335082|NCT00597896|811436|P2|NOT COMPLETED|Overall Study||2
335083|NCT00597896|811437|P1|NOT COMPLETED|Overall Study||3
335084|NCT00597896|811436|P2|COMPLETED|Overall Study||24
335085|NCT00597896|811437|P1|COMPLETED|Overall Study||21
335086|NCT00597896|811436|P2|STARTED|Overall Study||26
335087|NCT00597896|811437|P1|STARTED|Overall Study||24
335088|NCT00597766|811466|P3|NOT COMPLETED|Follow-up 3, Week 12||0
335089|NCT00597766|811467|P2|NOT COMPLETED|Follow-up 3, Week 12||0
335090|NCT00597766|811468|P1|NOT COMPLETED|Follow-up 3, Week 12||0
335091|NCT00597766|811466|P3|COMPLETED|Follow-up 3, Week 12||9
335092|NCT00597766|811467|P2|COMPLETED|Follow-up 3, Week 12||9
335093|NCT00597766|811468|P1|COMPLETED|Follow-up 3, Week 12||8
335094|NCT00597766|811466|P3|STARTED|Follow-up 3, Week 12||9
335095|NCT00597766|811467|P2|STARTED|Follow-up 3, Week 12||9
335096|NCT00597766|811468|P1|STARTED|Follow-up 3, Week 12||8
335097|NCT00597766|811466|P3|NOT COMPLETED|Follow-up 2, Week 8||1
335098|NCT00597766|811467|P2|NOT COMPLETED|Follow-up 2, Week 8||0
335099|NCT00597766|811468|P1|NOT COMPLETED|Follow-up 2, Week 8||0
335100|NCT00597766|811466|P3|COMPLETED|Follow-up 2, Week 8||9
335101|NCT00597766|811467|P2|COMPLETED|Follow-up 2, Week 8||9
335102|NCT00597766|811468|P1|COMPLETED|Follow-up 2, Week 8||8
335103|NCT00597766|811466|P3|STARTED|Follow-up 2, Week 8||10
335104|NCT00597766|811467|P2|STARTED|Follow-up 2, Week 8||9
335105|NCT00597766|811468|P1|STARTED|Follow-up 2, Week 8||8
335106|NCT00597766|811466|P3|NOT COMPLETED|Follow-up 1, Week 4||0
335107|NCT00597766|811467|P2|NOT COMPLETED|Follow-up 1, Week 4||0
335108|NCT00597766|811468|P1|NOT COMPLETED|Follow-up 1, Week 4||1
335109|NCT00597766|811466|P3|COMPLETED|Follow-up 1, Week 4||10
335110|NCT00597766|811467|P2|COMPLETED|Follow-up 1, Week 4||9
335111|NCT00597766|811468|P1|COMPLETED|Follow-up 1, Week 4||8
335112|NCT00597766|811466|P3|STARTED|Follow-up 1, Week 4||10
335113|NCT00597766|811467|P2|STARTED|Follow-up 1, Week 4||9
335114|NCT00597766|811468|P1|STARTED|Follow-up 1, Week 4||9
335115|NCT00597766|811466|P3|NOT COMPLETED|Enrolled||0
335116|NCT00597766|811467|P2|NOT COMPLETED|Enrolled||0
335117|NCT00597766|811468|P1|NOT COMPLETED|Enrolled||0
335118|NCT00597766|811466|P3|COMPLETED|Enrolled||10
335119|NCT00597766|811467|P2|COMPLETED|Enrolled||9
335120|NCT00597766|811468|P1|COMPLETED|Enrolled||9
335121|NCT00597766|811466|P3|STARTED|Enrolled||10
335122|NCT00597766|811467|P2|STARTED|Enrolled||9
335123|NCT00597766|811468|P1|STARTED|Enrolled||9
335124|NCT00597753|811487|P2|NOT COMPLETED|Overall Study||69
335125|NCT00597753|811488|P1|NOT COMPLETED|Overall Study||166
335126|NCT00597753|811487|P2|COMPLETED|Overall Study||202
335127|NCT00597753|811488|P1|COMPLETED|Overall Study||366
335128|NCT00597753|811487|P2|STARTED|Overall Study||271
335129|NCT00597753|811488|P1|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin alfa|532
335130|NCT00597727|811502|P5|NOT COMPLETED|Open-label Extended Maintenance Phase||2
335131|NCT00597727|811503|P4|NOT COMPLETED|Open-label Extended Maintenance Phase||3
335132|NCT00597727|811504|P3|NOT COMPLETED|Open-label Extended Maintenance Phase||6
335133|NCT00597727|811505|P2|NOT COMPLETED|Open-label Extended Maintenance Phase||0
335134|NCT00597727|811506|P1|NOT COMPLETED|Open-label Extended Maintenance Phase||0
335135|NCT00597727|811502|P5|COMPLETED|Open-label Extended Maintenance Phase||1
335136|NCT00597727|811503|P4|COMPLETED|Open-label Extended Maintenance Phase||14
335137|NCT00597727|811504|P3|COMPLETED|Open-label Extended Maintenance Phase||23
335138|NCT00597727|811505|P2|COMPLETED|Open-label Extended Maintenance Phase||0
335139|NCT00597727|811506|P1|COMPLETED|Open-label Extended Maintenance Phase||0
335140|NCT00597727|811502|P5|STARTED|Open-label Extended Maintenance Phase||3
335141|NCT00597727|811503|P4|STARTED|Open-label Extended Maintenance Phase||17
335142|NCT00597727|811504|P3|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding.|29
335143|NCT00597727|811505|P2|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
335144|NCT00597727|811506|P1|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
335145|NCT00597727|811502|P5|NOT COMPLETED|12 Month Blinded Phase||1
335146|NCT00597727|811503|P4|NOT COMPLETED|12 Month Blinded Phase||10
335147|NCT00597727|811504|P3|NOT COMPLETED|12 Month Blinded Phase||0
335148|NCT00597727|811505|P2|NOT COMPLETED|12 Month Blinded Phase||0
335149|NCT00597727|811506|P1|NOT COMPLETED|12 Month Blinded Phase||0
335150|NCT00597727|811502|P5|COMPLETED|12 Month Blinded Phase||3
335151|NCT00597727|811503|P4|COMPLETED|12 Month Blinded Phase||17
335152|NCT00597727|811504|P3|COMPLETED|12 Month Blinded Phase||0
335153|NCT00597727|811505|P2|COMPLETED|12 Month Blinded Phase||15
335154|NCT00597727|811506|P1|COMPLETED|12 Month Blinded Phase||14
335155|NCT00597727|811502|P5|STARTED|12 Month Blinded Phase||4
335156|NCT00597727|811503|P4|STARTED|12 Month Blinded Phase||27
335157|NCT00597727|811504|P3|STARTED|12 Month Blinded Phase||0
335158|NCT00597727|811505|P2|STARTED|12 Month Blinded Phase||15
335159|NCT00597727|811506|P1|STARTED|12 Month Blinded Phase||14
335160|NCT00597714|811522|P3|NOT COMPLETED|Overall Study||10
335161|NCT00597714|811523|P2|NOT COMPLETED|Overall Study||46
335162|NCT00597714|811524|P1|NOT COMPLETED|Overall Study||56
335163|NCT00597714|811522|P3|COMPLETED|Overall Study||84
335164|NCT00597714|811523|P2|COMPLETED|Overall Study||11
335165|NCT00597714|811524|P1|COMPLETED|Overall Study||24
335166|NCT00597714|811522|P3|STARTED|Overall Study||94
335167|NCT00597714|811523|P2|STARTED|Overall Study||57
335168|NCT00597714|811524|P1|STARTED|Overall Study||80
335169|NCT00597701|811536|P2|NOT COMPLETED|Overall Study||8
335170|NCT00597701|811537|P1|NOT COMPLETED|Overall Study||7
335171|NCT00597701|811536|P2|COMPLETED|Overall Study||13
335172|NCT00597701|811537|P1|COMPLETED|Overall Study||18
335173|NCT00597701|811536|P2|STARTED|Overall Study||21
335174|NCT00597701|811537|P1|STARTED|Overall Study||25
335175|NCT00597675|811545|P2|NOT COMPLETED|Open Label Phase||0
335176|NCT00597675|811546|P1|NOT COMPLETED|Open Label Phase||0
335177|NCT00597675|811545|P2|COMPLETED|Open Label Phase||5
335178|NCT00597675|811546|P1|COMPLETED|Open Label Phase||2
335179|NCT00597675|811545|P2|STARTED|Open Label Phase||5
335180|NCT00597675|811546|P1|STARTED|Open Label Phase|Patients previously on placebo were crossed over onto open label peanut OIT|2
335181|NCT00597675|811545|P2|NOT COMPLETED|Blinded Phase||1
335182|NCT00597675|811546|P1|NOT COMPLETED|Blinded Phase||2
335183|NCT00597675|811545|P2|COMPLETED|Blinded Phase||5
335184|NCT00597675|811546|P1|COMPLETED|Blinded Phase||2
335185|NCT00597675|811545|P2|STARTED|Blinded Phase||6
335186|NCT00597675|811546|P1|STARTED|Blinded Phase||4
335187|NCT00597584|811559|P2|NOT COMPLETED|Overall Study||63
335188|NCT00597584|811560|P1|NOT COMPLETED|Overall Study||128
335189|NCT00597584|811559|P2|COMPLETED|Overall Study||211
335190|NCT00597584|811560|P1|COMPLETED|Overall Study||421
335191|NCT00597584|811559|P2|STARTED|Overall Study||274
335192|NCT00597584|811560|P1|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin|549
335193|NCT00597558|811570|P1|NOT COMPLETED|Overall Study||4
335194|NCT00597558|811570|P1|COMPLETED|Overall Study||9
335195|NCT00597558|811570|P1|STARTED|Overall Study||13
335196|NCT00597545|811578|P2|NOT COMPLETED|Overall Study||0
335197|NCT00597545|811579|P1|NOT COMPLETED|Overall Study||0
335198|NCT00597545|811578|P2|COMPLETED|Overall Study||6
335199|NCT00597545|811579|P1|COMPLETED|Overall Study||4
335200|NCT00597545|811578|P2|STARTED|Overall Study||6
335201|NCT00597545|811579|P1|STARTED|Overall Study||4
335202|NCT00597519|811585|P1|NOT COMPLETED|Overall Study||1
335203|NCT00597519|811585|P1|COMPLETED|Overall Study||27
335204|NCT00597519|811585|P1|STARTED|Overall Study||28
335205|NCT00597506|811589|P1|NOT COMPLETED|Overall Study||1
335206|NCT00597506|811589|P1|COMPLETED|Overall Study||49
335207|NCT00597506|811589|P1|STARTED|Overall Study||50
335208|NCT00597493|811594|P1|NOT COMPLETED|Overall Study||0
335209|NCT00597493|811594|P1|COMPLETED|Overall Study||32
335210|NCT00597493|811594|P1|STARTED|Overall Study||32
335211|NCT00597428|811613|P2|NOT COMPLETED|Overall Study||71
335212|NCT00597428|811614|P1|NOT COMPLETED|Overall Study||61
335213|NCT00597428|811613|P2|COMPLETED|Overall Study||152
335214|NCT00597428|811614|P1|COMPLETED|Overall Study||153
335215|NCT00597428|811613|P2|STARTED|Overall Study||223
335216|NCT00597428|811614|P1|STARTED|Overall Study||214
335217|NCT00597402|811630|P1|NOT COMPLETED|Overall Study||0
335218|NCT00597402|811630|P1|COMPLETED|Overall Study||125
335219|NCT00597402|811630|P1|STARTED|Overall Study||125
335220|NCT00597376|811639|P2|NOT COMPLETED|Overall Study||4
335221|NCT00597376|811640|P1|NOT COMPLETED|Overall Study||8
335222|NCT00597376|811639|P2|COMPLETED|Overall Study|All participants started (53) were included in primary analyses.|49
335223|NCT00597376|811640|P1|COMPLETED|Overall Study|All participants started (51) were included in primary analyses.|43
335224|NCT00597376|811639|P2|STARTED|Overall Study||53
335225|NCT00597376|811640|P1|STARTED|Overall Study||51
335226|NCT00597272|811657|P7|NOT COMPLETED|Overall Study||0
335227|NCT00597272|811658|P6|NOT COMPLETED|Overall Study||0
335228|NCT00597272|811659|P5|NOT COMPLETED|Overall Study||0
335229|NCT00597272|811660|P4|NOT COMPLETED|Overall Study||0
335230|NCT00597272|811661|P3|NOT COMPLETED|Overall Study||0
335231|NCT00597272|811662|P2|NOT COMPLETED|Overall Study||0
335232|NCT00597272|811663|P1|NOT COMPLETED|Overall Study||0
335233|NCT00597272|811657|P7|COMPLETED|Overall Study||10
335234|NCT00597272|811658|P6|COMPLETED|Overall Study||10
335235|NCT00597272|811659|P5|COMPLETED|Overall Study||1
335236|NCT00597272|811660|P4|COMPLETED|Overall Study||1
335237|NCT00597272|811661|P3|COMPLETED|Overall Study||10
335238|NCT00597272|811662|P2|COMPLETED|Overall Study||1
335239|NCT00597272|811663|P1|COMPLETED|Overall Study||1
335240|NCT00597272|811657|P7|STARTED|Overall Study||10
335241|NCT00597272|811658|P6|STARTED|Overall Study||10
335242|NCT00597272|811659|P5|STARTED|Overall Study||1
335243|NCT00597272|811660|P4|STARTED|Overall Study||1
335244|NCT00597272|811661|P3|STARTED|Overall Study||10
335245|NCT00597272|811662|P2|STARTED|Overall Study||1
335246|NCT00597272|811663|P1|STARTED|Overall Study||1
335247|NCT00597207|811681|P2|NOT COMPLETED|Overall Study||7
335248|NCT00597207|811682|P1|NOT COMPLETED|Overall Study||5
335249|NCT00597207|811681|P2|COMPLETED|Overall Study||2125
335250|NCT00597207|811682|P1|COMPLETED|Overall Study||2094
335251|NCT00597207|811681|P2|STARTED|Overall Study||2132
335252|NCT00597207|811682|P1|STARTED|Overall Study||2099
335253|NCT00597116|811690|P2|NOT COMPLETED|Overall Study||11
335254|NCT00597116|811691|P1|NOT COMPLETED|Overall Study||14
335255|NCT00597116|811690|P2|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
335256|NCT00597116|811691|P1|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
335257|NCT00597116|811690|P2|STARTED|Overall Study||11
335258|NCT00597116|811691|P1|STARTED|Overall Study||14
335259|NCT00597038|811705|P2|NOT COMPLETED|Overall Study||4
335260|NCT00597038|811706|P1|NOT COMPLETED|Overall Study||2
335261|NCT00597038|811705|P2|COMPLETED|Overall Study|Two patients withdrew, one did not complete due to progressive disease, one patient died.|30
335262|NCT00597038|811706|P1|COMPLETED|Overall Study|One did not complete due to PI decision, one did not complete due to progressive disease.|14
335263|NCT00597038|811705|P2|STARTED|Overall Study||34
335264|NCT00597038|811706|P1|STARTED|Overall Study||16
335265|NCT00597012|811717|P2|NOT COMPLETED|Overall Study||8
335266|NCT00597012|811718|P1|NOT COMPLETED|Overall Study||13
335267|NCT00597012|811717|P2|COMPLETED|Overall Study||169
335268|NCT00597012|811718|P1|COMPLETED|Overall Study||161
335269|NCT00597012|811717|P2|STARTED|Overall Study||177
335270|NCT00597012|811718|P1|STARTED|Overall Study||174
335271|NCT00596960|811730|P2|NOT COMPLETED|Overall Study||9
335272|NCT00596960|811731|P1|NOT COMPLETED|Overall Study||11
335273|NCT00596960|811730|P2|COMPLETED|Overall Study||60
335274|NCT00596960|811731|P1|COMPLETED|Overall Study||59
335275|NCT00596960|811730|P2|STARTED|Overall Study|One subject did not have any alcohol use data and thus was excluded from the statistical analysis|69
335276|NCT00596960|811731|P1|STARTED|Overall Study||70
335277|NCT00596947|811743|P2|NOT COMPLETED|Overall Study||3
335278|NCT00596947|811744|P1|NOT COMPLETED|Overall Study||6
335279|NCT00596947|811743|P2|COMPLETED|Overall Study||6
335280|NCT00596947|811744|P1|COMPLETED|Overall Study||3
335281|NCT00596947|811743|P2|STARTED|Overall Study||9
335282|NCT00596947|811744|P1|STARTED|Overall Study||9
335283|NCT00596934|811784|P1|NOT COMPLETED|Overall Study||2
335284|NCT00596934|811784|P1|COMPLETED|Overall Study||7
335285|NCT00596934|811784|P1|STARTED|Overall Study||9
335286|NCT00596830|811797|P2|NOT COMPLETED|Overall Study||339
335287|NCT00596830|811798|P1|NOT COMPLETED|Overall Study||342
335288|NCT00596830|811797|P2|COMPLETED|Overall Study||0
335289|NCT00596830|811798|P1|COMPLETED|Overall Study||0
335290|NCT00596830|811797|P2|Treated|Overall Study||332
335291|NCT00596830|811798|P1|Treated|Overall Study|1 participant in this group only received chemo and did not complete due to death.|339
335292|NCT00596830|811797|P2|STARTED|Overall Study||339
335293|NCT00596830|811798|P1|STARTED|Overall Study|1 participant in this group only received paclitaxel and carboplatin (chemo).|342
335294|NCT00596817|811824|P2|NOT COMPLETED|Double-blind Period||79
335295|NCT00596817|811825|P1|NOT COMPLETED|Double-blind Period||88
335296|NCT00596817|811824|P2|COMPLETED|Double-blind Period||125
335297|NCT00596817|811825|P1|COMPLETED|Double-blind Period||104
335298|NCT00596817|811824|P2|STARTED|Double-blind Period|206 patients were randomised. 2 did not receive study medication. 204 is FAS.|204
335299|NCT00596817|811825|P1|STARTED|Double-blind Period|194 patients were randomised. 2 did not receive study medication. 192 is full-analysis set (FAS).|192
335300|NCT00596817|811824|P2|NOT COMPLETED|Open-label Period to Double-blind Period||92
335301|NCT00596817|811825|P1|NOT COMPLETED|Open-label Period to Double-blind Period||0
335302|NCT00596817|811824|P2|COMPLETED|Open-label Period to Double-blind Period||400
335303|NCT00596817|811825|P1|COMPLETED|Open-label Period to Double-blind Period||0
335304|NCT00596817|811824|P2|STARTED|Open-label Period to Double-blind Period||492
335305|NCT00596817|811825|P1|STARTED|Open-label Period to Double-blind Period||0
335306|NCT00596817|811824|P2|NOT COMPLETED|Open-label Period||147
335307|NCT00596817|811825|P1|NOT COMPLETED|Open-label Period||0
335308|NCT00596817|811824|P2|COMPLETED|Open-label Period||492
335309|NCT00596817|811825|P1|COMPLETED|Open-label Period||0
335310|NCT00596817|811824|P2|STARTED|Open-label Period||639
335311|NCT00596817|811825|P1|STARTED|Open-label Period||0
335312|NCT00596752|811850|P2|NOT COMPLETED|Overall Study||143
335313|NCT00596752|811851|P1|NOT COMPLETED|Overall Study||126
335314|NCT00596752|811850|P2|COMPLETED|Overall Study||282
335315|NCT00596752|811851|P1|COMPLETED|Overall Study||289
335316|NCT00596752|811850|P2|Randomized and Treated|Overall Study||424
335317|NCT00596752|811851|P1|Randomized and Treated|Overall Study||415
335318|NCT00596752|811850|P2|STARTED|Overall Study||425
335319|NCT00596752|811851|P1|STARTED|Overall Study||415
335320|NCT00596687|811881|P2|NOT COMPLETED|Overall Study||9
335321|NCT00596687|811882|P1|NOT COMPLETED|Overall Study||14
335322|NCT00596687|811881|P2|COMPLETED|Overall Study||107
335323|NCT00596687|811882|P1|COMPLETED|Overall Study||104
335324|NCT00596687|811881|P2|STARTED|Overall Study||116
335325|NCT00596687|811882|P1|STARTED|Overall Study||118
335326|NCT00596635|811893|P3|NOT COMPLETED|Overall Study||8
335327|NCT00596635|811894|P2|NOT COMPLETED|Overall Study||13
335328|NCT00596635|811895|P1|NOT COMPLETED|Overall Study||7
335329|NCT00596635|811893|P3|COMPLETED|Overall Study||11
335330|NCT00596635|811894|P2|COMPLETED|Overall Study||7
335331|NCT00596635|811895|P1|COMPLETED|Overall Study||10
335332|NCT00596635|811893|P3|STARTED|Overall Study||19
335333|NCT00596635|811894|P2|STARTED|Overall Study||20
335334|NCT00596635|811895|P1|STARTED|Overall Study||17
335335|NCT00596622|811912|P1|NOT COMPLETED|Overall Study||13
335336|NCT00596622|811912|P1|COMPLETED|Overall Study||33
335337|NCT00596622|811912|P1|STARTED|Overall Study||46
335338|NCT00596466|811921|P1|NOT COMPLETED|Overall Study||17
335339|NCT00596466|811921|P1|COMPLETED|Overall Study||58
335340|NCT00596466|811921|P1|Enrolled, Treated|Overall Study||73
335341|NCT00596466|811921|P1|STARTED|Overall Study||75
335342|NCT00596453|811929|P2|NOT COMPLETED|Overall Study||3
335343|NCT00596453|811930|P1|NOT COMPLETED|Overall Study||1
335344|NCT00596453|811929|P2|COMPLETED|Overall Study||12
335345|NCT00596453|811930|P1|COMPLETED|Overall Study||12
335346|NCT00596453|811929|P2|STARTED|Overall Study||15
335347|NCT00596453|811930|P1|STARTED|Overall Study||13
335348|NCT00596440|811938|P2|NOT COMPLETED|Overall Study||80
335349|NCT00596440|811939|P1|NOT COMPLETED|Overall Study||65
335350|NCT00596440|811938|P2|COMPLETED|Overall Study||41
335351|NCT00596440|811939|P1|COMPLETED|Overall Study||48
335352|NCT00596440|811938|P2|Showed to First Treatment Session|Overall Study||52
335353|NCT00596440|811939|P1|Showed to First Treatment Session|Overall Study||61
335354|NCT00596440|811938|P2|Showed to Eligibility Visit|Overall Study||72
335355|NCT00596440|811939|P1|Showed to Eligibility Visit|Overall Study||85
335356|NCT00596440|811938|P2|STARTED|Overall Study||121
335357|NCT00596440|811939|P1|STARTED|Overall Study||113
335358|NCT00596427|811951|P2|NOT COMPLETED|Overall Study||2
335359|NCT00596427|811952|P1|NOT COMPLETED|Overall Study||4
335360|NCT00596427|811951|P2|COMPLETED|Overall Study||28
335361|NCT00596427|811952|P1|COMPLETED|Overall Study||26
335362|NCT00596427|811951|P2|STARTED|Overall Study||30
335363|NCT00596427|811952|P1|STARTED|Overall Study||30
335364|NCT00596362|811980|P1|NOT COMPLETED|Overall Study||1
335365|NCT00596362|811980|P1|COMPLETED|Overall Study||0
335366|NCT00596362|811980|P1|STARTED|Overall Study||1
335367|NCT00596271|811987|P3|NOT COMPLETED|Overall Study||1
335368|NCT00596271|811988|P2|NOT COMPLETED|Overall Study||6
335369|NCT00596271|811989|P1|NOT COMPLETED|Overall Study||5
335370|NCT00596271|811987|P3|COMPLETED|Overall Study||61
335371|NCT00596271|811988|P2|COMPLETED|Overall Study||59
335372|NCT00596271|811989|P1|COMPLETED|Overall Study||60
335373|NCT00596271|811987|P3|STARTED|Overall Study||62
335374|NCT00596271|811988|P2|STARTED|Overall Study||65
335375|NCT00596271|811989|P1|STARTED|Overall Study||65
335376|NCT00596167|811998|P1|NOT COMPLETED|Overall Study||0
335377|NCT00596167|811998|P1|COMPLETED|Overall Study||6
335378|NCT00596167|811998|P1|STARTED|Overall Study|All recruited subjects completed the study.|6
335379|NCT00596102|812005|P3|NOT COMPLETED|Up to Month 60||637
335380|NCT00596102|812006|P2|NOT COMPLETED|Up to Month 60||338
335381|NCT00596102|812007|P1|NOT COMPLETED|Up to Month 60||2181
335382|NCT00596102|812005|P3|COMPLETED|Up to Month 60||0
335383|NCT00596102|812006|P2|COMPLETED|Up to Month 60||0
335384|NCT00596102|812007|P1|COMPLETED|Up to Month 60|"long-term safety follow-up beyond Month 6 for a sub-set of subjects in IC51 group only"|102
335385|NCT00596102|812005|P3|STARTED|Up to Month 60||637
335386|NCT00596102|812006|P2|STARTED|Up to Month 60||338
335387|NCT00596102|812007|P1|STARTED|Up to Month 60||2283
335388|NCT00596102|812005|P3|NOT COMPLETED|Up to Month 6||0
335389|NCT00596102|812006|P2|NOT COMPLETED|Up to Month 6||0
335390|NCT00596102|812007|P1|NOT COMPLETED|Up to Month 6||0
335391|NCT00596102|812005|P3|COMPLETED|Up to Month 6||637
335392|NCT00596102|812006|P2|COMPLETED|Up to Month 6||338
335393|NCT00596102|812007|P1|COMPLETED|Up to Month 6||2283
335394|NCT00596102|812005|P3|STARTED|Up to Month 6||637
335395|NCT00596102|812006|P2|STARTED|Up to Month 6||338
335396|NCT00596102|812007|P1|STARTED|Up to Month 6||2283
335397|NCT00596011|812016|P2|NOT COMPLETED|Overall Study||10
335398|NCT00596011|812017|P1|NOT COMPLETED|Overall Study||13
335399|NCT00596011|812016|P2|COMPLETED|Overall Study||38
335400|NCT00596011|812017|P1|COMPLETED|Overall Study||36
335401|NCT00596011|812016|P2|STARTED|Overall Study||48
335402|NCT00596011|812017|P1|STARTED|Overall Study||49
335403|NCT00595959|812033|P1|NOT COMPLETED|Overall Study||2
335404|NCT00595959|812033|P1|COMPLETED|Overall Study||63
335405|NCT00595959|812033|P1|STARTED|Overall Study||65
335406|NCT00595946|812050|P2|NOT COMPLETED|Overall Study||69
335407|NCT00595946|812051|P1|NOT COMPLETED|Overall Study||64
335408|NCT00595946|812050|P2|COMPLETED|Overall Study||152
335409|NCT00595946|812051|P1|COMPLETED|Overall Study||154
335410|NCT00595946|812050|P2|STARTED|Overall Study||221
335411|NCT00595946|812051|P1|STARTED|Overall Study||218
335412|NCT00595920|812067|P1|NOT COMPLETED|Overall Study||116
335413|NCT00595920|812067|P1|COMPLETED|Overall Study||0
335414|NCT00595920|812067|P1|Patients Dosed|Overall Study|116 patients enrolled; however, only 38 received at least 1 dose.|38
335415|NCT00595920|812067|P1|STARTED|Overall Study||116
335416|NCT00595881|812071|P1|NOT COMPLETED|Overall Study||0
335417|NCT00595881|812071|P1|COMPLETED|Overall Study||420
335418|NCT00595881|812071|P1|STARTED|Overall Study||420
335419|NCT00595868|812078|P2|NOT COMPLETED|Overall Study||50
335420|NCT00595868|812079|P1|NOT COMPLETED|Overall Study||45
335421|NCT00595868|812078|P2|COMPLETED|Overall Study||61
335422|NCT00595868|812079|P1|COMPLETED|Overall Study||62
335423|NCT00595868|812078|P2|STARTED|Overall Study||111
335424|NCT00595868|812079|P1|STARTED|Overall Study||107
335425|NCT00595790|812090|P3|NOT COMPLETED|Overall Study||3
335426|NCT00595790|812091|P2|NOT COMPLETED|Overall Study||1
335427|NCT00595790|812092|P1|NOT COMPLETED|Overall Study||2
335428|NCT00595790|812090|P3|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|122
335429|NCT00595790|812091|P2|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
335430|NCT00595790|812092|P1|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
335431|NCT00595790|812090|P3|STARTED|Overall Study|125 subjects randomized to this group, 124 subjects received 1x6 mcg.(Safety Population: N=124)|125
335432|NCT00595790|812091|P2|STARTED|Overall Study|124 subjects randomized to this group, 125 subjects received 1x12 mcg.(Safety Population: N=125)|124
335433|NCT00595790|812092|P1|STARTED|Overall Study||125
335434|NCT00595764|812102|P2|NOT COMPLETED|Overall Study||43
335435|NCT00595764|812103|P1|NOT COMPLETED|Overall Study||39
335436|NCT00595764|812102|P2|COMPLETED|Overall Study||27
335437|NCT00595764|812103|P1|COMPLETED|Overall Study||32
335438|NCT00595764|812102|P2|STARTED|Overall Study||70
335439|NCT00595764|812103|P1|STARTED|Overall Study||71
335440|NCT00595621|812119|P2|NOT COMPLETED|Randomization and Study||1
335441|NCT00595621|812120|P1|NOT COMPLETED|Randomization and Study||2
335442|NCT00595621|812119|P2|COMPLETED|Randomization and Study||8
335443|NCT00595621|812120|P1|COMPLETED|Randomization and Study||8
335444|NCT00595621|812119|P2|STARTED|Randomization and Study||9
335445|NCT00595621|812120|P1|STARTED|Randomization and Study||10
335446|NCT00595621|812119|P2|NOT COMPLETED|Open Label Run in||0
335447|NCT00595621|812120|P1|NOT COMPLETED|Open Label Run in||3
335448|NCT00595621|812119|P2|COMPLETED|Open Label Run in||0
335449|NCT00595621|812120|P1|COMPLETED|Open Label Run in||19
335450|NCT00595621|812119|P2|STARTED|Open Label Run in||0
335451|NCT00595621|812120|P1|STARTED|Open Label Run in||22
335452|NCT00595582|812137|P1|NOT COMPLETED|Overall Study||10
335453|NCT00595582|812137|P1|COMPLETED|Overall Study||0
335454|NCT00595582|812137|P1|STARTED|Overall Study||10
335455|NCT00595556|812143|P2|NOT COMPLETED|Overall Study||1
335456|NCT00595556|812144|P1|NOT COMPLETED|Overall Study||3
335457|NCT00595556|812143|P2|COMPLETED|Overall Study||19
335458|NCT00595556|812144|P1|COMPLETED|Overall Study||17
335459|NCT00595556|812143|P2|STARTED|Overall Study||20
335460|NCT00595556|812144|P1|STARTED|Overall Study||20
335461|NCT00595530|812158|P1|NOT COMPLETED|Overall Study||0
335462|NCT00595530|812158|P1|COMPLETED|Overall Study||3
335463|NCT00595530|812158|P1|STARTED|Overall Study||3
335464|NCT00595517|812163|P1|NOT COMPLETED|Overall Study||19
335465|NCT00595517|812163|P1|COMPLETED|Overall Study||111
335466|NCT00595517|812163|P1|STARTED|Overall Study||130
335467|NCT00595504|812172|P2|NOT COMPLETED|Overall Study||3
335468|NCT00595504|812173|P1|NOT COMPLETED|Overall Study||2
335469|NCT00595504|812172|P2|COMPLETED|Overall Study||6
335470|NCT00595504|812173|P1|COMPLETED|Overall Study||14
335471|NCT00595504|812172|P2|STARTED|Overall Study||9
335472|NCT00595504|812173|P1|STARTED|Overall Study||16
335473|NCT00595478|812185|P2|NOT COMPLETED|36-week Follow-up Period||8
335474|NCT00595478|812186|P1|NOT COMPLETED|36-week Follow-up Period||9
335475|NCT00595478|812185|P2|COMPLETED|36-week Follow-up Period||30
335476|NCT00595478|812186|P1|COMPLETED|36-week Follow-up Period||28
335477|NCT00595478|812185|P2|STARTED|36-week Follow-up Period||38
335478|NCT00595478|812186|P1|STARTED|36-week Follow-up Period||37
335479|NCT00595478|812185|P2|NOT COMPLETED|Treatment||0
335480|NCT00595478|812186|P1|NOT COMPLETED|Treatment||0
335481|NCT00595478|812185|P2|COMPLETED|Treatment||38
335482|NCT00595478|812186|P1|COMPLETED|Treatment||37
335483|NCT00595478|812185|P2|STARTED|Treatment||38
335484|NCT00595478|812186|P1|STARTED|Treatment||37
335485|NCT00595465|812197|P3|NOT COMPLETED|Overall Study||7
335486|NCT00595465|812198|P2|NOT COMPLETED|Overall Study||4
335487|NCT00595465|812199|P1|NOT COMPLETED|Overall Study||6
335488|NCT00595465|812197|P3|COMPLETED|Overall Study||121
335489|NCT00595465|812198|P2|COMPLETED|Overall Study||125
335490|NCT00595465|812199|P1|COMPLETED|Overall Study||124
335491|NCT00595465|812197|P3|STARTED|Overall Study||128
335492|NCT00595465|812198|P2|STARTED|Overall Study||129
335493|NCT00595465|812199|P1|STARTED|Overall Study||130
335494|NCT00595413|812211|P4|NOT COMPLETED|Overall Study||4
335495|NCT00595413|812212|P3|NOT COMPLETED|Overall Study||8
335496|NCT00595413|812213|P2|NOT COMPLETED|Overall Study||5
335497|NCT00595413|812214|P1|NOT COMPLETED|Overall Study||7
335498|NCT00595413|812211|P4|COMPLETED|Overall Study||75
335499|NCT00595413|812212|P3|COMPLETED|Overall Study||70
335500|NCT00595413|812213|P2|COMPLETED|Overall Study||73
335501|NCT00595413|812214|P1|COMPLETED|Overall Study||69
335502|NCT00595413|812211|P4|STARTED|Overall Study||79
335503|NCT00595413|812212|P3|STARTED|Overall Study||78
335504|NCT00595413|812213|P2|STARTED|Overall Study||78
335505|NCT00595413|812214|P1|STARTED|Overall Study||76
335506|NCT00595361|812242|P2|NOT COMPLETED|Overall Study||0
335507|NCT00595361|812243|P1|NOT COMPLETED|Overall Study||0
335508|NCT00595361|812242|P2|COMPLETED|Overall Study||18
335509|NCT00595361|812243|P1|COMPLETED|Overall Study||12
335510|NCT00595361|812242|P2|STARTED|Overall Study||18
335511|NCT00595361|812243|P1|STARTED|Overall Study||12
335512|NCT00595335|812255|P2|NOT COMPLETED|Six Months to Twelve Months||1
335513|NCT00595335|812256|P1|NOT COMPLETED|Six Months to Twelve Months||1
335514|NCT00595335|812255|P2|COMPLETED|Six Months to Twelve Months||9
335515|NCT00595335|812256|P1|COMPLETED|Six Months to Twelve Months||10
335516|NCT00595335|812255|P2|STARTED|Six Months to Twelve Months||10
335517|NCT00595335|812256|P1|STARTED|Six Months to Twelve Months||11
335518|NCT00595335|812255|P2|NOT COMPLETED|Baseline to Six Months||2
335519|NCT00595335|812256|P1|NOT COMPLETED|Baseline to Six Months||2
335520|NCT00595335|812255|P2|COMPLETED|Baseline to Six Months||10
335521|NCT00595335|812256|P1|COMPLETED|Baseline to Six Months||11
335522|NCT00595335|812255|P2|STARTED|Baseline to Six Months||12
335523|NCT00595335|812256|P1|STARTED|Baseline to Six Months||13
335524|NCT00595309|812276|P1|NOT COMPLETED|Overall Study||4
335525|NCT00595309|812276|P1|COMPLETED|Overall Study||194
335526|NCT00595309|812276|P1|STARTED|Overall Study||198
335527|NCT00595270|812283|P3|NOT COMPLETED|Overall Study||8
335528|NCT00595270|812284|P2|NOT COMPLETED|Overall Study||10
335529|NCT00595270|812285|P1|NOT COMPLETED|Overall Study||6
335530|NCT00595270|812283|P3|COMPLETED|Overall Study||108
335531|NCT00595270|812284|P2|COMPLETED|Overall Study||107
335532|NCT00595270|812285|P1|COMPLETED|Overall Study||110
335533|NCT00595270|812283|P3|STARTED|Overall Study||116
335534|NCT00595270|812284|P2|STARTED|Overall Study||117
335535|NCT00595270|812285|P1|STARTED|Overall Study||116
335536|NCT00595231|812295|P2|NOT COMPLETED|Overall Study||5
335537|NCT00595231|812296|P1|NOT COMPLETED|Overall Study||5
335538|NCT00595231|812295|P2|COMPLETED|Overall Study||114
335539|NCT00595231|812296|P1|COMPLETED|Overall Study||115
335540|NCT00595231|812295|P2|STARTED|Overall Study||119
335541|NCT00595231|812296|P1|STARTED|Overall Study||120
335542|NCT00595153|812315|P3|NOT COMPLETED|Overall Study||25
335543|NCT00595153|812316|P2|NOT COMPLETED|Overall Study||16
335544|NCT00595153|812317|P1|NOT COMPLETED|Overall Study||4
335545|NCT00595153|812315|P3|COMPLETED|Overall Study||36
335546|NCT00595153|812316|P2|COMPLETED|Overall Study||26
335547|NCT00595153|812317|P1|COMPLETED|Overall Study||20
335548|NCT00595153|812315|P3|STARTED|Overall Study||61
335549|NCT00595153|812316|P2|STARTED|Overall Study||42
335550|NCT00595153|812317|P1|STARTED|Overall Study||24
335551|NCT00595127|812325|P1|NOT COMPLETED|Overall Study||10
335552|NCT00595127|812325|P1|COMPLETED|Overall Study||11
335553|NCT00595127|812325|P1|STARTED|Overall Study||21
335554|NCT00595114|812331|P2|NOT COMPLETED|Overall Study||0
335555|NCT00595114|812332|P1|NOT COMPLETED|Overall Study||0
335556|NCT00595114|812331|P2|COMPLETED|Overall Study||19
335557|NCT00595114|812332|P1|COMPLETED|Overall Study||24
335558|NCT00595114|812331|P2|STARTED|Overall Study||19
335559|NCT00595114|812332|P1|STARTED|Overall Study||24
335560|NCT00595088|812338|P1|NOT COMPLETED|Overall Study||40
335561|NCT00595088|812338|P1|COMPLETED|Overall Study|5 patients ongoing, 7 completed the study (week 46)and 35 withdrew prematurely|7
335562|NCT00595088|812338|P1|STARTED|Overall Study||47
335563|NCT00595075|812346|P2|NOT COMPLETED|Overall Study||0
335564|NCT00595075|812347|P1|NOT COMPLETED|Overall Study||1
335565|NCT00595075|812346|P2|COMPLETED|Overall Study||5
335566|NCT00595075|812347|P1|COMPLETED|Overall Study||5
335567|NCT00595075|812346|P2|STARTED|Overall Study||5
335568|NCT00595075|812347|P1|STARTED|Overall Study||6
335569|NCT00594958|812368|P3|NOT COMPLETED|Overall Study||10
335570|NCT00594958|812369|P2|NOT COMPLETED|Overall Study||3
335571|NCT00594958|812370|P1|NOT COMPLETED|Overall Study||14
335572|NCT00594958|812368|P3|COMPLETED|Overall Study||202
335573|NCT00594958|812369|P2|COMPLETED|Overall Study||210
335574|NCT00594958|812370|P1|COMPLETED|Overall Study||200
335575|NCT00594958|812368|P3|Randomized and at Least 1 Vaccination|Overall Study||211
335576|NCT00594958|812369|P2|Randomized and at Least 1 Vaccination|Overall Study||213
335577|NCT00594958|812370|P1|Randomized and at Least 1 Vaccination|Overall Study||212
335578|NCT00594958|812368|P3|STARTED|Overall Study||212
335579|NCT00594958|812369|P2|STARTED|Overall Study||213
335580|NCT00594958|812370|P1|STARTED|Overall Study||214
335581|NCT00594945|812381|P3|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
335582|NCT00594945|812382|P2|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
335583|NCT00594945|812383|P1|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
335584|NCT00594945|812381|P3|COMPLETED|Cohort 2 / Treatment Period 2||2
335585|NCT00594945|812382|P2|COMPLETED|Cohort 2 / Treatment Period 2||3
335586|NCT00594945|812383|P1|COMPLETED|Cohort 2 / Treatment Period 2||0
335587|NCT00594945|812381|P3|STARTED|Cohort 2 / Treatment Period 2||2
335588|NCT00594945|812382|P2|STARTED|Cohort 2 / Treatment Period 2||3
335589|NCT00594945|812383|P1|STARTED|Cohort 2 / Treatment Period 2||0
335590|NCT00594945|812381|P3|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
335591|NCT00594945|812382|P2|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
335592|NCT00594945|812383|P1|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
335593|NCT00594945|812381|P3|COMPLETED|Cohort 1 / Treatment Period 1||2
335594|NCT00594945|812382|P2|COMPLETED|Cohort 1 / Treatment Period 1||0
335595|NCT00594945|812383|P1|COMPLETED|Cohort 1 / Treatment Period 1||4
335596|NCT00594945|812381|P3|STARTED|Cohort 1 / Treatment Period 1||2
335597|NCT00594945|812382|P2|STARTED|Cohort 1 / Treatment Period 1||0
335598|NCT00594945|812383|P1|STARTED|Cohort 1 / Treatment Period 1||4
335599|NCT00594906|812391|P2|NOT COMPLETED|Overall Study||2
335600|NCT00594906|812392|P1|NOT COMPLETED|Overall Study||1
335601|NCT00594906|812391|P2|COMPLETED|Overall Study||1
335602|NCT00594906|812392|P1|COMPLETED|Overall Study||6
335603|NCT00594906|812391|P2|STARTED|Overall Study||3
335604|NCT00594906|812392|P1|STARTED|Overall Study||7
335605|NCT00594880|812400|P2|NOT COMPLETED|Overall Study||1
335606|NCT00594880|812401|P1|NOT COMPLETED|Overall Study||2
335607|NCT00594880|812400|P2|COMPLETED|Overall Study||10
335608|NCT00594880|812401|P1|COMPLETED|Overall Study||10
335609|NCT00594880|812400|P2|STARTED|Overall Study||11
335610|NCT00594880|812401|P1|STARTED|Overall Study||12
335611|NCT00594854|812413|P2|NOT COMPLETED|Overall Study||10
335612|NCT00594854|812414|P1|NOT COMPLETED|Overall Study||7
335613|NCT00594854|812413|P2|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|1
335614|NCT00594854|812414|P1|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|2
335615|NCT00594854|812413|P2|STARTED|Overall Study||11
335616|NCT00594854|812414|P1|STARTED|Overall Study||9
335617|NCT00594815|812424|P1|NOT COMPLETED|Overall Study||9
335618|NCT00594815|812424|P1|COMPLETED|Overall Study||43
335619|NCT00594815|812424|P1|STARTED|Overall Study||52
335620|NCT00594685|812429|P1|NOT COMPLETED|Overall Study||0
335621|NCT00594685|812429|P1|COMPLETED|Overall Study||10
335622|NCT00594685|812429|P1|STARTED|Overall Study||10
335623|NCT00594659|812449|P3|NOT COMPLETED|Overall Study||7
335624|NCT00594659|812450|P2|NOT COMPLETED|Overall Study||9
335625|NCT00594659|812451|P1|NOT COMPLETED|Overall Study||13
335626|NCT00594659|812449|P3|COMPLETED|Overall Study||9
335627|NCT00594659|812450|P2|COMPLETED|Overall Study||21
335628|NCT00594659|812451|P1|COMPLETED|Overall Study||16
335629|NCT00594659|812449|P3|STARTED|Overall Study||16
335630|NCT00594659|812450|P2|STARTED|Overall Study||30
335631|NCT00594659|812451|P1|STARTED|Overall Study||29
335632|NCT00594646|812462|P1|NOT COMPLETED|Overall Study||16
335633|NCT00594646|812462|P1|COMPLETED|Overall Study||84
335634|NCT00594646|812462|P1|STARTED|Overall Study||100
335635|NCT00594568|812470|P3|NOT COMPLETED|Safety Follow Up (SFU)-Optional||42
335636|NCT00594568|812471|P2|NOT COMPLETED|Safety Follow Up (SFU)-Optional||55
335637|NCT00594568|812472|P1|NOT COMPLETED|Safety Follow Up (SFU)-Optional||61
335638|NCT00594568|812470|P3|COMPLETED|Safety Follow Up (SFU)-Optional||172
335639|NCT00594568|812471|P2|COMPLETED|Safety Follow Up (SFU)-Optional||168
335640|NCT00594568|812472|P1|COMPLETED|Safety Follow Up (SFU)-Optional||229
335641|NCT00594568|812470|P3|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional, pts entered from initial treatment and delayed start or did not enter SFU.|214
335642|NCT00594568|812471|P2|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|223
335643|NCT00594568|812472|P1|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|290
335644|NCT00594568|812470|P3|NOT COMPLETED|Delayed Start||66
335645|NCT00594568|812471|P2|NOT COMPLETED|Delayed Start||77
335646|NCT00594568|812472|P1|NOT COMPLETED|Delayed Start||98
335647|NCT00594568|812470|P3|COMPLETED|Delayed Start||55
335648|NCT00594568|812471|P2|COMPLETED|Delayed Start||76
335649|NCT00594568|812472|P1|COMPLETED|Delayed Start||91
335650|NCT00594568|812470|P3|STARTED|Delayed Start||121
335651|NCT00594568|812471|P2|STARTED|Delayed Start||153
335652|NCT00594568|812472|P1|STARTED|Delayed Start||189
335653|NCT00594568|812470|P3|NOT COMPLETED|Initial Treatment||408
335654|NCT00594568|812471|P2|NOT COMPLETED|Initial Treatment||354
335655|NCT00594568|812472|P1|NOT COMPLETED|Initial Treatment||312
335656|NCT00594568|812470|P3|COMPLETED|Initial Treatment||121
335657|NCT00594568|812471|P2|COMPLETED|Initial Treatment||153
335658|NCT00594568|812472|P1|COMPLETED|Initial Treatment||189
335659|NCT00594568|812470|P3|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|527
335660|NCT00594568|812471|P2|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|506
335661|NCT00594568|812472|P1|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants (pts) who had at least 1 dose of study drug.|501
335662|NCT00594568|812470|P3|STARTED|Initial Treatment||529
335663|NCT00594568|812471|P2|STARTED|Initial Treatment||507
335664|NCT00594568|812472|P1|STARTED|Initial Treatment||501
335665|NCT00594516|812560|P3|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||8
335666|NCT00594516|812561|P2|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||7
335667|NCT00594516|812562|P1|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
335668|NCT00594516|812560|P3|COMPLETED|DB: Tapentadol IR to ER & ER to IR||35
335669|NCT00594516|812561|P2|COMPLETED|DB: Tapentadol IR to ER & ER to IR||37
335670|NCT00594516|812562|P1|COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
335671|NCT00594516|812560|P3|STARTED|DB: Tapentadol IR to ER & ER to IR||43
335672|NCT00594516|812561|P2|STARTED|DB: Tapentadol IR to ER & ER to IR||44
335673|NCT00594516|812562|P1|STARTED|DB: Tapentadol IR to ER & ER to IR||0
335674|NCT00594516|812560|P3|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
335675|NCT00594516|812561|P2|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
335676|NCT00594516|812562|P1|NOT COMPLETED|Open Label (OL): Tapentadol IR||29
335677|NCT00594516|812560|P3|COMPLETED|Open Label (OL): Tapentadol IR||0
335678|NCT00594516|812561|P2|COMPLETED|Open Label (OL): Tapentadol IR||0
335679|NCT00594516|812562|P1|COMPLETED|Open Label (OL): Tapentadol IR||87
335680|NCT00594516|812560|P3|STARTED|Open Label (OL): Tapentadol IR||0
335681|NCT00594516|812561|P2|STARTED|Open Label (OL): Tapentadol IR||0
335682|NCT00594516|812562|P1|STARTED|Open Label (OL): Tapentadol IR|one patient was enrolled but lost to follow up at the start of open label therefore was not included|116
335683|NCT00594464|812570|P1|NOT COMPLETED|Overall Study||3
335684|NCT00594464|812570|P1|COMPLETED|Overall Study||11
335685|NCT00594464|812570|P1|STARTED|Overall Study||14
335686|NCT00594425|812585|P3|NOT COMPLETED|Overall Study||10
335687|NCT00594425|812586|P2|NOT COMPLETED|Overall Study||14
335688|NCT00594425|812587|P1|NOT COMPLETED|Overall Study||7
335689|NCT00594425|812585|P3|COMPLETED|Overall Study||42
335690|NCT00594425|812586|P2|COMPLETED|Overall Study||34
335691|NCT00594425|812587|P1|COMPLETED|Overall Study||43
335692|NCT00594425|812585|P3|STARTED|Overall Study||52
335693|NCT00594425|812586|P2|STARTED|Overall Study||48
335694|NCT00594425|812587|P1|STARTED|Overall Study||50
335695|NCT00594399|812699|P3|NOT COMPLETED|Rerandomization Arm 1 Only||0
335696|NCT00594399|812700|P2|NOT COMPLETED|Rerandomization Arm 1 Only||4
335697|NCT00594399|812701|P1|NOT COMPLETED|Rerandomization Arm 1 Only||2
335698|NCT00594399|812699|P3|COMPLETED|Rerandomization Arm 1 Only||82
335699|NCT00594399|812700|P2|COMPLETED|Rerandomization Arm 1 Only||114
335700|NCT00594399|812701|P1|COMPLETED|Rerandomization Arm 1 Only||79
335701|NCT00594399|812699|P3|Rerandomization|Rerandomization Arm 1 Only||82
335702|NCT00594399|812700|P2|Rerandomization|Rerandomization Arm 1 Only||114
335703|NCT00594399|812701|P1|Rerandomization|Rerandomization Arm 1 Only|Rerandomized to continue to receive telephone calls every 2 weeks or at a reduced dose of 1/ month|81
335704|NCT00594399|812699|P3|STARTED|Rerandomization Arm 1 Only|This sample reflects newly randomized study Arm|82
335705|NCT00594399|812700|P2|STARTED|Rerandomization Arm 1 Only||118
335706|NCT00594399|812701|P1|STARTED|Rerandomization Arm 1 Only|Total sample in Arm 1 was rerandomized and allocated to remain in Arm 1 or assigned to Arm 3|81
335707|NCT00594399|812699|P3|NOT COMPLETED|Initial 3 Month Counseling||0
335708|NCT00594399|812700|P2|NOT COMPLETED|Initial 3 Month Counseling||4
335709|NCT00594399|812701|P1|NOT COMPLETED|Initial 3 Month Counseling||17
335710|NCT00594399|812699|P3|COMPLETED|Initial 3 Month Counseling||0
335711|NCT00594399|812700|P2|COMPLETED|Initial 3 Month Counseling||118
335712|NCT00594399|812701|P1|COMPLETED|Initial 3 Month Counseling||163
335713|NCT00594399|812699|P3|STARTED|Initial 3 Month Counseling||0
335714|NCT00594399|812700|P2|STARTED|Initial 3 Month Counseling||122
335715|NCT00594399|812701|P1|STARTED|Initial 3 Month Counseling||180
335716|NCT00594386|812723|P1|NOT COMPLETED|Overall Study||258
335717|NCT00594386|812723|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
335718|NCT00594386|812723|P1|STARTED|Overall Study||258
335719|NCT00594308|812729|P1|NOT COMPLETED|Overall Study||0
335720|NCT00594308|812729|P1|COMPLETED|Overall Study||10
335721|NCT00594308|812729|P1|STARTED|Overall Study||10
335722|NCT00594256|812737|P1|NOT COMPLETED|Overall Study||0
335723|NCT00594256|812737|P1|COMPLETED|Overall Study||8
335724|NCT00594256|812737|P1|STARTED|Overall Study||8
335725|NCT00594230|812747|P2|NOT COMPLETED|Overall Study||9
335726|NCT00594230|812748|P1|NOT COMPLETED|Overall Study||15
335727|NCT00594230|812747|P2|COMPLETED|Overall Study||1
335728|NCT00594230|812748|P1|COMPLETED|Overall Study||1
335729|NCT00594230|812747|P2|STARTED|Overall Study||10
335730|NCT00594230|812748|P1|STARTED|Overall Study||16
335731|NCT00594204|812756|P2|NOT COMPLETED|Overall Study||45
335732|NCT00594204|812757|P1|NOT COMPLETED|Overall Study||58
335733|NCT00594204|812756|P2|COMPLETED|Overall Study||154
335734|NCT00594204|812757|P1|COMPLETED|Overall Study||336
335735|NCT00594204|812756|P2|Received Treatment|Overall Study||198
335736|NCT00594204|812757|P1|Received Treatment|Overall Study||390
335737|NCT00594204|812756|P2|STARTED|Overall Study||199
335738|NCT00594204|812757|P1|STARTED|Overall Study||394
335739|NCT00594178|812767|P1|NOT COMPLETED|Overall Study||5
335740|NCT00594178|812767|P1|COMPLETED|Overall Study||12
335741|NCT00594178|812767|P1|STARTED|Overall Study||17
335742|NCT00594165|812772|P1|NOT COMPLETED|Overall Study||217
335743|NCT00594165|812772|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
335744|NCT00594165|812772|P1|STARTED|Overall Study||217
335745|NCT00594100|812778|P1|NOT COMPLETED|Follow-up Through 30 Days Post Procedure||12
335746|NCT00594100|812778|P1|COMPLETED|Follow-up Through 30 Days Post Procedure||224
335747|NCT00594100|812778|P1|STARTED|Follow-up Through 30 Days Post Procedure||236
335748|NCT00594100|812778|P1|NOT COMPLETED|Procedure||9
335749|NCT00594100|812778|P1|COMPLETED|Procedure||236
335750|NCT00594100|812778|P1|STARTED|Procedure||245
335751|NCT00594061|812787|P1|NOT COMPLETED|Overall Study||0
335752|NCT00594061|812787|P1|COMPLETED|Overall Study||9
335753|NCT00594061|812787|P1|STARTED|Overall Study||9
335754|NCT00594035|812794|P2|NOT COMPLETED|Overall Study||3
335755|NCT00594035|812795|P1|NOT COMPLETED|Overall Study||2
335756|NCT00594035|812794|P2|COMPLETED|Overall Study|53 control group subjects were evaluable at the 90-day visit|53
335757|NCT00594035|812795|P1|COMPLETED|Overall Study|100 Spinal Sealant subjects were evaluable at the 90-day visit|100
335835|NCT00593684|813167|P1|STARTED|Overall Study||25
335758|NCT00594035|812794|P2|STARTED|Overall Study|56 subjects were randomized to the control group (standard of care)|56
335759|NCT00594035|812795|P1|STARTED|Overall Study|102 subjects were randomized to Spinal Sealant|102
335760|NCT00594022|812803|P2|NOT COMPLETED|Overall Study||0
335761|NCT00594022|812804|P1|NOT COMPLETED|Overall Study||0
335762|NCT00594022|812803|P2|COMPLETED|Overall Study||173
335763|NCT00594022|812804|P1|COMPLETED|Overall Study||176
335764|NCT00594022|812803|P2|STARTED|Overall Study||173
335765|NCT00594022|812804|P1|STARTED|Overall Study||176
335766|NCT00594009|812818|P1|NOT COMPLETED|Overall Study||0
335767|NCT00594009|812818|P1|COMPLETED|Overall Study||1
335768|NCT00594009|812818|P1|STARTED|Overall Study||1
335769|NCT00593957|812825|P3|NOT COMPLETED|Overall Study||2
335770|NCT00593957|812826|P2|NOT COMPLETED|Overall Study||1
335771|NCT00593957|812827|P1|NOT COMPLETED|Overall Study||0
335772|NCT00593957|812825|P3|COMPLETED|Overall Study||10
335773|NCT00593957|812826|P2|COMPLETED|Overall Study||12
335774|NCT00593957|812827|P1|COMPLETED|Overall Study||13
335775|NCT00593957|812825|P3|STARTED|Overall Study||12
335776|NCT00593957|812826|P2|STARTED|Overall Study||13
335777|NCT00593957|812827|P1|STARTED|Overall Study||13
335778|NCT00593918|812851|P2|NOT COMPLETED|Overall Study||24
335779|NCT00593918|812852|P1|NOT COMPLETED|Overall Study||5
335780|NCT00593918|812851|P2|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|50
335781|NCT00593918|812852|P1|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|12
335782|NCT00593918|812851|P2|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/AG and AA genotypes|74
335783|NCT00593918|812852|P1|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/GG Genotype|17
335784|NCT00593866|812860|P1|NOT COMPLETED|Overall Study||0
335785|NCT00593866|812860|P1|COMPLETED|Overall Study||50
335786|NCT00593866|812860|P1|STARTED|Overall Study||50
335787|NCT00593840|812865|P1|NOT COMPLETED|Overall Study||1
335788|NCT00593840|812865|P1|COMPLETED|Overall Study||72
335789|NCT00593840|812865|P1|STARTED|Overall Study||73
335790|NCT00593827|812877|P2|NOT COMPLETED|Overall Study||2
335791|NCT00593827|812878|P1|NOT COMPLETED|Overall Study||0
335792|NCT00593827|812877|P2|COMPLETED|Overall Study|Completed=off-study (Major reasons: AEs=30; disease progression=55; not treated=2).|89
335793|NCT00593827|812878|P1|COMPLETED|Overall Study|Completed=off-study (Major reasons: Adverse events (AE)=15; disease progression=76; not treated=3).|85
335794|NCT00593827|812877|P2|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|89
335795|NCT00593827|812878|P1|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|79
335796|NCT00593827|812877|P2|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|89
335797|NCT00593827|812878|P1|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|82
335798|NCT00593827|812877|P2|STARTED|Overall Study|ITT Population: Participants who were randomized (eligible and ineligible).|91
335799|NCT00593827|812878|P1|STARTED|Overall Study|Intent-to-Treat (ITT) Population: Participants who were randomized (eligible and ineligible).|85
335800|NCT00593814|812902|P2|NOT COMPLETED|Overall Study||0
335801|NCT00593814|812903|P1|NOT COMPLETED|Overall Study||24
335802|NCT00593814|812902|P2|COMPLETED|Overall Study||120
335803|NCT00593814|812903|P1|COMPLETED|Overall Study||115
335804|NCT00593814|812902|P2|STARTED|Overall Study||120
335805|NCT00593814|812903|P1|STARTED|Overall Study||139
335806|NCT00593736|812915|P4|NOT COMPLETED|Treatment Period and Placebo Run-out||4
335807|NCT00593736|812916|P3|NOT COMPLETED|Treatment Period and Placebo Run-out||5
335808|NCT00593736|812917|P2|NOT COMPLETED|Treatment Period and Placebo Run-out||2
335809|NCT00593736|812918|P1|NOT COMPLETED|Treatment Period and Placebo Run-out||3
335810|NCT00593736|812915|P4|COMPLETED|Treatment Period and Placebo Run-out||28
335811|NCT00593736|812916|P3|COMPLETED|Treatment Period and Placebo Run-out||30
335812|NCT00593736|812917|P2|COMPLETED|Treatment Period and Placebo Run-out||31
335813|NCT00593736|812918|P1|COMPLETED|Treatment Period and Placebo Run-out||29
335814|NCT00593736|812915|P4|STARTED|Treatment Period and Placebo Run-out||32
335815|NCT00593736|812916|P3|STARTED|Treatment Period and Placebo Run-out||35
335816|NCT00593736|812917|P2|STARTED|Treatment Period and Placebo Run-out||33
335817|NCT00593736|812918|P1|STARTED|Treatment Period and Placebo Run-out||32
335818|NCT00593736|812915|P4|NOT COMPLETED|Screening Period and Placebo Run-in||417
335819|NCT00593736|812916|P3|NOT COMPLETED|Screening Period and Placebo Run-in||0
335820|NCT00593736|812917|P2|NOT COMPLETED|Screening Period and Placebo Run-in||0
335821|NCT00593736|812918|P1|NOT COMPLETED|Screening Period and Placebo Run-in||0
335822|NCT00593736|812915|P4|COMPLETED|Screening Period and Placebo Run-in||132
335823|NCT00593736|812916|P3|COMPLETED|Screening Period and Placebo Run-in||0
335824|NCT00593736|812917|P2|COMPLETED|Screening Period and Placebo Run-in||0
335825|NCT00593736|812918|P1|COMPLETED|Screening Period and Placebo Run-in||0
335826|NCT00593736|812915|P4|STARTED|Screening Period and Placebo Run-in||549
335827|NCT00593736|812916|P3|STARTED|Screening Period and Placebo Run-in||0
335828|NCT00593736|812917|P2|STARTED|Screening Period and Placebo Run-in||0
335829|NCT00593736|812918|P1|STARTED|Screening Period and Placebo Run-in||0
335830|NCT00593684|813166|P2|NOT COMPLETED|Overall Study||1
335831|NCT00593684|813167|P1|NOT COMPLETED|Overall Study||2
335832|NCT00593684|813166|P2|COMPLETED|Overall Study||24
335833|NCT00593684|813167|P1|COMPLETED|Overall Study||23
335834|NCT00593684|813166|P2|STARTED|Overall Study||25
335836|NCT00593645|813179|P1|NOT COMPLETED|Overall Study||0
335837|NCT00593645|813179|P1|COMPLETED|Overall Study||7
335838|NCT00593645|813179|P1|STARTED|Overall Study||7
335839|NCT00593606|813193|P1|NOT COMPLETED|Overall Study||27
335840|NCT00593606|813193|P1|COMPLETED|Overall Study||97
335841|NCT00593606|813193|P1|Treatment Period Completed|Overall Study||99
335842|NCT00593606|813193|P1|Full Analysis Set|Overall Study||114
335843|NCT00593606|813193|P1|Start of Treatment - Safety Set|Overall Study||116
335844|NCT00593606|813193|P1|STARTED|Overall Study||124
335845|NCT00593554|813291|P2|NOT COMPLETED|Overall Study||5
335846|NCT00593554|813292|P1|NOT COMPLETED|Overall Study||3
335847|NCT00593554|813291|P2|COMPLETED|Overall Study||0
335848|NCT00593554|813292|P1|COMPLETED|Overall Study||0
335849|NCT00593554|813291|P2|STARTED|Overall Study||5
335850|NCT00593554|813292|P1|STARTED|Overall Study||3
335851|NCT00593450|813314|P4|NOT COMPLETED|Overall Study||29
335852|NCT00593450|813315|P3|NOT COMPLETED|Overall Study||13
335853|NCT00593450|813316|P2|NOT COMPLETED|Overall Study||21
335854|NCT00593450|813317|P1|NOT COMPLETED|Overall Study||17
335855|NCT00593450|813314|P4|COMPLETED|Overall Study||271
335856|NCT00593450|813315|P3|COMPLETED|Overall Study||285
335857|NCT00593450|813316|P2|COMPLETED|Overall Study||265
335858|NCT00593450|813317|P1|COMPLETED|Overall Study||284
335859|NCT00593450|813314|P4|STARTED|Overall Study||300
335860|NCT00593450|813315|P3|STARTED|Overall Study||298
335861|NCT00593450|813316|P2|STARTED|Overall Study||286
335862|NCT00593450|813317|P1|STARTED|Overall Study||301
335863|NCT00593385|813387|P1|NOT COMPLETED|Overall Study||40
335864|NCT00593385|813387|P1|COMPLETED|Overall Study|125 of 165 enrolled patients completed the study.|125
335865|NCT00593385|813387|P1|Intention to Treat (ITT) Population|Overall Study|Excludes 13 subjects who did not meet inclusion/exclusion criteria.|152
335866|NCT00593385|813387|P1|STARTED|Overall Study||165
335867|NCT00593372|813424|P2|NOT COMPLETED|Overall Study||0
335868|NCT00593372|813425|P1|NOT COMPLETED|Overall Study||0
335869|NCT00593372|813424|P2|COMPLETED|Overall Study|Three evaluated and completed protocol.|3
335870|NCT00593372|813425|P1|COMPLETED|Overall Study|Eight completed behavioral treatment.|8
335871|NCT00593372|813424|P2|STARTED|Overall Study|Three evaluated but only maintained medical treatment.|3
335872|NCT00593372|813425|P1|STARTED|Overall Study|Eight enrolled in behavioral treatment.|8
335873|NCT00593346|813431|P1|NOT COMPLETED|Overall Study||0
335874|NCT00593346|813431|P1|COMPLETED|Overall Study||151
335875|NCT00593346|813431|P1|STARTED|Overall Study||151
335876|NCT00593333|813448|P2|NOT COMPLETED|Overall Study||11
335877|NCT00593333|813449|P1|NOT COMPLETED|Overall Study||10
335878|NCT00593333|813448|P2|COMPLETED|Overall Study||45
335879|NCT00593333|813449|P1|COMPLETED|Overall Study||44
335880|NCT00593333|813448|P2|STARTED|Overall Study||56
335881|NCT00593333|813449|P1|STARTED|Overall Study||54
335882|NCT00593320|813457|P2|NOT COMPLETED|Overall Study||0
335883|NCT00593320|813458|P1|NOT COMPLETED|Overall Study||0
335884|NCT00593320|813457|P2|COMPLETED|Overall Study||1
335885|NCT00593320|813458|P1|COMPLETED|Overall Study||1
335886|NCT00593320|813457|P2|STARTED|Overall Study||1
335887|NCT00593320|813458|P1|STARTED|Overall Study||1
335888|NCT00593112|813472|P2|NOT COMPLETED|Overall Study||0
335889|NCT00593112|813473|P1|NOT COMPLETED|Overall Study||10
335890|NCT00593112|813472|P2|COMPLETED|Overall Study||12
335891|NCT00593112|813473|P1|COMPLETED|Overall Study||17
335892|NCT00593112|813472|P2|STARTED|Overall Study||12
335893|NCT00593112|813473|P1|STARTED|Overall Study||27
335894|NCT00592943|813485|P2|NOT COMPLETED|Overall Study||0
335895|NCT00592943|813486|P1|NOT COMPLETED|Overall Study||0
335896|NCT00592943|813485|P2|COMPLETED|Overall Study||6
335897|NCT00592943|813486|P1|COMPLETED|Overall Study||6
335898|NCT00592943|813485|P2|STARTED|Overall Study||6
335899|NCT00592943|813486|P1|STARTED|Overall Study||6
335900|NCT00592904|813500|P4|NOT COMPLETED|Overall Study||11
335901|NCT00592904|813501|P3|NOT COMPLETED|Overall Study||17
335902|NCT00592904|813502|P2|NOT COMPLETED|Overall Study||55
335903|NCT00592904|813503|P1|NOT COMPLETED|Overall Study||25
335904|NCT00592904|813500|P4|COMPLETED|Overall Study||19
335905|NCT00592904|813501|P3|COMPLETED|Overall Study||10
335906|NCT00592904|813502|P2|COMPLETED|Overall Study||93
335907|NCT00592904|813503|P1|COMPLETED|Overall Study||32
335908|NCT00592904|813500|P4|STARTED|Overall Study||30
335909|NCT00592904|813501|P3|STARTED|Overall Study||27
335910|NCT00592904|813502|P2|STARTED|Overall Study||148
335911|NCT00592904|813503|P1|STARTED|Overall Study||57
335912|NCT00592852|813529|P1|NOT COMPLETED|Overall Study||6
335913|NCT00592852|813529|P1|COMPLETED|Overall Study||7
335914|NCT00592852|813529|P1|STARTED|Overall Study||13
335915|NCT00592839|813537|P3|NOT COMPLETED|Overall Study||6
335916|NCT00592839|813538|P2|NOT COMPLETED|Overall Study||4
335917|NCT00592839|813539|P1|NOT COMPLETED|Overall Study||2
335918|NCT00592839|813537|P3|COMPLETED|Overall Study||46
335919|NCT00592839|813538|P2|COMPLETED|Overall Study||48
335920|NCT00592839|813539|P1|COMPLETED|Overall Study||51
335921|NCT00592839|813537|P3|STARTED|Overall Study||52
335922|NCT00592839|813538|P2|STARTED|Overall Study||52
335923|NCT00592839|813539|P1|STARTED|Overall Study||53
335924|NCT00592774|813567|P5|NOT COMPLETED|Overall Study||14
335925|NCT00592774|813568|P4|NOT COMPLETED|Overall Study||14
335926|NCT00592774|813569|P3|NOT COMPLETED|Overall Study||4
335927|NCT00592774|813570|P2|NOT COMPLETED|Overall Study||32
335928|NCT00592774|813571|P1|NOT COMPLETED|Overall Study||11
335929|NCT00592774|813567|P5|COMPLETED|Overall Study||9
335930|NCT00592774|813568|P4|COMPLETED|Overall Study||8
335931|NCT00592774|813569|P3|COMPLETED|Overall Study||18
335932|NCT00592774|813570|P2|COMPLETED|Overall Study||21
335933|NCT00592774|813571|P1|COMPLETED|Overall Study||15
335934|NCT00592774|813567|P5|STARTED|Overall Study||23
335935|NCT00592774|813568|P4|STARTED|Overall Study||22
335936|NCT00592774|813569|P3|STARTED|Overall Study||22
335937|NCT00592774|813570|P2|STARTED|Overall Study||53
335938|NCT00592774|813571|P1|STARTED|Overall Study||26
335939|NCT00592761|813628|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
335940|NCT00592761|813629|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
335941|NCT00592761|813628|P2|COMPLETED|Second Intervention (2 Weeks)||9
335942|NCT00592761|813629|P1|COMPLETED|Second Intervention (2 Weeks)||9
335943|NCT00592761|813628|P2|STARTED|Second Intervention (2 Weeks)||9
335944|NCT00592761|813629|P1|STARTED|Second Intervention (2 Weeks)||9
335945|NCT00592761|813628|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
335946|NCT00592761|813629|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
335947|NCT00592761|813628|P2|COMPLETED|First Intervention (2 Weeks)||9
335948|NCT00592761|813629|P1|COMPLETED|First Intervention (2 Weeks)||9
335949|NCT00592761|813628|P2|STARTED|First Intervention (2 Weeks)||9
335950|NCT00592761|813629|P1|STARTED|First Intervention (2 Weeks)||9
335951|NCT00592683|813643|P2|NOT COMPLETED|Overall Study||4
335952|NCT00592683|813644|P1|NOT COMPLETED|Overall Study||4
335953|NCT00592683|813643|P2|COMPLETED|Overall Study||6
335954|NCT00592683|813644|P1|COMPLETED|Overall Study||6
335955|NCT00592683|813643|P2|STARTED|Overall Study||10
335956|NCT00592683|813644|P1|STARTED|Overall Study||10
335957|NCT00592631|813654|P2|NOT COMPLETED|Overall Study||2
335958|NCT00592631|813655|P1|NOT COMPLETED|Overall Study||0
335959|NCT00592631|813654|P2|COMPLETED|Overall Study||9
335960|NCT00592631|813655|P1|COMPLETED|Overall Study||16
335961|NCT00592631|813654|P2|STARTED|Overall Study||11
335962|NCT00592631|813655|P1|STARTED|Overall Study||16
335963|NCT00592488|813663|P2|NOT COMPLETED|Overall Study||0
335964|NCT00592488|813664|P1|NOT COMPLETED|Overall Study||0
335965|NCT00592488|813663|P2|COMPLETED|Overall Study||7
335966|NCT00592488|813664|P1|COMPLETED|Overall Study||6
335967|NCT00592488|813663|P2|STARTED|Overall Study||7
335968|NCT00592488|813664|P1|STARTED|Overall Study||6
335969|NCT00592475|813677|P3|NOT COMPLETED|Overall Study||0
335970|NCT00592475|813678|P2|NOT COMPLETED|Overall Study||0
335971|NCT00592475|813679|P1|NOT COMPLETED|Overall Study||0
335972|NCT00592475|813677|P3|COMPLETED|Overall Study||5
335973|NCT00592475|813678|P2|COMPLETED|Overall Study||9
335974|NCT00592475|813679|P1|COMPLETED|Overall Study||6
335975|NCT00592475|813677|P3|STARTED|Overall Study||5
335976|NCT00592475|813678|P2|STARTED|Overall Study||9
335977|NCT00592475|813679|P1|STARTED|Overall Study||6
335978|NCT00592384|813704|P2|NOT COMPLETED|Overall Study||6
335979|NCT00592384|813705|P1|NOT COMPLETED|Overall Study||5
335980|NCT00592384|813704|P2|COMPLETED|Overall Study||63
335981|NCT00592384|813705|P1|COMPLETED|Overall Study||59
335982|NCT00592384|813704|P2|STARTED|Overall Study||69
335983|NCT00592384|813705|P1|STARTED|Overall Study||64
335984|NCT00592358|813713|P1|NOT COMPLETED|Overall Study||6
335985|NCT00592358|813713|P1|COMPLETED|Overall Study||11
335986|NCT00592358|813713|P1|STARTED|Overall Study||17
335987|NCT00592319|813720|P2|NOT COMPLETED|Overall Study||3
335988|NCT00592319|813721|P1|NOT COMPLETED|Overall Study||0
335989|NCT00592319|813720|P2|COMPLETED|Overall Study||5
335990|NCT00592319|813721|P1|COMPLETED|Overall Study||2
335991|NCT00592319|813720|P2|STARTED|Overall Study||8
335992|NCT00592319|813721|P1|STARTED|Overall Study||2
335993|NCT00592176|813729|P1|NOT COMPLETED|Overall Study||0
335994|NCT00592176|813729|P1|COMPLETED|Overall Study||5
335995|NCT00592176|813729|P1|STARTED|Overall Study||5
335996|NCT00592124|813740|P6|NOT COMPLETED|Overall Study||3
335997|NCT00592124|813741|P5|NOT COMPLETED|Overall Study||3
335998|NCT00592124|813742|P4|NOT COMPLETED|Overall Study||3
335999|NCT00592124|813743|P3|NOT COMPLETED|Overall Study||6
336000|NCT00592124|813744|P2|NOT COMPLETED|Overall Study||5
336001|NCT00592124|813745|P1|NOT COMPLETED|Overall Study||4
336002|NCT00592124|813740|P6|COMPLETED|Overall Study||24
336003|NCT00592124|813741|P5|COMPLETED|Overall Study||24
336004|NCT00592124|813742|P4|COMPLETED|Overall Study||24
336005|NCT00592124|813743|P3|COMPLETED|Overall Study||24
336006|NCT00592124|813744|P2|COMPLETED|Overall Study||24
336007|NCT00592124|813745|P1|COMPLETED|Overall Study||24
336008|NCT00592124|813740|P6|STARTED|Overall Study||27
336009|NCT00592124|813741|P5|STARTED|Overall Study||27
336010|NCT00592124|813742|P4|STARTED|Overall Study||27
336011|NCT00592124|813743|P3|STARTED|Overall Study||30
336012|NCT00592124|813744|P2|STARTED|Overall Study||29
336013|NCT00592124|813745|P1|STARTED|Overall Study||28
336014|NCT00592072|813796|P2|NOT COMPLETED|Second Sequence||0
336015|NCT00592072|813797|P1|NOT COMPLETED|Second Sequence||0
336016|NCT00592072|813796|P2|COMPLETED|Second Sequence||5
336017|NCT00592072|813797|P1|COMPLETED|Second Sequence||5
336018|NCT00592072|813796|P2|STARTED|Second Sequence||5
336019|NCT00592072|813797|P1|STARTED|Second Sequence||5
336020|NCT00592072|813796|P2|NOT COMPLETED|Wash Out Period||1
336021|NCT00592072|813797|P1|NOT COMPLETED|Wash Out Period||1
336022|NCT00592072|813796|P2|COMPLETED|Wash Out Period||5
336023|NCT00592072|813797|P1|COMPLETED|Wash Out Period||5
336024|NCT00592072|813796|P2|STARTED|Wash Out Period||6
336025|NCT00592072|813797|P1|STARTED|Wash Out Period||6
336026|NCT00592072|813796|P2|NOT COMPLETED|First Sequence||0
336027|NCT00592072|813797|P1|NOT COMPLETED|First Sequence||0
336028|NCT00592072|813796|P2|COMPLETED|First Sequence||6
336029|NCT00592072|813797|P1|COMPLETED|First Sequence||6
336030|NCT00592072|813796|P2|STARTED|First Sequence||6
336031|NCT00592072|813797|P1|STARTED|First Sequence||6
336032|NCT00592007|813819|P1|NOT COMPLETED|Overall Study||2
336033|NCT00592007|813819|P1|COMPLETED|Overall Study||5
336034|NCT00592007|813819|P1|STARTED|Overall Study||7
336035|NCT00591942|813824|P2|NOT COMPLETED|Overall Study||0
336036|NCT00591942|813825|P1|NOT COMPLETED|Overall Study||0
336037|NCT00591942|813824|P2|COMPLETED|Overall Study||36
336038|NCT00591942|813825|P1|COMPLETED|Overall Study||36
336039|NCT00591942|813824|P2|STARTED|Overall Study||36
336040|NCT00591942|813825|P1|STARTED|Overall Study||36
336041|NCT00591864|813831|P1|NOT COMPLETED|Overall Study||5
336042|NCT00591864|813831|P1|COMPLETED|Overall Study||84
336043|NCT00591864|813831|P1|STARTED|Overall Study||89
336044|NCT00591851|813837|P1|NOT COMPLETED|Overall Study||6
336045|NCT00591851|813837|P1|COMPLETED|Overall Study||64
336046|NCT00591851|813837|P1|STARTED|Overall Study||70
336047|NCT00591838|813846|P5|NOT COMPLETED|Overall Study||0
336048|NCT00591838|813847|P4|NOT COMPLETED|Overall Study||1
336049|NCT00591838|813848|P3|NOT COMPLETED|Overall Study||0
336050|NCT00591838|813849|P2|NOT COMPLETED|Overall Study||0
336051|NCT00591838|813850|P1|NOT COMPLETED|Overall Study||0
336052|NCT00591838|813846|P5|COMPLETED|Overall Study||51
336053|NCT00591838|813847|P4|COMPLETED|Overall Study||5
336054|NCT00591838|813848|P3|COMPLETED|Overall Study||6
336055|NCT00591838|813849|P2|COMPLETED|Overall Study||6
336056|NCT00591838|813850|P1|COMPLETED|Overall Study||5
336057|NCT00591838|813846|P5|STARTED|Overall Study||51
336058|NCT00591838|813847|P4|STARTED|Overall Study||6
336059|NCT00591838|813848|P3|STARTED|Overall Study||6
336060|NCT00591838|813849|P2|STARTED|Overall Study||6
336061|NCT00591838|813850|P1|STARTED|Overall Study||5
336062|NCT00591825|813875|P4|NOT COMPLETED|Overall Study||0
336063|NCT00591825|813876|P3|NOT COMPLETED|Overall Study||0
336064|NCT00591825|813877|P2|NOT COMPLETED|Overall Study||0
336065|NCT00591825|813878|P1|NOT COMPLETED|Overall Study||0
336066|NCT00591825|813875|P4|COMPLETED|Overall Study||14
336067|NCT00591825|813876|P3|COMPLETED|Overall Study||13
336068|NCT00591825|813877|P2|COMPLETED|Overall Study||13
336069|NCT00591825|813878|P1|COMPLETED|Overall Study||14
336070|NCT00591825|813875|P4|STARTED|Overall Study||14
336071|NCT00591825|813876|P3|STARTED|Overall Study||13
336072|NCT00591825|813877|P2|STARTED|Overall Study||13
336073|NCT00591825|813878|P1|STARTED|Overall Study||14
336074|NCT00591786|813914|P10|NOT COMPLETED|Overall Study||0
336075|NCT00591786|813915|P9|NOT COMPLETED|Overall Study||0
336076|NCT00591786|813916|P8|NOT COMPLETED|Overall Study||0
336077|NCT00591786|813917|P7|NOT COMPLETED|Overall Study||0
336078|NCT00591786|813918|P6|NOT COMPLETED|Overall Study||0
336079|NCT00591786|813919|P5|NOT COMPLETED|Overall Study||0
336080|NCT00591786|813920|P4|NOT COMPLETED|Overall Study||0
336081|NCT00591786|813921|P3|NOT COMPLETED|Overall Study||1
336082|NCT00591786|813922|P2|NOT COMPLETED|Overall Study||0
336083|NCT00591786|813923|P1|NOT COMPLETED|Overall Study||0
336084|NCT00591786|813914|P10|COMPLETED|Overall Study||10
336085|NCT00591786|813915|P9|COMPLETED|Overall Study||10
336086|NCT00591786|813916|P8|COMPLETED|Overall Study||10
336087|NCT00591786|813917|P7|COMPLETED|Overall Study||10
336088|NCT00591786|813918|P6|COMPLETED|Overall Study||10
336089|NCT00591786|813919|P5|COMPLETED|Overall Study||10
336090|NCT00591786|813920|P4|COMPLETED|Overall Study||11
336091|NCT00591786|813921|P3|COMPLETED|Overall Study||10
336092|NCT00591786|813922|P2|COMPLETED|Overall Study||9
336093|NCT00591786|813923|P1|COMPLETED|Overall Study||9
336094|NCT00591786|813914|P10|Treated Participants|Overall Study||10
336095|NCT00591786|813915|P9|Treated Participants|Overall Study||10
336096|NCT00591786|813916|P8|Treated Participants|Overall Study||10
336097|NCT00591786|813917|P7|Treated Participants|Overall Study||10
336098|NCT00591786|813918|P6|Treated Participants|Overall Study||10
336099|NCT00591786|813919|P5|Treated Participants|Overall Study||10
336100|NCT00591786|813920|P4|Treated Participants|Overall Study||11
336101|NCT00591786|813921|P3|Treated Participants|Overall Study||10
336102|NCT00591786|813922|P2|Treated Participants|Overall Study||9
336103|NCT00591786|813923|P1|Treated Participants|Overall Study||9
336104|NCT00591786|813914|P10|STARTED|Overall Study||10
336105|NCT00591786|813915|P9|STARTED|Overall Study||10
336106|NCT00591786|813916|P8|STARTED|Overall Study||10
336107|NCT00591786|813917|P7|STARTED|Overall Study||10
336108|NCT00591786|813918|P6|STARTED|Overall Study||10
336109|NCT00591786|813919|P5|STARTED|Overall Study||10
336110|NCT00591786|813920|P4|STARTED|Overall Study||11
336111|NCT00591786|813921|P3|STARTED|Overall Study||11
336112|NCT00591786|813922|P2|STARTED|Overall Study||9
336113|NCT00591786|813923|P1|STARTED|Overall Study||9
336114|NCT00591773|813968|P3|NOT COMPLETED|Overall Study||16
336115|NCT00591773|813969|P2|NOT COMPLETED|Overall Study||24
336116|NCT00591773|813970|P1|NOT COMPLETED|Overall Study||16
336117|NCT00591773|813968|P3|COMPLETED|Overall Study||168
336118|NCT00591773|813969|P2|COMPLETED|Overall Study||158
336119|NCT00591773|813970|P1|COMPLETED|Overall Study||169
336120|NCT00591773|813968|P3|STARTED|Overall Study||184
336121|NCT00591773|813969|P2|STARTED|Overall Study||182
336122|NCT00591773|813970|P1|STARTED|Overall Study||185
336123|NCT00591760|814022|P2|NOT COMPLETED|Overall Study||0
336124|NCT00591760|814023|P1|NOT COMPLETED|Overall Study||0
336125|NCT00591760|814022|P2|COMPLETED|Overall Study||28
336126|NCT00591760|814023|P1|COMPLETED|Overall Study||28
336127|NCT00591760|814022|P2|STARTED|Overall Study||28
336128|NCT00591760|814023|P1|STARTED|Overall Study||28
336129|NCT00591734|814029|P1|NOT COMPLETED|Overall Study||53
336130|NCT00591734|814029|P1|COMPLETED|Overall Study||4
336131|NCT00591734|814029|P1|STARTED|Overall Study||57
336132|NCT00591721|814035|P2|NOT COMPLETED|Overall Study||22
336133|NCT00591721|814036|P1|NOT COMPLETED|Overall Study||21
336134|NCT00591721|814035|P2|COMPLETED|Overall Study||70
336135|NCT00591721|814036|P1|COMPLETED|Overall Study||68
336136|NCT00591721|814035|P2|STARTED|Overall Study||92
336137|NCT00591721|814036|P1|STARTED|Overall Study||89
336138|NCT00591591|814044|P2|NOT COMPLETED|Overall Study||39
336139|NCT00591591|814045|P1|NOT COMPLETED|Overall Study||11
336140|NCT00591591|814044|P2|COMPLETED|Overall Study||94
336141|NCT00591591|814045|P1|COMPLETED|Overall Study||165
336142|NCT00591591|814044|P2|STARTED|Overall Study||133
336143|NCT00591591|814045|P1|STARTED|Overall Study||176
336144|NCT00591578|814062|P3|NOT COMPLETED|Open-Label Extension Phase||0
336145|NCT00591578|814063|P2|NOT COMPLETED|Open-Label Extension Phase||10
336146|NCT00591578|814064|P1|NOT COMPLETED|Open-Label Extension Phase||6
336147|NCT00591578|814062|P3|COMPLETED|Open-Label Extension Phase||0
336148|NCT00591578|814063|P2|COMPLETED|Open-Label Extension Phase||105
336149|NCT00591578|814064|P1|COMPLETED|Open-Label Extension Phase||49
336150|NCT00591578|814062|P3|STARTED|Open-Label Extension Phase||0
336151|NCT00591578|814063|P2|STARTED|Open-Label Extension Phase||115
336152|NCT00591578|814064|P1|STARTED|Open-Label Extension Phase||55
336153|NCT00591578|814062|P3|NOT COMPLETED|Double-Blind Treatment Phase||84
336154|NCT00591578|814063|P2|NOT COMPLETED|Double-Blind Treatment Phase||80
336155|NCT00591578|814064|P1|NOT COMPLETED|Double-Blind Treatment Phase||78
336156|NCT00591578|814062|P3|COMPLETED|Double-Blind Treatment Phase||244
336157|NCT00591578|814063|P2|COMPLETED|Double-Blind Treatment Phase||249
336158|NCT00591578|814064|P1|COMPLETED|Double-Blind Treatment Phase||249
336159|NCT00591578|814062|P3|STARTED|Double-Blind Treatment Phase|Two participants randomized but not treated.|328
336160|NCT00591578|814063|P2|STARTED|Double-Blind Treatment Phase||329
336161|NCT00591578|814064|P1|STARTED|Double-Blind Treatment Phase||327
336162|NCT00591565|814115|P1|NOT COMPLETED|Overall Study||5
336163|NCT00591565|814115|P1|COMPLETED|Overall Study||8
336164|NCT00591565|814115|P1|STARTED|Overall Study||13
336165|NCT00591409|814129|P10|NOT COMPLETED|Overall Study||1
336166|NCT00591409|814130|P9|NOT COMPLETED|Overall Study||0
336167|NCT00591409|814131|P8|NOT COMPLETED|Overall Study||0
336168|NCT00591409|814132|P7|NOT COMPLETED|Overall Study||0
336169|NCT00591409|814133|P6|NOT COMPLETED|Overall Study||0
336170|NCT00591409|814134|P5|NOT COMPLETED|Overall Study||1
336171|NCT00591409|814135|P4|NOT COMPLETED|Overall Study||0
336172|NCT00591409|814136|P3|NOT COMPLETED|Overall Study||0
336173|NCT00591409|814137|P2|NOT COMPLETED|Overall Study||0
336174|NCT00591409|814138|P1|NOT COMPLETED|Overall Study||0
336175|NCT00591409|814129|P10|COMPLETED|Overall Study||10
336176|NCT00591409|814130|P9|COMPLETED|Overall Study||9
336177|NCT00591409|814131|P8|COMPLETED|Overall Study||10
336178|NCT00591409|814132|P7|COMPLETED|Overall Study||10
336179|NCT00591409|814133|P6|COMPLETED|Overall Study||10
336180|NCT00591409|814134|P5|COMPLETED|Overall Study||9
336181|NCT00591409|814135|P4|COMPLETED|Overall Study||10
336182|NCT00591409|814136|P3|COMPLETED|Overall Study||10
336183|NCT00591409|814137|P2|COMPLETED|Overall Study||10
336184|NCT00591409|814138|P1|COMPLETED|Overall Study||10
336185|NCT00591409|814129|P10|Treated|Overall Study||10
336186|NCT00591409|814130|P9|Treated|Overall Study||9
336187|NCT00591409|814131|P8|Treated|Overall Study||10
336188|NCT00591409|814132|P7|Treated|Overall Study||10
336189|NCT00591409|814133|P6|Treated|Overall Study||10
336190|NCT00591409|814134|P5|Treated|Overall Study||9
336191|NCT00591409|814135|P4|Treated|Overall Study||10
336192|NCT00591409|814136|P3|Treated|Overall Study||10
336193|NCT00591409|814137|P2|Treated|Overall Study||10
336194|NCT00591409|814138|P1|Treated|Overall Study||10
336195|NCT00591409|814129|P10|STARTED|Overall Study||11
336196|NCT00591409|814130|P9|STARTED|Overall Study||9
336197|NCT00591409|814131|P8|STARTED|Overall Study||10
336198|NCT00591409|814132|P7|STARTED|Overall Study||10
336199|NCT00591409|814133|P6|STARTED|Overall Study||10
336200|NCT00591409|814134|P5|STARTED|Overall Study||10
336201|NCT00591409|814135|P4|STARTED|Overall Study||10
336202|NCT00591409|814136|P3|STARTED|Overall Study||10
336203|NCT00591409|814137|P2|STARTED|Overall Study||10
336204|NCT00591409|814138|P1|STARTED|Overall Study||10
336205|NCT00591370|814180|P1|NOT COMPLETED|Overall Study||2
336206|NCT00591370|814180|P1|COMPLETED|Overall Study||49
336207|NCT00591370|814180|P1|STARTED|Overall Study||51
336208|NCT00591344|814188|P2|NOT COMPLETED|Overall Study||8
336209|NCT00591344|814189|P1|NOT COMPLETED|Overall Study||5
336296|NCT00591006|814383|P6|NOT COMPLETED|Overall Study||0
336210|NCT00591344|814188|P2|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|18
336211|NCT00591344|814189|P1|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|20
336212|NCT00591344|814188|P2|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
336213|NCT00591344|814189|P1|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
336214|NCT00591344|814188|P2|STARTED|Overall Study|26 randomized, 2 withdrew before the 6 month test and were replaced, 24 completed 6 month test|26
336215|NCT00591344|814189|P1|STARTED|Overall Study|25 randomized, 1 withdrew before the 6 month test and was replaced; 24 completed the 6 month test|25
336216|NCT00591305|814201|P2|NOT COMPLETED|Overall Study||0
336217|NCT00591305|814202|P1|NOT COMPLETED|Overall Study||0
336218|NCT00591305|814201|P2|COMPLETED|Overall Study||0
336219|NCT00591305|814202|P1|COMPLETED|Overall Study||1
336220|NCT00591305|814201|P2|1st Follow-up in 2 Wks After Surgery|Overall Study||0
336221|NCT00591305|814202|P1|1st Follow-up in 2 Wks After Surgery|Overall Study||1
336222|NCT00591305|814201|P2|STARTED|Overall Study||0
336223|NCT00591305|814202|P1|STARTED|Overall Study||1
336224|NCT00591266|814215|P3|NOT COMPLETED|Overall Study||14
336225|NCT00591266|814216|P2|NOT COMPLETED|Overall Study||11
336226|NCT00591266|814217|P1|NOT COMPLETED|Overall Study||9
336227|NCT00591266|814215|P3|COMPLETED|Overall Study||175
336228|NCT00591266|814216|P2|COMPLETED|Overall Study||177
336229|NCT00591266|814217|P1|COMPLETED|Overall Study||180
336230|NCT00591266|814215|P3|STARTED|Overall Study|Randomized only|189
336231|NCT00591266|814216|P2|STARTED|Overall Study|Randomized only|188
336232|NCT00591266|814217|P1|STARTED|Overall Study|Randomized only|189
336233|NCT00591253|814270|P3|NOT COMPLETED|Overall Study||15
336234|NCT00591253|814271|P2|NOT COMPLETED|Overall Study||21
336235|NCT00591253|814272|P1|NOT COMPLETED|Overall Study||14
336236|NCT00591253|814270|P3|COMPLETED|Overall Study||123
336237|NCT00591253|814271|P2|COMPLETED|Overall Study||116
336238|NCT00591253|814272|P1|COMPLETED|Overall Study||126
336239|NCT00591253|814270|P3|STARTED|Overall Study|Randomized or Treated|138
336240|NCT00591253|814271|P2|STARTED|Overall Study|Randomized or Treated|137
336241|NCT00591253|814272|P1|STARTED|Overall Study|Randomized or Treated|140
336242|NCT00591240|814324|P2|NOT COMPLETED|Overall Study||0
336243|NCT00591240|814325|P1|NOT COMPLETED|Overall Study||0
336244|NCT00591240|814324|P2|COMPLETED|Overall Study||222
336245|NCT00591240|814325|P1|COMPLETED|Overall Study||116
336246|NCT00591240|814324|P2|STARTED|Overall Study||222
336247|NCT00591240|814325|P1|STARTED|Overall Study||116
336248|NCT00591227|814333|P2|NOT COMPLETED|Overall Study||0
336249|NCT00591227|814334|P1|NOT COMPLETED|Overall Study||0
336250|NCT00591227|814333|P2|COMPLETED|Overall Study||87
336251|NCT00591227|814334|P1|COMPLETED|Overall Study||89
336252|NCT00591227|814333|P2|STARTED|Overall Study||87
336253|NCT00591227|814334|P1|STARTED|Overall Study||89
336254|NCT00591214|814340|P1|NOT COMPLETED|Overall Study||8
336255|NCT00591214|814340|P1|COMPLETED|Overall Study||2
336256|NCT00591214|814340|P1|STARTED|Overall Study||10
336257|NCT00591149|814349|P1|NOT COMPLETED|Overall Study||5
336258|NCT00591149|814349|P1|COMPLETED|Overall Study||11
336259|NCT00591149|814349|P1|STARTED|Overall Study||16
336260|NCT00591019|814353|P2|NOT COMPLETED|Intevention 2 (14 Days)||0
336261|NCT00591019|814354|P1|NOT COMPLETED|Intevention 2 (14 Days)||0
336262|NCT00591019|814353|P2|COMPLETED|Intevention 2 (14 Days)||3
336263|NCT00591019|814354|P1|COMPLETED|Intevention 2 (14 Days)||2
336264|NCT00591019|814353|P2|STARTED|Intevention 2 (14 Days)||3
336265|NCT00591019|814354|P1|STARTED|Intevention 2 (14 Days)||2
336266|NCT00591019|814353|P2|NOT COMPLETED|Intervention 1 (14 Days)||0
336267|NCT00591019|814354|P1|NOT COMPLETED|Intervention 1 (14 Days)||0
336268|NCT00591019|814353|P2|COMPLETED|Intervention 1 (14 Days)||3
336269|NCT00591019|814354|P1|COMPLETED|Intervention 1 (14 Days)||2
336270|NCT00591019|814353|P2|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|3
336271|NCT00591019|814354|P1|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|2
336272|NCT00591019|814353|P2|NOT COMPLETED|Baseline (1 Day)||0
336273|NCT00591019|814354|P1|NOT COMPLETED|Baseline (1 Day)||0
336274|NCT00591019|814353|P2|COMPLETED|Baseline (1 Day)||4
336275|NCT00591019|814354|P1|COMPLETED|Baseline (1 Day)||3
336276|NCT00591019|814353|P2|STARTED|Baseline (1 Day)||4
336277|NCT00591019|814354|P1|STARTED|Baseline (1 Day)||3
336278|NCT00591006|814365|P24|NOT COMPLETED|Overall Study||1
336279|NCT00591006|814366|P23|NOT COMPLETED|Overall Study||1
336280|NCT00591006|814367|P22|NOT COMPLETED|Overall Study||0
336281|NCT00591006|814368|P21|NOT COMPLETED|Overall Study||0
336282|NCT00591006|814369|P20|NOT COMPLETED|Overall Study||0
336283|NCT00591006|814370|P19|NOT COMPLETED|Overall Study||0
336284|NCT00591006|814371|P18|NOT COMPLETED|Overall Study||0
336285|NCT00591006|814372|P17|NOT COMPLETED|Overall Study||0
336286|NCT00591006|814373|P16|NOT COMPLETED|Overall Study||1
336287|NCT00591006|814374|P15|NOT COMPLETED|Overall Study||0
336288|NCT00591006|814375|P14|NOT COMPLETED|Overall Study||0
336289|NCT00591006|814376|P13|NOT COMPLETED|Overall Study||0
336290|NCT00591006|814377|P12|NOT COMPLETED|Overall Study||0
336291|NCT00591006|814378|P11|NOT COMPLETED|Overall Study||0
336292|NCT00591006|814379|P10|NOT COMPLETED|Overall Study||0
336293|NCT00591006|814380|P9|NOT COMPLETED|Overall Study||0
336294|NCT00591006|814381|P8|NOT COMPLETED|Overall Study||0
336295|NCT00591006|814382|P7|NOT COMPLETED|Overall Study||0
336297|NCT00591006|814384|P5|NOT COMPLETED|Overall Study||0
336298|NCT00591006|814385|P4|NOT COMPLETED|Overall Study||0
336299|NCT00591006|814386|P3|NOT COMPLETED|Overall Study||0
336300|NCT00591006|814387|P2|NOT COMPLETED|Overall Study||0
336301|NCT00591006|814388|P1|NOT COMPLETED|Overall Study||0
336302|NCT00591006|814365|P24|COMPLETED|Overall Study||0
336303|NCT00591006|814366|P23|COMPLETED|Overall Study||0
336304|NCT00591006|814367|P22|COMPLETED|Overall Study||1
336305|NCT00591006|814368|P21|COMPLETED|Overall Study||0
336306|NCT00591006|814369|P20|COMPLETED|Overall Study||1
336307|NCT00591006|814370|P19|COMPLETED|Overall Study||0
336308|NCT00591006|814371|P18|COMPLETED|Overall Study||1
336309|NCT00591006|814372|P17|COMPLETED|Overall Study||0
336310|NCT00591006|814373|P16|COMPLETED|Overall Study||0
336311|NCT00591006|814374|P15|COMPLETED|Overall Study||0
336312|NCT00591006|814375|P14|COMPLETED|Overall Study||2
336313|NCT00591006|814376|P13|COMPLETED|Overall Study||1
336314|NCT00591006|814377|P12|COMPLETED|Overall Study||1
336315|NCT00591006|814378|P11|COMPLETED|Overall Study||0
336316|NCT00591006|814379|P10|COMPLETED|Overall Study||1
336317|NCT00591006|814380|P9|COMPLETED|Overall Study||1
336318|NCT00591006|814381|P8|COMPLETED|Overall Study||0
336319|NCT00591006|814382|P7|COMPLETED|Overall Study||1
336320|NCT00591006|814383|P6|COMPLETED|Overall Study||0
336321|NCT00591006|814384|P5|COMPLETED|Overall Study||1
336322|NCT00591006|814385|P4|COMPLETED|Overall Study||1
336323|NCT00591006|814386|P3|COMPLETED|Overall Study||1
336324|NCT00591006|814387|P2|COMPLETED|Overall Study||0
336325|NCT00591006|814388|P1|COMPLETED|Overall Study||1
336326|NCT00591006|814365|P24|Treatment #4|Overall Study||0
336327|NCT00591006|814366|P23|Treatment #4|Overall Study||0
336328|NCT00591006|814367|P22|Treatment #4|Overall Study||1
336329|NCT00591006|814368|P21|Treatment #4|Overall Study||0
336330|NCT00591006|814369|P20|Treatment #4|Overall Study||1
336331|NCT00591006|814370|P19|Treatment #4|Overall Study||0
336332|NCT00591006|814371|P18|Treatment #4|Overall Study||1
336333|NCT00591006|814372|P17|Treatment #4|Overall Study||0
336334|NCT00591006|814373|P16|Treatment #4|Overall Study||0
336335|NCT00591006|814374|P15|Treatment #4|Overall Study||0
336336|NCT00591006|814375|P14|Treatment #4|Overall Study||2
336337|NCT00591006|814376|P13|Treatment #4|Overall Study||1
336338|NCT00591006|814377|P12|Treatment #4|Overall Study||1
336339|NCT00591006|814378|P11|Treatment #4|Overall Study||0
336340|NCT00591006|814379|P10|Treatment #4|Overall Study||1
336341|NCT00591006|814380|P9|Treatment #4|Overall Study||1
336342|NCT00591006|814381|P8|Treatment #4|Overall Study||0
336343|NCT00591006|814382|P7|Treatment #4|Overall Study||1
336344|NCT00591006|814383|P6|Treatment #4|Overall Study||0
336345|NCT00591006|814384|P5|Treatment #4|Overall Study||1
336346|NCT00591006|814385|P4|Treatment #4|Overall Study||1
336347|NCT00591006|814386|P3|Treatment #4|Overall Study||1
336348|NCT00591006|814387|P2|Treatment #4|Overall Study||0
336349|NCT00591006|814388|P1|Treatment #4|Overall Study||1
336350|NCT00591006|814365|P24|Treatment #3|Overall Study||1
336351|NCT00591006|814366|P23|Treatment #3|Overall Study||1
336352|NCT00591006|814367|P22|Treatment #3|Overall Study||1
336353|NCT00591006|814368|P21|Treatment #3|Overall Study||0
336354|NCT00591006|814369|P20|Treatment #3|Overall Study||1
336355|NCT00591006|814370|P19|Treatment #3|Overall Study||0
336356|NCT00591006|814371|P18|Treatment #3|Overall Study||1
336357|NCT00591006|814372|P17|Treatment #3|Overall Study||0
336358|NCT00591006|814373|P16|Treatment #3|Overall Study||0
336359|NCT00591006|814374|P15|Treatment #3|Overall Study||0
336360|NCT00591006|814375|P14|Treatment #3|Overall Study||2
336361|NCT00591006|814376|P13|Treatment #3|Overall Study||1
336362|NCT00591006|814377|P12|Treatment #3|Overall Study||1
336363|NCT00591006|814378|P11|Treatment #3|Overall Study||0
336364|NCT00591006|814379|P10|Treatment #3|Overall Study||1
336365|NCT00591006|814380|P9|Treatment #3|Overall Study||1
336366|NCT00591006|814381|P8|Treatment #3|Overall Study||0
336367|NCT00591006|814382|P7|Treatment #3|Overall Study||1
336368|NCT00591006|814383|P6|Treatment #3|Overall Study||0
336369|NCT00591006|814384|P5|Treatment #3|Overall Study||1
336370|NCT00591006|814385|P4|Treatment #3|Overall Study||1
336371|NCT00591006|814386|P3|Treatment #3|Overall Study||1
336372|NCT00591006|814387|P2|Treatment #3|Overall Study||0
336373|NCT00591006|814388|P1|Treatment #3|Overall Study||1
336374|NCT00591006|814365|P24|Treatment #2|Overall Study||1
336375|NCT00591006|814366|P23|Treatment #2|Overall Study||1
336376|NCT00591006|814367|P22|Treatment #2|Overall Study||1
336377|NCT00591006|814368|P21|Treatment #2|Overall Study||0
336378|NCT00591006|814369|P20|Treatment #2|Overall Study||1
336379|NCT00591006|814370|P19|Treatment #2|Overall Study||0
336380|NCT00591006|814371|P18|Treatment #2|Overall Study||1
336381|NCT00591006|814372|P17|Treatment #2|Overall Study||0
336382|NCT00591006|814373|P16|Treatment #2|Overall Study||0
336383|NCT00591006|814374|P15|Treatment #2|Overall Study||0
336384|NCT00591006|814375|P14|Treatment #2|Overall Study||2
336385|NCT00591006|814376|P13|Treatment #2|Overall Study||1
336386|NCT00591006|814377|P12|Treatment #2|Overall Study||1
336387|NCT00591006|814378|P11|Treatment #2|Overall Study||0
336388|NCT00591006|814379|P10|Treatment #2|Overall Study||1
336389|NCT00591006|814380|P9|Treatment #2|Overall Study||1
336390|NCT00591006|814381|P8|Treatment #2|Overall Study||0
336391|NCT00591006|814382|P7|Treatment #2|Overall Study||1
336392|NCT00591006|814383|P6|Treatment #2|Overall Study||0
336393|NCT00591006|814384|P5|Treatment #2|Overall Study||1
336394|NCT00591006|814385|P4|Treatment #2|Overall Study||1
336395|NCT00591006|814386|P3|Treatment #2|Overall Study||1
336396|NCT00591006|814387|P2|Treatment #2|Overall Study||0
336397|NCT00591006|814388|P1|Treatment #2|Overall Study||1
336398|NCT00591006|814365|P24|STARTED|Overall Study||1
336399|NCT00591006|814366|P23|STARTED|Overall Study||1
336400|NCT00591006|814367|P22|STARTED|Overall Study||1
336401|NCT00591006|814368|P21|STARTED|Overall Study||0
336402|NCT00591006|814369|P20|STARTED|Overall Study||1
336403|NCT00591006|814370|P19|STARTED|Overall Study||0
336404|NCT00591006|814371|P18|STARTED|Overall Study||1
336405|NCT00591006|814372|P17|STARTED|Overall Study||0
336406|NCT00591006|814373|P16|STARTED|Overall Study||1
336407|NCT00591006|814374|P15|STARTED|Overall Study||0
336408|NCT00591006|814375|P14|STARTED|Overall Study||2
336409|NCT00591006|814376|P13|STARTED|Overall Study||1
336410|NCT00591006|814377|P12|STARTED|Overall Study||1
336411|NCT00591006|814378|P11|STARTED|Overall Study||0
336412|NCT00591006|814379|P10|STARTED|Overall Study||1
336413|NCT00591006|814380|P9|STARTED|Overall Study||1
336414|NCT00591006|814381|P8|STARTED|Overall Study||0
336415|NCT00591006|814382|P7|STARTED|Overall Study||1
336416|NCT00591006|814383|P6|STARTED|Overall Study||0
336417|NCT00591006|814384|P5|STARTED|Overall Study||1
336418|NCT00591006|814385|P4|STARTED|Overall Study||1
336419|NCT00591006|814386|P3|STARTED|Overall Study||1
336420|NCT00591006|814387|P2|STARTED|Overall Study||0
336421|NCT00591006|814388|P1|STARTED|Overall Study||1
336422|NCT00590980|814406|P1|NOT COMPLETED|Overall Study||10
336423|NCT00590980|814406|P1|COMPLETED|Overall Study||72
336424|NCT00590980|814406|P1|STARTED|Overall Study||82
336425|NCT00590967|814412|P2|NOT COMPLETED|Overall Study||5
336426|NCT00590967|814413|P1|NOT COMPLETED|Overall Study||3
336427|NCT00590967|814412|P2|COMPLETED|Overall Study||20
336428|NCT00590967|814413|P1|COMPLETED|Overall Study||41
336429|NCT00590967|814412|P2|STARTED|Overall Study||25
336430|NCT00590967|814413|P1|STARTED|Overall Study||44
336431|NCT00590902|814425|P1|NOT COMPLETED|Overall Study||1
336432|NCT00590902|814425|P1|COMPLETED|Overall Study||80
336433|NCT00590902|814425|P1|STARTED|Overall Study||81
336434|NCT00590889|814431|P2|NOT COMPLETED|Overall Study||299
336435|NCT00590889|814432|P1|NOT COMPLETED|Overall Study||286
336436|NCT00590889|814431|P2|COMPLETED|Overall Study||104
336437|NCT00590889|814432|P1|COMPLETED|Overall Study||118
336438|NCT00590889|814431|P2|STARTED|Overall Study||403
336439|NCT00590889|814432|P1|STARTED|Overall Study||404
336440|NCT00590863|814441|P3|NOT COMPLETED|Overall Study||78
336441|NCT00590863|814442|P2|NOT COMPLETED|Overall Study||82
336442|NCT00590863|814443|P1|NOT COMPLETED|Overall Study||84
336443|NCT00590863|814441|P3|COMPLETED|Overall Study||146
336444|NCT00590863|814442|P2|COMPLETED|Overall Study||138
336445|NCT00590863|814443|P1|COMPLETED|Overall Study||137
336446|NCT00590863|814441|P3|STARTED|Overall Study||224
336447|NCT00590863|814442|P2|STARTED|Overall Study||220
336448|NCT00590863|814443|P1|STARTED|Overall Study||221
336449|NCT00590824|814458|P4|NOT COMPLETED|Overall Study||1
336450|NCT00590824|814459|P3|NOT COMPLETED|Overall Study||1
336451|NCT00590824|814460|P2|NOT COMPLETED|Overall Study||2
336452|NCT00590824|814461|P1|NOT COMPLETED|Overall Study||0
336453|NCT00590824|814458|P4|COMPLETED|Overall Study||0
336454|NCT00590824|814459|P3|COMPLETED|Overall Study||1
336455|NCT00590824|814460|P2|COMPLETED|Overall Study||7
336456|NCT00590824|814461|P1|COMPLETED|Overall Study||11
336457|NCT00590824|814458|P4|STARTED|Overall Study||1
336458|NCT00590824|814459|P3|STARTED|Overall Study||2
336459|NCT00590824|814460|P2|STARTED|Overall Study||9
336460|NCT00590824|814461|P1|STARTED|Overall Study||11
336461|NCT00590772|814481|P1|NOT COMPLETED|Overall Study||0
336462|NCT00590772|814481|P1|COMPLETED|Overall Study||31
336463|NCT00590772|814481|P1|STARTED|Overall Study||31
336464|NCT00590759|814487|P1|NOT COMPLETED|Overall Study||80
336465|NCT00590759|814487|P1|COMPLETED|Overall Study||70
336466|NCT00590759|814487|P1|STARTED|Overall Study||150
336467|NCT00590720|814494|P2|NOT COMPLETED|Overall Study||1
336468|NCT00590720|814495|P1|NOT COMPLETED|Overall Study||1
336469|NCT00590720|814494|P2|COMPLETED|Overall Study||6
336470|NCT00590720|814495|P1|COMPLETED|Overall Study||3
336471|NCT00590720|814494|P2|STARTED|Overall Study||7
336472|NCT00590720|814495|P1|STARTED|Overall Study||4
336473|NCT00590707|814539|P2|NOT COMPLETED|Overall Study||0
336474|NCT00590707|814540|P1|NOT COMPLETED|Overall Study||0
336475|NCT00590707|814539|P2|COMPLETED|Overall Study||100
336476|NCT00590707|814540|P1|COMPLETED|Overall Study||100
336477|NCT00590707|814539|P2|STARTED|Overall Study||100
336478|NCT00590707|814540|P1|STARTED|Overall Study||100
336479|NCT00590590|814557|P3|NOT COMPLETED|Overall Study||6
336480|NCT00590590|814558|P2|NOT COMPLETED|Overall Study||6
336481|NCT00590590|814559|P1|NOT COMPLETED|Overall Study||7
336482|NCT00590590|814557|P3|COMPLETED|Overall Study||21
336483|NCT00590590|814558|P2|COMPLETED|Overall Study||33
336484|NCT00590590|814559|P1|COMPLETED|Overall Study||32
336485|NCT00590590|814557|P3|STARTED|Overall Study||27
336486|NCT00590590|814558|P2|STARTED|Overall Study||39
336487|NCT00590590|814559|P1|STARTED|Overall Study||39
336488|NCT00590577|814586|P4|NOT COMPLETED|Overall Study||93
336489|NCT00590577|814587|P3|NOT COMPLETED|Overall Study||73
336490|NCT00590577|814588|P2|NOT COMPLETED|Overall Study||76
336491|NCT00590577|814589|P1|NOT COMPLETED|Overall Study||77
336492|NCT00590577|814586|P4|COMPLETED|Overall Study||71
336493|NCT00590577|814587|P3|COMPLETED|Overall Study||90
336494|NCT00590577|814588|P2|COMPLETED|Overall Study||89
336495|NCT00590577|814589|P1|COMPLETED|Overall Study||83
336496|NCT00590577|814586|P4|STARTED|Overall Study||164
336497|NCT00590577|814587|P3|STARTED|Overall Study||163
336498|NCT00590577|814588|P2|STARTED|Overall Study||165
336499|NCT00590577|814589|P1|STARTED|Overall Study||160
336500|NCT00590564|814607|P1|NOT COMPLETED|Overall Study||18
336501|NCT00590564|814607|P1|COMPLETED|Overall Study||24
336502|NCT00590564|814607|P1|STARTED|Overall Study||42
336503|NCT00590538|814611|P1|NOT COMPLETED|Overall Study||2
336504|NCT00590538|814611|P1|COMPLETED|Overall Study||7
336505|NCT00590538|814611|P1|STARTED|Overall Study|STUDY NOT UNBLINDED AT TIME OF TERMINATION; THEREFORE NUMBER ASSIGNED TO EACH GROUP IS NOT KNOWN.|9
336506|NCT00590460|814619|P1|NOT COMPLETED|Overall Study||0
336507|NCT00590460|814619|P1|COMPLETED|Overall Study||5
336508|NCT00590460|814619|P1|STARTED|Overall Study||5
336509|NCT00590395|814632|P1|NOT COMPLETED|Overall Study||0
336510|NCT00590395|814632|P1|COMPLETED|Overall Study||19
336511|NCT00590395|814632|P1|STARTED|Overall Study||19
336512|NCT00590369|814638|P2|NOT COMPLETED|Overall Study||0
336513|NCT00590369|814639|P1|NOT COMPLETED|Overall Study||0
336514|NCT00590369|814638|P2|COMPLETED|Overall Study||5
336515|NCT00590369|814639|P1|COMPLETED|Overall Study|Study stopped early due to difficulty recruiting subjects|6
336516|NCT00590369|814638|P2|STARTED|Overall Study||5
336517|NCT00590369|814639|P1|STARTED|Overall Study||6
336518|NCT00590317|814657|P2|NOT COMPLETED|Overall Study||5
336519|NCT00590317|814658|P1|NOT COMPLETED|Overall Study||1
336520|NCT00590317|814657|P2|COMPLETED|Overall Study||27
336521|NCT00590317|814658|P1|COMPLETED|Overall Study||31
336522|NCT00590317|814657|P2|STARTED|Overall Study||32
336523|NCT00590317|814658|P1|STARTED|Overall Study||32
336524|NCT00590226|814670|P2|NOT COMPLETED|Overall Study||0
336525|NCT00590226|814671|P1|NOT COMPLETED|Overall Study||0
336526|NCT00590226|814670|P2|COMPLETED|Overall Study||63
336527|NCT00590226|814671|P1|COMPLETED|Overall Study||67
336528|NCT00590226|814670|P2|STARTED|Overall Study||63
336529|NCT00590226|814671|P1|STARTED|Overall Study||67
336530|NCT00590161|814681|P2|NOT COMPLETED|Overall Study||3
336531|NCT00590161|814682|P1|NOT COMPLETED|Overall Study||3
336532|NCT00590161|814681|P2|COMPLETED|Overall Study||26
336533|NCT00590161|814682|P1|COMPLETED|Overall Study||23
336534|NCT00590161|814681|P2|STARTED|Overall Study||29
336535|NCT00590161|814682|P1|STARTED|Overall Study||26
336536|NCT00590135|814688|P1|NOT COMPLETED|Overall Study||59
336537|NCT00590135|814688|P1|COMPLETED|Overall Study||0
336538|NCT00590135|814688|P1|STARTED|Overall Study||59
336539|NCT00590044|814698|P2|NOT COMPLETED|Overall Study||2
336540|NCT00590044|814699|P1|NOT COMPLETED|Overall Study||4
336541|NCT00590044|814698|P2|COMPLETED|Overall Study||34
336542|NCT00590044|814699|P1|COMPLETED|Overall Study||34
336543|NCT00590044|814698|P2|STARTED|Overall Study||36
336544|NCT00590044|814699|P1|STARTED|Overall Study||38
336545|NCT00590031|814711|P1|NOT COMPLETED|Overall Study||6
336546|NCT00590031|814711|P1|COMPLETED|Overall Study||55
336547|NCT00590031|814711|P1|STARTED|Overall Study||61
336548|NCT00590018|814718|P2|NOT COMPLETED|Overall Study||0
336549|NCT00590018|814719|P1|NOT COMPLETED|Overall Study||0
336550|NCT00590018|814718|P2|COMPLETED|Overall Study||9
336551|NCT00590018|814719|P1|COMPLETED|Overall Study||9
336552|NCT00590018|814718|P2|STARTED|Overall Study||9
336553|NCT00590018|814719|P1|STARTED|Overall Study||9
336554|NCT00590005|814727|P2|NOT COMPLETED|Overall Study||0
336555|NCT00590005|814728|P1|NOT COMPLETED|Overall Study||0
336556|NCT00590005|814727|P2|COMPLETED|Overall Study||119
336557|NCT00590005|814728|P1|COMPLETED|Overall Study||106
336558|NCT00590005|814727|P2|STARTED|Overall Study||119
336559|NCT00590005|814728|P1|STARTED|Overall Study||106
336560|NCT00589979|814738|P3|NOT COMPLETED|Double-Blind Treatment Period 3||1
336561|NCT00589979|814739|P2|NOT COMPLETED|Double-Blind Treatment Period 3||1
336562|NCT00589979|814740|P1|NOT COMPLETED|Double-Blind Treatment Period 3||0
336563|NCT00589979|814738|P3|COMPLETED|Double-Blind Treatment Period 3||38
336564|NCT00589979|814739|P2|COMPLETED|Double-Blind Treatment Period 3||46
336565|NCT00589979|814740|P1|COMPLETED|Double-Blind Treatment Period 3||0
336566|NCT00589979|814738|P3|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|39
336567|NCT00589979|814739|P2|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|47
336568|NCT00589979|814740|P1|STARTED|Double-Blind Treatment Period 3||0
336569|NCT00589979|814738|P3|NOT COMPLETED|Double-Blind Treatment Period 2||2
336570|NCT00589979|814739|P2|NOT COMPLETED|Double-Blind Treatment Period 2||1
336571|NCT00589979|814740|P1|NOT COMPLETED|Double-Blind Treatment Period 2||0
336572|NCT00589979|814738|P3|COMPLETED|Double-Blind Treatment Period 2||39
336573|NCT00589979|814739|P2|COMPLETED|Double-Blind Treatment Period 2||47
336574|NCT00589979|814740|P1|COMPLETED|Double-Blind Treatment Period 2||0
336575|NCT00589979|814738|P3|STARTED|Double-Blind Treatment Period 2|N=20 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|41
336576|NCT00589979|814739|P2|STARTED|Double-Blind Treatment Period 2|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|48
336577|NCT00589979|814740|P1|STARTED|Double-Blind Treatment Period 2||0
336578|NCT00589979|814738|P3|NOT COMPLETED|Double-Blind Treatment Period 1||2
336579|NCT00589979|814739|P2|NOT COMPLETED|Double-Blind Treatment Period 1||2
336580|NCT00589979|814740|P1|NOT COMPLETED|Double-Blind Treatment Period 1||0
336581|NCT00589979|814738|P3|COMPLETED|Double-Blind Treatment Period 1||41
336582|NCT00589979|814739|P2|COMPLETED|Double-Blind Treatment Period 1||48
336583|NCT00589979|814740|P1|COMPLETED|Double-Blind Treatment Period 1||0
336584|NCT00589979|814738|P3|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|43
336585|NCT00589979|814739|P2|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|50
336586|NCT00589979|814740|P1|STARTED|Double-Blind Treatment Period 1|Participants completing the Run-in Period were then randomized to two different treatment sequences.|0
336587|NCT00589979|814738|P3|NOT COMPLETED|Run-In Period||0
336588|NCT00589979|814739|P2|NOT COMPLETED|Run-In Period||0
336589|NCT00589979|814740|P1|NOT COMPLETED|Run-In Period||76
336590|NCT00589979|814738|P3|COMPLETED|Run-In Period||0
336591|NCT00589979|814739|P2|COMPLETED|Run-In Period||0
336592|NCT00589979|814740|P1|COMPLETED|Run-In Period||93
336593|NCT00589979|814738|P3|STARTED|Run-In Period||0
336594|NCT00589979|814739|P2|STARTED|Run-In Period||0
336595|NCT00589979|814740|P1|STARTED|Run-In Period||169
336596|NCT00589914|814779|P2|NOT COMPLETED|Overall Study||137
336597|NCT00589914|814780|P1|NOT COMPLETED|Overall Study||150
336598|NCT00589914|814779|P2|COMPLETED|Overall Study||471
336599|NCT00589914|814780|P1|COMPLETED|Overall Study||456
336600|NCT00589914|814779|P2|STARTED|Overall Study||608
336601|NCT00589914|814780|P1|STARTED|Overall Study||606
336602|NCT00589888|814790|P5|NOT COMPLETED|64-gram Oral Fat Load||0
336603|NCT00589888|814791|P4|NOT COMPLETED|64-gram Oral Fat Load||0
336604|NCT00589888|814792|P3|NOT COMPLETED|64-gram Oral Fat Load||0
336605|NCT00589888|814793|P2|NOT COMPLETED|64-gram Oral Fat Load||0
336606|NCT00589888|814794|P1|NOT COMPLETED|64-gram Oral Fat Load||0
336607|NCT00589888|814790|P5|COMPLETED|64-gram Oral Fat Load||13
336608|NCT00589888|814791|P4|COMPLETED|64-gram Oral Fat Load||0
336609|NCT00589888|814792|P3|COMPLETED|64-gram Oral Fat Load||0
336610|NCT00589888|814793|P2|COMPLETED|64-gram Oral Fat Load||0
336611|NCT00589888|814794|P1|COMPLETED|64-gram Oral Fat Load||0
336612|NCT00589888|814790|P5|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
336613|NCT00589888|814791|P4|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
336614|NCT00589888|814792|P3|STARTED|64-gram Oral Fat Load||0
336615|NCT00589888|814793|P2|STARTED|64-gram Oral Fat Load||0
336616|NCT00589888|814794|P1|STARTED|64-gram Oral Fat Load||0
336617|NCT00589888|814790|P5|NOT COMPLETED|32-gram Oral Fat Load||0
336618|NCT00589888|814791|P4|NOT COMPLETED|32-gram Oral Fat Load||0
336619|NCT00589888|814792|P3|NOT COMPLETED|32-gram Oral Fat Load||0
336620|NCT00589888|814793|P2|NOT COMPLETED|32-gram Oral Fat Load||0
336621|NCT00589888|814794|P1|NOT COMPLETED|32-gram Oral Fat Load||0
336622|NCT00589888|814790|P5|COMPLETED|32-gram Oral Fat Load||0
336623|NCT00589888|814791|P4|COMPLETED|32-gram Oral Fat Load||13
336624|NCT00589888|814792|P3|COMPLETED|32-gram Oral Fat Load||0
336625|NCT00589888|814793|P2|COMPLETED|32-gram Oral Fat Load||0
336626|NCT00589888|814794|P1|COMPLETED|32-gram Oral Fat Load||0
336627|NCT00589888|814790|P5|STARTED|32-gram Oral Fat Load||0
336628|NCT00589888|814791|P4|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
336629|NCT00589888|814792|P3|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
336630|NCT00589888|814793|P2|STARTED|32-gram Oral Fat Load||0
336631|NCT00589888|814794|P1|STARTED|32-gram Oral Fat Load||0
336632|NCT00589888|814790|P5|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
336633|NCT00589888|814791|P4|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
336634|NCT00589888|814792|P3|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
336635|NCT00589888|814793|P2|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
336636|NCT00589888|814794|P1|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
336637|NCT00589888|814790|P5|COMPLETED|Intralipid 20% @ 40cc/Hour||0
336638|NCT00589888|814791|P4|COMPLETED|Intralipid 20% @ 40cc/Hour||0
336639|NCT00589888|814792|P3|COMPLETED|Intralipid 20% @ 40cc/Hour||13
336640|NCT00589888|814793|P2|COMPLETED|Intralipid 20% @ 40cc/Hour||0
336641|NCT00589888|814794|P1|COMPLETED|Intralipid 20% @ 40cc/Hour||0
336642|NCT00589888|814790|P5|STARTED|Intralipid 20% @ 40cc/Hour||0
336643|NCT00589888|814791|P4|STARTED|Intralipid 20% @ 40cc/Hour||0
336644|NCT00589888|814792|P3|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
336645|NCT00589888|814793|P2|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|0
336646|NCT00589888|814794|P1|STARTED|Intralipid 20% @ 40cc/Hour||0
336647|NCT00589888|814790|P5|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
336648|NCT00589888|814791|P4|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
336649|NCT00589888|814792|P3|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
336650|NCT00589888|814793|P2|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
336651|NCT00589888|814794|P1|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
336652|NCT00589888|814790|P5|COMPLETED|Intralipid 20% @ 20cc/hr||0
336653|NCT00589888|814791|P4|COMPLETED|Intralipid 20% @ 20cc/hr||0
336654|NCT00589888|814792|P3|COMPLETED|Intralipid 20% @ 20cc/hr||0
336655|NCT00589888|814793|P2|COMPLETED|Intralipid 20% @ 20cc/hr||13
336656|NCT00589888|814794|P1|COMPLETED|Intralipid 20% @ 20cc/hr||0
336657|NCT00589888|814790|P5|STARTED|Intralipid 20% @ 20cc/hr||0
336658|NCT00589888|814791|P4|STARTED|Intralipid 20% @ 20cc/hr||0
336659|NCT00589888|814792|P3|STARTED|Intralipid 20% @ 20cc/hr||0
336660|NCT00589888|814793|P2|STARTED|Intralipid 20% @ 20cc/hr||13
336661|NCT00589888|814794|P1|STARTED|Intralipid 20% @ 20cc/hr|the same 13 patients did each of the 5 arms at 5 different visits|0
336662|NCT00589888|814790|P5|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
336663|NCT00589888|814791|P4|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
336664|NCT00589888|814792|P3|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
336665|NCT00589888|814793|P2|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
336666|NCT00589888|814794|P1|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
336667|NCT00589888|814790|P5|COMPLETED|Normal Saline @ 40cc/Hour||0
336668|NCT00589888|814791|P4|COMPLETED|Normal Saline @ 40cc/Hour||0
336669|NCT00589888|814792|P3|COMPLETED|Normal Saline @ 40cc/Hour||0
336670|NCT00589888|814793|P2|COMPLETED|Normal Saline @ 40cc/Hour||0
336671|NCT00589888|814794|P1|COMPLETED|Normal Saline @ 40cc/Hour||13
336672|NCT00589888|814790|P5|STARTED|Normal Saline @ 40cc/Hour||0
336673|NCT00589888|814791|P4|STARTED|Normal Saline @ 40cc/Hour||0
336674|NCT00589888|814792|P3|STARTED|Normal Saline @ 40cc/Hour||0
336675|NCT00589888|814793|P2|STARTED|Normal Saline @ 40cc/Hour||0
336676|NCT00589888|814794|P1|STARTED|Normal Saline @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
336677|NCT00589849|814826|P1|NOT COMPLETED|Overall Study||0
336678|NCT00589849|814826|P1|COMPLETED|Overall Study||32
336679|NCT00589849|814826|P1|STARTED|Overall Study||32
336680|NCT00589836|814830|P1|NOT COMPLETED|Overall Study||0
336681|NCT00589836|814830|P1|COMPLETED|Overall Study||20
336682|NCT00589836|814830|P1|STARTED|Overall Study||20
336683|NCT00589797|814836|P2|NOT COMPLETED|Overall Study||23
336684|NCT00589797|814837|P1|NOT COMPLETED|Overall Study||73
336685|NCT00589797|814836|P2|COMPLETED|Overall Study||89
336686|NCT00589797|814837|P1|COMPLETED|Overall Study||191
336687|NCT00589797|814836|P2|24 Months|Overall Study||89
336688|NCT00589797|814837|P1|24 Months|Overall Study||191
336689|NCT00589797|814836|P2|Baseline|Overall Study||106
336690|NCT00589797|814837|P1|Baseline|Overall Study||218
336691|NCT00589797|814836|P2|STARTED|Overall Study||112
336692|NCT00589797|814837|P1|STARTED|Overall Study||264
336693|NCT00589784|814861|P2|NOT COMPLETED|Overall Study||10
336694|NCT00589784|814862|P1|NOT COMPLETED|Overall Study||1
336695|NCT00589784|814861|P2|COMPLETED|Overall Study||4
336696|NCT00589784|814862|P1|COMPLETED|Overall Study||35
336697|NCT00589784|814861|P2|STARTED|Overall Study||14
336698|NCT00589784|814862|P1|STARTED|Overall Study||36
336699|NCT00589693|814869|P2|NOT COMPLETED|Overall Study||29
336700|NCT00589693|814870|P1|NOT COMPLETED|Overall Study||44
336701|NCT00589693|814869|P2|COMPLETED|Overall Study||83
336702|NCT00589693|814870|P1|COMPLETED|Overall Study||71
336703|NCT00589693|814869|P2|STARTED|Overall Study||112
336704|NCT00589693|814870|P1|STARTED|Overall Study||115
336705|NCT00589667|814884|P1|NOT COMPLETED|Overall Study||3
336706|NCT00589667|814884|P1|COMPLETED|Overall Study||23
336707|NCT00589667|814884|P1|STARTED|Overall Study||26
336708|NCT00589628|814891|P2|NOT COMPLETED|Overall Study||1
336709|NCT00589628|814892|P1|NOT COMPLETED|Overall Study||0
336710|NCT00589628|814891|P2|COMPLETED|Overall Study||5
336711|NCT00589628|814892|P1|COMPLETED|Overall Study||7
336712|NCT00589628|814891|P2|STARTED|Overall Study||6
336713|NCT00589628|814892|P1|STARTED|Overall Study||7
336714|NCT00589602|814898|P1|NOT COMPLETED|Overall Study||1
336715|NCT00589602|814898|P1|COMPLETED|Overall Study||12
336716|NCT00589602|814898|P1|STARTED|Overall Study||13
336717|NCT00589563|814906|P1|NOT COMPLETED|Overall Study||0
336718|NCT00589563|814906|P1|COMPLETED|Overall Study||32
336719|NCT00589563|814906|P1|STARTED|Overall Study||32
336720|NCT00589550|814923|P1|NOT COMPLETED|Overall Study||1
336721|NCT00589550|814923|P1|COMPLETED|Overall Study||0
336722|NCT00589550|814923|P1|Withdrew From Study|Overall Study||1
336723|NCT00589550|814923|P1|STARTED|Overall Study||1
336724|NCT00589472|814933|P1|NOT COMPLETED|Overall Study||1
336725|NCT00589472|814933|P1|COMPLETED|Overall Study||18
336726|NCT00589472|814933|P1|STARTED|Overall Study||19
336727|NCT00589329|814945|P2|NOT COMPLETED|Overall Study||0
336728|NCT00589329|814946|P1|NOT COMPLETED|Overall Study||0
336729|NCT00589329|814945|P2|COMPLETED|Overall Study||10
336730|NCT00589329|814946|P1|COMPLETED|Overall Study||10
336731|NCT00589329|814945|P2|STARTED|Overall Study||10
336732|NCT00589329|814946|P1|STARTED|Overall Study||10
336733|NCT00589303|814956|P2|NOT COMPLETED|Overall Study||1
336734|NCT00589303|814957|P1|NOT COMPLETED|Overall Study||2
336735|NCT00589303|814956|P2|COMPLETED|Overall Study||12
336736|NCT00589303|814957|P1|COMPLETED|Overall Study||12
336737|NCT00589303|814956|P2|STARTED|Overall Study||13
336738|NCT00589303|814957|P1|STARTED|Overall Study||14
336739|NCT00589290|814963|P1|NOT COMPLETED|Overall Study||1
336740|NCT00589290|814963|P1|COMPLETED|Overall Study||40
336741|NCT00589290|814963|P1|STARTED|Overall Study||41
336742|NCT00589277|814973|P2|NOT COMPLETED|Overall Study||286
336743|NCT00589277|814974|P1|NOT COMPLETED|Overall Study||460
336744|NCT00589277|814973|P2|COMPLETED|Overall Study||524
336745|NCT00589277|814974|P1|COMPLETED|Overall Study||762
336746|NCT00589277|814973|P2|Completed 3 Month Follow Up|Overall Study||524
336747|NCT00589277|814974|P1|Completed 3 Month Follow Up|Overall Study||762
336748|NCT00589277|814973|P2|Completed 2 Week Follow Up|Overall Study||424
336749|NCT00589277|814974|P1|Completed 2 Week Follow Up|Overall Study||603
336750|NCT00589277|814973|P2|STARTED|Overall Study||810
336751|NCT00589277|814974|P1|STARTED|Overall Study||1222
336752|NCT00589121|814986|P2|NOT COMPLETED|Overall Study||7
336753|NCT00589121|814987|P1|NOT COMPLETED|Overall Study||2
336754|NCT00589121|814986|P2|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|79
336755|NCT00589121|814987|P1|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|10
336756|NCT00589121|814986|P2|STARTED|Overall Study||86
336757|NCT00589121|814987|P1|STARTED|Overall Study||12
336758|NCT00589108|815009|P3|NOT COMPLETED|Overall Study||5
336759|NCT00589108|815010|P2|NOT COMPLETED|Overall Study||4
336760|NCT00589108|815011|P1|NOT COMPLETED|Overall Study||4
336761|NCT00589108|815009|P3|COMPLETED|Overall Study||75
336762|NCT00589108|815010|P2|COMPLETED|Overall Study||76
336763|NCT00589108|815011|P1|COMPLETED|Overall Study||76
336764|NCT00589108|815009|P3|STARTED|Overall Study||80
336765|NCT00589108|815010|P2|STARTED|Overall Study||80
336766|NCT00589108|815011|P1|STARTED|Overall Study||80
336767|NCT00588965|815031|P1|NOT COMPLETED|Overall Study||0
336768|NCT00588965|815031|P1|COMPLETED|Overall Study||35
336769|NCT00588965|815031|P1|STARTED|Overall Study||35
336770|NCT00588952|815041|P2|NOT COMPLETED|Overall Study||7
336771|NCT00588952|815042|P1|NOT COMPLETED|Overall Study||3
336772|NCT00588952|815041|P2|COMPLETED|Overall Study||63
336773|NCT00588952|815042|P1|COMPLETED|Overall Study||26
336774|NCT00588952|815041|P2|STARTED|Overall Study||70
336775|NCT00588952|815042|P1|STARTED|Overall Study||29
336776|NCT00588900|815062|P1|NOT COMPLETED|Overall Study||0
336777|NCT00588900|815062|P1|COMPLETED|Overall Study||5
336778|NCT00588900|815062|P1|STARTED|Overall Study||5
336779|NCT00588861|815070|P2|NOT COMPLETED|10 Years||114
336780|NCT00588861|815071|P1|NOT COMPLETED|10 Years||107
336781|NCT00588861|815070|P2|COMPLETED|10 Years||0
336782|NCT00588861|815071|P1|COMPLETED|10 Years||0
336783|NCT00588861|815070|P2|STARTED|10 Years|114 cases were due at 10 Years, however no patients returned for follow-up.|114
336784|NCT00588861|815071|P1|STARTED|10 Years|107 cases were due at 10 Years, however no patients returned for follow-up.|107
336785|NCT00588861|815070|P2|NOT COMPLETED|8 Years||114
336786|NCT00588861|815071|P1|NOT COMPLETED|8 Years||105
336787|NCT00588861|815070|P2|COMPLETED|8 Years||0
336788|NCT00588861|815071|P1|COMPLETED|8 Years||2
336789|NCT00588861|815070|P2|STARTED|8 Years|114 cases were due at 8 Years, however no patients returned for follow-up.|114
336790|NCT00588861|815071|P1|STARTED|8 Years|107 cases were due at 8 Years, however only 2 returned for follow-up.|107
336791|NCT00588861|815070|P2|NOT COMPLETED|6 Years||109
336792|NCT00588861|815071|P1|NOT COMPLETED|6 Years||104
336793|NCT00588861|815070|P2|COMPLETED|6 Years||5
336794|NCT00588861|815071|P1|COMPLETED|6 Years||3
336795|NCT00588861|815070|P2|STARTED|6 Years|114 cases were due at 6 Years, however only 5 returned for follow-up.|114
336796|NCT00588861|815071|P1|STARTED|6 Years|107 cases were due at 6 Years, however only 3 returned for follow-up.|107
336797|NCT00588861|815070|P2|NOT COMPLETED|4 Years||103
336798|NCT00588861|815071|P1|NOT COMPLETED|4 Years||91
336799|NCT00588861|815070|P2|COMPLETED|4 Years||11
336800|NCT00588861|815071|P1|COMPLETED|4 Years||16
336801|NCT00588861|815070|P2|STARTED|4 Years|114 cases were due at 4 Years, however only 11 returned for follow-up.|114
336802|NCT00588861|815071|P1|STARTED|4 Years|107 cases were due at 4 Years, however only 16 returned for follow-up.|107
336803|NCT00588861|815070|P2|NOT COMPLETED|2 Years||87
336804|NCT00588861|815071|P1|NOT COMPLETED|2 Years||92
336805|NCT00588861|815070|P2|COMPLETED|2 Years||27
336806|NCT00588861|815071|P1|COMPLETED|2 Years||15
336807|NCT00588861|815070|P2|STARTED|2 Years|114 cases were due at 2 Years, however only 27 returned for follow-up.|114
336808|NCT00588861|815071|P1|STARTED|2 Years|107 cases were due at 2 Years, however only 15 returned for follow-up.|107
336809|NCT00588861|815070|P2|NOT COMPLETED|1 Year||82
336810|NCT00588861|815071|P1|NOT COMPLETED|1 Year||89
336811|NCT00588861|815070|P2|COMPLETED|1 Year||32
336812|NCT00588861|815071|P1|COMPLETED|1 Year||18
336813|NCT00588861|815070|P2|STARTED|1 Year|114 cases were due at 1 Year, however only 32 returned for follow-up.|114
336814|NCT00588861|815071|P1|STARTED|1 Year|107 cases were due at 1 Year, however only 18 returned for follow-up.|107
336815|NCT00588861|815070|P2|NOT COMPLETED|6 Months||73
336816|NCT00588861|815071|P1|NOT COMPLETED|6 Months||98
336817|NCT00588861|815070|P2|COMPLETED|6 Months||41
336818|NCT00588861|815071|P1|COMPLETED|6 Months||9
336819|NCT00588861|815070|P2|STARTED|6 Months|114 cases were due at 6 Months, however only 41 returned for follow-up.|114
336820|NCT00588861|815071|P1|STARTED|6 Months|107 cases were due at 6 Months, however only 9 returned for follow-up.|107
336821|NCT00588861|815070|P2|NOT COMPLETED|Pre-Operative||86
336822|NCT00588861|815071|P1|NOT COMPLETED|Pre-Operative||95
336823|NCT00588861|815070|P2|COMPLETED|Pre-Operative||114
336824|NCT00588861|815071|P1|COMPLETED|Pre-Operative||107
336825|NCT00588861|815070|P2|STARTED|Pre-Operative|200 patients were enrolled, however only 114 contributed preop data.|200
336826|NCT00588861|815071|P1|STARTED|Pre-Operative|202 Patients were enrolled, however only 107 contributed preop data.|202
336827|NCT00588848|815081|P2|NOT COMPLETED|Overall Study||3
336828|NCT00588848|815082|P1|NOT COMPLETED|Overall Study||0
336829|NCT00588848|815081|P2|COMPLETED|Overall Study||5
336830|NCT00588848|815082|P1|COMPLETED|Overall Study||3
336831|NCT00588848|815081|P2|STARTED|Overall Study||8
336832|NCT00588848|815082|P1|STARTED|Overall Study||3
336833|NCT00588822|815092|P1|NOT COMPLETED|Overall Study||8
336834|NCT00588822|815092|P1|COMPLETED|Overall Study||13
336835|NCT00588822|815092|P1|STARTED|Overall Study||21
336836|NCT00588809|815101|P1|NOT COMPLETED|Overall Study||0
336837|NCT00588809|815101|P1|COMPLETED|Overall Study||47
336838|NCT00588809|815101|P1|STARTED|Overall Study||47
336839|NCT00588770|815112|P2|NOT COMPLETED|Overall Study||200
336840|NCT00588770|815113|P1|NOT COMPLETED|Overall Study||159
336841|NCT00588770|815112|P2|COMPLETED|Overall Study||3
336842|NCT00588770|815113|P1|COMPLETED|Overall Study||41
336843|NCT00588770|815112|P2|Start Protocol Therapy|Overall Study||194
336844|NCT00588770|815113|P1|Start Protocol Therapy|Overall Study||200
336845|NCT00588770|815112|P2|Eligible|Overall Study||183
336846|NCT00588770|815113|P1|Eligible|Overall Study||188
336847|NCT00588770|815112|P2|STARTED|Overall Study||203
336848|NCT00588770|815113|P1|STARTED|Overall Study||200
336849|NCT00588731|815125|P2|NOT COMPLETED|Overall Study||2
336850|NCT00588731|815126|P1|NOT COMPLETED|Overall Study||3
336851|NCT00588731|815125|P2|COMPLETED|Overall Study||18
336852|NCT00588731|815126|P1|COMPLETED|Overall Study||18
336853|NCT00588731|815125|P2|STARTED|Overall Study||20
336854|NCT00588731|815126|P1|STARTED|Overall Study||21
336855|NCT00588692|815136|P2|NOT COMPLETED|Overall Study||3
336856|NCT00588692|815137|P1|NOT COMPLETED|Overall Study||7
336857|NCT00588692|815136|P2|COMPLETED|Overall Study||27
336858|NCT00588692|815137|P1|COMPLETED|Overall Study||23
336859|NCT00588692|815136|P2|STARTED|Overall Study||30
336860|NCT00588692|815137|P1|STARTED|Overall Study||30
336861|NCT00588666|815173|P1|NOT COMPLETED|Overall Study||4
336862|NCT00588666|815173|P1|COMPLETED|Overall Study||47
336863|NCT00588666|815173|P1|STARTED|Overall Study||51
336864|NCT00588640|815178|P1|NOT COMPLETED|Overall Study||2
336865|NCT00588640|815178|P1|COMPLETED|Overall Study||8
336866|NCT00588640|815178|P1|STARTED|Overall Study||10
336867|NCT00588536|815182|P1|NOT COMPLETED|Overall Study||0
336868|NCT00588536|815182|P1|COMPLETED|Overall Study||5
336869|NCT00588536|815182|P1|STARTED|Overall Study||5
336870|NCT00588471|815188|P2|NOT COMPLETED|Overall Study||0
336871|NCT00588471|815189|P1|NOT COMPLETED|Overall Study||0
336872|NCT00588471|815188|P2|COMPLETED|Overall Study||29
336873|NCT00588471|815189|P1|COMPLETED|Overall Study||28
336874|NCT00588471|815188|P2|STARTED|Overall Study||29
336875|NCT00588471|815189|P1|STARTED|Overall Study||28
336876|NCT00588445|815197|P1|NOT COMPLETED|Overall Study||15
336877|NCT00588445|815197|P1|COMPLETED|Overall Study||50
336878|NCT00588445|815197|P1|STARTED|Overall Study||65
336879|NCT00588406|815205|P2|NOT COMPLETED|Overall Study||0
336880|NCT00588406|815206|P1|NOT COMPLETED|Overall Study||0
336881|NCT00588406|815205|P2|COMPLETED|Overall Study||49
336882|NCT00588406|815206|P1|COMPLETED|Overall Study||46
336883|NCT00588406|815205|P2|STARTED|Overall Study||49
336884|NCT00588406|815206|P1|STARTED|Overall Study||46
336885|NCT00588380|815214|P1|NOT COMPLETED|Overall Study||0
336886|NCT00588380|815214|P1|COMPLETED|Overall Study||88
336887|NCT00588380|815214|P1|STARTED|Overall Study||88
336888|NCT00588354|815221|P2|NOT COMPLETED|Baseline to 4 Weeks||1
336889|NCT00588354|815222|P1|NOT COMPLETED|Baseline to 4 Weeks||0
336890|NCT00588354|815221|P2|COMPLETED|Baseline to 4 Weeks||14
336891|NCT00588354|815222|P1|COMPLETED|Baseline to 4 Weeks||9
336892|NCT00588354|815221|P2|STARTED|Baseline to 4 Weeks||15
336893|NCT00588354|815222|P1|STARTED|Baseline to 4 Weeks||9
336894|NCT00588354|815221|P2|NOT COMPLETED|Baseline to 2 Weeks||0
336895|NCT00588354|815222|P1|NOT COMPLETED|Baseline to 2 Weeks||2
336896|NCT00588354|815221|P2|COMPLETED|Baseline to 2 Weeks||15
336897|NCT00588354|815222|P1|COMPLETED|Baseline to 2 Weeks||9
336898|NCT00588354|815221|P2|STARTED|Baseline to 2 Weeks||15
336899|NCT00588354|815222|P1|STARTED|Baseline to 2 Weeks||11
336900|NCT00588341|815242|P1|NOT COMPLETED|Overall Study||5
336901|NCT00588341|815242|P1|COMPLETED|Overall Study||19
336902|NCT00588341|815242|P1|STARTED|Overall Study||24
336903|NCT00588237|815246|P1|NOT COMPLETED|Overall Study||4
336904|NCT00588237|815246|P1|COMPLETED|Overall Study||38
336905|NCT00588237|815246|P1|STARTED|Overall Study||42
336906|NCT00588159|815252|P2|NOT COMPLETED|Overall Study||11
336907|NCT00588159|815253|P1|NOT COMPLETED|Overall Study||15
336908|NCT00588159|815252|P2|COMPLETED|Overall Study||63
336909|NCT00588159|815253|P1|COMPLETED|Overall Study||57
336910|NCT00588159|815252|P2|STARTED|Overall Study||74
336911|NCT00588159|815253|P1|STARTED|Overall Study||72
336912|NCT00588146|815269|P2|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
336913|NCT00588146|815270|P1|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
336914|NCT00588146|815269|P2|COMPLETED|Second Intervention (6 Months to 1 Year)||2
336915|NCT00588146|815270|P1|COMPLETED|Second Intervention (6 Months to 1 Year)||1
336916|NCT00588146|815269|P2|STARTED|Second Intervention (6 Months to 1 Year)||2
336917|NCT00588146|815270|P1|STARTED|Second Intervention (6 Months to 1 Year)||1
336918|NCT00588146|815269|P2|NOT COMPLETED|First Intervention (Baseline to 6 mo)||3
336919|NCT00588146|815270|P1|NOT COMPLETED|First Intervention (Baseline to 6 mo)||4
336920|NCT00588146|815269|P2|COMPLETED|First Intervention (Baseline to 6 mo)||2
336921|NCT00588146|815270|P1|COMPLETED|First Intervention (Baseline to 6 mo)||1
336922|NCT00588146|815269|P2|STARTED|First Intervention (Baseline to 6 mo)||5
336923|NCT00588146|815270|P1|STARTED|First Intervention (Baseline to 6 mo)||5
336924|NCT00588094|815276|P1|NOT COMPLETED|Overall Study||5
336925|NCT00588094|815276|P1|COMPLETED|Overall Study||15
336926|NCT00588094|815276|P1|STARTED|Overall Study||20
336927|NCT00587990|815283|P3|NOT COMPLETED|Overall Study||1
336928|NCT00587990|815284|P2|NOT COMPLETED|Overall Study||0
336929|NCT00587990|815285|P1|NOT COMPLETED|Overall Study||0
336930|NCT00587990|815283|P3|COMPLETED|Overall Study||2
336931|NCT00587990|815284|P2|COMPLETED|Overall Study||4
336932|NCT00587990|815285|P1|COMPLETED|Overall Study||2
336933|NCT00587990|815283|P3|STARTED|Overall Study||3
336934|NCT00587990|815284|P2|STARTED|Overall Study||4
336935|NCT00587990|815285|P1|STARTED|Overall Study||2
336936|NCT00587964|815328|P1|NOT COMPLETED|Overall Study||12
336937|NCT00587964|815328|P1|COMPLETED|Overall Study||39
336938|NCT00587964|815328|P1|STARTED|Overall Study||51
336939|NCT00587860|815334|P2|NOT COMPLETED|Overall Study||5
336940|NCT00587860|815335|P1|NOT COMPLETED|Overall Study||5
336941|NCT00587860|815334|P2|COMPLETED|Overall Study||30
336942|NCT00587860|815335|P1|COMPLETED|Overall Study||30
336943|NCT00587860|815334|P2|STARTED|Overall Study||35
336944|NCT00587860|815335|P1|STARTED|Overall Study||35
336945|NCT00587847|815355|P1|NOT COMPLETED|Overall Study||7
336946|NCT00587847|815355|P1|COMPLETED|Overall Study||5
336947|NCT00587847|815355|P1|STARTED|Overall Study||12
336948|NCT00587834|815360|P1|NOT COMPLETED|Overall Study||0
336949|NCT00587834|815360|P1|COMPLETED|Overall Study||96
336950|NCT00587834|815360|P1|STARTED|Overall Study||96
336951|NCT00587795|815378|P2|NOT COMPLETED|Overall Study||0
336952|NCT00587795|815379|P1|NOT COMPLETED|Overall Study||1
336953|NCT00587795|815378|P2|COMPLETED|Overall Study||0
336954|NCT00587795|815379|P1|COMPLETED|Overall Study||0
336955|NCT00587795|815378|P2|STARTED|Overall Study||0
336956|NCT00587795|815379|P1|STARTED|Overall Study||1
336957|NCT00587769|815385|P1|NOT COMPLETED|Overall Study||0
336958|NCT00587769|815385|P1|COMPLETED|Overall Study||38
336959|NCT00587769|815385|P1|STARTED|Overall Study||38
336960|NCT00587678|815393|P3|NOT COMPLETED|Overall Study||8
336961|NCT00587678|815394|P2|NOT COMPLETED|Overall Study||4
336962|NCT00587678|815395|P1|NOT COMPLETED|Overall Study||6
336963|NCT00587678|815393|P3|COMPLETED|Overall Study||33
336964|NCT00587678|815394|P2|COMPLETED|Overall Study||18
336965|NCT00587678|815395|P1|COMPLETED|Overall Study||16
336966|NCT00587678|815393|P3|STARTED|Overall Study||41
336967|NCT00587678|815394|P2|STARTED|Overall Study||22
336968|NCT00587678|815395|P1|STARTED|Overall Study||22
336969|NCT00587639|815433|P1|NOT COMPLETED|Overall Study||1
336970|NCT00587639|815433|P1|COMPLETED|Overall Study||7
336971|NCT00587639|815433|P1|STARTED|Overall Study||8
336972|NCT00587587|815440|P2|NOT COMPLETED|Overall Study||1
336973|NCT00587587|815441|P1|NOT COMPLETED|Overall Study||6
336974|NCT00587587|815440|P2|COMPLETED|Overall Study||12
336975|NCT00587587|815441|P1|COMPLETED|Overall Study||11
336976|NCT00587587|815440|P2|STARTED|Overall Study||13
336977|NCT00587587|815441|P1|STARTED|Overall Study||17
336978|NCT00587483|815464|P3|NOT COMPLETED|Overall Study||0
336979|NCT00587483|815465|P2|NOT COMPLETED|Overall Study||0
336980|NCT00587483|815466|P1|NOT COMPLETED|Overall Study||0
336981|NCT00587483|815464|P3|COMPLETED|Overall Study||112
336982|NCT00587483|815465|P2|COMPLETED|Overall Study||115
336983|NCT00587483|815466|P1|COMPLETED|Overall Study||115
336984|NCT00587483|815464|P3|STARTED|Overall Study||112
336985|NCT00587483|815465|P2|STARTED|Overall Study||115
336986|NCT00587483|815466|P1|STARTED|Overall Study||115
336987|NCT00587457|815495|P3|NOT COMPLETED|Overall Study||5
336988|NCT00587457|815496|P2|NOT COMPLETED|Overall Study||3
336989|NCT00587457|815497|P1|NOT COMPLETED|Overall Study||3
336990|NCT00587457|815495|P3|COMPLETED|Overall Study||0
336991|NCT00587457|815496|P2|COMPLETED|Overall Study||0
336992|NCT00587457|815497|P1|COMPLETED|Overall Study||0
336993|NCT00587457|815495|P3|STARTED|Overall Study||5
336994|NCT00587457|815496|P2|STARTED|Overall Study||3
336995|NCT00587457|815497|P1|STARTED|Overall Study||3
336996|NCT00587431|815534|P2|NOT COMPLETED|Overall Study||1
336997|NCT00587431|815535|P1|NOT COMPLETED|Overall Study||1
336998|NCT00587431|815534|P2|COMPLETED|Overall Study||38
336999|NCT00587431|815535|P1|COMPLETED|Overall Study||62
337000|NCT00587431|815534|P2|STARTED|Overall Study||39
337001|NCT00587431|815535|P1|STARTED|Overall Study||63
337002|NCT00587288|815546|P2|NOT COMPLETED|Overall Study||9
337003|NCT00587288|815547|P1|NOT COMPLETED|Overall Study||3
337004|NCT00587288|815546|P2|COMPLETED|Overall Study||44
337005|NCT00587288|815547|P1|COMPLETED|Overall Study||50
337006|NCT00587288|815546|P2|STARTED|Overall Study||53
337007|NCT00587288|815547|P1|STARTED|Overall Study||53
337008|NCT00587223|815565|P1|NOT COMPLETED|Overall Study||1
337009|NCT00587223|815565|P1|COMPLETED|Overall Study|Subject withdrawn from study at Day 7.|0
337010|NCT00587223|815565|P1|STARTED|Overall Study|Study design was within-subject control. Only 1 subject was enrolled in the study.|1
337011|NCT00587171|815582|P2|NOT COMPLETED|Overall Study||1
337012|NCT00587171|815583|P1|NOT COMPLETED|Overall Study||1
337013|NCT00587171|815582|P2|COMPLETED|Overall Study||9
337014|NCT00587171|815583|P1|COMPLETED|Overall Study||8
337015|NCT00587171|815582|P2|STARTED|Overall Study||10
337016|NCT00587171|815583|P1|STARTED|Overall Study||9
337017|NCT00587158|815613|P2|NOT COMPLETED|Overall Study||8
337018|NCT00587158|815614|P1|NOT COMPLETED|Overall Study||5
337019|NCT00587158|815613|P2|COMPLETED|Overall Study||43
337020|NCT00587158|815614|P1|COMPLETED|Overall Study||44
337021|NCT00587158|815613|P2|Continued in Study|Overall Study||46
337022|NCT00587158|815614|P1|Continued in Study|Overall Study||45
337023|NCT00587158|815613|P2|STARTED|Overall Study||51
337024|NCT00587158|815614|P1|STARTED|Overall Study||49
337025|NCT00587132|815648|P4|NOT COMPLETED|Overall Study||0
337026|NCT00587132|815649|P3|NOT COMPLETED|Overall Study||0
337027|NCT00587132|815650|P2|NOT COMPLETED|Overall Study||0
337028|NCT00587132|815651|P1|NOT COMPLETED|Overall Study||0
337029|NCT00587132|815648|P4|COMPLETED|Overall Study||0
337030|NCT00587132|815649|P3|COMPLETED|Overall Study||0
337031|NCT00587132|815650|P2|COMPLETED|Overall Study||0
337032|NCT00587132|815651|P1|COMPLETED|Overall Study||4
337033|NCT00587132|815648|P4|STARTED|Overall Study||0
337034|NCT00587132|815649|P3|STARTED|Overall Study||0
337035|NCT00587132|815650|P2|STARTED|Overall Study||0
337036|NCT00587132|815651|P1|STARTED|Overall Study||4
337037|NCT00587067|815661|P1|NOT COMPLETED|Overall Study||0
337038|NCT00587067|815661|P1|COMPLETED|Overall Study||34
337039|NCT00587067|815661|P1|STARTED|Overall Study||34
337040|NCT00587054|815667|P1|NOT COMPLETED|Overall Study||9
337041|NCT00587054|815667|P1|COMPLETED|Overall Study||120
337042|NCT00587054|815667|P1|STARTED|Overall Study||129
337043|NCT00587041|815674|P3|NOT COMPLETED|Overall Study||0
337044|NCT00587041|815675|P2|NOT COMPLETED|Overall Study||0
337045|NCT00587041|815676|P1|NOT COMPLETED|Overall Study||0
337046|NCT00587041|815674|P3|COMPLETED|Overall Study||14
337047|NCT00587041|815675|P2|COMPLETED|Overall Study||14
337048|NCT00587041|815676|P1|COMPLETED|Overall Study||12
337049|NCT00587041|815674|P3|STARTED|Overall Study||14
337050|NCT00587041|815675|P2|STARTED|Overall Study||14
337051|NCT00587041|815676|P1|STARTED|Overall Study||12
337052|NCT00586924|815693|P6|NOT COMPLETED|Overall Study||33
337053|NCT00586924|815694|P5|NOT COMPLETED|Overall Study||4
337054|NCT00586924|815695|P4|NOT COMPLETED|Overall Study||3
337055|NCT00586924|815696|P3|NOT COMPLETED|Overall Study||3
337056|NCT00586924|815697|P2|NOT COMPLETED|Overall Study||3
337057|NCT00586924|815698|P1|NOT COMPLETED|Overall Study||3
337058|NCT00586924|815693|P6|COMPLETED|Overall Study||0
337059|NCT00586924|815694|P5|COMPLETED|Overall Study||0
337060|NCT00586924|815695|P4|COMPLETED|Overall Study||0
337061|NCT00586924|815696|P3|COMPLETED|Overall Study||0
337062|NCT00586924|815697|P2|COMPLETED|Overall Study||0
337063|NCT00586924|815698|P1|COMPLETED|Overall Study||0
337064|NCT00586924|815693|P6|STARTED|Overall Study||33
337065|NCT00586924|815694|P5|STARTED|Overall Study||4
337066|NCT00586924|815695|P4|STARTED|Overall Study||3
337067|NCT00586924|815696|P3|STARTED|Overall Study||3
337068|NCT00586924|815697|P2|STARTED|Overall Study||3
337069|NCT00586924|815698|P1|STARTED|Overall Study||3
337070|NCT00586898|815898|P1|NOT COMPLETED|Overall Study||7
337071|NCT00586898|815898|P1|COMPLETED|Overall Study||29
337072|NCT00586898|815898|P1|STARTED|Overall Study||36
337073|NCT00586846|815902|P1|NOT COMPLETED|Overall Study||6
337074|NCT00586846|815902|P1|COMPLETED|Overall Study||34
337075|NCT00586846|815902|P1|STARTED|Overall Study||40
337076|NCT00586820|815908|P2|NOT COMPLETED|Overall Study||0
337077|NCT00586820|815909|P1|NOT COMPLETED|Overall Study||1
337078|NCT00586820|815908|P2|COMPLETED|Overall Study||11
337079|NCT00586820|815909|P1|COMPLETED|Overall Study||11
337080|NCT00586820|815908|P2|STARTED|Overall Study||11
337081|NCT00586820|815909|P1|STARTED|Overall Study||12
337082|NCT00586729|815919|P2|NOT COMPLETED|Overall Study||1
337083|NCT00586729|815920|P1|NOT COMPLETED|Overall Study||3
337084|NCT00586729|815919|P2|COMPLETED|Overall Study||8
337085|NCT00586729|815920|P1|COMPLETED|Overall Study||11
337086|NCT00586729|815919|P2|STARTED|Overall Study||9
337087|NCT00586729|815920|P1|STARTED|Overall Study||14
337088|NCT00586716|815932|P2|NOT COMPLETED|Overall Study||0
337089|NCT00586716|815933|P1|NOT COMPLETED|Overall Study||0
337090|NCT00586716|815932|P2|COMPLETED|Overall Study||8
337091|NCT00586716|815933|P1|COMPLETED|Overall Study||14
337092|NCT00586716|815932|P2|STARTED|Overall Study||8
337093|NCT00586716|815933|P1|STARTED|Overall Study||14
337094|NCT00586703|815940|P1|NOT COMPLETED|Overall Study||12
337095|NCT00586703|815940|P1|COMPLETED|Overall Study||4
337096|NCT00586703|815940|P1|STARTED|Overall Study||16
337097|NCT00586690|815947|P2|NOT COMPLETED|Overall Study||0
337098|NCT00586690|815948|P1|NOT COMPLETED|Overall Study||16
337099|NCT00586690|815947|P2|COMPLETED|Overall Study||22
337100|NCT00586690|815948|P1|COMPLETED|Overall Study||5
337101|NCT00586690|815947|P2|STARTED|Overall Study||22
337102|NCT00586690|815948|P1|STARTED|Overall Study|Four consented subjects were screen failures.|21
337103|NCT00586664|815958|P3|NOT COMPLETED|Overall Study||1
337104|NCT00586664|815959|P2|NOT COMPLETED|Overall Study||7
337105|NCT00586664|815960|P1|NOT COMPLETED|Overall Study||5
337106|NCT00586664|815958|P3|COMPLETED|Overall Study||43
337107|NCT00586664|815959|P2|COMPLETED|Overall Study||36
337108|NCT00586664|815960|P1|COMPLETED|Overall Study||38
337109|NCT00586664|815958|P3|STARTED|Overall Study||44
337110|NCT00586664|815959|P2|STARTED|Overall Study||43
337111|NCT00586664|815960|P1|STARTED|Overall Study||43
337112|NCT00586625|816006|P2|NOT COMPLETED|Overall Study||17
337113|NCT00586625|816007|P1|NOT COMPLETED|Overall Study||43
337114|NCT00586625|816006|P2|COMPLETED|Overall Study||269
337115|NCT00586625|816007|P1|COMPLETED|Overall Study||532
337116|NCT00586625|816006|P2|STARTED|Overall Study||286
337117|NCT00586625|816007|P1|STARTED|Overall Study||575
337118|NCT00586612|816015|P2|NOT COMPLETED|Booster Phase||1
337119|NCT00586612|816016|P1|NOT COMPLETED|Booster Phase||3
337120|NCT00586612|816015|P2|COMPLETED|Booster Phase||143
337121|NCT00586612|816016|P1|COMPLETED|Booster Phase||151
337122|NCT00586612|816015|P2|STARTED|Booster Phase||144
337123|NCT00586612|816016|P1|STARTED|Booster Phase||154
337124|NCT00586612|816015|P2|NOT COMPLETED|Primary Phase||3
337125|NCT00586612|816016|P1|NOT COMPLETED|Primary Phase||1
337126|NCT00586612|816015|P2|COMPLETED|Primary Phase||147
337127|NCT00586612|816016|P1|COMPLETED|Primary Phase||162
337128|NCT00586612|816015|P2|STARTED|Primary Phase||150
337129|NCT00586612|816016|P1|STARTED|Primary Phase||163
337130|NCT00586573|816082|P1|NOT COMPLETED|Overall Study||6
337131|NCT00586573|816082|P1|COMPLETED|Overall Study||28
337132|NCT00586573|816082|P1|STARTED|Overall Study||34
337133|NCT00586521|816086|P1|NOT COMPLETED|Prophylactic Treatment (Months 8-13)||0
337134|NCT00586521|816086|P1|COMPLETED|Prophylactic Treatment (Months 8-13)||19
337135|NCT00586521|816086|P1|STARTED|Prophylactic Treatment (Months 8-13)||19
337136|NCT00586521|816086|P1|NOT COMPLETED|On Demand Treatment (Months 1-6)||1
337137|NCT00586521|816086|P1|COMPLETED|On Demand Treatment (Months 1-6)||19
337138|NCT00586521|816086|P1|STARTED|On Demand Treatment (Months 1-6)||20
337139|NCT00586495|816093|P1|NOT COMPLETED|Follow-up||92
337140|NCT00586495|816093|P1|COMPLETED|Follow-up||0
337141|NCT00586495|816093|P1|STARTED|Follow-up||92
337142|NCT00586495|816093|P1|NOT COMPLETED|Treatment Period||95
337143|NCT00586495|816093|P1|COMPLETED|Treatment Period||0
337144|NCT00586495|816093|P1|STARTED|Treatment Period||95
337145|NCT00586482|816105|P2|NOT COMPLETED|Overall Study||0
337146|NCT00586482|816106|P1|NOT COMPLETED|Overall Study||0
337147|NCT00586482|816105|P2|COMPLETED|Overall Study||24
337148|NCT00586482|816106|P1|COMPLETED|Overall Study||22
337149|NCT00586482|816105|P2|STARTED|Overall Study||24
337150|NCT00586482|816106|P1|STARTED|Overall Study||22
337151|NCT00586469|816122|P2|NOT COMPLETED|Overall Study||1
337152|NCT00586469|816123|P1|NOT COMPLETED|Overall Study||0
337153|NCT00586469|816122|P2|COMPLETED|Overall Study||499
337154|NCT00586469|816123|P1|COMPLETED|Overall Study||500
337155|NCT00586469|816122|P2|STARTED|Overall Study||500
337156|NCT00586469|816123|P1|STARTED|Overall Study||500
337157|NCT00586339|816150|P3|NOT COMPLETED|Overall Study||6
337158|NCT00586339|816151|P2|NOT COMPLETED|Overall Study||7
337159|NCT00586339|816152|P1|NOT COMPLETED|Overall Study||7
337160|NCT00586339|816150|P3|COMPLETED|Overall Study||24
337161|NCT00586339|816151|P2|COMPLETED|Overall Study||52
337162|NCT00586339|816152|P1|COMPLETED|Overall Study||54
337163|NCT00586339|816150|P3|STARTED|Overall Study||30
337164|NCT00586339|816151|P2|STARTED|Overall Study||59
337165|NCT00586339|816152|P1|STARTED|Overall Study||61
337166|NCT00586326|816253|P1|NOT COMPLETED|Treated Through 5-yr Follow Up-Treated||26
337167|NCT00586326|816253|P1|COMPLETED|Treated Through 5-yr Follow Up-Treated||74
337168|NCT00586326|816253|P1|STARTED|Treated Through 5-yr Follow Up-Treated||100
337169|NCT00586326|816253|P1|NOT COMPLETED|Device Placed toTreatment-ITT||18
337170|NCT00586326|816253|P1|COMPLETED|Device Placed toTreatment-ITT||100
337171|NCT00586326|816253|P1|STARTED|Device Placed toTreatment-ITT||118
337172|NCT00586326|816253|P1|NOT COMPLETED|Enrollment to Device Placement-Enrolled||15
337173|NCT00586326|816253|P1|COMPLETED|Enrollment to Device Placement-Enrolled||118
337174|NCT00586326|816253|P1|STARTED|Enrollment to Device Placement-Enrolled||133
337175|NCT00586313|816264|P1|NOT COMPLETED|Overall Study||2
337176|NCT00586313|816264|P1|COMPLETED|Overall Study||19
337177|NCT00586313|816264|P1|STARTED|Overall Study||21
337178|NCT00586261|816271|P2|NOT COMPLETED|Overall Study||0
337179|NCT00586261|816272|P1|NOT COMPLETED|Overall Study||0
337180|NCT00586261|816271|P2|COMPLETED|Overall Study||19
337181|NCT00586261|816272|P1|COMPLETED|Overall Study||17
337182|NCT00586261|816271|P2|STARTED|Overall Study||19
337183|NCT00586261|816272|P1|STARTED|Overall Study||17
337184|NCT00586196|816280|P2|NOT COMPLETED|Overall Study||0
337185|NCT00586196|816281|P1|NOT COMPLETED|Overall Study||0
337186|NCT00586196|816280|P2|COMPLETED|Overall Study||9
337187|NCT00586196|816281|P1|COMPLETED|Overall Study||7
337188|NCT00586196|816280|P2|STARTED|Overall Study||9
337189|NCT00586196|816281|P1|STARTED|Overall Study||7
337190|NCT00586170|816291|P2|NOT COMPLETED|Overall Study||0
337191|NCT00586170|816292|P1|NOT COMPLETED|Overall Study||0
337192|NCT00586170|816291|P2|COMPLETED|Overall Study||3
337193|NCT00586170|816292|P1|COMPLETED|Overall Study||5
337194|NCT00586170|816291|P2|STARTED|Overall Study|Initially enrollment was listed as 9. 1 placebo patient withdrew prior to surgery, so enrollment=8.|3
337195|NCT00586170|816292|P1|STARTED|Overall Study||5
337196|NCT00586157|816300|P2|NOT COMPLETED|Second Intervention||1
337197|NCT00586157|816301|P1|NOT COMPLETED|Second Intervention||2
337198|NCT00586157|816300|P2|COMPLETED|Second Intervention||14
337199|NCT00586157|816301|P1|COMPLETED|Second Intervention||12
337200|NCT00586157|816300|P2|STARTED|Second Intervention||15
337201|NCT00586157|816301|P1|STARTED|Second Intervention||14
337202|NCT00586157|816300|P2|NOT COMPLETED|First Intervention||0
337203|NCT00586157|816301|P1|NOT COMPLETED|First Intervention||1
337204|NCT00586157|816300|P2|COMPLETED|First Intervention||15
337205|NCT00586157|816301|P1|COMPLETED|First Intervention||14
337206|NCT00586157|816300|P2|STARTED|First Intervention||15
337207|NCT00586157|816301|P1|STARTED|First Intervention||15
337208|NCT00586105|816311|P1|NOT COMPLETED|Overall Study||39
337209|NCT00586105|816311|P1|COMPLETED|Overall Study||0
337210|NCT00586105|816311|P1|STARTED|Overall Study||39
337211|NCT00586066|816326|P2|NOT COMPLETED|Overall Study||10
337212|NCT00586066|816327|P1|NOT COMPLETED|Overall Study||18
337213|NCT00586066|816326|P2|COMPLETED|Overall Study||14
337214|NCT00586066|816327|P1|COMPLETED|Overall Study||30
337215|NCT00586066|816326|P2|STARTED|Overall Study||24
337216|NCT00586066|816327|P1|STARTED|Overall Study||48
337217|NCT00586001|816339|P2|NOT COMPLETED|Overall Study||1
337218|NCT00586001|816340|P1|NOT COMPLETED|Overall Study||4
337219|NCT00586001|816339|P2|COMPLETED|Overall Study||10
337220|NCT00586001|816340|P1|COMPLETED|Overall Study||22
337221|NCT00586001|816339|P2|STARTED|Overall Study||11
337222|NCT00586001|816340|P1|STARTED|Overall Study||26
337223|NCT00585975|816384|P2|NOT COMPLETED|Overall Study||13
337224|NCT00585975|816385|P1|NOT COMPLETED|Overall Study||15
337225|NCT00585975|816384|P2|COMPLETED|Overall Study||278
337226|NCT00585975|816385|P1|COMPLETED|Overall Study||262
337227|NCT00585975|816384|P2|STARTED|Overall Study||291
337228|NCT00585975|816385|P1|STARTED|Overall Study||277
337229|NCT00585923|816395|P2|NOT COMPLETED|Overall Study||33
337230|NCT00585923|816396|P1|NOT COMPLETED|Overall Study||31
337231|NCT00585923|816395|P2|COMPLETED|Overall Study||26
337232|NCT00585923|816396|P1|COMPLETED|Overall Study||25
337233|NCT00585923|816395|P2|STARTED|Overall Study||59
337234|NCT00585923|816396|P1|STARTED|Overall Study||56
337235|NCT00585910|816410|P1|NOT COMPLETED|ATMX + Osmotic-Release Methylphenidate||9
337236|NCT00585910|816410|P1|COMPLETED|ATMX + Osmotic-Release Methylphenidate||41
337237|NCT00585910|816410|P1|STARTED|ATMX + Osmotic-Release Methylphenidate|Number of participants to add OROS MPH to their ATMX regimen|50
337238|NCT00585910|816410|P1|NOT COMPLETED|Atomoxetine (ATMX) Alone||17
337239|NCT00585910|816410|P1|COMPLETED|Atomoxetine (ATMX) Alone|Number of subjects who completed Phase I. 15 completed only Phase I. 40 proceeded onto Phase II.|55
337240|NCT00585910|816410|P1|STARTED|Atomoxetine (ATMX) Alone|This is the number of subjects who were exposed to ATMX in Phase I of the study.|72
337241|NCT00585715|816418|P2|NOT COMPLETED|Overall Study||0
337242|NCT00585715|816419|P1|NOT COMPLETED|Overall Study||3
337243|NCT00585715|816418|P2|COMPLETED|Overall Study||11
337244|NCT00585715|816419|P1|COMPLETED|Overall Study||8
337245|NCT00585715|816418|P2|STARTED|Overall Study||11
337246|NCT00585715|816419|P1|STARTED|Overall Study||11
337247|NCT00585689|816427|P1|NOT COMPLETED|Overall Study||7
337248|NCT00585689|816427|P1|COMPLETED|Overall Study||22
337249|NCT00585689|816427|P1|STARTED|Overall Study||29
337250|NCT00585650|816433|P2|NOT COMPLETED|Overall Study||0
337251|NCT00585650|816434|P1|NOT COMPLETED|Overall Study||0
337252|NCT00585650|816433|P2|COMPLETED|Overall Study||12
337253|NCT00585650|816434|P1|COMPLETED|Overall Study||8
337254|NCT00585650|816433|P2|STARTED|Overall Study||12
337255|NCT00585650|816434|P1|STARTED|Overall Study||8
337256|NCT00585637|816444|P4|NOT COMPLETED|6-month Time Point||6
337257|NCT00585637|816445|P3|NOT COMPLETED|6-month Time Point||11
337258|NCT00585637|816446|P2|NOT COMPLETED|6-month Time Point||13
337259|NCT00585637|816447|P1|NOT COMPLETED|6-month Time Point||6
337260|NCT00585637|816444|P4|COMPLETED|6-month Time Point||77
337261|NCT00585637|816445|P3|COMPLETED|6-month Time Point||72
337262|NCT00585637|816446|P2|COMPLETED|6-month Time Point||68
337263|NCT00585637|816447|P1|COMPLETED|6-month Time Point||75
337264|NCT00585637|816444|P4|STARTED|6-month Time Point||83
337265|NCT00585637|816445|P3|STARTED|6-month Time Point||83
337266|NCT00585637|816446|P2|STARTED|6-month Time Point||81
337267|NCT00585637|816447|P1|STARTED|6-month Time Point||81
337268|NCT00585637|816444|P4|NOT COMPLETED|3-month Time Point||5
337269|NCT00585637|816445|P3|NOT COMPLETED|3-month Time Point||7
337270|NCT00585637|816446|P2|NOT COMPLETED|3-month Time Point||14
337271|NCT00585637|816447|P1|NOT COMPLETED|3-month Time Point||10
337272|NCT00585637|816444|P4|COMPLETED|3-month Time Point||78
337273|NCT00585637|816445|P3|COMPLETED|3-month Time Point||76
337274|NCT00585637|816446|P2|COMPLETED|3-month Time Point||67
337275|NCT00585637|816447|P1|COMPLETED|3-month Time Point||71
337276|NCT00585637|816444|P4|STARTED|3-month Time Point||83
337277|NCT00585637|816445|P3|STARTED|3-month Time Point||83
337278|NCT00585637|816446|P2|STARTED|3-month Time Point||81
337279|NCT00585637|816447|P1|STARTED|3-month Time Point||81
337280|NCT00585637|816444|P4|NOT COMPLETED|Baseline||0
337281|NCT00585637|816445|P3|NOT COMPLETED|Baseline||0
337282|NCT00585637|816446|P2|NOT COMPLETED|Baseline||0
337283|NCT00585637|816447|P1|NOT COMPLETED|Baseline||0
337284|NCT00585637|816444|P4|COMPLETED|Baseline||83
337285|NCT00585637|816445|P3|COMPLETED|Baseline||83
337286|NCT00585637|816446|P2|COMPLETED|Baseline||81
337287|NCT00585637|816447|P1|COMPLETED|Baseline||81
337288|NCT00585637|816444|P4|STARTED|Baseline||83
337289|NCT00585637|816445|P3|STARTED|Baseline||83
337290|NCT00585637|816446|P2|STARTED|Baseline||81
337291|NCT00585637|816447|P1|STARTED|Baseline||81
337292|NCT00585611|816475|P2|NOT COMPLETED|Overall Study||0
337293|NCT00585611|816476|P1|NOT COMPLETED|Overall Study||0
337294|NCT00585611|816475|P2|COMPLETED|Overall Study||0
337295|NCT00585611|816476|P1|COMPLETED|Overall Study||0
337296|NCT00585611|816475|P2|STARTED|Overall Study||0
337297|NCT00585611|816476|P1|STARTED|Overall Study||0
337298|NCT00585585|816486|P1|NOT COMPLETED|Overall Study||1
337299|NCT00585585|816486|P1|COMPLETED|Overall Study||0
337300|NCT00585585|816486|P1|Patients Receiving Drug|Overall Study||1
337301|NCT00585585|816486|P1|STARTED|Overall Study||1
337302|NCT00585546|816490|P1|NOT COMPLETED|Clenbuterol Treatment - up to 12 Months||4
337303|NCT00585546|816490|P1|COMPLETED|Clenbuterol Treatment - up to 12 Months||9
337304|NCT00585546|816490|P1|STARTED|Clenbuterol Treatment - up to 12 Months||13
337305|NCT00585546|816490|P1|NOT COMPLETED|LVAD Implantation Required for 4 Months||5
337306|NCT00585546|816490|P1|COMPLETED|LVAD Implantation Required for 4 Months||13
337307|NCT00585546|816490|P1|STARTED|LVAD Implantation Required for 4 Months||18
337308|NCT00585533|816504|P1|NOT COMPLETED|Overall Study||9
337309|NCT00585533|816504|P1|COMPLETED|Overall Study||31
337310|NCT00585533|816504|P1|STARTED|Overall Study||40
337311|NCT00585494|816509|P1|NOT COMPLETED|Overall Study||56
337312|NCT00585494|816509|P1|COMPLETED|Overall Study||244
337313|NCT00585494|816509|P1|STARTED|Overall Study||300
337314|NCT00585468|816513|P2|NOT COMPLETED|Second Intervention||0
337315|NCT00585468|816514|P1|NOT COMPLETED|Second Intervention||0
337316|NCT00585468|816513|P2|COMPLETED|Second Intervention||10
337317|NCT00585468|816514|P1|COMPLETED|Second Intervention||9
337318|NCT00585468|816513|P2|STARTED|Second Intervention||10
337319|NCT00585468|816514|P1|STARTED|Second Intervention||9
337320|NCT00585468|816513|P2|NOT COMPLETED|First Intervention||1
337321|NCT00585468|816514|P1|NOT COMPLETED|First Intervention||1
337322|NCT00585468|816513|P2|COMPLETED|First Intervention||10
337323|NCT00585468|816514|P1|COMPLETED|First Intervention||9
337324|NCT00585468|816513|P2|STARTED|First Intervention||11
337325|NCT00585468|816514|P1|STARTED|First Intervention||10
337326|NCT00585377|816534|P1|NOT COMPLETED|Overall Study||0
337327|NCT00585377|816534|P1|COMPLETED|Overall Study||50
337328|NCT00585377|816534|P1|STARTED|Overall Study||50
337329|NCT00585351|816546|P8|NOT COMPLETED|Enrollment Period (Intervention)||1
337330|NCT00585351|816547|P7|NOT COMPLETED|Enrollment Period (Intervention)||2
337331|NCT00585351|816548|P6|NOT COMPLETED|Enrollment Period (Intervention)||2
337332|NCT00585351|816549|P5|NOT COMPLETED|Enrollment Period (Intervention)||2
337333|NCT00585351|816550|P4|NOT COMPLETED|Enrollment Period (Intervention)||0
337334|NCT00585351|816551|P3|NOT COMPLETED|Enrollment Period (Intervention)||0
337335|NCT00585351|816552|P2|NOT COMPLETED|Enrollment Period (Intervention)||0
337336|NCT00585351|816553|P1|NOT COMPLETED|Enrollment Period (Intervention)||0
337337|NCT00585351|816546|P8|COMPLETED|Enrollment Period (Intervention)||2
337338|NCT00585351|816547|P7|COMPLETED|Enrollment Period (Intervention)||5
337339|NCT00585351|816548|P6|COMPLETED|Enrollment Period (Intervention)||5
337340|NCT00585351|816549|P5|COMPLETED|Enrollment Period (Intervention)||3
337341|NCT00585351|816550|P4|COMPLETED|Enrollment Period (Intervention)||15
337342|NCT00585351|816551|P3|COMPLETED|Enrollment Period (Intervention)||15
337343|NCT00585351|816552|P2|COMPLETED|Enrollment Period (Intervention)||0
337344|NCT00585351|816553|P1|COMPLETED|Enrollment Period (Intervention)||0
337345|NCT00585351|816546|P8|STARTED|Enrollment Period (Intervention)||3
337346|NCT00585351|816547|P7|STARTED|Enrollment Period (Intervention)||7
337347|NCT00585351|816548|P6|STARTED|Enrollment Period (Intervention)||7
337348|NCT00585351|816549|P5|STARTED|Enrollment Period (Intervention)||5
337349|NCT00585351|816550|P4|STARTED|Enrollment Period (Intervention)||15
337350|NCT00585351|816551|P3|STARTED|Enrollment Period (Intervention)||15
337351|NCT00585351|816552|P2|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in No Advanced Notification group for this period."|0
337352|NCT00585351|816553|P1|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in Advanced Notification group for this period."|0
337353|NCT00585351|816546|P8|NOT COMPLETED|Notification Period (Informed Consent)||0
337354|NCT00585351|816547|P7|NOT COMPLETED|Notification Period (Informed Consent)||0
337355|NCT00585351|816548|P6|NOT COMPLETED|Notification Period (Informed Consent)||0
337356|NCT00585351|816549|P5|NOT COMPLETED|Notification Period (Informed Consent)||0
337357|NCT00585351|816550|P4|NOT COMPLETED|Notification Period (Informed Consent)||0
337358|NCT00585351|816551|P3|NOT COMPLETED|Notification Period (Informed Consent)||0
337359|NCT00585351|816552|P2|NOT COMPLETED|Notification Period (Informed Consent)||25
337360|NCT00585351|816553|P1|NOT COMPLETED|Notification Period (Informed Consent)||23
337361|NCT00585351|816546|P8|COMPLETED|Notification Period (Informed Consent)||0
337362|NCT00585351|816547|P7|COMPLETED|Notification Period (Informed Consent)||0
337363|NCT00585351|816548|P6|COMPLETED|Notification Period (Informed Consent)||0
337364|NCT00585351|816549|P5|COMPLETED|Notification Period (Informed Consent)||0
337365|NCT00585351|816550|P4|COMPLETED|Notification Period (Informed Consent)||0
337366|NCT00585351|816551|P3|COMPLETED|Notification Period (Informed Consent)||0
337367|NCT00585351|816552|P2|COMPLETED|Notification Period (Informed Consent)||25
337368|NCT00585351|816553|P1|COMPLETED|Notification Period (Informed Consent)||27
337369|NCT00585351|816546|P8|STARTED|Notification Period (Informed Consent)||0
337370|NCT00585351|816547|P7|STARTED|Notification Period (Informed Consent)||0
337371|NCT00585351|816548|P6|STARTED|Notification Period (Informed Consent)||0
337372|NCT00585351|816549|P5|STARTED|Notification Period (Informed Consent)||0
337373|NCT00585351|816550|P4|STARTED|Notification Period (Informed Consent)||0
337374|NCT00585351|816551|P3|STARTED|Notification Period (Informed Consent)||0
337375|NCT00585351|816552|P2|STARTED|Notification Period (Informed Consent)||50
337376|NCT00585351|816553|P1|STARTED|Notification Period (Informed Consent)||50
337377|NCT00585325|816569|P2|NOT COMPLETED|Overall Study||1
337378|NCT00585325|816570|P1|NOT COMPLETED|Overall Study||1
337379|NCT00585325|816569|P2|COMPLETED|Overall Study||12
337380|NCT00585325|816570|P1|COMPLETED|Overall Study||9
337381|NCT00585325|816569|P2|STARTED|Overall Study||13
337382|NCT00585325|816570|P1|STARTED|Overall Study||10
337383|NCT00585312|816578|P2|NOT COMPLETED|Overall Study||44
337384|NCT00585312|816579|P1|NOT COMPLETED|Overall Study||51
337385|NCT00585312|816578|P2|COMPLETED|Overall Study||7
337386|NCT00585312|816579|P1|COMPLETED|Overall Study||4
337387|NCT00585312|816578|P2|Treated|Overall Study||48
337388|NCT00585312|816579|P1|Treated|Overall Study||53
337389|NCT00585312|816578|P2|STARTED|Overall Study|STARTED=Randomized|51
337390|NCT00585312|816579|P1|STARTED|Overall Study|STARTED=Randomized|55
337391|NCT00585286|816591|P1|NOT COMPLETED|Overall Study||1
337392|NCT00585286|816591|P1|COMPLETED|Overall Study||14
337393|NCT00585286|816591|P1|STARTED|Overall Study||15
337394|NCT00585247|816600|P2|NOT COMPLETED|Overall Study||0
337395|NCT00585247|816601|P1|NOT COMPLETED|Overall Study||0
337396|NCT00585247|816600|P2|COMPLETED|Overall Study||13
337397|NCT00585247|816601|P1|COMPLETED|Overall Study||14
337398|NCT00585247|816600|P2|STARTED|Overall Study||13
337399|NCT00585247|816601|P1|STARTED|Overall Study||14
337400|NCT00585221|816607|P1|NOT COMPLETED|Overall Study||8
337401|NCT00585221|816607|P1|COMPLETED|Overall Study||0
337402|NCT00585221|816607|P1|STARTED|Overall Study||8
337403|NCT00585182|816612|P1|NOT COMPLETED|Overall Study||0
337404|NCT00585182|816612|P1|COMPLETED|Overall Study||28
337405|NCT00585182|816612|P1|STARTED|Overall Study||28
337406|NCT00585169|816617|P1|NOT COMPLETED|Overall Study||1
337407|NCT00585169|816617|P1|COMPLETED|Overall Study||28
337408|NCT00585169|816617|P1|STARTED|Overall Study||29
337409|NCT00585104|816623|P1|NOT COMPLETED|Overall Study||4
337410|NCT00585104|816623|P1|COMPLETED|Overall Study||6
337411|NCT00585104|816623|P1|STARTED|Overall Study||10
337412|NCT00585078|816627|P1|NOT COMPLETED|Overall Study||40
337413|NCT00585078|816627|P1|COMPLETED|Overall Study||0
337414|NCT00585078|816627|P1|Response Evaluable|Overall Study||24
337415|NCT00585078|816627|P1|Toxicity Evaluable|Overall Study||36
337416|NCT00585078|816627|P1|Treated|Overall Study||37
337417|NCT00585078|816627|P1|STARTED|Overall Study||40
337418|NCT00585052|816634|P1|NOT COMPLETED|Overall Study||1
337419|NCT00585052|816634|P1|COMPLETED|Overall Study||10
337420|NCT00585052|816634|P1|STARTED|Overall Study||11
337421|NCT00585039|816641|P2|NOT COMPLETED|Overall Study||0
337422|NCT00585039|816642|P1|NOT COMPLETED|Overall Study||2
337423|NCT00585039|816641|P2|COMPLETED|Overall Study||44
337424|NCT00585039|816642|P1|COMPLETED|Overall Study||55
337425|NCT00585039|816641|P2|STARTED|Overall Study||44
337426|NCT00585039|816642|P1|STARTED|Overall Study||57
337427|NCT00585013|816652|P2|NOT COMPLETED|Overall Study||0
337428|NCT00585013|816653|P1|NOT COMPLETED|Overall Study||0
337429|NCT00585013|816652|P2|COMPLETED|Overall Study||8
337430|NCT00585013|816653|P1|COMPLETED|Overall Study||8
337431|NCT00585013|816652|P2|STARTED|Overall Study||8
337432|NCT00585013|816653|P1|STARTED|Overall Study||8
337433|NCT00584987|816671|P4|NOT COMPLETED|Overall Study||1
337434|NCT00584987|816672|P3|NOT COMPLETED|Overall Study||1
337435|NCT00584987|816673|P2|NOT COMPLETED|Overall Study||1
337436|NCT00584987|816674|P1|NOT COMPLETED|Overall Study||1
337437|NCT00584987|816671|P4|COMPLETED|Overall Study||15
337438|NCT00584987|816672|P3|COMPLETED|Overall Study||16
337439|NCT00584987|816673|P2|COMPLETED|Overall Study||15
337440|NCT00584987|816674|P1|COMPLETED|Overall Study||14
337441|NCT00584987|816671|P4|STARTED|Overall Study||16
337442|NCT00584987|816672|P3|STARTED|Overall Study||17
337443|NCT00584987|816673|P2|STARTED|Overall Study||16
337444|NCT00584987|816674|P1|STARTED|Overall Study||15
337445|NCT00584948|816706|P2|NOT COMPLETED|Overall Study||11
337446|NCT00584948|816707|P1|NOT COMPLETED|Overall Study||13
337447|NCT00584948|816706|P2|COMPLETED|Overall Study||36
337448|NCT00584948|816707|P1|COMPLETED|Overall Study||34
337449|NCT00584948|816706|P2|STARTED|Overall Study||47
337450|NCT00584948|816707|P1|STARTED|Overall Study||47
337451|NCT00584935|816715|P1|NOT COMPLETED|Overall Study||0
337452|NCT00584935|816715|P1|COMPLETED|Overall Study||3
337453|NCT00584935|816715|P1|STARTED|Overall Study||3
337454|NCT00584922|816722|P1|NOT COMPLETED|Overall Study||0
337455|NCT00584922|816722|P1|COMPLETED|Overall Study||175
337456|NCT00584922|816722|P1|STARTED|Overall Study||175
337457|NCT00584909|816726|P1|NOT COMPLETED|Overall Study||4
337458|NCT00584909|816726|P1|COMPLETED|Overall Study||9
337459|NCT00584909|816726|P1|STARTED|Overall Study||13
337460|NCT00584857|816731|P1|NOT COMPLETED|Overall Study||0
337461|NCT00584857|816731|P1|COMPLETED|Overall Study||30
337462|NCT00584857|816731|P1|STARTED|Overall Study||30
337463|NCT00584844|816736|P1|NOT COMPLETED|Overall Study||79
337464|NCT00584844|816736|P1|COMPLETED|Overall Study||405
337465|NCT00584844|816736|P1|STARTED|Overall Study||484
337466|NCT00584831|816746|P19|NOT COMPLETED|Intervention 4||0
337467|NCT00584831|816747|P18|NOT COMPLETED|Intervention 4||0
337468|NCT00584831|816748|P17|NOT COMPLETED|Intervention 4||0
337469|NCT00584831|816749|P16|NOT COMPLETED|Intervention 4||0
337470|NCT00584831|816750|P15|NOT COMPLETED|Intervention 4||0
337471|NCT00584831|816751|P14|NOT COMPLETED|Intervention 4||0
337472|NCT00584831|816752|P13|NOT COMPLETED|Intervention 4||0
337473|NCT00584831|816753|P12|NOT COMPLETED|Intervention 4||0
337474|NCT00584831|816754|P11|NOT COMPLETED|Intervention 4||0
337475|NCT00584831|816755|P10|NOT COMPLETED|Intervention 4||0
337476|NCT00584831|816756|P9|NOT COMPLETED|Intervention 4||0
337477|NCT00584831|816757|P8|NOT COMPLETED|Intervention 4||0
337478|NCT00584831|816758|P7|NOT COMPLETED|Intervention 4||0
337479|NCT00584831|816759|P6|NOT COMPLETED|Intervention 4||0
337480|NCT00584831|816760|P5|NOT COMPLETED|Intervention 4||0
337481|NCT00584831|816761|P4|NOT COMPLETED|Intervention 4||0
337482|NCT00584831|816762|P3|NOT COMPLETED|Intervention 4||0
337483|NCT00584831|816763|P2|NOT COMPLETED|Intervention 4||0
337484|NCT00584831|816764|P1|NOT COMPLETED|Intervention 4||0
337485|NCT00584831|816746|P19|COMPLETED|Intervention 4||1
337486|NCT00584831|816747|P18|COMPLETED|Intervention 4||1
337487|NCT00584831|816748|P17|COMPLETED|Intervention 4||4
337488|NCT00584831|816749|P16|COMPLETED|Intervention 4||1
337489|NCT00584831|816750|P15|COMPLETED|Intervention 4||2
337490|NCT00584831|816751|P14|COMPLETED|Intervention 4||1
337491|NCT00584831|816752|P13|COMPLETED|Intervention 4||2
337492|NCT00584831|816753|P12|COMPLETED|Intervention 4||1
337493|NCT00584831|816754|P11|COMPLETED|Intervention 4||2
337494|NCT00584831|816755|P10|COMPLETED|Intervention 4||2
337495|NCT00584831|816756|P9|COMPLETED|Intervention 4||3
337496|NCT00584831|816757|P8|COMPLETED|Intervention 4||2
337497|NCT00584831|816758|P7|COMPLETED|Intervention 4||6
337498|NCT00584831|816759|P6|COMPLETED|Intervention 4||1
337499|NCT00584831|816760|P5|COMPLETED|Intervention 4||2
337500|NCT00584831|816761|P4|COMPLETED|Intervention 4||1
337501|NCT00584831|816762|P3|COMPLETED|Intervention 4||2
337502|NCT00584831|816763|P2|COMPLETED|Intervention 4||3
337503|NCT00584831|816764|P1|COMPLETED|Intervention 4||1
337504|NCT00584831|816746|P19|STARTED|Intervention 4||1
337505|NCT00584831|816747|P18|STARTED|Intervention 4||1
337506|NCT00584831|816748|P17|STARTED|Intervention 4||4
337507|NCT00584831|816749|P16|STARTED|Intervention 4||1
337508|NCT00584831|816750|P15|STARTED|Intervention 4||2
337509|NCT00584831|816751|P14|STARTED|Intervention 4||1
337510|NCT00584831|816752|P13|STARTED|Intervention 4||2
337511|NCT00584831|816753|P12|STARTED|Intervention 4||1
337512|NCT00584831|816754|P11|STARTED|Intervention 4||2
337513|NCT00584831|816755|P10|STARTED|Intervention 4||2
337514|NCT00584831|816756|P9|STARTED|Intervention 4||3
337515|NCT00584831|816757|P8|STARTED|Intervention 4||2
337516|NCT00584831|816758|P7|STARTED|Intervention 4||6
337517|NCT00584831|816759|P6|STARTED|Intervention 4||1
337518|NCT00584831|816760|P5|STARTED|Intervention 4||2
337519|NCT00584831|816761|P4|STARTED|Intervention 4||1
337520|NCT00584831|816762|P3|STARTED|Intervention 4||2
337521|NCT00584831|816763|P2|STARTED|Intervention 4||3
337522|NCT00584831|816764|P1|STARTED|Intervention 4||1
337523|NCT00584831|816746|P19|NOT COMPLETED|Intervention 3||0
337524|NCT00584831|816747|P18|NOT COMPLETED|Intervention 3||0
337525|NCT00584831|816748|P17|NOT COMPLETED|Intervention 3||0
337526|NCT00584831|816749|P16|NOT COMPLETED|Intervention 3||0
337527|NCT00584831|816750|P15|NOT COMPLETED|Intervention 3||0
337528|NCT00584831|816751|P14|NOT COMPLETED|Intervention 3||0
337529|NCT00584831|816752|P13|NOT COMPLETED|Intervention 3||0
337530|NCT00584831|816753|P12|NOT COMPLETED|Intervention 3||0
337531|NCT00584831|816754|P11|NOT COMPLETED|Intervention 3||0
337532|NCT00584831|816755|P10|NOT COMPLETED|Intervention 3||0
337533|NCT00584831|816756|P9|NOT COMPLETED|Intervention 3||0
337534|NCT00584831|816757|P8|NOT COMPLETED|Intervention 3||0
337535|NCT00584831|816758|P7|NOT COMPLETED|Intervention 3||0
337536|NCT00584831|816759|P6|NOT COMPLETED|Intervention 3||0
337537|NCT00584831|816760|P5|NOT COMPLETED|Intervention 3||0
337538|NCT00584831|816761|P4|NOT COMPLETED|Intervention 3||0
337539|NCT00584831|816762|P3|NOT COMPLETED|Intervention 3||0
337540|NCT00584831|816763|P2|NOT COMPLETED|Intervention 3||0
337541|NCT00584831|816764|P1|NOT COMPLETED|Intervention 3||0
337542|NCT00584831|816746|P19|COMPLETED|Intervention 3||1
337543|NCT00584831|816747|P18|COMPLETED|Intervention 3||1
337544|NCT00584831|816748|P17|COMPLETED|Intervention 3||4
337545|NCT00584831|816749|P16|COMPLETED|Intervention 3||1
337546|NCT00584831|816750|P15|COMPLETED|Intervention 3||3
337547|NCT00584831|816751|P14|COMPLETED|Intervention 3||1
337548|NCT00584831|816752|P13|COMPLETED|Intervention 3||2
337549|NCT00584831|816753|P12|COMPLETED|Intervention 3||1
337550|NCT00584831|816754|P11|COMPLETED|Intervention 3||2
337551|NCT00584831|816755|P10|COMPLETED|Intervention 3||2
337552|NCT00584831|816756|P9|COMPLETED|Intervention 3||4
337553|NCT00584831|816757|P8|COMPLETED|Intervention 3||2
337554|NCT00584831|816758|P7|COMPLETED|Intervention 3||6
337555|NCT00584831|816759|P6|COMPLETED|Intervention 3||1
337556|NCT00584831|816760|P5|COMPLETED|Intervention 3||2
337557|NCT00584831|816761|P4|COMPLETED|Intervention 3||1
337558|NCT00584831|816762|P3|COMPLETED|Intervention 3||2
337559|NCT00584831|816763|P2|COMPLETED|Intervention 3||3
337560|NCT00584831|816764|P1|COMPLETED|Intervention 3||1
337561|NCT00584831|816746|P19|STARTED|Intervention 3||1
337562|NCT00584831|816747|P18|STARTED|Intervention 3||1
337563|NCT00584831|816748|P17|STARTED|Intervention 3||4
337564|NCT00584831|816749|P16|STARTED|Intervention 3||1
337565|NCT00584831|816750|P15|STARTED|Intervention 3||3
337566|NCT00584831|816751|P14|STARTED|Intervention 3||1
337567|NCT00584831|816752|P13|STARTED|Intervention 3||2
337568|NCT00584831|816753|P12|STARTED|Intervention 3||1
337569|NCT00584831|816754|P11|STARTED|Intervention 3||2
337570|NCT00584831|816755|P10|STARTED|Intervention 3||2
337571|NCT00584831|816756|P9|STARTED|Intervention 3||4
337572|NCT00584831|816757|P8|STARTED|Intervention 3||2
337573|NCT00584831|816758|P7|STARTED|Intervention 3||6
337574|NCT00584831|816759|P6|STARTED|Intervention 3||1
337575|NCT00584831|816760|P5|STARTED|Intervention 3||2
337576|NCT00584831|816761|P4|STARTED|Intervention 3||1
337577|NCT00584831|816762|P3|STARTED|Intervention 3||2
337578|NCT00584831|816763|P2|STARTED|Intervention 3||3
337579|NCT00584831|816764|P1|STARTED|Intervention 3||1
337580|NCT00584831|816746|P19|NOT COMPLETED|Intervention 2||0
337581|NCT00584831|816747|P18|NOT COMPLETED|Intervention 2||0
337582|NCT00584831|816748|P17|NOT COMPLETED|Intervention 2||0
337583|NCT00584831|816749|P16|NOT COMPLETED|Intervention 2||0
337584|NCT00584831|816750|P15|NOT COMPLETED|Intervention 2||0
337585|NCT00584831|816751|P14|NOT COMPLETED|Intervention 2||0
337586|NCT00584831|816752|P13|NOT COMPLETED|Intervention 2||0
337587|NCT00584831|816753|P12|NOT COMPLETED|Intervention 2||0
337588|NCT00584831|816754|P11|NOT COMPLETED|Intervention 2||0
337589|NCT00584831|816755|P10|NOT COMPLETED|Intervention 2||0
337590|NCT00584831|816756|P9|NOT COMPLETED|Intervention 2||0
337591|NCT00584831|816757|P8|NOT COMPLETED|Intervention 2||0
337592|NCT00584831|816758|P7|NOT COMPLETED|Intervention 2||0
337593|NCT00584831|816759|P6|NOT COMPLETED|Intervention 2||0
337594|NCT00584831|816760|P5|NOT COMPLETED|Intervention 2||0
337595|NCT00584831|816761|P4|NOT COMPLETED|Intervention 2||0
337596|NCT00584831|816762|P3|NOT COMPLETED|Intervention 2||0
337597|NCT00584831|816763|P2|NOT COMPLETED|Intervention 2||0
337598|NCT00584831|816764|P1|NOT COMPLETED|Intervention 2||0
337599|NCT00584831|816746|P19|COMPLETED|Intervention 2||1
337600|NCT00584831|816747|P18|COMPLETED|Intervention 2||1
337601|NCT00584831|816748|P17|COMPLETED|Intervention 2||4
337602|NCT00584831|816749|P16|COMPLETED|Intervention 2||1
337603|NCT00584831|816750|P15|COMPLETED|Intervention 2||3
337604|NCT00584831|816751|P14|COMPLETED|Intervention 2||1
337605|NCT00584831|816752|P13|COMPLETED|Intervention 2||2
337606|NCT00584831|816753|P12|COMPLETED|Intervention 2||1
337607|NCT00584831|816754|P11|COMPLETED|Intervention 2||2
337608|NCT00584831|816755|P10|COMPLETED|Intervention 2||2
337609|NCT00584831|816756|P9|COMPLETED|Intervention 2||4
337610|NCT00584831|816757|P8|COMPLETED|Intervention 2||2
337611|NCT00584831|816758|P7|COMPLETED|Intervention 2||6
337612|NCT00584831|816759|P6|COMPLETED|Intervention 2||1
337613|NCT00584831|816760|P5|COMPLETED|Intervention 2||2
337614|NCT00584831|816761|P4|COMPLETED|Intervention 2||1
337615|NCT00584831|816762|P3|COMPLETED|Intervention 2||2
337616|NCT00584831|816763|P2|COMPLETED|Intervention 2||3
337617|NCT00584831|816764|P1|COMPLETED|Intervention 2||1
337618|NCT00584831|816746|P19|STARTED|Intervention 2||1
337619|NCT00584831|816747|P18|STARTED|Intervention 2||1
337620|NCT00584831|816748|P17|STARTED|Intervention 2||4
337621|NCT00584831|816749|P16|STARTED|Intervention 2||1
337622|NCT00584831|816750|P15|STARTED|Intervention 2||3
337623|NCT00584831|816751|P14|STARTED|Intervention 2||1
337624|NCT00584831|816752|P13|STARTED|Intervention 2||2
337625|NCT00584831|816753|P12|STARTED|Intervention 2||1
337626|NCT00584831|816754|P11|STARTED|Intervention 2||2
337627|NCT00584831|816755|P10|STARTED|Intervention 2||2
337628|NCT00584831|816756|P9|STARTED|Intervention 2||4
337629|NCT00584831|816757|P8|STARTED|Intervention 2||2
337630|NCT00584831|816758|P7|STARTED|Intervention 2||6
337631|NCT00584831|816759|P6|STARTED|Intervention 2||1
337632|NCT00584831|816760|P5|STARTED|Intervention 2||2
337633|NCT00584831|816761|P4|STARTED|Intervention 2||1
337634|NCT00584831|816762|P3|STARTED|Intervention 2||2
337635|NCT00584831|816763|P2|STARTED|Intervention 2||3
337636|NCT00584831|816764|P1|STARTED|Intervention 2||1
337637|NCT00584831|816746|P19|NOT COMPLETED|Intervention 1||0
337638|NCT00584831|816747|P18|NOT COMPLETED|Intervention 1||0
337639|NCT00584831|816748|P17|NOT COMPLETED|Intervention 1||0
337640|NCT00584831|816749|P16|NOT COMPLETED|Intervention 1||0
337641|NCT00584831|816750|P15|NOT COMPLETED|Intervention 1||0
337642|NCT00584831|816751|P14|NOT COMPLETED|Intervention 1||0
337643|NCT00584831|816752|P13|NOT COMPLETED|Intervention 1||0
337644|NCT00584831|816753|P12|NOT COMPLETED|Intervention 1||0
337645|NCT00584831|816754|P11|NOT COMPLETED|Intervention 1||0
337646|NCT00584831|816755|P10|NOT COMPLETED|Intervention 1||0
337647|NCT00584831|816756|P9|NOT COMPLETED|Intervention 1||0
337648|NCT00584831|816757|P8|NOT COMPLETED|Intervention 1||0
337649|NCT00584831|816758|P7|NOT COMPLETED|Intervention 1||0
337650|NCT00584831|816759|P6|NOT COMPLETED|Intervention 1||0
337651|NCT00584831|816760|P5|NOT COMPLETED|Intervention 1||0
337652|NCT00584831|816761|P4|NOT COMPLETED|Intervention 1||0
337653|NCT00584831|816762|P3|NOT COMPLETED|Intervention 1||0
337654|NCT00584831|816763|P2|NOT COMPLETED|Intervention 1||0
337655|NCT00584831|816764|P1|NOT COMPLETED|Intervention 1||0
337656|NCT00584831|816746|P19|COMPLETED|Intervention 1||1
337657|NCT00584831|816747|P18|COMPLETED|Intervention 1||1
337658|NCT00584831|816748|P17|COMPLETED|Intervention 1||4
337659|NCT00584831|816749|P16|COMPLETED|Intervention 1||1
337660|NCT00584831|816750|P15|COMPLETED|Intervention 1||3
337661|NCT00584831|816751|P14|COMPLETED|Intervention 1||1
337662|NCT00584831|816752|P13|COMPLETED|Intervention 1||2
337663|NCT00584831|816753|P12|COMPLETED|Intervention 1||1
337664|NCT00584831|816754|P11|COMPLETED|Intervention 1||2
337665|NCT00584831|816755|P10|COMPLETED|Intervention 1||2
337666|NCT00584831|816756|P9|COMPLETED|Intervention 1||4
337667|NCT00584831|816757|P8|COMPLETED|Intervention 1||2
337668|NCT00584831|816758|P7|COMPLETED|Intervention 1||6
337669|NCT00584831|816759|P6|COMPLETED|Intervention 1||1
337670|NCT00584831|816760|P5|COMPLETED|Intervention 1||2
337671|NCT00584831|816761|P4|COMPLETED|Intervention 1||1
337672|NCT00584831|816762|P3|COMPLETED|Intervention 1||2
337673|NCT00584831|816763|P2|COMPLETED|Intervention 1||3
337674|NCT00584831|816764|P1|COMPLETED|Intervention 1||1
337675|NCT00584831|816746|P19|STARTED|Intervention 1||1
337676|NCT00584831|816747|P18|STARTED|Intervention 1||1
337677|NCT00584831|816748|P17|STARTED|Intervention 1||4
337678|NCT00584831|816749|P16|STARTED|Intervention 1||1
337679|NCT00584831|816750|P15|STARTED|Intervention 1||3
337680|NCT00584831|816751|P14|STARTED|Intervention 1||1
337681|NCT00584831|816752|P13|STARTED|Intervention 1||2
337682|NCT00584831|816753|P12|STARTED|Intervention 1||1
337683|NCT00584831|816754|P11|STARTED|Intervention 1||2
337684|NCT00584831|816755|P10|STARTED|Intervention 1||2
337685|NCT00584831|816756|P9|STARTED|Intervention 1||4
337686|NCT00584831|816757|P8|STARTED|Intervention 1||2
337687|NCT00584831|816758|P7|STARTED|Intervention 1||6
337688|NCT00584831|816759|P6|STARTED|Intervention 1||1
337689|NCT00584831|816760|P5|STARTED|Intervention 1||2
337690|NCT00584831|816761|P4|STARTED|Intervention 1||1
337691|NCT00584831|816762|P3|STARTED|Intervention 1||2
337692|NCT00584831|816763|P2|STARTED|Intervention 1||3
337693|NCT00584831|816764|P1|STARTED|Intervention 1||1
337694|NCT00584805|816786|P1|NOT COMPLETED|Overall Study||99
337695|NCT00584805|816786|P1|COMPLETED|Overall Study||39
337696|NCT00584805|816786|P1|STARTED|Overall Study||138
337697|NCT00584740|816799|P2|NOT COMPLETED|Overall Study||6
337698|NCT00584740|816800|P1|NOT COMPLETED|Overall Study||12
337699|NCT00584740|816799|P2|COMPLETED|Overall Study||14
337700|NCT00584740|816800|P1|COMPLETED|Overall Study||27
337701|NCT00584740|816799|P2|STARTED|Overall Study||20
337702|NCT00584740|816800|P1|STARTED|Overall Study||39
337703|NCT00584727|816818|P6|NOT COMPLETED|Third Intervention||2
337704|NCT00584727|816819|P5|NOT COMPLETED|Third Intervention||4
337705|NCT00584727|816820|P4|NOT COMPLETED|Third Intervention||0
337706|NCT00584727|816821|P3|NOT COMPLETED|Third Intervention||1
337707|NCT00584727|816822|P2|NOT COMPLETED|Third Intervention||0
337708|NCT00584727|816823|P1|NOT COMPLETED|Third Intervention||0
337709|NCT00584727|816818|P6|COMPLETED|Third Intervention||14
337710|NCT00584727|816819|P5|COMPLETED|Third Intervention||12
337711|NCT00584727|816820|P4|COMPLETED|Third Intervention||14
337712|NCT00584727|816821|P3|COMPLETED|Third Intervention||14
337713|NCT00584727|816822|P2|COMPLETED|Third Intervention||17
337714|NCT00584727|816823|P1|COMPLETED|Third Intervention||17
337715|NCT00584727|816818|P6|STARTED|Third Intervention||16
337716|NCT00584727|816819|P5|STARTED|Third Intervention||16
337717|NCT00584727|816820|P4|STARTED|Third Intervention||14
337718|NCT00584727|816821|P3|STARTED|Third Intervention||15
337719|NCT00584727|816822|P2|STARTED|Third Intervention||17
337720|NCT00584727|816823|P1|STARTED|Third Intervention||17
337721|NCT00584727|816818|P6|NOT COMPLETED|Second Intervention||0
337722|NCT00584727|816819|P5|NOT COMPLETED|Second Intervention||0
337723|NCT00584727|816820|P4|NOT COMPLETED|Second Intervention||0
337724|NCT00584727|816821|P3|NOT COMPLETED|Second Intervention||0
337725|NCT00584727|816822|P2|NOT COMPLETED|Second Intervention||0
337726|NCT00584727|816823|P1|NOT COMPLETED|Second Intervention||0
337727|NCT00584727|816818|P6|COMPLETED|Second Intervention||16
337728|NCT00584727|816819|P5|COMPLETED|Second Intervention||16
337729|NCT00584727|816820|P4|COMPLETED|Second Intervention||14
337730|NCT00584727|816821|P3|COMPLETED|Second Intervention||15
337731|NCT00584727|816822|P2|COMPLETED|Second Intervention||17
337732|NCT00584727|816823|P1|COMPLETED|Second Intervention||17
337733|NCT00584727|816818|P6|STARTED|Second Intervention||16
337734|NCT00584727|816819|P5|STARTED|Second Intervention||16
337735|NCT00584727|816820|P4|STARTED|Second Intervention||14
337736|NCT00584727|816821|P3|STARTED|Second Intervention||15
337737|NCT00584727|816822|P2|STARTED|Second Intervention||17
337738|NCT00584727|816823|P1|STARTED|Second Intervention||17
337739|NCT00584727|816818|P6|NOT COMPLETED|First Intervention||0
337740|NCT00584727|816819|P5|NOT COMPLETED|First Intervention||0
337741|NCT00584727|816820|P4|NOT COMPLETED|First Intervention||0
337742|NCT00584727|816821|P3|NOT COMPLETED|First Intervention||1
337743|NCT00584727|816822|P2|NOT COMPLETED|First Intervention||0
337744|NCT00584727|816823|P1|NOT COMPLETED|First Intervention||0
337745|NCT00584727|816818|P6|COMPLETED|First Intervention||16
337746|NCT00584727|816819|P5|COMPLETED|First Intervention||16
337747|NCT00584727|816820|P4|COMPLETED|First Intervention||14
337748|NCT00584727|816821|P3|COMPLETED|First Intervention||15
337749|NCT00584727|816822|P2|COMPLETED|First Intervention||17
337750|NCT00584727|816823|P1|COMPLETED|First Intervention||17
337751|NCT00584727|816818|P6|STARTED|First Intervention||16
337752|NCT00584727|816819|P5|STARTED|First Intervention||16
337753|NCT00584727|816820|P4|STARTED|First Intervention||14
337754|NCT00584727|816821|P3|STARTED|First Intervention||16
337755|NCT00584727|816822|P2|STARTED|First Intervention||17
337756|NCT00584727|816823|P1|STARTED|First Intervention||17
337757|NCT00584701|816847|P1|NOT COMPLETED|Follow-up||12
337758|NCT00584701|816847|P1|COMPLETED|Follow-up||34
337759|NCT00584701|816847|P1|STARTED|Follow-up||46
337760|NCT00584701|816847|P1|NOT COMPLETED|Active Risperidone||3
337761|NCT00584701|816847|P1|COMPLETED|Active Risperidone||46
337762|NCT00584701|816847|P1|STARTED|Active Risperidone||49
337763|NCT00584558|816852|P1|NOT COMPLETED|Overall Study||0
337764|NCT00584558|816852|P1|COMPLETED|Overall Study||2420
337765|NCT00584558|816852|P1|STARTED|Overall Study||2420
337766|NCT00584480|816857|P1|NOT COMPLETED|Second 8 Weeks (40 Treatments)||0
337767|NCT00584480|816857|P1|COMPLETED|Second 8 Weeks (40 Treatments)||10
337768|NCT00584480|816857|P1|STARTED|Second 8 Weeks (40 Treatments)||10
337769|NCT00584480|816857|P1|NOT COMPLETED|4-Week Break From Treatment||0
337770|NCT00584480|816857|P1|COMPLETED|4-Week Break From Treatment||10
337771|NCT00584480|816857|P1|STARTED|4-Week Break From Treatment||10
337772|NCT00584480|816857|P1|NOT COMPLETED|First 8 Weeks (40 Treatments)||0
337773|NCT00584480|816857|P1|COMPLETED|First 8 Weeks (40 Treatments)||10
337774|NCT00584480|816857|P1|STARTED|First 8 Weeks (40 Treatments)||10
337775|NCT00584454|816861|P1|NOT COMPLETED|Overall Study||4
337776|NCT00584454|816861|P1|COMPLETED|Overall Study||6
337777|NCT00584454|816861|P1|STARTED|Overall Study||10
337778|NCT00584415|816865|P1|NOT COMPLETED|Overall Study||7
337779|NCT00584415|816865|P1|COMPLETED|Overall Study||112
337780|NCT00584415|816865|P1|STARTED|Overall Study|A total of 119 enrolled and 112 underwent the ablation procedure;|119
337781|NCT00584402|816870|P1|NOT COMPLETED|Overall Study||0
337782|NCT00584402|816870|P1|COMPLETED|Overall Study||8
337783|NCT00584402|816870|P1|STARTED|Overall Study||8
337784|NCT00584285|816875|P1|NOT COMPLETED|Overall Study||0
337785|NCT00584285|816875|P1|COMPLETED|Overall Study||18
337786|NCT00584285|816875|P1|STARTED|Overall Study||18
337787|NCT00584220|816879|P2|NOT COMPLETED|Second Period||0
337788|NCT00584220|816880|P1|NOT COMPLETED|Second Period||0
337789|NCT00584220|816879|P2|COMPLETED|Second Period||39
337790|NCT00584220|816880|P1|COMPLETED|Second Period||48
337791|NCT00584220|816879|P2|STARTED|Second Period||39
337792|NCT00584220|816880|P1|STARTED|Second Period||48
337793|NCT00584220|816879|P2|NOT COMPLETED|First Period||0
337794|NCT00584220|816880|P1|NOT COMPLETED|First Period||0
337795|NCT00584220|816879|P2|COMPLETED|First Period||39
337796|NCT00584220|816880|P1|COMPLETED|First Period||48
337797|NCT00584220|816879|P2|STARTED|First Period||39
337798|NCT00584220|816880|P1|STARTED|First Period||48
337799|NCT00584194|816888|P1|NOT COMPLETED|Overall Study||135
337800|NCT00584194|816888|P1|COMPLETED|Overall Study||143
337801|NCT00584194|816888|P1|STARTED|Overall Study||278
337802|NCT00584077|816896|P1|NOT COMPLETED|Overall Study||0
337803|NCT00584077|816896|P1|COMPLETED|Overall Study||15
337804|NCT00584077|816896|P1|STARTED|Overall Study||15
337805|NCT00584012|816901|P1|NOT COMPLETED|Overall Study||1
337806|NCT00584012|816901|P1|COMPLETED|Overall Study||8
337807|NCT00584012|816901|P1|STARTED|Overall Study||9
337808|NCT00583947|816907|P2|NOT COMPLETED|Open Label Period||0
337809|NCT00583947|816908|P1|NOT COMPLETED|Open Label Period||0
337810|NCT00583947|816907|P2|COMPLETED|Open Label Period||24
337811|NCT00583947|816908|P1|COMPLETED|Open Label Period||22
337812|NCT00583947|816907|P2|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|24
337813|NCT00583947|816908|P1|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|22
337814|NCT00583947|816907|P2|NOT COMPLETED|Washout||0
337815|NCT00583947|816908|P1|NOT COMPLETED|Washout||0
337816|NCT00583947|816907|P2|COMPLETED|Washout||24
337817|NCT00583947|816908|P1|COMPLETED|Washout||22
337818|NCT00583947|816907|P2|STARTED|Washout||24
337819|NCT00583947|816908|P1|STARTED|Washout||22
337820|NCT00583947|816907|P2|NOT COMPLETED|Cross-over Period||2
337821|NCT00583947|816908|P1|NOT COMPLETED|Cross-over Period||5
337822|NCT00583947|816907|P2|COMPLETED|Cross-over Period||24
337823|NCT00583947|816908|P1|COMPLETED|Cross-over Period||22
337824|NCT00583947|816907|P2|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|26
337825|NCT00583947|816908|P1|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|27
337826|NCT00583908|816958|P12|NOT COMPLETED|Period 4 - Fourth Intervention||0
337827|NCT00583908|816959|P11|NOT COMPLETED|Period 4 - Fourth Intervention||0
337828|NCT00583908|816960|P10|NOT COMPLETED|Period 4 - Fourth Intervention||0
337829|NCT00583908|816961|P9|NOT COMPLETED|Period 4 - Fourth Intervention||0
337830|NCT00583908|816962|P8|NOT COMPLETED|Period 4 - Fourth Intervention||0
337831|NCT00583908|816963|P7|NOT COMPLETED|Period 4 - Fourth Intervention||0
337832|NCT00583908|816964|P6|NOT COMPLETED|Period 4 - Fourth Intervention||0
337833|NCT00583908|816965|P5|NOT COMPLETED|Period 4 - Fourth Intervention||0
337834|NCT00583908|816966|P4|NOT COMPLETED|Period 4 - Fourth Intervention||0
337835|NCT00583908|816967|P3|NOT COMPLETED|Period 4 - Fourth Intervention||0
337836|NCT00583908|816968|P2|NOT COMPLETED|Period 4 - Fourth Intervention||0
337837|NCT00583908|816969|P1|NOT COMPLETED|Period 4 - Fourth Intervention||0
337838|NCT00583908|816958|P12|COMPLETED|Period 4 - Fourth Intervention||1
337839|NCT00583908|816959|P11|COMPLETED|Period 4 - Fourth Intervention||1
337840|NCT00583908|816960|P10|COMPLETED|Period 4 - Fourth Intervention||1
337841|NCT00583908|816961|P9|COMPLETED|Period 4 - Fourth Intervention||1
337842|NCT00583908|816962|P8|COMPLETED|Period 4 - Fourth Intervention||1
337843|NCT00583908|816963|P7|COMPLETED|Period 4 - Fourth Intervention||1
337844|NCT00583908|816964|P6|COMPLETED|Period 4 - Fourth Intervention||1
337845|NCT00583908|816965|P5|COMPLETED|Period 4 - Fourth Intervention||2
337846|NCT00583908|816966|P4|COMPLETED|Period 4 - Fourth Intervention||1
337847|NCT00583908|816967|P3|COMPLETED|Period 4 - Fourth Intervention||1
337848|NCT00583908|816968|P2|COMPLETED|Period 4 - Fourth Intervention||2
337849|NCT00583908|816969|P1|COMPLETED|Period 4 - Fourth Intervention||1
337850|NCT00583908|816958|P12|STARTED|Period 4 - Fourth Intervention||1
337851|NCT00583908|816959|P11|STARTED|Period 4 - Fourth Intervention||1
337852|NCT00583908|816960|P10|STARTED|Period 4 - Fourth Intervention||1
337853|NCT00583908|816961|P9|STARTED|Period 4 - Fourth Intervention||1
337854|NCT00583908|816962|P8|STARTED|Period 4 - Fourth Intervention||1
337855|NCT00583908|816963|P7|STARTED|Period 4 - Fourth Intervention||1
337856|NCT00583908|816964|P6|STARTED|Period 4 - Fourth Intervention||1
337857|NCT00583908|816965|P5|STARTED|Period 4 - Fourth Intervention||2
337858|NCT00583908|816966|P4|STARTED|Period 4 - Fourth Intervention||1
337859|NCT00583908|816967|P3|STARTED|Period 4 - Fourth Intervention||1
337860|NCT00583908|816968|P2|STARTED|Period 4 - Fourth Intervention||2
337861|NCT00583908|816969|P1|STARTED|Period 4 - Fourth Intervention||1
337862|NCT00583908|816958|P12|NOT COMPLETED|Period 3 - Third Intervention||0
337863|NCT00583908|816959|P11|NOT COMPLETED|Period 3 - Third Intervention||0
337864|NCT00583908|816960|P10|NOT COMPLETED|Period 3 - Third Intervention||0
337865|NCT00583908|816961|P9|NOT COMPLETED|Period 3 - Third Intervention||0
337866|NCT00583908|816962|P8|NOT COMPLETED|Period 3 - Third Intervention||0
337867|NCT00583908|816963|P7|NOT COMPLETED|Period 3 - Third Intervention||0
337868|NCT00583908|816964|P6|NOT COMPLETED|Period 3 - Third Intervention||0
337869|NCT00583908|816965|P5|NOT COMPLETED|Period 3 - Third Intervention||0
337870|NCT00583908|816966|P4|NOT COMPLETED|Period 3 - Third Intervention||0
337871|NCT00583908|816967|P3|NOT COMPLETED|Period 3 - Third Intervention||0
337872|NCT00583908|816968|P2|NOT COMPLETED|Period 3 - Third Intervention||0
337873|NCT00583908|816969|P1|NOT COMPLETED|Period 3 - Third Intervention||0
337874|NCT00583908|816958|P12|COMPLETED|Period 3 - Third Intervention||1
337875|NCT00583908|816959|P11|COMPLETED|Period 3 - Third Intervention||1
337876|NCT00583908|816960|P10|COMPLETED|Period 3 - Third Intervention||1
337877|NCT00583908|816961|P9|COMPLETED|Period 3 - Third Intervention||1
337878|NCT00583908|816962|P8|COMPLETED|Period 3 - Third Intervention||1
337879|NCT00583908|816963|P7|COMPLETED|Period 3 - Third Intervention||1
337880|NCT00583908|816964|P6|COMPLETED|Period 3 - Third Intervention||1
337881|NCT00583908|816965|P5|COMPLETED|Period 3 - Third Intervention||2
337882|NCT00583908|816966|P4|COMPLETED|Period 3 - Third Intervention||1
337883|NCT00583908|816967|P3|COMPLETED|Period 3 - Third Intervention||1
337884|NCT00583908|816968|P2|COMPLETED|Period 3 - Third Intervention||2
337885|NCT00583908|816969|P1|COMPLETED|Period 3 - Third Intervention||1
337886|NCT00583908|816958|P12|STARTED|Period 3 - Third Intervention||1
337887|NCT00583908|816959|P11|STARTED|Period 3 - Third Intervention||1
337888|NCT00583908|816960|P10|STARTED|Period 3 - Third Intervention||1
337889|NCT00583908|816961|P9|STARTED|Period 3 - Third Intervention||1
337890|NCT00583908|816962|P8|STARTED|Period 3 - Third Intervention||1
337891|NCT00583908|816963|P7|STARTED|Period 3 - Third Intervention||1
337892|NCT00583908|816964|P6|STARTED|Period 3 - Third Intervention||1
337893|NCT00583908|816965|P5|STARTED|Period 3 - Third Intervention||2
337894|NCT00583908|816966|P4|STARTED|Period 3 - Third Intervention||1
337895|NCT00583908|816967|P3|STARTED|Period 3 - Third Intervention||1
337896|NCT00583908|816968|P2|STARTED|Period 3 - Third Intervention||2
337897|NCT00583908|816969|P1|STARTED|Period 3 - Third Intervention||1
337898|NCT00583908|816958|P12|NOT COMPLETED|Period 2 - Second Intervention||0
337899|NCT00583908|816959|P11|NOT COMPLETED|Period 2 - Second Intervention||0
337900|NCT00583908|816960|P10|NOT COMPLETED|Period 2 - Second Intervention||0
337901|NCT00583908|816961|P9|NOT COMPLETED|Period 2 - Second Intervention||0
337902|NCT00583908|816962|P8|NOT COMPLETED|Period 2 - Second Intervention||0
337903|NCT00583908|816963|P7|NOT COMPLETED|Period 2 - Second Intervention||0
337904|NCT00583908|816964|P6|NOT COMPLETED|Period 2 - Second Intervention||0
337905|NCT00583908|816965|P5|NOT COMPLETED|Period 2 - Second Intervention||0
337906|NCT00583908|816966|P4|NOT COMPLETED|Period 2 - Second Intervention||0
337907|NCT00583908|816967|P3|NOT COMPLETED|Period 2 - Second Intervention||0
337908|NCT00583908|816968|P2|NOT COMPLETED|Period 2 - Second Intervention||0
337909|NCT00583908|816969|P1|NOT COMPLETED|Period 2 - Second Intervention||0
337910|NCT00583908|816958|P12|COMPLETED|Period 2 - Second Intervention||1
337911|NCT00583908|816959|P11|COMPLETED|Period 2 - Second Intervention||1
337912|NCT00583908|816960|P10|COMPLETED|Period 2 - Second Intervention||1
337913|NCT00583908|816961|P9|COMPLETED|Period 2 - Second Intervention||1
337914|NCT00583908|816962|P8|COMPLETED|Period 2 - Second Intervention||1
337915|NCT00583908|816963|P7|COMPLETED|Period 2 - Second Intervention||1
337916|NCT00583908|816964|P6|COMPLETED|Period 2 - Second Intervention||1
337917|NCT00583908|816965|P5|COMPLETED|Period 2 - Second Intervention||2
337918|NCT00583908|816966|P4|COMPLETED|Period 2 - Second Intervention||1
337919|NCT00583908|816967|P3|COMPLETED|Period 2 - Second Intervention||1
337920|NCT00583908|816968|P2|COMPLETED|Period 2 - Second Intervention||2
337921|NCT00583908|816969|P1|COMPLETED|Period 2 - Second Intervention||1
337922|NCT00583908|816958|P12|STARTED|Period 2 - Second Intervention||1
337923|NCT00583908|816959|P11|STARTED|Period 2 - Second Intervention||1
337924|NCT00583908|816960|P10|STARTED|Period 2 - Second Intervention||1
337925|NCT00583908|816961|P9|STARTED|Period 2 - Second Intervention||1
337926|NCT00583908|816962|P8|STARTED|Period 2 - Second Intervention||1
337927|NCT00583908|816963|P7|STARTED|Period 2 - Second Intervention||1
337928|NCT00583908|816964|P6|STARTED|Period 2 - Second Intervention||1
337929|NCT00583908|816965|P5|STARTED|Period 2 - Second Intervention||2
337930|NCT00583908|816966|P4|STARTED|Period 2 - Second Intervention||1
337931|NCT00583908|816967|P3|STARTED|Period 2 - Second Intervention||1
337932|NCT00583908|816968|P2|STARTED|Period 2 - Second Intervention||2
337933|NCT00583908|816969|P1|STARTED|Period 2 - Second Intervention||1
337934|NCT00583908|816958|P12|NOT COMPLETED|Period 1 - First Intervention||0
337935|NCT00583908|816959|P11|NOT COMPLETED|Period 1 - First Intervention||0
337936|NCT00583908|816960|P10|NOT COMPLETED|Period 1 - First Intervention||0
337937|NCT00583908|816961|P9|NOT COMPLETED|Period 1 - First Intervention||0
337938|NCT00583908|816962|P8|NOT COMPLETED|Period 1 - First Intervention||0
337939|NCT00583908|816963|P7|NOT COMPLETED|Period 1 - First Intervention||0
337940|NCT00583908|816964|P6|NOT COMPLETED|Period 1 - First Intervention||0
337941|NCT00583908|816965|P5|NOT COMPLETED|Period 1 - First Intervention||0
337942|NCT00583908|816966|P4|NOT COMPLETED|Period 1 - First Intervention||0
337943|NCT00583908|816967|P3|NOT COMPLETED|Period 1 - First Intervention||0
337944|NCT00583908|816968|P2|NOT COMPLETED|Period 1 - First Intervention||0
337945|NCT00583908|816969|P1|NOT COMPLETED|Period 1 - First Intervention||0
337946|NCT00583908|816958|P12|COMPLETED|Period 1 - First Intervention||1
337947|NCT00583908|816959|P11|COMPLETED|Period 1 - First Intervention||1
337948|NCT00583908|816960|P10|COMPLETED|Period 1 - First Intervention||1
337949|NCT00583908|816961|P9|COMPLETED|Period 1 - First Intervention||1
337950|NCT00583908|816962|P8|COMPLETED|Period 1 - First Intervention||1
337951|NCT00583908|816963|P7|COMPLETED|Period 1 - First Intervention||1
337952|NCT00583908|816964|P6|COMPLETED|Period 1 - First Intervention||1
337953|NCT00583908|816965|P5|COMPLETED|Period 1 - First Intervention||2
337954|NCT00583908|816966|P4|COMPLETED|Period 1 - First Intervention||1
337955|NCT00583908|816967|P3|COMPLETED|Period 1 - First Intervention||1
337956|NCT00583908|816968|P2|COMPLETED|Period 1 - First Intervention||2
337957|NCT00583908|816969|P1|COMPLETED|Period 1 - First Intervention||1
337958|NCT00583908|816958|P12|STARTED|Period 1 - First Intervention||1
337959|NCT00583908|816959|P11|STARTED|Period 1 - First Intervention||1
337960|NCT00583908|816960|P10|STARTED|Period 1 - First Intervention||1
337961|NCT00583908|816961|P9|STARTED|Period 1 - First Intervention||1
337962|NCT00583908|816962|P8|STARTED|Period 1 - First Intervention||1
337963|NCT00583908|816963|P7|STARTED|Period 1 - First Intervention||1
337964|NCT00583908|816964|P6|STARTED|Period 1 - First Intervention||1
337965|NCT00583908|816965|P5|STARTED|Period 1 - First Intervention||2
337966|NCT00583908|816966|P4|STARTED|Period 1 - First Intervention||1
337967|NCT00583908|816967|P3|STARTED|Period 1 - First Intervention||1
337968|NCT00583908|816968|P2|STARTED|Period 1 - First Intervention||2
337969|NCT00583908|816969|P1|STARTED|Period 1 - First Intervention||1
337970|NCT00583804|817023|P1|NOT COMPLETED|Overall Study||0
337971|NCT00583804|817023|P1|COMPLETED|Overall Study|Subjects were considered enrolled when they underwent implantation of the device. All completed.|10
337972|NCT00583804|817023|P1|STARTED|Overall Study||10
337973|NCT00583791|817029|P1|NOT COMPLETED|Overall Study||73
337974|NCT00583791|817029|P1|COMPLETED|Overall Study||18
337975|NCT00583791|817029|P1|STARTED|Overall Study||91
337976|NCT00583713|817036|P3|NOT COMPLETED|Overall Study||0
337977|NCT00583713|817037|P2|NOT COMPLETED|Overall Study||0
337978|NCT00583713|817038|P1|NOT COMPLETED|Overall Study||0
337979|NCT00583713|817036|P3|COMPLETED|Overall Study||6
337980|NCT00583713|817037|P2|COMPLETED|Overall Study||6
337981|NCT00583713|817038|P1|COMPLETED|Overall Study||6
337982|NCT00583713|817036|P3|STARTED|Overall Study||6
337983|NCT00583713|817037|P2|STARTED|Overall Study||6
337984|NCT00583713|817038|P1|STARTED|Overall Study||6
337985|NCT00583700|817063|P2|NOT COMPLETED|Overall Study||4
337986|NCT00583700|817064|P1|NOT COMPLETED|Overall Study||3
337987|NCT00583700|817063|P2|COMPLETED|Overall Study||23
337988|NCT00583700|817064|P1|COMPLETED|Overall Study||24
337989|NCT00583700|817063|P2|STARTED|Overall Study||27
337990|NCT00583700|817064|P1|STARTED|Overall Study||27
337991|NCT00583661|817072|P1|NOT COMPLETED|Overall Study||0
337992|NCT00583661|817072|P1|COMPLETED|Overall Study||48
337993|NCT00583661|817072|P1|STARTED|Overall Study||48
337994|NCT00583622|817079|P1|NOT COMPLETED|Overall Study||0
337995|NCT00583622|817079|P1|COMPLETED|Overall Study||12
337996|NCT00583622|817079|P1|STARTED|Overall Study||12
337997|NCT00583596|817084|P1|NOT COMPLETED|Overall Study||284
337998|NCT00583596|817084|P1|COMPLETED|Overall Study||152
337999|NCT00583596|817084|P1|STARTED|Overall Study|Subjects in Phase 2 clinical trial who received the AMPLATZER Duct Occluder.|436
338000|NCT00583557|817089|P1|NOT COMPLETED|Overall Study||70
338001|NCT00583557|817089|P1|COMPLETED|Overall Study|Completer defined as subjects whose reason for discontinuation was sponsor discontinuation of study|85
338002|NCT00583557|817089|P1|Received at Least 1 Dose Belimumab|Overall Study||153
338003|NCT00583557|817089|P1|STARTED|Overall Study||155
338004|NCT00583492|817095|P2|NOT COMPLETED|Overall Study||0
338005|NCT00583492|817096|P1|NOT COMPLETED|Overall Study||0
338006|NCT00583492|817095|P2|COMPLETED|Overall Study||23
338007|NCT00583492|817096|P1|COMPLETED|Overall Study||21
338008|NCT00583492|817095|P2|STARTED|Overall Study||23
338009|NCT00583492|817096|P1|STARTED|Overall Study||21
338010|NCT00583466|817112|P1|NOT COMPLETED|Overall Study||0
338011|NCT00583466|817112|P1|COMPLETED|Overall Study||18
338012|NCT00583466|817112|P1|STARTED|Overall Study||18
338013|NCT00583453|817120|P2|NOT COMPLETED|Overall Study||2
338014|NCT00583453|817121|P1|NOT COMPLETED|Overall Study||0
338015|NCT00583453|817120|P2|COMPLETED|Overall Study||6
338016|NCT00583453|817121|P1|COMPLETED|Overall Study||9
338017|NCT00583453|817120|P2|STARTED|Overall Study||8
338018|NCT00583453|817121|P1|STARTED|Overall Study||9
338019|NCT00583414|817135|P1|NOT COMPLETED|Overall Study||0
338020|NCT00583414|817135|P1|COMPLETED|Overall Study||401
338021|NCT00583414|817135|P1|STARTED|Overall Study||401
338022|NCT00583375|817141|P2|NOT COMPLETED|Overall Study||0
338023|NCT00583375|817142|P1|NOT COMPLETED|Overall Study||0
338024|NCT00583375|817141|P2|COMPLETED|Overall Study||272
338025|NCT00583375|817142|P1|COMPLETED|Overall Study||142
338026|NCT00583375|817141|P2|STARTED|Overall Study||272
338027|NCT00583375|817142|P1|STARTED|Overall Study||142
338028|NCT00583362|817158|P1|NOT COMPLETED|Overall Study||202
338029|NCT00583362|817158|P1|COMPLETED|Overall Study||96
338030|NCT00583362|817158|P1|STARTED|Overall Study||298
338031|NCT00583219|817182|P1|NOT COMPLETED|Phase 2||1
338032|NCT00583219|817182|P1|COMPLETED|Phase 2||21
338033|NCT00583219|817182|P1|STARTED|Phase 2|6 subjects from P1 continued in P2; plus 16 new subjects. All subjects in P2 got 300 units Botox.|22
338034|NCT00583219|817182|P1|NOT COMPLETED|Phase 1||0
338035|NCT00583219|817182|P1|COMPLETED|Phase 1||9
338036|NCT00583219|817182|P1|STARTED|Phase 1|First 3 subjects in Phase 1 received 200 units Botox. The remaining subjects got 300 units Botox.|9
338037|NCT00583115|817199|P1|NOT COMPLETED|Overall Study||1
338038|NCT00583115|817199|P1|COMPLETED|Overall Study||0
338039|NCT00583115|817199|P1|STARTED|Overall Study||1
338040|NCT00583102|817204|P1|NOT COMPLETED|Overall Study||3
338041|NCT00583102|817204|P1|COMPLETED|Overall Study||20
338042|NCT00583102|817204|P1|STARTED|Overall Study||23
338043|NCT00582998|817210|P2|NOT COMPLETED|Overall Study||0
338044|NCT00582998|817211|P1|NOT COMPLETED|Overall Study||0
338045|NCT00582998|817210|P2|COMPLETED|Overall Study||130
338046|NCT00582998|817211|P1|COMPLETED|Overall Study||119
338047|NCT00582998|817210|P2|STARTED|Overall Study||130
338048|NCT00582998|817211|P1|STARTED|Overall Study||119
338049|NCT00582972|817217|P1|NOT COMPLETED|Overall Study||2
338050|NCT00582972|817217|P1|COMPLETED|Overall Study||21
338051|NCT00582972|817217|P1|STARTED|Overall Study||23
338052|NCT00582946|817222|P1|NOT COMPLETED|Overall Study||0
338053|NCT00582946|817222|P1|COMPLETED|Overall Study||16
338054|NCT00582946|817222|P1|STARTED|Overall Study||16
338055|NCT00582933|817226|P1|NOT COMPLETED|Overall Study||3
338056|NCT00582933|817226|P1|COMPLETED|Overall Study||92
338057|NCT00582933|817226|P1|STARTED|Overall Study||95
338058|NCT00582907|817230|P4|NOT COMPLETED|4th Course||0
338059|NCT00582907|817231|P3|NOT COMPLETED|4th Course||0
338060|NCT00582907|817232|P2|NOT COMPLETED|4th Course||0
338061|NCT00582907|817233|P1|NOT COMPLETED|4th Course||0
338062|NCT00582907|817230|P4|COMPLETED|4th Course||3
338063|NCT00582907|817231|P3|COMPLETED|4th Course||3
338064|NCT00582907|817232|P2|COMPLETED|4th Course||3
338065|NCT00582907|817233|P1|COMPLETED|4th Course||2
338066|NCT00582907|817230|P4|STARTED|4th Course||3
338067|NCT00582907|817231|P3|STARTED|4th Course||3
338068|NCT00582907|817232|P2|STARTED|4th Course||3
338069|NCT00582907|817233|P1|STARTED|4th Course||2
338070|NCT00582907|817230|P4|NOT COMPLETED|3rd Course||0
338071|NCT00582907|817231|P3|NOT COMPLETED|3rd Course||0
338072|NCT00582907|817232|P2|NOT COMPLETED|3rd Course||0
338073|NCT00582907|817233|P1|NOT COMPLETED|3rd Course||0
338074|NCT00582907|817230|P4|COMPLETED|3rd Course||3
338075|NCT00582907|817231|P3|COMPLETED|3rd Course||3
338076|NCT00582907|817232|P2|COMPLETED|3rd Course||3
338077|NCT00582907|817233|P1|COMPLETED|3rd Course||2
338078|NCT00582907|817230|P4|STARTED|3rd Course||3
338079|NCT00582907|817231|P3|STARTED|3rd Course||3
338080|NCT00582907|817232|P2|STARTED|3rd Course||3
338081|NCT00582907|817233|P1|STARTED|3rd Course||2
338082|NCT00582907|817230|P4|NOT COMPLETED|2nd Course||0
338083|NCT00582907|817231|P3|NOT COMPLETED|2nd Course||0
338084|NCT00582907|817232|P2|NOT COMPLETED|2nd Course||0
338085|NCT00582907|817233|P1|NOT COMPLETED|2nd Course||1
338086|NCT00582907|817230|P4|COMPLETED|2nd Course||3
338087|NCT00582907|817231|P3|COMPLETED|2nd Course||3
338088|NCT00582907|817232|P2|COMPLETED|2nd Course||3
338089|NCT00582907|817233|P1|COMPLETED|2nd Course||2
338090|NCT00582907|817230|P4|STARTED|2nd Course||3
338091|NCT00582907|817231|P3|STARTED|2nd Course||3
338092|NCT00582907|817232|P2|STARTED|2nd Course||3
338093|NCT00582907|817233|P1|STARTED|2nd Course||3
338094|NCT00582907|817230|P4|NOT COMPLETED|1st Course||1
338095|NCT00582907|817231|P3|NOT COMPLETED|1st Course||0
338096|NCT00582907|817232|P2|NOT COMPLETED|1st Course||0
338097|NCT00582907|817233|P1|NOT COMPLETED|1st Course||1
338098|NCT00582907|817230|P4|COMPLETED|1st Course|Patient lost to follow-up towards end of 1st course|3
338099|NCT00582907|817231|P3|COMPLETED|1st Course||3
338100|NCT00582907|817232|P2|COMPLETED|1st Course||3
338101|NCT00582907|817233|P1|COMPLETED|1st Course|1 left after 1st course (transportation issues)|3
338102|NCT00582907|817230|P4|STARTED|1st Course||4
338103|NCT00582907|817231|P3|STARTED|1st Course||3
338104|NCT00582907|817232|P2|STARTED|1st Course||3
338105|NCT00582907|817233|P1|STARTED|1st Course||4
338106|NCT00582894|817265|P1|NOT COMPLETED|Overall Study||0
338107|NCT00582894|817265|P1|COMPLETED|Overall Study||17
338108|NCT00582894|817265|P1|Day 100 Post Transplant|Overall Study||17
338109|NCT00582894|817265|P1|STARTED|Overall Study||17
338110|NCT00582816|817272|P1|NOT COMPLETED|Overall Study||3
338111|NCT00582816|817272|P1|COMPLETED|Overall Study|"Completed here means patients stably engrafted with donor cells."|6
338112|NCT00582816|817272|P1|STARTED|Overall Study||9
338113|NCT00582790|817282|P1|NOT COMPLETED|Overall Study||1
338114|NCT00582790|817282|P1|COMPLETED|Overall Study||11
338115|NCT00582790|817282|P1|STARTED|Overall Study|only 11 of the 12 patients received study treatment.|12
338116|NCT00582738|817291|P2|NOT COMPLETED|Overall Study||18
338117|NCT00582738|817292|P1|NOT COMPLETED|Overall Study||9
338118|NCT00582738|817291|P2|COMPLETED|Overall Study||4
338119|NCT00582738|817292|P1|COMPLETED|Overall Study||12
338120|NCT00582738|817291|P2|STARTED|Overall Study||22
338121|NCT00582738|817292|P1|STARTED|Overall Study||21
338122|NCT00582712|817316|P1|NOT COMPLETED|Overall Study||4
338123|NCT00582712|817316|P1|COMPLETED|Overall Study||1
338124|NCT00582712|817316|P1|STARTED|Overall Study||5
338125|NCT00582660|817322|P2|NOT COMPLETED|Overall Study||0
338126|NCT00582660|817323|P1|NOT COMPLETED|Overall Study||0
338127|NCT00582660|817322|P2|COMPLETED|Overall Study||20
338128|NCT00582660|817323|P1|COMPLETED|Overall Study||20
338129|NCT00582660|817322|P2|STARTED|Overall Study||20
338130|NCT00582660|817323|P1|STARTED|Overall Study||20
338131|NCT00582608|817331|P1|NOT COMPLETED|Overall Study||12
338132|NCT00582608|817331|P1|COMPLETED|Overall Study||0
338133|NCT00582608|817331|P1|STARTED|Overall Study||12
338134|NCT00582556|817338|P3|NOT COMPLETED|Overall Study||2
338135|NCT00582556|817339|P2|NOT COMPLETED|Overall Study||1
338136|NCT00582556|817340|P1|NOT COMPLETED|Overall Study||0
338137|NCT00582556|817338|P3|COMPLETED|Overall Study||12
338138|NCT00582556|817339|P2|COMPLETED|Overall Study||14
338139|NCT00582556|817340|P1|COMPLETED|Overall Study||14
338140|NCT00582556|817338|P3|STARTED|Overall Study||14
338141|NCT00582556|817339|P2|STARTED|Overall Study||15
338142|NCT00582556|817340|P1|STARTED|Overall Study||14
338143|NCT00582517|817359|P2|NOT COMPLETED|Overall Study||0
338144|NCT00582517|817360|P1|NOT COMPLETED|Overall Study||0
338145|NCT00582517|817359|P2|COMPLETED|Overall Study||55
338146|NCT00582517|817360|P1|COMPLETED|Overall Study||45
338147|NCT00582517|817359|P2|STARTED|Overall Study||55
338148|NCT00582517|817360|P1|STARTED|Overall Study||45
338149|NCT00582491|817368|P2|NOT COMPLETED|Overall Study||0
338150|NCT00582491|817369|P1|NOT COMPLETED|Overall Study||1
338151|NCT00582491|817368|P2|COMPLETED|Overall Study||10
338152|NCT00582491|817369|P1|COMPLETED|Overall Study||10
338153|NCT00582491|817368|P2|STARTED|Overall Study||10
338154|NCT00582491|817369|P1|STARTED|Overall Study||11
338155|NCT00582426|817393|P2|NOT COMPLETED|Overall Study||13
338156|NCT00582426|817394|P1|NOT COMPLETED|Overall Study||20
338157|NCT00582426|817393|P2|COMPLETED|Overall Study||58
338158|NCT00582426|817394|P1|COMPLETED|Overall Study||48
338159|NCT00582426|817393|P2|STARTED|Overall Study||71
338160|NCT00582426|817394|P1|STARTED|Overall Study|"Patient in both arms belongs to started indicates safety and intent to treat (ITT) populations."|68
338161|NCT00582400|817420|P1|NOT COMPLETED|Overall Study||3
338162|NCT00582400|817420|P1|COMPLETED|Overall Study||6
338163|NCT00582400|817420|P1|STARTED|Overall Study||9
338164|NCT00582361|817429|P2|NOT COMPLETED|Overall Study||0
338165|NCT00582361|817430|P1|NOT COMPLETED|Overall Study||0
338166|NCT00582361|817429|P2|COMPLETED|Overall Study||38
338167|NCT00582361|817430|P1|COMPLETED|Overall Study||25
338168|NCT00582361|817429|P2|STARTED|Overall Study||38
338169|NCT00582361|817430|P1|STARTED|Overall Study||25
338170|NCT00582309|817441|P3|NOT COMPLETED|Overall Study||2
338171|NCT00582309|817442|P2|NOT COMPLETED|Overall Study||0
338172|NCT00582309|817443|P1|NOT COMPLETED|Overall Study||0
338173|NCT00582309|817441|P3|COMPLETED|Overall Study|2 did not have enough data collected to be used|44
338174|NCT00582309|817442|P2|COMPLETED|Overall Study||49
338175|NCT00582309|817443|P1|COMPLETED|Overall Study||56
338176|NCT00582309|817441|P3|STARTED|Overall Study||46
338177|NCT00582309|817442|P2|STARTED|Overall Study||49
338178|NCT00582309|817443|P1|STARTED|Overall Study||56
338179|NCT00582205|817451|P1|NOT COMPLETED|Overall Study||10
338180|NCT00582205|817451|P1|COMPLETED|Overall Study||11
338181|NCT00582205|817451|P1|STARTED|Overall Study||21
338182|NCT00582166|817456|P1|NOT COMPLETED|Overall Study||2
338183|NCT00582166|817456|P1|COMPLETED|Overall Study||16
338184|NCT00582166|817456|P1|STARTED|Overall Study||18
338185|NCT00582114|817466|P2|NOT COMPLETED|Overall Study||54
338186|NCT00582114|817467|P1|NOT COMPLETED|Overall Study||42
338187|NCT00582114|817466|P2|COMPLETED|Overall Study||46
338188|NCT00582114|817467|P1|COMPLETED|Overall Study||58
338189|NCT00582114|817466|P2|STARTED|Overall Study||100
338190|NCT00582114|817467|P1|STARTED|Overall Study||100
338191|NCT00582075|817475|P1|NOT COMPLETED|Overall Study||0
338192|NCT00582075|817475|P1|COMPLETED|Overall Study||25
338193|NCT00582075|817475|P1|STARTED|Overall Study||25
338194|NCT00582036|817482|P2|NOT COMPLETED|Overall Study||1
338195|NCT00582036|817483|P1|NOT COMPLETED|Overall Study||0
338196|NCT00582036|817482|P2|COMPLETED|Overall Study|One patient withdrew consent|5
338197|NCT00582036|817483|P1|COMPLETED|Overall Study||5
338198|NCT00582036|817482|P2|STARTED|Overall Study||6
338199|NCT00582036|817483|P1|STARTED|Overall Study||5
338200|NCT00582010|817491|P2|NOT COMPLETED|Overall Study||1
338201|NCT00582010|817492|P1|NOT COMPLETED|Overall Study||0
338202|NCT00582010|817491|P2|COMPLETED|Overall Study||39
338203|NCT00582010|817492|P1|COMPLETED|Overall Study||40
338204|NCT00582010|817491|P2|STARTED|Overall Study||40
338205|NCT00582010|817492|P1|STARTED|Overall Study||40
338206|NCT00581971|817514|P1|NOT COMPLETED|Overall Study||0
338207|NCT00581971|817514|P1|COMPLETED|Overall Study||30
338208|NCT00581971|817514|P1|STARTED|Overall Study||30
338209|NCT00581945|817521|P2|NOT COMPLETED|Overall Study||10
338210|NCT00581945|817522|P1|NOT COMPLETED|Overall Study||9
338211|NCT00581945|817521|P2|COMPLETED|Overall Study||63
338212|NCT00581945|817522|P1|COMPLETED|Overall Study||65
338213|NCT00581945|817521|P2|STARTED|Overall Study||73
338214|NCT00581945|817522|P1|STARTED|Overall Study||74
338215|NCT00581919|817538|P1|NOT COMPLETED|Overall Study||24
338216|NCT00581919|817538|P1|COMPLETED|Overall Study||8
338217|NCT00581919|817538|P1|STARTED|Overall Study||32
338218|NCT00581867|817544|P2|NOT COMPLETED|Second Intervention||0
338219|NCT00581867|817545|P1|NOT COMPLETED|Second Intervention||0
338220|NCT00581867|817544|P2|COMPLETED|Second Intervention||14
338221|NCT00581867|817545|P1|COMPLETED|Second Intervention||15
338222|NCT00581867|817544|P2|STARTED|Second Intervention|1 individual completed period 1 (Intranasal Insulin) but did not complete period 2 (Placebo).|14
338223|NCT00581867|817545|P1|STARTED|Second Intervention|n=1 completed period 1 (placebo) but not period 2 (insulin). This individuals died between periods.|15
338224|NCT00581867|817544|P2|NOT COMPLETED|First Intervention||0
338225|NCT00581867|817545|P1|NOT COMPLETED|First Intervention||0
338226|NCT00581867|817544|P2|COMPLETED|First Intervention||15
338227|NCT00581867|817545|P1|COMPLETED|First Intervention||16
338228|NCT00581867|817544|P2|STARTED|First Intervention||15
338229|NCT00581867|817545|P1|STARTED|First Intervention||16
338230|NCT00581854|817553|P1|NOT COMPLETED|Overall Study||0
338231|NCT00581854|817553|P1|COMPLETED|Overall Study||22
338232|NCT00581854|817553|P1|STARTED|Overall Study||22
338233|NCT00581828|817557|P1|NOT COMPLETED|Overall Study||1
338234|NCT00581828|817557|P1|COMPLETED|Overall Study||18
338235|NCT00581828|817557|P1|STARTED|Overall Study||19
338236|NCT00581776|817561|P1|NOT COMPLETED|Overall Study||3
338237|NCT00581776|817561|P1|COMPLETED|Overall Study|3 subjects did not complete the planned induction chemotherapy.|27
338238|NCT00581776|817561|P1|STARTED|Overall Study||30
338239|NCT00581581|817570|P2|NOT COMPLETED|Overall Study||0
338240|NCT00581581|817571|P1|NOT COMPLETED|Overall Study||0
338241|NCT00581581|817570|P2|COMPLETED|Overall Study||30
338242|NCT00581581|817571|P1|COMPLETED|Overall Study||32
338243|NCT00581581|817570|P2|STARTED|Overall Study||30
338244|NCT00581581|817571|P1|STARTED|Overall Study||32
338245|NCT00581555|817579|P2|NOT COMPLETED|Overall Study||20
338246|NCT00581555|817580|P1|NOT COMPLETED|Overall Study||43
338247|NCT00581555|817579|P2|COMPLETED|Overall Study||38
338248|NCT00581555|817580|P1|COMPLETED|Overall Study||19
338249|NCT00581555|817579|P2|STARTED|Overall Study||58
338250|NCT00581555|817580|P1|STARTED|Overall Study||62
338251|NCT00581542|817604|P2|NOT COMPLETED|Overall Study||23
338252|NCT00581542|817605|P1|NOT COMPLETED|Overall Study||11
338253|NCT00581542|817604|P2|COMPLETED|Overall Study||39
338254|NCT00581542|817605|P1|COMPLETED|Overall Study||51
338255|NCT00581542|817604|P2|STARTED|Overall Study||62
338256|NCT00581542|817605|P1|STARTED|Overall Study||62
338257|NCT00581529|817613|P1|NOT COMPLETED|Overall Study||0
338258|NCT00581529|817613|P1|COMPLETED|Overall Study||34
338259|NCT00581529|817613|P1|STARTED|Overall Study||34
338260|NCT00581399|817622|P2|NOT COMPLETED|Overall Study||0
338261|NCT00581399|817623|P1|NOT COMPLETED|Overall Study||0
338262|NCT00581399|817622|P2|COMPLETED|Overall Study||48
338263|NCT00581399|817623|P1|COMPLETED|Overall Study||46
338264|NCT00581399|817622|P2|STARTED|Overall Study||48
338265|NCT00581399|817623|P1|STARTED|Overall Study||46
338266|NCT00581386|817634|P3|NOT COMPLETED|Overall Study||0
338267|NCT00581386|817635|P2|NOT COMPLETED|Overall Study||0
338268|NCT00581386|817636|P1|NOT COMPLETED|Overall Study||0
338269|NCT00581386|817634|P3|COMPLETED|Overall Study|04/15/2009|72
338270|NCT00581386|817635|P2|COMPLETED|Overall Study|04/15/2009|73
338271|NCT00581386|817636|P1|COMPLETED|Overall Study|04/15/2009|73
338272|NCT00581386|817634|P3|STARTED|Overall Study|05/30/2007|72
338273|NCT00581386|817635|P2|STARTED|Overall Study|05/30/2007|73
338274|NCT00581386|817636|P1|STARTED|Overall Study|05/30/2007|73
338275|NCT00581360|817659|P1|NOT COMPLETED|Overall Study||1
338276|NCT00581360|817659|P1|COMPLETED|Overall Study||9
338277|NCT00581360|817659|P1|STARTED|Overall Study||10
338278|NCT00581347|817669|P2|NOT COMPLETED|Overall Study||0
338279|NCT00581347|817670|P1|NOT COMPLETED|Overall Study||0
338280|NCT00581347|817669|P2|COMPLETED|Overall Study||3707
338281|NCT00581347|817670|P1|COMPLETED|Overall Study||3839
338282|NCT00581347|817669|P2|STARTED|Overall Study||3707
338283|NCT00581347|817670|P1|STARTED|Overall Study||3839
338284|NCT00581308|817678|P1|NOT COMPLETED|60 Months||3
338285|NCT00581308|817678|P1|COMPLETED|60 Months||158
338286|NCT00581308|817678|P1|STARTED|60 Months||161
338287|NCT00581308|817678|P1|NOT COMPLETED|48 Months||9
338288|NCT00581308|817678|P1|COMPLETED|48 Months||161
338289|NCT00581308|817678|P1|STARTED|48 Months||170
338290|NCT00581308|817678|P1|NOT COMPLETED|36 Months||6
338291|NCT00581308|817678|P1|COMPLETED|36 Months||170
338292|NCT00581308|817678|P1|STARTED|36 Months||176
338293|NCT00581308|817678|P1|NOT COMPLETED|24 Months||6
338294|NCT00581308|817678|P1|COMPLETED|24 Months||176
338295|NCT00581308|817678|P1|STARTED|24 Months||182
338296|NCT00581308|817678|P1|NOT COMPLETED|Month 12||20
338297|NCT00581308|817678|P1|COMPLETED|Month 12||182
338298|NCT00581308|817678|P1|STARTED|Month 12||202
338299|NCT00581308|817678|P1|NOT COMPLETED|Month 6||3
338300|NCT00581308|817678|P1|COMPLETED|Month 6||202
338301|NCT00581308|817678|P1|STARTED|Month 6||205
338302|NCT00581308|817678|P1|NOT COMPLETED|Month 1||8
338303|NCT00581308|817678|P1|COMPLETED|Month 1||205
338304|NCT00581308|817678|P1|STARTED|Month 1||213
338305|NCT00581308|817678|P1|NOT COMPLETED|Pre Discharge||2
338306|NCT00581308|817678|P1|COMPLETED|Pre Discharge||213
338307|NCT00581308|817678|P1|STARTED|Pre Discharge||215
338308|NCT00581256|817687|P2|NOT COMPLETED|Overall Study||0
338309|NCT00581256|817688|P1|NOT COMPLETED|Overall Study||0
338310|NCT00581256|817687|P2|COMPLETED|Overall Study||26
338311|NCT00581256|817688|P1|COMPLETED|Overall Study||28
338312|NCT00581256|817687|P2|STARTED|Overall Study||26
338313|NCT00581256|817688|P1|STARTED|Overall Study||28
338314|NCT00581230|817700|P1|NOT COMPLETED|Overall Study||0
338315|NCT00581230|817700|P1|COMPLETED|Overall Study||51
338316|NCT00581230|817700|P1|Laryngoscopy With RAMP|Overall Study||51
338317|NCT00581230|817700|P1|Laryngoscopy Without RAMP|Overall Study||51
338318|NCT00581230|817700|P1|STARTED|Overall Study||51
338319|NCT00581113|817709|P2|NOT COMPLETED|Overall Study||1
338320|NCT00581113|817710|P1|NOT COMPLETED|Overall Study||0
338321|NCT00581113|817709|P2|COMPLETED|Overall Study||3
338322|NCT00581113|817710|P1|COMPLETED|Overall Study||4
338323|NCT00581113|817709|P2|STARTED|Overall Study||4
338324|NCT00581113|817710|P1|STARTED|Overall Study||4
338325|NCT00581100|817720|P2|NOT COMPLETED|Overall Study||5
338326|NCT00581100|817721|P1|NOT COMPLETED|Overall Study||7
338327|NCT00581100|817720|P2|COMPLETED|Overall Study||29
338328|NCT00581100|817721|P1|COMPLETED|Overall Study||31
338329|NCT00581100|817720|P2|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|33
338330|NCT00581100|817721|P1|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|36
338331|NCT00581100|817720|P2|STARTED|Overall Study||34
338332|NCT00581100|817721|P1|STARTED|Overall Study||38
338333|NCT00581061|817757|P1|NOT COMPLETED|Overall Study||0
338334|NCT00581061|817757|P1|COMPLETED|Overall Study||13
338335|NCT00581061|817757|P1|STARTED|Overall Study||13
338336|NCT00581048|817763|P1|NOT COMPLETED|Overall Study||0
338337|NCT00581048|817763|P1|COMPLETED|Overall Study||33
338338|NCT00581048|817763|P1|STARTED|Overall Study||33
338339|NCT00580983|817774|P1|NOT COMPLETED|Overall Study||7
338340|NCT00580983|817774|P1|COMPLETED|Overall Study||73
338341|NCT00580983|817774|P1|STARTED|Overall Study||80
338342|NCT00580970|817781|P1|NOT COMPLETED|Treatment (Lovastatin)||19
338343|NCT00580970|817781|P1|COMPLETED|Treatment (Lovastatin)||53
338344|NCT00580970|817781|P1|6 Months of Treatment|Treatment (Lovastatin)|Subjects evaluable for analysis|53
338345|NCT00580970|817781|P1|STARTED|Treatment (Lovastatin)||72
338346|NCT00580970|817781|P1|NOT COMPLETED|Pre-treatment||1
338347|NCT00580970|817781|P1|COMPLETED|Pre-treatment||72
338348|NCT00580970|817781|P1|STARTED|Pre-treatment||73
338349|NCT00580957|817787|P2|NOT COMPLETED|Overall Study||7
338350|NCT00580957|817788|P1|NOT COMPLETED|Overall Study||7
338351|NCT00580957|817787|P2|COMPLETED|Overall Study||21
338352|NCT00580957|817788|P1|COMPLETED|Overall Study||21
338353|NCT00580957|817787|P2|STARTED|Overall Study||28
338354|NCT00580957|817788|P1|STARTED|Overall Study||28
338355|NCT00580866|817796|P2|NOT COMPLETED|Overall Study||2
338356|NCT00580866|817797|P1|NOT COMPLETED|Overall Study||2
338357|NCT00580866|817796|P2|COMPLETED|Overall Study||5
338358|NCT00580866|817797|P1|COMPLETED|Overall Study||8
338359|NCT00580866|817796|P2|STARTED|Overall Study||7
338360|NCT00580866|817797|P1|STARTED|Overall Study||10
338361|NCT00580853|817808|P3|NOT COMPLETED|Overall Study||0
338362|NCT00580853|817809|P2|NOT COMPLETED|Overall Study||0
338363|NCT00580853|817810|P1|NOT COMPLETED|Overall Study||0
338364|NCT00580853|817808|P3|COMPLETED|Overall Study||21
338365|NCT00580853|817809|P2|COMPLETED|Overall Study||21
338366|NCT00580853|817810|P1|COMPLETED|Overall Study||20
338367|NCT00580853|817808|P3|STARTED|Overall Study||21
338368|NCT00580853|817809|P2|STARTED|Overall Study||21
338369|NCT00580853|817810|P1|STARTED|Overall Study||20
338370|NCT00580840|817821|P4|NOT COMPLETED|Double-Blind||15
338371|NCT00580840|817822|P3|NOT COMPLETED|Double-Blind||9
338372|NCT00580840|817823|P2|NOT COMPLETED|Double-Blind||7
338373|NCT00580840|817824|P1|NOT COMPLETED|Double-Blind||0
338374|NCT00580840|817821|P4|COMPLETED|Double-Blind||54
338375|NCT00580840|817822|P3|COMPLETED|Double-Blind||61
338376|NCT00580840|817823|P2|COMPLETED|Double-Blind||63
338377|NCT00580840|817824|P1|COMPLETED|Double-Blind||0
338378|NCT00580840|817821|P4|STARTED|Double-Blind||69
338379|NCT00580840|817822|P3|STARTED|Double-Blind||70
338380|NCT00580840|817823|P2|STARTED|Double-Blind||70
338381|NCT00580840|817824|P1|STARTED|Double-Blind||0
338382|NCT00580840|817821|P4|NOT COMPLETED|Run-in||0
338383|NCT00580840|817822|P3|NOT COMPLETED|Run-in||0
338384|NCT00580840|817823|P2|NOT COMPLETED|Run-in||0
338385|NCT00580840|817824|P1|NOT COMPLETED|Run-in||124
338386|NCT00580840|817821|P4|COMPLETED|Run-in||0
338387|NCT00580840|817822|P3|COMPLETED|Run-in||0
338388|NCT00580840|817823|P2|COMPLETED|Run-in||0
338389|NCT00580840|817824|P1|COMPLETED|Run-in|Of the 209 randomized participants, 208 are in the Full Analysis Set (FAS).|209
338390|NCT00580840|817821|P4|STARTED|Run-in||0
338391|NCT00580840|817822|P3|STARTED|Run-in||0
338392|NCT00580840|817823|P2|STARTED|Run-in||0
338393|NCT00580840|817824|P1|STARTED|Run-in|620 subjects were screened for the study with 333 being enrolled.|333
338394|NCT00580801|817932|P3|NOT COMPLETED|Overall Study||3
338395|NCT00580801|817933|P2|NOT COMPLETED|Overall Study||1
338396|NCT00580801|817934|P1|NOT COMPLETED|Overall Study||6
338397|NCT00580801|817932|P3|COMPLETED|Overall Study||5
338398|NCT00580801|817933|P2|COMPLETED|Overall Study||7
338399|NCT00580801|817934|P1|COMPLETED|Overall Study||2
338400|NCT00580801|817932|P3|STARTED|Overall Study||8
338401|NCT00580801|817933|P2|STARTED|Overall Study||8
338402|NCT00580801|817934|P1|STARTED|Overall Study||8
338403|NCT00580788|817973|P4|NOT COMPLETED|Overall Study||1
338404|NCT00580788|817974|P3|NOT COMPLETED|Overall Study||0
338405|NCT00580788|817975|P2|NOT COMPLETED|Overall Study||0
338406|NCT00580788|817976|P1|NOT COMPLETED|Overall Study||0
338407|NCT00580788|817973|P4|COMPLETED|Overall Study|One subject was stopped early for hypertension. One subject completed but was not analyzed.|1
338408|NCT00580788|817974|P3|COMPLETED|Overall Study||3
338409|NCT00580788|817975|P2|COMPLETED|Overall Study||6
338410|NCT00580788|817976|P1|COMPLETED|Overall Study||3
338411|NCT00580788|817973|P4|STARTED|Overall Study||2
338412|NCT00580788|817974|P3|STARTED|Overall Study||3
338413|NCT00580788|817975|P2|STARTED|Overall Study||6
338414|NCT00580788|817976|P1|STARTED|Overall Study||3
338415|NCT00580723|818034|P1|NOT COMPLETED|Overall Study||8
338416|NCT00580723|818034|P1|COMPLETED|Overall Study||16
338417|NCT00580723|818034|P1|STARTED|Overall Study||24
338418|NCT00580671|818043|P3|NOT COMPLETED|Overall Study||17
338419|NCT00580671|818044|P2|NOT COMPLETED|Overall Study||16
338420|NCT00580671|818045|P1|NOT COMPLETED|Overall Study||16
338421|NCT00580671|818043|P3|COMPLETED|Overall Study||34
338422|NCT00580671|818044|P2|COMPLETED|Overall Study||35
338423|NCT00580671|818045|P1|COMPLETED|Overall Study||35
338424|NCT00580671|818043|P3|STARTED|Overall Study||51
338425|NCT00580671|818044|P2|STARTED|Overall Study||51
338426|NCT00580671|818045|P1|STARTED|Overall Study||51
338427|NCT00580645|818062|P3|NOT COMPLETED|Overall Study||0
338428|NCT00580645|818063|P2|NOT COMPLETED|Overall Study||0
338429|NCT00580645|818064|P1|NOT COMPLETED|Overall Study||0
338430|NCT00580645|818062|P3|COMPLETED|Overall Study||20
338431|NCT00580645|818063|P2|COMPLETED|Overall Study||20
338432|NCT00580645|818064|P1|COMPLETED|Overall Study||20
338433|NCT00580645|818062|P3|STARTED|Overall Study||20
338434|NCT00580645|818063|P2|STARTED|Overall Study||20
338435|NCT00580645|818064|P1|STARTED|Overall Study||20
338436|NCT00580606|818077|P2|NOT COMPLETED|Open Label (OL)||12
338437|NCT00580606|818078|P1|NOT COMPLETED|Open Label (OL)||9
338438|NCT00580606|818077|P2|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|5
338439|NCT00580606|818078|P1|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|9
338440|NCT00580606|818077|P2|Had Week 172 Oral Food Challenge|Open Label (OL)||2
338441|NCT00580606|818078|P1|Had Week 172 Oral Food Challenge|Open Label (OL)||2
338442|NCT00580606|818077|P2|Had Week 164 Oral Food Challenge|Open Label (OL)||5
338443|NCT00580606|818078|P1|Had Week 164 Oral Food Challenge|Open Label (OL)||9
338444|NCT00580606|818077|P2|Had Week 116 Oral Food Challenge|Open Label (OL)||6
338445|NCT00580606|818078|P1|Had Week 116 Oral Food Challenge|Open Label (OL)||13
338446|NCT00580606|818077|P2|Had Week 68 Oral Food Challenge|Open Label (OL)||12
338447|NCT00580606|818078|P1|Had Week 68 Oral Food Challenge|Open Label (OL)||15
338448|NCT00580606|818077|P2|Had Week 44 Oral Food Challenge|Open Label (OL)|After 44 weeks of OL high dose SLIT; 1 additional participant declined Week 44 OFC in OL period.|12
338449|NCT00580606|818078|P1|Had Week 44 Oral Food Challenge|Open Label (OL)|The Week 44 OFC for Low Dose Peanut SLIT was done at the end of the DB Period, not the OL period.|0
338450|NCT00580606|818077|P2|STARTED|Open Label (OL)|1 participant discontinued dosing before OL period; 2 passed Week 44 OFC & ineligible to crossover.|17
338451|NCT00580606|818078|P1|STARTED|Open Label (OL)|2 participants discontinued dosing before Open Label (OL) period.|18
338452|NCT00580606|818077|P2|NOT COMPLETED|Double Blind (DB)||0
338453|NCT00580606|818078|P1|NOT COMPLETED|Double Blind (DB)||0
338454|NCT00580606|818077|P2|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
338455|NCT00580606|818078|P1|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
338456|NCT00580606|818077|P2|Had Week 44 Oral Food Challenge|Double Blind (DB)||19
338457|NCT00580606|818078|P1|Had Week 44 Oral Food Challenge|Double Blind (DB)||18
338458|NCT00580606|818077|P2|STARTED|Double Blind (DB)||20
338459|NCT00580606|818078|P1|STARTED|Double Blind (DB)||20
338460|NCT00580502|818096|P1|NOT COMPLETED|Overall Study||0
338461|NCT00580502|818096|P1|COMPLETED|Overall Study||50
338462|NCT00580502|818096|P1|STARTED|Overall Study||50
338463|NCT00580398|818105|P2|NOT COMPLETED|Overall Study||0
338464|NCT00580398|818106|P1|NOT COMPLETED|Overall Study||0
338465|NCT00580398|818105|P2|COMPLETED|Overall Study||32
338466|NCT00580398|818106|P1|COMPLETED|Overall Study||17
338467|NCT00580398|818105|P2|STARTED|Overall Study||32
338468|NCT00580398|818106|P1|STARTED|Overall Study||17
338469|NCT00580372|818114|P1|NOT COMPLETED|Overall Study||0
338470|NCT00580372|818114|P1|COMPLETED|Overall Study||231
338471|NCT00580372|818114|P1|STARTED|Overall Study||231
338472|NCT00580333|818118|P1|NOT COMPLETED|Overall Study||0
338473|NCT00580333|818118|P1|COMPLETED|Overall Study||51
338474|NCT00580333|818118|P1|STARTED|Overall Study||51
338475|NCT00580294|818125|P1|NOT COMPLETED|Overall Study||0
338476|NCT00580294|818125|P1|COMPLETED|Overall Study||12
338477|NCT00580294|818125|P1|STARTED|Overall Study||12
338478|NCT00580229|818129|P1|NOT COMPLETED|Overall Study||0
338479|NCT00580229|818129|P1|COMPLETED|Overall Study||50
338480|NCT00580229|818129|P1|STARTED|Overall Study||50
338481|NCT00580151|818137|P2|NOT COMPLETED|Overall Study||0
338482|NCT00580151|818138|P1|NOT COMPLETED|Overall Study||0
338483|NCT00580151|818137|P2|COMPLETED|Overall Study||0
338484|NCT00580151|818138|P1|COMPLETED|Overall Study||9
338485|NCT00580151|818137|P2|STARTED|Overall Study||0
338486|NCT00580151|818138|P1|STARTED|Overall Study||9
338487|NCT00580138|818146|P1|NOT COMPLETED|Overall Study||0
338488|NCT00580138|818146|P1|COMPLETED|Overall Study||30
338489|NCT00580138|818146|P1|STARTED|Overall Study||30
338490|NCT00580073|818150|P1|NOT COMPLETED|Overall Study||0
338491|NCT00580073|818150|P1|COMPLETED|Overall Study||6
338492|NCT00580073|818150|P1|STARTED|Overall Study||6
338493|NCT00580047|818159|P3|NOT COMPLETED|Overall Study||2
338494|NCT00580047|818160|P2|NOT COMPLETED|Overall Study||2
338495|NCT00580047|818161|P1|NOT COMPLETED|Overall Study||3
338496|NCT00580047|818159|P3|COMPLETED|Overall Study||10
338497|NCT00580047|818160|P2|COMPLETED|Overall Study||21
338498|NCT00580047|818161|P1|COMPLETED|Overall Study||21
338499|NCT00580047|818159|P3|STARTED|Overall Study||12
338500|NCT00580047|818160|P2|STARTED|Overall Study||23
338501|NCT00580047|818161|P1|STARTED|Overall Study||24
338502|NCT00580034|818172|P2|NOT COMPLETED|Overall Study||0
338503|NCT00580034|818173|P1|NOT COMPLETED|Overall Study||10
338504|NCT00580034|818172|P2|COMPLETED|Overall Study||88
338505|NCT00580034|818173|P1|COMPLETED|Overall Study||78
338506|NCT00580034|818172|P2|STARTED|Overall Study||88
338507|NCT00580034|818173|P1|STARTED|Overall Study||88
338508|NCT00579982|818179|P1|NOT COMPLETED|Overall Study||8
338509|NCT00579982|818179|P1|COMPLETED|Overall Study||89
338510|NCT00579982|818179|P1|STARTED|Overall Study||97
338511|NCT00579878|818201|P3|NOT COMPLETED|Overall Study||10
338512|NCT00579878|818202|P2|NOT COMPLETED|Overall Study||3
338513|NCT00579878|818203|P1|NOT COMPLETED|Overall Study||7
338514|NCT00579878|818201|P3|COMPLETED|Overall Study||14
338515|NCT00579878|818202|P2|COMPLETED|Overall Study||20
338516|NCT00579878|818203|P1|COMPLETED|Overall Study||15
338517|NCT00579878|818201|P3|STARTED|Overall Study||24
338518|NCT00579878|818202|P2|STARTED|Overall Study||23
338519|NCT00579878|818203|P1|STARTED|Overall Study||22
338520|NCT00579826|818213|P2|NOT COMPLETED|Overall Study||3
338521|NCT00579826|818214|P1|NOT COMPLETED|Overall Study||5
338522|NCT00579826|818213|P2|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|23
338523|NCT00579826|818214|P1|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|24
338524|NCT00579826|818213|P2|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|25
338525|NCT00579826|818214|P1|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|28
338526|NCT00579826|818213|P2|STARTED|Overall Study||26
338527|NCT00579826|818214|P1|STARTED|Overall Study||29
338528|NCT00579813|818226|P2|NOT COMPLETED|Overall Study||0
338529|NCT00579813|818227|P1|NOT COMPLETED|Overall Study||0
338530|NCT00579813|818226|P2|COMPLETED|Overall Study||10
338531|NCT00579813|818227|P1|COMPLETED|Overall Study||60
338532|NCT00579813|818226|P2|STARTED|Overall Study||10
338533|NCT00579813|818227|P1|STARTED|Overall Study||60
338534|NCT00579670|818248|P5|NOT COMPLETED|Overall Study||0
338535|NCT00579670|818249|P4|NOT COMPLETED|Overall Study||22
338536|NCT00579670|818250|P3|NOT COMPLETED|Overall Study||4
338537|NCT00579670|818251|P2|NOT COMPLETED|Overall Study||1
338538|NCT00579670|818252|P1|NOT COMPLETED|Overall Study||2
338539|NCT00579670|818248|P5|COMPLETED|Overall Study||5
338540|NCT00579670|818249|P4|COMPLETED|Overall Study||263
338541|NCT00579670|818250|P3|COMPLETED|Overall Study||84
338542|NCT00579670|818251|P2|COMPLETED|Overall Study||56
338543|NCT00579670|818252|P1|COMPLETED|Overall Study||13
338544|NCT00579670|818248|P5|Population: Within SmPC (Completed)|Overall Study||0
338545|NCT00579670|818249|P4|Population: Within SmPC (Completed)|Overall Study|DC: AE N=2; Lack of efficacy N=5; LTFU N=3; Other unspecified N=2|147
338546|NCT00579670|818250|P3|Population: Within SmPC (Completed)|Overall Study|DC: AE N=1; Lack of efficacy N=1; Other unspecified N=1; Withdrawal by subject N=1|79
338547|NCT00579670|818251|P2|Population: Within SmPC (Completed)|Overall Study|DC: Lost to follow-up (LTFU) N=1|55
338548|NCT00579670|818252|P1|Population: Within SmPC (Completed)|Overall Study|Not Completed (DC): Subject died N=1; Adverse Event (AE) N=1|13
338549|NCT00579670|818248|P5|Population: Within SmPC (Started)|Overall Study|"Ziprasidone Unknown reporting group is not applicable to the Within SmPC population"|0
338550|NCT00579670|818249|P4|Population: Within SmPC (Started)|Overall Study||159
338551|NCT00579670|818250|P3|Population: Within SmPC (Started)|Overall Study||83
338552|NCT00579670|818251|P2|Population: Within SmPC (Started)|Overall Study||56
338553|NCT00579670|818252|P1|Population: Within SmPC (Started)|Overall Study|"Within summary of product characteristics (SmPC): FAS subjects who received all doses Within SmPC"|15
338554|NCT00579670|818248|P5|STARTED|Overall Study||5
338555|NCT00579670|818249|P4|STARTED|Overall Study||285
338556|NCT00579670|818250|P3|STARTED|Overall Study||88
338557|NCT00579670|818251|P2|STARTED|Overall Study||57
338558|NCT00579670|818252|P1|STARTED|Overall Study|Full Analysis Set (FAS): at least 1 dose study medication and at least 1 efficacy measurement|15
338559|NCT00579501|818464|P1|NOT COMPLETED|Overall Study||29
338560|NCT00579501|818464|P1|COMPLETED|Overall Study||0
338561|NCT00579501|818464|P1|STARTED|Overall Study||29
338562|NCT00579436|818471|P2|NOT COMPLETED|Overall Study||0
338563|NCT00579436|818472|P1|NOT COMPLETED|Overall Study||0
338564|NCT00579436|818471|P2|COMPLETED|Overall Study||14
338565|NCT00579436|818472|P1|COMPLETED|Overall Study||19
338566|NCT00579436|818471|P2|STARTED|Overall Study||14
338567|NCT00579436|818472|P1|STARTED|Overall Study||19
338568|NCT00579345|818492|P8|NOT COMPLETED|Overall Study||2
338569|NCT00579345|818493|P7|NOT COMPLETED|Overall Study||0
338570|NCT00579345|818494|P6|NOT COMPLETED|Overall Study||0
338571|NCT00579345|818495|P5|NOT COMPLETED|Overall Study||0
338572|NCT00579345|818496|P4|NOT COMPLETED|Overall Study||1
338573|NCT00579345|818497|P3|NOT COMPLETED|Overall Study||2
338574|NCT00579345|818498|P2|NOT COMPLETED|Overall Study||1
338575|NCT00579345|818499|P1|NOT COMPLETED|Overall Study||5
338576|NCT00579345|818492|P8|COMPLETED|Overall Study||42
338577|NCT00579345|818493|P7|COMPLETED|Overall Study||57
338578|NCT00579345|818494|P6|COMPLETED|Overall Study||78
338579|NCT00579345|818495|P5|COMPLETED|Overall Study||90
338580|NCT00579345|818496|P4|COMPLETED|Overall Study||143
338581|NCT00579345|818497|P3|COMPLETED|Overall Study||389
338582|NCT00579345|818498|P2|COMPLETED|Overall Study||168
338583|NCT00579345|818499|P1|COMPLETED|Overall Study||544
338584|NCT00579345|818492|P8|STARTED|Overall Study||44
338585|NCT00579345|818493|P7|STARTED|Overall Study||57
338586|NCT00579345|818494|P6|STARTED|Overall Study||78
338587|NCT00579345|818495|P5|STARTED|Overall Study||90
338588|NCT00579345|818496|P4|STARTED|Overall Study||144
338589|NCT00579345|818497|P3|STARTED|Overall Study||391
338590|NCT00579345|818498|P2|STARTED|Overall Study||169
338591|NCT00579345|818499|P1|STARTED|Overall Study||549
338592|NCT00579254|818531|P1|NOT COMPLETED|Overall Study||112
338593|NCT00579254|818531|P1|COMPLETED|Overall Study||0
338594|NCT00579254|818531|P1|STARTED|Overall Study||112
338595|NCT00579137|818535|P1|NOT COMPLETED|Overall Study||0
338596|NCT00579137|818535|P1|COMPLETED|Overall Study||3
338597|NCT00579137|818535|P1|STARTED|Overall Study||3
338598|NCT00579111|818544|P2|NOT COMPLETED|Overall Study||1
338599|NCT00579111|818545|P1|NOT COMPLETED|Overall Study||2
338600|NCT00579111|818544|P2|COMPLETED|Overall Study||0
338601|NCT00579111|818545|P1|COMPLETED|Overall Study||1
338602|NCT00579111|818544|P2|STARTED|Overall Study||1
338603|NCT00579111|818545|P1|STARTED|Overall Study||3
338604|NCT00579098|818555|P2|NOT COMPLETED|Overall Study||8
338605|NCT00579098|818556|P1|NOT COMPLETED|Overall Study||9
338606|NCT00579098|818555|P2|COMPLETED|Overall Study||55
338607|NCT00579098|818556|P1|COMPLETED|Overall Study||53
338608|NCT00579098|818555|P2|STARTED|Overall Study||63
338609|NCT00579098|818556|P1|STARTED|Overall Study||62
338610|NCT00579059|818572|P2|NOT COMPLETED|Overall Study||10
338611|NCT00579059|818573|P1|NOT COMPLETED|Overall Study||21
338612|NCT00579059|818572|P2|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
338613|NCT00579059|818573|P1|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
338614|NCT00579059|818572|P2|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
338615|NCT00579059|818573|P1|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
338616|NCT00579059|818572|P2|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
338617|NCT00579059|818573|P1|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
338618|NCT00579059|818572|P2|1 Year|Overall Study|7 patients didn't return for follow-up.|3
338619|NCT00579059|818573|P1|1 Year|Overall Study|13 patients didn't return for follow-up.|8
338620|NCT00579059|818572|P2|6 Months|Overall Study|6 patients didn't return for follow-up.|4
338621|NCT00579059|818573|P1|6 Months|Overall Study|10 Patients didn't return for follow-up.|11
338622|NCT00579059|818572|P2|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|9
338623|NCT00579059|818573|P1|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|20
338624|NCT00579059|818572|P2|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|10
338625|NCT00579059|818573|P1|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|21
338626|NCT00578968|818584|P3|NOT COMPLETED|Intervention||0
338627|NCT00578968|818585|P2|NOT COMPLETED|Intervention||0
338628|NCT00578968|818586|P1|NOT COMPLETED|Intervention||0
338629|NCT00578968|818584|P3|COMPLETED|Intervention||0
338630|NCT00578968|818585|P2|COMPLETED|Intervention||12
338631|NCT00578968|818586|P1|COMPLETED|Intervention||12
338632|NCT00578968|818584|P3|STARTED|Intervention||0
338633|NCT00578968|818585|P2|STARTED|Intervention||12
338634|NCT00578968|818586|P1|STARTED|Intervention||12
338635|NCT00578968|818584|P3|NOT COMPLETED|Baseline (Prior to Intervention)||0
338636|NCT00578968|818585|P2|NOT COMPLETED|Baseline (Prior to Intervention)||0
338637|NCT00578968|818586|P1|NOT COMPLETED|Baseline (Prior to Intervention)||0
338638|NCT00578968|818584|P3|COMPLETED|Baseline (Prior to Intervention)||12
338639|NCT00578968|818585|P2|COMPLETED|Baseline (Prior to Intervention)||12
338640|NCT00578968|818586|P1|COMPLETED|Baseline (Prior to Intervention)||12
338641|NCT00578968|818584|P3|STARTED|Baseline (Prior to Intervention)||12
338642|NCT00578968|818585|P2|STARTED|Baseline (Prior to Intervention)||12
338643|NCT00578968|818586|P1|STARTED|Baseline (Prior to Intervention)||12
338644|NCT00578942|818647|P1|NOT COMPLETED|Overall Study||1
338645|NCT00578942|818647|P1|COMPLETED|Overall Study||47
338646|NCT00578942|818647|P1|STARTED|Overall Study||48
338647|NCT00578929|818657|P4|NOT COMPLETED|Randomized Period||14
338648|NCT00578929|818658|P3|NOT COMPLETED|Randomized Period||8
338649|NCT00578929|818659|P2|NOT COMPLETED|Randomized Period||14
338650|NCT00578929|818660|P1|NOT COMPLETED|Randomized Period||17
338651|NCT00578929|818657|P4|COMPLETED|Randomized Period||283
338652|NCT00578929|818658|P3|COMPLETED|Randomized Period||288
338653|NCT00578929|818659|P2|COMPLETED|Randomized Period||283
338654|NCT00578929|818660|P1|COMPLETED|Randomized Period||281
338655|NCT00578929|818657|P4|STARTED|Randomized Period||297
338656|NCT00578929|818658|P3|STARTED|Randomized Period||296
338657|NCT00578929|818659|P2|STARTED|Randomized Period||297
338658|NCT00578929|818660|P1|STARTED|Randomized Period||298
338659|NCT00578929|818657|P4|NOT COMPLETED|Vehicle Run-In Period||0
338660|NCT00578929|818658|P3|NOT COMPLETED|Vehicle Run-In Period||0
338661|NCT00578929|818659|P2|NOT COMPLETED|Vehicle Run-In Period||0
338662|NCT00578929|818660|P1|NOT COMPLETED|Vehicle Run-In Period||0
338663|NCT00578929|818657|P4|COMPLETED|Vehicle Run-In Period||0
338664|NCT00578929|818658|P3|COMPLETED|Vehicle Run-In Period||0
338665|NCT00578929|818659|P2|COMPLETED|Vehicle Run-In Period||2388
338666|NCT00578929|818660|P1|COMPLETED|Vehicle Run-In Period||0
338667|NCT00578929|818657|P4|STARTED|Vehicle Run-In Period||0
338668|NCT00578929|818658|P3|STARTED|Vehicle Run-In Period||0
338669|NCT00578929|818659|P2|STARTED|Vehicle Run-In Period||2388
338670|NCT00578929|818660|P1|STARTED|Vehicle Run-In Period||0
338671|NCT00578903|818675|P1|NOT COMPLETED|Overall Study||0
338672|NCT00578903|818675|P1|COMPLETED|Overall Study||22
338673|NCT00578903|818675|P1|STARTED|Overall Study||22
338674|NCT00578877|818686|P2|NOT COMPLETED|Overall Study||128
338675|NCT00578877|818687|P1|NOT COMPLETED|Overall Study||81
338676|NCT00578877|818686|P2|COMPLETED|Overall Study||172
338677|NCT00578877|818687|P1|COMPLETED|Overall Study||69
338678|NCT00578877|818686|P2|STARTED|Overall Study||300
338679|NCT00578877|818687|P1|STARTED|Overall Study||150
338680|NCT00578864|818695|P2|NOT COMPLETED|Overall Study||0
338681|NCT00578864|818696|P1|NOT COMPLETED|Overall Study||1
338682|NCT00578864|818695|P2|COMPLETED|Overall Study||6
338683|NCT00578864|818696|P1|COMPLETED|Overall Study|died of complications of surgery after 2 cycles|6
338684|NCT00578864|818695|P2|STARTED|Overall Study||6
338685|NCT00578864|818696|P1|STARTED|Overall Study||7
338686|NCT00578812|818712|P2|NOT COMPLETED|Overall Study||7
338687|NCT00578812|818713|P1|NOT COMPLETED|Overall Study||6
338688|NCT00578812|818712|P2|COMPLETED|Overall Study||185
338689|NCT00578812|818713|P1|COMPLETED|Overall Study|Modified Intent-to-Treat (treated patients; analyzed as randomized).|218
338690|NCT00578812|818712|P2|STARTED|Overall Study||192
338691|NCT00578812|818713|P1|STARTED|Overall Study|Does not include investigational training patients (78 STARTED, 76 COMPLETED, 2 Not Treated).|224
338692|NCT00578786|818752|P3|NOT COMPLETED|Overall Study||30
338693|NCT00578786|818753|P2|NOT COMPLETED|Overall Study||66
338694|NCT00578786|818754|P1|NOT COMPLETED|Overall Study||39
338695|NCT00578786|818752|P3|COMPLETED|Overall Study||67
338696|NCT00578786|818753|P2|COMPLETED|Overall Study||124
338697|NCT00578786|818754|P1|COMPLETED|Overall Study||57
338698|NCT00578786|818752|P3|STARTED|Overall Study||97
338699|NCT00578786|818753|P2|STARTED|Overall Study||190
338700|NCT00578786|818754|P1|STARTED|Overall Study||96
338701|NCT00578734|818835|P2|NOT COMPLETED|Overall Study||0
338702|NCT00578734|818836|P1|NOT COMPLETED|Overall Study||0
338703|NCT00578734|818835|P2|COMPLETED|Overall Study||81
338704|NCT00578734|818836|P1|COMPLETED|Overall Study||84
338705|NCT00578734|818835|P2|STARTED|Overall Study||81
338706|NCT00578734|818836|P1|STARTED|Overall Study||84
338707|NCT00578669|818846|P2|NOT COMPLETED|Overall Study||0
338708|NCT00578669|818847|P1|NOT COMPLETED|Overall Study||0
338709|NCT00578669|818846|P2|COMPLETED|Overall Study||99
338710|NCT00578669|818847|P1|COMPLETED|Overall Study||107
338711|NCT00578669|818846|P2|STARTED|Overall Study||99
338712|NCT00578669|818847|P1|STARTED|Overall Study||107
338713|NCT00578643|818855|P1|NOT COMPLETED|Overall Study||2
338714|NCT00578643|818855|P1|COMPLETED|Overall Study||13
338715|NCT00578643|818855|P1|STARTED|Overall Study||15
338716|NCT00578617|818864|P2|NOT COMPLETED|Overall Study||0
338717|NCT00578617|818865|P1|NOT COMPLETED|Overall Study||0
338718|NCT00578617|818864|P2|COMPLETED|Overall Study||29
338719|NCT00578617|818865|P1|COMPLETED|Overall Study||31
338720|NCT00578617|818864|P2|STARTED|Overall Study||29
338721|NCT00578617|818865|P1|STARTED|Overall Study||31
338722|NCT00578565|818871|P1|NOT COMPLETED|Overall Study||3
338723|NCT00578565|818871|P1|COMPLETED|Overall Study||7
338724|NCT00578565|818871|P1|STARTED|Overall Study||10
338725|NCT00578552|818883|P3|NOT COMPLETED|Overall Study||15
338726|NCT00578552|818884|P2|NOT COMPLETED|Overall Study||14
338727|NCT00578552|818885|P1|NOT COMPLETED|Overall Study||15
338728|NCT00578552|818883|P3|COMPLETED|Overall Study||11
338729|NCT00578552|818884|P2|COMPLETED|Overall Study||13
338730|NCT00578552|818885|P1|COMPLETED|Overall Study||12
338731|NCT00578552|818883|P3|STARTED|Overall Study||26
338732|NCT00578552|818884|P2|STARTED|Overall Study||27
338733|NCT00578552|818885|P1|STARTED|Overall Study||27
338734|NCT00578539|818893|P1|NOT COMPLETED|Overall Study||0
338735|NCT00578539|818893|P1|COMPLETED|Overall Study||24
338736|NCT00578539|818893|P1|STARTED|Overall Study||24
338737|NCT00578461|818897|P1|NOT COMPLETED|Overall Study||0
338738|NCT00578461|818897|P1|COMPLETED|Overall Study||26
338739|NCT00578461|818897|P1|STARTED|Overall Study||26
338740|NCT00578448|818901|P1|NOT COMPLETED|1 Year Long Term Extension (LTE)||1
338741|NCT00578448|818901|P1|COMPLETED|1 Year Long Term Extension (LTE)||8
338742|NCT00578448|818901|P1|STARTED|1 Year Long Term Extension (LTE)||9
338743|NCT00578448|818901|P1|NOT COMPLETED|Day 1 up to 3 Years of Planned Study||3
338744|NCT00578448|818901|P1|COMPLETED|Day 1 up to 3 Years of Planned Study||9
338745|NCT00578448|818901|P1|STARTED|Day 1 up to 3 Years of Planned Study||12
338746|NCT00578383|818919|P4|NOT COMPLETED|Overall Study||6
338747|NCT00578383|818920|P3|NOT COMPLETED|Overall Study||6
338748|NCT00578383|818921|P2|NOT COMPLETED|Overall Study||16
338749|NCT00578383|818922|P1|NOT COMPLETED|Overall Study||16
338750|NCT00578383|818919|P4|COMPLETED|Overall Study||9
338751|NCT00578383|818920|P3|COMPLETED|Overall Study||13
338752|NCT00578383|818921|P2|COMPLETED|Overall Study||20
338753|NCT00578383|818922|P1|COMPLETED|Overall Study||21
338754|NCT00578383|818919|P4|STARTED|Overall Study||15
338755|NCT00578383|818920|P3|STARTED|Overall Study||19
338756|NCT00578383|818921|P2|STARTED|Overall Study||36
338757|NCT00578383|818922|P1|STARTED|Overall Study||37
338758|NCT00578331|818954|P2|NOT COMPLETED|Overall Study||125
338759|NCT00578331|818955|P1|NOT COMPLETED|Overall Study||116
338760|NCT00578331|818954|P2|COMPLETED|Overall Study||320
338761|NCT00578331|818955|P1|COMPLETED|Overall Study||329
338762|NCT00578331|818954|P2|STARTED|Overall Study||445
338763|NCT00578331|818955|P1|STARTED|Overall Study||445
338764|NCT00578318|818965|P2|NOT COMPLETED|Overall Study||0
338765|NCT00578318|818966|P1|NOT COMPLETED|Overall Study||3
338766|NCT00578318|818965|P2|COMPLETED|Overall Study||8
338767|NCT00578318|818966|P1|COMPLETED|Overall Study||5
338768|NCT00578318|818965|P2|STARTED|Overall Study||8
338769|NCT00578318|818966|P1|STARTED|Overall Study||8
338770|NCT00578305|818975|P3|NOT COMPLETED|Safety Follow-up Phase||46
338771|NCT00578305|818976|P2|NOT COMPLETED|Safety Follow-up Phase||45
338772|NCT00578305|818977|P1|NOT COMPLETED|Safety Follow-up Phase||46
338773|NCT00578305|818975|P3|COMPLETED|Safety Follow-up Phase||8
338774|NCT00578305|818976|P2|COMPLETED|Safety Follow-up Phase||9
338775|NCT00578305|818977|P1|COMPLETED|Safety Follow-up Phase||11
338776|NCT00578305|818975|P3|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
338777|NCT00578305|818976|P2|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
338778|NCT00578305|818977|P1|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|57
338779|NCT00578305|818975|P3|NOT COMPLETED|Extension Phase||3
338780|NCT00578305|818976|P2|NOT COMPLETED|Extension Phase||1
338781|NCT00578305|818977|P1|NOT COMPLETED|Extension Phase||4
338782|NCT00578305|818975|P3|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|40
338783|NCT00578305|818976|P2|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
338784|NCT00578305|818977|P1|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
338785|NCT00578305|818975|P3|STARTED|Extension Phase||43
338786|NCT00578305|818976|P2|STARTED|Extension Phase||50
338787|NCT00578305|818977|P1|STARTED|Extension Phase||53
338788|NCT00578305|818975|P3|NOT COMPLETED|Double-blind Treatment Phase||14
338789|NCT00578305|818976|P2|NOT COMPLETED|Double-blind Treatment Phase||4
338790|NCT00578305|818977|P1|NOT COMPLETED|Double-blind Treatment Phase||3
338791|NCT00578305|818975|P3|COMPLETED|Double-blind Treatment Phase||49
338792|NCT00578305|818976|P2|COMPLETED|Double-blind Treatment Phase||56
338793|NCT00578305|818977|P1|COMPLETED|Double-blind Treatment Phase||59
338794|NCT00578305|818975|P3|Treated|Double-blind Treatment Phase||63
338795|NCT00578305|818976|P2|Treated|Double-blind Treatment Phase||60
338796|NCT00578305|818977|P1|Treated|Double-blind Treatment Phase||62
338797|NCT00578305|818975|P3|STARTED|Double-blind Treatment Phase||63
338798|NCT00578305|818976|P2|STARTED|Double-blind Treatment Phase||60
338799|NCT00578305|818977|P1|STARTED|Double-blind Treatment Phase||62
338800|NCT00578279|819038|P2|NOT COMPLETED|Overall Study||0
338801|NCT00578279|819039|P1|NOT COMPLETED|Overall Study||0
338802|NCT00578279|819038|P2|COMPLETED|Overall Study||10
338803|NCT00578279|819039|P1|COMPLETED|Overall Study||10
338804|NCT00578279|819038|P2|STARTED|Overall Study||10
338805|NCT00578279|819039|P1|STARTED|Overall Study||10
338806|NCT00578227|819048|P3|NOT COMPLETED|Overall Study||4
338807|NCT00578227|819049|P2|NOT COMPLETED|Overall Study||2
338808|NCT00578227|819050|P1|NOT COMPLETED|Overall Study||5
338809|NCT00578227|819048|P3|COMPLETED|Overall Study||267
338810|NCT00578227|819049|P2|COMPLETED|Overall Study||268
338811|NCT00578227|819050|P1|COMPLETED|Overall Study||267
338812|NCT00578227|819048|P3|STARTED|Overall Study||271
338813|NCT00578227|819049|P2|STARTED|Overall Study||270
338814|NCT00578227|819050|P1|STARTED|Overall Study||272
338815|NCT00578214|819123|P3|NOT COMPLETED|Overall Study||0
338816|NCT00578214|819124|P2|NOT COMPLETED|Overall Study||0
338817|NCT00578214|819125|P1|NOT COMPLETED|Overall Study||0
338818|NCT00578214|819123|P3|COMPLETED|Overall Study||31
338819|NCT00578214|819124|P2|COMPLETED|Overall Study||22
338820|NCT00578214|819125|P1|COMPLETED|Overall Study||22
338821|NCT00578214|819123|P3|STARTED|Overall Study||31
338822|NCT00578214|819124|P2|STARTED|Overall Study||22
338823|NCT00578214|819125|P1|STARTED|Overall Study||22
338824|NCT00578175|819175|P3|NOT COMPLETED|Overall Study||24
338825|NCT00578175|819176|P2|NOT COMPLETED|Overall Study||43
338826|NCT00578175|819177|P1|NOT COMPLETED|Overall Study||70
338827|NCT00578175|819175|P3|COMPLETED|Overall Study||365
338828|NCT00578175|819176|P2|COMPLETED|Overall Study||646
338829|NCT00578175|819177|P1|COMPLETED|Overall Study||635
338830|NCT00578175|819175|P3|STARTED|Overall Study||389
338831|NCT00578175|819176|P2|STARTED|Overall Study||689
338832|NCT00578175|819177|P1|STARTED|Overall Study||705
338833|NCT00578136|819256|P2|NOT COMPLETED|Overall Study||1
338834|NCT00578136|819257|P1|NOT COMPLETED|Overall Study||1
338835|NCT00578136|819256|P2|COMPLETED|Overall Study||26
338836|NCT00578136|819257|P1|COMPLETED|Overall Study||26
338837|NCT00578136|819256|P2|STARTED|Overall Study||27
338838|NCT00578136|819257|P1|STARTED|Overall Study||27
338839|NCT00578071|819265|P1|NOT COMPLETED|Overall Study||0
338840|NCT00578071|819265|P1|COMPLETED|Overall Study||29
338841|NCT00578071|819265|P1|STARTED|Overall Study||29
338842|NCT00577889|819275|P3|NOT COMPLETED|Overall Study||0
338843|NCT00577889|819276|P2|NOT COMPLETED|Overall Study||0
338844|NCT00577889|819277|P1|NOT COMPLETED|Overall Study||1
338845|NCT00577889|819275|P3|COMPLETED|Overall Study||6
338846|NCT00577889|819276|P2|COMPLETED|Overall Study||6
338847|NCT00577889|819277|P1|COMPLETED|Overall Study||8
338848|NCT00577889|819275|P3|STARTED|Overall Study||6
338849|NCT00577889|819276|P2|STARTED|Overall Study||6
338850|NCT00577889|819277|P1|STARTED|Overall Study||9
338851|NCT00577863|819296|P2|NOT COMPLETED|Overall Study||14
338852|NCT00577863|819297|P1|NOT COMPLETED|Overall Study||10
338853|NCT00577863|819296|P2|COMPLETED|Overall Study||94
338854|NCT00577863|819297|P1|COMPLETED|Overall Study||82
338855|NCT00577863|819296|P2|Received at Least One Injection|Overall Study||107
338856|NCT00577863|819297|P1|Received at Least One Injection|Overall Study||92
338857|NCT00577863|819296|P2|STARTED|Overall Study||108
338858|NCT00577863|819297|P1|STARTED|Overall Study||92
338859|NCT00577824|819339|P3|NOT COMPLETED|Overall Study||2
338860|NCT00577824|819340|P2|NOT COMPLETED|Overall Study||20
338861|NCT00577824|819341|P1|NOT COMPLETED|Overall Study||7
338862|NCT00577824|819339|P3|COMPLETED|Overall Study||34
338863|NCT00577824|819340|P2|COMPLETED|Overall Study||53
338864|NCT00577824|819341|P1|COMPLETED|Overall Study||65
338865|NCT00577824|819339|P3|Full Analysis Set|Overall Study||35
338866|NCT00577824|819340|P2|Full Analysis Set|Overall Study||72
338867|NCT00577824|819341|P1|Full Analysis Set|Overall Study|Full Analysis Set=subject received at least one dose of study medication (active or placebo)|72
338868|NCT00577824|819339|P3|STARTED|Overall Study||36
338869|NCT00577824|819340|P2|STARTED|Overall Study||73
338870|NCT00577824|819341|P1|STARTED|Overall Study|Started=Randomized|72
338871|NCT00577772|819399|P2|NOT COMPLETED|Overall Study||1
338872|NCT00577772|819400|P1|NOT COMPLETED|Overall Study||0
338873|NCT00577772|819399|P2|COMPLETED|Overall Study||6
338874|NCT00577772|819400|P1|COMPLETED|Overall Study||10
338875|NCT00577772|819399|P2|STARTED|Overall Study||7
338876|NCT00577772|819400|P1|STARTED|Overall Study||10
338877|NCT00577720|819410|P4|NOT COMPLETED|Overall Study||7
338878|NCT00577720|819411|P3|NOT COMPLETED|Overall Study||1
338879|NCT00577720|819412|P2|NOT COMPLETED|Overall Study||1
338880|NCT00577720|819413|P1|NOT COMPLETED|Overall Study||4
338881|NCT00577720|819410|P4|COMPLETED|Overall Study||65
338882|NCT00577720|819411|P3|COMPLETED|Overall Study||35
338883|NCT00577720|819412|P2|COMPLETED|Overall Study||35
338884|NCT00577720|819413|P1|COMPLETED|Overall Study||33
338885|NCT00577720|819410|P4|ITT (Intent to Treat) Population|Overall Study||65
338886|NCT00577720|819411|P3|ITT (Intent to Treat) Population|Overall Study||35
338887|NCT00577720|819412|P2|ITT (Intent to Treat) Population|Overall Study||35
338888|NCT00577720|819413|P1|ITT (Intent to Treat) Population|Overall Study||34
338889|NCT00577720|819410|P4|STARTED|Overall Study||72
338890|NCT00577720|819411|P3|STARTED|Overall Study||36
338891|NCT00577720|819412|P2|STARTED|Overall Study||36
338892|NCT00577720|819413|P1|STARTED|Overall Study||37
338893|NCT00577707|819431|P1|NOT COMPLETED|Overall Study||3
338894|NCT00577707|819431|P1|COMPLETED|Overall Study||6
338895|NCT00577707|819431|P1|STARTED|Overall Study||9
338896|NCT00577655|819439|P2|NOT COMPLETED|Overall Study||4
338897|NCT00577655|819440|P1|NOT COMPLETED|Overall Study||1
338898|NCT00577655|819439|P2|COMPLETED|Overall Study||47
338899|NCT00577655|819440|P1|COMPLETED|Overall Study||51
338900|NCT00577655|819439|P2|STARTED|Overall Study|This number represents the number of participants randomized.|51
338901|NCT00577655|819440|P1|STARTED|Overall Study|This number represents the number of participants randomized.|52
338902|NCT00577642|819478|P1|NOT COMPLETED|Overall Study||1
338903|NCT00577642|819478|P1|COMPLETED|Overall Study||28
338904|NCT00577642|819478|P1|STARTED|Overall Study||29
338905|NCT00577629|819482|P1|NOT COMPLETED|Long Term Follow-Up||25
338906|NCT00577629|819482|P1|COMPLETED|Long Term Follow-Up||13
338907|NCT00577629|819482|P1|STARTED|Long Term Follow-Up||38
338908|NCT00577629|819482|P1|NOT COMPLETED|Treatment Period||1
338909|NCT00577629|819482|P1|COMPLETED|Treatment Period||38
338910|NCT00577629|819482|P1|STARTED|Treatment Period||39
338911|NCT00577590|819493|P3|NOT COMPLETED|Overall Study||0
338912|NCT00577590|819494|P2|NOT COMPLETED|Overall Study||0
338913|NCT00577590|819495|P1|NOT COMPLETED|Overall Study||0
338914|NCT00577590|819493|P3|COMPLETED|Overall Study||23
338915|NCT00577590|819494|P2|COMPLETED|Overall Study||27
338916|NCT00577590|819495|P1|COMPLETED|Overall Study||28
338917|NCT00577590|819493|P3|STARTED|Overall Study||23
338918|NCT00577590|819494|P2|STARTED|Overall Study||27
338919|NCT00577590|819495|P1|STARTED|Overall Study||28
338920|NCT00577512|819503|P1|NOT COMPLETED|Overall Study||4
338921|NCT00577512|819503|P1|COMPLETED|Overall Study||0
338922|NCT00577512|819503|P1|STARTED|Overall Study||4
338923|NCT00577473|819509|P2|NOT COMPLETED|Overall Study||24
338924|NCT00577473|819510|P1|NOT COMPLETED|Overall Study||21
338925|NCT00577473|819509|P2|COMPLETED|Overall Study||123
338926|NCT00577473|819510|P1|COMPLETED|Overall Study||133
338927|NCT00577473|819509|P2|ITT Population|Overall Study||136
338928|NCT00577473|819510|P1|ITT Population|Overall Study||150
338929|NCT00577473|819509|P2|STARTED|Overall Study||147
338930|NCT00577473|819510|P1|STARTED|Overall Study||154
338931|NCT00577460|819541|P3|NOT COMPLETED|Overall Study||27
338932|NCT00577460|819542|P2|NOT COMPLETED|Overall Study||19
338933|NCT00577460|819543|P1|NOT COMPLETED|Overall Study||16
338934|NCT00577460|819541|P3|COMPLETED|Overall Study||112
338935|NCT00577460|819542|P2|COMPLETED|Overall Study||104
338936|NCT00577460|819543|P1|COMPLETED|Overall Study||113
338937|NCT00577460|819541|P3|STARTED|Overall Study||139
338938|NCT00577460|819542|P2|STARTED|Overall Study||123
338939|NCT00577460|819543|P1|STARTED|Overall Study||129
338940|NCT00577408|819652|P2|NOT COMPLETED|Overall Study||23
338941|NCT00577408|819653|P1|NOT COMPLETED|Overall Study||12
338942|NCT00577408|819652|P2|COMPLETED|Overall Study||9
338943|NCT00577408|819653|P1|COMPLETED|Overall Study||16
338944|NCT00577408|819652|P2|STARTED|Overall Study||32
338945|NCT00577408|819653|P1|STARTED|Overall Study||28
338946|NCT00577395|819661|P2|NOT COMPLETED|Overall Study||6
338947|NCT00577395|819662|P1|NOT COMPLETED|Overall Study||7
338948|NCT00577395|819661|P2|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
338949|NCT00577395|819662|P1|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
338950|NCT00577395|819661|P2|STARTED|Overall Study|67 were planned for Treatment 1, but due to enrollment difficulties this was not met.|6
338951|NCT00577395|819662|P1|STARTED|Overall Study|67 planned for Treatment 2, but due to enrollment difficulties this was not met.|7
338952|NCT00577382|819672|P2|NOT COMPLETED|Overall Study||31
338953|NCT00577382|819673|P1|NOT COMPLETED|Overall Study||21
338954|NCT00577382|819672|P2|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
338955|NCT00577382|819673|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
338956|NCT00577382|819672|P2|STARTED|Overall Study||31
338957|NCT00577382|819673|P1|STARTED|Overall Study||21
338958|NCT00577356|819685|P1|NOT COMPLETED|Overall Study||0
338959|NCT00577356|819685|P1|COMPLETED|Overall Study||6
338960|NCT00577356|819685|P1|STARTED|Overall Study||6
338961|NCT00577135|819693|P4|NOT COMPLETED|Overall Study||0
338962|NCT00577135|819694|P3|NOT COMPLETED|Overall Study||0
338963|NCT00577135|819695|P2|NOT COMPLETED|Overall Study||0
338964|NCT00577135|819696|P1|NOT COMPLETED|Overall Study||0
338965|NCT00577135|819693|P4|COMPLETED|Overall Study||75
338966|NCT00577135|819694|P3|COMPLETED|Overall Study||77
338967|NCT00577135|819695|P2|COMPLETED|Overall Study||82
338968|NCT00577135|819696|P1|COMPLETED|Overall Study||74
338969|NCT00577135|819693|P4|STARTED|Overall Study||75
338970|NCT00577135|819694|P3|STARTED|Overall Study||77
338971|NCT00577135|819695|P2|STARTED|Overall Study||82
338972|NCT00577135|819696|P1|STARTED|Overall Study||74
338973|NCT00577122|819816|P2|NOT COMPLETED|Overall Study||16
338974|NCT00577122|819817|P1|NOT COMPLETED|Overall Study||14
338975|NCT00577122|819816|P2|COMPLETED|Overall Study||0
338976|NCT00577122|819817|P1|COMPLETED|Overall Study||0
338977|NCT00577122|819816|P2|STARTED|Overall Study||16
338978|NCT00577122|819817|P1|STARTED|Overall Study||14
338979|NCT00577096|819831|P2|NOT COMPLETED|Long Term Participation||0
338980|NCT00577096|819832|P1|NOT COMPLETED|Long Term Participation||0
338981|NCT00577096|819831|P2|COMPLETED|Long Term Participation|Sub-set of patients (n=69) who completed short term (n=120) continued in long term participation.|35
338982|NCT00577096|819832|P1|COMPLETED|Long Term Participation||34
338983|NCT00577096|819831|P2|STARTED|Long Term Participation|Only 35 patients who met long-term eligibility (response to EPO) were enrolled.|35
338984|NCT00577096|819832|P1|STARTED|Long Term Participation|Only the first 34 patients who met long-term eligibility (response to EPO) were enrolled.|34
338985|NCT00577096|819831|P2|NOT COMPLETED|Short Term Participation||8
338986|NCT00577096|819832|P1|NOT COMPLETED|Short Term Participation||7
338987|NCT00577096|819831|P2|COMPLETED|Short Term Participation||58
338988|NCT00577096|819832|P1|COMPLETED|Short Term Participation||62
338989|NCT00577096|819831|P2|STARTED|Short Term Participation||66
338990|NCT00577096|819832|P1|STARTED|Short Term Participation||69
338991|NCT00577083|819858|P2|NOT COMPLETED|Second Intervention (14days)||0
338992|NCT00577083|819859|P1|NOT COMPLETED|Second Intervention (14days)||0
338993|NCT00577083|819858|P2|COMPLETED|Second Intervention (14days)||52
338994|NCT00577083|819859|P1|COMPLETED|Second Intervention (14days)||48
338995|NCT00577083|819858|P2|STARTED|Second Intervention (14days)||52
338996|NCT00577083|819859|P1|STARTED|Second Intervention (14days)||48
338997|NCT00577083|819858|P2|NOT COMPLETED|Washout (14 Days)||0
338998|NCT00577083|819859|P1|NOT COMPLETED|Washout (14 Days)||0
338999|NCT00577083|819858|P2|COMPLETED|Washout (14 Days)||52
339000|NCT00577083|819859|P1|COMPLETED|Washout (14 Days)||48
339001|NCT00577083|819858|P2|STARTED|Washout (14 Days)||52
339002|NCT00577083|819859|P1|STARTED|Washout (14 Days)||48
339003|NCT00577083|819858|P2|NOT COMPLETED|First Intervention (14 Days)||0
339004|NCT00577083|819859|P1|NOT COMPLETED|First Intervention (14 Days)||0
339005|NCT00577083|819858|P2|COMPLETED|First Intervention (14 Days)||52
339006|NCT00577083|819859|P1|COMPLETED|First Intervention (14 Days)||48
339007|NCT00577083|819858|P2|STARTED|First Intervention (14 Days)||52
339008|NCT00577083|819859|P1|STARTED|First Intervention (14 Days)||48
339009|NCT00577031|819871|P1|NOT COMPLETED|Overall Study||205
339010|NCT00577031|819871|P1|COMPLETED|Overall Study||0
339011|NCT00577031|819871|P1|STARTED|Overall Study||205
339012|NCT00577005|819892|P2|NOT COMPLETED|Overall Study||3
339013|NCT00577005|819893|P1|NOT COMPLETED|Overall Study||5
339014|NCT00577005|819892|P2|COMPLETED|Overall Study||9
339015|NCT00577005|819893|P1|COMPLETED|Overall Study||11
339016|NCT00577005|819892|P2|STARTED|Overall Study||12
339017|NCT00577005|819893|P1|STARTED|Overall Study||16
339018|NCT00576927|819907|P1|NOT COMPLETED|Randomization 1:1 Placebo or Active Drug||0
339019|NCT00576927|819907|P1|COMPLETED|Randomization 1:1 Placebo or Active Drug||22
339020|NCT00576927|819907|P1|STARTED|Randomization 1:1 Placebo or Active Drug||22
339021|NCT00576927|819907|P1|NOT COMPLETED|Sleep Hygiene With Study Drug||0
339022|NCT00576927|819907|P1|COMPLETED|Sleep Hygiene With Study Drug||22
339023|NCT00576927|819907|P1|STARTED|Sleep Hygiene With Study Drug||22
339024|NCT00576927|819907|P1|NOT COMPLETED|Sleep Hygiene With the Placebo||1
339025|NCT00576927|819907|P1|COMPLETED|Sleep Hygiene With the Placebo||22
339026|NCT00576927|819907|P1|STARTED|Sleep Hygiene With the Placebo||23
339027|NCT00576927|819907|P1|NOT COMPLETED|Sleep Hygiene Behavioral Intervention||7
339028|NCT00576927|819907|P1|COMPLETED|Sleep Hygiene Behavioral Intervention||23
339029|NCT00576927|819907|P1|STARTED|Sleep Hygiene Behavioral Intervention||30
339030|NCT00576927|819907|P1|NOT COMPLETED|Baseline||13
339031|NCT00576927|819907|P1|COMPLETED|Baseline||30
339032|NCT00576927|819907|P1|STARTED|Baseline||43
339033|NCT00576927|819907|P1|NOT COMPLETED|Clinical Assessment||36
339034|NCT00576927|819907|P1|COMPLETED|Clinical Assessment||43
339035|NCT00576927|819907|P1|STARTED|Clinical Assessment||79
339036|NCT00576901|819919|P1|NOT COMPLETED|Overall Study||3
339037|NCT00576901|819919|P1|COMPLETED|Overall Study||20
339038|NCT00576901|819919|P1|STARTED|Overall Study||23
339039|NCT00576823|819930|P3|NOT COMPLETED|40-week Safety Extension Phase||0
339040|NCT00576823|819931|P2|NOT COMPLETED|40-week Safety Extension Phase||0
339041|NCT00576823|819932|P1|NOT COMPLETED|40-week Safety Extension Phase||1
339042|NCT00576823|819930|P3|COMPLETED|40-week Safety Extension Phase||6
339043|NCT00576823|819931|P2|COMPLETED|40-week Safety Extension Phase||6
339044|NCT00576823|819932|P1|COMPLETED|40-week Safety Extension Phase||10
339045|NCT00576823|819930|P3|STARTED|40-week Safety Extension Phase|One patient refused to continue in the extension phase.|6
339046|NCT00576823|819931|P2|STARTED|40-week Safety Extension Phase||6
339047|NCT00576823|819932|P1|STARTED|40-week Safety Extension Phase||11
339048|NCT00576823|819930|P3|NOT COMPLETED|12-week Efficacy Phase||0
339049|NCT00576823|819931|P2|NOT COMPLETED|12-week Efficacy Phase||0
339050|NCT00576823|819932|P1|NOT COMPLETED|12-week Efficacy Phase||1
339051|NCT00576823|819930|P3|COMPLETED|12-week Efficacy Phase||7
339052|NCT00576823|819931|P2|COMPLETED|12-week Efficacy Phase||6
339053|NCT00576823|819932|P1|COMPLETED|12-week Efficacy Phase||11
339054|NCT00576823|819930|P3|STARTED|12-week Efficacy Phase||7
339055|NCT00576823|819931|P2|STARTED|12-week Efficacy Phase||6
339056|NCT00576823|819932|P1|STARTED|12-week Efficacy Phase||12
339057|NCT00576758|819948|P2|NOT COMPLETED|Follow-up Period||17
339058|NCT00576758|819949|P1|NOT COMPLETED|Follow-up Period||27
339059|NCT00576758|819948|P2|COMPLETED|Follow-up Period||34
339060|NCT00576758|819949|P1|COMPLETED|Follow-up Period||28
339061|NCT00576758|819948|P2|STARTED|Follow-up Period|Includes 21 pts who entered follow-up after induction and didn't enter the extended treatment phase.|51
339062|NCT00576758|819949|P1|STARTED|Follow-up Period|Includes 23 pts who entered follow-up after induction and didn't enter the extended treatment phase.|55
339063|NCT00576758|819948|P2|NOT COMPLETED|Extension Treatment Period||43
339064|NCT00576758|819949|P1|NOT COMPLETED|Extension Treatment Period||42
339065|NCT00576758|819948|P2|COMPLETED|Extension Treatment Period||30
339066|NCT00576758|819949|P1|COMPLETED|Extension Treatment Period|+ 2 patients (pts) who withdrew prior to receiving study drug.|30
339067|NCT00576758|819948|P2|STARTED|Extension Treatment Period|8 patients did not enter extended treatment phase/follow-up phase + 2 patients entered follow-up.|73
339068|NCT00576758|819949|P1|STARTED|Extension Treatment Period|6 patients did not enter extended treatment phase/follow-up + 1 patient entered follow-up.|72
339069|NCT00576758|819948|P2|NOT COMPLETED|Induction Treatment Period||5
339070|NCT00576758|819949|P1|NOT COMPLETED|Induction Treatment Period||8
339071|NCT00576758|819948|P2|COMPLETED|Induction Treatment Period||83
339072|NCT00576758|819949|P1|COMPLETED|Induction Treatment Period||79
339073|NCT00576758|819948|P2|Received Treatment|Induction Treatment Period||87
339074|NCT00576758|819949|P1|Received Treatment|Induction Treatment Period||86
339075|NCT00576758|819948|P2|STARTED|Induction Treatment Period||88
339076|NCT00576758|819949|P1|STARTED|Induction Treatment Period||87
339077|NCT00576732|819995|P6|NOT COMPLETED|OPEN LABEL||8
339078|NCT00576732|819996|P5|NOT COMPLETED|OPEN LABEL||4
339079|NCT00576732|819997|P4|NOT COMPLETED|OPEN LABEL||11
339080|NCT00576732|819998|P3|NOT COMPLETED|OPEN LABEL||0
339081|NCT00576732|819999|P2|NOT COMPLETED|OPEN LABEL||0
339082|NCT00576732|820000|P1|NOT COMPLETED|OPEN LABEL||0
339083|NCT00576732|819995|P6|COMPLETED|OPEN LABEL||17
339084|NCT00576732|819996|P5|COMPLETED|OPEN LABEL||20
339085|NCT00576732|819997|P4|COMPLETED|OPEN LABEL||19
339086|NCT00576732|819998|P3|COMPLETED|OPEN LABEL||0
339087|NCT00576732|819999|P2|COMPLETED|OPEN LABEL||0
339088|NCT00576732|820000|P1|COMPLETED|OPEN LABEL||0
339089|NCT00576732|819995|P6|STARTED|OPEN LABEL|All 25 double-blind RIS high dose completers and 0 RIS high dose non-completers entered open-label.|25
339090|NCT00576732|819996|P5|STARTED|OPEN LABEL|24 of 25 double-blind RIS low dose completers and 0 RIS low dose non-completers entered open-label.|24
339091|NCT00576732|819997|P4|STARTED|OPEN LABEL|26 of 27 double-blind placebo completers and 4 of 8 placebo non-completers entered open-label.|30
339092|NCT00576732|819998|P3|STARTED|OPEN LABEL||0
339093|NCT00576732|819999|P2|STARTED|OPEN LABEL||0
339094|NCT00576732|820000|P1|STARTED|OPEN LABEL||0
339095|NCT00576732|819995|P6|NOT COMPLETED|DOUBLE BLIND||0
339096|NCT00576732|819996|P5|NOT COMPLETED|DOUBLE BLIND||0
339097|NCT00576732|819997|P4|NOT COMPLETED|DOUBLE BLIND||0
339098|NCT00576732|819998|P3|NOT COMPLETED|DOUBLE BLIND||6
339099|NCT00576732|819999|P2|NOT COMPLETED|DOUBLE BLIND||5
339100|NCT00576732|820000|P1|NOT COMPLETED|DOUBLE BLIND||8
339101|NCT00576732|819995|P6|COMPLETED|DOUBLE BLIND||0
339102|NCT00576732|819996|P5|COMPLETED|DOUBLE BLIND||0
339103|NCT00576732|819997|P4|COMPLETED|DOUBLE BLIND||0
339104|NCT00576732|819998|P3|COMPLETED|DOUBLE BLIND||25
339105|NCT00576732|819999|P2|COMPLETED|DOUBLE BLIND||25
339106|NCT00576732|820000|P1|COMPLETED|DOUBLE BLIND||27
339107|NCT00576732|819995|P6|STARTED|DOUBLE BLIND||0
339108|NCT00576732|819996|P5|STARTED|DOUBLE BLIND||0
339109|NCT00576732|819997|P4|STARTED|DOUBLE BLIND||0
339110|NCT00576732|819998|P3|STARTED|DOUBLE BLIND||31
339111|NCT00576732|819999|P2|STARTED|DOUBLE BLIND||30
339112|NCT00576732|820000|P1|STARTED|DOUBLE BLIND||35
339113|NCT00576693|820032|P2|NOT COMPLETED|Overall Study||24
339114|NCT00576693|820033|P1|NOT COMPLETED|Overall Study||10
339115|NCT00576693|820032|P2|COMPLETED|Overall Study||203
339116|NCT00576693|820033|P1|COMPLETED|Overall Study||214
339117|NCT00576693|820032|P2|STARTED|Overall Study||227
339118|NCT00576693|820033|P1|STARTED|Overall Study||224
339119|NCT00576628|820039|P1|NOT COMPLETED|Overall Study||43
339120|NCT00576628|820039|P1|COMPLETED|Overall Study||82
339121|NCT00576628|820039|P1|STARTED|Overall Study||125
339122|NCT00576576|820059|P1|NOT COMPLETED|Overall Study||7
339123|NCT00576576|820059|P1|COMPLETED|Overall Study||20
339124|NCT00576576|820059|P1|STARTED|Overall Study||27
339125|NCT00576524|820067|P2|NOT COMPLETED|Overall Study||0
339126|NCT00576524|820068|P1|NOT COMPLETED|Overall Study||0
339127|NCT00576524|820067|P2|COMPLETED|Overall Study||0
339128|NCT00576524|820068|P1|COMPLETED|Overall Study||2
339129|NCT00576524|820067|P2|STARTED|Overall Study||0
339130|NCT00576524|820068|P1|STARTED|Overall Study||2
339131|NCT00576472|820093|P15|NOT COMPLETED|MPH Home Maintenance Phase||23
339132|NCT00576472|820094|P14|NOT COMPLETED|MPH Home Maintenance Phase||27
339133|NCT00576472|820095|P13|NOT COMPLETED|MPH Home Maintenance Phase||0
339134|NCT00576472|820096|P12|NOT COMPLETED|MPH Home Maintenance Phase||0
339135|NCT00576472|820097|P11|NOT COMPLETED|MPH Home Maintenance Phase||0
339136|NCT00576472|820098|P10|NOT COMPLETED|MPH Home Maintenance Phase||0
339137|NCT00576472|820099|P9|NOT COMPLETED|MPH Home Maintenance Phase||0
339138|NCT00576472|820100|P8|NOT COMPLETED|MPH Home Maintenance Phase||0
339139|NCT00576472|820101|P7|NOT COMPLETED|MPH Home Maintenance Phase||0
339140|NCT00576472|820102|P6|NOT COMPLETED|MPH Home Maintenance Phase||0
339141|NCT00576472|820103|P5|NOT COMPLETED|MPH Home Maintenance Phase||0
339142|NCT00576472|820104|P4|NOT COMPLETED|MPH Home Maintenance Phase||0
339143|NCT00576472|820105|P3|NOT COMPLETED|MPH Home Maintenance Phase||0
339144|NCT00576472|820106|P2|NOT COMPLETED|MPH Home Maintenance Phase||0
339145|NCT00576472|820107|P1|NOT COMPLETED|MPH Home Maintenance Phase||0
339146|NCT00576472|820093|P15|COMPLETED|MPH Home Maintenance Phase||68
339147|NCT00576472|820094|P14|COMPLETED|MPH Home Maintenance Phase||0
339148|NCT00576472|820095|P13|COMPLETED|MPH Home Maintenance Phase||0
339149|NCT00576472|820096|P12|COMPLETED|MPH Home Maintenance Phase||0
339150|NCT00576472|820097|P11|COMPLETED|MPH Home Maintenance Phase||0
339151|NCT00576472|820098|P10|COMPLETED|MPH Home Maintenance Phase||0
339152|NCT00576472|820099|P9|COMPLETED|MPH Home Maintenance Phase||0
339153|NCT00576472|820100|P8|COMPLETED|MPH Home Maintenance Phase||0
339154|NCT00576472|820101|P7|COMPLETED|MPH Home Maintenance Phase||0
339155|NCT00576472|820102|P6|COMPLETED|MPH Home Maintenance Phase||0
339156|NCT00576472|820103|P5|COMPLETED|MPH Home Maintenance Phase||0
339157|NCT00576472|820104|P4|COMPLETED|MPH Home Maintenance Phase||0
339158|NCT00576472|820105|P3|COMPLETED|MPH Home Maintenance Phase||0
339159|NCT00576472|820106|P2|COMPLETED|MPH Home Maintenance Phase||0
339160|NCT00576472|820107|P1|COMPLETED|MPH Home Maintenance Phase||0
339161|NCT00576472|820093|P15|STARTED|MPH Home Maintenance Phase||91
339162|NCT00576472|820094|P14|STARTED|MPH Home Maintenance Phase||27
339163|NCT00576472|820095|P13|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
339164|NCT00576472|820096|P12|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
339165|NCT00576472|820097|P11|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
339166|NCT00576472|820098|P10|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
339167|NCT00576472|820099|P9|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
339168|NCT00576472|820100|P8|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
339169|NCT00576472|820101|P7|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
339170|NCT00576472|820102|P6|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
339171|NCT00576472|820103|P5|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
339172|NCT00576472|820104|P4|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
339173|NCT00576472|820105|P3|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
339174|NCT00576472|820106|P2|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
339175|NCT00576472|820107|P1|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
339176|NCT00576472|820093|P15|NOT COMPLETED|MPH Cross Over Phase||0
339177|NCT00576472|820094|P14|NOT COMPLETED|MPH Cross Over Phase||0
339178|NCT00576472|820095|P13|NOT COMPLETED|MPH Cross Over Phase||0
339179|NCT00576472|820096|P12|NOT COMPLETED|MPH Cross Over Phase||1
339180|NCT00576472|820097|P11|NOT COMPLETED|MPH Cross Over Phase||1
339181|NCT00576472|820098|P10|NOT COMPLETED|MPH Cross Over Phase||0
339182|NCT00576472|820099|P9|NOT COMPLETED|MPH Cross Over Phase||2
339183|NCT00576472|820100|P8|NOT COMPLETED|MPH Cross Over Phase||0
339184|NCT00576472|820101|P7|NOT COMPLETED|MPH Cross Over Phase||12
339185|NCT00576472|820102|P6|NOT COMPLETED|MPH Cross Over Phase||0
339186|NCT00576472|820103|P5|NOT COMPLETED|MPH Cross Over Phase||0
339187|NCT00576472|820104|P4|NOT COMPLETED|MPH Cross Over Phase||0
339188|NCT00576472|820105|P3|NOT COMPLETED|MPH Cross Over Phase||0
339189|NCT00576472|820106|P2|NOT COMPLETED|MPH Cross Over Phase||0
339190|NCT00576472|820107|P1|NOT COMPLETED|MPH Cross Over Phase||0
339191|NCT00576472|820093|P15|COMPLETED|MPH Cross Over Phase||0
339192|NCT00576472|820094|P14|COMPLETED|MPH Cross Over Phase||0
339193|NCT00576472|820095|P13|COMPLETED|MPH Cross Over Phase||21
339194|NCT00576472|820096|P12|COMPLETED|MPH Cross Over Phase||17
339195|NCT00576472|820097|P11|COMPLETED|MPH Cross Over Phase||22
339196|NCT00576472|820098|P10|COMPLETED|MPH Cross Over Phase||22
339197|NCT00576472|820099|P9|COMPLETED|MPH Cross Over Phase||16
339198|NCT00576472|820100|P8|COMPLETED|MPH Cross Over Phase||20
339199|NCT00576472|820101|P7|COMPLETED|MPH Cross Over Phase||0
339200|NCT00576472|820102|P6|COMPLETED|MPH Cross Over Phase||0
339201|NCT00576472|820103|P5|COMPLETED|MPH Cross Over Phase||0
339202|NCT00576472|820104|P4|COMPLETED|MPH Cross Over Phase||0
339203|NCT00576472|820105|P3|COMPLETED|MPH Cross Over Phase||0
339204|NCT00576472|820106|P2|COMPLETED|MPH Cross Over Phase||0
339205|NCT00576472|820107|P1|COMPLETED|MPH Cross Over Phase||0
339206|NCT00576472|820093|P15|STARTED|MPH Cross Over Phase||0
339207|NCT00576472|820094|P14|STARTED|MPH Cross Over Phase||0
339208|NCT00576472|820095|P13|STARTED|MPH Cross Over Phase||21
339209|NCT00576472|820096|P12|STARTED|MPH Cross Over Phase||18
339210|NCT00576472|820097|P11|STARTED|MPH Cross Over Phase||23
339211|NCT00576472|820098|P10|STARTED|MPH Cross Over Phase||22
339212|NCT00576472|820099|P9|STARTED|MPH Cross Over Phase||18
339213|NCT00576472|820100|P8|STARTED|MPH Cross Over Phase||20
339214|NCT00576472|820101|P7|STARTED|MPH Cross Over Phase||12
339215|NCT00576472|820102|P6|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
339216|NCT00576472|820103|P5|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
339217|NCT00576472|820104|P4|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
339218|NCT00576472|820105|P3|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
339219|NCT00576472|820106|P2|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
339220|NCT00576472|820107|P1|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
339221|NCT00576472|820093|P15|NOT COMPLETED|MPH In-Lab Phase||0
339222|NCT00576472|820094|P14|NOT COMPLETED|MPH In-Lab Phase||0
339223|NCT00576472|820095|P13|NOT COMPLETED|MPH In-Lab Phase||0
339224|NCT00576472|820096|P12|NOT COMPLETED|MPH In-Lab Phase||0
339225|NCT00576472|820097|P11|NOT COMPLETED|MPH In-Lab Phase||0
339226|NCT00576472|820098|P10|NOT COMPLETED|MPH In-Lab Phase||0
339227|NCT00576472|820099|P9|NOT COMPLETED|MPH In-Lab Phase||0
339228|NCT00576472|820100|P8|NOT COMPLETED|MPH In-Lab Phase||0
339229|NCT00576472|820101|P7|NOT COMPLETED|MPH In-Lab Phase||0
339230|NCT00576472|820102|P6|NOT COMPLETED|MPH In-Lab Phase||0
339231|NCT00576472|820103|P5|NOT COMPLETED|MPH In-Lab Phase||0
339232|NCT00576472|820104|P4|NOT COMPLETED|MPH In-Lab Phase||335
339233|NCT00576472|820105|P3|NOT COMPLETED|MPH In-Lab Phase||0
339234|NCT00576472|820106|P2|NOT COMPLETED|MPH In-Lab Phase||0
339235|NCT00576472|820107|P1|NOT COMPLETED|MPH In-Lab Phase||0
339236|NCT00576472|820093|P15|COMPLETED|MPH In-Lab Phase||0
339237|NCT00576472|820094|P14|COMPLETED|MPH In-Lab Phase||0
339238|NCT00576472|820095|P13|COMPLETED|MPH In-Lab Phase||0
339239|NCT00576472|820096|P12|COMPLETED|MPH In-Lab Phase||0
339240|NCT00576472|820097|P11|COMPLETED|MPH In-Lab Phase||0
339241|NCT00576472|820098|P10|COMPLETED|MPH In-Lab Phase||0
339242|NCT00576472|820099|P9|COMPLETED|MPH In-Lab Phase||0
339243|NCT00576472|820100|P8|COMPLETED|MPH In-Lab Phase||0
339244|NCT00576472|820101|P7|COMPLETED|MPH In-Lab Phase||0
339245|NCT00576472|820102|P6|COMPLETED|MPH In-Lab Phase||67
339246|NCT00576472|820103|P5|COMPLETED|MPH In-Lab Phase||67
339247|NCT00576472|820104|P4|COMPLETED|MPH In-Lab Phase||0
339248|NCT00576472|820105|P3|COMPLETED|MPH In-Lab Phase||0
339249|NCT00576472|820106|P2|COMPLETED|MPH In-Lab Phase||0
339250|NCT00576472|820107|P1|COMPLETED|MPH In-Lab Phase||0
339251|NCT00576472|820093|P15|STARTED|MPH In-Lab Phase||0
339252|NCT00576472|820094|P14|STARTED|MPH In-Lab Phase||0
339253|NCT00576472|820095|P13|STARTED|MPH In-Lab Phase||0
339254|NCT00576472|820096|P12|STARTED|MPH In-Lab Phase||0
339255|NCT00576472|820097|P11|STARTED|MPH In-Lab Phase||0
339256|NCT00576472|820098|P10|STARTED|MPH In-Lab Phase||0
339257|NCT00576472|820099|P9|STARTED|MPH In-Lab Phase||0
339258|NCT00576472|820100|P8|STARTED|MPH In-Lab Phase||0
339259|NCT00576472|820101|P7|STARTED|MPH In-Lab Phase||0
339260|NCT00576472|820102|P6|STARTED|MPH In-Lab Phase||67
339261|NCT00576472|820103|P5|STARTED|MPH In-Lab Phase||67
339262|NCT00576472|820104|P4|STARTED|MPH In-Lab Phase||335
339263|NCT00576472|820105|P3|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
339264|NCT00576472|820106|P2|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
339265|NCT00576472|820107|P1|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
339266|NCT00576472|820093|P15|NOT COMPLETED|Initial Screening||0
339267|NCT00576472|820094|P14|NOT COMPLETED|Initial Screening||0
339268|NCT00576472|820095|P13|NOT COMPLETED|Initial Screening||0
339269|NCT00576472|820096|P12|NOT COMPLETED|Initial Screening||0
339270|NCT00576472|820097|P11|NOT COMPLETED|Initial Screening||0
339271|NCT00576472|820098|P10|NOT COMPLETED|Initial Screening||0
339272|NCT00576472|820099|P9|NOT COMPLETED|Initial Screening||0
339273|NCT00576472|820100|P8|NOT COMPLETED|Initial Screening||0
339274|NCT00576472|820101|P7|NOT COMPLETED|Initial Screening||0
339275|NCT00576472|820102|P6|NOT COMPLETED|Initial Screening||0
339276|NCT00576472|820103|P5|NOT COMPLETED|Initial Screening||0
339277|NCT00576472|820104|P4|NOT COMPLETED|Initial Screening||0
339278|NCT00576472|820105|P3|NOT COMPLETED|Initial Screening||0
339279|NCT00576472|820106|P2|NOT COMPLETED|Initial Screening||0
339280|NCT00576472|820107|P1|NOT COMPLETED|Initial Screening||0
339281|NCT00576472|820093|P15|COMPLETED|Initial Screening||0
339282|NCT00576472|820094|P14|COMPLETED|Initial Screening||0
339283|NCT00576472|820095|P13|COMPLETED|Initial Screening||0
339284|NCT00576472|820096|P12|COMPLETED|Initial Screening||0
339285|NCT00576472|820097|P11|COMPLETED|Initial Screening||0
339286|NCT00576472|820098|P10|COMPLETED|Initial Screening||0
339287|NCT00576472|820099|P9|COMPLETED|Initial Screening||0
339288|NCT00576472|820100|P8|COMPLETED|Initial Screening||0
339289|NCT00576472|820101|P7|COMPLETED|Initial Screening||0
339290|NCT00576472|820102|P6|COMPLETED|Initial Screening||0
339291|NCT00576472|820103|P5|COMPLETED|Initial Screening||0
339292|NCT00576472|820104|P4|COMPLETED|Initial Screening||0
339293|NCT00576472|820105|P3|COMPLETED|Initial Screening||199
339294|NCT00576472|820106|P2|COMPLETED|Initial Screening||40
339295|NCT00576472|820107|P1|COMPLETED|Initial Screening||230
339296|NCT00576472|820093|P15|STARTED|Initial Screening||0
339297|NCT00576472|820094|P14|STARTED|Initial Screening||0
339298|NCT00576472|820095|P13|STARTED|Initial Screening||0
339299|NCT00576472|820096|P12|STARTED|Initial Screening||0
339300|NCT00576472|820097|P11|STARTED|Initial Screening||0
339301|NCT00576472|820098|P10|STARTED|Initial Screening||0
339302|NCT00576472|820099|P9|STARTED|Initial Screening||0
339303|NCT00576472|820100|P8|STARTED|Initial Screening||0
339304|NCT00576472|820101|P7|STARTED|Initial Screening||0
339305|NCT00576472|820102|P6|STARTED|Initial Screening||0
339306|NCT00576472|820103|P5|STARTED|Initial Screening||0
339307|NCT00576472|820104|P4|STARTED|Initial Screening||0
339308|NCT00576472|820105|P3|STARTED|Initial Screening||199
339309|NCT00576472|820106|P2|STARTED|Initial Screening||40
339310|NCT00576472|820107|P1|STARTED|Initial Screening||230
339311|NCT00576420|820200|P3|NOT COMPLETED|Overall Study||1
339312|NCT00576420|820201|P2|NOT COMPLETED|Overall Study||0
339313|NCT00576420|820202|P1|NOT COMPLETED|Overall Study||0
339314|NCT00576420|820200|P3|COMPLETED|Overall Study||22
339315|NCT00576420|820201|P2|COMPLETED|Overall Study||24
339316|NCT00576420|820202|P1|COMPLETED|Overall Study||26
339317|NCT00576420|820200|P3|STARTED|Overall Study||23
339318|NCT00576420|820201|P2|STARTED|Overall Study||24
339319|NCT00576420|820202|P1|STARTED|Overall Study||26
339320|NCT00576381|820367|P1|NOT COMPLETED|Overall Study||7
339321|NCT00576381|820367|P1|COMPLETED|Overall Study||23
339322|NCT00576381|820367|P1|STARTED|Overall Study||30
339323|NCT00576316|820371|P1|NOT COMPLETED|Overall Study||20
339324|NCT00576316|820371|P1|COMPLETED|Overall Study|Number of patients who completed study|181
339325|NCT00576316|820371|P1|STARTED|Overall Study|Number of patients recruited|201
339326|NCT00576303|820376|P1|NOT COMPLETED|Long Term Safety Period||16
339327|NCT00576303|820376|P1|COMPLETED|Long Term Safety Period||162
339328|NCT00576303|820376|P1|STARTED|Long Term Safety Period||178
339329|NCT00576303|820376|P1|NOT COMPLETED|Efficacy Evaluation Period||5
339330|NCT00576303|820376|P1|COMPLETED|Efficacy Evaluation Period||178
339331|NCT00576303|820376|P1|STARTED|Efficacy Evaluation Period||183
339332|NCT00576303|820376|P1|NOT COMPLETED|Dose Titration Period||17
339333|NCT00576303|820376|P1|COMPLETED|Dose Titration Period||183
339334|NCT00576303|820376|P1|STARTED|Dose Titration Period||200
339335|NCT00576251|820387|P2|NOT COMPLETED|Overall Study||1
339336|NCT00576251|820388|P1|NOT COMPLETED|Overall Study||1
339337|NCT00576251|820387|P2|COMPLETED|Overall Study||111
339338|NCT00576251|820388|P1|COMPLETED|Overall Study||108
339339|NCT00576251|820387|P2|STARTED|Overall Study||112
339340|NCT00576251|820388|P1|STARTED|Overall Study||109
339341|NCT00576199|820394|P1|NOT COMPLETED|Overall Study||30
339342|NCT00576199|820394|P1|COMPLETED|Overall Study||0
339343|NCT00576199|820394|P1|STARTED|Overall Study||30
339344|NCT00576147|820403|P1|NOT COMPLETED|Overall Study||0
339345|NCT00576147|820403|P1|COMPLETED|Overall Study||431
339346|NCT00576147|820403|P1|STARTED|Overall Study||431
339347|NCT00576056|820407|P1|NOT COMPLETED|Overall Study||14
339348|NCT00576056|820407|P1|COMPLETED|Overall Study||5
339349|NCT00576056|820407|P1|STARTED|Overall Study||19
339350|NCT00575965|820412|P1|NOT COMPLETED|Overall Study||0
339351|NCT00575965|820412|P1|COMPLETED|Overall Study||18
339352|NCT00575965|820412|P1|STARTED|Overall Study||18
339353|NCT00575887|820417|P1|NOT COMPLETED|Overall Study||0
339354|NCT00575887|820417|P1|COMPLETED|Overall Study||25
339355|NCT00575887|820417|P1|STARTED|Overall Study||25
339356|NCT00575666|820423|P2|NOT COMPLETED|Overall Study||3
339357|NCT00575666|820424|P1|NOT COMPLETED|Overall Study||4
339358|NCT00575666|820423|P2|COMPLETED|Overall Study||21
339359|NCT00575666|820424|P1|COMPLETED|Overall Study||17
339360|NCT00575666|820423|P2|STARTED|Overall Study||24
339361|NCT00575666|820424|P1|STARTED|Overall Study||21
339362|NCT00575588|820464|P2|NOT COMPLETED|Overall Study||283
339363|NCT00575588|820465|P1|NOT COMPLETED|Overall Study||263
339364|NCT00575588|820464|P2|COMPLETED|Overall Study|Completed 104 weeks of treatment|147
339365|NCT00575588|820465|P1|COMPLETED|Overall Study|Completed 104 weeks of treatment|165
339366|NCT00575588|820464|P2|STARTED|Overall Study|Randomized and treated|430
339367|NCT00575588|820465|P1|STARTED|Overall Study|Randomized and treated|428
339368|NCT00575510|820488|P3|NOT COMPLETED|Overall Study||17
339369|NCT00575510|820489|P2|NOT COMPLETED|Overall Study||13
339370|NCT00575510|820490|P1|NOT COMPLETED|Overall Study||12
339371|NCT00575510|820488|P3|COMPLETED|Overall Study||96
339372|NCT00575510|820489|P2|COMPLETED|Overall Study||101
339373|NCT00575510|820490|P1|COMPLETED|Overall Study||102
339374|NCT00575510|820488|P3|STARTED|Overall Study||113
339375|NCT00575510|820489|P2|STARTED|Overall Study||114
339376|NCT00575510|820490|P1|STARTED|Overall Study||114
339377|NCT00575380|820503|P2|NOT COMPLETED|Overall Study||3
339378|NCT00575380|820504|P1|NOT COMPLETED|Overall Study||1
339379|NCT00575380|820503|P2|COMPLETED|Overall Study||55
339380|NCT00575380|820504|P1|COMPLETED|Overall Study||57
339381|NCT00575380|820503|P2|STARTED|Overall Study||58
339382|NCT00575380|820504|P1|STARTED|Overall Study||58
339383|NCT00575367|820514|P2|NOT COMPLETED|Overall Study||0
339384|NCT00575367|820515|P1|NOT COMPLETED|Overall Study||0
339385|NCT00575367|820514|P2|COMPLETED|Overall Study||18
339386|NCT00575367|820515|P1|COMPLETED|Overall Study||19
339387|NCT00575367|820514|P2|STARTED|Overall Study||18
339388|NCT00575367|820515|P1|STARTED|Overall Study||19
339389|NCT00575185|820523|P2|NOT COMPLETED|Overall Study||0
339390|NCT00575185|820524|P1|NOT COMPLETED|Overall Study||0
339391|NCT00575185|820523|P2|COMPLETED|Overall Study||11
339392|NCT00575185|820524|P1|COMPLETED|Overall Study||12
339393|NCT00575185|820523|P2|STARTED|Overall Study||11
339394|NCT00575185|820524|P1|STARTED|Overall Study||12
339395|NCT00575159|820532|P1|NOT COMPLETED|Overall Study||0
339396|NCT00575159|820532|P1|COMPLETED|Overall Study||10
339397|NCT00575159|820532|P1|STARTED|Overall Study||10
339398|NCT00575146|820640|P1|NOT COMPLETED|Overall Study||3
339399|NCT00575146|820640|P1|COMPLETED|Overall Study||17
339400|NCT00575146|820640|P1|STARTED|Overall Study||20
339401|NCT00575094|820646|P1|NOT COMPLETED|Overall Study||3
339402|NCT00575094|820646|P1|COMPLETED|Overall Study||6
339403|NCT00575094|820646|P1|STARTED|Overall Study||9
339404|NCT00575042|820650|P1|NOT COMPLETED|Overall Study||3
339405|NCT00575042|820650|P1|COMPLETED|Overall Study|2 with side effects and 1 lost to follow-up|17
339406|NCT00575042|820650|P1|STARTED|Overall Study||20
339407|NCT00575029|820655|P1|NOT COMPLETED|Overall Study||0
339408|NCT00575029|820655|P1|COMPLETED|Overall Study||7
339409|NCT00575029|820655|P1|STARTED|Overall Study||7
339410|NCT00575016|820664|P4|NOT COMPLETED|Treatment Cycle 2||0
339411|NCT00575016|820665|P3|NOT COMPLETED|Treatment Cycle 2||0
339412|NCT00575016|820666|P2|NOT COMPLETED|Treatment Cycle 2||0
339413|NCT00575016|820667|P1|NOT COMPLETED|Treatment Cycle 2||1
339414|NCT00575016|820664|P4|COMPLETED|Treatment Cycle 2||0
339415|NCT00575016|820665|P3|COMPLETED|Treatment Cycle 2||0
339416|NCT00575016|820666|P2|COMPLETED|Treatment Cycle 2||0
339417|NCT00575016|820667|P1|COMPLETED|Treatment Cycle 2||30
339418|NCT00575016|820664|P4|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
339419|NCT00575016|820665|P3|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
339420|NCT00575016|820666|P2|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
339421|NCT00575016|820667|P1|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|31
339422|NCT00575016|820664|P4|NOT COMPLETED|Treatment Cycle 1||5
339423|NCT00575016|820665|P3|NOT COMPLETED|Treatment Cycle 1||4
339424|NCT00575016|820666|P2|NOT COMPLETED|Treatment Cycle 1||5
339425|NCT00575016|820667|P1|NOT COMPLETED|Treatment Cycle 1||9
339426|NCT00575016|820664|P4|COMPLETED|Treatment Cycle 1|9 pts from Placebo group entered Cycle 2|12
339427|NCT00575016|820665|P3|COMPLETED|Treatment Cycle 1|8 pts from 50U group entered Cycle 2|15
339428|NCT00575016|820666|P2|COMPLETED|Treatment Cycle 1|11 pts from 100U group entered Cycle 2|16
339429|NCT00575016|820667|P1|COMPLETED|Treatment Cycle 1|3 pts from 200U group entered Cycle 2|8
339430|NCT00575016|820664|P4|STARTED|Treatment Cycle 1|1 pt randomized to Placebo never received treatment|17
339431|NCT00575016|820665|P3|STARTED|Treatment Cycle 1||19
339432|NCT00575016|820666|P2|STARTED|Treatment Cycle 1||21
339433|NCT00575016|820667|P1|STARTED|Treatment Cycle 1||17
339434|NCT00574990|820688|P3|NOT COMPLETED|Overall Study||0
339435|NCT00574990|820689|P2|NOT COMPLETED|Overall Study||0
339436|NCT00574990|820690|P1|NOT COMPLETED|Overall Study||0
339437|NCT00574990|820688|P3|COMPLETED|Overall Study||8
339438|NCT00574990|820689|P2|COMPLETED|Overall Study||19
339439|NCT00574990|820690|P1|COMPLETED|Overall Study||12
339440|NCT00574990|820688|P3|STARTED|Overall Study||8
339441|NCT00574990|820689|P2|STARTED|Overall Study||19
339442|NCT00574990|820690|P1|STARTED|Overall Study||12
339443|NCT00574951|820701|P1|NOT COMPLETED|Overall Study||1
339444|NCT00574951|820701|P1|COMPLETED|Overall Study||22
339445|NCT00574951|820701|P1|STARTED|Overall Study||23
339446|NCT00574912|820709|P1|NOT COMPLETED|Overall Study||8
339447|NCT00574912|820709|P1|COMPLETED|Overall Study||12
339448|NCT00574912|820709|P1|Completed 2.0|Overall Study||12
339449|NCT00574912|820709|P1|Completed 1.5|Overall Study||12
339450|NCT00574912|820709|P1|Completed 1.0|Overall Study||12
339451|NCT00574912|820709|P1|Completed 0.5|Overall Study||12
339452|NCT00574912|820709|P1|Completed Placebo|Overall Study|12 original participants started the trial.|12
339453|NCT00574912|820709|P1|STARTED|Overall Study||20
339454|NCT00574873|820723|P2|NOT COMPLETED|Overall Study||251
339455|NCT00574873|820724|P1|NOT COMPLETED|Overall Study||238
339456|NCT00574873|820723|P2|COMPLETED|Overall Study||1
339457|NCT00574873|820724|P1|COMPLETED|Overall Study||12
339458|NCT00574873|820723|P2|Treated|Overall Study||251
339459|NCT00574873|820724|P1|Treated|Overall Study||248
339460|NCT00574873|820723|P2|STARTED|Overall Study||252
339461|NCT00574873|820724|P1|STARTED|Overall Study||250
339462|NCT00574847|820742|P2|NOT COMPLETED|Overall Study||7
339463|NCT00574847|820743|P1|NOT COMPLETED|Overall Study||8
339464|NCT00574847|820742|P2|COMPLETED|Overall Study||56
339465|NCT00574847|820743|P1|COMPLETED|Overall Study||56
339466|NCT00574847|820742|P2|STARTED|Overall Study||63
339467|NCT00574847|820743|P1|STARTED|Overall Study||64
339468|NCT00574834|820778|P3|NOT COMPLETED|Overall Study||0
339469|NCT00574834|820779|P2|NOT COMPLETED|Overall Study||0
339470|NCT00574834|820780|P1|NOT COMPLETED|Overall Study||0
339471|NCT00574834|820778|P3|COMPLETED|Overall Study||4
339472|NCT00574834|820779|P2|COMPLETED|Overall Study||4
339473|NCT00574834|820780|P1|COMPLETED|Overall Study||9
339474|NCT00574834|820778|P3|STARTED|Overall Study||4
339475|NCT00574834|820779|P2|STARTED|Overall Study||4
339476|NCT00574834|820780|P1|STARTED|Overall Study||9
339477|NCT00574795|820788|P1|NOT COMPLETED|Toddler Dose||1
339478|NCT00574795|820788|P1|COMPLETED|Toddler Dose||184
339479|NCT00574795|820788|P1|STARTED|Toddler Dose||185
339480|NCT00574795|820788|P1|NOT COMPLETED|After Infant Series||3
339481|NCT00574795|820788|P1|COMPLETED|After Infant Series||185
339482|NCT00574795|820788|P1|STARTED|After Infant Series||188
339483|NCT00574795|820788|P1|NOT COMPLETED|Infant Series||5
339484|NCT00574795|820788|P1|COMPLETED|Infant Series||188
339485|NCT00574795|820788|P1|Vaccinated Dose 3|Infant Series||190
339486|NCT00574795|820788|P1|Vaccinated Dose 2|Infant Series||190
339487|NCT00574795|820788|P1|Vaccinated Dose 1|Infant Series||193
339488|NCT00574795|820788|P1|STARTED|Infant Series||193
339489|NCT00574704|820809|P4|NOT COMPLETED|Overall Study||0
339490|NCT00574704|820810|P3|NOT COMPLETED|Overall Study||1
339491|NCT00574704|820811|P2|NOT COMPLETED|Overall Study||0
339492|NCT00574704|820812|P1|NOT COMPLETED|Overall Study||0
339493|NCT00574704|820809|P4|COMPLETED|Overall Study||10
339494|NCT00574704|820810|P3|COMPLETED|Overall Study||9
339495|NCT00574704|820811|P2|COMPLETED|Overall Study||10
339496|NCT00574704|820812|P1|COMPLETED|Overall Study||10
339497|NCT00574704|820809|P4|STARTED|Overall Study||10
339498|NCT00574704|820810|P3|STARTED|Overall Study||10
339499|NCT00574704|820811|P2|STARTED|Overall Study||10
339500|NCT00574704|820812|P1|STARTED|Overall Study||10
339501|NCT00574548|820824|P2|NOT COMPLETED|Overall Study||16
339502|NCT00574548|820825|P1|NOT COMPLETED|Overall Study||61
339503|NCT00574548|820824|P2|COMPLETED|Overall Study||222
339504|NCT00574548|820825|P1|COMPLETED|Overall Study||421
339505|NCT00574548|820824|P2|Completed Vax 2 (6 Month Contact)|Overall Study||222
339506|NCT00574548|820825|P1|Completed Vax 2 (6 Month Contact)|Overall Study||421
339507|NCT00574548|820824|P2|Received Vax 2|Overall Study||223
339508|NCT00574548|820825|P1|Received Vax 2|Overall Study||427
339509|NCT00574548|820824|P2|Withdrawn Before Vax 2|Overall Study||11
339510|NCT00574548|820825|P1|Withdrawn Before Vax 2|Overall Study||41
339511|NCT00574548|820824|P2|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||3
339512|NCT00574548|820825|P1|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||7
339513|NCT00574548|820824|P2|Completed Vax 1 (6 Month Contact)|Overall Study||234
339514|NCT00574548|820825|P1|Completed Vax 1 (6 Month Contact)|Overall Study||468
339515|NCT00574548|820824|P2|Received Vaccination 1 (Vax 1)|Overall Study||237
339516|NCT00574548|820825|P1|Received Vaccination 1 (Vax 1)|Overall Study||478
339517|NCT00574548|820824|P2|STARTED|Overall Study||238
339518|NCT00574548|820825|P1|STARTED|Overall Study||482
339519|NCT00574405|820871|P2|NOT COMPLETED|Overall Study||2
339520|NCT00574405|820872|P1|NOT COMPLETED|Overall Study||3
339521|NCT00574405|820871|P2|COMPLETED|Overall Study||10
339522|NCT00574405|820872|P1|COMPLETED|Overall Study||9
339523|NCT00574405|820871|P2|STARTED|Overall Study||12
339524|NCT00574405|820872|P1|STARTED|Overall Study||12
339525|NCT00574340|820878|P2|NOT COMPLETED|Study 2 (2 Days)||0
339526|NCT00574340|820879|P1|NOT COMPLETED|Study 2 (2 Days)||0
339527|NCT00574340|820878|P2|COMPLETED|Study 2 (2 Days)||6
339528|NCT00574340|820879|P1|COMPLETED|Study 2 (2 Days)||6
339529|NCT00574340|820878|P2|STARTED|Study 2 (2 Days)||6
339530|NCT00574340|820879|P1|STARTED|Study 2 (2 Days)||6
339531|NCT00574340|820878|P2|NOT COMPLETED|Study 1 (2 Days)||0
339532|NCT00574340|820879|P1|NOT COMPLETED|Study 1 (2 Days)||0
339533|NCT00574340|820878|P2|COMPLETED|Study 1 (2 Days)||10
339534|NCT00574340|820879|P1|COMPLETED|Study 1 (2 Days)||10
339535|NCT00574340|820878|P2|STARTED|Study 1 (2 Days)||10
339536|NCT00574340|820879|P1|STARTED|Study 1 (2 Days)||10
339537|NCT00574288|820892|P7|NOT COMPLETED|Overall Study||28
339538|NCT00574288|820893|P6|NOT COMPLETED|Overall Study||26
339539|NCT00574288|820894|P5|NOT COMPLETED|Overall Study||2
339540|NCT00574288|820895|P4|NOT COMPLETED|Overall Study||2
339541|NCT00574288|820896|P3|NOT COMPLETED|Overall Study||3
339542|NCT00574288|820897|P2|NOT COMPLETED|Overall Study||3
339543|NCT00574288|820898|P1|NOT COMPLETED|Overall Study||20
339544|NCT00574288|820892|P7|COMPLETED|Overall Study||14
339545|NCT00574288|820893|P6|COMPLETED|Overall Study||4
339546|NCT00574288|820894|P5|COMPLETED|Overall Study||1
339547|NCT00574288|820895|P4|COMPLETED|Overall Study||1
339548|NCT00574288|820896|P3|COMPLETED|Overall Study||0
339549|NCT00574288|820897|P2|COMPLETED|Overall Study||0
339550|NCT00574288|820898|P1|COMPLETED|Overall Study||0
339551|NCT00574288|820892|P7|STARTED|Overall Study||42
339552|NCT00574288|820893|P6|STARTED|Overall Study||30
339553|NCT00574288|820894|P5|STARTED|Overall Study||3
339554|NCT00574288|820895|P4|STARTED|Overall Study||3
339555|NCT00574288|820896|P3|STARTED|Overall Study||3
339556|NCT00574288|820897|P2|STARTED|Overall Study||3
339557|NCT00574288|820898|P1|STARTED|Overall Study||20
339558|NCT00574275|820936|P2|NOT COMPLETED|Overall Study||271
339559|NCT00574275|820937|P1|NOT COMPLETED|Overall Study||275
339560|NCT00574275|820936|P2|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
339561|NCT00574275|820937|P1|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
339562|NCT00574275|820936|P2|SAFETY POPULATION|Overall Study|Includes 2 participants from the Placebo and Gemcitabine arm who received 1 dose of Aflibercept|270
339563|NCT00574275|820937|P1|SAFETY POPULATION|Overall Study|Excludes 2 participants who received 1 dose of Aflibercept|271
339564|NCT00574275|820936|P2|TREATED|Overall Study||268
339565|NCT00574275|820937|P1|TREATED|Overall Study||273
339566|NCT00574275|820936|P2|STARTED|Overall Study||271
339567|NCT00574275|820937|P1|STARTED|Overall Study||275
339568|NCT00574249|820955|P2|NOT COMPLETED|Overall Study||28
339569|NCT00574249|820956|P1|NOT COMPLETED|Overall Study||26
339570|NCT00574249|820955|P2|COMPLETED|Overall Study||338
339571|NCT00574249|820956|P1|COMPLETED|Overall Study||338
339572|NCT00574249|820955|P2|STARTED|Overall Study||366
339573|NCT00574249|820956|P1|STARTED|Overall Study||364
339574|NCT00574236|820996|P1|NOT COMPLETED|Overall Study||0
339575|NCT00574236|820996|P1|COMPLETED|Overall Study||4
339576|NCT00574236|820996|P1|STARTED|Overall Study||4
339577|NCT00574171|821001|P1|NOT COMPLETED|Overall Study||0
339578|NCT00574171|821001|P1|COMPLETED|Overall Study||29
339579|NCT00574171|821001|P1|STARTED|Overall Study||29
339580|NCT00574145|821007|P2|NOT COMPLETED|Overall Study||1
339581|NCT00574145|821008|P1|NOT COMPLETED|Overall Study||2
339582|NCT00574145|821007|P2|COMPLETED|Overall Study||21
339583|NCT00574145|821008|P1|COMPLETED|Overall Study||20
339584|NCT00574145|821007|P2|STARTED|Overall Study||22
339585|NCT00574145|821008|P1|STARTED|Overall Study||22
339586|NCT00574119|821018|P1|NOT COMPLETED|Overall Study||4
339587|NCT00574119|821018|P1|COMPLETED|Overall Study||12
339588|NCT00574119|821018|P1|STARTED|Overall Study||16
339589|NCT00574080|821032|P2|NOT COMPLETED|Overall Study||10
339590|NCT00574080|821033|P1|NOT COMPLETED|Overall Study||10
339591|NCT00574080|821032|P2|COMPLETED|Overall Study||0
339592|NCT00574080|821033|P1|COMPLETED|Overall Study||0
339593|NCT00574080|821032|P2|STARTED|Overall Study||10
339594|NCT00574080|821033|P1|STARTED|Overall Study||10
339595|NCT00574067|821043|P4|NOT COMPLETED|Overall Study||0
339596|NCT00574067|821044|P3|NOT COMPLETED|Overall Study||0
339597|NCT00574067|821045|P2|NOT COMPLETED|Overall Study||1
339598|NCT00574067|821046|P1|NOT COMPLETED|Overall Study||1
339599|NCT00574067|821043|P4|COMPLETED|Overall Study||53
339600|NCT00574067|821044|P3|COMPLETED|Overall Study||54
339601|NCT00574067|821045|P2|COMPLETED|Overall Study||52
339602|NCT00574067|821046|P1|COMPLETED|Overall Study||52
339603|NCT00574067|821043|P4|STARTED|Overall Study||53
339604|NCT00574067|821044|P3|STARTED|Overall Study||54
339605|NCT00574067|821045|P2|STARTED|Overall Study||53
339606|NCT00574067|821046|P1|STARTED|Overall Study||53
339607|NCT00573989|821080|P4|NOT COMPLETED|Erlotinib 125mg- Phase II||0
339608|NCT00573989|821081|P3|NOT COMPLETED|Erlotinib 125mg- Phase II||0
339609|NCT00573989|821082|P2|NOT COMPLETED|Erlotinib 125mg- Phase II||0
339610|NCT00573989|821083|P1|NOT COMPLETED|Erlotinib 125mg- Phase II||0
339611|NCT00573989|821080|P4|COMPLETED|Erlotinib 125mg- Phase II||12
339612|NCT00573989|821081|P3|COMPLETED|Erlotinib 125mg- Phase II||0
339613|NCT00573989|821082|P2|COMPLETED|Erlotinib 125mg- Phase II||0
339614|NCT00573989|821083|P1|COMPLETED|Erlotinib 125mg- Phase II||0
339615|NCT00573989|821080|P4|STARTED|Erlotinib 125mg- Phase II||12
339616|NCT00573989|821081|P3|STARTED|Erlotinib 125mg- Phase II||0
339617|NCT00573989|821082|P2|STARTED|Erlotinib 125mg- Phase II||0
339618|NCT00573989|821083|P1|STARTED|Erlotinib 125mg- Phase II||0
339619|NCT00573989|821080|P4|NOT COMPLETED|Erlotinib Phase I||0
339620|NCT00573989|821081|P3|NOT COMPLETED|Erlotinib Phase I||0
339621|NCT00573989|821082|P2|NOT COMPLETED|Erlotinib Phase I||0
339622|NCT00573989|821083|P1|NOT COMPLETED|Erlotinib Phase I||0
339623|NCT00573989|821080|P4|COMPLETED|Erlotinib Phase I||0
339624|NCT00573989|821081|P3|COMPLETED|Erlotinib Phase I||5
339625|NCT00573989|821082|P2|COMPLETED|Erlotinib Phase I||6
339626|NCT00573989|821083|P1|COMPLETED|Erlotinib Phase I||4
339627|NCT00573989|821080|P4|STARTED|Erlotinib Phase I||0
339628|NCT00573989|821081|P3|STARTED|Erlotinib Phase I||5
339629|NCT00573989|821082|P2|STARTED|Erlotinib Phase I||6
339630|NCT00573989|821083|P1|STARTED|Erlotinib Phase I||4
339631|NCT00573937|821102|P2|NOT COMPLETED|Overall Study||1
339632|NCT00573937|821103|P1|NOT COMPLETED|Overall Study||0
339633|NCT00573937|821102|P2|COMPLETED|Overall Study||0
339634|NCT00573937|821103|P1|COMPLETED|Overall Study||0
339635|NCT00573937|821102|P2|STARTED|Overall Study||1
339636|NCT00573937|821103|P1|STARTED|Overall Study||0
339637|NCT00573872|821111|P1|NOT COMPLETED|Overall Study||11
339638|NCT00573872|821111|P1|COMPLETED|Overall Study|# of patients that completed treatment|32
339639|NCT00573872|821111|P1|STARTED|Overall Study|# of patients that signed consent|43
339640|NCT00573859|821117|P1|NOT COMPLETED|Smoking Versus Abstinence||12
339641|NCT00573859|821117|P1|COMPLETED|Smoking Versus Abstinence||15
339642|NCT00573859|821117|P1|STARTED|Smoking Versus Abstinence||27
339643|NCT00573859|821117|P1|NOT COMPLETED|Medication Versus Placebo||12
339644|NCT00573859|821117|P1|COMPLETED|Medication Versus Placebo||15
339645|NCT00573859|821117|P1|STARTED|Medication Versus Placebo||27
339646|NCT00573833|821123|P1|NOT COMPLETED|Overall Study||2
339647|NCT00573833|821123|P1|COMPLETED|Overall Study||21
339648|NCT00573833|821123|P1|STARTED|Overall Study||23
339649|NCT00573794|821130|P1|NOT COMPLETED|Overall Study||330
339650|NCT00573794|821130|P1|COMPLETED|Overall Study||255
339651|NCT00573794|821130|P1|STARTED|Overall Study||585
339652|NCT00573768|821161|P3|NOT COMPLETED|Overall Study||4
339653|NCT00573768|821162|P2|NOT COMPLETED|Overall Study||2
339654|NCT00573768|821163|P1|NOT COMPLETED|Overall Study||2
339655|NCT00573768|821161|P3|COMPLETED|Overall Study||87
339656|NCT00573768|821162|P2|COMPLETED|Overall Study||89
339657|NCT00573768|821163|P1|COMPLETED|Overall Study||87
339658|NCT00573768|821161|P3|STARTED|Overall Study||91
339659|NCT00573768|821162|P2|STARTED|Overall Study||91
339660|NCT00573768|821163|P1|STARTED|Overall Study||89
339661|NCT00573755|821173|P2|NOT COMPLETED|Overall Study||0
339662|NCT00573755|821174|P1|NOT COMPLETED|Overall Study||1
339663|NCT00573755|821173|P2|COMPLETED|Overall Study||2
339664|NCT00573755|821174|P1|COMPLETED|Overall Study||1
339665|NCT00573755|821173|P2|STARTED|Overall Study||2
339666|NCT00573755|821174|P1|STARTED|Overall Study||2
339667|NCT00573534|821190|P1|NOT COMPLETED|Overall Study||3
339668|NCT00573534|821190|P1|COMPLETED|Overall Study||5
339669|NCT00573534|821190|P1|STARTED|Overall Study||8
339670|NCT00573508|821197|P2|NOT COMPLETED|Overall Study||41
339671|NCT00573508|821198|P1|NOT COMPLETED|Overall Study||64
339672|NCT00573508|821197|P2|COMPLETED|Overall Study||345
339673|NCT00573508|821198|P1|COMPLETED|Overall Study||318
339674|NCT00573508|821197|P2|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|377
339675|NCT00573508|821198|P1|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|374
339676|NCT00573508|821197|P2|STARTED|Overall Study||386
339677|NCT00573508|821198|P1|STARTED|Overall Study||382
339678|NCT00573469|821231|P3|NOT COMPLETED|Overall Study||4
339679|NCT00573469|821232|P2|NOT COMPLETED|Overall Study||4
339680|NCT00573469|821233|P1|NOT COMPLETED|Overall Study||6
339681|NCT00573469|821231|P3|COMPLETED|Overall Study||22
339682|NCT00573469|821232|P2|COMPLETED|Overall Study||21
339683|NCT00573469|821233|P1|COMPLETED|Overall Study||20
339684|NCT00573469|821231|P3|STARTED|Overall Study||26
339685|NCT00573469|821232|P2|STARTED|Overall Study||25
339686|NCT00573469|821233|P1|STARTED|Overall Study||26
339687|NCT00573443|821256|P3|NOT COMPLETED|Open-Label Extension Phase||0
339688|NCT00573443|821257|P2|NOT COMPLETED|Open-Label Extension Phase||0
339689|NCT00573443|821258|P1|NOT COMPLETED|Open-Label Extension Phase||18
339690|NCT00573443|821256|P3|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
339691|NCT00573443|821257|P2|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
339692|NCT00573443|821258|P1|COMPLETED|Open-Label Extension Phase||235
339693|NCT00573443|821256|P3|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
339694|NCT00573443|821257|P2|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
339695|NCT00573443|821258|P1|Subjects With PBA Secondary to MS|Open-Label Extension Phase||107
339696|NCT00573443|821256|P3|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
339697|NCT00573443|821257|P2|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
339698|NCT00573443|821258|P1|Subjects With PBA Secondary to ALS|Open-Label Extension Phase||146
339699|NCT00573443|821256|P3|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
339700|NCT00573443|821257|P2|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
339701|NCT00573443|821258|P1|STARTED|Open-Label Extension Phase|Subjects who completed any of the arms in the DB phase had the option to enroll in this OLE phase|253
339702|NCT00573443|821256|P3|NOT COMPLETED|Double-Blind Phase||15
339703|NCT00573443|821257|P2|NOT COMPLETED|Double-Blind Phase||19
339704|NCT00573443|821258|P1|NOT COMPLETED|Double-Blind Phase||9
339705|NCT00573443|821256|P3|COMPLETED|Double-Blind Phase||94
339706|NCT00573443|821257|P2|COMPLETED|Double-Blind Phase||88
339707|NCT00573443|821258|P1|COMPLETED|Double-Blind Phase||101
339708|NCT00573443|821256|P3|Subjects With PBA Secondary to MS|Double-Blind Phase||45
339709|NCT00573443|821257|P2|Subjects With PBA Secondary to MS|Double-Blind Phase||39
339710|NCT00573443|821258|P1|Subjects With PBA Secondary to MS|Double-Blind Phase||45
339711|NCT00573443|821256|P3|Subjects With PBA Secondary to ALS|Double-Blind Phase||64
339712|NCT00573443|821257|P2|Subjects With PBA Secondary to ALS|Double-Blind Phase||68
339713|NCT00573443|821258|P1|Subjects With PBA Secondary to ALS|Double-Blind Phase||65
339714|NCT00573443|821256|P3|STARTED|Double-Blind Phase||109
339715|NCT00573443|821257|P2|STARTED|Double-Blind Phase||107
339716|NCT00573443|821258|P1|STARTED|Double-Blind Phase||110
339717|NCT00573430|821288|P3|NOT COMPLETED|Overall Study||10
339718|NCT00573430|821289|P2|NOT COMPLETED|Overall Study||5
339719|NCT00573430|821290|P1|NOT COMPLETED|Overall Study||1
339720|NCT00573430|821288|P3|COMPLETED|Overall Study||33
339721|NCT00573430|821289|P2|COMPLETED|Overall Study||40
339722|NCT00573430|821290|P1|COMPLETED|Overall Study||39
339723|NCT00573430|821288|P3|STARTED|Overall Study|randomized|43
339724|NCT00573430|821289|P2|STARTED|Overall Study|randomized|45
339725|NCT00573430|821290|P1|STARTED|Overall Study|randomized|40
339726|NCT00573391|821312|P2|NOT COMPLETED|Overall Study||2
339727|NCT00573391|821313|P1|NOT COMPLETED|Overall Study||3
339728|NCT00573391|821312|P2|COMPLETED|Overall Study||0
339729|NCT00573391|821313|P1|COMPLETED|Overall Study||0
339730|NCT00573391|821312|P2|STARTED|Overall Study||2
339731|NCT00573391|821313|P1|STARTED|Overall Study||3
339732|NCT00573313|821323|P4|NOT COMPLETED|Overall Study||0
339733|NCT00573313|821324|P3|NOT COMPLETED|Overall Study||6
339734|NCT00573313|821325|P2|NOT COMPLETED|Overall Study||0
339735|NCT00573313|821326|P1|NOT COMPLETED|Overall Study||5
339736|NCT00573313|821323|P4|COMPLETED|Overall Study||26
339737|NCT00573313|821324|P3|COMPLETED|Overall Study||13
339738|NCT00573313|821325|P2|COMPLETED|Overall Study||28
339739|NCT00573313|821326|P1|COMPLETED|Overall Study||13
339740|NCT00573313|821323|P4|STARTED|Overall Study||26
339741|NCT00573313|821324|P3|STARTED|Overall Study|Nineteen recruited to start.|19
339742|NCT00573313|821325|P2|STARTED|Overall Study||28
339743|NCT00573313|821326|P1|STARTED|Overall Study|Eighteen participants recruited to start.|18
339744|NCT00573287|821336|P2|NOT COMPLETED|Overall Study||3
339745|NCT00573287|821337|P1|NOT COMPLETED|Overall Study||4
339746|NCT00573287|821336|P2|COMPLETED|Overall Study||4
339747|NCT00573287|821337|P1|COMPLETED|Overall Study||3
339748|NCT00573287|821336|P2|STARTED|Overall Study||7
339749|NCT00573287|821337|P1|STARTED|Overall Study||7
339750|NCT00573261|821347|P2|NOT COMPLETED|Overall Study||5
339751|NCT00573261|821348|P1|NOT COMPLETED|Overall Study||6
339752|NCT00573261|821347|P2|COMPLETED|Overall Study||15
339753|NCT00573261|821348|P1|COMPLETED|Overall Study||14
339754|NCT00573261|821347|P2|STARTED|Overall Study||20
339755|NCT00573261|821348|P1|STARTED|Overall Study||20
339756|NCT00573248|821376|P2|NOT COMPLETED|Overall Study||11
339757|NCT00573248|821377|P1|NOT COMPLETED|Overall Study||15
339758|NCT00573248|821376|P2|COMPLETED|Overall Study||27
339759|NCT00573248|821377|P1|COMPLETED|Overall Study||25
339760|NCT00573248|821376|P2|Nicotine Patches and Placebo Patches|Overall Study||27
339761|NCT00573248|821377|P1|Nicotine Patches and Placebo Patches|Overall Study||25
339762|NCT00573248|821376|P2|STARTED|Overall Study||38
339763|NCT00573248|821377|P1|STARTED|Overall Study||40
339764|NCT00573183|821391|P2|NOT COMPLETED|Overall Study||63
339765|NCT00573183|821392|P1|NOT COMPLETED|Overall Study||72
339766|NCT00573183|821391|P2|COMPLETED|Overall Study||174
339767|NCT00573183|821392|P1|COMPLETED|Overall Study||162
339768|NCT00573183|821391|P2|STARTED|Overall Study||237
339769|NCT00573183|821392|P1|STARTED|Overall Study||234
339770|NCT00573170|821400|P6|NOT COMPLETED|Third Treatment Period||2
339771|NCT00573170|821401|P5|NOT COMPLETED|Third Treatment Period||0
339772|NCT00573170|821402|P4|NOT COMPLETED|Third Treatment Period||0
339773|NCT00573170|821403|P3|NOT COMPLETED|Third Treatment Period||0
339774|NCT00573170|821404|P2|NOT COMPLETED|Third Treatment Period||0
339775|NCT00573170|821405|P1|NOT COMPLETED|Third Treatment Period||1
339776|NCT00573170|821400|P6|COMPLETED|Third Treatment Period||51
339777|NCT00573170|821401|P5|COMPLETED|Third Treatment Period||51
339778|NCT00573170|821402|P4|COMPLETED|Third Treatment Period||56
339779|NCT00573170|821403|P3|COMPLETED|Third Treatment Period||55
339780|NCT00573170|821404|P2|COMPLETED|Third Treatment Period||54
339781|NCT00573170|821405|P1|COMPLETED|Third Treatment Period||50
339782|NCT00573170|821400|P6|STARTED|Third Treatment Period||53
339783|NCT00573170|821401|P5|STARTED|Third Treatment Period||51
339784|NCT00573170|821402|P4|STARTED|Third Treatment Period||56
339785|NCT00573170|821403|P3|STARTED|Third Treatment Period||55
339786|NCT00573170|821404|P2|STARTED|Third Treatment Period||54
339787|NCT00573170|821405|P1|STARTED|Third Treatment Period||51
339788|NCT00573170|821400|P6|NOT COMPLETED|Second Washout Period||2
339789|NCT00573170|821401|P5|NOT COMPLETED|Second Washout Period||8
339790|NCT00573170|821402|P4|NOT COMPLETED|Second Washout Period||5
339791|NCT00573170|821403|P3|NOT COMPLETED|Second Washout Period||4
339792|NCT00573170|821404|P2|NOT COMPLETED|Second Washout Period||4
339793|NCT00573170|821405|P1|NOT COMPLETED|Second Washout Period||5
339794|NCT00573170|821400|P6|COMPLETED|Second Washout Period||53
339795|NCT00573170|821401|P5|COMPLETED|Second Washout Period||51
339796|NCT00573170|821402|P4|COMPLETED|Second Washout Period||56
339797|NCT00573170|821403|P3|COMPLETED|Second Washout Period||55
339798|NCT00573170|821404|P2|COMPLETED|Second Washout Period||54
339799|NCT00573170|821405|P1|COMPLETED|Second Washout Period||51
339800|NCT00573170|821400|P6|STARTED|Second Washout Period||55
339801|NCT00573170|821401|P5|STARTED|Second Washout Period||59
339802|NCT00573170|821402|P4|STARTED|Second Washout Period||61
339803|NCT00573170|821403|P3|STARTED|Second Washout Period||59
339804|NCT00573170|821404|P2|STARTED|Second Washout Period||58
339805|NCT00573170|821405|P1|STARTED|Second Washout Period||56
339806|NCT00573170|821400|P6|NOT COMPLETED|Second Treatment Period||0
339807|NCT00573170|821401|P5|NOT COMPLETED|Second Treatment Period||0
339808|NCT00573170|821402|P4|NOT COMPLETED|Second Treatment Period||0
339809|NCT00573170|821403|P3|NOT COMPLETED|Second Treatment Period||0
339810|NCT00573170|821404|P2|NOT COMPLETED|Second Treatment Period||0
339811|NCT00573170|821405|P1|NOT COMPLETED|Second Treatment Period||0
339812|NCT00573170|821400|P6|COMPLETED|Second Treatment Period||55
339813|NCT00573170|821401|P5|COMPLETED|Second Treatment Period||59
339814|NCT00573170|821402|P4|COMPLETED|Second Treatment Period||61
339815|NCT00573170|821403|P3|COMPLETED|Second Treatment Period||59
339816|NCT00573170|821404|P2|COMPLETED|Second Treatment Period||58
339817|NCT00573170|821405|P1|COMPLETED|Second Treatment Period||56
339818|NCT00573170|821400|P6|STARTED|Second Treatment Period||55
339819|NCT00573170|821401|P5|STARTED|Second Treatment Period||59
339820|NCT00573170|821402|P4|STARTED|Second Treatment Period||61
339821|NCT00573170|821403|P3|STARTED|Second Treatment Period||59
339822|NCT00573170|821404|P2|STARTED|Second Treatment Period||58
339823|NCT00573170|821405|P1|STARTED|Second Treatment Period||56
339824|NCT00573170|821400|P6|NOT COMPLETED|First Washout Period||7
339825|NCT00573170|821401|P5|NOT COMPLETED|First Washout Period||3
339826|NCT00573170|821402|P4|NOT COMPLETED|First Washout Period||5
339827|NCT00573170|821403|P3|NOT COMPLETED|First Washout Period||1
339828|NCT00573170|821404|P2|NOT COMPLETED|First Washout Period||2
339829|NCT00573170|821405|P1|NOT COMPLETED|First Washout Period||8
339830|NCT00573170|821400|P6|COMPLETED|First Washout Period||55
339831|NCT00573170|821401|P5|COMPLETED|First Washout Period|Source data list 4 noncompleters; per number starting next period, there were only 3 noncompleters.|59
339832|NCT00573170|821402|P4|COMPLETED|First Washout Period||61
339833|NCT00573170|821403|P3|COMPLETED|First Washout Period||59
339834|NCT00573170|821404|P2|COMPLETED|First Washout Period||58
339835|NCT00573170|821405|P1|COMPLETED|First Washout Period||56
339836|NCT00573170|821400|P6|STARTED|First Washout Period||62
339837|NCT00573170|821401|P5|STARTED|First Washout Period||62
339838|NCT00573170|821402|P4|STARTED|First Washout Period||66
339839|NCT00573170|821403|P3|STARTED|First Washout Period||60
339840|NCT00573170|821404|P2|STARTED|First Washout Period||60
339841|NCT00573170|821405|P1|STARTED|First Washout Period||64
339842|NCT00573170|821400|P6|NOT COMPLETED|First Treatment Period||0
339843|NCT00573170|821401|P5|NOT COMPLETED|First Treatment Period||1
339844|NCT00573170|821402|P4|NOT COMPLETED|First Treatment Period||0
339845|NCT00573170|821403|P3|NOT COMPLETED|First Treatment Period||0
339846|NCT00573170|821404|P2|NOT COMPLETED|First Treatment Period||0
339847|NCT00573170|821405|P1|NOT COMPLETED|First Treatment Period||0
339848|NCT00573170|821400|P6|COMPLETED|First Treatment Period||62
339849|NCT00573170|821401|P5|COMPLETED|First Treatment Period||62
339850|NCT00573170|821402|P4|COMPLETED|First Treatment Period||66
339851|NCT00573170|821403|P3|COMPLETED|First Treatment Period||60
339852|NCT00573170|821404|P2|COMPLETED|First Treatment Period||60
339853|NCT00573170|821405|P1|COMPLETED|First Treatment Period||64
339854|NCT00573170|821400|P6|STARTED|First Treatment Period||62
339855|NCT00573170|821401|P5|STARTED|First Treatment Period||63
339856|NCT00573170|821402|P4|STARTED|First Treatment Period||66
339857|NCT00573170|821403|P3|STARTED|First Treatment Period||60
339858|NCT00573170|821404|P2|STARTED|First Treatment Period||60
339859|NCT00573170|821405|P1|STARTED|First Treatment Period||64
339860|NCT00573157|821481|P2|NOT COMPLETED|Overall Study||2
339861|NCT00573157|821482|P1|NOT COMPLETED|Overall Study||4
339862|NCT00573157|821481|P2|COMPLETED|Overall Study||0
339863|NCT00573157|821482|P1|COMPLETED|Overall Study||0
339864|NCT00573157|821481|P2|STARTED|Overall Study||2
339865|NCT00573157|821482|P1|STARTED|Overall Study||4
339866|NCT00573144|821494|P2|NOT COMPLETED|Overall Study||3
339867|NCT00573144|821495|P1|NOT COMPLETED|Overall Study||2
339868|NCT00573144|821494|P2|COMPLETED|Overall Study||25
339869|NCT00573144|821495|P1|COMPLETED|Overall Study||28
339870|NCT00573144|821494|P2|STARTED|Overall Study||28
339871|NCT00573144|821495|P1|STARTED|Overall Study||30
339872|NCT00573131|821507|P2|NOT COMPLETED|Overall Study||8
339873|NCT00573131|821508|P1|NOT COMPLETED|Overall Study||10
339874|NCT00573131|821507|P2|COMPLETED|Overall Study||57
339875|NCT00573131|821508|P1|COMPLETED|Overall Study||62
339876|NCT00573131|821507|P2|STARTED|Overall Study||65
339877|NCT00573131|821508|P1|STARTED|Overall Study||72
339878|NCT00573066|821514|P1|NOT COMPLETED|Overall Study||20
339879|NCT00573066|821514|P1|COMPLETED|Overall Study||36
339880|NCT00573066|821514|P1|STARTED|Overall Study||56
339881|NCT00572936|821518|P6|NOT COMPLETED|Third Intervention||0
339882|NCT00572936|821519|P5|NOT COMPLETED|Third Intervention||0
339883|NCT00572936|821520|P4|NOT COMPLETED|Third Intervention||0
339884|NCT00572936|821521|P3|NOT COMPLETED|Third Intervention||0
339885|NCT00572936|821522|P2|NOT COMPLETED|Third Intervention||0
339886|NCT00572936|821523|P1|NOT COMPLETED|Third Intervention||0
339887|NCT00572936|821518|P6|COMPLETED|Third Intervention||5
339888|NCT00572936|821519|P5|COMPLETED|Third Intervention||3
339889|NCT00572936|821520|P4|COMPLETED|Third Intervention||5
339890|NCT00572936|821521|P3|COMPLETED|Third Intervention||4
339891|NCT00572936|821522|P2|COMPLETED|Third Intervention||3
339892|NCT00572936|821523|P1|COMPLETED|Third Intervention||4
339893|NCT00572936|821518|P6|STARTED|Third Intervention||5
339894|NCT00572936|821519|P5|STARTED|Third Intervention|1 participant dropped out between second intervention and third intervention due to increased IOP|3
339895|NCT00572936|821520|P4|STARTED|Third Intervention||5
339896|NCT00572936|821521|P3|STARTED|Third Intervention||4
339897|NCT00572936|821522|P2|STARTED|Third Intervention||3
339898|NCT00572936|821523|P1|STARTED|Third Intervention||4
339899|NCT00572936|821518|P6|NOT COMPLETED|Second Intervention||0
339900|NCT00572936|821519|P5|NOT COMPLETED|Second Intervention||0
339901|NCT00572936|821520|P4|NOT COMPLETED|Second Intervention||0
339902|NCT00572936|821521|P3|NOT COMPLETED|Second Intervention||0
339903|NCT00572936|821522|P2|NOT COMPLETED|Second Intervention||0
339904|NCT00572936|821523|P1|NOT COMPLETED|Second Intervention||0
339905|NCT00572936|821518|P6|COMPLETED|Second Intervention||5
339906|NCT00572936|821519|P5|COMPLETED|Second Intervention||4
339907|NCT00572936|821520|P4|COMPLETED|Second Intervention||5
339908|NCT00572936|821521|P3|COMPLETED|Second Intervention||4
339909|NCT00572936|821522|P2|COMPLETED|Second Intervention||3
339910|NCT00572936|821523|P1|COMPLETED|Second Intervention||4
339911|NCT00572936|821518|P6|STARTED|Second Intervention||5
339912|NCT00572936|821519|P5|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
339913|NCT00572936|821520|P4|STARTED|Second Intervention||5
339914|NCT00572936|821521|P3|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
339915|NCT00572936|821522|P2|STARTED|Second Intervention|1 participant dropped out between the first and second intervention due to car accident|3
339916|NCT00572936|821523|P1|STARTED|Second Intervention||4
339917|NCT00572936|821518|P6|NOT COMPLETED|First Intervention||0
339918|NCT00572936|821519|P5|NOT COMPLETED|First Intervention||0
339919|NCT00572936|821520|P4|NOT COMPLETED|First Intervention||0
339920|NCT00572936|821521|P3|NOT COMPLETED|First Intervention||0
339921|NCT00572936|821522|P2|NOT COMPLETED|First Intervention||0
339922|NCT00572936|821523|P1|NOT COMPLETED|First Intervention||0
339923|NCT00572936|821518|P6|COMPLETED|First Intervention||5
339924|NCT00572936|821519|P5|COMPLETED|First Intervention||5
339925|NCT00572936|821520|P4|COMPLETED|First Intervention||5
339926|NCT00572936|821521|P3|COMPLETED|First Intervention||5
339927|NCT00572936|821522|P2|COMPLETED|First Intervention||4
339928|NCT00572936|821523|P1|COMPLETED|First Intervention||4
339929|NCT00572936|821518|P6|STARTED|First Intervention||5
339930|NCT00572936|821519|P5|STARTED|First Intervention||5
339931|NCT00572936|821520|P4|STARTED|First Intervention||5
339932|NCT00572936|821521|P3|STARTED|First Intervention||5
339933|NCT00572936|821522|P2|STARTED|First Intervention||4
339934|NCT00572936|821523|P1|STARTED|First Intervention||4
339935|NCT00572910|821558|P11|NOT COMPLETED|Overall Study||3
339936|NCT00572910|821559|P10|NOT COMPLETED|Overall Study||6
339937|NCT00572910|821560|P9|NOT COMPLETED|Overall Study||3
339938|NCT00572910|821561|P8|NOT COMPLETED|Overall Study||4
339939|NCT00572910|821562|P7|NOT COMPLETED|Overall Study||4
339940|NCT00572910|821563|P6|NOT COMPLETED|Overall Study||3
339941|NCT00572910|821564|P5|NOT COMPLETED|Overall Study||2
339942|NCT00572910|821565|P4|NOT COMPLETED|Overall Study||4
339943|NCT00572910|821566|P3|NOT COMPLETED|Overall Study||2
339944|NCT00572910|821567|P2|NOT COMPLETED|Overall Study||3
339945|NCT00572910|821568|P1|NOT COMPLETED|Overall Study||4
339946|NCT00572910|821558|P11|COMPLETED|Overall Study||15
339947|NCT00572910|821559|P10|COMPLETED|Overall Study||13
339948|NCT00572910|821560|P9|COMPLETED|Overall Study||16
339949|NCT00572910|821561|P8|COMPLETED|Overall Study||15
339950|NCT00572910|821562|P7|COMPLETED|Overall Study||15
339951|NCT00572910|821563|P6|COMPLETED|Overall Study||16
339952|NCT00572910|821564|P5|COMPLETED|Overall Study||17
339953|NCT00572910|821565|P4|COMPLETED|Overall Study||14
339954|NCT00572910|821566|P3|COMPLETED|Overall Study||17
339955|NCT00572910|821567|P2|COMPLETED|Overall Study||15
339956|NCT00572910|821568|P1|COMPLETED|Overall Study||15
339957|NCT00572910|821558|P11|STARTED|Overall Study||18
339958|NCT00572910|821559|P10|STARTED|Overall Study||19
339959|NCT00572910|821560|P9|STARTED|Overall Study||19
339960|NCT00572910|821561|P8|STARTED|Overall Study||19
339961|NCT00572910|821562|P7|STARTED|Overall Study||19
339962|NCT00572910|821563|P6|STARTED|Overall Study||19
339963|NCT00572910|821564|P5|STARTED|Overall Study||19
339964|NCT00572910|821565|P4|STARTED|Overall Study||18
339965|NCT00572910|821566|P3|STARTED|Overall Study||19
339966|NCT00572910|821567|P2|STARTED|Overall Study||18
339967|NCT00572910|821568|P1|STARTED|Overall Study||19
339968|NCT00572897|821616|P2|NOT COMPLETED|Overall Study||0
339969|NCT00572897|821617|P1|NOT COMPLETED|Overall Study||0
339970|NCT00572897|821616|P2|COMPLETED|Overall Study||34
339971|NCT00572897|821617|P1|COMPLETED|Overall Study||32
339972|NCT00572897|821616|P2|STARTED|Overall Study||34
339973|NCT00572897|821617|P1|STARTED|Overall Study||32
339974|NCT00572832|821635|P2|NOT COMPLETED|Overall Study||12
339975|NCT00572832|821636|P1|NOT COMPLETED|Overall Study||0
339976|NCT00572832|821635|P2|COMPLETED|Overall Study||88
339977|NCT00572832|821636|P1|COMPLETED|Overall Study||100
339978|NCT00572832|821635|P2|STARTED|Overall Study||100
339979|NCT00572832|821636|P1|STARTED|Overall Study||100
339980|NCT00572728|821642|P1|NOT COMPLETED|Overall Study||39
339981|NCT00572728|821642|P1|COMPLETED|Overall Study|51 patients eligible for primary objective analysis|51
339982|NCT00572728|821642|P1|RCB Evaluation|Overall Study|Secondary: histopathology was available in 35 patients for RCB evaluation|35
339983|NCT00572728|821642|P1|LN Evaluation After NAC|Overall Study|Secondary:38 patients were available for histopathological LN evaluation after NAC|38
339984|NCT00572728|821642|P1|Completed FLT3 Scan|Overall Study|Secondary analysis milestone: 43 pts had FLT-3 performed.|43
339985|NCT00572728|821642|P1|Pathology Complete|Overall Study||51
339986|NCT00572728|821642|P1|Second Chemotherapy Initiated After FLT2|Overall Study||52
339987|NCT00572728|821642|P1|Second Chemotherapy Initiated|Overall Study||59
339988|NCT00572728|821642|P1|Completed FLT2 Scan|Overall Study||60
339989|NCT00572728|821642|P1|First Therapy Initiated|Overall Study||65
339990|NCT00572728|821642|P1|Completed FLT1 Scan|Overall Study||67
339991|NCT00572728|821642|P1|On Study|Overall Study||71
339992|NCT00572728|821642|P1|Did Not Withdraw|Overall Study||72
339993|NCT00572728|821642|P1|Enrolled Under Amendment 5 or Later|Overall Study||82
339994|NCT00572728|821642|P1|Eligible|Overall Study||87
339995|NCT00572728|821642|P1|STARTED|Overall Study|Registered|90
339996|NCT00572624|821656|P2|NOT COMPLETED|Overall Study||4
339997|NCT00572624|821657|P1|NOT COMPLETED|Overall Study||17
339998|NCT00572624|821656|P2|COMPLETED|Overall Study||10
339999|NCT00572624|821657|P1|COMPLETED|Overall Study||20
340000|NCT00572624|821656|P2|STARTED|Overall Study||14
340001|NCT00572624|821657|P1|STARTED|Overall Study||37
340002|NCT00572572|821685|P2|NOT COMPLETED|Overall Study||6
340003|NCT00572572|821686|P1|NOT COMPLETED|Overall Study||3
340004|NCT00572572|821685|P2|COMPLETED|Overall Study||28
340005|NCT00572572|821686|P1|COMPLETED|Overall Study||32
340006|NCT00572572|821685|P2|STARTED|Overall Study||34
340007|NCT00572572|821686|P1|STARTED|Overall Study||35
340008|NCT00572533|821704|P2|NOT COMPLETED|Overall Study||3
340009|NCT00572533|821705|P1|NOT COMPLETED|Overall Study||7
340010|NCT00572533|821704|P2|COMPLETED|Overall Study||28
340011|NCT00572533|821705|P1|COMPLETED|Overall Study||24
340012|NCT00572533|821704|P2|STARTED|Overall Study||31
340013|NCT00572533|821705|P1|STARTED|Overall Study||31
340014|NCT00572468|821727|P2|NOT COMPLETED|Overall Study||4
340015|NCT00572468|821728|P1|NOT COMPLETED|Overall Study||2
340016|NCT00572468|821727|P2|COMPLETED|Overall Study||16
340017|NCT00572468|821728|P1|COMPLETED|Overall Study||20
340018|NCT00572468|821727|P2|STARTED|Overall Study||20
340019|NCT00572468|821728|P1|STARTED|Overall Study||22
340020|NCT00572260|821736|P1|NOT COMPLETED|Overall Study||0
340021|NCT00572260|821736|P1|COMPLETED|Overall Study||11
340022|NCT00572260|821736|P1|STARTED|Overall Study||11
340023|NCT00572234|821742|P2|NOT COMPLETED|Overall Study||5
340024|NCT00572234|821743|P1|NOT COMPLETED|Overall Study||1
340025|NCT00572234|821742|P2|COMPLETED|Overall Study||16
340026|NCT00572234|821743|P1|COMPLETED|Overall Study||18
340027|NCT00572234|821742|P2|STARTED|Overall Study||21
340028|NCT00572234|821743|P1|STARTED|Overall Study||19
340029|NCT00572195|821749|P1|NOT COMPLETED|Overall Study||68
340030|NCT00572195|821749|P1|COMPLETED|Overall Study||162
340031|NCT00572195|821749|P1|STARTED|Overall Study||230
340032|NCT00572156|821761|P4|NOT COMPLETED|Overall Study||25
340033|NCT00572156|821762|P3|NOT COMPLETED|Overall Study||27
340034|NCT00572156|821763|P2|NOT COMPLETED|Overall Study||26
340035|NCT00572156|821764|P1|NOT COMPLETED|Overall Study||26
340036|NCT00572156|821761|P4|COMPLETED|Overall Study||1
340037|NCT00572156|821762|P3|COMPLETED|Overall Study||0
340038|NCT00572156|821763|P2|COMPLETED|Overall Study||1
340039|NCT00572156|821764|P1|COMPLETED|Overall Study||0
340040|NCT00572156|821761|P4|STARTED|Overall Study||26
340041|NCT00572156|821762|P3|STARTED|Overall Study||27
340042|NCT00572156|821763|P2|STARTED|Overall Study||27
340043|NCT00572156|821764|P1|STARTED|Overall Study||26
340044|NCT00572117|821824|P2|NOT COMPLETED|Overall Study||2
340045|NCT00572117|821825|P1|NOT COMPLETED|Overall Study||2
340046|NCT00572117|821824|P2|COMPLETED|Overall Study||5
340047|NCT00572117|821825|P1|COMPLETED|Overall Study||3
340048|NCT00572117|821824|P2|STARTED|Overall Study||7
340049|NCT00572117|821825|P1|STARTED|Overall Study||5
340050|NCT00572039|821835|P2|NOT COMPLETED|Overall Study||10
340051|NCT00572039|821836|P1|NOT COMPLETED|Overall Study||16
340052|NCT00572039|821835|P2|COMPLETED|Overall Study||110
340053|NCT00572039|821836|P1|COMPLETED|Overall Study||105
340054|NCT00572039|821835|P2|STARTED|Overall Study||120
340055|NCT00572039|821836|P1|STARTED|Overall Study||121
340056|NCT00571987|821848|P1|NOT COMPLETED|Overall Study||7
340057|NCT00571987|821848|P1|COMPLETED|Overall Study||100
340058|NCT00571987|821848|P1|STARTED|Overall Study||107
340059|NCT00571974|821855|P2|NOT COMPLETED|Phase II||4
340060|NCT00571974|821856|P1|NOT COMPLETED|Phase II||0
340061|NCT00571974|821855|P2|COMPLETED|Phase II||17
340062|NCT00571974|821856|P1|COMPLETED|Phase II||0
340063|NCT00571974|821855|P2|STARTED|Phase II|3 participants are from phase I|21
340064|NCT00571974|821856|P1|STARTED|Phase II||0
340065|NCT00571974|821855|P2|NOT COMPLETED|Phase I||0
340066|NCT00571974|821856|P1|NOT COMPLETED|Phase I||0
340067|NCT00571974|821855|P2|COMPLETED|Phase I||0
340068|NCT00571974|821856|P1|COMPLETED|Phase I||9
340069|NCT00571974|821855|P2|STARTED|Phase I||0
340070|NCT00571974|821856|P1|STARTED|Phase I||9
340071|NCT00571961|821862|P1|NOT COMPLETED|Overall Study||0
340072|NCT00571961|821862|P1|COMPLETED|Overall Study||12
340073|NCT00571961|821862|P1|STARTED|Overall Study||12
340074|NCT00571948|821868|P2|NOT COMPLETED|Overall Study||14
340075|NCT00571948|821869|P1|NOT COMPLETED|Overall Study||11
340076|NCT00571948|821868|P2|COMPLETED|Overall Study|Excluded n = 3) Reasons: diet record < 75 % of days (n = 2); blood analysis failed (n= 1)|52
340077|NCT00571948|821869|P1|COMPLETED|Overall Study|Excluded from analysis (n = 2) Reason: diet record for less than 75 % of days (n = 2)|55
340078|NCT00571948|821868|P2|STARTED|Overall Study||66
340079|NCT00571948|821869|P1|STARTED|Overall Study||66
340080|NCT00571922|821877|P2|NOT COMPLETED|Overall Study||36
340081|NCT00571922|821878|P1|NOT COMPLETED|Overall Study||36
340082|NCT00571922|821877|P2|COMPLETED|Overall Study||0
340083|NCT00571922|821878|P1|COMPLETED|Overall Study||0
340084|NCT00571922|821877|P2|STARTED|Overall Study||36
340085|NCT00571922|821878|P1|STARTED|Overall Study||36
340086|NCT00571701|821888|P2|NOT COMPLETED|Second Intervention 12 Months||1
340087|NCT00571701|821889|P1|NOT COMPLETED|Second Intervention 12 Months||3
340088|NCT00571701|821888|P2|COMPLETED|Second Intervention 12 Months||20
340089|NCT00571701|821889|P1|COMPLETED|Second Intervention 12 Months||13
340090|NCT00571701|821888|P2|STARTED|Second Intervention 12 Months||21
340091|NCT00571701|821889|P1|STARTED|Second Intervention 12 Months||16
340092|NCT00571701|821888|P2|NOT COMPLETED|First Intervention 12 Months||1
340093|NCT00571701|821889|P1|NOT COMPLETED|First Intervention 12 Months||3
340094|NCT00571701|821888|P2|COMPLETED|First Intervention 12 Months||21
340095|NCT00571701|821889|P1|COMPLETED|First Intervention 12 Months||16
340096|NCT00571701|821888|P2|STARTED|First Intervention 12 Months||22
340097|NCT00571701|821889|P1|STARTED|First Intervention 12 Months||19
340098|NCT00571688|821915|P2|NOT COMPLETED|Overall Study||6
340099|NCT00571688|821916|P1|NOT COMPLETED|Overall Study||5
340100|NCT00571688|821915|P2|COMPLETED|Overall Study||19
340101|NCT00571688|821916|P1|COMPLETED|Overall Study||20
340102|NCT00571688|821915|P2|STARTED|Overall Study||25
340103|NCT00571688|821916|P1|STARTED|Overall Study||25
340104|NCT00571662|821922|P1|NOT COMPLETED|Overall Study||8
340105|NCT00571662|821922|P1|COMPLETED|Overall Study||68
340106|NCT00571662|821922|P1|STARTED|Overall Study||76
340107|NCT00571649|821933|P2|NOT COMPLETED|Follow-up Period||528
340108|NCT00571649|821934|P1|NOT COMPLETED|Follow-up Period||545
340109|NCT00571649|821933|P2|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3107
340110|NCT00571649|821934|P1|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3038
340111|NCT00571649|821933|P2|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3635
340112|NCT00571649|821934|P1|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3583
340113|NCT00571649|821933|P2|NOT COMPLETED|Treatment Period||1004
340114|NCT00571649|821934|P1|NOT COMPLETED|Treatment Period||1092
340115|NCT00571649|821933|P2|COMPLETED|Treatment Period||3047
340116|NCT00571649|821934|P1|COMPLETED|Treatment Period||2958
340117|NCT00571649|821933|P2|Day 35|Treatment Period||3115
340118|NCT00571649|821934|P1|Day 35|Treatment Period||3033
340119|NCT00571649|821933|P2|Day 10|Treatment Period||3499
340120|NCT00571649|821934|P1|Day 10|Treatment Period||3454
340121|NCT00571649|821933|P2|Participants Received Treatment|Treatment Period||4001
340122|NCT00571649|821934|P1|Participants Received Treatment|Treatment Period||3997
340123|NCT00571649|821933|P2|STARTED|Treatment Period||4051
340124|NCT00571649|821934|P1|STARTED|Treatment Period||4050
340125|NCT00571493|821966|P7|NOT COMPLETED|Overall Study||0
340126|NCT00571493|821967|P6|NOT COMPLETED|Overall Study||0
340127|NCT00571493|821968|P5|NOT COMPLETED|Overall Study||0
340128|NCT00571493|821969|P4|NOT COMPLETED|Overall Study||0
340129|NCT00571493|821970|P3|NOT COMPLETED|Overall Study||0
340130|NCT00571493|821971|P2|NOT COMPLETED|Overall Study||0
340131|NCT00571493|821972|P1|NOT COMPLETED|Overall Study||0
340132|NCT00571493|821966|P7|COMPLETED|Overall Study||6
340133|NCT00571493|821967|P6|COMPLETED|Overall Study||12
340134|NCT00571493|821968|P5|COMPLETED|Overall Study||11
340135|NCT00571493|821969|P4|COMPLETED|Overall Study||3
340136|NCT00571493|821970|P3|COMPLETED|Overall Study||3
340137|NCT00571493|821971|P2|COMPLETED|Overall Study||4
340138|NCT00571493|821972|P1|COMPLETED|Overall Study||3
340139|NCT00571493|821966|P7|STARTED|Overall Study||6
340140|NCT00571493|821967|P6|STARTED|Overall Study||12
340141|NCT00571493|821968|P5|STARTED|Overall Study||11
340142|NCT00571493|821969|P4|STARTED|Overall Study||3
340143|NCT00571493|821970|P3|STARTED|Overall Study||3
340144|NCT00571493|821971|P2|STARTED|Overall Study||4
340145|NCT00571493|821972|P1|STARTED|Overall Study||3
340146|NCT00571428|821982|P2|NOT COMPLETED|Overall Study||0
340147|NCT00571428|821983|P1|NOT COMPLETED|Overall Study||0
340148|NCT00571428|821982|P2|COMPLETED|Overall Study||18
340149|NCT00571428|821983|P1|COMPLETED|Overall Study||15
340150|NCT00571428|821982|P2|STARTED|Overall Study||18
340151|NCT00571428|821983|P1|STARTED|Overall Study||15
340152|NCT00571324|822015|P2|NOT COMPLETED|Intervention 2 (7 Hours)||0
340153|NCT00571324|822016|P1|NOT COMPLETED|Intervention 2 (7 Hours)||0
340154|NCT00571324|822015|P2|COMPLETED|Intervention 2 (7 Hours)||4
340155|NCT00571324|822016|P1|COMPLETED|Intervention 2 (7 Hours)||5
340156|NCT00571324|822015|P2|STARTED|Intervention 2 (7 Hours)||4
340157|NCT00571324|822016|P1|STARTED|Intervention 2 (7 Hours)||5
340158|NCT00571324|822015|P2|NOT COMPLETED|Intervention 1 (7 Hours)||0
340159|NCT00571324|822016|P1|NOT COMPLETED|Intervention 1 (7 Hours)||0
340160|NCT00571324|822015|P2|COMPLETED|Intervention 1 (7 Hours)||4
340161|NCT00571324|822016|P1|COMPLETED|Intervention 1 (7 Hours)||5
340162|NCT00571324|822015|P2|STARTED|Intervention 1 (7 Hours)||4
340163|NCT00571324|822016|P1|STARTED|Intervention 1 (7 Hours)||5
340164|NCT00571194|822028|P1|NOT COMPLETED|Overall Study||0
340165|NCT00571194|822028|P1|COMPLETED|Overall Study||7
340166|NCT00571194|822028|P1|STARTED|Overall Study||7
340167|NCT00571103|822032|P1|NOT COMPLETED|Overall Study||2
340168|NCT00571103|822032|P1|COMPLETED|Overall Study|Of the 28 participants, 1 subject withdrew and 1 was lost to follow-up after their baseline visit.|26
340169|NCT00571103|822032|P1|STARTED|Overall Study||28
340170|NCT00571064|822037|P1|NOT COMPLETED|Overall Study||21
340171|NCT00571064|822037|P1|COMPLETED|Overall Study||76
340172|NCT00571064|822037|P1|STARTED|Overall Study||97
340173|NCT00571038|822052|P2|NOT COMPLETED|Overall Study||14
340174|NCT00571038|822053|P1|NOT COMPLETED|Overall Study||11
340175|NCT00571038|822052|P2|COMPLETED|Overall Study|5 died 2 moved 3 asked to be withdrawn 4 unable to reach|171
340176|NCT00571038|822053|P1|COMPLETED|Overall Study|"7 died 2 moved~1 asked to be withdrawn~1 unable to reach"|208
340177|NCT00571038|822052|P2|18 Month Survey Only|Overall Study||163
340178|NCT00571038|822053|P1|18 Month Survey Only|Overall Study||199
340179|NCT00571038|822052|P2|6 Month Follow up|Overall Study||176
340180|NCT00571038|822053|P1|6 Month Follow up|Overall Study||208
340181|NCT00571038|822052|P2|STARTED|Overall Study||185
340182|NCT00571038|822053|P1|STARTED|Overall Study||219
340183|NCT00570960|822101|P2|NOT COMPLETED|Overall Study||0
340184|NCT00570960|822102|P1|NOT COMPLETED|Overall Study||0
340185|NCT00570960|822101|P2|COMPLETED|Overall Study||4
340186|NCT00570960|822102|P1|COMPLETED|Overall Study||4
340187|NCT00570960|822101|P2|STARTED|Overall Study||4
340188|NCT00570960|822102|P1|STARTED|Overall Study||4
340189|NCT00570921|822108|P1|NOT COMPLETED|Overall Study||2
340190|NCT00570921|822108|P1|COMPLETED|Overall Study||31
340191|NCT00570921|822108|P1|STARTED|Overall Study||33
340192|NCT00570908|822114|P1|NOT COMPLETED|Overall Study||7
340193|NCT00570908|822114|P1|COMPLETED|Overall Study|5 patients progressed during the study treatment|5
340194|NCT00570908|822114|P1|STARTED|Overall Study||12
340195|NCT00570778|822118|P4|NOT COMPLETED|Overall Study||4
340196|NCT00570778|822119|P3|NOT COMPLETED|Overall Study||7
340197|NCT00570778|822120|P2|NOT COMPLETED|Overall Study||4
340198|NCT00570778|822121|P1|NOT COMPLETED|Overall Study||4
340199|NCT00570778|822118|P4|COMPLETED|Overall Study||34
340200|NCT00570778|822119|P3|COMPLETED|Overall Study||30
340201|NCT00570778|822120|P2|COMPLETED|Overall Study||34
340202|NCT00570778|822121|P1|COMPLETED|Overall Study||37
340203|NCT00570778|822118|P4|Modified Intent-to-treat Population|Overall Study||37
340204|NCT00570778|822119|P3|Modified Intent-to-treat Population|Overall Study||35
340205|NCT00570778|822120|P2|Modified Intent-to-treat Population|Overall Study||37
340206|NCT00570778|822121|P1|Modified Intent-to-treat Population|Overall Study||40
340207|NCT00570778|822118|P4|Safety Population: Received Study Drug|Overall Study||38
340208|NCT00570778|822119|P3|Safety Population: Received Study Drug|Overall Study||36
340209|NCT00570778|822120|P2|Safety Population: Received Study Drug|Overall Study||38
340294|NCT00570687|822345|P1|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
340210|NCT00570778|822121|P1|Safety Population: Received Study Drug|Overall Study|Safety Population included all participants who received at least 1 dose of any study drug.|41
340211|NCT00570778|822118|P4|STARTED|Overall Study||38
340212|NCT00570778|822119|P3|STARTED|Overall Study||37
340213|NCT00570778|822120|P2|STARTED|Overall Study||38
340214|NCT00570778|822121|P1|STARTED|Overall Study||41
340215|NCT00570765|822142|P3|NOT COMPLETED|Overall Study||0
340216|NCT00570765|822143|P2|NOT COMPLETED|Overall Study||7
340217|NCT00570765|822144|P1|NOT COMPLETED|Overall Study||4
340218|NCT00570765|822142|P3|COMPLETED|Overall Study||23
340219|NCT00570765|822143|P2|COMPLETED|Overall Study||9
340220|NCT00570765|822144|P1|COMPLETED|Overall Study||16
340221|NCT00570765|822142|P3|STARTED|Overall Study||23
340222|NCT00570765|822143|P2|STARTED|Overall Study||16
340223|NCT00570765|822144|P1|STARTED|Overall Study||20
340224|NCT00570739|822162|P4|NOT COMPLETED|Overall Study||12
340225|NCT00570739|822163|P3|NOT COMPLETED|Overall Study||16
340226|NCT00570739|822164|P2|NOT COMPLETED|Overall Study||21
340227|NCT00570739|822165|P1|NOT COMPLETED|Overall Study||21
340228|NCT00570739|822162|P4|COMPLETED|Overall Study||96
340229|NCT00570739|822163|P3|COMPLETED|Overall Study||92
340230|NCT00570739|822164|P2|COMPLETED|Overall Study||124
340231|NCT00570739|822165|P1|COMPLETED|Overall Study||120
340232|NCT00570739|822162|P4|STARTED|Overall Study||108
340233|NCT00570739|822163|P3|STARTED|Overall Study||108
340234|NCT00570739|822164|P2|STARTED|Overall Study||145
340235|NCT00570739|822165|P1|STARTED|Overall Study||141
340236|NCT00570713|822317|P2|NOT COMPLETED|Overall Study||77
340237|NCT00570713|822318|P1|NOT COMPLETED|Overall Study||78
340238|NCT00570713|822317|P2|COMPLETED|Overall Study||0
340239|NCT00570713|822318|P1|COMPLETED|Overall Study||0
340240|NCT00570713|822317|P2|STARTED|Overall Study||77
340241|NCT00570713|822318|P1|STARTED|Overall Study||78
340242|NCT00570700|822328|P1|NOT COMPLETED|Overall Study||11
340243|NCT00570700|822328|P1|COMPLETED|Overall Study||27
340244|NCT00570700|822328|P1|STARTED|Overall Study||38
340245|NCT00570687|822336|P10|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
340246|NCT00570687|822337|P9|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
340247|NCT00570687|822338|P8|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
340248|NCT00570687|822339|P7|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
340249|NCT00570687|822340|P6|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
340250|NCT00570687|822341|P5|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
340251|NCT00570687|822342|P4|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
340252|NCT00570687|822343|P3|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
340253|NCT00570687|822344|P2|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
340254|NCT00570687|822345|P1|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
340255|NCT00570687|822336|P10|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
340256|NCT00570687|822337|P9|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
340257|NCT00570687|822338|P8|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
340258|NCT00570687|822339|P7|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
340259|NCT00570687|822340|P6|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
340260|NCT00570687|822341|P5|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
340261|NCT00570687|822342|P4|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
340262|NCT00570687|822343|P3|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
340263|NCT00570687|822344|P2|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
340264|NCT00570687|822345|P1|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
340265|NCT00570687|822336|P10|STARTED|Clamp 2 (1 Day) - Amendment 1||0
340266|NCT00570687|822337|P9|STARTED|Clamp 2 (1 Day) - Amendment 1||0
340267|NCT00570687|822338|P8|STARTED|Clamp 2 (1 Day) - Amendment 1||0
340268|NCT00570687|822339|P7|STARTED|Clamp 2 (1 Day) - Amendment 1||0
340269|NCT00570687|822340|P6|STARTED|Clamp 2 (1 Day) - Amendment 1||0
340270|NCT00570687|822341|P5|STARTED|Clamp 2 (1 Day) - Amendment 1||0
340271|NCT00570687|822342|P4|STARTED|Clamp 2 (1 Day) - Amendment 1||4
340272|NCT00570687|822343|P3|STARTED|Clamp 2 (1 Day) - Amendment 1||2
340273|NCT00570687|822344|P2|STARTED|Clamp 2 (1 Day) - Amendment 1||2
340274|NCT00570687|822345|P1|STARTED|Clamp 2 (1 Day) - Amendment 1||4
340275|NCT00570687|822336|P10|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
340276|NCT00570687|822337|P9|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
340277|NCT00570687|822338|P8|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
340278|NCT00570687|822339|P7|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
340279|NCT00570687|822340|P6|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
340280|NCT00570687|822341|P5|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
340281|NCT00570687|822342|P4|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
340282|NCT00570687|822343|P3|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
340283|NCT00570687|822344|P2|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
340284|NCT00570687|822345|P1|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
340285|NCT00570687|822336|P10|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
340286|NCT00570687|822337|P9|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
340287|NCT00570687|822338|P8|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
340288|NCT00570687|822339|P7|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
340289|NCT00570687|822340|P6|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
340290|NCT00570687|822341|P5|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
340291|NCT00570687|822342|P4|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
340292|NCT00570687|822343|P3|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
340293|NCT00570687|822344|P2|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
340295|NCT00570687|822336|P10|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
340296|NCT00570687|822337|P9|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
340297|NCT00570687|822338|P8|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
340298|NCT00570687|822339|P7|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
340299|NCT00570687|822340|P6|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
340300|NCT00570687|822341|P5|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
340301|NCT00570687|822342|P4|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
340302|NCT00570687|822343|P3|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
340303|NCT00570687|822344|P2|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
340304|NCT00570687|822345|P1|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
340305|NCT00570687|822336|P10|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
340306|NCT00570687|822337|P9|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
340307|NCT00570687|822338|P8|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
340308|NCT00570687|822339|P7|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
340309|NCT00570687|822340|P6|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
340310|NCT00570687|822341|P5|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
340311|NCT00570687|822342|P4|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
340312|NCT00570687|822343|P3|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
340313|NCT00570687|822344|P2|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
340314|NCT00570687|822345|P1|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
340315|NCT00570687|822336|P10|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
340316|NCT00570687|822337|P9|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
340317|NCT00570687|822338|P8|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
340318|NCT00570687|822339|P7|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
340319|NCT00570687|822340|P6|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
340320|NCT00570687|822341|P5|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
340321|NCT00570687|822342|P4|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
340322|NCT00570687|822343|P3|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
340323|NCT00570687|822344|P2|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
340324|NCT00570687|822345|P1|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
340325|NCT00570687|822336|P10|STARTED|Clamp 1 (1 Day) - Amendment 1||0
340326|NCT00570687|822337|P9|STARTED|Clamp 1 (1 Day) - Amendment 1||0
340327|NCT00570687|822338|P8|STARTED|Clamp 1 (1 Day) - Amendment 1||0
340328|NCT00570687|822339|P7|STARTED|Clamp 1 (1 Day) - Amendment 1||0
340329|NCT00570687|822340|P6|STARTED|Clamp 1 (1 Day) - Amendment 1||0
340330|NCT00570687|822341|P5|STARTED|Clamp 1 (1 Day) - Amendment 1||0
340331|NCT00570687|822342|P4|STARTED|Clamp 1 (1 Day) - Amendment 1||4
340332|NCT00570687|822343|P3|STARTED|Clamp 1 (1 Day) - Amendment 1||2
340333|NCT00570687|822344|P2|STARTED|Clamp 1 (1 Day) - Amendment 1||2
340334|NCT00570687|822345|P1|STARTED|Clamp 1 (1 Day) - Amendment 1||4
340335|NCT00570687|822336|P10|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
340336|NCT00570687|822337|P9|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
340337|NCT00570687|822338|P8|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
340338|NCT00570687|822339|P7|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
340339|NCT00570687|822340|P6|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
340340|NCT00570687|822341|P5|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
340341|NCT00570687|822342|P4|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
340342|NCT00570687|822343|P3|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
340343|NCT00570687|822344|P2|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
340344|NCT00570687|822345|P1|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
340345|NCT00570687|822336|P10|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
340346|NCT00570687|822337|P9|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
340347|NCT00570687|822338|P8|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
340348|NCT00570687|822339|P7|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
340349|NCT00570687|822340|P6|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
340350|NCT00570687|822341|P5|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
340351|NCT00570687|822342|P4|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
340352|NCT00570687|822343|P3|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
340353|NCT00570687|822344|P2|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
340354|NCT00570687|822345|P1|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
340355|NCT00570687|822336|P10|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
340356|NCT00570687|822337|P9|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
340357|NCT00570687|822338|P8|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
340358|NCT00570687|822339|P7|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
340359|NCT00570687|822340|P6|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
340360|NCT00570687|822341|P5|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
340361|NCT00570687|822342|P4|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
340362|NCT00570687|822343|P3|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
340363|NCT00570687|822344|P2|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
340364|NCT00570687|822345|P1|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
340365|NCT00570687|822336|P10|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
340366|NCT00570687|822337|P9|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
340367|NCT00570687|822338|P8|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
340368|NCT00570687|822339|P7|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
340369|NCT00570687|822340|P6|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
340370|NCT00570687|822341|P5|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
340371|NCT00570687|822342|P4|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
340372|NCT00570687|822343|P3|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
340373|NCT00570687|822344|P2|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
340374|NCT00570687|822345|P1|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
340375|NCT00570687|822336|P10|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
340376|NCT00570687|822337|P9|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
340377|NCT00570687|822338|P8|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
340378|NCT00570687|822339|P7|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
340379|NCT00570687|822340|P6|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
340380|NCT00570687|822341|P5|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
340381|NCT00570687|822342|P4|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
340382|NCT00570687|822343|P3|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
340383|NCT00570687|822344|P2|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
340384|NCT00570687|822345|P1|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
340385|NCT00570687|822336|P10|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
340386|NCT00570687|822337|P9|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
340387|NCT00570687|822338|P8|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
340388|NCT00570687|822339|P7|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
340389|NCT00570687|822340|P6|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
340390|NCT00570687|822341|P5|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
340391|NCT00570687|822342|P4|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
340392|NCT00570687|822343|P3|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
340393|NCT00570687|822344|P2|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
340394|NCT00570687|822345|P1|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
340395|NCT00570687|822336|P10|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
340396|NCT00570687|822337|P9|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
340397|NCT00570687|822338|P8|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
340398|NCT00570687|822339|P7|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
340399|NCT00570687|822340|P6|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
340400|NCT00570687|822341|P5|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
340401|NCT00570687|822342|P4|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
340402|NCT00570687|822343|P3|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
340403|NCT00570687|822344|P2|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
340404|NCT00570687|822345|P1|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
340405|NCT00570687|822336|P10|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
340406|NCT00570687|822337|P9|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
340407|NCT00570687|822338|P8|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
340408|NCT00570687|822339|P7|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
340409|NCT00570687|822340|P6|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
340410|NCT00570687|822341|P5|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
340411|NCT00570687|822342|P4|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
340412|NCT00570687|822343|P3|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
340413|NCT00570687|822344|P2|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
340414|NCT00570687|822345|P1|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
340415|NCT00570687|822336|P10|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
340416|NCT00570687|822337|P9|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
340417|NCT00570687|822338|P8|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
340418|NCT00570687|822339|P7|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
340419|NCT00570687|822340|P6|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
340420|NCT00570687|822341|P5|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
340421|NCT00570687|822342|P4|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
340422|NCT00570687|822343|P3|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
340423|NCT00570687|822344|P2|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
340424|NCT00570687|822345|P1|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
340425|NCT00570687|822336|P10|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
340426|NCT00570687|822337|P9|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
340427|NCT00570687|822338|P8|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
340428|NCT00570687|822339|P7|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
340429|NCT00570687|822340|P6|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
340430|NCT00570687|822341|P5|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
340431|NCT00570687|822342|P4|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
340432|NCT00570687|822343|P3|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
340433|NCT00570687|822344|P2|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
340434|NCT00570687|822345|P1|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
340435|NCT00570687|822336|P10|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
340436|NCT00570687|822337|P9|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
340437|NCT00570687|822338|P8|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
340438|NCT00570687|822339|P7|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
340439|NCT00570687|822340|P6|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
340440|NCT00570687|822341|P5|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
340441|NCT00570687|822342|P4|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
340442|NCT00570687|822343|P3|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
340443|NCT00570687|822344|P2|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
340444|NCT00570687|822345|P1|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
340445|NCT00570687|822336|P10|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
340446|NCT00570687|822337|P9|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
340447|NCT00570687|822338|P8|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
340448|NCT00570687|822339|P7|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
340449|NCT00570687|822340|P6|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
340450|NCT00570687|822341|P5|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
340451|NCT00570687|822342|P4|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
340452|NCT00570687|822343|P3|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
340453|NCT00570687|822344|P2|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
340454|NCT00570687|822345|P1|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
340455|NCT00570687|822336|P10|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
340456|NCT00570687|822337|P9|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
340457|NCT00570687|822338|P8|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
340458|NCT00570687|822339|P7|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||1
340459|NCT00570687|822340|P6|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
340460|NCT00570687|822341|P5|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
340461|NCT00570687|822342|P4|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
340462|NCT00570687|822343|P3|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
340463|NCT00570687|822344|P2|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
340464|NCT00570687|822345|P1|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
340465|NCT00570687|822336|P10|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
340466|NCT00570687|822337|P9|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
340467|NCT00570687|822338|P8|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
340468|NCT00570687|822339|P7|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
340469|NCT00570687|822340|P6|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
340470|NCT00570687|822341|P5|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
340471|NCT00570687|822342|P4|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
340472|NCT00570687|822343|P3|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
340473|NCT00570687|822344|P2|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
340474|NCT00570687|822345|P1|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
340475|NCT00570687|822336|P10|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
340476|NCT00570687|822337|P9|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
340477|NCT00570687|822338|P8|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
340478|NCT00570687|822339|P7|STARTED|Washout 5 (7-21 Days) - Orig Protocol||1
340479|NCT00570687|822340|P6|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
340480|NCT00570687|822341|P5|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
340481|NCT00570687|822342|P4|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
340482|NCT00570687|822343|P3|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
340483|NCT00570687|822344|P2|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
340484|NCT00570687|822345|P1|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
340485|NCT00570687|822336|P10|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
340486|NCT00570687|822337|P9|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
340487|NCT00570687|822338|P8|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
340488|NCT00570687|822339|P7|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
340489|NCT00570687|822340|P6|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
340490|NCT00570687|822341|P5|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
340491|NCT00570687|822342|P4|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
340492|NCT00570687|822343|P3|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
340493|NCT00570687|822344|P2|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
340494|NCT00570687|822345|P1|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
340495|NCT00570687|822336|P10|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
340496|NCT00570687|822337|P9|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
340497|NCT00570687|822338|P8|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
340498|NCT00570687|822339|P7|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||1
340499|NCT00570687|822340|P6|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
340500|NCT00570687|822341|P5|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
340501|NCT00570687|822342|P4|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
340502|NCT00570687|822343|P3|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
340503|NCT00570687|822344|P2|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
340504|NCT00570687|822345|P1|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
340505|NCT00570687|822336|P10|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
340506|NCT00570687|822337|P9|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
340507|NCT00570687|822338|P8|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
340508|NCT00570687|822339|P7|STARTED|Clamp 2 (1 Day) - Orig Protocol||1
340509|NCT00570687|822340|P6|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
340510|NCT00570687|822341|P5|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
340511|NCT00570687|822342|P4|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
340512|NCT00570687|822343|P3|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
340513|NCT00570687|822344|P2|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
340514|NCT00570687|822345|P1|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
340515|NCT00570687|822336|P10|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
340516|NCT00570687|822337|P9|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
340517|NCT00570687|822338|P8|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
340518|NCT00570687|822339|P7|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
340519|NCT00570687|822340|P6|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
340520|NCT00570687|822341|P5|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
340521|NCT00570687|822342|P4|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
340522|NCT00570687|822343|P3|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
340523|NCT00570687|822344|P2|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
340524|NCT00570687|822345|P1|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
340930|NCT00569660|822834|P1|STARTED|Overall Study||34
340525|NCT00570687|822336|P10|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
340526|NCT00570687|822337|P9|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
340527|NCT00570687|822338|P8|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
340528|NCT00570687|822339|P7|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
340529|NCT00570687|822340|P6|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
340530|NCT00570687|822341|P5|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
340531|NCT00570687|822342|P4|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
340532|NCT00570687|822343|P3|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
340533|NCT00570687|822344|P2|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
340534|NCT00570687|822345|P1|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
340535|NCT00570687|822336|P10|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
340536|NCT00570687|822337|P9|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
340537|NCT00570687|822338|P8|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
340538|NCT00570687|822339|P7|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
340539|NCT00570687|822340|P6|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
340540|NCT00570687|822341|P5|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
340541|NCT00570687|822342|P4|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
340542|NCT00570687|822343|P3|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
340543|NCT00570687|822344|P2|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
340544|NCT00570687|822345|P1|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
340545|NCT00570687|822336|P10|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
340546|NCT00570687|822337|P9|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
340547|NCT00570687|822338|P8|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
340548|NCT00570687|822339|P7|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
340549|NCT00570687|822340|P6|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
340550|NCT00570687|822341|P5|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
340551|NCT00570687|822342|P4|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
340552|NCT00570687|822343|P3|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
340553|NCT00570687|822344|P2|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
340554|NCT00570687|822345|P1|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
340555|NCT00570687|822336|P10|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
340556|NCT00570687|822337|P9|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
340557|NCT00570687|822338|P8|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
340558|NCT00570687|822339|P7|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
340559|NCT00570687|822340|P6|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
340560|NCT00570687|822341|P5|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
340561|NCT00570687|822342|P4|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
340562|NCT00570687|822343|P3|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
340563|NCT00570687|822344|P2|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
340564|NCT00570687|822345|P1|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
340565|NCT00570687|822336|P10|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
340566|NCT00570687|822337|P9|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
340567|NCT00570687|822338|P8|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
340568|NCT00570687|822339|P7|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
340569|NCT00570687|822340|P6|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
340570|NCT00570687|822341|P5|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
340571|NCT00570687|822342|P4|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
340572|NCT00570687|822343|P3|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
340573|NCT00570687|822344|P2|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
340574|NCT00570687|822345|P1|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
340575|NCT00570687|822336|P10|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
340576|NCT00570687|822337|P9|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
340577|NCT00570687|822338|P8|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
340578|NCT00570687|822339|P7|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
340579|NCT00570687|822340|P6|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
340580|NCT00570687|822341|P5|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
340581|NCT00570687|822342|P4|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
340582|NCT00570687|822343|P3|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
340583|NCT00570687|822344|P2|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
340584|NCT00570687|822345|P1|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
340585|NCT00570687|822336|P10|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
340586|NCT00570687|822337|P9|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
340587|NCT00570687|822338|P8|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
340588|NCT00570687|822339|P7|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
340589|NCT00570687|822340|P6|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
340590|NCT00570687|822341|P5|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
340591|NCT00570687|822342|P4|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
340592|NCT00570687|822343|P3|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
340593|NCT00570687|822344|P2|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
340594|NCT00570687|822345|P1|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
340595|NCT00570687|822336|P10|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
340596|NCT00570687|822337|P9|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
340597|NCT00570687|822338|P8|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
340598|NCT00570687|822339|P7|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
340599|NCT00570687|822340|P6|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
340600|NCT00570687|822341|P5|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
340601|NCT00570687|822342|P4|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
340602|NCT00570687|822343|P3|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
340603|NCT00570687|822344|P2|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
340604|NCT00570687|822345|P1|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
340605|NCT00570687|822336|P10|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
340606|NCT00570687|822337|P9|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
340607|NCT00570687|822338|P8|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
340608|NCT00570687|822339|P7|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
340609|NCT00570687|822340|P6|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
340610|NCT00570687|822341|P5|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
340611|NCT00570687|822342|P4|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
340612|NCT00570687|822343|P3|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
340613|NCT00570687|822344|P2|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
340614|NCT00570687|822345|P1|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
340615|NCT00570687|822336|P10|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
340616|NCT00570687|822337|P9|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
340617|NCT00570687|822338|P8|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
340618|NCT00570687|822339|P7|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
340619|NCT00570687|822340|P6|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
340620|NCT00570687|822341|P5|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
340621|NCT00570687|822342|P4|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
340622|NCT00570687|822343|P3|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
340623|NCT00570687|822344|P2|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
340624|NCT00570687|822345|P1|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
340625|NCT00570687|822336|P10|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
340626|NCT00570687|822337|P9|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
340627|NCT00570687|822338|P8|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
340628|NCT00570687|822339|P7|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
340629|NCT00570687|822340|P6|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
340630|NCT00570687|822341|P5|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
340631|NCT00570687|822342|P4|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
340632|NCT00570687|822343|P3|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
340633|NCT00570687|822344|P2|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
340634|NCT00570687|822345|P1|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
340635|NCT00570687|822336|P10|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
340636|NCT00570687|822337|P9|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
340637|NCT00570687|822338|P8|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
340638|NCT00570687|822339|P7|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
340639|NCT00570687|822340|P6|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
340640|NCT00570687|822341|P5|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
340641|NCT00570687|822342|P4|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
340642|NCT00570687|822343|P3|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
340643|NCT00570687|822344|P2|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
340644|NCT00570687|822345|P1|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
340645|NCT00570687|822336|P10|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
340646|NCT00570687|822337|P9|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
340647|NCT00570687|822338|P8|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
340648|NCT00570687|822339|P7|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
340649|NCT00570687|822340|P6|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
340650|NCT00570687|822341|P5|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
340651|NCT00570687|822342|P4|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
340652|NCT00570687|822343|P3|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
340653|NCT00570687|822344|P2|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
340654|NCT00570687|822345|P1|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
340655|NCT00570687|822336|P10|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
340656|NCT00570687|822337|P9|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
340657|NCT00570687|822338|P8|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
340658|NCT00570687|822339|P7|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
340659|NCT00570687|822340|P6|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
340660|NCT00570687|822341|P5|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
340661|NCT00570687|822342|P4|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
340662|NCT00570687|822343|P3|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
340663|NCT00570687|822344|P2|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
340664|NCT00570687|822345|P1|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
340665|NCT00570687|822336|P10|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
340666|NCT00570687|822337|P9|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
340667|NCT00570687|822338|P8|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
340668|NCT00570687|822339|P7|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
340669|NCT00570687|822340|P6|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
340670|NCT00570687|822341|P5|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
340671|NCT00570687|822342|P4|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
340672|NCT00570687|822343|P3|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
340673|NCT00570687|822344|P2|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
340674|NCT00570687|822345|P1|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
340675|NCT00570687|822336|P10|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
340676|NCT00570687|822337|P9|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
340677|NCT00570687|822338|P8|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
340678|NCT00570687|822339|P7|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
340679|NCT00570687|822340|P6|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
340680|NCT00570687|822341|P5|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
340681|NCT00570687|822342|P4|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
340682|NCT00570687|822343|P3|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
340683|NCT00570687|822344|P2|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
340684|NCT00570687|822345|P1|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
340685|NCT00570687|822336|P10|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
340686|NCT00570687|822337|P9|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
340687|NCT00570687|822338|P8|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
340688|NCT00570687|822339|P7|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
340689|NCT00570687|822340|P6|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
340690|NCT00570687|822341|P5|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
340691|NCT00570687|822342|P4|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
340692|NCT00570687|822343|P3|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
340693|NCT00570687|822344|P2|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
340694|NCT00570687|822345|P1|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
340695|NCT00570687|822336|P10|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
340696|NCT00570687|822337|P9|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
340697|NCT00570687|822338|P8|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
340698|NCT00570687|822339|P7|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
340699|NCT00570687|822340|P6|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
340700|NCT00570687|822341|P5|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
340701|NCT00570687|822342|P4|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
340702|NCT00570687|822343|P3|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
340703|NCT00570687|822344|P2|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
340704|NCT00570687|822345|P1|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
340705|NCT00570687|822336|P10|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
340706|NCT00570687|822337|P9|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
340707|NCT00570687|822338|P8|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
340708|NCT00570687|822339|P7|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
340709|NCT00570687|822340|P6|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
340710|NCT00570687|822341|P5|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
340711|NCT00570687|822342|P4|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
340712|NCT00570687|822343|P3|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
340713|NCT00570687|822344|P2|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
340714|NCT00570687|822345|P1|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
340715|NCT00570687|822336|P10|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
340716|NCT00570687|822337|P9|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
340717|NCT00570687|822338|P8|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
340718|NCT00570687|822339|P7|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
340719|NCT00570687|822340|P6|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
340720|NCT00570687|822341|P5|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
340721|NCT00570687|822342|P4|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
340722|NCT00570687|822343|P3|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
340723|NCT00570687|822344|P2|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
340724|NCT00570687|822345|P1|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
340725|NCT00570687|822336|P10|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
340726|NCT00570687|822337|P9|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
340727|NCT00570687|822338|P8|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
340728|NCT00570687|822339|P7|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
340729|NCT00570687|822340|P6|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
340730|NCT00570687|822341|P5|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
340731|NCT00570687|822342|P4|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
340732|NCT00570687|822343|P3|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
340733|NCT00570687|822344|P2|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
340734|NCT00570687|822345|P1|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
340735|NCT00570687|822336|P10|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
340736|NCT00570687|822337|P9|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
340737|NCT00570687|822338|P8|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
340738|NCT00570687|822339|P7|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
340739|NCT00570687|822340|P6|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
340740|NCT00570687|822341|P5|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
340741|NCT00570687|822342|P4|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
340742|NCT00570687|822343|P3|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
340743|NCT00570687|822344|P2|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
340744|NCT00570687|822345|P1|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
340745|NCT00570687|822336|P10|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
340746|NCT00570687|822337|P9|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
340747|NCT00570687|822338|P8|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
340748|NCT00570687|822339|P7|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
340749|NCT00570687|822340|P6|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
340750|NCT00570687|822341|P5|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
340751|NCT00570687|822342|P4|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
340752|NCT00570687|822343|P3|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
340753|NCT00570687|822344|P2|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
340754|NCT00570687|822345|P1|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
340755|NCT00570674|822371|P7|NOT COMPLETED|Overall Study||0
340756|NCT00570674|822372|P6|NOT COMPLETED|Overall Study||0
340757|NCT00570674|822373|P5|NOT COMPLETED|Overall Study||0
340758|NCT00570674|822374|P4|NOT COMPLETED|Overall Study||0
340759|NCT00570674|822375|P3|NOT COMPLETED|Overall Study||1
340760|NCT00570674|822376|P2|NOT COMPLETED|Overall Study||0
340761|NCT00570674|822377|P1|NOT COMPLETED|Overall Study||0
340762|NCT00570674|822371|P7|COMPLETED|Overall Study||0
340763|NCT00570674|822372|P6|COMPLETED|Overall Study||10
340764|NCT00570674|822373|P5|COMPLETED|Overall Study||3
340765|NCT00570674|822374|P4|COMPLETED|Overall Study||3
340766|NCT00570674|822375|P3|COMPLETED|Overall Study||3
340767|NCT00570674|822376|P2|COMPLETED|Overall Study||3
340768|NCT00570674|822377|P1|COMPLETED|Overall Study||6
340769|NCT00570674|822371|P7|PEG Evaluable|Overall Study||0
340770|NCT00570674|822372|P6|PEG Evaluable|Overall Study||10
340771|NCT00570674|822373|P5|PEG Evaluable|Overall Study||2
340772|NCT00570674|822374|P4|PEG Evaluable|Overall Study||3
340773|NCT00570674|822375|P3|PEG Evaluable|Overall Study||3
340774|NCT00570674|822376|P2|PEG Evaluable|Overall Study||3
340775|NCT00570674|822377|P1|PEG Evaluable|Overall Study||6
340776|NCT00570674|822371|P7|Treated|Overall Study||0
340777|NCT00570674|822372|P6|Treated|Overall Study||10
340778|NCT00570674|822373|P5|Treated|Overall Study||3
340779|NCT00570674|822374|P4|Treated|Overall Study||3
340780|NCT00570674|822375|P3|Treated|Overall Study||3
340781|NCT00570674|822376|P2|Treated|Overall Study||3
340782|NCT00570674|822377|P1|Treated|Overall Study||6
340783|NCT00570674|822371|P7|STARTED|Overall Study|The study did not continue beyond phase I.|0
340784|NCT00570674|822372|P6|STARTED|Overall Study||10
340785|NCT00570674|822373|P5|STARTED|Overall Study||3
340786|NCT00570674|822374|P4|STARTED|Overall Study||3
340787|NCT00570674|822375|P3|STARTED|Overall Study||4
340788|NCT00570674|822376|P2|STARTED|Overall Study||3
340789|NCT00570674|822377|P1|STARTED|Overall Study||6
340790|NCT00570531|822394|P1|NOT COMPLETED|Overall Study||0
340791|NCT00570531|822394|P1|COMPLETED|Overall Study||6
340792|NCT00570531|822394|P1|STARTED|Overall Study||6
340793|NCT00570505|822400|P1|NOT COMPLETED|Overall Study||41
340794|NCT00570505|822400|P1|COMPLETED|Overall Study|The number of subjects completing the 60-month study|108
340795|NCT00570505|822400|P1|STARTED|Overall Study||149
340796|NCT00570492|822413|P3|NOT COMPLETED|52-week Double-blind Treatment Period||51
340797|NCT00570492|822414|P2|NOT COMPLETED|52-week Double-blind Treatment Period||50
340798|NCT00570492|822415|P1|NOT COMPLETED|52-week Double-blind Treatment Period||0
340799|NCT00570492|822413|P3|COMPLETED|52-week Double-blind Treatment Period||186
340800|NCT00570492|822414|P2|COMPLETED|52-week Double-blind Treatment Period||187
340801|NCT00570492|822415|P1|COMPLETED|52-week Double-blind Treatment Period||0
340802|NCT00570492|822413|P3|STARTED|52-week Double-blind Treatment Period||237
340803|NCT00570492|822414|P2|STARTED|52-week Double-blind Treatment Period||237
340804|NCT00570492|822415|P1|STARTED|52-week Double-blind Treatment Period||0
340805|NCT00570492|822413|P3|NOT COMPLETED|16-week Single-blind Baseline Period||0
340806|NCT00570492|822414|P2|NOT COMPLETED|16-week Single-blind Baseline Period||0
340807|NCT00570492|822415|P1|NOT COMPLETED|16-week Single-blind Baseline Period||436
340808|NCT00570492|822413|P3|COMPLETED|16-week Single-blind Baseline Period||0
340809|NCT00570492|822414|P2|COMPLETED|16-week Single-blind Baseline Period||0
340810|NCT00570492|822415|P1|COMPLETED|16-week Single-blind Baseline Period||474
340811|NCT00570492|822413|P3|STARTED|16-week Single-blind Baseline Period||0
340812|NCT00570492|822414|P2|STARTED|16-week Single-blind Baseline Period||0
340813|NCT00570492|822415|P1|STARTED|16-week Single-blind Baseline Period||910
340814|NCT00570401|822453|P1|NOT COMPLETED|Overall Study||2
340815|NCT00570401|822453|P1|COMPLETED|Overall Study||19
340816|NCT00570401|822453|P1|STARTED|Overall Study||21
340817|NCT00570362|822459|P2|NOT COMPLETED|Overall Study||0
340818|NCT00570362|822460|P1|NOT COMPLETED|Overall Study||0
340819|NCT00570362|822459|P2|COMPLETED|Overall Study||30
340820|NCT00570362|822460|P1|COMPLETED|Overall Study||19
340821|NCT00570362|822459|P2|STARTED|Overall Study||30
340822|NCT00570362|822460|P1|STARTED|Overall Study||19
340823|NCT00570349|822469|P3|NOT COMPLETED|Overall Study||0
340824|NCT00570349|822470|P2|NOT COMPLETED|Overall Study||0
340825|NCT00570349|822471|P1|NOT COMPLETED|Overall Study||0
340826|NCT00570349|822469|P3|COMPLETED|Overall Study||6
340827|NCT00570349|822470|P2|COMPLETED|Overall Study||6
340828|NCT00570349|822471|P1|COMPLETED|Overall Study||6
340829|NCT00570349|822469|P3|STARTED|Overall Study||6
340830|NCT00570349|822470|P2|STARTED|Overall Study||6
340831|NCT00570349|822471|P1|STARTED|Overall Study||6
340832|NCT00570323|822487|P2|NOT COMPLETED|Complete Study After Start||1
340833|NCT00570323|822488|P1|NOT COMPLETED|Complete Study After Start||3
340834|NCT00570323|822487|P2|COMPLETED|Complete Study After Start||34
340835|NCT00570323|822488|P1|COMPLETED|Complete Study After Start||31
340836|NCT00570323|822487|P2|STARTED|Complete Study After Start||35
340837|NCT00570323|822488|P1|STARTED|Complete Study After Start||34
340838|NCT00570323|822487|P2|NOT COMPLETED|Started Treatment After Randomization||1
340839|NCT00570323|822488|P1|NOT COMPLETED|Started Treatment After Randomization||2
340840|NCT00570323|822487|P2|COMPLETED|Started Treatment After Randomization||35
340841|NCT00570323|822488|P1|COMPLETED|Started Treatment After Randomization||34
340842|NCT00570323|822487|P2|STARTED|Started Treatment After Randomization||36
340843|NCT00570323|822488|P1|STARTED|Started Treatment After Randomization||36
340844|NCT00570310|822500|P2|NOT COMPLETED|Overall Study||6
340845|NCT00570310|822501|P1|NOT COMPLETED|Overall Study||2
340846|NCT00570310|822500|P2|COMPLETED|Overall Study||45
340847|NCT00570310|822501|P1|COMPLETED|Overall Study||51
340848|NCT00570310|822500|P2|STARTED|Overall Study||51
340849|NCT00570310|822501|P1|STARTED|Overall Study||53
340850|NCT00570258|822511|P2|NOT COMPLETED|Overall Study||15
340851|NCT00570258|822512|P1|NOT COMPLETED|Overall Study||12
340852|NCT00570258|822511|P2|COMPLETED|Overall Study|Early termination due to a change in drug FDA approval.|0
340853|NCT00570258|822512|P1|COMPLETED|Overall Study|Early termination due to a change in drug FDA approval.|0
340854|NCT00570258|822511|P2|STARTED|Overall Study||15
340855|NCT00570258|822512|P1|STARTED|Overall Study||12
340856|NCT00570232|822520|P1|NOT COMPLETED|Overall Study||23
340857|NCT00570232|822520|P1|COMPLETED|Overall Study||8
340858|NCT00570232|822520|P1|STARTED|Overall Study||31
340859|NCT00570141|822526|P1|NOT COMPLETED|Overall Study||3
340860|NCT00570141|822526|P1|COMPLETED|Overall Study||10
340861|NCT00570141|822526|P1|STARTED|Overall Study||13
340862|NCT00570089|822531|P2|NOT COMPLETED|Perod 2||0
340863|NCT00570089|822532|P1|NOT COMPLETED|Perod 2||0
340864|NCT00570089|822531|P2|COMPLETED|Perod 2||10
340865|NCT00570089|822532|P1|COMPLETED|Perod 2||10
340866|NCT00570089|822531|P2|STARTED|Perod 2||10
340867|NCT00570089|822532|P1|STARTED|Perod 2||10
340868|NCT00570089|822531|P2|NOT COMPLETED|Period 1||0
340869|NCT00570089|822532|P1|NOT COMPLETED|Period 1||0
340870|NCT00570089|822531|P2|COMPLETED|Period 1||10
340871|NCT00570089|822532|P1|COMPLETED|Period 1||10
340872|NCT00570089|822531|P2|STARTED|Period 1||10
340873|NCT00570089|822532|P1|STARTED|Period 1||10
340874|NCT00570063|822542|P2|NOT COMPLETED|Overall Study||8
340875|NCT00570063|822543|P1|NOT COMPLETED|Overall Study||15
340876|NCT00570063|822542|P2|COMPLETED|Overall Study||3
340877|NCT00570063|822543|P1|COMPLETED|Overall Study||9
340878|NCT00570063|822542|P2|STARTED|Overall Study||11
340879|NCT00570063|822543|P1|STARTED|Overall Study||24
340880|NCT00570037|822609|P2|NOT COMPLETED|Overall Study||69
340881|NCT00570037|822610|P1|NOT COMPLETED|Overall Study||44
340882|NCT00570037|822609|P2|COMPLETED|Overall Study||237
340883|NCT00570037|822610|P1|COMPLETED|Overall Study||194
340884|NCT00570037|822609|P2|STARTED|Overall Study||306
340885|NCT00570037|822610|P1|STARTED|Overall Study||238
340886|NCT00569946|822620|P1|NOT COMPLETED|Overall Study||59
340887|NCT00569946|822620|P1|COMPLETED|Overall Study||5
340888|NCT00569946|822620|P1|STARTED|Overall Study||64
340889|NCT00569868|822636|P1|NOT COMPLETED|Overall Study||0
340890|NCT00569868|822636|P1|COMPLETED|Overall Study||11
340891|NCT00569868|822636|P1|STARTED|Overall Study||11
340892|NCT00569855|822640|P1|NOT COMPLETED|Overall Study||0
340893|NCT00569855|822640|P1|COMPLETED|Overall Study|785 subjects treated with study drug|785
340894|NCT00569855|822640|P1|STARTED|Overall Study|832 subjects enrolled; however, study records only available for analysis from 2004 =446 subjects|785
340895|NCT00569803|822652|P8|NOT COMPLETED|Overall Study||1
340896|NCT00569803|822653|P7|NOT COMPLETED|Overall Study||0
340897|NCT00569803|822654|P6|NOT COMPLETED|Overall Study||0
340898|NCT00569803|822655|P5|NOT COMPLETED|Overall Study||0
340899|NCT00569803|822656|P4|NOT COMPLETED|Overall Study||1
340900|NCT00569803|822657|P3|NOT COMPLETED|Overall Study||0
340901|NCT00569803|822658|P2|NOT COMPLETED|Overall Study||0
340902|NCT00569803|822659|P1|NOT COMPLETED|Overall Study||1
340903|NCT00569803|822652|P8|COMPLETED|Overall Study||5
340904|NCT00569803|822653|P7|COMPLETED|Overall Study||10
340905|NCT00569803|822654|P6|COMPLETED|Overall Study||5
340906|NCT00569803|822655|P5|COMPLETED|Overall Study||5
340907|NCT00569803|822656|P4|COMPLETED|Overall Study||5
340908|NCT00569803|822657|P3|COMPLETED|Overall Study||5
340909|NCT00569803|822658|P2|COMPLETED|Overall Study||5
340910|NCT00569803|822659|P1|COMPLETED|Overall Study||4
340911|NCT00569803|822652|P8|STARTED|Overall Study||6
340912|NCT00569803|822653|P7|STARTED|Overall Study||10
340913|NCT00569803|822654|P6|STARTED|Overall Study||5
340914|NCT00569803|822655|P5|STARTED|Overall Study||5
340915|NCT00569803|822656|P4|STARTED|Overall Study||6
340916|NCT00569803|822657|P3|STARTED|Overall Study||5
340917|NCT00569803|822658|P2|STARTED|Overall Study||5
340918|NCT00569803|822659|P1|STARTED|Overall Study||5
340919|NCT00569777|822786|P2|NOT COMPLETED|Overall Study||3
340920|NCT00569777|822787|P1|NOT COMPLETED|Overall Study||10
340921|NCT00569777|822786|P2|COMPLETED|Overall Study||101
340922|NCT00569777|822787|P1|COMPLETED|Overall Study||196
340923|NCT00569777|822786|P2|STARTED|Overall Study||104
340924|NCT00569777|822787|P1|STARTED|Overall Study||206
340925|NCT00569673|822829|P1|NOT COMPLETED|Overall Study||0
340926|NCT00569673|822829|P1|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|71
340927|NCT00569673|822829|P1|STARTED|Overall Study|Total number participants enrolled on study|71
340928|NCT00569660|822834|P1|NOT COMPLETED|Overall Study||0
340929|NCT00569660|822834|P1|COMPLETED|Overall Study||34
340931|NCT00569582|822838|P1|NOT COMPLETED|Overall Study||16
340932|NCT00569582|822838|P1|COMPLETED|Overall Study||34
340933|NCT00569582|822838|P1|STARTED|Overall Study||50
340934|NCT00569530|822845|P2|NOT COMPLETED|Overall Study||0
340935|NCT00569530|822846|P1|NOT COMPLETED|Overall Study||0
340936|NCT00569530|822845|P2|COMPLETED|Overall Study||42
340937|NCT00569530|822846|P1|COMPLETED|Overall Study||43
340938|NCT00569530|822845|P2|STARTED|Overall Study||42
340939|NCT00569530|822846|P1|STARTED|Overall Study||43
340940|NCT00569374|822854|P1|NOT COMPLETED|Overall Study||4
340941|NCT00569374|822854|P1|COMPLETED|Overall Study||4
340942|NCT00569374|822854|P1|STARTED|Overall Study||8
340943|NCT00569309|822864|P1|NOT COMPLETED|Overall Study||0
340944|NCT00569309|822864|P1|COMPLETED|Overall Study||30
340945|NCT00569309|822864|P1|STARTED|Overall Study||30
340946|NCT00569270|822873|P2|NOT COMPLETED|Period: Second Intervention||0
340947|NCT00569270|822874|P1|NOT COMPLETED|Period: Second Intervention||0
340948|NCT00569270|822873|P2|COMPLETED|Period: Second Intervention||14
340949|NCT00569270|822874|P1|COMPLETED|Period: Second Intervention||15
340950|NCT00569270|822873|P2|29 Days|Period: Second Intervention||14
340951|NCT00569270|822874|P1|29 Days|Period: Second Intervention||15
340952|NCT00569270|822873|P2|STARTED|Period: Second Intervention||14
340953|NCT00569270|822874|P1|STARTED|Period: Second Intervention||15
340954|NCT00569270|822873|P2|NOT COMPLETED|Period: First Intervention||1
340955|NCT00569270|822874|P1|NOT COMPLETED|Period: First Intervention||0
340956|NCT00569270|822873|P2|COMPLETED|Period: First Intervention||14
340957|NCT00569270|822874|P1|COMPLETED|Period: First Intervention||15
340958|NCT00569270|822873|P2|STARTED|Period: First Intervention||15
340959|NCT00569270|822874|P1|STARTED|Period: First Intervention|randomized cross over study|15
340960|NCT00569231|822909|P1|NOT COMPLETED|Overall Study||7
340961|NCT00569231|822909|P1|COMPLETED|Overall Study||11
340962|NCT00569231|822909|P1|STARTED|Overall Study||18
340963|NCT00569192|822919|P3|NOT COMPLETED|Overall Study||25
340964|NCT00569192|822920|P2|NOT COMPLETED|Overall Study||20
340965|NCT00569192|822921|P1|NOT COMPLETED|Overall Study||23
340966|NCT00569192|822919|P3|COMPLETED|Overall Study||99
340967|NCT00569192|822920|P2|COMPLETED|Overall Study||105
340968|NCT00569192|822921|P1|COMPLETED|Overall Study||88
340969|NCT00569192|822919|P3|STARTED|Overall Study||124
340970|NCT00569192|822920|P2|STARTED|Overall Study||125
340971|NCT00569192|822921|P1|STARTED|Overall Study||111
340972|NCT00569166|822947|P3|NOT COMPLETED|Overall Study||4
340973|NCT00569166|822948|P2|NOT COMPLETED|Overall Study||6
340974|NCT00569166|822949|P1|NOT COMPLETED|Overall Study||9
340975|NCT00569166|822947|P3|COMPLETED|Overall Study||27
340976|NCT00569166|822948|P2|COMPLETED|Overall Study||25
340977|NCT00569166|822949|P1|COMPLETED|Overall Study||21
340978|NCT00569166|822947|P3|STARTED|Overall Study||31
340979|NCT00569166|822948|P2|STARTED|Overall Study||31
340980|NCT00569166|822949|P1|STARTED|Overall Study||30
340981|NCT00569127|822983|P2|NOT COMPLETED|Overall Study||213
340982|NCT00569127|822984|P1|NOT COMPLETED|Overall Study||214
340983|NCT00569127|822983|P2|COMPLETED|Overall Study||0
340984|NCT00569127|822984|P1|COMPLETED|Overall Study||0
340985|NCT00569127|822983|P2|Eligible|Overall Study||202
340986|NCT00569127|822984|P1|Eligible|Overall Study||200
340987|NCT00569127|822983|P2|STARTED|Overall Study||213
340988|NCT00569127|822984|P1|STARTED|Overall Study||214
340989|NCT00569010|823004|P4|NOT COMPLETED|Overall Study||0
340990|NCT00569010|823005|P3|NOT COMPLETED|Overall Study||0
340991|NCT00569010|823006|P2|NOT COMPLETED|Overall Study||0
340992|NCT00569010|823007|P1|NOT COMPLETED|Overall Study||0
340993|NCT00569010|823004|P4|COMPLETED|Overall Study||11
340994|NCT00569010|823005|P3|COMPLETED|Overall Study||11
340995|NCT00569010|823006|P2|COMPLETED|Overall Study||6
340996|NCT00569010|823007|P1|COMPLETED|Overall Study||6
340997|NCT00569010|823004|P4|STARTED|Overall Study||11
340998|NCT00569010|823005|P3|STARTED|Overall Study||11
340999|NCT00569010|823006|P2|STARTED|Overall Study||6
341000|NCT00569010|823007|P1|STARTED|Overall Study||6
341001|NCT00568958|823019|P2|NOT COMPLETED|Follow-Up||7
341002|NCT00568958|823020|P1|NOT COMPLETED|Follow-Up||9
341003|NCT00568958|823019|P2|COMPLETED|Follow-Up||60
341004|NCT00568958|823020|P1|COMPLETED|Follow-Up||52
341005|NCT00568958|823019|P2|STARTED|Follow-Up||67
341006|NCT00568958|823020|P1|STARTED|Follow-Up||61
341007|NCT00568958|823019|P2|NOT COMPLETED|Allocation||3
341008|NCT00568958|823020|P1|NOT COMPLETED|Allocation||9
341009|NCT00568958|823019|P2|COMPLETED|Allocation||67
341010|NCT00568958|823020|P1|COMPLETED|Allocation||61
341011|NCT00568958|823019|P2|STARTED|Allocation||70
341012|NCT00568958|823020|P1|STARTED|Allocation||70
341013|NCT00568854|823040|P2|NOT COMPLETED|Overall Study||0
341014|NCT00568854|823041|P1|NOT COMPLETED|Overall Study||0
341015|NCT00568854|823040|P2|COMPLETED|Overall Study||4
341016|NCT00568854|823041|P1|COMPLETED|Overall Study||6
341017|NCT00568854|823040|P2|STARTED|Overall Study||4
341018|NCT00568854|823041|P1|STARTED|Overall Study||6
341019|NCT00568802|823049|P1|NOT COMPLETED|Overall Study||3
341020|NCT00568802|823049|P1|COMPLETED|Overall Study||24
341021|NCT00568802|823049|P1|STARTED|Overall Study||27
341022|NCT00568776|823067|P4|NOT COMPLETED|Overall Study||72
341023|NCT00568776|823068|P3|NOT COMPLETED|Overall Study||74
341024|NCT00568776|823069|P2|NOT COMPLETED|Overall Study||36
341025|NCT00568776|823070|P1|NOT COMPLETED|Overall Study||30
341026|NCT00568776|823067|P4|COMPLETED|Overall Study||19
341027|NCT00568776|823068|P3|COMPLETED|Overall Study||15
341028|NCT00568776|823069|P2|COMPLETED|Overall Study||52
341029|NCT00568776|823070|P1|COMPLETED|Overall Study||53
341030|NCT00568776|823067|P4|STARTED|Overall Study|42 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|91
341031|NCT00568776|823068|P3|STARTED|Overall Study|41 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|89
341032|NCT00568776|823069|P2|STARTED|Overall Study|One randomized patient withdrew consent and did not receive ELND005 250 mg BID|88
341033|NCT00568776|823070|P1|STARTED|Overall Study|One randomized patient withdrew consent and did not receive placebo|83
341034|NCT00568698|823104|P1|NOT COMPLETED|Overall Study||11
341035|NCT00568698|823104|P1|COMPLETED|Overall Study||18
341036|NCT00568698|823104|P1|STARTED|Overall Study||29
341037|NCT00568685|823119|P3|NOT COMPLETED|Overall Study||5
341038|NCT00568685|823120|P2|NOT COMPLETED|Overall Study||5
341039|NCT00568685|823121|P1|NOT COMPLETED|Overall Study||10
341040|NCT00568685|823119|P3|COMPLETED|Overall Study||46
341041|NCT00568685|823120|P2|COMPLETED|Overall Study||46
341042|NCT00568685|823121|P1|COMPLETED|Overall Study||41
341043|NCT00568685|823119|P3|STARTED|Overall Study||51
341044|NCT00568685|823120|P2|STARTED|Overall Study||51
341045|NCT00568685|823121|P1|STARTED|Overall Study||51
341046|NCT00568633|823155|P2|NOT COMPLETED|Overall Study||0
341047|NCT00568633|823156|P1|NOT COMPLETED|Overall Study||0
341048|NCT00568633|823155|P2|COMPLETED|Overall Study||33
341049|NCT00568633|823156|P1|COMPLETED|Overall Study||25
341050|NCT00568633|823155|P2|STARTED|Overall Study||33
341051|NCT00568633|823156|P1|STARTED|Overall Study||25
341052|NCT00568555|823178|P2|NOT COMPLETED|Overall Study||1
341053|NCT00568555|823179|P1|NOT COMPLETED|Overall Study||1
341054|NCT00568555|823178|P2|COMPLETED|Overall Study||14
341055|NCT00568555|823179|P1|COMPLETED|Overall Study||15
341056|NCT00568555|823178|P2|STARTED|Overall Study||15
341057|NCT00568555|823179|P1|STARTED|Overall Study||16
341058|NCT00568451|823197|P4|NOT COMPLETED|Overall Study||7
341059|NCT00568451|823198|P3|NOT COMPLETED|Overall Study||2
341060|NCT00568451|823199|P2|NOT COMPLETED|Overall Study||0
341061|NCT00568451|823200|P1|NOT COMPLETED|Overall Study||0
341062|NCT00568451|823197|P4|COMPLETED|Overall Study||2
341063|NCT00568451|823198|P3|COMPLETED|Overall Study||0
341064|NCT00568451|823199|P2|COMPLETED|Overall Study||0
341065|NCT00568451|823200|P1|COMPLETED|Overall Study||0
341066|NCT00568451|823197|P4|STARTED|Overall Study||9
341067|NCT00568451|823198|P3|STARTED|Overall Study||2
341068|NCT00568451|823199|P2|STARTED|Overall Study||0
341069|NCT00568451|823200|P1|STARTED|Overall Study||0
341070|NCT00568399|823216|P1|NOT COMPLETED|Overall Study||15
341071|NCT00568399|823216|P1|COMPLETED|Overall Study|Of 48 subject enrolled, 37 initiated sodium thiosulfate treatment. 22 completed the entire protocol|22
341072|NCT00568399|823216|P1|STARTED|Overall Study||37
341073|NCT00568386|823222|P2|NOT COMPLETED|Overall Study||0
341074|NCT00568386|823223|P1|NOT COMPLETED|Overall Study||0
341075|NCT00568386|823222|P2|COMPLETED|Overall Study||20
341076|NCT00568386|823223|P1|COMPLETED|Overall Study||20
341077|NCT00568386|823222|P2|STARTED|Overall Study||20
341078|NCT00568386|823223|P1|STARTED|Overall Study||20
341079|NCT00568334|823231|P2|NOT COMPLETED|Overall Study||1
341080|NCT00568334|823232|P1|NOT COMPLETED|Overall Study||1
341081|NCT00568334|823231|P2|COMPLETED|Overall Study||121
341082|NCT00568334|823232|P1|COMPLETED|Overall Study||121
341083|NCT00568334|823231|P2|STARTED|Overall Study||122
341084|NCT00568334|823232|P1|STARTED|Overall Study||122
341085|NCT00568178|823258|P6|NOT COMPLETED|Open Label Extension||80
341086|NCT00568178|823259|P5|NOT COMPLETED|Open Label Extension||79
341087|NCT00568178|823260|P4|NOT COMPLETED|Open Label Extension||0
341088|NCT00568178|823261|P3|NOT COMPLETED|Open Label Extension||0
341089|NCT00568178|823262|P2|NOT COMPLETED|Open Label Extension||0
341090|NCT00568178|823263|P1|NOT COMPLETED|Open Label Extension||0
341091|NCT00568178|823258|P6|COMPLETED|Open Label Extension||54
341092|NCT00568178|823259|P5|COMPLETED|Open Label Extension||55
341093|NCT00568178|823260|P4|COMPLETED|Open Label Extension||0
341094|NCT00568178|823261|P3|COMPLETED|Open Label Extension||0
341095|NCT00568178|823262|P2|COMPLETED|Open Label Extension||0
341096|NCT00568178|823263|P1|COMPLETED|Open Label Extension||0
341097|NCT00568178|823258|P6|STARTED|Open Label Extension||134
341098|NCT00568178|823259|P5|STARTED|Open Label Extension||134
341099|NCT00568178|823260|P4|STARTED|Open Label Extension||0
341100|NCT00568178|823261|P3|STARTED|Open Label Extension||0
341101|NCT00568178|823262|P2|STARTED|Open Label Extension||0
341102|NCT00568178|823263|P1|STARTED|Open Label Extension||0
341103|NCT00568178|823258|P6|NOT COMPLETED|Double Blind Base Study||0
341104|NCT00568178|823259|P5|NOT COMPLETED|Double Blind Base Study||0
341105|NCT00568178|823260|P4|NOT COMPLETED|Double Blind Base Study||5
341106|NCT00568178|823261|P3|NOT COMPLETED|Double Blind Base Study||1
341107|NCT00568178|823262|P2|NOT COMPLETED|Double Blind Base Study||6
341108|NCT00568178|823263|P1|NOT COMPLETED|Double Blind Base Study||6
341109|NCT00568178|823258|P6|COMPLETED|Double Blind Base Study||0
341110|NCT00568178|823259|P5|COMPLETED|Double Blind Base Study||0
341111|NCT00568178|823260|P4|COMPLETED|Double Blind Base Study||25
341112|NCT00568178|823261|P3|COMPLETED|Double Blind Base Study||29
341113|NCT00568178|823262|P2|COMPLETED|Double Blind Base Study||118
341114|NCT00568178|823263|P1|COMPLETED|Double Blind Base Study||116
341115|NCT00568178|823258|P6|STARTED|Double Blind Base Study||0
341116|NCT00568178|823259|P5|STARTED|Double Blind Base Study||0
341117|NCT00568178|823260|P4|STARTED|Double Blind Base Study||30
341118|NCT00568178|823261|P3|STARTED|Double Blind Base Study||30
341119|NCT00568178|823262|P2|STARTED|Double Blind Base Study||124
341120|NCT00568178|823263|P1|STARTED|Double Blind Base Study||122
341121|NCT00568087|823281|P2|NOT COMPLETED|Overall Study||7
341122|NCT00568087|823282|P1|NOT COMPLETED|Overall Study||7
341123|NCT00568087|823281|P2|COMPLETED|Overall Study||17
341124|NCT00568087|823282|P1|COMPLETED|Overall Study||15
341125|NCT00568087|823281|P2|Received Intervention|Overall Study||23
341126|NCT00568087|823282|P1|Received Intervention|Overall Study||21
341127|NCT00568087|823281|P2|STARTED|Overall Study||24
341128|NCT00568087|823282|P1|STARTED|Overall Study||22
341129|NCT00568061|823294|P2|NOT COMPLETED|Overall Study||2
341130|NCT00568061|823295|P1|NOT COMPLETED|Overall Study||5
341131|NCT00568061|823294|P2|COMPLETED|Overall Study||14
341132|NCT00568061|823295|P1|COMPLETED|Overall Study||8
341133|NCT00568061|823294|P2|STARTED|Overall Study||16
341134|NCT00568061|823295|P1|STARTED|Overall Study||13
341135|NCT00568022|823323|P3|NOT COMPLETED|Overall Study||0
341136|NCT00568022|823324|P2|NOT COMPLETED|Overall Study||0
341137|NCT00568022|823325|P1|NOT COMPLETED|Overall Study||0
341138|NCT00568022|823323|P3|COMPLETED|Overall Study||3
341139|NCT00568022|823324|P2|COMPLETED|Overall Study||3
341140|NCT00568022|823325|P1|COMPLETED|Overall Study||3
341141|NCT00568022|823323|P3|STARTED|Overall Study||3
341142|NCT00568022|823324|P2|STARTED|Overall Study||3
341143|NCT00568022|823325|P1|STARTED|Overall Study||3
341144|NCT00567996|823358|P3|NOT COMPLETED|Overall Study||70
341145|NCT00567996|823359|P2|NOT COMPLETED|Overall Study||50
341146|NCT00567996|823360|P1|NOT COMPLETED|Overall Study||44
341147|NCT00567996|823358|P3|COMPLETED|Overall Study||265
341148|NCT00567996|823359|P2|COMPLETED|Overall Study||284
341149|NCT00567996|823360|P1|COMPLETED|Overall Study||289
341150|NCT00567996|823358|P3|Intent-to-treat: Received Study Drug|Overall Study||335
341151|NCT00567996|823359|P2|Intent-to-treat: Received Study Drug|Overall Study||333
341152|NCT00567996|823360|P1|Intent-to-treat: Received Study Drug|Overall Study||330
341153|NCT00567996|823358|P3|STARTED|Overall Study||335
341154|NCT00567996|823359|P2|STARTED|Overall Study||334
341155|NCT00567996|823360|P1|STARTED|Overall Study|Randomized participants|333
341156|NCT00567892|823376|P4|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||1
341157|NCT00567892|823377|P3|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
341158|NCT00567892|823378|P2|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
341159|NCT00567892|823379|P1|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
341160|NCT00567892|823376|P4|COMPLETED|Second Treatment (2 or 4 Weeks)||5
341161|NCT00567892|823377|P3|COMPLETED|Second Treatment (2 or 4 Weeks)||9
341162|NCT00567892|823378|P2|COMPLETED|Second Treatment (2 or 4 Weeks)||7
341163|NCT00567892|823379|P1|COMPLETED|Second Treatment (2 or 4 Weeks)||7
341164|NCT00567892|823376|P4|STARTED|Second Treatment (2 or 4 Weeks)||6
341165|NCT00567892|823377|P3|STARTED|Second Treatment (2 or 4 Weeks)||9
341166|NCT00567892|823378|P2|STARTED|Second Treatment (2 or 4 Weeks)||7
341167|NCT00567892|823379|P1|STARTED|Second Treatment (2 or 4 Weeks)||7
341168|NCT00567892|823376|P4|NOT COMPLETED|Washout (2 Weeks)||0
341169|NCT00567892|823377|P3|NOT COMPLETED|Washout (2 Weeks)||0
341170|NCT00567892|823378|P2|NOT COMPLETED|Washout (2 Weeks)||0
341171|NCT00567892|823379|P1|NOT COMPLETED|Washout (2 Weeks)||0
341172|NCT00567892|823376|P4|COMPLETED|Washout (2 Weeks)||6
341173|NCT00567892|823377|P3|COMPLETED|Washout (2 Weeks)||9
341174|NCT00567892|823378|P2|COMPLETED|Washout (2 Weeks)||7
341175|NCT00567892|823379|P1|COMPLETED|Washout (2 Weeks)||7
341176|NCT00567892|823376|P4|STARTED|Washout (2 Weeks)||6
341177|NCT00567892|823377|P3|STARTED|Washout (2 Weeks)||9
341178|NCT00567892|823378|P2|STARTED|Washout (2 Weeks)||7
341179|NCT00567892|823379|P1|STARTED|Washout (2 Weeks)||7
341180|NCT00567892|823376|P4|NOT COMPLETED|First Treatment (2 or 4 Weeks)||4
341181|NCT00567892|823377|P3|NOT COMPLETED|First Treatment (2 or 4 Weeks)||1
341182|NCT00567892|823378|P2|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
341183|NCT00567892|823379|P1|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
341184|NCT00567892|823376|P4|COMPLETED|First Treatment (2 or 4 Weeks)||6
341185|NCT00567892|823377|P3|COMPLETED|First Treatment (2 or 4 Weeks)||9
341186|NCT00567892|823378|P2|COMPLETED|First Treatment (2 or 4 Weeks)||7
341187|NCT00567892|823379|P1|COMPLETED|First Treatment (2 or 4 Weeks)||7
341188|NCT00567892|823376|P4|STARTED|First Treatment (2 or 4 Weeks)||10
341189|NCT00567892|823377|P3|STARTED|First Treatment (2 or 4 Weeks)||10
341190|NCT00567892|823378|P2|STARTED|First Treatment (2 or 4 Weeks)||7
341191|NCT00567892|823379|P1|STARTED|First Treatment (2 or 4 Weeks)||7
341192|NCT00567879|823397|P6|NOT COMPLETED|Overall Study||3
341193|NCT00567879|823398|P5|NOT COMPLETED|Overall Study||12
341194|NCT00567879|823399|P4|NOT COMPLETED|Overall Study||6
341195|NCT00567879|823400|P3|NOT COMPLETED|Overall Study||21
341196|NCT00567879|823401|P2|NOT COMPLETED|Overall Study||7
341197|NCT00567879|823402|P1|NOT COMPLETED|Overall Study||7
341198|NCT00567879|823397|P6|COMPLETED|Overall Study||0
341199|NCT00567879|823398|P5|COMPLETED|Overall Study||0
341200|NCT00567879|823399|P4|COMPLETED|Overall Study||0
341201|NCT00567879|823400|P3|COMPLETED|Overall Study||0
341202|NCT00567879|823401|P2|COMPLETED|Overall Study||0
341203|NCT00567879|823402|P1|COMPLETED|Overall Study||0
341204|NCT00567879|823397|P6|Maximum Tolerated Dose Determining Set|Overall Study||3
341205|NCT00567879|823398|P5|Maximum Tolerated Dose Determining Set|Overall Study||12
341206|NCT00567879|823399|P4|Maximum Tolerated Dose Determining Set|Overall Study||6
341207|NCT00567879|823400|P3|Maximum Tolerated Dose Determining Set|Overall Study|6 participants belonged to the dose expansion group at 20mg/m2 i.v.|18
341208|NCT00567879|823401|P2|Maximum Tolerated Dose Determining Set|Overall Study||7
341209|NCT00567879|823402|P1|Maximum Tolerated Dose Determining Set|Overall Study||5
341210|NCT00567879|823397|P6|STARTED|Overall Study||3
341211|NCT00567879|823398|P5|STARTED|Overall Study||12
341212|NCT00567879|823399|P4|STARTED|Overall Study||6
341213|NCT00567879|823400|P3|STARTED|Overall Study|7 participants belonged to the dose expansion group at 20mg/m2 i.v.|21
341214|NCT00567879|823401|P2|STARTED|Overall Study||7
341215|NCT00567879|823402|P1|STARTED|Overall Study||7
341216|NCT00567840|823428|P5|NOT COMPLETED|Overall Study||0
341217|NCT00567840|823429|P4|NOT COMPLETED|Overall Study||1
341218|NCT00567840|823430|P3|NOT COMPLETED|Overall Study||1
341219|NCT00567840|823431|P2|NOT COMPLETED|Overall Study||0
341220|NCT00567840|823432|P1|NOT COMPLETED|Overall Study||2
341221|NCT00567840|823428|P5|COMPLETED|Overall Study||8
341222|NCT00567840|823429|P4|COMPLETED|Overall Study||14
341223|NCT00567840|823430|P3|COMPLETED|Overall Study||15
341224|NCT00567840|823431|P2|COMPLETED|Overall Study||15
341225|NCT00567840|823432|P1|COMPLETED|Overall Study||13
341226|NCT00567840|823428|P5|STARTED|Overall Study||8
341227|NCT00567840|823429|P4|STARTED|Overall Study||15
341228|NCT00567840|823430|P3|STARTED|Overall Study||16
341229|NCT00567840|823431|P2|STARTED|Overall Study||15
341230|NCT00567840|823432|P1|STARTED|Overall Study||15
341231|NCT00567593|823469|P1|NOT COMPLETED|Overall Study||2
341232|NCT00567593|823469|P1|COMPLETED|Overall Study||10
341233|NCT00567593|823469|P1|STARTED|Overall Study||12
341234|NCT00567567|823476|P3|NOT COMPLETED|Overall Study||278
341235|NCT00567567|823477|P2|NOT COMPLETED|Overall Study||134
341236|NCT00567567|823478|P1|NOT COMPLETED|Overall Study||152
341237|NCT00567567|823476|P3|COMPLETED|Overall Study||1
341238|NCT00567567|823477|P2|COMPLETED|Overall Study||42
341239|NCT00567567|823478|P1|COMPLETED|Overall Study||58
341240|NCT00567567|823476|P3|STARTED|Overall Study||279
341241|NCT00567567|823477|P2|STARTED|Overall Study||176
341242|NCT00567567|823478|P1|STARTED|Overall Study||210
341243|NCT00567541|823504|P2|NOT COMPLETED|Overall Study||1
341244|NCT00567541|823505|P1|NOT COMPLETED|Overall Study||0
341245|NCT00567541|823504|P2|COMPLETED|Overall Study||8
341246|NCT00567541|823505|P1|COMPLETED|Overall Study||7
341247|NCT00567541|823504|P2|STARTED|Overall Study||9
341248|NCT00567541|823505|P1|STARTED|Overall Study||7
341249|NCT00567502|823515|P4|NOT COMPLETED|Overall Study||87
341250|NCT00567502|823516|P3|NOT COMPLETED|Overall Study||908
341251|NCT00567502|823517|P2|NOT COMPLETED|Overall Study||33
341252|NCT00567502|823518|P1|NOT COMPLETED|Overall Study||241
341253|NCT00567502|823515|P4|COMPLETED|Overall Study||23
341254|NCT00567502|823516|P3|COMPLETED|Overall Study||1758
341255|NCT00567502|823517|P2|COMPLETED|Overall Study||108
341256|NCT00567502|823518|P1|COMPLETED|Overall Study||563
341257|NCT00567502|823515|P4|Initiated Treatment|Overall Study||38
341258|NCT00567502|823516|P3|Initiated Treatment|Overall Study||2666
341259|NCT00567502|823517|P2|Initiated Treatment|Overall Study||141
341260|NCT00567502|823518|P1|Initiated Treatment|Overall Study||804
341261|NCT00567502|823515|P4|STARTED|Overall Study||110
341262|NCT00567502|823516|P3|STARTED|Overall Study||2666
341263|NCT00567502|823517|P2|STARTED|Overall Study||141
341264|NCT00567502|823518|P1|STARTED|Overall Study||804
341265|NCT00567489|823555|P2|NOT COMPLETED|Overall Study||23
341266|NCT00567489|823556|P1|NOT COMPLETED|Overall Study||7
341267|NCT00567489|823555|P2|COMPLETED|Overall Study||101
341268|NCT00567489|823556|P1|COMPLETED|Overall Study||120
341269|NCT00567489|823555|P2|STARTED|Overall Study||124
341270|NCT00567489|823556|P1|STARTED|Overall Study||127
341271|NCT00567476|823606|P2|NOT COMPLETED|Overall Study||4
341272|NCT00567476|823607|P1|NOT COMPLETED|Overall Study||8
341273|NCT00567476|823606|P2|COMPLETED|Overall Study||34
341274|NCT00567476|823607|P1|COMPLETED|Overall Study||70
341275|NCT00567476|823606|P2|STARTED|Overall Study||38
341276|NCT00567476|823607|P1|STARTED|Overall Study||78
341277|NCT00567398|823633|P2|NOT COMPLETED|Overall Study||23
341278|NCT00567398|823634|P1|NOT COMPLETED|Overall Study||7
341279|NCT00567398|823633|P2|COMPLETED|Overall Study||101
341280|NCT00567398|823634|P1|COMPLETED|Overall Study||120
341281|NCT00567398|823633|P2|STARTED|Overall Study||124
341282|NCT00567398|823634|P1|STARTED|Overall Study||127
341283|NCT00567359|823682|P1|NOT COMPLETED|Overall Study||1
341284|NCT00567359|823682|P1|COMPLETED|Overall Study||99
341285|NCT00567359|823682|P1|STARTED|Overall Study||100
341286|NCT00567320|823691|P2|NOT COMPLETED|Overall Study||0
341287|NCT00567320|823692|P1|NOT COMPLETED|Overall Study||0
341288|NCT00567320|823691|P2|COMPLETED|Overall Study||18
341289|NCT00567320|823692|P1|COMPLETED|Overall Study||13
341290|NCT00567320|823691|P2|STARTED|Overall Study||18
341291|NCT00567320|823692|P1|STARTED|Overall Study||13
341292|NCT00567307|823700|P2|NOT COMPLETED|Overall Study||1
341293|NCT00567307|823701|P1|NOT COMPLETED|Overall Study||12
341294|NCT00567307|823700|P2|COMPLETED|Overall Study||104
341295|NCT00567307|823701|P1|COMPLETED|Overall Study||99
341296|NCT00567307|823700|P2|STARTED|Overall Study||105
341297|NCT00567307|823701|P1|STARTED|Overall Study||111
341298|NCT00567268|823707|P1|NOT COMPLETED|Overall Study||50
341299|NCT00567268|823707|P1|COMPLETED|Overall Study||1144
341300|NCT00567268|823707|P1|STARTED|Overall Study||1194
341301|NCT00567255|823758|P2|NOT COMPLETED|Overall Study||228
341302|NCT00567255|823759|P1|NOT COMPLETED|Overall Study||463
341303|NCT00567255|823758|P2|COMPLETED|Overall Study||267
341304|NCT00567255|823759|P1|COMPLETED|Overall Study||538
341305|NCT00567255|823758|P2|STARTED|Overall Study||495
341306|NCT00567255|823759|P1|STARTED|Overall Study||1001
341307|NCT00567242|823805|P2|NOT COMPLETED|Overall Study||0
341308|NCT00567242|823806|P1|NOT COMPLETED|Overall Study||0
341309|NCT00567242|823805|P2|COMPLETED|Overall Study||7
341310|NCT00567242|823806|P1|COMPLETED|Overall Study||7
341311|NCT00567242|823805|P2|STARTED|Overall Study||7
341312|NCT00567242|823806|P1|STARTED|Overall Study||7
341313|NCT00567229|823816|P1|NOT COMPLETED|Overall Study||0
341314|NCT00567229|823816|P1|COMPLETED|Overall Study||3
341315|NCT00567229|823816|P1|STARTED|Overall Study||3
341316|NCT00567190|823822|P2|NOT COMPLETED|Overall Study||264
341317|NCT00567190|823823|P1|NOT COMPLETED|Overall Study||210
341318|NCT00567190|823822|P2|COMPLETED|Overall Study|On 11 February 2014, 37 were alive and on study treatment; 105 were alive and in survival follow-up|142
341319|NCT00567190|823823|P1|COMPLETED|Overall Study|On 11 February 2014, 67 were alive and on study treatment; 125 were alive and in survival follow-up|192
341320|NCT00567190|823822|P2|STARTED|Overall Study|All randomized patients (Intent-to-Treat [ITT]) population|406
341321|NCT00567190|823823|P1|STARTED|Overall Study|All randomized patients (Intent-to-Treat [ITT]) population|402
341322|NCT00567164|823843|P3|NOT COMPLETED|Overall Study||72
341323|NCT00567164|823844|P2|NOT COMPLETED|Overall Study||73
341324|NCT00567164|823845|P1|NOT COMPLETED|Overall Study||546
341325|NCT00567164|823843|P3|COMPLETED|Overall Study||160
341326|NCT00567164|823844|P2|COMPLETED|Overall Study||161
341327|NCT00567164|823845|P1|COMPLETED|Overall Study||875
341328|NCT00567164|823843|P3|Subjects Received Treatment|Overall Study|Full Analysis Set|226
341329|NCT00567164|823844|P2|Subjects Received Treatment|Overall Study|Full Analysis Set|232
341330|NCT00567164|823845|P1|Subjects Received Treatment|Overall Study|Full Analysis Set|1406
341331|NCT00567164|823843|P3|STARTED|Overall Study||232
341332|NCT00567164|823844|P2|STARTED|Overall Study||234
341333|NCT00567164|823845|P1|STARTED|Overall Study||1421
341334|NCT00567112|823917|P3|NOT COMPLETED|Treatment Period 4 (3 Days)||0
341335|NCT00567112|823918|P2|NOT COMPLETED|Treatment Period 4 (3 Days)||0
341336|NCT00567112|823919|P1|NOT COMPLETED|Treatment Period 4 (3 Days)||0
341337|NCT00567112|823917|P3|COMPLETED|Treatment Period 4 (3 Days)||3
341338|NCT00567112|823918|P2|COMPLETED|Treatment Period 4 (3 Days)||7
341339|NCT00567112|823919|P1|COMPLETED|Treatment Period 4 (3 Days)||4
341340|NCT00567112|823917|P3|STARTED|Treatment Period 4 (3 Days)||3
341341|NCT00567112|823918|P2|STARTED|Treatment Period 4 (3 Days)||7
341342|NCT00567112|823919|P1|STARTED|Treatment Period 4 (3 Days)||4
341343|NCT00567112|823917|P3|NOT COMPLETED|Washout Period 3 (3 Days)||0
341344|NCT00567112|823918|P2|NOT COMPLETED|Washout Period 3 (3 Days)||0
341345|NCT00567112|823919|P1|NOT COMPLETED|Washout Period 3 (3 Days)||3
341346|NCT00567112|823917|P3|COMPLETED|Washout Period 3 (3 Days)||3
341347|NCT00567112|823918|P2|COMPLETED|Washout Period 3 (3 Days)||7
341348|NCT00567112|823919|P1|COMPLETED|Washout Period 3 (3 Days)||4
341349|NCT00567112|823917|P3|STARTED|Washout Period 3 (3 Days)||3
341350|NCT00567112|823918|P2|STARTED|Washout Period 3 (3 Days)||7
341351|NCT00567112|823919|P1|STARTED|Washout Period 3 (3 Days)||7
341352|NCT00567112|823917|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
341353|NCT00567112|823918|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
341354|NCT00567112|823919|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
341355|NCT00567112|823917|P3|COMPLETED|Treatment Period 3 (3 Days)||3
341356|NCT00567112|823918|P2|COMPLETED|Treatment Period 3 (3 Days)||7
341357|NCT00567112|823919|P1|COMPLETED|Treatment Period 3 (3 Days)||7
341358|NCT00567112|823917|P3|STARTED|Treatment Period 3 (3 Days)||3
341359|NCT00567112|823918|P2|STARTED|Treatment Period 3 (3 Days)||7
341360|NCT00567112|823919|P1|STARTED|Treatment Period 3 (3 Days)||7
341361|NCT00567112|823917|P3|NOT COMPLETED|Washout Period 2 (3 Days)||0
341362|NCT00567112|823918|P2|NOT COMPLETED|Washout Period 2 (3 Days)||0
341363|NCT00567112|823919|P1|NOT COMPLETED|Washout Period 2 (3 Days)||0
341364|NCT00567112|823917|P3|COMPLETED|Washout Period 2 (3 Days)||3
341365|NCT00567112|823918|P2|COMPLETED|Washout Period 2 (3 Days)||7
341366|NCT00567112|823919|P1|COMPLETED|Washout Period 2 (3 Days)||7
341367|NCT00567112|823917|P3|STARTED|Washout Period 2 (3 Days)||3
341368|NCT00567112|823918|P2|STARTED|Washout Period 2 (3 Days)||7
341369|NCT00567112|823919|P1|STARTED|Washout Period 2 (3 Days)||7
341370|NCT00567112|823917|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||0
341371|NCT00567112|823918|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||1
341372|NCT00567112|823919|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
341373|NCT00567112|823917|P3|COMPLETED|Treatment Period 2 (3 Days)||3
341374|NCT00567112|823918|P2|COMPLETED|Treatment Period 2 (3 Days)||7
341375|NCT00567112|823919|P1|COMPLETED|Treatment Period 2 (3 Days)||7
341376|NCT00567112|823917|P3|STARTED|Treatment Period 2 (3 Days)|3 new participants added to Treatment Group ABCD & received treatment sequence BCD for Periods 2-4|3
341377|NCT00567112|823918|P2|STARTED|Treatment Period 2 (3 Days)||8
341378|NCT00567112|823919|P1|STARTED|Treatment Period 2 (3 Days)||7
341379|NCT00567112|823917|P3|NOT COMPLETED|Washout Period 1 (3 Days)||0
341380|NCT00567112|823918|P2|NOT COMPLETED|Washout Period 1 (3 Days)||0
341381|NCT00567112|823919|P1|NOT COMPLETED|Washout Period 1 (3 Days)||0
341382|NCT00567112|823917|P3|COMPLETED|Washout Period 1 (3 Days)||0
341383|NCT00567112|823918|P2|COMPLETED|Washout Period 1 (3 Days)||8
341384|NCT00567112|823919|P1|COMPLETED|Washout Period 1 (3 Days)||7
341385|NCT00567112|823917|P3|STARTED|Washout Period 1 (3 Days)||0
341386|NCT00567112|823918|P2|STARTED|Washout Period 1 (3 Days)||8
341387|NCT00567112|823919|P1|STARTED|Washout Period 1 (3 Days)||7
341388|NCT00567112|823917|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||0
341389|NCT00567112|823918|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
341390|NCT00567112|823919|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||0
341391|NCT00567112|823917|P3|COMPLETED|Treatment Period 1 (3 Days)||0
341392|NCT00567112|823918|P2|COMPLETED|Treatment Period 1 (3 Days)||8
341393|NCT00567112|823919|P1|COMPLETED|Treatment Period 1 (3 Days)||7
341394|NCT00567112|823917|P3|STARTED|Treatment Period 1 (3 Days)||0
341395|NCT00567112|823918|P2|STARTED|Treatment Period 1 (3 Days)||8
341396|NCT00567112|823919|P1|STARTED|Treatment Period 1 (3 Days)||7
341397|NCT00567008|823943|P2|NOT COMPLETED|Overall Study||1
341398|NCT00567008|823944|P1|NOT COMPLETED|Overall Study||1
341399|NCT00567008|823943|P2|COMPLETED|Overall Study||18
341400|NCT00567008|823944|P1|COMPLETED|Overall Study||17
341401|NCT00567008|823943|P2|STARTED|Overall Study||19
341402|NCT00567008|823944|P1|STARTED|Overall Study||18
341403|NCT00566995|823950|P1|NOT COMPLETED|Overall Study||7
341404|NCT00566995|823950|P1|COMPLETED|Overall Study||30
341405|NCT00566995|823950|P1|STARTED|Overall Study||37
341406|NCT00566982|823965|P2|NOT COMPLETED|Overall Study||69
341407|NCT00566982|823966|P1|NOT COMPLETED|Overall Study||8
341408|NCT00566982|823965|P2|COMPLETED|Overall Study||294
341409|NCT00566982|823966|P1|COMPLETED|Overall Study||55
341410|NCT00566982|823965|P2|STARTED|Overall Study||363
341411|NCT00566982|823966|P1|STARTED|Overall Study||63
341412|NCT00566969|823991|P3|NOT COMPLETED|Overall Study||12
341413|NCT00566969|823992|P2|NOT COMPLETED|Overall Study||9
341414|NCT00566969|823993|P1|NOT COMPLETED|Overall Study||15
341415|NCT00566969|823991|P3|COMPLETED|Overall Study||23
341416|NCT00566969|823992|P2|COMPLETED|Overall Study||28
341417|NCT00566969|823993|P1|COMPLETED|Overall Study||19
341418|NCT00566969|823991|P3|STARTED|Overall Study||35
341419|NCT00566969|823992|P2|STARTED|Overall Study||37
341420|NCT00566969|823993|P1|STARTED|Overall Study||34
341421|NCT00566943|824003|P2|NOT COMPLETED|Overall Study||0
341422|NCT00566943|824004|P1|NOT COMPLETED|Overall Study||0
341423|NCT00566943|824003|P2|COMPLETED|Overall Study||49
341424|NCT00566943|824004|P1|COMPLETED|Overall Study||52
341425|NCT00566943|824003|P2|STARTED|Overall Study||49
341426|NCT00566943|824004|P1|STARTED|Overall Study||52
341427|NCT00566930|824019|P3|NOT COMPLETED|Overall Study||1
341428|NCT00566930|824020|P2|NOT COMPLETED|Overall Study||4
341429|NCT00566930|824021|P1|NOT COMPLETED|Overall Study||2
341430|NCT00566930|824019|P3|COMPLETED|Overall Study||32
341431|NCT00566930|824020|P2|COMPLETED|Overall Study||32
341432|NCT00566930|824021|P1|COMPLETED|Overall Study||27
341433|NCT00566930|824019|P3|STARTED|Overall Study||33
341434|NCT00566930|824020|P2|STARTED|Overall Study||36
341435|NCT00566930|824021|P1|STARTED|Overall Study||29
341436|NCT00566852|824031|P2|NOT COMPLETED|Overall Study||198
341437|NCT00566852|824032|P1|NOT COMPLETED|Overall Study||207
341438|NCT00566852|824031|P2|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|78
341439|NCT00566852|824032|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|71
341440|NCT00566852|824031|P2|STARTED|Overall Study||276
341441|NCT00566852|824032|P1|STARTED|Overall Study||278
341442|NCT00566813|824050|P2|NOT COMPLETED|Overall Study||0
341443|NCT00566813|824051|P1|NOT COMPLETED|Overall Study||0
341444|NCT00566813|824050|P2|COMPLETED|Overall Study||6
341445|NCT00566813|824051|P1|COMPLETED|Overall Study||4
341446|NCT00566813|824050|P2|STARTED|Overall Study||6
341447|NCT00566813|824051|P1|STARTED|Overall Study||4
341448|NCT00566735|824063|P2|NOT COMPLETED|Overall Study||7
341449|NCT00566735|824064|P1|NOT COMPLETED|Overall Study||2
341450|NCT00566735|824063|P2|COMPLETED|Overall Study|7 participants withdrew before baselines. Therefore, 12 participants will be included in baselines.|12
341451|NCT00566735|824064|P1|COMPLETED|Overall Study|2 participants withdrew before baselines. Therefore, 18 participants will be included in baselines.|18
341452|NCT00566735|824063|P2|Withdrew Before Baseline Measures|Overall Study||7
341453|NCT00566735|824064|P1|Withdrew Before Baseline Measures|Overall Study||2
341454|NCT00566735|824063|P2|STARTED|Overall Study||19
341455|NCT00566735|824064|P1|STARTED|Overall Study||20
341456|NCT00566722|824077|P3|NOT COMPLETED|Overall Study||9
341457|NCT00566722|824078|P2|NOT COMPLETED|Overall Study||5
341458|NCT00566722|824079|P1|NOT COMPLETED|Overall Study||2
341459|NCT00566722|824077|P3|COMPLETED|Overall Study||73
341460|NCT00566722|824078|P2|COMPLETED|Overall Study||24
341461|NCT00566722|824079|P1|COMPLETED|Overall Study||39
341462|NCT00566722|824077|P3|STARTED|Overall Study||82
341463|NCT00566722|824078|P2|STARTED|Overall Study||29
341464|NCT00566722|824079|P1|STARTED|Overall Study||41
341465|NCT00566709|824125|P2|NOT COMPLETED|Overall Study||0
341466|NCT00566709|824126|P1|NOT COMPLETED|Overall Study||5
341467|NCT00566709|824125|P2|COMPLETED|Overall Study||51
341468|NCT00566709|824126|P1|COMPLETED|Overall Study||46
341469|NCT00566709|824125|P2|STARTED|Overall Study||51
341470|NCT00566709|824126|P1|STARTED|Overall Study||51
341471|NCT00566696|824142|P1|NOT COMPLETED|Overall Study||42
341472|NCT00566696|824142|P1|COMPLETED|Overall Study||31
341473|NCT00566696|824142|P1|STARTED|Overall Study||73
341474|NCT00566631|824152|P1|NOT COMPLETED|Part 2: Extension Phase||82
341475|NCT00566631|824152|P1|COMPLETED|Part 2: Extension Phase||57
341476|NCT00566631|824152|P1|STARTED|Part 2: Extension Phase||139
341477|NCT00566631|824152|P1|NOT COMPLETED|Between Treatment and Extension Phase||95
341478|NCT00566631|824152|P1|COMPLETED|Between Treatment and Extension Phase||139
341479|NCT00566631|824152|P1|STARTED|Between Treatment and Extension Phase||234
341480|NCT00566631|824152|P1|NOT COMPLETED|Part 1: Core Treatment Phase||60
341481|NCT00566631|824152|P1|COMPLETED|Part 1: Core Treatment Phase||234
341482|NCT00566631|824152|P1|STARTED|Part 1: Core Treatment Phase||294
341483|NCT00566579|824169|P2|NOT COMPLETED|Overall Study||0
341484|NCT00566579|824170|P1|NOT COMPLETED|Overall Study||0
341485|NCT00566579|824169|P2|COMPLETED|Overall Study||31
341486|NCT00566579|824170|P1|COMPLETED|Overall Study||29
341487|NCT00566579|824169|P2|STARTED|Overall Study||31
341488|NCT00566579|824170|P1|STARTED|Overall Study||29
341489|NCT00566527|824179|P3|NOT COMPLETED|Overall Study||78
341490|NCT00566527|824180|P2|NOT COMPLETED|Overall Study||66
341491|NCT00566527|824181|P1|NOT COMPLETED|Overall Study||17
341492|NCT00566527|824179|P3|COMPLETED|Overall Study||461
341493|NCT00566527|824180|P2|COMPLETED|Overall Study||474
341494|NCT00566527|824181|P1|COMPLETED|Overall Study||524
341495|NCT00566527|824179|P3|Received ProQuad® Dose 2|Overall Study||462
341496|NCT00566527|824180|P2|Received ProQuad® Dose 2|Overall Study||478
341497|NCT00566527|824181|P1|Received ProQuad® Dose 2|Overall Study||525
341498|NCT00566527|824179|P3|Received ProQuad® Dose 1|Overall Study||470
341499|NCT00566527|824180|P2|Received ProQuad® Dose 1|Overall Study||484
341500|NCT00566527|824181|P1|Received ProQuad® Dose 1|Overall Study||529
341501|NCT00566527|824179|P3|STARTED|Overall Study|Number randomized.|539
341502|NCT00566527|824180|P2|STARTED|Overall Study|Number randomized.|540
341503|NCT00566527|824181|P1|STARTED|Overall Study|Number randomized.|541
341504|NCT00566501|824222|P2|NOT COMPLETED|Overall Study||126
341505|NCT00566501|824223|P1|NOT COMPLETED|Overall Study||156
341506|NCT00566501|824222|P2|COMPLETED|Overall Study||210
341507|NCT00566501|824223|P1|COMPLETED|Overall Study||423
341508|NCT00566501|824222|P2|Not Determined|Overall Study||0
341509|NCT00566501|824223|P1|Not Determined|Overall Study||1
341510|NCT00566501|824222|P2|Other ( Not Specified)|Overall Study||21
341511|NCT00566501|824223|P1|Other ( Not Specified)|Overall Study||24
341512|NCT00566501|824222|P2|Medication Non-compliance|Overall Study||0
341513|NCT00566501|824223|P1|Medication Non-compliance|Overall Study||5
341514|NCT00566501|824222|P2|Protocol Violation|Overall Study||2
341515|NCT00566501|824223|P1|Protocol Violation|Overall Study||2
341516|NCT00566501|824222|P2|Request of Investigator or Sponsor|Overall Study||7
341517|NCT00566501|824223|P1|Request of Investigator or Sponsor|Overall Study||6
341518|NCT00566501|824222|P2|Withdraw of Consent by Subject|Overall Study||30
341519|NCT00566501|824223|P1|Withdraw of Consent by Subject|Overall Study||33
341520|NCT00566501|824222|P2|Lack of Efficacy|Overall Study||3
341521|NCT00566501|824223|P1|Lack of Efficacy|Overall Study||8
341522|NCT00566501|824222|P2|Adverse Event|Overall Study||59
341523|NCT00566501|824223|P1|Adverse Event|Overall Study||68
341524|NCT00566501|824222|P2|Discontinued|Overall Study||122
341525|NCT00566501|824223|P1|Discontinued|Overall Study||146
341526|NCT00566501|824222|P2|Safety Population|Overall Study||332
341527|NCT00566501|824223|P1|Safety Population|Overall Study||570
341528|NCT00566501|824222|P2|STARTED|Overall Study||336
341529|NCT00566501|824223|P1|STARTED|Overall Study||579
341530|NCT00566462|824231|P2|NOT COMPLETED|Overall Study||0
341531|NCT00566462|824232|P1|NOT COMPLETED|Overall Study||0
341532|NCT00566462|824231|P2|COMPLETED|Overall Study||0
341533|NCT00566462|824232|P1|COMPLETED|Overall Study||1
341534|NCT00566462|824231|P2|STARTED|Overall Study||0
341535|NCT00566462|824232|P1|STARTED|Overall Study||1
341536|NCT00566254|824242|P2|NOT COMPLETED|Overall Study||14
341537|NCT00566254|824243|P1|NOT COMPLETED|Overall Study||10
341538|NCT00566254|824242|P2|COMPLETED|Overall Study||93
341539|NCT00566254|824243|P1|COMPLETED|Overall Study||90
341540|NCT00566254|824242|P2|STARTED|Overall Study||107
341541|NCT00566254|824243|P1|STARTED|Overall Study||100
341542|NCT00566228|824257|P2|NOT COMPLETED|Overall Study||5
341543|NCT00566228|824258|P1|NOT COMPLETED|Overall Study||6
341544|NCT00566228|824257|P2|COMPLETED|Overall Study||55
341545|NCT00566228|824258|P1|COMPLETED|Overall Study||56
341546|NCT00566228|824257|P2|STARTED|Overall Study||60
341547|NCT00566228|824258|P1|STARTED|Overall Study||62
341548|NCT00566150|824276|P2|NOT COMPLETED|Overall Study||5
341549|NCT00566150|824277|P1|NOT COMPLETED|Overall Study||9
341550|NCT00566150|824276|P2|COMPLETED|Overall Study||11
341551|NCT00566150|824277|P1|COMPLETED|Overall Study||10
341552|NCT00566150|824276|P2|STARTED|Overall Study||16
341553|NCT00566150|824277|P1|STARTED|Overall Study||19
341554|NCT00566111|824291|P2|NOT COMPLETED|Overall Study||2
341555|NCT00566111|824292|P1|NOT COMPLETED|Overall Study||0
341556|NCT00566111|824291|P2|COMPLETED|Overall Study||1
341557|NCT00566111|824292|P1|COMPLETED|Overall Study||2
341558|NCT00566111|824291|P2|STARTED|Overall Study||3
341559|NCT00566111|824292|P1|STARTED|Overall Study||2
341560|NCT00566098|824306|P1|NOT COMPLETED|Administration of ASCT+MILs||18
341561|NCT00566098|824306|P1|COMPLETED|Administration of ASCT+MILs||4
341562|NCT00566098|824306|P1|STARTED|Administration of ASCT+MILs||22
341563|NCT00566098|824306|P1|NOT COMPLETED|Generation of MILs Product||1
341564|NCT00566098|824306|P1|COMPLETED|Generation of MILs Product||22
341565|NCT00566098|824306|P1|STARTED|Generation of MILs Product||23
341566|NCT00566098|824306|P1|NOT COMPLETED|Collection of MILs||2
341567|NCT00566098|824306|P1|COMPLETED|Collection of MILs||23
341568|NCT00566098|824306|P1|STARTED|Collection of MILs||25
341569|NCT00566020|824316|P2|NOT COMPLETED|46-week Long-term Administration Phase||17
341570|NCT00566020|824317|P1|NOT COMPLETED|46-week Long-term Administration Phase||0
341571|NCT00566020|824316|P2|COMPLETED|46-week Long-term Administration Phase||68
341572|NCT00566020|824317|P1|COMPLETED|46-week Long-term Administration Phase||0
341573|NCT00566020|824316|P2|STARTED|46-week Long-term Administration Phase||85
341574|NCT00566020|824317|P1|STARTED|46-week Long-term Administration Phase||0
341575|NCT00566020|824316|P2|NOT COMPLETED|6-week Dosage Adjustment Phase||0
341576|NCT00566020|824317|P1|NOT COMPLETED|6-week Dosage Adjustment Phase||7
341577|NCT00566020|824316|P2|COMPLETED|6-week Dosage Adjustment Phase||0
341578|NCT00566020|824317|P1|COMPLETED|6-week Dosage Adjustment Phase||85
341579|NCT00566020|824316|P2|STARTED|6-week Dosage Adjustment Phase||0
341580|NCT00566020|824317|P1|STARTED|6-week Dosage Adjustment Phase||92
341581|NCT00565916|824344|P2|NOT COMPLETED|Overall Study||0
341582|NCT00565916|824345|P1|NOT COMPLETED|Overall Study||0
341583|NCT00565916|824344|P2|COMPLETED|Overall Study||11
341584|NCT00565916|824345|P1|COMPLETED|Overall Study||11
341585|NCT00565916|824344|P2|STARTED|Overall Study||11
341586|NCT00565916|824345|P1|STARTED|Overall Study||11
341587|NCT00565864|824354|P3|NOT COMPLETED|Overall Study||11
341588|NCT00565864|824355|P2|NOT COMPLETED|Overall Study||12
341589|NCT00565864|824356|P1|NOT COMPLETED|Overall Study||12
341590|NCT00565864|824354|P3|COMPLETED|Overall Study||45
341591|NCT00565864|824355|P2|COMPLETED|Overall Study||47
341592|NCT00565864|824356|P1|COMPLETED|Overall Study||46
341593|NCT00565864|824354|P3|STARTED|Overall Study||56
341594|NCT00565864|824355|P2|STARTED|Overall Study||59
341595|NCT00565864|824356|P1|STARTED|Overall Study||58
341596|NCT00565812|824406|P3|NOT COMPLETED|Overall Study||130
341597|NCT00565812|824407|P2|NOT COMPLETED|Overall Study||135
341598|NCT00565812|824408|P1|NOT COMPLETED|Overall Study||144
341599|NCT00565812|824406|P3|COMPLETED|Overall Study||356
341600|NCT00565812|824407|P2|COMPLETED|Overall Study||351
341601|NCT00565812|824408|P1|COMPLETED|Overall Study||341
341602|NCT00565812|824406|P3|STARTED|Overall Study||486
341603|NCT00565812|824407|P2|STARTED|Overall Study||486
341604|NCT00565812|824408|P1|STARTED|Overall Study||485
341605|NCT00565747|824547|P2|NOT COMPLETED|Overall Study||73
341606|NCT00565747|824548|P1|NOT COMPLETED|Overall Study||67
341607|NCT00565747|824547|P2|COMPLETED|Overall Study|Completed with an embryo transfer|605
341608|NCT00565747|824548|P1|COMPLETED|Overall Study|Completed with an embryo transfer|587
341609|NCT00565747|824547|P2|STARTED|Overall Study||678
341610|NCT00565747|824548|P1|STARTED|Overall Study||654
341611|NCT00565721|824558|P1|NOT COMPLETED|Overall Study||17
341612|NCT00565721|824558|P1|COMPLETED|Overall Study||16
341613|NCT00565721|824558|P1|STARTED|Overall Study||33
341614|NCT00565669|824579|P2|NOT COMPLETED|Overall Study||0
341615|NCT00565669|824580|P1|NOT COMPLETED|Overall Study||0
341616|NCT00565669|824579|P2|COMPLETED|Overall Study||9
341617|NCT00565669|824580|P1|COMPLETED|Overall Study||11
341618|NCT00565669|824579|P2|STARTED|Overall Study||9
341619|NCT00565669|824580|P1|STARTED|Overall Study||11
341620|NCT00565643|824588|P2|NOT COMPLETED|Overall Study||0
341621|NCT00565643|824589|P1|NOT COMPLETED|Overall Study||0
341622|NCT00565643|824588|P2|COMPLETED|Overall Study||373
341623|NCT00565643|824589|P1|COMPLETED|Overall Study||380
341624|NCT00565643|824588|P2|Primary Outcome (Subsequent Cesarean)|Overall Study||92
341625|NCT00565643|824589|P1|Primary Outcome (Subsequent Cesarean)|Overall Study||80
341626|NCT00565643|824588|P2|Safety Data|Overall Study||373
341627|NCT00565643|824589|P1|Safety Data|Overall Study||380
341628|NCT00565643|824588|P2|STARTED|Overall Study||373
341629|NCT00565643|824589|P1|STARTED|Overall Study||380
341630|NCT00565617|824607|P1|NOT COMPLETED|Overall Study||1
341631|NCT00565617|824607|P1|COMPLETED|Overall Study||5
341632|NCT00565617|824607|P1|STARTED|Overall Study||6
341633|NCT00565604|824611|P1|NOT COMPLETED|Overall Study||4
341634|NCT00565604|824611|P1|COMPLETED|Overall Study||39
341635|NCT00565604|824611|P1|6 Month|Overall Study||39
341636|NCT00565604|824611|P1|6 Week|Overall Study||39
341637|NCT00565604|824611|P1|2 Week|Overall Study||41
341638|NCT00565604|824611|P1|7 Day|Overall Study||41
341639|NCT00565604|824611|P1|STARTED|Overall Study||43
341640|NCT00565461|824622|P4|NOT COMPLETED|Overall Study||3
341641|NCT00565461|824623|P3|NOT COMPLETED|Overall Study||1
341642|NCT00565461|824624|P2|NOT COMPLETED|Overall Study||1
341643|NCT00565461|824625|P1|NOT COMPLETED|Overall Study||0
341644|NCT00565461|824622|P4|COMPLETED|Overall Study||37
341645|NCT00565461|824623|P3|COMPLETED|Overall Study||39
341646|NCT00565461|824624|P2|COMPLETED|Overall Study||39
341647|NCT00565461|824625|P1|COMPLETED|Overall Study||40
341648|NCT00565461|824622|P4|STARTED|Overall Study||40
341649|NCT00565461|824623|P3|STARTED|Overall Study||40
341650|NCT00565461|824624|P2|STARTED|Overall Study||40
341651|NCT00565461|824625|P1|STARTED|Overall Study||40
341652|NCT00565448|824639|P2|NOT COMPLETED|Overall Study||2
341653|NCT00565448|824640|P1|NOT COMPLETED|Overall Study||3
341654|NCT00565448|824639|P2|COMPLETED|Overall Study|Completed induction period as per protocol.|23
341655|NCT00565448|824640|P1|COMPLETED|Overall Study|Completed induction period as per protocol.|47
341656|NCT00565448|824639|P2|STARTED|Overall Study|ITT population: all randomized participants. All were treated.|25
341657|NCT00565448|824640|P1|STARTED|Overall Study|Intent to treat (ITT) population: all randomized participants. All were treated.|50
341658|NCT00565409|824651|P4|NOT COMPLETED|Period 2 Double-Blind||59
341659|NCT00565409|824652|P3|NOT COMPLETED|Period 2 Double-Blind||27
341660|NCT00565409|824653|P2|NOT COMPLETED|Period 2 Double-Blind||21
341661|NCT00565409|824654|P1|NOT COMPLETED|Period 2 Double-Blind||0
341662|NCT00565409|824651|P4|COMPLETED|Period 2 Double-Blind||141
341663|NCT00565409|824652|P3|COMPLETED|Period 2 Double-Blind||175
341664|NCT00565409|824653|P2|COMPLETED|Period 2 Double-Blind||181
341665|NCT00565409|824654|P1|COMPLETED|Period 2 Double-Blind||0
341666|NCT00565409|824651|P4|STARTED|Period 2 Double-Blind||200
341667|NCT00565409|824652|P3|STARTED|Period 2 Double-Blind||202
341668|NCT00565409|824653|P2|STARTED|Period 2 Double-Blind||202
341669|NCT00565409|824654|P1|STARTED|Period 2 Double-Blind||0
341670|NCT00565409|824651|P4|NOT COMPLETED|After Period 1, Prior to Period 2||0
341671|NCT00565409|824652|P3|NOT COMPLETED|After Period 1, Prior to Period 2||0
341672|NCT00565409|824653|P2|NOT COMPLETED|After Period 1, Prior to Period 2||0
341673|NCT00565409|824654|P1|NOT COMPLETED|After Period 1, Prior to Period 2||152
341674|NCT00565409|824651|P4|COMPLETED|After Period 1, Prior to Period 2||0
341675|NCT00565409|824652|P3|COMPLETED|After Period 1, Prior to Period 2||0
341676|NCT00565409|824653|P2|COMPLETED|After Period 1, Prior to Period 2||0
341677|NCT00565409|824654|P1|COMPLETED|After Period 1, Prior to Period 2||604
341678|NCT00565409|824651|P4|STARTED|After Period 1, Prior to Period 2||0
341679|NCT00565409|824652|P3|STARTED|After Period 1, Prior to Period 2||0
341680|NCT00565409|824653|P2|STARTED|After Period 1, Prior to Period 2||0
341681|NCT00565409|824654|P1|STARTED|After Period 1, Prior to Period 2||756
341682|NCT00565409|824651|P4|NOT COMPLETED|Period 1 Open Label||0
341683|NCT00565409|824652|P3|NOT COMPLETED|Period 1 Open Label||0
341684|NCT00565409|824653|P2|NOT COMPLETED|Period 1 Open Label||0
341685|NCT00565409|824654|P1|NOT COMPLETED|Period 1 Open Label||78
341686|NCT00565409|824651|P4|COMPLETED|Period 1 Open Label||0
341687|NCT00565409|824652|P3|COMPLETED|Period 1 Open Label||0
341688|NCT00565409|824653|P2|COMPLETED|Period 1 Open Label||0
341689|NCT00565409|824654|P1|COMPLETED|Period 1 Open Label||756
341690|NCT00565409|824651|P4|STARTED|Period 1 Open Label||0
341691|NCT00565409|824652|P3|STARTED|Period 1 Open Label||0
341692|NCT00565409|824653|P2|STARTED|Period 1 Open Label||0
341693|NCT00565409|824654|P1|STARTED|Period 1 Open Label||834
341694|NCT00565370|824756|P1|NOT COMPLETED|Overall Study||0
341695|NCT00565370|824756|P1|COMPLETED|Overall Study||21
341696|NCT00565370|824756|P1|STARTED|Overall Study||21
341697|NCT00565266|824764|P1|NOT COMPLETED|Overall Study||36
341698|NCT00565266|824764|P1|COMPLETED|Overall Study||174
341699|NCT00565266|824764|P1|STARTED|Overall Study||210
341700|NCT00565136|824790|P1|NOT COMPLETED|Overall Study||3
341701|NCT00565136|824790|P1|COMPLETED|Overall Study||26
341702|NCT00565136|824790|P1|STARTED|Overall Study||29
341703|NCT00565110|824810|P2|NOT COMPLETED|Overall Study||131
341704|NCT00565110|824811|P1|NOT COMPLETED|Overall Study||131
341705|NCT00565110|824810|P2|COMPLETED|Overall Study||111
341706|NCT00565110|824811|P1|COMPLETED|Overall Study||99
341707|NCT00565110|824810|P2|12-Month|Overall Study||144
341708|NCT00565110|824811|P1|12-Month|Overall Study||114
341709|NCT00565110|824810|P2|STARTED|Overall Study||242
341710|NCT00565110|824811|P1|STARTED|Overall Study||230
341711|NCT00565084|824819|P3|NOT COMPLETED|Third Treatment Period||0
341712|NCT00565084|824820|P2|NOT COMPLETED|Third Treatment Period||0
341713|NCT00565084|824821|P1|NOT COMPLETED|Third Treatment Period||0
341714|NCT00565084|824819|P3|COMPLETED|Third Treatment Period||11
341715|NCT00565084|824820|P2|COMPLETED|Third Treatment Period||11
341716|NCT00565084|824821|P1|COMPLETED|Third Treatment Period||11
341717|NCT00565084|824819|P3|STARTED|Third Treatment Period||11
341718|NCT00565084|824820|P2|STARTED|Third Treatment Period||11
341719|NCT00565084|824821|P1|STARTED|Third Treatment Period||11
341720|NCT00565084|824819|P3|NOT COMPLETED|Second Treatment Period||0
341721|NCT00565084|824820|P2|NOT COMPLETED|Second Treatment Period||0
341722|NCT00565084|824821|P1|NOT COMPLETED|Second Treatment Period||0
341723|NCT00565084|824819|P3|COMPLETED|Second Treatment Period||11
341724|NCT00565084|824820|P2|COMPLETED|Second Treatment Period||11
341725|NCT00565084|824821|P1|COMPLETED|Second Treatment Period||11
341726|NCT00565084|824819|P3|STARTED|Second Treatment Period||11
341727|NCT00565084|824820|P2|STARTED|Second Treatment Period||11
341728|NCT00565084|824821|P1|STARTED|Second Treatment Period||11
341729|NCT00565084|824819|P3|NOT COMPLETED|First Treatment Period||0
341730|NCT00565084|824820|P2|NOT COMPLETED|First Treatment Period||0
341731|NCT00565084|824821|P1|NOT COMPLETED|First Treatment Period||0
341732|NCT00565084|824819|P3|COMPLETED|First Treatment Period||11
341733|NCT00565084|824820|P2|COMPLETED|First Treatment Period||11
341734|NCT00565084|824821|P1|COMPLETED|First Treatment Period||11
341735|NCT00565084|824819|P3|STARTED|First Treatment Period||11
341736|NCT00565084|824820|P2|STARTED|First Treatment Period||11
341737|NCT00565084|824821|P1|STARTED|First Treatment Period||11
341738|NCT00565058|824831|P2|NOT COMPLETED|Overall Study||0
341739|NCT00565058|824832|P1|NOT COMPLETED|Overall Study||1
341740|NCT00565058|824831|P2|COMPLETED|Overall Study||15
341741|NCT00565058|824832|P1|COMPLETED|Overall Study||9
341742|NCT00565058|824831|P2|STARTED|Overall Study||15
341743|NCT00565058|824832|P1|STARTED|Overall Study||10
341744|NCT00565045|824842|P2|NOT COMPLETED|Overall Study||3
341745|NCT00565045|824843|P1|NOT COMPLETED|Overall Study||1
341746|NCT00565045|824842|P2|COMPLETED|Overall Study||8
341747|NCT00565045|824843|P1|COMPLETED|Overall Study||9
341748|NCT00565045|824842|P2|STARTED|Overall Study||11
341749|NCT00565045|824843|P1|STARTED|Overall Study||10
341750|NCT00564954|824859|P2|NOT COMPLETED|Period 2- 1 Week||0
341751|NCT00564954|824860|P1|NOT COMPLETED|Period 2- 1 Week||0
341752|NCT00564954|824859|P2|COMPLETED|Period 2- 1 Week||42
341753|NCT00564954|824860|P1|COMPLETED|Period 2- 1 Week||44
341754|NCT00564954|824859|P2|STARTED|Period 2- 1 Week||42
341755|NCT00564954|824860|P1|STARTED|Period 2- 1 Week||44
341756|NCT00564954|824859|P2|NOT COMPLETED|Period 1- 1 Week||0
341757|NCT00564954|824860|P1|NOT COMPLETED|Period 1- 1 Week||0
341758|NCT00564954|824859|P2|COMPLETED|Period 1- 1 Week||42
341759|NCT00564954|824860|P1|COMPLETED|Period 1- 1 Week||44
341760|NCT00564954|824859|P2|STARTED|Period 1- 1 Week||42
341761|NCT00564954|824860|P1|STARTED|Period 1- 1 Week||44
341762|NCT00564902|824879|P3|NOT COMPLETED|Overall Study||4
341763|NCT00564902|824880|P2|NOT COMPLETED|Overall Study||4
341764|NCT00564902|824881|P1|NOT COMPLETED|Overall Study||1
341765|NCT00564902|824879|P3|COMPLETED|Overall Study||21
341766|NCT00564902|824880|P2|COMPLETED|Overall Study||21
341767|NCT00564902|824881|P1|COMPLETED|Overall Study||9
341768|NCT00564902|824879|P3|12 Months|Overall Study||21
341769|NCT00564902|824880|P2|12 Months|Overall Study||21
341770|NCT00564902|824881|P1|12 Months|Overall Study||9
341771|NCT00564902|824879|P3|8 Months|Overall Study||21
341772|NCT00564902|824880|P2|8 Months|Overall Study||22
341773|NCT00564902|824881|P1|8 Months|Overall Study||9
341774|NCT00564902|824879|P3|4 Months|Overall Study||23
341775|NCT00564902|824880|P2|4 Months|Overall Study||24
341776|NCT00564902|824881|P1|4 Months|Overall Study||9
341777|NCT00564902|824879|P3|STARTED|Overall Study||25
341778|NCT00564902|824880|P2|STARTED|Overall Study||25
341779|NCT00564902|824881|P1|STARTED|Overall Study||10
341780|NCT00564889|824913|P1|NOT COMPLETED|Overall Study||29
341781|NCT00564889|824913|P1|COMPLETED|Overall Study||6
341782|NCT00564889|824913|P1|STARTED|Overall Study||35
341783|NCT00564876|824921|P1|NOT COMPLETED|Overall Study||0
341784|NCT00564876|824921|P1|COMPLETED|Overall Study||2
341785|NCT00564876|824921|P1|STARTED|Overall Study||2
341786|NCT00564850|824928|P1|NOT COMPLETED|Overall Study||2
341787|NCT00564850|824928|P1|COMPLETED|Overall Study||35
341788|NCT00564850|824928|P1|STARTED|Overall Study||37
341789|NCT00564733|824946|P1|NOT COMPLETED|Overall Study||9
341790|NCT00564733|824946|P1|COMPLETED|Overall Study||46
341791|NCT00564733|824946|P1|STARTED|Overall Study||55
341792|NCT00564681|824954|P4|NOT COMPLETED|Overall Study||2
341793|NCT00564681|824955|P3|NOT COMPLETED|Overall Study||3
341794|NCT00564681|824956|P2|NOT COMPLETED|Overall Study||3
341795|NCT00564681|824957|P1|NOT COMPLETED|Overall Study||11
341796|NCT00564681|824954|P4|COMPLETED|Overall Study||19
341797|NCT00564681|824955|P3|COMPLETED|Overall Study||40
341798|NCT00564681|824956|P2|COMPLETED|Overall Study||58
341799|NCT00564681|824957|P1|COMPLETED|Overall Study||106
341800|NCT00564681|824954|P4|STARTED|Overall Study||21
341801|NCT00564681|824955|P3|STARTED|Overall Study||43
341802|NCT00564681|824956|P2|STARTED|Overall Study||61
341803|NCT00564681|824957|P1|STARTED|Overall Study||117
341804|NCT00564629|824980|P2|NOT COMPLETED|Overall Study||9
341805|NCT00564629|824981|P1|NOT COMPLETED|Overall Study||15
341806|NCT00564629|824980|P2|COMPLETED|Overall Study||45
341807|NCT00564629|824981|P1|COMPLETED|Overall Study||36
341808|NCT00564629|824980|P2|STARTED|Overall Study||54
341809|NCT00564629|824981|P1|STARTED|Overall Study||51
341810|NCT00564486|825006|P4|NOT COMPLETED|Overall Study||7
341811|NCT00564486|825007|P3|NOT COMPLETED|Overall Study||3
341812|NCT00564486|825008|P2|NOT COMPLETED|Overall Study||1
341813|NCT00564486|825009|P1|NOT COMPLETED|Overall Study||7
341814|NCT00564486|825006|P4|COMPLETED|Overall Study||60
341815|NCT00564486|825007|P3|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|39
341816|NCT00564486|825008|P2|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|91
341817|NCT00564486|825009|P1|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|36
341818|NCT00564486|825006|P4|STARTED|Overall Study||67
341819|NCT00564486|825007|P3|STARTED|Overall Study|One subject randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|42
341820|NCT00564486|825008|P2|STARTED|Overall Study|One subject was randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|92
341821|NCT00564486|825009|P1|STARTED|Overall Study||43
341822|NCT00564447|825033|P8|NOT COMPLETED|Overall Study||0
341823|NCT00564447|825034|P7|NOT COMPLETED|Overall Study||0
341824|NCT00564447|825035|P6|NOT COMPLETED|Overall Study||0
341825|NCT00564447|825036|P5|NOT COMPLETED|Overall Study||0
341826|NCT00564447|825037|P4|NOT COMPLETED|Overall Study||0
341827|NCT00564447|825038|P3|NOT COMPLETED|Overall Study||0
341828|NCT00564447|825039|P2|NOT COMPLETED|Overall Study||0
341829|NCT00564447|825040|P1|NOT COMPLETED|Overall Study||0
341830|NCT00564447|825033|P8|COMPLETED|Overall Study||6
341831|NCT00564447|825034|P7|COMPLETED|Overall Study||6
341832|NCT00564447|825035|P6|COMPLETED|Overall Study||6
341833|NCT00564447|825036|P5|COMPLETED|Overall Study||6
341834|NCT00564447|825037|P4|COMPLETED|Overall Study||6
341835|NCT00564447|825038|P3|COMPLETED|Overall Study||6
341836|NCT00564447|825039|P2|COMPLETED|Overall Study||6
341837|NCT00564447|825040|P1|COMPLETED|Overall Study||6
341838|NCT00564447|825033|P8|STARTED|Overall Study||6
341839|NCT00564447|825034|P7|STARTED|Overall Study||6
341840|NCT00564447|825035|P6|STARTED|Overall Study||6
341841|NCT00564447|825036|P5|STARTED|Overall Study||6
341842|NCT00564447|825037|P4|STARTED|Overall Study||6
341843|NCT00564447|825038|P3|STARTED|Overall Study||6
341844|NCT00564447|825039|P2|STARTED|Overall Study||6
341845|NCT00564447|825040|P1|STARTED|Overall Study||6
341846|NCT00564395|825058|P2|NOT COMPLETED|Second Intervention (10 Days)||0
341847|NCT00564395|825059|P1|NOT COMPLETED|Second Intervention (10 Days)||0
341848|NCT00564395|825058|P2|COMPLETED|Second Intervention (10 Days)||7
341849|NCT00564395|825059|P1|COMPLETED|Second Intervention (10 Days)||7
341850|NCT00564395|825058|P2|STARTED|Second Intervention (10 Days)||7
341851|NCT00564395|825059|P1|STARTED|Second Intervention (10 Days)||7
341852|NCT00564395|825058|P2|NOT COMPLETED|First Intervention (10 Days)||2
341853|NCT00564395|825059|P1|NOT COMPLETED|First Intervention (10 Days)||2
341854|NCT00564395|825058|P2|COMPLETED|First Intervention (10 Days)||7
341855|NCT00564395|825059|P1|COMPLETED|First Intervention (10 Days)||7
341856|NCT00564395|825058|P2|Received Intervention|First Intervention (10 Days)||7
341857|NCT00564395|825059|P1|Received Intervention|First Intervention (10 Days)||7
341858|NCT00564395|825058|P2|STARTED|First Intervention (10 Days)||9
341859|NCT00564395|825059|P1|STARTED|First Intervention (10 Days)||9
341860|NCT00564278|825067|P2|NOT COMPLETED|Overall Study||42
341861|NCT00564278|825068|P1|NOT COMPLETED|Overall Study||47
341862|NCT00564278|825067|P2|COMPLETED|Overall Study||56
341863|NCT00564278|825068|P1|COMPLETED|Overall Study||50
341864|NCT00564278|825067|P2|STARTED|Overall Study||98
341865|NCT00564278|825068|P1|STARTED|Overall Study||97
341866|NCT00564265|825084|P1|NOT COMPLETED|Overall Study||0
341867|NCT00564265|825084|P1|COMPLETED|Overall Study||24
341868|NCT00564265|825084|P1|STARTED|Overall Study||24
341869|NCT00564070|825090|P2|NOT COMPLETED|Overall Study||7
341870|NCT00564070|825091|P1|NOT COMPLETED|Overall Study||12
341871|NCT00564070|825090|P2|COMPLETED|Overall Study||38
341872|NCT00564070|825091|P1|COMPLETED|Overall Study||30
341873|NCT00564070|825090|P2|STARTED|Overall Study||45
341874|NCT00564070|825091|P1|STARTED|Overall Study||42
341875|NCT00564018|825118|P3|NOT COMPLETED|Overall Study||1
341876|NCT00564018|825119|P2|NOT COMPLETED|Overall Study||3
341877|NCT00564018|825120|P1|NOT COMPLETED|Overall Study||2
341878|NCT00564018|825118|P3|COMPLETED|Overall Study||11
341879|NCT00564018|825119|P2|COMPLETED|Overall Study||7
341880|NCT00564018|825120|P1|COMPLETED|Overall Study||9
341881|NCT00564018|825118|P3|STARTED|Overall Study||12
341882|NCT00564018|825119|P2|STARTED|Overall Study||10
341883|NCT00564018|825120|P1|STARTED|Overall Study||11
341884|NCT00563797|825133|P2|NOT COMPLETED|Overall Study||2
341885|NCT00563797|825134|P1|NOT COMPLETED|Overall Study||7
341886|NCT00563797|825133|P2|COMPLETED|Overall Study||8
341887|NCT00563797|825134|P1|COMPLETED|Overall Study||4
341888|NCT00563797|825133|P2|Follow-Up|Overall Study||10
341889|NCT00563797|825134|P1|Follow-Up|Overall Study||11
341890|NCT00563797|825133|P2|Received Allocated Intervention|Overall Study||10
341891|NCT00563797|825134|P1|Received Allocated Intervention|Overall Study||11
341892|NCT00563797|825133|P2|STARTED|Overall Study||10
341893|NCT00563797|825134|P1|STARTED|Overall Study||11
341894|NCT00563784|825146|P1|NOT COMPLETED|Overall Study||22
341895|NCT00563784|825146|P1|COMPLETED|Overall Study||46
341896|NCT00563784|825146|P1|STARTED|Overall Study||68
341897|NCT00563706|825160|P9|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
341898|NCT00563706|825161|P8|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
341899|NCT00563706|825162|P7|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
341900|NCT00563706|825163|P6|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
341901|NCT00563706|825164|P5|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
341902|NCT00563706|825165|P4|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
341903|NCT00563706|825166|P3|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
341904|NCT00563706|825167|P2|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
341905|NCT00563706|825168|P1|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
341906|NCT00563706|825160|P9|COMPLETED|Taper Phase (Day 29 up to Day 35)||32
341907|NCT00563706|825161|P8|COMPLETED|Taper Phase (Day 29 up to Day 35)||16
341908|NCT00563706|825162|P7|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
341909|NCT00563706|825163|P6|COMPLETED|Taper Phase (Day 29 up to Day 35)||14
341910|NCT00563706|825164|P5|COMPLETED|Taper Phase (Day 29 up to Day 35)||11
341911|NCT00563706|825165|P4|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
341912|NCT00563706|825166|P3|COMPLETED|Taper Phase (Day 29 up to Day 35)||3
341913|NCT00563706|825167|P2|COMPLETED|Taper Phase (Day 29 up to Day 35)||13
341914|NCT00563706|825168|P1|COMPLETED|Taper Phase (Day 29 up to Day 35)||20
341915|NCT00563706|825160|P9|STARTED|Taper Phase (Day 29 up to Day 35)||32
341916|NCT00563706|825161|P8|STARTED|Taper Phase (Day 29 up to Day 35)||16
341917|NCT00563706|825162|P7|STARTED|Taper Phase (Day 29 up to Day 35)||9
341918|NCT00563706|825163|P6|STARTED|Taper Phase (Day 29 up to Day 35)||14
341919|NCT00563706|825164|P5|STARTED|Taper Phase (Day 29 up to Day 35)||11
341920|NCT00563706|825165|P4|STARTED|Taper Phase (Day 29 up to Day 35)||9
341921|NCT00563706|825166|P3|STARTED|Taper Phase (Day 29 up to Day 35)||3
341922|NCT00563706|825167|P2|STARTED|Taper Phase (Day 29 up to Day 35)||13
341923|NCT00563706|825168|P1|STARTED|Taper Phase (Day 29 up to Day 35)||20
341924|NCT00563706|825160|P9|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
341925|NCT00563706|825161|P8|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
341926|NCT00563706|825162|P7|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
341927|NCT00563706|825163|P6|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
341928|NCT00563706|825164|P5|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
341929|NCT00563706|825165|P4|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||10
341930|NCT00563706|825166|P3|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
341931|NCT00563706|825167|P2|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
341932|NCT00563706|825168|P1|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||17
341933|NCT00563706|825160|P9|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||32
341934|NCT00563706|825161|P8|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||16
341935|NCT00563706|825162|P7|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
341936|NCT00563706|825163|P6|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
341937|NCT00563706|825164|P5|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
341938|NCT00563706|825165|P4|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
341939|NCT00563706|825166|P3|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
341940|NCT00563706|825167|P2|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||13
341941|NCT00563706|825168|P1|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||20
341942|NCT00563706|825160|P9|STARTED|DB Treatment Period (Day 1 up to Day 28)||43
341943|NCT00563706|825161|P8|STARTED|DB Treatment Period (Day 1 up to Day 28)||30
341944|NCT00563706|825162|P7|STARTED|DB Treatment Period (Day 1 up to Day 28)||12
341945|NCT00563706|825163|P6|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
341946|NCT00563706|825164|P5|STARTED|DB Treatment Period (Day 1 up to Day 28)||16
341947|NCT00563706|825165|P4|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
341948|NCT00563706|825166|P3|STARTED|DB Treatment Period (Day 1 up to Day 28)||8
341949|NCT00563706|825167|P2|STARTED|DB Treatment Period (Day 1 up to Day 28)||18
341950|NCT00563706|825168|P1|STARTED|DB Treatment Period (Day 1 up to Day 28)||37
341951|NCT00563576|825271|P2|NOT COMPLETED|Overall Study||14
341952|NCT00563576|825272|P1|NOT COMPLETED|Overall Study||14
341953|NCT00563576|825271|P2|COMPLETED|Overall Study||22
341954|NCT00563576|825272|P1|COMPLETED|Overall Study||21
341955|NCT00563576|825271|P2|STARTED|Overall Study||36
341956|NCT00563576|825272|P1|STARTED|Overall Study||35
341957|NCT00563381|825286|P2|NOT COMPLETED|Overall Study||648
341958|NCT00563381|825287|P1|NOT COMPLETED|Overall Study||585
341959|NCT00563381|825286|P2|COMPLETED|Overall Study|Completed treatment|3021
341960|NCT00563381|825287|P1|COMPLETED|Overall Study|Completed treatment|3122
341961|NCT00563381|825286|P2|STARTED|Overall Study|Started treatment|3669
341962|NCT00563381|825287|P1|STARTED|Overall Study|Started treatment|3707
341963|NCT00563368|825360|P7|NOT COMPLETED|Overall Study||33
341964|NCT00563368|825361|P6|NOT COMPLETED|Overall Study||30
341965|NCT00563368|825362|P5|NOT COMPLETED|Overall Study||28
341966|NCT00563368|825363|P4|NOT COMPLETED|Overall Study||29
341967|NCT00563368|825364|P3|NOT COMPLETED|Overall Study||30
341968|NCT00563368|825365|P2|NOT COMPLETED|Overall Study||30
341969|NCT00563368|825366|P1|NOT COMPLETED|Overall Study||35
341970|NCT00563368|825360|P7|COMPLETED|Overall Study||75
341971|NCT00563368|825361|P6|COMPLETED|Overall Study||77
341972|NCT00563368|825362|P5|COMPLETED|Overall Study||80
341973|NCT00563368|825363|P4|COMPLETED|Overall Study||78
341974|NCT00563368|825364|P3|COMPLETED|Overall Study||78
341975|NCT00563368|825365|P2|COMPLETED|Overall Study||79
341976|NCT00563368|825366|P1|COMPLETED|Overall Study||74
341977|NCT00563368|825360|P7|STARTED|Overall Study||108
341978|NCT00563368|825361|P6|STARTED|Overall Study||107
341979|NCT00563368|825362|P5|STARTED|Overall Study||108
341980|NCT00563368|825363|P4|STARTED|Overall Study||107
341981|NCT00563368|825364|P3|STARTED|Overall Study||108
341982|NCT00563368|825365|P2|STARTED|Overall Study||109
341983|NCT00563368|825366|P1|STARTED|Overall Study||109
341984|NCT00563316|825389|P1|NOT COMPLETED|Overall Study||12
341985|NCT00563316|825389|P1|COMPLETED|Overall Study||16
341986|NCT00563316|825389|P1|Received Investigational Product|Overall Study||27
341987|NCT00563316|825389|P1|STARTED|Overall Study||28
341988|NCT00563290|825402|P2|NOT COMPLETED|Overall Study||0
341989|NCT00563290|825403|P1|NOT COMPLETED|Overall Study||0
341990|NCT00563290|825402|P2|COMPLETED|Overall Study||4
341991|NCT00563290|825403|P1|COMPLETED|Overall Study||3
341992|NCT00563290|825402|P2|STARTED|Overall Study||4
341993|NCT00563290|825403|P1|STARTED|Overall Study||3
341994|NCT00563186|825414|P2|NOT COMPLETED|Overall Study||75
341995|NCT00563186|825415|P1|NOT COMPLETED|Overall Study||98
341996|NCT00563186|825414|P2|COMPLETED|Overall Study||604
341997|NCT00563186|825415|P1|COMPLETED|Overall Study||910
341998|NCT00563186|825414|P2|STARTED|Overall Study|Patients allocated to the Traditional Hospital Ward|679
341999|NCT00563186|825415|P1|STARTED|Overall Study|Patients allocated to the Novel Hospital Ward|1008
342000|NCT00562965|825426|P2|NOT COMPLETED|Overall Study||6
342001|NCT00562965|825427|P1|NOT COMPLETED|Overall Study||3
342002|NCT00562965|825426|P2|COMPLETED|Overall Study||8
342003|NCT00562965|825427|P1|COMPLETED|Overall Study||12
342004|NCT00562965|825426|P2|Treated|Overall Study||13
342005|NCT00562965|825427|P1|Treated|Overall Study||15
342006|NCT00562965|825426|P2|STARTED|Overall Study||14
342007|NCT00562965|825427|P1|STARTED|Overall Study||15
342008|NCT00562861|825448|P2|NOT COMPLETED|Overall Study||11
342009|NCT00562861|825449|P1|NOT COMPLETED|Overall Study||20
342010|NCT00562861|825448|P2|COMPLETED|Overall Study||48
342011|NCT00562861|825449|P1|COMPLETED|Overall Study||40
342012|NCT00562861|825448|P2|STARTED|Overall Study||59
342013|NCT00562861|825449|P1|STARTED|Overall Study||60
342014|NCT00562718|825455|P1|NOT COMPLETED|Overall Study||11
342015|NCT00562718|825455|P1|COMPLETED|Overall Study||39
342016|NCT00562718|825455|P1|STARTED|Overall Study||50
342017|NCT00562627|825464|P3|NOT COMPLETED|Overall Study||1
342018|NCT00562627|825465|P2|NOT COMPLETED|Overall Study||1
342019|NCT00562627|825466|P1|NOT COMPLETED|Overall Study||1
342020|NCT00562627|825464|P3|COMPLETED|Overall Study||33
342021|NCT00562627|825465|P2|COMPLETED|Overall Study||33
342022|NCT00562627|825466|P1|COMPLETED|Overall Study||33
342023|NCT00562627|825464|P3|STARTED|Overall Study||34
342024|NCT00562627|825465|P2|STARTED|Overall Study||34
342025|NCT00562627|825466|P1|STARTED|Overall Study||34
342026|NCT00562588|825482|P2|NOT COMPLETED|Overall Study||99
342027|NCT00562588|825483|P1|NOT COMPLETED|Overall Study||92
342028|NCT00562588|825482|P2|COMPLETED|Overall Study||184
342029|NCT00562588|825483|P1|COMPLETED|Overall Study||168
342030|NCT00562588|825482|P2|STARTED|Overall Study||283
342031|NCT00562588|825483|P1|STARTED|Overall Study||260
342032|NCT00562484|825513|P2|NOT COMPLETED|Overall Study||104
342033|NCT00562484|825514|P1|NOT COMPLETED|Overall Study||206
342034|NCT00562484|825513|P2|COMPLETED|Overall Study||4907
342035|NCT00562484|825514|P1|COMPLETED|Overall Study||9827
342036|NCT00562484|825513|P2|STARTED|Overall Study||5011
342037|NCT00562484|825514|P1|STARTED|Overall Study||10033
342038|NCT00562354|825546|P2|NOT COMPLETED|Overall Study||2
342039|NCT00562354|825547|P1|NOT COMPLETED|Overall Study||0
342040|NCT00562354|825546|P2|COMPLETED|Overall Study||135
342041|NCT00562354|825547|P1|COMPLETED|Overall Study||134
342042|NCT00562354|825546|P2|Evaluable Immunogenicity Population|Overall Study||134
342043|NCT00562354|825547|P1|Evaluable Immunogenicity Population|Overall Study||134
342044|NCT00562354|825546|P2|Received Study Treatment|Overall Study||136
342045|NCT00562354|825547|P1|Received Study Treatment|Overall Study||134
342046|NCT00562354|825546|P2|STARTED|Overall Study||137
342047|NCT00562354|825547|P1|STARTED|Overall Study||134
342048|NCT00562328|825588|P1|NOT COMPLETED|Overall Study||0
342049|NCT00562328|825588|P1|COMPLETED|Overall Study||33
342050|NCT00562328|825588|P1|STARTED|Overall Study||33
342051|NCT00562315|825592|P1|NOT COMPLETED|Overall Study||0
342052|NCT00562315|825592|P1|COMPLETED|Overall Study||93
342053|NCT00562315|825592|P1|STARTED|Overall Study||93
342054|NCT00562302|825609|P2|NOT COMPLETED|Overall Study||32
342055|NCT00562302|825610|P1|NOT COMPLETED|Overall Study||20
342056|NCT00562302|825609|P2|COMPLETED|Overall Study||137
342057|NCT00562302|825610|P1|COMPLETED|Overall Study||150
342058|NCT00562302|825609|P2|STARTED|Overall Study||169
342059|NCT00562302|825610|P1|STARTED|Overall Study||170
342060|NCT00562159|825632|P2|NOT COMPLETED|Overall Study||33
342061|NCT00562159|825633|P1|NOT COMPLETED|Overall Study||38
342062|NCT00562159|825632|P2|COMPLETED|Overall Study||192
342063|NCT00562159|825633|P1|COMPLETED|Overall Study||175
342064|NCT00562159|825632|P2|STARTED|Overall Study||225
342065|NCT00562159|825633|P1|STARTED|Overall Study||213
342066|NCT00562120|825645|P4|NOT COMPLETED|Fourth Intervention Period||0
342067|NCT00562120|825646|P3|NOT COMPLETED|Fourth Intervention Period||0
342068|NCT00562120|825647|P2|NOT COMPLETED|Fourth Intervention Period||0
342069|NCT00562120|825648|P1|NOT COMPLETED|Fourth Intervention Period||0
342070|NCT00562120|825645|P4|COMPLETED|Fourth Intervention Period||5
342071|NCT00562120|825646|P3|COMPLETED|Fourth Intervention Period||5
342072|NCT00562120|825647|P2|COMPLETED|Fourth Intervention Period||5
342073|NCT00562120|825648|P1|COMPLETED|Fourth Intervention Period||4
342074|NCT00562120|825645|P4|STARTED|Fourth Intervention Period||5
342075|NCT00562120|825646|P3|STARTED|Fourth Intervention Period||5
342076|NCT00562120|825647|P2|STARTED|Fourth Intervention Period||5
342077|NCT00562120|825648|P1|STARTED|Fourth Intervention Period||4
342078|NCT00562120|825645|P4|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
342079|NCT00562120|825646|P3|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
342080|NCT00562120|825647|P2|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
342081|NCT00562120|825648|P1|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
342082|NCT00562120|825645|P4|COMPLETED|Washout Period 3 (At Least 14 Days)||5
342083|NCT00562120|825646|P3|COMPLETED|Washout Period 3 (At Least 14 Days)||5
342084|NCT00562120|825647|P2|COMPLETED|Washout Period 3 (At Least 14 Days)||5
342085|NCT00562120|825648|P1|COMPLETED|Washout Period 3 (At Least 14 Days)||4
342086|NCT00562120|825645|P4|STARTED|Washout Period 3 (At Least 14 Days)||5
342087|NCT00562120|825646|P3|STARTED|Washout Period 3 (At Least 14 Days)||5
342088|NCT00562120|825647|P2|STARTED|Washout Period 3 (At Least 14 Days)||5
342089|NCT00562120|825648|P1|STARTED|Washout Period 3 (At Least 14 Days)||4
342090|NCT00562120|825645|P4|NOT COMPLETED|Third Intervention Period||0
342091|NCT00562120|825646|P3|NOT COMPLETED|Third Intervention Period||0
342092|NCT00562120|825647|P2|NOT COMPLETED|Third Intervention Period||0
342093|NCT00562120|825648|P1|NOT COMPLETED|Third Intervention Period||0
342094|NCT00562120|825645|P4|COMPLETED|Third Intervention Period||5
342095|NCT00562120|825646|P3|COMPLETED|Third Intervention Period||5
342096|NCT00562120|825647|P2|COMPLETED|Third Intervention Period||5
342097|NCT00562120|825648|P1|COMPLETED|Third Intervention Period||4
342098|NCT00562120|825645|P4|STARTED|Third Intervention Period||5
342099|NCT00562120|825646|P3|STARTED|Third Intervention Period||5
342100|NCT00562120|825647|P2|STARTED|Third Intervention Period||5
342101|NCT00562120|825648|P1|STARTED|Third Intervention Period||4
342102|NCT00562120|825645|P4|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
342103|NCT00562120|825646|P3|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
342104|NCT00562120|825647|P2|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
342105|NCT00562120|825648|P1|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
342106|NCT00562120|825645|P4|COMPLETED|Washout Period 2 (At Least 14 Days)||5
342107|NCT00562120|825646|P3|COMPLETED|Washout Period 2 (At Least 14 Days)||5
342108|NCT00562120|825647|P2|COMPLETED|Washout Period 2 (At Least 14 Days)||5
342109|NCT00562120|825648|P1|COMPLETED|Washout Period 2 (At Least 14 Days)||4
342110|NCT00562120|825645|P4|STARTED|Washout Period 2 (At Least 14 Days)||5
342111|NCT00562120|825646|P3|STARTED|Washout Period 2 (At Least 14 Days)||5
342112|NCT00562120|825647|P2|STARTED|Washout Period 2 (At Least 14 Days)||5
342113|NCT00562120|825648|P1|STARTED|Washout Period 2 (At Least 14 Days)||4
342114|NCT00562120|825645|P4|NOT COMPLETED|Second Intervention Period||0
342115|NCT00562120|825646|P3|NOT COMPLETED|Second Intervention Period||0
342116|NCT00562120|825647|P2|NOT COMPLETED|Second Intervention Period||0
342117|NCT00562120|825648|P1|NOT COMPLETED|Second Intervention Period||0
342118|NCT00562120|825645|P4|COMPLETED|Second Intervention Period||5
342119|NCT00562120|825646|P3|COMPLETED|Second Intervention Period||5
342120|NCT00562120|825647|P2|COMPLETED|Second Intervention Period||5
342121|NCT00562120|825648|P1|COMPLETED|Second Intervention Period||4
342122|NCT00562120|825645|P4|STARTED|Second Intervention Period||5
342123|NCT00562120|825646|P3|STARTED|Second Intervention Period||5
342124|NCT00562120|825647|P2|STARTED|Second Intervention Period||5
342125|NCT00562120|825648|P1|STARTED|Second Intervention Period||4
342126|NCT00562120|825645|P4|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
342127|NCT00562120|825646|P3|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
342128|NCT00562120|825647|P2|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
342129|NCT00562120|825648|P1|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
342130|NCT00562120|825645|P4|COMPLETED|Washout Period 1 (At Least 14 Days)||5
342131|NCT00562120|825646|P3|COMPLETED|Washout Period 1 (At Least 14 Days)||5
342132|NCT00562120|825647|P2|COMPLETED|Washout Period 1 (At Least 14 Days)||5
342133|NCT00562120|825648|P1|COMPLETED|Washout Period 1 (At Least 14 Days)||4
342134|NCT00562120|825645|P4|STARTED|Washout Period 1 (At Least 14 Days)||5
342135|NCT00562120|825646|P3|STARTED|Washout Period 1 (At Least 14 Days)||5
342136|NCT00562120|825647|P2|STARTED|Washout Period 1 (At Least 14 Days)||5
342137|NCT00562120|825648|P1|STARTED|Washout Period 1 (At Least 14 Days)||4
342138|NCT00562120|825645|P4|NOT COMPLETED|First Intervention Period||0
342139|NCT00562120|825646|P3|NOT COMPLETED|First Intervention Period||0
342140|NCT00562120|825647|P2|NOT COMPLETED|First Intervention Period||0
342141|NCT00562120|825648|P1|NOT COMPLETED|First Intervention Period||2
342142|NCT00562120|825645|P4|COMPLETED|First Intervention Period||5
342143|NCT00562120|825646|P3|COMPLETED|First Intervention Period||5
342144|NCT00562120|825647|P2|COMPLETED|First Intervention Period||5
342145|NCT00562120|825648|P1|COMPLETED|First Intervention Period||4
342146|NCT00562120|825645|P4|Treated|First Intervention Period||5
342147|NCT00562120|825646|P3|Treated|First Intervention Period||5
342148|NCT00562120|825647|P2|Treated|First Intervention Period||5
342149|NCT00562120|825648|P1|Treated|First Intervention Period||5
342150|NCT00562120|825645|P4|STARTED|First Intervention Period||5
342151|NCT00562120|825646|P3|STARTED|First Intervention Period||5
342152|NCT00562120|825647|P2|STARTED|First Intervention Period||5
342153|NCT00562120|825648|P1|STARTED|First Intervention Period||6
342154|NCT00562094|825680|P1|NOT COMPLETED|Overall Study||62
342155|NCT00562094|825680|P1|COMPLETED|Overall Study||8554
342156|NCT00562094|825680|P1|STARTED|Overall Study||8616
342157|NCT00561977|825695|P3|NOT COMPLETED|Overall Study||2
342158|NCT00561977|825696|P2|NOT COMPLETED|Overall Study||3
342159|NCT00561977|825697|P1|NOT COMPLETED|Overall Study||0
342160|NCT00561977|825695|P3|COMPLETED|Overall Study||10
342161|NCT00561977|825696|P2|COMPLETED|Overall Study||9
342162|NCT00561977|825697|P1|COMPLETED|Overall Study||12
342163|NCT00561977|825695|P3|STARTED|Overall Study||12
342164|NCT00561977|825696|P2|STARTED|Overall Study||12
342165|NCT00561977|825697|P1|STARTED|Overall Study||12
342166|NCT00561951|825723|P3|NOT COMPLETED|Overall Study||32
342167|NCT00561951|825724|P2|NOT COMPLETED|Overall Study||34
342168|NCT00561951|825725|P1|NOT COMPLETED|Overall Study||33
342169|NCT00561951|825723|P3|COMPLETED|Overall Study||281
342170|NCT00561951|825724|P2|COMPLETED|Overall Study||286
342171|NCT00561951|825725|P1|COMPLETED|Overall Study||285
342172|NCT00561951|825723|P3|STARTED|Overall Study||313
342173|NCT00561951|825724|P2|STARTED|Overall Study||320
342174|NCT00561951|825725|P1|STARTED|Overall Study||318
342175|NCT00561925|825781|P5|NOT COMPLETED|Open-Label Extension Period||50
342176|NCT00561925|825782|P4|NOT COMPLETED|Open-Label Extension Period||43
342177|NCT00561925|825783|P3|NOT COMPLETED|Open-Label Extension Period||0
342178|NCT00561925|825784|P2|NOT COMPLETED|Open-Label Extension Period||0
342179|NCT00561925|825785|P1|NOT COMPLETED|Open-Label Extension Period||0
342180|NCT00561925|825781|P5|COMPLETED|Open-Label Extension Period||328
342181|NCT00561925|825782|P4|COMPLETED|Open-Label Extension Period||315
342182|NCT00561925|825783|P3|COMPLETED|Open-Label Extension Period||0
342183|NCT00561925|825784|P2|COMPLETED|Open-Label Extension Period||1
342184|NCT00561925|825785|P1|COMPLETED|Open-Label Extension Period||0
342185|NCT00561925|825781|P5|STARTED|Open-Label Extension Period||378
342186|NCT00561925|825782|P4|STARTED|Open-Label Extension Period||358
342187|NCT00561925|825783|P3|STARTED|Open-Label Extension Period||0
342188|NCT00561925|825784|P2|STARTED|Open-Label Extension Period||1
342189|NCT00561925|825785|P1|STARTED|Open-Label Extension Period||0
342190|NCT00561925|825781|P5|NOT COMPLETED|144-week Double-blind, Double-dummy||0
342191|NCT00561925|825782|P4|NOT COMPLETED|144-week Double-blind, Double-dummy||0
342192|NCT00561925|825783|P3|NOT COMPLETED|144-week Double-blind, Double-dummy||127
342193|NCT00561925|825784|P2|NOT COMPLETED|144-week Double-blind, Double-dummy||150
342194|NCT00561925|825785|P1|NOT COMPLETED|144-week Double-blind, Double-dummy||0
342195|NCT00561925|825781|P5|COMPLETED|144-week Double-blind, Double-dummy||0
342196|NCT00561925|825782|P4|COMPLETED|144-week Double-blind, Double-dummy||0
342197|NCT00561925|825783|P3|COMPLETED|144-week Double-blind, Double-dummy||378
342198|NCT00561925|825784|P2|COMPLETED|144-week Double-blind, Double-dummy||358
342199|NCT00561925|825785|P1|COMPLETED|144-week Double-blind, Double-dummy||0
342200|NCT00561925|825781|P5|STARTED|144-week Double-blind, Double-dummy||0
342201|NCT00561925|825782|P4|STARTED|144-week Double-blind, Double-dummy||0
342202|NCT00561925|825783|P3|STARTED|144-week Double-blind, Double-dummy||505
342203|NCT00561925|825784|P2|STARTED|144-week Double-blind, Double-dummy||508
342204|NCT00561925|825785|P1|STARTED|144-week Double-blind, Double-dummy||0
342205|NCT00561925|825781|P5|NOT COMPLETED|14 Day Lead-In Period||0
342206|NCT00561925|825782|P4|NOT COMPLETED|14 Day Lead-In Period||0
342207|NCT00561925|825783|P3|NOT COMPLETED|14 Day Lead-In Period||0
342208|NCT00561925|825784|P2|NOT COMPLETED|14 Day Lead-In Period||0
342209|NCT00561925|825785|P1|NOT COMPLETED|14 Day Lead-In Period||55
342210|NCT00561925|825781|P5|COMPLETED|14 Day Lead-In Period||0
342211|NCT00561925|825782|P4|COMPLETED|14 Day Lead-In Period||0
342212|NCT00561925|825783|P3|COMPLETED|14 Day Lead-In Period||0
342213|NCT00561925|825784|P2|COMPLETED|14 Day Lead-In Period||0
342214|NCT00561925|825785|P1|COMPLETED|14 Day Lead-In Period||1013
342215|NCT00561925|825781|P5|STARTED|14 Day Lead-In Period||0
342216|NCT00561925|825782|P4|STARTED|14 Day Lead-In Period||0
342217|NCT00561925|825783|P3|STARTED|14 Day Lead-In Period||0
342218|NCT00561925|825784|P2|STARTED|14 Day Lead-In Period||0
342219|NCT00561925|825785|P1|STARTED|14 Day Lead-In Period||1068
342220|NCT00561912|825834|P1|NOT COMPLETED|Overall Study||1
342221|NCT00561912|825834|P1|COMPLETED|Overall Study||1
342222|NCT00561912|825834|P1|STARTED|Overall Study||2
342223|NCT00561834|825838|P1|NOT COMPLETED|Overall Study||0
342224|NCT00561834|825838|P1|COMPLETED|Overall Study||2
342225|NCT00561834|825838|P1|STARTED|Overall Study||2
342226|NCT00561821|825846|P4|NOT COMPLETED|Overall Study||3
342227|NCT00561821|825847|P3|NOT COMPLETED|Overall Study||2
342228|NCT00561821|825848|P2|NOT COMPLETED|Overall Study||6
342229|NCT00561821|825849|P1|NOT COMPLETED|Overall Study||5
342230|NCT00561821|825846|P4|COMPLETED|Overall Study||133
342231|NCT00561821|825847|P3|COMPLETED|Overall Study||132
342232|NCT00561821|825848|P2|COMPLETED|Overall Study||130
342233|NCT00561821|825849|P1|COMPLETED|Overall Study||127
342234|NCT00561821|825846|P4|Treated|Overall Study||136
342235|NCT00561821|825847|P3|Treated|Overall Study||133
342236|NCT00561821|825848|P2|Treated|Overall Study||136
342237|NCT00561821|825849|P1|Treated|Overall Study||132
342238|NCT00561821|825846|P4|STARTED|Overall Study||136
342239|NCT00561821|825847|P3|STARTED|Overall Study||134
342240|NCT00561821|825848|P2|STARTED|Overall Study||136
342241|NCT00561821|825849|P1|STARTED|Overall Study||132
342242|NCT00561795|825925|P4|NOT COMPLETED|Overall Study||0
342243|NCT00561795|825926|P3|NOT COMPLETED|Overall Study||0
342244|NCT00561795|825927|P2|NOT COMPLETED|Overall Study||6
342245|NCT00561795|825928|P1|NOT COMPLETED|Overall Study||4
342246|NCT00561795|825925|P4|COMPLETED|Overall Study||0
342247|NCT00561795|825926|P3|COMPLETED|Overall Study||0
342248|NCT00561795|825927|P2|COMPLETED|Overall Study||0
342249|NCT00561795|825928|P1|COMPLETED|Overall Study||2
342250|NCT00561795|825925|P4|STARTED|Overall Study||0
342251|NCT00561795|825926|P3|STARTED|Overall Study||0
342252|NCT00561795|825927|P2|STARTED|Overall Study||6
342253|NCT00561795|825928|P1|STARTED|Overall Study||6
342254|NCT00561730|825948|P1|NOT COMPLETED|Overall Study||9
342255|NCT00561730|825948|P1|COMPLETED|Overall Study||1986
342256|NCT00561730|825948|P1|STARTED|Overall Study||1995
342257|NCT00561678|825964|P2|NOT COMPLETED|Overall Study||6
342258|NCT00561678|825965|P1|NOT COMPLETED|Overall Study||8
342259|NCT00561678|825964|P2|COMPLETED|Overall Study||201
342260|NCT00561678|825965|P1|COMPLETED|Overall Study||189
342261|NCT00561678|825964|P2|STARTED|Overall Study||207
342262|NCT00561678|825965|P1|STARTED|Overall Study||197
342263|NCT00561652|825983|P2|NOT COMPLETED|Overall Study||1
342264|NCT00561652|825984|P1|NOT COMPLETED|Overall Study||0
342265|NCT00561652|825983|P2|COMPLETED|Overall Study||19
342266|NCT00561652|825984|P1|COMPLETED|Overall Study||10
342267|NCT00561652|825983|P2|STARTED|Overall Study||20
342268|NCT00561652|825984|P1|STARTED|Overall Study||10
342269|NCT00561600|826004|P2|NOT COMPLETED|Overall Study||16
342270|NCT00561600|826005|P1|NOT COMPLETED|Overall Study||18
342271|NCT00561600|826004|P2|COMPLETED|Overall Study||119
342272|NCT00561600|826005|P1|COMPLETED|Overall Study||112
342273|NCT00561600|826004|P2|STARTED|Overall Study||135
342274|NCT00561600|826005|P1|STARTED|Overall Study||130
342275|NCT00561574|826067|P2|NOT COMPLETED|Overall Study||58
342276|NCT00561574|826068|P1|NOT COMPLETED|Overall Study||48
342277|NCT00561574|826067|P2|COMPLETED|Overall Study||73
342278|NCT00561574|826068|P1|COMPLETED|Overall Study||80
342279|NCT00561574|826067|P2|STARTED|Overall Study||131
342280|NCT00561574|826068|P1|STARTED|Overall Study||128
342281|NCT00561470|826094|P2|NOT COMPLETED|Overall Study||612
342282|NCT00561470|826095|P1|NOT COMPLETED|Overall Study||614
342283|NCT00561470|826094|P2|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
342284|NCT00561470|826095|P1|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
342285|NCT00561470|826094|P2|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|14
342286|NCT00561470|826095|P1|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|11
342287|NCT00561470|826094|P2|SAFETY POPULATION|Overall Study|Treated participants including 4 from Placebo/FOLFIRI who received at least 1 dose of Aflibercept|611
342288|NCT00561470|826095|P1|SAFETY POPULATION|Overall Study|Treated participants excluding 4 who received at least 1 dose of Aflibercept|605
342289|NCT00561470|826094|P2|TREATED|Overall Study||607
342290|NCT00561470|826095|P1|TREATED|Overall Study||609
342291|NCT00561470|826094|P2|STARTED|Overall Study||612
342292|NCT00561470|826095|P1|STARTED|Overall Study||614
342293|NCT00561457|826109|P1|NOT COMPLETED|Overall Study||24
342294|NCT00561457|826109|P1|COMPLETED|Overall Study||110
342295|NCT00561457|826109|P1|STARTED|Overall Study||134
342296|NCT00561431|826115|P2|NOT COMPLETED|Overall Study||0
342297|NCT00561431|826116|P1|NOT COMPLETED|Overall Study||0
342298|NCT00561431|826115|P2|COMPLETED|Overall Study||100
342299|NCT00561431|826116|P1|COMPLETED|Overall Study||100
342300|NCT00561431|826115|P2|STARTED|Overall Study||100
342301|NCT00561431|826116|P1|STARTED|Overall Study||100
342302|NCT00561418|826124|P1|NOT COMPLETED|Overall Study||0
342303|NCT00561418|826124|P1|COMPLETED|Overall Study||23
342304|NCT00561418|826124|P1|STARTED|Overall Study||23
342305|NCT00561392|826131|P1|NOT COMPLETED|Overall Study||53
342306|NCT00561392|826131|P1|COMPLETED|Overall Study||155
342307|NCT00561392|826131|P1|STARTED|Overall Study||208
342308|NCT00561353|826153|P10|NOT COMPLETED|Overall Study||2
342309|NCT00561353|826154|P9|NOT COMPLETED|Overall Study||7
342310|NCT00561353|826155|P8|NOT COMPLETED|Overall Study||4
342311|NCT00561353|826156|P7|NOT COMPLETED|Overall Study||6
342312|NCT00561353|826157|P6|NOT COMPLETED|Overall Study||6
342313|NCT00561353|826158|P5|NOT COMPLETED|Overall Study||1
342314|NCT00561353|826159|P4|NOT COMPLETED|Overall Study||6
342315|NCT00561353|826160|P3|NOT COMPLETED|Overall Study||3
342316|NCT00561353|826161|P2|NOT COMPLETED|Overall Study||3
342317|NCT00561353|826162|P1|NOT COMPLETED|Overall Study||5
342318|NCT00561353|826153|P10|COMPLETED|Overall Study||3
342319|NCT00561353|826154|P9|COMPLETED|Overall Study||2
342320|NCT00561353|826155|P8|COMPLETED|Overall Study||6
342321|NCT00561353|826156|P7|COMPLETED|Overall Study||3
342322|NCT00561353|826157|P6|COMPLETED|Overall Study||3
342323|NCT00561353|826158|P5|COMPLETED|Overall Study||5
342324|NCT00561353|826159|P4|COMPLETED|Overall Study||12
342325|NCT00561353|826160|P3|COMPLETED|Overall Study||10
342326|NCT00561353|826161|P2|COMPLETED|Overall Study||16
342327|NCT00561353|826162|P1|COMPLETED|Overall Study||13
342328|NCT00561353|826153|P10|STARTED|Overall Study||5
342329|NCT00561353|826154|P9|STARTED|Overall Study||9
342330|NCT00561353|826155|P8|STARTED|Overall Study||10
342331|NCT00561353|826156|P7|STARTED|Overall Study||9
342332|NCT00561353|826157|P6|STARTED|Overall Study||9
342333|NCT00561353|826158|P5|STARTED|Overall Study||6
342334|NCT00561353|826159|P4|STARTED|Overall Study||18
342335|NCT00561353|826160|P3|STARTED|Overall Study||13
342336|NCT00561353|826161|P2|STARTED|Overall Study||19
342337|NCT00561353|826162|P1|STARTED|Overall Study||18
342338|NCT00561340|826317|P2|NOT COMPLETED|Overall Study||0
342339|NCT00561340|826318|P1|NOT COMPLETED|Overall Study||6
342340|NCT00561340|826317|P2|COMPLETED|Overall Study||16
342341|NCT00561340|826318|P1|COMPLETED|Overall Study||7
342342|NCT00561340|826317|P2|STARTED|Overall Study||16
342343|NCT00561340|826318|P1|STARTED|Overall Study||13
342344|NCT00561145|826328|P2|NOT COMPLETED|Overall Study||0
342345|NCT00561145|826329|P1|NOT COMPLETED|Overall Study||0
342346|NCT00561145|826328|P2|COMPLETED|Overall Study||17
342347|NCT00561145|826329|P1|COMPLETED|Overall Study||15
342348|NCT00561145|826328|P2|STARTED|Overall Study||17
342349|NCT00561145|826329|P1|STARTED|Overall Study||15
342350|NCT00561080|826338|P3|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
342351|NCT00561080|826339|P2|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
342352|NCT00561080|826340|P1|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
342353|NCT00561080|826338|P3|COMPLETED|36 Month Post Last Dose Follow-up||0
342354|NCT00561080|826339|P2|COMPLETED|36 Month Post Last Dose Follow-up||0
342355|NCT00561080|826340|P1|COMPLETED|36 Month Post Last Dose Follow-up||0
342356|NCT00561080|826338|P3|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
342357|NCT00561080|826339|P2|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
342358|NCT00561080|826340|P1|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
342359|NCT00561080|826338|P3|NOT COMPLETED|24-month Post Last Dose Follow-up||0
342360|NCT00561080|826339|P2|NOT COMPLETED|24-month Post Last Dose Follow-up||0
342361|NCT00561080|826340|P1|NOT COMPLETED|24-month Post Last Dose Follow-up||0
342362|NCT00561080|826338|P3|COMPLETED|24-month Post Last Dose Follow-up||0
342363|NCT00561080|826339|P2|COMPLETED|24-month Post Last Dose Follow-up||0
342364|NCT00561080|826340|P1|COMPLETED|24-month Post Last Dose Follow-up||0
342365|NCT00561080|826338|P3|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
342366|NCT00561080|826339|P2|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
342367|NCT00561080|826340|P1|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
342368|NCT00561080|826338|P3|NOT COMPLETED|12-month Post Last Dose Follow-up||10
342369|NCT00561080|826339|P2|NOT COMPLETED|12-month Post Last Dose Follow-up||9
342370|NCT00561080|826340|P1|NOT COMPLETED|12-month Post Last Dose Follow-up||7
342371|NCT00561080|826338|P3|COMPLETED|12-month Post Last Dose Follow-up||215
342372|NCT00561080|826339|P2|COMPLETED|12-month Post Last Dose Follow-up||220
342373|NCT00561080|826340|P1|COMPLETED|12-month Post Last Dose Follow-up||243
342374|NCT00561080|826338|P3|STARTED|12-month Post Last Dose Follow-up||225
342375|NCT00561080|826339|P2|STARTED|12-month Post Last Dose Follow-up||229
342376|NCT00561080|826340|P1|STARTED|12-month Post Last Dose Follow-up||250
342377|NCT00561080|826338|P3|NOT COMPLETED|Vaccination Period (up to Month 4)||26
342378|NCT00561080|826339|P2|NOT COMPLETED|Vaccination Period (up to Month 4)||26
342379|NCT00561080|826340|P1|NOT COMPLETED|Vaccination Period (up to Month 4)||3
342380|NCT00561080|826338|P3|COMPLETED|Vaccination Period (up to Month 4)||225
342381|NCT00561080|826339|P2|COMPLETED|Vaccination Period (up to Month 4)||229
342382|NCT00561080|826340|P1|COMPLETED|Vaccination Period (up to Month 4)||250
342383|NCT00561080|826338|P3|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||250
342384|NCT00561080|826339|P2|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||254
342385|NCT00561080|826340|P1|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||253
342386|NCT00561080|826338|P3|STARTED|Vaccination Period (up to Month 4)||251
342387|NCT00561080|826339|P2|STARTED|Vaccination Period (up to Month 4)||255
342388|NCT00561080|826340|P1|STARTED|Vaccination Period (up to Month 4)||253
342389|NCT00561015|826417|P6|NOT COMPLETED|Overall Study||3
342390|NCT00561015|826418|P5|NOT COMPLETED|Overall Study||1
342391|NCT00561015|826419|P4|NOT COMPLETED|Overall Study||1
342392|NCT00561015|826420|P3|NOT COMPLETED|Overall Study||0
342393|NCT00561015|826421|P2|NOT COMPLETED|Overall Study||0
342394|NCT00561015|826422|P1|NOT COMPLETED|Overall Study||4
342395|NCT00561015|826417|P6|COMPLETED|Overall Study||6
342396|NCT00561015|826418|P5|COMPLETED|Overall Study||8
342397|NCT00561015|826419|P4|COMPLETED|Overall Study||7
342398|NCT00561015|826420|P3|COMPLETED|Overall Study||9
342399|NCT00561015|826421|P2|COMPLETED|Overall Study||5
342400|NCT00561015|826422|P1|COMPLETED|Overall Study||5
342401|NCT00561015|826417|P6|STARTED|Overall Study||9
342402|NCT00561015|826418|P5|STARTED|Overall Study||9
342403|NCT00561015|826419|P4|STARTED|Overall Study||8
342404|NCT00561015|826420|P3|STARTED|Overall Study||9
342405|NCT00561015|826421|P2|STARTED|Overall Study||5
342406|NCT00561015|826422|P1|STARTED|Overall Study||9
342407|NCT00561002|826498|P2|NOT COMPLETED|Overall Study||0
342408|NCT00561002|826499|P1|NOT COMPLETED|Overall Study||0
342409|NCT00561002|826498|P2|COMPLETED|Overall Study||9
342410|NCT00561002|826499|P1|COMPLETED|Overall Study||23
342411|NCT00561002|826498|P2|STARTED|Overall Study||9
342412|NCT00561002|826499|P1|STARTED|Overall Study||23
342413|NCT00560950|826513|P2|NOT COMPLETED|Overall Study||0
342414|NCT00560950|826514|P1|NOT COMPLETED|Overall Study||1
342415|NCT00560950|826513|P2|COMPLETED|Overall Study||71
342416|NCT00560950|826514|P1|COMPLETED|Overall Study||71
342417|NCT00560950|826513|P2|STARTED|Overall Study||71
342418|NCT00560950|826514|P1|STARTED|Overall Study||72
342419|NCT00560937|826552|P2|NOT COMPLETED|Overall Study||2
342420|NCT00560937|826553|P1|NOT COMPLETED|Overall Study||1
342421|NCT00560937|826552|P2|COMPLETED|Overall Study||9
342422|NCT00560937|826553|P1|COMPLETED|Overall Study|One participant was withdrawn after 6 weeks and data were carried forward|9
342423|NCT00560937|826552|P2|STARTED|Overall Study||11
342424|NCT00560937|826553|P1|STARTED|Overall Study||10
342425|NCT00560885|826569|P1|NOT COMPLETED|Overall Study||8
342426|NCT00560885|826569|P1|COMPLETED|Overall Study||47
342427|NCT00560885|826569|P1|2 Year Follow-up|Overall Study||47
342428|NCT00560885|826569|P1|12 Month Follow-up|Overall Study|48 pts available for 12 month follow-up, 46 pts assessed|48
342429|NCT00560885|826569|P1|6 Month Follow-up|Overall Study|50 pts available for 6 month follow-up, 50 pts assessed|50
342430|NCT00560885|826569|P1|3 Month Follow-up|Overall Study|51 pts available for 3 month follow-up, 48 pts assessed.|51
342431|NCT00560885|826569|P1|30 Day Follow-up|Overall Study|53 pts available for 30 day follow-up, 52 pts assessed|53
342432|NCT00560885|826569|P1|STARTED|Overall Study||55
342433|NCT00560859|826578|P2|NOT COMPLETED|Overall Study||24
342434|NCT00560859|826579|P1|NOT COMPLETED|Overall Study||32
342435|NCT00560859|826578|P2|COMPLETED|Overall Study||203
342436|NCT00560859|826579|P1|COMPLETED|Overall Study||194
342437|NCT00560859|826578|P2|STARTED|Overall Study||227
342438|NCT00560859|826579|P1|STARTED|Overall Study||226
342439|NCT00560833|826594|P5|NOT COMPLETED|Overall Study||42
342440|NCT00560833|826595|P4|NOT COMPLETED|Overall Study||31
342441|NCT00560833|826596|P3|NOT COMPLETED|Overall Study||39
342442|NCT00560833|826597|P2|NOT COMPLETED|Overall Study||26
342443|NCT00560833|826598|P1|NOT COMPLETED|Overall Study||44
342444|NCT00560833|826594|P5|COMPLETED|Overall Study||114
342445|NCT00560833|826595|P4|COMPLETED|Overall Study||124
342446|NCT00560833|826596|P3|COMPLETED|Overall Study||121
342447|NCT00560833|826597|P2|COMPLETED|Overall Study||129
342448|NCT00560833|826598|P1|COMPLETED|Overall Study||273
342449|NCT00560833|826594|P5|Treated|Overall Study|One participant was randomized but not treated|155
342450|NCT00560833|826595|P4|Treated|Overall Study||155
342451|NCT00560833|826596|P3|Treated|Overall Study||160
342452|NCT00560833|826597|P2|Treated|Overall Study|One participant was randomized but not treated|154
342453|NCT00560833|826598|P1|Treated|Overall Study|One participant was not randomized but was treated with placebo|317
342454|NCT00560833|826594|P5|STARTED|Overall Study||156
342455|NCT00560833|826595|P4|STARTED|Overall Study||155
342456|NCT00560833|826596|P3|STARTED|Overall Study||160
342457|NCT00560833|826597|P2|STARTED|Overall Study||155
342458|NCT00560833|826598|P1|STARTED|Overall Study||317
342459|NCT00560794|826630|P1|NOT COMPLETED|Overall Study||11
342460|NCT00560794|826630|P1|COMPLETED|Overall Study||10
342461|NCT00560794|826630|P1|Completed 1 Treatment Cycle|Overall Study||20
342462|NCT00560794|826630|P1|STARTED|Overall Study||21
342463|NCT00560755|826647|P1|NOT COMPLETED|Overall Study||60
342464|NCT00560755|826647|P1|COMPLETED|Overall Study||3328
342465|NCT00560755|826647|P1|ProQuad® Dose 1 and Dose 2|Overall Study||3346
342466|NCT00560755|826647|P1|STARTED|Overall Study|Vaccinated (at least one ProQuad® dose)|3388
342467|NCT00560703|826668|P2|NOT COMPLETED|Overall Study||6
342468|NCT00560703|826669|P1|NOT COMPLETED|Overall Study||0
342469|NCT00560703|826668|P2|COMPLETED|Overall Study||18
342470|NCT00560703|826669|P1|COMPLETED|Overall Study||46
342471|NCT00560703|826668|P2|STARTED|Overall Study||24
342472|NCT00560703|826669|P1|STARTED|Overall Study||46
342473|NCT00560612|826679|P2|NOT COMPLETED|Overall Study||0
342474|NCT00560612|826680|P1|NOT COMPLETED|Overall Study||0
342475|NCT00560612|826679|P2|COMPLETED|Overall Study||7
342476|NCT00560612|826680|P1|COMPLETED|Overall Study||5
342477|NCT00560612|826679|P2|STARTED|Overall Study||7
342478|NCT00560612|826680|P1|STARTED|Overall Study||5
342479|NCT00560573|826692|P6|NOT COMPLETED|Overall Study||13
342480|NCT00560573|826693|P5|NOT COMPLETED|Overall Study||7
342481|NCT00560573|826694|P4|NOT COMPLETED|Overall Study||10
342482|NCT00560573|826695|P3|NOT COMPLETED|Overall Study||6
342483|NCT00560573|826696|P2|NOT COMPLETED|Overall Study||3
342484|NCT00560573|826697|P1|NOT COMPLETED|Overall Study||6
342485|NCT00560573|826692|P6|COMPLETED|Overall Study||0
342486|NCT00560573|826693|P5|COMPLETED|Overall Study||1
342487|NCT00560573|826694|P4|COMPLETED|Overall Study||0
342488|NCT00560573|826695|P3|COMPLETED|Overall Study||0
342489|NCT00560573|826696|P2|COMPLETED|Overall Study||0
342490|NCT00560573|826697|P1|COMPLETED|Overall Study||0
342491|NCT00560573|826692|P6|Treated|Overall Study||13
342492|NCT00560573|826693|P5|Treated|Overall Study||7
342493|NCT00560573|826694|P4|Treated|Overall Study||10
342494|NCT00560573|826695|P3|Treated|Overall Study||6
342495|NCT00560573|826696|P2|Treated|Overall Study||3
342496|NCT00560573|826697|P1|Treated|Overall Study||6
342497|NCT00560573|826692|P6|STARTED|Overall Study||13
342498|NCT00560573|826693|P5|STARTED|Overall Study||8
342499|NCT00560573|826694|P4|STARTED|Overall Study||10
342500|NCT00560573|826695|P3|STARTED|Overall Study||6
342501|NCT00560573|826696|P2|STARTED|Overall Study||3
342502|NCT00560573|826697|P1|STARTED|Overall Study||6
342503|NCT00560560|826751|P2|NOT COMPLETED|Overall Study||83
342504|NCT00560560|826752|P1|NOT COMPLETED|Overall Study||85
342505|NCT00560560|826751|P2|COMPLETED|Overall Study||0
342506|NCT00560560|826752|P1|COMPLETED|Overall Study||0
342507|NCT00560560|826751|P2|STARTED|Overall Study||83
342508|NCT00560560|826752|P1|STARTED|Overall Study||85
342509|NCT00560508|826774|P2|NOT COMPLETED|52-week Open-label Period Pramipexole ER||11
342510|NCT00560508|826775|P1|NOT COMPLETED|52-week Open-label Period Pramipexole ER||8
342511|NCT00560508|826774|P2|COMPLETED|52-week Open-label Period Pramipexole ER||42
342512|NCT00560508|826775|P1|COMPLETED|52-week Open-label Period Pramipexole ER||43
342513|NCT00560508|826774|P2|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|53
342514|NCT00560508|826775|P1|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|51
342515|NCT00560508|826774|P2|NOT COMPLETED|12 Week Double-blind Period||3
342516|NCT00560508|826775|P1|NOT COMPLETED|12 Week Double-blind Period||5
342517|NCT00560508|826774|P2|COMPLETED|12 Week Double-blind Period||53
342518|NCT00560508|826775|P1|COMPLETED|12 Week Double-blind Period||51
342519|NCT00560508|826774|P2|STARTED|12 Week Double-blind Period||56
342520|NCT00560508|826775|P1|STARTED|12 Week Double-blind Period||56
342521|NCT00560417|826834|P2|NOT COMPLETED|Overall Study||17
342522|NCT00560417|826835|P1|NOT COMPLETED|Overall Study||17
342523|NCT00560417|826834|P2|COMPLETED|Overall Study||151
342524|NCT00560417|826835|P1|COMPLETED|Overall Study||154
342525|NCT00560417|826834|P2|Intention to Treat (ITT) Population|Overall Study||167
342526|NCT00560417|826835|P1|Intention to Treat (ITT) Population|Overall Study||170
342527|NCT00560417|826834|P2|STARTED|Overall Study||168
342528|NCT00560417|826835|P1|STARTED|Overall Study||171
342529|NCT00560404|826863|P2|NOT COMPLETED|Overall Study||21
342530|NCT00560404|826864|P1|NOT COMPLETED|Overall Study||36
342531|NCT00560404|826863|P2|COMPLETED|Overall Study||100
342532|NCT00560404|826864|P1|COMPLETED|Overall Study||76
342533|NCT00560404|826863|P2|STARTED|Overall Study||121
342534|NCT00560404|826864|P1|STARTED|Overall Study||112
342535|NCT00560391|826911|P5|NOT COMPLETED|Overall Study||2
342536|NCT00560391|826912|P4|NOT COMPLETED|Overall Study||1
342537|NCT00560391|826913|P3|NOT COMPLETED|Overall Study||0
342538|NCT00560391|826914|P2|NOT COMPLETED|Overall Study||0
342539|NCT00560391|826915|P1|NOT COMPLETED|Overall Study||0
342540|NCT00560391|826911|P5|COMPLETED|Overall Study|Completed=offtreatment;Disease progression-6;Study drug toxicity-7; Unrelated AE-1,Subject request-1|15
342541|NCT00560391|826912|P4|COMPLETED|Overall Study|Completed=off treatment; Disease progression-2; Unrelated AE 1 and Subject request 2|5
342542|NCT00560391|826913|P3|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Maximum clinical benefit-1; Unrelated AE-1|3
342543|NCT00560391|826914|P2|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Death-1; Unrelated AE-1|3
342544|NCT00560391|826915|P1|COMPLETED|Overall Study|Completed=off treatment;Disease progression-1;Death-1;Max. clinical benefit-2;Study drug toxicity-2|6
342545|NCT00560391|826911|P5|STARTED|Overall Study|Participants who received treatment|17
342546|NCT00560391|826912|P4|STARTED|Overall Study|Participants who received treatment|6
342547|NCT00560391|826913|P3|STARTED|Overall Study|Participants who received treatment|3
342548|NCT00560391|826914|P2|STARTED|Overall Study|Participants who received treatment|3
342549|NCT00560391|826915|P1|STARTED|Overall Study|Participants who received treatment|6
342550|NCT00560352|826971|P3|NOT COMPLETED|Overall Study||4
342551|NCT00560352|826972|P2|NOT COMPLETED|Overall Study||3
342552|NCT00560352|826973|P1|NOT COMPLETED|Overall Study||7
342553|NCT00560352|826971|P3|COMPLETED|Overall Study||0
342554|NCT00560352|826972|P2|COMPLETED|Overall Study||0
342555|NCT00560352|826973|P1|COMPLETED|Overall Study||0
342556|NCT00560352|826971|P3|STARTED|Overall Study||4
342557|NCT00560352|826972|P2|STARTED|Overall Study||3
342558|NCT00560352|826973|P1|STARTED|Overall Study||7
342559|NCT00560313|826990|P1|NOT COMPLETED|Overall Study||6
342560|NCT00560313|826990|P1|COMPLETED|Overall Study||48
342561|NCT00560313|826990|P1|STARTED|Overall Study||54
342562|NCT00560235|827017|P3|NOT COMPLETED|Phase 2||97
342563|NCT00560235|827018|P2|NOT COMPLETED|Phase 2||0
342564|NCT00560235|827019|P1|NOT COMPLETED|Phase 2||0
342565|NCT00560235|827017|P3|COMPLETED|Phase 2||10
342566|NCT00560235|827018|P2|COMPLETED|Phase 2||0
342567|NCT00560235|827019|P1|COMPLETED|Phase 2||0
342568|NCT00560235|827017|P3|STARTED|Phase 2||107
342569|NCT00560235|827018|P2|STARTED|Phase 2||0
342570|NCT00560235|827019|P1|STARTED|Phase 2||0
342571|NCT00560235|827017|P3|NOT COMPLETED|Phase 1B||0
342572|NCT00560235|827018|P2|NOT COMPLETED|Phase 1B||19
342573|NCT00560235|827019|P1|NOT COMPLETED|Phase 1B||0
342574|NCT00560235|827017|P3|COMPLETED|Phase 1B||0
342575|NCT00560235|827018|P2|COMPLETED|Phase 1B||2
342576|NCT00560235|827019|P1|COMPLETED|Phase 1B||0
342577|NCT00560235|827017|P3|STARTED|Phase 1B||0
342578|NCT00560235|827018|P2|STARTED|Phase 1B||21
342579|NCT00560235|827019|P1|STARTED|Phase 1B||0
342580|NCT00560235|827017|P3|NOT COMPLETED|Phase 1||0
342581|NCT00560235|827018|P2|NOT COMPLETED|Phase 1||0
342582|NCT00560235|827019|P1|NOT COMPLETED|Phase 1||8
342583|NCT00560235|827017|P3|COMPLETED|Phase 1||0
342584|NCT00560235|827018|P2|COMPLETED|Phase 1||0
342585|NCT00560235|827019|P1|COMPLETED|Phase 1||2
342586|NCT00560235|827017|P3|STARTED|Phase 1||0
342587|NCT00560235|827018|P2|STARTED|Phase 1||0
342588|NCT00560235|827019|P1|STARTED|Phase 1||10
342589|NCT00560105|827050|P2|NOT COMPLETED|Overall Study||2
342590|NCT00560105|827051|P1|NOT COMPLETED|Overall Study||1
342591|NCT00560105|827050|P2|COMPLETED|Overall Study||18
342592|NCT00560105|827051|P1|COMPLETED|Overall Study||19
342593|NCT00560105|827050|P2|STARTED|Overall Study||20
342594|NCT00560105|827051|P1|STARTED|Overall Study||20
342595|NCT00560066|827065|P2|NOT COMPLETED|Overall Study||22
342596|NCT00560066|827066|P1|NOT COMPLETED|Overall Study||6
342597|NCT00560066|827065|P2|COMPLETED|Overall Study||980
342598|NCT00560066|827066|P1|COMPLETED|Overall Study||390
342599|NCT00560066|827065|P2|STARTED|Overall Study||1002
342600|NCT00560066|827066|P1|STARTED|Overall Study||396
342601|NCT00559988|827098|P2|NOT COMPLETED|Overall Study||352
342602|NCT00559988|827099|P1|NOT COMPLETED|Overall Study||351
342603|NCT00559988|827098|P2|COMPLETED|Overall Study||1009
342604|NCT00559988|827099|P1|COMPLETED|Overall Study||1006
342605|NCT00559988|827098|P2|STARTED|Overall Study||1361
342606|NCT00559988|827099|P1|STARTED|Overall Study||1357
342607|NCT00559962|827129|P8|NOT COMPLETED|Overall Study||4
342608|NCT00559962|827130|P7|NOT COMPLETED|Overall Study||5
342609|NCT00559962|827131|P6|NOT COMPLETED|Overall Study||5
342610|NCT00559962|827132|P5|NOT COMPLETED|Overall Study||14
342611|NCT00559962|827133|P4|NOT COMPLETED|Overall Study||5
342612|NCT00559962|827134|P3|NOT COMPLETED|Overall Study||10
342613|NCT00559962|827135|P2|NOT COMPLETED|Overall Study||9
342614|NCT00559962|827136|P1|NOT COMPLETED|Overall Study||2
342615|NCT00559962|827129|P8|COMPLETED|Overall Study||25
342616|NCT00559962|827130|P7|COMPLETED|Overall Study||28
342617|NCT00559962|827131|P6|COMPLETED|Overall Study||23
342618|NCT00559962|827132|P5|COMPLETED|Overall Study||21
342619|NCT00559962|827133|P4|COMPLETED|Overall Study||29
342620|NCT00559962|827134|P3|COMPLETED|Overall Study||24
342621|NCT00559962|827135|P2|COMPLETED|Overall Study||25
342622|NCT00559962|827136|P1|COMPLETED|Overall Study||31
342623|NCT00559962|827129|P8|STARTED|Overall Study||29
342624|NCT00559962|827130|P7|STARTED|Overall Study||33
342625|NCT00559962|827131|P6|STARTED|Overall Study||28
342626|NCT00559962|827132|P5|STARTED|Overall Study||35
342627|NCT00559962|827133|P4|STARTED|Overall Study||34
342628|NCT00559962|827134|P3|STARTED|Overall Study||34
342629|NCT00559962|827135|P2|STARTED|Overall Study||34
342630|NCT00559962|827136|P1|STARTED|Overall Study||33
342631|NCT00559949|827156|P1|NOT COMPLETED|Overall Study||7
342632|NCT00559949|827156|P1|COMPLETED|Overall Study||32
342633|NCT00559949|827156|P1|STARTED|Overall Study||39
342634|NCT00559936|827163|P1|NOT COMPLETED|Overall Study||4
342635|NCT00559936|827163|P1|COMPLETED|Overall Study||20
342636|NCT00559936|827163|P1|STARTED|Overall Study||24
342637|NCT00559897|827168|P1|NOT COMPLETED|Overall Study||0
342638|NCT00559897|827168|P1|COMPLETED|Overall Study||6
342639|NCT00559897|827168|P1|STARTED|Overall Study||6
342640|NCT00559845|827172|P1|NOT COMPLETED|Overall Study||7
342641|NCT00559845|827172|P1|COMPLETED|Overall Study||49
342642|NCT00559845|827172|P1|STARTED|Overall Study||56
342643|NCT00559754|827181|P1|NOT COMPLETED|Overall Study||11
342644|NCT00559754|827181|P1|COMPLETED|Overall Study||61
342645|NCT00559754|827181|P1|STARTED|Overall Study||72
342646|NCT00559637|827205|P1|NOT COMPLETED|Overall Study||54
342647|NCT00559637|827205|P1|COMPLETED|Overall Study||130
342648|NCT00559637|827205|P1|STARTED|Overall Study||184
342649|NCT00559585|827218|P2|NOT COMPLETED|Open Label LT Period Main + Sub-Study||0
342650|NCT00559585|827219|P1|NOT COMPLETED|Open Label LT Period Main + Sub-Study||428
342651|NCT00559585|827218|P2|COMPLETED|Open Label LT Period Main + Sub-Study||0
342652|NCT00559585|827219|P1|COMPLETED|Open Label LT Period Main + Sub-Study||945
342653|NCT00559585|827218|P2|STARTED|Open Label LT Period Main + Sub-Study|IV administration was discontinued and abatacept was only administered SC during LT Period.|0
342654|NCT00559585|827219|P1|STARTED|Open Label LT Period Main + Sub-Study|1373 includes 15 participants from ST Period Sub-Study who rolled over into LT Period (6 SC + 9 IV).|1373
342655|NCT00559585|827218|P2|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
342656|NCT00559585|827219|P1|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
342657|NCT00559585|827218|P2|COMPLETED|Anti-TNF Sub-Study in ST Period||9
342658|NCT00559585|827219|P1|COMPLETED|Anti-TNF Sub-Study in ST Period||7
342659|NCT00559585|827218|P2|STARTED|Anti-TNF Sub-Study in ST Period|9 completed Sub-Study ST Period and 9 chose to over into the LT Period.|10
342660|NCT00559585|827219|P1|STARTED|Anti-TNF Sub-Study in ST Period|7 completed Sub-Study ST period and 6 chose to roll over into LT Period.|8
342661|NCT00559585|827218|P2|NOT COMPLETED|Double Blind ST Period Main Study||45
342662|NCT00559585|827219|P1|NOT COMPLETED|Double Blind ST Period Main Study||43
342663|NCT00559585|827218|P2|COMPLETED|Double Blind ST Period Main Study||676
342664|NCT00559585|827219|P1|COMPLETED|Double Blind ST Period Main Study||693
342665|NCT00559585|827218|P2|STARTED|Double Blind ST Period Main Study|Randomized and treated|721
342666|NCT00559585|827219|P1|STARTED|Double Blind ST Period Main Study|Randomized and treated|736
342667|NCT00559507|827279|P1|NOT COMPLETED|Overall Study||3
342668|NCT00559507|827279|P1|COMPLETED|Overall Study||9
342669|NCT00559507|827279|P1|STARTED|Overall Study||12
342670|NCT00559468|827287|P2|NOT COMPLETED|Overall Study||1
342671|NCT00559468|827288|P1|NOT COMPLETED|Overall Study||0
342672|NCT00559468|827287|P2|COMPLETED|Overall Study||25
342673|NCT00559468|827288|P1|COMPLETED|Overall Study||26
342674|NCT00559468|827287|P2|Treated|Overall Study||25
342675|NCT00559468|827288|P1|Treated|Overall Study||26
342676|NCT00559468|827287|P2|STARTED|Overall Study||26
342677|NCT00559468|827288|P1|STARTED|Overall Study||26
342678|NCT00559377|827298|P1|NOT COMPLETED|Overall Study||9
342679|NCT00559377|827298|P1|COMPLETED|Overall Study||7
342680|NCT00559377|827298|P1|STARTED|Overall Study||16
342681|NCT00559364|827308|P2|NOT COMPLETED|Overall Study||0
342682|NCT00559364|827309|P1|NOT COMPLETED|Overall Study||1
342683|NCT00559364|827308|P2|COMPLETED|Overall Study||20
342684|NCT00559364|827309|P1|COMPLETED|Overall Study||29
342685|NCT00559364|827308|P2|STARTED|Overall Study||20
342686|NCT00559364|827309|P1|STARTED|Overall Study||30
342687|NCT00559273|827321|P2|NOT COMPLETED|Evaluation Period (8 Weeks)||5
342688|NCT00559273|827322|P1|NOT COMPLETED|Evaluation Period (8 Weeks)||3
342689|NCT00559273|827321|P2|COMPLETED|Evaluation Period (8 Weeks)||137
342690|NCT00559273|827322|P1|COMPLETED|Evaluation Period (8 Weeks)||141
342691|NCT00559273|827321|P2|STARTED|Evaluation Period (8 Weeks)||142
342692|NCT00559273|827322|P1|STARTED|Evaluation Period (8 Weeks)||144
342693|NCT00559273|827321|P2|NOT COMPLETED|Correction Period (20 Weeks)||12
342694|NCT00559273|827322|P1|NOT COMPLETED|Correction Period (20 Weeks)||9
342695|NCT00559273|827321|P2|COMPLETED|Correction Period (20 Weeks)||142
342696|NCT00559273|827322|P1|COMPLETED|Correction Period (20 Weeks)||144
342697|NCT00559273|827321|P2|Treated|Correction Period (20 Weeks)||154
342698|NCT00559273|827322|P1|Treated|Correction Period (20 Weeks)||151
342699|NCT00559273|827321|P2|STARTED|Correction Period (20 Weeks)||154
342700|NCT00559273|827322|P1|STARTED|Correction Period (20 Weeks)||153
342701|NCT00559104|827344|P2|NOT COMPLETED|Overall Study||0
342702|NCT00559104|827345|P1|NOT COMPLETED|Overall Study||9
342703|NCT00559104|827344|P2|COMPLETED|Overall Study||5
342704|NCT00559104|827345|P1|COMPLETED|Overall Study|Progression was the reason for off-treatment for 9 of 9 patients who went off of treatment.|46
342705|NCT00559104|827344|P2|STARTED|Overall Study||5
342706|NCT00559104|827345|P1|STARTED|Overall Study||55
342707|NCT00559013|827355|P1|NOT COMPLETED|Overall Study||0
342708|NCT00559013|827355|P1|COMPLETED|Overall Study||38
342709|NCT00559013|827355|P1|STARTED|Overall Study||38
342710|NCT00558896|827366|P7|NOT COMPLETED|Overall Study||24
342711|NCT00558896|827367|P6|NOT COMPLETED|Overall Study||52
342712|NCT00558896|827368|P5|NOT COMPLETED|Overall Study||23
342713|NCT00558896|827369|P4|NOT COMPLETED|Overall Study||12
342714|NCT00558896|827370|P3|NOT COMPLETED|Overall Study||5
342715|NCT00558896|827371|P2|NOT COMPLETED|Overall Study||7
342716|NCT00558896|827372|P1|NOT COMPLETED|Overall Study||21
342717|NCT00558896|827366|P7|COMPLETED|Overall Study||9
342718|NCT00558896|827367|P6|COMPLETED|Overall Study||68
342719|NCT00558896|827368|P5|COMPLETED|Overall Study||37
342720|NCT00558896|827369|P4|COMPLETED|Overall Study||23
342721|NCT00558896|827370|P3|COMPLETED|Overall Study||30
342722|NCT00558896|827371|P2|COMPLETED|Overall Study||27
342723|NCT00558896|827372|P1|COMPLETED|Overall Study||39
342724|NCT00558896|827366|P7|STARTED|Overall Study||33
342725|NCT00558896|827367|P6|STARTED|Overall Study||120
342726|NCT00558896|827368|P5|STARTED|Overall Study||60
342727|NCT00558896|827369|P4|STARTED|Overall Study||35
342728|NCT00558896|827370|P3|STARTED|Overall Study||35
342729|NCT00558896|827371|P2|STARTED|Overall Study||34
342730|NCT00558896|827372|P1|STARTED|Overall Study||60
342731|NCT00558870|827404|P2|NOT COMPLETED|Overall Study||0
342732|NCT00558870|827405|P1|NOT COMPLETED|Overall Study||0
342733|NCT00558870|827404|P2|COMPLETED|Overall Study||2
342734|NCT00558870|827405|P1|COMPLETED|Overall Study||2
342735|NCT00558870|827404|P2|STARTED|Overall Study||2
342736|NCT00558870|827405|P1|STARTED|Overall Study||2
342737|NCT00558844|827418|P5|NOT COMPLETED|Overall Study||1
342738|NCT00558844|827419|P4|NOT COMPLETED|Overall Study||0
342739|NCT00558844|827420|P3|NOT COMPLETED|Overall Study||1
342740|NCT00558844|827421|P2|NOT COMPLETED|Overall Study||0
342741|NCT00558844|827422|P1|NOT COMPLETED|Overall Study||3
342742|NCT00558844|827418|P5|COMPLETED|Overall Study||6
342743|NCT00558844|827419|P4|COMPLETED|Overall Study||5
342744|NCT00558844|827420|P3|COMPLETED|Overall Study||6
342745|NCT00558844|827421|P2|COMPLETED|Overall Study||7
342746|NCT00558844|827422|P1|COMPLETED|Overall Study||12
342747|NCT00558844|827418|P5|STARTED|Overall Study||7
342748|NCT00558844|827419|P4|STARTED|Overall Study||5
342749|NCT00558844|827420|P3|STARTED|Overall Study||7
342750|NCT00558844|827421|P2|STARTED|Overall Study||7
342751|NCT00558844|827422|P1|STARTED|Overall Study||15
342752|NCT00558831|827474|P1|NOT COMPLETED|Overall Study||1
342753|NCT00558831|827474|P1|COMPLETED|Overall Study||10
342754|NCT00558831|827474|P1|STARTED|Overall Study||11
342755|NCT00558792|827483|P3|NOT COMPLETED|Overall Study||0
342756|NCT00558792|827484|P2|NOT COMPLETED|Overall Study||0
342757|NCT00558792|827485|P1|NOT COMPLETED|Overall Study||0
342758|NCT00558792|827483|P3|COMPLETED|Overall Study||60
342759|NCT00558792|827484|P2|COMPLETED|Overall Study||63
342760|NCT00558792|827485|P1|COMPLETED|Overall Study||68
342761|NCT00558792|827483|P3|STARTED|Overall Study||60
342762|NCT00558792|827484|P2|STARTED|Overall Study||63
342763|NCT00558792|827485|P1|STARTED|Overall Study||68
342764|NCT00558753|827531|P2|NOT COMPLETED|Overall Study||7
342765|NCT00558753|827532|P1|NOT COMPLETED|Overall Study||5
342766|NCT00558753|827531|P2|COMPLETED|Overall Study||113
342767|NCT00558753|827532|P1|COMPLETED|Overall Study||115
342768|NCT00558753|827531|P2|STARTED|Overall Study||120
342769|NCT00558753|827532|P1|STARTED|Overall Study||120
342770|NCT00558701|827544|P2|NOT COMPLETED|Overall Study||4
342771|NCT00558701|827545|P1|NOT COMPLETED|Overall Study||1
342772|NCT00558701|827544|P2|COMPLETED|Overall Study||11
342773|NCT00558701|827545|P1|COMPLETED|Overall Study||14
342774|NCT00558701|827544|P2|STARTED|Overall Study||15
342775|NCT00558701|827545|P1|STARTED|Overall Study||15
342776|NCT00558636|827553|P2|NOT COMPLETED|Follow-up||7
342777|NCT00558636|827554|P1|NOT COMPLETED|Follow-up||12
342778|NCT00558636|827553|P2|COMPLETED|Follow-up|Study was prematurely terminated|0
342779|NCT00558636|827554|P1|COMPLETED|Follow-up|Study was prematurely terminated|0
342780|NCT00558636|827553|P2|STARTED|Follow-up|7 subjects entered Follow-up phase before they completed the treatment phase|7
342781|NCT00558636|827554|P1|STARTED|Follow-up|12 subjects entered Follow-up phase before they completed the treatment phase|12
342782|NCT00558636|827553|P2|NOT COMPLETED|Treatment||44
342783|NCT00558636|827554|P1|NOT COMPLETED|Treatment||47
342784|NCT00558636|827553|P2|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
342785|NCT00558636|827554|P1|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
342786|NCT00558636|827553|P2|Start of Maintenance Monotherapy|Treatment|Placebo taken as the single agent in the Maintenance Phase|2
342787|NCT00558636|827554|P1|Start of Maintenance Monotherapy|Treatment|Sorafenib taken as the single agent in the Maintenance Phase|2
342788|NCT00558636|827553|P2|STARTED|Treatment||44
342789|NCT00558636|827554|P1|STARTED|Treatment|up to 6 cycles of combination therapy|47
342790|NCT00558571|827576|P4|NOT COMPLETED|Overall Study||0
342791|NCT00558571|827577|P3|NOT COMPLETED|Overall Study||0
342792|NCT00558571|827578|P2|NOT COMPLETED|Overall Study||0
342793|NCT00558571|827579|P1|NOT COMPLETED|Overall Study||0
342794|NCT00558571|827576|P4|COMPLETED|Overall Study||30
342795|NCT00558571|827577|P3|COMPLETED|Overall Study||16
342796|NCT00558571|827578|P2|COMPLETED|Overall Study||16
342797|NCT00558571|827579|P1|COMPLETED|Overall Study||16
342798|NCT00558571|827576|P4|STARTED|Overall Study||30
342799|NCT00558571|827577|P3|STARTED|Overall Study||16
342800|NCT00558571|827578|P2|STARTED|Overall Study||16
342801|NCT00558571|827579|P1|STARTED|Overall Study||16
342802|NCT00558558|827654|P1|NOT COMPLETED|Overall Study||6
342803|NCT00558558|827654|P1|COMPLETED|Overall Study||0
342804|NCT00558558|827654|P1|STARTED|Overall Study||6
342805|NCT00558467|827660|P2|NOT COMPLETED|Overall Study||4
342806|NCT00558467|827661|P1|NOT COMPLETED|Overall Study||1
342807|NCT00558467|827660|P2|COMPLETED|Overall Study||39
342808|NCT00558467|827661|P1|COMPLETED|Overall Study||19
342809|NCT00558467|827660|P2|STARTED|Overall Study||43
342810|NCT00558467|827661|P1|STARTED|Overall Study||20
342811|NCT00558428|827721|P4|NOT COMPLETED|Overall Study||11
342812|NCT00558428|827722|P3|NOT COMPLETED|Overall Study||4
342813|NCT00558428|827723|P2|NOT COMPLETED|Overall Study||24
342814|NCT00558428|827724|P1|NOT COMPLETED|Overall Study||12
342815|NCT00558428|827721|P4|COMPLETED|Overall Study||266
342816|NCT00558428|827722|P3|COMPLETED|Overall Study||273
342817|NCT00558428|827723|P2|COMPLETED|Overall Study||252
342818|NCT00558428|827724|P1|COMPLETED|Overall Study||255
342819|NCT00558428|827721|P4|STARTED|Overall Study||277
342820|NCT00558428|827722|P3|STARTED|Overall Study||277
342821|NCT00558428|827723|P2|STARTED|Overall Study||276
342822|NCT00558428|827724|P1|STARTED|Overall Study||267
342823|NCT00558363|827764|P2|NOT COMPLETED|Overall Study||36
342824|NCT00558363|827765|P1|NOT COMPLETED|Overall Study||71
342825|NCT00558363|827764|P2|COMPLETED|Overall Study||111
342826|NCT00558363|827765|P1|COMPLETED|Overall Study||76
342827|NCT00558363|827764|P2|STARTED|Overall Study||147
342828|NCT00558363|827765|P1|STARTED|Overall Study||147
342829|NCT00558285|827820|P5|NOT COMPLETED|Overall Study||4
342830|NCT00558285|827821|P4|NOT COMPLETED|Overall Study||4
342831|NCT00558285|827822|P3|NOT COMPLETED|Overall Study||5
342832|NCT00558285|827823|P2|NOT COMPLETED|Overall Study||3
342833|NCT00558285|827824|P1|NOT COMPLETED|Overall Study||6
342834|NCT00558285|827820|P5|COMPLETED|Overall Study||49
342835|NCT00558285|827821|P4|COMPLETED|Overall Study||48
342836|NCT00558285|827822|P3|COMPLETED|Overall Study||46
342837|NCT00558285|827823|P2|COMPLETED|Overall Study||48
342838|NCT00558285|827824|P1|COMPLETED|Overall Study||44
342839|NCT00558285|827820|P5|Safety: Received Study Drug|Overall Study||53
342840|NCT00558285|827821|P4|Safety: Received Study Drug|Overall Study||51
342841|NCT00558285|827822|P3|Safety: Received Study Drug|Overall Study||51
342842|NCT00558285|827823|P2|Safety: Received Study Drug|Overall Study||51
342843|NCT00558285|827824|P1|Safety: Received Study Drug|Overall Study||49
342844|NCT00558285|827820|P5|STARTED|Overall Study||53
342845|NCT00558285|827821|P4|STARTED|Overall Study||52
342846|NCT00558285|827822|P3|STARTED|Overall Study||51
342847|NCT00558285|827823|P2|STARTED|Overall Study||51
342848|NCT00558285|827824|P1|STARTED|Overall Study||50
342849|NCT00558272|827868|P2|NOT COMPLETED|Overall Study||2
342850|NCT00558272|827869|P1|NOT COMPLETED|Overall Study||13
342851|NCT00558272|827868|P2|COMPLETED|Overall Study|4-week treatment period|68
342852|NCT00558272|827869|P1|COMPLETED|Overall Study|4-week treatment period|56
342853|NCT00558272|827868|P2|30 Days Follow-up|Overall Study|30 days after last dose|67
342854|NCT00558272|827869|P1|30 Days Follow-up|Overall Study|30 days after last dose|41
342855|NCT00558272|827868|P2|STARTED|Overall Study|Randomised|70
342856|NCT00558272|827869|P1|STARTED|Overall Study|Randomised|69
342857|NCT00558259|827909|P2|NOT COMPLETED|Overall Study||99
342858|NCT00558259|827910|P1|NOT COMPLETED|Overall Study||71
342859|NCT00558259|827909|P2|COMPLETED|Overall Study|Completed treatment.|563
342860|NCT00558259|827910|P1|COMPLETED|Overall Study|Completed treatment.|610
342861|NCT00558259|827909|P2|STARTED|Overall Study|Number who started treatment. There were 6 patients randomised to placebo and not treated.|662
342862|NCT00558259|827910|P1|STARTED|Overall Study|Number who started treatment. There were 4 patients randomised to Dabigatran and not treated.|681
342863|NCT00558246|827930|P1|NOT COMPLETED|Overall Study||0
342864|NCT00558246|827930|P1|COMPLETED|Overall Study||79
342865|NCT00558246|827930|P1|STARTED|Overall Study||79
342866|NCT00558103|827950|P6|NOT COMPLETED|Monotherapy Extension Phase||9
342867|NCT00558103|827951|P5|NOT COMPLETED|Monotherapy Extension Phase||0
342868|NCT00558103|827952|P4|NOT COMPLETED|Monotherapy Extension Phase||0
342869|NCT00558103|827953|P3|NOT COMPLETED|Monotherapy Extension Phase||0
342870|NCT00558103|827954|P2|NOT COMPLETED|Monotherapy Extension Phase||0
342871|NCT00558103|827955|P1|NOT COMPLETED|Monotherapy Extension Phase||0
342872|NCT00558103|827950|P6|COMPLETED|Monotherapy Extension Phase||0
342873|NCT00558103|827951|P5|COMPLETED|Monotherapy Extension Phase||0
342874|NCT00558103|827952|P4|COMPLETED|Monotherapy Extension Phase||0
342875|NCT00558103|827953|P3|COMPLETED|Monotherapy Extension Phase||0
342876|NCT00558103|827954|P2|COMPLETED|Monotherapy Extension Phase||0
342877|NCT00558103|827955|P1|COMPLETED|Monotherapy Extension Phase||0
342878|NCT00558103|827950|P6|STARTED|Monotherapy Extension Phase|9/11 participants completing pazopanib monotherapy elected to receive lapatinib monotherapy.|9
342879|NCT00558103|827951|P5|STARTED|Monotherapy Extension Phase||0
342880|NCT00558103|827952|P4|STARTED|Monotherapy Extension Phase||0
342881|NCT00558103|827953|P3|STARTED|Monotherapy Extension Phase||0
342882|NCT00558103|827954|P2|STARTED|Monotherapy Extension Phase||0
342883|NCT00558103|827955|P1|STARTED|Monotherapy Extension Phase||0
342884|NCT00558103|827950|P6|NOT COMPLETED|Randomized Treatment Phase||0
342885|NCT00558103|827951|P5|NOT COMPLETED|Randomized Treatment Phase||5
342886|NCT00558103|827952|P4|NOT COMPLETED|Randomized Treatment Phase||2
342887|NCT00558103|827953|P3|NOT COMPLETED|Randomized Treatment Phase||3
342888|NCT00558103|827954|P2|NOT COMPLETED|Randomized Treatment Phase||4
342889|NCT00558103|827955|P1|NOT COMPLETED|Randomized Treatment Phase||5
342890|NCT00558103|827950|P6|COMPLETED|Randomized Treatment Phase||0
342891|NCT00558103|827951|P5|COMPLETED|Randomized Treatment Phase||33
342892|NCT00558103|827952|P4|COMPLETED|Randomized Treatment Phase||11
342893|NCT00558103|827953|P3|COMPLETED|Randomized Treatment Phase||33
342894|NCT00558103|827954|P2|COMPLETED|Randomized Treatment Phase||34
342895|NCT00558103|827955|P1|COMPLETED|Randomized Treatment Phase||33
342896|NCT00558103|827950|P6|STARTED|Randomized Treatment Phase||0
342897|NCT00558103|827951|P5|STARTED|Randomized Treatment Phase||38
342898|NCT00558103|827952|P4|STARTED|Randomized Treatment Phase||13
342899|NCT00558103|827953|P3|STARTED|Randomized Treatment Phase||36
342900|NCT00558103|827954|P2|STARTED|Randomized Treatment Phase||38
342901|NCT00558103|827955|P1|STARTED|Randomized Treatment Phase||38
342902|NCT00558064|827985|P2|NOT COMPLETED|Overall Study||5
342903|NCT00558064|827986|P1|NOT COMPLETED|Overall Study||5
342904|NCT00558064|827985|P2|COMPLETED|Overall Study||257
342905|NCT00558064|827986|P1|COMPLETED|Overall Study||264
342906|NCT00558064|827985|P2|STARTED|Overall Study||262
342907|NCT00558064|827986|P1|STARTED|Overall Study||269
342908|NCT00558025|828008|P2|NOT COMPLETED|Overall Study||3
342909|NCT00558025|828009|P1|NOT COMPLETED|Overall Study||4
342910|NCT00558025|828008|P2|COMPLETED|Overall Study||49
342911|NCT00558025|828009|P1|COMPLETED|Overall Study||100
342912|NCT00558025|828008|P2|STARTED|Overall Study||52
342913|NCT00558025|828009|P1|STARTED|Overall Study||104
342914|NCT00558012|828033|P2|NOT COMPLETED|Overall Study||18
342915|NCT00558012|828034|P1|NOT COMPLETED|Overall Study||25
342916|NCT00558012|828033|P2|COMPLETED|Overall Study||74
342917|NCT00558012|828034|P1|COMPLETED|Overall Study||64
342918|NCT00558012|828033|P2|STARTED|Overall Study||92
342919|NCT00558012|828034|P1|STARTED|Overall Study||89
342920|NCT00557947|828040|P1|NOT COMPLETED|Overall Study||0
342921|NCT00557947|828040|P1|COMPLETED|Overall Study||83
342922|NCT00557947|828040|P1|STARTED|Overall Study||83
342923|NCT00557856|828056|P9|NOT COMPLETED|Part 2: Exploratory Phase||24
342924|NCT00557856|828057|P8|NOT COMPLETED|Part 2: Exploratory Phase||0
342925|NCT00557856|828058|P7|NOT COMPLETED|Part 2: Exploratory Phase||0
342926|NCT00557856|828059|P6|NOT COMPLETED|Part 2: Exploratory Phase||0
342927|NCT00557856|828060|P5|NOT COMPLETED|Part 2: Exploratory Phase||0
342928|NCT00557856|828061|P4|NOT COMPLETED|Part 2: Exploratory Phase||0
342929|NCT00557856|828062|P3|NOT COMPLETED|Part 2: Exploratory Phase||0
342930|NCT00557856|828063|P2|NOT COMPLETED|Part 2: Exploratory Phase||0
342931|NCT00557856|828064|P1|NOT COMPLETED|Part 2: Exploratory Phase||0
342932|NCT00557856|828056|P9|COMPLETED|Part 2: Exploratory Phase||0
342933|NCT00557856|828057|P8|COMPLETED|Part 2: Exploratory Phase||0
342934|NCT00557856|828058|P7|COMPLETED|Part 2: Exploratory Phase||0
342935|NCT00557856|828059|P6|COMPLETED|Part 2: Exploratory Phase||0
342936|NCT00557856|828060|P5|COMPLETED|Part 2: Exploratory Phase||0
342937|NCT00557856|828061|P4|COMPLETED|Part 2: Exploratory Phase||0
342938|NCT00557856|828062|P3|COMPLETED|Part 2: Exploratory Phase||0
342939|NCT00557856|828063|P2|COMPLETED|Part 2: Exploratory Phase||0
342940|NCT00557856|828064|P1|COMPLETED|Part 2: Exploratory Phase||0
342941|NCT00557856|828056|P9|STARTED|Part 2: Exploratory Phase||24
342942|NCT00557856|828057|P8|STARTED|Part 2: Exploratory Phase||0
342943|NCT00557856|828058|P7|STARTED|Part 2: Exploratory Phase||0
342944|NCT00557856|828059|P6|STARTED|Part 2: Exploratory Phase||0
342945|NCT00557856|828060|P5|STARTED|Part 2: Exploratory Phase||0
342946|NCT00557856|828061|P4|STARTED|Part 2: Exploratory Phase||0
342947|NCT00557856|828062|P3|STARTED|Part 2: Exploratory Phase||0
342948|NCT00557856|828063|P2|STARTED|Part 2: Exploratory Phase||0
342949|NCT00557856|828064|P1|STARTED|Part 2: Exploratory Phase||0
342950|NCT00557856|828056|P9|NOT COMPLETED|Part 1: Dose Escalation Phase||0
342951|NCT00557856|828057|P8|NOT COMPLETED|Part 1: Dose Escalation Phase||6
342952|NCT00557856|828058|P7|NOT COMPLETED|Part 1: Dose Escalation Phase||7
342953|NCT00557856|828059|P6|NOT COMPLETED|Part 1: Dose Escalation Phase||8
342954|NCT00557856|828060|P5|NOT COMPLETED|Part 1: Dose Escalation Phase||4
342955|NCT00557856|828061|P4|NOT COMPLETED|Part 1: Dose Escalation Phase||3
342956|NCT00557856|828062|P3|NOT COMPLETED|Part 1: Dose Escalation Phase||6
342957|NCT00557856|828063|P2|NOT COMPLETED|Part 1: Dose Escalation Phase||5
342958|NCT00557856|828064|P1|NOT COMPLETED|Part 1: Dose Escalation Phase||7
342959|NCT00557856|828056|P9|COMPLETED|Part 1: Dose Escalation Phase||0
342960|NCT00557856|828057|P8|COMPLETED|Part 1: Dose Escalation Phase||0
342961|NCT00557856|828058|P7|COMPLETED|Part 1: Dose Escalation Phase||0
342962|NCT00557856|828059|P6|COMPLETED|Part 1: Dose Escalation Phase||0
342963|NCT00557856|828060|P5|COMPLETED|Part 1: Dose Escalation Phase||0
342964|NCT00557856|828061|P4|COMPLETED|Part 1: Dose Escalation Phase||0
342965|NCT00557856|828062|P3|COMPLETED|Part 1: Dose Escalation Phase||0
342966|NCT00557856|828063|P2|COMPLETED|Part 1: Dose Escalation Phase||0
342967|NCT00557856|828064|P1|COMPLETED|Part 1: Dose Escalation Phase||0
342968|NCT00557856|828056|P9|Treated|Part 1: Dose Escalation Phase||0
342969|NCT00557856|828057|P8|Treated|Part 1: Dose Escalation Phase||6
342970|NCT00557856|828058|P7|Treated|Part 1: Dose Escalation Phase||7
342971|NCT00557856|828059|P6|Treated|Part 1: Dose Escalation Phase||8
342972|NCT00557856|828060|P5|Treated|Part 1: Dose Escalation Phase||4
342973|NCT00557856|828061|P4|Treated|Part 1: Dose Escalation Phase||3
342974|NCT00557856|828062|P3|Treated|Part 1: Dose Escalation Phase||6
342975|NCT00557856|828063|P2|Treated|Part 1: Dose Escalation Phase||5
342976|NCT00557856|828064|P1|Treated|Part 1: Dose Escalation Phase||5
342977|NCT00557856|828056|P9|STARTED|Part 1: Dose Escalation Phase||0
342978|NCT00557856|828057|P8|STARTED|Part 1: Dose Escalation Phase||6
342979|NCT00557856|828058|P7|STARTED|Part 1: Dose Escalation Phase||7
342980|NCT00557856|828059|P6|STARTED|Part 1: Dose Escalation Phase||8
342981|NCT00557856|828060|P5|STARTED|Part 1: Dose Escalation Phase||4
342982|NCT00557856|828061|P4|STARTED|Part 1: Dose Escalation Phase||3
342983|NCT00557856|828062|P3|STARTED|Part 1: Dose Escalation Phase||6
342984|NCT00557856|828063|P2|STARTED|Part 1: Dose Escalation Phase||5
342985|NCT00557856|828064|P1|STARTED|Part 1: Dose Escalation Phase||7
342986|NCT00557830|828263|P3|NOT COMPLETED|Treatment Phase||0
342987|NCT00557830|828264|P2|NOT COMPLETED|Treatment Phase||0
342988|NCT00557830|828265|P1|NOT COMPLETED|Treatment Phase||0
342989|NCT00557830|828263|P3|COMPLETED|Treatment Phase||2
342990|NCT00557830|828264|P2|COMPLETED|Treatment Phase||4
342991|NCT00557830|828265|P1|COMPLETED|Treatment Phase||0
342992|NCT00557830|828263|P3|STARTED|Treatment Phase||2
342993|NCT00557830|828264|P2|STARTED|Treatment Phase||4
342994|NCT00557830|828265|P1|STARTED|Treatment Phase||0
342995|NCT00557830|828263|P3|NOT COMPLETED|Screening Treatment Phase||0
342996|NCT00557830|828264|P2|NOT COMPLETED|Screening Treatment Phase||0
342997|NCT00557830|828265|P1|NOT COMPLETED|Screening Treatment Phase||6
342998|NCT00557830|828263|P3|COMPLETED|Screening Treatment Phase||0
342999|NCT00557830|828264|P2|COMPLETED|Screening Treatment Phase||0
343000|NCT00557830|828265|P1|COMPLETED|Screening Treatment Phase||6
343001|NCT00557830|828263|P3|STARTED|Screening Treatment Phase||0
343002|NCT00557830|828264|P2|STARTED|Screening Treatment Phase||0
343003|NCT00557830|828265|P1|STARTED|Screening Treatment Phase||12
343004|NCT00557622|828287|P2|NOT COMPLETED|12-Week Treatment Phase||1
343005|NCT00557622|828288|P1|NOT COMPLETED|12-Week Treatment Phase||0
343006|NCT00557622|828287|P2|COMPLETED|12-Week Treatment Phase||1
343007|NCT00557622|828288|P1|COMPLETED|12-Week Treatment Phase||1
343008|NCT00557622|828287|P2|STARTED|12-Week Treatment Phase||2
343009|NCT00557622|828288|P1|STARTED|12-Week Treatment Phase||1
343010|NCT00557622|828287|P2|NOT COMPLETED|4-Week Run-in Phase||0
343011|NCT00557622|828288|P1|NOT COMPLETED|4-Week Run-in Phase||2
343012|NCT00557622|828287|P2|COMPLETED|4-Week Run-in Phase||0
343013|NCT00557622|828288|P1|COMPLETED|4-Week Run-in Phase||3
343014|NCT00557622|828287|P2|STARTED|4-Week Run-in Phase||0
343015|NCT00557622|828288|P1|STARTED|4-Week Run-in Phase||5
343016|NCT00557505|828317|P9|NOT COMPLETED|Overall Study||17
343017|NCT00557505|828318|P8|NOT COMPLETED|Overall Study||5
343018|NCT00557505|828319|P7|NOT COMPLETED|Overall Study||3
343019|NCT00557505|828320|P6|NOT COMPLETED|Overall Study||3
343020|NCT00557505|828321|P5|NOT COMPLETED|Overall Study||2
343021|NCT00557505|828322|P4|NOT COMPLETED|Overall Study||3
343022|NCT00557505|828323|P3|NOT COMPLETED|Overall Study||4
343023|NCT00557505|828324|P2|NOT COMPLETED|Overall Study||3
343024|NCT00557505|828325|P1|NOT COMPLETED|Overall Study||3
343025|NCT00557505|828317|P9|COMPLETED|Overall Study||0
343026|NCT00557505|828318|P8|COMPLETED|Overall Study||0
343027|NCT00557505|828319|P7|COMPLETED|Overall Study||0
343028|NCT00557505|828320|P6|COMPLETED|Overall Study||0
343029|NCT00557505|828321|P5|COMPLETED|Overall Study||0
343030|NCT00557505|828322|P4|COMPLETED|Overall Study||0
343031|NCT00557505|828323|P3|COMPLETED|Overall Study||0
343032|NCT00557505|828324|P2|COMPLETED|Overall Study||0
343033|NCT00557505|828325|P1|COMPLETED|Overall Study||0
343034|NCT00557505|828317|P9|STARTED|Overall Study||17
343035|NCT00557505|828318|P8|STARTED|Overall Study||5
343036|NCT00557505|828319|P7|STARTED|Overall Study||3
343037|NCT00557505|828320|P6|STARTED|Overall Study||3
343038|NCT00557505|828321|P5|STARTED|Overall Study||2
343039|NCT00557505|828322|P4|STARTED|Overall Study||3
343040|NCT00557505|828323|P3|STARTED|Overall Study||4
343041|NCT00557505|828324|P2|STARTED|Overall Study||3
343042|NCT00557505|828325|P1|STARTED|Overall Study||3
343043|NCT00557492|828489|P1|NOT COMPLETED|Overall Study||1
343044|NCT00557492|828489|P1|COMPLETED|Overall Study|Evaluable for outcomes|58
343045|NCT00557492|828489|P1|STARTED|Overall Study||59
343046|NCT00557466|828507|P6|NOT COMPLETED|Overall Study||6
343047|NCT00557466|828508|P5|NOT COMPLETED|Overall Study||3
343048|NCT00557466|828509|P4|NOT COMPLETED|Overall Study||4
343049|NCT00557466|828510|P3|NOT COMPLETED|Overall Study||6
343050|NCT00557466|828511|P2|NOT COMPLETED|Overall Study||5
343051|NCT00557466|828512|P1|NOT COMPLETED|Overall Study||4
343052|NCT00557466|828507|P6|COMPLETED|Overall Study||85
343053|NCT00557466|828508|P5|COMPLETED|Overall Study||87
343054|NCT00557466|828509|P4|COMPLETED|Overall Study||92
343055|NCT00557466|828510|P3|COMPLETED|Overall Study||95
343056|NCT00557466|828511|P2|COMPLETED|Overall Study||87
343057|NCT00557466|828512|P1|COMPLETED|Overall Study||94
343058|NCT00557466|828507|P6|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|89
343059|NCT00557466|828508|P5|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|87
343060|NCT00557466|828509|P4|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|93
343061|NCT00557466|828510|P3|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
343062|NCT00557466|828511|P2|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|91
343063|NCT00557466|828512|P1|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
343064|NCT00557466|828507|P6|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|91
343065|NCT00557466|828508|P5|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|90
343066|NCT00557466|828509|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|96
343067|NCT00557466|828510|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|101
343068|NCT00557466|828511|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|92
343069|NCT00557466|828512|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|98
343070|NCT00557466|828507|P6|STARTED|Overall Study||91
343071|NCT00557466|828508|P5|STARTED|Overall Study||90
343072|NCT00557466|828509|P4|STARTED|Overall Study||96
343073|NCT00557466|828510|P3|STARTED|Overall Study||101
343074|NCT00557466|828511|P2|STARTED|Overall Study||92
343075|NCT00557466|828512|P1|STARTED|Overall Study||98
343076|NCT00557440|828565|P3|NOT COMPLETED|Treatment Period 3||0
343077|NCT00557440|828566|P2|NOT COMPLETED|Treatment Period 3||0
343078|NCT00557440|828567|P1|NOT COMPLETED|Treatment Period 3||0
343079|NCT00557440|828565|P3|COMPLETED|Treatment Period 3||12
343080|NCT00557440|828566|P2|COMPLETED|Treatment Period 3||12
343081|NCT00557440|828567|P1|COMPLETED|Treatment Period 3||12
343082|NCT00557440|828565|P3|STARTED|Treatment Period 3||12
343083|NCT00557440|828566|P2|STARTED|Treatment Period 3||12
343084|NCT00557440|828567|P1|STARTED|Treatment Period 3||12
343085|NCT00557440|828565|P3|NOT COMPLETED|Treatment Period 2||0
343086|NCT00557440|828566|P2|NOT COMPLETED|Treatment Period 2||0
343087|NCT00557440|828567|P1|NOT COMPLETED|Treatment Period 2||0
343088|NCT00557440|828565|P3|COMPLETED|Treatment Period 2||12
343089|NCT00557440|828566|P2|COMPLETED|Treatment Period 2||12
343090|NCT00557440|828567|P1|COMPLETED|Treatment Period 2||12
343091|NCT00557440|828565|P3|STARTED|Treatment Period 2||12
343092|NCT00557440|828566|P2|STARTED|Treatment Period 2||12
343093|NCT00557440|828567|P1|STARTED|Treatment Period 2||12
343094|NCT00557440|828565|P3|NOT COMPLETED|Treatment Period 1||1
343095|NCT00557440|828566|P2|NOT COMPLETED|Treatment Period 1||0
343096|NCT00557440|828567|P1|NOT COMPLETED|Treatment Period 1||0
343097|NCT00557440|828565|P3|COMPLETED|Treatment Period 1||12
343098|NCT00557440|828566|P2|COMPLETED|Treatment Period 1||12
343099|NCT00557440|828567|P1|COMPLETED|Treatment Period 1||12
343100|NCT00557440|828565|P3|STARTED|Treatment Period 1||13
343101|NCT00557440|828566|P2|STARTED|Treatment Period 1||12
343102|NCT00557440|828567|P1|STARTED|Treatment Period 1||12
343103|NCT00557362|828591|P4|NOT COMPLETED|Overall Study||3
343104|NCT00557362|828592|P3|NOT COMPLETED|Overall Study||4
343105|NCT00557362|828593|P2|NOT COMPLETED|Overall Study||2
343106|NCT00557362|828594|P1|NOT COMPLETED|Overall Study||2
343107|NCT00557362|828591|P4|COMPLETED|Overall Study||27
343108|NCT00557362|828592|P3|COMPLETED|Overall Study||26
343109|NCT00557362|828593|P2|COMPLETED|Overall Study||28
343110|NCT00557362|828594|P1|COMPLETED|Overall Study||28
343111|NCT00557362|828591|P4|STARTED|Overall Study||30
343112|NCT00557362|828592|P3|STARTED|Overall Study||30
343113|NCT00557362|828593|P2|STARTED|Overall Study||30
343114|NCT00557362|828594|P1|STARTED|Overall Study||30
343115|NCT00557349|828612|P2|NOT COMPLETED|Overall Study||5
343116|NCT00557349|828613|P1|NOT COMPLETED|Overall Study||5
343117|NCT00557349|828612|P2|COMPLETED|Overall Study||13
343118|NCT00557349|828613|P1|COMPLETED|Overall Study||17
343119|NCT00557349|828612|P2|STARTED|Overall Study||18
343120|NCT00557349|828613|P1|STARTED|Overall Study|omeprazole/bicarb|22
343121|NCT00557323|828621|P1|NOT COMPLETED|Overall Study||7
343122|NCT00557323|828621|P1|COMPLETED|Overall Study||27
343123|NCT00557323|828621|P1|STARTED|Overall Study||34
343124|NCT00557310|828626|P1|NOT COMPLETED|Extension Phase (18 - 24 Months)||5
343125|NCT00557310|828626|P1|COMPLETED|Extension Phase (18 - 24 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|25
343126|NCT00557310|828626|P1|STARTED|Extension Phase (18 - 24 Months)||30
343127|NCT00557310|828626|P1|NOT COMPLETED|Main Study (0 - 18 Months)||5
343128|NCT00557310|828626|P1|COMPLETED|Main Study (0 - 18 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|30
343129|NCT00557310|828626|P1|STARTED|Main Study (0 - 18 Months)||35
343130|NCT00557284|828648|P2|NOT COMPLETED|Overall Study||0
343131|NCT00557284|828649|P1|NOT COMPLETED|Overall Study||0
343132|NCT00557284|828648|P2|COMPLETED|Overall Study||11
343133|NCT00557284|828649|P1|COMPLETED|Overall Study||9
343134|NCT00557284|828648|P2|STARTED|Overall Study||11
343135|NCT00557284|828649|P1|STARTED|Overall Study||9
343136|NCT00557245|828672|P3|NOT COMPLETED|Overall Study||12
343137|NCT00557245|828673|P2|NOT COMPLETED|Overall Study||12
343138|NCT00557245|828674|P1|NOT COMPLETED|Overall Study||12
343139|NCT00557245|828672|P3|COMPLETED|Overall Study||1574
343140|NCT00557245|828673|P2|COMPLETED|Overall Study||1571
343141|NCT00557245|828674|P1|COMPLETED|Overall Study||1577
343142|NCT00557245|828672|P3|STARTED|Overall Study||1586
343143|NCT00557245|828673|P2|STARTED|Overall Study||1583
343144|NCT00557245|828674|P1|STARTED|Overall Study||1589
343145|NCT00557193|828712|P6|NOT COMPLETED|Post Induction Therapy by Tx Assignment||37
343146|NCT00557193|828713|P5|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7
343147|NCT00557193|828714|P4|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7
343148|NCT00557193|828715|P3|NOT COMPLETED|Post Induction Therapy by Tx Assignment||32
343149|NCT00557193|828716|P2|NOT COMPLETED|Post Induction Therapy by Tx Assignment||10
343150|NCT00557193|828717|P1|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
343151|NCT00557193|828712|P6|COMPLETED|Post Induction Therapy by Tx Assignment||19
343152|NCT00557193|828713|P5|COMPLETED|Post Induction Therapy by Tx Assignment||4
343153|NCT00557193|828714|P4|COMPLETED|Post Induction Therapy by Tx Assignment||4
343154|NCT00557193|828715|P3|COMPLETED|Post Induction Therapy by Tx Assignment||22
343155|NCT00557193|828716|P2|COMPLETED|Post Induction Therapy by Tx Assignment||50
343156|NCT00557193|828717|P1|COMPLETED|Post Induction Therapy by Tx Assignment||0
343157|NCT00557193|828712|P6|STARTED|Post Induction Therapy by Tx Assignment||56
343158|NCT00557193|828713|P5|STARTED|Post Induction Therapy by Tx Assignment||11
343159|NCT00557193|828714|P4|STARTED|Post Induction Therapy by Tx Assignment||11
343160|NCT00557193|828715|P3|STARTED|Post Induction Therapy by Tx Assignment||54
343161|NCT00557193|828716|P2|STARTED|Post Induction Therapy by Tx Assignment||60
343162|NCT00557193|828717|P1|STARTED|Post Induction Therapy by Tx Assignment||0
343163|NCT00557193|828712|P6|NOT COMPLETED|Induction||0
343164|NCT00557193|828713|P5|NOT COMPLETED|Induction||0
343165|NCT00557193|828714|P4|NOT COMPLETED|Induction||0
343166|NCT00557193|828715|P3|NOT COMPLETED|Induction||0
343167|NCT00557193|828716|P2|NOT COMPLETED|Induction||0
343168|NCT00557193|828717|P1|NOT COMPLETED|Induction||26
343169|NCT00557193|828712|P6|COMPLETED|Induction||0
343170|NCT00557193|828713|P5|COMPLETED|Induction||0
343171|NCT00557193|828714|P4|COMPLETED|Induction||0
343172|NCT00557193|828715|P3|COMPLETED|Induction||0
343173|NCT00557193|828716|P2|COMPLETED|Induction||0
343174|NCT00557193|828717|P1|COMPLETED|Induction||192
343175|NCT00557193|828712|P6|STARTED|Induction||0
343176|NCT00557193|828713|P5|STARTED|Induction||0
343177|NCT00557193|828714|P4|STARTED|Induction||0
343178|NCT00557193|828715|P3|STARTED|Induction||0
343179|NCT00557193|828716|P2|STARTED|Induction||0
343180|NCT00557193|828717|P1|STARTED|Induction||218
343181|NCT00557076|828757|P2|NOT COMPLETED|Overall Study||1
343182|NCT00557076|828758|P1|NOT COMPLETED|Overall Study||0
343183|NCT00557076|828757|P2|COMPLETED|Overall Study|One participant was withdrawn due to unblinding|7
343184|NCT00557076|828758|P1|COMPLETED|Overall Study||8
343185|NCT00557076|828757|P2|STARTED|Overall Study||8
343186|NCT00557076|828758|P1|STARTED|Overall Study||8
343187|NCT00556998|828766|P1|NOT COMPLETED|Voriconazole Oral||2
343188|NCT00556998|828766|P1|COMPLETED|Voriconazole Oral||20
343189|NCT00556998|828766|P1|STARTED|Voriconazole Oral|One participant received voriconazole 150 mg every 12 hours during oral phase.|22
343190|NCT00556998|828766|P1|NOT COMPLETED|Voriconazole Intravenous (IV)||5
343191|NCT00556998|828766|P1|COMPLETED|Voriconazole Intravenous (IV)|One participant received 2 days of oral; then received IV again before discontinuing from study.|21
343192|NCT00556998|828766|P1|Treated|Voriconazole Intravenous (IV)||26
343193|NCT00556998|828766|P1|STARTED|Voriconazole Intravenous (IV)||26
343194|NCT00556972|828786|P1|NOT COMPLETED|Overall Study||0
343195|NCT00556972|828786|P1|COMPLETED|Overall Study||4
343196|NCT00556972|828786|P1|STARTED|Overall Study||4
343197|NCT00556946|828793|P1|NOT COMPLETED|Overall Study||1
343198|NCT00556946|828793|P1|COMPLETED|Overall Study||16
343199|NCT00556946|828793|P1|STARTED|Overall Study||17
343200|NCT00556933|828801|P4|NOT COMPLETED|CNI Withdrawal vs. Minimization||2
343201|NCT00556933|828802|P3|NOT COMPLETED|CNI Withdrawal vs. Minimization||3
343202|NCT00556933|828803|P2|NOT COMPLETED|CNI Withdrawal vs. Minimization||4
343203|NCT00556933|828804|P1|NOT COMPLETED|CNI Withdrawal vs. Minimization||1
343204|NCT00556933|828801|P4|COMPLETED|CNI Withdrawal vs. Minimization||41
343205|NCT00556933|828802|P3|COMPLETED|CNI Withdrawal vs. Minimization||36
343206|NCT00556933|828803|P2|COMPLETED|CNI Withdrawal vs. Minimization||33
343207|NCT00556933|828804|P1|COMPLETED|CNI Withdrawal vs. Minimization||42
343208|NCT00556933|828801|P4|STARTED|CNI Withdrawal vs. Minimization||43
343209|NCT00556933|828802|P3|STARTED|CNI Withdrawal vs. Minimization||39
343210|NCT00556933|828803|P2|STARTED|CNI Withdrawal vs. Minimization||37
343211|NCT00556933|828804|P1|STARTED|CNI Withdrawal vs. Minimization||43
343212|NCT00556933|828801|P4|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
343213|NCT00556933|828802|P3|NOT COMPLETED|Single vs. Divided-dose rATG Induction||6
343214|NCT00556933|828803|P2|NOT COMPLETED|Single vs. Divided-dose rATG Induction||8
343215|NCT00556933|828804|P1|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
343216|NCT00556933|828801|P4|COMPLETED|Single vs. Divided-dose rATG Induction||43
343217|NCT00556933|828802|P3|COMPLETED|Single vs. Divided-dose rATG Induction||39
343218|NCT00556933|828803|P2|COMPLETED|Single vs. Divided-dose rATG Induction||37
343219|NCT00556933|828804|P1|COMPLETED|Single vs. Divided-dose rATG Induction||43
343220|NCT00556933|828801|P4|STARTED|Single vs. Divided-dose rATG Induction||45
343221|NCT00556933|828802|P3|STARTED|Single vs. Divided-dose rATG Induction||45
343222|NCT00556933|828803|P2|STARTED|Single vs. Divided-dose rATG Induction||45
343223|NCT00556933|828804|P1|STARTED|Single vs. Divided-dose rATG Induction||45
343224|NCT00556894|828861|P3|NOT COMPLETED|Overall Study||19
343225|NCT00556894|828862|P2|NOT COMPLETED|Overall Study||19
343226|NCT00556894|828863|P1|NOT COMPLETED|Overall Study||16
343227|NCT00556894|828861|P3|COMPLETED|Overall Study||65
343228|NCT00556894|828862|P2|COMPLETED|Overall Study||68
343229|NCT00556894|828863|P1|COMPLETED|Overall Study||66
343230|NCT00556894|828861|P3|STARTED|Overall Study||84
343231|NCT00556894|828862|P2|STARTED|Overall Study||87
343232|NCT00556894|828863|P1|STARTED|Overall Study||82
343233|NCT00556712|828873|P2|NOT COMPLETED|Overall Study||438
343234|NCT00556712|828874|P1|NOT COMPLETED|Overall Study||451
343235|NCT00556712|828873|P2|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
343236|NCT00556712|828874|P1|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
343237|NCT00556712|828873|P2|STARTED|Overall Study||438
343238|NCT00556712|828874|P1|STARTED|Overall Study||451
343239|NCT00556673|828952|P2|NOT COMPLETED|Overall Study||2
343240|NCT00556673|828953|P1|NOT COMPLETED|Overall Study||3
343241|NCT00556673|828952|P2|COMPLETED|Overall Study||13
343242|NCT00556673|828953|P1|COMPLETED|Overall Study||13
343243|NCT00556673|828952|P2|Pharmacodynamic (PD) Population|Overall Study|3 patients inadvertently unblinded were not included in PD analysis population.|12
343244|NCT00556673|828953|P1|Pharmacodynamic (PD) Population|Overall Study|4 patients inadvertently unblinded were not included in PD analysis population.|12
343245|NCT00556673|828952|P2|STARTED|Overall Study||15
343246|NCT00556673|828953|P1|STARTED|Overall Study||16
343247|NCT00556543|828989|P1|NOT COMPLETED|Overall Study||0
343248|NCT00556543|828989|P1|COMPLETED|Overall Study|Subjects completed 180 days of study enrollment|10
343249|NCT00556543|828989|P1|STARTED|Overall Study||10
343250|NCT00556504|829007|P2|NOT COMPLETED|Overall Study||9
343251|NCT00556504|829008|P1|NOT COMPLETED|Overall Study||8
343252|NCT00556504|829007|P2|COMPLETED|Overall Study||33
343253|NCT00556504|829008|P1|COMPLETED|Overall Study||34
343254|NCT00556504|829007|P2|Safety Population|Overall Study||42
343255|NCT00556504|829008|P1|Safety Population|Overall Study||41
343256|NCT00556504|829007|P2|Intend-to Treat Population|Overall Study||42
343257|NCT00556504|829008|P1|Intend-to Treat Population|Overall Study||42
343258|NCT00556504|829007|P2|STARTED|Overall Study||42
343259|NCT00556504|829008|P1|STARTED|Overall Study||42
343260|NCT00556491|829028|P2|NOT COMPLETED|Overall Study||1
343261|NCT00556491|829029|P1|NOT COMPLETED|Overall Study||1
343262|NCT00556491|829028|P2|COMPLETED|Overall Study||19
343263|NCT00556491|829029|P1|COMPLETED|Overall Study||19
343264|NCT00556491|829028|P2|STARTED|Overall Study||20
343265|NCT00556491|829029|P1|STARTED|Overall Study|January 2008|20
343266|NCT00556478|829047|P2|NOT COMPLETED|Open-Label Phase||10
343267|NCT00556478|829048|P1|NOT COMPLETED|Open-Label Phase||14
343268|NCT00556478|829047|P2|COMPLETED|Open-Label Phase||67
343269|NCT00556478|829048|P1|COMPLETED|Open-Label Phase||132
343270|NCT00556478|829047|P2|Treated in Open-label|Open-Label Phase||71
343271|NCT00556478|829048|P1|Treated in Open-label|Open-Label Phase||142
343272|NCT00556478|829047|P2|STARTED|Open-Label Phase||77
343273|NCT00556478|829048|P1|STARTED|Open-Label Phase||146
343274|NCT00556478|829047|P2|NOT COMPLETED|Double-blind Phase||8
343275|NCT00556478|829048|P1|NOT COMPLETED|Double-blind Phase||21
343276|NCT00556478|829047|P2|COMPLETED|Double-blind Phase||77
343277|NCT00556478|829048|P1|COMPLETED|Double-blind Phase||150
343278|NCT00556478|829047|P2|ITT|Double-blind Phase||82
343279|NCT00556478|829048|P1|ITT|Double-blind Phase||167
343280|NCT00556478|829047|P2|STARTED|Double-blind Phase||85
343281|NCT00556478|829048|P1|STARTED|Double-blind Phase||171
343282|NCT00556452|829076|P3|NOT COMPLETED|Overall Study||0
343283|NCT00556452|829077|P2|NOT COMPLETED|Overall Study||0
343284|NCT00556452|829078|P1|NOT COMPLETED|Overall Study||0
343285|NCT00556452|829076|P3|COMPLETED|Overall Study||19
343286|NCT00556452|829077|P2|COMPLETED|Overall Study||21
343287|NCT00556452|829078|P1|COMPLETED|Overall Study||6
343288|NCT00556452|829076|P3|STARTED|Overall Study||19
343289|NCT00556452|829077|P2|STARTED|Overall Study||21
343290|NCT00556452|829078|P1|STARTED|Overall Study||6
343291|NCT00556439|829089|P4|NOT COMPLETED|After Week 12 (Randomized Study Period)||1
343292|NCT00556439|829090|P3|NOT COMPLETED|After Week 12 (Randomized Study Period)||0
343293|NCT00556439|829091|P2|NOT COMPLETED|After Week 12 (Randomized Study Period)||4
343294|NCT00556439|829092|P1|NOT COMPLETED|After Week 12 (Randomized Study Period)||3
343295|NCT00556439|829089|P4|COMPLETED|After Week 12 (Randomized Study Period)||14
343296|NCT00556439|829090|P3|COMPLETED|After Week 12 (Randomized Study Period)||11
343297|NCT00556439|829091|P2|COMPLETED|After Week 12 (Randomized Study Period)||17
343298|NCT00556439|829092|P1|COMPLETED|After Week 12 (Randomized Study Period)||17
343299|NCT00556439|829089|P4|STARTED|After Week 12 (Randomized Study Period)||15
343300|NCT00556439|829090|P3|STARTED|After Week 12 (Randomized Study Period)||11
343301|NCT00556439|829091|P2|STARTED|After Week 12 (Randomized Study Period)||21
343302|NCT00556439|829092|P1|STARTED|After Week 12 (Randomized Study Period)||20
343303|NCT00556439|829089|P4|NOT COMPLETED|Study Entry to Week 12||0
343304|NCT00556439|829090|P3|NOT COMPLETED|Study Entry to Week 12||8
343305|NCT00556439|829091|P2|NOT COMPLETED|Study Entry to Week 12||0
343306|NCT00556439|829092|P1|NOT COMPLETED|Study Entry to Week 12||8
343307|NCT00556439|829089|P4|COMPLETED|Study Entry to Week 12||0
343308|NCT00556439|829090|P3|COMPLETED|Study Entry to Week 12||26
343309|NCT00556439|829091|P2|COMPLETED|Study Entry to Week 12||0
343310|NCT00556439|829092|P1|COMPLETED|Study Entry to Week 12||41
343311|NCT00556439|829089|P4|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
343312|NCT00556439|829090|P3|STARTED|Study Entry to Week 12|39 signed informed consent with 5 not being eligible. The remaining 34 received study drug.|34
343313|NCT00556439|829091|P2|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
343314|NCT00556439|829092|P1|STARTED|Study Entry to Week 12|58 signed informed consent with 9 not being eligible. The remaining 49 received study drug.|49
343315|NCT00556426|829102|P1|NOT COMPLETED|Overall Study||9
343316|NCT00556426|829102|P1|COMPLETED|Overall Study||91
343317|NCT00556426|829102|P1|STARTED|Overall Study||100
343318|NCT00556400|829112|P2|NOT COMPLETED|Overall Study||0
343319|NCT00556400|829113|P1|NOT COMPLETED|Overall Study||0
343320|NCT00556400|829112|P2|COMPLETED|Overall Study||0
343321|NCT00556400|829113|P1|COMPLETED|Overall Study||1
343322|NCT00556400|829112|P2|STARTED|Overall Study||0
343323|NCT00556400|829113|P1|STARTED|Overall Study||1
343324|NCT00556374|829124|P2|NOT COMPLETED|Overall Study||220
343325|NCT00556374|829125|P1|NOT COMPLETED|Overall Study||247
343326|NCT00556374|829124|P2|COMPLETED|Overall Study|Indicates participants continuing study|1491
343327|NCT00556374|829125|P1|COMPLETED|Overall Study|Indicates participants continuing study|1462
343328|NCT00556374|829124|P2|Received Study Drug|Overall Study||1700
343329|NCT00556374|829125|P1|Received Study Drug|Overall Study||1699
343330|NCT00556374|829124|P2|STARTED|Overall Study||1711
343331|NCT00556374|829125|P1|STARTED|Overall Study||1709
343332|NCT00556322|829143|P2|NOT COMPLETED|Overall Study||203
343333|NCT00556322|829144|P1|NOT COMPLETED|Overall Study||221
343334|NCT00556322|829143|P2|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
343335|NCT00556322|829144|P1|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
343336|NCT00556322|829143|P2|STARTED|Overall Study||203
343337|NCT00556322|829144|P1|STARTED|Overall Study||221
343338|NCT00556166|829192|P1|NOT COMPLETED|Overall Study||1
343339|NCT00556166|829192|P1|COMPLETED|Overall Study||3
343340|NCT00556166|829192|P1|STARTED|Overall Study||4
343341|NCT00556140|829197|P1|NOT COMPLETED|Overall Study||3
343342|NCT00556140|829197|P1|COMPLETED|Overall Study||13
343343|NCT00556140|829197|P1|STARTED|Overall Study||16
343344|NCT00556075|829205|P3|NOT COMPLETED|Overall Study||8
343345|NCT00556075|829206|P2|NOT COMPLETED|Overall Study||9
343346|NCT00556075|829207|P1|NOT COMPLETED|Overall Study||13
343347|NCT00556075|829205|P3|COMPLETED|Overall Study||15
343348|NCT00556075|829206|P2|COMPLETED|Overall Study||13
343349|NCT00556075|829207|P1|COMPLETED|Overall Study||9
343350|NCT00556075|829205|P3|STARTED|Overall Study||23
343351|NCT00556075|829206|P2|STARTED|Overall Study||22
343352|NCT00556075|829207|P1|STARTED|Overall Study||22
343353|NCT00556049|829230|P1|NOT COMPLETED|Overall Study||0
343354|NCT00556049|829230|P1|COMPLETED|Overall Study||72
343355|NCT00556049|829230|P1|STARTED|Overall Study||72
343356|NCT00555997|829237|P4|NOT COMPLETED|Phase 2 SPCD||3
343357|NCT00555997|829238|P3|NOT COMPLETED|Phase 2 SPCD||7
343358|NCT00555997|829239|P2|NOT COMPLETED|Phase 2 SPCD||0
343359|NCT00555997|829240|P1|NOT COMPLETED|Phase 2 SPCD||0
343360|NCT00555997|829237|P4|COMPLETED|Phase 2 SPCD||22
343361|NCT00555997|829238|P3|COMPLETED|Phase 2 SPCD||31
343362|NCT00555997|829239|P2|COMPLETED|Phase 2 SPCD||0
343363|NCT00555997|829240|P1|COMPLETED|Phase 2 SPCD||0
343364|NCT00555997|829237|P4|STARTED|Phase 2 SPCD||25
343365|NCT00555997|829238|P3|STARTED|Phase 2 SPCD||38
343366|NCT00555997|829239|P2|STARTED|Phase 2 SPCD||0
343367|NCT00555997|829240|P1|STARTED|Phase 2 SPCD||0
343368|NCT00555997|829237|P4|NOT COMPLETED|Phase 1 SPCD||0
343369|NCT00555997|829238|P3|NOT COMPLETED|Phase 1 SPCD||0
343370|NCT00555997|829239|P2|NOT COMPLETED|Phase 1 SPCD||15
343371|NCT00555997|829240|P1|NOT COMPLETED|Phase 1 SPCD||12
343372|NCT00555997|829237|P4|COMPLETED|Phase 1 SPCD||0
343373|NCT00555997|829238|P3|COMPLETED|Phase 1 SPCD||0
343374|NCT00555997|829239|P2|COMPLETED|Phase 1 SPCD||76
343375|NCT00555997|829240|P1|COMPLETED|Phase 1 SPCD||17
343376|NCT00555997|829237|P4|STARTED|Phase 1 SPCD||0
343377|NCT00555997|829238|P3|STARTED|Phase 1 SPCD||0
343378|NCT00555997|829239|P2|STARTED|Phase 1 SPCD||91
343379|NCT00555997|829240|P1|STARTED|Phase 1 SPCD||29
343380|NCT00555971|829258|P2|NOT COMPLETED|Overall Study||1
343381|NCT00555971|829259|P1|NOT COMPLETED|Overall Study||1
343382|NCT00555971|829258|P2|COMPLETED|Overall Study||7
343383|NCT00555971|829259|P1|COMPLETED|Overall Study||4
343384|NCT00555971|829258|P2|STARTED|Overall Study||8
343385|NCT00555971|829259|P1|STARTED|Overall Study||5
343386|NCT00555906|829270|P5|NOT COMPLETED|Phase 2||32
343387|NCT00555906|829271|P4|NOT COMPLETED|Phase 2||0
343388|NCT00555906|829272|P3|NOT COMPLETED|Phase 2||0
343389|NCT00555906|829273|P2|NOT COMPLETED|Phase 2||0
343390|NCT00555906|829274|P1|NOT COMPLETED|Phase 2||0
343391|NCT00555906|829270|P5|COMPLETED|Phase 2||0
343392|NCT00555906|829271|P4|COMPLETED|Phase 2||0
343393|NCT00555906|829272|P3|COMPLETED|Phase 2||0
343394|NCT00555906|829273|P2|COMPLETED|Phase 2||0
343395|NCT00555906|829274|P1|COMPLETED|Phase 2||0
343396|NCT00555906|829270|P5|Treated|Phase 2||30
343397|NCT00555906|829271|P4|Treated|Phase 2||0
343398|NCT00555906|829272|P3|Treated|Phase 2||0
343399|NCT00555906|829273|P2|Treated|Phase 2||0
343400|NCT00555906|829274|P1|Treated|Phase 2||0
343401|NCT00555906|829270|P5|STARTED|Phase 2||32
343402|NCT00555906|829271|P4|STARTED|Phase 2||0
343403|NCT00555906|829272|P3|STARTED|Phase 2||0
343404|NCT00555906|829273|P2|STARTED|Phase 2||0
343405|NCT00555906|829274|P1|STARTED|Phase 2||0
343406|NCT00555906|829270|P5|NOT COMPLETED|Phase 1||0
343407|NCT00555906|829271|P4|NOT COMPLETED|Phase 1||5
343408|NCT00555906|829272|P3|NOT COMPLETED|Phase 1||7
343409|NCT00555906|829273|P2|NOT COMPLETED|Phase 1||6
343410|NCT00555906|829274|P1|NOT COMPLETED|Phase 1||3
343411|NCT00555906|829270|P5|COMPLETED|Phase 1||0
343412|NCT00555906|829271|P4|COMPLETED|Phase 1||0
343413|NCT00555906|829272|P3|COMPLETED|Phase 1||0
343414|NCT00555906|829273|P2|COMPLETED|Phase 1||0
343415|NCT00555906|829274|P1|COMPLETED|Phase 1||0
343416|NCT00555906|829270|P5|STARTED|Phase 1||0
343417|NCT00555906|829271|P4|STARTED|Phase 1||5
343418|NCT00555906|829272|P3|STARTED|Phase 1||7
343419|NCT00555906|829273|P2|STARTED|Phase 1||6
343420|NCT00555906|829274|P1|STARTED|Phase 1||3
343421|NCT00555893|829306|P2|NOT COMPLETED|Overall Study||0
343422|NCT00555893|829307|P1|NOT COMPLETED|Overall Study||0
343423|NCT00555893|829306|P2|COMPLETED|Overall Study||63
343424|NCT00555893|829307|P1|COMPLETED|Overall Study||130
343425|NCT00555893|829306|P2|Final Analysis|Overall Study|n=12 excluded from number started because >119 hrs|51
343426|NCT00555893|829307|P1|Final Analysis|Overall Study|n=16 excluded from number started because >119 hrs|114
343427|NCT00555893|829306|P2|STARTED|Overall Study||63
343428|NCT00555893|829307|P1|STARTED|Overall Study||130
343429|NCT00555880|829323|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
343430|NCT00555880|829324|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
343431|NCT00555880|829323|P2|COMPLETED|Treatment Period 2 (1 Day)||11
343432|NCT00555880|829324|P1|COMPLETED|Treatment Period 2 (1 Day)||13
343433|NCT00555880|829323|P2|STARTED|Treatment Period 2 (1 Day)||11
343434|NCT00555880|829324|P1|STARTED|Treatment Period 2 (1 Day)||13
343435|NCT00555880|829323|P2|NOT COMPLETED|Washout (1 Day)||0
343436|NCT00555880|829324|P1|NOT COMPLETED|Washout (1 Day)||0
343437|NCT00555880|829323|P2|COMPLETED|Washout (1 Day)||11
343438|NCT00555880|829324|P1|COMPLETED|Washout (1 Day)||13
343439|NCT00555880|829323|P2|STARTED|Washout (1 Day)||11
343440|NCT00555880|829324|P1|STARTED|Washout (1 Day)||13
343441|NCT00555880|829323|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
343442|NCT00555880|829324|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
343443|NCT00555880|829323|P2|COMPLETED|Treatment Period 1 (1 Day)||11
343444|NCT00555880|829324|P1|COMPLETED|Treatment Period 1 (1 Day)||13
343445|NCT00555880|829323|P2|STARTED|Treatment Period 1 (1 Day)||11
343446|NCT00555880|829324|P1|STARTED|Treatment Period 1 (1 Day)||13
343447|NCT00555750|829363|P2|NOT COMPLETED|Overall Study||0
343448|NCT00555750|829364|P1|NOT COMPLETED|Overall Study||0
343449|NCT00555750|829363|P2|COMPLETED|Overall Study||10
343450|NCT00555750|829364|P1|COMPLETED|Overall Study||10
343451|NCT00555750|829363|P2|STARTED|Overall Study||10
343452|NCT00555750|829364|P1|STARTED|Overall Study||10
343453|NCT00555672|829396|P2|NOT COMPLETED|Overall Study||10
343454|NCT00555672|829397|P1|NOT COMPLETED|Overall Study||24
343455|NCT00555672|829396|P2|COMPLETED|Overall Study||0
343456|NCT00555672|829397|P1|COMPLETED|Overall Study||0
343457|NCT00555672|829396|P2|STARTED|Overall Study||10
343458|NCT00555672|829397|P1|STARTED|Overall Study||24
343459|NCT00555620|829422|P6|NOT COMPLETED|Overall Study||22
343460|NCT00555620|829423|P5|NOT COMPLETED|Overall Study||3
343461|NCT00555620|829424|P4|NOT COMPLETED|Overall Study||23
343462|NCT00555620|829425|P3|NOT COMPLETED|Overall Study||15
343463|NCT00555620|829426|P2|NOT COMPLETED|Overall Study||7
343464|NCT00555620|829427|P1|NOT COMPLETED|Overall Study||6
343465|NCT00555620|829422|P6|COMPLETED|Overall Study||0
343466|NCT00555620|829423|P5|COMPLETED|Overall Study||0
343467|NCT00555620|829424|P4|COMPLETED|Overall Study||0
343468|NCT00555620|829425|P3|COMPLETED|Overall Study||0
343469|NCT00555620|829426|P2|COMPLETED|Overall Study||0
343470|NCT00555620|829427|P1|COMPLETED|Overall Study||0
343471|NCT00555620|829422|P6|STARTED|Overall Study||22
343472|NCT00555620|829423|P5|STARTED|Overall Study||3
343473|NCT00555620|829424|P4|STARTED|Overall Study||23
343474|NCT00555620|829425|P3|STARTED|Overall Study||15
343475|NCT00555620|829426|P2|STARTED|Overall Study||7
343476|NCT00555620|829427|P1|STARTED|Overall Study||6
343477|NCT00555581|829539|P1|NOT COMPLETED|Overall Study||6
343478|NCT00555581|829539|P1|COMPLETED|Overall Study||24
343479|NCT00555581|829539|P1|STARTED|Overall Study||30
343480|NCT00555568|829551|P3|NOT COMPLETED|Overall Study||16
343481|NCT00555568|829552|P2|NOT COMPLETED|Overall Study||16
343482|NCT00555568|829553|P1|NOT COMPLETED|Overall Study||26
343483|NCT00555568|829551|P3|COMPLETED|Overall Study||84
343484|NCT00555568|829552|P2|COMPLETED|Overall Study||82
343485|NCT00555568|829553|P1|COMPLETED|Overall Study||74
343486|NCT00555568|829551|P3|STARTED|Overall Study||100
343487|NCT00555568|829552|P2|STARTED|Overall Study||98
343488|NCT00555568|829553|P1|STARTED|Overall Study||100
343489|NCT00555477|829575|P2|NOT COMPLETED|Overall Study||13
343490|NCT00555477|829576|P1|NOT COMPLETED|Overall Study||2
343491|NCT00555477|829575|P2|COMPLETED|Overall Study||32
343492|NCT00555477|829576|P1|COMPLETED|Overall Study||12
343493|NCT00555477|829575|P2|STARTED|Overall Study||45
343494|NCT00555477|829576|P1|STARTED|Overall Study||14
343495|NCT00555464|829583|P2|NOT COMPLETED|Overall Study||3
343496|NCT00555464|829584|P1|NOT COMPLETED|Overall Study||0
343497|NCT00555464|829583|P2|COMPLETED|Overall Study||1
343498|NCT00555464|829584|P1|COMPLETED|Overall Study||4
343499|NCT00555464|829583|P2|STARTED|Overall Study||4
343500|NCT00555464|829584|P1|STARTED|Overall Study||4
343501|NCT00555438|829592|P1|NOT COMPLETED|Between 10 Days and 30 Days Postoperativ||5
343502|NCT00555438|829592|P1|COMPLETED|Between 10 Days and 30 Days Postoperativ||433
343503|NCT00555438|829592|P1|STARTED|Between 10 Days and 30 Days Postoperativ||438
343504|NCT00555438|829592|P1|NOT COMPLETED|10 Days Post-operative||4
343505|NCT00555438|829592|P1|COMPLETED|10 Days Post-operative|438 patients attended the day 10 visit (four patients died during hospitalization)|438
343506|NCT00555438|829592|P1|STARTED|10 Days Post-operative||442
343507|NCT00555425|829602|P2|NOT COMPLETED|Overall Study||19
343508|NCT00555425|829603|P1|NOT COMPLETED|Overall Study||51
343509|NCT00555425|829602|P2|COMPLETED|Overall Study||37
343510|NCT00555425|829603|P1|COMPLETED|Overall Study||6
343511|NCT00555425|829602|P2|STARTED|Overall Study||56
343512|NCT00555425|829603|P1|STARTED|Overall Study||57
343513|NCT00555360|829623|P2|NOT COMPLETED|Overall Study||36
343514|NCT00555360|829624|P1|NOT COMPLETED|Overall Study||27
343515|NCT00555360|829623|P2|COMPLETED|Overall Study||153
343516|NCT00555360|829624|P1|COMPLETED|Overall Study||156
343517|NCT00555360|829623|P2|STARTED|Overall Study||189
343518|NCT00555360|829624|P1|STARTED|Overall Study||183
343519|NCT00555321|829639|P5|NOT COMPLETED|Long-term Extension Phase||26
343520|NCT00555321|829640|P4|NOT COMPLETED|Long-term Extension Phase||38
343521|NCT00555321|829641|P3|NOT COMPLETED|Long-term Extension Phase||24
343522|NCT00555321|829642|P2|NOT COMPLETED|Long-term Extension Phase||27
343523|NCT00555321|829643|P1|NOT COMPLETED|Long-term Extension Phase||30
343524|NCT00555321|829639|P5|COMPLETED|Long-term Extension Phase||0
343525|NCT00555321|829640|P4|COMPLETED|Long-term Extension Phase||0
343526|NCT00555321|829641|P3|COMPLETED|Long-term Extension Phase||0
343527|NCT00555321|829642|P2|COMPLETED|Long-term Extension Phase||0
343528|NCT00555321|829643|P1|COMPLETED|Long-term Extension Phase||0
343529|NCT00555321|829639|P5|STARTED|Long-term Extension Phase|6 participants did not enter LTE|26
343530|NCT00555321|829640|P4|STARTED|Long-term Extension Phase|8 participants did not enter LTE|38
343531|NCT00555321|829641|P3|STARTED|Long-term Extension Phase|2 participants did not enter LTE|24
343532|NCT00555321|829642|P2|STARTED|Long-term Extension Phase|2 participants did not enter LTE|27
343533|NCT00555321|829643|P1|STARTED|Long-term Extension Phase|1 participant did not enter LTE|30
343534|NCT00555321|829639|P5|NOT COMPLETED|Treatment Phase up to 12-months||22
343535|NCT00555321|829640|P4|NOT COMPLETED|Treatment Phase up to 12-months||7
343536|NCT00555321|829641|P3|NOT COMPLETED|Treatment Phase up to 12-months||24
343537|NCT00555321|829642|P2|NOT COMPLETED|Treatment Phase up to 12-months||22
343538|NCT00555321|829643|P1|NOT COMPLETED|Treatment Phase up to 12-months||21
343539|NCT00555321|829639|P5|COMPLETED|Treatment Phase up to 12-months||32
343540|NCT00555321|829640|P4|COMPLETED|Treatment Phase up to 12-months||46
343541|NCT00555321|829641|P3|COMPLETED|Treatment Phase up to 12-months||26
343542|NCT00555321|829642|P2|COMPLETED|Treatment Phase up to 12-months||29
343543|NCT00555321|829643|P1|COMPLETED|Treatment Phase up to 12-months||31
343544|NCT00555321|829639|P5|Received Transplant and Treated|Treatment Phase up to 12-months||50
343545|NCT00555321|829640|P4|Received Transplant and Treated|Treatment Phase up to 12-months||53
343546|NCT00555321|829641|P3|Received Transplant and Treated|Treatment Phase up to 12-months||49
343547|NCT00555321|829642|P2|Received Transplant and Treated|Treatment Phase up to 12-months||48
343548|NCT00555321|829643|P1|Received Transplant and Treated|Treatment Phase up to 12-months||50
343549|NCT00555321|829639|P5|STARTED|Treatment Phase up to 12-months||54
343550|NCT00555321|829640|P4|STARTED|Treatment Phase up to 12-months||53
343551|NCT00555321|829641|P3|STARTED|Treatment Phase up to 12-months||50
343552|NCT00555321|829642|P2|STARTED|Treatment Phase up to 12-months||51
343553|NCT00555321|829643|P1|STARTED|Treatment Phase up to 12-months||52
343554|NCT00555217|829947|P2|NOT COMPLETED|Overall Study||68
343555|NCT00555217|829948|P1|NOT COMPLETED|Overall Study||75
343556|NCT00555217|829947|P2|COMPLETED|Overall Study||656
343557|NCT00555217|829948|P1|COMPLETED|Overall Study||649
343558|NCT00555217|829947|P2|STARTED|Overall Study||724
343559|NCT00555217|829948|P1|STARTED|Overall Study||724
343560|NCT00555152|829960|P4|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
343561|NCT00555152|829961|P3|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
343562|NCT00555152|829962|P2|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
343563|NCT00555152|829963|P1|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
343564|NCT00555152|829960|P4|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||9
343565|NCT00555152|829961|P3|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
343566|NCT00555152|829962|P2|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||10
343567|NCT00555152|829963|P1|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
343568|NCT00555152|829960|P4|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||9
343569|NCT00555152|829961|P3|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||0
343570|NCT00555152|829962|P2|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||10
343661|NCT00554788|830118|P1|STARTED|Overall Study||21
343571|NCT00555152|829963|P1|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14|Participants in initial and second study registration periods reported separately.|0
343572|NCT00555152|829960|P4|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
343573|NCT00555152|829961|P3|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
343574|NCT00555152|829962|P2|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
343575|NCT00555152|829963|P1|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
343576|NCT00555152|829960|P4|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||1
343577|NCT00555152|829961|P3|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
343578|NCT00555152|829962|P2|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
343579|NCT00555152|829963|P1|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||2
343580|NCT00555152|829960|P4|STARTED|Period Open at BCM: 1/17/08-3/8/10||1
343581|NCT00555152|829961|P3|STARTED|Period Open at BCM: 1/17/08-3/8/10||0
343582|NCT00555152|829962|P2|STARTED|Period Open at BCM: 1/17/08-3/8/10|Participants in initial and second study registration periods reported separately.|0
343583|NCT00555152|829963|P1|STARTED|Period Open at BCM: 1/17/08-3/8/10||2
343584|NCT00555061|829985|P1|NOT COMPLETED|Overall Study||9
343585|NCT00555061|829985|P1|COMPLETED|Overall Study||78
343586|NCT00555061|829985|P1|STARTED|Overall Study|One participant did not receive study medication and was not included in the analysis population.|87
343587|NCT00555048|829992|P1|NOT COMPLETED|Overall Study||0
343588|NCT00555048|829992|P1|COMPLETED|Overall Study||1
343589|NCT00555048|829992|P1|STARTED|Overall Study||1
343590|NCT00555009|830004|P2|NOT COMPLETED|Overall Study||6
343591|NCT00555009|830005|P1|NOT COMPLETED|Overall Study||2
343592|NCT00555009|830004|P2|COMPLETED|Overall Study||0
343593|NCT00555009|830005|P1|COMPLETED|Overall Study||2
343594|NCT00555009|830004|P2|STARTED|Overall Study||6
343595|NCT00555009|830005|P1|STARTED|Overall Study||4
343596|NCT00554996|830027|P1|NOT COMPLETED|Overall Study||0
343597|NCT00554996|830027|P1|COMPLETED|Overall Study||10
343598|NCT00554996|830027|P1|STARTED|Overall Study||10
343599|NCT00554970|830035|P4|NOT COMPLETED|Period 2||0
343600|NCT00554970|830036|P3|NOT COMPLETED|Period 2||1
343601|NCT00554970|830037|P2|NOT COMPLETED|Period 2||0
343602|NCT00554970|830038|P1|NOT COMPLETED|Period 2||0
343603|NCT00554970|830035|P4|COMPLETED|Period 2||8
343604|NCT00554970|830036|P3|COMPLETED|Period 2||7
343605|NCT00554970|830037|P2|COMPLETED|Period 2||8
343606|NCT00554970|830038|P1|COMPLETED|Period 2||7
343607|NCT00554970|830035|P4|STARTED|Period 2||8
343608|NCT00554970|830036|P3|STARTED|Period 2||8
343609|NCT00554970|830037|P2|STARTED|Period 2||8
343610|NCT00554970|830038|P1|STARTED|Period 2||7
343611|NCT00554970|830035|P4|NOT COMPLETED|Period 1||0
343612|NCT00554970|830036|P3|NOT COMPLETED|Period 1||0
343613|NCT00554970|830037|P2|NOT COMPLETED|Period 1||0
343614|NCT00554970|830038|P1|NOT COMPLETED|Period 1||1
343615|NCT00554970|830035|P4|COMPLETED|Period 1||8
343616|NCT00554970|830036|P3|COMPLETED|Period 1||8
343617|NCT00554970|830037|P2|COMPLETED|Period 1||8
343618|NCT00554970|830038|P1|COMPLETED|Period 1||7
343619|NCT00554970|830035|P4|STARTED|Period 1||8
343620|NCT00554970|830036|P3|STARTED|Period 1||8
343621|NCT00554970|830037|P2|STARTED|Period 1||8
343622|NCT00554970|830038|P1|STARTED|Period 1||8
343623|NCT00554853|830070|P2|NOT COMPLETED|Crossover Arm (3 Months)||2
343624|NCT00554853|830071|P1|NOT COMPLETED|Crossover Arm (3 Months)||3
343625|NCT00554853|830070|P2|COMPLETED|Crossover Arm (3 Months)||55
343626|NCT00554853|830071|P1|COMPLETED|Crossover Arm (3 Months)||53
343627|NCT00554853|830070|P2|STARTED|Crossover Arm (3 Months)||57
343628|NCT00554853|830071|P1|STARTED|Crossover Arm (3 Months)||56
343629|NCT00554853|830070|P2|NOT COMPLETED|Washout Period (2 Weeks)||7
343630|NCT00554853|830071|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
343631|NCT00554853|830070|P2|COMPLETED|Washout Period (2 Weeks)||57
343632|NCT00554853|830071|P1|COMPLETED|Washout Period (2 Weeks)||56
343633|NCT00554853|830070|P2|STARTED|Washout Period (2 Weeks)||64
343634|NCT00554853|830071|P1|STARTED|Washout Period (2 Weeks)||56
343635|NCT00554853|830070|P2|NOT COMPLETED|First Arm of Study||7
343636|NCT00554853|830071|P1|NOT COMPLETED|First Arm of Study||16
343637|NCT00554853|830070|P2|COMPLETED|First Arm of Study||64
343638|NCT00554853|830071|P1|COMPLETED|First Arm of Study||56
343639|NCT00554853|830070|P2|STARTED|First Arm of Study||71
343640|NCT00554853|830071|P1|STARTED|First Arm of Study||72
343641|NCT00554840|830085|P2|NOT COMPLETED|Overall Study||1
343642|NCT00554840|830086|P1|NOT COMPLETED|Overall Study||0
343643|NCT00554840|830085|P2|COMPLETED|Overall Study||4
343644|NCT00554840|830086|P1|COMPLETED|Overall Study||4
343645|NCT00554840|830085|P2|STARTED|Overall Study||5
343646|NCT00554840|830086|P1|STARTED|Overall Study||4
343647|NCT00554801|830104|P2|NOT COMPLETED|Overall Study||0
343648|NCT00554801|830105|P1|NOT COMPLETED|Overall Study||19
343649|NCT00554801|830104|P2|COMPLETED|Overall Study||29
343650|NCT00554801|830105|P1|COMPLETED|Overall Study||36
343651|NCT00554801|830104|P2|STARTED|Overall Study||29
343652|NCT00554801|830105|P1|STARTED|Overall Study||55
343653|NCT00554788|830116|P3|NOT COMPLETED|Overall Study||14
343654|NCT00554788|830117|P2|NOT COMPLETED|Overall Study||6
343655|NCT00554788|830118|P1|NOT COMPLETED|Overall Study||7
343656|NCT00554788|830116|P3|COMPLETED|Overall Study||7
343657|NCT00554788|830117|P2|COMPLETED|Overall Study||12
343658|NCT00554788|830118|P1|COMPLETED|Overall Study||14
343659|NCT00554788|830116|P3|STARTED|Overall Study||21
343660|NCT00554788|830117|P2|STARTED|Overall Study||18
343662|NCT00554749|830130|P1|NOT COMPLETED|Overall Study||0
343663|NCT00554749|830130|P1|COMPLETED|Overall Study||7
343664|NCT00554749|830130|P1|STARTED|Overall Study||7
343665|NCT00554671|830137|P2|NOT COMPLETED|Overall Study||16
343666|NCT00554671|830138|P1|NOT COMPLETED|Overall Study||20
343667|NCT00554671|830137|P2|COMPLETED|Overall Study||117
343668|NCT00554671|830138|P1|COMPLETED|Overall Study||97
343669|NCT00554671|830137|P2|STARTED|Overall Study||133
343670|NCT00554671|830138|P1|STARTED|Overall Study||117
343671|NCT00554619|830150|P1|NOT COMPLETED|Overall Study||3
343672|NCT00554619|830150|P1|COMPLETED|Overall Study||18
343673|NCT00554619|830150|P1|STARTED|Overall Study||21
343674|NCT00554515|830162|P1|NOT COMPLETED|Overall Study||118
343675|NCT00554515|830162|P1|COMPLETED|Overall Study||5
343676|NCT00554515|830162|P1|Treated|Overall Study||120
343677|NCT00554515|830162|P1|STARTED|Overall Study||123
343678|NCT00554463|830191|P1|NOT COMPLETED|Overall Study||0
343679|NCT00554463|830191|P1|COMPLETED|Overall Study||5
343680|NCT00554463|830191|P1|STARTED|Overall Study||5
343681|NCT00554372|830203|P2|NOT COMPLETED|Overall Study||0
343682|NCT00554372|830204|P1|NOT COMPLETED|Overall Study||0
343683|NCT00554372|830203|P2|COMPLETED|Overall Study||16
343684|NCT00554372|830204|P1|COMPLETED|Overall Study||14
343685|NCT00554372|830203|P2|STARTED|Overall Study||16
343686|NCT00554372|830204|P1|STARTED|Overall Study||14
343687|NCT00554294|830218|P2|NOT COMPLETED|Overall Study||80
343688|NCT00554294|830219|P1|NOT COMPLETED|Overall Study||160
343689|NCT00554294|830218|P2|COMPLETED|Overall Study||1641
343690|NCT00554294|830219|P1|COMPLETED|Overall Study||1309
343691|NCT00554294|830218|P2|STARTED|Overall Study||1721
343692|NCT00554294|830219|P1|STARTED|Overall Study||1469
343693|NCT00554229|830225|P2|NOT COMPLETED|Overall Study||225
343694|NCT00554229|830226|P1|NOT COMPLETED|Overall Study||226
343695|NCT00554229|830225|P2|COMPLETED|Overall Study||70
343696|NCT00554229|830226|P1|COMPLETED|Overall Study||73
343697|NCT00554229|830225|P2|Patients Who Received Treatment|Overall Study||295
343698|NCT00554229|830226|P1|Patients Who Received Treatment|Overall Study||298
343699|NCT00554229|830225|P2|STARTED|Overall Study||295
343700|NCT00554229|830226|P1|STARTED|Overall Study||299
343701|NCT00554216|830251|P3|NOT COMPLETED|Overall Study||172
343702|NCT00554216|830252|P2|NOT COMPLETED|Overall Study||94
343703|NCT00554216|830253|P1|NOT COMPLETED|Overall Study||242
343704|NCT00554216|830251|P3|COMPLETED|Overall Study||340
343705|NCT00554216|830252|P2|COMPLETED|Overall Study||147
343706|NCT00554216|830253|P1|COMPLETED|Overall Study||272
343707|NCT00554216|830251|P3|STARTED|Overall Study||512
343708|NCT00554216|830252|P2|STARTED|Overall Study||241
343709|NCT00554216|830253|P1|STARTED|Overall Study||514
343710|NCT00554190|830264|P1|NOT COMPLETED|Overall Study||10
343711|NCT00554190|830264|P1|COMPLETED|Overall Study|10 subjects did not complete the Termination Study Forms|19
343712|NCT00554190|830264|P1|STARTED|Overall Study|29 subjects treated.|29
343713|NCT00554099|830273|P3|NOT COMPLETED|Non-Treatment Phase (9 Months)||3
343714|NCT00554099|830274|P2|NOT COMPLETED|Non-Treatment Phase (9 Months)||5
343715|NCT00554099|830275|P1|NOT COMPLETED|Non-Treatment Phase (9 Months)||7
343716|NCT00554099|830273|P3|COMPLETED|Non-Treatment Phase (9 Months)||24
343717|NCT00554099|830274|P2|COMPLETED|Non-Treatment Phase (9 Months)||27
343718|NCT00554099|830275|P1|COMPLETED|Non-Treatment Phase (9 Months)||22
343719|NCT00554099|830273|P3|STARTED|Non-Treatment Phase (9 Months)||27
343720|NCT00554099|830274|P2|STARTED|Non-Treatment Phase (9 Months)||32
343721|NCT00554099|830275|P1|STARTED|Non-Treatment Phase (9 Months)||29
343722|NCT00554099|830273|P3|NOT COMPLETED|Treatment Period (12 Weeks)||9
343723|NCT00554099|830274|P2|NOT COMPLETED|Treatment Period (12 Weeks)||8
343724|NCT00554099|830275|P1|NOT COMPLETED|Treatment Period (12 Weeks)||12
343725|NCT00554099|830273|P3|COMPLETED|Treatment Period (12 Weeks)||27
343726|NCT00554099|830274|P2|COMPLETED|Treatment Period (12 Weeks)||32
343727|NCT00554099|830275|P1|COMPLETED|Treatment Period (12 Weeks)||29
343728|NCT00554099|830273|P3|STARTED|Treatment Period (12 Weeks)||36
343729|NCT00554099|830274|P2|STARTED|Treatment Period (12 Weeks)||40
343730|NCT00554099|830275|P1|STARTED|Treatment Period (12 Weeks)||41
343731|NCT00553969|830308|P4|NOT COMPLETED|Overall Study||1
343732|NCT00553969|830309|P3|NOT COMPLETED|Overall Study||1
343733|NCT00553969|830310|P2|NOT COMPLETED|Overall Study||0
343734|NCT00553969|830311|P1|NOT COMPLETED|Overall Study||8
343735|NCT00553969|830308|P4|COMPLETED|Overall Study||23
343736|NCT00553969|830309|P3|COMPLETED|Overall Study||21
343737|NCT00553969|830310|P2|COMPLETED|Overall Study||24
343738|NCT00553969|830311|P1|COMPLETED|Overall Study||23
343739|NCT00553969|830308|P4|STARTED|Overall Study||24
343740|NCT00553969|830309|P3|STARTED|Overall Study||22
343741|NCT00553969|830310|P2|STARTED|Overall Study||24
343742|NCT00553969|830311|P1|STARTED|Overall Study||31
343743|NCT00553839|830321|P1|NOT COMPLETED|Overall Study||0
343744|NCT00553839|830321|P1|COMPLETED|Overall Study||21
343745|NCT00553839|830321|P1|STARTED|Overall Study||21
343746|NCT00553787|830330|P3|NOT COMPLETED|Overall Study||262
343747|NCT00553787|830331|P2|NOT COMPLETED|Overall Study||124
343748|NCT00553787|830332|P1|NOT COMPLETED|Overall Study||378
343749|NCT00553787|830330|P3|COMPLETED|Overall Study||733
343750|NCT00553787|830331|P2|COMPLETED|Overall Study||374
343751|NCT00553787|830332|P1|COMPLETED|Overall Study||616
343752|NCT00553787|830330|P3|STARTED|Overall Study||995
343753|NCT00553787|830331|P2|STARTED|Overall Study||498
343754|NCT00553787|830332|P1|STARTED|Overall Study||994
343755|NCT00553735|830343|P1|NOT COMPLETED|Overall Study||7
343756|NCT00553735|830343|P1|COMPLETED|Overall Study||1
343757|NCT00553735|830343|P1|STARTED|Overall Study||8
343758|NCT00553696|830364|P4|NOT COMPLETED|Overall Study||1
343759|NCT00553696|830365|P3|NOT COMPLETED|Overall Study||6
343760|NCT00553696|830366|P2|NOT COMPLETED|Overall Study||16
343761|NCT00553696|830367|P1|NOT COMPLETED|Overall Study||4
343762|NCT00553696|830364|P4|COMPLETED|Overall Study||0
343763|NCT00553696|830365|P3|COMPLETED|Overall Study||0
343764|NCT00553696|830366|P2|COMPLETED|Overall Study||0
343765|NCT00553696|830367|P1|COMPLETED|Overall Study||0
343766|NCT00553696|830364|P4|STARTED|Overall Study||1
343767|NCT00553696|830365|P3|STARTED|Overall Study||6
343768|NCT00553696|830366|P2|STARTED|Overall Study||16
343769|NCT00553696|830367|P1|STARTED|Overall Study||4
343770|NCT00553644|830405|P1|NOT COMPLETED|Overall Study||28
343771|NCT00553644|830405|P1|COMPLETED|Overall Study||25
343772|NCT00553644|830405|P1|STARTED|Overall Study||53
343773|NCT00553631|830414|P2|NOT COMPLETED|Overall Study||1
343774|NCT00553631|830415|P1|NOT COMPLETED|Overall Study||1
343775|NCT00553631|830414|P2|COMPLETED|Overall Study||16
343776|NCT00553631|830415|P1|COMPLETED|Overall Study||16
343777|NCT00553631|830414|P2|STARTED|Overall Study|Intent-to-treat (ITT) population|17
343778|NCT00553631|830415|P1|STARTED|Overall Study|Intent-to-treat (ITT) population|17
343779|NCT00553605|830437|P2|NOT COMPLETED|Overall Study||3
343780|NCT00553605|830438|P1|NOT COMPLETED|Overall Study||4
343781|NCT00553605|830437|P2|COMPLETED|Overall Study||161
343782|NCT00553605|830438|P1|COMPLETED|Overall Study||172
343783|NCT00553605|830437|P2|Treated|Overall Study||164
343784|NCT00553605|830438|P1|Treated|Overall Study||174
343785|NCT00553605|830437|P2|STARTED|Overall Study||164
343786|NCT00553605|830438|P1|STARTED|Overall Study||176
343787|NCT00553540|830464|P2|NOT COMPLETED|Overall Study||5
343788|NCT00553540|830465|P1|NOT COMPLETED|Overall Study||2
343789|NCT00553540|830464|P2|COMPLETED|Overall Study||20
343790|NCT00553540|830465|P1|COMPLETED|Overall Study||23
343791|NCT00553540|830464|P2|STARTED|Overall Study||25
343792|NCT00553540|830465|P1|STARTED|Overall Study||25
343793|NCT00553514|830476|P5|NOT COMPLETED|Overall Study||7
343794|NCT00553514|830477|P4|NOT COMPLETED|Overall Study||7
343795|NCT00553514|830478|P3|NOT COMPLETED|Overall Study||6
343796|NCT00553514|830479|P2|NOT COMPLETED|Overall Study||8
343797|NCT00553514|830480|P1|NOT COMPLETED|Overall Study||8
343798|NCT00553514|830476|P5|COMPLETED|Overall Study||8
343799|NCT00553514|830477|P4|COMPLETED|Overall Study||6
343800|NCT00553514|830478|P3|COMPLETED|Overall Study||9
343801|NCT00553514|830479|P2|COMPLETED|Overall Study||6
343802|NCT00553514|830480|P1|COMPLETED|Overall Study||6
343803|NCT00553514|830476|P5|STARTED|Overall Study||15
343804|NCT00553514|830477|P4|STARTED|Overall Study||13
343805|NCT00553514|830478|P3|STARTED|Overall Study||15
343806|NCT00553514|830479|P2|STARTED|Overall Study||14
343807|NCT00553514|830480|P1|STARTED|Overall Study||14
343808|NCT00553501|830517|P1|NOT COMPLETED|Overall Study||4
343809|NCT00553501|830517|P1|COMPLETED|Overall Study||55
343810|NCT00553501|830517|P1|STARTED|Overall Study||59
343811|NCT00553475|830526|P3|NOT COMPLETED|Overall Study||13
343812|NCT00553475|830527|P2|NOT COMPLETED|Overall Study||20
343813|NCT00553475|830528|P1|NOT COMPLETED|Overall Study||16
343814|NCT00553475|830526|P3|COMPLETED|Overall Study||32
343815|NCT00553475|830527|P2|COMPLETED|Overall Study||114
343816|NCT00553475|830528|P1|COMPLETED|Overall Study||119
343817|NCT00553475|830526|P3|STARTED|Overall Study||45
343818|NCT00553475|830527|P2|STARTED|Overall Study||134
343819|NCT00553475|830528|P1|STARTED|Overall Study||135
343820|NCT00553462|830650|P1|NOT COMPLETED|Overall Study||14
343821|NCT00553462|830650|P1|COMPLETED|Overall Study||61
343822|NCT00553462|830650|P1|STARTED|Overall Study||75
343823|NCT00553436|830656|P1|NOT COMPLETED|Overall Study||1
343824|NCT00553436|830656|P1|COMPLETED|Overall Study|09 April 2009|6
343825|NCT00553436|830656|P1|STARTED|Overall Study|20 August 2007|7
343826|NCT00553410|830664|P2|NOT COMPLETED|Overall Study||18
343827|NCT00553410|830665|P1|NOT COMPLETED|Overall Study||15
343828|NCT00553410|830664|P2|COMPLETED|Overall Study||2425
343829|NCT00553410|830665|P1|COMPLETED|Overall Study||2426
343830|NCT00553410|830664|P2|STARTED|Overall Study||2443
343831|NCT00553410|830665|P1|STARTED|Overall Study||2441
343832|NCT00553358|830680|P3|NOT COMPLETED|Overall Study||60
343833|NCT00553358|830681|P2|NOT COMPLETED|Overall Study||12
343834|NCT00553358|830682|P1|NOT COMPLETED|Overall Study||53
343835|NCT00553358|830680|P3|COMPLETED|Overall Study||92
343836|NCT00553358|830681|P2|COMPLETED|Overall Study||137
343837|NCT00553358|830682|P1|COMPLETED|Overall Study||101
343838|NCT00553358|830680|P3|STARTED|Overall Study||152
343839|NCT00553358|830681|P2|STARTED|Overall Study||149
343840|NCT00553358|830682|P1|STARTED|Overall Study||154
343841|NCT00553332|830708|P1|NOT COMPLETED|Overall Study||1
343842|NCT00553332|830708|P1|COMPLETED|Overall Study|evaluable for response|28
343843|NCT00553332|830708|P1|STARTED|Overall Study||29
343844|NCT00553319|830720|P3|NOT COMPLETED|Overall Study||9
343845|NCT00553319|830721|P2|NOT COMPLETED|Overall Study||10
343846|NCT00553319|830722|P1|NOT COMPLETED|Overall Study||14
343847|NCT00553319|830720|P3|COMPLETED|Overall Study||34
343848|NCT00553319|830721|P2|COMPLETED|Overall Study||30
343849|NCT00553319|830722|P1|COMPLETED|Overall Study||29
343850|NCT00553319|830720|P3|STARTED|Overall Study||43
343851|NCT00553319|830721|P2|STARTED|Overall Study||40
343852|NCT00553319|830722|P1|STARTED|Overall Study||43
343853|NCT00553280|830733|P1|NOT COMPLETED|Overall Study||26
343854|NCT00553280|830733|P1|COMPLETED|Overall Study||97
343855|NCT00553280|830733|P1|STARTED|Overall Study||123
343856|NCT00553267|830745|P3|NOT COMPLETED|Overall Study||10
343857|NCT00553267|830746|P2|NOT COMPLETED|Overall Study||18
343858|NCT00553267|830747|P1|NOT COMPLETED|Overall Study||14
343859|NCT00553267|830745|P3|COMPLETED|Overall Study||307
343860|NCT00553267|830746|P2|COMPLETED|Overall Study||297
343861|NCT00553267|830747|P1|COMPLETED|Overall Study||301
343862|NCT00553267|830745|P3|STARTED|Overall Study||317
343863|NCT00553267|830746|P2|STARTED|Overall Study||315
343864|NCT00553267|830747|P1|STARTED|Overall Study||315
343865|NCT00553202|830782|P1|NOT COMPLETED|Overall Study||68
343866|NCT00553202|830782|P1|COMPLETED|Overall Study||90
343867|NCT00553202|830782|P1|STARTED|Overall Study||158
343868|NCT00553163|830792|P2|NOT COMPLETED|Overall Study||0
343869|NCT00553163|830793|P1|NOT COMPLETED|Overall Study||0
343870|NCT00553163|830792|P2|COMPLETED|Overall Study||10
343871|NCT00553163|830793|P1|COMPLETED|Overall Study||16
343872|NCT00553163|830792|P2|STARTED|Overall Study||10
343873|NCT00553163|830793|P1|STARTED|Overall Study||16
343874|NCT00553150|830809|P4|NOT COMPLETED|Overall Study||4
343875|NCT00553150|830810|P3|NOT COMPLETED|Overall Study||0
343876|NCT00553150|830811|P2|NOT COMPLETED|Overall Study||0
343877|NCT00553150|830812|P1|NOT COMPLETED|Overall Study||0
343878|NCT00553150|830809|P4|COMPLETED|Overall Study||100
343879|NCT00553150|830810|P3|COMPLETED|Overall Study||6
343880|NCT00553150|830811|P2|COMPLETED|Overall Study||6
343881|NCT00553150|830812|P1|COMPLETED|Overall Study||6
343882|NCT00553150|830809|P4|STARTED|Overall Study||104
343883|NCT00553150|830810|P3|STARTED|Overall Study||6
343884|NCT00553150|830811|P2|STARTED|Overall Study||6
343885|NCT00553150|830812|P1|STARTED|Overall Study||6
343886|NCT00553098|830824|P1|NOT COMPLETED|Overall Study||1
343887|NCT00553098|830824|P1|COMPLETED|Overall Study||28
343888|NCT00553098|830824|P1|STARTED|Overall Study||29
343889|NCT00552929|830848|P10|NOT COMPLETED|Overall Study||0
343890|NCT00552929|830849|P9|NOT COMPLETED|Overall Study||1
343891|NCT00552929|830850|P8|NOT COMPLETED|Overall Study||0
343892|NCT00552929|830851|P7|NOT COMPLETED|Overall Study||0
343893|NCT00552929|830852|P6|NOT COMPLETED|Overall Study||1
343894|NCT00552929|830853|P5|NOT COMPLETED|Overall Study||0
343895|NCT00552929|830854|P4|NOT COMPLETED|Overall Study||0
343896|NCT00552929|830855|P3|NOT COMPLETED|Overall Study||0
343897|NCT00552929|830856|P2|NOT COMPLETED|Overall Study||0
343898|NCT00552929|830857|P1|NOT COMPLETED|Overall Study||0
343899|NCT00552929|830848|P10|COMPLETED|Overall Study||11
343900|NCT00552929|830849|P9|COMPLETED|Overall Study||9
343901|NCT00552929|830850|P8|COMPLETED|Overall Study||11
343902|NCT00552929|830851|P7|COMPLETED|Overall Study||10
343903|NCT00552929|830852|P6|COMPLETED|Overall Study||9
343904|NCT00552929|830853|P5|COMPLETED|Overall Study||10
343905|NCT00552929|830854|P4|COMPLETED|Overall Study||11
343906|NCT00552929|830855|P3|COMPLETED|Overall Study||10
343907|NCT00552929|830856|P2|COMPLETED|Overall Study||10
343908|NCT00552929|830857|P1|COMPLETED|Overall Study||9
343909|NCT00552929|830848|P10|Participants as Treated|Overall Study||11
343910|NCT00552929|830849|P9|Participants as Treated|Overall Study||10
343911|NCT00552929|830850|P8|Participants as Treated|Overall Study||11
343912|NCT00552929|830851|P7|Participants as Treated|Overall Study||10
343913|NCT00552929|830852|P6|Participants as Treated|Overall Study||9
343914|NCT00552929|830853|P5|Participants as Treated|Overall Study||10
343915|NCT00552929|830854|P4|Participants as Treated|Overall Study|One participant randomized to sugammadex 0.5 mg/kg received sugammadex 3.7 mg/kg (4.0 mg\kg group)|11
343916|NCT00552929|830855|P3|Participants as Treated|Overall Study||10
343917|NCT00552929|830856|P2|Participants as Treated|Overall Study||10
343918|NCT00552929|830857|P1|Participants as Treated|Overall Study|One participant randomized to sugammadex 0.5 mg/kg received sugammadex 3.7 mg/kg (4.0 mg\kg group)|9
343919|NCT00552929|830848|P10|STARTED|Overall Study||11
343920|NCT00552929|830849|P9|STARTED|Overall Study||10
343921|NCT00552929|830850|P8|STARTED|Overall Study||11
343922|NCT00552929|830851|P7|STARTED|Overall Study||10
343923|NCT00552929|830852|P6|STARTED|Overall Study||10
343924|NCT00552929|830853|P5|STARTED|Overall Study||10
343925|NCT00552929|830854|P4|STARTED|Overall Study||11
343926|NCT00552929|830855|P3|STARTED|Overall Study||10
343927|NCT00552929|830856|P2|STARTED|Overall Study||10
343928|NCT00552929|830857|P1|STARTED|Overall Study||9
343929|NCT00552812|830909|P1|NOT COMPLETED|Overall Study||20
343930|NCT00552812|830909|P1|COMPLETED|Overall Study|Some still remain inside the 2 year follow up window. 2 year follow up data is not yet complete.|85
343931|NCT00552812|830909|P1|STARTED|Overall Study|168 consents, 57 failed cath criteria, 5 met criteria but received covered stent, 1 withdrew consent|105
343932|NCT00552786|830917|P2|NOT COMPLETED|Second Intervention||0
343933|NCT00552786|830918|P1|NOT COMPLETED|Second Intervention||0
343934|NCT00552786|830917|P2|COMPLETED|Second Intervention||28
343935|NCT00552786|830918|P1|COMPLETED|Second Intervention||25
343936|NCT00552786|830917|P2|STARTED|Second Intervention||28
343937|NCT00552786|830918|P1|STARTED|Second Intervention||25
343938|NCT00552786|830917|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
343939|NCT00552786|830918|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
343940|NCT00552786|830917|P2|COMPLETED|Washout Period of 2 Weeks||28
343941|NCT00552786|830918|P1|COMPLETED|Washout Period of 2 Weeks||25
343942|NCT00552786|830917|P2|STARTED|Washout Period of 2 Weeks||28
343943|NCT00552786|830918|P1|STARTED|Washout Period of 2 Weeks||25
343944|NCT00552786|830917|P2|NOT COMPLETED|First Intervention||0
343945|NCT00552786|830918|P1|NOT COMPLETED|First Intervention||0
343946|NCT00552786|830917|P2|COMPLETED|First Intervention||28
343947|NCT00552786|830918|P1|COMPLETED|First Intervention||25
343948|NCT00552786|830917|P2|Medication and Hearing Evaluation|First Intervention||28
343949|NCT00552786|830918|P1|Medication and Hearing Evaluation|First Intervention||25
343950|NCT00552786|830917|P2|STARTED|First Intervention||28
343951|NCT00552786|830918|P1|STARTED|First Intervention||25
343952|NCT00552760|830928|P2|NOT COMPLETED|Overall Study||33
343953|NCT00552760|830929|P1|NOT COMPLETED|Overall Study||26
343954|NCT00552760|830928|P2|COMPLETED|Overall Study||8
343955|NCT00552760|830929|P1|COMPLETED|Overall Study||16
343956|NCT00552760|830928|P2|STARTED|Overall Study||41
343957|NCT00552760|830929|P1|STARTED|Overall Study||42
343958|NCT00552695|830945|P2|NOT COMPLETED|Overall Study||0
343959|NCT00552695|830946|P1|NOT COMPLETED|Overall Study||0
343960|NCT00552695|830945|P2|COMPLETED|Overall Study|September 2007|23
343961|NCT00552695|830946|P1|COMPLETED|Overall Study|September 2007|22
343962|NCT00552695|830945|P2|STARTED|Overall Study|August 2007|23
343963|NCT00552695|830946|P1|STARTED|Overall Study|August 2007|22
343964|NCT00552669|830956|P2|NOT COMPLETED|Overall Study||7
343965|NCT00552669|830957|P1|NOT COMPLETED|Overall Study||3
343966|NCT00552669|830956|P2|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|93
343967|NCT00552669|830957|P1|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|97
343968|NCT00552669|830956|P2|STARTED|Overall Study|patients|100
343969|NCT00552669|830957|P1|STARTED|Overall Study|patients|100
343970|NCT00552617|830977|P10|NOT COMPLETED|Overall Study||1
343971|NCT00552617|830978|P9|NOT COMPLETED|Overall Study||2
343972|NCT00552617|830979|P8|NOT COMPLETED|Overall Study||0
343973|NCT00552617|830980|P7|NOT COMPLETED|Overall Study||0
343974|NCT00552617|830981|P6|NOT COMPLETED|Overall Study||2
343975|NCT00552617|830982|P5|NOT COMPLETED|Overall Study||0
343976|NCT00552617|830983|P4|NOT COMPLETED|Overall Study||1
343977|NCT00552617|830984|P3|NOT COMPLETED|Overall Study||1
343978|NCT00552617|830985|P2|NOT COMPLETED|Overall Study||0
343979|NCT00552617|830986|P1|NOT COMPLETED|Overall Study||0
343980|NCT00552617|830977|P10|COMPLETED|Overall Study||9
343981|NCT00552617|830978|P9|COMPLETED|Overall Study||8
343982|NCT00552617|830979|P8|COMPLETED|Overall Study||10
343983|NCT00552617|830980|P7|COMPLETED|Overall Study||10
343984|NCT00552617|830981|P6|COMPLETED|Overall Study||8
343985|NCT00552617|830982|P5|COMPLETED|Overall Study||10
343986|NCT00552617|830983|P4|COMPLETED|Overall Study||9
343987|NCT00552617|830984|P3|COMPLETED|Overall Study||9
343988|NCT00552617|830985|P2|COMPLETED|Overall Study||10
343989|NCT00552617|830986|P1|COMPLETED|Overall Study||10
343990|NCT00552617|830977|P10|Treated|Overall Study||9
343991|NCT00552617|830978|P9|Treated|Overall Study||10
343992|NCT00552617|830979|P8|Treated|Overall Study||10
343993|NCT00552617|830980|P7|Treated|Overall Study||10
343994|NCT00552617|830981|P6|Treated|Overall Study||10
343995|NCT00552617|830982|P5|Treated|Overall Study||10
343996|NCT00552617|830983|P4|Treated|Overall Study||10
343997|NCT00552617|830984|P3|Treated|Overall Study||9
343998|NCT00552617|830985|P2|Treated|Overall Study||10
343999|NCT00552617|830986|P1|Treated|Overall Study||10
344000|NCT00552617|830977|P10|STARTED|Overall Study||10
344001|NCT00552617|830978|P9|STARTED|Overall Study||10
344002|NCT00552617|830979|P8|STARTED|Overall Study||10
344003|NCT00552617|830980|P7|STARTED|Overall Study||10
344004|NCT00552617|830981|P6|STARTED|Overall Study||10
344005|NCT00552617|830982|P5|STARTED|Overall Study||10
344006|NCT00552617|830983|P4|STARTED|Overall Study||10
344007|NCT00552617|830984|P3|STARTED|Overall Study||10
344008|NCT00552617|830985|P2|STARTED|Overall Study||10
344009|NCT00552617|830986|P1|STARTED|Overall Study||10
344010|NCT00552578|831030|P2|NOT COMPLETED|Overall Study||1
344011|NCT00552578|831031|P1|NOT COMPLETED|Overall Study||1
344012|NCT00552578|831030|P2|COMPLETED|Overall Study||5
344013|NCT00552578|831031|P1|COMPLETED|Overall Study||5
344014|NCT00552578|831030|P2|STARTED|Overall Study||6
344015|NCT00552578|831031|P1|STARTED|Overall Study||6
344016|NCT00552513|831043|P2|NOT COMPLETED|Overall Study||1
344017|NCT00552513|831044|P1|NOT COMPLETED|Overall Study||5
344018|NCT00552513|831043|P2|COMPLETED|Overall Study||1437
344019|NCT00552513|831044|P1|COMPLETED|Overall Study||1588
344020|NCT00552513|831043|P2|STARTED|Overall Study||1438
344021|NCT00552513|831044|P1|STARTED|Overall Study||1593
344022|NCT00552448|831056|P2|NOT COMPLETED|Overall Study||0
344023|NCT00552448|831057|P1|NOT COMPLETED|Overall Study||1
344024|NCT00552448|831056|P2|COMPLETED|Overall Study||16
344025|NCT00552448|831057|P1|COMPLETED|Overall Study||19
344026|NCT00552448|831056|P2|STARTED|Overall Study||16
344027|NCT00552448|831057|P1|STARTED|Overall Study||20
344028|NCT00552422|831069|P1|NOT COMPLETED|Overall Study||0
344029|NCT00552422|831069|P1|COMPLETED|Overall Study||6
344030|NCT00552422|831069|P1|STARTED|Overall Study||6
344031|NCT00552409|831075|P2|NOT COMPLETED|Overall Study||2
344032|NCT00552409|831076|P1|NOT COMPLETED|Overall Study||1
344033|NCT00552409|831075|P2|COMPLETED|Overall Study||9
344034|NCT00552409|831076|P1|COMPLETED|Overall Study||10
344035|NCT00552409|831075|P2|STARTED|Overall Study||11
344036|NCT00552409|831076|P1|STARTED|Overall Study||11
344037|NCT00552396|831089|P7|NOT COMPLETED|Overall Study||9
344038|NCT00552396|831090|P6|NOT COMPLETED|Overall Study||3
344039|NCT00552396|831091|P5|NOT COMPLETED|Overall Study||3
344040|NCT00552396|831092|P4|NOT COMPLETED|Overall Study||6
344041|NCT00552396|831093|P3|NOT COMPLETED|Overall Study||3
344042|NCT00552396|831094|P2|NOT COMPLETED|Overall Study||3
344043|NCT00552396|831095|P1|NOT COMPLETED|Overall Study||3
344044|NCT00552396|831089|P7|COMPLETED|Overall Study||1
344045|NCT00552396|831090|P6|COMPLETED|Overall Study||0
344046|NCT00552396|831091|P5|COMPLETED|Overall Study||0
344047|NCT00552396|831092|P4|COMPLETED|Overall Study||0
344048|NCT00552396|831093|P3|COMPLETED|Overall Study||0
344049|NCT00552396|831094|P2|COMPLETED|Overall Study||0
344050|NCT00552396|831095|P1|COMPLETED|Overall Study||1
344051|NCT00552396|831089|P7|STARTED|Overall Study||10
344052|NCT00552396|831090|P6|STARTED|Overall Study||3
344053|NCT00552396|831091|P5|STARTED|Overall Study||3
344054|NCT00552396|831092|P4|STARTED|Overall Study||6
344055|NCT00552396|831093|P3|STARTED|Overall Study||3
344056|NCT00552396|831094|P2|STARTED|Overall Study||3
344057|NCT00552396|831095|P1|STARTED|Overall Study||4
344058|NCT00552344|831132|P1|NOT COMPLETED|Overall Study||315
344059|NCT00552344|831132|P1|COMPLETED|Overall Study||87
344060|NCT00552344|831132|P1|STARTED|Overall Study||402
344061|NCT00552305|831141|P1|NOT COMPLETED|Overall Study||250
344062|NCT00552305|831141|P1|COMPLETED|Overall Study||120
344063|NCT00552305|831141|P1|STARTED|Overall Study||370
344064|NCT00552279|831151|P2|NOT COMPLETED|Overall Study||3
344065|NCT00552279|831152|P1|NOT COMPLETED|Overall Study||14
344066|NCT00552279|831151|P2|COMPLETED|Overall Study||398
344067|NCT00552279|831152|P1|COMPLETED|Overall Study||389
344068|NCT00552279|831151|P2|STARTED|Overall Study||401
344069|NCT00552279|831152|P1|STARTED|Overall Study||403
344070|NCT00552240|831178|P2|NOT COMPLETED|Overall Study||18
344071|NCT00552240|831179|P1|NOT COMPLETED|Overall Study||24
344072|NCT00552240|831178|P2|COMPLETED|Overall Study||59
344073|NCT00552240|831179|P1|COMPLETED|Overall Study||51
344074|NCT00552240|831178|P2|STARTED|Overall Study|Number in Full Analysis Set (FAS)|77
344075|NCT00552240|831179|P1|STARTED|Overall Study|Number in Full Analysis Set (FAS)|75
344076|NCT00552188|831281|P2|NOT COMPLETED|Overall Study||5
344077|NCT00552188|831282|P1|NOT COMPLETED|Overall Study||2
344078|NCT00552188|831281|P2|COMPLETED|Overall Study||21
344079|NCT00552188|831282|P1|COMPLETED|Overall Study||24
344080|NCT00552188|831281|P2|STARTED|Overall Study||26
344081|NCT00552188|831282|P1|STARTED|Overall Study||26
344082|NCT00552175|831293|P3|NOT COMPLETED|Overall Study||14
344083|NCT00552175|831294|P2|NOT COMPLETED|Overall Study||13
344084|NCT00552175|831295|P1|NOT COMPLETED|Overall Study||17
344085|NCT00552175|831293|P3|COMPLETED|Overall Study||72
344086|NCT00552175|831294|P2|COMPLETED|Overall Study||73
344087|NCT00552175|831295|P1|COMPLETED|Overall Study||150
344088|NCT00552175|831293|P3|Full Analysis Set Population|Overall Study||86
344089|NCT00552175|831294|P2|Full Analysis Set Population|Overall Study||85
344090|NCT00552175|831295|P1|Full Analysis Set Population|Overall Study||167
344091|NCT00552175|831293|P3|STARTED|Overall Study||86
344092|NCT00552175|831294|P2|STARTED|Overall Study||86
344093|NCT00552175|831295|P1|STARTED|Overall Study||167
344094|NCT00552110|831335|P5|NOT COMPLETED|Overall Study||9
344095|NCT00552110|831336|P4|NOT COMPLETED|Overall Study||8
344096|NCT00552110|831337|P3|NOT COMPLETED|Overall Study||2
344097|NCT00552110|831338|P2|NOT COMPLETED|Overall Study||5
344098|NCT00552110|831339|P1|NOT COMPLETED|Overall Study||4
344099|NCT00552110|831335|P5|COMPLETED|Overall Study||133
344100|NCT00552110|831336|P4|COMPLETED|Overall Study||133
344101|NCT00552110|831337|P3|COMPLETED|Overall Study||137
344102|NCT00552110|831338|P2|COMPLETED|Overall Study||134
344103|NCT00552110|831339|P1|COMPLETED|Overall Study||142
344104|NCT00552110|831335|P5|STARTED|Overall Study||142
344105|NCT00552110|831336|P4|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|141
344106|NCT00552110|831337|P3|STARTED|Overall Study||139
344107|NCT00552110|831338|P2|STARTED|Overall Study||139
344108|NCT00552110|831339|P1|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|146
344109|NCT00552084|831358|P2|NOT COMPLETED|Overall Study||9
344110|NCT00552084|831359|P1|NOT COMPLETED|Overall Study||8
344111|NCT00552084|831358|P2|COMPLETED|Overall Study||55
344112|NCT00552084|831359|P1|COMPLETED|Overall Study||118
344113|NCT00552084|831358|P2|STARTED|Overall Study||64
344114|NCT00552084|831359|P1|STARTED|Overall Study||126
344115|NCT00552071|831367|P2|NOT COMPLETED|Overall Study||2
344116|NCT00552071|831368|P1|NOT COMPLETED|Overall Study||4
344117|NCT00552071|831367|P2|COMPLETED|Overall Study||9
344118|NCT00552071|831368|P1|COMPLETED|Overall Study||6
344119|NCT00552071|831367|P2|STARTED|Overall Study||11
344120|NCT00552071|831368|P1|STARTED|Overall Study||10
344121|NCT00552058|831378|P2|NOT COMPLETED|Overall Study||24
344122|NCT00552058|831379|P1|NOT COMPLETED|Overall Study||16
344123|NCT00552058|831378|P2|COMPLETED|Overall Study||192
344124|NCT00552058|831379|P1|COMPLETED|Overall Study||207
344125|NCT00552058|831378|P2|STARTED|Overall Study||216
344126|NCT00552058|831379|P1|STARTED|Overall Study||223
344127|NCT00552032|831419|P2|NOT COMPLETED|Overall Study||19
344128|NCT00552032|831420|P1|NOT COMPLETED|Overall Study||17
344129|NCT00552032|831419|P2|COMPLETED|Overall Study||47
344130|NCT00552032|831420|P1|COMPLETED|Overall Study||49
344131|NCT00552032|831419|P2|STARTED|Overall Study||66
344132|NCT00552032|831420|P1|STARTED|Overall Study||66
344133|NCT00551759|831464|P1|NOT COMPLETED|Overall Study||13
344134|NCT00551759|831464|P1|COMPLETED|Overall Study||9
344135|NCT00551759|831464|P1|Received Adjuvant Therapy|Overall Study||12
344136|NCT00551759|831464|P1|Underwent Surgery|Overall Study||17
344137|NCT00551759|831464|P1|Eligible and Began Treatment|Overall Study||21
344138|NCT00551759|831464|P1|STARTED|Overall Study||22
344139|NCT00551746|831470|P2|NOT COMPLETED|Overall Study||8
344140|NCT00551746|831471|P1|NOT COMPLETED|Overall Study||11
344141|NCT00551746|831470|P2|COMPLETED|Overall Study||26
344142|NCT00551746|831471|P1|COMPLETED|Overall Study||25
344143|NCT00551746|831470|P2|STARTED|Overall Study||34
344144|NCT00551746|831471|P1|STARTED|Overall Study||36
344145|NCT00551707|831482|P5|NOT COMPLETED|Overall Study||1
344146|NCT00551707|831483|P4|NOT COMPLETED|Overall Study||4
344147|NCT00551707|831484|P3|NOT COMPLETED|Overall Study||3
344148|NCT00551707|831485|P2|NOT COMPLETED|Overall Study||6
344149|NCT00551707|831486|P1|NOT COMPLETED|Overall Study||0
344150|NCT00551707|831482|P5|COMPLETED|Overall Study||3
344151|NCT00551707|831483|P4|COMPLETED|Overall Study||4
344152|NCT00551707|831484|P3|COMPLETED|Overall Study||10
344153|NCT00551707|831485|P2|COMPLETED|Overall Study||16
344154|NCT00551707|831486|P1|COMPLETED|Overall Study||4
344155|NCT00551707|831482|P5|STARTED|Overall Study||4
344156|NCT00551707|831483|P4|STARTED|Overall Study||8
344157|NCT00551707|831484|P3|STARTED|Overall Study||13
344158|NCT00551707|831485|P2|STARTED|Overall Study||22
344159|NCT00551707|831486|P1|STARTED|Overall Study||4
344160|NCT00551642|831505|P2|NOT COMPLETED|Overall Study||63
344161|NCT00551642|831506|P1|NOT COMPLETED|Overall Study||61
344162|NCT00551642|831505|P2|COMPLETED|Overall Study||338
344163|NCT00551642|831506|P1|COMPLETED|Overall Study||338
344164|NCT00551642|831505|P2|STARTED|Overall Study||401
344165|NCT00551642|831506|P1|STARTED|Overall Study||399
344166|NCT00551525|831512|P1|NOT COMPLETED|Overall Study||5
344167|NCT00551525|831512|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study|62
344168|NCT00551525|831512|P1|STARTED|Overall Study||67
344169|NCT00551460|831521|P1|NOT COMPLETED|Overall Study||18
344170|NCT00551460|831521|P1|COMPLETED|Overall Study||60
344171|NCT00551460|831521|P1|STARTED|Overall Study||78
344172|NCT00551421|831527|P1|NOT COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||1
344173|NCT00551421|831527|P1|COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||13
344174|NCT00551421|831527|P1|STARTED|Amended Protocol (Cetuximab-refr. mCRC)||14
344175|NCT00551421|831527|P1|NOT COMPLETED|Original Protocol, Dose Level 1||0
344176|NCT00551421|831527|P1|COMPLETED|Original Protocol, Dose Level 1|1 subject developed Grade 3 diarrhea, all 3 subjects experienced significant skin toxicity.|3
344177|NCT00551421|831527|P1|STARTED|Original Protocol, Dose Level 1||3
344178|NCT00551369|831534|P1|NOT COMPLETED|Overall Study||7
344179|NCT00551369|831534|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|26
344180|NCT00551369|831534|P1|STARTED|Overall Study||33
344181|NCT00551291|831543|P1|NOT COMPLETED|Overall Study||1
344182|NCT00551291|831543|P1|COMPLETED|Overall Study||9
344183|NCT00551291|831543|P1|STARTED|Overall Study||10
344184|NCT00551213|831551|P2|NOT COMPLETED|Overall Study||17
344185|NCT00551213|831552|P1|NOT COMPLETED|Overall Study||50
344186|NCT00551213|831551|P2|COMPLETED|Overall Study||0
344187|NCT00551213|831552|P1|COMPLETED|Overall Study||0
344188|NCT00551213|831551|P2|Treated|Overall Study||15
344189|NCT00551213|831552|P1|Treated|Overall Study||49
344190|NCT00551213|831551|P2|STARTED|Overall Study||17
344191|NCT00551213|831552|P1|STARTED|Overall Study||50
344192|NCT00551200|831568|P1|NOT COMPLETED|Overall Study||4
344193|NCT00551200|831568|P1|COMPLETED|Overall Study||10
344194|NCT00551200|831568|P1|STARTED|Overall Study||14
344195|NCT00551174|831583|P2|NOT COMPLETED|Overall Study||6
344196|NCT00551174|831584|P1|NOT COMPLETED|Overall Study||19
344197|NCT00551174|831583|P2|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|394
344198|NCT00551174|831584|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|362
344199|NCT00551174|831583|P2|STARTED|Overall Study||400
344200|NCT00551174|831584|P1|STARTED|Overall Study||381
344201|NCT00551161|831596|P1|NOT COMPLETED|Overall Study||1
344202|NCT00551161|831596|P1|COMPLETED|Overall Study||11
344203|NCT00551161|831596|P1|STARTED|Overall Study||12
344204|NCT00551135|831604|P4|NOT COMPLETED|Overall Study||5
344205|NCT00551135|831605|P3|NOT COMPLETED|Overall Study||5
344206|NCT00551135|831606|P2|NOT COMPLETED|Overall Study||2
344207|NCT00551135|831607|P1|NOT COMPLETED|Overall Study||5
344208|NCT00551135|831604|P4|COMPLETED|Overall Study||103
344209|NCT00551135|831605|P3|COMPLETED|Overall Study||98
344210|NCT00551135|831606|P2|COMPLETED|Overall Study||104
344211|NCT00551135|831607|P1|COMPLETED|Overall Study||103
344212|NCT00551135|831604|P4|STARTED|Overall Study||108
344213|NCT00551135|831605|P3|STARTED|Overall Study||103
344214|NCT00551135|831606|P2|STARTED|Overall Study||106
344215|NCT00551135|831607|P1|STARTED|Overall Study||108
344216|NCT00551070|831721|P1|NOT COMPLETED|Overall Study||0
344217|NCT00551070|831721|P1|COMPLETED|Overall Study||52
344218|NCT00551070|831721|P1|STARTED|Overall Study||52
344219|NCT00551031|831736|P5|NOT COMPLETED|Overall Study||1
344220|NCT00551031|831737|P4|NOT COMPLETED|Overall Study||3
344221|NCT00551031|831738|P3|NOT COMPLETED|Overall Study||2
344222|NCT00551031|831739|P2|NOT COMPLETED|Overall Study||11
344223|NCT00551031|831740|P1|NOT COMPLETED|Overall Study||2
344224|NCT00551031|831736|P5|COMPLETED|Overall Study||185
344225|NCT00551031|831737|P4|COMPLETED|Overall Study||317
344226|NCT00551031|831738|P3|COMPLETED|Overall Study||317
344227|NCT00551031|831739|P2|COMPLETED|Overall Study||625
344228|NCT00551031|831740|P1|COMPLETED|Overall Study||635
344229|NCT00551031|831736|P5|STARTED|Overall Study||186
344230|NCT00551031|831737|P4|STARTED|Overall Study||320
344231|NCT00551031|831738|P3|STARTED|Overall Study||319
344232|NCT00551031|831739|P2|STARTED|Overall Study||636
344233|NCT00551031|831740|P1|STARTED|Overall Study||637
344234|NCT00550953|831769|P2|NOT COMPLETED|Overall Study||6
344235|NCT00550953|831770|P1|NOT COMPLETED|Overall Study||6
344236|NCT00550953|831769|P2|COMPLETED|Overall Study||152
344237|NCT00550953|831770|P1|COMPLETED|Overall Study||150
344238|NCT00550953|831769|P2|STARTED|Overall Study||158
344239|NCT00550953|831770|P1|STARTED|Overall Study||156
344240|NCT00550862|831794|P4|NOT COMPLETED|Overall Study||1
344241|NCT00550862|831795|P3|NOT COMPLETED|Overall Study||16
344242|NCT00550862|831796|P2|NOT COMPLETED|Overall Study||6
344243|NCT00550862|831797|P1|NOT COMPLETED|Overall Study||6
344244|NCT00550862|831794|P4|COMPLETED|Overall Study||37
344245|NCT00550862|831795|P3|COMPLETED|Overall Study||25
344246|NCT00550862|831796|P2|COMPLETED|Overall Study||42
344247|NCT00550862|831797|P1|COMPLETED|Overall Study||32
344248|NCT00550862|831794|P4|STARTED|Overall Study||38
344249|NCT00550862|831795|P3|STARTED|Overall Study||41
344250|NCT00550862|831796|P2|STARTED|Overall Study||48
344251|NCT00550862|831797|P1|STARTED|Overall Study||38
344252|NCT00550836|831817|P2|NOT COMPLETED|Overall Study||9
344253|NCT00550836|831818|P1|NOT COMPLETED|Overall Study||3
344254|NCT00550836|831817|P2|COMPLETED|Overall Study||46
344255|NCT00550836|831818|P1|COMPLETED|Overall Study||46
344256|NCT00550836|831817|P2|STARTED|Overall Study||55
344257|NCT00550836|831818|P1|STARTED|Overall Study||49
344258|NCT00550771|831834|P2|NOT COMPLETED|Overall Study||10
344259|NCT00550771|831835|P1|NOT COMPLETED|Overall Study||17
344260|NCT00550771|831834|P2|COMPLETED|Overall Study||50
344261|NCT00550771|831835|P1|COMPLETED|Overall Study||104
344262|NCT00550771|831834|P2|STARTED|Overall Study||60
344263|NCT00550771|831835|P1|STARTED|Overall Study||121
344264|NCT00550745|831849|P2|NOT COMPLETED|Overall Study||60
344265|NCT00550745|831850|P1|NOT COMPLETED|Overall Study||87
344266|NCT00550745|831849|P2|COMPLETED|Overall Study||5939
344267|NCT00550745|831850|P1|COMPLETED|Overall Study||5913
344268|NCT00550745|831849|P2|STARTED|Overall Study||5999
344269|NCT00550745|831850|P1|STARTED|Overall Study||6000
344270|NCT00550732|831858|P1|NOT COMPLETED|Overall Study||11
344271|NCT00550732|831858|P1|COMPLETED|Overall Study||29
344272|NCT00550732|831858|P1|STARTED|Overall Study||40
344273|NCT00550680|831869|P1|NOT COMPLETED|Overall Study||56
344274|NCT00550680|831869|P1|COMPLETED|Overall Study||152
344275|NCT00550680|831869|P1|STARTED|Overall Study||208
344276|NCT00550654|831878|P1|NOT COMPLETED|Overall Study||0
344277|NCT00550654|831878|P1|COMPLETED|Overall Study||1
344278|NCT00550654|831878|P1|STARTED|Overall Study||1
344279|NCT00550615|831890|P4|NOT COMPLETED|Overall Study||10
344280|NCT00550615|831891|P3|NOT COMPLETED|Overall Study||4
344281|NCT00550615|831892|P2|NOT COMPLETED|Overall Study||0
344282|NCT00550615|831893|P1|NOT COMPLETED|Overall Study||0
344283|NCT00550615|831890|P4|COMPLETED|Overall Study||12
344284|NCT00550615|831891|P3|COMPLETED|Overall Study||6
344285|NCT00550615|831892|P2|COMPLETED|Overall Study||3
344286|NCT00550615|831893|P1|COMPLETED|Overall Study||3
344287|NCT00550615|831890|P4|STARTED|Overall Study||22
344288|NCT00550615|831891|P3|STARTED|Overall Study||10
344289|NCT00550615|831892|P2|STARTED|Overall Study||3
344290|NCT00550615|831893|P1|STARTED|Overall Study||3
344291|NCT00550589|831899|P1|NOT COMPLETED|Overall Study||0
344292|NCT00550589|831899|P1|COMPLETED|Overall Study||33
344293|NCT00550589|831899|P1|STARTED|Overall Study||33
344294|NCT00550550|831912|P2|NOT COMPLETED|Overall Study||29
344295|NCT00550550|831913|P1|NOT COMPLETED|Overall Study||34
344296|NCT00550550|831912|P2|COMPLETED|Overall Study||140
344297|NCT00550550|831913|P1|COMPLETED|Overall Study||142
344298|NCT00550550|831912|P2|Number Treated|Overall Study||169
344299|NCT00550550|831913|P1|Number Treated|Overall Study||175
344300|NCT00550550|831912|P2|STARTED|Overall Study||169
344301|NCT00550550|831913|P1|STARTED|Overall Study||176
344302|NCT00550537|831925|P1|NOT COMPLETED|Overall Study||104
344303|NCT00550537|831925|P1|COMPLETED|Overall Study||12
344304|NCT00550537|831925|P1|STARTED|Overall Study||116
344305|NCT00550459|831942|P2|NOT COMPLETED|Overall Study||3
344306|NCT00550459|831943|P1|NOT COMPLETED|Overall Study||1
344307|NCT00550459|831942|P2|COMPLETED|Overall Study||26
344308|NCT00550459|831943|P1|COMPLETED|Overall Study||27
344309|NCT00550459|831942|P2|STARTED|Overall Study||29
344310|NCT00550459|831943|P1|STARTED|Overall Study||28
344311|NCT00550446|832012|P11|NOT COMPLETED|Post Week 12||1
344312|NCT00550446|832013|P10|NOT COMPLETED|Post Week 12||7
344313|NCT00550446|832014|P9|NOT COMPLETED|Post Week 12||2
344314|NCT00550446|832015|P8|NOT COMPLETED|Post Week 12||1
344315|NCT00550446|832016|P7|NOT COMPLETED|Post Week 12||2
344316|NCT00550446|832017|P6|NOT COMPLETED|Post Week 12||1
344317|NCT00550446|832018|P5|NOT COMPLETED|Post Week 12||2
344318|NCT00550446|832019|P4|NOT COMPLETED|Post Week 12||3
344319|NCT00550446|832020|P3|NOT COMPLETED|Post Week 12||3
344320|NCT00550446|832021|P2|NOT COMPLETED|Post Week 12||2
344321|NCT00550446|832022|P1|NOT COMPLETED|Post Week 12||3
344322|NCT00550446|832012|P11|COMPLETED|Post Week 12||24
344323|NCT00550446|832013|P10|COMPLETED|Post Week 12||37
344324|NCT00550446|832014|P9|COMPLETED|Post Week 12||15
344325|NCT00550446|832015|P8|COMPLETED|Post Week 12||16
344326|NCT00550446|832016|P7|COMPLETED|Post Week 12||19
344327|NCT00550446|832017|P6|COMPLETED|Post Week 12||0
344328|NCT00550446|832018|P5|COMPLETED|Post Week 12||52
344329|NCT00550446|832019|P4|COMPLETED|Post Week 12||55
344330|NCT00550446|832020|P3|COMPLETED|Post Week 12||43
344331|NCT00550446|832021|P2|COMPLETED|Post Week 12||28
344332|NCT00550446|832022|P1|COMPLETED|Post Week 12||24
344333|NCT00550446|832012|P11|STARTED|Post Week 12||25
344334|NCT00550446|832013|P10|STARTED|Post Week 12||44
344335|NCT00550446|832014|P9|STARTED|Post Week 12||17
344336|NCT00550446|832015|P8|STARTED|Post Week 12||17
344337|NCT00550446|832016|P7|STARTED|Post Week 12||21
344338|NCT00550446|832017|P6|STARTED|Post Week 12||1
344339|NCT00550446|832018|P5|STARTED|Post Week 12||54
344340|NCT00550446|832019|P4|STARTED|Post Week 12||58
344341|NCT00550446|832020|P3|STARTED|Post Week 12||46
344342|NCT00550446|832021|P2|STARTED|Post Week 12||30
344343|NCT00550446|832022|P1|STARTED|Post Week 12||27
344344|NCT00550446|832012|P11|NOT COMPLETED|Up To Week 12||0
344345|NCT00550446|832013|P10|NOT COMPLETED|Up To Week 12||0
344346|NCT00550446|832014|P9|NOT COMPLETED|Up To Week 12||0
344347|NCT00550446|832015|P8|NOT COMPLETED|Up To Week 12||0
344348|NCT00550446|832016|P7|NOT COMPLETED|Up To Week 12||13
344349|NCT00550446|832017|P6|NOT COMPLETED|Up To Week 12||8
344350|NCT00550446|832018|P5|NOT COMPLETED|Up To Week 12||3
344351|NCT00550446|832019|P4|NOT COMPLETED|Up To Week 12||3
344352|NCT00550446|832020|P3|NOT COMPLETED|Up To Week 12||4
344353|NCT00550446|832021|P2|NOT COMPLETED|Up To Week 12||5
344354|NCT00550446|832022|P1|NOT COMPLETED|Up To Week 12||10
344355|NCT00550446|832012|P11|COMPLETED|Up To Week 12||0
344356|NCT00550446|832013|P10|COMPLETED|Up To Week 12||0
344357|NCT00550446|832014|P9|COMPLETED|Up To Week 12||0
344358|NCT00550446|832015|P8|COMPLETED|Up To Week 12||0
344359|NCT00550446|832016|P7|COMPLETED|Up To Week 12||46
344360|NCT00550446|832017|P6|COMPLETED|Up To Week 12||45
344361|NCT00550446|832018|P5|COMPLETED|Up To Week 12||54
344362|NCT00550446|832019|P4|COMPLETED|Up To Week 12||58
344363|NCT00550446|832020|P3|COMPLETED|Up To Week 12||46
344364|NCT00550446|832021|P2|COMPLETED|Up To Week 12||47
344365|NCT00550446|832022|P1|COMPLETED|Up To Week 12||44
344366|NCT00550446|832012|P11|Treated|Up To Week 12||0
344367|NCT00550446|832013|P10|Treated|Up To Week 12||0
344368|NCT00550446|832014|P9|Treated|Up To Week 12||0
344369|NCT00550446|832015|P8|Treated|Up To Week 12||0
344370|NCT00550446|832016|P7|Treated|Up To Week 12||59
344371|NCT00550446|832017|P6|Treated|Up To Week 12||53
344372|NCT00550446|832018|P5|Treated|Up To Week 12||57
344373|NCT00550446|832019|P4|Treated|Up To Week 12||61
344374|NCT00550446|832020|P3|Treated|Up To Week 12||49
344375|NCT00550446|832021|P2|Treated|Up To Week 12||51
344376|NCT00550446|832022|P1|Treated|Up To Week 12||54
344377|NCT00550446|832012|P11|STARTED|Up To Week 12||0
344378|NCT00550446|832013|P10|STARTED|Up To Week 12||0
344379|NCT00550446|832014|P9|STARTED|Up To Week 12||0
344380|NCT00550446|832015|P8|STARTED|Up To Week 12||0
344381|NCT00550446|832016|P7|STARTED|Up To Week 12||59
344382|NCT00550446|832017|P6|STARTED|Up To Week 12||53
344383|NCT00550446|832018|P5|STARTED|Up To Week 12||57
344384|NCT00550446|832019|P4|STARTED|Up To Week 12||61
344385|NCT00550446|832020|P3|STARTED|Up To Week 12||50
344386|NCT00550446|832021|P2|STARTED|Up To Week 12||52
344387|NCT00550446|832022|P1|STARTED|Up To Week 12||54
344388|NCT00550420|832454|P1|NOT COMPLETED|Overall Study||305
344389|NCT00550420|832454|P1|COMPLETED|Overall Study||26
344390|NCT00550420|832454|P1|STARTED|Overall Study||331
344391|NCT00550407|832477|P3|NOT COMPLETED|26-Week Randomized Phase||24
344392|NCT00550407|832478|P2|NOT COMPLETED|26-Week Randomized Phase||43
344393|NCT00550407|832479|P1|NOT COMPLETED|26-Week Randomized Phase||0
344394|NCT00550407|832477|P3|COMPLETED|26-Week Randomized Phase||21
344395|NCT00550407|832478|P2|COMPLETED|26-Week Randomized Phase||15
344396|NCT00550407|832479|P1|COMPLETED|26-Week Randomized Phase||0
344397|NCT00550407|832477|P3|STARTED|26-Week Randomized Phase||45
344398|NCT00550407|832478|P2|STARTED|26-Week Randomized Phase||58
344399|NCT00550407|832479|P1|STARTED|26-Week Randomized Phase||0
344400|NCT00550407|832477|P3|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
344401|NCT00550407|832478|P2|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
344402|NCT00550407|832479|P1|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||112
344403|NCT00550407|832477|P3|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
344404|NCT00550407|832478|P2|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
344405|NCT00550407|832479|P1|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||103
344406|NCT00550407|832477|P3|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
344407|NCT00550407|832478|P2|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
344408|NCT00550407|832479|P1|STARTED|8-16 Week Preliminary (Open-Label) Phase||215
344409|NCT00550394|832514|P2|NOT COMPLETED|Overall Study||13
344410|NCT00550394|832515|P1|NOT COMPLETED|Overall Study||12
344411|NCT00550394|832514|P2|COMPLETED|Overall Study||5
344412|NCT00550394|832515|P1|COMPLETED|Overall Study||9
344413|NCT00550394|832514|P2|STARTED|Overall Study||18
344414|NCT00550394|832515|P1|STARTED|Overall Study||21
344415|NCT00550368|832529|P2|NOT COMPLETED|Overall Study||0
344416|NCT00550368|832530|P1|NOT COMPLETED|Overall Study||0
344417|NCT00550368|832529|P2|COMPLETED|Overall Study||19
344418|NCT00550368|832530|P1|COMPLETED|Overall Study||26
344419|NCT00550368|832529|P2|STARTED|Overall Study||19
344420|NCT00550368|832530|P1|STARTED|Overall Study||26
344421|NCT00550290|832540|P2|NOT COMPLETED|Overall Study||0
344422|NCT00550290|832541|P1|NOT COMPLETED|Overall Study||0
344423|NCT00550290|832540|P2|COMPLETED|Overall Study||8
344424|NCT00550290|832541|P1|COMPLETED|Overall Study||10
344425|NCT00550290|832540|P2|STARTED|Overall Study||8
344426|NCT00550290|832541|P1|STARTED|Overall Study||10
344427|NCT00550277|832547|P1|NOT COMPLETED|Overall Study||9
344428|NCT00550277|832547|P1|COMPLETED|Overall Study||11
344429|NCT00550277|832547|P1|STARTED|Overall Study||20
344430|NCT00550238|832551|P1|NOT COMPLETED|Overall Study||459
344431|NCT00550238|832551|P1|COMPLETED|Overall Study||0
344432|NCT00550238|832551|P1|STARTED|Overall Study||459
344433|NCT00550173|832558|P3|NOT COMPLETED|Overall Study||73
344434|NCT00550173|832559|P2|NOT COMPLETED|Overall Study||63
344435|NCT00550173|832560|P1|NOT COMPLETED|Overall Study||72
344436|NCT00550173|832558|P3|COMPLETED|Overall Study||11
344437|NCT00550173|832559|P2|COMPLETED|Overall Study||19
344438|NCT00550173|832560|P1|COMPLETED|Overall Study||9
344439|NCT00550173|832558|P3|Not Discontinued at 18 Months|Overall Study||11
344440|NCT00550173|832559|P2|Not Discontinued at 18 Months|Overall Study||19
344441|NCT00550173|832560|P1|Not Discontinued at 18 Months|Overall Study||9
344442|NCT00550173|832558|P3|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|80
344443|NCT00550173|832559|P2|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|82
344444|NCT00550173|832560|P1|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|78
344445|NCT00550173|832558|P3|STARTED|Overall Study||84
344446|NCT00550173|832559|P2|STARTED|Overall Study||82
344447|NCT00550173|832560|P1|STARTED|Overall Study||81
344448|NCT00550147|832589|P1|NOT COMPLETED|Quetiapine Addition Treatment Period||6
344449|NCT00550147|832589|P1|COMPLETED|Quetiapine Addition Treatment Period||18
344450|NCT00550147|832589|P1|STARTED|Quetiapine Addition Treatment Period||24
344451|NCT00550147|832589|P1|NOT COMPLETED|OROS Methylphenidate Monotherapy||6
344452|NCT00550147|832589|P1|COMPLETED|OROS Methylphenidate Monotherapy||24
344453|NCT00550147|832589|P1|STARTED|OROS Methylphenidate Monotherapy||30
344454|NCT00550043|832612|P5|NOT COMPLETED|Overall Study||1
344455|NCT00550043|832613|P4|NOT COMPLETED|Overall Study||2
344456|NCT00550043|832614|P3|NOT COMPLETED|Overall Study||1
344457|NCT00550043|832615|P2|NOT COMPLETED|Overall Study||3
344458|NCT00550043|832616|P1|NOT COMPLETED|Overall Study||0
344459|NCT00550043|832612|P5|COMPLETED|Overall Study||9
344460|NCT00550043|832613|P4|COMPLETED|Overall Study||8
344461|NCT00550043|832614|P3|COMPLETED|Overall Study||8
344462|NCT00550043|832615|P2|COMPLETED|Overall Study||9
344463|NCT00550043|832616|P1|COMPLETED|Overall Study||9
344464|NCT00550043|832612|P5|STARTED|Overall Study||10
344465|NCT00550043|832613|P4|STARTED|Overall Study||10
344466|NCT00550043|832614|P3|STARTED|Overall Study||9
344467|NCT00550043|832615|P2|STARTED|Overall Study||12
344468|NCT00550043|832616|P1|STARTED|Overall Study||9
344469|NCT00549939|832671|P3|NOT COMPLETED|40-week Open Label Treatment Period||5
344470|NCT00549939|832672|P2|NOT COMPLETED|40-week Open Label Treatment Period||5
344471|NCT00549939|832673|P1|NOT COMPLETED|40-week Open Label Treatment Period||0
344472|NCT00549939|832671|P3|COMPLETED|40-week Open Label Treatment Period||78
344473|NCT00549939|832672|P2|COMPLETED|40-week Open Label Treatment Period||75
344474|NCT00549939|832673|P1|COMPLETED|40-week Open Label Treatment Period||0
344475|NCT00549939|832671|P3|STARTED|40-week Open Label Treatment Period|55 patients continued Alfuzosin 0.2 mg/kg/day and 28 patients started Alfuzosin 0.2 mg/kg/day.|83
344476|NCT00549939|832672|P2|STARTED|40-week Open Label Treatment Period|54 patients continued Alfuzosin 0.1 mg/kg/day and 26 patients started Alfuzosin 0.1 mg/kg/day.|80
344477|NCT00549939|832673|P1|STARTED|40-week Open Label Treatment Period|54 patients continued and switched to Alfuzosin: 26 to 0.1 mg/kg/day and 28 to 0.2 mg/kg/day.|0
344478|NCT00549939|832671|P3|NOT COMPLETED|12-week Double Blind Treatment Period||2
344479|NCT00549939|832672|P2|NOT COMPLETED|12-week Double Blind Treatment Period||2
344480|NCT00549939|832673|P1|NOT COMPLETED|12-week Double Blind Treatment Period||1
344481|NCT00549939|832671|P3|COMPLETED|12-week Double Blind Treatment Period||56
344482|NCT00549939|832672|P2|COMPLETED|12-week Double Blind Treatment Period||55
344483|NCT00549939|832673|P1|COMPLETED|12-week Double Blind Treatment Period||56
344484|NCT00549939|832671|P3|STARTED|12-week Double Blind Treatment Period||58
344485|NCT00549939|832672|P2|STARTED|12-week Double Blind Treatment Period||57
344486|NCT00549939|832673|P1|STARTED|12-week Double Blind Treatment Period|29 (Alfuzosin 0.1 mg/kg/day matching placebo) + 28 (Alfuzosin 0.2 mg/kg/day matching placebo)|57
344487|NCT00549900|832700|P1|NOT COMPLETED|Overall Study||1
344488|NCT00549900|832700|P1|COMPLETED|Overall Study||29
344489|NCT00549900|832700|P1|STARTED|Overall Study||30
344490|NCT00549822|832709|P1|NOT COMPLETED|Overall Study||0
344491|NCT00549822|832709|P1|COMPLETED|Overall Study||3
344492|NCT00549822|832709|P1|STARTED|Overall Study||3
344493|NCT00549783|832717|P2|NOT COMPLETED|Overall Study||13
344494|NCT00549783|832718|P1|NOT COMPLETED|Overall Study||8
344495|NCT00549783|832717|P2|COMPLETED|Overall Study||122
344496|NCT00549783|832718|P1|COMPLETED|Overall Study||131
344497|NCT00549783|832717|P2|STARTED|Overall Study||135
344498|NCT00549783|832718|P1|STARTED|Overall Study||139
344499|NCT00549770|832756|P8|NOT COMPLETED|Overall Study||25
344500|NCT00549770|832757|P7|NOT COMPLETED|Overall Study||14
344501|NCT00549770|832758|P6|NOT COMPLETED|Overall Study||13
344502|NCT00549770|832759|P5|NOT COMPLETED|Overall Study||17
344503|NCT00549770|832760|P4|NOT COMPLETED|Overall Study||16
344504|NCT00549770|832761|P3|NOT COMPLETED|Overall Study||10
344505|NCT00549770|832762|P2|NOT COMPLETED|Overall Study||11
344506|NCT00549770|832763|P1|NOT COMPLETED|Overall Study||7
344507|NCT00549770|832756|P8|COMPLETED|Overall Study||148
344508|NCT00549770|832757|P7|COMPLETED|Overall Study||151
344509|NCT00549770|832758|P6|COMPLETED|Overall Study||151
344510|NCT00549770|832759|P5|COMPLETED|Overall Study||149
344511|NCT00549770|832760|P4|COMPLETED|Overall Study||147
344512|NCT00549770|832761|P3|COMPLETED|Overall Study||162
344513|NCT00549770|832762|P2|COMPLETED|Overall Study||158
344514|NCT00549770|832763|P1|COMPLETED|Overall Study||149
344515|NCT00549770|832756|P8|Ambulatory Blood Pressure Monitoring|Overall Study||57
344516|NCT00549770|832757|P7|Ambulatory Blood Pressure Monitoring|Overall Study||50
344517|NCT00549770|832758|P6|Ambulatory Blood Pressure Monitoring|Overall Study||54
344518|NCT00549770|832759|P5|Ambulatory Blood Pressure Monitoring|Overall Study||49
344519|NCT00549770|832760|P4|Ambulatory Blood Pressure Monitoring|Overall Study||55
344520|NCT00549770|832761|P3|Ambulatory Blood Pressure Monitoring|Overall Study||53
344521|NCT00549770|832762|P2|Ambulatory Blood Pressure Monitoring|Overall Study||61
344522|NCT00549770|832763|P1|Ambulatory Blood Pressure Monitoring|Overall Study||48
344523|NCT00549770|832756|P8|Intent-to-treat Population|Overall Study||172
344524|NCT00549770|832757|P7|Intent-to-treat Population|Overall Study||164
344525|NCT00549770|832758|P6|Intent-to-treat Population|Overall Study||163
344526|NCT00549770|832759|P5|Intent-to-treat Population|Overall Study||163
344527|NCT00549770|832760|P4|Intent-to-treat Population|Overall Study||163
344528|NCT00549770|832761|P3|Intent-to-treat Population|Overall Study||170
344529|NCT00549770|832762|P2|Intent-to-treat Population|Overall Study||168
344530|NCT00549770|832763|P1|Intent-to-treat Population|Overall Study||154
344531|NCT00549770|832756|P8|STARTED|Overall Study||173
344532|NCT00549770|832757|P7|STARTED|Overall Study||165
344533|NCT00549770|832758|P6|STARTED|Overall Study||164
344534|NCT00549770|832759|P5|STARTED|Overall Study||166
344535|NCT00549770|832760|P4|STARTED|Overall Study||163
344536|NCT00549770|832761|P3|STARTED|Overall Study||172
344537|NCT00549770|832762|P2|STARTED|Overall Study||169
344538|NCT00549770|832763|P1|STARTED|Overall Study||156
344539|NCT00549757|832847|P2|NOT COMPLETED|Extension Period (in Average 9 Months)||635
344540|NCT00549757|832848|P1|NOT COMPLETED|Extension Period (in Average 9 Months)||625
344541|NCT00549757|832847|P2|COMPLETED|Extension Period (in Average 9 Months)||3182
344542|NCT00549757|832848|P1|COMPLETED|Extension Period (in Average 9 Months)||3148
344543|NCT00549757|832847|P2|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3817
344544|NCT00549757|832848|P1|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3773
344545|NCT00549757|832847|P2|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4310
344546|NCT00549757|832848|P1|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4296
344547|NCT00549757|832847|P2|COMPLETED|Active Treatment Phase: Max. 50 Months||0
344548|NCT00549757|832848|P1|COMPLETED|Active Treatment Phase: Max. 50 Months||0
344549|NCT00549757|832847|P2|Safety Set|Active Treatment Phase: Max. 50 Months||4285
344550|NCT00549757|832848|P1|Safety Set|Active Treatment Phase: Max. 50 Months||4272
344551|NCT00549757|832847|P2|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4287
344552|NCT00549757|832848|P1|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4274
344553|NCT00549757|832847|P2|STARTED|Active Treatment Phase: Max. 50 Months||4310
344554|NCT00549757|832848|P1|STARTED|Active Treatment Phase: Max. 50 Months|"Started indicates randomized patients."|4296
344555|NCT00549718|832910|P4|NOT COMPLETED|Overall Study||55
344556|NCT00549718|832911|P3|NOT COMPLETED|Overall Study||39
344557|NCT00549718|832912|P2|NOT COMPLETED|Overall Study||37
344558|NCT00549718|832913|P1|NOT COMPLETED|Overall Study||41
344559|NCT00549718|832910|P4|COMPLETED|Overall Study||73
344560|NCT00549718|832911|P3|COMPLETED|Overall Study||85
344561|NCT00549718|832912|P2|COMPLETED|Overall Study||86
344562|NCT00549718|832913|P1|COMPLETED|Overall Study||84
344563|NCT00549718|832910|P4|STARTED|Overall Study||128
344564|NCT00549718|832911|P3|STARTED|Overall Study||124
344565|NCT00549718|832912|P2|STARTED|Overall Study||123
344566|NCT00549718|832913|P1|STARTED|Overall Study||125
344567|NCT00549640|832929|P2|NOT COMPLETED|Overall Study||16
344568|NCT00549640|832930|P1|NOT COMPLETED|Overall Study||18
344569|NCT00549640|832929|P2|COMPLETED|Overall Study||24
344570|NCT00549640|832930|P1|COMPLETED|Overall Study|For the primary endpoint, subjects who discontinued participation were assumed to be smoking.|22
344571|NCT00549640|832929|P2|STARTED|Overall Study||40
344572|NCT00549640|832930|P1|STARTED|Overall Study||40
344573|NCT00549601|832943|P3|NOT COMPLETED|Received Study Drug||4
344574|NCT00549601|832944|P2|NOT COMPLETED|Received Study Drug||11
344575|NCT00549601|832945|P1|NOT COMPLETED|Received Study Drug||7
344576|NCT00549601|832943|P3|COMPLETED|Received Study Drug||45
344577|NCT00549601|832944|P2|COMPLETED|Received Study Drug||36
344578|NCT00549601|832945|P1|COMPLETED|Received Study Drug||36
344579|NCT00549601|832943|P3|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|49
344580|NCT00549601|832944|P2|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|47
344581|NCT00549601|832945|P1|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|43
344582|NCT00549601|832943|P3|NOT COMPLETED|Randomized||2
344583|NCT00549601|832944|P2|NOT COMPLETED|Randomized||1
344584|NCT00549601|832945|P1|NOT COMPLETED|Randomized||0
344585|NCT00549601|832943|P3|COMPLETED|Randomized||49
344586|NCT00549601|832944|P2|COMPLETED|Randomized||47
344587|NCT00549601|832945|P1|COMPLETED|Randomized||43
344588|NCT00549601|832943|P3|STARTED|Randomized||51
344589|NCT00549601|832944|P2|STARTED|Randomized||48
344590|NCT00549601|832945|P1|STARTED|Randomized||43
344591|NCT00549562|832967|P1|NOT COMPLETED|Overall Study||2
344592|NCT00549562|832967|P1|COMPLETED|Overall Study||23
344593|NCT00549562|832967|P1|STARTED|Overall Study||25
344594|NCT00549549|832979|P4|NOT COMPLETED|Overall Study||25
344595|NCT00549549|832980|P3|NOT COMPLETED|Overall Study||17
344596|NCT00549549|832981|P2|NOT COMPLETED|Overall Study||22
344597|NCT00549549|832982|P1|NOT COMPLETED|Overall Study||24
344598|NCT00549549|832979|P4|COMPLETED|Overall Study||78
344599|NCT00549549|832980|P3|COMPLETED|Overall Study||82
344600|NCT00549549|832981|P2|COMPLETED|Overall Study||77
344601|NCT00549549|832982|P1|COMPLETED|Overall Study||77
344602|NCT00549549|832979|P4|Treated|Overall Study||102
344603|NCT00549549|832980|P3|Treated|Overall Study||98
344604|NCT00549549|832981|P2|Treated|Overall Study||99
344605|NCT00549549|832982|P1|Treated|Overall Study||101
344606|NCT00549549|832979|P4|STARTED|Overall Study||103
344607|NCT00549549|832980|P3|STARTED|Overall Study||99
344608|NCT00549549|832981|P2|STARTED|Overall Study||99
344609|NCT00549549|832982|P1|STARTED|Overall Study||101
344610|NCT00549445|833050|P2|NOT COMPLETED|Overall Study||17
344611|NCT00549445|833051|P1|NOT COMPLETED|Overall Study||15
344612|NCT00549445|833050|P2|COMPLETED|Overall Study||13
344613|NCT00549445|833051|P1|COMPLETED|Overall Study||8
344614|NCT00549445|833050|P2|STARTED|Overall Study||30
344615|NCT00549445|833051|P1|STARTED|Overall Study||23
344616|NCT00549393|833059|P2|NOT COMPLETED|Period 3 (6 Months)||0
344617|NCT00549393|833060|P1|NOT COMPLETED|Period 3 (6 Months)||0
344618|NCT00549393|833059|P2|COMPLETED|Period 3 (6 Months)||1326
344619|NCT00549393|833060|P1|COMPLETED|Period 3 (6 Months)||1103
344620|NCT00549393|833059|P2|Per Protocol|Period 3 (6 Months)||1326
344621|NCT00549393|833060|P1|Per Protocol|Period 3 (6 Months)||667
344622|NCT00549393|833059|P2|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1326
344623|NCT00549393|833060|P1|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1103
344624|NCT00549393|833059|P2|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
344625|NCT00549393|833060|P1|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
344626|NCT00549393|833059|P2|COMPLETED|Period 2 Washout (2 Weeks)||0
344627|NCT00549393|833060|P1|COMPLETED|Period 2 Washout (2 Weeks)||0
344628|NCT00549393|833059|P2|STARTED|Period 2 Washout (2 Weeks)||0
344629|NCT00549393|833060|P1|STARTED|Period 2 Washout (2 Weeks)||0
344630|NCT00549393|833059|P2|NOT COMPLETED|Period 1 (6 Months)||0
344631|NCT00549393|833060|P1|NOT COMPLETED|Period 1 (6 Months)||0
344632|NCT00549393|833059|P2|COMPLETED|Period 1 (6 Months)||1199
344633|NCT00549393|833060|P1|COMPLETED|Period 1 (6 Months)||1319
344634|NCT00549393|833059|P2|Per Protocol|Period 1 (6 Months)||1199
344635|NCT00549393|833060|P1|Per Protocol|Period 1 (6 Months)||880
344636|NCT00549393|833059|P2|STARTED|Period 1 (6 Months)|ITT|1199
344637|NCT00549393|833060|P1|STARTED|Period 1 (6 Months)|intention to treat (ITT)|1319
344638|NCT00549328|833070|P1|NOT COMPLETED|Overall Study||14
344639|NCT00549328|833070|P1|COMPLETED|Overall Study||0
344640|NCT00549328|833070|P1|STARTED|Overall Study||14
344641|NCT00549302|833081|P3|NOT COMPLETED|Open-Label||69
344642|NCT00549302|833082|P2|NOT COMPLETED|Open-Label||0
344643|NCT00549302|833083|P1|NOT COMPLETED|Open-Label||0
344644|NCT00549302|833081|P3|COMPLETED|Open-Label|Another death occurred during the 30-day follow-up period after study drug discontinuation|217
344645|NCT00549302|833082|P2|COMPLETED|Open-Label||0
344646|NCT00549302|833083|P1|COMPLETED|Open-Label||0
344647|NCT00549302|833081|P3|STARTED|Open-Label|7 participants who completed the Double-Blind Period did not enter the Open-Label Period.|286
344648|NCT00549302|833082|P2|STARTED|Open-Label||0
344649|NCT00549302|833083|P1|STARTED|Open-Label||0
344650|NCT00549302|833081|P3|NOT COMPLETED|Double-Blind||0
344651|NCT00549302|833082|P2|NOT COMPLETED|Double-Blind||53
344652|NCT00549302|833083|P1|NOT COMPLETED|Double-Blind||11
344653|NCT00549302|833081|P3|COMPLETED|Double-Blind||0
344654|NCT00549302|833082|P2|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|241
344655|NCT00549302|833083|P1|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|52
344656|NCT00549302|833081|P3|Received at Least One Dose of Study Drug|Double-Blind||0
344657|NCT00549302|833082|P2|Received at Least One Dose of Study Drug|Double-Blind||294
344658|NCT00549302|833083|P1|Received at Least One Dose of Study Drug|Double-Blind||63
344659|NCT00549302|833081|P3|STARTED|Double-Blind||0
344660|NCT00549302|833082|P2|STARTED|Double-Blind||294
344661|NCT00549302|833083|P1|STARTED|Double-Blind||63
344662|NCT00549198|833095|P2|NOT COMPLETED|Overall Study||63
344663|NCT00549198|833096|P1|NOT COMPLETED|Overall Study||80
344664|NCT00549198|833095|P2|COMPLETED|Overall Study||134
344665|NCT00549198|833096|P1|COMPLETED|Overall Study||115
344666|NCT00549198|833095|P2|STARTED|Overall Study|Four participants were randomized but were not exposed to study drug (TDF/FTC).|197
344667|NCT00549198|833096|P1|STARTED|Overall Study|Three participants were randomized but were not exposed to study drug (ABC/3TC).|195
344668|NCT00549172|833218|P2|NOT COMPLETED|Overall Study||0
344669|NCT00549172|833219|P1|NOT COMPLETED|Overall Study||0
344670|NCT00549172|833218|P2|COMPLETED|Overall Study||76
344671|NCT00549172|833219|P1|COMPLETED|Overall Study||70
344672|NCT00549172|833218|P2|STARTED|Overall Study||76
344673|NCT00549172|833219|P1|STARTED|Overall Study||70
344674|NCT00549055|833233|P1|NOT COMPLETED|Overall Study||35
344675|NCT00549055|833233|P1|COMPLETED|Overall Study||3
344676|NCT00549055|833233|P1|STARTED|Overall Study||38
344677|NCT00548886|833243|P1|NOT COMPLETED|Overall Study||0
344678|NCT00548886|833243|P1|COMPLETED|Overall Study||7
344679|NCT00548886|833243|P1|STARTED|Overall Study||7
344680|NCT00548860|833250|P2|NOT COMPLETED|Overall Study||175
344681|NCT00548860|833251|P1|NOT COMPLETED|Overall Study||136
344682|NCT00548860|833250|P2|COMPLETED|Overall Study||847
344683|NCT00548860|833251|P1|COMPLETED|Overall Study||860
344684|NCT00548860|833250|P2|STARTED|Overall Study||1022
344685|NCT00548860|833251|P1|STARTED|Overall Study||996
344686|NCT00548847|833257|P1|NOT COMPLETED|Overall Study||7
344687|NCT00548847|833257|P1|COMPLETED|Overall Study||8
344688|NCT00548847|833257|P1|STARTED|Overall Study||15
344689|NCT00548808|833264|P2|NOT COMPLETED|Overall Study||26
344690|NCT00548808|833265|P1|NOT COMPLETED|Overall Study||42
344691|NCT00548808|833264|P2|COMPLETED|Overall Study||186
344692|NCT00548808|833265|P1|COMPLETED|Overall Study||172
344693|NCT00548808|833264|P2|Per-Protocol Set|Overall Study||184
344694|NCT00548808|833265|P1|Per-Protocol Set|Overall Study||177
344695|NCT00548808|833264|P2|Full Analysis Set|Overall Study||212
344696|NCT00548808|833265|P1|Full Analysis Set|Overall Study||211
344697|NCT00548808|833264|P2|STARTED|Overall Study||212
344698|NCT00548808|833265|P1|STARTED|Overall Study||214
344699|NCT00548717|833289|P2|NOT COMPLETED|Overall Study||2
344700|NCT00548717|833290|P1|NOT COMPLETED|Overall Study||9
344701|NCT00548717|833289|P2|COMPLETED|Overall Study||0
344702|NCT00548717|833290|P1|COMPLETED|Overall Study||4
344703|NCT00548717|833289|P2|STARTED|Overall Study||2
344704|NCT00548717|833290|P1|STARTED|Overall Study||13
344705|NCT00548691|833309|P2|NOT COMPLETED|Overall Study||9
344706|NCT00548691|833310|P1|NOT COMPLETED|Overall Study||7
344707|NCT00548691|833309|P2|COMPLETED|Overall Study||250
344708|NCT00548691|833310|P1|COMPLETED|Overall Study||251
344709|NCT00548691|833309|P2|STARTED|Overall Study||259
344710|NCT00548691|833310|P1|STARTED|Overall Study||258
344711|NCT00548652|833319|P3|NOT COMPLETED|Overall Study||11
344712|NCT00548652|833320|P2|NOT COMPLETED|Overall Study||9
344713|NCT00548652|833321|P1|NOT COMPLETED|Overall Study||2
344714|NCT00548652|833319|P3|COMPLETED|Overall Study||34
344715|NCT00548652|833320|P2|COMPLETED|Overall Study||29
344716|NCT00548652|833321|P1|COMPLETED|Overall Study||16
344717|NCT00548652|833319|P3|STARTED|Overall Study||45
344718|NCT00548652|833320|P2|STARTED|Overall Study||38
344719|NCT00548652|833321|P1|STARTED|Overall Study||18
344720|NCT00548548|833334|P2|NOT COMPLETED|Overall Study||366
344721|NCT00548548|833335|P1|NOT COMPLETED|Overall Study||362
344722|NCT00548548|833334|P2|COMPLETED|Overall Study||21
344723|NCT00548548|833335|P1|COMPLETED|Overall Study|Completed treatment discontinuation form was not completed; patient was counted alive on treatment.|25
344724|NCT00548548|833334|P2|Safety Population|Overall Study||381
344725|NCT00548548|833335|P1|Safety Population|Overall Study|Four patients randomized to placebo received single doses of bevacizumab in error.|386
344726|NCT00548548|833334|P2|Treated|Overall Study||384
344727|NCT00548548|833335|P1|Treated|Overall Study||383
344728|NCT00548548|833334|P2|STARTED|Overall Study||387
344729|NCT00548548|833335|P1|STARTED|Overall Study||387
344730|NCT00548470|833355|P1|NOT COMPLETED|Overall Study||2
344731|NCT00548470|833355|P1|COMPLETED|Overall Study||12
344732|NCT00548470|833355|P1|STARTED|Overall Study||14
344733|NCT00548431|833363|P1|NOT COMPLETED|Overall Study||0
344734|NCT00548431|833363|P1|COMPLETED|Overall Study||38
344735|NCT00548431|833363|P1|STARTED|Overall Study||38
344736|NCT00548418|833367|P1|NOT COMPLETED|Overall Study||0
344737|NCT00548418|833367|P1|COMPLETED|Overall Study||27
344738|NCT00548418|833367|P1|STARTED|Overall Study||27
344739|NCT00548405|833378|P3|NOT COMPLETED|Overall Study||9
344740|NCT00548405|833379|P2|NOT COMPLETED|Overall Study||20
344741|NCT00548405|833380|P1|NOT COMPLETED|Overall Study||56
344742|NCT00548405|833378|P3|COMPLETED|Overall Study||164
344743|NCT00548405|833379|P2|COMPLETED|Overall Study||416
344744|NCT00548405|833380|P1|COMPLETED|Overall Study||175
344745|NCT00548405|833378|P3|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|170
344836|NCT00547911|833632|P4|STARTED|Overall Study||2
344746|NCT00548405|833379|P2|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|426
344747|NCT00548405|833380|P1|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|202
344748|NCT00548405|833378|P3|STARTED|Overall Study|Randomized.|173
344749|NCT00548405|833379|P2|STARTED|Overall Study|Randomized.|436
344750|NCT00548405|833380|P1|STARTED|Overall Study|Randomized.|231
344751|NCT00548340|833401|P3|NOT COMPLETED|Overall Study||9
344752|NCT00548340|833402|P2|NOT COMPLETED|Overall Study||11
344753|NCT00548340|833403|P1|NOT COMPLETED|Overall Study||8
344754|NCT00548340|833401|P3|COMPLETED|Overall Study||95
344755|NCT00548340|833402|P2|COMPLETED|Overall Study||98
344756|NCT00548340|833403|P1|COMPLETED|Overall Study||101
344757|NCT00548340|833401|P3|STARTED|Overall Study||104
344758|NCT00548340|833402|P2|STARTED|Overall Study||109
344759|NCT00548340|833403|P1|STARTED|Overall Study||109
344760|NCT00548327|833422|P2|NOT COMPLETED|Overall Study||1
344761|NCT00548327|833423|P1|NOT COMPLETED|Overall Study||0
344762|NCT00548327|833422|P2|COMPLETED|Overall Study|Patient randomized to receive placebo first. While on placebo, Adverse Event lead to discontinuation|4
344763|NCT00548327|833423|P1|COMPLETED|Overall Study||6
344764|NCT00548327|833422|P2|STARTED|Overall Study||5
344765|NCT00548327|833423|P1|STARTED|Overall Study||6
344766|NCT00548262|833441|P1|NOT COMPLETED|Overall Study||32
344767|NCT00548262|833441|P1|COMPLETED|Overall Study|1 N had D/C recorded as died and as lack of efficacy; reported as lack of efficacy in reason for D/C|22
344768|NCT00548262|833441|P1|STARTED|Overall Study|1 participant (N) had death recorded twice; reported as 1 death in reason for discontinuation (D/C)|54
344769|NCT00548249|833471|P5|NOT COMPLETED|Overall Study||21
344770|NCT00548249|833472|P4|NOT COMPLETED|Overall Study||13
344771|NCT00548249|833473|P3|NOT COMPLETED|Overall Study||20
344772|NCT00548249|833474|P2|NOT COMPLETED|Overall Study||13
344773|NCT00548249|833475|P1|NOT COMPLETED|Overall Study||16
344774|NCT00548249|833471|P5|COMPLETED|Overall Study||7
344775|NCT00548249|833472|P4|COMPLETED|Overall Study||9
344776|NCT00548249|833473|P3|COMPLETED|Overall Study||9
344777|NCT00548249|833474|P2|COMPLETED|Overall Study||13
344778|NCT00548249|833475|P1|COMPLETED|Overall Study||10
344779|NCT00548249|833471|P5|STARTED|Overall Study||28
344780|NCT00548249|833472|P4|STARTED|Overall Study||22
344781|NCT00548249|833473|P3|STARTED|Overall Study||29
344782|NCT00548249|833474|P2|STARTED|Overall Study||26
344783|NCT00548249|833475|P1|STARTED|Overall Study||26
344784|NCT00548197|833514|P2|NOT COMPLETED|Overall Study||0
344785|NCT00548197|833515|P1|NOT COMPLETED|Overall Study||0
344786|NCT00548197|833514|P2|COMPLETED|Overall Study||22
344787|NCT00548197|833515|P1|COMPLETED|Overall Study||18
344788|NCT00548197|833514|P2|STARTED|Overall Study||22
344789|NCT00548197|833515|P1|STARTED|Overall Study||18
344790|NCT00548184|833523|P1|NOT COMPLETED|Overall Study||5
344791|NCT00548184|833523|P1|COMPLETED|Overall Study|65 patients were on treatment. 5 did not complete due to adverse events or other reasons.|60
344792|NCT00548184|833523|P1|STARTED|Overall Study||65
344793|NCT00548171|833529|P2|NOT COMPLETED|Overall Study||0
344794|NCT00548171|833530|P1|NOT COMPLETED|Overall Study||0
344795|NCT00548171|833529|P2|COMPLETED|Overall Study||39
344796|NCT00548171|833530|P1|COMPLETED|Overall Study||164
344797|NCT00548171|833529|P2|STARTED|Overall Study||39
344798|NCT00548171|833530|P1|STARTED|Overall Study||164
344799|NCT00548145|833571|P2|NOT COMPLETED|Overall Study||4
344800|NCT00548145|833572|P1|NOT COMPLETED|Overall Study||1
344801|NCT00548145|833571|P2|COMPLETED|Overall Study||16
344802|NCT00548145|833572|P1|COMPLETED|Overall Study||17
344803|NCT00548145|833571|P2|STARTED|Overall Study||20
344804|NCT00548145|833572|P1|STARTED|Overall Study||18
344805|NCT00548132|833580|P2|NOT COMPLETED|Overall Study||0
344806|NCT00548132|833581|P1|NOT COMPLETED|Overall Study||0
344807|NCT00548132|833580|P2|COMPLETED|Overall Study||554
344808|NCT00548132|833581|P1|COMPLETED|Overall Study||534
344809|NCT00548132|833580|P2|Consented to Study|Overall Study||554
344810|NCT00548132|833581|P1|Consented to Study|Overall Study||534
344811|NCT00548132|833580|P2|STARTED|Overall Study||554
344812|NCT00548132|833581|P1|STARTED|Overall Study||534
344813|NCT00548093|833591|P2|NOT COMPLETED|Overall Study||16
344814|NCT00548093|833592|P1|NOT COMPLETED|Overall Study||50
344815|NCT00548093|833591|P2|COMPLETED|Overall Study||0
344816|NCT00548093|833592|P1|COMPLETED|Overall Study||0
344817|NCT00548093|833591|P2|STARTED|Overall Study||16
344818|NCT00548093|833592|P1|STARTED|Overall Study||50
344819|NCT00548041|833622|P1|NOT COMPLETED|Overall Study||0
344820|NCT00548041|833622|P1|COMPLETED|Overall Study||100
344821|NCT00548041|833622|P1|STARTED|Overall Study||100
344822|NCT00547911|833630|P6|NOT COMPLETED|Overall Study||0
344823|NCT00547911|833631|P5|NOT COMPLETED|Overall Study||0
344824|NCT00547911|833632|P4|NOT COMPLETED|Overall Study||1
344825|NCT00547911|833633|P3|NOT COMPLETED|Overall Study||0
344826|NCT00547911|833634|P2|NOT COMPLETED|Overall Study||0
344827|NCT00547911|833635|P1|NOT COMPLETED|Overall Study||0
344828|NCT00547911|833630|P6|COMPLETED|Overall Study||3
344829|NCT00547911|833631|P5|COMPLETED|Overall Study||3
344830|NCT00547911|833632|P4|COMPLETED|Overall Study||1
344831|NCT00547911|833633|P3|COMPLETED|Overall Study||2
344832|NCT00547911|833634|P2|COMPLETED|Overall Study||2
344833|NCT00547911|833635|P1|COMPLETED|Overall Study||2
344834|NCT00547911|833630|P6|STARTED|Overall Study||3
344835|NCT00547911|833631|P5|STARTED|Overall Study||3
344837|NCT00547911|833633|P3|STARTED|Overall Study||2
344838|NCT00547911|833634|P2|STARTED|Overall Study||2
344839|NCT00547911|833635|P1|STARTED|Overall Study||2
344840|NCT00547703|833666|P2|NOT COMPLETED|Overall Study||0
344841|NCT00547703|833667|P1|NOT COMPLETED|Overall Study||1
344842|NCT00547703|833666|P2|COMPLETED|Overall Study||1
344843|NCT00547703|833667|P1|COMPLETED|Overall Study||3
344844|NCT00547703|833666|P2|STARTED|Overall Study||1
344845|NCT00547703|833667|P1|STARTED|Overall Study||4
344846|NCT00547638|833675|P2|NOT COMPLETED|Overall Study||14
344847|NCT00547638|833676|P1|NOT COMPLETED|Overall Study||24
344848|NCT00547638|833675|P2|COMPLETED|Overall Study||59
344849|NCT00547638|833676|P1|COMPLETED|Overall Study||119
344850|NCT00547638|833675|P2|STARTED|Overall Study||73
344851|NCT00547638|833676|P1|STARTED|Overall Study||143
344852|NCT00547534|833692|P1|NOT COMPLETED|Overall Study||11
344853|NCT00547534|833692|P1|COMPLETED|Overall Study|25 patients received at least 4 cycles. 29 patients were evaluable for response.|19
344854|NCT00547534|833692|P1|STARTED|Overall Study|31 patients enrolled; one patient was determined to be ineligible, and did not receive any therapy.|30
344855|NCT00547521|833700|P2|NOT COMPLETED|Long Term Extension (LTE) Study||31
344856|NCT00547521|833701|P1|NOT COMPLETED|Long Term Extension (LTE) Study||0
344857|NCT00547521|833700|P2|COMPLETED|Long Term Extension (LTE) Study||59
344858|NCT00547521|833701|P1|COMPLETED|Long Term Extension (LTE) Study||0
344859|NCT00547521|833700|P2|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|90
344860|NCT00547521|833701|P1|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|0
344861|NCT00547521|833700|P2|NOT COMPLETED|Short Term Study (4 Months)||4
344862|NCT00547521|833701|P1|NOT COMPLETED|Short Term Study (4 Months)||1
344863|NCT00547521|833700|P2|COMPLETED|Short Term Study (4 Months)||45
344864|NCT00547521|833701|P1|COMPLETED|Short Term Study (4 Months)||50
344865|NCT00547521|833700|P2|STARTED|Short Term Study (4 Months)|Number of participants treated.|49
344866|NCT00547521|833701|P1|STARTED|Short Term Study (4 Months)|Number of participants treated.|51
344867|NCT00547456|833771|P1|NOT COMPLETED|Overall Study||0
344868|NCT00547456|833771|P1|COMPLETED|Overall Study||20
344869|NCT00547456|833771|P1|STARTED|Overall Study||20
344870|NCT00547378|833778|P3|NOT COMPLETED|All Implanted Cohort||70
344871|NCT00547378|833779|P2|NOT COMPLETED|All Implanted Cohort||18
344872|NCT00547378|833780|P1|NOT COMPLETED|All Implanted Cohort||15
344873|NCT00547378|833778|P3|COMPLETED|All Implanted Cohort||111
344874|NCT00547378|833779|P2|COMPLETED|All Implanted Cohort||22
344875|NCT00547378|833780|P1|COMPLETED|All Implanted Cohort||36
344876|NCT00547378|833778|P3|Month 60|All Implanted Cohort||114
344877|NCT00547378|833779|P2|Month 60|All Implanted Cohort||23
344878|NCT00547378|833780|P1|Month 60|All Implanted Cohort||36
344879|NCT00547378|833778|P3|Month 48|All Implanted Cohort||136
344880|NCT00547378|833779|P2|Month 48|All Implanted Cohort||27
344881|NCT00547378|833780|P1|Month 48|All Implanted Cohort||38
344882|NCT00547378|833778|P3|Month 36|All Implanted Cohort||146
344883|NCT00547378|833779|P2|Month 36|All Implanted Cohort||29
344884|NCT00547378|833780|P1|Month 36|All Implanted Cohort||42
344885|NCT00547378|833778|P3|Month 24|All Implanted Cohort||161
344886|NCT00547378|833779|P2|Month 24|All Implanted Cohort||30
344887|NCT00547378|833780|P1|Month 24|All Implanted Cohort||42
344888|NCT00547378|833778|P3|Month 12|All Implanted Cohort||175
344889|NCT00547378|833779|P2|Month 12|All Implanted Cohort||32
344890|NCT00547378|833780|P1|Month 12|All Implanted Cohort||48
344891|NCT00547378|833778|P3|Month 6|All Implanted Cohort||178
344892|NCT00547378|833779|P2|Month 6|All Implanted Cohort||36
344893|NCT00547378|833780|P1|Month 6|All Implanted Cohort||50
344894|NCT00547378|833778|P3|Month 3|All Implanted Cohort||178
344895|NCT00547378|833779|P2|Month 3|All Implanted Cohort||39
344896|NCT00547378|833780|P1|Month 3|All Implanted Cohort||51
344897|NCT00547378|833778|P3|STARTED|All Implanted Cohort|This included subjects who received full system implant from non-randomized subjects.|181
344898|NCT00547378|833779|P2|STARTED|All Implanted Cohort|This included SMT subjects who received full system implant after completing randomization period.|40
344899|NCT00547378|833780|P1|STARTED|All Implanted Cohort|This included subjects who received full system implant after randomized to IST.|51
344900|NCT00547378|833778|P3|NOT COMPLETED|Randomized Cohort||0
344901|NCT00547378|833779|P2|NOT COMPLETED|Randomized Cohort||6
344902|NCT00547378|833780|P1|NOT COMPLETED|Randomized Cohort||11
344903|NCT00547378|833778|P3|COMPLETED|Randomized Cohort||0
344904|NCT00547378|833779|P2|COMPLETED|Randomized Cohort||71
344905|NCT00547378|833780|P1|COMPLETED|Randomized Cohort||59
344906|NCT00547378|833778|P3|Month 6|Randomized Cohort||0
344907|NCT00547378|833779|P2|Month 6|Randomized Cohort|This included SMT subjects who reached SMT Month 6 visit.|71
344908|NCT00547378|833780|P1|Month 6|Randomized Cohort|This includes IST subjects reached Month 6 visit, regardless of implant or not.|59
344909|NCT00547378|833778|P3|Month 3|Randomized Cohort||0
344910|NCT00547378|833779|P2|Month 3|Randomized Cohort|This included SMT subjects who reached SMT Month 3 visit.|72
344911|NCT00547378|833780|P1|Month 3|Randomized Cohort|This includes IST subjects reached Month 3 visit, regardless of implant or not.|62
344912|NCT00547378|833778|P3|STARTED|Randomized Cohort||0
344913|NCT00547378|833779|P2|STARTED|Randomized Cohort||77
344914|NCT00547378|833780|P1|STARTED|Randomized Cohort||70
344915|NCT00547365|833790|P1|NOT COMPLETED|Overall Study||8
344916|NCT00547365|833790|P1|COMPLETED|Overall Study||2
344917|NCT00547365|833790|P1|STARTED|Overall Study||10
344918|NCT00547300|833797|P2|NOT COMPLETED|Overall Study||26
344919|NCT00547300|833798|P1|NOT COMPLETED|Overall Study||25
344920|NCT00547300|833797|P2|COMPLETED|Overall Study|No patients completed because the study was administratively terminated.|0
344921|NCT00547300|833798|P1|COMPLETED|Overall Study|No patients completed because the study was administratively terminated.|0
344922|NCT00547300|833797|P2|STARTED|Overall Study|Two (2) patients were randomized in error, but no study medication taken.|26
344923|NCT00547300|833798|P1|STARTED|Overall Study||25
344924|NCT00547248|833812|P4|NOT COMPLETED|Overall Study||2
344925|NCT00547248|833813|P3|NOT COMPLETED|Overall Study||10
344926|NCT00547248|833814|P2|NOT COMPLETED|Overall Study||0
344927|NCT00547248|833815|P1|NOT COMPLETED|Overall Study||0
344928|NCT00547248|833812|P4|COMPLETED|Overall Study||96
344929|NCT00547248|833813|P3|COMPLETED|Overall Study||275
344930|NCT00547248|833814|P2|COMPLETED|Overall Study||93
344931|NCT00547248|833815|P1|COMPLETED|Overall Study||280
344932|NCT00547248|833812|P4|STARTED|Overall Study||98
344933|NCT00547248|833813|P3|STARTED|Overall Study||285
344934|NCT00547248|833814|P2|STARTED|Overall Study||93
344935|NCT00547248|833815|P1|STARTED|Overall Study||280
344936|NCT00547157|833933|P2|NOT COMPLETED|Overall Study||23
344937|NCT00547157|833934|P1|NOT COMPLETED|Overall Study||49
344938|NCT00547157|833933|P2|COMPLETED|Overall Study||39
344939|NCT00547157|833934|P1|COMPLETED|Overall Study||41
344940|NCT00547157|833933|P2|STARTED|Overall Study||62
344941|NCT00547157|833934|P1|STARTED|Overall Study||90
344942|NCT00547118|833952|P2|NOT COMPLETED|Overall Study||9
344943|NCT00547118|833953|P1|NOT COMPLETED|Overall Study||8
344944|NCT00547118|833952|P2|COMPLETED|Overall Study||0
344945|NCT00547118|833953|P1|COMPLETED|Overall Study||0
344946|NCT00547118|833952|P2|STARTED|Overall Study||9
344947|NCT00547118|833953|P1|STARTED|Overall Study||8
344948|NCT00547105|833985|P1|NOT COMPLETED|Overall Study||0
344949|NCT00547105|833985|P1|COMPLETED|Overall Study||24
344950|NCT00547105|833985|P1|STARTED|Overall Study||24
344951|NCT00546910|833997|P2|NOT COMPLETED|Overall Study||11
344952|NCT00546910|833998|P1|NOT COMPLETED|Overall Study||9
344953|NCT00546910|833997|P2|COMPLETED|Overall Study||51
344954|NCT00546910|833998|P1|COMPLETED|Overall Study||54
344955|NCT00546910|833997|P2|STARTED|Overall Study||62
344956|NCT00546910|833998|P1|STARTED|Overall Study||63
344957|NCT00546897|834018|P2|NOT COMPLETED|Overall Study||0
344958|NCT00546897|834019|P1|NOT COMPLETED|Overall Study||0
344959|NCT00546897|834018|P2|COMPLETED|Overall Study||33
344960|NCT00546897|834019|P1|COMPLETED|Overall Study||15
344961|NCT00546897|834018|P2|STARTED|Overall Study||33
344962|NCT00546897|834019|P1|STARTED|Overall Study||15
344963|NCT00546884|834057|P2|NOT COMPLETED|Overall Study||0
344964|NCT00546884|834058|P1|NOT COMPLETED|Overall Study||0
344965|NCT00546884|834057|P2|COMPLETED|Overall Study||117
344966|NCT00546884|834058|P1|COMPLETED|Overall Study||145
344967|NCT00546884|834057|P2|STARTED|Overall Study||117
344968|NCT00546884|834058|P1|STARTED|Overall Study||145
344969|NCT00546871|834064|P2|NOT COMPLETED|Study Extension Period||1
344970|NCT00546871|834065|P1|NOT COMPLETED|Study Extension Period||1
344971|NCT00546871|834064|P2|COMPLETED|Study Extension Period||25
344972|NCT00546871|834065|P1|COMPLETED|Study Extension Period||9
344973|NCT00546871|834064|P2|STARTED|Study Extension Period|6 withdrawn after Part 3b|26
344974|NCT00546871|834065|P1|STARTED|Study Extension Period|2 withdrawn after Part 3b|10
344975|NCT00546871|834064|P2|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
344976|NCT00546871|834065|P1|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
344977|NCT00546871|834064|P2|COMPLETED|Part 3b - SC IGIV 12 Weeks||32
344978|NCT00546871|834065|P1|COMPLETED|Part 3b - SC IGIV 12 Weeks||12
344979|NCT00546871|834064|P2|STARTED|Part 3b - SC IGIV 12 Weeks||32
344980|NCT00546871|834065|P1|STARTED|Part 3b - SC IGIV 12 Weeks||12
344981|NCT00546871|834064|P2|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
344982|NCT00546871|834065|P1|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
344983|NCT00546871|834064|P2|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
344984|NCT00546871|834065|P1|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
344985|NCT00546871|834064|P2|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
344986|NCT00546871|834065|P1|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
344987|NCT00546871|834064|P2|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||3
344988|NCT00546871|834065|P1|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||1
344989|NCT00546871|834064|P2|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||32
344990|NCT00546871|834065|P1|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||12
344991|NCT00546871|834064|P2|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||35
344992|NCT00546871|834065|P1|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||13
344993|NCT00546871|834064|P2|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||0
344994|NCT00546871|834065|P1|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||1
344995|NCT00546871|834064|P2|COMPLETED|Part 1 - IV Infusions of IGIV, PK||35
344996|NCT00546871|834065|P1|COMPLETED|Part 1 - IV Infusions of IGIV, PK||13
344997|NCT00546871|834064|P2|STARTED|Part 1 - IV Infusions of IGIV, PK||35
344998|NCT00546871|834065|P1|STARTED|Part 1 - IV Infusions of IGIV, PK||14
344999|NCT00546819|834170|P2|NOT COMPLETED|Overall Study||6
345000|NCT00546819|834171|P1|NOT COMPLETED|Overall Study||8
345001|NCT00546819|834170|P2|COMPLETED|Overall Study||96
345002|NCT00546819|834171|P1|COMPLETED|Overall Study||199
345003|NCT00546819|834170|P2|VACCINATED|Overall Study||100
345004|NCT00546819|834171|P1|VACCINATED|Overall Study||206
345005|NCT00546819|834170|P2|STARTED|Overall Study||102
345006|NCT00546819|834171|P1|STARTED|Overall Study||207
345007|NCT00546754|834183|P2|NOT COMPLETED|Overall Study||49
345008|NCT00546754|834184|P1|NOT COMPLETED|Overall Study||50
345009|NCT00546754|834183|P2|COMPLETED|Overall Study||334
345010|NCT00546754|834184|P1|COMPLETED|Overall Study||375
345011|NCT00546754|834183|P2|Week 12|Overall Study||334
345012|NCT00546754|834184|P1|Week 12|Overall Study||375
345013|NCT00546754|834183|P2|Week 6|Overall Study||347
345014|NCT00546754|834184|P1|Week 6|Overall Study||396
345015|NCT00546754|834183|P2|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|373
345016|NCT00546754|834184|P1|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|416
345017|NCT00546754|834183|P2|STARTED|Overall Study|Number of patients enrolled and randomized|383
345018|NCT00546754|834184|P1|STARTED|Overall Study|Number of patients enrolled and randomized|425
345019|NCT00546728|834216|P2|NOT COMPLETED|Overall Study||0
345020|NCT00546728|834217|P1|NOT COMPLETED|Overall Study||0
345021|NCT00546728|834216|P2|COMPLETED|Overall Study||25
345022|NCT00546728|834217|P1|COMPLETED|Overall Study||25
345023|NCT00546728|834216|P2|STARTED|Overall Study||25
345024|NCT00546728|834217|P1|STARTED|Overall Study||25
345025|NCT00546715|834227|P4|NOT COMPLETED|Overall Study||0
345026|NCT00546715|834228|P3|NOT COMPLETED|Overall Study||0
345027|NCT00546715|834229|P2|NOT COMPLETED|Overall Study||1
345028|NCT00546715|834230|P1|NOT COMPLETED|Overall Study||0
345029|NCT00546715|834227|P4|COMPLETED|Overall Study||2
345030|NCT00546715|834228|P3|COMPLETED|Overall Study||5
345031|NCT00546715|834229|P2|COMPLETED|Overall Study||4
345032|NCT00546715|834230|P1|COMPLETED|Overall Study||6
345033|NCT00546715|834227|P4|STARTED|Overall Study||2
345034|NCT00546715|834228|P3|STARTED|Overall Study||5
345035|NCT00546715|834229|P2|STARTED|Overall Study||5
345036|NCT00546715|834230|P1|STARTED|Overall Study||6
345037|NCT00546637|834285|P2|NOT COMPLETED|Overall Study||49
345038|NCT00546637|834286|P1|NOT COMPLETED|Overall Study||73
345039|NCT00546637|834285|P2|COMPLETED|Overall Study||424
345040|NCT00546637|834286|P1|COMPLETED|Overall Study||401
345041|NCT00546637|834285|P2|Received Treatment|Overall Study||472
345042|NCT00546637|834286|P1|Received Treatment|Overall Study||471
345043|NCT00546637|834285|P2|STARTED|Overall Study||473
345044|NCT00546637|834286|P1|STARTED|Overall Study||474
345045|NCT00546572|834360|P2|NOT COMPLETED|Vax 2 / Year 1||2
345046|NCT00546572|834361|P1|NOT COMPLETED|Vax 2 / Year 1||4
345047|NCT00546572|834360|P2|COMPLETED|Vax 2 / Year 1||402
345048|NCT00546572|834361|P1|COMPLETED|Vax 2 / Year 1||387
345049|NCT00546572|834360|P2|Received Vax 2|Vax 2 / Year 1||404
345050|NCT00546572|834361|P1|Received Vax 2|Vax 2 / Year 1||391
345051|NCT00546572|834360|P2|STARTED|Vax 2 / Year 1||404
345052|NCT00546572|834361|P1|STARTED|Vax 2 / Year 1||391
345053|NCT00546572|834360|P2|NOT COMPLETED|Vax 1 / Year 0||70
345054|NCT00546572|834361|P1|NOT COMPLETED|Vax 1 / Year 0||73
345055|NCT00546572|834360|P2|COMPLETED|Vax 1 / Year 0||404
345056|NCT00546572|834361|P1|COMPLETED|Vax 1 / Year 0||391
345057|NCT00546572|834360|P2|Received Vax 1|Vax 1 / Year 0||473
345058|NCT00546572|834361|P1|Received Vax 1|Vax 1 / Year 0||463
345059|NCT00546572|834360|P2|STARTED|Vax 1 / Year 0||474
345060|NCT00546572|834361|P1|STARTED|Vax 1 / Year 0||464
345061|NCT00546481|834405|P3|NOT COMPLETED|Maintenance Phase (CERA)||4
345062|NCT00546481|834406|P2|NOT COMPLETED|Maintenance Phase (CERA)||0
345063|NCT00546481|834407|P1|NOT COMPLETED|Maintenance Phase (CERA)||0
345064|NCT00546481|834405|P3|COMPLETED|Maintenance Phase (CERA)||50
345065|NCT00546481|834406|P2|COMPLETED|Maintenance Phase (CERA)||0
345066|NCT00546481|834407|P1|COMPLETED|Maintenance Phase (CERA)||0
345067|NCT00546481|834405|P3|STARTED|Maintenance Phase (CERA)||54
345068|NCT00546481|834406|P2|STARTED|Maintenance Phase (CERA)||0
345069|NCT00546481|834407|P1|STARTED|Maintenance Phase (CERA)||0
345070|NCT00546481|834405|P3|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
345071|NCT00546481|834406|P2|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||5
345072|NCT00546481|834407|P1|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||6
345073|NCT00546481|834405|P3|COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
345074|NCT00546481|834406|P2|COMPLETED|Correction Phase (CERA or Epoetin Beta)||36
345075|NCT00546481|834407|P1|COMPLETED|Correction Phase (CERA or Epoetin Beta)||33
345076|NCT00546481|834405|P3|STARTED|Correction Phase (CERA or Epoetin Beta)||0
345077|NCT00546481|834406|P2|STARTED|Correction Phase (CERA or Epoetin Beta)||41
345078|NCT00546481|834407|P1|STARTED|Correction Phase (CERA or Epoetin Beta)||39
345079|NCT00546429|834430|P1|NOT COMPLETED|Overall Study||30
345080|NCT00546429|834430|P1|COMPLETED|Overall Study||32
345081|NCT00546429|834430|P1|STARTED|Overall Study|2 subjects did not have a preoperative Merle D'Aubigne score.|62
345082|NCT00546390|834436|P2|NOT COMPLETED|Overall Study||0
345083|NCT00546390|834437|P1|NOT COMPLETED|Overall Study||0
345084|NCT00546390|834436|P2|COMPLETED|Overall Study||28
345085|NCT00546390|834437|P1|COMPLETED|Overall Study||27
345086|NCT00546390|834436|P2|STARTED|Overall Study||28
345087|NCT00546390|834437|P1|STARTED|Overall Study||27
345088|NCT00546377|834445|P1|NOT COMPLETED|Overall Study||7
345089|NCT00546377|834445|P1|COMPLETED|Overall Study||43
345090|NCT00546377|834445|P1|STARTED|Overall Study||50
345091|NCT00546364|834453|P3|NOT COMPLETED|Overall Study||17
345092|NCT00546364|834454|P2|NOT COMPLETED|Overall Study||18
345093|NCT00546364|834455|P1|NOT COMPLETED|Overall Study||17
345094|NCT00546364|834453|P3|COMPLETED|Overall Study|Still on treatment|3
345095|NCT00546364|834454|P2|COMPLETED|Overall Study|Still on treatment|4
345096|NCT00546364|834455|P1|COMPLETED|Overall Study|Still on treatment|3
345097|NCT00546364|834453|P3|Never Treated|Overall Study||0
345098|NCT00546364|834454|P2|Never Treated|Overall Study||0
345099|NCT00546364|834455|P1|Never Treated|Overall Study||0
345100|NCT00546364|834453|P3|STARTED|Overall Study||20
345101|NCT00546364|834454|P2|STARTED|Overall Study||22
345102|NCT00546364|834455|P1|STARTED|Overall Study||20
345103|NCT00546351|834490|P1|NOT COMPLETED|Overall Study||236
345104|NCT00546351|834490|P1|COMPLETED|Overall Study||385
345105|NCT00546351|834490|P1|STARTED|Overall Study||621
345106|NCT00546273|834523|P5|NOT COMPLETED|IV||0
345107|NCT00546273|834524|P4|NOT COMPLETED|IV||0
345108|NCT00546273|834525|P3|NOT COMPLETED|IV||0
345109|NCT00546273|834526|P2|NOT COMPLETED|IV||0
345110|NCT00546273|834527|P1|NOT COMPLETED|IV||0
345111|NCT00546273|834523|P5|COMPLETED|IV||2
345112|NCT00546273|834524|P4|COMPLETED|IV||4
345113|NCT00546273|834525|P3|COMPLETED|IV||0
345114|NCT00546273|834526|P2|COMPLETED|IV||0
345115|NCT00546273|834527|P1|COMPLETED|IV||0
345116|NCT00546273|834523|P5|STARTED|IV||2
345117|NCT00546273|834524|P4|STARTED|IV||4
345118|NCT00546273|834525|P3|STARTED|IV||0
345119|NCT00546273|834526|P2|STARTED|IV||0
345120|NCT00546273|834527|P1|STARTED|IV||0
345121|NCT00546273|834523|P5|NOT COMPLETED|III||0
345122|NCT00546273|834524|P4|NOT COMPLETED|III||0
345123|NCT00546273|834525|P3|NOT COMPLETED|III||0
345124|NCT00546273|834526|P2|NOT COMPLETED|III||0
345125|NCT00546273|834527|P1|NOT COMPLETED|III||0
345126|NCT00546273|834523|P5|COMPLETED|III||2
345127|NCT00546273|834524|P4|COMPLETED|III||0
345128|NCT00546273|834525|P3|COMPLETED|III||4
345129|NCT00546273|834526|P2|COMPLETED|III||0
345130|NCT00546273|834527|P1|COMPLETED|III||0
345131|NCT00546273|834523|P5|STARTED|III||2
345132|NCT00546273|834524|P4|STARTED|III||0
345133|NCT00546273|834525|P3|STARTED|III||4
345134|NCT00546273|834526|P2|STARTED|III||0
345135|NCT00546273|834527|P1|STARTED|III||0
345136|NCT00546273|834523|P5|NOT COMPLETED|II||0
345137|NCT00546273|834524|P4|NOT COMPLETED|II||0
345138|NCT00546273|834525|P3|NOT COMPLETED|II||0
345139|NCT00546273|834526|P2|NOT COMPLETED|II||0
345140|NCT00546273|834527|P1|NOT COMPLETED|II||0
345141|NCT00546273|834523|P5|COMPLETED|II||2
345142|NCT00546273|834524|P4|COMPLETED|II||0
345143|NCT00546273|834525|P3|COMPLETED|II||0
345144|NCT00546273|834526|P2|COMPLETED|II||4
345145|NCT00546273|834527|P1|COMPLETED|II||0
345146|NCT00546273|834523|P5|STARTED|II||2
345147|NCT00546273|834524|P4|STARTED|II||0
345148|NCT00546273|834525|P3|STARTED|II||0
345149|NCT00546273|834526|P2|STARTED|II||4
345150|NCT00546273|834527|P1|STARTED|II||0
345151|NCT00546273|834523|P5|NOT COMPLETED|I||0
345152|NCT00546273|834524|P4|NOT COMPLETED|I||0
345153|NCT00546273|834525|P3|NOT COMPLETED|I||0
345154|NCT00546273|834526|P2|NOT COMPLETED|I||0
345155|NCT00546273|834527|P1|NOT COMPLETED|I||0
345156|NCT00546273|834523|P5|COMPLETED|I||2
345157|NCT00546273|834524|P4|COMPLETED|I||0
345158|NCT00546273|834525|P3|COMPLETED|I||0
345159|NCT00546273|834526|P2|COMPLETED|I||0
345160|NCT00546273|834527|P1|COMPLETED|I||4
345161|NCT00546273|834523|P5|STARTED|I||2
345162|NCT00546273|834524|P4|STARTED|I||0
345163|NCT00546273|834525|P3|STARTED|I||0
345164|NCT00546273|834526|P2|STARTED|I||0
345165|NCT00546273|834527|P1|STARTED|I||4
345166|NCT00546260|834536|P2|NOT COMPLETED|Overall Study||2
345167|NCT00546260|834537|P1|NOT COMPLETED|Overall Study||8
345168|NCT00546260|834536|P2|COMPLETED|Overall Study||32
345169|NCT00546260|834537|P1|COMPLETED|Overall Study||28
345170|NCT00546260|834536|P2|STARTED|Overall Study||34
345171|NCT00546260|834537|P1|STARTED|Overall Study||36
345172|NCT00546156|834549|P2|NOT COMPLETED|Overall Study||1
345173|NCT00546156|834550|P1|NOT COMPLETED|Overall Study||14
345174|NCT00546156|834549|P2|COMPLETED|Overall Study||19
345175|NCT00546156|834550|P1|COMPLETED|Overall Study||70
345176|NCT00546156|834549|P2|STARTED|Overall Study||20
345177|NCT00546156|834550|P1|STARTED|Overall Study||84
345178|NCT00546117|834559|P2|NOT COMPLETED|Overall Study||0
345179|NCT00546117|834560|P1|NOT COMPLETED|Overall Study||4
345180|NCT00546117|834559|P2|COMPLETED|Overall Study||7
345181|NCT00546117|834560|P1|COMPLETED|Overall Study||5
345182|NCT00546117|834559|P2|STARTED|Overall Study||7
345183|NCT00546117|834560|P1|STARTED|Overall Study||9
345184|NCT00546104|834574|P1|NOT COMPLETED|Overall Study||0
345185|NCT00546104|834574|P1|COMPLETED|Overall Study||31
345186|NCT00546104|834574|P1|STARTED|Overall Study||31
345187|NCT00546078|834585|P2|NOT COMPLETED|Overall Study||7
345188|NCT00546078|834586|P1|NOT COMPLETED|Overall Study||4
345189|NCT00546078|834585|P2|COMPLETED|Overall Study||43
345190|NCT00546078|834586|P1|COMPLETED|Overall Study||61
345191|NCT00546078|834585|P2|Month 18|Overall Study||45
345192|NCT00546078|834586|P1|Month 18|Overall Study||61
345193|NCT00546078|834585|P2|STARTED|Overall Study||50
345194|NCT00546078|834586|P1|STARTED|Overall Study||65
345195|NCT00546052|834624|P1|NOT COMPLETED|Overall Study||227
345196|NCT00546052|834624|P1|COMPLETED|Overall Study||1511
345197|NCT00546052|834624|P1|Week 52|Overall Study||1511
345198|NCT00546052|834624|P1|Week 32|Overall Study||1583
345199|NCT00546052|834624|P1|Week 12|Overall Study||1650
345200|NCT00546052|834624|P1|Week 8|Overall Study||1680
345201|NCT00546052|834624|P1|Week 4|Overall Study||1714
345202|NCT00546052|834624|P1|STARTED|Overall Study||1738
345203|NCT00546000|834642|P1|NOT COMPLETED|Overall Study||4
345204|NCT00546000|834642|P1|COMPLETED|Overall Study||52
345205|NCT00546000|834642|P1|STARTED|Overall Study||56
345206|NCT00545974|834649|P2|NOT COMPLETED|Overall Study||3
345207|NCT00545974|834650|P1|NOT COMPLETED|Overall Study||2
345208|NCT00545974|834649|P2|COMPLETED|Overall Study|subjects completed 26 weeks treatment in placebo cohort|39
345209|NCT00545974|834650|P1|COMPLETED|Overall Study|subjects completed 26 weeks treatment in memantine cohort|37
345210|NCT00545974|834649|P2|STARTED|Overall Study|subjects randomized to placebo cohort|42
345211|NCT00545974|834650|P1|STARTED|Overall Study|subjects randomized to memantine cohort|39
345212|NCT00545948|834661|P3|NOT COMPLETED|Overall Study||7
345213|NCT00545948|834662|P2|NOT COMPLETED|Overall Study||1
345214|NCT00545948|834663|P1|NOT COMPLETED|Overall Study||1
345215|NCT00545948|834661|P3|COMPLETED|Overall Study||0
345216|NCT00545948|834662|P2|COMPLETED|Overall Study|Patients who received pemetrexed + cisplatin protocol therapy.|14
345217|NCT00545948|834663|P1|COMPLETED|Overall Study|Patients who received vinorelbine + cisplatin protocol therapy.|8
345218|NCT00545948|834661|P3|Assigned Treatment|Overall Study||0
345219|NCT00545948|834662|P2|Assigned Treatment|Overall Study||15
345220|NCT00545948|834663|P1|Assigned Treatment|Overall Study||9
345221|NCT00545948|834661|P3|STARTED|Overall Study|Registered patients who were not assigned to receive protocol therapy.|7
345222|NCT00545948|834662|P2|STARTED|Overall Study|Registered patients assigned to receive pemetrexed + cisplatin protocol therapy.|15
345223|NCT00545948|834663|P1|STARTED|Overall Study|Registered patients assigned to receive vinorelbine + cisplatin protocol therapy.|9
345224|NCT00545844|834673|P1|NOT COMPLETED|Overall Study||12
345225|NCT00545844|834673|P1|COMPLETED|Overall Study||301
345226|NCT00545844|834673|P1|STARTED|Overall Study||313
345227|NCT00545792|834687|P1|NOT COMPLETED|Overall Study||1
345228|NCT00545792|834687|P1|COMPLETED|Overall Study||20
345229|NCT00545792|834687|P1|STARTED|Overall Study||21
345230|NCT00545779|834692|P1|NOT COMPLETED|Overall Study||44
345231|NCT00545779|834692|P1|COMPLETED|Overall Study||633
345232|NCT00545779|834692|P1|STARTED|Overall Study||677
345233|NCT00545766|834705|P1|NOT COMPLETED|Overall Study||5
345234|NCT00545766|834705|P1|COMPLETED|Overall Study||36
345235|NCT00545766|834705|P1|STARTED|Overall Study||41
345236|NCT00545753|834712|P3|NOT COMPLETED|Overall Study||26
345237|NCT00545753|834713|P2|NOT COMPLETED|Overall Study||5
345238|NCT00545753|834714|P1|NOT COMPLETED|Overall Study||16
345239|NCT00545753|834712|P3|COMPLETED|Overall Study||230
345240|NCT00545753|834713|P2|COMPLETED|Overall Study||54
345241|NCT00545753|834714|P1|COMPLETED|Overall Study||227
345242|NCT00545753|834712|P3|STARTED|Overall Study||256
345243|NCT00545753|834713|P2|STARTED|Overall Study||59
345244|NCT00545753|834714|P1|STARTED|Overall Study||243
345245|NCT00545740|834727|P4|NOT COMPLETED|Overall Study||71
345246|NCT00545740|834728|P3|NOT COMPLETED|Overall Study||96
345247|NCT00545740|834729|P2|NOT COMPLETED|Overall Study||83
345248|NCT00545740|834730|P1|NOT COMPLETED|Overall Study||75
345249|NCT00545740|834727|P4|COMPLETED|Overall Study||78
345250|NCT00545740|834728|P3|COMPLETED|Overall Study||55
345251|NCT00545740|834729|P2|COMPLETED|Overall Study||62
345252|NCT00545740|834730|P1|COMPLETED|Overall Study||70
345253|NCT00545740|834727|P4|STARTED|Overall Study||149
345254|NCT00545740|834728|P3|STARTED|Overall Study||151
345255|NCT00545740|834729|P2|STARTED|Overall Study||145
345256|NCT00545740|834730|P1|STARTED|Overall Study||145
345257|NCT00545714|834764|P1|NOT COMPLETED|Maintenance Phase (36 Months)||32
345258|NCT00545714|834764|P1|COMPLETED|Maintenance Phase (36 Months)||42
345259|NCT00545714|834764|P1|STARTED|Maintenance Phase (36 Months)||74
345260|NCT00545714|834764|P1|NOT COMPLETED|Induction Phase (6 Months)||12
345261|NCT00545714|834764|P1|COMPLETED|Induction Phase (6 Months)||74
345262|NCT00545714|834764|P1|Intent-to-Treat (ITT) Population|Induction Phase (6 Months)||84
345263|NCT00545714|834764|P1|Safety Population|Induction Phase (6 Months)||86
345264|NCT00545714|834764|P1|STARTED|Induction Phase (6 Months)||86
345265|NCT00545688|834785|P4|NOT COMPLETED|Follow-Up Period||27
345266|NCT00545688|834786|P3|NOT COMPLETED|Follow-Up Period||20
345267|NCT00545688|834787|P2|NOT COMPLETED|Follow-Up Period||19
345268|NCT00545688|834788|P1|NOT COMPLETED|Follow-Up Period||21
345269|NCT00545688|834785|P4|COMPLETED|Follow-Up Period||60
345270|NCT00545688|834786|P3|COMPLETED|Follow-Up Period||78
345271|NCT00545688|834787|P2|COMPLETED|Follow-Up Period||83
345272|NCT00545688|834788|P1|COMPLETED|Follow-Up Period||77
345273|NCT00545688|834785|P4|STARTED|Follow-Up Period||87
345274|NCT00545688|834786|P3|STARTED|Follow-Up Period||98
345275|NCT00545688|834787|P2|STARTED|Follow-Up Period||102
345276|NCT00545688|834788|P1|STARTED|Follow-Up Period||98
345277|NCT00545688|834785|P4|NOT COMPLETED|Adjuvant Treatment Period||14
345278|NCT00545688|834786|P3|NOT COMPLETED|Adjuvant Treatment Period||4
345279|NCT00545688|834787|P2|NOT COMPLETED|Adjuvant Treatment Period||8
345280|NCT00545688|834788|P1|NOT COMPLETED|Adjuvant Treatment Period||5
345281|NCT00545688|834785|P4|COMPLETED|Adjuvant Treatment Period||74
345282|NCT00545688|834786|P3|COMPLETED|Adjuvant Treatment Period||90
345283|NCT00545688|834787|P2|COMPLETED|Adjuvant Treatment Period||94
345284|NCT00545688|834788|P1|COMPLETED|Adjuvant Treatment Period||98
345285|NCT00545688|834785|P4|STARTED|Adjuvant Treatment Period||88
345286|NCT00545688|834786|P3|STARTED|Adjuvant Treatment Period||94
345287|NCT00545688|834787|P2|STARTED|Adjuvant Treatment Period||102
345288|NCT00545688|834788|P1|STARTED|Adjuvant Treatment Period||103
345289|NCT00545688|834785|P4|NOT COMPLETED|Neo-Adjuvant Treatment Period||6
345290|NCT00545688|834786|P3|NOT COMPLETED|Neo-Adjuvant Treatment Period||14
345291|NCT00545688|834787|P2|NOT COMPLETED|Neo-Adjuvant Treatment Period||5
345292|NCT00545688|834788|P1|NOT COMPLETED|Neo-Adjuvant Treatment Period||4
345293|NCT00545688|834785|P4|COMPLETED|Neo-Adjuvant Treatment Period||88
345294|NCT00545688|834786|P3|COMPLETED|Neo-Adjuvant Treatment Period||94
345295|NCT00545688|834787|P2|COMPLETED|Neo-Adjuvant Treatment Period||102
345296|NCT00545688|834788|P1|COMPLETED|Neo-Adjuvant Treatment Period||103
345297|NCT00545688|834785|P4|STARTED|Neo-Adjuvant Treatment Period||94
345298|NCT00545688|834786|P3|STARTED|Neo-Adjuvant Treatment Period||108
345299|NCT00545688|834787|P2|STARTED|Neo-Adjuvant Treatment Period||107
345300|NCT00545688|834788|P1|STARTED|Neo-Adjuvant Treatment Period||107
345301|NCT00545662|834860|P2|NOT COMPLETED|Overall Study||79
345302|NCT00545662|834861|P1|NOT COMPLETED|Overall Study||85
345303|NCT00545662|834860|P2|COMPLETED|Overall Study||528
345304|NCT00545662|834861|P1|COMPLETED|Overall Study||521
345305|NCT00545662|834860|P2|STARTED|Overall Study||607
345306|NCT00545662|834861|P1|STARTED|Overall Study||606
345307|NCT00545623|834871|P4|NOT COMPLETED|Overall Study||11
345308|NCT00545623|834872|P3|NOT COMPLETED|Overall Study||13
345309|NCT00545623|834873|P2|NOT COMPLETED|Overall Study||10
345310|NCT00545623|834874|P1|NOT COMPLETED|Overall Study||7
345311|NCT00545623|834871|P4|COMPLETED|Overall Study||23
345312|NCT00545623|834872|P3|COMPLETED|Overall Study||20
345313|NCT00545623|834873|P2|COMPLETED|Overall Study||21
345314|NCT00545623|834874|P1|COMPLETED|Overall Study||25
345315|NCT00545623|834871|P4|STARTED|Overall Study||34
345316|NCT00545623|834872|P3|STARTED|Overall Study||33
345317|NCT00545623|834873|P2|STARTED|Overall Study||31
345318|NCT00545623|834874|P1|STARTED|Overall Study||32
345319|NCT00545584|834887|P3|NOT COMPLETED|Overall Study||56
345320|NCT00545584|834888|P2|NOT COMPLETED|Overall Study||80
345321|NCT00545584|834889|P1|NOT COMPLETED|Overall Study||79
345322|NCT00545584|834887|P3|COMPLETED|Overall Study||250
345323|NCT00545584|834888|P2|COMPLETED|Overall Study||334
345324|NCT00545584|834889|P1|COMPLETED|Overall Study||333
345325|NCT00545584|834887|P3|STARTED|Overall Study|306 subjects were randomized but only 305 were treated.|306
345326|NCT00545584|834888|P2|STARTED|Overall Study||414
345327|NCT00545584|834889|P1|STARTED|Overall Study||412
345328|NCT00545571|834900|P1|NOT COMPLETED|Overall Study||67
345329|NCT00545571|834900|P1|COMPLETED|Overall Study||53
345330|NCT00545571|834900|P1|STARTED|Overall Study||120
345331|NCT00545532|834915|P2|NOT COMPLETED|Overall Study||10
345332|NCT00545532|834916|P1|NOT COMPLETED|Overall Study||6
345333|NCT00545532|834915|P2|COMPLETED|Overall Study||100
345334|NCT00545532|834916|P1|COMPLETED|Overall Study||99
345335|NCT00545532|834915|P2|STARTED|Overall Study||110
345336|NCT00545532|834916|P1|STARTED|Overall Study||105
345337|NCT00545506|834998|P2|NOT COMPLETED|Overall Study||0
345338|NCT00545506|834999|P1|NOT COMPLETED|Overall Study||0
345339|NCT00545506|834998|P2|COMPLETED|Overall Study||3
345340|NCT00545506|834999|P1|COMPLETED|Overall Study||3
345341|NCT00545506|834998|P2|STARTED|Overall Study||3
345342|NCT00545506|834999|P1|STARTED|Overall Study||3
345343|NCT00545441|835007|P2|NOT COMPLETED|Overall Study||16
345344|NCT00545441|835008|P1|NOT COMPLETED|Overall Study||18
345345|NCT00545441|835007|P2|COMPLETED|Overall Study||26
345346|NCT00545441|835008|P1|COMPLETED|Overall Study||26
345347|NCT00545441|835007|P2|STARTED|Overall Study||42
345348|NCT00545441|835008|P1|STARTED|Overall Study||44
345349|NCT00545402|835016|P2|NOT COMPLETED|Overall Study||29
345350|NCT00545402|835017|P1|NOT COMPLETED|Overall Study||34
345351|NCT00545402|835016|P2|COMPLETED|Overall Study||61
345352|NCT00545402|835017|P1|COMPLETED|Overall Study||56
345353|NCT00545402|835016|P2|STARTED|Overall Study||90
345354|NCT00545402|835017|P1|STARTED|Overall Study||90
345355|NCT00545363|835035|P2|NOT COMPLETED|Overall Study||15
345356|NCT00545363|835036|P1|NOT COMPLETED|Overall Study||19
345357|NCT00545363|835035|P2|COMPLETED|Overall Study||343
345358|NCT00545363|835036|P1|COMPLETED|Overall Study||339
345359|NCT00545363|835035|P2|Treated|Overall Study||357
345360|NCT00545363|835036|P1|Treated|Overall Study||354
345361|NCT00545363|835035|P2|STARTED|Overall Study||358
345362|NCT00545363|835036|P1|STARTED|Overall Study||358
345363|NCT00545298|835051|P3|NOT COMPLETED|Overall Study||1
345364|NCT00545298|835052|P2|NOT COMPLETED|Overall Study||0
345365|NCT00545298|835053|P1|NOT COMPLETED|Overall Study||2
345366|NCT00545298|835051|P3|COMPLETED|Overall Study||0
345367|NCT00545298|835052|P2|COMPLETED|Overall Study||1
345368|NCT00545298|835053|P1|COMPLETED|Overall Study||0
345369|NCT00545298|835051|P3|STARTED|Overall Study||1
345370|NCT00545298|835052|P2|STARTED|Overall Study||1
345371|NCT00545298|835053|P1|STARTED|Overall Study||2
345372|NCT00545272|835070|P6|NOT COMPLETED|Overall Study||3
345373|NCT00545272|835071|P5|NOT COMPLETED|Overall Study||2
345374|NCT00545272|835072|P4|NOT COMPLETED|Overall Study||1
345375|NCT00545272|835073|P3|NOT COMPLETED|Overall Study||1
345376|NCT00545272|835074|P2|NOT COMPLETED|Overall Study||1
345377|NCT00545272|835075|P1|NOT COMPLETED|Overall Study||0
345378|NCT00545272|835070|P6|COMPLETED|Overall Study||59
345379|NCT00545272|835071|P5|COMPLETED|Overall Study||62
345380|NCT00545272|835072|P4|COMPLETED|Overall Study||71
345381|NCT00545272|835073|P3|COMPLETED|Overall Study||64
345382|NCT00545272|835074|P2|COMPLETED|Overall Study||67
345383|NCT00545272|835075|P1|COMPLETED|Overall Study||61
345384|NCT00545272|835070|P6|STARTED|Overall Study||62
345385|NCT00545272|835071|P5|STARTED|Overall Study||64
345386|NCT00545272|835072|P4|STARTED|Overall Study||72
345387|NCT00545272|835073|P3|STARTED|Overall Study||65
345388|NCT00545272|835074|P2|STARTED|Overall Study||68
345389|NCT00545272|835075|P1|STARTED|Overall Study||61
345390|NCT00545233|835127|P2|NOT COMPLETED|Overall Study||35
345391|NCT00545233|835128|P1|NOT COMPLETED|Overall Study||46
345392|NCT00545233|835127|P2|COMPLETED|Overall Study||41
345393|NCT00545233|835128|P1|COMPLETED|Overall Study||33
345394|NCT00545233|835127|P2|Intent-to-Treat (ITT)|Overall Study||73
345395|NCT00545233|835128|P1|Intent-to-Treat (ITT)|Overall Study||77
345396|NCT00545233|835127|P2|Safety Set|Overall Study||75
345397|NCT00545233|835128|P1|Safety Set|Overall Study||77
345398|NCT00545233|835127|P2|STARTED|Overall Study||76
345399|NCT00545233|835128|P1|STARTED|Overall Study||79
345400|NCT00545181|835177|P2|NOT COMPLETED|Overall Study||0
345401|NCT00545181|835178|P1|NOT COMPLETED|Overall Study||0
345402|NCT00545181|835177|P2|COMPLETED|Overall Study||25
345403|NCT00545181|835178|P1|COMPLETED|Overall Study||29
345404|NCT00545181|835177|P2|STARTED|Overall Study||25
345405|NCT00545181|835178|P1|STARTED|Overall Study||29
345406|NCT00545168|835187|P3|NOT COMPLETED|Overall Study||21
345407|NCT00545168|835188|P2|NOT COMPLETED|Overall Study||5
345408|NCT00545168|835189|P1|NOT COMPLETED|Overall Study||16
345409|NCT00545168|835187|P3|COMPLETED|Overall Study||193
345410|NCT00545168|835188|P2|COMPLETED|Overall Study||58
345411|NCT00545168|835189|P1|COMPLETED|Overall Study||187
345412|NCT00545168|835187|P3|STARTED|Overall Study||214
345413|NCT00545168|835188|P2|STARTED|Overall Study||63
345414|NCT00545168|835189|P1|STARTED|Overall Study||203
345415|NCT00545155|835198|P1|NOT COMPLETED|Overall Study||0
345416|NCT00545155|835198|P1|COMPLETED|Overall Study||187
345417|NCT00545155|835198|P1|STARTED|Overall Study||187
345418|NCT00545103|835215|P4|NOT COMPLETED|Overall Study||70
345419|NCT00545103|835216|P3|NOT COMPLETED|Overall Study||76
345420|NCT00545103|835217|P2|NOT COMPLETED|Overall Study||78
345421|NCT00545103|835218|P1|NOT COMPLETED|Overall Study||75
345422|NCT00545103|835215|P4|COMPLETED|Overall Study||76
345423|NCT00545103|835216|P3|COMPLETED|Overall Study||74
345424|NCT00545103|835217|P2|COMPLETED|Overall Study||70
345425|NCT00545103|835218|P1|COMPLETED|Overall Study||73
345426|NCT00545103|835215|P4|STARTED|Overall Study||146
345427|NCT00545103|835216|P3|STARTED|Overall Study||150
345428|NCT00545103|835217|P2|STARTED|Overall Study||148
345429|NCT00545103|835218|P1|STARTED|Overall Study||148
345430|NCT00545077|835254|P2|NOT COMPLETED|Overall Study||155
345431|NCT00545077|835255|P1|NOT COMPLETED|Overall Study||148
345432|NCT00545077|835254|P2|COMPLETED|Overall Study||36
345433|NCT00545077|835255|P1|COMPLETED|Overall Study||41
345434|NCT00545077|835254|P2|STARTED|Overall Study||191
345435|NCT00545077|835255|P1|STARTED|Overall Study||189
345436|NCT00545064|835271|P1|NOT COMPLETED|Overall Study||8
345437|NCT00545064|835271|P1|COMPLETED|Overall Study||170
345438|NCT00545064|835271|P1|Visit 3 (Week 8)|Overall Study|8 patients didn’t complete the 8-week period. 6 were retrieved and considered as Visit 3 (Week 8)|176
345439|NCT00545064|835271|P1|Visit 2 (Week 4)|Overall Study||169
345440|NCT00545064|835271|P1|Visit 1 (Baseline)|Overall Study||178
345441|NCT00545064|835271|P1|STARTED|Overall Study||178
345442|NCT00545051|835282|P2|NOT COMPLETED|Overall Study||7
345443|NCT00545051|835283|P1|NOT COMPLETED|Overall Study||9
345444|NCT00545051|835282|P2|COMPLETED|Overall Study||65
345445|NCT00545051|835283|P1|COMPLETED|Overall Study||59
345446|NCT00545051|835282|P2|STARTED|Overall Study||72
345447|NCT00545051|835283|P1|STARTED|Overall Study||68
345448|NCT00545025|835299|P2|NOT COMPLETED|Overall Study||0
345449|NCT00545025|835300|P1|NOT COMPLETED|Overall Study||0
345450|NCT00545025|835299|P2|COMPLETED|Overall Study||83
345451|NCT00545025|835300|P1|COMPLETED|Overall Study||160
345452|NCT00545025|835299|P2|STARTED|Overall Study||83
345453|NCT00545025|835300|P1|STARTED|Overall Study||160
345454|NCT00544908|835320|P1|NOT COMPLETED|Overall Study||0
345455|NCT00544908|835320|P1|COMPLETED|Overall Study||7
345456|NCT00544908|835320|P1|STARTED|Overall Study||7
345457|NCT00544882|835327|P3|NOT COMPLETED|Cycle 3: Follow-up||0
345458|NCT00544882|835328|P2|NOT COMPLETED|Cycle 3: Follow-up||2
345459|NCT00544882|835329|P1|NOT COMPLETED|Cycle 3: Follow-up||0
345460|NCT00544882|835327|P3|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|28
345461|NCT00544882|835328|P2|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|26
345462|NCT00544882|835329|P1|COMPLETED|Cycle 3: Follow-up||0
345463|NCT00544882|835327|P3|STARTED|Cycle 3: Follow-up||28
345464|NCT00544882|835328|P2|STARTED|Cycle 3: Follow-up||28
345465|NCT00544882|835329|P1|STARTED|Cycle 3: Follow-up||0
345466|NCT00544882|835327|P3|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
345467|NCT00544882|835328|P2|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
345468|NCT00544882|835329|P1|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||0
345469|NCT00544882|835327|P3|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
345470|NCT00544882|835328|P2|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
345471|NCT00544882|835329|P1|COMPLETED|Cycle 2: Randomized Treatment Cycle||0
345472|NCT00544882|835327|P3|Treated|Cycle 2: Randomized Treatment Cycle|One participant was dropped from the study due to noncompliance prior to treatment.|28
345473|NCT00544882|835328|P2|Treated|Cycle 2: Randomized Treatment Cycle|One participant withdrew prior to treatment|28
345474|NCT00544882|835329|P1|Treated|Cycle 2: Randomized Treatment Cycle||0
345475|NCT00544882|835327|P3|STARTED|Cycle 2: Randomized Treatment Cycle||29
345476|NCT00544882|835328|P2|STARTED|Cycle 2: Randomized Treatment Cycle||29
345477|NCT00544882|835329|P1|STARTED|Cycle 2: Randomized Treatment Cycle||0
345478|NCT00544882|835327|P3|NOT COMPLETED|Cycle 1: Run-in Cycle||0
345479|NCT00544882|835328|P2|NOT COMPLETED|Cycle 1: Run-in Cycle||0
345480|NCT00544882|835329|P1|NOT COMPLETED|Cycle 1: Run-in Cycle||3
345481|NCT00544882|835327|P3|COMPLETED|Cycle 1: Run-in Cycle||0
345482|NCT00544882|835328|P2|COMPLETED|Cycle 1: Run-in Cycle||0
345483|NCT00544882|835329|P1|COMPLETED|Cycle 1: Run-in Cycle||58
345484|NCT00544882|835327|P3|STARTED|Cycle 1: Run-in Cycle||0
345485|NCT00544882|835328|P2|STARTED|Cycle 1: Run-in Cycle||0
345486|NCT00544882|835329|P1|STARTED|Cycle 1: Run-in Cycle||61
345487|NCT00544869|835354|P3|NOT COMPLETED|Overall Study||0
345488|NCT00544869|835355|P2|NOT COMPLETED|Overall Study||2
345489|NCT00544869|835356|P1|NOT COMPLETED|Overall Study||12
345490|NCT00544869|835354|P3|COMPLETED|Overall Study||2
345491|NCT00544869|835355|P2|COMPLETED|Overall Study||12
345492|NCT00544869|835356|P1|COMPLETED|Overall Study||24
345493|NCT00544869|835354|P3|STARTED|Overall Study||2
345494|NCT00544869|835355|P2|STARTED|Overall Study||14
345495|NCT00544869|835356|P1|STARTED|Overall Study||36
345496|NCT00544817|835364|P1|NOT COMPLETED|Follow-up Systemic Therapy||19
345497|NCT00544817|835364|P1|COMPLETED|Follow-up Systemic Therapy||9
345498|NCT00544817|835364|P1|STARTED|Follow-up Systemic Therapy||28
345499|NCT00544817|835364|P1|NOT COMPLETED|No Treatment Interval||12
345500|NCT00544817|835364|P1|COMPLETED|No Treatment Interval||28
345501|NCT00544817|835364|P1|STARTED|No Treatment Interval||40
345502|NCT00544817|835364|P1|NOT COMPLETED|Combined Modality||7
345503|NCT00544817|835364|P1|COMPLETED|Combined Modality||40
345504|NCT00544817|835364|P1|STARTED|Combined Modality||47
345505|NCT00544778|835370|P1|NOT COMPLETED|Overall Study||0
345506|NCT00544778|835370|P1|COMPLETED|Overall Study||7
345507|NCT00544778|835370|P1|STARTED|Overall Study||7
345508|NCT00544713|835376|P2|NOT COMPLETED|Overall Study||5
345509|NCT00544713|835377|P1|NOT COMPLETED|Overall Study||3
345510|NCT00544713|835376|P2|COMPLETED|Overall Study||109
345511|NCT00544713|835377|P1|COMPLETED|Overall Study||111
345512|NCT00544713|835376|P2|STARTED|Overall Study||114
345513|NCT00544713|835377|P1|STARTED|Overall Study||114
345514|NCT00544674|835407|P1|NOT COMPLETED|Overall Study||1
345515|NCT00544674|835407|P1|COMPLETED|Overall Study||4
345516|NCT00544674|835407|P1|STARTED|Overall Study|1 subject registered and expired prior to dosing|5
345517|NCT00544648|835413|P2|NOT COMPLETED|Overall Study||1
345518|NCT00544648|835414|P1|NOT COMPLETED|Overall Study||3
345519|NCT00544648|835413|P2|COMPLETED|Overall Study||1
345520|NCT00544648|835414|P1|COMPLETED|Overall Study||8
345521|NCT00544648|835413|P2|STARTED|Overall Study||2
345522|NCT00544648|835414|P1|STARTED|Overall Study||11
345523|NCT00544557|835428|P1|NOT COMPLETED|Overall Study||434
345524|NCT00544557|835428|P1|COMPLETED|Overall Study||1251
345525|NCT00544557|835428|P1|STARTED|Overall Study||1685
345526|NCT00544544|835459|P1|NOT COMPLETED|Overall Study||3
345527|NCT00544544|835459|P1|COMPLETED|Overall Study||11
345528|NCT00544544|835459|P1|STARTED|Overall Study||14
345529|NCT00544440|835466|P1|NOT COMPLETED|Overall Study||57
345530|NCT00544440|835466|P1|COMPLETED|Overall Study||0
345531|NCT00544440|835466|P1|STARTED|Overall Study||57
345532|NCT00544167|835473|P1|NOT COMPLETED|Overall Study||29
345533|NCT00544167|835473|P1|COMPLETED|Overall Study||16
345534|NCT00544167|835473|P1|STARTED|Overall Study||45
345535|NCT00544076|835480|P3|NOT COMPLETED|Overall Study||11
345536|NCT00544076|835481|P2|NOT COMPLETED|Overall Study||16
345537|NCT00544076|835482|P1|NOT COMPLETED|Overall Study||17
345538|NCT00544076|835480|P3|COMPLETED|Overall Study||20
345539|NCT00544076|835481|P2|COMPLETED|Overall Study||19
345540|NCT00544076|835482|P1|COMPLETED|Overall Study||17
345541|NCT00544076|835480|P3|STARTED|Overall Study||31
345542|NCT00544076|835481|P2|STARTED|Overall Study||35
345543|NCT00544076|835482|P1|STARTED|Overall Study||34
345544|NCT00543985|835499|P1|NOT COMPLETED|Overall Study||4
345545|NCT00543985|835499|P1|COMPLETED|Overall Study||32
345546|NCT00543985|835499|P1|STARTED|Overall Study||36
345547|NCT00543855|835510|P4|NOT COMPLETED|Overall Study||4
345548|NCT00543855|835511|P3|NOT COMPLETED|Overall Study||6
345549|NCT00543855|835512|P2|NOT COMPLETED|Overall Study||2
345550|NCT00543855|835513|P1|NOT COMPLETED|Overall Study||4
345551|NCT00543855|835510|P4|COMPLETED|Overall Study||30
345552|NCT00543855|835511|P3|COMPLETED|Overall Study||31
345553|NCT00543855|835512|P2|COMPLETED|Overall Study||31
345554|NCT00543855|835513|P1|COMPLETED|Overall Study||31
345555|NCT00543855|835510|P4|STARTED|Overall Study||34
345556|NCT00543855|835511|P3|STARTED|Overall Study||37
345557|NCT00543855|835512|P2|STARTED|Overall Study||33
345558|NCT00543855|835513|P1|STARTED|Overall Study||35
345559|NCT00543803|835535|P1|NOT COMPLETED|Overall Study||142
345560|NCT00543803|835535|P1|COMPLETED|Overall Study||192
345561|NCT00543803|835535|P1|STARTED|Overall Study||334
345562|NCT00543764|835554|P2|NOT COMPLETED|Overall Study||0
345563|NCT00543764|835555|P1|NOT COMPLETED|Overall Study||0
345564|NCT00543764|835554|P2|COMPLETED|Overall Study||50
345565|NCT00543764|835555|P1|COMPLETED|Overall Study||100
345566|NCT00543764|835554|P2|STARTED|Overall Study||50
345567|NCT00543764|835555|P1|STARTED|Overall Study||100
345568|NCT00543725|835563|P2|NOT COMPLETED|Overall Study||74
345569|NCT00543725|835564|P1|NOT COMPLETED|Overall Study||68
345570|NCT00543725|835563|P2|COMPLETED|Overall Study||264
345571|NCT00543725|835564|P1|COMPLETED|Overall Study||272
345572|NCT00543725|835563|P2|STARTED|Overall Study||338
345573|NCT00543725|835564|P1|STARTED|Overall Study||340
345574|NCT00543569|835590|P4|NOT COMPLETED|Overall Study||9
345575|NCT00543569|835591|P3|NOT COMPLETED|Overall Study||20
345576|NCT00543569|835592|P2|NOT COMPLETED|Overall Study||8
345577|NCT00543569|835593|P1|NOT COMPLETED|Overall Study||12
345578|NCT00543569|835590|P4|COMPLETED|Overall Study||72
345579|NCT00543569|835591|P3|COMPLETED|Overall Study||60
345580|NCT00543569|835592|P2|COMPLETED|Overall Study||72
345581|NCT00543569|835593|P1|COMPLETED|Overall Study||70
345582|NCT00543569|835590|P4|Received Treatment|Overall Study||78
345583|NCT00543569|835591|P3|Received Treatment|Overall Study||75
345584|NCT00543569|835592|P2|Received Treatment|Overall Study||77
345585|NCT00543569|835593|P1|Received Treatment|Overall Study||79
345586|NCT00543569|835590|P4|STARTED|Overall Study||81
345587|NCT00543569|835591|P3|STARTED|Overall Study||80
345588|NCT00543569|835592|P2|STARTED|Overall Study||80
345589|NCT00543569|835593|P1|STARTED|Overall Study||82
345590|NCT00543543|835699|P4|NOT COMPLETED|Extension Study||226
345591|NCT00543543|835700|P3|NOT COMPLETED|Extension Study||0
345592|NCT00543543|835701|P2|NOT COMPLETED|Extension Study||0
345593|NCT00543543|835702|P1|NOT COMPLETED|Extension Study||0
345594|NCT00543543|835699|P4|COMPLETED|Extension Study||2824
345595|NCT00543543|835700|P3|COMPLETED|Extension Study||0
345596|NCT00543543|835701|P2|COMPLETED|Extension Study||150
345597|NCT00543543|835702|P1|COMPLETED|Extension Study||0
345598|NCT00543543|835699|P4|STARTED|Extension Study|Cohort 2|3050
345599|NCT00543543|835700|P3|STARTED|Extension Study|This group did not participate in the Extension Study|0
345600|NCT00543543|835701|P2|STARTED|Extension Study|Cohort 1|150
345601|NCT00543543|835702|P1|STARTED|Extension Study|This group did not participate in the Extension Study|0
345602|NCT00543543|835699|P4|NOT COMPLETED|Base Study||1222
345603|NCT00543543|835700|P3|NOT COMPLETED|Base Study||14
345604|NCT00543543|835701|P2|NOT COMPLETED|Base Study||1252
345605|NCT00543543|835702|P1|NOT COMPLETED|Base Study||20
345606|NCT00543543|835699|P4|COMPLETED|Base Study|Follow-up was up to 54 months|5887
345607|NCT00543543|835700|P3|COMPLETED|Base Study|Follow-up was up to 7 months|296
345608|NCT00543543|835701|P2|COMPLETED|Base Study|Follow-up was up to 54 months|5854
345609|NCT00543543|835702|P1|COMPLETED|Base Study|Follow-up was up to 7 months|295
345610|NCT00543543|835699|P4|Completed 3 Vaccinations|Base Study||6934
345611|NCT00543543|835700|P3|Completed 3 Vaccinations|Base Study||297
345612|NCT00543543|835701|P2|Completed 3 Vaccinations|Base Study||6928
345613|NCT00543543|835702|P1|Completed 3 Vaccinations|Base Study||300
345614|NCT00543543|835699|P4|STARTED|Base Study||7109
345615|NCT00543543|835700|P3|STARTED|Base Study||310
345616|NCT00543543|835701|P2|STARTED|Base Study||7106
345617|NCT00543543|835702|P1|STARTED|Base Study||315
345618|NCT00543439|835746|P3|NOT COMPLETED|Period 2||2
345619|NCT00543439|835747|P2|NOT COMPLETED|Period 2||1
345620|NCT00543439|835748|P1|NOT COMPLETED|Period 2||1
345621|NCT00543439|835746|P3|COMPLETED|Period 2||23
345622|NCT00543439|835747|P2|COMPLETED|Period 2||25
345623|NCT00543439|835748|P1|COMPLETED|Period 2||8
345624|NCT00543439|835746|P3|STARTED|Period 2||25
345625|NCT00543439|835747|P2|STARTED|Period 2||26
345626|NCT00543439|835748|P1|STARTED|Period 2||9
345627|NCT00543439|835746|P3|NOT COMPLETED|Period 1||2
345628|NCT00543439|835747|P2|NOT COMPLETED|Period 1||3
345629|NCT00543439|835748|P1|NOT COMPLETED|Period 1||1
345630|NCT00543439|835746|P3|COMPLETED|Period 1||25
345631|NCT00543439|835747|P2|COMPLETED|Period 1||26
345632|NCT00543439|835748|P1|COMPLETED|Period 1||9
345633|NCT00543439|835746|P3|Treated|Period 1||27
345634|NCT00543439|835747|P2|Treated|Period 1||29
345635|NCT00543439|835748|P1|Treated|Period 1||9
345636|NCT00543439|835746|P3|STARTED|Period 1||27
345637|NCT00543439|835747|P2|STARTED|Period 1||29
345638|NCT00543439|835748|P1|STARTED|Period 1||10
345639|NCT00543400|835795|P4|NOT COMPLETED|Overall Study||5
345640|NCT00543400|835796|P3|NOT COMPLETED|Overall Study||4
345641|NCT00543400|835797|P2|NOT COMPLETED|Overall Study||1
345642|NCT00543400|835798|P1|NOT COMPLETED|Overall Study||5
345643|NCT00543400|835795|P4|COMPLETED|Overall Study||151
345644|NCT00543400|835796|P3|COMPLETED|Overall Study||148
345645|NCT00543400|835797|P2|COMPLETED|Overall Study||43
345646|NCT00543400|835798|P1|COMPLETED|Overall Study||146
345647|NCT00543400|835795|P4|STARTED|Overall Study||156
345648|NCT00543400|835796|P3|STARTED|Overall Study||152
345649|NCT00543400|835797|P2|STARTED|Overall Study||44
345650|NCT00543400|835798|P1|STARTED|Overall Study||151
345651|NCT00543387|835817|P11|NOT COMPLETED|Crossover Participants||3
345652|NCT00543387|835818|P10|NOT COMPLETED|Crossover Participants||1
345653|NCT00543387|835819|P9|NOT COMPLETED|Crossover Participants||0
345654|NCT00543387|835820|P8|NOT COMPLETED|Crossover Participants||0
345655|NCT00543387|835821|P7|NOT COMPLETED|Crossover Participants||0
345656|NCT00543387|835822|P6|NOT COMPLETED|Crossover Participants||0
345657|NCT00543387|835823|P5|NOT COMPLETED|Crossover Participants||0
345658|NCT00543387|835824|P4|NOT COMPLETED|Crossover Participants||0
345659|NCT00543387|835825|P3|NOT COMPLETED|Crossover Participants||0
345660|NCT00543387|835826|P2|NOT COMPLETED|Crossover Participants||0
345661|NCT00543387|835827|P1|NOT COMPLETED|Crossover Participants||0
345662|NCT00543387|835817|P11|COMPLETED|Crossover Participants||0
345663|NCT00543387|835818|P10|COMPLETED|Crossover Participants||0
345664|NCT00543387|835819|P9|COMPLETED|Crossover Participants||0
345665|NCT00543387|835820|P8|COMPLETED|Crossover Participants||0
345666|NCT00543387|835821|P7|COMPLETED|Crossover Participants||0
345667|NCT00543387|835822|P6|COMPLETED|Crossover Participants||0
345668|NCT00543387|835823|P5|COMPLETED|Crossover Participants||0
345669|NCT00543387|835824|P4|COMPLETED|Crossover Participants||0
345670|NCT00543387|835825|P3|COMPLETED|Crossover Participants||0
345671|NCT00543387|835826|P2|COMPLETED|Crossover Participants||0
345672|NCT00543387|835827|P1|COMPLETED|Crossover Participants||0
345673|NCT00543387|835817|P11|STARTED|Crossover Participants|3 participants originally treated with 1500 (2) and 1800 mg (1) MK-5108 in Panel 1 Period 1|3
345674|NCT00543387|835818|P10|STARTED|Crossover Participants|Participant originally treated in MK-5108 400 mg BID (Panel 1) in Period 1|1
345675|NCT00543387|835819|P9|STARTED|Crossover Participants||0
345676|NCT00543387|835820|P8|STARTED|Crossover Participants||0
345677|NCT00543387|835821|P7|STARTED|Crossover Participants||0
345678|NCT00543387|835822|P6|STARTED|Crossover Participants||0
345679|NCT00543387|835823|P5|STARTED|Crossover Participants||0
345680|NCT00543387|835824|P4|STARTED|Crossover Participants||0
345681|NCT00543387|835825|P3|STARTED|Crossover Participants||0
345682|NCT00543387|835826|P2|STARTED|Crossover Participants||0
345683|NCT00543387|835827|P1|STARTED|Crossover Participants||0
345684|NCT00543387|835817|P11|NOT COMPLETED|Panel 1 + Panel 2||0
345685|NCT00543387|835818|P10|NOT COMPLETED|Panel 1 + Panel 2||0
345686|NCT00543387|835819|P9|NOT COMPLETED|Panel 1 + Panel 2||5
345687|NCT00543387|835820|P8|NOT COMPLETED|Panel 1 + Panel 2||6
345688|NCT00543387|835821|P7|NOT COMPLETED|Panel 1 + Panel 2||6
345689|NCT00543387|835822|P6|NOT COMPLETED|Panel 1 + Panel 2||3
345690|NCT00543387|835823|P5|NOT COMPLETED|Panel 1 + Panel 2||3
345691|NCT00543387|835824|P4|NOT COMPLETED|Panel 1 + Panel 2||3
345692|NCT00543387|835825|P3|NOT COMPLETED|Panel 1 + Panel 2||3
345693|NCT00543387|835826|P2|NOT COMPLETED|Panel 1 + Panel 2||3
345694|NCT00543387|835827|P1|NOT COMPLETED|Panel 1 + Panel 2||3
345695|NCT00543387|835817|P11|COMPLETED|Panel 1 + Panel 2||0
345696|NCT00543387|835818|P10|COMPLETED|Panel 1 + Panel 2||0
345697|NCT00543387|835819|P9|COMPLETED|Panel 1 + Panel 2||0
345698|NCT00543387|835820|P8|COMPLETED|Panel 1 + Panel 2||0
345699|NCT00543387|835821|P7|COMPLETED|Panel 1 + Panel 2||0
345700|NCT00543387|835822|P6|COMPLETED|Panel 1 + Panel 2||0
345701|NCT00543387|835823|P5|COMPLETED|Panel 1 + Panel 2||0
345702|NCT00543387|835824|P4|COMPLETED|Panel 1 + Panel 2||0
345703|NCT00543387|835825|P3|COMPLETED|Panel 1 + Panel 2||0
345704|NCT00543387|835826|P2|COMPLETED|Panel 1 + Panel 2||0
345705|NCT00543387|835827|P1|COMPLETED|Panel 1 + Panel 2||0
345706|NCT00543387|835817|P11|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
345707|NCT00543387|835818|P10|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
345708|NCT00543387|835819|P9|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
345709|NCT00543387|835820|P8|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
345710|NCT00543387|835821|P7|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
345711|NCT00543387|835822|P6|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1
345712|NCT00543387|835823|P5|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||2
345713|NCT00543387|835824|P4|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
345714|NCT00543387|835825|P3|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
345715|NCT00543387|835826|P2|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1
345716|NCT00543387|835827|P1|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
345717|NCT00543387|835817|P11|STARTED|Panel 1 + Panel 2||0
345718|NCT00543387|835818|P10|STARTED|Panel 1 + Panel 2||0
345719|NCT00543387|835819|P9|STARTED|Panel 1 + Panel 2||5
345720|NCT00543387|835820|P8|STARTED|Panel 1 + Panel 2||6
345721|NCT00543387|835821|P7|STARTED|Panel 1 + Panel 2||6
345722|NCT00543387|835822|P6|STARTED|Panel 1 + Panel 2||3
345723|NCT00543387|835823|P5|STARTED|Panel 1 + Panel 2||3
345724|NCT00543387|835824|P4|STARTED|Panel 1 + Panel 2||3
345725|NCT00543387|835825|P3|STARTED|Panel 1 + Panel 2||3
345726|NCT00543387|835826|P2|STARTED|Panel 1 + Panel 2||3
345727|NCT00543387|835827|P1|STARTED|Panel 1 + Panel 2||3
345728|NCT00543309|835865|P3|NOT COMPLETED|Overall Study||0
345729|NCT00543309|835866|P2|NOT COMPLETED|Overall Study||1
345730|NCT00543309|835867|P1|NOT COMPLETED|Overall Study||0
345731|NCT00543309|835865|P3|COMPLETED|Overall Study||35
345732|NCT00543309|835866|P2|COMPLETED|Overall Study||35
345733|NCT00543309|835867|P1|COMPLETED|Overall Study||35
345734|NCT00543309|835865|P3|STARTED|Overall Study||35
345735|NCT00543309|835866|P2|STARTED|Overall Study||36
345736|NCT00543309|835867|P1|STARTED|Overall Study||35
345737|NCT00543296|835917|P1|NOT COMPLETED|Overall Study||7
345738|NCT00543296|835917|P1|COMPLETED|Overall Study||14
345739|NCT00543296|835917|P1|STARTED|Overall Study||21
345740|NCT00543140|835924|P1|NOT COMPLETED|Overall Study||72
345741|NCT00543140|835924|P1|COMPLETED|Overall Study||231
345742|NCT00543140|835924|P1|STARTED|Overall Study||303
345743|NCT00543127|835934|P2|NOT COMPLETED|Overall Study||87
345744|NCT00543127|835935|P1|NOT COMPLETED|Overall Study||130
345745|NCT00543127|835934|P2|COMPLETED|Overall Study||350
345746|NCT00543127|835935|P1|COMPLETED|Overall Study||303
345747|NCT00543127|835934|P2|STARTED|Overall Study||437
345748|NCT00543127|835935|P1|STARTED|Overall Study||433
345749|NCT00543101|835949|P2|NOT COMPLETED|Overall Study||0
345750|NCT00543101|835950|P1|NOT COMPLETED|Overall Study||0
345751|NCT00543101|835949|P2|COMPLETED|Overall Study||12
345752|NCT00543101|835950|P1|COMPLETED|Overall Study||12
345753|NCT00543101|835949|P2|STARTED|Overall Study||12
345754|NCT00543101|835950|P1|STARTED|Overall Study||12
345755|NCT00543062|835962|P4|NOT COMPLETED|Overall Study||1
345756|NCT00543062|835963|P3|NOT COMPLETED|Overall Study||3
345757|NCT00543062|835964|P2|NOT COMPLETED|Overall Study||1
345758|NCT00543062|835965|P1|NOT COMPLETED|Overall Study||2
345759|NCT00543062|835962|P4|COMPLETED|Overall Study||11
345760|NCT00543062|835963|P3|COMPLETED|Overall Study||9
345761|NCT00543062|835964|P2|COMPLETED|Overall Study||11
345762|NCT00543062|835965|P1|COMPLETED|Overall Study||10
345763|NCT00543062|835962|P4|STARTED|Overall Study||12
345764|NCT00543062|835963|P3|STARTED|Overall Study||12
345765|NCT00543062|835964|P2|STARTED|Overall Study||12
345766|NCT00543062|835965|P1|STARTED|Overall Study||12
345767|NCT00542997|835987|P1|NOT COMPLETED|Efficacy Period||3
345768|NCT00542997|835987|P1|COMPLETED|Efficacy Period||43
345769|NCT00542997|835987|P1|STARTED|Efficacy Period||46
345770|NCT00542997|835987|P1|NOT COMPLETED|Wash in / Wash Out Period||5
345771|NCT00542997|835987|P1|COMPLETED|Wash in / Wash Out Period||46
345772|NCT00542997|835987|P1|STARTED|Wash in / Wash Out Period||51
345773|NCT00542971|836002|P1|NOT COMPLETED|Overall Study||0
345774|NCT00542971|836002|P1|COMPLETED|Overall Study||75
345775|NCT00542971|836002|P1|STARTED|Overall Study||75
345776|NCT00542880|836009|P2|NOT COMPLETED|Period 3||2
345777|NCT00542880|836010|P1|NOT COMPLETED|Period 3||0
345778|NCT00542880|836009|P2|COMPLETED|Period 3||201
345779|NCT00542880|836010|P1|COMPLETED|Period 3||204
345780|NCT00542880|836009|P2|STARTED|Period 3||203
345781|NCT00542880|836010|P1|STARTED|Period 3||204
345782|NCT00542880|836009|P2|NOT COMPLETED|Period 2||10
345783|NCT00542880|836010|P1|NOT COMPLETED|Period 2||7
345784|NCT00542880|836009|P2|COMPLETED|Period 2||203
345785|NCT00542880|836010|P1|COMPLETED|Period 2||204
345786|NCT00542880|836009|P2|STARTED|Period 2||213
345787|NCT00542880|836010|P1|STARTED|Period 2||211
345788|NCT00542880|836009|P2|NOT COMPLETED|Period 1||12
345789|NCT00542880|836010|P1|NOT COMPLETED|Period 1||6
345790|NCT00542880|836009|P2|COMPLETED|Period 1||213
345791|NCT00542880|836010|P1|COMPLETED|Period 1||211
345792|NCT00542880|836009|P2|STARTED|Period 1||225
345793|NCT00542880|836010|P1|STARTED|Period 1|This was a cross-over study|217
345794|NCT00542828|836046|P1|NOT COMPLETED|Overall Study||13
345795|NCT00542828|836046|P1|COMPLETED|Overall Study|Number of participants who completed the 12-month study period.|3
345796|NCT00542828|836046|P1|STARTED|Overall Study|Number of participants enrolled in the study; of the 16 enrolled, 14 received study treatment.|16
345797|NCT00542815|836064|P3|NOT COMPLETED|Overall Study||32
345798|NCT00542815|836065|P2|NOT COMPLETED|Overall Study||32
345799|NCT00542815|836066|P1|NOT COMPLETED|Overall Study||106
345800|NCT00542815|836064|P3|COMPLETED|Overall Study||92
345801|NCT00542815|836065|P2|COMPLETED|Overall Study||44
345802|NCT00542815|836066|P1|COMPLETED|Overall Study||326
345803|NCT00542815|836064|P3|STARTED|Overall Study||124
345804|NCT00542815|836065|P2|STARTED|Overall Study||76
345805|NCT00542815|836066|P1|STARTED|Overall Study||432
345806|NCT00542789|836079|P2|NOT COMPLETED|Overall Study||78
345807|NCT00542789|836080|P1|NOT COMPLETED|Overall Study||41
345808|NCT00542789|836079|P2|COMPLETED|Overall Study||90
345809|NCT00542789|836080|P1|COMPLETED|Overall Study||134
345810|NCT00542789|836079|P2|STARTED|Overall Study|Randomised|168
345811|NCT00542789|836080|P1|STARTED|Overall Study|Randomised|175
345812|NCT00542750|836090|P1|NOT COMPLETED|Overall Study||0
345813|NCT00542750|836090|P1|COMPLETED|Overall Study||24
345814|NCT00542750|836090|P1|STARTED|Overall Study||24
345815|NCT00542620|836096|P2|NOT COMPLETED|Overall Study||0
345816|NCT00542620|836097|P1|NOT COMPLETED|Overall Study||0
345817|NCT00542620|836096|P2|COMPLETED|Overall Study||12
345818|NCT00542620|836097|P1|COMPLETED|Overall Study||13
345819|NCT00542620|836096|P2|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|13
345820|NCT00542620|836097|P1|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|12
345821|NCT00542620|836096|P2|STARTED|Overall Study||12
345822|NCT00542620|836097|P1|STARTED|Overall Study||13
345823|NCT00542542|836163|P2|NOT COMPLETED|Overall Study||0
345824|NCT00542542|836164|P1|NOT COMPLETED|Overall Study||0
345825|NCT00542542|836163|P2|COMPLETED|Overall Study||44
345826|NCT00542542|836164|P1|COMPLETED|Overall Study||44
345827|NCT00542542|836163|P2|STARTED|Overall Study||44
345828|NCT00542542|836164|P1|STARTED|Overall Study||44
345829|NCT00542490|836170|P1|NOT COMPLETED|Overall Study||2
345830|NCT00542490|836170|P1|COMPLETED|Overall Study||21
345831|NCT00542490|836170|P1|STARTED|Overall Study||23
345832|NCT00542425|836180|P5|NOT COMPLETED|Extended 24 Weeks of Treatment||1
345833|NCT00542425|836181|P4|NOT COMPLETED|Extended 24 Weeks of Treatment||1
345834|NCT00542425|836182|P3|NOT COMPLETED|Extended 24 Weeks of Treatment||2
345835|NCT00542425|836183|P2|NOT COMPLETED|Extended 24 Weeks of Treatment||2
345836|NCT00542425|836184|P1|NOT COMPLETED|Extended 24 Weeks of Treatment||1
345837|NCT00542425|836180|P5|COMPLETED|Extended 24 Weeks of Treatment||13
345838|NCT00542425|836181|P4|COMPLETED|Extended 24 Weeks of Treatment||6
345839|NCT00542425|836182|P3|COMPLETED|Extended 24 Weeks of Treatment||8
345840|NCT00542425|836183|P2|COMPLETED|Extended 24 Weeks of Treatment||11
345841|NCT00542425|836184|P1|COMPLETED|Extended 24 Weeks of Treatment||10
345842|NCT00542425|836180|P5|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|14
345843|NCT00542425|836181|P4|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|7
345844|NCT00542425|836182|P3|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|10
345845|NCT00542425|836183|P2|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|13
345846|NCT00542425|836184|P1|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|11
345847|NCT00542425|836180|P5|NOT COMPLETED|Initial 24 Weeks||6
345848|NCT00542425|836181|P4|NOT COMPLETED|Initial 24 Weeks||11
345849|NCT00542425|836182|P3|NOT COMPLETED|Initial 24 Weeks||7
345850|NCT00542425|836183|P2|NOT COMPLETED|Initial 24 Weeks||10
345851|NCT00542425|836184|P1|NOT COMPLETED|Initial 24 Weeks||4
345852|NCT00542425|836180|P5|COMPLETED|Initial 24 Weeks||39
345853|NCT00542425|836181|P4|COMPLETED|Initial 24 Weeks||34
345854|NCT00542425|836182|P3|COMPLETED|Initial 24 Weeks||36
345855|NCT00542425|836183|P2|COMPLETED|Initial 24 Weeks||33
345856|NCT00542425|836184|P1|COMPLETED|Initial 24 Weeks||42
345857|NCT00542425|836180|P5|STARTED|Initial 24 Weeks||45
345858|NCT00542425|836181|P4|STARTED|Initial 24 Weeks||45
345859|NCT00542425|836182|P3|STARTED|Initial 24 Weeks||43
345860|NCT00542425|836183|P2|STARTED|Initial 24 Weeks||43
345861|NCT00542425|836184|P1|STARTED|Initial 24 Weeks||46
345862|NCT00542386|836222|P6|NOT COMPLETED|Overall Study||50
345863|NCT00542386|836223|P5|NOT COMPLETED|Overall Study||40
345864|NCT00542386|836224|P4|NOT COMPLETED|Overall Study||38
345865|NCT00542386|836225|P3|NOT COMPLETED|Overall Study||33
345866|NCT00542386|836226|P2|NOT COMPLETED|Overall Study||28
345867|NCT00542386|836227|P1|NOT COMPLETED|Overall Study||43
345868|NCT00542386|836222|P6|COMPLETED|Overall Study||82
345869|NCT00542386|836223|P5|COMPLETED|Overall Study||62
345870|NCT00542386|836224|P4|COMPLETED|Overall Study||65
345871|NCT00542386|836225|P3|COMPLETED|Overall Study||66
345872|NCT00542386|836226|P2|COMPLETED|Overall Study||74
345873|NCT00542386|836227|P1|COMPLETED|Overall Study||61
345874|NCT00542386|836222|P6|STARTED|Overall Study||132
345875|NCT00542386|836223|P5|STARTED|Overall Study||102
345876|NCT00542386|836224|P4|STARTED|Overall Study||103
345877|NCT00542386|836225|P3|STARTED|Overall Study||99
345878|NCT00542386|836226|P2|STARTED|Overall Study||102
345879|NCT00542386|836227|P1|STARTED|Overall Study||104
345880|NCT00542321|836249|P2|NOT COMPLETED|Overall Study||1
345881|NCT00542321|836250|P1|NOT COMPLETED|Overall Study||0
345882|NCT00542321|836249|P2|COMPLETED|Overall Study||7
345883|NCT00542321|836250|P1|COMPLETED|Overall Study||8
345884|NCT00542321|836249|P2|STARTED|Overall Study||8
345885|NCT00542321|836250|P1|STARTED|Overall Study||8
345886|NCT00542308|836264|P1|NOT COMPLETED|Overall Study||0
345887|NCT00542308|836264|P1|COMPLETED|Overall Study||90
345888|NCT00542308|836264|P1|STARTED|Overall Study||90
345889|NCT00542269|836272|P3|NOT COMPLETED|Overall Study||6
345890|NCT00542269|836273|P2|NOT COMPLETED|Overall Study||6
345891|NCT00542269|836274|P1|NOT COMPLETED|Overall Study||13
345892|NCT00542269|836272|P3|COMPLETED|Overall Study||51
345893|NCT00542269|836273|P2|COMPLETED|Overall Study||54
345894|NCT00542269|836274|P1|COMPLETED|Overall Study||48
345895|NCT00542269|836272|P3|STARTED|Overall Study||57
345896|NCT00542269|836273|P2|STARTED|Overall Study||60
345897|NCT00542269|836274|P1|STARTED|Overall Study||61
345898|NCT00542191|836303|P1|NOT COMPLETED|Overall Study||3
345899|NCT00542191|836303|P1|COMPLETED|Overall Study||18
345900|NCT00542191|836303|P1|STARTED|Overall Study||21
345901|NCT00542178|836313|P8|NOT COMPLETED|Overall Study||85
345902|NCT00542178|836314|P7|NOT COMPLETED|Overall Study||87
345903|NCT00542178|836315|P6|NOT COMPLETED|Overall Study||89
345904|NCT00542178|836316|P5|NOT COMPLETED|Overall Study||64
345905|NCT00542178|836317|P4|NOT COMPLETED|Overall Study||62
345906|NCT00542178|836318|P3|NOT COMPLETED|Overall Study||74
345907|NCT00542178|836319|P2|NOT COMPLETED|Overall Study||80
345908|NCT00542178|836320|P1|NOT COMPLETED|Overall Study||75
345909|NCT00542178|836313|P8|COMPLETED|Overall Study||381
345910|NCT00542178|836314|P7|COMPLETED|Overall Study||406
345911|NCT00542178|836315|P6|COMPLETED|Overall Study||406
345912|NCT00542178|836316|P5|COMPLETED|Overall Study||400
345913|NCT00542178|836317|P4|COMPLETED|Overall Study||308
345914|NCT00542178|836318|P3|COMPLETED|Overall Study||308
345915|NCT00542178|836319|P2|COMPLETED|Overall Study||332
345916|NCT00542178|836320|P1|COMPLETED|Overall Study||315
345917|NCT00542178|836313|P8|STARTED|Overall Study||466
345918|NCT00542178|836314|P7|STARTED|Overall Study||493
345919|NCT00542178|836315|P6|STARTED|Overall Study||495
345920|NCT00542178|836316|P5|STARTED|Overall Study||464
345921|NCT00542178|836317|P4|STARTED|Overall Study||370
345922|NCT00542178|836318|P3|STARTED|Overall Study||382
345923|NCT00542178|836319|P2|STARTED|Overall Study||412
345924|NCT00542178|836320|P1|STARTED|Overall Study||390
345925|NCT00541970|836356|P4|NOT COMPLETED|Month 60||72
345926|NCT00541970|836357|P3|NOT COMPLETED|Month 60||82
345927|NCT00541970|836358|P2|NOT COMPLETED|Month 60||77
345928|NCT00541970|836359|P1|NOT COMPLETED|Month 60||78
345929|NCT00541970|836356|P4|COMPLETED|Month 60||167
345930|NCT00541970|836357|P3|COMPLETED|Month 60||158
345931|NCT00541970|836358|P2|COMPLETED|Month 60||164
345932|NCT00541970|836359|P1|COMPLETED|Month 60||162
345933|NCT00541970|836356|P4|STARTED|Month 60||239
345934|NCT00541970|836357|P3|STARTED|Month 60||240
345935|NCT00541970|836358|P2|STARTED|Month 60||241
345936|NCT00541970|836359|P1|STARTED|Month 60||240
345937|NCT00541970|836356|P4|NOT COMPLETED|Month 48||75
345938|NCT00541970|836357|P3|NOT COMPLETED|Month 48||73
345939|NCT00541970|836358|P2|NOT COMPLETED|Month 48||73
345940|NCT00541970|836359|P1|NOT COMPLETED|Month 48||71
345941|NCT00541970|836356|P4|COMPLETED|Month 48||164
345942|NCT00541970|836357|P3|COMPLETED|Month 48||167
345943|NCT00541970|836358|P2|COMPLETED|Month 48||168
345944|NCT00541970|836359|P1|COMPLETED|Month 48||169
345945|NCT00541970|836356|P4|STARTED|Month 48||239
345946|NCT00541970|836357|P3|STARTED|Month 48||240
345947|NCT00541970|836358|P2|STARTED|Month 48||241
345948|NCT00541970|836359|P1|STARTED|Month 48||240
345949|NCT00541970|836356|P4|NOT COMPLETED|Month 36||60
345950|NCT00541970|836357|P3|NOT COMPLETED|Month 36||66
345951|NCT00541970|836358|P2|NOT COMPLETED|Month 36||66
345952|NCT00541970|836359|P1|NOT COMPLETED|Month 36||61
345953|NCT00541970|836356|P4|COMPLETED|Month 36||179
345954|NCT00541970|836357|P3|COMPLETED|Month 36||174
345955|NCT00541970|836358|P2|COMPLETED|Month 36||175
345956|NCT00541970|836359|P1|COMPLETED|Month 36||179
345957|NCT00541970|836356|P4|STARTED|Month 36||239
345958|NCT00541970|836357|P3|STARTED|Month 36||240
345959|NCT00541970|836358|P2|STARTED|Month 36||241
345960|NCT00541970|836359|P1|STARTED|Month 36||240
345961|NCT00541970|836356|P4|NOT COMPLETED|Month 24||22
345962|NCT00541970|836357|P3|NOT COMPLETED|Month 24||32
345963|NCT00541970|836358|P2|NOT COMPLETED|Month 24||32
345964|NCT00541970|836359|P1|NOT COMPLETED|Month 24||29
345965|NCT00541970|836356|P4|COMPLETED|Month 24||217
345966|NCT00541970|836357|P3|COMPLETED|Month 24||208
345967|NCT00541970|836358|P2|COMPLETED|Month 24||209
345968|NCT00541970|836359|P1|COMPLETED|Month 24||211
345969|NCT00541970|836356|P4|STARTED|Month 24||239
345970|NCT00541970|836357|P3|STARTED|Month 24||240
345971|NCT00541970|836358|P2|STARTED|Month 24||241
345972|NCT00541970|836359|P1|STARTED|Month 24||240
345973|NCT00541970|836356|P4|NOT COMPLETED|Month 18||17
345974|NCT00541970|836357|P3|NOT COMPLETED|Month 18||25
345975|NCT00541970|836358|P2|NOT COMPLETED|Month 18||24
345976|NCT00541970|836359|P1|NOT COMPLETED|Month 18||14
345977|NCT00541970|836356|P4|COMPLETED|Month 18||222
345978|NCT00541970|836357|P3|COMPLETED|Month 18||215
345979|NCT00541970|836358|P2|COMPLETED|Month 18||217
345980|NCT00541970|836359|P1|COMPLETED|Month 18||226
345981|NCT00541970|836356|P4|STARTED|Month 18||239
345982|NCT00541970|836357|P3|STARTED|Month 18||240
345983|NCT00541970|836358|P2|STARTED|Month 18||241
345984|NCT00541970|836359|P1|STARTED|Month 18||240
345985|NCT00541970|836356|P4|NOT COMPLETED|Month 12||16
345986|NCT00541970|836357|P3|NOT COMPLETED|Month 12||21
345987|NCT00541970|836358|P2|NOT COMPLETED|Month 12||22
345988|NCT00541970|836359|P1|NOT COMPLETED|Month 12||12
345989|NCT00541970|836356|P4|COMPLETED|Month 12||223
345990|NCT00541970|836357|P3|COMPLETED|Month 12||219
345991|NCT00541970|836358|P2|COMPLETED|Month 12||219
345992|NCT00541970|836359|P1|COMPLETED|Month 12||228
345993|NCT00541970|836356|P4|STARTED|Month 12||239
345994|NCT00541970|836357|P3|STARTED|Month 12||240
345995|NCT00541970|836358|P2|STARTED|Month 12||241
345996|NCT00541970|836359|P1|STARTED|Month 12||240
345997|NCT00541970|836356|P4|NOT COMPLETED|Month 7||5
345998|NCT00541970|836357|P3|NOT COMPLETED|Month 7||11
345999|NCT00541970|836358|P2|NOT COMPLETED|Month 7||13
346000|NCT00541970|836359|P1|NOT COMPLETED|Month 7||9
346001|NCT00541970|836356|P4|COMPLETED|Month 7||234
346002|NCT00541970|836357|P3|COMPLETED|Month 7||229
346003|NCT00541970|836358|P2|COMPLETED|Month 7||228
346004|NCT00541970|836359|P1|COMPLETED|Month 7||231
346005|NCT00541970|836356|P4|STARTED|Month 7||239
346006|NCT00541970|836357|P3|STARTED|Month 7||240
346007|NCT00541970|836358|P2|STARTED|Month 7||241
346008|NCT00541970|836359|P1|STARTED|Month 7||240
346009|NCT00541931|836510|P2|NOT COMPLETED|Overall Study||4
346010|NCT00541931|836511|P1|NOT COMPLETED|Overall Study||5
346011|NCT00541931|836510|P2|COMPLETED|Overall Study||11
346012|NCT00541931|836511|P1|COMPLETED|Overall Study||17
346013|NCT00541931|836510|P2|STARTED|Overall Study||15
346014|NCT00541931|836511|P1|STARTED|Overall Study||22
346015|NCT00541866|836524|P5|NOT COMPLETED|Overall Study||15
346016|NCT00541866|836525|P4|NOT COMPLETED|Overall Study||16
346017|NCT00541866|836526|P3|NOT COMPLETED|Overall Study||15
346018|NCT00541866|836527|P2|NOT COMPLETED|Overall Study||18
346019|NCT00541866|836528|P1|NOT COMPLETED|Overall Study||34
346020|NCT00541866|836524|P5|COMPLETED|Overall Study||3
346021|NCT00541866|836525|P4|COMPLETED|Overall Study||0
346022|NCT00541866|836526|P3|COMPLETED|Overall Study||2
346023|NCT00541866|836527|P2|COMPLETED|Overall Study||0
346024|NCT00541866|836528|P1|COMPLETED|Overall Study||7
346025|NCT00541866|836524|P5|STARTED|Overall Study||18
346026|NCT00541866|836525|P4|STARTED|Overall Study||16
346027|NCT00541866|836526|P3|STARTED|Overall Study||17
346028|NCT00541866|836527|P2|STARTED|Overall Study||18
346029|NCT00541866|836528|P1|STARTED|Overall Study|41 started, but only 39 treated|41
346030|NCT00541775|836569|P3|NOT COMPLETED|Overall Study||8
346031|NCT00541775|836570|P2|NOT COMPLETED|Overall Study||2
346032|NCT00541775|836571|P1|NOT COMPLETED|Overall Study||9
346033|NCT00541775|836569|P3|COMPLETED|Overall Study||84
346034|NCT00541775|836570|P2|COMPLETED|Overall Study||85
346035|NCT00541775|836571|P1|COMPLETED|Overall Study||85
346036|NCT00541775|836569|P3|STARTED|Overall Study||92
346037|NCT00541775|836570|P2|STARTED|Overall Study||87
346038|NCT00541775|836571|P1|STARTED|Overall Study||94
346039|NCT00541671|836587|P2|NOT COMPLETED|Overall Study||0
346040|NCT00541671|836588|P1|NOT COMPLETED|Overall Study||0
346041|NCT00541671|836587|P2|COMPLETED|Overall Study||12
346042|NCT00541671|836588|P1|COMPLETED|Overall Study||13
346043|NCT00541671|836587|P2|STARTED|Overall Study||12
346044|NCT00541671|836588|P1|STARTED|Overall Study||13
346045|NCT00541658|836597|P3|NOT COMPLETED|Overall Study||68
346046|NCT00541658|836598|P2|NOT COMPLETED|Overall Study||73
346047|NCT00541658|836599|P1|NOT COMPLETED|Overall Study||60
346048|NCT00541658|836597|P3|COMPLETED|Overall Study||240
346049|NCT00541658|836598|P2|COMPLETED|Overall Study||234
346050|NCT00541658|836599|P1|COMPLETED|Overall Study||248
346051|NCT00541658|836597|P3|ITT Population|Overall Study||308
346052|NCT00541658|836598|P2|ITT Population|Overall Study||307
346053|NCT00541658|836599|P1|ITT Population|Overall Study||307
346054|NCT00541658|836597|P3|STARTED|Overall Study||308
346055|NCT00541658|836598|P2|STARTED|Overall Study||307
346056|NCT00541658|836599|P1|STARTED|Overall Study||308
346057|NCT00541593|836756|P1|NOT COMPLETED|Overall Study||0
346058|NCT00541593|836756|P1|COMPLETED|Overall Study||5
346059|NCT00541593|836756|P1|STARTED|Overall Study||5
346060|NCT00541450|836762|P2|NOT COMPLETED|Phase B||31
346061|NCT00541450|836763|P1|NOT COMPLETED|Phase B||37
346062|NCT00541450|836762|P2|COMPLETED|Phase B||200
346063|NCT00541450|836763|P1|COMPLETED|Phase B||187
346064|NCT00541450|836762|P2|STARTED|Phase B||231
346065|NCT00541450|836763|P1|STARTED|Phase B||224
346066|NCT00541450|836762|P2|NOT COMPLETED|Phase A||17
346067|NCT00541450|836763|P1|NOT COMPLETED|Phase A||20
346068|NCT00541450|836762|P2|COMPLETED|Phase A||231
346069|NCT00541450|836763|P1|COMPLETED|Phase A||224
346070|NCT00541450|836762|P2|STARTED|Phase A||248
346071|NCT00541450|836763|P1|STARTED|Phase A||244
346072|NCT00541346|836781|P1|NOT COMPLETED|Follow-up||1
346073|NCT00541346|836781|P1|COMPLETED|Follow-up||15
346074|NCT00541346|836781|P1|STARTED|Follow-up||16
346075|NCT00541346|836781|P1|NOT COMPLETED|Baseline||0
346076|NCT00541346|836781|P1|COMPLETED|Baseline||16
346077|NCT00541346|836781|P1|STARTED|Baseline||16
346078|NCT00541307|836795|P1|NOT COMPLETED|Overall Study||24
346079|NCT00541307|836795|P1|COMPLETED|Overall Study||95
346080|NCT00541307|836795|P1|STARTED|Overall Study||119
346081|NCT00541242|836805|P2|NOT COMPLETED|Treatment Period 2||7
346082|NCT00541242|836806|P1|NOT COMPLETED|Treatment Period 2||9
346083|NCT00541242|836805|P2|COMPLETED|Treatment Period 2||266
346084|NCT00541242|836806|P1|COMPLETED|Treatment Period 2||261
346085|NCT00541242|836805|P2|STARTED|Treatment Period 2||273
346086|NCT00541242|836806|P1|STARTED|Treatment Period 2||270
346087|NCT00541242|836805|P2|NOT COMPLETED|Treatment Period 1||0
346088|NCT00541242|836806|P1|NOT COMPLETED|Treatment Period 1||0
346089|NCT00541242|836805|P2|COMPLETED|Treatment Period 1|43 of the 586 patients did not enter Treatment Period 2 (Randomized at Week 6)|586
346090|NCT00541242|836806|P1|COMPLETED|Treatment Period 1||0
346091|NCT00541242|836805|P2|STARTED|Treatment Period 1|586 patients were enrolled and received open-label latanoprost for 6 weeks|586
346092|NCT00541242|836806|P1|STARTED|Treatment Period 1||0
346093|NCT00541229|836820|P6|NOT COMPLETED|Treatment Period III (Week 11)||1
346094|NCT00541229|836821|P5|NOT COMPLETED|Treatment Period III (Week 11)||1
346095|NCT00541229|836822|P4|NOT COMPLETED|Treatment Period III (Week 11)||0
346096|NCT00541229|836823|P3|NOT COMPLETED|Treatment Period III (Week 11)||1
346097|NCT00541229|836824|P2|NOT COMPLETED|Treatment Period III (Week 11)||0
346098|NCT00541229|836825|P1|NOT COMPLETED|Treatment Period III (Week 11)||0
346099|NCT00541229|836820|P6|COMPLETED|Treatment Period III (Week 11)||4
346100|NCT00541229|836821|P5|COMPLETED|Treatment Period III (Week 11)||6
346101|NCT00541229|836822|P4|COMPLETED|Treatment Period III (Week 11)||8
346102|NCT00541229|836823|P3|COMPLETED|Treatment Period III (Week 11)||9
346103|NCT00541229|836824|P2|COMPLETED|Treatment Period III (Week 11)||8
346104|NCT00541229|836825|P1|COMPLETED|Treatment Period III (Week 11)||7
346105|NCT00541229|836820|P6|STARTED|Treatment Period III (Week 11)||5
346106|NCT00541229|836821|P5|STARTED|Treatment Period III (Week 11)||7
346107|NCT00541229|836822|P4|STARTED|Treatment Period III (Week 11)||8
346108|NCT00541229|836823|P3|STARTED|Treatment Period III (Week 11)||10
346109|NCT00541229|836824|P2|STARTED|Treatment Period III (Week 11)||8
346110|NCT00541229|836825|P1|STARTED|Treatment Period III (Week 11)||7
346111|NCT00541229|836820|P6|NOT COMPLETED|Washout Period II (Week 7-10)||3
346112|NCT00541229|836821|P5|NOT COMPLETED|Washout Period II (Week 7-10)||4
346113|NCT00541229|836822|P4|NOT COMPLETED|Washout Period II (Week 7-10)||4
346114|NCT00541229|836823|P3|NOT COMPLETED|Washout Period II (Week 7-10)||2
346115|NCT00541229|836824|P2|NOT COMPLETED|Washout Period II (Week 7-10)||4
346116|NCT00541229|836825|P1|NOT COMPLETED|Washout Period II (Week 7-10)||4
346117|NCT00541229|836820|P6|COMPLETED|Washout Period II (Week 7-10)||5
346118|NCT00541229|836821|P5|COMPLETED|Washout Period II (Week 7-10)||7
346119|NCT00541229|836822|P4|COMPLETED|Washout Period II (Week 7-10)||8
346120|NCT00541229|836823|P3|COMPLETED|Washout Period II (Week 7-10)||10
346121|NCT00541229|836824|P2|COMPLETED|Washout Period II (Week 7-10)||8
346122|NCT00541229|836825|P1|COMPLETED|Washout Period II (Week 7-10)||7
346123|NCT00541229|836820|P6|STARTED|Washout Period II (Week 7-10)||8
346124|NCT00541229|836821|P5|STARTED|Washout Period II (Week 7-10)||11
346125|NCT00541229|836822|P4|STARTED|Washout Period II (Week 7-10)||12
346126|NCT00541229|836823|P3|STARTED|Washout Period II (Week 7-10)||12
346127|NCT00541229|836824|P2|STARTED|Washout Period II (Week 7-10)||12
346128|NCT00541229|836825|P1|STARTED|Washout Period II (Week 7-10)||11
346129|NCT00541229|836820|P6|NOT COMPLETED|Treatment Period II (Week 6)||3
346130|NCT00541229|836821|P5|NOT COMPLETED|Treatment Period II (Week 6)||2
346131|NCT00541229|836822|P4|NOT COMPLETED|Treatment Period II (Week 6)||1
346132|NCT00541229|836823|P3|NOT COMPLETED|Treatment Period II (Week 6)||1
346133|NCT00541229|836824|P2|NOT COMPLETED|Treatment Period II (Week 6)||1
346134|NCT00541229|836825|P1|NOT COMPLETED|Treatment Period II (Week 6)||2
346135|NCT00541229|836820|P6|COMPLETED|Treatment Period II (Week 6)||8
346136|NCT00541229|836821|P5|COMPLETED|Treatment Period II (Week 6)||11
346137|NCT00541229|836822|P4|COMPLETED|Treatment Period II (Week 6)||12
346138|NCT00541229|836823|P3|COMPLETED|Treatment Period II (Week 6)||12
346139|NCT00541229|836824|P2|COMPLETED|Treatment Period II (Week 6)||12
346140|NCT00541229|836825|P1|COMPLETED|Treatment Period II (Week 6)||11
346141|NCT00541229|836820|P6|STARTED|Treatment Period II (Week 6)||11
346142|NCT00541229|836821|P5|STARTED|Treatment Period II (Week 6)||13
346143|NCT00541229|836822|P4|STARTED|Treatment Period II (Week 6)||13
346144|NCT00541229|836823|P3|STARTED|Treatment Period II (Week 6)||13
346145|NCT00541229|836824|P2|STARTED|Treatment Period II (Week 6)||13
346146|NCT00541229|836825|P1|STARTED|Treatment Period II (Week 6)||13
346147|NCT00541229|836820|P6|NOT COMPLETED|Washout Period I (Week 2-5)||5
346148|NCT00541229|836821|P5|NOT COMPLETED|Washout Period I (Week 2-5)||1
346149|NCT00541229|836822|P4|NOT COMPLETED|Washout Period I (Week 2-5)||4
346150|NCT00541229|836823|P3|NOT COMPLETED|Washout Period I (Week 2-5)||4
346151|NCT00541229|836824|P2|NOT COMPLETED|Washout Period I (Week 2-5)||2
346152|NCT00541229|836825|P1|NOT COMPLETED|Washout Period I (Week 2-5)||4
346153|NCT00541229|836820|P6|COMPLETED|Washout Period I (Week 2-5)||11
346154|NCT00541229|836821|P5|COMPLETED|Washout Period I (Week 2-5)||13
346155|NCT00541229|836822|P4|COMPLETED|Washout Period I (Week 2-5)||13
346156|NCT00541229|836823|P3|COMPLETED|Washout Period I (Week 2-5)||13
346157|NCT00541229|836824|P2|COMPLETED|Washout Period I (Week 2-5)||13
346158|NCT00541229|836825|P1|COMPLETED|Washout Period I (Week 2-5)||13
346159|NCT00541229|836820|P6|STARTED|Washout Period I (Week 2-5)||16
346160|NCT00541229|836821|P5|STARTED|Washout Period I (Week 2-5)||14
346161|NCT00541229|836822|P4|STARTED|Washout Period I (Week 2-5)||17
346162|NCT00541229|836823|P3|STARTED|Washout Period I (Week 2-5)||17
346163|NCT00541229|836824|P2|STARTED|Washout Period I (Week 2-5)||15
346164|NCT00541229|836825|P1|STARTED|Washout Period I (Week 2-5)||17
346165|NCT00541229|836820|P6|NOT COMPLETED|Treatment Period I (Week 1)||2
346166|NCT00541229|836821|P5|NOT COMPLETED|Treatment Period I (Week 1)||0
346167|NCT00541229|836822|P4|NOT COMPLETED|Treatment Period I (Week 1)||1
346168|NCT00541229|836823|P3|NOT COMPLETED|Treatment Period I (Week 1)||3
346169|NCT00541229|836824|P2|NOT COMPLETED|Treatment Period I (Week 1)||1
346170|NCT00541229|836825|P1|NOT COMPLETED|Treatment Period I (Week 1)||0
346171|NCT00541229|836820|P6|COMPLETED|Treatment Period I (Week 1)||16
346172|NCT00541229|836821|P5|COMPLETED|Treatment Period I (Week 1)||14
346173|NCT00541229|836822|P4|COMPLETED|Treatment Period I (Week 1)||17
346174|NCT00541229|836823|P3|COMPLETED|Treatment Period I (Week 1)||17
346175|NCT00541229|836824|P2|COMPLETED|Treatment Period I (Week 1)||15
346176|NCT00541229|836825|P1|COMPLETED|Treatment Period I (Week 1)||17
346177|NCT00541229|836820|P6|STARTED|Treatment Period I (Week 1)||18
346178|NCT00541229|836821|P5|STARTED|Treatment Period I (Week 1)||14
346179|NCT00541229|836822|P4|STARTED|Treatment Period I (Week 1)||18
346180|NCT00541229|836823|P3|STARTED|Treatment Period I (Week 1)||20
346181|NCT00541229|836824|P2|STARTED|Treatment Period I (Week 1)||16
346182|NCT00541229|836825|P1|STARTED|Treatment Period I (Week 1)||17
346183|NCT00541190|836835|P2|NOT COMPLETED|Overall Study||0
346184|NCT00541190|836836|P1|NOT COMPLETED|Overall Study||0
346185|NCT00541190|836835|P2|COMPLETED|Overall Study||11
346186|NCT00541190|836836|P1|COMPLETED|Overall Study||10
346187|NCT00541190|836835|P2|STARTED|Overall Study||11
346188|NCT00541190|836836|P1|STARTED|Overall Study||10
346189|NCT00541099|836844|P1|NOT COMPLETED|Overall Study||3
346190|NCT00541099|836844|P1|COMPLETED|Overall Study||8
346191|NCT00541099|836844|P1|STARTED|Overall Study||11
346192|NCT00541034|836852|P1|NOT COMPLETED|Overall Study||3
346193|NCT00541034|836852|P1|COMPLETED|Overall Study||46
346194|NCT00541034|836852|P1|STARTED|Overall Study||49
346195|NCT00540982|836856|P1|NOT COMPLETED|Overall Study||0
346196|NCT00540982|836856|P1|COMPLETED|Overall Study||47
346197|NCT00540982|836856|P1|Severe Liver Dysfunction|Overall Study||12
346198|NCT00540982|836856|P1|Moderate Liver Dysfunction|Overall Study||18
346199|NCT00540982|836856|P1|Mild Liver Dysfunction|Overall Study||6
346200|NCT00540982|836856|P1|Normal Liver Function|Overall Study||11
346201|NCT00540982|836856|P1|STARTED|Overall Study||47
346202|NCT00540969|836880|P2|NOT COMPLETED|Overall Study||0
346203|NCT00540969|836881|P1|NOT COMPLETED|Overall Study||0
346204|NCT00540969|836880|P2|COMPLETED|Overall Study||1
346205|NCT00540969|836881|P1|COMPLETED|Overall Study||2
346206|NCT00540969|836880|P2|STARTED|Overall Study||1
346207|NCT00540969|836881|P1|STARTED|Overall Study||2
346208|NCT00540722|836891|P1|NOT COMPLETED|Overall Study||0
346209|NCT00540722|836891|P1|COMPLETED|Overall Study||56
346210|NCT00540722|836891|P1|STARTED|Overall Study||56
346211|NCT00540644|836901|P2|NOT COMPLETED|Overall Study||9
346212|NCT00540644|836902|P1|NOT COMPLETED|Overall Study||9
346213|NCT00540644|836901|P2|COMPLETED|Overall Study||13
346214|NCT00540644|836902|P1|COMPLETED|Overall Study||39
346215|NCT00540644|836901|P2|STARTED|Overall Study||22
346216|NCT00540644|836902|P1|STARTED|Overall Study||48
346217|NCT00540592|836922|P10|NOT COMPLETED|Overall Study||2
346218|NCT00540592|836923|P9|NOT COMPLETED|Overall Study||1
346219|NCT00540592|836924|P8|NOT COMPLETED|Overall Study||1
346220|NCT00540592|836925|P7|NOT COMPLETED|Overall Study||0
346221|NCT00540592|836926|P6|NOT COMPLETED|Overall Study||0
346222|NCT00540592|836927|P5|NOT COMPLETED|Overall Study||1
346223|NCT00540592|836928|P4|NOT COMPLETED|Overall Study||1
346224|NCT00540592|836929|P3|NOT COMPLETED|Overall Study||1
346225|NCT00540592|836930|P2|NOT COMPLETED|Overall Study||1
346226|NCT00540592|836931|P1|NOT COMPLETED|Overall Study||2
346227|NCT00540592|836922|P10|COMPLETED|Overall Study||201
346228|NCT00540592|836923|P9|COMPLETED|Overall Study||199
346229|NCT00540592|836924|P8|COMPLETED|Overall Study||198
346230|NCT00540592|836925|P7|COMPLETED|Overall Study||198
346231|NCT00540592|836926|P6|COMPLETED|Overall Study||198
346232|NCT00540592|836927|P5|COMPLETED|Overall Study||198
346233|NCT00540592|836928|P4|COMPLETED|Overall Study||201
346234|NCT00540592|836929|P3|COMPLETED|Overall Study||201
346235|NCT00540592|836930|P2|COMPLETED|Overall Study||201
346236|NCT00540592|836931|P1|COMPLETED|Overall Study||202
346237|NCT00540592|836922|P10|Completed at Day 180|Overall Study||189
346238|NCT00540592|836923|P9|Completed at Day 180|Overall Study||198
346239|NCT00540592|836924|P8|Completed at Day 180|Overall Study||193
346240|NCT00540592|836925|P7|Completed at Day 180|Overall Study||196
346241|NCT00540592|836926|P6|Completed at Day 180|Overall Study||198
346242|NCT00540592|836927|P5|Completed at Day 180|Overall Study||195
346243|NCT00540592|836928|P4|Completed at Day 180|Overall Study||197
346244|NCT00540592|836929|P3|Completed at Day 180|Overall Study||197
346245|NCT00540592|836930|P2|Completed at Day 180|Overall Study||201
346246|NCT00540592|836931|P1|Completed at Day 180|Overall Study||200
346247|NCT00540592|836922|P10|STARTED|Overall Study||203
346248|NCT00540592|836923|P9|STARTED|Overall Study||200
346249|NCT00540592|836924|P8|STARTED|Overall Study||199
346250|NCT00540592|836925|P7|STARTED|Overall Study||198
346251|NCT00540592|836926|P6|STARTED|Overall Study||198
346252|NCT00540592|836927|P5|STARTED|Overall Study||199
346253|NCT00540592|836928|P4|STARTED|Overall Study||202
346254|NCT00540592|836929|P3|STARTED|Overall Study||202
346255|NCT00540592|836930|P2|STARTED|Overall Study||202
346256|NCT00540592|836931|P1|STARTED|Overall Study||204
346257|NCT00540579|837163|P1|NOT COMPLETED|Overall Study||0
346258|NCT00540579|837163|P1|COMPLETED|Overall Study||23
346259|NCT00540579|837163|P1|STARTED|Overall Study||23
346260|NCT00540514|837170|P2|NOT COMPLETED|Overall Study||266
346261|NCT00540514|837171|P1|NOT COMPLETED|Overall Study||246
346262|NCT00540514|837170|P2|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|265
346263|NCT00540514|837171|P1|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|275
346264|NCT00540514|837170|P2|Biomarker Population|Overall Study||36
346265|NCT00540514|837171|P1|Biomarker Population|Overall Study||35
346266|NCT00540514|837170|P2|Treated|Overall Study||524
346267|NCT00540514|837171|P1|Treated|Overall Study||514
346268|NCT00540514|837170|P2|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|531
346269|NCT00540514|837171|P1|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|521
346270|NCT00540449|837203|P2|NOT COMPLETED|Overall Study||78
346271|NCT00540449|837204|P1|NOT COMPLETED|Overall Study||84
346272|NCT00540449|837203|P2|COMPLETED|Overall Study||266
346273|NCT00540449|837204|P1|COMPLETED|Overall Study||262
346274|NCT00540449|837203|P2|STARTED|Overall Study||344
346275|NCT00540449|837204|P1|STARTED|Overall Study||346
346276|NCT00540436|837226|P1|NOT COMPLETED|Second 12-Week Treatment Period||1
346277|NCT00540436|837226|P1|COMPLETED|Second 12-Week Treatment Period||21
346278|NCT00540436|837226|P1|STARTED|Second 12-Week Treatment Period||22
346279|NCT00540436|837226|P1|NOT COMPLETED|First 12-Week Treatment Period||3
346280|NCT00540436|837226|P1|COMPLETED|First 12-Week Treatment Period||22
346281|NCT00540436|837226|P1|STARTED|First 12-Week Treatment Period||25
346282|NCT00540423|837241|P3|NOT COMPLETED|Open-Label Treatment Period||2
346283|NCT00540423|837242|P2|NOT COMPLETED|Open-Label Treatment Period||0
346284|NCT00540423|837243|P1|NOT COMPLETED|Open-Label Treatment Period||0
346285|NCT00540423|837241|P3|COMPLETED|Open-Label Treatment Period||20
346286|NCT00540423|837242|P2|COMPLETED|Open-Label Treatment Period||0
346287|NCT00540423|837243|P1|COMPLETED|Open-Label Treatment Period||0
346288|NCT00540423|837241|P3|STARTED|Open-Label Treatment Period||22
346289|NCT00540423|837242|P2|STARTED|Open-Label Treatment Period||0
346290|NCT00540423|837243|P1|STARTED|Open-Label Treatment Period||0
346291|NCT00540423|837241|P3|NOT COMPLETED|Double-Blind Treatment Period||0
346292|NCT00540423|837242|P2|NOT COMPLETED|Double-Blind Treatment Period||1
346293|NCT00540423|837243|P1|NOT COMPLETED|Double-Blind Treatment Period||0
346294|NCT00540423|837241|P3|COMPLETED|Double-Blind Treatment Period||0
346295|NCT00540423|837242|P2|COMPLETED|Double-Blind Treatment Period||14
346296|NCT00540423|837243|P1|COMPLETED|Double-Blind Treatment Period||8
346297|NCT00540423|837241|P3|STARTED|Double-Blind Treatment Period||0
346298|NCT00540423|837242|P2|STARTED|Double-Blind Treatment Period||15
346299|NCT00540423|837243|P1|STARTED|Double-Blind Treatment Period||8
346300|NCT00540293|837293|P1|NOT COMPLETED|Overall Study||35
346301|NCT00540293|837293|P1|COMPLETED|Overall Study||390
346302|NCT00540293|837293|P1|STARTED|Overall Study||425
346303|NCT00540228|837341|P5|NOT COMPLETED|Overall Study||0
346304|NCT00540228|837342|P4|NOT COMPLETED|Overall Study||0
346305|NCT00540228|837343|P3|NOT COMPLETED|Overall Study||0
346306|NCT00540228|837344|P2|NOT COMPLETED|Overall Study||1
346307|NCT00540228|837345|P1|NOT COMPLETED|Overall Study||3
346308|NCT00540228|837341|P5|COMPLETED|Overall Study||202
346309|NCT00540228|837342|P4|COMPLETED|Overall Study||202
346310|NCT00540228|837343|P3|COMPLETED|Overall Study||204
346311|NCT00540228|837344|P2|COMPLETED|Overall Study||197
346312|NCT00540228|837345|P1|COMPLETED|Overall Study||197
346313|NCT00540228|837341|P5|STARTED|Overall Study||202
346314|NCT00540228|837342|P4|STARTED|Overall Study||202
346315|NCT00540228|837343|P3|STARTED|Overall Study||204
346316|NCT00540228|837344|P2|STARTED|Overall Study||198
346317|NCT00540228|837345|P1|STARTED|Overall Study||200
346318|NCT00540124|837415|P3|NOT COMPLETED|Overall Study||1
346319|NCT00540124|837416|P2|NOT COMPLETED|Overall Study||3
346320|NCT00540124|837417|P1|NOT COMPLETED|Overall Study||4
346321|NCT00540124|837415|P3|COMPLETED|Overall Study||48
346322|NCT00540124|837416|P2|COMPLETED|Overall Study||48
346323|NCT00540124|837417|P1|COMPLETED|Overall Study||47
346324|NCT00540124|837415|P3|STARTED|Overall Study||49
346325|NCT00540124|837416|P2|STARTED|Overall Study||51
346326|NCT00540124|837417|P1|STARTED|Overall Study||51
346327|NCT00540046|837463|P2|NOT COMPLETED|Overall Study||23
346328|NCT00540046|837464|P1|NOT COMPLETED|Overall Study||33
346329|NCT00540046|837463|P2|COMPLETED|Overall Study||88
346330|NCT00540046|837464|P1|COMPLETED|Overall Study||71
346331|NCT00540046|837463|P2|STARTED|Overall Study||111
346332|NCT00540046|837464|P1|STARTED|Overall Study||104
346333|NCT00540007|837474|P2|NOT COMPLETED|Overall Study||0
346334|NCT00540007|837475|P1|NOT COMPLETED|Overall Study||0
346335|NCT00540007|837474|P2|COMPLETED|Overall Study||42
346336|NCT00540007|837475|P1|COMPLETED|Overall Study||38
346337|NCT00540007|837474|P2|STARTED|Overall Study||42
346338|NCT00540007|837475|P1|STARTED|Overall Study||38
346339|NCT00539994|837500|P3|NOT COMPLETED|Overall Study||2
346340|NCT00539994|837501|P2|NOT COMPLETED|Overall Study||1
346341|NCT00539994|837502|P1|NOT COMPLETED|Overall Study||3
346342|NCT00539994|837500|P3|COMPLETED|Overall Study||13
346343|NCT00539994|837501|P2|COMPLETED|Overall Study||18
346344|NCT00539994|837502|P1|COMPLETED|Overall Study||20
346345|NCT00539994|837500|P3|STARTED|Overall Study||15
346346|NCT00539994|837501|P2|STARTED|Overall Study||19
346347|NCT00539994|837502|P1|STARTED|Overall Study||23
346348|NCT00539942|837541|P2|NOT COMPLETED|Overall Study||0
346349|NCT00539942|837542|P1|NOT COMPLETED|Overall Study||0
346350|NCT00539942|837541|P2|COMPLETED|Overall Study||3
346351|NCT00539942|837542|P1|COMPLETED|Overall Study||4
346352|NCT00539942|837541|P2|STARTED|Overall Study||3
346353|NCT00539942|837542|P1|STARTED|Overall Study||4
346354|NCT00539864|837552|P2|NOT COMPLETED|Overall Study||2
346355|NCT00539864|837553|P1|NOT COMPLETED|Overall Study||1
346356|NCT00539864|837552|P2|COMPLETED|Overall Study||300
346357|NCT00539864|837553|P1|COMPLETED|Overall Study||299
346358|NCT00539864|837552|P2|STARTED|Overall Study||302
346359|NCT00539864|837553|P1|STARTED|Overall Study||300
346360|NCT00539734|837565|P1|NOT COMPLETED|Overall Study||1
346361|NCT00539734|837565|P1|COMPLETED|Overall Study||25
346362|NCT00539734|837565|P1|STARTED|Overall Study||26
346363|NCT00539695|837570|P1|NOT COMPLETED|Overall Study||13
346364|NCT00539695|837570|P1|COMPLETED|Overall Study||12
346365|NCT00539695|837570|P1|Evaluable Patients|Overall Study|Patients who received IL-2.|22
346366|NCT00539695|837570|P1|STARTED|Overall Study||25
346367|NCT00539656|837576|P1|NOT COMPLETED|Overall Study||0
346368|NCT00539656|837576|P1|COMPLETED|Overall Study||3
346369|NCT00539656|837576|P1|STARTED|Overall Study||3
346370|NCT00539617|837582|P1|NOT COMPLETED|Treatment Period||0
346371|NCT00539617|837582|P1|COMPLETED|Treatment Period||3
346372|NCT00539617|837582|P1|STARTED|Treatment Period||3
346373|NCT00539617|837582|P1|NOT COMPLETED|Run-In Period||1
346374|NCT00539617|837582|P1|COMPLETED|Run-In Period||3
346375|NCT00539617|837582|P1|STARTED|Run-In Period||4
346376|NCT00539617|837582|P1|NOT COMPLETED|Pre-screening Period||3
346377|NCT00539617|837582|P1|COMPLETED|Pre-screening Period||4
346378|NCT00539617|837582|P1|STARTED|Pre-screening Period||7
346379|NCT00539591|837590|P3|NOT COMPLETED|Overall Study||3
346380|NCT00539591|837591|P2|NOT COMPLETED|Overall Study||2
346381|NCT00539591|837592|P1|NOT COMPLETED|Overall Study||5
346382|NCT00539591|837590|P3|COMPLETED|Overall Study||1
346383|NCT00539591|837591|P2|COMPLETED|Overall Study||0
346384|NCT00539591|837592|P1|COMPLETED|Overall Study||18
346385|NCT00539591|837590|P3|STARTED|Overall Study||4
346386|NCT00539591|837591|P2|STARTED|Overall Study||2
346387|NCT00539591|837592|P1|STARTED|Overall Study||23
346388|NCT00539539|837702|P2|NOT COMPLETED|Overall Study||0
346389|NCT00539539|837703|P1|NOT COMPLETED|Overall Study||0
346390|NCT00539539|837702|P2|COMPLETED|Overall Study||771
346391|NCT00539539|837703|P1|COMPLETED|Overall Study||815
346392|NCT00539539|837702|P2|STARTED|Overall Study||771
346393|NCT00539539|837703|P1|STARTED|Overall Study||815
346394|NCT00539526|837726|P3|NOT COMPLETED|Overall Study||2
346395|NCT00539526|837727|P2|NOT COMPLETED|Overall Study||2
346396|NCT00539526|837728|P1|NOT COMPLETED|Overall Study||3
346397|NCT00539526|837726|P3|COMPLETED|Overall Study||36
346398|NCT00539526|837727|P2|COMPLETED|Overall Study||31
346399|NCT00539526|837728|P1|COMPLETED|Overall Study||32
346400|NCT00539526|837726|P3|STARTED|Overall Study||38
346401|NCT00539526|837727|P2|STARTED|Overall Study||33
346402|NCT00539526|837728|P1|STARTED|Overall Study||35
346403|NCT00539513|837744|P2|NOT COMPLETED|Overall Study||2
346404|NCT00539513|837745|P1|NOT COMPLETED|Overall Study||2
346405|NCT00539513|837744|P2|COMPLETED|Overall Study||3
346406|NCT00539513|837745|P1|COMPLETED|Overall Study||3
346407|NCT00539513|837744|P2|Received Allocated Intervention|Overall Study||4
346408|NCT00539513|837745|P1|Received Allocated Intervention|Overall Study||3
346409|NCT00539513|837744|P2|STARTED|Overall Study||5
346410|NCT00539513|837745|P1|STARTED|Overall Study||5
346411|NCT00539500|837757|P1|NOT COMPLETED|Overall Study||3
346412|NCT00539500|837757|P1|COMPLETED|Overall Study||0
346413|NCT00539500|837757|P1|STARTED|Overall Study||3
346414|NCT00539305|837765|P2|NOT COMPLETED|Overall Study||2
346415|NCT00539305|837766|P1|NOT COMPLETED|Overall Study||1
346416|NCT00539305|837765|P2|COMPLETED|Overall Study||10
346417|NCT00539305|837766|P1|COMPLETED|Overall Study||9
346418|NCT00539305|837765|P2|STARTED|Overall Study||12
346419|NCT00539305|837766|P1|STARTED|Overall Study||10
346420|NCT00539279|837780|P2|NOT COMPLETED|6-Month Follow-Up Assessment||7
346421|NCT00539279|837781|P1|NOT COMPLETED|6-Month Follow-Up Assessment||1
346422|NCT00539279|837780|P2|COMPLETED|6-Month Follow-Up Assessment||22
346423|NCT00539279|837781|P1|COMPLETED|6-Month Follow-Up Assessment||17
346424|NCT00539279|837780|P2|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to RT)|29
346425|NCT00539279|837781|P1|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to PE)|18
346426|NCT00539279|837780|P2|NOT COMPLETED|Post-Treatment Assessment||9
346427|NCT00539279|837781|P1|NOT COMPLETED|Post-Treatment Assessment||12
346428|NCT00539279|837780|P2|COMPLETED|Post-Treatment Assessment||29
346429|NCT00539279|837781|P1|COMPLETED|Post-Treatment Assessment||18
346430|NCT00539279|837780|P2|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to RT)|38
346431|NCT00539279|837781|P1|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to PE)|30
346432|NCT00539279|837780|P2|NOT COMPLETED|Treatment||8
346433|NCT00539279|837781|P1|NOT COMPLETED|Treatment||11
346434|NCT00539279|837780|P2|COMPLETED|Treatment||38
346435|NCT00539279|837781|P1|COMPLETED|Treatment||30
346436|NCT00539279|837780|P2|STARTED|Treatment||46
346437|NCT00539279|837781|P1|STARTED|Treatment||41
346438|NCT00539253|837799|P1|NOT COMPLETED|Overall Study||26
346439|NCT00539253|837799|P1|COMPLETED|Overall Study||19
346440|NCT00539253|837799|P1|STARTED|Overall Study||45
346441|NCT00539240|837807|P3|NOT COMPLETED|Overall Study||15
346442|NCT00539240|837808|P2|NOT COMPLETED|Overall Study||7
346443|NCT00539240|837809|P1|NOT COMPLETED|Overall Study||6
346444|NCT00539240|837807|P3|COMPLETED|Overall Study||39
346445|NCT00539240|837808|P2|COMPLETED|Overall Study||48
346446|NCT00539240|837809|P1|COMPLETED|Overall Study||53
346447|NCT00539240|837807|P3|STARTED|Overall Study||54
346448|NCT00539240|837808|P2|STARTED|Overall Study||55
346449|NCT00539240|837809|P1|STARTED|Overall Study||59
346450|NCT00539188|837828|P2|NOT COMPLETED|Overall Study||1
346451|NCT00539188|837829|P1|NOT COMPLETED|Overall Study||3
346452|NCT00539188|837828|P2|COMPLETED|Overall Study||1
346453|NCT00539188|837829|P1|COMPLETED|Overall Study||1
346454|NCT00539188|837828|P2|Received Allocated Intervention|Overall Study||2
346455|NCT00539188|837829|P1|Received Allocated Intervention|Overall Study||3
346456|NCT00539188|837828|P2|STARTED|Overall Study||2
346457|NCT00539188|837829|P1|STARTED|Overall Study||4
346458|NCT00539110|837843|P2|NOT COMPLETED|Overall Study||0
346459|NCT00539110|837844|P1|NOT COMPLETED|Overall Study||0
346460|NCT00539110|837843|P2|COMPLETED|Overall Study||5
346461|NCT00539110|837844|P1|COMPLETED|Overall Study||5
346462|NCT00539110|837843|P2|STARTED|Overall Study||5
346463|NCT00539110|837844|P1|STARTED|Overall Study||5
346464|NCT00539032|837852|P2|NOT COMPLETED|Overall Study||1
346465|NCT00539032|837853|P1|NOT COMPLETED|Overall Study||2
346466|NCT00539032|837852|P2|COMPLETED|Overall Study||84
346467|NCT00539032|837853|P1|COMPLETED|Overall Study||151
346468|NCT00539032|837852|P2|STARTED|Overall Study||85
346469|NCT00539032|837853|P1|STARTED|Overall Study||153
346470|NCT00539006|837867|P4|NOT COMPLETED|Post-Study||0
346471|NCT00539006|837868|P3|NOT COMPLETED|Post-Study||0
346472|NCT00539006|837869|P2|NOT COMPLETED|Post-Study||0
346473|NCT00539006|837870|P1|NOT COMPLETED|Post-Study||0
346474|NCT00539006|837867|P4|COMPLETED|Post-Study||81
346475|NCT00539006|837868|P3|COMPLETED|Post-Study||77
346476|NCT00539006|837869|P2|COMPLETED|Post-Study||83
346477|NCT00539006|837870|P1|COMPLETED|Post-Study||75
346478|NCT00539006|837867|P4|STARTED|Post-Study||81
346479|NCT00539006|837868|P3|STARTED|Post-Study||77
346480|NCT00539006|837869|P2|STARTED|Post-Study||83
346481|NCT00539006|837870|P1|STARTED|Post-Study||75
346482|NCT00539006|837867|P4|NOT COMPLETED|Treatment Period 2||0
346483|NCT00539006|837868|P3|NOT COMPLETED|Treatment Period 2||0
346484|NCT00539006|837869|P2|NOT COMPLETED|Treatment Period 2||1
346485|NCT00539006|837870|P1|NOT COMPLETED|Treatment Period 2||1
346486|NCT00539006|837867|P4|COMPLETED|Treatment Period 2||81
346487|NCT00539006|837868|P3|COMPLETED|Treatment Period 2||77
346488|NCT00539006|837869|P2|COMPLETED|Treatment Period 2||83
346489|NCT00539006|837870|P1|COMPLETED|Treatment Period 2||75
346490|NCT00539006|837867|P4|STARTED|Treatment Period 2||81
346491|NCT00539006|837868|P3|STARTED|Treatment Period 2||77
346492|NCT00539006|837869|P2|STARTED|Treatment Period 2||84
346493|NCT00539006|837870|P1|STARTED|Treatment Period 2||76
346494|NCT00539006|837867|P4|NOT COMPLETED|Washout||9
346495|NCT00539006|837868|P3|NOT COMPLETED|Washout||16
346496|NCT00539006|837869|P2|NOT COMPLETED|Washout||10
346497|NCT00539006|837870|P1|NOT COMPLETED|Washout||20
346498|NCT00539006|837867|P4|COMPLETED|Washout||81
346499|NCT00539006|837868|P3|COMPLETED|Washout||77
346500|NCT00539006|837869|P2|COMPLETED|Washout||84
346501|NCT00539006|837870|P1|COMPLETED|Washout||76
346502|NCT00539006|837867|P4|STARTED|Washout||90
346503|NCT00539006|837868|P3|STARTED|Washout||93
346504|NCT00539006|837869|P2|STARTED|Washout||94
346505|NCT00539006|837870|P1|STARTED|Washout||96
346506|NCT00539006|837867|P4|NOT COMPLETED|Treatment Period 1||1
346507|NCT00539006|837868|P3|NOT COMPLETED|Treatment Period 1||2
346508|NCT00539006|837869|P2|NOT COMPLETED|Treatment Period 1||0
346509|NCT00539006|837870|P1|NOT COMPLETED|Treatment Period 1||0
346510|NCT00539006|837867|P4|COMPLETED|Treatment Period 1||90
346511|NCT00539006|837868|P3|COMPLETED|Treatment Period 1||93
346512|NCT00539006|837869|P2|COMPLETED|Treatment Period 1||94
346513|NCT00539006|837870|P1|COMPLETED|Treatment Period 1||96
346514|NCT00539006|837867|P4|STARTED|Treatment Period 1||91
346515|NCT00539006|837868|P3|STARTED|Treatment Period 1||95
346516|NCT00539006|837869|P2|STARTED|Treatment Period 1||94
346517|NCT00539006|837870|P1|STARTED|Treatment Period 1||96
346518|NCT00539006|837867|P4|NOT COMPLETED|Pre-treatment||0
346519|NCT00539006|837868|P3|NOT COMPLETED|Pre-treatment||0
346520|NCT00539006|837869|P2|NOT COMPLETED|Pre-treatment||1
346521|NCT00539006|837870|P1|NOT COMPLETED|Pre-treatment||0
346522|NCT00539006|837867|P4|COMPLETED|Pre-treatment||91
346523|NCT00539006|837868|P3|COMPLETED|Pre-treatment||95
346524|NCT00539006|837869|P2|COMPLETED|Pre-treatment||94
346525|NCT00539006|837870|P1|COMPLETED|Pre-treatment||96
346526|NCT00539006|837867|P4|STARTED|Pre-treatment||91
346527|NCT00539006|837868|P3|STARTED|Pre-treatment||95
346528|NCT00539006|837869|P2|STARTED|Pre-treatment||95
346529|NCT00539006|837870|P1|STARTED|Pre-treatment||96
346530|NCT00538980|837900|P1|NOT COMPLETED|Overall Study||10
346531|NCT00538980|837900|P1|COMPLETED|Overall Study||0
346532|NCT00538980|837900|P1|STARTED|Overall Study||10
346533|NCT00538915|837908|P1|NOT COMPLETED|Overall Study||11
346534|NCT00538915|837908|P1|COMPLETED|Overall Study||52
346535|NCT00538915|837908|P1|STARTED|Overall Study||63
346536|NCT00538902|837915|P3|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
346537|NCT00538902|837916|P2|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
346538|NCT00538902|837917|P1|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||36
346539|NCT00538902|837915|P3|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||52
346540|NCT00538902|837916|P2|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||55
346541|NCT00538902|837917|P1|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||23
346542|NCT00538902|837915|P3|STARTED|OL Wk 24 to End (Primary D/C Reasons)||116
346543|NCT00538902|837916|P2|STARTED|OL Wk 24 to End (Primary D/C Reasons)||119
346544|NCT00538902|837917|P1|STARTED|OL Wk 24 to End (Primary D/C Reasons)||59
346545|NCT00538902|837915|P3|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||5
346546|NCT00538902|837916|P2|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||2
346547|NCT00538902|837917|P1|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||1
346548|NCT00538902|837915|P3|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||116
346549|NCT00538902|837916|P2|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||119
346550|NCT00538902|837917|P1|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||59
346551|NCT00538902|837915|P3|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
346552|NCT00538902|837916|P2|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
346553|NCT00538902|837917|P1|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||60
346554|NCT00538863|837952|P1|NOT COMPLETED|Open-label Maintenance||106
346555|NCT00538863|837952|P1|COMPLETED|Open-label Maintenance||163
346556|NCT00538863|837952|P1|STARTED|Open-label Maintenance|Five participants who completed the titration period did not start the maintenance period.|269
346557|NCT00538863|837952|P1|NOT COMPLETED|Open-label Titration||45
346558|NCT00538863|837952|P1|COMPLETED|Open-label Titration||184
346559|NCT00538863|837952|P1|STARTED|Open-label Titration||229
346560|NCT00538850|837958|P3|NOT COMPLETED|Placebo - Double-blind||3
346561|NCT00538850|837959|P2|NOT COMPLETED|Placebo - Double-blind||0
346562|NCT00538850|837960|P1|NOT COMPLETED|Placebo - Double-blind||0
346563|NCT00538850|837958|P3|COMPLETED|Placebo - Double-blind||95
346564|NCT00538850|837959|P2|COMPLETED|Placebo - Double-blind||0
346565|NCT00538850|837960|P1|COMPLETED|Placebo - Double-blind||0
346566|NCT00538850|837958|P3|STARTED|Placebo - Double-blind||98
346567|NCT00538850|837959|P2|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
346568|NCT00538850|837960|P1|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
346569|NCT00538850|837958|P3|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
346570|NCT00538850|837959|P2|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||3
346571|NCT00538850|837960|P1|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
346572|NCT00538850|837958|P3|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
346573|NCT00538850|837959|P2|COMPLETED|Fentanyl Sublingual Spray - Double-blind||95
346574|NCT00538850|837960|P1|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
346575|NCT00538850|837958|P3|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
346576|NCT00538850|837959|P2|STARTED|Fentanyl Sublingual Spray - Double-blind||98
346577|NCT00538850|837960|P1|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
346578|NCT00538850|837958|P3|NOT COMPLETED|Titration Period||0
346579|NCT00538850|837959|P2|NOT COMPLETED|Titration Period||0
346580|NCT00538850|837960|P1|NOT COMPLETED|Titration Period||32
346581|NCT00538850|837958|P3|COMPLETED|Titration Period||0
346582|NCT00538850|837959|P2|COMPLETED|Titration Period||0
346583|NCT00538850|837960|P1|COMPLETED|Titration Period||98
346584|NCT00538850|837958|P3|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
346585|NCT00538850|837959|P2|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
346586|NCT00538850|837960|P1|STARTED|Titration Period||130
346587|NCT00538824|837972|P1|NOT COMPLETED|Overall Study||0
346588|NCT00538824|837972|P1|COMPLETED|Overall Study||5
346589|NCT00538824|837972|P1|Progression of Disease|Overall Study||2
346590|NCT00538824|837972|P1|STARTED|Overall Study||5
346591|NCT00538785|837978|P2|NOT COMPLETED|Overall Study||17
346592|NCT00538785|837979|P1|NOT COMPLETED|Overall Study||19
346593|NCT00538785|837978|P2|COMPLETED|Overall Study||595
346594|NCT00538785|837979|P1|COMPLETED|Overall Study||604
346595|NCT00538785|837978|P2|STARTED|Overall Study||612
346596|NCT00538785|837979|P1|STARTED|Overall Study|A subject was randomized without appropriate consent in France and is not included in the results.|623
346597|NCT00538759|838002|P2|NOT COMPLETED|Overall Study||0
346598|NCT00538759|838003|P1|NOT COMPLETED|Overall Study||0
346599|NCT00538759|838002|P2|COMPLETED|Overall Study||8
346600|NCT00538759|838003|P1|COMPLETED|Overall Study||13
346601|NCT00538759|838002|P2|STARTED|Overall Study||8
346602|NCT00538759|838003|P1|STARTED|Overall Study||13
346603|NCT00538733|838021|P1|NOT COMPLETED|Overall Study||12
346604|NCT00538733|838021|P1|COMPLETED|Overall Study||14
346605|NCT00538733|838021|P1|Removed to Pursue Alternative Theray|Overall Study||2
346606|NCT00538733|838021|P1|Removed to Pursue a Stem Cell Transplant|Overall Study||11
346607|NCT00538733|838021|P1|Removed Due to Progression of Disease|Overall Study||1
346608|NCT00538733|838021|P1|STARTED|Overall Study||26
346609|NCT00538642|838030|P2|NOT COMPLETED|Overall Study||5
346610|NCT00538642|838031|P1|NOT COMPLETED|Overall Study||1
346611|NCT00538642|838030|P2|COMPLETED|Overall Study||9
346612|NCT00538642|838031|P1|COMPLETED|Overall Study||9
346613|NCT00538642|838030|P2|STARTED|Overall Study||14
346614|NCT00538642|838031|P1|STARTED|Overall Study||10
346615|NCT00538629|838071|P1|NOT COMPLETED|Overall Study||22
346616|NCT00538629|838071|P1|COMPLETED|Overall Study||449
346617|NCT00538629|838071|P1|STARTED|Overall Study||471
346618|NCT00538616|838118|P2|NOT COMPLETED|Overall Study||0
346619|NCT00538616|838119|P1|NOT COMPLETED|Overall Study||0
346620|NCT00538616|838118|P2|COMPLETED|Overall Study||3
346621|NCT00538616|838119|P1|COMPLETED|Overall Study||5
346622|NCT00538616|838118|P2|STARTED|Overall Study||3
346623|NCT00538616|838119|P1|STARTED|Overall Study||5
346624|NCT00538590|838127|P2|NOT COMPLETED|Overall Study||0
346625|NCT00538590|838128|P1|NOT COMPLETED|Overall Study||1
346626|NCT00538590|838127|P2|COMPLETED|Overall Study||10
346627|NCT00538590|838128|P1|COMPLETED|Overall Study|Deceased 8 months after surgery due to known cardiovascular co-morbidity.|9
346628|NCT00538590|838127|P2|STARTED|Overall Study||10
346629|NCT00538590|838128|P1|STARTED|Overall Study||10
346630|NCT00538512|838145|P3|NOT COMPLETED|Overall Study||13
346631|NCT00538512|838146|P2|NOT COMPLETED|Overall Study||30
346632|NCT00538512|838147|P1|NOT COMPLETED|Overall Study||27
346633|NCT00538512|838145|P3|COMPLETED|Overall Study||312
346634|NCT00538512|838146|P2|COMPLETED|Overall Study||783
346635|NCT00538512|838147|P1|COMPLETED|Overall Study||787
346636|NCT00538512|838145|P3|STARTED|Overall Study||325
346637|NCT00538512|838146|P2|STARTED|Overall Study||813
346638|NCT00538512|838147|P1|STARTED|Overall Study||814
346639|NCT00538473|838166|P2|NOT COMPLETED|Overall Study||0
346640|NCT00538473|838167|P1|NOT COMPLETED|Overall Study||1
346641|NCT00538473|838166|P2|COMPLETED|Overall Study||35
346642|NCT00538473|838167|P1|COMPLETED|Overall Study||32
346643|NCT00538473|838166|P2|STARTED|Overall Study||35
346644|NCT00538473|838167|P1|STARTED|Overall Study||33
346645|NCT00538434|838203|P4|NOT COMPLETED|Overall Study||6
346646|NCT00538434|838204|P3|NOT COMPLETED|Overall Study||7
346647|NCT00538434|838205|P2|NOT COMPLETED|Overall Study||11
346648|NCT00538434|838206|P1|NOT COMPLETED|Overall Study||9
346649|NCT00538434|838203|P4|COMPLETED|Overall Study|Completed all scheduled study visits|51
346650|NCT00538434|838204|P3|COMPLETED|Overall Study|Completed all scheduled study visits|50
346651|NCT00538434|838205|P2|COMPLETED|Overall Study|Completed all scheduled study visits|46
346652|NCT00538434|838206|P1|COMPLETED|Overall Study|Completed all scheduled study visits|47
346653|NCT00538434|838203|P4|Intent-to-treat (ITT) Population|Overall Study||57
346654|NCT00538434|838204|P3|Intent-to-treat (ITT) Population|Overall Study||57
346655|NCT00538434|838205|P2|Intent-to-treat (ITT) Population|Overall Study||57
346656|NCT00538434|838206|P1|Intent-to-treat (ITT) Population|Overall Study|1 participant was randomized but not treated|55
346657|NCT00538434|838203|P4|STARTED|Overall Study||57
346658|NCT00538434|838204|P3|STARTED|Overall Study||57
346659|NCT00538434|838205|P2|STARTED|Overall Study||57
346660|NCT00538434|838206|P1|STARTED|Overall Study||56
346661|NCT00538304|838230|P2|NOT COMPLETED|Overall Study||5
346662|NCT00538304|838231|P1|NOT COMPLETED|Overall Study||7
346663|NCT00538304|838230|P2|COMPLETED|Overall Study||66
346664|NCT00538304|838231|P1|COMPLETED|Overall Study||144
346665|NCT00538304|838230|P2|STARTED|Overall Study||71
346666|NCT00538304|838231|P1|STARTED|Overall Study||151
346667|NCT00538291|838247|P1|NOT COMPLETED|Overall Study||3
346668|NCT00538291|838247|P1|COMPLETED|Overall Study||10
346669|NCT00538291|838247|P1|STARTED|Overall Study||13
346670|NCT00538213|838254|P3|NOT COMPLETED|Overall Study||0
346671|NCT00538213|838255|P2|NOT COMPLETED|Overall Study||0
346672|NCT00538213|838256|P1|NOT COMPLETED|Overall Study||0
346673|NCT00538213|838254|P3|COMPLETED|Overall Study||38
346674|NCT00538213|838255|P2|COMPLETED|Overall Study||40
346675|NCT00538213|838256|P1|COMPLETED|Overall Study||55
346676|NCT00538213|838254|P3|STARTED|Overall Study||38
346677|NCT00538213|838255|P2|STARTED|Overall Study||40
346678|NCT00538213|838256|P1|STARTED|Overall Study||55
346679|NCT00537979|838305|P2|NOT COMPLETED|Overall Study||20
346680|NCT00537979|838306|P1|NOT COMPLETED|Overall Study||6
346681|NCT00537979|838305|P2|COMPLETED|Overall Study||89
346682|NCT00537979|838306|P1|COMPLETED|Overall Study||32
346683|NCT00537979|838305|P2|STARTED|Overall Study||109
346684|NCT00537979|838306|P1|STARTED|Overall Study||38
346685|NCT00537940|838322|P2|NOT COMPLETED|Overall Study||179
346686|NCT00537940|838323|P1|NOT COMPLETED|Overall Study||183
346687|NCT00537940|838322|P2|COMPLETED|Overall Study||62
346688|NCT00537940|838323|P1|COMPLETED|Overall Study|2 participants had both treatment related and non-treatment related AE leading to discontinuation.|58
346689|NCT00537940|838322|P2|Entered Opt Blinded Continuation Phase|Overall Study||139
346690|NCT00537940|838323|P1|Entered Opt Blinded Continuation Phase|Overall Study||140
346691|NCT00537940|838322|P2|Completed Maintenance Phase|Overall Study||172
346692|NCT00537940|838323|P1|Completed Maintenance Phase|Overall Study||187
346693|NCT00537940|838322|P2|Completed Titration Phase|Overall Study||210
346694|NCT00537940|838323|P1|Completed Titration Phase|Overall Study||213
346695|NCT00537940|838322|P2|STARTED|Overall Study||241
346696|NCT00537940|838323|P1|STARTED|Overall Study||241
346697|NCT00537823|838347|P2|NOT COMPLETED|Overall Study||0
346698|NCT00537823|838348|P1|NOT COMPLETED|Overall Study||2
346699|NCT00537823|838347|P2|COMPLETED|Overall Study||2
346700|NCT00537823|838348|P1|COMPLETED|Overall Study||5
346701|NCT00537823|838347|P2|STARTED|Overall Study||2
346702|NCT00537823|838348|P1|STARTED|Overall Study||7
346703|NCT00537810|838374|P4|NOT COMPLETED|Overall Study||4
346704|NCT00537810|838375|P3|NOT COMPLETED|Overall Study||4
346705|NCT00537810|838376|P2|NOT COMPLETED|Overall Study||13
346706|NCT00537810|838377|P1|NOT COMPLETED|Overall Study||6
346707|NCT00537810|838374|P4|COMPLETED|Overall Study||22
346708|NCT00537810|838375|P3|COMPLETED|Overall Study||21
346709|NCT00537810|838376|P2|COMPLETED|Overall Study||14
346710|NCT00537810|838377|P1|COMPLETED|Overall Study||20
346711|NCT00537810|838374|P4|STARTED|Overall Study||26
346712|NCT00537810|838375|P3|STARTED|Overall Study||25
346713|NCT00537810|838376|P2|STARTED|Overall Study||27
346714|NCT00537810|838377|P1|STARTED|Overall Study||26
346715|NCT00537771|838393|P2|NOT COMPLETED|Overall Study||61
346716|NCT00537771|838394|P1|NOT COMPLETED|Overall Study||29
346717|NCT00537771|838393|P2|COMPLETED|Overall Study||114
346718|NCT00537771|838394|P1|COMPLETED|Overall Study||149
346719|NCT00537771|838393|P2|STARTED|Overall Study||175
346720|NCT00537771|838394|P1|STARTED|Overall Study||178
346721|NCT00537745|838404|P1|NOT COMPLETED|Overall Study||5
346722|NCT00537745|838404|P1|COMPLETED|Overall Study||9
346723|NCT00537745|838404|P1|Began Intervention|Overall Study||11
346724|NCT00537745|838404|P1|STARTED|Overall Study|There were three screen fails and two early terminations.|14
346725|NCT00537680|838412|P3|NOT COMPLETED|Overall Study||0
346726|NCT00537680|838413|P2|NOT COMPLETED|Overall Study||2
346727|NCT00537680|838414|P1|NOT COMPLETED|Overall Study||0
346728|NCT00537680|838412|P3|COMPLETED|Overall Study||24
346729|NCT00537680|838413|P2|COMPLETED|Overall Study||22
346730|NCT00537680|838414|P1|COMPLETED|Overall Study||22
346731|NCT00537680|838412|P3|STARTED|Overall Study||24
346732|NCT00537680|838413|P2|STARTED|Overall Study||24
346733|NCT00537680|838414|P1|STARTED|Overall Study||22
346734|NCT00537511|838422|P1|NOT COMPLETED|Maintenance Phase (Monotherapy)||8
346735|NCT00537511|838422|P1|COMPLETED|Maintenance Phase (Monotherapy)||0
346736|NCT00537511|838422|P1|STARTED|Maintenance Phase (Monotherapy)||8
346737|NCT00537511|838422|P1|NOT COMPLETED|Recovery Period (Monotherapy)||8
346738|NCT00537511|838422|P1|COMPLETED|Recovery Period (Monotherapy)||3
346739|NCT00537511|838422|P1|STARTED|Recovery Period (Monotherapy)||11
346740|NCT00537511|838422|P1|NOT COMPLETED|Extension Period (Combination)||6
346741|NCT00537511|838422|P1|COMPLETED|Extension Period (Combination)||11
346742|NCT00537511|838422|P1|STARTED|Extension Period (Combination)||17
346743|NCT00537511|838422|P1|NOT COMPLETED|Treatment Period (Combination)||5
346744|NCT00537511|838422|P1|COMPLETED|Treatment Period (Combination)||17
346745|NCT00537511|838422|P1|Safety Population|Treatment Period (Combination)|Safety = All participants who took ≥1 dose of study treatment.|22
346746|NCT00537511|838422|P1|Intent-to-Treat (ITT) Populaton|Treatment Period (Combination)|ITT = all participants enrolled in the study.|22
346747|NCT00537511|838422|P1|STARTED|Treatment Period (Combination)||22
346748|NCT00537485|838449|P2|NOT COMPLETED|Overall Study||10
346749|NCT00537485|838450|P1|NOT COMPLETED|Overall Study||15
346750|NCT00537485|838449|P2|COMPLETED|Overall Study||80
346751|NCT00537485|838450|P1|COMPLETED|Overall Study||75
346752|NCT00537485|838449|P2|STARTED|Overall Study||90
346753|NCT00537485|838450|P1|STARTED|Overall Study||90
346754|NCT00537407|838479|P5|NOT COMPLETED|Part 2 Weeks 5-48 or 72||7
346755|NCT00537407|838480|P4|NOT COMPLETED|Part 2 Weeks 5-48 or 72||6
346756|NCT00537407|838481|P3|NOT COMPLETED|Part 2 Weeks 5-48 or 72||9
346757|NCT00537407|838482|P2|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
346758|NCT00537407|838483|P1|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
346759|NCT00537407|838479|P5|COMPLETED|Part 2 Weeks 5-48 or 72||3
346760|NCT00537407|838480|P4|COMPLETED|Part 2 Weeks 5-48 or 72||4
346761|NCT00537407|838481|P3|COMPLETED|Part 2 Weeks 5-48 or 72||2
346762|NCT00537407|838482|P2|COMPLETED|Part 2 Weeks 5-48 or 72||1
346763|NCT00537407|838483|P1|COMPLETED|Part 2 Weeks 5-48 or 72||2
346764|NCT00537407|838479|P5|STARTED|Part 2 Weeks 5-48 or 72||10
346765|NCT00537407|838480|P4|STARTED|Part 2 Weeks 5-48 or 72||10
346766|NCT00537407|838481|P3|STARTED|Part 2 Weeks 5-48 or 72||11
346767|NCT00537407|838482|P2|STARTED|Part 2 Weeks 5-48 or 72||9
346768|NCT00537407|838483|P1|STARTED|Part 2 Weeks 5-48 or 72||10
346769|NCT00537407|838479|P5|NOT COMPLETED|Part 1 Weeks 1-4||0
346770|NCT00537407|838480|P4|NOT COMPLETED|Part 1 Weeks 1-4||0
346771|NCT00537407|838481|P3|NOT COMPLETED|Part 1 Weeks 1-4||0
346772|NCT00537407|838482|P2|NOT COMPLETED|Part 1 Weeks 1-4||0
346773|NCT00537407|838483|P1|NOT COMPLETED|Part 1 Weeks 1-4||0
346774|NCT00537407|838479|P5|COMPLETED|Part 1 Weeks 1-4||10
346775|NCT00537407|838480|P4|COMPLETED|Part 1 Weeks 1-4||10
346776|NCT00537407|838481|P3|COMPLETED|Part 1 Weeks 1-4||11
346777|NCT00537407|838482|P2|COMPLETED|Part 1 Weeks 1-4||9
346778|NCT00537407|838483|P1|COMPLETED|Part 1 Weeks 1-4||10
346779|NCT00537407|838479|P5|STARTED|Part 1 Weeks 1-4||10
346780|NCT00537407|838480|P4|STARTED|Part 1 Weeks 1-4||10
346781|NCT00537407|838481|P3|STARTED|Part 1 Weeks 1-4||11
346782|NCT00537407|838482|P2|STARTED|Part 1 Weeks 1-4||9
346783|NCT00537407|838483|P1|STARTED|Part 1 Weeks 1-4||10
346784|NCT00537394|838523|P3|NOT COMPLETED|2nd Year of Follow-up||6
346785|NCT00537394|838524|P2|NOT COMPLETED|2nd Year of Follow-up||9
346786|NCT00537394|838525|P1|NOT COMPLETED|2nd Year of Follow-up||11
346787|NCT00537394|838523|P3|COMPLETED|2nd Year of Follow-up||44
346788|NCT00537394|838524|P2|COMPLETED|2nd Year of Follow-up||159
346789|NCT00537394|838525|P1|COMPLETED|2nd Year of Follow-up||158
346790|NCT00537394|838523|P3|STARTED|2nd Year of Follow-up||50
346791|NCT00537394|838524|P2|STARTED|2nd Year of Follow-up||168
346792|NCT00537394|838525|P1|STARTED|2nd Year of Follow-up||169
346793|NCT00537394|838523|P3|NOT COMPLETED|First Year of Follow-up||3
346794|NCT00537394|838524|P2|NOT COMPLETED|First Year of Follow-up||11
346795|NCT00537394|838525|P1|NOT COMPLETED|First Year of Follow-up||12
346796|NCT00537394|838523|P3|COMPLETED|First Year of Follow-up||50
346797|NCT00537394|838524|P2|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|168
346798|NCT00537394|838525|P1|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|169
346799|NCT00537394|838523|P3|STARTED|First Year of Follow-up||53
346800|NCT00537394|838524|P2|STARTED|First Year of Follow-up||179
346801|NCT00537394|838525|P1|STARTED|First Year of Follow-up||181
346802|NCT00537381|838561|P2|NOT COMPLETED|Overall Study||62
346803|NCT00537381|838562|P1|NOT COMPLETED|Overall Study||56
346804|NCT00537381|838561|P2|COMPLETED|Overall Study||4
346805|NCT00537381|838562|P1|COMPLETED|Overall Study||9
346806|NCT00537381|838561|P2|STARTED|Overall Study||66
346807|NCT00537381|838562|P1|STARTED|Overall Study|11 Participants after disease progression switched to intetumumab alone (2) or D+P+ Intetumumab (9).|65
346808|NCT00537329|838582|P1|NOT COMPLETED|Overall Study||26
346809|NCT00537329|838582|P1|COMPLETED|Overall Study||17
346810|NCT00537329|838582|P1|STARTED|Overall Study||43
346811|NCT00537316|838602|P7|NOT COMPLETED|Part 2||2
346812|NCT00537316|838603|P6|NOT COMPLETED|Part 2||4
346813|NCT00537316|838604|P5|NOT COMPLETED|Part 2||1
346814|NCT00537316|838605|P4|NOT COMPLETED|Part 2||3
346815|NCT00537316|838606|P3|NOT COMPLETED|Part 2||32
346816|NCT00537316|838607|P2|NOT COMPLETED|Part 2||9
346817|NCT00537316|838608|P1|NOT COMPLETED|Part 2||26
346818|NCT00537316|838602|P7|COMPLETED|Part 2||0
346819|NCT00537316|838603|P6|COMPLETED|Part 2||0
346820|NCT00537316|838604|P5|COMPLETED|Part 2||1
346821|NCT00537316|838605|P4|COMPLETED|Part 2||2
346822|NCT00537316|838606|P3|COMPLETED|Part 2||16
346823|NCT00537316|838607|P2|COMPLETED|Part 2||1
346824|NCT00537316|838608|P1|COMPLETED|Part 2||11
346825|NCT00537316|838602|P7|STARTED|Part 2||2
346826|NCT00537316|838603|P6|STARTED|Part 2||4
346827|NCT00537316|838604|P5|STARTED|Part 2||2
346828|NCT00537316|838605|P4|STARTED|Part 2||5
346829|NCT00537316|838606|P3|STARTED|Part 2||48
346830|NCT00537316|838607|P2|STARTED|Part 2||10
346831|NCT00537316|838608|P1|STARTED|Part 2||37
346832|NCT00537316|838602|P7|NOT COMPLETED|Part 1||0
346833|NCT00537316|838603|P6|NOT COMPLETED|Part 1||0
346834|NCT00537316|838604|P5|NOT COMPLETED|Part 1||0
346835|NCT00537316|838605|P4|NOT COMPLETED|Part 1||0
346836|NCT00537316|838606|P3|NOT COMPLETED|Part 1||17
346837|NCT00537316|838607|P2|NOT COMPLETED|Part 1||27
346838|NCT00537316|838608|P1|NOT COMPLETED|Part 1||14
346839|NCT00537316|838602|P7|COMPLETED|Part 1||0
346840|NCT00537316|838603|P6|COMPLETED|Part 1||0
346841|NCT00537316|838604|P5|COMPLETED|Part 1||0
346842|NCT00537316|838605|P4|COMPLETED|Part 1||0
346843|NCT00537316|838606|P3|COMPLETED|Part 1||63
346844|NCT00537316|838607|P2|COMPLETED|Part 1||53
346845|NCT00537316|838608|P1|COMPLETED|Part 1||65
346846|NCT00537316|838602|P7|STARTED|Part 1||0
346847|NCT00537316|838603|P6|STARTED|Part 1||0
346848|NCT00537316|838604|P5|STARTED|Part 1||0
346849|NCT00537316|838605|P4|STARTED|Part 1||0
346850|NCT00537316|838606|P3|STARTED|Part 1||80
346851|NCT00537316|838607|P2|STARTED|Part 1||80
346852|NCT00537316|838608|P1|STARTED|Part 1||79
346853|NCT00537303|838635|P2|NOT COMPLETED|Overall Study||25
346854|NCT00537303|838636|P1|NOT COMPLETED|Overall Study||26
346855|NCT00537303|838635|P2|COMPLETED|Overall Study||125
346856|NCT00537303|838636|P1|COMPLETED|Overall Study||120
346857|NCT00537303|838635|P2|STARTED|Overall Study||150
346858|NCT00537303|838636|P1|STARTED|Overall Study||146
346859|NCT00537290|838652|P1|NOT COMPLETED|Overall Study||0
346860|NCT00537290|838652|P1|COMPLETED|Overall Study||19
346861|NCT00537290|838652|P1|STARTED|Overall Study||19
346862|NCT00537277|838657|P1|NOT COMPLETED|Overall Study||49
346863|NCT00537277|838657|P1|COMPLETED|Overall Study||112
346864|NCT00537277|838657|P1|Exposed to Trial Drug|Overall Study|One subject not exposed to trial drug, and thus not included in full analysis set (FAS)|160
346865|NCT00537277|838657|P1|STARTED|Overall Study||161
346866|NCT00537238|838668|P2|NOT COMPLETED|Overall Study||173
346867|NCT00537238|838669|P1|NOT COMPLETED|Overall Study||174
346868|NCT00537238|838668|P2|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|82
346869|NCT00537238|838669|P1|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|80
346870|NCT00537238|838668|P2|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|195
346871|NCT00537238|838669|P1|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|185
346872|NCT00537238|838668|P2|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|210
346873|NCT00537238|838669|P1|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|208
346874|NCT00537238|838668|P2|Completed Titration Phase|Overall Study||236
346875|NCT00537238|838669|P1|Completed Titration Phase|Overall Study||226
346876|NCT00537238|838668|P2|STARTED|Overall Study||255
346877|NCT00537238|838669|P1|STARTED|Overall Study||254
346878|NCT00537199|838689|P1|NOT COMPLETED|Overall Study||1
346879|NCT00537199|838689|P1|COMPLETED|Overall Study||0
346880|NCT00537199|838689|P1|STARTED|Overall Study||1
346881|NCT00537095|838695|P2|NOT COMPLETED|Overall Study||57
346882|NCT00537095|838696|P1|NOT COMPLETED|Overall Study||51
346883|NCT00537095|838695|P2|COMPLETED|Overall Study||16
346884|NCT00537095|838696|P1|COMPLETED|Overall Study||21
346885|NCT00537095|838695|P2|STARTED|Overall Study||73
346886|NCT00537095|838696|P1|STARTED|Overall Study||72
346887|NCT00537082|838711|P3|NOT COMPLETED|Overall Study||6
346888|NCT00537082|838712|P2|NOT COMPLETED|Overall Study||9
346889|NCT00537082|838713|P1|NOT COMPLETED|Overall Study||9
346890|NCT00537082|838711|P3|COMPLETED|Overall Study||51
346891|NCT00537082|838712|P2|COMPLETED|Overall Study||48
346892|NCT00537082|838713|P1|COMPLETED|Overall Study||48
346893|NCT00537082|838711|P3|STARTED|Overall Study||57
346894|NCT00537082|838712|P2|STARTED|Overall Study||57
346895|NCT00537082|838713|P1|STARTED|Overall Study||57
346896|NCT00537056|838730|P1|NOT COMPLETED|12-month Follow-up||0
346897|NCT00537056|838730|P1|COMPLETED|12-month Follow-up||17
346898|NCT00537056|838730|P1|STARTED|12-month Follow-up||17
346899|NCT00537056|838730|P1|NOT COMPLETED|Interim PET/CT||5
346900|NCT00537056|838730|P1|COMPLETED|Interim PET/CT||12
346901|NCT00537056|838730|P1|STARTED|Interim PET/CT||17
346902|NCT00537056|838730|P1|NOT COMPLETED|Baseline PET/CT||0
346903|NCT00537056|838730|P1|COMPLETED|Baseline PET/CT||17
346904|NCT00537056|838730|P1|STARTED|Baseline PET/CT||17
346905|NCT00537030|838742|P1|NOT COMPLETED|Overall Study||16
346906|NCT00537030|838742|P1|COMPLETED|Overall Study||43
346907|NCT00537030|838742|P1|STARTED|Overall Study||59
346908|NCT00537017|838749|P1|NOT COMPLETED|Follow-up Phase||9
346909|NCT00537017|838749|P1|COMPLETED|Follow-up Phase||126
346910|NCT00537017|838749|P1|STARTED|Follow-up Phase|All TP participants were eligible for FUP entry. 5 participants completing TP did not enter FUP.|135
346911|NCT00537017|838749|P1|NOT COMPLETED|Treatment Phase||34
346912|NCT00537017|838749|P1|COMPLETED|Treatment Phase||106
346913|NCT00537017|838749|P1|STARTED|Treatment Phase||140
346914|NCT00536991|838760|P1|NOT COMPLETED|Overall Study||13
346915|NCT00536991|838760|P1|COMPLETED|Overall Study||38
346916|NCT00536991|838760|P1|STARTED|Overall Study||51
346917|NCT00536978|838767|P1|NOT COMPLETED|Overall Study||22
346918|NCT00536978|838767|P1|COMPLETED|Overall Study||0
346919|NCT00536978|838767|P1|STARTED|Overall Study||22
346920|NCT00536913|838773|P2|NOT COMPLETED|Overall Study||0
346921|NCT00536913|838774|P1|NOT COMPLETED|Overall Study||0
346922|NCT00536913|838773|P2|COMPLETED|Overall Study||52
346923|NCT00536913|838774|P1|COMPLETED|Overall Study||55
346924|NCT00536913|838773|P2|STARTED|Overall Study||52
346925|NCT00536913|838774|P1|STARTED|Overall Study||55
346926|NCT00536874|838796|P1|NOT COMPLETED|Overall Study||4
346927|NCT00536874|838796|P1|COMPLETED|Overall Study||35
346928|NCT00536874|838796|P1|STARTED|Overall Study||39
346929|NCT00536809|838806|P1|NOT COMPLETED|Phase II||2
346930|NCT00536809|838806|P1|COMPLETED|Phase II||0
346931|NCT00536809|838806|P1|STARTED|Phase II||2
346932|NCT00536809|838806|P1|NOT COMPLETED|Phase I (Dose-finding Phase)||0
346933|NCT00536809|838806|P1|COMPLETED|Phase I (Dose-finding Phase)||10
346934|NCT00536809|838806|P1|STARTED|Phase I (Dose-finding Phase)||10
346935|NCT00536744|838829|P2|NOT COMPLETED|Overall Study||28
346936|NCT00536744|838830|P1|NOT COMPLETED|Overall Study||29
346937|NCT00536744|838829|P2|COMPLETED|Overall Study||71
346938|NCT00536744|838830|P1|COMPLETED|Overall Study||78
346939|NCT00536744|838829|P2|STARTED|Overall Study||99
346940|NCT00536744|838830|P1|STARTED|Overall Study||107
346941|NCT00536731|838839|P3|NOT COMPLETED|Overall Study||5
346942|NCT00536731|838840|P2|NOT COMPLETED|Overall Study||5
346943|NCT00536731|838841|P1|NOT COMPLETED|Overall Study||4
346944|NCT00536731|838839|P3|COMPLETED|Overall Study||238
346945|NCT00536731|838840|P2|COMPLETED|Overall Study||241
346946|NCT00536731|838841|P1|COMPLETED|Overall Study||249
346947|NCT00536731|838839|P3|STARTED|Overall Study||243
346948|NCT00536731|838840|P2|STARTED|Overall Study||246
346949|NCT00536731|838841|P1|STARTED|Overall Study||253
346950|NCT00536575|838885|P1|NOT COMPLETED|Overall Study||2
346951|NCT00536575|838885|P1|COMPLETED|Overall Study||11
346952|NCT00536575|838885|P1|STARTED|Overall Study||13
346953|NCT00536510|838891|P2|NOT COMPLETED|Overall Study||29
346954|NCT00536510|838892|P1|NOT COMPLETED|Overall Study||82
346955|NCT00536510|838891|P2|COMPLETED|Overall Study||295
346956|NCT00536510|838892|P1|COMPLETED|Overall Study||240
346957|NCT00536510|838891|P2|STARTED|Overall Study||324
346958|NCT00536510|838892|P1|STARTED|Overall Study||322
346959|NCT00536484|838902|P2|NOT COMPLETED|Overall Study||56
346960|NCT00536484|838903|P1|NOT COMPLETED|Overall Study||60
346961|NCT00536484|838902|P2|COMPLETED|Overall Study|134 completed on 4mg dose and 248 on 8mg dose|382
346962|NCT00536484|838903|P1|COMPLETED|Overall Study|88 completed on matched 4mg dose and 297 on matched 8mg dose|385
346963|NCT00536484|838902|P2|STARTED|Overall Study|448 participants randomised; 10 not treated|438
346964|NCT00536484|838903|P1|STARTED|Overall Study|448 participants randomised; 3 not treated|445
346965|NCT00536471|838937|P4|NOT COMPLETED|Overall Study||74
346966|NCT00536471|838938|P3|NOT COMPLETED|Overall Study||139
346967|NCT00536471|838939|P2|NOT COMPLETED|Overall Study||84
346968|NCT00536471|838940|P1|NOT COMPLETED|Overall Study||156
346969|NCT00536471|838937|P4|COMPLETED|Overall Study||57
346970|NCT00536471|838938|P3|COMPLETED|Overall Study||122
346971|NCT00536471|838939|P2|COMPLETED|Overall Study||43
346972|NCT00536471|838940|P1|COMPLETED|Overall Study||101
346973|NCT00536471|838937|P4|STARTED|Overall Study||131
346974|NCT00536471|838938|P3|STARTED|Overall Study||261
346975|NCT00536471|838939|P2|STARTED|Overall Study||127
346976|NCT00536471|838940|P1|STARTED|Overall Study||257
346977|NCT00536380|839185|P3|NOT COMPLETED|Overall Study||10
346978|NCT00536380|839186|P2|NOT COMPLETED|Overall Study||9
346979|NCT00536380|839187|P1|NOT COMPLETED|Overall Study||12
346980|NCT00536380|839185|P3|COMPLETED|Overall Study||94
346981|NCT00536380|839186|P2|COMPLETED|Overall Study||95
346982|NCT00536380|839187|P1|COMPLETED|Overall Study||94
346983|NCT00536380|839185|P3|STARTED|Overall Study||104
346984|NCT00536380|839186|P2|STARTED|Overall Study||104
346985|NCT00536380|839187|P1|STARTED|Overall Study||106
346986|NCT00536341|839197|P2|NOT COMPLETED|Overall Study||11
346987|NCT00536341|839198|P1|NOT COMPLETED|Overall Study||5
346988|NCT00536341|839197|P2|COMPLETED|Overall Study||43
346989|NCT00536341|839198|P1|COMPLETED|Overall Study||5
346990|NCT00536341|839197|P2|STARTED|Overall Study||54
346991|NCT00536341|839198|P1|STARTED|Overall Study||10
346992|NCT00536263|839211|P3|NOT COMPLETED|Overall Study||21
346993|NCT00536263|839212|P2|NOT COMPLETED|Overall Study||14
346994|NCT00536263|839213|P1|NOT COMPLETED|Overall Study||11
346995|NCT00536263|839211|P3|COMPLETED|Overall Study||204
346996|NCT00536263|839212|P2|COMPLETED|Overall Study||207
346997|NCT00536263|839213|P1|COMPLETED|Overall Study||214
346998|NCT00536263|839211|P3|STARTED|Overall Study|One (1) participant withdrawn from study for non-compliance.|225
346999|NCT00536263|839212|P2|STARTED|Overall Study||221
347000|NCT00536263|839213|P1|STARTED|Overall Study||225
347001|NCT00536198|839253|P2|NOT COMPLETED|Overall Study||39
347002|NCT00536198|839254|P1|NOT COMPLETED|Overall Study||37
347003|NCT00536198|839253|P2|COMPLETED|Overall Study||88
347004|NCT00536198|839254|P1|COMPLETED|Overall Study||88
347005|NCT00536198|839253|P2|Cycle 6|Overall Study||88
347006|NCT00536198|839254|P1|Cycle 6|Overall Study||88
347007|NCT00536198|839253|P2|Cycle 5|Overall Study||85
347008|NCT00536198|839254|P1|Cycle 5|Overall Study||88
347009|NCT00536198|839253|P2|Cycle 4|Overall Study||98
347010|NCT00536198|839254|P1|Cycle 4|Overall Study||95
347011|NCT00536198|839253|P2|Cycle 3|Overall Study||101
347012|NCT00536198|839254|P1|Cycle 3|Overall Study||100
347013|NCT00536198|839253|P2|Cycle 2|Overall Study||112
347014|NCT00536198|839254|P1|Cycle 2|Overall Study||104
347015|NCT00536198|839253|P2|Cycle 1|Overall Study||123
347016|NCT00536198|839254|P1|Cycle 1|Overall Study||110
347017|NCT00536198|839253|P2|STARTED|Overall Study||127
347018|NCT00536198|839254|P1|STARTED|Overall Study||125
347019|NCT00536172|839284|P2|NOT COMPLETED|Overall Study||9
347020|NCT00536172|839285|P1|NOT COMPLETED|Overall Study||14
347021|NCT00536172|839284|P2|COMPLETED|Overall Study||65
347022|NCT00536172|839285|P1|COMPLETED|Overall Study||60
347023|NCT00536172|839284|P2|STARTED|Overall Study||74
347024|NCT00536172|839285|P1|STARTED|Overall Study||74
347025|NCT00536120|839293|P2|NOT COMPLETED|Overall Study||3
347026|NCT00536120|839294|P1|NOT COMPLETED|Overall Study||6
347027|NCT00536120|839293|P2|COMPLETED|Overall Study||27
347028|NCT00536120|839294|P1|COMPLETED|Overall Study||24
347029|NCT00536120|839293|P2|STARTED|Overall Study||30
347030|NCT00536120|839294|P1|STARTED|Overall Study||30
347031|NCT00536107|839308|P2|NOT COMPLETED|Overall Study||6
347032|NCT00536107|839309|P1|NOT COMPLETED|Overall Study||8
347033|NCT00536107|839308|P2|COMPLETED|Overall Study||0
347034|NCT00536107|839309|P1|COMPLETED|Overall Study||0
347035|NCT00536107|839308|P2|STARTED|Overall Study||6
347036|NCT00536107|839309|P1|STARTED|Overall Study||8
347037|NCT00535938|839319|P2|NOT COMPLETED|Overall Study||462
347038|NCT00535938|839320|P1|NOT COMPLETED|Overall Study||391
347039|NCT00535938|839319|P2|COMPLETED|Overall Study||404
347040|NCT00535938|839320|P1|COMPLETED|Overall Study||115
347041|NCT00535938|839319|P2|STARTED|Overall Study||866
347042|NCT00535938|839320|P1|STARTED|Overall Study||506
347043|NCT00535873|839356|P1|NOT COMPLETED|Overall Study||0
347044|NCT00535873|839356|P1|COMPLETED|Overall Study||60
347045|NCT00535873|839356|P1|STARTED|Overall Study||60
347046|NCT00535847|839363|P3|NOT COMPLETED|Overall Study||2
347047|NCT00535847|839364|P2|NOT COMPLETED|Overall Study||14
347048|NCT00535847|839365|P1|NOT COMPLETED|Overall Study||22
347049|NCT00535847|839363|P3|COMPLETED|Overall Study||0
347050|NCT00535847|839364|P2|COMPLETED|Overall Study||20
347051|NCT00535847|839365|P1|COMPLETED|Overall Study||59
347052|NCT00535847|839363|P3|STARTED|Overall Study||2
347053|NCT00535847|839364|P2|STARTED|Overall Study||34
347054|NCT00535847|839365|P1|STARTED|Overall Study||81
347055|NCT00535821|839391|P2|NOT COMPLETED|Overall Study||0
347056|NCT00535821|839392|P1|NOT COMPLETED|Overall Study||0
347057|NCT00535821|839391|P2|COMPLETED|Overall Study||3
347058|NCT00535821|839392|P1|COMPLETED|Overall Study||2
347059|NCT00535821|839391|P2|STARTED|Overall Study||3
347060|NCT00535821|839392|P1|STARTED|Overall Study||2
347061|NCT00535782|839400|P3|NOT COMPLETED|Part 2: 80-Week Open-label Period||26
347062|NCT00535782|839401|P2|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
347063|NCT00535782|839402|P1|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
347064|NCT00535782|839400|P3|COMPLETED|Part 2: 80-Week Open-label Period||98
347065|NCT00535782|839401|P2|COMPLETED|Part 2: 80-Week Open-label Period||0
347066|NCT00535782|839402|P1|COMPLETED|Part 2: 80-Week Open-label Period||0
347067|NCT00535782|839400|P3|STARTED|Part 2: 80-Week Open-label Period||124
347068|NCT00535782|839401|P2|STARTED|Part 2: 80-Week Open-label Period||0
347069|NCT00535782|839402|P1|STARTED|Part 2: 80-Week Open-label Period||0
347070|NCT00535782|839400|P3|NOT COMPLETED|Part 1: 24-Week Double-blind Period||0
347071|NCT00535782|839401|P2|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
347072|NCT00535782|839402|P1|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
347073|NCT00535782|839400|P3|COMPLETED|Part 1: 24-Week Double-blind Period||0
347074|NCT00535782|839401|P2|COMPLETED|Part 1: 24-Week Double-blind Period||59
347075|NCT00535782|839402|P1|COMPLETED|Part 1: 24-Week Double-blind Period||65
347076|NCT00535782|839400|P3|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
347077|NCT00535782|839401|P2|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||62
347078|NCT00535782|839402|P1|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
347079|NCT00535782|839400|P3|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||0
347080|NCT00535782|839401|P2|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period|1 misrandomized patient received the TCZ in error, and 1 patient received TCZ as rescue therapy.|2
347081|NCT00535782|839402|P1|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||69
347082|NCT00535782|839400|P3|STARTED|Part 1: 24-Week Double-blind Period||0
347083|NCT00535782|839401|P2|STARTED|Part 1: 24-Week Double-blind Period||63
347084|NCT00535782|839402|P1|STARTED|Part 1: 24-Week Double-blind Period||69
347085|NCT00535769|839419|P2|NOT COMPLETED|Overall Study||0
347086|NCT00535769|839420|P1|NOT COMPLETED|Overall Study||0
347087|NCT00535769|839419|P2|COMPLETED|Overall Study||35
347088|NCT00535769|839420|P1|COMPLETED|Overall Study||35
347089|NCT00535769|839419|P2|STARTED|Overall Study||35
347090|NCT00535769|839420|P1|STARTED|Overall Study||35
347091|NCT00535743|839453|P24|NOT COMPLETED|Overall Study||0
347092|NCT00535743|839454|P23|NOT COMPLETED|Overall Study||0
347093|NCT00535743|839455|P22|NOT COMPLETED|Overall Study||1
347094|NCT00535743|839456|P21|NOT COMPLETED|Overall Study||0
347095|NCT00535743|839457|P20|NOT COMPLETED|Overall Study||0
347096|NCT00535743|839458|P19|NOT COMPLETED|Overall Study||0
347097|NCT00535743|839459|P18|NOT COMPLETED|Overall Study||0
347098|NCT00535743|839460|P17|NOT COMPLETED|Overall Study||0
347099|NCT00535743|839461|P16|NOT COMPLETED|Overall Study||0
347100|NCT00535743|839462|P15|NOT COMPLETED|Overall Study||0
347101|NCT00535743|839463|P14|NOT COMPLETED|Overall Study||0
347102|NCT00535743|839464|P13|NOT COMPLETED|Overall Study||0
347103|NCT00535743|839465|P12|NOT COMPLETED|Overall Study||0
347104|NCT00535743|839466|P11|NOT COMPLETED|Overall Study||0
347105|NCT00535743|839467|P10|NOT COMPLETED|Overall Study||1
347106|NCT00535743|839468|P9|NOT COMPLETED|Overall Study||1
347107|NCT00535743|839469|P8|NOT COMPLETED|Overall Study||0
347108|NCT00535743|839470|P7|NOT COMPLETED|Overall Study||0
347109|NCT00535743|839471|P6|NOT COMPLETED|Overall Study||0
347110|NCT00535743|839472|P5|NOT COMPLETED|Overall Study||0
347111|NCT00535743|839473|P4|NOT COMPLETED|Overall Study||0
347112|NCT00535743|839474|P3|NOT COMPLETED|Overall Study||0
347113|NCT00535743|839475|P2|NOT COMPLETED|Overall Study||0
347114|NCT00535743|839476|P1|NOT COMPLETED|Overall Study||0
347115|NCT00535743|839453|P24|COMPLETED|Overall Study||5
347116|NCT00535743|839454|P23|COMPLETED|Overall Study||6
347117|NCT00535743|839455|P22|COMPLETED|Overall Study||4
347118|NCT00535743|839456|P21|COMPLETED|Overall Study||5
347119|NCT00535743|839457|P20|COMPLETED|Overall Study||5
347120|NCT00535743|839458|P19|COMPLETED|Overall Study||3
347121|NCT00535743|839459|P18|COMPLETED|Overall Study||11
347122|NCT00535743|839460|P17|COMPLETED|Overall Study||10
347123|NCT00535743|839461|P16|COMPLETED|Overall Study||13
347124|NCT00535743|839462|P15|COMPLETED|Overall Study||9
347125|NCT00535743|839463|P14|COMPLETED|Overall Study||10
347126|NCT00535743|839464|P13|COMPLETED|Overall Study||5
347127|NCT00535743|839465|P12|COMPLETED|Overall Study||5
347128|NCT00535743|839466|P11|COMPLETED|Overall Study||5
347129|NCT00535743|839467|P10|COMPLETED|Overall Study||4
347130|NCT00535743|839468|P9|COMPLETED|Overall Study||4
347131|NCT00535743|839469|P8|COMPLETED|Overall Study||5
347132|NCT00535743|839470|P7|COMPLETED|Overall Study||3
347133|NCT00535743|839471|P6|COMPLETED|Overall Study||10
347134|NCT00535743|839472|P5|COMPLETED|Overall Study||11
347135|NCT00535743|839473|P4|COMPLETED|Overall Study||11
347136|NCT00535743|839474|P3|COMPLETED|Overall Study||11
347137|NCT00535743|839475|P2|COMPLETED|Overall Study||11
347138|NCT00535743|839476|P1|COMPLETED|Overall Study||5
347139|NCT00535743|839453|P24|Treated|Overall Study||5
347140|NCT00535743|839454|P23|Treated|Overall Study|N=1 (randomized to Arm Q) rec’d 12 mg/kg Sugammadex, 29 min after 1.2 mg/kg Esmeron®|6
347141|NCT00535743|839455|P22|Treated|Overall Study||5
347142|NCT00535743|839456|P21|Treated|Overall Study||5
347143|NCT00535743|839457|P20|Treated|Overall Study||5
347144|NCT00535743|839458|P19|Treated|Overall Study||3
347145|NCT00535743|839459|P18|Treated|Overall Study||11
347146|NCT00535743|839460|P17|Treated|Overall Study||10
347147|NCT00535743|839461|P16|Treated|Overall Study|N=2 (randomized to Arm O) rec’d 8 mg/kg Sugammadex, 3 min after 1.2 mg/kg Esmeron®|13
347148|NCT00535743|839462|P15|Treated|Overall Study||9
347149|NCT00535743|839463|P14|Treated|Overall Study||10
347150|NCT00535743|839464|P13|Treated|Overall Study||5
347151|NCT00535743|839465|P12|Treated|Overall Study||5
347152|NCT00535743|839466|P11|Treated|Overall Study||5
347153|NCT00535743|839467|P10|Treated|Overall Study||5
347154|NCT00535743|839468|P9|Treated|Overall Study||4
347155|NCT00535743|839469|P8|Treated|Overall Study||5
347156|NCT00535743|839470|P7|Treated|Overall Study||3
347157|NCT00535743|839471|P6|Treated|Overall Study||10
347158|NCT00535743|839472|P5|Treated|Overall Study||11
347159|NCT00535743|839473|P4|Treated|Overall Study||11
347160|NCT00535743|839474|P3|Treated|Overall Study||11
347161|NCT00535743|839475|P2|Treated|Overall Study||11
347162|NCT00535743|839476|P1|Treated|Overall Study||5
347163|NCT00535743|839453|P24|STARTED|Overall Study||5
347164|NCT00535743|839454|P23|STARTED|Overall Study|N=5 randomized to Arm W. An additional N=1 (randomized to Arm Q) is counted as Started in Arm W|6
347165|NCT00535743|839455|P22|STARTED|Overall Study||5
347166|NCT00535743|839456|P21|STARTED|Overall Study||5
347167|NCT00535743|839457|P20|STARTED|Overall Study||5
347168|NCT00535743|839458|P19|STARTED|Overall Study||3
347169|NCT00535743|839459|P18|STARTED|Overall Study||11
347170|NCT00535743|839460|P17|STARTED|Overall Study||10
347171|NCT00535743|839461|P16|STARTED|Overall Study|N=11 randomized to Arm P. An additional N=2 (randomized to Arm O) are counted as Started in Arm P|13
347172|NCT00535743|839462|P15|STARTED|Overall Study||9
347173|NCT00535743|839463|P14|STARTED|Overall Study||10
347174|NCT00535743|839464|P13|STARTED|Overall Study||5
347175|NCT00535743|839465|P12|STARTED|Overall Study||5
347176|NCT00535743|839466|P11|STARTED|Overall Study||5
347177|NCT00535743|839467|P10|STARTED|Overall Study||5
347178|NCT00535743|839468|P9|STARTED|Overall Study||5
347179|NCT00535743|839469|P8|STARTED|Overall Study||5
347180|NCT00535743|839470|P7|STARTED|Overall Study||3
347181|NCT00535743|839471|P6|STARTED|Overall Study||10
347182|NCT00535743|839472|P5|STARTED|Overall Study||11
347183|NCT00535743|839473|P4|STARTED|Overall Study||11
347184|NCT00535743|839474|P3|STARTED|Overall Study||11
347185|NCT00535743|839475|P2|STARTED|Overall Study||11
347186|NCT00535743|839476|P1|STARTED|Overall Study||5
347187|NCT00535730|839600|P2|NOT COMPLETED|Overall Study||7
347188|NCT00535730|839601|P1|NOT COMPLETED|Overall Study||2
347189|NCT00535730|839600|P2|COMPLETED|Overall Study||230
347190|NCT00535730|839601|P1|COMPLETED|Overall Study||234
347191|NCT00535730|839600|P2|STARTED|Overall Study|Two subjects were allocated but not vaccinated making the number of subjects vaccinated 235|237
347192|NCT00535730|839601|P1|STARTED|Overall Study||236
347193|NCT00535652|839618|P1|NOT COMPLETED|Overall Study||3
347194|NCT00535652|839618|P1|COMPLETED|Overall Study||20
347195|NCT00535652|839618|P1|STARTED|Overall Study||23
347196|NCT00535626|839622|P1|NOT COMPLETED|Overall Study||105
347197|NCT00535626|839622|P1|COMPLETED|Overall Study||85
347198|NCT00535626|839622|P1|STARTED|Overall Study||190
347199|NCT00535613|839634|P2|NOT COMPLETED|Overall Study||0
347200|NCT00535613|839635|P1|NOT COMPLETED|Overall Study||0
347201|NCT00535613|839634|P2|COMPLETED|Overall Study||50
347202|NCT00535613|839635|P1|COMPLETED|Overall Study||49
347203|NCT00535613|839634|P2|STARTED|Overall Study||50
347204|NCT00535613|839635|P1|STARTED|Overall Study||49
347205|NCT00535587|839649|P4|NOT COMPLETED|Overall Study||13
347206|NCT00535587|839650|P3|NOT COMPLETED|Overall Study||8
347207|NCT00535587|839651|P2|NOT COMPLETED|Overall Study||11
347208|NCT00535587|839652|P1|NOT COMPLETED|Overall Study||10
347209|NCT00535587|839649|P4|COMPLETED|Overall Study||41
347210|NCT00535587|839650|P3|COMPLETED|Overall Study||39
347211|NCT00535587|839651|P2|COMPLETED|Overall Study||42
347212|NCT00535587|839652|P1|COMPLETED|Overall Study||43
347213|NCT00535587|839649|P4|STARTED|Overall Study||54
347214|NCT00535587|839650|P3|STARTED|Overall Study||47
347215|NCT00535587|839651|P2|STARTED|Overall Study||53
347216|NCT00535587|839652|P1|STARTED|Overall Study||53
347217|NCT00535496|839662|P4|NOT COMPLETED|Overall Study||0
347218|NCT00535496|839663|P3|NOT COMPLETED|Overall Study||0
347219|NCT00535496|839664|P2|NOT COMPLETED|Overall Study||2
347220|NCT00535496|839665|P1|NOT COMPLETED|Overall Study||0
347221|NCT00535496|839662|P4|COMPLETED|Overall Study||31
347222|NCT00535496|839663|P3|COMPLETED|Overall Study||30
347223|NCT00535496|839664|P2|COMPLETED|Overall Study||13
347224|NCT00535496|839665|P1|COMPLETED|Overall Study||15
347225|NCT00535496|839662|P4|All-Subjects-Treated (AST) Group|Overall Study||31
347226|NCT00535496|839663|P3|All-Subjects-Treated (AST) Group|Overall Study||30
347227|NCT00535496|839664|P2|All-Subjects-Treated (AST) Group|Overall Study||14
347228|NCT00535496|839665|P1|All-Subjects-Treated (AST) Group|Overall Study||15
347229|NCT00535496|839662|P4|STARTED|Overall Study||31
347230|NCT00535496|839663|P3|STARTED|Overall Study||30
347231|NCT00535496|839664|P2|STARTED|Overall Study||15
347232|NCT00535496|839665|P1|STARTED|Overall Study||15
347233|NCT00535405|839685|P5|NOT COMPLETED|Overall Study||16
347234|NCT00535405|839686|P4|NOT COMPLETED|Overall Study||22
347235|NCT00535405|839687|P3|NOT COMPLETED|Overall Study||18
347236|NCT00535405|839688|P2|NOT COMPLETED|Overall Study||26
347237|NCT00535405|839689|P1|NOT COMPLETED|Overall Study||17
347238|NCT00535405|839685|P5|COMPLETED|Overall Study||241
347239|NCT00535405|839686|P4|COMPLETED|Overall Study||235
347240|NCT00535405|839687|P3|COMPLETED|Overall Study||241
347241|NCT00535405|839688|P2|COMPLETED|Overall Study||233
347242|NCT00535405|839689|P1|COMPLETED|Overall Study||240
347243|NCT00535405|839685|P5|STARTED|Overall Study||257
347244|NCT00535405|839686|P4|STARTED|Overall Study||257
347245|NCT00535405|839687|P3|STARTED|Overall Study||259
347246|NCT00535405|839688|P2|STARTED|Overall Study||259
347247|NCT00535405|839689|P1|STARTED|Overall Study||257
347248|NCT00535392|839726|P1|NOT COMPLETED|Overall Study||0
347249|NCT00535392|839726|P1|COMPLETED|Overall Study||33
347250|NCT00535392|839726|P1|STARTED|Overall Study||33
347251|NCT00535301|839734|P2|NOT COMPLETED|Overall Study||5
347252|NCT00535301|839735|P1|NOT COMPLETED|Overall Study||5
347253|NCT00535301|839734|P2|COMPLETED|Overall Study||33
347254|NCT00535301|839735|P1|COMPLETED|Overall Study||33
347255|NCT00535301|839734|P2|STARTED|Overall Study||38
347256|NCT00535301|839735|P1|STARTED|Overall Study||38
347257|NCT00535288|839750|P5|NOT COMPLETED|Overall Study||42
347258|NCT00535288|839751|P4|NOT COMPLETED|Overall Study||29
347259|NCT00535288|839752|P3|NOT COMPLETED|Overall Study||33
347260|NCT00535288|839753|P2|NOT COMPLETED|Overall Study||32
347261|NCT00535288|839754|P1|NOT COMPLETED|Overall Study||54
347262|NCT00535288|839750|P5|COMPLETED|Overall Study||116
347263|NCT00535288|839751|P4|COMPLETED|Overall Study||122
347264|NCT00535288|839752|P3|COMPLETED|Overall Study||127
347265|NCT00535288|839753|P2|COMPLETED|Overall Study||130
347266|NCT00535288|839754|P1|COMPLETED|Overall Study||260
347267|NCT00535288|839750|P5|STARTED|Overall Study|One participant randomized to receive placebo received esmirtazapine 18 mg.|158
347268|NCT00535288|839751|P4|STARTED|Overall Study||151
347269|NCT00535288|839752|P3|STARTED|Overall Study||160
347270|NCT00535288|839753|P2|STARTED|Overall Study||162
347271|NCT00535288|839754|P1|STARTED|Overall Study|2 participants randomized to receive placebo did not receive placebo|314
347272|NCT00535262|839831|P1|NOT COMPLETED|Overall Study||3
347273|NCT00535262|839831|P1|COMPLETED|Overall Study|Pharmaceutical company withdrew supply of EmSam prematurely before protocol was complete.|0
347274|NCT00535262|839831|P1|STARTED|Overall Study|3 patients were enrolled in the study. Data was collected for only two weeks before funding expired.|3
347275|NCT00535236|839845|P10|NOT COMPLETED|Overall Study||4
347276|NCT00535236|839846|P9|NOT COMPLETED|Overall Study||13
347277|NCT00535236|839847|P8|NOT COMPLETED|Overall Study||1
347278|NCT00535236|839848|P7|NOT COMPLETED|Overall Study||11
347279|NCT00535236|839849|P6|NOT COMPLETED|Overall Study||1
347280|NCT00535236|839850|P5|NOT COMPLETED|Overall Study||12
347281|NCT00535236|839851|P4|NOT COMPLETED|Overall Study||4
347282|NCT00535236|839852|P3|NOT COMPLETED|Overall Study||12
347283|NCT00535236|839853|P2|NOT COMPLETED|Overall Study||2
347284|NCT00535236|839854|P1|NOT COMPLETED|Overall Study||7
347285|NCT00535236|839845|P10|COMPLETED|Overall Study||16
347286|NCT00535236|839846|P9|COMPLETED|Overall Study||47
347287|NCT00535236|839847|P8|COMPLETED|Overall Study||18
347288|NCT00535236|839848|P7|COMPLETED|Overall Study||51
347289|NCT00535236|839849|P6|COMPLETED|Overall Study||19
347290|NCT00535236|839850|P5|COMPLETED|Overall Study||47
347291|NCT00535236|839851|P4|COMPLETED|Overall Study||6
347292|NCT00535236|839852|P3|COMPLETED|Overall Study||29
347293|NCT00535236|839853|P2|COMPLETED|Overall Study||8
347294|NCT00535236|839854|P1|COMPLETED|Overall Study||33
347295|NCT00535236|839845|P10|Vaccination 4|Overall Study||17
347296|NCT00535236|839846|P9|Vaccination 4|Overall Study||50
347297|NCT00535236|839847|P8|Vaccination 4|Overall Study||18
347298|NCT00535236|839848|P7|Vaccination 4|Overall Study||51
347299|NCT00535236|839849|P6|Vaccination 4|Overall Study||19
347300|NCT00535236|839850|P5|Vaccination 4|Overall Study||47
347301|NCT00535236|839851|P4|Vaccination 4|Overall Study||6
347302|NCT00535236|839852|P3|Vaccination 4|Overall Study||32
347303|NCT00535236|839853|P2|Vaccination 4|Overall Study||10
347304|NCT00535236|839854|P1|Vaccination 4|Overall Study||34
347305|NCT00535236|839845|P10|Vaccination 3|Overall Study||18
347306|NCT00535236|839846|P9|Vaccination 3|Overall Study||53
347307|NCT00535236|839847|P8|Vaccination 3|Overall Study||18
347308|NCT00535236|839848|P7|Vaccination 3|Overall Study||51
347309|NCT00535236|839849|P6|Vaccination 3|Overall Study||19
347310|NCT00535236|839850|P5|Vaccination 3|Overall Study||48
347311|NCT00535236|839851|P4|Vaccination 3|Overall Study||8
347312|NCT00535236|839852|P3|Vaccination 3|Overall Study||35
347313|NCT00535236|839853|P2|Vaccination 3|Overall Study||10
347314|NCT00535236|839854|P1|Vaccination 3|Overall Study||34
347315|NCT00535236|839845|P10|Vaccination 2|Overall Study||19
347316|NCT00535236|839846|P9|Vaccination 2|Overall Study||57
347317|NCT00535236|839847|P8|Vaccination 2|Overall Study||19
347318|NCT00535236|839848|P7|Vaccination 2|Overall Study||58
347319|NCT00535236|839849|P6|Vaccination 2|Overall Study||19
347320|NCT00535236|839850|P5|Vaccination 2|Overall Study||52
347321|NCT00535236|839851|P4|Vaccination 2|Overall Study||8
347322|NCT00535236|839852|P3|Vaccination 2|Overall Study||37
347323|NCT00535236|839853|P2|Vaccination 2|Overall Study||10
347324|NCT00535236|839854|P1|Vaccination 2|Overall Study||35
347325|NCT00535236|839845|P10|Vaccination 1|Overall Study||20
347326|NCT00535236|839846|P9|Vaccination 1|Overall Study||60
347327|NCT00535236|839847|P8|Vaccination 1|Overall Study||19
347328|NCT00535236|839848|P7|Vaccination 1|Overall Study||61
347329|NCT00535236|839849|P6|Vaccination 1|Overall Study||19
347330|NCT00535236|839850|P5|Vaccination 1|Overall Study||58
347331|NCT00535236|839851|P4|Vaccination 1|Overall Study||10
347332|NCT00535236|839852|P3|Vaccination 1|Overall Study||40
347333|NCT00535236|839853|P2|Vaccination 1|Overall Study||10
347334|NCT00535236|839854|P1|Vaccination 1|Overall Study||40
347335|NCT00535236|839845|P10|STARTED|Overall Study||20
347336|NCT00535236|839846|P9|STARTED|Overall Study||60
347337|NCT00535236|839847|P8|STARTED|Overall Study||19
347338|NCT00535236|839848|P7|STARTED|Overall Study||62
347339|NCT00535236|839849|P6|STARTED|Overall Study||20
347340|NCT00535236|839850|P5|STARTED|Overall Study||59
347341|NCT00535236|839851|P4|STARTED|Overall Study||10
347342|NCT00535236|839852|P3|STARTED|Overall Study||41
347343|NCT00535236|839853|P2|STARTED|Overall Study||10
347344|NCT00535236|839854|P1|STARTED|Overall Study||40
347345|NCT00535223|839914|P2|NOT COMPLETED|Overall Study||1
347346|NCT00535223|839915|P1|NOT COMPLETED|Overall Study||4
347347|NCT00535223|839914|P2|COMPLETED|Overall Study||39
347348|NCT00535223|839915|P1|COMPLETED|Overall Study||37
347349|NCT00535223|839914|P2|STARTED|Overall Study|Patients were randomized in cohorts of ten.|40
347350|NCT00535223|839915|P1|STARTED|Overall Study|Patients were randomized in cohorts of ten.|41
347351|NCT00535145|839923|P1|NOT COMPLETED|Phase II||15
347352|NCT00535145|839923|P1|COMPLETED|Phase II||69
347353|NCT00535145|839923|P1|STARTED|Phase II|Of the 85 participants who completed Phase 1, 84 met the criteria to enroll into Phase 2|84
347354|NCT00535145|839923|P1|NOT COMPLETED|Phase I||29
347355|NCT00535145|839923|P1|COMPLETED|Phase I||85
347356|NCT00535145|839923|P1|STARTED|Phase I||114
347357|NCT00535132|839935|P2|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
347358|NCT00535132|839936|P1|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
347359|NCT00535132|839935|P2|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|96
347360|NCT00535132|839936|P1|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|95
347361|NCT00535132|839935|P2|STARTED|Intent-to-Treat (ITT) Analysis Set||99
347362|NCT00535132|839936|P1|STARTED|Intent-to-Treat (ITT) Analysis Set||98
347363|NCT00535132|839935|P2|NOT COMPLETED|Safety Analysis Set||2
347364|NCT00535132|839936|P1|NOT COMPLETED|Safety Analysis Set||2
347365|NCT00535132|839935|P2|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|99
347366|NCT00535132|839936|P1|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|98
347367|NCT00535132|839935|P2|STARTED|Safety Analysis Set||101
347368|NCT00535132|839936|P1|STARTED|Safety Analysis Set||100
347369|NCT00535132|839935|P2|NOT COMPLETED|Randomized Population||0
347370|NCT00535132|839936|P1|NOT COMPLETED|Randomized Population||0
347371|NCT00535132|839935|P2|COMPLETED|Randomized Population||101
347372|NCT00535132|839936|P1|COMPLETED|Randomized Population||100
347373|NCT00535132|839935|P2|STARTED|Randomized Population|Number of Subjects Randomized|101
347374|NCT00535132|839936|P1|STARTED|Randomized Population|Number of Subjects Randomized|100
347375|NCT00535002|839994|P8|NOT COMPLETED|Overall Study||0
347376|NCT00535002|839995|P7|NOT COMPLETED|Overall Study||0
347377|NCT00535002|839996|P6|NOT COMPLETED|Overall Study||0
347378|NCT00535002|839997|P5|NOT COMPLETED|Overall Study||0
347379|NCT00535002|839998|P4|NOT COMPLETED|Overall Study||0
347380|NCT00535002|839999|P3|NOT COMPLETED|Overall Study||0
347381|NCT00535002|840000|P2|NOT COMPLETED|Overall Study||0
347382|NCT00535002|840001|P1|NOT COMPLETED|Overall Study||0
347383|NCT00535002|839994|P8|COMPLETED|Overall Study||16
347384|NCT00535002|839995|P7|COMPLETED|Overall Study||12
347385|NCT00535002|839996|P6|COMPLETED|Overall Study||17
347386|NCT00535002|839997|P5|COMPLETED|Overall Study||9
347387|NCT00535002|839998|P4|COMPLETED|Overall Study||14
347388|NCT00535002|839999|P3|COMPLETED|Overall Study||13
347389|NCT00535002|840000|P2|COMPLETED|Overall Study||12
347390|NCT00535002|840001|P1|COMPLETED|Overall Study||19
347391|NCT00535002|839994|P8|STARTED|Overall Study||16
347392|NCT00535002|839995|P7|STARTED|Overall Study||12
347393|NCT00535002|839996|P6|STARTED|Overall Study||17
347394|NCT00535002|839997|P5|STARTED|Overall Study||9
347395|NCT00535002|839998|P4|STARTED|Overall Study||14
347396|NCT00535002|839999|P3|STARTED|Overall Study||13
347397|NCT00535002|840000|P2|STARTED|Overall Study||12
347398|NCT00535002|840001|P1|STARTED|Overall Study||19
347399|NCT00534976|840017|P2|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||0
347400|NCT00534976|840018|P1|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||2
347401|NCT00534976|840017|P2|COMPLETED|Period 3: Crossover Placebo/ Montelukast||32
347402|NCT00534976|840018|P1|COMPLETED|Period 3: Crossover Placebo/ Montelukast||31
347403|NCT00534976|840017|P2|STARTED|Period 3: Crossover Placebo/ Montelukast||32
347404|NCT00534976|840018|P1|STARTED|Period 3: Crossover Placebo/ Montelukast||33
347405|NCT00534976|840017|P2|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||1
347406|NCT00534976|840018|P1|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||0
347407|NCT00534976|840017|P2|COMPLETED|Period 2: Treatment Montelukast/ Placebo||32
347408|NCT00534976|840018|P1|COMPLETED|Period 2: Treatment Montelukast/ Placebo||33
347409|NCT00534976|840017|P2|STARTED|Period 2: Treatment Montelukast/ Placebo||33
347410|NCT00534976|840018|P1|STARTED|Period 2: Treatment Montelukast/ Placebo||33
347411|NCT00534976|840017|P2|NOT COMPLETED|Period 1: Placebo Run-in||0
347412|NCT00534976|840018|P1|NOT COMPLETED|Period 1: Placebo Run-in||0
347413|NCT00534976|840017|P2|COMPLETED|Period 1: Placebo Run-in||33
347414|NCT00534976|840018|P1|COMPLETED|Period 1: Placebo Run-in||33
347415|NCT00534976|840017|P2|STARTED|Period 1: Placebo Run-in||33
347416|NCT00534976|840018|P1|STARTED|Period 1: Placebo Run-in||33
347417|NCT00534937|840040|P2|NOT COMPLETED|Overall Study||12
347418|NCT00534937|840041|P1|NOT COMPLETED|Overall Study||8
347419|NCT00534937|840040|P2|COMPLETED|Overall Study||35
347420|NCT00534937|840041|P1|COMPLETED|Overall Study||34
347421|NCT00534937|840040|P2|STARTED|Overall Study||47
347422|NCT00534937|840041|P1|STARTED|Overall Study||42
347423|NCT00534833|840055|P2|NOT COMPLETED|Overall Study||0
347424|NCT00534833|840056|P1|NOT COMPLETED|Overall Study||0
347425|NCT00534833|840055|P2|COMPLETED|Overall Study||180
347426|NCT00534833|840056|P1|COMPLETED|Overall Study||182
347427|NCT00534833|840055|P2|STARTED|Overall Study||180
347428|NCT00534833|840056|P1|STARTED|Overall Study||182
347429|NCT00534794|840068|P2|NOT COMPLETED|Overall Study||0
347430|NCT00534794|840069|P1|NOT COMPLETED|Overall Study||0
347431|NCT00534794|840068|P2|COMPLETED|Overall Study||39
347432|NCT00534794|840069|P1|COMPLETED|Overall Study||40
347433|NCT00534794|840068|P2|STARTED|Overall Study||39
347434|NCT00534794|840069|P1|STARTED|Overall Study||40
347435|NCT00534638|840079|P2|NOT COMPLETED|Overall Study||11791
347436|NCT00534638|840080|P1|NOT COMPLETED|Overall Study||6491
347437|NCT00534638|840079|P2|COMPLETED|Overall Study||5547
347438|NCT00534638|840080|P1|COMPLETED|Overall Study||8346
347439|NCT00534638|840079|P2|STARTED|Overall Study||17338
347440|NCT00534638|840080|P1|STARTED|Overall Study||14837
347441|NCT00534599|840118|P2|NOT COMPLETED|Overall Study||32
347442|NCT00534599|840119|P1|NOT COMPLETED|Overall Study||57
347443|NCT00534599|840118|P2|COMPLETED|Overall Study||168
347444|NCT00534599|840119|P1|COMPLETED|Overall Study||152
347445|NCT00534599|840118|P2|STARTED|Overall Study|Randomized|200
347446|NCT00534599|840119|P1|STARTED|Overall Study|Randomized|209
347447|NCT00534495|840155|P3|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||11
347448|NCT00534495|840156|P2|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
347449|NCT00534495|840157|P1|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
347450|NCT00534495|840155|P3|COMPLETED|Long Term Ext. Phase Week 24-month 21||29
347451|NCT00534495|840156|P2|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
347452|NCT00534495|840157|P1|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
347453|NCT00534495|840155|P3|STARTED|Long Term Ext. Phase Week 24-month 21||40
347454|NCT00534495|840156|P2|STARTED|Long Term Ext. Phase Week 24-month 21||0
347455|NCT00534495|840157|P1|STARTED|Long Term Ext. Phase Week 24-month 21||0
347456|NCT00534495|840155|P3|NOT COMPLETED|All Active Treatment Phase Week 4-24||0
347457|NCT00534495|840156|P2|NOT COMPLETED|All Active Treatment Phase Week 4-24||9
347458|NCT00534495|840157|P1|NOT COMPLETED|All Active Treatment Phase Week 4-24||4
347459|NCT00534495|840155|P3|COMPLETED|All Active Treatment Phase Week 4-24||0
347460|NCT00534495|840156|P2|COMPLETED|All Active Treatment Phase Week 4-24||25
347461|NCT00534495|840157|P1|COMPLETED|All Active Treatment Phase Week 4-24||32
347462|NCT00534495|840155|P3|STARTED|All Active Treatment Phase Week 4-24||0
347463|NCT00534495|840156|P2|STARTED|All Active Treatment Phase Week 4-24||34
347464|NCT00534495|840157|P1|STARTED|All Active Treatment Phase Week 4-24||36
347465|NCT00534495|840155|P3|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
347466|NCT00534495|840156|P2|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||1
347467|NCT00534495|840157|P1|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
347468|NCT00534495|840155|P3|COMPLETED|Double Blind Placebo Phase Week 0-4||0
347469|NCT00534495|840156|P2|COMPLETED|Double Blind Placebo Phase Week 0-4||34
347470|NCT00534495|840157|P1|COMPLETED|Double Blind Placebo Phase Week 0-4||36
347471|NCT00534495|840155|P3|STARTED|Double Blind Placebo Phase Week 0-4||0
347472|NCT00534495|840156|P2|STARTED|Double Blind Placebo Phase Week 0-4||35
347473|NCT00534495|840157|P1|STARTED|Double Blind Placebo Phase Week 0-4||36
347474|NCT00534417|840180|P1|NOT COMPLETED|Overall Study||0
347475|NCT00534417|840180|P1|COMPLETED|Overall Study||41
347476|NCT00534417|840180|P1|STARTED|Overall Study||41
347477|NCT00534404|840195|P3|NOT COMPLETED|Overall Study||242
347478|NCT00534404|840196|P2|NOT COMPLETED|Overall Study||143
347479|NCT00534404|840197|P1|NOT COMPLETED|Overall Study||180
347480|NCT00534404|840195|P3|COMPLETED|Overall Study||586
347481|NCT00534404|840196|P2|COMPLETED|Overall Study||687
347482|NCT00534404|840197|P1|COMPLETED|Overall Study||647
347483|NCT00534404|840195|P3|3-month Follow up Completed|Overall Study||593
347484|NCT00534404|840196|P2|3-month Follow up Completed|Overall Study||731
347485|NCT00534404|840197|P1|3-month Follow up Completed|Overall Study||682
347486|NCT00534404|840195|P3|1-month Follow up Completed|Overall Study||626
347487|NCT00534404|840196|P2|1-month Follow up Completed|Overall Study||781
347488|NCT00534404|840197|P1|1-month Follow up Completed|Overall Study||742
347489|NCT00534404|840195|P3|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
347490|NCT00534404|840196|P2|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
347491|NCT00534404|840197|P1|Completed at Least 1 Counseling Call|Overall Study||813
347492|NCT00534404|840195|P3|Completed Second NRT Order|Overall Study|NRT not available for this arm.|0
347493|NCT00534404|840196|P2|Completed Second NRT Order|Overall Study||789
347494|NCT00534404|840197|P1|Completed Second NRT Order|Overall Study||640
347495|NCT00534404|840195|P3|Completed First NRT Order|Overall Study|NRT was not available for this arm|0
347496|NCT00534404|840196|P2|Completed First NRT Order|Overall Study|Participants could order NRT without completing a web session|821
347497|NCT00534404|840197|P1|Completed First NRT Order|Overall Study||765
347498|NCT00534404|840195|P3|Completed at Least 1 Online Session|Overall Study||658
347499|NCT00534404|840196|P2|Completed at Least 1 Online Session|Overall Study||813
347500|NCT00534404|840197|P1|Completed at Least 1 Online Session|Overall Study||781
347501|NCT00534404|840195|P3|STARTED|Overall Study||828
347502|NCT00534404|840196|P2|STARTED|Overall Study||830
347503|NCT00534404|840197|P1|STARTED|Overall Study||827
347504|NCT00534365|840213|P2|NOT COMPLETED|Overall Study||7
347505|NCT00534365|840214|P1|NOT COMPLETED|Overall Study||0
347506|NCT00534365|840213|P2|COMPLETED|Overall Study||129
347507|NCT00534365|840214|P1|COMPLETED|Overall Study||127
347508|NCT00534365|840213|P2|Included in Intent to Treat Analysis|Overall Study||136
347509|NCT00534365|840214|P1|Included in Intent to Treat Analysis|Overall Study||127
347510|NCT00534365|840213|P2|Follow up at 12 Months or More|Overall Study||128
347511|NCT00534365|840214|P1|Follow up at 12 Months or More|Overall Study||119
347512|NCT00534365|840213|P2|Any Follow up|Overall Study||135
347513|NCT00534365|840214|P1|Any Follow up|Overall Study||126
347514|NCT00534365|840213|P2|Received Procedure|Overall Study|7 patients excluded due to receipt of sling other than mini-sling|129
347515|NCT00534365|840214|P1|Received Procedure|Overall Study||127
347516|NCT00534365|840213|P2|STARTED|Overall Study||136
347517|NCT00534365|840214|P1|STARTED|Overall Study||127
347518|NCT00534352|840228|P1|NOT COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||4
347519|NCT00534352|840228|P1|COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||14
347520|NCT00534352|840228|P1|STARTED|Optional Extension: DRV/Rtv + TDF/FTC||18
347521|NCT00534352|840228|P1|NOT COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||1
347522|NCT00534352|840228|P1|COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||20
347523|NCT00534352|840228|P1|STARTED|Treatment C: DRV/Rtv + TDF/FTC||21
347524|NCT00534352|840228|P1|NOT COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||0
347525|NCT00534352|840228|P1|COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
347526|NCT00534352|840228|P1|STARTED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
347527|NCT00534352|840228|P1|NOT COMPLETED|Treatment A: TMC125 + TDF/FTC||2
347528|NCT00534352|840228|P1|COMPLETED|Treatment A: TMC125 + TDF/FTC||21
347529|NCT00534352|840228|P1|STARTED|Treatment A: TMC125 + TDF/FTC||23
347530|NCT00534313|840272|P4|NOT COMPLETED|Long-term Period||33
347531|NCT00534313|840273|P3|NOT COMPLETED|Long-term Period||43
347532|NCT00534313|840274|P2|NOT COMPLETED|Long-term Period||34
347533|NCT00534313|840275|P1|NOT COMPLETED|Long-term Period||37
347534|NCT00534313|840272|P4|COMPLETED|Long-term Period||0
347535|NCT00534313|840273|P3|COMPLETED|Long-term Period||0
347536|NCT00534313|840274|P2|COMPLETED|Long-term Period||0
347537|NCT00534313|840275|P1|COMPLETED|Long-term Period||0
347538|NCT00534313|840272|P4|STARTED|Long-term Period||33
347539|NCT00534313|840273|P3|STARTED|Long-term Period||43
347540|NCT00534313|840274|P2|STARTED|Long-term Period||34
347541|NCT00534313|840275|P1|STARTED|Long-term Period||37
347542|NCT00534313|840272|P4|NOT COMPLETED|Short-term Period||9
347543|NCT00534313|840273|P3|NOT COMPLETED|Short-term Period||2
347544|NCT00534313|840274|P2|NOT COMPLETED|Short-term Period||6
347545|NCT00534313|840275|P1|NOT COMPLETED|Short-term Period||6
347546|NCT00534313|840272|P4|COMPLETED|Short-term Period|Completed the short-term study|33
347547|NCT00534313|840273|P3|COMPLETED|Short-term Period|Completed the short-term study|43
347548|NCT00534313|840274|P2|COMPLETED|Short-term Period|Completed the short-term study|34
347549|NCT00534313|840275|P1|COMPLETED|Short-term Period|Completed the short-term study|37
347550|NCT00534313|840272|P4|STARTED|Short-term Period||42
347551|NCT00534313|840273|P3|STARTED|Short-term Period||45
347552|NCT00534313|840274|P2|STARTED|Short-term Period||40
347553|NCT00534313|840275|P1|STARTED|Short-term Period||43
347554|NCT00534248|840370|P2|NOT COMPLETED|Overall Study||673
347555|NCT00534248|840371|P1|NOT COMPLETED|Overall Study||661
347556|NCT00534248|840370|P2|COMPLETED|Overall Study||10555
347557|NCT00534248|840371|P1|COMPLETED|Overall Study||10550
347558|NCT00534248|840370|P2|VACCINATED|Overall Study||11210
347559|NCT00534248|840371|P1|VACCINATED|Overall Study||11186
347560|NCT00534248|840370|P2|STARTED|Overall Study||11228
347561|NCT00534248|840371|P1|STARTED|Overall Study||11211
347562|NCT00534235|840383|P2|NOT COMPLETED|Overall Study||23
347563|NCT00534235|840384|P1|NOT COMPLETED|Overall Study||16
347564|NCT00534235|840383|P2|COMPLETED|Overall Study||192
347565|NCT00534235|840384|P1|COMPLETED|Overall Study||91
347566|NCT00534235|840383|P2|STARTED|Overall Study||215
347567|NCT00534235|840384|P1|STARTED|Overall Study||107
347568|NCT00534209|840508|P1|NOT COMPLETED|Overall Study||0
347569|NCT00534209|840508|P1|COMPLETED|Overall Study||1
347570|NCT00534209|840508|P1|STARTED|Overall Study||1
347571|NCT00534105|840528|P2|NOT COMPLETED|Overall Study||39
347572|NCT00534105|840529|P1|NOT COMPLETED|Overall Study||23
347573|NCT00534105|840528|P2|COMPLETED|Overall Study||20
347574|NCT00534105|840529|P1|COMPLETED|Overall Study||24
347575|NCT00534105|840528|P2|STARTED|Overall Study||59
347576|NCT00534105|840529|P1|STARTED|Overall Study||47
347577|NCT00534092|840543|P2|NOT COMPLETED|Overall Study||0
347578|NCT00534092|840544|P1|NOT COMPLETED|Overall Study||2
347579|NCT00534092|840543|P2|COMPLETED|Overall Study||14
347580|NCT00534092|840544|P1|COMPLETED|Overall Study||53
347581|NCT00534092|840543|P2|STARTED|Overall Study||14
347582|NCT00534092|840544|P1|STARTED|Overall Study||55
347583|NCT00534001|840569|P2|NOT COMPLETED|Overall Study||4
347584|NCT00534001|840570|P1|NOT COMPLETED|Overall Study||5
347585|NCT00534001|840569|P2|COMPLETED|Overall Study||43
347586|NCT00534001|840570|P1|COMPLETED|Overall Study||43
347587|NCT00534001|840569|P2|STARTED|Overall Study||47
347588|NCT00534001|840570|P1|STARTED|Overall Study||48
347589|NCT00533949|840582|P4|NOT COMPLETED|Overall Study||10
347590|NCT00533949|840583|P3|NOT COMPLETED|Overall Study||10
347591|NCT00533949|840584|P2|NOT COMPLETED|Overall Study||14
347592|NCT00533949|840585|P1|NOT COMPLETED|Overall Study||15
347593|NCT00533949|840582|P4|COMPLETED|Overall Study||100
347594|NCT00533949|840583|P3|COMPLETED|Overall Study||137
347595|NCT00533949|840584|P2|COMPLETED|Overall Study||107
347596|NCT00533949|840585|P1|COMPLETED|Overall Study||151
347597|NCT00533949|840582|P4|STARTED|Overall Study||110
347598|NCT00533949|840583|P3|STARTED|Overall Study||147
347599|NCT00533949|840584|P2|STARTED|Overall Study||121
347600|NCT00533949|840585|P1|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|166
347601|NCT00533897|840626|P8|NOT COMPLETED|Long Term Extension (LTE)||25
347602|NCT00533897|840627|P7|NOT COMPLETED|Long Term Extension (LTE)||13
347603|NCT00533897|840628|P6|NOT COMPLETED|Long Term Extension (LTE)||0
347604|NCT00533897|840629|P5|NOT COMPLETED|Long Term Extension (LTE)||0
347605|NCT00533897|840630|P4|NOT COMPLETED|Long Term Extension (LTE)||0
347606|NCT00533897|840631|P3|NOT COMPLETED|Long Term Extension (LTE)||0
347607|NCT00533897|840632|P2|NOT COMPLETED|Long Term Extension (LTE)||0
347608|NCT00533897|840633|P1|NOT COMPLETED|Long Term Extension (LTE)||0
347609|NCT00533897|840626|P8|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|88
347610|NCT00533897|840627|P7|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|24
347611|NCT00533897|840628|P6|COMPLETED|Long Term Extension (LTE)||0
347612|NCT00533897|840629|P5|COMPLETED|Long Term Extension (LTE)||0
347613|NCT00533897|840630|P4|COMPLETED|Long Term Extension (LTE)||0
347614|NCT00533897|840631|P3|COMPLETED|Long Term Extension (LTE)||0
347615|NCT00533897|840632|P2|COMPLETED|Long Term Extension (LTE)||0
347616|NCT00533897|840633|P1|COMPLETED|Long Term Extension (LTE)||0
347617|NCT00533897|840626|P8|STARTED|Long Term Extension (LTE)|117 completed RI but 4 did not enter LTE: 1 lack of efficacy and 3 had their site closed.|113
347618|NCT00533897|840627|P7|STARTED|Long Term Extension (LTE)|37 non-responders in Lead-In entered the LTE directly and didn't participate in DBW or RI Periods.|37
347619|NCT00533897|840628|P6|STARTED|Long Term Extension (LTE)||0
347620|NCT00533897|840629|P5|STARTED|Long Term Extension (LTE)||0
347621|NCT00533897|840630|P4|STARTED|Long Term Extension (LTE)||0
347622|NCT00533897|840631|P3|STARTED|Long Term Extension (LTE)||0
347623|NCT00533897|840632|P2|STARTED|Long Term Extension (LTE)||0
347624|NCT00533897|840633|P1|STARTED|Long Term Extension (LTE)||0
347625|NCT00533897|840626|P8|NOT COMPLETED|Re-introduction (RI) Period 3||0
347626|NCT00533897|840627|P7|NOT COMPLETED|Re-introduction (RI) Period 3||0
347627|NCT00533897|840628|P6|NOT COMPLETED|Re-introduction (RI) Period 3||2
347628|NCT00533897|840629|P5|NOT COMPLETED|Re-introduction (RI) Period 3||0
347629|NCT00533897|840630|P4|NOT COMPLETED|Re-introduction (RI) Period 3||0
347630|NCT00533897|840631|P3|NOT COMPLETED|Re-introduction (RI) Period 3||0
347631|NCT00533897|840632|P2|NOT COMPLETED|Re-introduction (RI) Period 3||0
347632|NCT00533897|840633|P1|NOT COMPLETED|Re-introduction (RI) Period 3||0
347633|NCT00533897|840626|P8|COMPLETED|Re-introduction (RI) Period 3||0
347634|NCT00533897|840627|P7|COMPLETED|Re-introduction (RI) Period 3||0
347635|NCT00533897|840628|P6|COMPLETED|Re-introduction (RI) Period 3||42
347636|NCT00533897|840629|P5|COMPLETED|Re-introduction (RI) Period 3||35
347637|NCT00533897|840630|P4|COMPLETED|Re-introduction (RI) Period 3||40
347638|NCT00533897|840631|P3|COMPLETED|Re-introduction (RI) Period 3||0
347639|NCT00533897|840632|P2|COMPLETED|Re-introduction (RI) Period 3||0
347640|NCT00533897|840633|P1|COMPLETED|Re-introduction (RI) Period 3||0
347641|NCT00533897|840626|P8|STARTED|Re-introduction (RI) Period 3||0
347642|NCT00533897|840627|P7|STARTED|Re-introduction (RI) Period 3||0
347643|NCT00533897|840628|P6|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|44
347644|NCT00533897|840629|P5|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|35
347645|NCT00533897|840630|P4|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|40
347646|NCT00533897|840631|P3|STARTED|Re-introduction (RI) Period 3||0
347647|NCT00533897|840632|P2|STARTED|Re-introduction (RI) Period 3||0
347648|NCT00533897|840633|P1|STARTED|Re-introduction (RI) Period 3||0
347649|NCT00533897|840626|P8|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
347650|NCT00533897|840627|P7|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
347651|NCT00533897|840628|P6|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
347652|NCT00533897|840629|P5|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
347653|NCT00533897|840630|P4|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
347654|NCT00533897|840631|P3|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||3
347655|NCT00533897|840632|P2|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||1
347656|NCT00533897|840633|P1|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
347657|NCT00533897|840626|P8|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
347658|NCT00533897|840627|P7|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
347659|NCT00533897|840628|P6|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
347660|NCT00533897|840629|P5|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
347661|NCT00533897|840630|P4|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
347662|NCT00533897|840631|P3|COMPLETED|Double-blind Withdrawal (DBW) Period 2|Two participants discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|77
347663|NCT00533897|840632|P2|COMPLETED|Double-blind Withdrawal (DBW) Period 2|One participant discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|39
347664|NCT00533897|840633|P1|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
347665|NCT00533897|840626|P8|STARTED|Double-blind Withdrawal (DBW) Period 2||0
347666|NCT00533897|840627|P7|STARTED|Double-blind Withdrawal (DBW) Period 2||0
347667|NCT00533897|840628|P6|STARTED|Double-blind Withdrawal (DBW) Period 2||0
347668|NCT00533897|840629|P5|STARTED|Double-blind Withdrawal (DBW) Period 2||0
347669|NCT00533897|840630|P4|STARTED|Double-blind Withdrawal (DBW) Period 2||0
347670|NCT00533897|840631|P3|STARTED|Double-blind Withdrawal (DBW) Period 2||80
347671|NCT00533897|840632|P2|STARTED|Double-blind Withdrawal (DBW) Period 2||40
347672|NCT00533897|840633|P1|STARTED|Double-blind Withdrawal (DBW) Period 2||0
347673|NCT00533897|840626|P8|NOT COMPLETED|Lead-in (LI) Period 1||0
347674|NCT00533897|840627|P7|NOT COMPLETED|Lead-in (LI) Period 1||0
347675|NCT00533897|840628|P6|NOT COMPLETED|Lead-in (LI) Period 1||0
347676|NCT00533897|840629|P5|NOT COMPLETED|Lead-in (LI) Period 1||0
347677|NCT00533897|840630|P4|NOT COMPLETED|Lead-in (LI) Period 1||0
347678|NCT00533897|840631|P3|NOT COMPLETED|Lead-in (LI) Period 1||0
347679|NCT00533897|840632|P2|NOT COMPLETED|Lead-in (LI) Period 1||0
347680|NCT00533897|840633|P1|NOT COMPLETED|Lead-in (LI) Period 1||10
347681|NCT00533897|840626|P8|COMPLETED|Lead-in (LI) Period 1||0
347682|NCT00533897|840627|P7|COMPLETED|Lead-in (LI) Period 1||0
347683|NCT00533897|840628|P6|COMPLETED|Lead-in (LI) Period 1||0
347684|NCT00533897|840629|P5|COMPLETED|Lead-in (LI) Period 1||0
347685|NCT00533897|840630|P4|COMPLETED|Lead-in (LI) Period 1||0
347686|NCT00533897|840631|P3|COMPLETED|Lead-in (LI) Period 1||0
347687|NCT00533897|840632|P2|COMPLETED|Lead-in (LI) Period 1||0
347688|NCT00533897|840633|P1|COMPLETED|Lead-in (LI) Period 1|37 participants entered the LTE directly and did not enter the DBW Period nor receive DBW treatment.|157
347689|NCT00533897|840626|P8|STARTED|Lead-in (LI) Period 1||0
347690|NCT00533897|840627|P7|STARTED|Lead-in (LI) Period 1||0
347691|NCT00533897|840628|P6|STARTED|Lead-in (LI) Period 1||0
347692|NCT00533897|840629|P5|STARTED|Lead-in (LI) Period 1||0
347693|NCT00533897|840630|P4|STARTED|Lead-in (LI) Period 1||0
347694|NCT00533897|840631|P3|STARTED|Lead-in (LI) Period 1||0
347695|NCT00533897|840632|P2|STARTED|Lead-in (LI) Period 1||0
347696|NCT00533897|840633|P1|STARTED|Lead-in (LI) Period 1||167
347697|NCT00533845|840773|P2|NOT COMPLETED|Overall Study||0
347698|NCT00533845|840774|P1|NOT COMPLETED|Overall Study||1
347699|NCT00533845|840773|P2|COMPLETED|Overall Study||15
347700|NCT00533845|840774|P1|COMPLETED|Overall Study||14
347701|NCT00533845|840773|P2|STARTED|Overall Study||15
347702|NCT00533845|840774|P1|STARTED|Overall Study||15
347703|NCT00533702|840782|P2|NOT COMPLETED|Overall Study||2
347704|NCT00533702|840783|P1|NOT COMPLETED|Overall Study||5
347705|NCT00533702|840782|P2|COMPLETED|Overall Study||50
347706|NCT00533702|840783|P1|COMPLETED|Overall Study||49
347707|NCT00533702|840782|P2|Received Any Quantity of Study Drug|Overall Study||50
347708|NCT00533702|840783|P1|Received Any Quantity of Study Drug|Overall Study||52
347709|NCT00533702|840782|P2|STARTED|Overall Study||52
347710|NCT00533702|840783|P1|STARTED|Overall Study||54
347711|NCT00533546|840807|P1|NOT COMPLETED|Overall Study||0
347712|NCT00533546|840807|P1|COMPLETED|Overall Study||12
347713|NCT00533546|840807|P1|STARTED|Overall Study||12
347714|NCT00533507|840814|P1|NOT COMPLETED|Overall Study||1
347715|NCT00533507|840814|P1|COMPLETED|Overall Study||229
347716|NCT00533507|840814|P1|STARTED|Overall Study||230
347717|NCT00533442|840835|P2|NOT COMPLETED|Follow-up||10
347718|NCT00533442|840836|P1|NOT COMPLETED|Follow-up||9
347719|NCT00533442|840835|P2|COMPLETED|Follow-up||74
347720|NCT00533442|840836|P1|COMPLETED|Follow-up||77
347721|NCT00533442|840835|P2|STARTED|Follow-up|Ongoing Follow-up at 17-124 months (N=74); Lost to Follow-up (N=10, at 5-67 months).|84
347722|NCT00533442|840836|P1|STARTED|Follow-up|Ongoing Follow-up at 13-123 months (N=77); Lost to Follow-up (N=9, at 5-100 months).|86
347723|NCT00533442|840835|P2|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
347724|NCT00533442|840836|P1|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
347725|NCT00533442|840835|P2|COMPLETED|Allocation and Intent to Treat Analysis||84
347726|NCT00533442|840836|P1|COMPLETED|Allocation and Intent to Treat Analysis||86
347727|NCT00533442|840835|P2|STARTED|Allocation and Intent to Treat Analysis||84
347728|NCT00533442|840836|P1|STARTED|Allocation and Intent to Treat Analysis||86
347729|NCT00533351|840848|P2|NOT COMPLETED|Period 3||0
347730|NCT00533351|840849|P1|NOT COMPLETED|Period 3||0
347731|NCT00533351|840848|P2|COMPLETED|Period 3||0
347732|NCT00533351|840849|P1|COMPLETED|Period 3||3
347733|NCT00533351|840848|P2|STARTED|Period 3|No patients continued to Period 3|0
347734|NCT00533351|840849|P1|STARTED|Period 3|Three out of the five patients who completed Period 2 continued to Period 3|3
347735|NCT00533351|840848|P2|NOT COMPLETED|Period 2||0
347736|NCT00533351|840849|P1|NOT COMPLETED|Period 2||0
347737|NCT00533351|840848|P2|COMPLETED|Period 2||1
347738|NCT00533351|840849|P1|COMPLETED|Period 2||5
347739|NCT00533351|840848|P2|STARTED|Period 2||1
347740|NCT00533351|840849|P1|STARTED|Period 2||5
347741|NCT00533351|840848|P2|NOT COMPLETED|Period 1||1
347742|NCT00533351|840849|P1|NOT COMPLETED|Period 1||2
347743|NCT00533351|840848|P2|COMPLETED|Period 1||1
347744|NCT00533351|840849|P1|COMPLETED|Period 1||5
347745|NCT00533351|840848|P2|STARTED|Period 1||2
347746|NCT00533351|840849|P1|STARTED|Period 1||7
347747|NCT00533273|840859|P2|NOT COMPLETED|Open-label||0
347748|NCT00533273|840860|P1|NOT COMPLETED|Open-label||6
347749|NCT00533273|840859|P2|COMPLETED|Open-label||0
347750|NCT00533273|840860|P1|COMPLETED|Open-label||58
347751|NCT00533273|840859|P2|STARTED|Open-label|no placebo - this phase was open label|0
347752|NCT00533273|840860|P1|STARTED|Open-label|open-label was extension of double-blind; 64 of 66 patients continued into open-label|64
347753|NCT00533273|840859|P2|NOT COMPLETED|Double-blind||2
347754|NCT00533273|840860|P1|NOT COMPLETED|Double-blind||0
347755|NCT00533273|840859|P2|COMPLETED|Double-blind||19
347756|NCT00533273|840860|P1|COMPLETED|Double-blind||45
347757|NCT00533273|840859|P2|STARTED|Double-blind||21
347758|NCT00533273|840860|P1|STARTED|Double-blind||45
347759|NCT00533117|840895|P4|NOT COMPLETED|Overall Study||5
347760|NCT00533117|840896|P3|NOT COMPLETED|Overall Study||6
347761|NCT00533117|840897|P2|NOT COMPLETED|Overall Study||5
347762|NCT00533117|840898|P1|NOT COMPLETED|Overall Study||4
347763|NCT00533117|840895|P4|COMPLETED|Overall Study||13
347764|NCT00533117|840896|P3|COMPLETED|Overall Study||14
347765|NCT00533117|840897|P2|COMPLETED|Overall Study||14
347766|NCT00533117|840898|P1|COMPLETED|Overall Study||14
347767|NCT00533117|840895|P4|STARTED|Overall Study||18
347768|NCT00533117|840896|P3|STARTED|Overall Study||20
347769|NCT00533117|840897|P2|STARTED|Overall Study||19
347770|NCT00533117|840898|P1|STARTED|Overall Study||18
347771|NCT00532948|840909|P3|NOT COMPLETED|Overall Study||4
347772|NCT00532948|840910|P2|NOT COMPLETED|Overall Study||5
347773|NCT00532948|840911|P1|NOT COMPLETED|Overall Study||4
347774|NCT00532948|840909|P3|COMPLETED|Overall Study||2
347775|NCT00532948|840910|P2|COMPLETED|Overall Study||9
347776|NCT00532948|840911|P1|COMPLETED|Overall Study||0
347777|NCT00532948|840909|P3|STARTED|Overall Study||6
347778|NCT00532948|840910|P2|STARTED|Overall Study||14
347779|NCT00532948|840911|P1|STARTED|Overall Study||4
347780|NCT00532935|840943|P2|NOT COMPLETED|Overall Study||52
347781|NCT00532935|840944|P1|NOT COMPLETED|Overall Study||51
347782|NCT00532935|840943|P2|COMPLETED|Overall Study||204
347783|NCT00532935|840944|P1|COMPLETED|Overall Study||210
347784|NCT00532935|840943|P2|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|256
347785|NCT00532935|840944|P1|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|261
347786|NCT00532883|840962|P4|NOT COMPLETED|Overall Study||5
347787|NCT00532883|840963|P3|NOT COMPLETED|Overall Study||4
347788|NCT00532883|840964|P2|NOT COMPLETED|Overall Study||7
347789|NCT00532883|840965|P1|NOT COMPLETED|Overall Study||6
347790|NCT00532883|840962|P4|COMPLETED|Overall Study|Study terminated early.|6
347791|NCT00532883|840963|P3|COMPLETED|Overall Study|Study terminated early.|6
347792|NCT00532883|840964|P2|COMPLETED|Overall Study|Study terminated early.|5
347793|NCT00532883|840965|P1|COMPLETED|Overall Study|Study terminated early.|5
347794|NCT00532883|840962|P4|STARTED|Overall Study||11
347795|NCT00532883|840963|P3|STARTED|Overall Study||10
347796|NCT00532883|840964|P2|STARTED|Overall Study||12
347797|NCT00532883|840965|P1|STARTED|Overall Study||11
347798|NCT00532779|840978|P3|NOT COMPLETED|Overall Study||291
347799|NCT00532779|840979|P2|NOT COMPLETED|Overall Study||287
347800|NCT00532779|840980|P1|NOT COMPLETED|Overall Study||294
347801|NCT00532779|840978|P3|COMPLETED|Overall Study||290
347802|NCT00532779|840979|P2|COMPLETED|Overall Study||296
347803|NCT00532779|840980|P1|COMPLETED|Overall Study||284
347804|NCT00532779|840978|P3|STARTED|Overall Study||581
347805|NCT00532779|840979|P2|STARTED|Overall Study||583
347806|NCT00532779|840980|P1|STARTED|Overall Study||578
347807|NCT00532493|841041|P2|NOT COMPLETED|Overall Study||29
347808|NCT00532493|841042|P1|NOT COMPLETED|Overall Study||30
347809|NCT00532493|841041|P2|COMPLETED|Overall Study||123
347810|NCT00532493|841042|P1|COMPLETED|Overall Study||122
347811|NCT00532493|841041|P2|STARTED|Overall Study||152
347812|NCT00532493|841042|P1|STARTED|Overall Study||152
347813|NCT00532480|841072|P1|NOT COMPLETED|Overall Study||3
347814|NCT00532480|841072|P1|COMPLETED|Overall Study||7
347815|NCT00532480|841072|P1|STARTED|Overall Study||10
347816|NCT00532441|841076|P2|NOT COMPLETED|Overall Study||0
347817|NCT00532441|841077|P1|NOT COMPLETED|Overall Study||1
347818|NCT00532441|841076|P2|COMPLETED|Overall Study||11
347819|NCT00532441|841077|P1|COMPLETED|Overall Study||13
347820|NCT00532441|841076|P2|STARTED|Overall Study||11
347821|NCT00532441|841077|P1|STARTED|Overall Study||14
347822|NCT00532298|841092|P6|NOT COMPLETED|Overall Study||2
347823|NCT00532298|841093|P5|NOT COMPLETED|Overall Study||1
347824|NCT00532298|841094|P4|NOT COMPLETED|Overall Study||0
347825|NCT00532298|841095|P3|NOT COMPLETED|Overall Study||1
347826|NCT00532298|841096|P2|NOT COMPLETED|Overall Study||1
347827|NCT00532298|841097|P1|NOT COMPLETED|Overall Study||2
347828|NCT00532298|841092|P6|COMPLETED|Overall Study||261
347829|NCT00532298|841093|P5|COMPLETED|Overall Study||267
347830|NCT00532298|841094|P4|COMPLETED|Overall Study||264
347831|NCT00532298|841095|P3|COMPLETED|Overall Study||263
347832|NCT00532298|841096|P2|COMPLETED|Overall Study||265
347833|NCT00532298|841097|P1|COMPLETED|Overall Study||267
347834|NCT00532298|841092|P6|STARTED|Overall Study||263
347835|NCT00532298|841093|P5|STARTED|Overall Study||268
347836|NCT00532298|841094|P4|STARTED|Overall Study||264
347837|NCT00532298|841095|P3|STARTED|Overall Study||264
347838|NCT00532298|841096|P2|STARTED|Overall Study||266
347839|NCT00532298|841097|P1|STARTED|Overall Study||269
347840|NCT00532259|841177|P1|NOT COMPLETED|Overall Study||32
347841|NCT00532259|841177|P1|COMPLETED|Overall Study||40
347842|NCT00532259|841177|P1|STARTED|Overall Study||72
347843|NCT00532155|841184|P2|NOT COMPLETED|Overall Study||456
347844|NCT00532155|841185|P1|NOT COMPLETED|Overall Study||457
347845|NCT00532155|841184|P2|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
347846|NCT00532155|841185|P1|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
347847|NCT00532155|841184|P2|SAFETY POPULATION|Overall Study||450
347848|NCT00532155|841185|P1|SAFETY POPULATION|Overall Study||455
347849|NCT00532155|841184|P2|STARTED|Overall Study||456
347850|NCT00532155|841185|P1|STARTED|Overall Study||457
347851|NCT00532129|841199|P1|NOT COMPLETED|Follow-up Period||65
347852|NCT00532129|841199|P1|COMPLETED|Follow-up Period||33
347853|NCT00532129|841199|P1|STARTED|Follow-up Period||98
347854|NCT00532129|841199|P1|NOT COMPLETED|Treatment Period||49
347855|NCT00532129|841199|P1|COMPLETED|Treatment Period||51
347856|NCT00532129|841199|P1|STARTED|Treatment Period||100
347857|NCT00531960|841219|P2|NOT COMPLETED|Overall Study||63
347858|NCT00531960|841220|P1|NOT COMPLETED|Overall Study||61
347859|NCT00531960|841219|P2|COMPLETED|Overall Study||0
347860|NCT00531960|841220|P1|COMPLETED|Overall Study||0
347861|NCT00531960|841219|P2|STARTED|Overall Study||63
347862|NCT00531960|841220|P1|STARTED|Overall Study||61
347863|NCT00531947|841238|P2|NOT COMPLETED|Overall Study||51
347864|NCT00531947|841239|P1|NOT COMPLETED|Overall Study||42
347865|NCT00531947|841238|P2|COMPLETED|Overall Study||101
347866|NCT00531947|841239|P1|COMPLETED|Overall Study||114
347867|NCT00531947|841238|P2|STARTED|Overall Study|all randomized subjects who received at least one dose of EMSAM study medication|152
347868|NCT00531947|841239|P1|STARTED|Overall Study|all randomized subjects who received at least one dose of placebo study medication|156
347869|NCT00531934|841283|P2|NOT COMPLETED|Overall Study||63
347870|NCT00531934|841284|P1|NOT COMPLETED|Overall Study||66
347871|NCT00531934|841283|P2|COMPLETED|Overall Study||11
347872|NCT00531934|841284|P1|COMPLETED|Overall Study||7
347873|NCT00531934|841283|P2|STARTED|Overall Study||74
347874|NCT00531934|841284|P1|STARTED|Overall Study||73
347875|NCT00531882|841355|P3|NOT COMPLETED|Overall Study||0
347876|NCT00531882|841356|P2|NOT COMPLETED|Overall Study||0
347877|NCT00531882|841357|P1|NOT COMPLETED|Overall Study||0
347878|NCT00531882|841355|P3|COMPLETED|Overall Study||5
347879|NCT00531882|841356|P2|COMPLETED|Overall Study||10
347880|NCT00531882|841357|P1|COMPLETED|Overall Study||10
347881|NCT00531882|841355|P3|STARTED|Overall Study||5
347882|NCT00531882|841356|P2|STARTED|Overall Study||10
347883|NCT00531882|841357|P1|STARTED|Overall Study||10
347884|NCT00531843|841367|P2|NOT COMPLETED|Overall Study||0
347885|NCT00531843|841368|P1|NOT COMPLETED|Overall Study||0
347886|NCT00531843|841367|P2|COMPLETED|Overall Study||6
347887|NCT00531843|841368|P1|COMPLETED|Overall Study||81
347888|NCT00531843|841367|P2|STARTED|Overall Study||6
347889|NCT00531843|841368|P1|STARTED|Overall Study||81
347890|NCT00531817|841380|P2|NOT COMPLETED|Entered Extended Treatment Period||57
347891|NCT00531817|841381|P1|NOT COMPLETED|Entered Extended Treatment Period||137
347892|NCT00531817|841380|P2|COMPLETED|Entered Extended Treatment Period||113
347893|NCT00531817|841381|P1|COMPLETED|Entered Extended Treatment Period||206
347894|NCT00531817|841380|P2|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator’s discretion.|170
347895|NCT00531817|841381|P1|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator’s discretion.|343
347896|NCT00531817|841380|P2|NOT COMPLETED|Randomized||34
347897|NCT00531817|841381|P1|NOT COMPLETED|Randomized||59
347898|NCT00531817|841380|P2|COMPLETED|Randomized||173
347899|NCT00531817|841381|P1|COMPLETED|Randomized||353
347900|NCT00531817|841380|P2|Received Study Drug in Core Study|Randomized|2 patients did not receive any study medication. Intent-to-treat population = 205.|205
347901|NCT00531817|841381|P1|Received Study Drug in Core Study|Randomized|3 patients did not receive any study medication. Intent-to-treat population = 409.|409
347902|NCT00531817|841380|P2|STARTED|Randomized||207
347903|NCT00531817|841381|P1|STARTED|Randomized||412
347904|NCT00531752|841412|P4|NOT COMPLETED|Second Double-blind Intervention Period||2
347905|NCT00531752|841413|P3|NOT COMPLETED|Second Double-blind Intervention Period||0
347906|NCT00531752|841414|P2|NOT COMPLETED|Second Double-blind Intervention Period||2
347907|NCT00531752|841415|P1|NOT COMPLETED|Second Double-blind Intervention Period||2
347908|NCT00531752|841412|P4|COMPLETED|Second Double-blind Intervention Period||11
347909|NCT00531752|841413|P3|COMPLETED|Second Double-blind Intervention Period||9
347910|NCT00531752|841414|P2|COMPLETED|Second Double-blind Intervention Period||11
347911|NCT00531752|841415|P1|COMPLETED|Second Double-blind Intervention Period||9
347912|NCT00531752|841412|P4|STARTED|Second Double-blind Intervention Period||13
347913|NCT00531752|841413|P3|STARTED|Second Double-blind Intervention Period||9
347914|NCT00531752|841414|P2|STARTED|Second Double-blind Intervention Period||13
347915|NCT00531752|841415|P1|STARTED|Second Double-blind Intervention Period||11
347916|NCT00531752|841412|P4|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
347917|NCT00531752|841413|P3|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
347918|NCT00531752|841414|P2|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
347919|NCT00531752|841415|P1|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
347920|NCT00531752|841412|P4|COMPLETED|Wash-out Period (at Least 7 Days)||13
347921|NCT00531752|841413|P3|COMPLETED|Wash-out Period (at Least 7 Days)||9
347922|NCT00531752|841414|P2|COMPLETED|Wash-out Period (at Least 7 Days)||13
347923|NCT00531752|841415|P1|COMPLETED|Wash-out Period (at Least 7 Days)||11
347924|NCT00531752|841412|P4|STARTED|Wash-out Period (at Least 7 Days)||13
347925|NCT00531752|841413|P3|STARTED|Wash-out Period (at Least 7 Days)||9
347926|NCT00531752|841414|P2|STARTED|Wash-out Period (at Least 7 Days)||13
347927|NCT00531752|841415|P1|STARTED|Wash-out Period (at Least 7 Days)||11
347928|NCT00531752|841412|P4|NOT COMPLETED|First Double-blind Intervention Period||3
347929|NCT00531752|841413|P3|NOT COMPLETED|First Double-blind Intervention Period||7
347930|NCT00531752|841414|P2|NOT COMPLETED|First Double-blind Intervention Period||4
347931|NCT00531752|841415|P1|NOT COMPLETED|First Double-blind Intervention Period||6
347932|NCT00531752|841412|P4|COMPLETED|First Double-blind Intervention Period||13
347933|NCT00531752|841413|P3|COMPLETED|First Double-blind Intervention Period||9
347934|NCT00531752|841414|P2|COMPLETED|First Double-blind Intervention Period||13
347935|NCT00531752|841415|P1|COMPLETED|First Double-blind Intervention Period||11
347936|NCT00531752|841412|P4|Treated|First Double-blind Intervention Period||16
347937|NCT00531752|841413|P3|Treated|First Double-blind Intervention Period||16
347938|NCT00531752|841414|P2|Treated|First Double-blind Intervention Period||17
347939|NCT00531752|841415|P1|Treated|First Double-blind Intervention Period||16
347940|NCT00531752|841412|P4|STARTED|First Double-blind Intervention Period||16
347941|NCT00531752|841413|P3|STARTED|First Double-blind Intervention Period||16
347942|NCT00531752|841414|P2|STARTED|First Double-blind Intervention Period||17
347943|NCT00531752|841415|P1|STARTED|First Double-blind Intervention Period||17
347944|NCT00531661|841494|P2|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||57
347945|NCT00531661|841495|P1|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||58
347946|NCT00531661|841494|P2|COMPLETED|Study Duration: 15 Months Avg. Follow-up||197
347947|NCT00531661|841495|P1|COMPLETED|Study Duration: 15 Months Avg. Follow-up||186
347948|NCT00531661|841494|P2|STARTED|Study Duration: 15 Months Avg. Follow-up||254
347949|NCT00531661|841495|P1|STARTED|Study Duration: 15 Months Avg. Follow-up||244
347950|NCT00531661|841494|P2|NOT COMPLETED|6 Months||26
347951|NCT00531661|841495|P1|NOT COMPLETED|6 Months||26
347952|NCT00531661|841494|P2|COMPLETED|6 Months||254
347953|NCT00531661|841495|P1|COMPLETED|6 Months||244
347954|NCT00531661|841494|P2|STARTED|6 Months||280
347955|NCT00531661|841495|P1|STARTED|6 Months||270
347956|NCT00531518|841517|P2|NOT COMPLETED|Overall Study||71
347957|NCT00531518|841518|P1|NOT COMPLETED|Overall Study||32
347958|NCT00531518|841517|P2|COMPLETED|Overall Study||134
347959|NCT00531518|841518|P1|COMPLETED|Overall Study||55
347960|NCT00531518|841517|P2|STARTED|Overall Study||205
347961|NCT00531518|841518|P1|STARTED|Overall Study||87
347962|NCT00531479|841526|P2|NOT COMPLETED|Overall Study||83
347963|NCT00531479|841527|P1|NOT COMPLETED|Overall Study||76
347964|NCT00531479|841526|P2|COMPLETED|Overall Study||146
347965|NCT00531479|841527|P1|COMPLETED|Overall Study||154
347966|NCT00531479|841526|P2|Treated|Overall Study||226
347967|NCT00531479|841527|P1|Treated|Overall Study||228
347968|NCT00531479|841526|P2|STARTED|Overall Study||229
347969|NCT00531479|841527|P1|STARTED|Overall Study||230
347970|NCT00531453|841547|P2|NOT COMPLETED|Overall Study||0
347971|NCT00531453|841548|P1|NOT COMPLETED|Overall Study||0
347972|NCT00531453|841547|P2|COMPLETED|Overall Study|10 April 2009|49
347973|NCT00531453|841548|P1|COMPLETED|Overall Study|10 April 2009|49
347974|NCT00531453|841547|P2|STARTED|Overall Study|02 October 2007|49
347975|NCT00531453|841548|P1|STARTED|Overall Study|02 October 2007|49
347976|NCT00531427|841558|P2|NOT COMPLETED|Overall Study||94
347977|NCT00531427|841559|P1|NOT COMPLETED|Overall Study||73
347978|NCT00531427|841558|P2|COMPLETED|Overall Study||191
347979|NCT00531427|841559|P1|COMPLETED|Overall Study||209
347980|NCT00531427|841558|P2|STARTED|Overall Study||285
347981|NCT00531427|841559|P1|STARTED|Overall Study||282
347982|NCT00531284|841587|P17|NOT COMPLETED|Overall Study||8
347983|NCT00531284|841588|P16|NOT COMPLETED|Overall Study||12
347984|NCT00531284|841589|P15|NOT COMPLETED|Overall Study||4
347985|NCT00531284|841590|P14|NOT COMPLETED|Overall Study||3
347986|NCT00531284|841591|P13|NOT COMPLETED|Overall Study||2
347987|NCT00531284|841592|P12|NOT COMPLETED|Overall Study||24
347988|NCT00531284|841593|P11|NOT COMPLETED|Overall Study||3
347989|NCT00531284|841594|P10|NOT COMPLETED|Overall Study||4
347990|NCT00531284|841595|P9|NOT COMPLETED|Overall Study||11
347991|NCT00531284|841596|P8|NOT COMPLETED|Overall Study||10
347992|NCT00531284|841597|P7|NOT COMPLETED|Overall Study||6
347993|NCT00531284|841598|P6|NOT COMPLETED|Overall Study||7
347994|NCT00531284|841599|P5|NOT COMPLETED|Overall Study||6
347995|NCT00531284|841600|P4|NOT COMPLETED|Overall Study||63
347996|NCT00531284|841601|P3|NOT COMPLETED|Overall Study||6
347997|NCT00531284|841602|P2|NOT COMPLETED|Overall Study||4
347998|NCT00531284|841603|P1|NOT COMPLETED|Overall Study||3
347999|NCT00531284|841587|P17|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
348000|NCT00531284|841588|P16|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|2
348001|NCT00531284|841589|P15|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|3
348002|NCT00531284|841590|P14|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
348003|NCT00531284|841591|P13|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
348004|NCT00531284|841592|P12|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
348005|NCT00531284|841593|P11|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
348006|NCT00531284|841594|P10|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
348007|NCT00531284|841595|P9|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
348008|NCT00531284|841596|P8|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
348009|NCT00531284|841597|P7|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
348010|NCT00531284|841598|P6|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
348011|NCT00531284|841599|P5|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
348012|NCT00531284|841600|P4|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|2
348013|NCT00531284|841601|P3|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|1
348014|NCT00531284|841602|P2|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
348015|NCT00531284|841603|P1|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
348016|NCT00531284|841587|P17|STARTED|Overall Study||8
348017|NCT00531284|841588|P16|STARTED|Overall Study||14
348018|NCT00531284|841589|P15|STARTED|Overall Study||7
348019|NCT00531284|841590|P14|STARTED|Overall Study||3
348020|NCT00531284|841591|P13|STARTED|Overall Study||2
348021|NCT00531284|841592|P12|STARTED|Overall Study||24
348022|NCT00531284|841593|P11|STARTED|Overall Study||3
348023|NCT00531284|841594|P10|STARTED|Overall Study||4
348024|NCT00531284|841595|P9|STARTED|Overall Study||11
348025|NCT00531284|841596|P8|STARTED|Overall Study||10
348026|NCT00531284|841597|P7|STARTED|Overall Study||6
348027|NCT00531284|841598|P6|STARTED|Overall Study||7
348028|NCT00531284|841599|P5|STARTED|Overall Study||6
348029|NCT00531284|841600|P4|STARTED|Overall Study||65
348030|NCT00531284|841601|P3|STARTED|Overall Study||7
348031|NCT00531284|841602|P2|STARTED|Overall Study||4
348032|NCT00531284|841603|P1|STARTED|Overall Study||3
348033|NCT00531206|841753|P1|NOT COMPLETED|Overall Study||20
348034|NCT00531206|841753|P1|COMPLETED|Overall Study||45
348035|NCT00531206|841753|P1|STARTED|Overall Study||65
348036|NCT00531050|841783|P6|NOT COMPLETED|Part 2: Period 3||1
348037|NCT00531050|841784|P5|NOT COMPLETED|Part 2: Period 3||0
348038|NCT00531050|841785|P4|NOT COMPLETED|Part 2: Period 3||0
348039|NCT00531050|841786|P3|NOT COMPLETED|Part 2: Period 3||0
348040|NCT00531050|841787|P2|NOT COMPLETED|Part 2: Period 3||0
348041|NCT00531050|841788|P1|NOT COMPLETED|Part 2: Period 3||1
348042|NCT00531050|841783|P6|COMPLETED|Part 2: Period 3||3
348043|NCT00531050|841784|P5|COMPLETED|Part 2: Period 3||4
348044|NCT00531050|841785|P4|COMPLETED|Part 2: Period 3||4
348045|NCT00531050|841786|P3|COMPLETED|Part 2: Period 3||4
348046|NCT00531050|841787|P2|COMPLETED|Part 2: Period 3||4
348047|NCT00531050|841788|P1|COMPLETED|Part 2: Period 3||2
348048|NCT00531050|841783|P6|STARTED|Part 2: Period 3||4
348049|NCT00531050|841784|P5|STARTED|Part 2: Period 3||4
348050|NCT00531050|841785|P4|STARTED|Part 2: Period 3||4
348051|NCT00531050|841786|P3|STARTED|Part 2: Period 3||4
348052|NCT00531050|841787|P2|STARTED|Part 2: Period 3||4
348053|NCT00531050|841788|P1|STARTED|Part 2: Period 3||3
348054|NCT00531050|841783|P6|NOT COMPLETED|Part 2: Period 2||0
348055|NCT00531050|841784|P5|NOT COMPLETED|Part 2: Period 2||0
348056|NCT00531050|841785|P4|NOT COMPLETED|Part 2: Period 2||0
348057|NCT00531050|841786|P3|NOT COMPLETED|Part 2: Period 2||0
348058|NCT00531050|841787|P2|NOT COMPLETED|Part 2: Period 2||0
348059|NCT00531050|841788|P1|NOT COMPLETED|Part 2: Period 2||0
348060|NCT00531050|841783|P6|COMPLETED|Part 2: Period 2||4
348061|NCT00531050|841784|P5|COMPLETED|Part 2: Period 2||4
348062|NCT00531050|841785|P4|COMPLETED|Part 2: Period 2||4
348063|NCT00531050|841786|P3|COMPLETED|Part 2: Period 2||4
348064|NCT00531050|841787|P2|COMPLETED|Part 2: Period 2||4
348065|NCT00531050|841788|P1|COMPLETED|Part 2: Period 2||3
348066|NCT00531050|841783|P6|STARTED|Part 2: Period 2||4
348067|NCT00531050|841784|P5|STARTED|Part 2: Period 2||4
348068|NCT00531050|841785|P4|STARTED|Part 2: Period 2||4
348069|NCT00531050|841786|P3|STARTED|Part 2: Period 2||4
348070|NCT00531050|841787|P2|STARTED|Part 2: Period 2||4
348071|NCT00531050|841788|P1|STARTED|Part 2: Period 2||3
348072|NCT00531050|841783|P6|NOT COMPLETED|Part 2: Period 1||1
348073|NCT00531050|841784|P5|NOT COMPLETED|Part 2: Period 1||0
348074|NCT00531050|841785|P4|NOT COMPLETED|Part 2: Period 1||0
348075|NCT00531050|841786|P3|NOT COMPLETED|Part 2: Period 1||0
348076|NCT00531050|841787|P2|NOT COMPLETED|Part 2: Period 1||0
348077|NCT00531050|841788|P1|NOT COMPLETED|Part 2: Period 1||0
348078|NCT00531050|841783|P6|COMPLETED|Part 2: Period 1||4
348079|NCT00531050|841784|P5|COMPLETED|Part 2: Period 1||4
348080|NCT00531050|841785|P4|COMPLETED|Part 2: Period 1||4
348081|NCT00531050|841786|P3|COMPLETED|Part 2: Period 1||4
348082|NCT00531050|841787|P2|COMPLETED|Part 2: Period 1||4
348083|NCT00531050|841788|P1|COMPLETED|Part 2: Period 1||3
348084|NCT00531050|841783|P6|STARTED|Part 2: Period 1||5
348085|NCT00531050|841784|P5|STARTED|Part 2: Period 1||4
348086|NCT00531050|841785|P4|STARTED|Part 2: Period 1||4
348087|NCT00531050|841786|P3|STARTED|Part 2: Period 1||4
348088|NCT00531050|841787|P2|STARTED|Part 2: Period 1||4
348089|NCT00531050|841788|P1|STARTED|Part 2: Period 1||3
348090|NCT00531050|841783|P6|NOT COMPLETED|Part 1: Period 3||0
348091|NCT00531050|841784|P5|NOT COMPLETED|Part 1: Period 3||0
348092|NCT00531050|841785|P4|NOT COMPLETED|Part 1: Period 3||0
348093|NCT00531050|841786|P3|NOT COMPLETED|Part 1: Period 3||0
348094|NCT00531050|841787|P2|NOT COMPLETED|Part 1: Period 3||0
348095|NCT00531050|841788|P1|NOT COMPLETED|Part 1: Period 3||1
348096|NCT00531050|841783|P6|COMPLETED|Part 1: Period 3||5
348097|NCT00531050|841784|P5|COMPLETED|Part 1: Period 3||4
348098|NCT00531050|841785|P4|COMPLETED|Part 1: Period 3||4
348099|NCT00531050|841786|P3|COMPLETED|Part 1: Period 3||4
348100|NCT00531050|841787|P2|COMPLETED|Part 1: Period 3||4
348101|NCT00531050|841788|P1|COMPLETED|Part 1: Period 3||3
348102|NCT00531050|841783|P6|STARTED|Part 1: Period 3||5
348103|NCT00531050|841784|P5|STARTED|Part 1: Period 3||4
348104|NCT00531050|841785|P4|STARTED|Part 1: Period 3||4
348105|NCT00531050|841786|P3|STARTED|Part 1: Period 3||4
348106|NCT00531050|841787|P2|STARTED|Part 1: Period 3||4
348107|NCT00531050|841788|P1|STARTED|Part 1: Period 3||4
348108|NCT00531050|841783|P6|NOT COMPLETED|Part 1: Period 2||0
348109|NCT00531050|841784|P5|NOT COMPLETED|Part 1: Period 2||0
348110|NCT00531050|841785|P4|NOT COMPLETED|Part 1: Period 2||0
348111|NCT00531050|841786|P3|NOT COMPLETED|Part 1: Period 2||0
348112|NCT00531050|841787|P2|NOT COMPLETED|Part 1: Period 2||0
348113|NCT00531050|841788|P1|NOT COMPLETED|Part 1: Period 2||0
348114|NCT00531050|841783|P6|COMPLETED|Part 1: Period 2||5
348115|NCT00531050|841784|P5|COMPLETED|Part 1: Period 2||4
348116|NCT00531050|841785|P4|COMPLETED|Part 1: Period 2||4
348117|NCT00531050|841786|P3|COMPLETED|Part 1: Period 2||4
348118|NCT00531050|841787|P2|COMPLETED|Part 1: Period 2||4
348119|NCT00531050|841788|P1|COMPLETED|Part 1: Period 2||4
348120|NCT00531050|841783|P6|STARTED|Part 1: Period 2||5
348121|NCT00531050|841784|P5|STARTED|Part 1: Period 2||4
348122|NCT00531050|841785|P4|STARTED|Part 1: Period 2||4
348123|NCT00531050|841786|P3|STARTED|Part 1: Period 2||4
348124|NCT00531050|841787|P2|STARTED|Part 1: Period 2||4
348125|NCT00531050|841788|P1|STARTED|Part 1: Period 2||4
348126|NCT00531050|841783|P6|NOT COMPLETED|Part 1: Period 1||0
348127|NCT00531050|841784|P5|NOT COMPLETED|Part 1: Period 1||0
348128|NCT00531050|841785|P4|NOT COMPLETED|Part 1: Period 1||1
348129|NCT00531050|841786|P3|NOT COMPLETED|Part 1: Period 1||0
348130|NCT00531050|841787|P2|NOT COMPLETED|Part 1: Period 1||1
348131|NCT00531050|841788|P1|NOT COMPLETED|Part 1: Period 1||0
348132|NCT00531050|841783|P6|COMPLETED|Part 1: Period 1||5
348133|NCT00531050|841784|P5|COMPLETED|Part 1: Period 1||4
348134|NCT00531050|841785|P4|COMPLETED|Part 1: Period 1||4
348135|NCT00531050|841786|P3|COMPLETED|Part 1: Period 1||4
348136|NCT00531050|841787|P2|COMPLETED|Part 1: Period 1||4
348137|NCT00531050|841788|P1|COMPLETED|Part 1: Period 1||4
348138|NCT00531050|841783|P6|STARTED|Part 1: Period 1||5
348139|NCT00531050|841784|P5|STARTED|Part 1: Period 1||4
348140|NCT00531050|841785|P4|STARTED|Part 1: Period 1||5
348141|NCT00531050|841786|P3|STARTED|Part 1: Period 1||4
348142|NCT00531050|841787|P2|STARTED|Part 1: Period 1||5
348143|NCT00531050|841788|P1|STARTED|Part 1: Period 1||4
348144|NCT00531011|841817|P2|NOT COMPLETED|Overall Study||7
348145|NCT00531011|841818|P1|NOT COMPLETED|Overall Study||4
348146|NCT00531011|841817|P2|COMPLETED|Overall Study||90
348147|NCT00531011|841818|P1|COMPLETED|Overall Study||99
348148|NCT00531011|841817|P2|STARTED|Overall Study||97
348149|NCT00531011|841818|P1|STARTED|Overall Study||103
348150|NCT00530946|841864|P4|NOT COMPLETED|Overall Study||2
348151|NCT00530946|841865|P3|NOT COMPLETED|Overall Study||1
348152|NCT00530946|841866|P2|NOT COMPLETED|Overall Study||2
348153|NCT00530946|841867|P1|NOT COMPLETED|Overall Study||2
348154|NCT00530946|841864|P4|COMPLETED|Overall Study||38
348155|NCT00530946|841865|P3|COMPLETED|Overall Study||40
348156|NCT00530946|841866|P2|COMPLETED|Overall Study||39
348157|NCT00530946|841867|P1|COMPLETED|Overall Study||41
348158|NCT00530946|841864|P4|STARTED|Overall Study||40
348159|NCT00530946|841865|P3|STARTED|Overall Study||41
348160|NCT00530946|841866|P2|STARTED|Overall Study||41
348161|NCT00530946|841867|P1|STARTED|Overall Study||43
348162|NCT00530920|841920|P3|NOT COMPLETED|Overall Study||4
348163|NCT00530920|841921|P2|NOT COMPLETED|Overall Study||2
348164|NCT00530920|841922|P1|NOT COMPLETED|Overall Study||0
348165|NCT00530920|841920|P3|COMPLETED|Overall Study||24
348166|NCT00530920|841921|P2|COMPLETED|Overall Study||25
348167|NCT00530920|841922|P1|COMPLETED|Overall Study||30
348168|NCT00530920|841920|P3|STARTED|Overall Study||28
348169|NCT00530920|841921|P2|STARTED|Overall Study||27
348170|NCT00530920|841922|P1|STARTED|Overall Study||30
348171|NCT00530894|841982|P4|NOT COMPLETED|Overall Study||94
348172|NCT00530894|841983|P3|NOT COMPLETED|Overall Study||55
348173|NCT00530894|841984|P2|NOT COMPLETED|Overall Study||115
348174|NCT00530894|841985|P1|NOT COMPLETED|Overall Study||88
348175|NCT00530894|841982|P4|COMPLETED|Overall Study||85
348176|NCT00530894|841983|P3|COMPLETED|Overall Study||124
348177|NCT00530894|841984|P2|COMPLETED|Overall Study||236
348178|NCT00530894|841985|P1|COMPLETED|Overall Study||260
348179|NCT00530894|841982|P4|STARTED|Overall Study||179
348180|NCT00530894|841983|P3|STARTED|Overall Study||179
348181|NCT00530894|841984|P2|STARTED|Overall Study||351
348182|NCT00530894|841985|P1|STARTED|Overall Study||348
348183|NCT00530855|842013|P1|NOT COMPLETED|Overall Study||112
348184|NCT00530855|842013|P1|COMPLETED|Overall Study||210
348185|NCT00530855|842013|P1|STARTED|Overall Study||322
348186|NCT00530842|842022|P2|NOT COMPLETED|Period 2||9
348187|NCT00530842|842023|P1|NOT COMPLETED|Period 2||8
348188|NCT00530842|842022|P2|COMPLETED|Period 2||151
348189|NCT00530842|842023|P1|COMPLETED|Period 2||149
348190|NCT00530842|842022|P2|STARTED|Period 2||160
348191|NCT00530842|842023|P1|STARTED|Period 2||157
348192|NCT00530842|842022|P2|NOT COMPLETED|Period 1||11
348193|NCT00530842|842023|P1|NOT COMPLETED|Period 1||14
348194|NCT00530842|842022|P2|COMPLETED|Period 1||161
348195|NCT00530842|842023|P1|COMPLETED|Period 1||158
348196|NCT00530842|842022|P2|STARTED|Period 1||172
348197|NCT00530842|842023|P1|STARTED|Period 1||172
348198|NCT00530842|842022|P2|NOT COMPLETED|Overall Study||21
348199|NCT00530842|842023|P1|NOT COMPLETED|Overall Study||23
348200|NCT00530842|842022|P2|COMPLETED|Overall Study||151
348201|NCT00530842|842023|P1|COMPLETED|Overall Study||149
348202|NCT00530842|842022|P2|STARTED|Overall Study||172
348203|NCT00530842|842023|P1|STARTED|Overall Study||172
348204|NCT00530816|842150|P3|NOT COMPLETED|Overall Study||41
348205|NCT00530816|842151|P2|NOT COMPLETED|Overall Study||42
348206|NCT00530816|842152|P1|NOT COMPLETED|Overall Study||26
348207|NCT00530816|842150|P3|COMPLETED|Overall Study||29
348208|NCT00530816|842151|P2|COMPLETED|Overall Study||17
348209|NCT00530816|842152|P1|COMPLETED|Overall Study||9
348210|NCT00530816|842150|P3|STARTED|Overall Study||70
348211|NCT00530816|842151|P2|STARTED|Overall Study||59
348212|NCT00530816|842152|P1|STARTED|Overall Study||35
348213|NCT00530803|842180|P2|NOT COMPLETED|Overall Study||0
348214|NCT00530803|842181|P1|NOT COMPLETED|Overall Study||0
348215|NCT00530803|842180|P2|COMPLETED|Overall Study||50
348216|NCT00530803|842181|P1|COMPLETED|Overall Study||50
348217|NCT00530803|842180|P2|STARTED|Overall Study||50
348218|NCT00530803|842181|P1|STARTED|Overall Study||50
348219|NCT00530790|842195|P1|NOT COMPLETED|Overall Study||5
348220|NCT00530790|842195|P1|COMPLETED|Overall Study||30
348221|NCT00530790|842195|P1|STARTED|Overall Study||35
348222|NCT00530777|842217|P2|NOT COMPLETED|Overall Study||5
348223|NCT00530777|842218|P1|NOT COMPLETED|Overall Study||7
348224|NCT00530777|842217|P2|COMPLETED|Overall Study||69
348225|NCT00530777|842218|P1|COMPLETED|Overall Study||67
348226|NCT00530777|842217|P2|STARTED|Overall Study||74
348227|NCT00530777|842218|P1|STARTED|Overall Study||74
348228|NCT00530764|842230|P4|NOT COMPLETED|Overall Study||25
348229|NCT00530764|842231|P3|NOT COMPLETED|Overall Study||20
348230|NCT00530764|842232|P2|NOT COMPLETED|Overall Study||21
348231|NCT00530764|842233|P1|NOT COMPLETED|Overall Study||31
348232|NCT00530764|842230|P4|COMPLETED|Overall Study||66
348233|NCT00530764|842231|P3|COMPLETED|Overall Study||71
348234|NCT00530764|842232|P2|COMPLETED|Overall Study||67
348235|NCT00530764|842233|P1|COMPLETED|Overall Study||59
348236|NCT00530764|842230|P4|STARTED|Overall Study||91
348237|NCT00530764|842231|P3|STARTED|Overall Study||91
348238|NCT00530764|842232|P2|STARTED|Overall Study||88
348239|NCT00530764|842233|P1|STARTED|Overall Study||90
348240|NCT00530712|842275|P1|NOT COMPLETED|12 Month Follow-up Visit||24
348241|NCT00530712|842275|P1|COMPLETED|12 Month Follow-up Visit|Subjects that Completed 12-Month Follow-up Visit|263
348242|NCT00530712|842275|P1|STARTED|12 Month Follow-up Visit|Subjects Expected for 12 Month Visit|287
348243|NCT00530712|842275|P1|NOT COMPLETED|6 Month Follow-up Visit||12
348244|NCT00530712|842275|P1|COMPLETED|6 Month Follow-up Visit|Subjects that Completed 6-Month Follow-up Visit|275
348245|NCT00530712|842275|P1|STARTED|6 Month Follow-up Visit|Subjects Expected for 6-Month Visit|287
348246|NCT00530712|842275|P1|NOT COMPLETED|30 Day Follow-up Visit||7
348247|NCT00530712|842275|P1|COMPLETED|30 Day Follow-up Visit|Subjects that Completed 30-Day Follow-up Visit|280
348248|NCT00530712|842275|P1|STARTED|30 Day Follow-up Visit|Subjects Expected for 30-Day Visit|287
348249|NCT00530712|842275|P1|NOT COMPLETED|Enrollment||0
348250|NCT00530712|842275|P1|COMPLETED|Enrollment|Subjects Available at Discharge|287
348251|NCT00530712|842275|P1|STARTED|Enrollment|Total Enrolled Subjects|287
348252|NCT00530634|842292|P1|NOT COMPLETED|Overall Study||0
348253|NCT00530634|842292|P1|COMPLETED|Overall Study||3
348254|NCT00530634|842292|P1|STARTED|Overall Study||3
348255|NCT00530504|842296|P1|NOT COMPLETED|Overall Study||152
348256|NCT00530504|842296|P1|COMPLETED|Overall Study||1348
348257|NCT00530504|842296|P1|STARTED|Overall Study||1500
348258|NCT00530439|842302|P2|NOT COMPLETED|Overall Study||26
348259|NCT00530439|842303|P1|NOT COMPLETED|Overall Study||30
348260|NCT00530439|842302|P2|COMPLETED|Overall Study||154
348261|NCT00530439|842303|P1|COMPLETED|Overall Study||150
348262|NCT00530439|842302|P2|STARTED|Overall Study||180
348263|NCT00530439|842303|P1|STARTED|Overall Study||180
348264|NCT00530348|842311|P2|NOT COMPLETED|Overall Study||19
348265|NCT00530348|842312|P1|NOT COMPLETED|Overall Study||22
348266|NCT00530348|842311|P2|COMPLETED|Overall Study||367
348267|NCT00530348|842312|P1|COMPLETED|Overall Study||173
348268|NCT00530348|842311|P2|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|376
348269|NCT00530348|842312|P1|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|187
348270|NCT00530348|842311|P2|STARTED|Overall Study|Randomized.|386
348271|NCT00530348|842312|P1|STARTED|Overall Study|Randomized.|195
348272|NCT00530335|842328|P1|NOT COMPLETED|Overall Study||6
348273|NCT00530335|842328|P1|COMPLETED|Overall Study||39
348274|NCT00530335|842328|P1|STARTED|Overall Study||45
348275|NCT00530270|842345|P2|NOT COMPLETED|Overall Study||0
348276|NCT00530270|842346|P1|NOT COMPLETED|Overall Study||1
348277|NCT00530270|842345|P2|COMPLETED|Overall Study||6
348278|NCT00530270|842346|P1|COMPLETED|Overall Study||5
348279|NCT00530270|842345|P2|STARTED|Overall Study||6
348280|NCT00530270|842346|P1|STARTED|Overall Study||6
348281|NCT00530257|842360|P1|NOT COMPLETED|Overall Study||1
348282|NCT00530257|842360|P1|COMPLETED|Overall Study||30
348283|NCT00530257|842360|P1|STARTED|Overall Study||31
348284|NCT00530218|842388|P1|NOT COMPLETED|Overall Study||25
348285|NCT00530218|842388|P1|COMPLETED|Overall Study|CMV Reactivation Was Detected|36
348286|NCT00530218|842388|P1|STARTED|Overall Study||61
348287|NCT00530088|842395|P1|NOT COMPLETED|Overall Study||10
348288|NCT00530088|842395|P1|COMPLETED|Overall Study||20
348289|NCT00530088|842395|P1|STARTED|Overall Study||30
348290|NCT00530075|842400|P1|NOT COMPLETED|Overall Study||7
348291|NCT00530075|842400|P1|COMPLETED|Overall Study||38
348292|NCT00530075|842400|P1|STARTED|Overall Study||45
348293|NCT00530023|842413|P2|NOT COMPLETED|Overall Study||1
348294|NCT00530023|842414|P1|NOT COMPLETED|Overall Study||0
348295|NCT00530023|842413|P2|COMPLETED|Overall Study||14
348296|NCT00530023|842414|P1|COMPLETED|Overall Study||14
348297|NCT00530023|842413|P2|STARTED|Overall Study||15
348298|NCT00530023|842414|P1|STARTED|Overall Study||14
348299|NCT00529958|842431|P3|NOT COMPLETED|5-Year Follow-up||1
348300|NCT00529958|842432|P2|NOT COMPLETED|5-Year Follow-up||3
348301|NCT00529958|842433|P1|NOT COMPLETED|5-Year Follow-up||3
348302|NCT00529958|842431|P3|COMPLETED|5-Year Follow-up||107
348303|NCT00529958|842432|P2|COMPLETED|5-Year Follow-up||105
348304|NCT00529958|842433|P1|COMPLETED|5-Year Follow-up||103
348305|NCT00529958|842431|P3|STARTED|5-Year Follow-up|108 DB patients available for 5-year follow-up includes n=1 cross-over with a single-bundle HT graft|108
348306|NCT00529958|842432|P2|STARTED|5-Year Follow-up|108 HT patients available for 5-year follow-up excludes n=1 cross-over patient from the DB group|108
348307|NCT00529958|842433|P1|STARTED|5-Year Follow-up||106
348308|NCT00529958|842431|P3|NOT COMPLETED|2-Year Follow-up||2
348309|NCT00529958|842432|P2|NOT COMPLETED|2-Year Follow-up||2
348310|NCT00529958|842433|P1|NOT COMPLETED|2-Year Follow-up||4
348311|NCT00529958|842431|P3|COMPLETED|2-Year Follow-up|108 DB patients analyzed include 1 cross-over with HT graft (analyzed on intention-to-treat basis).|108
348312|NCT00529958|842432|P2|COMPLETED|2-Year Follow-up|108 HT patients analyzed excludes n=1 cross-over patient (analyzed on intention-to-treat basis).|108
348313|NCT00529958|842433|P1|COMPLETED|2-Year Follow-up||106
348314|NCT00529958|842431|P3|STARTED|2-Year Follow-up|110 randomized to DB, but there was (n=1) cross-over to the HT group|110
348315|NCT00529958|842432|P2|STARTED|2-Year Follow-up|110 randomized to HT, but there was (n=1) cross-over from the DB group|110
348316|NCT00529958|842433|P1|STARTED|2-Year Follow-up||110
348317|NCT00529802|842474|P1|NOT COMPLETED|Evaluable for Secondary Endpoint||2
348318|NCT00529802|842474|P1|COMPLETED|Evaluable for Secondary Endpoint||48
348319|NCT00529802|842474|P1|STARTED|Evaluable for Secondary Endpoint||50
348320|NCT00529802|842474|P1|NOT COMPLETED|Evaluable for Primary Endpoint||10
348321|NCT00529802|842474|P1|COMPLETED|Evaluable for Primary Endpoint|Evaluable for primary endpoint|50
348322|NCT00529802|842474|P1|STARTED|Evaluable for Primary Endpoint|60 patients started trial|60
348323|NCT00529789|842480|P1|NOT COMPLETED|Study Period IV||6
348324|NCT00529789|842480|P1|COMPLETED|Study Period IV|Includes 1 patient who withdrew at last visit; didn't enter Taper; however received 30 weeks of drug|42
348325|NCT00529789|842480|P1|STARTED|Study Period IV||48
348326|NCT00529789|842480|P1|NOT COMPLETED|Study Period II/III||24
348327|NCT00529789|842480|P1|COMPLETED|Study Period II/III||48
348328|NCT00529789|842480|P1|STARTED|Study Period II/III||72
348329|NCT00529763|842505|P3|NOT COMPLETED|Overall Study||7
348330|NCT00529763|842506|P2|NOT COMPLETED|Overall Study||33
348331|NCT00529763|842507|P1|NOT COMPLETED|Overall Study||10
348332|NCT00529763|842505|P3|COMPLETED|Overall Study|52 participants still on treatment; not completed = off treatment (n=7)|52
348333|NCT00529763|842506|P2|COMPLETED|Overall Study|4 participants still on treatment; not completed = off treatment (n=33)|4
348334|NCT00529763|842507|P1|COMPLETED|Overall Study|15 participants still on treatment; not completed = off treatment (n=10)|15
348335|NCT00529763|842505|P3|STARTED|Overall Study||59
348336|NCT00529763|842506|P2|STARTED|Overall Study|38 participants were enrolled; 37 were treated in this cohort|37
348337|NCT00529763|842507|P1|STARTED|Overall Study||25
348338|NCT00529659|842545|P2|NOT COMPLETED|Overall Study||23
348339|NCT00529659|842546|P1|NOT COMPLETED|Overall Study||11
348340|NCT00529659|842545|P2|COMPLETED|Overall Study||66
348341|NCT00529659|842546|P1|COMPLETED|Overall Study||70
348342|NCT00529659|842545|P2|STARTED|Overall Study||89
348343|NCT00529659|842546|P1|STARTED|Overall Study||81
348344|NCT00529633|842564|P2|NOT COMPLETED|Overall Study||1
348345|NCT00529633|842565|P1|NOT COMPLETED|Overall Study||1
348346|NCT00529633|842564|P2|COMPLETED|Overall Study||1
348347|NCT00529633|842565|P1|COMPLETED|Overall Study||1
348348|NCT00529633|842564|P2|STARTED|Overall Study||2
348349|NCT00529633|842565|P1|STARTED|Overall Study||2
348350|NCT00529568|842577|P3|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||102
348351|NCT00529568|842578|P2|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||48
348352|NCT00529568|842579|P1|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||0
348353|NCT00529568|842577|P3|COMPLETED|Double-bilnd Antiviral Treatment Phase||404
348354|NCT00529568|842578|P2|COMPLETED|Double-bilnd Antiviral Treatment Phase||205
348355|NCT00529568|842579|P1|COMPLETED|Double-bilnd Antiviral Treatment Phase||0
348356|NCT00529568|842577|P3|STARTED|Double-bilnd Antiviral Treatment Phase||506
348357|NCT00529568|842578|P2|STARTED|Double-bilnd Antiviral Treatment Phase||253
348358|NCT00529568|842579|P1|STARTED|Double-bilnd Antiviral Treatment Phase||0
348359|NCT00529568|842577|P3|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
348360|NCT00529568|842578|P2|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
348361|NCT00529568|842579|P1|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||46
348362|NCT00529568|842577|P3|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
348363|NCT00529568|842578|P2|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
348364|NCT00529568|842579|P1|COMPLETED|Open-label Pre-Antiviral Treatment Phase||759
348365|NCT00529568|842577|P3|STARTED|Open-label Pre-Antiviral Treatment Phase||0
348366|NCT00529568|842578|P2|STARTED|Open-label Pre-Antiviral Treatment Phase||0
348367|NCT00529568|842579|P1|STARTED|Open-label Pre-Antiviral Treatment Phase||805
348368|NCT00529555|842630|P3|NOT COMPLETED|Overall Study||26
348369|NCT00529555|842631|P2|NOT COMPLETED|Overall Study||30
348370|NCT00529555|842632|P1|NOT COMPLETED|Overall Study||29
348371|NCT00529555|842630|P3|COMPLETED|Overall Study||174
348372|NCT00529555|842631|P2|COMPLETED|Overall Study||172
348373|NCT00529555|842632|P1|COMPLETED|Overall Study||171
348374|NCT00529555|842630|P3|STARTED|Overall Study||200
348375|NCT00529555|842631|P2|STARTED|Overall Study||202
348376|NCT00529555|842632|P1|STARTED|Overall Study||200
348377|NCT00529542|842642|P2|NOT COMPLETED|Overall Study||1
348378|NCT00529542|842643|P1|NOT COMPLETED|Overall Study||1
348379|NCT00529542|842642|P2|COMPLETED|Overall Study||10
348380|NCT00529542|842643|P1|COMPLETED|Overall Study||8
348381|NCT00529542|842642|P2|STARTED|Overall Study||11
348382|NCT00529542|842643|P1|STARTED|Overall Study||9
348383|NCT00529529|842686|P3|NOT COMPLETED|Overall Study||31
348384|NCT00529529|842687|P2|NOT COMPLETED|Overall Study||43
348385|NCT00529529|842688|P1|NOT COMPLETED|Overall Study||43
348386|NCT00529529|842686|P3|COMPLETED|Overall Study||238
348387|NCT00529529|842687|P2|COMPLETED|Overall Study||225
348388|NCT00529529|842688|P1|COMPLETED|Overall Study||225
348389|NCT00529529|842686|P3|STARTED|Overall Study||269
348390|NCT00529529|842687|P2|STARTED|Overall Study||268
348391|NCT00529529|842688|P1|STARTED|Overall Study||268
348392|NCT00529516|842747|P3|NOT COMPLETED|Overall Study||1
348393|NCT00529516|842748|P2|NOT COMPLETED|Overall Study||2
348394|NCT00529516|842749|P1|NOT COMPLETED|Overall Study||3
348395|NCT00529516|842747|P3|COMPLETED|Overall Study||288
348396|NCT00529516|842748|P2|COMPLETED|Overall Study||486
348397|NCT00529516|842749|P1|COMPLETED|Overall Study||472
348398|NCT00529516|842747|P3|STARTED|Overall Study||289
348399|NCT00529516|842748|P2|STARTED|Overall Study||488
348400|NCT00529516|842749|P1|STARTED|Overall Study||475
348401|NCT00529464|842820|P3|NOT COMPLETED|Overall Study||0
348402|NCT00529464|842821|P2|NOT COMPLETED|Overall Study||0
348403|NCT00529464|842822|P1|NOT COMPLETED|Overall Study||0
348404|NCT00529464|842820|P3|COMPLETED|Overall Study||0
348405|NCT00529464|842821|P2|COMPLETED|Overall Study||0
348406|NCT00529464|842822|P1|COMPLETED|Overall Study||0
348407|NCT00529464|842820|P3|STARTED|Overall Study||0
348408|NCT00529464|842821|P2|STARTED|Overall Study||0
348409|NCT00529464|842822|P1|STARTED|Overall Study||0
348410|NCT00529451|842834|P4|NOT COMPLETED|Overall Study||31
348411|NCT00529451|842835|P3|NOT COMPLETED|Overall Study||40
348412|NCT00529451|842836|P2|NOT COMPLETED|Overall Study||48
348413|NCT00529451|842837|P1|NOT COMPLETED|Overall Study||37
348414|NCT00529451|842834|P4|COMPLETED|Overall Study||299
348415|NCT00529451|842835|P3|COMPLETED|Overall Study||292
348416|NCT00529451|842836|P2|COMPLETED|Overall Study||275
348417|NCT00529451|842837|P1|COMPLETED|Overall Study||294
348418|NCT00529451|842834|P4|STARTED|Overall Study||330
348419|NCT00529451|842835|P3|STARTED|Overall Study||332
348420|NCT00529451|842836|P2|STARTED|Overall Study||323
348421|NCT00529451|842837|P1|STARTED|Overall Study||331
348422|NCT00529399|842864|P3|NOT COMPLETED|Overall Study||2
348423|NCT00529399|842865|P2|NOT COMPLETED|Overall Study||1
348424|NCT00529399|842866|P1|NOT COMPLETED|Overall Study||2
348425|NCT00529399|842864|P3|COMPLETED|Overall Study||46
348426|NCT00529399|842865|P2|COMPLETED|Overall Study||48
348427|NCT00529399|842866|P1|COMPLETED|Overall Study||46
348428|NCT00529399|842864|P3|STARTED|Overall Study||48
348429|NCT00529399|842865|P2|STARTED|Overall Study||49
348430|NCT00529399|842866|P1|STARTED|Overall Study||48
348431|NCT00529386|842874|P1|NOT COMPLETED|Overall Study||1
348432|NCT00529386|842874|P1|COMPLETED|Overall Study|Study discontinued after 7 patients enrolled and analyzed|6
348433|NCT00529386|842874|P1|STARTED|Overall Study|Study has been discontinued|7
348434|NCT00529373|842880|P2|NOT COMPLETED|Second Extension Study||197
348435|NCT00529373|842881|P1|NOT COMPLETED|Second Extension Study||300
348436|NCT00529373|842880|P2|COMPLETED|Second Extension Study||2112
348437|NCT00529373|842881|P1|COMPLETED|Second Extension Study||2844
348438|NCT00529373|842880|P2|STARTED|Second Extension Study||2309
348439|NCT00529373|842881|P1|STARTED|Second Extension Study||3144
348440|NCT00529373|842880|P2|NOT COMPLETED|First Extension Study||1651
348441|NCT00529373|842881|P1|NOT COMPLETED|First Extension Study||1153
348442|NCT00529373|842880|P2|COMPLETED|First Extension Study||2309
348443|NCT00529373|842881|P1|COMPLETED|First Extension Study||3144
348444|NCT00529373|842880|P2|STARTED|First Extension Study||3960
348445|NCT00529373|842881|P1|STARTED|First Extension Study||4297
348446|NCT00529373|842880|P2|NOT COMPLETED|Base Study||4068
348447|NCT00529373|842881|P1|NOT COMPLETED|Base Study||3746
348448|NCT00529373|842880|P2|COMPLETED|Base Study||3960
348449|NCT00529373|842881|P1|COMPLETED|Base Study||4297
348450|NCT00529373|842880|P2|STARTED|Base Study||8028
348451|NCT00529373|842881|P1|STARTED|Base Study||8043
348452|NCT00529308|843075|P2|NOT COMPLETED|Overall Study||1
348453|NCT00529308|843076|P1|NOT COMPLETED|Overall Study||1
348454|NCT00529308|843075|P2|COMPLETED|Overall Study||10
348455|NCT00529308|843076|P1|COMPLETED|Overall Study||8
348456|NCT00529308|843075|P2|STARTED|Overall Study||11
348457|NCT00529308|843076|P1|STARTED|Overall Study||9
348458|NCT00529282|843092|P2|NOT COMPLETED|Overall Study||0
348459|NCT00529282|843093|P1|NOT COMPLETED|Overall Study||0
348460|NCT00529282|843092|P2|COMPLETED|Overall Study||2
348461|NCT00529282|843093|P1|COMPLETED|Overall Study||0
348462|NCT00529282|843092|P2|STARTED|Overall Study||2
348463|NCT00529282|843093|P1|STARTED|Overall Study||0
348464|NCT00529243|843105|P1|NOT COMPLETED|Overall Study||3
348465|NCT00529243|843105|P1|COMPLETED|Overall Study||49
348466|NCT00529243|843105|P1|STARTED|Overall Study||52
348467|NCT00529217|843110|P1|NOT COMPLETED|Overall Study||4
348468|NCT00529217|843110|P1|COMPLETED|Overall Study||8
348469|NCT00529217|843110|P1|STARTED|Overall Study||12
348470|NCT00529204|843115|P1|NOT COMPLETED|Overall Study||0
348471|NCT00529204|843115|P1|COMPLETED|Overall Study||1
348472|NCT00529204|843115|P1|STARTED|Overall Study||1
348473|NCT00529191|843123|P2|NOT COMPLETED|Overall Study||0
348474|NCT00529191|843124|P1|NOT COMPLETED|Overall Study||3
348475|NCT00529191|843123|P2|COMPLETED|Overall Study||13
348476|NCT00529191|843124|P1|COMPLETED|Overall Study||24
348477|NCT00529191|843123|P2|STARTED|Overall Study||13
348478|NCT00529191|843124|P1|STARTED|Overall Study||27
348479|NCT00529152|843146|P1|NOT COMPLETED|Overall Study||5
348480|NCT00529152|843146|P1|COMPLETED|Overall Study||95
348481|NCT00529152|843146|P1|STARTED|Overall Study||100
348482|NCT00529126|843154|P4|NOT COMPLETED|Overall Study||0
348483|NCT00529126|843155|P3|NOT COMPLETED|Overall Study||0
348484|NCT00529126|843156|P2|NOT COMPLETED|Overall Study||0
348485|NCT00529126|843157|P1|NOT COMPLETED|Overall Study||0
348486|NCT00529126|843154|P4|COMPLETED|Overall Study||26
348487|NCT00529126|843155|P3|COMPLETED|Overall Study||24
348488|NCT00529126|843156|P2|COMPLETED|Overall Study||25
348489|NCT00529126|843157|P1|COMPLETED|Overall Study||25
348490|NCT00529126|843154|P4|STARTED|Overall Study||26
348491|NCT00529126|843155|P3|STARTED|Overall Study||24
348492|NCT00529126|843156|P2|STARTED|Overall Study||25
348493|NCT00529126|843157|P1|STARTED|Overall Study||25
348494|NCT00529100|843170|P2|NOT COMPLETED|Overall Study||9
348495|NCT00529100|843171|P1|NOT COMPLETED|Overall Study||0
348496|NCT00529100|843170|P2|COMPLETED|Overall Study||24
348497|NCT00529100|843171|P1|COMPLETED|Overall Study||16
348498|NCT00529100|843170|P2|Received at Least 1 Dose of Study Drug|Overall Study||33
348499|NCT00529100|843171|P1|Received at Least 1 Dose of Study Drug|Overall Study||16
348500|NCT00529100|843170|P2|STARTED|Overall Study||33
348501|NCT00529100|843171|P1|STARTED|Overall Study||16
348502|NCT00529087|843188|P3|NOT COMPLETED|Overall Study||16
348503|NCT00529087|843189|P2|NOT COMPLETED|Overall Study||28
348504|NCT00529087|843190|P1|NOT COMPLETED|Overall Study||28
348505|NCT00529087|843188|P3|COMPLETED|Overall Study||146
348506|NCT00529087|843189|P2|COMPLETED|Overall Study||120
348507|NCT00529087|843190|P1|COMPLETED|Overall Study||122
348508|NCT00529087|843188|P3|STARTED|Overall Study||162
348509|NCT00529087|843189|P2|STARTED|Overall Study||148
348510|NCT00529087|843190|P1|STARTED|Overall Study||150
348511|NCT00529035|843254|P1|NOT COMPLETED|Overall Study||1
348512|NCT00529035|843254|P1|COMPLETED|Overall Study|28 evaluable, 1 patient withdrew participation and was not evaluable|28
348513|NCT00529035|843254|P1|STARTED|Overall Study|29 enrolled|29
348514|NCT00528970|843268|P3|NOT COMPLETED|Overall Study||20
348515|NCT00528970|843269|P2|NOT COMPLETED|Overall Study||15
348516|NCT00528970|843270|P1|NOT COMPLETED|Overall Study||14
348517|NCT00528970|843268|P3|COMPLETED|Overall Study||105
348518|NCT00528970|843269|P2|COMPLETED|Overall Study||110
348519|NCT00528970|843270|P1|COMPLETED|Overall Study||110
348520|NCT00528970|843268|P3|Received at Least 1 Dose of Study Drug|Overall Study||124
348521|NCT00528970|843269|P2|Received at Least 1 Dose of Study Drug|Overall Study||125
348522|NCT00528970|843270|P1|Received at Least 1 Dose of Study Drug|Overall Study||124
348523|NCT00528970|843268|P3|STARTED|Overall Study||125
348524|NCT00528970|843269|P2|STARTED|Overall Study||125
348525|NCT00528970|843270|P1|STARTED|Overall Study||124
348526|NCT00528957|843289|P2|NOT COMPLETED|Long-Term Extension (Week 336 and On)||17
348527|NCT00528957|843290|P1|NOT COMPLETED|Long-Term Extension (Week 336 and On)||10
348528|NCT00528957|843289|P2|COMPLETED|Long-Term Extension (Week 336 and On)||8
348529|NCT00528957|843290|P1|COMPLETED|Long-Term Extension (Week 336 and On)||9
348530|NCT00528957|843289|P2|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|25
348531|NCT00528957|843290|P1|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|19
348532|NCT00528957|843289|P2|NOT COMPLETED|Third Extension (Week 240 to Week 336)||10
348533|NCT00528957|843290|P1|NOT COMPLETED|Third Extension (Week 240 to Week 336)||6
348534|NCT00528957|843289|P2|COMPLETED|Third Extension (Week 240 to Week 336)||27
348535|NCT00528957|843290|P1|COMPLETED|Third Extension (Week 240 to Week 336)||21
348536|NCT00528957|843289|P2|STARTED|Third Extension (Week 240 to Week 336)||37
348537|NCT00528957|843290|P1|STARTED|Third Extension (Week 240 to Week 336)||27
348538|NCT00528957|843289|P2|NOT COMPLETED|Second Extension (Week 144 to Week 240)||3
348539|NCT00528957|843290|P1|NOT COMPLETED|Second Extension (Week 144 to Week 240)||7
348540|NCT00528957|843289|P2|COMPLETED|Second Extension (Week 144 to Week 240)||37
348541|NCT00528957|843290|P1|COMPLETED|Second Extension (Week 144 to Week 240)||27
348542|NCT00528957|843289|P2|STARTED|Second Extension (Week 144 to Week 240)||40
348543|NCT00528957|843290|P1|STARTED|Second Extension (Week 144 to Week 240)|One participant completed the first extension and did not enroll in the second extension.|34
348544|NCT00528957|843289|P2|NOT COMPLETED|First Extension (Week 48 to Week 144)||1
348545|NCT00528957|843290|P1|NOT COMPLETED|First Extension (Week 48 to Week 144)||3
348546|NCT00528957|843289|P2|COMPLETED|First Extension (Week 48 to Week 144)||40
348547|NCT00528957|843290|P1|COMPLETED|First Extension (Week 48 to Week 144)||35
348548|NCT00528957|843289|P2|STARTED|First Extension (Week 48 to Week 144)|Seven participants completed the 48-week randomized phase and did not enroll in the first extension.|41
348549|NCT00528957|843290|P1|STARTED|First Extension (Week 48 to Week 144)|Six participants completed the 48-week randomized phase and did not enroll in the first extension.|38
348550|NCT00528957|843289|P2|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||1
348551|NCT00528957|843290|P1|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||4
348552|NCT00528957|843289|P2|COMPLETED|Randomized Phase (Baseline to Week 48)||48
348553|NCT00528957|843290|P1|COMPLETED|Randomized Phase (Baseline to Week 48)||44
348554|NCT00528957|843289|P2|STARTED|Randomized Phase (Baseline to Week 48)||49
348555|NCT00528957|843290|P1|STARTED|Randomized Phase (Baseline to Week 48)||48
348556|NCT00528931|843431|P1|NOT COMPLETED|Overall Study||1
348557|NCT00528931|843431|P1|COMPLETED|Overall Study||15
348558|NCT00528931|843431|P1|STARTED|Overall Study||16
348559|NCT00528879|843443|P4|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||24
348560|NCT00528879|843444|P3|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||33
348561|NCT00528879|843445|P2|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||38
348562|NCT00528879|843446|P1|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||42
348563|NCT00528879|843443|P4|COMPLETED|Long-term Period (Weeks 24 to 102)||95
348564|NCT00528879|843444|P3|COMPLETED|Long-term Period (Weeks 24 to 102)||89
348565|NCT00528879|843445|P2|COMPLETED|Long-term Period (Weeks 24 to 102)||82
348566|NCT00528879|843446|P1|COMPLETED|Long-term Period (Weeks 24 to 102)||73
348567|NCT00528879|843443|P4|STARTED|Long-term Period (Weeks 24 to 102)||119
348568|NCT00528879|843444|P3|STARTED|Long-term Period (Weeks 24 to 102)||122
348569|NCT00528879|843445|P2|STARTED|Long-term Period (Weeks 24 to 102)||120
348570|NCT00528879|843446|P1|STARTED|Long-term Period (Weeks 24 to 102)||115
348571|NCT00528879|843443|P4|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||16
348572|NCT00528879|843444|P3|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||15
348573|NCT00528879|843445|P2|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||17
348574|NCT00528879|843446|P1|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||22
348575|NCT00528879|843443|P4|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|119
348576|NCT00528879|843444|P3|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|122
348577|NCT00528879|843445|P2|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|120
348578|NCT00528879|843446|P1|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|115
348579|NCT00528879|843443|P4|Completed the Period|Short-term Period (Day 1 to Week 24)||121
348580|NCT00528879|843444|P3|Completed the Period|Short-term Period (Day 1 to Week 24)||122
348581|NCT00528879|843445|P2|Completed the Period|Short-term Period (Day 1 to Week 24)||121
348582|NCT00528879|843446|P1|Completed the Period|Short-term Period (Day 1 to Week 24)||119
348583|NCT00528879|843443|P4|STARTED|Short-term Period (Day 1 to Week 24)||135
348584|NCT00528879|843444|P3|STARTED|Short-term Period (Day 1 to Week 24)||137
348585|NCT00528879|843445|P2|STARTED|Short-term Period (Day 1 to Week 24)||137
348586|NCT00528879|843446|P1|STARTED|Short-term Period (Day 1 to Week 24)||137
348587|NCT00528866|843512|P1|NOT COMPLETED|Overall Study||6
348588|NCT00528866|843512|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|74
348589|NCT00528866|843512|P1|STARTED|Overall Study||80
348590|NCT00528840|843525|P1|NOT COMPLETED|Overall Study||33
348591|NCT00528840|843525|P1|COMPLETED|Overall Study||168
348592|NCT00528840|843525|P1|STARTED|Overall Study||201
348593|NCT00528801|843539|P2|NOT COMPLETED|Overall Study||11
348594|NCT00528801|843540|P1|NOT COMPLETED|Overall Study||27
348595|NCT00528801|843539|P2|COMPLETED|Overall Study||41
348596|NCT00528801|843540|P1|COMPLETED|Overall Study||133
348597|NCT00528801|843539|P2|STARTED|Overall Study||52
348598|NCT00528801|843540|P1|STARTED|Overall Study||160
348599|NCT00528788|843550|P1|NOT COMPLETED|Overall Study||4
348600|NCT00528788|843550|P1|COMPLETED|Overall Study||20
348601|NCT00528788|843550|P1|STARTED|Overall Study||24
348602|NCT00528775|843554|P1|NOT COMPLETED|Overall Study||1
348603|NCT00528775|843554|P1|COMPLETED|Overall Study||5
348604|NCT00528775|843554|P1|STARTED|Overall Study||6
348605|NCT00528645|843562|P1|NOT COMPLETED|Overall Study||3
348606|NCT00528645|843562|P1|COMPLETED|Overall Study||20
348607|NCT00528645|843562|P1|STARTED|Overall Study||23
348608|NCT00528606|843571|P2|NOT COMPLETED|Overall Study||4
348609|NCT00528606|843572|P1|NOT COMPLETED|Overall Study||13
348610|NCT00528606|843571|P2|COMPLETED|Overall Study||100
348611|NCT00528606|843572|P1|COMPLETED|Overall Study||191
348612|NCT00528606|843571|P2|STARTED|Overall Study||104
348613|NCT00528606|843572|P1|STARTED|Overall Study||204
348614|NCT00528580|843596|P2|NOT COMPLETED|Overall Study||0
348615|NCT00528580|843597|P1|NOT COMPLETED|Overall Study||0
348616|NCT00528580|843596|P2|COMPLETED|Overall Study||34
348617|NCT00528580|843597|P1|COMPLETED|Overall Study||34
348618|NCT00528580|843596|P2|STARTED|Overall Study||34
348619|NCT00528580|843597|P1|STARTED|Overall Study||34
348620|NCT00528567|843605|P2|NOT COMPLETED|Overall Study||308
348621|NCT00528567|843606|P1|NOT COMPLETED|Overall Study||431
348622|NCT00528567|843605|P2|COMPLETED|Overall Study||982
348623|NCT00528567|843606|P1|COMPLETED|Overall Study||870
348624|NCT00528567|843605|P2|Safety Population|Overall Study||1271
348625|NCT00528567|843606|P1|Safety Population|Overall Study||1288
348626|NCT00528567|843605|P2|Intention to Treat|Overall Study||1290
348627|NCT00528567|843606|P1|Intention to Treat|Overall Study||1301
348628|NCT00528567|843605|P2|STARTED|Overall Study||1290
348629|NCT00528567|843606|P1|STARTED|Overall Study||1301
348630|NCT00528541|843646|P2|NOT COMPLETED|Overall Study||1
348631|NCT00528541|843647|P1|NOT COMPLETED|Overall Study||2
348632|NCT00528541|843646|P2|COMPLETED|Overall Study||69
348633|NCT00528541|843647|P1|COMPLETED|Overall Study||73
348634|NCT00528541|843646|P2|STARTED|Overall Study||70
348635|NCT00528541|843647|P1|STARTED|Overall Study||75
348636|NCT00528528|843673|P4|NOT COMPLETED|Overall Study||3
348637|NCT00528528|843674|P3|NOT COMPLETED|Overall Study||3
348638|NCT00528528|843675|P2|NOT COMPLETED|Overall Study||3
348639|NCT00528528|843676|P1|NOT COMPLETED|Overall Study||3
348640|NCT00528528|843673|P4|COMPLETED|Overall Study||36
348641|NCT00528528|843674|P3|COMPLETED|Overall Study||37
348642|NCT00528528|843675|P2|COMPLETED|Overall Study||39
348643|NCT00528528|843676|P1|COMPLETED|Overall Study||37
348644|NCT00528528|843673|P4|Ongoing at Time of Cut-off|Overall Study||0
348645|NCT00528528|843674|P3|Ongoing at Time of Cut-off|Overall Study||1
348646|NCT00528528|843675|P2|Ongoing at Time of Cut-off|Overall Study||0
348647|NCT00528528|843676|P1|Ongoing at Time of Cut-off|Overall Study||0
348648|NCT00528528|843673|P4|STARTED|Overall Study||39
348649|NCT00528528|843674|P3|STARTED|Overall Study||40
348650|NCT00528528|843675|P2|STARTED|Overall Study||42
348651|NCT00528528|843676|P1|STARTED|Overall Study||40
348652|NCT00528450|843710|P1|NOT COMPLETED|Overall Study||0
348653|NCT00528450|843710|P1|COMPLETED|Overall Study||1
348654|NCT00528450|843710|P1|STARTED|Overall Study||1
348655|NCT00528424|843714|P1|NOT COMPLETED|Overall Study||29
348656|NCT00528424|843714|P1|COMPLETED|Overall Study||257
348657|NCT00528424|843714|P1|STARTED|Overall Study||286
348658|NCT00528411|843729|P3|NOT COMPLETED|Overall Study||1
348659|NCT00528411|843730|P2|NOT COMPLETED|Overall Study||3
348660|NCT00528411|843731|P1|NOT COMPLETED|Overall Study||5
348661|NCT00528411|843729|P3|COMPLETED|Overall Study||11
348662|NCT00528411|843730|P2|COMPLETED|Overall Study||51
348663|NCT00528411|843731|P1|COMPLETED|Overall Study||52
348664|NCT00528411|843729|P3|STARTED|Overall Study||12
348665|NCT00528411|843730|P2|STARTED|Overall Study||54
348666|NCT00528411|843731|P1|STARTED|Overall Study||57
348667|NCT00528398|843854|P1|NOT COMPLETED|Overall Study||0
348668|NCT00528398|843854|P1|COMPLETED|Overall Study||111
348669|NCT00528398|843854|P1|STARTED|Overall Study||111
348670|NCT00528372|843868|P9|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
348671|NCT00528372|843869|P8|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
348672|NCT00528372|843870|P7|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||17
348673|NCT00528372|843871|P6|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||15
348674|NCT00528372|843872|P5|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||21
348675|NCT00528372|843873|P4|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||14
348676|NCT00528372|843874|P3|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||8
348677|NCT00528372|843875|P2|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||19
348678|NCT00528372|843876|P1|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||20
348679|NCT00528372|843868|P9|COMPLETED|Long-term (LT) Period (Weeks 24-102)||27
348680|NCT00528372|843869|P8|COMPLETED|Long-term (LT) Period (Weeks 24-102)||22
348681|NCT00528372|843870|P7|COMPLETED|Long-term (LT) Period (Weeks 24-102)||48
348682|NCT00528372|843871|P6|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
348683|NCT00528372|843872|P5|COMPLETED|Long-term (LT) Period (Weeks 24-102)||37
348684|NCT00528372|843873|P4|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
348685|NCT00528372|843874|P3|COMPLETED|Long-term (LT) Period (Weeks 24-102)||43
348686|NCT00528372|843875|P2|COMPLETED|Long-term (LT) Period (Weeks 24-102)||40
348687|NCT00528372|843876|P1|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
348688|NCT00528372|843868|P9|STARTED|Long-term (LT) Period (Weeks 24-102)|1 patient completed ST phase but withdrew for sponsor administrative reason before start of LT phase|33
348689|NCT00528372|843869|P8|STARTED|Long-term (LT) Period (Weeks 24-102)||28
348690|NCT00528372|843870|P7|STARTED|Long-term (LT) Period (Weeks 24-102)||65
348691|NCT00528372|843871|P6|STARTED|Long-term (LT) Period (Weeks 24-102)||57
348692|NCT00528372|843872|P5|STARTED|Long-term (LT) Period (Weeks 24-102)||58
348693|NCT00528372|843873|P4|STARTED|Long-term (LT) Period (Weeks 24-102)||56
348694|NCT00528372|843874|P3|STARTED|Long-term (LT) Period (Weeks 24-102)||51
348695|NCT00528372|843875|P2|STARTED|Long-term (LT) Period (Weeks 24-102)||59
348696|NCT00528372|843876|P1|STARTED|Long-term (LT) Period (Weeks 24-102)||62
348697|NCT00528372|843868|P9|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
348698|NCT00528372|843869|P8|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||6
348699|NCT00528372|843870|P7|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
348700|NCT00528372|843871|P6|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
348701|NCT00528372|843872|P5|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||9
348702|NCT00528372|843873|P4|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||13
348703|NCT00528372|843874|P3|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
348704|NCT00528372|843875|P2|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
348705|NCT00528372|843876|P1|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
348706|NCT00528372|843868|P9|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||34
348707|NCT00528372|843869|P8|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||28
348708|NCT00528372|843870|P7|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||65
348709|NCT00528372|843871|P6|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
348710|NCT00528372|843872|P5|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||58
348711|NCT00528372|843873|P4|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
348712|NCT00528372|843874|P3|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||52
348713|NCT00528372|843875|P2|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||60
348714|NCT00528372|843876|P1|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||63
348715|NCT00528372|843868|P9|STARTED|Short-term (ST) Period (Day 1-Week 24)||39
348716|NCT00528372|843869|P8|STARTED|Short-term (ST) Period (Day 1-Week 24)||34
348717|NCT00528372|843870|P7|STARTED|Short-term (ST) Period (Day 1-Week 24)||76
348718|NCT00528372|843871|P6|STARTED|Short-term (ST) Period (Day 1-Week 24)||68
348719|NCT00528372|843872|P5|STARTED|Short-term (ST) Period (Day 1-Week 24)||67
348720|NCT00528372|843873|P4|STARTED|Short-term (ST) Period (Day 1-Week 24)||70
348721|NCT00528372|843874|P3|STARTED|Short-term (ST) Period (Day 1-Week 24)||64
348722|NCT00528372|843875|P2|STARTED|Short-term (ST) Period (Day 1-Week 24)||65
348723|NCT00528372|843876|P1|STARTED|Short-term (ST) Period (Day 1-Week 24)||75
348724|NCT00528268|843990|P2|NOT COMPLETED|Overall Study||1
348725|NCT00528268|843991|P1|NOT COMPLETED|Overall Study||1
348726|NCT00528268|843990|P2|COMPLETED|Overall Study||7
348727|NCT00528268|843991|P1|COMPLETED|Overall Study||5
348728|NCT00528268|843990|P2|STARTED|Overall Study||8
348729|NCT00528268|843991|P1|STARTED|Overall Study||6
348730|NCT00528190|843999|P2|NOT COMPLETED|Overall Study||1
348731|NCT00528190|844000|P1|NOT COMPLETED|Overall Study||0
348732|NCT00528190|843999|P2|COMPLETED|Overall Study||16
348733|NCT00528190|844000|P1|COMPLETED|Overall Study||18
348734|NCT00528190|843999|P2|STARTED|Overall Study||17
348735|NCT00528190|844000|P1|STARTED|Overall Study||18
348736|NCT00528112|844008|P2|NOT COMPLETED|Extension Phase||157
348737|NCT00528112|844009|P1|NOT COMPLETED|Extension Phase||0
348738|NCT00528112|844008|P2|COMPLETED|Extension Phase||550
348739|NCT00528112|844009|P1|COMPLETED|Extension Phase||0
348740|NCT00528112|844008|P2|STARTED|Extension Phase||707
348741|NCT00528112|844009|P1|STARTED|Extension Phase|Only subjects in the LCS16 groups could participate in the extension phase|0
348742|NCT00528112|844008|P2|NOT COMPLETED|Treatment up to 3 Years||583
348743|NCT00528112|844009|P1|NOT COMPLETED|Treatment up to 3 Years||613
348744|NCT00528112|844008|P2|COMPLETED|Treatment up to 3 Years||870
348745|NCT00528112|844009|P1|COMPLETED|Treatment up to 3 Years||819
348746|NCT00528112|844008|P2|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1452
348747|NCT00528112|844009|P1|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1432
348748|NCT00528112|844008|P2|STARTED|Treatment up to 3 Years||1453
348749|NCT00528112|844009|P1|STARTED|Treatment up to 3 Years||1432
348750|NCT00528021|844067|P4|NOT COMPLETED|Overall Study||9
348751|NCT00528021|844068|P3|NOT COMPLETED|Overall Study||7
348752|NCT00528021|844069|P2|NOT COMPLETED|Overall Study||13
348753|NCT00528021|844070|P1|NOT COMPLETED|Overall Study||17
348754|NCT00528021|844067|P4|COMPLETED|Overall Study||47
348755|NCT00528021|844068|P3|COMPLETED|Overall Study||49
348756|NCT00528021|844069|P2|COMPLETED|Overall Study||46
348757|NCT00528021|844070|P1|COMPLETED|Overall Study||42
348758|NCT00528021|844067|P4|STARTED|Overall Study||56
348759|NCT00528021|844068|P3|STARTED|Overall Study||56
348760|NCT00528021|844069|P2|STARTED|Overall Study||59
348761|NCT00528021|844070|P1|STARTED|Overall Study||59
348762|NCT00527982|844082|P2|NOT COMPLETED|Overall Study||0
348763|NCT00527982|844083|P1|NOT COMPLETED|Overall Study||1
348764|NCT00527982|844082|P2|COMPLETED|Overall Study||0
348765|NCT00527982|844083|P1|COMPLETED|Overall Study||0
348766|NCT00527982|844082|P2|STARTED|Overall Study||0
348767|NCT00527982|844083|P1|STARTED|Overall Study||1
348768|NCT00527943|844091|P2|NOT COMPLETED|Overall Study||146
348769|NCT00527943|844092|P1|NOT COMPLETED|Overall Study||160
348770|NCT00527943|844091|P2|COMPLETED|Overall Study||6327
348771|NCT00527943|844092|P1|COMPLETED|Overall Study||6311
348772|NCT00527943|844091|P2|Received Treatment|Overall Study||6446
348773|NCT00527943|844092|P1|Received Treatment|Overall Study||6441
348774|NCT00527943|844091|P2|STARTED|Overall Study||6473
348775|NCT00527943|844092|P1|STARTED|Overall Study||6471
348776|NCT00527904|844124|P1|NOT COMPLETED|Overall Study||96
348777|NCT00527904|844124|P1|COMPLETED|Overall Study||143
348778|NCT00527904|844124|P1|STARTED|Overall Study||239
348779|NCT00527878|844128|P2|NOT COMPLETED|Intervention 2||0
348780|NCT00527878|844129|P1|NOT COMPLETED|Intervention 2||0
348781|NCT00527878|844128|P2|COMPLETED|Intervention 2||4
348782|NCT00527878|844129|P1|COMPLETED|Intervention 2||5
348783|NCT00527878|844128|P2|STARTED|Intervention 2||4
348784|NCT00527878|844129|P1|STARTED|Intervention 2||5
348785|NCT00527878|844128|P2|NOT COMPLETED|Intervention 1||3
348786|NCT00527878|844129|P1|NOT COMPLETED|Intervention 1||2
348787|NCT00527878|844128|P2|COMPLETED|Intervention 1||4
348788|NCT00527878|844129|P1|COMPLETED|Intervention 1||5
348789|NCT00527878|844128|P2|STARTED|Intervention 1||7
348790|NCT00527878|844129|P1|STARTED|Intervention 1||7
348791|NCT00527826|844143|P2|NOT COMPLETED|Overall Study||26
348792|NCT00527826|844144|P1|NOT COMPLETED|Overall Study||21
348793|NCT00527826|844143|P2|COMPLETED|Overall Study||80
348794|NCT00527826|844144|P1|COMPLETED|Overall Study||87
348795|NCT00527826|844143|P2|STARTED|Overall Study||106
348796|NCT00527826|844144|P1|STARTED|Overall Study|All Patients Population was used for Participant Flow section.|108
348797|NCT00527787|844193|P2|NOT COMPLETED|Overall Study||63
348798|NCT00527787|844194|P1|NOT COMPLETED|Overall Study||38
348799|NCT00527787|844193|P2|COMPLETED|Overall Study||153
348800|NCT00527787|844194|P1|COMPLETED|Overall Study||180
348801|NCT00527787|844193|P2|STARTED|Overall Study|Safety and Intent-to-treat population (>=1 dose drug + no baseline ulcer) N=216|216
348802|NCT00527787|844194|P1|STARTED|Overall Study||218
348803|NCT00527748|844216|P1|NOT COMPLETED|Overall Study||3
348804|NCT00527748|844216|P1|COMPLETED|Overall Study||23
348805|NCT00527748|844216|P1|STARTED|Overall Study||26
348806|NCT00527735|844223|P3|NOT COMPLETED|Overall Study||107
348807|NCT00527735|844224|P2|NOT COMPLETED|Overall Study||107
348808|NCT00527735|844225|P1|NOT COMPLETED|Overall Study||108
348809|NCT00527735|844223|P3|COMPLETED|Overall Study|Still on treatment|2
348810|NCT00527735|844224|P2|COMPLETED|Overall Study|Still on treatment|2
348811|NCT00527735|844225|P1|COMPLETED|Overall Study|Still on treatment|5
348812|NCT00527735|844223|P3|STARTED|Overall Study|Treated|109
348813|NCT00527735|844224|P2|STARTED|Overall Study|Treated|109
348814|NCT00527735|844225|P1|STARTED|Overall Study|Treated|113
348815|NCT00527722|844299|P2|NOT COMPLETED|Overall Study||0
348816|NCT00527722|844300|P1|NOT COMPLETED|Overall Study||0
348817|NCT00527722|844299|P2|COMPLETED|Overall Study||25
348818|NCT00527722|844300|P1|COMPLETED|Overall Study||22
348819|NCT00527722|844299|P2|STARTED|Overall Study||25
348820|NCT00527722|844300|P1|STARTED|Overall Study||22
348821|NCT00527644|844306|P1|NOT COMPLETED|Overall Study||0
348822|NCT00527644|844306|P1|COMPLETED|Overall Study||14
348823|NCT00527644|844306|P1|STARTED|Overall Study||14
348824|NCT00527618|844311|P2|NOT COMPLETED|Week 15-18 (Second Intervention)||3
348825|NCT00527618|844312|P1|NOT COMPLETED|Week 15-18 (Second Intervention)||0
348826|NCT00527618|844311|P2|COMPLETED|Week 15-18 (Second Intervention)|Acyclovir|13
348827|NCT00527618|844312|P1|COMPLETED|Week 15-18 (Second Intervention)|Valacyclovir|12
348828|NCT00527618|844311|P2|STARTED|Week 15-18 (Second Intervention)|Acyclovir|16
348829|NCT00527618|844312|P1|STARTED|Week 15-18 (Second Intervention)|Valacyclovir|12
348830|NCT00527618|844311|P2|NOT COMPLETED|Week 13-14 (Washout)||0
348831|NCT00527618|844312|P1|NOT COMPLETED|Week 13-14 (Washout)||1
348832|NCT00527618|844311|P2|COMPLETED|Week 13-14 (Washout)||16
348833|NCT00527618|844312|P1|COMPLETED|Week 13-14 (Washout)||12
348834|NCT00527618|844311|P2|STARTED|Week 13-14 (Washout)||16
348835|NCT00527618|844312|P1|STARTED|Week 13-14 (Washout)||13
348836|NCT00527618|844311|P2|NOT COMPLETED|Week 1-12 (First Intervention)||2
348837|NCT00527618|844312|P1|NOT COMPLETED|Week 1-12 (First Intervention)||3
348838|NCT00527618|844311|P2|COMPLETED|Week 1-12 (First Intervention)|Valacyclovir|16
348839|NCT00527618|844312|P1|COMPLETED|Week 1-12 (First Intervention)|Acyclovir|13
348840|NCT00527618|844311|P2|STARTED|Week 1-12 (First Intervention)|Valacyclovir; one participant was removed from the study due to urticaria after 2.5 weeks|18
348841|NCT00527618|844312|P1|STARTED|Week 1-12 (First Intervention)|Acyclovir|16
348842|NCT00527605|844327|P2|NOT COMPLETED|Overall Study||11
348843|NCT00527605|844328|P1|NOT COMPLETED|Overall Study||13
348844|NCT00527605|844327|P2|COMPLETED|Overall Study||116
348845|NCT00527605|844328|P1|COMPLETED|Overall Study||113
348846|NCT00527605|844327|P2|STARTED|Overall Study||127
348847|NCT00527605|844328|P1|STARTED|Overall Study||126
348848|NCT00527592|844364|P1|NOT COMPLETED|Overall Study||0
348849|NCT00527592|844364|P1|COMPLETED|Overall Study||54
348850|NCT00527592|844364|P1|STARTED|Overall Study||54
348851|NCT00527566|844370|P1|NOT COMPLETED|Overall Study||0
348852|NCT00527566|844370|P1|COMPLETED|Overall Study||10
348853|NCT00527566|844370|P1|STARTED|Overall Study||10
348854|NCT00527514|844379|P1|NOT COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||2
348855|NCT00527514|844379|P1|COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||132
348856|NCT00527514|844379|P1|STARTED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|158 -24 who met blood pressure goal = 134|134
348857|NCT00527514|844379|P1|NOT COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||3
348858|NCT00527514|844379|P1|COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||158
348859|NCT00527514|844379|P1|STARTED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|178 -19 who met blood pressure goal + 2 who were mis-titrated = 161|161
348860|NCT00527514|844379|P1|NOT COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||2
348861|NCT00527514|844379|P1|COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||178
348862|NCT00527514|844379|P1|STARTED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|184 -2 who were mis-titrated -2 who met blood pressure goal = 180|180
348863|NCT00527514|844379|P1|NOT COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg||1
348864|NCT00527514|844379|P1|COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg|1 participant dropped out. 2 participants were subsequently mis-titrated to the third regimen.|184
348865|NCT00527514|844379|P1|STARTED|Weeks 1-3: Amlodipine (Aml) 5mg||185
348866|NCT00527488|844395|P4|NOT COMPLETED|Overall Study||0
348867|NCT00527488|844396|P3|NOT COMPLETED|Overall Study||1
348868|NCT00527488|844397|P2|NOT COMPLETED|Overall Study||1
348869|NCT00527488|844398|P1|NOT COMPLETED|Overall Study||0
348870|NCT00527488|844395|P4|COMPLETED|Overall Study||13
348871|NCT00527488|844396|P3|COMPLETED|Overall Study||12
348872|NCT00527488|844397|P2|COMPLETED|Overall Study||12
348873|NCT00527488|844398|P1|COMPLETED|Overall Study||13
348874|NCT00527488|844395|P4|STARTED|Overall Study||13
348875|NCT00527488|844396|P3|STARTED|Overall Study||13
348876|NCT00527488|844397|P2|STARTED|Overall Study||13
348877|NCT00527488|844398|P1|STARTED|Overall Study||13
348878|NCT00527475|844474|P2|NOT COMPLETED|Overall Study||1
348879|NCT00527475|844475|P1|NOT COMPLETED|Overall Study||3
348880|NCT00527475|844474|P2|COMPLETED|Overall Study||29
348881|NCT00527475|844475|P1|COMPLETED|Overall Study||27
348882|NCT00527475|844474|P2|STARTED|Overall Study||30
348883|NCT00527475|844475|P1|STARTED|Overall Study||30
348884|NCT00527423|844481|P1|NOT COMPLETED|Overall Study||37
348885|NCT00527423|844481|P1|COMPLETED|Overall Study||120
348886|NCT00527423|844481|P1|STARTED|Overall Study||157
348887|NCT00527397|844487|P1|NOT COMPLETED|Overall Study||24
348888|NCT00527397|844487|P1|COMPLETED|Overall Study||0
348889|NCT00527397|844487|P1|STARTED|Overall Study||24
348890|NCT00527332|844513|P2|NOT COMPLETED|Overall Study||9
348891|NCT00527332|844514|P1|NOT COMPLETED|Overall Study||9
348892|NCT00527332|844513|P2|COMPLETED|Overall Study||80
348893|NCT00527332|844514|P1|COMPLETED|Overall Study||82
348894|NCT00527332|844513|P2|STARTED|Overall Study||89
348895|NCT00527332|844514|P1|STARTED|Overall Study||91
348896|NCT00527319|844523|P3|NOT COMPLETED|Overall Study||6
348897|NCT00527319|844524|P2|NOT COMPLETED|Overall Study||4
348898|NCT00527319|844525|P1|NOT COMPLETED|Overall Study||6
348899|NCT00527319|844523|P3|COMPLETED|Overall Study||7
348900|NCT00527319|844524|P2|COMPLETED|Overall Study||8
348901|NCT00527319|844525|P1|COMPLETED|Overall Study||6
348902|NCT00527319|844523|P3|STARTED|Overall Study||13
348903|NCT00527319|844524|P2|STARTED|Overall Study||12
348904|NCT00527319|844525|P1|STARTED|Overall Study||12
348905|NCT00527124|844538|P2|NOT COMPLETED|Overall Study||0
348906|NCT00527124|844539|P1|NOT COMPLETED|Overall Study||0
348907|NCT00527124|844538|P2|COMPLETED|Overall Study||28
348908|NCT00527124|844539|P1|COMPLETED|Overall Study||29
348909|NCT00527124|844538|P2|STARTED|Overall Study||28
348910|NCT00527124|844539|P1|STARTED|Overall Study||29
348911|NCT00527111|844555|P2|NOT COMPLETED|Overall Study||22
348912|NCT00527111|844556|P1|NOT COMPLETED|Overall Study||20
348913|NCT00527111|844555|P2|COMPLETED|Overall Study||47
348914|NCT00527111|844556|P1|COMPLETED|Overall Study||50
348915|NCT00527111|844555|P2|STARTED|Overall Study||69
348916|NCT00527111|844556|P1|STARTED|Overall Study||70
348917|NCT00527098|844572|P2|NOT COMPLETED|Overall Study||0
348918|NCT00527098|844573|P1|NOT COMPLETED|Overall Study||0
348919|NCT00527098|844572|P2|COMPLETED|Overall Study||83
348920|NCT00527098|844573|P1|COMPLETED|Overall Study||36
348921|NCT00527098|844572|P2|STARTED|Overall Study||83
348922|NCT00527098|844573|P1|STARTED|Overall Study||36
348923|NCT00527072|844578|P1|NOT COMPLETED|Overall Study||36
348924|NCT00527072|844578|P1|COMPLETED|Overall Study||179
348925|NCT00527072|844578|P1|STARTED|Overall Study||215
348926|NCT00526994|844587|P3|NOT COMPLETED|Overall Study||107
348927|NCT00526994|844588|P2|NOT COMPLETED|Overall Study||121
348928|NCT00526994|844589|P1|NOT COMPLETED|Overall Study||108
348929|NCT00526994|844587|P3|COMPLETED|Overall Study||791
348930|NCT00526994|844588|P2|COMPLETED|Overall Study||772
348931|NCT00526994|844589|P1|COMPLETED|Overall Study||801
348932|NCT00526994|844587|P3|STARTED|Overall Study||898
348933|NCT00526994|844588|P2|STARTED|Overall Study||893
348934|NCT00526994|844589|P1|STARTED|Overall Study||909
348935|NCT00526890|844606|P1|NOT COMPLETED|Overall Study||2
348936|NCT00526890|844606|P1|COMPLETED|Overall Study||14
348937|NCT00526890|844606|P1|STARTED|Overall Study||16
348938|NCT00526799|844618|P2|NOT COMPLETED|Overall Study||1
348939|NCT00526799|844619|P1|NOT COMPLETED|Overall Study||1
348940|NCT00526799|844618|P2|COMPLETED|Overall Study||13
348941|NCT00526799|844619|P1|COMPLETED|Overall Study||15
348942|NCT00526799|844618|P2|STARTED|Overall Study||14
348943|NCT00526799|844619|P1|STARTED|Overall Study||16
348944|NCT00526669|844627|P2|NOT COMPLETED|Combined Treatment Phase||8
348945|NCT00526669|844628|P1|NOT COMPLETED|Combined Treatment Phase||0
348946|NCT00526669|844627|P2|COMPLETED|Combined Treatment Phase||59
348947|NCT00526669|844628|P1|COMPLETED|Combined Treatment Phase||0
348948|NCT00526669|844627|P2|STARTED|Combined Treatment Phase||67
348949|NCT00526669|844628|P1|STARTED|Combined Treatment Phase||0
348950|NCT00526669|844627|P2|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
348951|NCT00526669|844628|P1|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
348952|NCT00526669|844627|P2|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
348953|NCT00526669|844628|P1|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||67
348954|NCT00526669|844627|P2|STARTED|7-Day Run-in Monotherapy Treatment Phase||0
348955|NCT00526669|844628|P1|STARTED|7-Day Run-in Monotherapy Treatment Phase||67
348956|NCT00526656|844657|P1|NOT COMPLETED|Overall Study||2
348957|NCT00526656|844657|P1|COMPLETED|Overall Study||7
348958|NCT00526656|844657|P1|STARTED|Overall Study||9
348959|NCT00526630|844663|P2|NOT COMPLETED|Second Intervention Period - 12 Weeks||1
348960|NCT00526630|844664|P1|NOT COMPLETED|Second Intervention Period - 12 Weeks||2
348961|NCT00526630|844663|P2|COMPLETED|Second Intervention Period - 12 Weeks||7
348962|NCT00526630|844664|P1|COMPLETED|Second Intervention Period - 12 Weeks||10
348963|NCT00526630|844663|P2|STARTED|Second Intervention Period - 12 Weeks||8
348964|NCT00526630|844664|P1|STARTED|Second Intervention Period - 12 Weeks||12
348965|NCT00526630|844663|P2|NOT COMPLETED|First Intervention Period - 12 Weeks||3
348966|NCT00526630|844664|P1|NOT COMPLETED|First Intervention Period - 12 Weeks||0
348967|NCT00526630|844663|P2|COMPLETED|First Intervention Period - 12 Weeks||8
348968|NCT00526630|844664|P1|COMPLETED|First Intervention Period - 12 Weeks||12
348969|NCT00526630|844663|P2|STARTED|First Intervention Period - 12 Weeks||11
348970|NCT00526630|844664|P1|STARTED|First Intervention Period - 12 Weeks||12
348971|NCT00526591|844694|P2|NOT COMPLETED|Overall Study||0
348972|NCT00526591|844695|P1|NOT COMPLETED|Overall Study||0
348973|NCT00526591|844694|P2|COMPLETED|Overall Study||9
348974|NCT00526591|844695|P1|COMPLETED|Overall Study||8
348975|NCT00526591|844694|P2|STARTED|Overall Study||9
348976|NCT00526591|844695|P1|STARTED|Overall Study||8
348977|NCT00526474|844707|P2|NOT COMPLETED|Overall Study||272
348978|NCT00526474|844708|P1|NOT COMPLETED|Overall Study||292
348979|NCT00526474|844707|P2|COMPLETED|Overall Study||12953
348980|NCT00526474|844708|P1|COMPLETED|Overall Study||12932
348981|NCT00526474|844707|P2|Received Study Drug|Overall Study||13186
348982|NCT00526474|844708|P1|Received Study Drug|Overall Study||13166
348983|NCT00526474|844707|P2|STARTED|Overall Study||13225
348984|NCT00526474|844708|P1|STARTED|Overall Study||13224
348985|NCT00526331|844776|P1|NOT COMPLETED|Overall Study||55
348986|NCT00526331|844776|P1|COMPLETED|Overall Study||0
348987|NCT00526331|844776|P1|STARTED|Overall Study||55
348988|NCT00526292|844780|P1|NOT COMPLETED|Overall Study||0
348989|NCT00526292|844780|P1|COMPLETED|Overall Study||6
348990|NCT00526292|844780|P1|STARTED|Overall Study||6
348991|NCT00526227|844784|P1|NOT COMPLETED|Overall Study||2
348992|NCT00526227|844784|P1|COMPLETED|Overall Study||79
348993|NCT00526227|844784|P1|STARTED|Overall Study||81
348994|NCT00526188|844789|P1|NOT COMPLETED|Overall Study||0
348995|NCT00526188|844789|P1|COMPLETED|Overall Study||234
348996|NCT00526188|844789|P1|STARTED|Overall Study||234
348997|NCT00526162|844795|P1|NOT COMPLETED|Overall Study||3
348998|NCT00526162|844795|P1|COMPLETED|Overall Study||80
348999|NCT00526162|844795|P1|STARTED|Overall Study||83
349000|NCT00526123|844805|P2|NOT COMPLETED|Overall Study||246
349001|NCT00526123|844806|P1|NOT COMPLETED|Overall Study||264
349002|NCT00526123|844805|P2|COMPLETED|Overall Study||50
349003|NCT00526123|844806|P1|COMPLETED|Overall Study||39
349004|NCT00526123|844805|P2|STARTED|Overall Study|Intent-to-Treat population|296
349005|NCT00526123|844806|P1|STARTED|Overall Study|Intent-to-Treat population|303
349006|NCT00526110|844828|P2|NOT COMPLETED|Overall Study||41
349007|NCT00526110|844829|P1|NOT COMPLETED|Overall Study||2
349008|NCT00526110|844828|P2|COMPLETED|Overall Study||4
349009|NCT00526110|844829|P1|COMPLETED|Overall Study||51
349010|NCT00526110|844828|P2|STARTED|Overall Study||45
349011|NCT00526110|844829|P1|STARTED|Overall Study||53
349012|NCT00526097|844838|P2|NOT COMPLETED|Overall Study||56
349013|NCT00526097|844839|P1|NOT COMPLETED|Overall Study||15
349014|NCT00526097|844838|P2|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|191
349015|NCT00526097|844839|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|106
349016|NCT00526097|844838|P2|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|247
349017|NCT00526097|844839|P1|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|121
349018|NCT00526071|845015|P1|NOT COMPLETED|Overall Study||6
349019|NCT00526071|845015|P1|COMPLETED|Overall Study||17
349020|NCT00526071|845015|P1|Non-amenable Population; Women|Overall Study||4
349021|NCT00526071|845015|P1|Non-amenable Population; Men|Overall Study||3
349022|NCT00526071|845015|P1|Amenable Population; Women|Overall Study||5
349023|NCT00526071|845015|P1|Amenable Population; Men|Overall Study||11
349024|NCT00526071|845015|P1|Pharmacodynamic (PD) Population|Overall Study||23
349025|NCT00526071|845015|P1|Safety Population|Overall Study||23
349026|NCT00526071|845015|P1|STARTED|Overall Study||23
349027|NCT00526058|845026|P2|NOT COMPLETED|Period: Second Intervention||0
349028|NCT00526058|845027|P1|NOT COMPLETED|Period: Second Intervention||0
349029|NCT00526058|845026|P2|COMPLETED|Period: Second Intervention||9
349030|NCT00526058|845027|P1|COMPLETED|Period: Second Intervention||9
349031|NCT00526058|845026|P2|STARTED|Period: Second Intervention||9
349032|NCT00526058|845027|P1|STARTED|Period: Second Intervention||9
349033|NCT00526058|845026|P2|NOT COMPLETED|Period: First Intervention||0
349034|NCT00526058|845027|P1|NOT COMPLETED|Period: First Intervention||0
349035|NCT00526058|845026|P2|COMPLETED|Period: First Intervention||9
349036|NCT00526058|845027|P1|COMPLETED|Period: First Intervention||9
349037|NCT00526058|845026|P2|STARTED|Period: First Intervention||9
349038|NCT00526058|845027|P1|STARTED|Period: First Intervention||9
349039|NCT00525915|845041|P2|NOT COMPLETED|Overall Study||9
349040|NCT00525915|845042|P1|NOT COMPLETED|Overall Study||8
349041|NCT00525915|845041|P2|COMPLETED|Overall Study||54
349042|NCT00525915|845042|P1|COMPLETED|Overall Study|Participants who underwent surgery.|55
349043|NCT00525915|845041|P2|STARTED|Overall Study||63
349044|NCT00525915|845042|P1|STARTED|Overall Study||63
349045|NCT00525902|845048|P1|NOT COMPLETED|Overall Study||1
349046|NCT00525902|845048|P1|COMPLETED|Overall Study||30
349047|NCT00525902|845048|P1|50 Weeks|Overall Study||12
349048|NCT00525902|845048|P1|10 Weeks|Overall Study||30
349049|NCT00525902|845048|P1|STARTED|Overall Study||31
349050|NCT00525876|845055|P2|NOT COMPLETED|Overall Study||0
349051|NCT00525876|845056|P1|NOT COMPLETED|Overall Study||0
349052|NCT00525876|845055|P2|COMPLETED|Overall Study||20
349053|NCT00525876|845056|P1|COMPLETED|Overall Study||16
349054|NCT00525876|845055|P2|STARTED|Overall Study||20
349055|NCT00525876|845056|P1|STARTED|Overall Study||16
349056|NCT00525837|845062|P1|NOT COMPLETED|Overall Study||4
349057|NCT00525837|845062|P1|COMPLETED|Overall Study||14
349058|NCT00525837|845062|P1|STARTED|Overall Study||18
349059|NCT00525824|845072|P4|NOT COMPLETED|Overall Study||15
349060|NCT00525824|845073|P3|NOT COMPLETED|Overall Study||19
349061|NCT00525824|845074|P2|NOT COMPLETED|Overall Study||28
349062|NCT00525824|845075|P1|NOT COMPLETED|Overall Study||19
349063|NCT00525824|845072|P4|COMPLETED|Overall Study||188
349064|NCT00525824|845073|P3|COMPLETED|Overall Study||183
349065|NCT00525824|845074|P2|COMPLETED|Overall Study||186
349066|NCT00525824|845075|P1|COMPLETED|Overall Study||195
349067|NCT00525824|845072|P4|STARTED|Overall Study|Randomized population|203
349068|NCT00525824|845073|P3|STARTED|Overall Study|Randomized population|202
349069|NCT00525824|845074|P2|STARTED|Overall Study|Randomized population|214
349070|NCT00525824|845075|P1|STARTED|Overall Study|Randomized population|214
349071|NCT00525798|845139|P2|NOT COMPLETED|Overall Study||599
349072|NCT00525798|845140|P1|NOT COMPLETED|Overall Study||756
349073|NCT00525798|845139|P2|COMPLETED|Overall Study||1732
349074|NCT00525798|845140|P1|COMPLETED|Overall Study||1578
349075|NCT00525798|845139|P2|STARTED|Overall Study||2331
349076|NCT00525798|845140|P1|STARTED|Overall Study||2334
349077|NCT00525733|845150|P2|NOT COMPLETED|Overall Study||3
349078|NCT00525733|845151|P1|NOT COMPLETED|Overall Study||3
349079|NCT00525733|845150|P2|COMPLETED|Overall Study||23
349080|NCT00525733|845151|P1|COMPLETED|Overall Study||11
349081|NCT00525733|845150|P2|STARTED|Overall Study||26
349082|NCT00525733|845151|P1|STARTED|Overall Study||14
349083|NCT00525629|845157|P2|NOT COMPLETED|Second Intervention||15
349084|NCT00525629|845158|P1|NOT COMPLETED|Second Intervention||15
349085|NCT00525629|845157|P2|COMPLETED|Second Intervention||0
349086|NCT00525629|845158|P1|COMPLETED|Second Intervention||0
349087|NCT00525629|845157|P2|STARTED|Second Intervention||15
349088|NCT00525629|845158|P1|STARTED|Second Intervention||15
349089|NCT00525629|845157|P2|NOT COMPLETED|Washout||0
349090|NCT00525629|845158|P1|NOT COMPLETED|Washout||0
349091|NCT00525629|845157|P2|COMPLETED|Washout||15
349092|NCT00525629|845158|P1|COMPLETED|Washout||15
349093|NCT00525629|845157|P2|STARTED|Washout||15
349094|NCT00525629|845158|P1|STARTED|Washout||15
349095|NCT00525629|845157|P2|NOT COMPLETED|First Intervention||5
349096|NCT00525629|845158|P1|NOT COMPLETED|First Intervention||5
349097|NCT00525629|845157|P2|COMPLETED|First Intervention||15
349098|NCT00525629|845158|P1|COMPLETED|First Intervention||15
349099|NCT00525629|845157|P2|STARTED|First Intervention||20
349100|NCT00525629|845158|P1|STARTED|First Intervention||20
349101|NCT00525603|845164|P1|NOT COMPLETED|Overall Study||0
349102|NCT00525603|845164|P1|COMPLETED|Overall Study||60
349103|NCT00525603|845164|P1|STARTED|Overall Study||60
349104|NCT00525525|845170|P2|NOT COMPLETED|Overall Study||0
349105|NCT00525525|845171|P1|NOT COMPLETED|Overall Study||0
349106|NCT00525525|845170|P2|COMPLETED|Overall Study||15
349107|NCT00525525|845171|P1|COMPLETED|Overall Study||59
349108|NCT00525525|845170|P2|STARTED|Overall Study||15
349109|NCT00525525|845171|P1|STARTED|Overall Study||59
349110|NCT00525512|845180|P4|NOT COMPLETED|Open-Label Phase||5
349111|NCT00525512|845181|P3|NOT COMPLETED|Open-Label Phase||6
349112|NCT00525512|845182|P2|NOT COMPLETED|Open-Label Phase||0
349113|NCT00525512|845183|P1|NOT COMPLETED|Open-Label Phase||0
349114|NCT00525512|845180|P4|COMPLETED|Open-Label Phase||189
349115|NCT00525512|845181|P3|COMPLETED|Open-Label Phase||158
349116|NCT00525512|845182|P2|COMPLETED|Open-Label Phase||0
349117|NCT00525512|845183|P1|COMPLETED|Open-Label Phase||0
349118|NCT00525512|845180|P4|STARTED|Open-Label Phase||194
349119|NCT00525512|845181|P3|STARTED|Open-Label Phase||164
349120|NCT00525512|845182|P2|STARTED|Open-Label Phase||0
349121|NCT00525512|845183|P1|STARTED|Open-Label Phase||0
349122|NCT00525512|845180|P4|NOT COMPLETED|Double-Blind Phase||0
349123|NCT00525512|845181|P3|NOT COMPLETED|Double-Blind Phase||0
349124|NCT00525512|845182|P2|NOT COMPLETED|Double-Blind Phase||66
349125|NCT00525512|845183|P1|NOT COMPLETED|Double-Blind Phase||96
349126|NCT00525512|845180|P4|COMPLETED|Double-Blind Phase||0
349127|NCT00525512|845181|P3|COMPLETED|Double-Blind Phase||0
349128|NCT00525512|845182|P2|COMPLETED|Double-Blind Phase||194
349129|NCT00525512|845183|P1|COMPLETED|Double-Blind Phase||163
349130|NCT00525512|845180|P4|STARTED|Double-Blind Phase||0
349131|NCT00525512|845181|P3|STARTED|Double-Blind Phase||0
349132|NCT00525512|845182|P2|STARTED|Double-Blind Phase||260
349133|NCT00525512|845183|P1|STARTED|Double-Blind Phase||259
349134|NCT00525499|845325|P4|NOT COMPLETED|Overall Study||7
349135|NCT00525499|845326|P3|NOT COMPLETED|Overall Study||7
349136|NCT00525499|845327|P2|NOT COMPLETED|Overall Study||7
349137|NCT00525499|845328|P1|NOT COMPLETED|Overall Study||7
349138|NCT00525499|845325|P4|COMPLETED|Overall Study||39
349139|NCT00525499|845326|P3|COMPLETED|Overall Study||40
349140|NCT00525499|845327|P2|COMPLETED|Overall Study||39
349141|NCT00525499|845328|P1|COMPLETED|Overall Study||40
349142|NCT00525499|845325|P4|STARTED|Overall Study||46
349143|NCT00525499|845326|P3|STARTED|Overall Study||47
349144|NCT00525499|845327|P2|STARTED|Overall Study||46
349145|NCT00525499|845328|P1|STARTED|Overall Study||47
349146|NCT00525421|845344|P2|NOT COMPLETED|Overall Study||0
349147|NCT00525421|845345|P1|NOT COMPLETED|Overall Study||0
349148|NCT00525421|845344|P2|COMPLETED|Overall Study||10
349149|NCT00525421|845345|P1|COMPLETED|Overall Study||10
349150|NCT00525421|845344|P2|STARTED|Overall Study||10
349151|NCT00525421|845345|P1|STARTED|Overall Study|Enrollment started october 2007|10
349152|NCT00525265|845355|P2|NOT COMPLETED|Overall Study||0
349153|NCT00525265|845356|P1|NOT COMPLETED|Overall Study||1
349154|NCT00525265|845355|P2|COMPLETED|Overall Study||10
349155|NCT00525265|845356|P1|COMPLETED|Overall Study||9
349156|NCT00525265|845355|P2|STARTED|Overall Study||10
349157|NCT00525265|845356|P1|STARTED|Overall Study||10
349158|NCT00525174|845364|P2|NOT COMPLETED|Overall Study||8
349159|NCT00525174|845365|P1|NOT COMPLETED|Overall Study||9
349160|NCT00525174|845364|P2|COMPLETED|Overall Study||81
349161|NCT00525174|845365|P1|COMPLETED|Overall Study||88
349162|NCT00525174|845364|P2|STARTED|Overall Study||89
349163|NCT00525174|845365|P1|STARTED|Overall Study||97
349164|NCT00525161|845413|P1|NOT COMPLETED|Overall Study||1
349165|NCT00525161|845413|P1|COMPLETED|Overall Study||10
349166|NCT00525161|845413|P1|STARTED|Overall Study||11
349167|NCT00525148|845423|P4|NOT COMPLETED|Overall Study||61
349168|NCT00525148|845424|P3|NOT COMPLETED|Overall Study||7
349169|NCT00525148|845425|P2|NOT COMPLETED|Overall Study||38
349170|NCT00525148|845426|P1|NOT COMPLETED|Overall Study||23
349171|NCT00525148|845423|P4|COMPLETED|Overall Study||0
349172|NCT00525148|845424|P3|COMPLETED|Overall Study||0
349173|NCT00525148|845425|P2|COMPLETED|Overall Study||0
349174|NCT00525148|845426|P1|COMPLETED|Overall Study||0
349175|NCT00525148|845423|P4|STARTED|Overall Study|entered and treated|61
349176|NCT00525148|845424|P3|STARTED|Overall Study|entered and treated|7
349177|NCT00525148|845425|P2|STARTED|Overall Study|entered and treated|38
349178|NCT00525148|845426|P1|STARTED|Overall Study|entered and treated|23
349179|NCT00525135|845444|P1|NOT COMPLETED|Overall Study||0
349180|NCT00525135|845444|P1|COMPLETED|Overall Study||5
349181|NCT00525135|845444|P1|STARTED|Overall Study||5
349182|NCT00525044|845454|P2|NOT COMPLETED|Overall Study||1
349183|NCT00525044|845455|P1|NOT COMPLETED|Overall Study||0
349184|NCT00525044|845454|P2|COMPLETED|Overall Study||124
349185|NCT00525044|845455|P1|COMPLETED|Overall Study||124
349186|NCT00525044|845454|P2|STARTED|Overall Study||125
349187|NCT00525044|845455|P1|STARTED|Overall Study||124
349188|NCT00525031|845471|P2|NOT COMPLETED|Overall Study||1
349189|NCT00525031|845472|P1|NOT COMPLETED|Overall Study||1
349190|NCT00525031|845471|P2|COMPLETED|Overall Study||24
349191|NCT00525031|845472|P1|COMPLETED|Overall Study||26
349192|NCT00525031|845471|P2|STARTED|Overall Study||25
349193|NCT00525031|845472|P1|STARTED|Overall Study||27
349194|NCT00524940|845479|P1|NOT COMPLETED|Overall Study||0
349195|NCT00524940|845479|P1|COMPLETED|Overall Study||124
349196|NCT00524940|845479|P1|STARTED|Overall Study||124
349197|NCT00524771|845486|P2|NOT COMPLETED|Overall Study||585
349198|NCT00524771|845487|P1|NOT COMPLETED|Overall Study||220
349199|NCT00524771|845486|P2|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16431
349200|NCT00524771|845487|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16864
349201|NCT00524771|845486|P2|STARTED|Overall Study||17016
349202|NCT00524771|845487|P1|STARTED|Overall Study||17084
349203|NCT00524745|845501|P4|NOT COMPLETED|Overall Study||22
349204|NCT00524745|845502|P3|NOT COMPLETED|Overall Study||29
349205|NCT00524745|845503|P2|NOT COMPLETED|Overall Study||13
349206|NCT00524745|845504|P1|NOT COMPLETED|Overall Study||34
349207|NCT00524745|845501|P4|COMPLETED|Overall Study||205
349208|NCT00524745|845502|P3|COMPLETED|Overall Study||212
349209|NCT00524745|845503|P2|COMPLETED|Overall Study||193
349210|NCT00524745|845504|P1|COMPLETED|Overall Study||195
349211|NCT00524745|845501|P4|STARTED|Overall Study||227
349212|NCT00524745|845502|P3|STARTED|Overall Study||241
349213|NCT00524745|845503|P2|STARTED|Overall Study||206
349214|NCT00524745|845504|P1|STARTED|Overall Study||229
349215|NCT00524680|845530|P4|NOT COMPLETED|Overall Study||6
349216|NCT00524680|845531|P3|NOT COMPLETED|Overall Study||3
349217|NCT00524680|845532|P2|NOT COMPLETED|Overall Study||1
349218|NCT00524680|845533|P1|NOT COMPLETED|Overall Study||3
349219|NCT00524680|845530|P4|COMPLETED|Overall Study||34
349220|NCT00524680|845531|P3|COMPLETED|Overall Study||33
349221|NCT00524680|845532|P2|COMPLETED|Overall Study||34
349222|NCT00524680|845533|P1|COMPLETED|Overall Study||34
349223|NCT00524680|845530|P4|STARTED|Overall Study||40
349224|NCT00524680|845531|P3|STARTED|Overall Study||36
349225|NCT00524680|845532|P2|STARTED|Overall Study||35
349226|NCT00524680|845533|P1|STARTED|Overall Study||37
349227|NCT00524589|845555|P1|NOT COMPLETED|Overall Study||18
349228|NCT00524589|845555|P1|COMPLETED|Overall Study||0
349229|NCT00524589|845555|P1|STARTED|Overall Study||18
349230|NCT00524576|845562|P2|NOT COMPLETED|Overall Study||0
349231|NCT00524576|845563|P1|NOT COMPLETED|Overall Study||0
349232|NCT00524576|845562|P2|COMPLETED|Overall Study||47
349233|NCT00524576|845563|P1|COMPLETED|Overall Study||97
349234|NCT00524576|845562|P2|STARTED|Overall Study||47
349235|NCT00524576|845563|P1|STARTED|Overall Study||97
349236|NCT00524537|845581|P1|NOT COMPLETED|Overall Study||2574
349237|NCT00524537|845581|P1|COMPLETED|Overall Study|Still enrolled in study at the end of study|2451
349238|NCT00524537|845581|P1|Discontinued After Re-enrollment|Overall Study|Discontinued from study after re-enrollment|102
349239|NCT00524537|845581|P1|Re-enrolled|Overall Study|Discontinued from study and later re-enrolled in study|339
349240|NCT00524537|845581|P1|Discontinued|Overall Study|Discontinued from study|2811
349241|NCT00524537|845581|P1|STARTED|Overall Study|All Treated Population: All participants who received at least 1 injection of Humira in the registry|5025
349242|NCT00524511|845597|P2|NOT COMPLETED|Overall Study||7
349243|NCT00524511|845598|P1|NOT COMPLETED|Overall Study||4
349244|NCT00524511|845597|P2|COMPLETED|Overall Study||61
349245|NCT00524511|845598|P1|COMPLETED|Overall Study||64
349246|NCT00524511|845597|P2|STARTED|Overall Study||68
349247|NCT00524511|845598|P1|STARTED|Overall Study||68
349248|NCT00524485|845606|P1|NOT COMPLETED|Overall Study||5
349249|NCT00524485|845606|P1|COMPLETED|Overall Study||7
349250|NCT00524485|845606|P1|STARTED|Overall Study||12
349251|NCT00524472|845618|P2|NOT COMPLETED|Overall Study||0
349252|NCT00524472|845619|P1|NOT COMPLETED|Overall Study||0
349253|NCT00524472|845618|P2|COMPLETED|Overall Study||730
349254|NCT00524472|845619|P1|COMPLETED|Overall Study||709
349255|NCT00524472|845618|P2|STARTED|Overall Study||730
349256|NCT00524472|845619|P1|STARTED|Overall Study||709
349257|NCT00524459|845635|P1|NOT COMPLETED|Overall Study||2
349258|NCT00524459|845635|P1|COMPLETED|Overall Study||4
349259|NCT00524459|845635|P1|STARTED|Overall Study||6
349260|NCT00524420|845645|P2|NOT COMPLETED|Overall Study||0
349261|NCT00524420|845646|P1|NOT COMPLETED|Overall Study||1
349262|NCT00524420|845645|P2|COMPLETED|Overall Study||11
349263|NCT00524420|845646|P1|COMPLETED|Overall Study|1 dropped out after treatment 10 because of poor response and was included in the efficacy analyses.|7
349264|NCT00524420|845645|P2|STARTED|Overall Study||11
349265|NCT00524420|845646|P1|STARTED|Overall Study|One was incorrectly randomized;she did not have a BIRS of >7. Was excluded from efficacy analysis.|8
349266|NCT00524394|845658|P1|NOT COMPLETED|Overall Study||1
349267|NCT00524394|845658|P1|COMPLETED|Overall Study||1
349268|NCT00524394|845658|P1|STARTED|Overall Study||2
349269|NCT00524368|845664|P2|NOT COMPLETED|Overall Study||48
349270|NCT00524368|845665|P1|NOT COMPLETED|Overall Study||41
349271|NCT00524368|845664|P2|COMPLETED|Overall Study||248
349272|NCT00524368|845665|P1|COMPLETED|Overall Study||253
349273|NCT00524368|845664|P2|STARTED|Overall Study||296
349274|NCT00524368|845665|P1|STARTED|Overall Study||294
349275|NCT00524342|845693|P1|NOT COMPLETED|Overall Study||0
349276|NCT00524342|845693|P1|COMPLETED|Overall Study||7
349277|NCT00524342|845693|P1|STARTED|Overall Study||7
349278|NCT00524316|845699|P1|NOT COMPLETED|Overall Study||16
349279|NCT00524316|845699|P1|COMPLETED|Overall Study||0
349280|NCT00524316|845699|P1|STARTED|Overall Study||16
349281|NCT00524303|845711|P3|NOT COMPLETED|Overall Study||18
349282|NCT00524303|845712|P2|NOT COMPLETED|Overall Study||10
349283|NCT00524303|845713|P1|NOT COMPLETED|Overall Study||12
349284|NCT00524303|845711|P3|COMPLETED|Overall Study||15
349285|NCT00524303|845712|P2|COMPLETED|Overall Study||24
349286|NCT00524303|845713|P1|COMPLETED|Overall Study||21
349287|NCT00524303|845711|P3|STARTED|Overall Study||33
349288|NCT00524303|845712|P2|STARTED|Overall Study||34
349289|NCT00524303|845713|P1|STARTED|Overall Study||33
349290|NCT00524264|845743|P2|NOT COMPLETED|Overall Study||27
349291|NCT00524264|845744|P1|NOT COMPLETED|Overall Study||20
349292|NCT00524264|845743|P2|COMPLETED|Overall Study||57
349293|NCT00524264|845744|P1|COMPLETED|Overall Study||144
349294|NCT00524264|845743|P2|STARTED|Overall Study||84
349295|NCT00524264|845744|P1|STARTED|Overall Study||164
349296|NCT00524225|845756|P1|NOT COMPLETED|Overall Study||0
349297|NCT00524225|845756|P1|COMPLETED|Overall Study||3
349298|NCT00524225|845756|P1|STARTED|Overall Study||3
349299|NCT00524173|845765|P2|NOT COMPLETED|Overall Study||2
349300|NCT00524173|845766|P1|NOT COMPLETED|Overall Study||5
349301|NCT00524173|845765|P2|COMPLETED|Overall Study||13
349302|NCT00524173|845766|P1|COMPLETED|Overall Study||12
349303|NCT00524173|845765|P2|STARTED|Overall Study||15
349304|NCT00524173|845766|P1|STARTED|Overall Study||17
349305|NCT00524134|845778|P1|NOT COMPLETED|Overall Study||2
349306|NCT00524134|845778|P1|COMPLETED|Overall Study||4
349307|NCT00524134|845778|P1|STARTED|Overall Study||6
349308|NCT00524121|845785|P1|NOT COMPLETED|Overall Study||19
349309|NCT00524121|845785|P1|COMPLETED|Overall Study||3
349310|NCT00524121|845785|P1|STARTED|Overall Study||22
349311|NCT00524043|845805|P3|NOT COMPLETED|Overall Study||31
349312|NCT00524043|845806|P2|NOT COMPLETED|Overall Study||28
349313|NCT00524043|845807|P1|NOT COMPLETED|Overall Study||30
349314|NCT00524043|845805|P3|COMPLETED|Overall Study||35
349315|NCT00524043|845806|P2|COMPLETED|Overall Study||42
349316|NCT00524043|845807|P1|COMPLETED|Overall Study||34
349317|NCT00524043|845805|P3|STARTED|Overall Study||66
349318|NCT00524043|845806|P2|STARTED|Overall Study||70
349319|NCT00524043|845807|P1|STARTED|Overall Study|One patient was randomly assigned to treatment but did not receive placebo.|64
349320|NCT00524030|845829|P2|NOT COMPLETED|Overall Study||59
349321|NCT00524030|845830|P1|NOT COMPLETED|Overall Study||17
349322|NCT00524030|845829|P2|COMPLETED|Overall Study||70
349323|NCT00524030|845830|P1|COMPLETED|Overall Study||15
349324|NCT00524030|845829|P2|Completed Taper/Titration Phase|Overall Study||70
349325|NCT00524030|845830|P1|Completed Taper/Titration Phase|Overall Study||15
349326|NCT00524030|845829|P2|Completed Double-Blind Treatment Phase|Overall Study||70
349327|NCT00524030|845830|P1|Completed Double-Blind Treatment Phase|Overall Study||15
349328|NCT00524030|845829|P2|STARTED|Overall Study||129
349329|NCT00524030|845830|P1|STARTED|Overall Study||32
349330|NCT00523991|845850|P2|NOT COMPLETED|Overall Study||27
349331|NCT00523991|845851|P1|NOT COMPLETED|Overall Study||21
349332|NCT00523991|845850|P2|COMPLETED|Overall Study||211
349333|NCT00523991|845851|P1|COMPLETED|Overall Study||198
349334|NCT00523991|845850|P2|STARTED|Overall Study||238
349335|NCT00523991|845851|P1|STARTED|Overall Study||219
349336|NCT00523978|846131|P2|NOT COMPLETED|Overall Study||8
349337|NCT00523978|846132|P1|NOT COMPLETED|Overall Study||9
349338|NCT00523978|846131|P2|COMPLETED|Overall Study||79
349339|NCT00523978|846132|P1|COMPLETED|Overall Study||162
349340|NCT00523978|846131|P2|STARTED|Overall Study||87
349341|NCT00523978|846132|P1|STARTED|Overall Study||171
349342|NCT00523939|846146|P2|NOT COMPLETED|Overall Study||0
349343|NCT00523939|846147|P1|NOT COMPLETED|Overall Study||0
349344|NCT00523939|846146|P2|COMPLETED|Overall Study||2
349345|NCT00523939|846147|P1|COMPLETED|Overall Study||2
349346|NCT00523939|846146|P2|STARTED|Overall Study||2
349347|NCT00523939|846147|P1|STARTED|Overall Study||2
349348|NCT00523848|846154|P1|NOT COMPLETED|Overall Study||24
349349|NCT00523848|846154|P1|COMPLETED|Overall Study||22
349350|NCT00523848|846154|P1|Treated With Study Therapy|Overall Study||44
349351|NCT00523848|846154|P1|STARTED|Overall Study||46
349352|NCT00523809|846160|P1|NOT COMPLETED|Overall Study||0
349353|NCT00523809|846160|P1|COMPLETED|Overall Study||5
349354|NCT00523809|846160|P1|STARTED|Overall Study||5
349355|NCT00523744|846164|P1|NOT COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||0
349356|NCT00523744|846164|P1|COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||91
349357|NCT00523744|846164|P1|STARTED|Phase 3 - Amlodipine+Valsartan+HCTZ|Only patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg at the end of Phase 2.|91
349358|NCT00523744|846164|P1|NOT COMPLETED|Phase 2 - Amlodipine+Valsartan||3
349359|NCT00523744|846164|P1|COMPLETED|Phase 2 - Amlodipine+Valsartan||173
349360|NCT00523744|846164|P1|STARTED|Phase 2 - Amlodipine+Valsartan|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|176
349361|NCT00523744|846164|P1|NOT COMPLETED|Phase 1 - Amlodipine+Olmesartan||6
349362|NCT00523744|846164|P1|COMPLETED|Phase 1 - Amlodipine+Olmesartan||251
349363|NCT00523744|846164|P1|STARTED|Phase 1 - Amlodipine+Olmesartan||257
349364|NCT00523718|846183|P2|NOT COMPLETED|Overall Study||0
349365|NCT00523718|846184|P1|NOT COMPLETED|Overall Study||3
349366|NCT00523718|846183|P2|COMPLETED|Overall Study||18
349367|NCT00523718|846184|P1|COMPLETED|Overall Study||17
349368|NCT00523718|846183|P2|STARTED|Overall Study||18
349369|NCT00523718|846184|P1|STARTED|Overall Study||20
349370|NCT00523705|846198|P2|NOT COMPLETED|Overall Study||1
349371|NCT00523705|846199|P1|NOT COMPLETED|Overall Study||0
349372|NCT00523705|846198|P2|COMPLETED|Overall Study|1 withdrew due to no time|3
349373|NCT00523705|846199|P1|COMPLETED|Overall Study||7
349374|NCT00523705|846198|P2|STARTED|Overall Study||4
349375|NCT00523705|846199|P1|STARTED|Overall Study||7
349376|NCT00523640|846211|P1|NOT COMPLETED|Overall Study||1
349377|NCT00523640|846211|P1|COMPLETED|Overall Study|1 patient died before starting treatment|29
349378|NCT00523640|846211|P1|STARTED|Overall Study||30
349379|NCT00523614|846219|P2|NOT COMPLETED|Overall Study||0
349380|NCT00523614|846220|P1|NOT COMPLETED|Overall Study||0
349381|NCT00523614|846219|P2|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
349382|NCT00523614|846220|P1|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
349383|NCT00523614|846219|P2|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
349384|NCT00523614|846220|P1|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
349385|NCT00523549|846228|P2|NOT COMPLETED|Overall Study||16
349386|NCT00523549|846229|P1|NOT COMPLETED|Overall Study||19
349387|NCT00523549|846228|P2|COMPLETED|Overall Study||99
349388|NCT00523549|846229|P1|COMPLETED|Overall Study||95
349389|NCT00523549|846228|P2|STARTED|Overall Study||115
349390|NCT00523549|846229|P1|STARTED|Overall Study||114
349391|NCT00523419|846247|P1|NOT COMPLETED|Overall Study||32
349392|NCT00523419|846247|P1|COMPLETED|Overall Study||0
349393|NCT00523419|846247|P1|STARTED|Overall Study||32
349394|NCT00523367|846257|P1|NOT COMPLETED|Overall Study||23
349395|NCT00523367|846257|P1|COMPLETED|Overall Study||2
349396|NCT00523367|846257|P1|STARTED|Overall Study||25
349397|NCT00523341|846263|P2|NOT COMPLETED|Overall Study||1000
349398|NCT00523341|846264|P1|NOT COMPLETED|Overall Study||924
349399|NCT00523341|846263|P2|COMPLETED|Overall Study||1343
349400|NCT00523341|846264|P1|COMPLETED|Overall Study||1283
349401|NCT00523341|846263|P2|Received Treatment|Overall Study||2343
349402|NCT00523341|846264|P1|Received Treatment|Overall Study||2206
349403|NCT00523341|846263|P2|STARTED|Overall Study||2343
349404|NCT00523341|846264|P1|STARTED|Overall Study||2207
349405|NCT00523302|846366|P2|NOT COMPLETED|Overall Study||0
349406|NCT00523302|846367|P1|NOT COMPLETED|Overall Study||0
349407|NCT00523302|846366|P2|COMPLETED|Overall Study||10
349408|NCT00523302|846367|P1|COMPLETED|Overall Study||10
349409|NCT00523302|846366|P2|STARTED|Overall Study||10
349410|NCT00523302|846367|P1|STARTED|Overall Study||10
349411|NCT00523237|846377|P1|NOT COMPLETED|Overall Study||0
349412|NCT00523237|846377|P1|COMPLETED|Overall Study||14
349413|NCT00523237|846377|P1|STARTED|Overall Study||14
349414|NCT00522951|846381|P2|NOT COMPLETED|Period 2||1
349415|NCT00522951|846382|P1|NOT COMPLETED|Period 2||2
349416|NCT00522951|846381|P2|COMPLETED|Period 2||75
349417|NCT00522951|846382|P1|COMPLETED|Period 2||84
349418|NCT00522951|846381|P2|Subjects Received Treatment|Period 2||75
349419|NCT00522951|846382|P1|Subjects Received Treatment|Period 2||84
349420|NCT00522951|846381|P2|STARTED|Period 2||76
349421|NCT00522951|846382|P1|STARTED|Period 2||86
349422|NCT00522951|846381|P2|NOT COMPLETED|Washout Period||2
349423|NCT00522951|846382|P1|NOT COMPLETED|Washout Period||0
349424|NCT00522951|846381|P2|COMPLETED|Washout Period||76
349425|NCT00522951|846382|P1|COMPLETED|Washout Period||86
349426|NCT00522951|846381|P2|STARTED|Washout Period||78
349427|NCT00522951|846382|P1|STARTED|Washout Period||86
349428|NCT00522951|846381|P2|NOT COMPLETED|Period 1||1
349429|NCT00522951|846382|P1|NOT COMPLETED|Period 1||0
349430|NCT00522951|846381|P2|COMPLETED|Period 1||78
349431|NCT00522951|846382|P1|COMPLETED|Period 1||86
349432|NCT00522951|846381|P2|Received Treatment|Period 1||78
349433|NCT00522951|846382|P1|Received Treatment|Period 1||86
349434|NCT00522951|846381|P2|STARTED|Period 1||79
349435|NCT00522951|846382|P1|STARTED|Period 1||86
349436|NCT00522925|846425|P3|NOT COMPLETED|Overall Study||2
349437|NCT00522925|846426|P2|NOT COMPLETED|Overall Study||1
349438|NCT00522925|846427|P1|NOT COMPLETED|Overall Study||8
349439|NCT00522925|846425|P3|COMPLETED|Overall Study||36
349440|NCT00522925|846426|P2|COMPLETED|Overall Study||38
349441|NCT00522925|846427|P1|COMPLETED|Overall Study||28
349442|NCT00522925|846425|P3|STARTED|Overall Study||38
349443|NCT00522925|846426|P2|STARTED|Overall Study||39
349444|NCT00522925|846427|P1|STARTED|Overall Study||36
349445|NCT00522873|846437|P2|NOT COMPLETED|Overall Study||44
349446|NCT00522873|846438|P1|NOT COMPLETED|Overall Study||96
349447|NCT00522873|846437|P2|COMPLETED|Overall Study|128 women completed study medication. 129 women completed the study.|128
349448|NCT00522873|846438|P1|COMPLETED|Overall Study|394 women completed study medication. 398 women completed the study.|394
349449|NCT00522873|846437|P2|Received Treatment|Overall Study||172
349450|NCT00522873|846438|P1|Received Treatment|Overall Study||489
349451|NCT00522873|846437|P2|STARTED|Overall Study||172
349452|NCT00522873|846438|P1|STARTED|Overall Study||490
349453|NCT00522795|846447|P1|NOT COMPLETED|Overall Study||0
349454|NCT00522795|846447|P1|COMPLETED|Overall Study||40
349455|NCT00522795|846447|P1|STARTED|Overall Study||40
349456|NCT00522626|846451|P1|NOT COMPLETED|Overall Study||7
349457|NCT00522626|846451|P1|COMPLETED|Overall Study||12
349458|NCT00522626|846451|P1|STARTED|Overall Study||19
349459|NCT00522548|846457|P2|NOT COMPLETED|Overall Study||4
349460|NCT00522548|846458|P1|NOT COMPLETED|Overall Study||2
349461|NCT00522548|846457|P2|COMPLETED|Overall Study||15
349462|NCT00522548|846458|P1|COMPLETED|Overall Study||16
349463|NCT00522548|846457|P2|Completed 2/2 PK Visits|Overall Study||5
349464|NCT00522548|846458|P1|Completed 2/2 PK Visits|Overall Study||7
349465|NCT00522548|846457|P2|Completed 1/2 PK Visits|Overall Study||1
349466|NCT00522548|846458|P1|Completed 1/2 PK Visits|Overall Study||1
349467|NCT00522548|846457|P2|Completed 0/2 PK Visits|Overall Study||4
349468|NCT00522548|846458|P1|Completed 0/2 PK Visits|Overall Study||3
349469|NCT00522548|846457|P2|Consented to Pharmacokinetic Study|Overall Study||10
349470|NCT00522548|846458|P1|Consented to Pharmacokinetic Study|Overall Study||11
349471|NCT00522548|846457|P2|STARTED|Overall Study||19
349472|NCT00522548|846458|P1|STARTED|Overall Study||18
349473|NCT00522457|846486|P1|NOT COMPLETED|Overall Study||18
349474|NCT00522457|846486|P1|COMPLETED|Overall Study||1
349475|NCT00522457|846486|P1|STARTED|Overall Study||19
349476|NCT00522431|846492|P1|NOT COMPLETED|Overall Study||11
349477|NCT00522431|846492|P1|COMPLETED|Overall Study||138
349478|NCT00522431|846492|P1|STARTED|Overall Study||149
349479|NCT00522418|846499|P2|NOT COMPLETED|Overall Study||58
349480|NCT00522418|846500|P1|NOT COMPLETED|Overall Study||57
349481|NCT00522418|846499|P2|COMPLETED|Overall Study|Completed 2-year follow-up|5
349482|NCT00522418|846500|P1|COMPLETED|Overall Study|Completed 2-year follow-up|2
349483|NCT00522418|846499|P2|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|29
349484|NCT00522418|846500|P1|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|31
349485|NCT00522418|846499|P2|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|35
349486|NCT00522418|846500|P1|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|33
349487|NCT00522418|846499|P2|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|45
349488|NCT00522418|846500|P1|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|38
349489|NCT00522418|846499|P2|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
349490|NCT00522418|846500|P1|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
349491|NCT00522418|846499|P2|Efficacy Set|Overall Study|10 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
349492|NCT00522418|846500|P1|Efficacy Set|Overall Study|6 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
349493|NCT00522418|846499|P2|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site’s local ethics committee.|58
349494|NCT00522418|846500|P1|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site’s local ethics committee.|54
349495|NCT00522418|846499|P2|STARTED|Overall Study||63
349496|NCT00522418|846500|P1|STARTED|Overall Study||59
349497|NCT00522392|846548|P2|NOT COMPLETED|Overall Study||13
349498|NCT00522392|846549|P1|NOT COMPLETED|Overall Study||8
349499|NCT00522392|846548|P2|COMPLETED|Overall Study||12
349500|NCT00522392|846549|P1|COMPLETED|Overall Study||15
349501|NCT00522392|846548|P2|Pts w/ QOL Assessments Complete|Overall Study||8
349502|NCT00522392|846549|P1|Pts w/ QOL Assessments Complete|Overall Study||12
349503|NCT00522392|846548|P2|Pts w/ Measurable Disease at Baseline|Overall Study||16
349504|NCT00522392|846549|P1|Pts w/ Measurable Disease at Baseline|Overall Study||16
349505|NCT00522392|846548|P2|STARTED|Overall Study||25
349506|NCT00522392|846549|P1|STARTED|Overall Study||23
349507|NCT00522379|846566|P5|NOT COMPLETED|Overall Study||27
349508|NCT00522379|846567|P4|NOT COMPLETED|Overall Study||14
349509|NCT00522379|846568|P3|NOT COMPLETED|Overall Study||22
349510|NCT00522379|846569|P2|NOT COMPLETED|Overall Study||23
349511|NCT00522379|846570|P1|NOT COMPLETED|Overall Study||22
349512|NCT00522379|846566|P5|COMPLETED|Overall Study||81
349513|NCT00522379|846567|P4|COMPLETED|Overall Study||80
349514|NCT00522379|846568|P3|COMPLETED|Overall Study||82
349515|NCT00522379|846569|P2|COMPLETED|Overall Study||84
349516|NCT00522379|846570|P1|COMPLETED|Overall Study||79
349517|NCT00522379|846566|P5|STARTED|Overall Study||108
349518|NCT00522379|846567|P4|STARTED|Overall Study||94
349519|NCT00522379|846568|P3|STARTED|Overall Study||104
349520|NCT00522379|846569|P2|STARTED|Overall Study||107
349521|NCT00522379|846570|P1|STARTED|Overall Study||101
349522|NCT00522301|846672|P1|NOT COMPLETED|Overall Study||6
349523|NCT00522301|846672|P1|COMPLETED|Overall Study||0
349524|NCT00522301|846672|P1|STARTED|Overall Study||6
349525|NCT00522275|846676|P1|NOT COMPLETED|Overall Study||170
349526|NCT00522275|846676|P1|COMPLETED|Overall Study||138
349527|NCT00522275|846676|P1|STARTED|Overall Study||308
349528|NCT00522171|846686|P2|NOT COMPLETED|Overall Study||0
349529|NCT00522171|846687|P1|NOT COMPLETED|Overall Study||0
349530|NCT00522171|846686|P2|COMPLETED|Overall Study||15
349531|NCT00522171|846687|P1|COMPLETED|Overall Study||15
349532|NCT00522171|846686|P2|STARTED|Overall Study||15
349533|NCT00522171|846687|P1|STARTED|Overall Study||15
349534|NCT00522041|846697|P2|NOT COMPLETED|Overall Study||12
349535|NCT00522041|846698|P1|NOT COMPLETED|Overall Study||17
349536|NCT00522041|846697|P2|COMPLETED|Overall Study||113
349537|NCT00522041|846698|P1|COMPLETED|Overall Study||106
349538|NCT00522041|846697|P2|Received Treatment|Overall Study||124
349539|NCT00522041|846698|P1|Received Treatment|Overall Study||123
349540|NCT00522041|846697|P2|STARTED|Overall Study||125
349541|NCT00522041|846698|P1|STARTED|Overall Study||123
349542|NCT00521989|846713|P5|NOT COMPLETED|Overall Study||23
349543|NCT00521989|846714|P4|NOT COMPLETED|Overall Study||12
349544|NCT00521989|846715|P3|NOT COMPLETED|Overall Study||16
349545|NCT00521989|846716|P2|NOT COMPLETED|Overall Study||17
349546|NCT00521989|846717|P1|NOT COMPLETED|Overall Study||20
349547|NCT00521989|846713|P5|COMPLETED|Overall Study||35
349548|NCT00521989|846714|P4|COMPLETED|Overall Study||42
349549|NCT00521989|846715|P3|COMPLETED|Overall Study||41
349550|NCT00521989|846716|P2|COMPLETED|Overall Study||37
349551|NCT00521989|846717|P1|COMPLETED|Overall Study||36
349552|NCT00521989|846713|P5|STARTED|Overall Study||58
349553|NCT00521989|846714|P4|STARTED|Overall Study||54
349554|NCT00521989|846715|P3|STARTED|Overall Study||57
349555|NCT00521989|846716|P2|STARTED|Overall Study||54
349556|NCT00521989|846717|P1|STARTED|Overall Study||56
349557|NCT00521976|846729|P1|NOT COMPLETED|Overall Study||0
349558|NCT00521976|846729|P1|COMPLETED|Overall Study||871
349559|NCT00521976|846729|P1|STARTED|Overall Study||871
349560|NCT00521924|846736|P2|NOT COMPLETED|Overall Study||4
349561|NCT00521924|846737|P1|NOT COMPLETED|Overall Study||4
349562|NCT00521924|846736|P2|COMPLETED|Overall Study|At Early Termination, 3 patients completed Week 6 and 1 completed Week 22.|0
349563|NCT00521924|846737|P1|COMPLETED|Overall Study|At Early Termination, 1 patient completed Week 2 and 2 patients completed Week 6.|0
349564|NCT00521924|846736|P2|STARTED|Overall Study|Subjects randomized|4
349565|NCT00521924|846737|P1|STARTED|Overall Study|Subjects randomized|4
349566|NCT00521885|846745|P2|NOT COMPLETED|Overall Study||0
349567|NCT00521885|846746|P1|NOT COMPLETED|Overall Study||0
349568|NCT00521885|846745|P2|COMPLETED|Overall Study||0
349569|NCT00521885|846746|P1|COMPLETED|Overall Study||0
349570|NCT00521885|846745|P2|STARTED|Overall Study||0
349571|NCT00521885|846746|P1|STARTED|Overall Study||0
349572|NCT00521599|846757|P3|NOT COMPLETED|Overall Study||36
349573|NCT00521599|846758|P2|NOT COMPLETED|Overall Study||29
349574|NCT00521599|846759|P1|NOT COMPLETED|Overall Study||25
349575|NCT00521599|846757|P3|COMPLETED|Overall Study||100
349576|NCT00521599|846758|P2|COMPLETED|Overall Study||239
349577|NCT00521599|846759|P1|COMPLETED|Overall Study||243
349578|NCT00521599|846757|P3|STARTED|Overall Study||136
349579|NCT00521599|846758|P2|STARTED|Overall Study||268
349580|NCT00521599|846759|P1|STARTED|Overall Study||268
349581|NCT00521586|846770|P2|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||12
349582|NCT00521586|846771|P1|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||3
349583|NCT00521586|846770|P2|COMPLETED|Revaccination With 13vPnC (Year 5)||351
349584|NCT00521586|846771|P1|COMPLETED|Revaccination With 13vPnC (Year 5)||361
349585|NCT00521586|846770|P2|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||351
349586|NCT00521586|846771|P1|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||361
349587|NCT00521586|846770|P2|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||359
349588|NCT00521586|846771|P1|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||363
349589|NCT00521586|846770|P2|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||363
349590|NCT00521586|846771|P1|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||364
349591|NCT00521586|846770|P2|STARTED|Revaccination With 13vPnC (Year 5)||363
349592|NCT00521586|846771|P1|STARTED|Revaccination With 13vPnC (Year 5)||364
349593|NCT00521586|846770|P2|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||170
349594|NCT00521586|846771|P1|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||169
349595|NCT00521586|846770|P2|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||363
349596|NCT00521586|846771|P1|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||364
349597|NCT00521586|846770|P2|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
349598|NCT00521586|846771|P1|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
349599|NCT00521586|846770|P2|NOT COMPLETED|Initial Vaccination (Year 0)||29
349600|NCT00521586|846771|P1|NOT COMPLETED|Initial Vaccination (Year 0)||21
349601|NCT00521586|846770|P2|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
349602|NCT00521586|846771|P1|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
349603|NCT00521586|846770|P2|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|529
349604|NCT00521586|846771|P1|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|531
349605|NCT00521586|846770|P2|Vaccinated Dose 2|Initial Vaccination (Year 0)||543
349606|NCT00521586|846771|P1|Vaccinated Dose 2|Initial Vaccination (Year 0)||538
349607|NCT00521586|846770|P2|Vaccinated Dose 1|Initial Vaccination (Year 0)||560
349608|NCT00521586|846771|P1|Vaccinated Dose 1|Initial Vaccination (Year 0)||551
349609|NCT00521586|846770|P2|STARTED|Initial Vaccination (Year 0)||562
349610|NCT00521586|846771|P1|STARTED|Initial Vaccination (Year 0)||554
349611|NCT00521456|846831|P2|NOT COMPLETED|Overall Study||28
349612|NCT00521456|846832|P1|NOT COMPLETED|Overall Study||13
349613|NCT00521456|846831|P2|COMPLETED|Overall Study||59
349614|NCT00521456|846832|P1|COMPLETED|Overall Study||163
349615|NCT00521456|846831|P2|STARTED|Overall Study||87
349616|NCT00521456|846832|P1|STARTED|Overall Study||176
349617|NCT00521365|846844|P1|NOT COMPLETED|Overall Study||20
349618|NCT00521365|846844|P1|COMPLETED|Overall Study|68 participants completed the study and 68 completed without protocol deviations|68
349619|NCT00521365|846844|P1|Safety Analysis Set|Overall Study|All participants who received study treatment|88
349620|NCT00521365|846844|P1|Per Protocol (PP) Population|Overall Study|All participants without protocol deviations|68
349621|NCT00521365|846844|P1|Modified Intention to Treat (mITT)|Overall Study|Participants who have an YMRS assessment at inclusion, and at least one assessment after inclusion|88
349622|NCT00521365|846844|P1|STARTED|Overall Study|98 participants were screened and obtain 88 patients who receive study treatment|88
349623|NCT00521352|846863|P2|NOT COMPLETED|Overall Study||3
349624|NCT00521352|846864|P1|NOT COMPLETED|Overall Study||1
349625|NCT00521352|846863|P2|COMPLETED|Overall Study||10
349626|NCT00521352|846864|P1|COMPLETED|Overall Study||11
349627|NCT00521352|846863|P2|STARTED|Overall Study||13
349628|NCT00521352|846864|P1|STARTED|Overall Study||12
349629|NCT00521339|846874|P3|NOT COMPLETED|Observational Follow Up Phase||0
349630|NCT00521339|846875|P2|NOT COMPLETED|Observational Follow Up Phase||0
349631|NCT00521339|846876|P1|NOT COMPLETED|Observational Follow Up Phase||0
349632|NCT00521339|846874|P3|COMPLETED|Observational Follow Up Phase||4
349633|NCT00521339|846875|P2|COMPLETED|Observational Follow Up Phase||4
349634|NCT00521339|846876|P1|COMPLETED|Observational Follow Up Phase||14
349635|NCT00521339|846874|P3|STARTED|Observational Follow Up Phase||4
349636|NCT00521339|846875|P2|STARTED|Observational Follow Up Phase||4
349637|NCT00521339|846876|P1|STARTED|Observational Follow Up Phase||14
349638|NCT00521339|846874|P3|NOT COMPLETED|Treatment Extension Phase||3
349639|NCT00521339|846875|P2|NOT COMPLETED|Treatment Extension Phase||0
349640|NCT00521339|846876|P1|NOT COMPLETED|Treatment Extension Phase||0
349641|NCT00521339|846874|P3|COMPLETED|Treatment Extension Phase||4
349642|NCT00521339|846875|P2|COMPLETED|Treatment Extension Phase||4
349643|NCT00521339|846876|P1|COMPLETED|Treatment Extension Phase||0
349644|NCT00521339|846874|P3|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|7
349645|NCT00521339|846875|P2|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|4
349646|NCT00521339|846876|P1|STARTED|Treatment Extension Phase||0
349647|NCT00521339|846874|P3|NOT COMPLETED|Treatment Phase||0
349648|NCT00521339|846875|P2|NOT COMPLETED|Treatment Phase||0
349649|NCT00521339|846876|P1|NOT COMPLETED|Treatment Phase||12
349650|NCT00521339|846874|P3|COMPLETED|Treatment Phase||0
349651|NCT00521339|846875|P2|COMPLETED|Treatment Phase||0
349652|NCT00521339|846876|P1|COMPLETED|Treatment Phase||19
349653|NCT00521339|846874|P3|Received Apremilast|Treatment Phase||0
349654|NCT00521339|846875|P2|Received Apremilast|Treatment Phase||0
349655|NCT00521339|846876|P1|Received Apremilast|Treatment Phase|1 participant withdrew consent prior to first visit and was excluded from safety population|30
349656|NCT00521339|846874|P3|STARTED|Treatment Phase||0
349657|NCT00521339|846875|P2|STARTED|Treatment Phase||0
349658|NCT00521339|846876|P1|STARTED|Treatment Phase||31
349659|NCT00521144|846944|P5|NOT COMPLETED|Overall Study||7
349660|NCT00521144|846945|P4|NOT COMPLETED|Overall Study||1
349661|NCT00521144|846946|P3|NOT COMPLETED|Overall Study||2
349662|NCT00521144|846947|P2|NOT COMPLETED|Overall Study||3
349663|NCT00521144|846948|P1|NOT COMPLETED|Overall Study||4
349664|NCT00521144|846944|P5|COMPLETED|Overall Study||0
349665|NCT00521144|846945|P4|COMPLETED|Overall Study||0
349666|NCT00521144|846946|P3|COMPLETED|Overall Study||1
349667|NCT00521144|846947|P2|COMPLETED|Overall Study||2
349668|NCT00521144|846948|P1|COMPLETED|Overall Study||2
349669|NCT00521144|846944|P5|STARTED|Overall Study||7
349670|NCT00521144|846945|P4|STARTED|Overall Study||1
349671|NCT00521144|846946|P3|STARTED|Overall Study||3
349672|NCT00521144|846947|P2|STARTED|Overall Study||5
349673|NCT00521144|846948|P1|STARTED|Overall Study||6
349674|NCT00521079|846962|P2|NOT COMPLETED|Overall Study||5
349675|NCT00521079|846963|P1|NOT COMPLETED|Overall Study||14
349676|NCT00521079|846962|P2|COMPLETED|Overall Study||97
349677|NCT00521079|846963|P1|COMPLETED|Overall Study||178
349678|NCT00521079|846962|P2|Surgical Roll-In|Overall Study||5
349679|NCT00521079|846963|P1|Surgical Roll-In|Overall Study||9
349680|NCT00521079|846962|P2|STARTED|Overall Study||102
349681|NCT00521079|846963|P1|STARTED|Overall Study||192
349682|NCT00521053|846973|P1|NOT COMPLETED|Observation Phase||68
349683|NCT00521053|846973|P1|COMPLETED|Observation Phase||12
349684|NCT00521053|846973|P1|STARTED|Observation Phase||80
349685|NCT00521053|846973|P1|NOT COMPLETED|Treatment Phase||0
349686|NCT00521053|846973|P1|COMPLETED|Treatment Phase||80
349687|NCT00521053|846973|P1|Received 4 Cycles of PV-10|Treatment Phase||3
349688|NCT00521053|846973|P1|Received 3 Cycles of PV-10|Treatment Phase||16
349689|NCT00521053|846973|P1|Received 2 Cycles of PV-10|Treatment Phase||26
349690|NCT00521053|846973|P1|Received 1 Cycle of PV-10|Treatment Phase||35
349691|NCT00521053|846973|P1|STARTED|Treatment Phase||80
349692|NCT00521014|846983|P1|NOT COMPLETED|Overall Study||1
349693|NCT00521014|846983|P1|COMPLETED|Overall Study||13
349694|NCT00521014|846983|P1|STARTED|Overall Study||14
349695|NCT00521001|846987|P1|NOT COMPLETED|Overall Study||1
349696|NCT00521001|846987|P1|COMPLETED|Overall Study||48
349697|NCT00521001|846987|P1|STARTED|Overall Study||49
349698|NCT00520975|846996|P2|NOT COMPLETED|Overall Study||48
349699|NCT00520975|846997|P1|NOT COMPLETED|Overall Study||48
349700|NCT00520975|846996|P2|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
349701|NCT00520975|846997|P1|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
349702|NCT00520975|846996|P2|Treated and Reported Adverse Events Data|Overall Study||45
349703|NCT00520975|846997|P1|Treated and Reported Adverse Events Data|Overall Study||47
349704|NCT00520975|846996|P2|STARTED|Overall Study||48
349705|NCT00520975|846997|P1|STARTED|Overall Study||48
349706|NCT00520936|847029|P8|NOT COMPLETED|Overall Study||1
349707|NCT00520936|847030|P7|NOT COMPLETED|Overall Study||4
349708|NCT00520936|847031|P6|NOT COMPLETED|Overall Study||0
349709|NCT00520936|847032|P5|NOT COMPLETED|Overall Study||1
349710|NCT00520936|847033|P4|NOT COMPLETED|Overall Study||0
349711|NCT00520936|847034|P3|NOT COMPLETED|Overall Study||2
349712|NCT00520936|847035|P2|NOT COMPLETED|Overall Study||4
349713|NCT00520936|847036|P1|NOT COMPLETED|Overall Study||0
349714|NCT00520936|847029|P8|COMPLETED|Overall Study||9
349715|NCT00520936|847030|P7|COMPLETED|Overall Study||7
349716|NCT00520936|847031|P6|COMPLETED|Overall Study||10
349717|NCT00520936|847032|P5|COMPLETED|Overall Study||5
349718|NCT00520936|847033|P4|COMPLETED|Overall Study||5
349719|NCT00520936|847034|P3|COMPLETED|Overall Study||7
349720|NCT00520936|847035|P2|COMPLETED|Overall Study||7
349721|NCT00520936|847036|P1|COMPLETED|Overall Study|Study completion defined as treated until disease progression. Completed=progressive disease.|10
349722|NCT00520936|847029|P8|STARTED|Overall Study||10
349723|NCT00520936|847030|P7|STARTED|Overall Study||11
349724|NCT00520936|847031|P6|STARTED|Overall Study||10
349725|NCT00520936|847032|P5|STARTED|Overall Study||6
349726|NCT00520936|847033|P4|STARTED|Overall Study||5
349727|NCT00520936|847034|P3|STARTED|Overall Study||9
349728|NCT00520936|847035|P2|STARTED|Overall Study||11
349729|NCT00520936|847036|P1|STARTED|Overall Study|75 participants entered the study and 72 were enrolled and received study drug.|10
349730|NCT00520910|847065|P2|NOT COMPLETED|Overall Study||0
349731|NCT00520910|847066|P1|NOT COMPLETED|Overall Study||0
349732|NCT00520910|847065|P2|COMPLETED|Overall Study||5
349733|NCT00520910|847066|P1|COMPLETED|Overall Study||5
349734|NCT00520910|847065|P2|STARTED|Overall Study||5
349735|NCT00520910|847066|P1|STARTED|Overall Study||5
349736|NCT00520884|847076|P4|NOT COMPLETED|Overall Study||0
349737|NCT00520884|847077|P3|NOT COMPLETED|Overall Study||0
349738|NCT00520884|847078|P2|NOT COMPLETED|Overall Study||0
349739|NCT00520884|847079|P1|NOT COMPLETED|Overall Study||0
349740|NCT00520884|847076|P4|COMPLETED|Overall Study||3
349741|NCT00520884|847077|P3|COMPLETED|Overall Study||2
349742|NCT00520884|847078|P2|COMPLETED|Overall Study||2
349743|NCT00520884|847079|P1|COMPLETED|Overall Study||3
349744|NCT00520884|847076|P4|STARTED|Overall Study||3
349745|NCT00520884|847077|P3|STARTED|Overall Study||2
349746|NCT00520884|847078|P2|STARTED|Overall Study||2
349747|NCT00520884|847079|P1|STARTED|Overall Study||3
349748|NCT00520845|847091|P1|NOT COMPLETED|Overall Study||22
349749|NCT00520845|847091|P1|COMPLETED|Overall Study||1
349750|NCT00520845|847091|P1|STARTED|Overall Study||23
349751|NCT00520767|847099|P1|NOT COMPLETED|Overall Study||2
349752|NCT00520767|847099|P1|COMPLETED|Overall Study||33
349753|NCT00520767|847099|P1|STARTED|Overall Study||35
349754|NCT00520741|847105|P2|NOT COMPLETED|Overall Study||125
349755|NCT00520741|847106|P1|NOT COMPLETED|Overall Study||37
349756|NCT00520741|847105|P2|COMPLETED|Overall Study||194
349757|NCT00520741|847106|P1|COMPLETED|Overall Study||69
349758|NCT00520741|847105|P2|STARTED|Overall Study|One subject was randomized at 2 sites and excluded from the Safety Set.|319
349759|NCT00520741|847106|P1|STARTED|Overall Study||106
349760|NCT00520676|847124|P2|NOT COMPLETED|Overall Study||103
349761|NCT00520676|847125|P1|NOT COMPLETED|Overall Study||101
349762|NCT00520676|847124|P2|COMPLETED|Overall Study||29
349763|NCT00520676|847125|P1|COMPLETED|Overall Study||27
349764|NCT00520676|847124|P2|Qualified Intent-to-treat (Q-ITT)|Overall Study||105
349765|NCT00520676|847125|P1|Qualified Intent-to-treat (Q-ITT)|Overall Study||106
349766|NCT00520676|847124|P2|Received at Least 1 Dose of Study Drug|Overall Study||127
349767|NCT00520676|847125|P1|Received at Least 1 Dose of Study Drug|Overall Study||118
349768|NCT00520676|847124|P2|STARTED|Overall Study||132
349769|NCT00520676|847125|P1|STARTED|Overall Study||128
349770|NCT00520572|847151|P6|NOT COMPLETED|Overall Study||2
349771|NCT00520572|847152|P5|NOT COMPLETED|Overall Study||12
349772|NCT00520572|847153|P4|NOT COMPLETED|Overall Study||14
349773|NCT00520572|847154|P3|NOT COMPLETED|Overall Study||15
349774|NCT00520572|847155|P2|NOT COMPLETED|Overall Study||14
349775|NCT00520572|847156|P1|NOT COMPLETED|Overall Study||12
349776|NCT00520572|847151|P6|COMPLETED|Overall Study|Participants completed the study.|62
349777|NCT00520572|847152|P5|COMPLETED|Overall Study|Participants completed the study.|53
349778|NCT00520572|847153|P4|COMPLETED|Overall Study|Participants completed the study.|50
349779|NCT00520572|847154|P3|COMPLETED|Overall Study|Participants completed the study.|49
349780|NCT00520572|847155|P2|COMPLETED|Overall Study|Participants completed the study.|50
349781|NCT00520572|847156|P1|COMPLETED|Overall Study|Participants completed the study.|52
349782|NCT00520572|847151|P6|STARTED|Overall Study|Participants randomised.|64
349783|NCT00520572|847152|P5|STARTED|Overall Study|Participants randomised.|65
349784|NCT00520572|847153|P4|STARTED|Overall Study|Participants randomised.|64
349785|NCT00520572|847154|P3|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
349786|NCT00520572|847155|P2|STARTED|Overall Study|Participants randomised.|64
349787|NCT00520572|847156|P1|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
349788|NCT00520546|847194|P1|NOT COMPLETED|Overall Study||6
349789|NCT00520546|847194|P1|COMPLETED|Overall Study||38
349790|NCT00520546|847194|P1|STARTED|Overall Study||44
349791|NCT00520494|847209|P1|NOT COMPLETED|Overall Study||1
349792|NCT00520494|847209|P1|COMPLETED|Overall Study||17
349793|NCT00520494|847209|P1|STARTED|Overall Study||18
349794|NCT00520481|847234|P2|NOT COMPLETED|Overall Study||1
349795|NCT00520481|847235|P1|NOT COMPLETED|Overall Study||7
349796|NCT00520481|847234|P2|COMPLETED|Overall Study||9
349797|NCT00520481|847235|P1|COMPLETED|Overall Study||24
349798|NCT00520481|847234|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
349799|NCT00520481|847235|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
349800|NCT00520481|847234|P2|STARTED|Overall Study||10
349801|NCT00520481|847235|P1|STARTED|Overall Study||31
349802|NCT00520468|847255|P1|NOT COMPLETED|Overall Study||0
349803|NCT00520468|847255|P1|COMPLETED|Overall Study||14
349804|NCT00520468|847255|P1|STARTED|Overall Study||14
349805|NCT00520403|847259|P1|NOT COMPLETED|Bevacizumab Monotherapy||2
349806|NCT00520403|847259|P1|COMPLETED|Bevacizumab Monotherapy||0
349807|NCT00520403|847259|P1|STARTED|Bevacizumab Monotherapy|2 of 7 participants completing Bevacizumab+IFN/vinblastine cycles initiated bevacizumab monotherapy|2
349808|NCT00520403|847259|P1|NOT COMPLETED|Bevacizumab + IFN/Vinblastine||18
349809|NCT00520403|847259|P1|COMPLETED|Bevacizumab + IFN/Vinblastine||7
349810|NCT00520403|847259|P1|STARTED|Bevacizumab + IFN/Vinblastine||25
349811|NCT00520351|847268|P2|NOT COMPLETED|Second Intervention||0
349812|NCT00520351|847269|P1|NOT COMPLETED|Second Intervention||0
349813|NCT00520351|847268|P2|COMPLETED|Second Intervention||14
349814|NCT00520351|847269|P1|COMPLETED|Second Intervention||14
349815|NCT00520351|847268|P2|STARTED|Second Intervention||14
349816|NCT00520351|847269|P1|STARTED|Second Intervention||14
349817|NCT00520351|847268|P2|NOT COMPLETED|First Intervention||1
349818|NCT00520351|847269|P1|NOT COMPLETED|First Intervention||1
349819|NCT00520351|847268|P2|COMPLETED|First Intervention|End date is Feb.25, 2008|14
349820|NCT00520351|847269|P1|COMPLETED|First Intervention|End date is Feb.25, 2008|14
349821|NCT00520351|847268|P2|STARTED|First Intervention|Start date is Sep.06, 2007|15
349822|NCT00520351|847269|P1|STARTED|First Intervention|Start date is Sep.06, 2007|15
349823|NCT00520299|847284|P3|NOT COMPLETED|Overall Study||6
349824|NCT00520299|847285|P2|NOT COMPLETED|Overall Study||3
349825|NCT00520299|847286|P1|NOT COMPLETED|Overall Study||0
349826|NCT00520299|847284|P3|COMPLETED|Overall Study||13
349827|NCT00520299|847285|P2|COMPLETED|Overall Study||3
349828|NCT00520299|847286|P1|COMPLETED|Overall Study|Defined as completion of 1 treatment cycle|6
349829|NCT00520299|847284|P3|STARTED|Overall Study||19
349830|NCT00520299|847285|P2|STARTED|Overall Study||6
349831|NCT00520299|847286|P1|STARTED|Overall Study||6
349832|NCT00520286|847317|P2|NOT COMPLETED|Overall Study||32
349833|NCT00520286|847318|P1|NOT COMPLETED|Overall Study||66
349834|NCT00520286|847317|P2|COMPLETED|Overall Study||36
349835|NCT00520286|847318|P1|COMPLETED|Overall Study||76
349836|NCT00520286|847317|P2|STARTED|Overall Study||68
349837|NCT00520286|847318|P1|STARTED|Overall Study||142
349838|NCT00520234|847328|P2|NOT COMPLETED|Overall Study||2
349839|NCT00520234|847329|P1|NOT COMPLETED|Overall Study||1
349840|NCT00520234|847328|P2|COMPLETED|Overall Study||102
349841|NCT00520234|847329|P1|COMPLETED|Overall Study||117
349842|NCT00520234|847328|P2|STARTED|Overall Study||104
349843|NCT00520234|847329|P1|STARTED|Overall Study||118
349844|NCT00520130|847341|P2|NOT COMPLETED|Overall Study||1
349845|NCT00520130|847342|P1|NOT COMPLETED|Overall Study||5
349846|NCT00520130|847341|P2|COMPLETED|Overall Study||44
349847|NCT00520130|847342|P1|COMPLETED|Overall Study||39
349848|NCT00520130|847341|P2|STARTED|Overall Study||45
349849|NCT00520130|847342|P1|STARTED|Overall Study||44
349850|NCT00520039|847384|P2|NOT COMPLETED|Overall Study||5
349851|NCT00520039|847385|P1|NOT COMPLETED|Overall Study||7
349852|NCT00520039|847384|P2|COMPLETED|Overall Study||19
349853|NCT00520039|847385|P1|COMPLETED|Overall Study||21
349854|NCT00520039|847384|P2|STARTED|Overall Study||24
349855|NCT00520039|847385|P1|STARTED|Overall Study||28
349856|NCT00520013|847398|P3|NOT COMPLETED|Overall Study||11
349857|NCT00520013|847399|P2|NOT COMPLETED|Overall Study||15
349858|NCT00520013|847400|P1|NOT COMPLETED|Overall Study||12
349859|NCT00520013|847398|P3|COMPLETED|Overall Study||0
349860|NCT00520013|847399|P2|COMPLETED|Overall Study||10
349861|NCT00520013|847400|P1|COMPLETED|Overall Study||11
349862|NCT00520013|847398|P3|Treated|Overall Study||11
349863|NCT00520013|847399|P2|Treated|Overall Study||25
349864|NCT00520013|847400|P1|Treated|Overall Study||23
349865|NCT00520013|847398|P3|STARTED|Overall Study|Excludes a pt who went off-study (on reg day) due to consent that may not have been informed (ESL).|11
349866|NCT00520013|847399|P2|STARTED|Overall Study||25
349867|NCT00520013|847400|P1|STARTED|Overall Study||23
349868|NCT00519896|847410|P1|NOT COMPLETED|Overall Study||2
349869|NCT00519896|847410|P1|COMPLETED|Overall Study||33
349870|NCT00519896|847410|P1|STARTED|Overall Study||35
349871|NCT00519831|847416|P1|NOT COMPLETED|Overall Study||3
349872|NCT00519831|847416|P1|COMPLETED|Overall Study||13
349873|NCT00519831|847416|P1|STARTED|Overall Study||16
349874|NCT00519818|847423|P1|NOT COMPLETED|Overall Study||0
349875|NCT00519818|847423|P1|COMPLETED|Overall Study||14
349876|NCT00519818|847423|P1|STARTED|Overall Study||14
349877|NCT00519779|847433|P2|NOT COMPLETED|Overall Study||1
349878|NCT00519779|847434|P1|NOT COMPLETED|Overall Study||0
349879|NCT00519779|847433|P2|COMPLETED|Overall Study||33
349880|NCT00519779|847434|P1|COMPLETED|Overall Study||34
349881|NCT00519779|847433|P2|STARTED|Overall Study||34
349882|NCT00519779|847434|P1|STARTED|Overall Study||34
349883|NCT00519649|847450|P1|NOT COMPLETED|Overall Study||1
349884|NCT00519649|847450|P1|COMPLETED|Overall Study||299
349885|NCT00519649|847450|P1|STARTED|Overall Study||300
349886|NCT00519636|847463|P4|NOT COMPLETED|Post Study Period||1
349887|NCT00519636|847464|P3|NOT COMPLETED|Post Study Period||0
349888|NCT00519636|847465|P2|NOT COMPLETED|Post Study Period||0
349889|NCT00519636|847466|P1|NOT COMPLETED|Post Study Period||0
349890|NCT00519636|847463|P4|COMPLETED|Post Study Period||85
349891|NCT00519636|847464|P3|COMPLETED|Post Study Period||74
349892|NCT00519636|847465|P2|COMPLETED|Post Study Period||71
349893|NCT00519636|847466|P1|COMPLETED|Post Study Period||69
349894|NCT00519636|847463|P4|STARTED|Post Study Period||86
349895|NCT00519636|847464|P3|STARTED|Post Study Period||74
349896|NCT00519636|847465|P2|STARTED|Post Study Period||71
349897|NCT00519636|847466|P1|STARTED|Post Study Period||69
349898|NCT00519636|847463|P4|NOT COMPLETED|Treatment Period 2||2
349899|NCT00519636|847464|P3|NOT COMPLETED|Treatment Period 2||1
349900|NCT00519636|847465|P2|NOT COMPLETED|Treatment Period 2||1
349901|NCT00519636|847466|P1|NOT COMPLETED|Treatment Period 2||0
349902|NCT00519636|847463|P4|COMPLETED|Treatment Period 2||86
349903|NCT00519636|847464|P3|COMPLETED|Treatment Period 2||74
349904|NCT00519636|847465|P2|COMPLETED|Treatment Period 2||71
349905|NCT00519636|847466|P1|COMPLETED|Treatment Period 2||69
349906|NCT00519636|847463|P4|STARTED|Treatment Period 2||88
349907|NCT00519636|847464|P3|STARTED|Treatment Period 2||75
349908|NCT00519636|847465|P2|STARTED|Treatment Period 2||72
349909|NCT00519636|847466|P1|STARTED|Treatment Period 2||69
349910|NCT00519636|847463|P4|NOT COMPLETED|Washout Period||5
349911|NCT00519636|847464|P3|NOT COMPLETED|Washout Period||14
349912|NCT00519636|847465|P2|NOT COMPLETED|Washout Period||14
349913|NCT00519636|847466|P1|NOT COMPLETED|Washout Period||20
349914|NCT00519636|847463|P4|COMPLETED|Washout Period||88
349915|NCT00519636|847464|P3|COMPLETED|Washout Period||75
349916|NCT00519636|847465|P2|COMPLETED|Washout Period||72
349917|NCT00519636|847466|P1|COMPLETED|Washout Period||69
349918|NCT00519636|847463|P4|STARTED|Washout Period||93
349919|NCT00519636|847464|P3|STARTED|Washout Period||89
349920|NCT00519636|847465|P2|STARTED|Washout Period||86
349921|NCT00519636|847466|P1|STARTED|Washout Period||89
349922|NCT00519636|847463|P4|NOT COMPLETED|Treatment Period 1||0
349923|NCT00519636|847464|P3|NOT COMPLETED|Treatment Period 1||1
349924|NCT00519636|847465|P2|NOT COMPLETED|Treatment Period 1||0
349925|NCT00519636|847466|P1|NOT COMPLETED|Treatment Period 1||2
349926|NCT00519636|847463|P4|COMPLETED|Treatment Period 1||93
349927|NCT00519636|847464|P3|COMPLETED|Treatment Period 1||89
349928|NCT00519636|847465|P2|COMPLETED|Treatment Period 1||86
349929|NCT00519636|847466|P1|COMPLETED|Treatment Period 1||89
349930|NCT00519636|847463|P4|STARTED|Treatment Period 1||93
349931|NCT00519636|847464|P3|STARTED|Treatment Period 1||90
349932|NCT00519636|847465|P2|STARTED|Treatment Period 1||86
349933|NCT00519636|847466|P1|STARTED|Treatment Period 1||91
349934|NCT00519623|847496|P1|NOT COMPLETED|Overall Study||1
349935|NCT00519623|847496|P1|COMPLETED|Overall Study||8
349936|NCT00519623|847496|P1|STARTED|Overall Study||9
349937|NCT00519584|847505|P4|NOT COMPLETED|Overall Study||0
349938|NCT00519584|847506|P3|NOT COMPLETED|Overall Study||0
349939|NCT00519584|847507|P2|NOT COMPLETED|Overall Study||0
349940|NCT00519584|847508|P1|NOT COMPLETED|Overall Study||0
349941|NCT00519584|847505|P4|COMPLETED|Overall Study||56
349942|NCT00519584|847506|P3|COMPLETED|Overall Study||54
349943|NCT00519584|847507|P2|COMPLETED|Overall Study||54
349944|NCT00519584|847508|P1|COMPLETED|Overall Study||54
349945|NCT00519584|847505|P4|STARTED|Overall Study||56
349946|NCT00519584|847506|P3|STARTED|Overall Study||54
349947|NCT00519584|847507|P2|STARTED|Overall Study||54
349948|NCT00519584|847508|P1|STARTED|Overall Study||54
349949|NCT00519532|847530|P1|NOT COMPLETED|Overall Study||18
349950|NCT00519532|847530|P1|COMPLETED|Overall Study||66
349951|NCT00519532|847530|P1|STARTED|Overall Study||84
349952|NCT00519428|847540|P3|NOT COMPLETED|Overall Study||25
349953|NCT00519428|847541|P2|NOT COMPLETED|Overall Study||15
349954|NCT00519428|847542|P1|NOT COMPLETED|Overall Study||21
349955|NCT00519428|847540|P3|COMPLETED|Overall Study||58
349956|NCT00519428|847541|P2|COMPLETED|Overall Study||69
349957|NCT00519428|847542|P1|COMPLETED|Overall Study||57
349958|NCT00519428|847540|P3|STARTED|Overall Study||83
349959|NCT00519428|847541|P2|STARTED|Overall Study||84
349960|NCT00519428|847542|P1|STARTED|Overall Study||78
349961|NCT00519376|847562|P16|NOT COMPLETED|Treatment Period 4||0
349962|NCT00519376|847563|P15|NOT COMPLETED|Treatment Period 4||0
349963|NCT00519376|847564|P14|NOT COMPLETED|Treatment Period 4||0
349964|NCT00519376|847565|P13|NOT COMPLETED|Treatment Period 4||0
349965|NCT00519376|847566|P12|NOT COMPLETED|Treatment Period 4||0
349966|NCT00519376|847567|P11|NOT COMPLETED|Treatment Period 4||0
349967|NCT00519376|847568|P10|NOT COMPLETED|Treatment Period 4||0
349968|NCT00519376|847569|P9|NOT COMPLETED|Treatment Period 4||0
349969|NCT00519376|847570|P8|NOT COMPLETED|Treatment Period 4||0
349970|NCT00519376|847571|P7|NOT COMPLETED|Treatment Period 4||0
349971|NCT00519376|847572|P6|NOT COMPLETED|Treatment Period 4||0
349972|NCT00519376|847573|P5|NOT COMPLETED|Treatment Period 4||0
349973|NCT00519376|847574|P4|NOT COMPLETED|Treatment Period 4||0
349974|NCT00519376|847575|P3|NOT COMPLETED|Treatment Period 4||1
349975|NCT00519376|847576|P2|NOT COMPLETED|Treatment Period 4||0
349976|NCT00519376|847577|P1|NOT COMPLETED|Treatment Period 4||0
349977|NCT00519376|847562|P16|COMPLETED|Treatment Period 4||1
349978|NCT00519376|847563|P15|COMPLETED|Treatment Period 4||1
349979|NCT00519376|847564|P14|COMPLETED|Treatment Period 4||1
349980|NCT00519376|847565|P13|COMPLETED|Treatment Period 4||0
349981|NCT00519376|847566|P12|COMPLETED|Treatment Period 4||1
349982|NCT00519376|847567|P11|COMPLETED|Treatment Period 4||1
349983|NCT00519376|847568|P10|COMPLETED|Treatment Period 4||1
349984|NCT00519376|847569|P9|COMPLETED|Treatment Period 4||1
349985|NCT00519376|847570|P8|COMPLETED|Treatment Period 4||1
349986|NCT00519376|847571|P7|COMPLETED|Treatment Period 4||1
349987|NCT00519376|847572|P6|COMPLETED|Treatment Period 4||1
349988|NCT00519376|847573|P5|COMPLETED|Treatment Period 4||1
349989|NCT00519376|847574|P4|COMPLETED|Treatment Period 4||2
349990|NCT00519376|847575|P3|COMPLETED|Treatment Period 4||1
349991|NCT00519376|847576|P2|COMPLETED|Treatment Period 4||2
349992|NCT00519376|847577|P1|COMPLETED|Treatment Period 4||2
349993|NCT00519376|847562|P16|STARTED|Treatment Period 4||1
349994|NCT00519376|847563|P15|STARTED|Treatment Period 4||1
349995|NCT00519376|847564|P14|STARTED|Treatment Period 4||1
349996|NCT00519376|847565|P13|STARTED|Treatment Period 4||0
349997|NCT00519376|847566|P12|STARTED|Treatment Period 4||1
349998|NCT00519376|847567|P11|STARTED|Treatment Period 4||1
349999|NCT00519376|847568|P10|STARTED|Treatment Period 4||1
350000|NCT00519376|847569|P9|STARTED|Treatment Period 4||1
350001|NCT00519376|847570|P8|STARTED|Treatment Period 4||1
350002|NCT00519376|847571|P7|STARTED|Treatment Period 4||1
350003|NCT00519376|847572|P6|STARTED|Treatment Period 4||1
350004|NCT00519376|847573|P5|STARTED|Treatment Period 4||1
350005|NCT00519376|847574|P4|STARTED|Treatment Period 4||2
350006|NCT00519376|847575|P3|STARTED|Treatment Period 4||2
350007|NCT00519376|847576|P2|STARTED|Treatment Period 4||2
350008|NCT00519376|847577|P1|STARTED|Treatment Period 4||2
350009|NCT00519376|847562|P16|NOT COMPLETED|Washout Period 3||0
350010|NCT00519376|847563|P15|NOT COMPLETED|Washout Period 3||0
350011|NCT00519376|847564|P14|NOT COMPLETED|Washout Period 3||0
350012|NCT00519376|847565|P13|NOT COMPLETED|Washout Period 3||0
350013|NCT00519376|847566|P12|NOT COMPLETED|Washout Period 3||0
350014|NCT00519376|847567|P11|NOT COMPLETED|Washout Period 3||0
350015|NCT00519376|847568|P10|NOT COMPLETED|Washout Period 3||0
350016|NCT00519376|847569|P9|NOT COMPLETED|Washout Period 3||0
350017|NCT00519376|847570|P8|NOT COMPLETED|Washout Period 3||0
350018|NCT00519376|847571|P7|NOT COMPLETED|Washout Period 3||0
350019|NCT00519376|847572|P6|NOT COMPLETED|Washout Period 3||0
350020|NCT00519376|847573|P5|NOT COMPLETED|Washout Period 3||0
350021|NCT00519376|847574|P4|NOT COMPLETED|Washout Period 3||0
350022|NCT00519376|847575|P3|NOT COMPLETED|Washout Period 3||0
350023|NCT00519376|847576|P2|NOT COMPLETED|Washout Period 3||0
350024|NCT00519376|847577|P1|NOT COMPLETED|Washout Period 3||0
350025|NCT00519376|847562|P16|COMPLETED|Washout Period 3||1
350026|NCT00519376|847563|P15|COMPLETED|Washout Period 3||1
350027|NCT00519376|847564|P14|COMPLETED|Washout Period 3||1
350028|NCT00519376|847565|P13|COMPLETED|Washout Period 3||0
350029|NCT00519376|847566|P12|COMPLETED|Washout Period 3||1
350030|NCT00519376|847567|P11|COMPLETED|Washout Period 3||1
350031|NCT00519376|847568|P10|COMPLETED|Washout Period 3||1
350032|NCT00519376|847569|P9|COMPLETED|Washout Period 3||1
350033|NCT00519376|847570|P8|COMPLETED|Washout Period 3||1
350034|NCT00519376|847571|P7|COMPLETED|Washout Period 3||1
350035|NCT00519376|847572|P6|COMPLETED|Washout Period 3||1
350036|NCT00519376|847573|P5|COMPLETED|Washout Period 3||1
350037|NCT00519376|847574|P4|COMPLETED|Washout Period 3||2
350038|NCT00519376|847575|P3|COMPLETED|Washout Period 3||2
350039|NCT00519376|847576|P2|COMPLETED|Washout Period 3||2
350040|NCT00519376|847577|P1|COMPLETED|Washout Period 3||2
350041|NCT00519376|847562|P16|STARTED|Washout Period 3||1
350042|NCT00519376|847563|P15|STARTED|Washout Period 3||1
350043|NCT00519376|847564|P14|STARTED|Washout Period 3||1
350044|NCT00519376|847565|P13|STARTED|Washout Period 3||0
350045|NCT00519376|847566|P12|STARTED|Washout Period 3||1
350046|NCT00519376|847567|P11|STARTED|Washout Period 3||1
350047|NCT00519376|847568|P10|STARTED|Washout Period 3||1
350048|NCT00519376|847569|P9|STARTED|Washout Period 3||1
350049|NCT00519376|847570|P8|STARTED|Washout Period 3||1
350050|NCT00519376|847571|P7|STARTED|Washout Period 3||1
350051|NCT00519376|847572|P6|STARTED|Washout Period 3||1
350052|NCT00519376|847573|P5|STARTED|Washout Period 3||1
350053|NCT00519376|847574|P4|STARTED|Washout Period 3||2
350054|NCT00519376|847575|P3|STARTED|Washout Period 3||2
350055|NCT00519376|847576|P2|STARTED|Washout Period 3||2
350056|NCT00519376|847577|P1|STARTED|Washout Period 3||2
350057|NCT00519376|847562|P16|NOT COMPLETED|Treatment Period 3||0
350058|NCT00519376|847563|P15|NOT COMPLETED|Treatment Period 3||0
350059|NCT00519376|847564|P14|NOT COMPLETED|Treatment Period 3||0
350060|NCT00519376|847565|P13|NOT COMPLETED|Treatment Period 3||0
350061|NCT00519376|847566|P12|NOT COMPLETED|Treatment Period 3||0
350062|NCT00519376|847567|P11|NOT COMPLETED|Treatment Period 3||0
350063|NCT00519376|847568|P10|NOT COMPLETED|Treatment Period 3||0
350064|NCT00519376|847569|P9|NOT COMPLETED|Treatment Period 3||0
350065|NCT00519376|847570|P8|NOT COMPLETED|Treatment Period 3||0
350066|NCT00519376|847571|P7|NOT COMPLETED|Treatment Period 3||0
350067|NCT00519376|847572|P6|NOT COMPLETED|Treatment Period 3||0
350068|NCT00519376|847573|P5|NOT COMPLETED|Treatment Period 3||0
350069|NCT00519376|847574|P4|NOT COMPLETED|Treatment Period 3||0
350070|NCT00519376|847575|P3|NOT COMPLETED|Treatment Period 3||0
350071|NCT00519376|847576|P2|NOT COMPLETED|Treatment Period 3||0
350072|NCT00519376|847577|P1|NOT COMPLETED|Treatment Period 3||0
350073|NCT00519376|847562|P16|COMPLETED|Treatment Period 3||1
350074|NCT00519376|847563|P15|COMPLETED|Treatment Period 3||1
350075|NCT00519376|847564|P14|COMPLETED|Treatment Period 3||1
350076|NCT00519376|847565|P13|COMPLETED|Treatment Period 3||0
350077|NCT00519376|847566|P12|COMPLETED|Treatment Period 3||1
350078|NCT00519376|847567|P11|COMPLETED|Treatment Period 3||1
350079|NCT00519376|847568|P10|COMPLETED|Treatment Period 3||1
350080|NCT00519376|847569|P9|COMPLETED|Treatment Period 3||1
350081|NCT00519376|847570|P8|COMPLETED|Treatment Period 3||1
350082|NCT00519376|847571|P7|COMPLETED|Treatment Period 3||1
350083|NCT00519376|847572|P6|COMPLETED|Treatment Period 3||1
350084|NCT00519376|847573|P5|COMPLETED|Treatment Period 3||1
350085|NCT00519376|847574|P4|COMPLETED|Treatment Period 3||2
350086|NCT00519376|847575|P3|COMPLETED|Treatment Period 3||2
350087|NCT00519376|847576|P2|COMPLETED|Treatment Period 3||2
350088|NCT00519376|847577|P1|COMPLETED|Treatment Period 3||2
350089|NCT00519376|847562|P16|STARTED|Treatment Period 3||1
350090|NCT00519376|847563|P15|STARTED|Treatment Period 3||1
350091|NCT00519376|847564|P14|STARTED|Treatment Period 3||1
350092|NCT00519376|847565|P13|STARTED|Treatment Period 3||0
350093|NCT00519376|847566|P12|STARTED|Treatment Period 3||1
350094|NCT00519376|847567|P11|STARTED|Treatment Period 3||1
350095|NCT00519376|847568|P10|STARTED|Treatment Period 3||1
350096|NCT00519376|847569|P9|STARTED|Treatment Period 3||1
350097|NCT00519376|847570|P8|STARTED|Treatment Period 3||1
350098|NCT00519376|847571|P7|STARTED|Treatment Period 3||1
350099|NCT00519376|847572|P6|STARTED|Treatment Period 3||1
350100|NCT00519376|847573|P5|STARTED|Treatment Period 3||1
350101|NCT00519376|847574|P4|STARTED|Treatment Period 3||2
350102|NCT00519376|847575|P3|STARTED|Treatment Period 3||2
350103|NCT00519376|847576|P2|STARTED|Treatment Period 3||2
350104|NCT00519376|847577|P1|STARTED|Treatment Period 3||2
350105|NCT00519376|847562|P16|NOT COMPLETED|Washout Period 2||0
350106|NCT00519376|847563|P15|NOT COMPLETED|Washout Period 2||0
350107|NCT00519376|847564|P14|NOT COMPLETED|Washout Period 2||0
350108|NCT00519376|847565|P13|NOT COMPLETED|Washout Period 2||0
350109|NCT00519376|847566|P12|NOT COMPLETED|Washout Period 2||0
350110|NCT00519376|847567|P11|NOT COMPLETED|Washout Period 2||0
350111|NCT00519376|847568|P10|NOT COMPLETED|Washout Period 2||0
350112|NCT00519376|847569|P9|NOT COMPLETED|Washout Period 2||0
350113|NCT00519376|847570|P8|NOT COMPLETED|Washout Period 2||0
350114|NCT00519376|847571|P7|NOT COMPLETED|Washout Period 2||0
350115|NCT00519376|847572|P6|NOT COMPLETED|Washout Period 2||0
350116|NCT00519376|847573|P5|NOT COMPLETED|Washout Period 2||0
350117|NCT00519376|847574|P4|NOT COMPLETED|Washout Period 2||0
350118|NCT00519376|847575|P3|NOT COMPLETED|Washout Period 2||0
350119|NCT00519376|847576|P2|NOT COMPLETED|Washout Period 2||0
350120|NCT00519376|847577|P1|NOT COMPLETED|Washout Period 2||0
350121|NCT00519376|847562|P16|COMPLETED|Washout Period 2||1
350122|NCT00519376|847563|P15|COMPLETED|Washout Period 2||1
350123|NCT00519376|847564|P14|COMPLETED|Washout Period 2||1
350124|NCT00519376|847565|P13|COMPLETED|Washout Period 2||0
350125|NCT00519376|847566|P12|COMPLETED|Washout Period 2||1
350126|NCT00519376|847567|P11|COMPLETED|Washout Period 2||1
350127|NCT00519376|847568|P10|COMPLETED|Washout Period 2||1
350128|NCT00519376|847569|P9|COMPLETED|Washout Period 2||1
350129|NCT00519376|847570|P8|COMPLETED|Washout Period 2||1
350130|NCT00519376|847571|P7|COMPLETED|Washout Period 2||1
350131|NCT00519376|847572|P6|COMPLETED|Washout Period 2||1
350132|NCT00519376|847573|P5|COMPLETED|Washout Period 2||1
350133|NCT00519376|847574|P4|COMPLETED|Washout Period 2||2
350134|NCT00519376|847575|P3|COMPLETED|Washout Period 2||2
350135|NCT00519376|847576|P2|COMPLETED|Washout Period 2||2
350136|NCT00519376|847577|P1|COMPLETED|Washout Period 2||2
350137|NCT00519376|847562|P16|STARTED|Washout Period 2||1
350138|NCT00519376|847563|P15|STARTED|Washout Period 2||1
350139|NCT00519376|847564|P14|STARTED|Washout Period 2||1
350140|NCT00519376|847565|P13|STARTED|Washout Period 2||0
350141|NCT00519376|847566|P12|STARTED|Washout Period 2||1
350142|NCT00519376|847567|P11|STARTED|Washout Period 2||1
350143|NCT00519376|847568|P10|STARTED|Washout Period 2||1
350144|NCT00519376|847569|P9|STARTED|Washout Period 2||1
350145|NCT00519376|847570|P8|STARTED|Washout Period 2||1
350146|NCT00519376|847571|P7|STARTED|Washout Period 2||1
350147|NCT00519376|847572|P6|STARTED|Washout Period 2||1
350148|NCT00519376|847573|P5|STARTED|Washout Period 2||1
350149|NCT00519376|847574|P4|STARTED|Washout Period 2||2
350150|NCT00519376|847575|P3|STARTED|Washout Period 2||2
350151|NCT00519376|847576|P2|STARTED|Washout Period 2||2
350152|NCT00519376|847577|P1|STARTED|Washout Period 2||2
350153|NCT00519376|847562|P16|NOT COMPLETED|Treatment Period 2||0
350154|NCT00519376|847563|P15|NOT COMPLETED|Treatment Period 2||0
350155|NCT00519376|847564|P14|NOT COMPLETED|Treatment Period 2||0
350156|NCT00519376|847565|P13|NOT COMPLETED|Treatment Period 2||1
350157|NCT00519376|847566|P12|NOT COMPLETED|Treatment Period 2||0
350158|NCT00519376|847567|P11|NOT COMPLETED|Treatment Period 2||0
350159|NCT00519376|847568|P10|NOT COMPLETED|Treatment Period 2||0
350160|NCT00519376|847569|P9|NOT COMPLETED|Treatment Period 2||0
350161|NCT00519376|847570|P8|NOT COMPLETED|Treatment Period 2||0
350162|NCT00519376|847571|P7|NOT COMPLETED|Treatment Period 2||0
350163|NCT00519376|847572|P6|NOT COMPLETED|Treatment Period 2||0
350164|NCT00519376|847573|P5|NOT COMPLETED|Treatment Period 2||0
350165|NCT00519376|847574|P4|NOT COMPLETED|Treatment Period 2||0
350166|NCT00519376|847575|P3|NOT COMPLETED|Treatment Period 2||0
350167|NCT00519376|847576|P2|NOT COMPLETED|Treatment Period 2||0
350168|NCT00519376|847577|P1|NOT COMPLETED|Treatment Period 2||0
350169|NCT00519376|847562|P16|COMPLETED|Treatment Period 2||1
350170|NCT00519376|847563|P15|COMPLETED|Treatment Period 2||1
350171|NCT00519376|847564|P14|COMPLETED|Treatment Period 2||1
350172|NCT00519376|847565|P13|COMPLETED|Treatment Period 2||0
350173|NCT00519376|847566|P12|COMPLETED|Treatment Period 2||1
350174|NCT00519376|847567|P11|COMPLETED|Treatment Period 2||1
350175|NCT00519376|847568|P10|COMPLETED|Treatment Period 2||1
350176|NCT00519376|847569|P9|COMPLETED|Treatment Period 2||1
350177|NCT00519376|847570|P8|COMPLETED|Treatment Period 2||1
350178|NCT00519376|847571|P7|COMPLETED|Treatment Period 2||1
350179|NCT00519376|847572|P6|COMPLETED|Treatment Period 2||1
350180|NCT00519376|847573|P5|COMPLETED|Treatment Period 2||1
350181|NCT00519376|847574|P4|COMPLETED|Treatment Period 2||2
350182|NCT00519376|847575|P3|COMPLETED|Treatment Period 2||2
350183|NCT00519376|847576|P2|COMPLETED|Treatment Period 2||2
350184|NCT00519376|847577|P1|COMPLETED|Treatment Period 2||2
350185|NCT00519376|847562|P16|STARTED|Treatment Period 2||1
350186|NCT00519376|847563|P15|STARTED|Treatment Period 2||1
350187|NCT00519376|847564|P14|STARTED|Treatment Period 2||1
350188|NCT00519376|847565|P13|STARTED|Treatment Period 2||1
350189|NCT00519376|847566|P12|STARTED|Treatment Period 2||1
350190|NCT00519376|847567|P11|STARTED|Treatment Period 2||1
350191|NCT00519376|847568|P10|STARTED|Treatment Period 2||1
350192|NCT00519376|847569|P9|STARTED|Treatment Period 2||1
350193|NCT00519376|847570|P8|STARTED|Treatment Period 2||1
350194|NCT00519376|847571|P7|STARTED|Treatment Period 2||1
350195|NCT00519376|847572|P6|STARTED|Treatment Period 2||1
350196|NCT00519376|847573|P5|STARTED|Treatment Period 2||1
350197|NCT00519376|847574|P4|STARTED|Treatment Period 2||2
350198|NCT00519376|847575|P3|STARTED|Treatment Period 2||2
350199|NCT00519376|847576|P2|STARTED|Treatment Period 2||2
350200|NCT00519376|847577|P1|STARTED|Treatment Period 2||2
350201|NCT00519376|847562|P16|NOT COMPLETED|Washout Period 1||0
350202|NCT00519376|847563|P15|NOT COMPLETED|Washout Period 1||0
350203|NCT00519376|847564|P14|NOT COMPLETED|Washout Period 1||0
350204|NCT00519376|847565|P13|NOT COMPLETED|Washout Period 1||0
350205|NCT00519376|847566|P12|NOT COMPLETED|Washout Period 1||0
350206|NCT00519376|847567|P11|NOT COMPLETED|Washout Period 1||0
350207|NCT00519376|847568|P10|NOT COMPLETED|Washout Period 1||0
350208|NCT00519376|847569|P9|NOT COMPLETED|Washout Period 1||0
350209|NCT00519376|847570|P8|NOT COMPLETED|Washout Period 1||0
350210|NCT00519376|847571|P7|NOT COMPLETED|Washout Period 1||0
350211|NCT00519376|847572|P6|NOT COMPLETED|Washout Period 1||0
350212|NCT00519376|847573|P5|NOT COMPLETED|Washout Period 1||0
350213|NCT00519376|847574|P4|NOT COMPLETED|Washout Period 1||0
350214|NCT00519376|847575|P3|NOT COMPLETED|Washout Period 1||0
350215|NCT00519376|847576|P2|NOT COMPLETED|Washout Period 1||0
350216|NCT00519376|847577|P1|NOT COMPLETED|Washout Period 1||0
350217|NCT00519376|847562|P16|COMPLETED|Washout Period 1||1
350218|NCT00519376|847563|P15|COMPLETED|Washout Period 1||1
350219|NCT00519376|847564|P14|COMPLETED|Washout Period 1||1
350220|NCT00519376|847565|P13|COMPLETED|Washout Period 1||1
350221|NCT00519376|847566|P12|COMPLETED|Washout Period 1||1
350222|NCT00519376|847567|P11|COMPLETED|Washout Period 1||1
350223|NCT00519376|847568|P10|COMPLETED|Washout Period 1||1
350224|NCT00519376|847569|P9|COMPLETED|Washout Period 1||1
350225|NCT00519376|847570|P8|COMPLETED|Washout Period 1||1
350226|NCT00519376|847571|P7|COMPLETED|Washout Period 1||1
350227|NCT00519376|847572|P6|COMPLETED|Washout Period 1||1
350228|NCT00519376|847573|P5|COMPLETED|Washout Period 1||1
350229|NCT00519376|847574|P4|COMPLETED|Washout Period 1||2
350230|NCT00519376|847575|P3|COMPLETED|Washout Period 1||2
350231|NCT00519376|847576|P2|COMPLETED|Washout Period 1||2
350232|NCT00519376|847577|P1|COMPLETED|Washout Period 1||2
350233|NCT00519376|847562|P16|STARTED|Washout Period 1||1
350234|NCT00519376|847563|P15|STARTED|Washout Period 1||1
350235|NCT00519376|847564|P14|STARTED|Washout Period 1||1
350236|NCT00519376|847565|P13|STARTED|Washout Period 1||1
350237|NCT00519376|847566|P12|STARTED|Washout Period 1||1
350238|NCT00519376|847567|P11|STARTED|Washout Period 1||1
350239|NCT00519376|847568|P10|STARTED|Washout Period 1||1
350240|NCT00519376|847569|P9|STARTED|Washout Period 1||1
350241|NCT00519376|847570|P8|STARTED|Washout Period 1||1
350242|NCT00519376|847571|P7|STARTED|Washout Period 1||1
350243|NCT00519376|847572|P6|STARTED|Washout Period 1||1
350244|NCT00519376|847573|P5|STARTED|Washout Period 1||1
350245|NCT00519376|847574|P4|STARTED|Washout Period 1||2
350246|NCT00519376|847575|P3|STARTED|Washout Period 1||2
350247|NCT00519376|847576|P2|STARTED|Washout Period 1||2
350248|NCT00519376|847577|P1|STARTED|Washout Period 1||2
350249|NCT00519376|847562|P16|NOT COMPLETED|Treatment Period 1||0
350250|NCT00519376|847563|P15|NOT COMPLETED|Treatment Period 1||0
350251|NCT00519376|847564|P14|NOT COMPLETED|Treatment Period 1||0
350252|NCT00519376|847565|P13|NOT COMPLETED|Treatment Period 1||0
350253|NCT00519376|847566|P12|NOT COMPLETED|Treatment Period 1||0
350254|NCT00519376|847567|P11|NOT COMPLETED|Treatment Period 1||0
350255|NCT00519376|847568|P10|NOT COMPLETED|Treatment Period 1||0
350256|NCT00519376|847569|P9|NOT COMPLETED|Treatment Period 1||0
350257|NCT00519376|847570|P8|NOT COMPLETED|Treatment Period 1||0
350258|NCT00519376|847571|P7|NOT COMPLETED|Treatment Period 1||0
350259|NCT00519376|847572|P6|NOT COMPLETED|Treatment Period 1||0
350260|NCT00519376|847573|P5|NOT COMPLETED|Treatment Period 1||0
350261|NCT00519376|847574|P4|NOT COMPLETED|Treatment Period 1||0
350262|NCT00519376|847575|P3|NOT COMPLETED|Treatment Period 1||0
350263|NCT00519376|847576|P2|NOT COMPLETED|Treatment Period 1||0
350264|NCT00519376|847577|P1|NOT COMPLETED|Treatment Period 1||0
350265|NCT00519376|847562|P16|COMPLETED|Treatment Period 1||1
350266|NCT00519376|847563|P15|COMPLETED|Treatment Period 1||1
350267|NCT00519376|847564|P14|COMPLETED|Treatment Period 1||1
350268|NCT00519376|847565|P13|COMPLETED|Treatment Period 1||1
350269|NCT00519376|847566|P12|COMPLETED|Treatment Period 1||1
350270|NCT00519376|847567|P11|COMPLETED|Treatment Period 1||1
350271|NCT00519376|847568|P10|COMPLETED|Treatment Period 1||1
350272|NCT00519376|847569|P9|COMPLETED|Treatment Period 1||1
350273|NCT00519376|847570|P8|COMPLETED|Treatment Period 1||1
350274|NCT00519376|847571|P7|COMPLETED|Treatment Period 1||1
350275|NCT00519376|847572|P6|COMPLETED|Treatment Period 1||1
350276|NCT00519376|847573|P5|COMPLETED|Treatment Period 1||1
350277|NCT00519376|847574|P4|COMPLETED|Treatment Period 1||2
350278|NCT00519376|847575|P3|COMPLETED|Treatment Period 1||2
350279|NCT00519376|847576|P2|COMPLETED|Treatment Period 1||2
350280|NCT00519376|847577|P1|COMPLETED|Treatment Period 1||2
350281|NCT00519376|847562|P16|STARTED|Treatment Period 1||1
350282|NCT00519376|847563|P15|STARTED|Treatment Period 1||1
350283|NCT00519376|847564|P14|STARTED|Treatment Period 1||1
350284|NCT00519376|847565|P13|STARTED|Treatment Period 1||1
350285|NCT00519376|847566|P12|STARTED|Treatment Period 1||1
350286|NCT00519376|847567|P11|STARTED|Treatment Period 1||1
350287|NCT00519376|847568|P10|STARTED|Treatment Period 1||1
350288|NCT00519376|847569|P9|STARTED|Treatment Period 1||1
350289|NCT00519376|847570|P8|STARTED|Treatment Period 1||1
350290|NCT00519376|847571|P7|STARTED|Treatment Period 1||1
350291|NCT00519376|847572|P6|STARTED|Treatment Period 1||1
350292|NCT00519376|847573|P5|STARTED|Treatment Period 1||1
350293|NCT00519376|847574|P4|STARTED|Treatment Period 1||2
350294|NCT00519376|847575|P3|STARTED|Treatment Period 1||2
350295|NCT00519376|847576|P2|STARTED|Treatment Period 1||2
350296|NCT00519376|847577|P1|STARTED|Treatment Period 1||2
350297|NCT00519285|847701|P2|NOT COMPLETED|Overall Study||612
350298|NCT00519285|847702|P1|NOT COMPLETED|Overall Study||612
350299|NCT00519285|847701|P2|COMPLETED|Overall Study||0
350300|NCT00519285|847702|P1|COMPLETED|Overall Study|Participants were treated until progressive disease, unacceptable toxicity, or refusal of treatment|0
350301|NCT00519285|847701|P2|Still Treated at Cut-off Date|Overall Study||2
350302|NCT00519285|847702|P1|Still Treated at Cut-off Date|Overall Study|The cut-off date for analysis was defined as 07 February 2012, date at which 873 deaths has occurred|1
350303|NCT00519285|847701|P2|TREATED|Overall Study|Received at least part of one dose of aflibercept|605
350304|NCT00519285|847702|P1|TREATED|Overall Study|Received at least part of one dose of placebo|604
350305|NCT00519285|847701|P2|STARTED|Overall Study|Randomized|612
350306|NCT00519285|847702|P1|STARTED|Overall Study|Randomized|612
350307|NCT00519194|847728|P1|NOT COMPLETED|Overall Study||21
350308|NCT00519194|847728|P1|COMPLETED|Overall Study||91
350309|NCT00519194|847728|P1|STARTED|Overall Study||112
350310|NCT00519090|847734|P2|NOT COMPLETED|Overall Study||0
350311|NCT00519090|847735|P1|NOT COMPLETED|Overall Study||0
350312|NCT00519090|847734|P2|COMPLETED|Overall Study||4
350313|NCT00519090|847735|P1|COMPLETED|Overall Study||2
350314|NCT00519090|847734|P2|STARTED|Overall Study||4
350315|NCT00519090|847735|P1|STARTED|Overall Study||2
350316|NCT00519077|847743|P1|NOT COMPLETED|Overall Study||8
350317|NCT00519077|847743|P1|COMPLETED|Overall Study||36
350318|NCT00519077|847743|P1|STARTED|Overall Study||44
350319|NCT00518986|847750|P2|NOT COMPLETED|Overall Study||26
350320|NCT00518986|847751|P1|NOT COMPLETED|Overall Study||26
350321|NCT00518986|847750|P2|COMPLETED|Overall Study||98
350322|NCT00518986|847751|P1|COMPLETED|Overall Study||99
350323|NCT00518986|847750|P2|STARTED|Overall Study||124
350324|NCT00518986|847751|P1|STARTED|Overall Study|One subject discontinued before treatment, only 124 subjects in each treatment group were dosed.|125
350325|NCT00518973|847877|P2|NOT COMPLETED|Overall Study||2
350326|NCT00518973|847878|P1|NOT COMPLETED|Overall Study||3
350327|NCT00518973|847877|P2|COMPLETED|Overall Study||4
350328|NCT00518973|847878|P1|COMPLETED|Overall Study||6
350329|NCT00518973|847877|P2|STARTED|Overall Study||6
350330|NCT00518973|847878|P1|STARTED|Overall Study||9
350331|NCT00518882|847894|P2|NOT COMPLETED|Open-Label Extension, Week 26-78||49
350332|NCT00518882|847895|P1|NOT COMPLETED|Open-Label Extension, Week 26-78||41
350333|NCT00518882|847894|P2|COMPLETED|Open-Label Extension, Week 26-78||138
350334|NCT00518882|847895|P1|COMPLETED|Open-Label Extension, Week 26-78||161
350335|NCT00518882|847894|P2|STARTED|Open-Label Extension, Week 26-78||187
350336|NCT00518882|847895|P1|STARTED|Open-Label Extension, Week 26-78||202
350337|NCT00518882|847894|P2|NOT COMPLETED|Double-Blind, Week 0-26||45
350338|NCT00518882|847895|P1|NOT COMPLETED|Double-Blind, Week 0-26||33
350339|NCT00518882|847894|P2|COMPLETED|Double-Blind, Week 0-26||187
350340|NCT00518882|847895|P1|COMPLETED|Double-Blind, Week 0-26||202
350341|NCT00518882|847894|P2|Randomised|Double-Blind, Week 0-26||231
350342|NCT00518882|847895|P1|Randomised|Double-Blind, Week 0-26||233
350343|NCT00518882|847894|P2|STARTED|Double-Blind, Week 0-26|1 subject exposed to study drug before randomisation. Subject only included in safety analysis set|232
350344|NCT00518882|847895|P1|STARTED|Double-Blind, Week 0-26|2 subjects exposed to study drug before randomisation. Subjects only included in safety analysis set|235
350345|NCT00518713|848013|P4|NOT COMPLETED|Overall Study||18
350346|NCT00518713|848014|P3|NOT COMPLETED|Overall Study||18
350347|NCT00518713|848015|P2|NOT COMPLETED|Overall Study||17
350348|NCT00518713|848016|P1|NOT COMPLETED|Overall Study||8
350349|NCT00518713|848013|P4|COMPLETED|Overall Study||41
350350|NCT00518713|848014|P3|COMPLETED|Overall Study||41
350351|NCT00518713|848015|P2|COMPLETED|Overall Study||45
350352|NCT00518713|848016|P1|COMPLETED|Overall Study||50
350353|NCT00518713|848013|P4|Modified Intent-to-Treat Population|Overall Study||57
350354|NCT00518713|848014|P3|Modified Intent-to-Treat Population|Overall Study||49
350355|NCT00518713|848015|P2|Modified Intent-to-Treat Population|Overall Study||58
350356|NCT00518713|848016|P1|Modified Intent-to-Treat Population|Overall Study||53
350357|NCT00518713|848013|P4|STARTED|Overall Study||59
350358|NCT00518713|848014|P3|STARTED|Overall Study||59
350359|NCT00518713|848015|P2|STARTED|Overall Study||62
350360|NCT00518713|848016|P1|STARTED|Overall Study||58
350361|NCT00518687|848076|P2|NOT COMPLETED|Overall Study||1420
350362|NCT00518687|848077|P1|NOT COMPLETED|Overall Study||1437
350363|NCT00518687|848076|P2|COMPLETED|Overall Study||2585
350364|NCT00518687|848077|P1|COMPLETED|Overall Study||2568
350365|NCT00518687|848076|P2|Vaccinated|Overall Study||3982
350366|NCT00518687|848077|P1|Vaccinated|Overall Study||3981
350367|NCT00518687|848076|P2|STARTED|Overall Study|An additional 11 participants were not analyzed because of questionable clinical practices at 1 site|4005
350368|NCT00518687|848077|P1|STARTED|Overall Study|An additional 10 participants were not analyzed because of questionable clinical practices at 1 site|4005
350369|NCT00518622|848097|P8|NOT COMPLETED|Overall Study||0
350370|NCT00518622|848098|P7|NOT COMPLETED|Overall Study||0
350371|NCT00518622|848099|P6|NOT COMPLETED|Overall Study||0
350372|NCT00518622|848100|P5|NOT COMPLETED|Overall Study||0
350373|NCT00518622|848101|P4|NOT COMPLETED|Overall Study||0
350374|NCT00518622|848102|P3|NOT COMPLETED|Overall Study||1
350375|NCT00518622|848103|P2|NOT COMPLETED|Overall Study||1
350376|NCT00518622|848104|P1|NOT COMPLETED|Overall Study||0
350377|NCT00518622|848097|P8|COMPLETED|Overall Study||5
350378|NCT00518622|848098|P7|COMPLETED|Overall Study||4
350379|NCT00518622|848099|P6|COMPLETED|Overall Study||5
350380|NCT00518622|848100|P5|COMPLETED|Overall Study||6
350381|NCT00518622|848101|P4|COMPLETED|Overall Study||5
350382|NCT00518622|848102|P3|COMPLETED|Overall Study||5
350383|NCT00518622|848103|P2|COMPLETED|Overall Study||5
350384|NCT00518622|848104|P1|COMPLETED|Overall Study||3
350385|NCT00518622|848097|P8|Discontinued Therapy|Overall Study||0
350386|NCT00518622|848098|P7|Discontinued Therapy|Overall Study||0
350387|NCT00518622|848099|P6|Discontinued Therapy|Overall Study||0
350388|NCT00518622|848100|P5|Discontinued Therapy|Overall Study||0
350389|NCT00518622|848101|P4|Discontinued Therapy|Overall Study||0
350390|NCT00518622|848102|P3|Discontinued Therapy|Overall Study||0
350391|NCT00518622|848103|P2|Discontinued Therapy|Overall Study||1
350392|NCT00518622|848104|P1|Discontinued Therapy|Overall Study|Discontinued therapy defined if participant has not taken 8 days of medication per the protocol.|0
350393|NCT00518622|848097|P8|Completed Therapy|Overall Study||5
350394|NCT00518622|848098|P7|Completed Therapy|Overall Study||4
350395|NCT00518622|848099|P6|Completed Therapy|Overall Study||5
350396|NCT00518622|848100|P5|Completed Therapy|Overall Study||6
350397|NCT00518622|848101|P4|Completed Therapy|Overall Study||5
350398|NCT00518622|848102|P3|Completed Therapy|Overall Study||6
350399|NCT00518622|848103|P2|Completed Therapy|Overall Study||5
350400|NCT00518622|848104|P1|Completed Therapy|Overall Study|Completed therapy defined if participant has taken 8 days of study medication per the protocol.|3
350401|NCT00518622|848097|P8|STARTED|Overall Study||5
350402|NCT00518622|848098|P7|STARTED|Overall Study||4
350403|NCT00518622|848099|P6|STARTED|Overall Study||5
350404|NCT00518622|848100|P5|STARTED|Overall Study||6
350405|NCT00518622|848101|P4|STARTED|Overall Study||5
350406|NCT00518622|848102|P3|STARTED|Overall Study||6
350407|NCT00518622|848103|P2|STARTED|Overall Study||6
350408|NCT00518622|848104|P1|STARTED|Overall Study||3
350409|NCT00518531|848132|P2|NOT COMPLETED|Treatment Period 2||20
350410|NCT00518531|848133|P1|NOT COMPLETED|Treatment Period 2||3
350411|NCT00518531|848132|P2|COMPLETED|Treatment Period 2||95
350412|NCT00518531|848133|P1|COMPLETED|Treatment Period 2||103
350413|NCT00518531|848132|P2|Received Treatment|Treatment Period 2||110
350414|NCT00518531|848133|P1|Received Treatment|Treatment Period 2||106
350415|NCT00518531|848132|P2|STARTED|Treatment Period 2|Participants can start Treatment Period 2 without completing Treatment Period 1.|115
350416|NCT00518531|848133|P1|STARTED|Treatment Period 2||106
350417|NCT00518531|848132|P2|NOT COMPLETED|Treatment Period 1||12
350418|NCT00518531|848133|P1|NOT COMPLETED|Treatment Period 1||18
350419|NCT00518531|848132|P2|COMPLETED|Treatment Period 1|Participants who completed Treatment Period 1 may choose not to start Treatment Period 2|114
350420|NCT00518531|848133|P1|COMPLETED|Treatment Period 1||106
350421|NCT00518531|848132|P2|Received Treatment|Treatment Period 1||124
350422|NCT00518531|848133|P1|Received Treatment|Treatment Period 1||119
350423|NCT00518531|848132|P2|STARTED|Treatment Period 1||126
350424|NCT00518531|848133|P1|STARTED|Treatment Period 1||124
350425|NCT00518349|848169|P2|NOT COMPLETED|Overall Study||0
350426|NCT00518349|848170|P1|NOT COMPLETED|Overall Study||0
350427|NCT00518349|848169|P2|COMPLETED|Overall Study||60
350428|NCT00518349|848170|P1|COMPLETED|Overall Study||60
350429|NCT00518349|848169|P2|STARTED|Overall Study||60
350430|NCT00518349|848170|P1|STARTED|Overall Study||60
350431|NCT00518336|848178|P2|NOT COMPLETED|Year 9||1
350432|NCT00518336|848179|P1|NOT COMPLETED|Year 9||5
350433|NCT00518336|848178|P2|COMPLETED|Year 9||212
350434|NCT00518336|848179|P1|COMPLETED|Year 9||219
350435|NCT00518336|848178|P2|STARTED|Year 9||213
350436|NCT00518336|848179|P1|STARTED|Year 9|1 subject did not particpate at the previous timepoint, came back and was added in the Total cohort|224
350437|NCT00518336|848178|P2|NOT COMPLETED|Year 8||2
350438|NCT00518336|848179|P1|NOT COMPLETED|Year 8||1
350439|NCT00518336|848178|P2|COMPLETED|Year 8||211
350440|NCT00518336|848179|P1|COMPLETED|Year 8||222
350441|NCT00518336|848178|P2|STARTED|Year 8|2 subjects withdrawn at Year 7 came back and were therefore no longer considered as withdrawn.|213
350442|NCT00518336|848179|P1|STARTED|Year 8|1 subject withdrawn at Year 7 came back and was therefore no longer considered as withdrawn.|223
350443|NCT00518336|848178|P2|NOT COMPLETED|Year 7||3
350444|NCT00518336|848179|P1|NOT COMPLETED|Year 7||2
350445|NCT00518336|848178|P2|COMPLETED|Year 7||208
350446|NCT00518336|848179|P1|COMPLETED|Year 7||220
350447|NCT00518336|848178|P2|STARTED|Year 7||211
350448|NCT00518336|848179|P1|STARTED|Year 7||222
350449|NCT00518323|848345|P4|NOT COMPLETED|Overall Study||25
350450|NCT00518323|848346|P3|NOT COMPLETED|Overall Study||11
350451|NCT00518323|848347|P2|NOT COMPLETED|Overall Study||8
350452|NCT00518323|848348|P1|NOT COMPLETED|Overall Study||19
350453|NCT00518323|848345|P4|COMPLETED|Overall Study||26
350454|NCT00518323|848346|P3|COMPLETED|Overall Study||37
350455|NCT00518323|848347|P2|COMPLETED|Overall Study||40
350456|NCT00518323|848348|P1|COMPLETED|Overall Study||35
350457|NCT00518323|848345|P4|STARTED|Overall Study||51
350458|NCT00518323|848346|P3|STARTED|Overall Study||48
350459|NCT00518323|848347|P2|STARTED|Overall Study||48
350460|NCT00518323|848348|P1|STARTED|Overall Study||54
350461|NCT00518284|848378|P4|NOT COMPLETED|Overall Study||2
350462|NCT00518284|848379|P3|NOT COMPLETED|Overall Study||1
350463|NCT00518284|848380|P2|NOT COMPLETED|Overall Study||3
350464|NCT00518284|848381|P1|NOT COMPLETED|Overall Study||0
350465|NCT00518284|848378|P4|COMPLETED|Overall Study||0
350466|NCT00518284|848379|P3|COMPLETED|Overall Study||0
350467|NCT00518284|848380|P2|COMPLETED|Overall Study||0
350468|NCT00518284|848381|P1|COMPLETED|Overall Study||0
350469|NCT00518284|848378|P4|STARTED|Overall Study||2
350470|NCT00518284|848379|P3|STARTED|Overall Study||1
350471|NCT00518284|848380|P2|STARTED|Overall Study||3
350472|NCT00518284|848381|P1|STARTED|Overall Study||0
350473|NCT00518206|848437|P2|NOT COMPLETED|Overall Study||6
350474|NCT00518206|848438|P1|NOT COMPLETED|Overall Study||11
350475|NCT00518206|848437|P2|COMPLETED|Overall Study||13
350476|NCT00518206|848438|P1|COMPLETED|Overall Study||16
350477|NCT00518206|848437|P2|STARTED|Overall Study||19
350478|NCT00518206|848438|P1|STARTED|Overall Study||27
350479|NCT00518180|848455|P3|NOT COMPLETED|Overall Study||82
350480|NCT00518180|848456|P2|NOT COMPLETED|Overall Study||69
350481|NCT00518180|848457|P1|NOT COMPLETED|Overall Study||65
350482|NCT00518180|848455|P3|COMPLETED|Overall Study||457
350483|NCT00518180|848456|P2|COMPLETED|Overall Study||472
350484|NCT00518180|848457|P1|COMPLETED|Overall Study||475
350485|NCT00518180|848455|P3|STARTED|Overall Study||539
350486|NCT00518180|848456|P2|STARTED|Overall Study||541
350487|NCT00518180|848457|P1|STARTED|Overall Study||540
350488|NCT00518154|848499|P1|NOT COMPLETED|Overall Study||0
350489|NCT00518154|848499|P1|COMPLETED|Overall Study||7
350490|NCT00518154|848499|P1|STARTED|Overall Study||7
350491|NCT00518115|848513|P10|NOT COMPLETED|Overall Study||15
350492|NCT00518115|848514|P9|NOT COMPLETED|Overall Study||5
350493|NCT00518115|848515|P8|NOT COMPLETED|Overall Study||15
350494|NCT00518115|848516|P7|NOT COMPLETED|Overall Study||8
350495|NCT00518115|848517|P6|NOT COMPLETED|Overall Study||15
350496|NCT00518115|848518|P5|NOT COMPLETED|Overall Study||10
350497|NCT00518115|848519|P4|NOT COMPLETED|Overall Study||11
350498|NCT00518115|848520|P3|NOT COMPLETED|Overall Study||17
350499|NCT00518115|848521|P2|NOT COMPLETED|Overall Study||6
350500|NCT00518115|848522|P1|NOT COMPLETED|Overall Study||12
350501|NCT00518115|848513|P10|COMPLETED|Overall Study||20
350502|NCT00518115|848514|P9|COMPLETED|Overall Study||30
350503|NCT00518115|848515|P8|COMPLETED|Overall Study||20
350504|NCT00518115|848516|P7|COMPLETED|Overall Study||25
350505|NCT00518115|848517|P6|COMPLETED|Overall Study||19
350506|NCT00518115|848518|P5|COMPLETED|Overall Study||21
350507|NCT00518115|848519|P4|COMPLETED|Overall Study||24
350508|NCT00518115|848520|P3|COMPLETED|Overall Study||19
350509|NCT00518115|848521|P2|COMPLETED|Overall Study||29
350510|NCT00518115|848522|P1|COMPLETED|Overall Study||40
350511|NCT00518115|848513|P10|Safety Population|Overall Study|These participants received at least one dose of study drug.|34
350512|NCT00518115|848514|P9|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
350513|NCT00518115|848515|P8|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
350514|NCT00518115|848516|P7|Safety Population|Overall Study|These participants received at least one dose of study drug.|32
350515|NCT00518115|848517|P6|Safety Population|Overall Study|These participants received at least one dose of study drug.|33
350516|NCT00518115|848518|P5|Safety Population|Overall Study|These participants received at least one dose of study drug.|31
350517|NCT00518115|848519|P4|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
350518|NCT00518115|848520|P3|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
350519|NCT00518115|848521|P2|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
350520|NCT00518115|848522|P1|Safety Population|Overall Study|These participants received at least one dose of study drug.|51
350521|NCT00518115|848513|P10|STARTED|Overall Study||35
350522|NCT00518115|848514|P9|STARTED|Overall Study||35
350523|NCT00518115|848515|P8|STARTED|Overall Study||35
350524|NCT00518115|848516|P7|STARTED|Overall Study||33
350525|NCT00518115|848517|P6|STARTED|Overall Study||34
350526|NCT00518115|848518|P5|STARTED|Overall Study||31
350527|NCT00518115|848519|P4|STARTED|Overall Study||35
350528|NCT00518115|848520|P3|STARTED|Overall Study||36
350529|NCT00518115|848521|P2|STARTED|Overall Study||35
350530|NCT00518115|848522|P1|STARTED|Overall Study||52
350531|NCT00518089|848680|P2|NOT COMPLETED|Overall Study||31
350532|NCT00518089|848681|P1|NOT COMPLETED|Overall Study||28
350533|NCT00518089|848680|P2|COMPLETED|Overall Study||398
350534|NCT00518089|848681|P1|COMPLETED|Overall Study||402
350535|NCT00518089|848680|P2|STARTED|Overall Study||429
350536|NCT00518089|848681|P1|STARTED|Overall Study||430
350537|NCT00518011|848697|P2|NOT COMPLETED|Overall Study||8
350538|NCT00518011|848698|P1|NOT COMPLETED|Overall Study||9
350539|NCT00518011|848697|P2|COMPLETED|Overall Study||0
350540|NCT00518011|848698|P1|COMPLETED|Overall Study||0
350541|NCT00518011|848697|P2|STARTED|Overall Study||8
350542|NCT00518011|848698|P1|STARTED|Overall Study||9
350543|NCT00517933|848720|P2|NOT COMPLETED|Period 2||13
350544|NCT00517933|848721|P1|NOT COMPLETED|Period 2||6
350545|NCT00517933|848720|P2|COMPLETED|Period 2||70
350546|NCT00517933|848721|P1|COMPLETED|Period 2||73
350547|NCT00517933|848720|P2|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|83
350548|NCT00517933|848721|P1|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|79
350549|NCT00517933|848720|P2|NOT COMPLETED|Period 1||6
350550|NCT00517933|848721|P1|NOT COMPLETED|Period 1||8
350551|NCT00517933|848720|P2|COMPLETED|Period 1||85
350552|NCT00517933|848721|P1|COMPLETED|Period 1||81
350553|NCT00517933|848720|P2|STARTED|Period 1|Patients decreased due to death, adverse event and other (see below)|91
350554|NCT00517933|848721|P1|STARTED|Period 1|Patients decreased due to death, adverse event, lost to follow up and other (see below)|89
350555|NCT00517881|848785|P1|NOT COMPLETED|Overall Study||5
350556|NCT00517881|848785|P1|COMPLETED|Overall Study||24
350557|NCT00517881|848785|P1|STARTED|Overall Study||29
350558|NCT00517829|848797|P2|NOT COMPLETED|Overall Study||75
350559|NCT00517829|848798|P1|NOT COMPLETED|Overall Study||75
350560|NCT00517829|848797|P2|COMPLETED|Overall Study||0
350561|NCT00517829|848798|P1|COMPLETED|Overall Study||0
350562|NCT00517829|848797|P2|STARTED|Overall Study||75
350563|NCT00517829|848798|P1|STARTED|Overall Study||75
350564|NCT00517751|848812|P1|NOT COMPLETED|Overall Study||129
350565|NCT00517751|848812|P1|COMPLETED|Overall Study||33
350566|NCT00517751|848812|P1|STARTED|Overall Study||162
350567|NCT00517699|848835|P1|NOT COMPLETED|Overall Study||5
350568|NCT00517699|848835|P1|COMPLETED|Overall Study||0
350569|NCT00517699|848835|P1|STARTED|Overall Study||5
350570|NCT00517634|848843|P6|NOT COMPLETED|Third Treatment Period||0
350571|NCT00517634|848844|P5|NOT COMPLETED|Third Treatment Period||0
350572|NCT00517634|848845|P4|NOT COMPLETED|Third Treatment Period||0
350573|NCT00517634|848846|P3|NOT COMPLETED|Third Treatment Period||0
350574|NCT00517634|848847|P2|NOT COMPLETED|Third Treatment Period||0
350575|NCT00517634|848848|P1|NOT COMPLETED|Third Treatment Period||0
350576|NCT00517634|848843|P6|COMPLETED|Third Treatment Period||4
350577|NCT00517634|848844|P5|COMPLETED|Third Treatment Period||3
350578|NCT00517634|848845|P4|COMPLETED|Third Treatment Period||3
350579|NCT00517634|848846|P3|COMPLETED|Third Treatment Period||4
350580|NCT00517634|848847|P2|COMPLETED|Third Treatment Period||4
350581|NCT00517634|848848|P1|COMPLETED|Third Treatment Period||4
350582|NCT00517634|848843|P6|STARTED|Third Treatment Period||4
350583|NCT00517634|848844|P5|STARTED|Third Treatment Period||3
350584|NCT00517634|848845|P4|STARTED|Third Treatment Period||3
350585|NCT00517634|848846|P3|STARTED|Third Treatment Period||4
350586|NCT00517634|848847|P2|STARTED|Third Treatment Period||4
350587|NCT00517634|848848|P1|STARTED|Third Treatment Period||4
350588|NCT00517634|848843|P6|NOT COMPLETED|Second Treatment Period||0
350589|NCT00517634|848844|P5|NOT COMPLETED|Second Treatment Period||1
350590|NCT00517634|848845|P4|NOT COMPLETED|Second Treatment Period||0
350591|NCT00517634|848846|P3|NOT COMPLETED|Second Treatment Period||0
350592|NCT00517634|848847|P2|NOT COMPLETED|Second Treatment Period||0
350593|NCT00517634|848848|P1|NOT COMPLETED|Second Treatment Period||0
350594|NCT00517634|848843|P6|COMPLETED|Second Treatment Period||4
350595|NCT00517634|848844|P5|COMPLETED|Second Treatment Period||3
350596|NCT00517634|848845|P4|COMPLETED|Second Treatment Period||3
350597|NCT00517634|848846|P3|COMPLETED|Second Treatment Period||4
350598|NCT00517634|848847|P2|COMPLETED|Second Treatment Period||4
350599|NCT00517634|848848|P1|COMPLETED|Second Treatment Period||4
350600|NCT00517634|848843|P6|STARTED|Second Treatment Period||4
350601|NCT00517634|848844|P5|STARTED|Second Treatment Period||4
350602|NCT00517634|848845|P4|STARTED|Second Treatment Period||3
350603|NCT00517634|848846|P3|STARTED|Second Treatment Period||4
350604|NCT00517634|848847|P2|STARTED|Second Treatment Period||4
350605|NCT00517634|848848|P1|STARTED|Second Treatment Period||4
350606|NCT00517634|848843|P6|NOT COMPLETED|First Treatment Period||0
350607|NCT00517634|848844|P5|NOT COMPLETED|First Treatment Period||0
350608|NCT00517634|848845|P4|NOT COMPLETED|First Treatment Period||0
350609|NCT00517634|848846|P3|NOT COMPLETED|First Treatment Period||0
350610|NCT00517634|848847|P2|NOT COMPLETED|First Treatment Period||0
350611|NCT00517634|848848|P1|NOT COMPLETED|First Treatment Period||0
350612|NCT00517634|848843|P6|COMPLETED|First Treatment Period||4
350613|NCT00517634|848844|P5|COMPLETED|First Treatment Period||4
350614|NCT00517634|848845|P4|COMPLETED|First Treatment Period||3
350615|NCT00517634|848846|P3|COMPLETED|First Treatment Period||4
350616|NCT00517634|848847|P2|COMPLETED|First Treatment Period||4
350617|NCT00517634|848848|P1|COMPLETED|First Treatment Period||4
350618|NCT00517634|848843|P6|STARTED|First Treatment Period||4
350619|NCT00517634|848844|P5|STARTED|First Treatment Period||4
350620|NCT00517634|848845|P4|STARTED|First Treatment Period||3
350621|NCT00517634|848846|P3|STARTED|First Treatment Period||4
350622|NCT00517634|848847|P2|STARTED|First Treatment Period||4
350623|NCT00517634|848848|P1|STARTED|First Treatment Period||4
350624|NCT00517595|848859|P1|NOT COMPLETED|Overall Study||0
350625|NCT00517595|848859|P1|COMPLETED|Overall Study||48
350626|NCT00517595|848859|P1|STARTED|Overall Study||48
350627|NCT00517556|848870|P2|NOT COMPLETED|Overall Study||5
350628|NCT00517556|848871|P1|NOT COMPLETED|Overall Study||4
350629|NCT00517556|848870|P2|COMPLETED|Overall Study||14
350630|NCT00517556|848871|P1|COMPLETED|Overall Study||15
350631|NCT00517556|848870|P2|STARTED|Overall Study||19
350632|NCT00517556|848871|P1|STARTED|Overall Study||19
350633|NCT00517530|848884|P7|NOT COMPLETED|Overall Study||19
350634|NCT00517530|848885|P6|NOT COMPLETED|Overall Study||19
350635|NCT00517530|848886|P5|NOT COMPLETED|Overall Study||20
350636|NCT00517530|848887|P4|NOT COMPLETED|Overall Study||21
350637|NCT00517530|848888|P3|NOT COMPLETED|Overall Study||18
350638|NCT00517530|848889|P2|NOT COMPLETED|Overall Study||13
350639|NCT00517530|848890|P1|NOT COMPLETED|Overall Study||19
350640|NCT00517530|848884|P7|COMPLETED|Overall Study||1
350641|NCT00517530|848885|P6|COMPLETED|Overall Study||0
350642|NCT00517530|848886|P5|COMPLETED|Overall Study||1
350643|NCT00517530|848887|P4|COMPLETED|Overall Study||1
350644|NCT00517530|848888|P3|COMPLETED|Overall Study||0
350645|NCT00517530|848889|P2|COMPLETED|Overall Study||0
350646|NCT00517530|848890|P1|COMPLETED|Overall Study||2
350647|NCT00517530|848884|P7|Retreated Population|Overall Study||0
350648|NCT00517530|848885|P6|Retreated Population|Overall Study||2
350649|NCT00517530|848886|P5|Retreated Population|Overall Study||2
350650|NCT00517530|848887|P4|Retreated Population|Overall Study||4
350651|NCT00517530|848888|P3|Retreated Population|Overall Study||1
350652|NCT00517530|848889|P2|Retreated Population|Overall Study||2
350653|NCT00517530|848890|P1|Retreated Population|Overall Study||2
350654|NCT00517530|848884|P7|Completed Follow-up|Overall Study||1
350655|NCT00517530|848885|P6|Completed Follow-up|Overall Study||0
350656|NCT00517530|848886|P5|Completed Follow-up|Overall Study||0
350657|NCT00517530|848887|P4|Completed Follow-up|Overall Study||1
350658|NCT00517530|848888|P3|Completed Follow-up|Overall Study||0
350659|NCT00517530|848889|P2|Completed Follow-up|Overall Study||0
350660|NCT00517530|848890|P1|Completed Follow-up|Overall Study||2
350661|NCT00517530|848884|P7|Started Follow-up|Overall Study||19
350662|NCT00517530|848885|P6|Started Follow-up|Overall Study||16
350663|NCT00517530|848886|P5|Started Follow-up|Overall Study||17
350664|NCT00517530|848887|P4|Started Follow-up|Overall Study||21
350665|NCT00517530|848888|P3|Started Follow-up|Overall Study||17
350666|NCT00517530|848889|P2|Started Follow-up|Overall Study||13
350667|NCT00517530|848890|P1|Started Follow-up|Overall Study||20
350668|NCT00517530|848884|P7|Completed Treatment|Overall Study||13
350669|NCT00517530|848885|P6|Completed Treatment|Overall Study||9
350670|NCT00517530|848886|P5|Completed Treatment|Overall Study||9
350671|NCT00517530|848887|P4|Completed Treatment|Overall Study||18
350672|NCT00517530|848888|P3|Completed Treatment|Overall Study||13
350673|NCT00517530|848889|P2|Completed Treatment|Overall Study||13
350674|NCT00517530|848890|P1|Completed Treatment|Overall Study||11
350675|NCT00517530|848884|P7|STARTED|Overall Study||20
350676|NCT00517530|848885|P6|STARTED|Overall Study||19
350677|NCT00517530|848886|P5|STARTED|Overall Study||21
350678|NCT00517530|848887|P4|STARTED|Overall Study||22
350679|NCT00517530|848888|P3|STARTED|Overall Study||18
350680|NCT00517530|848889|P2|STARTED|Overall Study||13
350681|NCT00517530|848890|P1|STARTED|Overall Study||21
350682|NCT00517413|848950|P1|NOT COMPLETED|Overall Study||61
350683|NCT00517413|848950|P1|COMPLETED|Overall Study||102
350684|NCT00517413|848950|P1|STARTED|Overall Study||163
350685|NCT00517361|848971|P1|NOT COMPLETED|Overall Study||11
350686|NCT00517361|848971|P1|COMPLETED|Overall Study|This study has been terminated due to poor accrual.|0
350687|NCT00517361|848971|P1|STARTED|Overall Study||11
350688|NCT00517296|848980|P2|NOT COMPLETED|Overall Study||0
350689|NCT00517296|848981|P1|NOT COMPLETED|Overall Study||1
350690|NCT00517296|848980|P2|COMPLETED|Overall Study||11
350691|NCT00517296|848981|P1|COMPLETED|Overall Study||9
350692|NCT00517296|848980|P2|STARTED|Overall Study||11
350693|NCT00517296|848981|P1|STARTED|Overall Study||10
350694|NCT00517192|848993|P2|NOT COMPLETED|Overall Study||20
350695|NCT00517192|848994|P1|NOT COMPLETED|Overall Study||19
350696|NCT00517192|848993|P2|COMPLETED|Overall Study||0
350697|NCT00517192|848994|P1|COMPLETED|Overall Study||0
350698|NCT00517192|848993|P2|STARTED|Overall Study||20
350699|NCT00517192|848994|P1|STARTED|Overall Study||19
350700|NCT00517075|849046|P4|NOT COMPLETED|Overall Study||0
350701|NCT00517075|849047|P3|NOT COMPLETED|Overall Study||0
350702|NCT00517075|849048|P2|NOT COMPLETED|Overall Study||0
350703|NCT00517075|849049|P1|NOT COMPLETED|Overall Study||0
350704|NCT00517075|849046|P4|COMPLETED|Overall Study||0
350705|NCT00517075|849047|P3|COMPLETED|Overall Study||0
350706|NCT00517075|849048|P2|COMPLETED|Overall Study||0
350707|NCT00517075|849049|P1|COMPLETED|Overall Study||0
350708|NCT00517075|849046|P4|STARTED|Overall Study||0
350709|NCT00517075|849047|P3|STARTED|Overall Study||0
350710|NCT00517075|849048|P2|STARTED|Overall Study||0
350711|NCT00517075|849049|P1|STARTED|Overall Study||0
350712|NCT00517010|849087|P1|NOT COMPLETED|Overall Study||1
350713|NCT00517010|849087|P1|COMPLETED|Overall Study||5
350714|NCT00517010|849087|P1|STARTED|Overall Study||6
350715|NCT00516919|849092|P2|NOT COMPLETED|Overall Study||7
350716|NCT00516919|849093|P1|NOT COMPLETED|Overall Study||10
350717|NCT00516919|849092|P2|COMPLETED|Overall Study||32
350718|NCT00516919|849093|P1|COMPLETED|Overall Study||30
350719|NCT00516919|849092|P2|STARTED|Overall Study||39
350720|NCT00516919|849093|P1|STARTED|Overall Study||40
350721|NCT00516906|849101|P2|NOT COMPLETED|Overall Study||2
350722|NCT00516906|849102|P1|NOT COMPLETED|Overall Study||6
350723|NCT00516906|849101|P2|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
350724|NCT00516906|849102|P1|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
350725|NCT00516906|849101|P2|STARTED|Overall Study|33 patients were randomized but one patient was discharged prior to treatment.|32
350726|NCT00516906|849102|P1|STARTED|Overall Study||36
350727|NCT00516893|849112|P1|NOT COMPLETED|Overall Study||21
350728|NCT00516893|849112|P1|COMPLETED|Overall Study||92
350729|NCT00516893|849112|P1|Received Study Treatment|Overall Study||112
350730|NCT00516893|849112|P1|STARTED|Overall Study||113
350731|NCT00516737|849121|P2|NOT COMPLETED|Overall Study||8
350732|NCT00516737|849122|P1|NOT COMPLETED|Overall Study||11
350733|NCT00516737|849121|P2|COMPLETED|Overall Study||96
350734|NCT00516737|849122|P1|COMPLETED|Overall Study||92
350735|NCT00516737|849121|P2|STARTED|Overall Study||104
350736|NCT00516737|849122|P1|STARTED|Overall Study||103
350737|NCT00516503|849142|P2|NOT COMPLETED|Overall Study||0
350738|NCT00516503|849143|P1|NOT COMPLETED|Overall Study||0
350739|NCT00516503|849142|P2|COMPLETED|Overall Study||102
350740|NCT00516503|849143|P1|COMPLETED|Overall Study||101
350741|NCT00516503|849142|P2|STARTED|Overall Study||102
350742|NCT00516503|849143|P1|STARTED|Overall Study||101
350743|NCT00516386|849161|P1|NOT COMPLETED|Overall Study||6
350744|NCT00516386|849161|P1|COMPLETED|Overall Study||10
350745|NCT00516386|849161|P1|STARTED|Overall Study||16
350746|NCT00516321|849168|P3|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||54
350747|NCT00516321|849169|P2|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||35
350748|NCT00516321|849170|P1|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||0
350749|NCT00516321|849168|P3|COMPLETED|Double-blind (DB) Antiviral Treatment||396
350750|NCT00516321|849169|P2|COMPLETED|Double-blind (DB) Antiviral Treatment||197
350751|NCT00516321|849170|P1|COMPLETED|Double-blind (DB) Antiviral Treatment||0
350752|NCT00516321|849168|P3|STARTED|Double-blind (DB) Antiviral Treatment||450
350753|NCT00516321|849169|P2|STARTED|Double-blind (DB) Antiviral Treatment||232
350754|NCT00516321|849170|P1|STARTED|Double-blind (DB) Antiviral Treatment||0
350755|NCT00516321|849168|P3|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
350756|NCT00516321|849169|P2|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
350757|NCT00516321|849170|P1|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||33
350758|NCT00516321|849168|P3|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
350759|NCT00516321|849169|P2|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
350760|NCT00516321|849170|P1|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||682
350761|NCT00516321|849168|P3|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
350762|NCT00516321|849169|P2|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
350763|NCT00516321|849170|P1|STARTED|Open-label (OL) Pre-Antiviral Treatment||715
350764|NCT00516295|849221|P3|NOT COMPLETED|Overall Study||0
350765|NCT00516295|849222|P2|NOT COMPLETED|Overall Study||0
350766|NCT00516295|849223|P1|NOT COMPLETED|Overall Study||3
350767|NCT00516295|849221|P3|COMPLETED|Overall Study||0
350768|NCT00516295|849222|P2|COMPLETED|Overall Study||0
350769|NCT00516295|849223|P1|COMPLETED|Overall Study||4
350770|NCT00516295|849221|P3|STARTED|Overall Study||0
350771|NCT00516295|849222|P2|STARTED|Overall Study||0
350772|NCT00516295|849223|P1|STARTED|Overall Study||7
350773|NCT00516269|849236|P2|NOT COMPLETED|Overall Study||3
350774|NCT00516269|849237|P1|NOT COMPLETED|Overall Study||2
350775|NCT00516269|849236|P2|COMPLETED|Overall Study|2 patients did not complete the study and 1 randomized to placebo twice.|16
350776|NCT00516269|849237|P1|COMPLETED|Overall Study|2 patients had an early termination|17
350777|NCT00516269|849236|P2|STARTED|Overall Study||19
350778|NCT00516269|849237|P1|STARTED|Overall Study||19
350779|NCT00516217|849243|P1|NOT COMPLETED|Overall Study||0
350780|NCT00516217|849243|P1|COMPLETED|Overall Study||29
350781|NCT00516217|849243|P1|STARTED|Overall Study||29
350782|NCT00516165|849249|P1|NOT COMPLETED|Overall Study||0
350783|NCT00516165|849249|P1|COMPLETED|Overall Study||28
350784|NCT00516165|849249|P1|STARTED|Overall Study||28
350785|NCT00516139|849258|P1|NOT COMPLETED|Overall Study||38
350786|NCT00516139|849258|P1|COMPLETED|Overall Study|Study completers completed Escalation, AM, and either AO or both Conversion and Monotherapy Phases.|84
350787|NCT00516139|849258|P1|STARTED|Overall Study||122
350788|NCT00516074|849289|P2|NOT COMPLETED|Overall Study||3
350789|NCT00516074|849290|P1|NOT COMPLETED|Overall Study||6
350790|NCT00516074|849289|P2|COMPLETED|Overall Study||23
350791|NCT00516074|849290|P1|COMPLETED|Overall Study||22
350792|NCT00516074|849289|P2|STARTED|Overall Study||26
350793|NCT00516074|849290|P1|STARTED|Overall Study||28
350794|NCT00516048|849308|P3|NOT COMPLETED|Overall Study||1
350795|NCT00516048|849309|P2|NOT COMPLETED|Overall Study||2
350796|NCT00516048|849310|P1|NOT COMPLETED|Overall Study||0
350797|NCT00516048|849308|P3|COMPLETED|Overall Study||0
350798|NCT00516048|849309|P2|COMPLETED|Overall Study||40
350799|NCT00516048|849310|P1|COMPLETED|Overall Study||15
350800|NCT00516048|849308|P3|STARTED|Overall Study||1
350801|NCT00516048|849309|P2|STARTED|Overall Study||42
350802|NCT00516048|849310|P1|STARTED|Overall Study||15
350803|NCT00515879|849326|P2|NOT COMPLETED|Overall Study||20
350804|NCT00515879|849327|P1|NOT COMPLETED|Overall Study||25
350805|NCT00515879|849326|P2|COMPLETED|Overall Study||62
350806|NCT00515879|849327|P1|COMPLETED|Overall Study||62
350807|NCT00515879|849326|P2|STARTED|Overall Study||82
350808|NCT00515879|849327|P1|STARTED|Overall Study||87
350809|NCT00515827|849345|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
350810|NCT00515827|849346|P1|NOT COMPLETED|Second Intervention (12 Weeks)||1
350811|NCT00515827|849345|P2|COMPLETED|Second Intervention (12 Weeks)||25
350812|NCT00515827|849346|P1|COMPLETED|Second Intervention (12 Weeks)||25
350813|NCT00515827|849345|P2|STARTED|Second Intervention (12 Weeks)||25
350814|NCT00515827|849346|P1|STARTED|Second Intervention (12 Weeks)||26
350815|NCT00515827|849345|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
350816|NCT00515827|849346|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
350817|NCT00515827|849345|P2|COMPLETED|First Intervention (12 Weeks)||25
350818|NCT00515827|849346|P1|COMPLETED|First Intervention (12 Weeks)||26
350819|NCT00515827|849345|P2|STARTED|First Intervention (12 Weeks)||26
350820|NCT00515827|849346|P1|STARTED|First Intervention (12 Weeks)||27
350821|NCT00515723|849372|P4|NOT COMPLETED|Overall Study||6
350822|NCT00515723|849373|P3|NOT COMPLETED|Overall Study||1
350823|NCT00515723|849374|P2|NOT COMPLETED|Overall Study||1
350824|NCT00515723|849375|P1|NOT COMPLETED|Overall Study||5
350825|NCT00515723|849372|P4|COMPLETED|Overall Study||21
350826|NCT00515723|849373|P3|COMPLETED|Overall Study||21
350827|NCT00515723|849374|P2|COMPLETED|Overall Study||21
350828|NCT00515723|849375|P1|COMPLETED|Overall Study||20
350829|NCT00515723|849372|P4|STARTED|Overall Study||27
350830|NCT00515723|849373|P3|STARTED|Overall Study||22
350831|NCT00515723|849374|P2|STARTED|Overall Study||22
350832|NCT00515723|849375|P1|STARTED|Overall Study||25
350833|NCT00515697|849391|P1|NOT COMPLETED|Overall Study||0
350834|NCT00515697|849391|P1|COMPLETED|Overall Study||39
350835|NCT00515697|849391|P1|Received at Least 1 Dose of Study Drug|Overall Study||39
350836|NCT00515697|849391|P1|STARTED|Overall Study||39
350837|NCT00515671|849404|P2|NOT COMPLETED|Overall Study||17
350838|NCT00515671|849405|P1|NOT COMPLETED|Overall Study||17
350839|NCT00515671|849404|P2|COMPLETED|Overall Study||41
350840|NCT00515671|849405|P1|COMPLETED|Overall Study||43
350841|NCT00515671|849404|P2|STARTED|Overall Study||58
350842|NCT00515671|849405|P1|STARTED|Overall Study||60
350843|NCT00515619|849413|P1|NOT COMPLETED|Overall Study||216
350844|NCT00515619|849413|P1|COMPLETED|Overall Study||160
350845|NCT00515619|849413|P1|Safety Set|Overall Study||376
350846|NCT00515619|849413|P1|STARTED|Overall Study||376
350847|NCT00515541|849425|P4|NOT COMPLETED|Overall Study||5
350848|NCT00515541|849426|P3|NOT COMPLETED|Overall Study||0
350849|NCT00515541|849427|P2|NOT COMPLETED|Overall Study||5
350850|NCT00515541|849428|P1|NOT COMPLETED|Overall Study||0
350851|NCT00515541|849425|P4|COMPLETED|Overall Study||6
350852|NCT00515541|849426|P3|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
350853|NCT00515541|849427|P2|COMPLETED|Overall Study||7
350854|NCT00515541|849428|P1|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
350855|NCT00515541|849425|P4|24 Weeks (8 gm Lovaza)|Overall Study|Three subjects withdrew after 18 weeks (1 GI problem, 1 undefined medical problem, 1 no show)|6
350856|NCT00515541|849426|P3|24 Weeks (8 gm Lovaza)|Overall Study||10
350857|NCT00515541|849427|P2|24 Weeks (8 gm Lovaza)|Overall Study|Two subjects withdrew at 20 and 21 weeks due to nausea. Subjects were closed out early.|7
350858|NCT00515541|849428|P1|24 Weeks (8 gm Lovaza)|Overall Study||10
350859|NCT00515541|849425|P4|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 14 weeks with GI problems.|9
350860|NCT00515541|849426|P3|18 Weeks (4 gm Lovaza)|Overall Study||10
350861|NCT00515541|849427|P2|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 12 weeks due to acquired bleeding disorder present before enrolling.|9
350862|NCT00515541|849428|P1|18 Weeks (4 gm Lovaza)|Overall Study||10
350863|NCT00515541|849425|P4|12 Weeks (2 gm Lovaza)|Overall Study||10
350864|NCT00515541|849426|P3|12 Weeks (2 gm Lovaza)|Overall Study||10
350865|NCT00515541|849427|P2|12 Weeks (2 gm Lovaza)|Overall Study||10
350866|NCT00515541|849428|P1|12 Weeks (2 gm Lovaza)|Overall Study||10
350867|NCT00515541|849425|P4|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled due to no show for appt. after baseline.|10
350868|NCT00515541|849426|P3|6 Weeks (1 gm Lovaza)|Overall Study||10
350869|NCT00515541|849427|P2|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled after baseline. One subject pulled due to no show for appt.after baseline|10
350870|NCT00515541|849428|P1|6 Weeks (1 gm Lovaza)|Overall Study||10
350871|NCT00515541|849425|P4|STARTED|Overall Study||11
350872|NCT00515541|849426|P3|STARTED|Overall Study||10
350873|NCT00515541|849427|P2|STARTED|Overall Study||12
350874|NCT00515541|849428|P1|STARTED|Overall Study||10
350875|NCT00515502|849450|P12|NOT COMPLETED|Treatment Period 4||0
350876|NCT00515502|849451|P11|NOT COMPLETED|Treatment Period 4||0
350877|NCT00515502|849452|P10|NOT COMPLETED|Treatment Period 4||0
350878|NCT00515502|849453|P9|NOT COMPLETED|Treatment Period 4||0
350879|NCT00515502|849454|P8|NOT COMPLETED|Treatment Period 4||0
350880|NCT00515502|849455|P7|NOT COMPLETED|Treatment Period 4||0
350881|NCT00515502|849456|P6|NOT COMPLETED|Treatment Period 4||0
350882|NCT00515502|849457|P5|NOT COMPLETED|Treatment Period 4||0
350883|NCT00515502|849458|P4|NOT COMPLETED|Treatment Period 4||0
350884|NCT00515502|849459|P3|NOT COMPLETED|Treatment Period 4||0
350885|NCT00515502|849460|P2|NOT COMPLETED|Treatment Period 4||0
350886|NCT00515502|849461|P1|NOT COMPLETED|Treatment Period 4||0
350887|NCT00515502|849450|P12|COMPLETED|Treatment Period 4||0
350888|NCT00515502|849451|P11|COMPLETED|Treatment Period 4||1
350889|NCT00515502|849452|P10|COMPLETED|Treatment Period 4||2
350890|NCT00515502|849453|P9|COMPLETED|Treatment Period 4||0
350891|NCT00515502|849454|P8|COMPLETED|Treatment Period 4||1
350892|NCT00515502|849455|P7|COMPLETED|Treatment Period 4||1
350893|NCT00515502|849456|P6|COMPLETED|Treatment Period 4||1
350894|NCT00515502|849457|P5|COMPLETED|Treatment Period 4||3
350895|NCT00515502|849458|P4|COMPLETED|Treatment Period 4||3
350896|NCT00515502|849459|P3|COMPLETED|Treatment Period 4||4
350897|NCT00515502|849460|P2|COMPLETED|Treatment Period 4||3
350898|NCT00515502|849461|P1|COMPLETED|Treatment Period 4||1
350899|NCT00515502|849450|P12|STARTED|Treatment Period 4||0
350900|NCT00515502|849451|P11|STARTED|Treatment Period 4||1
350901|NCT00515502|849452|P10|STARTED|Treatment Period 4||2
350902|NCT00515502|849453|P9|STARTED|Treatment Period 4||0
350903|NCT00515502|849454|P8|STARTED|Treatment Period 4||1
350904|NCT00515502|849455|P7|STARTED|Treatment Period 4||1
350905|NCT00515502|849456|P6|STARTED|Treatment Period 4||1
350906|NCT00515502|849457|P5|STARTED|Treatment Period 4||3
350907|NCT00515502|849458|P4|STARTED|Treatment Period 4||3
350908|NCT00515502|849459|P3|STARTED|Treatment Period 4||4
350909|NCT00515502|849460|P2|STARTED|Treatment Period 4||3
350910|NCT00515502|849461|P1|STARTED|Treatment Period 4||1
350911|NCT00515502|849450|P12|NOT COMPLETED|Washout Period 3||0
350912|NCT00515502|849451|P11|NOT COMPLETED|Washout Period 3||0
350913|NCT00515502|849452|P10|NOT COMPLETED|Washout Period 3||0
350914|NCT00515502|849453|P9|NOT COMPLETED|Washout Period 3||0
350915|NCT00515502|849454|P8|NOT COMPLETED|Washout Period 3||0
350916|NCT00515502|849455|P7|NOT COMPLETED|Washout Period 3||0
350917|NCT00515502|849456|P6|NOT COMPLETED|Washout Period 3||0
350918|NCT00515502|849457|P5|NOT COMPLETED|Washout Period 3||0
350919|NCT00515502|849458|P4|NOT COMPLETED|Washout Period 3||0
350920|NCT00515502|849459|P3|NOT COMPLETED|Washout Period 3||0
350921|NCT00515502|849460|P2|NOT COMPLETED|Washout Period 3||0
350922|NCT00515502|849461|P1|NOT COMPLETED|Washout Period 3||0
350923|NCT00515502|849450|P12|COMPLETED|Washout Period 3||0
350924|NCT00515502|849451|P11|COMPLETED|Washout Period 3||1
350925|NCT00515502|849452|P10|COMPLETED|Washout Period 3||2
350926|NCT00515502|849453|P9|COMPLETED|Washout Period 3||0
350927|NCT00515502|849454|P8|COMPLETED|Washout Period 3||1
350928|NCT00515502|849455|P7|COMPLETED|Washout Period 3||1
350929|NCT00515502|849456|P6|COMPLETED|Washout Period 3||1
350930|NCT00515502|849457|P5|COMPLETED|Washout Period 3||3
350931|NCT00515502|849458|P4|COMPLETED|Washout Period 3||3
350932|NCT00515502|849459|P3|COMPLETED|Washout Period 3||4
350933|NCT00515502|849460|P2|COMPLETED|Washout Period 3||3
350934|NCT00515502|849461|P1|COMPLETED|Washout Period 3||1
350935|NCT00515502|849450|P12|STARTED|Washout Period 3||0
350936|NCT00515502|849451|P11|STARTED|Washout Period 3||1
350937|NCT00515502|849452|P10|STARTED|Washout Period 3||2
350938|NCT00515502|849453|P9|STARTED|Washout Period 3||0
350939|NCT00515502|849454|P8|STARTED|Washout Period 3||1
350940|NCT00515502|849455|P7|STARTED|Washout Period 3||1
350941|NCT00515502|849456|P6|STARTED|Washout Period 3||1
350942|NCT00515502|849457|P5|STARTED|Washout Period 3||3
350943|NCT00515502|849458|P4|STARTED|Washout Period 3||3
350944|NCT00515502|849459|P3|STARTED|Washout Period 3||4
350945|NCT00515502|849460|P2|STARTED|Washout Period 3||3
350946|NCT00515502|849461|P1|STARTED|Washout Period 3||1
350947|NCT00515502|849450|P12|NOT COMPLETED|Treatment Period 3||0
350948|NCT00515502|849451|P11|NOT COMPLETED|Treatment Period 3||0
350949|NCT00515502|849452|P10|NOT COMPLETED|Treatment Period 3||0
350950|NCT00515502|849453|P9|NOT COMPLETED|Treatment Period 3||0
350951|NCT00515502|849454|P8|NOT COMPLETED|Treatment Period 3||0
350952|NCT00515502|849455|P7|NOT COMPLETED|Treatment Period 3||0
350953|NCT00515502|849456|P6|NOT COMPLETED|Treatment Period 3||0
350954|NCT00515502|849457|P5|NOT COMPLETED|Treatment Period 3||0
350955|NCT00515502|849458|P4|NOT COMPLETED|Treatment Period 3||0
350956|NCT00515502|849459|P3|NOT COMPLETED|Treatment Period 3||0
350957|NCT00515502|849460|P2|NOT COMPLETED|Treatment Period 3||0
350958|NCT00515502|849461|P1|NOT COMPLETED|Treatment Period 3||0
350959|NCT00515502|849450|P12|COMPLETED|Treatment Period 3||0
350960|NCT00515502|849451|P11|COMPLETED|Treatment Period 3||1
350961|NCT00515502|849452|P10|COMPLETED|Treatment Period 3||2
350962|NCT00515502|849453|P9|COMPLETED|Treatment Period 3||0
350963|NCT00515502|849454|P8|COMPLETED|Treatment Period 3||1
350964|NCT00515502|849455|P7|COMPLETED|Treatment Period 3||1
350965|NCT00515502|849456|P6|COMPLETED|Treatment Period 3||1
350966|NCT00515502|849457|P5|COMPLETED|Treatment Period 3||3
350967|NCT00515502|849458|P4|COMPLETED|Treatment Period 3||3
350968|NCT00515502|849459|P3|COMPLETED|Treatment Period 3||4
350969|NCT00515502|849460|P2|COMPLETED|Treatment Period 3||3
350970|NCT00515502|849461|P1|COMPLETED|Treatment Period 3||1
350971|NCT00515502|849450|P12|STARTED|Treatment Period 3||0
350972|NCT00515502|849451|P11|STARTED|Treatment Period 3||1
350973|NCT00515502|849452|P10|STARTED|Treatment Period 3||2
350974|NCT00515502|849453|P9|STARTED|Treatment Period 3||0
350975|NCT00515502|849454|P8|STARTED|Treatment Period 3||1
350976|NCT00515502|849455|P7|STARTED|Treatment Period 3||1
350977|NCT00515502|849456|P6|STARTED|Treatment Period 3||1
350978|NCT00515502|849457|P5|STARTED|Treatment Period 3||3
350979|NCT00515502|849458|P4|STARTED|Treatment Period 3||3
350980|NCT00515502|849459|P3|STARTED|Treatment Period 3||4
350981|NCT00515502|849460|P2|STARTED|Treatment Period 3||3
350982|NCT00515502|849461|P1|STARTED|Treatment Period 3||1
350983|NCT00515502|849450|P12|NOT COMPLETED|Washout Period 2||0
350984|NCT00515502|849451|P11|NOT COMPLETED|Washout Period 2||0
350985|NCT00515502|849452|P10|NOT COMPLETED|Washout Period 2||0
350986|NCT00515502|849453|P9|NOT COMPLETED|Washout Period 2||0
350987|NCT00515502|849454|P8|NOT COMPLETED|Washout Period 2||0
350988|NCT00515502|849455|P7|NOT COMPLETED|Washout Period 2||0
350989|NCT00515502|849456|P6|NOT COMPLETED|Washout Period 2||0
350990|NCT00515502|849457|P5|NOT COMPLETED|Washout Period 2||0
350991|NCT00515502|849458|P4|NOT COMPLETED|Washout Period 2||0
350992|NCT00515502|849459|P3|NOT COMPLETED|Washout Period 2||0
350993|NCT00515502|849460|P2|NOT COMPLETED|Washout Period 2||0
350994|NCT00515502|849461|P1|NOT COMPLETED|Washout Period 2||0
350995|NCT00515502|849450|P12|COMPLETED|Washout Period 2||0
350996|NCT00515502|849451|P11|COMPLETED|Washout Period 2||1
350997|NCT00515502|849452|P10|COMPLETED|Washout Period 2||2
350998|NCT00515502|849453|P9|COMPLETED|Washout Period 2||0
350999|NCT00515502|849454|P8|COMPLETED|Washout Period 2||1
351000|NCT00515502|849455|P7|COMPLETED|Washout Period 2||1
351001|NCT00515502|849456|P6|COMPLETED|Washout Period 2||1
351002|NCT00515502|849457|P5|COMPLETED|Washout Period 2||3
351003|NCT00515502|849458|P4|COMPLETED|Washout Period 2||3
351004|NCT00515502|849459|P3|COMPLETED|Washout Period 2||4
351005|NCT00515502|849460|P2|COMPLETED|Washout Period 2||3
351006|NCT00515502|849461|P1|COMPLETED|Washout Period 2||1
351007|NCT00515502|849450|P12|STARTED|Washout Period 2||0
351008|NCT00515502|849451|P11|STARTED|Washout Period 2||1
351009|NCT00515502|849452|P10|STARTED|Washout Period 2||2
351010|NCT00515502|849453|P9|STARTED|Washout Period 2||0
351011|NCT00515502|849454|P8|STARTED|Washout Period 2||1
351012|NCT00515502|849455|P7|STARTED|Washout Period 2||1
351013|NCT00515502|849456|P6|STARTED|Washout Period 2||1
351014|NCT00515502|849457|P5|STARTED|Washout Period 2||3
351015|NCT00515502|849458|P4|STARTED|Washout Period 2||3
351016|NCT00515502|849459|P3|STARTED|Washout Period 2||4
351017|NCT00515502|849460|P2|STARTED|Washout Period 2||3
351018|NCT00515502|849461|P1|STARTED|Washout Period 2||1
351019|NCT00515502|849450|P12|NOT COMPLETED|Treatment Period 2||0
351020|NCT00515502|849451|P11|NOT COMPLETED|Treatment Period 2||0
351021|NCT00515502|849452|P10|NOT COMPLETED|Treatment Period 2||0
351022|NCT00515502|849453|P9|NOT COMPLETED|Treatment Period 2||0
351023|NCT00515502|849454|P8|NOT COMPLETED|Treatment Period 2||0
351024|NCT00515502|849455|P7|NOT COMPLETED|Treatment Period 2||0
351025|NCT00515502|849456|P6|NOT COMPLETED|Treatment Period 2||0
351026|NCT00515502|849457|P5|NOT COMPLETED|Treatment Period 2||0
351027|NCT00515502|849458|P4|NOT COMPLETED|Treatment Period 2||0
351028|NCT00515502|849459|P3|NOT COMPLETED|Treatment Period 2||0
351029|NCT00515502|849460|P2|NOT COMPLETED|Treatment Period 2||1
351030|NCT00515502|849461|P1|NOT COMPLETED|Treatment Period 2||0
351031|NCT00515502|849450|P12|COMPLETED|Treatment Period 2||0
351032|NCT00515502|849451|P11|COMPLETED|Treatment Period 2||1
351033|NCT00515502|849452|P10|COMPLETED|Treatment Period 2||2
351034|NCT00515502|849453|P9|COMPLETED|Treatment Period 2||0
351035|NCT00515502|849454|P8|COMPLETED|Treatment Period 2||1
351036|NCT00515502|849455|P7|COMPLETED|Treatment Period 2||1
351037|NCT00515502|849456|P6|COMPLETED|Treatment Period 2||1
351038|NCT00515502|849457|P5|COMPLETED|Treatment Period 2||3
351039|NCT00515502|849458|P4|COMPLETED|Treatment Period 2||3
351040|NCT00515502|849459|P3|COMPLETED|Treatment Period 2||4
351041|NCT00515502|849460|P2|COMPLETED|Treatment Period 2||3
351042|NCT00515502|849461|P1|COMPLETED|Treatment Period 2||1
351043|NCT00515502|849450|P12|STARTED|Treatment Period 2||0
351044|NCT00515502|849451|P11|STARTED|Treatment Period 2||1
351045|NCT00515502|849452|P10|STARTED|Treatment Period 2||2
351046|NCT00515502|849453|P9|STARTED|Treatment Period 2||0
351047|NCT00515502|849454|P8|STARTED|Treatment Period 2||1
351048|NCT00515502|849455|P7|STARTED|Treatment Period 2||1
351049|NCT00515502|849456|P6|STARTED|Treatment Period 2||1
351050|NCT00515502|849457|P5|STARTED|Treatment Period 2||3
351051|NCT00515502|849458|P4|STARTED|Treatment Period 2||3
351052|NCT00515502|849459|P3|STARTED|Treatment Period 2||4
351053|NCT00515502|849460|P2|STARTED|Treatment Period 2||4
351054|NCT00515502|849461|P1|STARTED|Treatment Period 2||1
351055|NCT00515502|849450|P12|NOT COMPLETED|Washout Period 1||0
351056|NCT00515502|849451|P11|NOT COMPLETED|Washout Period 1||0
351057|NCT00515502|849452|P10|NOT COMPLETED|Washout Period 1||0
351058|NCT00515502|849453|P9|NOT COMPLETED|Washout Period 1||0
351059|NCT00515502|849454|P8|NOT COMPLETED|Washout Period 1||0
351060|NCT00515502|849455|P7|NOT COMPLETED|Washout Period 1||0
351061|NCT00515502|849456|P6|NOT COMPLETED|Washout Period 1||0
351062|NCT00515502|849457|P5|NOT COMPLETED|Washout Period 1||0
351063|NCT00515502|849458|P4|NOT COMPLETED|Washout Period 1||0
351064|NCT00515502|849459|P3|NOT COMPLETED|Washout Period 1||0
351065|NCT00515502|849460|P2|NOT COMPLETED|Washout Period 1||0
351066|NCT00515502|849461|P1|NOT COMPLETED|Washout Period 1||0
351067|NCT00515502|849450|P12|COMPLETED|Washout Period 1||0
351068|NCT00515502|849451|P11|COMPLETED|Washout Period 1||1
351069|NCT00515502|849452|P10|COMPLETED|Washout Period 1||2
351070|NCT00515502|849453|P9|COMPLETED|Washout Period 1||0
351071|NCT00515502|849454|P8|COMPLETED|Washout Period 1||1
351072|NCT00515502|849455|P7|COMPLETED|Washout Period 1||1
351073|NCT00515502|849456|P6|COMPLETED|Washout Period 1||1
351074|NCT00515502|849457|P5|COMPLETED|Washout Period 1||3
351075|NCT00515502|849458|P4|COMPLETED|Washout Period 1||3
351076|NCT00515502|849459|P3|COMPLETED|Washout Period 1||4
351077|NCT00515502|849460|P2|COMPLETED|Washout Period 1||4
351078|NCT00515502|849461|P1|COMPLETED|Washout Period 1||1
351079|NCT00515502|849450|P12|STARTED|Washout Period 1||0
351080|NCT00515502|849451|P11|STARTED|Washout Period 1||1
351081|NCT00515502|849452|P10|STARTED|Washout Period 1||2
351082|NCT00515502|849453|P9|STARTED|Washout Period 1||0
351083|NCT00515502|849454|P8|STARTED|Washout Period 1||1
351084|NCT00515502|849455|P7|STARTED|Washout Period 1||1
351085|NCT00515502|849456|P6|STARTED|Washout Period 1||1
351086|NCT00515502|849457|P5|STARTED|Washout Period 1||3
351087|NCT00515502|849458|P4|STARTED|Washout Period 1||3
351088|NCT00515502|849459|P3|STARTED|Washout Period 1||4
351089|NCT00515502|849460|P2|STARTED|Washout Period 1||4
351090|NCT00515502|849461|P1|STARTED|Washout Period 1||1
351091|NCT00515502|849450|P12|NOT COMPLETED|Treatment Period 1||1
351092|NCT00515502|849451|P11|NOT COMPLETED|Treatment Period 1||0
351093|NCT00515502|849452|P10|NOT COMPLETED|Treatment Period 1||0
351094|NCT00515502|849453|P9|NOT COMPLETED|Treatment Period 1||1
351095|NCT00515502|849454|P8|NOT COMPLETED|Treatment Period 1||0
351096|NCT00515502|849455|P7|NOT COMPLETED|Treatment Period 1||1
351097|NCT00515502|849456|P6|NOT COMPLETED|Treatment Period 1||0
351098|NCT00515502|849457|P5|NOT COMPLETED|Treatment Period 1||0
351099|NCT00515502|849458|P4|NOT COMPLETED|Treatment Period 1||0
351100|NCT00515502|849459|P3|NOT COMPLETED|Treatment Period 1||0
351101|NCT00515502|849460|P2|NOT COMPLETED|Treatment Period 1||0
351102|NCT00515502|849461|P1|NOT COMPLETED|Treatment Period 1||0
351103|NCT00515502|849450|P12|COMPLETED|Treatment Period 1||0
351104|NCT00515502|849451|P11|COMPLETED|Treatment Period 1||1
351105|NCT00515502|849452|P10|COMPLETED|Treatment Period 1||2
351106|NCT00515502|849453|P9|COMPLETED|Treatment Period 1||0
351107|NCT00515502|849454|P8|COMPLETED|Treatment Period 1||1
351108|NCT00515502|849455|P7|COMPLETED|Treatment Period 1||1
351109|NCT00515502|849456|P6|COMPLETED|Treatment Period 1||1
351110|NCT00515502|849457|P5|COMPLETED|Treatment Period 1||3
351111|NCT00515502|849458|P4|COMPLETED|Treatment Period 1||3
351112|NCT00515502|849459|P3|COMPLETED|Treatment Period 1||4
351113|NCT00515502|849460|P2|COMPLETED|Treatment Period 1||4
351114|NCT00515502|849461|P1|COMPLETED|Treatment Period 1||1
351115|NCT00515502|849450|P12|STARTED|Treatment Period 1||1
351116|NCT00515502|849451|P11|STARTED|Treatment Period 1||1
351117|NCT00515502|849452|P10|STARTED|Treatment Period 1||2
351118|NCT00515502|849453|P9|STARTED|Treatment Period 1||1
351119|NCT00515502|849454|P8|STARTED|Treatment Period 1||1
351120|NCT00515502|849455|P7|STARTED|Treatment Period 1||2
351121|NCT00515502|849456|P6|STARTED|Treatment Period 1||1
351122|NCT00515502|849457|P5|STARTED|Treatment Period 1||3
351123|NCT00515502|849458|P4|STARTED|Treatment Period 1||3
351124|NCT00515502|849459|P3|STARTED|Treatment Period 1||4
351125|NCT00515502|849460|P2|STARTED|Treatment Period 1||4
351126|NCT00515502|849461|P1|STARTED|Treatment Period 1||1
351127|NCT00515463|849621|P2|NOT COMPLETED|Overall Study||14
351128|NCT00515463|849622|P1|NOT COMPLETED|Overall Study||14
351129|NCT00515463|849621|P2|COMPLETED|Overall Study||142
351130|NCT00515463|849622|P1|COMPLETED|Overall Study||141
351131|NCT00515463|849621|P2|Received Study Medication|Overall Study||156
351132|NCT00515463|849622|P1|Received Study Medication|Overall Study||154
351133|NCT00515463|849621|P2|STARTED|Overall Study||156
351134|NCT00515463|849622|P1|STARTED|Overall Study||155
351135|NCT00515437|849776|P4|NOT COMPLETED|Overall Study||1
351136|NCT00515437|849777|P3|NOT COMPLETED|Overall Study||0
351137|NCT00515437|849778|P2|NOT COMPLETED|Overall Study||0
351138|NCT00515437|849779|P1|NOT COMPLETED|Overall Study||0
351139|NCT00515437|849776|P4|COMPLETED|Overall Study||14
351140|NCT00515437|849777|P3|COMPLETED|Overall Study||13
351141|NCT00515437|849778|P2|COMPLETED|Overall Study||12
351142|NCT00515437|849779|P1|COMPLETED|Overall Study||14
351143|NCT00515437|849776|P4|STARTED|Overall Study||15
351144|NCT00515437|849777|P3|STARTED|Overall Study||13
351145|NCT00515437|849778|P2|STARTED|Overall Study||12
351146|NCT00515437|849779|P1|STARTED|Overall Study||14
351147|NCT00515294|849805|P4|NOT COMPLETED|Overall Study||4
351148|NCT00515294|849806|P3|NOT COMPLETED|Overall Study||11
351149|NCT00515294|849807|P2|NOT COMPLETED|Overall Study||3
351150|NCT00515294|849808|P1|NOT COMPLETED|Overall Study||9
351151|NCT00515294|849805|P4|COMPLETED|Overall Study||35
351152|NCT00515294|849806|P3|COMPLETED|Overall Study||27
351153|NCT00515294|849807|P2|COMPLETED|Overall Study||36
351154|NCT00515294|849808|P1|COMPLETED|Overall Study||29
351155|NCT00515294|849805|P4|STARTED|Overall Study||39
351156|NCT00515294|849806|P3|STARTED|Overall Study||38
351157|NCT00515294|849807|P2|STARTED|Overall Study||39
351158|NCT00515294|849808|P1|STARTED|Overall Study||38
351159|NCT00515216|849822|P1|NOT COMPLETED|Overall Study||1
351160|NCT00515216|849822|P1|COMPLETED|Overall Study||25
351161|NCT00515216|849822|P1|STARTED|Overall Study||26
351162|NCT00515203|849846|P2|NOT COMPLETED|Overall Study||0
351163|NCT00515203|849847|P1|NOT COMPLETED|Overall Study||0
351164|NCT00515203|849846|P2|COMPLETED|Overall Study||5
351165|NCT00515203|849847|P1|COMPLETED|Overall Study||17
351166|NCT00515203|849846|P2|STARTED|Overall Study||5
351167|NCT00515203|849847|P1|STARTED|Overall Study||17
351168|NCT00515177|849865|P2|NOT COMPLETED|Overall Study||1
351169|NCT00515177|849866|P1|NOT COMPLETED|Overall Study||2
351170|NCT00515177|849865|P2|COMPLETED|Overall Study||9
351171|NCT00515177|849866|P1|COMPLETED|Overall Study||18
351172|NCT00515177|849865|P2|STARTED|Overall Study||10
351173|NCT00515177|849866|P1|STARTED|Overall Study||20
351174|NCT00515112|849884|P2|NOT COMPLETED|Overall Study||3
351175|NCT00515112|849885|P1|NOT COMPLETED|Overall Study||3
351176|NCT00515112|849884|P2|COMPLETED|Overall Study||0
351177|NCT00515112|849885|P1|COMPLETED|Overall Study||0
351178|NCT00515112|849884|P2|STARTED|Overall Study||3
351179|NCT00515112|849885|P1|STARTED|Overall Study||3
351180|NCT00515099|849895|P2|NOT COMPLETED|Overall Study||4
351181|NCT00515099|849896|P1|NOT COMPLETED|Overall Study||3
351182|NCT00515099|849895|P2|COMPLETED|Overall Study||16
351183|NCT00515099|849896|P1|COMPLETED|Overall Study||35
351184|NCT00515099|849895|P2|STARTED|Overall Study||20
351185|NCT00515099|849896|P1|STARTED|Overall Study||38
351186|NCT00515086|849918|P4|NOT COMPLETED|Overall Study||6
351187|NCT00515086|849919|P3|NOT COMPLETED|Overall Study||5
351188|NCT00515086|849920|P2|NOT COMPLETED|Overall Study||6
351189|NCT00515086|849921|P1|NOT COMPLETED|Overall Study||24
351190|NCT00515086|849918|P4|COMPLETED|Overall Study||0
351191|NCT00515086|849919|P3|COMPLETED|Overall Study||0
351192|NCT00515086|849920|P2|COMPLETED|Overall Study||0
351193|NCT00515086|849921|P1|COMPLETED|Overall Study||0
351194|NCT00515086|849918|P4|STARTED|Overall Study||6
351195|NCT00515086|849919|P3|STARTED|Overall Study||5
351196|NCT00515086|849920|P2|STARTED|Overall Study||6
351197|NCT00515086|849921|P1|STARTED|Overall Study||24
351198|NCT00515073|849948|P1|NOT COMPLETED|Overall Study||2
351199|NCT00515073|849948|P1|COMPLETED|Overall Study||28
351200|NCT00515073|849948|P1|STARTED|Overall Study||30
351201|NCT00515034|849956|P4|NOT COMPLETED|Overall Study||5
351202|NCT00515034|849957|P3|NOT COMPLETED|Overall Study||8
351203|NCT00515034|849958|P2|NOT COMPLETED|Overall Study||2
351204|NCT00515034|849959|P1|NOT COMPLETED|Overall Study||8
351205|NCT00515034|849956|P4|COMPLETED|Overall Study||15
351206|NCT00515034|849957|P3|COMPLETED|Overall Study||54
351207|NCT00515034|849958|P2|COMPLETED|Overall Study||13
351208|NCT00515034|849959|P1|COMPLETED|Overall Study||41
351209|NCT00515034|849956|P4|TREATED|Overall Study||19
351210|NCT00515034|849957|P3|TREATED|Overall Study||61
351211|NCT00515034|849958|P2|TREATED|Overall Study||15
351212|NCT00515034|849959|P1|TREATED|Overall Study||48
351213|NCT00515034|849956|P4|STARTED|Overall Study||20
351214|NCT00515034|849957|P3|STARTED|Overall Study||62
351215|NCT00515034|849958|P2|STARTED|Overall Study||15
351216|NCT00515034|849959|P1|STARTED|Overall Study||49
351217|NCT00515021|849979|P2|NOT COMPLETED|Overall Study||0
351218|NCT00515021|849980|P1|NOT COMPLETED|Overall Study||0
351219|NCT00515021|849979|P2|COMPLETED|Overall Study||11
351220|NCT00515021|849980|P1|COMPLETED|Overall Study||9
351221|NCT00515021|849979|P2|STARTED|Overall Study||11
351222|NCT00515021|849980|P1|STARTED|Overall Study||9
351223|NCT00515008|849990|P2|NOT COMPLETED|Overall Study||4
351224|NCT00515008|849991|P1|NOT COMPLETED|Overall Study||3
351225|NCT00515008|849990|P2|COMPLETED|Overall Study||29
351226|NCT00515008|849991|P1|COMPLETED|Overall Study||30
351227|NCT00515008|849990|P2|Completed 12 Week Evaluation|Overall Study||29
351228|NCT00515008|849991|P1|Completed 12 Week Evaluation|Overall Study||32
351229|NCT00515008|849990|P2|STARTED|Overall Study||33
351230|NCT00515008|849991|P1|STARTED|Overall Study||33
351231|NCT00514943|850015|P2|NOT COMPLETED|Stage 2||36
351232|NCT00514943|850016|P1|NOT COMPLETED|Stage 2||32
351233|NCT00514943|850015|P2|COMPLETED|Stage 2||0
351234|NCT00514943|850016|P1|COMPLETED|Stage 2||0
351235|NCT00514943|850015|P2|STARTED|Stage 2||36
351236|NCT00514943|850016|P1|STARTED|Stage 2||32
351237|NCT00514943|850015|P2|NOT COMPLETED|Stage 1||26
351238|NCT00514943|850016|P1|NOT COMPLETED|Stage 1||30
351239|NCT00514943|850015|P2|COMPLETED|Stage 1||36
351240|NCT00514943|850016|P1|COMPLETED|Stage 1||32
351241|NCT00514943|850015|P2|STARTED|Stage 1|2 randomized patients were not treated|62
351242|NCT00514943|850016|P1|STARTED|Stage 1|1 randomized patient was not treated|62
351243|NCT00514917|850074|P2|NOT COMPLETED|Overall Study||115
351244|NCT00514917|850075|P1|NOT COMPLETED|Overall Study||126
351245|NCT00514917|850074|P2|COMPLETED|Overall Study||91
351246|NCT00514917|850075|P1|COMPLETED|Overall Study||81
351247|NCT00514917|850074|P2|Testosterone-Specific Evaluable|Overall Study||124
351248|NCT00514917|850075|P1|Testosterone-Specific Evaluable|Overall Study||122
351249|NCT00514917|850074|P2|Completed Study Treatment|Overall Study||182
351250|NCT00514917|850075|P1|Completed Study Treatment|Overall Study||170
351251|NCT00514917|850074|P2|Treated|Overall Study||204
351252|NCT00514917|850075|P1|Treated|Overall Study||196
351253|NCT00514917|850074|P2|STARTED|Overall Study||206
351254|NCT00514917|850075|P1|STARTED|Overall Study||207
351255|NCT00514904|850103|P2|NOT COMPLETED|Overall Study||5
351256|NCT00514904|850104|P1|NOT COMPLETED|Overall Study||24
351257|NCT00514904|850103|P2|COMPLETED|Overall Study||371
351258|NCT00514904|850104|P1|COMPLETED|Overall Study||1101
351259|NCT00514904|850103|P2|STARTED|Overall Study||376
351260|NCT00514904|850104|P1|STARTED|Overall Study||1125
351261|NCT00514852|850140|P2|NOT COMPLETED|Overall Study||5
351262|NCT00514852|850141|P1|NOT COMPLETED|Overall Study||5
351263|NCT00514852|850140|P2|COMPLETED|Overall Study||154
351264|NCT00514852|850141|P1|COMPLETED|Overall Study||152
351265|NCT00514852|850140|P2|STARTED|Overall Study||159
351266|NCT00514852|850141|P1|STARTED|Overall Study||157
351267|NCT00514813|850169|P4|NOT COMPLETED|Overall Study||4
351268|NCT00514813|850170|P3|NOT COMPLETED|Overall Study||47
351269|NCT00514813|850171|P2|NOT COMPLETED|Overall Study||86
351270|NCT00514813|850172|P1|NOT COMPLETED|Overall Study||15
351271|NCT00514813|850169|P4|COMPLETED|Overall Study||0
351272|NCT00514813|850170|P3|COMPLETED|Overall Study||0
351273|NCT00514813|850171|P2|COMPLETED|Overall Study||0
351274|NCT00514813|850172|P1|COMPLETED|Overall Study||0
351275|NCT00514813|850169|P4|STARTED|Overall Study||4
351276|NCT00514813|850170|P3|STARTED|Overall Study||47
351277|NCT00514813|850171|P2|STARTED|Overall Study||86
351278|NCT00514813|850172|P1|STARTED|Overall Study||15
351279|NCT00514735|850192|P2|NOT COMPLETED|Overall Study||6
351280|NCT00514735|850193|P1|NOT COMPLETED|Overall Study||14
351281|NCT00514735|850192|P2|COMPLETED|Overall Study||66
351282|NCT00514735|850193|P1|COMPLETED|Overall Study||124
351283|NCT00514735|850192|P2|STARTED|Overall Study||72
351284|NCT00514735|850193|P1|STARTED|Overall Study||138
351285|NCT00514709|850213|P2|NOT COMPLETED|Overall Study||0
351286|NCT00514709|850214|P1|NOT COMPLETED|Overall Study||0
351287|NCT00514709|850213|P2|COMPLETED|Overall Study||613
351288|NCT00514709|850214|P1|COMPLETED|Overall Study||1230
351289|NCT00514709|850213|P2|STARTED|Overall Study||613
351290|NCT00514709|850214|P1|STARTED|Overall Study||1230
351291|NCT00514683|850229|P5|NOT COMPLETED|Overall Study||33
351292|NCT00514683|850230|P4|NOT COMPLETED|Overall Study||14
351293|NCT00514683|850231|P3|NOT COMPLETED|Overall Study||18
351294|NCT00514683|850232|P2|NOT COMPLETED|Overall Study||25
351295|NCT00514683|850233|P1|NOT COMPLETED|Overall Study||26
351296|NCT00514683|850229|P5|COMPLETED|Overall Study||53
351297|NCT00514683|850230|P4|COMPLETED|Overall Study||72
351298|NCT00514683|850231|P3|COMPLETED|Overall Study||68
351299|NCT00514683|850232|P2|COMPLETED|Overall Study||62
351300|NCT00514683|850233|P1|COMPLETED|Overall Study||61
351301|NCT00514683|850229|P5|STARTED|Overall Study|Randomised|86
351302|NCT00514683|850230|P4|STARTED|Overall Study|Randomised|86
351303|NCT00514683|850231|P3|STARTED|Overall Study|Randomised|86
351304|NCT00514683|850232|P2|STARTED|Overall Study|Randomised|87
351305|NCT00514683|850233|P1|STARTED|Overall Study|Randomised|87
351306|NCT00514592|850424|P1|NOT COMPLETED|Overall Study||0
351307|NCT00514592|850424|P1|COMPLETED|Overall Study||230
351308|NCT00514592|850424|P1|STARTED|Overall Study||230
351309|NCT00514514|850432|P3|NOT COMPLETED|Extension - 4 Years||21
351310|NCT00514514|850433|P2|NOT COMPLETED|Extension - 4 Years||22
351311|NCT00514514|850434|P1|NOT COMPLETED|Extension - 4 Years||37
351312|NCT00514514|850432|P3|COMPLETED|Extension - 4 Years||113
351313|NCT00514514|850433|P2|COMPLETED|Extension - 4 Years||117
351314|NCT00514514|850434|P1|COMPLETED|Extension - 4 Years||108
351315|NCT00514514|850432|P3|Non-randomized (Followed)|Extension - 4 Years||0
351316|NCT00514514|850433|P2|Non-randomized (Followed)|Extension - 4 Years||0
351317|NCT00514514|850434|P1|Non-randomized (Followed)|Extension - 4 Years|Patients were not randomized but continued on standard regimen and entered follow up.|95
351318|NCT00514514|850432|P3|STARTED|Extension - 4 Years||134
351319|NCT00514514|850433|P2|STARTED|Extension - 4 Years||139
351320|NCT00514514|850434|P1|STARTED|Extension - 4 Years||145
351321|NCT00514514|850432|P3|NOT COMPLETED|Randomized - 9 Month||38
351322|NCT00514514|850433|P2|NOT COMPLETED|Randomized - 9 Month||61
351323|NCT00514514|850434|P1|NOT COMPLETED|Randomized - 9 Month||39
351324|NCT00514514|850432|P3|COMPLETED|Randomized - 9 Month||124
351325|NCT00514514|850433|P2|COMPLETED|Randomized - 9 Month||110
351326|NCT00514514|850434|P1|COMPLETED|Randomized - 9 Month||127
351327|NCT00514514|850432|P3|Randomized - Received Treatment|Randomized - 9 Month||161
351328|NCT00514514|850433|P2|Randomized - Received Treatment|Randomized - 9 Month||171
351329|NCT00514514|850434|P1|Randomized - Received Treatment|Randomized - 9 Month||165
351330|NCT00514514|850432|P3|STARTED|Randomized - 9 Month||162
351331|NCT00514514|850433|P2|STARTED|Randomized - 9 Month||171
351332|NCT00514514|850434|P1|STARTED|Randomized - 9 Month||166
351333|NCT00514514|850432|P3|NOT COMPLETED|Pre-phase||0
351334|NCT00514514|850433|P2|NOT COMPLETED|Pre-phase||0
351335|NCT00514514|850434|P1|NOT COMPLETED|Pre-phase||303
351336|NCT00514514|850432|P3|COMPLETED|Pre-phase||0
351337|NCT00514514|850433|P2|COMPLETED|Pre-phase||0
351338|NCT00514514|850434|P1|COMPLETED|Pre-phase||499
351339|NCT00514514|850432|P3|STARTED|Pre-phase||0
351340|NCT00514514|850433|P2|STARTED|Pre-phase||0
351341|NCT00514514|850434|P1|STARTED|Pre-phase|All enrolled patients received standard regimen for 3 months|802
351342|NCT00514501|850478|P1|NOT COMPLETED|Overall Study||3
351343|NCT00514501|850478|P1|COMPLETED|Overall Study||507
351344|NCT00514501|850478|P1|STARTED|Overall Study||510
351345|NCT00514449|850486|P2|NOT COMPLETED|Overall Study||4
351346|NCT00514449|850487|P1|NOT COMPLETED|Overall Study||3
351347|NCT00514449|850486|P2|COMPLETED|Overall Study||8
351348|NCT00514449|850487|P1|COMPLETED|Overall Study||9
351349|NCT00514449|850486|P2|STARTED|Overall Study||12
351350|NCT00514449|850487|P1|STARTED|Overall Study||12
351351|NCT00514215|850497|P1|NOT COMPLETED|Overall Study||0
351352|NCT00514215|850497|P1|COMPLETED|Overall Study||8
351353|NCT00514215|850497|P1|STARTED|Overall Study||8
351354|NCT00514137|850504|P1|NOT COMPLETED|Overall Study||0
351355|NCT00514137|850504|P1|COMPLETED|Overall Study||13
351356|NCT00514137|850504|P1|STARTED|Overall Study||13
351357|NCT00514020|850511|P1|NOT COMPLETED|Overall Study||28
351358|NCT00514020|850511|P1|COMPLETED|Overall Study||5
351359|NCT00514020|850511|P1|STARTED|Overall Study|two patients withdrew before treatment; one withdrew after treatment|33
351360|NCT00513799|850519|P4|NOT COMPLETED|Four-Month Follow-Up||3
351361|NCT00513799|850520|P3|NOT COMPLETED|Four-Month Follow-Up||7
351362|NCT00513799|850521|P2|NOT COMPLETED|Four-Month Follow-Up||5
351363|NCT00513799|850522|P1|NOT COMPLETED|Four-Month Follow-Up||0
351364|NCT00513799|850519|P4|COMPLETED|Four-Month Follow-Up||51
351365|NCT00513799|850520|P3|COMPLETED|Four-Month Follow-Up||57
351366|NCT00513799|850521|P2|COMPLETED|Four-Month Follow-Up||57
351367|NCT00513799|850522|P1|COMPLETED|Four-Month Follow-Up||64
351368|NCT00513799|850519|P4|STARTED|Four-Month Follow-Up||54
351369|NCT00513799|850520|P3|STARTED|Four-Month Follow-Up||64
351370|NCT00513799|850521|P2|STARTED|Four-Month Follow-Up||62
351371|NCT00513799|850522|P1|STARTED|Four-Month Follow-Up||64
351372|NCT00513799|850519|P4|NOT COMPLETED|One-Month Follow-Up||21
351373|NCT00513799|850520|P3|NOT COMPLETED|One-Month Follow-Up||11
351374|NCT00513799|850521|P2|NOT COMPLETED|One-Month Follow-Up||13
351375|NCT00513799|850522|P1|NOT COMPLETED|One-Month Follow-Up||11
351376|NCT00513799|850519|P4|COMPLETED|One-Month Follow-Up||54
351377|NCT00513799|850520|P3|COMPLETED|One-Month Follow-Up||64
351378|NCT00513799|850521|P2|COMPLETED|One-Month Follow-Up||62
351379|NCT00513799|850522|P1|COMPLETED|One-Month Follow-Up||64
351380|NCT00513799|850519|P4|STARTED|One-Month Follow-Up||75
351381|NCT00513799|850520|P3|STARTED|One-Month Follow-Up||75
351382|NCT00513799|850521|P2|STARTED|One-Month Follow-Up||75
351383|NCT00513799|850522|P1|STARTED|One-Month Follow-Up||75
351384|NCT00513708|850543|P3|NOT COMPLETED|Overall Study||4
351385|NCT00513708|850544|P2|NOT COMPLETED|Overall Study||4
351386|NCT00513708|850545|P1|NOT COMPLETED|Overall Study||4
351387|NCT00513708|850543|P3|COMPLETED|Overall Study||46
351388|NCT00513708|850544|P2|COMPLETED|Overall Study||46
351389|NCT00513708|850545|P1|COMPLETED|Overall Study||46
351390|NCT00513708|850543|P3|STARTED|Overall Study||50
351391|NCT00513708|850544|P2|STARTED|Overall Study||50
351392|NCT00513708|850545|P1|STARTED|Overall Study||50
351393|NCT00513695|850559|P1|NOT COMPLETED|Overall Study||5
351394|NCT00513695|850559|P1|COMPLETED|Overall Study||63
351395|NCT00513695|850559|P1|STARTED|Overall Study||68
351396|NCT00513682|850568|P1|NOT COMPLETED|Treatment Phase||0
351397|NCT00513682|850568|P1|COMPLETED|Treatment Phase||7
351398|NCT00513682|850568|P1|STARTED|Treatment Phase||7
351399|NCT00513682|850568|P1|NOT COMPLETED|Washout Phase||2
351400|NCT00513682|850568|P1|COMPLETED|Washout Phase||7
351401|NCT00513682|850568|P1|STARTED|Washout Phase||9
351402|NCT00513682|850568|P1|NOT COMPLETED|Screening Phase||0
351403|NCT00513682|850568|P1|COMPLETED|Screening Phase||9
351404|NCT00513682|850568|P1|STARTED|Screening Phase||9
351405|NCT00513617|850580|P3|NOT COMPLETED|Overall Study||8
351406|NCT00513617|850581|P2|NOT COMPLETED|Overall Study||10
351407|NCT00513617|850582|P1|NOT COMPLETED|Overall Study||11
351408|NCT00513617|850580|P3|COMPLETED|Overall Study||30
351409|NCT00513617|850581|P2|COMPLETED|Overall Study||25
351410|NCT00513617|850582|P1|COMPLETED|Overall Study||25
351411|NCT00513617|850580|P3|STARTED|Overall Study||38
351412|NCT00513617|850581|P2|STARTED|Overall Study||35
351413|NCT00513617|850582|P1|STARTED|Overall Study||36
351414|NCT00513604|850598|P5|NOT COMPLETED|Overall Study||0
351415|NCT00513604|850599|P4|NOT COMPLETED|Overall Study||0
351416|NCT00513604|850600|P3|NOT COMPLETED|Overall Study||3
351417|NCT00513604|850601|P2|NOT COMPLETED|Overall Study||3
351418|NCT00513604|850602|P1|NOT COMPLETED|Overall Study||2
351419|NCT00513604|850598|P5|COMPLETED|Overall Study||35
351420|NCT00513604|850599|P4|COMPLETED|Overall Study||34
351421|NCT00513604|850600|P3|COMPLETED|Overall Study||21
351422|NCT00513604|850601|P2|COMPLETED|Overall Study||36
351423|NCT00513604|850602|P1|COMPLETED|Overall Study||24
351424|NCT00513604|850598|P5|STARTED|Overall Study|Cohort 5 = CD4+ depleted TIL-it is the SAME as cohort 2|35
351425|NCT00513604|850599|P4|STARTED|Overall Study|Cohort 4 = unselected TIL - it is the SAME as cohort 1|34
351426|NCT00513604|850600|P3|STARTED|Overall Study|Cohort 3 = CD4+ depleted (selected) TIL + 600Gy radiation|24
351427|NCT00513604|850601|P2|STARTED|Overall Study|Cohort 2 = CD4+ depleted (selected) TIL|39
351428|NCT00513604|850602|P1|STARTED|Overall Study|Cohort 1 = unselected TIL|26
351429|NCT00513526|850619|P1|NOT COMPLETED|Overall Study||17
351430|NCT00513526|850619|P1|COMPLETED|Overall Study||92
351431|NCT00513526|850619|P1|STARTED|Overall Study||109
351432|NCT00513500|850636|P2|NOT COMPLETED|Overall Study||54
351433|NCT00513500|850637|P1|NOT COMPLETED|Overall Study||41
351434|NCT00513500|850636|P2|COMPLETED|Overall Study||2054
351435|NCT00513500|850637|P1|COMPLETED|Overall Study||976
351436|NCT00513500|850636|P2|STARTED|Overall Study||2108
351437|NCT00513500|850637|P1|STARTED|Overall Study||1017
351438|NCT00513474|850649|P2|NOT COMPLETED|Overall Study||9
351439|NCT00513474|850650|P1|NOT COMPLETED|Overall Study||7
351440|NCT00513474|850649|P2|COMPLETED|Overall Study||12
351441|NCT00513474|850650|P1|COMPLETED|Overall Study||18
351442|NCT00513474|850649|P2|Received Rasburicase Per Protocol|Overall Study||0
351443|NCT00513474|850650|P1|Received Rasburicase Per Protocol|Overall Study||24
351444|NCT00513474|850649|P2|STARTED|Overall Study||21
351445|NCT00513474|850650|P1|STARTED|Overall Study||25
351446|NCT00513461|850664|P2|NOT COMPLETED|Overall Study||10
351447|NCT00513461|850665|P1|NOT COMPLETED|Overall Study||13
351448|NCT00513461|850664|P2|COMPLETED|Overall Study||43
351449|NCT00513461|850665|P1|COMPLETED|Overall Study||44
351450|NCT00513461|850664|P2|STARTED|Overall Study||53
351451|NCT00513461|850665|P1|STARTED|Overall Study||57
351452|NCT00513435|850699|P1|NOT COMPLETED|Overall Study||0
351453|NCT00513435|850699|P1|COMPLETED|Overall Study||9
351454|NCT00513435|850699|P1|STARTED|Overall Study||9
351455|NCT00513409|850706|P2|NOT COMPLETED|Overall Study||6
351456|NCT00513409|850707|P1|NOT COMPLETED|Overall Study||2
351457|NCT00513409|850706|P2|COMPLETED|Overall Study||73
351458|NCT00513409|850707|P1|COMPLETED|Overall Study||82
351459|NCT00513409|850706|P2|STARTED|Overall Study||79
351460|NCT00513409|850707|P1|STARTED|Overall Study||84
351461|NCT00513370|850733|P1|NOT COMPLETED|Overall Study||24
351462|NCT00513370|850733|P1|COMPLETED|Overall Study||179
351463|NCT00513370|850733|P1|STARTED|Overall Study||203
351464|NCT00513357|850763|P2|NOT COMPLETED|Overall Study||10
351465|NCT00513357|850764|P1|NOT COMPLETED|Overall Study||15
351466|NCT00513357|850763|P2|COMPLETED|Overall Study||25
351467|NCT00513357|850764|P1|COMPLETED|Overall Study||23
351468|NCT00513357|850763|P2|STARTED|Overall Study||35
351469|NCT00513357|850764|P1|STARTED|Overall Study||38
351470|NCT00513344|850770|P1|NOT COMPLETED|3rd Intervention 1 Day||0
351471|NCT00513344|850770|P1|COMPLETED|3rd Intervention 1 Day||5
351472|NCT00513344|850770|P1|STARTED|3rd Intervention 1 Day||5
351473|NCT00513344|850770|P1|NOT COMPLETED|Washout Period 3 Days||0
351474|NCT00513344|850770|P1|COMPLETED|Washout Period 3 Days||5
351475|NCT00513344|850770|P1|STARTED|Washout Period 3 Days||5
351476|NCT00513344|850770|P1|NOT COMPLETED|2nd Intervention 1 Day||0
351477|NCT00513344|850770|P1|COMPLETED|2nd Intervention 1 Day||5
351478|NCT00513344|850770|P1|STARTED|2nd Intervention 1 Day||5
351479|NCT00513344|850770|P1|NOT COMPLETED|Washout Period 3 Days||0
351480|NCT00513344|850770|P1|COMPLETED|Washout Period 3 Days||5
351481|NCT00513344|850770|P1|STARTED|Washout Period 3 Days||5
351482|NCT00513344|850770|P1|NOT COMPLETED|1st Intervention 1 Day||0
351483|NCT00513344|850770|P1|COMPLETED|1st Intervention 1 Day||5
351484|NCT00513344|850770|P1|STARTED|1st Intervention 1 Day||5
351485|NCT00513344|850770|P1|NOT COMPLETED|Diet Restriction (3 Days)||0
351486|NCT00513344|850770|P1|COMPLETED|Diet Restriction (3 Days)||5
351487|NCT00513344|850770|P1|STARTED|Diet Restriction (3 Days)||5
351488|NCT00513305|850783|P2|NOT COMPLETED|Overall Study||27
351489|NCT00513305|850784|P1|NOT COMPLETED|Overall Study||28
351490|NCT00513305|850783|P2|COMPLETED|Overall Study||7
351491|NCT00513305|850784|P1|COMPLETED|Overall Study||5
351492|NCT00513305|850783|P2|STARTED|Overall Study|One subject withdrew prior to receiving study medication|34
351493|NCT00513305|850784|P1|STARTED|Overall Study||33
351494|NCT00513292|850802|P2|NOT COMPLETED|Overall Study||0
351495|NCT00513292|850803|P1|NOT COMPLETED|Overall Study||0
351496|NCT00513292|850802|P2|COMPLETED|Overall Study||142
351497|NCT00513292|850803|P1|COMPLETED|Overall Study||138
351498|NCT00513292|850802|P2|STARTED|Overall Study||142
351499|NCT00513292|850803|P1|STARTED|Overall Study||138
351500|NCT00513240|850827|P2|NOT COMPLETED|Overall Study||7
351501|NCT00513240|850828|P1|NOT COMPLETED|Overall Study||13
351502|NCT00513240|850827|P2|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|20
351503|NCT00513240|850828|P1|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|22
351504|NCT00513240|850827|P2|Clinical Data Collection &Pre/Postop MRI|Overall Study||27
351505|NCT00513240|850828|P1|Clinical Data Collection &Pre/Postop MRI|Overall Study|3 not having intended surgery are subtracted from original 35 subjects, leaving 32|32
351506|NCT00513240|850827|P2|STARTED|Overall Study|25 had 3 doses; 1 had 1 dose due to rash; 1 had 2 doses and 1 dose of EPO due to pharmacy error|27
351507|NCT00513240|850828|P1|STARTED|Overall Study|3 did not have intended surgery; 28 had all 3 doses; 4 had 1 dose but no more due to delayed surgery|35
351508|NCT00513071|850835|P1|NOT COMPLETED|Overall Study||5
351509|NCT00513071|850835|P1|COMPLETED|Overall Study||23
351510|NCT00513071|850835|P1|STARTED|Overall Study||28
351511|NCT00513019|850847|P2|NOT COMPLETED|Overall Study||5
351512|NCT00513019|850848|P1|NOT COMPLETED|Overall Study||5
351513|NCT00513019|850847|P2|COMPLETED|Overall Study||13
351514|NCT00513019|850848|P1|COMPLETED|Overall Study||12
351515|NCT00513019|850847|P2|STARTED|Overall Study||18
351516|NCT00513019|850848|P1|STARTED|Overall Study||17
351517|NCT00512902|850854|P1|NOT COMPLETED|Overall Study||8
351518|NCT00512902|850854|P1|COMPLETED|Overall Study||12
351519|NCT00512902|850854|P1|STARTED|Overall Study||20
351520|NCT00512876|850862|P1|NOT COMPLETED|Overall Study||4
351521|NCT00512876|850862|P1|COMPLETED|Overall Study||20
351522|NCT00512876|850862|P1|STARTED|Overall Study||24
351523|NCT00512798|850869|P2|NOT COMPLETED|Overall Study||27
351524|NCT00512798|850870|P1|NOT COMPLETED|Overall Study||19
351525|NCT00512798|850869|P2|COMPLETED|Overall Study||1
351526|NCT00512798|850870|P1|COMPLETED|Overall Study||0
351527|NCT00512798|850869|P2|STARTED|Overall Study||28
351528|NCT00512798|850870|P1|STARTED|Overall Study||19
351529|NCT00512707|850881|P2|NOT COMPLETED|Overall Study||12
351530|NCT00512707|850882|P1|NOT COMPLETED|Overall Study||10
351531|NCT00512707|850881|P2|COMPLETED|Overall Study||58
351532|NCT00512707|850882|P1|COMPLETED|Overall Study||60
351533|NCT00512707|850881|P2|STARTED|Overall Study||70
351534|NCT00512707|850882|P1|STARTED|Overall Study||70
351535|NCT00512278|850914|P2|NOT COMPLETED|Overall Study||17
351536|NCT00512278|850915|P1|NOT COMPLETED|Overall Study||28
351537|NCT00512278|850914|P2|COMPLETED|Overall Study||56
351538|NCT00512278|850915|P1|COMPLETED|Overall Study||45
351539|NCT00512278|850914|P2|STARTED|Overall Study||73
351540|NCT00512278|850915|P1|STARTED|Overall Study||73
351541|NCT00512252|850932|P3|NOT COMPLETED|Overall Study||3
351542|NCT00512252|850933|P2|NOT COMPLETED|Overall Study||0
351543|NCT00512252|850934|P1|NOT COMPLETED|Overall Study||0
351544|NCT00512252|850932|P3|COMPLETED|Overall Study||43
351545|NCT00512252|850933|P2|COMPLETED|Overall Study||3
351546|NCT00512252|850934|P1|COMPLETED|Overall Study||3
351547|NCT00512252|850932|P3|STARTED|Overall Study||46
351548|NCT00512252|850933|P2|STARTED|Overall Study||3
351549|NCT00512252|850934|P1|STARTED|Overall Study||3
351550|NCT00512148|850962|P1|NOT COMPLETED|Long Term Follow Up Period||6
351551|NCT00512148|850962|P1|COMPLETED|Long Term Follow Up Period|6 patients are being followed in long term follow up|0
351552|NCT00512148|850962|P1|STARTED|Long Term Follow Up Period||6
351553|NCT00512148|850962|P1|NOT COMPLETED|Primay Study Period||1
351554|NCT00512148|850962|P1|COMPLETED|Primay Study Period||6
351555|NCT00512148|850962|P1|STARTED|Primay Study Period||7
351556|NCT00512096|850968|P1|NOT COMPLETED|Overall Study||7
351557|NCT00512096|850968|P1|COMPLETED|Overall Study||23
351558|NCT00512096|850968|P1|STARTED|Overall Study||30
351559|NCT00511992|850972|P1|NOT COMPLETED|Overall Study||7
351560|NCT00511992|850972|P1|COMPLETED|Overall Study||13
351561|NCT00511992|850972|P1|STARTED|Overall Study||20
351562|NCT00511914|850979|P2|NOT COMPLETED|Overall Study||0
351563|NCT00511914|850980|P1|NOT COMPLETED|Overall Study||0
351564|NCT00511914|850979|P2|COMPLETED|Overall Study||67
351565|NCT00511914|850980|P1|COMPLETED|Overall Study||68
351566|NCT00511914|850979|P2|STARTED|Overall Study||67
351567|NCT00511914|850980|P1|STARTED|Overall Study||68
351568|NCT00511901|850996|P2|NOT COMPLETED|Overall Study||3
351569|NCT00511901|850997|P1|NOT COMPLETED|Overall Study||1
351570|NCT00511901|850996|P2|COMPLETED|Overall Study||8
351571|NCT00511901|850997|P1|COMPLETED|Overall Study||10
351572|NCT00511901|850996|P2|STARTED|Overall Study||11
351573|NCT00511901|850997|P1|STARTED|Overall Study||11
351574|NCT00511875|851019|P2|NOT COMPLETED|Overall Study||0
351575|NCT00511875|851020|P1|NOT COMPLETED|Overall Study||5
351576|NCT00511875|851019|P2|COMPLETED|Overall Study||15
351577|NCT00511875|851020|P1|COMPLETED|Overall Study||10
351578|NCT00511875|851019|P2|STARTED|Overall Study||15
351579|NCT00511875|851020|P1|STARTED|Overall Study||15
351580|NCT00511862|851045|P3|NOT COMPLETED|Overall Study||0
351581|NCT00511862|851046|P2|NOT COMPLETED|Overall Study||0
351582|NCT00511862|851047|P1|NOT COMPLETED|Overall Study||0
351583|NCT00511862|851045|P3|COMPLETED|Overall Study||47
351584|NCT00511862|851046|P2|COMPLETED|Overall Study||43
351585|NCT00511862|851047|P1|COMPLETED|Overall Study||61
351586|NCT00511862|851045|P3|STARTED|Overall Study||47
351587|NCT00511862|851046|P2|STARTED|Overall Study||43
351588|NCT00511862|851047|P1|STARTED|Overall Study||61
351589|NCT00511836|851060|P2|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||0
351590|NCT00511836|851061|P1|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||16
351591|NCT00511836|851060|P2|COMPLETED|Optional Open-label VIVITROL (2 Months)||0
351592|NCT00511836|851061|P1|COMPLETED|Optional Open-label VIVITROL (2 Months)||6
351593|NCT00511836|851060|P2|STARTED|Optional Open-label VIVITROL (2 Months)|Not all subjects from the double-blind phase entered the optional open-label extension.|0
351594|NCT00511836|851061|P1|STARTED|Optional Open-label VIVITROL (2 Months)|Subjects who received placebo during Month 1 switched to VIVITROL for the optional extension phase.|22
351595|NCT00511836|851060|P2|NOT COMPLETED|Double-blind Period||0
351596|NCT00511836|851061|P1|NOT COMPLETED|Double-blind Period||1
351597|NCT00511836|851060|P2|COMPLETED|Double-blind Period||15
351598|NCT00511836|851061|P1|COMPLETED|Double-blind Period||15
351599|NCT00511836|851060|P2|STARTED|Double-blind Period||15
351600|NCT00511836|851061|P1|STARTED|Double-blind Period||16
351601|NCT00511810|851078|P2|NOT COMPLETED|Overall Study||5
351602|NCT00511810|851079|P1|NOT COMPLETED|Overall Study||1
351603|NCT00511810|851078|P2|COMPLETED|Overall Study|2 terminated for worsening symptoms;1 refused a scan;2 lost to follow up (could not be contacted)|7
351604|NCT00511810|851079|P1|COMPLETED|Overall Study||7
351605|NCT00511810|851078|P2|STARTED|Overall Study||12
351606|NCT00511810|851079|P1|STARTED|Overall Study||8
351607|NCT00511797|851089|P4|NOT COMPLETED|Overall Study||15
351608|NCT00511797|851090|P3|NOT COMPLETED|Overall Study||11
351609|NCT00511797|851091|P2|NOT COMPLETED|Overall Study||8
351610|NCT00511797|851092|P1|NOT COMPLETED|Overall Study||7
351611|NCT00511797|851089|P4|COMPLETED|Overall Study||47
351612|NCT00511797|851090|P3|COMPLETED|Overall Study||51
351613|NCT00511797|851091|P2|COMPLETED|Overall Study||55
351614|NCT00511797|851092|P1|COMPLETED|Overall Study||55
351615|NCT00511797|851089|P4|Subjects Received Treatment|Overall Study|FAS|58
351616|NCT00511797|851090|P3|Subjects Received Treatment|Overall Study|FAS|61
351617|NCT00511797|851091|P2|Subjects Received Treatment|Overall Study|FAS|62
351618|NCT00511797|851092|P1|Subjects Received Treatment|Overall Study|FAS|61
351619|NCT00511797|851089|P4|Subjects Dispensed Drugs|Overall Study||59
351620|NCT00511797|851090|P3|Subjects Dispensed Drugs|Overall Study||61
351621|NCT00511797|851091|P2|Subjects Dispensed Drugs|Overall Study||63
351622|NCT00511797|851092|P1|Subjects Dispensed Drugs|Overall Study||61
351623|NCT00511797|851089|P4|STARTED|Overall Study||62
351624|NCT00511797|851090|P3|STARTED|Overall Study||62
351625|NCT00511797|851091|P2|STARTED|Overall Study||63
351626|NCT00511797|851092|P1|STARTED|Overall Study||62
351627|NCT00511706|851196|P2|NOT COMPLETED|Overall Study||5
351628|NCT00511706|851197|P1|NOT COMPLETED|Overall Study||8
351629|NCT00511706|851196|P2|COMPLETED|Overall Study||115
351630|NCT00511706|851197|P1|COMPLETED|Overall Study||115
351631|NCT00511706|851196|P2|STARTED|Overall Study||120
351632|NCT00511706|851197|P1|STARTED|Overall Study||123
351633|NCT00511667|851211|P2|NOT COMPLETED|Overall Study||3
351634|NCT00511667|851212|P1|NOT COMPLETED|Overall Study||12
351635|NCT00511667|851211|P2|COMPLETED|Overall Study||15
351636|NCT00511667|851212|P1|COMPLETED|Overall Study||40
351637|NCT00511667|851211|P2|STARTED|Overall Study||18
351638|NCT00511667|851212|P1|STARTED|Overall Study||52
351639|NCT00511472|851247|P2|NOT COMPLETED|Overall Study||6
351640|NCT00511472|851248|P1|NOT COMPLETED|Overall Study||3
351641|NCT00511472|851247|P2|COMPLETED|Overall Study||17
351642|NCT00511472|851248|P1|COMPLETED|Overall Study||44
351643|NCT00511472|851247|P2|STARTED|Overall Study||23
351644|NCT00511472|851248|P1|STARTED|Overall Study||47
351645|NCT00511433|851267|P2|NOT COMPLETED|Overall Study||1
351646|NCT00511433|851268|P1|NOT COMPLETED|Overall Study||6
351647|NCT00511433|851267|P2|COMPLETED|Overall Study||15
351648|NCT00511433|851268|P1|COMPLETED|Overall Study||26
351649|NCT00511433|851267|P2|STARTED|Overall Study||16
351650|NCT00511433|851268|P1|STARTED|Overall Study||32
351651|NCT00511355|851308|P2|NOT COMPLETED|Overall Study||9
351652|NCT00511355|851309|P1|NOT COMPLETED|Overall Study||7
351653|NCT00511355|851308|P2|COMPLETED|Overall Study||52
351654|NCT00511355|851309|P1|COMPLETED|Overall Study||53
351655|NCT00511355|851308|P2|STARTED|Overall Study||61
351656|NCT00511355|851309|P1|STARTED|Overall Study||60
351657|NCT00511342|851409|P2|NOT COMPLETED|Overall Study||22
351658|NCT00511342|851410|P1|NOT COMPLETED|Overall Study||13
351659|NCT00511342|851409|P2|COMPLETED|Overall Study||32
351660|NCT00511342|851410|P1|COMPLETED|Overall Study||43
351661|NCT00511342|851409|P2|STARTED|Overall Study||54
351662|NCT00511342|851410|P1|STARTED|Overall Study||56
351663|NCT00511329|851434|P1|NOT COMPLETED|Overall Study||0
351664|NCT00511329|851434|P1|COMPLETED|Overall Study||0
351665|NCT00511329|851434|P1|STARTED|Overall Study||0
351666|NCT00511238|851441|P2|NOT COMPLETED|Overall Study||226
351667|NCT00511238|851442|P1|NOT COMPLETED|Overall Study||42
351668|NCT00511238|851441|P2|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|40
351669|NCT00511238|851442|P1|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|4
351670|NCT00511238|851441|P2|STARTED|Overall Study||266
351671|NCT00511238|851442|P1|STARTED|Overall Study||46
351672|NCT00511199|851461|P2|NOT COMPLETED|Overall Study||125
351673|NCT00511199|851462|P1|NOT COMPLETED|Overall Study||449
351674|NCT00511199|851461|P2|COMPLETED|Overall Study||410
351675|NCT00511199|851462|P1|COMPLETED|Overall Study||1142
351676|NCT00511199|851461|P2|STARTED|Overall Study||535
351677|NCT00511199|851462|P1|STARTED|Overall Study||1591
351678|NCT00511173|851486|P1|NOT COMPLETED|Overall Study||0
351679|NCT00511173|851486|P1|COMPLETED|Overall Study||102
351680|NCT00511173|851486|P1|STARTED|Overall Study||102
351681|NCT00511147|851491|P1|NOT COMPLETED|Overall Study||7
351682|NCT00511147|851491|P1|COMPLETED|Overall Study||57
351683|NCT00511147|851491|P1|STARTED|Overall Study||64
351684|NCT00511134|851500|P2|NOT COMPLETED|Overall Study||2
351685|NCT00511134|851501|P1|NOT COMPLETED|Overall Study||0
351686|NCT00511134|851500|P2|COMPLETED|Overall Study||1
351687|NCT00511134|851501|P1|COMPLETED|Overall Study||1
351688|NCT00511134|851500|P2|STARTED|Overall Study||3
351689|NCT00511134|851501|P1|STARTED|Overall Study||1
351690|NCT00511108|851513|P4|NOT COMPLETED|Overall Study||5
351691|NCT00511108|851514|P3|NOT COMPLETED|Overall Study||5
351692|NCT00511108|851515|P2|NOT COMPLETED|Overall Study||2
351693|NCT00511108|851516|P1|NOT COMPLETED|Overall Study||6
351694|NCT00511108|851513|P4|COMPLETED|Overall Study||48
351695|NCT00511108|851514|P3|COMPLETED|Overall Study||47
351696|NCT00511108|851515|P2|COMPLETED|Overall Study||52
351697|NCT00511108|851516|P1|COMPLETED|Overall Study||46
351698|NCT00511108|851513|P4|STARTED|Overall Study||53
351699|NCT00511108|851514|P3|STARTED|Overall Study||52
351700|NCT00511108|851515|P2|STARTED|Overall Study||54
351701|NCT00511108|851516|P1|STARTED|Overall Study||52
351702|NCT00511095|851534|P1|NOT COMPLETED|Overall Study||11
351703|NCT00511095|851534|P1|COMPLETED|Overall Study||196
351704|NCT00511095|851534|P1|STARTED|Overall Study||207
351705|NCT00511004|851547|P3|NOT COMPLETED|Overall Study||4
351706|NCT00511004|851548|P2|NOT COMPLETED|Overall Study||0
351707|NCT00511004|851549|P1|NOT COMPLETED|Overall Study||0
351708|NCT00511004|851547|P3|COMPLETED|Overall Study||10
351709|NCT00511004|851548|P2|COMPLETED|Overall Study||13
351710|NCT00511004|851549|P1|COMPLETED|Overall Study||13
351711|NCT00511004|851547|P3|STARTED|Overall Study||14
351712|NCT00511004|851548|P2|STARTED|Overall Study||13
351713|NCT00511004|851549|P1|STARTED|Overall Study||13
351714|NCT00510952|851568|P2|NOT COMPLETED|Overall Study||16
351715|NCT00510952|851569|P1|NOT COMPLETED|Overall Study||26
351716|NCT00510952|851568|P2|COMPLETED|Overall Study||220
351717|NCT00510952|851569|P1|COMPLETED|Overall Study||209
351718|NCT00510952|851568|P2|Full Analysis Set (Intent to Treat)|Overall Study||229
351719|NCT00510952|851569|P1|Full Analysis Set (Intent to Treat)|Overall Study||229
351720|NCT00510952|851568|P2|STARTED|Overall Study||236
351721|NCT00510952|851569|P1|STARTED|Overall Study||235
351722|NCT00510887|851595|P1|NOT COMPLETED|Overall Study||1
351723|NCT00510887|851595|P1|COMPLETED|Overall Study||11
351724|NCT00510887|851595|P1|STARTED|Overall Study||12
351725|NCT00510874|851611|P7|NOT COMPLETED|Overall Study||1
351726|NCT00510874|851612|P6|NOT COMPLETED|Overall Study||0
351727|NCT00510874|851613|P5|NOT COMPLETED|Overall Study||7
351728|NCT00510874|851614|P4|NOT COMPLETED|Overall Study||3
351729|NCT00510874|851615|P3|NOT COMPLETED|Overall Study||1
351730|NCT00510874|851616|P2|NOT COMPLETED|Overall Study||4
351731|NCT00510874|851617|P1|NOT COMPLETED|Overall Study||3
351732|NCT00510874|851611|P7|COMPLETED|Overall Study|Upto Day 182|49
351733|NCT00510874|851612|P6|COMPLETED|Overall Study|Upto Day 182|50
351734|NCT00510874|851613|P5|COMPLETED|Overall Study|Upto Day 182|141
351735|NCT00510874|851614|P4|COMPLETED|Overall Study|Upto Day 182|148
351736|NCT00510874|851615|P3|COMPLETED|Overall Study|Upto Day 182|150
351737|NCT00510874|851616|P2|COMPLETED|Overall Study|Upto Day 182|148
351738|NCT00510874|851617|P1|COMPLETED|Overall Study|Upto Day 182|75
351739|NCT00510874|851611|P7|STARTED|Overall Study||50
351740|NCT00510874|851612|P6|STARTED|Overall Study||50
351741|NCT00510874|851613|P5|STARTED|Overall Study||148
351742|NCT00510874|851614|P4|STARTED|Overall Study||151
351743|NCT00510874|851615|P3|STARTED|Overall Study||151
351744|NCT00510874|851616|P2|STARTED|Overall Study||152
351745|NCT00510874|851617|P1|STARTED|Overall Study||78
351746|NCT00510835|851720|P3|NOT COMPLETED|Overall Study||2
351747|NCT00510835|851721|P2|NOT COMPLETED|Overall Study||2
351748|NCT00510835|851722|P1|NOT COMPLETED|Overall Study||6
351749|NCT00510835|851720|P3|COMPLETED|Overall Study||456
351750|NCT00510835|851721|P2|COMPLETED|Overall Study||446
351751|NCT00510835|851722|P1|COMPLETED|Overall Study||439
351752|NCT00510835|851720|P3|STARTED|Overall Study||458
351753|NCT00510835|851721|P2|STARTED|Overall Study||448
351754|NCT00510835|851722|P1|STARTED|Overall Study||445
351755|NCT00510809|851733|P3|NOT COMPLETED|Overall Study||0
351756|NCT00510809|851734|P2|NOT COMPLETED|Overall Study||0
351757|NCT00510809|851735|P1|NOT COMPLETED|Overall Study||0
351758|NCT00510809|851733|P3|COMPLETED|Overall Study||18
351759|NCT00510809|851734|P2|COMPLETED|Overall Study||18
351760|NCT00510809|851735|P1|COMPLETED|Overall Study||18
351761|NCT00510809|851733|P3|STARTED|Overall Study||18
351762|NCT00510809|851734|P2|STARTED|Overall Study||18
351763|NCT00510809|851735|P1|STARTED|Overall Study||18
351764|NCT00510783|851748|P2|NOT COMPLETED|Overall Study||29
351765|NCT00510783|851749|P1|NOT COMPLETED|Overall Study||31
351766|NCT00510783|851748|P2|COMPLETED|Overall Study||47
351767|NCT00510783|851749|P1|COMPLETED|Overall Study||51
351768|NCT00510783|851748|P2|STARTED|Overall Study||76
351769|NCT00510783|851749|P1|STARTED|Overall Study||82
351770|NCT00510744|851755|P1|NOT COMPLETED|Overall Study||0
351771|NCT00510744|851755|P1|COMPLETED|Overall Study||5
351772|NCT00510744|851755|P1|STARTED|Overall Study||5
351773|NCT00510718|851766|P2|NOT COMPLETED|Multiple Dose Period: 12 Weeks||32
351774|NCT00510718|851767|P1|NOT COMPLETED|Multiple Dose Period: 12 Weeks||15
351775|NCT00510718|851766|P2|COMPLETED|Multiple Dose Period: 12 Weeks||43
351776|NCT00510718|851767|P1|COMPLETED|Multiple Dose Period: 12 Weeks||50
351777|NCT00510718|851766|P2|600 mg/Day|Multiple Dose Period: 12 Weeks||3
351778|NCT00510718|851767|P1|600 mg/Day|Multiple Dose Period: 12 Weeks||0
351779|NCT00510718|851766|P2|480 mg/Day|Multiple Dose Period: 12 Weeks||22
351780|NCT00510718|851767|P1|480 mg/Day|Multiple Dose Period: 12 Weeks||0
351781|NCT00510718|851766|P2|360 mg/Day|Multiple Dose Period: 12 Weeks||13
351782|NCT00510718|851767|P1|360 mg/Day|Multiple Dose Period: 12 Weeks||15
351783|NCT00510718|851766|P2|240 mg/Day|Multiple Dose Period: 12 Weeks||12
351784|NCT00510718|851767|P1|240 mg/Day|Multiple Dose Period: 12 Weeks||17
351785|NCT00510718|851766|P2|150/160 mg/Day|Multiple Dose Period: 12 Weeks||13
351786|NCT00510718|851767|P1|150/160 mg/Day|Multiple Dose Period: 12 Weeks||15
351787|NCT00510718|851766|P2|60 mg/Day|Multiple Dose Period: 12 Weeks||12
351788|NCT00510718|851767|P1|60 mg/Day|Multiple Dose Period: 12 Weeks||15
351789|NCT00510718|851766|P2|30 mg/Day|Multiple Dose Period: 12 Weeks||0
351790|NCT00510718|851767|P1|30 mg/Day|Multiple Dose Period: 12 Weeks||3
351791|NCT00510718|851766|P2|STARTED|Multiple Dose Period: 12 Weeks|Participants who completed single dose period + new participants enrolled in multiple dose period.|75
351792|NCT00510718|851767|P1|STARTED|Multiple Dose Period: 12 Weeks|Participants who completed single dose period + new participants enrolled in multiple dose period.|65
351793|NCT00510718|851766|P2|NOT COMPLETED|Single Dose Period: 1 Week||0
351794|NCT00510718|851767|P1|NOT COMPLETED|Single Dose Period: 1 Week||0
351795|NCT00510718|851766|P2|COMPLETED|Single Dose Period: 1 Week||12
351796|NCT00510718|851767|P1|COMPLETED|Single Dose Period: 1 Week||15
351797|NCT00510718|851766|P2|600 mg/Day|Single Dose Period: 1 Week||3
351798|NCT00510718|851767|P1|600 mg/Day|Single Dose Period: 1 Week||0
351799|NCT00510718|851766|P2|480 mg/Day|Single Dose Period: 1 Week||6
351800|NCT00510718|851767|P1|480 mg/Day|Single Dose Period: 1 Week||0
351801|NCT00510718|851766|P2|360 mg/Day|Single Dose Period: 1 Week||2
351802|NCT00510718|851767|P1|360 mg/Day|Single Dose Period: 1 Week||4
351803|NCT00510718|851766|P2|240 mg/Day|Single Dose Period: 1 Week||0
351804|NCT00510718|851767|P1|240 mg/Day|Single Dose Period: 1 Week||3
351805|NCT00510718|851766|P2|150/160 mg/Day|Single Dose Period: 1 Week||1
351806|NCT00510718|851767|P1|150/160 mg/Day|Single Dose Period: 1 Week||2
351807|NCT00510718|851766|P2|60 mg/Day|Single Dose Period: 1 Week||0
351808|NCT00510718|851767|P1|60 mg/Day|Single Dose Period: 1 Week||3
351809|NCT00510718|851766|P2|30 mg/Day|Single Dose Period: 1 Week||0
351810|NCT00510718|851767|P1|30 mg/Day|Single Dose Period: 1 Week||3
351811|NCT00510718|851766|P2|STARTED|Single Dose Period: 1 Week||12
351812|NCT00510718|851767|P1|STARTED|Single Dose Period: 1 Week||15
351813|NCT00510692|851893|P2|NOT COMPLETED|Overall Study||3
351814|NCT00510692|851894|P1|NOT COMPLETED|Overall Study||2
351815|NCT00510692|851893|P2|COMPLETED|Overall Study||26
351816|NCT00510692|851894|P1|COMPLETED|Overall Study||27
351817|NCT00510692|851893|P2|STARTED|Overall Study||29
351818|NCT00510692|851894|P1|STARTED|Overall Study||29
351819|NCT00510653|851908|P1|NOT COMPLETED|Overall Study||11
351820|NCT00510653|851908|P1|COMPLETED|Overall Study||13
351821|NCT00510653|851908|P1|STARTED|Overall Study||24
351822|NCT00510510|851915|P3|NOT COMPLETED|Overall Study||17
351823|NCT00510510|851916|P2|NOT COMPLETED|Overall Study||9
351824|NCT00510510|851917|P1|NOT COMPLETED|Overall Study||5
351825|NCT00510510|851915|P3|COMPLETED|Overall Study||74
351826|NCT00510510|851916|P2|COMPLETED|Overall Study||89
351827|NCT00510510|851917|P1|COMPLETED|Overall Study||87
351828|NCT00510510|851915|P3|STARTED|Overall Study||91
351829|NCT00510510|851916|P2|STARTED|Overall Study||98
351830|NCT00510510|851917|P1|STARTED|Overall Study||92
351831|NCT00510497|851928|P1|NOT COMPLETED|Overall Study||3
351832|NCT00510497|851928|P1|COMPLETED|Overall Study||8
351833|NCT00510497|851928|P1|STARTED|Overall Study||11
351834|NCT00510484|851935|P2|NOT COMPLETED|Period 2||0
351835|NCT00510484|851936|P1|NOT COMPLETED|Period 2||0
351836|NCT00510484|851935|P2|COMPLETED|Period 2||15
351837|NCT00510484|851936|P1|COMPLETED|Period 2||16
351838|NCT00510484|851935|P2|STARTED|Period 2||15
351839|NCT00510484|851936|P1|STARTED|Period 2||16
351840|NCT00510484|851935|P2|NOT COMPLETED|Wash-out Period||1
351841|NCT00510484|851936|P1|NOT COMPLETED|Wash-out Period||0
351842|NCT00510484|851935|P2|COMPLETED|Wash-out Period||15
351843|NCT00510484|851936|P1|COMPLETED|Wash-out Period||16
351844|NCT00510484|851935|P2|STARTED|Wash-out Period||16
351845|NCT00510484|851936|P1|STARTED|Wash-out Period||16
351846|NCT00510484|851935|P2|NOT COMPLETED|Period 1||0
351847|NCT00510484|851936|P1|NOT COMPLETED|Period 1||0
351848|NCT00510484|851935|P2|COMPLETED|Period 1||16
351849|NCT00510484|851936|P1|COMPLETED|Period 1||16
351850|NCT00510484|851935|P2|STARTED|Period 1||16
351851|NCT00510484|851936|P1|STARTED|Period 1||16
351852|NCT00510458|851956|P1|NOT COMPLETED|Overall Study||47
351853|NCT00510458|851956|P1|COMPLETED|Overall Study||27
351854|NCT00510458|851956|P1|STARTED|Overall Study||74
351855|NCT00510289|851969|P1|NOT COMPLETED|Overall Study||12
351856|NCT00510289|851969|P1|COMPLETED|Overall Study|Completed at least one cycle of study drug and had disease assessments|7
351857|NCT00510289|851969|P1|Started Study Drug|Overall Study|3 patients progressed prior to starting study drug|16
351858|NCT00510289|851969|P1|STARTED|Overall Study|All patients who consented|19
351859|NCT00510276|851979|P2|NOT COMPLETED|Extension Open-Label Phase||48
351860|NCT00510276|851980|P1|NOT COMPLETED|Extension Open-Label Phase||33
351861|NCT00510276|851979|P2|COMPLETED|Extension Open-Label Phase||81
351862|NCT00510276|851980|P1|COMPLETED|Extension Open-Label Phase||78
351863|NCT00510276|851979|P2|STARTED|Extension Open-Label Phase|1 patient who completed acute phase did not participate in the optional atometine extension phase|129
351864|NCT00510276|851980|P1|STARTED|Extension Open-Label Phase|4 patients who completed acute phase did not participate in the optional atomoxetine extension phase|111
351865|NCT00510276|851979|P2|NOT COMPLETED|Acute Double-Blind Phase||95
351866|NCT00510276|851980|P1|NOT COMPLETED|Acute Double-Blind Phase||105
351867|NCT00510276|851979|P2|COMPLETED|Acute Double-Blind Phase||130
351868|NCT00510276|851980|P1|COMPLETED|Acute Double-Blind Phase||115
351869|NCT00510276|851979|P2|STARTED|Acute Double-Blind Phase||225
351870|NCT00510276|851980|P1|STARTED|Acute Double-Blind Phase||220
351871|NCT00510224|852065|P1|NOT COMPLETED|Overall Study||3
351872|NCT00510224|852065|P1|COMPLETED|Overall Study||10
351873|NCT00510224|852065|P1|STARTED|Overall Study||13
351874|NCT00510198|852074|P2|NOT COMPLETED|Overall Study||4
351875|NCT00510198|852075|P1|NOT COMPLETED|Overall Study||5
351876|NCT00510198|852074|P2|COMPLETED|Overall Study||54
351877|NCT00510198|852075|P1|COMPLETED|Overall Study||54
351878|NCT00510198|852074|P2|STARTED|Overall Study||58
351879|NCT00510198|852075|P1|STARTED|Overall Study||59
351880|NCT00510146|852089|P2|NOT COMPLETED|Open-Label Treatment||26
351881|NCT00510146|852090|P1|NOT COMPLETED|Open-Label Treatment||71
351882|NCT00510146|852089|P2|COMPLETED|Open-Label Treatment||96
351883|NCT00510146|852090|P1|COMPLETED|Open-Label Treatment||196
351884|NCT00510146|852089|P2|STARTED|Open-Label Treatment||122
351885|NCT00510146|852090|P1|STARTED|Open-Label Treatment||267
351886|NCT00510146|852089|P2|NOT COMPLETED|Double-Blind Treatment||49
351887|NCT00510146|852090|P1|NOT COMPLETED|Double-Blind Treatment||76
351888|NCT00510146|852089|P2|COMPLETED|Double-Blind Treatment||122
351889|NCT00510146|852090|P1|COMPLETED|Double-Blind Treatment||267
351890|NCT00510146|852089|P2|STARTED|Double-Blind Treatment||171
351891|NCT00510146|852090|P1|STARTED|Double-Blind Treatment||343
351892|NCT00510068|852179|P2|NOT COMPLETED|Open-label Period||0
351893|NCT00510068|852180|P1|NOT COMPLETED|Open-label Period||225
351894|NCT00510068|852179|P2|COMPLETED|Open-label Period||0
351895|NCT00510068|852180|P1|COMPLETED|Open-label Period||0
351896|NCT00510068|852179|P2|STARTED|Open-label Period||0
351897|NCT00510068|852180|P1|STARTED|Open-label Period|172 patients switched over from placebo & 53 who were initially randomized to Everolimus arm.|225
351898|NCT00510068|852179|P2|NOT COMPLETED|Double-blind Period||203
351899|NCT00510068|852180|P1|NOT COMPLETED|Double-blind Period||207
351900|NCT00510068|852179|P2|COMPLETED|Double-blind Period||0
351901|NCT00510068|852180|P1|COMPLETED|Double-blind Period||0
351902|NCT00510068|852179|P2|Safety Population|Double-blind Period||203
351903|NCT00510068|852180|P1|Safety Population|Double-blind Period||204
351904|NCT00510068|852179|P2|STARTED|Double-blind Period||203
351905|NCT00510068|852180|P1|STARTED|Double-blind Period||207
351906|NCT00509925|852221|P2|NOT COMPLETED|Overall Study||1
351907|NCT00509925|852222|P1|NOT COMPLETED|Overall Study||0
351908|NCT00509925|852221|P2|COMPLETED|Overall Study||10
351909|NCT00509925|852222|P1|COMPLETED|Overall Study||12
351910|NCT00509925|852221|P2|STARTED|Overall Study||11
351911|NCT00509925|852222|P1|STARTED|Overall Study||12
351912|NCT00509899|852270|P8|NOT COMPLETED|Overall Study||1
351913|NCT00509899|852271|P7|NOT COMPLETED|Overall Study||1
351914|NCT00509899|852272|P6|NOT COMPLETED|Overall Study||10
351915|NCT00509899|852273|P5|NOT COMPLETED|Overall Study||5
351916|NCT00509899|852274|P4|NOT COMPLETED|Overall Study||4
351917|NCT00509899|852275|P3|NOT COMPLETED|Overall Study||20
351918|NCT00509899|852276|P2|NOT COMPLETED|Overall Study||9
351919|NCT00509899|852277|P1|NOT COMPLETED|Overall Study||16
351920|NCT00509899|852270|P8|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|2
351921|NCT00509899|852271|P7|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|5
351922|NCT00509899|852272|P6|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|12
351923|NCT00509899|852273|P5|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
351924|NCT00509899|852274|P4|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
351925|NCT00509899|852275|P3|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|27
351926|NCT00509899|852276|P2|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|26
352010|NCT00509392|852432|P3|NOT COMPLETED|Overall Study||0
351927|NCT00509899|852277|P1|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|14
351928|NCT00509899|852270|P8|STARTED|Overall Study||3
351929|NCT00509899|852271|P7|STARTED|Overall Study||6
351930|NCT00509899|852272|P6|STARTED|Overall Study||22
351931|NCT00509899|852273|P5|STARTED|Overall Study||6
351932|NCT00509899|852274|P4|STARTED|Overall Study||5
351933|NCT00509899|852275|P3|STARTED|Overall Study||47
351934|NCT00509899|852276|P2|STARTED|Overall Study||35
351935|NCT00509899|852277|P1|STARTED|Overall Study||30
351936|NCT00509873|852317|P2|NOT COMPLETED|Overall Study||15
351937|NCT00509873|852318|P1|NOT COMPLETED|Overall Study||11
351938|NCT00509873|852317|P2|COMPLETED|Overall Study||276
351939|NCT00509873|852318|P1|COMPLETED|Overall Study||276
351940|NCT00509873|852317|P2|STARTED|Overall Study||291
351941|NCT00509873|852318|P1|STARTED|Overall Study||287
351942|NCT00509821|852334|P2|NOT COMPLETED|Study Period 4 (Follow Up)||0
351943|NCT00509821|852335|P1|NOT COMPLETED|Study Period 4 (Follow Up)||0
351944|NCT00509821|852334|P2|COMPLETED|Study Period 4 (Follow Up)||50
351945|NCT00509821|852335|P1|COMPLETED|Study Period 4 (Follow Up)||2
351946|NCT00509821|852334|P2|STARTED|Study Period 4 (Follow Up)|1 Participant completed Radiation Phase, did not enter Maintenance Phase but entered Follow Up.|50
351947|NCT00509821|852335|P1|STARTED|Study Period 4 (Follow Up)|1 Participant completed Maintenance Phase but did not enter Follow-Up.|2
351948|NCT00509821|852334|P2|NOT COMPLETED|Study Period 3 (Maintenance)||49
351949|NCT00509821|852335|P1|NOT COMPLETED|Study Period 3 (Maintenance)||0
351950|NCT00509821|852334|P2|COMPLETED|Study Period 3 (Maintenance)||0
351951|NCT00509821|852335|P1|COMPLETED|Study Period 3 (Maintenance)||3
351952|NCT00509821|852334|P2|STARTED|Study Period 3 (Maintenance)|4 participants completed Radiation Phase but did not enter Maintenance Phase.|49
351953|NCT00509821|852335|P1|STARTED|Study Period 3 (Maintenance)||3
351954|NCT00509821|852334|P2|NOT COMPLETED|Study Period 2 (Radiation)||53
351955|NCT00509821|852335|P1|NOT COMPLETED|Study Period 2 (Radiation)||0
351956|NCT00509821|852334|P2|COMPLETED|Study Period 2 (Radiation)||0
351957|NCT00509821|852335|P1|COMPLETED|Study Period 2 (Radiation)||3
351958|NCT00509821|852334|P2|STARTED|Study Period 2 (Radiation)|Participants moved to Radiation Phase.|53
351959|NCT00509821|852335|P1|STARTED|Study Period 2 (Radiation)|Participants moved to Radiation Phase.|3
351960|NCT00509821|852334|P2|NOT COMPLETED|Study Period 1 (Induction)||4
351961|NCT00509821|852335|P1|NOT COMPLETED|Study Period 1 (Induction)||0
351962|NCT00509821|852334|P2|COMPLETED|Study Period 1 (Induction)||53
351963|NCT00509821|852335|P1|COMPLETED|Study Period 1 (Induction)||3
351964|NCT00509821|852334|P2|Received at Least 1 Dose of Study Drug|Study Period 1 (Induction)||57
351965|NCT00509821|852335|P1|Received at Least 1 Dose of Study Drug|Study Period 1 (Induction)||3
351966|NCT00509821|852334|P2|STARTED|Study Period 1 (Induction)||57
351967|NCT00509821|852335|P1|STARTED|Study Period 1 (Induction)||3
351968|NCT00509795|852353|P4|NOT COMPLETED|Overall Study||27
351969|NCT00509795|852354|P3|NOT COMPLETED|Overall Study||27
351970|NCT00509795|852355|P2|NOT COMPLETED|Overall Study||11
351971|NCT00509795|852356|P1|NOT COMPLETED|Overall Study||22
351972|NCT00509795|852353|P4|COMPLETED|Overall Study||276
351973|NCT00509795|852354|P3|COMPLETED|Overall Study||277
351974|NCT00509795|852355|P2|COMPLETED|Overall Study||293
351975|NCT00509795|852356|P1|COMPLETED|Overall Study||284
351976|NCT00509795|852353|P4|Per Protocol Set (PPS) Population|Overall Study||265
351977|NCT00509795|852354|P3|Per Protocol Set (PPS) Population|Overall Study||270
351978|NCT00509795|852355|P2|Per Protocol Set (PPS) Population|Overall Study||285
351979|NCT00509795|852356|P1|Per Protocol Set (PPS) Population|Overall Study||269
351980|NCT00509795|852353|P4|Full Analysis Set (FAS) Population|Overall Study||301
351981|NCT00509795|852354|P3|Full Analysis Set (FAS) Population|Overall Study||301
351982|NCT00509795|852355|P2|Full Analysis Set (FAS) Population|Overall Study||304
351983|NCT00509795|852356|P1|Full Analysis Set (FAS) Population|Overall Study||304
351984|NCT00509795|852353|P4|Patients Received Treatment (SAF)|Overall Study||303
351985|NCT00509795|852354|P3|Patients Received Treatment (SAF)|Overall Study||304
351986|NCT00509795|852355|P2|Patients Received Treatment (SAF)|Overall Study||304
351987|NCT00509795|852356|P1|Patients Received Treatment (SAF)|Overall Study||304
351988|NCT00509795|852353|P4|STARTED|Overall Study||303
351989|NCT00509795|852354|P3|STARTED|Overall Study||304
351990|NCT00509795|852355|P2|STARTED|Overall Study||304
351991|NCT00509795|852356|P1|STARTED|Overall Study||306
351992|NCT00509769|852387|P1|NOT COMPLETED|Overall Study||91
351993|NCT00509769|852387|P1|COMPLETED|Overall Study||21
351994|NCT00509769|852387|P1|STARTED|Overall Study||112
351995|NCT00509665|852396|P1|NOT COMPLETED|Overall Study||0
351996|NCT00509665|852396|P1|COMPLETED|Overall Study||18
351997|NCT00509665|852396|P1|STARTED|Overall Study||18
351998|NCT00509600|852406|P1|NOT COMPLETED|Overall Study||1
351999|NCT00509600|852406|P1|COMPLETED|Overall Study||0
352000|NCT00509600|852406|P1|STARTED|Overall Study||1
352001|NCT00509587|852410|P1|NOT COMPLETED|Overall Study||0
352002|NCT00509587|852410|P1|COMPLETED|Overall Study||21
352003|NCT00509587|852410|P1|STARTED|Overall Study||21
352004|NCT00509496|852421|P2|NOT COMPLETED|Overall Study||0
352005|NCT00509496|852422|P1|NOT COMPLETED|Overall Study||0
352006|NCT00509496|852421|P2|COMPLETED|Overall Study||2
352007|NCT00509496|852422|P1|COMPLETED|Overall Study||19
352008|NCT00509496|852421|P2|STARTED|Overall Study||2
352009|NCT00509496|852422|P1|STARTED|Overall Study||19
352011|NCT00509392|852433|P2|NOT COMPLETED|Overall Study||0
352012|NCT00509392|852434|P1|NOT COMPLETED|Overall Study||0
352013|NCT00509392|852432|P3|COMPLETED|Overall Study||4
352014|NCT00509392|852433|P2|COMPLETED|Overall Study||33
352015|NCT00509392|852434|P1|COMPLETED|Overall Study||32
352016|NCT00509392|852432|P3|STARTED|Overall Study||4
352017|NCT00509392|852433|P2|STARTED|Overall Study||33
352018|NCT00509392|852434|P1|STARTED|Overall Study||32
352019|NCT00509366|852485|P5|NOT COMPLETED|Overall Study||0
352020|NCT00509366|852486|P4|NOT COMPLETED|Overall Study||0
352021|NCT00509366|852487|P3|NOT COMPLETED|Overall Study||1
352022|NCT00509366|852488|P2|NOT COMPLETED|Overall Study||1
352023|NCT00509366|852489|P1|NOT COMPLETED|Overall Study||1
352024|NCT00509366|852485|P5|COMPLETED|Overall Study|Patients who were neither assigned nor treated with protocol-based therapy.|51
352025|NCT00509366|852486|P4|COMPLETED|Overall Study|Patients assigned to treatment and treated with docetaxel/gemcitabine treatment combination.|2
352026|NCT00509366|852487|P3|COMPLETED|Overall Study|Patients assigned to treatment and treated with pemetrexed/gemcitabine treatment combination.|21
352027|NCT00509366|852488|P2|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/pemetrexed treatment combination.|7
352028|NCT00509366|852489|P1|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/gemcitabine treatment combination.|17
352029|NCT00509366|852485|P5|Assigned Treatment|Overall Study||0
352030|NCT00509366|852486|P4|Assigned Treatment|Overall Study|Patients who were assigned to docetaxel/gemcitabine treatment arm.|2
352031|NCT00509366|852487|P3|Assigned Treatment|Overall Study|Patients who were assigned to pemetrexed/gemcitabine treatment arm.|22
352032|NCT00509366|852488|P2|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/pemetrexed treatment arm.|8
352033|NCT00509366|852489|P1|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/gemcitabine treatment arm.|18
352034|NCT00509366|852485|P5|STARTED|Overall Study|Registered patients who were neither assigned nor treated with protocol-based therapy.|51
352035|NCT00509366|852486|P4|STARTED|Overall Study|Registered patients who were assigned docetaxel/gemcitabine treatment.|2
352036|NCT00509366|852487|P3|STARTED|Overall Study|Registered patients who were assigned pemetrexed/gemcitabine treatment.|22
352037|NCT00509366|852488|P2|STARTED|Overall Study|Registered patients who were assigned cisplatin/pemetrexed treatment.|8
352038|NCT00509366|852489|P1|STARTED|Overall Study|Registered patients who were assigned cisplatin/gemcitabine treatment.|18
352039|NCT00509288|852502|P2|NOT COMPLETED|Overall Study||0
352040|NCT00509288|852503|P1|NOT COMPLETED|Overall Study||0
352041|NCT00509288|852502|P2|COMPLETED|Overall Study||3
352042|NCT00509288|852503|P1|COMPLETED|Overall Study||21
352043|NCT00509288|852502|P2|STARTED|Overall Study||3
352044|NCT00509288|852503|P1|STARTED|Overall Study||21
352045|NCT00509262|852513|P2|NOT COMPLETED|Overall Study||42
352046|NCT00509262|852514|P1|NOT COMPLETED|Overall Study||47
352047|NCT00509262|852513|P2|COMPLETED|Overall Study||170
352048|NCT00509262|852514|P1|COMPLETED|Overall Study||164
352049|NCT00509262|852513|P2|STARTED|Overall Study||212
352050|NCT00509262|852514|P1|STARTED|Overall Study||211
352051|NCT00509249|852526|P1|NOT COMPLETED|Overall Study||0
352052|NCT00509249|852526|P1|COMPLETED|Overall Study||18
352053|NCT00509249|852526|P1|STARTED|Overall Study||18
352054|NCT00509236|852532|P2|NOT COMPLETED|Overall Study||20
352055|NCT00509236|852533|P1|NOT COMPLETED|Overall Study||17
352056|NCT00509236|852532|P2|COMPLETED|Overall Study||45
352057|NCT00509236|852533|P1|COMPLETED|Overall Study||47
352058|NCT00509236|852532|P2|STARTED|Overall Study||65
352059|NCT00509236|852533|P1|STARTED|Overall Study||64
352060|NCT00509223|852548|P2|NOT COMPLETED|Overall Study||72
352061|NCT00509223|852549|P1|NOT COMPLETED|Overall Study||88
352062|NCT00509223|852548|P2|COMPLETED|Overall Study||137
352063|NCT00509223|852549|P1|COMPLETED|Overall Study||119
352064|NCT00509223|852548|P2|STARTED|Overall Study||209
352065|NCT00509223|852549|P1|STARTED|Overall Study||207
352066|NCT00509197|852557|P2|NOT COMPLETED|Overall Study||0
352067|NCT00509197|852558|P1|NOT COMPLETED|Overall Study||0
352068|NCT00509197|852557|P2|COMPLETED|Overall Study||6
352069|NCT00509197|852558|P1|COMPLETED|Overall Study||6
352070|NCT00509197|852557|P2|STARTED|Overall Study||6
352071|NCT00509197|852558|P1|STARTED|Overall Study||6
352072|NCT00509106|852572|P2|NOT COMPLETED|Overall Study||29
352073|NCT00509106|852573|P1|NOT COMPLETED|Overall Study||31
352074|NCT00509106|852572|P2|COMPLETED|Overall Study||278
352075|NCT00509106|852573|P1|COMPLETED|Overall Study||284
352076|NCT00509106|852572|P2|STARTED|Overall Study||307
352077|NCT00509106|852573|P1|STARTED|Overall Study||315
352078|NCT00509067|852581|P2|NOT COMPLETED|Overall Study||5
352079|NCT00509067|852582|P1|NOT COMPLETED|Overall Study||4
352080|NCT00509067|852581|P2|COMPLETED|Overall Study||19
352081|NCT00509067|852582|P1|COMPLETED|Overall Study||15
352082|NCT00509067|852581|P2|STARTED|Overall Study||24
352083|NCT00509067|852582|P1|STARTED|Overall Study||19
352084|NCT00509041|852592|P1|NOT COMPLETED|Overall Study||0
352085|NCT00509041|852592|P1|COMPLETED|Overall Study||43
352086|NCT00509041|852592|P1|STARTED|Overall Study||43
352087|NCT00509028|852601|P2|NOT COMPLETED|Overall Study||7
352088|NCT00509028|852602|P1|NOT COMPLETED|Overall Study||12
352089|NCT00509028|852601|P2|COMPLETED|Overall Study||113
352090|NCT00509028|852602|P1|COMPLETED|Overall Study||109
352091|NCT00509028|852601|P2|STARTED|Overall Study||120
352092|NCT00509028|852602|P1|STARTED|Overall Study||121
352093|NCT00509002|852634|P1|NOT COMPLETED|Overall Study||0
352094|NCT00509002|852634|P1|COMPLETED|Overall Study||37
352095|NCT00509002|852634|P1|STARTED|Overall Study||37
352096|NCT00508924|852642|P4|NOT COMPLETED|Overall Study||1
352097|NCT00508924|852643|P3|NOT COMPLETED|Overall Study||1
352098|NCT00508924|852644|P2|NOT COMPLETED|Overall Study||0
352099|NCT00508924|852645|P1|NOT COMPLETED|Overall Study||0
352100|NCT00508924|852642|P4|COMPLETED|Overall Study||33
352101|NCT00508924|852643|P3|COMPLETED|Overall Study||31
352102|NCT00508924|852644|P2|COMPLETED|Overall Study||38
352103|NCT00508924|852645|P1|COMPLETED|Overall Study||36
352104|NCT00508924|852642|P4|STARTED|Overall Study||34
352105|NCT00508924|852643|P3|STARTED|Overall Study||32
352106|NCT00508924|852644|P2|STARTED|Overall Study||38
352107|NCT00508924|852645|P1|STARTED|Overall Study||36
352108|NCT00508872|852659|P1|NOT COMPLETED|Overall Study||2
352109|NCT00508872|852659|P1|COMPLETED|Overall Study||0
352110|NCT00508872|852659|P1|STARTED|Overall Study||2
352111|NCT00508820|852665|P2|NOT COMPLETED|Overall Study||64
352112|NCT00508820|852666|P1|NOT COMPLETED|Overall Study||55
352113|NCT00508820|852665|P2|COMPLETED|Overall Study||175
352114|NCT00508820|852666|P1|COMPLETED|Overall Study||113
352115|NCT00508820|852665|P2|STARTED|Overall Study||239
352116|NCT00508820|852666|P1|STARTED|Overall Study||168
352117|NCT00508755|852676|P1|NOT COMPLETED|Overall Study||1
352118|NCT00508755|852676|P1|COMPLETED|Overall Study||5
352119|NCT00508755|852676|P1|STARTED|Overall Study||6
352120|NCT00508742|852684|P2|NOT COMPLETED|Period 3: Toddler Dose||15
352121|NCT00508742|852685|P1|NOT COMPLETED|Period 3: Toddler Dose||25
352122|NCT00508742|852684|P2|COMPLETED|Period 3: Toddler Dose||863
352123|NCT00508742|852685|P1|COMPLETED|Period 3: Toddler Dose||858
352124|NCT00508742|852684|P2|STARTED|Period 3: Toddler Dose||878
352125|NCT00508742|852685|P1|STARTED|Period 3: Toddler Dose||883
352126|NCT00508742|852684|P2|NOT COMPLETED|Period 2: After Infant Series||11
352127|NCT00508742|852685|P1|NOT COMPLETED|Period 2: After Infant Series||7
352128|NCT00508742|852684|P2|COMPLETED|Period 2: After Infant Series||878
352129|NCT00508742|852685|P1|COMPLETED|Period 2: After Infant Series||883
352130|NCT00508742|852684|P2|STARTED|Period 2: After Infant Series||889
352131|NCT00508742|852685|P1|STARTED|Period 2: After Infant Series||890
352132|NCT00508742|852684|P2|NOT COMPLETED|Period 1: Infant Series||45
352133|NCT00508742|852685|P1|NOT COMPLETED|Period 1: Infant Series||42
352134|NCT00508742|852684|P2|COMPLETED|Period 1: Infant Series||889
352135|NCT00508742|852685|P1|COMPLETED|Period 1: Infant Series||890
352136|NCT00508742|852684|P2|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||892
352137|NCT00508742|852685|P1|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||898
352138|NCT00508742|852684|P2|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||902
352139|NCT00508742|852685|P1|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||904
352140|NCT00508742|852684|P2|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||933
352141|NCT00508742|852685|P1|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||930
352142|NCT00508742|852684|P2|STARTED|Period 1: Infant Series||934
352143|NCT00508742|852685|P1|STARTED|Period 1: Infant Series||932
352144|NCT00508716|852701|P2|NOT COMPLETED|Overall Study||0
352145|NCT00508716|852702|P1|NOT COMPLETED|Overall Study||0
352146|NCT00508716|852701|P2|COMPLETED|Overall Study||63
352147|NCT00508716|852702|P1|COMPLETED|Overall Study||61
352148|NCT00508716|852701|P2|STARTED|Overall Study||63
352149|NCT00508716|852702|P1|STARTED|Overall Study||61
352150|NCT00508651|852710|P2|NOT COMPLETED|Overall Study||2
352151|NCT00508651|852711|P1|NOT COMPLETED|Overall Study||4
352152|NCT00508651|852710|P2|COMPLETED|Overall Study||8
352153|NCT00508651|852711|P1|COMPLETED|Overall Study||16
352154|NCT00508651|852710|P2|STARTED|Overall Study||10
352155|NCT00508651|852711|P1|STARTED|Overall Study||20
352156|NCT00508521|852785|P1|NOT COMPLETED|Overall Study||0
352157|NCT00508521|852785|P1|COMPLETED|Overall Study||4
352158|NCT00508521|852785|P1|STARTED|Overall Study||4
352159|NCT00508482|852792|P3|NOT COMPLETED|at the 12th Week of Follow-up||0
352160|NCT00508482|852793|P2|NOT COMPLETED|at the 12th Week of Follow-up||0
352161|NCT00508482|852794|P1|NOT COMPLETED|at the 12th Week of Follow-up||0
352162|NCT00508482|852792|P3|COMPLETED|at the 12th Week of Follow-up||98
352163|NCT00508482|852793|P2|COMPLETED|at the 12th Week of Follow-up||96
352164|NCT00508482|852794|P1|COMPLETED|at the 12th Week of Follow-up||196
352165|NCT00508482|852792|P3|STARTED|at the 12th Week of Follow-up||98
352166|NCT00508482|852793|P2|STARTED|at the 12th Week of Follow-up||96
352167|NCT00508482|852794|P1|STARTED|at the 12th Week of Follow-up||196
352168|NCT00508482|852792|P3|NOT COMPLETED|at the 4th Week of Follow-up||1
352169|NCT00508482|852793|P2|NOT COMPLETED|at the 4th Week of Follow-up||6
352170|NCT00508482|852794|P1|NOT COMPLETED|at the 4th Week of Follow-up||20
352171|NCT00508482|852792|P3|COMPLETED|at the 4th Week of Follow-up||98
352172|NCT00508482|852793|P2|COMPLETED|at the 4th Week of Follow-up||96
352173|NCT00508482|852794|P1|COMPLETED|at the 4th Week of Follow-up||196
352174|NCT00508482|852792|P3|STARTED|at the 4th Week of Follow-up||99
352175|NCT00508482|852793|P2|STARTED|at the 4th Week of Follow-up||102
352176|NCT00508482|852794|P1|STARTED|at the 4th Week of Follow-up||216
352177|NCT00508482|852792|P3|NOT COMPLETED|Over 4 Weeks of Treatment||20
352178|NCT00508482|852793|P2|NOT COMPLETED|Over 4 Weeks of Treatment||17
352179|NCT00508482|852794|P1|NOT COMPLETED|Over 4 Weeks of Treatment||21
352180|NCT00508482|852792|P3|COMPLETED|Over 4 Weeks of Treatment||99
352181|NCT00508482|852793|P2|COMPLETED|Over 4 Weeks of Treatment||102
352182|NCT00508482|852794|P1|COMPLETED|Over 4 Weeks of Treatment||216
352183|NCT00508482|852792|P3|STARTED|Over 4 Weeks of Treatment||119
352184|NCT00508482|852793|P2|STARTED|Over 4 Weeks of Treatment||119
352185|NCT00508482|852794|P1|STARTED|Over 4 Weeks of Treatment||237
352186|NCT00508469|852831|P2|NOT COMPLETED|Overall Study||10
352187|NCT00508469|852832|P1|NOT COMPLETED|Overall Study||17
352188|NCT00508469|852831|P2|COMPLETED|Overall Study||40
352189|NCT00508469|852832|P1|COMPLETED|Overall Study||35
352190|NCT00508469|852831|P2|STARTED|Overall Study||50
352191|NCT00508469|852832|P1|STARTED|Overall Study||52
352192|NCT00508404|852838|P1|NOT COMPLETED|Overall Study||42
352193|NCT00508404|852838|P1|COMPLETED|Overall Study|Completion of safety follow-up visit conducted 8 weeks after last dose|112
352194|NCT00508404|852838|P1|STARTED|Overall Study||154
352195|NCT00508391|852865|P2|NOT COMPLETED|Second Treatment||0
352196|NCT00508391|852866|P1|NOT COMPLETED|Second Treatment||2
352197|NCT00508391|852865|P2|COMPLETED|Second Treatment||59
352198|NCT00508391|852866|P1|COMPLETED|Second Treatment||52
352199|NCT00508391|852865|P2|STARTED|Second Treatment||59
352200|NCT00508391|852866|P1|STARTED|Second Treatment||54
352201|NCT00508391|852865|P2|NOT COMPLETED|First Treatment||3
352202|NCT00508391|852866|P1|NOT COMPLETED|First Treatment||6
352203|NCT00508391|852865|P2|COMPLETED|First Treatment||59
352204|NCT00508391|852866|P1|COMPLETED|First Treatment||54
352205|NCT00508391|852865|P2|STARTED|First Treatment||62
352206|NCT00508391|852866|P1|STARTED|First Treatment||60
352207|NCT00508300|852879|P2|NOT COMPLETED|Overall Study||4
352208|NCT00508300|852880|P1|NOT COMPLETED|Overall Study||2
352209|NCT00508300|852879|P2|COMPLETED|Overall Study||57
352210|NCT00508300|852880|P1|COMPLETED|Overall Study||65
352211|NCT00508300|852879|P2|STARTED|Overall Study||61
352212|NCT00508300|852880|P1|STARTED|Overall Study||67
352213|NCT00508274|852886|P1|NOT COMPLETED|Overall Study||2
352214|NCT00508274|852886|P1|COMPLETED|Overall Study||50
352215|NCT00508274|852886|P1|STARTED|Overall Study||52
352216|NCT00508261|852899|P4|NOT COMPLETED|Overall Study||1
352217|NCT00508261|852900|P3|NOT COMPLETED|Overall Study||6
352218|NCT00508261|852901|P2|NOT COMPLETED|Overall Study||8
352219|NCT00508261|852902|P1|NOT COMPLETED|Overall Study||3
352220|NCT00508261|852899|P4|COMPLETED|Overall Study||126
352221|NCT00508261|852900|P3|COMPLETED|Overall Study||218
352222|NCT00508261|852901|P2|COMPLETED|Overall Study||212
352223|NCT00508261|852902|P1|COMPLETED|Overall Study||219
352224|NCT00508261|852899|P4|STARTED|Overall Study||127
352225|NCT00508261|852900|P3|STARTED|Overall Study||224
352226|NCT00508261|852901|P2|STARTED|Overall Study||220
352227|NCT00508261|852902|P1|STARTED|Overall Study||222
352228|NCT00508196|853012|P2|NOT COMPLETED|Overall Study||0
352229|NCT00508196|853013|P1|NOT COMPLETED|Overall Study||0
352230|NCT00508196|853012|P2|COMPLETED|Overall Study||11
352231|NCT00508196|853013|P1|COMPLETED|Overall Study||11
352232|NCT00508196|853012|P2|STARTED|Overall Study||11
352233|NCT00508196|853013|P1|STARTED|Overall Study||11
352234|NCT00508183|853025|P2|NOT COMPLETED|Overall Study||8
352235|NCT00508183|853026|P1|NOT COMPLETED|Overall Study||9
352236|NCT00508183|853025|P2|COMPLETED|Overall Study||34
352237|NCT00508183|853026|P1|COMPLETED|Overall Study||39
352238|NCT00508183|853025|P2|STARTED|Overall Study||42
352239|NCT00508183|853026|P1|STARTED|Overall Study||48
352240|NCT00508157|853042|P2|NOT COMPLETED|Overall Study||3
352241|NCT00508157|853043|P1|NOT COMPLETED|Overall Study||2
352242|NCT00508157|853042|P2|COMPLETED|Overall Study||23
352243|NCT00508157|853043|P1|COMPLETED|Overall Study||24
352244|NCT00508157|853042|P2|Safety Sample|Overall Study|1 participant was withdrawn from study prior to receiving study drug & excluded from safety sample.|25
352245|NCT00508157|853043|P1|Safety Sample|Overall Study||26
352246|NCT00508157|853042|P2|Randomized Sample|Overall Study||26
352247|NCT00508157|853043|P1|Randomized Sample|Overall Study||26
352248|NCT00508157|853042|P2|STARTED|Overall Study||26
352249|NCT00508157|853043|P1|STARTED|Overall Study||26
352250|NCT00508144|853065|P1|NOT COMPLETED|Overall Study||11
352251|NCT00508144|853065|P1|COMPLETED|Overall Study||53
352252|NCT00508144|853065|P1|STARTED|Overall Study||64
352253|NCT00508118|853071|P2|NOT COMPLETED|Overall Study||0
352254|NCT00508118|853072|P1|NOT COMPLETED|Overall Study||0
352255|NCT00508118|853071|P2|COMPLETED|Overall Study||4
352256|NCT00508118|853072|P1|COMPLETED|Overall Study||3
352257|NCT00508118|853071|P2|STARTED|Overall Study|Documentation is not available for the 7th subject and treatment arm.|4
352258|NCT00508118|853072|P1|STARTED|Overall Study||3
352259|NCT00508027|853091|P1|NOT COMPLETED|Dose Level 3||0
352260|NCT00508027|853091|P1|COMPLETED|Dose Level 3||2
352261|NCT00508027|853091|P1|STARTED|Dose Level 3|enrollment discontinued due to FDA recommendations regarding high dose (80mg/day) simvastatin|2
352262|NCT00508027|853091|P1|NOT COMPLETED|Dose Level 2||4
352263|NCT00508027|853091|P1|COMPLETED|Dose Level 2||16
352264|NCT00508027|853091|P1|STARTED|Dose Level 2|The participants starting each dose period is a new cohort of subjects. 20 new subjects in dose 2|20
352265|NCT00508027|853091|P1|NOT COMPLETED|Dose Level 1||8
352266|NCT00508027|853091|P1|COMPLETED|Dose Level 1||12
352267|NCT00508027|853091|P1|STARTED|Dose Level 1|The participants starting each dose period is a new cohort of subjects. 20 subjects started dose 1|20
352268|NCT00508001|853132|P3|NOT COMPLETED|Overall Study||7
352269|NCT00508001|853133|P2|NOT COMPLETED|Overall Study||12
352270|NCT00508001|853134|P1|NOT COMPLETED|Overall Study||19
352271|NCT00508001|853132|P3|COMPLETED|Overall Study||16
352272|NCT00508001|853133|P2|COMPLETED|Overall Study||13
352273|NCT00508001|853134|P1|COMPLETED|Overall Study||0
352274|NCT00508001|853132|P3|Secondary Treatment Phase|Overall Study||16
352275|NCT00508001|853133|P2|Secondary Treatment Phase|Overall Study||13
352276|NCT00508001|853134|P1|Secondary Treatment Phase|Overall Study||0
352277|NCT00508001|853132|P3|STARTED|Overall Study||23
352278|NCT00508001|853133|P2|STARTED|Overall Study||25
352279|NCT00508001|853134|P1|STARTED|Overall Study||19
352280|NCT00507819|853151|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
352281|NCT00507819|853152|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
352282|NCT00507819|853151|P2|COMPLETED|Second Intervention (6 Weeks)||14
352283|NCT00507819|853152|P1|COMPLETED|Second Intervention (6 Weeks)||13
352284|NCT00507819|853151|P2|STARTED|Second Intervention (6 Weeks)||14
352285|NCT00507819|853152|P1|STARTED|Second Intervention (6 Weeks)||13
352286|NCT00507819|853151|P2|NOT COMPLETED|Washout (6 Weeks)||0
352287|NCT00507819|853152|P1|NOT COMPLETED|Washout (6 Weeks)||1
352288|NCT00507819|853151|P2|COMPLETED|Washout (6 Weeks)||14
352289|NCT00507819|853152|P1|COMPLETED|Washout (6 Weeks)||13
352290|NCT00507819|853151|P2|STARTED|Washout (6 Weeks)||14
352291|NCT00507819|853152|P1|STARTED|Washout (6 Weeks)||14
352292|NCT00507819|853151|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
352293|NCT00507819|853152|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
352294|NCT00507819|853151|P2|COMPLETED|First Intervention (6 Weeks)||14
352295|NCT00507819|853152|P1|COMPLETED|First Intervention (6 Weeks)||14
352296|NCT00507819|853151|P2|STARTED|First Intervention (6 Weeks)||14
352297|NCT00507819|853152|P1|STARTED|First Intervention (6 Weeks)||14
352298|NCT00507767|853164|P1|NOT COMPLETED|Overall Study||0
352299|NCT00507767|853164|P1|COMPLETED|Overall Study||15
352300|NCT00507767|853164|P1|STARTED|Overall Study||15
352301|NCT00507689|853171|P2|NOT COMPLETED|Randomized Period||2
352302|NCT00507689|853172|P1|NOT COMPLETED|Randomized Period||1
352303|NCT00507689|853171|P2|COMPLETED|Randomized Period||16
352304|NCT00507689|853172|P1|COMPLETED|Randomized Period||18
352305|NCT00507689|853171|P2|STARTED|Randomized Period|18 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF.|18
352306|NCT00507689|853172|P1|STARTED|Randomized Period|19 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF+HBIg.|19
352307|NCT00507689|853171|P2|NOT COMPLETED|Pre-Randomization Period||0
352308|NCT00507689|853172|P1|NOT COMPLETED|Pre-Randomization Period||3
352309|NCT00507689|853171|P2|COMPLETED|Pre-Randomization Period||0
352310|NCT00507689|853172|P1|COMPLETED|Pre-Randomization Period||37
352311|NCT00507689|853171|P2|STARTED|Pre-Randomization Period||0
352312|NCT00507689|853172|P1|STARTED|Pre-Randomization Period||40
352313|NCT00507559|853189|P1|NOT COMPLETED|Overall Study||71
352314|NCT00507559|853189|P1|COMPLETED|Overall Study||84
352315|NCT00507559|853189|P1|STARTED|Overall Study||155
352316|NCT00507546|853204|P2|NOT COMPLETED|Overall Study||1
352317|NCT00507546|853205|P1|NOT COMPLETED|Overall Study||2
352318|NCT00507546|853204|P2|COMPLETED|Overall Study||3
352319|NCT00507546|853205|P1|COMPLETED|Overall Study||2
352320|NCT00507546|853204|P2|STARTED|Overall Study||4
352321|NCT00507546|853205|P1|STARTED|Overall Study||4
352322|NCT00507507|853215|P2|NOT COMPLETED|24-week Treatment-free Follow-up Period||17
352323|NCT00507507|853216|P1|NOT COMPLETED|24-week Treatment-free Follow-up Period||10
352324|NCT00507507|853215|P2|COMPLETED|24-week Treatment-free Follow-up Period||12
352325|NCT00507507|853216|P1|COMPLETED|24-week Treatment-free Follow-up Period||16
352326|NCT00507507|853215|P2|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|29
352327|NCT00507507|853216|P1|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|26
352328|NCT00507507|853215|P2|NOT COMPLETED|Treatment Period||53
352329|NCT00507507|853216|P1|NOT COMPLETED|Treatment Period||52
352330|NCT00507507|853215|P2|COMPLETED|Treatment Period||9
352331|NCT00507507|853216|P1|COMPLETED|Treatment Period||12
352332|NCT00507507|853215|P2|Completed 192 Weeks of Treatment|Treatment Period||52
352333|NCT00507507|853216|P1|Completed 192 Weeks of Treatment|Treatment Period||52
352334|NCT00507507|853215|P2|STARTED|Treatment Period||62
352335|NCT00507507|853216|P1|STARTED|Treatment Period||64
352336|NCT00507455|853251|P3|NOT COMPLETED|Overall Study||12
352337|NCT00507455|853252|P2|NOT COMPLETED|Overall Study||6
352338|NCT00507455|853253|P1|NOT COMPLETED|Overall Study||12
352339|NCT00507455|853251|P3|COMPLETED|Overall Study||62
352340|NCT00507455|853252|P2|COMPLETED|Overall Study||68
352341|NCT00507455|853253|P1|COMPLETED|Overall Study||62
352342|NCT00507455|853251|P3|STARTED|Overall Study||74
352343|NCT00507455|853252|P2|STARTED|Overall Study||74
352344|NCT00507455|853253|P1|STARTED|Overall Study||74
352345|NCT00507442|853316|P4|NOT COMPLETED|Overall Study||5
352346|NCT00507442|853317|P3|NOT COMPLETED|Overall Study||15
352347|NCT00507442|853318|P2|NOT COMPLETED|Overall Study||27
352348|NCT00507442|853319|P1|NOT COMPLETED|Overall Study||16
352349|NCT00507442|853316|P4|COMPLETED|Overall Study||12
352350|NCT00507442|853317|P3|COMPLETED|Overall Study||18
352351|NCT00507442|853318|P2|COMPLETED|Overall Study||39
352352|NCT00507442|853319|P1|COMPLETED|Overall Study||26
352353|NCT00507442|853316|P4|STARTED|Overall Study||17
352354|NCT00507442|853317|P3|STARTED|Overall Study||33
352355|NCT00507442|853318|P2|STARTED|Overall Study||66
352356|NCT00507442|853319|P1|STARTED|Overall Study||42
352357|NCT00507429|853371|P2|NOT COMPLETED|Maintenance Phase||0
352358|NCT00507429|853372|P1|NOT COMPLETED|Maintenance Phase||14
352359|NCT00507429|853371|P2|COMPLETED|Maintenance Phase||0
352360|NCT00507429|853372|P1|COMPLETED|Maintenance Phase|14 subjects were withdrawn due to progressive disease, 2 subjects continued beyond data cut-off|2
352361|NCT00507429|853371|P2|STARTED|Maintenance Phase|Control arm subjects followed for survival only; not enrolled in Maintenance period|0
352362|NCT00507429|853372|P1|STARTED|Maintenance Phase|2 subjects did not enter maintenance: 1/18 progressive disease; 1/18 lost to follow-up.|16
352363|NCT00507429|853371|P2|NOT COMPLETED|Treatment Phase||18
352364|NCT00507429|853372|P1|NOT COMPLETED|Treatment Phase||37
352365|NCT00507429|853371|P2|COMPLETED|Treatment Phase||7
352366|NCT00507429|853372|P1|COMPLETED|Treatment Phase||18
352367|NCT00507429|853371|P2|STARTED|Treatment Phase|Randomized|25
352368|NCT00507429|853372|P1|STARTED|Treatment Phase|Randomized|55
352369|NCT00507416|853383|P3|NOT COMPLETED|Overall Study||114
352370|NCT00507416|853384|P2|NOT COMPLETED|Overall Study||125
352371|NCT00507416|853385|P1|NOT COMPLETED|Overall Study||118
352372|NCT00507416|853383|P3|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|53
352373|NCT00507416|853384|P2|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|42
352374|NCT00507416|853385|P1|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|50
352375|NCT00507416|853383|P3|Completed 8 Treatment Cycles|Overall Study||69
352376|NCT00507416|853384|P2|Completed 8 Treatment Cycles|Overall Study||60
352377|NCT00507416|853385|P1|Completed 8 Treatment Cycles|Overall Study||82
352378|NCT00507416|853383|P3|Treated (Safety Population)|Overall Study||163
352379|NCT00507416|853384|P2|Treated (Safety Population)|Overall Study||158
352380|NCT00507416|853385|P1|Treated (Safety Population)|Overall Study||165
352381|NCT00507416|853383|P3|STARTED|Overall Study||167
352382|NCT00507416|853384|P2|STARTED|Overall Study||167
352383|NCT00507416|853385|P1|STARTED|Overall Study||168
352384|NCT00507208|853416|P2|NOT COMPLETED|Overall Study||0
352385|NCT00507208|853417|P1|NOT COMPLETED|Overall Study||0
352386|NCT00507208|853416|P2|COMPLETED|Overall Study||26
352387|NCT00507208|853417|P1|COMPLETED|Overall Study||27
352388|NCT00507208|853416|P2|Received Dynasplint in Crossover|Overall Study||3
352389|NCT00507208|853417|P1|Received Dynasplint in Crossover|Overall Study||0
352390|NCT00507208|853416|P2|STARTED|Overall Study||26
352391|NCT00507208|853417|P1|STARTED|Overall Study||27
352392|NCT00507130|853427|P4|NOT COMPLETED|Overall Study||1
352393|NCT00507130|853428|P3|NOT COMPLETED|Overall Study||1
352394|NCT00507130|853429|P2|NOT COMPLETED|Overall Study||0
352395|NCT00507130|853430|P1|NOT COMPLETED|Overall Study||1
352396|NCT00507130|853427|P4|COMPLETED|Overall Study||8
352397|NCT00507130|853428|P3|COMPLETED|Overall Study||8
352398|NCT00507130|853429|P2|COMPLETED|Overall Study||9
352399|NCT00507130|853430|P1|COMPLETED|Overall Study||8
352400|NCT00507130|853427|P4|STARTED|Overall Study||9
352401|NCT00507130|853428|P3|STARTED|Overall Study||9
352402|NCT00507130|853429|P2|STARTED|Overall Study||9
352403|NCT00507130|853430|P1|STARTED|Overall Study||9
352404|NCT00506948|853472|P1|NOT COMPLETED|Overall Study||10
352405|NCT00506948|853472|P1|COMPLETED|Overall Study||0
352406|NCT00506948|853472|P1|STARTED|Overall Study||10
352407|NCT00506922|853481|P5|NOT COMPLETED|Overall Study||1
352408|NCT00506922|853482|P4|NOT COMPLETED|Overall Study||2
352409|NCT00506922|853483|P3|NOT COMPLETED|Overall Study||0
352410|NCT00506922|853484|P2|NOT COMPLETED|Overall Study||0
352411|NCT00506922|853485|P1|NOT COMPLETED|Overall Study||0
352412|NCT00506922|853481|P5|COMPLETED|Overall Study||10
352413|NCT00506922|853482|P4|COMPLETED|Overall Study||61
352414|NCT00506922|853483|P3|COMPLETED|Overall Study||29
352415|NCT00506922|853484|P2|COMPLETED|Overall Study||10
352416|NCT00506922|853485|P1|COMPLETED|Overall Study||37
352417|NCT00506922|853481|P5|STARTED|Overall Study||11
352418|NCT00506922|853482|P4|STARTED|Overall Study||63
352419|NCT00506922|853483|P3|STARTED|Overall Study||29
352420|NCT00506922|853484|P2|STARTED|Overall Study||10
352421|NCT00506922|853485|P1|STARTED|Overall Study||37
352422|NCT00506909|853493|P1|NOT COMPLETED|Overall Study||0
352423|NCT00506909|853493|P1|COMPLETED|Overall Study||0
352424|NCT00506909|853493|P1|STARTED|Overall Study||0
352425|NCT00506883|853512|P3|NOT COMPLETED|Overall Study||4
352426|NCT00506883|853513|P2|NOT COMPLETED|Overall Study||3
352427|NCT00506883|853514|P1|NOT COMPLETED|Overall Study||7
352428|NCT00506883|853512|P3|COMPLETED|Overall Study||55
352429|NCT00506883|853513|P2|COMPLETED|Overall Study||71
352430|NCT00506883|853514|P1|COMPLETED|Overall Study||45
352431|NCT00506883|853512|P3|STARTED|Overall Study||59
352432|NCT00506883|853513|P2|STARTED|Overall Study||74
352433|NCT00506883|853514|P1|STARTED|Overall Study||52
352434|NCT00506857|853522|P1|NOT COMPLETED|Overall Study||0
352435|NCT00506857|853522|P1|COMPLETED|Overall Study||80
352436|NCT00506857|853522|P1|STARTED|Overall Study||80
352437|NCT00506831|853527|P1|NOT COMPLETED|Overall Study||2
352438|NCT00506831|853527|P1|COMPLETED|Overall Study||7
352439|NCT00506831|853527|P1|STARTED|Overall Study||9
352440|NCT00506753|853540|P2|NOT COMPLETED|Overall Study||15
352441|NCT00506753|853541|P1|NOT COMPLETED|Overall Study||21
352442|NCT00506753|853540|P2|COMPLETED|Overall Study||84
352443|NCT00506753|853541|P1|COMPLETED|Overall Study||79
352444|NCT00506753|853540|P2|STARTED|Overall Study||99
352445|NCT00506753|853541|P1|STARTED|Overall Study||100
352446|NCT00506714|853553|P2|NOT COMPLETED|Overall Study||0
352447|NCT00506714|853554|P1|NOT COMPLETED|Overall Study||0
352448|NCT00506714|853553|P2|COMPLETED|Overall Study||13
352449|NCT00506714|853554|P1|COMPLETED|Overall Study||13
352450|NCT00506714|853553|P2|STARTED|Overall Study||13
352451|NCT00506714|853554|P1|STARTED|Overall Study||13
352452|NCT00506675|853564|P2|NOT COMPLETED|Overall Study||0
352453|NCT00506675|853565|P1|NOT COMPLETED|Overall Study||0
352454|NCT00506675|853564|P2|COMPLETED|Overall Study||28
352455|NCT00506675|853565|P1|COMPLETED|Overall Study||27
352456|NCT00506675|853564|P2|STARTED|Overall Study||28
352457|NCT00506675|853565|P1|STARTED|Overall Study||27
352458|NCT00506662|853579|P2|NOT COMPLETED|Overall Study||28
352459|NCT00506662|853580|P1|NOT COMPLETED|Overall Study||17
352460|NCT00506662|853579|P2|COMPLETED|Overall Study||20
352461|NCT00506662|853580|P1|COMPLETED|Overall Study||21
352462|NCT00506662|853579|P2|STARTED|Overall Study||48
352463|NCT00506662|853580|P1|STARTED|Overall Study||38
352464|NCT00506597|853610|P1|NOT COMPLETED|Overall Study||0
352465|NCT00506597|853610|P1|COMPLETED|Overall Study||33
352466|NCT00506597|853610|P1|STARTED|Overall Study||33
352467|NCT00506493|853614|P1|NOT COMPLETED|Overall Study||11
352468|NCT00506493|853614|P1|COMPLETED|Overall Study||64
352469|NCT00506493|853614|P1|STARTED|Overall Study||75
352470|NCT00506454|853623|P2|NOT COMPLETED|Overall Study||1
352471|NCT00506454|853624|P1|NOT COMPLETED|Overall Study||1
352472|NCT00506454|853623|P2|COMPLETED|Overall Study||10
352473|NCT00506454|853624|P1|COMPLETED|Overall Study||10
352474|NCT00506454|853623|P2|STARTED|Overall Study||11
352475|NCT00506454|853624|P1|STARTED|Overall Study||11
352476|NCT00506441|853630|P2|NOT COMPLETED|Period 2; Double-blind Period||5
352477|NCT00506441|853631|P1|NOT COMPLETED|Period 2; Double-blind Period||3
352478|NCT00506441|853630|P2|COMPLETED|Period 2; Double-blind Period||79
352479|NCT00506441|853631|P1|COMPLETED|Period 2; Double-blind Period||82
352480|NCT00506441|853630|P2|STARTED|Period 2; Double-blind Period||84
352481|NCT00506441|853631|P1|STARTED|Period 2; Double-blind Period||85
352482|NCT00506441|853630|P2|NOT COMPLETED|Period 1; Open-label Period||0
352483|NCT00506441|853631|P1|NOT COMPLETED|Period 1; Open-label Period||76
352484|NCT00506441|853630|P2|COMPLETED|Period 1; Open-label Period||0
352485|NCT00506441|853631|P1|COMPLETED|Period 1; Open-label Period||169
352486|NCT00506441|853630|P2|STARTED|Period 1; Open-label Period||0
352487|NCT00506441|853631|P1|STARTED|Period 1; Open-label Period||245
352488|NCT00506415|853639|P4|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||62
352489|NCT00506415|853640|P3|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
352490|NCT00506415|853641|P2|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
352491|NCT00506415|853642|P1|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
352492|NCT00506415|853639|P4|COMPLETED|Extended Open Label (Maximum 48 Weeks)||395
352493|NCT00506415|853640|P3|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
352494|NCT00506415|853641|P2|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
352495|NCT00506415|853642|P1|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
352496|NCT00506415|853639|P4|STARTED|Extended Open Label (Maximum 48 Weeks)|Two participants did not receive study drug, hence excluded from this arm.|457
352497|NCT00506415|853640|P3|STARTED|Extended Open Label (Maximum 48 Weeks)||0
352498|NCT00506415|853641|P2|STARTED|Extended Open Label (Maximum 48 Weeks)||0
352499|NCT00506415|853642|P1|STARTED|Extended Open Label (Maximum 48 Weeks)||0
352500|NCT00506415|853639|P4|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
352501|NCT00506415|853640|P3|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||73
352502|NCT00506415|853641|P2|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||83
352503|NCT00506415|853642|P1|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
352504|NCT00506415|853639|P4|COMPLETED|Double Blind (Maximum 48 Weeks )||0
352505|NCT00506415|853640|P3|COMPLETED|Double Blind (Maximum 48 Weeks )||207
352506|NCT00506415|853641|P2|COMPLETED|Double Blind (Maximum 48 Weeks )||203
352507|NCT00506415|853642|P1|COMPLETED|Double Blind (Maximum 48 Weeks )||0
352508|NCT00506415|853639|P4|STARTED|Double Blind (Maximum 48 Weeks )||0
352509|NCT00506415|853640|P3|STARTED|Double Blind (Maximum 48 Weeks )||280
352510|NCT00506415|853641|P2|STARTED|Double Blind (Maximum 48 Weeks )|1 patient was randomized in error and did not receive study drug, hence excluded from this arm.|286
352511|NCT00506415|853642|P1|STARTED|Double Blind (Maximum 48 Weeks )||0
352512|NCT00506415|853639|P4|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
352513|NCT00506415|853640|P3|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
352514|NCT00506415|853641|P2|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
352515|NCT00506415|853642|P1|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||499
352516|NCT00506415|853639|P4|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
352517|NCT00506415|853640|P3|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
352518|NCT00506415|853641|P2|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
352519|NCT00506415|853642|P1|COMPLETED|Initial Open Label (Maximum 48 Weeks)||1085
352520|NCT00506415|853639|P4|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
352521|NCT00506415|853640|P3|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
352522|NCT00506415|853641|P2|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
352523|NCT00506415|853642|P1|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||1582
352524|NCT00506415|853639|P4|STARTED|Initial Open Label (Maximum 48 Weeks)||0
352525|NCT00506415|853640|P3|STARTED|Initial Open Label (Maximum 48 Weeks)||0
352526|NCT00506415|853641|P2|STARTED|Initial Open Label (Maximum 48 Weeks)||0
352527|NCT00506415|853642|P1|STARTED|Initial Open Label (Maximum 48 Weeks)|Enrolled patients.|1584
352528|NCT00506389|853667|P3|NOT COMPLETED|Follow-up Period||0
352529|NCT00506389|853668|P2|NOT COMPLETED|Follow-up Period||0
352530|NCT00506389|853669|P1|NOT COMPLETED|Follow-up Period||0
352531|NCT00506389|853667|P3|COMPLETED|Follow-up Period||136
352532|NCT00506389|853668|P2|COMPLETED|Follow-up Period||138
352533|NCT00506389|853669|P1|COMPLETED|Follow-up Period||139
352534|NCT00506389|853667|P3|STARTED|Follow-up Period|11 participants who discontinued treatment entered the Follow-up Period.|136
352535|NCT00506389|853668|P2|STARTED|Follow-up Period|14 participants who discontinued treatment entered the Follow-up Period.|138
352536|NCT00506389|853669|P1|STARTED|Follow-up Period|22 participants who discontinued treatment entered the Follow-up Period.|139
352537|NCT00506389|853667|P3|NOT COMPLETED|In-treatment Period||12
352538|NCT00506389|853668|P2|NOT COMPLETED|In-treatment Period||15
352539|NCT00506389|853669|P1|NOT COMPLETED|In-treatment Period||26
352540|NCT00506389|853667|P3|COMPLETED|In-treatment Period||125
352541|NCT00506389|853668|P2|COMPLETED|In-treatment Period||124
352542|NCT00506389|853669|P1|COMPLETED|In-treatment Period||117
352543|NCT00506389|853667|P3|All Participants Treated|In-treatment Period||136
352544|NCT00506389|853668|P2|All Participants Treated|In-treatment Period||138
352545|NCT00506389|853669|P1|All Participants Treated|In-treatment Period||139
352546|NCT00506389|853667|P3|STARTED|In-treatment Period||137
352547|NCT00506389|853668|P2|STARTED|In-treatment Period||139
352548|NCT00506389|853669|P1|STARTED|In-treatment Period||143
352549|NCT00506350|853695|P9|NOT COMPLETED|Overall Study||5
352550|NCT00506350|853696|P8|NOT COMPLETED|Overall Study||5
352551|NCT00506350|853697|P7|NOT COMPLETED|Overall Study||2
352552|NCT00506350|853698|P6|NOT COMPLETED|Overall Study||2
352553|NCT00506350|853699|P5|NOT COMPLETED|Overall Study||10
352554|NCT00506350|853700|P4|NOT COMPLETED|Overall Study||2
352555|NCT00506350|853701|P3|NOT COMPLETED|Overall Study||6
352556|NCT00506350|853702|P2|NOT COMPLETED|Overall Study||3
352557|NCT00506350|853703|P1|NOT COMPLETED|Overall Study||3
352558|NCT00506350|853695|P9|COMPLETED|Overall Study||30
352559|NCT00506350|853696|P8|COMPLETED|Overall Study||36
352560|NCT00506350|853697|P7|COMPLETED|Overall Study||33
352561|NCT00506350|853698|P6|COMPLETED|Overall Study||38
352562|NCT00506350|853699|P5|COMPLETED|Overall Study||40
352563|NCT00506350|853700|P4|COMPLETED|Overall Study||34
352564|NCT00506350|853701|P3|COMPLETED|Overall Study||31
352565|NCT00506350|853702|P2|COMPLETED|Overall Study||37
352566|NCT00506350|853703|P1|COMPLETED|Overall Study||33
352567|NCT00506350|853695|P9|STARTED|Overall Study||35
352568|NCT00506350|853696|P8|STARTED|Overall Study||41
352569|NCT00506350|853697|P7|STARTED|Overall Study||35
352570|NCT00506350|853698|P6|STARTED|Overall Study||40
352571|NCT00506350|853699|P5|STARTED|Overall Study||50
352572|NCT00506350|853700|P4|STARTED|Overall Study||36
352573|NCT00506350|853701|P3|STARTED|Overall Study||37
352574|NCT00506350|853702|P2|STARTED|Overall Study||40
352575|NCT00506350|853703|P1|STARTED|Overall Study||36
352576|NCT00506285|853850|P2|NOT COMPLETED|6-month Open Label Phase||12
352577|NCT00506285|853851|P1|NOT COMPLETED|6-month Open Label Phase||10
352578|NCT00506285|853850|P2|COMPLETED|6-month Open Label Phase||19
352579|NCT00506285|853851|P1|COMPLETED|6-month Open Label Phase||10
352580|NCT00506285|853850|P2|STARTED|6-month Open Label Phase||31
352581|NCT00506285|853851|P1|STARTED|6-month Open Label Phase||20
352582|NCT00506285|853850|P2|NOT COMPLETED|Double Blind Cross-Over Phase||5
352583|NCT00506285|853851|P1|NOT COMPLETED|Double Blind Cross-Over Phase||9
352584|NCT00506285|853850|P2|COMPLETED|Double Blind Cross-Over Phase||31
352585|NCT00506285|853851|P1|COMPLETED|Double Blind Cross-Over Phase||20
352586|NCT00506285|853850|P2|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||31
352587|NCT00506285|853851|P1|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||29
352588|NCT00506285|853850|P2|STARTED|Double Blind Cross-Over Phase||36
352589|NCT00506285|853851|P1|STARTED|Double Blind Cross-Over Phase||29
352590|NCT00506285|853850|P2|NOT COMPLETED|3 Week Screening Phase||10
352591|NCT00506285|853851|P1|NOT COMPLETED|3 Week Screening Phase||17
352592|NCT00506285|853850|P2|COMPLETED|3 Week Screening Phase||36
352593|NCT00506285|853851|P1|COMPLETED|3 Week Screening Phase||29
352594|NCT00506285|853850|P2|STARTED|3 Week Screening Phase||46
352595|NCT00506285|853851|P1|STARTED|3 Week Screening Phase||46
352596|NCT00506155|853859|P1|NOT COMPLETED|Overall Study||0
352597|NCT00506155|853859|P1|COMPLETED|Overall Study||60
352598|NCT00506155|853859|P1|STARTED|Overall Study||60
352599|NCT00506142|853866|P2|NOT COMPLETED|Overall Study||19
352600|NCT00506142|853867|P1|NOT COMPLETED|Overall Study||35
352601|NCT00506142|853866|P2|COMPLETED|Overall Study||0
352602|NCT00506142|853867|P1|COMPLETED|Overall Study||0
352603|NCT00506142|853866|P2|STARTED|Overall Study||19
352604|NCT00506142|853867|P1|STARTED|Overall Study||35
352605|NCT00506077|853875|P2|NOT COMPLETED|Treatment Period 2||1
352606|NCT00506077|853876|P1|NOT COMPLETED|Treatment Period 2||1
352607|NCT00506077|853875|P2|COMPLETED|Treatment Period 2||23
352608|NCT00506077|853876|P1|COMPLETED|Treatment Period 2||23
352609|NCT00506077|853875|P2|STARTED|Treatment Period 2||24
352610|NCT00506077|853876|P1|STARTED|Treatment Period 2||24
352611|NCT00506077|853875|P2|NOT COMPLETED|Washout||0
352612|NCT00506077|853876|P1|NOT COMPLETED|Washout||0
352613|NCT00506077|853875|P2|COMPLETED|Washout||24
352614|NCT00506077|853876|P1|COMPLETED|Washout||24
352615|NCT00506077|853875|P2|STARTED|Washout||24
352616|NCT00506077|853876|P1|STARTED|Washout||24
352617|NCT00506077|853875|P2|NOT COMPLETED|Treatment Period 1||3
352618|NCT00506077|853876|P1|NOT COMPLETED|Treatment Period 1||4
352619|NCT00506077|853875|P2|COMPLETED|Treatment Period 1||24
352620|NCT00506077|853876|P1|COMPLETED|Treatment Period 1||24
352621|NCT00506077|853875|P2|STARTED|Treatment Period 1||27
352622|NCT00506077|853876|P1|STARTED|Treatment Period 1||28
352623|NCT00506064|853898|P2|NOT COMPLETED|Overall Study||0
352624|NCT00506064|853899|P1|NOT COMPLETED|Overall Study||0
352625|NCT00506064|853898|P2|COMPLETED|Overall Study||0
352626|NCT00506064|853899|P1|COMPLETED|Overall Study||1
352627|NCT00506064|853898|P2|STARTED|Overall Study||0
352628|NCT00506064|853899|P1|STARTED|Overall Study||1
352629|NCT00506025|853908|P3|NOT COMPLETED|Overall Study||0
352630|NCT00506025|853909|P2|NOT COMPLETED|Overall Study||0
352631|NCT00506025|853910|P1|NOT COMPLETED|Overall Study||0
352632|NCT00506025|853908|P3|COMPLETED|Overall Study||8
352633|NCT00506025|853909|P2|COMPLETED|Overall Study||9
352634|NCT00506025|853910|P1|COMPLETED|Overall Study||10
352635|NCT00506025|853908|P3|STARTED|Overall Study||8
352636|NCT00506025|853909|P2|STARTED|Overall Study||9
352637|NCT00506025|853910|P1|STARTED|Overall Study||10
352638|NCT00505934|853918|P1|NOT COMPLETED|Overall Study||3
352639|NCT00505934|853918|P1|COMPLETED|Overall Study||16
352640|NCT00505934|853918|P1|STARTED|Overall Study|Of the 23 subjects screened, 19 were enrolled into the study and received levetiracetam IV (LEV IV).|19
352641|NCT00505921|853924|P1|NOT COMPLETED|Overall Study||9
352642|NCT00505921|853924|P1|COMPLETED|Overall Study||18
352643|NCT00505921|853924|P1|STARTED|Overall Study||27
352644|NCT00505895|853930|P2|NOT COMPLETED|Overall Study||0
352645|NCT00505895|853931|P1|NOT COMPLETED|Overall Study||0
352646|NCT00505895|853930|P2|COMPLETED|Overall Study||23
352647|NCT00505895|853931|P1|COMPLETED|Overall Study||27
352648|NCT00505895|853930|P2|STARTED|Overall Study||23
352649|NCT00505895|853931|P1|STARTED|Overall Study||27
352650|NCT00505778|853941|P2|NOT COMPLETED|Overall Study||135
352651|NCT00505778|853942|P1|NOT COMPLETED|Overall Study||134
352652|NCT00505778|853941|P2|COMPLETED|Overall Study||378
352653|NCT00505778|853942|P1|COMPLETED|Overall Study||380
352654|NCT00505778|853941|P2|Intent to Treat (ITT) Population|Overall Study||511
352655|NCT00505778|853942|P1|Intent to Treat (ITT) Population|Overall Study||512
352656|NCT00505778|853941|P2|STARTED|Overall Study||513
352657|NCT00505778|853942|P1|STARTED|Overall Study||514
352658|NCT00505765|853961|P3|NOT COMPLETED|Overall Study||3
352659|NCT00505765|853962|P2|NOT COMPLETED|Overall Study||3
352660|NCT00505765|853963|P1|NOT COMPLETED|Overall Study||2
352661|NCT00505765|853961|P3|COMPLETED|Overall Study||19
352662|NCT00505765|853962|P2|COMPLETED|Overall Study||17
352663|NCT00505765|853963|P1|COMPLETED|Overall Study||19
352664|NCT00505765|853961|P3|Mid-Point Assessment|Overall Study||21
352665|NCT00505765|853962|P2|Mid-Point Assessment|Overall Study||19
352666|NCT00505765|853963|P1|Mid-Point Assessment|Overall Study||20
352667|NCT00505765|853961|P3|STARTED|Overall Study||22
352668|NCT00505765|853962|P2|STARTED|Overall Study||20
352669|NCT00505765|853963|P1|STARTED|Overall Study||21
352670|NCT00505752|853990|P4|NOT COMPLETED|Overall Study||6
352671|NCT00505752|853991|P3|NOT COMPLETED|Overall Study||8
352672|NCT00505752|853992|P2|NOT COMPLETED|Overall Study||9
352673|NCT00505752|853993|P1|NOT COMPLETED|Overall Study||6
352674|NCT00505752|853990|P4|COMPLETED|Overall Study||126
352675|NCT00505752|853991|P3|COMPLETED|Overall Study||120
352676|NCT00505752|853992|P2|COMPLETED|Overall Study||119
352677|NCT00505752|853993|P1|COMPLETED|Overall Study||126
352678|NCT00505752|853990|P4|STARTED|Overall Study||132
352679|NCT00505752|853991|P3|STARTED|Overall Study||128
352680|NCT00505752|853992|P2|STARTED|Overall Study||128
352681|NCT00505752|853993|P1|STARTED|Overall Study||132
352682|NCT00505687|854007|P1|NOT COMPLETED|Overall Study||95
352683|NCT00505687|854007|P1|COMPLETED|Overall Study||91
352684|NCT00505687|854007|P1|STARTED|Overall Study||186
352685|NCT00505661|854013|P1|NOT COMPLETED|Overall Study||4
352686|NCT00505661|854013|P1|COMPLETED|Overall Study||12
352687|NCT00505661|854013|P1|STARTED|Overall Study||16
352688|NCT00505635|854017|P1|NOT COMPLETED|Overall Study||0
352689|NCT00505635|854017|P1|COMPLETED|Overall Study||5
352690|NCT00505635|854017|P1|STARTED|Overall Study||5
352691|NCT00505622|854024|P3|NOT COMPLETED|Overall Study||96
352692|NCT00505622|854025|P2|NOT COMPLETED|Overall Study||108
352693|NCT00505622|854026|P1|NOT COMPLETED|Overall Study||121
352694|NCT00505622|854024|P3|COMPLETED|Overall Study||0
352695|NCT00505622|854025|P2|COMPLETED|Overall Study||0
352696|NCT00505622|854026|P1|COMPLETED|Overall Study||0
352697|NCT00505622|854024|P3|STARTED|Overall Study||96
352698|NCT00505622|854025|P2|STARTED|Overall Study||108
352699|NCT00505622|854026|P1|STARTED|Overall Study||121
352700|NCT00505518|854043|P1|NOT COMPLETED|Overall Study||0
352701|NCT00505518|854043|P1|COMPLETED|Overall Study||9
352702|NCT00505518|854043|P1|STARTED|Overall Study||9
352703|NCT00505414|854051|P5|NOT COMPLETED|Maintenance Phase||0
352704|NCT00505414|854052|P4|NOT COMPLETED|Maintenance Phase||0
352705|NCT00505414|854053|P3|NOT COMPLETED|Maintenance Phase||8
352706|NCT00505414|854054|P2|NOT COMPLETED|Maintenance Phase||5
352707|NCT00505414|854055|P1|NOT COMPLETED|Maintenance Phase||6
352708|NCT00505414|854051|P5|COMPLETED|Maintenance Phase||0
352709|NCT00505414|854052|P4|COMPLETED|Maintenance Phase||0
352710|NCT00505414|854053|P3|COMPLETED|Maintenance Phase||6
352711|NCT00505414|854054|P2|COMPLETED|Maintenance Phase||10
352712|NCT00505414|854055|P1|COMPLETED|Maintenance Phase||12
352713|NCT00505414|854051|P5|Did Not Qualify for Maintenance Phase|Maintenance Phase||1
352714|NCT00505414|854052|P4|Did Not Qualify for Maintenance Phase|Maintenance Phase||3
352715|NCT00505414|854053|P3|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
352716|NCT00505414|854054|P2|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
352717|NCT00505414|854055|P1|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
352718|NCT00505414|854051|P5|STARTED|Maintenance Phase|18 of 19 participants completing the morphine titration phase were continued on morphine.|0
352719|NCT00505414|854052|P4|STARTED|Maintenance Phase|29 of 32 participants were treated in the maintenance phase either with placebo or tapentadol|0
352720|NCT00505414|854053|P3|STARTED|Maintenance Phase|14 of 32 tapentadol titration participants were treated with placebo in the maintenance phase.|14
352721|NCT00505414|854054|P2|STARTED|Maintenance Phase|15 of 32 tapentadol titration participants continued with tapentadol in the maintenance phase|15
352722|NCT00505414|854055|P1|STARTED|Maintenance Phase|18 of the 19 morphine participants continued with morphine in the maintenance phase.|18
352723|NCT00505414|854051|P5|NOT COMPLETED|Titration Phase||12
352724|NCT00505414|854052|P4|NOT COMPLETED|Titration Phase||30
352725|NCT00505414|854053|P3|NOT COMPLETED|Titration Phase||0
352726|NCT00505414|854054|P2|NOT COMPLETED|Titration Phase||0
352727|NCT00505414|854055|P1|NOT COMPLETED|Titration Phase||0
352728|NCT00505414|854051|P5|COMPLETED|Titration Phase||19
352729|NCT00505414|854052|P4|COMPLETED|Titration Phase||32
352730|NCT00505414|854053|P3|COMPLETED|Titration Phase||0
352731|NCT00505414|854054|P2|COMPLETED|Titration Phase||0
352732|NCT00505414|854055|P1|COMPLETED|Titration Phase||0
352733|NCT00505414|854051|P5|STARTED|Titration Phase||31
352734|NCT00505414|854052|P4|STARTED|Titration Phase||62
352735|NCT00505414|854053|P3|STARTED|Titration Phase||0
352736|NCT00505414|854054|P2|STARTED|Titration Phase||0
352737|NCT00505414|854055|P1|STARTED|Titration Phase||0
352738|NCT00505375|854072|P2|NOT COMPLETED|Overall Study||5
352739|NCT00505375|854073|P1|NOT COMPLETED|Overall Study||4
352740|NCT00505375|854072|P2|COMPLETED|Overall Study||30
352741|NCT00505375|854073|P1|COMPLETED|Overall Study||73
352742|NCT00505375|854072|P2|STARTED|Overall Study||35
352743|NCT00505375|854073|P1|STARTED|Overall Study||77
352744|NCT00505362|854081|P2|NOT COMPLETED|Overall Study||0
352745|NCT00505362|854082|P1|NOT COMPLETED|Overall Study||0
352746|NCT00505362|854081|P2|COMPLETED|Overall Study||28
352747|NCT00505362|854082|P1|COMPLETED|Overall Study||35
352748|NCT00505362|854081|P2|STARTED|Overall Study||28
352749|NCT00505362|854082|P1|STARTED|Overall Study||35
352750|NCT00505284|854095|P5|NOT COMPLETED|Overall Study||33
352751|NCT00505284|854096|P4|NOT COMPLETED|Overall Study||19
352752|NCT00505284|854097|P3|NOT COMPLETED|Overall Study||12
352753|NCT00505284|854098|P2|NOT COMPLETED|Overall Study||16
352754|NCT00505284|854099|P1|NOT COMPLETED|Overall Study||10
352755|NCT00505284|854095|P5|COMPLETED|Overall Study||37
352756|NCT00505284|854096|P4|COMPLETED|Overall Study||49
352757|NCT00505284|854097|P3|COMPLETED|Overall Study||57
352758|NCT00505284|854098|P2|COMPLETED|Overall Study||56
352759|NCT00505284|854099|P1|COMPLETED|Overall Study||63
352760|NCT00505284|854095|P5|STARTED|Overall Study||70
352761|NCT00505284|854096|P4|STARTED|Overall Study||68
352762|NCT00505284|854097|P3|STARTED|Overall Study||69
352763|NCT00505284|854098|P2|STARTED|Overall Study||72
352764|NCT00505284|854099|P1|STARTED|Overall Study||73
352765|NCT00505076|854169|P3|NOT COMPLETED|Overall Study||5
352766|NCT00505076|854170|P2|NOT COMPLETED|Overall Study||2
352767|NCT00505076|854171|P1|NOT COMPLETED|Overall Study||3
352768|NCT00505076|854169|P3|COMPLETED|Overall Study||17
352769|NCT00505076|854170|P2|COMPLETED|Overall Study||17
352770|NCT00505076|854171|P1|COMPLETED|Overall Study||19
352771|NCT00505076|854169|P3|STARTED|Overall Study||22
352772|NCT00505076|854170|P2|STARTED|Overall Study||19
352773|NCT00505076|854171|P1|STARTED|Overall Study||22
352774|NCT00504985|854185|P1|NOT COMPLETED|Overall Study||0
352775|NCT00504985|854185|P1|COMPLETED|Overall Study||14
352776|NCT00504985|854185|P1|STARTED|Overall Study||14
352777|NCT00504894|854191|P2|NOT COMPLETED|Overall Study||0
352778|NCT00504894|854192|P1|NOT COMPLETED|Overall Study||0
352779|NCT00504894|854191|P2|COMPLETED|Overall Study||18
352780|NCT00504894|854192|P1|COMPLETED|Overall Study||17
352781|NCT00504894|854191|P2|STARTED|Overall Study||18
352782|NCT00504894|854192|P1|STARTED|Overall Study||17
352783|NCT00504881|854200|P2|NOT COMPLETED|Overall Study||36
352784|NCT00504881|854201|P1|NOT COMPLETED|Overall Study||10
352785|NCT00504881|854200|P2|COMPLETED|Overall Study||323
352786|NCT00504881|854201|P1|COMPLETED|Overall Study||111
352787|NCT00504881|854200|P2|STARTED|Overall Study||359
352788|NCT00504881|854201|P1|STARTED|Overall Study||121
352789|NCT00504777|854251|P1|NOT COMPLETED|Overall Study||1
352790|NCT00504777|854251|P1|COMPLETED|Overall Study||35
352791|NCT00504777|854251|P1|STARTED|Overall Study||36
352792|NCT00504751|854258|P1|NOT COMPLETED|Overall Study||0
352793|NCT00504751|854258|P1|COMPLETED|Overall Study||15
352794|NCT00504751|854258|P1|STARTED|Overall Study||15
352795|NCT00504725|854264|P2|NOT COMPLETED|Overall Study||0
352796|NCT00504725|854265|P1|NOT COMPLETED|Overall Study||1
352797|NCT00504725|854264|P2|COMPLETED|Overall Study||20
352798|NCT00504725|854265|P1|COMPLETED|Overall Study|Prior to unblinding, one subject was discontinued due to elevated CRP levels at baseline.|20
352799|NCT00504725|854264|P2|STARTED|Overall Study||20
352800|NCT00504725|854265|P1|STARTED|Overall Study||21
352801|NCT00504660|854277|P2|NOT COMPLETED|Overall Study||0
352802|NCT00504660|854278|P1|NOT COMPLETED|Overall Study||0
352803|NCT00504660|854277|P2|COMPLETED|Overall Study||43
352804|NCT00504660|854278|P1|COMPLETED|Overall Study||31
352805|NCT00504660|854277|P2|STARTED|Overall Study||43
352806|NCT00504660|854278|P1|STARTED|Overall Study||31
352807|NCT00504595|854288|P4|NOT COMPLETED|Overall Study||0
352808|NCT00504595|854289|P3|NOT COMPLETED|Overall Study||2
352809|NCT00504595|854290|P2|NOT COMPLETED|Overall Study||0
352810|NCT00504595|854291|P1|NOT COMPLETED|Overall Study||1
352811|NCT00504595|854288|P4|COMPLETED|Overall Study||10
352812|NCT00504595|854289|P3|COMPLETED|Overall Study||8
352813|NCT00504595|854290|P2|COMPLETED|Overall Study||10
352814|NCT00504595|854291|P1|COMPLETED|Overall Study||49
352815|NCT00504595|854288|P4|STARTED|Overall Study||10
352816|NCT00504595|854289|P3|STARTED|Overall Study||10
352817|NCT00504595|854290|P2|STARTED|Overall Study||10
352818|NCT00504595|854291|P1|STARTED|Overall Study||50
352819|NCT00504556|854308|P5|NOT COMPLETED|Overall Study||25
352820|NCT00504556|854309|P4|NOT COMPLETED|Overall Study||128
352821|NCT00504556|854310|P3|NOT COMPLETED|Overall Study||31
352822|NCT00504556|854311|P2|NOT COMPLETED|Overall Study||38
352823|NCT00504556|854312|P1|NOT COMPLETED|Overall Study||35
352824|NCT00504556|854308|P5|COMPLETED|Overall Study||226
352825|NCT00504556|854309|P4|COMPLETED|Overall Study||52
352826|NCT00504556|854310|P3|COMPLETED|Overall Study||204
352827|NCT00504556|854311|P2|COMPLETED|Overall Study||207
352828|NCT00504556|854312|P1|COMPLETED|Overall Study||200
352829|NCT00504556|854308|P5|Pharmacodynamic Analysis Set|Overall Study||244
352830|NCT00504556|854309|P4|Pharmacodynamic Analysis Set|Overall Study||170
352831|NCT00504556|854310|P3|Pharmacodynamic Analysis Set|Overall Study||228
352832|NCT00504556|854311|P2|Pharmacodynamic Analysis Set|Overall Study||236
352833|NCT00504556|854312|P1|Pharmacodynamic Analysis Set|Overall Study||230
352834|NCT00504556|854308|P5|Per Protocol Analysis Set|Overall Study||250
352835|NCT00504556|854309|P4|Per Protocol Analysis Set|Overall Study||180
352836|NCT00504556|854310|P3|Per Protocol Analysis Set|Overall Study||234
352837|NCT00504556|854311|P2|Per Protocol Analysis Set|Overall Study||243
352838|NCT00504556|854312|P1|Per Protocol Analysis Set|Overall Study||235
352839|NCT00504556|854308|P5|Safety Analysis Set|Overall Study||250
352840|NCT00504556|854309|P4|Safety Analysis Set|Overall Study||180
352841|NCT00504556|854310|P3|Safety Analysis Set|Overall Study||234
352842|NCT00504556|854311|P2|Safety Analysis Set|Overall Study||244
352843|NCT00504556|854312|P1|Safety Analysis Set|Overall Study||235
352844|NCT00504556|854308|P5|STARTED|Overall Study||251
352845|NCT00504556|854309|P4|STARTED|Overall Study||180
352846|NCT00504556|854310|P3|STARTED|Overall Study||235
352847|NCT00504556|854311|P2|STARTED|Overall Study||245
352848|NCT00504556|854312|P1|STARTED|Overall Study||235
352849|NCT00504504|854372|P1|NOT COMPLETED|Overall Study||0
352850|NCT00504504|854372|P1|COMPLETED|Overall Study||82
352851|NCT00504504|854372|P1|STARTED|Overall Study||82
352852|NCT00504426|854380|P4|NOT COMPLETED|Overall Study||0
352853|NCT00504426|854381|P3|NOT COMPLETED|Overall Study||4
352854|NCT00504426|854382|P2|NOT COMPLETED|Overall Study||1
352855|NCT00504426|854383|P1|NOT COMPLETED|Overall Study||3
352856|NCT00504426|854380|P4|COMPLETED|Overall Study||24
352857|NCT00504426|854381|P3|COMPLETED|Overall Study||18
352858|NCT00504426|854382|P2|COMPLETED|Overall Study||22
352859|NCT00504426|854383|P1|COMPLETED|Overall Study||29
352860|NCT00504426|854380|P4|STARTED|Overall Study||24
352861|NCT00504426|854381|P3|STARTED|Overall Study||22
352862|NCT00504426|854382|P2|STARTED|Overall Study||23
352863|NCT00504426|854383|P1|STARTED|Overall Study||32
352864|NCT00504309|854403|P6|NOT COMPLETED|Overall Study||0
352865|NCT00504309|854404|P5|NOT COMPLETED|Overall Study||1
352866|NCT00504309|854405|P4|NOT COMPLETED|Overall Study||0
352867|NCT00504309|854406|P3|NOT COMPLETED|Overall Study||1
352868|NCT00504309|854407|P2|NOT COMPLETED|Overall Study||0
352869|NCT00504309|854408|P1|NOT COMPLETED|Overall Study||0
352870|NCT00504309|854403|P6|COMPLETED|Overall Study||3
352871|NCT00504309|854404|P5|COMPLETED|Overall Study|Participant died during washout after 2nd period|7
352872|NCT00504309|854405|P4|COMPLETED|Overall Study||3
352873|NCT00504309|854406|P3|COMPLETED|Overall Study|Participant dropped out during second period|1
352874|NCT00504309|854407|P2|COMPLETED|Overall Study||5
352875|NCT00504309|854408|P1|COMPLETED|Overall Study||7
352876|NCT00504309|854403|P6|STARTED|Overall Study||3
352877|NCT00504309|854404|P5|STARTED|Overall Study||8
352878|NCT00504309|854405|P4|STARTED|Overall Study||3
352879|NCT00504309|854406|P3|STARTED|Overall Study||2
352880|NCT00504309|854407|P2|STARTED|Overall Study||5
352881|NCT00504309|854408|P1|STARTED|Overall Study||7
352882|NCT00504257|854446|P1|NOT COMPLETED|Overall Study||4
352883|NCT00504257|854446|P1|COMPLETED|Overall Study||41
352884|NCT00504257|854446|P1|STARTED|Overall Study||45
352885|NCT00504231|854458|P4|NOT COMPLETED|Overall Study||0
352886|NCT00504231|854459|P3|NOT COMPLETED|Overall Study||1
352887|NCT00504231|854460|P2|NOT COMPLETED|Overall Study||0
352888|NCT00504231|854461|P1|NOT COMPLETED|Overall Study||0
352889|NCT00504231|854458|P4|COMPLETED|Overall Study||65
352890|NCT00504231|854459|P3|COMPLETED|Overall Study||63
352891|NCT00504231|854460|P2|COMPLETED|Overall Study||64
352892|NCT00504231|854461|P1|COMPLETED|Overall Study||65
352893|NCT00504231|854458|P4|STARTED|Overall Study||65
352894|NCT00504231|854459|P3|STARTED|Overall Study||64
352895|NCT00504231|854460|P2|STARTED|Overall Study||64
352896|NCT00504231|854461|P1|STARTED|Overall Study||65
352897|NCT00504166|854481|P2|NOT COMPLETED|Overall Study||14
352898|NCT00504166|854482|P1|NOT COMPLETED|Overall Study||6
352899|NCT00504166|854481|P2|COMPLETED|Overall Study||13
352900|NCT00504166|854482|P1|COMPLETED|Overall Study||20
352901|NCT00504166|854481|P2|STARTED|Overall Study||27
352902|NCT00504166|854482|P1|STARTED|Overall Study||26
352903|NCT00504153|854488|P1|NOT COMPLETED|Overall Study||6
352904|NCT00504153|854488|P1|COMPLETED|Overall Study||13
352905|NCT00504153|854488|P1|STARTED|Overall Study||19
352906|NCT00504075|854496|P1|NOT COMPLETED|Overall Study||8
352907|NCT00504075|854496|P1|COMPLETED|Overall Study||27
352908|NCT00504075|854496|P1|STARTED|Overall Study||35
352909|NCT00504023|854502|P1|NOT COMPLETED|Overall Study||0
352910|NCT00504023|854502|P1|COMPLETED|Overall Study||8
352911|NCT00504023|854502|P1|STARTED|Overall Study||8
352912|NCT00503997|854506|P1|NOT COMPLETED|Overall Study||8
352913|NCT00503997|854506|P1|COMPLETED|Overall Study||34
352914|NCT00503997|854506|P1|STARTED|Overall Study||42
352915|NCT00503984|854512|P6|NOT COMPLETED|Overall Study||0
352916|NCT00503984|854513|P5|NOT COMPLETED|Overall Study||1
352917|NCT00503984|854514|P4|NOT COMPLETED|Overall Study||0
352918|NCT00503984|854515|P3|NOT COMPLETED|Overall Study||0
352919|NCT00503984|854516|P2|NOT COMPLETED|Overall Study||2
352920|NCT00503984|854517|P1|NOT COMPLETED|Overall Study||0
352921|NCT00503984|854512|P6|COMPLETED|Overall Study||1
352922|NCT00503984|854513|P5|COMPLETED|Overall Study||5
352923|NCT00503984|854514|P4|COMPLETED|Overall Study||6
352924|NCT00503984|854515|P3|COMPLETED|Overall Study||3
352925|NCT00503984|854516|P2|COMPLETED|Overall Study||1
352926|NCT00503984|854517|P1|COMPLETED|Overall Study||3
352927|NCT00503984|854512|P6|STARTED|Overall Study||1
352928|NCT00503984|854513|P5|STARTED|Overall Study||6
352929|NCT00503984|854514|P4|STARTED|Overall Study||6
352930|NCT00503984|854515|P3|STARTED|Overall Study||3
352931|NCT00503984|854516|P2|STARTED|Overall Study||3
352932|NCT00503984|854517|P1|STARTED|Overall Study||3
352933|NCT00503906|854543|P1|NOT COMPLETED|Overall Study||1
352934|NCT00503906|854543|P1|COMPLETED|Overall Study||29
352935|NCT00503906|854543|P1|STARTED|Overall Study||30
352936|NCT00503880|854552|P5|NOT COMPLETED|Overall Study||0
352937|NCT00503880|854553|P4|NOT COMPLETED|Overall Study||0
352938|NCT00503880|854554|P3|NOT COMPLETED|Overall Study||0
352939|NCT00503880|854555|P2|NOT COMPLETED|Overall Study||0
352940|NCT00503880|854556|P1|NOT COMPLETED|Overall Study||2
352941|NCT00503880|854552|P5|COMPLETED|Overall Study||0
352942|NCT00503880|854553|P4|COMPLETED|Overall Study||0
352943|NCT00503880|854554|P3|COMPLETED|Overall Study||0
352944|NCT00503880|854555|P2|COMPLETED|Overall Study||0
352945|NCT00503880|854556|P1|COMPLETED|Overall Study||0
352946|NCT00503880|854552|P5|STARTED|Overall Study||0
352947|NCT00503880|854553|P4|STARTED|Overall Study||0
352948|NCT00503880|854554|P3|STARTED|Overall Study||0
352949|NCT00503880|854555|P2|STARTED|Overall Study||0
352950|NCT00503880|854556|P1|STARTED|Overall Study||2
352951|NCT00503841|854565|P1|NOT COMPLETED|Overall Study||44
352952|NCT00503841|854565|P1|COMPLETED|Overall Study||0
352953|NCT00503841|854565|P1|STARTED|Overall Study||44
352954|NCT00503776|854576|P4|NOT COMPLETED|Overall Study||2
352955|NCT00503776|854577|P3|NOT COMPLETED|Overall Study||2
352956|NCT00503776|854578|P2|NOT COMPLETED|Overall Study||0
352957|NCT00503776|854579|P1|NOT COMPLETED|Overall Study||1
352958|NCT00503776|854576|P4|COMPLETED|Overall Study||8
352959|NCT00503776|854577|P3|COMPLETED|Overall Study||10
352960|NCT00503776|854578|P2|COMPLETED|Overall Study||12
352961|NCT00503776|854579|P1|COMPLETED|Overall Study||7
352962|NCT00503776|854576|P4|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|10
352963|NCT00503776|854577|P3|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|12
352964|NCT00503776|854578|P2|STARTED|Overall Study||12
352965|NCT00503776|854579|P1|STARTED|Overall Study||8
352966|NCT00503750|854605|P1|NOT COMPLETED|Overall Study||0
352967|NCT00503750|854605|P1|COMPLETED|Overall Study||27
352968|NCT00503750|854605|P1|STARTED|Overall Study||27
352969|NCT00503698|854612|P2|NOT COMPLETED|Overall Study||355
352970|NCT00503698|854613|P1|NOT COMPLETED|Overall Study||357
352971|NCT00503698|854612|P2|COMPLETED|Overall Study|Trial prematurely terminated|0
352972|NCT00503698|854613|P1|COMPLETED|Overall Study|Trial prematurely terminated|0
352973|NCT00503698|854612|P2|Exposed to Trial Drug|Overall Study|6 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|349
352974|NCT00503698|854613|P1|Exposed to Trial Drug|Overall Study|11 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|346
352975|NCT00503698|854612|P2|STARTED|Overall Study|Randomised|355
352976|NCT00503698|854613|P1|STARTED|Overall Study|Randomised|357
352977|NCT00503685|854630|P3|NOT COMPLETED|Overall Study||2
352978|NCT00503685|854631|P2|NOT COMPLETED|Overall Study||3
352979|NCT00503685|854632|P1|NOT COMPLETED|Overall Study||0
352980|NCT00503685|854630|P3|COMPLETED|Overall Study||18
352981|NCT00503685|854631|P2|COMPLETED|Overall Study||19
352982|NCT00503685|854632|P1|COMPLETED|Overall Study||23
352983|NCT00503685|854630|P3|Received at Least 1 Dose of Study Drug|Overall Study||20
352984|NCT00503685|854631|P2|Received at Least 1 Dose of Study Drug|Overall Study||21
352985|NCT00503685|854632|P1|Received at Least 1 Dose of Study Drug|Overall Study||23
352986|NCT00503685|854630|P3|STARTED|Overall Study||20
352987|NCT00503685|854631|P2|STARTED|Overall Study||22
352988|NCT00503685|854632|P1|STARTED|Overall Study||23
352989|NCT00503425|854674|P1|NOT COMPLETED|Overall Study||54
352990|NCT00503425|854674|P1|COMPLETED|Overall Study||161
352991|NCT00503425|854674|P1|STARTED|Overall Study||215
352992|NCT00503399|854684|P2|NOT COMPLETED|Overall Study||8
352993|NCT00503399|854685|P1|NOT COMPLETED|Overall Study||7
352994|NCT00503399|854684|P2|COMPLETED|Overall Study||39
352995|NCT00503399|854685|P1|COMPLETED|Overall Study||38
352996|NCT00503399|854684|P2|STARTED|Overall Study||47
352997|NCT00503399|854685|P1|STARTED|Overall Study||45
352998|NCT00503308|854709|P2|NOT COMPLETED|Overall Study||1
352999|NCT00503308|854710|P1|NOT COMPLETED|Overall Study||2
353000|NCT00503308|854709|P2|COMPLETED|Overall Study||134
353001|NCT00503308|854710|P1|COMPLETED|Overall Study||144
353002|NCT00503308|854709|P2|STARTED|Overall Study||135
353003|NCT00503308|854710|P1|STARTED|Overall Study||146
353004|NCT00503139|854716|P1|NOT COMPLETED|Overall Study||8
353005|NCT00503139|854716|P1|COMPLETED|Overall Study||676
353006|NCT00503139|854716|P1|STARTED|Overall Study||684
353007|NCT00503113|854730|P3|NOT COMPLETED|Overall Study||28
353008|NCT00503113|854731|P2|NOT COMPLETED|Overall Study||28
353009|NCT00503113|854732|P1|NOT COMPLETED|Overall Study||33
353010|NCT00503113|854730|P3|COMPLETED|Overall Study||241
353011|NCT00503113|854731|P2|COMPLETED|Overall Study||236
353012|NCT00503113|854732|P1|COMPLETED|Overall Study||235
353013|NCT00503113|854730|P3|Safety Population|Overall Study||267
353014|NCT00503113|854731|P2|Safety Population|Overall Study||263
353015|NCT00503113|854732|P1|Safety Population|Overall Study||263
353016|NCT00503113|854730|P3|Per Protocol Population (PP)|Overall Study||241
353017|NCT00503113|854731|P2|Per Protocol Population (PP)|Overall Study||243
353018|NCT00503113|854732|P1|Per Protocol Population (PP)|Overall Study||246
353019|NCT00503113|854730|P3|Intent to Treat Population (ITT)|Overall Study||268
353020|NCT00503113|854731|P2|Intent to Treat Population (ITT)|Overall Study||261
353021|NCT00503113|854732|P1|Intent to Treat Population (ITT)|Overall Study||262
353022|NCT00503113|854730|P3|STARTED|Overall Study||269
353023|NCT00503113|854731|P2|STARTED|Overall Study||264
353024|NCT00503113|854732|P1|STARTED|Overall Study||268
353025|NCT00503009|854764|P3|NOT COMPLETED|Overall Study||3
353026|NCT00503009|854765|P2|NOT COMPLETED|Overall Study||2
353027|NCT00503009|854766|P1|NOT COMPLETED|Overall Study||1
353028|NCT00503009|854764|P3|COMPLETED|Overall Study||3
353029|NCT00503009|854765|P2|COMPLETED|Overall Study||3
353030|NCT00503009|854766|P1|COMPLETED|Overall Study||4
353031|NCT00503009|854764|P3|STARTED|Overall Study||6
353032|NCT00503009|854765|P2|STARTED|Overall Study||5
353033|NCT00503009|854766|P1|STARTED|Overall Study||5
353034|NCT00502996|854783|P1|NOT COMPLETED|Overall Study||44
353035|NCT00502996|854783|P1|COMPLETED|Overall Study||188
353036|NCT00502996|854783|P1|STARTED|Overall Study||232
353037|NCT00502944|854809|P2|NOT COMPLETED|Overall Study||1766
353038|NCT00502944|854810|P1|NOT COMPLETED|Overall Study||1064
353039|NCT00502944|854809|P2|COMPLETED|Overall Study||643
353040|NCT00502944|854810|P1|COMPLETED|Overall Study||1382
353041|NCT00502944|854809|P2|STARTED|Overall Study||2409
353042|NCT00502944|854810|P1|STARTED|Overall Study||2446
353043|NCT00502905|854822|P1|NOT COMPLETED|Overall Study||0
353044|NCT00502905|854822|P1|COMPLETED|Overall Study||196
353045|NCT00502905|854822|P1|STARTED|Overall Study||196
353046|NCT00502853|854826|P1|NOT COMPLETED|Overall Study||0
353047|NCT00502853|854826|P1|COMPLETED|Overall Study||10
353048|NCT00502853|854826|P1|STARTED|Overall Study||10
353049|NCT00502840|854851|P1|NOT COMPLETED|Overall Study||100
353050|NCT00502840|854851|P1|COMPLETED|Overall Study||93
353051|NCT00502840|854851|P1|STARTED|Overall Study||193
353052|NCT00502801|854879|P1|NOT COMPLETED|End of Therapy to Test of Cure||8
353053|NCT00502801|854879|P1|COMPLETED|End of Therapy to Test of Cure||121
353054|NCT00502801|854879|P1|STARTED|End of Therapy to Test of Cure||129
353055|NCT00502801|854879|P1|NOT COMPLETED|Treatment Period||54
353056|NCT00502801|854879|P1|COMPLETED|Treatment Period||129
353057|NCT00502801|854879|P1|STARTED|Treatment Period||183
353058|NCT00502775|854887|P3|NOT COMPLETED|Overall Study||13
353059|NCT00502775|854888|P2|NOT COMPLETED|Overall Study||15
353060|NCT00502775|854889|P1|NOT COMPLETED|Overall Study||10
353061|NCT00502775|854887|P3|COMPLETED|Overall Study||214
353062|NCT00502775|854888|P2|COMPLETED|Overall Study||209
353063|NCT00502775|854889|P1|COMPLETED|Overall Study||219
353064|NCT00502775|854887|P3|STARTED|Overall Study||227
353065|NCT00502775|854888|P2|STARTED|Overall Study||224
353066|NCT00502775|854889|P1|STARTED|Overall Study||229
353067|NCT00502697|854932|P2|NOT COMPLETED|Overall Study||12
353068|NCT00502697|854933|P1|NOT COMPLETED|Overall Study||13
353069|NCT00502697|854932|P2|COMPLETED|Overall Study||102
353070|NCT00502697|854933|P1|COMPLETED|Overall Study||109
353071|NCT00502697|854932|P2|STARTED|Overall Study||114
353072|NCT00502697|854933|P1|STARTED|Overall Study||122
353073|NCT00502671|854941|P1|NOT COMPLETED|Overall Study||77
353074|NCT00502671|854941|P1|COMPLETED|Overall Study||151
353075|NCT00502671|854941|P1|STARTED|Overall Study||228
353076|NCT00502593|854958|P12|NOT COMPLETED|Overall Study||0
353077|NCT00502593|854959|P11|NOT COMPLETED|Overall Study||2
353078|NCT00502593|854960|P10|NOT COMPLETED|Overall Study||0
353079|NCT00502593|854961|P9|NOT COMPLETED|Overall Study||6
353080|NCT00502593|854962|P8|NOT COMPLETED|Overall Study||0
353081|NCT00502593|854963|P7|NOT COMPLETED|Overall Study||5
353082|NCT00502593|854964|P6|NOT COMPLETED|Overall Study||0
353083|NCT00502593|854965|P5|NOT COMPLETED|Overall Study||4
353084|NCT00502593|854966|P4|NOT COMPLETED|Overall Study||4
353085|NCT00502593|854967|P3|NOT COMPLETED|Overall Study||10
353086|NCT00502593|854968|P2|NOT COMPLETED|Overall Study||2
353087|NCT00502593|854969|P1|NOT COMPLETED|Overall Study||3
353088|NCT00502593|854958|P12|COMPLETED|Overall Study||18
353089|NCT00502593|854959|P11|COMPLETED|Overall Study||47
353090|NCT00502593|854960|P10|COMPLETED|Overall Study||17
353091|NCT00502593|854961|P9|COMPLETED|Overall Study||43
353092|NCT00502593|854962|P8|COMPLETED|Overall Study||17
353093|NCT00502593|854963|P7|COMPLETED|Overall Study||44
353094|NCT00502593|854964|P6|COMPLETED|Overall Study||17
353095|NCT00502593|854965|P5|COMPLETED|Overall Study||47
353096|NCT00502593|854966|P4|COMPLETED|Overall Study||14
353097|NCT00502593|854967|P3|COMPLETED|Overall Study||41
353098|NCT00502593|854968|P2|COMPLETED|Overall Study||16
353099|NCT00502593|854969|P1|COMPLETED|Overall Study||48
353100|NCT00502593|854958|P12|STARTED|Overall Study||18
353101|NCT00502593|854959|P11|STARTED|Overall Study||49
353102|NCT00502593|854960|P10|STARTED|Overall Study||17
353103|NCT00502593|854961|P9|STARTED|Overall Study||49
353104|NCT00502593|854962|P8|STARTED|Overall Study||17
353105|NCT00502593|854963|P7|STARTED|Overall Study||49
353106|NCT00502593|854964|P6|STARTED|Overall Study||17
353107|NCT00502593|854965|P5|STARTED|Overall Study||51
353108|NCT00502593|854966|P4|STARTED|Overall Study||18
353109|NCT00502593|854967|P3|STARTED|Overall Study||51
353110|NCT00502593|854968|P2|STARTED|Overall Study||18
353111|NCT00502593|854969|P1|STARTED|Overall Study||51
353112|NCT00502320|855485|P2|NOT COMPLETED|Overall Study||7
353113|NCT00502320|855486|P1|NOT COMPLETED|Overall Study||6
353114|NCT00502320|855485|P2|COMPLETED|Overall Study||18
353115|NCT00502320|855486|P1|COMPLETED|Overall Study||19
353116|NCT00502320|855485|P2|Screening Visit|Overall Study|Participant signed informed consent but was a screen failure because she was nursing at the time.|24
353117|NCT00502320|855486|P1|Screening Visit|Overall Study||25
353118|NCT00502320|855485|P2|STARTED|Overall Study||25
353119|NCT00502320|855486|P1|STARTED|Overall Study||25
353120|NCT00502242|855498|P2|NOT COMPLETED|Overall Study||56
353121|NCT00502242|855499|P1|NOT COMPLETED|Overall Study||51
353122|NCT00502242|855498|P2|COMPLETED|Overall Study||84
353123|NCT00502242|855499|P1|COMPLETED|Overall Study||104
353124|NCT00502242|855498|P2|STARTED|Overall Study||140
353125|NCT00502242|855499|P1|STARTED|Overall Study||155
353126|NCT00502216|855552|P2|NOT COMPLETED|Overall Study||0
353127|NCT00502216|855553|P1|NOT COMPLETED|Overall Study||0
353128|NCT00502216|855552|P2|COMPLETED|Overall Study||19
353129|NCT00502216|855553|P1|COMPLETED|Overall Study||21
353130|NCT00502216|855552|P2|STARTED|Overall Study||19
353131|NCT00502216|855553|P1|STARTED|Overall Study||21
353132|NCT00502203|855563|P1|NOT COMPLETED|Overall Study||1
353133|NCT00502203|855563|P1|COMPLETED|Overall Study||22
353134|NCT00502203|855563|P1|STARTED|Overall Study||23
353135|NCT00501995|855567|P1|NOT COMPLETED|Overall Study||1
353136|NCT00501995|855567|P1|COMPLETED|Overall Study||5
353137|NCT00501995|855567|P1|STARTED|Overall Study||6
353138|NCT00501969|855572|P1|NOT COMPLETED|Overall Study||206
353139|NCT00501969|855572|P1|COMPLETED|Overall Study||189
353140|NCT00501969|855572|P1|STARTED|Overall Study||395
353141|NCT00501943|855580|P2|NOT COMPLETED|Overall Study||3
353142|NCT00501943|855581|P1|NOT COMPLETED|Overall Study||2
353143|NCT00501943|855580|P2|COMPLETED|Overall Study||18
353144|NCT00501943|855581|P1|COMPLETED|Overall Study||20
353145|NCT00501943|855580|P2|STARTED|Overall Study||21
353146|NCT00501943|855581|P1|STARTED|Overall Study||22
353147|NCT00501891|855597|P1|NOT COMPLETED|Overall Study||0
353148|NCT00501891|855597|P1|COMPLETED|Overall Study||32
353149|NCT00501891|855597|P1|STARTED|Overall Study||32
353150|NCT00501852|855604|P1|NOT COMPLETED|Overall Study||5
353151|NCT00501852|855604|P1|COMPLETED|Overall Study||78
353152|NCT00501852|855604|P1|Tiotropium|Overall Study||55
353153|NCT00501852|855604|P1|Placebo|Overall Study||55
353154|NCT00501852|855604|P1|NVA237 100µg|Overall Study||54
353155|NCT00501852|855604|P1|NVA237 50µg|Overall Study||53
353156|NCT00501852|855604|P1|NVA237 25µg|Overall Study||51
353157|NCT00501852|855604|P1|NVA237 12.5µg|Overall Study||55
353158|NCT00501852|855604|P1|STARTED|Overall Study||83
353159|NCT00501644|855624|P1|NOT COMPLETED|Overall Study||5
353160|NCT00501644|855624|P1|COMPLETED|Overall Study||54
353161|NCT00501644|855624|P1|STARTED|Overall Study||59
353162|NCT00501631|855630|P2|NOT COMPLETED|Part B (Open-label Period)||51
353163|NCT00501631|855631|P1|NOT COMPLETED|Part B (Open-label Period)||53
353164|NCT00501631|855630|P2|COMPLETED|Part B (Open-label Period)||48
353165|NCT00501631|855631|P1|COMPLETED|Part B (Open-label Period)||37
353166|NCT00501631|855630|P2|STARTED|Part B (Open-label Period)||99
353167|NCT00501631|855631|P1|STARTED|Part B (Open-label Period)||90
353168|NCT00501631|855630|P2|NOT COMPLETED|Part A (Double-blind Period)||49
353169|NCT00501631|855631|P1|NOT COMPLETED|Part A (Double-blind Period)||62
353170|NCT00501631|855630|P2|COMPLETED|Part A (Double-blind Period)||99
353171|NCT00501631|855631|P1|COMPLETED|Part A (Double-blind Period)||90
353172|NCT00501631|855630|P2|STARTED|Part A (Double-blind Period)||148
353173|NCT00501631|855631|P1|STARTED|Part A (Double-blind Period)||152
353174|NCT00501592|855640|P3|NOT COMPLETED|Overall Study||3
353175|NCT00501592|855641|P2|NOT COMPLETED|Overall Study||5
353176|NCT00501592|855642|P1|NOT COMPLETED|Overall Study||0
353177|NCT00501592|855640|P3|COMPLETED|Overall Study||20
353178|NCT00501592|855641|P2|COMPLETED|Overall Study||16
353179|NCT00501592|855642|P1|COMPLETED|Overall Study||20
353180|NCT00501592|855640|P3|STARTED|Overall Study||23
353181|NCT00501592|855641|P2|STARTED|Overall Study||21
353182|NCT00501592|855642|P1|STARTED|Overall Study||20
353183|NCT00501540|855653|P1|NOT COMPLETED|Overall Study||5
353184|NCT00501540|855653|P1|COMPLETED|Overall Study||10
353185|NCT00501540|855653|P1|STARTED|Overall Study||15
353186|NCT00501345|855659|P1|NOT COMPLETED|Overall Study||0
353187|NCT00501345|855659|P1|COMPLETED|Overall Study||5
353188|NCT00501345|855659|P1|STARTED|Overall Study||5
353189|NCT00501293|855665|P2|NOT COMPLETED|Maintenance Period||28
353190|NCT00501293|855666|P1|NOT COMPLETED|Maintenance Period||46
353191|NCT00501293|855665|P2|COMPLETED|Maintenance Period||25
353192|NCT00501293|855666|P1|COMPLETED|Maintenance Period||63
353193|NCT00501293|855665|P2|STARTED|Maintenance Period||53
353194|NCT00501293|855666|P1|STARTED|Maintenance Period||109
353195|NCT00501293|855665|P2|NOT COMPLETED|Optimization Period||0
353196|NCT00501293|855666|P1|NOT COMPLETED|Optimization Period||1
353197|NCT00501293|855665|P2|COMPLETED|Optimization Period||53
353198|NCT00501293|855666|P1|COMPLETED|Optimization Period||109
353199|NCT00501293|855665|P2|STARTED|Optimization Period||53
353200|NCT00501293|855666|P1|STARTED|Optimization Period||110
353201|NCT00501228|855693|P1|NOT COMPLETED|Overall Study||1
353202|NCT00501228|855693|P1|COMPLETED|Overall Study||1
353203|NCT00501228|855693|P1|STARTED|Overall Study||2
353204|NCT00501085|855697|P1|NOT COMPLETED|Overall Study||432
353205|NCT00501085|855697|P1|COMPLETED|Overall Study|Number of participants completing 5 year follow-up visit.|83
353206|NCT00501085|855697|P1|STARTED|Overall Study|Number of participants who were treated with the LAP-BAND System.|515
353207|NCT00501059|855707|P2|NOT COMPLETED|Overall Study||1892
353208|NCT00501059|855708|P1|NOT COMPLETED|Overall Study||1868
353209|NCT00501059|855707|P2|COMPLETED|Overall Study||4384
353210|NCT00501059|855708|P1|COMPLETED|Overall Study||4402
353211|NCT00501059|855707|P2|STARTED|Overall Study||6276
353212|NCT00501059|855708|P1|STARTED|Overall Study||6270
353213|NCT00501046|855732|P2|NOT COMPLETED|Overall Study||294
353214|NCT00501046|855733|P1|NOT COMPLETED|Overall Study||270
353215|NCT00501046|855732|P2|COMPLETED|Overall Study||213
353216|NCT00501046|855733|P1|COMPLETED|Overall Study||238
353217|NCT00501046|855732|P2|STARTED|Overall Study||507
353218|NCT00501046|855733|P1|STARTED|Overall Study||508
353219|NCT00501007|855739|P2|NOT COMPLETED|Overall Study||25
353220|NCT00501007|855740|P1|NOT COMPLETED|Overall Study||29
353221|NCT00501007|855739|P2|COMPLETED|Overall Study||78
353222|NCT00501007|855740|P1|COMPLETED|Overall Study||71
353223|NCT00501007|855739|P2|STARTED|Overall Study||103
353224|NCT00501007|855740|P1|STARTED|Overall Study||100
353225|NCT00500903|855749|P3|NOT COMPLETED|Overall Study||20
353226|NCT00500903|855750|P2|NOT COMPLETED|Overall Study||2
353227|NCT00500903|855751|P1|NOT COMPLETED|Overall Study||65
353228|NCT00500903|855749|P3|COMPLETED|Overall Study||0
353229|NCT00500903|855750|P2|COMPLETED|Overall Study||0
353230|NCT00500903|855751|P1|COMPLETED|Overall Study||0
353231|NCT00500903|855749|P3|STARTED|Overall Study||20
353232|NCT00500903|855750|P2|STARTED|Overall Study||2
353233|NCT00500903|855751|P1|STARTED|Overall Study||65
353234|NCT00500760|855932|P2|NOT COMPLETED|Overall Study||24
353235|NCT00500760|855933|P1|NOT COMPLETED|Overall Study||43
353236|NCT00500760|855932|P2|COMPLETED|Overall Study||40
353237|NCT00500760|855933|P1|COMPLETED|Overall Study||46
353238|NCT00500760|855932|P2|Received Treatment|Overall Study||63
353239|NCT00500760|855933|P1|Received Treatment|Overall Study||87
353240|NCT00500760|855932|P2|STARTED|Overall Study||64
353241|NCT00500760|855933|P1|STARTED|Overall Study||89
353242|NCT00500682|855953|P2|NOT COMPLETED|Overall Study||287
353243|NCT00500682|855954|P1|NOT COMPLETED|Overall Study||306
353244|NCT00500682|855953|P2|COMPLETED|Overall Study||223
353245|NCT00500682|855954|P1|COMPLETED|Overall Study||204
353246|NCT00500682|855953|P2|STARTED|Overall Study||510
353247|NCT00500682|855954|P1|STARTED|Overall Study||510
353248|NCT00500656|855964|P4|NOT COMPLETED|Open Label Extension (OLE) Phase||2
353249|NCT00500656|855965|P3|NOT COMPLETED|Open Label Extension (OLE) Phase||1
353250|NCT00500656|855966|P2|NOT COMPLETED|Open Label Extension (OLE) Phase||12
353251|NCT00500656|855967|P1|NOT COMPLETED|Open Label Extension (OLE) Phase||7
353252|NCT00500656|855964|P4|COMPLETED|Open Label Extension (OLE) Phase||6
353253|NCT00500656|855965|P3|COMPLETED|Open Label Extension (OLE) Phase||1
353254|NCT00500656|855966|P2|COMPLETED|Open Label Extension (OLE) Phase||9
353255|NCT00500656|855967|P1|COMPLETED|Open Label Extension (OLE) Phase||16
353256|NCT00500656|855964|P4|STARTED|Open Label Extension (OLE) Phase|Subjects did not experience an angioedema attack during the controlled phase|8
353257|NCT00500656|855965|P3|STARTED|Open Label Extension (OLE) Phase||2
353342|NCT00500240|856251|P1|NOT COMPLETED|Overall Study||0
353258|NCT00500656|855966|P2|STARTED|Open Label Extension (OLE) Phase|7 Subjects did not experience an angioedema attack after their first attack in the controlled phase|21
353259|NCT00500656|855967|P1|STARTED|Open Label Extension (OLE) Phase|3 Subjects did not experience an angioedema attack after their first attack in the controlled phase|23
353260|NCT00500656|855964|P4|NOT COMPLETED|Controlled Phase||8
353261|NCT00500656|855965|P3|NOT COMPLETED|Controlled Phase||1
353262|NCT00500656|855966|P2|NOT COMPLETED|Controlled Phase||10
353263|NCT00500656|855967|P1|NOT COMPLETED|Controlled Phase||10
353264|NCT00500656|855964|P4|COMPLETED|Controlled Phase||0
353265|NCT00500656|855965|P3|COMPLETED|Controlled Phase||2
353266|NCT00500656|855966|P2|COMPLETED|Controlled Phase||28
353267|NCT00500656|855967|P1|COMPLETED|Controlled Phase||26
353268|NCT00500656|855964|P4|STARTED|Controlled Phase||8
353269|NCT00500656|855965|P3|STARTED|Controlled Phase||3
353270|NCT00500656|855966|P2|STARTED|Controlled Phase||38
353271|NCT00500656|855967|P1|STARTED|Controlled Phase||36
353272|NCT00500578|855981|P2|NOT COMPLETED|Overall Study||0
353273|NCT00500578|855982|P1|NOT COMPLETED|Overall Study||0
353274|NCT00500578|855981|P2|COMPLETED|Overall Study|All completed|32
353275|NCT00500578|855982|P1|COMPLETED|Overall Study|All completed|18
353276|NCT00500578|855981|P2|STARTED|Overall Study||32
353277|NCT00500578|855982|P1|STARTED|Overall Study||18
353278|NCT00500539|855988|P1|NOT COMPLETED|Follow-up Period (16 Weeks)||12
353279|NCT00500539|855988|P1|COMPLETED|Follow-up Period (16 Weeks)||136
353280|NCT00500539|855988|P1|STARTED|Follow-up Period (16 Weeks)|Participants could discontinue study drug and still enter the follow-up period.|148
353281|NCT00500539|855988|P1|NOT COMPLETED|Treatment Period (24 Weeks)||15
353282|NCT00500539|855988|P1|COMPLETED|Treatment Period (24 Weeks)||140
353283|NCT00500539|855988|P1|STARTED|Treatment Period (24 Weeks)||155
353284|NCT00500448|855997|P2|NOT COMPLETED|Overall Study||0
353285|NCT00500448|855998|P1|NOT COMPLETED|Overall Study||0
353286|NCT00500448|855997|P2|COMPLETED|Overall Study||16
353287|NCT00500448|855998|P1|COMPLETED|Overall Study||14
353288|NCT00500448|855997|P2|STARTED|Overall Study||16
353289|NCT00500448|855998|P1|STARTED|Overall Study||14
353290|NCT00500370|856014|P2|NOT COMPLETED|Overall Study||34
353291|NCT00500370|856015|P1|NOT COMPLETED|Overall Study||33
353292|NCT00500370|856014|P2|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|49
353293|NCT00500370|856015|P1|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|47
353294|NCT00500370|856014|P2|Treatment Complete (Week 24)|Overall Study||54
353295|NCT00500370|856015|P1|Treatment Complete (Week 24)|Overall Study||48
353296|NCT00500370|856014|P2|Treatment Start-Baseline (Week 0)|Overall Study||79
353297|NCT00500370|856015|P1|Treatment Start-Baseline (Week 0)|Overall Study||73
353298|NCT00500370|856014|P2|STARTED|Overall Study||83
353299|NCT00500370|856015|P1|STARTED|Overall Study||80
353300|NCT00500357|856051|P1|NOT COMPLETED|Overall Study||1
353301|NCT00500357|856051|P1|COMPLETED|Overall Study||104
353302|NCT00500357|856051|P1|Evaluable Immunogenicity Population|Overall Study|Administered Vax 1 and Vax 2 in study 6115A1-500; Vax 3 and at least 1 assay result in 6115A1-3009.|98
353303|NCT00500357|856051|P1|Received 13vPnC (Vax 3)|Overall Study||105
353304|NCT00500357|856051|P1|STARTED|Overall Study||105
353305|NCT00500331|856077|P7|NOT COMPLETED|Overall Study||2
353306|NCT00500331|856078|P6|NOT COMPLETED|Overall Study||5
353307|NCT00500331|856079|P5|NOT COMPLETED|Overall Study||4
353308|NCT00500331|856080|P4|NOT COMPLETED|Overall Study||10
353309|NCT00500331|856081|P3|NOT COMPLETED|Overall Study||5
353310|NCT00500331|856082|P2|NOT COMPLETED|Overall Study||5
353311|NCT00500331|856083|P1|NOT COMPLETED|Overall Study||15
353312|NCT00500331|856077|P7|COMPLETED|Overall Study||46
353313|NCT00500331|856078|P6|COMPLETED|Overall Study||42
353314|NCT00500331|856079|P5|COMPLETED|Overall Study||44
353315|NCT00500331|856080|P4|COMPLETED|Overall Study||38
353316|NCT00500331|856081|P3|COMPLETED|Overall Study||43
353317|NCT00500331|856082|P2|COMPLETED|Overall Study||42
353318|NCT00500331|856083|P1|COMPLETED|Overall Study||33
353319|NCT00500331|856077|P7|STARTED|Overall Study||48
353320|NCT00500331|856078|P6|STARTED|Overall Study||47
353321|NCT00500331|856079|P5|STARTED|Overall Study||48
353322|NCT00500331|856080|P4|STARTED|Overall Study||48
353323|NCT00500331|856081|P3|STARTED|Overall Study||48
353324|NCT00500331|856082|P2|STARTED|Overall Study||47
353325|NCT00500331|856083|P1|STARTED|Overall Study||48
353326|NCT00500318|856220|P2|NOT COMPLETED|Overall Study||17
353327|NCT00500318|856221|P1|NOT COMPLETED|Overall Study||5
353328|NCT00500318|856220|P2|COMPLETED|Overall Study||78
353329|NCT00500318|856221|P1|COMPLETED|Overall Study||81
353330|NCT00500318|856220|P2|STARTED|Overall Study||95
353331|NCT00500318|856221|P1|STARTED|Overall Study||86
353332|NCT00500292|856238|P3|NOT COMPLETED|Overall Study||27
353333|NCT00500292|856239|P2|NOT COMPLETED|Overall Study||31
353334|NCT00500292|856240|P1|NOT COMPLETED|Overall Study||25
353335|NCT00500292|856238|P3|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|10
353336|NCT00500292|856239|P2|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|4
353337|NCT00500292|856240|P1|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|7
353338|NCT00500292|856238|P3|STARTED|Overall Study|randomised patients|37
353339|NCT00500292|856239|P2|STARTED|Overall Study|randomised patients|35
353340|NCT00500292|856240|P1|STARTED|Overall Study|randomised patients|32
353341|NCT00500240|856250|P2|NOT COMPLETED|Overall Study||0
353343|NCT00500240|856250|P2|COMPLETED|Overall Study||26
353344|NCT00500240|856251|P1|COMPLETED|Overall Study||25
353345|NCT00500240|856250|P2|STARTED|Overall Study||26
353346|NCT00500240|856251|P1|STARTED|Overall Study||25
353347|NCT00500149|856261|P2|NOT COMPLETED|Second Intervention (Cross-over Phase)||0
353348|NCT00500149|856262|P1|NOT COMPLETED|Second Intervention (Cross-over Phase)||2
353349|NCT00500149|856261|P2|COMPLETED|Second Intervention (Cross-over Phase)||57
353350|NCT00500149|856262|P1|COMPLETED|Second Intervention (Cross-over Phase)||54
353351|NCT00500149|856261|P2|STARTED|Second Intervention (Cross-over Phase)||57
353352|NCT00500149|856262|P1|STARTED|Second Intervention (Cross-over Phase)||56
353353|NCT00500149|856261|P2|NOT COMPLETED|First Intervention (Cross-over Phase)||2
353354|NCT00500149|856262|P1|NOT COMPLETED|First Intervention (Cross-over Phase)||2
353355|NCT00500149|856261|P2|COMPLETED|First Intervention (Cross-over Phase)||57
353356|NCT00500149|856262|P1|COMPLETED|First Intervention (Cross-over Phase)||56
353357|NCT00500149|856261|P2|STARTED|First Intervention (Cross-over Phase)||59
353358|NCT00500149|856262|P1|STARTED|First Intervention (Cross-over Phase)||58
353359|NCT00500149|856261|P2|NOT COMPLETED|Enrolled (Dose-optimization Phase)||0
353360|NCT00500149|856262|P1|NOT COMPLETED|Enrolled (Dose-optimization Phase)||12
353361|NCT00500149|856261|P2|COMPLETED|Enrolled (Dose-optimization Phase)||0
353362|NCT00500149|856262|P1|COMPLETED|Enrolled (Dose-optimization Phase)||117
353363|NCT00500149|856261|P2|STARTED|Enrolled (Dose-optimization Phase)||0
353364|NCT00500149|856262|P1|STARTED|Enrolled (Dose-optimization Phase)||129
353365|NCT00500110|856270|P1|NOT COMPLETED|Overall Study||3
353366|NCT00500110|856270|P1|COMPLETED|Overall Study||36
353367|NCT00500110|856270|P1|STARTED|Overall Study||39
353368|NCT00500071|856274|P1|NOT COMPLETED|30-day Safety Follow-up||17
353369|NCT00500071|856274|P1|COMPLETED|30-day Safety Follow-up||278
353370|NCT00500071|856274|P1|STARTED|30-day Safety Follow-up||295
353371|NCT00500071|856274|P1|NOT COMPLETED|Dose-optimization and Maintenance Phase||22
353372|NCT00500071|856274|P1|COMPLETED|Dose-optimization and Maintenance Phase||295
353373|NCT00500071|856274|P1|STARTED|Dose-optimization and Maintenance Phase|Safety population (i.e., received at least one dose of study medication)|317
353374|NCT00500071|856274|P1|NOT COMPLETED|Screening and Washout Phase||1
353375|NCT00500071|856274|P1|COMPLETED|Screening and Washout Phase||317
353376|NCT00500071|856274|P1|STARTED|Screening and Washout Phase||318
353377|NCT00500045|856283|P1|NOT COMPLETED|Overall Study||0
353378|NCT00500045|856283|P1|COMPLETED|Overall Study||0
353379|NCT00500045|856283|P1|STARTED|Overall Study||0
353380|NCT00499915|856290|P2|NOT COMPLETED|Overall Study||6
353381|NCT00499915|856291|P1|NOT COMPLETED|Overall Study||15
353382|NCT00499915|856290|P2|COMPLETED|Overall Study||76
353383|NCT00499915|856291|P1|COMPLETED|Overall Study||68
353384|NCT00499915|856290|P2|STARTED|Overall Study||82
353385|NCT00499915|856291|P1|STARTED|Overall Study||83
353386|NCT00499889|856297|P1|NOT COMPLETED|Overall Study||1
353387|NCT00499889|856297|P1|COMPLETED|Overall Study||41
353388|NCT00499889|856297|P1|STARTED|Overall Study||42
353389|NCT00499863|856305|P2|NOT COMPLETED|Overall Study||43
353390|NCT00499863|856306|P1|NOT COMPLETED|Overall Study||50
353391|NCT00499863|856305|P2|COMPLETED|Overall Study||29
353392|NCT00499863|856306|P1|COMPLETED|Overall Study||95
353393|NCT00499863|856305|P2|STARTED|Overall Study||72
353394|NCT00499863|856306|P1|STARTED|Overall Study||145
353395|NCT00500266|856334|P1|NOT COMPLETED|Overall Study||13
353396|NCT00500266|856334|P1|COMPLETED|Overall Study||1040
353397|NCT00500266|856334|P1|Treated|Overall Study||1049
353398|NCT00500266|856334|P1|STARTED|Overall Study||1053
353399|NCT00499746|856341|P1|NOT COMPLETED|Phase 3 (9-14 One Day Sessions)||0
353400|NCT00499746|856341|P1|COMPLETED|Phase 3 (9-14 One Day Sessions)||8
353401|NCT00499746|856341|P1|STARTED|Phase 3 (9-14 One Day Sessions)||8
353402|NCT00499746|856341|P1|NOT COMPLETED|Phase 2 (6-9 One Day Sessions)||0
353403|NCT00499746|856341|P1|COMPLETED|Phase 2 (6-9 One Day Sessions)||8
353404|NCT00499746|856341|P1|STARTED|Phase 2 (6-9 One Day Sessions)||8
353405|NCT00499746|856341|P1|NOT COMPLETED|Phase 1(6-9 One Day Sessions)||12
353406|NCT00499746|856341|P1|COMPLETED|Phase 1(6-9 One Day Sessions)||8
353407|NCT00499746|856341|P1|STARTED|Phase 1(6-9 One Day Sessions)||20
353408|NCT00499694|856410|P1|NOT COMPLETED|Overall Study||1
353409|NCT00499694|856410|P1|COMPLETED|Overall Study||30
353410|NCT00499694|856410|P1|STARTED|Overall Study||31
353411|NCT00499681|856419|P2|NOT COMPLETED|Overall Study||2
353412|NCT00499681|856420|P1|NOT COMPLETED|Overall Study||0
353413|NCT00499681|856419|P2|COMPLETED|Overall Study||0
353414|NCT00499681|856420|P1|COMPLETED|Overall Study||4
353415|NCT00499681|856419|P2|STARTED|Overall Study||2
353416|NCT00499681|856420|P1|STARTED|Overall Study||4
353417|NCT00499655|856428|P2|NOT COMPLETED|Overall Study||0
353418|NCT00499655|856429|P1|NOT COMPLETED|Overall Study||0
353419|NCT00499655|856428|P2|COMPLETED|Overall Study||54
353420|NCT00499655|856429|P1|COMPLETED|Overall Study||53
353421|NCT00499655|856428|P2|STARTED|Overall Study||54
353422|NCT00499655|856429|P1|STARTED|Overall Study||53
353423|NCT00499616|856447|P4|NOT COMPLETED|Overall Study||57
353424|NCT00499616|856448|P3|NOT COMPLETED|Overall Study||36
353425|NCT00499616|856449|P2|NOT COMPLETED|Overall Study||28
353426|NCT00499616|856450|P1|NOT COMPLETED|Overall Study||15
353427|NCT00499616|856447|P4|COMPLETED|Overall Study||0
353428|NCT00499616|856448|P3|COMPLETED|Overall Study||53
353429|NCT00499616|856449|P2|COMPLETED|Overall Study||114
353430|NCT00499616|856450|P1|COMPLETED|Overall Study||161
353431|NCT00499616|856447|P4|STARTED|Overall Study||57
353432|NCT00499616|856448|P3|STARTED|Overall Study||89
353433|NCT00499616|856449|P2|STARTED|Overall Study||142
353434|NCT00499616|856450|P1|STARTED|Overall Study||176
353435|NCT00499603|856495|P2|NOT COMPLETED|Overall Study||1
353436|NCT00499603|856496|P1|NOT COMPLETED|Overall Study||0
353437|NCT00499603|856495|P2|COMPLETED|Overall Study||22
353438|NCT00499603|856496|P1|COMPLETED|Overall Study||27
353439|NCT00499603|856495|P2|STARTED|Overall Study||23
353440|NCT00499603|856496|P1|STARTED|Overall Study||27
353441|NCT00499590|856509|P3|NOT COMPLETED|Overall Study||113
353442|NCT00499590|856510|P2|NOT COMPLETED|Overall Study||112
353443|NCT00499590|856511|P1|NOT COMPLETED|Overall Study||113
353444|NCT00499590|856509|P3|COMPLETED|Overall Study||0
353445|NCT00499590|856510|P2|COMPLETED|Overall Study||0
353446|NCT00499590|856511|P1|COMPLETED|Overall Study||0
353447|NCT00499590|856509|P3|STARTED|Overall Study||113
353448|NCT00499590|856510|P2|STARTED|Overall Study||112
353449|NCT00499590|856511|P1|STARTED|Overall Study||113
353450|NCT00499486|856522|P1|NOT COMPLETED|Overall Study||16
353451|NCT00499486|856522|P1|COMPLETED|Overall Study||31
353452|NCT00499486|856522|P1|STARTED|Overall Study||47
353453|NCT00499473|856530|P2|NOT COMPLETED|Overall Study||0
353454|NCT00499473|856531|P1|NOT COMPLETED|Overall Study||6
353455|NCT00499473|856530|P2|COMPLETED|Overall Study||4
353456|NCT00499473|856531|P1|COMPLETED|Overall Study|Patients evaluable|21
353457|NCT00499473|856530|P2|STARTED|Overall Study||4
353458|NCT00499473|856531|P1|STARTED|Overall Study||27
353459|NCT00499460|856549|P2|NOT COMPLETED|Intervention 2 (30 Days)||1
353460|NCT00499460|856550|P1|NOT COMPLETED|Intervention 2 (30 Days)||0
353461|NCT00499460|856549|P2|COMPLETED|Intervention 2 (30 Days)||6
353462|NCT00499460|856550|P1|COMPLETED|Intervention 2 (30 Days)||6
353463|NCT00499460|856549|P2|STARTED|Intervention 2 (30 Days)||7
353464|NCT00499460|856550|P1|STARTED|Intervention 2 (30 Days)||6
353465|NCT00499460|856549|P2|NOT COMPLETED|Intervention 1 (30 Days)||0
353466|NCT00499460|856550|P1|NOT COMPLETED|Intervention 1 (30 Days)||2
353467|NCT00499460|856549|P2|COMPLETED|Intervention 1 (30 Days)||7
353468|NCT00499460|856550|P1|COMPLETED|Intervention 1 (30 Days)||6
353469|NCT00499460|856549|P2|STARTED|Intervention 1 (30 Days)||7
353470|NCT00499460|856550|P1|STARTED|Intervention 1 (30 Days)||8
353471|NCT00499447|856566|P1|NOT COMPLETED|Overall Study||0
353472|NCT00499447|856566|P1|COMPLETED|Overall Study||13
353473|NCT00499447|856566|P1|STARTED|Overall Study||13
353474|NCT00499408|856570|P1|NOT COMPLETED|Overall Study||0
353475|NCT00499408|856570|P1|COMPLETED|Overall Study|Three patients did not have adequate testing to be evaluable for a response.|26
353476|NCT00499408|856570|P1|STARTED|Overall Study||26
353477|NCT00499369|856583|P5|NOT COMPLETED|Overall Study||12
353478|NCT00499369|856584|P4|NOT COMPLETED|Overall Study||9
353479|NCT00499369|856585|P3|NOT COMPLETED|Overall Study||17
353480|NCT00499369|856586|P2|NOT COMPLETED|Overall Study||18
353481|NCT00499369|856587|P1|NOT COMPLETED|Overall Study||16
353482|NCT00499369|856583|P5|COMPLETED|Overall Study||0
353483|NCT00499369|856584|P4|COMPLETED|Overall Study||0
353484|NCT00499369|856585|P3|COMPLETED|Overall Study||0
353485|NCT00499369|856586|P2|COMPLETED|Overall Study||0
353486|NCT00499369|856587|P1|COMPLETED|Overall Study||0
353487|NCT00499369|856583|P5|Eligible|Overall Study||12
353488|NCT00499369|856584|P4|Eligible|Overall Study||8
353489|NCT00499369|856585|P3|Eligible|Overall Study||16
353490|NCT00499369|856586|P2|Eligible|Overall Study||16
353491|NCT00499369|856587|P1|Eligible|Overall Study||14
353492|NCT00499369|856583|P5|STARTED|Overall Study||12
353493|NCT00499369|856584|P4|STARTED|Overall Study||9
353494|NCT00499369|856585|P3|STARTED|Overall Study||17
353495|NCT00499369|856586|P2|STARTED|Overall Study||18
353496|NCT00499369|856587|P1|STARTED|Overall Study||16
353497|NCT00499343|856616|P2|NOT COMPLETED|Overall Study||0
353498|NCT00499343|856617|P1|NOT COMPLETED|Overall Study||0
353499|NCT00499343|856616|P2|COMPLETED|Overall Study||43
353500|NCT00499343|856617|P1|COMPLETED|Overall Study||41
353501|NCT00499343|856616|P2|STARTED|Overall Study||43
353502|NCT00499343|856617|P1|STARTED|Overall Study||41
353503|NCT00499252|856623|P1|NOT COMPLETED|Overall Study||12
353504|NCT00499252|856623|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|39
353505|NCT00499252|856623|P1|STARTED|Overall Study||51
353506|NCT00499122|856633|P1|NOT COMPLETED|Overall Study||2
353507|NCT00499122|856633|P1|COMPLETED|Overall Study||39
353508|NCT00499122|856633|P1|STARTED|Overall Study||41
353509|NCT00499109|856641|P2|NOT COMPLETED|Overall Study||7
353510|NCT00499109|856642|P1|NOT COMPLETED|Overall Study||18
353511|NCT00499109|856641|P2|COMPLETED|Overall Study||85
353512|NCT00499109|856642|P1|COMPLETED|Overall Study||165
353513|NCT00499109|856641|P2|STARTED|Overall Study||92
353514|NCT00499109|856642|P1|STARTED|Overall Study||183
353515|NCT00499096|856657|P2|NOT COMPLETED|Overall Study||20
353516|NCT00499096|856658|P1|NOT COMPLETED|Overall Study||23
353517|NCT00499096|856657|P2|COMPLETED|Overall Study||40
353518|NCT00499096|856658|P1|COMPLETED|Overall Study||35
353519|NCT00499096|856657|P2|STARTED|Overall Study||60
353520|NCT00499096|856658|P1|STARTED|Overall Study||58
353521|NCT00499083|856676|P1|NOT COMPLETED|Overall Study||3
353522|NCT00499083|856676|P1|COMPLETED|Overall Study||14
353523|NCT00499083|856676|P1|Participants at Moffitt Cancer Center|Overall Study||14
353524|NCT00499083|856676|P1|Participants at UNMC|Overall Study||3
353525|NCT00499083|856676|P1|STARTED|Overall Study||17
353526|NCT00499031|856683|P1|NOT COMPLETED|Overall Study||3
353527|NCT00499031|856683|P1|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|35
353528|NCT00499031|856683|P1|STARTED|Overall Study|Total number participants enrolled on study|38
353529|NCT00498940|856690|P2|NOT COMPLETED|Overall Study||0
353530|NCT00498940|856691|P1|NOT COMPLETED|Overall Study||0
353531|NCT00498940|856690|P2|COMPLETED|Overall Study||31
353532|NCT00498940|856691|P1|COMPLETED|Overall Study||30
353533|NCT00498940|856690|P2|STARTED|Overall Study||31
353534|NCT00498940|856691|P1|STARTED|Overall Study||30
353535|NCT00498927|856699|P1|NOT COMPLETED|Overall Study||0
353536|NCT00498927|856699|P1|COMPLETED|Overall Study||47
353537|NCT00498927|856699|P1|STARTED|Overall Study||47
353538|NCT00498797|856706|P2|NOT COMPLETED|Overall Study||29
353539|NCT00498797|856707|P1|NOT COMPLETED|Overall Study||38
353540|NCT00498797|856706|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
353541|NCT00498797|856707|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
353542|NCT00498797|856706|P2|STARTED|Overall Study|randomised patients|43
353543|NCT00498797|856707|P1|STARTED|Overall Study|randomised patients|43
353544|NCT00498706|856717|P2|NOT COMPLETED|Overall Study||0
353545|NCT00498706|856718|P1|NOT COMPLETED|Overall Study||0
353546|NCT00498706|856717|P2|COMPLETED|Overall Study||162
353547|NCT00498706|856718|P1|COMPLETED|Overall Study||163
353548|NCT00498706|856717|P2|Post Treatment Week 18|Overall Study||162
353549|NCT00498706|856718|P1|Post Treatment Week 18|Overall Study||163
353550|NCT00498706|856717|P2|STARTED|Overall Study||162
353551|NCT00498706|856718|P1|STARTED|Overall Study||163
353552|NCT00498628|856732|P2|NOT COMPLETED|Overall Study||21
353553|NCT00498628|856733|P1|NOT COMPLETED|Overall Study||15
353554|NCT00498628|856732|P2|COMPLETED|Overall Study||92
353555|NCT00498628|856733|P1|COMPLETED|Overall Study||90
353556|NCT00498628|856732|P2|STARTED|Overall Study||113
353557|NCT00498628|856733|P1|STARTED|Overall Study||105
353558|NCT00498615|856765|P6|NOT COMPLETED|Placebo||0
353559|NCT00498615|856766|P5|NOT COMPLETED|Placebo||0
353560|NCT00498615|856767|P4|NOT COMPLETED|Placebo||0
353561|NCT00498615|856768|P3|NOT COMPLETED|Placebo||0
353562|NCT00498615|856769|P2|NOT COMPLETED|Placebo||0
353563|NCT00498615|856770|P1|NOT COMPLETED|Placebo||0
353564|NCT00498615|856765|P6|COMPLETED|Placebo||3
353565|NCT00498615|856766|P5|COMPLETED|Placebo||3
353566|NCT00498615|856767|P4|COMPLETED|Placebo||2
353567|NCT00498615|856768|P3|COMPLETED|Placebo||3
353568|NCT00498615|856769|P2|COMPLETED|Placebo||4
353569|NCT00498615|856770|P1|COMPLETED|Placebo||2
353570|NCT00498615|856765|P6|STARTED|Placebo||3
353571|NCT00498615|856766|P5|STARTED|Placebo||3
353572|NCT00498615|856767|P4|STARTED|Placebo||2
353573|NCT00498615|856768|P3|STARTED|Placebo||3
353574|NCT00498615|856769|P2|STARTED|Placebo||4
353575|NCT00498615|856770|P1|STARTED|Placebo||2
353576|NCT00498615|856765|P6|NOT COMPLETED|Fasudil 40mg||0
353577|NCT00498615|856766|P5|NOT COMPLETED|Fasudil 40mg||0
353578|NCT00498615|856767|P4|NOT COMPLETED|Fasudil 40mg||0
353579|NCT00498615|856768|P3|NOT COMPLETED|Fasudil 40mg||0
353580|NCT00498615|856769|P2|NOT COMPLETED|Fasudil 40mg||0
353581|NCT00498615|856770|P1|NOT COMPLETED|Fasudil 40mg||0
353582|NCT00498615|856765|P6|COMPLETED|Fasudil 40mg||3
353583|NCT00498615|856766|P5|COMPLETED|Fasudil 40mg||3
353584|NCT00498615|856767|P4|COMPLETED|Fasudil 40mg||2
353585|NCT00498615|856768|P3|COMPLETED|Fasudil 40mg||3
353586|NCT00498615|856769|P2|COMPLETED|Fasudil 40mg||4
353587|NCT00498615|856770|P1|COMPLETED|Fasudil 40mg||2
353588|NCT00498615|856765|P6|STARTED|Fasudil 40mg||3
353589|NCT00498615|856766|P5|STARTED|Fasudil 40mg||3
353590|NCT00498615|856767|P4|STARTED|Fasudil 40mg||2
353591|NCT00498615|856768|P3|STARTED|Fasudil 40mg||3
353592|NCT00498615|856769|P2|STARTED|Fasudil 40mg||4
353593|NCT00498615|856770|P1|STARTED|Fasudil 40mg||2
353594|NCT00498615|856765|P6|NOT COMPLETED|Fasudil 80mg||0
353595|NCT00498615|856766|P5|NOT COMPLETED|Fasudil 80mg||0
353596|NCT00498615|856767|P4|NOT COMPLETED|Fasudil 80mg||0
353597|NCT00498615|856768|P3|NOT COMPLETED|Fasudil 80mg||0
353598|NCT00498615|856769|P2|NOT COMPLETED|Fasudil 80mg||0
353599|NCT00498615|856770|P1|NOT COMPLETED|Fasudil 80mg||0
353600|NCT00498615|856765|P6|COMPLETED|Fasudil 80mg||3
353601|NCT00498615|856766|P5|COMPLETED|Fasudil 80mg||3
353602|NCT00498615|856767|P4|COMPLETED|Fasudil 80mg||2
353603|NCT00498615|856768|P3|COMPLETED|Fasudil 80mg||3
353604|NCT00498615|856769|P2|COMPLETED|Fasudil 80mg||4
353605|NCT00498615|856770|P1|COMPLETED|Fasudil 80mg||2
353606|NCT00498615|856765|P6|STARTED|Fasudil 80mg||3
353607|NCT00498615|856766|P5|STARTED|Fasudil 80mg||3
353608|NCT00498615|856767|P4|STARTED|Fasudil 80mg||2
353609|NCT00498615|856768|P3|STARTED|Fasudil 80mg||3
353610|NCT00498615|856769|P2|STARTED|Fasudil 80mg||4
353611|NCT00498615|856770|P1|STARTED|Fasudil 80mg||2
353612|NCT00498602|856791|P7|NOT COMPLETED|Overall Study||2
353613|NCT00498602|856792|P6|NOT COMPLETED|Overall Study||13
353614|NCT00498602|856793|P5|NOT COMPLETED|Overall Study||4
353615|NCT00498602|856794|P4|NOT COMPLETED|Overall Study||5
353616|NCT00498602|856795|P3|NOT COMPLETED|Overall Study||8
353617|NCT00498602|856796|P2|NOT COMPLETED|Overall Study||10
353618|NCT00498602|856797|P1|NOT COMPLETED|Overall Study||10
353619|NCT00498602|856791|P7|COMPLETED|Overall Study||15
353620|NCT00498602|856792|P6|COMPLETED|Overall Study||31
353621|NCT00498602|856793|P5|COMPLETED|Overall Study||8
353622|NCT00498602|856794|P4|COMPLETED|Overall Study||30
353623|NCT00498602|856795|P3|COMPLETED|Overall Study||32
353624|NCT00498602|856796|P2|COMPLETED|Overall Study||51
353625|NCT00498602|856797|P1|COMPLETED|Overall Study||26
353626|NCT00498602|856791|P7|Treated|Overall Study||17
353627|NCT00498602|856792|P6|Treated|Overall Study||44
353628|NCT00498602|856793|P5|Treated|Overall Study||12
353629|NCT00498602|856794|P4|Treated|Overall Study||35
353630|NCT00498602|856795|P3|Treated|Overall Study||40
353631|NCT00498602|856796|P2|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
353632|NCT00498602|856797|P1|Treated|Overall Study||36
353633|NCT00498602|856791|P7|STARTED|Overall Study||17
353634|NCT00498602|856792|P6|STARTED|Overall Study||44
353635|NCT00498602|856793|P5|STARTED|Overall Study||12
353636|NCT00498602|856794|P4|STARTED|Overall Study||35
353637|NCT00498602|856795|P3|STARTED|Overall Study||40
353638|NCT00498602|856796|P2|STARTED|Overall Study||61
353639|NCT00498602|856797|P1|STARTED|Overall Study||36
353640|NCT00498550|856836|P2|NOT COMPLETED|Overall Study||1
353641|NCT00498550|856837|P1|NOT COMPLETED|Overall Study||0
353642|NCT00498550|856836|P2|COMPLETED|Overall Study||15
353643|NCT00498550|856837|P1|COMPLETED|Overall Study|13 of 15 received clozapine all 12 visits, two discontinued clozapine early but remained in study.|15
353644|NCT00498550|856836|P2|STARTED|Overall Study||16
353645|NCT00498550|856837|P1|STARTED|Overall Study||15
353646|NCT00498485|856845|P2|NOT COMPLETED|Overall Study||5
353647|NCT00498485|856846|P1|NOT COMPLETED|Overall Study||1
353648|NCT00498485|856845|P2|COMPLETED|Overall Study||5
353649|NCT00498485|856846|P1|COMPLETED|Overall Study||6
353650|NCT00498485|856845|P2|STARTED|Overall Study||10
353651|NCT00498485|856846|P1|STARTED|Overall Study||7
353652|NCT00498433|856857|P3|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
353653|NCT00498433|856858|P2|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
353654|NCT00498433|856859|P1|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
353655|NCT00498433|856857|P3|COMPLETED|Part 2: Double Blind (12 Weeks)||8
353656|NCT00498433|856858|P2|COMPLETED|Part 2: Double Blind (12 Weeks)||8
353657|NCT00498433|856859|P1|COMPLETED|Part 2: Double Blind (12 Weeks)||0
353658|NCT00498433|856857|P3|STARTED|Part 2: Double Blind (12 Weeks)||8
353659|NCT00498433|856858|P2|STARTED|Part 2: Double Blind (12 Weeks)||8
353660|NCT00498433|856859|P1|STARTED|Part 2: Double Blind (12 Weeks)||0
353661|NCT00498433|856857|P3|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
353662|NCT00498433|856858|P2|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
353663|NCT00498433|856859|P1|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||20
353664|NCT00498433|856857|P3|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
353665|NCT00498433|856858|P2|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
353666|NCT00498433|856859|P1|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||16
353667|NCT00498433|856857|P3|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
353668|NCT00498433|856858|P2|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
353669|NCT00498433|856859|P1|STARTED|Part 2: Placebo Run-in (2 Weeks)||36
353670|NCT00498433|856857|P3|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
353671|NCT00498433|856858|P2|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
353672|NCT00498433|856859|P1|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
353673|NCT00498433|856857|P3|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
353674|NCT00498433|856858|P2|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
353675|NCT00498433|856859|P1|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
353676|NCT00498433|856857|P3|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
353677|NCT00498433|856858|P2|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
353678|NCT00498433|856859|P1|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
353679|NCT00498433|856857|P3|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
353680|NCT00498433|856858|P2|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
353681|NCT00498433|856859|P1|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
353682|NCT00498433|856857|P3|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
353683|NCT00498433|856858|P2|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||10
353684|NCT00498433|856859|P1|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
353685|NCT00498433|856857|P3|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
353686|NCT00498433|856858|P2|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||10
353687|NCT00498433|856859|P1|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
353688|NCT00498433|856857|P3|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
353689|NCT00498433|856858|P2|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
353690|NCT00498433|856859|P1|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
353691|NCT00498433|856857|P3|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
353692|NCT00498433|856858|P2|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
353693|NCT00498433|856859|P1|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
353694|NCT00498433|856857|P3|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
353695|NCT00498433|856858|P2|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
353696|NCT00498433|856859|P1|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
353697|NCT00498368|856904|P2|NOT COMPLETED|Overall Study||2
353698|NCT00498368|856905|P1|NOT COMPLETED|Overall Study||3
353699|NCT00498368|856904|P2|COMPLETED|Overall Study||15
353700|NCT00498368|856905|P1|COMPLETED|Overall Study||14
353701|NCT00498368|856904|P2|STARTED|Overall Study||17
353702|NCT00498368|856905|P1|STARTED|Overall Study||17
353703|NCT00498355|856917|P1|NOT COMPLETED|Overall Study||1
353704|NCT00498355|856917|P1|COMPLETED|Overall Study||6
353705|NCT00498355|856917|P1|STARTED|Overall Study||7
353706|NCT00498186|856925|P1|NOT COMPLETED|Overall Study||173
353707|NCT00498186|856925|P1|COMPLETED|Overall Study||122
353708|NCT00498186|856925|P1|STARTED|Overall Study||295
353709|NCT00498173|856932|P3|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
353710|NCT00498173|856933|P2|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
353711|NCT00498173|856934|P1|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
353712|NCT00498173|856932|P3|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
353713|NCT00498173|856933|P2|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
353714|NCT00498173|856934|P1|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
353715|NCT00498173|856932|P3|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
353716|NCT00498173|856933|P2|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
353717|NCT00498173|856934|P1|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
353718|NCT00498173|856932|P3|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
353719|NCT00498173|856933|P2|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||1
353720|NCT00498173|856934|P1|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||2
353721|NCT00498173|856932|P3|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
353722|NCT00498173|856933|P2|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||30
353723|NCT00498173|856934|P1|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||27
353724|NCT00498173|856932|P3|STARTED|Phase 1-Blinded Randomization (8 Weeks)||0
353725|NCT00498173|856933|P2|STARTED|Phase 1-Blinded Randomization (8 Weeks)||31
353726|NCT00498173|856934|P1|STARTED|Phase 1-Blinded Randomization (8 Weeks)||29
353727|NCT00497874|856964|P2|NOT COMPLETED|Overall Study||116
353728|NCT00497874|856965|P1|NOT COMPLETED|Overall Study||147
353729|NCT00497874|856964|P2|COMPLETED|Overall Study||343
353730|NCT00497874|856965|P1|COMPLETED|Overall Study||296
353731|NCT00497874|856964|P2|STARTED|Overall Study||459
353732|NCT00497874|856965|P1|STARTED|Overall Study||443
353733|NCT00497796|856983|P2|NOT COMPLETED|Overall Study||59
353734|NCT00497796|856984|P1|NOT COMPLETED|Overall Study||85
353735|NCT00497796|856983|P2|COMPLETED|Overall Study||101
353736|NCT00497796|856984|P1|COMPLETED|Overall Study||62
353737|NCT00497796|856983|P2|STARTED|Overall Study||160
353738|NCT00497796|856984|P1|STARTED|Overall Study||147
353739|NCT00497770|857016|P4|NOT COMPLETED|Overall Study||0
353740|NCT00497770|857017|P3|NOT COMPLETED|Overall Study||0
353741|NCT00497770|857018|P2|NOT COMPLETED|Overall Study||0
353742|NCT00497770|857019|P1|NOT COMPLETED|Overall Study||0
353743|NCT00497770|857016|P4|COMPLETED|Overall Study||28
353744|NCT00497770|857017|P3|COMPLETED|Overall Study||37
353745|NCT00497770|857018|P2|COMPLETED|Overall Study||65
353746|NCT00497770|857019|P1|COMPLETED|Overall Study||304
353747|NCT00497770|857016|P4|STARTED|Overall Study||28
353748|NCT00497770|857017|P3|STARTED|Overall Study||37
353749|NCT00497770|857018|P2|STARTED|Overall Study||65
353750|NCT00497770|857019|P1|STARTED|Overall Study||304
353751|NCT00497198|857071|P2|NOT COMPLETED|Overall Study||5
353752|NCT00497198|857072|P1|NOT COMPLETED|Overall Study||5
353753|NCT00497198|857071|P2|COMPLETED|Overall Study||86
353754|NCT00497198|857072|P1|COMPLETED|Overall Study||87
353755|NCT00497198|857071|P2|STARTED|Overall Study||91
353756|NCT00497198|857072|P1|STARTED|Overall Study||92
353757|NCT00497146|857088|P2|NOT COMPLETED|Long-term Follow-up Period||6
353758|NCT00497146|857089|P1|NOT COMPLETED|Long-term Follow-up Period||15
353759|NCT00497146|857088|P2|COMPLETED|Long-term Follow-up Period||66
353760|NCT00497146|857089|P1|COMPLETED|Long-term Follow-up Period||50
353761|NCT00497146|857088|P2|STARTED|Long-term Follow-up Period||72
353762|NCT00497146|857089|P1|STARTED|Long-term Follow-up Period||65
353763|NCT00497146|857088|P2|NOT COMPLETED|Treatment Period||21
353764|NCT00497146|857089|P1|NOT COMPLETED|Treatment Period||27
353765|NCT00497146|857088|P2|COMPLETED|Treatment Period||91
353766|NCT00497146|857089|P1|COMPLETED|Treatment Period||88
353767|NCT00497146|857088|P2|STARTED|Treatment Period||112
353768|NCT00497146|857089|P1|STARTED|Treatment Period||115
353769|NCT00497081|857131|P2|NOT COMPLETED|Overall Study||2
353770|NCT00497081|857132|P1|NOT COMPLETED|Overall Study||2
353771|NCT00497081|857131|P2|COMPLETED|Overall Study||28
353772|NCT00497081|857132|P1|COMPLETED|Overall Study||28
353773|NCT00497081|857131|P2|STARTED|Overall Study||30
353774|NCT00497081|857132|P1|STARTED|Overall Study||30
353775|NCT00497055|857144|P2|NOT COMPLETED|Overall Study||5
353776|NCT00497055|857145|P1|NOT COMPLETED|Overall Study||10
353777|NCT00497055|857144|P2|COMPLETED|Overall Study||40
353778|NCT00497055|857145|P1|COMPLETED|Overall Study||35
353779|NCT00497055|857144|P2|STARTED|Overall Study||45
353780|NCT00497055|857145|P1|STARTED|Overall Study||45
353781|NCT00496964|857157|P2|NOT COMPLETED|Overall Study||1
353782|NCT00496964|857158|P1|NOT COMPLETED|Overall Study||0
353783|NCT00496964|857157|P2|COMPLETED|Overall Study||3
353784|NCT00496964|857158|P1|COMPLETED|Overall Study||1
353785|NCT00496964|857157|P2|STARTED|Overall Study||4
353786|NCT00496964|857158|P1|STARTED|Overall Study||1
353787|NCT00496873|857176|P1|NOT COMPLETED|Overall Study||7
353788|NCT00496873|857176|P1|COMPLETED|Overall Study||78
353789|NCT00496873|857176|P1|STARTED|Overall Study||85
353790|NCT00496860|857185|P3|NOT COMPLETED|Overall Study||0
353791|NCT00496860|857186|P2|NOT COMPLETED|Overall Study||1
353792|NCT00496860|857187|P1|NOT COMPLETED|Overall Study||1
353793|NCT00496860|857185|P3|COMPLETED|Overall Study||6
353794|NCT00496860|857186|P2|COMPLETED|Overall Study||15
353795|NCT00496860|857187|P1|COMPLETED|Overall Study||3
353796|NCT00496860|857185|P3|STARTED|Overall Study||6
353797|NCT00496860|857186|P2|STARTED|Overall Study||16
353798|NCT00496860|857187|P1|STARTED|Overall Study||4
353799|NCT00496834|857209|P2|NOT COMPLETED|Overall Study||13
353800|NCT00496834|857210|P1|NOT COMPLETED|Overall Study||18
353801|NCT00496834|857209|P2|COMPLETED|Overall Study||87
353802|NCT00496834|857210|P1|COMPLETED|Overall Study||83
353803|NCT00496834|857209|P2|STARTED|Overall Study||100
353804|NCT00496834|857210|P1|STARTED|Overall Study||101
353805|NCT00496808|857222|P1|NOT COMPLETED|Overall Study||0
353806|NCT00496808|857222|P1|COMPLETED|Overall Study||69
353807|NCT00496808|857222|P1|STARTED|Overall Study||69
353808|NCT00496782|857229|P2|NOT COMPLETED|Overall Study||2
353809|NCT00496782|857230|P1|NOT COMPLETED|Overall Study||1
353810|NCT00496782|857229|P2|COMPLETED|Overall Study||5
353811|NCT00496782|857230|P1|COMPLETED|Overall Study||8
353812|NCT00496782|857229|P2|STARTED|Overall Study||7
353813|NCT00496782|857230|P1|STARTED|Overall Study||9
353814|NCT00496769|857264|P3|NOT COMPLETED|Open Label||1011
353815|NCT00496769|857265|P2|NOT COMPLETED|Open Label||0
353816|NCT00496769|857266|P1|NOT COMPLETED|Open Label||0
353817|NCT00496769|857264|P3|COMPLETED|Open Label||2264
353818|NCT00496769|857265|P2|COMPLETED|Open Label||0
353819|NCT00496769|857266|P1|COMPLETED|Open Label||0
353820|NCT00496769|857264|P3|STARTED|Open Label||3275
353821|NCT00496769|857265|P2|STARTED|Open Label||0
353822|NCT00496769|857266|P1|STARTED|Open Label||0
353823|NCT00496769|857264|P3|NOT COMPLETED|Double Blind||0
353824|NCT00496769|857265|P2|NOT COMPLETED|Double Blind||649
353825|NCT00496769|857266|P1|NOT COMPLETED|Double Blind||558
353826|NCT00496769|857264|P3|COMPLETED|Double Blind||0
353827|NCT00496769|857265|P2|COMPLETED|Double Blind||2142
353828|NCT00496769|857266|P1|COMPLETED|Double Blind||2249
353829|NCT00496769|857264|P3|Received Treatment|Double Blind||0
353830|NCT00496769|857265|P2|Received Treatment|Double Blind||2708
353831|NCT00496769|857266|P1|Received Treatment|Double Blind||2798
353832|NCT00496769|857264|P3|STARTED|Double Blind||0
353833|NCT00496769|857265|P2|STARTED|Double Blind|Randomized|2791
353834|NCT00496769|857266|P1|STARTED|Double Blind|Randomized|2807
353835|NCT00496756|857289|P1|NOT COMPLETED|Overall Study||3
353836|NCT00496756|857289|P1|COMPLETED|Overall Study||11
353837|NCT00496756|857289|P1|STARTED|Overall Study||14
353838|NCT00496730|857296|P2|NOT COMPLETED|Overall Study||5
353839|NCT00496730|857297|P1|NOT COMPLETED|Overall Study||6
353840|NCT00496730|857296|P2|COMPLETED|Overall Study||121
353841|NCT00496730|857297|P1|COMPLETED|Overall Study||124
353842|NCT00496730|857296|P2|STARTED|Overall Study||126
353843|NCT00496730|857297|P1|STARTED|Overall Study||130
353844|NCT00496626|857309|P2|NOT COMPLETED|Overall Study||6
353845|NCT00496626|857310|P1|NOT COMPLETED|Overall Study||6
353846|NCT00496626|857309|P2|COMPLETED|Overall Study||292
353847|NCT00496626|857310|P1|COMPLETED|Overall Study||296
353848|NCT00496626|857309|P2|STARTED|Overall Study||298
353849|NCT00496626|857310|P1|STARTED|Overall Study||302
353850|NCT00496587|857322|P1|NOT COMPLETED|Overall Study||31
353851|NCT00496587|857322|P1|COMPLETED|Overall Study||3
353852|NCT00496587|857322|P1|STARTED|Overall Study||34
353853|NCT00496483|857328|P1|NOT COMPLETED|Overall Study||12
353854|NCT00496483|857328|P1|COMPLETED|Overall Study||48
353855|NCT00496483|857328|P1|Dosed|Overall Study||51
353856|NCT00496483|857328|P1|STARTED|Overall Study||60
353857|NCT00496470|857345|P2|NOT COMPLETED|Overall Study||29
353858|NCT00496470|857346|P1|NOT COMPLETED|Overall Study||26
353859|NCT00496470|857345|P2|COMPLETED|Overall Study||302
353860|NCT00496470|857346|P1|COMPLETED|Overall Study||303
353861|NCT00496470|857345|P2|Received Study Medication|Overall Study||330
353862|NCT00496470|857346|P1|Received Study Medication|Overall Study||329
353863|NCT00496470|857345|P2|STARTED|Overall Study||331
353864|NCT00496470|857346|P1|STARTED|Overall Study||329
353865|NCT00496379|857424|P1|NOT COMPLETED|Overall Study||0
353866|NCT00496379|857424|P1|COMPLETED|Overall Study||15
353867|NCT00496379|857424|P1|STARTED|Overall Study||15
353868|NCT00496366|857432|P1|NOT COMPLETED|Overall Study||1
353869|NCT00496366|857432|P1|COMPLETED|Overall Study||10
353870|NCT00496366|857432|P1|STARTED|Overall Study||11
353871|NCT00496340|857437|P1|NOT COMPLETED|Overall Study||0
353872|NCT00496340|857437|P1|COMPLETED|Overall Study||42
353873|NCT00496340|857437|P1|STARTED|Overall Study||42
353874|NCT00496262|857450|P1|NOT COMPLETED|Overall Study||0
353875|NCT00496262|857450|P1|COMPLETED|Overall Study||15
353876|NCT00496262|857450|P1|STARTED|Overall Study||15
353877|NCT00496197|857463|P1|NOT COMPLETED|Overall Study||122
353878|NCT00496197|857463|P1|COMPLETED|Overall Study||160
353879|NCT00496197|857463|P1|STARTED|Overall Study||282
353880|NCT00496080|857490|P1|NOT COMPLETED|Overall Study||27
353881|NCT00496080|857490|P1|COMPLETED|Overall Study||60
353882|NCT00496080|857490|P1|STARTED|Overall Study||87
353883|NCT00496054|857500|P1|NOT COMPLETED|Overall Study||8
353884|NCT00496054|857500|P1|COMPLETED|Overall Study||102
353885|NCT00496054|857500|P1|STARTED|Overall Study||110
353886|NCT00496015|857532|P5|NOT COMPLETED|Overall Study||0
353887|NCT00496015|857533|P4|NOT COMPLETED|Overall Study||1
353888|NCT00496015|857534|P3|NOT COMPLETED|Overall Study||0
353889|NCT00496015|857535|P2|NOT COMPLETED|Overall Study||0
353890|NCT00496015|857536|P1|NOT COMPLETED|Overall Study||1
353891|NCT00496015|857532|P5|COMPLETED|Overall Study||336
353892|NCT00496015|857533|P4|COMPLETED|Overall Study||36
353893|NCT00496015|857534|P3|COMPLETED|Overall Study||172
353894|NCT00496015|857535|P2|COMPLETED|Overall Study||27
353895|NCT00496015|857536|P1|COMPLETED|Overall Study||177
353896|NCT00496015|857532|P5|STARTED|Overall Study||336
353897|NCT00496015|857533|P4|STARTED|Overall Study||37
353898|NCT00496015|857534|P3|STARTED|Overall Study||172
353899|NCT00496015|857535|P2|STARTED|Overall Study||27
353900|NCT00496015|857536|P1|STARTED|Overall Study||178
353901|NCT00495820|857660|P2|NOT COMPLETED|Overall Study||1
353902|NCT00495820|857661|P1|NOT COMPLETED|Overall Study||1
353903|NCT00495820|857660|P2|COMPLETED|Overall Study||29
353904|NCT00495820|857661|P1|COMPLETED|Overall Study||29
353905|NCT00495820|857660|P2|STARTED|Overall Study||30
353906|NCT00495820|857661|P1|STARTED|Overall Study||30
353907|NCT00495794|857673|P2|NOT COMPLETED|Overall Study||0
353908|NCT00495794|857674|P1|NOT COMPLETED|Overall Study||522
353909|NCT00495794|857673|P2|COMPLETED|Overall Study||2303
353910|NCT00495794|857674|P1|COMPLETED|Overall Study||1797
353911|NCT00495794|857673|P2|STARTED|Overall Study||2303
353912|NCT00495794|857674|P1|STARTED|Overall Study||2319
353913|NCT00495755|857684|P1|NOT COMPLETED|Overall Study||3
353914|NCT00495755|857684|P1|COMPLETED|Overall Study||10
353915|NCT00495755|857684|P1|STARTED|Overall Study||13
353916|NCT00495677|857696|P7|NOT COMPLETED|Stage 2 (25 Days)||0
353917|NCT00495677|857697|P6|NOT COMPLETED|Stage 2 (25 Days)||0
353918|NCT00495677|857698|P5|NOT COMPLETED|Stage 2 (25 Days)||0
353919|NCT00495677|857699|P4|NOT COMPLETED|Stage 2 (25 Days)||0
353920|NCT00495677|857700|P3|NOT COMPLETED|Stage 2 (25 Days)||0
353921|NCT00495677|857701|P2|NOT COMPLETED|Stage 2 (25 Days)||0
353922|NCT00495677|857702|P1|NOT COMPLETED|Stage 2 (25 Days)||0
353923|NCT00495677|857696|P7|COMPLETED|Stage 2 (25 Days)||7
353924|NCT00495677|857697|P6|COMPLETED|Stage 2 (25 Days)||8
353925|NCT00495677|857698|P5|COMPLETED|Stage 2 (25 Days)||8
353926|NCT00495677|857699|P4|COMPLETED|Stage 2 (25 Days)||0
353927|NCT00495677|857700|P3|COMPLETED|Stage 2 (25 Days)||0
353928|NCT00495677|857701|P2|COMPLETED|Stage 2 (25 Days)||0
353929|NCT00495677|857702|P1|COMPLETED|Stage 2 (25 Days)||0
353930|NCT00495677|857696|P7|STARTED|Stage 2 (25 Days)||7
353931|NCT00495677|857697|P6|STARTED|Stage 2 (25 Days)||8
353932|NCT00495677|857698|P5|STARTED|Stage 2 (25 Days)||8
353933|NCT00495677|857699|P4|STARTED|Stage 2 (25 Days)||0
353934|NCT00495677|857700|P3|STARTED|Stage 2 (25 Days)||0
353935|NCT00495677|857701|P2|STARTED|Stage 2 (25 Days)||0
353936|NCT00495677|857702|P1|STARTED|Stage 2 (25 Days)||0
353937|NCT00495677|857696|P7|NOT COMPLETED|Stage 1 (25 Days)||0
353938|NCT00495677|857697|P6|NOT COMPLETED|Stage 1 (25 Days)||0
353939|NCT00495677|857698|P5|NOT COMPLETED|Stage 1 (25 Days)||0
353940|NCT00495677|857699|P4|NOT COMPLETED|Stage 1 (25 Days)||0
353941|NCT00495677|857700|P3|NOT COMPLETED|Stage 1 (25 Days)||1
353942|NCT00495677|857701|P2|NOT COMPLETED|Stage 1 (25 Days)||0
353943|NCT00495677|857702|P1|NOT COMPLETED|Stage 1 (25 Days)||0
353944|NCT00495677|857696|P7|COMPLETED|Stage 1 (25 Days)||0
353945|NCT00495677|857697|P6|COMPLETED|Stage 1 (25 Days)||0
353946|NCT00495677|857698|P5|COMPLETED|Stage 1 (25 Days)||0
353947|NCT00495677|857699|P4|COMPLETED|Stage 1 (25 Days)||6
353948|NCT00495677|857700|P3|COMPLETED|Stage 1 (25 Days)||5
353949|NCT00495677|857701|P2|COMPLETED|Stage 1 (25 Days)||6
353950|NCT00495677|857702|P1|COMPLETED|Stage 1 (25 Days)||2
353951|NCT00495677|857696|P7|STARTED|Stage 1 (25 Days)||0
353952|NCT00495677|857697|P6|STARTED|Stage 1 (25 Days)||0
353953|NCT00495677|857698|P5|STARTED|Stage 1 (25 Days)||0
353954|NCT00495677|857699|P4|STARTED|Stage 1 (25 Days)||6
353955|NCT00495677|857700|P3|STARTED|Stage 1 (25 Days)||6
353956|NCT00495677|857701|P2|STARTED|Stage 1 (25 Days)||6
353957|NCT00495677|857702|P1|STARTED|Stage 1 (25 Days)||2
353958|NCT00495625|857757|P1|NOT COMPLETED|Overall Study||10
353959|NCT00495625|857757|P1|COMPLETED|Overall Study||23
353960|NCT00495625|857757|P1|STARTED|Overall Study||33
353961|NCT00495612|857768|P2|NOT COMPLETED|Overall Study||0
353962|NCT00495612|857769|P1|NOT COMPLETED|Overall Study||4
353963|NCT00495612|857768|P2|COMPLETED|Overall Study||33
353964|NCT00495612|857769|P1|COMPLETED|Overall Study||32
353965|NCT00495612|857768|P2|STARTED|Overall Study||33
353966|NCT00495612|857769|P1|STARTED|Overall Study||36
353967|NCT00495586|857787|P2|NOT COMPLETED|Overall Study||4
353968|NCT00495586|857788|P1|NOT COMPLETED|Overall Study||4
353969|NCT00495586|857787|P2|COMPLETED|Overall Study||158
353970|NCT00495586|857788|P1|COMPLETED|Overall Study||152
353971|NCT00495586|857787|P2|STARTED|Overall Study||162
353972|NCT00495586|857788|P1|STARTED|Overall Study||156
353973|NCT00495521|857798|P2|NOT COMPLETED|Overall Study||1
353974|NCT00495521|857799|P1|NOT COMPLETED|Overall Study||0
353975|NCT00495521|857798|P2|COMPLETED|Overall Study||0
353976|NCT00495521|857799|P1|COMPLETED|Overall Study||1
353977|NCT00495521|857798|P2|STARTED|Overall Study||1
353978|NCT00495521|857799|P1|STARTED|Overall Study||1
353979|NCT00495495|857829|P1|NOT COMPLETED|Overall Study||99
353980|NCT00495495|857829|P1|COMPLETED|Overall Study||295
353981|NCT00495495|857829|P1|STARTED|Overall Study||394
353982|NCT00495469|857849|P7|NOT COMPLETED|Overall Study||5
353983|NCT00495469|857850|P6|NOT COMPLETED|Overall Study||5
353984|NCT00495469|857851|P5|NOT COMPLETED|Overall Study||5
353985|NCT00495469|857852|P4|NOT COMPLETED|Overall Study||4
353986|NCT00495469|857853|P3|NOT COMPLETED|Overall Study||7
353987|NCT00495469|857854|P2|NOT COMPLETED|Overall Study||7
353988|NCT00495469|857855|P1|NOT COMPLETED|Overall Study||6
353989|NCT00495469|857849|P7|COMPLETED|Overall Study||30
353990|NCT00495469|857850|P6|COMPLETED|Overall Study||31
353991|NCT00495469|857851|P5|COMPLETED|Overall Study||31
353992|NCT00495469|857852|P4|COMPLETED|Overall Study||32
353993|NCT00495469|857853|P3|COMPLETED|Overall Study||27
353994|NCT00495469|857854|P2|COMPLETED|Overall Study||30
353995|NCT00495469|857855|P1|COMPLETED|Overall Study||30
353996|NCT00495469|857849|P7|STARTED|Overall Study||35
353997|NCT00495469|857850|P6|STARTED|Overall Study||36
353998|NCT00495469|857851|P5|STARTED|Overall Study||36
353999|NCT00495469|857852|P4|STARTED|Overall Study||36
354000|NCT00495469|857853|P3|STARTED|Overall Study||34
354001|NCT00495469|857854|P2|STARTED|Overall Study||37
354002|NCT00495469|857855|P1|STARTED|Overall Study||36
354003|NCT00495391|857999|P2|NOT COMPLETED|Overall Study||21
354004|NCT00495391|858000|P1|NOT COMPLETED|Overall Study||36
354005|NCT00495391|857999|P2|COMPLETED|Overall Study||1
354006|NCT00495391|858000|P1|COMPLETED|Overall Study||6
354007|NCT00495391|857999|P2|From Baseline to End of Follow up|Overall Study||1
354008|NCT00495391|858000|P1|From Baseline to End of Follow up|Overall Study||6
354009|NCT00495391|857999|P2|From Baseline to End of Treatment|Overall Study||1
354010|NCT00495391|858000|P1|From Baseline to End of Treatment|Overall Study||6
354011|NCT00495391|857999|P2|From Baseline to Week 16|Overall Study||11
354012|NCT00495391|858000|P1|From Baseline to Week 16|Overall Study||24
354013|NCT00495391|857999|P2|From Baseline to Week 8|Overall Study||20
354014|NCT00495391|858000|P1|From Baseline to Week 8|Overall Study||31
354015|NCT00495391|857999|P2|STARTED|Overall Study||22
354016|NCT00495391|858000|P1|STARTED|Overall Study||42
354017|NCT00495222|858020|P1|NOT COMPLETED|Overall Study||0
354018|NCT00495222|858020|P1|COMPLETED|Overall Study||9
354019|NCT00495222|858020|P1|STARTED|Overall Study||9
354020|NCT00495170|858023|P1|NOT COMPLETED|Overall Study||20
354021|NCT00495170|858023|P1|COMPLETED|Overall Study||64
354022|NCT00495170|858023|P1|STARTED|Overall Study||84
354023|NCT00495157|858030|P3|NOT COMPLETED|Overall Study||13
354024|NCT00495157|858031|P2|NOT COMPLETED|Overall Study||23
354025|NCT00495157|858032|P1|NOT COMPLETED|Overall Study||16
354026|NCT00495157|858030|P3|COMPLETED|Overall Study||101
354027|NCT00495157|858031|P2|COMPLETED|Overall Study||92
354028|NCT00495157|858032|P1|COMPLETED|Overall Study||97
354029|NCT00495157|858030|P3|STARTED|Overall Study||114
354030|NCT00495157|858031|P2|STARTED|Overall Study||115
354031|NCT00495157|858032|P1|STARTED|Overall Study||113
354032|NCT00495131|858042|P2|NOT COMPLETED|Overall Study||6
354033|NCT00495131|858043|P1|NOT COMPLETED|Overall Study||7
354034|NCT00495131|858042|P2|COMPLETED|Overall Study||148
354035|NCT00495131|858043|P1|COMPLETED|Overall Study||147
354036|NCT00495131|858042|P2|STARTED|Overall Study||154
354037|NCT00495131|858043|P1|STARTED|Overall Study||154
354038|NCT00495079|858053|P1|NOT COMPLETED|Overall Study||0
354039|NCT00495079|858053|P1|COMPLETED|Overall Study||65
354040|NCT00495079|858053|P1|STARTED|Overall Study||65
354041|NCT00495040|858060|P1|NOT COMPLETED|Overall Study||3
354042|NCT00495040|858060|P1|COMPLETED|Overall Study||35
354043|NCT00495040|858060|P1|STARTED|Overall Study||38
354044|NCT00494975|858066|P2|NOT COMPLETED|Overall Study||1
354045|NCT00494975|858067|P1|NOT COMPLETED|Overall Study||2
354046|NCT00494975|858066|P2|COMPLETED|Overall Study||10
354047|NCT00494975|858067|P1|COMPLETED|Overall Study||8
354048|NCT00494975|858066|P2|STARTED|Overall Study||11
354049|NCT00494975|858067|P1|STARTED|Overall Study||10
354050|NCT00494871|858075|P2|NOT COMPLETED|Follow-up (FU) Period||23
354051|NCT00494871|858076|P1|NOT COMPLETED|Follow-up (FU) Period||29
354052|NCT00494871|858075|P2|COMPLETED|Follow-up (FU) Period||616
354053|NCT00494871|858076|P1|COMPLETED|Follow-up (FU) Period||610
354054|NCT00494871|858075|P2|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|630
354055|NCT00494871|858076|P1|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|628
354056|NCT00494871|858075|P2|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
354057|NCT00494871|858076|P1|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
354058|NCT00494871|858075|P2|NOT COMPLETED|Double-blind (DB) Treatment Period||172
354059|NCT00494871|858076|P1|NOT COMPLETED|Double-blind (DB) Treatment Period||160
354060|NCT00494871|858075|P2|COMPLETED|Double-blind (DB) Treatment Period||468
354061|NCT00494871|858076|P1|COMPLETED|Double-blind (DB) Treatment Period||480
354062|NCT00494871|858075|P2|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
354063|NCT00494871|858076|P1|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
354064|NCT00494871|858075|P2|STARTED|Double-blind (DB) Treatment Period||640
354065|NCT00494871|858076|P1|STARTED|Double-blind (DB) Treatment Period||640
354066|NCT00494806|858108|P2|NOT COMPLETED|Overall Study||0
354067|NCT00494806|858109|P1|NOT COMPLETED|Overall Study||0
354068|NCT00494806|858108|P2|COMPLETED|Overall Study||32
354069|NCT00494806|858109|P1|COMPLETED|Overall Study||34
354070|NCT00494806|858108|P2|STARTED|Overall Study||32
354071|NCT00494806|858109|P1|STARTED|Overall Study||34
354072|NCT00494780|858117|P2|NOT COMPLETED|Overall Study||13
354073|NCT00494780|858118|P1|NOT COMPLETED|Overall Study||11
354074|NCT00494780|858117|P2|COMPLETED|Overall Study||17
354075|NCT00494780|858118|P1|COMPLETED|Overall Study||18
354076|NCT00494780|858117|P2|STARTED|Overall Study||30
354077|NCT00494780|858118|P1|STARTED|Overall Study||29
354078|NCT00494676|858156|P2|NOT COMPLETED|Second Intervention||1
354079|NCT00494676|858157|P1|NOT COMPLETED|Second Intervention||1
354080|NCT00494676|858156|P2|COMPLETED|Second Intervention||28
354081|NCT00494676|858157|P1|COMPLETED|Second Intervention||33
354082|NCT00494676|858156|P2|STARTED|Second Intervention||29
354083|NCT00494676|858157|P1|STARTED|Second Intervention||34
354084|NCT00494676|858156|P2|NOT COMPLETED|First Intervention||3
354085|NCT00494676|858157|P1|NOT COMPLETED|First Intervention||1
354086|NCT00494676|858156|P2|COMPLETED|First Intervention||29
354087|NCT00494676|858157|P1|COMPLETED|First Intervention||34
354088|NCT00494676|858156|P2|STARTED|First Intervention||32
354089|NCT00494676|858157|P1|STARTED|First Intervention||35
354090|NCT00494676|858156|P2|NOT COMPLETED|Allocation||4
354091|NCT00494676|858157|P1|NOT COMPLETED|Allocation||2
354092|NCT00494676|858156|P2|COMPLETED|Allocation||32
354093|NCT00494676|858157|P1|COMPLETED|Allocation||35
354094|NCT00494676|858156|P2|STARTED|Allocation||36
354095|NCT00494676|858157|P1|STARTED|Allocation||37
354096|NCT00494585|858164|P1|NOT COMPLETED|Overall Study||0
354097|NCT00494585|858164|P1|COMPLETED|Overall Study||22
354098|NCT00494585|858164|P1|STARTED|Overall Study||22
354099|NCT00494507|858172|P4|NOT COMPLETED|Open-Label Phase||5
354100|NCT00494507|858173|P3|NOT COMPLETED|Open-Label Phase||5
354101|NCT00494507|858174|P2|NOT COMPLETED|Open-Label Phase||1
354102|NCT00494507|858175|P1|NOT COMPLETED|Open-Label Phase||0
354103|NCT00494507|858172|P4|COMPLETED|Open-Label Phase||14
354104|NCT00494507|858173|P3|COMPLETED|Open-Label Phase||17
354105|NCT00494507|858174|P2|COMPLETED|Open-Label Phase||7
354106|NCT00494507|858175|P1|COMPLETED|Open-Label Phase||9
354107|NCT00494507|858172|P4|STARTED|Open-Label Phase||19
354108|NCT00494507|858173|P3|STARTED|Open-Label Phase||22
354109|NCT00494507|858174|P2|STARTED|Open-Label Phase|1 subject randomized to Acetazolamide in this phase is not included-drug arm was removed from trial.|8
354110|NCT00494507|858175|P1|STARTED|Open-Label Phase||9
354111|NCT00494507|858172|P4|NOT COMPLETED|Double-Blind Phase||1
354112|NCT00494507|858173|P3|NOT COMPLETED|Double-Blind Phase||2
354113|NCT00494507|858174|P2|NOT COMPLETED|Double-Blind Phase||0
354114|NCT00494507|858175|P1|NOT COMPLETED|Double-Blind Phase||3
354115|NCT00494507|858172|P4|COMPLETED|Double-Blind Phase||19
354116|NCT00494507|858173|P3|COMPLETED|Double-Blind Phase||22
354117|NCT00494507|858174|P2|COMPLETED|Double-Blind Phase||9
354118|NCT00494507|858175|P1|COMPLETED|Double-Blind Phase||9
354119|NCT00494507|858172|P4|Reached Endpoint of Acute Worsening|Double-Blind Phase||5
354120|NCT00494507|858173|P3|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
354121|NCT00494507|858174|P2|Reached Endpoint of Acute Worsening|Double-Blind Phase||2
354122|NCT00494507|858175|P1|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
354123|NCT00494507|858172|P4|STARTED|Double-Blind Phase||20
354124|NCT00494507|858173|P3|STARTED|Double-Blind Phase||24
354125|NCT00494507|858174|P2|STARTED|Double-Blind Phase||9
354126|NCT00494507|858175|P1|STARTED|Double-Blind Phase||12
354127|NCT00494494|858225|P2|NOT COMPLETED|Overall Study||0
354128|NCT00494494|858226|P1|NOT COMPLETED|Overall Study||0
354129|NCT00494494|858225|P2|COMPLETED|Overall Study||39
354130|NCT00494494|858226|P1|COMPLETED|Overall Study||40
354131|NCT00494494|858225|P2|STARTED|Overall Study||39
354132|NCT00494494|858226|P1|STARTED|Overall Study||40
354133|NCT00494481|858242|P2|NOT COMPLETED|Overall Study||24
354134|NCT00494481|858243|P1|NOT COMPLETED|Overall Study||29
354135|NCT00494481|858242|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
354136|NCT00494481|858243|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|6
354137|NCT00494481|858242|P2|STARTED|Overall Study|randomised patients|29
354138|NCT00494481|858243|P1|STARTED|Overall Study|randomised patients|35
354139|NCT00494442|858251|P2|NOT COMPLETED|Overall Study||16
354140|NCT00494442|858252|P1|NOT COMPLETED|Overall Study||17
354141|NCT00494442|858251|P2|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|17
354142|NCT00494442|858252|P1|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|7
354143|NCT00494442|858251|P2|STARTED|Overall Study|Patients received treatment|33
354144|NCT00494442|858252|P1|STARTED|Overall Study|Patients received treatment|24
354145|NCT00494299|858268|P2|NOT COMPLETED|Overall Study||229
354146|NCT00494299|858269|P1|NOT COMPLETED|Overall Study||229
354147|NCT00494299|858268|P2|COMPLETED|Overall Study||0
354148|NCT00494299|858269|P1|COMPLETED|Overall Study||0
354149|NCT00494299|858268|P2|Received Treatment|Overall Study||227
354150|NCT00494299|858269|P1|Received Treatment|Overall Study||229
354151|NCT00494299|858268|P2|STARTED|Overall Study||229
354152|NCT00494299|858269|P1|STARTED|Overall Study||229
354153|NCT00494234|858281|P2|NOT COMPLETED|Overall Study||10
354154|NCT00494234|858282|P1|NOT COMPLETED|Overall Study||15
354155|NCT00494234|858281|P2|COMPLETED|Overall Study||17
354156|NCT00494234|858282|P1|COMPLETED|Overall Study||12
354157|NCT00494234|858281|P2|STARTED|Overall Study||27
354158|NCT00494234|858282|P1|STARTED|Overall Study||27
354159|NCT00494221|858301|P3|NOT COMPLETED|Overall Study||14
354160|NCT00494221|858302|P2|NOT COMPLETED|Overall Study||11
354161|NCT00494221|858303|P1|NOT COMPLETED|Overall Study||16
354162|NCT00494221|858301|P3|COMPLETED|Overall Study||44
354163|NCT00494221|858302|P2|COMPLETED|Overall Study||45
354164|NCT00494221|858303|P1|COMPLETED|Overall Study||42
354165|NCT00494221|858301|P3|STARTED|Overall Study||58
354166|NCT00494221|858302|P2|STARTED|Overall Study||56
354167|NCT00494221|858303|P1|STARTED|Overall Study||58
354168|NCT00494143|858323|P6|NOT COMPLETED|Overall Study||0
354169|NCT00494143|858324|P5|NOT COMPLETED|Overall Study||0
354170|NCT00494143|858325|P4|NOT COMPLETED|Overall Study||0
354171|NCT00494143|858326|P3|NOT COMPLETED|Overall Study||0
354172|NCT00494143|858327|P2|NOT COMPLETED|Overall Study||0
354173|NCT00494143|858328|P1|NOT COMPLETED|Overall Study||0
354174|NCT00494143|858323|P6|COMPLETED|Overall Study||0
354175|NCT00494143|858324|P5|COMPLETED|Overall Study||1
354176|NCT00494143|858325|P4|COMPLETED|Overall Study||0
354177|NCT00494143|858326|P3|COMPLETED|Overall Study||3
354178|NCT00494143|858327|P2|COMPLETED|Overall Study||2
354179|NCT00494143|858328|P1|COMPLETED|Overall Study||1
354180|NCT00494143|858323|P6|STARTED|Overall Study||0
354181|NCT00494143|858324|P5|STARTED|Overall Study||1
354182|NCT00494143|858325|P4|STARTED|Overall Study||0
354183|NCT00494143|858326|P3|STARTED|Overall Study||3
354184|NCT00494143|858327|P2|STARTED|Overall Study||2
354185|NCT00494143|858328|P1|STARTED|Overall Study||1
354186|NCT00494091|858344|P2|NOT COMPLETED|Overall Study||76
354187|NCT00494091|858345|P1|NOT COMPLETED|Overall Study||6
354188|NCT00494091|858344|P2|COMPLETED|Overall Study||0
354189|NCT00494091|858345|P1|COMPLETED|Overall Study||0
354190|NCT00494091|858344|P2|STARTED|Overall Study||76
354191|NCT00494091|858345|P1|STARTED|Overall Study||6
354192|NCT00494026|858367|P1|NOT COMPLETED|Overall Study||4
354193|NCT00494026|858367|P1|COMPLETED|Overall Study|2 patients did receive the full study treatment prior to the study being terminated.|0
354194|NCT00494026|858367|P1|STARTED|Overall Study||4
354195|NCT00494013|858377|P2|NOT COMPLETED|Overall Study||36
354196|NCT00494013|858378|P1|NOT COMPLETED|Overall Study||30
354197|NCT00494013|858377|P2|COMPLETED|Overall Study||183
354198|NCT00494013|858378|P1|COMPLETED|Overall Study||193
354199|NCT00494013|858377|P2|Full Analysis Set (Intent to Treat)|Overall Study||210
354200|NCT00494013|858378|P1|Full Analysis Set (Intent to Treat)|Overall Study||219
354201|NCT00494013|858377|P2|STARTED|Overall Study||219
354202|NCT00494013|858378|P1|STARTED|Overall Study||223
354203|NCT00493974|858408|P2|NOT COMPLETED|Overall Study||14
354204|NCT00493974|858409|P1|NOT COMPLETED|Overall Study||13
354205|NCT00493974|858408|P2|COMPLETED|Overall Study||45
354206|NCT00493974|858409|P1|COMPLETED|Overall Study||47
354207|NCT00493974|858408|P2|STARTED|Overall Study||59
354208|NCT00493974|858409|P1|STARTED|Overall Study||60
354209|NCT00493805|858427|P2|NOT COMPLETED|Overall Study||0
354210|NCT00493805|858428|P1|NOT COMPLETED|Overall Study||0
354211|NCT00493805|858427|P2|COMPLETED|Overall Study||42
354212|NCT00493805|858428|P1|COMPLETED|Overall Study||17
354213|NCT00493805|858427|P2|STARTED|Overall Study||42
354214|NCT00493805|858428|P1|STARTED|Overall Study||17
354215|NCT00493779|858436|P1|NOT COMPLETED|Overall Study||1
354216|NCT00493779|858436|P1|COMPLETED|Overall Study|Completed follow-up phase|97
354217|NCT00493779|858436|P1|STARTED|Overall Study|Number of subjects who had discontinued clopidogrel treatment and entered follow-up phase|98
354218|NCT00493649|858443|P1|NOT COMPLETED|Overall Study||82
354219|NCT00493649|858443|P1|COMPLETED|Overall Study||411
354220|NCT00493649|858443|P1|STARTED|Overall Study||493
354221|NCT00493636|858456|P2|NOT COMPLETED|Overall Study||2
354222|NCT00493636|858457|P1|NOT COMPLETED|Overall Study||2
354223|NCT00493636|858456|P2|COMPLETED|Overall Study||77
354224|NCT00493636|858457|P1|COMPLETED|Overall Study||79
354225|NCT00493636|858456|P2|STARTED|Overall Study||79
354226|NCT00493636|858457|P1|STARTED|Overall Study||81
354227|NCT00493454|858471|P1|NOT COMPLETED|Overall Study||1
354228|NCT00493454|858471|P1|COMPLETED|Overall Study||5
354229|NCT00493454|858471|P1|STARTED|Overall Study||6
354230|NCT00493311|858477|P2|NOT COMPLETED|Overall Study||2
354231|NCT00493311|858478|P1|NOT COMPLETED|Overall Study||2
354232|NCT00493311|858477|P2|COMPLETED|Overall Study||29
354233|NCT00493311|858478|P1|COMPLETED|Overall Study||27
354234|NCT00493311|858477|P2|STARTED|Overall Study||31
354235|NCT00493311|858478|P1|STARTED|Overall Study||29
354236|NCT00493285|858498|P6|NOT COMPLETED|Overall Study||0
354237|NCT00493285|858499|P5|NOT COMPLETED|Overall Study||1
354238|NCT00493285|858500|P4|NOT COMPLETED|Overall Study||0
354239|NCT00493285|858501|P3|NOT COMPLETED|Overall Study||0
354240|NCT00493285|858502|P2|NOT COMPLETED|Overall Study||0
354241|NCT00493285|858503|P1|NOT COMPLETED|Overall Study||0
354242|NCT00493285|858498|P6|COMPLETED|Overall Study||5
354243|NCT00493285|858499|P5|COMPLETED|Overall Study||9
354244|NCT00493285|858500|P4|COMPLETED|Overall Study||6
354245|NCT00493285|858501|P3|COMPLETED|Overall Study||9
354246|NCT00493285|858502|P2|COMPLETED|Overall Study||6
354247|NCT00493285|858503|P1|COMPLETED|Overall Study||13
354248|NCT00493285|858498|P6|STARTED|Overall Study||5
354249|NCT00493285|858499|P5|STARTED|Overall Study||10
354250|NCT00493285|858500|P4|STARTED|Overall Study||6
354251|NCT00493285|858501|P3|STARTED|Overall Study||9
354252|NCT00493285|858502|P2|STARTED|Overall Study||6
354253|NCT00493285|858503|P1|STARTED|Overall Study||13
354254|NCT00493246|858735|P8|NOT COMPLETED|Overall Study||0
354255|NCT00493246|858736|P7|NOT COMPLETED|Overall Study||1
354256|NCT00493246|858737|P6|NOT COMPLETED|Overall Study||1
354257|NCT00493246|858738|P5|NOT COMPLETED|Overall Study||1
354258|NCT00493246|858739|P4|NOT COMPLETED|Overall Study||0
354259|NCT00493246|858740|P3|NOT COMPLETED|Overall Study||0
354260|NCT00493246|858741|P2|NOT COMPLETED|Overall Study||0
354261|NCT00493246|858742|P1|NOT COMPLETED|Overall Study||0
354262|NCT00493246|858735|P8|COMPLETED|Overall Study|Completed study 30 days after the last dose|10
354263|NCT00493246|858736|P7|COMPLETED|Overall Study|Completed study 30 days after the last dose|11
354264|NCT00493246|858737|P6|COMPLETED|Overall Study|Completed study 30 days after the last dose|15
354265|NCT00493246|858738|P5|COMPLETED|Overall Study|Completed study 30 days after the last dose|8
354266|NCT00493246|858739|P4|COMPLETED|Overall Study|Completed study 30 days after the last dose|13
354267|NCT00493246|858740|P3|COMPLETED|Overall Study|Completed study 30 days after the last dose|12
354268|NCT00493246|858741|P2|COMPLETED|Overall Study|Completed study 30 days after the last dose|1
354269|NCT00493246|858742|P1|COMPLETED|Overall Study|Completed study 30 days after the last dose|2
354270|NCT00493246|858735|P8|STARTED|Overall Study|All subjects who were randomized.|10
354271|NCT00493246|858736|P7|STARTED|Overall Study|All subjects who were randomized.|12
354272|NCT00493246|858737|P6|STARTED|Overall Study|All subjects who were randomized.|16
354273|NCT00493246|858738|P5|STARTED|Overall Study|All subjects who were randomized.Excludes 1 subject who was randomized in error.|9
354274|NCT00493246|858739|P4|STARTED|Overall Study||13
354275|NCT00493246|858740|P3|STARTED|Overall Study||12
354276|NCT00493246|858741|P2|STARTED|Overall Study||1
354277|NCT00493246|858742|P1|STARTED|Overall Study||2
354278|NCT00493220|858806|P6|NOT COMPLETED|Final 7-Day Safety Follow-up||0
354279|NCT00493220|858807|P5|NOT COMPLETED|Final 7-Day Safety Follow-up||0
354280|NCT00493220|858808|P4|NOT COMPLETED|Final 7-Day Safety Follow-up||0
354281|NCT00493220|858809|P3|NOT COMPLETED|Final 7-Day Safety Follow-up||0
354282|NCT00493220|858810|P2|NOT COMPLETED|Final 7-Day Safety Follow-up||0
354283|NCT00493220|858811|P1|NOT COMPLETED|Final 7-Day Safety Follow-up||0
354284|NCT00493220|858806|P6|COMPLETED|Final 7-Day Safety Follow-up||5
354285|NCT00493220|858807|P5|COMPLETED|Final 7-Day Safety Follow-up||5
354286|NCT00493220|858808|P4|COMPLETED|Final 7-Day Safety Follow-up||5
354287|NCT00493220|858809|P3|COMPLETED|Final 7-Day Safety Follow-up||5
354288|NCT00493220|858810|P2|COMPLETED|Final 7-Day Safety Follow-up||5
354289|NCT00493220|858811|P1|COMPLETED|Final 7-Day Safety Follow-up||4
354290|NCT00493220|858806|P6|STARTED|Final 7-Day Safety Follow-up||5
354291|NCT00493220|858807|P5|STARTED|Final 7-Day Safety Follow-up||5
354292|NCT00493220|858808|P4|STARTED|Final 7-Day Safety Follow-up||5
354293|NCT00493220|858809|P3|STARTED|Final 7-Day Safety Follow-up||5
354294|NCT00493220|858810|P2|STARTED|Final 7-Day Safety Follow-up||5
354295|NCT00493220|858811|P1|STARTED|Final 7-Day Safety Follow-up||4
354296|NCT00493220|858806|P6|NOT COMPLETED|Third Intervention||0
354297|NCT00493220|858807|P5|NOT COMPLETED|Third Intervention||0
354298|NCT00493220|858808|P4|NOT COMPLETED|Third Intervention||0
354299|NCT00493220|858809|P3|NOT COMPLETED|Third Intervention||0
354300|NCT00493220|858810|P2|NOT COMPLETED|Third Intervention||0
354301|NCT00493220|858811|P1|NOT COMPLETED|Third Intervention||1
354302|NCT00493220|858806|P6|COMPLETED|Third Intervention||5
354303|NCT00493220|858807|P5|COMPLETED|Third Intervention||5
354304|NCT00493220|858808|P4|COMPLETED|Third Intervention||5
354305|NCT00493220|858809|P3|COMPLETED|Third Intervention||5
354306|NCT00493220|858810|P2|COMPLETED|Third Intervention||5
354307|NCT00493220|858811|P1|COMPLETED|Third Intervention||4
354308|NCT00493220|858806|P6|STARTED|Third Intervention||5
354309|NCT00493220|858807|P5|STARTED|Third Intervention||5
354310|NCT00493220|858808|P4|STARTED|Third Intervention||5
354311|NCT00493220|858809|P3|STARTED|Third Intervention||5
354312|NCT00493220|858810|P2|STARTED|Third Intervention||5
354313|NCT00493220|858811|P1|STARTED|Third Intervention||5
354314|NCT00493220|858806|P6|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
354315|NCT00493220|858807|P5|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
354316|NCT00493220|858808|P4|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
354317|NCT00493220|858809|P3|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
354318|NCT00493220|858810|P2|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
354319|NCT00493220|858811|P1|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
354320|NCT00493220|858806|P6|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
354321|NCT00493220|858807|P5|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
354322|NCT00493220|858808|P4|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
354323|NCT00493220|858809|P3|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
354324|NCT00493220|858810|P2|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
354325|NCT00493220|858811|P1|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
354326|NCT00493220|858806|P6|STARTED|Second 7-Day Washout & Safety Follow-up||5
354327|NCT00493220|858807|P5|STARTED|Second 7-Day Washout & Safety Follow-up||5
354328|NCT00493220|858808|P4|STARTED|Second 7-Day Washout & Safety Follow-up||5
354329|NCT00493220|858809|P3|STARTED|Second 7-Day Washout & Safety Follow-up||5
354330|NCT00493220|858810|P2|STARTED|Second 7-Day Washout & Safety Follow-up||5
354331|NCT00493220|858811|P1|STARTED|Second 7-Day Washout & Safety Follow-up||5
354332|NCT00493220|858806|P6|NOT COMPLETED|Second Intervention||0
354333|NCT00493220|858807|P5|NOT COMPLETED|Second Intervention||0
354334|NCT00493220|858808|P4|NOT COMPLETED|Second Intervention||0
354335|NCT00493220|858809|P3|NOT COMPLETED|Second Intervention||0
354336|NCT00493220|858810|P2|NOT COMPLETED|Second Intervention||0
354337|NCT00493220|858811|P1|NOT COMPLETED|Second Intervention||0
354338|NCT00493220|858806|P6|COMPLETED|Second Intervention||5
354339|NCT00493220|858807|P5|COMPLETED|Second Intervention||5
354340|NCT00493220|858808|P4|COMPLETED|Second Intervention||5
354341|NCT00493220|858809|P3|COMPLETED|Second Intervention||5
354342|NCT00493220|858810|P2|COMPLETED|Second Intervention||5
354343|NCT00493220|858811|P1|COMPLETED|Second Intervention||5
354344|NCT00493220|858806|P6|STARTED|Second Intervention||5
354345|NCT00493220|858807|P5|STARTED|Second Intervention||5
354346|NCT00493220|858808|P4|STARTED|Second Intervention||5
354347|NCT00493220|858809|P3|STARTED|Second Intervention||5
354348|NCT00493220|858810|P2|STARTED|Second Intervention||5
354349|NCT00493220|858811|P1|STARTED|Second Intervention||5
354350|NCT00493220|858806|P6|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
354351|NCT00493220|858807|P5|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
354352|NCT00493220|858808|P4|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
354353|NCT00493220|858809|P3|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
354354|NCT00493220|858810|P2|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
354355|NCT00493220|858811|P1|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
354356|NCT00493220|858806|P6|COMPLETED|First 7-Day Washout & Safety Follow-up||5
354357|NCT00493220|858807|P5|COMPLETED|First 7-Day Washout & Safety Follow-up||5
354358|NCT00493220|858808|P4|COMPLETED|First 7-Day Washout & Safety Follow-up||5
354359|NCT00493220|858809|P3|COMPLETED|First 7-Day Washout & Safety Follow-up||5
354360|NCT00493220|858810|P2|COMPLETED|First 7-Day Washout & Safety Follow-up||5
354361|NCT00493220|858811|P1|COMPLETED|First 7-Day Washout & Safety Follow-up||5
354362|NCT00493220|858806|P6|STARTED|First 7-Day Washout & Safety Follow-up||5
354363|NCT00493220|858807|P5|STARTED|First 7-Day Washout & Safety Follow-up||5
354364|NCT00493220|858808|P4|STARTED|First 7-Day Washout & Safety Follow-up||5
354365|NCT00493220|858809|P3|STARTED|First 7-Day Washout & Safety Follow-up||5
354366|NCT00493220|858810|P2|STARTED|First 7-Day Washout & Safety Follow-up||5
354367|NCT00493220|858811|P1|STARTED|First 7-Day Washout & Safety Follow-up||5
354368|NCT00493220|858806|P6|NOT COMPLETED|First Intervention||0
354369|NCT00493220|858807|P5|NOT COMPLETED|First Intervention||0
354370|NCT00493220|858808|P4|NOT COMPLETED|First Intervention||0
354371|NCT00493220|858809|P3|NOT COMPLETED|First Intervention||0
354372|NCT00493220|858810|P2|NOT COMPLETED|First Intervention||0
354373|NCT00493220|858811|P1|NOT COMPLETED|First Intervention||0
354374|NCT00493220|858806|P6|COMPLETED|First Intervention||5
354375|NCT00493220|858807|P5|COMPLETED|First Intervention||5
354376|NCT00493220|858808|P4|COMPLETED|First Intervention||5
354377|NCT00493220|858809|P3|COMPLETED|First Intervention||5
354378|NCT00493220|858810|P2|COMPLETED|First Intervention||5
354379|NCT00493220|858811|P1|COMPLETED|First Intervention||5
354380|NCT00493220|858806|P6|STARTED|First Intervention||5
354381|NCT00493220|858807|P5|STARTED|First Intervention||5
354382|NCT00493220|858808|P4|STARTED|First Intervention||5
354383|NCT00493220|858809|P3|STARTED|First Intervention||5
354384|NCT00493220|858810|P2|STARTED|First Intervention||5
354385|NCT00493220|858811|P1|STARTED|First Intervention||5
354386|NCT00493181|858828|P1|NOT COMPLETED|Overall Study||0
354387|NCT00493181|858828|P1|COMPLETED|Overall Study||8
354388|NCT00493181|858828|P1|STARTED|Overall Study||8
354389|NCT00493064|858832|P1|NOT COMPLETED|Overall Study||11
354390|NCT00493064|858832|P1|COMPLETED|Overall Study||52
354391|NCT00493064|858832|P1|STARTED|Overall Study||63
354392|NCT00493038|858839|P2|NOT COMPLETED|Follow-up||0
354393|NCT00493038|858840|P1|NOT COMPLETED|Follow-up||1
354394|NCT00493038|858839|P2|COMPLETED|Follow-up||126
354395|NCT00493038|858840|P1|COMPLETED|Follow-up||122
354396|NCT00493038|858839|P2|STARTED|Follow-up||126
354397|NCT00493038|858840|P1|STARTED|Follow-up||123
354398|NCT00493038|858839|P2|NOT COMPLETED|Treatment||20
354399|NCT00493038|858840|P1|NOT COMPLETED|Treatment||24
354400|NCT00493038|858839|P2|COMPLETED|Treatment||126
354401|NCT00493038|858840|P1|COMPLETED|Treatment||123
354402|NCT00493038|858839|P2|Test-of-Cure Visit|Treatment||126
354403|NCT00493038|858840|P1|Test-of-Cure Visit|Treatment||123
354404|NCT00493038|858839|P2|Treated With Study Medication|Treatment||142
354405|NCT00493038|858840|P1|Treated With Study Medication|Treatment||145
354406|NCT00493038|858839|P2|Randomization|Treatment||146
354407|NCT00493038|858840|P1|Randomization|Treatment||147
354408|NCT00493038|858839|P2|STARTED|Treatment||146
354409|NCT00493038|858840|P1|STARTED|Treatment||147
354410|NCT00493025|858854|P1|NOT COMPLETED|Overall Study||19
354411|NCT00493025|858854|P1|COMPLETED|Overall Study|Trial stopped due to early stopping rule|0
354412|NCT00493025|858854|P1|STARTED|Overall Study||19
354413|NCT00493012|858865|P2|NOT COMPLETED|Overall Study||17
354414|NCT00493012|858866|P1|NOT COMPLETED|Overall Study||18
354415|NCT00493012|858865|P2|COMPLETED|Overall Study||83
354416|NCT00493012|858866|P1|COMPLETED|Overall Study||82
354417|NCT00493012|858865|P2|STARTED|Overall Study||100
354418|NCT00493012|858866|P1|STARTED|Overall Study||100
354419|NCT00492973|858894|P2|NOT COMPLETED|Overall Study||1
354420|NCT00492973|858895|P1|NOT COMPLETED|Overall Study||0
354421|NCT00492973|858894|P2|COMPLETED|Overall Study|One patient died of complications related to deep joint sepsis in the early postoperative period.|38
354422|NCT00492973|858895|P1|COMPLETED|Overall Study||37
354423|NCT00492973|858894|P2|STARTED|Overall Study||39
354424|NCT00492973|858895|P1|STARTED|Overall Study||37
354425|NCT00492921|858909|P3|NOT COMPLETED|Overall Study||1
354426|NCT00492921|858910|P2|NOT COMPLETED|Overall Study||0
354427|NCT00492921|858911|P1|NOT COMPLETED|Overall Study||1
354428|NCT00492921|858909|P3|COMPLETED|Overall Study||2
354429|NCT00492921|858910|P2|COMPLETED|Overall Study||4
354430|NCT00492921|858911|P1|COMPLETED|Overall Study||4
354431|NCT00492921|858909|P3|STARTED|Overall Study||3
354432|NCT00492921|858910|P2|STARTED|Overall Study||4
354433|NCT00492921|858911|P1|STARTED|Overall Study||5
354434|NCT00492856|858922|P4|NOT COMPLETED|Post-consolidation||1
354435|NCT00492856|858923|P3|NOT COMPLETED|Post-consolidation||27
354436|NCT00492856|858924|P2|NOT COMPLETED|Post-consolidation||12
354437|NCT00492856|858925|P1|NOT COMPLETED|Post-consolidation||0
354438|NCT00492856|858922|P4|COMPLETED|Post-consolidation||0
354439|NCT00492856|858923|P3|COMPLETED|Post-consolidation||0
354440|NCT00492856|858924|P2|COMPLETED|Post-consolidation||29
354441|NCT00492856|858925|P1|COMPLETED|Post-consolidation||0
354442|NCT00492856|858922|P4|STARTED|Post-consolidation||1
354443|NCT00492856|858923|P3|STARTED|Post-consolidation||27
354444|NCT00492856|858924|P2|STARTED|Post-consolidation||41
354445|NCT00492856|858925|P1|STARTED|Post-consolidation|Patients who achieve CRm, are randomized to the treatment arm, and are eligible.|0
354446|NCT00492856|858922|P4|NOT COMPLETED|Consolidation||0
354447|NCT00492856|858923|P3|NOT COMPLETED|Consolidation||0
354448|NCT00492856|858924|P2|NOT COMPLETED|Consolidation||0
354449|NCT00492856|858925|P1|NOT COMPLETED|Consolidation||9
354450|NCT00492856|858922|P4|COMPLETED|Consolidation||0
354451|NCT00492856|858923|P3|COMPLETED|Consolidation||0
354452|NCT00492856|858924|P2|COMPLETED|Consolidation||0
354453|NCT00492856|858925|P1|COMPLETED|Consolidation||83
354454|NCT00492856|858922|P4|STARTED|Consolidation||0
354455|NCT00492856|858923|P3|STARTED|Consolidation||0
354456|NCT00492856|858924|P2|STARTED|Consolidation||0
354457|NCT00492856|858925|P1|STARTED|Consolidation|Patients in CR (CRm), CRi, or PR after induction, register for consolidation and are eligible.|92
354458|NCT00492856|858922|P4|NOT COMPLETED|Induction||0
354459|NCT00492856|858923|P3|NOT COMPLETED|Induction||0
354460|NCT00492856|858924|P2|NOT COMPLETED|Induction||0
354461|NCT00492856|858925|P1|NOT COMPLETED|Induction||6
354462|NCT00492856|858922|P4|COMPLETED|Induction||0
354463|NCT00492856|858923|P3|COMPLETED|Induction||0
354464|NCT00492856|858924|P2|COMPLETED|Induction||0
354465|NCT00492856|858925|P1|COMPLETED|Induction||99
354466|NCT00492856|858922|P4|STARTED|Induction||0
354467|NCT00492856|858923|P3|STARTED|Induction||0
354468|NCT00492856|858924|P2|STARTED|Induction||0
354469|NCT00492856|858925|P1|STARTED|Induction||105
354470|NCT00492752|858939|P4|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||6
354471|NCT00492752|858940|P3|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||47
354472|NCT00492752|858941|P2|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||16
354473|NCT00492752|858942|P1|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||86
354474|NCT00492752|858939|P4|COMPLETED|Follow-up and/or Open Label Sorafenib||0
354475|NCT00492752|858940|P3|COMPLETED|Follow-up and/or Open Label Sorafenib|20 participants were followed up until the end of this trial|20
354476|NCT00492752|858941|P2|COMPLETED|Follow-up and/or Open Label Sorafenib||0
354477|NCT00492752|858942|P1|COMPLETED|Follow-up and/or Open Label Sorafenib|1 participant completed all assessments, 33 were followed up until the end of this trial|34
354478|NCT00492752|858939|P4|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||6
354479|NCT00492752|858940|P3|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
354480|NCT00492752|858941|P2|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||16
354481|NCT00492752|858942|P1|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
354482|NCT00492752|858939|P4|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
354483|NCT00492752|858940|P3|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||67
354484|NCT00492752|858941|P2|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
354485|NCT00492752|858942|P1|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||120
354486|NCT00492752|858939|P4|STARTED|Follow-up and/or Open Label Sorafenib||6
354487|NCT00492752|858940|P3|STARTED|Follow-up and/or Open Label Sorafenib||67
354488|NCT00492752|858941|P2|STARTED|Follow-up and/or Open Label Sorafenib||16
354489|NCT00492752|858942|P1|STARTED|Follow-up and/or Open Label Sorafenib||120
354490|NCT00492752|858939|P4|NOT COMPLETED|Double Blind Treatment||0
354491|NCT00492752|858940|P3|NOT COMPLETED|Double Blind Treatment||3
354492|NCT00492752|858941|P2|NOT COMPLETED|Double Blind Treatment||0
354493|NCT00492752|858942|P1|NOT COMPLETED|Double Blind Treatment||14
354494|NCT00492752|858939|P4|COMPLETED|Double Blind Treatment||6
354495|NCT00492752|858940|P3|COMPLETED|Double Blind Treatment||67
354496|NCT00492752|858941|P2|COMPLETED|Double Blind Treatment||16
354497|NCT00492752|858942|P1|COMPLETED|Double Blind Treatment||120
354498|NCT00492752|858939|P4|Received Treatment|Double Blind Treatment|Safety Population|6
354499|NCT00492752|858940|P3|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to protocol violation.|69
354586|NCT00492284|859175|P4|NOT COMPLETED|Overall Study||10
354500|NCT00492752|858941|P2|Received Treatment|Double Blind Treatment|Safety Population|16
354501|NCT00492752|858942|P1|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to an Adverse Event.|133
354502|NCT00492752|858939|P4|STARTED|Double Blind Treatment||6
354503|NCT00492752|858940|P3|STARTED|Double Blind Treatment||70
354504|NCT00492752|858941|P2|STARTED|Double Blind Treatment||16
354505|NCT00492752|858942|P1|STARTED|Double Blind Treatment||134
354506|NCT00492726|858977|P2|NOT COMPLETED|Overall Study||36
354507|NCT00492726|858978|P1|NOT COMPLETED|Overall Study||50
354508|NCT00492726|858977|P2|COMPLETED|Overall Study||358
354509|NCT00492726|858978|P1|COMPLETED|Overall Study||360
354510|NCT00492726|858977|P2|End of Study|Overall Study||358
354511|NCT00492726|858978|P1|End of Study|Overall Study||360
354512|NCT00492726|858977|P2|End of Treatment (EOT, Day 5 to 14)|Overall Study||377
354513|NCT00492726|858978|P1|End of Treatment (EOT, Day 5 to 14)|Overall Study||387
354514|NCT00492726|858977|P2|STARTED|Overall Study||394
354515|NCT00492726|858978|P1|STARTED|Overall Study||410
354516|NCT00492648|859004|P2|NOT COMPLETED|Month 42 (109674 Study)||0
354517|NCT00492648|859005|P1|NOT COMPLETED|Month 42 (109674 Study)||0
354518|NCT00492648|859004|P2|COMPLETED|Month 42 (109674 Study)||20
354519|NCT00492648|859005|P1|COMPLETED|Month 42 (109674 Study)||3
354520|NCT00492648|859004|P2|STARTED|Month 42 (109674 Study)||20
354521|NCT00492648|859005|P1|STARTED|Month 42 (109674 Study)||3
354522|NCT00492648|859004|P2|NOT COMPLETED|Month 30 (109671 Study)||1
354523|NCT00492648|859005|P1|NOT COMPLETED|Month 30 (109671 Study)||0
354524|NCT00492648|859004|P2|COMPLETED|Month 30 (109671 Study)||29
354525|NCT00492648|859005|P1|COMPLETED|Month 30 (109671 Study)||4
354526|NCT00492648|859004|P2|STARTED|Month 30 (109671 Study)||30
354527|NCT00492648|859005|P1|STARTED|Month 30 (109671 Study)||4
354528|NCT00492622|859031|P1|NOT COMPLETED|Overall Study||0
354529|NCT00492622|859031|P1|COMPLETED|Overall Study||12
354530|NCT00492622|859031|P1|STARTED|Overall Study|all subjects received the immediate release formulation|12
354531|NCT00492583|859043|P2|NOT COMPLETED|Overall Study||0
354532|NCT00492583|859044|P1|NOT COMPLETED|Overall Study||0
354533|NCT00492583|859043|P2|COMPLETED|Overall Study||87
354534|NCT00492583|859044|P1|COMPLETED|Overall Study||95
354535|NCT00492583|859043|P2|STARTED|Overall Study||87
354536|NCT00492583|859044|P1|STARTED|Overall Study||95
354537|NCT00492557|859052|P2|NOT COMPLETED|Overall Study||23
354538|NCT00492557|859053|P1|NOT COMPLETED|Overall Study||24
354539|NCT00492557|859052|P2|COMPLETED|Overall Study||557
354540|NCT00492557|859053|P1|COMPLETED|Overall Study||556
354541|NCT00492557|859052|P2|Vaccinated Dose 2|Overall Study||558
354542|NCT00492557|859053|P1|Vaccinated Dose 2|Overall Study||560
354543|NCT00492557|859052|P2|Vaccinated Dose 1|Overall Study||575
354544|NCT00492557|859053|P1|Vaccinated Dose 1|Overall Study||577
354545|NCT00492557|859052|P2|STARTED|Overall Study||580
354546|NCT00492557|859053|P1|STARTED|Overall Study||580
354547|NCT00492544|859069|P1|NOT COMPLETED|Overall Study||0
354548|NCT00492544|859069|P1|COMPLETED|Overall Study||100
354549|NCT00492544|859069|P1|STARTED|Overall Study||100
354550|NCT00492531|859083|P2|NOT COMPLETED|Overall Study||23
354551|NCT00492531|859084|P1|NOT COMPLETED|Overall Study||22
354552|NCT00492531|859083|P2|COMPLETED|Overall Study|Of 14 subjects who completed study, 13 were enrolled in Open label.|14
354553|NCT00492531|859084|P1|COMPLETED|Overall Study|Of 15 subjects who completed study, 13 were enrolled in Open label.|15
354554|NCT00492531|859083|P2|STARTED|Overall Study||37
354555|NCT00492531|859084|P1|STARTED|Overall Study||37
354556|NCT00492401|859096|P1|NOT COMPLETED|Overall Study||0
354557|NCT00492401|859096|P1|COMPLETED|Overall Study||55
354558|NCT00492401|859096|P1|STARTED|Overall Study||55
354559|NCT00492349|859107|P2|NOT COMPLETED|Overall Study||7
354560|NCT00492349|859108|P1|NOT COMPLETED|Overall Study||3
354561|NCT00492349|859107|P2|COMPLETED|Overall Study||27
354562|NCT00492349|859108|P1|COMPLETED|Overall Study||32
354563|NCT00492349|859107|P2|Week 8|Overall Study||27
354564|NCT00492349|859108|P1|Week 8|Overall Study||32
354565|NCT00492349|859107|P2|Week 2|Overall Study||33
354566|NCT00492349|859108|P1|Week 2|Overall Study||32
354567|NCT00492349|859107|P2|STARTED|Overall Study||34
354568|NCT00492349|859108|P1|STARTED|Overall Study||35
354569|NCT00492336|859130|P2|NOT COMPLETED|Overall Study||6
354570|NCT00492336|859131|P1|NOT COMPLETED|Overall Study||2
354571|NCT00492336|859130|P2|COMPLETED|Overall Study||23
354572|NCT00492336|859131|P1|COMPLETED|Overall Study||26
354573|NCT00492336|859130|P2|STARTED|Overall Study||29
354574|NCT00492336|859131|P1|STARTED|Overall Study||28
354575|NCT00492297|859157|P1|NOT COMPLETED|Survival Only Follow-up||59
354576|NCT00492297|859157|P1|COMPLETED|Survival Only Follow-up||0
354577|NCT00492297|859157|P1|STARTED|Survival Only Follow-up||59
354578|NCT00492297|859157|P1|NOT COMPLETED|Active Follow-up 30(+4) Days Duration||19
354579|NCT00492297|859157|P1|COMPLETED|Active Follow-up 30(+4) Days Duration||59
354580|NCT00492297|859157|P1|STARTED|Active Follow-up 30(+4) Days Duration|AFU is 30(+4) days duration for subjects withdrawn from sorafenib due to PD.|78
354581|NCT00492297|859157|P1|NOT COMPLETED|Treatment||5
354582|NCT00492297|859157|P1|COMPLETED|Treatment||78
354583|NCT00492297|859157|P1|Second Stage of Simon Optimal Design|Treatment|Recruitment continued into the second stage. 51 of 83 subjects were treated in the second stage.|51
354584|NCT00492297|859157|P1|First Stage of Simon Optimal Design|Treatment|32 subjects of 83 subjects enrolled were treated in first stage.|32
354585|NCT00492297|859157|P1|STARTED|Treatment||83
354587|NCT00492284|859176|P3|NOT COMPLETED|Overall Study||6
354588|NCT00492284|859177|P2|NOT COMPLETED|Overall Study||4
354589|NCT00492284|859178|P1|NOT COMPLETED|Overall Study||1
354590|NCT00492284|859175|P4|COMPLETED|Overall Study||31
354591|NCT00492284|859176|P3|COMPLETED|Overall Study||37
354592|NCT00492284|859177|P2|COMPLETED|Overall Study||35
354593|NCT00492284|859178|P1|COMPLETED|Overall Study||38
354594|NCT00492284|859175|P4|STARTED|Overall Study||41
354595|NCT00492284|859176|P3|STARTED|Overall Study||43
354596|NCT00492284|859177|P2|STARTED|Overall Study||39
354597|NCT00492284|859178|P1|STARTED|Overall Study||39
354598|NCT00492232|859222|P2|NOT COMPLETED|Open-Label Treatment||0
354599|NCT00492232|859223|P1|NOT COMPLETED|Open-Label Treatment||1
354600|NCT00492232|859222|P2|COMPLETED|Open-Label Treatment||0
354601|NCT00492232|859223|P1|COMPLETED|Open-Label Treatment||88
354602|NCT00492232|859222|P2|STARTED|Open-Label Treatment|All subjects received ramelteon in the OLTP.|0
354603|NCT00492232|859223|P1|STARTED|Open-Label Treatment|In the previous DBTP, 45 and 44 subjects were randomized to ramelteon and placebo, respectively.|89
354604|NCT00492232|859222|P2|NOT COMPLETED|Double-Blind Treatment||25
354605|NCT00492232|859223|P1|NOT COMPLETED|Double-Blind Treatment||18
354606|NCT00492232|859222|P2|COMPLETED|Double-Blind Treatment||45
354607|NCT00492232|859223|P1|COMPLETED|Double-Blind Treatment||47
354608|NCT00492232|859222|P2|STARTED|Double-Blind Treatment||70
354609|NCT00492232|859223|P1|STARTED|Double-Blind Treatment||65
354610|NCT00492232|859222|P2|NOT COMPLETED|Placebo Run-in||70
354611|NCT00492232|859223|P1|NOT COMPLETED|Placebo Run-in||0
354612|NCT00492232|859222|P2|COMPLETED|Placebo Run-in|These subjects successfully completed the placebo run-in period and were randomized to the DBTP.|135
354613|NCT00492232|859223|P1|COMPLETED|Placebo Run-in||0
354614|NCT00492232|859222|P2|STARTED|Placebo Run-in|All subjects received placebo in the placebo run-in period.|205
354615|NCT00492232|859223|P1|STARTED|Placebo Run-in||0
354616|NCT00492206|859255|P1|NOT COMPLETED|Overall Study||0
354617|NCT00492206|859255|P1|COMPLETED|Overall Study||40
354618|NCT00492206|859255|P1|STARTED|Overall Study||40
354619|NCT00492115|859264|P2|NOT COMPLETED|Overall Study||4
354620|NCT00492115|859265|P1|NOT COMPLETED|Overall Study||3
354621|NCT00492115|859264|P2|COMPLETED|Overall Study|4 dropped due to not being able to tolerate CPAP|15
354622|NCT00492115|859265|P1|COMPLETED|Overall Study|3 dropped due to anxiety or not being able to tolerate CPAP|16
354623|NCT00492115|859264|P2|STARTED|Overall Study||19
354624|NCT00492115|859265|P1|STARTED|Overall Study||19
354625|NCT00492089|859275|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
354626|NCT00492089|859276|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
354627|NCT00492089|859275|P2|COMPLETED|Second Intervention (6 Weeks)||6
354628|NCT00492089|859276|P1|COMPLETED|Second Intervention (6 Weeks)||5
354629|NCT00492089|859275|P2|STARTED|Second Intervention (6 Weeks)||6
354630|NCT00492089|859276|P1|STARTED|Second Intervention (6 Weeks)||5
354631|NCT00492089|859275|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
354632|NCT00492089|859276|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
354633|NCT00492089|859275|P2|COMPLETED|First Intervention (6 Weeks)||6
354634|NCT00492089|859276|P1|COMPLETED|First Intervention (6 Weeks)||5
354635|NCT00492089|859275|P2|STARTED|First Intervention (6 Weeks)||6
354636|NCT00492089|859276|P1|STARTED|First Intervention (6 Weeks)||5
354637|NCT00492063|859286|P4|NOT COMPLETED|Overall Study||10
354638|NCT00492063|859287|P3|NOT COMPLETED|Overall Study||11
354639|NCT00492063|859288|P2|NOT COMPLETED|Overall Study||14
354640|NCT00492063|859289|P1|NOT COMPLETED|Overall Study||10
354641|NCT00492063|859286|P4|COMPLETED|Overall Study||666
354642|NCT00492063|859287|P3|COMPLETED|Overall Study||667
354643|NCT00492063|859288|P2|COMPLETED|Overall Study||634
354644|NCT00492063|859289|P1|COMPLETED|Overall Study||642
354645|NCT00492063|859286|P4|STARTED|Overall Study||676
354646|NCT00492063|859287|P3|STARTED|Overall Study||678
354647|NCT00492063|859288|P2|STARTED|Overall Study||648
354648|NCT00492063|859289|P1|STARTED|Overall Study||652
354649|NCT00492024|859313|P2|NOT COMPLETED|Follow up||2
354650|NCT00492024|859314|P1|NOT COMPLETED|Follow up||1
354651|NCT00492024|859313|P2|COMPLETED|Follow up||99
354652|NCT00492024|859314|P1|COMPLETED|Follow up||221
354653|NCT00492024|859313|P2|STARTED|Follow up||101
354654|NCT00492024|859314|P1|STARTED|Follow up||222
354655|NCT00492024|859313|P2|NOT COMPLETED|Treatment||22
354656|NCT00492024|859314|P1|NOT COMPLETED|Treatment||29
354657|NCT00492024|859313|P2|COMPLETED|Treatment||101
354658|NCT00492024|859314|P1|COMPLETED|Treatment||222
354659|NCT00492024|859313|P2|STARTED|Treatment||123
354660|NCT00492024|859314|P1|STARTED|Treatment||251
354661|NCT00491894|859330|P1|NOT COMPLETED|Overall Study||34
354662|NCT00491894|859330|P1|COMPLETED|Overall Study||103
354663|NCT00491894|859330|P1|STARTED|Overall Study||137
354664|NCT00491829|859341|P3|NOT COMPLETED|Overall Study||75
354665|NCT00491829|859342|P2|NOT COMPLETED|Overall Study||114
354666|NCT00491829|859343|P1|NOT COMPLETED|Overall Study||95
354667|NCT00491829|859341|P3|COMPLETED|Overall Study||243
354668|NCT00491829|859342|P2|COMPLETED|Overall Study||202
354669|NCT00491829|859343|P1|COMPLETED|Overall Study||216
354670|NCT00491829|859341|P3|STARTED|Overall Study||318
354671|NCT00491829|859342|P2|STARTED|Overall Study||316
354672|NCT00491829|859343|P1|STARTED|Overall Study||311
354673|NCT00491764|859357|P6|NOT COMPLETED|Overall Study||9
354674|NCT00491764|859358|P5|NOT COMPLETED|Overall Study||3
354675|NCT00491764|859359|P4|NOT COMPLETED|Overall Study||8
354676|NCT00491764|859360|P3|NOT COMPLETED|Overall Study||8
354677|NCT00491764|859361|P2|NOT COMPLETED|Overall Study||7
354678|NCT00491764|859362|P1|NOT COMPLETED|Overall Study||5
354679|NCT00491764|859357|P6|COMPLETED|Overall Study||27
354680|NCT00491764|859358|P5|COMPLETED|Overall Study||33
354681|NCT00491764|859359|P4|COMPLETED|Overall Study||28
354682|NCT00491764|859360|P3|COMPLETED|Overall Study||28
354683|NCT00491764|859361|P2|COMPLETED|Overall Study||30
354684|NCT00491764|859362|P1|COMPLETED|Overall Study||32
354685|NCT00491764|859357|P6|STARTED|Overall Study||36
354686|NCT00491764|859358|P5|STARTED|Overall Study||36
354687|NCT00491764|859359|P4|STARTED|Overall Study||36
354688|NCT00491764|859360|P3|STARTED|Overall Study||36
354689|NCT00491764|859361|P2|STARTED|Overall Study||37
354690|NCT00491764|859362|P1|STARTED|Overall Study||37
354691|NCT00491751|859391|P3|NOT COMPLETED|Overall Study||0
354692|NCT00491751|859392|P2|NOT COMPLETED|Overall Study||0
354693|NCT00491751|859393|P1|NOT COMPLETED|Overall Study||0
354694|NCT00491751|859391|P3|COMPLETED|Overall Study||42
354695|NCT00491751|859392|P2|COMPLETED|Overall Study||44
354696|NCT00491751|859393|P1|COMPLETED|Overall Study||22
354697|NCT00491751|859391|P3|STARTED|Overall Study||42
354698|NCT00491751|859392|P2|STARTED|Overall Study||44
354699|NCT00491751|859393|P1|STARTED|Overall Study||22
354700|NCT00491738|859405|P2|NOT COMPLETED|Overall Study||0
354701|NCT00491738|859406|P1|NOT COMPLETED|Overall Study||0
354702|NCT00491738|859405|P2|COMPLETED|Overall Study||9
354703|NCT00491738|859406|P1|COMPLETED|Overall Study||7
354704|NCT00491738|859405|P2|STARTED|Overall Study||9
354705|NCT00491738|859406|P1|STARTED|Overall Study||7
354706|NCT00491608|859410|P1|NOT COMPLETED|Overall Study||3
354707|NCT00491608|859410|P1|COMPLETED|Overall Study||206
354708|NCT00491608|859410|P1|STARTED|Overall Study|Participants who received treatment|209
354709|NCT00491556|859421|P2|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||5
354710|NCT00491556|859422|P1|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||24
354711|NCT00491556|859421|P2|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||22
354712|NCT00491556|859422|P1|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||25
354713|NCT00491556|859421|P2|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||27
354714|NCT00491556|859422|P1|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||49
354715|NCT00491556|859421|P2|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||0
354716|NCT00491556|859422|P1|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||26
354717|NCT00491556|859421|P2|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||27
354718|NCT00491556|859422|P1|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||49
354719|NCT00491556|859421|P2|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||27
354720|NCT00491556|859422|P1|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||53
354721|NCT00491556|859421|P2|STARTED|Entry-Week (WK) 48: EXP/Standard Care||27
354722|NCT00491556|859422|P1|STARTED|Entry-Week (WK) 48: EXP/Standard Care||75
354723|NCT00491530|859481|P3|NOT COMPLETED|Overall Study||5
354724|NCT00491530|859482|P2|NOT COMPLETED|Overall Study||6
354725|NCT00491530|859483|P1|NOT COMPLETED|Overall Study||12
354726|NCT00491530|859481|P3|COMPLETED|Overall Study||81
354727|NCT00491530|859482|P2|COMPLETED|Overall Study||44
354728|NCT00491530|859483|P1|COMPLETED|Overall Study||162
354729|NCT00491530|859481|P3|STARTED|Overall Study||86
354730|NCT00491530|859482|P2|STARTED|Overall Study||50
354731|NCT00491530|859483|P1|STARTED|Overall Study||174
354732|NCT00491504|859513|P4|NOT COMPLETED|Overall Study||4
354733|NCT00491504|859514|P3|NOT COMPLETED|Overall Study||4
354734|NCT00491504|859515|P2|NOT COMPLETED|Overall Study||1
354735|NCT00491504|859516|P1|NOT COMPLETED|Overall Study||0
354736|NCT00491504|859513|P4|COMPLETED|Overall Study||73
354737|NCT00491504|859514|P3|COMPLETED|Overall Study||74
354738|NCT00491504|859515|P2|COMPLETED|Overall Study||77
354739|NCT00491504|859516|P1|COMPLETED|Overall Study||77
354740|NCT00491504|859513|P4|STARTED|Overall Study|All subjects who received placebo on Day 1 through Day 7|77
354741|NCT00491504|859514|P3|STARTED|Overall Study|All subjects who received MFNS on Day 1 through Day 7|78
354742|NCT00491504|859515|P2|STARTED|Overall Study|All subjects who received placebo only on Day 1|78
354743|NCT00491504|859516|P1|STARTED|Overall Study|All subjects who received MFNS only on Day 1|77
354744|NCT00491400|859526|P2|NOT COMPLETED|Overall Study||4
354745|NCT00491400|859527|P1|NOT COMPLETED|Overall Study||5
354746|NCT00491400|859526|P2|COMPLETED|Overall Study||9
354747|NCT00491400|859527|P1|COMPLETED|Overall Study||10
354748|NCT00491400|859526|P2|Finished Second Treatment|Overall Study|None withdrew during fenofibrate treatment (second treatment)|9
354749|NCT00491400|859527|P1|Finished Second Treatment|Overall Study|2 withdrew during atorvastatin treatment (second treatment)|10
354750|NCT00491400|859526|P2|Started Second Treatment|Overall Study|None withdrew during the washout period|9
354751|NCT00491400|859527|P1|Started Second Treatment|Overall Study|2 withdrew during washout period|12
354752|NCT00491400|859526|P2|Completed First Treatment|Overall Study|4 withdrew during atorvastatin treatment (first treatment)|9
354753|NCT00491400|859527|P1|Completed First Treatment|Overall Study|None withdrew during fenofibrate treatment (first treatment)|14
354754|NCT00491400|859526|P2|Started First Treatment|Overall Study|None withdrew prior to starting atorvastatin|13
354755|NCT00491400|859527|P1|Started First Treatment|Overall Study|1 withdrew prior to starting fenofibrate|14
354756|NCT00491400|859526|P2|STARTED|Overall Study||13
354757|NCT00491400|859527|P1|STARTED|Overall Study||15
354758|NCT00491387|859535|P1|NOT COMPLETED|Overall Study||20
354759|NCT00491387|859535|P1|COMPLETED|Overall Study||4
354760|NCT00491387|859535|P1|Study Enrollment|Overall Study||24
354761|NCT00491387|859535|P1|STARTED|Overall Study||24
354762|NCT00491374|859541|P2|NOT COMPLETED|Overall Study||0
354763|NCT00491374|859542|P1|NOT COMPLETED|Overall Study||0
354764|NCT00491374|859541|P2|COMPLETED|Overall Study||0
354765|NCT00491374|859542|P1|COMPLETED|Overall Study||0
354766|NCT00491374|859541|P2|STARTED|Overall Study||0
354767|NCT00491374|859542|P1|STARTED|Overall Study||0
354768|NCT00491322|859550|P2|NOT COMPLETED|Overall Study||1
354769|NCT00491322|859551|P1|NOT COMPLETED|Overall Study||1
354770|NCT00491322|859550|P2|COMPLETED|Overall Study||50
354771|NCT00491322|859551|P1|COMPLETED|Overall Study||40
354772|NCT00491322|859550|P2|STARTED|Overall Study||51
354773|NCT00491322|859551|P1|STARTED|Overall Study||41
354774|NCT00491244|859559|P2|NOT COMPLETED|Overall Study||20
354775|NCT00491244|859560|P1|NOT COMPLETED|Overall Study||27
354776|NCT00491244|859559|P2|COMPLETED|Overall Study||168
354777|NCT00491244|859560|P1|COMPLETED|Overall Study||162
354778|NCT00491244|859559|P2|STARTED|Overall Study||188
354779|NCT00491244|859560|P1|STARTED|Overall Study||189
354780|NCT00491179|859570|P2|NOT COMPLETED|Overall Study||2
354781|NCT00491179|859571|P1|NOT COMPLETED|Overall Study||7
354782|NCT00491179|859570|P2|COMPLETED|Overall Study||8
354783|NCT00491179|859571|P1|COMPLETED|Overall Study||18
354784|NCT00491179|859570|P2|STARTED|Overall Study||10
354785|NCT00491179|859571|P1|STARTED|Overall Study||25
354786|NCT00491075|859579|P1|NOT COMPLETED|Overall Study||2
354787|NCT00491075|859579|P1|COMPLETED|Overall Study||14
354788|NCT00491075|859579|P1|STARTED|Overall Study||16
354789|NCT00490971|859585|P5|NOT COMPLETED|Maintenance||39
354790|NCT00490971|859586|P4|NOT COMPLETED|Maintenance||53
354791|NCT00490971|859587|P3|NOT COMPLETED|Maintenance||51
354792|NCT00490971|859588|P2|NOT COMPLETED|Maintenance||0
354793|NCT00490971|859589|P1|NOT COMPLETED|Maintenance||0
354794|NCT00490971|859585|P5|COMPLETED|Maintenance||44
354795|NCT00490971|859586|P4|COMPLETED|Maintenance||96
354796|NCT00490971|859587|P3|COMPLETED|Maintenance||96
354797|NCT00490971|859588|P2|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
354798|NCT00490971|859589|P1|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
354799|NCT00490971|859585|P5|STARTED|Maintenance||83
354800|NCT00490971|859586|P4|STARTED|Maintenance|152 participants were assigned to pali/pali, out of which 149 took the study medication.|149
354801|NCT00490971|859587|P3|STARTED|Maintenance|148 participants were assigned to pali/placebo, out of which 147 took the study medication.|147
354802|NCT00490971|859588|P2|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
354803|NCT00490971|859589|P1|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
354804|NCT00490971|859585|P5|NOT COMPLETED|Acute/Continuation||0
354805|NCT00490971|859586|P4|NOT COMPLETED|Acute/Continuation||0
354806|NCT00490971|859587|P3|NOT COMPLETED|Acute/Continuation||0
354807|NCT00490971|859588|P2|NOT COMPLETED|Acute/Continuation||62
354808|NCT00490971|859589|P1|NOT COMPLETED|Acute/Continuation||306
354809|NCT00490971|859585|P5|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
354810|NCT00490971|859586|P4|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
354811|NCT00490971|859587|P3|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
354812|NCT00490971|859588|P2|COMPLETED|Acute/Continuation||86
354813|NCT00490971|859589|P1|COMPLETED|Acute/Continuation||308
354814|NCT00490971|859585|P5|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
354815|NCT00490971|859586|P4|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
354816|NCT00490971|859587|P3|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
354817|NCT00490971|859588|P2|STARTED|Acute/Continuation|149 participants were assigned to paliperidone, out of which 148 took the study medication.|148
354818|NCT00490971|859589|P1|STARTED|Acute/Continuation|617 participants were assigned to paliperidone, out of which 614 took the study medication.|614
354819|NCT00490945|859636|P5|NOT COMPLETED|Overall Study||0
354820|NCT00490945|859637|P4|NOT COMPLETED|Overall Study||0
354821|NCT00490945|859638|P3|NOT COMPLETED|Overall Study||0
354822|NCT00490945|859639|P2|NOT COMPLETED|Overall Study||1
354823|NCT00490945|859640|P1|NOT COMPLETED|Overall Study||0
354824|NCT00490945|859636|P5|COMPLETED|Overall Study||7
354825|NCT00490945|859637|P4|COMPLETED|Overall Study||7
354826|NCT00490945|859638|P3|COMPLETED|Overall Study||8
354827|NCT00490945|859639|P2|COMPLETED|Overall Study||8
354828|NCT00490945|859640|P1|COMPLETED|Overall Study||8
354829|NCT00490945|859636|P5|STARTED|Overall Study||7
354830|NCT00490945|859637|P4|STARTED|Overall Study||7
354831|NCT00490945|859638|P3|STARTED|Overall Study||8
354832|NCT00490945|859639|P2|STARTED|Overall Study||9
354833|NCT00490945|859640|P1|STARTED|Overall Study||8
354834|NCT00490919|859676|P3|NOT COMPLETED|Double-blind Phase||84
354835|NCT00490919|859677|P2|NOT COMPLETED|Double-blind Phase||86
354836|NCT00490919|859678|P1|NOT COMPLETED|Double-blind Phase||0
354837|NCT00490919|859676|P3|COMPLETED|Double-blind Phase||199
354838|NCT00490919|859677|P2|COMPLETED|Double-blind Phase||170
354839|NCT00490919|859678|P1|COMPLETED|Double-blind Phase||0
354930|NCT00490451|859914|P1|NOT COMPLETED|Overall Study||63
354931|NCT00490451|859913|P2|COMPLETED|Overall Study||0
354840|NCT00490919|859676|P3|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|283
354841|NCT00490919|859677|P2|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|256
354842|NCT00490919|859678|P1|STARTED|Double-blind Phase||0
354843|NCT00490919|859676|P3|NOT COMPLETED|Open-label Run-in Period||0
354844|NCT00490919|859677|P2|NOT COMPLETED|Open-label Run-in Period||0
354845|NCT00490919|859678|P1|NOT COMPLETED|Open-label Run-in Period||483
354846|NCT00490919|859676|P3|COMPLETED|Open-label Run-in Period||0
354847|NCT00490919|859677|P2|COMPLETED|Open-label Run-in Period||0
354848|NCT00490919|859678|P1|COMPLETED|Open-label Run-in Period|Completed run-in and randomized; however 2 had no safety data after randomization visit (N = 539)|541
354849|NCT00490919|859676|P3|STARTED|Open-label Run-in Period||0
354850|NCT00490919|859677|P2|STARTED|Open-label Run-in Period||0
354851|NCT00490919|859678|P1|STARTED|Open-label Run-in Period||1024
354852|NCT00490841|859689|P1|NOT COMPLETED|Overall Study||13
354853|NCT00490841|859689|P1|COMPLETED|Overall Study||189
354854|NCT00490841|859689|P1|STARTED|Overall Study||202
354855|NCT00490815|859711|P2|NOT COMPLETED|Overall Study||9
354856|NCT00490815|859712|P1|NOT COMPLETED|Overall Study||8
354857|NCT00490815|859711|P2|COMPLETED|Overall Study||8
354858|NCT00490815|859712|P1|COMPLETED|Overall Study||12
354859|NCT00490815|859711|P2|STARTED|Overall Study||17
354860|NCT00490815|859712|P1|STARTED|Overall Study||20
354861|NCT00490802|859722|P2|NOT COMPLETED|Overall Study||2
354862|NCT00490802|859723|P1|NOT COMPLETED|Overall Study||1
354863|NCT00490802|859722|P2|COMPLETED|Overall Study||7
354864|NCT00490802|859723|P1|COMPLETED|Overall Study||9
354865|NCT00490802|859722|P2|STARTED|Overall Study||9
354866|NCT00490802|859723|P1|STARTED|Overall Study||10
354867|NCT00490724|859740|P3|NOT COMPLETED|Period II||3
354868|NCT00490724|859741|P2|NOT COMPLETED|Period II||1
354869|NCT00490724|859742|P1|NOT COMPLETED|Period II||3
354870|NCT00490724|859740|P3|COMPLETED|Period II||16
354871|NCT00490724|859741|P2|COMPLETED|Period II||19
354872|NCT00490724|859742|P1|COMPLETED|Period II||18
354873|NCT00490724|859740|P3|STARTED|Period II||19
354874|NCT00490724|859741|P2|STARTED|Period II||20
354875|NCT00490724|859742|P1|STARTED|Period II||21
354876|NCT00490724|859740|P3|NOT COMPLETED|Period I||1
354877|NCT00490724|859741|P2|NOT COMPLETED|Period I||0
354878|NCT00490724|859742|P1|NOT COMPLETED|Period I||0
354879|NCT00490724|859740|P3|COMPLETED|Period I||19
354880|NCT00490724|859741|P2|COMPLETED|Period I||20
354881|NCT00490724|859742|P1|COMPLETED|Period I||21
354882|NCT00490724|859740|P3|STARTED|Period I||20
354883|NCT00490724|859741|P2|STARTED|Period I||20
354884|NCT00490724|859742|P1|STARTED|Period I||21
354885|NCT00490698|859807|P1|NOT COMPLETED|Overall Study||10
354886|NCT00490698|859807|P1|COMPLETED|Overall Study||1
354887|NCT00490698|859807|P1|STARTED|Overall Study||11
354888|NCT00490646|859813|P2|NOT COMPLETED|Overall Study||2
354889|NCT00490646|859814|P1|NOT COMPLETED|Overall Study||2
354890|NCT00490646|859813|P2|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=13; study drug toxicity=1)|23
354891|NCT00490646|859814|P1|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=14; study drug toxicity=4)|23
354892|NCT00490646|859813|P2|Treated|Overall Study||24
354893|NCT00490646|859814|P1|Treated|Overall Study||24
354894|NCT00490646|859813|P2|STARTED|Overall Study||25
354895|NCT00490646|859814|P1|STARTED|Overall Study||25
354896|NCT00490568|859834|P1|NOT COMPLETED|Overall Study||1364
354897|NCT00490568|859834|P1|COMPLETED|Overall Study||97
354898|NCT00490568|859834|P1|STARTED|Overall Study||1461
354899|NCT00490555|859858|P4|NOT COMPLETED|Overall Study||0
354900|NCT00490555|859859|P3|NOT COMPLETED|Overall Study||2
354901|NCT00490555|859860|P2|NOT COMPLETED|Overall Study||0
354902|NCT00490555|859861|P1|NOT COMPLETED|Overall Study||0
354903|NCT00490555|859858|P4|COMPLETED|Overall Study||7
354904|NCT00490555|859859|P3|COMPLETED|Overall Study||7
354905|NCT00490555|859860|P2|COMPLETED|Overall Study||8
354906|NCT00490555|859861|P1|COMPLETED|Overall Study||8
354907|NCT00490555|859858|P4|STARTED|Overall Study||7
354908|NCT00490555|859859|P3|STARTED|Overall Study||9
354909|NCT00490555|859860|P2|STARTED|Overall Study||8
354910|NCT00490555|859861|P1|STARTED|Overall Study||8
354911|NCT00490542|859889|P2|NOT COMPLETED|Overall Study||4
354912|NCT00490542|859890|P1|NOT COMPLETED|Overall Study||7
354913|NCT00490542|859889|P2|COMPLETED|Overall Study||31
354914|NCT00490542|859890|P1|COMPLETED|Overall Study||31
354915|NCT00490542|859889|P2|STARTED|Overall Study||35
354916|NCT00490542|859890|P1|STARTED|Overall Study||38
354917|NCT00490490|859896|P1|NOT COMPLETED|Completed Assessment for TTP||3
354918|NCT00490490|859896|P1|COMPLETED|Completed Assessment for TTP||5
354919|NCT00490490|859896|P1|STARTED|Completed Assessment for TTP||8
354920|NCT00490490|859896|P1|NOT COMPLETED|Completed Assessment for CR||0
354921|NCT00490490|859896|P1|COMPLETED|Completed Assessment for CR||8
354922|NCT00490490|859896|P1|STARTED|Completed Assessment for CR||8
354923|NCT00490477|859904|P2|NOT COMPLETED|Overall Study||0
354924|NCT00490477|859905|P1|NOT COMPLETED|Overall Study||0
354925|NCT00490477|859904|P2|COMPLETED|Overall Study||8
354926|NCT00490477|859905|P1|COMPLETED|Overall Study||8
354927|NCT00490477|859904|P2|STARTED|Overall Study||8
354928|NCT00490477|859905|P1|STARTED|Overall Study||8
354929|NCT00490451|859913|P2|NOT COMPLETED|Overall Study||38
354932|NCT00490451|859914|P1|COMPLETED|Overall Study||0
354933|NCT00490451|859913|P2|STARTED|Overall Study||38
354934|NCT00490451|859914|P1|STARTED|Overall Study||63
354935|NCT00490269|859936|P2|NOT COMPLETED|Placebo Then Dronabinol||0
354936|NCT00490269|859937|P1|NOT COMPLETED|Placebo Then Dronabinol||0
354937|NCT00490269|859936|P2|COMPLETED|Placebo Then Dronabinol||6
354938|NCT00490269|859937|P1|COMPLETED|Placebo Then Dronabinol||6
354939|NCT00490269|859936|P2|STARTED|Placebo Then Dronabinol||6
354940|NCT00490269|859937|P1|STARTED|Placebo Then Dronabinol||6
354941|NCT00490269|859936|P2|NOT COMPLETED|Dronabinol Then Placebo||0
354942|NCT00490269|859937|P1|NOT COMPLETED|Dronabinol Then Placebo||0
354943|NCT00490269|859936|P2|COMPLETED|Dronabinol Then Placebo||6
354944|NCT00490269|859937|P1|COMPLETED|Dronabinol Then Placebo||6
354945|NCT00490269|859936|P2|STARTED|Dronabinol Then Placebo||6
354946|NCT00490269|859937|P1|STARTED|Dronabinol Then Placebo||6
354947|NCT00490256|859945|P2|NOT COMPLETED|Overall Study||0
354948|NCT00490256|859946|P1|NOT COMPLETED|Overall Study||0
354949|NCT00490256|859945|P2|COMPLETED|Overall Study||7
354950|NCT00490256|859946|P1|COMPLETED|Overall Study||7
354951|NCT00490256|859945|P2|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
354952|NCT00490256|859946|P1|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
354953|NCT00490256|859945|P2|STARTED|Overall Study||7
354954|NCT00490256|859946|P1|STARTED|Overall Study||7
354955|NCT00490139|859956|P4|NOT COMPLETED|Overall Study||307
354956|NCT00490139|859957|P3|NOT COMPLETED|Overall Study||434
354957|NCT00490139|859958|P2|NOT COMPLETED|Overall Study||275
354958|NCT00490139|859959|P1|NOT COMPLETED|Overall Study||308
354959|NCT00490139|859956|P4|COMPLETED|Overall Study||1790
354960|NCT00490139|859957|P3|COMPLETED|Overall Study||1666
354961|NCT00490139|859958|P2|COMPLETED|Overall Study||1816
354962|NCT00490139|859959|P1|COMPLETED|Overall Study||1785
354963|NCT00490139|859956|P4|STARTED|Overall Study||2097
354964|NCT00490139|859957|P3|STARTED|Overall Study||2100
354965|NCT00490139|859958|P2|STARTED|Overall Study||2091
354966|NCT00490139|859959|P1|STARTED|Overall Study||2093
354967|NCT00490100|859989|P1|NOT COMPLETED|Overall Study||3
354968|NCT00490100|859989|P1|COMPLETED|Overall Study||3
354969|NCT00490100|859989|P1|STARTED|Overall Study||6
354970|NCT00490061|859994|P1|NOT COMPLETED|Overall Study||1
354971|NCT00490061|859994|P1|COMPLETED|Overall Study||16
354972|NCT00490061|859994|P1|STARTED|Overall Study||17
354973|NCT00490035|860003|P4|NOT COMPLETED|Overall Study||6
354974|NCT00490035|860004|P3|NOT COMPLETED|Overall Study||12
354975|NCT00490035|860005|P2|NOT COMPLETED|Overall Study||6
354976|NCT00490035|860006|P1|NOT COMPLETED|Overall Study||8
354977|NCT00490035|860003|P4|COMPLETED|Overall Study||94
354978|NCT00490035|860004|P3|COMPLETED|Overall Study||88
354979|NCT00490035|860005|P2|COMPLETED|Overall Study||93
354980|NCT00490035|860006|P1|COMPLETED|Overall Study||92
354981|NCT00490035|860003|P4|STARTED|Overall Study||100
354982|NCT00490035|860004|P3|STARTED|Overall Study||100
354983|NCT00490035|860005|P2|STARTED|Overall Study||99
354984|NCT00490035|860006|P1|STARTED|Overall Study||100
354985|NCT00490022|860106|P2|NOT COMPLETED|Overall Study||3
354986|NCT00490022|860107|P1|NOT COMPLETED|Overall Study||1
354987|NCT00490022|860106|P2|COMPLETED|Overall Study||12
354988|NCT00490022|860107|P1|COMPLETED|Overall Study||15
354989|NCT00490022|860106|P2|STARTED|Overall Study||15
354990|NCT00490022|860107|P1|STARTED|Overall Study||16
354991|NCT00490009|860115|P1|NOT COMPLETED|Overall Study||0
354992|NCT00490009|860115|P1|COMPLETED|Overall Study||9
354993|NCT00490009|860115|P1|STARTED|Overall Study||9
354994|NCT00489970|860124|P3|NOT COMPLETED|Persistence Year 9||5
354995|NCT00489970|860125|P2|NOT COMPLETED|Persistence Year 9||2
354996|NCT00489970|860126|P1|NOT COMPLETED|Persistence Year 9||3
354997|NCT00489970|860124|P3|COMPLETED|Persistence Year 9||357
354998|NCT00489970|860125|P2|COMPLETED|Persistence Year 9||136
354999|NCT00489970|860126|P1|COMPLETED|Persistence Year 9||306
355000|NCT00489970|860124|P3|STARTED|Persistence Year 9|Number of subjects who received the first dose at Year 9.|362
355001|NCT00489970|860125|P2|STARTED|Persistence Year 9|Number of subjects who returned at Year 9.|138
355002|NCT00489970|860126|P1|STARTED|Persistence Year 9|Number of subjects who returned at Year 9.|309
355003|NCT00489970|860124|P3|NOT COMPLETED|Persistence Year 5||0
355004|NCT00489970|860125|P2|NOT COMPLETED|Persistence Year 5||0
355005|NCT00489970|860126|P1|NOT COMPLETED|Persistence Year 5||0
355006|NCT00489970|860124|P3|COMPLETED|Persistence Year 5||0
355007|NCT00489970|860125|P2|COMPLETED|Persistence Year 5||401
355008|NCT00489970|860126|P1|COMPLETED|Persistence Year 5||856
355009|NCT00489970|860124|P3|STARTED|Persistence Year 5||0
355010|NCT00489970|860125|P2|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|401
355011|NCT00489970|860126|P1|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|856
355012|NCT00489970|860124|P3|NOT COMPLETED|Persistence Year 3||0
355013|NCT00489970|860125|P2|NOT COMPLETED|Persistence Year 3||0
355014|NCT00489970|860126|P1|NOT COMPLETED|Persistence Year 3||0
355015|NCT00489970|860124|P3|COMPLETED|Persistence Year 3||0
355016|NCT00489970|860125|P2|COMPLETED|Persistence Year 3||486
355017|NCT00489970|860126|P1|COMPLETED|Persistence Year 3||1019
355018|NCT00489970|860124|P3|STARTED|Persistence Year 3||0
355019|NCT00489970|860125|P2|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|486
355020|NCT00489970|860126|P1|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|1019
355021|NCT00489970|860124|P3|NOT COMPLETED|Persistence Year 1||0
355022|NCT00489970|860125|P2|NOT COMPLETED|Persistence Year 1||0
355023|NCT00489970|860126|P1|NOT COMPLETED|Persistence Year 1||0
355024|NCT00489970|860124|P3|COMPLETED|Persistence Year 1||0
355025|NCT00489970|860125|P2|COMPLETED|Persistence Year 1||523
355026|NCT00489970|860126|P1|COMPLETED|Persistence Year 1||1069
355027|NCT00489970|860124|P3|STARTED|Persistence Year 1||0
355028|NCT00489970|860125|P2|STARTED|Persistence Year 1||523
355029|NCT00489970|860126|P1|STARTED|Persistence Year 1||1069
355030|NCT00489918|860230|P5|NOT COMPLETED|Overall Study||1
355031|NCT00489918|860231|P4|NOT COMPLETED|Overall Study||1
355032|NCT00489918|860232|P3|NOT COMPLETED|Overall Study||4
355033|NCT00489918|860233|P2|NOT COMPLETED|Overall Study||2
355034|NCT00489918|860234|P1|NOT COMPLETED|Overall Study||2
355035|NCT00489918|860230|P5|COMPLETED|Overall Study||32
355036|NCT00489918|860231|P4|COMPLETED|Overall Study||32
355037|NCT00489918|860232|P3|COMPLETED|Overall Study||28
355038|NCT00489918|860233|P2|COMPLETED|Overall Study||32
355039|NCT00489918|860234|P1|COMPLETED|Overall Study||31
355040|NCT00489918|860230|P5|STARTED|Overall Study||33
355041|NCT00489918|860231|P4|STARTED|Overall Study||33
355042|NCT00489918|860232|P3|STARTED|Overall Study||32
355043|NCT00489918|860233|P2|STARTED|Overall Study||34
355044|NCT00489918|860234|P1|STARTED|Overall Study||33
355045|NCT00489866|860268|P2|NOT COMPLETED|Overall Study||0
355046|NCT00489866|860269|P1|NOT COMPLETED|Overall Study||2
355047|NCT00489866|860268|P2|COMPLETED|Overall Study||7
355048|NCT00489866|860269|P1|COMPLETED|Overall Study||5
355049|NCT00489866|860268|P2|STARTED|Overall Study||7
355050|NCT00489866|860269|P1|STARTED|Overall Study||7
355051|NCT00489853|860283|P3|NOT COMPLETED|Follow-up Period||0
355052|NCT00489853|860284|P2|NOT COMPLETED|Follow-up Period||0
355053|NCT00489853|860285|P1|NOT COMPLETED|Follow-up Period||0
355054|NCT00489853|860283|P3|COMPLETED|Follow-up Period||33
355055|NCT00489853|860284|P2|COMPLETED|Follow-up Period||29
355056|NCT00489853|860285|P1|COMPLETED|Follow-up Period||29
355057|NCT00489853|860283|P3|STARTED|Follow-up Period||33
355058|NCT00489853|860284|P2|STARTED|Follow-up Period||29
355059|NCT00489853|860285|P1|STARTED|Follow-up Period||29
355060|NCT00489853|860283|P3|NOT COMPLETED|Treatment Period 3||0
355061|NCT00489853|860284|P2|NOT COMPLETED|Treatment Period 3||1
355062|NCT00489853|860285|P1|NOT COMPLETED|Treatment Period 3||0
355063|NCT00489853|860283|P3|COMPLETED|Treatment Period 3||33
355064|NCT00489853|860284|P2|COMPLETED|Treatment Period 3||29
355065|NCT00489853|860285|P1|COMPLETED|Treatment Period 3||29
355066|NCT00489853|860283|P3|STARTED|Treatment Period 3||33
355067|NCT00489853|860284|P2|STARTED|Treatment Period 3||30
355068|NCT00489853|860285|P1|STARTED|Treatment Period 3||29
355069|NCT00489853|860283|P3|NOT COMPLETED|Wash-out Period 2||2
355070|NCT00489853|860284|P2|NOT COMPLETED|Wash-out Period 2||3
355071|NCT00489853|860285|P1|NOT COMPLETED|Wash-out Period 2||4
355072|NCT00489853|860283|P3|COMPLETED|Wash-out Period 2||31
355073|NCT00489853|860284|P2|COMPLETED|Wash-out Period 2||32
355074|NCT00489853|860285|P1|COMPLETED|Wash-out Period 2||29
355075|NCT00489853|860283|P3|STARTED|Wash-out Period 2||33
355076|NCT00489853|860284|P2|STARTED|Wash-out Period 2||35
355077|NCT00489853|860285|P1|STARTED|Wash-out Period 2||33
355078|NCT00489853|860283|P3|NOT COMPLETED|Treatment Period 2||0
355079|NCT00489853|860284|P2|NOT COMPLETED|Treatment Period 2||0
355080|NCT00489853|860285|P1|NOT COMPLETED|Treatment Period 2||0
355081|NCT00489853|860283|P3|COMPLETED|Treatment Period 2||33
355082|NCT00489853|860284|P2|COMPLETED|Treatment Period 2||35
355083|NCT00489853|860285|P1|COMPLETED|Treatment Period 2||33
355084|NCT00489853|860283|P3|STARTED|Treatment Period 2||33
355085|NCT00489853|860284|P2|STARTED|Treatment Period 2||35
355086|NCT00489853|860285|P1|STARTED|Treatment Period 2||33
355087|NCT00489853|860283|P3|NOT COMPLETED|Wash-out Period 1||6
355088|NCT00489853|860284|P2|NOT COMPLETED|Wash-out Period 1||3
355089|NCT00489853|860285|P1|NOT COMPLETED|Wash-out Period 1||1
355090|NCT00489853|860283|P3|COMPLETED|Wash-out Period 1||32
355091|NCT00489853|860284|P2|COMPLETED|Wash-out Period 1||34
355092|NCT00489853|860285|P1|COMPLETED|Wash-out Period 1||35
355093|NCT00489853|860283|P3|STARTED|Wash-out Period 1||38
355094|NCT00489853|860284|P2|STARTED|Wash-out Period 1||37
355095|NCT00489853|860285|P1|STARTED|Wash-out Period 1||36
355096|NCT00489853|860283|P3|NOT COMPLETED|Treatment Period 1||0
355097|NCT00489853|860284|P2|NOT COMPLETED|Treatment Period 1||0
355098|NCT00489853|860285|P1|NOT COMPLETED|Treatment Period 1||0
355099|NCT00489853|860283|P3|COMPLETED|Treatment Period 1||38
355100|NCT00489853|860284|P2|COMPLETED|Treatment Period 1||37
355101|NCT00489853|860285|P1|COMPLETED|Treatment Period 1||36
355102|NCT00489853|860283|P3|STARTED|Treatment Period 1||38
355103|NCT00489853|860284|P2|STARTED|Treatment Period 1||37
355104|NCT00489853|860285|P1|STARTED|Treatment Period 1||36
355105|NCT00489827|860382|P2|NOT COMPLETED|Overall Study||2
355106|NCT00489827|860383|P1|NOT COMPLETED|Overall Study||2
355107|NCT00489827|860382|P2|COMPLETED|Overall Study||433
355108|NCT00489827|860383|P1|COMPLETED|Overall Study||428
355109|NCT00489827|860382|P2|STARTED|Overall Study||435
355110|NCT00489827|860383|P1|STARTED|Overall Study||430
355111|NCT00489736|860407|P2|NOT COMPLETED|Overall Study||69
355112|NCT00489736|860408|P1|NOT COMPLETED|Overall Study||96
355113|NCT00489736|860407|P2|COMPLETED|Overall Study|completed study drug period|186
355114|NCT00489736|860408|P1|COMPLETED|Overall Study|completed study drug period|153
355115|NCT00489736|860407|P2|STARTED|Overall Study|Randomized and treated patients|255
355116|NCT00489736|860408|P1|STARTED|Overall Study|Randomized and treated patients|249
355117|NCT00489554|860418|P1|NOT COMPLETED|Overall Study||4
355118|NCT00489554|860418|P1|COMPLETED|Overall Study||226
355119|NCT00489554|860418|P1|STARTED|Overall Study||230
355120|NCT00489541|860438|P2|NOT COMPLETED|9-Month Angiographic Follow-up||17
355121|NCT00489541|860439|P1|NOT COMPLETED|9-Month Angiographic Follow-up||27
355122|NCT00489541|860438|P2|COMPLETED|9-Month Angiographic Follow-up||108
355123|NCT00489541|860439|P1|COMPLETED|9-Month Angiographic Follow-up||197
355124|NCT00489541|860438|P2|STARTED|9-Month Angiographic Follow-up||125
355125|NCT00489541|860439|P1|STARTED|9-Month Angiographic Follow-up||224
355126|NCT00489541|860438|P2|NOT COMPLETED|12-Month Clinical Follow-up||5
355127|NCT00489541|860439|P1|NOT COMPLETED|12-Month Clinical Follow-up||9
355128|NCT00489541|860438|P2|COMPLETED|12-Month Clinical Follow-up||120
355129|NCT00489541|860439|P1|COMPLETED|12-Month Clinical Follow-up||215
355130|NCT00489541|860438|P2|STARTED|12-Month Clinical Follow-up||125
355131|NCT00489541|860439|P1|STARTED|12-Month Clinical Follow-up||224
355132|NCT00489489|860450|P3|NOT COMPLETED|Overall Study||3
355133|NCT00489489|860451|P2|NOT COMPLETED|Overall Study||5
355134|NCT00489489|860452|P1|NOT COMPLETED|Overall Study||3
355135|NCT00489489|860450|P3|COMPLETED|Overall Study|completed treatment period|37
355136|NCT00489489|860451|P2|COMPLETED|Overall Study|completed treatment period|32
355137|NCT00489489|860452|P1|COMPLETED|Overall Study|completed treatment period|38
355138|NCT00489489|860450|P3|Treated|Overall Study|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|39
355139|NCT00489489|860451|P2|Treated|Overall Study||36
355140|NCT00489489|860452|P1|Treated|Overall Study||41
355141|NCT00489489|860450|P3|STARTED|Overall Study|randomized|40
355142|NCT00489489|860451|P2|STARTED|Overall Study|randomized|37
355143|NCT00489489|860452|P1|STARTED|Overall Study|randomized|41
355144|NCT00489476|860484|P4|NOT COMPLETED|Overall Study||0
355145|NCT00489476|860485|P3|NOT COMPLETED|Overall Study||0
355146|NCT00489476|860486|P2|NOT COMPLETED|Overall Study||1
355147|NCT00489476|860487|P1|NOT COMPLETED|Overall Study||0
355148|NCT00489476|860484|P4|COMPLETED|Overall Study||43
355149|NCT00489476|860485|P3|COMPLETED|Overall Study||43
355150|NCT00489476|860486|P2|COMPLETED|Overall Study||42
355151|NCT00489476|860487|P1|COMPLETED|Overall Study||39
355152|NCT00489476|860484|P4|STARTED|Overall Study||43
355153|NCT00489476|860485|P3|STARTED|Overall Study||43
355154|NCT00489476|860486|P2|STARTED|Overall Study||43
355155|NCT00489476|860487|P1|STARTED|Overall Study||39
355156|NCT00489424|860508|P3|NOT COMPLETED|Overall Study||5
355157|NCT00489424|860509|P2|NOT COMPLETED|Overall Study||5
355158|NCT00489424|860510|P1|NOT COMPLETED|Overall Study||4
355159|NCT00489424|860508|P3|COMPLETED|Overall Study||257
355160|NCT00489424|860509|P2|COMPLETED|Overall Study||259
355161|NCT00489424|860510|P1|COMPLETED|Overall Study||263
355162|NCT00489424|860508|P3|STARTED|Overall Study||262
355163|NCT00489424|860509|P2|STARTED|Overall Study||264
355164|NCT00489424|860510|P1|STARTED|Overall Study||267
355165|NCT00489411|860541|P2|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||19
355166|NCT00489411|860542|P1|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||18
355167|NCT00489411|860541|P2|COMPLETED|Crossover Treatment Period (Weeks 8-12)||74
355168|NCT00489411|860542|P1|COMPLETED|Crossover Treatment Period (Weeks 8-12)||67
355169|NCT00489411|860541|P2|STARTED|Crossover Treatment Period (Weeks 8-12)||93
355170|NCT00489411|860542|P1|STARTED|Crossover Treatment Period (Weeks 8-12)||85
355171|NCT00489411|860541|P2|NOT COMPLETED|Washout Period (Weeks 6-7)||1
355172|NCT00489411|860542|P1|NOT COMPLETED|Washout Period (Weeks 6-7)||2
355173|NCT00489411|860541|P2|COMPLETED|Washout Period (Weeks 6-7)||93
355174|NCT00489411|860542|P1|COMPLETED|Washout Period (Weeks 6-7)||85
355175|NCT00489411|860541|P2|STARTED|Washout Period (Weeks 6-7)||94
355176|NCT00489411|860542|P1|STARTED|Washout Period (Weeks 6-7)||87
355177|NCT00489411|860541|P2|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||22
355178|NCT00489411|860542|P1|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||28
355179|NCT00489411|860541|P2|COMPLETED|Initial Treatment Period (Weeks 1-5)||94
355180|NCT00489411|860542|P1|COMPLETED|Initial Treatment Period (Weeks 1-5)||87
355181|NCT00489411|860541|P2|STARTED|Initial Treatment Period (Weeks 1-5)||116
355182|NCT00489411|860542|P1|STARTED|Initial Treatment Period (Weeks 1-5)||115
355183|NCT00489359|860556|P2|NOT COMPLETED|Overall Study||29
355184|NCT00489359|860557|P1|NOT COMPLETED|Overall Study||7
355185|NCT00489359|860556|P2|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|37
355186|NCT00489359|860557|P1|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|13
355187|NCT00489359|860556|P2|STARTED|Overall Study||66
355188|NCT00489359|860557|P1|STARTED|Overall Study||20
355189|NCT00489281|860582|P2|NOT COMPLETED|Overall Study||0
355190|NCT00489281|860583|P1|NOT COMPLETED|Overall Study||0
355191|NCT00489281|860582|P2|COMPLETED|Overall Study||13
355192|NCT00489281|860583|P1|COMPLETED|Overall Study||29
355193|NCT00489281|860582|P2|STARTED|Overall Study||13
355194|NCT00489281|860583|P1|STARTED|Overall Study||29
355195|NCT00489268|860600|P5|NOT COMPLETED|Overall Study||20
355196|NCT00489268|860601|P4|NOT COMPLETED|Overall Study||0
355197|NCT00489268|860602|P3|NOT COMPLETED|Overall Study||1
355198|NCT00489268|860603|P2|NOT COMPLETED|Overall Study||0
355199|NCT00489268|860604|P1|NOT COMPLETED|Overall Study||0
355200|NCT00489268|860600|P5|COMPLETED|Overall Study||50
355201|NCT00489268|860601|P4|COMPLETED|Overall Study||11
355202|NCT00489268|860602|P3|COMPLETED|Overall Study||9
355203|NCT00489268|860603|P2|COMPLETED|Overall Study||10
355204|NCT00489268|860604|P1|COMPLETED|Overall Study||1
355205|NCT00489268|860600|P5|STARTED|Overall Study||70
355206|NCT00489268|860601|P4|STARTED|Overall Study||11
355207|NCT00489268|860602|P3|STARTED|Overall Study||10
355208|NCT00489268|860603|P2|STARTED|Overall Study||10
355209|NCT00489268|860604|P1|STARTED|Overall Study||1
355210|NCT00489255|860633|P2|NOT COMPLETED|Period 3: Days 57 to 84||4
355211|NCT00489255|860634|P1|NOT COMPLETED|Period 3: Days 57 to 84||4
355212|NCT00489255|860633|P2|COMPLETED|Period 3: Days 57 to 84|Re-randomized participants is 27.Sample sizes differed due to withdrawal&re-randomization design.|78
355213|NCT00489255|860634|P1|COMPLETED|Period 3: Days 57 to 84||24
355214|NCT00489255|860633|P2|STARTED|Period 3: Days 57 to 84|Re-randomized participants is 30.Sample sizes differed due to withdrawal&re-randomization design.|82
355215|NCT00489255|860634|P1|STARTED|Period 3: Days 57 to 84||28
355216|NCT00489255|860633|P2|NOT COMPLETED|Period 2: Days 29 to 56||4
355217|NCT00489255|860634|P1|NOT COMPLETED|Period 2: Days 29 to 56||3
355218|NCT00489255|860633|P2|COMPLETED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|55
355219|NCT00489255|860634|P1|COMPLETED|Period 2: Days 29 to 56||61
355220|NCT00489255|860633|P2|Completed But Discontinued Study|Period 2: Days 29 to 56|Re-randomized participants is 2.Sample sizes differed due to withdrawal&re-randomization design.|3
355221|NCT00489255|860634|P1|Completed But Discontinued Study|Period 2: Days 29 to 56||3
355222|NCT00489255|860633|P2|Completed and Follow Period 3|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|52
355223|NCT00489255|860634|P1|Completed and Follow Period 3|Period 2: Days 29 to 56||58
355224|NCT00489255|860633|P2|STARTED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|59
355225|NCT00489255|860634|P1|STARTED|Period 2: Days 29 to 56||64
355226|NCT00489255|860633|P2|NOT COMPLETED|Period 1: Days 1 to 28||12
355227|NCT00489255|860634|P1|NOT COMPLETED|Period 1: Days 1 to 28||29
355228|NCT00489255|860633|P2|COMPLETED|Period 1: Days 1 to 28||34
355229|NCT00489255|860634|P1|COMPLETED|Period 1: Days 1 to 28||107
355230|NCT00489255|860633|P2|Completed But Discontinued Study|Period 1: Days 1 to 28||5
355231|NCT00489255|860634|P1|Completed But Discontinued Study|Period 1: Days 1 to 28||13
355232|NCT00489255|860633|P2|Completed and Follow Period 2|Period 1: Days 1 to 28||29
355233|NCT00489255|860634|P1|Completed and Follow Period 2|Period 1: Days 1 to 28||94
355234|NCT00489255|860633|P2|STARTED|Period 1: Days 1 to 28||46
355235|NCT00489255|860634|P1|STARTED|Period 1: Days 1 to 28||136
355236|NCT00489255|860633|P2|NOT COMPLETED|Screening and Initial Randomization||3
355237|NCT00489255|860634|P1|NOT COMPLETED|Screening and Initial Randomization||9
355238|NCT00489255|860633|P2|COMPLETED|Screening and Initial Randomization||46
355239|NCT00489255|860634|P1|COMPLETED|Screening and Initial Randomization||136
355240|NCT00489255|860633|P2|STARTED|Screening and Initial Randomization|Total randomized subjects to receive placebo|49
355241|NCT00489255|860634|P1|STARTED|Screening and Initial Randomization|Total randomized subjects to receive Tigan|145
355242|NCT00489216|860682|P1|NOT COMPLETED|Overall Study||1
355243|NCT00489216|860682|P1|COMPLETED|Overall Study||1
355244|NCT00489216|860682|P1|STARTED|Overall Study||2
355245|NCT00489086|860691|P1|NOT COMPLETED|Overall Study||23
355246|NCT00489086|860691|P1|COMPLETED|Overall Study|23 subjects completed 18 months|13
355247|NCT00489086|860691|P1|STARTED|Overall Study||36
355248|NCT00488982|860695|P3|NOT COMPLETED|Response to Course 3||3
355249|NCT00488982|860696|P2|NOT COMPLETED|Response to Course 3||1
355250|NCT00488982|860697|P1|NOT COMPLETED|Response to Course 3||0
355251|NCT00488982|860695|P3|COMPLETED|Response to Course 3||0
355252|NCT00488982|860696|P2|COMPLETED|Response to Course 3||1
355253|NCT00488982|860697|P1|COMPLETED|Response to Course 3||0
355254|NCT00488982|860695|P3|STARTED|Response to Course 3||3
355255|NCT00488982|860696|P2|STARTED|Response to Course 3||2
355256|NCT00488982|860697|P1|STARTED|Response to Course 3||0
355257|NCT00488982|860695|P3|NOT COMPLETED|Course 3||5
355258|NCT00488982|860696|P2|NOT COMPLETED|Course 3||2
355259|NCT00488982|860697|P1|NOT COMPLETED|Course 3||0
355260|NCT00488982|860695|P3|COMPLETED|Course 3||3
355261|NCT00488982|860696|P2|COMPLETED|Course 3||2
355262|NCT00488982|860697|P1|COMPLETED|Course 3||0
355263|NCT00488982|860695|P3|STARTED|Course 3||8
355264|NCT00488982|860696|P2|STARTED|Course 3||4
355265|NCT00488982|860697|P1|STARTED|Course 3||0
355266|NCT00488982|860695|P3|NOT COMPLETED|Course 2||5
355267|NCT00488982|860696|P2|NOT COMPLETED|Course 2||9
355268|NCT00488982|860697|P1|NOT COMPLETED|Course 2||0
355269|NCT00488982|860695|P3|COMPLETED|Course 2||8
355270|NCT00488982|860696|P2|COMPLETED|Course 2||4
355271|NCT00488982|860697|P1|COMPLETED|Course 2||0
355272|NCT00488982|860695|P3|STARTED|Course 2||13
355273|NCT00488982|860696|P2|STARTED|Course 2||13
355274|NCT00488982|860697|P1|STARTED|Course 2||0
355275|NCT00488982|860695|P3|NOT COMPLETED|Course 1||14
355276|NCT00488982|860696|P2|NOT COMPLETED|Course 1||12
355277|NCT00488982|860697|P1|NOT COMPLETED|Course 1||0
355278|NCT00488982|860695|P3|COMPLETED|Course 1||13
355279|NCT00488982|860696|P2|COMPLETED|Course 1||13
355280|NCT00488982|860697|P1|COMPLETED|Course 1||0
355281|NCT00488982|860695|P3|STARTED|Course 1||27
355282|NCT00488982|860696|P2|STARTED|Course 1||25
355283|NCT00488982|860697|P1|STARTED|Course 1||0
355284|NCT00488982|860695|P3|NOT COMPLETED|Induction Chemotherapy||0
355285|NCT00488982|860696|P2|NOT COMPLETED|Induction Chemotherapy||0
355286|NCT00488982|860697|P1|NOT COMPLETED|Induction Chemotherapy||73
355287|NCT00488982|860695|P3|COMPLETED|Induction Chemotherapy||0
355288|NCT00488982|860696|P2|COMPLETED|Induction Chemotherapy||0
355289|NCT00488982|860697|P1|COMPLETED|Induction Chemotherapy||52
355290|NCT00488982|860695|P3|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||0
355291|NCT00488982|860696|P2|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||0
355292|NCT00488982|860697|P1|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||52
355293|NCT00488982|860695|P3|6 Cycles Completed|Induction Chemotherapy||0
355294|NCT00488982|860696|P2|6 Cycles Completed|Induction Chemotherapy||0
355295|NCT00488982|860697|P1|6 Cycles Completed|Induction Chemotherapy||94
355296|NCT00488982|860695|P3|STARTED|Induction Chemotherapy||0
355297|NCT00488982|860696|P2|STARTED|Induction Chemotherapy||0
355298|NCT00488982|860697|P1|STARTED|Induction Chemotherapy||125
355299|NCT00488865|860711|P1|NOT COMPLETED|Overall Study||0
355300|NCT00488865|860711|P1|COMPLETED|Overall Study||100
355301|NCT00488865|860711|P1|STARTED|Overall Study||100
355302|NCT00488826|860720|P3|NOT COMPLETED|Overall Study||26
355303|NCT00488826|860721|P2|NOT COMPLETED|Overall Study||52
355304|NCT00488826|860722|P1|NOT COMPLETED|Overall Study||56
355305|NCT00488826|860720|P3|COMPLETED|Overall Study||178
355306|NCT00488826|860721|P2|COMPLETED|Overall Study||244
355307|NCT00488826|860722|P1|COMPLETED|Overall Study||244
355308|NCT00488826|860720|P3|STARTED|Overall Study||204
355309|NCT00488826|860721|P2|STARTED|Overall Study||296
355310|NCT00488826|860722|P1|STARTED|Overall Study||300
355311|NCT00488774|860737|P4|NOT COMPLETED|Overall Study||3
355312|NCT00488774|860738|P3|NOT COMPLETED|Overall Study||5
355313|NCT00488774|860739|P2|NOT COMPLETED|Overall Study||5
355314|NCT00488774|860740|P1|NOT COMPLETED|Overall Study||8
355315|NCT00488774|860737|P4|COMPLETED|Overall Study||74
355316|NCT00488774|860738|P3|COMPLETED|Overall Study||70
355317|NCT00488774|860739|P2|COMPLETED|Overall Study||57
355318|NCT00488774|860740|P1|COMPLETED|Overall Study||69
355319|NCT00488774|860737|P4|STARTED|Overall Study||77
355320|NCT00488774|860738|P3|STARTED|Overall Study||75
355321|NCT00488774|860739|P2|STARTED|Overall Study||62
355322|NCT00488774|860740|P1|STARTED|Overall Study||77
355323|NCT00488683|860757|P3|NOT COMPLETED|Overall Study||2
355324|NCT00488683|860758|P2|NOT COMPLETED|Overall Study||6
355325|NCT00488683|860759|P1|NOT COMPLETED|Overall Study||12
355326|NCT00488683|860757|P3|COMPLETED|Overall Study||52
355327|NCT00488683|860758|P2|COMPLETED|Overall Study||48
355328|NCT00488683|860759|P1|COMPLETED|Overall Study||96
355329|NCT00488683|860757|P3|STARTED|Overall Study||54
355330|NCT00488683|860758|P2|STARTED|Overall Study||54
355331|NCT00488683|860759|P1|STARTED|Overall Study||108
355332|NCT00488644|860818|P1|NOT COMPLETED|Overall Study||2
355333|NCT00488644|860818|P1|COMPLETED|Overall Study||10
355334|NCT00488644|860818|P1|STARTED|Overall Study||12
355335|NCT00488631|860828|P10|NOT COMPLETED|Open Label Study Extension (Week 54-228)||3
355336|NCT00488631|860829|P9|NOT COMPLETED|Open Label Study Extension (Week 54-228)||182
355337|NCT00488631|860830|P8|NOT COMPLETED|Open Label Study Extension (Week 54-228)||27
355338|NCT00488631|860831|P7|NOT COMPLETED|Open Label Study Extension (Week 54-228)||80
355339|NCT00488631|860832|P6|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
355340|NCT00488631|860833|P5|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
355341|NCT00488631|860834|P4|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
355342|NCT00488631|860835|P3|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
355343|NCT00488631|860836|P2|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
355344|NCT00488631|860837|P1|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
355345|NCT00488631|860828|P10|COMPLETED|Open Label Study Extension (Week 54-228)||4
355346|NCT00488631|860829|P9|COMPLETED|Open Label Study Extension (Week 54-228)||288
355347|NCT00488631|860830|P8|COMPLETED|Open Label Study Extension (Week 54-228)||66
355348|NCT00488631|860831|P7|COMPLETED|Open Label Study Extension (Week 54-228)||16
355349|NCT00488631|860832|P6|COMPLETED|Open Label Study Extension (Week 54-228)||0
355350|NCT00488631|860833|P5|COMPLETED|Open Label Study Extension (Week 54-228)||0
355351|NCT00488631|860834|P4|COMPLETED|Open Label Study Extension (Week 54-228)||0
355352|NCT00488631|860835|P3|COMPLETED|Open Label Study Extension (Week 54-228)||0
355353|NCT00488631|860836|P2|COMPLETED|Open Label Study Extension (Week 54-228)||0
355354|NCT00488631|860837|P1|COMPLETED|Open Label Study Extension (Week 54-228)||0
355355|NCT00488631|860828|P10|STARTED|Open Label Study Extension (Week 54-228)||7
355356|NCT00488631|860829|P9|STARTED|Open Label Study Extension (Week 54-228)||470
355357|NCT00488631|860830|P8|STARTED|Open Label Study Extension (Week 54-228)||93
355358|NCT00488631|860831|P7|STARTED|Open Label Study Extension (Week 54-228)||96
355359|NCT00488631|860832|P6|STARTED|Open Label Study Extension (Week 54-228)||0
355360|NCT00488631|860833|P5|STARTED|Open Label Study Extension (Week 54-228)||0
355361|NCT00488631|860834|P4|STARTED|Open Label Study Extension (Week 54-228)||0
355362|NCT00488631|860835|P3|STARTED|Open Label Study Extension (Week 54-228)||0
355363|NCT00488631|860836|P2|STARTED|Open Label Study Extension (Week 54-228)||0
355364|NCT00488631|860837|P1|STARTED|Open Label Study Extension (Week 54-228)||0
355365|NCT00488631|860828|P10|NOT COMPLETED|Double Blind Period (Week 0-54)||0
355366|NCT00488631|860829|P9|NOT COMPLETED|Double Blind Period (Week 0-54)||0
355367|NCT00488631|860830|P8|NOT COMPLETED|Double Blind Period (Week 0-54)||0
355368|NCT00488631|860831|P7|NOT COMPLETED|Double Blind Period (Week 0-54)||0
355369|NCT00488631|860832|P6|NOT COMPLETED|Double Blind Period (Week 0-54)||216
355370|NCT00488631|860833|P5|NOT COMPLETED|Double Blind Period (Week 0-54)||103
355371|NCT00488631|860834|P4|NOT COMPLETED|Double Blind Period (Week 0-54)||41
355372|NCT00488631|860835|P3|NOT COMPLETED|Double Blind Period (Week 0-54)||45
355373|NCT00488631|860836|P2|NOT COMPLETED|Double Blind Period (Week 0-54)||43
355374|NCT00488631|860837|P1|NOT COMPLETED|Double Blind Period (Week 0-54)||43
355375|NCT00488631|860828|P10|COMPLETED|Double Blind Period (Week 0-54)||0
355376|NCT00488631|860829|P9|COMPLETED|Double Blind Period (Week 0-54)||0
355377|NCT00488631|860830|P8|COMPLETED|Double Blind Period (Week 0-54)||0
355378|NCT00488631|860831|P7|COMPLETED|Double Blind Period (Week 0-54)||0
355379|NCT00488631|860832|P6|COMPLETED|Double Blind Period (Week 0-54)||189
355380|NCT00488631|860833|P5|COMPLETED|Double Blind Period (Week 0-54)||127
355381|NCT00488631|860834|P4|COMPLETED|Double Blind Period (Week 0-54)||88
355382|NCT00488631|860835|P3|COMPLETED|Double Blind Period (Week 0-54)||109
355383|NCT00488631|860836|P2|COMPLETED|Double Blind Period (Week 0-54)||111
355384|NCT00488631|860837|P1|COMPLETED|Double Blind Period (Week 0-54)||113
355385|NCT00488631|860828|P10|STARTED|Double Blind Period (Week 0-54)||0
355386|NCT00488631|860829|P9|STARTED|Double Blind Period (Week 0-54)||0
355387|NCT00488631|860830|P8|STARTED|Double Blind Period (Week 0-54)||0
355388|NCT00488631|860831|P7|STARTED|Double Blind Period (Week 0-54)||0
355389|NCT00488631|860832|P6|STARTED|Double Blind Period (Week 0-54)||405
355390|NCT00488631|860833|P5|STARTED|Double Blind Period (Week 0-54)||230
355391|NCT00488631|860834|P4|STARTED|Double Blind Period (Week 0-54)||129
355392|NCT00488631|860835|P3|STARTED|Double Blind Period (Week 0-54)||154
355393|NCT00488631|860836|P2|STARTED|Double Blind Period (Week 0-54)||154
355394|NCT00488631|860837|P1|STARTED|Double Blind Period (Week 0-54)||156
355395|NCT00488618|860874|P2|NOT COMPLETED|Overall Study||43
355396|NCT00488618|860875|P1|NOT COMPLETED|Overall Study||47
355397|NCT00488618|860874|P2|COMPLETED|Overall Study||75
355398|NCT00488618|860875|P1|COMPLETED|Overall Study||73
355399|NCT00488618|860874|P2|Safety Population: Received Study Drug|Overall Study||118
355400|NCT00488618|860875|P1|Safety Population: Received Study Drug|Overall Study||118
355401|NCT00488618|860874|P2|STARTED|Overall Study||118
355402|NCT00488618|860875|P1|STARTED|Overall Study||120
355403|NCT00488592|860883|P1|NOT COMPLETED|Overall Study||3
355404|NCT00488592|860883|P1|COMPLETED|Overall Study|7 completed the initial series of 6 vaccinations|7
355405|NCT00488592|860883|P1|STARTED|Overall Study|10 subjects were accrued|10
355406|NCT00488514|860887|P1|NOT COMPLETED|Overall Study||293
355407|NCT00488514|860887|P1|COMPLETED|Overall Study||363
355408|NCT00488514|860887|P1|STARTED|Overall Study||656
355409|NCT00488488|860960|P1|NOT COMPLETED|Overall Study||268
355410|NCT00488488|860960|P1|COMPLETED|Overall Study|Excludes 4 participants with missing information.|760
355411|NCT00488488|860960|P1|Analyzed|Overall Study|3 participants were not analyzed due to retrospective documentation.|1025
355412|NCT00488488|860960|P1|STARTED|Overall Study||1028
355413|NCT00488475|860975|P1|NOT COMPLETED|Overall Study||1754
355414|NCT00488475|860975|P1|COMPLETED|Overall Study||3191
355415|NCT00488475|860975|P1|STARTED|Overall Study||4945
355416|NCT00488345|861004|P3|NOT COMPLETED|Overall Study||3
355417|NCT00488345|861005|P2|NOT COMPLETED|Overall Study||4
355418|NCT00488345|861006|P1|NOT COMPLETED|Overall Study||0
355419|NCT00488345|861004|P3|COMPLETED|Overall Study||17
355420|NCT00488345|861005|P2|COMPLETED|Overall Study||17
355421|NCT00488345|861006|P1|COMPLETED|Overall Study||17
355422|NCT00488345|861004|P3|STARTED|Overall Study||20
355423|NCT00488345|861005|P2|STARTED|Overall Study||21
355424|NCT00488345|861006|P1|STARTED|Overall Study||17
355425|NCT00488319|861032|P3|NOT COMPLETED|Overall Study||122
355426|NCT00488319|861033|P2|NOT COMPLETED|Overall Study||43
355427|NCT00488319|861034|P1|NOT COMPLETED|Overall Study||15
355428|NCT00488319|861032|P3|COMPLETED|Overall Study||121
355429|NCT00488319|861033|P2|COMPLETED|Overall Study||75
355430|NCT00488319|861034|P1|COMPLETED|Overall Study||24
355431|NCT00488319|861032|P3|STARTED|Overall Study||243
355432|NCT00488319|861033|P2|STARTED|Overall Study||118
355433|NCT00488319|861034|P1|STARTED|Overall Study||39
355434|NCT00488293|861121|P2|NOT COMPLETED|Overall Study||30
355435|NCT00488293|861122|P1|NOT COMPLETED|Overall Study||36
355436|NCT00488293|861121|P2|COMPLETED|Overall Study||166
355437|NCT00488293|861122|P1|COMPLETED|Overall Study||160
355438|NCT00488293|861121|P2|STARTED|Overall Study||196
355439|NCT00488293|861122|P1|STARTED|Overall Study||196
355440|NCT00488059|861146|P3|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||4
355441|NCT00488059|861147|P2|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
355442|NCT00488059|861148|P1|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
355443|NCT00488059|861146|P3|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||1
355444|NCT00488059|861147|P2|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
355445|NCT00488059|861148|P1|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
355446|NCT00488059|861146|P3|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||5
355447|NCT00488059|861147|P2|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
355448|NCT00488059|861148|P1|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
355449|NCT00488059|861146|P3|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
355450|NCT00488059|861147|P2|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||2
355451|NCT00488059|861148|P1|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
355452|NCT00488059|861146|P3|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
355453|NCT00488059|861147|P2|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||7
355454|NCT00488059|861148|P1|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
355455|NCT00488059|861146|P3|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
355456|NCT00488059|861147|P2|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||9
355457|NCT00488059|861148|P1|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
355458|NCT00488059|861146|P3|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
355459|NCT00488059|861147|P2|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
355460|NCT00488059|861148|P1|NOT COMPLETED|Phase I: ENF 90mg SC BID||15
355461|NCT00488059|861146|P3|COMPLETED|Phase I: ENF 90mg SC BID||0
355462|NCT00488059|861147|P2|COMPLETED|Phase I: ENF 90mg SC BID||0
355463|NCT00488059|861148|P1|COMPLETED|Phase I: ENF 90mg SC BID||14
355464|NCT00488059|861146|P3|STARTED|Phase I: ENF 90mg SC BID||0
355465|NCT00488059|861147|P2|STARTED|Phase I: ENF 90mg SC BID||0
355466|NCT00488059|861148|P1|STARTED|Phase I: ENF 90mg SC BID||29
355467|NCT00488033|861167|P2|NOT COMPLETED|Overall Study||0
355468|NCT00488033|861168|P1|NOT COMPLETED|Overall Study||1
355469|NCT00488033|861167|P2|COMPLETED|Overall Study||452
355470|NCT00488033|861168|P1|COMPLETED|Overall Study||447
355471|NCT00488033|861167|P2|STARTED|Overall Study||452
355472|NCT00488033|861168|P1|STARTED|Overall Study||448
355473|NCT00487981|861184|P1|NOT COMPLETED|Overall Study||1
355474|NCT00487981|861184|P1|COMPLETED|Overall Study||0
355475|NCT00487981|861184|P1|STARTED|Overall Study||1
355476|NCT00487942|861192|P4|NOT COMPLETED|Overall Study||2
355477|NCT00487942|861193|P3|NOT COMPLETED|Overall Study||3
355478|NCT00487942|861194|P2|NOT COMPLETED|Overall Study||3
355479|NCT00487942|861195|P1|NOT COMPLETED|Overall Study||3
355480|NCT00487942|861192|P4|COMPLETED|Overall Study||13
355481|NCT00487942|861193|P3|COMPLETED|Overall Study||12
355482|NCT00487942|861194|P2|COMPLETED|Overall Study||12
355483|NCT00487942|861195|P1|COMPLETED|Overall Study||12
355484|NCT00487942|861192|P4|STARTED|Overall Study|One subject randomized to placebo discontinued prior to receiving any study drug, leaving 14.|15
355485|NCT00487942|861193|P3|STARTED|Overall Study||15
355486|NCT00487942|861194|P2|STARTED|Overall Study||15
355487|NCT00487942|861195|P1|STARTED|Overall Study||15
355488|NCT00487825|861579|P2|NOT COMPLETED|Overall Study||5
355489|NCT00487825|861580|P1|NOT COMPLETED|Overall Study||6
355490|NCT00487825|861579|P2|COMPLETED|Overall Study||21
355491|NCT00487825|861580|P1|COMPLETED|Overall Study||46
355492|NCT00487825|861579|P2|STARTED|Overall Study||26
355493|NCT00487825|861580|P1|STARTED|Overall Study|"Started indicates Intent-to-treat population (ITT)"|52
355494|NCT00487747|861592|P1|NOT COMPLETED|Overall Study||11
355495|NCT00487747|861592|P1|COMPLETED|Overall Study||7
355496|NCT00487747|861592|P1|STARTED|Overall Study||18
355497|NCT00487721|861603|P2|NOT COMPLETED|Overall Study||0
355498|NCT00487721|861604|P1|NOT COMPLETED|Overall Study||0
355499|NCT00487721|861603|P2|COMPLETED|Overall Study||6
355500|NCT00487721|861604|P1|COMPLETED|Overall Study||6
355501|NCT00487721|861603|P2|STARTED|Overall Study||6
355502|NCT00487721|861604|P1|STARTED|Overall Study||6
355503|NCT00487695|861609|P2|NOT COMPLETED|Second Procedure||3
355504|NCT00487695|861610|P1|NOT COMPLETED|Second Procedure||1
355505|NCT00487695|861609|P2|COMPLETED|Second Procedure||20
355506|NCT00487695|861610|P1|COMPLETED|Second Procedure||19
355507|NCT00487695|861609|P2|STARTED|Second Procedure||23
355508|NCT00487695|861610|P1|STARTED|Second Procedure||20
355509|NCT00487695|861609|P2|NOT COMPLETED|First Procedure||0
355510|NCT00487695|861610|P1|NOT COMPLETED|First Procedure||3
355511|NCT00487695|861609|P2|COMPLETED|First Procedure||23
355512|NCT00487695|861610|P1|COMPLETED|First Procedure||20
355513|NCT00487695|861609|P2|STARTED|First Procedure||23
355514|NCT00487695|861610|P1|STARTED|First Procedure||23
355515|NCT00487669|861626|P1|NOT COMPLETED|Overall Study||0
355516|NCT00487669|861626|P1|COMPLETED|Overall Study||12
355517|NCT00487669|861626|P1|STARTED|Overall Study||12
355518|NCT00487578|861638|P2|NOT COMPLETED|Overall Study||4
355519|NCT00487578|861639|P1|NOT COMPLETED|Overall Study||1
355520|NCT00487578|861638|P2|COMPLETED|Overall Study||5
355521|NCT00487578|861639|P1|COMPLETED|Overall Study||2
355522|NCT00487578|861638|P2|STARTED|Overall Study||9
355523|NCT00487578|861639|P1|STARTED|Overall Study||3
355524|NCT00487565|861655|P1|NOT COMPLETED|Overall Study||28
355525|NCT00487565|861655|P1|COMPLETED|Overall Study||182
355526|NCT00487565|861655|P1|STARTED|Overall Study||210
355527|NCT00487552|861659|P1|NOT COMPLETED|Overall Study||6
355528|NCT00487552|861659|P1|COMPLETED|Overall Study||12
355529|NCT00487552|861659|P1|STARTED|Overall Study||18
355530|NCT00487539|861668|P4|NOT COMPLETED|Overall Study||4
355531|NCT00487539|861669|P3|NOT COMPLETED|Overall Study||3
355532|NCT00487539|861670|P2|NOT COMPLETED|Overall Study||3
355533|NCT00487539|861671|P1|NOT COMPLETED|Overall Study||7
355534|NCT00487539|861668|P4|COMPLETED|Overall Study||327
355535|NCT00487539|861669|P3|COMPLETED|Overall Study||328
355536|NCT00487539|861670|P2|COMPLETED|Overall Study||69
355537|NCT00487539|861671|P1|COMPLETED|Overall Study||324
355538|NCT00487539|861668|P4|STARTED|Overall Study||331
355539|NCT00487539|861669|P3|STARTED|Overall Study||331
355540|NCT00487539|861670|P2|STARTED|Overall Study||72
355541|NCT00487539|861671|P1|STARTED|Overall Study||331
355542|NCT00487461|861692|P3|NOT COMPLETED|Overall Study||4
355543|NCT00487461|861693|P2|NOT COMPLETED|Overall Study||2
355544|NCT00487461|861694|P1|NOT COMPLETED|Overall Study||0
355545|NCT00487461|861692|P3|COMPLETED|Overall Study||7
355546|NCT00487461|861693|P2|COMPLETED|Overall Study||10
355547|NCT00487461|861694|P1|COMPLETED|Overall Study||2
355548|NCT00487461|861692|P3|STARTED|Overall Study||11
355549|NCT00487461|861693|P2|STARTED|Overall Study||12
355550|NCT00487461|861694|P1|STARTED|Overall Study||2
355551|NCT00487435|861705|P1|NOT COMPLETED|Overall Study||485
355552|NCT00487435|861705|P1|COMPLETED|Overall Study||669
355553|NCT00487435|861705|P1|STARTED|Overall Study|Patients who received at least one dose of Tapentadol (CG5503) Extended Release (ER)|1154
355554|NCT00487396|861710|P1|NOT COMPLETED|Overall Study||3
355555|NCT00487396|861710|P1|COMPLETED|Overall Study||95
355556|NCT00487396|861710|P1|STARTED|Overall Study||98
355557|NCT00487279|861718|P2|NOT COMPLETED|Overall Study||2
355558|NCT00487279|861719|P1|NOT COMPLETED|Overall Study||1
355559|NCT00487279|861718|P2|COMPLETED|Overall Study||35
355560|NCT00487279|861719|P1|COMPLETED|Overall Study||43
355561|NCT00487279|861718|P2|STARTED|Overall Study||37
355562|NCT00487279|861719|P1|STARTED|Overall Study||44
355563|NCT00487240|861729|P2|NOT COMPLETED|Overall Study||26
355564|NCT00487240|861730|P1|NOT COMPLETED|Overall Study||31
355565|NCT00487240|861729|P2|COMPLETED|Overall Study||166
355566|NCT00487240|861730|P1|COMPLETED|Overall Study||164
355567|NCT00487240|861729|P2|Full Analysis Set (ITT Population)|Overall Study||189
355568|NCT00487240|861730|P1|Full Analysis Set (ITT Population)|Overall Study||192
355569|NCT00487240|861729|P2|STARTED|Overall Study||192
355570|NCT00487240|861730|P1|STARTED|Overall Study||195
355571|NCT00487188|861758|P3|NOT COMPLETED|Maintenance Phase||1
355572|NCT00487188|861759|P2|NOT COMPLETED|Maintenance Phase||0
355573|NCT00487188|861760|P1|NOT COMPLETED|Maintenance Phase||3
355574|NCT00487188|861758|P3|COMPLETED|Maintenance Phase||8
355575|NCT00487188|861759|P2|COMPLETED|Maintenance Phase||8
355576|NCT00487188|861760|P1|COMPLETED|Maintenance Phase||7
355577|NCT00487188|861758|P3|STARTED|Maintenance Phase||9
355578|NCT00487188|861759|P2|STARTED|Maintenance Phase||8
355579|NCT00487188|861760|P1|STARTED|Maintenance Phase||10
355580|NCT00487188|861758|P3|NOT COMPLETED|Induction Phase||0
355581|NCT00487188|861759|P2|NOT COMPLETED|Induction Phase||7
355582|NCT00487188|861760|P1|NOT COMPLETED|Induction Phase||9
355583|NCT00487188|861758|P3|COMPLETED|Induction Phase||0
355584|NCT00487188|861759|P2|COMPLETED|Induction Phase||9
355585|NCT00487188|861760|P1|COMPLETED|Induction Phase||22
355586|NCT00487188|861758|P3|Safety Population|Induction Phase||0
355587|NCT00487188|861759|P2|Safety Population|Induction Phase|2 patients randomized to ENF + HARRT only received treatment with HAART|18
355588|NCT00487188|861760|P1|Safety Population|Induction Phase||29
355589|NCT00487188|861758|P3|STARTED|Induction Phase|Participants were only randomized to this treatment arm in the Maintenance Phase|0
355590|NCT00487188|861759|P2|STARTED|Induction Phase||16
355591|NCT00487188|861760|P1|STARTED|Induction Phase||31
355592|NCT00487162|861799|P2|NOT COMPLETED|Overall Study||5
355593|NCT00487162|861800|P1|NOT COMPLETED|Overall Study||2
355594|NCT00487162|861799|P2|COMPLETED|Overall Study||21
355595|NCT00487162|861800|P1|COMPLETED|Overall Study||28
355596|NCT00487162|861799|P2|STARTED|Overall Study||26
355597|NCT00487162|861800|P1|STARTED|Overall Study||30
355598|NCT00487084|861811|P3|NOT COMPLETED|Overall Study||5
355599|NCT00487084|861812|P2|NOT COMPLETED|Overall Study||3
355600|NCT00487084|861813|P1|NOT COMPLETED|Overall Study||4
355601|NCT00487084|861811|P3|COMPLETED|Overall Study||28
355602|NCT00487084|861812|P2|COMPLETED|Overall Study||30
355603|NCT00487084|861813|P1|COMPLETED|Overall Study||29
355604|NCT00487084|861811|P3|STARTED|Overall Study||33
355605|NCT00487084|861812|P2|STARTED|Overall Study||33
355606|NCT00487084|861813|P1|STARTED|Overall Study||33
355607|NCT00486954|861834|P5|NOT COMPLETED|Randomized Part||14
355608|NCT00486954|861835|P4|NOT COMPLETED|Randomized Part||20
355609|NCT00486954|861836|P3|NOT COMPLETED|Randomized Part||0
355610|NCT00486954|861837|P2|NOT COMPLETED|Randomized Part||0
355611|NCT00486954|861838|P1|NOT COMPLETED|Randomized Part||0
355612|NCT00486954|861834|P5|COMPLETED|Randomized Part||115
355613|NCT00486954|861835|P4|COMPLETED|Randomized Part||112
355614|NCT00486954|861836|P3|COMPLETED|Randomized Part||0
355615|NCT00486954|861837|P2|COMPLETED|Randomized Part||0
355616|NCT00486954|861838|P1|COMPLETED|Randomized Part||0
355617|NCT00486954|861834|P5|STARTED|Randomized Part||129
355618|NCT00486954|861835|P4|STARTED|Randomized Part||132
355619|NCT00486954|861836|P3|STARTED|Randomized Part||0
355620|NCT00486954|861837|P2|STARTED|Randomized Part||0
355621|NCT00486954|861838|P1|STARTED|Randomized Part||0
355622|NCT00486954|861834|P5|NOT COMPLETED|Pilot Part||0
355623|NCT00486954|861835|P4|NOT COMPLETED|Pilot Part||0
355624|NCT00486954|861836|P3|NOT COMPLETED|Pilot Part||6
355625|NCT00486954|861837|P2|NOT COMPLETED|Pilot Part||0
355626|NCT00486954|861838|P1|NOT COMPLETED|Pilot Part||6
355627|NCT00486954|861834|P5|COMPLETED|Pilot Part||0
355628|NCT00486954|861835|P4|COMPLETED|Pilot Part||0
355629|NCT00486954|861836|P3|COMPLETED|Pilot Part||0
355630|NCT00486954|861837|P2|COMPLETED|Pilot Part||0
355631|NCT00486954|861838|P1|COMPLETED|Pilot Part||0
355632|NCT00486954|861834|P5|STARTED|Pilot Part||0
355633|NCT00486954|861835|P4|STARTED|Pilot Part||0
355634|NCT00486954|861836|P3|STARTED|Pilot Part||6
355635|NCT00486954|861837|P2|STARTED|Pilot Part||0
355636|NCT00486954|861838|P1|STARTED|Pilot Part||6
355637|NCT00486902|861936|P2|NOT COMPLETED|Overall Study||5
355638|NCT00486902|861937|P1|NOT COMPLETED|Overall Study||9
355639|NCT00486902|861936|P2|COMPLETED|Overall Study||89
355640|NCT00486902|861937|P1|COMPLETED|Overall Study||85
355641|NCT00486902|861936|P2|STARTED|Overall Study||94
355642|NCT00486902|861937|P1|STARTED|Overall Study||94
355643|NCT00486863|861959|P2|NOT COMPLETED|Overall Study||3
355644|NCT00486863|861960|P1|NOT COMPLETED|Overall Study||1
355645|NCT00486863|861959|P2|COMPLETED|Overall Study||183
355646|NCT00486863|861960|P1|COMPLETED|Overall Study||183
355647|NCT00486863|861959|P2|STARTED|Overall Study||186
355648|NCT00486863|861960|P1|STARTED|Overall Study||184
355649|NCT00486837|862004|P2|NOT COMPLETED|Overall Study||7
355650|NCT00486837|862005|P1|NOT COMPLETED|Overall Study||9
355651|NCT00486837|862004|P2|COMPLETED|Overall Study||28
355652|NCT00486837|862005|P1|COMPLETED|Overall Study||28
355653|NCT00486837|862004|P2|STARTED|Overall Study||35
355654|NCT00486837|862005|P1|STARTED|Overall Study||37
355655|NCT00486824|862023|P2|NOT COMPLETED|Overall Study||2
355656|NCT00486824|862024|P1|NOT COMPLETED|Overall Study||2
355657|NCT00486824|862023|P2|COMPLETED|Overall Study||3
355658|NCT00486824|862024|P1|COMPLETED|Overall Study||3
355659|NCT00486824|862023|P2|STARTED|Overall Study||5
355660|NCT00486824|862024|P1|STARTED|Overall Study||5
355661|NCT00486811|862045|P3|NOT COMPLETED|Overall Study||214
355662|NCT00486811|862046|P2|NOT COMPLETED|Overall Study||141
355663|NCT00486811|862047|P1|NOT COMPLETED|Overall Study||122
355664|NCT00486811|862045|P3|COMPLETED|Overall Study||119
355665|NCT00486811|862046|P2|COMPLETED|Overall Study||179
355666|NCT00486811|862047|P1|COMPLETED|Overall Study||215
355667|NCT00486811|862045|P3|STARTED|Overall Study|Two participants were not eligible to be dosed.|333
355668|NCT00486811|862046|P2|STARTED|Overall Study|One participant was not eligible to be dosed.|320
355669|NCT00486811|862047|P1|STARTED|Overall Study||337
355670|NCT00486759|862090|P2|NOT COMPLETED|Safety Follow-up||118
355671|NCT00486759|862091|P1|NOT COMPLETED|Safety Follow-up||139
355672|NCT00486759|862090|P2|COMPLETED|Safety Follow-up||142
355673|NCT00486759|862091|P1|COMPLETED|Safety Follow-up||64
355674|NCT00486759|862090|P2|STARTED|Safety Follow-up||260
355675|NCT00486759|862091|P1|STARTED|Safety Follow-up||203
355676|NCT00486759|862090|P2|NOT COMPLETED|Treatment||137
355677|NCT00486759|862091|P1|NOT COMPLETED|Treatment||187
355678|NCT00486759|862090|P2|COMPLETED|Treatment||260
355679|NCT00486759|862091|P1|COMPLETED|Treatment||203
355680|NCT00486759|862090|P2|STARTED|Treatment||397
355681|NCT00486759|862091|P1|STARTED|Treatment||390
355682|NCT00486720|862103|P2|NOT COMPLETED|Overall Study||12
355683|NCT00486720|862104|P1|NOT COMPLETED|Overall Study||10
355684|NCT00486720|862103|P2|COMPLETED|Overall Study||0
355685|NCT00486720|862104|P1|COMPLETED|Overall Study||0
355686|NCT00486720|862103|P2|STARTED|Overall Study||12
355687|NCT00486720|862104|P1|STARTED|Overall Study|1 randomized patient was discontinued before receiving treatment due to a protocol violation|10
355688|NCT00486642|862114|P2|NOT COMPLETED|Overall Study||0
355689|NCT00486642|862115|P1|NOT COMPLETED|Overall Study||0
355690|NCT00486642|862114|P2|COMPLETED|Overall Study||13
355691|NCT00486642|862115|P1|COMPLETED|Overall Study||10
355692|NCT00486642|862114|P2|STARTED|Overall Study||13
355693|NCT00486642|862115|P1|STARTED|Overall Study||10
355694|NCT00486603|862139|P5|NOT COMPLETED|Overall Study||0
355695|NCT00486603|862140|P4|NOT COMPLETED|Overall Study||0
355696|NCT00486603|862141|P3|NOT COMPLETED|Overall Study||0
355697|NCT00486603|862142|P2|NOT COMPLETED|Overall Study||1
355698|NCT00486603|862143|P1|NOT COMPLETED|Overall Study||1
355699|NCT00486603|862139|P5|COMPLETED|Overall Study||76
355700|NCT00486603|862140|P4|COMPLETED|Overall Study||3
355701|NCT00486603|862141|P3|COMPLETED|Overall Study||3
355702|NCT00486603|862142|P2|COMPLETED|Overall Study||6
355703|NCT00486603|862143|P1|COMPLETED|Overall Study||2
355704|NCT00486603|862139|P5|STARTED|Overall Study||76
355705|NCT00486603|862140|P4|STARTED|Overall Study||3
355706|NCT00486603|862141|P3|STARTED|Overall Study||3
355707|NCT00486603|862142|P2|STARTED|Overall Study||7
355708|NCT00486603|862143|P1|STARTED|Overall Study||3
355709|NCT00486525|862167|P2|NOT COMPLETED|Overall Study||13
355710|NCT00486525|862168|P1|NOT COMPLETED|Overall Study||6
355711|NCT00486525|862167|P2|COMPLETED|Overall Study||87
355712|NCT00486525|862168|P1|COMPLETED|Overall Study||94
355713|NCT00486525|862167|P2|STARTED|Overall Study||100
355714|NCT00486525|862168|P1|STARTED|Overall Study||100
355715|NCT00486447|862184|P1|NOT COMPLETED|Overall Study||0
355716|NCT00486447|862184|P1|COMPLETED|Overall Study||249
355717|NCT00486447|862184|P1|STARTED|Overall Study||249
355718|NCT00486434|862191|P2|NOT COMPLETED|Overall Study||134
355719|NCT00486434|862192|P1|NOT COMPLETED|Overall Study||194
355720|NCT00486434|862191|P2|COMPLETED|Overall Study||454
355721|NCT00486434|862192|P1|COMPLETED|Overall Study||394
355722|NCT00486434|862191|P2|STARTED|Overall Study||588
355723|NCT00486434|862192|P1|STARTED|Overall Study||588
355724|NCT00486330|862211|P1|NOT COMPLETED|Overall Study||2
355725|NCT00486330|862211|P1|COMPLETED|Overall Study|Of the 12 subjects treated, two developed adverse events leading to study drug discontinuation.|10
355726|NCT00486330|862211|P1|STARTED|Overall Study|Twelve subjects met inclusion/exclusion criteria|12
355727|NCT00486291|862217|P2|NOT COMPLETED|Overall Study||29
355728|NCT00486291|862218|P1|NOT COMPLETED|Overall Study||16
355729|NCT00486291|862217|P2|COMPLETED|Overall Study||76
355730|NCT00486291|862218|P1|COMPLETED|Overall Study||89
355731|NCT00486291|862217|P2|STARTED|Overall Study|1 subject discontinued prior to first dose|105
355732|NCT00486291|862218|P1|STARTED|Overall Study|3 subjects discontinued prior to first dose|105
355733|NCT00486278|862226|P1|NOT COMPLETED|Overall Study||9
355734|NCT00486278|862226|P1|COMPLETED|Overall Study||42
355735|NCT00486278|862226|P1|STARTED|Overall Study|96 bleeds by 51 subjects, 77 were treated with vatreptacog alfa and 19 with rFVIIa|51
355736|NCT00486265|862360|P1|NOT COMPLETED|Overall Study||9
355737|NCT00486265|862360|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met|0
355738|NCT00486265|862360|P1|STARTED|Overall Study|Partipants dosed on day 1.|9
355739|NCT00486252|862364|P1|NOT COMPLETED|Overall Study||58
355740|NCT00486252|862364|P1|COMPLETED|Overall Study||938
355741|NCT00486252|862364|P1|STARTED|Overall Study||996
355742|NCT00486226|862379|P1|NOT COMPLETED|Overall Study||13
355743|NCT00486226|862379|P1|COMPLETED|Overall Study||92
355744|NCT00486226|862379|P1|STARTED|Overall Study||105
355745|NCT00486044|862389|P2|NOT COMPLETED|Overall Study||3
355746|NCT00486044|862390|P1|NOT COMPLETED|Overall Study||2
355747|NCT00486044|862389|P2|COMPLETED|Overall Study|21 completed MRI sub-study|46
355748|NCT00486044|862390|P1|COMPLETED|Overall Study|27 completed MRI sub-study|49
355749|NCT00486044|862389|P2|STARTED|Overall Study|23 in MRI sub-study|49
355750|NCT00486044|862390|P1|STARTED|Overall Study|50 received assigned intervention (1 withdrew during baseline) 27 in MRI sub-study|51
355751|NCT00486031|862402|P1|NOT COMPLETED|Overall Study||3
355752|NCT00486031|862402|P1|COMPLETED|Overall Study||440
355753|NCT00486031|862402|P1|STARTED|Overall Study||443
355754|NCT00486018|862410|P3|NOT COMPLETED|Overall Study||6
355755|NCT00486018|862411|P2|NOT COMPLETED|Overall Study||6
355756|NCT00486018|862412|P1|NOT COMPLETED|Overall Study||9
355757|NCT00486018|862410|P3|COMPLETED|Overall Study||125
355758|NCT00486018|862411|P2|COMPLETED|Overall Study||128
355759|NCT00486018|862412|P1|COMPLETED|Overall Study||123
355760|NCT00486018|862410|P3|Received Drug (Safety Population)|Overall Study||130
355761|NCT00486018|862411|P2|Received Drug (Safety Population)|Overall Study||134
355762|NCT00486018|862412|P1|Received Drug (Safety Population)|Overall Study||131
355763|NCT00486018|862410|P3|STARTED|Overall Study||131
355764|NCT00486018|862411|P2|STARTED|Overall Study||134
355765|NCT00486018|862412|P1|STARTED|Overall Study||132
355766|NCT00485953|862440|P2|NOT COMPLETED|Overall Study||7
355767|NCT00485953|862441|P1|NOT COMPLETED|Overall Study||7
355768|NCT00485953|862440|P2|COMPLETED|Overall Study||47
355769|NCT00485953|862441|P1|COMPLETED|Overall Study||48
355770|NCT00485953|862440|P2|STARTED|Overall Study||54
355771|NCT00485953|862441|P1|STARTED|Overall Study||55
355772|NCT00485836|862454|P3|NOT COMPLETED|Overall Study||11
355773|NCT00485836|862455|P2|NOT COMPLETED|Overall Study||3
355774|NCT00485836|862456|P1|NOT COMPLETED|Overall Study||15
355775|NCT00485836|862454|P3|COMPLETED|Overall Study||119
355776|NCT00485836|862455|P2|COMPLETED|Overall Study||129
355777|NCT00485836|862456|P1|COMPLETED|Overall Study||115
355778|NCT00485836|862454|P3|Received Study Drug (Safety Population)|Overall Study||129
355779|NCT00485836|862455|P2|Received Study Drug (Safety Population)|Overall Study||132
355780|NCT00485836|862456|P1|Received Study Drug (Safety Population)|Overall Study||129
355781|NCT00485836|862454|P3|STARTED|Overall Study||130
355782|NCT00485836|862455|P2|STARTED|Overall Study||132
355783|NCT00485836|862456|P1|STARTED|Overall Study||130
355784|NCT00485758|862484|P2|NOT COMPLETED|Overall Study||65
355785|NCT00485758|862485|P1|NOT COMPLETED|Overall Study||156
355786|NCT00485758|862484|P2|COMPLETED|Overall Study||277
355787|NCT00485758|862485|P1|COMPLETED|Overall Study||298
355788|NCT00485758|862484|P2|STARTED|Overall Study||342
355789|NCT00485758|862485|P1|STARTED|Overall Study||454
355790|NCT00485732|862497|P2|NOT COMPLETED|Overall Study||9
355791|NCT00485732|862498|P1|NOT COMPLETED|Overall Study||8
355792|NCT00485732|862497|P2|COMPLETED|Overall Study||67
355793|NCT00485732|862498|P1|COMPLETED|Overall Study||141
355794|NCT00485732|862497|P2|STARTED|Overall Study||76
355795|NCT00485732|862498|P1|STARTED|Overall Study||149
355796|NCT00485693|862520|P2|NOT COMPLETED|Overall Study||0
355797|NCT00485693|862521|P1|NOT COMPLETED|Overall Study||0
355798|NCT00485693|862520|P2|COMPLETED|Overall Study||104
355799|NCT00485693|862521|P1|COMPLETED|Overall Study||34
355800|NCT00485693|862520|P2|STARTED|Overall Study||104
355801|NCT00485693|862521|P1|STARTED|Overall Study||34
355802|NCT00485485|862530|P1|NOT COMPLETED|Overall Study||0
355803|NCT00485485|862530|P1|COMPLETED|Overall Study||7
355804|NCT00485485|862530|P1|STARTED|Overall Study||7
355805|NCT00485472|862536|P2|NOT COMPLETED|Overall Study||12
355806|NCT00485472|862537|P1|NOT COMPLETED|Overall Study||16
355807|NCT00485472|862536|P2|COMPLETED|Overall Study||64
355808|NCT00485472|862537|P1|COMPLETED|Overall Study||57
355809|NCT00485472|862536|P2|Entered Maintenance Phase|Overall Study||67
355810|NCT00485472|862537|P1|Entered Maintenance Phase|Overall Study||65
355811|NCT00485472|862536|P2|STARTED|Overall Study||76
355812|NCT00485472|862537|P1|STARTED|Overall Study||73
355813|NCT00485433|862563|P4|NOT COMPLETED|Overall Study||0
355814|NCT00485433|862564|P3|NOT COMPLETED|Overall Study||0
355815|NCT00485433|862565|P2|NOT COMPLETED|Overall Study||0
355816|NCT00485433|862566|P1|NOT COMPLETED|Overall Study||0
355817|NCT00485433|862563|P4|COMPLETED|Overall Study||25
355818|NCT00485433|862564|P3|COMPLETED|Overall Study||24
355819|NCT00485433|862565|P2|COMPLETED|Overall Study||25
355820|NCT00485433|862566|P1|COMPLETED|Overall Study||24
355821|NCT00485433|862563|P4|STARTED|Overall Study||25
355822|NCT00485433|862564|P3|STARTED|Overall Study||24
355823|NCT00485433|862565|P2|STARTED|Overall Study||25
355824|NCT00485433|862566|P1|STARTED|Overall Study||24
355825|NCT00485303|862574|P1|NOT COMPLETED|Overall Study||56
355826|NCT00485303|862574|P1|COMPLETED|Overall Study||2
355827|NCT00485303|862574|P1|STARTED|Overall Study||58
355828|NCT00485264|862592|P6|NOT COMPLETED|Overall Study||7
355829|NCT00485264|862593|P5|NOT COMPLETED|Overall Study||6
355830|NCT00485264|862594|P4|NOT COMPLETED|Overall Study||4
355831|NCT00485264|862595|P3|NOT COMPLETED|Overall Study||6
355832|NCT00485264|862596|P2|NOT COMPLETED|Overall Study||7
355833|NCT00485264|862597|P1|NOT COMPLETED|Overall Study||36
355834|NCT00485264|862592|P6|COMPLETED|Overall Study||5
355835|NCT00485264|862593|P5|COMPLETED|Overall Study||9
355836|NCT00485264|862594|P4|COMPLETED|Overall Study||17
355837|NCT00485264|862595|P3|COMPLETED|Overall Study||12
355838|NCT00485264|862596|P2|COMPLETED|Overall Study||9
355839|NCT00485264|862597|P1|COMPLETED|Overall Study||35
355840|NCT00485264|862592|P6|Completed Week 24|Overall Study||11
355841|NCT00485264|862593|P5|Completed Week 24|Overall Study||14
355842|NCT00485264|862594|P4|Completed Week 24|Overall Study||21
355843|NCT00485264|862595|P3|Completed Week 24|Overall Study||18
355844|NCT00485264|862596|P2|Completed Week 24|Overall Study||16
355845|NCT00485264|862597|P1|Completed Week 24|Overall Study||67
355846|NCT00485264|862592|P6|STARTED|Overall Study||12
355847|NCT00485264|862593|P5|STARTED|Overall Study||15
355848|NCT00485264|862594|P4|STARTED|Overall Study||21
355849|NCT00485264|862595|P3|STARTED|Overall Study||18
355850|NCT00485264|862596|P2|STARTED|Overall Study||16
355851|NCT00485264|862597|P1|STARTED|Overall Study||71
355852|NCT00485173|862685|P2|NOT COMPLETED|Overall Study||64
355853|NCT00485173|862686|P1|NOT COMPLETED|Overall Study||36
355854|NCT00485173|862685|P2|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|422
355855|NCT00485173|862686|P1|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|188
355856|NCT00485173|862685|P2|STARTED|Overall Study||486
355857|NCT00485173|862686|P1|STARTED|Overall Study||224
355858|NCT00485134|862734|P8|NOT COMPLETED|Overall Study||1
355859|NCT00485134|862735|P7|NOT COMPLETED|Overall Study||3
355860|NCT00485134|862736|P6|NOT COMPLETED|Overall Study||4
355861|NCT00485134|862737|P5|NOT COMPLETED|Overall Study||3
355862|NCT00485134|862738|P4|NOT COMPLETED|Overall Study||1
355863|NCT00485134|862739|P3|NOT COMPLETED|Overall Study||3
355864|NCT00485134|862740|P2|NOT COMPLETED|Overall Study||2
355865|NCT00485134|862741|P1|NOT COMPLETED|Overall Study||1
355866|NCT00485134|862734|P8|COMPLETED|Overall Study||20
355867|NCT00485134|862735|P7|COMPLETED|Overall Study||28
355868|NCT00485134|862736|P6|COMPLETED|Overall Study||3
355869|NCT00485134|862737|P5|COMPLETED|Overall Study||7
355870|NCT00485134|862738|P4|COMPLETED|Overall Study||7
355871|NCT00485134|862739|P3|COMPLETED|Overall Study||9
355872|NCT00485134|862740|P2|COMPLETED|Overall Study||10
355873|NCT00485134|862741|P1|COMPLETED|Overall Study||11
355874|NCT00485134|862734|P8|STARTED|Overall Study||21
355875|NCT00485134|862735|P7|STARTED|Overall Study||31
355876|NCT00485134|862736|P6|STARTED|Overall Study||7
355877|NCT00485134|862737|P5|STARTED|Overall Study||10
355878|NCT00485134|862738|P4|STARTED|Overall Study||8
355879|NCT00485134|862739|P3|STARTED|Overall Study||12
355880|NCT00485134|862740|P2|STARTED|Overall Study||12
355881|NCT00485134|862741|P1|STARTED|Overall Study||12
355882|NCT00485069|862763|P2|NOT COMPLETED|Overall Study||12
355883|NCT00485069|862764|P1|NOT COMPLETED|Overall Study||18
355884|NCT00485069|862763|P2|COMPLETED|Overall Study||46
355885|NCT00485069|862764|P1|COMPLETED|Overall Study||47
355886|NCT00485069|862763|P2|STARTED|Overall Study||58
355887|NCT00485069|862764|P1|STARTED|Overall Study||65
355888|NCT00484939|862809|P2|NOT COMPLETED|Overall Study||140
355889|NCT00484939|862810|P1|NOT COMPLETED|Overall Study||140
355890|NCT00484939|862809|P2|COMPLETED|Overall Study||0
355891|NCT00484939|862810|P1|COMPLETED|Overall Study||0
355892|NCT00484939|862809|P2|STARTED|Overall Study||140
355893|NCT00484939|862810|P1|STARTED|Overall Study||140
355894|NCT00484874|862830|P1|NOT COMPLETED|Overall Study||0
355895|NCT00484874|862830|P1|COMPLETED|Overall Study||12
355896|NCT00484874|862830|P1|STARTED|Overall Study||12
355897|NCT00484679|862837|P1|NOT COMPLETED|Overall Study||3
355898|NCT00484679|862837|P1|COMPLETED|Overall Study||15
355899|NCT00484679|862837|P1|STARTED|Overall Study||18
355900|NCT00484419|862844|P3|NOT COMPLETED|Overall Study||11
355901|NCT00484419|862845|P2|NOT COMPLETED|Overall Study||5
355902|NCT00484419|862846|P1|NOT COMPLETED|Overall Study||12
355903|NCT00484419|862844|P3|COMPLETED|Overall Study||45
355904|NCT00484419|862845|P2|COMPLETED|Overall Study||51
355905|NCT00484419|862846|P1|COMPLETED|Overall Study||45
355906|NCT00484419|862844|P3|STARTED|Overall Study||56
355907|NCT00484419|862845|P2|STARTED|Overall Study||56
355908|NCT00484419|862846|P1|STARTED|Overall Study||57
355909|NCT00484393|862904|P2|NOT COMPLETED|Overall Study||0
355910|NCT00484393|862905|P1|NOT COMPLETED|Overall Study||0
355911|NCT00484393|862904|P2|COMPLETED|Overall Study||3
355912|NCT00484393|862905|P1|COMPLETED|Overall Study||4
355913|NCT00484393|862904|P2|STARTED|Overall Study||3
355914|NCT00484393|862905|P1|STARTED|Overall Study||4
355915|NCT00484354|862913|P2|NOT COMPLETED|Overall Study||2
355916|NCT00484354|862914|P1|NOT COMPLETED|Overall Study||1
355917|NCT00484354|862913|P2|COMPLETED|Overall Study||57
355918|NCT00484354|862914|P1|COMPLETED|Overall Study||63
355919|NCT00484354|862913|P2|STARTED|Overall Study||59
355920|NCT00484354|862914|P1|STARTED|Overall Study||64
355921|NCT00484315|862930|P2|NOT COMPLETED|9-Month Angiographic Follow-up||13
355922|NCT00484315|862931|P1|NOT COMPLETED|9-Month Angiographic Follow-up||28
355923|NCT00484315|862930|P2|COMPLETED|9-Month Angiographic Follow-up||61
355924|NCT00484315|862931|P1|COMPLETED|9-Month Angiographic Follow-up||228
355925|NCT00484315|862930|P2|STARTED|9-Month Angiographic Follow-up||74
355926|NCT00484315|862931|P1|STARTED|9-Month Angiographic Follow-up||256
355927|NCT00484315|862930|P2|NOT COMPLETED|12-Month Clinical Follow-up||9
355928|NCT00484315|862931|P1|NOT COMPLETED|12-Month Clinical Follow-up||28
355929|NCT00484315|862930|P2|COMPLETED|12-Month Clinical Follow-up||311
355930|NCT00484315|862931|P1|COMPLETED|12-Month Clinical Follow-up||914
355931|NCT00484315|862930|P2|STARTED|12-Month Clinical Follow-up||320
355932|NCT00484315|862931|P1|STARTED|12-Month Clinical Follow-up||942
355933|NCT00484289|862942|P3|NOT COMPLETED|Post Marketing Phase||0
355934|NCT00484289|862943|P2|NOT COMPLETED|Post Marketing Phase||1
355935|NCT00484289|862944|P1|NOT COMPLETED|Post Marketing Phase||0
355936|NCT00484289|862942|P3|COMPLETED|Post Marketing Phase||10
355937|NCT00484289|862943|P2|COMPLETED|Post Marketing Phase||141
355938|NCT00484289|862944|P1|COMPLETED|Post Marketing Phase||10
355939|NCT00484289|862942|P3|STARTED|Post Marketing Phase||10
355940|NCT00484289|862943|P2|STARTED|Post Marketing Phase||142
355941|NCT00484289|862944|P1|STARTED|Post Marketing Phase||10
355942|NCT00484289|862942|P3|NOT COMPLETED|Long Term Phase||16
355943|NCT00484289|862943|P2|NOT COMPLETED|Long Term Phase||36
355944|NCT00484289|862944|P1|NOT COMPLETED|Long Term Phase||3
355945|NCT00484289|862942|P3|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
355946|NCT00484289|862943|P2|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|142
355947|NCT00484289|862944|P1|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
355948|NCT00484289|862942|P3|STARTED|Long Term Phase||26
355949|NCT00484289|862943|P2|STARTED|Long Term Phase||178
355950|NCT00484289|862944|P1|STARTED|Long Term Phase||13
355951|NCT00484185|863016|P1|NOT COMPLETED|Overall Study||71
355952|NCT00484185|863016|P1|COMPLETED|Overall Study||112
355953|NCT00484185|863016|P1|Treated|Overall Study||178
355954|NCT00484185|863016|P1|STARTED|Overall Study||183
355955|NCT00484159|863038|P3|NOT COMPLETED|Overall Study||0
355956|NCT00484159|863039|P2|NOT COMPLETED|Overall Study||1
355957|NCT00484159|863040|P1|NOT COMPLETED|Overall Study||1
355958|NCT00484159|863038|P3|COMPLETED|Overall Study||51
355959|NCT00484159|863039|P2|COMPLETED|Overall Study||49
355960|NCT00484159|863040|P1|COMPLETED|Overall Study||49
355961|NCT00484159|863038|P3|STARTED|Overall Study||51
355962|NCT00484159|863039|P2|STARTED|Overall Study||50
355963|NCT00484159|863040|P1|STARTED|Overall Study||50
355964|NCT00484094|863051|P1|NOT COMPLETED|Overall Study||42
355965|NCT00484094|863051|P1|COMPLETED|Overall Study||167
355966|NCT00484094|863051|P1|STARTED|Overall Study||209
355967|NCT00483938|863067|P7|NOT COMPLETED|Overall Study||40
355968|NCT00483938|863068|P6|NOT COMPLETED|Overall Study||8
355969|NCT00483938|863069|P5|NOT COMPLETED|Overall Study||2
355970|NCT00483938|863070|P4|NOT COMPLETED|Overall Study||6
355971|NCT00483938|863071|P3|NOT COMPLETED|Overall Study||0
355972|NCT00483938|863072|P2|NOT COMPLETED|Overall Study||19
355973|NCT00483938|863073|P1|NOT COMPLETED|Overall Study||5
355974|NCT00483938|863067|P7|COMPLETED|Overall Study||0
355975|NCT00483938|863068|P6|COMPLETED|Overall Study||18
355976|NCT00483938|863069|P5|COMPLETED|Overall Study||23
355977|NCT00483938|863070|P4|COMPLETED|Overall Study||25
355978|NCT00483938|863071|P3|COMPLETED|Overall Study||30
355979|NCT00483938|863072|P2|COMPLETED|Overall Study||24
355980|NCT00483938|863073|P1|COMPLETED|Overall Study||36
355981|NCT00483938|863067|P7|STARTED|Overall Study||40
355982|NCT00483938|863068|P6|STARTED|Overall Study||26
355983|NCT00483938|863069|P5|STARTED|Overall Study||25
355984|NCT00483938|863070|P4|STARTED|Overall Study||31
355985|NCT00483938|863071|P3|STARTED|Overall Study||30
355986|NCT00483938|863072|P2|STARTED|Overall Study||43
355987|NCT00483938|863073|P1|STARTED|Overall Study||41
355988|NCT00483756|863097|P3|NOT COMPLETED|Overall Study||52
355989|NCT00483756|863098|P2|NOT COMPLETED|Overall Study||50
355990|NCT00483756|863099|P1|NOT COMPLETED|Overall Study||33
355991|NCT00483756|863097|P3|COMPLETED|Overall Study||59
355992|NCT00483756|863098|P2|COMPLETED|Overall Study||60
355993|NCT00483756|863099|P1|COMPLETED|Overall Study||77
355994|NCT00483756|863097|P3|Treated|Overall Study||107
355995|NCT00483756|863098|P2|Treated|Overall Study||106
355996|NCT00483756|863099|P1|Treated|Overall Study||109
355997|NCT00483756|863097|P3|STARTED|Overall Study||111
355998|NCT00483756|863098|P2|STARTED|Overall Study||110
355999|NCT00483756|863099|P1|STARTED|Overall Study||110
356000|NCT00483717|863163|P2|NOT COMPLETED|Overall Study||21
356001|NCT00483717|863164|P1|NOT COMPLETED|Overall Study||24
356002|NCT00483717|863163|P2|COMPLETED|Overall Study||65
356003|NCT00483717|863164|P1|COMPLETED|Overall Study||63
356004|NCT00483717|863163|P2|STARTED|Overall Study||86
356005|NCT00483717|863164|P1|STARTED|Overall Study||87
356006|NCT00483704|863187|P3|NOT COMPLETED|Treatment||156
356007|NCT00483704|863188|P2|NOT COMPLETED|Treatment||129
356008|NCT00483704|863189|P1|NOT COMPLETED|Treatment||129
356009|NCT00483704|863187|P3|COMPLETED|Treatment||399
356010|NCT00483704|863188|P2|COMPLETED|Treatment||420
356011|NCT00483704|863189|P1|COMPLETED|Treatment||444
356012|NCT00483704|863187|P3|STARTED|Treatment||555
356013|NCT00483704|863188|P2|STARTED|Treatment||549
356014|NCT00483704|863189|P1|STARTED|Treatment||573
356015|NCT00483704|863187|P3|NOT COMPLETED|Randomization||91
356016|NCT00483704|863188|P2|NOT COMPLETED|Randomization||96
356017|NCT00483704|863189|P1|NOT COMPLETED|Randomization||71
356018|NCT00483704|863187|P3|COMPLETED|Randomization||555
356019|NCT00483704|863188|P2|COMPLETED|Randomization||549
356020|NCT00483704|863189|P1|COMPLETED|Randomization||573
356021|NCT00483704|863187|P3|STARTED|Randomization||646
356022|NCT00483704|863188|P2|STARTED|Randomization||645
356023|NCT00483704|863189|P1|STARTED|Randomization||644
356024|NCT00483652|863235|P2|NOT COMPLETED|Post-study Follow-up||0
356025|NCT00483652|863236|P1|NOT COMPLETED|Post-study Follow-up||0
356026|NCT00483652|863235|P2|COMPLETED|Post-study Follow-up||114
356027|NCT00483652|863236|P1|COMPLETED|Post-study Follow-up||113
356028|NCT00483652|863235|P2|STARTED|Post-study Follow-up||114
356029|NCT00483652|863236|P1|STARTED|Post-study Follow-up||113
356030|NCT00483652|863235|P2|NOT COMPLETED|Double-blind Treatment Period||5
356031|NCT00483652|863236|P1|NOT COMPLETED|Double-blind Treatment Period||7
356032|NCT00483652|863235|P2|COMPLETED|Double-blind Treatment Period||114
356033|NCT00483652|863236|P1|COMPLETED|Double-blind Treatment Period||113
356034|NCT00483652|863235|P2|STARTED|Double-blind Treatment Period||119
356035|NCT00483652|863236|P1|STARTED|Double-blind Treatment Period||120
356036|NCT00483574|863246|P2|NOT COMPLETED|Overall Study||13
356037|NCT00483574|863247|P1|NOT COMPLETED|Overall Study||102
356038|NCT00483574|863246|P2|COMPLETED|Overall Study||308
356039|NCT00483574|863247|P1|COMPLETED|Overall Study||951
356040|NCT00483574|863246|P2|STARTED|Overall Study||321
356041|NCT00483574|863247|P1|STARTED|Overall Study||1053
356042|NCT00483561|863255|P1|NOT COMPLETED|Overall Study||11
356043|NCT00483561|863255|P1|COMPLETED|Overall Study||15
356044|NCT00483561|863255|P1|STARTED|Overall Study||26
356045|NCT00483548|863262|P2|NOT COMPLETED|Overall Study||46
356046|NCT00483548|863263|P1|NOT COMPLETED|Overall Study||60
356047|NCT00483548|863262|P2|COMPLETED|Overall Study||104
356048|NCT00483548|863263|P1|COMPLETED|Overall Study||88
356049|NCT00483548|863262|P2|Received Study Treatment|Overall Study|3 subjects randomized but not treated.|147
356050|NCT00483548|863263|P1|Received Study Treatment|Overall Study|1 subject randomized but lost to follow up; no treatment data.|147
356051|NCT00483548|863262|P2|STARTED|Overall Study||150
356052|NCT00483548|863263|P1|STARTED|Overall Study||148
356053|NCT00483509|863301|P1|NOT COMPLETED|Overall Study||0
356054|NCT00483509|863301|P1|COMPLETED|Overall Study||28
356055|NCT00483509|863301|P1|STARTED|Overall Study||28
356056|NCT00483496|863309|P1|NOT COMPLETED|Overall Study||1
356057|NCT00483496|863309|P1|COMPLETED|Overall Study||15
356058|NCT00483496|863309|P1|STARTED|Overall Study||16
356059|NCT00483405|863321|P1|NOT COMPLETED|Overall Study||28
356060|NCT00483405|863321|P1|COMPLETED|Overall Study||0
356061|NCT00483405|863321|P1|STARTED|Overall Study||28
356062|NCT00483379|863330|P2|NOT COMPLETED|Extension Period||0
356063|NCT00483379|863331|P1|NOT COMPLETED|Extension Period||0
356064|NCT00483379|863330|P2|COMPLETED|Extension Period||2
356065|NCT00483379|863331|P1|COMPLETED|Extension Period||1
356066|NCT00483379|863330|P2|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|2
356067|NCT00483379|863331|P1|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|1
356068|NCT00483379|863330|P2|NOT COMPLETED|Treatment Period||0
356069|NCT00483379|863331|P1|NOT COMPLETED|Treatment Period||2
356070|NCT00483379|863330|P2|COMPLETED|Treatment Period||7
356071|NCT00483379|863331|P1|COMPLETED|Treatment Period||4
356072|NCT00483379|863330|P2|STARTED|Treatment Period||7
356073|NCT00483379|863331|P1|STARTED|Treatment Period||6
356074|NCT00483327|863367|P1|NOT COMPLETED|Overall Study||10
356075|NCT00483327|863367|P1|COMPLETED|Overall Study||20
356076|NCT00483327|863367|P1|STARTED|Overall Study||30
356077|NCT00483262|863378|P2|NOT COMPLETED|Overall Study||0
356078|NCT00483262|863379|P1|NOT COMPLETED|Overall Study||0
356079|NCT00483262|863378|P2|COMPLETED|Overall Study||43
356080|NCT00483262|863379|P1|COMPLETED|Overall Study||20
356081|NCT00483262|863378|P2|STARTED|Overall Study||43
356082|NCT00483262|863379|P1|STARTED|Overall Study||20
356083|NCT00483223|863389|P1|NOT COMPLETED|Overall Study||0
356084|NCT00483223|863389|P1|COMPLETED|Overall Study||86
356085|NCT00483223|863389|P1|STARTED|Overall Study||86
356086|NCT00483184|863399|P3|NOT COMPLETED|Overall Study||3
356087|NCT00483184|863400|P2|NOT COMPLETED|Overall Study||4
356088|NCT00483184|863401|P1|NOT COMPLETED|Overall Study||5
356089|NCT00483184|863399|P3|COMPLETED|Overall Study||23
356090|NCT00483184|863400|P2|COMPLETED|Overall Study||27
356091|NCT00483184|863401|P1|COMPLETED|Overall Study||22
356092|NCT00483184|863399|P3|STARTED|Overall Study||26
356093|NCT00483184|863400|P2|STARTED|Overall Study||31
356094|NCT00483184|863401|P1|STARTED|Overall Study||27
356095|NCT00483119|863411|P2|NOT COMPLETED|Overall Study||1
356096|NCT00483119|863412|P1|NOT COMPLETED|Overall Study||1
356097|NCT00483119|863411|P2|COMPLETED|Overall Study||3
356098|NCT00483119|863412|P1|COMPLETED|Overall Study||4
356099|NCT00483119|863411|P2|STARTED|Overall Study||4
356100|NCT00483119|863412|P1|STARTED|Overall Study||5
356101|NCT00483041|863426|P2|NOT COMPLETED|Overall Study||1
356102|NCT00483041|863427|P1|NOT COMPLETED|Overall Study||0
356103|NCT00483041|863426|P2|COMPLETED|Overall Study||5
356104|NCT00483041|863427|P1|COMPLETED|Overall Study||5
356105|NCT00483041|863426|P2|STARTED|Overall Study||6
356106|NCT00483041|863427|P1|STARTED|Overall Study||5
356107|NCT00483002|863457|P1|NOT COMPLETED|Overall Study||2554
356108|NCT00483002|863457|P1|COMPLETED|Overall Study||1165
356109|NCT00483002|863457|P1|STARTED|Overall Study||3719
356110|NCT00482911|863465|P2|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
356111|NCT00482911|863466|P1|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
356112|NCT00482911|863465|P2|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun|5 stopped at Dose D-QOD, 2 stopped at Dose D-QD (1 after first increasing to Dose E-QD)|7
356113|NCT00482911|863466|P1|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
356114|NCT00482911|863465|P2|STARTED|Dosing Schedule 2: Len, Cyc, & Sun|All received Dose D-QD in cycle 1|7
356115|NCT00482911|863466|P1|STARTED|Dosing Schedule 2: Len, Cyc, & Sun||0
356116|NCT00482911|863465|P2|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
356117|NCT00482911|863466|P1|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
356118|NCT00482911|863465|P2|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QOD|2
356119|NCT00482911|863466|P1|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QD, 1 stopped at Dose C-QOD|3
356120|NCT00482911|863465|P2|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 1|2
356121|NCT00482911|863466|P1|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 2|3
356122|NCT00482911|863465|P2|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
356123|NCT00482911|863466|P1|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
356124|NCT00482911|863465|P2|COMPLETED|Dosing Schedule 1: Len & Cyc||0
356125|NCT00482911|863466|P1|COMPLETED|Dosing Schedule 1: Len & Cyc||3
356126|NCT00482911|863465|P2|STARTED|Dosing Schedule 1: Len & Cyc||0
356127|NCT00482911|863466|P1|STARTED|Dosing Schedule 1: Len & Cyc|All received Dose A-QD in cycle 1|3
356128|NCT00482729|863482|P2|NOT COMPLETED|Overall Study||218
356129|NCT00482729|863483|P1|NOT COMPLETED|Overall Study||217
356130|NCT00482729|863482|P2|COMPLETED|Overall Study||406
356131|NCT00482729|863483|P1|COMPLETED|Overall Study||409
356132|NCT00482729|863482|P2|Completed Phase B|Overall Study||406
356133|NCT00482729|863483|P1|Completed Phase B|Overall Study||409
356134|NCT00482729|863482|P2|Completed Phase A|Overall Study||482
356135|NCT00482729|863483|P1|Completed Phase A|Overall Study||484
356136|NCT00482729|863482|P2|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 3 patients were excluded from all analysis|624
356137|NCT00482729|863483|P1|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 1 patient was excluded from all analysis|626
356138|NCT00482703|863499|P2|NOT COMPLETED|Overall Study||0
356139|NCT00482703|863500|P1|NOT COMPLETED|Overall Study||1
356140|NCT00482703|863499|P2|COMPLETED|Overall Study||12
356141|NCT00482703|863500|P1|COMPLETED|Overall Study||10
356142|NCT00482703|863499|P2|STARTED|Overall Study|number enrolled, randomized and treated|12
356143|NCT00482703|863500|P1|STARTED|Overall Study|number enrolled, randomized and treated|11
356144|NCT00482677|863547|P2|NOT COMPLETED|Overall Study||0
356145|NCT00482677|863548|P1|NOT COMPLETED|Overall Study||0
356146|NCT00482677|863547|P2|COMPLETED|Overall Study||281
356147|NCT00482677|863548|P1|COMPLETED|Overall Study||281
356148|NCT00482677|863547|P2|STARTED|Overall Study||281
356149|NCT00482677|863548|P1|STARTED|Overall Study||281
356150|NCT00482625|863558|P1|NOT COMPLETED|Overall Study||0
356151|NCT00482625|863558|P1|COMPLETED|Overall Study||6
356152|NCT00482625|863558|P1|STARTED|Overall Study||6
356153|NCT00482612|863571|P4|NOT COMPLETED|Follow-up Period||8
356154|NCT00482612|863572|P3|NOT COMPLETED|Follow-up Period||22
356155|NCT00482612|863573|P2|NOT COMPLETED|Follow-up Period||18
356156|NCT00482612|863574|P1|NOT COMPLETED|Follow-up Period||14
356157|NCT00482612|863571|P4|COMPLETED|Follow-up Period||127
356158|NCT00482612|863572|P3|COMPLETED|Follow-up Period||106
356159|NCT00482612|863573|P2|COMPLETED|Follow-up Period||107
356160|NCT00482612|863574|P1|COMPLETED|Follow-up Period||123
356161|NCT00482612|863571|P4|STARTED|Follow-up Period||135
356162|NCT00482612|863572|P3|STARTED|Follow-up Period||128
356163|NCT00482612|863573|P2|STARTED|Follow-up Period||125
356164|NCT00482612|863574|P1|STARTED|Follow-up Period||137
356165|NCT00482612|863571|P4|NOT COMPLETED|In-treatment Period||0
356166|NCT00482612|863572|P3|NOT COMPLETED|In-treatment Period||1
356167|NCT00482612|863573|P2|NOT COMPLETED|In-treatment Period||0
356168|NCT00482612|863574|P1|NOT COMPLETED|In-treatment Period||0
356169|NCT00482612|863571|P4|COMPLETED|In-treatment Period||135
356170|NCT00482612|863572|P3|COMPLETED|In-treatment Period||128
356171|NCT00482612|863573|P2|COMPLETED|In-treatment Period||125
356172|NCT00482612|863574|P1|COMPLETED|In-treatment Period||137
356173|NCT00482612|863571|P4|Treated|In-treatment Period||135
356174|NCT00482612|863572|P3|Treated|In-treatment Period||128
356175|NCT00482612|863573|P2|Treated|In-treatment Period||125
356176|NCT00482612|863574|P1|Treated|In-treatment Period||137
356177|NCT00482612|863571|P4|STARTED|In-treatment Period||135
356178|NCT00482612|863572|P3|STARTED|In-treatment Period||129
356179|NCT00482612|863573|P2|STARTED|In-treatment Period||125
356180|NCT00482612|863574|P1|STARTED|In-treatment Period||137
356181|NCT00482547|863602|P2|NOT COMPLETED|Overall Study||161
356182|NCT00482547|863603|P1|NOT COMPLETED|Overall Study||173
356183|NCT00482547|863602|P2|COMPLETED|Overall Study||428
356184|NCT00482547|863603|P1|COMPLETED|Overall Study||426
356185|NCT00482547|863602|P2|48 Hour Evaluation|Overall Study|428 went on to be included in the Silicone-coated 48 hour efficacy evaluable population.|428
356186|NCT00482547|863603|P1|48 Hour Evaluation|Overall Study|426 went on to be included in the Silver-coated 48 hour efficacy evaluable population.|426
356187|NCT00482547|863602|P2|Successful Catheterization|Overall Study|Out of the 589 SiCS catheter subjects 568 (96.4%) had a successful catheterization.|568
356188|NCT00482547|863603|P1|Successful Catheterization|Overall Study|Out of the 599 AgCS subjects 565 (94.3%) had a successful catheterization.|565
356189|NCT00482547|863602|P2|STARTED|Overall Study|589 subjects were enrolled in the silicone-coated catheter group.|589
356190|NCT00482547|863603|P1|STARTED|Overall Study|599 subjects were enrolled in the silver-coated catheter group.|599
356191|NCT00482391|863623|P1|NOT COMPLETED|Overall Study||3
356192|NCT00482391|863623|P1|COMPLETED|Overall Study||92
356193|NCT00482391|863623|P1|STARTED|Overall Study||95
356194|NCT00482274|863628|P1|NOT COMPLETED|Overall Study||1
356195|NCT00482274|863628|P1|COMPLETED|Overall Study||2
356196|NCT00482274|863628|P1|STARTED|Overall Study||3
356197|NCT00482170|863638|P2|NOT COMPLETED|Overall Study||20
356198|NCT00482170|863639|P1|NOT COMPLETED|Overall Study||15
356199|NCT00482170|863638|P2|COMPLETED|Overall Study||194
356200|NCT00482170|863639|P1|COMPLETED|Overall Study||192
356201|NCT00482170|863638|P2|Treated|Overall Study||211
356202|NCT00482170|863639|P1|Treated|Overall Study||207
356203|NCT00482170|863638|P2|STARTED|Overall Study||214
356204|NCT00482170|863639|P1|STARTED|Overall Study||207
356205|NCT00482053|863757|P1|NOT COMPLETED|Allogeneic Peripheral Stem Cells||0
356206|NCT00482053|863757|P1|COMPLETED|Allogeneic Peripheral Stem Cells||2
356207|NCT00482053|863757|P1|STARTED|Allogeneic Peripheral Stem Cells||2
356208|NCT00482053|863757|P1|NOT COMPLETED|Inter-treatment Period||1
356209|NCT00482053|863757|P1|COMPLETED|Inter-treatment Period||2
356210|NCT00482053|863757|P1|STARTED|Inter-treatment Period||3
356211|NCT00482053|863757|P1|NOT COMPLETED|Autologous Peripheral Stem Cells||0
356212|NCT00482053|863757|P1|COMPLETED|Autologous Peripheral Stem Cells||3
356213|NCT00482053|863757|P1|STARTED|Autologous Peripheral Stem Cells||3
356214|NCT00482014|863771|P4|NOT COMPLETED|Overall Study||23
356215|NCT00482014|863772|P3|NOT COMPLETED|Overall Study||11
356216|NCT00482014|863773|P2|NOT COMPLETED|Overall Study||6
356217|NCT00482014|863774|P1|NOT COMPLETED|Overall Study||7
356218|NCT00482014|863771|P4|COMPLETED|Overall Study||29
356219|NCT00482014|863772|P3|COMPLETED|Overall Study||35
356220|NCT00482014|863773|P2|COMPLETED|Overall Study||7
356221|NCT00482014|863774|P1|COMPLETED|Overall Study||2
356222|NCT00482014|863771|P4|STARTED|Overall Study||52
356223|NCT00482014|863772|P3|STARTED|Overall Study||46
356224|NCT00482014|863773|P2|STARTED|Overall Study||13
356225|NCT00482014|863774|P1|STARTED|Overall Study||9
356226|NCT00482001|863798|P2|NOT COMPLETED|Overall Study||1
356227|NCT00482001|863799|P1|NOT COMPLETED|Overall Study||1
356228|NCT00482001|863798|P2|COMPLETED|Overall Study||10
356229|NCT00482001|863799|P1|COMPLETED|Overall Study||10
356230|NCT00482001|863798|P2|STARTED|Overall Study||11
356231|NCT00482001|863799|P1|STARTED|Overall Study||11
356232|NCT00481988|863819|P2|NOT COMPLETED|Overall Study||1
356233|NCT00481988|863820|P1|NOT COMPLETED|Overall Study||1
356234|NCT00481988|863819|P2|COMPLETED|Overall Study||8
356235|NCT00481988|863820|P1|COMPLETED|Overall Study||11
356236|NCT00481988|863819|P2|Crossover|Overall Study|patient dropped out of study after 5 sessions to illness unrelated to study|8
356237|NCT00481988|863820|P1|Crossover|Overall Study|patient dropped out of study after 5 sessions to pursue other treatment options|11
356238|NCT00481988|863819|P2|STARTED|Overall Study|one patient was dropped from the study before randomization|9
356239|NCT00481988|863820|P1|STARTED|Overall Study||12
356240|NCT00481871|863833|P5|NOT COMPLETED|Overall Study||0
356241|NCT00481871|863834|P4|NOT COMPLETED|Overall Study||0
356242|NCT00481871|863835|P3|NOT COMPLETED|Overall Study||1
356243|NCT00481871|863836|P2|NOT COMPLETED|Overall Study||0
356244|NCT00481871|863837|P1|NOT COMPLETED|Overall Study||0
356245|NCT00481871|863833|P5|COMPLETED|Overall Study||34
356246|NCT00481871|863834|P4|COMPLETED|Overall Study||38
356247|NCT00481871|863835|P3|COMPLETED|Overall Study||17
356248|NCT00481871|863836|P2|COMPLETED|Overall Study||10
356249|NCT00481871|863837|P1|COMPLETED|Overall Study||7
356250|NCT00481871|863833|P5|STARTED|Overall Study||34
356251|NCT00481871|863834|P4|STARTED|Overall Study||38
356252|NCT00481871|863835|P3|STARTED|Overall Study||18
356253|NCT00481871|863836|P2|STARTED|Overall Study||10
356254|NCT00481871|863837|P1|STARTED|Overall Study||7
356255|NCT00481845|863853|P2|NOT COMPLETED|Overall Study||0
356256|NCT00481845|863854|P1|NOT COMPLETED|Overall Study||0
356257|NCT00481845|863853|P2|COMPLETED|Overall Study||0
356258|NCT00481845|863854|P1|COMPLETED|Overall Study||1
356259|NCT00481845|863853|P2|STARTED|Overall Study||0
356260|NCT00481845|863854|P1|STARTED|Overall Study||1
356261|NCT00481832|863862|P1|NOT COMPLETED|Allogenic Hematopoietic Cell Transplant||0
356262|NCT00481832|863862|P1|COMPLETED|Allogenic Hematopoietic Cell Transplant||13
356263|NCT00481832|863862|P1|STARTED|Allogenic Hematopoietic Cell Transplant||13
356264|NCT00481832|863862|P1|NOT COMPLETED|Inter-transplant Period||27
356265|NCT00481832|863862|P1|COMPLETED|Inter-transplant Period||13
356266|NCT00481832|863862|P1|STARTED|Inter-transplant Period||40
356267|NCT00481832|863862|P1|NOT COMPLETED|Autologous Hematopoietic Cell Transplant||0
356268|NCT00481832|863862|P1|COMPLETED|Autologous Hematopoietic Cell Transplant||40
356269|NCT00481832|863862|P1|STARTED|Autologous Hematopoietic Cell Transplant||40
356270|NCT00481832|863862|P1|NOT COMPLETED|Enrollment||10
356271|NCT00481832|863862|P1|COMPLETED|Enrollment||40
356272|NCT00481832|863862|P1|STARTED|Enrollment||50
356273|NCT00481767|863877|P2|NOT COMPLETED|Overall Study||21
356274|NCT00481767|863878|P1|NOT COMPLETED|Overall Study||32
356275|NCT00481767|863877|P2|COMPLETED|Overall Study||205
356276|NCT00481767|863878|P1|COMPLETED|Overall Study||418
356277|NCT00481767|863877|P2|STARTED|Overall Study||226
356278|NCT00481767|863878|P1|STARTED|Overall Study||450
356279|NCT00481676|863912|P2|NOT COMPLETED|Overall Study||5
356280|NCT00481676|863913|P1|NOT COMPLETED|Overall Study||2
356281|NCT00481676|863912|P2|COMPLETED|Overall Study||17
356282|NCT00481676|863913|P1|COMPLETED|Overall Study||25
356283|NCT00481676|863912|P2|STARTED|Overall Study||22
356284|NCT00481676|863913|P1|STARTED|Overall Study||27
356285|NCT00481507|863937|P2|NOT COMPLETED|Overall Study||0
356286|NCT00481507|863938|P1|NOT COMPLETED|Overall Study||0
356287|NCT00481507|863937|P2|COMPLETED|Overall Study||61
356288|NCT00481507|863938|P1|COMPLETED|Overall Study||64
356289|NCT00481507|863937|P2|STARTED|Overall Study||61
356290|NCT00481507|863938|P1|STARTED|Overall Study||64
356291|NCT00481351|863948|P2|NOT COMPLETED|Overall Study||0
356292|NCT00481351|863949|P1|NOT COMPLETED|Overall Study||0
356293|NCT00481351|863948|P2|COMPLETED|Overall Study||12
356294|NCT00481351|863949|P1|COMPLETED|Overall Study||13
356295|NCT00481351|863948|P2|STARTED|Overall Study||12
356296|NCT00481351|863949|P1|STARTED|Overall Study||13
356297|NCT00481247|863965|P2|NOT COMPLETED|Overall Study||260
356298|NCT00481247|863966|P1|NOT COMPLETED|Overall Study||259
356299|NCT00481247|863965|P2|COMPLETED|Overall Study||0
356300|NCT00481247|863966|P1|COMPLETED|Overall Study||0
356301|NCT00481247|863965|P2|Received Treatment|Overall Study||258
356302|NCT00481247|863966|P1|Received Treatment|Overall Study||258
356303|NCT00481247|863965|P2|STARTED|Overall Study|Randomized|260
356304|NCT00481247|863966|P1|STARTED|Overall Study|Randomized|259
356305|NCT00481195|863990|P2|NOT COMPLETED|Overall Study||39
356306|NCT00481195|863991|P1|NOT COMPLETED|Overall Study||39
356307|NCT00481195|863990|P2|COMPLETED|Overall Study||90
356308|NCT00481195|863991|P1|COMPLETED|Overall Study||89
356309|NCT00481195|863990|P2|STARTED|Overall Study|Four of these subjects were randomized but never received study medication.|129
356310|NCT00481195|863991|P1|STARTED|Overall Study|Two of these subjects were randomized but never received study medication.|128
356311|NCT00481078|864077|P2|NOT COMPLETED|Overall Study||20
356312|NCT00481078|864078|P1|NOT COMPLETED|Overall Study||42
356313|NCT00481078|864077|P2|COMPLETED|Overall Study||12
356314|NCT00481078|864078|P1|COMPLETED|Overall Study||20
356315|NCT00481078|864077|P2|STARTED|Overall Study||32
356316|NCT00481078|864078|P1|STARTED|Overall Study||62
356317|NCT00481065|864096|P8|NOT COMPLETED|Overall Study||19
356318|NCT00481065|864097|P7|NOT COMPLETED|Overall Study||16
356319|NCT00481065|864098|P6|NOT COMPLETED|Overall Study||24
356320|NCT00481065|864099|P5|NOT COMPLETED|Overall Study||23
356321|NCT00481065|864100|P4|NOT COMPLETED|Overall Study||15
356322|NCT00481065|864101|P3|NOT COMPLETED|Overall Study||19
356323|NCT00481065|864102|P2|NOT COMPLETED|Overall Study||17
356324|NCT00481065|864103|P1|NOT COMPLETED|Overall Study||22
356325|NCT00481065|864096|P8|COMPLETED|Overall Study||30
356326|NCT00481065|864097|P7|COMPLETED|Overall Study||34
356327|NCT00481065|864098|P6|COMPLETED|Overall Study||27
356328|NCT00481065|864099|P5|COMPLETED|Overall Study||28
356329|NCT00481065|864100|P4|COMPLETED|Overall Study||37
356330|NCT00481065|864101|P3|COMPLETED|Overall Study||32
356331|NCT00481065|864102|P2|COMPLETED|Overall Study||33
356332|NCT00481065|864103|P1|COMPLETED|Overall Study||29
356333|NCT00481065|864096|P8|STARTED|Overall Study||49
356334|NCT00481065|864097|P7|STARTED|Overall Study||50
356335|NCT00481065|864098|P6|STARTED|Overall Study||51
356336|NCT00481065|864099|P5|STARTED|Overall Study||51
356337|NCT00481065|864100|P4|STARTED|Overall Study||52
356338|NCT00481065|864101|P3|STARTED|Overall Study||51
356339|NCT00481065|864102|P2|STARTED|Overall Study||50
356340|NCT00481065|864103|P1|STARTED|Overall Study||51
356341|NCT00480987|864189|P1|NOT COMPLETED|Overall Study||0
356342|NCT00480987|864189|P1|COMPLETED|Overall Study||27
356343|NCT00480987|864189|P1|STARTED|Overall Study||27
356344|NCT00480857|864193|P1|NOT COMPLETED|Overall Study||2
356345|NCT00480857|864193|P1|COMPLETED|Overall Study||17
356346|NCT00480857|864193|P1|STARTED|Overall Study||19
356347|NCT00480779|864203|P2|NOT COMPLETED|Overall Study||3
356348|NCT00480779|864204|P1|NOT COMPLETED|Overall Study||2
356349|NCT00480779|864203|P2|COMPLETED|Overall Study||19
356350|NCT00480779|864204|P1|COMPLETED|Overall Study||24
356351|NCT00480779|864203|P2|STARTED|Overall Study||22
356352|NCT00480779|864204|P1|STARTED|Overall Study||26
356353|NCT00480740|864231|P3|NOT COMPLETED|Overall Study||0
356354|NCT00480740|864232|P2|NOT COMPLETED|Overall Study||0
356355|NCT00480740|864233|P1|NOT COMPLETED|Overall Study||0
356356|NCT00480740|864231|P3|COMPLETED|Overall Study||6
356357|NCT00480740|864232|P2|COMPLETED|Overall Study||9
356358|NCT00480740|864233|P1|COMPLETED|Overall Study||26
356359|NCT00480740|864231|P3|STARTED|Overall Study||6
356360|NCT00480740|864232|P2|STARTED|Overall Study||9
356361|NCT00480740|864233|P1|STARTED|Overall Study||26
356362|NCT00480636|864241|P1|NOT COMPLETED|Overall Study||19
356363|NCT00480636|864241|P1|COMPLETED|Overall Study||83
356364|NCT00480636|864241|P1|STARTED|Overall Study||102
356365|NCT00480532|864253|P4|NOT COMPLETED|Overall Study||1
356366|NCT00480532|864254|P3|NOT COMPLETED|Overall Study||4
356367|NCT00480532|864255|P2|NOT COMPLETED|Overall Study||4
356368|NCT00480532|864256|P1|NOT COMPLETED|Overall Study||2
356369|NCT00480532|864253|P4|COMPLETED|Overall Study||31
356370|NCT00480532|864254|P3|COMPLETED|Overall Study||29
356371|NCT00480532|864255|P2|COMPLETED|Overall Study||29
356372|NCT00480532|864256|P1|COMPLETED|Overall Study||31
356373|NCT00480532|864253|P4|STARTED|Overall Study||32
356374|NCT00480532|864254|P3|STARTED|Overall Study||33
356375|NCT00480532|864255|P2|STARTED|Overall Study||33
356376|NCT00480532|864256|P1|STARTED|Overall Study||33
356377|NCT00480493|864276|P2|NOT COMPLETED|Overall Study||7
356378|NCT00480493|864277|P1|NOT COMPLETED|Overall Study||2
356379|NCT00480493|864276|P2|COMPLETED|Overall Study||21
356380|NCT00480493|864277|P1|COMPLETED|Overall Study||30
356381|NCT00480493|864276|P2|Randomized|Overall Study||28
356382|NCT00480493|864277|P1|Randomized|Overall Study||32
356383|NCT00480493|864276|P2|STARTED|Overall Study||28
356384|NCT00480493|864277|P1|STARTED|Overall Study||32
356385|NCT00480441|864289|P3|NOT COMPLETED|Randomization||2
356386|NCT00480441|864290|P2|NOT COMPLETED|Randomization||7
356387|NCT00480441|864291|P1|NOT COMPLETED|Randomization||0
356388|NCT00480441|864289|P3|COMPLETED|Randomization||9
356389|NCT00480441|864290|P2|COMPLETED|Randomization||6
356390|NCT00480441|864291|P1|COMPLETED|Randomization||0
356391|NCT00480441|864289|P3|STARTED|Randomization||11
356392|NCT00480441|864290|P2|STARTED|Randomization||13
356393|NCT00480441|864291|P1|STARTED|Randomization||0
356394|NCT00480441|864289|P3|NOT COMPLETED|Baseline Functional MRI||0
356395|NCT00480441|864290|P2|NOT COMPLETED|Baseline Functional MRI||0
356396|NCT00480441|864291|P1|NOT COMPLETED|Baseline Functional MRI||12
356397|NCT00480441|864289|P3|COMPLETED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
356398|NCT00480441|864290|P2|COMPLETED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
356399|NCT00480441|864291|P1|COMPLETED|Baseline Functional MRI||12
356400|NCT00480441|864289|P3|STARTED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
356401|NCT00480441|864290|P2|STARTED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
356402|NCT00480441|864291|P1|STARTED|Baseline Functional MRI|All non-randomized participants who also met specific eligibility for baseline functional MRI|24
356403|NCT00480441|864289|P3|NOT COMPLETED|Screening||0
356404|NCT00480441|864290|P2|NOT COMPLETED|Screening||0
356405|NCT00480441|864291|P1|NOT COMPLETED|Screening||37
356406|NCT00480441|864289|P3|COMPLETED|Screening|"Participants did not enter this arm until period 3 randomization"|0
356407|NCT00480441|864290|P2|COMPLETED|Screening|"Participants did not enter this arm until period 3 randomization"|0
356408|NCT00480441|864291|P1|COMPLETED|Screening||24
356409|NCT00480441|864289|P3|STARTED|Screening|"Participants did not enter this arm until period 3 randomization"|0
356410|NCT00480441|864290|P2|STARTED|Screening|"Participants did not enter this arm until period 3 randomization"|0
356411|NCT00480441|864291|P1|STARTED|Screening||61
356412|NCT00480324|864300|P2|NOT COMPLETED|Overall Study||16
356413|NCT00480324|864301|P1|NOT COMPLETED|Overall Study||32
356414|NCT00480324|864300|P2|COMPLETED|Overall Study||241
356415|NCT00480324|864301|P1|COMPLETED|Overall Study||476
356416|NCT00480324|864300|P2|STARTED|Overall Study||257
356417|NCT00480324|864301|P1|STARTED|Overall Study||508
356418|NCT00480077|864329|P2|NOT COMPLETED|Overall Study||26
356419|NCT00480077|864330|P1|NOT COMPLETED|Overall Study||31
356420|NCT00480077|864329|P2|COMPLETED|Overall Study||141
356421|NCT00480077|864330|P1|COMPLETED|Overall Study||137
356422|NCT00480077|864329|P2|STARTED|Overall Study||167
356423|NCT00480077|864330|P1|STARTED|Overall Study||168
356424|NCT00480025|864338|P2|NOT COMPLETED|Overall Study||369
356425|NCT00480025|864339|P1|NOT COMPLETED|Overall Study||752
356426|NCT00480025|864338|P2|COMPLETED|Overall Study||388
356427|NCT00480025|864339|P1|COMPLETED|Overall Study||763
356428|NCT00480025|864338|P2|STARTED|Overall Study||757
356429|NCT00480025|864339|P1|STARTED|Overall Study||1515
356430|NCT00479882|864411|P4|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||18
356431|NCT00479882|864412|P3|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||20
356432|NCT00479882|864413|P2|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||21
356433|NCT00479882|864414|P1|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||25
356434|NCT00479882|864411|P4|COMPLETED|Crossover: Period III (Weeks 13-20)||447
356435|NCT00479882|864412|P3|COMPLETED|Crossover: Period III (Weeks 13-20)||420
356436|NCT00479882|864413|P2|COMPLETED|Crossover: Period III (Weeks 13-20)||419
356437|NCT00479882|864414|P1|COMPLETED|Crossover: Period III (Weeks 13-20)||447
356438|NCT00479882|864411|P4|STARTED|Crossover: Period III (Weeks 13-20)||465
356439|NCT00479882|864412|P3|STARTED|Crossover: Period III (Weeks 13-20)||440
356440|NCT00479882|864413|P2|STARTED|Crossover: Period III (Weeks 13-20)||440
356441|NCT00479882|864414|P1|STARTED|Crossover: Period III (Weeks 13-20)||472
356442|NCT00479882|864411|P4|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||140
356443|NCT00479882|864412|P3|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||157
356444|NCT00479882|864413|P2|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||162
356445|NCT00479882|864414|P1|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||138
356446|NCT00479882|864411|P4|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||465
356447|NCT00479882|864412|P3|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
356448|NCT00479882|864413|P2|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
356449|NCT00479882|864414|P1|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||472
356450|NCT00479882|864411|P4|STARTED|Precrossover: Periods I/II (Weeks 1-12)||605
356451|NCT00479882|864412|P3|STARTED|Precrossover: Periods I/II (Weeks 1-12)||597
356452|NCT00479882|864413|P2|STARTED|Precrossover: Periods I/II (Weeks 1-12)||602
356453|NCT00479882|864414|P1|STARTED|Precrossover: Periods I/II (Weeks 1-12)||610
356454|NCT00479856|864544|P1|NOT COMPLETED|Overall Study||3
356455|NCT00479856|864544|P1|COMPLETED|Overall Study||6
356456|NCT00479856|864544|P1|STARTED|Overall Study||9
356457|NCT00479765|864553|P1|NOT COMPLETED|Overall Study||4
356458|NCT00479765|864553|P1|COMPLETED|Overall Study||0
356459|NCT00479765|864553|P1|STARTED|Overall Study||4
356460|NCT00479713|864559|P2|NOT COMPLETED|Overall Study||9
356461|NCT00479713|864560|P1|NOT COMPLETED|Overall Study||13
356462|NCT00479713|864559|P2|COMPLETED|Overall Study||295
356463|NCT00479713|864560|P1|COMPLETED|Overall Study||301
356464|NCT00479713|864559|P2|STARTED|Overall Study||304
356465|NCT00479713|864560|P1|STARTED|Overall Study||314
356466|NCT00479674|864584|P1|NOT COMPLETED|Overall Study||41
356467|NCT00479674|864584|P1|COMPLETED|Overall Study||0
356468|NCT00479674|864584|P1|STARTED|Overall Study||41
356469|NCT00479557|864599|P7|NOT COMPLETED|Overall Study||2
356470|NCT00479557|864600|P6|NOT COMPLETED|Overall Study||13
356471|NCT00479557|864601|P5|NOT COMPLETED|Overall Study||4
356472|NCT00479557|864602|P4|NOT COMPLETED|Overall Study||5
356473|NCT00479557|864603|P3|NOT COMPLETED|Overall Study||8
356474|NCT00479557|864604|P2|NOT COMPLETED|Overall Study||10
356475|NCT00479557|864605|P1|NOT COMPLETED|Overall Study||10
356476|NCT00479557|864599|P7|COMPLETED|Overall Study||15
356477|NCT00479557|864600|P6|COMPLETED|Overall Study||31
356478|NCT00479557|864601|P5|COMPLETED|Overall Study||8
356479|NCT00479557|864602|P4|COMPLETED|Overall Study||30
356480|NCT00479557|864603|P3|COMPLETED|Overall Study||32
356481|NCT00479557|864604|P2|COMPLETED|Overall Study||51
356482|NCT00479557|864605|P1|COMPLETED|Overall Study||26
356483|NCT00479557|864599|P7|Treated|Overall Study||17
356484|NCT00479557|864600|P6|Treated|Overall Study||44
356485|NCT00479557|864601|P5|Treated|Overall Study||12
356486|NCT00479557|864602|P4|Treated|Overall Study||35
356487|NCT00479557|864603|P3|Treated|Overall Study||40
356488|NCT00479557|864604|P2|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
356489|NCT00479557|864605|P1|Treated|Overall Study||36
356490|NCT00479557|864599|P7|STARTED|Overall Study||17
356491|NCT00479557|864600|P6|STARTED|Overall Study||44
356492|NCT00479557|864601|P5|STARTED|Overall Study||12
356493|NCT00479557|864602|P4|STARTED|Overall Study||35
356494|NCT00479557|864603|P3|STARTED|Overall Study||40
356495|NCT00479557|864604|P2|STARTED|Overall Study||61
356496|NCT00479557|864605|P1|STARTED|Overall Study||36
356497|NCT00479466|864648|P6|NOT COMPLETED|Overall Study||4
356498|NCT00479466|864649|P5|NOT COMPLETED|Overall Study||8
356499|NCT00479466|864650|P4|NOT COMPLETED|Overall Study||3
356500|NCT00479466|864651|P3|NOT COMPLETED|Overall Study||3
356501|NCT00479466|864652|P2|NOT COMPLETED|Overall Study||8
356502|NCT00479466|864653|P1|NOT COMPLETED|Overall Study||13
356503|NCT00479466|864648|P6|COMPLETED|Overall Study||53
356504|NCT00479466|864649|P5|COMPLETED|Overall Study||48
356505|NCT00479466|864650|P4|COMPLETED|Overall Study||55
356506|NCT00479466|864651|P3|COMPLETED|Overall Study||54
356507|NCT00479466|864652|P2|COMPLETED|Overall Study||49
356508|NCT00479466|864653|P1|COMPLETED|Overall Study||44
356509|NCT00479466|864648|P6|STARTED|Overall Study||57
356510|NCT00479466|864649|P5|STARTED|Overall Study||56
356511|NCT00479466|864650|P4|STARTED|Overall Study||58
356512|NCT00479466|864651|P3|STARTED|Overall Study||57
356513|NCT00479466|864652|P2|STARTED|Overall Study||57
356514|NCT00479466|864653|P1|STARTED|Overall Study||57
356515|NCT00479401|864682|P3|NOT COMPLETED|Overall Study||12
356516|NCT00479401|864683|P2|NOT COMPLETED|Overall Study||37
356517|NCT00479401|864684|P1|NOT COMPLETED|Overall Study||49
356518|NCT00479401|864682|P3|COMPLETED|Overall Study||91
356519|NCT00479401|864683|P2|COMPLETED|Overall Study||176
356520|NCT00479401|864684|P1|COMPLETED|Overall Study||174
356521|NCT00479401|864682|P3|STARTED|Overall Study||103
356522|NCT00479401|864683|P2|STARTED|Overall Study||213
356523|NCT00479401|864684|P1|STARTED|Overall Study||223
356524|NCT00479388|864739|P2|NOT COMPLETED|Overall Study||73
356525|NCT00479388|864740|P1|NOT COMPLETED|Overall Study||132
356526|NCT00479388|864739|P2|COMPLETED|Overall Study||537
356527|NCT00479388|864740|P1|COMPLETED|Overall Study||474
356528|NCT00479388|864739|P2|STARTED|Overall Study||610
356529|NCT00479388|864740|P1|STARTED|Overall Study||606
356530|NCT00479336|864754|P4|NOT COMPLETED|Overall Study||5
356531|NCT00479336|864755|P3|NOT COMPLETED|Overall Study||1
356532|NCT00479336|864756|P2|NOT COMPLETED|Overall Study||6
356533|NCT00479336|864757|P1|NOT COMPLETED|Overall Study||4
356534|NCT00479336|864754|P4|COMPLETED|Overall Study||21
356535|NCT00479336|864755|P3|COMPLETED|Overall Study||24
356536|NCT00479336|864756|P2|COMPLETED|Overall Study||20
356537|NCT00479336|864757|P1|COMPLETED|Overall Study||23
356538|NCT00479336|864754|P4|STARTED|Overall Study||26
356539|NCT00479336|864755|P3|STARTED|Overall Study||25
356540|NCT00479336|864756|P2|STARTED|Overall Study||26
356541|NCT00479336|864757|P1|STARTED|Overall Study||27
356542|NCT00479258|864773|P2|NOT COMPLETED|Overall Study||0
356543|NCT00479258|864774|P1|NOT COMPLETED|Overall Study||0
356544|NCT00479258|864773|P2|COMPLETED|Overall Study||0
356545|NCT00479258|864774|P1|COMPLETED|Overall Study||0
356546|NCT00479258|864773|P2|STARTED|Overall Study||0
356547|NCT00479258|864774|P1|STARTED|Overall Study||0
356548|NCT00479232|864780|P6|NOT COMPLETED|Overall Study||30
356549|NCT00479232|864781|P5|NOT COMPLETED|Overall Study||4
356550|NCT00479232|864782|P4|NOT COMPLETED|Overall Study||3
356551|NCT00479232|864783|P3|NOT COMPLETED|Overall Study||28
356552|NCT00479232|864784|P2|NOT COMPLETED|Overall Study||3
356553|NCT00479232|864785|P1|NOT COMPLETED|Overall Study||3
356554|NCT00479232|864780|P6|COMPLETED|Overall Study||0
356555|NCT00479232|864781|P5|COMPLETED|Overall Study||0
356556|NCT00479232|864782|P4|COMPLETED|Overall Study||0
356557|NCT00479232|864783|P3|COMPLETED|Overall Study||0
356558|NCT00479232|864784|P2|COMPLETED|Overall Study||0
356559|NCT00479232|864785|P1|COMPLETED|Overall Study||0
356560|NCT00479232|864780|P6|STARTED|Overall Study||30
356561|NCT00479232|864781|P5|STARTED|Overall Study||4
356562|NCT00479232|864782|P4|STARTED|Overall Study||3
356563|NCT00479232|864783|P3|STARTED|Overall Study||28
356564|NCT00479232|864784|P2|STARTED|Overall Study||3
356565|NCT00479232|864785|P1|STARTED|Overall Study||3
356566|NCT00479154|864805|P2|NOT COMPLETED|Overall Study||0
356567|NCT00479154|864806|P1|NOT COMPLETED|Overall Study||0
356568|NCT00479154|864805|P2|COMPLETED|Overall Study||3
356569|NCT00479154|864806|P1|COMPLETED|Overall Study||3
356570|NCT00479154|864805|P2|STARTED|Overall Study||3
356571|NCT00479154|864806|P1|STARTED|Overall Study||3
356572|NCT00479089|864814|P2|NOT COMPLETED|Overall Study||0
356573|NCT00479089|864815|P1|NOT COMPLETED|Overall Study||0
356574|NCT00479089|864814|P2|COMPLETED|Overall Study||25
356575|NCT00479089|864815|P1|COMPLETED|Overall Study||25
356576|NCT00479089|864814|P2|STARTED|Overall Study||25
356577|NCT00479089|864815|P1|STARTED|Overall Study||25
356578|NCT00479037|864827|P2|NOT COMPLETED|Overall Study||6
356579|NCT00479037|864828|P1|NOT COMPLETED|Overall Study||3
356580|NCT00479037|864827|P2|COMPLETED|Overall Study||34
356581|NCT00479037|864828|P1|COMPLETED|Overall Study||38
356582|NCT00479037|864827|P2|STARTED|Overall Study||40
356583|NCT00479037|864828|P1|STARTED|Overall Study||41
356584|NCT00478933|864838|P1|NOT COMPLETED|Overall Study||78
356585|NCT00478933|864838|P1|COMPLETED|Overall Study||1145
356586|NCT00478933|864838|P1|STARTED|Overall Study||1223
356587|NCT00478881|864864|P2|NOT COMPLETED|Overall Study||22
356588|NCT00478881|864865|P1|NOT COMPLETED|Overall Study||39
356589|NCT00478881|864864|P2|COMPLETED|Overall Study||176
356590|NCT00478881|864865|P1|COMPLETED|Overall Study||160
356591|NCT00478881|864864|P2|Received Medication|Overall Study||198
356592|NCT00478881|864865|P1|Received Medication|Overall Study||198
356593|NCT00478881|864864|P2|STARTED|Overall Study||198
356594|NCT00478881|864865|P1|STARTED|Overall Study||199
356595|NCT00478777|864889|P1|NOT COMPLETED|Overall Study||77
356596|NCT00478777|864889|P1|COMPLETED|Overall Study|10 participants had >= 6 months and 63 participants < 6 months treatment prior to study termination.|73
356597|NCT00478777|864889|P1|Safety and Full Analysis Set (FAS)|Overall Study|6 enrolled participants did not receive lenalidomide.|144
356598|NCT00478777|864889|P1|STARTED|Overall Study||150
356599|NCT00478673|864896|P1|NOT COMPLETED|12-Months Post-Procedure||64
356600|NCT00478673|864896|P1|COMPLETED|12-Months Post-Procedure||231
356601|NCT00478673|864896|P1|STARTED|12-Months Post-Procedure|3 participants who did not complete Period 1 due to death (2) and withdrawal (1) are not included.|295
356602|NCT00478673|864896|P1|NOT COMPLETED|30-Days Post-Procedure||10
356603|NCT00478673|864896|P1|COMPLETED|30-Days Post-Procedure|"7 participants who did not complete this Period due to Missed Visit still continued on to Period 2"|288
356604|NCT00478673|864896|P1|STARTED|30-Days Post-Procedure||298
356605|NCT00478647|864901|P1|NOT COMPLETED|Overall Study||2
356606|NCT00478647|864901|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT)=participants who have received at least 1 full or partial dose of study drug.|38
356607|NCT00478647|864901|P1|STARTED|Overall Study||40
356608|NCT00478608|864909|P1|NOT COMPLETED|Overall Study||20
356609|NCT00478608|864909|P1|COMPLETED|Overall Study||59
356610|NCT00478608|864909|P1|STARTED|Overall Study||79
356611|NCT00478569|864917|P1|NOT COMPLETED|Overall Study||409
356612|NCT00478569|864917|P1|COMPLETED|Overall Study||761
356613|NCT00478569|864917|P1|STARTED|Overall Study||1170
356614|NCT00478556|864933|P2|NOT COMPLETED|Overall Study||0
356615|NCT00478556|864934|P1|NOT COMPLETED|Overall Study||0
356616|NCT00478556|864933|P2|COMPLETED|Overall Study||149
356617|NCT00478556|864934|P1|COMPLETED|Overall Study||151
356618|NCT00478556|864933|P2|STARTED|Overall Study||149
356619|NCT00478556|864934|P1|STARTED|Overall Study||151
356620|NCT00478335|864944|P2|NOT COMPLETED|Period 2 (4 Days)||0
356621|NCT00478335|864945|P1|NOT COMPLETED|Period 2 (4 Days)||0
356622|NCT00478335|864944|P2|COMPLETED|Period 2 (4 Days)||2
356623|NCT00478335|864945|P1|COMPLETED|Period 2 (4 Days)||2
356624|NCT00478335|864944|P2|STARTED|Period 2 (4 Days)||2
356625|NCT00478335|864945|P1|STARTED|Period 2 (4 Days)||2
356626|NCT00478335|864944|P2|NOT COMPLETED|Period 1 (4 Days)||0
356627|NCT00478335|864945|P1|NOT COMPLETED|Period 1 (4 Days)||0
356628|NCT00478335|864944|P2|COMPLETED|Period 1 (4 Days)||2
356629|NCT00478335|864945|P1|COMPLETED|Period 1 (4 Days)||2
356630|NCT00478335|864944|P2|STARTED|Period 1 (4 Days)||2
356631|NCT00478335|864945|P1|STARTED|Period 1 (4 Days)||2
356632|NCT00478257|864953|P2|NOT COMPLETED|Overall Study||3
356633|NCT00478257|864954|P1|NOT COMPLETED|Overall Study||8
356634|NCT00478257|864953|P2|COMPLETED|Overall Study||13
356635|NCT00478257|864954|P1|COMPLETED|Overall Study||15
356636|NCT00478257|864953|P2|STARTED|Overall Study||16
356637|NCT00478257|864954|P1|STARTED|Overall Study||23
356638|NCT00478244|864960|P1|NOT COMPLETED|Overall Study||1
356639|NCT00478244|864960|P1|COMPLETED|Overall Study||6
356640|NCT00478244|864960|P1|STARTED|Overall Study||7
356641|NCT00478231|864973|P1|NOT COMPLETED|Overall Study||84
356642|NCT00478231|864973|P1|COMPLETED|Overall Study||125
356643|NCT00478231|864973|P1|Treated|Overall Study||206
356644|NCT00478231|864973|P1|STARTED|Overall Study||209
356645|NCT00478218|864994|P2|NOT COMPLETED|Overall Study||0
356646|NCT00478218|864995|P1|NOT COMPLETED|Overall Study||0
356647|NCT00478218|864994|P2|COMPLETED|Overall Study||19
356648|NCT00478218|864995|P1|COMPLETED|Overall Study||34
356649|NCT00478218|864994|P2|STARTED|Overall Study||19
356650|NCT00478218|864995|P1|STARTED|Overall Study||34
356651|NCT00478205|865009|P2|NOT COMPLETED|Overall Study||87
356652|NCT00478205|865010|P1|NOT COMPLETED|Overall Study||296
356653|NCT00478205|865009|P2|COMPLETED|Overall Study||399
356654|NCT00478205|865010|P1|COMPLETED|Overall Study||685
356655|NCT00478205|865009|P2|STARTED|Overall Study||486
356656|NCT00478205|865010|P1|STARTED|Overall Study||981
356657|NCT00478192|865025|P3|NOT COMPLETED|Overall Study||2
356658|NCT00478192|865026|P2|NOT COMPLETED|Overall Study||5
356659|NCT00478192|865027|P1|NOT COMPLETED|Overall Study||4
356660|NCT00478192|865025|P3|COMPLETED|Overall Study||8
356661|NCT00478192|865026|P2|COMPLETED|Overall Study||15
356662|NCT00478192|865027|P1|COMPLETED|Overall Study||16
356663|NCT00478192|865025|P3|End of Treatment|Overall Study||8
356664|NCT00478192|865026|P2|End of Treatment|Overall Study||16
356665|NCT00478192|865027|P1|End of Treatment|Overall Study||18
356666|NCT00478192|865025|P3|Full Analysis Set / Safety Analysis Set|Overall Study||9
356667|NCT00478192|865026|P2|Full Analysis Set / Safety Analysis Set|Overall Study||20
356668|NCT00478192|865027|P1|Full Analysis Set / Safety Analysis Set|Overall Study||20
356669|NCT00478192|865025|P3|STARTED|Overall Study||10
356670|NCT00478192|865026|P2|STARTED|Overall Study||20
356671|NCT00478192|865027|P1|STARTED|Overall Study||20
356672|NCT00478140|865054|P1|NOT COMPLETED|Overall Study||1
356673|NCT00478140|865054|P1|COMPLETED|Overall Study||3
356674|NCT00478140|865054|P1|STARTED|Overall Study||4
356675|NCT00478062|865061|P1|NOT COMPLETED|Overall Study||0
356676|NCT00478062|865061|P1|COMPLETED|Overall Study||1
356677|NCT00478062|865061|P1|STARTED|Overall Study||1
356678|NCT00478036|865071|P3|NOT COMPLETED|Overall Study||0
356679|NCT00478036|865072|P2|NOT COMPLETED|Overall Study||0
356680|NCT00478036|865073|P1|NOT COMPLETED|Overall Study||0
356681|NCT00478036|865071|P3|COMPLETED|Overall Study||14
356682|NCT00478036|865072|P2|COMPLETED|Overall Study||7
356683|NCT00478036|865073|P1|COMPLETED|Overall Study||10
356684|NCT00478036|865071|P3|STARTED|Overall Study||14
356685|NCT00478036|865072|P2|STARTED|Overall Study||7
356686|NCT00478036|865073|P1|STARTED|Overall Study||10
356687|NCT00478023|865086|P5|NOT COMPLETED|Overall Study||55
356688|NCT00478023|865087|P4|NOT COMPLETED|Overall Study||30
356689|NCT00478023|865088|P3|NOT COMPLETED|Overall Study||20
356690|NCT00478023|865089|P2|NOT COMPLETED|Overall Study||24
356691|NCT00478023|865090|P1|NOT COMPLETED|Overall Study||35
356692|NCT00478023|865086|P5|COMPLETED|Overall Study||114
356693|NCT00478023|865087|P4|COMPLETED|Overall Study||146
356694|NCT00478023|865088|P3|COMPLETED|Overall Study||151
356695|NCT00478023|865089|P2|COMPLETED|Overall Study||144
356696|NCT00478023|865090|P1|COMPLETED|Overall Study||135
356697|NCT00478023|865086|P5|STARTED|Overall Study||169
356698|NCT00478023|865087|P4|STARTED|Overall Study||176
356699|NCT00478023|865088|P3|STARTED|Overall Study||171
356700|NCT00478023|865089|P2|STARTED|Overall Study||168
356701|NCT00478023|865090|P1|STARTED|Overall Study||170
356702|NCT00477971|865109|P2|NOT COMPLETED|Overall Study||6
356703|NCT00477971|865110|P1|NOT COMPLETED|Overall Study||17
356704|NCT00477971|865109|P2|COMPLETED|Overall Study||49
356705|NCT00477971|865110|P1|COMPLETED|Overall Study||17
356706|NCT00477971|865109|P2|STARTED|Overall Study||55
356707|NCT00477971|865110|P1|STARTED|Overall Study||34
356708|NCT00477750|865122|P1|NOT COMPLETED|Overall Study||11
356709|NCT00477750|865122|P1|COMPLETED|Overall Study||15
356710|NCT00477750|865122|P1|STARTED|Overall Study||26
356711|NCT00477685|865130|P1|NOT COMPLETED|Overall Study||0
356712|NCT00477685|865130|P1|COMPLETED|Overall Study||10
356713|NCT00477685|865130|P1|STARTED|Overall Study||10
356714|NCT00477672|865138|P3|NOT COMPLETED|Overall Study||16
356715|NCT00477672|865139|P2|NOT COMPLETED|Overall Study||16
356716|NCT00477672|865140|P1|NOT COMPLETED|Overall Study||7
356717|NCT00477672|865138|P3|COMPLETED|Overall Study||83
356718|NCT00477672|865139|P2|COMPLETED|Overall Study||85
356719|NCT00477672|865140|P1|COMPLETED|Overall Study||91
356720|NCT00477672|865138|P3|STARTED|Overall Study||99
356721|NCT00477672|865139|P2|STARTED|Overall Study||101
356722|NCT00477672|865140|P1|STARTED|Overall Study||98
356723|NCT00477633|865151|P1|NOT COMPLETED|Overall Study||709
356724|NCT00477633|865151|P1|COMPLETED|Overall Study||991
356725|NCT00477633|865151|P1|STARTED|Overall Study||1700
356726|NCT00477607|865159|P2|NOT COMPLETED|Overall Study||7
356727|NCT00477607|865160|P1|NOT COMPLETED|Overall Study||7
356728|NCT00477607|865159|P2|COMPLETED|Overall Study||13
356729|NCT00477607|865160|P1|COMPLETED|Overall Study||12
356730|NCT00477607|865159|P2|STARTED|Overall Study||20
356731|NCT00477607|865160|P1|STARTED|Overall Study||19
356732|NCT00477594|865172|P2|NOT COMPLETED|Follow-up Period||1
356733|NCT00477594|865173|P1|NOT COMPLETED|Follow-up Period||3
356734|NCT00477594|865172|P2|COMPLETED|Follow-up Period||4
356735|NCT00477594|865173|P1|COMPLETED|Follow-up Period||13
356736|NCT00477594|865172|P2|STARTED|Follow-up Period||5
356737|NCT00477594|865173|P1|STARTED|Follow-up Period||16
356738|NCT00477594|865172|P2|NOT COMPLETED|Year 3||0
356739|NCT00477594|865173|P1|NOT COMPLETED|Year 3||2
356740|NCT00477594|865172|P2|COMPLETED|Year 3||0
356741|NCT00477594|865173|P1|COMPLETED|Year 3||2
356742|NCT00477594|865172|P2|STARTED|Year 3||0
356743|NCT00477594|865173|P1|STARTED|Year 3||4
356744|NCT00477594|865172|P2|NOT COMPLETED|Year 1 and Year 2||4
356745|NCT00477594|865173|P1|NOT COMPLETED|Year 1 and Year 2||9
356746|NCT00477594|865172|P2|COMPLETED|Year 1 and Year 2||1
356747|NCT00477594|865173|P1|COMPLETED|Year 1 and Year 2||7
356748|NCT00477594|865172|P2|STARTED|Year 1 and Year 2||5
356749|NCT00477594|865173|P1|STARTED|Year 1 and Year 2||16
356750|NCT00477490|865234|P9|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||8
356751|NCT00477490|865235|P8|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
356752|NCT00477490|865236|P7|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
356753|NCT00477490|865237|P6|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||6
356754|NCT00477490|865238|P5|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||20
356755|NCT00477490|865239|P4|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||12
356756|NCT00477490|865240|P3|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||15
356757|NCT00477490|865241|P2|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||28
356758|NCT00477490|865242|P1|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||0
356759|NCT00477490|865234|P9|COMPLETED|Part II: Extension Week 5 up to Day 169||26
356760|NCT00477490|865235|P8|COMPLETED|Part II: Extension Week 5 up to Day 169||29
356761|NCT00477490|865236|P7|COMPLETED|Part II: Extension Week 5 up to Day 169||32
356762|NCT00477490|865237|P6|COMPLETED|Part II: Extension Week 5 up to Day 169||25
356763|NCT00477490|865238|P5|COMPLETED|Part II: Extension Week 5 up to Day 169||107
356764|NCT00477490|865239|P4|COMPLETED|Part II: Extension Week 5 up to Day 169||120
356765|NCT00477490|865240|P3|COMPLETED|Part II: Extension Week 5 up to Day 169||120
356766|NCT00477490|865241|P2|COMPLETED|Part II: Extension Week 5 up to Day 169||107
356767|NCT00477490|865242|P1|COMPLETED|Part II: Extension Week 5 up to Day 169||0
356768|NCT00477490|865234|P9|STARTED|Part II: Extension Week 5 up to Day 169||34
356769|NCT00477490|865235|P8|STARTED|Part II: Extension Week 5 up to Day 169||34
356770|NCT00477490|865236|P7|STARTED|Part II: Extension Week 5 up to Day 169||37
356771|NCT00477490|865237|P6|STARTED|Part II: Extension Week 5 up to Day 169||31
356772|NCT00477490|865238|P5|STARTED|Part II: Extension Week 5 up to Day 169||127
356773|NCT00477490|865239|P4|STARTED|Part II: Extension Week 5 up to Day 169||132
356774|NCT00477490|865240|P3|STARTED|Part II: Extension Week 5 up to Day 169||135
356775|NCT00477490|865241|P2|STARTED|Part II: Extension Week 5 up to Day 169||135
356776|NCT00477490|865242|P1|STARTED|Part II: Extension Week 5 up to Day 169||0
356777|NCT00477490|865234|P9|NOT COMPLETED|Part I: 4 Week Efficacy||0
356778|NCT00477490|865235|P8|NOT COMPLETED|Part I: 4 Week Efficacy||0
356779|NCT00477490|865236|P7|NOT COMPLETED|Part I: 4 Week Efficacy||0
356780|NCT00477490|865237|P6|NOT COMPLETED|Part I: 4 Week Efficacy||0
356781|NCT00477490|865238|P5|NOT COMPLETED|Part I: 4 Week Efficacy||25
356782|NCT00477490|865239|P4|NOT COMPLETED|Part I: 4 Week Efficacy||20
356783|NCT00477490|865240|P3|NOT COMPLETED|Part I: 4 Week Efficacy||10
356784|NCT00477490|865241|P2|NOT COMPLETED|Part I: 4 Week Efficacy||19
356785|NCT00477490|865242|P1|NOT COMPLETED|Part I: 4 Week Efficacy||15
356786|NCT00477490|865234|P9|COMPLETED|Part I: 4 Week Efficacy||0
356787|NCT00477490|865235|P8|COMPLETED|Part I: 4 Week Efficacy||0
356788|NCT00477490|865236|P7|COMPLETED|Part I: 4 Week Efficacy||0
356789|NCT00477490|865237|P6|COMPLETED|Part I: 4 Week Efficacy||0
356790|NCT00477490|865238|P5|COMPLETED|Part I: 4 Week Efficacy||135
356791|NCT00477490|865239|P4|COMPLETED|Part I: 4 Week Efficacy||138
356792|NCT00477490|865240|P3|COMPLETED|Part I: 4 Week Efficacy||148
356793|NCT00477490|865241|P2|COMPLETED|Part I: 4 Week Efficacy||144
356794|NCT00477490|865242|P1|COMPLETED|Part I: 4 Week Efficacy||145
356795|NCT00477490|865234|P9|ITT Population|Part I: 4 Week Efficacy||0
356796|NCT00477490|865235|P8|ITT Population|Part I: 4 Week Efficacy||0
356797|NCT00477490|865236|P7|ITT Population|Part I: 4 Week Efficacy||0
356798|NCT00477490|865237|P6|ITT Population|Part I: 4 Week Efficacy||0
356799|NCT00477490|865238|P5|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|146
356885|NCT00477191|865509|P1|COMPLETED|Overall Study||13
356886|NCT00477191|865509|P1|STARTED|Overall Study||18
356800|NCT00477490|865239|P4|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|148
356801|NCT00477490|865240|P3|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|152
356802|NCT00477490|865241|P2|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|155
356803|NCT00477490|865242|P1|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|156
356804|NCT00477490|865234|P9|STARTED|Part I: 4 Week Efficacy||0
356805|NCT00477490|865235|P8|STARTED|Part I: 4 Week Efficacy||0
356806|NCT00477490|865236|P7|STARTED|Part I: 4 Week Efficacy||0
356807|NCT00477490|865237|P6|STARTED|Part I: 4 Week Efficacy||0
356808|NCT00477490|865238|P5|STARTED|Part I: 4 Week Efficacy||160
356809|NCT00477490|865239|P4|STARTED|Part I: 4 Week Efficacy||158
356810|NCT00477490|865240|P3|STARTED|Part I: 4 Week Efficacy||158
356811|NCT00477490|865241|P2|STARTED|Part I: 4 Week Efficacy||163
356812|NCT00477490|865242|P1|STARTED|Part I: 4 Week Efficacy||160
356813|NCT00477464|865326|P1|NOT COMPLETED|Overall Study||51
356814|NCT00477464|865326|P1|COMPLETED|Overall Study||0
356815|NCT00477464|865326|P1|STARTED|Overall Study||51
356816|NCT00477451|865353|P4|NOT COMPLETED|Overall Study||0
356817|NCT00477451|865354|P3|NOT COMPLETED|Overall Study||0
356818|NCT00477451|865355|P2|NOT COMPLETED|Overall Study||0
356819|NCT00477451|865356|P1|NOT COMPLETED|Overall Study||0
356820|NCT00477451|865353|P4|COMPLETED|Overall Study||2
356821|NCT00477451|865354|P3|COMPLETED|Overall Study||7
356822|NCT00477451|865355|P2|COMPLETED|Overall Study||20
356823|NCT00477451|865356|P1|COMPLETED|Overall Study||20
356824|NCT00477451|865353|P4|STARTED|Overall Study||2
356825|NCT00477451|865354|P3|STARTED|Overall Study||7
356826|NCT00477451|865355|P2|STARTED|Overall Study||20
356827|NCT00477451|865356|P1|STARTED|Overall Study||20
356828|NCT00477386|865370|P2|NOT COMPLETED|Overall Study||17
356829|NCT00477386|865371|P1|NOT COMPLETED|Overall Study||11
356830|NCT00477386|865370|P2|COMPLETED|Overall Study||0
356831|NCT00477386|865371|P1|COMPLETED|Overall Study||0
356832|NCT00477386|865370|P2|STARTED|Overall Study||17
356833|NCT00477386|865371|P1|STARTED|Overall Study||11
356834|NCT00477334|865381|P2|NOT COMPLETED|Overall Study||76
356835|NCT00477334|865382|P1|NOT COMPLETED|Overall Study||170
356836|NCT00477334|865381|P2|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|75
356837|NCT00477334|865382|P1|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|142
356838|NCT00477334|865381|P2|Modified Intent to Treat Population|Overall Study||78
356839|NCT00477334|865382|P1|Modified Intent to Treat Population|Overall Study||152
356840|NCT00477334|865381|P2|Participants Completing First Recurrence|Overall Study||92
356841|NCT00477334|865382|P1|Participants Completing First Recurrence|Overall Study||187
356842|NCT00477334|865381|P2|Intent to Treat Population|Overall Study||98
356843|NCT00477334|865382|P1|Intent to Treat Population|Overall Study||201
356844|NCT00477334|865381|P2|Randomized and Took Study Drug|Overall Study||98
356845|NCT00477334|865382|P1|Randomized and Took Study Drug|Overall Study||206
356846|NCT00477334|865381|P2|STARTED|Overall Study||151
356847|NCT00477334|865382|P1|STARTED|Overall Study||312
356848|NCT00477295|865408|P2|NOT COMPLETED|Overall Study||109
356849|NCT00477295|865409|P1|NOT COMPLETED|Overall Study||121
356850|NCT00477295|865408|P2|COMPLETED|Overall Study||192
356851|NCT00477295|865409|P1|COMPLETED|Overall Study||161
356852|NCT00477295|865408|P2|STARTED|Overall Study||301
356853|NCT00477295|865409|P1|STARTED|Overall Study||282
356854|NCT00477269|865437|P3|NOT COMPLETED|Open Label Extension||13
356855|NCT00477269|865438|P2|NOT COMPLETED|Open Label Extension||0
356856|NCT00477269|865439|P1|NOT COMPLETED|Open Label Extension||0
356857|NCT00477269|865437|P3|COMPLETED|Open Label Extension||9
356858|NCT00477269|865438|P2|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
356859|NCT00477269|865439|P1|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
356860|NCT00477269|865437|P3|STARTED|Open Label Extension||22
356861|NCT00477269|865438|P2|STARTED|Open Label Extension|Arm in the Core study not extension|0
356862|NCT00477269|865439|P1|STARTED|Open Label Extension|Arm in the Core study not extension|0
356863|NCT00477269|865437|P3|NOT COMPLETED|Core Study||0
356864|NCT00477269|865438|P2|NOT COMPLETED|Core Study||8
356865|NCT00477269|865439|P1|NOT COMPLETED|Core Study||9
356866|NCT00477269|865437|P3|COMPLETED|Core Study||0
356867|NCT00477269|865438|P2|COMPLETED|Core Study||23
356868|NCT00477269|865439|P1|COMPLETED|Core Study||19
356869|NCT00477269|865437|P3|STARTED|Core Study||0
356870|NCT00477269|865438|P2|STARTED|Core Study||31
356871|NCT00477269|865439|P1|STARTED|Core Study||28
356872|NCT00477230|865493|P2|NOT COMPLETED|Overall Study||31
356873|NCT00477230|865494|P1|NOT COMPLETED|Overall Study||20
356874|NCT00477230|865493|P2|COMPLETED|Overall Study||1
356875|NCT00477230|865494|P1|COMPLETED|Overall Study||12
356876|NCT00477230|865493|P2|STARTED|Overall Study||32
356877|NCT00477230|865494|P1|STARTED|Overall Study||32
356878|NCT00477204|865502|P2|NOT COMPLETED|Overall Study||0
356879|NCT00477204|865503|P1|NOT COMPLETED|Overall Study||0
356880|NCT00477204|865502|P2|COMPLETED|Overall Study||5
356881|NCT00477204|865503|P1|COMPLETED|Overall Study||4
356882|NCT00477204|865502|P2|STARTED|Overall Study||5
356883|NCT00477204|865503|P1|STARTED|Overall Study||4
356884|NCT00477191|865509|P1|NOT COMPLETED|Overall Study||5
356887|NCT00477165|865518|P2|NOT COMPLETED|Overall Study||2
356888|NCT00477165|865519|P1|NOT COMPLETED|Overall Study||7
356889|NCT00477165|865518|P2|COMPLETED|Overall Study||25
356890|NCT00477165|865519|P1|COMPLETED|Overall Study||20
356891|NCT00477165|865518|P2|STARTED|Overall Study||27
356892|NCT00477165|865519|P1|STARTED|Overall Study||27
356893|NCT00477152|865531|P1|NOT COMPLETED|Overall Study||3
356894|NCT00477152|865531|P1|COMPLETED|Overall Study|Two patients treated, but assessments incomplete. All available data included in analyses for these.|49
356895|NCT00477152|865531|P1|STARTED|Overall Study|One patient withdrawn prior to treatment, so not included in analyses.|52
356896|NCT00477087|865538|P1|NOT COMPLETED|Overall Study||0
356897|NCT00477087|865538|P1|COMPLETED|Overall Study||10
356898|NCT00477087|865538|P1|STARTED|Overall Study||10
356899|NCT00476996|865547|P4|NOT COMPLETED|OLE Phase (From Week 48)||664
356900|NCT00476996|865548|P3|NOT COMPLETED|OLE Phase (From Week 48)||0
356901|NCT00476996|865549|P2|NOT COMPLETED|OLE Phase (From Week 48)||0
356902|NCT00476996|865550|P1|NOT COMPLETED|OLE Phase (From Week 48)||0
356903|NCT00476996|865547|P4|COMPLETED|OLE Phase (From Week 48)||0
356904|NCT00476996|865548|P3|COMPLETED|OLE Phase (From Week 48)||0
356905|NCT00476996|865549|P2|COMPLETED|OLE Phase (From Week 48)||0
356906|NCT00476996|865550|P1|COMPLETED|OLE Phase (From Week 48)||0
356907|NCT00476996|865547|P4|STARTED|OLE Phase (From Week 48)||664
356908|NCT00476996|865548|P3|STARTED|OLE Phase (From Week 48)||0
356909|NCT00476996|865549|P2|STARTED|OLE Phase (From Week 48)||0
356910|NCT00476996|865550|P1|STARTED|OLE Phase (From Week 48)||0
356911|NCT00476996|865547|P4|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||0
356912|NCT00476996|865548|P3|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||45
356913|NCT00476996|865549|P2|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||55
356914|NCT00476996|865550|P1|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||72
356915|NCT00476996|865547|P4|COMPLETED|Blinded Treatment Phase (up to Week 48)||0
356916|NCT00476996|865548|P3|COMPLETED|Blinded Treatment Phase (up to Week 48)||237
356917|NCT00476996|865549|P2|COMPLETED|Blinded Treatment Phase (up to Week 48)||222
356918|NCT00476996|865550|P1|COMPLETED|Blinded Treatment Phase (up to Week 48)||205
356919|NCT00476996|865547|P4|STARTED|Blinded Treatment Phase (up to Week 48)||0
356920|NCT00476996|865548|P3|STARTED|Blinded Treatment Phase (up to Week 48)||282
356921|NCT00476996|865549|P2|STARTED|Blinded Treatment Phase (up to Week 48)||277
356922|NCT00476996|865550|P1|STARTED|Blinded Treatment Phase (up to Week 48)||277
356923|NCT00476957|865582|P2|NOT COMPLETED|Overall Study||193
356924|NCT00476957|865583|P1|NOT COMPLETED|Overall Study||176
356925|NCT00476957|865582|P2|COMPLETED|Overall Study||4159
356926|NCT00476957|865583|P1|COMPLETED|Overall Study||4181
356927|NCT00476957|865582|P2|STARTED|Overall Study||4352
356928|NCT00476957|865583|P1|STARTED|Overall Study||4357
356929|NCT00476827|865597|P6|NOT COMPLETED|Overall Study||0
356930|NCT00476827|865598|P5|NOT COMPLETED|Overall Study||0
356931|NCT00476827|865599|P4|NOT COMPLETED|Overall Study||0
356932|NCT00476827|865600|P3|NOT COMPLETED|Overall Study||0
356933|NCT00476827|865601|P2|NOT COMPLETED|Overall Study||0
356934|NCT00476827|865602|P1|NOT COMPLETED|Overall Study||0
356935|NCT00476827|865597|P6|COMPLETED|Overall Study||2
356936|NCT00476827|865598|P5|COMPLETED|Overall Study||2
356937|NCT00476827|865599|P4|COMPLETED|Overall Study||0
356938|NCT00476827|865600|P3|COMPLETED|Overall Study||1
356939|NCT00476827|865601|P2|COMPLETED|Overall Study||0
356940|NCT00476827|865602|P1|COMPLETED|Overall Study||3
356941|NCT00476827|865597|P6|STARTED|Overall Study||2
356942|NCT00476827|865598|P5|STARTED|Overall Study||2
356943|NCT00476827|865599|P4|STARTED|Overall Study||0
356944|NCT00476827|865600|P3|STARTED|Overall Study||1
356945|NCT00476827|865601|P2|STARTED|Overall Study||0
356946|NCT00476827|865602|P1|STARTED|Overall Study||3
356947|NCT00476788|865632|P1|NOT COMPLETED|Overall Study||3
356948|NCT00476788|865632|P1|COMPLETED|Overall Study||11
356949|NCT00476788|865632|P1|STARTED|Overall Study||14
356950|NCT00476645|865637|P1|NOT COMPLETED|Overall Study||0
356951|NCT00476645|865637|P1|COMPLETED|Overall Study||10
356952|NCT00476645|865637|P1|STARTED|Overall Study||10
356953|NCT00476593|865647|P4|NOT COMPLETED|Overall Study||22
356954|NCT00476593|865648|P3|NOT COMPLETED|Overall Study||8
356955|NCT00476593|865649|P2|NOT COMPLETED|Overall Study||2
356956|NCT00476593|865650|P1|NOT COMPLETED|Overall Study||10
356957|NCT00476593|865647|P4|COMPLETED|Overall Study||107
356958|NCT00476593|865648|P3|COMPLETED|Overall Study||30
356959|NCT00476593|865649|P2|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 17 cases|17
356960|NCT00476593|865650|P1|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 22 cases|22
356961|NCT00476593|865647|P4|STARTED|Overall Study||129
356962|NCT00476593|865648|P3|STARTED|Overall Study||38
356963|NCT00476593|865649|P2|STARTED|Overall Study||19
356964|NCT00476593|865650|P1|STARTED|Overall Study||32
356965|NCT00476476|865662|P2|NOT COMPLETED|Overall Study||24
356966|NCT00476476|865663|P1|NOT COMPLETED|Overall Study||2
356967|NCT00476476|865662|P2|COMPLETED|Overall Study|Treatment was not of fixed duration and thus pts are not considered to have 'Completed' treatment.|0
356968|NCT00476476|865663|P1|COMPLETED|Overall Study||15
356969|NCT00476476|865662|P2|Response Evaluable|Overall Study|One woman was unevaluable due to an allergic reaction that developed after the 2nd dose.|23
356970|NCT00476476|865663|P1|Response Evaluable|Overall Study||17
356971|NCT00476476|865662|P2|STARTED|Overall Study||24
356972|NCT00476476|865663|P1|STARTED|Overall Study||17
356973|NCT00476242|865670|P2|NOT COMPLETED|Overall Study||16
356974|NCT00476242|865671|P1|NOT COMPLETED|Overall Study||8
356975|NCT00476242|865670|P2|COMPLETED|Overall Study||12
356976|NCT00476242|865671|P1|COMPLETED|Overall Study||19
356977|NCT00476242|865670|P2|STARTED|Overall Study||28
356978|NCT00476242|865671|P1|STARTED|Overall Study||27
356979|NCT00476229|865681|P1|NOT COMPLETED|Overall Study||1
356980|NCT00476229|865681|P1|COMPLETED|Overall Study||19
356981|NCT00476229|865681|P1|STARTED|Overall Study||20
356982|NCT00476151|865687|P2|NOT COMPLETED|Overall Study||7
356983|NCT00476151|865688|P1|NOT COMPLETED|Overall Study||3
356984|NCT00476151|865687|P2|COMPLETED|Overall Study||107
356985|NCT00476151|865688|P1|COMPLETED|Overall Study||109
356986|NCT00476151|865687|P2|STARTED|Overall Study||114
356987|NCT00476151|865688|P1|STARTED|Overall Study||112
356988|NCT00476086|865694|P1|NOT COMPLETED|Overall Study||5
356989|NCT00476086|865694|P1|COMPLETED|Overall Study||15
356990|NCT00476086|865694|P1|Received Radiation|Overall Study||15
356991|NCT00476086|865694|P1|Received Chemotherapy|Overall Study||19
356992|NCT00476086|865694|P1|STARTED|Overall Study||20
356993|NCT00476047|865700|P1|NOT COMPLETED|Overall Study||1
356994|NCT00476047|865700|P1|COMPLETED|Overall Study||15
356995|NCT00476047|865700|P1|Completed Treatment|Overall Study||16
356996|NCT00476047|865700|P1|STARTED|Overall Study||16
356997|NCT00476021|865709|P2|NOT COMPLETED|Overall Study||0
356998|NCT00476021|865710|P1|NOT COMPLETED|Overall Study||0
356999|NCT00476021|865709|P2|COMPLETED|Overall Study||51
357000|NCT00476021|865710|P1|COMPLETED|Overall Study||51
357001|NCT00476021|865709|P2|STARTED|Overall Study||51
357002|NCT00476021|865710|P1|STARTED|Overall Study||51
357003|NCT00476008|865726|P2|NOT COMPLETED|Overall Study||8
357004|NCT00476008|865727|P1|NOT COMPLETED|Overall Study||9
357005|NCT00476008|865726|P2|COMPLETED|Overall Study||13
357006|NCT00476008|865727|P1|COMPLETED|Overall Study||13
357007|NCT00476008|865726|P2|6 Month Testing|Overall Study||14
357008|NCT00476008|865727|P1|6 Month Testing|Overall Study||15
357009|NCT00476008|865726|P2|STARTED|Overall Study||21
357010|NCT00476008|865727|P1|STARTED|Overall Study||22
357011|NCT00475982|865753|P2|NOT COMPLETED|Overall Study||3
357012|NCT00475982|865754|P1|NOT COMPLETED|Overall Study||7
357013|NCT00475982|865753|P2|COMPLETED|Overall Study||18
357014|NCT00475982|865754|P1|COMPLETED|Overall Study||16
357015|NCT00475982|865753|P2|STARTED|Overall Study||21
357016|NCT00475982|865754|P1|STARTED|Overall Study||23
357017|NCT00475904|865775|P3|NOT COMPLETED|Overall Study||4
357018|NCT00475904|865776|P2|NOT COMPLETED|Overall Study||13
357019|NCT00475904|865777|P1|NOT COMPLETED|Overall Study||15
357020|NCT00475904|865775|P3|COMPLETED|Overall Study||72
357021|NCT00475904|865776|P2|COMPLETED|Overall Study||131
357022|NCT00475904|865777|P1|COMPLETED|Overall Study||125
357023|NCT00475904|865775|P3|STARTED|Overall Study||76
357024|NCT00475904|865776|P2|STARTED|Overall Study||144
357025|NCT00475904|865777|P1|STARTED|Overall Study||140
357026|NCT00475878|865790|P2|NOT COMPLETED|Overall Study||0
357027|NCT00475878|865791|P1|NOT COMPLETED|Overall Study||0
357028|NCT00475878|865790|P2|COMPLETED|Overall Study||72
357029|NCT00475878|865791|P1|COMPLETED|Overall Study||75
357030|NCT00475878|865790|P2|STARTED|Overall Study||72
357031|NCT00475878|865791|P1|STARTED|Overall Study||75
357032|NCT00475865|865802|P3|NOT COMPLETED|Overall Study||6
357033|NCT00475865|865803|P2|NOT COMPLETED|Overall Study||5
357034|NCT00475865|865804|P1|NOT COMPLETED|Overall Study||2
357035|NCT00475865|865802|P3|COMPLETED|Overall Study|completed treatment period|34
357036|NCT00475865|865803|P2|COMPLETED|Overall Study|completed treatment period|37
357037|NCT00475865|865804|P1|COMPLETED|Overall Study||39
357038|NCT00475865|865802|P3|Treated|Overall Study||40
357039|NCT00475865|865803|P2|Treated|Overall Study||42
357040|NCT00475865|865804|P1|Treated|Overall Study|completed treatment period|41
357041|NCT00475865|865802|P3|STARTED|Overall Study|randomized|40
357042|NCT00475865|865803|P2|STARTED|Overall Study|randomized|42
357043|NCT00475865|865804|P1|STARTED|Overall Study|randomized|41
357044|NCT00475852|865834|P2|NOT COMPLETED|Overall Study||548
357045|NCT00475852|865835|P1|NOT COMPLETED|Overall Study||517
357046|NCT00475852|865834|P2|COMPLETED|Overall Study||3029
357047|NCT00475852|865835|P1|COMPLETED|Overall Study||3047
357048|NCT00475852|865834|P2|STARTED|Overall Study||3577
357049|NCT00475852|865835|P1|STARTED|Overall Study||3564
357050|NCT00475787|865865|P2|NOT COMPLETED|Overall Study||7
357051|NCT00475787|865866|P1|NOT COMPLETED|Overall Study||8
357052|NCT00475787|865865|P2|COMPLETED|Overall Study||60
357053|NCT00475787|865866|P1|COMPLETED|Overall Study||61
357054|NCT00475787|865865|P2|STARTED|Overall Study||67
357055|NCT00475787|865866|P1|STARTED|Overall Study||69
357056|NCT00475735|865886|P6|NOT COMPLETED|Treatment Period 2||1
357057|NCT00475735|865887|P5|NOT COMPLETED|Treatment Period 2||1
357058|NCT00475735|865888|P4|NOT COMPLETED|Treatment Period 2||2
357059|NCT00475735|865889|P3|NOT COMPLETED|Treatment Period 2||0
357060|NCT00475735|865890|P2|NOT COMPLETED|Treatment Period 2||1
357061|NCT00475735|865891|P1|NOT COMPLETED|Treatment Period 2||0
357062|NCT00475735|865886|P6|COMPLETED|Treatment Period 2||13
357063|NCT00475735|865887|P5|COMPLETED|Treatment Period 2||15
357064|NCT00475735|865888|P4|COMPLETED|Treatment Period 2||4
357065|NCT00475735|865889|P3|COMPLETED|Treatment Period 2||7
357066|NCT00475735|865890|P2|COMPLETED|Treatment Period 2||9
357067|NCT00475735|865891|P1|COMPLETED|Treatment Period 2||10
357068|NCT00475735|865886|P6|STARTED|Treatment Period 2||14
357069|NCT00475735|865887|P5|STARTED|Treatment Period 2||16
357070|NCT00475735|865888|P4|STARTED|Treatment Period 2||6
357071|NCT00475735|865889|P3|STARTED|Treatment Period 2||7
357072|NCT00475735|865890|P2|STARTED|Treatment Period 2||10
357073|NCT00475735|865891|P1|STARTED|Treatment Period 2||10
357074|NCT00475735|865886|P6|NOT COMPLETED|Treatment Washout||0
357075|NCT00475735|865887|P5|NOT COMPLETED|Treatment Washout||0
357076|NCT00475735|865888|P4|NOT COMPLETED|Treatment Washout||0
357077|NCT00475735|865889|P3|NOT COMPLETED|Treatment Washout||0
357078|NCT00475735|865890|P2|NOT COMPLETED|Treatment Washout||2
357079|NCT00475735|865891|P1|NOT COMPLETED|Treatment Washout||0
357080|NCT00475735|865886|P6|COMPLETED|Treatment Washout||14
357081|NCT00475735|865887|P5|COMPLETED|Treatment Washout||16
357082|NCT00475735|865888|P4|COMPLETED|Treatment Washout||6
357083|NCT00475735|865889|P3|COMPLETED|Treatment Washout||7
357084|NCT00475735|865890|P2|COMPLETED|Treatment Washout||10
357085|NCT00475735|865891|P1|COMPLETED|Treatment Washout||10
357086|NCT00475735|865886|P6|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|14
357087|NCT00475735|865887|P5|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|16
357088|NCT00475735|865888|P4|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|6
357089|NCT00475735|865889|P3|STARTED|Treatment Washout||7
357090|NCT00475735|865890|P2|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|12
357091|NCT00475735|865891|P1|STARTED|Treatment Washout||10
357092|NCT00475735|865886|P6|NOT COMPLETED|Treatment Period 1||3
357093|NCT00475735|865887|P5|NOT COMPLETED|Treatment Period 1||2
357094|NCT00475735|865888|P4|NOT COMPLETED|Treatment Period 1||2
357095|NCT00475735|865889|P3|NOT COMPLETED|Treatment Period 1||0
357096|NCT00475735|865890|P2|NOT COMPLETED|Treatment Period 1||2
357097|NCT00475735|865891|P1|NOT COMPLETED|Treatment Period 1||4
357098|NCT00475735|865886|P6|COMPLETED|Treatment Period 1||12
357099|NCT00475735|865887|P5|COMPLETED|Treatment Period 1||14
357100|NCT00475735|865888|P4|COMPLETED|Treatment Period 1||5
357101|NCT00475735|865889|P3|COMPLETED|Treatment Period 1||7
357102|NCT00475735|865890|P2|COMPLETED|Treatment Period 1||11
357103|NCT00475735|865891|P1|COMPLETED|Treatment Period 1||10
357104|NCT00475735|865886|P6|STARTED|Treatment Period 1||15
357105|NCT00475735|865887|P5|STARTED|Treatment Period 1||16
357106|NCT00475735|865888|P4|STARTED|Treatment Period 1||7
357107|NCT00475735|865889|P3|STARTED|Treatment Period 1||7
357108|NCT00475735|865890|P2|STARTED|Treatment Period 1||13
357109|NCT00475735|865891|P1|STARTED|Treatment Period 1||14
357110|NCT00475722|865904|P2|NOT COMPLETED|Overall Study||12
357111|NCT00475722|865905|P1|NOT COMPLETED|Overall Study||15
357112|NCT00475722|865904|P2|COMPLETED|Overall Study||47
357113|NCT00475722|865905|P1|COMPLETED|Overall Study||46
357114|NCT00475722|865904|P2|STARTED|Overall Study||59
357115|NCT00475722|865905|P1|STARTED|Overall Study||61
357116|NCT00475709|865911|P1|NOT COMPLETED|Overall Study||76
357117|NCT00475709|865911|P1|COMPLETED|Overall Study||946
357118|NCT00475709|865911|P1|Eligible of Analysis|Overall Study|Excludes eight ineligible subjects|1014
357119|NCT00475709|865911|P1|STARTED|Overall Study||1022
357120|NCT00475670|865919|P2|NOT COMPLETED|Overall Study||41
357121|NCT00475670|865920|P1|NOT COMPLETED|Overall Study||3
357122|NCT00475670|865919|P2|COMPLETED|Overall Study||0
357123|NCT00475670|865920|P1|COMPLETED|Overall Study|This cohort was closed prematurely (with only 3 participants) because of enrollment difficulties.|0
357124|NCT00475670|865919|P2|STARTED|Overall Study||41
357125|NCT00475670|865920|P1|STARTED|Overall Study||3
357126|NCT00475657|865944|P1|NOT COMPLETED|Overall Study||4
357127|NCT00475657|865944|P1|COMPLETED|Overall Study||1
357128|NCT00475657|865944|P1|STARTED|Overall Study||5
357129|NCT00475644|865952|P1|NOT COMPLETED|Overall Study||13
357130|NCT00475644|865952|P1|COMPLETED|Overall Study||53
357131|NCT00475644|865952|P1|Received at Least One Dose of Study Drug|Overall Study||66
357132|NCT00475644|865952|P1|STARTED|Overall Study||66
357133|NCT00475501|865964|P4|NOT COMPLETED|Overall Study||4
357134|NCT00475501|865965|P3|NOT COMPLETED|Overall Study||4
357135|NCT00475501|865966|P2|NOT COMPLETED|Overall Study||5
357136|NCT00475501|865967|P1|NOT COMPLETED|Overall Study||7
357137|NCT00475501|865964|P4|COMPLETED|Overall Study||12
357138|NCT00475501|865965|P3|COMPLETED|Overall Study||13
357139|NCT00475501|865966|P2|COMPLETED|Overall Study||8
357140|NCT00475501|865967|P1|COMPLETED|Overall Study||7
357141|NCT00475501|865964|P4|STARTED|Overall Study||16
357142|NCT00475501|865965|P3|STARTED|Overall Study||17
357143|NCT00475501|865966|P2|STARTED|Overall Study||13
357144|NCT00475501|865967|P1|STARTED|Overall Study||14
357145|NCT00475423|866017|P1|NOT COMPLETED|Overall Study||32
357146|NCT00475423|866017|P1|COMPLETED|Overall Study||90
357147|NCT00475423|866017|P1|STARTED|Overall Study||122
357148|NCT00475332|866038|P1|NOT COMPLETED|Overall Study||0
357149|NCT00475332|866038|P1|COMPLETED|Overall Study||2
357150|NCT00475332|866038|P1|STARTED|Overall Study||2
357151|NCT00475319|866046|P3|NOT COMPLETED|Overall Study||4
357152|NCT00475319|866047|P2|NOT COMPLETED|Overall Study||1
357153|NCT00475319|866048|P1|NOT COMPLETED|Overall Study||2
357154|NCT00475319|866046|P3|COMPLETED|Overall Study||99
357155|NCT00475319|866047|P2|COMPLETED|Overall Study||101
357156|NCT00475319|866048|P1|COMPLETED|Overall Study||101
357157|NCT00475319|866046|P3|STARTED|Overall Study||103
357158|NCT00475319|866047|P2|STARTED|Overall Study||102
357159|NCT00475319|866048|P1|STARTED|Overall Study||103
357160|NCT00475306|866063|P4|NOT COMPLETED|Overall Study||1
357161|NCT00475306|866064|P3|NOT COMPLETED|Overall Study||0
357162|NCT00475306|866065|P2|NOT COMPLETED|Overall Study||1
357163|NCT00475306|866066|P1|NOT COMPLETED|Overall Study||1
357164|NCT00475306|866063|P4|COMPLETED|Overall Study|1 patient's intravenous line infiltrated.|71
357165|NCT00475306|866064|P3|COMPLETED|Overall Study||72
357166|NCT00475306|866065|P2|COMPLETED|Overall Study|For 1 patient, data collection was incomplete and results could not be analyzed|71
357167|NCT00475306|866066|P1|COMPLETED|Overall Study|1 patient had resolution of nausea prior and did not receive the investigational medication|72
357168|NCT00475306|866063|P4|STARTED|Overall Study||72
357169|NCT00475306|866064|P3|STARTED|Overall Study||72
357170|NCT00475306|866065|P2|STARTED|Overall Study||72
357171|NCT00475306|866066|P1|STARTED|Overall Study||73
357172|NCT00475241|866082|P2|NOT COMPLETED|Overall Study||3
357173|NCT00475241|866083|P1|NOT COMPLETED|Overall Study||7
357174|NCT00475241|866082|P2|COMPLETED|Overall Study||15
357175|NCT00475241|866083|P1|COMPLETED|Overall Study||11
357176|NCT00475241|866082|P2|STARTED|Overall Study||18
357177|NCT00475241|866083|P1|STARTED|Overall Study||18
357178|NCT00475228|866097|P2|NOT COMPLETED|Overall Study||17
357179|NCT00475228|866098|P1|NOT COMPLETED|Overall Study||17
357180|NCT00475228|866097|P2|COMPLETED|Overall Study||27
357181|NCT00475228|866098|P1|COMPLETED|Overall Study||27
357182|NCT00475228|866097|P2|STARTED|Overall Study||44
357183|NCT00475228|866098|P1|STARTED|Overall Study||44
357184|NCT00475215|866110|P2|NOT COMPLETED|Overall Study||4
357185|NCT00475215|866111|P1|NOT COMPLETED|Overall Study||5
357186|NCT00475215|866110|P2|COMPLETED|Overall Study||38
357187|NCT00475215|866111|P1|COMPLETED|Overall Study||39
357188|NCT00475215|866110|P2|Treated|Overall Study||38
357189|NCT00475215|866111|P1|Treated|Overall Study||39
357190|NCT00475215|866110|P2|STARTED|Overall Study||42
357191|NCT00475215|866111|P1|STARTED|Overall Study||44
357192|NCT00475176|866137|P1|NOT COMPLETED|Overall Study||4
357193|NCT00475176|866137|P1|COMPLETED|Overall Study||20
357194|NCT00475176|866137|P1|STARTED|Overall Study||24
357195|NCT00475150|866144|P2|NOT COMPLETED|Overall Study||0
357196|NCT00475150|866145|P1|NOT COMPLETED|Overall Study||0
357197|NCT00475150|866144|P2|COMPLETED|Overall Study||16
357198|NCT00475150|866145|P1|COMPLETED|Overall Study||23
357199|NCT00475150|866144|P2|STARTED|Overall Study||16
357200|NCT00475150|866145|P1|STARTED|Overall Study||23
357201|NCT00475085|866162|P4|NOT COMPLETED|Overall Study||20
357202|NCT00475085|866163|P3|NOT COMPLETED|Overall Study||19
357203|NCT00475085|866164|P2|NOT COMPLETED|Overall Study||20
357204|NCT00475085|866165|P1|NOT COMPLETED|Overall Study||18
357205|NCT00475085|866162|P4|COMPLETED|Overall Study||234
357206|NCT00475085|866163|P3|COMPLETED|Overall Study||241
357207|NCT00475085|866164|P2|COMPLETED|Overall Study||234
357208|NCT00475085|866165|P1|COMPLETED|Overall Study||235
357209|NCT00475085|866162|P4|STARTED|Overall Study||254
357210|NCT00475085|866163|P3|STARTED|Overall Study||260
357211|NCT00475085|866164|P2|STARTED|Overall Study||254
357212|NCT00475085|866165|P1|STARTED|Overall Study||253
357213|NCT00475033|866177|P2|NOT COMPLETED|Toddler Dose||0
357214|NCT00475033|866178|P1|NOT COMPLETED|Toddler Dose||4
357215|NCT00475033|866177|P2|COMPLETED|Toddler Dose||282
357216|NCT00475033|866178|P1|COMPLETED|Toddler Dose||283
357217|NCT00475033|866177|P2|STARTED|Toddler Dose|Vaccinated Toddler Dose|282
357218|NCT00475033|866178|P1|STARTED|Toddler Dose|Vaccinated Toddler Dose|287
357219|NCT00475033|866177|P2|NOT COMPLETED|After the Infant Series||8
357220|NCT00475033|866178|P1|NOT COMPLETED|After the Infant Series||6
357221|NCT00475033|866177|P2|COMPLETED|After the Infant Series||282
357222|NCT00475033|866178|P1|COMPLETED|After the Infant Series||287
357223|NCT00475033|866177|P2|Withdrawn After Infant Series|After the Infant Series||8
357224|NCT00475033|866178|P1|Withdrawn After Infant Series|After the Infant Series||6
357225|NCT00475033|866177|P2|STARTED|After the Infant Series||290
357226|NCT00475033|866178|P1|STARTED|After the Infant Series||293
357227|NCT00475033|866177|P2|NOT COMPLETED|Infant Series||13
357228|NCT00475033|866178|P1|NOT COMPLETED|Infant Series||7
357229|NCT00475033|866177|P2|COMPLETED|Infant Series||290
357230|NCT00475033|866178|P1|COMPLETED|Infant Series||293
357231|NCT00475033|866177|P2|Vaccinated Dose 3|Infant Series||294
357232|NCT00475033|866178|P1|Vaccinated Dose 3|Infant Series||293
357233|NCT00475033|866177|P2|Vaccinated Dose 2|Infant Series||296
357234|NCT00475033|866178|P1|Vaccinated Dose 2|Infant Series||297
357235|NCT00475033|866177|P2|Vaccinated Dose 1|Infant Series||303
357236|NCT00475033|866178|P1|Vaccinated Dose 1|Infant Series||300
357237|NCT00475033|866177|P2|STARTED|Infant Series||303
357238|NCT00475033|866178|P1|STARTED|Infant Series||300
357239|NCT00475020|866226|P1|NOT COMPLETED|Overall Study||5
357240|NCT00475020|866226|P1|COMPLETED|Overall Study||58
357241|NCT00475020|866226|P1|STARTED|Overall Study||63
357242|NCT00474994|866231|P1|NOT COMPLETED|Overall Study||5
357243|NCT00474994|866231|P1|COMPLETED|Overall Study||48
357244|NCT00474994|866231|P1|STARTED|Overall Study||53
357245|NCT00474968|866237|P2|NOT COMPLETED|Overall Study||16
357246|NCT00474968|866238|P1|NOT COMPLETED|Overall Study||18
357247|NCT00474968|866237|P2|COMPLETED|Overall Study||355
357248|NCT00474968|866238|P1|COMPLETED|Overall Study||348
357249|NCT00474968|866237|P2|STARTED|Overall Study||371
357250|NCT00474968|866238|P1|STARTED|Overall Study||366
357251|NCT00474955|866248|P1|NOT COMPLETED|Overall Study||8
357252|NCT00474955|866248|P1|COMPLETED|Overall Study||19
357253|NCT00474955|866248|P1|STARTED|Overall Study||27
357254|NCT00474929|866264|P5|NOT COMPLETED|Overall Study||0
357255|NCT00474929|866265|P4|NOT COMPLETED|Overall Study||2
357256|NCT00474929|866266|P3|NOT COMPLETED|Overall Study||2
357257|NCT00474929|866267|P2|NOT COMPLETED|Overall Study||1
357258|NCT00474929|866268|P1|NOT COMPLETED|Overall Study||0
357259|NCT00474929|866264|P5|COMPLETED|Overall Study||77
357260|NCT00474929|866265|P4|COMPLETED|Overall Study||5
357261|NCT00474929|866266|P3|COMPLETED|Overall Study||5
357262|NCT00474929|866267|P2|COMPLETED|Overall Study||5
357263|NCT00474929|866268|P1|COMPLETED|Overall Study||6
357264|NCT00474929|866264|P5|STARTED|Overall Study||77
357265|NCT00474929|866265|P4|STARTED|Overall Study||7
357266|NCT00474929|866266|P3|STARTED|Overall Study||7
357267|NCT00474929|866267|P2|STARTED|Overall Study||6
357268|NCT00474929|866268|P1|STARTED|Overall Study||6
357269|NCT00474903|866285|P3|NOT COMPLETED|Overall Study||2
357270|NCT00474903|866286|P2|NOT COMPLETED|Overall Study||5
357271|NCT00474903|866287|P1|NOT COMPLETED|Overall Study||1
357272|NCT00474903|866285|P3|COMPLETED|Overall Study||43
357273|NCT00474903|866286|P2|COMPLETED|Overall Study||42
357274|NCT00474903|866287|P1|COMPLETED|Overall Study||29
357275|NCT00474903|866285|P3|STARTED|Overall Study||45
357276|NCT00474903|866286|P2|STARTED|Overall Study||47
357277|NCT00474903|866287|P1|STARTED|Overall Study||30
357278|NCT00474851|866300|P2|NOT COMPLETED|Overall Study||11
357279|NCT00474851|866301|P1|NOT COMPLETED|Overall Study||8
357280|NCT00474851|866300|P2|COMPLETED|Overall Study||16
357281|NCT00474851|866301|P1|COMPLETED|Overall Study||18
357282|NCT00474851|866300|P2|Completed Baseline|Overall Study||26
357283|NCT00474851|866301|P1|Completed Baseline|Overall Study||25
357284|NCT00474851|866300|P2|STARTED|Overall Study||27
357285|NCT00474851|866301|P1|STARTED|Overall Study||26
357286|NCT00474812|866309|P1|NOT COMPLETED|Overall Study||7
357287|NCT00474812|866309|P1|COMPLETED|Overall Study||44
357288|NCT00474812|866309|P1|STARTED|Overall Study||51
357289|NCT00474786|866319|P2|NOT COMPLETED|Overall Study||253
357290|NCT00474786|866320|P1|NOT COMPLETED|Overall Study||259
357291|NCT00474786|866319|P2|COMPLETED|Overall Study||0
357292|NCT00474786|866320|P1|COMPLETED|Overall Study||0
357293|NCT00474786|866319|P2|STARTED|Overall Study||253
357294|NCT00474786|866320|P1|STARTED|Overall Study||259
357295|NCT00474760|866345|P7|NOT COMPLETED|Overall Study||10
357296|NCT00474760|866346|P6|NOT COMPLETED|Overall Study||29
357297|NCT00474760|866347|P5|NOT COMPLETED|Overall Study||12
357298|NCT00474760|866348|P4|NOT COMPLETED|Overall Study||3
357299|NCT00474760|866349|P3|NOT COMPLETED|Overall Study||3
357300|NCT00474760|866350|P2|NOT COMPLETED|Overall Study||3
357301|NCT00474760|866351|P1|NOT COMPLETED|Overall Study||3
357302|NCT00474760|866345|P7|COMPLETED|Overall Study||1
357303|NCT00474760|866346|P6|COMPLETED|Overall Study||0
357304|NCT00474760|866347|P5|COMPLETED|Overall Study||1
357305|NCT00474760|866348|P4|COMPLETED|Overall Study||0
357306|NCT00474760|866349|P3|COMPLETED|Overall Study||0
357307|NCT00474760|866350|P2|COMPLETED|Overall Study||0
357308|NCT00474760|866351|P1|COMPLETED|Overall Study||0
357309|NCT00474760|866345|P7|STARTED|Overall Study||11
357310|NCT00474760|866346|P6|STARTED|Overall Study||29
357311|NCT00474760|866347|P5|STARTED|Overall Study||13
357312|NCT00474760|866348|P4|STARTED|Overall Study||3
357313|NCT00474760|866349|P3|STARTED|Overall Study||3
357314|NCT00474760|866350|P2|STARTED|Overall Study||3
357315|NCT00474760|866351|P1|STARTED|Overall Study||3
357316|NCT00474708|866458|P2|NOT COMPLETED|Overall Study||25
357317|NCT00474708|866459|P1|NOT COMPLETED|Overall Study||57
357318|NCT00474708|866458|P2|COMPLETED|Overall Study||342
357319|NCT00474708|866459|P1|COMPLETED|Overall Study||734
357320|NCT00474708|866458|P2|STARTED|Overall Study||367
357321|NCT00474708|866459|P1|STARTED|Overall Study||791
357322|NCT00474630|866469|P2|NOT COMPLETED|Overall Study||70
357323|NCT00474630|866470|P1|NOT COMPLETED|Overall Study||160
357324|NCT00474630|866469|P2|COMPLETED|Overall Study||100
357325|NCT00474630|866470|P1|COMPLETED|Overall Study||175
357326|NCT00474630|866469|P2|STARTED|Overall Study||170
357327|NCT00474630|866470|P1|STARTED|Overall Study||335
357328|NCT00474617|866527|P3|NOT COMPLETED|Overall Study||2
357329|NCT00474617|866528|P2|NOT COMPLETED|Overall Study||3
357330|NCT00474617|866529|P1|NOT COMPLETED|Overall Study||8
357331|NCT00474617|866527|P3|COMPLETED|Overall Study||40
357332|NCT00474617|866528|P2|COMPLETED|Overall Study||61
357333|NCT00474617|866529|P1|COMPLETED|Overall Study||48
357334|NCT00474617|866527|P3|Treated|Overall Study||40
357335|NCT00474617|866528|P2|Treated|Overall Study||62
357336|NCT00474617|866529|P1|Treated|Overall Study||48
357337|NCT00474617|866527|P3|STARTED|Overall Study||42
357338|NCT00474617|866528|P2|STARTED|Overall Study||64
357339|NCT00474617|866529|P1|STARTED|Overall Study||56
357340|NCT00474539|866563|P2|NOT COMPLETED|Toddler Dose||0
357341|NCT00474539|866564|P1|NOT COMPLETED|Toddler Dose||1
357342|NCT00474539|866563|P2|COMPLETED|Toddler Dose||220
357343|NCT00474539|866564|P1|COMPLETED|Toddler Dose||208
357344|NCT00474539|866563|P2|STARTED|Toddler Dose||220
357345|NCT00474539|866564|P1|STARTED|Toddler Dose||209
357346|NCT00474539|866563|P2|NOT COMPLETED|After Infant Series||0
357347|NCT00474539|866564|P1|NOT COMPLETED|After Infant Series||4
357348|NCT00474539|866563|P2|COMPLETED|After Infant Series||220
357349|NCT00474539|866564|P1|COMPLETED|After Infant Series||209
357350|NCT00474539|866563|P2|STARTED|After Infant Series||220
357351|NCT00474539|866564|P1|STARTED|After Infant Series||213
357352|NCT00474539|866563|P2|NOT COMPLETED|Infant Series||6
357353|NCT00474539|866564|P1|NOT COMPLETED|Infant Series||10
357354|NCT00474539|866563|P2|COMPLETED|Infant Series||220
357355|NCT00474539|866564|P1|COMPLETED|Infant Series||213
357356|NCT00474539|866563|P2|Vaccinated Dose 3|Infant Series||221
357357|NCT00474539|866564|P1|Vaccinated Dose 3|Infant Series||214
357358|NCT00474539|866563|P2|Vaccinated Dose 2|Infant Series||222
357359|NCT00474539|866564|P1|Vaccinated Dose 2|Infant Series||217
357360|NCT00474539|866563|P2|Vaccinated Dose 1|Infant Series||226
357361|NCT00474539|866564|P1|Vaccinated Dose 1|Infant Series||218
357362|NCT00474539|866563|P2|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|226
357363|NCT00474539|866564|P1|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|223
357364|NCT00474526|866629|P17|NOT COMPLETED|Overall Study||9
357365|NCT00474526|866630|P16|NOT COMPLETED|Overall Study||18
357366|NCT00474526|866631|P15|NOT COMPLETED|Overall Study||77
357367|NCT00474526|866632|P14|NOT COMPLETED|Overall Study||156
357368|NCT00474526|866633|P13|NOT COMPLETED|Overall Study||15
357369|NCT00474526|866634|P12|NOT COMPLETED|Overall Study||11
357370|NCT00474526|866635|P11|NOT COMPLETED|Overall Study||10
357371|NCT00474526|866636|P10|NOT COMPLETED|Overall Study||27
357372|NCT00474526|866637|P9|NOT COMPLETED|Overall Study||6
357373|NCT00474526|866638|P8|NOT COMPLETED|Overall Study||6
357374|NCT00474526|866639|P7|NOT COMPLETED|Overall Study||25
357375|NCT00474526|866640|P6|NOT COMPLETED|Overall Study||16
357376|NCT00474526|866641|P5|NOT COMPLETED|Overall Study||68
357377|NCT00474526|866642|P4|NOT COMPLETED|Overall Study||119
357378|NCT00474526|866643|P3|NOT COMPLETED|Overall Study||49
357379|NCT00474526|866644|P2|NOT COMPLETED|Overall Study||46
357380|NCT00474526|866645|P1|NOT COMPLETED|Overall Study||33
357381|NCT00474526|866629|P17|COMPLETED|Overall Study||174
357382|NCT00474526|866630|P16|COMPLETED|Overall Study||152
357383|NCT00474526|866631|P15|COMPLETED|Overall Study||281
357384|NCT00474526|866632|P14|COMPLETED|Overall Study||1270
357385|NCT00474526|866633|P13|COMPLETED|Overall Study||135
357386|NCT00474526|866634|P12|COMPLETED|Overall Study||139
357387|NCT00474526|866635|P11|COMPLETED|Overall Study||141
357388|NCT00474526|866636|P10|COMPLETED|Overall Study||121
357389|NCT00474526|866637|P9|COMPLETED|Overall Study||144
357390|NCT00474526|866638|P8|COMPLETED|Overall Study||145
357391|NCT00474526|866639|P7|COMPLETED|Overall Study||178
357392|NCT00474526|866640|P6|COMPLETED|Overall Study||54
357393|NCT00474526|866641|P5|COMPLETED|Overall Study||8
357394|NCT00474526|866642|P4|COMPLETED|Overall Study||561
357395|NCT00474526|866643|P3|COMPLETED|Overall Study||110
357396|NCT00474526|866644|P2|COMPLETED|Overall Study||120
357397|NCT00474526|866645|P1|COMPLETED|Overall Study||121
357398|NCT00474526|866629|P17|STARTED|Overall Study||183
357399|NCT00474526|866630|P16|STARTED|Overall Study||170
357400|NCT00474526|866631|P15|STARTED|Overall Study||358
357401|NCT00474526|866632|P14|STARTED|Overall Study||1426
357402|NCT00474526|866633|P13|STARTED|Overall Study||150
357403|NCT00474526|866634|P12|STARTED|Overall Study||150
357404|NCT00474526|866635|P11|STARTED|Overall Study||151
357405|NCT00474526|866636|P10|STARTED|Overall Study||148
357406|NCT00474526|866637|P9|STARTED|Overall Study||150
357407|NCT00474526|866638|P8|STARTED|Overall Study||151
357408|NCT00474526|866639|P7|STARTED|Overall Study||203
357409|NCT00474526|866640|P6|STARTED|Overall Study||70
357410|NCT00474526|866641|P5|STARTED|Overall Study||76
357411|NCT00474526|866642|P4|STARTED|Overall Study||680
357412|NCT00474526|866643|P3|STARTED|Overall Study||159
357413|NCT00474526|866644|P2|STARTED|Overall Study||166
357414|NCT00474526|866645|P1|STARTED|Overall Study||154
357415|NCT00474487|866810|P4|NOT COMPLETED|Overall Study||0
357416|NCT00474487|866811|P3|NOT COMPLETED|Overall Study||14
357417|NCT00474487|866812|P2|NOT COMPLETED|Overall Study||2
357418|NCT00474487|866813|P1|NOT COMPLETED|Overall Study||30
357419|NCT00474487|866810|P4|COMPLETED|Overall Study||109
357420|NCT00474487|866811|P3|COMPLETED|Overall Study||885
357421|NCT00474487|866812|P2|COMPLETED|Overall Study||215
357422|NCT00474487|866813|P1|COMPLETED|Overall Study||1576
357423|NCT00474487|866810|P4|STARTED|Overall Study||109
357424|NCT00474487|866811|P3|STARTED|Overall Study||899
357425|NCT00474487|866812|P2|STARTED|Overall Study||217
357426|NCT00474487|866813|P1|STARTED|Overall Study||1606
357427|NCT00474383|866833|P2|NOT COMPLETED|Extension||5
357428|NCT00474383|866834|P1|NOT COMPLETED|Extension||0
357429|NCT00474383|866833|P2|COMPLETED|Extension||0
357430|NCT00474383|866834|P1|COMPLETED|Extension||0
357431|NCT00474383|866833|P2|STARTED|Extension||5
357432|NCT00474383|866834|P1|STARTED|Extension||0
357433|NCT00474383|866833|P2|NOT COMPLETED|Between Main Study and Extension||0
357434|NCT00474383|866834|P1|NOT COMPLETED|Between Main Study and Extension||6
357435|NCT00474383|866833|P2|COMPLETED|Between Main Study and Extension||0
357436|NCT00474383|866834|P1|COMPLETED|Between Main Study and Extension||5
357437|NCT00474383|866833|P2|STARTED|Between Main Study and Extension||0
357438|NCT00474383|866834|P1|STARTED|Between Main Study and Extension||11
357439|NCT00474383|866833|P2|NOT COMPLETED|Main Study||0
357440|NCT00474383|866834|P1|NOT COMPLETED|Main Study||36
357441|NCT00474383|866833|P2|COMPLETED|Main Study||0
357442|NCT00474383|866834|P1|COMPLETED|Main Study||11
357443|NCT00474383|866833|P2|STARTED|Main Study||0
357444|NCT00474383|866834|P1|STARTED|Main Study||47
357445|NCT00474266|866849|P4|NOT COMPLETED|Overall Study||7
357446|NCT00474266|866850|P3|NOT COMPLETED|Overall Study||4
357447|NCT00474266|866851|P2|NOT COMPLETED|Overall Study||20
357448|NCT00474266|866852|P1|NOT COMPLETED|Overall Study||7
357449|NCT00474266|866849|P4|COMPLETED|Overall Study||118
357450|NCT00474266|866850|P3|COMPLETED|Overall Study||122
357451|NCT00474266|866851|P2|COMPLETED|Overall Study||354
357452|NCT00474266|866852|P1|COMPLETED|Overall Study||368
357453|NCT00474266|866849|P4|STARTED|Overall Study||125
357454|NCT00474266|866850|P3|STARTED|Overall Study||126
357455|NCT00474266|866851|P2|STARTED|Overall Study||374
357456|NCT00474266|866852|P1|STARTED|Overall Study||375
357457|NCT00474253|866956|P2|NOT COMPLETED|Overall Study||4
357458|NCT00474253|866957|P1|NOT COMPLETED|Overall Study||3
357459|NCT00474253|866956|P2|COMPLETED|Overall Study|Based on actual treatment received.|53
357460|NCT00474253|866957|P1|COMPLETED|Overall Study|Based on actual treatment received.|55
357461|NCT00474253|866956|P2|Treated|Overall Study|Based on actual treatment received.|54
357462|NCT00474253|866957|P1|Treated|Overall Study|Based on actual treatment received.|56
357463|NCT00474253|866956|P2|STARTED|Overall Study|Includes 1 participant randomized to rocuronium + sugammadex group who received succinylcholine.|57
357464|NCT00474253|866957|P1|STARTED|Overall Study|Includes 2 participants randomized to succinylcholine group who received rocuronium + sugammadex.|58
357465|NCT00474240|866981|P6|NOT COMPLETED|Overall Study||18
357466|NCT00474240|866982|P5|NOT COMPLETED|Overall Study||8
357467|NCT00474240|866983|P4|NOT COMPLETED|Overall Study||16
357468|NCT00474240|866984|P3|NOT COMPLETED|Overall Study||9
357469|NCT00474240|866985|P2|NOT COMPLETED|Overall Study||1
357470|NCT00474240|866986|P1|NOT COMPLETED|Overall Study||1
357471|NCT00474240|866981|P6|COMPLETED|Overall Study||8
357472|NCT00474240|866982|P5|COMPLETED|Overall Study||18
357473|NCT00474240|866983|P4|COMPLETED|Overall Study||10
357474|NCT00474240|866984|P3|COMPLETED|Overall Study||17
357475|NCT00474240|866985|P2|COMPLETED|Overall Study||25
357476|NCT00474240|866986|P1|COMPLETED|Overall Study||26
357477|NCT00474240|866981|P6|STARTED|Overall Study||26
357478|NCT00474240|866982|P5|STARTED|Overall Study||26
357479|NCT00474240|866983|P4|STARTED|Overall Study||26
357480|NCT00474240|866984|P3|STARTED|Overall Study||26
357481|NCT00474240|866985|P2|STARTED|Overall Study||26
357482|NCT00474240|866986|P1|STARTED|Overall Study||27
357483|NCT00474201|867006|P1|NOT COMPLETED|Overall Study||0
357484|NCT00474201|867006|P1|COMPLETED|Overall Study||15
357485|NCT00474201|867006|P1|STARTED|Overall Study||15
357486|NCT00474188|867011|P1|NOT COMPLETED|Overall Study||6
357487|NCT00474188|867011|P1|COMPLETED|Overall Study|Disease progression=15, adverse event=4, death=1|20
357488|NCT00474188|867011|P1|STARTED|Overall Study||26
357489|NCT00474175|867021|P3|NOT COMPLETED|Overall Study||4
357490|NCT00474175|867022|P2|NOT COMPLETED|Overall Study||7
357491|NCT00474175|867023|P1|NOT COMPLETED|Overall Study||1
357492|NCT00474175|867021|P3|COMPLETED|Overall Study||225
357493|NCT00474175|867022|P2|COMPLETED|Overall Study||226
357494|NCT00474175|867023|P1|COMPLETED|Overall Study||114
357495|NCT00474175|867021|P3|Treated|Overall Study||228
357496|NCT00474175|867022|P2|Treated|Overall Study||233
357497|NCT00474175|867023|P1|Treated|Overall Study||115
357498|NCT00474175|867021|P3|STARTED|Overall Study||229
357499|NCT00474175|867022|P2|STARTED|Overall Study||233
357500|NCT00474175|867023|P1|STARTED|Overall Study||115
357501|NCT00474123|867060|P2|NOT COMPLETED|Overall Study||0
357502|NCT00474123|867061|P1|NOT COMPLETED|Overall Study||0
357503|NCT00474123|867060|P2|COMPLETED|Overall Study||40
357504|NCT00474123|867061|P1|COMPLETED|Overall Study||38
357505|NCT00474123|867060|P2|STARTED|Overall Study||40
357506|NCT00474123|867061|P1|STARTED|Overall Study||38
357507|NCT00474058|867087|P2|NOT COMPLETED|Overall Study||17
357508|NCT00474058|867088|P1|NOT COMPLETED|Overall Study||24
357509|NCT00474058|867087|P2|COMPLETED|Overall Study||80
357510|NCT00474058|867088|P1|COMPLETED|Overall Study||166
357511|NCT00474058|867087|P2|STARTED|Overall Study||97
357512|NCT00474058|867088|P1|STARTED|Overall Study||190
357513|NCT00474045|867102|P2|NOT COMPLETED|Overall Study||101
357514|NCT00474045|867103|P1|NOT COMPLETED|Overall Study||106
357515|NCT00474045|867102|P2|COMPLETED|Overall Study||136
357516|NCT00474045|867103|P1|COMPLETED|Overall Study||127
357517|NCT00474045|867102|P2|Pregnancies (for Exposed-pregnant)|Overall Study|2 subjects had spontaneous abortion and became pregnant again|160
357518|NCT00474045|867103|P1|Pregnancies (for Exposed-pregnant)|Overall Study||152
357519|NCT00474045|867102|P2|Exposed-Pregnant Subjects|Overall Study|3 withdrawn before treatment initiation|158
357520|NCT00474045|867103|P1|Exposed-Pregnant Subjects|Overall Study||152
357521|NCT00474045|867102|P2|Exposed-All Subjects|Overall Study|5 withdrawn before treatment initiation|232
357522|NCT00474045|867103|P1|Exposed-All Subjects|Overall Study||233
357523|NCT00474045|867102|P2|STARTED|Overall Study||237
357524|NCT00474045|867103|P1|STARTED|Overall Study||233
357525|NCT00473889|867203|P2|NOT COMPLETED|Overall Study||64
357526|NCT00473889|867204|P1|NOT COMPLETED|Overall Study||83
357527|NCT00473889|867203|P2|COMPLETED|Overall Study||63
357528|NCT00473889|867204|P1|COMPLETED|Overall Study||43
357529|NCT00473889|867203|P2|STARTED|Overall Study||127
357530|NCT00473889|867204|P1|STARTED|Overall Study||126
357531|NCT00473876|867216|P2|NOT COMPLETED|Overall Study||1
357532|NCT00473876|867217|P1|NOT COMPLETED|Overall Study||3
357533|NCT00473876|867216|P2|COMPLETED|Overall Study||22
357534|NCT00473876|867217|P1|COMPLETED|Overall Study||36
357535|NCT00473876|867216|P2|STARTED|Overall Study||23
357536|NCT00473876|867217|P1|STARTED|Overall Study||39
357537|NCT00473837|867227|P2|NOT COMPLETED|Overall Study||3
357538|NCT00473837|867228|P1|NOT COMPLETED|Overall Study||1
357539|NCT00473837|867227|P2|COMPLETED|Overall Study||43
357540|NCT00473837|867228|P1|COMPLETED|Overall Study||49
357541|NCT00473837|867227|P2|STARTED|Overall Study||46
357542|NCT00473837|867228|P1|STARTED|Overall Study||50
357543|NCT00473824|867236|P2|NOT COMPLETED|Overall Study||0
357544|NCT00473824|867237|P1|NOT COMPLETED|Overall Study||5
357545|NCT00473824|867236|P2|COMPLETED|Overall Study|Study Completion/Early Termination Date|2
357546|NCT00473824|867237|P1|COMPLETED|Overall Study|Study Completion/Early Termination Date|0
357547|NCT00473824|867236|P2|STARTED|Overall Study||2
357548|NCT00473824|867237|P1|STARTED|Overall Study||5
357549|NCT00473746|867248|P5|NOT COMPLETED|Period 2 (Phase 2)||27
357550|NCT00473746|867249|P4|NOT COMPLETED|Period 2 (Phase 2)||0
357551|NCT00473746|867250|P3|NOT COMPLETED|Period 2 (Phase 2)||0
357552|NCT00473746|867251|P2|NOT COMPLETED|Period 2 (Phase 2)||0
357553|NCT00473746|867252|P1|NOT COMPLETED|Period 2 (Phase 2)||0
357554|NCT00473746|867248|P5|COMPLETED|Period 2 (Phase 2)||6
357555|NCT00473746|867249|P4|COMPLETED|Period 2 (Phase 2)||0
357556|NCT00473746|867250|P3|COMPLETED|Period 2 (Phase 2)||0
357557|NCT00473746|867251|P2|COMPLETED|Period 2 (Phase 2)||0
357558|NCT00473746|867252|P1|COMPLETED|Period 2 (Phase 2)||0
357559|NCT00473746|867248|P5|STARTED|Period 2 (Phase 2)||33
357560|NCT00473746|867249|P4|STARTED|Period 2 (Phase 2)||0
357561|NCT00473746|867250|P3|STARTED|Period 2 (Phase 2)||0
357562|NCT00473746|867251|P2|STARTED|Period 2 (Phase 2)||0
357563|NCT00473746|867252|P1|STARTED|Period 2 (Phase 2)||0
357564|NCT00473746|867248|P5|NOT COMPLETED|Period 1 (Phase 1)||0
357565|NCT00473746|867249|P4|NOT COMPLETED|Period 1 (Phase 1)||10
357566|NCT00473746|867250|P3|NOT COMPLETED|Period 1 (Phase 1)||6
357567|NCT00473746|867251|P2|NOT COMPLETED|Period 1 (Phase 1)||9
357568|NCT00473746|867252|P1|NOT COMPLETED|Period 1 (Phase 1)||6
357569|NCT00473746|867248|P5|COMPLETED|Period 1 (Phase 1)||0
357570|NCT00473746|867249|P4|COMPLETED|Period 1 (Phase 1)|Treatment ongoing|2
357571|NCT00473746|867250|P3|COMPLETED|Period 1 (Phase 1)||0
357572|NCT00473746|867251|P2|COMPLETED|Period 1 (Phase 1)||0
357573|NCT00473746|867252|P1|COMPLETED|Period 1 (Phase 1)||0
357574|NCT00473746|867248|P5|STARTED|Period 1 (Phase 1)||0
357575|NCT00473746|867249|P4|STARTED|Period 1 (Phase 1)||12
357576|NCT00473746|867250|P3|STARTED|Period 1 (Phase 1)||6
357577|NCT00473746|867251|P2|STARTED|Period 1 (Phase 1)||9
357578|NCT00473746|867252|P1|STARTED|Period 1 (Phase 1)||6
357579|NCT00473694|867301|P4|NOT COMPLETED|Overall Study||7
357580|NCT00473694|867302|P3|NOT COMPLETED|Overall Study||5
357581|NCT00473694|867303|P2|NOT COMPLETED|Overall Study||4
357582|NCT00473694|867304|P1|NOT COMPLETED|Overall Study||11
357583|NCT00473694|867301|P4|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|35
357584|NCT00473694|867302|P3|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|46
357585|NCT00473694|867303|P2|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|37
357586|NCT00473694|867304|P1|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|37
357587|NCT00473694|867301|P4|Treated|Overall Study|Number of participants treated was based on actual treatment received.|36
357588|NCT00473694|867302|P3|Treated|Overall Study|Number of participants treated was based on actual treatment received.|46
357589|NCT00473694|867303|P2|Treated|Overall Study|Number of participants treated was based on actual treatment received.|38
357590|NCT00473694|867304|P1|Treated|Overall Study|Number of participants treated was based on actual treatment received.|37
357591|NCT00473694|867301|P4|STARTED|Overall Study||42
357592|NCT00473694|867302|P3|STARTED|Overall Study||51
357593|NCT00473694|867303|P2|STARTED|Overall Study|Includes 1 participant randomized to vecuronium+sugammadex but treated with rocuronium+neostigmine|41
357594|NCT00473694|867304|P1|STARTED|Overall Study||48
357595|NCT00473668|867345|P3|NOT COMPLETED|Overall Study||10
357596|NCT00473668|867346|P2|NOT COMPLETED|Overall Study||11
357597|NCT00473668|867347|P1|NOT COMPLETED|Overall Study||5
357598|NCT00473668|867345|P3|COMPLETED|Overall Study||89
357599|NCT00473668|867346|P2|COMPLETED|Overall Study||89
357600|NCT00473668|867347|P1|COMPLETED|Overall Study||95
357601|NCT00473668|867345|P3|STARTED|Overall Study||99
357602|NCT00473668|867346|P2|STARTED|Overall Study||100
357603|NCT00473668|867347|P1|STARTED|Overall Study||100
357604|NCT00473655|867400|P3|NOT COMPLETED|Overall Study||8
357605|NCT00473655|867401|P2|NOT COMPLETED|Overall Study||5
357606|NCT00473655|867402|P1|NOT COMPLETED|Overall Study||9
357607|NCT00473655|867400|P3|COMPLETED|Overall Study|8 participants were lost of follow up|103
357608|NCT00473655|867401|P2|COMPLETED|Overall Study|5 participants were lost of follow up|107
357609|NCT00473655|867402|P1|COMPLETED|Overall Study|9 participants were lost of follow up|102
357610|NCT00473655|867400|P3|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
357611|NCT00473655|867401|P2|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|112
357612|NCT00473655|867402|P1|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
357613|NCT00473642|867437|P3|NOT COMPLETED|Overall Study||2
357614|NCT00473642|867438|P2|NOT COMPLETED|Overall Study||1
357615|NCT00473642|867439|P1|NOT COMPLETED|Overall Study||2
357616|NCT00473642|867437|P3|COMPLETED|Overall Study||8
357617|NCT00473642|867438|P2|COMPLETED|Overall Study||10
357618|NCT00473642|867439|P1|COMPLETED|Overall Study||8
357619|NCT00473642|867437|P3|STARTED|Overall Study||10
357620|NCT00473642|867438|P2|STARTED|Overall Study||11
357621|NCT00473642|867439|P1|STARTED|Overall Study||10
357622|NCT00473590|867449|P2|NOT COMPLETED|Overall Study||38
357623|NCT00473590|867450|P1|NOT COMPLETED|Overall Study||45
357624|NCT00473590|867449|P2|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|11
357625|NCT00473590|867450|P1|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|8
357626|NCT00473590|867449|P2|Safety Population|Overall Study||50
357627|NCT00473590|867450|P1|Safety Population|Overall Study|2 patients received at least 1 bevacizumab dose & were analyzed as bevacizumab-treated patients|50
357628|NCT00473590|867449|P2|Treated|Overall Study||48
357629|NCT00473590|867450|P1|Treated|Overall Study||52
357630|NCT00473590|867449|P2|STARTED|Overall Study||49
357631|NCT00473590|867450|P1|STARTED|Overall Study||53
357632|NCT00473564|867466|P1|NOT COMPLETED|Overall Study||23
357633|NCT00473564|867466|P1|COMPLETED|Overall Study||147
357634|NCT00473564|867466|P1|STARTED|Overall Study||170
357635|NCT00473512|867476|P5|NOT COMPLETED|Period 2 (Phase 2)||2
357636|NCT00473512|867477|P4|NOT COMPLETED|Period 2 (Phase 2)||23
357637|NCT00473512|867478|P3|NOT COMPLETED|Period 2 (Phase 2)||2
357638|NCT00473512|867479|P2|NOT COMPLETED|Period 2 (Phase 2)||2
357639|NCT00473512|867480|P1|NOT COMPLETED|Period 2 (Phase 2)||1
357640|NCT00473512|867476|P5|COMPLETED|Period 2 (Phase 2)||0
357641|NCT00473512|867477|P4|COMPLETED|Period 2 (Phase 2)||0
357642|NCT00473512|867478|P3|COMPLETED|Period 2 (Phase 2)||0
357643|NCT00473512|867479|P2|COMPLETED|Period 2 (Phase 2)||0
357644|NCT00473512|867480|P1|COMPLETED|Period 2 (Phase 2)||0
357645|NCT00473512|867476|P5|STARTED|Period 2 (Phase 2)||2
357646|NCT00473512|867477|P4|STARTED|Period 2 (Phase 2)|2 participants did not continue to Phase 2 of the study.|23
357647|NCT00473512|867478|P3|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|2
357648|NCT00473512|867479|P2|STARTED|Period 2 (Phase 2)||2
357649|NCT00473512|867480|P1|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|1
357650|NCT00473512|867476|P5|NOT COMPLETED|Period 1 (Phase 1)||1
357651|NCT00473512|867477|P4|NOT COMPLETED|Period 1 (Phase 1)||17
357652|NCT00473512|867478|P3|NOT COMPLETED|Period 1 (Phase 1)||0
357653|NCT00473512|867479|P2|NOT COMPLETED|Period 1 (Phase 1)||1
357654|NCT00473512|867480|P1|NOT COMPLETED|Period 1 (Phase 1)||1
357655|NCT00473512|867476|P5|COMPLETED|Period 1 (Phase 1)||2
357656|NCT00473512|867477|P4|COMPLETED|Period 1 (Phase 1)||25
357657|NCT00473512|867478|P3|COMPLETED|Period 1 (Phase 1)||3
357658|NCT00473512|867479|P2|COMPLETED|Period 1 (Phase 1)||2
357659|NCT00473512|867480|P1|COMPLETED|Period 1 (Phase 1)||2
357660|NCT00473512|867476|P5|STARTED|Period 1 (Phase 1)||3
357661|NCT00473512|867477|P4|STARTED|Period 1 (Phase 1)||42
357662|NCT00473512|867478|P3|STARTED|Period 1 (Phase 1)||3
357663|NCT00473512|867479|P2|STARTED|Period 1 (Phase 1)||3
357664|NCT00473512|867480|P1|STARTED|Period 1 (Phase 1)||3
357665|NCT00473434|867538|P1|NOT COMPLETED|Overall Study||32
357666|NCT00473434|867538|P1|COMPLETED|Overall Study||32
357667|NCT00473434|867538|P1|STARTED|Overall Study||64
357668|NCT00473382|867603|P3|NOT COMPLETED|Open-label Extension Through Month 60||82
357669|NCT00473382|867604|P2|NOT COMPLETED|Open-label Extension Through Month 60||82
357670|NCT00473382|867605|P1|NOT COMPLETED|Open-label Extension Through Month 60||86
357671|NCT00473382|867603|P3|COMPLETED|Open-label Extension Through Month 60||2
357672|NCT00473382|867604|P2|COMPLETED|Open-label Extension Through Month 60||1
357673|NCT00473382|867605|P1|COMPLETED|Open-label Extension Through Month 60||2
357674|NCT00473382|867603|P3|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|84
357675|NCT00473382|867604|P2|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|83
357676|NCT00473382|867605|P1|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|88
357677|NCT00473382|867603|P3|NOT COMPLETED|Open-label Extension Through Month 48||47
357678|NCT00473382|867604|P2|NOT COMPLETED|Open-label Extension Through Month 48||41
357679|NCT00473382|867605|P1|NOT COMPLETED|Open-label Extension Through Month 48||50
357680|NCT00473382|867603|P3|COMPLETED|Open-label Extension Through Month 48||37
357681|NCT00473382|867604|P2|COMPLETED|Open-label Extension Through Month 48||42
357682|NCT00473382|867605|P1|COMPLETED|Open-label Extension Through Month 48||38
357683|NCT00473382|867603|P3|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|84
357684|NCT00473382|867604|P2|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|83
357685|NCT00473382|867605|P1|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|88
357686|NCT00473382|867603|P3|NOT COMPLETED|Core Study||29
357687|NCT00473382|867604|P2|NOT COMPLETED|Core Study||27
357688|NCT00473382|867605|P1|NOT COMPLETED|Core Study||28
357689|NCT00473382|867603|P3|COMPLETED|Core Study||98
357690|NCT00473382|867604|P2|COMPLETED|Core Study||98
357691|NCT00473382|867605|P1|COMPLETED|Core Study||102
357692|NCT00473382|867603|P3|STARTED|Core Study||127
357693|NCT00473382|867604|P2|STARTED|Core Study||125
357694|NCT00473382|867605|P1|STARTED|Core Study||130
357695|NCT00473330|867663|P3|NOT COMPLETED|Open-label Extension Through Month 60||77
357696|NCT00473330|867664|P2|NOT COMPLETED|Open-label Extension Through Month 60||78
357697|NCT00473330|867665|P1|NOT COMPLETED|Open-label Extension Through Month 60||88
357698|NCT00473330|867663|P3|COMPLETED|Open-label Extension Through Month 60||0
357699|NCT00473330|867664|P2|COMPLETED|Open-label Extension Through Month 60||1
357700|NCT00473330|867665|P1|COMPLETED|Open-label Extension Through Month 60||1
357701|NCT00473330|867663|P3|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|77
357702|NCT00473330|867664|P2|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|79
357703|NCT00473330|867665|P1|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|89
357704|NCT00473330|867663|P3|NOT COMPLETED|Open-label Extension Through Month 48||27
357705|NCT00473330|867664|P2|NOT COMPLETED|Open-label Extension Through Month 48||20
357706|NCT00473330|867665|P1|NOT COMPLETED|Open-label Extension Through Month 48||26
357707|NCT00473330|867663|P3|COMPLETED|Open-label Extension Through Month 48||50
357708|NCT00473330|867664|P2|COMPLETED|Open-label Extension Through Month 48||59
357709|NCT00473330|867665|P1|COMPLETED|Open-label Extension Through Month 48||63
357710|NCT00473330|867663|P3|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|77
357711|NCT00473330|867664|P2|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|79
357712|NCT00473330|867665|P1|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|89
357713|NCT00473330|867663|P3|NOT COMPLETED|Core Study||41
357714|NCT00473330|867664|P2|NOT COMPLETED|Core Study||25
357715|NCT00473330|867665|P1|NOT COMPLETED|Core Study||27
357716|NCT00473330|867663|P3|COMPLETED|Core Study||86
357717|NCT00473330|867664|P2|COMPLETED|Core Study||100
357718|NCT00473330|867665|P1|COMPLETED|Core Study||98
357719|NCT00473330|867663|P3|STARTED|Core Study||127
357720|NCT00473330|867664|P2|STARTED|Core Study||125
357721|NCT00473330|867665|P1|STARTED|Core Study||125
357722|NCT00473265|867720|P1|NOT COMPLETED|Overall Study||20
357723|NCT00473265|867720|P1|COMPLETED|Overall Study||48
357724|NCT00473265|867720|P1|STARTED|Overall Study||68
357725|NCT00473083|867732|P3|NOT COMPLETED|Overall Study||0
357726|NCT00473083|867733|P2|NOT COMPLETED|Overall Study||0
357727|NCT00473083|867734|P1|NOT COMPLETED|Overall Study||1
357728|NCT00473083|867732|P3|COMPLETED|Overall Study||50
357729|NCT00473083|867733|P2|COMPLETED|Overall Study||50
357730|NCT00473083|867734|P1|COMPLETED|Overall Study|One patient (2%) from treatment arm 1 discontinued the study drug as a result of a TEAE (dizziness)|49
357731|NCT00473083|867732|P3|STARTED|Overall Study||50
357732|NCT00473083|867733|P2|STARTED|Overall Study||50
357733|NCT00473083|867734|P1|STARTED|Overall Study||50
357734|NCT00472849|867762|P2|NOT COMPLETED|Overall Study||0
357735|NCT00472849|867763|P1|NOT COMPLETED|Overall Study||0
357736|NCT00472849|867762|P2|COMPLETED|Overall Study||78
357737|NCT00472849|867763|P1|COMPLETED|Overall Study||12
357738|NCT00472849|867762|P2|STARTED|Overall Study||78
357739|NCT00472849|867763|P1|STARTED|Overall Study||12
357740|NCT00472797|867771|P2|NOT COMPLETED|Overall Study||1
357741|NCT00472797|867772|P1|NOT COMPLETED|Overall Study||4
357742|NCT00472797|867771|P2|COMPLETED|Overall Study||112
357743|NCT00472797|867772|P1|COMPLETED|Overall Study||115
357744|NCT00472797|867771|P2|STARTED|Overall Study||113
357745|NCT00472797|867772|P1|STARTED|Overall Study||119
357746|NCT00472732|867798|P2|NOT COMPLETED|Overall Study||0
357747|NCT00472732|867799|P1|NOT COMPLETED|Overall Study||0
357748|NCT00472732|867798|P2|COMPLETED|Overall Study||22
357749|NCT00472732|867799|P1|COMPLETED|Overall Study||24
357750|NCT00472732|867798|P2|STARTED|Overall Study||22
357751|NCT00472732|867799|P1|STARTED|Overall Study||24
357752|NCT00472641|867809|P1|NOT COMPLETED|Overall Study||7
357753|NCT00472641|867809|P1|COMPLETED|Overall Study||18
357754|NCT00472641|867809|P1|STARTED|Overall Study||25
357755|NCT00472576|867816|P2|NOT COMPLETED|Second Intervention||0
357756|NCT00472576|867817|P1|NOT COMPLETED|Second Intervention||0
357757|NCT00472576|867816|P2|COMPLETED|Second Intervention||3
357758|NCT00472576|867817|P1|COMPLETED|Second Intervention||2
357759|NCT00472576|867816|P2|STARTED|Second Intervention||3
357760|NCT00472576|867817|P1|STARTED|Second Intervention||2
357761|NCT00472576|867816|P2|NOT COMPLETED|First Intervention||0
357762|NCT00472576|867817|P1|NOT COMPLETED|First Intervention||0
357763|NCT00472576|867816|P2|COMPLETED|First Intervention||3
357764|NCT00472576|867817|P1|COMPLETED|First Intervention||2
357765|NCT00472576|867816|P2|STARTED|First Intervention||3
357766|NCT00472576|867817|P1|STARTED|First Intervention||2
357767|NCT00472446|867829|P4|NOT COMPLETED|Overall Study||6
357768|NCT00472446|867830|P3|NOT COMPLETED|Overall Study||7
357769|NCT00472446|867831|P2|NOT COMPLETED|Overall Study||6
357770|NCT00472446|867832|P1|NOT COMPLETED|Overall Study||5
357771|NCT00472446|867829|P4|COMPLETED|Overall Study||39
357772|NCT00472446|867830|P3|COMPLETED|Overall Study||38
357773|NCT00472446|867831|P2|COMPLETED|Overall Study||41
357774|NCT00472446|867832|P1|COMPLETED|Overall Study||41
357775|NCT00472446|867829|P4|STARTED|Overall Study||45
357776|NCT00472446|867830|P3|STARTED|Overall Study||45
357777|NCT00472446|867831|P2|STARTED|Overall Study||47
357778|NCT00472446|867832|P1|STARTED|Overall Study||46
357779|NCT00472420|867862|P1|NOT COMPLETED|Follow-up Period||17
357780|NCT00472420|867862|P1|COMPLETED|Follow-up Period||15
357781|NCT00472420|867862|P1|STARTED|Follow-up Period||32
357782|NCT00472420|867862|P1|NOT COMPLETED|Induction Treatment Period||16
357783|NCT00472420|867862|P1|COMPLETED|Induction Treatment Period||32
357784|NCT00472420|867862|P1|STARTED|Induction Treatment Period||48
357785|NCT00472303|867870|P3|NOT COMPLETED|Maintenance Phase||17
357786|NCT00472303|867871|P2|NOT COMPLETED|Maintenance Phase||16
357787|NCT00472303|867872|P1|NOT COMPLETED|Maintenance Phase||17
357788|NCT00472303|867870|P3|COMPLETED|Maintenance Phase||95
357789|NCT00472303|867871|P2|COMPLETED|Maintenance Phase||93
357790|NCT00472303|867872|P1|COMPLETED|Maintenance Phase||89
357791|NCT00472303|867870|P3|STARTED|Maintenance Phase|112 of 218 participants in the tapentadol titration arm were re-randomized and treated.|112
357792|NCT00472303|867871|P2|STARTED|Maintenance Phase||109
357793|NCT00472303|867872|P1|STARTED|Maintenance Phase|106 of 218 participants in the tapentadol titration arm were re-randomized and treated.|106
357794|NCT00472303|867870|P3|NOT COMPLETED|Discontinuations After Titration Phase||0
357795|NCT00472303|867871|P2|NOT COMPLETED|Discontinuations After Titration Phase||20
357796|NCT00472303|867872|P1|NOT COMPLETED|Discontinuations After Titration Phase||61
357797|NCT00472303|867870|P3|COMPLETED|Discontinuations After Titration Phase||0
357798|NCT00472303|867871|P2|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|109
357799|NCT00472303|867872|P1|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|218
357800|NCT00472303|867870|P3|STARTED|Discontinuations After Titration Phase||0
357801|NCT00472303|867871|P2|STARTED|Discontinuations After Titration Phase||129
357802|NCT00472303|867872|P1|STARTED|Discontinuations After Titration Phase||279
357803|NCT00472303|867870|P3|NOT COMPLETED|Titration Phase||0
357804|NCT00472303|867871|P2|NOT COMPLETED|Titration Phase||29
357805|NCT00472303|867872|P1|NOT COMPLETED|Titration Phase||59
357806|NCT00472303|867870|P3|COMPLETED|Titration Phase||0
357807|NCT00472303|867871|P2|COMPLETED|Titration Phase||129
357808|NCT00472303|867872|P1|COMPLETED|Titration Phase||279
357809|NCT00472303|867870|P3|STARTED|Titration Phase|All participants in the titration phase were in the tapentadol arm during the titration phase.|0
357810|NCT00472303|867871|P2|STARTED|Titration Phase||158
357811|NCT00472303|867872|P1|STARTED|Titration Phase||338
357812|NCT00472290|867935|P1|NOT COMPLETED|Overall Study||72
357813|NCT00472290|867935|P1|COMPLETED|Overall Study||0
357814|NCT00472290|867935|P1|STARTED|Overall Study||72
357815|NCT00472199|867947|P2|NOT COMPLETED|Overall Study||60
357816|NCT00472199|867948|P1|NOT COMPLETED|Overall Study||35
357817|NCT00472199|867947|P2|COMPLETED|Overall Study||103
357818|NCT00472199|867948|P1|COMPLETED|Overall Study||131
357819|NCT00472199|867947|P2|STARTED|Overall Study||163
357820|NCT00472199|867948|P1|STARTED|Overall Study||166
357821|NCT00472082|868014|P1|NOT COMPLETED|Overall Study||5
357822|NCT00472082|868014|P1|COMPLETED|Overall Study||0
357823|NCT00472082|868014|P1|STARTED|Overall Study||5
357824|NCT00472056|868023|P4|NOT COMPLETED|Overall Study||0
357825|NCT00472056|868024|P3|NOT COMPLETED|Overall Study||0
357826|NCT00472056|868025|P2|NOT COMPLETED|Overall Study||0
357827|NCT00472056|868026|P1|NOT COMPLETED|Overall Study||0
357828|NCT00472056|868023|P4|COMPLETED|Overall Study||17
357829|NCT00472056|868024|P3|COMPLETED|Overall Study||32
357830|NCT00472056|868025|P2|COMPLETED|Overall Study||19
357831|NCT00472056|868026|P1|COMPLETED|Overall Study||25
357832|NCT00472056|868023|P4|STARTED|Overall Study||17
357833|NCT00472056|868024|P3|STARTED|Overall Study||32
357834|NCT00472056|868025|P2|STARTED|Overall Study||19
357835|NCT00472056|868026|P1|STARTED|Overall Study||25
357836|NCT00472030|868036|P2|NOT COMPLETED|Overall Study||0
357837|NCT00472030|868037|P1|NOT COMPLETED|Overall Study||1
357838|NCT00472030|868036|P2|COMPLETED|Overall Study||0
357839|NCT00472030|868037|P1|COMPLETED|Overall Study||1
357840|NCT00472030|868036|P2|STARTED|Overall Study||0
357841|NCT00472030|868037|P1|STARTED|Overall Study||2
357842|NCT00471822|868053|P1|NOT COMPLETED|Overall Study||2
357843|NCT00471822|868053|P1|COMPLETED|Overall Study||9705
357844|NCT00471822|868053|P1|Treated|Overall Study||9705
357845|NCT00471822|868053|P1|STARTED|Overall Study||9707
357846|NCT00471718|868061|P1|NOT COMPLETED|Overall Study||27
357847|NCT00471718|868061|P1|COMPLETED|Overall Study||0
357848|NCT00471718|868061|P1|STARTED|Overall Study||27
357849|NCT00471705|868073|P3|NOT COMPLETED|Overall Study||15
357850|NCT00471705|868074|P2|NOT COMPLETED|Overall Study||22
357851|NCT00471705|868075|P1|NOT COMPLETED|Overall Study||24
357852|NCT00471705|868073|P3|COMPLETED|Overall Study||134
357853|NCT00471705|868074|P2|COMPLETED|Overall Study||121
357854|NCT00471705|868075|P1|COMPLETED|Overall Study||121
357855|NCT00471705|868073|P3|STARTED|Overall Study||149
357856|NCT00471705|868074|P2|STARTED|Overall Study||143
357857|NCT00471705|868075|P1|STARTED|Overall Study||145
357858|NCT00471536|868089|P1|NOT COMPLETED|Overall Study||1
357859|NCT00471536|868089|P1|COMPLETED|Overall Study||18
357860|NCT00471536|868089|P1|STARTED|Overall Study||19
357861|NCT00471497|868101|P3|NOT COMPLETED|Overall Study||40
357862|NCT00471497|868102|P2|NOT COMPLETED|Overall Study||35
357863|NCT00471497|868103|P1|NOT COMPLETED|Overall Study||46
357864|NCT00471497|868101|P3|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|241
357865|NCT00471497|868102|P2|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|247
357866|NCT00471497|868103|P1|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|237
357867|NCT00471497|868101|P3|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|277
357868|NCT00471497|868102|P2|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|279
357869|NCT00471497|868103|P1|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|280
357870|NCT00471497|868101|P3|STARTED|Overall Study||281
357871|NCT00471497|868102|P2|STARTED|Overall Study||282
357872|NCT00471497|868103|P1|STARTED|Overall Study||283
357873|NCT00471445|868113|P2|NOT COMPLETED|Overall Study||2
357874|NCT00471445|868114|P1|NOT COMPLETED|Overall Study||2
357875|NCT00471445|868113|P2|COMPLETED|Overall Study||231
357876|NCT00471445|868114|P1|COMPLETED|Overall Study||227
357877|NCT00471445|868113|P2|STARTED|Overall Study||233
357878|NCT00471445|868114|P1|STARTED|Overall Study||229
357879|NCT00471380|868120|P2|NOT COMPLETED|Third Intervention||2
357880|NCT00471380|868121|P1|NOT COMPLETED|Third Intervention||1
357881|NCT00471380|868120|P2|COMPLETED|Third Intervention||14
357882|NCT00471380|868121|P1|COMPLETED|Third Intervention||17
357883|NCT00471380|868120|P2|STARTED|Third Intervention||16
357884|NCT00471380|868121|P1|STARTED|Third Intervention||18
357885|NCT00471380|868120|P2|NOT COMPLETED|Second Intervention||4
357886|NCT00471380|868121|P1|NOT COMPLETED|Second Intervention||0
357887|NCT00471380|868120|P2|COMPLETED|Second Intervention||16
357888|NCT00471380|868121|P1|COMPLETED|Second Intervention||18
357889|NCT00471380|868120|P2|STARTED|Second Intervention||20
357890|NCT00471380|868121|P1|STARTED|Second Intervention||18
357891|NCT00471380|868120|P2|NOT COMPLETED|First Intervention||4
357892|NCT00471380|868121|P1|NOT COMPLETED|First Intervention||4
357893|NCT00471380|868120|P2|COMPLETED|First Intervention||20
357894|NCT00471380|868121|P1|COMPLETED|First Intervention||18
357895|NCT00471380|868120|P2|STARTED|First Intervention||24
357896|NCT00471380|868121|P1|STARTED|First Intervention||22
357897|NCT00471354|868127|P1|NOT COMPLETED|Overall Study||52
357898|NCT00471354|868127|P1|COMPLETED|Overall Study||176
357899|NCT00471354|868127|P1|STARTED|Overall Study||228
357900|NCT00471328|868139|P2|NOT COMPLETED|Extension Phase||67
357901|NCT00471328|868140|P1|NOT COMPLETED|Extension Phase||41
357902|NCT00471328|868139|P2|COMPLETED|Extension Phase||0
357903|NCT00471328|868140|P1|COMPLETED|Extension Phase||0
357904|NCT00471328|868139|P2|Started:CrossOver During Extension|Extension Phase||10
357905|NCT00471328|868140|P1|Started:CrossOver During Extension|Extension Phase||0
357906|NCT00471328|868139|P2|Started:CrossOver After PrimaryAnalysis|Extension Phase||4
357907|NCT00471328|868140|P1|Started:CrossOver After PrimaryAnalysis|Extension Phase||0
357908|NCT00471328|868139|P2|Started:CrossOver Before PrimaryAnalysis|Extension Phase||53
357909|NCT00471328|868140|P1|Started:CrossOver Before PrimaryAnalysis|Extension Phase||0
357910|NCT00471328|868139|P2|STARTED|Extension Phase||67
357911|NCT00471328|868140|P1|STARTED|Extension Phase|Out of 58 ongoing patients, 17 patients had progression or died before they could enter extension|41
357912|NCT00471328|868139|P2|NOT COMPLETED|Core Phase||67
357913|NCT00471328|868140|P1|NOT COMPLETED|Core Phase||107
357914|NCT00471328|868139|P2|COMPLETED|Core Phase|Ongoing on treatment during completion of core|16
357915|NCT00471328|868140|P1|COMPLETED|Core Phase|Ongoing on treatment during completion of core.|58
357916|NCT00471328|868139|P2|Crossover to Nilotinib:Started Extension|Core Phase||53
357917|NCT00471328|868140|P1|Crossover to Nilotinib:Started Extension|Core Phase||0
357918|NCT00471328|868139|P2|STARTED|Core Phase||83
357919|NCT00471328|868140|P1|STARTED|Core Phase||165
357920|NCT00471315|868159|P1|NOT COMPLETED|Overall Study||8
357921|NCT00471315|868159|P1|COMPLETED|Overall Study||10
357922|NCT00471315|868159|P1|STARTED|Overall Study||18
357923|NCT00471276|868164|P1|NOT COMPLETED|Overall Study||83
357924|NCT00471276|868164|P1|COMPLETED|Overall Study||0
357925|NCT00471276|868164|P1|STARTED|Overall Study||83
357926|NCT00471237|868194|P7|NOT COMPLETED|Overall Study||3
357927|NCT00471237|868195|P6|NOT COMPLETED|Overall Study||39
357928|NCT00471237|868196|P5|NOT COMPLETED|Overall Study||41
357929|NCT00471237|868197|P4|NOT COMPLETED|Overall Study||45
357930|NCT00471237|868198|P3|NOT COMPLETED|Overall Study||34
357931|NCT00471237|868199|P2|NOT COMPLETED|Overall Study||42
357932|NCT00471237|868200|P1|NOT COMPLETED|Overall Study||41
357933|NCT00471237|868194|P7|COMPLETED|Overall Study||38
357934|NCT00471237|868195|P6|COMPLETED|Overall Study||50
357935|NCT00471237|868196|P5|COMPLETED|Overall Study||46
357936|NCT00471237|868197|P4|COMPLETED|Overall Study||43
357937|NCT00471237|868198|P3|COMPLETED|Overall Study||48
357938|NCT00471237|868199|P2|COMPLETED|Overall Study||45
357939|NCT00471237|868200|P1|COMPLETED|Overall Study||49
357940|NCT00471237|868194|P7|STARTED|Overall Study||41
357941|NCT00471237|868195|P6|STARTED|Overall Study||89
357942|NCT00471237|868196|P5|STARTED|Overall Study||87
357943|NCT00471237|868197|P4|STARTED|Overall Study||88
357944|NCT00471237|868198|P3|STARTED|Overall Study||82
357945|NCT00471237|868199|P2|STARTED|Overall Study||87
357946|NCT00471237|868200|P1|STARTED|Overall Study||90
357947|NCT00471146|868350|P2|NOT COMPLETED|Overall Study||174
357948|NCT00471146|868351|P1|NOT COMPLETED|Overall Study||172
357949|NCT00471146|868350|P2|COMPLETED|Overall Study||142
357950|NCT00471146|868351|P1|COMPLETED|Overall Study||142
357951|NCT00471146|868350|P2|Treated|Overall Study||308
357952|NCT00471146|868351|P1|Treated|Overall Study||305
357953|NCT00471146|868350|P2|STARTED|Overall Study||316
357954|NCT00471146|868351|P1|STARTED|Overall Study||314
357955|NCT00471107|868376|P3|NOT COMPLETED|Overall Study||3
357956|NCT00471107|868377|P2|NOT COMPLETED|Overall Study||1
357957|NCT00471107|868378|P1|NOT COMPLETED|Overall Study||3
357958|NCT00471107|868376|P3|COMPLETED|Overall Study||12
357959|NCT00471107|868377|P2|COMPLETED|Overall Study||14
357960|NCT00471107|868378|P1|COMPLETED|Overall Study||12
357961|NCT00471107|868376|P3|STARTED|Overall Study||15
357962|NCT00471107|868377|P2|STARTED|Overall Study||15
357963|NCT00471107|868378|P1|STARTED|Overall Study||15
357964|NCT00471081|868388|P2|NOT COMPLETED|Extended Safety Follow-Up||13
357965|NCT00471081|868389|P1|NOT COMPLETED|Extended Safety Follow-Up||2
357966|NCT00471081|868388|P2|COMPLETED|Extended Safety Follow-Up||176
357967|NCT00471081|868389|P1|COMPLETED|Extended Safety Follow-Up||158
357968|NCT00471081|868388|P2|STARTED|Extended Safety Follow-Up||189
357969|NCT00471081|868389|P1|STARTED|Extended Safety Follow-Up||160
357970|NCT00471081|868388|P2|NOT COMPLETED|Active Phase||13
357971|NCT00471081|868389|P1|NOT COMPLETED|Active Phase||2
357972|NCT00471081|868388|P2|COMPLETED|Active Phase||176
357973|NCT00471081|868389|P1|COMPLETED|Active Phase||158
357974|NCT00471081|868388|P2|STARTED|Active Phase||189
357975|NCT00471081|868389|P1|STARTED|Active Phase||160
357976|NCT00471068|868428|P2|NOT COMPLETED|Overall Study||1
357977|NCT00471068|868429|P1|NOT COMPLETED|Overall Study||1
357978|NCT00471068|868428|P2|COMPLETED|Overall Study||24
357979|NCT00471068|868429|P1|COMPLETED|Overall Study||20
357980|NCT00471068|868428|P2|STARTED|Overall Study||25
357981|NCT00471068|868429|P1|STARTED|Overall Study||21
357982|NCT00470847|868435|P1|NOT COMPLETED|Overall Study||1
357983|NCT00470847|868435|P1|COMPLETED|Overall Study||34
357984|NCT00470847|868435|P1|STARTED|Overall Study||35
357985|NCT00470834|868448|P2|NOT COMPLETED|Extension Period (24 Months)||23
357986|NCT00470834|868449|P1|NOT COMPLETED|Extension Period (24 Months)||15
357987|NCT00470834|868448|P2|COMPLETED|Extension Period (24 Months)||7
357988|NCT00470834|868449|P1|COMPLETED|Extension Period (24 Months)||11
357989|NCT00470834|868448|P2|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|30
357990|NCT00470834|868449|P1|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|26
357991|NCT00470834|868448|P2|NOT COMPLETED|Treatment Period (18 Months)||31
357992|NCT00470834|868449|P1|NOT COMPLETED|Treatment Period (18 Months)||38
357993|NCT00470834|868448|P2|COMPLETED|Treatment Period (18 Months)||31
357994|NCT00470834|868449|P1|COMPLETED|Treatment Period (18 Months)||27
357995|NCT00470834|868448|P2|STARTED|Treatment Period (18 Months)||62
357996|NCT00470834|868449|P1|STARTED|Treatment Period (18 Months)||65
357997|NCT00470626|868463|P1|NOT COMPLETED|Overall Study||17
357998|NCT00470626|868463|P1|COMPLETED|Overall Study||112
357999|NCT00470626|868463|P1|STARTED|Overall Study||129
358000|NCT00470600|868471|P2|NOT COMPLETED|Overall Study||0
358001|NCT00470600|868472|P1|NOT COMPLETED|Overall Study||0
358002|NCT00470600|868471|P2|COMPLETED|Overall Study|One subject was randomized to incorrect stratification categories (weight).|99
358003|NCT00470600|868472|P1|COMPLETED|Overall Study|Two subjects were randomized to incorrect stratification categories (weight).|86
358004|NCT00470600|868471|P2|STARTED|Overall Study||99
358005|NCT00470600|868472|P1|STARTED|Overall Study||86
358006|NCT00470548|868484|P4|NOT COMPLETED|Overall Study||0
358007|NCT00470548|868485|P3|NOT COMPLETED|Overall Study||0
358008|NCT00470548|868486|P2|NOT COMPLETED|Overall Study||0
358009|NCT00470548|868487|P1|NOT COMPLETED|Overall Study||0
358010|NCT00470548|868484|P4|COMPLETED|Overall Study||37
358011|NCT00470548|868485|P3|COMPLETED|Overall Study||6
358012|NCT00470548|868486|P2|COMPLETED|Overall Study||3
358013|NCT00470548|868487|P1|COMPLETED|Overall Study||3
358014|NCT00470548|868484|P4|STARTED|Overall Study||37
358015|NCT00470548|868485|P3|STARTED|Overall Study||6
358016|NCT00470548|868486|P2|STARTED|Overall Study||3
358017|NCT00470548|868487|P1|STARTED|Overall Study||3
358018|NCT00470535|868505|P1|NOT COMPLETED|Overall Study||18
358019|NCT00470535|868505|P1|COMPLETED|Overall Study||0
358020|NCT00470535|868505|P1|STARTED|Overall Study||18
358021|NCT00470470|868514|P1|NOT COMPLETED|Overall Study||5
358022|NCT00470470|868514|P1|COMPLETED|Overall Study||25
358023|NCT00470470|868514|P1|STARTED|Overall Study||30
358024|NCT00470418|868521|P2|NOT COMPLETED|Overall Study||0
358025|NCT00470418|868522|P1|NOT COMPLETED|Overall Study||1
358026|NCT00470418|868521|P2|COMPLETED|Overall Study||3
358027|NCT00470418|868522|P1|COMPLETED|Overall Study||6
358028|NCT00470418|868521|P2|STARTED|Overall Study||3
358029|NCT00470418|868522|P1|STARTED|Overall Study||7
358030|NCT00470392|868532|P2|NOT COMPLETED|Overall Study||0
358031|NCT00470392|868533|P1|NOT COMPLETED|Overall Study||0
358032|NCT00470392|868532|P2|COMPLETED|Overall Study||2
358033|NCT00470392|868533|P1|COMPLETED|Overall Study||7
358034|NCT00470392|868532|P2|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|2
358035|NCT00470392|868533|P1|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|7
358036|NCT00470366|868543|P1|NOT COMPLETED|Overall Study||4
358037|NCT00470366|868543|P1|COMPLETED|Overall Study||56
358038|NCT00470366|868543|P1|STARTED|Overall Study||60
358039|NCT00470301|868550|P1|NOT COMPLETED|Overall Study||5
358040|NCT00470301|868550|P1|COMPLETED|Overall Study||55
358041|NCT00470301|868550|P1|STARTED|Overall Study||60
358042|NCT00470275|868554|P1|NOT COMPLETED|Overall Study||10
358043|NCT00470275|868554|P1|COMPLETED|Overall Study||0
358044|NCT00470275|868554|P1|STARTED|Overall Study||10
358045|NCT00470262|868560|P2|NOT COMPLETED|Overall Study||0
358046|NCT00470262|868561|P1|NOT COMPLETED|Overall Study||2
358047|NCT00470262|868560|P2|COMPLETED|Overall Study||12
358048|NCT00470262|868561|P1|COMPLETED|Overall Study||13
358049|NCT00470262|868560|P2|STARTED|Overall Study||12
358050|NCT00470262|868561|P1|STARTED|Overall Study||15
358051|NCT00470184|868569|P1|NOT COMPLETED|Overall Study||22
358052|NCT00470184|868569|P1|COMPLETED|Overall Study||19
358053|NCT00470184|868569|P1|Treated With Study Therapy|Overall Study||36
358054|NCT00470184|868569|P1|STARTED|Overall Study||41
358055|NCT00470158|868581|P5|NOT COMPLETED|Overall Study||6
358056|NCT00470158|868582|P4|NOT COMPLETED|Overall Study||5
358057|NCT00470158|868583|P3|NOT COMPLETED|Overall Study||8
358058|NCT00470158|868584|P2|NOT COMPLETED|Overall Study||8
358059|NCT00470158|868585|P1|NOT COMPLETED|Overall Study||8
358060|NCT00470158|868581|P5|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|195
358061|NCT00470158|868582|P4|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
358062|NCT00470158|868583|P3|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
358063|NCT00470158|868584|P2|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|191
358064|NCT00470158|868585|P1|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
358065|NCT00470158|868581|P5|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
358066|NCT00470158|868582|P4|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|198
358067|NCT00470158|868583|P3|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
358068|NCT00470158|868584|P2|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|199
358069|NCT00470158|868585|P1|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
358070|NCT00470106|868601|P4|NOT COMPLETED|Overall Study||2
358071|NCT00470106|868602|P3|NOT COMPLETED|Overall Study||7
358072|NCT00470106|868603|P2|NOT COMPLETED|Overall Study||5
358073|NCT00470106|868604|P1|NOT COMPLETED|Overall Study||3
358074|NCT00470106|868601|P4|COMPLETED|Overall Study||19
358075|NCT00470106|868602|P3|COMPLETED|Overall Study||14
358076|NCT00470106|868603|P2|COMPLETED|Overall Study||19
358077|NCT00470106|868604|P1|COMPLETED|Overall Study||16
358078|NCT00470106|868601|P4|STARTED|Overall Study||21
358079|NCT00470106|868602|P3|STARTED|Overall Study||21
358080|NCT00470106|868603|P2|STARTED|Overall Study||24
358081|NCT00470106|868604|P1|STARTED|Overall Study||19
358082|NCT00470093|868618|P1|NOT COMPLETED|Overall Study||2
358083|NCT00470093|868618|P1|COMPLETED|Overall Study||0
358084|NCT00470093|868618|P1|STARTED|Overall Study||2
358085|NCT00470067|868625|P1|NOT COMPLETED|Overall Study||7
358086|NCT00470067|868625|P1|COMPLETED|Overall Study||2
358087|NCT00470067|868625|P1|STARTED|Overall Study||9
358088|NCT00470054|868629|P1|NOT COMPLETED|Overall Study||1
358089|NCT00470054|868629|P1|COMPLETED|Overall Study||43
358090|NCT00470054|868629|P1|STARTED|Overall Study||44
358091|NCT00469911|868639|P2|NOT COMPLETED|Overall Study||0
358092|NCT00469911|868640|P1|NOT COMPLETED|Overall Study||0
358093|NCT00469911|868639|P2|COMPLETED|Overall Study||10
358094|NCT00469911|868640|P1|COMPLETED|Overall Study||8
358095|NCT00469911|868639|P2|STARTED|Overall Study||10
358096|NCT00469911|868640|P1|STARTED|Overall Study||8
358097|NCT00469898|868645|P1|NOT COMPLETED|Overall Study||25
358098|NCT00469898|868645|P1|COMPLETED|Overall Study||25
358099|NCT00469898|868645|P1|STARTED|Overall Study||50
358100|NCT00469859|868654|P2|NOT COMPLETED|Overall Study||2
358101|NCT00469859|868655|P1|NOT COMPLETED|Overall Study||0
358102|NCT00469859|868654|P2|COMPLETED|Overall Study||6
358103|NCT00469859|868655|P1|COMPLETED|Overall Study||6
358104|NCT00469859|868654|P2|STARTED|Overall Study||8
358105|NCT00469859|868655|P1|STARTED|Overall Study||6
358106|NCT00469833|868663|P1|NOT COMPLETED|Overall Study||2
358107|NCT00469833|868663|P1|COMPLETED|Overall Study||15
358108|NCT00469833|868663|P1|STARTED|Overall Study|17 subjects met inclusion criteria and consented for the study|17
358109|NCT00469612|868675|P2|NOT COMPLETED|Overall Study||0
358110|NCT00469612|868676|P1|NOT COMPLETED|Overall Study||2
358111|NCT00469612|868675|P2|COMPLETED|Overall Study||0
358112|NCT00469612|868676|P1|COMPLETED|Overall Study|Subjects enrolled, but no data collected. Study terminated before data collection.|0
358113|NCT00469612|868675|P2|STARTED|Overall Study||0
358114|NCT00469612|868676|P1|STARTED|Overall Study||2
358115|NCT00469508|868688|P2|NOT COMPLETED|Overall Study||24
358116|NCT00469508|868689|P1|NOT COMPLETED|Overall Study||20
358117|NCT00469508|868688|P2|COMPLETED|Overall Study||13
358118|NCT00469508|868689|P1|COMPLETED|Overall Study||14
358119|NCT00469508|868688|P2|STARTED|Overall Study||37
358120|NCT00469508|868689|P1|STARTED|Overall Study||34
358121|NCT00469456|868703|P2|NOT COMPLETED|Overall Study||4
358122|NCT00469456|868704|P1|NOT COMPLETED|Overall Study||9
358123|NCT00469456|868703|P2|COMPLETED|Overall Study||131
358124|NCT00469456|868704|P1|COMPLETED|Overall Study||120
358125|NCT00469456|868703|P2|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug.|135
358126|NCT00469456|868704|P1|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|129
358127|NCT00469391|868714|P2|NOT COMPLETED|Overall Study||5
358128|NCT00469391|868715|P1|NOT COMPLETED|Overall Study||14
358129|NCT00469391|868714|P2|COMPLETED|Overall Study||24
358130|NCT00469391|868715|P1|COMPLETED|Overall Study||13
358131|NCT00469391|868714|P2|Patient Preference|Overall Study||1
358132|NCT00469391|868715|P1|Patient Preference|Overall Study||0
358133|NCT00469391|868714|P2|Lost to Follow up|Overall Study||1
358134|NCT00469391|868715|P1|Lost to Follow up|Overall Study||0
358135|NCT00469391|868714|P2|Adverse Event|Overall Study||0
358136|NCT00469391|868715|P1|Adverse Event|Overall Study||8
358137|NCT00469391|868714|P2|Unsuccessful Implant Procedure|Overall Study||0
358138|NCT00469391|868715|P1|Unsuccessful Implant Procedure|Overall Study||4
358139|NCT00469391|868714|P2|Discontinued Prior to Procedure|Overall Study||3
358140|NCT00469391|868715|P1|Discontinued Prior to Procedure|Overall Study||2
358141|NCT00469391|868714|P2|STARTED|Overall Study||29
358142|NCT00469391|868715|P1|STARTED|Overall Study||27
358143|NCT00469274|868723|P2|NOT COMPLETED|Overall Study||0
358144|NCT00469274|868724|P1|NOT COMPLETED|Overall Study||0
358145|NCT00469274|868723|P2|COMPLETED|Overall Study||42
358146|NCT00469274|868724|P1|COMPLETED|Overall Study||44
358147|NCT00469274|868723|P2|STARTED|Overall Study||42
358148|NCT00469274|868724|P1|STARTED|Overall Study||44
358149|NCT00469209|868733|P3|NOT COMPLETED|Overall Study||1
358150|NCT00469209|868734|P2|NOT COMPLETED|Overall Study||0
358151|NCT00469209|868735|P1|NOT COMPLETED|Overall Study||1
358152|NCT00469209|868733|P3|COMPLETED|Overall Study||19
358153|NCT00469209|868734|P2|COMPLETED|Overall Study||20
358154|NCT00469209|868735|P1|COMPLETED|Overall Study||19
358155|NCT00469209|868733|P3|STARTED|Overall Study||20
358156|NCT00469209|868734|P2|STARTED|Overall Study||20
358157|NCT00469209|868735|P1|STARTED|Overall Study||20
358158|NCT00469092|868745|P2|NOT COMPLETED|Overall Study||21
358159|NCT00469092|868746|P1|NOT COMPLETED|Overall Study||26
358160|NCT00469092|868745|P2|COMPLETED|Overall Study||220
358161|NCT00469092|868746|P1|COMPLETED|Overall Study||213
358162|NCT00469092|868745|P2|Exposed to Study Drug|Overall Study||238
358163|NCT00469092|868746|P1|Exposed to Study Drug|Overall Study||231
358164|NCT00469092|868745|P2|STARTED|Overall Study||241
358165|NCT00469092|868746|P1|STARTED|Overall Study||239
358166|NCT00469079|868765|P3|NOT COMPLETED|Overall Study||19
358167|NCT00469079|868766|P2|NOT COMPLETED|Overall Study||22
358168|NCT00469079|868767|P1|NOT COMPLETED|Overall Study||9
358169|NCT00469079|868765|P3|COMPLETED|Overall Study||32
358170|NCT00469079|868766|P2|COMPLETED|Overall Study||30
358171|NCT00469079|868767|P1|COMPLETED|Overall Study||18
358172|NCT00469079|868765|P3|STARTED|Overall Study||51
358173|NCT00469079|868766|P2|STARTED|Overall Study||52
358174|NCT00469079|868767|P1|STARTED|Overall Study||27
358175|NCT00468910|868786|P2|NOT COMPLETED|Overall Study||3
358176|NCT00468910|868787|P1|NOT COMPLETED|Overall Study||4
358177|NCT00468910|868786|P2|COMPLETED|Overall Study||36
358178|NCT00468910|868787|P1|COMPLETED|Overall Study||36
358179|NCT00468910|868786|P2|Follow-up|Overall Study||36
358180|NCT00468910|868787|P1|Follow-up|Overall Study||36
358181|NCT00468910|868786|P2|Post-Treatment Biopsy|Overall Study||36
358182|NCT00468910|868787|P1|Post-Treatment Biopsy|Overall Study||36
358183|NCT00468910|868786|P2|Treatment|Overall Study||36
358184|NCT00468910|868787|P1|Treatment|Overall Study||36
358185|NCT00468910|868786|P2|Randomization|Overall Study||39
358186|NCT00468910|868787|P1|Randomization|Overall Study||40
358187|NCT00468910|868786|P2|STARTED|Overall Study||39
358188|NCT00468910|868787|P1|STARTED|Overall Study||40
358189|NCT00468858|868806|P3|NOT COMPLETED|Overall Study||14
358190|NCT00468858|868807|P2|NOT COMPLETED|Overall Study||10
358191|NCT00468858|868808|P1|NOT COMPLETED|Overall Study||9
358192|NCT00468858|868806|P3|COMPLETED|Overall Study||199
358193|NCT00468858|868807|P2|COMPLETED|Overall Study||202
358194|NCT00468858|868808|P1|COMPLETED|Overall Study||202
358195|NCT00468858|868806|P3|STARTED|Overall Study||213
358196|NCT00468858|868807|P2|STARTED|Overall Study||212
358197|NCT00468858|868808|P1|STARTED|Overall Study||211
358198|NCT00468845|868929|P3|NOT COMPLETED|Overall Study||30
358199|NCT00468845|868930|P2|NOT COMPLETED|Overall Study||34
358200|NCT00468845|868931|P1|NOT COMPLETED|Overall Study||21
358201|NCT00468845|868929|P3|COMPLETED|Overall Study||139
358202|NCT00468845|868930|P2|COMPLETED|Overall Study||136
358203|NCT00468845|868931|P1|COMPLETED|Overall Study||141
358204|NCT00468845|868929|P3|Received Treatment|Overall Study||167
358205|NCT00468845|868930|P2|Received Treatment|Overall Study||166
358206|NCT00468845|868931|P1|Received Treatment|Overall Study||161
358207|NCT00468845|868929|P3|STARTED|Overall Study||169
358208|NCT00468845|868930|P2|STARTED|Overall Study||170
358209|NCT00468845|868931|P1|STARTED|Overall Study||162
358210|NCT00468819|869068|P3|NOT COMPLETED|Overall Study||2
358211|NCT00468819|869069|P2|NOT COMPLETED|Overall Study||0
358212|NCT00468819|869070|P1|NOT COMPLETED|Overall Study||6
358213|NCT00468819|869068|P3|COMPLETED|Overall Study||46
358214|NCT00468819|869069|P2|COMPLETED|Overall Study||44
358215|NCT00468819|869070|P1|COMPLETED|Overall Study||42
358216|NCT00468819|869068|P3|Treatment Received/ Safety Follow-up|Overall Study|FAS|48
358217|NCT00468819|869069|P2|Treatment Received/ Safety Follow-up|Overall Study|FAS|44
358218|NCT00468819|869070|P1|Treatment Received/ Safety Follow-up|Overall Study|FAS (Full Analysis Set)|46
358219|NCT00468819|869068|P3|STARTED|Overall Study|Enrolled participants|48
358220|NCT00468819|869069|P2|STARTED|Overall Study|Enrolled participants|44
358221|NCT00468819|869070|P1|STARTED|Overall Study|Enrolled participants|48
358222|NCT00468728|869150|P2|NOT COMPLETED|Follow-up||31
358223|NCT00468728|869151|P1|NOT COMPLETED|Follow-up||34
358224|NCT00468728|869150|P2|COMPLETED|Follow-up||222
358225|NCT00468728|869151|P1|COMPLETED|Follow-up||222
358226|NCT00468728|869150|P2|STARTED|Follow-up||253
358227|NCT00468728|869151|P1|STARTED|Follow-up||256
358228|NCT00468728|869150|P2|NOT COMPLETED|Treatment||11
358229|NCT00468728|869151|P1|NOT COMPLETED|Treatment||4
358230|NCT00468728|869150|P2|COMPLETED|Treatment||253
358231|NCT00468728|869151|P1|COMPLETED|Treatment||256
358232|NCT00468728|869150|P2|STARTED|Treatment||264
358233|NCT00468728|869151|P1|STARTED|Treatment||260
358234|NCT00468728|869150|P2|NOT COMPLETED|Enrollment||7
358235|NCT00468728|869151|P1|NOT COMPLETED|Enrollment||4
358236|NCT00468728|869150|P2|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|264
358237|NCT00468728|869151|P1|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|260
358238|NCT00468728|869150|P2|STARTED|Enrollment||271
358239|NCT00468728|869151|P1|STARTED|Enrollment||264
358240|NCT00468676|869163|P2|NOT COMPLETED|Overall Study||12
358241|NCT00468676|869164|P1|NOT COMPLETED|Overall Study||16
358242|NCT00468676|869163|P2|COMPLETED|Overall Study||94
358243|NCT00468676|869164|P1|COMPLETED|Overall Study||92
358244|NCT00468676|869163|P2|STARTED|Overall Study||106
358245|NCT00468676|869164|P1|STARTED|Overall Study||108
358246|NCT00468650|869181|P1|NOT COMPLETED|Overall Study||7
358247|NCT00468650|869181|P1|COMPLETED|Overall Study||110
358248|NCT00468650|869181|P1|STARTED|Overall Study||117
358249|NCT00468585|869229|P4|NOT COMPLETED|Overall Study||1
358250|NCT00468585|869230|P3|NOT COMPLETED|Overall Study||5
358251|NCT00468585|869231|P2|NOT COMPLETED|Overall Study||0
358252|NCT00468585|869232|P1|NOT COMPLETED|Overall Study||1
358253|NCT00468585|869229|P4|COMPLETED|Overall Study||5
358254|NCT00468585|869230|P3|COMPLETED|Overall Study||45
358255|NCT00468585|869231|P2|COMPLETED|Overall Study||3
358256|NCT00468585|869232|P1|COMPLETED|Overall Study||3
358257|NCT00468585|869229|P4|STARTED|Overall Study||6
358258|NCT00468585|869230|P3|STARTED|Overall Study||50
358259|NCT00468585|869231|P2|STARTED|Overall Study||3
358260|NCT00468585|869232|P1|STARTED|Overall Study||4
358261|NCT00468559|869244|P3|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||17
358262|NCT00468559|869245|P2|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||10
358263|NCT00468559|869246|P1|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||0
358264|NCT00468559|869244|P3|COMPLETED|Double-blind, Treatment-withdrawal Phase||24
358265|NCT00468559|869245|P2|COMPLETED|Double-blind, Treatment-withdrawal Phase||29
358266|NCT00468559|869246|P1|COMPLETED|Double-blind, Treatment-withdrawal Phase||0
358267|NCT00468559|869244|P3|STARTED|Double-blind, Treatment-withdrawal Phase||41
358268|NCT00468559|869245|P2|STARTED|Double-blind, Treatment-withdrawal Phase||39
358269|NCT00468559|869246|P1|STARTED|Double-blind, Treatment-withdrawal Phase||0
358270|NCT00468559|869244|P3|NOT COMPLETED|Open-label Treatment Phase||0
358271|NCT00468559|869245|P2|NOT COMPLETED|Open-label Treatment Phase||0
358272|NCT00468559|869246|P1|NOT COMPLETED|Open-label Treatment Phase||18
358273|NCT00468559|869244|P3|COMPLETED|Open-label Treatment Phase||0
358274|NCT00468559|869245|P2|COMPLETED|Open-label Treatment Phase||0
358275|NCT00468559|869246|P1|COMPLETED|Open-label Treatment Phase|18 patients discontinued (were not randomized into the double-blind treatment withdrawal phase)|80
358276|NCT00468559|869244|P3|STARTED|Open-label Treatment Phase||0
358277|NCT00468559|869245|P2|STARTED|Open-label Treatment Phase||0
358278|NCT00468559|869246|P1|STARTED|Open-label Treatment Phase|All participants received open-label esomeprazole during this phase of the study|98
358279|NCT00468546|869274|P2|NOT COMPLETED|Week 24 to Week 104 Analysis||225
358280|NCT00468546|869275|P1|NOT COMPLETED|Week 24 to Week 104 Analysis||105
358281|NCT00468546|869274|P2|COMPLETED|Week 24 to Week 104 Analysis||83
358282|NCT00468546|869275|P1|COMPLETED|Week 24 to Week 104 Analysis||103
358283|NCT00468546|869274|P2|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed W24 analysis were entered in W24 to W104 analysis.|308
358284|NCT00468546|869275|P1|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed Week (W) 24 analysis were entered in W24 to W104 analysis.|208
358285|NCT00468546|869274|P2|NOT COMPLETED|Week 24 Analysis||55
358286|NCT00468546|869275|P1|NOT COMPLETED|Week 24 Analysis||97
358287|NCT00468546|869274|P2|COMPLETED|Week 24 Analysis||253
358288|NCT00468546|869275|P1|COMPLETED|Week 24 Analysis||111
358289|NCT00468546|869274|P2|STARTED|Week 24 Analysis||308
358290|NCT00468546|869275|P1|STARTED|Week 24 Analysis||208
358291|NCT00468481|869305|P2|NOT COMPLETED|Overall Study||24
358292|NCT00468481|869306|P1|NOT COMPLETED|Overall Study||88
358293|NCT00468481|869305|P2|COMPLETED|Overall Study||70
358294|NCT00468481|869306|P1|COMPLETED|Overall Study||203
358295|NCT00468481|869305|P2|Subjects Treated|Overall Study||94
358296|NCT00468481|869306|P1|Subjects Treated|Overall Study||285
358297|NCT00468481|869305|P2|STARTED|Overall Study||94
358298|NCT00468481|869306|P1|STARTED|Overall Study|6 of these randomized subjects did not take any study medication|291
358299|NCT00468312|869406|P2|NOT COMPLETED|Overall Study||5
358300|NCT00468312|869407|P1|NOT COMPLETED|Overall Study||4
358301|NCT00468312|869406|P2|COMPLETED|Overall Study||204
358302|NCT00468312|869407|P1|COMPLETED|Overall Study||216
358303|NCT00468312|869406|P2|STARTED|Overall Study||209
358304|NCT00468312|869407|P1|STARTED|Overall Study||220
358305|NCT00468299|869423|P2|NOT COMPLETED|Overall Study||1
358306|NCT00468299|869424|P1|NOT COMPLETED|Overall Study||0
358307|NCT00468299|869423|P2|COMPLETED|Overall Study||7
358308|NCT00468299|869424|P1|COMPLETED|Overall Study||9
358309|NCT00468299|869423|P2|STARTED|Overall Study||8
358310|NCT00468299|869424|P1|STARTED|Overall Study||9
358311|NCT00468286|869434|P2|NOT COMPLETED|Overall Study||12
358312|NCT00468286|869435|P1|NOT COMPLETED|Overall Study||7
358313|NCT00468286|869434|P2|COMPLETED|Overall Study||54
358314|NCT00468286|869435|P1|COMPLETED|Overall Study||60
358315|NCT00468286|869434|P2|STARTED|Overall Study||66
358316|NCT00468286|869435|P1|STARTED|Overall Study|Started=Intention to treat (ITT) population.|67
358317|NCT00468208|869457|P1|NOT COMPLETED|Overall Study||0
358318|NCT00468208|869457|P1|COMPLETED|Overall Study|All patients reached common closing or early termination|20
358319|NCT00468208|869457|P1|STARTED|Overall Study||20
358320|NCT00468169|869467|P2|NOT COMPLETED|Overall Study||0
358321|NCT00468169|869468|P1|NOT COMPLETED|Overall Study||1
358322|NCT00468169|869467|P2|COMPLETED|Overall Study||53
358323|NCT00468169|869468|P1|COMPLETED|Overall Study||56
358324|NCT00468169|869467|P2|STARTED|Overall Study||53
358325|NCT00468169|869468|P1|STARTED|Overall Study||57
358326|NCT00468143|869484|P2|NOT COMPLETED|Second Intervention (3 Weeks)||3
358327|NCT00468143|869485|P1|NOT COMPLETED|Second Intervention (3 Weeks)||3
358328|NCT00468143|869484|P2|COMPLETED|Second Intervention (3 Weeks)||24
358329|NCT00468143|869485|P1|COMPLETED|Second Intervention (3 Weeks)||25
358330|NCT00468143|869484|P2|STARTED|Second Intervention (3 Weeks)||27
358331|NCT00468143|869485|P1|STARTED|Second Intervention (3 Weeks)||28
358332|NCT00468143|869484|P2|NOT COMPLETED|First Intervention (3 Weeks)||4
358333|NCT00468143|869485|P1|NOT COMPLETED|First Intervention (3 Weeks)||3
358334|NCT00468143|869484|P2|COMPLETED|First Intervention (3 Weeks)||27
358335|NCT00468143|869485|P1|COMPLETED|First Intervention (3 Weeks)||28
358336|NCT00468143|869484|P2|STARTED|First Intervention (3 Weeks)||31
358337|NCT00468143|869485|P1|STARTED|First Intervention (3 Weeks)||31
358338|NCT00468104|869499|P2|NOT COMPLETED|Second Intervention||4
358339|NCT00468104|869500|P1|NOT COMPLETED|Second Intervention||5
358340|NCT00468104|869499|P2|COMPLETED|Second Intervention||37
358341|NCT00468104|869500|P1|COMPLETED|Second Intervention||3
358342|NCT00468104|869499|P2|STARTED|Second Intervention|4 patients responded to Placebo and did not go to the second intervention|41
358343|NCT00468104|869500|P1|STARTED|Second Intervention|37 responded to Alteplase and did not go to the second intervention|8
358344|NCT00468104|869499|P2|NOT COMPLETED|First Intervention||1
358345|NCT00468104|869500|P1|NOT COMPLETED|First Intervention||9
358346|NCT00468104|869499|P2|COMPLETED|First Intervention||45
358347|NCT00468104|869500|P1|COMPLETED|First Intervention||45
358348|NCT00468104|869499|P2|STARTED|First Intervention||46
358349|NCT00468104|869500|P1|STARTED|First Intervention||54
358350|NCT00468052|869517|P2|NOT COMPLETED|Overall Study||8
358351|NCT00468052|869518|P1|NOT COMPLETED|Overall Study||7
358352|NCT00468052|869517|P2|COMPLETED|Overall Study||61
358353|NCT00468052|869518|P1|COMPLETED|Overall Study||61
358354|NCT00468052|869517|P2|Target Enrollment|Overall Study||70
358355|NCT00468052|869518|P1|Target Enrollment|Overall Study||70
358356|NCT00468052|869517|P2|STARTED|Overall Study|One had an intraoperative complication and was withdrawn. 7 eliminated for a break in protocol.|69
358357|NCT00468052|869518|P1|STARTED|Overall Study|1 subject withdrew consent.Surgery was cancelled for 2. 4 subjects eliminated for break in protocol|68
358358|NCT00467961|869536|P1|NOT COMPLETED|Overall Study||7
358359|NCT00467961|869536|P1|COMPLETED|Overall Study||24
358360|NCT00467961|869536|P1|STARTED|Overall Study||31
358361|NCT00467896|869540|P1|NOT COMPLETED|Overall Study||51
358362|NCT00467896|869540|P1|COMPLETED|Overall Study||11
358363|NCT00467896|869540|P1|STARTED|Overall Study||62
358364|NCT00467870|869566|P6|NOT COMPLETED|Overall Study||2
358365|NCT00467870|869567|P5|NOT COMPLETED|Overall Study||37
358366|NCT00467870|869568|P4|NOT COMPLETED|Overall Study||33
358367|NCT00467870|869569|P3|NOT COMPLETED|Overall Study||4
358368|NCT00467870|869570|P2|NOT COMPLETED|Overall Study||43
358369|NCT00467870|869571|P1|NOT COMPLETED|Overall Study||45
358370|NCT00467870|869566|P6|COMPLETED|Overall Study||21
358371|NCT00467870|869567|P5|COMPLETED|Overall Study||93
358372|NCT00467870|869568|P4|COMPLETED|Overall Study||79
358373|NCT00467870|869569|P3|COMPLETED|Overall Study||18
358374|NCT00467870|869570|P2|COMPLETED|Overall Study||74
358375|NCT00467870|869571|P1|COMPLETED|Overall Study||75
358376|NCT00467870|869566|P6|STARTED|Overall Study||23
358377|NCT00467870|869567|P5|STARTED|Overall Study||130
358378|NCT00467870|869568|P4|STARTED|Overall Study||112
358379|NCT00467870|869569|P3|STARTED|Overall Study||22
358380|NCT00467870|869570|P2|STARTED|Overall Study||117
358381|NCT00467870|869571|P1|STARTED|Overall Study||120
358382|NCT00467857|869614|P2|NOT COMPLETED|Overall Study||8
358383|NCT00467857|869615|P1|NOT COMPLETED|Overall Study||3
358384|NCT00467857|869614|P2|COMPLETED|Overall Study||139
358385|NCT00467857|869615|P1|COMPLETED|Overall Study||143
358386|NCT00467857|869614|P2|STARTED|Overall Study||147
358387|NCT00467857|869615|P1|STARTED|Overall Study||146
358388|NCT00467844|869650|P3|NOT COMPLETED|Overall Study||14
358389|NCT00467844|869651|P2|NOT COMPLETED|Overall Study||20
358390|NCT00467844|869652|P1|NOT COMPLETED|Overall Study||19
358391|NCT00467844|869650|P3|COMPLETED|Overall Study||38
358392|NCT00467844|869651|P2|COMPLETED|Overall Study||34
358393|NCT00467844|869652|P1|COMPLETED|Overall Study||34
358394|NCT00467844|869650|P3|STARTED|Overall Study||52
358395|NCT00467844|869651|P2|STARTED|Overall Study||54
358396|NCT00467844|869652|P1|STARTED|Overall Study||53
358397|NCT00467831|869663|P1|NOT COMPLETED|Overall Study||3
358398|NCT00467831|869663|P1|COMPLETED|Overall Study||0
358399|NCT00467831|869663|P1|STARTED|Overall Study||3
358400|NCT00467779|869682|P15|NOT COMPLETED|Stage 3||17
358401|NCT00467779|869683|P14|NOT COMPLETED|Stage 3||0
358402|NCT00467779|869684|P13|NOT COMPLETED|Stage 3||0
358403|NCT00467779|869685|P12|NOT COMPLETED|Stage 3||0
358404|NCT00467779|869686|P11|NOT COMPLETED|Stage 3||0
358405|NCT00467779|869687|P10|NOT COMPLETED|Stage 3||0
358406|NCT00467779|869688|P9|NOT COMPLETED|Stage 3||0
358407|NCT00467779|869689|P8|NOT COMPLETED|Stage 3||0
358408|NCT00467779|869690|P7|NOT COMPLETED|Stage 3||0
358409|NCT00467779|869691|P6|NOT COMPLETED|Stage 3||0
358410|NCT00467779|869692|P5|NOT COMPLETED|Stage 3||0
358411|NCT00467779|869693|P4|NOT COMPLETED|Stage 3||0
358412|NCT00467779|869694|P3|NOT COMPLETED|Stage 3||0
358413|NCT00467779|869695|P2|NOT COMPLETED|Stage 3||0
358414|NCT00467779|869696|P1|NOT COMPLETED|Stage 3||0
358415|NCT00467779|869682|P15|COMPLETED|Stage 3||3
358416|NCT00467779|869683|P14|COMPLETED|Stage 3||0
358417|NCT00467779|869684|P13|COMPLETED|Stage 3||0
358418|NCT00467779|869685|P12|COMPLETED|Stage 3||0
358419|NCT00467779|869686|P11|COMPLETED|Stage 3||0
358420|NCT00467779|869687|P10|COMPLETED|Stage 3||0
358421|NCT00467779|869688|P9|COMPLETED|Stage 3||0
358422|NCT00467779|869689|P8|COMPLETED|Stage 3||0
358423|NCT00467779|869690|P7|COMPLETED|Stage 3||0
358424|NCT00467779|869691|P6|COMPLETED|Stage 3||0
358425|NCT00467779|869692|P5|COMPLETED|Stage 3||0
358426|NCT00467779|869693|P4|COMPLETED|Stage 3||0
358427|NCT00467779|869694|P3|COMPLETED|Stage 3||0
358428|NCT00467779|869695|P2|COMPLETED|Stage 3||0
358429|NCT00467779|869696|P1|COMPLETED|Stage 3||0
358430|NCT00467779|869682|P15|STARTED|Stage 3||20
358431|NCT00467779|869683|P14|STARTED|Stage 3||0
358432|NCT00467779|869684|P13|STARTED|Stage 3||0
358433|NCT00467779|869685|P12|STARTED|Stage 3||0
358434|NCT00467779|869686|P11|STARTED|Stage 3||0
358435|NCT00467779|869687|P10|STARTED|Stage 3||0
358436|NCT00467779|869688|P9|STARTED|Stage 3||0
358437|NCT00467779|869689|P8|STARTED|Stage 3||0
358438|NCT00467779|869690|P7|STARTED|Stage 3||0
358439|NCT00467779|869691|P6|STARTED|Stage 3||0
358440|NCT00467779|869692|P5|STARTED|Stage 3||0
358441|NCT00467779|869693|P4|STARTED|Stage 3||0
358442|NCT00467779|869694|P3|STARTED|Stage 3||0
358443|NCT00467779|869695|P2|STARTED|Stage 3||0
358444|NCT00467779|869696|P1|STARTED|Stage 3||0
358445|NCT00467779|869682|P15|NOT COMPLETED|Stage 2A||0
358446|NCT00467779|869683|P14|NOT COMPLETED|Stage 2A||21
358447|NCT00467779|869684|P13|NOT COMPLETED|Stage 2A||0
358448|NCT00467779|869685|P12|NOT COMPLETED|Stage 2A||0
358449|NCT00467779|869686|P11|NOT COMPLETED|Stage 2A||0
358450|NCT00467779|869687|P10|NOT COMPLETED|Stage 2A||0
358451|NCT00467779|869688|P9|NOT COMPLETED|Stage 2A||0
358452|NCT00467779|869689|P8|NOT COMPLETED|Stage 2A||0
358453|NCT00467779|869690|P7|NOT COMPLETED|Stage 2A||0
358454|NCT00467779|869691|P6|NOT COMPLETED|Stage 2A||0
358455|NCT00467779|869692|P5|NOT COMPLETED|Stage 2A||0
358456|NCT00467779|869693|P4|NOT COMPLETED|Stage 2A||0
358457|NCT00467779|869694|P3|NOT COMPLETED|Stage 2A||0
358458|NCT00467779|869695|P2|NOT COMPLETED|Stage 2A||0
358459|NCT00467779|869696|P1|NOT COMPLETED|Stage 2A||0
358460|NCT00467779|869682|P15|COMPLETED|Stage 2A||0
358461|NCT00467779|869683|P14|COMPLETED|Stage 2A||1
358462|NCT00467779|869684|P13|COMPLETED|Stage 2A||0
358463|NCT00467779|869685|P12|COMPLETED|Stage 2A||0
358464|NCT00467779|869686|P11|COMPLETED|Stage 2A||0
358465|NCT00467779|869687|P10|COMPLETED|Stage 2A||0
358466|NCT00467779|869688|P9|COMPLETED|Stage 2A||0
358467|NCT00467779|869689|P8|COMPLETED|Stage 2A||0
358468|NCT00467779|869690|P7|COMPLETED|Stage 2A||0
358469|NCT00467779|869691|P6|COMPLETED|Stage 2A||0
358470|NCT00467779|869692|P5|COMPLETED|Stage 2A||0
358471|NCT00467779|869693|P4|COMPLETED|Stage 2A||0
358472|NCT00467779|869694|P3|COMPLETED|Stage 2A||0
358473|NCT00467779|869695|P2|COMPLETED|Stage 2A||0
358474|NCT00467779|869696|P1|COMPLETED|Stage 2A||0
358475|NCT00467779|869682|P15|STARTED|Stage 2A||0
358476|NCT00467779|869683|P14|STARTED|Stage 2A||22
358477|NCT00467779|869684|P13|STARTED|Stage 2A||0
358478|NCT00467779|869685|P12|STARTED|Stage 2A||0
358479|NCT00467779|869686|P11|STARTED|Stage 2A||0
358480|NCT00467779|869687|P10|STARTED|Stage 2A||0
358481|NCT00467779|869688|P9|STARTED|Stage 2A||0
358482|NCT00467779|869689|P8|STARTED|Stage 2A||0
358483|NCT00467779|869690|P7|STARTED|Stage 2A||0
358484|NCT00467779|869691|P6|STARTED|Stage 2A||0
358485|NCT00467779|869692|P5|STARTED|Stage 2A||0
358486|NCT00467779|869693|P4|STARTED|Stage 2A||0
358487|NCT00467779|869694|P3|STARTED|Stage 2A||0
358488|NCT00467779|869695|P2|STARTED|Stage 2A||0
358489|NCT00467779|869696|P1|STARTED|Stage 2A||0
358490|NCT00467779|869682|P15|NOT COMPLETED|Stage 2||0
358491|NCT00467779|869683|P14|NOT COMPLETED|Stage 2||0
358492|NCT00467779|869684|P13|NOT COMPLETED|Stage 2||0
358493|NCT00467779|869685|P12|NOT COMPLETED|Stage 2||0
358494|NCT00467779|869686|P11|NOT COMPLETED|Stage 2||0
358495|NCT00467779|869687|P10|NOT COMPLETED|Stage 2||0
358496|NCT00467779|869688|P9|NOT COMPLETED|Stage 2||21
358497|NCT00467779|869689|P8|NOT COMPLETED|Stage 2||0
358498|NCT00467779|869690|P7|NOT COMPLETED|Stage 2||0
358499|NCT00467779|869691|P6|NOT COMPLETED|Stage 2||0
358500|NCT00467779|869692|P5|NOT COMPLETED|Stage 2||0
358501|NCT00467779|869693|P4|NOT COMPLETED|Stage 2||0
358502|NCT00467779|869694|P3|NOT COMPLETED|Stage 2||0
358503|NCT00467779|869695|P2|NOT COMPLETED|Stage 2||0
358504|NCT00467779|869696|P1|NOT COMPLETED|Stage 2||0
358505|NCT00467779|869682|P15|COMPLETED|Stage 2||0
358506|NCT00467779|869683|P14|COMPLETED|Stage 2||0
358507|NCT00467779|869684|P13|COMPLETED|Stage 2||0
358508|NCT00467779|869685|P12|COMPLETED|Stage 2||0
358509|NCT00467779|869686|P11|COMPLETED|Stage 2||0
358510|NCT00467779|869687|P10|COMPLETED|Stage 2||0
358511|NCT00467779|869688|P9|COMPLETED|Stage 2||0
358512|NCT00467779|869689|P8|COMPLETED|Stage 2||0
358513|NCT00467779|869690|P7|COMPLETED|Stage 2||0
358514|NCT00467779|869691|P6|COMPLETED|Stage 2||0
358515|NCT00467779|869692|P5|COMPLETED|Stage 2||0
358516|NCT00467779|869693|P4|COMPLETED|Stage 2||0
358517|NCT00467779|869694|P3|COMPLETED|Stage 2||0
358518|NCT00467779|869695|P2|COMPLETED|Stage 2||0
358519|NCT00467779|869696|P1|COMPLETED|Stage 2||0
358520|NCT00467779|869682|P15|STARTED|Stage 2||0
358521|NCT00467779|869683|P14|STARTED|Stage 2||0
358522|NCT00467779|869684|P13|STARTED|Stage 2||0
358523|NCT00467779|869685|P12|STARTED|Stage 2||0
358524|NCT00467779|869686|P11|STARTED|Stage 2||0
358525|NCT00467779|869687|P10|STARTED|Stage 2||0
358526|NCT00467779|869688|P9|STARTED|Stage 2||21
358527|NCT00467779|869689|P8|STARTED|Stage 2||0
358528|NCT00467779|869690|P7|STARTED|Stage 2||0
358529|NCT00467779|869691|P6|STARTED|Stage 2||0
358530|NCT00467779|869692|P5|STARTED|Stage 2||0
358531|NCT00467779|869693|P4|STARTED|Stage 2||0
358532|NCT00467779|869694|P3|STARTED|Stage 2||0
358533|NCT00467779|869695|P2|STARTED|Stage 2||0
358534|NCT00467779|869696|P1|STARTED|Stage 2||0
358535|NCT00467779|869682|P15|NOT COMPLETED|Stage 1A||0
358536|NCT00467779|869683|P14|NOT COMPLETED|Stage 1A||0
358537|NCT00467779|869684|P13|NOT COMPLETED|Stage 1A||6
358538|NCT00467779|869685|P12|NOT COMPLETED|Stage 1A||8
358539|NCT00467779|869686|P11|NOT COMPLETED|Stage 1A||3
358540|NCT00467779|869687|P10|NOT COMPLETED|Stage 1A||3
358541|NCT00467779|869688|P9|NOT COMPLETED|Stage 1A||0
358542|NCT00467779|869689|P8|NOT COMPLETED|Stage 1A||0
358543|NCT00467779|869690|P7|NOT COMPLETED|Stage 1A||0
358544|NCT00467779|869691|P6|NOT COMPLETED|Stage 1A||0
358545|NCT00467779|869692|P5|NOT COMPLETED|Stage 1A||0
358546|NCT00467779|869693|P4|NOT COMPLETED|Stage 1A||0
358547|NCT00467779|869694|P3|NOT COMPLETED|Stage 1A||0
358548|NCT00467779|869695|P2|NOT COMPLETED|Stage 1A||0
358549|NCT00467779|869696|P1|NOT COMPLETED|Stage 1A||0
358550|NCT00467779|869682|P15|COMPLETED|Stage 1A||0
358551|NCT00467779|869683|P14|COMPLETED|Stage 1A||0
358552|NCT00467779|869684|P13|COMPLETED|Stage 1A||0
358553|NCT00467779|869685|P12|COMPLETED|Stage 1A||0
358554|NCT00467779|869686|P11|COMPLETED|Stage 1A||0
358555|NCT00467779|869687|P10|COMPLETED|Stage 1A||0
358556|NCT00467779|869688|P9|COMPLETED|Stage 1A||0
358557|NCT00467779|869689|P8|COMPLETED|Stage 1A||0
358558|NCT00467779|869690|P7|COMPLETED|Stage 1A||0
358559|NCT00467779|869691|P6|COMPLETED|Stage 1A||0
358560|NCT00467779|869692|P5|COMPLETED|Stage 1A||0
358561|NCT00467779|869693|P4|COMPLETED|Stage 1A||0
358562|NCT00467779|869694|P3|COMPLETED|Stage 1A||0
358563|NCT00467779|869695|P2|COMPLETED|Stage 1A||0
358564|NCT00467779|869696|P1|COMPLETED|Stage 1A||0
358565|NCT00467779|869682|P15|STARTED|Stage 1A||0
358566|NCT00467779|869683|P14|STARTED|Stage 1A||0
358567|NCT00467779|869684|P13|STARTED|Stage 1A||6
358568|NCT00467779|869685|P12|STARTED|Stage 1A||8
358569|NCT00467779|869686|P11|STARTED|Stage 1A||3
358570|NCT00467779|869687|P10|STARTED|Stage 1A||3
358571|NCT00467779|869688|P9|STARTED|Stage 1A||0
358572|NCT00467779|869689|P8|STARTED|Stage 1A||0
358573|NCT00467779|869690|P7|STARTED|Stage 1A||0
358574|NCT00467779|869691|P6|STARTED|Stage 1A||0
358575|NCT00467779|869692|P5|STARTED|Stage 1A||0
358576|NCT00467779|869693|P4|STARTED|Stage 1A||0
358577|NCT00467779|869694|P3|STARTED|Stage 1A||0
358578|NCT00467779|869695|P2|STARTED|Stage 1A||0
358579|NCT00467779|869696|P1|STARTED|Stage 1A||0
358580|NCT00467779|869682|P15|NOT COMPLETED|Stage 1||0
358581|NCT00467779|869683|P14|NOT COMPLETED|Stage 1||0
358582|NCT00467779|869684|P13|NOT COMPLETED|Stage 1||0
358583|NCT00467779|869685|P12|NOT COMPLETED|Stage 1||0
358584|NCT00467779|869686|P11|NOT COMPLETED|Stage 1||0
358585|NCT00467779|869687|P10|NOT COMPLETED|Stage 1||0
358586|NCT00467779|869688|P9|NOT COMPLETED|Stage 1||0
358587|NCT00467779|869689|P8|NOT COMPLETED|Stage 1||7
358588|NCT00467779|869690|P7|NOT COMPLETED|Stage 1||7
358589|NCT00467779|869691|P6|NOT COMPLETED|Stage 1||5
358590|NCT00467779|869692|P5|NOT COMPLETED|Stage 1||3
358591|NCT00467779|869693|P4|NOT COMPLETED|Stage 1||3
358592|NCT00467779|869694|P3|NOT COMPLETED|Stage 1||3
358593|NCT00467779|869695|P2|NOT COMPLETED|Stage 1||3
358594|NCT00467779|869696|P1|NOT COMPLETED|Stage 1||4
358595|NCT00467779|869682|P15|COMPLETED|Stage 1||0
358596|NCT00467779|869683|P14|COMPLETED|Stage 1||0
358597|NCT00467779|869684|P13|COMPLETED|Stage 1||0
358598|NCT00467779|869685|P12|COMPLETED|Stage 1||0
358599|NCT00467779|869686|P11|COMPLETED|Stage 1||0
358600|NCT00467779|869687|P10|COMPLETED|Stage 1||0
358601|NCT00467779|869688|P9|COMPLETED|Stage 1||0
358602|NCT00467779|869689|P8|COMPLETED|Stage 1||0
358603|NCT00467779|869690|P7|COMPLETED|Stage 1||0
358604|NCT00467779|869691|P6|COMPLETED|Stage 1||1
358605|NCT00467779|869692|P5|COMPLETED|Stage 1||0
358606|NCT00467779|869693|P4|COMPLETED|Stage 1||0
358607|NCT00467779|869694|P3|COMPLETED|Stage 1||0
358608|NCT00467779|869695|P2|COMPLETED|Stage 1||0
358609|NCT00467779|869696|P1|COMPLETED|Stage 1||0
358610|NCT00467779|869682|P15|STARTED|Stage 1||0
358611|NCT00467779|869683|P14|STARTED|Stage 1||0
358612|NCT00467779|869684|P13|STARTED|Stage 1||0
358613|NCT00467779|869685|P12|STARTED|Stage 1||0
358614|NCT00467779|869686|P11|STARTED|Stage 1||0
358615|NCT00467779|869687|P10|STARTED|Stage 1||0
358616|NCT00467779|869688|P9|STARTED|Stage 1||0
358617|NCT00467779|869689|P8|STARTED|Stage 1||7
358618|NCT00467779|869690|P7|STARTED|Stage 1||7
358619|NCT00467779|869691|P6|STARTED|Stage 1||6
358620|NCT00467779|869692|P5|STARTED|Stage 1||3
358621|NCT00467779|869693|P4|STARTED|Stage 1||3
358622|NCT00467779|869694|P3|STARTED|Stage 1||3
358623|NCT00467779|869695|P2|STARTED|Stage 1||3
358624|NCT00467779|869696|P1|STARTED|Stage 1||4
358625|NCT00467753|869870|P2|NOT COMPLETED|Overall Study||2
358626|NCT00467753|869871|P1|NOT COMPLETED|Overall Study||3
358627|NCT00467753|869870|P2|COMPLETED|Overall Study||0
358628|NCT00467753|869871|P1|COMPLETED|Overall Study||0
358629|NCT00467753|869870|P2|STARTED|Overall Study||2
358630|NCT00467753|869871|P1|STARTED|Overall Study||3
358631|NCT00467740|869882|P5|NOT COMPLETED|Overall Study||0
358632|NCT00467740|869883|P4|NOT COMPLETED|Overall Study||1
358633|NCT00467740|869884|P3|NOT COMPLETED|Overall Study||2
358634|NCT00467740|869885|P2|NOT COMPLETED|Overall Study||3
358635|NCT00467740|869886|P1|NOT COMPLETED|Overall Study||1
358636|NCT00467740|869882|P5|COMPLETED|Overall Study||61
358637|NCT00467740|869883|P4|COMPLETED|Overall Study||59
358638|NCT00467740|869884|P3|COMPLETED|Overall Study||58
358639|NCT00467740|869885|P2|COMPLETED|Overall Study||58
358640|NCT00467740|869886|P1|COMPLETED|Overall Study||53
358641|NCT00467740|869882|P5|STARTED|Overall Study||61
358642|NCT00467740|869883|P4|STARTED|Overall Study||60
358643|NCT00467740|869884|P3|STARTED|Overall Study||60
358644|NCT00467740|869885|P2|STARTED|Overall Study||61
358645|NCT00467740|869886|P1|STARTED|Overall Study||54
358646|NCT00467649|870075|P6|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||1
358647|NCT00467649|870076|P5|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
358648|NCT00467649|870077|P4|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||2
358649|NCT00467649|870078|P3|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
358650|NCT00467649|870079|P2|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
358651|NCT00467649|870080|P1|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
358652|NCT00467649|870075|P6|COMPLETED|Phase 2 (Intent-to-Treat Population)||35
358653|NCT00467649|870076|P5|COMPLETED|Phase 2 (Intent-to-Treat Population)||14
358654|NCT00467649|870077|P4|COMPLETED|Phase 2 (Intent-to-Treat Population)||29
358655|NCT00467649|870078|P3|COMPLETED|Phase 2 (Intent-to-Treat Population)||17
358656|NCT00467649|870079|P2|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
358657|NCT00467649|870080|P1|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
358658|NCT00467649|870075|P6|STARTED|Phase 2 (Intent-to-Treat Population)||36
358659|NCT00467649|870076|P5|STARTED|Phase 2 (Intent-to-Treat Population)||14
358660|NCT00467649|870077|P4|STARTED|Phase 2 (Intent-to-Treat Population)||31
358661|NCT00467649|870078|P3|STARTED|Phase 2 (Intent-to-Treat Population)||17
358662|NCT00467649|870079|P2|STARTED|Phase 2 (Intent-to-Treat Population)||0
358663|NCT00467649|870080|P1|STARTED|Phase 2 (Intent-to-Treat Population)||0
358664|NCT00467649|870075|P6|NOT COMPLETED|Phase 1 (Randomized Population)||0
358665|NCT00467649|870076|P5|NOT COMPLETED|Phase 1 (Randomized Population)||0
358666|NCT00467649|870077|P4|NOT COMPLETED|Phase 1 (Randomized Population)||0
358667|NCT00467649|870078|P3|NOT COMPLETED|Phase 1 (Randomized Population)||0
358668|NCT00467649|870079|P2|NOT COMPLETED|Phase 1 (Randomized Population)||6
358669|NCT00467649|870080|P1|NOT COMPLETED|Phase 1 (Randomized Population)||9
358670|NCT00467649|870075|P6|COMPLETED|Phase 1 (Randomized Population)||0
358671|NCT00467649|870076|P5|COMPLETED|Phase 1 (Randomized Population)||0
358672|NCT00467649|870077|P4|COMPLETED|Phase 1 (Randomized Population)||0
358673|NCT00467649|870078|P3|COMPLETED|Phase 1 (Randomized Population)||0
358674|NCT00467649|870079|P2|COMPLETED|Phase 1 (Randomized Population)||50
358675|NCT00467649|870080|P1|COMPLETED|Phase 1 (Randomized Population)||48
358676|NCT00467649|870075|P6|Intent to Treat|Phase 1 (Randomized Population)||0
358677|NCT00467649|870076|P5|Intent to Treat|Phase 1 (Randomized Population)||0
358678|NCT00467649|870077|P4|Intent to Treat|Phase 1 (Randomized Population)||0
358679|NCT00467649|870078|P3|Intent to Treat|Phase 1 (Randomized Population)||0
358680|NCT00467649|870079|P2|Intent to Treat|Phase 1 (Randomized Population)||56
358681|NCT00467649|870080|P1|Intent to Treat|Phase 1 (Randomized Population)||56
358682|NCT00467649|870075|P6|STARTED|Phase 1 (Randomized Population)||0
358683|NCT00467649|870076|P5|STARTED|Phase 1 (Randomized Population)||0
358684|NCT00467649|870077|P4|STARTED|Phase 1 (Randomized Population)||0
358685|NCT00467649|870078|P3|STARTED|Phase 1 (Randomized Population)||0
358686|NCT00467649|870079|P2|STARTED|Phase 1 (Randomized Population)||56
358687|NCT00467649|870080|P1|STARTED|Phase 1 (Randomized Population)|One patient randomized to the SYMLIN group withdrew consent prior to receiving the first dose|57
358688|NCT00467610|870120|P1|NOT COMPLETED|Overall Study||1
358689|NCT00467610|870120|P1|COMPLETED|Overall Study||5
358690|NCT00467610|870120|P1|STARTED|Overall Study||6
358691|NCT00467597|870131|P2|NOT COMPLETED|Overall Study||0
358692|NCT00467597|870132|P1|NOT COMPLETED|Overall Study||2
358693|NCT00467597|870131|P2|COMPLETED|Overall Study||6
358694|NCT00467597|870132|P1|COMPLETED|Overall Study||24
358695|NCT00467597|870131|P2|STARTED|Overall Study||6
358696|NCT00467597|870132|P1|STARTED|Overall Study||26
358697|NCT00467584|870145|P3|NOT COMPLETED|Overall Study||1
358698|NCT00467584|870146|P2|NOT COMPLETED|Overall Study||5
358699|NCT00467584|870147|P1|NOT COMPLETED|Overall Study||4
358700|NCT00467584|870145|P3|COMPLETED|Overall Study||20
358701|NCT00467584|870146|P2|COMPLETED|Overall Study||15
358702|NCT00467584|870147|P1|COMPLETED|Overall Study||17
358703|NCT00467584|870145|P3|STARTED|Overall Study||21
358704|NCT00467584|870146|P2|STARTED|Overall Study||20
358705|NCT00467584|870147|P1|STARTED|Overall Study||21
358706|NCT00467558|870157|P2|NOT COMPLETED|Overall Study||0
358707|NCT00467558|870158|P1|NOT COMPLETED|Overall Study||2
358708|NCT00467558|870157|P2|COMPLETED|Overall Study||3
358709|NCT00467558|870158|P1|COMPLETED|Overall Study||2
358710|NCT00467558|870157|P2|STARTED|Overall Study||3
358711|NCT00467558|870158|P1|STARTED|Overall Study||4
358712|NCT00467519|870168|P2|NOT COMPLETED|Overall Study||23
358713|NCT00467519|870169|P1|NOT COMPLETED|Overall Study||14
358714|NCT00467519|870168|P2|COMPLETED|Overall Study||488
358715|NCT00467519|870169|P1|COMPLETED|Overall Study||517
358716|NCT00467519|870168|P2|STARTED|Overall Study||511
358717|NCT00467519|870169|P1|STARTED|Overall Study||531
358718|NCT00467389|870185|P2|NOT COMPLETED|Overall Study||0
358719|NCT00467389|870186|P1|NOT COMPLETED|Overall Study||0
358720|NCT00467389|870185|P2|COMPLETED|Overall Study||6
358721|NCT00467389|870186|P1|COMPLETED|Overall Study||6
358722|NCT00467389|870185|P2|STARTED|Overall Study||6
358723|NCT00467389|870186|P1|STARTED|Overall Study||6
358724|NCT00467363|870198|P2|NOT COMPLETED|Overall Study||70
358725|NCT00467363|870199|P1|NOT COMPLETED|Overall Study||80
358726|NCT00467363|870198|P2|COMPLETED|Overall Study||543
358727|NCT00467363|870199|P1|COMPLETED|Overall Study||535
358728|NCT00467363|870198|P2|STARTED|Overall Study||613
358729|NCT00467363|870199|P1|STARTED|Overall Study||615
358730|NCT00467298|870235|P2|NOT COMPLETED|Overall Study||6
358731|NCT00467298|870236|P1|NOT COMPLETED|Overall Study||4
358732|NCT00467298|870235|P2|COMPLETED|Overall Study||38
358733|NCT00467298|870236|P1|COMPLETED|Overall Study||42
358734|NCT00467298|870235|P2|STARTED|Overall Study||44
358735|NCT00467298|870236|P1|STARTED|Overall Study||46
358736|NCT00467285|870246|P2|NOT COMPLETED|Overall Study||4
358737|NCT00467285|870247|P1|NOT COMPLETED|Overall Study||4
358738|NCT00467285|870246|P2|COMPLETED|Overall Study||60
358739|NCT00467285|870247|P1|COMPLETED|Overall Study||28
358740|NCT00467285|870246|P2|STARTED|Overall Study||64
358741|NCT00467285|870247|P1|STARTED|Overall Study||32
358742|NCT00467259|870267|P2|NOT COMPLETED|Overall Study||242
358743|NCT00467259|870268|P1|NOT COMPLETED|Overall Study||75
358744|NCT00467259|870267|P2|COMPLETED|Overall Study||778
358745|NCT00467259|870268|P1|COMPLETED|Overall Study||176
358746|NCT00467259|870267|P2|ITT Population|Overall Study|One subject did not take any study medication and was excluded from ITT population.|1019
358747|NCT00467259|870268|P1|ITT Population|Overall Study||251
358748|NCT00467259|870267|P2|STARTED|Overall Study||1020
358749|NCT00467259|870268|P1|STARTED|Overall Study||251
358750|NCT00467077|870278|P1|NOT COMPLETED|Overall Study||0
358751|NCT00467077|870278|P1|COMPLETED|Overall Study||21
358752|NCT00467077|870278|P1|STARTED|Overall Study||21
358753|NCT00467051|870285|P1|NOT COMPLETED|Overall Study||2
358754|NCT00467051|870285|P1|COMPLETED|Overall Study||18
358755|NCT00467051|870285|P1|STARTED|Overall Study||20
358756|NCT00467038|870292|P2|NOT COMPLETED|Overall Study||0
358757|NCT00467038|870293|P1|NOT COMPLETED|Overall Study||0
358758|NCT00467038|870292|P2|COMPLETED|Overall Study||11
358759|NCT00467038|870293|P1|COMPLETED|Overall Study||11
358760|NCT00467038|870292|P2|STARTED|Overall Study||11
358761|NCT00467038|870293|P1|STARTED|Overall Study||11
358762|NCT00466960|870301|P1|NOT COMPLETED|Overall Study||0
358763|NCT00466960|870301|P1|COMPLETED|Overall Study||21
358764|NCT00466960|870301|P1|STARTED|Overall Study||21
358765|NCT00466947|870312|P2|NOT COMPLETED|Study End Analysis Period||2534
358766|NCT00466947|870313|P1|NOT COMPLETED|Study End Analysis Period||2496
358767|NCT00466947|870312|P2|COMPLETED|Study End Analysis Period||9265
358768|NCT00466947|870313|P1|COMPLETED|Study End Analysis Period||9302
358769|NCT00466947|870312|P2|STARTED|Study End Analysis Period||11799
358770|NCT00466947|870313|P1|STARTED|Study End Analysis Period||11798
358771|NCT00466947|870312|P2|NOT COMPLETED|Primary Outcome Analysis Period||11863
358772|NCT00466947|870313|P1|NOT COMPLETED|Primary Outcome Analysis Period||11875
358773|NCT00466947|870312|P2|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
358774|NCT00466947|870313|P1|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
358775|NCT00466947|870312|P2|Ongoing|Primary Outcome Analysis Period||11863
358776|NCT00466947|870313|P1|Ongoing|Primary Outcome Analysis Period||11875
358777|NCT00466947|870312|P2|STARTED|Primary Outcome Analysis Period||11863
358778|NCT00466947|870313|P1|STARTED|Primary Outcome Analysis Period||11875
358779|NCT00466817|870437|P2|NOT COMPLETED|Overall Study||4
358780|NCT00466817|870438|P1|NOT COMPLETED|Overall Study||5
358781|NCT00466817|870437|P2|COMPLETED|Overall Study||43
358782|NCT00466817|870438|P1|COMPLETED|Overall Study||44
358783|NCT00466817|870437|P2|STARTED|Overall Study||47
358784|NCT00466817|870438|P1|STARTED|Overall Study||49
358785|NCT00466752|870493|P2|NOT COMPLETED|Overall Study||0
358786|NCT00466752|870494|P1|NOT COMPLETED|Overall Study||0
358787|NCT00466752|870493|P2|COMPLETED|Overall Study||0
358788|NCT00466752|870494|P1|COMPLETED|Overall Study||5
358789|NCT00466752|870493|P2|STARTED|Overall Study||0
358790|NCT00466752|870494|P1|STARTED|Overall Study||5
358791|NCT00466726|870504|P1|NOT COMPLETED|Overall Study||14
358792|NCT00466726|870504|P1|COMPLETED|Overall Study||43
358793|NCT00466726|870504|P1|STARTED|Overall Study||57
358794|NCT00466687|870510|P1|NOT COMPLETED|Overall Study||34
358795|NCT00466687|870510|P1|COMPLETED|Overall Study||0
358796|NCT00466687|870510|P1|STARTED|Overall Study||34
358797|NCT00466661|870519|P2|NOT COMPLETED|Overall Study||6
358798|NCT00466661|870520|P1|NOT COMPLETED|Overall Study||4
358799|NCT00466661|870519|P2|COMPLETED|Overall Study||11
358800|NCT00466661|870520|P1|COMPLETED|Overall Study||12
358801|NCT00466661|870519|P2|At Least 1 Postrandomization Visit|Overall Study||16
358802|NCT00466661|870520|P1|At Least 1 Postrandomization Visit|Overall Study||14
358803|NCT00466661|870519|P2|STARTED|Overall Study||17
358804|NCT00466661|870520|P1|STARTED|Overall Study||16
358805|NCT00466505|870542|P1|NOT COMPLETED|Overall Study||17
358806|NCT00466505|870542|P1|COMPLETED|Overall Study||0
358807|NCT00466505|870542|P1|STARTED|Overall Study||17
358808|NCT00466323|870556|P2|NOT COMPLETED|Overall Study||23
358809|NCT00466323|870557|P1|NOT COMPLETED|Overall Study||28
358810|NCT00466323|870556|P2|COMPLETED|Overall Study||92
358811|NCT00466323|870557|P1|COMPLETED|Overall Study||89
358812|NCT00466323|870556|P2|STARTED|Overall Study||115
358813|NCT00466323|870557|P1|STARTED|Overall Study||117
358814|NCT00466310|870572|P3|NOT COMPLETED|Overall Study||0
358815|NCT00466310|870573|P2|NOT COMPLETED|Overall Study||0
358816|NCT00466310|870574|P1|NOT COMPLETED|Overall Study||0
358817|NCT00466310|870572|P3|COMPLETED|Overall Study||31
358818|NCT00466310|870573|P2|COMPLETED|Overall Study||20
358819|NCT00466310|870574|P1|COMPLETED|Overall Study||20
358820|NCT00466310|870572|P3|STARTED|Overall Study||31
358821|NCT00466310|870573|P2|STARTED|Overall Study||20
358822|NCT00466310|870574|P1|STARTED|Overall Study||20
358823|NCT00466206|870582|P1|NOT COMPLETED|Overall Study||0
358824|NCT00466206|870582|P1|COMPLETED|Overall Study|One of 10 patients withdrawn from study but completed treatment under Compassionate Use Designation|10
358825|NCT00466206|870582|P1|STARTED|Overall Study||10
358826|NCT00466193|870592|P2|NOT COMPLETED|Overall Study||8
358827|NCT00466193|870593|P1|NOT COMPLETED|Overall Study||12
358828|NCT00466193|870592|P2|COMPLETED|Overall Study|One patient did not report at least one Latency Sleep Onset following middle-of-the-night awakening.|137
358829|NCT00466193|870593|P1|COMPLETED|Overall Study||138
358830|NCT00466193|870592|P2|STARTED|Overall Study||145
358831|NCT00466193|870593|P1|STARTED|Overall Study||150
358832|NCT00466167|870620|P3|NOT COMPLETED|Overall Study||21
358833|NCT00466167|870621|P2|NOT COMPLETED|Overall Study||12
358834|NCT00466167|870622|P1|NOT COMPLETED|Overall Study||20
358835|NCT00466167|870620|P3|COMPLETED|Overall Study||157
358836|NCT00466167|870621|P2|COMPLETED|Overall Study||163
358837|NCT00466167|870622|P1|COMPLETED|Overall Study||145
358838|NCT00466167|870620|P3|STARTED|Overall Study||178
358839|NCT00466167|870621|P2|STARTED|Overall Study||175
358840|NCT00466167|870622|P1|STARTED|Overall Study||165
358841|NCT00465998|870678|P1|NOT COMPLETED|Overall Study||0
358842|NCT00465998|870678|P1|COMPLETED|Overall Study||275
358843|NCT00465998|870678|P1|STARTED|Overall Study||275
358844|NCT00465985|870683|P2|NOT COMPLETED|Part III - Open-label Treatment Period||0
358845|NCT00465985|870684|P1|NOT COMPLETED|Part III - Open-label Treatment Period||2
358846|NCT00465985|870683|P2|COMPLETED|Part III - Open-label Treatment Period||0
358847|NCT00465985|870684|P1|COMPLETED|Part III - Open-label Treatment Period||29
358848|NCT00465985|870683|P2|STARTED|Part III - Open-label Treatment Period||0
358849|NCT00465985|870684|P1|STARTED|Part III - Open-label Treatment Period|All patients received treatment with ACZ885 in Part III of the study.|31
358850|NCT00465985|870683|P2|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||12
358851|NCT00465985|870684|P1|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||0
358852|NCT00465985|870683|P2|COMPLETED|Part II - 1:1 ACZ885:Placebo||4
358853|NCT00465985|870684|P1|COMPLETED|Part II - 1:1 ACZ885:Placebo||15
358854|NCT00465985|870683|P2|STARTED|Part II - 1:1 ACZ885:Placebo||16
358855|NCT00465985|870684|P1|STARTED|Part II - 1:1 ACZ885:Placebo|Patients with complete response to treatment entered Part II and were randomized to ACZ885 ,placebo.|15
358856|NCT00465985|870683|P2|NOT COMPLETED|Part I - Open-label Treatment Period||0
358857|NCT00465985|870684|P1|NOT COMPLETED|Part I - Open-label Treatment Period||4
358858|NCT00465985|870683|P2|COMPLETED|Part I - Open-label Treatment Period||0
358859|NCT00465985|870684|P1|COMPLETED|Part I - Open-label Treatment Period|Only patients with a complete response completed Part I and entered Part II of the study.|31
358860|NCT00465985|870683|P2|STARTED|Part I - Open-label Treatment Period||0
358861|NCT00465985|870684|P1|STARTED|Part I - Open-label Treatment Period|All patients received treatment with ACZ885 in Part I of the study.|35
358862|NCT00465972|870707|P2|NOT COMPLETED|Overall Study||1
358863|NCT00465972|870708|P1|NOT COMPLETED|Overall Study||2
358864|NCT00465972|870707|P2|COMPLETED|Overall Study||23
358865|NCT00465972|870708|P1|COMPLETED|Overall Study||18
358866|NCT00465972|870707|P2|STARTED|Overall Study||24
358867|NCT00465972|870708|P1|STARTED|Overall Study||20
358868|NCT00465894|870718|P2|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0
358869|NCT00465894|870719|P1|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0
358870|NCT00465894|870718|P2|COMPLETED|Treatment From 24 Weeks to 52 Weeks||14
358871|NCT00465894|870719|P1|COMPLETED|Treatment From 24 Weeks to 52 Weeks||11
358872|NCT00465894|870718|P2|STARTED|Treatment From 24 Weeks to 52 Weeks||14
358873|NCT00465894|870719|P1|STARTED|Treatment From 24 Weeks to 52 Weeks|We included data only from participants that had complete data sets.|11
358874|NCT00465894|870718|P2|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0
358875|NCT00465894|870719|P1|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0
358876|NCT00465894|870718|P2|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14
358877|NCT00465894|870719|P1|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14
358878|NCT00465894|870718|P2|STARTED|Treatment From 12 Weeks To 24 Weeks|We included data only from participants that had complete data sets.|14
358879|NCT00465894|870719|P1|STARTED|Treatment From 12 Weeks To 24 Weeks|We included data only from participants that had complete data sets.|14
358880|NCT00465894|870718|P2|NOT COMPLETED|Treatment For 12 Weeks||3
358881|NCT00465894|870719|P1|NOT COMPLETED|Treatment For 12 Weeks||5
358882|NCT00465894|870718|P2|COMPLETED|Treatment For 12 Weeks||25
358883|NCT00465894|870719|P1|COMPLETED|Treatment For 12 Weeks||25
358884|NCT00465894|870718|P2|STARTED|Treatment For 12 Weeks||28
358885|NCT00465894|870719|P1|STARTED|Treatment For 12 Weeks||30
358886|NCT00465816|870752|P3|NOT COMPLETED|Overall Study||2
358887|NCT00465816|870753|P2|NOT COMPLETED|Overall Study||0
358888|NCT00465816|870754|P1|NOT COMPLETED|Overall Study||0
358889|NCT00465816|870752|P3|COMPLETED|Overall Study||120
358890|NCT00465816|870753|P2|COMPLETED|Overall Study||122
358891|NCT00465816|870754|P1|COMPLETED|Overall Study||367
358892|NCT00465816|870752|P3|STARTED|Overall Study||122
358893|NCT00465816|870753|P2|STARTED|Overall Study||122
358894|NCT00465816|870754|P1|STARTED|Overall Study||367
358895|NCT00465738|870817|P2|NOT COMPLETED|Overall Study||6
358896|NCT00465738|870818|P1|NOT COMPLETED|Overall Study||6
358897|NCT00465738|870817|P2|COMPLETED|Overall Study||89
358898|NCT00465738|870818|P1|COMPLETED|Overall Study||91
358899|NCT00465738|870817|P2|STARTED|Overall Study||95
358900|NCT00465738|870818|P1|STARTED|Overall Study||97
358901|NCT00465647|870912|P4|NOT COMPLETED|Overall Study||13
358902|NCT00465647|870913|P3|NOT COMPLETED|Overall Study||11
358903|NCT00465647|870914|P2|NOT COMPLETED|Overall Study||8
358904|NCT00465647|870915|P1|NOT COMPLETED|Overall Study||13
358905|NCT00465647|870912|P4|COMPLETED|Overall Study||12
358906|NCT00465647|870913|P3|COMPLETED|Overall Study||18
358907|NCT00465647|870914|P2|COMPLETED|Overall Study||15
358908|NCT00465647|870915|P1|COMPLETED|Overall Study||26
358909|NCT00465647|870912|P4|STARTED|Overall Study||25
358910|NCT00465647|870913|P3|STARTED|Overall Study||29
358911|NCT00465647|870914|P2|STARTED|Overall Study||23
358912|NCT00465647|870915|P1|STARTED|Overall Study||39
358913|NCT00465595|870940|P2|NOT COMPLETED|Overall Study||5
358914|NCT00465595|870941|P1|NOT COMPLETED|Overall Study||5
358915|NCT00465595|870940|P2|COMPLETED|Overall Study||24
358916|NCT00465595|870941|P1|COMPLETED|Overall Study||22
358917|NCT00465595|870940|P2|STARTED|Overall Study||29
358918|NCT00465595|870941|P1|STARTED|Overall Study||27
358919|NCT00465569|870963|P2|NOT COMPLETED|Overall Study||0
358920|NCT00465569|870964|P1|NOT COMPLETED|Overall Study||1
358921|NCT00465569|870963|P2|COMPLETED|Overall Study||7
358922|NCT00465569|870964|P1|COMPLETED|Overall Study||12
358923|NCT00465569|870963|P2|STARTED|Overall Study||7
358924|NCT00465569|870964|P1|STARTED|Overall Study||13
358925|NCT00465530|870976|P2|NOT COMPLETED|Overall Study||4
358926|NCT00465530|870977|P1|NOT COMPLETED|Overall Study||2
358927|NCT00465530|870976|P2|COMPLETED|Overall Study||15
358928|NCT00465530|870977|P1|COMPLETED|Overall Study||19
358929|NCT00465530|870976|P2|STARTED|Overall Study||19
358930|NCT00465530|870977|P1|STARTED|Overall Study||21
358931|NCT00465361|870987|P1|NOT COMPLETED|Post-Intervention Assessment||0
358932|NCT00465361|870987|P1|COMPLETED|Post-Intervention Assessment||3
358933|NCT00465361|870987|P1|STARTED|Post-Intervention Assessment||3
358934|NCT00465361|870987|P1|NOT COMPLETED|Baseline Assessment||4
358935|NCT00465361|870987|P1|COMPLETED|Baseline Assessment||3
358936|NCT00465361|870987|P1|STARTED|Baseline Assessment||7
358937|NCT00465270|870993|P2|NOT COMPLETED|Overall Study||160
358938|NCT00465270|870994|P1|NOT COMPLETED|Overall Study||104
358939|NCT00465270|870993|P2|COMPLETED|Overall Study||321
358940|NCT00465270|870994|P1|COMPLETED|Overall Study||395
358941|NCT00465270|870993|P2|STARTED|Overall Study||481
358942|NCT00465270|870994|P1|STARTED|Overall Study||499
358943|NCT00465179|871003|P1|NOT COMPLETED|Overall Study||53
358944|NCT00465179|871003|P1|COMPLETED|Overall Study||4
358945|NCT00465179|871003|P1|STARTED|Overall Study||57
358946|NCT00465101|871009|P1|NOT COMPLETED|Overall Study||59
358947|NCT00465101|871009|P1|COMPLETED|Overall Study||91
358948|NCT00465101|871009|P1|STARTED|Overall Study||150
358949|NCT00465088|871044|P2|NOT COMPLETED|Overall Study||9
358950|NCT00465088|871045|P1|NOT COMPLETED|Overall Study||32
358951|NCT00465088|871044|P2|COMPLETED|Overall Study||70
358952|NCT00465088|871045|P1|COMPLETED|Overall Study||82
358953|NCT00465088|871044|P2|STARTED|Overall Study||79
358954|NCT00465088|871045|P1|STARTED|Overall Study|For both arms, started means treated.|114
358955|NCT00464945|871079|P2|NOT COMPLETED|Toddler Dose||1
358956|NCT00464945|871080|P1|NOT COMPLETED|Toddler Dose||0
358957|NCT00464945|871079|P2|COMPLETED|Toddler Dose||130
358958|NCT00464945|871080|P1|COMPLETED|Toddler Dose||131
358959|NCT00464945|871079|P2|STARTED|Toddler Dose||131
358960|NCT00464945|871080|P1|STARTED|Toddler Dose||131
358961|NCT00464945|871079|P2|NOT COMPLETED|After Infant Series||2
358962|NCT00464945|871080|P1|NOT COMPLETED|After Infant Series||0
358963|NCT00464945|871079|P2|COMPLETED|After Infant Series||131
358964|NCT00464945|871080|P1|COMPLETED|After Infant Series||131
358965|NCT00464945|871079|P2|STARTED|After Infant Series||133
358966|NCT00464945|871080|P1|STARTED|After Infant Series||131
358967|NCT00464945|871079|P2|NOT COMPLETED|Infant Series||1
358968|NCT00464945|871080|P1|NOT COMPLETED|Infant Series||4
358969|NCT00464945|871079|P2|COMPLETED|Infant Series||133
358970|NCT00464945|871080|P1|COMPLETED|Infant Series||131
358971|NCT00464945|871079|P2|Vaccinated Dose 3|Infant Series||133
358972|NCT00464945|871080|P1|Vaccinated Dose 3|Infant Series||132
358973|NCT00464945|871079|P2|Vaccinated Dose 2|Infant Series||133
358974|NCT00464945|871080|P1|Vaccinated Dose 2|Infant Series||132
358975|NCT00464945|871079|P2|Vaccinated Dose 1|Infant Series||134
358976|NCT00464945|871080|P1|Vaccinated Dose 1|Infant Series||134
358977|NCT00464945|871079|P2|STARTED|Infant Series||134
358978|NCT00464945|871080|P1|STARTED|Infant Series||135
358979|NCT00464815|871110|P2|NOT COMPLETED|Overall Study||3
358980|NCT00464815|871111|P1|NOT COMPLETED|Overall Study||6
358981|NCT00464815|871110|P2|COMPLETED|Overall Study||254
358982|NCT00464815|871111|P1|COMPLETED|Overall Study||762
358983|NCT00464815|871110|P2|STARTED|Overall Study||257
358984|NCT00464815|871111|P1|STARTED|Overall Study||768
358985|NCT00464737|871144|P3|NOT COMPLETED|Overall Study||55
358986|NCT00464737|871145|P2|NOT COMPLETED|Overall Study||32
358987|NCT00464737|871146|P1|NOT COMPLETED|Overall Study||32
358988|NCT00464737|871144|P3|COMPLETED|Overall Study||19
358989|NCT00464737|871145|P2|COMPLETED|Overall Study||42
358990|NCT00464737|871146|P1|COMPLETED|Overall Study||50
358991|NCT00464737|871144|P3|STARTED|Overall Study||74
358992|NCT00464737|871145|P2|STARTED|Overall Study||74
358993|NCT00464737|871146|P1|STARTED|Overall Study||82
358994|NCT00464711|871193|P1|NOT COMPLETED|Overall Study||15
358995|NCT00464711|871193|P1|COMPLETED|Overall Study||25
358996|NCT00464711|871193|P1|STARTED|Overall Study||40
358997|NCT00464698|871197|P1|NOT COMPLETED|Period 3: 120mg||2
358998|NCT00464698|871197|P1|COMPLETED|Period 3: 120mg||12
358999|NCT00464698|871197|P1|STARTED|Period 3: 120mg||14
359000|NCT00464698|871197|P1|NOT COMPLETED|Period 2: 60 mg||0
359001|NCT00464698|871197|P1|COMPLETED|Period 2: 60 mg||17
359002|NCT00464698|871197|P1|STARTED|Period 2: 60 mg||17
359003|NCT00464698|871197|P1|NOT COMPLETED|Period 1: 30 mg||3
359004|NCT00464698|871197|P1|COMPLETED|Period 1: 30 mg||17
359005|NCT00464698|871197|P1|STARTED|Period 1: 30 mg||20
359006|NCT00464685|871209|P2|NOT COMPLETED|Overall Study||33
359007|NCT00464685|871210|P1|NOT COMPLETED|Overall Study||23
359008|NCT00464685|871209|P2|COMPLETED|Overall Study||94
359009|NCT00464685|871210|P1|COMPLETED|Overall Study||103
359010|NCT00464685|871209|P2|STARTED|Overall Study||127
359011|NCT00464685|871210|P1|STARTED|Overall Study||126
359012|NCT00464672|871226|P6|NOT COMPLETED|Overall Study||4
359013|NCT00464672|871227|P5|NOT COMPLETED|Overall Study||10
359014|NCT00464672|871228|P4|NOT COMPLETED|Overall Study||1
359015|NCT00464672|871229|P3|NOT COMPLETED|Overall Study||0
359016|NCT00464672|871230|P2|NOT COMPLETED|Overall Study||10
359017|NCT00464672|871231|P1|NOT COMPLETED|Overall Study||25
359018|NCT00464672|871226|P6|COMPLETED|Overall Study||195
359019|NCT00464672|871227|P5|COMPLETED|Overall Study||392
359020|NCT00464672|871228|P4|COMPLETED|Overall Study||199
359021|NCT00464672|871229|P3|COMPLETED|Overall Study||400
359022|NCT00464672|871230|P2|COMPLETED|Overall Study||222
359023|NCT00464672|871231|P1|COMPLETED|Overall Study||435
359024|NCT00464672|871226|P6|STARTED|Overall Study||199
359025|NCT00464672|871227|P5|STARTED|Overall Study||402
359026|NCT00464672|871228|P4|STARTED|Overall Study||200
359027|NCT00464672|871229|P3|STARTED|Overall Study||400
359028|NCT00464672|871230|P2|STARTED|Overall Study||232
359029|NCT00464672|871231|P1|STARTED|Overall Study||460
359030|NCT00464646|871303|P2|NOT COMPLETED|Overall Study||0
359031|NCT00464646|871304|P1|NOT COMPLETED|Overall Study||0
359032|NCT00464646|871303|P2|COMPLETED|Overall Study||29
359033|NCT00464646|871304|P1|COMPLETED|Overall Study||76
359034|NCT00464646|871303|P2|STARTED|Overall Study||29
359035|NCT00464646|871304|P1|STARTED|Overall Study||76
359036|NCT00464620|871310|P3|NOT COMPLETED|Overall Study||7
359037|NCT00464620|871311|P2|NOT COMPLETED|Overall Study||2
359038|NCT00464620|871312|P1|NOT COMPLETED|Overall Study||2
359039|NCT00464620|871310|P3|COMPLETED|Overall Study||109
359040|NCT00464620|871311|P2|COMPLETED|Overall Study||198
359041|NCT00464620|871312|P1|COMPLETED|Overall Study|48 patients were evaluable.|48
359042|NCT00464620|871310|P3|STARTED|Overall Study||116
359043|NCT00464620|871311|P2|STARTED|Overall Study||200
359044|NCT00464620|871312|P1|STARTED|Overall Study||50
359045|NCT00464568|871339|P1|NOT COMPLETED|Overall Study||2
359046|NCT00464568|871339|P1|COMPLETED|Overall Study||30
359047|NCT00464568|871339|P1|STARTED|Overall Study||32
359048|NCT00464542|871412|P1|NOT COMPLETED|Post-treatment||0
359049|NCT00464542|871412|P1|COMPLETED|Post-treatment||10
359050|NCT00464542|871412|P1|STARTED|Post-treatment||10
359051|NCT00464542|871412|P1|NOT COMPLETED|Pre-treatment||2
359052|NCT00464542|871412|P1|COMPLETED|Pre-treatment||10
359053|NCT00464542|871412|P1|STARTED|Pre-treatment||12
359054|NCT00464490|871419|P2|NOT COMPLETED|Overall Study||11
359055|NCT00464490|871420|P1|NOT COMPLETED|Overall Study||11
359056|NCT00464490|871419|P2|COMPLETED|Overall Study||10
359057|NCT00464490|871420|P1|COMPLETED|Overall Study||10
359058|NCT00464490|871419|P2|STARTED|Overall Study||21
359059|NCT00464490|871420|P1|STARTED|Overall Study||21
359060|NCT00464464|871428|P2|NOT COMPLETED|Overall Study||3
359061|NCT00464464|871429|P1|NOT COMPLETED|Overall Study||5
359062|NCT00464464|871428|P2|COMPLETED|Overall Study||36
359063|NCT00464464|871429|P1|COMPLETED|Overall Study||36
359064|NCT00464464|871428|P2|STARTED|Overall Study||39
359065|NCT00464464|871429|P1|STARTED|Overall Study||41
359066|NCT00464438|871443|P2|NOT COMPLETED|Overall Study||6
359067|NCT00464438|871444|P1|NOT COMPLETED|Overall Study||2
359068|NCT00464438|871443|P2|COMPLETED|Overall Study||80
359069|NCT00464438|871444|P1|COMPLETED|Overall Study||83
359070|NCT00464438|871443|P2|STARTED|Overall Study||86
359071|NCT00464438|871444|P1|STARTED|Overall Study||85
359072|NCT00464334|871467|P11|NOT COMPLETED|Overall Study||4
359073|NCT00464334|871468|P10|NOT COMPLETED|Overall Study||1
359074|NCT00464334|871469|P9|NOT COMPLETED|Overall Study||6
359075|NCT00464334|871470|P8|NOT COMPLETED|Overall Study||1
359076|NCT00464334|871471|P7|NOT COMPLETED|Overall Study||3
359077|NCT00464334|871472|P6|NOT COMPLETED|Overall Study||4
359078|NCT00464334|871473|P5|NOT COMPLETED|Overall Study||4
359079|NCT00464334|871474|P4|NOT COMPLETED|Overall Study||4
359080|NCT00464334|871475|P3|NOT COMPLETED|Overall Study||5
359081|NCT00464334|871476|P2|NOT COMPLETED|Overall Study||8
359082|NCT00464334|871477|P1|NOT COMPLETED|Overall Study||1
359083|NCT00464334|871467|P11|COMPLETED|Overall Study||4
359084|NCT00464334|871468|P10|COMPLETED|Overall Study||4
359085|NCT00464334|871469|P9|COMPLETED|Overall Study||2
359086|NCT00464334|871470|P8|COMPLETED|Overall Study||7
359087|NCT00464334|871471|P7|COMPLETED|Overall Study||6
359088|NCT00464334|871472|P6|COMPLETED|Overall Study||3
359089|NCT00464334|871473|P5|COMPLETED|Overall Study||3
359090|NCT00464334|871474|P4|COMPLETED|Overall Study||4
359091|NCT00464334|871475|P3|COMPLETED|Overall Study||3
359092|NCT00464334|871476|P2|COMPLETED|Overall Study||5
359093|NCT00464334|871477|P1|COMPLETED|Overall Study||4
359094|NCT00464334|871467|P11|STARTED|Overall Study||8
359095|NCT00464334|871468|P10|STARTED|Overall Study||5
359096|NCT00464334|871469|P9|STARTED|Overall Study||8
359097|NCT00464334|871470|P8|STARTED|Overall Study||8
359098|NCT00464334|871471|P7|STARTED|Overall Study||9
359099|NCT00464334|871472|P6|STARTED|Overall Study||7
359100|NCT00464334|871473|P5|STARTED|Overall Study||7
359101|NCT00464334|871474|P4|STARTED|Overall Study||8
359102|NCT00464334|871475|P3|STARTED|Overall Study||8
359103|NCT00464334|871476|P2|STARTED|Overall Study||13
359104|NCT00464334|871477|P1|STARTED|Overall Study||5
359105|NCT00464308|871537|P3|NOT COMPLETED|Overall Study||59
359106|NCT00464308|871538|P2|NOT COMPLETED|Overall Study||63
359107|NCT00464308|871539|P1|NOT COMPLETED|Overall Study||69
359108|NCT00464308|871537|P3|COMPLETED|Overall Study||400
359109|NCT00464308|871538|P2|COMPLETED|Overall Study||406
359110|NCT00464308|871539|P1|COMPLETED|Overall Study||395
359111|NCT00464308|871537|P3|STARTED|Overall Study||459
359112|NCT00464308|871538|P2|STARTED|Overall Study||469
359113|NCT00464308|871539|P1|STARTED|Overall Study||464
359114|NCT00464269|871569|P4|NOT COMPLETED|Overall Study||9
359115|NCT00464269|871570|P3|NOT COMPLETED|Overall Study||7
359116|NCT00464269|871571|P2|NOT COMPLETED|Overall Study||17
359117|NCT00464269|871572|P1|NOT COMPLETED|Overall Study||6
359118|NCT00464269|871569|P4|COMPLETED|Overall Study||93
359119|NCT00464269|871570|P3|COMPLETED|Overall Study||93
359120|NCT00464269|871571|P2|COMPLETED|Overall Study||82
359121|NCT00464269|871572|P1|COMPLETED|Overall Study||93
359122|NCT00464269|871569|P4|STARTED|Overall Study||102
359123|NCT00464269|871570|P3|STARTED|Overall Study||100
359124|NCT00464269|871571|P2|STARTED|Overall Study||99
359125|NCT00464269|871572|P1|STARTED|Overall Study||99
359126|NCT00464204|871672|P2|NOT COMPLETED|Overall Study||32
359127|NCT00464204|871673|P1|NOT COMPLETED|Overall Study||49
359128|NCT00464204|871672|P2|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|64
359129|NCT00464204|871673|P1|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|51
359130|NCT00464204|871672|P2|Withdrawal Due to Discharge From ICU|Overall Study||11
359131|NCT00464204|871673|P1|Withdrawal Due to Discharge From ICU|Overall Study||18
359132|NCT00464204|871672|P2|Day 90 Follow-up Performed|Overall Study||74
359133|NCT00464204|871673|P1|Day 90 Follow-up Performed|Overall Study||69
359134|NCT00464204|871672|P2|Day 30 Follow-up Performed|Overall Study||83
359135|NCT00464204|871673|P1|Day 30 Follow-up Performed|Overall Study||89
359136|NCT00464204|871672|P2|Completed Treatment|Overall Study||83
359137|NCT00464204|871673|P1|Completed Treatment|Overall Study||81
359138|NCT00464204|871672|P2|STARTED|Overall Study||96
359139|NCT00464204|871673|P1|STARTED|Overall Study||100
359140|NCT00464087|871710|P3|NOT COMPLETED|Overall Study||29
359141|NCT00464087|871711|P2|NOT COMPLETED|Overall Study||0
359142|NCT00464087|871712|P1|NOT COMPLETED|Overall Study||0
359143|NCT00464087|871710|P3|COMPLETED|Overall Study||0
359144|NCT00464087|871711|P2|COMPLETED|Overall Study||51
359145|NCT00464087|871712|P1|COMPLETED|Overall Study||49
359146|NCT00464087|871710|P3|STARTED|Overall Study||29
359147|NCT00464087|871711|P2|STARTED|Overall Study||51
359148|NCT00464087|871712|P1|STARTED|Overall Study||49
359149|NCT00463866|871730|P2|NOT COMPLETED|Overall Study||340
359150|NCT00463866|871731|P1|NOT COMPLETED|Overall Study||309
359151|NCT00463866|871730|P2|COMPLETED|Overall Study||3705
359152|NCT00463866|871731|P1|COMPLETED|Overall Study||3699
359153|NCT00463866|871730|P2|STARTED|Overall Study|4221 participants randomised. Out of these, 176 had no efficacy data after randomisation.|4045
359154|NCT00463866|871731|P1|STARTED|Overall Study|4203 participants randomised. Out of these, 195 had no efficacy data after randomisation.|4008
359155|NCT00463840|871751|P1|NOT COMPLETED|Overall Study||12
359156|NCT00463840|871751|P1|COMPLETED|Overall Study||12
359157|NCT00463840|871751|P1|STARTED|Overall Study||24
359158|NCT00463801|871756|P1|NOT COMPLETED|Overall Study||13
359159|NCT00463801|871756|P1|COMPLETED|Overall Study||39
359160|NCT00463801|871756|P1|STARTED|Overall Study||52
359161|NCT00463788|871762|P2|NOT COMPLETED|Overall Study||54
359162|NCT00463788|871763|P1|NOT COMPLETED|Overall Study||109
359163|NCT00463788|871762|P2|COMPLETED|Overall Study||4
359164|NCT00463788|871763|P1|COMPLETED|Overall Study||6
359165|NCT00463788|871762|P2|Treated|Overall Study||57
359166|NCT00463788|871763|P1|Treated|Overall Study||114
359167|NCT00463788|871762|P2|STARTED|Overall Study||58
359168|NCT00463788|871763|P1|STARTED|Overall Study||115
359169|NCT00463684|871778|P1|NOT COMPLETED|Overall Study||4
359170|NCT00463684|871778|P1|COMPLETED|Overall Study||274
359171|NCT00463684|871778|P1|STARTED|Overall Study||278
359172|NCT00463606|871796|P3|NOT COMPLETED|Overall Study||20
359173|NCT00463606|871797|P2|NOT COMPLETED|Overall Study||34
359174|NCT00463606|871798|P1|NOT COMPLETED|Overall Study||41
359175|NCT00463606|871796|P3|COMPLETED|Overall Study||231
359176|NCT00463606|871797|P2|COMPLETED|Overall Study||220
359177|NCT00463606|871798|P1|COMPLETED|Overall Study||212
359178|NCT00463606|871796|P3|STARTED|Overall Study||251
359179|NCT00463606|871797|P2|STARTED|Overall Study||254
359180|NCT00463606|871798|P1|STARTED|Overall Study||253
359181|NCT00463580|871823|P2|NOT COMPLETED|Overall Study||2
359182|NCT00463580|871824|P1|NOT COMPLETED|Overall Study||3
359183|NCT00463580|871823|P2|COMPLETED|Overall Study||28
359184|NCT00463580|871824|P1|COMPLETED|Overall Study||27
359185|NCT00463580|871823|P2|STARTED|Overall Study||30
359186|NCT00463580|871824|P1|STARTED|Overall Study||30
359187|NCT00463567|871857|P7|NOT COMPLETED|Overall Study||11
359188|NCT00463567|871858|P6|NOT COMPLETED|Overall Study||21
359189|NCT00463567|871859|P5|NOT COMPLETED|Overall Study||23
359190|NCT00463567|871860|P4|NOT COMPLETED|Overall Study||131
359191|NCT00463567|871861|P3|NOT COMPLETED|Overall Study||89
359192|NCT00463567|871862|P2|NOT COMPLETED|Overall Study||77
359193|NCT00463567|871863|P1|NOT COMPLETED|Overall Study||95
359194|NCT00463567|871857|P7|COMPLETED|Overall Study||112
359195|NCT00463567|871858|P6|COMPLETED|Overall Study||102
359196|NCT00463567|871859|P5|COMPLETED|Overall Study||107
359197|NCT00463567|871860|P4|COMPLETED|Overall Study||294
359198|NCT00463567|871861|P3|COMPLETED|Overall Study||331
359199|NCT00463567|871862|P2|COMPLETED|Overall Study||341
359200|NCT00463567|871863|P1|COMPLETED|Overall Study||325
359201|NCT00463567|871857|P7|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
359202|NCT00463567|871858|P6|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
359203|NCT00463567|871859|P5|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|127
359204|NCT00463567|871860|P4|Safety Population: Received Study Drug|Overall Study||418
359205|NCT00463567|871861|P3|Safety Population: Received Study Drug|Overall Study||415
359206|NCT00463567|871862|P2|Safety Population: Received Study Drug|Overall Study||416
359207|NCT00463567|871863|P1|Safety Population: Received Study Drug|Overall Study||416
359208|NCT00463567|871857|P7|STARTED|Overall Study||123
359209|NCT00463567|871858|P6|STARTED|Overall Study||123
359210|NCT00463567|871859|P5|STARTED|Overall Study||130
359211|NCT00463567|871860|P4|STARTED|Overall Study||425
359212|NCT00463567|871861|P3|STARTED|Overall Study||420
359213|NCT00463567|871862|P2|STARTED|Overall Study||418
359214|NCT00463567|871863|P1|STARTED|Overall Study|Randomized Participants|420
359215|NCT00463437|871898|P4|NOT COMPLETED|Overall Study||7
359216|NCT00463437|871899|P3|NOT COMPLETED|Overall Study||6
359217|NCT00463437|871900|P2|NOT COMPLETED|Overall Study||11
359218|NCT00463437|871901|P1|NOT COMPLETED|Overall Study||4
359219|NCT00463437|871898|P4|COMPLETED|Overall Study||350
359220|NCT00463437|871899|P3|COMPLETED|Overall Study||352
359221|NCT00463437|871900|P2|COMPLETED|Overall Study||352
359222|NCT00463437|871901|P1|COMPLETED|Overall Study||355
359223|NCT00463437|871898|P4|STARTED|Overall Study||357
359224|NCT00463437|871899|P3|STARTED|Overall Study||358
359225|NCT00463437|871900|P2|STARTED|Overall Study||363
359226|NCT00463437|871901|P1|STARTED|Overall Study||359
359227|NCT00463385|871967|P4|NOT COMPLETED|Overall Study||22
359228|NCT00463385|871968|P3|NOT COMPLETED|Overall Study||22
359229|NCT00463385|871969|P2|NOT COMPLETED|Overall Study||22
359230|NCT00463385|871970|P1|NOT COMPLETED|Overall Study||22
359231|NCT00463385|871967|P4|COMPLETED|Overall Study||0
359232|NCT00463385|871968|P3|COMPLETED|Overall Study||0
359233|NCT00463385|871969|P2|COMPLETED|Overall Study||0
359234|NCT00463385|871970|P1|COMPLETED|Overall Study||0
359235|NCT00463385|871967|P4|Treated|Overall Study||22
359236|NCT00463385|871968|P3|Treated|Overall Study||19
359237|NCT00463385|871969|P2|Treated|Overall Study||22
359238|NCT00463385|871970|P1|Treated|Overall Study||22
359239|NCT00463385|871967|P4|STARTED|Overall Study||22
359240|NCT00463385|871968|P3|STARTED|Overall Study||22
359241|NCT00463385|871969|P2|STARTED|Overall Study||22
359242|NCT00463385|871970|P1|STARTED|Overall Study||22
359243|NCT00463346|872022|P2|NOT COMPLETED|Overall Study||3
359244|NCT00463346|872023|P1|NOT COMPLETED|Overall Study||3
359245|NCT00463346|872022|P2|COMPLETED|Overall Study||8
359246|NCT00463346|872023|P1|COMPLETED|Overall Study||9
359247|NCT00463346|872022|P2|STARTED|Overall Study||11
359248|NCT00463346|872023|P1|STARTED|Overall Study||12
359249|NCT00463229|872033|P2|NOT COMPLETED|Overall Study||10
359250|NCT00463229|872034|P1|NOT COMPLETED|Overall Study||9
359251|NCT00463229|872033|P2|COMPLETED|Overall Study||39
359252|NCT00463229|872034|P1|COMPLETED|Overall Study||43
359253|NCT00463229|872033|P2|STARTED|Overall Study||49
359254|NCT00463229|872034|P1|STARTED|Overall Study||52
359255|NCT00463060|872054|P1|NOT COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||1
359256|NCT00463060|872054|P1|COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||25
359257|NCT00463060|872054|P1|STARTED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Not all patients participated in both Phase 1 and Phase II|26
359258|NCT00463060|872054|P1|NOT COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5
359259|NCT00463060|872054|P1|COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||0
359260|NCT00463060|872054|P1|STARTED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5
359261|NCT00463060|872054|P1|NOT COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||0
359262|NCT00463060|872054|P1|COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10
359263|NCT00463060|872054|P1|STARTED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10
359264|NCT00463060|872054|P1|NOT COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||0
359265|NCT00463060|872054|P1|COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3
359266|NCT00463060|872054|P1|STARTED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3
359267|NCT00463060|872054|P1|NOT COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||0
359268|NCT00463060|872054|P1|COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3
359269|NCT00463060|872054|P1|STARTED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3
359270|NCT00463047|872068|P2|NOT COMPLETED|Double-Blind Treatment Period 2||2
359271|NCT00463047|872069|P1|NOT COMPLETED|Double-Blind Treatment Period 2||1
359272|NCT00463047|872068|P2|COMPLETED|Double-Blind Treatment Period 2||88
359273|NCT00463047|872069|P1|COMPLETED|Double-Blind Treatment Period 2||92
359274|NCT00463047|872068|P2|STARTED|Double-Blind Treatment Period 2||90
359275|NCT00463047|872069|P1|STARTED|Double-Blind Treatment Period 2||93
359276|NCT00463047|872068|P2|NOT COMPLETED|Double-Blind Treatment Period 1||4
359277|NCT00463047|872069|P1|NOT COMPLETED|Double-Blind Treatment Period 1||3
359278|NCT00463047|872068|P2|COMPLETED|Double-Blind Treatment Period 1||90
359279|NCT00463047|872069|P1|COMPLETED|Double-Blind Treatment Period 1||93
359280|NCT00463047|872068|P2|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|94
359281|NCT00463047|872069|P1|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|96
359282|NCT00463047|872068|P2|NOT COMPLETED|Titration Period 2||23
359283|NCT00463047|872069|P1|NOT COMPLETED|Titration Period 2||30
359284|NCT00463047|872068|P2|COMPLETED|Titration Period 2||98
359285|NCT00463047|872069|P1|COMPLETED|Titration Period 2||93
359286|NCT00463047|872068|P2|STARTED|Titration Period 2||121
359287|NCT00463047|872069|P1|STARTED|Titration Period 2||123
359288|NCT00463047|872068|P2|NOT COMPLETED|Titration Period 1||39
359289|NCT00463047|872069|P1|NOT COMPLETED|Titration Period 1||37
359290|NCT00463047|872068|P2|COMPLETED|Titration Period 1||121
359291|NCT00463047|872069|P1|COMPLETED|Titration Period 1||123
359292|NCT00463047|872068|P2|STARTED|Titration Period 1||160
359293|NCT00463047|872069|P1|STARTED|Titration Period 1|323 subjects entered study period but 3 discontinued before being randomized to treatment|160
359294|NCT00462982|872154|P1|NOT COMPLETED|Overall Study||3
359295|NCT00462982|872154|P1|COMPLETED|Overall Study||5
359296|NCT00462982|872154|P1|STARTED|Overall Study||8
359297|NCT00462943|872161|P3|NOT COMPLETED|Overall Study||23
359298|NCT00462943|872162|P2|NOT COMPLETED|Overall Study||30
359299|NCT00462943|872163|P1|NOT COMPLETED|Overall Study||45
359300|NCT00462943|872161|P3|COMPLETED|Overall Study||0
359301|NCT00462943|872162|P2|COMPLETED|Overall Study||1
359302|NCT00462943|872163|P1|COMPLETED|Overall Study||1
359303|NCT00462943|872161|P3|STARTED|Overall Study||23
359304|NCT00462943|872162|P2|STARTED|Overall Study||31
359305|NCT00462943|872163|P1|STARTED|Overall Study||46
359306|NCT00462917|872234|P4|NOT COMPLETED|Overall Study||11
359307|NCT00462917|872235|P3|NOT COMPLETED|Overall Study||12
359308|NCT00462917|872236|P2|NOT COMPLETED|Overall Study||10
359309|NCT00462917|872237|P1|NOT COMPLETED|Overall Study||10
359310|NCT00462917|872234|P4|COMPLETED|Overall Study||66
359311|NCT00462917|872235|P3|COMPLETED|Overall Study||54
359312|NCT00462917|872236|P2|COMPLETED|Overall Study||65
359313|NCT00462917|872237|P1|COMPLETED|Overall Study||62
359314|NCT00462917|872234|P4|Completed 6 Month Follow-up|Overall Study||66
359315|NCT00462917|872235|P3|Completed 6 Month Follow-up|Overall Study||55
359316|NCT00462917|872236|P2|Completed 6 Month Follow-up|Overall Study||68
359317|NCT00462917|872237|P1|Completed 6 Month Follow-up|Overall Study||63
359318|NCT00462917|872234|P4|Completed 6 Week Follow-up|Overall Study||68
359319|NCT00462917|872235|P3|Completed 6 Week Follow-up|Overall Study||55
359320|NCT00462917|872236|P2|Completed 6 Week Follow-up|Overall Study||70
359321|NCT00462917|872237|P1|Completed 6 Week Follow-up|Overall Study||63
359322|NCT00462917|872234|P4|Received Risk Information|Overall Study||68
359323|NCT00462917|872235|P3|Received Risk Information|Overall Study||55
359324|NCT00462917|872236|P2|Received Risk Information|Overall Study||70
359325|NCT00462917|872237|P1|Received Risk Information|Overall Study||64
359326|NCT00462917|872234|P4|Met With Genetic Counselor|Overall Study||71
359327|NCT00462917|872235|P3|Met With Genetic Counselor|Overall Study||56
359328|NCT00462917|872236|P2|Met With Genetic Counselor|Overall Study||71
359329|NCT00462917|872237|P1|Met With Genetic Counselor|Overall Study||66
359330|NCT00462917|872234|P4|STARTED|Overall Study||77
359331|NCT00462917|872235|P3|STARTED|Overall Study||66
359332|NCT00462917|872236|P2|STARTED|Overall Study||75
359333|NCT00462917|872237|P1|STARTED|Overall Study||72
359334|NCT00462904|872255|P1|NOT COMPLETED|Overall Study||1
359335|NCT00462904|872255|P1|COMPLETED|Overall Study||3
359336|NCT00462904|872255|P1|STARTED|Overall Study||4
359337|NCT00462865|872260|P1|NOT COMPLETED|Overall Study||1
359338|NCT00462865|872260|P1|COMPLETED|Overall Study||17
359339|NCT00462865|872260|P1|STARTED|Overall Study|18 pts enrolled,1 pt experienced a SAE infection normal ANC (gr 3) and did not begin study,see SAE|18
359340|NCT00462839|872267|P2|NOT COMPLETED|Viewed Second||0
359341|NCT00462839|872268|P1|NOT COMPLETED|Viewed Second||0
359342|NCT00462839|872267|P2|COMPLETED|Viewed Second||53
359343|NCT00462839|872268|P1|COMPLETED|Viewed Second||53
359344|NCT00462839|872267|P2|STARTED|Viewed Second||53
359345|NCT00462839|872268|P1|STARTED|Viewed Second||53
359346|NCT00462839|872267|P2|NOT COMPLETED|Viewed First||0
359347|NCT00462839|872268|P1|NOT COMPLETED|Viewed First||0
359348|NCT00462839|872267|P2|COMPLETED|Viewed First||53
359349|NCT00462839|872268|P1|COMPLETED|Viewed First||53
359350|NCT00462839|872267|P2|STARTED|Viewed First||53
359351|NCT00462839|872268|P1|STARTED|Viewed First||53
359352|NCT00462826|872280|P1|NOT COMPLETED|Overall Study||5
359353|NCT00462826|872280|P1|COMPLETED|Overall Study||44
359354|NCT00462826|872280|P1|STARTED|Overall Study||49
359355|NCT00462748|872296|P3|NOT COMPLETED|Overall Study||11
359356|NCT00462748|872297|P2|NOT COMPLETED|Overall Study||11
359357|NCT00462748|872298|P1|NOT COMPLETED|Overall Study||12
359358|NCT00462748|872296|P3|COMPLETED|Overall Study||251
359359|NCT00462748|872297|P2|COMPLETED|Overall Study||252
359360|NCT00462748|872298|P1|COMPLETED|Overall Study||249
359361|NCT00462748|872296|P3|STARTED|Overall Study||262
359362|NCT00462748|872297|P2|STARTED|Overall Study||263
359363|NCT00462748|872298|P1|STARTED|Overall Study||261
359364|NCT00462735|872306|P1|NOT COMPLETED|Overall Study||0
359365|NCT00462735|872306|P1|COMPLETED|Overall Study||33
359366|NCT00462735|872306|P1|STARTED|Overall Study||33
359367|NCT00462722|872317|P3|NOT COMPLETED|Overall Study||12
359368|NCT00462722|872318|P2|NOT COMPLETED|Overall Study||4
359369|NCT00462722|872319|P1|NOT COMPLETED|Overall Study||13
359370|NCT00462722|872317|P3|COMPLETED|Overall Study||42
359371|NCT00462722|872318|P2|COMPLETED|Overall Study||51
359372|NCT00462722|872319|P1|COMPLETED|Overall Study||37
359373|NCT00462722|872317|P3|STARTED|Overall Study||54
359374|NCT00462722|872318|P2|STARTED|Overall Study||55
359375|NCT00462722|872319|P1|STARTED|Overall Study||50
359376|NCT00462709|872351|P1|NOT COMPLETED|Overall Study||67
359377|NCT00462709|872351|P1|COMPLETED|Overall Study||79
359378|NCT00462709|872351|P1|STARTED|Overall Study||146
359379|NCT00462670|872360|P2|NOT COMPLETED|Overall Study||7
359380|NCT00462670|872361|P1|NOT COMPLETED|Overall Study||5
359381|NCT00462670|872360|P2|COMPLETED|Overall Study||46
359382|NCT00462670|872361|P1|COMPLETED|Overall Study||52
359383|NCT00462670|872360|P2|STARTED|Overall Study||53
359384|NCT00462670|872361|P1|STARTED|Overall Study||57
359385|NCT00462644|872371|P2|NOT COMPLETED|Overall Study||0
359386|NCT00462644|872372|P1|NOT COMPLETED|Overall Study||0
359387|NCT00462644|872371|P2|COMPLETED|Overall Study||12
359388|NCT00462644|872372|P1|COMPLETED|Overall Study||18
359389|NCT00462644|872371|P2|STARTED|Overall Study||12
359390|NCT00462644|872372|P1|STARTED|Overall Study||18
359391|NCT00462605|872390|P1|NOT COMPLETED|Overall Study||14
359392|NCT00462605|872390|P1|COMPLETED|Overall Study||10
359393|NCT00462605|872390|P1|STARTED|Overall Study||24
359394|NCT00462501|872398|P1|NOT COMPLETED|Overall Study||5
359395|NCT00462501|872398|P1|COMPLETED|Overall Study||30
359396|NCT00462501|872398|P1|STARTED|Overall Study||35
359397|NCT00462462|872404|P2|NOT COMPLETED|Overall Study||1
359398|NCT00462462|872405|P1|NOT COMPLETED|Overall Study||0
359399|NCT00462462|872404|P2|COMPLETED|Overall Study||13
359400|NCT00462462|872405|P1|COMPLETED|Overall Study||17
359401|NCT00462462|872404|P2|STARTED|Overall Study||14
359402|NCT00462462|872405|P1|STARTED|Overall Study||17
359403|NCT00462449|872415|P2|NOT COMPLETED|Overall Study||0
359404|NCT00462449|872416|P1|NOT COMPLETED|Overall Study||0
359405|NCT00462449|872415|P2|COMPLETED|Overall Study||10
359406|NCT00462449|872416|P1|COMPLETED|Overall Study||13
359407|NCT00462449|872415|P2|STARTED|Overall Study||10
359408|NCT00462449|872416|P1|STARTED|Overall Study||13
359409|NCT00462423|872426|P1|NOT COMPLETED|Overall Study||0
359410|NCT00462423|872426|P1|COMPLETED|Overall Study||50
359411|NCT00462423|872426|P1|STARTED|Overall Study||50
359412|NCT00462384|872433|P1|NOT COMPLETED|Overall Study||9
359413|NCT00462384|872433|P1|COMPLETED|Overall Study||30
359414|NCT00462384|872433|P1|STARTED|Overall Study||39
359415|NCT00462345|872441|P1|NOT COMPLETED|Overall Study||3
359416|NCT00462345|872441|P1|COMPLETED|Overall Study||37
359417|NCT00462345|872441|P1|Completed First Course|Overall Study||38
359418|NCT00462345|872441|P1|STARTED|Overall Study||40
359419|NCT00462332|872465|P2|NOT COMPLETED|Overall Study||0
359420|NCT00462332|872466|P1|NOT COMPLETED|Overall Study||0
359421|NCT00462332|872465|P2|COMPLETED|Overall Study||41
359422|NCT00462332|872466|P1|COMPLETED|Overall Study||45
359423|NCT00462332|872465|P2|STARTED|Overall Study||41
359424|NCT00462332|872466|P1|STARTED|Overall Study||45
359425|NCT00462306|872476|P2|NOT COMPLETED|Overall Study||13
359426|NCT00462306|872477|P1|NOT COMPLETED|Overall Study||0
359427|NCT00462306|872476|P2|COMPLETED|Overall Study||490
359428|NCT00462306|872477|P1|COMPLETED|Overall Study||4074
359429|NCT00462306|872476|P2|STARTED|Overall Study||503
359430|NCT00462306|872477|P1|STARTED|Overall Study||4074
359431|NCT00462280|872489|P4|NOT COMPLETED|Overall Study||3
359432|NCT00462280|872490|P3|NOT COMPLETED|Overall Study||0
359433|NCT00462280|872491|P2|NOT COMPLETED|Overall Study||7
359434|NCT00462280|872492|P1|NOT COMPLETED|Overall Study||10
359435|NCT00462280|872489|P4|COMPLETED|Overall Study||4
359436|NCT00462280|872490|P3|COMPLETED|Overall Study||7
359437|NCT00462280|872491|P2|COMPLETED|Overall Study||25
359438|NCT00462280|872492|P1|COMPLETED|Overall Study||24
359439|NCT00462280|872489|P4|STARTED|Overall Study||7
359440|NCT00462280|872490|P3|STARTED|Overall Study||7
359441|NCT00462280|872491|P2|STARTED|Overall Study||32
359442|NCT00462280|872492|P1|STARTED|Overall Study||34
359443|NCT00462228|872552|P1|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
359444|NCT00462228|872552|P1|COMPLETED|No Treatment (Washout) 4 Weeks||11
359445|NCT00462228|872552|P1|STARTED|No Treatment (Washout) 4 Weeks||11
359446|NCT00462228|872552|P1|NOT COMPLETED|Placebo or Memantine 12 Weeks||0
359447|NCT00462228|872552|P1|COMPLETED|Placebo or Memantine 12 Weeks||11
359448|NCT00462228|872552|P1|STARTED|Placebo or Memantine 12 Weeks||11
359449|NCT00462228|872552|P1|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
359450|NCT00462228|872552|P1|COMPLETED|No Treatment (Washout) 4 Weeks||11
359451|NCT00462228|872552|P1|STARTED|No Treatment (Washout) 4 Weeks||11
359452|NCT00462228|872552|P1|NOT COMPLETED|Memantine or Placebo 12 Weeks||0
359453|NCT00462228|872552|P1|COMPLETED|Memantine or Placebo 12 Weeks||11
359454|NCT00462228|872552|P1|STARTED|Memantine or Placebo 12 Weeks||11
359455|NCT00462124|872573|P1|NOT COMPLETED|Overall Study||1
359456|NCT00462124|872573|P1|COMPLETED|Overall Study|One implant was misplaced and was disacitivated by puncture.|6
359457|NCT00462124|872573|P1|STARTED|Overall Study||7
359458|NCT00462072|872581|P3|NOT COMPLETED|Week 10||0
359459|NCT00462072|872582|P2|NOT COMPLETED|Week 10||0
359460|NCT00462072|872583|P1|NOT COMPLETED|Week 10||0
359461|NCT00462072|872581|P3|COMPLETED|Week 10||9
359462|NCT00462072|872582|P2|COMPLETED|Week 10||12
359463|NCT00462072|872583|P1|COMPLETED|Week 10||10
359464|NCT00462072|872581|P3|STARTED|Week 10||9
359465|NCT00462072|872582|P2|STARTED|Week 10||12
359466|NCT00462072|872583|P1|STARTED|Week 10||10
359467|NCT00462072|872581|P3|NOT COMPLETED|Baseline (Week 0)||0
359468|NCT00462072|872582|P2|NOT COMPLETED|Baseline (Week 0)||0
359469|NCT00462072|872583|P1|NOT COMPLETED|Baseline (Week 0)||0
359470|NCT00462072|872581|P3|COMPLETED|Baseline (Week 0)||9
359471|NCT00462072|872582|P2|COMPLETED|Baseline (Week 0)||12
359472|NCT00462072|872583|P1|COMPLETED|Baseline (Week 0)||10
359473|NCT00462072|872581|P3|STARTED|Baseline (Week 0)||9
359474|NCT00462072|872582|P2|STARTED|Baseline (Week 0)||12
359475|NCT00462072|872583|P1|STARTED|Baseline (Week 0)||10
359476|NCT00462020|872599|P2|NOT COMPLETED|Overall Study||0
359477|NCT00462020|872600|P1|NOT COMPLETED|Overall Study||0
359478|NCT00462020|872599|P2|COMPLETED|Overall Study||50
359479|NCT00462020|872600|P1|COMPLETED|Overall Study||52
359480|NCT00462020|872599|P2|STARTED|Overall Study||50
359481|NCT00462020|872600|P1|STARTED|Overall Study||52
359482|NCT00461981|872608|P2|NOT COMPLETED|Overall Study||9
359483|NCT00461981|872609|P1|NOT COMPLETED|Overall Study||11
359484|NCT00461981|872608|P2|COMPLETED|Overall Study||42
359485|NCT00461981|872609|P1|COMPLETED|Overall Study||39
359486|NCT00461981|872608|P2|STARTED|Overall Study||51
359487|NCT00461981|872609|P1|STARTED|Overall Study||50
359488|NCT00461851|872719|P1|NOT COMPLETED|Overall Study||0
359489|NCT00461851|872719|P1|COMPLETED|Overall Study||17
359490|NCT00461851|872719|P1|STARTED|Overall Study||17
359491|NCT00461812|872725|P1|NOT COMPLETED|Overall Study||10
359492|NCT00461812|872725|P1|COMPLETED|Overall Study||0
359493|NCT00461812|872725|P1|STARTED|Overall Study||10
359494|NCT00461786|872730|P1|NOT COMPLETED|Overall Study||3
359495|NCT00461786|872730|P1|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|48
359496|NCT00461786|872730|P1|STARTED|Overall Study||51
359497|NCT00461734|872740|P2|NOT COMPLETED|Overall Study||60
359498|NCT00461734|872741|P1|NOT COMPLETED|Overall Study||58
359499|NCT00461734|872740|P2|COMPLETED|Overall Study||60
359500|NCT00461734|872741|P1|COMPLETED|Overall Study||62
359501|NCT00461734|872740|P2|STARTED|Overall Study||120
359502|NCT00461734|872741|P1|STARTED|Overall Study||120
359503|NCT00461708|872775|P2|NOT COMPLETED|Overall Study||38
359504|NCT00461708|872776|P1|NOT COMPLETED|Overall Study||115
359505|NCT00461708|872775|P2|COMPLETED|Overall Study||0
359506|NCT00461708|872776|P1|COMPLETED|Overall Study||0
359507|NCT00461708|872775|P2|STARTED|Overall Study||38
359508|NCT00461708|872776|P1|STARTED|Overall Study||115
359509|NCT00461682|872802|P1|NOT COMPLETED|Overall Study||1
359510|NCT00461682|872802|P1|COMPLETED|Overall Study||0
359511|NCT00461682|872802|P1|STARTED|Overall Study||1
359512|NCT00461630|872830|P2|NOT COMPLETED|Overall Study||827
359513|NCT00461630|872831|P1|NOT COMPLETED|Overall Study||906
359514|NCT00461630|872830|P2|COMPLETED|Overall Study||12008
359515|NCT00461630|872831|P1|COMPLETED|Overall Study||11932
359516|NCT00461630|872830|P2|STARTED|Overall Study||12835
359517|NCT00461630|872831|P1|STARTED|Overall Study||12838
359518|NCT00461591|872847|P2|NOT COMPLETED|Overall Study||85
359519|NCT00461591|872848|P1|NOT COMPLETED|Overall Study||89
359520|NCT00461591|872847|P2|COMPLETED|Overall Study||311
359521|NCT00461591|872848|P1|COMPLETED|Overall Study||317
359522|NCT00461591|872847|P2|STARTED|Overall Study||396
359523|NCT00461591|872848|P1|STARTED|Overall Study||406
359524|NCT00461552|872870|P2|NOT COMPLETED|Overall Study||2
359525|NCT00461552|872871|P1|NOT COMPLETED|Overall Study||0
359526|NCT00461552|872870|P2|COMPLETED|Overall Study||5
359527|NCT00461552|872871|P1|COMPLETED|Overall Study||7
359528|NCT00461552|872870|P2|STARTED|Overall Study||7
359529|NCT00461552|872871|P1|STARTED|Overall Study||7
359530|NCT00461513|872881|P2|NOT COMPLETED|Overall Study||25
359531|NCT00461513|872882|P1|NOT COMPLETED|Overall Study||22
359532|NCT00461513|872881|P2|COMPLETED|Overall Study||172
359533|NCT00461513|872882|P1|COMPLETED|Overall Study||165
359534|NCT00461513|872881|P2|STARTED|Overall Study|2 patients dropped at time of randomization|197
359535|NCT00461513|872882|P1|STARTED|Overall Study|6 patients dropped at time of randomization|187
359536|NCT00461500|872894|P2|NOT COMPLETED|Overall Study||6
359537|NCT00461500|872895|P1|NOT COMPLETED|Overall Study||7
359538|NCT00461500|872894|P2|COMPLETED|Overall Study||38
359539|NCT00461500|872895|P1|COMPLETED|Overall Study||30
359540|NCT00461500|872894|P2|STARTED|Overall Study||44
359541|NCT00461500|872895|P1|STARTED|Overall Study||37
359542|NCT00461331|872925|P2|NOT COMPLETED|Intervention 2||0
359543|NCT00461331|872926|P1|NOT COMPLETED|Intervention 2||0
359544|NCT00461331|872925|P2|COMPLETED|Intervention 2||10
359545|NCT00461331|872926|P1|COMPLETED|Intervention 2||10
359546|NCT00461331|872925|P2|STARTED|Intervention 2||10
359547|NCT00461331|872926|P1|STARTED|Intervention 2||10
359548|NCT00461331|872925|P2|NOT COMPLETED|Washout||0
359549|NCT00461331|872926|P1|NOT COMPLETED|Washout||0
359550|NCT00461331|872925|P2|COMPLETED|Washout||10
359551|NCT00461331|872926|P1|COMPLETED|Washout||10
359552|NCT00461331|872925|P2|STARTED|Washout||10
359553|NCT00461331|872926|P1|STARTED|Washout||10
359554|NCT00461331|872925|P2|NOT COMPLETED|Intervention 1||0
359555|NCT00461331|872926|P1|NOT COMPLETED|Intervention 1||0
359556|NCT00461331|872925|P2|COMPLETED|Intervention 1||10
359557|NCT00461331|872926|P1|COMPLETED|Intervention 1||10
359558|NCT00461331|872925|P2|STARTED|Intervention 1||10
359559|NCT00461331|872926|P1|STARTED|Intervention 1||10
359560|NCT00461305|872938|P2|NOT COMPLETED|Continued Treatment||0
359561|NCT00461305|872939|P1|NOT COMPLETED|Continued Treatment||95
359562|NCT00461305|872938|P2|COMPLETED|Continued Treatment||0
359563|NCT00461305|872939|P1|COMPLETED|Continued Treatment||254
359564|NCT00461305|872938|P2|STARTED|Continued Treatment|no participants were treated with the DRSP 3 mg/EE 30 μg combination beyond 6 cycles|0
359565|NCT00461305|872939|P1|STARTED|Continued Treatment|FAS, participants from previous treatment who were available to continue treatment|349
359566|NCT00461305|872938|P2|NOT COMPLETED|Treatment||9
359567|NCT00461305|872939|P1|NOT COMPLETED|Treatment||101
359568|NCT00461305|872938|P2|COMPLETED|Treatment||56
359569|NCT00461305|872939|P1|COMPLETED|Treatment||254
359570|NCT00461305|872938|P2|Subjects Received Treatment|Treatment|FAS, safety population|65
359571|NCT00461305|872939|P1|Subjects Received Treatment|Treatment|FAS, safety population|349
359572|NCT00461305|872938|P2|Subjects Dispensed Drugs|Treatment||65
359573|NCT00461305|872939|P1|Subjects Dispensed Drugs|Treatment||350
359574|NCT00461305|872938|P2|STARTED|Treatment|Enrolled|65
359575|NCT00461305|872939|P1|STARTED|Treatment|Enrolled|355
359576|NCT00461292|873002|P3|NOT COMPLETED|Treatment Cycle 2||0
359577|NCT00461292|873003|P2|NOT COMPLETED|Treatment Cycle 2||2
359578|NCT00461292|873004|P1|NOT COMPLETED|Treatment Cycle 2||5
359579|NCT00461292|873002|P3|COMPLETED|Treatment Cycle 2||0
359580|NCT00461292|873003|P2|COMPLETED|Treatment Cycle 2||72
359581|NCT00461292|873004|P1|COMPLETED|Treatment Cycle 2||58
359582|NCT00461292|873002|P3|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200 U in Cycle 2|0
359583|NCT00461292|873003|P2|STARTED|Treatment Cycle 2|42 from the 200U group + 32 from the Placebo group entered Cycle 2|74
359584|NCT00461292|873004|P1|STARTED|Treatment Cycle 2|32 from the 300U group + 31 from the Placebo group entered Cycle 2|63
359585|NCT00461292|873002|P3|NOT COMPLETED|Treatment Cycle 1||11
359586|NCT00461292|873003|P2|NOT COMPLETED|Treatment Cycle 1||12
359587|NCT00461292|873004|P1|NOT COMPLETED|Treatment Cycle 1||15
359588|NCT00461292|873002|P3|COMPLETED|Treatment Cycle 1||81
359589|NCT00461292|873003|P2|COMPLETED|Treatment Cycle 1||80
359590|NCT00461292|873004|P1|COMPLETED|Treatment Cycle 1||76
359591|NCT00461292|873002|P3|STARTED|Treatment Cycle 1||92
359592|NCT00461292|873003|P2|STARTED|Treatment Cycle 1||92
359593|NCT00461292|873004|P1|STARTED|Treatment Cycle 1||91
359594|NCT00461253|873023|P2|NOT COMPLETED|Overall Study||19798
359595|NCT00461253|873024|P1|NOT COMPLETED|Overall Study||4980
359596|NCT00461253|873023|P2|COMPLETED|Overall Study|Analyzed controls|20452
359597|NCT00461253|873024|P1|COMPLETED|Overall Study|Analyzed cases|5113
359598|NCT00461253|873023|P2|STARTED|Overall Study|Identified controls|40250
359599|NCT00461253|873024|P1|STARTED|Overall Study|Identified cases|10093
359600|NCT00461175|873032|P2|NOT COMPLETED|Overall Study||365
359601|NCT00461175|873033|P1|NOT COMPLETED|Overall Study||522
359602|NCT00461175|873032|P2|COMPLETED|Overall Study||18370
359603|NCT00461175|873033|P1|COMPLETED|Overall Study||43078
359604|NCT00461175|873032|P2|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|18735
359605|NCT00461175|873033|P1|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|43600
359606|NCT00461123|873043|P2|NOT COMPLETED|Overall Study||6
359607|NCT00461123|873044|P1|NOT COMPLETED|Overall Study||6
359608|NCT00461123|873043|P2|COMPLETED|Overall Study||19
359609|NCT00461123|873044|P1|COMPLETED|Overall Study||19
359610|NCT00461123|873043|P2|STARTED|Overall Study||25
359611|NCT00461123|873044|P1|STARTED|Overall Study||25
359612|NCT00461097|873060|P2|NOT COMPLETED|Overall Study||0
359613|NCT00461097|873061|P1|NOT COMPLETED|Overall Study||0
359614|NCT00461097|873060|P2|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure.|15
359615|NCT00461097|873061|P1|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure and outcome measure #6.|40
359616|NCT00461097|873060|P2|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||0
359617|NCT00461097|873061|P1|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||7
359618|NCT00461097|873060|P2|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||0
359619|NCT00461097|873061|P1|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||16
359620|NCT00461097|873060|P2|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||1
359621|NCT00461097|873061|P1|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||34
359622|NCT00461097|873060|P2|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||13
359623|NCT00461097|873061|P1|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||35
359624|NCT00461097|873060|P2|STARTED|Overall Study||15
359625|NCT00461097|873061|P1|STARTED|Overall Study||40
359626|NCT00461045|873077|P1|NOT COMPLETED|Overall Study||0
359627|NCT00461045|873077|P1|COMPLETED|Overall Study||15
359628|NCT00461045|873077|P1|STARTED|Overall Study||15
359629|NCT00461032|873089|P2|NOT COMPLETED|Overall Study||44
359630|NCT00461032|873090|P1|NOT COMPLETED|Overall Study||37
359631|NCT00461032|873089|P2|COMPLETED|Overall Study||536
359632|NCT00461032|873090|P1|COMPLETED|Overall Study||545
359633|NCT00461032|873089|P2|STARTED|Overall Study||580
359634|NCT00461032|873090|P1|STARTED|Overall Study||582
359635|NCT00460993|873104|P2|NOT COMPLETED|Phase 2 (6 Days)||0
359636|NCT00460993|873105|P1|NOT COMPLETED|Phase 2 (6 Days)||0
359637|NCT00460993|873104|P2|COMPLETED|Phase 2 (6 Days)||17
359638|NCT00460993|873105|P1|COMPLETED|Phase 2 (6 Days)||14
359639|NCT00460993|873104|P2|STARTED|Phase 2 (6 Days)||17
359640|NCT00460993|873105|P1|STARTED|Phase 2 (6 Days)||14
359641|NCT00460993|873104|P2|NOT COMPLETED|Phase 1 (6 Days)||0
359642|NCT00460993|873105|P1|NOT COMPLETED|Phase 1 (6 Days)||0
359643|NCT00460993|873104|P2|COMPLETED|Phase 1 (6 Days)||17
359644|NCT00460993|873105|P1|COMPLETED|Phase 1 (6 Days)||14
359645|NCT00460993|873104|P2|STARTED|Phase 1 (6 Days)||17
359646|NCT00460993|873105|P1|STARTED|Phase 1 (6 Days)||14
359647|NCT00460811|873116|P5|NOT COMPLETED|Overall Study||20
359648|NCT00460811|873117|P4|NOT COMPLETED|Overall Study||18
359649|NCT00460811|873118|P3|NOT COMPLETED|Overall Study||14
359650|NCT00460811|873119|P2|NOT COMPLETED|Overall Study||15
359651|NCT00460811|873120|P1|NOT COMPLETED|Overall Study||16
359652|NCT00460811|873116|P5|COMPLETED|Overall Study||65
359653|NCT00460811|873117|P4|COMPLETED|Overall Study||71
359654|NCT00460811|873118|P3|COMPLETED|Overall Study||71
359655|NCT00460811|873119|P2|COMPLETED|Overall Study||67
359656|NCT00460811|873120|P1|COMPLETED|Overall Study||63
359657|NCT00460811|873116|P5|STARTED|Overall Study||85
359658|NCT00460811|873117|P4|STARTED|Overall Study||89
359659|NCT00460811|873118|P3|STARTED|Overall Study||85
359660|NCT00460811|873119|P2|STARTED|Overall Study||82
359661|NCT00460811|873120|P1|STARTED|Overall Study||79
359662|NCT00460798|873162|P1|NOT COMPLETED|Overall Study||340
359663|NCT00460798|873162|P1|COMPLETED|Overall Study||108
359664|NCT00460798|873162|P1|Treated|Overall Study|Subjects with complete dosing information were recorded as 'Treated'|421
359665|NCT00460798|873162|P1|STARTED|Overall Study||448
359666|NCT00460746|873170|P1|NOT COMPLETED|Overall Study||2
359667|NCT00460746|873170|P1|COMPLETED|Overall Study||8
359668|NCT00460746|873170|P1|STARTED|Overall Study||10
359669|NCT00460655|873185|P4|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
359670|NCT00460655|873186|P3|NOT COMPLETED|Open-Label Phase (36 Weeks)||7
359671|NCT00460655|873187|P2|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
359672|NCT00460655|873188|P1|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
359673|NCT00460655|873185|P4|COMPLETED|Open-Label Phase (36 Weeks)||52
359674|NCT00460655|873186|P3|COMPLETED|Open-Label Phase (36 Weeks)||45
359675|NCT00460655|873187|P2|COMPLETED|Open-Label Phase (36 Weeks)||0
359676|NCT00460655|873188|P1|COMPLETED|Open-Label Phase (36 Weeks)||0
359677|NCT00460655|873185|P4|STARTED|Open-Label Phase (36 Weeks)||61
359678|NCT00460655|873186|P3|STARTED|Open-Label Phase (36 Weeks)||52
359679|NCT00460655|873187|P2|STARTED|Open-Label Phase (36 Weeks)||0
359680|NCT00460655|873188|P1|STARTED|Open-Label Phase (36 Weeks)||0
359681|NCT00460655|873185|P4|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
359682|NCT00460655|873186|P3|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
359683|NCT00460655|873187|P2|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
359684|NCT00460655|873188|P1|NOT COMPLETED|Double-Blind Phase (12 Weeks)||6
359685|NCT00460655|873185|P4|COMPLETED|Double-Blind Phase (12 Weeks)||0
359686|NCT00460655|873186|P3|COMPLETED|Double-Blind Phase (12 Weeks)||0
359687|NCT00460655|873187|P2|COMPLETED|Double-Blind Phase (12 Weeks)||61
359688|NCT00460655|873188|P1|COMPLETED|Double-Blind Phase (12 Weeks)||52
359689|NCT00460655|873185|P4|STARTED|Double-Blind Phase (12 Weeks)||0
359690|NCT00460655|873186|P3|STARTED|Double-Blind Phase (12 Weeks)||0
359691|NCT00460655|873187|P2|STARTED|Double-Blind Phase (12 Weeks)||62
359692|NCT00460655|873188|P1|STARTED|Double-Blind Phase (12 Weeks)||58
359693|NCT00460603|873232|P12|NOT COMPLETED|Phase 2||41
359694|NCT00460603|873233|P11|NOT COMPLETED|Phase 2||43
359695|NCT00460603|873234|P10|NOT COMPLETED|Phase 2||42
359696|NCT00460603|873235|P9|NOT COMPLETED|Phase 2||0
359697|NCT00460603|873236|P8|NOT COMPLETED|Phase 2||0
359698|NCT00460603|873237|P7|NOT COMPLETED|Phase 2||0
359699|NCT00460603|873238|P6|NOT COMPLETED|Phase 2||0
359700|NCT00460603|873239|P5|NOT COMPLETED|Phase 2||0
359701|NCT00460603|873240|P4|NOT COMPLETED|Phase 2||0
359702|NCT00460603|873241|P3|NOT COMPLETED|Phase 2||0
359703|NCT00460603|873242|P2|NOT COMPLETED|Phase 2||0
359704|NCT00460603|873243|P1|NOT COMPLETED|Phase 2||0
359705|NCT00460603|873232|P12|COMPLETED|Phase 2||0
359706|NCT00460603|873233|P11|COMPLETED|Phase 2||0
359707|NCT00460603|873234|P10|COMPLETED|Phase 2||0
359708|NCT00460603|873235|P9|COMPLETED|Phase 2||0
359709|NCT00460603|873236|P8|COMPLETED|Phase 2||0
359710|NCT00460603|873237|P7|COMPLETED|Phase 2||0
359711|NCT00460603|873238|P6|COMPLETED|Phase 2||0
359712|NCT00460603|873239|P5|COMPLETED|Phase 2||0
359713|NCT00460603|873240|P4|COMPLETED|Phase 2||0
359714|NCT00460603|873241|P3|COMPLETED|Phase 2||0
359715|NCT00460603|873242|P2|COMPLETED|Phase 2||0
359716|NCT00460603|873243|P1|COMPLETED|Phase 2||0
359717|NCT00460603|873232|P12|Treated|Phase 2||41
359718|NCT00460603|873233|P11|Treated|Phase 2||43
359719|NCT00460603|873234|P10|Treated|Phase 2||39
359720|NCT00460603|873235|P9|Treated|Phase 2||0
359721|NCT00460603|873236|P8|Treated|Phase 2||0
359722|NCT00460603|873237|P7|Treated|Phase 2||0
359723|NCT00460603|873238|P6|Treated|Phase 2||0
359724|NCT00460603|873239|P5|Treated|Phase 2||0
359725|NCT00460603|873240|P4|Treated|Phase 2||0
359726|NCT00460603|873241|P3|Treated|Phase 2||0
359727|NCT00460603|873242|P2|Treated|Phase 2||0
359728|NCT00460603|873243|P1|Treated|Phase 2||0
359729|NCT00460603|873232|P12|STARTED|Phase 2||41
359730|NCT00460603|873233|P11|STARTED|Phase 2||43
359731|NCT00460603|873234|P10|STARTED|Phase 2||42
359732|NCT00460603|873235|P9|STARTED|Phase 2||0
359733|NCT00460603|873236|P8|STARTED|Phase 2||0
359734|NCT00460603|873237|P7|STARTED|Phase 2||0
359735|NCT00460603|873238|P6|STARTED|Phase 2||0
359736|NCT00460603|873239|P5|STARTED|Phase 2||0
359737|NCT00460603|873240|P4|STARTED|Phase 2||0
359738|NCT00460603|873241|P3|STARTED|Phase 2||0
359739|NCT00460603|873242|P2|STARTED|Phase 2||0
359740|NCT00460603|873243|P1|STARTED|Phase 2||0
359741|NCT00460603|873232|P12|NOT COMPLETED|Phase 1||0
359742|NCT00460603|873233|P11|NOT COMPLETED|Phase 1||0
359743|NCT00460603|873234|P10|NOT COMPLETED|Phase 1||0
359744|NCT00460603|873235|P9|NOT COMPLETED|Phase 1||18
359745|NCT00460603|873236|P8|NOT COMPLETED|Phase 1||3
359746|NCT00460603|873237|P7|NOT COMPLETED|Phase 1||6
359747|NCT00460603|873238|P6|NOT COMPLETED|Phase 1||4
359748|NCT00460603|873239|P5|NOT COMPLETED|Phase 1||6
359749|NCT00460603|873240|P4|NOT COMPLETED|Phase 1||8
359750|NCT00460603|873241|P3|NOT COMPLETED|Phase 1||4
359751|NCT00460603|873242|P2|NOT COMPLETED|Phase 1||6
359752|NCT00460603|873243|P1|NOT COMPLETED|Phase 1||6
359753|NCT00460603|873232|P12|COMPLETED|Phase 1||0
359754|NCT00460603|873233|P11|COMPLETED|Phase 1||0
359755|NCT00460603|873234|P10|COMPLETED|Phase 1||0
359756|NCT00460603|873235|P9|COMPLETED|Phase 1||0
359757|NCT00460603|873236|P8|COMPLETED|Phase 1||0
359758|NCT00460603|873237|P7|COMPLETED|Phase 1||0
359759|NCT00460603|873238|P6|COMPLETED|Phase 1||0
359760|NCT00460603|873239|P5|COMPLETED|Phase 1||0
359761|NCT00460603|873240|P4|COMPLETED|Phase 1||0
359762|NCT00460603|873241|P3|COMPLETED|Phase 1||0
359763|NCT00460603|873242|P2|COMPLETED|Phase 1||0
359764|NCT00460603|873243|P1|COMPLETED|Phase 1||0
359765|NCT00460603|873232|P12|STARTED|Phase 1||0
359766|NCT00460603|873233|P11|STARTED|Phase 1||0
359767|NCT00460603|873234|P10|STARTED|Phase 1||0
359768|NCT00460603|873235|P9|STARTED|Phase 1||18
359769|NCT00460603|873236|P8|STARTED|Phase 1||3
359770|NCT00460603|873237|P7|STARTED|Phase 1||6
359771|NCT00460603|873238|P6|STARTED|Phase 1||4
359772|NCT00460603|873239|P5|STARTED|Phase 1||6
359773|NCT00460603|873240|P4|STARTED|Phase 1||8
359774|NCT00460603|873241|P3|STARTED|Phase 1||4
359775|NCT00460603|873242|P2|STARTED|Phase 1||6
359776|NCT00460603|873243|P1|STARTED|Phase 1||6
359777|NCT00460577|873337|P2|NOT COMPLETED|Overall Study||6
359778|NCT00460577|873338|P1|NOT COMPLETED|Overall Study||2
359779|NCT00460577|873337|P2|COMPLETED|Overall Study||24
359780|NCT00460577|873338|P1|COMPLETED|Overall Study||28
359781|NCT00460577|873337|P2|STARTED|Overall Study||30
359782|NCT00460577|873338|P1|STARTED|Overall Study|148 patients were screened; however, 22 did not consent and 66 did not meet inclusion/exclusion.|30
359783|NCT00460564|873356|P8|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
359784|NCT00460564|873357|P7|NOT COMPLETED|Open-Label Phase (36 Weeks)||2
359785|NCT00460564|873358|P6|NOT COMPLETED|Open-Label Phase (36 Weeks)||6
359786|NCT00460564|873359|P5|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
359787|NCT00460564|873360|P4|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
359788|NCT00460564|873361|P3|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
359789|NCT00460564|873362|P2|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
359790|NCT00460564|873363|P1|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
359791|NCT00460564|873356|P8|COMPLETED|Open-Label Phase (36 Weeks)||11
359792|NCT00460564|873357|P7|COMPLETED|Open-Label Phase (36 Weeks)||19
359793|NCT00460564|873358|P6|COMPLETED|Open-Label Phase (36 Weeks)||19
359794|NCT00460564|873359|P5|COMPLETED|Open-Label Phase (36 Weeks)||38
359795|NCT00460564|873360|P4|COMPLETED|Open-Label Phase (36 Weeks)||0
359796|NCT00460564|873361|P3|COMPLETED|Open-Label Phase (36 Weeks)||0
359797|NCT00460564|873362|P2|COMPLETED|Open-Label Phase (36 Weeks)||0
359798|NCT00460564|873363|P1|COMPLETED|Open-Label Phase (36 Weeks)||0
359799|NCT00460564|873356|P8|STARTED|Open-Label Phase (36 Weeks)||11
359800|NCT00460564|873357|P7|STARTED|Open-Label Phase (36 Weeks)||21
359801|NCT00460564|873358|P6|STARTED|Open-Label Phase (36 Weeks)||25
359802|NCT00460564|873359|P5|STARTED|Open-Label Phase (36 Weeks)||47
359803|NCT00460564|873360|P4|STARTED|Open-Label Phase (36 Weeks)||0
359804|NCT00460564|873361|P3|STARTED|Open-Label Phase (36 Weeks)||0
359805|NCT00460564|873362|P2|STARTED|Open-Label Phase (36 Weeks)||0
359806|NCT00460564|873363|P1|STARTED|Open-Label Phase (36 Weeks)||0
359807|NCT00460564|873356|P8|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
359808|NCT00460564|873357|P7|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
359809|NCT00460564|873358|P6|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
359810|NCT00460564|873359|P5|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
359811|NCT00460564|873360|P4|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
359812|NCT00460564|873361|P3|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
359813|NCT00460564|873362|P2|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
359814|NCT00460564|873363|P1|NOT COMPLETED|Double-Blind Phase (12 Weeks)||4
359815|NCT00460564|873356|P8|COMPLETED|Double-Blind Phase (12 Weeks)||0
359816|NCT00460564|873357|P7|COMPLETED|Double-Blind Phase (12 Weeks)||0
359817|NCT00460564|873358|P6|COMPLETED|Double-Blind Phase (12 Weeks)||0
359818|NCT00460564|873359|P5|COMPLETED|Double-Blind Phase (12 Weeks)||0
359819|NCT00460564|873360|P4|COMPLETED|Double-Blind Phase (12 Weeks)||11
359820|NCT00460564|873361|P3|COMPLETED|Double-Blind Phase (12 Weeks)||21
359821|NCT00460564|873362|P2|COMPLETED|Double-Blind Phase (12 Weeks)||25
359822|NCT00460564|873363|P1|COMPLETED|Double-Blind Phase (12 Weeks)||47
359823|NCT00460564|873356|P8|STARTED|Double-Blind Phase (12 Weeks)||0
359824|NCT00460564|873357|P7|STARTED|Double-Blind Phase (12 Weeks)||0
359825|NCT00460564|873358|P6|STARTED|Double-Blind Phase (12 Weeks)||0
359826|NCT00460564|873359|P5|STARTED|Double-Blind Phase (12 Weeks)||0
359827|NCT00460564|873360|P4|STARTED|Double-Blind Phase (12 Weeks)||11
359828|NCT00460564|873361|P3|STARTED|Double-Blind Phase (12 Weeks)||21
359829|NCT00460564|873362|P2|STARTED|Double-Blind Phase (12 Weeks)||26
359830|NCT00460564|873363|P1|STARTED|Double-Blind Phase (12 Weeks)||51
359831|NCT00460551|873457|P1|NOT COMPLETED|Overall Study||0
359832|NCT00460551|873457|P1|COMPLETED|Overall Study|The trial was terminated after Period 1A. Only safety was measured.|13
359833|NCT00460551|873457|P1|STARTED|Overall Study||13
359834|NCT00460525|873464|P2|NOT COMPLETED|Overall Study||5
359835|NCT00460525|873465|P1|NOT COMPLETED|Overall Study||11
359836|NCT00460525|873464|P2|COMPLETED|Overall Study||194
359837|NCT00460525|873465|P1|COMPLETED|Overall Study||190
359838|NCT00460525|873464|P2|STARTED|Overall Study||199
359839|NCT00460525|873465|P1|STARTED|Overall Study||201
359840|NCT00460434|873507|P2|NOT COMPLETED|Overall Study||7
359841|NCT00460434|873508|P1|NOT COMPLETED|Overall Study||3
359842|NCT00460434|873507|P2|COMPLETED|Overall Study||165
359843|NCT00460434|873508|P1|COMPLETED|Overall Study||162
359844|NCT00460434|873507|P2|12 Months|Overall Study||165
359845|NCT00460434|873508|P1|12 Months|Overall Study||162
359846|NCT00460434|873507|P2|3 Months|Overall Study||171
359847|NCT00460434|873508|P1|3 Months|Overall Study||163
359848|NCT00460434|873507|P2|STARTED|Overall Study||172
359849|NCT00460434|873508|P1|STARTED|Overall Study||165
359850|NCT00460421|873537|P3|NOT COMPLETED|Overall Study||0
359851|NCT00460421|873538|P2|NOT COMPLETED|Overall Study||0
359852|NCT00460421|873539|P1|NOT COMPLETED|Overall Study||0
359853|NCT00460421|873537|P3|COMPLETED|Overall Study||9
359854|NCT00460421|873538|P2|COMPLETED|Overall Study||9
359855|NCT00460421|873539|P1|COMPLETED|Overall Study||9
359856|NCT00460421|873537|P3|STARTED|Overall Study||9
359857|NCT00460421|873538|P2|STARTED|Overall Study||9
359858|NCT00460421|873539|P1|STARTED|Overall Study||9
359859|NCT00460408|873587|P4|NOT COMPLETED|Overall Study||0
359860|NCT00460408|873588|P3|NOT COMPLETED|Overall Study||6
359861|NCT00460408|873589|P2|NOT COMPLETED|Overall Study||3
359862|NCT00460408|873590|P1|NOT COMPLETED|Overall Study||67
359863|NCT00460408|873587|P4|COMPLETED|Overall Study||7
359864|NCT00460408|873588|P3|COMPLETED|Overall Study||69
359865|NCT00460408|873589|P2|COMPLETED|Overall Study||13
359866|NCT00460408|873590|P1|COMPLETED|Overall Study||336
359867|NCT00460408|873587|P4|STARTED|Overall Study||7
359868|NCT00460408|873588|P3|STARTED|Overall Study||75
359869|NCT00460408|873589|P2|STARTED|Overall Study||16
359870|NCT00460408|873590|P1|STARTED|Overall Study||403
359871|NCT00460265|873627|P2|NOT COMPLETED|Overall Study||89
359872|NCT00460265|873628|P1|NOT COMPLETED|Overall Study||85
359873|NCT00460265|873627|P2|COMPLETED|Overall Study|Completed study=death|241
359874|NCT00460265|873628|P1|COMPLETED|Overall Study|Completed study=death|243
359875|NCT00460265|873627|P2|Received Study Medication|Overall Study||325
359876|NCT00460265|873628|P1|Received Study Medication|Overall Study||325
359877|NCT00460265|873627|P2|Randomized While Alive|Overall Study||330
359878|NCT00460265|873628|P1|Randomized While Alive|Overall Study|1 subject was randomized by error after death|327
359879|NCT00460265|873627|P2|STARTED|Overall Study||330
359880|NCT00460265|873628|P1|STARTED|Overall Study||328
359881|NCT00460239|873644|P9|NOT COMPLETED|Overall Study||0
359882|NCT00460239|873645|P8|NOT COMPLETED|Overall Study||0
359883|NCT00460239|873646|P7|NOT COMPLETED|Overall Study||0
359884|NCT00460239|873647|P6|NOT COMPLETED|Overall Study||3
359885|NCT00460239|873648|P5|NOT COMPLETED|Overall Study||0
359886|NCT00460239|873649|P4|NOT COMPLETED|Overall Study||0
359887|NCT00460239|873650|P3|NOT COMPLETED|Overall Study||0
359888|NCT00460239|873651|P2|NOT COMPLETED|Overall Study||1
359889|NCT00460239|873652|P1|NOT COMPLETED|Overall Study||0
359890|NCT00460239|873644|P9|COMPLETED|Overall Study||1
359891|NCT00460239|873645|P8|COMPLETED|Overall Study||1
359892|NCT00460239|873646|P7|COMPLETED|Overall Study||1
359893|NCT00460239|873647|P6|COMPLETED|Overall Study||1
359894|NCT00460239|873648|P5|COMPLETED|Overall Study||1
359895|NCT00460239|873649|P4|COMPLETED|Overall Study||0
359896|NCT00460239|873650|P3|COMPLETED|Overall Study||1
359897|NCT00460239|873651|P2|COMPLETED|Overall Study||2
359898|NCT00460239|873652|P1|COMPLETED|Overall Study||0
359899|NCT00460239|873644|P9|STARTED|Overall Study||1
359900|NCT00460239|873645|P8|STARTED|Overall Study||1
359901|NCT00460239|873646|P7|STARTED|Overall Study||1
359902|NCT00460239|873647|P6|STARTED|Overall Study||4
359903|NCT00460239|873648|P5|STARTED|Overall Study||1
359904|NCT00460239|873649|P4|STARTED|Overall Study||0
359905|NCT00460239|873650|P3|STARTED|Overall Study||1
359906|NCT00460239|873651|P2|STARTED|Overall Study||3
359907|NCT00460239|873652|P1|STARTED|Overall Study||0
359908|NCT00460109|873721|P1|NOT COMPLETED|Overall Study||1
359909|NCT00460109|873721|P1|COMPLETED|Overall Study||23
359910|NCT00460109|873721|P1|STARTED|Overall Study||24
359911|NCT00460031|873729|P1|NOT COMPLETED|Overall Study||11
359912|NCT00460031|873729|P1|COMPLETED|Overall Study||23
359913|NCT00460031|873729|P1|STARTED|Overall Study||34
359914|NCT00459979|873737|P1|NOT COMPLETED|Overall Study||2
359915|NCT00459979|873737|P1|COMPLETED|Overall Study||28
359916|NCT00459979|873737|P1|STARTED|Overall Study||30
359917|NCT00459953|873749|P2|NOT COMPLETED|Overall Study||1
359918|NCT00459953|873750|P1|NOT COMPLETED|Overall Study||1
359919|NCT00459953|873749|P2|COMPLETED|Overall Study||70
359920|NCT00459953|873750|P1|COMPLETED|Overall Study||71
359921|NCT00459953|873749|P2|STARTED|Overall Study||71
359922|NCT00459953|873750|P1|STARTED|Overall Study||72
359923|NCT00459875|873756|P1|NOT COMPLETED|Overall Study||3
359924|NCT00459875|873756|P1|COMPLETED|Overall Study||21
359925|NCT00459875|873756|P1|STARTED|Overall Study||24
359926|NCT00459862|873760|P1|NOT COMPLETED|Overall Study||0
359927|NCT00459862|873760|P1|COMPLETED|Overall Study||34
359928|NCT00459862|873760|P1|STARTED|Overall Study||34
359929|NCT00459810|873769|P1|NOT COMPLETED|Overall Study||0
359930|NCT00459810|873769|P1|COMPLETED|Overall Study||21
359931|NCT00459810|873769|P1|STARTED|Overall Study||21
359932|NCT00459732|873779|P2|NOT COMPLETED|Overall Study||3
359933|NCT00459732|873780|P1|NOT COMPLETED|Overall Study||4
359934|NCT00459732|873779|P2|COMPLETED|Overall Study|3 on placebo dropped: 1 pregnant after 12 mo, 1 lost to followup, one died after 12 month timepoint|14
359935|NCT00459732|873780|P1|COMPLETED|Overall Study|4 on zn dropped: 1 pregnant and 1 nausea after baseline, 1 lost to followup, 1 exited after 12 month|19
359936|NCT00459732|873779|P2|STARTED|Overall Study||17
359937|NCT00459732|873780|P1|STARTED|Overall Study||23
359938|NCT00459706|873792|P2|NOT COMPLETED|Overall Study||21
359939|NCT00459706|873793|P1|NOT COMPLETED|Overall Study||26
359940|NCT00459706|873792|P2|COMPLETED|Overall Study||294
359941|NCT00459706|873793|P1|COMPLETED|Overall Study||299
359942|NCT00459706|873792|P2|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|2 participants withdrew consent before the first injection|313
359943|NCT00459706|873793|P1|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|1 participant had no evaluation after the first injection|324
359944|NCT00459706|873792|P2|STARTED|Overall Study||315
359945|NCT00459706|873793|P1|STARTED|Overall Study||325
359946|NCT00459667|873936|P3|NOT COMPLETED|Overall Study||20
359947|NCT00459667|873937|P2|NOT COMPLETED|Overall Study||47
359948|NCT00459667|873938|P1|NOT COMPLETED|Overall Study||38
359949|NCT00459667|873936|P3|COMPLETED|Overall Study||161
359950|NCT00459667|873937|P2|COMPLETED|Overall Study||600
359951|NCT00459667|873938|P1|COMPLETED|Overall Study||554
359952|NCT00459667|873936|P3|Started Treatment|Overall Study||180
359953|NCT00459667|873937|P2|Started Treatment|Overall Study||644
359954|NCT00459667|873938|P1|Started Treatment|Overall Study||586
359955|NCT00459667|873936|P3|Study Medication Dispensed|Overall Study||180
359956|NCT00459667|873937|P2|Study Medication Dispensed|Overall Study||645
359957|NCT00459667|873938|P1|Study Medication Dispensed|Overall Study||586
359958|NCT00459667|873936|P3|STARTED|Overall Study||181
359959|NCT00459667|873937|P2|STARTED|Overall Study||647
359960|NCT00459667|873938|P1|STARTED|Overall Study||592
359961|NCT00459537|873960|P2|NOT COMPLETED|Overall Study||76
359962|NCT00459537|873961|P1|NOT COMPLETED|Overall Study||66
359963|NCT00459537|873960|P2|COMPLETED|Overall Study||446
359964|NCT00459537|873961|P1|COMPLETED|Overall Study||441
359965|NCT00459537|873960|P2|Safety Population|Overall Study||512
359966|NCT00459537|873961|P1|Safety Population|Overall Study|Participants who had at least one dose of study drug and one post-baseline safety assessment.|493
359967|NCT00459537|873960|P2|STARTED|Overall Study||522
359968|NCT00459537|873961|P1|STARTED|Overall Study||507
359969|NCT00459381|873975|P1|NOT COMPLETED|Overall Study||0
359970|NCT00459381|873975|P1|COMPLETED|Overall Study||35
359971|NCT00459381|873975|P1|STARTED|Overall Study||35
359972|NCT00459368|873987|P2|NOT COMPLETED|Overall Study||329
359973|NCT00459368|873988|P1|NOT COMPLETED|Overall Study||295
359974|NCT00459368|873987|P2|COMPLETED|Overall Study||1034
359975|NCT00459368|873988|P1|COMPLETED|Overall Study||1040
359976|NCT00459368|873987|P2|STARTED|Overall Study||1363
359977|NCT00459368|873988|P1|STARTED|Overall Study||1335
359978|NCT00459355|873996|P2|NOT COMPLETED|Overall Study||18
359979|NCT00459355|873997|P1|NOT COMPLETED|Overall Study||20
359980|NCT00459355|873996|P2|COMPLETED|Overall Study|Includes 48 dyads, caregiver + care-recipient|96
359981|NCT00459355|873997|P1|COMPLETED|Overall Study|Includes 60 dyads, caregiver + care-recipient|120
359982|NCT00459355|873996|P2|STARTED|Overall Study|Includes 57 dyads, caregiver + care-recipient|114
359983|NCT00459355|873997|P1|STARTED|Overall Study|Includes 70 dyads, caregiver/care-recipient|140
359984|NCT00459342|874009|P1|NOT COMPLETED|Overall Study||1
359985|NCT00459342|874009|P1|COMPLETED|Overall Study||34
359986|NCT00459342|874009|P1|STARTED|Overall Study||35
359987|NCT00459316|874022|P3|NOT COMPLETED|Step 3||1
359988|NCT00459316|874023|P2|NOT COMPLETED|Step 3||0
359989|NCT00459316|874024|P1|NOT COMPLETED|Step 3||3
359990|NCT00459316|874022|P3|COMPLETED|Step 3||39
359991|NCT00459316|874023|P2|COMPLETED|Step 3||0
359992|NCT00459316|874024|P1|COMPLETED|Step 3||149
359993|NCT00459316|874022|P3|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|40
359994|NCT00459316|874023|P2|STARTED|Step 3|Group 2 participants were not eligible for Step 3|0
359995|NCT00459316|874024|P1|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|152
359996|NCT00459316|874022|P3|NOT COMPLETED|Steps 1 & 2||2
359997|NCT00459316|874023|P2|NOT COMPLETED|Steps 1 & 2||7
359998|NCT00459316|874024|P1|NOT COMPLETED|Steps 1 & 2||21
359999|NCT00459316|874022|P3|COMPLETED|Steps 1 & 2||57
360000|NCT00459316|874023|P2|COMPLETED|Steps 1 & 2||32
360001|NCT00459316|874024|P1|COMPLETED|Steps 1 & 2||259
360002|NCT00459316|874022|P3|STARTED|Steps 1 & 2||59
360003|NCT00459316|874023|P2|STARTED|Steps 1 & 2||39
360004|NCT00459316|874024|P1|STARTED|Steps 1 & 2||280
360005|NCT00459303|874078|P1|NOT COMPLETED|Overall Study||0
360006|NCT00459303|874078|P1|COMPLETED|Overall Study||20
360007|NCT00459303|874078|P1|STARTED|Overall Study||20
360008|NCT00459290|874089|P1|NOT COMPLETED|Overall Study||5
360009|NCT00459290|874089|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|19
360010|NCT00459290|874089|P1|STARTED|Overall Study||24
360011|NCT00459186|874104|P1|NOT COMPLETED|Combination RAD001 + Docetaxel||0
360012|NCT00459186|874104|P1|COMPLETED|Combination RAD001 + Docetaxel||15
360013|NCT00459186|874104|P1|STARTED|Combination RAD001 + Docetaxel||15
360014|NCT00459186|874104|P1|NOT COMPLETED|PET Imaging and Assessment||3
360015|NCT00459186|874104|P1|COMPLETED|PET Imaging and Assessment||15
360016|NCT00459186|874104|P1|STARTED|PET Imaging and Assessment||18
360017|NCT00459186|874104|P1|NOT COMPLETED|Single Agent RAD001||1
360018|NCT00459186|874104|P1|COMPLETED|Single Agent RAD001||18
360019|NCT00459186|874104|P1|STARTED|Single Agent RAD001||19
360020|NCT00459134|874111|P2|NOT COMPLETED|Overall Study||25
360021|NCT00459134|874112|P1|NOT COMPLETED|Overall Study||23
360022|NCT00459134|874111|P2|COMPLETED|Overall Study||67
360023|NCT00459134|874112|P1|COMPLETED|Overall Study||71
360024|NCT00459134|874111|P2|STARTED|Overall Study||92
360025|NCT00459134|874112|P1|STARTED|Overall Study||94
360026|NCT00459121|874120|P1|NOT COMPLETED|Overall Study||0
360027|NCT00459121|874120|P1|COMPLETED|Overall Study||2
360028|NCT00459121|874120|P1|STARTED|Overall Study||2
360029|NCT00459108|874128|P1|NOT COMPLETED|Overall Study||11
360030|NCT00459108|874128|P1|COMPLETED|Overall Study||14
360031|NCT00459108|874128|P1|STARTED|Overall Study||25
360032|NCT00459056|874138|P2|NOT COMPLETED|Second Intervention (Final Three Months)||0
360033|NCT00459056|874139|P1|NOT COMPLETED|Second Intervention (Final Three Months)||0
360034|NCT00459056|874138|P2|COMPLETED|Second Intervention (Final Three Months)||14
360035|NCT00459056|874139|P1|COMPLETED|Second Intervention (Final Three Months)||9
360036|NCT00459056|874138|P2|STARTED|Second Intervention (Final Three Months)||14
360037|NCT00459056|874139|P1|STARTED|Second Intervention (Final Three Months)||9
360038|NCT00459056|874138|P2|NOT COMPLETED|Washout (1 Month)||0
360039|NCT00459056|874139|P1|NOT COMPLETED|Washout (1 Month)||0
360040|NCT00459056|874138|P2|COMPLETED|Washout (1 Month)||14
360041|NCT00459056|874139|P1|COMPLETED|Washout (1 Month)||9
360042|NCT00459056|874138|P2|STARTED|Washout (1 Month)||14
360043|NCT00459056|874139|P1|STARTED|Washout (1 Month)||9
360044|NCT00459056|874138|P2|NOT COMPLETED|First Intervention (First Three Months)||1
360045|NCT00459056|874139|P1|NOT COMPLETED|First Intervention (First Three Months)||1
360046|NCT00459056|874138|P2|COMPLETED|First Intervention (First Three Months)||14
360047|NCT00459056|874139|P1|COMPLETED|First Intervention (First Three Months)||9
360048|NCT00459056|874138|P2|STARTED|First Intervention (First Three Months)||15
360049|NCT00459056|874139|P1|STARTED|First Intervention (First Three Months)||10
360050|NCT00459043|874147|P2|NOT COMPLETED|Overall Study||0
360051|NCT00459043|874148|P1|NOT COMPLETED|Overall Study||1
360052|NCT00459043|874147|P2|COMPLETED|Overall Study||15
360053|NCT00459043|874148|P1|COMPLETED|Overall Study||14
360054|NCT00459043|874147|P2|STARTED|Overall Study||15
360055|NCT00459043|874148|P1|STARTED|Overall Study||15
360056|NCT00458952|874160|P2|NOT COMPLETED|Overall Study||5
360057|NCT00458952|874161|P1|NOT COMPLETED|Overall Study||2
360058|NCT00458952|874160|P2|COMPLETED|Overall Study||9
360059|NCT00458952|874161|P1|COMPLETED|Overall Study||5
360060|NCT00458952|874160|P2|STARTED|Overall Study||14
360061|NCT00458952|874161|P1|STARTED|Overall Study||7
360062|NCT00458848|874165|P1|NOT COMPLETED|Overall Study||0
360063|NCT00458848|874165|P1|COMPLETED|Overall Study||51
360064|NCT00458848|874165|P1|STARTED|Overall Study||51
360065|NCT00458822|874171|P1|NOT COMPLETED|Overall Study||0
360066|NCT00458822|874171|P1|COMPLETED|Overall Study||40
360067|NCT00458822|874171|P1|STARTED|Overall Study||40
360068|NCT00458705|874175|P1|NOT COMPLETED|Overall Study||5
360069|NCT00458705|874175|P1|COMPLETED|Overall Study||40
360070|NCT00458705|874175|P1|STARTED|Overall Study||45
360071|NCT00458536|874179|P1|NOT COMPLETED|Overall Study||19
360072|NCT00458536|874179|P1|COMPLETED|Overall Study||19
360073|NCT00458536|874179|P1|STARTED|Overall Study||38
360074|NCT00458406|874185|P2|NOT COMPLETED|Month 3||0
360075|NCT00458406|874186|P1|NOT COMPLETED|Month 3||0
360076|NCT00458406|874185|P2|COMPLETED|Month 3||13
360077|NCT00458406|874186|P1|COMPLETED|Month 3||43
360078|NCT00458406|874185|P2|STARTED|Month 3||13
360079|NCT00458406|874186|P1|STARTED|Month 3||43
360080|NCT00458406|874185|P2|NOT COMPLETED|Month 1||0
360081|NCT00458406|874186|P1|NOT COMPLETED|Month 1||0
360082|NCT00458406|874185|P2|COMPLETED|Month 1||13
360083|NCT00458406|874186|P1|COMPLETED|Month 1||43
360084|NCT00458406|874185|P2|STARTED|Month 1||13
360085|NCT00458406|874186|P1|STARTED|Month 1||43
360086|NCT00458393|874210|P2|NOT COMPLETED|Overall Study||295
360087|NCT00458393|874211|P1|NOT COMPLETED|Overall Study||309
360088|NCT00458393|874210|P2|COMPLETED|Overall Study||953
360089|NCT00458393|874211|P1|COMPLETED|Overall Study||942
360090|NCT00458393|874210|P2|STARTED|Overall Study||1248
360091|NCT00458393|874211|P1|STARTED|Overall Study||1251
360092|NCT00458302|874259|P2|NOT COMPLETED|Overall Study||24
360093|NCT00458302|874260|P1|NOT COMPLETED|Overall Study||20
360094|NCT00458302|874259|P2|COMPLETED|Overall Study||103
360095|NCT00458302|874260|P1|COMPLETED|Overall Study||109
360096|NCT00458302|874259|P2|STARTED|Overall Study||127
360097|NCT00458302|874260|P1|STARTED|Overall Study||129
360098|NCT00458237|874294|P3|NOT COMPLETED|Overall Study||0
360099|NCT00458237|874295|P2|NOT COMPLETED|Overall Study||0
360100|NCT00458237|874296|P1|NOT COMPLETED|Overall Study||0
360101|NCT00458237|874294|P3|COMPLETED|Overall Study||5
360102|NCT00458237|874295|P2|COMPLETED|Overall Study||3
360103|NCT00458237|874296|P1|COMPLETED|Overall Study||3
360104|NCT00458237|874294|P3|STARTED|Overall Study||5
360105|NCT00458237|874295|P2|STARTED|Overall Study||3
360106|NCT00458237|874296|P1|STARTED|Overall Study||3
360107|NCT00458211|874305|P1|NOT COMPLETED|Overall Study||16
360108|NCT00458211|874305|P1|COMPLETED|Overall Study|12 early termination 2 protocol violation 2 ( from Rochester) withdrawn from further analysis|24
360109|NCT00458211|874305|P1|STARTED|Overall Study||40
360110|NCT00457977|874318|P2|NOT COMPLETED|Overall Study||25
360111|NCT00457977|874319|P1|NOT COMPLETED|Overall Study||28
360112|NCT00457977|874318|P2|COMPLETED|Overall Study||66
360113|NCT00457977|874319|P1|COMPLETED|Overall Study||62
360114|NCT00457977|874318|P2|2-Year|Overall Study||66
360115|NCT00457977|874319|P1|2-Year|Overall Study||62
360116|NCT00457977|874318|P2|1-Year|Overall Study||76
360117|NCT00457977|874319|P1|1-Year|Overall Study||69
360118|NCT00457977|874318|P2|1-Month|Overall Study||87
360119|NCT00457977|874319|P1|1-Month|Overall Study||88
360120|NCT00457977|874318|P2|STARTED|Overall Study||91
360121|NCT00457977|874319|P1|STARTED|Overall Study||90
360122|NCT00457951|874330|P3|NOT COMPLETED|Overall Study||12
360123|NCT00457951|874331|P2|NOT COMPLETED|Overall Study||16
360124|NCT00457951|874332|P1|NOT COMPLETED|Overall Study||0
360125|NCT00457951|874330|P3|COMPLETED|Overall Study||60
360126|NCT00457951|874331|P2|COMPLETED|Overall Study||50
360127|NCT00457951|874332|P1|COMPLETED|Overall Study||13
360128|NCT00457951|874330|P3|STARTED|Overall Study||72
360129|NCT00457951|874331|P2|STARTED|Overall Study||66
360130|NCT00457951|874332|P1|STARTED|Overall Study||13
360131|NCT00457821|874347|P8|NOT COMPLETED|Part 2||1
360132|NCT00457821|874348|P7|NOT COMPLETED|Part 2||0
360133|NCT00457821|874349|P6|NOT COMPLETED|Part 2||0
360134|NCT00457821|874350|P5|NOT COMPLETED|Part 2||0
360135|NCT00457821|874351|P4|NOT COMPLETED|Part 2||0
360136|NCT00457821|874352|P3|NOT COMPLETED|Part 2||0
360137|NCT00457821|874353|P2|NOT COMPLETED|Part 2||0
360138|NCT00457821|874354|P1|NOT COMPLETED|Part 2||0
360139|NCT00457821|874347|P8|COMPLETED|Part 2||4
360140|NCT00457821|874348|P7|COMPLETED|Part 2||7
360141|NCT00457821|874349|P6|COMPLETED|Part 2||8
360142|NCT00457821|874350|P5|COMPLETED|Part 2||0
360143|NCT00457821|874351|P4|COMPLETED|Part 2||0
360144|NCT00457821|874352|P3|COMPLETED|Part 2||0
360145|NCT00457821|874353|P2|COMPLETED|Part 2||0
360146|NCT00457821|874354|P1|COMPLETED|Part 2||0
360147|NCT00457821|874347|P8|Completed Study Drug Treatment|Part 2||4
360148|NCT00457821|874348|P7|Completed Study Drug Treatment|Part 2|1 subject missed a 250-mg dose of ivacaftor on Day 28 of Part 2.|7
360149|NCT00457821|874349|P6|Completed Study Drug Treatment|Part 2||8
360150|NCT00457821|874350|P5|Completed Study Drug Treatment|Part 2||0
360151|NCT00457821|874351|P4|Completed Study Drug Treatment|Part 2||0
360152|NCT00457821|874352|P3|Completed Study Drug Treatment|Part 2||0
360153|NCT00457821|874353|P2|Completed Study Drug Treatment|Part 2||0
360154|NCT00457821|874354|P1|Completed Study Drug Treatment|Part 2||0
360155|NCT00457821|874347|P8|STARTED|Part 2|All subjects who received at least 1 dose of study drug (placebo).|5
360156|NCT00457821|874348|P7|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|7
360157|NCT00457821|874349|P6|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|8
360158|NCT00457821|874350|P5|STARTED|Part 2|Arm in Part 1 only|0
360159|NCT00457821|874351|P4|STARTED|Part 2|Arm in Part 1 only|0
360160|NCT00457821|874352|P3|STARTED|Part 2|Arm in Part 1 only|0
360161|NCT00457821|874353|P2|STARTED|Part 2|Arm in Part 1 only|0
360162|NCT00457821|874354|P1|STARTED|Part 2|Arm in Part 1 only|0
360163|NCT00457821|874347|P8|NOT COMPLETED|Part 1||0
360164|NCT00457821|874348|P7|NOT COMPLETED|Part 1||0
360165|NCT00457821|874349|P6|NOT COMPLETED|Part 1||0
360166|NCT00457821|874350|P5|NOT COMPLETED|Part 1||0
360167|NCT00457821|874351|P4|NOT COMPLETED|Part 1||0
360168|NCT00457821|874352|P3|NOT COMPLETED|Part 1||1
360169|NCT00457821|874353|P2|NOT COMPLETED|Part 1||0
360170|NCT00457821|874354|P1|NOT COMPLETED|Part 1||0
360171|NCT00457821|874347|P8|COMPLETED|Part 1||0
360172|NCT00457821|874348|P7|COMPLETED|Part 1||0
360173|NCT00457821|874349|P6|COMPLETED|Part 1||0
360174|NCT00457821|874350|P5|COMPLETED|Part 1||4
360175|NCT00457821|874351|P4|COMPLETED|Part 1||4
360176|NCT00457821|874352|P3|COMPLETED|Part 1||4
360177|NCT00457821|874353|P2|COMPLETED|Part 1||4
360178|NCT00457821|874354|P1|COMPLETED|Part 1||4
360179|NCT00457821|874347|P8|STARTED|Part 1|Arm in Part 2 only|0
360180|NCT00457821|874348|P7|STARTED|Part 1|Arm in Part 2 only|0
360181|NCT00457821|874349|P6|STARTED|Part 1|Arm in Part 2 only|0
360182|NCT00457821|874350|P5|STARTED|Part 1|Number of subjects randomized|4
360183|NCT00457821|874351|P4|STARTED|Part 1|Number of subjects randomized|4
360184|NCT00457821|874352|P3|STARTED|Part 1|Number of subjects randomized|5
360185|NCT00457821|874353|P2|STARTED|Part 1|Number of subjects randomized|4
360186|NCT00457821|874354|P1|STARTED|Part 1|Number of subjects randomized|4
360187|NCT00457795|874383|P1|NOT COMPLETED|Overall Study||0
360188|NCT00457795|874383|P1|COMPLETED|Overall Study||15
360189|NCT00457795|874383|P1|STARTED|Overall Study||15
360190|NCT00457743|874393|P3|NOT COMPLETED|Overall Study||3
360191|NCT00457743|874394|P2|NOT COMPLETED|Overall Study||27
360192|NCT00457743|874395|P1|NOT COMPLETED|Overall Study||3
360193|NCT00457743|874393|P3|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis(Intent-to treat population).|0
360194|NCT00457743|874394|P2|COMPLETED|Overall Study|However, all 30 subjects enrolled were included in analysis(Intent-to treat population).|3
360195|NCT00457743|874395|P1|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis (Intent-to treat population).|0
360196|NCT00457743|874393|P3|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
360197|NCT00457743|874394|P2|Enrolled in Phase 2|Overall Study|Six subjects who completed Phase 1 entered Phase 2, and 24 subjects were newly enrolled.|30
360198|NCT00457743|874395|P1|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
360199|NCT00457743|874393|P3|Completed Phase 1|Overall Study||3
360200|NCT00457743|874394|P2|Completed Phase 1|Overall Study||6
360201|NCT00457743|874395|P1|Completed Phase 1|Overall Study||3
360202|NCT00457743|874393|P3|Enrolled in Phase 1|Overall Study||3
360203|NCT00457743|874394|P2|Enrolled in Phase 1|Overall Study||6
360204|NCT00457743|874395|P1|Enrolled in Phase 1|Overall Study||3
360205|NCT00457743|874393|P3|STARTED|Overall Study|Overall study|3
360206|NCT00457743|874394|P2|STARTED|Overall Study|Overall study|30
360207|NCT00457743|874395|P1|STARTED|Overall Study|Overall study|3
360208|NCT00457730|874439|P2|NOT COMPLETED|Overall Study||1
360209|NCT00457730|874440|P1|NOT COMPLETED|Overall Study||4
360210|NCT00457730|874439|P2|COMPLETED|Overall Study||19
360211|NCT00457730|874440|P1|COMPLETED|Overall Study||14
360212|NCT00457730|874439|P2|STARTED|Overall Study||20
360213|NCT00457730|874440|P1|STARTED|Overall Study||18
360214|NCT00457691|874452|P2|NOT COMPLETED|Overall Study||382
360215|NCT00457691|874453|P1|NOT COMPLETED|Overall Study||386
360216|NCT00457691|874452|P2|COMPLETED|Overall Study||0
360217|NCT00457691|874453|P1|COMPLETED|Overall Study||0
360218|NCT00457691|874452|P2|STARTED|Overall Study||382
360219|NCT00457691|874453|P1|STARTED|Overall Study||386
360220|NCT00457665|874475|P2|NOT COMPLETED|24 Months||8
360221|NCT00457665|874476|P1|NOT COMPLETED|24 Months||5
360222|NCT00457665|874475|P2|COMPLETED|24 Months||11
360223|NCT00457665|874476|P1|COMPLETED|24 Months||15
360224|NCT00457665|874475|P2|STARTED|24 Months||19
360225|NCT00457665|874476|P1|STARTED|24 Months||20
360226|NCT00457665|874475|P2|NOT COMPLETED|12 Months||9
360227|NCT00457665|874476|P1|NOT COMPLETED|12 Months||8
360228|NCT00457665|874475|P2|COMPLETED|12 Months||19
360229|NCT00457665|874476|P1|COMPLETED|12 Months||20
360230|NCT00457665|874475|P2|STARTED|12 Months||28
360231|NCT00457665|874476|P1|STARTED|12 Months||28
360232|NCT00457639|874482|P2|NOT COMPLETED|Intervention 2 (6 Months)||1
360233|NCT00457639|874483|P1|NOT COMPLETED|Intervention 2 (6 Months)||0
360234|NCT00457639|874482|P2|COMPLETED|Intervention 2 (6 Months)||6
360235|NCT00457639|874483|P1|COMPLETED|Intervention 2 (6 Months)||6
360236|NCT00457639|874482|P2|STARTED|Intervention 2 (6 Months)||7
360237|NCT00457639|874483|P1|STARTED|Intervention 2 (6 Months)||6
360238|NCT00457639|874482|P2|NOT COMPLETED|Intervention 1 (6 Months)||2
360239|NCT00457639|874483|P1|NOT COMPLETED|Intervention 1 (6 Months)||3
360240|NCT00457639|874482|P2|COMPLETED|Intervention 1 (6 Months)|Number of patients completing Placebo Phase|7
360241|NCT00457639|874483|P1|COMPLETED|Intervention 1 (6 Months)|Number of Patients completing Cholic Acid Phase|6
360242|NCT00457639|874482|P2|STARTED|Intervention 1 (6 Months)|6 months on Placebo and crossover to cholic acid for 6 months|9
360243|NCT00457639|874483|P1|STARTED|Intervention 1 (6 Months)|6 months on Cholic Acid and crossover to Placebo for 6 months|9
360244|NCT00457418|874491|P1|NOT COMPLETED|Post PK Maintenance||28
360245|NCT00457418|874491|P1|COMPLETED|Post PK Maintenance||3
360246|NCT00457418|874491|P1|STARTED|Post PK Maintenance|4 participants didn't complete the PK sampling phase but continued to post PK maintenance treatment.|31
360247|NCT00457418|874491|P1|NOT COMPLETED|Pharmacokinetic (PK) Sampling Phase||5
360248|NCT00457418|874491|P1|COMPLETED|Pharmacokinetic (PK) Sampling Phase||27
360249|NCT00457418|874491|P1|STARTED|Pharmacokinetic (PK) Sampling Phase||32
360250|NCT00457392|874503|P2|NOT COMPLETED|Overall Study||480
360251|NCT00457392|874504|P1|NOT COMPLETED|Overall Study||480
360252|NCT00457392|874503|P2|COMPLETED|Overall Study||0
360253|NCT00457392|874504|P1|COMPLETED|Overall Study||0
360254|NCT00457392|874503|P2|Treated|Overall Study||477
360255|NCT00457392|874504|P1|Treated|Overall Study||473
360256|NCT00457392|874503|P2|STARTED|Overall Study||480
360257|NCT00457392|874504|P1|STARTED|Overall Study||480
360258|NCT00457366|874522|P2|NOT COMPLETED|Overall Study||0
360259|NCT00457366|874523|P1|NOT COMPLETED|Overall Study||0
360260|NCT00457366|874522|P2|COMPLETED|Overall Study||32
360261|NCT00457366|874523|P1|COMPLETED|Overall Study||40
360262|NCT00457366|874522|P2|STARTED|Overall Study||32
360263|NCT00457366|874523|P1|STARTED|Overall Study||40
360264|NCT00457301|874531|P2|NOT COMPLETED|Overall Study||24
360265|NCT00457301|874532|P1|NOT COMPLETED|Overall Study||23
360266|NCT00457301|874531|P2|COMPLETED|Overall Study||84
360267|NCT00457301|874532|P1|COMPLETED|Overall Study||82
360268|NCT00457301|874531|P2|STARTED|Overall Study||108
360269|NCT00457301|874532|P1|STARTED|Overall Study||105
360270|NCT00457249|874546|P2|NOT COMPLETED|Overall Study||2
360271|NCT00457249|874547|P1|NOT COMPLETED|Overall Study||12
360272|NCT00457249|874546|P2|COMPLETED|Overall Study||389
360273|NCT00457249|874547|P1|COMPLETED|Overall Study||1158
360274|NCT00457249|874546|P2|STARTED|Overall Study||391
360275|NCT00457249|874547|P1|STARTED|Overall Study||1170
360276|NCT00457197|874561|P2|NOT COMPLETED|Overall Study||1
360277|NCT00457197|874562|P1|NOT COMPLETED|Overall Study||1
360278|NCT00457197|874561|P2|COMPLETED|Overall Study||44
360279|NCT00457197|874562|P1|COMPLETED|Overall Study||44
360280|NCT00457197|874561|P2|STARTED|Overall Study||45
360281|NCT00457197|874562|P1|STARTED|Overall Study||45
360282|NCT00457015|874586|P2|NOT COMPLETED|Overall Study||1
360283|NCT00457015|874587|P1|NOT COMPLETED|Overall Study||0
360284|NCT00457015|874586|P2|COMPLETED|Overall Study||47
360285|NCT00457015|874587|P1|COMPLETED|Overall Study||48
360286|NCT00457015|874586|P2|STARTED|Overall Study||48
360287|NCT00457015|874587|P1|STARTED|Overall Study||48
360288|NCT00457002|874603|P2|NOT COMPLETED|Overall Study||757
360289|NCT00457002|874604|P1|NOT COMPLETED|Overall Study||813
360290|NCT00457002|874603|P2|COMPLETED|Overall Study||2516
360291|NCT00457002|874604|P1|COMPLETED|Overall Study||2442
360292|NCT00457002|874603|P2|STARTED|Overall Study||3273
360293|NCT00457002|874604|P1|STARTED|Overall Study||3255
360294|NCT00456989|874672|P1|NOT COMPLETED|Overall Study||0
360295|NCT00456989|874672|P1|COMPLETED|Overall Study||39
360296|NCT00456989|874672|P1|STARTED|Overall Study||39
360297|NCT00456885|874677|P2|NOT COMPLETED|Second Treatment Period, 16 Weeks||0
360298|NCT00456885|874678|P1|NOT COMPLETED|Second Treatment Period, 16 Weeks||1
360299|NCT00456885|874677|P2|COMPLETED|Second Treatment Period, 16 Weeks||17
360300|NCT00456885|874678|P1|COMPLETED|Second Treatment Period, 16 Weeks||23
360301|NCT00456885|874677|P2|STARTED|Second Treatment Period, 16 Weeks||17
360302|NCT00456885|874678|P1|STARTED|Second Treatment Period, 16 Weeks||24
360303|NCT00456885|874677|P2|NOT COMPLETED|Washout, 3 Weeks||0
360304|NCT00456885|874678|P1|NOT COMPLETED|Washout, 3 Weeks||0
360305|NCT00456885|874677|P2|COMPLETED|Washout, 3 Weeks||17
360306|NCT00456885|874678|P1|COMPLETED|Washout, 3 Weeks||24
360307|NCT00456885|874677|P2|STARTED|Washout, 3 Weeks||17
360308|NCT00456885|874678|P1|STARTED|Washout, 3 Weeks||24
360309|NCT00456885|874677|P2|NOT COMPLETED|First Treatment Period, 16 Weeks||0
360310|NCT00456885|874678|P1|NOT COMPLETED|First Treatment Period, 16 Weeks||0
360311|NCT00456885|874677|P2|COMPLETED|First Treatment Period, 16 Weeks||17
360312|NCT00456885|874678|P1|COMPLETED|First Treatment Period, 16 Weeks||24
360313|NCT00456885|874677|P2|STARTED|First Treatment Period, 16 Weeks||17
360314|NCT00456885|874678|P1|STARTED|First Treatment Period, 16 Weeks||24
360315|NCT00456846|874709|P2|NOT COMPLETED|Overall Study||28
360316|NCT00456846|874710|P1|NOT COMPLETED|Overall Study||16
360317|NCT00456846|874709|P2|COMPLETED|Overall Study|Treatment considered completed upon disease progression|48
360318|NCT00456846|874710|P1|COMPLETED|Overall Study|Treatment considered completed upon disease progression|31
360319|NCT00456846|874709|P2|STARTED|Overall Study||76
360320|NCT00456846|874710|P1|STARTED|Overall Study||47
360321|NCT00456807|874732|P2|NOT COMPLETED|Overall Study||0
360322|NCT00456807|874733|P1|NOT COMPLETED|Overall Study||1
360323|NCT00456807|874732|P2|COMPLETED|Overall Study||47
360324|NCT00456807|874733|P1|COMPLETED|Overall Study||52
360325|NCT00456807|874732|P2|STARTED|Overall Study||47
360326|NCT00456807|874733|P1|STARTED|Overall Study||53
360327|NCT00456755|874751|P2|NOT COMPLETED|Overall Study||1
360328|NCT00456755|874752|P1|NOT COMPLETED|Overall Study||2
360329|NCT00456755|874751|P2|COMPLETED|Overall Study||62
360330|NCT00456755|874752|P1|COMPLETED|Overall Study||61
360331|NCT00456755|874751|P2|STARTED|Overall Study||63
360332|NCT00456755|874752|P1|STARTED|Overall Study||63
360333|NCT00456625|874760|P1|NOT COMPLETED|Overall Study||0
360334|NCT00456625|874760|P1|COMPLETED|Overall Study||76
360335|NCT00456625|874760|P1|STARTED|Overall Study||76
360336|NCT00456612|874766|P1|NOT COMPLETED|Overall Study||3
360337|NCT00456612|874766|P1|COMPLETED|Overall Study||1
360338|NCT00456612|874766|P1|STARTED|Overall Study||4
360339|NCT00456599|874771|P1|NOT COMPLETED|Overall Study||3
360340|NCT00456599|874771|P1|COMPLETED|Overall Study||68
360341|NCT00456599|874771|P1|Completed 4th Cycle of Chemotherapy|Overall Study|24 patients (63%) completed a fourth cycle of chemotherapy.|24
360342|NCT00456599|874771|P1|Post-Surgery Adjuvent Therapy|Overall Study|After resection, 26 patients (68%) initiated adjuvant therapy.|26
360343|NCT00456599|874771|P1|Completed Resection|Overall Study|43 patients underwent resection.|43
360344|NCT00456599|874771|P1|Completed Protocol Surgery|Overall Study|Forty-eight patients (71%) underwent laparotomy according to the protocol.|48
360345|NCT00456599|874771|P1|Initiated Cycle 2|Overall Study|5 patients were removed from study prior to initiation of a second cycle.|61
360346|NCT00456599|874771|P1|Completed Cycle 1|Overall Study|Of the 71 patients, 1 was removed for noncompliance; 2 withdrew; 2 did not complete cycle 1.|66
360347|NCT00456599|874771|P1|STARTED|Overall Study||71
360348|NCT00456547|874779|P2|NOT COMPLETED|Overall Study||0
360349|NCT00456547|874780|P1|NOT COMPLETED|Overall Study||0
360350|NCT00456547|874779|P2|COMPLETED|Overall Study||12
360351|NCT00456547|874780|P1|COMPLETED|Overall Study||12
360352|NCT00456547|874779|P2|STARTED|Overall Study||12
360353|NCT00456547|874780|P1|STARTED|Overall Study||12
360354|NCT00456521|874794|P2|NOT COMPLETED|Overall Study||84
360355|NCT00456521|874795|P1|NOT COMPLETED|Overall Study||249
360356|NCT00456521|874794|P2|COMPLETED|Overall Study||118
360357|NCT00456521|874795|P1|COMPLETED|Overall Study||342
360358|NCT00456521|874794|P2|STARTED|Overall Study||202
360359|NCT00456521|874795|P1|STARTED|Overall Study||591
360360|NCT00456508|874835|P1|NOT COMPLETED|Overall Study||0
360361|NCT00456508|874835|P1|COMPLETED|Overall Study||147
360362|NCT00456508|874835|P1|STARTED|Overall Study||147
360363|NCT00456495|874841|P1|NOT COMPLETED|Overall Study||2
360364|NCT00456495|874841|P1|COMPLETED|Overall Study||3
360365|NCT00456495|874841|P1|STARTED|Overall Study||5
360366|NCT00456365|874848|P2|NOT COMPLETED|Overall Study||12
360367|NCT00456365|874849|P1|NOT COMPLETED|Overall Study||7
360368|NCT00456365|874848|P2|COMPLETED|Overall Study||42
360369|NCT00456365|874849|P1|COMPLETED|Overall Study||49
360370|NCT00456365|874848|P2|STARTED|Overall Study||54
360371|NCT00456365|874849|P1|STARTED|Overall Study||56
360372|NCT00456300|874861|P2|NOT COMPLETED|Overall Study||0
360373|NCT00456300|874862|P1|NOT COMPLETED|Overall Study||1
360374|NCT00456300|874861|P2|COMPLETED|Overall Study||4
360375|NCT00456300|874862|P1|COMPLETED|Overall Study||4
360376|NCT00456300|874861|P2|STARTED|Overall Study||4
360377|NCT00456300|874862|P1|STARTED|Overall Study||5
360378|NCT00456261|874872|P2|NOT COMPLETED|Maintenance Therapy||0
360379|NCT00456261|874873|P1|NOT COMPLETED|Maintenance Therapy||0
360380|NCT00456261|874872|P2|COMPLETED|Maintenance Therapy||29
360381|NCT00456261|874873|P1|COMPLETED|Maintenance Therapy||3
360382|NCT00456261|874872|P2|STARTED|Maintenance Therapy||29
360383|NCT00456261|874873|P1|STARTED|Maintenance Therapy||3
360384|NCT00456261|874872|P2|NOT COMPLETED|Combination Therapy||26
360385|NCT00456261|874873|P1|NOT COMPLETED|Combination Therapy||52
360386|NCT00456261|874872|P2|COMPLETED|Combination Therapy||29
360387|NCT00456261|874873|P1|COMPLETED|Combination Therapy||3
360388|NCT00456261|874872|P2|STARTED|Combination Therapy||55
360389|NCT00456261|874873|P1|STARTED|Combination Therapy||55
360390|NCT00456092|874886|P5|NOT COMPLETED|Treatment Phase (12 Weeks)||0
360391|NCT00456092|874887|P4|NOT COMPLETED|Treatment Phase (12 Weeks)||0
360392|NCT00456092|874888|P3|NOT COMPLETED|Treatment Phase (12 Weeks)||18
360393|NCT00456092|874889|P2|NOT COMPLETED|Treatment Phase (12 Weeks)||14
360394|NCT00456092|874890|P1|NOT COMPLETED|Treatment Phase (12 Weeks)||7
360395|NCT00456092|874886|P5|COMPLETED|Treatment Phase (12 Weeks)||0
360396|NCT00456092|874887|P4|COMPLETED|Treatment Phase (12 Weeks)||0
360397|NCT00456092|874888|P3|COMPLETED|Treatment Phase (12 Weeks)||50
360398|NCT00456092|874889|P2|COMPLETED|Treatment Phase (12 Weeks)||55
360399|NCT00456092|874890|P1|COMPLETED|Treatment Phase (12 Weeks)||60
360400|NCT00456092|874886|P5|STARTED|Treatment Phase (12 Weeks)||0
360401|NCT00456092|874887|P4|STARTED|Treatment Phase (12 Weeks)||0
360402|NCT00456092|874888|P3|STARTED|Treatment Phase (12 Weeks)||68
360403|NCT00456092|874889|P2|STARTED|Treatment Phase (12 Weeks)||69
360404|NCT00456092|874890|P1|STARTED|Treatment Phase (12 Weeks)||67
360405|NCT00456092|874886|P5|NOT COMPLETED|Extension Phase||7
360406|NCT00456092|874887|P4|NOT COMPLETED|Extension Phase||1
360407|NCT00456092|874888|P3|NOT COMPLETED|Extension Phase||0
360408|NCT00456092|874889|P2|NOT COMPLETED|Extension Phase||4
360409|NCT00456092|874890|P1|NOT COMPLETED|Extension Phase||11
360410|NCT00456092|874886|P5|COMPLETED|Extension Phase||13
360411|NCT00456092|874887|P4|COMPLETED|Extension Phase||19
360412|NCT00456092|874888|P3|COMPLETED|Extension Phase||0
360413|NCT00456092|874889|P2|COMPLETED|Extension Phase||36
360414|NCT00456092|874890|P1|COMPLETED|Extension Phase||35
360415|NCT00456092|874886|P5|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|20
360416|NCT00456092|874887|P4|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|20
360417|NCT00456092|874888|P3|STARTED|Extension Phase||0
360418|NCT00456092|874889|P2|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|40
360419|NCT00456092|874890|P1|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|46
360420|NCT00456014|875040|P1|NOT COMPLETED|Tricyclic Phase||3
360421|NCT00456014|875040|P1|COMPLETED|Tricyclic Phase||1
360422|NCT00456014|875040|P1|STARTED|Tricyclic Phase|Only non-remitters from phase 1 were eligible for phase 2, and not all those eligible continued.|4
360423|NCT00456014|875040|P1|NOT COMPLETED|SSRI Phase||9
360424|NCT00456014|875040|P1|COMPLETED|SSRI Phase||28
360425|NCT00456014|875040|P1|STARTED|SSRI Phase||37
360426|NCT00455975|875048|P2|NOT COMPLETED|Overall Study||21
360427|NCT00455975|875049|P1|NOT COMPLETED|Overall Study||18
360428|NCT00455975|875048|P2|COMPLETED|Overall Study||40
360429|NCT00455975|875049|P1|COMPLETED|Overall Study||40
360430|NCT00455975|875048|P2|STARTED|Overall Study||61
360431|NCT00455975|875049|P1|STARTED|Overall Study||58
360432|NCT00455962|875063|P2|NOT COMPLETED|Overall Study||0
360433|NCT00455962|875064|P1|NOT COMPLETED|Overall Study||0
360434|NCT00455962|875063|P2|COMPLETED|Overall Study||13
360435|NCT00455962|875064|P1|COMPLETED|Overall Study||10
360436|NCT00455962|875063|P2|STARTED|Overall Study||13
360437|NCT00455962|875064|P1|STARTED|Overall Study||10
360438|NCT00455923|875072|P2|NOT COMPLETED|Overall Study||3
360439|NCT00455923|875073|P1|NOT COMPLETED|Overall Study||3
360440|NCT00455923|875072|P2|COMPLETED|Overall Study||47
360441|NCT00455923|875073|P1|COMPLETED|Overall Study||47
360442|NCT00455923|875072|P2|STARTED|Overall Study||50
360443|NCT00455923|875073|P1|STARTED|Overall Study||50
360444|NCT00455858|875089|P1|NOT COMPLETED|Overall Study||6
360445|NCT00455858|875089|P1|COMPLETED|Overall Study||81
360446|NCT00455858|875089|P1|STARTED|Overall Study|Enrolled in study and exposed to study drug|87
360447|NCT00455741|875099|P2|NOT COMPLETED|Overall Study||1
360448|NCT00455741|875100|P1|NOT COMPLETED|Overall Study||0
360449|NCT00455741|875099|P2|COMPLETED|Overall Study||11
360450|NCT00455741|875100|P1|COMPLETED|Overall Study||13
360451|NCT00455741|875099|P2|STARTED|Overall Study||12
360452|NCT00455741|875100|P1|STARTED|Overall Study||13
360453|NCT00455702|875118|P2|NOT COMPLETED|Overall Study||3
360454|NCT00455702|875119|P1|NOT COMPLETED|Overall Study||3
360455|NCT00455702|875118|P2|COMPLETED|Overall Study||16
360456|NCT00455702|875119|P1|COMPLETED|Overall Study||16
360457|NCT00455702|875118|P2|STARTED|Overall Study||19
360458|NCT00455702|875119|P1|STARTED|Overall Study||19
360459|NCT00455689|875129|P2|NOT COMPLETED|Overall Study||0
360460|NCT00455689|875130|P1|NOT COMPLETED|Overall Study||0
360461|NCT00455689|875129|P2|COMPLETED|Overall Study||6
360462|NCT00455689|875130|P1|COMPLETED|Overall Study||14
360463|NCT00455689|875129|P2|STARTED|Overall Study||6
360464|NCT00455689|875130|P1|STARTED|Overall Study||14
360465|NCT00455663|875140|P3|NOT COMPLETED|Overall Study||3
360466|NCT00455663|875141|P2|NOT COMPLETED|Overall Study||4
360467|NCT00455663|875142|P1|NOT COMPLETED|Overall Study||3
360468|NCT00455663|875140|P3|COMPLETED|Overall Study||29
360469|NCT00455663|875141|P2|COMPLETED|Overall Study||32
360470|NCT00455663|875142|P1|COMPLETED|Overall Study||34
360471|NCT00455663|875140|P3|STARTED|Overall Study||32
360472|NCT00455663|875141|P2|STARTED|Overall Study||36
360473|NCT00455663|875142|P1|STARTED|Overall Study||37
360474|NCT00455650|875161|P6|NOT COMPLETED|Week 3||0
360475|NCT00455650|875162|P5|NOT COMPLETED|Week 3||0
360476|NCT00455650|875163|P4|NOT COMPLETED|Week 3||0
360477|NCT00455650|875164|P3|NOT COMPLETED|Week 3||0
360478|NCT00455650|875165|P2|NOT COMPLETED|Week 3||0
360479|NCT00455650|875166|P1|NOT COMPLETED|Week 3||0
360480|NCT00455650|875161|P6|COMPLETED|Week 3||13
360481|NCT00455650|875162|P5|COMPLETED|Week 3||14
360482|NCT00455650|875163|P4|COMPLETED|Week 3||14
360483|NCT00455650|875164|P3|COMPLETED|Week 3||10
360484|NCT00455650|875165|P2|COMPLETED|Week 3||10
360485|NCT00455650|875166|P1|COMPLETED|Week 3||10
360486|NCT00455650|875161|P6|STARTED|Week 3||13
360487|NCT00455650|875162|P5|STARTED|Week 3||14
360488|NCT00455650|875163|P4|STARTED|Week 3||14
360489|NCT00455650|875164|P3|STARTED|Week 3||10
360490|NCT00455650|875165|P2|STARTED|Week 3||10
360491|NCT00455650|875166|P1|STARTED|Week 3||10
360492|NCT00455650|875161|P6|NOT COMPLETED|Week 2||0
360493|NCT00455650|875162|P5|NOT COMPLETED|Week 2||0
360494|NCT00455650|875163|P4|NOT COMPLETED|Week 2||0
360495|NCT00455650|875164|P3|NOT COMPLETED|Week 2||0
360496|NCT00455650|875165|P2|NOT COMPLETED|Week 2||0
360497|NCT00455650|875166|P1|NOT COMPLETED|Week 2||0
360498|NCT00455650|875161|P6|COMPLETED|Week 2||13
360499|NCT00455650|875162|P5|COMPLETED|Week 2||14
360500|NCT00455650|875163|P4|COMPLETED|Week 2||14
360501|NCT00455650|875164|P3|COMPLETED|Week 2||10
360502|NCT00455650|875165|P2|COMPLETED|Week 2||10
360503|NCT00455650|875166|P1|COMPLETED|Week 2||10
360504|NCT00455650|875161|P6|STARTED|Week 2||13
360505|NCT00455650|875162|P5|STARTED|Week 2||14
360506|NCT00455650|875163|P4|STARTED|Week 2||14
360507|NCT00455650|875164|P3|STARTED|Week 2||10
360508|NCT00455650|875165|P2|STARTED|Week 2||10
360509|NCT00455650|875166|P1|STARTED|Week 2||10
360510|NCT00455650|875161|P6|NOT COMPLETED|Week 1||0
360511|NCT00455650|875162|P5|NOT COMPLETED|Week 1||0
360512|NCT00455650|875163|P4|NOT COMPLETED|Week 1||0
360513|NCT00455650|875164|P3|NOT COMPLETED|Week 1||0
360514|NCT00455650|875165|P2|NOT COMPLETED|Week 1||0
360515|NCT00455650|875166|P1|NOT COMPLETED|Week 1||0
360516|NCT00455650|875161|P6|COMPLETED|Week 1||13
360517|NCT00455650|875162|P5|COMPLETED|Week 1||14
360518|NCT00455650|875163|P4|COMPLETED|Week 1||14
360519|NCT00455650|875164|P3|COMPLETED|Week 1||10
360520|NCT00455650|875165|P2|COMPLETED|Week 1||10
360521|NCT00455650|875166|P1|COMPLETED|Week 1||10
360522|NCT00455650|875161|P6|STARTED|Week 1||13
360523|NCT00455650|875162|P5|STARTED|Week 1||14
360524|NCT00455650|875163|P4|STARTED|Week 1||14
360525|NCT00455650|875164|P3|STARTED|Week 1||10
360526|NCT00455650|875165|P2|STARTED|Week 1||10
360527|NCT00455650|875166|P1|STARTED|Week 1||10
360528|NCT00455533|875196|P3|NOT COMPLETED|Period Two: Randomized Period||6
360529|NCT00455533|875197|P2|NOT COMPLETED|Period Two: Randomized Period||6
360530|NCT00455533|875198|P1|NOT COMPLETED|Period Two: Randomized Period||0
360531|NCT00455533|875196|P3|COMPLETED|Period Two: Randomized Period||138
360532|NCT00455533|875197|P2|COMPLETED|Period Two: Randomized Period||139
360533|NCT00455533|875198|P1|COMPLETED|Period Two: Randomized Period||0
360534|NCT00455533|875196|P3|STARTED|Period Two: Randomized Period|147 randomized, 144 randomized and treated with paclitaxel|144
360535|NCT00455533|875197|P2|STARTED|Period Two: Randomized Period|148 randomized, 145 randomized and treated with ixabepilone|145
360536|NCT00455533|875198|P1|STARTED|Period Two: Randomized Period||0
360537|NCT00455533|875196|P3|NOT COMPLETED|Period One: Initial Chemotherapy||0
360538|NCT00455533|875197|P2|NOT COMPLETED|Period One: Initial Chemotherapy||0
360539|NCT00455533|875198|P1|NOT COMPLETED|Period One: Initial Chemotherapy||18
360540|NCT00455533|875196|P3|COMPLETED|Period One: Initial Chemotherapy||0
360541|NCT00455533|875197|P2|COMPLETED|Period One: Initial Chemotherapy||0
360542|NCT00455533|875198|P1|COMPLETED|Period One: Initial Chemotherapy||295
360543|NCT00455533|875196|P3|STARTED|Period One: Initial Chemotherapy||0
360544|NCT00455533|875197|P2|STARTED|Period One: Initial Chemotherapy||0
360545|NCT00455533|875198|P1|STARTED|Period One: Initial Chemotherapy||313
360546|NCT00455520|875247|P2|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||62
360547|NCT00455520|875248|P1|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||63
360548|NCT00455520|875247|P2|COMPLETED|Double Blind Tapentadol ER vs Placebo||131
360549|NCT00455520|875248|P1|COMPLETED|Double Blind Tapentadol ER vs Placebo||133
360550|NCT00455520|875247|P2|STARTED|Double Blind Tapentadol ER vs Placebo|1 subject enrolled two separate times in this study, 2 subjects did not receive study medication|193
360551|NCT00455520|875248|P1|STARTED|Double Blind Tapentadol ER vs Placebo|2 subjects enrolled two separate times in this study, 1 subject did not receive study medication|196
360552|NCT00455520|875247|P2|NOT COMPLETED|Open Label Tapentadol Extended Release||0
360553|NCT00455520|875248|P1|NOT COMPLETED|Open Label Tapentadol Extended Release||196
360554|NCT00455520|875247|P2|COMPLETED|Open Label Tapentadol Extended Release||0
360555|NCT00455520|875248|P1|COMPLETED|Open Label Tapentadol Extended Release||395
360556|NCT00455520|875247|P2|STARTED|Open Label Tapentadol Extended Release||0
360557|NCT00455520|875248|P1|STARTED|Open Label Tapentadol Extended Release||591
360558|NCT00455455|875264|P2|NOT COMPLETED|Second Intervention||0
360559|NCT00455455|875265|P1|NOT COMPLETED|Second Intervention||0
360560|NCT00455455|875264|P2|COMPLETED|Second Intervention||24
360561|NCT00455455|875265|P1|COMPLETED|Second Intervention||24
360562|NCT00455455|875264|P2|STARTED|Second Intervention||24
360563|NCT00455455|875265|P1|STARTED|Second Intervention||24
360564|NCT00455455|875264|P2|NOT COMPLETED|Washout||0
360565|NCT00455455|875265|P1|NOT COMPLETED|Washout||1
360566|NCT00455455|875264|P2|COMPLETED|Washout||24
360567|NCT00455455|875265|P1|COMPLETED|Washout||24
360568|NCT00455455|875264|P2|STARTED|Washout||24
360569|NCT00455455|875265|P1|STARTED|Washout||25
360570|NCT00455455|875264|P2|NOT COMPLETED|First Intervention||0
360571|NCT00455455|875265|P1|NOT COMPLETED|First Intervention||0
360572|NCT00455455|875264|P2|COMPLETED|First Intervention||24
360573|NCT00455455|875265|P1|COMPLETED|First Intervention||25
360574|NCT00455455|875264|P2|STARTED|First Intervention||24
360575|NCT00455455|875265|P1|STARTED|First Intervention||25
360576|NCT00455455|875264|P2|NOT COMPLETED|Washout||1
360577|NCT00455455|875265|P1|NOT COMPLETED|Washout||0
360578|NCT00455455|875264|P2|COMPLETED|Washout||24
360579|NCT00455455|875265|P1|COMPLETED|Washout||25
360580|NCT00455455|875264|P2|STARTED|Washout||25
360581|NCT00455455|875265|P1|STARTED|Washout||25
360582|NCT00455429|875285|P4|NOT COMPLETED|Overall Study||14
360583|NCT00455429|875286|P3|NOT COMPLETED|Overall Study||1
360584|NCT00455429|875287|P2|NOT COMPLETED|Overall Study||5
360585|NCT00455429|875288|P1|NOT COMPLETED|Overall Study||2
360586|NCT00455429|875285|P4|COMPLETED|Overall Study||20
360587|NCT00455429|875286|P3|COMPLETED|Overall Study||16
360588|NCT00455429|875287|P2|COMPLETED|Overall Study||10
360589|NCT00455429|875288|P1|COMPLETED|Overall Study||16
360590|NCT00455429|875285|P4|Treated|Overall Study||32
360591|NCT00455429|875286|P3|Treated|Overall Study||17
360592|NCT00455429|875287|P2|Treated|Overall Study||15
360593|NCT00455429|875288|P1|Treated|Overall Study||18
360594|NCT00455429|875285|P4|STARTED|Overall Study||34
360595|NCT00455429|875286|P3|STARTED|Overall Study||17
360596|NCT00455429|875287|P2|STARTED|Overall Study||15
360597|NCT00455429|875288|P1|STARTED|Overall Study||18
360598|NCT00455312|875347|P2|NOT COMPLETED|Overall Study||1
360599|NCT00455312|875348|P1|NOT COMPLETED|Overall Study||0
360600|NCT00455312|875347|P2|COMPLETED|Overall Study||20
360601|NCT00455312|875348|P1|COMPLETED|Overall Study||15
360602|NCT00455312|875347|P2|STARTED|Overall Study||21
360603|NCT00455312|875348|P1|STARTED|Overall Study||15
360604|NCT00455195|875374|P2|NOT COMPLETED|Extension Study AGLU03206||0
360605|NCT00455195|875375|P1|NOT COMPLETED|Extension Study AGLU03206||0
360606|NCT00455195|875374|P2|COMPLETED|Extension Study AGLU03206||26
360607|NCT00455195|875375|P1|COMPLETED|Extension Study AGLU03206||55
360608|NCT00455195|875374|P2|STARTED|Extension Study AGLU03206|These 26 participants completed placebo double-blind treatment in the AGLU02704 (NCT00158600) study.|26
360609|NCT00455195|875375|P1|STARTED|Extension Study AGLU03206||55
360610|NCT00455195|875374|P2|NOT COMPLETED|Double-blind Study AGLU02704||4
360611|NCT00455195|875375|P1|NOT COMPLETED|Double-blind Study AGLU02704||5
360612|NCT00455195|875374|P2|COMPLETED|Double-blind Study AGLU02704||26
360613|NCT00455195|875375|P1|COMPLETED|Double-blind Study AGLU02704||55
360614|NCT00455195|875374|P2|STARTED|Double-blind Study AGLU02704|See study AGLU02704 (NCT00158600) for results while on placebo.|30
360615|NCT00455195|875375|P1|STARTED|Double-blind Study AGLU02704|Patients randomized to alglucosidase alfa treatment group in AGLU02704 (NCT00158600).|60
360616|NCT00455143|875389|P1|NOT COMPLETED|Overall Study||6
360617|NCT00455143|875389|P1|COMPLETED|Overall Study||21
360618|NCT00455143|875389|P1|STARTED|Overall Study||27
360619|NCT00455013|875413|P3|NOT COMPLETED|Long Term Extension (LTE)||7
360620|NCT00455013|875414|P2|NOT COMPLETED|Long Term Extension (LTE)||3
360621|NCT00455013|875415|P1|NOT COMPLETED|Long Term Extension (LTE)||2
360622|NCT00455013|875413|P3|COMPLETED|Long Term Extension (LTE)||20
360623|NCT00455013|875414|P2|COMPLETED|Long Term Extension (LTE)||16
360624|NCT00455013|875415|P1|COMPLETED|Long Term Extension (LTE)||25
360625|NCT00455013|875413|P3|STARTED|Long Term Extension (LTE)|1 Participant chose not to enter the LTE.|27
360626|NCT00455013|875414|P2|STARTED|Long Term Extension (LTE)|2 Participants chose not to enter the LTE.|19
360627|NCT00455013|875415|P1|STARTED|Long Term Extension (LTE)||27
360628|NCT00455013|875413|P3|NOT COMPLETED|Short Term Period||2
360629|NCT00455013|875414|P2|NOT COMPLETED|Short Term Period||5
360630|NCT00455013|875415|P1|NOT COMPLETED|Short Term Period||6
360631|NCT00455013|875413|P3|COMPLETED|Short Term Period|1 discontinued tacrolimus by Month 6 and 2 discontinued by Month 12 (1 more by Month 12)|28
360632|NCT00455013|875414|P2|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6; 10 additional switched from sirolimus to MMF.|21
360633|NCT00455013|875415|P1|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6 (1 more by Month 12), 2 switched from MMF to sirolimus.|27
360634|NCT00455013|875413|P3|STARTED|Short Term Period|31 randomized, 30 transplanted and treated|30
360635|NCT00455013|875414|P2|STARTED|Short Term Period|27 randomized, 26 transplanted and treated.|26
360636|NCT00455013|875415|P1|STARTED|Short Term Period|35 randomized, 33 transplanted and treated.|33
360637|NCT00454987|875483|P3|NOT COMPLETED|Year 4||0
360638|NCT00454987|875484|P2|NOT COMPLETED|Year 4||0
360639|NCT00454987|875485|P1|NOT COMPLETED|Year 4||0
360640|NCT00454987|875483|P3|COMPLETED|Year 4||0
360641|NCT00454987|875484|P2|COMPLETED|Year 4||62
360642|NCT00454987|875485|P1|COMPLETED|Year 4||206
360643|NCT00454987|875483|P3|STARTED|Year 4||0
360644|NCT00454987|875484|P2|STARTED|Year 4||62
360645|NCT00454987|875485|P1|STARTED|Year 4||206
360646|NCT00454987|875483|P3|NOT COMPLETED|Year 2||0
360647|NCT00454987|875484|P2|NOT COMPLETED|Year 2||0
360648|NCT00454987|875485|P1|NOT COMPLETED|Year 2||0
360649|NCT00454987|875483|P3|COMPLETED|Year 2||74
360650|NCT00454987|875484|P2|COMPLETED|Year 2||77
360651|NCT00454987|875485|P1|COMPLETED|Year 2||235
360652|NCT00454987|875483|P3|STARTED|Year 2||74
360653|NCT00454987|875484|P2|STARTED|Year 2||77
360654|NCT00454987|875485|P1|STARTED|Year 2||235
360655|NCT00454987|875483|P3|NOT COMPLETED|Year 1||0
360656|NCT00454987|875484|P2|NOT COMPLETED|Year 1||0
360657|NCT00454987|875485|P1|NOT COMPLETED|Year 1||0
360658|NCT00454987|875483|P3|COMPLETED|Year 1||0
360659|NCT00454987|875484|P2|COMPLETED|Year 1||67
360660|NCT00454987|875485|P1|COMPLETED|Year 1||221
360661|NCT00454987|875483|P3|STARTED|Year 1||0
360662|NCT00454987|875484|P2|STARTED|Year 1||67
360663|NCT00454987|875485|P1|STARTED|Year 1||221
360664|NCT00454987|875483|P3|NOT COMPLETED|Booster Period||0
360665|NCT00454987|875484|P2|NOT COMPLETED|Booster Period||1
360666|NCT00454987|875485|P1|NOT COMPLETED|Booster Period||2
360667|NCT00454987|875483|P3|COMPLETED|Booster Period||0
360668|NCT00454987|875484|P2|COMPLETED|Booster Period||116
360669|NCT00454987|875485|P1|COMPLETED|Booster Period||357
360670|NCT00454987|875483|P3|STARTED|Booster Period||0
360671|NCT00454987|875484|P2|STARTED|Booster Period||117
360672|NCT00454987|875485|P1|STARTED|Booster Period||359
360673|NCT00454909|875559|P3|NOT COMPLETED|Overall Study||2
360674|NCT00454909|875560|P2|NOT COMPLETED|Overall Study||3
360675|NCT00454909|875561|P1|NOT COMPLETED|Overall Study||7
360676|NCT00454909|875559|P3|COMPLETED|Overall Study||86
360677|NCT00454909|875560|P2|COMPLETED|Overall Study||194
360678|NCT00454909|875561|P1|COMPLETED|Overall Study||580
360679|NCT00454909|875559|P3|STARTED|Overall Study||88
360680|NCT00454909|875560|P2|STARTED|Overall Study||197
360681|NCT00454909|875561|P1|STARTED|Overall Study||587
360682|NCT00454857|875599|P1|NOT COMPLETED|Overall Study||54
360683|NCT00454857|875599|P1|COMPLETED|Overall Study||272
360684|NCT00454857|875599|P1|Completed ≥1 Observational Study Visit|Overall Study||319
360685|NCT00454857|875599|P1|Completed Retrospective Chart Review|Overall Study||324
360686|NCT00454857|875599|P1|STARTED|Overall Study||326
360687|NCT00454818|875624|P5|NOT COMPLETED|Phase 2: Randomized Double-blind||4
360688|NCT00454818|875625|P4|NOT COMPLETED|Phase 2: Randomized Double-blind||1
360689|NCT00454818|875626|P3|NOT COMPLETED|Phase 2: Randomized Double-blind||3
360690|NCT00454818|875627|P2|NOT COMPLETED|Phase 2: Randomized Double-blind||2
360691|NCT00454818|875628|P1|NOT COMPLETED|Phase 2: Randomized Double-blind||0
360692|NCT00454818|875624|P5|COMPLETED|Phase 2: Randomized Double-blind||10
360693|NCT00454818|875625|P4|COMPLETED|Phase 2: Randomized Double-blind||8
360694|NCT00454818|875626|P3|COMPLETED|Phase 2: Randomized Double-blind||5
360695|NCT00454818|875627|P2|COMPLETED|Phase 2: Randomized Double-blind||6
360696|NCT00454818|875628|P1|COMPLETED|Phase 2: Randomized Double-blind||0
360697|NCT00454818|875624|P5|STARTED|Phase 2: Randomized Double-blind||14
360698|NCT00454818|875625|P4|STARTED|Phase 2: Randomized Double-blind||9
360699|NCT00454818|875626|P3|STARTED|Phase 2: Randomized Double-blind||8
360700|NCT00454818|875627|P2|STARTED|Phase 2: Randomized Double-blind||8
360701|NCT00454818|875628|P1|STARTED|Phase 2: Randomized Double-blind||0
360702|NCT00454818|875624|P5|NOT COMPLETED|Phase I: Open-label Dose-escalation||0
360703|NCT00454818|875625|P4|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
360704|NCT00454818|875626|P3|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
360705|NCT00454818|875627|P2|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
360706|NCT00454818|875628|P1|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
360707|NCT00454818|875624|P5|COMPLETED|Phase I: Open-label Dose-escalation||0
360708|NCT00454818|875625|P4|COMPLETED|Phase I: Open-label Dose-escalation||2
360709|NCT00454818|875626|P3|COMPLETED|Phase I: Open-label Dose-escalation||2
360710|NCT00454818|875627|P2|COMPLETED|Phase I: Open-label Dose-escalation||2
360711|NCT00454818|875628|P1|COMPLETED|Phase I: Open-label Dose-escalation||2
360712|NCT00454818|875624|P5|STARTED|Phase I: Open-label Dose-escalation||0
360713|NCT00454818|875625|P4|STARTED|Phase I: Open-label Dose-escalation||3
360714|NCT00454818|875626|P3|STARTED|Phase I: Open-label Dose-escalation||3
360715|NCT00454818|875627|P2|STARTED|Phase I: Open-label Dose-escalation||3
360716|NCT00454818|875628|P1|STARTED|Phase I: Open-label Dose-escalation||3
360717|NCT00454805|875707|P2|NOT COMPLETED|Overall Study||23
360718|NCT00454805|875708|P1|NOT COMPLETED|Overall Study||26
360719|NCT00454805|875707|P2|COMPLETED|Overall Study|Ongoing at data cut-off|8
360720|NCT00454805|875708|P1|COMPLETED|Overall Study|Ongoing at data cut-off|5
360721|NCT00454805|875707|P2|STARTED|Overall Study|Randomised|31
360722|NCT00454805|875708|P1|STARTED|Overall Study|Randomised|31
360723|NCT00454779|875724|P2|NOT COMPLETED|Second-line Treatment Phase||3
360724|NCT00454779|875725|P1|NOT COMPLETED|Second-line Treatment Phase||0
360725|NCT00454779|875724|P2|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|27
360726|NCT00454779|875725|P1|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|0
360727|NCT00454779|875724|P2|STARTED|Second-line Treatment Phase|Second-line Panitumumab Monotherapy|30
360728|NCT00454779|875725|P1|STARTED|Second-line Treatment Phase|Subjects in this arm do not have second-line treatment period|0
360729|NCT00454779|875724|P2|NOT COMPLETED|First-line Treatment Phase||8
360730|NCT00454779|875725|P1|NOT COMPLETED|First-line Treatment Phase||5
360816|NCT00454571|875965|P1|NOT COMPLETED|Overall Study||13
360731|NCT00454779|875724|P2|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|49
360732|NCT00454779|875725|P1|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|51
360733|NCT00454779|875724|P2|Received Study Medication|First-line Treatment Phase||55
360734|NCT00454779|875725|P1|Received Study Medication|First-line Treatment Phase||56
360735|NCT00454779|875724|P2|STARTED|First-line Treatment Phase||57
360736|NCT00454779|875725|P1|STARTED|First-line Treatment Phase||56
360737|NCT00454649|875763|P10|NOT COMPLETED|Overall Study||5
360738|NCT00454649|875764|P9|NOT COMPLETED|Overall Study||20
360739|NCT00454649|875765|P8|NOT COMPLETED|Overall Study||19
360740|NCT00454649|875766|P7|NOT COMPLETED|Overall Study||9
360741|NCT00454649|875767|P6|NOT COMPLETED|Overall Study||7
360742|NCT00454649|875768|P5|NOT COMPLETED|Overall Study||1
360743|NCT00454649|875769|P4|NOT COMPLETED|Overall Study||6
360744|NCT00454649|875770|P3|NOT COMPLETED|Overall Study||19
360745|NCT00454649|875771|P2|NOT COMPLETED|Overall Study||4
360746|NCT00454649|875772|P1|NOT COMPLETED|Overall Study||3
360747|NCT00454649|875763|P10|COMPLETED|Overall Study||1
360748|NCT00454649|875764|P9|COMPLETED|Overall Study||1
360749|NCT00454649|875765|P8|COMPLETED|Overall Study||0
360750|NCT00454649|875766|P7|COMPLETED|Overall Study||0
360751|NCT00454649|875767|P6|COMPLETED|Overall Study||0
360752|NCT00454649|875768|P5|COMPLETED|Overall Study||0
360753|NCT00454649|875769|P4|COMPLETED|Overall Study||1
360754|NCT00454649|875770|P3|COMPLETED|Overall Study||1
360755|NCT00454649|875771|P2|COMPLETED|Overall Study||1
360756|NCT00454649|875772|P1|COMPLETED|Overall Study||0
360757|NCT00454649|875763|P10|STARTED|Overall Study||6
360758|NCT00454649|875764|P9|STARTED|Overall Study||21
360759|NCT00454649|875765|P8|STARTED|Overall Study||19
360760|NCT00454649|875766|P7|STARTED|Overall Study||9
360761|NCT00454649|875767|P6|STARTED|Overall Study||7
360762|NCT00454649|875768|P5|STARTED|Overall Study||1
360763|NCT00454649|875769|P4|STARTED|Overall Study||7
360764|NCT00454649|875770|P3|STARTED|Overall Study||20
360765|NCT00454649|875771|P2|STARTED|Overall Study||5
360766|NCT00454649|875772|P1|STARTED|Overall Study||3
360767|NCT00454636|875901|P4|NOT COMPLETED|Overall Study||32
360768|NCT00454636|875902|P3|NOT COMPLETED|Overall Study||20
360769|NCT00454636|875903|P2|NOT COMPLETED|Overall Study||23
360770|NCT00454636|875904|P1|NOT COMPLETED|Overall Study||31
360771|NCT00454636|875901|P4|COMPLETED|Overall Study||26
360772|NCT00454636|875902|P3|COMPLETED|Overall Study||7
360773|NCT00454636|875903|P2|COMPLETED|Overall Study||9
360774|NCT00454636|875904|P1|COMPLETED|Overall Study||10
360775|NCT00454636|875901|P4|STARTED|Overall Study||58
360776|NCT00454636|875902|P3|STARTED|Overall Study||27
360777|NCT00454636|875903|P2|STARTED|Overall Study||32
360778|NCT00454636|875904|P1|STARTED|Overall Study||41
360779|NCT00454584|875937|P6|NOT COMPLETED|After Controlled Period||32
360780|NCT00454584|875938|P5|NOT COMPLETED|After Controlled Period||12
360781|NCT00454584|875939|P4|NOT COMPLETED|After Controlled Period||26
360782|NCT00454584|875940|P3|NOT COMPLETED|After Controlled Period||0
360783|NCT00454584|875941|P2|NOT COMPLETED|After Controlled Period||0
360784|NCT00454584|875942|P1|NOT COMPLETED|After Controlled Period||0
360785|NCT00454584|875937|P6|COMPLETED|After Controlled Period||310
360786|NCT00454584|875938|P5|COMPLETED|After Controlled Period||189
360787|NCT00454584|875939|P4|COMPLETED|After Controlled Period||310
360788|NCT00454584|875940|P3|COMPLETED|After Controlled Period||0
360789|NCT00454584|875941|P2|COMPLETED|After Controlled Period||0
360790|NCT00454584|875942|P1|COMPLETED|After Controlled Period||0
360791|NCT00454584|875937|P6|STARTED|After Controlled Period||342
360792|NCT00454584|875938|P5|STARTED|After Controlled Period||201
360793|NCT00454584|875939|P4|STARTED|After Controlled Period||336
360794|NCT00454584|875940|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
360795|NCT00454584|875941|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
360796|NCT00454584|875942|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
360797|NCT00454584|875937|P6|NOT COMPLETED|Controlled Period||0
360798|NCT00454584|875938|P5|NOT COMPLETED|Controlled Period||0
360799|NCT00454584|875939|P4|NOT COMPLETED|Controlled Period||0
360800|NCT00454584|875940|P3|NOT COMPLETED|Controlled Period||5
360801|NCT00454584|875941|P2|NOT COMPLETED|Controlled Period||8
360802|NCT00454584|875942|P1|NOT COMPLETED|Controlled Period||11
360803|NCT00454584|875937|P6|COMPLETED|Controlled Period||0
360804|NCT00454584|875938|P5|COMPLETED|Controlled Period||0
360805|NCT00454584|875939|P4|COMPLETED|Controlled Period||0
360806|NCT00454584|875940|P3|COMPLETED|Controlled Period||342
360807|NCT00454584|875941|P2|COMPLETED|Controlled Period||201
360808|NCT00454584|875942|P1|COMPLETED|Controlled Period||336
360809|NCT00454584|875937|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
360810|NCT00454584|875938|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
360811|NCT00454584|875939|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
360812|NCT00454584|875940|P3|STARTED|Controlled Period||347
360813|NCT00454584|875941|P2|STARTED|Controlled Period||209
360814|NCT00454584|875942|P1|STARTED|Controlled Period||347
360815|NCT00454571|875964|P2|NOT COMPLETED|Overall Study||6
360817|NCT00454571|875964|P2|COMPLETED|Overall Study||13
360818|NCT00454571|875965|P1|COMPLETED|Overall Study||5
360819|NCT00454571|875964|P2|STARTED|Overall Study||19
360820|NCT00454571|875965|P1|STARTED|Overall Study||18
360821|NCT00454532|875977|P4|NOT COMPLETED|Overall Study||0
360822|NCT00454532|875978|P3|NOT COMPLETED|Overall Study||0
360823|NCT00454532|875979|P2|NOT COMPLETED|Overall Study||0
360824|NCT00454532|875980|P1|NOT COMPLETED|Overall Study||0
360825|NCT00454532|875977|P4|COMPLETED|Overall Study||7
360826|NCT00454532|875978|P3|COMPLETED|Overall Study||3
360827|NCT00454532|875979|P2|COMPLETED|Overall Study||6
360828|NCT00454532|875980|P1|COMPLETED|Overall Study||11
360829|NCT00454532|875977|P4|STARTED|Overall Study||7
360830|NCT00454532|875978|P3|STARTED|Overall Study||3
360831|NCT00454532|875979|P2|STARTED|Overall Study||6
360832|NCT00454532|875980|P1|STARTED|Overall Study||11
360833|NCT00454363|876000|P2|NOT COMPLETED|Overall Study||2
360834|NCT00454363|876001|P1|NOT COMPLETED|Overall Study||5
360835|NCT00454363|876000|P2|COMPLETED|Overall Study||29
360836|NCT00454363|876001|P1|COMPLETED|Overall Study||15
360837|NCT00454363|876000|P2|STARTED|Overall Study||31
360838|NCT00454363|876001|P1|STARTED|Overall Study||20
360839|NCT00454324|876010|P2|NOT COMPLETED|Overall Study||0
360840|NCT00454324|876011|P1|NOT COMPLETED|Overall Study||0
360841|NCT00454324|876010|P2|COMPLETED|Overall Study||13
360842|NCT00454324|876011|P1|COMPLETED|Overall Study||14
360843|NCT00454324|876010|P2|STARTED|Overall Study||13
360844|NCT00454324|876011|P1|STARTED|Overall Study||14
360845|NCT00454246|876026|P3|NOT COMPLETED|Overall Study||9
360846|NCT00454246|876027|P2|NOT COMPLETED|Overall Study||29
360847|NCT00454246|876028|P1|NOT COMPLETED|Overall Study||73
360848|NCT00454246|876026|P3|COMPLETED|Overall Study||0
360849|NCT00454246|876027|P2|COMPLETED|Overall Study||0
360850|NCT00454246|876028|P1|COMPLETED|Overall Study||0
360851|NCT00454246|876026|P3|STARTED|Overall Study||9
360852|NCT00454246|876027|P2|STARTED|Overall Study||29
360853|NCT00454246|876028|P1|STARTED|Overall Study||73
360854|NCT00454207|876044|P2|NOT COMPLETED|Overall Study||2
360855|NCT00454207|876045|P1|NOT COMPLETED|Overall Study||4
360856|NCT00454207|876044|P2|COMPLETED|Overall Study||21
360857|NCT00454207|876045|P1|COMPLETED|Overall Study|19 participants completed Part I period. 17 of 19 participants continued from part I into Part II.|17
360858|NCT00454207|876044|P2|STARTED|Overall Study||23
360859|NCT00454207|876045|P1|STARTED|Overall Study||21
360860|NCT00454194|876090|P2|NOT COMPLETED|Overall Study||14
360861|NCT00454194|876091|P1|NOT COMPLETED|Overall Study||22
360862|NCT00454194|876090|P2|COMPLETED|Overall Study||37
360863|NCT00454194|876091|P1|COMPLETED|Overall Study||25
360864|NCT00454194|876090|P2|STARTED|Overall Study||51
360865|NCT00454194|876091|P1|STARTED|Overall Study||47
360866|NCT00454181|876109|P2|NOT COMPLETED|Overall Study||3
360867|NCT00454181|876110|P1|NOT COMPLETED|Overall Study||15
360868|NCT00454181|876109|P2|COMPLETED|Overall Study||11
360869|NCT00454181|876110|P1|COMPLETED|Overall Study||30
360870|NCT00454181|876109|P2|STARTED|Overall Study||14
360871|NCT00454181|876110|P1|STARTED|Overall Study||45
360872|NCT00454142|876126|P1|NOT COMPLETED|Overall Study||1
360873|NCT00454142|876126|P1|COMPLETED|Overall Study||32
360874|NCT00454142|876126|P1|STARTED|Overall Study||33
360875|NCT00454116|876144|P3|NOT COMPLETED|Overall Study||28
360876|NCT00454116|876145|P2|NOT COMPLETED|Overall Study||29
360877|NCT00454116|876146|P1|NOT COMPLETED|Overall Study||27
360878|NCT00454116|876144|P3|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
360879|NCT00454116|876145|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
360880|NCT00454116|876146|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|8
360881|NCT00454116|876144|P3|STARTED|Overall Study|randomised patients|35
360882|NCT00454116|876145|P2|STARTED|Overall Study|randomised patients|36
360883|NCT00454116|876146|P1|STARTED|Overall Study|randomised patients|35
360884|NCT00454051|876156|P2|NOT COMPLETED|Overall Study||3
360885|NCT00454051|876157|P1|NOT COMPLETED|Overall Study||3
360886|NCT00454051|876156|P2|COMPLETED|Overall Study||8
360887|NCT00454051|876157|P1|COMPLETED|Overall Study||17
360888|NCT00454051|876156|P2|STARTED|Overall Study||11
360889|NCT00454051|876157|P1|STARTED|Overall Study||20
360890|NCT00453999|876190|P3|NOT COMPLETED|Overall Study||3
360891|NCT00453999|876191|P2|NOT COMPLETED|Overall Study||5
360892|NCT00453999|876192|P1|NOT COMPLETED|Overall Study||5
360893|NCT00453999|876190|P3|COMPLETED|Overall Study||43
360894|NCT00453999|876191|P2|COMPLETED|Overall Study||41
360895|NCT00453999|876192|P1|COMPLETED|Overall Study||40
360896|NCT00453999|876190|P3|STARTED|Overall Study||46
360897|NCT00453999|876191|P2|STARTED|Overall Study||46
360898|NCT00453999|876192|P1|STARTED|Overall Study||45
360899|NCT00453986|876220|P5|NOT COMPLETED|Overall Study||0
360900|NCT00453986|876221|P4|NOT COMPLETED|Overall Study||2
360901|NCT00453986|876222|P3|NOT COMPLETED|Overall Study||6
360902|NCT00453986|876223|P2|NOT COMPLETED|Overall Study||5
360903|NCT00453986|876224|P1|NOT COMPLETED|Overall Study||6
360904|NCT00453986|876220|P5|COMPLETED|Overall Study||105
360905|NCT00453986|876221|P4|COMPLETED|Overall Study||310
360906|NCT00453986|876222|P3|COMPLETED|Overall Study||307
360907|NCT00453986|876223|P2|COMPLETED|Overall Study||306
360908|NCT00453986|876224|P1|COMPLETED|Overall Study||305
360909|NCT00453986|876220|P5|STARTED|Overall Study||105
360910|NCT00453986|876221|P4|STARTED|Overall Study||312
360911|NCT00453986|876222|P3|STARTED|Overall Study||313
360912|NCT00453986|876223|P2|STARTED|Overall Study||311
360913|NCT00453986|876224|P1|STARTED|Overall Study||311
360914|NCT00453973|876317|P2|NOT COMPLETED|Overall Study||48
360915|NCT00453973|876318|P1|NOT COMPLETED|Overall Study||51
360916|NCT00453973|876317|P2|COMPLETED|Overall Study||15
360917|NCT00453973|876318|P1|COMPLETED|Overall Study||0
360918|NCT00453973|876317|P2|STARTED|Overall Study||63
360919|NCT00453973|876318|P1|STARTED|Overall Study||51
360920|NCT00453921|876328|P4|NOT COMPLETED|Overall Study||1
360921|NCT00453921|876329|P3|NOT COMPLETED|Overall Study||2
360922|NCT00453921|876330|P2|NOT COMPLETED|Overall Study||1
360923|NCT00453921|876331|P1|NOT COMPLETED|Overall Study||1
360924|NCT00453921|876328|P4|COMPLETED|Overall Study||18
360925|NCT00453921|876329|P3|COMPLETED|Overall Study||18
360926|NCT00453921|876330|P2|COMPLETED|Overall Study||17
360927|NCT00453921|876331|P1|COMPLETED|Overall Study||18
360928|NCT00453921|876328|P4|STARTED|Overall Study||19
360929|NCT00453921|876329|P3|STARTED|Overall Study||20
360930|NCT00453921|876330|P2|STARTED|Overall Study||18
360931|NCT00453921|876331|P1|STARTED|Overall Study||19
360932|NCT00453895|876365|P1|NOT COMPLETED|Overall Study||0
360933|NCT00453895|876365|P1|COMPLETED|Overall Study||39
360934|NCT00453895|876365|P1|STARTED|Overall Study||39
360935|NCT00453479|876376|P3|NOT COMPLETED|Overall Study||0
360936|NCT00453479|876377|P2|NOT COMPLETED|Overall Study||0
360937|NCT00453479|876378|P1|NOT COMPLETED|Overall Study||0
360938|NCT00453479|876376|P3|COMPLETED|Overall Study||8
360939|NCT00453479|876377|P2|COMPLETED|Overall Study||9
360940|NCT00453479|876378|P1|COMPLETED|Overall Study||6
360941|NCT00453479|876376|P3|STARTED|Overall Study||8
360942|NCT00453479|876377|P2|STARTED|Overall Study||9
360943|NCT00453479|876378|P1|STARTED|Overall Study||6
360944|NCT00453388|876453|P4|NOT COMPLETED|Overall Study||0
360945|NCT00453388|876454|P3|NOT COMPLETED|Overall Study||0
360946|NCT00453388|876455|P2|NOT COMPLETED|Overall Study||0
360947|NCT00453388|876456|P1|NOT COMPLETED|Overall Study||0
360948|NCT00453388|876453|P4|COMPLETED|Overall Study||0
360949|NCT00453388|876454|P3|COMPLETED|Overall Study||1
360950|NCT00453388|876455|P2|COMPLETED|Overall Study||5
360951|NCT00453388|876456|P1|COMPLETED|Overall Study||0
360952|NCT00453388|876453|P4|STARTED|Overall Study||0
360953|NCT00453388|876454|P3|STARTED|Overall Study||1
360954|NCT00453388|876455|P2|STARTED|Overall Study||5
360955|NCT00453388|876456|P1|STARTED|Overall Study||0
360956|NCT00453362|876478|P1|NOT COMPLETED|Overall Study||87
360957|NCT00453362|876478|P1|COMPLETED|Overall Study||1
360958|NCT00453362|876478|P1|FLT-PET Evaluable|Overall Study|Participants who completed all FLT-PET scans through day 56.|50
360959|NCT00453362|876478|P1|FDG-PET Evaluable|Overall Study|Participants who completed all FDG-PET scans through day 56.|51
360960|NCT00453362|876478|P1|Treated With Erlotinib|Overall Study||74
360961|NCT00453362|876478|P1|STARTED|Overall Study|14 participants consented but did not receive drug and are not represented in the baseline data|88
360962|NCT00453349|876504|P2|NOT COMPLETED|Completed Study||34
360963|NCT00453349|876505|P1|NOT COMPLETED|Completed Study||27
360964|NCT00453349|876504|P2|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|198
360965|NCT00453349|876505|P1|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|201
360966|NCT00453349|876504|P2|Completed Study Treatment|Completed Study|23 terminated prematurely|209
360967|NCT00453349|876505|P1|Completed Study Treatment|Completed Study|25 terminated prematurely|203
360968|NCT00453349|876504|P2|STARTED|Completed Study||232
360969|NCT00453349|876505|P1|STARTED|Completed Study||228
360970|NCT00453349|876504|P2|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||11
360971|NCT00453349|876505|P1|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||10
360972|NCT00453349|876504|P2|COMPLETED|Reaching of Primary Endpoint (TOC)||219
360973|NCT00453349|876505|P1|COMPLETED|Reaching of Primary Endpoint (TOC)|All PP patients and ITT patients with a clinical response with no missing information|215
360974|NCT00453349|876504|P2|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||190
360975|NCT00453349|876505|P1|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||194
360976|NCT00453349|876504|P2|STARTED|Reaching of Primary Endpoint (TOC)|i.e. the ITT population|230
360977|NCT00453349|876505|P1|STARTED|Reaching of Primary Endpoint (TOC)|Subjects who attended the TOC visit or at least had a clinical evaluation at TOC|225
360978|NCT00453349|876504|P2|NOT COMPLETED|Randomized||23
360979|NCT00453349|876505|P1|NOT COMPLETED|Randomized||25
360980|NCT00453349|876504|P2|COMPLETED|Randomized||209
360981|NCT00453349|876505|P1|COMPLETED|Randomized||203
360982|NCT00453349|876504|P2|STARTED|Randomized||232
360983|NCT00453349|876505|P1|STARTED|Randomized||228
360984|NCT00453336|876531|P1|NOT COMPLETED|Overall Study||0
360985|NCT00453336|876531|P1|COMPLETED|Overall Study||45
360986|NCT00453336|876531|P1|STARTED|Overall Study||45
360987|NCT00453310|876536|P1|NOT COMPLETED|Overall Study||10
360988|NCT00453310|876536|P1|COMPLETED|Overall Study||0
360989|NCT00453310|876536|P1|STARTED|Overall Study||10
360990|NCT00453206|876540|P1|NOT COMPLETED|Overall Study||1
360991|NCT00453206|876540|P1|COMPLETED|Overall Study||65
360992|NCT00453206|876540|P1|STARTED|Overall Study||66
360993|NCT00453193|876544|P1|NOT COMPLETED|Overall Study||0
360994|NCT00453193|876544|P1|COMPLETED|Overall Study||24
360995|NCT00453193|876544|P1|STARTED|Overall Study||24
360996|NCT00453180|876550|P2|NOT COMPLETED|Overall Study||3
360997|NCT00453180|876551|P1|NOT COMPLETED|Overall Study||3
360998|NCT00453180|876550|P2|COMPLETED|Overall Study||12
360999|NCT00453180|876551|P1|COMPLETED|Overall Study||13
361000|NCT00453180|876550|P2|STARTED|Overall Study||15
361001|NCT00453180|876551|P1|STARTED|Overall Study||16
361002|NCT00453154|876570|P4|NOT COMPLETED|Open Label Sunitinib Crossover||0
361003|NCT00453154|876571|P3|NOT COMPLETED|Open Label Sunitinib Crossover||0
361004|NCT00453154|876572|P2|NOT COMPLETED|Open Label Sunitinib Crossover||0
361005|NCT00453154|876573|P1|NOT COMPLETED|Open Label Sunitinib Crossover||0
361006|NCT00453154|876570|P4|COMPLETED|Open Label Sunitinib Crossover||0
361007|NCT00453154|876571|P3|COMPLETED|Open Label Sunitinib Crossover||18
361008|NCT00453154|876572|P2|COMPLETED|Open Label Sunitinib Crossover||0
361009|NCT00453154|876573|P1|COMPLETED|Open Label Sunitinib Crossover||0
361010|NCT00453154|876570|P4|STARTED|Open Label Sunitinib Crossover||0
361011|NCT00453154|876571|P3|STARTED|Open Label Sunitinib Crossover||18
361012|NCT00453154|876572|P2|STARTED|Open Label Sunitinib Crossover||0
361013|NCT00453154|876573|P1|STARTED|Open Label Sunitinib Crossover||0
361014|NCT00453154|876570|P4|NOT COMPLETED|Double BIind Maintenance||49
361015|NCT00453154|876571|P3|NOT COMPLETED|Double BIind Maintenance||46
361016|NCT00453154|876572|P2|NOT COMPLETED|Double BIind Maintenance||0
361017|NCT00453154|876573|P1|NOT COMPLETED|Double BIind Maintenance||0
361018|NCT00453154|876570|P4|COMPLETED|Double BIind Maintenance||0
361019|NCT00453154|876571|P3|COMPLETED|Double BIind Maintenance||0
361020|NCT00453154|876572|P2|COMPLETED|Double BIind Maintenance||0
361021|NCT00453154|876573|P1|COMPLETED|Double BIind Maintenance||0
361022|NCT00453154|876570|P4|STARTED|Double BIind Maintenance||49
361023|NCT00453154|876571|P3|STARTED|Double BIind Maintenance||46
361024|NCT00453154|876572|P2|STARTED|Double BIind Maintenance||0
361025|NCT00453154|876573|P1|STARTED|Double BIind Maintenance||0
361026|NCT00453154|876570|P4|NOT COMPLETED|Combination Chemotherapy||0
361027|NCT00453154|876571|P3|NOT COMPLETED|Combination Chemotherapy||0
361028|NCT00453154|876572|P2|NOT COMPLETED|Combination Chemotherapy||49
361029|NCT00453154|876573|P1|NOT COMPLETED|Combination Chemotherapy||0
361030|NCT00453154|876570|P4|COMPLETED|Combination Chemotherapy||0
361031|NCT00453154|876571|P3|COMPLETED|Combination Chemotherapy||0
361032|NCT00453154|876572|P2|COMPLETED|Combination Chemotherapy||95
361033|NCT00453154|876573|P1|COMPLETED|Combination Chemotherapy||12
361034|NCT00453154|876570|P4|STARTED|Combination Chemotherapy||0
361035|NCT00453154|876571|P3|STARTED|Combination Chemotherapy||0
361036|NCT00453154|876572|P2|STARTED|Combination Chemotherapy||144
361037|NCT00453154|876573|P1|STARTED|Combination Chemotherapy||12
361038|NCT00453102|876586|P1|NOT COMPLETED|Overall Study||2
361039|NCT00453102|876586|P1|COMPLETED|Overall Study||16
361040|NCT00453102|876586|P1|STARTED|Overall Study||18
361041|NCT00453063|876597|P2|NOT COMPLETED|Overall Study||3
361042|NCT00453063|876598|P1|NOT COMPLETED|Overall Study||3
361043|NCT00453063|876597|P2|COMPLETED|Overall Study||212
361044|NCT00453063|876598|P1|COMPLETED|Overall Study||208
361045|NCT00453063|876597|P2|STARTED|Overall Study||215
361046|NCT00453063|876598|P1|STARTED|Overall Study||211
361047|NCT00452868|876612|P1|NOT COMPLETED|Overall Study||2
361048|NCT00452868|876612|P1|COMPLETED|Overall Study||11
361049|NCT00452868|876612|P1|STARTED|Overall Study||13
361050|NCT00452790|876618|P2|NOT COMPLETED|Toddler Dose||2
361051|NCT00452790|876619|P1|NOT COMPLETED|Toddler Dose||0
361052|NCT00452790|876618|P2|COMPLETED|Toddler Dose||198
361053|NCT00452790|876619|P1|COMPLETED|Toddler Dose||198
361054|NCT00452790|876618|P2|STARTED|Toddler Dose||200
361055|NCT00452790|876619|P1|STARTED|Toddler Dose||198
361056|NCT00452790|876618|P2|NOT COMPLETED|After Infant Series||14
361057|NCT00452790|876619|P1|NOT COMPLETED|After Infant Series||21
361058|NCT00452790|876618|P2|COMPLETED|After Infant Series||200
361059|NCT00452790|876619|P1|COMPLETED|After Infant Series||198
361060|NCT00452790|876618|P2|STARTED|After Infant Series||214
361061|NCT00452790|876619|P1|STARTED|After Infant Series||219
361062|NCT00452790|876618|P2|NOT COMPLETED|Infant Series||141
361063|NCT00452790|876619|P1|NOT COMPLETED|Infant Series||135
361064|NCT00452790|876618|P2|COMPLETED|Infant Series||214
361065|NCT00452790|876619|P1|COMPLETED|Infant Series||219
361066|NCT00452790|876618|P2|Vaccinated Dose 3|Infant Series||218
361067|NCT00452790|876619|P1|Vaccinated Dose 3|Infant Series||221
361068|NCT00452790|876618|P2|Vaccinated Dose 2|Infant Series||300
361069|NCT00452790|876619|P1|Vaccinated Dose 2|Infant Series||300
361070|NCT00452790|876618|P2|Vaccinated Dose 1|Infant Series||353
361071|NCT00452790|876619|P1|Vaccinated Dose 1|Infant Series||353
361072|NCT00452790|876618|P2|STARTED|Infant Series||355
361073|NCT00452790|876619|P1|STARTED|Infant Series||354
361074|NCT00452699|876655|P2|NOT COMPLETED|Overall Study||73
361075|NCT00452699|876656|P1|NOT COMPLETED|Overall Study||81
361076|NCT00452699|876655|P2|COMPLETED|Overall Study||242
361077|NCT00452699|876656|P1|COMPLETED|Overall Study||225
361078|NCT00452699|876655|P2|STARTED|Overall Study||315
361079|NCT00452699|876656|P1|STARTED|Overall Study||306
361080|NCT00452673|876672|P5|NOT COMPLETED|Dose Expansion Period||21
361081|NCT00452673|876673|P4|NOT COMPLETED|Dose Expansion Period||0
361082|NCT00452673|876674|P3|NOT COMPLETED|Dose Expansion Period||0
361083|NCT00452673|876675|P2|NOT COMPLETED|Dose Expansion Period||0
361084|NCT00452673|876676|P1|NOT COMPLETED|Dose Expansion Period||0
361085|NCT00452673|876672|P5|COMPLETED|Dose Expansion Period||0
361086|NCT00452673|876673|P4|COMPLETED|Dose Expansion Period||0
361087|NCT00452673|876674|P3|COMPLETED|Dose Expansion Period||0
361088|NCT00452673|876675|P2|COMPLETED|Dose Expansion Period||0
361089|NCT00452673|876676|P1|COMPLETED|Dose Expansion Period||0
361090|NCT00452673|876672|P5|STARTED|Dose Expansion Period|The last dose level arm in the escalation period was selected for the dose expansion period.|21
361091|NCT00452673|876673|P4|STARTED|Dose Expansion Period||0
361092|NCT00452673|876674|P3|STARTED|Dose Expansion Period||0
361093|NCT00452673|876675|P2|STARTED|Dose Expansion Period||0
361094|NCT00452673|876676|P1|STARTED|Dose Expansion Period||0
361095|NCT00452673|876672|P5|NOT COMPLETED|Dose Escalation Period||0
361096|NCT00452673|876673|P4|NOT COMPLETED|Dose Escalation Period||9
361097|NCT00452673|876674|P3|NOT COMPLETED|Dose Escalation Period||6
361098|NCT00452673|876675|P2|NOT COMPLETED|Dose Escalation Period||9
361099|NCT00452673|876676|P1|NOT COMPLETED|Dose Escalation Period||7
361100|NCT00452673|876672|P5|COMPLETED|Dose Escalation Period||0
361101|NCT00452673|876673|P4|COMPLETED|Dose Escalation Period||0
361102|NCT00452673|876674|P3|COMPLETED|Dose Escalation Period||0
361103|NCT00452673|876675|P2|COMPLETED|Dose Escalation Period||0
361104|NCT00452673|876676|P1|COMPLETED|Dose Escalation Period||0
361105|NCT00452673|876672|P5|STARTED|Dose Escalation Period||0
361106|NCT00452673|876673|P4|STARTED|Dose Escalation Period||9
361107|NCT00452673|876674|P3|STARTED|Dose Escalation Period||6
361108|NCT00452673|876675|P2|STARTED|Dose Escalation Period||9
361109|NCT00452673|876676|P1|STARTED|Dose Escalation Period||7
361110|NCT00452543|876708|P2|NOT COMPLETED|Overall Study||6
361111|NCT00452543|876709|P1|NOT COMPLETED|Overall Study||5
361112|NCT00452543|876708|P2|COMPLETED|Overall Study||5
361113|NCT00452543|876709|P1|COMPLETED|Overall Study||7
361114|NCT00452543|876708|P2|STARTED|Overall Study||11
361115|NCT00452543|876709|P1|STARTED|Overall Study||12
361116|NCT00452530|876723|P2|NOT COMPLETED|Overall Study||136
361117|NCT00452530|876724|P1|NOT COMPLETED|Overall Study||136
361118|NCT00452530|876723|P2|COMPLETED|Overall Study||1393
361119|NCT00452530|876724|P1|COMPLETED|Overall Study||1392
361120|NCT00452530|876723|P2|Primary Participants|Overall Study||997
361121|NCT00452530|876724|P1|Primary Participants|Overall Study||976
361122|NCT00452530|876723|P2|Evaluable Participants|Overall Study||921
361123|NCT00452530|876724|P1|Evaluable Participants|Overall Study||907
361124|NCT00452530|876723|P2|Received Treatment|Overall Study||1508
361125|NCT00452530|876724|P1|Received Treatment|Overall Study||1501
361126|NCT00452530|876723|P2|STARTED|Overall Study|Randomized|1529
361127|NCT00452530|876724|P1|STARTED|Overall Study|Randomized|1528
361128|NCT00452452|876745|P3|NOT COMPLETED|Overall Study||1
361129|NCT00452452|876746|P2|NOT COMPLETED|Overall Study||0
361130|NCT00452452|876747|P1|NOT COMPLETED|Overall Study||2
361131|NCT00452452|876745|P3|COMPLETED|Overall Study||152
361132|NCT00452452|876746|P2|COMPLETED|Overall Study||112
361133|NCT00452452|876747|P1|COMPLETED|Overall Study||88
361134|NCT00452452|876745|P3|Vaccinated Dose 3|Overall Study||0
361135|NCT00452452|876746|P2|Vaccinated Dose 3|Overall Study||0
361136|NCT00452452|876747|P1|Vaccinated Dose 3|Overall Study||89
361137|NCT00452452|876745|P3|Vaccinated Dose 2|Overall Study||0
361138|NCT00452452|876746|P2|Vaccinated Dose 2|Overall Study||112
361139|NCT00452452|876747|P1|Vaccinated Dose 2|Overall Study||90
361140|NCT00452452|876745|P3|Vaccinated Dose 1|Overall Study||152
361141|NCT00452452|876746|P2|Vaccinated Dose 1|Overall Study||112
361142|NCT00452452|876747|P1|Vaccinated Dose 1|Overall Study||90
361143|NCT00452452|876745|P3|STARTED|Overall Study||153
361144|NCT00452452|876746|P2|STARTED|Overall Study||112
361145|NCT00452452|876747|P1|STARTED|Overall Study||90
361146|NCT00452426|876772|P2|NOT COMPLETED|Overall Study||11
361147|NCT00452426|876773|P1|NOT COMPLETED|Overall Study||7
361148|NCT00452426|876772|P2|COMPLETED|Overall Study||493
361149|NCT00452426|876773|P1|COMPLETED|Overall Study||489
361150|NCT00452426|876772|P2|STARTED|Overall Study||504
361151|NCT00452426|876773|P1|STARTED|Overall Study||496
361152|NCT00452400|876792|P5|NOT COMPLETED|Overall Study||3
361153|NCT00452400|876793|P4|NOT COMPLETED|Overall Study||1
361154|NCT00452400|876794|P3|NOT COMPLETED|Overall Study||7
361155|NCT00452400|876795|P2|NOT COMPLETED|Overall Study||1
361156|NCT00452400|876796|P1|NOT COMPLETED|Overall Study||5
361157|NCT00452400|876792|P5|COMPLETED|Overall Study||76
361158|NCT00452400|876793|P4|COMPLETED|Overall Study||85
361159|NCT00452400|876794|P3|COMPLETED|Overall Study||73
361160|NCT00452400|876795|P2|COMPLETED|Overall Study||80
361161|NCT00452400|876796|P1|COMPLETED|Overall Study||74
361162|NCT00452400|876792|P5|STARTED|Overall Study||79
361163|NCT00452400|876793|P4|STARTED|Overall Study||86
361164|NCT00452400|876794|P3|STARTED|Overall Study||80
361165|NCT00452400|876795|P2|STARTED|Overall Study||81
361166|NCT00452400|876796|P1|STARTED|Overall Study||79
361167|NCT00452387|876968|P1|NOT COMPLETED|Overall Study||0
361168|NCT00452387|876968|P1|COMPLETED|Overall Study||22
361169|NCT00452387|876968|P1|STARTED|Overall Study||22
361170|NCT00452374|876976|P1|NOT COMPLETED|Overall Study||0
361171|NCT00452374|876976|P1|COMPLETED|Overall Study||48
361172|NCT00452374|876976|P1|STARTED|Overall Study||48
361173|NCT00452361|876983|P2|NOT COMPLETED|Overall Study||10
361174|NCT00452361|876984|P1|NOT COMPLETED|Overall Study||21
361175|NCT00452361|876983|P2|COMPLETED|Overall Study||0
361176|NCT00452361|876984|P1|COMPLETED|Overall Study||0
361177|NCT00452361|876983|P2|STARTED|Overall Study||10
361178|NCT00452361|876984|P1|STARTED|Overall Study||21
361179|NCT00452348|877028|P2|NOT COMPLETED|Overall Study||84
361180|NCT00452348|877029|P1|NOT COMPLETED|Overall Study||79
361181|NCT00452348|877028|P2|COMPLETED|Overall Study||234
361182|NCT00452348|877029|P1|COMPLETED|Overall Study||231
361183|NCT00452348|877028|P2|STARTED|Overall Study||318
361184|NCT00452348|877029|P1|STARTED|Overall Study||310
361185|NCT00452335|877044|P3|NOT COMPLETED|Overall Study||9
361186|NCT00452335|877045|P2|NOT COMPLETED|Overall Study||4
361187|NCT00452335|877046|P1|NOT COMPLETED|Overall Study||2
361188|NCT00452335|877044|P3|COMPLETED|Overall Study||23
361189|NCT00452335|877045|P2|COMPLETED|Overall Study||61
361190|NCT00452335|877046|P1|COMPLETED|Overall Study||25
361191|NCT00452335|877044|P3|STARTED|Overall Study||32
361192|NCT00452335|877045|P2|STARTED|Overall Study||65
361193|NCT00452335|877046|P1|STARTED|Overall Study||27
361194|NCT00452114|877083|P2|NOT COMPLETED|Overall Study||3
361195|NCT00452114|877084|P1|NOT COMPLETED|Overall Study||3
361196|NCT00452114|877083|P2|COMPLETED|Overall Study||10
361197|NCT00452114|877084|P1|COMPLETED|Overall Study||12
361198|NCT00452114|877083|P2|STARTED|Overall Study||13
361199|NCT00452114|877084|P1|STARTED|Overall Study||15
361200|NCT00451958|877100|P5|NOT COMPLETED|CS21A (NCT00451958)||0
361201|NCT00451958|877101|P4|NOT COMPLETED|CS21A (NCT00451958)||39
361202|NCT00451958|877102|P3|NOT COMPLETED|CS21A (NCT00451958)||42
361203|NCT00451958|877103|P2|NOT COMPLETED|CS21A (NCT00451958)||77
361204|NCT00451958|877104|P1|NOT COMPLETED|CS21A (NCT00451958)||65
361205|NCT00451958|877100|P5|COMPLETED|CS21A (NCT00451958)||0
361206|NCT00451958|877101|P4|COMPLETED|CS21A (NCT00451958)||27
361207|NCT00451958|877102|P3|COMPLETED|CS21A (NCT00451958)||27
361208|NCT00451958|877103|P2|COMPLETED|CS21A (NCT00451958)||49
361209|NCT00451958|877104|P1|COMPLETED|CS21A (NCT00451958)||60
361210|NCT00451958|877100|P5|STARTED|CS21A (NCT00451958)|Participants were switched to the degarelix groups when CS21 was completed.|0
361211|NCT00451958|877101|P4|STARTED|CS21A (NCT00451958)|One of the enrolled participants never received any treatment, i.e. the CS21A ITT population=65.|66
361212|NCT00451958|877102|P3|STARTED|CS21A (NCT00451958)|CS21A ITT population.|69
361213|NCT00451958|877103|P2|STARTED|CS21A (NCT00451958)|CS21A ITT population.|126
361214|NCT00451958|877104|P1|STARTED|CS21A (NCT00451958)|CS21A intention-to-treat (ITT) population.|125
361215|NCT00451958|877100|P5|NOT COMPLETED|CS21 (NCT00295750)||32
361216|NCT00451958|877101|P4|NOT COMPLETED|CS21 (NCT00295750)||0
361217|NCT00451958|877102|P3|NOT COMPLETED|CS21 (NCT00295750)||0
361218|NCT00451958|877103|P2|NOT COMPLETED|CS21 (NCT00295750)||43
361219|NCT00451958|877104|P1|NOT COMPLETED|CS21 (NCT00295750)||41
361220|NCT00451958|877100|P5|COMPLETED|CS21 (NCT00295750)||172
361221|NCT00451958|877101|P4|COMPLETED|CS21 (NCT00295750)||0
361222|NCT00451958|877102|P3|COMPLETED|CS21 (NCT00295750)||0
361223|NCT00451958|877103|P2|COMPLETED|CS21 (NCT00295750)||163
361224|NCT00451958|877104|P1|COMPLETED|CS21 (NCT00295750)||169
361225|NCT00451958|877100|P5|STARTED|CS21 (NCT00295750)||204
361226|NCT00451958|877101|P4|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
361227|NCT00451958|877102|P3|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
361228|NCT00451958|877103|P2|STARTED|CS21 (NCT00295750)|CS21 ITT population.|206
361229|NCT00451958|877104|P1|STARTED|CS21 (NCT00295750)|CS21 intention-to-treat (ITT) population.|210
361230|NCT00451906|877134|P1|NOT COMPLETED|Overall Study||2239
361231|NCT00451906|877134|P1|COMPLETED|Overall Study||13
361232|NCT00451906|877134|P1|STARTED|Overall Study||2252
361233|NCT00451698|877144|P2|NOT COMPLETED|Overall Study||0
361234|NCT00451698|877145|P1|NOT COMPLETED|Overall Study||0
361235|NCT00451698|877144|P2|COMPLETED|Overall Study||6
361236|NCT00451698|877145|P1|COMPLETED|Overall Study||3
361237|NCT00451698|877144|P2|STARTED|Overall Study||6
361238|NCT00451698|877145|P1|STARTED|Overall Study||3
361239|NCT00451555|877162|P2|NOT COMPLETED|Overall Study||4
361240|NCT00451555|877163|P1|NOT COMPLETED|Overall Study||13
361241|NCT00451555|877162|P2|COMPLETED|Overall Study||56
361242|NCT00451555|877163|P1|COMPLETED|Overall Study||83
361243|NCT00451555|877162|P2|Death|Overall Study||0
361244|NCT00451555|877163|P1|Death|Overall Study||2
361245|NCT00451555|877162|P2|Progressive Disease|Overall Study||54
361246|NCT00451555|877163|P1|Progressive Disease|Overall Study||75
361247|NCT00451555|877162|P2|Enzastaurin Once Daily Dosing (QD)|Overall Study||0
361248|NCT00451555|877163|P1|Enzastaurin Once Daily Dosing (QD)|Overall Study||55
361249|NCT00451555|877162|P2|Enzastaurin Twice Daily Dosing (BID)|Overall Study||0
361250|NCT00451555|877163|P1|Enzastaurin Twice Daily Dosing (BID)|Overall Study||39
361251|NCT00451555|877162|P2|Received at Least One Dose of Study Drug|Overall Study||58
361252|NCT00451555|877163|P1|Received at Least One Dose of Study Drug|Overall Study||94
361253|NCT00451555|877162|P2|STARTED|Overall Study||60
361254|NCT00451555|877163|P1|STARTED|Overall Study||96
361255|NCT00451451|877197|P4|NOT COMPLETED|Overall Study||58
361256|NCT00451451|877198|P3|NOT COMPLETED|Overall Study||72
361257|NCT00451451|877199|P2|NOT COMPLETED|Overall Study||75
361258|NCT00451451|877200|P1|NOT COMPLETED|Overall Study||85
361259|NCT00451451|877197|P4|COMPLETED|Overall Study||292
361260|NCT00451451|877198|P3|COMPLETED|Overall Study||273
361261|NCT00451451|877199|P2|COMPLETED|Overall Study||284
361262|NCT00451451|877200|P1|COMPLETED|Overall Study||278
361263|NCT00451451|877197|P4|STARTED|Overall Study|350 participants were dosed; 360 participants were randomized|350
361264|NCT00451451|877198|P3|STARTED|Overall Study|345 participants were dosed; 345 participants were randomized|345
361265|NCT00451451|877199|P2|STARTED|Overall Study|359 participants were dosed; 362 participants were randomized|359
361266|NCT00451451|877200|P1|STARTED|Overall Study|363 participants were dosed; 363 participants were randomized|363
361267|NCT00451321|877235|P8|NOT COMPLETED|Overall Study||6
361268|NCT00451321|877236|P7|NOT COMPLETED|Overall Study||6
361269|NCT00451321|877237|P6|NOT COMPLETED|Overall Study||9
361270|NCT00451321|877238|P5|NOT COMPLETED|Overall Study||7
361271|NCT00451321|877239|P4|NOT COMPLETED|Overall Study||12
361272|NCT00451321|877240|P3|NOT COMPLETED|Overall Study||18
361273|NCT00451321|877241|P2|NOT COMPLETED|Overall Study||5
361274|NCT00451321|877242|P1|NOT COMPLETED|Overall Study||7
361275|NCT00451321|877235|P8|COMPLETED|Overall Study||0
361276|NCT00451321|877236|P7|COMPLETED|Overall Study||0
361277|NCT00451321|877237|P6|COMPLETED|Overall Study||0
361278|NCT00451321|877238|P5|COMPLETED|Overall Study||0
361279|NCT00451321|877239|P4|COMPLETED|Overall Study||7
361280|NCT00451321|877240|P3|COMPLETED|Overall Study||0
361281|NCT00451321|877241|P2|COMPLETED|Overall Study||10
361282|NCT00451321|877242|P1|COMPLETED|Overall Study||1
361283|NCT00451321|877235|P8|STARTED|Overall Study||6
361284|NCT00451321|877236|P7|STARTED|Overall Study||6
361285|NCT00451321|877237|P6|STARTED|Overall Study||9
361286|NCT00451321|877238|P5|STARTED|Overall Study||7
361287|NCT00451321|877239|P4|STARTED|Overall Study||19
361288|NCT00451321|877240|P3|STARTED|Overall Study||18
361289|NCT00451321|877241|P2|STARTED|Overall Study||15
361290|NCT00451321|877242|P1|STARTED|Overall Study||8
361291|NCT00451282|877414|P2|NOT COMPLETED|Overall Study||5
361292|NCT00451282|877415|P1|NOT COMPLETED|Overall Study||6
361293|NCT00451282|877414|P2|COMPLETED|Overall Study||34
361294|NCT00451282|877415|P1|COMPLETED|Overall Study||40
361295|NCT00451282|877414|P2|STARTED|Overall Study||39
361296|NCT00451282|877415|P1|STARTED|Overall Study||46
361297|NCT00451217|877431|P4|NOT COMPLETED|Overall Study||5
361298|NCT00451217|877432|P3|NOT COMPLETED|Overall Study||4
361299|NCT00451217|877433|P2|NOT COMPLETED|Overall Study||2
361300|NCT00451217|877434|P1|NOT COMPLETED|Overall Study||2
361301|NCT00451217|877431|P4|COMPLETED|Overall Study||44
361302|NCT00451217|877432|P3|COMPLETED|Overall Study||47
361303|NCT00451217|877433|P2|COMPLETED|Overall Study||47
361304|NCT00451217|877434|P1|COMPLETED|Overall Study||47
361305|NCT00451217|877431|P4|Treated|Overall Study||45
361306|NCT00451217|877432|P3|Treated|Overall Study||48
361307|NCT00451217|877433|P2|Treated|Overall Study||48
361308|NCT00451217|877434|P1|Treated|Overall Study||48
361309|NCT00451217|877431|P4|STARTED|Overall Study||49
361310|NCT00451217|877432|P3|STARTED|Overall Study||51
361311|NCT00451217|877433|P2|STARTED|Overall Study||49
361312|NCT00451217|877434|P1|STARTED|Overall Study||49
361313|NCT00451204|877462|P2|NOT COMPLETED|Overall Study||20
361314|NCT00451204|877463|P1|NOT COMPLETED|Overall Study||22
361315|NCT00451204|877462|P2|COMPLETED|Overall Study||56
361316|NCT00451204|877463|P1|COMPLETED|Overall Study|60 completed the study but 3 stopped study drug(s) early|60
361317|NCT00451204|877462|P2|STARTED|Overall Study||76
361318|NCT00451204|877463|P1|STARTED|Overall Study||82
361319|NCT00451191|877481|P2|NOT COMPLETED|Overall Study||11
361320|NCT00451191|877482|P1|NOT COMPLETED|Overall Study||15
361321|NCT00451191|877481|P2|COMPLETED|Overall Study||55
361322|NCT00451191|877482|P1|COMPLETED|Overall Study||53
361323|NCT00451191|877481|P2|STARTED|Overall Study||66
361324|NCT00451191|877482|P1|STARTED|Overall Study||68
361325|NCT00451048|877488|P1|NOT COMPLETED|Overall Study||0
361326|NCT00451048|877488|P1|COMPLETED|Overall Study||10
361327|NCT00451048|877488|P1|STARTED|Overall Study||10
361328|NCT00450983|877497|P1|NOT COMPLETED|Overall Study||0
361329|NCT00450983|877497|P1|COMPLETED|Overall Study||1
361330|NCT00450983|877497|P1|STARTED|Overall Study||1
361331|NCT00450866|877509|P2|NOT COMPLETED|Overall Study||3
361332|NCT00450866|877510|P1|NOT COMPLETED|Overall Study||7
361333|NCT00450866|877509|P2|COMPLETED|Overall Study||7
361334|NCT00450866|877510|P1|COMPLETED|Overall Study||38
361335|NCT00450866|877509|P2|STARTED|Overall Study||10
361336|NCT00450866|877510|P1|STARTED|Overall Study||45
361337|NCT00450801|877520|P1|NOT COMPLETED|Overall Study||1
361338|NCT00450801|877520|P1|COMPLETED|Overall Study||21
361339|NCT00450801|877520|P1|STARTED|Overall Study||22
361340|NCT00450749|877534|P3|NOT COMPLETED|Overall Study||2
361341|NCT00450749|877535|P2|NOT COMPLETED|Overall Study||1
361342|NCT00450749|877536|P1|NOT COMPLETED|Overall Study||0
361343|NCT00450749|877534|P3|COMPLETED|Overall Study||2
361344|NCT00450749|877535|P2|COMPLETED|Overall Study||2
361345|NCT00450749|877536|P1|COMPLETED|Overall Study||3
361346|NCT00450749|877534|P3|STARTED|Overall Study||4
361347|NCT00450749|877535|P2|STARTED|Overall Study||3
361348|NCT00450749|877536|P1|STARTED|Overall Study||3
361349|NCT00450723|877544|P1|NOT COMPLETED|Overall Study||5
361350|NCT00450723|877544|P1|COMPLETED|Overall Study||34
361351|NCT00450723|877544|P1|STARTED|Overall Study||39
361352|NCT00450658|877552|P2|NOT COMPLETED|Overall Study||90
361353|NCT00450658|877553|P1|NOT COMPLETED|Overall Study||143
361354|NCT00450658|877552|P2|COMPLETED|Overall Study||122
361355|NCT00450658|877553|P1|COMPLETED|Overall Study||272
361356|NCT00450658|877552|P2|STARTED|Overall Study||212
361357|NCT00450658|877553|P1|STARTED|Overall Study||415
361358|NCT00450619|877567|P2|NOT COMPLETED|Overall Study||1
361359|NCT00450619|877568|P1|NOT COMPLETED|Overall Study||4
361360|NCT00450619|877567|P2|COMPLETED|Overall Study||21
361361|NCT00450619|877568|P1|COMPLETED|Overall Study||18
361362|NCT00450619|877567|P2|STARTED|Overall Study||22
361363|NCT00450619|877568|P1|STARTED|Overall Study||22
361364|NCT00450580|877594|P2|NOT COMPLETED|Overall Study||16
361365|NCT00450580|877595|P1|NOT COMPLETED|Overall Study||16
361366|NCT00450580|877594|P2|COMPLETED|Overall Study||90
361367|NCT00450580|877595|P1|COMPLETED|Overall Study||90
361368|NCT00450580|877594|P2|STARTED|Overall Study||106
361369|NCT00450580|877595|P1|STARTED|Overall Study||106
361370|NCT00450463|877615|P2|NOT COMPLETED|Progressed to Receive Vaccine Alone||0
361371|NCT00450463|877616|P1|NOT COMPLETED|Progressed to Receive Vaccine Alone||0
361372|NCT00450463|877615|P2|COMPLETED|Progressed to Receive Vaccine Alone||0
361373|NCT00450463|877616|P1|COMPLETED|Progressed to Receive Vaccine Alone||11
361374|NCT00450463|877615|P2|STARTED|Progressed to Receive Vaccine Alone||0
361375|NCT00450463|877616|P1|STARTED|Progressed to Receive Vaccine Alone||11
361376|NCT00450463|877615|P2|NOT COMPLETED|Initial Drug Administration||0
361377|NCT00450463|877616|P1|NOT COMPLETED|Initial Drug Administration||0
361378|NCT00450463|877615|P2|COMPLETED|Initial Drug Administration||31
361379|NCT00450463|877616|P1|COMPLETED|Initial Drug Administration||33
361380|NCT00450463|877615|P2|STARTED|Initial Drug Administration||31
361381|NCT00450463|877616|P1|STARTED|Initial Drug Administration||33
361382|NCT00450450|877632|P2|NOT COMPLETED|Overall Study||3
361383|NCT00450450|877633|P1|NOT COMPLETED|Overall Study||5
361384|NCT00450450|877632|P2|COMPLETED|Overall Study||11
361385|NCT00450450|877633|P1|COMPLETED|Overall Study||8
361386|NCT00450450|877632|P2|STARTED|Overall Study||14
361387|NCT00450450|877633|P1|STARTED|Overall Study||13
361388|NCT00450437|877657|P4|NOT COMPLETED|Overall Study||11
361389|NCT00450437|877658|P3|NOT COMPLETED|Overall Study||24
361390|NCT00450437|877659|P2|NOT COMPLETED|Overall Study||16
361391|NCT00450437|877660|P1|NOT COMPLETED|Overall Study||46
361392|NCT00450437|877657|P4|COMPLETED|Overall Study||325
361393|NCT00450437|877658|P3|COMPLETED|Overall Study||999
361394|NCT00450437|877659|P2|COMPLETED|Overall Study||524
361395|NCT00450437|877660|P1|COMPLETED|Overall Study||1594
361396|NCT00450437|877657|P4|STARTED|Overall Study||336
361397|NCT00450437|877658|P3|STARTED|Overall Study||1023
361398|NCT00450437|877659|P2|STARTED|Overall Study||540
361399|NCT00450437|877660|P1|STARTED|Overall Study||1640
361400|NCT00450424|877684|P2|NOT COMPLETED|Overall Study||11
361401|NCT00450424|877685|P1|NOT COMPLETED|Overall Study||20
361402|NCT00450424|877684|P2|COMPLETED|Overall Study||106
361403|NCT00450424|877685|P1|COMPLETED|Overall Study||102
361404|NCT00450424|877684|P2|STARTED|Overall Study||117
361405|NCT00450424|877685|P1|STARTED|Overall Study||122
361406|NCT00450411|877691|P1|NOT COMPLETED|Overall Study||8
361407|NCT00450411|877691|P1|COMPLETED|Overall Study||92
361408|NCT00450411|877691|P1|STARTED|Overall Study||100
361409|NCT00450385|877696|P1|NOT COMPLETED|Overall Study||13
361410|NCT00450385|877696|P1|COMPLETED|Overall Study||44
361411|NCT00450385|877696|P1|STARTED|Overall Study||57
361412|NCT00450372|877705|P1|NOT COMPLETED|Overall Study||1
361413|NCT00450372|877705|P1|COMPLETED|Overall Study||37
361414|NCT00450372|877705|P1|STARTED|Overall Study||38
361415|NCT00450333|877718|P4|NOT COMPLETED|Overall Study||28
361416|NCT00450333|877719|P3|NOT COMPLETED|Overall Study||25
361417|NCT00450333|877720|P2|NOT COMPLETED|Overall Study||63
361418|NCT00450333|877721|P1|NOT COMPLETED|Overall Study||54
361419|NCT00450333|877718|P4|COMPLETED|Overall Study||74
361420|NCT00450333|877719|P3|COMPLETED|Overall Study||75
361421|NCT00450333|877720|P2|COMPLETED|Overall Study||44
361422|NCT00450333|877721|P1|COMPLETED|Overall Study||44
361423|NCT00450333|877718|P4|STARTED|Overall Study||102
361424|NCT00450333|877719|P3|STARTED|Overall Study||100
361425|NCT00450333|877720|P2|STARTED|Overall Study||107
361426|NCT00450333|877721|P1|STARTED|Overall Study||98
361427|NCT00450294|877739|P1|NOT COMPLETED|Overall Study||0
361428|NCT00450294|877739|P1|COMPLETED|Overall Study||10
361429|NCT00450294|877739|P1|STARTED|Overall Study||10
361430|NCT00450255|877744|P1|NOT COMPLETED|Overall Study||1
361431|NCT00450255|877744|P1|COMPLETED|Overall Study||40
361432|NCT00450255|877744|P1|STARTED|Overall Study||41
361433|NCT00450242|877754|P2|NOT COMPLETED|Overall Study||1
361434|NCT00450242|877755|P1|NOT COMPLETED|Overall Study||3
361435|NCT00450242|877754|P2|COMPLETED|Overall Study||6
361436|NCT00450242|877755|P1|COMPLETED|Overall Study||4
361437|NCT00450242|877754|P2|STARTED|Overall Study||7
361438|NCT00450242|877755|P1|STARTED|Overall Study||7
361439|NCT00450216|877769|P2|NOT COMPLETED|Overall Study||129
361440|NCT00450216|877770|P1|NOT COMPLETED|Overall Study||174
361441|NCT00450216|877769|P2|COMPLETED|Overall Study||170
361442|NCT00450216|877770|P1|COMPLETED|Overall Study||433
361443|NCT00450216|877769|P2|STARTED|Overall Study||299
361444|NCT00450216|877770|P1|STARTED|Overall Study||607
361445|NCT00450190|877782|P1|NOT COMPLETED|Overall Study||2
361446|NCT00450190|877782|P1|COMPLETED|Overall Study||18
361447|NCT00450190|877782|P1|STARTED|Overall Study||20
361448|NCT00450177|877792|P2|NOT COMPLETED|Overall Study||11
361449|NCT00450177|877793|P1|NOT COMPLETED|Overall Study||9
361450|NCT00450177|877792|P2|COMPLETED|Overall Study||92
361451|NCT00450177|877793|P1|COMPLETED|Overall Study||88
361452|NCT00450177|877792|P2|STARTED|Overall Study||103
361453|NCT00450177|877793|P1|STARTED|Overall Study||97
361454|NCT00450112|877819|P2|NOT COMPLETED|Overall Study||6
361455|NCT00450112|877820|P1|NOT COMPLETED|Overall Study||13
361456|NCT00450112|877819|P2|COMPLETED|Overall Study||71
361457|NCT00450112|877820|P1|COMPLETED|Overall Study||112
361458|NCT00450112|877819|P2|Analyzed Participants|Overall Study||74
361459|NCT00450112|877820|P1|Analyzed Participants|Overall Study|3 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|122
361460|NCT00450112|877819|P2|Received Injection|Overall Study||74
361461|NCT00450112|877820|P1|Received Injection|Overall Study||125
361462|NCT00450112|877819|P2|STARTED|Overall Study||77
361463|NCT00450112|877820|P1|STARTED|Overall Study||125
361464|NCT00450073|877845|P3|NOT COMPLETED|Overall Study||1
361465|NCT00450073|877846|P2|NOT COMPLETED|Overall Study||0
361466|NCT00450073|877847|P1|NOT COMPLETED|Overall Study||1
361467|NCT00450073|877845|P3|COMPLETED|Overall Study||9
361468|NCT00450073|877846|P2|COMPLETED|Overall Study||10
361469|NCT00450073|877847|P1|COMPLETED|Overall Study||9
361470|NCT00450073|877845|P3|STARTED|Overall Study||10
361471|NCT00450073|877846|P2|STARTED|Overall Study||10
361472|NCT00450073|877847|P1|STARTED|Overall Study||10
361473|NCT00449956|877858|P3|NOT COMPLETED|Overall Study||9
361474|NCT00449956|877859|P2|NOT COMPLETED|Overall Study||4
361475|NCT00449956|877860|P1|NOT COMPLETED|Overall Study||10
361476|NCT00449956|877858|P3|COMPLETED|Overall Study||184
361477|NCT00449956|877859|P2|COMPLETED|Overall Study||88
361478|NCT00449956|877860|P1|COMPLETED|Overall Study||179
361479|NCT00449956|877858|P3|STARTED|Overall Study||193
361480|NCT00449956|877859|P2|STARTED|Overall Study||92
361481|NCT00449956|877860|P1|STARTED|Overall Study||189
361482|NCT00449930|877876|P2|NOT COMPLETED|Overall Study||75
361483|NCT00449930|877877|P1|NOT COMPLETED|Overall Study||61
361484|NCT00449930|877876|P2|COMPLETED|Overall Study||447
361485|NCT00449930|877877|P1|COMPLETED|Overall Study||467
361486|NCT00449930|877876|P2|STARTED|Overall Study||522
361487|NCT00449930|877877|P1|STARTED|Overall Study||528
361488|NCT00449865|877893|P2|NOT COMPLETED|Overall Study||534
361489|NCT00449865|877894|P1|NOT COMPLETED|Overall Study||522
361490|NCT00449865|877893|P2|COMPLETED|Overall Study|477 Expected at Year 5|340
361491|NCT00449865|877894|P1|COMPLETED|Overall Study|478 Expected at Year 5|345
361492|NCT00449865|877893|P2|Completed Year 4|Overall Study|686 Expected at Year 4|523
361493|NCT00449865|877894|P1|Completed Year 4|Overall Study|679 Expected at Year 4|521
361494|NCT00449865|877893|P2|Completed Year 3|Overall Study|874 Expected at Year 3|715
361495|NCT00449865|877894|P1|Completed Year 3|Overall Study|867 Expected at Year 3|719
361496|NCT00449865|877893|P2|Completed Year 2|Overall Study|874 Expected at Year 2|766
361497|NCT00449865|877894|P1|Completed Year 2|Overall Study|867 Expected at Year 2|768
361498|NCT00449865|877893|P2|Completed Year 1|Overall Study|874 Expected at Year 1|822
361499|NCT00449865|877894|P1|Completed Year 1|Overall Study|867 Expected at Year 1|802
361500|NCT00449865|877893|P2|STARTED|Overall Study||874
361501|NCT00449865|877894|P1|STARTED|Overall Study||867
361502|NCT00449787|877902|P2|NOT COMPLETED|Overall Study||100
361503|NCT00449787|877903|P1|NOT COMPLETED|Overall Study||105
361504|NCT00449787|877902|P2|COMPLETED|Overall Study||98
361505|NCT00449787|877903|P1|COMPLETED|Overall Study||98
361506|NCT00449787|877902|P2|STARTED|Overall Study||198
361507|NCT00449787|877903|P1|STARTED|Overall Study||203
361508|NCT00449748|877913|P1|NOT COMPLETED|Overall Study||0
361509|NCT00449748|877913|P1|COMPLETED|Overall Study||10
361510|NCT00449748|877913|P1|STARTED|Overall Study||10
361511|NCT00449696|877919|P2|NOT COMPLETED|Overall Study||9
361512|NCT00449696|877920|P1|NOT COMPLETED|Overall Study||20
361513|NCT00449696|877919|P2|COMPLETED|Overall Study||119
361514|NCT00449696|877920|P1|COMPLETED|Overall Study||231
361515|NCT00449696|877919|P2|Analyzed Participants|Overall Study||128
361516|NCT00449696|877920|P1|Analyzed Participants|Overall Study|2 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|247
361517|NCT00449696|877919|P2|Received Injection|Overall Study||128
361518|NCT00449696|877920|P1|Received Injection|Overall Study||249
361519|NCT00449696|877919|P2|STARTED|Overall Study||128
361520|NCT00449696|877920|P1|STARTED|Overall Study||251
361521|NCT00449644|877946|P4|NOT COMPLETED|Overall Study||32
361522|NCT00449644|877947|P3|NOT COMPLETED|Overall Study||29
361523|NCT00449644|877948|P2|NOT COMPLETED|Overall Study||13
361524|NCT00449644|877949|P1|NOT COMPLETED|Overall Study||10
361525|NCT00449644|877946|P4|COMPLETED|Overall Study|After Week 24, 1 patient rolled over to treatment with TMC207 and was not completed or discontinued.|49
361526|NCT00449644|877947|P3|COMPLETED|Overall Study||50
361527|NCT00449644|877948|P2|COMPLETED|Overall Study||11
361528|NCT00449644|877949|P1|COMPLETED|Overall Study||13
361529|NCT00449644|877946|P4|Rollover|Overall Study||1
361530|NCT00449644|877947|P3|Rollover|Overall Study||0
361531|NCT00449644|877948|P2|Rollover|Overall Study||0
361532|NCT00449644|877949|P1|Rollover|Overall Study||0
361533|NCT00449644|877946|P4|STARTED|Overall Study||81
361534|NCT00449644|877947|P3|STARTED|Overall Study||79
361535|NCT00449644|877948|P2|STARTED|Overall Study||24
361536|NCT00449644|877949|P1|STARTED|Overall Study||23
361537|NCT00449540|877969|P3|NOT COMPLETED|Treatment Phase||17
361538|NCT00449540|877970|P2|NOT COMPLETED|Treatment Phase||20
361539|NCT00449540|877971|P1|NOT COMPLETED|Treatment Phase||0
361540|NCT00449540|877969|P3|COMPLETED|Treatment Phase||82
361541|NCT00449540|877970|P2|COMPLETED|Treatment Phase||82
361542|NCT00449540|877971|P1|COMPLETED|Treatment Phase||0
361543|NCT00449540|877969|P3|STARTED|Treatment Phase||99
361544|NCT00449540|877970|P2|STARTED|Treatment Phase||102
361545|NCT00449540|877971|P1|STARTED|Treatment Phase||0
361546|NCT00449540|877969|P3|NOT COMPLETED|Pretreatment Phase||0
361547|NCT00449540|877970|P2|NOT COMPLETED|Pretreatment Phase||0
361548|NCT00449540|877971|P1|NOT COMPLETED|Pretreatment Phase||66
361549|NCT00449540|877969|P3|COMPLETED|Pretreatment Phase||0
361550|NCT00449540|877970|P2|COMPLETED|Pretreatment Phase||0
361551|NCT00449540|877971|P1|COMPLETED|Pretreatment Phase||201
361552|NCT00449540|877969|P3|STARTED|Pretreatment Phase||0
361553|NCT00449540|877970|P2|STARTED|Pretreatment Phase||0
361554|NCT00449540|877971|P1|STARTED|Pretreatment Phase||267
361555|NCT00449176|877988|P3|NOT COMPLETED|Overall Study||167
361556|NCT00449176|877989|P2|NOT COMPLETED|Overall Study||195
361557|NCT00449176|877990|P1|NOT COMPLETED|Overall Study||152
361558|NCT00449176|877988|P3|COMPLETED|Overall Study||152
361559|NCT00449176|877989|P2|COMPLETED|Overall Study||133
361560|NCT00449176|877990|P1|COMPLETED|Overall Study||166
361561|NCT00449176|877988|P3|STARTED|Overall Study|5 randomly assigned to this group did not receive drug, 2 enrolled twice(of 326 subjects randomized)|319
361562|NCT00449176|877989|P2|STARTED|Overall Study|6 randomly assigned to this treatment group did not take drug (of 334 subjects initially randomized)|328
361563|NCT00449176|877990|P1|STARTED|Overall Study|3 randomly assigned to this treatment group did not take drug (of 321 subjects initially randomized)|318
361564|NCT00449163|878016|P1|NOT COMPLETED|Overall Study||3
361565|NCT00449163|878016|P1|COMPLETED|Overall Study||22
361566|NCT00449163|878016|P1|STARTED|Overall Study||25
361567|NCT00449150|878026|P3|NOT COMPLETED|Overall Study||47
361568|NCT00449150|878027|P2|NOT COMPLETED|Overall Study||53
361569|NCT00449150|878028|P1|NOT COMPLETED|Overall Study||46
361570|NCT00449150|878026|P3|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|171
361571|NCT00449150|878027|P2|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|177
361572|NCT00449150|878028|P1|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|173
361573|NCT00449150|878026|P3|STARTED|Overall Study||218
361574|NCT00449150|878027|P2|STARTED|Overall Study||230
361575|NCT00449150|878028|P1|STARTED|Overall Study||219
361576|NCT00449072|878041|P2|NOT COMPLETED|Overall Study||42
361577|NCT00449072|878042|P1|NOT COMPLETED|Overall Study||41
361578|NCT00449072|878041|P2|COMPLETED|Overall Study||109
361579|NCT00449072|878042|P1|COMPLETED|Overall Study||107
361580|NCT00449072|878041|P2|STARTED|Overall Study||151
361581|NCT00449072|878042|P1|STARTED|Overall Study||148
361582|NCT00449046|878066|P1|NOT COMPLETED|Overall Study||0
361583|NCT00449046|878066|P1|COMPLETED|Overall Study||40
361584|NCT00449046|878066|P1|STARTED|Overall Study||40
361585|NCT00449033|878079|P2|NOT COMPLETED|Follow-up Period||434
361586|NCT00449033|878080|P1|NOT COMPLETED|Follow-up Period||425
361587|NCT00449033|878079|P2|COMPLETED|Follow-up Period||0
361588|NCT00449033|878080|P1|COMPLETED|Follow-up Period||0
361589|NCT00449033|878079|P2|STARTED|Follow-up Period|434 entered, comprising 452 randomized less 12 deaths, 2 lost to follow-up & 4 ongoing on treatment|434
361590|NCT00449033|878080|P1|STARTED|Follow-up Period|425 entered, comprising 452 randomized less 21 deaths & 6 ongoing on treatment|425
361591|NCT00449033|878079|P2|NOT COMPLETED|Treatment Period||452
361592|NCT00449033|878080|P1|NOT COMPLETED|Treatment Period||452
361593|NCT00449033|878079|P2|COMPLETED|Treatment Period||0
361594|NCT00449033|878080|P1|COMPLETED|Treatment Period||0
361595|NCT00449033|878079|P2|Received Treatment|Treatment Period||449
361596|NCT00449033|878080|P1|Received Treatment|Treatment Period||452
361597|NCT00449033|878079|P2|STARTED|Treatment Period|Reasons for not treated: Adverse event (N=1); Consent withdrawn (N=1); Reason missing (N=1)|452
361598|NCT00449033|878080|P1|STARTED|Treatment Period||452
361599|NCT00448916|878118|P4|NOT COMPLETED|Overall Study||6
361600|NCT00448916|878119|P3|NOT COMPLETED|Overall Study||6
361601|NCT00448916|878120|P2|NOT COMPLETED|Overall Study||6
361602|NCT00448916|878121|P1|NOT COMPLETED|Overall Study||7
361603|NCT00448916|878118|P4|COMPLETED|Overall Study||5
361604|NCT00448916|878119|P3|COMPLETED|Overall Study||6
361605|NCT00448916|878120|P2|COMPLETED|Overall Study||9
361606|NCT00448916|878121|P1|COMPLETED|Overall Study||9
361607|NCT00448916|878118|P4|STARTED|Overall Study||11
361608|NCT00448916|878119|P3|STARTED|Overall Study||12
361609|NCT00448916|878120|P2|STARTED|Overall Study||15
361610|NCT00448916|878121|P1|STARTED|Overall Study||16
361611|NCT00448864|878195|P3|NOT COMPLETED|Overall Study||1
361612|NCT00448864|878196|P2|NOT COMPLETED|Overall Study||5
361613|NCT00448864|878197|P1|NOT COMPLETED|Overall Study||5
361614|NCT00448864|878195|P3|COMPLETED|Overall Study||18
361615|NCT00448864|878196|P2|COMPLETED|Overall Study||24
361616|NCT00448864|878197|P1|COMPLETED|Overall Study||22
361617|NCT00448864|878195|P3|Completed Post-operative Period|Overall Study||18
361618|NCT00448864|878196|P2|Completed Post-operative Period|Overall Study||25
361619|NCT00448864|878197|P1|Completed Post-operative Period|Overall Study||26
361620|NCT00448864|878195|P3|Started Post-operative Period|Overall Study||18
361621|NCT00448864|878196|P2|Started Post-operative Period|Overall Study||25
361622|NCT00448864|878197|P1|Started Post-operative Period|Overall Study||26
361623|NCT00448864|878195|P3|Received at Least 1 Dose of Study Drug|Overall Study||18
361624|NCT00448864|878196|P2|Received at Least 1 Dose of Study Drug|Overall Study||25
361714|NCT00448279|878391|P2|STARTED|Overall Study||29
361625|NCT00448864|878197|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
361626|NCT00448864|878195|P3|STARTED|Overall Study||19
361627|NCT00448864|878196|P2|STARTED|Overall Study||29
361628|NCT00448864|878197|P1|STARTED|Overall Study||27
361629|NCT00448760|878213|P1|NOT COMPLETED|Overall Study||3
361630|NCT00448760|878213|P1|COMPLETED|Overall Study||26
361631|NCT00448760|878213|P1|STARTED|Overall Study||29
361632|NCT00448747|878222|P2|NOT COMPLETED|Overall Study||0
361633|NCT00448747|878223|P1|NOT COMPLETED|Overall Study||1
361634|NCT00448747|878222|P2|COMPLETED|Overall Study||48
361635|NCT00448747|878223|P1|COMPLETED|Overall Study||52
361636|NCT00448747|878222|P2|Per Protocol Population (PPS)|Overall Study||48
361637|NCT00448747|878223|P1|Per Protocol Population (PPS)|Overall Study||50
361638|NCT00448747|878222|P2|Received L-ARG-GHRH and AEZS-130|Overall Study||10
361639|NCT00448747|878223|P1|Received L-ARG-GHRH and AEZS-130|Overall Study||42
361640|NCT00448747|878222|P2|Received L-ARG-GHRH|Overall Study||10
361641|NCT00448747|878223|P1|Received L-ARG-GHRH|Overall Study||43
361642|NCT00448747|878222|P2|Received AEZS-130|Overall Study||48
361643|NCT00448747|878223|P1|Received AEZS-130|Overall Study||52
361644|NCT00448747|878222|P2|Received Second Drug Administration|Overall Study||10
361645|NCT00448747|878223|P1|Received Second Drug Administration|Overall Study||42
361646|NCT00448747|878222|P2|Received First Drug Administration|Overall Study||48
361647|NCT00448747|878223|P1|Received First Drug Administration|Overall Study||53
361648|NCT00448747|878222|P2|STARTED|Overall Study||48
361649|NCT00448747|878223|P1|STARTED|Overall Study||53
361650|NCT00448708|878241|P2|NOT COMPLETED|Overall Study||31
361651|NCT00448708|878242|P1|NOT COMPLETED|Overall Study||35
361652|NCT00448708|878241|P2|COMPLETED|Overall Study||79
361653|NCT00448708|878242|P1|COMPLETED|Overall Study||77
361654|NCT00448708|878241|P2|STARTED|Overall Study||110
361655|NCT00448708|878242|P1|STARTED|Overall Study||112
361656|NCT00448682|878250|P1|NOT COMPLETED|Overall Study||0
361657|NCT00448682|878250|P1|COMPLETED|Overall Study||25
361658|NCT00448682|878250|P1|STARTED|Overall Study||25
361659|NCT00448630|878256|P1|NOT COMPLETED|Overall Study||27
361660|NCT00448630|878256|P1|COMPLETED|Overall Study|Number of patients who remained on same medication to end of study.|301
361661|NCT00448630|878256|P1|STARTED|Overall Study||328
361662|NCT00448591|878301|P1|NOT COMPLETED|Overall Study||2296
361663|NCT00448591|878301|P1|COMPLETED|Overall Study||0
361664|NCT00448591|878301|P1|STARTED|Overall Study||2296
361665|NCT00448539|878312|P2|NOT COMPLETED|Overall Study||152
361666|NCT00448539|878313|P1|NOT COMPLETED|Overall Study||134
361667|NCT00448539|878312|P2|COMPLETED|Overall Study||0
361668|NCT00448539|878313|P1|COMPLETED|Overall Study||0
361669|NCT00448539|878312|P2|STARTED|Overall Study||152
361670|NCT00448539|878313|P1|STARTED|Overall Study||134
361671|NCT00448448|878321|P2|NOT COMPLETED|Overall Study||41
361672|NCT00448448|878322|P1|NOT COMPLETED|Overall Study||100
361673|NCT00448448|878321|P2|COMPLETED|Overall Study||96
361674|NCT00448448|878322|P1|COMPLETED|Overall Study||146
361675|NCT00448448|878321|P2|STARTED|Overall Study||137
361676|NCT00448448|878322|P1|STARTED|Overall Study||246
361677|NCT00448435|878328|P2|NOT COMPLETED|Extension Period - 20 Weeks||0
361678|NCT00448435|878329|P1|NOT COMPLETED|Extension Period - 20 Weeks||0
361679|NCT00448435|878328|P2|COMPLETED|Extension Period - 20 Weeks||0
361680|NCT00448435|878329|P1|COMPLETED|Extension Period - 20 Weeks||50
361681|NCT00448435|878328|P2|STARTED|Extension Period - 20 Weeks||0
361682|NCT00448435|878329|P1|STARTED|Extension Period - 20 Weeks||50
361683|NCT00448435|878328|P2|NOT COMPLETED|Treatment Period II - 4 Weeks||0
361684|NCT00448435|878329|P1|NOT COMPLETED|Treatment Period II - 4 Weeks||0
361685|NCT00448435|878328|P2|COMPLETED|Treatment Period II - 4 Weeks||25
361686|NCT00448435|878329|P1|COMPLETED|Treatment Period II - 4 Weeks||25
361687|NCT00448435|878328|P2|STARTED|Treatment Period II - 4 Weeks||25
361688|NCT00448435|878329|P1|STARTED|Treatment Period II - 4 Weeks||25
361689|NCT00448435|878328|P2|NOT COMPLETED|Washout Period - 2 Weeks||0
361690|NCT00448435|878329|P1|NOT COMPLETED|Washout Period - 2 Weeks||1
361691|NCT00448435|878328|P2|COMPLETED|Washout Period - 2 Weeks||25
361692|NCT00448435|878329|P1|COMPLETED|Washout Period - 2 Weeks||25
361693|NCT00448435|878328|P2|STARTED|Washout Period - 2 Weeks||25
361694|NCT00448435|878329|P1|STARTED|Washout Period - 2 Weeks||26
361695|NCT00448435|878328|P2|NOT COMPLETED|Treatment Period I - 4 Weeks||0
361696|NCT00448435|878329|P1|NOT COMPLETED|Treatment Period I - 4 Weeks||0
361697|NCT00448435|878328|P2|COMPLETED|Treatment Period I - 4 Weeks||25
361698|NCT00448435|878329|P1|COMPLETED|Treatment Period I - 4 Weeks||26
361699|NCT00448435|878328|P2|STARTED|Treatment Period I - 4 Weeks||25
361700|NCT00448435|878329|P1|STARTED|Treatment Period I - 4 Weeks||26
361701|NCT00448357|878355|P1|NOT COMPLETED|Overall Study||0
361702|NCT00448357|878355|P1|COMPLETED|Overall Study||54
361703|NCT00448357|878355|P1|STARTED|Overall Study||54
361704|NCT00448344|878380|P2|NOT COMPLETED|Overall Study||36
361705|NCT00448344|878381|P1|NOT COMPLETED|Overall Study||30
361706|NCT00448344|878380|P2|COMPLETED|Overall Study||200
361707|NCT00448344|878381|P1|COMPLETED|Overall Study||205
361708|NCT00448344|878380|P2|STARTED|Overall Study||236
361709|NCT00448344|878381|P1|STARTED|Overall Study||235
361710|NCT00448279|878391|P2|NOT COMPLETED|Overall Study||29
361711|NCT00448279|878392|P1|NOT COMPLETED|Overall Study||29
361712|NCT00448279|878391|P2|COMPLETED|Overall Study||0
361713|NCT00448279|878392|P1|COMPLETED|Overall Study||0
361715|NCT00448279|878392|P1|STARTED|Overall Study||29
361716|NCT00448227|878408|P1|NOT COMPLETED|Overall Study||0
361717|NCT00448227|878408|P1|COMPLETED|Overall Study||18
361718|NCT00448227|878408|P1|STARTED|Overall Study||18
361719|NCT00448201|878435|P1|NOT COMPLETED|Overall Study||0
361720|NCT00448201|878435|P1|COMPLETED|Overall Study||71
361721|NCT00448201|878435|P1|STARTED|Overall Study||71
361722|NCT00448175|878446|P2|NOT COMPLETED|Continued PTNS Through 12 Months||0
361723|NCT00448175|878447|P1|NOT COMPLETED|Continued PTNS Through 12 Months||10
361724|NCT00448175|878446|P2|COMPLETED|Continued PTNS Through 12 Months||0
361725|NCT00448175|878447|P1|COMPLETED|Continued PTNS Through 12 Months||25
361726|NCT00448175|878446|P2|STARTED|Continued PTNS Through 12 Months||0
361727|NCT00448175|878447|P1|STARTED|Continued PTNS Through 12 Months||35
361728|NCT00448175|878446|P2|NOT COMPLETED|12 Weeks PTNS vs. Drug||7
361729|NCT00448175|878447|P1|NOT COMPLETED|12 Weeks PTNS vs. Drug||9
361730|NCT00448175|878446|P2|COMPLETED|12 Weeks PTNS vs. Drug||43
361731|NCT00448175|878447|P1|COMPLETED|12 Weeks PTNS vs. Drug||41
361732|NCT00448175|878446|P2|STARTED|12 Weeks PTNS vs. Drug||50
361733|NCT00448175|878447|P1|STARTED|12 Weeks PTNS vs. Drug||50
361734|NCT00448136|878455|P2|NOT COMPLETED|Overall Study||8
361735|NCT00448136|878456|P1|NOT COMPLETED|Overall Study||4
361736|NCT00448136|878455|P2|COMPLETED|Overall Study||41
361737|NCT00448136|878456|P1|COMPLETED|Overall Study||30
361738|NCT00448136|878455|P2|STARTED|Overall Study||49
361739|NCT00448136|878456|P1|STARTED|Overall Study||34
361740|NCT00448123|878494|P2|NOT COMPLETED|Overall Study||12
361741|NCT00448123|878495|P1|NOT COMPLETED|Overall Study||15
361742|NCT00448123|878494|P2|COMPLETED|Overall Study||53
361743|NCT00448123|878495|P1|COMPLETED|Overall Study||47
361744|NCT00448123|878494|P2|STARTED|Overall Study||65
361745|NCT00448123|878495|P1|STARTED|Overall Study||62
361746|NCT00448019|878505|P1|NOT COMPLETED|Overall Study||7
361747|NCT00448019|878505|P1|COMPLETED|Overall Study||57
361748|NCT00448019|878505|P1|STARTED|Overall Study||64
361749|NCT00447902|878513|P2|NOT COMPLETED|Overall Study||6
361750|NCT00447902|878514|P1|NOT COMPLETED|Overall Study||4
361751|NCT00447902|878513|P2|COMPLETED|Overall Study||0
361752|NCT00447902|878514|P1|COMPLETED|Overall Study||1
361753|NCT00447902|878513|P2|STARTED|Overall Study||6
361754|NCT00447902|878514|P1|STARTED|Overall Study||5
361755|NCT00447876|878556|P2|NOT COMPLETED|Overall Study||4
361756|NCT00447876|878557|P1|NOT COMPLETED|Overall Study||3
361757|NCT00447876|878556|P2|COMPLETED|Overall Study||16
361758|NCT00447876|878557|P1|COMPLETED|Overall Study||17
361759|NCT00447876|878556|P2|STARTED|Overall Study||20
361760|NCT00447876|878557|P1|STARTED|Overall Study||20
361761|NCT00447772|878587|P1|NOT COMPLETED|Overall Study||27
361762|NCT00447772|878587|P1|COMPLETED|Overall Study||489
361763|NCT00447772|878587|P1|STARTED|Overall Study||516
361764|NCT00447603|878607|P3|NOT COMPLETED|Filter Period||15
361765|NCT00447603|878608|P2|NOT COMPLETED|Filter Period||4
361766|NCT00447603|878609|P1|NOT COMPLETED|Filter Period||0
361767|NCT00447603|878607|P3|COMPLETED|Filter Period||0
361768|NCT00447603|878608|P2|COMPLETED|Filter Period||0
361769|NCT00447603|878609|P1|COMPLETED|Filter Period||0
361770|NCT00447603|878607|P3|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|15
361771|NCT00447603|878608|P2|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|4
361772|NCT00447603|878609|P1|STARTED|Filter Period||0
361773|NCT00447603|878607|P3|NOT COMPLETED|Screening||0
361774|NCT00447603|878608|P2|NOT COMPLETED|Screening||0
361775|NCT00447603|878609|P1|NOT COMPLETED|Screening||21
361776|NCT00447603|878607|P3|COMPLETED|Screening||0
361777|NCT00447603|878608|P2|COMPLETED|Screening||0
361778|NCT00447603|878609|P1|COMPLETED|Screening||19
361779|NCT00447603|878607|P3|STARTED|Screening||0
361780|NCT00447603|878608|P2|STARTED|Screening||0
361781|NCT00447603|878609|P1|STARTED|Screening||40
361782|NCT00447590|878629|P1|NOT COMPLETED|Overall Study||60
361783|NCT00447590|878629|P1|COMPLETED|Overall Study|Completing the study was defined as the number of participants in the study at month 60 (5 years).|93
361784|NCT00447590|878629|P1|STARTED|Overall Study|153 participants were treated with the LAP-BAND System.|153
361785|NCT00447499|878638|P1|NOT COMPLETED|Overall Study||7
361786|NCT00447499|878638|P1|COMPLETED|Overall Study||52
361787|NCT00447499|878638|P1|STARTED|Overall Study||59
361788|NCT00447421|878648|P1|NOT COMPLETED|Overall Study||6
361789|NCT00447421|878648|P1|COMPLETED|Overall Study||3
361790|NCT00447421|878648|P1|STARTED|Overall Study||9
361791|NCT00447382|878660|P2|NOT COMPLETED|Overall Study||6
361792|NCT00447382|878661|P1|NOT COMPLETED|Overall Study||6
361793|NCT00447382|878660|P2|COMPLETED|Overall Study||160
361794|NCT00447382|878661|P1|COMPLETED|Overall Study||158
361795|NCT00447382|878660|P2|STARTED|Overall Study||166
361796|NCT00447382|878661|P1|STARTED|Overall Study||164
361797|NCT00447330|878713|P1|NOT COMPLETED|Overall Study||2
361798|NCT00447330|878713|P1|COMPLETED|Overall Study||58
361799|NCT00447330|878713|P1|STARTED|Overall Study|2 subjects signed the ICF, but were withdrawn from study prior to receiving any study drug|60
361800|NCT00447278|878722|P2|NOT COMPLETED|Period III (Optional 6 Month Extension)||15
361801|NCT00447278|878723|P1|NOT COMPLETED|Period III (Optional 6 Month Extension)||30
361802|NCT00447278|878722|P2|COMPLETED|Period III (Optional 6 Month Extension)||140
361803|NCT00447278|878723|P1|COMPLETED|Period III (Optional 6 Month Extension)||109
361804|NCT00447278|878722|P2|STARTED|Period III (Optional 6 Month Extension)|16 choose not to enter this optional period.|155
361805|NCT00447278|878723|P1|STARTED|Period III (Optional 6 Month Extension)|18 choose not to enter this optional period.|139
361806|NCT00447278|878722|P2|NOT COMPLETED|Period II (6 Month Open-Label)||29
361807|NCT00447278|878723|P1|NOT COMPLETED|Period II (6 Month Open-Label)||42
361808|NCT00447278|878722|P2|COMPLETED|Period II (6 Month Open-Label)||171
361809|NCT00447278|878723|P1|COMPLETED|Period II (6 Month Open-Label)||157
361810|NCT00447278|878722|P2|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)|1 patient withdrew due to parent/guardian decision prior to receiving study drug.|199
361811|NCT00447278|878723|P1|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)||199
361812|NCT00447278|878722|P2|STARTED|Period II (6 Month Open-Label)||200
361813|NCT00447278|878723|P1|STARTED|Period II (6 Month Open-Label)||199
361814|NCT00447265|878744|P2|NOT COMPLETED|Overall Study||0
361815|NCT00447265|878745|P1|NOT COMPLETED|Overall Study||1
361816|NCT00447265|878744|P2|COMPLETED|Overall Study||0
361817|NCT00447265|878745|P1|COMPLETED|Overall Study|The participant completed treatment and discontinued follow-up at week 39 after randomization|0
361818|NCT00447265|878744|P2|STARTED|Overall Study||0
361819|NCT00447265|878745|P1|STARTED|Overall Study||1
361820|NCT00447226|878758|P2|NOT COMPLETED|Double-blind Phase||3
361821|NCT00447226|878759|P1|NOT COMPLETED|Double-blind Phase||4
361822|NCT00447226|878758|P2|COMPLETED|Double-blind Phase||0
361823|NCT00447226|878759|P1|COMPLETED|Double-blind Phase||0
361824|NCT00447226|878758|P2|STARTED|Double-blind Phase||3
361825|NCT00447226|878759|P1|STARTED|Double-blind Phase||4
361826|NCT00447226|878758|P2|NOT COMPLETED|12-Week Open-label Phase||25
361827|NCT00447226|878759|P1|NOT COMPLETED|12-Week Open-label Phase||0
361828|NCT00447226|878758|P2|COMPLETED|12-Week Open-label Phase||7
361829|NCT00447226|878759|P1|COMPLETED|12-Week Open-label Phase||0
361830|NCT00447226|878758|P2|STARTED|12-Week Open-label Phase||32
361831|NCT00447226|878759|P1|STARTED|12-Week Open-label Phase||0
361832|NCT00447122|878777|P1|NOT COMPLETED|Overall Study||2
361833|NCT00447122|878777|P1|COMPLETED|Overall Study|29 evaluable thus 29 represented in efficacy and safety portion|29
361834|NCT00447122|878777|P1|STARTED|Overall Study||31
361835|NCT00447083|878783|P4|NOT COMPLETED|Phase II||1
361836|NCT00447083|878784|P3|NOT COMPLETED|Phase II||1
361837|NCT00447083|878785|P2|NOT COMPLETED|Phase II||0
361838|NCT00447083|878786|P1|NOT COMPLETED|Phase II||0
361839|NCT00447083|878783|P4|COMPLETED|Phase II||7
361840|NCT00447083|878784|P3|COMPLETED|Phase II||7
361841|NCT00447083|878785|P2|COMPLETED|Phase II||0
361842|NCT00447083|878786|P1|COMPLETED|Phase II||0
361843|NCT00447083|878783|P4|STARTED|Phase II|Only 8 participants qualified from the end of phase 1|8
361844|NCT00447083|878784|P3|STARTED|Phase II|Only 8 participants qualified from the end of phase 1|8
361845|NCT00447083|878785|P2|STARTED|Phase II|Participants in this group will then be randomized to a phase 2 group in phase2|0
361846|NCT00447083|878786|P1|STARTED|Phase II|Participants in this group will then be randomized to a phase 2 group in phase2|0
361847|NCT00447083|878783|P4|NOT COMPLETED|Phase I||0
361848|NCT00447083|878784|P3|NOT COMPLETED|Phase I||0
361849|NCT00447083|878785|P2|NOT COMPLETED|Phase I||0
361850|NCT00447083|878786|P1|NOT COMPLETED|Phase I||0
361851|NCT00447083|878783|P4|COMPLETED|Phase I||0
361852|NCT00447083|878784|P3|COMPLETED|Phase I||0
361853|NCT00447083|878785|P2|COMPLETED|Phase I|1 participant did not acclimate to phase II|9
361854|NCT00447083|878786|P1|COMPLETED|Phase I|2 participants did not acclimate to phase II|10
361855|NCT00447083|878783|P4|STARTED|Phase I||0
361856|NCT00447083|878784|P3|STARTED|Phase I||0
361857|NCT00447083|878785|P2|STARTED|Phase I||9
361858|NCT00447083|878786|P1|STARTED|Phase I||10
361859|NCT00447057|878802|P4|NOT COMPLETED|Overall Study||26
361860|NCT00447057|878803|P3|NOT COMPLETED|Overall Study||19
361861|NCT00447057|878804|P2|NOT COMPLETED|Overall Study||73
361862|NCT00447057|878805|P1|NOT COMPLETED|Overall Study||83
361863|NCT00447057|878802|P4|COMPLETED|Overall Study||0
361864|NCT00447057|878803|P3|COMPLETED|Overall Study||0
361865|NCT00447057|878804|P2|COMPLETED|Overall Study||3
361866|NCT00447057|878805|P1|COMPLETED|Overall Study||0
361867|NCT00447057|878802|P4|STARTED|Overall Study||26
361868|NCT00447057|878803|P3|STARTED|Overall Study||19
361869|NCT00447057|878804|P2|STARTED|Overall Study||76
361870|NCT00447057|878805|P1|STARTED|Overall Study||83
361871|NCT00447005|878823|P1|NOT COMPLETED|Overall Study||12
361872|NCT00447005|878823|P1|COMPLETED|Overall Study||0
361873|NCT00447005|878823|P1|STARTED|Overall Study||12
361874|NCT00446992|878837|P1|NOT COMPLETED|Overall Study||16
361875|NCT00446992|878837|P1|COMPLETED|Overall Study|Intervention Completion|14
361876|NCT00446992|878837|P1|STARTED|Overall Study|Beginning of Intervention|30
361877|NCT00446966|878851|P2|NOT COMPLETED|Overall Study||7
361878|NCT00446966|878852|P1|NOT COMPLETED|Overall Study||10
361879|NCT00446966|878851|P2|COMPLETED|Overall Study||123
361880|NCT00446966|878852|P1|COMPLETED|Overall Study||120
361881|NCT00446966|878851|P2|STARTED|Overall Study||130
361882|NCT00446966|878852|P1|STARTED|Overall Study||130
361883|NCT00446849|878858|P1|NOT COMPLETED|Maintenance Phase||70
361884|NCT00446849|878858|P1|COMPLETED|Maintenance Phase||138
361885|NCT00446849|878858|P1|STARTED|Maintenance Phase||208
361886|NCT00446849|878858|P1|NOT COMPLETED|Acute Phase||82
361887|NCT00446849|878858|P1|COMPLETED|Acute Phase||56
361888|NCT00446849|878858|P1|STARTED|Acute Phase||138
361889|NCT00446797|878870|P2|NOT COMPLETED|Overall Study||12
361890|NCT00446797|878871|P1|NOT COMPLETED|Overall Study||8
361891|NCT00446797|878870|P2|COMPLETED|Overall Study||125
361892|NCT00446797|878871|P1|COMPLETED|Overall Study||133
361893|NCT00446797|878870|P2|STARTED|Overall Study||137
361894|NCT00446797|878871|P1|STARTED|Overall Study||141
361895|NCT00446654|878917|P2|NOT COMPLETED|Overall Study||0
361896|NCT00446654|878918|P1|NOT COMPLETED|Overall Study||2
361897|NCT00446654|878917|P2|COMPLETED|Overall Study||22
361898|NCT00446654|878918|P1|COMPLETED|Overall Study||19
361899|NCT00446654|878917|P2|STARTED|Overall Study||22
361900|NCT00446654|878918|P1|STARTED|Overall Study||21
361901|NCT00446641|878926|P2|NOT COMPLETED|Overall Study||10
361902|NCT00446641|878927|P1|NOT COMPLETED|Overall Study||17
361903|NCT00446641|878926|P2|COMPLETED|Overall Study||109
361904|NCT00446641|878927|P1|COMPLETED|Overall Study||108
361905|NCT00446641|878926|P2|STARTED|Overall Study||119
361906|NCT00446641|878927|P1|STARTED|Overall Study||125
361907|NCT00446563|878947|P2|NOT COMPLETED|Overall Study||9
361908|NCT00446563|878948|P1|NOT COMPLETED|Overall Study||7
361909|NCT00446563|878947|P2|COMPLETED|Overall Study||38
361910|NCT00446563|878948|P1|COMPLETED|Overall Study||36
361911|NCT00446563|878947|P2|STARTED|Overall Study||47
361912|NCT00446563|878948|P1|STARTED|Overall Study||43
361913|NCT00446550|878984|P2|NOT COMPLETED|Overall Study||0
361914|NCT00446550|878985|P1|NOT COMPLETED|Overall Study||1
361915|NCT00446550|878984|P2|COMPLETED|Overall Study||8
361916|NCT00446550|878985|P1|COMPLETED|Overall Study||10
361917|NCT00446550|878984|P2|PD Population|Overall Study||8
361918|NCT00446550|878985|P1|PD Population|Overall Study||11
361919|NCT00446550|878984|P2|Safety Population|Overall Study||8
361920|NCT00446550|878985|P1|Safety Population|Overall Study||11
361921|NCT00446550|878984|P2|STARTED|Overall Study||8
361922|NCT00446550|878985|P1|STARTED|Overall Study||11
361923|NCT00446511|878997|P4|NOT COMPLETED|Overall Study||6
361924|NCT00446511|878998|P3|NOT COMPLETED|Overall Study||7
361925|NCT00446511|878999|P2|NOT COMPLETED|Overall Study||2
361926|NCT00446511|879000|P1|NOT COMPLETED|Overall Study||10
361927|NCT00446511|878997|P4|COMPLETED|Overall Study||103
361928|NCT00446511|878998|P3|COMPLETED|Overall Study||96
361929|NCT00446511|878999|P2|COMPLETED|Overall Study||15
361930|NCT00446511|879000|P1|COMPLETED|Overall Study||11
361931|NCT00446511|878997|P4|STARTED|Overall Study||109
361932|NCT00446511|878998|P3|STARTED|Overall Study||103
361933|NCT00446511|878999|P2|STARTED|Overall Study||17
361934|NCT00446511|879000|P1|STARTED|Overall Study||21
361935|NCT00446459|879024|P1|NOT COMPLETED|12 Months||18
361936|NCT00446459|879024|P1|COMPLETED|12 Months|4 subjects remained at month 12|4
361937|NCT00446459|879024|P1|STARTED|12 Months|22 subjects remained on-study at month 8|22
361938|NCT00446459|879024|P1|NOT COMPLETED|8 Months||12
361939|NCT00446459|879024|P1|COMPLETED|8 Months|22 subjects were on study at month 8.|22
361940|NCT00446459|879024|P1|STARTED|8 Months|34 subjects received any amount of MMF.|34
361941|NCT00446446|879032|P1|NOT COMPLETED|Overall Study||24
361942|NCT00446446|879032|P1|COMPLETED|Overall Study|Participants who completed the 60-day safety visit|28
361943|NCT00446446|879032|P1|STARTED|Overall Study||52
361944|NCT00446290|879043|P1|NOT COMPLETED|Overall Study||0
361945|NCT00446290|879043|P1|COMPLETED|Overall Study||22
361946|NCT00446290|879043|P1|STARTED|Overall Study||22
361947|NCT00446264|879047|P1|NOT COMPLETED|Overall Study||0
361948|NCT00446264|879047|P1|COMPLETED|Overall Study||14
361949|NCT00446264|879047|P1|STARTED|Overall Study||14
361950|NCT00446251|879056|P1|NOT COMPLETED|Overall Study||5
361951|NCT00446251|879056|P1|COMPLETED|Overall Study||9
361952|NCT00446251|879056|P1|STARTED|Overall Study|14 subjects were enrolled in this Rituximab-mycophenolic mofetil group.|14
361953|NCT00446199|879066|P4|NOT COMPLETED|Overall Study||30
361954|NCT00446199|879067|P3|NOT COMPLETED|Overall Study||27
361955|NCT00446199|879068|P2|NOT COMPLETED|Overall Study||20
361956|NCT00446199|879069|P1|NOT COMPLETED|Overall Study||23
361957|NCT00446199|879066|P4|COMPLETED|Overall Study||153
361958|NCT00446199|879067|P3|COMPLETED|Overall Study||158
361959|NCT00446199|879068|P2|COMPLETED|Overall Study||164
361960|NCT00446199|879069|P1|COMPLETED|Overall Study||160
361961|NCT00446199|879066|P4|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|176
361962|NCT00446199|879067|P3|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|179
361963|NCT00446199|879068|P2|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|177
361964|NCT00446199|879069|P1|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|178
361965|NCT00446199|879066|P4|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|180
361966|NCT00446199|879067|P3|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|182
361967|NCT00446199|879068|P2|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|183
361968|NCT00446199|879069|P1|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|181
361969|NCT00446199|879066|P4|STARTED|Overall Study||183
361970|NCT00446199|879067|P3|STARTED|Overall Study||185
361971|NCT00446199|879068|P2|STARTED|Overall Study||184
361972|NCT00446199|879069|P1|STARTED|Overall Study||183
361973|NCT00446147|879149|P2|NOT COMPLETED|Overall Study||14
361974|NCT00446147|879150|P1|NOT COMPLETED|Overall Study||15
361975|NCT00446147|879149|P2|COMPLETED|Overall Study||180
361976|NCT00446147|879150|P1|COMPLETED|Overall Study||180
361977|NCT00446147|879149|P2|STARTED|Overall Study||194
361978|NCT00446147|879150|P1|STARTED|Overall Study||195
361979|NCT00446134|879162|P4|NOT COMPLETED|Overall Study||45
361980|NCT00446134|879163|P3|NOT COMPLETED|Overall Study||43
361981|NCT00446134|879164|P2|NOT COMPLETED|Overall Study||45
361982|NCT00446134|879165|P1|NOT COMPLETED|Overall Study||34
361983|NCT00446134|879162|P4|COMPLETED|Overall Study||25
361984|NCT00446134|879163|P3|COMPLETED|Overall Study||26
361985|NCT00446134|879164|P2|COMPLETED|Overall Study||25
361986|NCT00446134|879165|P1|COMPLETED|Overall Study||35
361987|NCT00446134|879162|P4|STARTED|Overall Study||70
361988|NCT00446134|879163|P3|STARTED|Overall Study|Includes 1 patient who did not receive study drug and was not included in any other analysis|69
361989|NCT00446134|879164|P2|STARTED|Overall Study||70
361990|NCT00446134|879165|P1|STARTED|Overall Study|Includes 2 patients who did not receive study drug and was not included in any other analysis|69
361991|NCT00446095|879192|P5|NOT COMPLETED|Phase I (28 Days)||3
361992|NCT00446095|879193|P4|NOT COMPLETED|Phase I (28 Days)||1
361993|NCT00446095|879194|P3|NOT COMPLETED|Phase I (28 Days)||0
361994|NCT00446095|879195|P2|NOT COMPLETED|Phase I (28 Days)||0
361995|NCT00446095|879196|P1|NOT COMPLETED|Phase I (28 Days)||0
361996|NCT00446095|879192|P5|COMPLETED|Phase I (28 Days)||4
361997|NCT00446095|879193|P4|COMPLETED|Phase I (28 Days)||5
361998|NCT00446095|879194|P3|COMPLETED|Phase I (28 Days)||0
361999|NCT00446095|879195|P2|COMPLETED|Phase I (28 Days)||0
362000|NCT00446095|879196|P1|COMPLETED|Phase I (28 Days)||0
362001|NCT00446095|879192|P5|STARTED|Phase I (28 Days)||7
362002|NCT00446095|879193|P4|STARTED|Phase I (28 Days)||6
362003|NCT00446095|879194|P3|STARTED|Phase I (28 Days)||0
362004|NCT00446095|879195|P2|STARTED|Phase I (28 Days)||0
362005|NCT00446095|879196|P1|STARTED|Phase I (28 Days)||0
362006|NCT00446095|879192|P5|NOT COMPLETED|Phase II (8 Weeks)||0
362007|NCT00446095|879193|P4|NOT COMPLETED|Phase II (8 Weeks)||0
362008|NCT00446095|879194|P3|NOT COMPLETED|Phase II (8 Weeks)||3
362009|NCT00446095|879195|P2|NOT COMPLETED|Phase II (8 Weeks)||3
362010|NCT00446095|879196|P1|NOT COMPLETED|Phase II (8 Weeks)||12
362011|NCT00446095|879192|P5|COMPLETED|Phase II (8 Weeks)||0
362012|NCT00446095|879193|P4|COMPLETED|Phase II (8 Weeks)||0
362013|NCT00446095|879194|P3|COMPLETED|Phase II (8 Weeks)||21
362014|NCT00446095|879195|P2|COMPLETED|Phase II (8 Weeks)||18
362015|NCT00446095|879196|P1|COMPLETED|Phase II (8 Weeks)||11
362016|NCT00446095|879192|P5|STARTED|Phase II (8 Weeks)||0
362017|NCT00446095|879193|P4|STARTED|Phase II (8 Weeks)||0
362018|NCT00446095|879194|P3|STARTED|Phase II (8 Weeks)||24
362019|NCT00446095|879195|P2|STARTED|Phase II (8 Weeks)||21
362020|NCT00446095|879196|P1|STARTED|Phase II (8 Weeks)||23
362021|NCT00446030|879219|P2|NOT COMPLETED|FOLLOW-UP (up to 2-years)||9
362022|NCT00446030|879220|P1|NOT COMPLETED|FOLLOW-UP (up to 2-years)||30
362023|NCT00446030|879219|P2|COMPLETED|FOLLOW-UP (up to 2-years)||25
362024|NCT00446030|879220|P1|COMPLETED|FOLLOW-UP (up to 2-years)||63
362025|NCT00446030|879219|P2|STARTED|FOLLOW-UP (up to 2-years)||34
362026|NCT00446030|879220|P1|STARTED|FOLLOW-UP (up to 2-years)|All participants, including those who discontinued treatment, continued to the follow-up period.|93
362027|NCT00446030|879219|P2|NOT COMPLETED|TREATMENT (up to 52 Weeks)||9
362028|NCT00446030|879220|P1|NOT COMPLETED|TREATMENT (up to 52 Weeks)||44
362029|NCT00446030|879219|P2|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|25
362030|NCT00446030|879220|P1|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|49
362031|NCT00446030|879219|P2|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||34
362032|NCT00446030|879220|P1|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||92
362033|NCT00446030|879219|P2|STARTED|TREATMENT (up to 52 Weeks)||34
362034|NCT00446030|879220|P1|STARTED|TREATMENT (up to 52 Weeks)||93
362035|NCT00445939|879231|P4|NOT COMPLETED|Period B - Week 4 - Week 8||1
362036|NCT00445939|879232|P3|NOT COMPLETED|Period B - Week 4 - Week 8||0
362037|NCT00445939|879233|P2|NOT COMPLETED|Period B - Week 4 - Week 8||0
362038|NCT00445939|879234|P1|NOT COMPLETED|Period B - Week 4 - Week 8||2
362039|NCT00445939|879231|P4|COMPLETED|Period B - Week 4 - Week 8||20
362040|NCT00445939|879232|P3|COMPLETED|Period B - Week 4 - Week 8||0
362041|NCT00445939|879233|P2|COMPLETED|Period B - Week 4 - Week 8||0
362042|NCT00445939|879234|P1|COMPLETED|Period B - Week 4 - Week 8||14
362043|NCT00445939|879231|P4|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 160/80 and 80/40 subjects allocated to 40/40 group.|21
362044|NCT00445939|879232|P3|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous placebo subjects allocated to 160/80 mg group.|0
362045|NCT00445939|879233|P2|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 80/40 mg subjects allocated to 40/40 mg group.|0
362046|NCT00445939|879234|P1|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 16 placebo subjects allocated to 160/80 mg group.|16
362047|NCT00445939|879231|P4|NOT COMPLETED|Period A - Week 0 - Week 4||0
362048|NCT00445939|879232|P3|NOT COMPLETED|Period A - Week 0 - Week 4||0
362049|NCT00445939|879233|P2|NOT COMPLETED|Period A - Week 0 - Week 4||2
362050|NCT00445939|879234|P1|NOT COMPLETED|Period A - Week 0 - Week 4||1
362051|NCT00445939|879231|P4|COMPLETED|Period A - Week 0 - Week 4||0
362144|NCT00445432|879508|P3|COMPLETED|148 Weeks of Adalimumab Treatment||0
362052|NCT00445939|879232|P3|COMPLETED|Period A - Week 0 - Week 4|7 rated as responders and 16 rated as non-responders in evaluation on Week 4.|23
362053|NCT00445939|879233|P2|COMPLETED|Period A - Week 0 - Week 4|20 rated as responders and 12 rated as non-responders in evaluation on Week 4.|32
362054|NCT00445939|879234|P1|COMPLETED|Period A - Week 0 - Week 4|23 rated as responders and 9 rated as non-responders in evaluation on Week 4.|32
362055|NCT00445939|879231|P4|STARTED|Period A - Week 0 - Week 4||0
362056|NCT00445939|879232|P3|STARTED|Period A - Week 0 - Week 4||23
362057|NCT00445939|879233|P2|STARTED|Period A - Week 0 - Week 4||34
362058|NCT00445939|879234|P1|STARTED|Period A - Week 0 - Week 4||33
362059|NCT00445887|879259|P2|NOT COMPLETED|Overall Study||0
362060|NCT00445887|879260|P1|NOT COMPLETED|Overall Study||0
362061|NCT00445887|879259|P2|COMPLETED|Overall Study||31
362062|NCT00445887|879260|P1|COMPLETED|Overall Study||33
362063|NCT00445887|879259|P2|STARTED|Overall Study||31
362064|NCT00445887|879260|P1|STARTED|Overall Study||33
362065|NCT00445848|879282|P1|NOT COMPLETED|Overall Study||85
362066|NCT00445848|879282|P1|COMPLETED|Overall Study||0
362067|NCT00445848|879282|P1|STARTED|Overall Study||85
362068|NCT00445770|879292|P3|NOT COMPLETED|Overall Study||31
362069|NCT00445770|879293|P2|NOT COMPLETED|Overall Study||35
362070|NCT00445770|879294|P1|NOT COMPLETED|Overall Study||53
362071|NCT00445770|879292|P3|COMPLETED|Overall Study||151
362072|NCT00445770|879293|P2|COMPLETED|Overall Study||157
362073|NCT00445770|879294|P1|COMPLETED|Overall Study||123
362074|NCT00445770|879292|P3|STARTED|Overall Study||182
362075|NCT00445770|879293|P2|STARTED|Overall Study||192
362076|NCT00445770|879294|P1|STARTED|Overall Study||176
362077|NCT00445744|879361|P1|NOT COMPLETED|Overall Study||1
362078|NCT00445744|879361|P1|COMPLETED|Overall Study||51
362079|NCT00445744|879361|P1|STARTED|Overall Study||52
362080|NCT00445705|879370|P4|NOT COMPLETED|Overall Study||14
362081|NCT00445705|879371|P3|NOT COMPLETED|Overall Study||11
362082|NCT00445705|879372|P2|NOT COMPLETED|Overall Study||11
362083|NCT00445705|879373|P1|NOT COMPLETED|Overall Study||9
362084|NCT00445705|879370|P4|COMPLETED|Overall Study||39
362085|NCT00445705|879371|P3|COMPLETED|Overall Study||41
362086|NCT00445705|879372|P2|COMPLETED|Overall Study||42
362087|NCT00445705|879373|P1|COMPLETED|Overall Study||44
362088|NCT00445705|879370|P4|STARTED|Overall Study||53
362089|NCT00445705|879371|P3|STARTED|Overall Study||52
362090|NCT00445705|879372|P2|STARTED|Overall Study||53
362091|NCT00445705|879373|P1|STARTED|Overall Study||53
362092|NCT00445692|879395|P1|NOT COMPLETED|Overall Study||16
362093|NCT00445692|879395|P1|COMPLETED|Overall Study||15
362094|NCT00445692|879395|P1|STARTED|Overall Study||31
362095|NCT00445679|879405|P4|NOT COMPLETED|Overall Study||47
362096|NCT00445679|879406|P3|NOT COMPLETED|Overall Study||66
362097|NCT00445679|879407|P2|NOT COMPLETED|Overall Study||46
362098|NCT00445679|879408|P1|NOT COMPLETED|Overall Study||48
362099|NCT00445679|879405|P4|COMPLETED|Overall Study||149
362100|NCT00445679|879406|P3|COMPLETED|Overall Study||139
362101|NCT00445679|879407|P2|COMPLETED|Overall Study||157
362102|NCT00445679|879408|P1|COMPLETED|Overall Study||155
362103|NCT00445679|879405|P4|STARTED|Overall Study||196
362104|NCT00445679|879406|P3|STARTED|Overall Study||205
362105|NCT00445679|879407|P2|STARTED|Overall Study||203
362106|NCT00445679|879408|P1|STARTED|Overall Study||203
362107|NCT00445601|879444|P2|NOT COMPLETED|Overall Study||28
362108|NCT00445601|879445|P1|NOT COMPLETED|Overall Study||33
362109|NCT00445601|879444|P2|COMPLETED|Overall Study||177
362110|NCT00445601|879445|P1|COMPLETED|Overall Study||168
362111|NCT00445601|879444|P2|Received TURBT|Overall Study||193
362112|NCT00445601|879445|P1|Received TURBT|Overall Study||190
362113|NCT00445601|879444|P2|STARTED|Overall Study||205
362114|NCT00445601|879445|P1|STARTED|Overall Study||201
362115|NCT00445588|879457|P1|NOT COMPLETED|Overall Study||0
362116|NCT00445588|879457|P1|COMPLETED|Overall Study||56
362117|NCT00445588|879457|P1|STARTED|Overall Study||56
362118|NCT00445549|879462|P1|NOT COMPLETED|Overall Study||12
362119|NCT00445549|879462|P1|COMPLETED|Overall Study||0
362120|NCT00445549|879462|P1|STARTED|Overall Study||12
362121|NCT00445484|879469|P2|NOT COMPLETED|Overall Study||1
362122|NCT00445484|879470|P1|NOT COMPLETED|Overall Study||4
362123|NCT00445484|879469|P2|COMPLETED|Overall Study||10
362124|NCT00445484|879470|P1|COMPLETED|Overall Study||7
362125|NCT00445484|879469|P2|STARTED|Overall Study||11
362126|NCT00445484|879470|P1|STARTED|Overall Study||11
362127|NCT00445458|879486|P4|NOT COMPLETED|Overall Study||28
362128|NCT00445458|879487|P3|NOT COMPLETED|Overall Study||68
362129|NCT00445458|879488|P2|NOT COMPLETED|Overall Study||5
362130|NCT00445458|879489|P1|NOT COMPLETED|Overall Study||3
362131|NCT00445458|879486|P4|COMPLETED|Overall Study||3
362132|NCT00445458|879487|P3|COMPLETED|Overall Study||3
362133|NCT00445458|879488|P2|COMPLETED|Overall Study||0
362134|NCT00445458|879489|P1|COMPLETED|Overall Study||0
362135|NCT00445458|879486|P4|STARTED|Overall Study||31
362136|NCT00445458|879487|P3|STARTED|Overall Study||71
362137|NCT00445458|879488|P2|STARTED|Overall Study||5
362138|NCT00445458|879489|P1|STARTED|Overall Study||3
362139|NCT00445432|879507|P4|NOT COMPLETED|148 Weeks of Adalimumab Treatment||44
362140|NCT00445432|879508|P3|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
362141|NCT00445432|879509|P2|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
362142|NCT00445432|879510|P1|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
362143|NCT00445432|879507|P4|COMPLETED|148 Weeks of Adalimumab Treatment||35
362145|NCT00445432|879509|P2|COMPLETED|148 Weeks of Adalimumab Treatment||0
362146|NCT00445432|879510|P1|COMPLETED|148 Weeks of Adalimumab Treatment||0
362147|NCT00445432|879507|P4|STARTED|148 Weeks of Adalimumab Treatment|3 participants discontinued while receiving double-blind placebo and never received any adalimumab|79
362148|NCT00445432|879508|P3|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
362149|NCT00445432|879509|P2|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
362150|NCT00445432|879510|P1|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
362151|NCT00445432|879507|P4|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
362152|NCT00445432|879508|P3|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||11
362153|NCT00445432|879509|P2|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||23
362154|NCT00445432|879510|P1|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||15
362155|NCT00445432|879507|P4|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
362156|NCT00445432|879508|P3|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||21
362157|NCT00445432|879509|P2|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||2
362158|NCT00445432|879510|P1|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||10
362159|NCT00445432|879507|P4|STARTED|Through Week 52 of NCT00445432 (M06-837)|This treatment group is not applicable for this period.|0
362160|NCT00445432|879508|P3|STARTED|Through Week 52 of NCT00445432 (M06-837)||32
362161|NCT00445432|879509|P2|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
362162|NCT00445432|879510|P1|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
362163|NCT00445341|879543|P1|NOT COMPLETED|Overall Study||2
362164|NCT00445341|879543|P1|COMPLETED|Overall Study||26
362165|NCT00445341|879543|P1|STARTED|Overall Study||28
362166|NCT00445328|879550|P2|NOT COMPLETED|Overall Study||6
362167|NCT00445328|879551|P1|NOT COMPLETED|Overall Study||3
362168|NCT00445328|879550|P2|COMPLETED|Overall Study||36
362169|NCT00445328|879551|P1|COMPLETED|Overall Study||39
362170|NCT00445328|879550|P2|Received Treatment|Overall Study||42
362171|NCT00445328|879551|P1|Received Treatment|Overall Study|1 subject discontinued after enrollment but prior to study treatment.|41
362172|NCT00445328|879550|P2|STARTED|Overall Study||42
362173|NCT00445328|879551|P1|STARTED|Overall Study||42
362174|NCT00445315|879574|P5|NOT COMPLETED|Overall Study||0
362175|NCT00445315|879575|P4|NOT COMPLETED|Overall Study||0
362176|NCT00445315|879576|P3|NOT COMPLETED|Overall Study||0
362177|NCT00445315|879577|P2|NOT COMPLETED|Overall Study||0
362178|NCT00445315|879578|P1|NOT COMPLETED|Overall Study||0
362179|NCT00445315|879574|P5|COMPLETED|Overall Study||8
362180|NCT00445315|879575|P4|COMPLETED|Overall Study||6
362181|NCT00445315|879576|P3|COMPLETED|Overall Study||6
362182|NCT00445315|879577|P2|COMPLETED|Overall Study||6
362183|NCT00445315|879578|P1|COMPLETED|Overall Study||6
362184|NCT00445315|879574|P5|STARTED|Overall Study||8
362185|NCT00445315|879575|P4|STARTED|Overall Study||6
362186|NCT00445315|879576|P3|STARTED|Overall Study||6
362187|NCT00445315|879577|P2|STARTED|Overall Study||6
362188|NCT00445315|879578|P1|STARTED|Overall Study||6
362189|NCT00445302|879672|P4|NOT COMPLETED|Overall Study||0
362190|NCT00445302|879673|P3|NOT COMPLETED|Overall Study||0
362191|NCT00445302|879674|P2|NOT COMPLETED|Overall Study||0
362192|NCT00445302|879675|P1|NOT COMPLETED|Overall Study||0
362193|NCT00445302|879672|P4|COMPLETED|Overall Study||6
362194|NCT00445302|879673|P3|COMPLETED|Overall Study||6
362195|NCT00445302|879674|P2|COMPLETED|Overall Study||5
362196|NCT00445302|879675|P1|COMPLETED|Overall Study||6
362197|NCT00445302|879672|P4|STARTED|Overall Study||6
362198|NCT00445302|879673|P3|STARTED|Overall Study||6
362199|NCT00445302|879674|P2|STARTED|Overall Study||5
362200|NCT00445302|879675|P1|STARTED|Overall Study||6
362201|NCT00445263|879703|P2|NOT COMPLETED|Overall Study||1
362202|NCT00445263|879704|P1|NOT COMPLETED|Overall Study||0
362203|NCT00445263|879703|P2|COMPLETED|Overall Study||86
362204|NCT00445263|879704|P1|COMPLETED|Overall Study||83
362205|NCT00445263|879703|P2|STARTED|Overall Study||87
362206|NCT00445263|879704|P1|STARTED|Overall Study||83
362207|NCT00445224|879712|P2|NOT COMPLETED|Combined Exercises||0
362208|NCT00445224|879713|P1|NOT COMPLETED|Combined Exercises||0
362209|NCT00445224|879712|P2|COMPLETED|Combined Exercises||13
362210|NCT00445224|879713|P1|COMPLETED|Combined Exercises||13
362211|NCT00445224|879712|P2|STARTED|Combined Exercises||13
362212|NCT00445224|879713|P1|STARTED|Combined Exercises||13
362213|NCT00445224|879712|P2|NOT COMPLETED|Specific Exercises||3
362214|NCT00445224|879713|P1|NOT COMPLETED|Specific Exercises||4
362215|NCT00445224|879712|P2|COMPLETED|Specific Exercises|No adverse event occurred|13
362216|NCT00445224|879713|P1|COMPLETED|Specific Exercises|No adverse event occurred|13
362217|NCT00445224|879712|P2|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|13
362218|NCT00445224|879713|P1|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|14
362219|NCT00445224|879712|P2|Baseline|Specific Exercises||16
362220|NCT00445224|879713|P1|Baseline|Specific Exercises||17
362221|NCT00445224|879712|P2|STARTED|Specific Exercises||16
362222|NCT00445224|879713|P1|STARTED|Specific Exercises||17
362223|NCT00445211|879725|P2|NOT COMPLETED|Overall Study||0
362224|NCT00445211|879726|P1|NOT COMPLETED|Overall Study||0
362225|NCT00445211|879725|P2|COMPLETED|Overall Study||23
362226|NCT00445211|879726|P1|COMPLETED|Overall Study||23
362227|NCT00445211|879725|P2|STARTED|Overall Study||23
362228|NCT00445211|879726|P1|STARTED|Overall Study||23
362229|NCT00445146|879740|P1|NOT COMPLETED|Overall Study||119
362230|NCT00445146|879740|P1|COMPLETED|Overall Study||73
362231|NCT00445146|879740|P1|STARTED|Overall Study||192
362232|NCT00445003|879762|P3|NOT COMPLETED|Overall Study||4
362233|NCT00445003|879763|P2|NOT COMPLETED|Overall Study||10
362234|NCT00445003|879764|P1|NOT COMPLETED|Overall Study||5
362235|NCT00445003|879762|P3|COMPLETED|Overall Study||105
362236|NCT00445003|879763|P2|COMPLETED|Overall Study||103
362237|NCT00445003|879764|P1|COMPLETED|Overall Study||118
362238|NCT00445003|879762|P3|STARTED|Overall Study||109
362239|NCT00445003|879763|P2|STARTED|Overall Study||113
362240|NCT00445003|879764|P1|STARTED|Overall Study||123
362241|NCT00444951|879796|P3|NOT COMPLETED|Overall Study||3
362242|NCT00444951|879797|P2|NOT COMPLETED|Overall Study||6
362243|NCT00444951|879798|P1|NOT COMPLETED|Overall Study||5
362244|NCT00444951|879796|P3|COMPLETED|Overall Study||160
362245|NCT00444951|879797|P2|COMPLETED|Overall Study||136
362246|NCT00444951|879798|P1|COMPLETED|Overall Study||140
362247|NCT00444951|879796|P3|STARTED|Overall Study||163
362248|NCT00444951|879797|P2|STARTED|Overall Study||142
362249|NCT00444951|879798|P1|STARTED|Overall Study||145
362250|NCT00444925|879815|P3|NOT COMPLETED|Double-blind Treatment Period||81
362251|NCT00444925|879816|P2|NOT COMPLETED|Double-blind Treatment Period||56
362252|NCT00444925|879817|P1|NOT COMPLETED|Double-blind Treatment Period||30
362253|NCT00444925|879815|P3|COMPLETED|Double-blind Treatment Period||598
362254|NCT00444925|879816|P2|COMPLETED|Double-blind Treatment Period||628
362255|NCT00444925|879817|P1|COMPLETED|Double-blind Treatment Period||304
362256|NCT00444925|879815|P3|STARTED|Double-blind Treatment Period||679
362257|NCT00444925|879816|P2|STARTED|Double-blind Treatment Period||684
362258|NCT00444925|879817|P1|STARTED|Double-blind Treatment Period||334
362259|NCT00444925|879815|P3|NOT COMPLETED|Randomized to Double-blind Treatment||6
362260|NCT00444925|879816|P2|NOT COMPLETED|Randomized to Double-blind Treatment||6
362261|NCT00444925|879817|P1|NOT COMPLETED|Randomized to Double-blind Treatment||3
362262|NCT00444925|879815|P3|COMPLETED|Randomized to Double-blind Treatment||679
362263|NCT00444925|879816|P2|COMPLETED|Randomized to Double-blind Treatment||684
362264|NCT00444925|879817|P1|COMPLETED|Randomized to Double-blind Treatment||334
362265|NCT00444925|879815|P3|STARTED|Randomized to Double-blind Treatment||685
362266|NCT00444925|879816|P2|STARTED|Randomized to Double-blind Treatment||690
362267|NCT00444925|879817|P1|STARTED|Randomized to Double-blind Treatment||337
362268|NCT00444925|879815|P3|NOT COMPLETED|Single-blind Placebo Run-In Period||0
362269|NCT00444925|879816|P2|NOT COMPLETED|Single-blind Placebo Run-In Period||0
362270|NCT00444925|879817|P1|NOT COMPLETED|Single-blind Placebo Run-In Period||734
362271|NCT00444925|879815|P3|COMPLETED|Single-blind Placebo Run-In Period||0
362272|NCT00444925|879816|P2|COMPLETED|Single-blind Placebo Run-In Period||0
362273|NCT00444925|879817|P1|COMPLETED|Single-blind Placebo Run-In Period|progressed to randomization in double-blind treatment period|1712
362274|NCT00444925|879815|P3|STARTED|Single-blind Placebo Run-In Period||0
362275|NCT00444925|879816|P2|STARTED|Single-blind Placebo Run-In Period||0
362276|NCT00444925|879817|P1|STARTED|Single-blind Placebo Run-In Period||2446
362277|NCT00444912|879881|P2|NOT COMPLETED|Overall Study||2
362278|NCT00444912|879882|P1|NOT COMPLETED|Overall Study||3
362279|NCT00444912|879881|P2|COMPLETED|Overall Study||13
362280|NCT00444912|879882|P1|COMPLETED|Overall Study||12
362281|NCT00444912|879881|P2|Received Transplant|Overall Study||14
362282|NCT00444912|879882|P1|Received Transplant|Overall Study||14
362283|NCT00444912|879881|P2|Received Plerixafor|Overall Study||15
362284|NCT00444912|879882|P1|Received Plerixafor|Overall Study||15
362285|NCT00444912|879881|P2|STARTED|Overall Study||15
362286|NCT00444912|879882|P1|STARTED|Overall Study||15
362287|NCT00444821|879912|P2|NOT COMPLETED|Overall Study||366
362288|NCT00444821|879913|P1|NOT COMPLETED|Overall Study||362
362289|NCT00444821|879912|P2|COMPLETED|Overall Study||0
362290|NCT00444821|879913|P1|COMPLETED|Overall Study||0
362291|NCT00444821|879912|P2|Received AAA Repair|Overall Study|Underwent AAA repair per protocol|326
362292|NCT00444821|879913|P1|Received AAA Repair|Overall Study|Crossed over to AAA repair|122
362293|NCT00444821|879912|P2|STARTED|Overall Study||366
362294|NCT00444821|879913|P1|STARTED|Overall Study||362
362295|NCT00444795|879923|P1|NOT COMPLETED|Overall Study||3
362296|NCT00444795|879923|P1|COMPLETED|Overall Study|Refer to the Safety Analysis Set.|617
362297|NCT00444795|879923|P1|STARTED|Overall Study||620
362298|NCT00444626|879928|P1|NOT COMPLETED|Repeat Treatment Period||0
362299|NCT00444626|879928|P1|COMPLETED|Repeat Treatment Period||105
362300|NCT00444626|879928|P1|STARTED|Repeat Treatment Period|23 subjects withdrew after completing the Initial Treatment and did not enter the Repeat Treatment|105
362301|NCT00444626|879928|P1|NOT COMPLETED|Initial Treatment Period||12
362302|NCT00444626|879928|P1|COMPLETED|Initial Treatment Period||128
362303|NCT00444626|879928|P1|STARTED|Initial Treatment Period||140
362304|NCT00444600|879958|P4|NOT COMPLETED|Overall Study||10
362305|NCT00444600|879959|P3|NOT COMPLETED|Overall Study||10
362306|NCT00444600|879960|P2|NOT COMPLETED|Overall Study||16
362307|NCT00444600|879961|P1|NOT COMPLETED|Overall Study||19
362308|NCT00444600|879958|P4|COMPLETED|Overall Study|Number of eyes|176
362309|NCT00444600|879959|P3|COMPLETED|Overall Study|Number of eyes|178
362310|NCT00444600|879960|P2|COMPLETED|Overall Study|Number of eyes|171
362311|NCT00444600|879961|P1|COMPLETED|Overall Study|Number of eyes|274
362312|NCT00444600|879958|P4|STARTED|Overall Study|Number of eyes|186
362313|NCT00444600|879959|P3|STARTED|Overall Study|Number of eyes|188
362314|NCT00444600|879960|P2|STARTED|Overall Study|Number of eyes|187
362315|NCT00444600|879961|P1|STARTED|Overall Study|Number of eyes|293
362316|NCT00444587|880053|P2|NOT COMPLETED|Overall Study||15
362317|NCT00444587|880054|P1|NOT COMPLETED|Overall Study||83
362318|NCT00444587|880053|P2|COMPLETED|Overall Study||1
362319|NCT00444587|880054|P1|COMPLETED|Overall Study||10
362320|NCT00444587|880053|P2|STARTED|Overall Study||16
362321|NCT00444587|880054|P1|STARTED|Overall Study||93
362322|NCT00444535|880075|P1|NOT COMPLETED|Overall Study||24
362323|NCT00444535|880075|P1|COMPLETED|Overall Study||28
362324|NCT00444535|880075|P1|STARTED|Overall Study||52
362325|NCT00444457|880086|P4|NOT COMPLETED|Toddler Dose||8
362326|NCT00444457|880087|P3|NOT COMPLETED|Toddler Dose||4
362327|NCT00444457|880088|P2|NOT COMPLETED|Toddler Dose||6
362328|NCT00444457|880089|P1|NOT COMPLETED|Toddler Dose||7
362329|NCT00444457|880086|P4|COMPLETED|Toddler Dose||200
362330|NCT00444457|880087|P3|COMPLETED|Toddler Dose||404
362331|NCT00444457|880088|P2|COMPLETED|Toddler Dose||391
362332|NCT00444457|880089|P1|COMPLETED|Toddler Dose||408
362333|NCT00444457|880086|P4|STARTED|Toddler Dose|Vaccinated toddler dose|208
362334|NCT00444457|880087|P3|STARTED|Toddler Dose|Vaccinated toddler dose|408
362335|NCT00444457|880088|P2|STARTED|Toddler Dose|Vaccinated toddler dose|397
362336|NCT00444457|880089|P1|STARTED|Toddler Dose|Vaccinated toddler dose|415
362337|NCT00444457|880086|P4|NOT COMPLETED|After Infant Series||10
362338|NCT00444457|880087|P3|NOT COMPLETED|After Infant Series||19
362339|NCT00444457|880088|P2|NOT COMPLETED|After Infant Series||30
362340|NCT00444457|880089|P1|NOT COMPLETED|After Infant Series||20
362341|NCT00444457|880086|P4|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|208
362342|NCT00444457|880087|P3|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|408
362343|NCT00444457|880088|P2|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|397
362344|NCT00444457|880089|P1|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|415
362345|NCT00444457|880086|P4|STARTED|After Infant Series||218
362346|NCT00444457|880087|P3|STARTED|After Infant Series||427
362347|NCT00444457|880088|P2|STARTED|After Infant Series||427
362348|NCT00444457|880089|P1|STARTED|After Infant Series||435
362349|NCT00444457|880086|P4|NOT COMPLETED|Infant Series||28
362350|NCT00444457|880087|P3|NOT COMPLETED|Infant Series||61
362351|NCT00444457|880088|P2|NOT COMPLETED|Infant Series||61
362352|NCT00444457|880089|P1|NOT COMPLETED|Infant Series||54
362353|NCT00444457|880086|P4|COMPLETED|Infant Series||218
362354|NCT00444457|880087|P3|COMPLETED|Infant Series||428
362355|NCT00444457|880088|P2|COMPLETED|Infant Series||427
362356|NCT00444457|880089|P1|COMPLETED|Infant Series||435
362357|NCT00444457|880086|P4|Vaccinated Dose 3|Infant Series||225
362358|NCT00444457|880087|P3|Vaccinated Dose 3|Infant Series||438
362359|NCT00444457|880088|P2|Vaccinated Dose 3|Infant Series||435
362360|NCT00444457|880089|P1|Vaccinated Dose 3|Infant Series||442
362361|NCT00444457|880086|P4|Vaccinated Dose 2|Infant Series||228
362362|NCT00444457|880087|P3|Vaccinated Dose 2|Infant Series||455
362363|NCT00444457|880088|P2|Vaccinated Dose 2|Infant Series||447
362364|NCT00444457|880089|P1|Vaccinated Dose 2|Infant Series||455
362365|NCT00444457|880086|P4|Vaccinated Dose 1|Infant Series||244
362366|NCT00444457|880087|P3|Vaccinated Dose 1|Infant Series||485
362367|NCT00444457|880088|P2|Vaccinated Dose 1|Infant Series||484
362368|NCT00444457|880089|P1|Vaccinated Dose 1|Infant Series||486
362369|NCT00444457|880086|P4|STARTED|Infant Series||246
362370|NCT00444457|880087|P3|STARTED|Infant Series||489
362371|NCT00444457|880088|P2|STARTED|Infant Series||488
362372|NCT00444457|880089|P1|STARTED|Infant Series||489
362373|NCT00444275|880154|P5|NOT COMPLETED|Maintenance Treatment Phase||179
362374|NCT00444275|880155|P4|NOT COMPLETED|Maintenance Treatment Phase||133
362375|NCT00444275|880156|P3|NOT COMPLETED|Maintenance Treatment Phase||161
362376|NCT00444275|880157|P2|NOT COMPLETED|Maintenance Treatment Phase||0
362377|NCT00444275|880158|P1|NOT COMPLETED|Maintenance Treatment Phase||0
362378|NCT00444275|880154|P5|COMPLETED|Maintenance Treatment Phase||701
362379|NCT00444275|880155|P4|COMPLETED|Maintenance Treatment Phase||764
362380|NCT00444275|880156|P3|COMPLETED|Maintenance Treatment Phase||747
362381|NCT00444275|880157|P2|COMPLETED|Maintenance Treatment Phase||0
362382|NCT00444275|880158|P1|COMPLETED|Maintenance Treatment Phase||0
362383|NCT00444275|880154|P5|STARTED|Maintenance Treatment Phase||880
362384|NCT00444275|880155|P4|STARTED|Maintenance Treatment Phase||897
362385|NCT00444275|880156|P3|STARTED|Maintenance Treatment Phase||908
362386|NCT00444275|880157|P2|STARTED|Maintenance Treatment Phase||0
362387|NCT00444275|880158|P1|STARTED|Maintenance Treatment Phase||0
362388|NCT00444275|880154|P5|NOT COMPLETED|Initial Treatment Phase||0
362389|NCT00444275|880155|P4|NOT COMPLETED|Initial Treatment Phase||0
362390|NCT00444275|880156|P3|NOT COMPLETED|Initial Treatment Phase||0
362391|NCT00444275|880157|P2|NOT COMPLETED|Initial Treatment Phase||96
362392|NCT00444275|880158|P1|NOT COMPLETED|Initial Treatment Phase||248
362393|NCT00444275|880154|P5|COMPLETED|Initial Treatment Phase||0
362394|NCT00444275|880155|P4|COMPLETED|Initial Treatment Phase||0
362395|NCT00444275|880156|P3|COMPLETED|Initial Treatment Phase||0
362396|NCT00444275|880157|P2|COMPLETED|Initial Treatment Phase||777
362397|NCT00444275|880158|P1|COMPLETED|Initial Treatment Phase||1908
362398|NCT00444275|880154|P5|STARTED|Initial Treatment Phase||0
362399|NCT00444275|880155|P4|STARTED|Initial Treatment Phase||0
362400|NCT00444275|880156|P3|STARTED|Initial Treatment Phase||0
362401|NCT00444275|880157|P2|STARTED|Initial Treatment Phase||873
362402|NCT00444275|880158|P1|STARTED|Initial Treatment Phase||2156
362403|NCT00444145|880208|P1|NOT COMPLETED|Overall Study||19
362404|NCT00444145|880208|P1|COMPLETED|Overall Study||19
362405|NCT00444145|880208|P1|STARTED|Overall Study||38
362406|NCT00444106|880215|P3|NOT COMPLETED|Overall Study||1
362407|NCT00444106|880216|P2|NOT COMPLETED|Overall Study||1
362408|NCT00444106|880217|P1|NOT COMPLETED|Overall Study||2
362409|NCT00444106|880215|P3|COMPLETED|Overall Study||52
362410|NCT00444106|880216|P2|COMPLETED|Overall Study||52
362411|NCT00444106|880217|P1|COMPLETED|Overall Study||157
362412|NCT00444106|880215|P3|Completed Treatment Period|Overall Study||53
362413|NCT00444106|880216|P2|Completed Treatment Period|Overall Study||53
362414|NCT00444106|880217|P1|Completed Treatment Period|Overall Study||159
362415|NCT00444106|880215|P3|STARTED|Overall Study||53
362416|NCT00444106|880216|P2|STARTED|Overall Study||53
362417|NCT00444106|880217|P1|STARTED|Overall Study||159
362418|NCT00444067|880234|P2|NOT COMPLETED|Overall Study||1
362419|NCT00444067|880235|P1|NOT COMPLETED|Overall Study||0
362420|NCT00444067|880234|P2|COMPLETED|Overall Study||23
362421|NCT00444067|880235|P1|COMPLETED|Overall Study||74
362422|NCT00444067|880234|P2|STARTED|Overall Study||24
362423|NCT00444067|880235|P1|STARTED|Overall Study||74
362424|NCT00444028|880251|P6|NOT COMPLETED|Overall Study||0
362425|NCT00444028|880252|P5|NOT COMPLETED|Overall Study||0
362426|NCT00444028|880253|P4|NOT COMPLETED|Overall Study||0
362427|NCT00444028|880254|P3|NOT COMPLETED|Overall Study||0
362428|NCT00444028|880255|P2|NOT COMPLETED|Overall Study||0
362429|NCT00444028|880256|P1|NOT COMPLETED|Overall Study||0
362430|NCT00444028|880251|P6|COMPLETED|Overall Study||8
362431|NCT00444028|880252|P5|COMPLETED|Overall Study||7
362432|NCT00444028|880253|P4|COMPLETED|Overall Study||6
362433|NCT00444028|880254|P3|COMPLETED|Overall Study||8
362434|NCT00444028|880255|P2|COMPLETED|Overall Study||7
362435|NCT00444028|880256|P1|COMPLETED|Overall Study||14
362436|NCT00444028|880251|P6|STARTED|Overall Study||8
362437|NCT00444028|880252|P5|STARTED|Overall Study||7
362438|NCT00444028|880253|P4|STARTED|Overall Study||6
362439|NCT00444028|880254|P3|STARTED|Overall Study||8
362440|NCT00444028|880255|P2|STARTED|Overall Study||7
362441|NCT00444028|880256|P1|STARTED|Overall Study||14
362442|NCT00443898|880298|P4|NOT COMPLETED|Overall Study||18
362443|NCT00443898|880299|P3|NOT COMPLETED|Overall Study||29
362444|NCT00443898|880300|P2|NOT COMPLETED|Overall Study||25
362445|NCT00443898|880301|P1|NOT COMPLETED|Overall Study||24
362446|NCT00443898|880298|P4|COMPLETED|Overall Study||110
362447|NCT00443898|880299|P3|COMPLETED|Overall Study||107
362448|NCT00443898|880300|P2|COMPLETED|Overall Study||103
362449|NCT00443898|880301|P1|COMPLETED|Overall Study||102
362450|NCT00443898|880298|P4|STARTED|Overall Study||128
362451|NCT00443898|880299|P3|STARTED|Overall Study||136
362452|NCT00443898|880300|P2|STARTED|Overall Study||128
362453|NCT00443898|880301|P1|STARTED|Overall Study||126
362454|NCT00443872|880323|P1|NOT COMPLETED|Overall Study||17
362455|NCT00443872|880323|P1|COMPLETED|Overall Study||60
362456|NCT00443872|880323|P1|STARTED|Overall Study||77
362457|NCT00443846|880338|P2|NOT COMPLETED|Overall Study||6
362458|NCT00443846|880339|P1|NOT COMPLETED|Overall Study||11
362459|NCT00443846|880338|P2|COMPLETED|Overall Study||117
362460|NCT00443846|880339|P1|COMPLETED|Overall Study||113
362461|NCT00443846|880338|P2|Vaccinated|Overall Study||123
362462|NCT00443846|880339|P1|Vaccinated|Overall Study||116
362463|NCT00443846|880338|P2|STARTED|Overall Study||123
362464|NCT00443846|880339|P1|STARTED|Overall Study||124
362465|NCT00443820|880349|P4|NOT COMPLETED|Overall Study||17
362466|NCT00443820|880350|P3|NOT COMPLETED|Overall Study||18
362467|NCT00443820|880351|P2|NOT COMPLETED|Overall Study||19
362468|NCT00443820|880352|P1|NOT COMPLETED|Overall Study||21
362469|NCT00443820|880349|P4|COMPLETED|Overall Study||111
362470|NCT00443820|880350|P3|COMPLETED|Overall Study||117
362471|NCT00443820|880351|P2|COMPLETED|Overall Study|A participant from this gr. discont'ed due to renal failure, was counted as an AE and also as a SAE.|111
362472|NCT00443820|880352|P1|COMPLETED|Overall Study||112
362473|NCT00443820|880349|P4|Safety Population|Overall Study||126
362474|NCT00443820|880350|P3|Safety Population|Overall Study||134
362475|NCT00443820|880351|P2|Safety Population|Overall Study||129
362476|NCT00443820|880352|P1|Safety Population|Overall Study|Participants who received study drug and had at least one post-baseline safety assessment.|131
362477|NCT00443820|880349|P4|STARTED|Overall Study||128
362478|NCT00443820|880350|P3|STARTED|Overall Study||135
362479|NCT00443820|880351|P2|STARTED|Overall Study||130
362480|NCT00443820|880352|P1|STARTED|Overall Study||133
362481|NCT00443781|880374|P1|NOT COMPLETED|Overall Study||25
362482|NCT00443781|880374|P1|COMPLETED|Overall Study||37
362483|NCT00443781|880374|P1|STARTED|Overall Study||62
362484|NCT00443755|880380|P2|NOT COMPLETED|Overall Study||1
362485|NCT00443755|880381|P1|NOT COMPLETED|Overall Study||2
362486|NCT00443755|880380|P2|COMPLETED|Overall Study||13
362487|NCT00443755|880381|P1|COMPLETED|Overall Study||12
362488|NCT00443755|880380|P2|STARTED|Overall Study||14
362489|NCT00443755|880381|P1|STARTED|Overall Study||14
362490|NCT00443729|880415|P2|NOT COMPLETED|Overall Study||7
362491|NCT00443729|880416|P1|NOT COMPLETED|Overall Study||10
362492|NCT00443729|880415|P2|COMPLETED|Overall Study||172
362493|NCT00443729|880416|P1|COMPLETED|Overall Study||166
362494|NCT00443729|880415|P2|Treated|Overall Study||178
362495|NCT00443729|880416|P1|Treated|Overall Study||176
362496|NCT00443729|880415|P2|STARTED|Overall Study||179
362497|NCT00443729|880416|P1|STARTED|Overall Study||176
362498|NCT00443703|880464|P2|NOT COMPLETED|Overall Study||18
362499|NCT00443703|880465|P1|NOT COMPLETED|Overall Study||28
362500|NCT00443703|880464|P2|COMPLETED|Overall Study||157
362501|NCT00443703|880465|P1|COMPLETED|Overall Study||149
362502|NCT00443703|880464|P2|Treated|Overall Study||174
362503|NCT00443703|880465|P1|Treated|Overall Study||174
362504|NCT00443703|880464|P2|STARTED|Overall Study||175
362505|NCT00443703|880465|P1|STARTED|Overall Study||177
362506|NCT00443651|880517|P2|NOT COMPLETED|Overall Study||58
362507|NCT00443651|880518|P1|NOT COMPLETED|Overall Study||95
362508|NCT00443651|880517|P2|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|118
362509|NCT00443651|880518|P1|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|306
362510|NCT00443651|880517|P2|Week 48|Overall Study||134
362511|NCT00443651|880518|P1|Week 48|Overall Study||338
362512|NCT00443651|880517|P2|Week 24|Overall Study||160
362513|NCT00443651|880518|P1|Week 24|Overall Study||376
362514|NCT00443651|880517|P2|STARTED|Overall Study||176
362515|NCT00443651|880518|P1|STARTED|Overall Study||401
362516|NCT00443599|880538|P2|NOT COMPLETED|Overall Study||3
362517|NCT00443599|880539|P1|NOT COMPLETED|Overall Study||6
362518|NCT00443599|880538|P2|COMPLETED|Overall Study|Included in per-protocol analysis|490
362519|NCT00443599|880539|P1|COMPLETED|Overall Study|Included in per-protocol analysis|490
362520|NCT00443599|880538|P2|STARTED|Overall Study|Randomly Assigned to Standard Care|493
362521|NCT00443599|880539|P1|STARTED|Overall Study|Randomly Assigned to Tight Glycemic Control|496
362522|NCT00443560|880573|P2|NOT COMPLETED|Overall Study||30
362523|NCT00443560|880574|P1|NOT COMPLETED|Overall Study||60
362524|NCT00443560|880573|P2|COMPLETED|Overall Study||1051
362525|NCT00443560|880574|P1|COMPLETED|Overall Study||1021
362526|NCT00443560|880573|P2|STARTED|Overall Study||1081
362527|NCT00443560|880574|P1|STARTED|Overall Study||1081
362528|NCT00443547|880588|P4|NOT COMPLETED|Overall Study||2
362529|NCT00443547|880589|P3|NOT COMPLETED|Overall Study||21
362530|NCT00443547|880590|P2|NOT COMPLETED|Overall Study||42
362531|NCT00443547|880591|P1|NOT COMPLETED|Overall Study||45
362532|NCT00443547|880588|P4|COMPLETED|Overall Study||4
362533|NCT00443547|880589|P3|COMPLETED|Overall Study||27
362534|NCT00443547|880590|P2|COMPLETED|Overall Study||46
362535|NCT00443547|880591|P1|COMPLETED|Overall Study||44
362536|NCT00443547|880588|P4|Evaluated at 12 Months|Overall Study||5
362537|NCT00443547|880589|P3|Evaluated at 12 Months|Overall Study||37
362538|NCT00443547|880590|P2|Evaluated at 12 Months|Overall Study||55
362539|NCT00443547|880591|P1|Evaluated at 12 Months|Overall Study||58
362540|NCT00443547|880588|P4|STARTED|Overall Study|Enrolled and Treated Per Protocol|6
362541|NCT00443547|880589|P3|STARTED|Overall Study|Enrolled and Treated Per Protocol|48
362542|NCT00443547|880590|P2|STARTED|Overall Study|Enrolled and Treated Per Protocol|88
362543|NCT00443547|880591|P1|STARTED|Overall Study|Enrolled and Treated Per Protocol|89
362544|NCT00443534|880609|P1|NOT COMPLETED|Overall Study||123
362545|NCT00443534|880609|P1|COMPLETED|Overall Study||0
362546|NCT00443534|880609|P1|Treated|Overall Study||122
362547|NCT00443534|880609|P1|STARTED|Overall Study||123
362548|NCT00443456|880616|P1|NOT COMPLETED|Overall Study||18
362549|NCT00443456|880616|P1|COMPLETED|Overall Study||116
362550|NCT00443456|880616|P1|STARTED|Overall Study||134
362551|NCT00443430|880651|P2|NOT COMPLETED|Overall Study||4
362552|NCT00443430|880652|P1|NOT COMPLETED|Overall Study||4
362553|NCT00443430|880651|P2|COMPLETED|Overall Study||38
362554|NCT00443430|880652|P1|COMPLETED|Overall Study||39
362555|NCT00443430|880651|P2|STARTED|Overall Study||42
362556|NCT00443430|880652|P1|STARTED|Overall Study||43
362557|NCT00443352|880662|P1|NOT COMPLETED|Overall Study||5
362558|NCT00443352|880662|P1|COMPLETED|Overall Study||22
362559|NCT00443352|880662|P1|STARTED|Overall Study||27
362560|NCT00443261|880666|P1|NOT COMPLETED|Overall Study||1
362561|NCT00443261|880666|P1|COMPLETED|Overall Study|Study terminated due to poor accrual and only patient enrolled died|0
362562|NCT00443261|880666|P1|Accrual in 10 Months|Overall Study|Patient died due to progressive disease after cycle 1 of treatment|1
362563|NCT00443261|880666|P1|STARTED|Overall Study||1
362564|NCT00443209|880672|P2|NOT COMPLETED|Months 13 to 18 Treatment Period||47
362565|NCT00443209|880673|P1|NOT COMPLETED|Months 13 to 18 Treatment Period||99
362566|NCT00443209|880672|P2|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|39
362567|NCT00443209|880673|P1|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|87
362568|NCT00443209|880672|P2|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period was optional. 116 participants chose not to continue.|86
362569|NCT00443209|880673|P1|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period.was optional. 181 participants chose not to continue.|186
362570|NCT00443209|880672|P2|NOT COMPLETED|Months 1 to 12 Treatment Period||154
362571|NCT00443209|880673|P1|NOT COMPLETED|Months 1 to 12 Treatment Period||345
362572|NCT00443209|880672|P2|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|202
362573|NCT00443209|880673|P1|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|367
362574|NCT00443209|880672|P2|Treated|Months 1 to 12 Treatment Period||313
362575|NCT00443209|880673|P1|Treated|Months 1 to 12 Treatment Period||641
362576|NCT00443209|880672|P2|STARTED|Months 1 to 12 Treatment Period||356
362577|NCT00443209|880673|P1|STARTED|Months 1 to 12 Treatment Period||712
362578|NCT00443118|880690|P3|NOT COMPLETED|Overall Study||0
362579|NCT00443118|880691|P2|NOT COMPLETED|Overall Study||1
362580|NCT00443118|880692|P1|NOT COMPLETED|Overall Study||4
362581|NCT00443118|880690|P3|COMPLETED|Overall Study||226
362582|NCT00443118|880691|P2|COMPLETED|Overall Study||290
362583|NCT00443118|880692|P1|COMPLETED|Overall Study||511
362584|NCT00443118|880690|P3|STARTED|Overall Study||226
362585|NCT00443118|880691|P2|STARTED|Overall Study||291
362586|NCT00443118|880692|P1|STARTED|Overall Study||515
362587|NCT00443053|880741|P2|NOT COMPLETED|Overall Study||33
362588|NCT00443053|880742|P1|NOT COMPLETED|Overall Study||21
362589|NCT00443053|880741|P2|COMPLETED|Overall Study||1467
362590|NCT00443053|880742|P1|COMPLETED|Overall Study||1481
362591|NCT00443053|880741|P2|STARTED|Overall Study||1500
362592|NCT00443053|880742|P1|STARTED|Overall Study||1502
362593|NCT00443040|880763|P3|NOT COMPLETED|Overall Study||1
362594|NCT00443040|880764|P2|NOT COMPLETED|Overall Study||0
362595|NCT00443040|880765|P1|NOT COMPLETED|Overall Study||4
362596|NCT00443040|880763|P3|COMPLETED|Overall Study||9
362597|NCT00443040|880764|P2|COMPLETED|Overall Study||11
362598|NCT00443040|880765|P1|COMPLETED|Overall Study||10
362599|NCT00443040|880763|P3|STARTED|Overall Study||10
362600|NCT00443040|880764|P2|STARTED|Overall Study||11
362601|NCT00443040|880765|P1|STARTED|Overall Study||14
362602|NCT00442962|880773|P1|NOT COMPLETED|Overall Study||8
362603|NCT00442962|880773|P1|COMPLETED|Overall Study|Completed 48 weeks of follow-up.|46
362604|NCT00442962|880773|P1|Primary Outcome Evaluation|Overall Study|Primary outcome evaluation at week 24.|52
362605|NCT00442962|880773|P1|STARTED|Overall Study||54
362606|NCT00442936|880791|P4|NOT COMPLETED|Overall Study||1
362607|NCT00442936|880792|P3|NOT COMPLETED|Overall Study||1
362608|NCT00442936|880793|P2|NOT COMPLETED|Overall Study||0
362609|NCT00442936|880794|P1|NOT COMPLETED|Overall Study||1
362610|NCT00442936|880791|P4|COMPLETED|Overall Study||347
362611|NCT00442936|880792|P3|COMPLETED|Overall Study||344
362612|NCT00442936|880793|P2|COMPLETED|Overall Study||354
362613|NCT00442936|880794|P1|COMPLETED|Overall Study||332
362614|NCT00442936|880791|P4|STARTED|Overall Study||348
362615|NCT00442936|880792|P3|STARTED|Overall Study||345
362616|NCT00442936|880793|P2|STARTED|Overall Study||354
362617|NCT00442936|880794|P1|STARTED|Overall Study||333
362618|NCT00442897|880842|P2|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
362619|NCT00442897|880843|P1|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
362620|NCT00442897|880842|P2|COMPLETED|24 Weeks Follow-up (3 Centers)||28
362621|NCT00442897|880843|P1|COMPLETED|24 Weeks Follow-up (3 Centers)||29
362622|NCT00442897|880842|P2|STARTED|24 Weeks Follow-up (3 Centers)|65 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|34
362623|NCT00442897|880843|P1|STARTED|24 Weeks Follow-up (3 Centers)|66 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|35
362624|NCT00442897|880842|P2|NOT COMPLETED|Base Study (12 Week Follow-up)||12
362625|NCT00442897|880843|P1|NOT COMPLETED|Base Study (12 Week Follow-up)||17
362626|NCT00442897|880842|P2|COMPLETED|Base Study (12 Week Follow-up)||99
362627|NCT00442897|880843|P1|COMPLETED|Base Study (12 Week Follow-up)||101
362628|NCT00442897|880842|P2|STARTED|Base Study (12 Week Follow-up)||111
362629|NCT00442897|880843|P1|STARTED|Base Study (12 Week Follow-up)||118
362630|NCT00442767|880851|P1|NOT COMPLETED|Overall Study||0
362631|NCT00442767|880851|P1|COMPLETED|Overall Study||8
362632|NCT00442767|880851|P1|STARTED|Overall Study||8
362633|NCT00442702|880861|P2|NOT COMPLETED|Evaluation Period||4
362634|NCT00442702|880862|P1|NOT COMPLETED|Evaluation Period||5
362635|NCT00442702|880861|P2|COMPLETED|Evaluation Period||107
362636|NCT00442702|880862|P1|COMPLETED|Evaluation Period||97
362637|NCT00442702|880861|P2|STARTED|Evaluation Period||111
362638|NCT00442702|880862|P1|STARTED|Evaluation Period||102
362639|NCT00442702|880861|P2|NOT COMPLETED|Titration Period||3
362640|NCT00442702|880862|P1|NOT COMPLETED|Titration Period||12
362641|NCT00442702|880861|P2|COMPLETED|Titration Period||111
362642|NCT00442702|880862|P1|COMPLETED|Titration Period||102
362643|NCT00442702|880861|P2|Safety Population|Titration Period||113
362644|NCT00442702|880862|P1|Safety Population|Titration Period|One patient was randomized to darbepoetin alfa but treated by mistake with Mircera|115
362645|NCT00442702|880861|P2|STARTED|Titration Period||114
362646|NCT00442702|880862|P1|STARTED|Titration Period||114
362647|NCT00442689|880877|P3|NOT COMPLETED|Overall Study||9
362648|NCT00442689|880878|P2|NOT COMPLETED|Overall Study||11
362649|NCT00442689|880879|P1|NOT COMPLETED|Overall Study||10
362650|NCT00442689|880877|P3|COMPLETED|Overall Study||13
362651|NCT00442689|880878|P2|COMPLETED|Overall Study||13
362652|NCT00442689|880879|P1|COMPLETED|Overall Study||11
362653|NCT00442689|880877|P3|STARTED|Overall Study||22
362654|NCT00442689|880878|P2|STARTED|Overall Study||24
362655|NCT00442689|880879|P1|STARTED|Overall Study||21
362656|NCT00442611|880907|P2|NOT COMPLETED|Overall Study||0
362657|NCT00442611|880908|P1|NOT COMPLETED|Overall Study||1
362658|NCT00442611|880907|P2|COMPLETED|Overall Study||3
362659|NCT00442611|880908|P1|COMPLETED|Overall Study||6
362660|NCT00442611|880907|P2|STARTED|Overall Study||3
362661|NCT00442611|880908|P1|STARTED|Overall Study||7
362662|NCT00442598|880927|P3|NOT COMPLETED|Overall Study||0
362663|NCT00442598|880928|P2|NOT COMPLETED|Overall Study||8
362664|NCT00442598|880929|P1|NOT COMPLETED|Overall Study||6
362665|NCT00442598|880927|P3|COMPLETED|Overall Study||0
362666|NCT00442598|880928|P2|COMPLETED|Overall Study||2
362667|NCT00442598|880929|P1|COMPLETED|Overall Study||1
362668|NCT00442598|880927|P3|Two Cycles|Overall Study||0
362669|NCT00442598|880928|P2|Two Cycles|Overall Study||6
362670|NCT00442598|880929|P1|Two Cycles|Overall Study||5
362671|NCT00442598|880927|P3|STARTED|Overall Study||0
362672|NCT00442598|880928|P2|STARTED|Overall Study||10
362673|NCT00442598|880929|P1|STARTED|Overall Study||7
362674|NCT00442572|880947|P2|NOT COMPLETED|Overall Study||3
362675|NCT00442572|880948|P1|NOT COMPLETED|Overall Study||8
362676|NCT00442572|880947|P2|COMPLETED|Overall Study||1
362677|NCT00442572|880948|P1|COMPLETED|Overall Study||9
362678|NCT00442572|880947|P2|STARTED|Overall Study||4
362679|NCT00442572|880948|P1|STARTED|Overall Study||17
362680|NCT00442559|880988|P2|NOT COMPLETED|Overall Study||35
362681|NCT00442559|880989|P1|NOT COMPLETED|Overall Study||34
362682|NCT00442559|880988|P2|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|56
362683|NCT00442559|880989|P1|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|66
362684|NCT00442559|880988|P2|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|60
362685|NCT00442559|880989|P1|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|68
362686|NCT00442559|880988|P2|STARTED|Overall Study||91
362687|NCT00442559|880989|P1|STARTED|Overall Study||100
362688|NCT00442546|881004|P3|NOT COMPLETED|Overall Study||33
362689|NCT00442546|881005|P2|NOT COMPLETED|Overall Study||37
362690|NCT00442546|881006|P1|NOT COMPLETED|Overall Study||26
362691|NCT00442546|881004|P3|COMPLETED|Overall Study||71
362692|NCT00442546|881005|P2|COMPLETED|Overall Study||63
362693|NCT00442546|881006|P1|COMPLETED|Overall Study||77
362694|NCT00442546|881004|P3|Received Treatment|Overall Study||98
362695|NCT00442546|881005|P2|Received Treatment|Overall Study||96
362696|NCT00442546|881006|P1|Received Treatment|Overall Study||98
362697|NCT00442546|881004|P3|STARTED|Overall Study||104
362698|NCT00442546|881005|P2|STARTED|Overall Study||100
362699|NCT00442546|881006|P1|STARTED|Overall Study||103
362700|NCT00442507|881128|P1|NOT COMPLETED|Overall Study||0
362701|NCT00442507|881128|P1|COMPLETED|Overall Study||6
362702|NCT00442507|881128|P1|STARTED|Overall Study||6
362703|NCT00442468|881135|P1|NOT COMPLETED|Overall Study||183
362704|NCT00442468|881135|P1|COMPLETED|Overall Study||1100
362705|NCT00442468|881135|P1|STARTED|Overall Study||1283
362706|NCT00442416|881165|P2|NOT COMPLETED|Overall Study||39
362707|NCT00442416|881166|P1|NOT COMPLETED|Overall Study||37
362708|NCT00442416|881165|P2|COMPLETED|Overall Study||2
362709|NCT00442416|881166|P1|COMPLETED|Overall Study||2
362710|NCT00442416|881165|P2|STARTED|Overall Study||41
362711|NCT00442416|881166|P1|STARTED|Overall Study||39
362712|NCT00442364|881199|P1|NOT COMPLETED|Overall Study||0
362713|NCT00442364|881199|P1|COMPLETED|Overall Study||60
362714|NCT00442364|881199|P1|STARTED|Overall Study||60
362715|NCT00442351|881205|P2|NOT COMPLETED|Overall Study||6
362716|NCT00442351|881206|P1|NOT COMPLETED|Overall Study||7
362717|NCT00442351|881205|P2|COMPLETED|Overall Study||3
362718|NCT00442351|881206|P1|COMPLETED|Overall Study||10
362719|NCT00442351|881205|P2|STARTED|Overall Study||9
362720|NCT00442351|881206|P1|STARTED|Overall Study|Due to poor enrollment and a high screening failure rate, this study was terminated early.|17
362721|NCT00442338|881215|P3|NOT COMPLETED|Overall Study||0
362722|NCT00442338|881216|P2|NOT COMPLETED|Overall Study||0
362723|NCT00442338|881217|P1|NOT COMPLETED|Overall Study||0
362724|NCT00442338|881215|P3|COMPLETED|Overall Study||31
362725|NCT00442338|881216|P2|COMPLETED|Overall Study||30
362726|NCT00442338|881217|P1|COMPLETED|Overall Study||30
362727|NCT00442338|881215|P3|STARTED|Overall Study||31
362728|NCT00442338|881216|P2|STARTED|Overall Study||30
362729|NCT00442338|881217|P1|STARTED|Overall Study||30
362730|NCT00442286|881228|P2|NOT COMPLETED|Overall Study||2
362731|NCT00442286|881229|P1|NOT COMPLETED|Overall Study||7
362732|NCT00442286|881228|P2|COMPLETED|Overall Study||82
362733|NCT00442286|881229|P1|COMPLETED|Overall Study||174
362734|NCT00442286|881228|P2|12 Months|Overall Study||82
362735|NCT00442286|881229|P1|12 Months|Overall Study||174
362736|NCT00442286|881228|P2|6 Months|Overall Study||83
362737|NCT00442286|881229|P1|6 Months|Overall Study||177
362738|NCT00442286|881228|P2|STARTED|Overall Study||84
362739|NCT00442286|881229|P1|STARTED|Overall Study||181
362740|NCT00442169|881246|P6|NOT COMPLETED|Part 2||0
362741|NCT00442169|881247|P5|NOT COMPLETED|Part 2||0
362742|NCT00442169|881248|P4|NOT COMPLETED|Part 2||0
362743|NCT00442169|881249|P3|NOT COMPLETED|Part 2||0
362744|NCT00442169|881250|P2|NOT COMPLETED|Part 2||0
362745|NCT00442169|881251|P1|NOT COMPLETED|Part 2||0
362746|NCT00442169|881246|P6|COMPLETED|Part 2||57
362747|NCT00442169|881247|P5|COMPLETED|Part 2||25
362748|NCT00442169|881248|P4|COMPLETED|Part 2||0
362749|NCT00442169|881249|P3|COMPLETED|Part 2||0
362750|NCT00442169|881250|P2|COMPLETED|Part 2||0
362751|NCT00442169|881251|P1|COMPLETED|Part 2||0
362752|NCT00442169|881246|P6|STARTED|Part 2||57
362753|NCT00442169|881247|P5|STARTED|Part 2||25
362754|NCT00442169|881248|P4|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
362755|NCT00442169|881249|P3|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
362850|NCT00441584|881506|P1|STARTED|Overall Study||117
362756|NCT00442169|881250|P2|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
362757|NCT00442169|881251|P1|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
362758|NCT00442169|881246|P6|NOT COMPLETED|Part 1||0
362759|NCT00442169|881247|P5|NOT COMPLETED|Part 1||0
362760|NCT00442169|881248|P4|NOT COMPLETED|Part 1||0
362761|NCT00442169|881249|P3|NOT COMPLETED|Part 1||0
362762|NCT00442169|881250|P2|NOT COMPLETED|Part 1||0
362763|NCT00442169|881251|P1|NOT COMPLETED|Part 1||0
362764|NCT00442169|881246|P6|COMPLETED|Part 1||0
362765|NCT00442169|881247|P5|COMPLETED|Part 1||0
362766|NCT00442169|881248|P4|COMPLETED|Part 1||31
362767|NCT00442169|881249|P3|COMPLETED|Part 1||40
362768|NCT00442169|881250|P2|COMPLETED|Part 1||24
362769|NCT00442169|881251|P1|COMPLETED|Part 1||17
362770|NCT00442169|881246|P6|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
362771|NCT00442169|881247|P5|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
362772|NCT00442169|881248|P4|STARTED|Part 1||31
362773|NCT00442169|881249|P3|STARTED|Part 1||40
362774|NCT00442169|881250|P2|STARTED|Part 1||24
362775|NCT00442169|881251|P1|STARTED|Part 1||17
362776|NCT00442117|881291|P2|NOT COMPLETED|Overall Study||38
362777|NCT00442117|881292|P1|NOT COMPLETED|Overall Study||38
362778|NCT00442117|881291|P2|COMPLETED|Overall Study||49
362779|NCT00442117|881292|P1|COMPLETED|Overall Study||47
362780|NCT00442117|881291|P2|STARTED|Overall Study||87
362781|NCT00442117|881292|P1|STARTED|Overall Study||85
362782|NCT00442013|881306|P2|NOT COMPLETED|Overall Study||17
362783|NCT00442013|881307|P1|NOT COMPLETED|Overall Study||26
362784|NCT00442013|881306|P2|COMPLETED|Overall Study||132
362785|NCT00442013|881307|P1|COMPLETED|Overall Study||131
362786|NCT00442013|881306|P2|STARTED|Overall Study||149
362787|NCT00442013|881307|P1|STARTED|Overall Study||157
362788|NCT00441974|881323|P1|NOT COMPLETED|Overall Study||128
362789|NCT00441974|881323|P1|COMPLETED|Overall Study||1342
362790|NCT00441974|881323|P1|STARTED|Overall Study||1470
362791|NCT00441792|881339|P2|NOT COMPLETED|Overall Study||2
362792|NCT00441792|881340|P1|NOT COMPLETED|Overall Study||0
362793|NCT00441792|881339|P2|COMPLETED|Overall Study|2 patients lost to follow up in Etomidate arm due to transfer to outside hospital.|61
362794|NCT00441792|881340|P1|COMPLETED|Overall Study||59
362795|NCT00441792|881339|P2|STARTED|Overall Study||63
362796|NCT00441792|881340|P1|STARTED|Overall Study||59
362797|NCT00441766|881352|P4|NOT COMPLETED|Overall Study||6
362798|NCT00441766|881353|P3|NOT COMPLETED|Overall Study||9
362799|NCT00441766|881354|P2|NOT COMPLETED|Overall Study||7
362800|NCT00441766|881355|P1|NOT COMPLETED|Overall Study||14
362801|NCT00441766|881352|P4|COMPLETED|Overall Study||48
362802|NCT00441766|881353|P3|COMPLETED|Overall Study||44
362803|NCT00441766|881354|P2|COMPLETED|Overall Study||46
362804|NCT00441766|881355|P1|COMPLETED|Overall Study||39
362805|NCT00441766|881352|P4|STARTED|Overall Study||54
362806|NCT00441766|881353|P3|STARTED|Overall Study||53
362807|NCT00441766|881354|P2|STARTED|Overall Study||53
362808|NCT00441766|881355|P1|STARTED|Overall Study||53
362809|NCT00441727|881380|P3|NOT COMPLETED|Overall Study||168
362810|NCT00441727|881381|P2|NOT COMPLETED|Overall Study||118
362811|NCT00441727|881382|P1|NOT COMPLETED|Overall Study||106
362812|NCT00441727|881380|P3|COMPLETED|Overall Study|ITT/randomised|637
362813|NCT00441727|881381|P2|COMPLETED|Overall Study|ITT/randomised|686
362814|NCT00441727|881382|P1|COMPLETED|Overall Study|ITT/randomised|711
362815|NCT00441727|881380|P3|STARTED|Overall Study|ITT/randomised|805
362816|NCT00441727|881381|P2|STARTED|Overall Study|ITT/randomised|804
362817|NCT00441727|881382|P1|STARTED|Overall Study|ITT/randomised|817
362818|NCT00441701|881415|P10|NOT COMPLETED|Overall Study||0
362819|NCT00441701|881416|P9|NOT COMPLETED|Overall Study||0
362820|NCT00441701|881417|P8|NOT COMPLETED|Overall Study||0
362821|NCT00441701|881418|P7|NOT COMPLETED|Overall Study||0
362822|NCT00441701|881419|P6|NOT COMPLETED|Overall Study||3
362823|NCT00441701|881420|P5|NOT COMPLETED|Overall Study||2
362824|NCT00441701|881421|P4|NOT COMPLETED|Overall Study||3
362825|NCT00441701|881422|P3|NOT COMPLETED|Overall Study||4
362826|NCT00441701|881423|P2|NOT COMPLETED|Overall Study||4
362827|NCT00441701|881424|P1|NOT COMPLETED|Overall Study||5
362828|NCT00441701|881415|P10|COMPLETED|Overall Study||0
362829|NCT00441701|881416|P9|COMPLETED|Overall Study||0
362830|NCT00441701|881417|P8|COMPLETED|Overall Study||0
362831|NCT00441701|881418|P7|COMPLETED|Overall Study||0
362832|NCT00441701|881419|P6|COMPLETED|Overall Study||8
362833|NCT00441701|881420|P5|COMPLETED|Overall Study||20
362834|NCT00441701|881421|P4|COMPLETED|Overall Study||8
362835|NCT00441701|881422|P3|COMPLETED|Overall Study||18
362836|NCT00441701|881423|P2|COMPLETED|Overall Study||7
362837|NCT00441701|881424|P1|COMPLETED|Overall Study||17
362838|NCT00441701|881415|P10|STARTED|Overall Study||0
362839|NCT00441701|881416|P9|STARTED|Overall Study||0
362840|NCT00441701|881417|P8|STARTED|Overall Study||0
362841|NCT00441701|881418|P7|STARTED|Overall Study||0
362842|NCT00441701|881419|P6|STARTED|Overall Study||11
362843|NCT00441701|881420|P5|STARTED|Overall Study||22
362844|NCT00441701|881421|P4|STARTED|Overall Study||11
362845|NCT00441701|881422|P3|STARTED|Overall Study||22
362846|NCT00441701|881423|P2|STARTED|Overall Study||11
362847|NCT00441701|881424|P1|STARTED|Overall Study||22
362848|NCT00441584|881506|P1|NOT COMPLETED|Overall Study||105
362849|NCT00441584|881506|P1|COMPLETED|Overall Study||12
362851|NCT00441558|881510|P1|NOT COMPLETED|Overall Study||1056
362852|NCT00441558|881510|P1|COMPLETED|Overall Study||667
362853|NCT00441558|881510|P1|STARTED|Overall Study||1723
362854|NCT00441545|881514|P2|NOT COMPLETED|Second Intervention||7
362855|NCT00441545|881515|P1|NOT COMPLETED|Second Intervention||12
362856|NCT00441545|881514|P2|COMPLETED|Second Intervention||68
362857|NCT00441545|881515|P1|COMPLETED|Second Intervention||65
362858|NCT00441545|881514|P2|STARTED|Second Intervention||75
362859|NCT00441545|881515|P1|STARTED|Second Intervention||77
362860|NCT00441545|881514|P2|NOT COMPLETED|Washout||0
362861|NCT00441545|881515|P1|NOT COMPLETED|Washout||0
362862|NCT00441545|881514|P2|COMPLETED|Washout||75
362863|NCT00441545|881515|P1|COMPLETED|Washout||77
362864|NCT00441545|881514|P2|STARTED|Washout||75
362865|NCT00441545|881515|P1|STARTED|Washout||77
362866|NCT00441545|881514|P2|NOT COMPLETED|First Intervention||12
362867|NCT00441545|881515|P1|NOT COMPLETED|First Intervention||18
362868|NCT00441545|881514|P2|COMPLETED|First Intervention||75
362869|NCT00441545|881515|P1|COMPLETED|First Intervention||77
362870|NCT00441545|881514|P2|STARTED|First Intervention||87
362871|NCT00441545|881515|P1|STARTED|First Intervention||95
362872|NCT00441480|881529|P2|NOT COMPLETED|Overall Study||4
362873|NCT00441480|881530|P1|NOT COMPLETED|Overall Study||3
362874|NCT00441480|881529|P2|COMPLETED|Overall Study||41
362875|NCT00441480|881530|P1|COMPLETED|Overall Study||43
362876|NCT00441480|881529|P2|STARTED|Overall Study||45
362877|NCT00441480|881530|P1|STARTED|Overall Study||46
362878|NCT00441467|881562|P1|NOT COMPLETED|Overall Study||18
362879|NCT00441467|881562|P1|COMPLETED|Overall Study||4
362880|NCT00441467|881562|P1|4 Cycles|Overall Study||7
362881|NCT00441467|881562|P1|2 Cycles|Overall Study||17
362882|NCT00441467|881562|P1|STARTED|Overall Study||22
362883|NCT00441441|881570|P2|NOT COMPLETED|Overall Study||14
362884|NCT00441441|881571|P1|NOT COMPLETED|Overall Study||11
362885|NCT00441441|881570|P2|COMPLETED|Overall Study||163
362886|NCT00441441|881571|P1|COMPLETED|Overall Study||162
362887|NCT00441441|881570|P2|STARTED|Overall Study||177
362888|NCT00441441|881571|P1|STARTED|Overall Study||173
362889|NCT00441363|881631|P2|NOT COMPLETED|Overall Study||15
362890|NCT00441363|881632|P1|NOT COMPLETED|Overall Study||17
362891|NCT00441363|881631|P2|COMPLETED|Overall Study||19
362892|NCT00441363|881632|P1|COMPLETED|Overall Study|no subject withdrew early since the trial was terminated|15
362893|NCT00441363|881631|P2|STARTED|Overall Study||34
362894|NCT00441363|881632|P1|STARTED|Overall Study||32
362895|NCT00441337|881644|P4|NOT COMPLETED|Overall Study||21
362896|NCT00441337|881645|P3|NOT COMPLETED|Overall Study||6
362897|NCT00441337|881646|P2|NOT COMPLETED|Overall Study||6
362898|NCT00441337|881647|P1|NOT COMPLETED|Overall Study||6
362899|NCT00441337|881644|P4|COMPLETED|Overall Study||0
362900|NCT00441337|881645|P3|COMPLETED|Overall Study||0
362901|NCT00441337|881646|P2|COMPLETED|Overall Study||0
362902|NCT00441337|881647|P1|COMPLETED|Overall Study||0
362903|NCT00441337|881644|P4|STARTED|Overall Study||21
362904|NCT00441337|881645|P3|STARTED|Overall Study||6
362905|NCT00441337|881646|P2|STARTED|Overall Study||6
362906|NCT00441337|881647|P1|STARTED|Overall Study||6
362907|NCT00441285|881730|P5|NOT COMPLETED|Overall Study||0
362908|NCT00441285|881731|P4|NOT COMPLETED|Overall Study||0
362909|NCT00441285|881732|P3|NOT COMPLETED|Overall Study||0
362910|NCT00441285|881733|P2|NOT COMPLETED|Overall Study||0
362911|NCT00441285|881734|P1|NOT COMPLETED|Overall Study||0
362912|NCT00441285|881730|P5|COMPLETED|Overall Study||43
362913|NCT00441285|881731|P4|COMPLETED|Overall Study||40
362914|NCT00441285|881732|P3|COMPLETED|Overall Study||41
362915|NCT00441285|881733|P2|COMPLETED|Overall Study||16
362916|NCT00441285|881734|P1|COMPLETED|Overall Study||16
362917|NCT00441285|881730|P5|STARTED|Overall Study||43
362918|NCT00441285|881731|P4|STARTED|Overall Study||40
362919|NCT00441285|881732|P3|STARTED|Overall Study||41
362920|NCT00441285|881733|P2|STARTED|Overall Study||16
362921|NCT00441285|881734|P1|STARTED|Overall Study||16
362922|NCT00441272|881760|P2|NOT COMPLETED|Overall Study||25
362923|NCT00441272|881761|P1|NOT COMPLETED|Overall Study||25
362924|NCT00441272|881760|P2|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
362925|NCT00441272|881761|P1|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
362926|NCT00441272|881760|P2|STARTED|Overall Study||25
362927|NCT00441272|881761|P1|STARTED|Overall Study||25
362928|NCT00441259|881769|P2|NOT COMPLETED|Overall Study||0
362929|NCT00441259|881770|P1|NOT COMPLETED|Overall Study||0
362930|NCT00441259|881769|P2|COMPLETED|Overall Study||48
362931|NCT00441259|881770|P1|COMPLETED|Overall Study||48
362932|NCT00441259|881769|P2|STARTED|Overall Study||48
362933|NCT00441259|881770|P1|STARTED|Overall Study||48
362934|NCT00441168|881788|P2|NOT COMPLETED|Follow-up Period||9
362935|NCT00441168|881789|P1|NOT COMPLETED|Follow-up Period||12
362936|NCT00441168|881788|P2|COMPLETED|Follow-up Period||4
362937|NCT00441168|881789|P1|COMPLETED|Follow-up Period||5
362938|NCT00441168|881788|P2|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|13
362939|NCT00441168|881789|P1|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|17
362940|NCT00441168|881788|P2|NOT COMPLETED|Treatment Period||6
362941|NCT00441168|881789|P1|NOT COMPLETED|Treatment Period||11
362942|NCT00441168|881788|P2|COMPLETED|Treatment Period||7
362943|NCT00441168|881789|P1|COMPLETED|Treatment Period||6
362944|NCT00441168|881788|P2|TREATED|Treatment Period||13
362945|NCT00441168|881789|P1|TREATED|Treatment Period||16
362946|NCT00441168|881788|P2|STARTED|Treatment Period||13
362947|NCT00441168|881789|P1|STARTED|Treatment Period||17
362948|NCT00441142|881803|P4|NOT COMPLETED|Overall Study||68
362949|NCT00441142|881804|P3|NOT COMPLETED|Overall Study||22
362950|NCT00441142|881805|P2|NOT COMPLETED|Overall Study||7
362951|NCT00441142|881806|P1|NOT COMPLETED|Overall Study||6
362952|NCT00441142|881803|P4|COMPLETED|Overall Study||1
362953|NCT00441142|881804|P3|COMPLETED|Overall Study||7
362954|NCT00441142|881805|P2|COMPLETED|Overall Study||0
362955|NCT00441142|881806|P1|COMPLETED|Overall Study||0
362956|NCT00441142|881803|P4|STARTED|Overall Study||69
362957|NCT00441142|881804|P3|STARTED|Overall Study||29
362958|NCT00441142|881805|P2|STARTED|Overall Study||7
362959|NCT00441142|881806|P1|STARTED|Overall Study||6
362960|NCT00441129|881828|P2|NOT COMPLETED|Overall Study||14
362961|NCT00441129|881829|P1|NOT COMPLETED|Overall Study||6
362962|NCT00441129|881828|P2|COMPLETED|Overall Study||41
362963|NCT00441129|881829|P1|COMPLETED|Overall Study||54
362964|NCT00441129|881828|P2|STARTED|Overall Study||55
362965|NCT00441129|881829|P1|STARTED|Overall Study||60
362966|NCT00441116|881841|P2|NOT COMPLETED|Overall Study||2
362967|NCT00441116|881842|P1|NOT COMPLETED|Overall Study||3
362968|NCT00441116|881841|P2|COMPLETED|Overall Study||75
362969|NCT00441116|881842|P1|COMPLETED|Overall Study||73
362970|NCT00441116|881841|P2|STARTED|Overall Study||77
362971|NCT00441116|881842|P1|STARTED|Overall Study||76
362972|NCT00441103|881910|P2|NOT COMPLETED|Overall Study||4
362973|NCT00441103|881911|P1|NOT COMPLETED|Overall Study||11
362974|NCT00441103|881910|P2|COMPLETED|Overall Study||56
362975|NCT00441103|881911|P1|COMPLETED|Overall Study||109
362976|NCT00441103|881910|P2|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|60
362977|NCT00441103|881911|P1|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|120
362978|NCT00441090|881927|P5|NOT COMPLETED|Overall Study||0
362979|NCT00441090|881928|P4|NOT COMPLETED|Overall Study||2
362980|NCT00441090|881929|P3|NOT COMPLETED|Overall Study||2
362981|NCT00441090|881930|P2|NOT COMPLETED|Overall Study||1
362982|NCT00441090|881931|P1|NOT COMPLETED|Overall Study||2
362983|NCT00441090|881927|P5|COMPLETED|Overall Study||5
362984|NCT00441090|881928|P4|COMPLETED|Overall Study||13
362985|NCT00441090|881929|P3|COMPLETED|Overall Study||12
362986|NCT00441090|881930|P2|COMPLETED|Overall Study||14
362987|NCT00441090|881931|P1|COMPLETED|Overall Study||13
362988|NCT00441090|881927|P5|STARTED|Overall Study||5
362989|NCT00441090|881928|P4|STARTED|Overall Study||15
362990|NCT00441090|881929|P3|STARTED|Overall Study||14
362991|NCT00441090|881930|P2|STARTED|Overall Study||15
362992|NCT00441090|881931|P1|STARTED|Overall Study||15
362993|NCT00441064|881975|P2|NOT COMPLETED|Overall Study||7
362994|NCT00441064|881976|P1|NOT COMPLETED|Overall Study||10
362995|NCT00441064|881975|P2|COMPLETED|Overall Study||56
362996|NCT00441064|881976|P1|COMPLETED|Overall Study||59
362997|NCT00441064|881975|P2|Intent-to-treat (ITT) Population|Overall Study||57
362998|NCT00441064|881976|P1|Intent-to-treat (ITT) Population|Overall Study||61
362999|NCT00441064|881975|P2|Safety Population (SP)|Overall Study||63
363000|NCT00441064|881976|P1|Safety Population (SP)|Overall Study||69
363001|NCT00441064|881975|P2|STARTED|Overall Study||63
363002|NCT00441064|881976|P1|STARTED|Overall Study||69
363003|NCT00441012|881988|P2|NOT COMPLETED|Overall Study||13
363004|NCT00441012|881989|P1|NOT COMPLETED|Overall Study||18
363005|NCT00441012|881988|P2|COMPLETED|Overall Study||263
363006|NCT00441012|881989|P1|COMPLETED|Overall Study||252
363007|NCT00441012|881988|P2|Vaccination Visit 3|Overall Study||269
363008|NCT00441012|881989|P1|Vaccination Visit 3|Overall Study||265
363009|NCT00441012|881988|P2|Vaccination Visit 2|Overall Study||272
363010|NCT00441012|881989|P1|Vaccination Visit 2|Overall Study||267
363011|NCT00441012|881988|P2|Vaccination Visit 1|Overall Study|3 participants were vaccinated but were never randomized in the COMVAX™ group|276
363012|NCT00441012|881989|P1|Vaccination Visit 1|Overall Study|1 participant was randomized but not vaccinated in the Modified Process Vaccine group|269
363013|NCT00441012|881988|P2|STARTED|Overall Study||276
363014|NCT00441012|881989|P1|STARTED|Overall Study||270
363015|NCT00440947|882003|P5|NOT COMPLETED|Optional 60-Week Extension Phase||26
363016|NCT00440947|882004|P4|NOT COMPLETED|Optional 60-Week Extension Phase||29
363017|NCT00440947|882005|P3|NOT COMPLETED|Optional 60-Week Extension Phase||0
363018|NCT00440947|882006|P2|NOT COMPLETED|Optional 60-Week Extension Phase||0
363019|NCT00440947|882007|P1|NOT COMPLETED|Optional 60-Week Extension Phase||0
363020|NCT00440947|882003|P5|COMPLETED|Optional 60-Week Extension Phase||154
363021|NCT00440947|882004|P4|COMPLETED|Optional 60-Week Extension Phase||160
363022|NCT00440947|882005|P3|COMPLETED|Optional 60-Week Extension Phase||0
363023|NCT00440947|882006|P2|COMPLETED|Optional 60-Week Extension Phase||0
363024|NCT00440947|882007|P1|COMPLETED|Optional 60-Week Extension Phase||0
363025|NCT00440947|882003|P5|STARTED|Optional 60-Week Extension Phase||180
363026|NCT00440947|882004|P4|STARTED|Optional 60-Week Extension Phase||189
363027|NCT00440947|882005|P3|STARTED|Optional 60-Week Extension Phase||0
363028|NCT00440947|882006|P2|STARTED|Optional 60-Week Extension Phase||0
363029|NCT00440947|882007|P1|STARTED|Optional 60-Week Extension Phase||0
363030|NCT00440947|882003|P5|NOT COMPLETED|48-Week Randomization Phase||0
363031|NCT00440947|882004|P4|NOT COMPLETED|48-Week Randomization Phase||0
363032|NCT00440947|882005|P3|NOT COMPLETED|48-Week Randomization Phase||24
363033|NCT00440947|882006|P2|NOT COMPLETED|48-Week Randomization Phase||16
363034|NCT00440947|882007|P1|NOT COMPLETED|48-Week Randomization Phase||0
363035|NCT00440947|882003|P5|COMPLETED|48-Week Randomization Phase||0
363036|NCT00440947|882004|P4|COMPLETED|48-Week Randomization Phase||0
363037|NCT00440947|882005|P3|COMPLETED|48-Week Randomization Phase||185
363038|NCT00440947|882006|P2|COMPLETED|48-Week Randomization Phase||194
363039|NCT00440947|882007|P1|COMPLETED|48-Week Randomization Phase||0
363040|NCT00440947|882003|P5|STARTED|48-Week Randomization Phase||0
363041|NCT00440947|882004|P4|STARTED|48-Week Randomization Phase||0
363042|NCT00440947|882005|P3|STARTED|48-Week Randomization Phase||209
363043|NCT00440947|882006|P2|STARTED|48-Week Randomization Phase||210
363044|NCT00440947|882007|P1|STARTED|48-Week Randomization Phase||0
363045|NCT00440947|882003|P5|NOT COMPLETED|36-Week Induction Phase||0
363046|NCT00440947|882004|P4|NOT COMPLETED|36-Week Induction Phase||0
363047|NCT00440947|882005|P3|NOT COMPLETED|36-Week Induction Phase||0
363048|NCT00440947|882006|P2|NOT COMPLETED|36-Week Induction Phase||0
363049|NCT00440947|882007|P1|NOT COMPLETED|36-Week Induction Phase||73
363050|NCT00440947|882003|P5|COMPLETED|36-Week Induction Phase||0
363051|NCT00440947|882004|P4|COMPLETED|36-Week Induction Phase||0
363052|NCT00440947|882005|P3|COMPLETED|36-Week Induction Phase||0
363053|NCT00440947|882006|P2|COMPLETED|36-Week Induction Phase||0
363054|NCT00440947|882007|P1|COMPLETED|36-Week Induction Phase|23 PAR without confirmed HIV-RNA<50c/mL prior to Wk 36 couldn’t be randomized but weren’t withdrawn.|442
363055|NCT00440947|882003|P5|STARTED|36-Week Induction Phase||0
363056|NCT00440947|882004|P4|STARTED|36-Week Induction Phase||0
363057|NCT00440947|882005|P3|STARTED|36-Week Induction Phase||0
363058|NCT00440947|882006|P2|STARTED|36-Week Induction Phase||0
363059|NCT00440947|882007|P1|STARTED|36-Week Induction Phase||515
363060|NCT00440830|882062|P4|NOT COMPLETED|Overall Study||0
363061|NCT00440830|882063|P3|NOT COMPLETED|Overall Study||0
363062|NCT00440830|882064|P2|NOT COMPLETED|Overall Study||0
363063|NCT00440830|882065|P1|NOT COMPLETED|Overall Study||0
363064|NCT00440830|882062|P4|COMPLETED|Overall Study||10
363065|NCT00440830|882063|P3|COMPLETED|Overall Study||30
363066|NCT00440830|882064|P2|COMPLETED|Overall Study||8
363067|NCT00440830|882065|P1|COMPLETED|Overall Study||20
363068|NCT00440830|882062|P4|STARTED|Overall Study||10
363069|NCT00440830|882063|P3|STARTED|Overall Study||30
363070|NCT00440830|882064|P2|STARTED|Overall Study||8
363071|NCT00440830|882065|P1|STARTED|Overall Study||20
363072|NCT00440700|882082|P3|NOT COMPLETED|Overall Study||4
363073|NCT00440700|882083|P2|NOT COMPLETED|Overall Study||8
363074|NCT00440700|882084|P1|NOT COMPLETED|Overall Study||8
363075|NCT00440700|882082|P3|COMPLETED|Overall Study||120
363076|NCT00440700|882083|P2|COMPLETED|Overall Study||110
363077|NCT00440700|882084|P1|COMPLETED|Overall Study||114
363078|NCT00440700|882082|P3|STARTED|Overall Study||124
363079|NCT00440700|882083|P2|STARTED|Overall Study||118
363080|NCT00440700|882084|P1|STARTED|Overall Study||122
363081|NCT00440557|882107|P3|NOT COMPLETED|Overall Study||35
363082|NCT00440557|882108|P2|NOT COMPLETED|Overall Study||29
363083|NCT00440557|882109|P1|NOT COMPLETED|Overall Study||25
363084|NCT00440557|882107|P3|COMPLETED|Overall Study||90
363085|NCT00440557|882108|P2|COMPLETED|Overall Study||96
363086|NCT00440557|882109|P1|COMPLETED|Overall Study||98
363087|NCT00440557|882107|P3|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
363088|NCT00440557|882108|P2|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
363089|NCT00440557|882109|P1|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|123
363090|NCT00440531|882141|P3|NOT COMPLETED|Overall Study||7
363091|NCT00440531|882142|P2|NOT COMPLETED|Overall Study||5
363092|NCT00440531|882143|P1|NOT COMPLETED|Overall Study||10
363093|NCT00440531|882141|P3|COMPLETED|Overall Study||165
363094|NCT00440531|882142|P2|COMPLETED|Overall Study||178
363095|NCT00440531|882143|P1|COMPLETED|Overall Study||175
363096|NCT00440531|882141|P3|Vaccination 3|Overall Study||166
363097|NCT00440531|882142|P2|Vaccination 3|Overall Study||178
363098|NCT00440531|882143|P1|Vaccination 3|Overall Study||176
363099|NCT00440531|882141|P3|Vaccination 2|Overall Study||171
363100|NCT00440531|882142|P2|Vaccination 2|Overall Study||182
363101|NCT00440531|882143|P1|Vaccination 2|Overall Study||181
363102|NCT00440531|882141|P3|Vaccination 1|Overall Study||172
363103|NCT00440531|882142|P2|Vaccination 1|Overall Study||183
363104|NCT00440531|882143|P1|Vaccination 1|Overall Study||183
363105|NCT00440531|882141|P3|STARTED|Overall Study||172
363106|NCT00440531|882142|P2|STARTED|Overall Study||183
363107|NCT00440531|882143|P1|STARTED|Overall Study||185
363108|NCT00440518|882160|P3|NOT COMPLETED|Maintenance and Safety Follow-up Periods||15
363109|NCT00440518|882161|P2|NOT COMPLETED|Maintenance and Safety Follow-up Periods||12
363110|NCT00440518|882162|P1|NOT COMPLETED|Maintenance and Safety Follow-up Periods||7
363111|NCT00440518|882160|P3|COMPLETED|Maintenance and Safety Follow-up Periods||55
363112|NCT00440518|882161|P2|COMPLETED|Maintenance and Safety Follow-up Periods||51
363113|NCT00440518|882162|P1|COMPLETED|Maintenance and Safety Follow-up Periods||52
363114|NCT00440518|882160|P3|STARTED|Maintenance and Safety Follow-up Periods||70
363115|NCT00440518|882161|P2|STARTED|Maintenance and Safety Follow-up Periods||63
363116|NCT00440518|882162|P1|STARTED|Maintenance and Safety Follow-up Periods||59
363117|NCT00440518|882160|P3|NOT COMPLETED|Randomized /Titration Period||4
363118|NCT00440518|882161|P2|NOT COMPLETED|Randomized /Titration Period||9
363119|NCT00440518|882162|P1|NOT COMPLETED|Randomized /Titration Period||13
363120|NCT00440518|882160|P3|COMPLETED|Randomized /Titration Period||70
363121|NCT00440518|882161|P2|COMPLETED|Randomized /Titration Period||63
363122|NCT00440518|882162|P1|COMPLETED|Randomized /Titration Period||59
363123|NCT00440518|882160|P3|STARTED|Randomized /Titration Period||74
363124|NCT00440518|882161|P2|STARTED|Randomized /Titration Period||72
363125|NCT00440518|882162|P1|STARTED|Randomized /Titration Period||72
363126|NCT00440505|882182|P6|NOT COMPLETED|Third Intervention||0
363127|NCT00440505|882183|P5|NOT COMPLETED|Third Intervention||0
363128|NCT00440505|882184|P4|NOT COMPLETED|Third Intervention||1
363129|NCT00440505|882185|P3|NOT COMPLETED|Third Intervention||0
363130|NCT00440505|882186|P2|NOT COMPLETED|Third Intervention||0
363131|NCT00440505|882187|P1|NOT COMPLETED|Third Intervention||0
363132|NCT00440505|882182|P6|COMPLETED|Third Intervention||5
363133|NCT00440505|882183|P5|COMPLETED|Third Intervention||5
363134|NCT00440505|882184|P4|COMPLETED|Third Intervention||1
363135|NCT00440505|882185|P3|COMPLETED|Third Intervention||1
363136|NCT00440505|882186|P2|COMPLETED|Third Intervention||2
363137|NCT00440505|882187|P1|COMPLETED|Third Intervention||5
363138|NCT00440505|882182|P6|STARTED|Third Intervention||5
363139|NCT00440505|882183|P5|STARTED|Third Intervention||5
363140|NCT00440505|882184|P4|STARTED|Third Intervention||2
363141|NCT00440505|882185|P3|STARTED|Third Intervention||1
363142|NCT00440505|882186|P2|STARTED|Third Intervention||2
363143|NCT00440505|882187|P1|STARTED|Third Intervention||5
363144|NCT00440505|882182|P6|NOT COMPLETED|Second Intervention||0
363145|NCT00440505|882183|P5|NOT COMPLETED|Second Intervention||0
363146|NCT00440505|882184|P4|NOT COMPLETED|Second Intervention||0
363147|NCT00440505|882185|P3|NOT COMPLETED|Second Intervention||0
363148|NCT00440505|882186|P2|NOT COMPLETED|Second Intervention||0
363149|NCT00440505|882187|P1|NOT COMPLETED|Second Intervention||0
363150|NCT00440505|882182|P6|COMPLETED|Second Intervention||5
363151|NCT00440505|882183|P5|COMPLETED|Second Intervention||5
363152|NCT00440505|882184|P4|COMPLETED|Second Intervention||2
363153|NCT00440505|882185|P3|COMPLETED|Second Intervention||1
363154|NCT00440505|882186|P2|COMPLETED|Second Intervention||2
363155|NCT00440505|882187|P1|COMPLETED|Second Intervention||5
363156|NCT00440505|882182|P6|STARTED|Second Intervention||5
363157|NCT00440505|882183|P5|STARTED|Second Intervention||5
363158|NCT00440505|882184|P4|STARTED|Second Intervention||2
363159|NCT00440505|882185|P3|STARTED|Second Intervention||1
363160|NCT00440505|882186|P2|STARTED|Second Intervention||2
363161|NCT00440505|882187|P1|STARTED|Second Intervention||5
363162|NCT00440505|882182|P6|NOT COMPLETED|First Intervention||0
363163|NCT00440505|882183|P5|NOT COMPLETED|First Intervention||0
363164|NCT00440505|882184|P4|NOT COMPLETED|First Intervention||0
363165|NCT00440505|882185|P3|NOT COMPLETED|First Intervention||0
363166|NCT00440505|882186|P2|NOT COMPLETED|First Intervention||0
363167|NCT00440505|882187|P1|NOT COMPLETED|First Intervention||0
363168|NCT00440505|882182|P6|COMPLETED|First Intervention||5
363169|NCT00440505|882183|P5|COMPLETED|First Intervention||5
363170|NCT00440505|882184|P4|COMPLETED|First Intervention||2
363171|NCT00440505|882185|P3|COMPLETED|First Intervention||1
363172|NCT00440505|882186|P2|COMPLETED|First Intervention||2
363173|NCT00440505|882187|P1|COMPLETED|First Intervention||5
363174|NCT00440505|882182|P6|STARTED|First Intervention||5
363175|NCT00440505|882183|P5|STARTED|First Intervention||5
363176|NCT00440505|882184|P4|STARTED|First Intervention||2
363177|NCT00440505|882185|P3|STARTED|First Intervention||1
363178|NCT00440505|882186|P2|STARTED|First Intervention||2
363179|NCT00440505|882187|P1|STARTED|First Intervention||5
363180|NCT00440466|882207|P3|NOT COMPLETED|Overall Study||41
363181|NCT00440466|882208|P2|NOT COMPLETED|Overall Study||15
363182|NCT00440466|882209|P1|NOT COMPLETED|Overall Study||13
363183|NCT00440466|882207|P3|COMPLETED|Overall Study||174
363184|NCT00440466|882208|P2|COMPLETED|Overall Study||92
363185|NCT00440466|882209|P1|COMPLETED|Overall Study||95
363186|NCT00440466|882207|P3|STARTED|Overall Study||215
363187|NCT00440466|882208|P2|STARTED|Overall Study||107
363188|NCT00440466|882209|P1|STARTED|Overall Study||108
363189|NCT00440401|882243|P2|NOT COMPLETED|Overall Study||6
363190|NCT00440401|882244|P1|NOT COMPLETED|Overall Study||4
363191|NCT00440401|882243|P2|COMPLETED|Overall Study||54
363192|NCT00440401|882244|P1|COMPLETED|Overall Study||55
363193|NCT00440401|882243|P2|STARTED|Overall Study||60
363194|NCT00440401|882244|P1|STARTED|Overall Study||59
363195|NCT00440310|882254|P2|NOT COMPLETED|Overall Study||30
363196|NCT00440310|882255|P1|NOT COMPLETED|Overall Study||28
363197|NCT00440310|882254|P2|COMPLETED|Overall Study||209
363198|NCT00440310|882255|P1|COMPLETED|Overall Study||216
363199|NCT00440310|882254|P2|Treated|Overall Study||232
363200|NCT00440310|882255|P1|Treated|Overall Study||222
363201|NCT00440310|882254|P2|STARTED|Overall Study||239
363202|NCT00440310|882255|P1|STARTED|Overall Study||244
363203|NCT00440297|882263|P2|NOT COMPLETED|Overall Study||18
363204|NCT00440297|882264|P1|NOT COMPLETED|Overall Study||23
363205|NCT00440297|882263|P2|COMPLETED|Overall Study||120
363206|NCT00440297|882264|P1|COMPLETED|Overall Study||116
363207|NCT00440297|882263|P2|Vaccination Visit 4|Overall Study||122
363208|NCT00440297|882264|P1|Vaccination Visit 4|Overall Study||116
363209|NCT00440297|882263|P2|Vaccination Visit 3|Overall Study||125
363210|NCT00440297|882264|P1|Vaccination Visit 3|Overall Study||124
363211|NCT00440297|882263|P2|Vaccination Visit 2|Overall Study||134
363212|NCT00440297|882264|P1|Vaccination Visit 2|Overall Study||136
363213|NCT00440297|882263|P2|Vaccination Visit 1|Overall Study||138
363214|NCT00440297|882264|P1|Vaccination Visit 1|Overall Study||138
363215|NCT00440297|882263|P2|STARTED|Overall Study||138
363216|NCT00440297|882264|P1|STARTED|Overall Study||139
363217|NCT00440271|882280|P2|NOT COMPLETED|Overall Study||15
363218|NCT00440271|882281|P1|NOT COMPLETED|Overall Study||12
363219|NCT00440271|882280|P2|COMPLETED|Overall Study||3
363220|NCT00440271|882281|P1|COMPLETED|Overall Study||3
363221|NCT00440271|882280|P2|STARTED|Overall Study||18
363222|NCT00440271|882281|P1|STARTED|Overall Study||15
363223|NCT00440232|882315|P2|NOT COMPLETED|Overall Study||4
363224|NCT00440232|882316|P1|NOT COMPLETED|Overall Study||3
363225|NCT00440232|882315|P2|COMPLETED|Overall Study||34
363226|NCT00440232|882316|P1|COMPLETED|Overall Study||33
363227|NCT00440232|882315|P2|STARTED|Overall Study||38
363228|NCT00440232|882316|P1|STARTED|Overall Study||36
363229|NCT00440193|882326|P2|NOT COMPLETED|Observational Period||38
363230|NCT00440193|882327|P1|NOT COMPLETED|Observational Period||45
363231|NCT00440193|882326|P2|COMPLETED|Observational Period||1369
363232|NCT00440193|882327|P1|COMPLETED|Observational Period||1380
363233|NCT00440193|882326|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1407
363234|NCT00440193|882327|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1425
363235|NCT00440193|882326|P2|NOT COMPLETED|Treatment Period||351
363236|NCT00440193|882327|P1|NOT COMPLETED|Treatment Period||305
363237|NCT00440193|882326|P2|COMPLETED|Treatment Period||1367
363238|NCT00440193|882327|P1|COMPLETED|Treatment Period||1426
363239|NCT00440193|882326|P2|Participants Received Treatment|Treatment Period||1711
363240|NCT00440193|882327|P1|Participants Received Treatment|Treatment Period||1718
363241|NCT00440193|882326|P2|STARTED|Treatment Period||1718
363242|NCT00440193|882327|P1|STARTED|Treatment Period||1731
363243|NCT00440180|882363|P2|NOT COMPLETED|Overall Study||0
363244|NCT00440180|882364|P1|NOT COMPLETED|Overall Study||0
363245|NCT00440180|882363|P2|COMPLETED|Overall Study||10
363246|NCT00440180|882364|P1|COMPLETED|Overall Study||10
363247|NCT00440180|882363|P2|STARTED|Overall Study||10
363248|NCT00440180|882364|P1|STARTED|Overall Study||10
363249|NCT00440115|882373|P3|NOT COMPLETED|Overall Study||6
363250|NCT00440115|882374|P2|NOT COMPLETED|Overall Study||11
363251|NCT00440115|882375|P1|NOT COMPLETED|Overall Study||7
363252|NCT00440115|882373|P3|COMPLETED|Overall Study||244
363253|NCT00440115|882374|P2|COMPLETED|Overall Study||238
363254|NCT00440115|882375|P1|COMPLETED|Overall Study||244
363255|NCT00440115|882373|P3|STARTED|Overall Study||250
363256|NCT00440115|882374|P2|STARTED|Overall Study||249
363257|NCT00440115|882375|P1|STARTED|Overall Study||251
363258|NCT00440050|882391|P2|NOT COMPLETED|Overall Study||67
363259|NCT00440050|882392|P1|NOT COMPLETED|Overall Study||40
363260|NCT00440050|882391|P2|COMPLETED|Overall Study||171
363261|NCT00440050|882392|P1|COMPLETED|Overall Study||124
363262|NCT00440050|882391|P2|STARTED|Overall Study||238
363263|NCT00440050|882392|P1|STARTED|Overall Study||164
363264|NCT00440011|882406|P2|NOT COMPLETED|Overall Study||3
363265|NCT00440011|882407|P1|NOT COMPLETED|Overall Study||4
363266|NCT00440011|882406|P2|COMPLETED|Overall Study||132
363267|NCT00440011|882407|P1|COMPLETED|Overall Study||127
363268|NCT00440011|882406|P2|STARTED|Overall Study||135
363269|NCT00440011|882407|P1|STARTED|Overall Study||131
363270|NCT00439946|882415|P1|NOT COMPLETED|Overall Study||0
363271|NCT00439946|882415|P1|COMPLETED|Overall Study||8
363272|NCT00439946|882415|P1|STARTED|Overall Study||8
363273|NCT00439777|882434|P2|NOT COMPLETED|Observational Period||41
363274|NCT00439777|882435|P1|NOT COMPLETED|Observational Period||41
363275|NCT00439777|882434|P2|COMPLETED|Observational Period||2156
363276|NCT00439777|882435|P1|COMPLETED|Observational Period||2165
363277|NCT00439777|882434|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2197
363278|NCT00439777|882435|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2206
363279|NCT00439777|882434|P2|NOT COMPLETED|Treatment Period||459
363280|NCT00439777|882435|P1|NOT COMPLETED|Treatment Period||419
363281|NCT00439777|882434|P2|COMPLETED|Treatment Period||1954
363282|NCT00439777|882435|P1|COMPLETED|Treatment Period||2001
363283|NCT00439777|882434|P2|Participants Received Treatment|Treatment Period||2405
363284|NCT00439777|882435|P1|Participants Received Treatment|Treatment Period||2412
363285|NCT00439777|882434|P2|STARTED|Treatment Period||2413
363286|NCT00439777|882435|P1|STARTED|Treatment Period||2420
363287|NCT00439738|882473|P2|NOT COMPLETED|Overall Study||28
363288|NCT00439738|882474|P1|NOT COMPLETED|Overall Study||36
363289|NCT00439738|882473|P2|COMPLETED|Overall Study||178
363290|NCT00439738|882474|P1|COMPLETED|Overall Study||170
363291|NCT00439738|882473|P2|STARTED|Overall Study||206
363292|NCT00439738|882474|P1|STARTED|Overall Study||206
363293|NCT00439725|882492|P2|NOT COMPLETED|Observational Period||7
363294|NCT00439725|882493|P1|NOT COMPLETED|Observational Period||8
363295|NCT00439725|882492|P2|COMPLETED|Observational Period||553
363296|NCT00439725|882493|P1|COMPLETED|Observational Period||569
363297|NCT00439725|882492|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|560
363298|NCT00439725|882493|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|577
363299|NCT00439725|882492|P2|NOT COMPLETED|Treatment Period||246
363300|NCT00439725|882493|P1|NOT COMPLETED|Treatment Period||236
363301|NCT00439725|882492|P2|COMPLETED|Treatment Period||349
363302|NCT00439725|882493|P1|COMPLETED|Treatment Period||366
363303|NCT00439725|882492|P2|Participants Received Treatment|Treatment Period|Safety population|590
363304|NCT00439725|882493|P1|Participants Received Treatment|Treatment Period|Safety population|598
363305|NCT00439725|882492|P2|STARTED|Treatment Period||595
363306|NCT00439725|882493|P1|STARTED|Treatment Period||602
363307|NCT00439673|882537|P1|NOT COMPLETED|Overall Study||36
363308|NCT00439673|882537|P1|COMPLETED|Overall Study||26
363309|NCT00439673|882537|P1|STARTED|Overall Study||62
363310|NCT00439647|882544|P2|NOT COMPLETED|Overall Study||71
363311|NCT00439647|882545|P1|NOT COMPLETED|Overall Study||58
363312|NCT00439647|882544|P2|COMPLETED|Overall Study||540
363313|NCT00439647|882545|P1|COMPLETED|Overall Study||530
363314|NCT00439647|882544|P2|Modified Intent to Treat (mITT)|Overall Study||574
363315|NCT00439647|882545|P1|Modified Intent to Treat (mITT)|Overall Study||553
363316|NCT00439647|882544|P2|STARTED|Overall Study||611
363317|NCT00439647|882545|P1|STARTED|Overall Study|"Started indicates intent to treat (ITT) and safety set."|588
363318|NCT00439608|882577|P1|NOT COMPLETED|Overall Study||0
363319|NCT00439608|882577|P1|COMPLETED|Overall Study||60
363320|NCT00439608|882577|P1|STARTED|Overall Study||60
363321|NCT00439569|882582|P1|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||1
363322|NCT00439569|882582|P1|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
363323|NCT00439569|882582|P1|STARTED|Cohort 2 (500 mg/kg/Day)|2 new subjects in Cohort 2 were enrolled into the study after Cohort 1 completed the study.|2
363324|NCT00439569|882582|P1|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||4
363325|NCT00439569|882582|P1|COMPLETED|Cohort 1 (500 mg/kg/Day)||3
363326|NCT00439569|882582|P1|STARTED|Cohort 1 (500 mg/kg/Day)||7
363327|NCT00439556|882596|P3|NOT COMPLETED|Overall Study||0
363328|NCT00439556|882597|P2|NOT COMPLETED|Overall Study||1
363329|NCT00439556|882598|P1|NOT COMPLETED|Overall Study||0
363330|NCT00439556|882596|P3|COMPLETED|Overall Study||0
363331|NCT00439556|882597|P2|COMPLETED|Overall Study||3
363332|NCT00439556|882598|P1|COMPLETED|Overall Study||36
363333|NCT00439556|882596|P3|STARTED|Overall Study||0
363334|NCT00439556|882597|P2|STARTED|Overall Study||4
363335|NCT00439556|882598|P1|STARTED|Overall Study||36
363336|NCT00439517|882611|P2|NOT COMPLETED|Overall Study||0
363337|NCT00439517|882612|P1|NOT COMPLETED|Overall Study||2
363338|NCT00439517|882611|P2|COMPLETED|Overall Study||150
363339|NCT00439517|882612|P1|COMPLETED|Overall Study||150
363340|NCT00439517|882611|P2|STARTED|Overall Study||150
363341|NCT00439517|882612|P1|STARTED|Overall Study||152
363342|NCT00439465|882634|P1|NOT COMPLETED|Overall Study||4
363343|NCT00439465|882634|P1|COMPLETED|Overall Study||19
363344|NCT00439465|882634|P1|STARTED|Overall Study||23
363345|NCT00439413|882646|P2|NOT COMPLETED|Overall Study||37
363346|NCT00439413|882647|P1|NOT COMPLETED|Overall Study||31
363347|NCT00439413|882646|P2|COMPLETED|Overall Study||88
363348|NCT00439413|882647|P1|COMPLETED|Overall Study||90
363349|NCT00439413|882646|P2|STARTED|Overall Study||125
363350|NCT00439413|882647|P1|STARTED|Overall Study||121
363351|NCT00439374|882657|P2|NOT COMPLETED|Overall Study||0
363352|NCT00439374|882658|P1|NOT COMPLETED|Overall Study||0
363353|NCT00439374|882657|P2|COMPLETED|Overall Study||330
363354|NCT00439374|882658|P1|COMPLETED|Overall Study||327
363355|NCT00439374|882657|P2|STARTED|Overall Study||330
363356|NCT00439374|882658|P1|STARTED|Overall Study||327
363357|NCT00439335|882718|P2|NOT COMPLETED|Overall Study||0
363358|NCT00439335|882719|P1|NOT COMPLETED|Overall Study||2
363359|NCT00439335|882718|P2|COMPLETED|Overall Study||114
363360|NCT00439335|882719|P1|COMPLETED|Overall Study||111
363361|NCT00439335|882718|P2|STARTED|Overall Study||114
363362|NCT00439335|882719|P1|STARTED|Overall Study||113
363363|NCT00439309|882751|P2|NOT COMPLETED|Follow-Up||2
363364|NCT00439309|882752|P1|NOT COMPLETED|Follow-Up||3
363365|NCT00439309|882751|P2|COMPLETED|Follow-Up||13
363366|NCT00439309|882752|P1|COMPLETED|Follow-Up||51
363367|NCT00439309|882751|P2|STARTED|Follow-Up||15
363368|NCT00439309|882752|P1|STARTED|Follow-Up||54
363369|NCT00439309|882751|P2|NOT COMPLETED|Treatment||0
363370|NCT00439309|882752|P1|NOT COMPLETED|Treatment||0
363371|NCT00439309|882751|P2|COMPLETED|Treatment||15
363372|NCT00439309|882752|P1|COMPLETED|Treatment||54
363373|NCT00439309|882751|P2|STARTED|Treatment||15
363374|NCT00439309|882752|P1|STARTED|Treatment||54
363375|NCT00439270|882771|P5|NOT COMPLETED|Phase 2 (51.6 Months)||0
363376|NCT00439270|882772|P4|NOT COMPLETED|Phase 2 (51.6 Months)||34
363377|NCT00439270|882773|P3|NOT COMPLETED|Phase 2 (51.6 Months)||0
363378|NCT00439270|882774|P2|NOT COMPLETED|Phase 2 (51.6 Months)||0
363379|NCT00439270|882775|P1|NOT COMPLETED|Phase 2 (51.6 Months)||0
363380|NCT00439270|882771|P5|COMPLETED|Phase 2 (51.6 Months)||0
363381|NCT00439270|882772|P4|COMPLETED|Phase 2 (51.6 Months)||0
363382|NCT00439270|882773|P3|COMPLETED|Phase 2 (51.6 Months)||0
363383|NCT00439270|882774|P2|COMPLETED|Phase 2 (51.6 Months)||0
363384|NCT00439270|882775|P1|COMPLETED|Phase 2 (51.6 Months)||0
363385|NCT00439270|882771|P5|STARTED|Phase 2 (51.6 Months)||0
363386|NCT00439270|882772|P4|STARTED|Phase 2 (51.6 Months)|Includes 4 patients who completed Phase 1|34
363387|NCT00439270|882773|P3|STARTED|Phase 2 (51.6 Months)||0
363388|NCT00439270|882774|P2|STARTED|Phase 2 (51.6 Months)||0
363389|NCT00439270|882775|P1|STARTED|Phase 2 (51.6 Months)||0
363390|NCT00439270|882771|P5|NOT COMPLETED|Phase 1 (18.1 Months)||3
363391|NCT00439270|882772|P4|NOT COMPLETED|Phase 1 (18.1 Months)||0
363392|NCT00439270|882773|P3|NOT COMPLETED|Phase 1 (18.1 Months)||3
363393|NCT00439270|882774|P2|NOT COMPLETED|Phase 1 (18.1 Months)||3
363394|NCT00439270|882775|P1|NOT COMPLETED|Phase 1 (18.1 Months)||3
363395|NCT00439270|882771|P5|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
363396|NCT00439270|882772|P4|COMPLETED|Phase 1 (18.1 Months)|Remained on study|4
363397|NCT00439270|882773|P3|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
363398|NCT00439270|882774|P2|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
363399|NCT00439270|882775|P1|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
363400|NCT00439270|882771|P5|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
363401|NCT00439270|882772|P4|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|4
363402|NCT00439270|882773|P3|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
363403|NCT00439270|882774|P2|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
363404|NCT00439270|882775|P1|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
363405|NCT00439244|882817|P3|NOT COMPLETED|Overall Study||7
363406|NCT00439244|882818|P2|NOT COMPLETED|Overall Study||6
363407|NCT00439244|882819|P1|NOT COMPLETED|Overall Study||11
363408|NCT00439244|882817|P3|COMPLETED|Overall Study||131
363409|NCT00439244|882818|P2|COMPLETED|Overall Study||131
363410|NCT00439244|882819|P1|COMPLETED|Overall Study||126
363411|NCT00439244|882817|P3|Safety Population|Overall Study||137
363412|NCT00439244|882818|P2|Safety Population|Overall Study||137
363413|NCT00439244|882819|P1|Safety Population|Overall Study|Total safety population is 411. One patient was randomized, but never received any study medication.|137
363414|NCT00439244|882817|P3|STARTED|Overall Study||138
363415|NCT00439244|882818|P2|STARTED|Overall Study||137
363416|NCT00439244|882819|P1|STARTED|Overall Study|"Started indicates randomized as well as intent to treat (ITT) population enrolled to study."|137
363417|NCT00439231|882839|P1|NOT COMPLETED|Overall Study||28
363418|NCT00439231|882839|P1|COMPLETED|Overall Study|5 subjects had a partial response, 0 complete response, 28 completed off study,|5
363419|NCT00439231|882839|P1|STARTED|Overall Study||33
363420|NCT00439218|882843|P1|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||0
363421|NCT00439218|882843|P1|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
363422|NCT00439218|882843|P1|STARTED|Cohort 2 (500 mg/kg/Day)|One new subject was enrolled into the study after Cohort 1 completed the study.|1
363423|NCT00439218|882843|P1|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||1
363424|NCT00439218|882843|P1|COMPLETED|Cohort 1 (500 mg/kg/Day)|3 subjects completed the study in Cohort 1. Cohort 2 was then opened for new enrollments.|3
363425|NCT00439218|882843|P1|STARTED|Cohort 1 (500 mg/kg/Day)||4
363426|NCT00439179|882858|P4|NOT COMPLETED|Overall Study||0
363427|NCT00439179|882859|P3|NOT COMPLETED|Overall Study||0
363428|NCT00439179|882860|P2|NOT COMPLETED|Overall Study||2
363429|NCT00439179|882861|P1|NOT COMPLETED|Overall Study||0
363430|NCT00439179|882858|P4|COMPLETED|Overall Study||5
363431|NCT00439179|882859|P3|COMPLETED|Overall Study||6
363432|NCT00439179|882860|P2|COMPLETED|Overall Study||11
363433|NCT00439179|882861|P1|COMPLETED|Overall Study||3
363434|NCT00439179|882858|P4|STARTED|Overall Study|2 with biliry|5
363435|NCT00439179|882859|P3|STARTED|Overall Study|2 with biliary|6
363436|NCT00439179|882860|P2|STARTED|Overall Study|2 with biliary|13
363437|NCT00439179|882861|P1|STARTED|Overall Study|1 with biliary|3
363438|NCT00439140|882878|P3|NOT COMPLETED|Treatment Cycle 2||0
363439|NCT00439140|882879|P2|NOT COMPLETED|Treatment Cycle 2||1
363440|NCT00439140|882880|P1|NOT COMPLETED|Treatment Cycle 2||2
363441|NCT00439140|882878|P3|COMPLETED|Treatment Cycle 2||0
363442|NCT00439140|882879|P2|COMPLETED|Treatment Cycle 2||6
363443|NCT00439140|882880|P1|COMPLETED|Treatment Cycle 2||11
363444|NCT00439140|882878|P3|STARTED|Treatment Cycle 2|No patients received placebo in Cycle 2.|0
363445|NCT00439140|882879|P2|STARTED|Treatment Cycle 2|6 patients from the 300U arm plus 1 patient from the placebo arm in Cycle 1 entered Cycle 2.|7
363446|NCT00439140|882880|P1|STARTED|Treatment Cycle 2|8 patients from the 200U arm plus 5 patients from the placebo arm in Cycle 1 entered Cycle 2.|13
363447|NCT00439140|882878|P3|NOT COMPLETED|Treatment Cycle 1||1
363448|NCT00439140|882879|P2|NOT COMPLETED|Treatment Cycle 1||4
363449|NCT00439140|882880|P1|NOT COMPLETED|Treatment Cycle 1||1
363450|NCT00439140|882878|P3|COMPLETED|Treatment Cycle 1|5 patients did not enter Cycle 2. 6 patients received botulinum toxin Type A in Cycle 2.|11
363451|NCT00439140|882879|P2|COMPLETED|Treatment Cycle 1||10
363452|NCT00439140|882880|P1|COMPLETED|Treatment Cycle 1||14
363453|NCT00439140|882878|P3|STARTED|Treatment Cycle 1||12
363454|NCT00439140|882879|P2|STARTED|Treatment Cycle 1||14
363455|NCT00439140|882880|P1|STARTED|Treatment Cycle 1||15
363456|NCT00438971|882909|P1|NOT COMPLETED|Overall Study||2
363457|NCT00438971|882909|P1|COMPLETED|Overall Study||15
363458|NCT00438971|882909|P1|STARTED|Overall Study||17
363459|NCT00438932|882924|P4|NOT COMPLETED|Overall Study||0
363460|NCT00438932|882925|P3|NOT COMPLETED|Overall Study||0
363461|NCT00438932|882926|P2|NOT COMPLETED|Overall Study||0
363462|NCT00438932|882927|P1|NOT COMPLETED|Overall Study||0
363463|NCT00438932|882924|P4|COMPLETED|Overall Study||4
363464|NCT00438932|882925|P3|COMPLETED|Overall Study||4
363465|NCT00438932|882926|P2|COMPLETED|Overall Study||4
363466|NCT00438932|882927|P1|COMPLETED|Overall Study||4
363467|NCT00438932|882924|P4|STARTED|Overall Study||4
363468|NCT00438932|882925|P3|STARTED|Overall Study||4
363469|NCT00438932|882926|P2|STARTED|Overall Study||4
363470|NCT00438932|882927|P1|STARTED|Overall Study||4
363471|NCT00438880|882943|P2|NOT COMPLETED|Overall Study||0
363472|NCT00438880|882944|P1|NOT COMPLETED|Overall Study||0
363473|NCT00438880|882943|P2|COMPLETED|Overall Study||8
363474|NCT00438880|882944|P1|COMPLETED|Overall Study||30
363475|NCT00438880|882943|P2|STARTED|Overall Study||8
363476|NCT00438880|882944|P1|STARTED|Overall Study||30
363477|NCT00438854|882956|P1|NOT COMPLETED|Overall Study||0
363478|NCT00438854|882956|P1|COMPLETED|Overall Study||15
363479|NCT00438854|882956|P1|STARTED|Overall Study||15
363480|NCT00438815|882963|P1|NOT COMPLETED|Overall Study||70
363481|NCT00438815|882963|P1|COMPLETED|Overall Study||43
363482|NCT00438815|882963|P1|STARTED|Overall Study||113
363483|NCT00438802|882976|P3|NOT COMPLETED|Overall Study||0
363484|NCT00438802|882977|P2|NOT COMPLETED|Overall Study||0
363485|NCT00438802|882978|P1|NOT COMPLETED|Overall Study||0
363486|NCT00438802|882976|P3|COMPLETED|Overall Study||9
363487|NCT00438802|882977|P2|COMPLETED|Overall Study||8
363488|NCT00438802|882978|P1|COMPLETED|Overall Study||6
363489|NCT00438802|882976|P3|STARTED|Overall Study||9
363490|NCT00438802|882977|P2|STARTED|Overall Study||8
363491|NCT00438802|882978|P1|STARTED|Overall Study||6
363492|NCT00438750|882992|P2|NOT COMPLETED|Overall Study||9
363493|NCT00438750|882993|P1|NOT COMPLETED|Overall Study||9
363494|NCT00438750|882992|P2|COMPLETED|Overall Study||37
363495|NCT00438750|882993|P1|COMPLETED|Overall Study||39
363496|NCT00438750|882992|P2|STARTED|Overall Study||46
363497|NCT00438750|882993|P1|STARTED|Overall Study||48
363498|NCT00438672|883013|P2|NOT COMPLETED|Overall Study||9
363499|NCT00438672|883014|P1|NOT COMPLETED|Overall Study||7
363500|NCT00438672|883013|P2|COMPLETED|Overall Study||24
363501|NCT00438672|883014|P1|COMPLETED|Overall Study||24
363502|NCT00438672|883013|P2|STARTED|Overall Study||33
363503|NCT00438672|883014|P1|STARTED|Overall Study||31
363504|NCT00438659|883024|P2|NOT COMPLETED|Overall Study||4
363505|NCT00438659|883025|P1|NOT COMPLETED|Overall Study||6
363506|NCT00438659|883024|P2|COMPLETED|Overall Study||82
363507|NCT00438659|883025|P1|COMPLETED|Overall Study||84
363508|NCT00438659|883024|P2|STARTED|Overall Study||86
363509|NCT00438659|883025|P1|STARTED|Overall Study||90
363510|NCT00438633|883049|P2|NOT COMPLETED|Overall Study||17
363511|NCT00438633|883050|P1|NOT COMPLETED|Overall Study||16
363512|NCT00438633|883049|P2|COMPLETED|Overall Study||14
363513|NCT00438633|883050|P1|COMPLETED|Overall Study||16
363514|NCT00438633|883049|P2|3-month Follow-up|Overall Study||24
363515|NCT00438633|883050|P1|3-month Follow-up|Overall Study||26
363516|NCT00438633|883049|P2|STARTED|Overall Study||31
363517|NCT00438633|883050|P1|STARTED|Overall Study||32
363518|NCT00438490|883066|P2|NOT COMPLETED|Overall Study||0
363519|NCT00438490|883067|P1|NOT COMPLETED|Overall Study||0
363520|NCT00438490|883066|P2|COMPLETED|Overall Study||9
363521|NCT00438490|883067|P1|COMPLETED|Overall Study||12
363522|NCT00438490|883066|P2|STARTED|Overall Study||9
363523|NCT00438490|883067|P1|STARTED|Overall Study||12
363524|NCT00438464|883081|P2|NOT COMPLETED|Overall Study||7
363525|NCT00438464|883082|P1|NOT COMPLETED|Overall Study||14
363526|NCT00438464|883081|P2|COMPLETED|Overall Study||94
363527|NCT00438464|883082|P1|COMPLETED|Overall Study||89
363528|NCT00438464|883081|P2|Received Assigned Intervention|Overall Study||94
363529|NCT00438464|883082|P1|Received Assigned Intervention|Overall Study||89
363530|NCT00438464|883081|P2|STARTED|Overall Study||101
363531|NCT00438464|883082|P1|STARTED|Overall Study||103
363532|NCT00438451|883137|P3|NOT COMPLETED|Overall Study||53
363533|NCT00438451|883138|P2|NOT COMPLETED|Overall Study||66
363534|NCT00438451|883139|P1|NOT COMPLETED|Overall Study||47
363535|NCT00438451|883137|P3|COMPLETED|Overall Study||65
363536|NCT00438451|883138|P2|COMPLETED|Overall Study||55
363537|NCT00438451|883139|P1|COMPLETED|Overall Study||75
363538|NCT00438451|883137|P3|Maintenance Phase (Week 7-58)|Overall Study||93
363539|NCT00438451|883138|P2|Maintenance Phase (Week 7-58)|Overall Study||89
363540|NCT00438451|883139|P1|Maintenance Phase (Week 7-58)|Overall Study||93
363541|NCT00438451|883137|P3|ITT Population|Overall Study||117
363542|NCT00438451|883138|P2|ITT Population|Overall Study||120
363543|NCT00438451|883139|P1|ITT Population|Overall Study||122
363544|NCT00438451|883137|P3|Safety Population|Overall Study||117
363545|NCT00438451|883138|P2|Safety Population|Overall Study||121
363546|NCT00438451|883139|P1|Safety Population|Overall Study||122
363547|NCT00438451|883137|P3|STARTED|Overall Study||118
363548|NCT00438451|883138|P2|STARTED|Overall Study||121
363549|NCT00438451|883139|P1|STARTED|Overall Study||122
363550|NCT00438399|883183|P6|NOT COMPLETED|Overall Study||6
363551|NCT00438399|883184|P5|NOT COMPLETED|Overall Study||3
363552|NCT00438399|883185|P4|NOT COMPLETED|Overall Study||4
363553|NCT00438399|883186|P3|NOT COMPLETED|Overall Study||7
363554|NCT00438399|883187|P2|NOT COMPLETED|Overall Study||8
363555|NCT00438399|883188|P1|NOT COMPLETED|Overall Study||8
363556|NCT00438399|883183|P6|COMPLETED|Overall Study||31
363557|NCT00438399|883184|P5|COMPLETED|Overall Study||30
363558|NCT00438399|883185|P4|COMPLETED|Overall Study||32
363559|NCT00438399|883186|P3|COMPLETED|Overall Study||28
363560|NCT00438399|883187|P2|COMPLETED|Overall Study||32
363561|NCT00438399|883188|P1|COMPLETED|Overall Study||30
363562|NCT00438399|883183|P6|TREATED & ANALYZED|Overall Study||31
363563|NCT00438399|883184|P5|TREATED & ANALYZED|Overall Study||30
363564|NCT00438399|883185|P4|TREATED & ANALYZED|Overall Study||32
363565|NCT00438399|883186|P3|TREATED & ANALYZED|Overall Study||28
363566|NCT00438399|883187|P2|TREATED & ANALYZED|Overall Study||32
363567|NCT00438399|883188|P1|TREATED & ANALYZED|Overall Study||30
363568|NCT00438399|883183|P6|STARTED|Overall Study||37
363569|NCT00438399|883184|P5|STARTED|Overall Study||33
363570|NCT00438399|883185|P4|STARTED|Overall Study||36
363571|NCT00438399|883186|P3|STARTED|Overall Study||35
363572|NCT00438399|883187|P2|STARTED|Overall Study||40
363573|NCT00438399|883188|P1|STARTED|Overall Study||38
363574|NCT00438360|883199|P2|NOT COMPLETED|Overall Study||43
363575|NCT00438360|883200|P1|NOT COMPLETED|Overall Study||72
363576|NCT00438360|883199|P2|COMPLETED|Overall Study||38
363577|NCT00438360|883200|P1|COMPLETED|Overall Study||90
363578|NCT00438360|883199|P2|Intention to Treat (ITT) Population|Overall Study||79
363579|NCT00438360|883200|P1|Intention to Treat (ITT) Population|Overall Study|These numbers are different from those started (randomized) as 2 pts from each arm never took drug.|160
363580|NCT00438360|883199|P2|STARTED|Overall Study||81
363581|NCT00438360|883200|P1|STARTED|Overall Study|"Started indicates randomized patients."|162
363582|NCT00438256|883214|P4|NOT COMPLETED|Overall Study||9
363583|NCT00438256|883215|P3|NOT COMPLETED|Overall Study||1
363584|NCT00438256|883216|P2|NOT COMPLETED|Overall Study||1
363585|NCT00438256|883217|P1|NOT COMPLETED|Overall Study||2
363586|NCT00438256|883214|P4|COMPLETED|Overall Study||32
363587|NCT00438256|883215|P3|COMPLETED|Overall Study||2
363588|NCT00438256|883216|P2|COMPLETED|Overall Study||2
363589|NCT00438256|883217|P1|COMPLETED|Overall Study||1
363590|NCT00438256|883214|P4|Surgical Resection|Overall Study||34
363591|NCT00438256|883215|P3|Surgical Resection|Overall Study||2
363592|NCT00438256|883216|P2|Surgical Resection|Overall Study||2
363593|NCT00438256|883217|P1|Surgical Resection|Overall Study||1
363594|NCT00438256|883214|P4|STARTED|Overall Study||41
363595|NCT00438256|883215|P3|STARTED|Overall Study||3
363596|NCT00438256|883216|P2|STARTED|Overall Study||3
363597|NCT00438256|883217|P1|STARTED|Overall Study||3
363598|NCT00438204|883233|P1|NOT COMPLETED|Overall Study||0
363599|NCT00438204|883233|P1|COMPLETED|Overall Study||39
363600|NCT00438204|883233|P1|STARTED|Overall Study||39
363601|NCT00438191|883243|P2|NOT COMPLETED|Overall Study||14
363602|NCT00438191|883244|P1|NOT COMPLETED|Overall Study||11
363603|NCT00438191|883243|P2|COMPLETED|Overall Study||26
363604|NCT00438191|883244|P1|COMPLETED|Overall Study||32
363605|NCT00438191|883243|P2|STARTED|Overall Study||40
363606|NCT00438191|883244|P1|STARTED|Overall Study||43
363607|NCT00438100|883258|P2|NOT COMPLETED|Overall Study||4
363608|NCT00438100|883259|P1|NOT COMPLETED|Overall Study||2
363609|NCT00438100|883258|P2|COMPLETED|Overall Study||65
363610|NCT00438100|883259|P1|COMPLETED|Overall Study||71
363611|NCT00438100|883258|P2|STARTED|Overall Study||69
363612|NCT00438100|883259|P1|STARTED|Overall Study||73
363613|NCT00437983|883267|P2|NOT COMPLETED|Overall Study||13
363614|NCT00437983|883268|P1|NOT COMPLETED|Overall Study||13
363615|NCT00437983|883267|P2|COMPLETED|Overall Study||65
363616|NCT00437983|883268|P1|COMPLETED|Overall Study||66
363617|NCT00437983|883267|P2|STARTED|Overall Study||78
363618|NCT00437983|883268|P1|STARTED|Overall Study||79
363619|NCT00437658|883281|P3|NOT COMPLETED|Post-treatment Period (24 Weeks)||14
363620|NCT00437658|883282|P2|NOT COMPLETED|Post-treatment Period (24 Weeks)||8
363621|NCT00437658|883283|P1|NOT COMPLETED|Post-treatment Period (24 Weeks)||24
363622|NCT00437658|883281|P3|COMPLETED|Post-treatment Period (24 Weeks)||37
363623|NCT00437658|883282|P2|COMPLETED|Post-treatment Period (24 Weeks)||54
363624|NCT00437658|883283|P1|COMPLETED|Post-treatment Period (24 Weeks)||32
363625|NCT00437658|883281|P3|STARTED|Post-treatment Period (24 Weeks)||51
363626|NCT00437658|883282|P2|STARTED|Post-treatment Period (24 Weeks)||62
363627|NCT00437658|883283|P1|STARTED|Post-treatment Period (24 Weeks)||56
363628|NCT00437658|883281|P3|NOT COMPLETED|Treatment Period (24 Weeks)||33
363629|NCT00437658|883282|P2|NOT COMPLETED|Treatment Period (24 Weeks)||22
363630|NCT00437658|883283|P1|NOT COMPLETED|Treatment Period (24 Weeks)||28
363631|NCT00437658|883281|P3|COMPLETED|Treatment Period (24 Weeks)||51
363632|NCT00437658|883282|P2|COMPLETED|Treatment Period (24 Weeks)||62
363633|NCT00437658|883283|P1|COMPLETED|Treatment Period (24 Weeks)||56
363634|NCT00437658|883281|P3|Received Study Drug|Treatment Period (24 Weeks)||84
363635|NCT00437658|883282|P2|Received Study Drug|Treatment Period (24 Weeks)||84
363636|NCT00437658|883283|P1|Received Study Drug|Treatment Period (24 Weeks)||84
363637|NCT00437658|883281|P3|STARTED|Treatment Period (24 Weeks)||84
363638|NCT00437658|883282|P2|STARTED|Treatment Period (24 Weeks)||84
363639|NCT00437658|883283|P1|STARTED|Treatment Period (24 Weeks)||84
363640|NCT00437645|883377|P2|NOT COMPLETED|Overall Study||115
363641|NCT00437645|883378|P1|NOT COMPLETED|Overall Study||35
363642|NCT00437645|883377|P2|COMPLETED|Overall Study||476
363643|NCT00437645|883378|P1|COMPLETED|Overall Study||557
363644|NCT00437645|883377|P2|STARTED|Overall Study||591
363645|NCT00437645|883378|P1|STARTED|Overall Study||592
363646|NCT00437489|883394|P2|NOT COMPLETED|Overall Study||22
363647|NCT00437489|883395|P1|NOT COMPLETED|Overall Study||23
363648|NCT00437489|883394|P2|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
363649|NCT00437489|883395|P1|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
363650|NCT00437489|883394|P2|STARTED|Overall Study||24
363651|NCT00437489|883395|P1|STARTED|Overall Study||25
363652|NCT00437398|883407|P1|NOT COMPLETED|Overall Study||0
363653|NCT00437398|883407|P1|COMPLETED|Overall Study||2
363654|NCT00437398|883407|P1|STARTED|Overall Study||2
363655|NCT00437281|883432|P20|NOT COMPLETED|Overall Study||1
363656|NCT00437281|883433|P19|NOT COMPLETED|Overall Study||1
363657|NCT00437281|883434|P18|NOT COMPLETED|Overall Study||0
363658|NCT00437281|883435|P17|NOT COMPLETED|Overall Study||0
363659|NCT00437281|883436|P16|NOT COMPLETED|Overall Study||0
363660|NCT00437281|883437|P15|NOT COMPLETED|Overall Study||1
363661|NCT00437281|883438|P14|NOT COMPLETED|Overall Study||1
363662|NCT00437281|883439|P13|NOT COMPLETED|Overall Study||0
363663|NCT00437281|883440|P12|NOT COMPLETED|Overall Study||0
363664|NCT00437281|883441|P11|NOT COMPLETED|Overall Study||0
363665|NCT00437281|883442|P10|NOT COMPLETED|Overall Study||1
363666|NCT00437281|883443|P9|NOT COMPLETED|Overall Study||0
363667|NCT00437281|883444|P8|NOT COMPLETED|Overall Study||0
363668|NCT00437281|883445|P7|NOT COMPLETED|Overall Study||0
363669|NCT00437281|883446|P6|NOT COMPLETED|Overall Study||1
363670|NCT00437281|883447|P5|NOT COMPLETED|Overall Study||0
363671|NCT00437281|883448|P4|NOT COMPLETED|Overall Study||1
363672|NCT00437281|883449|P3|NOT COMPLETED|Overall Study||0
363673|NCT00437281|883450|P2|NOT COMPLETED|Overall Study||0
363674|NCT00437281|883451|P1|NOT COMPLETED|Overall Study||0
363675|NCT00437281|883432|P20|COMPLETED|Overall Study||2
363676|NCT00437281|883433|P19|COMPLETED|Overall Study||1
363677|NCT00437281|883434|P18|COMPLETED|Overall Study||4
363678|NCT00437281|883435|P17|COMPLETED|Overall Study||3
363679|NCT00437281|883436|P16|COMPLETED|Overall Study||3
363680|NCT00437281|883437|P15|COMPLETED|Overall Study||4
363681|NCT00437281|883438|P14|COMPLETED|Overall Study||2
363682|NCT00437281|883439|P13|COMPLETED|Overall Study||2
363683|NCT00437281|883440|P12|COMPLETED|Overall Study||3
363684|NCT00437281|883441|P11|COMPLETED|Overall Study||3
363685|NCT00437281|883442|P10|COMPLETED|Overall Study||4
363686|NCT00437281|883443|P9|COMPLETED|Overall Study||3
363687|NCT00437281|883444|P8|COMPLETED|Overall Study||3
363688|NCT00437281|883445|P7|COMPLETED|Overall Study||3
363689|NCT00437281|883446|P6|COMPLETED|Overall Study||3
363690|NCT00437281|883447|P5|COMPLETED|Overall Study||4
363691|NCT00437281|883448|P4|COMPLETED|Overall Study||2
363692|NCT00437281|883449|P3|COMPLETED|Overall Study||3
363693|NCT00437281|883450|P2|COMPLETED|Overall Study||3
363694|NCT00437281|883451|P1|COMPLETED|Overall Study||3
363695|NCT00437281|883432|P20|STARTED|Overall Study||3
363696|NCT00437281|883433|P19|STARTED|Overall Study||2
363697|NCT00437281|883434|P18|STARTED|Overall Study||4
363698|NCT00437281|883435|P17|STARTED|Overall Study||3
363699|NCT00437281|883436|P16|STARTED|Overall Study||3
363700|NCT00437281|883437|P15|STARTED|Overall Study||5
363701|NCT00437281|883438|P14|STARTED|Overall Study||3
363702|NCT00437281|883439|P13|STARTED|Overall Study||2
363703|NCT00437281|883440|P12|STARTED|Overall Study||3
363704|NCT00437281|883441|P11|STARTED|Overall Study||3
363705|NCT00437281|883442|P10|STARTED|Overall Study||5
363706|NCT00437281|883443|P9|STARTED|Overall Study||3
363707|NCT00437281|883444|P8|STARTED|Overall Study||3
363708|NCT00437281|883445|P7|STARTED|Overall Study||3
363709|NCT00437281|883446|P6|STARTED|Overall Study||4
363710|NCT00437281|883447|P5|STARTED|Overall Study||4
363711|NCT00437281|883448|P4|STARTED|Overall Study||3
363712|NCT00437281|883449|P3|STARTED|Overall Study||3
363713|NCT00437281|883450|P2|STARTED|Overall Study||3
363714|NCT00437281|883451|P1|STARTED|Overall Study||3
363715|NCT00437203|883755|P10|NOT COMPLETED|Overall Study||4
363716|NCT00437203|883756|P9|NOT COMPLETED|Overall Study||3
363717|NCT00437203|883757|P8|NOT COMPLETED|Overall Study||3
363718|NCT00437203|883758|P7|NOT COMPLETED|Overall Study||7
363719|NCT00437203|883759|P6|NOT COMPLETED|Overall Study||3
363720|NCT00437203|883760|P5|NOT COMPLETED|Overall Study||3
363721|NCT00437203|883761|P4|NOT COMPLETED|Overall Study||3
363722|NCT00437203|883762|P3|NOT COMPLETED|Overall Study||3
363723|NCT00437203|883763|P2|NOT COMPLETED|Overall Study||8
363724|NCT00437203|883764|P1|NOT COMPLETED|Overall Study||6
363725|NCT00437203|883755|P10|COMPLETED|Overall Study||0
363726|NCT00437203|883756|P9|COMPLETED|Overall Study||0
363727|NCT00437203|883757|P8|COMPLETED|Overall Study||0
363728|NCT00437203|883758|P7|COMPLETED|Overall Study||0
363729|NCT00437203|883759|P6|COMPLETED|Overall Study||0
363730|NCT00437203|883760|P5|COMPLETED|Overall Study||0
363731|NCT00437203|883761|P4|COMPLETED|Overall Study||0
363732|NCT00437203|883762|P3|COMPLETED|Overall Study||0
363733|NCT00437203|883763|P2|COMPLETED|Overall Study||0
363734|NCT00437203|883764|P1|COMPLETED|Overall Study||0
363735|NCT00437203|883755|P10|STARTED|Overall Study||4
363736|NCT00437203|883756|P9|STARTED|Overall Study||3
363737|NCT00437203|883757|P8|STARTED|Overall Study||3
363738|NCT00437203|883758|P7|STARTED|Overall Study||7
363739|NCT00437203|883759|P6|STARTED|Overall Study||3
363740|NCT00437203|883760|P5|STARTED|Overall Study||3
363741|NCT00437203|883761|P4|STARTED|Overall Study||3
363742|NCT00437203|883762|P3|STARTED|Overall Study||3
363743|NCT00437203|883763|P2|STARTED|Overall Study||8
363744|NCT00437203|883764|P1|STARTED|Overall Study||6
363745|NCT00437125|883868|P1|NOT COMPLETED|Overall Study||32
363746|NCT00437125|883868|P1|COMPLETED|Overall Study||119
363747|NCT00437125|883868|P1|STARTED|Overall Study||151
363748|NCT00437073|883889|P2|NOT COMPLETED|Overall Study||1
363749|NCT00437073|883890|P1|NOT COMPLETED|Overall Study||1
363750|NCT00437073|883889|P2|COMPLETED|Overall Study||8
363751|NCT00437073|883890|P1|COMPLETED|Overall Study||12
363752|NCT00437073|883889|P2|STARTED|Overall Study||9
363753|NCT00437073|883890|P1|STARTED|Overall Study||13
363754|NCT00437034|883918|P1|NOT COMPLETED|Overall Study||6
363755|NCT00437034|883918|P1|COMPLETED|Overall Study||0
363756|NCT00437034|883918|P1|STARTED|Overall Study||6
363757|NCT00436982|883924|P2|NOT COMPLETED|Overall Study||4
363758|NCT00436982|883925|P1|NOT COMPLETED|Overall Study||4
363759|NCT00436982|883924|P2|COMPLETED|Overall Study||26
363760|NCT00436982|883925|P1|COMPLETED|Overall Study||26
363761|NCT00436982|883924|P2|STARTED|Overall Study||30
363762|NCT00436982|883925|P1|STARTED|Overall Study||30
363763|NCT00436969|883947|P2|NOT COMPLETED|Overall Study||52
363764|NCT00436969|883948|P1|NOT COMPLETED|Overall Study||22
363765|NCT00436969|883947|P2|COMPLETED|Overall Study||134
363766|NCT00436969|883948|P1|COMPLETED|Overall Study||66
363767|NCT00436969|883947|P2|Randomized But Not Treated|Overall Study||3
363768|NCT00436969|883948|P1|Randomized But Not Treated|Overall Study||1
363769|NCT00436969|883947|P2|STARTED|Overall Study||186
363770|NCT00436969|883948|P1|STARTED|Overall Study||88
363771|NCT00436956|883996|P2|NOT COMPLETED|Overall Study||0
363772|NCT00436956|883997|P1|NOT COMPLETED|Overall Study||1
363773|NCT00436956|883996|P2|COMPLETED|Overall Study||23
363774|NCT00436956|883997|P1|COMPLETED|Overall Study|One pt was not evaluable due to a cord compression on day 2 of therapy; was removed from the trial.|35
363775|NCT00436956|883996|P2|STARTED|Overall Study||23
363776|NCT00436956|883997|P1|STARTED|Overall Study||36
363777|NCT00436917|884011|P1|NOT COMPLETED|Overall Study||21
363778|NCT00436917|884011|P1|COMPLETED|Overall Study||32
363779|NCT00436917|884011|P1|STARTED|Overall Study|7 participants (1 cancellation, 1 major violation, 5 ineligibles) were excluded from all analysis.|53
363780|NCT00436904|884026|P1|NOT COMPLETED|Overall Study||0
363781|NCT00436904|884026|P1|COMPLETED|Overall Study||30
363782|NCT00436904|884026|P1|STARTED|Overall Study||30
363783|NCT00436852|884037|P2|NOT COMPLETED|Overall Study||45
363784|NCT00436852|884038|P1|NOT COMPLETED|Overall Study||35
363785|NCT00436852|884037|P2|COMPLETED|Overall Study||2
363786|NCT00436852|884038|P1|COMPLETED|Overall Study||10
363787|NCT00436852|884037|P2|STARTED|Overall Study||47
363788|NCT00436852|884038|P1|STARTED|Overall Study||45
363789|NCT00436826|884057|P6|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||7
363790|NCT00436826|884058|P5|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||51
363791|NCT00436826|884059|P4|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
363792|NCT00436826|884060|P3|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
363793|NCT00436826|884061|P2|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
363794|NCT00436826|884062|P1|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
363795|NCT00436826|884057|P6|COMPLETED|Ext. Period (No Cladribine Treatment)||0
363796|NCT00436826|884058|P5|COMPLETED|Ext. Period (No Cladribine Treatment)||1
363797|NCT00436826|884059|P4|COMPLETED|Ext. Period (No Cladribine Treatment)||0
363798|NCT00436826|884060|P3|COMPLETED|Ext. Period (No Cladribine Treatment)||0
363799|NCT00436826|884061|P2|COMPLETED|Ext. Period (No Cladribine Treatment)||0
363800|NCT00436826|884062|P1|COMPLETED|Ext. Period (No Cladribine Treatment)||0
363801|NCT00436826|884057|P6|STARTED|Ext. Period (No Cladribine Treatment)||7
363802|NCT00436826|884058|P5|STARTED|Ext. Period (No Cladribine Treatment)||52
363803|NCT00436826|884059|P4|STARTED|Ext. Period (No Cladribine Treatment)||0
363804|NCT00436826|884060|P3|STARTED|Ext. Period (No Cladribine Treatment)||0
363805|NCT00436826|884061|P2|STARTED|Ext. Period (No Cladribine Treatment)||0
363806|NCT00436826|884062|P1|STARTED|Ext. Period (No Cladribine Treatment)||0
363807|NCT00436826|884057|P6|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
363808|NCT00436826|884058|P5|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
363809|NCT00436826|884059|P4|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||24
363810|NCT00436826|884060|P3|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||44
363811|NCT00436826|884061|P2|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
363812|NCT00436826|884062|P1|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
363813|NCT00436826|884057|P6|COMPLETED|Ext. Period (With Cladribine Treatment)||0
363814|NCT00436826|884058|P5|COMPLETED|Ext. Period (With Cladribine Treatment)||0
363815|NCT00436826|884059|P4|COMPLETED|Ext. Period (With Cladribine Treatment)||4
363816|NCT00436826|884060|P3|COMPLETED|Ext. Period (With Cladribine Treatment)||3
363817|NCT00436826|884061|P2|COMPLETED|Ext. Period (With Cladribine Treatment)||0
363818|NCT00436826|884062|P1|COMPLETED|Ext. Period (With Cladribine Treatment)||0
363819|NCT00436826|884057|P6|STARTED|Ext. Period (With Cladribine Treatment)||0
363820|NCT00436826|884058|P5|STARTED|Ext. Period (With Cladribine Treatment)||0
363821|NCT00436826|884059|P4|STARTED|Ext. Period (With Cladribine Treatment)||28
363822|NCT00436826|884060|P3|STARTED|Ext. Period (With Cladribine Treatment)||47
363823|NCT00436826|884061|P2|STARTED|Ext. Period (With Cladribine Treatment)||0
363824|NCT00436826|884062|P1|STARTED|Ext. Period (With Cladribine Treatment)||0
363825|NCT00436826|884057|P6|NOT COMPLETED|Double Blind Period||0
363826|NCT00436826|884058|P5|NOT COMPLETED|Double Blind Period||0
363827|NCT00436826|884059|P4|NOT COMPLETED|Double Blind Period||0
363828|NCT00436826|884060|P3|NOT COMPLETED|Double Blind Period||0
363829|NCT00436826|884061|P2|NOT COMPLETED|Double Blind Period||11
363830|NCT00436826|884062|P1|NOT COMPLETED|Double Blind Period||13
363831|NCT00436826|884057|P6|COMPLETED|Double Blind Period||0
363832|NCT00436826|884058|P5|COMPLETED|Double Blind Period||0
363833|NCT00436826|884059|P4|COMPLETED|Double Blind Period||0
363834|NCT00436826|884060|P3|COMPLETED|Double Blind Period||0
363835|NCT00436826|884061|P2|COMPLETED|Double Blind Period||37
363836|NCT00436826|884062|P1|COMPLETED|Double Blind Period||111
363837|NCT00436826|884057|P6|STARTED|Double Blind Period||0
363838|NCT00436826|884058|P5|STARTED|Double Blind Period||0
363839|NCT00436826|884059|P4|STARTED|Double Blind Period||0
363840|NCT00436826|884060|P3|STARTED|Double Blind Period||0
363841|NCT00436826|884061|P2|STARTED|Double Blind Period||48
363842|NCT00436826|884062|P1|STARTED|Double Blind Period||124
363843|NCT00436748|884084|P2|NOT COMPLETED|Overall Study||12
363844|NCT00436748|884085|P1|NOT COMPLETED|Overall Study||11
363845|NCT00436748|884084|P2|COMPLETED|Overall Study||45
363846|NCT00436748|884085|P1|COMPLETED|Overall Study||48
363847|NCT00436748|884084|P2|Received Treatment|Overall Study||56
363848|NCT00436748|884085|P1|Received Treatment|Overall Study||58
363849|NCT00436748|884084|P2|STARTED|Overall Study||57
363850|NCT00436748|884085|P1|STARTED|Overall Study||59
363851|NCT00436644|884119|P1|NOT COMPLETED|Overall Study||3
363852|NCT00436644|884119|P1|COMPLETED|Overall Study||15
363853|NCT00436644|884119|P1|STARTED|Overall Study||18
363854|NCT00436618|884129|P3|NOT COMPLETED|Overall Study||61
363855|NCT00436618|884130|P2|NOT COMPLETED|Overall Study||27
363856|NCT00436618|884131|P1|NOT COMPLETED|Overall Study||30
363857|NCT00436618|884129|P3|COMPLETED|Overall Study||46
363858|NCT00436618|884130|P2|COMPLETED|Overall Study||28
363859|NCT00436618|884131|P1|COMPLETED|Overall Study||84
363860|NCT00436618|884129|P3|STARTED|Overall Study||107
363861|NCT00436618|884130|P2|STARTED|Overall Study||55
363862|NCT00436618|884131|P1|STARTED|Overall Study||114
363863|NCT00436605|884148|P1|NOT COMPLETED|Overall Study||3
363864|NCT00436605|884148|P1|COMPLETED|Overall Study||36
363865|NCT00436605|884148|P1|STARTED|Overall Study||39
363866|NCT00436566|884153|P1|NOT COMPLETED|Overall Study||3
363867|NCT00436566|884153|P1|COMPLETED|Overall Study||109
363868|NCT00436566|884153|P1|STARTED|Overall Study||112
363869|NCT00436553|884160|P3|NOT COMPLETED|Overall Study||10
363870|NCT00436553|884161|P2|NOT COMPLETED|Overall Study||12
363871|NCT00436553|884162|P1|NOT COMPLETED|Overall Study||13
363872|NCT00436553|884160|P3|COMPLETED|Overall Study||102
363873|NCT00436553|884161|P2|COMPLETED|Overall Study||93
363874|NCT00436553|884162|P1|COMPLETED|Overall Study|Completed the 12 month study phase.|91
363875|NCT00436553|884160|P3|STARTED|Overall Study||112
363876|NCT00436553|884161|P2|STARTED|Overall Study||105
363877|NCT00436553|884162|P1|STARTED|Overall Study|"The table shows 12 month data. Started indicates Randomized set of population."|104
363878|NCT00436501|884183|P2|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||3
363879|NCT00436501|884184|P1|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
363880|NCT00436501|884183|P2|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||46
363881|NCT00436501|884184|P1|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
363882|NCT00436501|884183|P2|STARTED|Phase 2: MTD VEGF Trap + Docetaxel|After toxicity observations Phase 2 opened June 4, 2008 and closed to entry September 27, 2010.|49
363883|NCT00436501|884184|P1|STARTED|Phase 2: MTD VEGF Trap + Docetaxel||0
363884|NCT00436501|884183|P2|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
363885|NCT00436501|884184|P1|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
363886|NCT00436501|884183|P2|COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
363887|NCT00436501|884184|P1|COMPLETED|Phase 1: VEGF Trap Escalating Dose||9
363888|NCT00436501|884183|P2|STARTED|Phase 1: VEGF Trap Escalating Dose|Participants registered in next period.|0
363889|NCT00436501|884184|P1|STARTED|Phase 1: VEGF Trap Escalating Dose|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
363890|NCT00436501|884183|P2|NOT COMPLETED|Complete Study Participation||0
363891|NCT00436501|884184|P1|NOT COMPLETED|Complete Study Participation||0
363892|NCT00436501|884183|P2|COMPLETED|Complete Study Participation||49
363893|NCT00436501|884184|P1|COMPLETED|Complete Study Participation||9
363894|NCT00436501|884183|P2|STARTED|Complete Study Participation|After toxicity observations, Phase 2 opened June 4, 2008 and closed September 27, 2010.|49
363895|NCT00436501|884184|P1|STARTED|Complete Study Participation|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
363896|NCT00436475|884203|P4|NOT COMPLETED|Overall Study||2
363897|NCT00436475|884204|P3|NOT COMPLETED|Overall Study||1
363898|NCT00436475|884205|P2|NOT COMPLETED|Overall Study||1
363899|NCT00436475|884206|P1|NOT COMPLETED|Overall Study||0
363900|NCT00436475|884203|P4|COMPLETED|Overall Study||22
363901|NCT00436475|884204|P3|COMPLETED|Overall Study||21
363902|NCT00436475|884205|P2|COMPLETED|Overall Study||22
363903|NCT00436475|884206|P1|COMPLETED|Overall Study||23
363904|NCT00436475|884203|P4|STARTED|Overall Study||24
363905|NCT00436475|884204|P3|STARTED|Overall Study||22
363906|NCT00436475|884205|P2|STARTED|Overall Study||23
363907|NCT00436475|884206|P1|STARTED|Overall Study||23
363908|NCT00436436|884220|P1|NOT COMPLETED|Overall Study||12
363909|NCT00436436|884220|P1|COMPLETED|Overall Study||0
363910|NCT00436436|884220|P1|STARTED|Overall Study||12
363911|NCT00436345|884231|P2|NOT COMPLETED|Overall Study||0
363912|NCT00436345|884232|P1|NOT COMPLETED|Overall Study||3
363913|NCT00436345|884231|P2|COMPLETED|Overall Study||18
363914|NCT00436345|884232|P1|COMPLETED|Overall Study||18
363915|NCT00436345|884231|P2|STARTED|Overall Study||18
363916|NCT00436345|884232|P1|STARTED|Overall Study||21
363917|NCT00436332|884285|P1|NOT COMPLETED|Overall Study||83
363918|NCT00436332|884285|P1|COMPLETED|Overall Study||1
363919|NCT00436332|884285|P1|Eligible and Began Protocol Therapy|Overall Study||79
363920|NCT00436332|884285|P1|Eligible|Overall Study||82
363921|NCT00436332|884285|P1|STARTED|Overall Study||84
363922|NCT00436215|884292|P1|NOT COMPLETED|Overall Study||4
363923|NCT00436215|884292|P1|COMPLETED|Overall Study||51
363924|NCT00436215|884292|P1|STARTED|Overall Study||55
363925|NCT00436163|884298|P1|NOT COMPLETED|Overall Study||3
363926|NCT00436163|884298|P1|COMPLETED|Overall Study||36
363927|NCT00436163|884298|P1|STARTED|Overall Study||39
363928|NCT00436046|884312|P3|NOT COMPLETED|Overall Study||0
363929|NCT00436046|884313|P2|NOT COMPLETED|Overall Study||0
363930|NCT00436046|884314|P1|NOT COMPLETED|Overall Study||0
363931|NCT00436046|884312|P3|COMPLETED|Overall Study||31
363932|NCT00436046|884313|P2|COMPLETED|Overall Study||32
363933|NCT00436046|884314|P1|COMPLETED|Overall Study||32
363934|NCT00436046|884312|P3|STARTED|Overall Study||31
363935|NCT00436046|884313|P2|STARTED|Overall Study||32
363936|NCT00436046|884314|P1|STARTED|Overall Study||32
363937|NCT00436007|884346|P3|NOT COMPLETED|Overall Study||23
363938|NCT00436007|884347|P2|NOT COMPLETED|Overall Study||14
363939|NCT00436007|884348|P1|NOT COMPLETED|Overall Study||19
363940|NCT00436007|884346|P3|COMPLETED|Overall Study||148
363941|NCT00436007|884347|P2|COMPLETED|Overall Study||156
363942|NCT00436007|884348|P1|COMPLETED|Overall Study||151
363943|NCT00436007|884346|P3|STARTED|Overall Study||171
363944|NCT00436007|884347|P2|STARTED|Overall Study||170
363945|NCT00436007|884348|P1|STARTED|Overall Study||170
363946|NCT00435994|884396|P3|NOT COMPLETED|Overall Study||0
363947|NCT00435994|884397|P2|NOT COMPLETED|Overall Study||0
363948|NCT00435994|884398|P1|NOT COMPLETED|Overall Study||7
363949|NCT00435994|884396|P3|COMPLETED|Overall Study||12
363950|NCT00435994|884397|P2|COMPLETED|Overall Study||25
363951|NCT00435994|884398|P1|COMPLETED|Overall Study|7 of the subjects were consented and did not complete the study procedures.|15
363952|NCT00435994|884396|P3|STARTED|Overall Study||12
363953|NCT00435994|884397|P2|STARTED|Overall Study||25
363954|NCT00435994|884398|P1|STARTED|Overall Study||22
363955|NCT00435942|884409|P2|NOT COMPLETED|Overall Study||27
363956|NCT00435942|884410|P1|NOT COMPLETED|Overall Study||23
363957|NCT00435942|884409|P2|COMPLETED|Overall Study||33
363958|NCT00435942|884410|P1|COMPLETED|Overall Study||97
363959|NCT00435942|884409|P2|STARTED|Overall Study||60
363960|NCT00435942|884410|P1|STARTED|Overall Study||120
363961|NCT00435929|884419|P2|NOT COMPLETED|Overall Study||0
363962|NCT00435929|884420|P1|NOT COMPLETED|Overall Study||0
363963|NCT00435929|884419|P2|COMPLETED|Overall Study||9
363964|NCT00435929|884420|P1|COMPLETED|Overall Study||7
363965|NCT00435929|884419|P2|STARTED|Overall Study||9
363966|NCT00435929|884420|P1|STARTED|Overall Study||7
363967|NCT00435825|884450|P4|NOT COMPLETED|Overall Study||16
363968|NCT00435825|884451|P3|NOT COMPLETED|Overall Study||11
363969|NCT00435825|884452|P2|NOT COMPLETED|Overall Study||12
363970|NCT00435825|884453|P1|NOT COMPLETED|Overall Study||18
363971|NCT00435825|884450|P4|COMPLETED|Overall Study||120
363972|NCT00435825|884451|P3|COMPLETED|Overall Study||127
363973|NCT00435825|884452|P2|COMPLETED|Overall Study||124
363974|NCT00435825|884453|P1|COMPLETED|Overall Study|Completed is the number of participants who received study treatment and completed follow-up.|123
363975|NCT00435825|884450|P4|Completed 48 Weeks Treatment|Overall Study||117
363976|NCT00435825|884451|P3|Completed 48 Weeks Treatment|Overall Study||124
363977|NCT00435825|884452|P2|Completed 48 Weeks Treatment|Overall Study||0
363978|NCT00435825|884453|P1|Completed 48 Weeks Treatment|Overall Study||0
363979|NCT00435825|884450|P4|Completed 24 Weeks Treatment|Overall Study||131
363980|NCT00435825|884451|P3|Completed 24 Weeks Treatment|Overall Study||134
363981|NCT00435825|884452|P2|Completed 24 Weeks Treatment|Overall Study||126
363982|NCT00435825|884453|P1|Completed 24 Weeks Treatment|Overall Study||128
363983|NCT00435825|884450|P4|Entered Follow-up|Overall Study||133
363984|NCT00435825|884451|P3|Entered Follow-up|Overall Study||135
363985|NCT00435825|884452|P2|Entered Follow-up|Overall Study||132
363986|NCT00435825|884453|P1|Entered Follow-up|Overall Study||140
363987|NCT00435825|884450|P4|Received Study Drug|Overall Study||136
363988|NCT00435825|884451|P3|Received Study Drug|Overall Study||136
363989|NCT00435825|884452|P2|Received Study Drug|Overall Study||136
363990|NCT00435825|884453|P1|Received Study Drug|Overall Study||140
363991|NCT00435825|884450|P4|STARTED|Overall Study||136
363992|NCT00435825|884451|P3|STARTED|Overall Study||138
363993|NCT00435825|884452|P2|STARTED|Overall Study||136
363994|NCT00435825|884453|P1|STARTED|Overall Study||141
363995|NCT00435812|884509|P2|NOT COMPLETED|Overall Study||18
363996|NCT00435812|884510|P1|NOT COMPLETED|Overall Study||63
363997|NCT00435812|884509|P2|COMPLETED|Overall Study||590
363998|NCT00435812|884510|P1|COMPLETED|Overall Study||1757
363999|NCT00435812|884509|P2|STARTED|Overall Study||608
364000|NCT00435812|884510|P1|STARTED|Overall Study||1820
364001|NCT00435591|884522|P4|NOT COMPLETED|Overall Study||11
364002|NCT00435591|884523|P3|NOT COMPLETED|Overall Study||5
364003|NCT00435591|884524|P2|NOT COMPLETED|Overall Study||4
364004|NCT00435591|884525|P1|NOT COMPLETED|Overall Study||7
364005|NCT00435591|884522|P4|COMPLETED|Overall Study||19
364006|NCT00435591|884523|P3|COMPLETED|Overall Study||25
364007|NCT00435591|884524|P2|COMPLETED|Overall Study||27
364008|NCT00435591|884525|P1|COMPLETED|Overall Study||23
364009|NCT00435591|884522|P4|End of Treatment|Overall Study||23
364010|NCT00435591|884523|P3|End of Treatment|Overall Study||27
364011|NCT00435591|884524|P2|End of Treatment|Overall Study||27
364012|NCT00435591|884525|P1|End of Treatment|Overall Study||25
364013|NCT00435591|884522|P4|Full Analysis Set|Overall Study||29
364014|NCT00435591|884523|P3|Full Analysis Set|Overall Study||30
364015|NCT00435591|884524|P2|Full Analysis Set|Overall Study||29
364016|NCT00435591|884525|P1|Full Analysis Set|Overall Study||28
364017|NCT00435591|884522|P4|Safety Analysis Set|Overall Study||29
364018|NCT00435591|884523|P3|Safety Analysis Set|Overall Study||30
364019|NCT00435591|884524|P2|Safety Analysis Set|Overall Study||30
364020|NCT00435591|884525|P1|Safety Analysis Set|Overall Study||28
364021|NCT00435591|884522|P4|STARTED|Overall Study||30
364022|NCT00435591|884523|P3|STARTED|Overall Study||30
364023|NCT00435591|884524|P2|STARTED|Overall Study||31
364024|NCT00435591|884525|P1|STARTED|Overall Study||30
364025|NCT00435539|884555|P5|NOT COMPLETED|Overall Study||0
364026|NCT00435539|884556|P4|NOT COMPLETED|Overall Study||0
364027|NCT00435539|884557|P3|NOT COMPLETED|Overall Study||0
364028|NCT00435539|884558|P2|NOT COMPLETED|Overall Study||0
364029|NCT00435539|884559|P1|NOT COMPLETED|Overall Study||0
364030|NCT00435539|884555|P5|COMPLETED|Overall Study||12
364031|NCT00435539|884556|P4|COMPLETED|Overall Study||12
364032|NCT00435539|884557|P3|COMPLETED|Overall Study||11
364033|NCT00435539|884558|P2|COMPLETED|Overall Study||13
364034|NCT00435539|884559|P1|COMPLETED|Overall Study||12
364035|NCT00435539|884555|P5|STARTED|Overall Study||12
364036|NCT00435539|884556|P4|STARTED|Overall Study||12
364037|NCT00435539|884557|P3|STARTED|Overall Study||11
364038|NCT00435539|884558|P2|STARTED|Overall Study||13
364039|NCT00435539|884559|P1|STARTED|Overall Study||12
364040|NCT00435487|884576|P2|NOT COMPLETED|Overall Study||15
364041|NCT00435487|884577|P1|NOT COMPLETED|Overall Study||12
364042|NCT00435487|884576|P2|COMPLETED|Overall Study||71
364043|NCT00435487|884577|P1|COMPLETED|Overall Study||76
364044|NCT00435487|884576|P2|TREATED|Overall Study|One subject was mistakenly treated with Dalteparin, two subjects withdrew consent before treatment.|83
364045|NCT00435487|884577|P1|TREATED|Overall Study|One additional subject originally randomized to Unfractioned Heparin was treated with Dalteparin.|88
364046|NCT00435487|884576|P2|STARTED|Overall Study||86
364047|NCT00435487|884577|P1|STARTED|Overall Study|87 subjects were randomized however one additional subject originally randomized to UFH was treated.|88
364048|NCT00435461|884596|P3|NOT COMPLETED|Overall Study||24
364049|NCT00435461|884597|P2|NOT COMPLETED|Overall Study||14
364050|NCT00435461|884598|P1|NOT COMPLETED|Overall Study||23
364051|NCT00435461|884596|P3|COMPLETED|Overall Study||287
364052|NCT00435461|884597|P2|COMPLETED|Overall Study||298
364053|NCT00435461|884598|P1|COMPLETED|Overall Study||290
364054|NCT00435461|884596|P3|STARTED|Overall Study||311
364055|NCT00435461|884597|P2|STARTED|Overall Study||312
364056|NCT00435461|884598|P1|STARTED|Overall Study||313
364057|NCT00435409|884635|P3|NOT COMPLETED|Overall Study||78
364058|NCT00435409|884636|P2|NOT COMPLETED|Overall Study||143
364059|NCT00435409|884637|P1|NOT COMPLETED|Overall Study||221
364060|NCT00435409|884635|P3|COMPLETED|Overall Study||0
364061|NCT00435409|884636|P2|COMPLETED|Overall Study||0
364062|NCT00435409|884637|P1|COMPLETED|Overall Study||0
364063|NCT00435409|884635|P3|Treated|Overall Study||78
364064|NCT00435409|884636|P2|Treated|Overall Study||139
364065|NCT00435409|884637|P1|Treated|Overall Study||217
364066|NCT00435409|884635|P3|STARTED|Overall Study||78
364067|NCT00435409|884636|P2|STARTED|Overall Study||143
364068|NCT00435409|884637|P1|STARTED|Overall Study||221
364069|NCT00435370|884659|P2|NOT COMPLETED|Overall Study||20
364070|NCT00435370|884660|P1|NOT COMPLETED|Overall Study||22
364071|NCT00435370|884659|P2|COMPLETED|Overall Study|The entire recruitment has been completed in December, 2011.|69
364072|NCT00435370|884660|P1|COMPLETED|Overall Study||68
364073|NCT00435370|884659|P2|STARTED|Overall Study|The recruitment restarted in August, 2010.|89
364074|NCT00435370|884660|P1|STARTED|Overall Study||90
364075|NCT00435188|884668|P2|NOT COMPLETED|Overall Study||23
364076|NCT00435188|884669|P1|NOT COMPLETED|Overall Study||22
364077|NCT00435188|884668|P2|COMPLETED|Overall Study||176
364078|NCT00435188|884669|P1|COMPLETED|Overall Study||177
364079|NCT00435188|884668|P2|STARTED|Overall Study||199
364080|NCT00435188|884669|P1|STARTED|Overall Study||199
364081|NCT00435162|884712|P6|NOT COMPLETED|Period 2 (2 Weeks)||0
364082|NCT00435162|884713|P5|NOT COMPLETED|Period 2 (2 Weeks)||0
364083|NCT00435162|884714|P4|NOT COMPLETED|Period 2 (2 Weeks)||0
364084|NCT00435162|884715|P3|NOT COMPLETED|Period 2 (2 Weeks)||0
364085|NCT00435162|884716|P2|NOT COMPLETED|Period 2 (2 Weeks)||1
364086|NCT00435162|884717|P1|NOT COMPLETED|Period 2 (2 Weeks)||0
364087|NCT00435162|884712|P6|COMPLETED|Period 2 (2 Weeks)||15
364088|NCT00435162|884713|P5|COMPLETED|Period 2 (2 Weeks)||15
364089|NCT00435162|884714|P4|COMPLETED|Period 2 (2 Weeks)||8
364090|NCT00435162|884715|P3|COMPLETED|Period 2 (2 Weeks)||6
364091|NCT00435162|884716|P2|COMPLETED|Period 2 (2 Weeks)||14
364092|NCT00435162|884717|P1|COMPLETED|Period 2 (2 Weeks)||15
364093|NCT00435162|884712|P6|STARTED|Period 2 (2 Weeks)||15
364094|NCT00435162|884713|P5|STARTED|Period 2 (2 Weeks)||15
364095|NCT00435162|884714|P4|STARTED|Period 2 (2 Weeks)||8
364096|NCT00435162|884715|P3|STARTED|Period 2 (2 Weeks)||6
364097|NCT00435162|884716|P2|STARTED|Period 2 (2 Weeks)||15
364098|NCT00435162|884717|P1|STARTED|Period 2 (2 Weeks)||15
364099|NCT00435162|884712|P6|NOT COMPLETED|Period 1 (6 Weeks)||0
364100|NCT00435162|884713|P5|NOT COMPLETED|Period 1 (6 Weeks)||0
364101|NCT00435162|884714|P4|NOT COMPLETED|Period 1 (6 Weeks)||0
364102|NCT00435162|884715|P3|NOT COMPLETED|Period 1 (6 Weeks)||0
364103|NCT00435162|884716|P2|NOT COMPLETED|Period 1 (6 Weeks)||0
364104|NCT00435162|884717|P1|NOT COMPLETED|Period 1 (6 Weeks)||0
364105|NCT00435162|884712|P6|COMPLETED|Period 1 (6 Weeks)||15
364106|NCT00435162|884713|P5|COMPLETED|Period 1 (6 Weeks)||15
364107|NCT00435162|884714|P4|COMPLETED|Period 1 (6 Weeks)||8
364108|NCT00435162|884715|P3|COMPLETED|Period 1 (6 Weeks)||6
364109|NCT00435162|884716|P2|COMPLETED|Period 1 (6 Weeks)||15
364110|NCT00435162|884717|P1|COMPLETED|Period 1 (6 Weeks)||15
364111|NCT00435162|884712|P6|STARTED|Period 1 (6 Weeks)||15
364112|NCT00435162|884713|P5|STARTED|Period 1 (6 Weeks)||15
364113|NCT00435162|884714|P4|STARTED|Period 1 (6 Weeks)||8
364114|NCT00435162|884715|P3|STARTED|Period 1 (6 Weeks)||6
364115|NCT00435162|884716|P2|STARTED|Period 1 (6 Weeks)||15
364116|NCT00435162|884717|P1|STARTED|Period 1 (6 Weeks)||15
364117|NCT00435045|884737|P2|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||2
364118|NCT00435045|884738|P1|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||5
364119|NCT00435045|884737|P2|COMPLETED|Weeks 13-16 / 40mg Dose Level||111
364120|NCT00435045|884738|P1|COMPLETED|Weeks 13-16 / 40mg Dose Level||108
364121|NCT00435045|884737|P2|STARTED|Weeks 13-16 / 40mg Dose Level||113
364122|NCT00435045|884738|P1|STARTED|Weeks 13-16 / 40mg Dose Level||113
364123|NCT00435045|884737|P2|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
364124|NCT00435045|884738|P1|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
364125|NCT00435045|884737|P2|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
364126|NCT00435045|884738|P1|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
364127|NCT00435045|884737|P2|STARTED|Weeks 9-12 / 20mg Dose Level||118
364128|NCT00435045|884738|P1|STARTED|Weeks 9-12 / 20mg Dose Level||118
364129|NCT00435045|884737|P2|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||4
364130|NCT00435045|884738|P1|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||5
364131|NCT00435045|884737|P2|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
364132|NCT00435045|884738|P1|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
364133|NCT00435045|884737|P2|STARTED|Weeks 1-8 / 10 mg Dose Level||122
364134|NCT00435045|884738|P1|STARTED|Weeks 1-8 / 10 mg Dose Level||123
364135|NCT00435019|884794|P2|NOT COMPLETED|Overall Study||10
364136|NCT00435019|884795|P1|NOT COMPLETED|Overall Study||13
364137|NCT00435019|884794|P2|COMPLETED|Overall Study||161
364138|NCT00435019|884795|P1|COMPLETED|Overall Study||164
364139|NCT00435019|884794|P2|Exposed to Study Drug|Overall Study|One subject withdrew before receiving study drug, and thus not included in the full analysis set.|170
364140|NCT00435019|884795|P1|Exposed to Study Drug|Overall Study||177
364141|NCT00435019|884794|P2|STARTED|Overall Study|Randomised|171
364142|NCT00435019|884795|P1|STARTED|Overall Study|Randomised|177
364143|NCT00434993|884807|P2|NOT COMPLETED|Overall Study||0
364144|NCT00434993|884808|P1|NOT COMPLETED|Overall Study||0
364145|NCT00434993|884807|P2|COMPLETED|Overall Study||130
364146|NCT00434993|884808|P1|COMPLETED|Overall Study||152
364147|NCT00434993|884807|P2|STARTED|Overall Study||130
364148|NCT00434993|884808|P1|STARTED|Overall Study||152
364149|NCT00434967|884836|P4|NOT COMPLETED|Overall Study||14
364150|NCT00434967|884837|P3|NOT COMPLETED|Overall Study||9
364151|NCT00434967|884838|P2|NOT COMPLETED|Overall Study||8
364152|NCT00434967|884839|P1|NOT COMPLETED|Overall Study||7
364153|NCT00434967|884836|P4|COMPLETED|Overall Study||478
364154|NCT00434967|884837|P3|COMPLETED|Overall Study||461
364155|NCT00434967|884838|P2|COMPLETED|Overall Study||457
364156|NCT00434967|884839|P1|COMPLETED|Overall Study||90
364157|NCT00434967|884836|P4|STARTED|Overall Study||492
364158|NCT00434967|884837|P3|STARTED|Overall Study||470
364159|NCT00434967|884838|P2|STARTED|Overall Study||465
364160|NCT00434967|884839|P1|STARTED|Overall Study||97
364161|NCT00434954|884859|P2|NOT COMPLETED|Overall Study||71
364162|NCT00434954|884860|P1|NOT COMPLETED|Overall Study||82
364163|NCT00434954|884859|P2|COMPLETED|Overall Study||175
364164|NCT00434954|884860|P1|COMPLETED|Overall Study||166
364165|NCT00434954|884859|P2|Completed - Previous Treatment MET + SU|Overall Study||38
364166|NCT00434954|884860|P1|Completed - Previous Treatment MET + SU|Overall Study||31
364167|NCT00434954|884859|P2|Completed - Previous Treatment MET Only|Overall Study||137
364168|NCT00434954|884860|P1|Completed - Previous Treatment MET Only|Overall Study||135
364169|NCT00434954|884859|P2|FAS - Previous Treatment MET + SU|Overall Study||60
364170|NCT00434954|884860|P1|FAS - Previous Treatment MET + SU|Overall Study||66
364171|NCT00434954|884859|P2|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|173
364172|NCT00434954|884860|P1|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|181
364173|NCT00434954|884859|P2|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|233
364174|NCT00434954|884860|P1|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|247
364175|NCT00434954|884859|P2|Started - Previous Treatment MET + SU|Overall Study||65
364176|NCT00434954|884860|P1|Started - Previous Treatment MET + SU|Overall Study||66
364177|NCT00434954|884859|P2|Started - Previous Treatment MET Only|Overall Study||181
364178|NCT00434954|884860|P1|Started - Previous Treatment MET Only|Overall Study||182
364179|NCT00434954|884859|P2|STARTED|Overall Study||246
364180|NCT00434954|884860|P1|STARTED|Overall Study||248
364181|NCT00434876|884890|P2|NOT COMPLETED|Overall Study||1
364182|NCT00434876|884891|P1|NOT COMPLETED|Overall Study||1
364183|NCT00434876|884890|P2|COMPLETED|Overall Study||10
364184|NCT00434876|884891|P1|COMPLETED|Overall Study||10
364185|NCT00434876|884890|P2|STARTED|Overall Study||11
364186|NCT00434876|884891|P1|STARTED|Overall Study||11
364187|NCT00434759|884905|P2|NOT COMPLETED|Overall Study||5
364188|NCT00434759|884906|P1|NOT COMPLETED|Overall Study||24
364189|NCT00434759|884905|P2|COMPLETED|Overall Study||38
364190|NCT00434759|884906|P1|COMPLETED|Overall Study||22
364191|NCT00434759|884905|P2|STARTED|Overall Study||43
364192|NCT00434759|884906|P1|STARTED|Overall Study||46
364193|NCT00434642|884922|P2|NOT COMPLETED|Open-label Treatment Phase||11
364194|NCT00434642|884923|P1|NOT COMPLETED|Open-label Treatment Phase||0
364195|NCT00434642|884922|P2|COMPLETED|Open-label Treatment Phase||1
364196|NCT00434642|884923|P1|COMPLETED|Open-label Treatment Phase||0
364197|NCT00434642|884922|P2|STARTED|Open-label Treatment Phase|One participant did not continue into the open-label treatment phase.|12
364198|NCT00434642|884923|P1|STARTED|Open-label Treatment Phase||0
364199|NCT00434642|884922|P2|NOT COMPLETED|Blinded Treatment Phase||229
364200|NCT00434642|884923|P1|NOT COMPLETED|Blinded Treatment Phase||242
364201|NCT00434642|884922|P2|COMPLETED|Blinded Treatment Phase||13
364202|NCT00434642|884923|P1|COMPLETED|Blinded Treatment Phase||0
364203|NCT00434642|884922|P2|STARTED|Blinded Treatment Phase||242
364204|NCT00434642|884923|P1|STARTED|Blinded Treatment Phase||242
364205|NCT00434590|884941|P2|NOT COMPLETED|Overall Study||5
364206|NCT00434590|884942|P1|NOT COMPLETED|Overall Study||5
364207|NCT00434590|884941|P2|COMPLETED|Overall Study||0
364208|NCT00434590|884942|P1|COMPLETED|Overall Study|All patients randomized had study discontinued because of premature study termination.|0
364209|NCT00434590|884941|P2|STARTED|Overall Study||5
364210|NCT00434590|884942|P1|STARTED|Overall Study||5
364211|NCT00434577|884953|P5|NOT COMPLETED|Month 36||0
364212|NCT00434577|884954|P4|NOT COMPLETED|Month 36||0
364213|NCT00434577|884955|P3|NOT COMPLETED|Month 36||0
364214|NCT00434577|884956|P2|NOT COMPLETED|Month 36||0
364215|NCT00434577|884957|P1|NOT COMPLETED|Month 36||0
364216|NCT00434577|884953|P5|COMPLETED|Month 36||47
364217|NCT00434577|884954|P4|COMPLETED|Month 36||155
364218|NCT00434577|884955|P3|COMPLETED|Month 36||150
364219|NCT00434577|884956|P2|COMPLETED|Month 36||147
364220|NCT00434577|884957|P1|COMPLETED|Month 36||147
364221|NCT00434577|884953|P5|STARTED|Month 36||47
364222|NCT00434577|884954|P4|STARTED|Month 36||155
364223|NCT00434577|884955|P3|STARTED|Month 36||150
364224|NCT00434577|884956|P2|STARTED|Month 36||147
364225|NCT00434577|884957|P1|STARTED|Month 36||147
364226|NCT00434577|884953|P5|NOT COMPLETED|Month 24||0
364227|NCT00434577|884954|P4|NOT COMPLETED|Month 24||0
364228|NCT00434577|884955|P3|NOT COMPLETED|Month 24||0
364229|NCT00434577|884956|P2|NOT COMPLETED|Month 24||0
364230|NCT00434577|884957|P1|NOT COMPLETED|Month 24||0
364231|NCT00434577|884953|P5|COMPLETED|Month 24||49
364232|NCT00434577|884954|P4|COMPLETED|Month 24||157
364233|NCT00434577|884955|P3|COMPLETED|Month 24||154
364234|NCT00434577|884956|P2|COMPLETED|Month 24||155
364235|NCT00434577|884957|P1|COMPLETED|Month 24||150
364236|NCT00434577|884953|P5|STARTED|Month 24||49
364237|NCT00434577|884954|P4|STARTED|Month 24||157
364238|NCT00434577|884955|P3|STARTED|Month 24||154
364239|NCT00434577|884956|P2|STARTED|Month 24||155
364240|NCT00434577|884957|P1|STARTED|Month 24||150
364241|NCT00434577|884953|P5|NOT COMPLETED|Month 12||0
364242|NCT00434577|884954|P4|NOT COMPLETED|Month 12||0
364243|NCT00434577|884955|P3|NOT COMPLETED|Month 12||0
364244|NCT00434577|884956|P2|NOT COMPLETED|Month 12||0
364245|NCT00434577|884957|P1|NOT COMPLETED|Month 12||0
364246|NCT00434577|884953|P5|COMPLETED|Month 12||50
364247|NCT00434577|884954|P4|COMPLETED|Month 12||161
364248|NCT00434577|884955|P3|COMPLETED|Month 12||159
364249|NCT00434577|884956|P2|COMPLETED|Month 12||159
364250|NCT00434577|884957|P1|COMPLETED|Month 12||156
364251|NCT00434577|884953|P5|STARTED|Month 12||50
364252|NCT00434577|884954|P4|STARTED|Month 12||161
364253|NCT00434577|884955|P3|STARTED|Month 12||159
364254|NCT00434577|884956|P2|STARTED|Month 12||159
364255|NCT00434577|884957|P1|STARTED|Month 12||156
364256|NCT00434577|884953|P5|NOT COMPLETED|Months 0-3||3
364257|NCT00434577|884954|P4|NOT COMPLETED|Months 0-3||1
364258|NCT00434577|884955|P3|NOT COMPLETED|Months 0-3||4
364259|NCT00434577|884956|P2|NOT COMPLETED|Months 0-3||2
364260|NCT00434577|884957|P1|NOT COMPLETED|Months 0-3||3
364261|NCT00434577|884953|P5|COMPLETED|Months 0-3||51
364262|NCT00434577|884954|P4|COMPLETED|Months 0-3||164
364263|NCT00434577|884955|P3|COMPLETED|Months 0-3||161
364264|NCT00434577|884956|P2|COMPLETED|Months 0-3||164
364265|NCT00434577|884957|P1|COMPLETED|Months 0-3||161
364266|NCT00434577|884953|P5|STARTED|Months 0-3||54
364267|NCT00434577|884954|P4|STARTED|Months 0-3||165
364268|NCT00434577|884955|P3|STARTED|Months 0-3||165
364269|NCT00434577|884956|P2|STARTED|Months 0-3||166
364270|NCT00434577|884957|P1|STARTED|Months 0-3||164
364271|NCT00434512|885135|P6|NOT COMPLETED|Overall Study||1
364272|NCT00434512|885136|P5|NOT COMPLETED|Overall Study||1
364273|NCT00434512|885137|P4|NOT COMPLETED|Overall Study||1
364274|NCT00434512|885138|P3|NOT COMPLETED|Overall Study||0
364275|NCT00434512|885139|P2|NOT COMPLETED|Overall Study||1
364276|NCT00434512|885140|P1|NOT COMPLETED|Overall Study||0
364277|NCT00434512|885135|P6|COMPLETED|Overall Study||49
364278|NCT00434512|885136|P5|COMPLETED|Overall Study||49
364279|NCT00434512|885137|P4|COMPLETED|Overall Study||49
364280|NCT00434512|885138|P3|COMPLETED|Overall Study||10
364281|NCT00434512|885139|P2|COMPLETED|Overall Study||9
364282|NCT00434512|885140|P1|COMPLETED|Overall Study||10
364283|NCT00434512|885135|P6|STARTED|Overall Study||50
364284|NCT00434512|885136|P5|STARTED|Overall Study||50
364285|NCT00434512|885137|P4|STARTED|Overall Study||50
364286|NCT00434512|885138|P3|STARTED|Overall Study||10
364287|NCT00434512|885139|P2|STARTED|Overall Study||10
364288|NCT00434512|885140|P1|STARTED|Overall Study||10
364289|NCT00434434|885241|P3|NOT COMPLETED|Overall Study||1
364290|NCT00434434|885242|P2|NOT COMPLETED|Overall Study||0
364291|NCT00434434|885243|P1|NOT COMPLETED|Overall Study||2
364292|NCT00434434|885241|P3|COMPLETED|Overall Study||13
364293|NCT00434434|885242|P2|COMPLETED|Overall Study||24
364294|NCT00434434|885243|P1|COMPLETED|Overall Study||21
364295|NCT00434434|885241|P3|STARTED|Overall Study||14
364296|NCT00434434|885242|P2|STARTED|Overall Study||24
364297|NCT00434434|885243|P1|STARTED|Overall Study||23
364298|NCT00434421|885254|P1|NOT COMPLETED|Overall Study||2
364299|NCT00434421|885254|P1|COMPLETED|Overall Study||26
364300|NCT00434421|885254|P1|STARTED|Overall Study||28
364301|NCT00434356|885260|P2|NOT COMPLETED|Overall Study||23
364302|NCT00434356|885261|P1|NOT COMPLETED|Overall Study||23
364303|NCT00434356|885260|P2|COMPLETED|Overall Study||0
364304|NCT00434356|885261|P1|COMPLETED|Overall Study||0
364305|NCT00434356|885260|P2|STARTED|Overall Study||23
364306|NCT00434356|885261|P1|STARTED|Overall Study||23
364307|NCT00434330|885282|P6|NOT COMPLETED|Overall Study||1
364308|NCT00434330|885283|P5|NOT COMPLETED|Overall Study||1
364309|NCT00434330|885284|P4|NOT COMPLETED|Overall Study||2
364310|NCT00434330|885285|P3|NOT COMPLETED|Overall Study||3
364311|NCT00434330|885286|P2|NOT COMPLETED|Overall Study||0
364312|NCT00434330|885287|P1|NOT COMPLETED|Overall Study||1
364313|NCT00434330|885282|P6|COMPLETED|Overall Study||14
364314|NCT00434330|885283|P5|COMPLETED|Overall Study||14
364315|NCT00434330|885284|P4|COMPLETED|Overall Study||13
364316|NCT00434330|885285|P3|COMPLETED|Overall Study||13
364317|NCT00434330|885286|P2|COMPLETED|Overall Study||15
364318|NCT00434330|885287|P1|COMPLETED|Overall Study||14
364319|NCT00434330|885282|P6|STARTED|Overall Study||15
364320|NCT00434330|885283|P5|STARTED|Overall Study||15
364321|NCT00434330|885284|P4|STARTED|Overall Study||15
364322|NCT00434330|885285|P3|STARTED|Overall Study||16
364323|NCT00434330|885286|P2|STARTED|Overall Study||15
364324|NCT00434330|885287|P1|STARTED|Overall Study||15
364325|NCT00434304|885319|P1|NOT COMPLETED|Overall Study||20
364326|NCT00434304|885319|P1|COMPLETED|Overall Study||42
364327|NCT00434304|885319|P1|STARTED|Overall Study||62
364328|NCT00434278|885357|P2|NOT COMPLETED|Overall Study||0
364329|NCT00434278|885358|P1|NOT COMPLETED|Overall Study||2
364330|NCT00434278|885357|P2|COMPLETED|Overall Study||13
364331|NCT00434278|885358|P1|COMPLETED|Overall Study||12
364332|NCT00434278|885357|P2|STARTED|Overall Study||13
364333|NCT00434278|885358|P1|STARTED|Overall Study||14
364334|NCT00434252|885368|P2|NOT COMPLETED|Overall Study||131
364335|NCT00434252|885369|P1|NOT COMPLETED|Overall Study||64
364336|NCT00434252|885368|P2|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|12
364337|NCT00434252|885369|P1|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|7
364338|NCT00434252|885368|P2|Treated|Overall Study||143
364339|NCT00434252|885369|P1|Treated|Overall Study|One patient died and one patient withdrew prior to receiving study treatment|69
364340|NCT00434252|885368|P2|STARTED|Overall Study||143
364341|NCT00434252|885369|P1|STARTED|Overall Study||71
364342|NCT00434226|885391|P2|NOT COMPLETED|Overall Study||26
364343|NCT00434226|885392|P1|NOT COMPLETED|Overall Study||30
364344|NCT00434226|885391|P2|COMPLETED|Overall Study||0
364345|NCT00434226|885392|P1|COMPLETED|Overall Study||0
364346|NCT00434226|885391|P2|STARTED|Overall Study||26
364347|NCT00434226|885392|P1|STARTED|Overall Study||30
364348|NCT00434213|885403|P1|NOT COMPLETED|Overall Study||49
364349|NCT00434213|885403|P1|COMPLETED|Overall Study||260
364350|NCT00434213|885403|P1|STARTED|Overall Study||309
364351|NCT00434161|885411|P3|NOT COMPLETED|Overall Study||11
364352|NCT00434161|885412|P2|NOT COMPLETED|Overall Study||3
364353|NCT00434161|885413|P1|NOT COMPLETED|Overall Study||10
364354|NCT00434161|885411|P3|COMPLETED|Overall Study||104
364355|NCT00434161|885412|P2|COMPLETED|Overall Study||54
364356|NCT00434161|885413|P1|COMPLETED|Overall Study||99
364357|NCT00434161|885411|P3|STARTED|Overall Study||115
364358|NCT00434161|885412|P2|STARTED|Overall Study||57
364359|NCT00434161|885413|P1|STARTED|Overall Study||109
364360|NCT00434148|885457|P2|NOT COMPLETED|Overall Study||73
364361|NCT00434148|885458|P1|NOT COMPLETED|Overall Study||69
364362|NCT00434148|885457|P2|COMPLETED|Overall Study||7
364363|NCT00434148|885458|P1|COMPLETED|Overall Study||13
364364|NCT00434148|885457|P2|Completed Month 12; Entered Extension|Overall Study||32
364365|NCT00434148|885458|P1|Completed Month 12; Entered Extension|Overall Study||26
364366|NCT00434148|885457|P2|Completed m. 12; Did Not Enter Extension|Overall Study||7
364367|NCT00434148|885458|P1|Completed m. 12; Did Not Enter Extension|Overall Study||13
364368|NCT00434148|885457|P2|Completed Month 12|Overall Study||39
364369|NCT00434148|885458|P1|Completed Month 12|Overall Study||39
364370|NCT00434148|885457|P2|STARTED|Overall Study||80
364371|NCT00434148|885458|P1|STARTED|Overall Study|"Started indicates Full Analysis Set. Patients randomized and treated."|82
364372|NCT00434122|885494|P2|NOT COMPLETED|Overall Study||7
364373|NCT00434122|885495|P1|NOT COMPLETED|Overall Study||6
364374|NCT00434122|885494|P2|COMPLETED|Overall Study||36
364375|NCT00434122|885495|P1|COMPLETED|Overall Study||36
364376|NCT00434122|885494|P2|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
364377|NCT00434122|885495|P1|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
364378|NCT00434122|885494|P2|STARTED|Overall Study|Randomised|43
364379|NCT00434122|885495|P1|STARTED|Overall Study|Randomised|42
364380|NCT00434109|885504|P1|NOT COMPLETED|Overall Study||18
364381|NCT00434109|885504|P1|COMPLETED|Overall Study|Patients completing the maximum eight cycles of sunitinib.|21
364382|NCT00434109|885504|P1|STARTED|Overall Study||39
364383|NCT00434057|885513|P1|NOT COMPLETED|Overall Study||1
364384|NCT00434057|885513|P1|COMPLETED|Overall Study|One patient withdrew from the study after signing the Informed Consent Form|1382
364385|NCT00434057|885513|P1|STARTED|Overall Study||1383
364386|NCT00434018|885519|P2|NOT COMPLETED|Overall Study||12
364387|NCT00434018|885520|P1|NOT COMPLETED|Overall Study||17
364388|NCT00434018|885519|P2|COMPLETED|Overall Study||57
364389|NCT00434018|885520|P1|COMPLETED|Overall Study||52
364390|NCT00434018|885519|P2|STARTED|Overall Study||69
364391|NCT00434018|885520|P1|STARTED|Overall Study||69
364392|NCT00433992|885538|P2|NOT COMPLETED|Overall Study||8
364393|NCT00433992|885539|P1|NOT COMPLETED|Overall Study||9
364394|NCT00433992|885538|P2|COMPLETED|Overall Study||20
364395|NCT00433992|885539|P1|COMPLETED|Overall Study||19
364396|NCT00433992|885538|P2|STARTED|Overall Study||28
364397|NCT00433992|885539|P1|STARTED|Overall Study||28
364398|NCT00433966|885551|P4|NOT COMPLETED|Stent Intervention/Randomization||62
364399|NCT00433966|885552|P3|NOT COMPLETED|Stent Intervention/Randomization||154
364400|NCT00433966|885553|P2|NOT COMPLETED|Stent Intervention/Randomization||0
364401|NCT00433966|885554|P1|NOT COMPLETED|Stent Intervention/Randomization||0
364402|NCT00433966|885551|P4|COMPLETED|Stent Intervention/Randomization||687
364403|NCT00433966|885552|P3|COMPLETED|Stent Intervention/Randomization||2103
364404|NCT00433966|885553|P2|COMPLETED|Stent Intervention/Randomization||0
364405|NCT00433966|885554|P1|COMPLETED|Stent Intervention/Randomization||0
364406|NCT00433966|885551|P4|3-Year Follow-up|Stent Intervention/Randomization||687
364407|NCT00433966|885552|P3|3-Year Follow-up|Stent Intervention/Randomization||2103
364408|NCT00433966|885553|P2|3-Year Follow-up|Stent Intervention/Randomization||0
364409|NCT00433966|885554|P1|3-Year Follow-up|Stent Intervention/Randomization||0
364410|NCT00433966|885551|P4|1-Year Follow-up|Stent Intervention/Randomization||715
364411|NCT00433966|885552|P3|1-Year Follow-up|Stent Intervention/Randomization||2186
364412|NCT00433966|885553|P2|1-Year Follow-up|Stent Intervention/Randomization||0
364413|NCT00433966|885554|P1|1-Year Follow-up|Stent Intervention/Randomization||0
364414|NCT00433966|885551|P4|STARTED|Stent Intervention/Randomization||749
364415|NCT00433966|885552|P3|STARTED|Stent Intervention/Randomization||2257
364416|NCT00433966|885553|P2|STARTED|Stent Intervention/Randomization||0
364417|NCT00433966|885554|P1|STARTED|Stent Intervention/Randomization||0
364418|NCT00433966|885551|P4|NOT COMPLETED|Pharmacology Intervention/Randomization||0
364419|NCT00433966|885552|P3|NOT COMPLETED|Pharmacology Intervention/Randomization||0
364420|NCT00433966|885553|P2|NOT COMPLETED|Pharmacology Intervention/Randomization||174
364421|NCT00433966|885554|P1|NOT COMPLETED|Pharmacology Intervention/Randomization||166
364422|NCT00433966|885551|P4|COMPLETED|Pharmacology Intervention/Randomization||0
364423|NCT00433966|885552|P3|COMPLETED|Pharmacology Intervention/Randomization||0
364424|NCT00433966|885553|P2|COMPLETED|Pharmacology Intervention/Randomization||1628
364425|NCT00433966|885554|P1|COMPLETED|Pharmacology Intervention/Randomization||1634
364426|NCT00433966|885551|P4|3-Year Follow-up|Pharmacology Intervention/Randomization||0
364427|NCT00433966|885552|P3|3-Year Follow-up|Pharmacology Intervention/Randomization||0
364428|NCT00433966|885553|P2|3-Year Follow-up|Pharmacology Intervention/Randomization||1628
364429|NCT00433966|885554|P1|3-Year Follow-up|Pharmacology Intervention/Randomization||1634
364430|NCT00433966|885551|P4|1-Year Follow-up|Pharmacology Intervention/Randomization||0
364431|NCT00433966|885552|P3|1-Year Follow-up|Pharmacology Intervention/Randomization||0
364432|NCT00433966|885553|P2|1-Year Follow-up|Pharmacology Intervention/Randomization||1702
364433|NCT00433966|885554|P1|1-Year Follow-up|Pharmacology Intervention/Randomization||1696
364434|NCT00433966|885551|P4|30-Day Follow-up|Pharmacology Intervention/Randomization||0
364435|NCT00433966|885552|P3|30-Day Follow-up|Pharmacology Intervention/Randomization||0
364436|NCT00433966|885553|P2|30-Day Follow-up|Pharmacology Intervention/Randomization||1791
364437|NCT00433966|885554|P1|30-Day Follow-up|Pharmacology Intervention/Randomization||1787
364438|NCT00433966|885551|P4|STARTED|Pharmacology Intervention/Randomization||0
364439|NCT00433966|885552|P3|STARTED|Pharmacology Intervention/Randomization||0
364440|NCT00433966|885553|P2|STARTED|Pharmacology Intervention/Randomization||1802
364441|NCT00433966|885554|P1|STARTED|Pharmacology Intervention/Randomization||1800
364442|NCT00433914|885576|P2|NOT COMPLETED|Overall Study||3
364443|NCT00433914|885577|P1|NOT COMPLETED|Overall Study||0
364444|NCT00433914|885576|P2|COMPLETED|Overall Study||27
364445|NCT00433914|885577|P1|COMPLETED|Overall Study||30
364446|NCT00433914|885576|P2|STARTED|Overall Study||30
364447|NCT00433914|885577|P1|STARTED|Overall Study||30
364448|NCT00433836|885597|P2|NOT COMPLETED|Overall Study||6
364449|NCT00433836|885598|P1|NOT COMPLETED|Overall Study||13
364450|NCT00433836|885597|P2|COMPLETED|Overall Study||143
364451|NCT00433836|885598|P1|COMPLETED|Overall Study||138
364452|NCT00433836|885597|P2|STARTED|Overall Study||149
364453|NCT00433836|885598|P1|STARTED|Overall Study||151
364454|NCT00433771|885610|P1|NOT COMPLETED|Overall Study||19
364455|NCT00433771|885610|P1|COMPLETED|Overall Study|55 out of 58 patients were evaluable(had a stent placed and had at least 1 week of follow up)|55
364456|NCT00433771|885610|P1|STARTED|Overall Study|74 enrolled patients(signed an Informed Consent Form)were screened.58 were eligible(intent to treat)|74
364457|NCT00433745|885626|P1|NOT COMPLETED|Overall Study||0
364458|NCT00433745|885626|P1|COMPLETED|Overall Study||4
364459|NCT00433745|885626|P1|STARTED|Overall Study||4
364460|NCT00433654|885633|P2|NOT COMPLETED|Overall Study||5
364461|NCT00433654|885634|P1|NOT COMPLETED|Overall Study||15
364462|NCT00433654|885633|P2|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|201
364463|NCT00433654|885634|P1|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|243
364464|NCT00433654|885633|P2|STARTED|Overall Study||206
364465|NCT00433654|885634|P1|STARTED|Overall Study||258
364466|NCT00433550|885668|P3|NOT COMPLETED|Overall Study||0
364467|NCT00433550|885669|P2|NOT COMPLETED|Overall Study||0
364468|NCT00433550|885670|P1|NOT COMPLETED|Overall Study||0
364469|NCT00433550|885668|P3|COMPLETED|Overall Study||6
364470|NCT00433550|885669|P2|COMPLETED|Overall Study||10
364471|NCT00433550|885670|P1|COMPLETED|Overall Study||17
364472|NCT00433550|885668|P3|STARTED|Overall Study||6
364473|NCT00433550|885669|P2|STARTED|Overall Study||10
364474|NCT00433550|885670|P1|STARTED|Overall Study||17
364475|NCT00433537|885680|P3|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
364476|NCT00433537|885681|P2|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
364477|NCT00433537|885682|P1|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||16
364478|NCT00433537|885680|P3|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
364479|NCT00433537|885681|P2|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||22
364480|NCT00433537|885682|P1|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||29
364481|NCT00433537|885680|P3|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||0
364482|NCT00433537|885681|P2|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||22
364483|NCT00433537|885682|P1|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||44
364484|NCT00433537|885680|P3|STARTED|Step 2 - Maintenance Rituximab or ASCT|One patient completed VcR-CVAD and then withdrew from the study.|0
364485|NCT00433537|885681|P2|STARTED|Step 2 - Maintenance Rituximab or ASCT||22
364486|NCT00433537|885682|P1|STARTED|Step 2 - Maintenance Rituximab or ASCT|This included all treated patients regardless of eligibility.|45
364487|NCT00433537|885680|P3|NOT COMPLETED|Step 1 - VcR-CVAD Induction||9
364488|NCT00433537|885681|P2|NOT COMPLETED|Step 1 - VcR-CVAD Induction||0
364489|NCT00433537|885682|P1|NOT COMPLETED|Step 1 - VcR-CVAD Induction||1
364490|NCT00433537|885680|P3|COMPLETED|Step 1 - VcR-CVAD Induction||1
364491|NCT00433537|885681|P2|COMPLETED|Step 1 - VcR-CVAD Induction||22
364492|NCT00433537|885682|P1|COMPLETED|Step 1 - VcR-CVAD Induction||44
364493|NCT00433537|885680|P3|Eligible and Treated|Step 1 - VcR-CVAD Induction||9
364494|NCT00433537|885681|P2|Eligible and Treated|Step 1 - VcR-CVAD Induction||22
364495|NCT00433537|885682|P1|Eligible and Treated|Step 1 - VcR-CVAD Induction||44
364496|NCT00433537|885680|P3|STARTED|Step 1 - VcR-CVAD Induction||10
364497|NCT00433537|885681|P2|STARTED|Step 1 - VcR-CVAD Induction||22
364498|NCT00433537|885682|P1|STARTED|Step 1 - VcR-CVAD Induction||45
364499|NCT00433511|885694|P3|NOT COMPLETED|Step 2 (Arm D)||491
364500|NCT00433511|885695|P2|NOT COMPLETED|Step 2 (Arm D)||0
364501|NCT00433511|885696|P1|NOT COMPLETED|Step 2 (Arm D)||0
364502|NCT00433511|885694|P3|COMPLETED|Step 2 (Arm D)||825
364503|NCT00433511|885695|P2|COMPLETED|Step 2 (Arm D)||0
364504|NCT00433511|885696|P1|COMPLETED|Step 2 (Arm D)||0
364505|NCT00433511|885694|P3|Patients Who Received Treatment|Step 2 (Arm D)||1168
364506|NCT00433511|885695|P2|Patients Who Received Treatment|Step 2 (Arm D)||0
364507|NCT00433511|885696|P1|Patients Who Received Treatment|Step 2 (Arm D)||0
364508|NCT00433511|885694|P3|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|1316
364509|NCT00433511|885695|P2|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|0
364510|NCT00433511|885696|P1|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|0
364511|NCT00433511|885694|P3|NOT COMPLETED|Step 1||390
364512|NCT00433511|885695|P2|NOT COMPLETED|Step 1||385
364513|NCT00433511|885696|P1|NOT COMPLETED|Step 1||136
364514|NCT00433511|885694|P3|COMPLETED|Step 1||1618
364515|NCT00433511|885695|P2|COMPLETED|Step 1||1601
364516|NCT00433511|885696|P1|COMPLETED|Step 1||864
364517|NCT00433511|885694|P3|Patients in Genetic Ancestry Analysis|Step 1||1158
364518|NCT00433511|885695|P2|Patients in Genetic Ancestry Analysis|Step 1||1126
364519|NCT00433511|885696|P1|Patients in Genetic Ancestry Analysis|Step 1||575
364520|NCT00433511|885694|P3|Patients Who Received Treatment|Step 1||1942
364521|NCT00433511|885695|P2|Patients Who Received Treatment|Step 1||1922
364522|NCT00433511|885696|P1|Patients Who Received Treatment|Step 1||972
364523|NCT00433511|885694|P3|STARTED|Step 1||2008
364524|NCT00433511|885695|P2|STARTED|Step 1||1986
364525|NCT00433511|885696|P1|STARTED|Step 1||1000
364526|NCT00433446|885710|P1|NOT COMPLETED|Overall Study||61
364527|NCT00433446|885710|P1|COMPLETED|Overall Study||1
364528|NCT00433446|885710|P1|Eligible and Began Protocol Therapy|Overall Study||53
364529|NCT00433446|885710|P1|Eligible|Overall Study||53
364530|NCT00433446|885710|P1|STARTED|Overall Study||62
364531|NCT00433381|885720|P2|NOT COMPLETED|Overall Study||3
364532|NCT00433381|885721|P1|NOT COMPLETED|Overall Study||3
364533|NCT00433381|885720|P2|COMPLETED|Overall Study||57
364534|NCT00433381|885721|P1|COMPLETED|Overall Study|Subjects contributing data to [the primary] analysis are considered to have completed the study.|60
364535|NCT00433381|885720|P2|STARTED|Overall Study||60
364536|NCT00433381|885721|P1|STARTED|Overall Study||63
364537|NCT00433329|885740|P1|NOT COMPLETED|Overall Study||21
364538|NCT00433329|885740|P1|COMPLETED|Overall Study||79
364539|NCT00433329|885740|P1|STARTED|Overall Study||100
364540|NCT00433290|885746|P2|NOT COMPLETED|Overall Study||17
364541|NCT00433290|885747|P1|NOT COMPLETED|Overall Study||35
364542|NCT00433290|885746|P2|COMPLETED|Overall Study||111
364543|NCT00433290|885747|P1|COMPLETED|Overall Study||93
364544|NCT00433290|885746|P2|STARTED|Overall Study||128
364545|NCT00433290|885747|P1|STARTED|Overall Study||128
364546|NCT00433199|885816|P2|NOT COMPLETED|Open-Label Period||34
364547|NCT00433199|885817|P1|NOT COMPLETED|Open-Label Period||0
364548|NCT00433199|885816|P2|COMPLETED|Open-Label Period||185
364549|NCT00433199|885817|P1|COMPLETED|Open-Label Period||0
364550|NCT00433199|885816|P2|STARTED|Open-Label Period||219
364551|NCT00433199|885817|P1|STARTED|Open-Label Period||0
364552|NCT00433199|885816|P2|NOT COMPLETED|Double-Blind Period||66
364553|NCT00433199|885817|P1|NOT COMPLETED|Double-Blind Period||12
364554|NCT00433199|885816|P2|COMPLETED|Double-Blind Period||168
364555|NCT00433199|885817|P1|COMPLETED|Double-Blind Period||28
364556|NCT00433199|885816|P2|STARTED|Double-Blind Period||234
364557|NCT00433199|885817|P1|STARTED|Double-Blind Period||40
364558|NCT00433160|885837|P2|NOT COMPLETED|104 Weeks, 28-Week OL Period||3
364559|NCT00433160|885838|P1|NOT COMPLETED|104 Weeks, 28-Week OL Period||10
364560|NCT00433160|885837|P2|COMPLETED|104 Weeks, 28-Week OL Period||47
364561|NCT00433160|885838|P1|COMPLETED|104 Weeks, 28-Week OL Period||92
364562|NCT00433160|885837|P2|Received Treatment|104 Weeks, 28-Week OL Period||50
364563|NCT00433160|885838|P1|Received Treatment|104 Weeks, 28-Week OL Period||102
364564|NCT00433160|885837|P2|STARTED|104 Weeks, 28-Week OL Period|Five participants withdrew at end of first OL period and did not continue on to second OL period.|50
364565|NCT00433160|885838|P1|STARTED|104 Weeks, 28-Week OL Period|Eleven participants withdrew at end of first OL period and did not continue on to second OL period.|102
364566|NCT00433160|885837|P2|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||4
364567|NCT00433160|885838|P1|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||6
364568|NCT00433160|885837|P2|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||55
364569|NCT00433160|885838|P1|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||113
364570|NCT00433160|885837|P2|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||59
364571|NCT00433160|885838|P1|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||119
364572|NCT00433160|885837|P2|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|59
364573|NCT00433160|885838|P1|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|119
364574|NCT00433160|885837|P2|NOT COMPLETED|52-Week Double-Blind (DB) Period||10
364575|NCT00433160|885838|P1|NOT COMPLETED|52-Week Double-Blind (DB) Period||17
364576|NCT00433160|885837|P2|COMPLETED|52-Week Double-Blind (DB) Period||60
364577|NCT00433160|885838|P1|COMPLETED|52-Week Double-Blind (DB) Period||120
364578|NCT00433160|885837|P2|Received Treatment|52-Week Double-Blind (DB) Period||68
364579|NCT00433160|885838|P1|Received Treatment|52-Week Double-Blind (DB) Period||136
364580|NCT00433160|885837|P2|STARTED|52-Week Double-Blind (DB) Period||70
364581|NCT00433160|885838|P1|STARTED|52-Week Double-Blind (DB) Period||137
364582|NCT00433147|885890|P4|NOT COMPLETED|Overall Study||0
364583|NCT00433147|885891|P3|NOT COMPLETED|Overall Study||0
364584|NCT00433147|885892|P2|NOT COMPLETED|Overall Study||1
364585|NCT00433147|885893|P1|NOT COMPLETED|Overall Study||0
364586|NCT00433147|885890|P4|COMPLETED|Overall Study||7
364587|NCT00433147|885891|P3|COMPLETED|Overall Study||9
364588|NCT00433147|885892|P2|COMPLETED|Overall Study||6
364589|NCT00433147|885893|P1|COMPLETED|Overall Study||7
364590|NCT00433147|885890|P4|Received at Least One Dose of Study Drug|Overall Study||7
364591|NCT00433147|885891|P3|Received at Least One Dose of Study Drug|Overall Study||9
364592|NCT00433147|885892|P2|Received at Least One Dose of Study Drug|Overall Study||7
364593|NCT00433147|885893|P1|Received at Least One Dose of Study Drug|Overall Study||7
364594|NCT00433147|885890|P4|PD Population|Overall Study||7
364595|NCT00433147|885891|P3|PD Population|Overall Study||9
364596|NCT00433147|885892|P2|PD Population|Overall Study||6
364597|NCT00433147|885893|P1|PD Population|Overall Study||7
364598|NCT00433147|885890|P4|Safety Population|Overall Study||7
364599|NCT00433147|885891|P3|Safety Population|Overall Study||9
364600|NCT00433147|885892|P2|Safety Population|Overall Study||7
364601|NCT00433147|885893|P1|Safety Population|Overall Study||7
364602|NCT00433147|885890|P4|STARTED|Overall Study||7
364603|NCT00433147|885891|P3|STARTED|Overall Study||9
364604|NCT00433147|885892|P2|STARTED|Overall Study||7
364605|NCT00433147|885893|P1|STARTED|Overall Study||7
364606|NCT00433017|885909|P2|NOT COMPLETED|Overall Study||101
364607|NCT00433017|885910|P1|NOT COMPLETED|Overall Study||96
364608|NCT00433017|885909|P2|COMPLETED|Overall Study||32
364609|NCT00433017|885910|P1|COMPLETED|Overall Study||26
364610|NCT00433017|885909|P2|Completed 12 Month Phase|Overall Study||126
364611|NCT00433017|885910|P1|Completed 12 Month Phase|Overall Study||114
364612|NCT00433017|885909|P2|STARTED|Overall Study||133
364613|NCT00433017|885910|P1|STARTED|Overall Study||122
364614|NCT00433004|885926|P2|NOT COMPLETED|Overall Study||7
364615|NCT00433004|885927|P1|NOT COMPLETED|Overall Study||5
364616|NCT00433004|885926|P2|COMPLETED|Overall Study||16
364617|NCT00433004|885927|P1|COMPLETED|Overall Study||22
364618|NCT00433004|885926|P2|STARTED|Overall Study||23
364619|NCT00433004|885927|P1|STARTED|Overall Study||27
364620|NCT00432991|885939|P2|NOT COMPLETED|Overall Study||12
364621|NCT00432991|885940|P1|NOT COMPLETED|Overall Study||7
364622|NCT00432991|885939|P2|COMPLETED|Overall Study||19
364623|NCT00432991|885940|P1|COMPLETED|Overall Study||15
364624|NCT00432991|885939|P2|STARTED|Overall Study||31
364625|NCT00432991|885940|P1|STARTED|Overall Study||22
364626|NCT00432965|885952|P2|NOT COMPLETED|Overall Study||86
364627|NCT00432965|885953|P1|NOT COMPLETED|Overall Study||94
364628|NCT00432965|885952|P2|COMPLETED|Overall Study||80
364629|NCT00432965|885953|P1|COMPLETED|Overall Study||75
364630|NCT00432965|885952|P2|STARTED|Overall Study||166
364631|NCT00432965|885953|P1|STARTED|Overall Study||169
364632|NCT00432835|885961|P2|NOT COMPLETED|Overall Study||7
364633|NCT00432835|885962|P1|NOT COMPLETED|Overall Study||6
364634|NCT00432835|885961|P2|COMPLETED|Overall Study|These 23 patients completed the entire 8 day protocol.|23
364635|NCT00432835|885962|P1|COMPLETED|Overall Study|These 22 patients completed the entire 8 day protocol.|22
364636|NCT00432835|885961|P2|Completed 2nd Intervention|Overall Study||23
364637|NCT00432835|885962|P1|Completed 2nd Intervention|Overall Study||22
364638|NCT00432835|885961|P2|Completed 1st Intervention|Overall Study||23
364639|NCT00432835|885962|P1|Completed 1st Intervention|Overall Study||22
364640|NCT00432835|885961|P2|STARTED|Overall Study||30
364641|NCT00432835|885962|P1|STARTED|Overall Study||28
364642|NCT00432809|885975|P3|NOT COMPLETED|2 Year Sub-study||1
364643|NCT00432809|885976|P2|NOT COMPLETED|2 Year Sub-study||2
364644|NCT00432809|885977|P1|NOT COMPLETED|2 Year Sub-study||3
364645|NCT00432809|885975|P3|COMPLETED|2 Year Sub-study||19
364646|NCT00432809|885976|P2|COMPLETED|2 Year Sub-study||18
364647|NCT00432809|885977|P1|COMPLETED|2 Year Sub-study||17
364648|NCT00432809|885975|P3|STARTED|2 Year Sub-study||20
364649|NCT00432809|885976|P2|STARTED|2 Year Sub-study||20
364650|NCT00432809|885977|P1|STARTED|2 Year Sub-study||20
364651|NCT00432809|885975|P3|NOT COMPLETED|1 Year Follow-up||1
364652|NCT00432809|885976|P2|NOT COMPLETED|1 Year Follow-up||0
364653|NCT00432809|885977|P1|NOT COMPLETED|1 Year Follow-up||9
364654|NCT00432809|885975|P3|COMPLETED|1 Year Follow-up||49
364655|NCT00432809|885976|P2|COMPLETED|1 Year Follow-up||50
364656|NCT00432809|885977|P1|COMPLETED|1 Year Follow-up||41
364657|NCT00432809|885975|P3|STARTED|1 Year Follow-up||50
364658|NCT00432809|885976|P2|STARTED|1 Year Follow-up||50
364659|NCT00432809|885977|P1|STARTED|1 Year Follow-up||50
364660|NCT00432744|886050|P2|NOT COMPLETED|Months 7 - 12||1
364661|NCT00432744|886051|P1|NOT COMPLETED|Months 7 - 12||1
364662|NCT00432744|886050|P2|COMPLETED|Months 7 - 12||7
364663|NCT00432744|886051|P1|COMPLETED|Months 7 - 12||6
364664|NCT00432744|886050|P2|STARTED|Months 7 - 12||8
364665|NCT00432744|886051|P1|STARTED|Months 7 - 12||7
364666|NCT00432744|886050|P2|NOT COMPLETED|Months 0-6||4
364667|NCT00432744|886051|P1|NOT COMPLETED|Months 0-6||5
364668|NCT00432744|886050|P2|COMPLETED|Months 0-6|"One patient in period 1 other reason for loss became too disabled to complete the 6 month test."|8
364669|NCT00432744|886051|P1|COMPLETED|Months 0-6||7
364670|NCT00432744|886050|P2|STARTED|Months 0-6||12
364671|NCT00432744|886051|P1|STARTED|Months 0-6||12
364672|NCT00432679|886063|P2|NOT COMPLETED|Overall Study||3
364673|NCT00432679|886064|P1|NOT COMPLETED|Overall Study||5
364674|NCT00432679|886063|P2|COMPLETED|Overall Study||72
364675|NCT00432679|886064|P1|COMPLETED|Overall Study||69
364676|NCT00432679|886063|P2|STARTED|Overall Study||75
364677|NCT00432679|886064|P1|STARTED|Overall Study||74
364678|NCT00432666|886088|P2|NOT COMPLETED|Open-Label Extension Period||0
364679|NCT00432666|886089|P1|NOT COMPLETED|Open-Label Extension Period||25
364680|NCT00432666|886088|P2|COMPLETED|Open-Label Extension Period||0
364681|NCT00432666|886089|P1|COMPLETED|Open-Label Extension Period||120
364682|NCT00432666|886088|P2|STARTED|Open-Label Extension Period|In the Open-Label Extension Period no placebo treatment arm was given.|0
364683|NCT00432666|886089|P1|STARTED|Open-Label Extension Period||145
364684|NCT00432666|886088|P2|NOT COMPLETED|Main Period||1
364685|NCT00432666|886089|P1|NOT COMPLETED|Main Period||2
364686|NCT00432666|886088|P2|COMPLETED|Main Period||74
364687|NCT00432666|886089|P1|COMPLETED|Main Period||71
364688|NCT00432666|886088|P2|STARTED|Main Period||75
364689|NCT00432666|886089|P1|STARTED|Main Period||73
364690|NCT00432601|886253|P2|NOT COMPLETED|Time 2 to Time 3||22
364691|NCT00432601|886254|P1|NOT COMPLETED|Time 2 to Time 3||19
364692|NCT00432601|886253|P2|COMPLETED|Time 2 to Time 3||122
364693|NCT00432601|886254|P1|COMPLETED|Time 2 to Time 3||122
364694|NCT00432601|886253|P2|STARTED|Time 2 to Time 3||144
364695|NCT00432601|886254|P1|STARTED|Time 2 to Time 3||141
364696|NCT00432601|886253|P2|NOT COMPLETED|Time 1 to Time 2||368
364697|NCT00432601|886254|P1|NOT COMPLETED|Time 1 to Time 2||369
364783|NCT00432159|886535|P4|STARTED|Overall Study||20
364698|NCT00432601|886253|P2|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|144
364699|NCT00432601|886254|P1|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|141
364700|NCT00432601|886253|P2|STARTED|Time 1 to Time 2||512
364701|NCT00432601|886254|P1|STARTED|Time 1 to Time 2||510
364702|NCT00432562|886262|P2|NOT COMPLETED|Overall Study||0
364703|NCT00432562|886263|P1|NOT COMPLETED|Overall Study||3
364704|NCT00432562|886262|P2|COMPLETED|Overall Study||15
364705|NCT00432562|886263|P1|COMPLETED|Overall Study||13
364706|NCT00432562|886262|P2|STARTED|Overall Study||15
364707|NCT00432562|886263|P1|STARTED|Overall Study||16
364708|NCT00432458|886289|P2|NOT COMPLETED|Overall Study||1
364709|NCT00432458|886290|P1|NOT COMPLETED|Overall Study||5
364710|NCT00432458|886289|P2|COMPLETED|Overall Study||32
364711|NCT00432458|886290|P1|COMPLETED|Overall Study||30
364712|NCT00432458|886289|P2|STARTED|Overall Study||33
364713|NCT00432458|886290|P1|STARTED|Overall Study||35
364714|NCT00432445|886308|P1|NOT COMPLETED|Overall Study||0
364715|NCT00432445|886308|P1|COMPLETED|Overall Study||2
364716|NCT00432445|886308|P1|STARTED|Overall Study||2
364717|NCT00432380|886315|P3|NOT COMPLETED|Overall Study||1
364718|NCT00432380|886316|P2|NOT COMPLETED|Overall Study||4
364719|NCT00432380|886317|P1|NOT COMPLETED|Overall Study||4
364720|NCT00432380|886315|P3|COMPLETED|Overall Study||74
364721|NCT00432380|886316|P2|COMPLETED|Overall Study||146
364722|NCT00432380|886317|P1|COMPLETED|Overall Study||146
364723|NCT00432380|886315|P3|STARTED|Overall Study||75
364724|NCT00432380|886316|P2|STARTED|Overall Study||150
364725|NCT00432380|886317|P1|STARTED|Overall Study||150
364726|NCT00432341|886343|P2|NOT COMPLETED|Overall Study||0
364727|NCT00432341|886344|P1|NOT COMPLETED|Overall Study||0
364728|NCT00432341|886343|P2|COMPLETED|Overall Study||30
364729|NCT00432341|886344|P1|COMPLETED|Overall Study||24
364730|NCT00432341|886343|P2|STARTED|Overall Study||30
364731|NCT00432341|886344|P1|STARTED|Overall Study||24
364732|NCT00432276|886370|P2|NOT COMPLETED|Overall Study||156
364733|NCT00432276|886371|P1|NOT COMPLETED|Overall Study||121
364734|NCT00432276|886370|P2|COMPLETED|Overall Study||243
364735|NCT00432276|886371|P1|COMPLETED|Overall Study||283
364736|NCT00432276|886370|P2|Per Protocol Set|Overall Study||306
364737|NCT00432276|886371|P1|Per Protocol Set|Overall Study|Patients who received at least 1 dose of study medication and who had no major protocol violations.|303
364738|NCT00432276|886370|P2|STARTED|Overall Study||399
364739|NCT00432276|886371|P1|STARTED|Overall Study||404
364740|NCT00432237|886461|P4|NOT COMPLETED|Overall Study||124
364741|NCT00432237|886462|P3|NOT COMPLETED|Overall Study||109
364742|NCT00432237|886463|P2|NOT COMPLETED|Overall Study||101
364743|NCT00432237|886464|P1|NOT COMPLETED|Overall Study||67
364744|NCT00432237|886461|P4|COMPLETED|Overall Study||366
364745|NCT00432237|886462|P3|COMPLETED|Overall Study||375
364746|NCT00432237|886463|P2|COMPLETED|Overall Study||384
364747|NCT00432237|886464|P1|COMPLETED|Overall Study||177
364748|NCT00432237|886461|P4|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
364749|NCT00432237|886462|P3|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|5
364750|NCT00432237|886463|P2|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|3
364751|NCT00432237|886464|P1|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
364752|NCT00432237|886461|P4|Completed--With Data|Overall Study||365
364753|NCT00432237|886462|P3|Completed--With Data|Overall Study||370
364754|NCT00432237|886463|P2|Completed--With Data|Overall Study||381
364755|NCT00432237|886464|P1|Completed--With Data|Overall Study||176
364756|NCT00432237|886461|P4|STARTED|Overall Study||490
364757|NCT00432237|886462|P3|STARTED|Overall Study|1 patient in the MK0974 300 mg group was treated but withdrew consent.|484
364758|NCT00432237|886463|P2|STARTED|Overall Study||485
364759|NCT00432237|886464|P1|STARTED|Overall Study|1 patient in the MK0974 50 mg group was treated but withdrew consent.|244
364760|NCT00432172|886506|P4|NOT COMPLETED|Overall Study||7
364761|NCT00432172|886507|P3|NOT COMPLETED|Overall Study||11
364762|NCT00432172|886508|P2|NOT COMPLETED|Overall Study||7
364763|NCT00432172|886509|P1|NOT COMPLETED|Overall Study||6
364764|NCT00432172|886506|P4|COMPLETED|Overall Study||41
364765|NCT00432172|886507|P3|COMPLETED|Overall Study||35
364766|NCT00432172|886508|P2|COMPLETED|Overall Study||41
364767|NCT00432172|886509|P1|COMPLETED|Overall Study||41
364768|NCT00432172|886506|P4|STARTED|Overall Study||48
364769|NCT00432172|886507|P3|STARTED|Overall Study||46
364770|NCT00432172|886508|P2|STARTED|Overall Study||48
364771|NCT00432172|886509|P1|STARTED|Overall Study||47
364772|NCT00432159|886534|P5|NOT COMPLETED|Overall Study||10
364773|NCT00432159|886535|P4|NOT COMPLETED|Overall Study||5
364774|NCT00432159|886536|P3|NOT COMPLETED|Overall Study||4
364775|NCT00432159|886537|P2|NOT COMPLETED|Overall Study||30
364776|NCT00432159|886538|P1|NOT COMPLETED|Overall Study||22
364777|NCT00432159|886534|P5|COMPLETED|Overall Study|Actual (Complete efficacy)|79
364778|NCT00432159|886535|P4|COMPLETED|Overall Study|Actual (Complete efficacy)|15
364779|NCT00432159|886536|P3|COMPLETED|Overall Study|Actual (Complete efficacy)|35
364780|NCT00432159|886537|P2|COMPLETED|Overall Study|Actual (Complete efficacy)|137
364781|NCT00432159|886538|P1|COMPLETED|Overall Study|Actual (Complete efficacy)|163
364782|NCT00432159|886534|P5|STARTED|Overall Study||89
364784|NCT00432159|886536|P3|STARTED|Overall Study||39
364785|NCT00432159|886537|P2|STARTED|Overall Study||167
364786|NCT00432159|886538|P1|STARTED|Overall Study||185
364787|NCT00432042|886645|P3|NOT COMPLETED|Overall Study||2
364788|NCT00432042|886646|P2|NOT COMPLETED|Overall Study||1
364789|NCT00432042|886647|P1|NOT COMPLETED|Overall Study||7
364790|NCT00432042|886645|P3|COMPLETED|Overall Study||239
364791|NCT00432042|886646|P2|COMPLETED|Overall Study||234
364792|NCT00432042|886647|P1|COMPLETED|Overall Study||472
364793|NCT00432042|886645|P3|Vaccinated|Overall Study||240
364794|NCT00432042|886646|P2|Vaccinated|Overall Study||235
364795|NCT00432042|886647|P1|Vaccinated|Overall Study||477
364796|NCT00432042|886645|P3|STARTED|Overall Study|Number randomized.|241
364797|NCT00432042|886646|P2|STARTED|Overall Study|Number randomized.|235
364798|NCT00432042|886647|P1|STARTED|Overall Study|Number randomized.|479
364799|NCT00431964|886660|P2|NOT COMPLETED|Overall Study||8
364800|NCT00431964|886661|P1|NOT COMPLETED|Overall Study||6
364801|NCT00431964|886660|P2|COMPLETED|Overall Study||124
364802|NCT00431964|886661|P1|COMPLETED|Overall Study||125
364803|NCT00431964|886660|P2|Withdrew From Study|Overall Study||5
364804|NCT00431964|886661|P1|Withdrew From Study|Overall Study||6
364805|NCT00431964|886660|P2|Did Not Receive Drug|Overall Study||3
364806|NCT00431964|886661|P1|Did Not Receive Drug|Overall Study||0
364807|NCT00431964|886660|P2|Randomized/Received Drug|Overall Study||129
364808|NCT00431964|886661|P1|Randomized/Received Drug|Overall Study||131
364809|NCT00431964|886660|P2|STARTED|Overall Study||132
364810|NCT00431964|886661|P1|STARTED|Overall Study||131
364811|NCT00431951|886671|P4|NOT COMPLETED|Overall Study||2
364812|NCT00431951|886672|P3|NOT COMPLETED|Overall Study||2
364813|NCT00431951|886673|P2|NOT COMPLETED|Overall Study||2
364814|NCT00431951|886674|P1|NOT COMPLETED|Overall Study||1
364815|NCT00431951|886671|P4|COMPLETED|Overall Study||4
364816|NCT00431951|886672|P3|COMPLETED|Overall Study||6
364817|NCT00431951|886673|P2|COMPLETED|Overall Study||6
364818|NCT00431951|886674|P1|COMPLETED|Overall Study||7
364819|NCT00431951|886671|P4|STARTED|Overall Study||6
364820|NCT00431951|886672|P3|STARTED|Overall Study||8
364821|NCT00431951|886673|P2|STARTED|Overall Study||8
364822|NCT00431951|886674|P1|STARTED|Overall Study||8
364823|NCT00431847|886736|P5|NOT COMPLETED|Overall Study||1
364824|NCT00431847|886737|P4|NOT COMPLETED|Overall Study||14
364825|NCT00431847|886738|P3|NOT COMPLETED|Overall Study||4
364826|NCT00431847|886739|P2|NOT COMPLETED|Overall Study||3
364827|NCT00431847|886740|P1|NOT COMPLETED|Overall Study||6
364828|NCT00431847|886736|P5|COMPLETED|Overall Study||0
364829|NCT00431847|886737|P4|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|170
364830|NCT00431847|886738|P3|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|20
364831|NCT00431847|886739|P2|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|42
364832|NCT00431847|886740|P1|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|126
364833|NCT00431847|886736|P5|STARTED|Overall Study||1
364834|NCT00431847|886737|P4|STARTED|Overall Study||184
364835|NCT00431847|886738|P3|STARTED|Overall Study||24
364836|NCT00431847|886739|P2|STARTED|Overall Study||45
364837|NCT00431847|886740|P1|STARTED|Overall Study||132
364838|NCT00431834|886814|P1|NOT COMPLETED|Overall Study||13
364839|NCT00431834|886814|P1|COMPLETED|Overall Study||62
364840|NCT00431834|886814|P1|STARTED|Overall Study||75
364841|NCT00431626|886823|P2|NOT COMPLETED|Overall Study||0
364842|NCT00431626|886824|P1|NOT COMPLETED|Overall Study||0
364843|NCT00431626|886823|P2|COMPLETED|Overall Study||0
364844|NCT00431626|886824|P1|COMPLETED|Overall Study||4
364845|NCT00431626|886823|P2|STARTED|Overall Study||0
364846|NCT00431626|886824|P1|STARTED|Overall Study||4
364847|NCT00431496|886830|P1|NOT COMPLETED|Overall Study||11
364848|NCT00431496|886830|P1|COMPLETED|Overall Study||60
364849|NCT00431496|886830|P1|STARTED|Overall Study||71
364850|NCT00431444|886841|P2|NOT COMPLETED|Overall Study||7
364851|NCT00431444|886842|P1|NOT COMPLETED|Overall Study||5
364852|NCT00431444|886841|P2|COMPLETED|Overall Study||46
364853|NCT00431444|886842|P1|COMPLETED|Overall Study||51
364854|NCT00431444|886841|P2|STARTED|Overall Study|"Initially 110 randomized, 1 participant of Raloxifene group never took study drug."|53
364855|NCT00431444|886842|P1|STARTED|Overall Study||56
364856|NCT00431184|886868|P2|NOT COMPLETED|Second Intervention (Day 2)||0
364857|NCT00431184|886869|P1|NOT COMPLETED|Second Intervention (Day 2)||0
364858|NCT00431184|886868|P2|COMPLETED|Second Intervention (Day 2)||9
364859|NCT00431184|886869|P1|COMPLETED|Second Intervention (Day 2)||10
364860|NCT00431184|886868|P2|STARTED|Second Intervention (Day 2)||9
364861|NCT00431184|886869|P1|STARTED|Second Intervention (Day 2)||10
364862|NCT00431184|886868|P2|NOT COMPLETED|1st Intervention (Day 1)||0
364863|NCT00431184|886869|P1|NOT COMPLETED|1st Intervention (Day 1)||0
364864|NCT00431184|886868|P2|COMPLETED|1st Intervention (Day 1)||9
364865|NCT00431184|886869|P1|COMPLETED|1st Intervention (Day 1)||10
364866|NCT00431184|886868|P2|STARTED|1st Intervention (Day 1)||9
364867|NCT00431184|886869|P1|STARTED|1st Intervention (Day 1)||10
364868|NCT00431132|886877|P1|NOT COMPLETED|Overall Study||44
364869|NCT00431132|886877|P1|COMPLETED|Overall Study||292
364870|NCT00431132|886877|P1|STARTED|Overall Study||336
364871|NCT00431067|886882|P1|NOT COMPLETED|Overall Study||41
364872|NCT00431067|886882|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (22-Sep-2009)|0
364873|NCT00431067|886882|P1|STARTED|Overall Study|52 patients screened, 41 treated|41
364874|NCT00431041|886892|P2|NOT COMPLETED|Overall Study||24
364875|NCT00431041|886893|P1|NOT COMPLETED|Overall Study||16
364876|NCT00431041|886892|P2|COMPLETED|Overall Study||40
364877|NCT00431041|886893|P1|COMPLETED|Overall Study||52
364878|NCT00431041|886892|P2|STARTED|Overall Study|Data represents ITT Population: All randomized subjects|64
364879|NCT00431041|886893|P1|STARTED|Overall Study|Data represents Intention To Treat(ITT) Population: All randomized subjects|68
364880|NCT00430989|886907|P2|NOT COMPLETED|Overall Study||60
364881|NCT00430989|886908|P1|NOT COMPLETED|Overall Study||60
364882|NCT00430989|886907|P2|COMPLETED|Overall Study||3509
364883|NCT00430989|886908|P1|COMPLETED|Overall Study||3483
364884|NCT00430989|886907|P2|STARTED|Overall Study||3569
364885|NCT00430989|886908|P1|STARTED|Overall Study||3543
364886|NCT00430950|886928|P2|NOT COMPLETED|Overall Study||13
364887|NCT00430950|886929|P1|NOT COMPLETED|Overall Study||13
364888|NCT00430950|886928|P2|COMPLETED|Overall Study||495
364889|NCT00430950|886929|P1|COMPLETED|Overall Study||489
364890|NCT00430950|886928|P2|STARTED|Overall Study||508
364891|NCT00430950|886929|P1|STARTED|Overall Study||502
364892|NCT00430937|886943|P2|NOT COMPLETED|Overall Study||28
364893|NCT00430937|886944|P1|NOT COMPLETED|Overall Study||27
364894|NCT00430937|886943|P2|COMPLETED|Overall Study||64
364895|NCT00430937|886944|P1|COMPLETED|Overall Study||70
364896|NCT00430937|886943|P2|STARTED|Overall Study||92
364897|NCT00430937|886944|P1|STARTED|Overall Study|Additional 5 participants were randomized; however, they were not exposed to study drug by mistake.|97
364898|NCT00430781|886955|P3|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||20
364899|NCT00430781|886956|P2|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||18
364900|NCT00430781|886957|P1|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||24
364901|NCT00430781|886955|P3|COMPLETED|End-of-Study Analysis; 28 July 2011||54
364902|NCT00430781|886956|P2|COMPLETED|End-of-Study Analysis; 28 July 2011||59
364903|NCT00430781|886957|P1|COMPLETED|End-of-Study Analysis; 28 July 2011||53
364904|NCT00430781|886955|P3|STARTED|End-of-Study Analysis; 28 July 2011||74
364905|NCT00430781|886956|P2|STARTED|End-of-Study Analysis; 28 July 2011|1 participant randomized to lapatinib (final analysis table) actually received combination therapy.|77
364906|NCT00430781|886957|P1|STARTED|End-of-Study Analysis; 28 July 2011|Enrollment continued in this arm after data cut for Interim Analysis and before arm closed.|77
364907|NCT00430781|886955|P3|NOT COMPLETED|Final Analysis; 31 July 2008||48
364908|NCT00430781|886956|P2|NOT COMPLETED|Final Analysis; 31 July 2008||39
364909|NCT00430781|886957|P1|NOT COMPLETED|Final Analysis; 31 July 2008||0
364910|NCT00430781|886955|P3|COMPLETED|Final Analysis; 31 July 2008||26
364911|NCT00430781|886956|P2|COMPLETED|Final Analysis; 31 July 2008||39
364912|NCT00430781|886957|P1|COMPLETED|Final Analysis; 31 July 2008||0
364913|NCT00430781|886955|P3|Ongoing|Final Analysis; 31 July 2008||32
364914|NCT00430781|886956|P2|Ongoing|Final Analysis; 31 July 2008||29
364915|NCT00430781|886957|P1|Ongoing|Final Analysis; 31 July 2008||0
364916|NCT00430781|886955|P3|STARTED|Final Analysis; 31 July 2008||74
364917|NCT00430781|886956|P2|STARTED|Final Analysis; 31 July 2008||78
364918|NCT00430781|886957|P1|STARTED|Final Analysis; 31 July 2008||0
364919|NCT00430781|886955|P3|NOT COMPLETED|Interim Analysis; 11 February 2008||60
364920|NCT00430781|886956|P2|NOT COMPLETED|Interim Analysis; 11 February 2008||58
364921|NCT00430781|886957|P1|NOT COMPLETED|Interim Analysis; 11 February 2008||59
364922|NCT00430781|886955|P3|COMPLETED|Interim Analysis; 11 February 2008||0
364923|NCT00430781|886956|P2|COMPLETED|Interim Analysis; 11 February 2008||0
364924|NCT00430781|886957|P1|COMPLETED|Interim Analysis; 11 February 2008||0
364925|NCT00430781|886955|P3|Ongoing|Interim Analysis; 11 February 2008||25
364926|NCT00430781|886956|P2|Ongoing|Interim Analysis; 11 February 2008||20
364927|NCT00430781|886957|P1|Ongoing|Interim Analysis; 11 February 2008||23
364928|NCT00430781|886955|P3|STARTED|Interim Analysis; 11 February 2008||60
364929|NCT00430781|886956|P2|STARTED|Interim Analysis; 11 February 2008||58
364930|NCT00430781|886957|P1|STARTED|Interim Analysis; 11 February 2008||59
364931|NCT00430768|886983|P3|NOT COMPLETED|Overall Study||0
364932|NCT00430768|886984|P2|NOT COMPLETED|Overall Study||0
364933|NCT00430768|886985|P1|NOT COMPLETED|Overall Study||0
364934|NCT00430768|886983|P3|COMPLETED|Overall Study||3
364935|NCT00430768|886984|P2|COMPLETED|Overall Study||3
364936|NCT00430768|886985|P1|COMPLETED|Overall Study||3
364937|NCT00430768|886983|P3|STARTED|Overall Study||3
364938|NCT00430768|886984|P2|STARTED|Overall Study||3
364939|NCT00430768|886985|P1|STARTED|Overall Study||3
364940|NCT00430755|886999|P1|NOT COMPLETED|Overall Study||53
364941|NCT00430755|886999|P1|COMPLETED|Overall Study||45
364942|NCT00430755|886999|P1|STARTED|Overall Study||98
364943|NCT00430716|887006|P3|NOT COMPLETED|Open Label Phase||7
364944|NCT00430716|887007|P2|NOT COMPLETED|Open Label Phase||7
364945|NCT00430716|887008|P1|NOT COMPLETED|Open Label Phase||9
364946|NCT00430716|887006|P3|COMPLETED|Open Label Phase||32
364947|NCT00430716|887007|P2|COMPLETED|Open Label Phase||31
364948|NCT00430716|887008|P1|COMPLETED|Open Label Phase||27
364949|NCT00430716|887006|P3|STARTED|Open Label Phase||39
364950|NCT00430716|887007|P2|STARTED|Open Label Phase||38
364951|NCT00430716|887008|P1|STARTED|Open Label Phase||36
364952|NCT00430716|887006|P3|NOT COMPLETED|Double Blind Phase||6
364953|NCT00430716|887007|P2|NOT COMPLETED|Double Blind Phase||5
364954|NCT00430716|887008|P1|NOT COMPLETED|Double Blind Phase||6
364955|NCT00430716|887006|P3|COMPLETED|Double Blind Phase||39
364956|NCT00430716|887007|P2|COMPLETED|Double Blind Phase||38
364957|NCT00430716|887008|P1|COMPLETED|Double Blind Phase||36
364958|NCT00430716|887006|P3|Treated|Double Blind Phase||45
364959|NCT00430716|887007|P2|Treated|Double Blind Phase||43
364960|NCT00430716|887008|P1|Treated|Double Blind Phase||41
364961|NCT00430716|887006|P3|STARTED|Double Blind Phase||45
364962|NCT00430716|887007|P2|STARTED|Double Blind Phase||43
364963|NCT00430716|887008|P1|STARTED|Double Blind Phase||42
364964|NCT00430677|887040|P3|NOT COMPLETED|Long-term Extension Period||63
364965|NCT00430677|887041|P2|NOT COMPLETED|Long-term Extension Period||58
364966|NCT00430677|887042|P1|NOT COMPLETED|Long-term Extension Period||60
364967|NCT00430677|887040|P3|COMPLETED|Long-term Extension Period|Completed the long-term extension period|11
364968|NCT00430677|887041|P2|COMPLETED|Long-term Extension Period|Completed the long-term extension period|9
364969|NCT00430677|887042|P1|COMPLETED|Long-term Extension Period|Completed the long-term extension period|10
364970|NCT00430677|887040|P3|STARTED|Long-term Extension Period||74
364971|NCT00430677|887041|P2|STARTED|Long-term Extension Period||67
364972|NCT00430677|887042|P1|STARTED|Long-term Extension Period||70
364973|NCT00430677|887040|P3|NOT COMPLETED|Short-term Period||22
364974|NCT00430677|887041|P2|NOT COMPLETED|Short-term Period||25
364975|NCT00430677|887042|P1|NOT COMPLETED|Short-term Period||23
364976|NCT00430677|887040|P3|COMPLETED|Short-term Period|Completed the short-term period|78
364977|NCT00430677|887041|P2|COMPLETED|Short-term Period|Completed the short-term period|74
364978|NCT00430677|887042|P1|COMPLETED|Short-term Period|Completed the short-term period|76
364979|NCT00430677|887040|P3|STARTED|Short-term Period||100
364980|NCT00430677|887041|P2|STARTED|Short-term Period|1 participant took infliximab on day 1 and was discontinued before receiving study medication.|99
364981|NCT00430677|887042|P1|STARTED|Short-term Period|1 participant died before receiving the first dose of study medication|99
364982|NCT00430638|887165|P2|NOT COMPLETED|Overall Study||48
364983|NCT00430638|887166|P1|NOT COMPLETED|Overall Study||78
364984|NCT00430638|887165|P2|COMPLETED|Overall Study||92
364985|NCT00430638|887166|P1|COMPLETED|Overall Study||60
364986|NCT00430638|887165|P2|STARTED|Overall Study|2 participants were erroneously assigned to olmesartan 40 mg instead of 20 mg|140
364987|NCT00430638|887166|P1|STARTED|Overall Study||138
364988|NCT00430625|887184|P2|NOT COMPLETED|Overall Study||0
364989|NCT00430625|887185|P1|NOT COMPLETED|Overall Study||0
364990|NCT00430625|887184|P2|COMPLETED|Overall Study||12
364991|NCT00430625|887185|P1|COMPLETED|Overall Study||13
364992|NCT00430625|887184|P2|STARTED|Overall Study||12
364993|NCT00430625|887185|P1|STARTED|Overall Study||13
364994|NCT00430573|887201|P1|NOT COMPLETED|Overall Study||5
364995|NCT00430573|887201|P1|COMPLETED|Overall Study|Only 5 took study drug on at least one occasion and 8 completed the baseline ASI.|5
364996|NCT00430573|887201|P1|STARTED|Overall Study||10
364997|NCT00430521|887214|P8|NOT COMPLETED|Overall Study||12
364998|NCT00430521|887215|P7|NOT COMPLETED|Overall Study||10
364999|NCT00430521|887216|P6|NOT COMPLETED|Overall Study||5
365000|NCT00430521|887217|P5|NOT COMPLETED|Overall Study||5
365001|NCT00430521|887218|P4|NOT COMPLETED|Overall Study||8
365002|NCT00430521|887219|P3|NOT COMPLETED|Overall Study||3
365003|NCT00430521|887220|P2|NOT COMPLETED|Overall Study||9
365004|NCT00430521|887221|P1|NOT COMPLETED|Overall Study||11
365005|NCT00430521|887214|P8|COMPLETED|Overall Study||51
365006|NCT00430521|887215|P7|COMPLETED|Overall Study||55
365007|NCT00430521|887216|P6|COMPLETED|Overall Study||59
365008|NCT00430521|887217|P5|COMPLETED|Overall Study||59
365009|NCT00430521|887218|P4|COMPLETED|Overall Study||55
365010|NCT00430521|887219|P3|COMPLETED|Overall Study||61
365011|NCT00430521|887220|P2|COMPLETED|Overall Study||57
365012|NCT00430521|887221|P1|COMPLETED|Overall Study||52
365013|NCT00430521|887214|P8|STARTED|Overall Study||63
365014|NCT00430521|887215|P7|STARTED|Overall Study||65
365015|NCT00430521|887216|P6|STARTED|Overall Study||64
365016|NCT00430521|887217|P5|STARTED|Overall Study||64
365017|NCT00430521|887218|P4|STARTED|Overall Study||63
365018|NCT00430521|887219|P3|STARTED|Overall Study||64
365019|NCT00430521|887220|P2|STARTED|Overall Study||66
365020|NCT00430521|887221|P1|STARTED|Overall Study||63
365021|NCT00430508|887463|P4|NOT COMPLETED|Overall Study||5
365022|NCT00430508|887464|P3|NOT COMPLETED|Overall Study||13
365023|NCT00430508|887465|P2|NOT COMPLETED|Overall Study||6
365024|NCT00430508|887466|P1|NOT COMPLETED|Overall Study||3
365025|NCT00430508|887463|P4|COMPLETED|Overall Study||269
365026|NCT00430508|887464|P3|COMPLETED|Overall Study||266
365027|NCT00430508|887465|P2|COMPLETED|Overall Study||272
365028|NCT00430508|887466|P1|COMPLETED|Overall Study||137
365029|NCT00430508|887463|P4|STARTED|Overall Study||274
365030|NCT00430508|887464|P3|STARTED|Overall Study||279
365031|NCT00430508|887465|P2|STARTED|Overall Study||278
365032|NCT00430508|887466|P1|STARTED|Overall Study||140
365033|NCT00430495|887504|P4|NOT COMPLETED|Overall Study||4
365034|NCT00430495|887505|P3|NOT COMPLETED|Overall Study||13
365035|NCT00430495|887506|P2|NOT COMPLETED|Overall Study||7
365036|NCT00430495|887507|P1|NOT COMPLETED|Overall Study||14
365037|NCT00430495|887504|P4|COMPLETED|Overall Study||60
365038|NCT00430495|887505|P3|COMPLETED|Overall Study||49
365039|NCT00430495|887506|P2|COMPLETED|Overall Study||59
365040|NCT00430495|887507|P1|COMPLETED|Overall Study||50
365041|NCT00430495|887504|P4|Treated|Overall Study||64
365042|NCT00430495|887505|P3|Treated|Overall Study||62
365043|NCT00430495|887506|P2|Treated|Overall Study||66
365044|NCT00430495|887507|P1|Treated|Overall Study||62
365045|NCT00430495|887504|P4|STARTED|Overall Study||64
365046|NCT00430495|887505|P3|STARTED|Overall Study||62
365047|NCT00430495|887506|P2|STARTED|Overall Study||66
365048|NCT00430495|887507|P1|STARTED|Overall Study||64
365049|NCT00430482|887547|P2|NOT COMPLETED|Completed 2 Follow-Up Visits||6
365050|NCT00430482|887548|P1|NOT COMPLETED|Completed 2 Follow-Up Visits||5
365051|NCT00430482|887547|P2|COMPLETED|Completed 2 Follow-Up Visits||20
365052|NCT00430482|887548|P1|COMPLETED|Completed 2 Follow-Up Visits||29
365053|NCT00430482|887547|P2|Completed ASI at Follow-Up #2|Completed 2 Follow-Up Visits||20
365054|NCT00430482|887548|P1|Completed ASI at Follow-Up #2|Completed 2 Follow-Up Visits||29
365055|NCT00430482|887547|P2|Completed ASI at Follow-Up #1|Completed 2 Follow-Up Visits||20
365056|NCT00430482|887548|P1|Completed ASI at Follow-Up #1|Completed 2 Follow-Up Visits||27
365057|NCT00430482|887547|P2|STARTED|Completed 2 Follow-Up Visits||26
365058|NCT00430482|887548|P1|STARTED|Completed 2 Follow-Up Visits||34
365059|NCT00430482|887547|P2|NOT COMPLETED|Completed Treatment||11
365060|NCT00430482|887548|P1|NOT COMPLETED|Completed Treatment||7
365061|NCT00430482|887547|P2|COMPLETED|Completed Treatment||26
365062|NCT00430482|887548|P1|COMPLETED|Completed Treatment||34
365063|NCT00430482|887547|P2|Completed ASI at Midpoint|Completed Treatment||29
365064|NCT00430482|887548|P1|Completed ASI at Midpoint|Completed Treatment||35
365065|NCT00430482|887547|P2|STARTED|Completed Treatment||37
365066|NCT00430482|887548|P1|STARTED|Completed Treatment||41
365067|NCT00430352|887556|P1|NOT COMPLETED|Overall Study||138
365068|NCT00430352|887556|P1|COMPLETED|Overall Study||407
365069|NCT00430352|887556|P1|STARTED|Overall Study||545
365070|NCT00430300|887574|P4|NOT COMPLETED|Overall Study||2
365071|NCT00430300|887575|P3|NOT COMPLETED|Overall Study||6
365072|NCT00430300|887576|P2|NOT COMPLETED|Overall Study||2
365073|NCT00430300|887577|P1|NOT COMPLETED|Overall Study||2
365074|NCT00430300|887574|P4|COMPLETED|Overall Study||15
365075|NCT00430300|887575|P3|COMPLETED|Overall Study||29
365076|NCT00430300|887576|P2|COMPLETED|Overall Study||16
365077|NCT00430300|887577|P1|COMPLETED|Overall Study||15
365078|NCT00430300|887574|P4|STARTED|Overall Study||17
365079|NCT00430300|887575|P3|STARTED|Overall Study||35
365080|NCT00430300|887576|P2|STARTED|Overall Study||18
365081|NCT00430300|887577|P1|STARTED|Overall Study||17
365082|NCT00430248|887682|P3|NOT COMPLETED|Overall Study||135
365083|NCT00430248|887683|P2|NOT COMPLETED|Overall Study||158
365084|NCT00430248|887684|P1|NOT COMPLETED|Overall Study||125
365085|NCT00430248|887682|P3|COMPLETED|Overall Study||621
365086|NCT00430248|887683|P2|COMPLETED|Overall Study||598
365087|NCT00430248|887684|P1|COMPLETED|Overall Study||632
365088|NCT00430248|887682|P3|STARTED|Overall Study||756
365089|NCT00430248|887683|P2|STARTED|Overall Study||756
365090|NCT00430248|887684|P1|STARTED|Overall Study||757
365091|NCT00430092|887743|P3|NOT COMPLETED|Overall Study||57
365092|NCT00430092|887744|P2|NOT COMPLETED|Overall Study||4
365093|NCT00430092|887745|P1|NOT COMPLETED|Overall Study||6
365094|NCT00430092|887743|P3|COMPLETED|Overall Study||56
365095|NCT00430092|887744|P2|COMPLETED|Overall Study||48
365096|NCT00430092|887745|P1|COMPLETED|Overall Study||48
365097|NCT00430092|887743|P3|STARTED|Overall Study||113
365098|NCT00430092|887744|P2|STARTED|Overall Study||52
365099|NCT00430092|887745|P1|STARTED|Overall Study||54
365100|NCT00430027|887750|P1|NOT COMPLETED|Overall Study||8
365101|NCT00430027|887750|P1|COMPLETED|Overall Study||0
365102|NCT00430027|887750|P1|STARTED|Overall Study||8
365103|NCT00429949|887754|P1|NOT COMPLETED|Overall Study||0
365104|NCT00429949|887754|P1|COMPLETED|Overall Study||21
365105|NCT00429949|887754|P1|STARTED|Overall Study||21
365106|NCT00429923|887767|P3|NOT COMPLETED|Overall Study||39
365107|NCT00429923|887768|P2|NOT COMPLETED|Overall Study||4
365108|NCT00429923|887769|P1|NOT COMPLETED|Overall Study||5
365109|NCT00429923|887767|P3|COMPLETED|Overall Study||68
365110|NCT00429923|887768|P2|COMPLETED|Overall Study||51
365111|NCT00429923|887769|P1|COMPLETED|Overall Study||52
365112|NCT00429923|887767|P3|STARTED|Overall Study||107
365113|NCT00429923|887768|P2|STARTED|Overall Study||55
365114|NCT00429923|887769|P1|STARTED|Overall Study||57
365115|NCT00429793|887774|P1|NOT COMPLETED|Overall Study||6
365116|NCT00429793|887774|P1|COMPLETED|Overall Study||54
365117|NCT00429793|887774|P1|STARTED|Overall Study||60
365118|NCT00429702|887790|P2|NOT COMPLETED|Overall Study||0
365119|NCT00429702|887791|P1|NOT COMPLETED|Overall Study||0
365120|NCT00429702|887790|P2|COMPLETED|Overall Study||4
365121|NCT00429702|887791|P1|COMPLETED|Overall Study||3
365122|NCT00429702|887790|P2|STARTED|Overall Study||4
365123|NCT00429702|887791|P1|STARTED|Overall Study||3
365124|NCT00429663|887801|P2|NOT COMPLETED|Overall Study||39
365125|NCT00429663|887802|P1|NOT COMPLETED|Overall Study||36
365126|NCT00429663|887801|P2|COMPLETED|Overall Study||41
365127|NCT00429663|887802|P1|COMPLETED|Overall Study||40
365128|NCT00429663|887801|P2|STARTED|Overall Study||80
365129|NCT00429663|887802|P1|STARTED|Overall Study||76
365130|NCT00429572|887816|P1|NOT COMPLETED|Overall Study||1
365131|NCT00429572|887816|P1|COMPLETED|Overall Study||18
365132|NCT00429572|887816|P1|STARTED|Overall Study||19
365133|NCT00429507|887824|P1|NOT COMPLETED|Overall Study||0
365134|NCT00429507|887824|P1|COMPLETED|Overall Study||12
365135|NCT00429507|887824|P1|STARTED|Overall Study||12
365136|NCT00429494|887828|P1|NOT COMPLETED|Overall Study||15
365137|NCT00429494|887828|P1|COMPLETED|Overall Study||44
365138|NCT00429494|887828|P1|STARTED|Overall Study||59
365139|NCT00429416|887832|P1|NOT COMPLETED|Overall Study||1
365140|NCT00429416|887832|P1|COMPLETED|Overall Study||13
365141|NCT00429416|887832|P1|STARTED|Overall Study||14
365142|NCT00429403|887842|P2|NOT COMPLETED|Overall Study||0
365143|NCT00429403|887843|P1|NOT COMPLETED|Overall Study||0
365144|NCT00429403|887842|P2|COMPLETED|Overall Study||0
365145|NCT00429403|887843|P1|COMPLETED|Overall Study||1
365146|NCT00429403|887842|P2|STARTED|Overall Study||0
365147|NCT00429403|887843|P1|STARTED|Overall Study||1
365148|NCT00429364|887851|P2|NOT COMPLETED|Overall Study||33
365149|NCT00429364|887852|P1|NOT COMPLETED|Overall Study||32
365150|NCT00429364|887851|P2|COMPLETED|Overall Study||272
365151|NCT00429364|887852|P1|COMPLETED|Overall Study||271
365152|NCT00429364|887851|P2|STARTED|Overall Study||305
365153|NCT00429364|887852|P1|STARTED|Overall Study||303
365154|NCT00429299|887911|P3|NOT COMPLETED|Overall Study||4
365155|NCT00429299|887912|P2|NOT COMPLETED|Overall Study||7
365156|NCT00429299|887913|P1|NOT COMPLETED|Overall Study||4
365157|NCT00429299|887911|P3|COMPLETED|Overall Study||42
365158|NCT00429299|887912|P2|COMPLETED|Overall Study||32
365159|NCT00429299|887913|P1|COMPLETED|Overall Study||32
365160|NCT00429299|887911|P3|STARTED|Overall Study||46
365161|NCT00429299|887912|P2|STARTED|Overall Study||39
365162|NCT00429299|887913|P1|STARTED|Overall Study||36
365163|NCT00429273|887945|P3|NOT COMPLETED|Overall Study||9
365164|NCT00429273|887946|P2|NOT COMPLETED|Overall Study||8
365165|NCT00429273|887947|P1|NOT COMPLETED|Overall Study||8
365166|NCT00429273|887945|P3|COMPLETED|Overall Study||61
365167|NCT00429273|887946|P2|COMPLETED|Overall Study||61
365168|NCT00429273|887947|P1|COMPLETED|Overall Study||60
365169|NCT00429273|887945|P3|STARTED|Overall Study||70
365170|NCT00429273|887946|P2|STARTED|Overall Study||69
365171|NCT00429273|887947|P1|STARTED|Overall Study||68
365172|NCT00429182|887955|P1|NOT COMPLETED|Overall Study||7
365173|NCT00429182|887955|P1|COMPLETED|Overall Study||25
365174|NCT00429182|887955|P1|STARTED|Overall Study||32
365175|NCT00429169|887962|P2|NOT COMPLETED|Overall Study||2
365176|NCT00429169|887963|P1|NOT COMPLETED|Overall Study||2
365177|NCT00429169|887962|P2|COMPLETED|Overall Study|2 subjects excluded: re-diagnosis/ineligibility (1), and did not return after randomization (1).|38
365178|NCT00429169|887963|P1|COMPLETED|Overall Study|2 subjects excluded due to re-diagnosis/ineligibility.|36
365179|NCT00429169|887962|P2|STARTED|Overall Study||40
365180|NCT00429169|887963|P1|STARTED|Overall Study||38
365181|NCT00429143|887975|P1|NOT COMPLETED|Overall Study||0
365182|NCT00429143|887975|P1|COMPLETED|Overall Study||27
365183|NCT00429143|887975|P1|STARTED|Overall Study||27
365184|NCT00429104|887983|P1|NOT COMPLETED|Overall Study||1
365185|NCT00429104|887983|P1|COMPLETED|Overall Study||17
365186|NCT00429104|887983|P1|STARTED|Overall Study||18
365187|NCT00429026|887988|P1|NOT COMPLETED|Overall Study||40
365188|NCT00429026|887988|P1|COMPLETED|Overall Study||0
365189|NCT00429026|887988|P1|STARTED|Overall Study||40
365190|NCT00428974|887996|P4|NOT COMPLETED|Overall Study||3
365191|NCT00428974|887997|P3|NOT COMPLETED|Overall Study||1
365192|NCT00428974|887998|P2|NOT COMPLETED|Overall Study||0
365193|NCT00428974|887999|P1|NOT COMPLETED|Overall Study||8
365194|NCT00428974|887996|P4|COMPLETED|Overall Study||16
365195|NCT00428974|887997|P3|COMPLETED|Overall Study||14
365196|NCT00428974|887998|P2|COMPLETED|Overall Study||17
365197|NCT00428974|887999|P1|COMPLETED|Overall Study||17
365198|NCT00428974|887996|P4|STARTED|Overall Study||19
365199|NCT00428974|887997|P3|STARTED|Overall Study||15
365200|NCT00428974|887998|P2|STARTED|Overall Study||17
365201|NCT00428974|887999|P1|STARTED|Overall Study|one patient was randomized but never received study treatment|25
365202|NCT00428948|888015|P2|NOT COMPLETED|Overall Study||67
365203|NCT00428948|888016|P1|NOT COMPLETED|Overall Study||221
365204|NCT00428948|888015|P2|COMPLETED|Overall Study||417
365205|NCT00428948|888016|P1|COMPLETED|Overall Study||740
365206|NCT00428948|888015|P2|Received Treatment|Overall Study||483
365207|NCT00428948|888016|P1|Received Treatment|Overall Study||961
365208|NCT00428948|888015|P2|STARTED|Overall Study||484
365209|NCT00428948|888016|P1|STARTED|Overall Study||961
365210|NCT00428922|888034|P1|NOT COMPLETED|Overall Study||0
365211|NCT00428922|888034|P1|COMPLETED|Overall Study||26
365212|NCT00428922|888034|P1|STARTED|Overall Study||26
365213|NCT00428844|888044|P3|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
365214|NCT00428844|888045|P2|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
365215|NCT00428844|888046|P1|NOT COMPLETED|Completed Test of Cure (TOC) Visit||3
365216|NCT00428844|888044|P3|COMPLETED|Completed Test of Cure (TOC) Visit||17
365217|NCT00428844|888045|P2|COMPLETED|Completed Test of Cure (TOC) Visit||16
365218|NCT00428844|888046|P1|COMPLETED|Completed Test of Cure (TOC) Visit||20
365219|NCT00428844|888044|P3|STARTED|Completed Test of Cure (TOC) Visit||19
365220|NCT00428844|888045|P2|STARTED|Completed Test of Cure (TOC) Visit||18
365221|NCT00428844|888046|P1|STARTED|Completed Test of Cure (TOC) Visit||23
365222|NCT00428844|888044|P3|NOT COMPLETED|Completed Study Drug Treatment||7
365223|NCT00428844|888045|P2|NOT COMPLETED|Completed Study Drug Treatment||6
365224|NCT00428844|888046|P1|NOT COMPLETED|Completed Study Drug Treatment||2
365225|NCT00428844|888044|P3|COMPLETED|Completed Study Drug Treatment||19
365226|NCT00428844|888045|P2|COMPLETED|Completed Study Drug Treatment||18
365227|NCT00428844|888046|P1|COMPLETED|Completed Study Drug Treatment||23
365228|NCT00428844|888044|P3|Received First Dose|Completed Study Drug Treatment||25
365229|NCT00428844|888045|P2|Received First Dose|Completed Study Drug Treatment||24
365230|NCT00428844|888046|P1|Received First Dose|Completed Study Drug Treatment||25
365231|NCT00428844|888044|P3|STARTED|Completed Study Drug Treatment||26
365232|NCT00428844|888045|P2|STARTED|Completed Study Drug Treatment||24
365233|NCT00428844|888046|P1|STARTED|Completed Study Drug Treatment||25
365234|NCT00428792|888069|P2|NOT COMPLETED|Overall Study||4
365235|NCT00428792|888070|P1|NOT COMPLETED|Overall Study||1
365236|NCT00428792|888069|P2|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|66
365237|NCT00428792|888070|P1|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|79
365238|NCT00428792|888069|P2|STARTED|Overall Study||70
365239|NCT00428792|888070|P1|STARTED|Overall Study||80
365240|NCT00428610|888097|P3|NOT COMPLETED|Overall Study||32
365241|NCT00428610|888098|P2|NOT COMPLETED|Overall Study||18
365242|NCT00428610|888099|P1|NOT COMPLETED|Overall Study||53
365243|NCT00428610|888097|P3|COMPLETED|Overall Study||0
365244|NCT00428610|888098|P2|COMPLETED|Overall Study||0
365245|NCT00428610|888099|P1|COMPLETED|Overall Study||0
365246|NCT00428610|888097|P3|Received at Least One Dose of Study Drug|Overall Study||32
365247|NCT00428610|888098|P2|Received at Least One Dose of Study Drug|Overall Study||18
365248|NCT00428610|888099|P1|Received at Least One Dose of Study Drug|Overall Study||53
365249|NCT00428610|888097|P3|STARTED|Overall Study||32
365250|NCT00428610|888098|P2|STARTED|Overall Study||18
365251|NCT00428610|888099|P1|STARTED|Overall Study||53
365252|NCT00428597|888133|P2|NOT COMPLETED|Overall Study||85
365253|NCT00428597|888134|P1|NOT COMPLETED|Overall Study||86
365254|NCT00428597|888133|P2|COMPLETED|Overall Study||0
365255|NCT00428597|888134|P1|COMPLETED|Overall Study||0
365256|NCT00428597|888133|P2|Received Treatment|Overall Study||82
365257|NCT00428597|888134|P1|Received Treatment|Overall Study||83
365258|NCT00428597|888133|P2|STARTED|Overall Study||85
365259|NCT00428597|888134|P1|STARTED|Overall Study||86
365260|NCT00428584|888176|P2|NOT COMPLETED|Extension Phase||29
365261|NCT00428584|888177|P1|NOT COMPLETED|Extension Phase||21
365262|NCT00428584|888176|P2|COMPLETED|Extension Phase||34
365263|NCT00428584|888177|P1|COMPLETED|Extension Phase||35
365264|NCT00428584|888176|P2|STARTED|Extension Phase||63
365265|NCT00428584|888177|P1|STARTED|Extension Phase|Extension Phase - new formulation of rebif to new formulation of rebif|56
365266|NCT00428584|888176|P2|NOT COMPLETED|Comparative Phase||1
365267|NCT00428584|888177|P1|NOT COMPLETED|Comparative Phase||9
365268|NCT00428584|888176|P2|COMPLETED|Comparative Phase||63
365269|NCT00428584|888177|P1|COMPLETED|Comparative Phase|Comparator Phase - new formulation of rebif and Betaseron|56
365270|NCT00428584|888176|P2|STARTED|Comparative Phase||64
365271|NCT00428584|888177|P1|STARTED|Comparative Phase||65
365272|NCT00428441|888201|P1|NOT COMPLETED|Overall Study||1
365273|NCT00428441|888201|P1|COMPLETED|Overall Study||74
365274|NCT00428441|888201|P1|STARTED|Overall Study||75
365275|NCT00428389|888207|P2|NOT COMPLETED|Extension Phase||26
365276|NCT00428389|888208|P1|NOT COMPLETED|Extension Phase||32
365277|NCT00428389|888207|P2|COMPLETED|Extension Phase||91
365278|NCT00428389|888208|P1|COMPLETED|Extension Phase||85
365279|NCT00428389|888207|P2|STARTED|Extension Phase||117
365280|NCT00428389|888208|P1|STARTED|Extension Phase|Participants were required to sign a separate informed consent prior to entering the extension phase|117
365281|NCT00428389|888207|P2|NOT COMPLETED|Core Phase||11
365282|NCT00428389|888208|P1|NOT COMPLETED|Core Phase||11
365283|NCT00428389|888207|P2|COMPLETED|Core Phase||120
365284|NCT00428389|888208|P1|COMPLETED|Core Phase||120
365285|NCT00428389|888207|P2|Intent-to-treat Population|Core Phase|1 patient was discontinued from the study the same day as randomization & excluded from all analyses|130
365286|NCT00428389|888208|P1|Intent-to-treat Population|Core Phase||131
365287|NCT00428389|888207|P2|STARTED|Core Phase||131
365288|NCT00428389|888208|P1|STARTED|Core Phase||131
365289|NCT00428298|888228|P2|NOT COMPLETED|Overall Study||11
365290|NCT00428298|888229|P1|NOT COMPLETED|Overall Study||14
365291|NCT00428298|888228|P2|COMPLETED|Overall Study||19
365292|NCT00428298|888229|P1|COMPLETED|Overall Study||16
365293|NCT00428298|888228|P2|Second RBANS at Study Exit|Overall Study||3
365294|NCT00428298|888229|P1|Second RBANS at Study Exit|Overall Study||3
365295|NCT00428298|888228|P2|STARTED|Overall Study||30
365296|NCT00428298|888229|P1|STARTED|Overall Study||30
365297|NCT00428246|888242|P3|NOT COMPLETED|Overall Study||1
365298|NCT00428246|888243|P2|NOT COMPLETED|Overall Study||0
365299|NCT00428246|888244|P1|NOT COMPLETED|Overall Study||1
365300|NCT00428246|888242|P3|COMPLETED|Overall Study||7
365301|NCT00428246|888243|P2|COMPLETED|Overall Study||8
365302|NCT00428246|888244|P1|COMPLETED|Overall Study||7
365303|NCT00428246|888242|P3|STARTED|Overall Study||8
365304|NCT00428246|888243|P2|STARTED|Overall Study||8
365305|NCT00428246|888244|P1|STARTED|Overall Study||8
365306|NCT00428220|888252|P1|NOT COMPLETED|Overall Study||223
365307|NCT00428220|888252|P1|COMPLETED|Overall Study||0
365308|NCT00428220|888252|P1|STARTED|Overall Study||223
365309|NCT00428207|888268|P2|NOT COMPLETED|Overall Study||0
365310|NCT00428207|888269|P1|NOT COMPLETED|Overall Study||0
365311|NCT00428207|888268|P2|COMPLETED|Overall Study||2
365312|NCT00428207|888269|P1|COMPLETED|Overall Study||2
365313|NCT00428207|888268|P2|STARTED|Overall Study||2
365314|NCT00428207|888269|P1|STARTED|Overall Study||2
365315|NCT00428116|888277|P2|NOT COMPLETED|Overall Study||0
365316|NCT00428116|888278|P1|NOT COMPLETED|Overall Study||3
365317|NCT00428116|888277|P2|COMPLETED|Overall Study||21
365318|NCT00428116|888278|P1|COMPLETED|Overall Study||18
365319|NCT00428116|888277|P2|STARTED|Overall Study||21
365320|NCT00428116|888278|P1|STARTED|Overall Study||21
365321|NCT00428090|888290|P4|NOT COMPLETED|Overall Study||28
365322|NCT00428090|888291|P3|NOT COMPLETED|Overall Study||38
365323|NCT00428090|888292|P2|NOT COMPLETED|Overall Study||31
365324|NCT00428090|888293|P1|NOT COMPLETED|Overall Study||34
365325|NCT00428090|888290|P4|COMPLETED|Overall Study||55
365326|NCT00428090|888291|P3|COMPLETED|Overall Study||127
365327|NCT00428090|888292|P2|COMPLETED|Overall Study||135
365328|NCT00428090|888293|P1|COMPLETED|Overall Study||131
365329|NCT00428090|888290|P4|STARTED|Overall Study||83
365330|NCT00428090|888291|P3|STARTED|Overall Study||165
365331|NCT00428090|888292|P2|STARTED|Overall Study||166
365332|NCT00428090|888293|P1|STARTED|Overall Study||165
365333|NCT00428077|888407|P1|NOT COMPLETED|Overall Study||0
365334|NCT00428077|888407|P1|COMPLETED|Overall Study||4
365335|NCT00428077|888407|P1|STARTED|Overall Study||4
365336|NCT00427999|888411|P1|NOT COMPLETED|Overall Study||32
365337|NCT00427999|888411|P1|COMPLETED|Overall Study||33
365338|NCT00427999|888411|P1|Extension Follow-up|Overall Study||19
365339|NCT00427999|888411|P1|Intent to Treat (ITT)|Overall Study||61
365340|NCT00427999|888411|P1|STARTED|Overall Study||65
365341|NCT00427973|888420|P1|NOT COMPLETED|Overall Study||0
365342|NCT00427973|888420|P1|COMPLETED|Overall Study||17
365343|NCT00427973|888420|P1|STARTED|Overall Study||17
365344|NCT00427960|888429|P2|NOT COMPLETED|Overall Study||4
365345|NCT00427960|888430|P1|NOT COMPLETED|Overall Study||2
365346|NCT00427960|888429|P2|COMPLETED|Overall Study||21
365347|NCT00427960|888430|P1|COMPLETED|Overall Study||28
365348|NCT00427960|888429|P2|STARTED|Overall Study||25
365349|NCT00427960|888430|P1|STARTED|Overall Study||30
365350|NCT00427934|888468|P4|NOT COMPLETED|Overall Study||15
365351|NCT00427934|888469|P3|NOT COMPLETED|Overall Study||23
365352|NCT00427934|888470|P2|NOT COMPLETED|Overall Study||0
365353|NCT00427934|888471|P1|NOT COMPLETED|Overall Study||1
365354|NCT00427934|888468|P4|COMPLETED|Overall Study||19
365355|NCT00427934|888469|P3|COMPLETED|Overall Study||55
365356|NCT00427934|888470|P2|COMPLETED|Overall Study||8
365357|NCT00427934|888471|P1|COMPLETED|Overall Study||7
365358|NCT00427934|888468|P4|Treated|Overall Study||33
365359|NCT00427934|888469|P3|Treated|Overall Study||77
365360|NCT00427934|888470|P2|Treated|Overall Study||8
365361|NCT00427934|888471|P1|Treated|Overall Study||8
365362|NCT00427934|888468|P4|STARTED|Overall Study||34
365363|NCT00427934|888469|P3|STARTED|Overall Study||78
365364|NCT00427934|888470|P2|STARTED|Overall Study||8
365365|NCT00427934|888471|P1|STARTED|Overall Study||8
365366|NCT00427921|888539|P1|NOT COMPLETED|Overall Study||50
365367|NCT00427921|888539|P1|COMPLETED|Overall Study||254
365368|NCT00427921|888539|P1|STARTED|Overall Study||304
365369|NCT00427908|888562|P4|NOT COMPLETED|Persistence Phase Year 5||0
365370|NCT00427908|888563|P3|NOT COMPLETED|Persistence Phase Year 5||0
365371|NCT00427908|888564|P2|NOT COMPLETED|Persistence Phase Year 5||0
365372|NCT00427908|888565|P1|NOT COMPLETED|Persistence Phase Year 5||0
365373|NCT00427908|888562|P4|COMPLETED|Persistence Phase Year 5||13
365374|NCT00427908|888563|P3|COMPLETED|Persistence Phase Year 5||12
365375|NCT00427908|888564|P2|COMPLETED|Persistence Phase Year 5||99
365376|NCT00427908|888565|P1|COMPLETED|Persistence Phase Year 5||52
365377|NCT00427908|888562|P4|STARTED|Persistence Phase Year 5||13
365378|NCT00427908|888563|P3|STARTED|Persistence Phase Year 5||12
365379|NCT00427908|888564|P2|STARTED|Persistence Phase Year 5||99
365380|NCT00427908|888565|P1|STARTED|Persistence Phase Year 5||52
365381|NCT00427908|888562|P4|NOT COMPLETED|Persistence Phase Year 4||0
365382|NCT00427908|888563|P3|NOT COMPLETED|Persistence Phase Year 4||0
365383|NCT00427908|888564|P2|NOT COMPLETED|Persistence Phase Year 4||0
365384|NCT00427908|888565|P1|NOT COMPLETED|Persistence Phase Year 4||0
365385|NCT00427908|888562|P4|COMPLETED|Persistence Phase Year 4||32
365386|NCT00427908|888563|P3|COMPLETED|Persistence Phase Year 4||34
365387|NCT00427908|888564|P2|COMPLETED|Persistence Phase Year 4||192
365388|NCT00427908|888565|P1|COMPLETED|Persistence Phase Year 4||165
365389|NCT00427908|888562|P4|STARTED|Persistence Phase Year 4||32
365390|NCT00427908|888563|P3|STARTED|Persistence Phase Year 4||34
365391|NCT00427908|888564|P2|STARTED|Persistence Phase Year 4||192
365392|NCT00427908|888565|P1|STARTED|Persistence Phase Year 4||165
365393|NCT00427908|888562|P4|NOT COMPLETED|Persistence Phase Year 3||0
365394|NCT00427908|888563|P3|NOT COMPLETED|Persistence Phase Year 3||0
365395|NCT00427908|888564|P2|NOT COMPLETED|Persistence Phase Year 3||0
365396|NCT00427908|888565|P1|NOT COMPLETED|Persistence Phase Year 3||0
365397|NCT00427908|888562|P4|COMPLETED|Persistence Phase Year 3||38
365398|NCT00427908|888563|P3|COMPLETED|Persistence Phase Year 3||38
365399|NCT00427908|888564|P2|COMPLETED|Persistence Phase Year 3||201
365400|NCT00427908|888565|P1|COMPLETED|Persistence Phase Year 3||185
365401|NCT00427908|888562|P4|STARTED|Persistence Phase Year 3||38
365402|NCT00427908|888563|P3|STARTED|Persistence Phase Year 3||38
365403|NCT00427908|888564|P2|STARTED|Persistence Phase Year 3||201
365404|NCT00427908|888565|P1|STARTED|Persistence Phase Year 3||185
365405|NCT00427908|888562|P4|NOT COMPLETED|Persistence Phase Year 2||0
365406|NCT00427908|888563|P3|NOT COMPLETED|Persistence Phase Year 2||0
365407|NCT00427908|888564|P2|NOT COMPLETED|Persistence Phase Year 2||0
365408|NCT00427908|888565|P1|NOT COMPLETED|Persistence Phase Year 2||0
365409|NCT00427908|888562|P4|COMPLETED|Persistence Phase Year 2||61
365410|NCT00427908|888563|P3|COMPLETED|Persistence Phase Year 2||53
365411|NCT00427908|888564|P2|COMPLETED|Persistence Phase Year 2||215
365412|NCT00427908|888565|P1|COMPLETED|Persistence Phase Year 2||208
365413|NCT00427908|888562|P4|STARTED|Persistence Phase Year 2||61
365414|NCT00427908|888563|P3|STARTED|Persistence Phase Year 2||53
365415|NCT00427908|888564|P2|STARTED|Persistence Phase Year 2||215
365416|NCT00427908|888565|P1|STARTED|Persistence Phase Year 2||208
365417|NCT00427908|888562|P4|NOT COMPLETED|Persistence Phase Year 1||0
365418|NCT00427908|888563|P3|NOT COMPLETED|Persistence Phase Year 1||0
365419|NCT00427908|888564|P2|NOT COMPLETED|Persistence Phase Year 1||0
365420|NCT00427908|888565|P1|NOT COMPLETED|Persistence Phase Year 1||0
365421|NCT00427908|888562|P4|COMPLETED|Persistence Phase Year 1||78
365422|NCT00427908|888563|P3|COMPLETED|Persistence Phase Year 1||71
365423|NCT00427908|888564|P2|COMPLETED|Persistence Phase Year 1||221
365424|NCT00427908|888565|P1|COMPLETED|Persistence Phase Year 1||222
365425|NCT00427908|888562|P4|STARTED|Persistence Phase Year 1||78
365426|NCT00427908|888563|P3|STARTED|Persistence Phase Year 1||71
365427|NCT00427908|888564|P2|STARTED|Persistence Phase Year 1||221
365428|NCT00427908|888565|P1|STARTED|Persistence Phase Year 1||222
365429|NCT00427908|888562|P4|NOT COMPLETED|Primary Phase||0
365430|NCT00427908|888563|P3|NOT COMPLETED|Primary Phase||3
365431|NCT00427908|888564|P2|NOT COMPLETED|Primary Phase||3
365432|NCT00427908|888565|P1|NOT COMPLETED|Primary Phase||5
365433|NCT00427908|888562|P4|COMPLETED|Primary Phase||78
365434|NCT00427908|888563|P3|COMPLETED|Primary Phase||72
365435|NCT00427908|888564|P2|COMPLETED|Primary Phase||228
365436|NCT00427908|888565|P1|COMPLETED|Primary Phase||224
365437|NCT00427908|888562|P4|STARTED|Primary Phase||78
365438|NCT00427908|888563|P3|STARTED|Primary Phase||75
365439|NCT00427908|888564|P2|STARTED|Primary Phase||231
365440|NCT00427908|888565|P1|STARTED|Primary Phase||229
365441|NCT00427895|888765|P8|NOT COMPLETED|Vax 2/Year 3 to 4||2
365442|NCT00427895|888766|P7|NOT COMPLETED|Vax 2/Year 3 to 4||0
365443|NCT00427895|888767|P6|NOT COMPLETED|Vax 2/Year 3 to 4||0
365444|NCT00427895|888768|P5|NOT COMPLETED|Vax 2/Year 3 to 4||1
365445|NCT00427895|888769|P4|NOT COMPLETED|Vax 2/Year 3 to 4||0
365446|NCT00427895|888770|P3|NOT COMPLETED|Vax 2/Year 3 to 4||0
365447|NCT00427895|888771|P2|NOT COMPLETED|Vax 2/Year 3 to 4||0
365448|NCT00427895|888772|P1|NOT COMPLETED|Vax 2/Year 3 to 4||0
365449|NCT00427895|888765|P8|COMPLETED|Vax 2/Year 3 to 4||212
365450|NCT00427895|888766|P7|COMPLETED|Vax 2/Year 3 to 4||189
365451|NCT00427895|888767|P6|COMPLETED|Vax 2/Year 3 to 4||108
365452|NCT00427895|888768|P5|COMPLETED|Vax 2/Year 3 to 4||107
365453|NCT00427895|888769|P4|COMPLETED|Vax 2/Year 3 to 4||0
365454|NCT00427895|888770|P3|COMPLETED|Vax 2/Year 3 to 4||0
365455|NCT00427895|888771|P2|COMPLETED|Vax 2/Year 3 to 4||0
365456|NCT00427895|888772|P1|COMPLETED|Vax 2/Year 3 to 4||0
365457|NCT00427895|888765|P8|STARTED|Vax 2/Year 3 to 4||214
365458|NCT00427895|888766|P7|STARTED|Vax 2/Year 3 to 4||189
365459|NCT00427895|888767|P6|STARTED|Vax 2/Year 3 to 4||108
365460|NCT00427895|888768|P5|STARTED|Vax 2/Year 3 to 4||108
365461|NCT00427895|888769|P4|STARTED|Vax 2/Year 3 to 4||0
365462|NCT00427895|888770|P3|STARTED|Vax 2/Year 3 to 4||0
365463|NCT00427895|888771|P2|STARTED|Vax 2/Year 3 to 4||0
365464|NCT00427895|888772|P1|STARTED|Vax 2/Year 3 to 4||0
365465|NCT00427895|888765|P8|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
365466|NCT00427895|888766|P7|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
365467|NCT00427895|888767|P6|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
365468|NCT00427895|888768|P5|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
365469|NCT00427895|888769|P4|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||469
365470|NCT00427895|888770|P3|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||159
365471|NCT00427895|888771|P2|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||207
365472|NCT00427895|888772|P1|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||188
365473|NCT00427895|888765|P8|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
365474|NCT00427895|888766|P7|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
365475|NCT00427895|888767|P6|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
365476|NCT00427895|888768|P5|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
365477|NCT00427895|888769|P4|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
365478|NCT00427895|888770|P3|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||214
365479|NCT00427895|888771|P2|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||189
365480|NCT00427895|888772|P1|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||216
365481|NCT00427895|888765|P8|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
365482|NCT00427895|888766|P7|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
365483|NCT00427895|888767|P6|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
365484|NCT00427895|888768|P5|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
365485|NCT00427895|888769|P4|STARTED|Between Year 1 - Vax 2/Year 3 to 4||469
365486|NCT00427895|888770|P3|STARTED|Between Year 1 - Vax 2/Year 3 to 4||373
365487|NCT00427895|888771|P2|STARTED|Between Year 1 - Vax 2/Year 3 to 4||396
365488|NCT00427895|888772|P1|STARTED|Between Year 1 - Vax 2/Year 3 to 4||404
365489|NCT00427895|888765|P8|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
365490|NCT00427895|888766|P7|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
365491|NCT00427895|888767|P6|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
365492|NCT00427895|888768|P5|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
365493|NCT00427895|888769|P4|NOT COMPLETED|Vax 1/Year 1 Follow-up||33
365494|NCT00427895|888770|P3|NOT COMPLETED|Vax 1/Year 1 Follow-up||19
365495|NCT00427895|888771|P2|NOT COMPLETED|Vax 1/Year 1 Follow-up||15
365496|NCT00427895|888772|P1|NOT COMPLETED|Vax 1/Year 1 Follow-up||7
365497|NCT00427895|888765|P8|COMPLETED|Vax 1/Year 1 Follow-up||0
365498|NCT00427895|888766|P7|COMPLETED|Vax 1/Year 1 Follow-up||0
365499|NCT00427895|888767|P6|COMPLETED|Vax 1/Year 1 Follow-up||0
365500|NCT00427895|888768|P5|COMPLETED|Vax 1/Year 1 Follow-up||0
365501|NCT00427895|888769|P4|COMPLETED|Vax 1/Year 1 Follow-up||469
365502|NCT00427895|888770|P3|COMPLETED|Vax 1/Year 1 Follow-up||373
365503|NCT00427895|888771|P2|COMPLETED|Vax 1/Year 1 Follow-up||396
365504|NCT00427895|888772|P1|COMPLETED|Vax 1/Year 1 Follow-up||404
365505|NCT00427895|888765|P8|STARTED|Vax 1/Year 1 Follow-up||0
365506|NCT00427895|888766|P7|STARTED|Vax 1/Year 1 Follow-up||0
365507|NCT00427895|888767|P6|STARTED|Vax 1/Year 1 Follow-up||0
365508|NCT00427895|888768|P5|STARTED|Vax 1/Year 1 Follow-up||0
365509|NCT00427895|888769|P4|STARTED|Vax 1/Year 1 Follow-up||502
365510|NCT00427895|888770|P3|STARTED|Vax 1/Year 1 Follow-up||392
365511|NCT00427895|888771|P2|STARTED|Vax 1/Year 1 Follow-up||411
365512|NCT00427895|888772|P1|STARTED|Vax 1/Year 1 Follow-up||411
365513|NCT00427895|888765|P8|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
365514|NCT00427895|888766|P7|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
365515|NCT00427895|888767|P6|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
365516|NCT00427895|888768|P5|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
365517|NCT00427895|888769|P4|NOT COMPLETED|Between 6-Month Follow-up - Year 1||352
365518|NCT00427895|888770|P3|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
365519|NCT00427895|888771|P2|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
365520|NCT00427895|888772|P1|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
365521|NCT00427895|888765|P8|COMPLETED|Between 6-Month Follow-up - Year 1||0
365522|NCT00427895|888766|P7|COMPLETED|Between 6-Month Follow-up - Year 1||0
365523|NCT00427895|888767|P6|COMPLETED|Between 6-Month Follow-up - Year 1||0
365524|NCT00427895|888768|P5|COMPLETED|Between 6-Month Follow-up - Year 1||0
365525|NCT00427895|888769|P4|COMPLETED|Between 6-Month Follow-up - Year 1||502
365526|NCT00427895|888770|P3|COMPLETED|Between 6-Month Follow-up - Year 1||392
365527|NCT00427895|888771|P2|COMPLETED|Between 6-Month Follow-up - Year 1||411
365528|NCT00427895|888772|P1|COMPLETED|Between 6-Month Follow-up - Year 1||411
365529|NCT00427895|888765|P8|STARTED|Between 6-Month Follow-up - Year 1||0
365530|NCT00427895|888766|P7|STARTED|Between 6-Month Follow-up - Year 1||0
365531|NCT00427895|888767|P6|STARTED|Between 6-Month Follow-up - Year 1||0
365532|NCT00427895|888768|P5|STARTED|Between 6-Month Follow-up - Year 1||0
365533|NCT00427895|888769|P4|STARTED|Between 6-Month Follow-up - Year 1||854
365534|NCT00427895|888770|P3|STARTED|Between 6-Month Follow-up - Year 1||392
365535|NCT00427895|888771|P2|STARTED|Between 6-Month Follow-up - Year 1||411
365536|NCT00427895|888772|P1|STARTED|Between 6-Month Follow-up - Year 1||411
365537|NCT00427895|888765|P8|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
365538|NCT00427895|888766|P7|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
365539|NCT00427895|888767|P6|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
365540|NCT00427895|888768|P5|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
365541|NCT00427895|888769|P4|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||46
365542|NCT00427895|888770|P3|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||14
365543|NCT00427895|888771|P2|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||6
365544|NCT00427895|888772|P1|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||7
365545|NCT00427895|888765|P8|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
365546|NCT00427895|888766|P7|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
365547|NCT00427895|888767|P6|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
365548|NCT00427895|888768|P5|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
365549|NCT00427895|888769|P4|COMPLETED|Vax 1 Baseline/6-Month Follow-up||854
365550|NCT00427895|888770|P3|COMPLETED|Vax 1 Baseline/6-Month Follow-up||392
365551|NCT00427895|888771|P2|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
365552|NCT00427895|888772|P1|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
365553|NCT00427895|888765|P8|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
365554|NCT00427895|888766|P7|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
365555|NCT00427895|888767|P6|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
365556|NCT00427895|888768|P5|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
365557|NCT00427895|888769|P4|Vaccinated|Vax 1 Baseline/6-Month Follow-up||899
365558|NCT00427895|888770|P3|Vaccinated|Vax 1 Baseline/6-Month Follow-up||404
365559|NCT00427895|888771|P2|Vaccinated|Vax 1 Baseline/6-Month Follow-up||414
365560|NCT00427895|888772|P1|Vaccinated|Vax 1 Baseline/6-Month Follow-up||417
365561|NCT00427895|888765|P8|STARTED|Vax 1 Baseline/6-Month Follow-up||0
365562|NCT00427895|888766|P7|STARTED|Vax 1 Baseline/6-Month Follow-up||0
365563|NCT00427895|888767|P6|STARTED|Vax 1 Baseline/6-Month Follow-up||0
365564|NCT00427895|888768|P5|STARTED|Vax 1 Baseline/6-Month Follow-up||0
365565|NCT00427895|888769|P4|STARTED|Vax 1 Baseline/6-Month Follow-up||900
365566|NCT00427895|888770|P3|STARTED|Vax 1 Baseline/6-Month Follow-up||406
365567|NCT00427895|888771|P2|STARTED|Vax 1 Baseline/6-Month Follow-up||417
365568|NCT00427895|888772|P1|STARTED|Vax 1 Baseline/6-Month Follow-up||418
365569|NCT00427804|888829|P2|NOT COMPLETED|Overall Study||0
365570|NCT00427804|888830|P1|NOT COMPLETED|Overall Study||0
365571|NCT00427804|888829|P2|COMPLETED|Overall Study||5
365572|NCT00427804|888830|P1|COMPLETED|Overall Study||4
365573|NCT00427804|888829|P2|STARTED|Overall Study||5
365574|NCT00427804|888830|P1|STARTED|Overall Study||4
365575|NCT00427791|888838|P2|NOT COMPLETED|Overall Study||0
365576|NCT00427791|888839|P1|NOT COMPLETED|Overall Study||0
365577|NCT00427791|888838|P2|COMPLETED|Overall Study||13
365578|NCT00427791|888839|P1|COMPLETED|Overall Study||10
365579|NCT00427791|888838|P2|STARTED|Overall Study||13
365580|NCT00427791|888839|P1|STARTED|Overall Study||10
365581|NCT00427778|888847|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
365582|NCT00427778|888848|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
365583|NCT00427778|888847|P2|COMPLETED|Second Intervention (4 Weeks)||14
365584|NCT00427778|888848|P1|COMPLETED|Second Intervention (4 Weeks)||10
365585|NCT00427778|888847|P2|STARTED|Second Intervention (4 Weeks)||14
365586|NCT00427778|888848|P1|STARTED|Second Intervention (4 Weeks)||10
365587|NCT00427778|888847|P2|NOT COMPLETED|Wash Out (2 Weeks)||0
365588|NCT00427778|888848|P1|NOT COMPLETED|Wash Out (2 Weeks)||0
365589|NCT00427778|888847|P2|COMPLETED|Wash Out (2 Weeks)||14
365590|NCT00427778|888848|P1|COMPLETED|Wash Out (2 Weeks)||10
365591|NCT00427778|888847|P2|STARTED|Wash Out (2 Weeks)||14
365592|NCT00427778|888848|P1|STARTED|Wash Out (2 Weeks)||10
365593|NCT00427778|888847|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
365594|NCT00427778|888848|P1|NOT COMPLETED|First Intervention (4 Weeks)||4
365595|NCT00427778|888847|P2|COMPLETED|First Intervention (4 Weeks)||14
365596|NCT00427778|888848|P1|COMPLETED|First Intervention (4 Weeks)||10
365597|NCT00427778|888847|P2|STARTED|First Intervention (4 Weeks)||15
365598|NCT00427778|888848|P1|STARTED|First Intervention (4 Weeks)||14
365599|NCT00427765|888867|P1|NOT COMPLETED|Overall Study||0
365600|NCT00427765|888867|P1|COMPLETED|Overall Study||164
365601|NCT00427765|888867|P1|STARTED|Overall Study||164
365602|NCT00427700|888873|P2|NOT COMPLETED|Overall Study||11
365603|NCT00427700|888874|P1|NOT COMPLETED|Overall Study||3
365604|NCT00427700|888873|P2|COMPLETED|Overall Study||31
365605|NCT00427700|888874|P1|COMPLETED|Overall Study||37
365606|NCT00427700|888873|P2|STARTED|Overall Study||42
365607|NCT00427700|888874|P1|STARTED|Overall Study||40
365608|NCT00427661|888882|P1|NOT COMPLETED|Overall Study||0
365609|NCT00427661|888882|P1|COMPLETED|Overall Study||8
365610|NCT00427661|888882|P1|STARTED|Overall Study||8
365611|NCT00427635|888890|P2|NOT COMPLETED|Study Completion to Safety Follow-up||1
365612|NCT00427635|888891|P1|NOT COMPLETED|Study Completion to Safety Follow-up||0
365613|NCT00427635|888890|P2|COMPLETED|Study Completion to Safety Follow-up|One participant lost to follow-up|25
365614|NCT00427635|888891|P1|COMPLETED|Study Completion to Safety Follow-up||25
365615|NCT00427635|888890|P2|STARTED|Study Completion to Safety Follow-up||26
365616|NCT00427635|888891|P1|STARTED|Study Completion to Safety Follow-up||25
365617|NCT00427635|888890|P2|NOT COMPLETED|Treatment Phase||0
365618|NCT00427635|888891|P1|NOT COMPLETED|Treatment Phase||1
365619|NCT00427635|888890|P2|COMPLETED|Treatment Phase|ITT population|26
365620|NCT00427635|888891|P1|COMPLETED|Treatment Phase|ITT population. One voluntary discontinuation by parent/guardian|25
365621|NCT00427635|888890|P2|STARTED|Treatment Phase|Randomised|26
365622|NCT00427635|888891|P1|STARTED|Treatment Phase|Randomised|26
365623|NCT00427557|888919|P1|NOT COMPLETED|Overall Study||0
365624|NCT00427557|888919|P1|COMPLETED|Overall Study||30
365625|NCT00427557|888919|P1|STARTED|Overall Study||30
365626|NCT00427349|888923|P1|NOT COMPLETED|Overall Study||46
365627|NCT00427349|888923|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity|0
365628|NCT00427349|888923|P1|Eligible and Treated|Overall Study||44
365629|NCT00427349|888923|P1|Treated|Overall Study||45
365630|NCT00427349|888923|P1|Eligible|Overall Study||45
365631|NCT00427349|888923|P1|STARTED|Overall Study||46
365632|NCT00427336|888929|P1|NOT COMPLETED|Overall Study||0
365633|NCT00427336|888929|P1|COMPLETED|Overall Study||9
365634|NCT00427336|888929|P1|STARTED|Overall Study||9
365635|NCT00427297|888935|P2|NOT COMPLETED|Overall Study||0
365636|NCT00427297|888936|P1|NOT COMPLETED|Overall Study||0
365637|NCT00427297|888935|P2|COMPLETED|Overall Study||17
365638|NCT00427297|888936|P1|COMPLETED|Overall Study||17
365639|NCT00427297|888935|P2|STARTED|Overall Study||17
365640|NCT00427297|888936|P1|STARTED|Overall Study||17
365641|NCT00427193|888950|P2|NOT COMPLETED|Overall Study||4
365642|NCT00427193|888951|P1|NOT COMPLETED|Overall Study||26
365643|NCT00427193|888950|P2|COMPLETED|Overall Study||71
365644|NCT00427193|888951|P1|COMPLETED|Overall Study||117
365645|NCT00427193|888950|P2|STARTED|Overall Study||75
365646|NCT00427193|888951|P1|STARTED|Overall Study||143
365647|NCT00427037|888971|P2|NOT COMPLETED|Overall Study||7
365648|NCT00427037|888972|P1|NOT COMPLETED|Overall Study||7
365649|NCT00427037|888971|P2|COMPLETED|Overall Study||10
365650|NCT00427037|888972|P1|COMPLETED|Overall Study||10
365651|NCT00427037|888971|P2|STARTED|Overall Study||17
365652|NCT00427037|888972|P1|STARTED|Overall Study||17
365653|NCT00427011|888980|P1|NOT COMPLETED|Overall Study||25
365654|NCT00427011|888980|P1|COMPLETED|Overall Study||0
365655|NCT00427011|888980|P1|STARTED|Overall Study||25
365656|NCT00426855|888991|P1|NOT COMPLETED|Overall Study||0
365657|NCT00426855|888991|P1|COMPLETED|Overall Study||12
365658|NCT00426855|888991|P1|STARTED|Overall Study||12
365659|NCT00426842|888995|P1|NOT COMPLETED|Overall Study||1
365660|NCT00426842|888995|P1|COMPLETED|Overall Study||10
365661|NCT00426842|888995|P1|STARTED|Overall Study||11
365662|NCT00426764|889001|P1|NOT COMPLETED|Overall Study||131
365663|NCT00426764|889001|P1|COMPLETED|Overall Study||0
365664|NCT00426764|889001|P1|Discontinued at End of or After Cycle 6|Overall Study||33
365665|NCT00426764|889001|P1|Discontinued Prior to or During Cycle 6|Overall Study||98
365666|NCT00426764|889001|P1|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|131
365667|NCT00426751|889018|P2|NOT COMPLETED|Overall Study||20
365668|NCT00426751|889019|P1|NOT COMPLETED|Overall Study||22
365669|NCT00426751|889018|P2|COMPLETED|Overall Study||183
365670|NCT00426751|889019|P1|COMPLETED|Overall Study||204
365671|NCT00426751|889018|P2|STARTED|Overall Study||203
365672|NCT00426751|889019|P1|STARTED|Overall Study||226
365673|NCT00426660|889063|P1|NOT COMPLETED|Overall Study||131
365674|NCT00426660|889063|P1|COMPLETED|Overall Study||916
365675|NCT00426660|889063|P1|Safety Analysis Set|Overall Study||1032
365676|NCT00426660|889063|P1|Treated|Overall Study||1032
365677|NCT00426660|889063|P1|STARTED|Overall Study||1047
365678|NCT00426556|889094|P4|NOT COMPLETED|Phase II - Extension Phase||23
365679|NCT00426556|889095|P3|NOT COMPLETED|Phase II - Extension Phase||0
365680|NCT00426556|889096|P2|NOT COMPLETED|Phase II - Extension Phase||0
365681|NCT00426556|889097|P1|NOT COMPLETED|Phase II - Extension Phase||0
365682|NCT00426556|889094|P4|COMPLETED|Phase II - Extension Phase|Completed means 'Ongoing'|1
365683|NCT00426556|889095|P3|COMPLETED|Phase II - Extension Phase||0
365684|NCT00426556|889096|P2|COMPLETED|Phase II - Extension Phase||0
365685|NCT00426556|889097|P1|COMPLETED|Phase II - Extension Phase||0
365686|NCT00426556|889094|P4|STARTED|Phase II - Extension Phase|4 patients did not enter the Extension phase.|24
365687|NCT00426556|889095|P3|STARTED|Phase II - Extension Phase||0
365688|NCT00426556|889096|P2|STARTED|Phase II - Extension Phase||0
365689|NCT00426556|889097|P1|STARTED|Phase II - Extension Phase||0
365690|NCT00426556|889094|P4|NOT COMPLETED|Phase II - Core Phase||27
365691|NCT00426556|889095|P3|NOT COMPLETED|Phase II - Core Phase||0
365692|NCT00426556|889096|P2|NOT COMPLETED|Phase II - Core Phase||0
365693|NCT00426556|889097|P1|NOT COMPLETED|Phase II - Core Phase||0
365694|NCT00426556|889094|P4|COMPLETED|Phase II - Core Phase||28
365695|NCT00426556|889095|P3|COMPLETED|Phase II - Core Phase||0
365696|NCT00426556|889096|P2|COMPLETED|Phase II - Core Phase||0
365697|NCT00426556|889097|P1|COMPLETED|Phase II - Core Phase||0
365698|NCT00426556|889094|P4|STARTED|Phase II - Core Phase||55
365699|NCT00426556|889095|P3|STARTED|Phase II - Core Phase||0
365700|NCT00426556|889096|P2|STARTED|Phase II - Core Phase||0
365701|NCT00426556|889097|P1|STARTED|Phase II - Core Phase||0
365702|NCT00426556|889094|P4|NOT COMPLETED|Phase I - Extension Phase||0
365703|NCT00426556|889095|P3|NOT COMPLETED|Phase I - Extension Phase||7
365704|NCT00426556|889096|P2|NOT COMPLETED|Phase I - Extension Phase||6
365705|NCT00426556|889097|P1|NOT COMPLETED|Phase I - Extension Phase||5
365706|NCT00426556|889094|P4|COMPLETED|Phase I - Extension Phase||0
365707|NCT00426556|889095|P3|COMPLETED|Phase I - Extension Phase||0
365708|NCT00426556|889096|P2|COMPLETED|Phase I - Extension Phase||1
365709|NCT00426556|889097|P1|COMPLETED|Phase I - Extension Phase||0
365710|NCT00426556|889094|P4|STARTED|Phase I - Extension Phase||0
365711|NCT00426556|889095|P3|STARTED|Phase I - Extension Phase||7
365712|NCT00426556|889096|P2|STARTED|Phase I - Extension Phase||7
365713|NCT00426556|889097|P1|STARTED|Phase I - Extension Phase||5
365714|NCT00426556|889094|P4|NOT COMPLETED|Phase I - Core Phase||0
365715|NCT00426556|889095|P3|NOT COMPLETED|Phase I - Core Phase||3
365716|NCT00426556|889096|P2|NOT COMPLETED|Phase I - Core Phase||10
365717|NCT00426556|889097|P1|NOT COMPLETED|Phase I - Core Phase||1
365718|NCT00426556|889094|P4|COMPLETED|Phase I - Core Phase||0
365719|NCT00426556|889095|P3|COMPLETED|Phase I - Core Phase||7
365720|NCT00426556|889096|P2|COMPLETED|Phase I - Core Phase||7
365721|NCT00426556|889097|P1|COMPLETED|Phase I - Core Phase||5
365722|NCT00426556|889094|P4|STARTED|Phase I - Core Phase||0
365723|NCT00426556|889095|P3|STARTED|Phase I - Core Phase||10
365724|NCT00426556|889096|P2|STARTED|Phase I - Core Phase||17
365725|NCT00426556|889097|P1|STARTED|Phase I - Core Phase||6
365726|NCT00426361|889122|P3|NOT COMPLETED|Overall Study||5
365727|NCT00426361|889123|P2|NOT COMPLETED|Overall Study||5
365728|NCT00426361|889124|P1|NOT COMPLETED|Overall Study||4
365729|NCT00426361|889122|P3|COMPLETED|Overall Study||243
365730|NCT00426361|889123|P2|COMPLETED|Overall Study||250
365731|NCT00426361|889124|P1|COMPLETED|Overall Study||244
365732|NCT00426361|889122|P3|STARTED|Overall Study||248
365733|NCT00426361|889123|P2|STARTED|Overall Study||255
365734|NCT00426361|889124|P1|STARTED|Overall Study||248
365735|NCT00426283|889176|P2|NOT COMPLETED|Overall Study||1
365736|NCT00426283|889177|P1|NOT COMPLETED|Overall Study||5
365737|NCT00426283|889176|P2|COMPLETED|Overall Study||13
365738|NCT00426283|889177|P1|COMPLETED|Overall Study||23
365739|NCT00426283|889176|P2|STARTED|Overall Study||14
365740|NCT00426283|889177|P1|STARTED|Overall Study||28
365741|NCT00426270|889183|P1|NOT COMPLETED|Overall Study||6
365742|NCT00426270|889183|P1|COMPLETED|Overall Study||110
365743|NCT00426270|889183|P1|STARTED|Overall Study||116
365744|NCT00426231|889193|P2|NOT COMPLETED|Overall Study||12
365745|NCT00426231|889194|P1|NOT COMPLETED|Overall Study||9
365746|NCT00426231|889193|P2|COMPLETED|Overall Study|For the 6-month endpoint|25
365747|NCT00426231|889194|P1|COMPLETED|Overall Study|For the 6 month endpoint|27
365748|NCT00426231|889193|P2|STARTED|Overall Study||37
365749|NCT00426231|889194|P1|STARTED|Overall Study||36
365750|NCT00426153|889204|P2|NOT COMPLETED|Overall Study||0
365751|NCT00426153|889205|P1|NOT COMPLETED|Overall Study||0
365752|NCT00426153|889204|P2|COMPLETED|Overall Study||14
365753|NCT00426153|889205|P1|COMPLETED|Overall Study||28
365754|NCT00426153|889204|P2|STARTED|Overall Study||14
365755|NCT00426153|889205|P1|STARTED|Overall Study|Participants were randomized in a 2:1 ratio, Octreotide LAR depot: Placebo|28
365756|NCT00426127|889217|P1|NOT COMPLETED|Overall Study||2
365757|NCT00426127|889217|P1|COMPLETED|Overall Study||0
365758|NCT00426127|889217|P1|STARTED|Overall Study||2
365759|NCT00425945|889225|P2|NOT COMPLETED|Overall Study||5
365760|NCT00425945|889226|P1|NOT COMPLETED|Overall Study||4
365761|NCT00425945|889225|P2|COMPLETED|Overall Study||61
365762|NCT00425945|889226|P1|COMPLETED|Overall Study||60
365763|NCT00425945|889225|P2|STARTED|Overall Study||66
365764|NCT00425945|889226|P1|STARTED|Overall Study||64
365765|NCT00425854|889264|P2|NOT COMPLETED|Overall Study||21
365766|NCT00425854|889265|P1|NOT COMPLETED|Overall Study||29
365767|NCT00425854|889264|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
365768|NCT00425854|889265|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
365769|NCT00425854|889264|P2|STARTED|Overall Study|Treated|21
365770|NCT00425854|889265|P1|STARTED|Overall Study|Treated|29
365771|NCT00425802|889286|P1|NOT COMPLETED|Overall Study||0
365772|NCT00425802|889286|P1|COMPLETED|Overall Study||61
365773|NCT00425802|889286|P1|STARTED|Overall Study||61
365774|NCT00425750|889298|P1|NOT COMPLETED|Overall Study||25
365775|NCT00425750|889298|P1|COMPLETED|Overall Study||0
365776|NCT00425750|889298|P1|STARTED|Overall Study||25
365777|NCT00425698|889306|P2|NOT COMPLETED|Overall Study||2
365778|NCT00425698|889307|P1|NOT COMPLETED|Overall Study||3
365779|NCT00425698|889306|P2|COMPLETED|Overall Study||42
365780|NCT00425698|889307|P1|COMPLETED|Overall Study||41
365781|NCT00425698|889306|P2|STARTED|Overall Study||44
365782|NCT00425698|889307|P1|STARTED|Overall Study||44
365783|NCT00425672|889313|P1|NOT COMPLETED|Overall Study||1
365784|NCT00425672|889313|P1|COMPLETED|Overall Study||14
365785|NCT00425672|889313|P1|STARTED|Overall Study||15
365786|NCT00425607|889322|P1|NOT COMPLETED|Overall Study||2
365787|NCT00425607|889322|P1|COMPLETED|Overall Study||27
365788|NCT00425607|889322|P1|Received Treatment|Overall Study||28
365789|NCT00425607|889322|P1|STARTED|Overall Study||29
365790|NCT00425503|889326|P1|NOT COMPLETED|Overall Study||3
365791|NCT00425503|889326|P1|COMPLETED|Overall Study||37
365792|NCT00425503|889326|P1|STARTED|Overall Study||40
365793|NCT00425477|889330|P1|NOT COMPLETED|Overall Study||13
365794|NCT00425477|889330|P1|COMPLETED|Overall Study||13
365795|NCT00425477|889330|P1|STARTED|Overall Study||26
365796|NCT00425438|889338|P2|NOT COMPLETED|Overall Study||27
365797|NCT00425438|889339|P1|NOT COMPLETED|Overall Study||25
365798|NCT00425438|889338|P2|COMPLETED|Overall Study||0
365799|NCT00425438|889339|P1|COMPLETED|Overall Study||0
365800|NCT00425438|889338|P2|STARTED|Overall Study||27
365801|NCT00425438|889339|P1|STARTED|Overall Study||25
365802|NCT00425386|889355|P1|NOT COMPLETED|Overall Study||3
365803|NCT00425386|889355|P1|COMPLETED|Overall Study||43
365804|NCT00425386|889355|P1|STARTED|Overall Study||46
365805|NCT00425373|889373|P9|NOT COMPLETED|Overall Study||18
365806|NCT00425373|889374|P8|NOT COMPLETED|Overall Study||10
365807|NCT00425373|889375|P7|NOT COMPLETED|Overall Study||7
365808|NCT00425373|889376|P6|NOT COMPLETED|Overall Study||9
365809|NCT00425373|889377|P5|NOT COMPLETED|Overall Study||10
365810|NCT00425373|889378|P4|NOT COMPLETED|Overall Study||2
365811|NCT00425373|889379|P3|NOT COMPLETED|Overall Study||3
365812|NCT00425373|889380|P2|NOT COMPLETED|Overall Study||3
365813|NCT00425373|889381|P1|NOT COMPLETED|Overall Study||5
365814|NCT00425373|889373|P9|COMPLETED|Overall Study||148
365815|NCT00425373|889374|P8|COMPLETED|Overall Study||151
365816|NCT00425373|889375|P7|COMPLETED|Overall Study||154
365817|NCT00425373|889376|P6|COMPLETED|Overall Study||154
365818|NCT00425373|889377|P5|COMPLETED|Overall Study||159
365819|NCT00425373|889378|P4|COMPLETED|Overall Study||160
365820|NCT00425373|889379|P3|COMPLETED|Overall Study||157
365821|NCT00425373|889380|P2|COMPLETED|Overall Study||164
365822|NCT00425373|889381|P1|COMPLETED|Overall Study||154
365823|NCT00425373|889373|P9|STARTED|Overall Study||166
365824|NCT00425373|889374|P8|STARTED|Overall Study||161
365825|NCT00425373|889375|P7|STARTED|Overall Study||161
365826|NCT00425373|889376|P6|STARTED|Overall Study||163
365827|NCT00425373|889377|P5|STARTED|Overall Study||169
365828|NCT00425373|889378|P4|STARTED|Overall Study||162
365829|NCT00425373|889379|P3|STARTED|Overall Study||160
365830|NCT00425373|889380|P2|STARTED|Overall Study||167
365831|NCT00425373|889381|P1|STARTED|Overall Study||159
365832|NCT00425308|889439|P2|NOT COMPLETED|Overall Study||1
365833|NCT00425308|889440|P1|NOT COMPLETED|Overall Study||4
365834|NCT00425308|889439|P2|COMPLETED|Overall Study||14
365835|NCT00425308|889440|P1|COMPLETED|Overall Study||11
365836|NCT00425308|889439|P2|STARTED|Overall Study||15
365837|NCT00425308|889440|P1|STARTED|Overall Study||15
365838|NCT00425269|889470|P2|NOT COMPLETED|Overall Study||20
365839|NCT00425269|889471|P1|NOT COMPLETED|Overall Study||19
365840|NCT00425269|889470|P2|COMPLETED|Overall Study||77
365841|NCT00425269|889471|P1|COMPLETED|Overall Study||82
365842|NCT00425269|889470|P2|STARTED|Overall Study||97
365843|NCT00425269|889471|P1|STARTED|Overall Study||101
365844|NCT00425113|889549|P2|NOT COMPLETED|Overall Study||2
365845|NCT00425113|889550|P1|NOT COMPLETED|Overall Study||2
365846|NCT00425113|889549|P2|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|16
365847|NCT00425113|889550|P1|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|15
365848|NCT00425113|889549|P2|Exposed to Study Drug|Overall Study||17
365849|NCT00425113|889550|P1|Exposed to Study Drug|Overall Study||16
365850|NCT00425113|889549|P2|STARTED|Overall Study||18
365851|NCT00425113|889550|P1|STARTED|Overall Study||17
365852|NCT00425100|889558|P1|NOT COMPLETED|Overall Study||53
365853|NCT00425100|889558|P1|COMPLETED|Overall Study||463
365854|NCT00425100|889558|P1|STARTED|Overall Study||516
365855|NCT00425061|889602|P7|NOT COMPLETED|Overall Study||19
365856|NCT00425061|889603|P6|NOT COMPLETED|Overall Study||4
365857|NCT00425061|889604|P5|NOT COMPLETED|Overall Study||26
365858|NCT00425061|889605|P4|NOT COMPLETED|Overall Study||2
365859|NCT00425061|889606|P3|NOT COMPLETED|Overall Study||0
365860|NCT00425061|889607|P2|NOT COMPLETED|Overall Study||2
365861|NCT00425061|889608|P1|NOT COMPLETED|Overall Study||2
365862|NCT00425061|889602|P7|COMPLETED|Overall Study||26
365863|NCT00425061|889603|P6|COMPLETED|Overall Study||0
365864|NCT00425061|889604|P5|COMPLETED|Overall Study||19
365865|NCT00425061|889605|P4|COMPLETED|Overall Study||14
365866|NCT00425061|889606|P3|COMPLETED|Overall Study||16
365867|NCT00425061|889607|P2|COMPLETED|Overall Study||15
365868|NCT00425061|889608|P1|COMPLETED|Overall Study||14
365869|NCT00425061|889602|P7|STARTED|Overall Study||45
365870|NCT00425061|889603|P6|STARTED|Overall Study||4
365871|NCT00425061|889604|P5|STARTED|Overall Study||45
365872|NCT00425061|889605|P4|STARTED|Overall Study||16
365873|NCT00425061|889606|P3|STARTED|Overall Study||16
365874|NCT00425061|889607|P2|STARTED|Overall Study||17
365875|NCT00425061|889608|P1|STARTED|Overall Study||16
365876|NCT00424840|889724|P3|NOT COMPLETED|Overall Study||0
365877|NCT00424840|889725|P2|NOT COMPLETED|Overall Study||0
365878|NCT00424840|889726|P1|NOT COMPLETED|Overall Study||0
365879|NCT00424840|889724|P3|COMPLETED|Overall Study||5
365880|NCT00424840|889725|P2|COMPLETED|Overall Study||4
365881|NCT00424840|889726|P1|COMPLETED|Overall Study||3
365882|NCT00424840|889724|P3|STARTED|Overall Study||5
365883|NCT00424840|889725|P2|STARTED|Overall Study||4
365884|NCT00424840|889726|P1|STARTED|Overall Study||3
365885|NCT00424827|889732|P1|NOT COMPLETED|Overall Study||1
365886|NCT00424827|889732|P1|COMPLETED|Overall Study||10
365887|NCT00424827|889732|P1|STARTED|Overall Study||11
365888|NCT00424775|889740|P2|NOT COMPLETED|Overall Study||0
365889|NCT00424775|889741|P1|NOT COMPLETED|Overall Study||3
365890|NCT00424775|889740|P2|COMPLETED|Overall Study||0
365891|NCT00424775|889741|P1|COMPLETED|Overall Study||0
365892|NCT00424775|889740|P2|STARTED|Overall Study||0
365893|NCT00424775|889741|P1|STARTED|Overall Study||3
365894|NCT00424762|889751|P2|NOT COMPLETED|Overall Study||22
365895|NCT00424762|889752|P1|NOT COMPLETED|Overall Study||20
365896|NCT00424762|889751|P2|COMPLETED|Overall Study||54
365897|NCT00424762|889752|P1|COMPLETED|Overall Study||54
365898|NCT00424762|889751|P2|STARTED|Overall Study||76
365899|NCT00424762|889752|P1|STARTED|Overall Study||74
365900|NCT00424749|889762|P1|NOT COMPLETED|Overall Study||1
365901|NCT00424749|889762|P1|COMPLETED|Overall Study||3
365902|NCT00424749|889762|P1|STARTED|Overall Study||4
365903|NCT00424645|889769|P2|NOT COMPLETED|Overall Study||0
365904|NCT00424645|889770|P1|NOT COMPLETED|Overall Study||1
365905|NCT00424645|889769|P2|COMPLETED|Overall Study||0
365906|NCT00424645|889770|P1|COMPLETED|Overall Study||2
365907|NCT00424645|889769|P2|STARTED|Overall Study||0
365908|NCT00424645|889770|P1|STARTED|Overall Study||3
365909|NCT00424632|889778|P10|NOT COMPLETED|Overall Study||6
365910|NCT00424632|889779|P9|NOT COMPLETED|Overall Study||16
365911|NCT00424632|889780|P8|NOT COMPLETED|Overall Study||3
365912|NCT00424632|889781|P7|NOT COMPLETED|Overall Study||7
365913|NCT00424632|889782|P6|NOT COMPLETED|Overall Study||15
365914|NCT00424632|889783|P5|NOT COMPLETED|Overall Study||3
365915|NCT00424632|889784|P4|NOT COMPLETED|Overall Study||4
365916|NCT00424632|889785|P3|NOT COMPLETED|Overall Study||1
365917|NCT00424632|889786|P2|NOT COMPLETED|Overall Study||1
365918|NCT00424632|889787|P1|NOT COMPLETED|Overall Study||1
365919|NCT00424632|889778|P10|COMPLETED|Overall Study||0
365920|NCT00424632|889779|P9|COMPLETED|Overall Study||0
365921|NCT00424632|889780|P8|COMPLETED|Overall Study||0
365922|NCT00424632|889781|P7|COMPLETED|Overall Study||0
365923|NCT00424632|889782|P6|COMPLETED|Overall Study||0
365924|NCT00424632|889783|P5|COMPLETED|Overall Study||0
365925|NCT00424632|889784|P4|COMPLETED|Overall Study||0
365926|NCT00424632|889785|P3|COMPLETED|Overall Study||0
365927|NCT00424632|889786|P2|COMPLETED|Overall Study||0
365928|NCT00424632|889787|P1|COMPLETED|Overall Study||0
365929|NCT00424632|889778|P10|STARTED|Overall Study||6
365930|NCT00424632|889779|P9|STARTED|Overall Study||16
365931|NCT00424632|889780|P8|STARTED|Overall Study||3
365932|NCT00424632|889781|P7|STARTED|Overall Study||7
365933|NCT00424632|889782|P6|STARTED|Overall Study||15
365934|NCT00424632|889783|P5|STARTED|Overall Study||3
365935|NCT00424632|889784|P4|STARTED|Overall Study||4
365936|NCT00424632|889785|P3|STARTED|Overall Study||1
365937|NCT00424632|889786|P2|STARTED|Overall Study||1
365938|NCT00424632|889787|P1|STARTED|Overall Study||1
365939|NCT00424619|889921|P3|NOT COMPLETED|3 Month||0
365940|NCT00424619|889922|P2|NOT COMPLETED|3 Month||0
365941|NCT00424619|889923|P1|NOT COMPLETED|3 Month||0
365942|NCT00424619|889921|P3|COMPLETED|3 Month||17
365943|NCT00424619|889922|P2|COMPLETED|3 Month||18
365944|NCT00424619|889923|P1|COMPLETED|3 Month||12
365945|NCT00424619|889921|P3|STARTED|3 Month||17
365946|NCT00424619|889922|P2|STARTED|3 Month||18
365947|NCT00424619|889923|P1|STARTED|3 Month||12
365948|NCT00424619|889921|P3|NOT COMPLETED|4 Week||0
365949|NCT00424619|889922|P2|NOT COMPLETED|4 Week||0
365950|NCT00424619|889923|P1|NOT COMPLETED|4 Week||0
365951|NCT00424619|889921|P3|COMPLETED|4 Week||17
365952|NCT00424619|889922|P2|COMPLETED|4 Week||17
365953|NCT00424619|889923|P1|COMPLETED|4 Week||18
365954|NCT00424619|889921|P3|STARTED|4 Week||17
365955|NCT00424619|889922|P2|STARTED|4 Week||17
365956|NCT00424619|889923|P1|STARTED|4 Week||18
365957|NCT00424619|889921|P3|NOT COMPLETED|Baseline||1
365958|NCT00424619|889922|P2|NOT COMPLETED|Baseline||0
365959|NCT00424619|889923|P1|NOT COMPLETED|Baseline||0
365960|NCT00424619|889921|P3|COMPLETED|Baseline||20
365961|NCT00424619|889922|P2|COMPLETED|Baseline||22
365962|NCT00424619|889923|P1|COMPLETED|Baseline||22
365963|NCT00424619|889921|P3|STARTED|Baseline|n=21 but one participant was lost as a screen failure|21
365964|NCT00424619|889922|P2|STARTED|Baseline||22
365965|NCT00424619|889923|P1|STARTED|Baseline||22
365966|NCT00424593|889957|P2|NOT COMPLETED|Dose-Blind Extension Period||0
365967|NCT00424593|889958|P1|NOT COMPLETED|Dose-Blind Extension Period||64
365968|NCT00424593|889957|P2|COMPLETED|Dose-Blind Extension Period||0
365969|NCT00424593|889958|P1|COMPLETED|Dose-Blind Extension Period||117
365970|NCT00424593|889957|P2|STARTED|Dose-Blind Extension Period|98 placebo patients from acute phase entered dose-blind period and received duloxetine.|0
365971|NCT00424593|889958|P1|STARTED|Dose-Blind Extension Period|83 duloxetine patients from the acute phase entered the dose-blind period.|181
365972|NCT00424593|889957|P2|NOT COMPLETED|Acute Double-Blind Period||23
365973|NCT00424593|889958|P1|NOT COMPLETED|Acute Double-Blind Period||31
365974|NCT00424593|889957|P2|COMPLETED|Acute Double-Blind Period||98
365975|NCT00424593|889958|P1|COMPLETED|Acute Double-Blind Period||84
365976|NCT00424593|889957|P2|STARTED|Acute Double-Blind Period||121
365977|NCT00424593|889958|P1|STARTED|Acute Double-Blind Period||115
365978|NCT00424554|890004|P2|NOT COMPLETED|Overall Study||0
365979|NCT00424554|890005|P1|NOT COMPLETED|Overall Study||0
365980|NCT00424554|890004|P2|COMPLETED|Overall Study||6
365981|NCT00424554|890005|P1|COMPLETED|Overall Study||34
365982|NCT00424554|890004|P2|STARTED|Overall Study||6
365983|NCT00424554|890005|P1|STARTED|Overall Study||34
365984|NCT00424528|890022|P3|NOT COMPLETED|Overall Study||4
365985|NCT00424528|890023|P2|NOT COMPLETED|Overall Study||4
365986|NCT00424528|890024|P1|NOT COMPLETED|Overall Study||5
365987|NCT00424528|890022|P3|COMPLETED|Overall Study||74
365988|NCT00424528|890023|P2|COMPLETED|Overall Study||76
365989|NCT00424528|890024|P1|COMPLETED|Overall Study||71
365990|NCT00424528|890022|P3|STARTED|Overall Study||78
365991|NCT00424528|890023|P2|STARTED|Overall Study||80
365992|NCT00424528|890024|P1|STARTED|Overall Study||76
365993|NCT00424515|890079|P2|NOT COMPLETED|Overall Study||13
365994|NCT00424515|890080|P1|NOT COMPLETED|Overall Study||11
365995|NCT00424515|890079|P2|COMPLETED|Overall Study||0
365996|NCT00424515|890080|P1|COMPLETED|Overall Study||0
365997|NCT00424515|890079|P2|STARTED|Overall Study||13
365998|NCT00424515|890080|P1|STARTED|Overall Study||11
365999|NCT00424502|890090|P1|NOT COMPLETED|Overall Study||0
366000|NCT00424502|890090|P1|COMPLETED|Overall Study||20
366001|NCT00424502|890090|P1|STARTED|Overall Study||20
366002|NCT00424489|890099|P1|NOT COMPLETED|Overall Study||3
366003|NCT00424489|890099|P1|COMPLETED|Overall Study||6
366004|NCT00424489|890099|P1|STARTED|Overall Study||9
366005|NCT00424476|890106|P3|NOT COMPLETED|Overall Study||49
366006|NCT00424476|890107|P2|NOT COMPLETED|Overall Study||48
366007|NCT00424476|890108|P1|NOT COMPLETED|Overall Study||61
366008|NCT00424476|890106|P3|COMPLETED|Overall Study||241
366009|NCT00424476|890107|P2|COMPLETED|Overall Study||240
366010|NCT00424476|890108|P1|COMPLETED|Overall Study||226
366011|NCT00424476|890106|P3|STARTED|Overall Study||290
366012|NCT00424476|890107|P2|STARTED|Overall Study||288
366013|NCT00424476|890108|P1|STARTED|Overall Study||287
366014|NCT00424463|890134|P3|NOT COMPLETED|Overall Study||16
366015|NCT00424463|890135|P2|NOT COMPLETED|Overall Study||14
366016|NCT00424463|890136|P1|NOT COMPLETED|Overall Study||7
366017|NCT00424463|890134|P3|COMPLETED|Overall Study||72
366018|NCT00424463|890135|P2|COMPLETED|Overall Study||34
366019|NCT00424463|890136|P1|COMPLETED|Overall Study||38
366020|NCT00424463|890134|P3|STARTED|Overall Study||88
366021|NCT00424463|890135|P2|STARTED|Overall Study||48
366022|NCT00424463|890136|P1|STARTED|Overall Study||45
366023|NCT00424398|890165|P3|NOT COMPLETED|Overall Study||0
366024|NCT00424398|890166|P2|NOT COMPLETED|Overall Study||1
366025|NCT00424398|890167|P1|NOT COMPLETED|Overall Study||3
366026|NCT00424398|890165|P3|COMPLETED|Overall Study||36
366027|NCT00424398|890166|P2|COMPLETED|Overall Study||35
366028|NCT00424398|890167|P1|COMPLETED|Overall Study||32
366029|NCT00424398|890165|P3|STARTED|Overall Study||36
366030|NCT00424398|890166|P2|STARTED|Overall Study||36
366031|NCT00424398|890167|P1|STARTED|Overall Study||35
366032|NCT00424385|890211|P1|NOT COMPLETED|Cohort 1||1
366033|NCT00424385|890211|P1|COMPLETED|Cohort 1||4
366034|NCT00424385|890211|P1|STARTED|Cohort 1||5
366035|NCT00424385|890211|P1|NOT COMPLETED|Cohort 0||6
366036|NCT00424385|890211|P1|COMPLETED|Cohort 0||6
366037|NCT00424385|890211|P1|STARTED|Cohort 0||12
366038|NCT00424372|890218|P1|NOT COMPLETED|Overall Study||31
366039|NCT00424372|890218|P1|COMPLETED|Overall Study||95
366040|NCT00424372|890218|P1|STARTED|Overall Study||126
366041|NCT00424346|890230|P4|NOT COMPLETED|Extension Phase||55
366042|NCT00424346|890231|P3|NOT COMPLETED|Extension Phase||55
366043|NCT00424346|890232|P2|NOT COMPLETED|Extension Phase||102
366044|NCT00424346|890233|P1|NOT COMPLETED|Extension Phase||0
366045|NCT00424346|890230|P4|COMPLETED|Extension Phase||3
366046|NCT00424346|890231|P3|COMPLETED|Extension Phase||4
366047|NCT00424346|890232|P2|COMPLETED|Extension Phase||8
366048|NCT00424346|890233|P1|COMPLETED|Extension Phase||0
366049|NCT00424346|890230|P4|STARTED|Extension Phase||58
366050|NCT00424346|890231|P3|STARTED|Extension Phase||59
366051|NCT00424346|890232|P2|STARTED|Extension Phase|Includes participants who completed the Core phase in the Canakinumab 600 mg IV + 300 mg q2wk group.|110
366052|NCT00424346|890233|P1|STARTED|Extension Phase|Participants are represented in the Canakinumab 300 mg q2wk treatment group.|0
366053|NCT00424346|890230|P4|NOT COMPLETED|Core Study||7
366054|NCT00424346|890231|P3|NOT COMPLETED|Core Study||4
366055|NCT00424346|890232|P2|NOT COMPLETED|Core Study||8
366056|NCT00424346|890233|P1|NOT COMPLETED|Core Study||9
366057|NCT00424346|890230|P4|COMPLETED|Core Study||63
366058|NCT00424346|890231|P3|COMPLETED|Core Study||65
366059|NCT00424346|890232|P2|COMPLETED|Core Study||56
366060|NCT00424346|890233|P1|COMPLETED|Core Study||62
366061|NCT00424346|890230|P4|STARTED|Core Study||70
366062|NCT00424346|890231|P3|STARTED|Core Study||69
366063|NCT00424346|890232|P2|STARTED|Core Study||64
366064|NCT00424346|890233|P1|STARTED|Core Study||71
366065|NCT00424294|890348|P2|NOT COMPLETED|Overall Study||15
366066|NCT00424294|890349|P1|NOT COMPLETED|Overall Study||8
366067|NCT00424294|890348|P2|COMPLETED|Overall Study||19
366068|NCT00424294|890349|P1|COMPLETED|Overall Study||28
366069|NCT00424294|890348|P2|Treated|Overall Study||34
366070|NCT00424294|890349|P1|Treated|Overall Study||35
366071|NCT00424294|890348|P2|STARTED|Overall Study||34
366072|NCT00424294|890349|P1|STARTED|Overall Study||36
366073|NCT00424268|890399|P2|NOT COMPLETED|Overall Study||39
366074|NCT00424268|890400|P1|NOT COMPLETED|Overall Study||62
366075|NCT00424268|890399|P2|COMPLETED|Overall Study||333
366076|NCT00424268|890400|P1|COMPLETED|Overall Study||309
366077|NCT00424268|890399|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|372
366078|NCT00424268|890400|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|371
366079|NCT00424255|890416|P2|NOT COMPLETED|Overall Study||346
366080|NCT00424255|890417|P1|NOT COMPLETED|Overall Study||342
366081|NCT00424255|890416|P2|COMPLETED|Overall Study||0
366082|NCT00424255|890417|P1|COMPLETED|Overall Study||0
366083|NCT00424255|890416|P2|STARTED|Overall Study||346
366084|NCT00424255|890417|P1|STARTED|Overall Study||342
366085|NCT00424190|890465|P2|NOT COMPLETED|Overall Study||30
366086|NCT00424190|890466|P1|NOT COMPLETED|Overall Study||22
366087|NCT00424190|890465|P2|COMPLETED|Overall Study||317
366088|NCT00424190|890466|P1|COMPLETED|Overall Study||329
366089|NCT00424190|890465|P2|STARTED|Overall Study||347
366090|NCT00424190|890466|P1|STARTED|Overall Study||351
366091|NCT00424177|890472|P1|NOT COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||3
366092|NCT00424177|890472|P1|COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||48
366093|NCT00424177|890472|P1|STARTED|Cycle 3: Eltrombopag 50 or 75 mg||51
366094|NCT00424177|890472|P1|NOT COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||4
366095|NCT00424177|890472|P1|COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||51
366096|NCT00424177|890472|P1|STARTED|Cycle 2: Eltrombopag 50 or 75 mg||55
366097|NCT00424177|890472|P1|NOT COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||11
366098|NCT00424177|890472|P1|COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||55
366099|NCT00424177|890472|P1|STARTED|Cycle 1: Eltrombopag 50 mg Starting Dose||66
366100|NCT00424047|890501|P2|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||8
366101|NCT00424047|890502|P1|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||21
366102|NCT00424047|890501|P2|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
366103|NCT00424047|890502|P1|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
366104|NCT00424047|890501|P2|STARTED|Long Term Extension (Up to 25 Jun 2013)|2 participants opted to receive dex alone, 3 crossed over to Len/Dex and 3 added Len at a later date|8
366105|NCT00424047|890502|P1|STARTED|Long Term Extension (Up to 25 Jun 2013)||21
366106|NCT00424047|890501|P2|NOT COMPLETED|On Study at Time of Unblinding||167
366107|NCT00424047|890502|P1|NOT COMPLETED|On Study at Time of Unblinding||155
366108|NCT00424047|890501|P2|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term dexamethasone|8
366109|NCT00424047|890502|P1|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term Lenalidomide and dexamethasone|21
366110|NCT00424047|890501|P2|STARTED|On Study at Time of Unblinding||175
366111|NCT00424047|890502|P1|STARTED|On Study at Time of Unblinding|Refers to original treatment group assignment in the study.|176
366112|NCT00424047|890501|P2|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||156
366113|NCT00424047|890502|P1|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||122
366114|NCT00424047|890501|P2|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|Ongoing and includes 15 participants who crossed over to lenalidomide/dexamethasone after unblinding|19
366202|NCT00423813|890719|P1|NOT COMPLETED|Overall Study||57
366115|NCT00424047|890502|P1|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|54 participants ongoing and continuing on lenalidomide/dexamethasone treatment|54
366116|NCT00424047|890501|P2|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|4 participants excluded because they had no baseline M-protein assessment|171
366117|NCT00424047|890502|P1|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|1 participant excluded because they had no baseline M-protein assessment|175
366118|NCT00424047|890501|P2|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|175
366119|NCT00424047|890502|P1|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|176
366120|NCT00424047|890501|P2|STARTED|Blinded Treatment (Up to 03 Aug 2005)||175
366121|NCT00424047|890502|P1|STARTED|Blinded Treatment (Up to 03 Aug 2005)||176
366122|NCT00424021|890534|P4|NOT COMPLETED|AMB-220-E Study Period||10
366123|NCT00424021|890535|P3|NOT COMPLETED|AMB-220-E Study Period||5
366124|NCT00424021|890536|P2|NOT COMPLETED|AMB-220-E Study Period||2
366125|NCT00424021|890537|P1|NOT COMPLETED|AMB-220-E Study Period||1
366126|NCT00424021|890534|P4|COMPLETED|AMB-220-E Study Period||16
366127|NCT00424021|890535|P3|COMPLETED|AMB-220-E Study Period||14
366128|NCT00424021|890536|P2|COMPLETED|AMB-220-E Study Period||5
366129|NCT00424021|890537|P1|COMPLETED|AMB-220-E Study Period||1
366130|NCT00424021|890534|P4|STARTED|AMB-220-E Study Period||26
366131|NCT00424021|890535|P3|STARTED|AMB-220-E Study Period||19
366132|NCT00424021|890536|P2|STARTED|AMB-220-E Study Period||7
366133|NCT00424021|890537|P1|STARTED|AMB-220-E Study Period||2
366134|NCT00424021|890534|P4|NOT COMPLETED|NCT00046319 Study Period||1
366135|NCT00424021|890535|P3|NOT COMPLETED|NCT00046319 Study Period||1
366136|NCT00424021|890536|P2|NOT COMPLETED|NCT00046319 Study Period||3
366137|NCT00424021|890537|P1|NOT COMPLETED|NCT00046319 Study Period||1
366138|NCT00424021|890534|P4|COMPLETED|NCT00046319 Study Period||12
366139|NCT00424021|890535|P3|COMPLETED|NCT00046319 Study Period||15
366140|NCT00424021|890536|P2|COMPLETED|NCT00046319 Study Period||16
366141|NCT00424021|890537|P1|COMPLETED|NCT00046319 Study Period||15
366142|NCT00424021|890534|P4|STARTED|NCT00046319 Study Period||13
366143|NCT00424021|890535|P3|STARTED|NCT00046319 Study Period||16
366144|NCT00424021|890536|P2|STARTED|NCT00046319 Study Period||19
366145|NCT00424021|890537|P1|STARTED|NCT00046319 Study Period||16
366146|NCT00424008|890580|P2|NOT COMPLETED|Overall Study||335
366147|NCT00424008|890581|P1|NOT COMPLETED|Overall Study||349
366148|NCT00424008|890580|P2|COMPLETED|Overall Study||16
366149|NCT00424008|890581|P1|COMPLETED|Overall Study||22
366150|NCT00424008|890580|P2|STARTED|Overall Study||351
366151|NCT00424008|890581|P1|STARTED|Overall Study||371
366152|NCT00423943|890596|P2|NOT COMPLETED|Overall Study||1
366153|NCT00423943|890597|P1|NOT COMPLETED|Overall Study||3
366154|NCT00423943|890596|P2|COMPLETED|Overall Study||13
366155|NCT00423943|890597|P1|COMPLETED|Overall Study||16
366156|NCT00423943|890596|P2|STARTED|Overall Study||14
366157|NCT00423943|890597|P1|STARTED|Overall Study||19
366158|NCT00423930|890611|P1|NOT COMPLETED|Overall Study||2
366159|NCT00423930|890611|P1|COMPLETED|Overall Study||42
366160|NCT00423930|890611|P1|STARTED|Overall Study||44
366161|NCT00423917|890616|P1|NOT COMPLETED|Overall Study||3
366162|NCT00423917|890616|P1|COMPLETED|Overall Study||33
366163|NCT00423917|890616|P1|STARTED|Overall Study||36
366164|NCT00423891|890629|P3|NOT COMPLETED|Post-Dosing Follow Up||2
366165|NCT00423891|890630|P2|NOT COMPLETED|Post-Dosing Follow Up||3
366166|NCT00423891|890631|P1|NOT COMPLETED|Post-Dosing Follow Up||2
366167|NCT00423891|890629|P3|COMPLETED|Post-Dosing Follow Up||3
366168|NCT00423891|890630|P2|COMPLETED|Post-Dosing Follow Up||15
366169|NCT00423891|890631|P1|COMPLETED|Post-Dosing Follow Up||20
366170|NCT00423891|890629|P3|STARTED|Post-Dosing Follow Up||5
366171|NCT00423891|890630|P2|STARTED|Post-Dosing Follow Up||18
366172|NCT00423891|890631|P1|STARTED|Post-Dosing Follow Up||22
366173|NCT00423891|890629|P3|NOT COMPLETED|Treatment||0
366174|NCT00423891|890630|P2|NOT COMPLETED|Treatment||0
366175|NCT00423891|890631|P1|NOT COMPLETED|Treatment||2
366176|NCT00423891|890629|P3|COMPLETED|Treatment||5
366177|NCT00423891|890630|P2|COMPLETED|Treatment||19
366178|NCT00423891|890631|P1|COMPLETED|Treatment||22
366179|NCT00423891|890629|P3|STARTED|Treatment||5
366180|NCT00423891|890630|P2|STARTED|Treatment||19
366181|NCT00423891|890631|P1|STARTED|Treatment||24
366182|NCT00423891|890629|P3|NOT COMPLETED|Enrolled||3
366183|NCT00423891|890630|P2|NOT COMPLETED|Enrolled||2
366184|NCT00423891|890631|P1|NOT COMPLETED|Enrolled||11
366185|NCT00423891|890629|P3|COMPLETED|Enrolled||5
366186|NCT00423891|890630|P2|COMPLETED|Enrolled||19
366187|NCT00423891|890631|P1|COMPLETED|Enrolled||24
366188|NCT00423891|890629|P3|STARTED|Enrolled||8
366189|NCT00423891|890630|P2|STARTED|Enrolled||21
366190|NCT00423891|890631|P1|STARTED|Enrolled||35
366191|NCT00423878|890700|P2|NOT COMPLETED|Overall Study||8
366192|NCT00423878|890701|P1|NOT COMPLETED|Overall Study||20
366193|NCT00423878|890700|P2|COMPLETED|Overall Study||98
366194|NCT00423878|890701|P1|COMPLETED|Overall Study||89
366195|NCT00423878|890700|P2|STARTED|Overall Study||106
366196|NCT00423878|890701|P1|STARTED|Overall Study||109
366197|NCT00423852|890709|P1|NOT COMPLETED|Overall Study||3
366198|NCT00423852|890709|P1|COMPLETED|Overall Study||23
366199|NCT00423852|890709|P1|STARTED|Overall Study||26
366200|NCT00423813|890717|P3|NOT COMPLETED|Overall Study||74
366201|NCT00423813|890718|P2|NOT COMPLETED|Overall Study||66
366203|NCT00423813|890717|P3|COMPLETED|Overall Study||116
366204|NCT00423813|890718|P2|COMPLETED|Overall Study||129
366205|NCT00423813|890719|P1|COMPLETED|Overall Study||131
366206|NCT00423813|890717|P3|Treated|Overall Study||189
366207|NCT00423813|890718|P2|Treated|Overall Study||194
366208|NCT00423813|890719|P1|Treated|Overall Study||188
366209|NCT00423813|890717|P3|STARTED|Overall Study||190
366210|NCT00423813|890718|P2|STARTED|Overall Study||195
366211|NCT00423813|890719|P1|STARTED|Overall Study||188
366212|NCT00423800|890729|P2|NOT COMPLETED|Overall Study||1
366213|NCT00423800|890730|P1|NOT COMPLETED|Overall Study||0
366214|NCT00423800|890729|P2|COMPLETED|Overall Study||1
366215|NCT00423800|890730|P1|COMPLETED|Overall Study||3
366216|NCT00423800|890729|P2|STARTED|Overall Study||2
366217|NCT00423800|890730|P1|STARTED|Overall Study||3
366218|NCT00423735|890742|P3|NOT COMPLETED|Overall Study||0
366219|NCT00423735|890743|P2|NOT COMPLETED|Overall Study||6
366220|NCT00423735|890744|P1|NOT COMPLETED|Overall Study||8
366221|NCT00423735|890742|P3|COMPLETED|Overall Study||0
366222|NCT00423735|890743|P2|COMPLETED|Overall Study||29
366223|NCT00423735|890744|P1|COMPLETED|Overall Study||21
366224|NCT00423735|890742|P3|STARTED|Overall Study||0
366225|NCT00423735|890743|P2|STARTED|Overall Study||35
366226|NCT00423735|890744|P1|STARTED|Overall Study||29
366227|NCT00423722|890767|P2|NOT COMPLETED|Overall Study||13
366228|NCT00423722|890768|P1|NOT COMPLETED|Overall Study||14
366229|NCT00423722|890767|P2|COMPLETED|Overall Study||53
366230|NCT00423722|890768|P1|COMPLETED|Overall Study||49
366231|NCT00423722|890767|P2|STARTED|Overall Study||66
366232|NCT00423722|890768|P1|STARTED|Overall Study||63
366233|NCT00423683|890790|P2|NOT COMPLETED|Overall Study||0
366234|NCT00423683|890791|P1|NOT COMPLETED|Overall Study||1
366235|NCT00423683|890790|P2|COMPLETED|Overall Study||33
366236|NCT00423683|890791|P1|COMPLETED|Overall Study||30
366237|NCT00423683|890790|P2|STARTED|Overall Study||33
366238|NCT00423683|890791|P1|STARTED|Overall Study||31
366239|NCT00423670|890810|P8|NOT COMPLETED|Follow-up Period||3
366240|NCT00423670|890811|P7|NOT COMPLETED|Follow-up Period||9
366241|NCT00423670|890812|P6|NOT COMPLETED|Follow-up Period||0
366242|NCT00423670|890813|P5|NOT COMPLETED|Follow-up Period||2
366243|NCT00423670|890814|P4|NOT COMPLETED|Follow-up Period||5
366244|NCT00423670|890815|P3|NOT COMPLETED|Follow-up Period||11
366245|NCT00423670|890816|P2|NOT COMPLETED|Follow-up Period||16
366246|NCT00423670|890817|P1|NOT COMPLETED|Follow-up Period||3
366247|NCT00423670|890810|P8|COMPLETED|Follow-up Period||32
366248|NCT00423670|890811|P7|COMPLETED|Follow-up Period||41
366249|NCT00423670|890812|P6|COMPLETED|Follow-up Period||14
366250|NCT00423670|890813|P5|COMPLETED|Follow-up Period||89
366251|NCT00423670|890814|P4|COMPLETED|Follow-up Period||91
366252|NCT00423670|890815|P3|COMPLETED|Follow-up Period||85
366253|NCT00423670|890816|P2|COMPLETED|Follow-up Period||84
366254|NCT00423670|890817|P1|COMPLETED|Follow-up Period||94
366255|NCT00423670|890810|P8|STARTED|Follow-up Period||35
366256|NCT00423670|890811|P7|STARTED|Follow-up Period||50
366257|NCT00423670|890812|P6|STARTED|Follow-up Period||14
366258|NCT00423670|890813|P5|STARTED|Follow-up Period||91
366259|NCT00423670|890814|P4|STARTED|Follow-up Period||96
366260|NCT00423670|890815|P3|STARTED|Follow-up Period||96
366261|NCT00423670|890816|P2|STARTED|Follow-up Period||100
366262|NCT00423670|890817|P1|STARTED|Follow-up Period||97
366263|NCT00423670|890810|P8|NOT COMPLETED|Treatment Period||21
366264|NCT00423670|890811|P7|NOT COMPLETED|Treatment Period||31
366265|NCT00423670|890812|P6|NOT COMPLETED|Treatment Period||8
366266|NCT00423670|890813|P5|NOT COMPLETED|Treatment Period||27
366267|NCT00423670|890814|P4|NOT COMPLETED|Treatment Period||40
366268|NCT00423670|890815|P3|NOT COMPLETED|Treatment Period||27
366269|NCT00423670|890816|P2|NOT COMPLETED|Treatment Period||30
366270|NCT00423670|890817|P1|NOT COMPLETED|Treatment Period||52
366271|NCT00423670|890810|P8|COMPLETED|Treatment Period||15
366272|NCT00423670|890811|P7|COMPLETED|Treatment Period||28
366273|NCT00423670|890812|P6|COMPLETED|Treatment Period||8
366274|NCT00423670|890813|P5|COMPLETED|Treatment Period||76
366275|NCT00423670|890814|P4|COMPLETED|Treatment Period||63
366276|NCT00423670|890815|P3|COMPLETED|Treatment Period||76
366277|NCT00423670|890816|P2|COMPLETED|Treatment Period||77
366278|NCT00423670|890817|P1|COMPLETED|Treatment Period||52
366279|NCT00423670|890810|P8|STARTED|Treatment Period|Arm 8 were Arm 1 participants that were positive for HCV-RNA at TW 24 and had the option to switch.|36
366280|NCT00423670|890811|P7|STARTED|Treatment Period||59
366281|NCT00423670|890812|P6|STARTED|Treatment Period||16
366282|NCT00423670|890813|P5|STARTED|Treatment Period||103
366283|NCT00423670|890814|P4|STARTED|Treatment Period||103
366284|NCT00423670|890815|P3|STARTED|Treatment Period||103
366285|NCT00423670|890816|P2|STARTED|Treatment Period||107
366286|NCT00423670|890817|P1|STARTED|Treatment Period||104
366287|NCT00423657|890875|P2|NOT COMPLETED|Overall Study||25
366288|NCT00423657|890876|P1|NOT COMPLETED|Overall Study||26
366289|NCT00423657|890875|P2|COMPLETED|Overall Study||313
366290|NCT00423657|890876|P1|COMPLETED|Overall Study||316
366291|NCT00423657|890875|P2|STARTED|Overall Study||338
366292|NCT00423657|890876|P1|STARTED|Overall Study||342
366293|NCT00423605|890882|P1|NOT COMPLETED|Overall Study||241
366294|NCT00423605|890882|P1|COMPLETED|Overall Study||319
366295|NCT00423605|890882|P1|STARTED|Overall Study||560
366296|NCT00423592|890886|P1|NOT COMPLETED|Overall Study||7
366297|NCT00423592|890886|P1|COMPLETED|Overall Study|Completed study|29
366298|NCT00423592|890886|P1|Completed Preliminary Analysis Cut-off|Overall Study|Preliminary analysis cut-off at Week 12 for primary/secondary endpoint analysis|34
366299|NCT00423592|890886|P1|STARTED|Overall Study|Enrolled|36
366300|NCT00423579|890907|P2|NOT COMPLETED|Overall Study||4
366301|NCT00423579|890908|P1|NOT COMPLETED|Overall Study||4
366302|NCT00423579|890907|P2|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
366303|NCT00423579|890908|P1|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
366304|NCT00423579|890907|P2|STARTED|Overall Study||60
366305|NCT00423579|890908|P1|STARTED|Overall Study|61 enrolled, however one subject was ineligible and was removed.|60
366306|NCT00423488|890916|P2|NOT COMPLETED|Overall Study||1
366307|NCT00423488|890917|P1|NOT COMPLETED|Overall Study||5
366308|NCT00423488|890916|P2|COMPLETED|Overall Study||50
366309|NCT00423488|890917|P1|COMPLETED|Overall Study||37
366310|NCT00423488|890916|P2|STARTED|Overall Study||51
366311|NCT00423488|890917|P1|STARTED|Overall Study||42
366312|NCT00423449|890923|P5|NOT COMPLETED|Overall Study||7
366313|NCT00423449|890924|P4|NOT COMPLETED|Overall Study||22
366314|NCT00423449|890925|P3|NOT COMPLETED|Overall Study||15
366315|NCT00423449|890926|P2|NOT COMPLETED|Overall Study||4
366316|NCT00423449|890927|P1|NOT COMPLETED|Overall Study||3
366317|NCT00423449|890923|P5|COMPLETED|Overall Study||0
366318|NCT00423449|890924|P4|COMPLETED|Overall Study||5
366319|NCT00423449|890925|P3|COMPLETED|Overall Study||2
366320|NCT00423449|890926|P2|COMPLETED|Overall Study||2
366321|NCT00423449|890927|P1|COMPLETED|Overall Study||1
366322|NCT00423449|890923|P5|STARTED|Overall Study||7
366323|NCT00423449|890924|P4|STARTED|Overall Study||27
366324|NCT00423449|890925|P3|STARTED|Overall Study||17
366325|NCT00423449|890926|P2|STARTED|Overall Study||6
366326|NCT00423449|890927|P1|STARTED|Overall Study||4
366327|NCT00423436|890952|P2|NOT COMPLETED|Overall Study||0
366328|NCT00423436|890953|P1|NOT COMPLETED|Overall Study||0
366329|NCT00423436|890952|P2|COMPLETED|Overall Study||33
366330|NCT00423436|890953|P1|COMPLETED|Overall Study||35
366331|NCT00423436|890952|P2|STARTED|Overall Study||33
366332|NCT00423436|890953|P1|STARTED|Overall Study||35
366333|NCT00423358|890961|P2|NOT COMPLETED|Overall Study||0
366334|NCT00423358|890962|P1|NOT COMPLETED|Overall Study||0
366335|NCT00423358|890961|P2|COMPLETED|Overall Study||11
366336|NCT00423358|890962|P1|COMPLETED|Overall Study||11
366337|NCT00423358|890961|P2|STARTED|Overall Study||11
366338|NCT00423358|890962|P1|STARTED|Overall Study||11
366339|NCT00423332|890974|P2|NOT COMPLETED|Overall Study||7
366340|NCT00423332|890975|P1|NOT COMPLETED|Overall Study||9
366341|NCT00423332|890974|P2|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|11
366342|NCT00423332|890975|P1|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|44
366343|NCT00423332|890974|P2|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|4
366344|NCT00423332|890975|P1|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|22
366345|NCT00423332|890974|P2|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|14
366346|NCT00423332|890975|P1|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|44
366347|NCT00423332|890974|P2|STARTED|Overall Study|Number randomised|18
366348|NCT00423332|890975|P1|STARTED|Overall Study|Randomised|53
366349|NCT00423319|890994|P2|NOT COMPLETED|Overall Study||252
366350|NCT00423319|890995|P1|NOT COMPLETED|Overall Study||224
366351|NCT00423319|890994|P2|COMPLETED|Overall Study||2447
366352|NCT00423319|890995|P1|COMPLETED|Overall Study||2484
366353|NCT00423319|890994|P2|Participants Who Received Treatment|Overall Study||2659
366354|NCT00423319|890995|P1|Participants Who Received Treatment|Overall Study||2673
366355|NCT00423319|890994|P2|STARTED|Overall Study|Randomized|2699
366356|NCT00423319|890995|P1|STARTED|Overall Study|Randomized|2708
366357|NCT00423293|891027|P1|NOT COMPLETED|Overall Study||11
366358|NCT00423293|891027|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
366359|NCT00423293|891027|P1|STARTED|Overall Study||63
366360|NCT00423267|891044|P2|NOT COMPLETED|Period B||0
366361|NCT00423267|891045|P1|NOT COMPLETED|Period B||0
366362|NCT00423267|891044|P2|COMPLETED|Period B||0
366363|NCT00423267|891045|P1|COMPLETED|Period B||12
366364|NCT00423267|891044|P2|STARTED|Period B||0
366365|NCT00423267|891045|P1|STARTED|Period B||12
366366|NCT00423267|891044|P2|NOT COMPLETED|Period A||1
366367|NCT00423267|891045|P1|NOT COMPLETED|Period A||2
366368|NCT00423267|891044|P2|COMPLETED|Period A||6
366369|NCT00423267|891045|P1|COMPLETED|Period A||7
366370|NCT00423267|891044|P2|STARTED|Period A||7
366371|NCT00423267|891045|P1|STARTED|Period A||9
366372|NCT00423189|891065|P3|NOT COMPLETED|Overall Study||0
366373|NCT00423189|891066|P2|NOT COMPLETED|Overall Study||1
366374|NCT00423189|891067|P1|NOT COMPLETED|Overall Study||0
366375|NCT00423189|891065|P3|COMPLETED|Overall Study||2
366376|NCT00423189|891066|P2|COMPLETED|Overall Study||2
366377|NCT00423189|891067|P1|COMPLETED|Overall Study||2
366378|NCT00423189|891065|P3|STARTED|Overall Study||2
366379|NCT00423189|891066|P2|STARTED|Overall Study||3
366380|NCT00423189|891067|P1|STARTED|Overall Study||2
366381|NCT00423176|891089|P2|NOT COMPLETED|Overall Study||29
366382|NCT00423176|891090|P1|NOT COMPLETED|Overall Study||16
366383|NCT00423176|891089|P2|COMPLETED|Overall Study||94
366384|NCT00423176|891090|P1|COMPLETED|Overall Study||98
366385|NCT00423176|891089|P2|STARTED|Overall Study||123
366386|NCT00423176|891090|P1|STARTED|Overall Study||114
366387|NCT00423150|891098|P1|NOT COMPLETED|Overall Study||86
366388|NCT00423150|891098|P1|COMPLETED|Overall Study||0
366389|NCT00423150|891098|P1|STARTED|Overall Study||86
366390|NCT00423098|891104|P2|NOT COMPLETED|Overall Study||4
366391|NCT00423098|891105|P1|NOT COMPLETED|Overall Study||3
366392|NCT00423098|891104|P2|COMPLETED|Overall Study||35
366393|NCT00423098|891105|P1|COMPLETED|Overall Study|Completed 24 weeks of study medication.|39
366394|NCT00423098|891104|P2|STARTED|Overall Study||39
366395|NCT00423098|891105|P1|STARTED|Overall Study|Total number of patients screened was 90, but the total number of randomized patients was 81.|42
366396|NCT00423085|891132|P4|NOT COMPLETED|52-Week Open-Label Extension Phase||163
366397|NCT00423085|891133|P3|NOT COMPLETED|52-Week Open-Label Extension Phase||0
366398|NCT00423085|891134|P2|NOT COMPLETED|52-Week Open-Label Extension Phase||0
366399|NCT00423085|891135|P1|NOT COMPLETED|52-Week Open-Label Extension Phase||0
366400|NCT00423085|891132|P4|COMPLETED|52-Week Open-Label Extension Phase||474
366401|NCT00423085|891133|P3|COMPLETED|52-Week Open-Label Extension Phase||0
366402|NCT00423085|891134|P2|COMPLETED|52-Week Open-Label Extension Phase||0
366403|NCT00423085|891135|P1|COMPLETED|52-Week Open-Label Extension Phase||0
366404|NCT00423085|891132|P4|STARTED|52-Week Open-Label Extension Phase|Patients who completed the 24-wk treatment phase were eligible to enroll in the open-label extension|637
366405|NCT00423085|891133|P3|STARTED|52-Week Open-Label Extension Phase||0
366406|NCT00423085|891134|P2|STARTED|52-Week Open-Label Extension Phase||0
366407|NCT00423085|891135|P1|STARTED|52-Week Open-Label Extension Phase||0
366408|NCT00423085|891132|P4|NOT COMPLETED|24-Week Double-Blind Treatment Phase||0
366409|NCT00423085|891133|P3|NOT COMPLETED|24-Week Double-Blind Treatment Phase||59
366410|NCT00423085|891134|P2|NOT COMPLETED|24-Week Double-Blind Treatment Phase||64
366411|NCT00423085|891135|P1|NOT COMPLETED|24-Week Double-Blind Treatment Phase||46
366412|NCT00423085|891132|P4|COMPLETED|24-Week Double-Blind Treatment Phase||0
366413|NCT00423085|891133|P3|COMPLETED|24-Week Double-Blind Treatment Phase||228
366414|NCT00423085|891134|P2|COMPLETED|24-Week Double-Blind Treatment Phase||220
366415|NCT00423085|891135|P1|COMPLETED|24-Week Double-Blind Treatment Phase||242
366416|NCT00423085|891132|P4|STARTED|24-Week Double-Blind Treatment Phase||0
366417|NCT00423085|891133|P3|STARTED|24-Week Double-Blind Treatment Phase||287
366418|NCT00423085|891134|P2|STARTED|24-Week Double-Blind Treatment Phase||284
366419|NCT00423085|891135|P1|STARTED|24-Week Double-Blind Treatment Phase||288
366420|NCT00423046|891164|P2|NOT COMPLETED|Overall Study||345
366421|NCT00423046|891165|P1|NOT COMPLETED|Overall Study||340
366422|NCT00423046|891164|P2|COMPLETED|Overall Study|Completed until Month 60|208
366423|NCT00423046|891165|P1|COMPLETED|Overall Study|Completed until Month 60|213
366424|NCT00423046|891164|P2|STARTED|Overall Study||553
366425|NCT00423046|891165|P1|STARTED|Overall Study||553
366426|NCT00422942|891231|P1|NOT COMPLETED|Overall Study||3
366427|NCT00422942|891231|P1|COMPLETED|Overall Study||0
366428|NCT00422942|891231|P1|STARTED|Overall Study||3
366429|NCT00422903|891250|P2|NOT COMPLETED|Overall Study||5
366430|NCT00422903|891251|P1|NOT COMPLETED|Overall Study||4
366431|NCT00422903|891250|P2|COMPLETED|Overall Study||38
366432|NCT00422903|891251|P1|COMPLETED|Overall Study||45
366433|NCT00422903|891250|P2|STARTED|Overall Study||43
366434|NCT00422903|891251|P1|STARTED|Overall Study||49
366435|NCT00422812|891279|P4|NOT COMPLETED|Overall Study||2
366436|NCT00422812|891280|P3|NOT COMPLETED|Overall Study||2
366437|NCT00422812|891281|P2|NOT COMPLETED|Overall Study||1
366438|NCT00422812|891282|P1|NOT COMPLETED|Overall Study||0
366439|NCT00422812|891279|P4|COMPLETED|Overall Study||103
366440|NCT00422812|891280|P3|COMPLETED|Overall Study||91
366441|NCT00422812|891281|P2|COMPLETED|Overall Study||103
366442|NCT00422812|891282|P1|COMPLETED|Overall Study||98
366443|NCT00422812|891279|P4|STARTED|Overall Study||105
366444|NCT00422812|891280|P3|STARTED|Overall Study||93
366445|NCT00422812|891281|P2|STARTED|Overall Study||104
366446|NCT00422812|891282|P1|STARTED|Overall Study||98
366447|NCT00422799|891300|P1|NOT COMPLETED|Overall Study||13
366448|NCT00422799|891300|P1|COMPLETED|Overall Study||50
366449|NCT00422799|891300|P1|STARTED|Overall Study||63
366450|NCT00422734|891309|P2|NOT COMPLETED|Overall Study||21
366451|NCT00422734|891310|P1|NOT COMPLETED|Overall Study||14
366452|NCT00422734|891309|P2|COMPLETED|Overall Study||243
366453|NCT00422734|891310|P1|COMPLETED|Overall Study||64
366454|NCT00422734|891309|P2|STARTED|Overall Study||264
366455|NCT00422734|891310|P1|STARTED|Overall Study||78
366456|NCT00422695|891344|P2|NOT COMPLETED|Overall Study||0
366457|NCT00422695|891345|P1|NOT COMPLETED|Overall Study||0
366458|NCT00422695|891344|P2|COMPLETED|Overall Study||38
366459|NCT00422695|891345|P1|COMPLETED|Overall Study||105
366460|NCT00422695|891344|P2|STARTED|Overall Study||38
366461|NCT00422695|891345|P1|STARTED|Overall Study||105
366462|NCT00422669|891356|P3|NOT COMPLETED|Overall Study||7
366463|NCT00422669|891357|P2|NOT COMPLETED|Overall Study||100
366464|NCT00422669|891358|P1|NOT COMPLETED|Overall Study||98
366465|NCT00422669|891356|P3|COMPLETED|Overall Study||0
366466|NCT00422669|891357|P2|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
366467|NCT00422669|891358|P1|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
366468|NCT00422669|891356|P3|STARTED|Overall Study||7
366469|NCT00422669|891357|P2|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|100
366470|NCT00422669|891358|P1|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|98
366471|NCT00422656|891379|P1|NOT COMPLETED|Overall Study||0
366472|NCT00422656|891379|P1|COMPLETED|Overall Study||37
366473|NCT00422656|891379|P1|STARTED|Overall Study||37
366474|NCT00422591|891386|P1|NOT COMPLETED|Overall Study||6
366475|NCT00422591|891386|P1|COMPLETED|Overall Study||169
366476|NCT00422591|891386|P1|STARTED|Overall Study||175
366477|NCT00422513|891394|P2|NOT COMPLETED|Overall Study||106
366478|NCT00422513|891395|P1|NOT COMPLETED|Overall Study||107
366479|NCT00422513|891394|P2|COMPLETED|Overall Study||24
366480|NCT00422513|891395|P1|COMPLETED|Overall Study||23
366481|NCT00422513|891394|P2|STARTED|Overall Study||130
366482|NCT00422513|891395|P1|STARTED|Overall Study||130
366483|NCT00422448|891407|P1|NOT COMPLETED|Overall Study||0
366484|NCT00422448|891407|P1|COMPLETED|Overall Study||43
366485|NCT00422448|891407|P1|STARTED|Overall Study|22 prospectively enrolled during study period and 21 retrospectively enrolled|43
366486|NCT00422422|891412|P1|NOT COMPLETED|Overall Study||10
366487|NCT00422422|891412|P1|COMPLETED|Overall Study||90
366488|NCT00422422|891412|P1|STARTED|Overall Study||100
366489|NCT00422383|891429|P5|NOT COMPLETED|Overall Study||3
366490|NCT00422383|891430|P4|NOT COMPLETED|Overall Study||2
366491|NCT00422383|891431|P3|NOT COMPLETED|Overall Study||4
366492|NCT00422383|891432|P2|NOT COMPLETED|Overall Study||14
366493|NCT00422383|891433|P1|NOT COMPLETED|Overall Study||15
366494|NCT00422383|891429|P5|COMPLETED|Overall Study||22
366495|NCT00422383|891430|P4|COMPLETED|Overall Study||4
366496|NCT00422383|891431|P3|COMPLETED|Overall Study||89
366497|NCT00422383|891432|P2|COMPLETED|Overall Study||106
366498|NCT00422383|891433|P1|COMPLETED|Overall Study||119
366499|NCT00422383|891429|P5|STARTED|Overall Study||25
366500|NCT00422383|891430|P4|STARTED|Overall Study||6
366501|NCT00422383|891431|P3|STARTED|Overall Study||93
366502|NCT00422383|891432|P2|STARTED|Overall Study||120
366503|NCT00422383|891433|P1|STARTED|Overall Study||134
366504|NCT00422292|891576|P4|NOT COMPLETED|Overall Study||24
366505|NCT00422292|891577|P3|NOT COMPLETED|Overall Study||22
366506|NCT00422292|891578|P2|NOT COMPLETED|Overall Study||66
366507|NCT00422292|891579|P1|NOT COMPLETED|Overall Study||18
366508|NCT00422292|891576|P4|COMPLETED|Overall Study||452
366509|NCT00422292|891577|P3|COMPLETED|Overall Study||224
366510|NCT00422292|891578|P2|COMPLETED|Overall Study||598
366511|NCT00422292|891579|P1|COMPLETED|Overall Study||239
366512|NCT00422292|891576|P4|STARTED|Overall Study||476
366513|NCT00422292|891577|P3|STARTED|Overall Study||246
366514|NCT00422292|891578|P2|STARTED|Overall Study||664
366515|NCT00422292|891579|P1|STARTED|Overall Study||257
366516|NCT00422279|891607|P2|NOT COMPLETED|Overall Study||0
366517|NCT00422279|891608|P1|NOT COMPLETED|Overall Study||0
366518|NCT00422279|891607|P2|COMPLETED|Overall Study||2
366519|NCT00422279|891608|P1|COMPLETED|Overall Study||2
366520|NCT00422279|891607|P2|24 Month After Loading Period|Overall Study||2
366521|NCT00422279|891608|P1|24 Month After Loading Period|Overall Study||2
366522|NCT00422279|891607|P2|STARTED|Overall Study||2
366523|NCT00422279|891608|P1|STARTED|Overall Study||2
366524|NCT00422227|891618|P2|NOT COMPLETED|Overall Study||15
366525|NCT00422227|891619|P1|NOT COMPLETED|Overall Study||4
366526|NCT00422227|891618|P2|COMPLETED|Overall Study||88
366527|NCT00422227|891619|P1|COMPLETED|Overall Study||193
366528|NCT00422227|891618|P2|STARTED|Overall Study||103
366529|NCT00422227|891619|P1|STARTED|Overall Study||197
366530|NCT00422201|891643|P1|NOT COMPLETED|Overall Study||11
366531|NCT00422201|891643|P1|COMPLETED|Overall Study||7
366532|NCT00422201|891643|P1|STARTED|Overall Study||18
366533|NCT00422162|891650|P2|NOT COMPLETED|Overall Study||30
366534|NCT00422162|891651|P1|NOT COMPLETED|Overall Study||24
366535|NCT00422162|891650|P2|COMPLETED|Overall Study||142
366536|NCT00422162|891651|P1|COMPLETED|Overall Study||143
366537|NCT00422162|891650|P2|Received Treatment|Overall Study||171
366538|NCT00422162|891651|P1|Received Treatment|Overall Study||167
366539|NCT00422162|891650|P2|STARTED|Overall Study||172
366540|NCT00422162|891651|P1|STARTED|Overall Study||167
366541|NCT00422097|891711|P8|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
366542|NCT00422097|891712|P7|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
366543|NCT00422097|891713|P6|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
366544|NCT00422097|891714|P5|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
366545|NCT00422097|891715|P4|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
366546|NCT00422097|891716|P3|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
366547|NCT00422097|891717|P2|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
366548|NCT00422097|891718|P1|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
366549|NCT00422097|891711|P8|COMPLETED|Ixabepilone With Famotidine or Food||7
366550|NCT00422097|891712|P7|COMPLETED|Ixabepilone With Famotidine or Food||8
366551|NCT00422097|891713|P6|COMPLETED|Ixabepilone With Famotidine or Food||0
366552|NCT00422097|891714|P5|COMPLETED|Ixabepilone With Famotidine or Food||0
366553|NCT00422097|891715|P4|COMPLETED|Ixabepilone With Famotidine or Food||0
366554|NCT00422097|891716|P3|COMPLETED|Ixabepilone With Famotidine or Food||0
366555|NCT00422097|891717|P2|COMPLETED|Ixabepilone With Famotidine or Food||0
366651|NCT00422097|891717|P2|COMPLETED|Dose Level 3||0
366556|NCT00422097|891718|P1|COMPLETED|Ixabepilone With Famotidine or Food||0
366557|NCT00422097|891711|P8|STARTED|Ixabepilone With Famotidine or Food||7
366558|NCT00422097|891712|P7|STARTED|Ixabepilone With Famotidine or Food||8
366559|NCT00422097|891713|P6|STARTED|Ixabepilone With Famotidine or Food||0
366560|NCT00422097|891714|P5|STARTED|Ixabepilone With Famotidine or Food||0
366561|NCT00422097|891715|P4|STARTED|Ixabepilone With Famotidine or Food||0
366562|NCT00422097|891716|P3|STARTED|Ixabepilone With Famotidine or Food||0
366563|NCT00422097|891717|P2|STARTED|Ixabepilone With Famotidine or Food||0
366564|NCT00422097|891718|P1|STARTED|Ixabepilone With Famotidine or Food||0
366565|NCT00422097|891711|P8|NOT COMPLETED|Dose Level 6||0
366566|NCT00422097|891712|P7|NOT COMPLETED|Dose Level 6||0
366567|NCT00422097|891713|P6|NOT COMPLETED|Dose Level 6||0
366568|NCT00422097|891714|P5|NOT COMPLETED|Dose Level 6||0
366569|NCT00422097|891715|P4|NOT COMPLETED|Dose Level 6||0
366570|NCT00422097|891716|P3|NOT COMPLETED|Dose Level 6||0
366571|NCT00422097|891717|P2|NOT COMPLETED|Dose Level 6||0
366572|NCT00422097|891718|P1|NOT COMPLETED|Dose Level 6||0
366573|NCT00422097|891711|P8|COMPLETED|Dose Level 6||0
366574|NCT00422097|891712|P7|COMPLETED|Dose Level 6||0
366575|NCT00422097|891713|P6|COMPLETED|Dose Level 6||6
366576|NCT00422097|891714|P5|COMPLETED|Dose Level 6||0
366577|NCT00422097|891715|P4|COMPLETED|Dose Level 6||0
366578|NCT00422097|891716|P3|COMPLETED|Dose Level 6||0
366579|NCT00422097|891717|P2|COMPLETED|Dose Level 6||0
366580|NCT00422097|891718|P1|COMPLETED|Dose Level 6||0
366581|NCT00422097|891711|P8|STARTED|Dose Level 6||0
366582|NCT00422097|891712|P7|STARTED|Dose Level 6||0
366583|NCT00422097|891713|P6|STARTED|Dose Level 6||6
366584|NCT00422097|891714|P5|STARTED|Dose Level 6||0
366585|NCT00422097|891715|P4|STARTED|Dose Level 6||0
366586|NCT00422097|891716|P3|STARTED|Dose Level 6||0
366587|NCT00422097|891717|P2|STARTED|Dose Level 6||0
366588|NCT00422097|891718|P1|STARTED|Dose Level 6||0
366589|NCT00422097|891711|P8|NOT COMPLETED|Dose Level 5||0
366590|NCT00422097|891712|P7|NOT COMPLETED|Dose Level 5||0
366591|NCT00422097|891713|P6|NOT COMPLETED|Dose Level 5||0
366592|NCT00422097|891714|P5|NOT COMPLETED|Dose Level 5||0
366593|NCT00422097|891715|P4|NOT COMPLETED|Dose Level 5||0
366594|NCT00422097|891716|P3|NOT COMPLETED|Dose Level 5||0
366595|NCT00422097|891717|P2|NOT COMPLETED|Dose Level 5||0
366596|NCT00422097|891718|P1|NOT COMPLETED|Dose Level 5||0
366597|NCT00422097|891711|P8|COMPLETED|Dose Level 5||0
366598|NCT00422097|891712|P7|COMPLETED|Dose Level 5||0
366599|NCT00422097|891713|P6|COMPLETED|Dose Level 5||0
366600|NCT00422097|891714|P5|COMPLETED|Dose Level 5||23
366601|NCT00422097|891715|P4|COMPLETED|Dose Level 5||0
366602|NCT00422097|891716|P3|COMPLETED|Dose Level 5||0
366603|NCT00422097|891717|P2|COMPLETED|Dose Level 5||0
366604|NCT00422097|891718|P1|COMPLETED|Dose Level 5||0
366605|NCT00422097|891711|P8|STARTED|Dose Level 5||0
366606|NCT00422097|891712|P7|STARTED|Dose Level 5||0
366607|NCT00422097|891713|P6|STARTED|Dose Level 5||0
366608|NCT00422097|891714|P5|STARTED|Dose Level 5||23
366609|NCT00422097|891715|P4|STARTED|Dose Level 5||0
366610|NCT00422097|891716|P3|STARTED|Dose Level 5||0
366611|NCT00422097|891717|P2|STARTED|Dose Level 5||0
366612|NCT00422097|891718|P1|STARTED|Dose Level 5||0
366613|NCT00422097|891711|P8|NOT COMPLETED|Dose Level 4||0
366614|NCT00422097|891712|P7|NOT COMPLETED|Dose Level 4||0
366615|NCT00422097|891713|P6|NOT COMPLETED|Dose Level 4||0
366616|NCT00422097|891714|P5|NOT COMPLETED|Dose Level 4||0
366617|NCT00422097|891715|P4|NOT COMPLETED|Dose Level 4||0
366618|NCT00422097|891716|P3|NOT COMPLETED|Dose Level 4||0
366619|NCT00422097|891717|P2|NOT COMPLETED|Dose Level 4||0
366620|NCT00422097|891718|P1|NOT COMPLETED|Dose Level 4||0
366621|NCT00422097|891711|P8|COMPLETED|Dose Level 4||0
366622|NCT00422097|891712|P7|COMPLETED|Dose Level 4||0
366623|NCT00422097|891713|P6|COMPLETED|Dose Level 4||0
366624|NCT00422097|891714|P5|COMPLETED|Dose Level 4||0
366625|NCT00422097|891715|P4|COMPLETED|Dose Level 4||3
366626|NCT00422097|891716|P3|COMPLETED|Dose Level 4||0
366627|NCT00422097|891717|P2|COMPLETED|Dose Level 4||0
366628|NCT00422097|891718|P1|COMPLETED|Dose Level 4||0
366629|NCT00422097|891711|P8|STARTED|Dose Level 4||0
366630|NCT00422097|891712|P7|STARTED|Dose Level 4||0
366631|NCT00422097|891713|P6|STARTED|Dose Level 4||0
366632|NCT00422097|891714|P5|STARTED|Dose Level 4||0
366633|NCT00422097|891715|P4|STARTED|Dose Level 4||3
366634|NCT00422097|891716|P3|STARTED|Dose Level 4||0
366635|NCT00422097|891717|P2|STARTED|Dose Level 4||0
366636|NCT00422097|891718|P1|STARTED|Dose Level 4||0
366637|NCT00422097|891711|P8|NOT COMPLETED|Dose Level 3||0
366638|NCT00422097|891712|P7|NOT COMPLETED|Dose Level 3||0
366639|NCT00422097|891713|P6|NOT COMPLETED|Dose Level 3||0
366640|NCT00422097|891714|P5|NOT COMPLETED|Dose Level 3||0
366641|NCT00422097|891715|P4|NOT COMPLETED|Dose Level 3||0
366642|NCT00422097|891716|P3|NOT COMPLETED|Dose Level 3||0
366643|NCT00422097|891717|P2|NOT COMPLETED|Dose Level 3||0
366644|NCT00422097|891718|P1|NOT COMPLETED|Dose Level 3||0
366645|NCT00422097|891711|P8|COMPLETED|Dose Level 3||0
366646|NCT00422097|891712|P7|COMPLETED|Dose Level 3||0
366647|NCT00422097|891713|P6|COMPLETED|Dose Level 3||0
366648|NCT00422097|891714|P5|COMPLETED|Dose Level 3||0
366649|NCT00422097|891715|P4|COMPLETED|Dose Level 3||0
366650|NCT00422097|891716|P3|COMPLETED|Dose Level 3||3
366652|NCT00422097|891718|P1|COMPLETED|Dose Level 3||0
366653|NCT00422097|891711|P8|STARTED|Dose Level 3||0
366654|NCT00422097|891712|P7|STARTED|Dose Level 3||0
366655|NCT00422097|891713|P6|STARTED|Dose Level 3||0
366656|NCT00422097|891714|P5|STARTED|Dose Level 3||0
366657|NCT00422097|891715|P4|STARTED|Dose Level 3||0
366658|NCT00422097|891716|P3|STARTED|Dose Level 3||3
366659|NCT00422097|891717|P2|STARTED|Dose Level 3||0
366660|NCT00422097|891718|P1|STARTED|Dose Level 3||0
366661|NCT00422097|891711|P8|NOT COMPLETED|Dose Level 2||0
366662|NCT00422097|891712|P7|NOT COMPLETED|Dose Level 2||0
366663|NCT00422097|891713|P6|NOT COMPLETED|Dose Level 2||0
366664|NCT00422097|891714|P5|NOT COMPLETED|Dose Level 2||0
366665|NCT00422097|891715|P4|NOT COMPLETED|Dose Level 2||0
366666|NCT00422097|891716|P3|NOT COMPLETED|Dose Level 2||0
366667|NCT00422097|891717|P2|NOT COMPLETED|Dose Level 2||1
366668|NCT00422097|891718|P1|NOT COMPLETED|Dose Level 2||0
366669|NCT00422097|891711|P8|COMPLETED|Dose Level 2||0
366670|NCT00422097|891712|P7|COMPLETED|Dose Level 2||0
366671|NCT00422097|891713|P6|COMPLETED|Dose Level 2||0
366672|NCT00422097|891714|P5|COMPLETED|Dose Level 2||0
366673|NCT00422097|891715|P4|COMPLETED|Dose Level 2||0
366674|NCT00422097|891716|P3|COMPLETED|Dose Level 2||0
366675|NCT00422097|891717|P2|COMPLETED|Dose Level 2||5
366676|NCT00422097|891718|P1|COMPLETED|Dose Level 2||0
366677|NCT00422097|891711|P8|STARTED|Dose Level 2||0
366678|NCT00422097|891712|P7|STARTED|Dose Level 2||0
366679|NCT00422097|891713|P6|STARTED|Dose Level 2||0
366680|NCT00422097|891714|P5|STARTED|Dose Level 2||0
366681|NCT00422097|891715|P4|STARTED|Dose Level 2||0
366682|NCT00422097|891716|P3|STARTED|Dose Level 2||0
366683|NCT00422097|891717|P2|STARTED|Dose Level 2||6
366684|NCT00422097|891718|P1|STARTED|Dose Level 2||0
366685|NCT00422097|891711|P8|NOT COMPLETED|Dose Level 1||0
366686|NCT00422097|891712|P7|NOT COMPLETED|Dose Level 1||0
366687|NCT00422097|891713|P6|NOT COMPLETED|Dose Level 1||0
366688|NCT00422097|891714|P5|NOT COMPLETED|Dose Level 1||0
366689|NCT00422097|891715|P4|NOT COMPLETED|Dose Level 1||0
366690|NCT00422097|891716|P3|NOT COMPLETED|Dose Level 1||0
366691|NCT00422097|891717|P2|NOT COMPLETED|Dose Level 1||0
366692|NCT00422097|891718|P1|NOT COMPLETED|Dose Level 1||0
366693|NCT00422097|891711|P8|COMPLETED|Dose Level 1||0
366694|NCT00422097|891712|P7|COMPLETED|Dose Level 1||0
366695|NCT00422097|891713|P6|COMPLETED|Dose Level 1||0
366696|NCT00422097|891714|P5|COMPLETED|Dose Level 1||0
366697|NCT00422097|891715|P4|COMPLETED|Dose Level 1||0
366698|NCT00422097|891716|P3|COMPLETED|Dose Level 1||0
366699|NCT00422097|891717|P2|COMPLETED|Dose Level 1||0
366700|NCT00422097|891718|P1|COMPLETED|Dose Level 1||3
366701|NCT00422097|891711|P8|STARTED|Dose Level 1||0
366702|NCT00422097|891712|P7|STARTED|Dose Level 1||0
366703|NCT00422097|891713|P6|STARTED|Dose Level 1||0
366704|NCT00422097|891714|P5|STARTED|Dose Level 1||0
366705|NCT00422097|891715|P4|STARTED|Dose Level 1||0
366706|NCT00422097|891716|P3|STARTED|Dose Level 1||0
366707|NCT00422097|891717|P2|STARTED|Dose Level 1||0
366708|NCT00422097|891718|P1|STARTED|Dose Level 1||3
366709|NCT00422058|891783|P6|NOT COMPLETED|Open-Label Extension, Week 20-104||34
366710|NCT00422058|891784|P5|NOT COMPLETED|Open-Label Extension, Week 20-104||35
366711|NCT00422058|891785|P4|NOT COMPLETED|Open-Label Extension, Week 20-104||28
366712|NCT00422058|891786|P3|NOT COMPLETED|Open-Label Extension, Week 20-104||36
366713|NCT00422058|891787|P2|NOT COMPLETED|Open-Label Extension, Week 20-104||39
366714|NCT00422058|891788|P1|NOT COMPLETED|Open-Label Extension, Week 20-104||32
366715|NCT00422058|891783|P6|COMPLETED|Open-Label Extension, Week 20-104||45
366716|NCT00422058|891784|P5|COMPLETED|Open-Label Extension, Week 20-104||47
366717|NCT00422058|891785|P4|COMPLETED|Open-Label Extension, Week 20-104||45
366718|NCT00422058|891786|P3|COMPLETED|Open-Label Extension, Week 20-104||38
366719|NCT00422058|891787|P2|COMPLETED|Open-Label Extension, Week 20-104||46
366720|NCT00422058|891788|P1|COMPLETED|Open-Label Extension, Week 20-104||47
366721|NCT00422058|891783|P6|Enrolled in Extension|Open-Label Extension, Week 20-104||67
366722|NCT00422058|891784|P5|Enrolled in Extension|Open-Label Extension, Week 20-104||72
366723|NCT00422058|891785|P4|Enrolled in Extension|Open-Label Extension, Week 20-104||65
366724|NCT00422058|891786|P3|Enrolled in Extension|Open-Label Extension, Week 20-104||59
366725|NCT00422058|891787|P2|Enrolled in Extension|Open-Label Extension, Week 20-104||68
366726|NCT00422058|891788|P1|Enrolled in Extension|Open-Label Extension, Week 20-104||67
366727|NCT00422058|891783|P6|STARTED|Open-Label Extension, Week 20-104||79
366728|NCT00422058|891784|P5|STARTED|Open-Label Extension, Week 20-104||82
366729|NCT00422058|891785|P4|STARTED|Open-Label Extension, Week 20-104||73
366730|NCT00422058|891786|P3|STARTED|Open-Label Extension, Week 20-104||74
366731|NCT00422058|891787|P2|STARTED|Open-Label Extension, Week 20-104||85
366732|NCT00422058|891788|P1|STARTED|Open-Label Extension, Week 20-104||79
366733|NCT00422058|891783|P6|NOT COMPLETED|Double-Blind, Week 0-20||16
366734|NCT00422058|891784|P5|NOT COMPLETED|Double-Blind, Week 0-20||11
366735|NCT00422058|891785|P4|NOT COMPLETED|Double-Blind, Week 0-20||20
366736|NCT00422058|891786|P3|NOT COMPLETED|Double-Blind, Week 0-20||16
366737|NCT00422058|891787|P2|NOT COMPLETED|Double-Blind, Week 0-20||10
366738|NCT00422058|891788|P1|NOT COMPLETED|Double-Blind, Week 0-20||19
366739|NCT00422058|891783|P6|COMPLETED|Double-Blind, Week 0-20||79
366740|NCT00422058|891784|P5|COMPLETED|Double-Blind, Week 0-20||82
366741|NCT00422058|891785|P4|COMPLETED|Double-Blind, Week 0-20||73
366742|NCT00422058|891786|P3|COMPLETED|Double-Blind, Week 0-20||74
366743|NCT00422058|891787|P2|COMPLETED|Double-Blind, Week 0-20||85
366744|NCT00422058|891788|P1|COMPLETED|Double-Blind, Week 0-20||79
366745|NCT00422058|891783|P6|STARTED|Double-Blind, Week 0-20||95
366746|NCT00422058|891784|P5|STARTED|Double-Blind, Week 0-20||93
366747|NCT00422058|891785|P4|STARTED|Double-Blind, Week 0-20||93
366748|NCT00422058|891786|P3|STARTED|Double-Blind, Week 0-20||90
366749|NCT00422058|891787|P2|STARTED|Double-Blind, Week 0-20||95
366750|NCT00422058|891788|P1|STARTED|Double-Blind, Week 0-20||98
366751|NCT00422032|891918|P2|NOT COMPLETED|Overall Study||0
366752|NCT00422032|891919|P1|NOT COMPLETED|Overall Study||0
366753|NCT00422032|891918|P2|COMPLETED|Overall Study||21
366754|NCT00422032|891919|P1|COMPLETED|Overall Study||37
366755|NCT00422032|891918|P2|STARTED|Overall Study||21
366756|NCT00422032|891919|P1|STARTED|Overall Study||37
366757|NCT00421993|891929|P4|NOT COMPLETED|Overall Study||57
366758|NCT00421993|891930|P3|NOT COMPLETED|Overall Study||52
366759|NCT00421993|891931|P2|NOT COMPLETED|Overall Study||49
366760|NCT00421993|891932|P1|NOT COMPLETED|Overall Study||53
366761|NCT00421993|891929|P4|COMPLETED|Overall Study||361
366762|NCT00421993|891930|P3|COMPLETED|Overall Study||363
366763|NCT00421993|891931|P2|COMPLETED|Overall Study||369
366764|NCT00421993|891932|P1|COMPLETED|Overall Study||366
366765|NCT00421993|891929|P4|STARTED|Overall Study||418
366766|NCT00421993|891930|P3|STARTED|Overall Study||415
366767|NCT00421993|891931|P2|STARTED|Overall Study||418
366768|NCT00421993|891932|P1|STARTED|Overall Study||419
366769|NCT00421954|891962|P1|NOT COMPLETED|Overall Study||0
366770|NCT00421954|891962|P1|COMPLETED|Overall Study||0
366771|NCT00421954|891962|P1|STARTED|Overall Study||0
366772|NCT00421928|891969|P3|NOT COMPLETED|Overall Study||134
366773|NCT00421928|891970|P2|NOT COMPLETED|Overall Study||224
366774|NCT00421928|891971|P1|NOT COMPLETED|Overall Study||163
366775|NCT00421928|891969|P3|COMPLETED|Overall Study||203
366776|NCT00421928|891970|P2|COMPLETED|Overall Study||118
366777|NCT00421928|891971|P1|COMPLETED|Overall Study||181
366778|NCT00421928|891969|P3|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|337
366779|NCT00421928|891970|P2|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug. One subject was enrolled twice.|342
366780|NCT00421928|891971|P1|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|344
366781|NCT00421889|892006|P9|NOT COMPLETED|Overall Study||11
366782|NCT00421889|892007|P8|NOT COMPLETED|Overall Study||2
366783|NCT00421889|892008|P7|NOT COMPLETED|Overall Study||4
366784|NCT00421889|892009|P6|NOT COMPLETED|Overall Study||35
366785|NCT00421889|892010|P5|NOT COMPLETED|Overall Study||6
366786|NCT00421889|892011|P4|NOT COMPLETED|Overall Study||4
366787|NCT00421889|892012|P3|NOT COMPLETED|Overall Study||3
366788|NCT00421889|892013|P2|NOT COMPLETED|Overall Study||5
366789|NCT00421889|892014|P1|NOT COMPLETED|Overall Study||5
366790|NCT00421889|892006|P9|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 4.27|4
366791|NCT00421889|892007|P8|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|1
366792|NCT00421889|892008|P7|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.50|0
366793|NCT00421889|892009|P6|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 7.69|0
366794|NCT00421889|892010|P5|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.00|0
366795|NCT00421889|892011|P4|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 9.25|0
366796|NCT00421889|892012|P3|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|0
366797|NCT00421889|892013|P2|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 8.20|0
366798|NCT00421889|892014|P1|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.20|0
366799|NCT00421889|892006|P9|STARTED|Overall Study||15
366800|NCT00421889|892007|P8|STARTED|Overall Study||3
366801|NCT00421889|892008|P7|STARTED|Overall Study||4
366802|NCT00421889|892009|P6|STARTED|Overall Study||35
366803|NCT00421889|892010|P5|STARTED|Overall Study||6
366804|NCT00421889|892011|P4|STARTED|Overall Study||4
366805|NCT00421889|892012|P3|STARTED|Overall Study||3
366806|NCT00421889|892013|P2|STARTED|Overall Study||5
366807|NCT00421889|892014|P1|STARTED|Overall Study||5
366808|NCT00421733|892059|P3|NOT COMPLETED|Overall Study||20
366809|NCT00421733|892060|P2|NOT COMPLETED|Overall Study||26
366810|NCT00421733|892061|P1|NOT COMPLETED|Overall Study||15
366811|NCT00421733|892059|P3|COMPLETED|Overall Study||73
366812|NCT00421733|892060|P2|COMPLETED|Overall Study||69
366813|NCT00421733|892061|P1|COMPLETED|Overall Study||78
366814|NCT00421733|892059|P3|STARTED|Overall Study||93
366815|NCT00421733|892060|P2|STARTED|Overall Study||95
366816|NCT00421733|892061|P1|STARTED|Overall Study||93
366817|NCT00421707|892081|P2|NOT COMPLETED|Period 3:Treatment Period 2||3
366818|NCT00421707|892082|P1|NOT COMPLETED|Period 3:Treatment Period 2||2
366819|NCT00421707|892081|P2|COMPLETED|Period 3:Treatment Period 2||49
366820|NCT00421707|892082|P1|COMPLETED|Period 3:Treatment Period 2||53
366821|NCT00421707|892081|P2|STARTED|Period 3:Treatment Period 2||52
366822|NCT00421707|892082|P1|STARTED|Period 3:Treatment Period 2||55
366823|NCT00421707|892081|P2|NOT COMPLETED|Period 2: Washout||4
366824|NCT00421707|892082|P1|NOT COMPLETED|Period 2: Washout||1
366825|NCT00421707|892081|P2|COMPLETED|Period 2: Washout||52
366826|NCT00421707|892082|P1|COMPLETED|Period 2: Washout||55
366827|NCT00421707|892081|P2|STARTED|Period 2: Washout||56
366828|NCT00421707|892082|P1|STARTED|Period 2: Washout||56
366829|NCT00421707|892081|P2|NOT COMPLETED|Period 1: Treatment Period 1||9
366830|NCT00421707|892082|P1|NOT COMPLETED|Period 1: Treatment Period 1||11
366831|NCT00421707|892081|P2|COMPLETED|Period 1: Treatment Period 1||56
366832|NCT00421707|892082|P1|COMPLETED|Period 1: Treatment Period 1||56
366833|NCT00421707|892081|P2|STARTED|Period 1: Treatment Period 1||65
366834|NCT00421707|892082|P1|STARTED|Period 1: Treatment Period 1||67
366835|NCT00421603|892124|P2|NOT COMPLETED|Overall Study||12
366836|NCT00421603|892125|P1|NOT COMPLETED|Overall Study||11
366837|NCT00421603|892124|P2|COMPLETED|Overall Study|Completed all 14 week sof trial|30
366838|NCT00421603|892125|P1|COMPLETED|Overall Study|Completed all 14 week sof trial|28
366839|NCT00421603|892124|P2|STARTED|Overall Study||42
366840|NCT00421603|892125|P1|STARTED|Overall Study||39
366841|NCT00421408|892133|P2|NOT COMPLETED|Overall Study||45
366842|NCT00421408|892134|P1|NOT COMPLETED|Overall Study||42
366843|NCT00421408|892133|P2|COMPLETED|Overall Study||61
366844|NCT00421408|892134|P1|COMPLETED|Overall Study||60
366845|NCT00421408|892133|P2|STARTED|Overall Study||106
366846|NCT00421408|892134|P1|STARTED|Overall Study||102
366847|NCT00421343|892152|P1|NOT COMPLETED|Overall Study||6
366848|NCT00421343|892152|P1|COMPLETED|Overall Study||23
366849|NCT00421343|892152|P1|STARTED|Overall Study||29
366850|NCT00421174|892158|P2|NOT COMPLETED|Overall Study||1
366851|NCT00421174|892159|P1|NOT COMPLETED|Overall Study||2
366852|NCT00421174|892158|P2|COMPLETED|Overall Study||18
366853|NCT00421174|892159|P1|COMPLETED|Overall Study||16
366854|NCT00421174|892158|P2|STARTED|Overall Study||19
366855|NCT00421174|892159|P1|STARTED|Overall Study||18
366856|NCT00421148|892207|P20|NOT COMPLETED|Overall Study||0
366857|NCT00421148|892208|P19|NOT COMPLETED|Overall Study||1
366858|NCT00421148|892209|P18|NOT COMPLETED|Overall Study||2
366859|NCT00421148|892210|P17|NOT COMPLETED|Overall Study||0
366860|NCT00421148|892211|P16|NOT COMPLETED|Overall Study||0
366861|NCT00421148|892212|P15|NOT COMPLETED|Overall Study||0
366862|NCT00421148|892213|P14|NOT COMPLETED|Overall Study||0
366863|NCT00421148|892214|P13|NOT COMPLETED|Overall Study||0
366864|NCT00421148|892215|P12|NOT COMPLETED|Overall Study||0
366865|NCT00421148|892216|P11|NOT COMPLETED|Overall Study||0
366866|NCT00421148|892217|P10|NOT COMPLETED|Overall Study||0
366867|NCT00421148|892218|P9|NOT COMPLETED|Overall Study||0
366868|NCT00421148|892219|P8|NOT COMPLETED|Overall Study||0
366869|NCT00421148|892220|P7|NOT COMPLETED|Overall Study||0
366870|NCT00421148|892221|P6|NOT COMPLETED|Overall Study||1
366871|NCT00421148|892222|P5|NOT COMPLETED|Overall Study||0
366872|NCT00421148|892223|P4|NOT COMPLETED|Overall Study||0
366873|NCT00421148|892224|P3|NOT COMPLETED|Overall Study||0
366874|NCT00421148|892225|P2|NOT COMPLETED|Overall Study||0
366875|NCT00421148|892226|P1|NOT COMPLETED|Overall Study||0
366876|NCT00421148|892207|P20|COMPLETED|Overall Study||6
366877|NCT00421148|892208|P19|COMPLETED|Overall Study||5
366878|NCT00421148|892209|P18|COMPLETED|Overall Study||4
366879|NCT00421148|892210|P17|COMPLETED|Overall Study||6
366880|NCT00421148|892211|P16|COMPLETED|Overall Study||6
366881|NCT00421148|892212|P15|COMPLETED|Overall Study||6
366882|NCT00421148|892213|P14|COMPLETED|Overall Study||6
366883|NCT00421148|892214|P13|COMPLETED|Overall Study||6
366884|NCT00421148|892215|P12|COMPLETED|Overall Study||6
366885|NCT00421148|892216|P11|COMPLETED|Overall Study||6
366886|NCT00421148|892217|P10|COMPLETED|Overall Study||5
366887|NCT00421148|892218|P9|COMPLETED|Overall Study||5
366888|NCT00421148|892219|P8|COMPLETED|Overall Study||5
366889|NCT00421148|892220|P7|COMPLETED|Overall Study||6
366890|NCT00421148|892221|P6|COMPLETED|Overall Study||4
366891|NCT00421148|892222|P5|COMPLETED|Overall Study||1
366892|NCT00421148|892223|P4|COMPLETED|Overall Study||1
366893|NCT00421148|892224|P3|COMPLETED|Overall Study||2
366894|NCT00421148|892225|P2|COMPLETED|Overall Study||2
366895|NCT00421148|892226|P1|COMPLETED|Overall Study||2
366896|NCT00421148|892207|P20|Treated|Overall Study||6
366897|NCT00421148|892208|P19|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|5
366898|NCT00421148|892209|P18|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|5
366899|NCT00421148|892210|P17|Treated|Overall Study||6
366900|NCT00421148|892211|P16|Treated|Overall Study||6
366901|NCT00421148|892212|P15|Treated|Overall Study||6
366902|NCT00421148|892213|P14|Treated|Overall Study||6
366903|NCT00421148|892214|P13|Treated|Overall Study||6
366904|NCT00421148|892215|P12|Treated|Overall Study|Includes 1 participant who was inadvertently randomized to group but received 5 mg/kg sugammadex|6
366905|NCT00421148|892216|P11|Treated|Overall Study||6
366906|NCT00421148|892217|P10|Treated|Overall Study|Includes 1 participant who was inadvertently randomized to group but was an adolescent|5
366907|NCT00421148|892218|P9|Treated|Overall Study||5
366908|NCT00421148|892219|P8|Treated|Overall Study||5
366909|NCT00421148|892220|P7|Treated|Overall Study||6
366910|NCT00421148|892221|P6|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|4
366911|NCT00421148|892222|P5|Treated|Overall Study||1
366912|NCT00421148|892223|P4|Treated|Overall Study||1
366913|NCT00421148|892224|P3|Treated|Overall Study||2
366914|NCT00421148|892225|P2|Treated|Overall Study||2
366915|NCT00421148|892226|P1|Treated|Overall Study||2
366916|NCT00421148|892207|P20|STARTED|Overall Study||6
366917|NCT00421148|892208|P19|STARTED|Overall Study||6
366918|NCT00421148|892209|P18|STARTED|Overall Study||6
366919|NCT00421148|892210|P17|STARTED|Overall Study||6
366920|NCT00421148|892211|P16|STARTED|Overall Study||6
366921|NCT00421148|892212|P15|STARTED|Overall Study||6
366922|NCT00421148|892213|P14|STARTED|Overall Study||6
366923|NCT00421148|892214|P13|STARTED|Overall Study||6
366924|NCT00421148|892215|P12|STARTED|Overall Study||6
366925|NCT00421148|892216|P11|STARTED|Overall Study||6
366926|NCT00421148|892217|P10|STARTED|Overall Study||5
366927|NCT00421148|892218|P9|STARTED|Overall Study||5
366928|NCT00421148|892219|P8|STARTED|Overall Study||5
366929|NCT00421148|892220|P7|STARTED|Overall Study||6
366930|NCT00421148|892221|P6|STARTED|Overall Study||5
366931|NCT00421148|892222|P5|STARTED|Overall Study||1
366932|NCT00421148|892223|P4|STARTED|Overall Study||1
366933|NCT00421148|892224|P3|STARTED|Overall Study||2
366934|NCT00421148|892225|P2|STARTED|Overall Study||2
366935|NCT00421148|892226|P1|STARTED|Overall Study||2
366936|NCT00420992|892310|P2|NOT COMPLETED|Maintenance Phase||75
366937|NCT00420992|892311|P1|NOT COMPLETED|Maintenance Phase||61
366938|NCT00420992|892310|P2|COMPLETED|Maintenance Phase||98
366939|NCT00420992|892311|P1|COMPLETED|Maintenance Phase||110
366940|NCT00420992|892310|P2|STARTED|Maintenance Phase||173
366941|NCT00420992|892311|P1|STARTED|Maintenance Phase||171
366942|NCT00420992|892310|P2|NOT COMPLETED|Titration Phase||0
366943|NCT00420992|892311|P1|NOT COMPLETED|Titration Phase||203
366944|NCT00420992|892310|P2|COMPLETED|Titration Phase||0
366945|NCT00420992|892311|P1|COMPLETED|Titration Phase||344
366946|NCT00420992|892310|P2|STARTED|Titration Phase||0
366947|NCT00420992|892311|P1|STARTED|Titration Phase|All patients received ALO-01 during open-label titration phase|547
366948|NCT00420927|892325|P7|NOT COMPLETED|Period 2||53
366949|NCT00420927|892326|P6|NOT COMPLETED|Period 2||15
366950|NCT00420927|892327|P5|NOT COMPLETED|Period 2||43
366951|NCT00420927|892328|P4|NOT COMPLETED|Period 2||10
366952|NCT00420927|892329|P3|NOT COMPLETED|Period 2||13
366953|NCT00420927|892330|P2|NOT COMPLETED|Period 2||0
366954|NCT00420927|892331|P1|NOT COMPLETED|Period 2||0
366955|NCT00420927|892325|P7|COMPLETED|Period 2||295
366956|NCT00420927|892326|P6|COMPLETED|Period 2||97
366957|NCT00420927|892327|P5|COMPLETED|Period 2||216
366958|NCT00420927|892328|P4|COMPLETED|Period 2||95
366959|NCT00420927|892329|P3|COMPLETED|Period 2||89
366960|NCT00420927|892330|P2|COMPLETED|Period 2||0
366961|NCT00420927|892331|P1|COMPLETED|Period 2||0
366962|NCT00420927|892325|P7|STARTED|Period 2||348
366963|NCT00420927|892326|P6|STARTED|Period 2||112
366964|NCT00420927|892327|P5|STARTED|Period 2||259
366965|NCT00420927|892328|P4|STARTED|Period 2||105
366966|NCT00420927|892329|P3|STARTED|Period 2||102
366967|NCT00420927|892330|P2|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
366968|NCT00420927|892331|P1|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
366969|NCT00420927|892325|P7|NOT COMPLETED|Period 1||0
366970|NCT00420927|892326|P6|NOT COMPLETED|Period 1||0
366971|NCT00420927|892327|P5|NOT COMPLETED|Period 1||0
366972|NCT00420927|892328|P4|NOT COMPLETED|Period 1||0
366973|NCT00420927|892329|P3|NOT COMPLETED|Period 1||0
366974|NCT00420927|892330|P2|NOT COMPLETED|Period 1||57
366975|NCT00420927|892331|P1|NOT COMPLETED|Period 1||49
366976|NCT00420927|892325|P7|COMPLETED|Period 1||0
366977|NCT00420927|892326|P6|COMPLETED|Period 1||0
366978|NCT00420927|892327|P5|COMPLETED|Period 1||0
366979|NCT00420927|892328|P4|COMPLETED|Period 1||0
366980|NCT00420927|892329|P3|COMPLETED|Period 1||0
366981|NCT00420927|892330|P2|COMPLETED|Period 1||460
366982|NCT00420927|892331|P1|COMPLETED|Period 1||466
366983|NCT00420927|892325|P7|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
366984|NCT00420927|892326|P6|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
366985|NCT00420927|892327|P5|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
366986|NCT00420927|892328|P4|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
366987|NCT00420927|892329|P3|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
366988|NCT00420927|892330|P2|STARTED|Period 1||517
366989|NCT00420927|892331|P1|STARTED|Period 1||515
366990|NCT00420849|892435|P1|NOT COMPLETED|Overall Study||331
366991|NCT00420849|892435|P1|COMPLETED|Overall Study|Participants completed the study upon commercial availability of lenalidomide|256
366992|NCT00420849|892435|P1|STARTED|Overall Study||587
366993|NCT00420784|892504|P4|NOT COMPLETED|Overall Study||78
366994|NCT00420784|892505|P3|NOT COMPLETED|Overall Study||53
366995|NCT00420784|892506|P2|NOT COMPLETED|Overall Study||58
366996|NCT00420784|892507|P1|NOT COMPLETED|Overall Study||29
366997|NCT00420784|892504|P4|COMPLETED|Overall Study||36
366998|NCT00420784|892505|P3|COMPLETED|Overall Study||58
366999|NCT00420784|892506|P2|COMPLETED|Overall Study||55
367000|NCT00420784|892507|P1|COMPLETED|Overall Study||86
367001|NCT00420784|892504|P4|STARTED|Overall Study||114
367002|NCT00420784|892505|P3|STARTED|Overall Study||111
367003|NCT00420784|892506|P2|STARTED|Overall Study||113
367004|NCT00420784|892507|P1|STARTED|Overall Study||115
367005|NCT00420771|892536|P2|NOT COMPLETED|Overall Study||4
367006|NCT00420771|892537|P1|NOT COMPLETED|Overall Study||3
367007|NCT00420771|892536|P2|COMPLETED|Overall Study||7
367008|NCT00420771|892537|P1|COMPLETED|Overall Study||5
367009|NCT00420771|892536|P2|STARTED|Overall Study||11
367010|NCT00420771|892537|P1|STARTED|Overall Study||8
367011|NCT00420745|892545|P2|NOT COMPLETED|Overall Study||6
367012|NCT00420745|892546|P1|NOT COMPLETED|Overall Study||15
367013|NCT00420745|892545|P2|COMPLETED|Overall Study||333
367014|NCT00420745|892546|P1|COMPLETED|Overall Study||655
367015|NCT00420745|892545|P2|STARTED|Overall Study||339
367016|NCT00420745|892546|P1|STARTED|Overall Study||670
367017|NCT00420641|892565|P3|NOT COMPLETED|Overall Study||44
367018|NCT00420641|892566|P2|NOT COMPLETED|Overall Study||72
367019|NCT00420641|892567|P1|NOT COMPLETED|Overall Study||45
367020|NCT00420641|892565|P3|COMPLETED|Overall Study||128
367021|NCT00420641|892566|P2|COMPLETED|Overall Study||100
367022|NCT00420641|892567|P1|COMPLETED|Overall Study||115
367023|NCT00420641|892565|P3|STARTED|Overall Study||172
367024|NCT00420641|892566|P2|STARTED|Overall Study||172
367025|NCT00420641|892567|P1|STARTED|Overall Study||160
367026|NCT00420628|892643|P2|NOT COMPLETED|Overall Study||4
367027|NCT00420628|892644|P1|NOT COMPLETED|Overall Study||9
367028|NCT00420628|892643|P2|COMPLETED|Overall Study||32
367029|NCT00420628|892644|P1|COMPLETED|Overall Study||63
367030|NCT00420628|892643|P2|STARTED|Overall Study||36
367031|NCT00420628|892644|P1|STARTED|Overall Study||72
367032|NCT00420511|892660|P2|NOT COMPLETED|Overall Study||1
367033|NCT00420511|892661|P1|NOT COMPLETED|Overall Study||2
367034|NCT00420511|892660|P2|COMPLETED|Overall Study||10
367035|NCT00420511|892661|P1|COMPLETED|Overall Study||8
367036|NCT00420511|892660|P2|STARTED|Overall Study||11
367037|NCT00420511|892661|P1|STARTED|Overall Study||10
367038|NCT00420459|892671|P1|NOT COMPLETED|Overall Study||0
367039|NCT00420459|892671|P1|COMPLETED|Overall Study||12
367040|NCT00420459|892671|P1|STARTED|Overall Study||12
367041|NCT00420420|892682|P2|NOT COMPLETED|Overall Study||4
367042|NCT00420420|892683|P1|NOT COMPLETED|Overall Study||8
367043|NCT00420420|892682|P2|COMPLETED|Overall Study||67
367044|NCT00420420|892683|P1|COMPLETED|Overall Study|One patient from the MK-0249 arm discontinued the trial due to an AE prior to receiving study drug.|65
367045|NCT00420420|892682|P2|STARTED|Overall Study|Number of patients randomized.|71
367046|NCT00420420|892683|P1|STARTED|Overall Study|Number of patients randomized.|73
367047|NCT00420407|892701|P2|NOT COMPLETED|Overall Study||6
367048|NCT00420407|892702|P1|NOT COMPLETED|Overall Study||4
367049|NCT00420407|892701|P2|COMPLETED|Overall Study||34
367050|NCT00420407|892702|P1|COMPLETED|Overall Study||37
367051|NCT00420407|892701|P2|STARTED|Overall Study||40
367052|NCT00420407|892702|P1|STARTED|Overall Study||41
367053|NCT00420342|892712|P3|NOT COMPLETED|Overall Study||1
367054|NCT00420342|892713|P2|NOT COMPLETED|Overall Study||2
367055|NCT00420342|892714|P1|NOT COMPLETED|Overall Study||1
367056|NCT00420342|892712|P3|COMPLETED|Overall Study||28
367057|NCT00420342|892713|P2|COMPLETED|Overall Study||31
367058|NCT00420342|892714|P1|COMPLETED|Overall Study||29
367059|NCT00420342|892712|P3|Received Treatment|Overall Study||29
367060|NCT00420342|892713|P2|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|32
367061|NCT00420342|892714|P1|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|29
367062|NCT00420342|892712|P3|STARTED|Overall Study||29
367063|NCT00420342|892713|P2|STARTED|Overall Study||33
367064|NCT00420342|892714|P1|STARTED|Overall Study||30
367065|NCT00420316|892757|P2|NOT COMPLETED|Overall Study||9
367066|NCT00420316|892758|P1|NOT COMPLETED|Overall Study||12
367067|NCT00420316|892757|P2|COMPLETED|Overall Study||522
367068|NCT00420316|892758|P1|COMPLETED|Overall Study||1070
367069|NCT00420316|892757|P2|STARTED|Overall Study||531
367070|NCT00420316|892758|P1|STARTED|Overall Study||1082
367071|NCT00420303|892782|P2|NOT COMPLETED|Overall Study||4
367072|NCT00420303|892783|P1|NOT COMPLETED|Overall Study||1
367073|NCT00420303|892782|P2|COMPLETED|Overall Study||8
367074|NCT00420303|892783|P1|COMPLETED|Overall Study||11
367075|NCT00420303|892782|P2|STARTED|Overall Study||12
367076|NCT00420303|892783|P1|STARTED|Overall Study||12
367077|NCT00420290|892795|P2|NOT COMPLETED|Overall Study||4
367078|NCT00420290|892796|P1|NOT COMPLETED|Overall Study||4
367079|NCT00420290|892795|P2|COMPLETED|Overall Study||7
367080|NCT00420290|892796|P1|COMPLETED|Overall Study||7
367081|NCT00420290|892795|P2|STARTED|Overall Study||11
367082|NCT00420290|892796|P1|STARTED|Overall Study||11
367083|NCT00420238|892812|P2|NOT COMPLETED|12 Week Open-Label Treatment Period 2||1
367084|NCT00420238|892813|P1|NOT COMPLETED|12 Week Open-Label Treatment Period 2||2
367085|NCT00420238|892812|P2|COMPLETED|12 Week Open-Label Treatment Period 2||38
367086|NCT00420238|892813|P1|COMPLETED|12 Week Open-Label Treatment Period 2||36
367087|NCT00420238|892812|P2|STARTED|12 Week Open-Label Treatment Period 2||39
367088|NCT00420238|892813|P1|STARTED|12 Week Open-Label Treatment Period 2||38
367089|NCT00420238|892812|P2|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||4
367090|NCT00420238|892813|P1|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||1
367091|NCT00420238|892812|P2|COMPLETED|12 Week Double-Blind Treatment Period 1||39
367092|NCT00420238|892813|P1|COMPLETED|12 Week Double-Blind Treatment Period 1||38
367093|NCT00420238|892812|P2|STARTED|12 Week Double-Blind Treatment Period 1||43
367094|NCT00420238|892813|P1|STARTED|12 Week Double-Blind Treatment Period 1||39
367095|NCT00420212|892952|P3|NOT COMPLETED|Overall Study||96
367096|NCT00420212|892953|P2|NOT COMPLETED|Overall Study||95
367097|NCT00420212|892954|P1|NOT COMPLETED|Overall Study||91
367098|NCT00420212|892952|P3|COMPLETED|Overall Study||320
367099|NCT00420212|892953|P2|COMPLETED|Overall Study||315
367100|NCT00420212|892954|P1|COMPLETED|Overall Study||317
367101|NCT00420212|892952|P3|STARTED|Overall Study|416 participants were dosed; 416 participants were randomized|416
367102|NCT00420212|892953|P2|STARTED|Overall Study|410 participants were dosed; 411 participants were randomized|410
367103|NCT00420212|892954|P1|STARTED|Overall Study|408 participants were dosed; 410 participants were randomized|408
367104|NCT00420199|892980|P2|NOT COMPLETED|Overall Study||0
367105|NCT00420199|892981|P1|NOT COMPLETED|Overall Study||1
367106|NCT00420199|892980|P2|COMPLETED|Overall Study||23
367107|NCT00420199|892981|P1|COMPLETED|Overall Study||26
367108|NCT00420199|892980|P2|STARTED|Overall Study||23
367109|NCT00420199|892981|P1|STARTED|Overall Study||27
367110|NCT00420147|893036|P2|NOT COMPLETED|Overall Study||0
367111|NCT00420147|893037|P1|NOT COMPLETED|Overall Study||0
367112|NCT00420147|893036|P2|COMPLETED|Overall Study||19
367113|NCT00420147|893037|P1|COMPLETED|Overall Study||19
367114|NCT00420147|893036|P2|STARTED|Overall Study||19
367115|NCT00420147|893037|P1|STARTED|Overall Study||19
367116|NCT00420095|893047|P2|NOT COMPLETED|Overall Study||1
367117|NCT00420095|893048|P1|NOT COMPLETED|Overall Study||3
367118|NCT00420095|893047|P2|COMPLETED|Overall Study||59
367119|NCT00420095|893048|P1|COMPLETED|Overall Study||54
367120|NCT00420095|893047|P2|STARTED|Overall Study||60
367121|NCT00420095|893048|P1|STARTED|Overall Study||57
367122|NCT00420056|893066|P1|NOT COMPLETED|Overall Study||17
367123|NCT00420056|893066|P1|COMPLETED|Overall Study||0
367124|NCT00420056|893066|P1|STARTED|Overall Study||17
367125|NCT00420017|893090|P2|NOT COMPLETED|Overall Study||0
367126|NCT00420017|893091|P1|NOT COMPLETED|Overall Study||2
367127|NCT00420017|893090|P2|COMPLETED|Overall Study||40
367128|NCT00420017|893091|P1|COMPLETED|Overall Study|40 completed analysis|38
367129|NCT00420017|893090|P2|STARTED|Overall Study||40
367130|NCT00420017|893091|P1|STARTED|Overall Study||40
367131|NCT00420004|893106|P3|NOT COMPLETED|Overall Study||32
367132|NCT00420004|893107|P2|NOT COMPLETED|Overall Study||71
367133|NCT00420004|893108|P1|NOT COMPLETED|Overall Study||129
367134|NCT00420004|893106|P3|COMPLETED|Overall Study||30
367135|NCT00420004|893107|P2|COMPLETED|Overall Study||67
367136|NCT00420004|893108|P1|COMPLETED|Overall Study||140
367137|NCT00420004|893106|P3|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|54
367138|NCT00420004|893107|P2|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|122
367139|NCT00420004|893108|P1|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|249
367140|NCT00420004|893106|P3|STARTED|Overall Study||62
367141|NCT00420004|893107|P2|STARTED|Overall Study||138
367142|NCT00420004|893108|P1|STARTED|Overall Study||269
367143|NCT00419952|893173|P2|NOT COMPLETED|Overall Study||125
367144|NCT00419952|893174|P1|NOT COMPLETED|Overall Study||149
367145|NCT00419952|893173|P2|COMPLETED|Overall Study||240
367146|NCT00419952|893174|P1|COMPLETED|Overall Study||228
367147|NCT00419952|893173|P2|STARTED|Overall Study||365
367148|NCT00419952|893174|P1|STARTED|Overall Study||377
367149|NCT00419926|893208|P2|NOT COMPLETED|Overall Study||10
367150|NCT00419926|893209|P1|NOT COMPLETED|Overall Study||14
367151|NCT00419926|893208|P2|COMPLETED|Overall Study||148
367152|NCT00419926|893209|P1|COMPLETED|Overall Study||141
367153|NCT00419926|893208|P2|STARTED|Overall Study|Intention to treat population, 154 is safety population.|158
367154|NCT00419926|893209|P1|STARTED|Overall Study|Intention to treat population, 150 is safety population.|155
367155|NCT00419770|893225|P2|NOT COMPLETED|Overall Study||1
367156|NCT00419770|893226|P1|NOT COMPLETED|Overall Study||5
367157|NCT00419770|893225|P2|COMPLETED|Overall Study||8
367158|NCT00419770|893226|P1|COMPLETED|Overall Study||6
367159|NCT00419770|893225|P2|STARTED|Overall Study||9
367160|NCT00419770|893226|P1|STARTED|Overall Study||11
367161|NCT00419757|893234|P2|NOT COMPLETED|Overall Study||21
367162|NCT00419757|893235|P1|NOT COMPLETED|Overall Study||18
367163|NCT00419757|893234|P2|COMPLETED|Overall Study|Randomized patients|102
367164|NCT00419757|893235|P1|COMPLETED|Overall Study|Randomized patients|109
367165|NCT00419757|893234|P2|STARTED|Overall Study|Randomized patients|123
367166|NCT00419757|893235|P1|STARTED|Overall Study|Randomized patients|127
367167|NCT00419744|893274|P3|NOT COMPLETED|Overall Study||133
367168|NCT00419744|893275|P2|NOT COMPLETED|Overall Study||118
367169|NCT00419744|893276|P1|NOT COMPLETED|Overall Study||117
367170|NCT00419744|893274|P3|COMPLETED|Overall Study||271
367171|NCT00419744|893275|P2|COMPLETED|Overall Study||290
367172|NCT00419744|893276|P1|COMPLETED|Overall Study||290
367173|NCT00419744|893274|P3|STARTED|Overall Study||404
367174|NCT00419744|893275|P2|STARTED|Overall Study||408
367175|NCT00419744|893276|P1|STARTED|Overall Study||407
367176|NCT00419445|893308|P3|NOT COMPLETED|Overall Study||1
367177|NCT00419445|893309|P2|NOT COMPLETED|Overall Study||2
367178|NCT00419445|893310|P1|NOT COMPLETED|Overall Study||1
367179|NCT00419445|893308|P3|COMPLETED|Overall Study||7
367180|NCT00419445|893309|P2|COMPLETED|Overall Study||14
367181|NCT00419445|893310|P1|COMPLETED|Overall Study||7
367182|NCT00419445|893308|P3|STARTED|Overall Study||8
367183|NCT00419445|893309|P2|STARTED|Overall Study||16
367184|NCT00419445|893310|P1|STARTED|Overall Study||8
367185|NCT00419393|893318|P1|NOT COMPLETED|Overall Study||24
367186|NCT00419393|893318|P1|COMPLETED|Overall Study||166
367275|NCT00418886|893532|P2|NOT COMPLETED|Overall Study||255
367187|NCT00419393|893318|P1|STARTED|Overall Study|One subject did not receive medication|190
367188|NCT00419380|893328|P2|NOT COMPLETED|Overall Study||10
367189|NCT00419380|893329|P1|NOT COMPLETED|Overall Study||1
367190|NCT00419380|893328|P2|COMPLETED|Overall Study||12
367191|NCT00419380|893329|P1|COMPLETED|Overall Study||18
367192|NCT00419380|893328|P2|STARTED|Overall Study||22
367193|NCT00419380|893329|P1|STARTED|Overall Study||19
367194|NCT00419341|893337|P1|NOT COMPLETED|Efficacy Period||10
367195|NCT00419341|893337|P1|COMPLETED|Efficacy Period||28
367196|NCT00419341|893337|P1|STARTED|Efficacy Period||38
367197|NCT00419341|893337|P1|NOT COMPLETED|Wash in/Wash Out Period||11
367198|NCT00419341|893337|P1|COMPLETED|Wash in/Wash Out Period||38
367199|NCT00419341|893337|P1|STARTED|Wash in/Wash Out Period||49
367200|NCT00419315|893360|P2|NOT COMPLETED|Overall Study||0
367201|NCT00419315|893361|P1|NOT COMPLETED|Overall Study||0
367202|NCT00419315|893360|P2|COMPLETED|Overall Study||78
367203|NCT00419315|893361|P1|COMPLETED|Overall Study||85
367204|NCT00419315|893360|P2|STARTED|Overall Study||78
367205|NCT00419315|893361|P1|STARTED|Overall Study||85
367206|NCT00419263|893372|P3|NOT COMPLETED|Overall Study||3
367207|NCT00419263|893373|P2|NOT COMPLETED|Overall Study||2
367208|NCT00419263|893374|P1|NOT COMPLETED|Overall Study||3
367209|NCT00419263|893372|P3|COMPLETED|Overall Study||112
367210|NCT00419263|893373|P2|COMPLETED|Overall Study||112
367211|NCT00419263|893374|P1|COMPLETED|Overall Study||112
367212|NCT00419263|893372|P3|STARTED|Overall Study||115
367213|NCT00419263|893373|P2|STARTED|Overall Study||114
367214|NCT00419263|893374|P1|STARTED|Overall Study||115
367215|NCT00419159|893403|P2|NOT COMPLETED|Overall Study||100
367216|NCT00419159|893404|P1|NOT COMPLETED|Overall Study||99
367217|NCT00419159|893403|P2|COMPLETED|Overall Study||0
367218|NCT00419159|893404|P1|COMPLETED|Overall Study||0
367219|NCT00419159|893403|P2|STARTED|Overall Study||100
367220|NCT00419159|893404|P1|STARTED|Overall Study|Full Analysis Set|99
367221|NCT00419120|893434|P1|NOT COMPLETED|Long Term Follow up Period||10
367222|NCT00419120|893434|P1|COMPLETED|Long Term Follow up Period||0
367223|NCT00419120|893434|P1|STARTED|Long Term Follow up Period|10 patients are being followed in long term follow up.|10
367224|NCT00419120|893434|P1|NOT COMPLETED|Primary Study Period||0
367225|NCT00419120|893434|P1|COMPLETED|Primary Study Period||10
367226|NCT00419120|893434|P1|STARTED|Primary Study Period||10
367227|NCT00419094|893441|P2|NOT COMPLETED|Overall Study||30
367228|NCT00419094|893442|P1|NOT COMPLETED|Overall Study||7
367229|NCT00419094|893441|P2|COMPLETED|Overall Study||141
367230|NCT00419094|893442|P1|COMPLETED|Overall Study||50
367231|NCT00419094|893441|P2|STARTED|Overall Study||171
367232|NCT00419094|893442|P1|STARTED|Overall Study|Number started refers to number randomized; 303 subjects were screened/enrolled and 228 randomized.|57
367233|NCT00419003|893456|P2|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||0
367234|NCT00419003|893457|P1|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||1
367235|NCT00419003|893456|P2|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||8
367236|NCT00419003|893457|P1|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||5
367237|NCT00419003|893456|P2|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn’t split up evenly (same way as phase I) in the riluzole/placebo phase.|8
367238|NCT00419003|893457|P1|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn’t split up evenly (same way as phase I) in the riluzole/placebo phase.|6
367239|NCT00419003|893456|P2|NOT COMPLETED|Phase I, Ketamine Infusion||6
367240|NCT00419003|893457|P1|NOT COMPLETED|Phase I, Ketamine Infusion||6
367241|NCT00419003|893456|P2|COMPLETED|Phase I, Ketamine Infusion||7
367242|NCT00419003|893457|P1|COMPLETED|Phase I, Ketamine Infusion||7
367243|NCT00419003|893456|P2|STARTED|Phase I, Ketamine Infusion||13
367244|NCT00419003|893457|P1|STARTED|Phase I, Ketamine Infusion||13
367245|NCT00418977|893468|P2|NOT COMPLETED|Overall Study||3
367246|NCT00418977|893469|P1|NOT COMPLETED|Overall Study||3
367247|NCT00418977|893468|P2|COMPLETED|Overall Study||13
367248|NCT00418977|893469|P1|COMPLETED|Overall Study||40
367249|NCT00418977|893468|P2|STARTED|Overall Study||16
367250|NCT00418977|893469|P1|STARTED|Overall Study||43
367251|NCT00418964|893486|P3|NOT COMPLETED|Overall Study||6
367252|NCT00418964|893487|P2|NOT COMPLETED|Overall Study||3
367253|NCT00418964|893488|P1|NOT COMPLETED|Overall Study||1
367254|NCT00418964|893486|P3|COMPLETED|Overall Study||14
367255|NCT00418964|893487|P2|COMPLETED|Overall Study||17
367256|NCT00418964|893488|P1|COMPLETED|Overall Study||21
367257|NCT00418964|893486|P3|STARTED|Overall Study||20
367258|NCT00418964|893487|P2|STARTED|Overall Study||20
367259|NCT00418964|893488|P1|STARTED|Overall Study||22
367260|NCT00418951|893499|P3|NOT COMPLETED|Overall Study||0
367261|NCT00418951|893500|P2|NOT COMPLETED|Overall Study||0
367262|NCT00418951|893501|P1|NOT COMPLETED|Overall Study||0
367263|NCT00418951|893499|P3|COMPLETED|Overall Study||40
367264|NCT00418951|893500|P2|COMPLETED|Overall Study||33
367265|NCT00418951|893501|P1|COMPLETED|Overall Study||39
367266|NCT00418951|893499|P3|STARTED|Overall Study||40
367267|NCT00418951|893500|P2|STARTED|Overall Study||33
367268|NCT00418951|893501|P1|STARTED|Overall Study||39
367269|NCT00418938|893511|P2|NOT COMPLETED|Overall Study||23
367270|NCT00418938|893512|P1|NOT COMPLETED|Overall Study||24
367271|NCT00418938|893511|P2|COMPLETED|Overall Study||108
367272|NCT00418938|893512|P1|COMPLETED|Overall Study||109
367273|NCT00418938|893511|P2|STARTED|Overall Study||131
367274|NCT00418938|893512|P1|STARTED|Overall Study||133
367276|NCT00418886|893533|P1|NOT COMPLETED|Overall Study||226
367277|NCT00418886|893532|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|23
367278|NCT00418886|893533|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|30
367279|NCT00418886|893532|P2|STARTED|Overall Study|randomised patients|278
367280|NCT00418886|893533|P1|STARTED|Overall Study|randomised patients|256
367281|NCT00418834|893559|P2|NOT COMPLETED|Overall Study||20
367282|NCT00418834|893560|P1|NOT COMPLETED|Overall Study||23
367283|NCT00418834|893559|P2|COMPLETED|Overall Study||507
367284|NCT00418834|893560|P1|COMPLETED|Overall Study||503
367285|NCT00418834|893559|P2|STARTED|Overall Study||527
367286|NCT00418834|893560|P1|STARTED|Overall Study||526
367287|NCT00418717|893620|P1|NOT COMPLETED|Treatment Period B - Weeks 5-12||2
367288|NCT00418717|893620|P1|COMPLETED|Treatment Period B - Weeks 5-12||39
367289|NCT00418717|893620|P1|STARTED|Treatment Period B - Weeks 5-12||41
367290|NCT00418717|893620|P1|NOT COMPLETED|Treatment Period A - Weeks 1-4||1
367291|NCT00418717|893620|P1|COMPLETED|Treatment Period A - Weeks 1-4||41
367292|NCT00418717|893620|P1|STARTED|Treatment Period A - Weeks 1-4||42
367293|NCT00418691|893628|P3|NOT COMPLETED|Overall Study||5
367294|NCT00418691|893629|P2|NOT COMPLETED|Overall Study||2
367295|NCT00418691|893630|P1|NOT COMPLETED|Overall Study||2
367296|NCT00418691|893628|P3|COMPLETED|Overall Study||5
367297|NCT00418691|893629|P2|COMPLETED|Overall Study||10
367298|NCT00418691|893630|P1|COMPLETED|Overall Study||9
367299|NCT00418691|893628|P3|STARTED|Overall Study||10
367300|NCT00418691|893629|P2|STARTED|Overall Study||12
367301|NCT00418691|893630|P1|STARTED|Overall Study||11
367302|NCT00418665|893641|P3|NOT COMPLETED|Treatment Extension||2
367303|NCT00418665|893642|P2|NOT COMPLETED|Treatment Extension||4
367304|NCT00418665|893643|P1|NOT COMPLETED|Treatment Extension||6
367305|NCT00418665|893641|P3|COMPLETED|Treatment Extension||7
367306|NCT00418665|893642|P2|COMPLETED|Treatment Extension||4
367307|NCT00418665|893643|P1|COMPLETED|Treatment Extension||1
367308|NCT00418665|893641|P3|STARTED|Treatment Extension||9
367309|NCT00418665|893642|P2|STARTED|Treatment Extension||8
367310|NCT00418665|893643|P1|STARTED|Treatment Extension||7
367311|NCT00418665|893641|P3|NOT COMPLETED|Treatment Period||4
367312|NCT00418665|893642|P2|NOT COMPLETED|Treatment Period||6
367313|NCT00418665|893643|P1|NOT COMPLETED|Treatment Period||5
367314|NCT00418665|893641|P3|COMPLETED|Treatment Period||9
367315|NCT00418665|893642|P2|COMPLETED|Treatment Period||8
367316|NCT00418665|893643|P1|COMPLETED|Treatment Period||7
367317|NCT00418665|893641|P3|Received Study Medication|Treatment Period||13
367318|NCT00418665|893642|P2|Received Study Medication|Treatment Period||13
367319|NCT00418665|893643|P1|Received Study Medication|Treatment Period||11
367320|NCT00418665|893641|P3|STARTED|Treatment Period||13
367321|NCT00418665|893642|P2|STARTED|Treatment Period||14
367322|NCT00418665|893643|P1|STARTED|Treatment Period||12
367323|NCT00418574|893662|P2|NOT COMPLETED|Overall Study||23
367324|NCT00418574|893663|P1|NOT COMPLETED|Overall Study||48
367325|NCT00418574|893662|P2|COMPLETED|Overall Study||272
367326|NCT00418574|893663|P1|COMPLETED|Overall Study||545
367327|NCT00418574|893662|P2|TREATED|Overall Study||294
367328|NCT00418574|893663|P1|TREATED|Overall Study||592
367329|NCT00418574|893662|P2|STARTED|Overall Study||295
367330|NCT00418574|893663|P1|STARTED|Overall Study||593
367331|NCT00418561|893677|P3|NOT COMPLETED|Overall Study||0
367332|NCT00418561|893678|P2|NOT COMPLETED|Overall Study||1
367333|NCT00418561|893679|P1|NOT COMPLETED|Overall Study||0
367334|NCT00418561|893677|P3|COMPLETED|Overall Study||4
367335|NCT00418561|893678|P2|COMPLETED|Overall Study||4
367336|NCT00418561|893679|P1|COMPLETED|Overall Study||4
367337|NCT00418561|893677|P3|STARTED|Overall Study||4
367338|NCT00418561|893678|P2|STARTED|Overall Study||5
367339|NCT00418561|893679|P1|STARTED|Overall Study||4
367340|NCT00418522|893749|P2|NOT COMPLETED|Overall Study||42
367341|NCT00418522|893750|P1|NOT COMPLETED|Overall Study||83
367342|NCT00418522|893749|P2|COMPLETED|Overall Study||152
367343|NCT00418522|893750|P1|COMPLETED|Overall Study||136
367344|NCT00418522|893749|P2|Received Treatment|Overall Study||190
367345|NCT00418522|893750|P1|Received Treatment|Overall Study||212
367346|NCT00418522|893749|P2|STARTED|Overall Study||194
367347|NCT00418522|893750|P1|STARTED|Overall Study||219
367348|NCT00418379|893797|P3|NOT COMPLETED|Year 5||3
367349|NCT00418379|893798|P2|NOT COMPLETED|Year 5||5
367350|NCT00418379|893799|P1|NOT COMPLETED|Year 5||2
367351|NCT00418379|893797|P3|COMPLETED|Year 5||131
367352|NCT00418379|893798|P2|COMPLETED|Year 5||115
367353|NCT00418379|893799|P1|COMPLETED|Year 5||126
367354|NCT00418379|893797|P3|STARTED|Year 5|20 patients withdrew between Year 4 and Year 5 study periods.|134
367355|NCT00418379|893798|P2|STARTED|Year 5|16 patients withdrew between Year 4 and Year 5 study periods.|120
367356|NCT00418379|893799|P1|STARTED|Year 5|14 patients withdrew between Year 4 and Year 5 study periods.|128
367357|NCT00418379|893797|P3|NOT COMPLETED|Year 4||2
367358|NCT00418379|893798|P2|NOT COMPLETED|Year 4||5
367359|NCT00418379|893799|P1|NOT COMPLETED|Year 4||3
367360|NCT00418379|893797|P3|COMPLETED|Year 4||154
367361|NCT00418379|893798|P2|COMPLETED|Year 4||136
367362|NCT00418379|893799|P1|COMPLETED|Year 4||142
367363|NCT00418379|893797|P3|STARTED|Year 4|7 patients withdrew between Year 3 and Year 4 study periods.|156
367364|NCT00418379|893798|P2|STARTED|Year 4|5 patients withdrew between Year 3 and Year 4 study periods.|141
367365|NCT00418379|893799|P1|STARTED|Year 4|3 patients withdrew between Year 3 and Year 4 study periods.|145
367366|NCT00418379|893797|P3|NOT COMPLETED|Year 3||3
367367|NCT00418379|893798|P2|NOT COMPLETED|Year 3||2
367368|NCT00418379|893799|P1|NOT COMPLETED|Year 3||3
367369|NCT00418379|893797|P3|COMPLETED|Year 3||163
367370|NCT00418379|893798|P2|COMPLETED|Year 3||146
367371|NCT00418379|893799|P1|COMPLETED|Year 3||148
367372|NCT00418379|893797|P3|STARTED|Year 3|6 patients withdrew between Year 2 and Year 3 treatment periods.|166
367373|NCT00418379|893798|P2|STARTED|Year 3|7 patients withdrew between Year 2 and Year 3 treatment periods.|148
367374|NCT00418379|893799|P1|STARTED|Year 3|8 patients withdrew between Year 2 and Year 3 treatment periods.|151
367375|NCT00418379|893797|P3|NOT COMPLETED|Year 2||10
367376|NCT00418379|893798|P2|NOT COMPLETED|Year 2||4
367377|NCT00418379|893799|P1|NOT COMPLETED|Year 2||8
367378|NCT00418379|893797|P3|COMPLETED|Year 2||172
367379|NCT00418379|893798|P2|COMPLETED|Year 2||155
367380|NCT00418379|893799|P1|COMPLETED|Year 2||159
367381|NCT00418379|893797|P3|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|182
367382|NCT00418379|893798|P2|STARTED|Year 2|20 patients withdrew between Year 1 and Year 2 treatment periods.|159
367383|NCT00418379|893799|P1|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|167
367384|NCT00418379|893797|P3|NOT COMPLETED|Year 1||15
367385|NCT00418379|893798|P2|NOT COMPLETED|Year 1||28
367386|NCT00418379|893799|P1|NOT COMPLETED|Year 1||18
367387|NCT00418379|893797|P3|COMPLETED|Year 1||204
367388|NCT00418379|893798|P2|COMPLETED|Year 1||179
367389|NCT00418379|893799|P1|COMPLETED|Year 1||189
367390|NCT00418379|893797|P3|STARTED|Year 1||219
367391|NCT00418379|893798|P2|STARTED|Year 1||207
367392|NCT00418379|893799|P1|STARTED|Year 1||207
367393|NCT00418314|893809|P2|NOT COMPLETED|Overall Study||2
367394|NCT00418314|893810|P1|NOT COMPLETED|Overall Study||1
367395|NCT00418314|893809|P2|COMPLETED|Overall Study||828
367396|NCT00418314|893810|P1|COMPLETED|Overall Study||816
367397|NCT00418314|893809|P2|STARTED|Overall Study||830
367398|NCT00418314|893810|P1|STARTED|Overall Study||817
367399|NCT00418262|893820|P1|NOT COMPLETED|Visits 8 Thru 10||5
367400|NCT00418262|893820|P1|COMPLETED|Visits 8 Thru 10||11
367401|NCT00418262|893820|P1|STARTED|Visits 8 Thru 10||16
367402|NCT00418262|893820|P1|NOT COMPLETED|Visits 5 Thru 8||9
367403|NCT00418262|893820|P1|COMPLETED|Visits 5 Thru 8||16
367404|NCT00418262|893820|P1|STARTED|Visits 5 Thru 8||25
367405|NCT00418262|893820|P1|NOT COMPLETED|Visits 1 (Baseline) Thru 5||2
367406|NCT00418262|893820|P1|COMPLETED|Visits 1 (Baseline) Thru 5||25
367407|NCT00418262|893820|P1|STARTED|Visits 1 (Baseline) Thru 5||27
367408|NCT00418184|893840|P2|NOT COMPLETED|Open-label Phase||5
367409|NCT00418184|893841|P1|NOT COMPLETED|Open-label Phase||5
367410|NCT00418184|893840|P2|COMPLETED|Open-label Phase|5 dropped out|43
367411|NCT00418184|893841|P1|COMPLETED|Open-label Phase|5 dropped out|97
367412|NCT00418184|893840|P2|STARTED|Open-label Phase|1 was not included due to low compliance in the double blind phase, 3 didn't want to participate.|48
367413|NCT00418184|893841|P1|STARTED|Open-label Phase|3 were not included due to low compliance in the double blind phase, 5 didn't want to participate.|102
367414|NCT00418184|893840|P2|NOT COMPLETED|Double-blind Phase||11
367415|NCT00418184|893841|P1|NOT COMPLETED|Double-blind Phase||27
367416|NCT00418184|893840|P2|COMPLETED|Double-blind Phase||52
367417|NCT00418184|893841|P1|COMPLETED|Double-blind Phase||110
367418|NCT00418184|893840|P2|STARTED|Double-blind Phase||63
367419|NCT00418184|893841|P1|STARTED|Double-blind Phase||137
367420|NCT00418145|893849|P1|NOT COMPLETED|Overall Study||6
367421|NCT00418145|893849|P1|COMPLETED|Overall Study||10
367422|NCT00418145|893849|P1|STARTED|Overall Study||16
367423|NCT00418093|893861|P1|NOT COMPLETED|Overall Study||0
367424|NCT00418093|893861|P1|COMPLETED|Overall Study||19
367425|NCT00418093|893861|P1|Completed Study|Overall Study||19
367426|NCT00418093|893861|P1|STARTED|Overall Study||19
367427|NCT00418028|893870|P2|NOT COMPLETED|Overall Study||1
367428|NCT00418028|893871|P1|NOT COMPLETED|Overall Study||2
367429|NCT00418028|893870|P2|COMPLETED|Overall Study||97
367430|NCT00418028|893871|P1|COMPLETED|Overall Study||95
367431|NCT00418028|893870|P2|STARTED|Overall Study||98
367432|NCT00418028|893871|P1|STARTED|Overall Study||97
367433|NCT00418015|893893|P4|NOT COMPLETED|Overall Study||0
367434|NCT00418015|893894|P3|NOT COMPLETED|Overall Study||0
367435|NCT00418015|893895|P2|NOT COMPLETED|Overall Study||0
367436|NCT00418015|893896|P1|NOT COMPLETED|Overall Study||0
367437|NCT00418015|893893|P4|COMPLETED|Overall Study||25
367438|NCT00418015|893894|P3|COMPLETED|Overall Study||78
367439|NCT00418015|893895|P2|COMPLETED|Overall Study||46
367440|NCT00418015|893896|P1|COMPLETED|Overall Study||144
367441|NCT00418015|893893|P4|STARTED|Overall Study||25
367442|NCT00418015|893894|P3|STARTED|Overall Study||78
367443|NCT00418015|893895|P2|STARTED|Overall Study||46
367444|NCT00418015|893896|P1|STARTED|Overall Study||144
367445|NCT00417989|893924|P2|NOT COMPLETED|Overall Study||22
367446|NCT00417989|893925|P1|NOT COMPLETED|Overall Study||20
367447|NCT00417989|893924|P2|COMPLETED|Overall Study||219
367448|NCT00417989|893925|P1|COMPLETED|Overall Study||224
367449|NCT00417989|893924|P2|STARTED|Overall Study||241
367450|NCT00417989|893925|P1|STARTED|Overall Study|Intent to Treat include safety population & subjects with baseline & 1 post baseline A1C measurement|244
367451|NCT00417976|893947|P1|NOT COMPLETED|Overall Study||3
367452|NCT00417976|893947|P1|COMPLETED|Overall Study||39
367453|NCT00417976|893947|P1|STARTED|Overall Study||42
367454|NCT00417963|893952|P1|NOT COMPLETED|Overall Study||41
367455|NCT00417963|893952|P1|COMPLETED|Overall Study|79 subjects completed in the roll-in cohort and 371 in the pivotal cohort.|445
367456|NCT00417963|893952|P1|STARTED|Overall Study|79 participants were enrolled in the roll-in cohort and 407 in the pivotal cohort.|486
367457|NCT00417885|893969|P1|NOT COMPLETED|Overall Study||6
367458|NCT00417885|893969|P1|COMPLETED|Overall Study||0
367459|NCT00417885|893969|P1|STARTED|Overall Study||6
367460|NCT00417612|893980|P2|NOT COMPLETED|Overall Study||3
367461|NCT00417612|893981|P1|NOT COMPLETED|Overall Study||3
367462|NCT00417612|893980|P2|COMPLETED|Overall Study||8
367463|NCT00417612|893981|P1|COMPLETED|Overall Study||19
367464|NCT00417612|893980|P2|STARTED|Overall Study||11
367465|NCT00417612|893981|P1|STARTED|Overall Study||22
367466|NCT00417482|894007|P3|NOT COMPLETED|Phase B 2nd 16 Weeks||3
367467|NCT00417482|894008|P2|NOT COMPLETED|Phase B 2nd 16 Weeks||13
367468|NCT00417482|894009|P1|NOT COMPLETED|Phase B 2nd 16 Weeks||3
367469|NCT00417482|894007|P3|COMPLETED|Phase B 2nd 16 Weeks||10
367470|NCT00417482|894008|P2|COMPLETED|Phase B 2nd 16 Weeks||14
367471|NCT00417482|894009|P1|COMPLETED|Phase B 2nd 16 Weeks||10
367472|NCT00417482|894007|P3|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|13
367473|NCT00417482|894008|P2|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|27
367474|NCT00417482|894009|P1|STARTED|Phase B 2nd 16 Weeks|Risperidone for 16 weeks.|13
367475|NCT00417482|894007|P3|NOT COMPLETED|Phase B 1st 16 Weeks||27
367476|NCT00417482|894008|P2|NOT COMPLETED|Phase B 1st 16 Weeks||11
367477|NCT00417482|894009|P1|NOT COMPLETED|Phase B 1st 16 Weeks||19
367478|NCT00417482|894007|P3|COMPLETED|Phase B 1st 16 Weeks||13
367479|NCT00417482|894008|P2|COMPLETED|Phase B 1st 16 Weeks||27
367480|NCT00417482|894009|P1|COMPLETED|Phase B 1st 16 Weeks||13
367481|NCT00417482|894007|P3|STARTED|Phase B 1st 16 Weeks|Placebo 16 weeks.|40
367482|NCT00417482|894008|P2|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|38
367483|NCT00417482|894009|P1|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|32
367484|NCT00417417|894035|P2|NOT COMPLETED|Overall Study||0
367485|NCT00417417|894036|P1|NOT COMPLETED|Overall Study||0
367486|NCT00417417|894035|P2|COMPLETED|Overall Study||6
367487|NCT00417417|894036|P1|COMPLETED|Overall Study||4
367488|NCT00417417|894035|P2|STARTED|Overall Study||6
367489|NCT00417417|894036|P1|STARTED|Overall Study||4
367490|NCT00417274|894044|P1|NOT COMPLETED|Overall Study||0
367491|NCT00417274|894044|P1|COMPLETED|Overall Study||31
367492|NCT00417274|894044|P1|STARTED|Overall Study||31
367493|NCT00417248|894048|P1|NOT COMPLETED|Overall Study||8
367494|NCT00417248|894048|P1|COMPLETED|Overall Study||0
367495|NCT00417248|894048|P1|STARTED|Overall Study||8
367496|NCT00417170|894055|P2|NOT COMPLETED|Overall Study||3
367497|NCT00417170|894056|P1|NOT COMPLETED|Overall Study||2
367498|NCT00417170|894055|P2|COMPLETED|Overall Study||22
367499|NCT00417170|894056|P1|COMPLETED|Overall Study||21
367500|NCT00417170|894055|P2|Pharmacodynamics Population|Overall Study||23
367501|NCT00417170|894056|P1|Pharmacodynamics Population|Overall Study||21
367502|NCT00417170|894055|P2|STARTED|Overall Study||25
367503|NCT00417170|894056|P1|STARTED|Overall Study|"Started indicates Safety population."|23
367504|NCT00417079|894072|P2|NOT COMPLETED|Overall Study||273
367505|NCT00417079|894073|P1|NOT COMPLETED|Overall Study||331
367506|NCT00417079|894072|P2|COMPLETED|Overall Study|Randomized patients|105
367507|NCT00417079|894073|P1|COMPLETED|Overall Study|Randomized patients|46
367508|NCT00417079|894072|P2|STARTED|Overall Study|Randomized patients|378
367509|NCT00417079|894073|P1|STARTED|Overall Study|Randomized patients|377
367510|NCT00417027|894096|P3|NOT COMPLETED|Overall Study||5
367511|NCT00417027|894097|P2|NOT COMPLETED|Overall Study||5
367512|NCT00417027|894098|P1|NOT COMPLETED|Overall Study||0
367513|NCT00417027|894096|P3|COMPLETED|Overall Study||54
367514|NCT00417027|894097|P2|COMPLETED|Overall Study||60
367515|NCT00417027|894098|P1|COMPLETED|Overall Study||66
367516|NCT00417027|894096|P3|STARTED|Overall Study||59
367517|NCT00417027|894097|P2|STARTED|Overall Study||65
367518|NCT00417027|894098|P1|STARTED|Overall Study||66
367519|NCT00416949|894124|P1|NOT COMPLETED|Overall Study||5
367520|NCT00416949|894124|P1|COMPLETED|Overall Study||4
367521|NCT00416949|894124|P1|STARTED|Overall Study||9
367522|NCT00416884|894128|P1|NOT COMPLETED|Overall Study||1
367523|NCT00416884|894128|P1|COMPLETED|Overall Study||0
367524|NCT00416884|894128|P1|STARTED|Overall Study||1
367525|NCT00416793|894132|P1|NOT COMPLETED|Overall Study||0
367526|NCT00416793|894132|P1|COMPLETED|Overall Study||9
367527|NCT00416793|894132|P1|STARTED|Overall Study||9
367528|NCT00416715|894137|P1|NOT COMPLETED|Overall Study||15
367529|NCT00416715|894137|P1|COMPLETED|Overall Study||85
367530|NCT00416715|894137|P1|STARTED|Overall Study||100
367531|NCT00416624|894148|P4|NOT COMPLETED|Overall Study||17
367532|NCT00416624|894149|P3|NOT COMPLETED|Overall Study||18
367533|NCT00416624|894150|P2|NOT COMPLETED|Overall Study||27
367534|NCT00416624|894151|P1|NOT COMPLETED|Overall Study||22
367535|NCT00416624|894148|P4|COMPLETED|Overall Study||40
367536|NCT00416624|894149|P3|COMPLETED|Overall Study||40
367537|NCT00416624|894150|P2|COMPLETED|Overall Study||33
367538|NCT00416624|894151|P1|COMPLETED|Overall Study||39
367539|NCT00416624|894148|P4|STARTED|Overall Study||57
367540|NCT00416624|894149|P3|STARTED|Overall Study||58
367541|NCT00416624|894150|P2|STARTED|Overall Study||60
367542|NCT00416624|894151|P1|STARTED|Overall Study||61
367543|NCT00416598|894205|P1|NOT COMPLETED|Decitabine Maintenance||72
367544|NCT00416598|894205|P1|COMPLETED|Decitabine Maintenance||62
367545|NCT00416598|894205|P1|STARTED|Decitabine Maintenance||134
367546|NCT00416598|894205|P1|NOT COMPLETED|Induction & Intensification||412
367547|NCT00416598|894205|P1|COMPLETED|Induction & Intensification||134
367548|NCT00416598|894205|P1|STARTED|Induction & Intensification||546
367549|NCT00416572|894213|P3|NOT COMPLETED|Overall Study||8
367550|NCT00416572|894214|P2|NOT COMPLETED|Overall Study||7
367551|NCT00416572|894215|P1|NOT COMPLETED|Overall Study||13
367552|NCT00416572|894213|P3|COMPLETED|Overall Study||76
367553|NCT00416572|894214|P2|COMPLETED|Overall Study||78
367554|NCT00416572|894215|P1|COMPLETED|Overall Study||70
367555|NCT00416572|894213|P3|STARTED|Overall Study||84
367556|NCT00416572|894214|P2|STARTED|Overall Study||85
367557|NCT00416572|894215|P1|STARTED|Overall Study||83
367558|NCT00416520|894231|P4|NOT COMPLETED|Placebo-controlled Withdrawal Period||5
367559|NCT00416520|894232|P3|NOT COMPLETED|Placebo-controlled Withdrawal Period||1
367560|NCT00416520|894233|P2|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
367561|NCT00416520|894234|P1|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
367562|NCT00416520|894231|P4|COMPLETED|Placebo-controlled Withdrawal Period||49
367563|NCT00416520|894232|P3|COMPLETED|Placebo-controlled Withdrawal Period||49
367564|NCT00416520|894233|P2|COMPLETED|Placebo-controlled Withdrawal Period||0
367565|NCT00416520|894234|P1|COMPLETED|Placebo-controlled Withdrawal Period||0
367566|NCT00416520|894231|P4|STARTED|Placebo-controlled Withdrawal Period||54
367567|NCT00416520|894232|P3|STARTED|Placebo-controlled Withdrawal Period||50
367568|NCT00416520|894233|P2|STARTED|Placebo-controlled Withdrawal Period||0
367569|NCT00416520|894234|P1|STARTED|Placebo-controlled Withdrawal Period||0
367570|NCT00416520|894231|P4|NOT COMPLETED|Open-label Period||0
367571|NCT00416520|894232|P3|NOT COMPLETED|Open-label Period||0
367572|NCT00416520|894233|P2|NOT COMPLETED|Open-label Period||32
367573|NCT00416520|894234|P1|NOT COMPLETED|Open-label Period||60
367574|NCT00416520|894231|P4|COMPLETED|Open-label Period||0
367575|NCT00416520|894232|P3|COMPLETED|Open-label Period||0
367576|NCT00416520|894233|P2|COMPLETED|Open-label Period||139
367577|NCT00416520|894234|P1|COMPLETED|Open-label Period||105
367578|NCT00416520|894231|P4|STARTED|Open-label Period||0
367579|NCT00416520|894232|P3|STARTED|Open-label Period||0
367580|NCT00416520|894233|P2|STARTED|Open-label Period||171
367581|NCT00416520|894234|P1|STARTED|Open-label Period||165
367582|NCT00416494|894246|P2|NOT COMPLETED|Overall Study||0
367583|NCT00416494|894247|P1|NOT COMPLETED|Overall Study||0
367584|NCT00416494|894246|P2|COMPLETED|Overall Study||31
367585|NCT00416494|894247|P1|COMPLETED|Overall Study||19
367586|NCT00416494|894246|P2|STARTED|Overall Study||31
367587|NCT00416494|894247|P1|STARTED|Overall Study||19
367588|NCT00416455|894263|P2|NOT COMPLETED|Overall Study||8
367589|NCT00416455|894264|P1|NOT COMPLETED|Overall Study||16
367590|NCT00416455|894263|P2|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|207
367591|NCT00416455|894264|P1|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|153
367592|NCT00416455|894263|P2|STARTED|Overall Study|This is a diagnostic imaging study.|215
367593|NCT00416455|894264|P1|STARTED|Overall Study|This is a diagnostic imaging study.|169
367594|NCT00416312|894299|P1|NOT COMPLETED|Overall Study||2
367595|NCT00416312|894299|P1|COMPLETED|Overall Study||7
367596|NCT00416312|894299|P1|Patient-specific Dosimetry|Overall Study||9
367597|NCT00416312|894299|P1|Conventional Dosimetry|Overall Study||9
367598|NCT00416312|894299|P1|STARTED|Overall Study||9
367599|NCT00416195|894305|P2|NOT COMPLETED|Overall Study||4
367600|NCT00416195|894306|P1|NOT COMPLETED|Overall Study||2
367601|NCT00416195|894305|P2|COMPLETED|Overall Study||34
367602|NCT00416195|894306|P1|COMPLETED|Overall Study||8
367603|NCT00416195|894305|P2|STARTED|Overall Study||38
367604|NCT00416195|894306|P1|STARTED|Overall Study||10
367605|NCT00416182|894316|P2|NOT COMPLETED|Overall Study||2
367606|NCT00416182|894317|P1|NOT COMPLETED|Overall Study||3
367607|NCT00416182|894316|P2|COMPLETED|Overall Study||6
367608|NCT00416182|894317|P1|COMPLETED|Overall Study||5
367609|NCT00416182|894316|P2|STARTED|Overall Study||8
367610|NCT00416182|894317|P1|STARTED|Overall Study||8
367611|NCT00416078|894331|P2|NOT COMPLETED|Overall Study||8
367612|NCT00416078|894332|P1|NOT COMPLETED|Overall Study||11
367613|NCT00416078|894331|P2|COMPLETED|Overall Study||16
367614|NCT00416078|894332|P1|COMPLETED|Overall Study||18
367615|NCT00416078|894331|P2|STARTED|Overall Study||24
367616|NCT00416078|894332|P1|STARTED|Overall Study||29
367617|NCT00415909|894348|P1|NOT COMPLETED|Overall Study||3
367618|NCT00415909|894348|P1|COMPLETED|Overall Study||0
367619|NCT00415909|894348|P1|STARTED|Overall Study||3
367620|NCT00415870|894354|P2|NOT COMPLETED|Overall Study||7
367621|NCT00415870|894355|P1|NOT COMPLETED|Overall Study||6
367622|NCT00415870|894354|P2|COMPLETED|Overall Study||26
367623|NCT00415870|894355|P1|COMPLETED|Overall Study||26
367624|NCT00415870|894354|P2|STARTED|Overall Study||33
367625|NCT00415870|894355|P1|STARTED|Overall Study||32
367626|NCT00415857|894367|P2|NOT COMPLETED|Overall Study||0
367627|NCT00415857|894368|P1|NOT COMPLETED|Overall Study||0
367628|NCT00415857|894367|P2|COMPLETED|Overall Study||3
367629|NCT00415857|894368|P1|COMPLETED|Overall Study||2
367630|NCT00415857|894367|P2|STARTED|Overall Study||3
367631|NCT00415857|894368|P1|STARTED|Overall Study||2
367632|NCT00415636|894382|P6|NOT COMPLETED|Overall Study||2
367633|NCT00415636|894383|P5|NOT COMPLETED|Overall Study||2
367634|NCT00415636|894384|P4|NOT COMPLETED|Overall Study||6
367635|NCT00415636|894385|P3|NOT COMPLETED|Overall Study||1
367636|NCT00415636|894386|P2|NOT COMPLETED|Overall Study||0
367637|NCT00415636|894387|P1|NOT COMPLETED|Overall Study||1
367638|NCT00415636|894382|P6|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|1
367639|NCT00415636|894383|P5|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|4
367640|NCT00415636|894384|P4|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|7
367641|NCT00415636|894385|P3|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|2
367642|NCT00415636|894386|P2|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|3
367643|NCT00415636|894387|P1|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|2
367644|NCT00415636|894382|P6|STARTED|Overall Study||3
367645|NCT00415636|894383|P5|STARTED|Overall Study||6
367646|NCT00415636|894384|P4|STARTED|Overall Study||13
367647|NCT00415636|894385|P3|STARTED|Overall Study||3
367648|NCT00415636|894386|P2|STARTED|Overall Study||3
367649|NCT00415636|894387|P1|STARTED|Overall Study||3
367650|NCT00415623|894421|P2|NOT COMPLETED|Overall Study||5
367651|NCT00415623|894422|P1|NOT COMPLETED|Overall Study||5
367652|NCT00415623|894421|P2|COMPLETED|Overall Study||146
367653|NCT00415623|894422|P1|COMPLETED|Overall Study||149
367654|NCT00415623|894421|P2|STARTED|Overall Study||151
367655|NCT00415623|894422|P1|STARTED|Overall Study||154
367656|NCT00415610|894449|P3|NOT COMPLETED|Overall Study||5
367657|NCT00415610|894450|P2|NOT COMPLETED|Overall Study||2
367658|NCT00415610|894451|P1|NOT COMPLETED|Overall Study||3
367659|NCT00415610|894449|P3|COMPLETED|Overall Study||17
367660|NCT00415610|894450|P2|COMPLETED|Overall Study||18
367661|NCT00415610|894451|P1|COMPLETED|Overall Study||15
367662|NCT00415610|894449|P3|STARTED|Overall Study||22
367663|NCT00415610|894450|P2|STARTED|Overall Study||20
367664|NCT00415610|894451|P1|STARTED|Overall Study||18
367665|NCT00415597|894471|P1|NOT COMPLETED|Treatment||305
367666|NCT00415597|894471|P1|COMPLETED|Treatment||160
367667|NCT00415597|894471|P1|STARTED|Treatment||465
367668|NCT00415597|894471|P1|NOT COMPLETED|Enrollment||2
367669|NCT00415597|894471|P1|COMPLETED|Enrollment||465
367670|NCT00415597|894471|P1|STARTED|Enrollment||467
367671|NCT00415532|894479|P2|NOT COMPLETED|Safety Follow Up Period||12
367672|NCT00415532|894480|P1|NOT COMPLETED|Safety Follow Up Period||9
367673|NCT00415532|894479|P2|COMPLETED|Safety Follow Up Period||18
367674|NCT00415532|894480|P1|COMPLETED|Safety Follow Up Period||34
367675|NCT00415532|894479|P2|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|30
367676|NCT00415532|894480|P1|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|43
367677|NCT00415532|894479|P2|NOT COMPLETED|Treatment Period||15
367678|NCT00415532|894480|P1|NOT COMPLETED|Treatment Period||17
367679|NCT00415532|894479|P2|COMPLETED|Treatment Period||142
367680|NCT00415532|894480|P1|COMPLETED|Treatment Period||60
367681|NCT00415532|894479|P2|Switched to Romiplostim Group|Treatment Period||0
367682|NCT00415532|894480|P1|Switched to Romiplostim Group|Treatment Period||2
367683|NCT00415532|894479|P2|Received Treatment|Treatment Period||154
367684|NCT00415532|894480|P1|Received Treatment|Treatment Period||75
367685|NCT00415532|894479|P2|STARTED|Treatment Period||157
367686|NCT00415532|894480|P1|STARTED|Treatment Period||77
367687|NCT00415519|894502|P2|NOT COMPLETED|Overall Study||0
367688|NCT00415519|894503|P1|NOT COMPLETED|Overall Study||4
367689|NCT00415519|894502|P2|COMPLETED|Overall Study||12
367690|NCT00415519|894503|P1|COMPLETED|Overall Study||9
367691|NCT00415519|894502|P2|STARTED|Overall Study||12
367692|NCT00415519|894503|P1|STARTED|Overall Study||13
367693|NCT00415506|894523|P2|NOT COMPLETED|Overall Study||1
367694|NCT00415506|894524|P1|NOT COMPLETED|Overall Study||3
367695|NCT00415506|894523|P2|COMPLETED|Overall Study||9
367696|NCT00415506|894524|P1|COMPLETED|Overall Study||9
367697|NCT00415506|894523|P2|STARTED|Overall Study||10
367698|NCT00415506|894524|P1|STARTED|Overall Study||12
367699|NCT00415493|894534|P2|NOT COMPLETED|Overall Study||0
367700|NCT00415493|894535|P1|NOT COMPLETED|Overall Study||0
367701|NCT00415493|894534|P2|COMPLETED|Overall Study||12
367702|NCT00415493|894535|P1|COMPLETED|Overall Study||12
367703|NCT00415493|894534|P2|STARTED|Overall Study||12
367704|NCT00415493|894535|P1|STARTED|Overall Study||12
367705|NCT00415194|894543|P2|NOT COMPLETED|Overall Study||342
367706|NCT00415194|894544|P1|NOT COMPLETED|Overall Study||328
367707|NCT00415194|894543|P2|COMPLETED|Overall Study||55
367708|NCT00415194|894544|P1|COMPLETED|Overall Study||70
367709|NCT00415194|894543|P2|Received at Least 1 Dose of Study Drug|Overall Study||385
367710|NCT00415194|894544|P1|Received at Least 1 Dose of Study Drug|Overall Study||392
367711|NCT00415194|894543|P2|STARTED|Overall Study||397
367712|NCT00415194|894544|P1|STARTED|Overall Study||398
367713|NCT00415168|894560|P1|NOT COMPLETED|Overall Study||52
367714|NCT00415168|894560|P1|COMPLETED|Overall Study||1
367715|NCT00415168|894560|P1|Completed Treatment|Overall Study||15
367716|NCT00415168|894560|P1|STARTED|Overall Study||53
367717|NCT00415051|894570|P1|NOT COMPLETED|Overall Study||1
367718|NCT00415051|894570|P1|COMPLETED|Overall Study||19
367719|NCT00415051|894570|P1|STARTED|Overall Study||20
367720|NCT00414973|894581|P4|NOT COMPLETED|Overall Study||0
367721|NCT00414973|894582|P3|NOT COMPLETED|Overall Study||3
367722|NCT00414973|894583|P2|NOT COMPLETED|Overall Study||10
367723|NCT00414973|894584|P1|NOT COMPLETED|Overall Study||28
367724|NCT00414973|894581|P4|COMPLETED|Overall Study||11
367725|NCT00414973|894582|P3|COMPLETED|Overall Study||21
367726|NCT00414973|894583|P2|COMPLETED|Overall Study||99
367727|NCT00414973|894584|P1|COMPLETED|Overall Study||190
367728|NCT00414973|894581|P4|STARTED|Overall Study||11
367729|NCT00414973|894582|P3|STARTED|Overall Study||24
367730|NCT00414973|894583|P2|STARTED|Overall Study||109
367731|NCT00414973|894584|P1|STARTED|Overall Study||218
367732|NCT00414908|894604|P2|NOT COMPLETED|Overall Study||1
367733|NCT00414908|894605|P1|NOT COMPLETED|Overall Study||1
367734|NCT00414908|894604|P2|COMPLETED|Overall Study||28
367735|NCT00414908|894605|P1|COMPLETED|Overall Study||24
367736|NCT00414908|894604|P2|STARTED|Overall Study||29
367737|NCT00414908|894605|P1|STARTED|Overall Study||25
367738|NCT00414817|894629|P2|NOT COMPLETED|Overall Study||3016
367739|NCT00414817|894630|P1|NOT COMPLETED|Overall Study||3130
367740|NCT00414817|894629|P2|COMPLETED|Overall Study|Qualified for primary analysis (3260 prior ICS users) or secondary analysis (755 new users) samples.|4015
367741|NCT00414817|894630|P1|COMPLETED|Overall Study|Qualified for primary analysis (3171 prior ICS users) or secondary analysis (732 new users) samples.|3903
367742|NCT00414817|894629|P2|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|184
367743|NCT00414817|894630|P1|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|175
367744|NCT00414817|894629|P2|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|123
367745|NCT00414817|894630|P1|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|117
367746|NCT00414817|894629|P2|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|900
367747|NCT00414817|894630|P1|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|922
367748|NCT00414817|894629|P2|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|417
367749|NCT00414817|894630|P1|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|451
367750|NCT00414817|894629|P2|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1392
367751|NCT00414817|894630|P1|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1465
367752|NCT00414817|894629|P2|STARTED|Overall Study||7031
367753|NCT00414817|894630|P1|STARTED|Overall Study||7033
367754|NCT00414726|894642|P2|NOT COMPLETED|Overall Study||1
367755|NCT00414726|894643|P1|NOT COMPLETED|Overall Study||0
367756|NCT00414726|894642|P2|COMPLETED|Overall Study||41
367757|NCT00414726|894643|P1|COMPLETED|Overall Study||43
367758|NCT00414726|894642|P2|STARTED|Overall Study||42
367759|NCT00414726|894643|P1|STARTED|Overall Study||43
367760|NCT00414700|894653|P2|NOT COMPLETED|Overall Study||3
367761|NCT00414700|894654|P1|NOT COMPLETED|Overall Study||6
367762|NCT00414700|894653|P2|COMPLETED|Overall Study||58
367763|NCT00414700|894654|P1|COMPLETED|Overall Study||51
367764|NCT00414700|894653|P2|STARTED|Overall Study||61
367765|NCT00414700|894654|P1|STARTED|Overall Study||57
367766|NCT00414661|894678|P4|NOT COMPLETED|Overall Study||3
367767|NCT00414661|894679|P3|NOT COMPLETED|Overall Study||2
367768|NCT00414661|894680|P2|NOT COMPLETED|Overall Study||14
367769|NCT00414661|894681|P1|NOT COMPLETED|Overall Study||14
367770|NCT00414661|894678|P4|COMPLETED|Overall Study||0
367771|NCT00414661|894679|P3|COMPLETED|Overall Study||20
367772|NCT00414661|894680|P2|COMPLETED|Overall Study||75
367773|NCT00414661|894681|P1|COMPLETED|Overall Study||34
367774|NCT00414661|894678|P4|STARTED|Overall Study||3
367775|NCT00414661|894679|P3|STARTED|Overall Study||22
367776|NCT00414661|894680|P2|STARTED|Overall Study||89
367777|NCT00414661|894681|P1|STARTED|Overall Study||48
367778|NCT00414635|894705|P2|NOT COMPLETED|Overall Study||2
367779|NCT00414635|894706|P1|NOT COMPLETED|Overall Study||5
367780|NCT00414635|894705|P2|COMPLETED|Overall Study||28
367781|NCT00414635|894706|P1|COMPLETED|Overall Study||25
367782|NCT00414635|894705|P2|STARTED|Overall Study||30
367783|NCT00414635|894706|P1|STARTED|Overall Study||30
367784|NCT00414609|894726|P3|NOT COMPLETED|Extension Study||57
367785|NCT00414609|894727|P2|NOT COMPLETED|Extension Study||0
367786|NCT00414609|894728|P1|NOT COMPLETED|Extension Study||0
367787|NCT00414609|894726|P3|COMPLETED|Extension Study||365
367788|NCT00414609|894727|P2|COMPLETED|Extension Study||0
367789|NCT00414609|894728|P1|COMPLETED|Extension Study||0
367790|NCT00414609|894726|P3|Echocardiogram (ECHO) Analysis Set|Extension Study||400
367791|NCT00414609|894727|P2|Echocardiogram (ECHO) Analysis Set|Extension Study||0
367792|NCT00414609|894728|P1|Echocardiogram (ECHO) Analysis Set|Extension Study||0
367793|NCT00414609|894726|P3|STARTED|Extension Study|Patients of both core arms who completed core study and signed informed consent form for extension.|422
367794|NCT00414609|894727|P2|STARTED|Extension Study||0
367795|NCT00414609|894728|P1|STARTED|Extension Study||0
367796|NCT00414609|894726|P3|NOT COMPLETED|Core Study||0
367797|NCT00414609|894727|P2|NOT COMPLETED|Core Study||45
367798|NCT00414609|894728|P1|NOT COMPLETED|Core Study||34
367799|NCT00414609|894726|P3|COMPLETED|Core Study||0
367800|NCT00414609|894727|P2|COMPLETED|Core Study||378
367801|NCT00414609|894728|P1|COMPLETED|Core Study||363
367802|NCT00414609|894726|P3|Echocardiogram Evaluable Set|Core Study||0
367803|NCT00414609|894727|P2|Echocardiogram Evaluable Set|Core Study||343
367804|NCT00414609|894728|P1|Echocardiogram Evaluable Set|Core Study||330
367805|NCT00414609|894726|P3|Received Study Drug|Core Study||0
367806|NCT00414609|894727|P2|Received Study Drug|Core Study||422
367807|NCT00414609|894728|P1|Received Study Drug|Core Study||397
367808|NCT00414609|894726|P3|STARTED|Core Study||0
367809|NCT00414609|894727|P2|STARTED|Core Study||423
367810|NCT00414609|894728|P1|STARTED|Core Study||397
367811|NCT00414596|894751|P1|NOT COMPLETED|Overall Study||2
367812|NCT00414596|894751|P1|COMPLETED|Overall Study|April 2007|18
367813|NCT00414596|894751|P1|STARTED|Overall Study|December 2006|20
367814|NCT00414544|894760|P1|NOT COMPLETED|Overall Study||14
367815|NCT00414544|894760|P1|COMPLETED|Overall Study||131
367816|NCT00414544|894760|P1|STARTED|Overall Study||145
367817|NCT00414518|894768|P2|NOT COMPLETED|Overall Study||0
367818|NCT00414518|894769|P1|NOT COMPLETED|Overall Study||0
367819|NCT00414518|894768|P2|COMPLETED|Overall Study||9
367820|NCT00414518|894769|P1|COMPLETED|Overall Study||7
367821|NCT00414518|894768|P2|STARTED|Overall Study||9
367822|NCT00414518|894769|P1|STARTED|Overall Study||7
367823|NCT00414466|894783|P4|NOT COMPLETED|Overall Study||1
367824|NCT00414466|894784|P3|NOT COMPLETED|Overall Study||1
367825|NCT00414466|894785|P2|NOT COMPLETED|Overall Study||0
367826|NCT00414466|894786|P1|NOT COMPLETED|Overall Study||2
367827|NCT00414466|894783|P4|COMPLETED|Overall Study||42
367828|NCT00414466|894784|P3|COMPLETED|Overall Study||40
367829|NCT00414466|894785|P2|COMPLETED|Overall Study||42
367830|NCT00414466|894786|P1|COMPLETED|Overall Study||42
367831|NCT00414466|894783|P4|STARTED|Overall Study||43
367832|NCT00414466|894784|P3|STARTED|Overall Study||41
367833|NCT00414466|894785|P2|STARTED|Overall Study||42
367834|NCT00414466|894786|P1|STARTED|Overall Study||44
367835|NCT00414453|894804|P1|NOT COMPLETED|Overall Study||16
367836|NCT00414453|894804|P1|COMPLETED|Overall Study||3
367837|NCT00414453|894804|P1|STARTED|Overall Study||19
367838|NCT00414440|894852|P2|NOT COMPLETED|Extension Period||140
367839|NCT00414440|894853|P1|NOT COMPLETED|Extension Period||150
367840|NCT00414440|894852|P2|COMPLETED|Extension Period|Extension|77
367841|NCT00414440|894853|P1|COMPLETED|Extension Period|Extension|64
367842|NCT00414440|894852|P2|STARTED|Extension Period|Extension|217
367843|NCT00414440|894853|P1|STARTED|Extension Period|Extension|214
367844|NCT00414440|894852|P2|NOT COMPLETED|Core Period||32
367845|NCT00414440|894853|P1|NOT COMPLETED|Core Period||70
367846|NCT00414440|894852|P2|COMPLETED|Core Period|Core period|185
367847|NCT00414440|894853|P1|COMPLETED|Core Period|Core period|144
367848|NCT00414440|894852|P2|STARTED|Core Period|Core period|217
367849|NCT00414440|894853|P1|STARTED|Core Period|Core period|214
367850|NCT00414388|894867|P1|NOT COMPLETED|Overall Study||1
367851|NCT00414388|894867|P1|COMPLETED|Overall Study||21
367852|NCT00414388|894867|P1|STARTED|Overall Study||22
367853|NCT00414310|894875|P2|NOT COMPLETED|Overall Study||0
367854|NCT00414310|894876|P1|NOT COMPLETED|Overall Study||1
367855|NCT00414310|894875|P2|COMPLETED|Overall Study||79
367856|NCT00414310|894876|P1|COMPLETED|Overall Study||70
367857|NCT00414310|894875|P2|STARTED|Overall Study||79
367858|NCT00414310|894876|P1|STARTED|Overall Study||71
367859|NCT00414271|894886|P1|NOT COMPLETED|Overall Study||0
367860|NCT00414271|894886|P1|COMPLETED|Overall Study||18
367861|NCT00414271|894886|P1|STARTED|Overall Study||18
367862|NCT00414206|894897|P3|NOT COMPLETED|Overall Study||55
367863|NCT00414206|894898|P2|NOT COMPLETED|Overall Study||56
367864|NCT00414206|894899|P1|NOT COMPLETED|Overall Study||58
367865|NCT00414206|894897|P3|COMPLETED|Overall Study||59
367866|NCT00414206|894898|P2|COMPLETED|Overall Study||58
367867|NCT00414206|894899|P1|COMPLETED|Overall Study||57
367868|NCT00414206|894897|P3|STARTED|Overall Study||114
367869|NCT00414206|894898|P2|STARTED|Overall Study||114
367870|NCT00414206|894899|P1|STARTED|Overall Study||115
367871|NCT00414167|894909|P2|NOT COMPLETED|Overall Study||3
367872|NCT00414167|894910|P1|NOT COMPLETED|Overall Study||4
367873|NCT00414167|894909|P2|COMPLETED|Overall Study||27
367874|NCT00414167|894910|P1|COMPLETED|Overall Study||27
367875|NCT00414167|894909|P2|STARTED|Overall Study||30
367876|NCT00414167|894910|P1|STARTED|Overall Study||31
367877|NCT00414076|894920|P2|NOT COMPLETED|Overall Study||5
367878|NCT00414076|894921|P1|NOT COMPLETED|Overall Study||3
367879|NCT00414076|894920|P2|COMPLETED|Overall Study||0
367880|NCT00414076|894921|P1|COMPLETED|Overall Study||1
367881|NCT00414076|894920|P2|STARTED|Overall Study||5
367882|NCT00414076|894921|P1|STARTED|Overall Study||4
367883|NCT00414050|894931|P4|NOT COMPLETED|Overall Study||8
367884|NCT00414050|894932|P3|NOT COMPLETED|Overall Study||6
367885|NCT00414050|894933|P2|NOT COMPLETED|Overall Study||8
367886|NCT00414050|894934|P1|NOT COMPLETED|Overall Study||9
367887|NCT00414050|894931|P4|COMPLETED|Overall Study||423
367888|NCT00414050|894932|P3|COMPLETED|Overall Study||423
367889|NCT00414050|894933|P2|COMPLETED|Overall Study||419
367890|NCT00414050|894934|P1|COMPLETED|Overall Study||422
367891|NCT00414050|894931|P4|Received Vaccination 3|Overall Study||424
367892|NCT00414050|894932|P3|Received Vaccination 3|Overall Study||425
367893|NCT00414050|894933|P2|Received Vaccination 3|Overall Study||419
367894|NCT00414050|894934|P1|Received Vaccination 3|Overall Study||424
367895|NCT00414050|894931|P4|Received Vaccination 2|Overall Study||425
367896|NCT00414050|894932|P3|Received Vaccination 2|Overall Study||425
367897|NCT00414050|894933|P2|Received Vaccination 2|Overall Study||421
367898|NCT00414050|894934|P1|Received Vaccination 2|Overall Study||425
367899|NCT00414050|894931|P4|Received Vaccination 1|Overall Study||431
367900|NCT00414050|894932|P3|Received Vaccination 1|Overall Study||429
367901|NCT00414050|894933|P2|Received Vaccination 1|Overall Study||426
367902|NCT00414050|894934|P1|Received Vaccination 1|Overall Study||431
367903|NCT00414050|894931|P4|STARTED|Overall Study||431
367904|NCT00414050|894932|P3|STARTED|Overall Study||429
367905|NCT00414050|894933|P2|STARTED|Overall Study||427
367906|NCT00414050|894934|P1|STARTED|Overall Study||431
367907|NCT00414011|894948|P1|NOT COMPLETED|Overall Study||5
367908|NCT00414011|894948|P1|COMPLETED|Overall Study||35
367909|NCT00414011|894948|P1|STARTED|Overall Study||40
367910|NCT00413972|894957|P4|NOT COMPLETED|Overall Study||3
367911|NCT00413972|894958|P3|NOT COMPLETED|Overall Study||10
367912|NCT00413972|894959|P2|NOT COMPLETED|Overall Study||8
367913|NCT00413972|894960|P1|NOT COMPLETED|Overall Study||7
367914|NCT00413972|894957|P4|COMPLETED|Overall Study||95
367915|NCT00413972|894958|P3|COMPLETED|Overall Study||88
367916|NCT00413972|894959|P2|COMPLETED|Overall Study||90
367917|NCT00413972|894960|P1|COMPLETED|Overall Study||91
367918|NCT00413972|894957|P4|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
367919|NCT00413972|894958|P3|STARTED|Overall Study||98
367920|NCT00413972|894959|P2|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
367921|NCT00413972|894960|P1|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
367922|NCT00413959|894970|P1|NOT COMPLETED|Overall Study||1
367923|NCT00413959|894970|P1|COMPLETED|Overall Study||11
367924|NCT00413959|894970|P1|STARTED|Overall Study||12
367925|NCT00413920|894977|P2|NOT COMPLETED|Overall Study||28
367926|NCT00413920|894978|P1|NOT COMPLETED|Overall Study||28
367927|NCT00413920|894977|P2|COMPLETED|Overall Study||82
367928|NCT00413920|894978|P1|COMPLETED|Overall Study||84
367929|NCT00413920|894977|P2|STARTED|Overall Study||110
367930|NCT00413920|894978|P1|STARTED|Overall Study||112
367931|NCT00413894|894993|P1|NOT COMPLETED|Overall Study||80
367932|NCT00413894|894993|P1|COMPLETED|Overall Study||344
367933|NCT00413894|894993|P1|STARTED|Overall Study||424
367934|NCT00413777|895010|P2|NOT COMPLETED|Extension Period||0
367935|NCT00413777|895011|P1|NOT COMPLETED|Extension Period||0
367936|NCT00413777|895010|P2|COMPLETED|Extension Period||18
367937|NCT00413777|895011|P1|COMPLETED|Extension Period||17
367938|NCT00413777|895010|P2|STARTED|Extension Period||18
367939|NCT00413777|895011|P1|STARTED|Extension Period||17
367940|NCT00413777|895010|P2|NOT COMPLETED|Fixed-dose Period||3
367941|NCT00413777|895011|P1|NOT COMPLETED|Fixed-dose Period||4
367942|NCT00413777|895010|P2|COMPLETED|Fixed-dose Period||21
367943|NCT00413777|895011|P1|COMPLETED|Fixed-dose Period||18
367944|NCT00413777|895010|P2|STARTED|Fixed-dose Period||24
367945|NCT00413777|895011|P1|STARTED|Fixed-dose Period||22
367946|NCT00413699|895059|P3|NOT COMPLETED|Extension Period||5
367947|NCT00413699|895060|P2|NOT COMPLETED|Extension Period||0
367948|NCT00413699|895061|P1|NOT COMPLETED|Extension Period||0
367949|NCT00413699|895059|P3|COMPLETED|Extension Period||43
367950|NCT00413699|895060|P2|COMPLETED|Extension Period||0
367951|NCT00413699|895061|P1|COMPLETED|Extension Period||0
367952|NCT00413699|895059|P3|STARTED|Extension Period||48
367953|NCT00413699|895060|P2|STARTED|Extension Period||0
367954|NCT00413699|895061|P1|STARTED|Extension Period||0
367955|NCT00413699|895059|P3|NOT COMPLETED|Initial Period||0
367956|NCT00413699|895060|P2|NOT COMPLETED|Initial Period||1705
367957|NCT00413699|895061|P1|NOT COMPLETED|Initial Period||639
367958|NCT00413699|895059|P3|COMPLETED|Initial Period||0
367959|NCT00413699|895060|P2|COMPLETED|Initial Period||1653
367960|NCT00413699|895061|P1|COMPLETED|Initial Period||484
367961|NCT00413699|895059|P3|STARTED|Initial Period||0
367962|NCT00413699|895060|P2|STARTED|Initial Period||3358
367963|NCT00413699|895061|P1|STARTED|Initial Period||1123
367964|NCT00413660|895143|P11|NOT COMPLETED|Post Week 12||1
367965|NCT00413660|895144|P10|NOT COMPLETED|Post Week 12||1
367966|NCT00413660|895145|P9|NOT COMPLETED|Post Week 12||0
367967|NCT00413660|895146|P8|NOT COMPLETED|Post Week 12||0
367968|NCT00413660|895147|P7|NOT COMPLETED|Post Week 12||3
367969|NCT00413660|895148|P6|NOT COMPLETED|Post Week 12||3
367970|NCT00413660|895149|P5|NOT COMPLETED|Post Week 12||6
367971|NCT00413660|895150|P4|NOT COMPLETED|Post Week 12||1
367972|NCT00413660|895151|P3|NOT COMPLETED|Post Week 12||8
367973|NCT00413660|895152|P2|NOT COMPLETED|Post Week 12||4
367974|NCT00413660|895153|P1|NOT COMPLETED|Post Week 12||3
367975|NCT00413660|895143|P11|COMPLETED|Post Week 12||17
367976|NCT00413660|895144|P10|COMPLETED|Post Week 12||12
367977|NCT00413660|895145|P9|COMPLETED|Post Week 12||13
367978|NCT00413660|895146|P8|COMPLETED|Post Week 12||21
367979|NCT00413660|895147|P7|COMPLETED|Post Week 12||37
367980|NCT00413660|895148|P6|COMPLETED|Post Week 12||54
367981|NCT00413660|895149|P5|COMPLETED|Post Week 12||60
367982|NCT00413660|895150|P4|COMPLETED|Post Week 12||66
367983|NCT00413660|895151|P3|COMPLETED|Post Week 12||56
367984|NCT00413660|895152|P2|COMPLETED|Post Week 12||44
367985|NCT00413660|895153|P1|COMPLETED|Post Week 12||40
367986|NCT00413660|895143|P11|STARTED|Post Week 12||18
367987|NCT00413660|895144|P10|STARTED|Post Week 12||13
367988|NCT00413660|895145|P9|STARTED|Post Week 12||13
367989|NCT00413660|895146|P8|STARTED|Post Week 12||21
367990|NCT00413660|895147|P7|STARTED|Post Week 12||40
367991|NCT00413660|895148|P6|STARTED|Post Week 12||57
367992|NCT00413660|895149|P5|STARTED|Post Week 12||66
367993|NCT00413660|895150|P4|STARTED|Post Week 12||67
367994|NCT00413660|895151|P3|STARTED|Post Week 12||64
367995|NCT00413660|895152|P2|STARTED|Post Week 12||48
367996|NCT00413660|895153|P1|STARTED|Post Week 12||43
367997|NCT00413660|895143|P11|NOT COMPLETED|Up To Week 12||0
367998|NCT00413660|895144|P10|NOT COMPLETED|Up To Week 12||0
367999|NCT00413660|895145|P9|NOT COMPLETED|Up To Week 12||0
368000|NCT00413660|895146|P8|NOT COMPLETED|Up To Week 12||0
368001|NCT00413660|895147|P7|NOT COMPLETED|Up To Week 12||11
368002|NCT00413660|895148|P6|NOT COMPLETED|Up To Week 12||10
368003|NCT00413660|895149|P5|NOT COMPLETED|Up To Week 12||9
368004|NCT00413660|895150|P4|NOT COMPLETED|Up To Week 12||8
368005|NCT00413660|895151|P3|NOT COMPLETED|Up To Week 12||7
368006|NCT00413660|895152|P2|NOT COMPLETED|Up To Week 12||7
368007|NCT00413660|895153|P1|NOT COMPLETED|Up To Week 12||7
368008|NCT00413660|895143|P11|COMPLETED|Up To Week 12||0
368009|NCT00413660|895144|P10|COMPLETED|Up To Week 12||0
368010|NCT00413660|895145|P9|COMPLETED|Up To Week 12||0
368011|NCT00413660|895146|P8|COMPLETED|Up To Week 12||0
368012|NCT00413660|895147|P7|COMPLETED|Up To Week 12||58
368013|NCT00413660|895148|P6|COMPLETED|Up To Week 12||70
368014|NCT00413660|895149|P5|COMPLETED|Up To Week 12||66
368015|NCT00413660|895150|P4|COMPLETED|Up To Week 12||67
368016|NCT00413660|895151|P3|COMPLETED|Up To Week 12||64
368017|NCT00413660|895152|P2|COMPLETED|Up To Week 12||61
368018|NCT00413660|895153|P1|COMPLETED|Up To Week 12||64
368019|NCT00413660|895143|P11|Treated|Up To Week 12||0
368020|NCT00413660|895144|P10|Treated|Up To Week 12||0
368021|NCT00413660|895145|P9|Treated|Up To Week 12||0
368022|NCT00413660|895146|P8|Treated|Up To Week 12||0
368023|NCT00413660|895147|P7|Treated|Up To Week 12||69
368024|NCT00413660|895148|P6|Treated|Up To Week 12||80
368025|NCT00413660|895149|P5|Treated|Up To Week 12||75
368026|NCT00413660|895150|P4|Treated|Up To Week 12||74
368027|NCT00413660|895151|P3|Treated|Up To Week 12||71
368028|NCT00413660|895152|P2|Treated|Up To Week 12||68
368029|NCT00413660|895153|P1|Treated|Up To Week 12||70
368030|NCT00413660|895143|P11|STARTED|Up To Week 12||0
368031|NCT00413660|895144|P10|STARTED|Up To Week 12||0
368032|NCT00413660|895145|P9|STARTED|Up To Week 12||0
368033|NCT00413660|895146|P8|STARTED|Up To Week 12||0
368034|NCT00413660|895147|P7|STARTED|Up To Week 12||69
368035|NCT00413660|895148|P6|STARTED|Up To Week 12||80
368036|NCT00413660|895149|P5|STARTED|Up To Week 12||75
368037|NCT00413660|895150|P4|STARTED|Up To Week 12||75
368038|NCT00413660|895151|P3|STARTED|Up To Week 12||71
368039|NCT00413660|895152|P2|STARTED|Up To Week 12||68
368040|NCT00413660|895153|P1|STARTED|Up To Week 12||71
368041|NCT00413634|895501|P2|NOT COMPLETED|Overall Study||0
368042|NCT00413634|895502|P1|NOT COMPLETED|Overall Study||0
368043|NCT00413634|895501|P2|COMPLETED|Overall Study||12
368044|NCT00413634|895502|P1|COMPLETED|Overall Study||12
368045|NCT00413634|895501|P2|STARTED|Overall Study||12
368046|NCT00413634|895502|P1|STARTED|Overall Study||12
368047|NCT00413582|895540|P2|NOT COMPLETED|Overall Study||0
368048|NCT00413582|895541|P1|NOT COMPLETED|Overall Study||0
368049|NCT00413582|895540|P2|COMPLETED|Overall Study|all enrolled completed|55
368050|NCT00413582|895541|P1|COMPLETED|Overall Study|all enrolled completed|55
368051|NCT00413582|895540|P2|Completion of Study|Overall Study|all enrolled completed|55
368052|NCT00413582|895541|P1|Completion of Study|Overall Study|all enrolled completed|55
368053|NCT00413582|895540|P2|STARTED|Overall Study|all enrolled completed|55
368054|NCT00413582|895541|P1|STARTED|Overall Study|all enrolled completed|55
368055|NCT00413478|895549|P1|NOT COMPLETED|Overall Study||0
368056|NCT00413478|895549|P1|COMPLETED|Overall Study||9
368057|NCT00413478|895549|P1|STARTED|Overall Study||9
368058|NCT00413413|895556|P3|NOT COMPLETED|Double-Blind||18
368059|NCT00413413|895557|P2|NOT COMPLETED|Double-Blind||14
368060|NCT00413413|895558|P1|NOT COMPLETED|Double-Blind||15
368061|NCT00413413|895556|P3|COMPLETED|Double-Blind||285
368062|NCT00413413|895557|P2|COMPLETED|Double-Blind||293
368063|NCT00413413|895558|P1|COMPLETED|Double-Blind||293
368064|NCT00413413|895556|P3|STARTED|Double-Blind||303
368065|NCT00413413|895557|P2|STARTED|Double-Blind||307
368066|NCT00413413|895558|P1|STARTED|Double-Blind||308
368067|NCT00413413|895556|P3|NOT COMPLETED|Single-Blind||0
368068|NCT00413413|895557|P2|NOT COMPLETED|Single-Blind||216
368069|NCT00413413|895558|P1|NOT COMPLETED|Single-Blind||0
368070|NCT00413413|895556|P3|COMPLETED|Single-Blind||0
368071|NCT00413413|895557|P2|COMPLETED|Single-Blind||918
368072|NCT00413413|895558|P1|COMPLETED|Single-Blind||0
368073|NCT00413413|895556|P3|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
368074|NCT00413413|895557|P2|STARTED|Single-Blind||1134
368075|NCT00413413|895558|P1|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
368076|NCT00413400|895580|P2|NOT COMPLETED|Overall Study||4
368077|NCT00413400|895581|P1|NOT COMPLETED|Overall Study||2
368078|NCT00413400|895580|P2|COMPLETED|Overall Study||12
368079|NCT00413400|895581|P1|COMPLETED|Overall Study||22
368080|NCT00413400|895580|P2|3 Month Visit|Overall Study||12
368081|NCT00413400|895581|P1|3 Month Visit|Overall Study||22
368082|NCT00413400|895580|P2|STARTED|Overall Study||16
368083|NCT00413400|895581|P1|STARTED|Overall Study||24
368084|NCT00413374|895611|P2|NOT COMPLETED|Overall Study||0
368085|NCT00413374|895612|P1|NOT COMPLETED|Overall Study||6
368086|NCT00413374|895611|P2|COMPLETED|Overall Study||80
368087|NCT00413374|895612|P1|COMPLETED|Overall Study||34
368088|NCT00413374|895611|P2|STARTED|Overall Study||80
368089|NCT00413374|895612|P1|STARTED|Overall Study||40
368090|NCT00413335|895624|P2|NOT COMPLETED|Overall Study||0
368091|NCT00413335|895625|P1|NOT COMPLETED|Overall Study||0
368092|NCT00413335|895624|P2|COMPLETED|Overall Study||9
368093|NCT00413335|895625|P1|COMPLETED|Overall Study||12
368094|NCT00413335|895624|P2|STARTED|Overall Study||9
368095|NCT00413335|895625|P1|STARTED|Overall Study||12
368096|NCT00413283|895643|P4|NOT COMPLETED|Overall Study||4
368097|NCT00413283|895644|P3|NOT COMPLETED|Overall Study||2
368098|NCT00413283|895645|P2|NOT COMPLETED|Overall Study||3
368099|NCT00413283|895646|P1|NOT COMPLETED|Overall Study||1
368100|NCT00413283|895643|P4|COMPLETED|Overall Study||13
368101|NCT00413283|895644|P3|COMPLETED|Overall Study||16
368102|NCT00413283|895645|P2|COMPLETED|Overall Study||13
368103|NCT00413283|895646|P1|COMPLETED|Overall Study||11
368104|NCT00413283|895643|P4|Received Study Drug|Overall Study||16
368105|NCT00413283|895644|P3|Received Study Drug|Overall Study||18
368106|NCT00413283|895645|P2|Received Study Drug|Overall Study||16
368107|NCT00413283|895646|P1|Received Study Drug|Overall Study||12
368108|NCT00413283|895643|P4|STARTED|Overall Study||17
368109|NCT00413283|895644|P3|STARTED|Overall Study||18
368110|NCT00413283|895645|P2|STARTED|Overall Study||16
368111|NCT00413283|895646|P1|STARTED|Overall Study||12
368112|NCT00413244|895678|P2|NOT COMPLETED|Overall Study||1
368113|NCT00413244|895679|P1|NOT COMPLETED|Overall Study||10
368114|NCT00413244|895678|P2|COMPLETED|Overall Study||19
368115|NCT00413244|895679|P1|COMPLETED|Overall Study||21
368116|NCT00413244|895678|P2|STARTED|Overall Study||20
368117|NCT00413244|895679|P1|STARTED|Overall Study||31
368118|NCT00413231|895707|P1|NOT COMPLETED|365-day to 60-month Post Treatment||46
368119|NCT00413231|895707|P1|COMPLETED|365-day to 60-month Post Treatment||93
368120|NCT00413231|895707|P1|STARTED|365-day to 60-month Post Treatment||139
368121|NCT00413231|895707|P1|NOT COMPLETED|30-day to 365-day Post Treatment||13
368122|NCT00413231|895707|P1|COMPLETED|30-day to 365-day Post Treatment||139
368123|NCT00413231|895707|P1|STARTED|30-day to 365-day Post Treatment||152
368124|NCT00413231|895707|P1|NOT COMPLETED|0 to 30-day Post Treatment||8
368125|NCT00413231|895707|P1|COMPLETED|0 to 30-day Post Treatment||152
368126|NCT00413231|895707|P1|STARTED|0 to 30-day Post Treatment||160
368127|NCT00413218|895739|P2|NOT COMPLETED|Overall Study||96
368128|NCT00413218|895740|P1|NOT COMPLETED|Overall Study||103
368129|NCT00413218|895739|P2|COMPLETED|Overall Study||131
368130|NCT00413218|895740|P1|COMPLETED|Overall Study||120
368131|NCT00413218|895739|P2|Intent to Treat Population (ITT)|Overall Study||219
368132|NCT00413218|895740|P1|Intent to Treat Population (ITT)|Overall Study||221
368133|NCT00413218|895739|P2|STARTED|Overall Study||227
368134|NCT00413218|895740|P1|STARTED|Overall Study||223
368135|NCT00413192|895766|P4|NOT COMPLETED|Overall Study||32
368136|NCT00413192|895767|P3|NOT COMPLETED|Overall Study||19
368137|NCT00413192|895768|P2|NOT COMPLETED|Overall Study||40
368138|NCT00413192|895769|P1|NOT COMPLETED|Overall Study||37
368139|NCT00413192|895766|P4|COMPLETED|Overall Study||0
368140|NCT00413192|895767|P3|COMPLETED|Overall Study||0
368141|NCT00413192|895768|P2|COMPLETED|Overall Study||0
368142|NCT00413192|895769|P1|COMPLETED|Overall Study||0
368143|NCT00413192|895766|P4|STARTED|Overall Study||32
368144|NCT00413192|895767|P3|STARTED|Overall Study||19
368145|NCT00413192|895768|P2|STARTED|Overall Study||40
368146|NCT00413192|895769|P1|STARTED|Overall Study||37
368147|NCT00413166|895810|P3|NOT COMPLETED|Overall Study||0
368148|NCT00413166|895811|P2|NOT COMPLETED|Overall Study||0
368149|NCT00413166|895812|P1|NOT COMPLETED|Overall Study||0
368150|NCT00413166|895810|P3|COMPLETED|Overall Study||16
368151|NCT00413166|895811|P2|COMPLETED|Overall Study||5
368152|NCT00413166|895812|P1|COMPLETED|Overall Study||57
368153|NCT00413166|895810|P3|STARTED|Overall Study||16
368154|NCT00413166|895811|P2|STARTED|Overall Study||5
368155|NCT00413166|895812|P1|STARTED|Overall Study||57
368156|NCT00413153|895822|P2|NOT COMPLETED|Overall Study||1
368157|NCT00413153|895823|P1|NOT COMPLETED|Overall Study||2
368158|NCT00413153|895822|P2|COMPLETED|Overall Study||7
368159|NCT00413153|895823|P1|COMPLETED|Overall Study||5
368160|NCT00413153|895822|P2|STARTED|Overall Study||8
368161|NCT00413153|895823|P1|STARTED|Overall Study||7
368162|NCT00413062|895847|P2|NOT COMPLETED|Overall Study||210
368163|NCT00413062|895848|P1|NOT COMPLETED|Overall Study||678
368164|NCT00413062|895847|P2|COMPLETED|Overall Study||344
368165|NCT00413062|895848|P1|COMPLETED|Overall Study||988
368166|NCT00413062|895847|P2|STARTED|Overall Study||554
368167|NCT00413062|895848|P1|STARTED|Overall Study||1666
368168|NCT00413049|895874|P2|NOT COMPLETED|Overall Study||18
368169|NCT00413049|895875|P1|NOT COMPLETED|Overall Study||24
368170|NCT00413049|895874|P2|COMPLETED|Overall Study||331
368171|NCT00413049|895875|P1|COMPLETED|Overall Study||325
368172|NCT00413049|895874|P2|STARTED|Overall Study||349
368173|NCT00413049|895875|P1|STARTED|Overall Study||349
368174|NCT00413036|895891|P1|NOT COMPLETED|Overall Study||217
368263|NCT00412542|896150|P2|COMPLETED|Overall Study||42
368175|NCT00413036|895891|P1|COMPLETED|Overall Study|Participants remain on study drug until progressive disease or unacceptable adverse events develop.|0
368176|NCT00413036|895891|P1|STARTED|Overall Study||217
368177|NCT00413010|895901|P2|NOT COMPLETED|Overall Study||63
368178|NCT00413010|895902|P1|NOT COMPLETED|Overall Study||72
368179|NCT00413010|895901|P2|COMPLETED|Overall Study||113
368180|NCT00413010|895902|P1|COMPLETED|Overall Study||108
368181|NCT00413010|895901|P2|STARTED|Overall Study||176
368182|NCT00413010|895902|P1|STARTED|Overall Study||180
368183|NCT00412984|895924|P2|NOT COMPLETED|Overall Study||2493
368184|NCT00412984|895925|P1|NOT COMPLETED|Overall Study||2310
368185|NCT00412984|895924|P2|COMPLETED|Overall Study||6588
368186|NCT00412984|895925|P1|COMPLETED|Overall Study||6810
368187|NCT00412984|895924|P2|STARTED|Overall Study|Randomized participants|9081
368188|NCT00412984|895925|P1|STARTED|Overall Study|Randomized participants|9120
368189|NCT00412971|895969|P2|NOT COMPLETED|Overall Study||10
368190|NCT00412971|895970|P1|NOT COMPLETED|Overall Study||30
368191|NCT00412971|895969|P2|COMPLETED|Overall Study||108
368192|NCT00412971|895970|P1|COMPLETED|Overall Study||85
368193|NCT00412971|895969|P2|STARTED|Overall Study||118
368194|NCT00412971|895970|P1|STARTED|Overall Study||115
368195|NCT00412958|895983|P4|NOT COMPLETED|Overall Study||1
368196|NCT00412958|895984|P3|NOT COMPLETED|Overall Study||0
368197|NCT00412958|895985|P2|NOT COMPLETED|Overall Study||4
368198|NCT00412958|895986|P1|NOT COMPLETED|Overall Study||3
368199|NCT00412958|895983|P4|COMPLETED|Overall Study||30
368200|NCT00412958|895984|P3|COMPLETED|Overall Study||32
368201|NCT00412958|895985|P2|COMPLETED|Overall Study||29
368202|NCT00412958|895986|P1|COMPLETED|Overall Study||26
368203|NCT00412958|895983|P4|STARTED|Overall Study||31
368204|NCT00412958|895984|P3|STARTED|Overall Study||32
368205|NCT00412958|895985|P2|STARTED|Overall Study||33
368206|NCT00412958|895986|P1|STARTED|Overall Study||29
368207|NCT00412932|895996|P1|NOT COMPLETED|Olm+ Hydrochlorothiazide 25 mg||2
368208|NCT00412932|895996|P1|COMPLETED|Olm+ Hydrochlorothiazide 25 mg||123
368209|NCT00412932|895996|P1|STARTED|Olm+ Hydrochlorothiazide 25 mg|153 -28 met their blood pressure goal (stayed on olmesartan 40/hydrochlorothiazide 12.5) = 125|125
368210|NCT00412932|895996|P1|NOT COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||6
368211|NCT00412932|895996|P1|COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||153
368212|NCT00412932|895996|P1|STARTED|Olm+Hydrochlorothiazide 12.5 mg|161 -2 met blood pressure goal (stayed on olmesartan 40) = 159|159
368213|NCT00412932|895996|P1|NOT COMPLETED|Olmesartan 40 mg||8
368214|NCT00412932|895996|P1|COMPLETED|Olmesartan 40 mg||161
368215|NCT00412932|895996|P1|STARTED|Olmesartan 40 mg|171 -1 met blood pressure goal (stayed on olmesartan 20) -1 who erroneously skipped this step = 169.|169
368216|NCT00412932|895996|P1|NOT COMPLETED|Olmesartan (Olm) 20 mg||7
368217|NCT00412932|895996|P1|COMPLETED|Olmesartan (Olm) 20 mg||171
368218|NCT00412932|895996|P1|STARTED|Olmesartan (Olm) 20 mg||178
368219|NCT00412893|896007|P2|NOT COMPLETED|Overall Study||144
368220|NCT00412893|896008|P1|NOT COMPLETED|Overall Study||145
368221|NCT00412893|896007|P2|COMPLETED|Overall Study|Defined as completed treatment|120
368222|NCT00412893|896008|P1|COMPLETED|Overall Study|Defined as completed treatment|118
368223|NCT00412893|896007|P2|Received Treatment|Overall Study||258
368224|NCT00412893|896008|P1|Received Treatment|Overall Study|One participant randomized to this group received voriconazole treatment for the first 7 days|258
368225|NCT00412893|896007|P2|STARTED|Overall Study||264
368226|NCT00412893|896008|P1|STARTED|Overall Study||263
368227|NCT00412867|896034|P1|NOT COMPLETED|Overall Study||0
368228|NCT00412867|896034|P1|COMPLETED|Overall Study||58
368229|NCT00412867|896034|P1|STARTED|Overall Study||58
368230|NCT00412854|896046|P2|NOT COMPLETED|Overall Study||16
368231|NCT00412854|896047|P1|NOT COMPLETED|Overall Study||14
368232|NCT00412854|896046|P2|COMPLETED|Overall Study||314
368233|NCT00412854|896047|P1|COMPLETED|Overall Study||316
368234|NCT00412854|896046|P2|STARTED|Overall Study||330
368235|NCT00412854|896047|P1|STARTED|Overall Study||330
368236|NCT00412841|896075|P2|NOT COMPLETED|Overall Study||5
368237|NCT00412841|896076|P1|NOT COMPLETED|Overall Study||10
368238|NCT00412841|896075|P2|COMPLETED|Overall Study||16
368239|NCT00412841|896076|P1|COMPLETED|Overall Study||12
368240|NCT00412841|896075|P2|STARTED|Overall Study||21
368241|NCT00412841|896076|P1|STARTED|Overall Study||22
368242|NCT00412750|896091|P3|NOT COMPLETED|Overall Study||23
368243|NCT00412750|896092|P2|NOT COMPLETED|Overall Study||21
368244|NCT00412750|896093|P1|NOT COMPLETED|Overall Study||31
368245|NCT00412750|896091|P3|COMPLETED|Overall Study||31
368246|NCT00412750|896092|P2|COMPLETED|Overall Study||34
368247|NCT00412750|896093|P1|COMPLETED|Overall Study||19
368248|NCT00412750|896091|P3|STARTED|Overall Study||54
368249|NCT00412750|896092|P2|STARTED|Overall Study||55
368250|NCT00412750|896093|P1|STARTED|Overall Study||50
368251|NCT00412737|896118|P2|NOT COMPLETED|Overall Study||6
368252|NCT00412737|896119|P1|NOT COMPLETED|Overall Study||16
368253|NCT00412737|896118|P2|COMPLETED|Overall Study||232
368254|NCT00412737|896119|P1|COMPLETED|Overall Study||221
368255|NCT00412737|896118|P2|STARTED|Overall Study||238
368256|NCT00412737|896119|P1|STARTED|Overall Study||237
368257|NCT00412607|896137|P1|NOT COMPLETED|Overall Study||104
368258|NCT00412607|896137|P1|COMPLETED|Overall Study||145
368259|NCT00412607|896137|P1|Started Study Catheter|Overall Study||233
368260|NCT00412607|896137|P1|STARTED|Overall Study||249
368261|NCT00412542|896150|P2|NOT COMPLETED|Overall Study||3
368262|NCT00412542|896151|P1|NOT COMPLETED|Overall Study||0
368264|NCT00412542|896151|P1|COMPLETED|Overall Study||33
368265|NCT00412542|896150|P2|STARTED|Overall Study||45
368266|NCT00412542|896151|P1|STARTED|Overall Study||33
368267|NCT00412529|896157|P2|NOT COMPLETED|Overall Study||0
368268|NCT00412529|896158|P1|NOT COMPLETED|Overall Study||0
368269|NCT00412529|896157|P2|COMPLETED|Overall Study||21
368270|NCT00412529|896158|P1|COMPLETED|Overall Study||23
368271|NCT00412529|896157|P2|STARTED|Overall Study||21
368272|NCT00412529|896158|P1|STARTED|Overall Study||23
368273|NCT00412516|896181|P3|NOT COMPLETED|Overall Study||0
368274|NCT00412516|896182|P2|NOT COMPLETED|Overall Study||0
368275|NCT00412516|896183|P1|NOT COMPLETED|Overall Study||0
368276|NCT00412516|896181|P3|COMPLETED|Overall Study||214
368277|NCT00412516|896182|P2|COMPLETED|Overall Study||212
368278|NCT00412516|896183|P1|COMPLETED|Overall Study||93
368279|NCT00412516|896181|P3|STARTED|Overall Study||214
368280|NCT00412516|896182|P2|STARTED|Overall Study||212
368281|NCT00412516|896183|P1|STARTED|Overall Study||93
368282|NCT00412464|896200|P1|NOT COMPLETED|Overall Study||0
368283|NCT00412464|896200|P1|COMPLETED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
368284|NCT00412464|896200|P1|STARTED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
368285|NCT00412451|896212|P4|NOT COMPLETED|Overall Study||2
368286|NCT00412451|896213|P3|NOT COMPLETED|Overall Study||1
368287|NCT00412451|896214|P2|NOT COMPLETED|Overall Study||0
368288|NCT00412451|896215|P1|NOT COMPLETED|Overall Study||0
368289|NCT00412451|896212|P4|COMPLETED|Overall Study||11
368290|NCT00412451|896213|P3|COMPLETED|Overall Study||14
368291|NCT00412451|896214|P2|COMPLETED|Overall Study||15
368292|NCT00412451|896215|P1|COMPLETED|Overall Study||8
368293|NCT00412451|896212|P4|STARTED|Overall Study||13
368294|NCT00412451|896213|P3|STARTED|Overall Study||15
368295|NCT00412451|896214|P2|STARTED|Overall Study||15
368296|NCT00412451|896215|P1|STARTED|Overall Study||8
368297|NCT00412425|896227|P2|NOT COMPLETED|Overall Study||0
368298|NCT00412425|896228|P1|NOT COMPLETED|Overall Study||0
368299|NCT00412425|896227|P2|COMPLETED|Overall Study||15
368300|NCT00412425|896228|P1|COMPLETED|Overall Study||15
368301|NCT00412425|896227|P2|STARTED|Overall Study||15
368302|NCT00412425|896228|P1|STARTED|Overall Study||15
368303|NCT00412373|896236|P2|NOT COMPLETED|Overall Study||77
368304|NCT00412373|896237|P1|NOT COMPLETED|Overall Study||41
368305|NCT00412373|896236|P2|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment..|134
368306|NCT00412373|896237|P1|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment.|52
368307|NCT00412373|896236|P2|STARTED|Overall Study|Number of Subjects Intent-to-Treat Analysis Set.|211
368308|NCT00412373|896237|P1|STARTED|Overall Study|Number of Subjects in Intent-to-Treat Analysis Set.|93
368309|NCT00412360|896279|P2|NOT COMPLETED|Overall Study||3
368310|NCT00412360|896280|P1|NOT COMPLETED|Overall Study||1
368311|NCT00412360|896279|P2|COMPLETED|Overall Study||108
368312|NCT00412360|896280|P1|COMPLETED|Overall Study||112
368313|NCT00412360|896279|P2|STARTED|Overall Study||111
368314|NCT00412360|896280|P1|STARTED|Overall Study||113
368315|NCT00412243|896304|P1|NOT COMPLETED|Overall Study||0
368316|NCT00412243|896304|P1|COMPLETED|Overall Study||50
368317|NCT00412243|896304|P1|STARTED|Overall Study||50
368318|NCT00412217|896310|P2|NOT COMPLETED|Overall Study||48
368319|NCT00412217|896311|P1|NOT COMPLETED|Overall Study||46
368320|NCT00412217|896310|P2|COMPLETED|Overall Study||0
368321|NCT00412217|896311|P1|COMPLETED|Overall Study||0
368322|NCT00412217|896310|P2|STARTED|Overall Study||48
368323|NCT00412217|896311|P1|STARTED|Overall Study||46
368324|NCT00412113|896325|P2|NOT COMPLETED|Overall Study||15
368325|NCT00412113|896326|P1|NOT COMPLETED|Overall Study||12
368326|NCT00412113|896325|P2|COMPLETED|Overall Study|15-April-2008|107
368327|NCT00412113|896326|P1|COMPLETED|Overall Study|15-April-2008|111
368328|NCT00412113|896325|P2|Received Treatment|Overall Study||122
368329|NCT00412113|896326|P1|Received Treatment|Overall Study|One subject assigned to Norvasc and TLC did not receive treatment and was excluded from all analyses|122
368330|NCT00412113|896325|P2|STARTED|Overall Study|15-January-2007|122
368331|NCT00412113|896326|P1|STARTED|Overall Study|15-January-2007|123
368332|NCT00412087|896380|P2|NOT COMPLETED|Overall Study||65
368333|NCT00412087|896381|P1|NOT COMPLETED|Overall Study||62
368334|NCT00412087|896380|P2|COMPLETED|Overall Study||66
368335|NCT00412087|896381|P1|COMPLETED|Overall Study||72
368336|NCT00412087|896380|P2|STARTED|Overall Study||131
368337|NCT00412087|896381|P1|STARTED|Overall Study||134
368338|NCT00412074|896392|P3|NOT COMPLETED|Overall Study||67
368339|NCT00412074|896393|P2|NOT COMPLETED|Overall Study||22
368340|NCT00412074|896394|P1|NOT COMPLETED|Overall Study||77
368341|NCT00412074|896392|P3|COMPLETED|Overall Study||128
368342|NCT00412074|896393|P2|COMPLETED|Overall Study||44
368343|NCT00412074|896394|P1|COMPLETED|Overall Study||122
368344|NCT00412074|896392|P3|STARTED|Overall Study||195
368345|NCT00412074|896393|P2|STARTED|Overall Study||66
368346|NCT00412074|896394|P1|STARTED|Overall Study||199
368347|NCT00412061|896410|P2|NOT COMPLETED|Open Label Phase||170
368348|NCT00412061|896411|P1|NOT COMPLETED|Open Label Phase||0
368349|NCT00412061|896410|P2|COMPLETED|Open Label Phase||0
368350|NCT00412061|896411|P1|COMPLETED|Open Label Phase||0
368351|NCT00412061|896410|P2|STARTED|Open Label Phase||170
368352|NCT00412061|896411|P1|STARTED|Open Label Phase||0
368353|NCT00412061|896410|P2|NOT COMPLETED|Double Blind Phase||213
368354|NCT00412061|896411|P1|NOT COMPLETED|Double Blind Phase||216
368355|NCT00412061|896410|P2|COMPLETED|Double Blind Phase||0
368356|NCT00412061|896411|P1|COMPLETED|Double Blind Phase||0
368357|NCT00412061|896410|P2|Safety Set|Double Blind Phase|1 pt randomized never took drug Another randomized did not have valid post BL safety assessment|211
368358|NCT00412061|896411|P1|Safety Set|Double Blind Phase|1 patient did not provide at laest one valid post baseline safety assessment.|215
368359|NCT00412061|896410|P2|STARTED|Double Blind Phase||213
368360|NCT00412061|896411|P1|STARTED|Double Blind Phase||216
368361|NCT00411788|896429|P1|NOT COMPLETED|Overall Study||2
368362|NCT00411788|896429|P1|COMPLETED|Overall Study||9
368363|NCT00411788|896429|P1|STARTED|Overall Study||11
368364|NCT00411762|896438|P1|NOT COMPLETED|Overall Study||5
368365|NCT00411762|896438|P1|COMPLETED|Overall Study||20
368366|NCT00411762|896438|P1|STARTED|Overall Study||25
368367|NCT00411749|896445|P2|NOT COMPLETED|Overall Study||0
368368|NCT00411749|896446|P1|NOT COMPLETED|Overall Study||0
368369|NCT00411749|896445|P2|COMPLETED|Overall Study|Completed at 1 month after vaccination series (Month 7). Subjects were followed until Month 7|25
368370|NCT00411749|896446|P1|COMPLETED|Overall Study|Completed at 24 month after vaccination series (Month 30). Subjects were followed until Month 30|82
368371|NCT00411749|896445|P2|Vaccinated|Overall Study||25
368372|NCT00411749|896446|P1|Vaccinated|Overall Study||82
368373|NCT00411749|896445|P2|STARTED|Overall Study||25
368374|NCT00411749|896446|P1|STARTED|Overall Study||82
368375|NCT00411671|896462|P1|NOT COMPLETED|Overall Study||20
368376|NCT00411671|896462|P1|COMPLETED|Overall Study||85
368377|NCT00411671|896462|P1|STARTED|Overall Study||105
368378|NCT00411645|896470|P2|NOT COMPLETED|Overall Study||164
368379|NCT00411645|896471|P1|NOT COMPLETED|Overall Study||81
368380|NCT00411645|896470|P2|COMPLETED|Overall Study||290
368381|NCT00411645|896471|P1|COMPLETED|Overall Study||146
368382|NCT00411645|896470|P2|STARTED|Overall Study||454
368383|NCT00411645|896471|P1|STARTED|Overall Study||227
368384|NCT00411619|896495|P1|NOT COMPLETED|Overall Study||6
368385|NCT00411619|896495|P1|COMPLETED|Overall Study||22
368386|NCT00411619|896495|P1|STARTED|Overall Study||28
368387|NCT00411554|896502|P2|NOT COMPLETED|Overall Study||9
368388|NCT00411554|896503|P1|NOT COMPLETED|Overall Study||8
368389|NCT00411554|896502|P2|COMPLETED|Overall Study||147
368390|NCT00411554|896503|P1|COMPLETED|Overall Study||155
368391|NCT00411554|896502|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|156
368392|NCT00411554|896503|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|163
368393|NCT00411463|896515|P2|NOT COMPLETED|Overall Study||3
368394|NCT00411463|896516|P1|NOT COMPLETED|Overall Study||3
368395|NCT00411463|896515|P2|COMPLETED|Overall Study||8
368396|NCT00411463|896516|P1|COMPLETED|Overall Study||11
368397|NCT00411463|896515|P2|STARTED|Overall Study||11
368398|NCT00411463|896516|P1|STARTED|Overall Study||14
368399|NCT00411450|896529|P1|NOT COMPLETED|Overall Study||3
368400|NCT00411450|896529|P1|COMPLETED|Overall Study|Ended second-line treatment|113
368401|NCT00411450|896529|P1|Received Treatment|Overall Study||115
368402|NCT00411450|896529|P1|STARTED|Overall Study||116
368403|NCT00411411|896557|P2|NOT COMPLETED|Overall Study||0
368404|NCT00411411|896558|P1|NOT COMPLETED|Overall Study||0
368405|NCT00411411|896557|P2|COMPLETED|Overall Study||25
368406|NCT00411411|896558|P1|COMPLETED|Overall Study||24
368407|NCT00411411|896557|P2|STARTED|Overall Study||25
368408|NCT00411411|896558|P1|STARTED|Overall Study||24
368409|NCT00411398|896566|P1|NOT COMPLETED|Overall Study||5
368410|NCT00411398|896566|P1|COMPLETED|Overall Study||10
368411|NCT00411398|896566|P1|STARTED|Overall Study||15
368412|NCT00411216|896572|P2|NOT COMPLETED|Overall Study||2
368413|NCT00411216|896573|P1|NOT COMPLETED|Overall Study||0
368414|NCT00411216|896572|P2|COMPLETED|Overall Study||8
368415|NCT00411216|896573|P1|COMPLETED|Overall Study||13
368416|NCT00411216|896572|P2|STARTED|Overall Study||10
368417|NCT00411216|896573|P1|STARTED|Overall Study||13
368418|NCT00411151|896579|P1|NOT COMPLETED|Overall Study||47
368419|NCT00411151|896579|P1|COMPLETED|Overall Study||5
368420|NCT00411151|896579|P1|STARTED|Overall Study||52
368421|NCT00411086|896589|P1|NOT COMPLETED|Overall Study||0
368422|NCT00411086|896589|P1|COMPLETED|Overall Study||52
368423|NCT00411086|896589|P1|STARTED|Overall Study||52
368424|NCT00410904|896597|P2|NOT COMPLETED|Overall Study||0
368425|NCT00410904|896598|P1|NOT COMPLETED|Overall Study||0
368426|NCT00410904|896597|P2|COMPLETED|Overall Study||20
368427|NCT00410904|896598|P1|COMPLETED|Overall Study||40
368428|NCT00410904|896597|P2|STARTED|Overall Study||20
368429|NCT00410904|896598|P1|STARTED|Overall Study||40
368430|NCT00410891|896606|P1|NOT COMPLETED|Overall Study||0
368431|NCT00410891|896606|P1|COMPLETED|Overall Study||129
368432|NCT00410891|896606|P1|STARTED|Overall Study||129
368433|NCT00410826|896612|P2|NOT COMPLETED|Overall Study||4
368434|NCT00410826|896613|P1|NOT COMPLETED|Overall Study||9
368435|NCT00410826|896612|P2|COMPLETED|Overall Study||95
368436|NCT00410826|896613|P1|COMPLETED|Overall Study||96
368437|NCT00410826|896612|P2|STARTED|Overall Study||99
368438|NCT00410826|896613|P1|STARTED|Overall Study||105
368439|NCT00410813|896623|P2|NOT COMPLETED|Overall Study||42
368440|NCT00410813|896624|P1|NOT COMPLETED|Overall Study||43
368441|NCT00410813|896623|P2|COMPLETED|Overall Study||0
368442|NCT00410813|896624|P1|COMPLETED|Overall Study|Patients treated until progression.|0
368443|NCT00410813|896623|P2|Eligible|Overall Study||38
368444|NCT00410813|896624|P1|Eligible|Overall Study||41
368445|NCT00410813|896623|P2|STARTED|Overall Study||42
368446|NCT00410813|896624|P1|STARTED|Overall Study||43
368447|NCT00410761|896661|P2|NOT COMPLETED|Overall Study||72
368448|NCT00410761|896662|P1|NOT COMPLETED|Overall Study||120
368449|NCT00410761|896661|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|28
368450|NCT00410761|896662|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|111
368451|NCT00410761|896661|P2|STARTED|Overall Study|randomised patients|100
368452|NCT00410761|896662|P1|STARTED|Overall Study|randomised patients|231
368453|NCT00410605|896682|P1|NOT COMPLETED|Overall Study||25
368454|NCT00410605|896682|P1|COMPLETED|Overall Study||14
368455|NCT00410605|896682|P1|STARTED|Overall Study||39
368456|NCT00410514|896694|P3|NOT COMPLETED|Overall Study||7
368457|NCT00410514|896695|P2|NOT COMPLETED|Overall Study||3
368458|NCT00410514|896696|P1|NOT COMPLETED|Overall Study||2
368459|NCT00410514|896694|P3|COMPLETED|Overall Study||58
368460|NCT00410514|896695|P2|COMPLETED|Overall Study||67
368461|NCT00410514|896696|P1|COMPLETED|Overall Study||63
368462|NCT00410514|896694|P3|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|58
368463|NCT00410514|896695|P2|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|64
368464|NCT00410514|896696|P1|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|63
368465|NCT00410514|896694|P3|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
368466|NCT00410514|896695|P2|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|70
368467|NCT00410514|896696|P1|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
368468|NCT00410514|896694|P3|STARTED|Overall Study||65
368469|NCT00410514|896695|P2|STARTED|Overall Study||70
368470|NCT00410514|896696|P1|STARTED|Overall Study||65
368471|NCT00410488|896757|P2|NOT COMPLETED|Overall Study||0
368472|NCT00410488|896758|P1|NOT COMPLETED|Overall Study||0
368473|NCT00410488|896757|P2|COMPLETED|Overall Study||34
368474|NCT00410488|896758|P1|COMPLETED|Overall Study||16
368475|NCT00410488|896757|P2|STARTED|Overall Study||34
368476|NCT00410488|896758|P1|STARTED|Overall Study||16
368477|NCT00410423|896763|P4|NOT COMPLETED|Phase 2||0
368478|NCT00410423|896764|P3|NOT COMPLETED|Phase 2||0
368479|NCT00410423|896765|P2|NOT COMPLETED|Phase 2||0
368480|NCT00410423|896766|P1|NOT COMPLETED|Phase 2||0
368481|NCT00410423|896763|P4|COMPLETED|Phase 2||44
368482|NCT00410423|896764|P3|COMPLETED|Phase 2||0
368483|NCT00410423|896765|P2|COMPLETED|Phase 2||0
368484|NCT00410423|896766|P1|COMPLETED|Phase 2||0
368485|NCT00410423|896763|P4|STARTED|Phase 2||44
368486|NCT00410423|896764|P3|STARTED|Phase 2||0
368487|NCT00410423|896765|P2|STARTED|Phase 2||0
368488|NCT00410423|896766|P1|STARTED|Phase 2||0
368489|NCT00410423|896763|P4|NOT COMPLETED|Phase 1 - Dose Level 3||0
368490|NCT00410423|896764|P3|NOT COMPLETED|Phase 1 - Dose Level 3||0
368491|NCT00410423|896765|P2|NOT COMPLETED|Phase 1 - Dose Level 3||0
368492|NCT00410423|896766|P1|NOT COMPLETED|Phase 1 - Dose Level 3||0
368493|NCT00410423|896763|P4|COMPLETED|Phase 1 - Dose Level 3||0
368494|NCT00410423|896764|P3|COMPLETED|Phase 1 - Dose Level 3||3
368495|NCT00410423|896765|P2|COMPLETED|Phase 1 - Dose Level 3||0
368496|NCT00410423|896766|P1|COMPLETED|Phase 1 - Dose Level 3||0
368497|NCT00410423|896763|P4|STARTED|Phase 1 - Dose Level 3||0
368498|NCT00410423|896764|P3|STARTED|Phase 1 - Dose Level 3||3
368499|NCT00410423|896765|P2|STARTED|Phase 1 - Dose Level 3||0
368500|NCT00410423|896766|P1|STARTED|Phase 1 - Dose Level 3||0
368501|NCT00410423|896763|P4|NOT COMPLETED|Phase 1 - Dose Level 2||0
368502|NCT00410423|896764|P3|NOT COMPLETED|Phase 1 - Dose Level 2||0
368503|NCT00410423|896765|P2|NOT COMPLETED|Phase 1 - Dose Level 2||0
368504|NCT00410423|896766|P1|NOT COMPLETED|Phase 1 - Dose Level 2||0
368505|NCT00410423|896763|P4|COMPLETED|Phase 1 - Dose Level 2||0
368506|NCT00410423|896764|P3|COMPLETED|Phase 1 - Dose Level 2||0
368507|NCT00410423|896765|P2|COMPLETED|Phase 1 - Dose Level 2||5
368508|NCT00410423|896766|P1|COMPLETED|Phase 1 - Dose Level 2||0
368509|NCT00410423|896763|P4|STARTED|Phase 1 - Dose Level 2||0
368510|NCT00410423|896764|P3|STARTED|Phase 1 - Dose Level 2||0
368511|NCT00410423|896765|P2|STARTED|Phase 1 - Dose Level 2||5
368512|NCT00410423|896766|P1|STARTED|Phase 1 - Dose Level 2||0
368513|NCT00410423|896763|P4|NOT COMPLETED|Phase 1 - Dose Level 1||0
368514|NCT00410423|896764|P3|NOT COMPLETED|Phase 1 - Dose Level 1||0
368515|NCT00410423|896765|P2|NOT COMPLETED|Phase 1 - Dose Level 1||0
368516|NCT00410423|896766|P1|NOT COMPLETED|Phase 1 - Dose Level 1||0
368517|NCT00410423|896763|P4|COMPLETED|Phase 1 - Dose Level 1||0
368518|NCT00410423|896764|P3|COMPLETED|Phase 1 - Dose Level 1||0
368519|NCT00410423|896765|P2|COMPLETED|Phase 1 - Dose Level 1||0
368520|NCT00410423|896766|P1|COMPLETED|Phase 1 - Dose Level 1||3
368521|NCT00410423|896763|P4|STARTED|Phase 1 - Dose Level 1||0
368522|NCT00410423|896764|P3|STARTED|Phase 1 - Dose Level 1||0
368523|NCT00410423|896765|P2|STARTED|Phase 1 - Dose Level 1||0
368524|NCT00410423|896766|P1|STARTED|Phase 1 - Dose Level 1||3
368525|NCT00410410|896779|P9|NOT COMPLETED|Open-Label Period (OL)||349
368526|NCT00410410|896780|P8|NOT COMPLETED|Open-Label Period (OL)||0
368527|NCT00410410|896781|P7|NOT COMPLETED|Open-Label Period (OL)||0
368528|NCT00410410|896782|P6|NOT COMPLETED|Open-Label Period (OL)||0
368529|NCT00410410|896783|P5|NOT COMPLETED|Open-Label Period (OL)||0
368530|NCT00410410|896784|P4|NOT COMPLETED|Open-Label Period (OL)||0
368531|NCT00410410|896785|P3|NOT COMPLETED|Open-Label Period (OL)||0
368532|NCT00410410|896786|P2|NOT COMPLETED|Open-Label Period (OL)||0
368533|NCT00410410|896787|P1|NOT COMPLETED|Open-Label Period (OL)||0
368534|NCT00410410|896779|P9|COMPLETED|Open-Label Period (OL)||0
368535|NCT00410410|896780|P8|COMPLETED|Open-Label Period (OL)||0
368536|NCT00410410|896781|P7|COMPLETED|Open-Label Period (OL)||0
368537|NCT00410410|896782|P6|COMPLETED|Open-Label Period (OL)||0
368538|NCT00410410|896783|P5|COMPLETED|Open-Label Period (OL)||0
368539|NCT00410410|896784|P4|COMPLETED|Open-Label Period (OL)||0
368540|NCT00410410|896785|P3|COMPLETED|Open-Label Period (OL)||0
368541|NCT00410410|896786|P2|COMPLETED|Open-Label Period (OL)||0
368542|NCT00410410|896787|P1|COMPLETED|Open-Label Period (OL)||0
368543|NCT00410410|896779|P9|STARTED|Open-Label Period (OL)|349 entered OL (those who completed IP but failed response criteria, or completed/relapsed on MP).|349
368544|NCT00410410|896780|P8|STARTED|Open-Label Period (OL)||0
368545|NCT00410410|896781|P7|STARTED|Open-Label Period (OL)||0
368546|NCT00410410|896782|P6|STARTED|Open-Label Period (OL)||0
368547|NCT00410410|896783|P5|STARTED|Open-Label Period (OL)||0
368548|NCT00410410|896784|P4|STARTED|Open-Label Period (OL)||0
368549|NCT00410410|896785|P3|STARTED|Open-Label Period (OL)||0
368550|NCT00410410|896786|P2|STARTED|Open-Label Period (OL)||0
368551|NCT00410410|896787|P1|STARTED|Open-Label Period (OL)||0
368552|NCT00410410|896779|P9|NOT COMPLETED|Maintenance Period (MP)||0
368553|NCT00410410|896780|P8|NOT COMPLETED|Maintenance Period (MP)||55
368554|NCT00410410|896781|P7|NOT COMPLETED|Maintenance Period (MP)||50
368555|NCT00410410|896782|P6|NOT COMPLETED|Maintenance Period (MP)||0
368556|NCT00410410|896783|P5|NOT COMPLETED|Maintenance Period (MP)||0
368557|NCT00410410|896784|P4|NOT COMPLETED|Maintenance Period (MP)||0
368558|NCT00410410|896785|P3|NOT COMPLETED|Maintenance Period (MP)||0
368559|NCT00410410|896786|P2|NOT COMPLETED|Maintenance Period (MP)||0
368560|NCT00410410|896787|P1|NOT COMPLETED|Maintenance Period (MP)||0
368561|NCT00410410|896779|P9|COMPLETED|Maintenance Period (MP)||0
368562|NCT00410410|896780|P8|COMPLETED|Maintenance Period (MP)||11
368563|NCT00410410|896781|P7|COMPLETED|Maintenance Period (MP)||15
368564|NCT00410410|896782|P6|COMPLETED|Maintenance Period (MP)||0
368565|NCT00410410|896783|P5|COMPLETED|Maintenance Period (MP)||0
368566|NCT00410410|896784|P4|COMPLETED|Maintenance Period (MP)||0
368567|NCT00410410|896785|P3|COMPLETED|Maintenance Period (MP)||0
368568|NCT00410410|896786|P2|COMPLETED|Maintenance Period (MP)||0
368569|NCT00410410|896787|P1|COMPLETED|Maintenance Period (MP)||0
368570|NCT00410410|896779|P9|STARTED|Maintenance Period (MP)||0
368571|NCT00410410|896780|P8|STARTED|Maintenance Period (MP)|At end of IP, 66 participants met response criteria and were randomly assigned to placebo in MP.|66
368572|NCT00410410|896781|P7|STARTED|Maintenance Period (MP)|At end of IP, 65 participants met response criteria and were randomly assigned to abatacept in MP.|65
368573|NCT00410410|896782|P6|STARTED|Maintenance Period (MP)||0
368574|NCT00410410|896783|P5|STARTED|Maintenance Period (MP)||0
368575|NCT00410410|896784|P4|STARTED|Maintenance Period (MP)||0
368576|NCT00410410|896785|P3|STARTED|Maintenance Period (MP)||0
368577|NCT00410410|896786|P2|STARTED|Maintenance Period (MP)||0
368578|NCT00410410|896787|P1|STARTED|Maintenance Period (MP)||0
368579|NCT00410410|896779|P9|NOT COMPLETED|Induction Period (IP)||0
368580|NCT00410410|896780|P8|NOT COMPLETED|Induction Period (IP)||0
368581|NCT00410410|896781|P7|NOT COMPLETED|Induction Period (IP)||0
368582|NCT00410410|896782|P6|NOT COMPLETED|Induction Period (IP)||29
368583|NCT00410410|896783|P5|NOT COMPLETED|Induction Period (IP)||32
368584|NCT00410410|896784|P4|NOT COMPLETED|Induction Period (IP)||20
368585|NCT00410410|896785|P3|NOT COMPLETED|Induction Period (IP)||17
368586|NCT00410410|896786|P2|NOT COMPLETED|Induction Period (IP)||35
368587|NCT00410410|896787|P1|NOT COMPLETED|Induction Period (IP)||35
368588|NCT00410410|896779|P9|COMPLETED|Induction Period (IP)||0
368589|NCT00410410|896780|P8|COMPLETED|Induction Period (IP)||0
368590|NCT00410410|896781|P7|COMPLETED|Induction Period (IP)||0
368591|NCT00410410|896782|P6|COMPLETED|Induction Period (IP)||21
368592|NCT00410410|896783|P5|COMPLETED|Induction Period (IP)||19
368593|NCT00410410|896784|P4|COMPLETED|Induction Period (IP)||120
368594|NCT00410410|896785|P3|COMPLETED|Induction Period (IP)||53
368595|NCT00410410|896786|P2|COMPLETED|Induction Period (IP)||104
368596|NCT00410410|896787|P1|COMPLETED|Induction Period (IP)||106
368597|NCT00410410|896779|P9|STARTED|Induction Period (IP)||0
368598|NCT00410410|896780|P8|STARTED|Induction Period (IP)||0
368599|NCT00410410|896781|P7|STARTED|Induction Period (IP)||0
368600|NCT00410410|896782|P6|STARTED|Induction Period (IP)||50
368601|NCT00410410|896783|P5|STARTED|Induction Period (IP)||51
368602|NCT00410410|896784|P4|STARTED|Induction Period (IP)||140
368603|NCT00410410|896785|P3|STARTED|Induction Period (IP)||70
368604|NCT00410410|896786|P2|STARTED|Induction Period (IP)||139
368605|NCT00410410|896787|P1|STARTED|Induction Period (IP)||141
368606|NCT00410384|896948|P3|NOT COMPLETED|Overall Study||82
368607|NCT00410384|896949|P2|NOT COMPLETED|Overall Study||72
368608|NCT00410384|896950|P1|NOT COMPLETED|Overall Study||89
368609|NCT00410384|896948|P3|COMPLETED|Overall Study||191
368610|NCT00410384|896949|P2|COMPLETED|Overall Study||199
368611|NCT00410384|896950|P1|COMPLETED|Overall Study||186
368612|NCT00410384|896948|P3|STARTED|Overall Study||273
368613|NCT00410384|896949|P2|STARTED|Overall Study||271
368614|NCT00410384|896950|P1|STARTED|Overall Study||275
368615|NCT00410280|896978|P2|NOT COMPLETED|Overall Study||0
368616|NCT00410280|896979|P1|NOT COMPLETED|Overall Study||0
368617|NCT00410280|896978|P2|COMPLETED|Overall Study||13
368618|NCT00410280|896979|P1|COMPLETED|Overall Study||14
368619|NCT00410280|896978|P2|STARTED|Overall Study||13
368620|NCT00410280|896979|P1|STARTED|Overall Study||14
368621|NCT00410202|897023|P3|NOT COMPLETED|Off-treatment Follow up||12
368622|NCT00410202|897024|P2|NOT COMPLETED|Off-treatment Follow up||8
368623|NCT00410202|897025|P1|NOT COMPLETED|Off-treatment Follow up||14
368624|NCT00410202|897023|P3|COMPLETED|Off-treatment Follow up||2
368625|NCT00410202|897024|P2|COMPLETED|Off-treatment Follow up||0
368626|NCT00410202|897025|P1|COMPLETED|Off-treatment Follow up||1
368627|NCT00410202|897023|P3|STARTED|Off-treatment Follow up||14
368628|NCT00410202|897024|P2|STARTED|Off-treatment Follow up||8
368629|NCT00410202|897025|P1|STARTED|Off-treatment Follow up||15
368630|NCT00410202|897023|P3|NOT COMPLETED|On-Treatment||71
368631|NCT00410202|897024|P2|NOT COMPLETED|On-Treatment||79
368632|NCT00410202|897025|P1|NOT COMPLETED|On-Treatment||75
368633|NCT00410202|897023|P3|COMPLETED|On-Treatment|Completed the 100 week dosing|66
368634|NCT00410202|897024|P2|COMPLETED|On-Treatment|Completed the 100 week dosing|61
368635|NCT00410202|897025|P1|COMPLETED|On-Treatment|Completed the 100 week dosing|63
368636|NCT00410202|897023|P3|Discontinued at or After Week 48 Visit|On-Treatment||3
368637|NCT00410202|897024|P2|Discontinued at or After Week 48 Visit|On-Treatment||6
368638|NCT00410202|897025|P1|Discontinued at or After Week 48 Visit|On-Treatment||2
368639|NCT00410202|897023|P3|Discontinued Prior to Week 48 Visit|On-Treatment||2
368640|NCT00410202|897024|P2|Discontinued Prior to Week 48 Visit|On-Treatment||2
368641|NCT00410202|897025|P1|Discontinued Prior to Week 48 Visit|On-Treatment||4
368642|NCT00410202|897023|P3|STARTED|On-Treatment||137
368643|NCT00410202|897024|P2|STARTED|On-Treatment||140
368644|NCT00410202|897025|P1|STARTED|On-Treatment||138
368645|NCT00410189|897105|P1|NOT COMPLETED|Overall Study||0
368646|NCT00410189|897105|P1|COMPLETED|Overall Study||54
368647|NCT00410189|897105|P1|STARTED|Overall Study||54
368648|NCT00410163|897112|P2|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
368649|NCT00410163|897113|P1|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
368650|NCT00410163|897112|P2|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||11
368651|NCT00410163|897113|P1|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
368652|NCT00410163|897112|P2|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|21
368653|NCT00410163|897113|P1|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|20
368654|NCT00410163|897112|P2|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||11
368655|NCT00410163|897113|P1|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||12
368656|NCT00410163|897112|P2|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
368657|NCT00410163|897113|P1|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
368658|NCT00410163|897112|P2|STARTED|Treatment and Follow-up Phase (2 Years)||30
368659|NCT00410163|897113|P1|STARTED|Treatment and Follow-up Phase (2 Years)||31
368660|NCT00410150|897157|P2|NOT COMPLETED|Overall Study||3
368661|NCT00410150|897158|P1|NOT COMPLETED|Overall Study||2
368662|NCT00410150|897157|P2|COMPLETED|Overall Study|3 study withdrawals (analyzed by intention-to-treat0|17
368663|NCT00410150|897158|P1|COMPLETED|Overall Study|2 study withdrawals (analyzed by intention-to-treat)|20
368664|NCT00410150|897157|P2|STARTED|Overall Study||20
368665|NCT00410150|897158|P1|STARTED|Overall Study||22
368666|NCT00410124|897166|P2|NOT COMPLETED|Extension Phase - Open Label (45 Months)||111
368667|NCT00410124|897167|P1|NOT COMPLETED|Extension Phase - Open Label (45 Months)||67
368668|NCT00410124|897166|P2|COMPLETED|Extension Phase - Open Label (45 Months)||0
368669|NCT00410124|897167|P1|COMPLETED|Extension Phase - Open Label (45 Months)||0
368670|NCT00410124|897166|P2|STARTED|Extension Phase - Open Label (45 Months)|Patients on placebo in core received RAD001 in extension phase.|111
368671|NCT00410124|897167|P1|STARTED|Extension Phase - Open Label (45 Months)||67
368672|NCT00410124|897166|P2|NOT COMPLETED|Core Phase Double Blind (15 Months)||133
368673|NCT00410124|897167|P1|NOT COMPLETED|Core Phase Double Blind (15 Months)||202
368674|NCT00410124|897166|P2|COMPLETED|Core Phase Double Blind (15 Months)|All patients ongoing/completed/not completed in core had option to enter extension taking RAD001.|6
368675|NCT00410124|897167|P1|COMPLETED|Core Phase Double Blind (15 Months)|Patients ongoing/completed double blind phase had option entering extension phase continuing RAD001.|75
368676|NCT00410124|897166|P2|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||2
368677|NCT00410124|897167|P1|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||62
368678|NCT00410124|897166|P2|Ongoing|Core Phase Double Blind (15 Months)||4
368679|NCT00410124|897167|P1|Ongoing|Core Phase Double Blind (15 Months)||13
368680|NCT00410124|897166|P2|STARTED|Core Phase Double Blind (15 Months)||139
368681|NCT00410124|897167|P1|STARTED|Core Phase Double Blind (15 Months)|Started indicates randomized (FAS) and treated|277
368682|NCT00410072|897198|P2|NOT COMPLETED|After Week 48 to Week 96||11
368683|NCT00410072|897199|P1|NOT COMPLETED|After Week 48 to Week 96||6
368684|NCT00410072|897198|P2|COMPLETED|After Week 48 to Week 96||174
368685|NCT00410072|897199|P1|COMPLETED|After Week 48 to Week 96||170
368686|NCT00410072|897198|P2|STARTED|After Week 48 to Week 96||185
368687|NCT00410072|897199|P1|STARTED|After Week 48 to Week 96||176
368688|NCT00410072|897198|P2|NOT COMPLETED|Day 1 to Week 48||12
368689|NCT00410072|897199|P1|NOT COMPLETED|Day 1 to Week 48||6
368690|NCT00410072|897198|P2|COMPLETED|Day 1 to Week 48||185
368691|NCT00410072|897199|P1|COMPLETED|Day 1 to Week 48||176
368692|NCT00410072|897198|P2|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 1 more was randomized but not treated.|197
368693|NCT00410072|897199|P1|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 4 more were randomized but not treated.|182
368694|NCT00410059|897235|P1|NOT COMPLETED|Overall Study||0
368695|NCT00410059|897235|P1|COMPLETED|Overall Study||59
368696|NCT00410059|897235|P1|STARTED|Overall Study||59
368697|NCT00410046|897239|P1|NOT COMPLETED|Overall Study||5
368698|NCT00410046|897239|P1|COMPLETED|Overall Study||79
368699|NCT00410046|897239|P1|STARTED|Overall Study||84
368700|NCT00409838|897270|P2|NOT COMPLETED|Long-term Extension Period||0
368701|NCT00409838|897271|P1|NOT COMPLETED|Long-term Extension Period||18
368702|NCT00409838|897270|P2|COMPLETED|Long-term Extension Period||0
368703|NCT00409838|897271|P1|COMPLETED|Long-term Extension Period||87
368704|NCT00409838|897270|P2|STARTED|Long-term Extension Period||0
368705|NCT00409838|897271|P1|STARTED|Long-term Extension Period||105
368706|NCT00409838|897270|P2|NOT COMPLETED|Short-term Period||5
368707|NCT00409838|897271|P1|NOT COMPLETED|Short-term Period||3
368708|NCT00409838|897270|P2|COMPLETED|Short-term Period|Participants who received placebo in this period received abatacept in next period.|52
368709|NCT00409838|897271|P1|COMPLETED|Short-term Period||53
368710|NCT00409838|897270|P2|Treated (Baseline) Population|Short-term Period||57
368711|NCT00409838|897271|P1|Treated (Baseline) Population|Short-term Period||55
368712|NCT00409838|897270|P2|STARTED|Short-term Period|Randomized|57
368713|NCT00409838|897271|P1|STARTED|Short-term Period|Randomized|56
368714|NCT00409825|897332|P1|NOT COMPLETED|Overall Study||0
368715|NCT00409825|897332|P1|COMPLETED|Overall Study||61
368716|NCT00409825|897332|P1|STARTED|Overall Study||61
368717|NCT00409786|897336|P1|NOT COMPLETED|Overall Study||3
368718|NCT00409786|897336|P1|COMPLETED|Overall Study||47
368719|NCT00409786|897336|P1|STARTED|Overall Study||50
368720|NCT00409773|897345|P5|NOT COMPLETED|Overall Study||10
368721|NCT00409773|897346|P4|NOT COMPLETED|Overall Study||12
368722|NCT00409773|897347|P3|NOT COMPLETED|Overall Study||9
368723|NCT00409773|897348|P2|NOT COMPLETED|Overall Study||7
368724|NCT00409773|897349|P1|NOT COMPLETED|Overall Study||9
368725|NCT00409773|897345|P5|COMPLETED|Overall Study||218
368726|NCT00409773|897346|P4|COMPLETED|Overall Study||216
368727|NCT00409773|897347|P3|COMPLETED|Overall Study||220
368728|NCT00409773|897348|P2|COMPLETED|Overall Study||222
368729|NCT00409773|897349|P1|COMPLETED|Overall Study||220
368730|NCT00409773|897345|P5|STARTED|Overall Study||228
368731|NCT00409773|897346|P4|STARTED|Overall Study||228
368732|NCT00409773|897347|P3|STARTED|Overall Study||229
368733|NCT00409773|897348|P2|STARTED|Overall Study||229
368734|NCT00409773|897349|P1|STARTED|Overall Study||229
368735|NCT00409747|897431|P1|NOT COMPLETED|Overall Study||1
368736|NCT00409747|897431|P1|COMPLETED|Overall Study||10
368737|NCT00409747|897431|P1|STARTED|Overall Study||11
368738|NCT00409708|897438|P2|NOT COMPLETED|Washout||10
368739|NCT00409708|897439|P1|NOT COMPLETED|Washout||21
368740|NCT00409708|897438|P2|COMPLETED|Washout||29
368741|NCT00409708|897439|P1|COMPLETED|Washout||17
368742|NCT00409708|897438|P2|STARTED|Washout||39
368743|NCT00409708|897439|P1|STARTED|Washout||38
368744|NCT00409708|897438|P2|NOT COMPLETED|Treatment||17
368745|NCT00409708|897439|P1|NOT COMPLETED|Treatment||15
368746|NCT00409708|897438|P2|COMPLETED|Treatment||39
368747|NCT00409708|897439|P1|COMPLETED|Treatment||38
368748|NCT00409708|897438|P2|STARTED|Treatment||56
368749|NCT00409708|897439|P1|STARTED|Treatment|A total of 142 participants were screened for the study but only 109 were randomized to treatment|53
368750|NCT00409682|897460|P3|NOT COMPLETED|EOW Double-blind Maintenance Period||27
368751|NCT00409682|897461|P2|NOT COMPLETED|EOW Double-blind Maintenance Period||37
368752|NCT00409682|897462|P1|NOT COMPLETED|EOW Double-blind Maintenance Period||0
368753|NCT00409682|897460|P3|COMPLETED|EOW Double-blind Maintenance Period||66
368754|NCT00409682|897461|P2|COMPLETED|EOW Double-blind Maintenance Period||58
368755|NCT00409682|897462|P1|COMPLETED|EOW Double-blind Maintenance Period||0
368756|NCT00409682|897460|P3|STARTED|EOW Double-blind Maintenance Period||93
368757|NCT00409682|897461|P2|STARTED|EOW Double-blind Maintenance Period||95
368758|NCT00409682|897462|P1|STARTED|EOW Double-blind Maintenance Period||0
368759|NCT00409682|897460|P3|NOT COMPLETED|Open-label Induction Period||0
368760|NCT00409682|897461|P2|NOT COMPLETED|Open-label Induction Period||0
368761|NCT00409682|897462|P1|NOT COMPLETED|Open-label Induction Period||4
368762|NCT00409682|897460|P3|COMPLETED|Open-label Induction Period||0
368763|NCT00409682|897461|P2|COMPLETED|Open-label Induction Period||0
368764|NCT00409682|897462|P1|COMPLETED|Open-label Induction Period||188
368765|NCT00409682|897460|P3|STARTED|Open-label Induction Period||0
368766|NCT00409682|897461|P2|STARTED|Open-label Induction Period||0
368767|NCT00409682|897462|P1|STARTED|Open-label Induction Period||192
368768|NCT00409617|897479|P1|NOT COMPLETED|Overall Study||160
368769|NCT00409617|897479|P1|COMPLETED|Overall Study||785
368770|NCT00409617|897479|P1|STARTED|Overall Study||945
368771|NCT00409578|897495|P4|NOT COMPLETED|Overall Study||67
368772|NCT00409578|897496|P3|NOT COMPLETED|Overall Study||54
368773|NCT00409578|897497|P2|NOT COMPLETED|Overall Study||70
368774|NCT00409578|897498|P1|NOT COMPLETED|Overall Study||52
368775|NCT00409578|897495|P4|COMPLETED|Overall Study||214
368776|NCT00409578|897496|P3|COMPLETED|Overall Study||215
368777|NCT00409578|897497|P2|COMPLETED|Overall Study||201
368778|NCT00409578|897498|P1|COMPLETED|Overall Study||228
368779|NCT00409578|897495|P4|STARTED|Overall Study||281
368780|NCT00409578|897496|P3|STARTED|Overall Study||269
368781|NCT00409578|897497|P2|STARTED|Overall Study||271
368782|NCT00409578|897498|P1|STARTED|Overall Study||280
368783|NCT00409565|897520|P1|NOT COMPLETED|Overall Study||1
368784|NCT00409565|897520|P1|COMPLETED|Overall Study||45
368785|NCT00409565|897520|P1|Overall Response Rate|Overall Study||7
368786|NCT00409565|897520|P1|STARTED|Overall Study||46
368787|NCT00409539|897533|P5|NOT COMPLETED|Overall Study||25
368788|NCT00409539|897534|P4|NOT COMPLETED|Overall Study||12
368789|NCT00409539|897535|P3|NOT COMPLETED|Overall Study||14
368790|NCT00409539|897536|P2|NOT COMPLETED|Overall Study||11
368791|NCT00409539|897537|P1|NOT COMPLETED|Overall Study||11
368792|NCT00409539|897533|P5|COMPLETED|Overall Study||85
368793|NCT00409539|897534|P4|COMPLETED|Overall Study||97
368794|NCT00409539|897535|P3|COMPLETED|Overall Study||95
368795|NCT00409539|897536|P2|COMPLETED|Overall Study||100
368796|NCT00409539|897537|P1|COMPLETED|Overall Study||100
368797|NCT00409539|897533|P5|STARTED|Overall Study||110
368798|NCT00409539|897534|P4|STARTED|Overall Study||109
368799|NCT00409539|897535|P3|STARTED|Overall Study||109
368800|NCT00409539|897536|P2|STARTED|Overall Study||111
368801|NCT00409539|897537|P1|STARTED|Overall Study||111
368802|NCT00409409|897556|P2|NOT COMPLETED|Overall Study||4
368803|NCT00409409|897557|P1|NOT COMPLETED|Overall Study||8
368804|NCT00409409|897556|P2|COMPLETED|Overall Study||135
368805|NCT00409409|897557|P1|COMPLETED|Overall Study||131
368806|NCT00409409|897556|P2|STARTED|Overall Study||139
368807|NCT00409409|897557|P1|STARTED|Overall Study||139
368808|NCT00409344|897565|P2|NOT COMPLETED|Overall Study||0
368809|NCT00409344|897566|P1|NOT COMPLETED|Overall Study||0
368810|NCT00409344|897565|P2|COMPLETED|Overall Study|No participants were enrolled to completion|0
368811|NCT00409344|897566|P1|COMPLETED|Overall Study|No participants were enrolled to completion|0
368812|NCT00409344|897565|P2|STARTED|Overall Study|No participants enrolled|0
368813|NCT00409344|897566|P1|STARTED|Overall Study|No participants enrolled|0
368814|NCT00409331|897584|P1|NOT COMPLETED|Overall Study||1
368815|NCT00409331|897584|P1|COMPLETED|Overall Study||0
368816|NCT00409331|897584|P1|STARTED|Overall Study||1
368817|NCT00409292|897588|P1|NOT COMPLETED|Overall Study||0
368818|NCT00409292|897588|P1|COMPLETED|Overall Study||33
368819|NCT00409292|897588|P1|STARTED|Overall Study||33
368820|NCT00409240|897597|P2|NOT COMPLETED|Overall Study||1
368821|NCT00409240|897598|P1|NOT COMPLETED|Overall Study||3
368822|NCT00409240|897597|P2|COMPLETED|Overall Study||49
368823|NCT00409240|897598|P1|COMPLETED|Overall Study||50
368824|NCT00409240|897597|P2|STARTED|Overall Study||50
368825|NCT00409240|897598|P1|STARTED|Overall Study||53
368826|NCT00409188|897606|P2|NOT COMPLETED|Overall Study||175
368827|NCT00409188|897607|P1|NOT COMPLETED|Overall Study||383
368828|NCT00409188|897606|P2|COMPLETED|Overall Study||332
368829|NCT00409188|897607|P1|COMPLETED|Overall Study||623
368830|NCT00409188|897606|P2|STARTED|Overall Study||507
368831|NCT00409188|897607|P1|STARTED|Overall Study||1006
368832|NCT00409175|897623|P2|NOT COMPLETED|Overall Study||19
368833|NCT00409175|897624|P1|NOT COMPLETED|Overall Study||18
368834|NCT00409175|897623|P2|COMPLETED|Overall Study||44
368835|NCT00409175|897624|P1|COMPLETED|Overall Study||47
368836|NCT00409175|897623|P2|STARTED|Overall Study||63
368837|NCT00409175|897624|P1|STARTED|Overall Study||65
368838|NCT00409006|897650|P2|NOT COMPLETED|Overall Study||12
368839|NCT00409006|897651|P1|NOT COMPLETED|Overall Study||20
368840|NCT00409006|897650|P2|COMPLETED|Overall Study||19
368841|NCT00409006|897651|P1|COMPLETED|Overall Study||19
368842|NCT00409006|897650|P2|STARTED|Overall Study||31
368843|NCT00409006|897651|P1|STARTED|Overall Study||39
368844|NCT00408993|897667|P2|NOT COMPLETED|Overall Study||17
368845|NCT00408993|897668|P1|NOT COMPLETED|Overall Study||19
368846|NCT00408993|897667|P2|COMPLETED|Overall Study||92
368847|NCT00408993|897668|P1|COMPLETED|Overall Study||87
368848|NCT00408993|897667|P2|STARTED|Overall Study||109
368849|NCT00408993|897668|P1|STARTED|Overall Study||106
368850|NCT00408928|897700|P1|NOT COMPLETED|Overall Study||3
368851|NCT00408928|897700|P1|COMPLETED|Overall Study||8
368852|NCT00408928|897700|P1|STARTED|Overall Study||11
368853|NCT00408902|897705|P1|NOT COMPLETED|Overall Study||10
368854|NCT00408902|897705|P1|COMPLETED|Overall Study||0
368855|NCT00408902|897705|P1|STARTED|Overall Study||10
368856|NCT00408876|897715|P4|NOT COMPLETED|Overall Study||35
368857|NCT00408876|897716|P3|NOT COMPLETED|Overall Study||50
368858|NCT00408876|897717|P2|NOT COMPLETED|Overall Study||36
368859|NCT00408876|897718|P1|NOT COMPLETED|Overall Study||16
368860|NCT00408876|897715|P4|COMPLETED|Overall Study||82
368861|NCT00408876|897716|P3|COMPLETED|Overall Study||62
368862|NCT00408876|897717|P2|COMPLETED|Overall Study||80
368863|NCT00408876|897718|P1|COMPLETED|Overall Study||43
368864|NCT00408876|897715|P4|STARTED|Overall Study||117
368865|NCT00408876|897716|P3|STARTED|Overall Study||112
368866|NCT00408876|897717|P2|STARTED|Overall Study||116
368867|NCT00408876|897718|P1|STARTED|Overall Study||59
368868|NCT00408694|897968|P1|NOT COMPLETED|Overall Study||2
368956|NCT00408421|898118|P2|COMPLETED|Treatment Re-Randomization||39
368869|NCT00408694|897968|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
368870|NCT00408694|897968|P1|STARTED|Overall Study||46
368871|NCT00408681|897980|P1|NOT COMPLETED|Overall Study||9
368872|NCT00408681|897980|P1|COMPLETED|Overall Study|Completion was defined as administration of the study product for at least 28 days.|11
368873|NCT00408681|897980|P1|STARTED|Overall Study||20
368874|NCT00408629|897999|P2|NOT COMPLETED|Overall Study||125
368875|NCT00408629|898000|P1|NOT COMPLETED|Overall Study||97
368876|NCT00408629|897999|P2|COMPLETED|Overall Study||135
368877|NCT00408629|898000|P1|COMPLETED|Overall Study|1 ADA recipient did not receive study drug and discontinued due to other reasons.|161
368878|NCT00408629|897999|P2|STARTED|Overall Study|14 PLB recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (246).|260
368879|NCT00408629|898000|P1|STARTED|Overall Study|10 ADA recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (248).|258
368880|NCT00408603|898042|P3|NOT COMPLETED|Overall Study||40
368881|NCT00408603|898043|P2|NOT COMPLETED|Overall Study||2
368882|NCT00408603|898044|P1|NOT COMPLETED|Overall Study||4
368883|NCT00408603|898042|P3|COMPLETED|Overall Study||35
368884|NCT00408603|898043|P2|COMPLETED|Overall Study||37
368885|NCT00408603|898044|P1|COMPLETED|Overall Study||65
368886|NCT00408603|898042|P3|STARTED|Overall Study||75
368887|NCT00408603|898043|P2|STARTED|Overall Study||39
368888|NCT00408603|898044|P1|STARTED|Overall Study||69
368889|NCT00408590|898060|P9|NOT COMPLETED|Overall Study||0
368890|NCT00408590|898061|P8|NOT COMPLETED|Overall Study||0
368891|NCT00408590|898062|P7|NOT COMPLETED|Overall Study||0
368892|NCT00408590|898063|P6|NOT COMPLETED|Overall Study||0
368893|NCT00408590|898064|P5|NOT COMPLETED|Overall Study||0
368894|NCT00408590|898065|P4|NOT COMPLETED|Overall Study||0
368895|NCT00408590|898066|P3|NOT COMPLETED|Overall Study||0
368896|NCT00408590|898067|P2|NOT COMPLETED|Overall Study||0
368897|NCT00408590|898068|P1|NOT COMPLETED|Overall Study||0
368898|NCT00408590|898060|P9|COMPLETED|Overall Study||13
368899|NCT00408590|898061|P8|COMPLETED|Overall Study||3
368900|NCT00408590|898062|P7|COMPLETED|Overall Study||3
368901|NCT00408590|898063|P6|COMPLETED|Overall Study||3
368902|NCT00408590|898064|P5|COMPLETED|Overall Study||3
368903|NCT00408590|898065|P4|COMPLETED|Overall Study||3
368904|NCT00408590|898066|P3|COMPLETED|Overall Study||3
368905|NCT00408590|898067|P2|COMPLETED|Overall Study||3
368906|NCT00408590|898068|P1|COMPLETED|Overall Study||3
368907|NCT00408590|898060|P9|STARTED|Overall Study||13
368908|NCT00408590|898061|P8|STARTED|Overall Study||3
368909|NCT00408590|898062|P7|STARTED|Overall Study||3
368910|NCT00408590|898063|P6|STARTED|Overall Study||3
368911|NCT00408590|898064|P5|STARTED|Overall Study||3
368912|NCT00408590|898065|P4|STARTED|Overall Study||3
368913|NCT00408590|898066|P3|STARTED|Overall Study||3
368914|NCT00408590|898067|P2|STARTED|Overall Study||3
368915|NCT00408590|898068|P1|STARTED|Overall Study||3
368916|NCT00408564|898087|P1|NOT COMPLETED|Overall Study||0
368917|NCT00408564|898087|P1|COMPLETED|Overall Study||39
368918|NCT00408564|898087|P1|STARTED|Overall Study||39
368919|NCT00408499|898096|P5|NOT COMPLETED|Phase II- MTD Expansion||20
368920|NCT00408499|898097|P4|NOT COMPLETED|Phase II- MTD Expansion||0
368921|NCT00408499|898098|P3|NOT COMPLETED|Phase II- MTD Expansion||0
368922|NCT00408499|898099|P2|NOT COMPLETED|Phase II- MTD Expansion||0
368923|NCT00408499|898100|P1|NOT COMPLETED|Phase II- MTD Expansion||0
368924|NCT00408499|898096|P5|COMPLETED|Phase II- MTD Expansion||24
368925|NCT00408499|898097|P4|COMPLETED|Phase II- MTD Expansion||0
368926|NCT00408499|898098|P3|COMPLETED|Phase II- MTD Expansion||0
368927|NCT00408499|898099|P2|COMPLETED|Phase II- MTD Expansion||0
368928|NCT00408499|898100|P1|COMPLETED|Phase II- MTD Expansion||0
368929|NCT00408499|898096|P5|STARTED|Phase II- MTD Expansion||44
368930|NCT00408499|898097|P4|STARTED|Phase II- MTD Expansion||0
368931|NCT00408499|898098|P3|STARTED|Phase II- MTD Expansion||0
368932|NCT00408499|898099|P2|STARTED|Phase II- MTD Expansion||0
368933|NCT00408499|898100|P1|STARTED|Phase II- MTD Expansion||0
368934|NCT00408499|898096|P5|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
368935|NCT00408499|898097|P4|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
368936|NCT00408499|898098|P3|NOT COMPLETED|Phase 1: Dose Levels 1-4||1
368937|NCT00408499|898099|P2|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
368938|NCT00408499|898100|P1|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
368939|NCT00408499|898096|P5|COMPLETED|Phase 1: Dose Levels 1-4||0
368940|NCT00408499|898097|P4|COMPLETED|Phase 1: Dose Levels 1-4||6
368941|NCT00408499|898098|P3|COMPLETED|Phase 1: Dose Levels 1-4||2
368942|NCT00408499|898099|P2|COMPLETED|Phase 1: Dose Levels 1-4||5
368943|NCT00408499|898100|P1|COMPLETED|Phase 1: Dose Levels 1-4||2
368944|NCT00408499|898096|P5|STARTED|Phase 1: Dose Levels 1-4||0
368945|NCT00408499|898097|P4|STARTED|Phase 1: Dose Levels 1-4||6
368946|NCT00408499|898098|P3|STARTED|Phase 1: Dose Levels 1-4||3
368947|NCT00408499|898099|P2|STARTED|Phase 1: Dose Levels 1-4||7
368948|NCT00408499|898100|P1|STARTED|Phase 1: Dose Levels 1-4||4
368949|NCT00408460|898109|P1|NOT COMPLETED|Overall Study||0
368950|NCT00408460|898109|P1|COMPLETED|Overall Study||34
368951|NCT00408460|898109|P1|STARTED|Overall Study||34
368952|NCT00408421|898117|P3|NOT COMPLETED|Treatment Re-Randomization||5
368953|NCT00408421|898118|P2|NOT COMPLETED|Treatment Re-Randomization||7
368954|NCT00408421|898119|P1|NOT COMPLETED|Treatment Re-Randomization||7
368955|NCT00408421|898117|P3|COMPLETED|Treatment Re-Randomization||38
368957|NCT00408421|898119|P1|COMPLETED|Treatment Re-Randomization||96
368958|NCT00408421|898117|P3|STARTED|Treatment Re-Randomization||43
368959|NCT00408421|898118|P2|STARTED|Treatment Re-Randomization||46
368960|NCT00408421|898119|P1|STARTED|Treatment Re-Randomization||103
368961|NCT00408421|898117|P3|NOT COMPLETED|Treatment Initial Randomization||0
368962|NCT00408421|898118|P2|NOT COMPLETED|Treatment Initial Randomization||22
368963|NCT00408421|898119|P1|NOT COMPLETED|Treatment Initial Randomization||17
368964|NCT00408421|898117|P3|COMPLETED|Treatment Initial Randomization|Patients weren't randomized to Duloxetine 120 mg until Visit 4.|0
368965|NCT00408421|898118|P2|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|89
368966|NCT00408421|898119|P1|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|103
368967|NCT00408421|898117|P3|STARTED|Treatment Initial Randomization||0
368968|NCT00408421|898118|P2|STARTED|Treatment Initial Randomization||111
368969|NCT00408421|898119|P1|STARTED|Treatment Initial Randomization||120
368970|NCT00408408|898199|P6|NOT COMPLETED|Overall Study||3
368971|NCT00408408|898200|P5|NOT COMPLETED|Overall Study||5
368972|NCT00408408|898201|P4|NOT COMPLETED|Overall Study||7
368973|NCT00408408|898202|P3|NOT COMPLETED|Overall Study||0
368974|NCT00408408|898203|P2|NOT COMPLETED|Overall Study||3
368975|NCT00408408|898204|P1|NOT COMPLETED|Overall Study||2
368976|NCT00408408|898199|P6|COMPLETED|Overall Study||201
368977|NCT00408408|898200|P5|COMPLETED|Overall Study||192
368978|NCT00408408|898201|P4|COMPLETED|Overall Study||194
368979|NCT00408408|898202|P3|COMPLETED|Overall Study||204
368980|NCT00408408|898203|P2|COMPLETED|Overall Study||196
368981|NCT00408408|898204|P1|COMPLETED|Overall Study||199
368982|NCT00408408|898199|P6|STARTED|Overall Study||204
368983|NCT00408408|898200|P5|STARTED|Overall Study||197
368984|NCT00408408|898201|P4|STARTED|Overall Study||201
368985|NCT00408408|898202|P3|STARTED|Overall Study||204
368986|NCT00408408|898203|P2|STARTED|Overall Study||199
368987|NCT00408408|898204|P1|STARTED|Overall Study||201
368988|NCT00408317|898266|P2|NOT COMPLETED|Second Intervention Period||2
368989|NCT00408317|898267|P1|NOT COMPLETED|Second Intervention Period||2
368990|NCT00408317|898266|P2|COMPLETED|Second Intervention Period||14
368991|NCT00408317|898267|P1|COMPLETED|Second Intervention Period||12
368992|NCT00408317|898266|P2|STARTED|Second Intervention Period||16
368993|NCT00408317|898267|P1|STARTED|Second Intervention Period||14
368994|NCT00408317|898266|P2|NOT COMPLETED|First Intervention Period||1
368995|NCT00408317|898267|P1|NOT COMPLETED|First Intervention Period||0
368996|NCT00408317|898266|P2|COMPLETED|First Intervention Period||16
368997|NCT00408317|898267|P1|COMPLETED|First Intervention Period||14
368998|NCT00408317|898266|P2|STARTED|First Intervention Period||17
368999|NCT00408317|898267|P1|STARTED|First Intervention Period||14
369000|NCT00408200|898281|P2|NOT COMPLETED|Overall Study||0
369001|NCT00408200|898282|P1|NOT COMPLETED|Overall Study||0
369002|NCT00408200|898281|P2|COMPLETED|Overall Study||53
369003|NCT00408200|898282|P1|COMPLETED|Overall Study||57
369004|NCT00408200|898281|P2|STARTED|Overall Study||53
369005|NCT00408200|898282|P1|STARTED|Overall Study||57
369006|NCT00408070|898290|P1|NOT COMPLETED|Overall Study||0
369007|NCT00408070|898290|P1|COMPLETED|Overall Study||5
369008|NCT00408070|898290|P1|STARTED|Overall Study||5
369009|NCT00408005|898300|P8|NOT COMPLETED|Post Induction Therapy by Tx Assignment||14
369010|NCT00408005|898301|P7|NOT COMPLETED|Post Induction Therapy by Tx Assignment||28
369011|NCT00408005|898302|P6|NOT COMPLETED|Post Induction Therapy by Tx Assignment||101
369012|NCT00408005|898303|P5|NOT COMPLETED|Post Induction Therapy by Tx Assignment||132
369013|NCT00408005|898304|P4|NOT COMPLETED|Post Induction Therapy by Tx Assignment||44
369014|NCT00408005|898305|P3|NOT COMPLETED|Post Induction Therapy by Tx Assignment||85
369015|NCT00408005|898306|P2|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
369016|NCT00408005|898307|P1|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
369017|NCT00408005|898300|P8|COMPLETED|Post Induction Therapy by Tx Assignment||48
369018|NCT00408005|898301|P7|COMPLETED|Post Induction Therapy by Tx Assignment||115
369019|NCT00408005|898302|P6|COMPLETED|Post Induction Therapy by Tx Assignment||118
369020|NCT00408005|898303|P5|COMPLETED|Post Induction Therapy by Tx Assignment||319
369021|NCT00408005|898304|P4|COMPLETED|Post Induction Therapy by Tx Assignment||103
369022|NCT00408005|898305|P3|COMPLETED|Post Induction Therapy by Tx Assignment||287
369023|NCT00408005|898306|P2|COMPLETED|Post Induction Therapy by Tx Assignment||0
369024|NCT00408005|898307|P1|COMPLETED|Post Induction Therapy by Tx Assignment||0
369025|NCT00408005|898300|P8|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||2
369026|NCT00408005|898301|P7|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
369027|NCT00408005|898302|P6|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
369028|NCT00408005|898303|P5|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
369029|NCT00408005|898304|P4|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
369030|NCT00408005|898305|P3|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
369031|NCT00408005|898306|P2|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
369032|NCT00408005|898307|P1|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
369033|NCT00408005|898300|P8|T-LLy High Risk|Post Induction Therapy by Tx Assignment||60
369034|NCT00408005|898301|P7|T-LLy High Risk|Post Induction Therapy by Tx Assignment||61
369035|NCT00408005|898302|P6|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
369036|NCT00408005|898303|P5|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
369037|NCT00408005|898304|P4|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
369038|NCT00408005|898305|P3|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
369039|NCT00408005|898306|P2|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
369040|NCT00408005|898307|P1|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
369041|NCT00408005|898300|P8|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
369042|NCT00408005|898301|P7|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||82
369043|NCT00408005|898302|P6|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
369044|NCT00408005|898303|P5|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
369045|NCT00408005|898304|P4|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
369046|NCT00408005|898305|P3|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
369047|NCT00408005|898306|P2|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
369048|NCT00408005|898307|P1|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
369049|NCT00408005|898300|P8|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
369050|NCT00408005|898301|P7|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
369051|NCT00408005|898302|P6|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||43
369052|NCT00408005|898303|P5|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
369053|NCT00408005|898304|P4|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
369054|NCT00408005|898305|P3|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
369055|NCT00408005|898306|P2|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
369056|NCT00408005|898307|P1|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
369057|NCT00408005|898300|P8|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
369058|NCT00408005|898301|P7|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
369059|NCT00408005|898302|P6|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||31
369060|NCT00408005|898303|P5|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||84
369061|NCT00408005|898304|P4|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
369062|NCT00408005|898305|P3|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
369063|NCT00408005|898306|P2|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
369064|NCT00408005|898307|P1|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
369065|NCT00408005|898300|P8|High Risk|Post Induction Therapy by Tx Assignment||0
369066|NCT00408005|898301|P7|High Risk|Post Induction Therapy by Tx Assignment||0
369067|NCT00408005|898302|P6|High Risk|Post Induction Therapy by Tx Assignment||52
369068|NCT00408005|898303|P5|High Risk|Post Induction Therapy by Tx Assignment||55
369069|NCT00408005|898304|P4|High Risk|Post Induction Therapy by Tx Assignment||52
369070|NCT00408005|898305|P3|High Risk|Post Induction Therapy by Tx Assignment||56
369071|NCT00408005|898306|P2|High Risk|Post Induction Therapy by Tx Assignment||0
369072|NCT00408005|898307|P1|High Risk|Post Induction Therapy by Tx Assignment||0
369073|NCT00408005|898300|P8|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
369074|NCT00408005|898301|P7|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
369075|NCT00408005|898302|P6|Intermediate Risk|Post Induction Therapy by Tx Assignment||93
369076|NCT00408005|898303|P5|Intermediate Risk|Post Induction Therapy by Tx Assignment||257
369077|NCT00408005|898304|P4|Intermediate Risk|Post Induction Therapy by Tx Assignment||95
369078|NCT00408005|898305|P3|Intermediate Risk|Post Induction Therapy by Tx Assignment||99
369079|NCT00408005|898306|P2|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
369080|NCT00408005|898307|P1|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
369081|NCT00408005|898300|P8|Low Risk|Post Induction Therapy by Tx Assignment||0
369082|NCT00408005|898301|P7|Low Risk|Post Induction Therapy by Tx Assignment||0
369083|NCT00408005|898302|P6|Low Risk|Post Induction Therapy by Tx Assignment||0
369084|NCT00408005|898303|P5|Low Risk|Post Induction Therapy by Tx Assignment||55
369085|NCT00408005|898304|P4|Low Risk|Post Induction Therapy by Tx Assignment||0
369086|NCT00408005|898305|P3|Low Risk|Post Induction Therapy by Tx Assignment||217
369087|NCT00408005|898306|P2|Low Risk|Post Induction Therapy by Tx Assignment||0
369088|NCT00408005|898307|P1|Low Risk|Post Induction Therapy by Tx Assignment||0
369089|NCT00408005|898300|P8|STARTED|Post Induction Therapy by Tx Assignment||62
369090|NCT00408005|898301|P7|STARTED|Post Induction Therapy by Tx Assignment||143
369091|NCT00408005|898302|P6|STARTED|Post Induction Therapy by Tx Assignment||219
369092|NCT00408005|898303|P5|STARTED|Post Induction Therapy by Tx Assignment||451
369093|NCT00408005|898304|P4|STARTED|Post Induction Therapy by Tx Assignment||147
369094|NCT00408005|898305|P3|STARTED|Post Induction Therapy by Tx Assignment||372
369095|NCT00408005|898306|P2|STARTED|Post Induction Therapy by Tx Assignment||0
369096|NCT00408005|898307|P1|STARTED|Post Induction Therapy by Tx Assignment||0
369097|NCT00408005|898300|P8|NOT COMPLETED|Induction||0
369098|NCT00408005|898301|P7|NOT COMPLETED|Induction||0
369099|NCT00408005|898302|P6|NOT COMPLETED|Induction||0
369100|NCT00408005|898303|P5|NOT COMPLETED|Induction||0
369101|NCT00408005|898304|P4|NOT COMPLETED|Induction||0
369102|NCT00408005|898305|P3|NOT COMPLETED|Induction||0
369103|NCT00408005|898306|P2|NOT COMPLETED|Induction||94
369104|NCT00408005|898307|P1|NOT COMPLETED|Induction||407
369105|NCT00408005|898300|P8|COMPLETED|Induction||0
369106|NCT00408005|898301|P7|COMPLETED|Induction||0
369107|NCT00408005|898302|P6|COMPLETED|Induction||0
369108|NCT00408005|898303|P5|COMPLETED|Induction||0
369109|NCT00408005|898304|P4|COMPLETED|Induction||0
369110|NCT00408005|898305|P3|COMPLETED|Induction||0
369111|NCT00408005|898306|P2|COMPLETED|Induction||205
369112|NCT00408005|898307|P1|COMPLETED|Induction||1189
369113|NCT00408005|898300|P8|STARTED|Induction||0
369114|NCT00408005|898301|P7|STARTED|Induction||0
369115|NCT00408005|898302|P6|STARTED|Induction||0
369116|NCT00408005|898303|P5|STARTED|Induction||0
369117|NCT00408005|898304|P4|STARTED|Induction||0
369118|NCT00408005|898305|P3|STARTED|Induction||0
369119|NCT00408005|898306|P2|STARTED|Induction||299
369120|NCT00408005|898307|P1|STARTED|Induction||1596
369121|NCT00407966|898337|P1|NOT COMPLETED|Overall Study||0
369122|NCT00407966|898337|P1|COMPLETED|Overall Study||45
369123|NCT00407966|898337|P1|CR|Overall Study||30
369124|NCT00407966|898337|P1|STARTED|Overall Study||45
369125|NCT00407888|898341|P1|NOT COMPLETED|Overall Study||0
369126|NCT00407888|898341|P1|COMPLETED|Overall Study||60
369127|NCT00407888|898341|P1|STARTED|Overall Study||60
369128|NCT00407797|898349|P1|NOT COMPLETED|Overall Study||18
369129|NCT00407797|898349|P1|COMPLETED|Overall Study||118
369130|NCT00407797|898349|P1|Full Analysis Set|Overall Study|At least 1 dose of study medication and had a baseline and at least 1 post-baseline measurement.|135
369131|NCT00407797|898349|P1|STARTED|Overall Study||136
369132|NCT00407758|898364|P1|NOT COMPLETED|Overall Study||1
369133|NCT00407758|898364|P1|COMPLETED|Overall Study||27
369134|NCT00407758|898364|P1|STARTED|Overall Study||28
369135|NCT00407745|898377|P2|NOT COMPLETED|Overall Study||17
369136|NCT00407745|898378|P1|NOT COMPLETED|Overall Study||19
369137|NCT00407745|898377|P2|COMPLETED|Overall Study||91
369138|NCT00407745|898378|P1|COMPLETED|Overall Study||93
369139|NCT00407745|898377|P2|Treated|Overall Study||107
369140|NCT00407745|898378|P1|Treated|Overall Study||112
369141|NCT00407745|898377|P2|STARTED|Overall Study||108
369142|NCT00407745|898378|P1|STARTED|Overall Study||112
369143|NCT00407654|898450|P1|NOT COMPLETED|Overall Study||0
369144|NCT00407654|898450|P1|COMPLETED|Overall Study||75
369145|NCT00407654|898450|P1|STARTED|Overall Study||75
369146|NCT00407563|898464|P1|NOT COMPLETED|Overall Study||1
369147|NCT00407563|898464|P1|COMPLETED|Overall Study|One patient remains on study treatment.|47
369148|NCT00407563|898464|P1|STARTED|Overall Study||48
369149|NCT00407550|898474|P2|NOT COMPLETED|Overall Study||4
369150|NCT00407550|898475|P1|NOT COMPLETED|Overall Study||3
369151|NCT00407550|898474|P2|COMPLETED|Overall Study||5
369152|NCT00407550|898475|P1|COMPLETED|Overall Study||7
369153|NCT00407550|898474|P2|STARTED|Overall Study||9
369154|NCT00407550|898475|P1|STARTED|Overall Study||10
369155|NCT00407537|898489|P2|NOT COMPLETED|Overall Study||44
369156|NCT00407537|898490|P1|NOT COMPLETED|Overall Study||93
369157|NCT00407537|898489|P2|COMPLETED|Overall Study||638
369158|NCT00407537|898490|P1|COMPLETED|Overall Study||686
369159|NCT00407537|898489|P2|Eligible for Efficacy Analysis|Overall Study||657
369160|NCT00407537|898490|P1|Eligible for Efficacy Analysis|Overall Study||760
369161|NCT00407537|898489|P2|STARTED|Overall Study|4 participants assigned to Caduet treatment received usual care only during the study|682
369162|NCT00407537|898490|P1|STARTED|Overall Study||779
369163|NCT00407511|898538|P1|NOT COMPLETED|Overall Study||22
369164|NCT00407511|898538|P1|COMPLETED|Overall Study||99
369165|NCT00407511|898538|P1|STARTED|Overall Study||121
369166|NCT00407485|898552|P1|NOT COMPLETED|Overall Study||0
369167|NCT00407485|898552|P1|COMPLETED|Overall Study||22
369168|NCT00407485|898552|P1|STARTED|Overall Study||22
369169|NCT00407420|898559|P2|NOT COMPLETED|Overall Study||6
369170|NCT00407420|898560|P1|NOT COMPLETED|Overall Study||9
369171|NCT00407420|898559|P2|COMPLETED|Overall Study||46
369172|NCT00407420|898560|P1|COMPLETED|Overall Study||45
369173|NCT00407420|898559|P2|STARTED|Overall Study||52
369174|NCT00407420|898560|P1|STARTED|Overall Study||54
369175|NCT00407381|898575|P3|NOT COMPLETED|Overall Study||2
369176|NCT00407381|898576|P2|NOT COMPLETED|Overall Study||4
369177|NCT00407381|898577|P1|NOT COMPLETED|Overall Study||3
369178|NCT00407381|898575|P3|COMPLETED|Overall Study||40
369179|NCT00407381|898576|P2|COMPLETED|Overall Study||38
369180|NCT00407381|898577|P1|COMPLETED|Overall Study||39
369181|NCT00407381|898575|P3|STARTED|Overall Study||42
369182|NCT00407381|898576|P2|STARTED|Overall Study||42
369183|NCT00407381|898577|P1|STARTED|Overall Study||42
369184|NCT00407355|898587|P2|NOT COMPLETED|Overall Study||11
369185|NCT00407355|898588|P1|NOT COMPLETED|Overall Study||10
369186|NCT00407355|898587|P2|COMPLETED|Overall Study||9
369187|NCT00407355|898588|P1|COMPLETED|Overall Study||10
369188|NCT00407355|898587|P2|STARTED|Overall Study||20
369189|NCT00407355|898588|P1|STARTED|Overall Study||20
369190|NCT00407030|898599|P3|NOT COMPLETED|Extension Period - up to 68 Weeks||0
369191|NCT00407030|898600|P2|NOT COMPLETED|Extension Period - up to 68 Weeks||29
369192|NCT00407030|898601|P1|NOT COMPLETED|Extension Period - up to 68 Weeks||27
369193|NCT00407030|898599|P3|COMPLETED|Extension Period - up to 68 Weeks||0
369194|NCT00407030|898600|P2|COMPLETED|Extension Period - up to 68 Weeks||74
369195|NCT00407030|898601|P1|COMPLETED|Extension Period - up to 68 Weeks||84
369196|NCT00407030|898599|P3|STARTED|Extension Period - up to 68 Weeks|After the Main Period all patients were randomly assigned to the 2 active treatment arms.|0
369197|NCT00407030|898600|P2|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|103
369198|NCT00407030|898601|P1|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|111
369199|NCT00407030|898599|P3|NOT COMPLETED|Main Period - 8 to 20 Weeks||6
369200|NCT00407030|898600|P2|NOT COMPLETED|Main Period - 8 to 20 Weeks||3
369201|NCT00407030|898601|P1|NOT COMPLETED|Main Period - 8 to 20 Weeks||5
369202|NCT00407030|898599|P3|COMPLETED|Main Period - 8 to 20 Weeks||68
369203|NCT00407030|898600|P2|COMPLETED|Main Period - 8 to 20 Weeks||75
369204|NCT00407030|898601|P1|COMPLETED|Main Period - 8 to 20 Weeks||76
369205|NCT00407030|898599|P3|STARTED|Main Period - 8 to 20 Weeks||74
369206|NCT00407030|898600|P2|STARTED|Main Period - 8 to 20 Weeks||78
369207|NCT00407030|898601|P1|STARTED|Main Period - 8 to 20 Weeks||81
369208|NCT00406848|898629|P2|NOT COMPLETED|Overall Study||54
369209|NCT00406848|898630|P1|NOT COMPLETED|Overall Study||93
369210|NCT00406848|898629|P2|COMPLETED|Overall Study||67
369211|NCT00406848|898630|P1|COMPLETED|Overall Study||156
369212|NCT00406848|898629|P2|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=95.|121
369213|NCT00406848|898630|P1|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=204.|249
369214|NCT00406783|898694|P2|NOT COMPLETED|Overall Study||15
369215|NCT00406783|898695|P1|NOT COMPLETED|Overall Study||14
369216|NCT00406783|898694|P2|COMPLETED|Overall Study||256
369217|NCT00406783|898695|P1|COMPLETED|Overall Study||262
369218|NCT00406783|898694|P2|STARTED|Overall Study||271
369219|NCT00406783|898695|P1|STARTED|Overall Study||276
369220|NCT00406718|898710|P3|NOT COMPLETED|Overall Study||8
369221|NCT00406718|898711|P2|NOT COMPLETED|Overall Study||14
369222|NCT00406718|898712|P1|NOT COMPLETED|Overall Study||4
369223|NCT00406718|898710|P3|COMPLETED|Overall Study||39
369224|NCT00406718|898711|P2|COMPLETED|Overall Study||34
369225|NCT00406718|898712|P1|COMPLETED|Overall Study||43
369226|NCT00406718|898710|P3|STARTED|Overall Study||47
369227|NCT00406718|898711|P2|STARTED|Overall Study||48
369228|NCT00406718|898712|P1|STARTED|Overall Study||47
369229|NCT00406692|898726|P1|NOT COMPLETED|Overall Study||7
369230|NCT00406692|898726|P1|COMPLETED|Overall Study||9
369231|NCT00406692|898726|P1|STARTED|Overall Study||16
369232|NCT00406653|898736|P7|NOT COMPLETED|Open-Label Period||324
369233|NCT00406653|898737|P6|NOT COMPLETED|Open-Label Period||0
369234|NCT00406653|898738|P5|NOT COMPLETED|Open-Label Period||0
369235|NCT00406653|898739|P4|NOT COMPLETED|Open-Label Period||0
369236|NCT00406653|898740|P3|NOT COMPLETED|Open-Label Period||0
369237|NCT00406653|898741|P2|NOT COMPLETED|Open-Label Period||0
369238|NCT00406653|898742|P1|NOT COMPLETED|Open-Label Period||0
369239|NCT00406653|898736|P7|COMPLETED|Open-Label Period||0
369240|NCT00406653|898737|P6|COMPLETED|Open-Label Period||0
369241|NCT00406653|898738|P5|COMPLETED|Open-Label Period||0
369242|NCT00406653|898739|P4|COMPLETED|Open-Label Period||0
369243|NCT00406653|898740|P3|COMPLETED|Open-Label Period||0
369244|NCT00406653|898741|P2|COMPLETED|Open-Label Period||0
369245|NCT00406653|898742|P1|COMPLETED|Open-Label Period||0
369246|NCT00406653|898736|P7|STARTED|Open-Label Period|All completing IP but failing response criteria and those completing or relapsing on MP entered OL.|324
369247|NCT00406653|898737|P6|STARTED|Open-Label Period||0
369248|NCT00406653|898738|P5|STARTED|Open-Label Period||0
369249|NCT00406653|898739|P4|STARTED|Open-Label Period||0
369250|NCT00406653|898740|P3|STARTED|Open-Label Period||0
369251|NCT00406653|898741|P2|STARTED|Open-Label Period||0
369252|NCT00406653|898742|P1|STARTED|Open-Label Period||0
369253|NCT00406653|898736|P7|NOT COMPLETED|Maintenance Period||0
369254|NCT00406653|898737|P6|NOT COMPLETED|Maintenance Period||36
369255|NCT00406653|898738|P5|NOT COMPLETED|Maintenance Period||30
369256|NCT00406653|898739|P4|NOT COMPLETED|Maintenance Period||0
369257|NCT00406653|898740|P3|NOT COMPLETED|Maintenance Period||0
369258|NCT00406653|898741|P2|NOT COMPLETED|Maintenance Period||0
369259|NCT00406653|898742|P1|NOT COMPLETED|Maintenance Period||0
369260|NCT00406653|898736|P7|COMPLETED|Maintenance Period||0
369261|NCT00406653|898737|P6|COMPLETED|Maintenance Period||10
369262|NCT00406653|898738|P5|COMPLETED|Maintenance Period||14
369263|NCT00406653|898739|P4|COMPLETED|Maintenance Period||0
369264|NCT00406653|898740|P3|COMPLETED|Maintenance Period||0
369265|NCT00406653|898741|P2|COMPLETED|Maintenance Period||0
369266|NCT00406653|898742|P1|COMPLETED|Maintenance Period||0
369267|NCT00406653|898736|P7|STARTED|Maintenance Period||0
369268|NCT00406653|898737|P6|STARTED|Maintenance Period|At end of IP, 46 participants met response criteria and were randomly assigned to placebo in MP.|46
369269|NCT00406653|898738|P5|STARTED|Maintenance Period|At end of IP, 44 participants met response criteria and were randomly assigned to abatacept in MP.|44
369270|NCT00406653|898739|P4|STARTED|Maintenance Period||0
369271|NCT00406653|898740|P3|STARTED|Maintenance Period||0
369272|NCT00406653|898741|P2|STARTED|Maintenance Period||0
369273|NCT00406653|898742|P1|STARTED|Maintenance Period||0
369274|NCT00406653|898736|P7|NOT COMPLETED|Induction Period||0
369275|NCT00406653|898737|P6|NOT COMPLETED|Induction Period||0
369276|NCT00406653|898738|P5|NOT COMPLETED|Induction Period||0
369277|NCT00406653|898739|P4|NOT COMPLETED|Induction Period||26
369278|NCT00406653|898740|P3|NOT COMPLETED|Induction Period||18
369279|NCT00406653|898741|P2|NOT COMPLETED|Induction Period||34
369280|NCT00406653|898742|P1|NOT COMPLETED|Induction Period||15
369281|NCT00406653|898736|P7|COMPLETED|Induction Period||0
369282|NCT00406653|898737|P6|COMPLETED|Induction Period||0
369283|NCT00406653|898738|P5|COMPLETED|Induction Period||0
369284|NCT00406653|898739|P4|COMPLETED|Induction Period||102
369285|NCT00406653|898740|P3|COMPLETED|Induction Period||112
369286|NCT00406653|898741|P2|COMPLETED|Induction Period||94
369287|NCT00406653|898742|P1|COMPLETED|Induction Period||50
369288|NCT00406653|898736|P7|STARTED|Induction Period||0
369289|NCT00406653|898737|P6|STARTED|Induction Period||0
369290|NCT00406653|898738|P5|STARTED|Induction Period||0
369291|NCT00406653|898739|P4|STARTED|Induction Period||128
369292|NCT00406653|898740|P3|STARTED|Induction Period||130
369293|NCT00406653|898741|P2|STARTED|Induction Period||128
369294|NCT00406653|898742|P1|STARTED|Induction Period||65
369295|NCT00406640|898823|P2|NOT COMPLETED|OL Extension Phase for Non-Responders||24
369296|NCT00406640|898824|P1|NOT COMPLETED|OL Extension Phase for Non-Responders||22
369297|NCT00406640|898823|P2|COMPLETED|OL Extension Phase for Non-Responders||36
369298|NCT00406640|898824|P1|COMPLETED|OL Extension Phase for Non-Responders||47
369299|NCT00406640|898823|P2|STARTED|OL Extension Phase for Non-Responders||60
369300|NCT00406640|898824|P1|STARTED|OL Extension Phase for Non-Responders||69
369301|NCT00406640|898823|P2|NOT COMPLETED|DB Continuation Phase for Responders||37
369302|NCT00406640|898824|P1|NOT COMPLETED|DB Continuation Phase for Responders||33
369303|NCT00406640|898823|P2|COMPLETED|DB Continuation Phase for Responders||151
369304|NCT00406640|898824|P1|COMPLETED|DB Continuation Phase for Responders||139
369305|NCT00406640|898823|P2|STARTED|DB Continuation Phase for Responders||188
369306|NCT00406640|898824|P1|STARTED|DB Continuation Phase for Responders||172
369307|NCT00406640|898823|P2|NOT COMPLETED|Acute Phase||43
369308|NCT00406640|898824|P1|NOT COMPLETED|Acute Phase||51
369309|NCT00406640|898823|P2|COMPLETED|Acute Phase||256
369310|NCT00406640|898824|P1|COMPLETED|Acute Phase||245
369311|NCT00406640|898823|P2|STARTED|Acute Phase||299
369312|NCT00406640|898824|P1|STARTED|Acute Phase||296
369313|NCT00406393|898856|P2|NOT COMPLETED|Overall Study||1
369314|NCT00406393|898857|P1|NOT COMPLETED|Overall Study||2
369315|NCT00406393|898856|P2|COMPLETED|Overall Study||152
369316|NCT00406393|898857|P1|COMPLETED|Overall Study||149
369317|NCT00406393|898856|P2|STARTED|Overall Study||153
369318|NCT00406393|898857|P1|STARTED|Overall Study||151
369319|NCT00406367|898887|P2|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
369320|NCT00406367|898888|P1|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||20
369321|NCT00406367|898887|P2|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
369322|NCT00406367|898888|P1|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||82
369323|NCT00406367|898887|P2|STARTED|Open-Label Ext. Period - up to 68 Weeks|In the Open-Label Extension Period no placebo treatment arm was given.|0
369324|NCT00406367|898888|P1|STARTED|Open-Label Ext. Period - up to 68 Weeks||102
369325|NCT00406367|898887|P2|NOT COMPLETED|Main Period - 6 to 20 Weeks||2
369326|NCT00406367|898888|P1|NOT COMPLETED|Main Period - 6 to 20 Weeks||5
369327|NCT00406367|898887|P2|COMPLETED|Main Period - 6 to 20 Weeks||32
369328|NCT00406367|898888|P1|COMPLETED|Main Period - 6 to 20 Weeks||70
369329|NCT00406367|898887|P2|STARTED|Main Period - 6 to 20 Weeks||34
369330|NCT00406367|898888|P1|STARTED|Main Period - 6 to 20 Weeks||75
369331|NCT00406354|898903|P3|NOT COMPLETED|All Randomized and Treated Patients||22
369332|NCT00406354|898904|P2|NOT COMPLETED|All Randomized and Treated Patients||13
369333|NCT00406354|898905|P1|NOT COMPLETED|All Randomized and Treated Patients||16
369334|NCT00406354|898903|P3|COMPLETED|All Randomized and Treated Patients||37
369335|NCT00406354|898904|P2|COMPLETED|All Randomized and Treated Patients||48
369336|NCT00406354|898905|P1|COMPLETED|All Randomized and Treated Patients||44
369337|NCT00406354|898903|P3|STARTED|All Randomized and Treated Patients||59
369338|NCT00406354|898904|P2|STARTED|All Randomized and Treated Patients||61
369339|NCT00406354|898905|P1|STARTED|All Randomized and Treated Patients||60
369340|NCT00406354|898903|P3|NOT COMPLETED|All Randomized Patients||1
369341|NCT00406354|898904|P2|NOT COMPLETED|All Randomized Patients||0
369342|NCT00406354|898905|P1|NOT COMPLETED|All Randomized Patients||0
369343|NCT00406354|898903|P3|COMPLETED|All Randomized Patients|One patient was randomized but never received study treatment.|59
369344|NCT00406354|898904|P2|COMPLETED|All Randomized Patients||61
369345|NCT00406354|898905|P1|COMPLETED|All Randomized Patients||60
369346|NCT00406354|898903|P3|STARTED|All Randomized Patients||60
369347|NCT00406354|898904|P2|STARTED|All Randomized Patients||61
369348|NCT00406354|898905|P1|STARTED|All Randomized Patients||60
369349|NCT00406315|898976|P1|NOT COMPLETED|Overall Study||141
369350|NCT00406315|898976|P1|COMPLETED|Overall Study||100
369351|NCT00406315|898976|P1|STARTED|Overall Study|Started = Treated|241
369352|NCT00406276|898994|P1|NOT COMPLETED|Overall Study||4
369353|NCT00406276|898994|P1|COMPLETED|Overall Study||24
369354|NCT00406276|898994|P1|STARTED|Overall Study||28
369355|NCT00406133|899003|P4|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
369356|NCT00406133|899004|P3|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
369357|NCT00406133|899005|P2|NOT COMPLETED|Phase 2 (Second 26 Week Period)||3
369358|NCT00406133|899006|P1|NOT COMPLETED|Phase 2 (Second 26 Week Period)||2
369359|NCT00406133|899003|P4|COMPLETED|Phase 2 (Second 26 Week Period)||60
369360|NCT00406133|899004|P3|COMPLETED|Phase 2 (Second 26 Week Period)||67
369361|NCT00406133|899005|P2|COMPLETED|Phase 2 (Second 26 Week Period)||152
369362|NCT00406133|899006|P1|COMPLETED|Phase 2 (Second 26 Week Period)||157
369363|NCT00406133|899003|P4|STARTED|Phase 2 (Second 26 Week Period)||60
369364|NCT00406133|899004|P3|STARTED|Phase 2 (Second 26 Week Period)||67
369365|NCT00406133|899005|P2|STARTED|Phase 2 (Second 26 Week Period)||155
369366|NCT00406133|899006|P1|STARTED|Phase 2 (Second 26 Week Period)|3 subjects completed phase 1 but elected not to go into phase 2.|159
369367|NCT00406133|899003|P4|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
369457|NCT00405756|899247|P2|Safety Population|Double-blind Treatment||152
369368|NCT00406133|899004|P3|NOT COMPLETED|Phase 1 (First 26 Week Period)||0
369369|NCT00406133|899005|P2|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
369370|NCT00406133|899006|P1|NOT COMPLETED|Phase 1 (First 26 Week Period)||3
369371|NCT00406133|899003|P4|COMPLETED|Phase 1 (First 26 Week Period)||60
369372|NCT00406133|899004|P3|COMPLETED|Phase 1 (First 26 Week Period)||67
369373|NCT00406133|899005|P2|COMPLETED|Phase 1 (First 26 Week Period)||155
369374|NCT00406133|899006|P1|COMPLETED|Phase 1 (First 26 Week Period)||162
369375|NCT00406133|899003|P4|STARTED|Phase 1 (First 26 Week Period)||62
369376|NCT00406133|899004|P3|STARTED|Phase 1 (First 26 Week Period)||67
369377|NCT00406133|899005|P2|STARTED|Phase 1 (First 26 Week Period)||157
369378|NCT00406133|899006|P1|STARTED|Phase 1 (First 26 Week Period)||165
369379|NCT00406107|899070|P2|NOT COMPLETED|Overall Study||1
369380|NCT00406107|899071|P1|NOT COMPLETED|Overall Study||1
369381|NCT00406107|899070|P2|COMPLETED|Overall Study||4
369382|NCT00406107|899071|P1|COMPLETED|Overall Study||14
369383|NCT00406107|899070|P2|STARTED|Overall Study||5
369384|NCT00406107|899071|P1|STARTED|Overall Study||15
369385|NCT00406029|899086|P5|NOT COMPLETED|Overall Study||8
369386|NCT00406029|899087|P4|NOT COMPLETED|Overall Study||17
369387|NCT00406029|899088|P3|NOT COMPLETED|Overall Study||10
369388|NCT00406029|899089|P2|NOT COMPLETED|Overall Study||8
369389|NCT00406029|899090|P1|NOT COMPLETED|Overall Study||16
369390|NCT00406029|899086|P5|COMPLETED|Overall Study||41
369391|NCT00406029|899087|P4|COMPLETED|Overall Study||40
369392|NCT00406029|899088|P3|COMPLETED|Overall Study||39
369393|NCT00406029|899089|P2|COMPLETED|Overall Study||41
369394|NCT00406029|899090|P1|COMPLETED|Overall Study||33
369395|NCT00406029|899086|P5|Treated|Overall Study||47
369396|NCT00406029|899087|P4|Treated|Overall Study||54
369397|NCT00406029|899088|P3|Treated|Overall Study||47
369398|NCT00406029|899089|P2|Treated|Overall Study||49
369399|NCT00406029|899090|P1|Treated|Overall Study||49
369400|NCT00406029|899086|P5|STARTED|Overall Study||49
369401|NCT00406029|899087|P4|STARTED|Overall Study||57
369402|NCT00406029|899088|P3|STARTED|Overall Study||49
369403|NCT00406029|899089|P2|STARTED|Overall Study||49
369404|NCT00406029|899090|P1|STARTED|Overall Study||49
369405|NCT00405964|899194|P2|NOT COMPLETED|Overall Study||95
369406|NCT00405964|899195|P1|NOT COMPLETED|Overall Study||59
369407|NCT00405964|899194|P2|COMPLETED|Overall Study||261
369408|NCT00405964|899195|P1|COMPLETED|Overall Study||301
369409|NCT00405964|899194|P2|STARTED|Overall Study||356
369410|NCT00405964|899195|P1|STARTED|Overall Study||360
369411|NCT00405938|899207|P2|NOT COMPLETED|Overall Study||0
369412|NCT00405938|899208|P1|NOT COMPLETED|Overall Study||0
369413|NCT00405938|899207|P2|COMPLETED|Overall Study||41
369414|NCT00405938|899208|P1|COMPLETED|Overall Study||38
369415|NCT00405938|899207|P2|STARTED|Overall Study||41
369416|NCT00405938|899208|P1|STARTED|Overall Study||38
369417|NCT00405912|899217|P3|NOT COMPLETED|Overall Study||16
369418|NCT00405912|899218|P2|NOT COMPLETED|Overall Study||19
369419|NCT00405912|899219|P1|NOT COMPLETED|Overall Study||16
369420|NCT00405912|899217|P3|COMPLETED|Overall Study||23
369421|NCT00405912|899218|P2|COMPLETED|Overall Study||21
369422|NCT00405912|899219|P1|COMPLETED|Overall Study||23
369423|NCT00405912|899217|P3|STARTED|Overall Study||39
369424|NCT00405912|899218|P2|STARTED|Overall Study||40
369425|NCT00405912|899219|P1|STARTED|Overall Study||39
369426|NCT00405821|899232|P2|NOT COMPLETED|Overall Study||22
369427|NCT00405821|899233|P1|NOT COMPLETED|Overall Study||22
369428|NCT00405821|899232|P2|COMPLETED|Overall Study||198
369429|NCT00405821|899233|P1|COMPLETED|Overall Study||198
369430|NCT00405821|899232|P2|STARTED|Overall Study||220
369431|NCT00405821|899233|P1|STARTED|Overall Study||220
369432|NCT00405756|899246|P3|NOT COMPLETED|Follow-up||88
369433|NCT00405756|899247|P2|NOT COMPLETED|Follow-up||90
369434|NCT00405756|899248|P1|NOT COMPLETED|Follow-up||75
369435|NCT00405756|899246|P3|COMPLETED|Follow-up||0
369436|NCT00405756|899247|P2|COMPLETED|Follow-up||0
369437|NCT00405756|899248|P1|COMPLETED|Follow-up||0
369438|NCT00405756|899246|P3|STARTED|Follow-up|52 participants from the Double-blind and 36 from the Open Label Extension|88
369439|NCT00405756|899247|P2|STARTED|Follow-up|65 participants from the Double-blind and 25 from the Open Label Extension|90
369440|NCT00405756|899248|P1|STARTED|Follow-up|66 participants from Double-blind and 9 from the Open Label Extension|75
369441|NCT00405756|899246|P3|NOT COMPLETED|Open-label Extension||72
369442|NCT00405756|899247|P2|NOT COMPLETED|Open-label Extension||47
369443|NCT00405756|899248|P1|NOT COMPLETED|Open-label Extension||19
369444|NCT00405756|899246|P3|COMPLETED|Open-label Extension||0
369445|NCT00405756|899247|P2|COMPLETED|Open-label Extension||0
369446|NCT00405756|899248|P1|COMPLETED|Open-label Extension|Participants continue until disease progression or other reason for discontinuing.|0
369447|NCT00405756|899246|P3|STARTED|Open-label Extension||72
369448|NCT00405756|899247|P2|STARTED|Open-label Extension||47
369449|NCT00405756|899248|P1|STARTED|Open-label Extension||19
369450|NCT00405756|899246|P3|NOT COMPLETED|Double-blind Treatment||154
369451|NCT00405756|899247|P2|NOT COMPLETED|Double-blind Treatment||153
369452|NCT00405756|899248|P1|NOT COMPLETED|Double-blind Treatment||152
369453|NCT00405756|899246|P3|COMPLETED|Double-blind Treatment||0
369454|NCT00405756|899247|P2|COMPLETED|Double-blind Treatment||0
369455|NCT00405756|899248|P1|COMPLETED|Double-blind Treatment|Double-blind Treatment Period had no defined completion.|0
369456|NCT00405756|899246|P3|Safety Population|Double-blind Treatment||153
369458|NCT00405756|899248|P1|Safety Population|Double-blind Treatment|Participants who took at least one dose of study drug.|150
369459|NCT00405756|899246|P3|STARTED|Double-blind Treatment||154
369460|NCT00405756|899247|P2|STARTED|Double-blind Treatment||153
369461|NCT00405756|899248|P1|STARTED|Double-blind Treatment|Intent to treat population of all randomized participants|152
369462|NCT00405704|899338|P2|NOT COMPLETED|Overall Study||46
369463|NCT00405704|899339|P1|NOT COMPLETED|Overall Study||41
369464|NCT00405704|899338|P2|COMPLETED|Overall Study||259
369465|NCT00405704|899339|P1|COMPLETED|Overall Study||261
369466|NCT00405704|899338|P2|Recurrent UTI With TMP-SMZ Panel|Overall Study||69
369467|NCT00405704|899339|P1|Recurrent UTI With TMP-SMZ Panel|Overall Study||38
369468|NCT00405704|899338|P2|Recurrent UTI With E. Coli|Overall Study||57
369469|NCT00405704|899339|P1|Recurrent UTI With E. Coli|Overall Study||30
369470|NCT00405704|899338|P2|Outcome Stool Assessed|Overall Study||210
369471|NCT00405704|899339|P1|Outcome Stool Assessed|Overall Study||203
369472|NCT00405704|899338|P2|Completed Assessments for New Scarring|Overall Study||227
369473|NCT00405704|899339|P1|Completed Assessments for New Scarring|Overall Study||220
369474|NCT00405704|899338|P2|Completed Outcome Renal Scan|Overall Study||235
369475|NCT00405704|899339|P1|Completed Outcome Renal Scan|Overall Study||227
369476|NCT00405704|899338|P2|STARTED|Overall Study||305
369477|NCT00405704|899339|P1|STARTED|Overall Study||302
369478|NCT00405652|899359|P1|NOT COMPLETED|Overall Study||4
369479|NCT00405652|899359|P1|COMPLETED|Overall Study||30
369480|NCT00405652|899359|P1|STARTED|Overall Study||34
369481|NCT00405639|899366|P2|NOT COMPLETED|Overall Study||0
369482|NCT00405639|899367|P1|NOT COMPLETED|Overall Study||3
369483|NCT00405639|899366|P2|COMPLETED|Overall Study||12
369484|NCT00405639|899367|P1|COMPLETED|Overall Study||22
369485|NCT00405639|899366|P2|STARTED|Overall Study||12
369486|NCT00405639|899367|P1|STARTED|Overall Study||25
369487|NCT00405587|899383|P4|NOT COMPLETED|Overall Study||20
369488|NCT00405587|899384|P3|NOT COMPLETED|Overall Study||22
369489|NCT00405587|899385|P2|NOT COMPLETED|Overall Study||28
369490|NCT00405587|899386|P1|NOT COMPLETED|Overall Study||26
369491|NCT00405587|899383|P4|COMPLETED|Overall Study||1
369492|NCT00405587|899384|P3|COMPLETED|Overall Study||10
369493|NCT00405587|899385|P2|COMPLETED|Overall Study||2
369494|NCT00405587|899386|P1|COMPLETED|Overall Study||0
369495|NCT00405587|899383|P4|STARTED|Overall Study||21
369496|NCT00405587|899384|P3|STARTED|Overall Study||32
369497|NCT00405587|899385|P2|STARTED|Overall Study||30
369498|NCT00405587|899386|P1|STARTED|Overall Study||26
369499|NCT00405548|899504|P2|NOT COMPLETED|Overall Study||1
369500|NCT00405548|899505|P1|NOT COMPLETED|Overall Study||4
369501|NCT00405548|899504|P2|COMPLETED|Overall Study||12
369502|NCT00405548|899505|P1|COMPLETED|Overall Study||24
369503|NCT00405548|899504|P2|STARTED|Overall Study||13
369504|NCT00405548|899505|P1|STARTED|Overall Study||28
369505|NCT00405522|899519|P2|NOT COMPLETED|Overall Study||0
369506|NCT00405522|899520|P1|NOT COMPLETED|Overall Study||0
369507|NCT00405522|899519|P2|COMPLETED|Overall Study||17
369508|NCT00405522|899520|P1|COMPLETED|Overall Study||17
369509|NCT00405522|899519|P2|STARTED|Overall Study||17
369510|NCT00405522|899520|P1|STARTED|Overall Study||17
369511|NCT00405509|899532|P2|NOT COMPLETED|Overall Study||0
369512|NCT00405509|899533|P1|NOT COMPLETED|Overall Study||0
369513|NCT00405509|899532|P2|COMPLETED|Overall Study||22
369514|NCT00405509|899533|P1|COMPLETED|Overall Study||11
369515|NCT00405509|899532|P2|STARTED|Overall Study||22
369516|NCT00405509|899533|P1|STARTED|Overall Study||11
369517|NCT00405392|899549|P2|NOT COMPLETED|Overall Study||27
369518|NCT00405392|899550|P1|NOT COMPLETED|Overall Study||30
369519|NCT00405392|899549|P2|COMPLETED|Overall Study||155
369520|NCT00405392|899550|P1|COMPLETED|Overall Study||153
369521|NCT00405392|899549|P2|STARTED|Overall Study||182
369522|NCT00405392|899550|P1|STARTED|Overall Study||183
369523|NCT00405353|899560|P1|NOT COMPLETED|Overall Study||0
369524|NCT00405353|899560|P1|COMPLETED|Overall Study||10
369525|NCT00405353|899560|P1|STARTED|Overall Study||10
369526|NCT00405288|899566|P2|NOT COMPLETED|Overall Study||0
369527|NCT00405288|899567|P1|NOT COMPLETED|Overall Study||0
369528|NCT00405288|899566|P2|COMPLETED|Overall Study||204
369529|NCT00405288|899567|P1|COMPLETED|Overall Study||204
369530|NCT00405288|899566|P2|STARTED|Overall Study||204
369531|NCT00405288|899567|P1|STARTED|Overall Study||204
369532|NCT00405275|899597|P2|NOT COMPLETED|Overall Study||19
369533|NCT00405275|899598|P1|NOT COMPLETED|Overall Study||23
369534|NCT00405275|899597|P2|COMPLETED|Overall Study||156
369535|NCT00405275|899598|P1|COMPLETED|Overall Study||155
369536|NCT00405275|899597|P2|24 Week (Switch)|Overall Study||44
369537|NCT00405275|899598|P1|24 Week (Switch)|Overall Study||44
369538|NCT00405275|899597|P2|24 Week (no Switch)|Overall Study||121
369539|NCT00405275|899598|P1|24 Week (no Switch)|Overall Study||119
369540|NCT00405275|899597|P2|24 Weeks (Total)|Overall Study||165
369541|NCT00405275|899598|P1|24 Weeks (Total)|Overall Study||163
369542|NCT00405275|899597|P2|STARTED|Overall Study||175
369543|NCT00405275|899598|P1|STARTED|Overall Study||178
369544|NCT00405067|899607|P3|NOT COMPLETED|Overall Study||5
369545|NCT00405067|899608|P2|NOT COMPLETED|Overall Study||9
369546|NCT00405067|899609|P1|NOT COMPLETED|Overall Study||4
369547|NCT00405067|899607|P3|COMPLETED|Overall Study||24
369548|NCT00405067|899608|P2|COMPLETED|Overall Study||19
369549|NCT00405067|899609|P1|COMPLETED|Overall Study||24
369550|NCT00405067|899607|P3|STARTED|Overall Study||29
369551|NCT00405067|899608|P2|STARTED|Overall Study||28
369552|NCT00405067|899609|P1|STARTED|Overall Study||28
369553|NCT00404924|899646|P2|NOT COMPLETED|Overall Study||306
369554|NCT00404924|899647|P1|NOT COMPLETED|Overall Study||603
369555|NCT00404924|899646|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|1
369556|NCT00404924|899647|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
369557|NCT00404924|899646|P2|STARTED|Overall Study|randomised patients|307
369558|NCT00404924|899647|P1|STARTED|Overall Study|randomised patients|617
369559|NCT00404820|899665|P2|NOT COMPLETED|Overall Study||24
369560|NCT00404820|899666|P1|NOT COMPLETED|Overall Study||19
369561|NCT00404820|899665|P2|COMPLETED|Overall Study||172
369562|NCT00404820|899666|P1|COMPLETED|Overall Study||389
369563|NCT00404820|899665|P2|Started Treatment|Overall Study|The reason why 2 patients did not start treatment is unavailable.|194
369564|NCT00404820|899666|P1|Started Treatment|Overall Study||408
369565|NCT00404820|899665|P2|STARTED|Overall Study||196
369566|NCT00404820|899666|P1|STARTED|Overall Study||408
369567|NCT00404768|899688|P4|NOT COMPLETED|Part C||14
369568|NCT00404768|899689|P3|NOT COMPLETED|Part C||8
369569|NCT00404768|899690|P2|NOT COMPLETED|Part C||0
369570|NCT00404768|899691|P1|NOT COMPLETED|Part C||0
369571|NCT00404768|899688|P4|COMPLETED|Part C||20
369572|NCT00404768|899689|P3|COMPLETED|Part C||22
369573|NCT00404768|899690|P2|COMPLETED|Part C||0
369574|NCT00404768|899691|P1|COMPLETED|Part C||0
369575|NCT00404768|899688|P4|STARTED|Part C||34
369576|NCT00404768|899689|P3|STARTED|Part C||30
369577|NCT00404768|899690|P2|STARTED|Part C||0
369578|NCT00404768|899691|P1|STARTED|Part C||0
369579|NCT00404768|899688|P4|NOT COMPLETED|Part A and B||0
369580|NCT00404768|899689|P3|NOT COMPLETED|Part A and B||0
369581|NCT00404768|899690|P2|NOT COMPLETED|Part A and B||1
369582|NCT00404768|899691|P1|NOT COMPLETED|Part A and B||1
369583|NCT00404768|899688|P4|COMPLETED|Part A and B||0
369584|NCT00404768|899689|P3|COMPLETED|Part A and B||0
369585|NCT00404768|899690|P2|COMPLETED|Part A and B||8
369586|NCT00404768|899691|P1|COMPLETED|Part A and B||19
369587|NCT00404768|899688|P4|STARTED|Part A and B||0
369588|NCT00404768|899689|P3|STARTED|Part A and B||0
369589|NCT00404768|899690|P2|STARTED|Part A and B||9
369590|NCT00404768|899691|P1|STARTED|Part A and B||20
369591|NCT00404755|899752|P1|NOT COMPLETED|Phase III (Imipramine)||0
369592|NCT00404755|899752|P1|COMPLETED|Phase III (Imipramine)||3
369593|NCT00404755|899752|P1|STARTED|Phase III (Imipramine)||3
369594|NCT00404755|899752|P1|NOT COMPLETED|Phase II (Escitalopram)||2
369595|NCT00404755|899752|P1|COMPLETED|Phase II (Escitalopram)||9
369596|NCT00404755|899752|P1|STARTED|Phase II (Escitalopram)||11
369597|NCT00404755|899752|P1|NOT COMPLETED|Phase I (Bupropion)||4
369598|NCT00404755|899752|P1|COMPLETED|Phase I (Bupropion)||13
369599|NCT00404755|899752|P1|STARTED|Phase I (Bupropion)|3 went directly into Phase II (intolerant of bupropion), 1 withdrew consent and 4 did not return|17
369600|NCT00404651|899767|P4|NOT COMPLETED|Overall Study||21
369601|NCT00404651|899768|P3|NOT COMPLETED|Overall Study||45
369602|NCT00404651|899769|P2|NOT COMPLETED|Overall Study||28
369603|NCT00404651|899770|P1|NOT COMPLETED|Overall Study||39
369604|NCT00404651|899767|P4|COMPLETED|Overall Study||146
369605|NCT00404651|899768|P3|COMPLETED|Overall Study||294
369606|NCT00404651|899769|P2|COMPLETED|Overall Study||315
369607|NCT00404651|899770|P1|COMPLETED|Overall Study||301
369608|NCT00404651|899767|P4|STARTED|Overall Study||167
369609|NCT00404651|899768|P3|STARTED|Overall Study||339
369610|NCT00404651|899769|P2|STARTED|Overall Study||343
369611|NCT00404651|899770|P1|STARTED|Overall Study||340
369612|NCT00404547|899798|P2|NOT COMPLETED|Overall Study||25
369613|NCT00404547|899799|P1|NOT COMPLETED|Overall Study||90
369614|NCT00404547|899798|P2|COMPLETED|Overall Study||334
369615|NCT00404547|899799|P1|COMPLETED|Overall Study||672
369616|NCT00404547|899798|P2|STARTED|Overall Study||359
369617|NCT00404547|899799|P1|STARTED|Overall Study||762
369618|NCT00404495|899809|P2|NOT COMPLETED|Overall Study||11
369619|NCT00404495|899810|P1|NOT COMPLETED|Overall Study||44
369620|NCT00404495|899809|P2|COMPLETED|Overall Study||6
369621|NCT00404495|899810|P1|COMPLETED|Overall Study||22
369622|NCT00404495|899809|P2|STARTED|Overall Study||17
369623|NCT00404495|899810|P1|STARTED|Overall Study||66
369624|NCT00404352|899829|P9|NOT COMPLETED|Open Label Extension (up to 36 Months)||2
369625|NCT00404352|899830|P8|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
369626|NCT00404352|899831|P7|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
369627|NCT00404352|899832|P6|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
369628|NCT00404352|899833|P5|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
369629|NCT00404352|899834|P4|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
369630|NCT00404352|899835|P3|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
369631|NCT00404352|899836|P2|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
369632|NCT00404352|899837|P1|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
369633|NCT00404352|899829|P9|COMPLETED|Open Label Extension (up to 36 Months)||9
369634|NCT00404352|899830|P8|COMPLETED|Open Label Extension (up to 36 Months)||4
369635|NCT00404352|899831|P7|COMPLETED|Open Label Extension (up to 36 Months)||3
369636|NCT00404352|899832|P6|COMPLETED|Open Label Extension (up to 36 Months)||0
369637|NCT00404352|899833|P5|COMPLETED|Open Label Extension (up to 36 Months)||0
369638|NCT00404352|899834|P4|COMPLETED|Open Label Extension (up to 36 Months)||0
369639|NCT00404352|899835|P3|COMPLETED|Open Label Extension (up to 36 Months)||0
369640|NCT00404352|899836|P2|COMPLETED|Open Label Extension (up to 36 Months)||0
369641|NCT00404352|899837|P1|COMPLETED|Open Label Extension (up to 36 Months)||0
369642|NCT00404352|899829|P9|STARTED|Open Label Extension (up to 36 Months)|11 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|11
369643|NCT00404352|899830|P8|STARTED|Open Label Extension (up to 36 Months)|5 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|5
369644|NCT00404352|899831|P7|STARTED|Open Label Extension (up to 36 Months)|4 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|4
369645|NCT00404352|899832|P6|STARTED|Open Label Extension (up to 36 Months)||0
369646|NCT00404352|899833|P5|STARTED|Open Label Extension (up to 36 Months)||0
369647|NCT00404352|899834|P4|STARTED|Open Label Extension (up to 36 Months)||0
369648|NCT00404352|899835|P3|STARTED|Open Label Extension (up to 36 Months)||0
369649|NCT00404352|899836|P2|STARTED|Open Label Extension (up to 36 Months)||0
369650|NCT00404352|899837|P1|STARTED|Open Label Extension (up to 36 Months)||0
369651|NCT00404352|899829|P9|NOT COMPLETED|Open Label (up to 24 Month)||0
369652|NCT00404352|899830|P8|NOT COMPLETED|Open Label (up to 24 Month)||0
369653|NCT00404352|899831|P7|NOT COMPLETED|Open Label (up to 24 Month)||0
369654|NCT00404352|899832|P6|NOT COMPLETED|Open Label (up to 24 Month)||7
369655|NCT00404352|899833|P5|NOT COMPLETED|Open Label (up to 24 Month)||2
369656|NCT00404352|899834|P4|NOT COMPLETED|Open Label (up to 24 Month)||3
369657|NCT00404352|899835|P3|NOT COMPLETED|Open Label (up to 24 Month)||0
369658|NCT00404352|899836|P2|NOT COMPLETED|Open Label (up to 24 Month)||0
369659|NCT00404352|899837|P1|NOT COMPLETED|Open Label (up to 24 Month)||0
369660|NCT00404352|899829|P9|COMPLETED|Open Label (up to 24 Month)||0
369661|NCT00404352|899830|P8|COMPLETED|Open Label (up to 24 Month)||0
369662|NCT00404352|899831|P7|COMPLETED|Open Label (up to 24 Month)||0
369663|NCT00404352|899832|P6|COMPLETED|Open Label (up to 24 Month)||52
369664|NCT00404352|899833|P5|COMPLETED|Open Label (up to 24 Month)||28
369665|NCT00404352|899834|P4|COMPLETED|Open Label (up to 24 Month)||28
369666|NCT00404352|899835|P3|COMPLETED|Open Label (up to 24 Month)||0
369667|NCT00404352|899836|P2|COMPLETED|Open Label (up to 24 Month)||0
369668|NCT00404352|899837|P1|COMPLETED|Open Label (up to 24 Month)||0
369669|NCT00404352|899829|P9|STARTED|Open Label (up to 24 Month)||0
369670|NCT00404352|899830|P8|STARTED|Open Label (up to 24 Month)||0
369671|NCT00404352|899831|P7|STARTED|Open Label (up to 24 Month)||0
369672|NCT00404352|899832|P6|STARTED|Open Label (up to 24 Month)|From DB period, 59 participants converted to CDMS and switched to OL period in this study|59
369673|NCT00404352|899833|P5|STARTED|Open Label (up to 24 Month)|From DB period, 30 participants converted to CDMS and switched to OL period in this study|30
369674|NCT00404352|899834|P4|STARTED|Open Label (up to 24 Month)|From DB period, 31 participants converted to CDMS and switched to OL period in this study|31
369675|NCT00404352|899835|P3|STARTED|Open Label (up to 24 Month)||0
369676|NCT00404352|899836|P2|STARTED|Open Label (up to 24 Month)||0
369677|NCT00404352|899837|P1|STARTED|Open Label (up to 24 Month)||0
369678|NCT00404352|899829|P9|NOT COMPLETED|Double Blind (up to 24 Month)||0
369679|NCT00404352|899830|P8|NOT COMPLETED|Double Blind (up to 24 Month)||0
369680|NCT00404352|899831|P7|NOT COMPLETED|Double Blind (up to 24 Month)||0
369681|NCT00404352|899832|P6|NOT COMPLETED|Double Blind (up to 24 Month)||0
369682|NCT00404352|899833|P5|NOT COMPLETED|Double Blind (up to 24 Month)||0
369683|NCT00404352|899834|P4|NOT COMPLETED|Double Blind (up to 24 Month)||0
369684|NCT00404352|899835|P3|NOT COMPLETED|Double Blind (up to 24 Month)||79
369685|NCT00404352|899836|P2|NOT COMPLETED|Double Blind (up to 24 Month)||47
369686|NCT00404352|899837|P1|NOT COMPLETED|Double Blind (up to 24 Month)||52
369687|NCT00404352|899829|P9|COMPLETED|Double Blind (up to 24 Month)||0
369688|NCT00404352|899830|P8|COMPLETED|Double Blind (up to 24 Month)||0
369689|NCT00404352|899831|P7|COMPLETED|Double Blind (up to 24 Month)||0
369690|NCT00404352|899832|P6|COMPLETED|Double Blind (up to 24 Month)||0
369691|NCT00404352|899833|P5|COMPLETED|Double Blind (up to 24 Month)||0
369692|NCT00404352|899834|P4|COMPLETED|Double Blind (up to 24 Month)||0
369693|NCT00404352|899835|P3|COMPLETED|Double Blind (up to 24 Month)||92
369694|NCT00404352|899836|P2|COMPLETED|Double Blind (up to 24 Month)||128
369695|NCT00404352|899837|P1|COMPLETED|Double Blind (up to 24 Month)||119
369696|NCT00404352|899829|P9|Treated|Double Blind (up to 24 Month)||0
369697|NCT00404352|899830|P8|Treated|Double Blind (up to 24 Month)||0
369698|NCT00404352|899831|P7|Treated|Double Blind (up to 24 Month)||0
369699|NCT00404352|899832|P6|Treated|Double Blind (up to 24 Month)||0
369700|NCT00404352|899833|P5|Treated|Double Blind (up to 24 Month)||0
369701|NCT00404352|899834|P4|Treated|Double Blind (up to 24 Month)||0
369702|NCT00404352|899835|P3|Treated|Double Blind (up to 24 Month)||171
369703|NCT00404352|899836|P2|Treated|Double Blind (up to 24 Month)||173
369704|NCT00404352|899837|P1|Treated|Double Blind (up to 24 Month)||171
369705|NCT00404352|899829|P9|STARTED|Double Blind (up to 24 Month)||0
369706|NCT00404352|899830|P8|STARTED|Double Blind (up to 24 Month)||0
369707|NCT00404352|899831|P7|STARTED|Double Blind (up to 24 Month)||0
369708|NCT00404352|899832|P6|STARTED|Double Blind (up to 24 Month)||0
369709|NCT00404352|899833|P5|STARTED|Double Blind (up to 24 Month)||0
369710|NCT00404352|899834|P4|STARTED|Double Blind (up to 24 Month)||0
369711|NCT00404352|899835|P3|STARTED|Double Blind (up to 24 Month)||171
369712|NCT00404352|899836|P2|STARTED|Double Blind (up to 24 Month)||175
369713|NCT00404352|899837|P1|STARTED|Double Blind (up to 24 Month)||171
369714|NCT00404248|899872|P9|NOT COMPLETED|Overall Study||0
369715|NCT00404248|899873|P8|NOT COMPLETED|Overall Study||0
369716|NCT00404248|899874|P7|NOT COMPLETED|Overall Study||0
369717|NCT00404248|899875|P6|NOT COMPLETED|Overall Study||0
369718|NCT00404248|899876|P5|NOT COMPLETED|Overall Study||0
369719|NCT00404248|899877|P4|NOT COMPLETED|Overall Study||0
369720|NCT00404248|899878|P3|NOT COMPLETED|Overall Study||0
369721|NCT00404248|899879|P2|NOT COMPLETED|Overall Study||1
369722|NCT00404248|899880|P1|NOT COMPLETED|Overall Study||0
369723|NCT00404248|899872|P9|COMPLETED|Overall Study||3
369724|NCT00404248|899873|P8|COMPLETED|Overall Study||6
369725|NCT00404248|899874|P7|COMPLETED|Overall Study||6
369726|NCT00404248|899875|P6|COMPLETED|Overall Study||3
369727|NCT00404248|899876|P5|COMPLETED|Overall Study||3
369728|NCT00404248|899877|P4|COMPLETED|Overall Study||2
369729|NCT00404248|899878|P3|COMPLETED|Overall Study||5
369730|NCT00404248|899879|P2|COMPLETED|Overall Study||3
369731|NCT00404248|899880|P1|COMPLETED|Overall Study||3
369732|NCT00404248|899872|P9|STARTED|Overall Study||3
369733|NCT00404248|899873|P8|STARTED|Overall Study||6
369734|NCT00404248|899874|P7|STARTED|Overall Study||6
369735|NCT00404248|899875|P6|STARTED|Overall Study||3
369736|NCT00404248|899876|P5|STARTED|Overall Study||3
369737|NCT00404248|899877|P4|STARTED|Overall Study||2
369738|NCT00404248|899878|P3|STARTED|Overall Study||5
369739|NCT00404248|899879|P2|STARTED|Overall Study||4
369740|NCT00404248|899880|P1|STARTED|Overall Study||3
369741|NCT00404235|899913|P2|NOT COMPLETED|Overall Study||2
369742|NCT00404235|899914|P1|NOT COMPLETED|Overall Study||1
369743|NCT00404235|899913|P2|COMPLETED|Overall Study||39
369744|NCT00404235|899914|P1|COMPLETED|Overall Study||34
369745|NCT00404235|899913|P2|STARTED|Overall Study||41
369746|NCT00404235|899914|P1|STARTED|Overall Study||35
369747|NCT00404092|899932|P4|NOT COMPLETED|Overall Study||0
369748|NCT00404092|899933|P3|NOT COMPLETED|Overall Study||1
369749|NCT00404092|899934|P2|NOT COMPLETED|Overall Study||0
369750|NCT00404092|899935|P1|NOT COMPLETED|Overall Study||1
369751|NCT00404092|899932|P4|COMPLETED|Overall Study||20
369752|NCT00404092|899933|P3|COMPLETED|Overall Study||8
369753|NCT00404092|899934|P2|COMPLETED|Overall Study||8
369754|NCT00404092|899935|P1|COMPLETED|Overall Study||8
369755|NCT00404092|899932|P4|STARTED|Overall Study||20
369756|NCT00404092|899933|P3|STARTED|Overall Study||9
369757|NCT00404092|899934|P2|STARTED|Overall Study||8
369758|NCT00404092|899935|P1|STARTED|Overall Study||9
369759|NCT00404079|899951|P2|NOT COMPLETED|Overall Study||20
369760|NCT00404079|899952|P1|NOT COMPLETED|Overall Study||22
369761|NCT00404079|899951|P2|COMPLETED|Overall Study||105
369762|NCT00404079|899952|P1|COMPLETED|Overall Study||103
369763|NCT00404079|899951|P2|STARTED|Overall Study||125
369764|NCT00404079|899952|P1|STARTED|Overall Study||125
369765|NCT00404066|899958|P1|NOT COMPLETED|Overall Study||3
369766|NCT00404066|899958|P1|COMPLETED|Overall Study||18
369767|NCT00404066|899958|P1|STARTED|Overall Study|1 subject started but withdrew after adriamycin+cytoxan, but before study drugs lapatinib+docetaxel.|21
369768|NCT00403845|899963|P4|NOT COMPLETED|Treatment Period 4||0
369769|NCT00403845|899964|P3|NOT COMPLETED|Treatment Period 4||0
369770|NCT00403845|899965|P2|NOT COMPLETED|Treatment Period 4||0
369771|NCT00403845|899966|P1|NOT COMPLETED|Treatment Period 4||0
369772|NCT00403845|899963|P4|COMPLETED|Treatment Period 4||11
369773|NCT00403845|899964|P3|COMPLETED|Treatment Period 4||11
369774|NCT00403845|899965|P2|COMPLETED|Treatment Period 4||13
369775|NCT00403845|899966|P1|COMPLETED|Treatment Period 4||10
369776|NCT00403845|899963|P4|STARTED|Treatment Period 4||11
369777|NCT00403845|899964|P3|STARTED|Treatment Period 4||11
369778|NCT00403845|899965|P2|STARTED|Treatment Period 4||13
369779|NCT00403845|899966|P1|STARTED|Treatment Period 4||10
369780|NCT00403845|899963|P4|NOT COMPLETED|Treatment Period 3||2
369781|NCT00403845|899964|P3|NOT COMPLETED|Treatment Period 3||0
369782|NCT00403845|899965|P2|NOT COMPLETED|Treatment Period 3||0
369783|NCT00403845|899966|P1|NOT COMPLETED|Treatment Period 3||0
369784|NCT00403845|899963|P4|COMPLETED|Treatment Period 3||11
369785|NCT00403845|899964|P3|COMPLETED|Treatment Period 3||11
369786|NCT00403845|899965|P2|COMPLETED|Treatment Period 3||13
369787|NCT00403845|899966|P1|COMPLETED|Treatment Period 3||10
369788|NCT00403845|899963|P4|STARTED|Treatment Period 3||13
369789|NCT00403845|899964|P3|STARTED|Treatment Period 3||11
369790|NCT00403845|899965|P2|STARTED|Treatment Period 3||13
369791|NCT00403845|899966|P1|STARTED|Treatment Period 3||10
369792|NCT00403845|899963|P4|NOT COMPLETED|Treatment Period 2||0
369793|NCT00403845|899964|P3|NOT COMPLETED|Treatment Period 2||0
369794|NCT00403845|899965|P2|NOT COMPLETED|Treatment Period 2||0
369795|NCT00403845|899966|P1|NOT COMPLETED|Treatment Period 2||1
369796|NCT00403845|899963|P4|COMPLETED|Treatment Period 2||13
369797|NCT00403845|899964|P3|COMPLETED|Treatment Period 2||11
369798|NCT00403845|899965|P2|COMPLETED|Treatment Period 2||13
369799|NCT00403845|899966|P1|COMPLETED|Treatment Period 2||10
369800|NCT00403845|899963|P4|STARTED|Treatment Period 2||13
369801|NCT00403845|899964|P3|STARTED|Treatment Period 2||11
369802|NCT00403845|899965|P2|STARTED|Treatment Period 2||13
369803|NCT00403845|899966|P1|STARTED|Treatment Period 2||11
369804|NCT00403845|899963|P4|NOT COMPLETED|Treatment Period 1||1
369805|NCT00403845|899964|P3|NOT COMPLETED|Treatment Period 1||0
369806|NCT00403845|899965|P2|NOT COMPLETED|Treatment Period 1||0
369807|NCT00403845|899966|P1|NOT COMPLETED|Treatment Period 1||1
369808|NCT00403845|899963|P4|COMPLETED|Treatment Period 1||13
369809|NCT00403845|899964|P3|COMPLETED|Treatment Period 1||11
369810|NCT00403845|899965|P2|COMPLETED|Treatment Period 1||13
369811|NCT00403845|899966|P1|COMPLETED|Treatment Period 1||11
369812|NCT00403845|899963|P4|STARTED|Treatment Period 1||14
369813|NCT00403845|899964|P3|STARTED|Treatment Period 1||11
369814|NCT00403845|899965|P2|STARTED|Treatment Period 1||13
369815|NCT00403845|899966|P1|STARTED|Treatment Period 1||12
369816|NCT00403767|899990|P2|NOT COMPLETED|Overall Study||2468
369817|NCT00403767|899991|P1|NOT COMPLETED|Overall Study||2520
369818|NCT00403767|899990|P2|COMPLETED|Overall Study||4657
369819|NCT00403767|899991|P1|COMPLETED|Overall Study||4591
369820|NCT00403767|899990|P2|STARTED|Overall Study||7125
369821|NCT00403767|899991|P1|STARTED|Overall Study||7111
369822|NCT00403754|900015|P4|NOT COMPLETED|Open Label: Salmeterol||0
369823|NCT00403754|900016|P3|NOT COMPLETED|Open Label: Salmeterol||0
369824|NCT00403754|900017|P2|NOT COMPLETED|Open Label: Salmeterol||0
369825|NCT00403754|900018|P1|NOT COMPLETED|Open Label: Salmeterol||0
369826|NCT00403754|900015|P4|COMPLETED|Open Label: Salmeterol||11
369827|NCT00403754|900016|P3|COMPLETED|Open Label: Salmeterol||8
369828|NCT00403754|900017|P2|COMPLETED|Open Label: Salmeterol||9
369829|NCT00403754|900018|P1|COMPLETED|Open Label: Salmeterol||11
369830|NCT00403754|900015|P4|STARTED|Open Label: Salmeterol||11
369831|NCT00403754|900016|P3|STARTED|Open Label: Salmeterol||8
369832|NCT00403754|900017|P2|STARTED|Open Label: Salmeterol||9
369833|NCT00403754|900018|P1|STARTED|Open Label: Salmeterol||11
369834|NCT00403754|900015|P4|NOT COMPLETED|Core Treatment Period 4||0
369835|NCT00403754|900016|P3|NOT COMPLETED|Core Treatment Period 4||0
369836|NCT00403754|900017|P2|NOT COMPLETED|Core Treatment Period 4||0
369837|NCT00403754|900018|P1|NOT COMPLETED|Core Treatment Period 4||0
369838|NCT00403754|900015|P4|COMPLETED|Core Treatment Period 4||11
369839|NCT00403754|900016|P3|COMPLETED|Core Treatment Period 4||8
369840|NCT00403754|900017|P2|COMPLETED|Core Treatment Period 4||9
369841|NCT00403754|900018|P1|COMPLETED|Core Treatment Period 4||11
369842|NCT00403754|900015|P4|STARTED|Core Treatment Period 4||11
369843|NCT00403754|900016|P3|STARTED|Core Treatment Period 4||8
369844|NCT00403754|900017|P2|STARTED|Core Treatment Period 4||9
369845|NCT00403754|900018|P1|STARTED|Core Treatment Period 4||11
369846|NCT00403754|900015|P4|NOT COMPLETED|Core Treatment Period 3||0
369847|NCT00403754|900016|P3|NOT COMPLETED|Core Treatment Period 3||0
369848|NCT00403754|900017|P2|NOT COMPLETED|Core Treatment Period 3||0
369849|NCT00403754|900018|P1|NOT COMPLETED|Core Treatment Period 3||0
369850|NCT00403754|900015|P4|COMPLETED|Core Treatment Period 3||11
369851|NCT00403754|900016|P3|COMPLETED|Core Treatment Period 3||8
369852|NCT00403754|900017|P2|COMPLETED|Core Treatment Period 3||9
369853|NCT00403754|900018|P1|COMPLETED|Core Treatment Period 3||11
369854|NCT00403754|900015|P4|STARTED|Core Treatment Period 3||11
369855|NCT00403754|900016|P3|STARTED|Core Treatment Period 3||8
369856|NCT00403754|900017|P2|STARTED|Core Treatment Period 3||9
369857|NCT00403754|900018|P1|STARTED|Core Treatment Period 3||11
369858|NCT00403754|900015|P4|NOT COMPLETED|Core Treatment Period 2||0
369859|NCT00403754|900016|P3|NOT COMPLETED|Core Treatment Period 2||1
369860|NCT00403754|900017|P2|NOT COMPLETED|Core Treatment Period 2||0
369861|NCT00403754|900018|P1|NOT COMPLETED|Core Treatment Period 2||0
369862|NCT00403754|900015|P4|COMPLETED|Core Treatment Period 2||11
369863|NCT00403754|900016|P3|COMPLETED|Core Treatment Period 2||8
369864|NCT00403754|900017|P2|COMPLETED|Core Treatment Period 2||9
369865|NCT00403754|900018|P1|COMPLETED|Core Treatment Period 2||11
369866|NCT00403754|900015|P4|STARTED|Core Treatment Period 2||11
369867|NCT00403754|900016|P3|STARTED|Core Treatment Period 2||9
369868|NCT00403754|900017|P2|STARTED|Core Treatment Period 2||9
369869|NCT00403754|900018|P1|STARTED|Core Treatment Period 2||11
369870|NCT00403754|900015|P4|NOT COMPLETED|Core Treatment Period 1||0
369871|NCT00403754|900016|P3|NOT COMPLETED|Core Treatment Period 1||0
369872|NCT00403754|900017|P2|NOT COMPLETED|Core Treatment Period 1||1
369873|NCT00403754|900018|P1|NOT COMPLETED|Core Treatment Period 1||0
369874|NCT00403754|900015|P4|COMPLETED|Core Treatment Period 1||11
369875|NCT00403754|900016|P3|COMPLETED|Core Treatment Period 1||9
369876|NCT00403754|900017|P2|COMPLETED|Core Treatment Period 1||9
369877|NCT00403754|900018|P1|COMPLETED|Core Treatment Period 1||11
369878|NCT00403754|900015|P4|STARTED|Core Treatment Period 1||11
369879|NCT00403754|900016|P3|STARTED|Core Treatment Period 1||9
369880|NCT00403754|900017|P2|STARTED|Core Treatment Period 1||10
369881|NCT00403754|900018|P1|STARTED|Core Treatment Period 1||11
369882|NCT00403585|900045|P1|NOT COMPLETED|Open-Label Phase; Extension Study||6
369883|NCT00403585|900045|P1|COMPLETED|Open-Label Phase; Extension Study||74
369884|NCT00403585|900045|P1|STARTED|Open-Label Phase; Extension Study|80 of 102 participants completing Study 103814 enrolled in extension (22 didn't continue medication)|80
369885|NCT00403585|900045|P1|NOT COMPLETED|Initial Treatment Phase||2
369886|NCT00403585|900045|P1|COMPLETED|Initial Treatment Phase||102
369887|NCT00403585|900045|P1|STARTED|Initial Treatment Phase||104
369888|NCT00403546|900056|P3|NOT COMPLETED|Randomized Trial||16
369889|NCT00403546|900057|P2|NOT COMPLETED|Randomized Trial||17
369890|NCT00403546|900058|P1|NOT COMPLETED|Randomized Trial||0
369891|NCT00403546|900056|P3|COMPLETED|Randomized Trial||21
369892|NCT00403546|900057|P2|COMPLETED|Randomized Trial||21
369893|NCT00403546|900058|P1|COMPLETED|Randomized Trial||0
369894|NCT00403546|900056|P3|STARTED|Randomized Trial||37
369895|NCT00403546|900057|P2|STARTED|Randomized Trial||38
369896|NCT00403546|900058|P1|STARTED|Randomized Trial|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|0
369897|NCT00403546|900056|P3|NOT COMPLETED|Screening Phase||0
369898|NCT00403546|900057|P2|NOT COMPLETED|Screening Phase||0
369899|NCT00403546|900058|P1|NOT COMPLETED|Screening Phase||28
369900|NCT00403546|900056|P3|COMPLETED|Screening Phase||0
369901|NCT00403546|900057|P2|COMPLETED|Screening Phase||0
369902|NCT00403546|900058|P1|COMPLETED|Screening Phase|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|75
369903|NCT00403546|900056|P3|STARTED|Screening Phase||0
369904|NCT00403546|900057|P2|STARTED|Screening Phase||0
369905|NCT00403546|900058|P1|STARTED|Screening Phase||103
369906|NCT00403546|900056|P3|NOT COMPLETED|Signed Informed Consent/Open-Label||0
369907|NCT00403546|900057|P2|NOT COMPLETED|Signed Informed Consent/Open-Label||0
369908|NCT00403546|900058|P1|NOT COMPLETED|Signed Informed Consent/Open-Label||28
369909|NCT00403546|900056|P3|COMPLETED|Signed Informed Consent/Open-Label||0
369910|NCT00403546|900057|P2|COMPLETED|Signed Informed Consent/Open-Label||0
369911|NCT00403546|900058|P1|COMPLETED|Signed Informed Consent/Open-Label||103
369912|NCT00403546|900056|P3|STARTED|Signed Informed Consent/Open-Label||0
369913|NCT00403546|900057|P2|STARTED|Signed Informed Consent/Open-Label||0
369914|NCT00403546|900058|P1|STARTED|Signed Informed Consent/Open-Label||131
369915|NCT00403481|900098|P1|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||2
369916|NCT00403481|900098|P1|COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||142
369917|NCT00403481|900098|P1|STARTED|Olm 40 mg + Hydrochlorothiazide 25 mg|168 -24 met their blood pressure goal (remained on olmesartan 40 mg/hydrochlorothiazide 12.5mg)= 144|144
369918|NCT00403481|900098|P1|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||5
369919|NCT00403481|900098|P1|COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||168
369920|NCT00403481|900098|P1|STARTED|Olm 40 mg + Hydrochlorothiazide 12.5 mg|177 -4 met their blood pressure goal (remained on olmesartan 40 mg)= 173|173
369921|NCT00403481|900098|P1|NOT COMPLETED|Olm 40 mg||5
369922|NCT00403481|900098|P1|COMPLETED|Olm 40 mg||177
369923|NCT00403481|900098|P1|STARTED|Olm 40 mg|186 -4 met their blood pressure goal (remained on olmesartan 20 mg) = 182|182
369924|NCT00403481|900098|P1|NOT COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||6
369925|NCT00403481|900098|P1|COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||186
369926|NCT00403481|900098|P1|STARTED|Olmesartan Medoxomil (Olm) 20 mg||192
369927|NCT00403455|900113|P1|NOT COMPLETED|Overall Study||1
369928|NCT00403455|900113|P1|COMPLETED|Overall Study||37
369929|NCT00403455|900113|P1|STARTED|Overall Study||38
369930|NCT00403403|900119|P2|NOT COMPLETED|Overall Study||0
369931|NCT00403403|900120|P1|NOT COMPLETED|Overall Study||0
369932|NCT00403403|900119|P2|COMPLETED|Overall Study||52
369933|NCT00403403|900120|P1|COMPLETED|Overall Study||50
369934|NCT00403403|900119|P2|Safety-Evaluable Patients|Overall Study||51
369935|NCT00403403|900120|P1|Safety-Evaluable Patients|Overall Study||47
369936|NCT00403403|900119|P2|STARTED|Overall Study||52
369937|NCT00403403|900120|P1|STARTED|Overall Study||50
369938|NCT00403390|900136|P2|NOT COMPLETED|Overall Study||0
369939|NCT00403390|900137|P1|NOT COMPLETED|Overall Study||3
369940|NCT00403390|900136|P2|COMPLETED|Overall Study||18
369941|NCT00403390|900137|P1|COMPLETED|Overall Study||13
369942|NCT00403390|900136|P2|STARTED|Overall Study||18
369943|NCT00403390|900137|P1|STARTED|Overall Study||16
369944|NCT00403273|900145|P2|NOT COMPLETED|Overall Study||4
369945|NCT00403273|900146|P1|NOT COMPLETED|Overall Study||3
369946|NCT00403273|900145|P2|COMPLETED|Overall Study||25
369947|NCT00403273|900146|P1|COMPLETED|Overall Study||22
369948|NCT00403273|900145|P2|STARTED|Overall Study||29
369949|NCT00403273|900146|P1|STARTED|Overall Study||25
369950|NCT00403234|900188|P4|NOT COMPLETED|Overall Study||0
369951|NCT00403234|900189|P3|NOT COMPLETED|Overall Study||1
369952|NCT00403234|900190|P2|NOT COMPLETED|Overall Study||1
369953|NCT00403234|900191|P1|NOT COMPLETED|Overall Study||1
369954|NCT00403234|900188|P4|COMPLETED|Overall Study||2
369955|NCT00403234|900189|P3|COMPLETED|Overall Study||2
369956|NCT00403234|900190|P2|COMPLETED|Overall Study||2
369957|NCT00403234|900191|P1|COMPLETED|Overall Study||1
369958|NCT00403234|900188|P4|STARTED|Overall Study||2
369959|NCT00403234|900189|P3|STARTED|Overall Study||3
369960|NCT00403234|900190|P2|STARTED|Overall Study||3
369961|NCT00403234|900191|P1|STARTED|Overall Study||2
369962|NCT00403130|900201|P1|NOT COMPLETED|Survival Follow-up up to 6 Years||10
369963|NCT00403130|900201|P1|COMPLETED|Survival Follow-up up to 6 Years||16
369964|NCT00403130|900201|P1|STARTED|Survival Follow-up up to 6 Years||26
369965|NCT00403130|900201|P1|NOT COMPLETED|2 Years From Start of Treatment||5
369966|NCT00403130|900201|P1|COMPLETED|2 Years From Start of Treatment||26
369967|NCT00403130|900201|P1|STARTED|2 Years From Start of Treatment||31
369968|NCT00403117|900208|P1|NOT COMPLETED|Overall Study||20
369969|NCT00403117|900208|P1|COMPLETED|Overall Study||29
369970|NCT00403117|900208|P1|STARTED|Overall Study||49
369971|NCT00402987|900254|P4|NOT COMPLETED|Overall Study||0
369972|NCT00402987|900255|P3|NOT COMPLETED|Overall Study||1
369973|NCT00402987|900256|P2|NOT COMPLETED|Overall Study||0
369974|NCT00402987|900257|P1|NOT COMPLETED|Overall Study||0
369975|NCT00402987|900254|P4|COMPLETED|Overall Study||89
369976|NCT00402987|900255|P3|COMPLETED|Overall Study||44
369977|NCT00402987|900256|P2|COMPLETED|Overall Study||45
369978|NCT00402987|900257|P1|COMPLETED|Overall Study||90
369979|NCT00402987|900254|P4|STARTED|Overall Study||89
369980|NCT00402987|900255|P3|STARTED|Overall Study||45
369981|NCT00402987|900256|P2|STARTED|Overall Study||45
369982|NCT00402987|900257|P1|STARTED|Overall Study||90
369983|NCT00402896|900419|P1|NOT COMPLETED|Overall Study||0
369984|NCT00402896|900419|P1|COMPLETED|Overall Study||20
369985|NCT00402896|900419|P1|STARTED|Overall Study||20
369986|NCT00402883|900423|P1|NOT COMPLETED|Maintenance Therapy||0
369987|NCT00402883|900423|P1|COMPLETED|Maintenance Therapy|All 5 patients received limited maintenance therapy due to early trial closure.|5
369988|NCT00402883|900423|P1|STARTED|Maintenance Therapy||5
369989|NCT00402883|900423|P1|NOT COMPLETED|Consolidation Therapy||0
369990|NCT00402883|900423|P1|COMPLETED|Consolidation Therapy||5
369991|NCT00402883|900423|P1|STARTED|Consolidation Therapy||5
369992|NCT00402883|900423|P1|NOT COMPLETED|Induction Therapy||0
369993|NCT00402883|900423|P1|COMPLETED|Induction Therapy||5
369994|NCT00402883|900423|P1|STARTED|Induction Therapy||5
369995|NCT00402831|900429|P2|NOT COMPLETED|Overall Study||3
369996|NCT00402831|900430|P1|NOT COMPLETED|Overall Study||1
369997|NCT00402831|900429|P2|COMPLETED|Overall Study||200
369998|NCT00402831|900430|P1|COMPLETED|Overall Study||201
369999|NCT00402831|900429|P2|ProQuad® Dose 1 (Day 30)|Overall Study||203
370000|NCT00402831|900430|P1|ProQuad® Dose 1 (Day 30)|Overall Study||202
370001|NCT00402831|900429|P2|ProQuad® Dose 1 (Day 1)|Overall Study||203
370002|NCT00402831|900430|P1|ProQuad® Dose 1 (Day 1)|Overall Study||202
370003|NCT00402831|900429|P2|STARTED|Overall Study||203
370004|NCT00402831|900430|P1|STARTED|Overall Study||202
370005|NCT00402740|900462|P1|NOT COMPLETED|Overall Study||80
370006|NCT00402740|900462|P1|COMPLETED|Overall Study||242
370007|NCT00402740|900462|P1|STARTED|Overall Study||322
370008|NCT00402727|900474|P2|NOT COMPLETED|Overall Study||34
370009|NCT00402727|900475|P1|NOT COMPLETED|Overall Study||42
370010|NCT00402727|900474|P2|COMPLETED|Overall Study||347
370011|NCT00402727|900475|P1|COMPLETED|Overall Study||390
370012|NCT00402727|900474|P2|Achieving Test Of Cure (TOC)|Overall Study||347
370013|NCT00402727|900475|P1|Achieving Test Of Cure (TOC)|Overall Study||390
370014|NCT00402727|900474|P2|Achieving End Of Treatment (EOT)|Overall Study||355
370015|NCT00402727|900475|P1|Achieving End Of Treatment (EOT)|Overall Study||408
370016|NCT00402727|900474|P2|STARTED|Overall Study||381
370017|NCT00402727|900475|P1|STARTED|Overall Study||432
370018|NCT00402714|900505|P2|NOT COMPLETED|Overall Study||0
370019|NCT00402714|900506|P1|NOT COMPLETED|Overall Study||0
370020|NCT00402714|900505|P2|COMPLETED|Overall Study||11
370021|NCT00402714|900506|P1|COMPLETED|Overall Study||3
370022|NCT00402714|900505|P2|STARTED|Overall Study||11
370023|NCT00402714|900506|P1|STARTED|Overall Study||3
370024|NCT00402688|900517|P3|NOT COMPLETED|Overall Study||15
370025|NCT00402688|900518|P2|NOT COMPLETED|Overall Study||16
370026|NCT00402688|900519|P1|NOT COMPLETED|Overall Study||21
370027|NCT00402688|900517|P3|COMPLETED|Overall Study||65
370028|NCT00402688|900518|P2|COMPLETED|Overall Study||65
370029|NCT00402688|900519|P1|COMPLETED|Overall Study||60
370030|NCT00402688|900517|P3|STARTED|Overall Study||80
370031|NCT00402688|900518|P2|STARTED|Overall Study||81
370032|NCT00402688|900519|P1|STARTED|Overall Study||81
370033|NCT00402649|900542|P1|NOT COMPLETED|Overall Study||2
370034|NCT00402649|900542|P1|COMPLETED|Overall Study||33
370035|NCT00402649|900542|P1|STARTED|Overall Study||35
370036|NCT00402597|900557|P5|NOT COMPLETED|Overall Study||124
370037|NCT00402597|900558|P4|NOT COMPLETED|Overall Study||74
370038|NCT00402597|900559|P3|NOT COMPLETED|Overall Study||212
370039|NCT00402597|900560|P2|NOT COMPLETED|Overall Study||46
370040|NCT00402597|900561|P1|NOT COMPLETED|Overall Study||191
370041|NCT00402597|900557|P5|COMPLETED|Overall Study||479
370042|NCT00402597|900558|P4|COMPLETED|Overall Study||279
370043|NCT00402597|900559|P3|COMPLETED|Overall Study||834
370044|NCT00402597|900560|P2|COMPLETED|Overall Study||261
370045|NCT00402597|900561|P1|COMPLETED|Overall Study||962
370046|NCT00402597|900557|P5|STARTED|Overall Study||603
370047|NCT00402597|900558|P4|STARTED|Overall Study||353
370048|NCT00402597|900559|P3|STARTED|Overall Study||1046
370049|NCT00402597|900560|P2|STARTED|Overall Study||307
370050|NCT00402597|900561|P1|STARTED|Overall Study||1153
370051|NCT00402363|900602|P4|NOT COMPLETED|Overall Study||10
370052|NCT00402363|900603|P3|NOT COMPLETED|Overall Study||6
370053|NCT00402363|900604|P2|NOT COMPLETED|Overall Study||30
370054|NCT00402363|900605|P1|NOT COMPLETED|Overall Study||33
370055|NCT00402363|900602|P4|COMPLETED|Overall Study||45
370056|NCT00402363|900603|P3|COMPLETED|Overall Study||60
370057|NCT00402363|900604|P2|COMPLETED|Overall Study||246
370058|NCT00402363|900605|P1|COMPLETED|Overall Study||233
370059|NCT00402363|900602|P4|STARTED|Overall Study||55
370060|NCT00402363|900603|P3|STARTED|Overall Study||66
370061|NCT00402363|900604|P2|STARTED|Overall Study||276
370062|NCT00402363|900605|P1|STARTED|Overall Study||266
370063|NCT00402337|900668|P5|NOT COMPLETED|Overall Study||8
370064|NCT00402337|900669|P4|NOT COMPLETED|Overall Study||12
370065|NCT00402337|900670|P3|NOT COMPLETED|Overall Study||4
370066|NCT00402337|900671|P2|NOT COMPLETED|Overall Study||6
370067|NCT00402337|900672|P1|NOT COMPLETED|Overall Study||5
370068|NCT00402337|900668|P5|COMPLETED|Overall Study||61
370069|NCT00402337|900669|P4|COMPLETED|Overall Study||51
370070|NCT00402337|900670|P3|COMPLETED|Overall Study||58
370071|NCT00402337|900671|P2|COMPLETED|Overall Study||51
370072|NCT00402337|900672|P1|COMPLETED|Overall Study||54
370073|NCT00402337|900668|P5|STARTED|Overall Study||69
370074|NCT00402337|900669|P4|STARTED|Overall Study||63
370075|NCT00402337|900670|P3|STARTED|Overall Study||62
370076|NCT00402337|900671|P2|STARTED|Overall Study||57
370077|NCT00402337|900672|P1|STARTED|Overall Study||59
370078|NCT00402324|900711|P2|NOT COMPLETED|Overall Study||41
370079|NCT00402324|900712|P1|NOT COMPLETED|Overall Study||43
370080|NCT00402324|900711|P2|COMPLETED|Overall Study||60
370081|NCT00402324|900712|P1|COMPLETED|Overall Study||58
370082|NCT00402324|900711|P2|STARTED|Overall Study||101
370083|NCT00402324|900712|P1|STARTED|Overall Study||101
370084|NCT00402285|900745|P3|NOT COMPLETED|Overall Study||2
370085|NCT00402285|900746|P2|NOT COMPLETED|Overall Study||6
370086|NCT00402285|900747|P1|NOT COMPLETED|Overall Study||7
370087|NCT00402285|900745|P3|COMPLETED|Overall Study||26
370088|NCT00402285|900746|P2|COMPLETED|Overall Study||21
370089|NCT00402285|900747|P1|COMPLETED|Overall Study||22
370090|NCT00402285|900745|P3|STARTED|Overall Study||28
370091|NCT00402285|900746|P2|STARTED|Overall Study||27
370092|NCT00402285|900747|P1|STARTED|Overall Study||29
370093|NCT00402246|900755|P2|NOT COMPLETED|Overall Study||234
370094|NCT00402246|900756|P1|NOT COMPLETED|Overall Study||220
370095|NCT00402246|900755|P2|COMPLETED|Overall Study||749
370096|NCT00402246|900756|P1|COMPLETED|Overall Study||794
370097|NCT00402246|900755|P2|STARTED|Overall Study||983
370098|NCT00402246|900756|P1|STARTED|Overall Study||1014
370099|NCT00402233|900790|P4|NOT COMPLETED|Overall Study||11
370100|NCT00402233|900791|P3|NOT COMPLETED|Overall Study||11
370101|NCT00402233|900792|P2|NOT COMPLETED|Overall Study||10
370102|NCT00402233|900793|P1|NOT COMPLETED|Overall Study||5
370103|NCT00402233|900790|P4|COMPLETED|Overall Study||62
370104|NCT00402233|900791|P3|COMPLETED|Overall Study||70
370105|NCT00402233|900792|P2|COMPLETED|Overall Study||70
370106|NCT00402233|900793|P1|COMPLETED|Overall Study||72
370107|NCT00402233|900790|P4|STARTED|Overall Study||73
370108|NCT00402233|900791|P3|STARTED|Overall Study||81
370109|NCT00402233|900792|P2|STARTED|Overall Study||80
370110|NCT00402233|900793|P1|STARTED|Overall Study||77
370111|NCT00402194|900817|P2|NOT COMPLETED|Overall Study||0
370112|NCT00402194|900818|P1|NOT COMPLETED|Overall Study||0
370113|NCT00402194|900817|P2|COMPLETED|Overall Study||8
370114|NCT00402194|900818|P1|COMPLETED|Overall Study||9
370115|NCT00402194|900817|P2|STARTED|Overall Study||8
370116|NCT00402194|900818|P1|STARTED|Overall Study||9
370117|NCT00402168|900828|P2|NOT COMPLETED|Switched From CNI to Belatacept in LT||0
370118|NCT00402168|900829|P1|NOT COMPLETED|Switched From CNI to Belatacept in LT||6
370119|NCT00402168|900828|P2|COMPLETED|Switched From CNI to Belatacept in LT||0
370120|NCT00402168|900829|P1|COMPLETED|Switched From CNI to Belatacept in LT||32
370121|NCT00402168|900828|P2|STARTED|Switched From CNI to Belatacept in LT|Out of 81 starting LT period in CNI group, 38 switched from CNI to Belatacept during the LT period.|0
370122|NCT00402168|900829|P1|STARTED|Switched From CNI to Belatacept in LT|Participants switched from CNI to Belatacept during LT period.|38
370123|NCT00402168|900828|P2|NOT COMPLETED|Long Term (LT)||17
370124|NCT00402168|900829|P1|NOT COMPLETED|Long Term (LT)||11
370125|NCT00402168|900828|P2|COMPLETED|Long Term (LT)||64
370126|NCT00402168|900829|P1|COMPLETED|Long Term (LT)||70
370127|NCT00402168|900828|P2|STARTED|Long Term (LT)|5 completed 12 months, did not enter long term: 1 AE, 1 lack of efficacy, 3 other(non-specified).|81
370128|NCT00402168|900829|P1|STARTED|Long Term (LT)||81
370129|NCT00402168|900828|P2|NOT COMPLETED|Treatment (up to 12 Months)||2
370130|NCT00402168|900829|P1|NOT COMPLETED|Treatment (up to 12 Months)||2
370131|NCT00402168|900828|P2|COMPLETED|Treatment (up to 12 Months)||86
370132|NCT00402168|900829|P1|COMPLETED|Treatment (up to 12 Months)||81
370133|NCT00402168|900828|P2|STARTED|Treatment (up to 12 Months)||88
370134|NCT00402168|900829|P1|STARTED|Treatment (up to 12 Months)||83
370135|NCT00402168|900828|P2|NOT COMPLETED|Randomized||1
370136|NCT00402168|900829|P1|NOT COMPLETED|Randomized||1
370137|NCT00402168|900828|P2|COMPLETED|Randomized||88
370138|NCT00402168|900829|P1|COMPLETED|Randomized||83
370139|NCT00402168|900828|P2|STARTED|Randomized||89
370140|NCT00402168|900829|P1|STARTED|Randomized||84
370141|NCT00402103|900886|P2|NOT COMPLETED|Overall Study||13
370142|NCT00402103|900887|P1|NOT COMPLETED|Overall Study||91
370143|NCT00402103|900886|P2|COMPLETED|Overall Study||73
370144|NCT00402103|900887|P1|COMPLETED|Overall Study||379
370145|NCT00402103|900886|P2|STARTED|Overall Study||86
370146|NCT00402103|900887|P1|STARTED|Overall Study||470
370147|NCT00402051|900903|P2|NOT COMPLETED|Overall Study||35
370148|NCT00402051|900904|P1|NOT COMPLETED|Overall Study||38
370149|NCT00402051|900903|P2|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|32
370150|NCT00402051|900904|P1|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|28
370151|NCT00402051|900903|P2|Received Treatment|Overall Study||65
370152|NCT00402051|900904|P1|Received Treatment|Overall Study||65
370153|NCT00402051|900903|P2|STARTED|Overall Study||67
370154|NCT00402051|900904|P1|STARTED|Overall Study||66
370155|NCT00402025|900921|P3|NOT COMPLETED|Overall Study||10
370156|NCT00402025|900922|P2|NOT COMPLETED|Overall Study||3
370157|NCT00402025|900923|P1|NOT COMPLETED|Overall Study||2
370158|NCT00402025|900921|P3|COMPLETED|Overall Study||0
370159|NCT00402025|900922|P2|COMPLETED|Overall Study||1
370160|NCT00402025|900923|P1|COMPLETED|Overall Study||1
370161|NCT00402025|900921|P3|STARTED|Overall Study||10
370162|NCT00402025|900922|P2|STARTED|Overall Study||4
370163|NCT00402025|900923|P1|STARTED|Overall Study||3
370164|NCT00401973|900949|P3|NOT COMPLETED|Overall Study||23
370165|NCT00401973|900950|P2|NOT COMPLETED|Overall Study||26
370166|NCT00401973|900951|P1|NOT COMPLETED|Overall Study||11
370167|NCT00401973|900949|P3|COMPLETED|Overall Study||50
370168|NCT00401973|900950|P2|COMPLETED|Overall Study||50
370169|NCT00401973|900951|P1|COMPLETED|Overall Study||39
370170|NCT00401973|900949|P3|STARTED|Overall Study||73
370171|NCT00401973|900950|P2|STARTED|Overall Study||76
370172|NCT00401973|900951|P1|STARTED|Overall Study||50
370173|NCT00401960|900990|P2|NOT COMPLETED|Overall Study||0
370174|NCT00401960|900991|P1|NOT COMPLETED|Overall Study||5
370175|NCT00401960|900990|P2|COMPLETED|Overall Study||1
370176|NCT00401960|900991|P1|COMPLETED|Overall Study||0
370177|NCT00401960|900990|P2|STARTED|Overall Study||1
370178|NCT00401960|900991|P1|STARTED|Overall Study||5
370179|NCT00401882|901001|P2|NOT COMPLETED|Overall Study||0
370180|NCT00401882|901002|P1|NOT COMPLETED|Overall Study||0
370181|NCT00401882|901001|P2|COMPLETED|Overall Study||5
370182|NCT00401882|901002|P1|COMPLETED|Overall Study||2
370183|NCT00401882|901001|P2|STARTED|Overall Study||5
370184|NCT00401882|901002|P1|STARTED|Overall Study||2
370185|NCT00401843|901021|P3|NOT COMPLETED|Overall Study||142
370186|NCT00401843|901022|P2|NOT COMPLETED|Overall Study||144
370187|NCT00401843|901023|P1|NOT COMPLETED|Overall Study||21
370188|NCT00401843|901021|P3|COMPLETED|Overall Study||0
370189|NCT00401843|901022|P2|COMPLETED|Overall Study||0
370190|NCT00401843|901023|P1|COMPLETED|Overall Study||0
370191|NCT00401843|901021|P3|Treated|Overall Study||139
370192|NCT00401843|901022|P2|Treated|Overall Study||142
370193|NCT00401843|901023|P1|Treated|Overall Study||21
370194|NCT00401843|901021|P3|STARTED|Overall Study||142
370195|NCT00401843|901022|P2|STARTED|Overall Study||144
370196|NCT00401843|901023|P1|STARTED|Overall Study||21
370197|NCT00401830|901041|P2|NOT COMPLETED|Overall Study||32
370198|NCT00401830|901042|P1|NOT COMPLETED|Overall Study||31
370199|NCT00401830|901041|P2|COMPLETED|Overall Study||46
370200|NCT00401830|901042|P1|COMPLETED|Overall Study||50
370201|NCT00401830|901041|P2|STARTED|Overall Study||78
370202|NCT00401830|901042|P1|STARTED|Overall Study||81
370203|NCT00401817|901074|P1|NOT COMPLETED|Overall Study||0
370204|NCT00401817|901074|P1|COMPLETED|Overall Study||11
370205|NCT00401817|901074|P1|STARTED|Overall Study||11
370206|NCT00401778|901084|P3|NOT COMPLETED|Overall Study||1
370207|NCT00401778|901085|P2|NOT COMPLETED|Overall Study||1
370208|NCT00401778|901086|P1|NOT COMPLETED|Overall Study||1
370209|NCT00401778|901084|P3|COMPLETED|Overall Study||10
370210|NCT00401778|901085|P2|COMPLETED|Overall Study||11
370211|NCT00401778|901086|P1|COMPLETED|Overall Study||9
370212|NCT00401778|901084|P3|STARTED|Overall Study||11
370213|NCT00401778|901085|P2|STARTED|Overall Study||12
370214|NCT00401778|901086|P1|STARTED|Overall Study||10
370215|NCT00401752|901100|P2|NOT COMPLETED|Overall Study||18
370216|NCT00401752|901101|P1|NOT COMPLETED|Overall Study||10
370217|NCT00401752|901100|P2|COMPLETED|Overall Study||94
370218|NCT00401752|901101|P1|COMPLETED|Overall Study||97
370219|NCT00401752|901100|P2|Patients Included in Per-Protocol Popula|Overall Study||99
370220|NCT00401752|901101|P1|Patients Included in Per-Protocol Popula|Overall Study||100
370221|NCT00401752|901100|P2|Patients Included in Safety Population|Overall Study||110
370222|NCT00401752|901101|P1|Patients Included in Safety Population|Overall Study||107
370223|NCT00401752|901100|P2|Patients Included in ITT Population|Overall Study||111
370224|NCT00401752|901101|P1|Patients Included in ITT Population|Overall Study||106
370225|NCT00401752|901100|P2|Number of Patients Received Treatment|Overall Study||111
370226|NCT00401752|901101|P1|Number of Patients Received Treatment|Overall Study||107
370227|NCT00401752|901100|P2|STARTED|Overall Study||112
370228|NCT00401752|901101|P1|STARTED|Overall Study||107
370229|NCT00401726|901119|P2|NOT COMPLETED|Overall Study||112
370230|NCT00401726|901120|P1|NOT COMPLETED|Overall Study||97
370231|NCT00401726|901119|P2|COMPLETED|Overall Study||156
370232|NCT00401726|901120|P1|COMPLETED|Overall Study||172
370233|NCT00401726|901119|P2|STARTED|Overall Study||268
370234|NCT00401726|901120|P1|STARTED|Overall Study||269
370235|NCT00401622|901142|P2|NOT COMPLETED|Overall Study||43
370236|NCT00401622|901143|P1|NOT COMPLETED|Overall Study||34
370237|NCT00401622|901142|P2|COMPLETED|Overall Study||117
370238|NCT00401622|901143|P1|COMPLETED|Overall Study||126
370239|NCT00401622|901142|P2|STARTED|Overall Study||160
370240|NCT00401622|901143|P1|STARTED|Overall Study||160
370241|NCT00401544|901155|P4|NOT COMPLETED|Overall Study||16
370242|NCT00401544|901156|P3|NOT COMPLETED|Overall Study||12
370243|NCT00401544|901157|P2|NOT COMPLETED|Overall Study||18
370244|NCT00401544|901158|P1|NOT COMPLETED|Overall Study||18
370245|NCT00401544|901155|P4|COMPLETED|Overall Study||44
370246|NCT00401544|901156|P3|COMPLETED|Overall Study||48
370247|NCT00401544|901157|P2|COMPLETED|Overall Study||44
370248|NCT00401544|901158|P1|COMPLETED|Overall Study||38
370249|NCT00401544|901155|P4|STARTED|Overall Study|Randomized and treated|60
370250|NCT00401544|901156|P3|STARTED|Overall Study|Randomized and treated|60
370251|NCT00401544|901157|P2|STARTED|Overall Study|Randomized and treated|62
370252|NCT00401544|901158|P1|STARTED|Overall Study|Randomized and treated|56
370253|NCT00401531|901198|P2|NOT COMPLETED|Overall Study||10
370254|NCT00401531|901199|P1|NOT COMPLETED|Overall Study||9
370255|NCT00401531|901198|P2|COMPLETED|Overall Study||196
370256|NCT00401531|901199|P1|COMPLETED|Overall Study||197
370257|NCT00401531|901198|P2|STARTED|Overall Study||206
370258|NCT00401531|901199|P1|STARTED|Overall Study||206
370259|NCT00401414|901218|P3|NOT COMPLETED|Overall Study||0
370260|NCT00401414|901219|P2|NOT COMPLETED|Overall Study||0
370261|NCT00401414|901220|P1|NOT COMPLETED|Overall Study||0
370262|NCT00401414|901218|P3|COMPLETED|Overall Study||79
370263|NCT00401414|901219|P2|COMPLETED|Overall Study||147
370264|NCT00401414|901220|P1|COMPLETED|Overall Study||118
370265|NCT00401414|901218|P3|STARTED|Overall Study||79
370266|NCT00401414|901219|P2|STARTED|Overall Study||147
370267|NCT00401414|901220|P1|STARTED|Overall Study||118
370268|NCT00401401|901244|P4|NOT COMPLETED|Overall Study||3
370269|NCT00401401|901245|P3|NOT COMPLETED|Overall Study||1
370270|NCT00401401|901246|P2|NOT COMPLETED|Overall Study||0
370271|NCT00401401|901247|P1|NOT COMPLETED|Overall Study||0
370272|NCT00401401|901244|P4|COMPLETED|Overall Study||9
370273|NCT00401401|901245|P3|COMPLETED|Overall Study||5
370274|NCT00401401|901246|P2|COMPLETED|Overall Study||6
370275|NCT00401401|901247|P1|COMPLETED|Overall Study||6
370276|NCT00401401|901244|P4|STARTED|Overall Study||12
370277|NCT00401401|901245|P3|STARTED|Overall Study||6
370278|NCT00401401|901246|P2|STARTED|Overall Study||6
370279|NCT00401401|901247|P1|STARTED|Overall Study||6
370280|NCT00401375|901272|P3|NOT COMPLETED|Overall Study||25
370281|NCT00401375|901273|P2|NOT COMPLETED|Overall Study||25
370282|NCT00401375|901274|P1|NOT COMPLETED|Overall Study||22
370283|NCT00401375|901272|P3|COMPLETED|Overall Study||149
370284|NCT00401375|901273|P2|COMPLETED|Overall Study||151
370285|NCT00401375|901274|P1|COMPLETED|Overall Study||152
370286|NCT00401375|901272|P3|Received at Least 1 Dose of Study Drug|Overall Study||171
370287|NCT00401375|901273|P2|Received at Least 1 Dose of Study Drug|Overall Study||173
370288|NCT00401375|901274|P1|Received at Least 1 Dose of Study Drug|Overall Study||171
370289|NCT00401375|901272|P3|STARTED|Overall Study||174
370290|NCT00401375|901273|P2|STARTED|Overall Study||176
370291|NCT00401375|901274|P1|STARTED|Overall Study||174
370292|NCT00401258|901291|P1|NOT COMPLETED|Overall Study||7
370293|NCT00401258|901291|P1|COMPLETED|Overall Study||8
370294|NCT00401258|901291|P1|STARTED|Overall Study||15
370295|NCT00401245|901306|P8|NOT COMPLETED|Double Blind Tapering Phase||7
370296|NCT00401245|901307|P7|NOT COMPLETED|Double Blind Tapering Phase||7
370297|NCT00401245|901308|P6|NOT COMPLETED|Double Blind Tapering Phase||4
370298|NCT00401245|901309|P5|NOT COMPLETED|Double Blind Tapering Phase||4
370299|NCT00401245|901310|P4|NOT COMPLETED|Double Blind Tapering Phase||0
370300|NCT00401245|901311|P3|NOT COMPLETED|Double Blind Tapering Phase||0
370301|NCT00401245|901312|P2|NOT COMPLETED|Double Blind Tapering Phase||0
370302|NCT00401245|901313|P1|NOT COMPLETED|Double Blind Tapering Phase||0
370303|NCT00401245|901306|P8|COMPLETED|Double Blind Tapering Phase||95
370304|NCT00401245|901307|P7|COMPLETED|Double Blind Tapering Phase||80
370305|NCT00401245|901308|P6|COMPLETED|Double Blind Tapering Phase||90
370306|NCT00401245|901309|P5|COMPLETED|Double Blind Tapering Phase||97
370307|NCT00401245|901310|P4|COMPLETED|Double Blind Tapering Phase||0
370308|NCT00401245|901311|P3|COMPLETED|Double Blind Tapering Phase||0
370309|NCT00401245|901312|P2|COMPLETED|Double Blind Tapering Phase||0
370310|NCT00401245|901313|P1|COMPLETED|Double Blind Tapering Phase||0
370311|NCT00401245|901306|P8|STARTED|Double Blind Tapering Phase||102
370312|NCT00401245|901307|P7|STARTED|Double Blind Tapering Phase||87
370313|NCT00401245|901308|P6|STARTED|Double Blind Tapering Phase||94
370314|NCT00401245|901309|P5|STARTED|Double Blind Tapering Phase||101
370315|NCT00401245|901310|P4|STARTED|Double Blind Tapering Phase||0
370316|NCT00401245|901311|P3|STARTED|Double Blind Tapering Phase||0
370317|NCT00401245|901312|P2|STARTED|Double Blind Tapering Phase||0
370318|NCT00401245|901313|P1|STARTED|Double Blind Tapering Phase||0
370319|NCT00401245|901306|P8|NOT COMPLETED|Open Label Phase||0
370320|NCT00401245|901307|P7|NOT COMPLETED|Open Label Phase||0
370321|NCT00401245|901308|P6|NOT COMPLETED|Open Label Phase||0
370322|NCT00401245|901309|P5|NOT COMPLETED|Open Label Phase||0
370323|NCT00401245|901310|P4|NOT COMPLETED|Open Label Phase||21
370324|NCT00401245|901311|P3|NOT COMPLETED|Open Label Phase||23
370325|NCT00401245|901312|P2|NOT COMPLETED|Open Label Phase||35
370326|NCT00401245|901313|P1|NOT COMPLETED|Open Label Phase||21
370327|NCT00401245|901306|P8|COMPLETED|Open Label Phase||0
370328|NCT00401245|901307|P7|COMPLETED|Open Label Phase||0
370329|NCT00401245|901308|P6|COMPLETED|Open Label Phase||0
370330|NCT00401245|901309|P5|COMPLETED|Open Label Phase||0
370331|NCT00401245|901310|P4|COMPLETED|Open Label Phase||84
370332|NCT00401245|901311|P3|COMPLETED|Open Label Phase||95
370333|NCT00401245|901312|P2|COMPLETED|Open Label Phase||81
370334|NCT00401245|901313|P1|COMPLETED|Open Label Phase||101
370335|NCT00401245|901306|P8|STARTED|Open Label Phase||0
370336|NCT00401245|901307|P7|STARTED|Open Label Phase||0
370337|NCT00401245|901308|P6|STARTED|Open Label Phase||0
370338|NCT00401245|901309|P5|STARTED|Open Label Phase||0
370339|NCT00401245|901310|P4|STARTED|Open Label Phase||105
370340|NCT00401245|901311|P3|STARTED|Open Label Phase||118
370341|NCT00401245|901312|P2|STARTED|Open Label Phase||116
370342|NCT00401245|901313|P1|STARTED|Open Label Phase||122
370343|NCT00401245|901306|P8|NOT COMPLETED|Between Titration and Open Label Phase||0
370344|NCT00401245|901307|P7|NOT COMPLETED|Between Titration and Open Label Phase||0
370345|NCT00401245|901308|P6|NOT COMPLETED|Between Titration and Open Label Phase||0
370346|NCT00401245|901309|P5|NOT COMPLETED|Between Titration and Open Label Phase||0
370347|NCT00401245|901310|P4|NOT COMPLETED|Between Titration and Open Label Phase||2
370348|NCT00401245|901311|P3|NOT COMPLETED|Between Titration and Open Label Phase||0
370349|NCT00401245|901312|P2|NOT COMPLETED|Between Titration and Open Label Phase||2
370350|NCT00401245|901313|P1|NOT COMPLETED|Between Titration and Open Label Phase||0
370351|NCT00401245|901306|P8|COMPLETED|Between Titration and Open Label Phase||0
370352|NCT00401245|901307|P7|COMPLETED|Between Titration and Open Label Phase||0
370353|NCT00401245|901308|P6|COMPLETED|Between Titration and Open Label Phase||0
370354|NCT00401245|901309|P5|COMPLETED|Between Titration and Open Label Phase||0
370355|NCT00401245|901310|P4|COMPLETED|Between Titration and Open Label Phase||105
370356|NCT00401245|901311|P3|COMPLETED|Between Titration and Open Label Phase||118
370357|NCT00401245|901312|P2|COMPLETED|Between Titration and Open Label Phase||116
370358|NCT00401245|901313|P1|COMPLETED|Between Titration and Open Label Phase||122
370359|NCT00401245|901306|P8|STARTED|Between Titration and Open Label Phase||0
370360|NCT00401245|901307|P7|STARTED|Between Titration and Open Label Phase||0
370361|NCT00401245|901308|P6|STARTED|Between Titration and Open Label Phase||0
370362|NCT00401245|901309|P5|STARTED|Between Titration and Open Label Phase||0
370363|NCT00401245|901310|P4|STARTED|Between Titration and Open Label Phase||107
370364|NCT00401245|901311|P3|STARTED|Between Titration and Open Label Phase||118
370365|NCT00401245|901312|P2|STARTED|Between Titration and Open Label Phase||118
370366|NCT00401245|901313|P1|STARTED|Between Titration and Open Label Phase||122
370367|NCT00401245|901306|P8|NOT COMPLETED|Double Blind Titration Phase||0
370368|NCT00401245|901307|P7|NOT COMPLETED|Double Blind Titration Phase||0
370369|NCT00401245|901308|P6|NOT COMPLETED|Double Blind Titration Phase||0
370370|NCT00401245|901309|P5|NOT COMPLETED|Double Blind Titration Phase||0
370371|NCT00401245|901310|P4|NOT COMPLETED|Double Blind Titration Phase||15
370372|NCT00401245|901311|P3|NOT COMPLETED|Double Blind Titration Phase||6
370373|NCT00401245|901312|P2|NOT COMPLETED|Double Blind Titration Phase||3
370374|NCT00401245|901313|P1|NOT COMPLETED|Double Blind Titration Phase||4
370375|NCT00401245|901306|P8|COMPLETED|Double Blind Titration Phase||0
370376|NCT00401245|901307|P7|COMPLETED|Double Blind Titration Phase||0
370377|NCT00401245|901308|P6|COMPLETED|Double Blind Titration Phase||0
370378|NCT00401245|901309|P5|COMPLETED|Double Blind Titration Phase||0
370379|NCT00401245|901310|P4|COMPLETED|Double Blind Titration Phase||107
370380|NCT00401245|901311|P3|COMPLETED|Double Blind Titration Phase||118
370381|NCT00401245|901312|P2|COMPLETED|Double Blind Titration Phase||118
370382|NCT00401245|901313|P1|COMPLETED|Double Blind Titration Phase||122
370383|NCT00401245|901306|P8|STARTED|Double Blind Titration Phase||0
370384|NCT00401245|901307|P7|STARTED|Double Blind Titration Phase||0
370385|NCT00401245|901308|P6|STARTED|Double Blind Titration Phase||0
370386|NCT00401245|901309|P5|STARTED|Double Blind Titration Phase||0
370387|NCT00401245|901310|P4|STARTED|Double Blind Titration Phase||122
370388|NCT00401245|901311|P3|STARTED|Double Blind Titration Phase||124
370389|NCT00401245|901312|P2|STARTED|Double Blind Titration Phase||121
370390|NCT00401245|901313|P1|STARTED|Double Blind Titration Phase||126
370391|NCT00401193|901381|P3|NOT COMPLETED|Overall Study||6
370392|NCT00401193|901382|P2|NOT COMPLETED|Overall Study||11
370393|NCT00401193|901383|P1|NOT COMPLETED|Overall Study||15
370394|NCT00401193|901381|P3|COMPLETED|Overall Study||63
370395|NCT00401193|901382|P2|COMPLETED|Overall Study||106
370396|NCT00401193|901383|P1|COMPLETED|Overall Study||103
370397|NCT00401193|901381|P3|Modified Intent to Treat Population|Overall Study||67
370398|NCT00401193|901382|P2|Modified Intent to Treat Population|Overall Study||115
370399|NCT00401193|901383|P1|Modified Intent to Treat Population|Overall Study||112
370400|NCT00401193|901381|P3|Intent to Treat Population|Overall Study||67
370401|NCT00401193|901382|P2|Intent to Treat Population|Overall Study||115
370402|NCT00401193|901383|P1|Intent to Treat Population|Overall Study||115
370403|NCT00401193|901381|P3|STARTED|Overall Study||69
370404|NCT00401193|901382|P2|STARTED|Overall Study||117
370405|NCT00401193|901383|P1|STARTED|Overall Study||118
370406|NCT00401102|901397|P1|NOT COMPLETED|Overall Study||7
370407|NCT00401102|901397|P1|COMPLETED|Overall Study||5
370408|NCT00401102|901397|P1|STARTED|Overall Study||12
370409|NCT00400985|901401|P1|NOT COMPLETED|Overall Study||52
370410|NCT00400985|901401|P1|COMPLETED|Overall Study||449
370411|NCT00400985|901401|P1|STARTED|Overall Study||501
370412|NCT00400946|901410|P5|NOT COMPLETED|Overall Study||38
370413|NCT00400946|901411|P4|NOT COMPLETED|Overall Study||47
370414|NCT00400946|901412|P3|NOT COMPLETED|Overall Study||2
370415|NCT00400946|901413|P2|NOT COMPLETED|Overall Study||11
370416|NCT00400946|901414|P1|NOT COMPLETED|Overall Study||14
370417|NCT00400946|901410|P5|COMPLETED|Overall Study||206
370418|NCT00400946|901411|P4|COMPLETED|Overall Study||4
370419|NCT00400946|901412|P3|COMPLETED|Overall Study||40
370420|NCT00400946|901413|P2|COMPLETED|Overall Study||221
370421|NCT00400946|901414|P1|COMPLETED|Overall Study||217
370422|NCT00400946|901410|P5|Eligible and Treated|Overall Study||243
370423|NCT00400946|901411|P4|Eligible and Treated|Overall Study||46
370424|NCT00400946|901412|P3|Eligible and Treated|Overall Study||42
370425|NCT00400946|901413|P2|Eligible and Treated|Overall Study||232
370426|NCT00400946|901414|P1|Eligible and Treated|Overall Study||231
370427|NCT00400946|901410|P5|Evaluable for Day 32 MRD|Overall Study||168
370428|NCT00400946|901411|P4|Evaluable for Day 32 MRD|Overall Study||12
370429|NCT00400946|901412|P3|Evaluable for Day 32 MRD|Overall Study||33
370430|NCT00400946|901413|P2|Evaluable for Day 32 MRD|Overall Study||167
370431|NCT00400946|901414|P1|Evaluable for Day 32 MRD|Overall Study||166
370432|NCT00400946|901410|P5|Evaluable for Day 18 Marrow Morphology|Overall Study||152
370433|NCT00400946|901411|P4|Evaluable for Day 18 Marrow Morphology|Overall Study||13
370434|NCT00400946|901412|P3|Evaluable for Day 18 Marrow Morphology|Overall Study||19
370435|NCT00400946|901413|P2|Evaluable for Day 18 Marrow Morphology|Overall Study||161
370436|NCT00400946|901414|P1|Evaluable for Day 18 Marrow Morphology|Overall Study||158
370437|NCT00400946|901410|P5|Evaluable for CNS Directed-Treatment|Overall Study||227
370438|NCT00400946|901411|P4|Evaluable for CNS Directed-Treatment|Overall Study||21
370439|NCT00400946|901412|P3|Evaluable for CNS Directed-Treatment|Overall Study||42
370440|NCT00400946|901413|P2|Evaluable for CNS Directed-Treatment|Overall Study||232
370441|NCT00400946|901414|P1|Evaluable for CNS Directed-Treatment|Overall Study||231
370442|NCT00400946|901410|P5|STARTED|Overall Study||244
370443|NCT00400946|901411|P4|STARTED|Overall Study||51
370444|NCT00400946|901412|P3|STARTED|Overall Study||42
370445|NCT00400946|901413|P2|STARTED|Overall Study||232
370446|NCT00400946|901414|P1|STARTED|Overall Study||231
370447|NCT00400881|901442|P2|NOT COMPLETED|Overall Study||0
370448|NCT00400881|901443|P1|NOT COMPLETED|Overall Study||0
370449|NCT00400881|901442|P2|COMPLETED|Overall Study||60
370450|NCT00400881|901443|P1|COMPLETED|Overall Study||62
370451|NCT00400881|901442|P2|STARTED|Overall Study||60
370452|NCT00400881|901443|P1|STARTED|Overall Study||62
370453|NCT00400829|901451|P1|NOT COMPLETED|Overall Study||0
370454|NCT00400829|901451|P1|COMPLETED|Overall Study||66
370455|NCT00400829|901451|P1|STARTED|Overall Study||66
370456|NCT00400803|901457|P1|NOT COMPLETED|Overall Study||0
370457|NCT00400803|901457|P1|COMPLETED|Overall Study||35
370458|NCT00400803|901457|P1|STARTED|Overall Study||35
370459|NCT00400764|901473|P5|NOT COMPLETED|Phase II||11
370460|NCT00400764|901474|P4|NOT COMPLETED|Phase II||26
370461|NCT00400764|901475|P3|NOT COMPLETED|Phase II||23
370462|NCT00400764|901476|P2|NOT COMPLETED|Phase II||0
370463|NCT00400764|901477|P1|NOT COMPLETED|Phase II||0
370464|NCT00400764|901473|P5|COMPLETED|Phase II||0
370465|NCT00400764|901474|P4|COMPLETED|Phase II||0
370466|NCT00400764|901475|P3|COMPLETED|Phase II||0
370467|NCT00400764|901476|P2|COMPLETED|Phase II||0
370468|NCT00400764|901477|P1|COMPLETED|Phase II||0
370469|NCT00400764|901473|P5|Treated|Phase II||11
370470|NCT00400764|901474|P4|Treated|Phase II||26
370471|NCT00400764|901475|P3|Treated|Phase II|One patient in the Rituximab arm withdrew prior to treatment|22
370472|NCT00400764|901476|P2|Treated|Phase II||0
370473|NCT00400764|901477|P1|Treated|Phase II||0
370474|NCT00400764|901473|P5|STARTED|Phase II||11
370475|NCT00400764|901474|P4|STARTED|Phase II||26
370476|NCT00400764|901475|P3|STARTED|Phase II||23
370477|NCT00400764|901476|P2|STARTED|Phase II||0
370478|NCT00400764|901477|P1|STARTED|Phase II||0
370479|NCT00400764|901473|P5|NOT COMPLETED|Phase Ib||0
370480|NCT00400764|901474|P4|NOT COMPLETED|Phase Ib||0
370481|NCT00400764|901475|P3|NOT COMPLETED|Phase Ib||0
370482|NCT00400764|901476|P2|NOT COMPLETED|Phase Ib||4
370483|NCT00400764|901477|P1|NOT COMPLETED|Phase Ib||6
370484|NCT00400764|901473|P5|COMPLETED|Phase Ib||0
370485|NCT00400764|901474|P4|COMPLETED|Phase Ib||0
370486|NCT00400764|901475|P3|COMPLETED|Phase Ib||0
370487|NCT00400764|901476|P2|COMPLETED|Phase Ib||2
370488|NCT00400764|901477|P1|COMPLETED|Phase Ib|One patient reported as discontinued due to an AE should have been reported as death.|0
370489|NCT00400764|901473|P5|Treated|Phase Ib||0
370490|NCT00400764|901474|P4|Treated|Phase Ib||0
370491|NCT00400764|901475|P3|Treated|Phase Ib||0
370492|NCT00400764|901476|P2|Treated|Phase Ib||6
370493|NCT00400764|901477|P1|Treated|Phase Ib||6
370494|NCT00400764|901473|P5|STARTED|Phase Ib||0
370495|NCT00400764|901474|P4|STARTED|Phase Ib||0
370496|NCT00400764|901475|P3|STARTED|Phase Ib||0
370497|NCT00400764|901476|P2|STARTED|Phase Ib||6
370498|NCT00400764|901477|P1|STARTED|Phase Ib||6
370499|NCT00400712|901530|P2|NOT COMPLETED|Overall Study||16
370500|NCT00400712|901531|P1|NOT COMPLETED|Overall Study||17
370501|NCT00400712|901530|P2|COMPLETED|Overall Study||35
370502|NCT00400712|901531|P1|COMPLETED|Overall Study||35
370503|NCT00400712|901530|P2|STARTED|Overall Study||51
370504|NCT00400712|901531|P1|STARTED|Overall Study||52
370505|NCT00400686|901549|P1|NOT COMPLETED|Overall Study||0
370506|NCT00400686|901549|P1|COMPLETED|Overall Study||31
370507|NCT00400686|901549|P1|STARTED|Overall Study||31
370508|NCT00400634|901557|P2|NOT COMPLETED|Overall Study||1
370509|NCT00400634|901558|P1|NOT COMPLETED|Overall Study||4
370510|NCT00400634|901557|P2|COMPLETED|Overall Study||19
370511|NCT00400634|901558|P1|COMPLETED|Overall Study||34
370512|NCT00400634|901557|P2|STARTED|Overall Study||20
370513|NCT00400634|901558|P1|STARTED|Overall Study||38
370514|NCT00400569|901566|P1|NOT COMPLETED|Overall Study||1
370515|NCT00400569|901566|P1|COMPLETED|Overall Study||47
370516|NCT00400569|901566|P1|STARTED|Overall Study||48
370517|NCT00400517|901577|P1|NOT COMPLETED|Overall Study||2
370518|NCT00400517|901577|P1|COMPLETED|Overall Study||26
370612|NCT00399035|902107|P3|STARTED|Overall Study||358
370613|NCT00399035|902108|P2|STARTED|Overall Study||216
370519|NCT00400517|901577|P1|STARTED|Overall Study|1 pt w/d consent. 1 pt found to have unresectable dx at time of sx and is exc. in tissue analysis.|28
370520|NCT00400400|901586|P2|NOT COMPLETED|Overall Study||15
370521|NCT00400400|901587|P1|NOT COMPLETED|Overall Study||14
370522|NCT00400400|901586|P2|COMPLETED|Overall Study||185
370523|NCT00400400|901587|P1|COMPLETED|Overall Study||186
370524|NCT00400400|901586|P2|Intent-to-Treat Population|Overall Study||197
370525|NCT00400400|901587|P1|Intent-to-Treat Population|Overall Study|Participants who received study drug.|199
370526|NCT00400400|901586|P2|STARTED|Overall Study||200
370527|NCT00400400|901587|P1|STARTED|Overall Study||200
370528|NCT00400205|901605|P1|NOT COMPLETED|Overall Study||5
370529|NCT00400205|901605|P1|COMPLETED|Overall Study||9
370530|NCT00400205|901605|P1|STARTED|Overall Study||14
370531|NCT00400179|901612|P2|NOT COMPLETED|Overall Study||18
370532|NCT00400179|901613|P1|NOT COMPLETED|Overall Study||6
370533|NCT00400179|901612|P2|COMPLETED|Overall Study||508
370534|NCT00400179|901613|P1|COMPLETED|Overall Study|Received Treatment|521
370535|NCT00400179|901612|P2|STARTED|Overall Study||526
370536|NCT00400179|901613|P1|STARTED|Overall Study|Signed informed consent form and randomized|527
370537|NCT00400153|901630|P3|NOT COMPLETED|Overall Study||61
370538|NCT00400153|901631|P2|NOT COMPLETED|Overall Study||55
370539|NCT00400153|901632|P1|NOT COMPLETED|Overall Study||48
370540|NCT00400153|901630|P3|COMPLETED|Overall Study||422
370541|NCT00400153|901631|P2|COMPLETED|Overall Study||436
370542|NCT00400153|901632|P1|COMPLETED|Overall Study||438
370543|NCT00400153|901630|P3|STARTED|Overall Study||483
370544|NCT00400153|901631|P2|STARTED|Overall Study||491
370545|NCT00400153|901632|P1|STARTED|Overall Study||486
370546|NCT00399893|901879|P2|NOT COMPLETED|Overall Study||0
370547|NCT00399893|901880|P1|NOT COMPLETED|Overall Study||1
370548|NCT00399893|901879|P2|COMPLETED|Overall Study||3
370549|NCT00399893|901880|P1|COMPLETED|Overall Study|Participant withdrew after 3 months but was included in results|1
370550|NCT00399893|901879|P2|STARTED|Overall Study||3
370551|NCT00399893|901880|P1|STARTED|Overall Study||2
370552|NCT00399880|901908|P2|NOT COMPLETED|Overall Study||0
370553|NCT00399880|901909|P1|NOT COMPLETED|Overall Study||0
370554|NCT00399880|901908|P2|COMPLETED|Overall Study||65
370555|NCT00399880|901909|P1|COMPLETED|Overall Study||65
370556|NCT00399880|901908|P2|STARTED|Overall Study||65
370557|NCT00399880|901909|P1|STARTED|Overall Study||65
370558|NCT00399802|901919|P2|NOT COMPLETED|Overall Study||3
370559|NCT00399802|901920|P1|NOT COMPLETED|Overall Study||0
370560|NCT00399802|901919|P2|COMPLETED|Overall Study||26
370561|NCT00399802|901920|P1|COMPLETED|Overall Study||14
370562|NCT00399802|901919|P2|STARTED|Overall Study||29
370563|NCT00399802|901920|P1|STARTED|Overall Study||14
370564|NCT00399763|901934|P2|NOT COMPLETED|Overall Study||3
370565|NCT00399763|901935|P1|NOT COMPLETED|Overall Study||2
370566|NCT00399763|901934|P2|COMPLETED|Overall Study||32
370567|NCT00399763|901935|P1|COMPLETED|Overall Study||33
370568|NCT00399763|901934|P2|STARTED|Overall Study||35
370569|NCT00399763|901935|P1|STARTED|Overall Study||35
370570|NCT00399568|901947|P2|NOT COMPLETED|Overall Study||9
370571|NCT00399568|901948|P1|NOT COMPLETED|Overall Study||12
370572|NCT00399568|901947|P2|COMPLETED|Overall Study||156
370573|NCT00399568|901948|P1|COMPLETED|Overall Study||154
370574|NCT00399568|901947|P2|STARTED|Overall Study||165
370575|NCT00399568|901948|P1|STARTED|Overall Study||166
370576|NCT00399542|901962|P2|NOT COMPLETED|Overall Study||43
370577|NCT00399542|901963|P1|NOT COMPLETED|Overall Study||84
370578|NCT00399542|901962|P2|COMPLETED|Overall Study||151
370579|NCT00399542|901963|P1|COMPLETED|Overall Study||303
370580|NCT00399542|901962|P2|STARTED|Overall Study||194
370581|NCT00399542|901963|P1|STARTED|Overall Study||387
370582|NCT00399516|902025|P1|NOT COMPLETED|Overall Study||2
370583|NCT00399516|902025|P1|COMPLETED|Overall Study||19
370584|NCT00399516|902025|P1|STARTED|Overall Study||21
370585|NCT00399360|902033|P4|NOT COMPLETED|Overall Study||6
370586|NCT00399360|902034|P3|NOT COMPLETED|Overall Study||3
370587|NCT00399360|902035|P2|NOT COMPLETED|Overall Study||3
370588|NCT00399360|902036|P1|NOT COMPLETED|Overall Study||2
370589|NCT00399360|902033|P4|COMPLETED|Overall Study||9
370590|NCT00399360|902034|P3|COMPLETED|Overall Study||10
370591|NCT00399360|902035|P2|COMPLETED|Overall Study||8
370592|NCT00399360|902036|P1|COMPLETED|Overall Study||9
370593|NCT00399360|902033|P4|STARTED|Overall Study||15
370594|NCT00399360|902034|P3|STARTED|Overall Study||13
370595|NCT00399360|902035|P2|STARTED|Overall Study||11
370596|NCT00399360|902036|P1|STARTED|Overall Study||11
370597|NCT00399308|902085|P3|NOT COMPLETED|Overall Study||1
370598|NCT00399308|902086|P2|NOT COMPLETED|Overall Study||0
370599|NCT00399308|902087|P1|NOT COMPLETED|Overall Study||0
370600|NCT00399308|902085|P3|COMPLETED|Overall Study|One patient withdrew: did not want to comply with study requirements|11
370601|NCT00399308|902086|P2|COMPLETED|Overall Study||15
370602|NCT00399308|902087|P1|COMPLETED|Overall Study||13
370603|NCT00399308|902085|P3|STARTED|Overall Study||12
370604|NCT00399308|902086|P2|STARTED|Overall Study||15
370605|NCT00399308|902087|P1|STARTED|Overall Study||13
370606|NCT00399035|902107|P3|NOT COMPLETED|Overall Study||252
370607|NCT00399035|902108|P2|NOT COMPLETED|Overall Study||158
370608|NCT00399035|902109|P1|NOT COMPLETED|Overall Study||313
370609|NCT00399035|902107|P3|COMPLETED|Overall Study||106
370610|NCT00399035|902108|P2|COMPLETED|Overall Study||58
370611|NCT00399035|902109|P1|COMPLETED|Overall Study||189
370614|NCT00399035|902109|P1|STARTED|Overall Study||502
370615|NCT00398983|902130|P2|NOT COMPLETED|Overall Study||0
370616|NCT00398983|902131|P1|NOT COMPLETED|Overall Study||0
370617|NCT00398983|902130|P2|COMPLETED|Overall Study||25
370618|NCT00398983|902131|P1|COMPLETED|Overall Study||20
370619|NCT00398983|902130|P2|STARTED|Overall Study||25
370620|NCT00398983|902131|P1|STARTED|Overall Study||20
370621|NCT00398918|902137|P1|NOT COMPLETED|Overall Study||0
370622|NCT00398918|902137|P1|COMPLETED|Overall Study||10
370623|NCT00398918|902137|P1|STARTED|Overall Study||10
370624|NCT00398866|902145|P3|NOT COMPLETED|Overall Study||8
370625|NCT00398866|902146|P2|NOT COMPLETED|Overall Study||8
370626|NCT00398866|902147|P1|NOT COMPLETED|Overall Study||14
370627|NCT00398866|902145|P3|COMPLETED|Overall Study||58
370628|NCT00398866|902146|P2|COMPLETED|Overall Study||60
370629|NCT00398866|902147|P1|COMPLETED|Overall Study||52
370630|NCT00398866|902145|P3|STARTED|Overall Study||66
370631|NCT00398866|902146|P2|STARTED|Overall Study||68
370632|NCT00398866|902147|P1|STARTED|Overall Study||66
370633|NCT00398632|902158|P1|NOT COMPLETED|Overall Study||2
370634|NCT00398632|902158|P1|COMPLETED|Overall Study|2/6 subjects withdrew at end of week 6; 1 for lack of efficacy, 1 because of time constraints.|4
370635|NCT00398632|902158|P1|STARTED|Overall Study||6
370636|NCT00398567|902166|P3|NOT COMPLETED|Overall Study||34
370637|NCT00398567|902167|P2|NOT COMPLETED|Overall Study||4
370638|NCT00398567|902168|P1|NOT COMPLETED|Overall Study||4
370639|NCT00398567|902166|P3|COMPLETED|Overall Study||3
370640|NCT00398567|902167|P2|COMPLETED|Overall Study||0
370641|NCT00398567|902168|P1|COMPLETED|Overall Study||0
370642|NCT00398567|902166|P3|STARTED|Overall Study||37
370643|NCT00398567|902167|P2|STARTED|Overall Study||4
370644|NCT00398567|902168|P1|STARTED|Overall Study||4
370645|NCT00398476|902180|P2|NOT COMPLETED|Treatment Period 2||0
370646|NCT00398476|902181|P1|NOT COMPLETED|Treatment Period 2||0
370647|NCT00398476|902180|P2|COMPLETED|Treatment Period 2||64
370648|NCT00398476|902181|P1|COMPLETED|Treatment Period 2||63
370649|NCT00398476|902180|P2|STARTED|Treatment Period 2||64
370650|NCT00398476|902181|P1|STARTED|Treatment Period 2||63
370651|NCT00398476|902180|P2|NOT COMPLETED|Washout Period (20 Minutes)||0
370652|NCT00398476|902181|P1|NOT COMPLETED|Washout Period (20 Minutes)||0
370653|NCT00398476|902180|P2|COMPLETED|Washout Period (20 Minutes)||64
370654|NCT00398476|902181|P1|COMPLETED|Washout Period (20 Minutes)||63
370655|NCT00398476|902180|P2|STARTED|Washout Period (20 Minutes)||64
370656|NCT00398476|902181|P1|STARTED|Washout Period (20 Minutes)||63
370657|NCT00398476|902180|P2|NOT COMPLETED|Treatment Period 1||0
370658|NCT00398476|902181|P1|NOT COMPLETED|Treatment Period 1||0
370659|NCT00398476|902180|P2|COMPLETED|Treatment Period 1||64
370660|NCT00398476|902181|P1|COMPLETED|Treatment Period 1||63
370661|NCT00398476|902180|P2|STARTED|Treatment Period 1||64
370662|NCT00398476|902181|P1|STARTED|Treatment Period 1||63
370663|NCT00398411|902222|P2|NOT COMPLETED|Overall Study||1
370664|NCT00398411|902223|P1|NOT COMPLETED|Overall Study||0
370665|NCT00398411|902222|P2|COMPLETED|Overall Study||31
370666|NCT00398411|902223|P1|COMPLETED|Overall Study||34
370667|NCT00398411|902222|P2|STARTED|Overall Study||32
370668|NCT00398411|902223|P1|STARTED|Overall Study||34
370669|NCT00398398|902239|P1|NOT COMPLETED|Overall Study||0
370670|NCT00398398|902239|P1|COMPLETED|Overall Study||44
370671|NCT00398398|902239|P1|STARTED|Overall Study||44
370672|NCT00398320|902246|P1|NOT COMPLETED|Overall Study||6
370673|NCT00398320|902246|P1|COMPLETED|Overall Study||34
370674|NCT00398320|902246|P1|STARTED|Overall Study||40
370675|NCT00398216|902259|P5|NOT COMPLETED|Overall Study||15
370676|NCT00398216|902260|P4|NOT COMPLETED|Overall Study||22
370677|NCT00398216|902261|P3|NOT COMPLETED|Overall Study||21
370678|NCT00398216|902262|P2|NOT COMPLETED|Overall Study||19
370679|NCT00398216|902263|P1|NOT COMPLETED|Overall Study||11
370680|NCT00398216|902259|P5|COMPLETED|Overall Study||157
370681|NCT00398216|902260|P4|COMPLETED|Overall Study||155
370682|NCT00398216|902261|P3|COMPLETED|Overall Study||164
370683|NCT00398216|902262|P2|COMPLETED|Overall Study||151
370684|NCT00398216|902263|P1|COMPLETED|Overall Study||181
370685|NCT00398216|902259|P5|STARTED|Overall Study||172
370686|NCT00398216|902260|P4|STARTED|Overall Study||177
370687|NCT00398216|902261|P3|STARTED|Overall Study||185
370688|NCT00398216|902262|P2|STARTED|Overall Study||170
370689|NCT00398216|902263|P1|STARTED|Overall Study||192
370690|NCT00398138|902290|P1|NOT COMPLETED|Overall Study||2
370691|NCT00398138|902290|P1|COMPLETED|Overall Study||10
370692|NCT00398138|902290|P1|STARTED|Overall Study||12
370693|NCT00398112|902295|P1|NOT COMPLETED|Overall Study||18
370694|NCT00398112|902295|P1|COMPLETED|Overall Study||0
370695|NCT00398112|902295|P1|STARTED|Overall Study||18
370696|NCT00398086|902306|P3|NOT COMPLETED|Overall Study||2
370697|NCT00398086|902307|P2|NOT COMPLETED|Overall Study||23
370698|NCT00398086|902308|P1|NOT COMPLETED|Overall Study||9
370699|NCT00398086|902306|P3|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|1
370700|NCT00398086|902307|P2|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|21
370701|NCT00398086|902308|P1|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|11
370702|NCT00398086|902306|P3|Phase 1, Dose Escalation Population|Overall Study||3
370703|NCT00398086|902307|P2|Phase 1, Dose Escalation Population|Overall Study||7
370704|NCT00398086|902308|P1|Phase 1, Dose Escalation Population|Overall Study||20
370705|NCT00398086|902306|P3|STARTED|Overall Study||3
370706|NCT00398086|902307|P2|STARTED|Overall Study||44
370707|NCT00398086|902308|P1|STARTED|Overall Study||20
370708|NCT00398073|902342|P2|NOT COMPLETED|Overall Study||0
370709|NCT00398073|902343|P1|NOT COMPLETED|Overall Study||1
370710|NCT00398073|902342|P2|COMPLETED|Overall Study||17
370711|NCT00398073|902343|P1|COMPLETED|Overall Study||17
370712|NCT00398073|902342|P2|STARTED|Overall Study||17
370713|NCT00398073|902343|P1|STARTED|Overall Study||18
370714|NCT00398047|902353|P1|NOT COMPLETED|Overall Study||3
370715|NCT00398047|902353|P1|COMPLETED|Overall Study|all three patients progressed before completing|0
370716|NCT00398047|902353|P1|STARTED|Overall Study||3
370717|NCT00397982|902363|P1|NOT COMPLETED|Overall Study||4
370718|NCT00397982|902363|P1|COMPLETED|Overall Study||13
370719|NCT00397982|902363|P1|STARTED|Overall Study||17
370720|NCT00397943|902377|P5|NOT COMPLETED|Overall Study||0
370721|NCT00397943|902378|P4|NOT COMPLETED|Overall Study||0
370722|NCT00397943|902379|P3|NOT COMPLETED|Overall Study||0
370723|NCT00397943|902380|P2|NOT COMPLETED|Overall Study||9
370724|NCT00397943|902381|P1|NOT COMPLETED|Overall Study||12
370725|NCT00397943|902377|P5|COMPLETED|Overall Study||10
370726|NCT00397943|902378|P4|COMPLETED|Overall Study||10
370727|NCT00397943|902379|P3|COMPLETED|Overall Study||10
370728|NCT00397943|902380|P2|COMPLETED|Overall Study||31
370729|NCT00397943|902381|P1|COMPLETED|Overall Study||28
370730|NCT00397943|902377|P5|STARTED|Overall Study||10
370731|NCT00397943|902378|P4|STARTED|Overall Study||10
370732|NCT00397943|902379|P3|STARTED|Overall Study||10
370733|NCT00397943|902380|P2|STARTED|Overall Study||40
370734|NCT00397943|902381|P1|STARTED|Overall Study||40
370735|NCT00397930|902537|P2|NOT COMPLETED|Overall Study||51
370736|NCT00397930|902538|P1|NOT COMPLETED|Overall Study||38
370737|NCT00397930|902537|P2|COMPLETED|Overall Study||153
370738|NCT00397930|902538|P1|COMPLETED|Overall Study||168
370739|NCT00397930|902537|P2|STARTED|Overall Study||204
370740|NCT00397930|902538|P1|STARTED|Overall Study||206
370741|NCT00397904|902544|P1|NOT COMPLETED|Overall Study||0
370742|NCT00397904|902544|P1|COMPLETED|Overall Study||16
370743|NCT00397904|902544|P1|STARTED|Overall Study||16
370744|NCT00397891|902553|P5|NOT COMPLETED|Overall Study||1
370745|NCT00397891|902554|P4|NOT COMPLETED|Overall Study||0
370746|NCT00397891|902555|P3|NOT COMPLETED|Overall Study||0
370747|NCT00397891|902556|P2|NOT COMPLETED|Overall Study||0
370748|NCT00397891|902557|P1|NOT COMPLETED|Overall Study||1
370749|NCT00397891|902553|P5|COMPLETED|Overall Study||7
370750|NCT00397891|902554|P4|COMPLETED|Overall Study||6
370751|NCT00397891|902555|P3|COMPLETED|Overall Study||6
370752|NCT00397891|902556|P2|COMPLETED|Overall Study||6
370753|NCT00397891|902557|P1|COMPLETED|Overall Study||5
370754|NCT00397891|902553|P5|STARTED|Overall Study||8
370755|NCT00397891|902554|P4|STARTED|Overall Study||6
370756|NCT00397891|902555|P3|STARTED|Overall Study||6
370757|NCT00397891|902556|P2|STARTED|Overall Study||6
370758|NCT00397891|902557|P1|STARTED|Overall Study||6
370759|NCT00397878|902655|P1|NOT COMPLETED|Overall Study||0
370760|NCT00397878|902655|P1|COMPLETED|Overall Study||10
370761|NCT00397878|902655|P1|STARTED|Overall Study||10
370762|NCT00397839|902664|P2|NOT COMPLETED|Overall Study||18
370763|NCT00397839|902665|P1|NOT COMPLETED|Overall Study||7
370764|NCT00397839|902664|P2|COMPLETED|Overall Study||69
370765|NCT00397839|902665|P1|COMPLETED|Overall Study||41
370766|NCT00397839|902664|P2|STARTED|Overall Study||87
370767|NCT00397839|902665|P1|STARTED|Overall Study||48
370768|NCT00397813|902685|P6|NOT COMPLETED|Overall Study||0
370769|NCT00397813|902686|P5|NOT COMPLETED|Overall Study||0
370770|NCT00397813|902687|P4|NOT COMPLETED|Overall Study||0
370771|NCT00397813|902688|P3|NOT COMPLETED|Overall Study||0
370772|NCT00397813|902689|P2|NOT COMPLETED|Overall Study||0
370773|NCT00397813|902690|P1|NOT COMPLETED|Overall Study||0
370774|NCT00397813|902685|P6|COMPLETED|Overall Study||24
370775|NCT00397813|902686|P5|COMPLETED|Overall Study||5
370776|NCT00397813|902687|P4|COMPLETED|Overall Study||12
370777|NCT00397813|902688|P3|COMPLETED|Overall Study||0
370778|NCT00397813|902689|P2|COMPLETED|Overall Study||0
370779|NCT00397813|902690|P1|COMPLETED|Overall Study||36
370780|NCT00397813|902685|P6|STARTED|Overall Study||24
370781|NCT00397813|902686|P5|STARTED|Overall Study||5
370782|NCT00397813|902687|P4|STARTED|Overall Study||12
370783|NCT00397813|902688|P3|STARTED|Overall Study||0
370784|NCT00397813|902689|P2|STARTED|Overall Study||0
370785|NCT00397813|902690|P1|STARTED|Overall Study||36
370786|NCT00397631|902730|P2|NOT COMPLETED|Overall Study||44
370787|NCT00397631|902731|P1|NOT COMPLETED|Overall Study||30
370788|NCT00397631|902730|P2|COMPLETED|Overall Study||215
370789|NCT00397631|902731|P1|COMPLETED|Overall Study||231
370790|NCT00397631|902730|P2|STARTED|Overall Study||259
370791|NCT00397631|902731|P1|STARTED|Overall Study|Randomization ratio was 1:1|261
370792|NCT00397579|902741|P1|NOT COMPLETED|Overall Study||0
370793|NCT00397579|902741|P1|COMPLETED|Overall Study||11
370794|NCT00397579|902741|P1|STARTED|Overall Study||11
370795|NCT00397540|902747|P2|NOT COMPLETED|Overall Study||0
370796|NCT00397540|902748|P1|NOT COMPLETED|Overall Study||1
370797|NCT00397540|902747|P2|COMPLETED|Overall Study||85
370798|NCT00397540|902748|P1|COMPLETED|Overall Study||59
370799|NCT00397540|902747|P2|STARTED|Overall Study||85
370800|NCT00397540|902748|P1|STARTED|Overall Study||60
370801|NCT00397514|902756|P1|NOT COMPLETED|Overall Study||9
370802|NCT00397514|902756|P1|COMPLETED|Overall Study||25
370803|NCT00397514|902756|P1|STARTED|Overall Study||34
370804|NCT00397488|902766|P1|NOT COMPLETED|Overall Study||7
370805|NCT00397488|902766|P1|COMPLETED|Overall Study||71
370806|NCT00397488|902766|P1|STARTED|Overall Study||78
370807|NCT00397462|902773|P3|NOT COMPLETED|Overall Study||0
370808|NCT00397462|902774|P2|NOT COMPLETED|Overall Study||0
370809|NCT00397462|902775|P1|NOT COMPLETED|Overall Study||0
370810|NCT00397462|902773|P3|COMPLETED|Overall Study||15
370811|NCT00397462|902774|P2|COMPLETED|Overall Study||13
370812|NCT00397462|902775|P1|COMPLETED|Overall Study||16
370813|NCT00397462|902773|P3|STARTED|Overall Study||15
370814|NCT00397462|902774|P2|STARTED|Overall Study||13
370815|NCT00397462|902775|P1|STARTED|Overall Study||16
370816|NCT00397254|902786|P2|NOT COMPLETED|Overall Study||2
370817|NCT00397254|902787|P1|NOT COMPLETED|Overall Study||2
370818|NCT00397254|902786|P2|COMPLETED|Overall Study||74
370819|NCT00397254|902787|P1|COMPLETED|Overall Study||77
370820|NCT00397254|902786|P2|STARTED|Overall Study||76
370821|NCT00397254|902787|P1|STARTED|Overall Study||79
370822|NCT00397215|902809|P4|NOT COMPLETED|Month 24 (Day 720)||0
370823|NCT00397215|902810|P3|NOT COMPLETED|Month 24 (Day 720)||0
370824|NCT00397215|902811|P2|NOT COMPLETED|Month 24 (Day 720)||0
370825|NCT00397215|902812|P1|NOT COMPLETED|Month 24 (Day 720)||0
370826|NCT00397215|902809|P4|COMPLETED|Month 24 (Day 720)||36
370827|NCT00397215|902810|P3|COMPLETED|Month 24 (Day 720)||117
370828|NCT00397215|902811|P2|COMPLETED|Month 24 (Day 720)||45
370829|NCT00397215|902812|P1|COMPLETED|Month 24 (Day 720)||122
370830|NCT00397215|902809|P4|STARTED|Month 24 (Day 720)||36
370831|NCT00397215|902810|P3|STARTED|Month 24 (Day 720)||117
370832|NCT00397215|902811|P2|STARTED|Month 24 (Day 720)||45
370833|NCT00397215|902812|P1|STARTED|Month 24 (Day 720)||122
370834|NCT00397215|902809|P4|NOT COMPLETED|Month 12 (Day 360)||0
370835|NCT00397215|902810|P3|NOT COMPLETED|Month 12 (Day 360)||0
370836|NCT00397215|902811|P2|NOT COMPLETED|Month 12 (Day 360)||0
370837|NCT00397215|902812|P1|NOT COMPLETED|Month 12 (Day 360)||0
370838|NCT00397215|902809|P4|COMPLETED|Month 12 (Day 360)||42
370839|NCT00397215|902810|P3|COMPLETED|Month 12 (Day 360)||125
370840|NCT00397215|902811|P2|COMPLETED|Month 12 (Day 360)||48
370841|NCT00397215|902812|P1|COMPLETED|Month 12 (Day 360)||130
370842|NCT00397215|902809|P4|STARTED|Month 12 (Day 360)||42
370843|NCT00397215|902810|P3|STARTED|Month 12 (Day 360)||125
370844|NCT00397215|902811|P2|STARTED|Month 12 (Day 360)||48
370845|NCT00397215|902812|P1|STARTED|Month 12 (Day 360)||130
370846|NCT00397215|902809|P4|NOT COMPLETED|Month 6 (Day 180)||0
370847|NCT00397215|902810|P3|NOT COMPLETED|Month 6 (Day 180)||5
370848|NCT00397215|902811|P2|NOT COMPLETED|Month 6 (Day 180)||3
370849|NCT00397215|902812|P1|NOT COMPLETED|Month 6 (Day 180)||2
370850|NCT00397215|902809|P4|COMPLETED|Month 6 (Day 180)||51
370851|NCT00397215|902810|P3|COMPLETED|Month 6 (Day 180)||153
370852|NCT00397215|902811|P2|COMPLETED|Month 6 (Day 180)||55
370853|NCT00397215|902812|P1|COMPLETED|Month 6 (Day 180)||162
370854|NCT00397215|902809|P4|STARTED|Month 6 (Day 180)||51
370855|NCT00397215|902810|P3|STARTED|Month 6 (Day 180)||158
370856|NCT00397215|902811|P2|STARTED|Month 6 (Day 180)||58
370857|NCT00397215|902812|P1|STARTED|Month 6 (Day 180)||164
370858|NCT00397215|902809|P4|NOT COMPLETED|Month 0 (Day 0)||4
370859|NCT00397215|902810|P3|NOT COMPLETED|Month 0 (Day 0)||6
370860|NCT00397215|902811|P2|NOT COMPLETED|Month 0 (Day 0)||5
370861|NCT00397215|902812|P1|NOT COMPLETED|Month 0 (Day 0)||7
370862|NCT00397215|902809|P4|COMPLETED|Month 0 (Day 0)||48
370863|NCT00397215|902810|P3|COMPLETED|Month 0 (Day 0)||153
370864|NCT00397215|902811|P2|COMPLETED|Month 0 (Day 0)||56
370865|NCT00397215|902812|P1|COMPLETED|Month 0 (Day 0)||158
370866|NCT00397215|902809|P4|STARTED|Month 0 (Day 0)||52
370867|NCT00397215|902810|P3|STARTED|Month 0 (Day 0)||159
370868|NCT00397215|902811|P2|STARTED|Month 0 (Day 0)||61
370869|NCT00397215|902812|P1|STARTED|Month 0 (Day 0)||165
370870|NCT00397189|902948|P2|NOT COMPLETED|Extension Period||43
370871|NCT00397189|902949|P1|NOT COMPLETED|Extension Period||113
370872|NCT00397189|902948|P2|COMPLETED|Extension Period||134
370873|NCT00397189|902949|P1|COMPLETED|Extension Period||421
370874|NCT00397189|902948|P2|STARTED|Extension Period|Please note randomization ratio in extension is 3:1|177
370875|NCT00397189|902949|P1|STARTED|Extension Period|Not all completers continued to extension as only patients who wished to proceed were randomized.|534
370876|NCT00397189|902948|P2|NOT COMPLETED|3 Weeks Period||22
370877|NCT00397189|902949|P1|NOT COMPLETED|3 Weeks Period||21
370878|NCT00397189|902948|P2|COMPLETED|3 Weeks Period|out of 373, 362 were included in the ITT population detailed in the Baseline Characteristics|373
370879|NCT00397189|902949|P1|COMPLETED|3 Weeks Period|out of 373, 360 were included in the ITT population detailed in the Baseline Characteristics.|373
370880|NCT00397189|902948|P2|STARTED|3 Weeks Period||395
370881|NCT00397189|902949|P1|STARTED|3 Weeks Period||394
370882|NCT00397150|902959|P2|NOT COMPLETED|Overall Study||145
370883|NCT00397150|902960|P1|NOT COMPLETED|Overall Study||135
370884|NCT00397150|902959|P2|COMPLETED|Overall Study||1111
370885|NCT00397150|902960|P1|COMPLETED|Overall Study||1188
370886|NCT00397150|902959|P2|STARTED|Overall Study||1256
370887|NCT00397150|902960|P1|STARTED|Overall Study||1323
370888|NCT00397046|902976|P4|NOT COMPLETED|Overall Study||5
370889|NCT00397046|902977|P3|NOT COMPLETED|Overall Study||10
370890|NCT00397046|902978|P2|NOT COMPLETED|Overall Study||3
370891|NCT00397046|902979|P1|NOT COMPLETED|Overall Study||3
370892|NCT00397046|902976|P4|COMPLETED|Overall Study||0
370893|NCT00397046|902977|P3|COMPLETED|Overall Study||0
370894|NCT00397046|902978|P2|COMPLETED|Overall Study||0
370895|NCT00397046|902979|P1|COMPLETED|Overall Study||0
370896|NCT00397046|902976|P4|STARTED|Overall Study||5
370897|NCT00397046|902977|P3|STARTED|Overall Study||10
370898|NCT00397046|902978|P2|STARTED|Overall Study||3
370899|NCT00397046|902979|P1|STARTED|Overall Study||3
370900|NCT00397033|903001|P3|NOT COMPLETED|Overall Study||23
370901|NCT00397033|903002|P2|NOT COMPLETED|Overall Study||37
370902|NCT00397033|903003|P1|NOT COMPLETED|Overall Study||44
370903|NCT00397033|903001|P3|COMPLETED|Overall Study||77
370904|NCT00397033|903002|P2|COMPLETED|Overall Study||72
370905|NCT00397033|903003|P1|COMPLETED|Overall Study||63
370906|NCT00397033|903001|P3|ITT Population|Overall Study||98
370907|NCT00397033|903002|P2|ITT Population|Overall Study||105
370908|NCT00397033|903003|P1|ITT Population|Overall Study||107
370909|NCT00397033|903001|P3|Safety Population: >= 1 Dose of Drug|Overall Study||98
370910|NCT00397033|903002|P2|Safety Population: >= 1 Dose of Drug|Overall Study||108
370911|NCT00397033|903003|P1|Safety Population: >= 1 Dose of Drug|Overall Study||107
370912|NCT00397033|903001|P3|STARTED|Overall Study||100
370913|NCT00397033|903002|P2|STARTED|Overall Study||109
370914|NCT00397033|903003|P1|STARTED|Overall Study||107
370915|NCT00397020|903064|P2|NOT COMPLETED|Overall Study||1
370916|NCT00397020|903065|P1|NOT COMPLETED|Overall Study||1
370917|NCT00397020|903064|P2|COMPLETED|Overall Study||15
370918|NCT00397020|903065|P1|COMPLETED|Overall Study||13
370919|NCT00397020|903064|P2|STARTED|Overall Study||16
370920|NCT00397020|903065|P1|STARTED|Overall Study||14
370921|NCT00396981|903073|P2|NOT COMPLETED|Overall Study||9
370922|NCT00396981|903074|P1|NOT COMPLETED|Overall Study||15
370923|NCT00396981|903073|P2|COMPLETED|Overall Study||306
370924|NCT00396981|903074|P1|COMPLETED|Overall Study||296
370925|NCT00396981|903073|P2|STARTED|Overall Study||315
370926|NCT00396981|903074|P1|STARTED|Overall Study||311
370927|NCT00396877|903094|P2|NOT COMPLETED|Overall Study||8
370928|NCT00396877|903095|P1|NOT COMPLETED|Overall Study||6
370929|NCT00396877|903094|P2|COMPLETED|Overall Study|Completed follow-up|459
370930|NCT00396877|903095|P1|COMPLETED|Overall Study|Completed follow-up|433
370931|NCT00396877|903094|P2|Completed Treatment|Overall Study||352
370932|NCT00396877|903095|P1|Completed Treatment|Overall Study||356
370933|NCT00396877|903094|P2|Treated|Overall Study||464
370934|NCT00396877|903095|P1|Treated|Overall Study||436
370935|NCT00396877|903094|P2|STARTED|Overall Study|Randomized|467
370936|NCT00396877|903095|P1|STARTED|Overall Study|Randomized|439
370937|NCT00396812|903105|P1|NOT COMPLETED|Overall Study||1
370938|NCT00396812|903105|P1|COMPLETED|Overall Study|4 subjects completed treatment, but 1 subject terminated early due to disease progression|3
370939|NCT00396812|903105|P1|STARTED|Overall Study||4
370940|NCT00396656|903117|P2|NOT COMPLETED|Second Treatment Period||1
370941|NCT00396656|903118|P1|NOT COMPLETED|Second Treatment Period||0
370942|NCT00396656|903117|P2|COMPLETED|Second Treatment Period||12
370943|NCT00396656|903118|P1|COMPLETED|Second Treatment Period||15
370944|NCT00396656|903117|P2|STARTED|Second Treatment Period||13
370945|NCT00396656|903118|P1|STARTED|Second Treatment Period||15
370946|NCT00396656|903117|P2|NOT COMPLETED|First Treatment Period||2
370947|NCT00396656|903118|P1|NOT COMPLETED|First Treatment Period||0
370948|NCT00396656|903117|P2|COMPLETED|First Treatment Period||13
370949|NCT00396656|903118|P1|COMPLETED|First Treatment Period||15
370950|NCT00396656|903117|P2|STARTED|First Treatment Period||15
370951|NCT00396656|903118|P1|STARTED|First Treatment Period||15
370952|NCT00396630|903136|P2|NOT COMPLETED|Overall Study||5
370953|NCT00396630|903137|P1|NOT COMPLETED|Overall Study||5
370954|NCT00396630|903136|P2|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
370955|NCT00396630|903137|P1|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
370956|NCT00396630|903136|P2|STARTED|Overall Study||100
370957|NCT00396630|903137|P1|STARTED|Overall Study||100
370958|NCT00396591|903157|P1|NOT COMPLETED|Overall Study||16
370959|NCT00396591|903157|P1|COMPLETED|Overall Study||0
370960|NCT00396591|903157|P1|STARTED|Overall Study||16
370961|NCT00396565|903170|P3|NOT COMPLETED|Overall Study||17
370962|NCT00396565|903171|P2|NOT COMPLETED|Overall Study||91
370963|NCT00396565|903172|P1|NOT COMPLETED|Overall Study||48
370964|NCT00396565|903170|P3|COMPLETED|Overall Study||30
370965|NCT00396565|903171|P2|COMPLETED|Overall Study||47
370966|NCT00396565|903172|P1|COMPLETED|Overall Study||88
370967|NCT00396565|903170|P3|STARTED|Overall Study||47
370968|NCT00396565|903171|P2|STARTED|Overall Study||138
370969|NCT00396565|903172|P1|STARTED|Overall Study||136
370970|NCT00396409|903197|P2|NOT COMPLETED|Period 2 - 2008||2
370971|NCT00396409|903198|P1|NOT COMPLETED|Period 2 - 2008||7
370972|NCT00396409|903197|P2|COMPLETED|Period 2 - 2008||53
370973|NCT00396409|903198|P1|COMPLETED|Period 2 - 2008||52
370974|NCT00396409|903197|P2|STARTED|Period 2 - 2008||55
370975|NCT00396409|903198|P1|STARTED|Period 2 - 2008||59
370976|NCT00396409|903197|P2|NOT COMPLETED|Between Period 1 and Period 2||2
370977|NCT00396409|903198|P1|NOT COMPLETED|Between Period 1 and Period 2||3
370978|NCT00396409|903197|P2|COMPLETED|Between Period 1 and Period 2||55
370979|NCT00396409|903198|P1|COMPLETED|Between Period 1 and Period 2||59
370980|NCT00396409|903197|P2|STARTED|Between Period 1 and Period 2||57
370981|NCT00396409|903198|P1|STARTED|Between Period 1 and Period 2||62
370982|NCT00396409|903197|P2|NOT COMPLETED|Period 1 - 2007||6
370983|NCT00396409|903198|P1|NOT COMPLETED|Period 1 - 2007||3
370984|NCT00396409|903197|P2|COMPLETED|Period 1 - 2007||57
370985|NCT00396409|903198|P1|COMPLETED|Period 1 - 2007||62
370986|NCT00396409|903197|P2|STARTED|Period 1 - 2007||63
370987|NCT00396409|903198|P1|STARTED|Period 1 - 2007||65
370988|NCT00396383|903228|P1|NOT COMPLETED|Overall Study||3
370989|NCT00396383|903228|P1|COMPLETED|Overall Study||6
370990|NCT00396383|903228|P1|STARTED|Overall Study||9
370991|NCT00396331|903241|P1|NOT COMPLETED|Overall Study||32
370992|NCT00396331|903241|P1|COMPLETED|Overall Study||68
370993|NCT00396331|903241|P1|Number of Participants Transplanted|Overall Study|7 participants had two transplants|87
370994|NCT00396331|903241|P1|Number of Participants Treated|Overall Study||100
370995|NCT00396331|903241|P1|STARTED|Overall Study||100
370996|NCT00396318|903294|P1|NOT COMPLETED|7-Day Post-Treatment Contact||1
370997|NCT00396318|903294|P1|COMPLETED|7-Day Post-Treatment Contact||240
370998|NCT00396318|903294|P1|STARTED|7-Day Post-Treatment Contact||241
370999|NCT00396318|903294|P1|NOT COMPLETED|48- to 96-Hour Follow-Up Period||5
371000|NCT00396318|903294|P1|COMPLETED|48- to 96-Hour Follow-Up Period||241
371001|NCT00396318|903294|P1|STARTED|48- to 96-Hour Follow-Up Period||246
371002|NCT00396318|903294|P1|NOT COMPLETED|At Least One Dose of Tenecteplase (MITT)||5
371003|NCT00396318|903294|P1|COMPLETED|At Least One Dose of Tenecteplase (MITT)||241
371004|NCT00396318|903294|P1|STARTED|At Least One Dose of Tenecteplase (MITT)||246
371005|NCT00396292|903307|P2|NOT COMPLETED|Overall Study||16
371006|NCT00396292|903308|P1|NOT COMPLETED|Overall Study||9
371007|NCT00396292|903307|P2|COMPLETED|Overall Study||162
371008|NCT00396292|903308|P1|COMPLETED|Overall Study||165
371009|NCT00396292|903307|P2|STARTED|Overall Study||178
371010|NCT00396292|903308|P1|STARTED|Overall Study||174
371011|NCT00396279|903314|P1|NOT COMPLETED|Overall Study||30
371012|NCT00396279|903314|P1|COMPLETED|Overall Study|Defined as participants with a complete resection|7
371013|NCT00396279|903314|P1|STARTED|Overall Study||37
371014|NCT00396266|903325|P2|NOT COMPLETED|Overall Study||0
371015|NCT00396266|903326|P1|NOT COMPLETED|Overall Study||0
371016|NCT00396266|903325|P2|COMPLETED|Overall Study||14
371017|NCT00396266|903326|P1|COMPLETED|Overall Study||8
371018|NCT00396266|903325|P2|STARTED|Overall Study||14
371019|NCT00396266|903326|P1|STARTED|Overall Study||8
371020|NCT00396253|903347|P1|NOT COMPLETED|Overall Study||13
371021|NCT00396253|903347|P1|COMPLETED|Overall Study||210
371022|NCT00396253|903347|P1|STARTED|Overall Study||223
371023|NCT00396201|903359|P1|NOT COMPLETED|Follow-up Period||0
371024|NCT00396201|903359|P1|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|21
371025|NCT00396201|903359|P1|STARTED|Follow-up Period|Participants who had transplants. One had insufficient collection of cells so no transplant.|21
371026|NCT00396201|903359|P1|NOT COMPLETED|Treatment Period||0
371027|NCT00396201|903359|P1|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|22
371028|NCT00396201|903359|P1|STARTED|Treatment Period||22
371029|NCT00396162|903378|P2|NOT COMPLETED|Overall Study||3
371030|NCT00396162|903379|P1|NOT COMPLETED|Overall Study||2
371031|NCT00396162|903378|P2|COMPLETED|Overall Study||35
371032|NCT00396162|903379|P1|COMPLETED|Overall Study||37
371033|NCT00396162|903378|P2|STARTED|Overall Study||38
371034|NCT00396162|903379|P1|STARTED|Overall Study||39
371035|NCT00396136|903391|P1|NOT COMPLETED|Overall Study||125
371036|NCT00396136|903391|P1|COMPLETED|Overall Study||96
371037|NCT00396136|903391|P1|STARTED|Overall Study||221
371038|NCT00396097|903398|P2|NOT COMPLETED|Overall Study||46
371039|NCT00396097|903399|P1|NOT COMPLETED|Overall Study||26
371040|NCT00396097|903398|P2|COMPLETED|Overall Study||156
371041|NCT00396097|903399|P1|COMPLETED|Overall Study||88
371042|NCT00396097|903398|P2|STARTED|Overall Study||202
371043|NCT00396097|903399|P1|STARTED|Overall Study|4 participants randomized to Individualized Dose, received Standard Dose throughout the study.|114
371044|NCT00396084|903427|P6|NOT COMPLETED|Overall Study||2
371045|NCT00396084|903428|P5|NOT COMPLETED|Overall Study||1
371046|NCT00396084|903429|P4|NOT COMPLETED|Overall Study||1
371047|NCT00396084|903430|P3|NOT COMPLETED|Overall Study||0
371048|NCT00396084|903431|P2|NOT COMPLETED|Overall Study||0
371049|NCT00396084|903432|P1|NOT COMPLETED|Overall Study||0
371050|NCT00396084|903427|P6|COMPLETED|Overall Study||18
371051|NCT00396084|903428|P5|COMPLETED|Overall Study||9
371052|NCT00396084|903429|P4|COMPLETED|Overall Study||9
371053|NCT00396084|903430|P3|COMPLETED|Overall Study||10
371054|NCT00396084|903431|P2|COMPLETED|Overall Study||10
371055|NCT00396084|903432|P1|COMPLETED|Overall Study||10
371056|NCT00396084|903427|P6|STARTED|Overall Study||20
371057|NCT00396084|903428|P5|STARTED|Overall Study||10
371058|NCT00396084|903429|P4|STARTED|Overall Study||10
371059|NCT00396084|903430|P3|STARTED|Overall Study||10
371060|NCT00396084|903431|P2|STARTED|Overall Study||10
371061|NCT00396084|903432|P1|STARTED|Overall Study||10
371062|NCT00396032|903507|P2|NOT COMPLETED|Overall Study||5
371063|NCT00396032|903508|P1|NOT COMPLETED|Overall Study||4
371064|NCT00396032|903507|P2|COMPLETED|Overall Study||71
371065|NCT00396032|903508|P1|COMPLETED|Overall Study||70
371066|NCT00396032|903507|P2|STARTED|Overall Study||76
371067|NCT00396032|903508|P1|STARTED|Overall Study||74
371068|NCT00396019|903525|P3|NOT COMPLETED|Overall Study||1
371069|NCT00396019|903526|P2|NOT COMPLETED|Overall Study||3
371070|NCT00396019|903527|P1|NOT COMPLETED|Overall Study||0
371071|NCT00396019|903525|P3|COMPLETED|Overall Study||29
371072|NCT00396019|903526|P2|COMPLETED|Overall Study||26
371073|NCT00396019|903527|P1|COMPLETED|Overall Study||27
371074|NCT00396019|903525|P3|STARTED|Overall Study||30
371075|NCT00396019|903526|P2|STARTED|Overall Study||29
371076|NCT00396019|903527|P1|STARTED|Overall Study||27
371077|NCT00396006|903537|P1|NOT COMPLETED|Overall Study||0
371078|NCT00396006|903537|P1|COMPLETED|Overall Study||13
371079|NCT00396006|903537|P1|STARTED|Overall Study||13
371080|NCT00395993|903554|P2|NOT COMPLETED|Overall Study||19
371081|NCT00395993|903555|P1|NOT COMPLETED|Overall Study||35
371082|NCT00395993|903554|P2|COMPLETED|Overall Study||212
371083|NCT00395993|903555|P1|COMPLETED|Overall Study||211
371084|NCT00395993|903554|P2|STARTED|Overall Study||231
371085|NCT00395993|903555|P1|STARTED|Overall Study||246
371086|NCT00395967|903561|P1|NOT COMPLETED|Follow-up Period||2
371087|NCT00395967|903561|P1|COMPLETED|Follow-up Period||3
371088|NCT00395967|903561|P1|STARTED|Follow-up Period|Participants who had transplants.|5
371089|NCT00395967|903561|P1|NOT COMPLETED|Treatment Period||1
371090|NCT00395967|903561|P1|COMPLETED|Treatment Period|Failed mobilization due to <2 fold yield after one day of plerixafor treatment|4
371091|NCT00395967|903561|P1|STARTED|Treatment Period||5
371092|NCT00395876|903572|P2|NOT COMPLETED|Overall Study||0
371093|NCT00395876|903573|P1|NOT COMPLETED|Overall Study||3
371094|NCT00395876|903572|P2|COMPLETED|Overall Study||50
371095|NCT00395876|903573|P1|COMPLETED|Overall Study||47
371096|NCT00395876|903572|P2|STARTED|Overall Study||50
371097|NCT00395876|903573|P1|STARTED|Overall Study||50
371098|NCT00395863|903601|P2|NOT COMPLETED|Overall Study||3
371099|NCT00395863|903602|P1|NOT COMPLETED|Overall Study||2
371100|NCT00395863|903601|P2|COMPLETED|Overall Study||20
371101|NCT00395863|903602|P1|COMPLETED|Overall Study||21
371102|NCT00395863|903601|P2|STARTED|Overall Study||23
371103|NCT00395863|903602|P1|STARTED|Overall Study||23
371104|NCT00395850|903637|P4|NOT COMPLETED|Disulfiram/Placebo Treatment||13
371105|NCT00395850|903638|P3|NOT COMPLETED|Disulfiram/Placebo Treatment||19
371106|NCT00395850|903639|P2|NOT COMPLETED|Disulfiram/Placebo Treatment||14
371107|NCT00395850|903640|P1|NOT COMPLETED|Disulfiram/Placebo Treatment||9
371108|NCT00395850|903637|P4|COMPLETED|Disulfiram/Placebo Treatment||8
371109|NCT00395850|903638|P3|COMPLETED|Disulfiram/Placebo Treatment||5
371110|NCT00395850|903639|P2|COMPLETED|Disulfiram/Placebo Treatment||9
371111|NCT00395850|903640|P1|COMPLETED|Disulfiram/Placebo Treatment||11
371112|NCT00395850|903637|P4|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|21
371113|NCT00395850|903638|P3|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|24
371114|NCT00395850|903639|P2|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|23
371115|NCT00395850|903640|P1|STARTED|Disulfiram/Placebo Treatment|Received >= 1 disulfiram dose. Two baseline/randomized subjects dropped out before receiving disulf|20
371116|NCT00395850|903637|P4|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||4
371117|NCT00395850|903638|P3|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||6
371118|NCT00395850|903639|P2|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||2
371119|NCT00395850|903640|P1|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||5
371120|NCT00395850|903637|P4|COMPLETED|Randomization to Disulfiram/ Pre-admin||21
371121|NCT00395850|903638|P3|COMPLETED|Randomization to Disulfiram/ Pre-admin||24
371122|NCT00395850|903639|P2|COMPLETED|Randomization to Disulfiram/ Pre-admin||23
371123|NCT00395850|903640|P1|COMPLETED|Randomization to Disulfiram/ Pre-admin||22
371124|NCT00395850|903637|P4|STARTED|Randomization to Disulfiram/ Pre-admin||25
371125|NCT00395850|903638|P3|STARTED|Randomization to Disulfiram/ Pre-admin||30
371126|NCT00395850|903639|P2|STARTED|Randomization to Disulfiram/ Pre-admin||25
371127|NCT00395850|903640|P1|STARTED|Randomization to Disulfiram/ Pre-admin||27
371128|NCT00395850|903637|P4|NOT COMPLETED|Pre-randomization Baseline/Induction||0
371129|NCT00395850|903638|P3|NOT COMPLETED|Pre-randomization Baseline/Induction||0
371130|NCT00395850|903639|P2|NOT COMPLETED|Pre-randomization Baseline/Induction||0
371131|NCT00395850|903640|P1|NOT COMPLETED|Pre-randomization Baseline/Induction||11
371132|NCT00395850|903637|P4|COMPLETED|Pre-randomization Baseline/Induction||0
371133|NCT00395850|903638|P3|COMPLETED|Pre-randomization Baseline/Induction||0
371134|NCT00395850|903639|P2|COMPLETED|Pre-randomization Baseline/Induction||0
371135|NCT00395850|903640|P1|COMPLETED|Pre-randomization Baseline/Induction||107
371136|NCT00395850|903637|P4|STARTED|Pre-randomization Baseline/Induction||0
371137|NCT00395850|903638|P3|STARTED|Pre-randomization Baseline/Induction||0
371138|NCT00395850|903639|P2|STARTED|Pre-randomization Baseline/Induction||0
371139|NCT00395850|903640|P1|STARTED|Pre-randomization Baseline/Induction|Pre-randomization and disulfiram (disulf) administration|118
371140|NCT00395746|903657|P3|NOT COMPLETED|Overall Study||22
371141|NCT00395746|903658|P2|NOT COMPLETED|Overall Study||4
371142|NCT00395746|903659|P1|NOT COMPLETED|Overall Study||10
371143|NCT00395746|903657|P3|COMPLETED|Overall Study|Completed 52 weeks treatment|66
371144|NCT00395746|903658|P2|COMPLETED|Overall Study|Completed 52 weeks treatment|84
371145|NCT00395746|903659|P1|COMPLETED|Overall Study|Completed 52 weeks treatment|78
371146|NCT00395746|903657|P3|STARTED|Overall Study|Exposed to study drug|88
371147|NCT00395746|903658|P2|STARTED|Overall Study|Exposed to study drug|88
371148|NCT00395746|903659|P1|STARTED|Overall Study|Exposed to study drug|88
371149|NCT00395733|903705|P2|NOT COMPLETED|Period 2||5
371150|NCT00395733|903706|P1|NOT COMPLETED|Period 2||2
371151|NCT00395733|903705|P2|COMPLETED|Period 2||37
371152|NCT00395733|903706|P1|COMPLETED|Period 2||39
371153|NCT00395733|903705|P2|STARTED|Period 2||42
371154|NCT00395733|903706|P1|STARTED|Period 2||41
371155|NCT00395733|903705|P2|NOT COMPLETED|Period 1||0
371156|NCT00395733|903706|P1|NOT COMPLETED|Period 1||0
371157|NCT00395733|903705|P2|COMPLETED|Period 1||42
371158|NCT00395733|903706|P1|COMPLETED|Period 1||41
371159|NCT00395733|903705|P2|STARTED|Period 1||42
371160|NCT00395733|903706|P1|STARTED|Period 1||41
371161|NCT00395694|903730|P2|NOT COMPLETED|Continuation Phase||13
371162|NCT00395694|903731|P1|NOT COMPLETED|Continuation Phase||15
371163|NCT00395694|903730|P2|COMPLETED|Continuation Phase||35
371164|NCT00395694|903731|P1|COMPLETED|Continuation Phase||34
371165|NCT00395694|903730|P2|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|48
371166|NCT00395694|903731|P1|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|49
371167|NCT00395694|903730|P2|NOT COMPLETED|Escalation Phase + Maintenance Phase||2
371168|NCT00395694|903731|P1|NOT COMPLETED|Escalation Phase + Maintenance Phase||1
371169|NCT00395694|903730|P2|COMPLETED|Escalation Phase + Maintenance Phase||49
371170|NCT00395694|903731|P1|COMPLETED|Escalation Phase + Maintenance Phase||50
371171|NCT00395694|903730|P2|STARTED|Escalation Phase + Maintenance Phase||51
371172|NCT00395694|903731|P1|STARTED|Escalation Phase + Maintenance Phase||51
371173|NCT00395642|903762|P1|NOT COMPLETED|Overall Study||13
371174|NCT00395642|903762|P1|COMPLETED|Overall Study||53
371175|NCT00395642|903762|P1|STARTED|Overall Study||66
371176|NCT00395629|903769|P3|NOT COMPLETED|Extension Study||3
371177|NCT00395629|903770|P2|NOT COMPLETED|Extension Study||0
371178|NCT00395629|903771|P1|NOT COMPLETED|Extension Study||0
371179|NCT00395629|903769|P3|COMPLETED|Extension Study||8
371180|NCT00395629|903770|P2|COMPLETED|Extension Study||6
371181|NCT00395629|903771|P1|COMPLETED|Extension Study||9
371182|NCT00395629|903769|P3|STARTED|Extension Study||11
371183|NCT00395629|903770|P2|STARTED|Extension Study||6
371184|NCT00395629|903771|P1|STARTED|Extension Study||9
371185|NCT00395629|903769|P3|NOT COMPLETED|Core Study||7
371186|NCT00395629|903770|P2|NOT COMPLETED|Core Study||4
371187|NCT00395629|903771|P1|NOT COMPLETED|Core Study||1
371188|NCT00395629|903769|P3|COMPLETED|Core Study||16
371189|NCT00395629|903770|P2|COMPLETED|Core Study||11
371190|NCT00395629|903771|P1|COMPLETED|Core Study||10
371191|NCT00395629|903769|P3|STARTED|Core Study||23
371192|NCT00395629|903770|P2|STARTED|Core Study||15
371193|NCT00395629|903771|P1|STARTED|Core Study||11
371194|NCT00395538|903788|P3|NOT COMPLETED|Overall Study||23
371195|NCT00395538|903789|P2|NOT COMPLETED|Overall Study||13
371196|NCT00395538|903790|P1|NOT COMPLETED|Overall Study||3
371197|NCT00395538|903788|P3|COMPLETED|Overall Study||0
371198|NCT00395538|903789|P2|COMPLETED|Overall Study||2
371199|NCT00395538|903790|P1|COMPLETED|Overall Study||5
371200|NCT00395538|903788|P3|Completed Bone Biopsy Year 4|Overall Study||1
371201|NCT00395538|903789|P2|Completed Bone Biopsy Year 4|Overall Study||1
371202|NCT00395538|903790|P1|Completed Bone Biopsy Year 4|Overall Study||0
371203|NCT00395538|903788|P3|Completed Bone Biopsy Year 2|Overall Study||3
371204|NCT00395538|903789|P2|Completed Bone Biopsy Year 2|Overall Study||2
371205|NCT00395538|903790|P1|Completed Bone Biopsy Year 2|Overall Study||0
371206|NCT00395538|903788|P3|Completed Bone Biopsy Year 1|Overall Study||4
371207|NCT00395538|903789|P2|Completed Bone Biopsy Year 1|Overall Study||1
371208|NCT00395538|903790|P1|Completed Bone Biopsy Year 1|Overall Study||0
371209|NCT00395538|903788|P3|Randomized to Bone Biospy Year 4|Overall Study||8
371210|NCT00395538|903789|P2|Randomized to Bone Biospy Year 4|Overall Study||2
371211|NCT00395538|903790|P1|Randomized to Bone Biospy Year 4|Overall Study||0
371212|NCT00395538|903788|P3|Randomized to Bone Biopsy Year 2|Overall Study||6
371213|NCT00395538|903789|P2|Randomized to Bone Biopsy Year 2|Overall Study||2
371214|NCT00395538|903790|P1|Randomized to Bone Biopsy Year 2|Overall Study||0
371215|NCT00395538|903788|P3|Randomized to Bone Biopsy Year 1|Overall Study||5
371216|NCT00395538|903789|P2|Randomized to Bone Biopsy Year 1|Overall Study||1
371217|NCT00395538|903790|P1|Randomized to Bone Biopsy Year 1|Overall Study||0
371218|NCT00395538|903788|P3|Received HPTH on New Protocol|Overall Study||19
371219|NCT00395538|903789|P2|Received HPTH on New Protocol|Overall Study||5
371220|NCT00395538|903790|P1|Received HPTH on New Protocol|Overall Study||7
371221|NCT00395538|903788|P3|Signed Consent to the New Protocol|Overall Study||23
371222|NCT00395538|903789|P2|Signed Consent to the New Protocol|Overall Study||5
371223|NCT00395538|903790|P1|Signed Consent to the New Protocol|Overall Study||7
371224|NCT00395538|903788|P3|STARTED|Overall Study||23
371225|NCT00395538|903789|P2|STARTED|Overall Study||15
371226|NCT00395538|903790|P1|STARTED|Overall Study||8
371227|NCT00395512|903863|P4|NOT COMPLETED|Overall Study||38
371228|NCT00395512|903864|P3|NOT COMPLETED|Overall Study||28
371229|NCT00395512|903865|P2|NOT COMPLETED|Overall Study||37
371230|NCT00395512|903866|P1|NOT COMPLETED|Overall Study||38
371231|NCT00395512|903863|P4|COMPLETED|Overall Study||126
371232|NCT00395512|903864|P3|COMPLETED|Overall Study||136
371233|NCT00395512|903865|P2|COMPLETED|Overall Study||126
371234|NCT00395512|903866|P1|COMPLETED|Overall Study||126
371235|NCT00395512|903863|P4|Safety Set|Overall Study|1 participant was lost to follow-up post visit 1. It is unknown if they took any study medication.|163
371236|NCT00395512|903864|P3|Safety Set|Overall Study||164
371237|NCT00395512|903865|P2|Safety Set|Overall Study||163
371238|NCT00395512|903866|P1|Safety Set|Overall Study||164
371239|NCT00395512|903863|P4|STARTED|Overall Study||164
371240|NCT00395512|903864|P3|STARTED|Overall Study||164
371241|NCT00395512|903865|P2|STARTED|Overall Study||163
371242|NCT00395512|903866|P1|STARTED|Overall Study||164
371243|NCT00395486|904038|P2|NOT COMPLETED|Overall Study||5
371244|NCT00395486|904039|P1|NOT COMPLETED|Overall Study||6
371245|NCT00395486|904038|P2|COMPLETED|Overall Study|Completed subjects|121
371246|NCT00395486|904039|P1|COMPLETED|Overall Study|Completed subjects|126
371247|NCT00395486|904038|P2|STARTED|Overall Study|Randomized subjects|126
371248|NCT00395486|904039|P1|STARTED|Overall Study|Randomized subjects|132
371249|NCT00395460|904069|P2|NOT COMPLETED|Overall Study||0
371250|NCT00395460|904070|P1|NOT COMPLETED|Overall Study||1
371251|NCT00395460|904069|P2|COMPLETED|Overall Study||75
371252|NCT00395460|904070|P1|COMPLETED|Overall Study||71
371253|NCT00395460|904069|P2|Received Treatment|Overall Study||75
371254|NCT00395460|904070|P1|Received Treatment|Overall Study|1 participant withdrew consent prior to study drug injection and did not receive any study drug.|71
371255|NCT00395460|904069|P2|STARTED|Overall Study||75
371256|NCT00395460|904070|P1|STARTED|Overall Study||72
371257|NCT00395447|904094|P2|NOT COMPLETED|Overall Study||111
371258|NCT00395447|904095|P1|NOT COMPLETED|Overall Study||121
371259|NCT00395447|904094|P2|COMPLETED|Overall Study||602
371260|NCT00395447|904095|P1|COMPLETED|Overall Study||910
371261|NCT00395447|904094|P2|STARTED|Overall Study||713
371262|NCT00395447|904095|P1|STARTED|Overall Study||1031
371263|NCT00395343|904103|P2|NOT COMPLETED|Overall Study||36
371264|NCT00395343|904104|P1|NOT COMPLETED|Overall Study||41
371265|NCT00395343|904103|P2|COMPLETED|Overall Study||283
371266|NCT00395343|904104|P1|COMPLETED|Overall Study||281
371267|NCT00395343|904103|P2|STARTED|Overall Study||319
371268|NCT00395343|904104|P1|STARTED|Overall Study||322
371269|NCT00395304|904122|P6|NOT COMPLETED|Treatment Period 3||1
371270|NCT00395304|904123|P5|NOT COMPLETED|Treatment Period 3||0
371271|NCT00395304|904124|P4|NOT COMPLETED|Treatment Period 3||2
371272|NCT00395304|904125|P3|NOT COMPLETED|Treatment Period 3||0
371273|NCT00395304|904126|P2|NOT COMPLETED|Treatment Period 3||2
371274|NCT00395304|904127|P1|NOT COMPLETED|Treatment Period 3||1
371275|NCT00395304|904122|P6|COMPLETED|Treatment Period 3||27
371276|NCT00395304|904123|P5|COMPLETED|Treatment Period 3||27
371277|NCT00395304|904124|P4|COMPLETED|Treatment Period 3||25
371278|NCT00395304|904125|P3|COMPLETED|Treatment Period 3||29
371279|NCT00395304|904126|P2|COMPLETED|Treatment Period 3||20
371280|NCT00395304|904127|P1|COMPLETED|Treatment Period 3||29
371281|NCT00395304|904122|P6|STARTED|Treatment Period 3||28
371282|NCT00395304|904123|P5|STARTED|Treatment Period 3||27
371283|NCT00395304|904124|P4|STARTED|Treatment Period 3||27
371284|NCT00395304|904125|P3|STARTED|Treatment Period 3||29
371285|NCT00395304|904126|P2|STARTED|Treatment Period 3||22
371286|NCT00395304|904127|P1|STARTED|Treatment Period 3||30
371287|NCT00395304|904122|P6|NOT COMPLETED|Treatment Period 2||2
371288|NCT00395304|904123|P5|NOT COMPLETED|Treatment Period 2||0
371289|NCT00395304|904124|P4|NOT COMPLETED|Treatment Period 2||1
371290|NCT00395304|904125|P3|NOT COMPLETED|Treatment Period 2||1
371291|NCT00395304|904126|P2|NOT COMPLETED|Treatment Period 2||4
371292|NCT00395304|904127|P1|NOT COMPLETED|Treatment Period 2||0
371293|NCT00395304|904122|P6|COMPLETED|Treatment Period 2||28
371294|NCT00395304|904123|P5|COMPLETED|Treatment Period 2||27
371295|NCT00395304|904124|P4|COMPLETED|Treatment Period 2||27
371296|NCT00395304|904125|P3|COMPLETED|Treatment Period 2||29
371297|NCT00395304|904126|P2|COMPLETED|Treatment Period 2||22
371298|NCT00395304|904127|P1|COMPLETED|Treatment Period 2||30
371299|NCT00395304|904122|P6|STARTED|Treatment Period 2||30
371300|NCT00395304|904123|P5|STARTED|Treatment Period 2||27
371301|NCT00395304|904124|P4|STARTED|Treatment Period 2||28
371302|NCT00395304|904125|P3|STARTED|Treatment Period 2||30
371303|NCT00395304|904126|P2|STARTED|Treatment Period 2||26
371304|NCT00395304|904127|P1|STARTED|Treatment Period 2||30
371305|NCT00395304|904122|P6|NOT COMPLETED|Treatment Period 1||2
371306|NCT00395304|904123|P5|NOT COMPLETED|Treatment Period 1||1
371307|NCT00395304|904124|P4|NOT COMPLETED|Treatment Period 1||3
371308|NCT00395304|904125|P3|NOT COMPLETED|Treatment Period 1||0
371309|NCT00395304|904126|P2|NOT COMPLETED|Treatment Period 1||4
371310|NCT00395304|904127|P1|NOT COMPLETED|Treatment Period 1||1
371311|NCT00395304|904122|P6|COMPLETED|Treatment Period 1||30
371312|NCT00395304|904123|P5|COMPLETED|Treatment Period 1||27
371313|NCT00395304|904124|P4|COMPLETED|Treatment Period 1||28
371314|NCT00395304|904125|P3|COMPLETED|Treatment Period 1||30
371315|NCT00395304|904126|P2|COMPLETED|Treatment Period 1||26
371316|NCT00395304|904127|P1|COMPLETED|Treatment Period 1||30
371317|NCT00395304|904122|P6|STARTED|Treatment Period 1||32
371318|NCT00395304|904123|P5|STARTED|Treatment Period 1||28
371319|NCT00395304|904124|P4|STARTED|Treatment Period 1||31
371320|NCT00395304|904125|P3|STARTED|Treatment Period 1||30
371321|NCT00395304|904126|P2|STARTED|Treatment Period 1||30
371322|NCT00395304|904127|P1|STARTED|Treatment Period 1||31
371323|NCT00395291|904170|P2|NOT COMPLETED|Second Intervention||0
371324|NCT00395291|904171|P1|NOT COMPLETED|Second Intervention||0
371325|NCT00395291|904170|P2|COMPLETED|Second Intervention||9
371326|NCT00395291|904171|P1|COMPLETED|Second Intervention||13
371327|NCT00395291|904170|P2|STARTED|Second Intervention||9
371328|NCT00395291|904171|P1|STARTED|Second Intervention||13
371329|NCT00395291|904170|P2|NOT COMPLETED|Washout Period for 30 Days||0
371330|NCT00395291|904171|P1|NOT COMPLETED|Washout Period for 30 Days||2
371331|NCT00395291|904170|P2|COMPLETED|Washout Period for 30 Days||9
371332|NCT00395291|904171|P1|COMPLETED|Washout Period for 30 Days||13
371333|NCT00395291|904170|P2|STARTED|Washout Period for 30 Days||9
371334|NCT00395291|904171|P1|STARTED|Washout Period for 30 Days||15
371335|NCT00395291|904170|P2|NOT COMPLETED|First Intervention||0
371336|NCT00395291|904171|P1|NOT COMPLETED|First Intervention||2
371337|NCT00395291|904170|P2|COMPLETED|First Intervention||9
371338|NCT00395291|904171|P1|COMPLETED|First Intervention||15
371339|NCT00395291|904170|P2|STARTED|First Intervention||9
371340|NCT00395291|904171|P1|STARTED|First Intervention||17
371341|NCT00395226|904203|P2|NOT COMPLETED|Overall Study||5
371342|NCT00395226|904204|P1|NOT COMPLETED|Overall Study||4
371343|NCT00395226|904203|P2|COMPLETED|Overall Study||22
371344|NCT00395226|904204|P1|COMPLETED|Overall Study||22
371345|NCT00395226|904203|P2|STARTED|Overall Study||27
371346|NCT00395226|904204|P1|STARTED|Overall Study||26
371347|NCT00395161|904212|P2|NOT COMPLETED|Overall Study||0
371348|NCT00395161|904213|P1|NOT COMPLETED|Overall Study||0
371349|NCT00395161|904212|P2|COMPLETED|Overall Study||144
371350|NCT00395161|904213|P1|COMPLETED|Overall Study||149
371351|NCT00395161|904212|P2|STARTED|Overall Study||144
371352|NCT00395161|904213|P1|STARTED|Overall Study||149
371353|NCT00395135|904229|P5|NOT COMPLETED|Year 2||190
371354|NCT00395135|904230|P4|NOT COMPLETED|Year 2||88
371355|NCT00395135|904231|P3|NOT COMPLETED|Year 2||147
371356|NCT00395135|904232|P2|NOT COMPLETED|Year 2||0
371357|NCT00395135|904233|P1|NOT COMPLETED|Year 2||0
371358|NCT00395135|904229|P5|COMPLETED|Year 2||507
371359|NCT00395135|904230|P4|COMPLETED|Year 2||195
371360|NCT00395135|904231|P3|COMPLETED|Year 2||426
371361|NCT00395135|904232|P2|COMPLETED|Year 2||0
371362|NCT00395135|904233|P1|COMPLETED|Year 2||0
371363|NCT00395135|904229|P5|STARTED|Year 2||697
371364|NCT00395135|904230|P4|STARTED|Year 2||283
371365|NCT00395135|904231|P3|STARTED|Year 2||573
371366|NCT00395135|904232|P2|STARTED|Year 2||0
371367|NCT00395135|904233|P1|STARTED|Year 2||0
371368|NCT00395135|904229|P5|NOT COMPLETED|Year 1||0
371369|NCT00395135|904230|P4|NOT COMPLETED|Year 1||0
371370|NCT00395135|904231|P3|NOT COMPLETED|Year 1||0
371371|NCT00395135|904232|P2|NOT COMPLETED|Year 1||871
371372|NCT00395135|904233|P1|NOT COMPLETED|Year 1||712
371373|NCT00395135|904229|P5|COMPLETED|Year 1||0
371374|NCT00395135|904230|P4|COMPLETED|Year 1||0
371375|NCT00395135|904231|P3|COMPLETED|Year 1||0
371376|NCT00395135|904232|P2|COMPLETED|Year 1||716
371377|NCT00395135|904233|P1|COMPLETED|Year 1||883
371378|NCT00395135|904229|P5|STARTED|Year 1||0
371379|NCT00395135|904230|P4|STARTED|Year 1||0
371380|NCT00395135|904231|P3|STARTED|Year 1||0
371381|NCT00395135|904232|P2|STARTED|Year 1||1587
371382|NCT00395135|904233|P1|STARTED|Year 1||1595
371383|NCT00395083|904251|P2|NOT COMPLETED|Overall Study||8
371384|NCT00395083|904252|P1|NOT COMPLETED|Overall Study||10
371385|NCT00395083|904251|P2|COMPLETED|Overall Study||201
371386|NCT00395083|904252|P1|COMPLETED|Overall Study||207
371387|NCT00395083|904251|P2|STARTED|Overall Study||209
371388|NCT00395083|904252|P1|STARTED|Overall Study||217
371389|NCT00395057|904268|P4|NOT COMPLETED|Overall Study||33
371390|NCT00395057|904269|P3|NOT COMPLETED|Overall Study||33
371391|NCT00395057|904270|P2|NOT COMPLETED|Overall Study||34
371392|NCT00395057|904271|P1|NOT COMPLETED|Overall Study||32
371393|NCT00395057|904268|P4|COMPLETED|Overall Study||1
371394|NCT00395057|904269|P3|COMPLETED|Overall Study||2
371395|NCT00395057|904270|P2|COMPLETED|Overall Study||1
371396|NCT00395057|904271|P1|COMPLETED|Overall Study||2
371397|NCT00395057|904268|P4|STARTED|Overall Study||34
371398|NCT00395057|904269|P3|STARTED|Overall Study||35
371399|NCT00395057|904270|P2|STARTED|Overall Study||35
371400|NCT00395057|904271|P1|STARTED|Overall Study||34
371401|NCT00395044|904299|P2|NOT COMPLETED|Overall Study||14
371402|NCT00395044|904300|P1|NOT COMPLETED|Overall Study||18
371403|NCT00395044|904299|P2|COMPLETED|Overall Study||11
371404|NCT00395044|904300|P1|COMPLETED|Overall Study||7
371405|NCT00395044|904299|P2|STARTED|Overall Study||25
371406|NCT00395044|904300|P1|STARTED|Overall Study||25
371407|NCT00395018|904318|P1|NOT COMPLETED|Off-Treatment Follow-up||4
371408|NCT00395018|904318|P1|COMPLETED|Off-Treatment Follow-up|"Completed means completed the study"|1
371409|NCT00395018|904318|P1|STARTED|Off-Treatment Follow-up|Treated participants who discontinued =<72 weeks and did not start other anti-HBV therapy|5
371410|NCT00395018|904318|P1|NOT COMPLETED|On-Treatment||10
371411|NCT00395018|904318|P1|COMPLETED|On-Treatment|"Completed means received treatment through Week 72"|55
371412|NCT00395018|904318|P1|DISCONTINUED AT OR AFTER WEEK 72 VISIT|On-Treatment||0
371413|NCT00395018|904318|P1|DISCONTINUED PRIOR TO WEEK 72 VISIT|On-Treatment||10
371414|NCT00395018|904318|P1|STARTED|On-Treatment|Started = treated (participants who received at least 1 dose of study therapy)|65
371415|NCT00394953|904339|P2|NOT COMPLETED|Second Treatment Period||74
371416|NCT00394953|904340|P1|NOT COMPLETED|Second Treatment Period||29
371417|NCT00394953|904339|P2|COMPLETED|Second Treatment Period||148
371418|NCT00394953|904340|P1|COMPLETED|Second Treatment Period||187
371419|NCT00394953|904339|P2|STARTED|Second Treatment Period||222
371420|NCT00394953|904340|P1|STARTED|Second Treatment Period||216
371421|NCT00394953|904339|P2|NOT COMPLETED|First Treatment Period||22
371422|NCT00394953|904340|P1|NOT COMPLETED|First Treatment Period||29
371423|NCT00394953|904339|P2|COMPLETED|First Treatment Period||222
371424|NCT00394953|904340|P1|COMPLETED|First Treatment Period||216
371425|NCT00394953|904339|P2|STARTED|First Treatment Period||244
371426|NCT00394953|904340|P1|STARTED|First Treatment Period||245
371427|NCT00394914|904358|P3|NOT COMPLETED|Treatment Period||6
371428|NCT00394914|904359|P2|NOT COMPLETED|Treatment Period||10
371429|NCT00394914|904360|P1|NOT COMPLETED|Treatment Period||0
371430|NCT00394914|904358|P3|COMPLETED|Treatment Period||151
371431|NCT00394914|904359|P2|COMPLETED|Treatment Period||144
371432|NCT00394914|904360|P1|COMPLETED|Treatment Period||0
371433|NCT00394914|904358|P3|STARTED|Treatment Period||157
371434|NCT00394914|904359|P2|STARTED|Treatment Period||154
371435|NCT00394914|904360|P1|STARTED|Treatment Period||0
371436|NCT00394914|904358|P3|NOT COMPLETED|Pre-exposure Period||0
371437|NCT00394914|904359|P2|NOT COMPLETED|Pre-exposure Period||0
371438|NCT00394914|904360|P1|NOT COMPLETED|Pre-exposure Period||0
371439|NCT00394914|904358|P3|COMPLETED|Pre-exposure Period||0
371440|NCT00394914|904359|P2|COMPLETED|Pre-exposure Period||0
371441|NCT00394914|904360|P1|COMPLETED|Pre-exposure Period||311
371442|NCT00394914|904358|P3|STARTED|Pre-exposure Period||0
371443|NCT00394914|904359|P2|STARTED|Pre-exposure Period||0
371444|NCT00394914|904360|P1|STARTED|Pre-exposure Period||311
371445|NCT00394914|904358|P3|NOT COMPLETED|Screening Period||0
371446|NCT00394914|904359|P2|NOT COMPLETED|Screening Period||0
371447|NCT00394914|904360|P1|NOT COMPLETED|Screening Period||0
371448|NCT00394914|904358|P3|COMPLETED|Screening Period||0
371449|NCT00394914|904359|P2|COMPLETED|Screening Period||0
371450|NCT00394914|904360|P1|COMPLETED|Screening Period||311
371451|NCT00394914|904358|P3|STARTED|Screening Period||0
371452|NCT00394914|904359|P2|STARTED|Screening Period||0
371453|NCT00394914|904360|P1|STARTED|Screening Period||311
371454|NCT00394901|904388|P4|NOT COMPLETED|Double-blind Phase||27
371455|NCT00394901|904389|P3|NOT COMPLETED|Double-blind Phase||18
371456|NCT00394901|904390|P2|NOT COMPLETED|Double-blind Phase||14
371457|NCT00394901|904391|P1|NOT COMPLETED|Double-blind Phase||15
371458|NCT00394901|904388|P4|COMPLETED|Double-blind Phase||70
371459|NCT00394901|904389|P3|COMPLETED|Double-blind Phase||71
371460|NCT00394901|904390|P2|COMPLETED|Double-blind Phase||73
371461|NCT00394901|904391|P1|COMPLETED|Double-blind Phase||83
371462|NCT00394901|904388|P4|STARTED|Double-blind Phase|Subjects treated with the study drug.|97
371463|NCT00394901|904389|P3|STARTED|Double-blind Phase|Subjects treated with the study drug.|89
371464|NCT00394901|904390|P2|STARTED|Double-blind Phase|Subjects treated with the study drug.|87
371465|NCT00394901|904391|P1|STARTED|Double-blind Phase|Subjects treated with the study drug.|98
371466|NCT00394901|904388|P4|NOT COMPLETED|Baseline Phase||0
371467|NCT00394901|904389|P3|NOT COMPLETED|Baseline Phase||1
371468|NCT00394901|904390|P2|NOT COMPLETED|Baseline Phase||0
371469|NCT00394901|904391|P1|NOT COMPLETED|Baseline Phase||0
371470|NCT00394901|904388|P4|COMPLETED|Baseline Phase||97
371471|NCT00394901|904389|P3|COMPLETED|Baseline Phase||89
371472|NCT00394901|904390|P2|COMPLETED|Baseline Phase||87
371473|NCT00394901|904391|P1|COMPLETED|Baseline Phase||98
371474|NCT00394901|904388|P4|STARTED|Baseline Phase|Subjects randomized|97
371475|NCT00394901|904389|P3|STARTED|Baseline Phase|Subjects randomized|90
371476|NCT00394901|904390|P2|STARTED|Baseline Phase|Subjects randomized|87
371477|NCT00394901|904391|P1|STARTED|Baseline Phase|Subjects randomized|98
371478|NCT00394888|904619|P3|NOT COMPLETED|Overall Study||0
371479|NCT00394888|904620|P2|NOT COMPLETED|Overall Study||0
371480|NCT00394888|904621|P1|NOT COMPLETED|Overall Study||0
371481|NCT00394888|904619|P3|COMPLETED|Overall Study||201
371482|NCT00394888|904620|P2|COMPLETED|Overall Study||48
371483|NCT00394888|904621|P1|COMPLETED|Overall Study||108
371484|NCT00394888|904619|P3|STARTED|Overall Study||201
371485|NCT00394888|904620|P2|STARTED|Overall Study||48
371486|NCT00394888|904621|P1|STARTED|Overall Study||108
371487|NCT00394836|904634|P2|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||53
371488|NCT00394836|904635|P1|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||20
371489|NCT00394836|904634|P2|COMPLETED|Extended Follow-up Phase (2-5 Years)||5
371490|NCT00394836|904635|P1|COMPLETED|Extended Follow-up Phase (2-5 Years)||0
371491|NCT00394836|904634|P2|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|58
371492|NCT00394836|904635|P1|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|20
371493|NCT00394836|904634|P2|NOT COMPLETED|Teatment or Follow-up Phase||78
371494|NCT00394836|904635|P1|NOT COMPLETED|Teatment or Follow-up Phase||28
371495|NCT00394836|904634|P2|COMPLETED|Teatment or Follow-up Phase||8
371496|NCT00394836|904635|P1|COMPLETED|Teatment or Follow-up Phase||2
371497|NCT00394836|904634|P2|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|8
371498|NCT00394836|904635|P1|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|4
371499|NCT00394836|904634|P2|STARTED|Teatment or Follow-up Phase||86
371500|NCT00394836|904635|P1|STARTED|Teatment or Follow-up Phase||30
371501|NCT00394771|904681|P4|NOT COMPLETED|Overall Study||39
371502|NCT00394771|904682|P3|NOT COMPLETED|Overall Study||47
371503|NCT00394771|904683|P2|NOT COMPLETED|Overall Study||34
371504|NCT00394771|904684|P1|NOT COMPLETED|Overall Study||41
371505|NCT00394771|904681|P4|COMPLETED|Overall Study||109
371506|NCT00394771|904682|P3|COMPLETED|Overall Study||96
371507|NCT00394771|904683|P2|COMPLETED|Overall Study||102
371508|NCT00394771|904684|P1|COMPLETED|Overall Study||99
371509|NCT00394771|904681|P4|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|120
371510|NCT00394771|904682|P3|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|108
371511|NCT00394771|904683|P2|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
371512|NCT00394771|904684|P1|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
371513|NCT00394771|904681|P4|STARTED|Overall Study|Safety population of treated participants|148
371514|NCT00394771|904682|P3|STARTED|Overall Study|Safety population of treated participants|143
371515|NCT00394771|904683|P2|STARTED|Overall Study|Safety population of treated participants|136
371516|NCT00394771|904684|P1|STARTED|Overall Study|Safety population of treated participants|140
371517|NCT00394706|904754|P8|NOT COMPLETED|Overall Study||0
371518|NCT00394706|904755|P7|NOT COMPLETED|Overall Study||3
371519|NCT00394706|904756|P6|NOT COMPLETED|Overall Study||7
371520|NCT00394706|904757|P5|NOT COMPLETED|Overall Study||2
371521|NCT00394706|904758|P4|NOT COMPLETED|Overall Study||1
371522|NCT00394706|904759|P3|NOT COMPLETED|Overall Study||9
371523|NCT00394706|904760|P2|NOT COMPLETED|Overall Study||2
371524|NCT00394706|904761|P1|NOT COMPLETED|Overall Study||4
371525|NCT00394706|904754|P8|COMPLETED|Overall Study||851
371526|NCT00394706|904755|P7|COMPLETED|Overall Study||926
371527|NCT00394706|904756|P6|COMPLETED|Overall Study||1377
371528|NCT00394706|904757|P5|COMPLETED|Overall Study||1634
371529|NCT00394706|904758|P4|COMPLETED|Overall Study||1632
371530|NCT00394706|904759|P3|COMPLETED|Overall Study||1615
371531|NCT00394706|904760|P2|COMPLETED|Overall Study||1860
371532|NCT00394706|904761|P1|COMPLETED|Overall Study||1815
371533|NCT00394706|904754|P8|STARTED|Overall Study||851
371534|NCT00394706|904755|P7|STARTED|Overall Study||929
371535|NCT00394706|904756|P6|STARTED|Overall Study||1384
371536|NCT00394706|904757|P5|STARTED|Overall Study||1636
371537|NCT00394706|904758|P4|STARTED|Overall Study||1633
371538|NCT00394706|904759|P3|STARTED|Overall Study||1624
371539|NCT00394706|904760|P2|STARTED|Overall Study||1862
371540|NCT00394706|904761|P1|STARTED|Overall Study||1819
371541|NCT00394654|904793|P2|NOT COMPLETED|Overall Study||0
371542|NCT00394654|904794|P1|NOT COMPLETED|Overall Study||2
371543|NCT00394654|904793|P2|COMPLETED|Overall Study||15
371544|NCT00394654|904794|P1|COMPLETED|Overall Study||13
371545|NCT00394654|904793|P2|STARTED|Overall Study||15
371546|NCT00394654|904794|P1|STARTED|Overall Study||15
371547|NCT00394589|904859|P3|NOT COMPLETED|Overall Study||7
371548|NCT00394589|904860|P2|NOT COMPLETED|Overall Study||3
371549|NCT00394589|904861|P1|NOT COMPLETED|Overall Study||8
371550|NCT00394589|904859|P3|COMPLETED|Overall Study||11
371551|NCT00394589|904860|P2|COMPLETED|Overall Study||8
371552|NCT00394589|904861|P1|COMPLETED|Overall Study||6
371553|NCT00394589|904859|P3|STARTED|Overall Study||18
371554|NCT00394589|904860|P2|STARTED|Overall Study||11
371555|NCT00394589|904861|P1|STARTED|Overall Study||14
371556|NCT00394524|904871|P2|NOT COMPLETED|Overall Study||4
371557|NCT00394524|904872|P1|NOT COMPLETED|Overall Study||3
371558|NCT00394524|904871|P2|COMPLETED|Overall Study||76
371559|NCT00394524|904872|P1|COMPLETED|Overall Study||77
371560|NCT00394524|904871|P2|STARTED|Overall Study||80
371561|NCT00394524|904872|P1|STARTED|Overall Study||80
371562|NCT00394472|904886|P2|NOT COMPLETED|Overall Study||11
371563|NCT00394472|904887|P1|NOT COMPLETED|Overall Study||9
371564|NCT00394472|904886|P2|COMPLETED|Overall Study||111
371565|NCT00394472|904887|P1|COMPLETED|Overall Study||113
371566|NCT00394472|904886|P2|STARTED|Overall Study||122
371567|NCT00394472|904887|P1|STARTED|Overall Study||122
371568|NCT00394433|904895|P1|NOT COMPLETED|Overall Study||3
371569|NCT00394433|904895|P1|COMPLETED|Overall Study||35
371570|NCT00394433|904895|P1|Evaluable and Treated|Overall Study||35
371571|NCT00394433|904895|P1|STARTED|Overall Study||38
371572|NCT00394355|904906|P4|NOT COMPLETED|Overall Study||31
371573|NCT00394355|904907|P3|NOT COMPLETED|Overall Study||38
371574|NCT00394355|904908|P2|NOT COMPLETED|Overall Study||34
371575|NCT00394355|904909|P1|NOT COMPLETED|Overall Study||35
371576|NCT00394355|904906|P4|COMPLETED|Overall Study||111
371577|NCT00394355|904907|P3|COMPLETED|Overall Study||109
371578|NCT00394355|904908|P2|COMPLETED|Overall Study||103
371579|NCT00394355|904909|P1|COMPLETED|Overall Study||105
371580|NCT00394355|904906|P4|STARTED|Overall Study||142
371581|NCT00394355|904907|P3|STARTED|Overall Study||147
371582|NCT00394355|904908|P2|STARTED|Overall Study||137
371583|NCT00394355|904909|P1|STARTED|Overall Study||140
371584|NCT00394329|904935|P4|NOT COMPLETED|Overall Study||24
371585|NCT00394329|904936|P3|NOT COMPLETED|Overall Study||13
371586|NCT00394329|904937|P2|NOT COMPLETED|Overall Study||9
371587|NCT00394329|904938|P1|NOT COMPLETED|Overall Study||8
371588|NCT00394329|904935|P4|COMPLETED|Overall Study||50
371589|NCT00394329|904936|P3|COMPLETED|Overall Study||58
371590|NCT00394329|904937|P2|COMPLETED|Overall Study||63
371591|NCT00394329|904938|P1|COMPLETED|Overall Study||63
371592|NCT00394329|904935|P4|STARTED|Overall Study||74
371593|NCT00394329|904936|P3|STARTED|Overall Study||71
371594|NCT00394329|904937|P2|STARTED|Overall Study||72
371595|NCT00394329|904938|P1|STARTED|Overall Study||71
371596|NCT00394277|904988|P4|NOT COMPLETED|Overall Study||125
371597|NCT00394277|904989|P3|NOT COMPLETED|Overall Study||120
371598|NCT00394277|904990|P2|NOT COMPLETED|Overall Study||60
371599|NCT00394277|904991|P1|NOT COMPLETED|Overall Study||58
371600|NCT00394277|904988|P4|COMPLETED|Overall Study||266
371601|NCT00394277|904989|P3|COMPLETED|Overall Study||273
371602|NCT00394277|904990|P2|COMPLETED|Overall Study||136
371603|NCT00394277|904991|P1|COMPLETED|Overall Study||137
371604|NCT00394277|904988|P4|STARTED|Overall Study||391
371605|NCT00394277|904989|P3|STARTED|Overall Study||393
371606|NCT00394277|904990|P2|STARTED|Overall Study||196
371607|NCT00394277|904991|P1|STARTED|Overall Study||195
371608|NCT00394251|905015|P2|NOT COMPLETED|Overall Study||38
371609|NCT00394251|905016|P1|NOT COMPLETED|Overall Study||37
371610|NCT00394251|905015|P2|COMPLETED|Overall Study||61
371611|NCT00394251|905016|P1|COMPLETED|Overall Study||61
371612|NCT00394251|905015|P2|At Least One Dose of Taxane|Overall Study||93
371613|NCT00394251|905016|P1|At Least One Dose of Taxane|Overall Study||93
371614|NCT00394251|905015|P2|STARTED|Overall Study||99
371615|NCT00394251|905016|P1|STARTED|Overall Study||98
371616|NCT00394212|905044|P2|NOT COMPLETED|Overall Study||1
371617|NCT00394212|905045|P1|NOT COMPLETED|Overall Study||7
371618|NCT00394212|905044|P2|COMPLETED|Overall Study||26
371619|NCT00394212|905045|P1|COMPLETED|Overall Study||43
371620|NCT00394212|905044|P2|6 Month Follow-up|Overall Study||26
371621|NCT00394212|905045|P1|6 Month Follow-up|Overall Study||43
371622|NCT00394212|905044|P2|3 Month Follow-up|Overall Study||26
371623|NCT00394212|905045|P1|3 Month Follow-up|Overall Study||45
371624|NCT00394212|905044|P2|6 Week Follow-up|Overall Study||26
371625|NCT00394212|905045|P1|6 Week Follow-up|Overall Study||45
371626|NCT00394212|905044|P2|STARTED|Overall Study||27
371627|NCT00394212|905045|P1|STARTED|Overall Study|2 subjects assigned to suturing underwent sham procedure, results based on Intent-To-Treat (ITT)|50
371628|NCT00394095|905059|P2|NOT COMPLETED|Overall Study||0
371629|NCT00394095|905060|P1|NOT COMPLETED|Overall Study||1
371630|NCT00394095|905059|P2|COMPLETED|Overall Study||14
371631|NCT00394095|905060|P1|COMPLETED|Overall Study||16
371632|NCT00394095|905059|P2|Screened|Overall Study||14
371633|NCT00394095|905060|P1|Screened|Overall Study||17
371634|NCT00394095|905059|P2|STARTED|Overall Study||14
371635|NCT00394095|905060|P1|STARTED|Overall Study||17
371636|NCT00394082|905068|P1|NOT COMPLETED|Overall Study||26
371637|NCT00394082|905068|P1|COMPLETED|Overall Study|Treatment completed upon disease progression|24
371638|NCT00394082|905068|P1|At Least One Response Assessment|Overall Study||43
371639|NCT00394082|905068|P1|STARTED|Overall Study||50
371640|NCT00393978|905079|P2|NOT COMPLETED|Overall Study||20
371641|NCT00393978|905080|P1|NOT COMPLETED|Overall Study||16
371642|NCT00393978|905079|P2|COMPLETED|Overall Study||18
371643|NCT00393978|905080|P1|COMPLETED|Overall Study||21
371644|NCT00393978|905079|P2|STARTED|Overall Study||38
371645|NCT00393978|905080|P1|STARTED|Overall Study||37
371646|NCT00393939|905090|P2|NOT COMPLETED|Overall Study||297
371647|NCT00393939|905091|P1|NOT COMPLETED|Overall Study||296
371648|NCT00393939|905090|P2|COMPLETED|Overall Study||0
371649|NCT00393939|905091|P1|COMPLETED|Overall Study||0
371650|NCT00393939|905090|P2|Treated|Overall Study||293
371651|NCT00393939|905091|P1|Treated|Overall Study||295
371652|NCT00393939|905090|P2|STARTED|Overall Study||297
371653|NCT00393939|905091|P1|STARTED|Overall Study||296
371654|NCT00393913|905109|P1|NOT COMPLETED|CPAP Withdrawal||0
371655|NCT00393913|905109|P1|COMPLETED|CPAP Withdrawal||42
371656|NCT00393913|905109|P1|CPAP Compliance|CPAP Withdrawal|Only subjects with sufficient CPAP complaince (>4 hrs/night) were included.|42
371657|NCT00393913|905109|P1|STARTED|CPAP Withdrawal|Includes only subjects with good CPAP adherence|42
371658|NCT00393913|905109|P1|NOT COMPLETED|CPAP||7
371659|NCT00393913|905109|P1|COMPLETED|CPAP||93
371660|NCT00393913|905109|P1|STARTED|CPAP|Excludes normal volunteers without OSA|100
371661|NCT00393913|905109|P1|NOT COMPLETED|Initial Assessment||37
371662|NCT00393913|905109|P1|COMPLETED|Initial Assessment||107
371663|NCT00393913|905109|P1|STARTED|Initial Assessment||144
371664|NCT00393887|905117|P2|NOT COMPLETED|Overall Study||9
371665|NCT00393887|905118|P1|NOT COMPLETED|Overall Study||16
371666|NCT00393887|905117|P2|COMPLETED|Overall Study||41
371667|NCT00393887|905118|P1|COMPLETED|Overall Study||34
371668|NCT00393887|905117|P2|1 Year|Overall Study||50
371669|NCT00393887|905118|P1|1 Year|Overall Study||45
371670|NCT00393887|905117|P2|STARTED|Overall Study||50
371671|NCT00393887|905118|P1|STARTED|Overall Study||50
371672|NCT00393874|905127|P3|NOT COMPLETED|Overall Study||2
371673|NCT00393874|905128|P2|NOT COMPLETED|Overall Study||4
371674|NCT00393874|905129|P1|NOT COMPLETED|Overall Study||3
371675|NCT00393874|905127|P3|COMPLETED|Overall Study||13
371676|NCT00393874|905128|P2|COMPLETED|Overall Study||13
371677|NCT00393874|905129|P1|COMPLETED|Overall Study||15
371678|NCT00393874|905127|P3|STARTED|Overall Study||15
371679|NCT00393874|905128|P2|STARTED|Overall Study||17
371680|NCT00393874|905129|P1|STARTED|Overall Study||18
371681|NCT00393861|905146|P1|NOT COMPLETED|Overall Study||26
371682|NCT00393861|905146|P1|COMPLETED|Overall Study||3
371683|NCT00393861|905146|P1|STARTED|Overall Study||29
371684|NCT00393848|905157|P4|NOT COMPLETED|Overall Study||1
371685|NCT00393848|905158|P3|NOT COMPLETED|Overall Study||2
371686|NCT00393848|905159|P2|NOT COMPLETED|Overall Study||0
371687|NCT00393848|905160|P1|NOT COMPLETED|Overall Study||0
371688|NCT00393848|905157|P4|COMPLETED|Overall Study||8
371689|NCT00393848|905158|P3|COMPLETED|Overall Study||4
371690|NCT00393848|905159|P2|COMPLETED|Overall Study||9
371691|NCT00393848|905160|P1|COMPLETED|Overall Study||16
371692|NCT00393848|905157|P4|STARTED|Overall Study||9
371693|NCT00393848|905158|P3|STARTED|Overall Study||6
371694|NCT00393848|905159|P2|STARTED|Overall Study||9
371695|NCT00393848|905160|P1|STARTED|Overall Study||16
371696|NCT00393796|905174|P2|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
371697|NCT00393796|905175|P1|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
371698|NCT00393796|905174|P2|COMPLETED|Open Label Period - Placebo to SUTENT||16
371699|NCT00393796|905175|P1|COMPLETED|Open Label Period - Placebo to SUTENT||0
371700|NCT00393796|905174|P2|STARTED|Open Label Period - Placebo to SUTENT||16
371701|NCT00393796|905175|P1|STARTED|Open Label Period - Placebo to SUTENT||0
371702|NCT00393796|905174|P2|NOT COMPLETED|Double Blind Period||0
371703|NCT00393796|905175|P1|NOT COMPLETED|Double Blind Period||0
371704|NCT00393796|905174|P2|COMPLETED|Double Blind Period||28
371705|NCT00393796|905175|P1|COMPLETED|Double Blind Period||26
371706|NCT00393796|905174|P2|STARTED|Double Blind Period||28
371707|NCT00393796|905175|P1|STARTED|Double Blind Period||26
371708|NCT00393718|905183|P2|NOT COMPLETED|Overall Study||22
371709|NCT00393718|905184|P1|NOT COMPLETED|Overall Study||43
371710|NCT00393718|905183|P2|COMPLETED|Overall Study||110
371711|NCT00393718|905184|P1|COMPLETED|Overall Study||225
371712|NCT00393718|905183|P2|STARTED|Overall Study||132
371713|NCT00393718|905184|P1|STARTED|Overall Study||268
371714|NCT00393705|905216|P2|NOT COMPLETED|Overall Study||23
371715|NCT00393705|905217|P1|NOT COMPLETED|Overall Study||23
371716|NCT00393705|905216|P2|COMPLETED|Overall Study||128
371717|NCT00393705|905217|P1|COMPLETED|Overall Study||128
371718|NCT00393705|905216|P2|Received at Least One Dose of Study Drug|Overall Study||139
371719|NCT00393705|905217|P1|Received at Least One Dose of Study Drug|Overall Study||139
371720|NCT00393705|905216|P2|STARTED|Overall Study||151
371721|NCT00393705|905217|P1|STARTED|Overall Study||151
371722|NCT00393523|905246|P5|NOT COMPLETED|Overall Study||1
371723|NCT00393523|905247|P4|NOT COMPLETED|Overall Study||6
371724|NCT00393523|905248|P3|NOT COMPLETED|Overall Study||4
371725|NCT00393523|905249|P2|NOT COMPLETED|Overall Study||9
371726|NCT00393523|905250|P1|NOT COMPLETED|Overall Study||12
371727|NCT00393523|905246|P5|COMPLETED|Overall Study||19
371728|NCT00393523|905247|P4|COMPLETED|Overall Study||348
371729|NCT00393523|905248|P3|COMPLETED|Overall Study||349
371730|NCT00393523|905249|P2|COMPLETED|Overall Study||366
371731|NCT00393523|905250|P1|COMPLETED|Overall Study||364
371732|NCT00393523|905246|P5|Vaccination Visit 1|Overall Study||20
371733|NCT00393523|905247|P4|Vaccination Visit 1|Overall Study||352
371734|NCT00393523|905248|P3|Vaccination Visit 1|Overall Study||349
371735|NCT00393523|905249|P2|Vaccination Visit 1|Overall Study||375
371736|NCT00393523|905250|P1|Vaccination Visit 1|Overall Study||374
371737|NCT00393523|905246|P5|STARTED|Overall Study||20
371738|NCT00393523|905247|P4|STARTED|Overall Study||354
371739|NCT00393523|905248|P3|STARTED|Overall Study||353
371740|NCT00393523|905249|P2|STARTED|Overall Study||375
371741|NCT00393523|905250|P1|STARTED|Overall Study||376
371742|NCT00393510|905267|P2|NOT COMPLETED|Overall Study||9
371743|NCT00393510|905268|P1|NOT COMPLETED|Overall Study||3
371744|NCT00393510|905267|P2|COMPLETED|Overall Study||31
371745|NCT00393510|905268|P1|COMPLETED|Overall Study||37
371746|NCT00393510|905267|P2|STARTED|Overall Study||40
371747|NCT00393510|905268|P1|STARTED|Overall Study||40
371748|NCT00393484|905280|P2|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||23
371749|NCT00393484|905281|P1|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||8
371750|NCT00393484|905280|P2|COMPLETED|Open-label Period (Weeks 96 to 240)||21
371751|NCT00393484|905281|P1|COMPLETED|Open-label Period (Weeks 96 to 240)||40
371752|NCT00393484|905280|P2|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|2
371753|NCT00393484|905281|P1|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|0
371754|NCT00393484|905280|P2|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
371755|NCT00393484|905281|P1|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
371756|NCT00393484|905280|P2|STARTED|Open-label Period (Weeks 96 to 240)||44
371757|NCT00393484|905281|P1|STARTED|Open-label Period (Weeks 96 to 240)||48
371758|NCT00393484|905280|P2|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||12
371759|NCT00393484|905281|P1|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||2
371760|NCT00393484|905280|P2|COMPLETED|Double-blind Period (Day 1 to Week 96)||52
371761|NCT00393484|905281|P1|COMPLETED|Double-blind Period (Day 1 to Week 96)||54
371762|NCT00393484|905280|P2|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
371763|NCT00393484|905281|P1|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
371764|NCT00393484|905280|P2|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|64
371765|NCT00393484|905281|P1|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|56
371766|NCT00393458|905317|P4|NOT COMPLETED|Overall Study||137
371767|NCT00393458|905318|P3|NOT COMPLETED|Overall Study||112
371768|NCT00393458|905319|P2|NOT COMPLETED|Overall Study||102
371769|NCT00393458|905320|P1|NOT COMPLETED|Overall Study||99
371770|NCT00393458|905317|P4|COMPLETED|Overall Study||295
371771|NCT00393458|905318|P3|COMPLETED|Overall Study||323
371772|NCT00393458|905319|P2|COMPLETED|Overall Study||326
371773|NCT00393458|905320|P1|COMPLETED|Overall Study||338
371774|NCT00393458|905317|P4|Exposed to Study Medication or Placebo|Overall Study||432
371775|NCT00393458|905318|P3|Exposed to Study Medication or Placebo|Overall Study||434
371776|NCT00393458|905319|P2|Exposed to Study Medication or Placebo|Overall Study||425
371777|NCT00393458|905320|P1|Exposed to Study Medication or Placebo|Overall Study||437
371778|NCT00393458|905317|P4|STARTED|Overall Study||432
371779|NCT00393458|905318|P3|STARTED|Overall Study||435
371780|NCT00393458|905319|P2|STARTED|Overall Study||428
371781|NCT00393458|905320|P1|STARTED|Overall Study||437
371782|NCT00393380|905334|P1|NOT COMPLETED|Overall Study||0
371783|NCT00393380|905334|P1|COMPLETED|Overall Study||13
371784|NCT00393380|905334|P1|STARTED|Overall Study||13
371785|NCT00393367|905347|P2|NOT COMPLETED|Overall Study||7
371786|NCT00393367|905348|P1|NOT COMPLETED|Overall Study||2
371787|NCT00393367|905347|P2|COMPLETED|Overall Study||81
371788|NCT00393367|905348|P1|COMPLETED|Overall Study||89
371789|NCT00393367|905347|P2|STARTED|Overall Study||88
371790|NCT00393367|905348|P1|STARTED|Overall Study||91
371791|NCT00393094|905376|P1|NOT COMPLETED|Disease Progression After Trtmt: Onstudy||1
371792|NCT00393094|905376|P1|COMPLETED|Disease Progression After Trtmt: Onstudy||29
371793|NCT00393094|905376|P1|STARTED|Disease Progression After Trtmt: Onstudy||30
371794|NCT00393094|905376|P1|NOT COMPLETED|Period1Bevacizumab & Irinotecan Patients||1
371795|NCT00393094|905376|P1|COMPLETED|Period1Bevacizumab & Irinotecan Patients||30
371796|NCT00393094|905376|P1|STARTED|Period1Bevacizumab & Irinotecan Patients||31
371797|NCT00393068|905383|P1|NOT COMPLETED|Overall Study||18
371798|NCT00393068|905383|P1|COMPLETED|Overall Study||44
371799|NCT00393068|905383|P1|STARTED|Overall Study||62
371800|NCT00393042|905387|P2|NOT COMPLETED|Second Intervetion||8
371801|NCT00393042|905388|P1|NOT COMPLETED|Second Intervetion||2
371802|NCT00393042|905387|P2|COMPLETED|Second Intervetion||19
371803|NCT00393042|905388|P1|COMPLETED|Second Intervetion||24
371804|NCT00393042|905387|P2|Completed 25/30 mg Dosage|Second Intervetion||20
371805|NCT00393042|905388|P1|Completed 25/30 mg Dosage|Second Intervetion||24
371806|NCT00393042|905387|P2|Completed the 20mg Dosage|Second Intervetion||21
371807|NCT00393042|905388|P1|Completed the 20mg Dosage|Second Intervetion||24
371808|NCT00393042|905387|P2|Completed 10 mg Dosage|Second Intervetion||24
371809|NCT00393042|905388|P1|Completed 10 mg Dosage|Second Intervetion||26
371810|NCT00393042|905387|P2|Completed Placebo Dosage|Second Intervetion||21
371811|NCT00393042|905388|P1|Completed Placebo Dosage|Second Intervetion||25
371812|NCT00393042|905387|P2|STARTED|Second Intervetion||27
371813|NCT00393042|905388|P1|STARTED|Second Intervetion||26
371814|NCT00393042|905387|P2|NOT COMPLETED|First Intervention||6
371815|NCT00393042|905388|P1|NOT COMPLETED|First Intervention||5
371816|NCT00393042|905387|P2|COMPLETED|First Intervention||27
371817|NCT00393042|905388|P1|COMPLETED|First Intervention||26
371818|NCT00393042|905387|P2|Completed 25/30mg Dosage|First Intervention||27
371819|NCT00393042|905388|P1|Completed 25/30mg Dosage|First Intervention||27
371820|NCT00393042|905387|P2|Completed 20 mg Dosage|First Intervention||28
371821|NCT00393042|905388|P1|Completed 20 mg Dosage|First Intervention||26
371822|NCT00393042|905387|P2|Completed 10mg Dosage|First Intervention||29
371823|NCT00393042|905388|P1|Completed 10mg Dosage|First Intervention||29
371824|NCT00393042|905387|P2|Completed the Placebo Dosage|First Intervention||29
371825|NCT00393042|905388|P1|Completed the Placebo Dosage|First Intervention||27
371826|NCT00393042|905387|P2|STARTED|First Intervention||33
371827|NCT00393042|905388|P1|STARTED|First Intervention||31
371828|NCT00393029|905460|P2|NOT COMPLETED|Overall Study||1
371829|NCT00393029|905461|P1|NOT COMPLETED|Overall Study||0
371830|NCT00393029|905460|P2|COMPLETED|Overall Study||9
371831|NCT00393029|905461|P1|COMPLETED|Overall Study||2
371832|NCT00393029|905460|P2|STARTED|Overall Study||10
371833|NCT00393029|905461|P1|STARTED|Overall Study||2
371834|NCT00392990|905472|P2|NOT COMPLETED|Follow up for 2 Years||0
371835|NCT00392990|905473|P1|NOT COMPLETED|Follow up for 2 Years||4
371836|NCT00392990|905472|P2|COMPLETED|Follow up for 2 Years||5
371837|NCT00392990|905473|P1|COMPLETED|Follow up for 2 Years||16
371838|NCT00392990|905472|P2|STARTED|Follow up for 2 Years||5
371839|NCT00392990|905473|P1|STARTED|Follow up for 2 Years||20
371840|NCT00392990|905472|P2|NOT COMPLETED|Treatment on Study||1
371841|NCT00392990|905473|P1|NOT COMPLETED|Treatment on Study||3
371842|NCT00392990|905472|P2|COMPLETED|Treatment on Study||4
371843|NCT00392990|905473|P1|COMPLETED|Treatment on Study||17
371844|NCT00392990|905472|P2|STARTED|Treatment on Study||5
371845|NCT00392990|905473|P1|STARTED|Treatment on Study||20
371846|NCT00392951|905485|P1|NOT COMPLETED|Overall Study||0
371847|NCT00392951|905485|P1|COMPLETED|Overall Study||30
371848|NCT00392951|905485|P1|STARTED|Overall Study||30
371849|NCT00392925|905497|P4|NOT COMPLETED|Randomization to Treatment Group Period||18
371850|NCT00392925|905498|P3|NOT COMPLETED|Randomization to Treatment Group Period||19
371851|NCT00392925|905499|P2|NOT COMPLETED|Randomization to Treatment Group Period||8
371852|NCT00392925|905500|P1|NOT COMPLETED|Randomization to Treatment Group Period||0
371853|NCT00392925|905497|P4|COMPLETED|Randomization to Treatment Group Period|At Week 20|38
371854|NCT00392925|905498|P3|COMPLETED|Randomization to Treatment Group Period|At Week 20|37
371855|NCT00392925|905499|P2|COMPLETED|Randomization to Treatment Group Period|AT Week 20|19
371856|NCT00392925|905500|P1|COMPLETED|Randomization to Treatment Group Period||0
371857|NCT00392925|905497|P4|STARTED|Randomization to Treatment Group Period||56
371858|NCT00392925|905498|P3|STARTED|Randomization to Treatment Group Period||56
371859|NCT00392925|905499|P2|STARTED|Randomization to Treatment Group Period||27
371860|NCT00392925|905500|P1|STARTED|Randomization to Treatment Group Period||0
371861|NCT00392925|905497|P4|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
371862|NCT00392925|905498|P3|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
371863|NCT00392925|905499|P2|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
371864|NCT00392925|905500|P1|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||38
371865|NCT00392925|905497|P4|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
371866|NCT00392925|905498|P3|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
371867|NCT00392925|905499|P2|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
371868|NCT00392925|905500|P1|COMPLETED|4 Week Lead-In Period - Non-Randomized||139
371869|NCT00392925|905497|P4|STARTED|4 Week Lead-In Period - Non-Randomized||0
371870|NCT00392925|905498|P3|STARTED|4 Week Lead-In Period - Non-Randomized||0
371871|NCT00392925|905499|P2|STARTED|4 Week Lead-In Period - Non-Randomized||0
371872|NCT00392925|905500|P1|STARTED|4 Week Lead-In Period - Non-Randomized||177
371873|NCT00392860|905588|P3|NOT COMPLETED|Overall Study||0
371874|NCT00392860|905589|P2|NOT COMPLETED|Overall Study||0
371875|NCT00392860|905590|P1|NOT COMPLETED|Overall Study||0
371876|NCT00392860|905588|P3|COMPLETED|Overall Study||1
371877|NCT00392860|905589|P2|COMPLETED|Overall Study||0
371878|NCT00392860|905590|P1|COMPLETED|Overall Study||3
371879|NCT00392860|905588|P3|STARTED|Overall Study||1
371880|NCT00392860|905589|P2|STARTED|Overall Study||0
371881|NCT00392860|905590|P1|STARTED|Overall Study||3
371882|NCT00392834|905598|P2|NOT COMPLETED|Overall Study||0
371883|NCT00392834|905599|P1|NOT COMPLETED|Overall Study||0
371884|NCT00392834|905598|P2|COMPLETED|Overall Study||32
371885|NCT00392834|905599|P1|COMPLETED|Overall Study||2
371886|NCT00392834|905598|P2|STARTED|Overall Study||32
371887|NCT00392834|905599|P1|STARTED|Overall Study||2
371888|NCT00392821|905605|P1|NOT COMPLETED|Overall Study||19
371889|NCT00392821|905605|P1|COMPLETED|Overall Study||59
371890|NCT00392821|905605|P1|STARTED|Overall Study||78
371891|NCT00392808|905614|P4|NOT COMPLETED|Overall Study||4
371892|NCT00392808|905615|P3|NOT COMPLETED|Overall Study||2
371893|NCT00392808|905616|P2|NOT COMPLETED|Overall Study||3
371894|NCT00392808|905617|P1|NOT COMPLETED|Overall Study||6
371895|NCT00392808|905614|P4|COMPLETED|Overall Study||100
371896|NCT00392808|905615|P3|COMPLETED|Overall Study||107
371897|NCT00392808|905616|P2|COMPLETED|Overall Study||86
371898|NCT00392808|905617|P1|COMPLETED|Overall Study||81
371899|NCT00392808|905614|P4|STARTED|Overall Study||104
371900|NCT00392808|905615|P3|STARTED|Overall Study||109
371901|NCT00392808|905616|P2|STARTED|Overall Study||89
371902|NCT00392808|905617|P1|STARTED|Overall Study||87
371903|NCT00392782|905631|P1|NOT COMPLETED|Overall Study||0
371904|NCT00392782|905631|P1|COMPLETED|Overall Study||24
371905|NCT00392782|905631|P1|STARTED|Overall Study||24
371906|NCT00392769|905641|P1|NOT COMPLETED|Overall Study||10
371907|NCT00392769|905641|P1|COMPLETED|Overall Study||23
371908|NCT00392769|905641|P1|STARTED|Overall Study||33
371909|NCT00392704|905645|P1|NOT COMPLETED|Combined Modality Therapy||5
371910|NCT00392704|905645|P1|COMPLETED|Combined Modality Therapy||49
371911|NCT00392704|905645|P1|STARTED|Combined Modality Therapy||54
371912|NCT00392704|905645|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||6
371913|NCT00392704|905645|P1|COMPLETED|Neoadjuvant Chemotherapy||54
371914|NCT00392704|905645|P1|STARTED|Neoadjuvant Chemotherapy||60
371915|NCT00392678|905654|P4|NOT COMPLETED|Overall Study||1
371916|NCT00392678|905655|P3|NOT COMPLETED|Overall Study||2
371917|NCT00392678|905656|P2|NOT COMPLETED|Overall Study||1
371918|NCT00392678|905657|P1|NOT COMPLETED|Overall Study||0
371919|NCT00392678|905654|P4|COMPLETED|Overall Study||26
371920|NCT00392678|905655|P3|COMPLETED|Overall Study||25
371921|NCT00392678|905656|P2|COMPLETED|Overall Study||26
371922|NCT00392678|905657|P1|COMPLETED|Overall Study||27
371923|NCT00392678|905654|P4|STARTED|Overall Study||27
371924|NCT00392678|905655|P3|STARTED|Overall Study||27
371925|NCT00392678|905656|P2|STARTED|Overall Study||27
371926|NCT00392678|905657|P1|STARTED|Overall Study||27
371927|NCT00392665|905693|P2|NOT COMPLETED|Overall Study||15
371928|NCT00392665|905694|P1|NOT COMPLETED|Overall Study||17
371929|NCT00392665|905693|P2|COMPLETED|Overall Study||3
371930|NCT00392665|905694|P1|COMPLETED|Overall Study||1
371931|NCT00392665|905693|P2|STARTED|Overall Study||18
371932|NCT00392665|905694|P1|STARTED|Overall Study||18
371933|NCT00392496|905706|P1|NOT COMPLETED|Overall Study||0
371934|NCT00392496|905706|P1|COMPLETED|Overall Study||19
371935|NCT00392496|905706|P1|STARTED|Overall Study||19
371936|NCT00392444|905710|P1|NOT COMPLETED|Overall Study||0
371937|NCT00392444|905710|P1|COMPLETED|Overall Study||39
371938|NCT00392444|905710|P1|STARTED|Overall Study||39
371939|NCT00392392|905714|P1|NOT COMPLETED|Overall Study||20
371940|NCT00392392|905714|P1|COMPLETED|Overall Study||9
371941|NCT00392392|905714|P1|STARTED|Overall Study||29
371942|NCT00392379|905720|P2|NOT COMPLETED|Overall Study||38
371943|NCT00392379|905721|P1|NOT COMPLETED|Overall Study||22
371944|NCT00392379|905720|P2|COMPLETED|Overall Study|Medication period|96
371945|NCT00392379|905721|P1|COMPLETED|Overall Study|Medication period|114
371946|NCT00392379|905720|P2|STARTED|Overall Study|Medication period|134
371947|NCT00392379|905721|P1|STARTED|Overall Study|Medication period|136
371948|NCT00392288|905734|P3|NOT COMPLETED|Overall Study||17
371949|NCT00392288|905735|P2|NOT COMPLETED|Overall Study||22
371950|NCT00392288|905736|P1|NOT COMPLETED|Overall Study||32
371951|NCT00392288|905734|P3|COMPLETED|Overall Study|ITT set = 172 patients|159
371952|NCT00392288|905735|P2|COMPLETED|Overall Study|ITT set = 166 patients|155
371953|NCT00392288|905736|P1|COMPLETED|Overall Study|ITT set = 163 patients|143
371954|NCT00392288|905734|P3|Treatment Period|Overall Study||175
371955|NCT00392288|905735|P2|Treatment Period|Overall Study||174
371956|NCT00392288|905736|P1|Treatment Period|Overall Study||172
371957|NCT00392288|905734|P3|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|176
371958|NCT00392288|905735|P2|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|177
371959|NCT00392288|905736|P1|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|175
371960|NCT00392236|905752|P2|NOT COMPLETED|Overall Study||6
371961|NCT00392236|905753|P1|NOT COMPLETED|Overall Study||12
371962|NCT00392236|905752|P2|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|12
371963|NCT00392236|905753|P1|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|8
371964|NCT00392236|905752|P2|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|18
371965|NCT00392236|905753|P1|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|20
371966|NCT00392223|905761|P2|NOT COMPLETED|Overall Study||13
371967|NCT00392223|905762|P1|NOT COMPLETED|Overall Study||9
371968|NCT00392223|905761|P2|COMPLETED|Overall Study||47
371969|NCT00392223|905762|P1|COMPLETED|Overall Study||49
371970|NCT00392223|905761|P2|STARTED|Overall Study||60
371971|NCT00392223|905762|P1|STARTED|Overall Study||58
371972|NCT00392210|905780|P2|NOT COMPLETED|Second Voiding Trial||0
371973|NCT00392210|905781|P1|NOT COMPLETED|Second Voiding Trial||0
371974|NCT00392210|905780|P2|COMPLETED|Second Voiding Trial||31
371975|NCT00392210|905781|P1|COMPLETED|Second Voiding Trial||34
371976|NCT00392210|905780|P2|STARTED|Second Voiding Trial||31
371977|NCT00392210|905781|P1|STARTED|Second Voiding Trial||34
371978|NCT00392210|905780|P2|NOT COMPLETED|First Voiding Trial||2
371979|NCT00392210|905781|P1|NOT COMPLETED|First Voiding Trial||2
371980|NCT00392210|905780|P2|COMPLETED|First Voiding Trial||31
371981|NCT00392210|905781|P1|COMPLETED|First Voiding Trial||34
371982|NCT00392210|905780|P2|STARTED|First Voiding Trial||33
371983|NCT00392210|905781|P1|STARTED|First Voiding Trial||36
371984|NCT00392197|905789|P2|NOT COMPLETED|Overall Study||30
371985|NCT00392197|905790|P1|NOT COMPLETED|Overall Study||21
371986|NCT00392197|905789|P2|COMPLETED|Overall Study||33
371987|NCT00392197|905790|P1|COMPLETED|Overall Study||27
371988|NCT00392197|905789|P2|STARTED|Overall Study||63
371989|NCT00392197|905790|P1|STARTED|Overall Study||48
371990|NCT00392171|905798|P1|NOT COMPLETED|Overall Study||105
371991|NCT00392171|905798|P1|COMPLETED|Overall Study||15
371992|NCT00392171|905798|P1|STARTED|Overall Study||120
371993|NCT00391989|905802|P1|NOT COMPLETED|Overall Study||2
371994|NCT00391989|905802|P1|COMPLETED|Overall Study||53
371995|NCT00391989|905802|P1|STARTED|Overall Study||55
371996|NCT00391976|905809|P3|NOT COMPLETED|Overall Study||35
371997|NCT00391976|905810|P2|NOT COMPLETED|Overall Study||25
371998|NCT00391976|905811|P1|NOT COMPLETED|Overall Study||27
371999|NCT00391976|905809|P3|COMPLETED|Overall Study||0
372000|NCT00391976|905810|P2|COMPLETED|Overall Study||18
372001|NCT00391976|905811|P1|COMPLETED|Overall Study||18
372002|NCT00391976|905809|P3|Safety Population|Overall Study||35
372003|NCT00391976|905810|P2|Safety Population|Overall Study||43
372004|NCT00391976|905811|P1|Safety Population|Overall Study|Patients who were enrolled and received at least one dose of study medication.|44
372005|NCT00391976|905809|P3|Randomized|Overall Study||0
372006|NCT00391976|905810|P2|Randomized|Overall Study||43
372007|NCT00391976|905811|P1|Randomized|Overall Study|Randomization occurred after 28 days of treatment & negative antibody test aeruginosa antibody test|45
372008|NCT00391976|905809|P3|STARTED|Overall Study||35
372009|NCT00391976|905810|P2|STARTED|Overall Study||43
372010|NCT00391976|905811|P1|STARTED|Overall Study|Started indicates all patients who were enrolled at Visit 1|45
372011|NCT00391898|905835|P2|NOT COMPLETED|Overall Study||10
372012|NCT00391898|905836|P1|NOT COMPLETED|Overall Study||11
372013|NCT00391898|905835|P2|COMPLETED|Overall Study||39
372014|NCT00391898|905836|P1|COMPLETED|Overall Study||35
372015|NCT00391898|905835|P2|STARTED|Overall Study||49
372016|NCT00391898|905836|P1|STARTED|Overall Study|Safety population for Levodopa/carbidopa/entacapone is 45, for Levodopa/carbidopa, per randomized.|46
372017|NCT00391872|905856|P2|NOT COMPLETED|Overall Study||255
372018|NCT00391872|905857|P1|NOT COMPLETED|Overall Study||307
372019|NCT00391872|905856|P2|COMPLETED|Overall Study||9036
372020|NCT00391872|905857|P1|COMPLETED|Overall Study||9026
372021|NCT00391872|905856|P2|STARTED|Overall Study||9291
372022|NCT00391872|905857|P1|STARTED|Overall Study||9333
372023|NCT00391846|905895|P2|NOT COMPLETED|Overall Study||7
372024|NCT00391846|905896|P1|NOT COMPLETED|Overall Study||8
372025|NCT00391846|905895|P2|COMPLETED|Overall Study|118 completed patients includes 5 CV related deaths|118
372026|NCT00391846|905896|P1|COMPLETED|Overall Study|119 completed patients includes 4 CV related deaths|119
372027|NCT00391846|905895|P2|STARTED|Overall Study|Of th 125 randomised patients 7 were discontinued|125
372028|NCT00391846|905896|P1|STARTED|Overall Study|Of the 127 randomised patients 8 were discontinued|127
372029|NCT00391807|905916|P1|NOT COMPLETED|Overall Study||715
372030|NCT00391807|905916|P1|COMPLETED|Overall Study||968
372031|NCT00391807|905916|P1|STARTED|Overall Study||1683
372032|NCT00391768|905943|P7|NOT COMPLETED|Overall Study||4
372033|NCT00391768|905944|P6|NOT COMPLETED|Overall Study||3
372034|NCT00391768|905945|P5|NOT COMPLETED|Overall Study||2
372035|NCT00391768|905946|P4|NOT COMPLETED|Overall Study||1
372036|NCT00391768|905947|P3|NOT COMPLETED|Overall Study||1
372037|NCT00391768|905948|P2|NOT COMPLETED|Overall Study||0
372038|NCT00391768|905949|P1|NOT COMPLETED|Overall Study||0
372039|NCT00391768|905943|P7|COMPLETED|Overall Study||19
372040|NCT00391768|905944|P6|COMPLETED|Overall Study||7
372041|NCT00391768|905945|P5|COMPLETED|Overall Study||22
372042|NCT00391768|905946|P4|COMPLETED|Overall Study||7
372043|NCT00391768|905947|P3|COMPLETED|Overall Study||6
372044|NCT00391768|905948|P2|COMPLETED|Overall Study||3
372045|NCT00391768|905949|P1|COMPLETED|Overall Study||12
372046|NCT00391768|905943|P7|STARTED|Overall Study||23
372047|NCT00391768|905944|P6|STARTED|Overall Study||10
372048|NCT00391768|905945|P5|STARTED|Overall Study||24
372049|NCT00391768|905946|P4|STARTED|Overall Study||8
372050|NCT00391768|905947|P3|STARTED|Overall Study||7
372051|NCT00391768|905948|P2|STARTED|Overall Study||3
372052|NCT00391768|905949|P1|STARTED|Overall Study||12
372053|NCT00391716|906017|P3|NOT COMPLETED|Overall Study||19
372054|NCT00391716|906018|P2|NOT COMPLETED|Overall Study||19
372055|NCT00391716|906019|P1|NOT COMPLETED|Overall Study||27
372056|NCT00391716|906017|P3|COMPLETED|Overall Study||30
372057|NCT00391716|906018|P2|COMPLETED|Overall Study||28
372058|NCT00391716|906019|P1|COMPLETED|Overall Study||27
372059|NCT00391716|906017|P3|STARTED|Overall Study||49
372060|NCT00391716|906018|P2|STARTED|Overall Study||47
372061|NCT00391716|906019|P1|STARTED|Overall Study||54
372062|NCT00391625|906036|P1|NOT COMPLETED|Month 84||0
372063|NCT00391625|906036|P1|COMPLETED|Month 84||8
372064|NCT00391625|906036|P1|STARTED|Month 84||8
372065|NCT00391625|906036|P1|NOT COMPLETED|Month 50||1
372066|NCT00391625|906036|P1|COMPLETED|Month 50||8
372067|NCT00391625|906036|P1|STARTED|Month 50||9
372068|NCT00391625|906036|P1|NOT COMPLETED|Month 14||1
372069|NCT00391625|906036|P1|COMPLETED|Month 14||9
372070|NCT00391625|906036|P1|STARTED|Month 14||10
372071|NCT00391625|906036|P1|NOT COMPLETED|Baseline||0
372072|NCT00391625|906036|P1|COMPLETED|Baseline||10
372073|NCT00391625|906036|P1|STARTED|Baseline||10
372074|NCT00391599|906078|P2|NOT COMPLETED|Overall Study||0
372075|NCT00391599|906079|P1|NOT COMPLETED|Overall Study||0
372076|NCT00391599|906078|P2|COMPLETED|Overall Study||65
372077|NCT00391599|906079|P1|COMPLETED|Overall Study||65
372078|NCT00391599|906078|P2|STARTED|Overall Study||65
372079|NCT00391599|906079|P1|STARTED|Overall Study||65
372080|NCT00391586|906089|P1|NOT COMPLETED|Overall Study||24
372081|NCT00391586|906089|P1|COMPLETED|Overall Study|These patients received at least 2 cycles of erlotinib|21
372082|NCT00391586|906089|P1|Received Platinum-based Chemotherapy|Overall Study|Total number of patients who received platinum-based chemotherapy after erlotinib treatment|10
372083|NCT00391586|906089|P1|Received First-line Erlotinib|Overall Study|These patients received at least one dose of on-study first-line erlotinib|43
372084|NCT00391586|906089|P1|STARTED|Overall Study||45
372085|NCT00391469|906098|P2|NOT COMPLETED|Overall Study||0
372086|NCT00391469|906099|P1|NOT COMPLETED|Overall Study||0
372087|NCT00391469|906098|P2|COMPLETED|Overall Study||671
372088|NCT00391469|906099|P1|COMPLETED|Overall Study|5 patients were found to be incarcerated at time of randomization, thus data was not included|688
372089|NCT00391469|906098|P2|STARTED|Overall Study||671
372090|NCT00391469|906099|P1|STARTED|Overall Study||688
372091|NCT00391443|906113|P2|NOT COMPLETED|Overall Study||0
372092|NCT00391443|906114|P1|NOT COMPLETED|Overall Study||0
372093|NCT00391443|906113|P2|COMPLETED|Overall Study||407
372094|NCT00391443|906114|P1|COMPLETED|Overall Study||209
372095|NCT00391443|906113|P2|STARTED|Overall Study||407
372096|NCT00391443|906114|P1|STARTED|Overall Study|1 patient in the bosentan arm did not receive treatment & was excluded from the Safety Population.|209
372097|NCT00391391|906126|P4|NOT COMPLETED|Overall Study||19
372098|NCT00391391|906127|P3|NOT COMPLETED|Overall Study||23
372099|NCT00391391|906128|P2|NOT COMPLETED|Overall Study||10
372100|NCT00391391|906129|P1|NOT COMPLETED|Overall Study||9
372101|NCT00391391|906126|P4|COMPLETED|Overall Study||145
372102|NCT00391391|906127|P3|COMPLETED|Overall Study||138
372103|NCT00391391|906128|P2|COMPLETED|Overall Study||87
372104|NCT00391391|906129|P1|COMPLETED|Overall Study||89
372105|NCT00391391|906126|P4|STARTED|Overall Study|1 participant was not vaccinated.|164
372106|NCT00391391|906127|P3|STARTED|Overall Study|1 participant was not vaccinated.|161
372107|NCT00391391|906128|P2|STARTED|Overall Study||97
372108|NCT00391391|906129|P1|STARTED|Overall Study|1 participant was not vaccinated.|98
372109|NCT00391365|906161|P2|NOT COMPLETED|Overall Study||19
372110|NCT00391365|906162|P1|NOT COMPLETED|Overall Study||25
372111|NCT00391365|906161|P2|COMPLETED|Overall Study||151
372112|NCT00391365|906162|P1|COMPLETED|Overall Study||78
372113|NCT00391365|906161|P2|STARTED|Overall Study||170
372114|NCT00391365|906162|P1|STARTED|Overall Study||103
372115|NCT00391274|906174|P2|NOT COMPLETED|Overall Study||57
372116|NCT00391274|906175|P1|NOT COMPLETED|Overall Study||61
372117|NCT00391274|906174|P2|COMPLETED|Overall Study||47
372118|NCT00391274|906175|P1|COMPLETED|Overall Study||46
372119|NCT00391274|906174|P2|Received at Least One Dose of Study Drug|Overall Study||102
372120|NCT00391274|906175|P1|Received at Least One Dose of Study Drug|Overall Study||106
372121|NCT00391274|906174|P2|STARTED|Overall Study||104
372122|NCT00391274|906175|P1|STARTED|Overall Study||107
372123|NCT00391222|906194|P4|NOT COMPLETED|Period III (Double-Blind Treatment)||0
372124|NCT00391222|906195|P3|NOT COMPLETED|Period III (Double-Blind Treatment)||23
372125|NCT00391222|906196|P2|NOT COMPLETED|Period III (Double-Blind Treatment)||22
372126|NCT00391222|906197|P1|NOT COMPLETED|Period III (Double-Blind Treatment)||28
372127|NCT00391222|906194|P4|COMPLETED|Period III (Double-Blind Treatment)||0
372128|NCT00391222|906195|P3|COMPLETED|Period III (Double-Blind Treatment)||108
372129|NCT00391222|906196|P2|COMPLETED|Period III (Double-Blind Treatment)||113
372130|NCT00391222|906197|P1|COMPLETED|Period III (Double-Blind Treatment)||104
372131|NCT00391222|906194|P4|STARTED|Period III (Double-Blind Treatment)||0
372132|NCT00391222|906195|P3|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|131
372133|NCT00391222|906196|P2|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|135
372134|NCT00391222|906197|P1|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|132
372135|NCT00391222|906194|P4|NOT COMPLETED|Period II (Open-label Risperidone LAI)||162
372136|NCT00391222|906195|P3|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
372137|NCT00391222|906196|P2|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
372138|NCT00391222|906197|P1|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
372139|NCT00391222|906194|P4|COMPLETED|Period II (Open-label Risperidone LAI)||398
372140|NCT00391222|906195|P3|COMPLETED|Period II (Open-label Risperidone LAI)||0
372141|NCT00391222|906196|P2|COMPLETED|Period II (Open-label Risperidone LAI)||0
372142|NCT00391222|906197|P1|COMPLETED|Period II (Open-label Risperidone LAI)||0
372143|NCT00391222|906194|P4|STARTED|Period II (Open-label Risperidone LAI)|The 25 patients at the site of Dr. Parikh were excluded from the analysis due to GCP non-compliance|560
372144|NCT00391222|906195|P3|STARTED|Period II (Open-label Risperidone LAI)||0
372145|NCT00391222|906196|P2|STARTED|Period II (Open-label Risperidone LAI)||0
372146|NCT00391222|906197|P1|STARTED|Period II (Open-label Risperidone LAI)||0
372147|NCT00391092|906223|P2|NOT COMPLETED|Overall Study||216
372148|NCT00391092|906224|P1|NOT COMPLETED|Overall Study||208
372149|NCT00391092|906223|P2|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
372150|NCT00391092|906224|P1|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
372151|NCT00391092|906223|P2|Received Treatment|Overall Study||215
372152|NCT00391092|906224|P1|Received Treatment|Overall Study||206
372153|NCT00391092|906223|P2|STARTED|Overall Study||216
372154|NCT00391092|906224|P1|STARTED|Overall Study||208
372155|NCT00391079|906244|P2|NOT COMPLETED|Overall Study||16
372156|NCT00391079|906245|P1|NOT COMPLETED|Overall Study||26
372157|NCT00391079|906244|P2|COMPLETED|Overall Study||156
372158|NCT00391079|906245|P1|COMPLETED|Overall Study||141
372159|NCT00391079|906244|P2|STARTED|Overall Study||172
372160|NCT00391079|906245|P1|STARTED|Overall Study||167
372161|NCT00391053|906267|P4|NOT COMPLETED|Overall Study||10
372162|NCT00391053|906268|P3|NOT COMPLETED|Overall Study||2
372163|NCT00391053|906269|P2|NOT COMPLETED|Overall Study||1
372164|NCT00391053|906270|P1|NOT COMPLETED|Overall Study||9
372165|NCT00391053|906267|P4|COMPLETED|Overall Study||1252
372166|NCT00391053|906268|P3|COMPLETED|Overall Study||868
372167|NCT00391053|906269|P2|COMPLETED|Overall Study||847
372168|NCT00391053|906270|P1|COMPLETED|Overall Study||848
372169|NCT00391053|906267|P4|STARTED|Overall Study||1262
372170|NCT00391053|906268|P3|STARTED|Overall Study||870
372171|NCT00391053|906269|P2|STARTED|Overall Study||848
372172|NCT00391053|906270|P1|STARTED|Overall Study||857
372173|NCT00391027|906294|P2|NOT COMPLETED|Overall Study||12
372174|NCT00391027|906295|P1|NOT COMPLETED|Overall Study||25
372175|NCT00391027|906294|P2|COMPLETED|Overall Study||110
372176|NCT00391027|906295|P1|COMPLETED|Overall Study||110
372177|NCT00391027|906294|P2|STARTED|Overall Study|Full Analysis Set = 121; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|122
372178|NCT00391027|906295|P1|STARTED|Overall Study|Full Analysis Set = 134; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|135
372179|NCT00390949|906335|P2|NOT COMPLETED|Overall Study||2128
372180|NCT00390949|906336|P1|NOT COMPLETED|Overall Study||2098
372181|NCT00390949|906335|P2|COMPLETED|Overall Study||2664
372182|NCT00390949|906336|P1|COMPLETED|Overall Study||2564
372183|NCT00390949|906335|P2|STARTED|Overall Study||4792
372184|NCT00390949|906336|P1|STARTED|Overall Study||4662
372185|NCT00390910|906345|P3|NOT COMPLETED|Overall Study||10
372186|NCT00390910|906346|P2|NOT COMPLETED|Overall Study||4
372187|NCT00390910|906347|P1|NOT COMPLETED|Overall Study||2
372188|NCT00390910|906345|P3|COMPLETED|Overall Study||139
372189|NCT00390910|906346|P2|COMPLETED|Overall Study||83
372190|NCT00390910|906347|P1|COMPLETED|Overall Study||48
372191|NCT00390910|906345|P3|STARTED|Overall Study||149
372192|NCT00390910|906346|P2|STARTED|Overall Study||87
372193|NCT00390910|906347|P1|STARTED|Overall Study||50
372194|NCT00390884|906435|P2|NOT COMPLETED|Overall Study||2
372195|NCT00390884|906436|P1|NOT COMPLETED|Overall Study||2
372196|NCT00390884|906435|P2|COMPLETED|Overall Study||55
372197|NCT00390884|906436|P1|COMPLETED|Overall Study||114
372198|NCT00390884|906435|P2|STARTED|Overall Study||57
372199|NCT00390884|906436|P1|STARTED|Overall Study||116
372200|NCT00390858|906448|P2|NOT COMPLETED|Overall Study||7
372201|NCT00390858|906449|P1|NOT COMPLETED|Overall Study||9
372202|NCT00390858|906448|P2|COMPLETED|Overall Study|13 Participants completed the Extension Study|13
372203|NCT00390858|906449|P1|COMPLETED|Overall Study|11 participants Completed the Extension Study|11
372204|NCT00390858|906448|P2|Completed Core & Entered Extension Study|Overall Study||20
372205|NCT00390858|906449|P1|Completed Core & Entered Extension Study|Overall Study||19
372206|NCT00390858|906448|P2|STARTED|Overall Study|20 Participants started the Core Study|20
372207|NCT00390858|906449|P1|STARTED|Overall Study|20 participants started the Core Study|20
372208|NCT00390806|906463|P2|NOT COMPLETED|Overall Study||32
372209|NCT00390806|906464|P1|NOT COMPLETED|Overall Study||30
372210|NCT00390806|906463|P2|COMPLETED|Overall Study||204
372211|NCT00390806|906464|P1|COMPLETED|Overall Study||206
372212|NCT00390806|906463|P2|Ongoing|Overall Study||2
372213|NCT00390806|906464|P1|Ongoing|Overall Study||4
372214|NCT00390806|906463|P2|STARTED|Overall Study||236
372215|NCT00390806|906464|P1|STARTED|Overall Study||236
372216|NCT00390780|906532|P2|NOT COMPLETED|Overall Study||27
372217|NCT00390780|906533|P1|NOT COMPLETED|Overall Study||23
372218|NCT00390780|906532|P2|COMPLETED|Overall Study||260
372219|NCT00390780|906533|P1|COMPLETED|Overall Study||268
372220|NCT00390780|906532|P2|Treatment|Overall Study||287
372221|NCT00390780|906533|P1|Treatment|Overall Study|One patient randomized to miconazole lost study drug, never started treatment, and was discontinued.|290
372222|NCT00390780|906532|P2|STARTED|Overall Study||287
372223|NCT00390780|906533|P1|STARTED|Overall Study||291
372224|NCT00390689|906566|P3|NOT COMPLETED|Overall Study||3
372225|NCT00390689|906567|P2|NOT COMPLETED|Overall Study||5
372226|NCT00390689|906568|P1|NOT COMPLETED|Overall Study||5
372227|NCT00390689|906566|P3|COMPLETED|Overall Study||50
372228|NCT00390689|906567|P2|COMPLETED|Overall Study||48
372229|NCT00390689|906568|P1|COMPLETED|Overall Study||43
372230|NCT00390689|906566|P3|STARTED|Overall Study||53
372231|NCT00390689|906567|P2|STARTED|Overall Study||53
372232|NCT00390689|906568|P1|STARTED|Overall Study||48
372233|NCT00390611|906628|P2|NOT COMPLETED|Maintenance Sorafenib to Month 12||0
372234|NCT00390611|906629|P1|NOT COMPLETED|Maintenance Sorafenib to Month 12||10
372235|NCT00390611|906628|P2|COMPLETED|Maintenance Sorafenib to Month 12||0
372236|NCT00390611|906629|P1|COMPLETED|Maintenance Sorafenib to Month 12||13
372237|NCT00390611|906628|P2|STARTED|Maintenance Sorafenib to Month 12|Patients in the Paclitaxel/carboplatin arm did not recieve maintenance sorafenib|0
372238|NCT00390611|906629|P1|STARTED|Maintenance Sorafenib to Month 12|11 patients came off-study between the end of cycle 6 and the start of maintenance|23
372239|NCT00390611|906628|P2|NOT COMPLETED|6 Cycles of Study Treatment||5
372240|NCT00390611|906629|P1|NOT COMPLETED|6 Cycles of Study Treatment||9
372241|NCT00390611|906628|P2|COMPLETED|6 Cycles of Study Treatment||37
372242|NCT00390611|906629|P1|COMPLETED|6 Cycles of Study Treatment||34
372243|NCT00390611|906628|P2|STARTED|6 Cycles of Study Treatment||42
372244|NCT00390611|906629|P1|STARTED|6 Cycles of Study Treatment||43
372245|NCT00390572|906643|P2|NOT COMPLETED|Overall Study||5
372246|NCT00390572|906644|P1|NOT COMPLETED|Overall Study||8
372247|NCT00390572|906643|P2|COMPLETED|Overall Study||64
372248|NCT00390572|906644|P1|COMPLETED|Overall Study||60
372249|NCT00390572|906643|P2|STARTED|Overall Study||69
372250|NCT00390572|906644|P1|STARTED|Overall Study||68
372251|NCT00390559|906658|P1|NOT COMPLETED|Overall Study||44
372252|NCT00390559|906658|P1|COMPLETED|Overall Study||80
372253|NCT00390559|906658|P1|ActiveP/PlaceboC|Overall Study||90
372254|NCT00390559|906658|P1|PlaceboP/PlaceboC|Overall Study||93
372255|NCT00390559|906658|P1|ActiveP/ActiveC|Overall Study||87
372256|NCT00390559|906658|P1|Received PlaceboP/Active C|Overall Study||93
372257|NCT00390559|906658|P1|STARTED|Overall Study||124
372258|NCT00390546|906670|P2|NOT COMPLETED|Overall Study||5
372259|NCT00390546|906671|P1|NOT COMPLETED|Overall Study||6
372260|NCT00390546|906670|P2|COMPLETED|Overall Study||34
372261|NCT00390546|906671|P1|COMPLETED|Overall Study||27
372262|NCT00390546|906670|P2|STARTED|Overall Study||39
372263|NCT00390546|906671|P1|STARTED|Overall Study||33
372264|NCT00390468|906681|P1|NOT COMPLETED|Overall Study||3
372265|NCT00390468|906681|P1|COMPLETED|Overall Study||15
372266|NCT00390468|906681|P1|STARTED|Overall Study||18
372267|NCT00390455|906687|P2|NOT COMPLETED|Overall Study||23
372268|NCT00390455|906688|P1|NOT COMPLETED|Overall Study||32
372269|NCT00390455|906687|P2|COMPLETED|Overall Study||124
372270|NCT00390455|906688|P1|COMPLETED|Overall Study||116
372271|NCT00390455|906687|P2|STARTED|Overall Study||147
372272|NCT00390455|906688|P1|STARTED|Overall Study||148
372273|NCT00390429|906709|P4|NOT COMPLETED|Overall Study||0
372274|NCT00390429|906710|P3|NOT COMPLETED|Overall Study||0
372275|NCT00390429|906711|P2|NOT COMPLETED|Overall Study||0
372276|NCT00390429|906712|P1|NOT COMPLETED|Overall Study||0
372277|NCT00390429|906709|P4|COMPLETED|Overall Study||39
372278|NCT00390429|906710|P3|COMPLETED|Overall Study||25
372279|NCT00390429|906711|P2|COMPLETED|Overall Study||12
372280|NCT00390429|906712|P1|COMPLETED|Overall Study||5
372281|NCT00390429|906709|P4|STARTED|Overall Study||39
372282|NCT00390429|906710|P3|STARTED|Overall Study||25
372283|NCT00390429|906711|P2|STARTED|Overall Study||12
372284|NCT00390429|906712|P1|STARTED|Overall Study||5
372285|NCT00390416|906733|P1|NOT COMPLETED|Overall Study||4
372286|NCT00390416|906733|P1|COMPLETED|Overall Study||44
372287|NCT00390416|906733|P1|STARTED|Overall Study||48
372288|NCT00390364|906739|P1|NOT COMPLETED|Overall Study||0
372289|NCT00390364|906739|P1|COMPLETED|Overall Study||1
372290|NCT00390364|906739|P1|STARTED|Overall Study||1
372291|NCT00390325|906745|P2|NOT COMPLETED|Overall Study||0
372292|NCT00390325|906746|P1|NOT COMPLETED|Overall Study||0
372293|NCT00390325|906745|P2|COMPLETED|Overall Study||16
372294|NCT00390325|906746|P1|COMPLETED|Overall Study||5
372295|NCT00390325|906745|P2|STARTED|Overall Study||16
372296|NCT00390325|906746|P1|STARTED|Overall Study||5
372297|NCT00390234|906766|P1|NOT COMPLETED|Overall Study||0
372298|NCT00390234|906766|P1|COMPLETED|Overall Study||63
372299|NCT00390234|906766|P1|STARTED|Overall Study||63
372300|NCT00390221|906777|P3|NOT COMPLETED|Overall Study||15
372301|NCT00390221|906778|P2|NOT COMPLETED|Overall Study||20
372302|NCT00390221|906779|P1|NOT COMPLETED|Overall Study||18
372303|NCT00390221|906777|P3|COMPLETED|Overall Study||194
372304|NCT00390221|906778|P2|COMPLETED|Overall Study||188
372305|NCT00390221|906779|P1|COMPLETED|Overall Study||186
372306|NCT00390221|906777|P3|STARTED|Overall Study||209
372307|NCT00390221|906778|P2|STARTED|Overall Study||208
372308|NCT00390221|906779|P1|STARTED|Overall Study||204
372309|NCT00390182|906800|P1|NOT COMPLETED|Overall Study||5
372310|NCT00390182|906800|P1|COMPLETED|Overall Study||33
372311|NCT00390182|906800|P1|STARTED|Overall Study||38
372312|NCT00390013|906809|P4|NOT COMPLETED|Phase 2 Second Treatment||0
372313|NCT00390013|906810|P3|NOT COMPLETED|Phase 2 Second Treatment||0
372314|NCT00390013|906811|P2|NOT COMPLETED|Phase 2 Second Treatment||0
372315|NCT00390013|906812|P1|NOT COMPLETED|Phase 2 Second Treatment||0
372316|NCT00390013|906809|P4|COMPLETED|Phase 2 Second Treatment||0
372317|NCT00390013|906810|P3|COMPLETED|Phase 2 Second Treatment||0
372318|NCT00390013|906811|P2|COMPLETED|Phase 2 Second Treatment||1
372319|NCT00390013|906812|P1|COMPLETED|Phase 2 Second Treatment||2
372320|NCT00390013|906809|P4|STARTED|Phase 2 Second Treatment||0
372321|NCT00390013|906810|P3|STARTED|Phase 2 Second Treatment||0
372322|NCT00390013|906811|P2|STARTED|Phase 2 Second Treatment||1
372323|NCT00390013|906812|P1|STARTED|Phase 2 Second Treatment||2
372324|NCT00390013|906809|P4|NOT COMPLETED|Phase 2 First Treatment||0
372325|NCT00390013|906810|P3|NOT COMPLETED|Phase 2 First Treatment||0
372326|NCT00390013|906811|P2|NOT COMPLETED|Phase 2 First Treatment||1
372327|NCT00390013|906812|P1|NOT COMPLETED|Phase 2 First Treatment||1
372328|NCT00390013|906809|P4|COMPLETED|Phase 2 First Treatment||0
372329|NCT00390013|906810|P3|COMPLETED|Phase 2 First Treatment||0
372330|NCT00390013|906811|P2|COMPLETED|Phase 2 First Treatment||1
372331|NCT00390013|906812|P1|COMPLETED|Phase 2 First Treatment||2
372332|NCT00390013|906809|P4|STARTED|Phase 2 First Treatment||0
372333|NCT00390013|906810|P3|STARTED|Phase 2 First Treatment||0
372334|NCT00390013|906811|P2|STARTED|Phase 2 First Treatment||2
372335|NCT00390013|906812|P1|STARTED|Phase 2 First Treatment||3
372336|NCT00390013|906809|P4|NOT COMPLETED|Phase 1||1
372337|NCT00390013|906810|P3|NOT COMPLETED|Phase 1||0
372338|NCT00390013|906811|P2|NOT COMPLETED|Phase 1||0
372339|NCT00390013|906812|P1|NOT COMPLETED|Phase 1||0
372340|NCT00390013|906809|P4|COMPLETED|Phase 1||1
372341|NCT00390013|906810|P3|COMPLETED|Phase 1||2
372342|NCT00390013|906811|P2|COMPLETED|Phase 1||0
372343|NCT00390013|906812|P1|COMPLETED|Phase 1||0
372344|NCT00390013|906809|P4|STARTED|Phase 1||2
372345|NCT00390013|906810|P3|STARTED|Phase 1||2
372346|NCT00390013|906811|P2|STARTED|Phase 1||0
372347|NCT00390013|906812|P1|STARTED|Phase 1||0
372348|NCT00389974|906818|P1|NOT COMPLETED|Overall Study||0
372349|NCT00389974|906818|P1|COMPLETED|Overall Study||19
372350|NCT00389974|906818|P1|STARTED|Overall Study||19
372351|NCT00389857|906824|P2|NOT COMPLETED|Overall Study||0
372352|NCT00389857|906825|P1|NOT COMPLETED|Overall Study||0
372353|NCT00389857|906824|P2|COMPLETED|Overall Study||17
372354|NCT00389857|906825|P1|COMPLETED|Overall Study||14
372355|NCT00389857|906824|P2|STARTED|Overall Study||17
372356|NCT00389857|906825|P1|STARTED|Overall Study||14
372357|NCT00389831|906837|P2|NOT COMPLETED|Overall Study||7
372358|NCT00389831|906838|P1|NOT COMPLETED|Overall Study||0
372359|NCT00389831|906837|P2|COMPLETED|Overall Study||27
372360|NCT00389831|906838|P1|COMPLETED|Overall Study||10
372361|NCT00389831|906837|P2|STARTED|Overall Study||34
372362|NCT00389831|906838|P1|STARTED|Overall Study||10
372363|NCT00389818|906864|P1|NOT COMPLETED|Overall Study||3
372364|NCT00389818|906864|P1|COMPLETED|Overall Study||40
372365|NCT00389818|906864|P1|STARTED|Overall Study||43
372366|NCT00389805|906870|P2|NOT COMPLETED|Phase II||0
372367|NCT00389805|906871|P1|NOT COMPLETED|Phase II||0
372368|NCT00389805|906870|P2|COMPLETED|Phase II||0
372369|NCT00389805|906871|P1|COMPLETED|Phase II||0
372370|NCT00389805|906870|P2|STARTED|Phase II|The Phase II study was not conducted.|0
372371|NCT00389805|906871|P1|STARTED|Phase II|The Phase II study was not conducted.|0
372372|NCT00389805|906870|P2|NOT COMPLETED|Phase I||0
372373|NCT00389805|906871|P1|NOT COMPLETED|Phase I||0
372374|NCT00389805|906870|P2|COMPLETED|Phase I||12
372375|NCT00389805|906871|P1|COMPLETED|Phase I||15
372376|NCT00389805|906870|P2|STARTED|Phase I||12
372377|NCT00389805|906871|P1|STARTED|Phase I||15
372378|NCT00389597|906901|P4|NOT COMPLETED|Overall Study||6
372379|NCT00389597|906902|P3|NOT COMPLETED|Overall Study||4
372380|NCT00389597|906903|P2|NOT COMPLETED|Overall Study||6
372381|NCT00389597|906904|P1|NOT COMPLETED|Overall Study||8
372382|NCT00389597|906901|P4|COMPLETED|Overall Study||99
372383|NCT00389597|906902|P3|COMPLETED|Overall Study||221
372384|NCT00389597|906903|P2|COMPLETED|Overall Study||75
372385|NCT00389597|906904|P1|COMPLETED|Overall Study||156
372386|NCT00389597|906901|P4|24 mo|Overall Study||99
372387|NCT00389597|906902|P3|24 mo|Overall Study||221
372388|NCT00389597|906903|P2|24 mo|Overall Study||75
372389|NCT00389597|906904|P1|24 mo|Overall Study||156
372390|NCT00389597|906901|P4|STARTED|Overall Study||105
372391|NCT00389597|906902|P3|STARTED|Overall Study||225
372392|NCT00389597|906903|P2|STARTED|Overall Study||81
372393|NCT00389597|906904|P1|STARTED|Overall Study||164
372394|NCT00389532|906916|P2|NOT COMPLETED|Overall Study||0
372395|NCT00389532|906917|P1|NOT COMPLETED|Overall Study||0
372396|NCT00389532|906916|P2|COMPLETED|Overall Study||56
372397|NCT00389532|906917|P1|COMPLETED|Overall Study|3 of the participants did not have valid post-vaccination serological results|60
372398|NCT00389532|906916|P2|STARTED|Overall Study||56
372399|NCT00389532|906917|P1|STARTED|Overall Study||60
372400|NCT00389519|906929|P4|NOT COMPLETED|Treated||4
372401|NCT00389519|906930|P3|NOT COMPLETED|Treated||0
372402|NCT00389519|906931|P2|NOT COMPLETED|Treated||1
372403|NCT00389519|906932|P1|NOT COMPLETED|Treated||2
372404|NCT00389519|906929|P4|COMPLETED|Treated||76
372405|NCT00389519|906930|P3|COMPLETED|Treated||40
372406|NCT00389519|906931|P2|COMPLETED|Treated||40
372407|NCT00389519|906932|P1|COMPLETED|Treated||79
372408|NCT00389519|906929|P4|STARTED|Treated||80
372409|NCT00389519|906930|P3|STARTED|Treated||40
372410|NCT00389519|906931|P2|STARTED|Treated||41
372411|NCT00389519|906932|P1|STARTED|Treated||81
372412|NCT00389519|906929|P4|NOT COMPLETED|Randomized||0
372413|NCT00389519|906930|P3|NOT COMPLETED|Randomized||0
372414|NCT00389519|906931|P2|NOT COMPLETED|Randomized||0
372415|NCT00389519|906932|P1|NOT COMPLETED|Randomized||2
372416|NCT00389519|906929|P4|COMPLETED|Randomized||80
372417|NCT00389519|906930|P3|COMPLETED|Randomized||40
372418|NCT00389519|906931|P2|COMPLETED|Randomized||41
372419|NCT00389519|906932|P1|COMPLETED|Randomized||81
372420|NCT00389519|906929|P4|STARTED|Randomized||80
372421|NCT00389519|906930|P3|STARTED|Randomized||40
372422|NCT00389519|906931|P2|STARTED|Randomized||41
372423|NCT00389519|906932|P1|STARTED|Randomized||83
372424|NCT00389519|906929|P4|NOT COMPLETED|Placebo Run-In||0
372425|NCT00389519|906930|P3|NOT COMPLETED|Placebo Run-In||0
372426|NCT00389519|906931|P2|NOT COMPLETED|Placebo Run-In||0
372427|NCT00389519|906932|P1|NOT COMPLETED|Placebo Run-In||178
372428|NCT00389519|906929|P4|COMPLETED|Placebo Run-In||0
372429|NCT00389519|906930|P3|COMPLETED|Placebo Run-In||0
372430|NCT00389519|906931|P2|COMPLETED|Placebo Run-In||0
372431|NCT00389519|906932|P1|COMPLETED|Placebo Run-In||244
372432|NCT00389519|906929|P4|STARTED|Placebo Run-In||0
372433|NCT00389519|906930|P3|STARTED|Placebo Run-In||0
372434|NCT00389519|906931|P2|STARTED|Placebo Run-In||0
372435|NCT00389519|906932|P1|STARTED|Placebo Run-In||422
372436|NCT00389493|906961|P3|NOT COMPLETED|Overall Study||3
372437|NCT00389493|906962|P2|NOT COMPLETED|Overall Study||8
372438|NCT00389493|906963|P1|NOT COMPLETED|Overall Study||3
372439|NCT00389493|906961|P3|COMPLETED|Overall Study||17
372440|NCT00389493|906962|P2|COMPLETED|Overall Study||32
372441|NCT00389493|906963|P1|COMPLETED|Overall Study||37
372442|NCT00389493|906961|P3|STARTED|Overall Study||20
372443|NCT00389493|906962|P2|STARTED|Overall Study||40
372444|NCT00389493|906963|P1|STARTED|Overall Study||40
372445|NCT00389467|906987|P4|NOT COMPLETED|Overall Study||0
372446|NCT00389467|906988|P3|NOT COMPLETED|Overall Study||0
372447|NCT00389467|906989|P2|NOT COMPLETED|Overall Study||0
372448|NCT00389467|906990|P1|NOT COMPLETED|Overall Study||0
372449|NCT00389467|906987|P4|COMPLETED|Overall Study||20
372450|NCT00389467|906988|P3|COMPLETED|Overall Study||30
372451|NCT00389467|906989|P2|COMPLETED|Overall Study||34
372452|NCT00389467|906990|P1|COMPLETED|Overall Study||34
372453|NCT00389467|906987|P4|STARTED|Overall Study||20
372454|NCT00389467|906988|P3|STARTED|Overall Study||30
372455|NCT00389467|906989|P2|STARTED|Overall Study||34
372456|NCT00389467|906990|P1|STARTED|Overall Study||34
372457|NCT00389441|907009|P1|NOT COMPLETED|Overall Study||52
372458|NCT00389441|907009|P1|COMPLETED|Overall Study||0
372459|NCT00389441|907009|P1|STARTED|Overall Study||52
372460|NCT00389324|907018|P1|NOT COMPLETED|Subcutaneous Phase||7
372461|NCT00389324|907018|P1|COMPLETED|Subcutaneous Phase||25
372462|NCT00389324|907018|P1|STARTED|Subcutaneous Phase||32
372463|NCT00389324|907018|P1|NOT COMPLETED|Intravenous Phase||0
372464|NCT00389324|907018|P1|COMPLETED|Intravenous Phase||32
372465|NCT00389324|907018|P1|STARTED|Intravenous Phase|18 subjects entered from the Run-in Phase and 14 new participants entered directly|32
372466|NCT00389324|907018|P1|NOT COMPLETED|Run-In Phase||3
372467|NCT00389324|907018|P1|COMPLETED|Run-In Phase||18
372468|NCT00389324|907018|P1|STARTED|Run-In Phase||21
372469|NCT00389207|907028|P3|NOT COMPLETED|Overall Study||41
372470|NCT00389207|907029|P2|NOT COMPLETED|Overall Study||72
372471|NCT00389207|907030|P1|NOT COMPLETED|Overall Study||63
372472|NCT00389207|907028|P3|COMPLETED|Overall Study||152
372473|NCT00389207|907029|P2|COMPLETED|Overall Study||116
372474|NCT00389207|907030|P1|COMPLETED|Overall Study||125
372475|NCT00389207|907028|P3|STARTED|Overall Study||193
372476|NCT00389207|907029|P2|STARTED|Overall Study|4 patients were randomized to NVP BID but not treated and so are not part of the FAS|188
372477|NCT00389207|907030|P1|STARTED|Overall Study|3 patients were randomized to NVP QD but not treated and so not part of the Full Analysis Set (FAS)|188
372478|NCT00389168|907134|P2|NOT COMPLETED|Overall Study||5
372479|NCT00389168|907135|P1|NOT COMPLETED|Overall Study||9
372480|NCT00389168|907134|P2|COMPLETED|Overall Study||53
372481|NCT00389168|907135|P1|COMPLETED|Overall Study||47
372482|NCT00389168|907134|P2|STARTED|Overall Study||58
372483|NCT00389168|907135|P1|STARTED|Overall Study||56
372484|NCT00389064|907153|P2|NOT COMPLETED|Overall Study||59
372485|NCT00389064|907154|P1|NOT COMPLETED|Overall Study||45
372486|NCT00389064|907153|P2|COMPLETED|Overall Study||168
372487|NCT00389064|907154|P1|COMPLETED|Overall Study||178
372488|NCT00389064|907153|P2|STARTED|Overall Study||227
372489|NCT00389064|907154|P1|STARTED|Overall Study||223
372490|NCT00388973|907182|P2|NOT COMPLETED|Overall Study||58
372491|NCT00388973|907183|P1|NOT COMPLETED|Overall Study||56
372492|NCT00388973|907182|P2|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|114
372493|NCT00388973|907183|P1|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|110
372494|NCT00388973|907182|P2|Completed Study|Overall Study||114
372495|NCT00388973|907183|P1|Completed Study|Overall Study||110
372496|NCT00388973|907182|P2|STARTED|Overall Study|Randomized|172
372497|NCT00388973|907183|P1|STARTED|Overall Study|Randomized|166
372498|NCT00388947|907203|P1|NOT COMPLETED|Overall Study||47
372499|NCT00388947|907203|P1|COMPLETED|Overall Study|47 patients excluded because no AMS prolapse device was noted.|1543
372500|NCT00388947|907203|P1|STARTED|Overall Study||1590
372501|NCT00388804|907210|P2|NOT COMPLETED|Overall Study||0
372502|NCT00388804|907211|P1|NOT COMPLETED|Overall Study||0
372503|NCT00388804|907210|P2|COMPLETED|Overall Study||21
372504|NCT00388804|907211|P1|COMPLETED|Overall Study||17
372505|NCT00388804|907210|P2|STARTED|Overall Study||21
372506|NCT00388804|907211|P1|STARTED|Overall Study||17
372507|NCT00388726|907219|P2|NOT COMPLETED|Overall Study||244
372508|NCT00388726|907220|P1|NOT COMPLETED|Overall Study||484
372509|NCT00388726|907219|P2|COMPLETED|Overall Study||10
372510|NCT00388726|907220|P1|COMPLETED|Overall Study||24
372511|NCT00388726|907219|P2|STARTED|Overall Study||254
372512|NCT00388726|907220|P1|STARTED|Overall Study||508
372513|NCT00388674|907234|P2|NOT COMPLETED|End of Study||2169
372514|NCT00388674|907235|P1|NOT COMPLETED|End of Study||1734
372515|NCT00388674|907234|P2|COMPLETED|End of Study|Completed=Reason of ‘other: end of study’|3993
372516|NCT00388674|907235|P1|COMPLETED|End of Study|Completed=Reason of ‘other: end of study’|4482
372517|NCT00388674|907234|P2|STARTED|End of Study||6162
372518|NCT00388674|907235|P1|STARTED|End of Study||6216
372519|NCT00388674|907234|P2|NOT COMPLETED|Initial Treatment||2586
372520|NCT00388674|907235|P1|NOT COMPLETED|Initial Treatment||1828
372521|NCT00388674|907234|P2|COMPLETED|Initial Treatment|Completed=discontinued initial treatment reason of “successful treatment” or “end of study”|3576
372522|NCT00388674|907235|P1|COMPLETED|Initial Treatment|Completed=Reason of ‘successful treatment’, ‘other: successful treatment’ or ‘other: end of study’|4388
372523|NCT00388674|907234|P2|STARTED|Initial Treatment||6162
372524|NCT00388674|907235|P1|STARTED|Initial Treatment||6216
372525|NCT00388583|907253|P2|NOT COMPLETED|Overall Study||4
372526|NCT00388583|907254|P1|NOT COMPLETED|Overall Study||6
372527|NCT00388583|907253|P2|COMPLETED|Overall Study||406
372528|NCT00388583|907254|P1|COMPLETED|Overall Study||401
372529|NCT00388583|907253|P2|STARTED|Overall Study||410
372530|NCT00388583|907254|P1|STARTED|Overall Study||407
372531|NCT00388505|907268|P2|NOT COMPLETED|Overall Study||38
372532|NCT00388505|907269|P1|NOT COMPLETED|Overall Study||83
372533|NCT00388505|907268|P2|COMPLETED|Overall Study||171
372534|NCT00388505|907269|P1|COMPLETED|Overall Study||225
372535|NCT00388505|907268|P2|STARTED|Overall Study|Randomized patients who received any amount of study medication|209
372536|NCT00388505|907269|P1|STARTED|Overall Study|Randomized patients who received any amount of study medication|308
372537|NCT00388453|907294|P3|NOT COMPLETED|Overall Study||0
372538|NCT00388453|907295|P2|NOT COMPLETED|Overall Study||0
372539|NCT00388453|907296|P1|NOT COMPLETED|Overall Study||0
372540|NCT00388453|907294|P3|COMPLETED|Overall Study||10
372541|NCT00388453|907295|P2|COMPLETED|Overall Study||17
372542|NCT00388453|907296|P1|COMPLETED|Overall Study||20
372543|NCT00388453|907294|P3|STARTED|Overall Study||10
372544|NCT00388453|907295|P2|STARTED|Overall Study||17
372545|NCT00388453|907296|P1|STARTED|Overall Study||20
372546|NCT00388414|907315|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
372547|NCT00388414|907316|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
372548|NCT00388414|907315|P2|COMPLETED|Second Intervention (8 Weeks)||7
372549|NCT00388414|907316|P1|COMPLETED|Second Intervention (8 Weeks)||7
372550|NCT00388414|907315|P2|STARTED|Second Intervention (8 Weeks)||7
372551|NCT00388414|907316|P1|STARTED|Second Intervention (8 Weeks)||7
372552|NCT00388414|907315|P2|NOT COMPLETED|Washout (1 Week)||0
372553|NCT00388414|907316|P1|NOT COMPLETED|Washout (1 Week)||0
372554|NCT00388414|907315|P2|COMPLETED|Washout (1 Week)||7
372555|NCT00388414|907316|P1|COMPLETED|Washout (1 Week)||7
372556|NCT00388414|907315|P2|STARTED|Washout (1 Week)||7
372557|NCT00388414|907316|P1|STARTED|Washout (1 Week)||7
372558|NCT00388414|907315|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
372559|NCT00388414|907316|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
372560|NCT00388414|907315|P2|COMPLETED|First Intervention (8 Weeks)||7
372561|NCT00388414|907316|P1|COMPLETED|First Intervention (8 Weeks)||7
372562|NCT00388414|907315|P2|STARTED|First Intervention (8 Weeks)||7
372563|NCT00388414|907316|P1|STARTED|First Intervention (8 Weeks)||7
372564|NCT00388362|907324|P1|NOT COMPLETED|Remained on Study Median of 514 Days||2
372565|NCT00388362|907324|P1|COMPLETED|Remained on Study Median of 514 Days||21
372566|NCT00388362|907324|P1|STARTED|Remained on Study Median of 514 Days||23
372567|NCT00388362|907324|P1|NOT COMPLETED|Enrolled||13
372568|NCT00388362|907324|P1|COMPLETED|Enrolled||23
372569|NCT00388362|907324|P1|STARTED|Enrolled||36
372570|NCT00388349|907329|P2|NOT COMPLETED|Phase 2 Dose Expansion||0
372571|NCT00388349|907330|P1|NOT COMPLETED|Phase 2 Dose Expansion||0
372572|NCT00388349|907329|P2|COMPLETED|Phase 2 Dose Expansion||0
372573|NCT00388349|907330|P1|COMPLETED|Phase 2 Dose Expansion||139
372574|NCT00388349|907329|P2|STARTED|Phase 2 Dose Expansion|No participants were treated in Phase 2 at 1500 mg/m2 gemcitabine (MTD exceeded)|0
372575|NCT00388349|907330|P1|STARTED|Phase 2 Dose Expansion|Includes the three phase 1 participants who received 1250 mg/m2 gemcitabine (MTD)|139
372576|NCT00388349|907329|P2|NOT COMPLETED|Phase I Dose Escalation||3
372577|NCT00388349|907330|P1|NOT COMPLETED|Phase I Dose Escalation||0
372578|NCT00388349|907329|P2|COMPLETED|Phase I Dose Escalation||1
372579|NCT00388349|907330|P1|COMPLETED|Phase I Dose Escalation||3
372580|NCT00388349|907329|P2|STARTED|Phase I Dose Escalation||4
372581|NCT00388349|907330|P1|STARTED|Phase I Dose Escalation||3
372582|NCT00388297|907343|P4|NOT COMPLETED|Overall Study||8
372583|NCT00388297|907344|P3|NOT COMPLETED|Overall Study||11
372584|NCT00388297|907345|P2|NOT COMPLETED|Overall Study||12
372585|NCT00388297|907346|P1|NOT COMPLETED|Overall Study||16
372586|NCT00388297|907343|P4|COMPLETED|Overall Study||253
372587|NCT00388297|907344|P3|COMPLETED|Overall Study||254
372588|NCT00388297|907345|P2|COMPLETED|Overall Study||326
372589|NCT00388297|907346|P1|COMPLETED|Overall Study||323
372590|NCT00388297|907343|P4|STARTED|Overall Study||261
372591|NCT00388297|907344|P3|STARTED|Overall Study||265
372592|NCT00388297|907345|P2|STARTED|Overall Study||338
372593|NCT00388297|907346|P1|STARTED|Overall Study||339
372594|NCT00388154|907456|P1|NOT COMPLETED|Overall Study||1
372595|NCT00388154|907456|P1|COMPLETED|Overall Study||20
372596|NCT00388154|907456|P1|STARTED|Overall Study||21
372597|NCT00388037|907461|P1|NOT COMPLETED|Overall Study||1
372598|NCT00388037|907461|P1|COMPLETED|Overall Study||30
372599|NCT00388037|907461|P1|STARTED|Overall Study||31
372600|NCT00387959|907465|P1|NOT COMPLETED|Overall Study||1
372601|NCT00387959|907465|P1|COMPLETED|Overall Study||16
372602|NCT00387959|907465|P1|STARTED|Overall Study||17
372603|NCT00387894|907469|P1|NOT COMPLETED|Overall Study||1
372604|NCT00387894|907469|P1|COMPLETED|Overall Study||5
372605|NCT00387894|907469|P1|STARTED|Overall Study||6
372606|NCT00387881|907476|P2|NOT COMPLETED|Overall Study||102
372607|NCT00387881|907477|P1|NOT COMPLETED|Overall Study||89
372608|NCT00387881|907476|P2|COMPLETED|Overall Study||243
372609|NCT00387881|907477|P1|COMPLETED|Overall Study||245
372610|NCT00387881|907476|P2|STARTED|Overall Study||345
372611|NCT00387881|907477|P1|STARTED|Overall Study||334
372612|NCT00387829|907501|P2|NOT COMPLETED|Intent-to-treat Population||30
372613|NCT00387829|907502|P1|NOT COMPLETED|Intent-to-treat Population||38
372614|NCT00387829|907501|P2|COMPLETED|Intent-to-treat Population||136
372615|NCT00387829|907502|P1|COMPLETED|Intent-to-treat Population||139
372616|NCT00387829|907501|P2|STARTED|Intent-to-treat Population||166
372617|NCT00387829|907502|P1|STARTED|Intent-to-treat Population||177
372618|NCT00387829|907501|P2|NOT COMPLETED|Safety Population||33
372619|NCT00387829|907502|P1|NOT COMPLETED|Safety Population||39
372620|NCT00387829|907501|P2|COMPLETED|Safety Population||136
372621|NCT00387829|907502|P1|COMPLETED|Safety Population||139
372622|NCT00387829|907501|P2|STARTED|Safety Population||169
372623|NCT00387829|907502|P1|STARTED|Safety Population||178
372624|NCT00387790|907510|P1|NOT COMPLETED|Overall Study||14
372625|NCT00387790|907510|P1|COMPLETED|Overall Study||50
372626|NCT00387790|907510|P1|STARTED|Overall Study||64
372627|NCT00387764|907516|P1|NOT COMPLETED|Overall Study||31
372628|NCT00387764|907516|P1|COMPLETED|Overall Study|Participants completed treatment (until disease progression), but may not have completed the study.|49
372629|NCT00387764|907516|P1|STARTED|Overall Study||80
372630|NCT00387751|907534|P1|NOT COMPLETED|Overall Study||0
372631|NCT00387751|907534|P1|COMPLETED|Overall Study||14
372632|NCT00387751|907534|P1|STARTED|Overall Study||14
372633|NCT00387725|907544|P4|NOT COMPLETED|Overall Study||2
372634|NCT00387725|907545|P3|NOT COMPLETED|Overall Study||2
372635|NCT00387725|907546|P2|NOT COMPLETED|Overall Study||1
372636|NCT00387725|907547|P1|NOT COMPLETED|Overall Study||1
372637|NCT00387725|907544|P4|COMPLETED|Overall Study||43
372638|NCT00387725|907545|P3|COMPLETED|Overall Study||43
372639|NCT00387725|907546|P2|COMPLETED|Overall Study||15
372640|NCT00387725|907547|P1|COMPLETED|Overall Study||20
372641|NCT00387725|907544|P4|STARTED|Overall Study||45
372642|NCT00387725|907545|P3|STARTED|Overall Study||45
372643|NCT00387725|907546|P2|STARTED|Overall Study||16
372644|NCT00387725|907547|P1|STARTED|Overall Study||21
372645|NCT00387712|907567|P2|NOT COMPLETED|Overall Study||36
372646|NCT00387712|907568|P1|NOT COMPLETED|Overall Study||29
372647|NCT00387712|907567|P2|COMPLETED|Overall Study||16
372648|NCT00387712|907568|P1|COMPLETED|Overall Study||18
372649|NCT00387712|907567|P2|STARTED|Overall Study||52
372650|NCT00387712|907568|P1|STARTED|Overall Study||47
372651|NCT00387673|907578|P3|NOT COMPLETED|Overall Study||0
372652|NCT00387673|907579|P2|NOT COMPLETED|Overall Study||0
372653|NCT00387673|907580|P1|NOT COMPLETED|Overall Study||0
372654|NCT00387673|907578|P3|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
372655|NCT00387673|907579|P2|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
372656|NCT00387673|907580|P1|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
372657|NCT00387673|907578|P3|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
372658|NCT00387673|907579|P2|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
372659|NCT00387673|907580|P1|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
372660|NCT00387660|907588|P2|NOT COMPLETED|Overall Study||0
372661|NCT00387660|907589|P1|NOT COMPLETED|Overall Study||0
372662|NCT00387660|907588|P2|COMPLETED|Overall Study||40
372663|NCT00387660|907589|P1|COMPLETED|Overall Study||40
372664|NCT00387660|907588|P2|STARTED|Overall Study||40
372665|NCT00387660|907589|P1|STARTED|Overall Study||40
372666|NCT00387647|907599|P1|NOT COMPLETED|Overall Study||18
372667|NCT00387647|907599|P1|COMPLETED|Overall Study||6
372668|NCT00387647|907599|P1|STARTED|Overall Study||24
372669|NCT00387621|907608|P2|NOT COMPLETED|Second Intervention||0
372670|NCT00387621|907609|P1|NOT COMPLETED|Second Intervention||0
372671|NCT00387621|907608|P2|COMPLETED|Second Intervention||29
372672|NCT00387621|907609|P1|COMPLETED|Second Intervention||29
372673|NCT00387621|907608|P2|STARTED|Second Intervention||29
372674|NCT00387621|907609|P1|STARTED|Second Intervention||29
372675|NCT00387621|907608|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
372676|NCT00387621|907609|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
372677|NCT00387621|907608|P2|COMPLETED|Washout Period of 2 Weeks||29
372678|NCT00387621|907609|P1|COMPLETED|Washout Period of 2 Weeks||29
372679|NCT00387621|907608|P2|STARTED|Washout Period of 2 Weeks||29
372680|NCT00387621|907609|P1|STARTED|Washout Period of 2 Weeks||29
372681|NCT00387621|907608|P2|NOT COMPLETED|First Intervention||0
372682|NCT00387621|907609|P1|NOT COMPLETED|First Intervention||0
372683|NCT00387621|907608|P2|COMPLETED|First Intervention||29
372684|NCT00387621|907609|P1|COMPLETED|First Intervention||29
372685|NCT00387621|907608|P2|STARTED|First Intervention||29
372686|NCT00387621|907609|P1|STARTED|First Intervention||29
372687|NCT00387465|907642|P3|NOT COMPLETED|Overall Study||0
372688|NCT00387465|907643|P2|NOT COMPLETED|Overall Study||1
372689|NCT00387465|907644|P1|NOT COMPLETED|Overall Study||0
372690|NCT00387465|907642|P3|COMPLETED|Overall Study||35
372691|NCT00387465|907643|P2|COMPLETED|Overall Study||6
372692|NCT00387465|907644|P1|COMPLETED|Overall Study||3
372693|NCT00387465|907642|P3|STARTED|Overall Study||35
372694|NCT00387465|907643|P2|STARTED|Overall Study||7
372695|NCT00387465|907644|P1|STARTED|Overall Study||3
372696|NCT00387426|907661|P1|NOT COMPLETED|Overall Study||14
372697|NCT00387426|907661|P1|COMPLETED|Overall Study||0
372698|NCT00387426|907661|P1|STARTED|Overall Study||14
372699|NCT00387348|907668|P3|NOT COMPLETED|Overall Study||4
372700|NCT00387348|907669|P2|NOT COMPLETED|Overall Study||3
372701|NCT00387348|907670|P1|NOT COMPLETED|Overall Study||3
372702|NCT00387348|907668|P3|COMPLETED|Overall Study||7
372703|NCT00387348|907669|P2|COMPLETED|Overall Study||2
372704|NCT00387348|907670|P1|COMPLETED|Overall Study||5
372705|NCT00387348|907668|P3|STARTED|Overall Study||11
372706|NCT00387348|907669|P2|STARTED|Overall Study||5
372707|NCT00387348|907670|P1|STARTED|Overall Study||8
372708|NCT00387335|907686|P2|NOT COMPLETED|Overall Study||0
372709|NCT00387335|907687|P1|NOT COMPLETED|Overall Study||0
372710|NCT00387335|907686|P2|COMPLETED|Overall Study||7
372711|NCT00387335|907687|P1|COMPLETED|Overall Study||15
372712|NCT00387335|907686|P2|STARTED|Overall Study||7
372713|NCT00387335|907687|P1|STARTED|Overall Study||15
372714|NCT00387153|907699|P1|NOT COMPLETED|Overall Study||8
372715|NCT00387153|907699|P1|COMPLETED|Overall Study||0
372716|NCT00387153|907699|P1|STARTED|Overall Study||8
372717|NCT00387127|907705|P2|NOT COMPLETED|Overall Study||34
372718|NCT00387127|907706|P1|NOT COMPLETED|Overall Study||33
372719|NCT00387127|907705|P2|COMPLETED|Overall Study||0
372720|NCT00387127|907706|P1|COMPLETED|Overall Study||0
372721|NCT00387127|907705|P2|STARTED|Overall Study||34
372722|NCT00387127|907706|P1|STARTED|Overall Study||33
372723|NCT00387088|907748|P2|NOT COMPLETED|Overall Study||373
372724|NCT00387088|907749|P1|NOT COMPLETED|Overall Study||318
372725|NCT00387088|907748|P2|COMPLETED|Overall Study||1629
372726|NCT00387088|907749|P1|COMPLETED|Overall Study||1671
372727|NCT00387088|907748|P2|STARTED|Overall Study||2002
372728|NCT00387088|907749|P1|STARTED|Overall Study||1989
372729|NCT00387036|907793|P2|NOT COMPLETED|2-Week Crossover Second Intervention||0
372730|NCT00387036|907794|P1|NOT COMPLETED|2-Week Crossover Second Intervention||0
372731|NCT00387036|907793|P2|COMPLETED|2-Week Crossover Second Intervention||6
372732|NCT00387036|907794|P1|COMPLETED|2-Week Crossover Second Intervention||6
372733|NCT00387036|907793|P2|STARTED|2-Week Crossover Second Intervention||6
372734|NCT00387036|907794|P1|STARTED|2-Week Crossover Second Intervention||6
372735|NCT00387036|907793|P2|NOT COMPLETED|2-Week Placebo Washout||0
372736|NCT00387036|907794|P1|NOT COMPLETED|2-Week Placebo Washout||0
372737|NCT00387036|907793|P2|COMPLETED|2-Week Placebo Washout||6
372738|NCT00387036|907794|P1|COMPLETED|2-Week Placebo Washout||6
372739|NCT00387036|907793|P2|STARTED|2-Week Placebo Washout||6
372740|NCT00387036|907794|P1|STARTED|2-Week Placebo Washout||6
372741|NCT00387036|907793|P2|NOT COMPLETED|2-Week First Intervention||0
372742|NCT00387036|907794|P1|NOT COMPLETED|2-Week First Intervention||0
372743|NCT00387036|907793|P2|COMPLETED|2-Week First Intervention||6
372744|NCT00387036|907794|P1|COMPLETED|2-Week First Intervention||6
372745|NCT00387036|907793|P2|STARTED|2-Week First Intervention||6
372746|NCT00387036|907794|P1|STARTED|2-Week First Intervention||6
372747|NCT00387023|907802|P1|NOT COMPLETED|Overall Study||0
372748|NCT00387023|907802|P1|COMPLETED|Overall Study||12
372749|NCT00387023|907802|P1|STARTED|Overall Study||12
372750|NCT00387010|907806|P1|NOT COMPLETED|Treatment Period||11
372751|NCT00387010|907806|P1|COMPLETED|Treatment Period||169
372752|NCT00387010|907806|P1|Full Analysis Set|Treatment Period|FAS: treated patients with at least 1 paired baseline and post baseline efficacy assessment|175
372753|NCT00387010|907806|P1|STARTED|Treatment Period||180
372754|NCT00387010|907806|P1|NOT COMPLETED|Dose Titration Period||38
372755|NCT00387010|907806|P1|COMPLETED|Dose Titration Period||180
372756|NCT00387010|907806|P1|STARTED|Dose Titration Period||218
372757|NCT00386880|907827|P2|NOT COMPLETED|Overall Study||0
372758|NCT00386880|907828|P1|NOT COMPLETED|Overall Study||0
372759|NCT00386880|907827|P2|COMPLETED|Overall Study||8
372760|NCT00386880|907828|P1|COMPLETED|Overall Study||30
372761|NCT00386880|907827|P2|STARTED|Overall Study||8
372762|NCT00386880|907828|P1|STARTED|Overall Study||30
372763|NCT00386776|907833|P1|NOT COMPLETED|Overall Study||8
372764|NCT00386776|907833|P1|COMPLETED|Overall Study||32
372765|NCT00386776|907833|P1|STARTED|Overall Study||40
372766|NCT00386607|907843|P2|NOT COMPLETED|Extension||17
372767|NCT00386607|907844|P1|NOT COMPLETED|Extension||0
372768|NCT00386607|907843|P2|COMPLETED|Extension||145
372769|NCT00386607|907844|P1|COMPLETED|Extension||0
372770|NCT00386607|907843|P2|STARTED|Extension||162
372771|NCT00386607|907844|P1|STARTED|Extension||0
372772|NCT00386607|907843|P2|NOT COMPLETED|Core||0
372773|NCT00386607|907844|P1|NOT COMPLETED|Core||115
372774|NCT00386607|907843|P2|COMPLETED|Core||0
372775|NCT00386607|907844|P1|COMPLETED|Core||486
372776|NCT00386607|907843|P2|STARTED|Core||0
372777|NCT00386607|907844|P1|STARTED|Core||601
372778|NCT00386477|907862|P2|NOT COMPLETED|Overall Study||0
372779|NCT00386477|907863|P1|NOT COMPLETED|Overall Study||0
372780|NCT00386477|907862|P2|COMPLETED|Overall Study||145
372781|NCT00386477|907863|P1|COMPLETED|Overall Study||155
372782|NCT00386477|907862|P2|STARTED|Overall Study||145
372783|NCT00386477|907863|P1|STARTED|Overall Study||155
372784|NCT00386425|907872|P3|NOT COMPLETED|Overall Study||0
372785|NCT00386425|907873|P2|NOT COMPLETED|Overall Study||1
372786|NCT00386425|907874|P1|NOT COMPLETED|Overall Study||3
372787|NCT00386425|907872|P3|COMPLETED|Overall Study||53
372788|NCT00386425|907873|P2|COMPLETED|Overall Study|33 severe protein C deficiency; 172 moderate protein C deficiency|205
372789|NCT00386425|907874|P1|COMPLETED|Overall Study|51 severe protein C deficiency; 173 moderate protein C deficiency|224
372790|NCT00386425|907872|P3|Received Study Drug|Overall Study||53
372791|NCT00386425|907873|P2|Received Study Drug|Overall Study||206
372792|NCT00386425|907874|P1|Received Study Drug|Overall Study||227
372793|NCT00386425|907872|P3|STARTED|Overall Study||53
372794|NCT00386425|907873|P2|STARTED|Overall Study|33 severe protein C deficiency; 173 moderate protein C deficiency|206
372795|NCT00386425|907874|P1|STARTED|Overall Study|51 severe protein C deficiency; 176 moderate protein C deficiency|227
372796|NCT00386360|907900|P2|NOT COMPLETED|Overall Study||17
372797|NCT00386360|907901|P1|NOT COMPLETED|Overall Study||9
372798|NCT00386360|907900|P2|COMPLETED|Overall Study||95
372799|NCT00386360|907901|P1|COMPLETED|Overall Study||40
372800|NCT00386360|907900|P2|Primary Efficacy|Overall Study||77
372801|NCT00386360|907901|P1|Primary Efficacy|Overall Study|Per-protocol patients with evaluable BVTV (trabecular bone volume/tissue volume) at baseline & M12.|36
372802|NCT00386360|907900|P2|Intent to Treat Population (ITT)|Overall Study||110
372803|NCT00386360|907901|P1|Intent to Treat Population (ITT)|Overall Study|Includes all patients randomized and took at least one dose of study drug.|49
372804|NCT00386360|907900|P2|STARTED|Overall Study||112
372805|NCT00386360|907901|P1|STARTED|Overall Study||49
372806|NCT00386334|907935|P2|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||1
372807|NCT00386334|907936|P1|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||3
372808|NCT00386334|907935|P2|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||144
372809|NCT00386334|907936|P1|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||143
372810|NCT00386334|907935|P2|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|145
372811|NCT00386334|907936|P1|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|146
372812|NCT00386334|907935|P2|NOT COMPLETED|Double Blind Period||47
372813|NCT00386334|907936|P1|NOT COMPLETED|Double Blind Period||46
372814|NCT00386334|907935|P2|COMPLETED|Double Blind Period||147
372815|NCT00386334|907936|P1|COMPLETED|Double Blind Period||148
372816|NCT00386334|907935|P2|STARTED|Double Blind Period||194
372817|NCT00386334|907936|P1|STARTED|Double Blind Period||194
372818|NCT00386308|908080|P2|NOT COMPLETED|Overall Study||19
372819|NCT00386308|908081|P1|NOT COMPLETED|Overall Study||29
372820|NCT00386308|908080|P2|COMPLETED|Overall Study||54
372821|NCT00386308|908081|P1|COMPLETED|Overall Study||94
372822|NCT00386308|908080|P2|Modified Intent to Treat Population|Overall Study||72
372823|NCT00386308|908081|P1|Modified Intent to Treat Population|Overall Study||115
372824|NCT00386308|908080|P2|Intent to Treat Population|Overall Study||72
372825|NCT00386308|908081|P1|Intent to Treat Population|Overall Study||117
372826|NCT00386308|908080|P2|STARTED|Overall Study||73
372827|NCT00386308|908081|P1|STARTED|Overall Study||123
372828|NCT00386256|908097|P4|NOT COMPLETED|Overall Study||0
372829|NCT00386256|908098|P3|NOT COMPLETED|Overall Study||0
372830|NCT00386256|908099|P2|NOT COMPLETED|Overall Study||0
372831|NCT00386256|908100|P1|NOT COMPLETED|Overall Study||0
372832|NCT00386256|908097|P4|COMPLETED|Overall Study||3
372833|NCT00386256|908098|P3|COMPLETED|Overall Study||4
372834|NCT00386256|908099|P2|COMPLETED|Overall Study||15
372835|NCT00386256|908100|P1|COMPLETED|Overall Study||16
372836|NCT00386256|908097|P4|STARTED|Overall Study||3
372837|NCT00386256|908098|P3|STARTED|Overall Study||4
372838|NCT00386256|908099|P2|STARTED|Overall Study||15
372839|NCT00386256|908100|P1|STARTED|Overall Study||16
372840|NCT00386243|908116|P2|NOT COMPLETED|Overall Study||13
372841|NCT00386243|908117|P1|NOT COMPLETED|Overall Study||7
372842|NCT00386243|908116|P2|COMPLETED|Overall Study||108
372843|NCT00386243|908117|P1|COMPLETED|Overall Study||114
372844|NCT00386243|908116|P2|STARTED|Overall Study||121
372845|NCT00386243|908117|P1|STARTED|Overall Study||121
372846|NCT00386152|908138|P3|NOT COMPLETED|Overall Study||33
372847|NCT00386152|908139|P2|NOT COMPLETED|Overall Study||40
372848|NCT00386152|908140|P1|NOT COMPLETED|Overall Study||44
372849|NCT00386152|908138|P3|COMPLETED|Overall Study||42
372850|NCT00386152|908139|P2|COMPLETED|Overall Study||37
372851|NCT00386152|908140|P1|COMPLETED|Overall Study||31
372852|NCT00386152|908138|P3|STARTED|Overall Study|number of subjects treated|75
372853|NCT00386152|908139|P2|STARTED|Overall Study|number of subjects treated|77
372854|NCT00386152|908140|P1|STARTED|Overall Study|number of subjects treated|75
372855|NCT00386100|908159|P2|NOT COMPLETED|Overall Study||131
372856|NCT00386100|908160|P1|NOT COMPLETED|Overall Study||154
372857|NCT00386100|908159|P2|COMPLETED|Overall Study||217
372858|NCT00386100|908160|P1|COMPLETED|Overall Study||186
372859|NCT00386100|908159|P2|STARTED|Overall Study||348
372860|NCT00386100|908160|P1|STARTED|Overall Study||340
372861|NCT00386022|908224|P2|NOT COMPLETED|Plus Estrogen||1
372862|NCT00386022|908225|P1|NOT COMPLETED|Plus Estrogen||2
372863|NCT00386022|908224|P2|COMPLETED|Plus Estrogen||8
372864|NCT00386022|908225|P1|COMPLETED|Plus Estrogen||8
372865|NCT00386022|908224|P2|All Doses GnRH|Plus Estrogen||8
372866|NCT00386022|908225|P1|All Doses GnRH|Plus Estrogen||8
372867|NCT00386022|908224|P2|Estrogen Patch|Plus Estrogen||9
372868|NCT00386022|908225|P1|Estrogen Patch|Plus Estrogen||8
372869|NCT00386022|908224|P2|STARTED|Plus Estrogen||9
372870|NCT00386022|908225|P1|STARTED|Plus Estrogen||10
372871|NCT00386022|908224|P2|NOT COMPLETED|Baseline||0
372872|NCT00386022|908225|P1|NOT COMPLETED|Baseline||0
372873|NCT00386022|908224|P2|COMPLETED|Baseline||9
372874|NCT00386022|908225|P1|COMPLETED|Baseline||10
372875|NCT00386022|908224|P2|All Doses of GnRH|Baseline||9
372876|NCT00386022|908225|P1|All Doses of GnRH|Baseline||10
372877|NCT00386022|908224|P2|STARTED|Baseline||9
372878|NCT00386022|908225|P1|STARTED|Baseline||10
372879|NCT00386009|908235|P2|NOT COMPLETED|Overall Study||10
372880|NCT00386009|908236|P1|NOT COMPLETED|Overall Study||9
372881|NCT00386009|908235|P2|COMPLETED|Overall Study||89
372882|NCT00386009|908236|P1|COMPLETED|Overall Study||92
372883|NCT00386009|908235|P2|STARTED|Overall Study||99
372884|NCT00386009|908236|P1|STARTED|Overall Study||101
372885|NCT00385996|908274|P1|NOT COMPLETED|Overall Study||0
372886|NCT00385996|908274|P1|COMPLETED|Overall Study||22
372887|NCT00385996|908274|P1|STARTED|Overall Study||22
372888|NCT00385944|908283|P3|NOT COMPLETED|2nd Maintenance Dose Period||0
372889|NCT00385944|908284|P2|NOT COMPLETED|2nd Maintenance Dose Period||3
372890|NCT00385944|908285|P1|NOT COMPLETED|2nd Maintenance Dose Period||2
372891|NCT00385944|908283|P3|COMPLETED|2nd Maintenance Dose Period||0
372892|NCT00385944|908284|P2|COMPLETED|2nd Maintenance Dose Period||19
372893|NCT00385944|908285|P1|COMPLETED|2nd Maintenance Dose Period||22
372894|NCT00385944|908283|P3|STARTED|2nd Maintenance Dose Period||0
372895|NCT00385944|908284|P2|STARTED|2nd Maintenance Dose Period|2 patients discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|22
372896|NCT00385944|908285|P1|STARTED|2nd Maintenance Dose Period|1 patient discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|24
372897|NCT00385944|908283|P3|NOT COMPLETED|1st Maintenance Dose Period||0
372898|NCT00385944|908284|P2|NOT COMPLETED|1st Maintenance Dose Period||1
372899|NCT00385944|908285|P1|NOT COMPLETED|1st Maintenance Dose Period||4
372900|NCT00385944|908283|P3|COMPLETED|1st Maintenance Dose Period||0
372901|NCT00385944|908284|P2|COMPLETED|1st Maintenance Dose Period||24
372902|NCT00385944|908285|P1|COMPLETED|1st Maintenance Dose Period||25
372903|NCT00385944|908283|P3|STARTED|1st Maintenance Dose Period||0
372904|NCT00385944|908284|P2|STARTED|1st Maintenance Dose Period|Two patients withdrew from the study after randomization but prior to receiving the 1st MD.|25
372905|NCT00385944|908285|P1|STARTED|1st Maintenance Dose Period||29
372906|NCT00385944|908283|P3|NOT COMPLETED|Loading Dose||0
372907|NCT00385944|908284|P2|NOT COMPLETED|Loading Dose||0
372908|NCT00385944|908285|P1|NOT COMPLETED|Loading Dose||0
372909|NCT00385944|908283|P3|COMPLETED|Loading Dose||56
372910|NCT00385944|908284|P2|COMPLETED|Loading Dose||0
372911|NCT00385944|908285|P1|COMPLETED|Loading Dose||0
372912|NCT00385944|908283|P3|STARTED|Loading Dose||56
372913|NCT00385944|908284|P2|STARTED|Loading Dose||0
372914|NCT00385944|908285|P1|STARTED|Loading Dose||0
372915|NCT00385918|908328|P3|NOT COMPLETED|Intervention Phase After Randomization||0
372916|NCT00385918|908329|P2|NOT COMPLETED|Intervention Phase After Randomization||0
372917|NCT00385918|908330|P1|NOT COMPLETED|Intervention Phase After Randomization||3
372918|NCT00385918|908328|P3|COMPLETED|Intervention Phase After Randomization||0
372919|NCT00385918|908329|P2|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month home-base intervention|6
372920|NCT00385918|908330|P1|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month training intervention|12
372921|NCT00385918|908328|P3|STARTED|Intervention Phase After Randomization||0
372922|NCT00385918|908329|P2|STARTED|Intervention Phase After Randomization|Participants successfully completed screening; this is the number in the home stretching arm.|6
372923|NCT00385918|908330|P1|STARTED|Intervention Phase After Randomization|Participant successfully completed screening; this is the number in the Lokomat training arm.|15
372924|NCT00385918|908328|P3|NOT COMPLETED|Feasibility & Baseline Measurement Phase||14
372925|NCT00385918|908329|P2|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
372926|NCT00385918|908330|P1|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
372927|NCT00385918|908328|P3|COMPLETED|Feasibility & Baseline Measurement Phase||21
372928|NCT00385918|908329|P2|COMPLETED|Feasibility & Baseline Measurement Phase||0
372929|NCT00385918|908330|P1|COMPLETED|Feasibility & Baseline Measurement Phase||0
372930|NCT00385918|908328|P3|Completed Baseline Tests|Feasibility & Baseline Measurement Phase|6 subjects did not complete all baseline tests.|21
372931|NCT00385918|908329|P2|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
372932|NCT00385918|908330|P1|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
372933|NCT00385918|908328|P3|Number Eligible|Feasibility & Baseline Measurement Phase|8 subjects failed screening.|27
372934|NCT00385918|908329|P2|Number Eligible|Feasibility & Baseline Measurement Phase||0
372935|NCT00385918|908330|P1|Number Eligible|Feasibility & Baseline Measurement Phase||0
372936|NCT00385918|908328|P3|STARTED|Feasibility & Baseline Measurement Phase|Total # of subjects screened.The screening occurred before randomization.|35
372937|NCT00385918|908329|P2|STARTED|Feasibility & Baseline Measurement Phase||0
372938|NCT00385918|908330|P1|STARTED|Feasibility & Baseline Measurement Phase||0
372939|NCT00385840|908354|P2|NOT COMPLETED|Overall Study||14
372940|NCT00385840|908355|P1|NOT COMPLETED|Overall Study||4
372941|NCT00385840|908354|P2|COMPLETED|Overall Study||531
372942|NCT00385840|908355|P1|COMPLETED|Overall Study||129
372943|NCT00385840|908354|P2|STARTED|Overall Study||545
372944|NCT00385840|908355|P1|STARTED|Overall Study||133
372945|NCT00385827|908378|P3|NOT COMPLETED|Part 2||48
372946|NCT00385827|908379|P2|NOT COMPLETED|Part 2||33
372947|NCT00385827|908380|P1|NOT COMPLETED|Part 2||0
372948|NCT00385827|908378|P3|COMPLETED|Part 2||0
372949|NCT00385827|908379|P2|COMPLETED|Part 2||16
372950|NCT00385827|908380|P1|COMPLETED|Part 2||0
372951|NCT00385827|908378|P3|Treated|Part 2||46
372952|NCT00385827|908379|P2|Treated|Part 2||47
372953|NCT00385827|908380|P1|Treated|Part 2||0
372954|NCT00385827|908378|P3|STARTED|Part 2||48
372955|NCT00385827|908379|P2|STARTED|Part 2||49
372956|NCT00385827|908380|P1|STARTED|Part 2||0
372957|NCT00385827|908378|P3|NOT COMPLETED|Part 1||0
372958|NCT00385827|908379|P2|NOT COMPLETED|Part 1||0
372959|NCT00385827|908380|P1|NOT COMPLETED|Part 1||9
372960|NCT00385827|908378|P3|COMPLETED|Part 1||0
372961|NCT00385827|908379|P2|COMPLETED|Part 1||0
372962|NCT00385827|908380|P1|COMPLETED|Part 1||0
372963|NCT00385827|908378|P3|Treated|Part 1||0
372964|NCT00385827|908379|P2|Treated|Part 1||0
372965|NCT00385827|908380|P1|Treated|Part 1||9
372966|NCT00385827|908378|P3|STARTED|Part 1||0
372967|NCT00385827|908379|P2|STARTED|Part 1||0
372968|NCT00385827|908380|P1|STARTED|Part 1||9
372969|NCT00385801|908402|P2|NOT COMPLETED|Overall Study||8
372970|NCT00385801|908403|P1|NOT COMPLETED|Overall Study||9
372971|NCT00385801|908402|P2|COMPLETED|Overall Study||8
372972|NCT00385801|908403|P1|COMPLETED|Overall Study||6
372973|NCT00385801|908402|P2|STARTED|Overall Study||16
372974|NCT00385801|908403|P1|STARTED|Overall Study||15
372975|NCT00385788|908417|P2|NOT COMPLETED|Overall Study||0
372976|NCT00385788|908418|P1|NOT COMPLETED|Overall Study||0
372977|NCT00385788|908417|P2|COMPLETED|Overall Study||40
372978|NCT00385788|908418|P1|COMPLETED|Overall Study||12
372979|NCT00385788|908417|P2|STARTED|Overall Study||40
372980|NCT00385788|908418|P1|STARTED|Overall Study||12
372981|NCT00385762|908424|P1|NOT COMPLETED|Overall Study||2
372982|NCT00385762|908424|P1|COMPLETED|Overall Study||33
372983|NCT00385762|908424|P1|STARTED|Overall Study||35
372984|NCT00385736|908434|P3|NOT COMPLETED|Safety Analysis Set||80
372985|NCT00385736|908435|P2|NOT COMPLETED|Safety Analysis Set||44
372986|NCT00385736|908436|P1|NOT COMPLETED|Safety Analysis Set||70
372987|NCT00385736|908434|P3|COMPLETED|Safety Analysis Set||143
372988|NCT00385736|908435|P2|COMPLETED|Safety Analysis Set||86
372989|NCT00385736|908436|P1|COMPLETED|Safety Analysis Set||153
372990|NCT00385736|908434|P3|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
372991|NCT00385736|908435|P2|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|130
372992|NCT00385736|908436|P1|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
372993|NCT00385736|908434|P3|NOT COMPLETED|Efficacy Analysis Set - Maintenance||80
372994|NCT00385736|908435|P2|NOT COMPLETED|Efficacy Analysis Set - Maintenance||44
372995|NCT00385736|908436|P1|NOT COMPLETED|Efficacy Analysis Set - Maintenance||69
372996|NCT00385736|908434|P3|COMPLETED|Efficacy Analysis Set - Maintenance||143
372997|NCT00385736|908435|P2|COMPLETED|Efficacy Analysis Set - Maintenance||86
372998|NCT00385736|908436|P1|COMPLETED|Efficacy Analysis Set - Maintenance||153
372999|NCT00385736|908434|P3|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|223
373000|NCT00385736|908435|P2|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|130
373001|NCT00385736|908436|P1|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|222
373002|NCT00385736|908434|P3|NOT COMPLETED|Efficacy Analysis Set - Induction||9
373003|NCT00385736|908435|P2|NOT COMPLETED|Efficacy Analysis Set - Induction||12
373004|NCT00385736|908436|P1|NOT COMPLETED|Efficacy Analysis Set - Induction||9
373005|NCT00385736|908434|P3|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
373006|NCT00385736|908435|P2|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|118
373007|NCT00385736|908436|P1|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
373008|NCT00385736|908434|P3|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
373009|NCT00385736|908435|P2|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
373010|NCT00385736|908436|P1|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
373011|NCT00385723|908481|P3|NOT COMPLETED|Overall Study||2
373012|NCT00385723|908482|P2|NOT COMPLETED|Overall Study||1
373013|NCT00385723|908483|P1|NOT COMPLETED|Overall Study||2
373014|NCT00385723|908481|P3|COMPLETED|Overall Study||44
373015|NCT00385723|908482|P2|COMPLETED|Overall Study||45
373016|NCT00385723|908483|P1|COMPLETED|Overall Study||44
373017|NCT00385723|908481|P3|STARTED|Overall Study||46
373018|NCT00385723|908482|P2|STARTED|Overall Study||46
373019|NCT00385723|908483|P1|STARTED|Overall Study||46
373020|NCT00385684|908497|P2|NOT COMPLETED|PHASE B||0
373021|NCT00385684|908498|P1|NOT COMPLETED|PHASE B||0
373022|NCT00385684|908497|P2|COMPLETED|PHASE B||3
373023|NCT00385684|908498|P1|COMPLETED|PHASE B||5
373024|NCT00385684|908497|P2|STARTED|PHASE B||3
373025|NCT00385684|908498|P1|STARTED|PHASE B||5
373026|NCT00385684|908497|P2|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||2
373027|NCT00385684|908498|P1|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||0
373028|NCT00385684|908497|P2|COMPLETED|SECOND INTERVENTION OF PHASE A||3
373029|NCT00385684|908498|P1|COMPLETED|SECOND INTERVENTION OF PHASE A||5
373030|NCT00385684|908497|P2|STARTED|SECOND INTERVENTION OF PHASE A||5
373031|NCT00385684|908498|P1|STARTED|SECOND INTERVENTION OF PHASE A||5
373032|NCT00385684|908497|P2|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||0
373033|NCT00385684|908498|P1|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||1
373034|NCT00385684|908497|P2|COMPLETED|FIRST INTERVENTION OF PHASE A||5
373035|NCT00385684|908498|P1|COMPLETED|FIRST INTERVENTION OF PHASE A||5
373036|NCT00385684|908497|P2|STARTED|FIRST INTERVENTION OF PHASE A||5
373037|NCT00385684|908498|P1|STARTED|FIRST INTERVENTION OF PHASE A||6
373038|NCT00385671|908507|P3|NOT COMPLETED|Overall Study||36
373039|NCT00385671|908508|P2|NOT COMPLETED|Overall Study||51
373040|NCT00385671|908509|P1|NOT COMPLETED|Overall Study||38
373041|NCT00385671|908507|P3|COMPLETED|Overall Study||99
373042|NCT00385671|908508|P2|COMPLETED|Overall Study||87
373043|NCT00385671|908509|P1|COMPLETED|Overall Study||96
373044|NCT00385671|908507|P3|STARTED|Overall Study||135
373045|NCT00385671|908508|P2|STARTED|Overall Study||138
373046|NCT00385671|908509|P1|STARTED|Overall Study||134
373047|NCT00385593|908665|P2|NOT COMPLETED|Overall Study||37
373048|NCT00385593|908666|P1|NOT COMPLETED|Overall Study||58
373049|NCT00385593|908665|P2|COMPLETED|Overall Study||289
373050|NCT00385593|908666|P1|COMPLETED|Overall Study||270
373051|NCT00385593|908665|P2|STARTED|Overall Study||326
373052|NCT00385593|908666|P1|STARTED|Overall Study||328
373053|NCT00385580|908684|P2|NOT COMPLETED|Overall Study||0
373054|NCT00385580|908685|P1|NOT COMPLETED|Overall Study||0
373055|NCT00385580|908684|P2|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|47
373056|NCT00385580|908685|P1|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|48
373057|NCT00385580|908684|P2|STARTED|Overall Study|Number of participants treated.|47
373058|NCT00385580|908685|P1|STARTED|Overall Study|Number of participants treated.|48
373059|NCT00385541|908776|P2|NOT COMPLETED|Overall Study||1
373060|NCT00385541|908777|P1|NOT COMPLETED|Overall Study||0
373061|NCT00385541|908776|P2|COMPLETED|Overall Study||24
373062|NCT00385541|908777|P1|COMPLETED|Overall Study||25
373063|NCT00385541|908776|P2|STARTED|Overall Study||25
373064|NCT00385541|908777|P1|STARTED|Overall Study||25
373065|NCT00385515|908793|P2|NOT COMPLETED|Overall Study||3
373066|NCT00385515|908794|P1|NOT COMPLETED|Overall Study||4
373067|NCT00385515|908793|P2|COMPLETED|Overall Study||21
373068|NCT00385515|908794|P1|COMPLETED|Overall Study||53
373069|NCT00385515|908793|P2|STARTED|Overall Study||24
373070|NCT00385515|908794|P1|STARTED|Overall Study||57
373071|NCT00385268|908802|P2|NOT COMPLETED|Overall Study||8
373072|NCT00385268|908803|P1|NOT COMPLETED|Overall Study||16
373073|NCT00385268|908802|P2|COMPLETED|Overall Study||18
373074|NCT00385268|908803|P1|COMPLETED|Overall Study||18
373075|NCT00385268|908802|P2|STARTED|Overall Study||26
373076|NCT00385268|908803|P1|STARTED|Overall Study||34
373077|NCT00385255|908813|P2|NOT COMPLETED|Overall Study||73
373078|NCT00385255|908814|P1|NOT COMPLETED|Overall Study||21
373079|NCT00385255|908813|P2|COMPLETED|Overall Study||785
373080|NCT00385255|908814|P1|COMPLETED|Overall Study||839
373081|NCT00385255|908813|P2|19-64 Years of Age (YOA) Cohort|Overall Study||749
373082|NCT00385255|908814|P1|19-64 Years of Age (YOA) Cohort|Overall Study||748
373083|NCT00385255|908813|P2|≥ 65 Years of Age (YOA) Cohort|Overall Study||109
373084|NCT00385255|908814|P1|≥ 65 Years of Age (YOA) Cohort|Overall Study||112
373085|NCT00385255|908813|P2|STARTED|Overall Study||858
373086|NCT00385255|908814|P1|STARTED|Overall Study||860
373087|NCT00385216|908878|P2|NOT COMPLETED|Second Intervention||0
373088|NCT00385216|908879|P1|NOT COMPLETED|Second Intervention||0
373089|NCT00385216|908878|P2|COMPLETED|Second Intervention||9
373090|NCT00385216|908879|P1|COMPLETED|Second Intervention||11
373091|NCT00385216|908878|P2|STARTED|Second Intervention||9
373092|NCT00385216|908879|P1|STARTED|Second Intervention||11
373093|NCT00385216|908878|P2|NOT COMPLETED|First Intervention||0
373094|NCT00385216|908879|P1|NOT COMPLETED|First Intervention||0
373095|NCT00385216|908878|P2|COMPLETED|First Intervention||9
373096|NCT00385216|908879|P1|COMPLETED|First Intervention||11
373097|NCT00385216|908878|P2|STARTED|First Intervention||9
373098|NCT00385216|908879|P1|STARTED|First Intervention||11
373099|NCT00385203|908893|P2|NOT COMPLETED|Overall Study||7
373100|NCT00385203|908894|P1|NOT COMPLETED|Overall Study||26
373101|NCT00385203|908893|P2|COMPLETED|Overall Study||3
373102|NCT00385203|908894|P1|COMPLETED|Overall Study||0
373103|NCT00385203|908893|P2|STARTED|Overall Study||10
373104|NCT00385203|908894|P1|STARTED|Overall Study||26
373105|NCT00385138|908914|P2|NOT COMPLETED|Overall Study||28
373106|NCT00385138|908915|P1|NOT COMPLETED|Overall Study||30
373107|NCT00385138|908914|P2|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2641
373108|NCT00385138|908915|P1|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2665
373109|NCT00385138|908914|P2|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2650
373110|NCT00385138|908915|P1|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2662
373111|NCT00385138|908914|P2|Modified Intent-to-treat (mITT)|Overall Study|Excludes 24 patients who either did not received study drug or have PCI.|2645
373112|NCT00385138|908915|P1|Modified Intent-to-treat (mITT)|Overall Study|Excludes 37 patients who either did not receive study drug or have PCI.|2656
373113|NCT00385138|908914|P2|Intent-to-treat (ITT)|Overall Study||2669
373114|NCT00385138|908915|P1|Intent-to-treat (ITT)|Overall Study|All patients randomized excluding two (2) who withdrew consent for using study data.|2693
373115|NCT00385138|908914|P2|STARTED|Overall Study||2669
373116|NCT00385138|908915|P1|STARTED|Overall Study||2695
373117|NCT00385008|908961|P2|NOT COMPLETED|Overall Study||0
373118|NCT00385008|908962|P1|NOT COMPLETED|Overall Study||0
373119|NCT00385008|908961|P2|COMPLETED|Overall Study||10
373120|NCT00385008|908962|P1|COMPLETED|Overall Study||10
373121|NCT00385008|908961|P2|In Presence of Migraine|Overall Study||5
373122|NCT00385008|908962|P1|In Presence of Migraine|Overall Study||5
373123|NCT00385008|908961|P2|In Absence of Migraine|Overall Study||10
373124|NCT00385008|908962|P1|In Absence of Migraine|Overall Study||10
373125|NCT00385008|908961|P2|STARTED|Overall Study||10
373126|NCT00385008|908962|P1|STARTED|Overall Study||10
373127|NCT00384956|908982|P1|NOT COMPLETED|Overall Study||3
373128|NCT00384956|908982|P1|COMPLETED|Overall Study||22
373129|NCT00384956|908982|P1|STARTED|Overall Study||25
373130|NCT00384930|908999|P5|NOT COMPLETED|Overall Study||47
373131|NCT00384930|909000|P4|NOT COMPLETED|Overall Study||41
373132|NCT00384930|909001|P3|NOT COMPLETED|Overall Study||30
373133|NCT00384930|909002|P2|NOT COMPLETED|Overall Study||27
373134|NCT00384930|909003|P1|NOT COMPLETED|Overall Study||27
373135|NCT00384930|908999|P5|COMPLETED|Overall Study||162
373136|NCT00384930|909000|P4|COMPLETED|Overall Study||175
373137|NCT00384930|909001|P3|COMPLETED|Overall Study||182
373138|NCT00384930|909002|P2|COMPLETED|Overall Study||182
373139|NCT00384930|909003|P1|COMPLETED|Overall Study||185
373140|NCT00384930|908999|P5|Received Double-Blind Study Drug|Overall Study||209
373141|NCT00384930|909000|P4|Received Double-Blind Study Drug|Overall Study||216
373142|NCT00384930|909001|P3|Received Double-Blind Study Drug|Overall Study||212
373143|NCT00384930|909002|P2|Received Double-Blind Study Drug|Overall Study||208
373144|NCT00384930|909003|P1|Received Double-Blind Study Drug|Overall Study||211
373145|NCT00384930|908999|P5|STARTED|Overall Study||209
373146|NCT00384930|909000|P4|STARTED|Overall Study||216
373147|NCT00384930|909001|P3|STARTED|Overall Study||212
373148|NCT00384930|909002|P2|STARTED|Overall Study||209
373149|NCT00384930|909003|P1|STARTED|Overall Study||212
373150|NCT00384865|909061|P4|NOT COMPLETED|Overall Study||0
373151|NCT00384865|909062|P3|NOT COMPLETED|Overall Study||0
373152|NCT00384865|909063|P2|NOT COMPLETED|Overall Study||0
373153|NCT00384865|909064|P1|NOT COMPLETED|Overall Study||0
373154|NCT00384865|909061|P4|COMPLETED|Overall Study||16
373155|NCT00384865|909062|P3|COMPLETED|Overall Study||16
373156|NCT00384865|909063|P2|COMPLETED|Overall Study||16
373157|NCT00384865|909064|P1|COMPLETED|Overall Study||16
373158|NCT00384865|909061|P4|Completed Six Month Assessment|Overall Study||11
373159|NCT00384865|909062|P3|Completed Six Month Assessment|Overall Study||15
373160|NCT00384865|909063|P2|Completed Six Month Assessment|Overall Study||12
373161|NCT00384865|909064|P1|Completed Six Month Assessment|Overall Study||11
373162|NCT00384865|909061|P4|STARTED|Overall Study||16
373163|NCT00384865|909062|P3|STARTED|Overall Study||16
373164|NCT00384865|909063|P2|STARTED|Overall Study||16
373165|NCT00384865|909064|P1|STARTED|Overall Study||16
373166|NCT00384839|909082|P1|NOT COMPLETED|Overall Study||8
373167|NCT00384839|909082|P1|COMPLETED|Overall Study||28
373168|NCT00384839|909082|P1|STARTED|Overall Study||36
373169|NCT00384813|909093|P2|NOT COMPLETED|Overall Study||0
373170|NCT00384813|909094|P1|NOT COMPLETED|Overall Study||2
373171|NCT00384813|909093|P2|COMPLETED|Overall Study||20
373172|NCT00384813|909094|P1|COMPLETED|Overall Study||21
373173|NCT00384813|909093|P2|STARTED|Overall Study||20
373174|NCT00384813|909094|P1|STARTED|Overall Study||23
373175|NCT00384748|909102|P2|NOT COMPLETED|Overall Study||0
373176|NCT00384748|909103|P1|NOT COMPLETED|Overall Study||0
373177|NCT00384748|909102|P2|COMPLETED|Overall Study||23
373178|NCT00384748|909103|P1|COMPLETED|Overall Study||25
373179|NCT00384748|909102|P2|STARTED|Overall Study||23
373180|NCT00384748|909103|P1|STARTED|Overall Study||25
373181|NCT00384670|909109|P1|NOT COMPLETED|Overall Study||0
373182|NCT00384670|909109|P1|COMPLETED|Overall Study||7
373183|NCT00384670|909109|P1|STARTED|Overall Study||7
373184|NCT00384449|909119|P1|NOT COMPLETED|Overall Study||0
373185|NCT00384449|909119|P1|COMPLETED|Overall Study||1
373186|NCT00384449|909119|P1|STARTED|Overall Study||1
373187|NCT00384397|909130|P3|NOT COMPLETED|Overall Study||33
373188|NCT00384397|909131|P2|NOT COMPLETED|Overall Study||46
373189|NCT00384397|909132|P1|NOT COMPLETED|Overall Study||32
373190|NCT00384397|909130|P3|COMPLETED|Overall Study||385
373191|NCT00384397|909131|P2|COMPLETED|Overall Study||247
373192|NCT00384397|909132|P1|COMPLETED|Overall Study||375
373193|NCT00384397|909130|P3|STARTED|Overall Study||418
373194|NCT00384397|909131|P2|STARTED|Overall Study||293
373195|NCT00384397|909132|P1|STARTED|Overall Study||407
373196|NCT00384332|909151|P2|NOT COMPLETED|Overall Study||0
373197|NCT00384332|909152|P1|NOT COMPLETED|Overall Study||4
373198|NCT00384332|909151|P2|COMPLETED|Overall Study||10
373199|NCT00384332|909152|P1|COMPLETED|Overall Study||9
373200|NCT00384332|909151|P2|STARTED|Overall Study||10
373201|NCT00384332|909152|P1|STARTED|Overall Study||13
373202|NCT00384293|909162|P3|NOT COMPLETED|Post-randomization Period||219
373203|NCT00384293|909163|P2|NOT COMPLETED|Post-randomization Period||214
373204|NCT00384293|909164|P1|NOT COMPLETED|Post-randomization Period||0
373205|NCT00384293|909162|P3|COMPLETED|Post-randomization Period||0
373206|NCT00384293|909163|P2|COMPLETED|Post-randomization Period||0
373207|NCT00384293|909164|P1|COMPLETED|Post-randomization Period||0
373208|NCT00384293|909162|P3|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||218
373209|NCT00384293|909163|P2|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period|Received at least one dose of randomized study drug (All Patients as Treated Population)|214
373210|NCT00384293|909164|P1|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||0
373211|NCT00384293|909162|P3|STARTED|Post-randomization Period||219
373212|NCT00384293|909163|P2|STARTED|Post-randomization Period||214
373213|NCT00384293|909164|P1|STARTED|Post-randomization Period||0
373214|NCT00384293|909162|P3|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
373215|NCT00384293|909163|P2|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
373216|NCT00384293|909164|P1|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||504
373217|NCT00384293|909162|P3|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
373218|NCT00384293|909163|P2|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
373219|NCT00384293|909164|P1|COMPLETED|MK0524A Active Run-In, Pre-randomization||433
373220|NCT00384293|909162|P3|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
373221|NCT00384293|909163|P2|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
373222|NCT00384293|909164|P1|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization|MK0524A dose increased to 2 g in active run-in period|813
373223|NCT00384293|909162|P3|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
373224|NCT00384293|909163|P2|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
373225|NCT00384293|909164|P1|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization|Entered active run-in period and received MK0524A 1 g|937
373226|NCT00384293|909162|P3|STARTED|MK0524A Active Run-In, Pre-randomization||0
373227|NCT00384293|909163|P2|STARTED|MK0524A Active Run-In, Pre-randomization||0
373228|NCT00384293|909164|P1|STARTED|MK0524A Active Run-In, Pre-randomization||937
373229|NCT00384241|909177|P2|NOT COMPLETED|Overall Study||0
373230|NCT00384241|909178|P1|NOT COMPLETED|Overall Study||0
373231|NCT00384241|909177|P2|COMPLETED|Overall Study||599
373232|NCT00384241|909178|P1|COMPLETED|Overall Study||500
373233|NCT00384241|909177|P2|STARTED|Overall Study||599
373234|NCT00384241|909178|P1|STARTED|Overall Study||500
373235|NCT00384189|909188|P4|NOT COMPLETED|Overall Study||40
373236|NCT00384189|909189|P3|NOT COMPLETED|Overall Study||58
373237|NCT00384189|909190|P2|NOT COMPLETED|Overall Study||57
373238|NCT00384189|909191|P1|NOT COMPLETED|Overall Study||50
373239|NCT00384189|909188|P4|COMPLETED|Overall Study||110
373240|NCT00384189|909189|P3|COMPLETED|Overall Study||255
373241|NCT00384189|909190|P2|COMPLETED|Overall Study||255
373242|NCT00384189|909191|P1|COMPLETED|Overall Study||255
373243|NCT00384189|909188|P4|Actual Treatment Received|Overall Study||146
373244|NCT00384189|909189|P3|Actual Treatment Received|Overall Study|1 participants in the 160 μg arm actually received 40 μg and is moved to that arm.|310
373245|NCT00384189|909190|P2|Actual Treatment Received|Overall Study||312
373246|NCT00384189|909191|P1|Actual Treatment Received|Overall Study|1 participant randomized to 160 μg who actually received 40 μg is included.|305
373247|NCT00384189|909188|P4|Randomized, Not Treated|Overall Study||4
373248|NCT00384189|909189|P3|Randomized, Not Treated|Overall Study||2
373249|NCT00384189|909190|P2|Randomized, Not Treated|Overall Study||0
373250|NCT00384189|909191|P1|Randomized, Not Treated|Overall Study||1
373251|NCT00384189|909188|P4|STARTED|Overall Study||150
373252|NCT00384189|909189|P3|STARTED|Overall Study||313
373253|NCT00384189|909190|P2|STARTED|Overall Study||312
373254|NCT00384189|909191|P1|STARTED|Overall Study||305
373255|NCT00384176|909252|P3|NOT COMPLETED|Overall Study||132
373256|NCT00384176|909253|P2|NOT COMPLETED|Overall Study||319
373257|NCT00384176|909254|P1|NOT COMPLETED|Overall Study||312
373258|NCT00384176|909252|P3|COMPLETED|Overall Study||60
373259|NCT00384176|909253|P2|COMPLETED|Overall Study||394
373260|NCT00384176|909254|P1|COMPLETED|Overall Study||397
373261|NCT00384176|909252|P3|STARTED|Overall Study||192
373262|NCT00384176|909253|P2|STARTED|Overall Study||713
373263|NCT00384176|909254|P1|STARTED|Overall Study||709
373264|NCT00384085|909280|P3|NOT COMPLETED|Overall Study||56
373265|NCT00384085|909281|P2|NOT COMPLETED|Overall Study||46
373266|NCT00384085|909282|P1|NOT COMPLETED|Overall Study||39
373267|NCT00384085|909280|P3|COMPLETED|Overall Study|Based on the entire ITT population|141
373268|NCT00384085|909281|P2|COMPLETED|Overall Study|Based on the entire ITT population|150
373269|NCT00384085|909282|P1|COMPLETED|Overall Study|Based on the entire ITT population|156
373270|NCT00384085|909280|P3|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||189
373271|NCT00384085|909281|P2|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||186
373272|NCT00384085|909282|P1|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||187
373273|NCT00384085|909280|P3|Treated (Safety Population)|Overall Study||194
373274|NCT00384085|909281|P2|Treated (Safety Population)|Overall Study||194
373275|NCT00384085|909282|P1|Treated (Safety Population)|Overall Study||194
373276|NCT00384085|909280|P3|Intent-To-Treat (ITT)|Overall Study||197
373277|NCT00384085|909281|P2|Intent-To-Treat (ITT)|Overall Study||196
373278|NCT00384085|909282|P1|Intent-To-Treat (ITT)|Overall Study||195
373279|NCT00384085|909280|P3|STARTED|Overall Study|Randomized|197
373280|NCT00384085|909281|P2|STARTED|Overall Study|Randomized|196
373281|NCT00384085|909282|P1|STARTED|Overall Study|Randomized|195
373282|NCT00384059|909308|P2|NOT COMPLETED|Toddler Dose||2
373283|NCT00384059|909309|P1|NOT COMPLETED|Toddler Dose||1
373284|NCT00384059|909308|P2|COMPLETED|Toddler Dose||120
373285|NCT00384059|909309|P1|COMPLETED|Toddler Dose||130
373286|NCT00384059|909308|P2|STARTED|Toddler Dose||122
373287|NCT00384059|909309|P1|STARTED|Toddler Dose||131
373288|NCT00384059|909308|P2|NOT COMPLETED|After Infant Series||10
373289|NCT00384059|909309|P1|NOT COMPLETED|After Infant Series||4
373290|NCT00384059|909308|P2|COMPLETED|After Infant Series||122
373291|NCT00384059|909309|P1|COMPLETED|After Infant Series||131
373292|NCT00384059|909308|P2|STARTED|After Infant Series||132
373293|NCT00384059|909309|P1|STARTED|After Infant Series||135
373294|NCT00384059|909308|P2|NOT COMPLETED|Infant Series||13
373295|NCT00384059|909309|P1|NOT COMPLETED|Infant Series||6
373296|NCT00384059|909308|P2|COMPLETED|Infant Series||132
373297|NCT00384059|909309|P1|COMPLETED|Infant Series||135
373298|NCT00384059|909308|P2|Vaccinated Dose 2|Infant Series||135
373299|NCT00384059|909309|P1|Vaccinated Dose 2|Infant Series||136
373300|NCT00384059|909308|P2|Vaccinated Dose 1|Infant Series||139
373301|NCT00384059|909309|P1|Vaccinated Dose 1|Infant Series||139
373302|NCT00384059|909308|P2|STARTED|Infant Series||145
373303|NCT00384059|909309|P1|STARTED|Infant Series||141
373304|NCT00384033|909359|P4|NOT COMPLETED|Overall Study||40
373305|NCT00384033|909360|P3|NOT COMPLETED|Overall Study||43
373306|NCT00384033|909361|P2|NOT COMPLETED|Overall Study||35
373307|NCT00384033|909362|P1|NOT COMPLETED|Overall Study||41
373308|NCT00384033|909359|P4|COMPLETED|Overall Study||119
373309|NCT00384033|909360|P3|COMPLETED|Overall Study||117
373310|NCT00384033|909361|P2|COMPLETED|Overall Study||120
373311|NCT00384033|909362|P1|COMPLETED|Overall Study||123
373312|NCT00384033|909359|P4|Treated|Overall Study||157
373313|NCT00384033|909360|P3|Treated|Overall Study||150
373314|NCT00384033|909361|P2|Treated|Overall Study||148
373315|NCT00384033|909362|P1|Treated|Overall Study||161
373316|NCT00384033|909359|P4|STARTED|Overall Study||159
373317|NCT00384033|909360|P3|STARTED|Overall Study||160
373318|NCT00384033|909361|P2|STARTED|Overall Study||155
373319|NCT00384033|909362|P1|STARTED|Overall Study||164
373320|NCT00383942|909406|P2|NOT COMPLETED|Overall Study||0
373321|NCT00383942|909407|P1|NOT COMPLETED|Overall Study||0
373322|NCT00383942|909406|P2|COMPLETED|Overall Study||40
373323|NCT00383942|909407|P1|COMPLETED|Overall Study||40
373324|NCT00383942|909406|P2|STARTED|Overall Study||40
373325|NCT00383942|909407|P1|STARTED|Overall Study||40
373326|NCT00383786|909415|P2|NOT COMPLETED|Overall Study||12
373327|NCT00383786|909416|P1|NOT COMPLETED|Overall Study||4
373328|NCT00383786|909415|P2|COMPLETED|Overall Study||13
373329|NCT00383786|909416|P1|COMPLETED|Overall Study||18
373330|NCT00383786|909415|P2|STARTED|Overall Study||25
373331|NCT00383786|909416|P1|STARTED|Overall Study||22
373332|NCT00383760|909422|P1|NOT COMPLETED|Overall Study||0
373333|NCT00383760|909422|P1|COMPLETED|Overall Study||15
373334|NCT00383760|909422|P1|STARTED|Overall Study||15
373335|NCT00383747|909438|P4|NOT COMPLETED|Visit 2||0
373336|NCT00383747|909439|P3|NOT COMPLETED|Visit 2||0
373337|NCT00383747|909440|P2|NOT COMPLETED|Visit 2||0
373338|NCT00383747|909441|P1|NOT COMPLETED|Visit 2||0
373339|NCT00383747|909438|P4|COMPLETED|Visit 2||16
373340|NCT00383747|909439|P3|COMPLETED|Visit 2||16
373341|NCT00383747|909440|P2|COMPLETED|Visit 2||14
373342|NCT00383747|909441|P1|COMPLETED|Visit 2||14
373343|NCT00383747|909438|P4|STARTED|Visit 2||16
373344|NCT00383747|909439|P3|STARTED|Visit 2||16
373345|NCT00383747|909440|P2|STARTED|Visit 2||14
373346|NCT00383747|909441|P1|STARTED|Visit 2||14
373347|NCT00383747|909438|P4|NOT COMPLETED|Visit 1||0
373348|NCT00383747|909439|P3|NOT COMPLETED|Visit 1||0
373349|NCT00383747|909440|P2|NOT COMPLETED|Visit 1||0
373350|NCT00383747|909441|P1|NOT COMPLETED|Visit 1||0
373351|NCT00383747|909438|P4|COMPLETED|Visit 1||16
373352|NCT00383747|909439|P3|COMPLETED|Visit 1||16
373353|NCT00383747|909440|P2|COMPLETED|Visit 1||14
373354|NCT00383747|909441|P1|COMPLETED|Visit 1||14
373355|NCT00383747|909438|P4|STARTED|Visit 1||16
373356|NCT00383747|909439|P3|STARTED|Visit 1||16
373357|NCT00383747|909440|P2|STARTED|Visit 1||14
373358|NCT00383747|909441|P1|STARTED|Visit 1||14
373359|NCT00383721|909466|P5|NOT COMPLETED|26-Week Treatment Safety Extension||0
373360|NCT00383721|909467|P4|NOT COMPLETED|26-Week Treatment Safety Extension||17
373361|NCT00383721|909468|P3|NOT COMPLETED|26-Week Treatment Safety Extension||23
373362|NCT00383721|909469|P2|NOT COMPLETED|26-Week Treatment Safety Extension||17
373363|NCT00383721|909470|P1|NOT COMPLETED|26-Week Treatment Safety Extension||19
373364|NCT00383721|909466|P5|COMPLETED|26-Week Treatment Safety Extension||8
373365|NCT00383721|909467|P4|COMPLETED|26-Week Treatment Safety Extension||131
373366|NCT00383721|909468|P3|COMPLETED|26-Week Treatment Safety Extension||126
373367|NCT00383721|909469|P2|COMPLETED|26-Week Treatment Safety Extension||136
373368|NCT00383721|909470|P1|COMPLETED|26-Week Treatment Safety Extension||126
373369|NCT00383721|909466|P5|STARTED|26-Week Treatment Safety Extension||8
373370|NCT00383721|909467|P4|STARTED|26-Week Treatment Safety Extension||148
373371|NCT00383721|909468|P3|STARTED|26-Week Treatment Safety Extension||149
373372|NCT00383721|909469|P2|STARTED|26-Week Treatment Safety Extension||153
373373|NCT00383721|909470|P1|STARTED|26-Week Treatment Safety Extension||145
373374|NCT00383721|909466|P5|NOT COMPLETED|26-Week Double-Blind Treatment Period||67
373375|NCT00383721|909467|P4|NOT COMPLETED|26-Week Double-Blind Treatment Period||50
373376|NCT00383721|909468|P3|NOT COMPLETED|26-Week Double-Blind Treatment Period||51
373377|NCT00383721|909469|P2|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
373378|NCT00383721|909470|P1|NOT COMPLETED|26-Week Double-Blind Treatment Period||35
373379|NCT00383721|909466|P5|COMPLETED|26-Week Double-Blind Treatment Period||169
373380|NCT00383721|909467|P4|COMPLETED|26-Week Double-Blind Treatment Period||193
373381|NCT00383721|909468|P3|COMPLETED|26-Week Double-Blind Treatment Period||202
373382|NCT00383721|909469|P2|COMPLETED|26-Week Double-Blind Treatment Period||202
373383|NCT00383721|909470|P1|COMPLETED|26-Week Double-Blind Treatment Period|1 participant listed as “ongoing” since the participant status could not be formally confirmed.|190
373384|NCT00383721|909466|P5|STARTED|26-Week Double-Blind Treatment Period||236
373385|NCT00383721|909467|P4|STARTED|26-Week Double-Blind Treatment Period||243
373386|NCT00383721|909468|P3|STARTED|26-Week Double-Blind Treatment Period||253
373387|NCT00383721|909469|P2|STARTED|26-Week Double-Blind Treatment Period||239
373388|NCT00383721|909470|P1|STARTED|26-Week Double-Blind Treatment Period||225
373389|NCT00383708|909507|P1|NOT COMPLETED|Co-administration Period||5
373390|NCT00383708|909507|P1|COMPLETED|Co-administration Period||52
373391|NCT00383708|909507|P1|STARTED|Co-administration Period||57
373392|NCT00383708|909507|P1|NOT COMPLETED|Run-in Period||7
373393|NCT00383708|909507|P1|COMPLETED|Run-in Period||85
373394|NCT00383708|909507|P1|STARTED|Run-in Period||92
373395|NCT00383708|909507|P1|NOT COMPLETED|Enrolment Through Start Treatment||33
373396|NCT00383708|909507|P1|COMPLETED|Enrolment Through Start Treatment||92
373397|NCT00383708|909507|P1|STARTED|Enrolment Through Start Treatment||125
373398|NCT00383643|909544|P3|NOT COMPLETED|Overall Study||1
373399|NCT00383643|909545|P2|NOT COMPLETED|Overall Study||1
373400|NCT00383643|909546|P1|NOT COMPLETED|Overall Study||1
373401|NCT00383643|909544|P3|COMPLETED|Overall Study||13
373402|NCT00383643|909545|P2|COMPLETED|Overall Study||15
373403|NCT00383643|909546|P1|COMPLETED|Overall Study||17
373404|NCT00383643|909544|P3|STARTED|Overall Study||14
373405|NCT00383643|909545|P2|STARTED|Overall Study||16
373406|NCT00383643|909546|P1|STARTED|Overall Study||18
373407|NCT00383630|909566|P1|NOT COMPLETED|Overall Study||0
373408|NCT00383630|909566|P1|COMPLETED|Overall Study||1
373409|NCT00383630|909566|P1|STARTED|Overall Study||1
373410|NCT00383565|909572|P1|NOT COMPLETED|Overall Study||0
373411|NCT00383565|909572|P1|COMPLETED|Overall Study||9
373412|NCT00383565|909572|P1|STARTED|Overall Study||9
373413|NCT00383552|909582|P4|NOT COMPLETED|Overall Study||72
373414|NCT00383552|909583|P3|NOT COMPLETED|Overall Study||61
373415|NCT00383552|909584|P2|NOT COMPLETED|Overall Study||41
373416|NCT00383552|909585|P1|NOT COMPLETED|Overall Study||36
373417|NCT00383552|909582|P4|COMPLETED|Overall Study||116
373418|NCT00383552|909583|P3|COMPLETED|Overall Study||127
373419|NCT00383552|909584|P2|COMPLETED|Overall Study||147
373420|NCT00383552|909585|P1|COMPLETED|Overall Study||146
373421|NCT00383552|909582|P4|STARTED|Overall Study||188
373422|NCT00383552|909583|P3|STARTED|Overall Study||188
373423|NCT00383552|909584|P2|STARTED|Overall Study||188
373424|NCT00383552|909585|P1|STARTED|Overall Study||182
373425|NCT00383500|909627|P3|NOT COMPLETED|Overall Study||2
373426|NCT00383500|909628|P2|NOT COMPLETED|Overall Study||3
373427|NCT00383500|909629|P1|NOT COMPLETED|Overall Study||8
373428|NCT00383500|909627|P3|COMPLETED|Overall Study||22
373429|NCT00383500|909628|P2|COMPLETED|Overall Study||21
373430|NCT00383500|909629|P1|COMPLETED|Overall Study||19
373431|NCT00383500|909627|P3|STARTED|Overall Study||24
373432|NCT00383500|909628|P2|STARTED|Overall Study||24
373433|NCT00383500|909629|P1|STARTED|Overall Study||27
373434|NCT00383448|909640|P1|NOT COMPLETED|Overall Study||0
373435|NCT00383448|909640|P1|COMPLETED|Overall Study||38
373436|NCT00383448|909640|P1|STARTED|Overall Study||38
373437|NCT00383435|909653|P5|NOT COMPLETED|26-Week Treatment Safety Extension||3
373438|NCT00383435|909654|P4|NOT COMPLETED|26-Week Treatment Safety Extension||15
373439|NCT00383435|909655|P3|NOT COMPLETED|26-Week Treatment Safety Extension||16
373440|NCT00383435|909656|P2|NOT COMPLETED|26-Week Treatment Safety Extension||9
373441|NCT00383435|909657|P1|NOT COMPLETED|26-Week Treatment Safety Extension||14
373442|NCT00383435|909653|P5|COMPLETED|26-Week Treatment Safety Extension||10
373443|NCT00383435|909654|P4|COMPLETED|26-Week Treatment Safety Extension||116
373444|NCT00383435|909655|P3|COMPLETED|26-Week Treatment Safety Extension||108
373445|NCT00383435|909656|P2|COMPLETED|26-Week Treatment Safety Extension||121
373446|NCT00383435|909657|P1|COMPLETED|26-Week Treatment Safety Extension||117
373447|NCT00383435|909653|P5|STARTED|26-Week Treatment Safety Extension||13
373448|NCT00383435|909654|P4|STARTED|26-Week Treatment Safety Extension||131
373449|NCT00383435|909655|P3|STARTED|26-Week Treatment Safety Extension||124
373450|NCT00383435|909656|P2|STARTED|26-Week Treatment Safety Extension||130
373451|NCT00383435|909657|P1|STARTED|26-Week Treatment Safety Extension||131
373452|NCT00383435|909653|P5|NOT COMPLETED|26-Week Double-Blind Treatment Period||53
373453|NCT00383435|909654|P4|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
373454|NCT00383435|909655|P3|NOT COMPLETED|26-Week Double-Blind Treatment Period||46
373455|NCT00383435|909656|P2|NOT COMPLETED|26-Week Double-Blind Treatment Period||38
373456|NCT00383435|909657|P1|NOT COMPLETED|26-Week Double-Blind Treatment Period||41
373457|NCT00383435|909653|P5|COMPLETED|26-Week Double-Blind Treatment Period||159
373458|NCT00383435|909654|P4|COMPLETED|26-Week Double-Blind Treatment Period||172
373459|NCT00383435|909655|P3|COMPLETED|26-Week Double-Blind Treatment Period||164
373460|NCT00383435|909656|P2|COMPLETED|26-Week Double-Blind Treatment Period||169
373461|NCT00383435|909657|P1|COMPLETED|26-Week Double-Blind Treatment Period||176
373462|NCT00383435|909653|P5|STARTED|26-Week Double-Blind Treatment Period||212
373463|NCT00383435|909654|P4|STARTED|26-Week Double-Blind Treatment Period||209
373464|NCT00383435|909655|P3|STARTED|26-Week Double-Blind Treatment Period||210
373465|NCT00383435|909656|P2|STARTED|26-Week Double-Blind Treatment Period||207
373466|NCT00383435|909657|P1|STARTED|26-Week Double-Blind Treatment Period||217
373467|NCT00383331|909696|P2|NOT COMPLETED|Overall Study||1
373468|NCT00383331|909697|P1|NOT COMPLETED|Overall Study||0
373469|NCT00383331|909696|P2|COMPLETED|Overall Study||8
373470|NCT00383331|909697|P1|COMPLETED|Overall Study||10
373471|NCT00383331|909696|P2|STARTED|Overall Study||9
373472|NCT00383331|909697|P1|STARTED|Overall Study||10
373473|NCT00383292|909716|P3|NOT COMPLETED|Overall Study||8
373474|NCT00383292|909717|P2|NOT COMPLETED|Overall Study||6
373475|NCT00383292|909718|P1|NOT COMPLETED|Overall Study||15
373476|NCT00383292|909716|P3|COMPLETED|Overall Study||22
373477|NCT00383292|909717|P2|COMPLETED|Overall Study||26
373478|NCT00383292|909718|P1|COMPLETED|Overall Study||53
373479|NCT00383292|909716|P3|Received at Least One Dose of Study Drug|Overall Study||30
373480|NCT00383292|909717|P2|Received at Least One Dose of Study Drug|Overall Study||32
373481|NCT00383292|909718|P1|Received at Least One Dose of Study Drug|Overall Study||68
373482|NCT00383292|909716|P3|STARTED|Overall Study||30
373483|NCT00383292|909717|P2|STARTED|Overall Study||32
373484|NCT00383292|909718|P1|STARTED|Overall Study||68
373485|NCT00383266|909746|P1|NOT COMPLETED|Overall Study||0
373486|NCT00383266|909746|P1|COMPLETED|Overall Study||9
373487|NCT00383266|909746|P1|STARTED|Overall Study||9
373488|NCT00383240|909759|P4|NOT COMPLETED|Overall Study||77
373489|NCT00383240|909760|P3|NOT COMPLETED|Overall Study||85
373490|NCT00383240|909761|P2|NOT COMPLETED|Overall Study||33
373491|NCT00383240|909762|P1|NOT COMPLETED|Overall Study||35
373492|NCT00383240|909759|P4|COMPLETED|Overall Study||119
373493|NCT00383240|909760|P3|COMPLETED|Overall Study||117
373494|NCT00383240|909761|P2|COMPLETED|Overall Study||159
373495|NCT00383240|909762|P1|COMPLETED|Overall Study||156
373496|NCT00383240|909759|P4|STARTED|Overall Study||196
373497|NCT00383240|909760|P3|STARTED|Overall Study||202
373498|NCT00383240|909761|P2|STARTED|Overall Study||192
373499|NCT00383240|909762|P1|STARTED|Overall Study||191
373500|NCT00383162|909793|P2|NOT COMPLETED|Migraine Attack 2 (Period 2)||7
373501|NCT00383162|909794|P1|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
373502|NCT00383162|909793|P2|COMPLETED|Migraine Attack 2 (Period 2)||66
373503|NCT00383162|909794|P1|COMPLETED|Migraine Attack 2 (Period 2)||65
373504|NCT00383162|909793|P2|STARTED|Migraine Attack 2 (Period 2)||73
373505|NCT00383162|909794|P1|STARTED|Migraine Attack 2 (Period 2)||67
373506|NCT00383162|909793|P2|NOT COMPLETED|Migraine Attack 1 (Period 1)||13
373507|NCT00383162|909794|P1|NOT COMPLETED|Migraine Attack 1 (Period 1)||20
373508|NCT00383162|909793|P2|COMPLETED|Migraine Attack 1 (Period 1)|Participants not completing did not take investigational product.|73
373509|NCT00383162|909794|P1|COMPLETED|Migraine Attack 1 (Period 1)|Participants completing a period treated a migraine with investigational product.|67
373510|NCT00383162|909793|P2|STARTED|Migraine Attack 1 (Period 1)||86
373511|NCT00383162|909794|P1|STARTED|Migraine Attack 1 (Period 1)||87
373512|NCT00383149|909836|P1|NOT COMPLETED|Overall Study||54
373513|NCT00383149|909836|P1|COMPLETED|Overall Study||0
373514|NCT00383149|909836|P1|STARTED|Overall Study||54
373515|NCT00383123|909855|P2|NOT COMPLETED|Overall Study||86
373516|NCT00383123|909856|P1|NOT COMPLETED|Overall Study||111
373517|NCT00383123|909855|P2|COMPLETED|Overall Study||1124
373518|NCT00383123|909856|P1|COMPLETED|Overall Study||2004
373519|NCT00383123|909855|P2|STARTED|Overall Study||1210
373520|NCT00383123|909856|P1|STARTED|Overall Study||2115
373521|NCT00383110|909878|P2|NOT COMPLETED|Overall Study||0
373522|NCT00383110|909879|P1|NOT COMPLETED|Overall Study||0
373523|NCT00383110|909878|P2|COMPLETED|Overall Study||150
373524|NCT00383110|909879|P1|COMPLETED|Overall Study||150
373525|NCT00383110|909878|P2|STARTED|Overall Study||150
373526|NCT00383110|909879|P1|STARTED|Overall Study||150
373527|NCT00383084|909897|P2|NOT COMPLETED|Overall Study||10
373528|NCT00383084|909898|P1|NOT COMPLETED|Overall Study||12
373529|NCT00383084|909897|P2|COMPLETED|Overall Study||28
373530|NCT00383084|909898|P1|COMPLETED|Overall Study||34
373531|NCT00383084|909897|P2|STARTED|Overall Study||38
373532|NCT00383084|909898|P1|STARTED|Overall Study||46
373533|NCT00383071|909914|P4|NOT COMPLETED|Overall Study||3
373534|NCT00383071|909915|P3|NOT COMPLETED|Overall Study||7
373535|NCT00383071|909916|P2|NOT COMPLETED|Overall Study||4
373536|NCT00383071|909917|P1|NOT COMPLETED|Overall Study||0
373537|NCT00383071|909914|P4|COMPLETED|Overall Study||22
373538|NCT00383071|909915|P3|COMPLETED|Overall Study||44
373539|NCT00383071|909916|P2|COMPLETED|Overall Study||21
373540|NCT00383071|909917|P1|COMPLETED|Overall Study||25
373541|NCT00383071|909914|P4|STARTED|Overall Study||25
373542|NCT00383071|909915|P3|STARTED|Overall Study||51
373543|NCT00383071|909916|P2|STARTED|Overall Study||25
373544|NCT00383071|909917|P1|STARTED|Overall Study||25
373545|NCT00383019|909929|P2|NOT COMPLETED|Overall Study||2
373546|NCT00383019|909930|P1|NOT COMPLETED|Overall Study||5
373547|NCT00383019|909929|P2|COMPLETED|Overall Study||143
373548|NCT00383019|909930|P1|COMPLETED|Overall Study||139
373549|NCT00383019|909929|P2|STARTED|Overall Study||145
373550|NCT00383019|909930|P1|STARTED|Overall Study||144
373551|NCT00382993|909952|P2|NOT COMPLETED|Migraine Attack 2 (Period 2)||4
373552|NCT00382993|909953|P1|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
373553|NCT00382993|909952|P2|COMPLETED|Migraine Attack 2 (Period 2)||63
373554|NCT00382993|909953|P1|COMPLETED|Migraine Attack 2 (Period 2)||68
373555|NCT00382993|909952|P2|STARTED|Migraine Attack 2 (Period 2)||67
373556|NCT00382993|909953|P1|STARTED|Migraine Attack 2 (Period 2)||70
373557|NCT00382993|909952|P2|NOT COMPLETED|Migraine Attack 1 (Period 1)||18
373558|NCT00382993|909953|P1|NOT COMPLETED|Migraine Attack 1 (Period 1)||14
373559|NCT00382993|909952|P2|COMPLETED|Migraine Attack 1 (Period 1)||67
373560|NCT00382993|909953|P1|COMPLETED|Migraine Attack 1 (Period 1)|Participant considered to have completed period if treated a migraine with investigational product.|70
373561|NCT00382993|909952|P2|STARTED|Migraine Attack 1 (Period 1)||85
373562|NCT00382993|909953|P1|STARTED|Migraine Attack 1 (Period 1)||84
373563|NCT00382967|909997|P2|NOT COMPLETED|Overall Study||1
373564|NCT00382967|909998|P1|NOT COMPLETED|Overall Study||1
373565|NCT00382967|909997|P2|COMPLETED|Overall Study|Subject dosed in error, should not have received Datscan product|137
373566|NCT00382967|909998|P1|COMPLETED|Overall Study|Patient lost to followup and the data was not recorded.|121
373567|NCT00382967|909997|P2|STARTED|Overall Study||138
373568|NCT00382967|909998|P1|STARTED|Overall Study|135 subjects enrolled at the start of the study, however, 13 subjects withdrew prior to dosing.|122
373569|NCT00382928|910008|P2|NOT COMPLETED|Overall Study||0
373570|NCT00382928|910009|P1|NOT COMPLETED|Overall Study||0
373571|NCT00382928|910008|P2|COMPLETED|Overall Study||95
373572|NCT00382928|910009|P1|COMPLETED|Overall Study||97
373573|NCT00382928|910008|P2|STARTED|Overall Study||95
373574|NCT00382928|910009|P1|STARTED|Overall Study||97
373575|NCT00382863|910023|P2|NOT COMPLETED|Overall Study||36
373576|NCT00382863|910024|P1|NOT COMPLETED|Overall Study||15
373577|NCT00382863|910023|P2|COMPLETED|Overall Study||78
373578|NCT00382863|910024|P1|COMPLETED|Overall Study||81
373579|NCT00382863|910023|P2|STARTED|Overall Study||114
373580|NCT00382863|910024|P1|STARTED|Overall Study||96
373581|NCT00382824|910080|P2|NOT COMPLETED|Overall Study||13
373582|NCT00382824|910081|P1|NOT COMPLETED|Overall Study||12
373583|NCT00382824|910080|P2|COMPLETED|Overall Study||16
373584|NCT00382824|910081|P1|COMPLETED|Overall Study||20
373585|NCT00382824|910080|P2|STARTED|Overall Study||29
373586|NCT00382824|910081|P1|STARTED|Overall Study||32
373587|NCT00382785|910097|P2|NOT COMPLETED|Overall Study||0
373588|NCT00382785|910098|P1|NOT COMPLETED|Overall Study||0
373589|NCT00382785|910097|P2|COMPLETED|Overall Study||26
373590|NCT00382785|910098|P1|COMPLETED|Overall Study||25
373591|NCT00382785|910097|P2|STARTED|Overall Study||26
373592|NCT00382785|910098|P1|STARTED|Overall Study||25
373593|NCT00382733|910108|P5|NOT COMPLETED|Overall Study||0
373594|NCT00382733|910109|P4|NOT COMPLETED|Overall Study||0
373595|NCT00382733|910110|P3|NOT COMPLETED|Overall Study||0
373596|NCT00382733|910111|P2|NOT COMPLETED|Overall Study||1
373597|NCT00382733|910112|P1|NOT COMPLETED|Overall Study||0
373598|NCT00382733|910108|P5|COMPLETED|Overall Study||2
373599|NCT00382733|910109|P4|COMPLETED|Overall Study||14
373600|NCT00382733|910110|P3|COMPLETED|Overall Study||3
373601|NCT00382733|910111|P2|COMPLETED|Overall Study|1 subject withdrew consent before completing Cycle 1 - that subject was replaced|3
373602|NCT00382733|910112|P1|COMPLETED|Overall Study||3
373603|NCT00382733|910108|P5|STARTED|Overall Study||2
373604|NCT00382733|910109|P4|STARTED|Overall Study||14
373605|NCT00382733|910110|P3|STARTED|Overall Study||3
373606|NCT00382733|910111|P2|STARTED|Overall Study||4
373607|NCT00382733|910112|P1|STARTED|Overall Study||3
373608|NCT00382720|910133|P3|NOT COMPLETED|Overall Study||86
373609|NCT00382720|910134|P2|NOT COMPLETED|Overall Study||89
373610|NCT00382720|910135|P1|NOT COMPLETED|Overall Study||79
373611|NCT00382720|910133|P3|COMPLETED|Overall Study||0
373612|NCT00382720|910134|P2|COMPLETED|Overall Study||0
373613|NCT00382720|910135|P1|COMPLETED|Overall Study||0
373614|NCT00382720|910133|P3|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|82
373615|NCT00382720|910134|P2|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|88
373616|NCT00382720|910135|P1|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|78
373617|NCT00382720|910133|P3|Administered Optimal Dose (Parts I & II)|Overall Study||82
373618|NCT00382720|910134|P2|Administered Optimal Dose (Parts I & II)|Overall Study||88
373619|NCT00382720|910135|P1|Administered Optimal Dose (Parts I & II)|Overall Study||78
373620|NCT00382720|910133|P3|Administered Non-Optimal Dose (Part I)|Overall Study||0
373621|NCT00382720|910134|P2|Administered Non-Optimal Dose (Part I)|Overall Study||11
373622|NCT00382720|910135|P1|Administered Non-Optimal Dose (Part I)|Overall Study||10
373623|NCT00382720|910133|P3|STARTED|Overall Study||86
373624|NCT00382720|910134|P2|STARTED|Overall Study||89
373625|NCT00382720|910135|P1|STARTED|Overall Study||79
373626|NCT00382590|910151|P2|NOT COMPLETED|Overall Study||0
373627|NCT00382590|910152|P1|NOT COMPLETED|Overall Study||0
373628|NCT00382590|910151|P2|COMPLETED|Overall Study||6
373629|NCT00382590|910152|P1|COMPLETED|Overall Study||4
373630|NCT00382590|910151|P2|STARTED|Overall Study||6
373631|NCT00382590|910152|P1|STARTED|Overall Study||4
373632|NCT00382408|910160|P2|NOT COMPLETED|Overall Study||54
373633|NCT00382408|910161|P1|NOT COMPLETED|Overall Study||144
373634|NCT00382408|910160|P2|COMPLETED|Overall Study||955
373635|NCT00382408|910161|P1|COMPLETED|Overall Study||2887
373636|NCT00382408|910160|P2|STARTED|Overall Study||1009
373637|NCT00382408|910161|P1|STARTED|Overall Study||3031
373638|NCT00382291|910188|P3|NOT COMPLETED|Overall Study||8
373639|NCT00382291|910189|P2|NOT COMPLETED|Overall Study||7
373640|NCT00382291|910190|P1|NOT COMPLETED|Overall Study||4
373641|NCT00382291|910188|P3|COMPLETED|Overall Study||13
373642|NCT00382291|910189|P2|COMPLETED|Overall Study||10
373643|NCT00382291|910190|P1|COMPLETED|Overall Study||14
373644|NCT00382291|910188|P3|STARTED|Overall Study||21
373645|NCT00382291|910189|P2|STARTED|Overall Study||17
373646|NCT00382291|910190|P1|STARTED|Overall Study||18
373647|NCT00382265|910203|P2|NOT COMPLETED|Overall Study||6
373648|NCT00382265|910204|P1|NOT COMPLETED|Overall Study||9
373649|NCT00382265|910203|P2|COMPLETED|Overall Study||239
373650|NCT00382265|910204|P1|COMPLETED|Overall Study||258
373651|NCT00382265|910203|P2|STARTED|Overall Study||245
373652|NCT00382265|910204|P1|STARTED|Overall Study||267
373653|NCT00382174|910222|P3|NOT COMPLETED|Overall Study||21
373654|NCT00382174|910223|P2|NOT COMPLETED|Overall Study||17
373655|NCT00382174|910224|P1|NOT COMPLETED|Overall Study||4
373656|NCT00382174|910222|P3|COMPLETED|Overall Study||51
373657|NCT00382174|910223|P2|COMPLETED|Overall Study||37
373658|NCT00382174|910224|P1|COMPLETED|Overall Study||14
373659|NCT00382174|910222|P3|STARTED|Overall Study||72
373660|NCT00382174|910223|P2|STARTED|Overall Study||54
373661|NCT00382174|910224|P1|STARTED|Overall Study||18
373662|NCT00382148|910237|P2|NOT COMPLETED|Overall Study||0
373663|NCT00382148|910238|P1|NOT COMPLETED|Overall Study||1
373664|NCT00382148|910237|P2|COMPLETED|Overall Study||7
373665|NCT00382148|910238|P1|COMPLETED|Overall Study||3
373666|NCT00382148|910237|P2|STARTED|Overall Study||7
373667|NCT00382148|910238|P1|STARTED|Overall Study||4
373668|NCT00382109|910252|P2|NOT COMPLETED|Overall Study||4
373669|NCT00382109|910253|P1|NOT COMPLETED|Overall Study||12
373670|NCT00382109|910252|P2|COMPLETED|Overall Study||66
373671|NCT00382109|910253|P1|COMPLETED|Overall Study||64
373672|NCT00382109|910252|P2|STARTED|Overall Study||70
373673|NCT00382109|910253|P1|STARTED|Overall Study||76
373674|NCT00382031|910275|P2|NOT COMPLETED|Overall Study||0
373675|NCT00382031|910276|P1|NOT COMPLETED|Overall Study||0
373676|NCT00382031|910275|P2|COMPLETED|Overall Study||95
373677|NCT00382031|910276|P1|COMPLETED|Overall Study||191
373678|NCT00382031|910275|P2|STARTED|Overall Study|Of the 95 randomized patients 94 attended Visit2.|95
373679|NCT00382031|910276|P1|STARTED|Overall Study|Of the 191 randomized patients 189 received at least one infusion of zalutumumab|191
373680|NCT00382018|910292|P4|NOT COMPLETED|Overall Study||59
373681|NCT00382018|910293|P3|NOT COMPLETED|Overall Study||64
373682|NCT00382018|910294|P2|NOT COMPLETED|Overall Study||165
373683|NCT00382018|910295|P1|NOT COMPLETED|Overall Study||0
373684|NCT00382018|910292|P4|COMPLETED|Overall Study||0
373685|NCT00382018|910293|P3|COMPLETED|Overall Study||0
373686|NCT00382018|910294|P2|COMPLETED|Overall Study||0
373687|NCT00382018|910295|P1|COMPLETED|Overall Study|This group of patients did not receive protocol treatment.|276
373688|NCT00382018|910292|P4|STARTED|Overall Study||59
373689|NCT00382018|910293|P3|STARTED|Overall Study||64
373690|NCT00382018|910294|P2|STARTED|Overall Study||165
373691|NCT00382018|910295|P1|STARTED|Overall Study||276
373692|NCT00381966|910313|P1|NOT COMPLETED|Overall Study||0
373693|NCT00381966|910313|P1|COMPLETED|Overall Study||5
373694|NCT00381966|910313|P1|STARTED|Overall Study||5
373695|NCT00381940|910318|P1|NOT COMPLETED|Overall Study||5
373696|NCT00381940|910318|P1|COMPLETED|Overall Study||21
373697|NCT00381940|910318|P1|STARTED|Overall Study||26
373698|NCT00381888|910322|P1|NOT COMPLETED|Overall Study||17
373699|NCT00381888|910322|P1|COMPLETED|Overall Study||27
373700|NCT00381888|910322|P1|STARTED|Overall Study||44
373701|NCT00381862|910327|P1|NOT COMPLETED|Overall Study||10
373702|NCT00381862|910327|P1|COMPLETED|Overall Study||44
373703|NCT00381862|910327|P1|STARTED|Overall Study||54
373704|NCT00381849|910333|P2|NOT COMPLETED|Open-label||0
373705|NCT00381849|910334|P1|NOT COMPLETED|Open-label||0
373706|NCT00381849|910333|P2|COMPLETED|Open-label||9
373707|NCT00381849|910334|P1|COMPLETED|Open-label||10
373708|NCT00381849|910333|P2|STARTED|Open-label||9
373709|NCT00381849|910334|P1|STARTED|Open-label||10
373710|NCT00381849|910333|P2|NOT COMPLETED|Second Intervention||0
373711|NCT00381849|910334|P1|NOT COMPLETED|Second Intervention||0
373712|NCT00381849|910333|P2|COMPLETED|Second Intervention||9
373713|NCT00381849|910334|P1|COMPLETED|Second Intervention||10
373714|NCT00381849|910333|P2|STARTED|Second Intervention||9
373715|NCT00381849|910334|P1|STARTED|Second Intervention||10
373716|NCT00381849|910333|P2|NOT COMPLETED|Wash Out||1
373717|NCT00381849|910334|P1|NOT COMPLETED|Wash Out||0
373718|NCT00381849|910333|P2|COMPLETED|Wash Out||9
373719|NCT00381849|910334|P1|COMPLETED|Wash Out||10
373720|NCT00381849|910333|P2|STARTED|Wash Out||10
373721|NCT00381849|910334|P1|STARTED|Wash Out||10
373722|NCT00381849|910333|P2|NOT COMPLETED|First Intervention||0
373723|NCT00381849|910334|P1|NOT COMPLETED|First Intervention||0
373724|NCT00381849|910333|P2|COMPLETED|First Intervention||10
373725|NCT00381849|910334|P1|COMPLETED|First Intervention||10
373726|NCT00381849|910333|P2|STARTED|First Intervention||10
373727|NCT00381849|910334|P1|STARTED|First Intervention||10
373728|NCT00381810|910352|P1|NOT COMPLETED|B Cell Follow-up||7
373729|NCT00381810|910352|P1|COMPLETED|B Cell Follow-up||0
373730|NCT00381810|910352|P1|STARTED|B Cell Follow-up|Participants only entered the B cell follow-up period if their peripheral B cells were depleted.|7
373731|NCT00381810|910352|P1|NOT COMPLETED|Treatment and Safety Follow-up||15
373732|NCT00381810|910352|P1|COMPLETED|Treatment and Safety Follow-up||16
373733|NCT00381810|910352|P1|STARTED|Treatment and Safety Follow-up||31
373734|NCT00381797|910361|P5|NOT COMPLETED|Overall Study||2
373735|NCT00381797|910362|P4|NOT COMPLETED|Overall Study||1
373736|NCT00381797|910363|P3|NOT COMPLETED|Overall Study||0
373737|NCT00381797|910364|P2|NOT COMPLETED|Overall Study||1
373738|NCT00381797|910365|P1|NOT COMPLETED|Overall Study||1
373739|NCT00381797|910361|P5|COMPLETED|Overall Study||35
373740|NCT00381797|910362|P4|COMPLETED|Overall Study||14
373741|NCT00381797|910363|P3|COMPLETED|Overall Study||10
373742|NCT00381797|910364|P2|COMPLETED|Overall Study||16
373743|NCT00381797|910365|P1|COMPLETED|Overall Study||17
373744|NCT00381797|910361|P5|STARTED|Overall Study||37
373745|NCT00381797|910362|P4|STARTED|Overall Study||15
373746|NCT00381797|910363|P3|STARTED|Overall Study||10
373747|NCT00381797|910364|P2|STARTED|Overall Study||17
373748|NCT00381797|910365|P1|STARTED|Overall Study||18
373749|NCT00381706|910440|P3|NOT COMPLETED|Overall Study||1
373750|NCT00381706|910441|P2|NOT COMPLETED|Overall Study||2
373751|NCT00381706|910442|P1|NOT COMPLETED|Overall Study||7
373752|NCT00381706|910440|P3|COMPLETED|Overall Study||79
373753|NCT00381706|910441|P2|COMPLETED|Overall Study||81
373754|NCT00381706|910442|P1|COMPLETED|Overall Study||75
373755|NCT00381706|910440|P3|STARTED|Overall Study||80
373756|NCT00381706|910441|P2|STARTED|Overall Study||83
373757|NCT00381706|910442|P1|STARTED|Overall Study||82
373758|NCT00381693|910465|P1|NOT COMPLETED|Overall Study||8
373759|NCT00381693|910465|P1|COMPLETED|Overall Study||2
373760|NCT00381693|910465|P1|STARTED|Overall Study||10
373761|NCT00381680|910474|P2|NOT COMPLETED|Overall Study||50
373762|NCT00381680|910475|P1|NOT COMPLETED|Overall Study||125
373763|NCT00381680|910474|P2|COMPLETED|Overall Study||19
373764|NCT00381680|910475|P1|COMPLETED|Overall Study||81
373765|NCT00381680|910474|P2|STARTED|Overall Study||69
373766|NCT00381680|910475|P1|STARTED|Overall Study||206
373767|NCT00381641|910492|P2|NOT COMPLETED|Overall Study||2
373768|NCT00381641|910493|P1|NOT COMPLETED|Overall Study||0
373769|NCT00381641|910492|P2|COMPLETED|Overall Study||23
373770|NCT00381641|910493|P1|COMPLETED|Overall Study||38
373771|NCT00381641|910492|P2|STARTED|Overall Study||25
373772|NCT00381641|910493|P1|STARTED|Overall Study||38
373773|NCT00381628|910509|P4|NOT COMPLETED|Overall Study||0
373774|NCT00381628|910510|P3|NOT COMPLETED|Overall Study||0
373775|NCT00381628|910511|P2|NOT COMPLETED|Overall Study||0
373776|NCT00381628|910512|P1|NOT COMPLETED|Overall Study||0
373777|NCT00381628|910509|P4|COMPLETED|Overall Study||14
373778|NCT00381628|910510|P3|COMPLETED|Overall Study||0
373779|NCT00381628|910511|P2|COMPLETED|Overall Study||27
373780|NCT00381628|910512|P1|COMPLETED|Overall Study||18
373781|NCT00381628|910509|P4|STARTED|Overall Study||14
373782|NCT00381628|910510|P3|STARTED|Overall Study||0
373783|NCT00381628|910511|P2|STARTED|Overall Study||27
373784|NCT00381628|910512|P1|STARTED|Overall Study||18
373785|NCT00381615|910526|P4|NOT COMPLETED|Overall Study||2
373786|NCT00381615|910527|P3|NOT COMPLETED|Overall Study||1
373787|NCT00381615|910528|P2|NOT COMPLETED|Overall Study||5
373788|NCT00381615|910529|P1|NOT COMPLETED|Overall Study||4
373789|NCT00381615|910526|P4|COMPLETED|Overall Study||22
373790|NCT00381615|910527|P3|COMPLETED|Overall Study||24
373791|NCT00381615|910528|P2|COMPLETED|Overall Study||45
373792|NCT00381615|910529|P1|COMPLETED|Overall Study||44
373793|NCT00381615|910526|P4|STARTED|Overall Study||24
373794|NCT00381615|910527|P3|STARTED|Overall Study||25
373795|NCT00381615|910528|P2|STARTED|Overall Study||50
373796|NCT00381615|910529|P1|STARTED|Overall Study||48
373797|NCT00381563|910581|P2|NOT COMPLETED|Overall Study||6
373798|NCT00381563|910582|P1|NOT COMPLETED|Overall Study||7
373799|NCT00381563|910581|P2|COMPLETED|Overall Study||33
373800|NCT00381563|910582|P1|COMPLETED|Overall Study||34
373801|NCT00381563|910581|P2|STARTED|Overall Study||39
373802|NCT00381563|910582|P1|STARTED|Overall Study||41
373803|NCT00381550|910589|P1|NOT COMPLETED|Overall Study||0
373804|NCT00381550|910589|P1|COMPLETED|Overall Study||35
373805|NCT00381550|910589|P1|STARTED|Overall Study||35
373806|NCT00381485|910597|P4|NOT COMPLETED|Double-Blind Treatment Period||33
373807|NCT00381485|910598|P3|NOT COMPLETED|Double-Blind Treatment Period||25
373808|NCT00381485|910599|P2|NOT COMPLETED|Double-Blind Treatment Period||27
373809|NCT00381485|910600|P1|NOT COMPLETED|Double-Blind Treatment Period||0
373810|NCT00381485|910597|P4|COMPLETED|Double-Blind Treatment Period||207
373811|NCT00381485|910598|P3|COMPLETED|Double-Blind Treatment Period||208
373812|NCT00381485|910599|P2|COMPLETED|Double-Blind Treatment Period||228
373813|NCT00381485|910600|P1|COMPLETED|Double-Blind Treatment Period||0
373814|NCT00381485|910597|P4|STARTED|Double-Blind Treatment Period||240
373815|NCT00381485|910598|P3|STARTED|Double-Blind Treatment Period||233
373816|NCT00381485|910599|P2|STARTED|Double-Blind Treatment Period||255
373817|NCT00381485|910600|P1|STARTED|Double-Blind Treatment Period||0
373818|NCT00381485|910597|P4|NOT COMPLETED|Open-Label Run-In Period||0
373819|NCT00381485|910598|P3|NOT COMPLETED|Open-Label Run-In Period||0
373820|NCT00381485|910599|P2|NOT COMPLETED|Open-Label Run-In Period||0
373821|NCT00381485|910600|P1|NOT COMPLETED|Open-Label Run-In Period||106
373822|NCT00381485|910597|P4|COMPLETED|Open-Label Run-In Period||0
373823|NCT00381485|910598|P3|COMPLETED|Open-Label Run-In Period||0
373824|NCT00381485|910599|P2|COMPLETED|Open-Label Run-In Period||0
373825|NCT00381485|910600|P1|COMPLETED|Open-Label Run-In Period||728
373826|NCT00381485|910597|P4|STARTED|Open-Label Run-In Period||0
373827|NCT00381485|910598|P3|STARTED|Open-Label Run-In Period||0
373828|NCT00381485|910599|P2|STARTED|Open-Label Run-In Period||0
373829|NCT00381485|910600|P1|STARTED|Open-Label Run-In Period||834
373830|NCT00381381|910618|P1|NOT COMPLETED|Overall Study||64
373831|NCT00381381|910618|P1|COMPLETED|Overall Study||135
373832|NCT00381381|910618|P1|STARTED|Overall Study||199
373833|NCT00381303|910627|P2|NOT COMPLETED|Overall Study||33
373834|NCT00381303|910628|P1|NOT COMPLETED|Overall Study||94
373835|NCT00381303|910627|P2|COMPLETED|Overall Study||109
373836|NCT00381303|910628|P1|COMPLETED|Overall Study||193
373837|NCT00381303|910627|P2|STARTED|Overall Study||142
373838|NCT00381303|910628|P1|STARTED|Overall Study||287
373839|NCT00381238|910688|P1|NOT COMPLETED|Overall Study||12
373840|NCT00381238|910688|P1|COMPLETED|Overall Study||21
373841|NCT00381238|910688|P1|STARTED|Overall Study||33
373842|NCT00381095|910704|P2|NOT COMPLETED|Overall Study||21
373843|NCT00381095|910705|P1|NOT COMPLETED|Overall Study||13
373844|NCT00381095|910704|P2|COMPLETED|Overall Study||59
373845|NCT00381095|910705|P1|COMPLETED|Overall Study||59
373846|NCT00381095|910704|P2|STARTED|Overall Study||80
373847|NCT00381095|910705|P1|STARTED|Overall Study||72
373848|NCT00381043|910737|P2|NOT COMPLETED|Overall Study||8
373849|NCT00381043|910738|P1|NOT COMPLETED|Overall Study||12
373850|NCT00381043|910737|P2|COMPLETED|Overall Study||41
373851|NCT00381043|910738|P1|COMPLETED|Overall Study||39
373852|NCT00381043|910737|P2|STARTED|Overall Study||49
373853|NCT00381043|910738|P1|STARTED|Overall Study||51
373854|NCT00381004|910756|P1|NOT COMPLETED|Overall Study||0
373855|NCT00381004|910756|P1|COMPLETED|Overall Study||60
373856|NCT00381004|910756|P1|STARTED|Overall Study||60
373857|NCT00380978|910764|P2|NOT COMPLETED|Overall Study||10
373858|NCT00380978|910765|P1|NOT COMPLETED|Overall Study||2
373859|NCT00380978|910764|P2|COMPLETED|Overall Study||400
373860|NCT00380978|910765|P1|COMPLETED|Overall Study||406
373861|NCT00380978|910764|P2|STARTED|Overall Study||410
373862|NCT00380978|910765|P1|STARTED|Overall Study||408
373863|NCT00380874|910787|P2|NOT COMPLETED|Overall Study||10
373864|NCT00380874|910788|P1|NOT COMPLETED|Overall Study||13
373865|NCT00380874|910787|P2|COMPLETED|Overall Study||19
373866|NCT00380874|910788|P1|COMPLETED|Overall Study||19
373867|NCT00380874|910787|P2|STARTED|Overall Study||29
373868|NCT00380874|910788|P1|STARTED|Overall Study||32
373869|NCT00380861|910806|P2|NOT COMPLETED|Overall Study||17
373870|NCT00380861|910807|P1|NOT COMPLETED|Overall Study||18
373871|NCT00380861|910806|P2|COMPLETED|Overall Study||74
373872|NCT00380861|910807|P1|COMPLETED|Overall Study||75
373873|NCT00380861|910806|P2|STARTED|Overall Study|Two subjects received the PFC Sigma RP-F device but not the RP and their results are not included.|91
373874|NCT00380861|910807|P1|STARTED|Overall Study||93
373875|NCT00380744|910820|P7|NOT COMPLETED|Overall Study||1
373876|NCT00380744|910821|P6|NOT COMPLETED|Overall Study||0
373877|NCT00380744|910822|P5|NOT COMPLETED|Overall Study||0
373878|NCT00380744|910823|P4|NOT COMPLETED|Overall Study||0
373879|NCT00380744|910824|P3|NOT COMPLETED|Overall Study||0
373880|NCT00380744|910825|P2|NOT COMPLETED|Overall Study||0
373881|NCT00380744|910826|P1|NOT COMPLETED|Overall Study||1
373882|NCT00380744|910820|P7|COMPLETED|Overall Study||24
373883|NCT00380744|910821|P6|COMPLETED|Overall Study||25
373884|NCT00380744|910822|P5|COMPLETED|Overall Study||23
373885|NCT00380744|910823|P4|COMPLETED|Overall Study||4
373886|NCT00380744|910824|P3|COMPLETED|Overall Study||20
373887|NCT00380744|910825|P2|COMPLETED|Overall Study||4
373888|NCT00380744|910826|P1|COMPLETED|Overall Study||19
373889|NCT00380744|910820|P7|Received at Least 1 Dose of Study Drug|Overall Study||25
373890|NCT00380744|910821|P6|Received at Least 1 Dose of Study Drug|Overall Study||25
373891|NCT00380744|910822|P5|Received at Least 1 Dose of Study Drug|Overall Study||23
373892|NCT00380744|910823|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
373893|NCT00380744|910824|P3|Received at Least 1 Dose of Study Drug|Overall Study||20
373894|NCT00380744|910825|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
373895|NCT00380744|910826|P1|Received at Least 1 Dose of Study Drug|Overall Study||20
373896|NCT00380744|910820|P7|STARTED|Overall Study||25
373897|NCT00380744|910821|P6|STARTED|Overall Study||25
373898|NCT00380744|910822|P5|STARTED|Overall Study||23
373899|NCT00380744|910823|P4|STARTED|Overall Study||4
373900|NCT00380744|910824|P3|STARTED|Overall Study||20
373901|NCT00380744|910825|P2|STARTED|Overall Study||4
373902|NCT00380744|910826|P1|STARTED|Overall Study||20
373903|NCT00380718|910876|P1|NOT COMPLETED|Overall Study||18
373904|NCT00380718|910876|P1|COMPLETED|Overall Study||15
373905|NCT00380718|910876|P1|Received Escalated Dose in Cycle 2|Overall Study||25
373906|NCT00380718|910876|P1|Received at Least One Dose of Study Drug|Overall Study||33
373907|NCT00380718|910876|P1|STARTED|Overall Study||33
373908|NCT00380692|910888|P2|NOT COMPLETED|Study Period III - Open Label||12
373909|NCT00380692|910889|P1|NOT COMPLETED|Study Period III - Open Label||6
373910|NCT00380692|910888|P2|COMPLETED|Study Period III - Open Label||34
373911|NCT00380692|910889|P1|COMPLETED|Study Period III - Open Label||36
373912|NCT00380692|910888|P2|STARTED|Study Period III - Open Label||46
373913|NCT00380692|910889|P1|STARTED|Study Period III - Open Label|One patient who completed Study Period II did not enter Study Period III.|42
373914|NCT00380692|910888|P2|NOT COMPLETED|Study Period II - Double Blind||3
373915|NCT00380692|910889|P1|NOT COMPLETED|Study Period II - Double Blind||5
373916|NCT00380692|910888|P2|COMPLETED|Study Period II - Double Blind||46
373917|NCT00380692|910889|P1|COMPLETED|Study Period II - Double Blind||43
373918|NCT00380692|910888|P2|STARTED|Study Period II - Double Blind||49
373919|NCT00380692|910889|P1|STARTED|Study Period II - Double Blind||48
373920|NCT00380588|910937|P2|NOT COMPLETED|Overall Study||40
373921|NCT00380588|910938|P1|NOT COMPLETED|Overall Study||39
373922|NCT00380588|910937|P2|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|2
373923|NCT00380588|910938|P1|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|3
373924|NCT00380588|910937|P2|Received at Least One Dose of Study Drug|Overall Study||42
373925|NCT00380588|910938|P1|Received at Least One Dose of Study Drug|Overall Study||41
373926|NCT00380588|910937|P2|STARTED|Overall Study||42
373927|NCT00380588|910938|P1|STARTED|Overall Study||42
373928|NCT00380393|910952|P2|NOT COMPLETED|Month 14||56
373929|NCT00380393|910953|P1|NOT COMPLETED|Month 14||57
373930|NCT00380393|910952|P2|COMPLETED|Month 14||391
373931|NCT00380393|910953|P1|COMPLETED|Month 14||390
373932|NCT00380393|910952|P2|STARTED|Month 14||447
373933|NCT00380393|910953|P1|STARTED|Month 14||447
373934|NCT00380393|910952|P2|NOT COMPLETED|Month 8 (Cross-sectional Visit)||40
373935|NCT00380393|910953|P1|NOT COMPLETED|Month 8 (Cross-sectional Visit)||49
373936|NCT00380393|910952|P2|COMPLETED|Month 8 (Cross-sectional Visit)||407
373937|NCT00380393|910953|P1|COMPLETED|Month 8 (Cross-sectional Visit)||398
373938|NCT00380393|910952|P2|STARTED|Month 8 (Cross-sectional Visit)||447
373939|NCT00380393|910953|P1|STARTED|Month 8 (Cross-sectional Visit)||447
373940|NCT00380367|911001|P1|NOT COMPLETED|Overall Study||2
373941|NCT00380367|911001|P1|COMPLETED|Overall Study||108
373942|NCT00380367|911001|P1|STARTED|Overall Study||110
373943|NCT00380250|911008|P2|NOT COMPLETED|Overall Study||55
373944|NCT00380250|911009|P1|NOT COMPLETED|Overall Study||99
373945|NCT00380250|911008|P2|COMPLETED|Overall Study||139
373946|NCT00380250|911009|P1|COMPLETED|Overall Study||297
373947|NCT00380250|911008|P2|STARTED|Overall Study||194
373948|NCT00380250|911009|P1|STARTED|Overall Study||396
373949|NCT00380081|911077|P6|NOT COMPLETED|Overall Study||1
373950|NCT00380081|911078|P5|NOT COMPLETED|Overall Study||1
373951|NCT00380081|911079|P4|NOT COMPLETED|Overall Study||0
373952|NCT00380081|911080|P3|NOT COMPLETED|Overall Study||0
373953|NCT00380081|911081|P2|NOT COMPLETED|Overall Study||0
373954|NCT00380081|911082|P1|NOT COMPLETED|Overall Study||0
373955|NCT00380081|911077|P6|COMPLETED|Overall Study||13
373956|NCT00380081|911078|P5|COMPLETED|Overall Study||12
373957|NCT00380081|911079|P4|COMPLETED|Overall Study||15
373958|NCT00380081|911080|P3|COMPLETED|Overall Study||13
373959|NCT00380081|911081|P2|COMPLETED|Overall Study||13
373960|NCT00380081|911082|P1|COMPLETED|Overall Study||14
373961|NCT00380081|911077|P6|STARTED|Overall Study||14
373962|NCT00380081|911078|P5|STARTED|Overall Study||13
373963|NCT00380081|911079|P4|STARTED|Overall Study||15
373964|NCT00380081|911080|P3|STARTED|Overall Study||13
373965|NCT00380081|911081|P2|STARTED|Overall Study||13
373966|NCT00380081|911082|P1|STARTED|Overall Study||14
373967|NCT00380068|911132|P1|NOT COMPLETED|Overall Study||69
373968|NCT00380068|911132|P1|COMPLETED|Overall Study||155
373969|NCT00380068|911132|P1|STARTED|Overall Study||224
373970|NCT00380029|911152|P1|NOT COMPLETED|Overall Study||0
373971|NCT00380029|911152|P1|COMPLETED|Overall Study||20
373972|NCT00380029|911152|P1|STARTED|Overall Study||20
373973|NCT00379912|911164|P2|NOT COMPLETED|Overall Study||0
373974|NCT00379912|911165|P1|NOT COMPLETED|Overall Study||1
373975|NCT00379912|911164|P2|COMPLETED|Overall Study||8
373976|NCT00379912|911165|P1|COMPLETED|Overall Study||6
373977|NCT00379912|911164|P2|STARTED|Overall Study||8
373978|NCT00379912|911165|P1|STARTED|Overall Study||7
373979|NCT00379899|911187|P2|NOT COMPLETED|Overall Study||40
373980|NCT00379899|911188|P1|NOT COMPLETED|Overall Study||40
373981|NCT00379899|911187|P2|COMPLETED|Overall Study||140
373982|NCT00379899|911188|P1|COMPLETED|Overall Study||140
373983|NCT00379899|911187|P2|STARTED|Overall Study||180
373984|NCT00379899|911188|P1|STARTED|Overall Study||180
373985|NCT00379834|911216|P1|NOT COMPLETED|Overall Study||2
373986|NCT00379834|911216|P1|COMPLETED|Overall Study||8
373987|NCT00379834|911216|P1|STARTED|Overall Study||10
373988|NCT00379821|911224|P4|NOT COMPLETED|Overall Study||79
373989|NCT00379821|911225|P3|NOT COMPLETED|Overall Study||67
373990|NCT00379821|911226|P2|NOT COMPLETED|Overall Study||89
373991|NCT00379821|911227|P1|NOT COMPLETED|Overall Study||73
373992|NCT00379821|911224|P4|COMPLETED|Overall Study||81
373993|NCT00379821|911225|P3|COMPLETED|Overall Study||93
373994|NCT00379821|911226|P2|COMPLETED|Overall Study||71
373995|NCT00379821|911227|P1|COMPLETED|Overall Study||87
373996|NCT00379821|911224|P4|STARTED|Overall Study||160
373997|NCT00379821|911225|P3|STARTED|Overall Study||160
373998|NCT00379821|911226|P2|STARTED|Overall Study||160
373999|NCT00379821|911227|P1|STARTED|Overall Study||160
374000|NCT00379808|911368|P2|NOT COMPLETED|Intervention Period 2 (4 Weeks)||1
374001|NCT00379808|911369|P1|NOT COMPLETED|Intervention Period 2 (4 Weeks)||0
374002|NCT00379808|911368|P2|COMPLETED|Intervention Period 2 (4 Weeks)||10
374003|NCT00379808|911369|P1|COMPLETED|Intervention Period 2 (4 Weeks)||11
374004|NCT00379808|911368|P2|STARTED|Intervention Period 2 (4 Weeks)||11
374005|NCT00379808|911369|P1|STARTED|Intervention Period 2 (4 Weeks)||11
374006|NCT00379808|911368|P2|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
374007|NCT00379808|911369|P1|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
374008|NCT00379808|911368|P2|COMPLETED|Intervention Period 1 (4 Weeks)||11
374009|NCT00379808|911369|P1|COMPLETED|Intervention Period 1 (4 Weeks)||11
374010|NCT00379808|911368|P2|STARTED|Intervention Period 1 (4 Weeks)||11
374011|NCT00379808|911369|P1|STARTED|Intervention Period 1 (4 Weeks)||11
374012|NCT00379795|911390|P5|NOT COMPLETED|Overall Study||49
374013|NCT00379795|911391|P4|NOT COMPLETED|Overall Study||68
374014|NCT00379795|911392|P3|NOT COMPLETED|Overall Study||93
374015|NCT00379795|911393|P2|NOT COMPLETED|Overall Study||51
374016|NCT00379795|911394|P1|NOT COMPLETED|Overall Study||476
374017|NCT00379795|911390|P5|COMPLETED|Overall Study||14
374018|NCT00379795|911391|P4|COMPLETED|Overall Study||6
374019|NCT00379795|911392|P3|COMPLETED|Overall Study||23
374020|NCT00379795|911393|P2|COMPLETED|Overall Study||23
374021|NCT00379795|911394|P1|COMPLETED|Overall Study||50
374022|NCT00379795|911390|P5|Received Ranibizumab in Extension Study|Overall Study||0
374023|NCT00379795|911391|P4|Received Ranibizumab in Extension Study|Overall Study||55
374024|NCT00379795|911392|P3|Received Ranibizumab in Extension Study|Overall Study||113
374025|NCT00379795|911393|P2|Received Ranibizumab in Extension Study|Overall Study||41
374026|NCT00379795|911394|P1|Received Ranibizumab in Extension Study|Overall Study||377
374027|NCT00379795|911390|P5|STARTED|Overall Study||63
374028|NCT00379795|911391|P4|STARTED|Overall Study||74
374029|NCT00379795|911392|P3|STARTED|Overall Study||116
374030|NCT00379795|911393|P2|STARTED|Overall Study||74
374031|NCT00379795|911394|P1|STARTED|Overall Study||526
374032|NCT00379769|911424|P6|NOT COMPLETED|Observational Follow-up||148
374033|NCT00379769|911425|P5|NOT COMPLETED|Observational Follow-up||149
374034|NCT00379769|911426|P4|NOT COMPLETED|Observational Follow-up||0
374035|NCT00379769|911427|P3|NOT COMPLETED|Observational Follow-up||0
374036|NCT00379769|911428|P2|NOT COMPLETED|Observational Follow-up||0
374037|NCT00379769|911429|P1|NOT COMPLETED|Observational Follow-up||0
374038|NCT00379769|911424|P6|COMPLETED|Observational Follow-up||1102
374039|NCT00379769|911425|P5|COMPLETED|Observational Follow-up||1131
374040|NCT00379769|911426|P4|COMPLETED|Observational Follow-up||0
374041|NCT00379769|911427|P3|COMPLETED|Observational Follow-up||0
374042|NCT00379769|911428|P2|COMPLETED|Observational Follow-up||0
374043|NCT00379769|911429|P1|COMPLETED|Observational Follow-up||0
374044|NCT00379769|911424|P6|STARTED|Observational Follow-up|647 from “SU in Addition to Background MET” arm; 603 from “MET in Addition to Background SU” arm.|1250
374045|NCT00379769|911425|P5|STARTED|Observational Follow-up|665 from “RSG in Addition to Background MET” arm; 615 from “RGS in Addition to Background SU” arm.|1280
374046|NCT00379769|911426|P4|STARTED|Observational Follow-up||0
374047|NCT00379769|911427|P3|STARTED|Observational Follow-up||0
374048|NCT00379769|911428|P2|STARTED|Observational Follow-up||0
374049|NCT00379769|911429|P1|STARTED|Observational Follow-up||0
374050|NCT00379769|911424|P6|NOT COMPLETED|Main Study||0
374051|NCT00379769|911425|P5|NOT COMPLETED|Main Study||0
374052|NCT00379769|911426|P4|NOT COMPLETED|Main Study||230
374053|NCT00379769|911427|P3|NOT COMPLETED|Main Study||207
374054|NCT00379769|911428|P2|NOT COMPLETED|Main Study||199
374055|NCT00379769|911429|P1|NOT COMPLETED|Main Study||178
374056|NCT00379769|911424|P6|COMPLETED|Main Study||0
374057|NCT00379769|911425|P5|COMPLETED|Main Study||0
374058|NCT00379769|911426|P4|COMPLETED|Main Study||892
374059|NCT00379769|911427|P3|COMPLETED|Main Study||896
374060|NCT00379769|911428|P2|COMPLETED|Main Study||906
374061|NCT00379769|911429|P1|COMPLETED|Main Study||939
374062|NCT00379769|911424|P6|STARTED|Main Study||0
374063|NCT00379769|911425|P5|STARTED|Main Study||0
374064|NCT00379769|911426|P4|STARTED|Main Study||1122
374065|NCT00379769|911427|P3|STARTED|Main Study||1103
374066|NCT00379769|911428|P2|STARTED|Main Study||1105
374067|NCT00379769|911429|P1|STARTED|Main Study||1117
374068|NCT00379639|911588|P5|NOT COMPLETED|Overall Study||6
374069|NCT00379639|911589|P4|NOT COMPLETED|Overall Study||6
374070|NCT00379639|911590|P3|NOT COMPLETED|Overall Study||9
374071|NCT00379639|911591|P2|NOT COMPLETED|Overall Study||5
374072|NCT00379639|911592|P1|NOT COMPLETED|Overall Study||3
374073|NCT00379639|911588|P5|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
374074|NCT00379639|911589|P4|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
374075|NCT00379639|911590|P3|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|1
374076|NCT00379639|911591|P2|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|2
374077|NCT00379639|911592|P1|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|4
374078|NCT00379639|911588|P5|Completed 6 Cycles of Therapy|Overall Study||0
374079|NCT00379639|911589|P4|Completed 6 Cycles of Therapy|Overall Study||0
374080|NCT00379639|911590|P3|Completed 6 Cycles of Therapy|Overall Study||1
374081|NCT00379639|911591|P2|Completed 6 Cycles of Therapy|Overall Study||2
374082|NCT00379639|911592|P1|Completed 6 Cycles of Therapy|Overall Study||4
374083|NCT00379639|911588|P5|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|3
374084|NCT00379639|911589|P4|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|4
374085|NCT00379639|911590|P3|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
374086|NCT00379639|911591|P2|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
374087|NCT00379639|911592|P1|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|6
374088|NCT00379639|911588|P5|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
374089|NCT00379639|911589|P4|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
374090|NCT00379639|911590|P3|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|10
374091|NCT00379639|911591|P2|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
374092|NCT00379639|911592|P1|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
374093|NCT00379587|911614|P1|NOT COMPLETED|Overall Study||2
374094|NCT00379587|911614|P1|COMPLETED|Overall Study||63
374095|NCT00379587|911614|P1|STARTED|Overall Study||65
374096|NCT00379574|911621|P1|NOT COMPLETED|Overall Study||0
374097|NCT00379574|911621|P1|COMPLETED|Overall Study|Phase I (9) + Phase II (40)|49
374098|NCT00379574|911621|P1|STARTED|Overall Study|Phase I (9) + Phase II (40)|49
374099|NCT00379353|911628|P2|NOT COMPLETED|Overall Study||6
374100|NCT00379353|911629|P1|NOT COMPLETED|Overall Study||11
374101|NCT00379353|911628|P2|COMPLETED|Overall Study||9
374102|NCT00379353|911629|P1|COMPLETED|Overall Study||5
374103|NCT00379353|911628|P2|STARTED|Overall Study||15
374104|NCT00379353|911629|P1|STARTED|Overall Study||16
374105|NCT00379340|911664|P5|NOT COMPLETED|Overall Study||14
374106|NCT00379340|911665|P4|NOT COMPLETED|Overall Study||13
374107|NCT00379340|911666|P3|NOT COMPLETED|Overall Study||2
374108|NCT00379340|911667|P2|NOT COMPLETED|Overall Study||3
374109|NCT00379340|911668|P1|NOT COMPLETED|Overall Study||13
374110|NCT00379340|911664|P5|COMPLETED|Overall Study||9
374111|NCT00379340|911665|P4|COMPLETED|Overall Study||37
374112|NCT00379340|911666|P3|COMPLETED|Overall Study||50
374113|NCT00379340|911667|P2|COMPLETED|Overall Study||132
374114|NCT00379340|911668|P1|COMPLETED|Overall Study||107
374115|NCT00379340|911664|P5|STARTED|Overall Study||23
374116|NCT00379340|911665|P4|STARTED|Overall Study||50
374117|NCT00379340|911666|P3|STARTED|Overall Study||52
374118|NCT00379340|911667|P2|STARTED|Overall Study||135
374119|NCT00379340|911668|P1|STARTED|Overall Study||120
374120|NCT00379288|911685|P4|NOT COMPLETED|Overall Study||8
374121|NCT00379288|911686|P3|NOT COMPLETED|Overall Study||10
374122|NCT00379288|911687|P2|NOT COMPLETED|Overall Study||22
374123|NCT00379288|911688|P1|NOT COMPLETED|Overall Study||19
374124|NCT00379288|911685|P4|COMPLETED|Overall Study||57
374125|NCT00379288|911686|P3|COMPLETED|Overall Study||58
374126|NCT00379288|911687|P2|COMPLETED|Overall Study||108
374127|NCT00379288|911688|P1|COMPLETED|Overall Study||122
374128|NCT00379288|911685|P4|STARTED|Overall Study||65
374129|NCT00379288|911686|P3|STARTED|Overall Study||68
374130|NCT00379288|911687|P2|STARTED|Overall Study||130
374131|NCT00379288|911688|P1|STARTED|Overall Study||141
374132|NCT00379236|911700|P3|NOT COMPLETED|Open-label Extension||55
374133|NCT00379236|911701|P2|NOT COMPLETED|Open-label Extension||0
374134|NCT00379236|911702|P1|NOT COMPLETED|Open-label Extension||0
374135|NCT00379236|911700|P3|COMPLETED|Open-label Extension||378
374136|NCT00379236|911701|P2|COMPLETED|Open-label Extension||0
374137|NCT00379236|911702|P1|COMPLETED|Open-label Extension||0
374138|NCT00379236|911700|P3|STARTED|Open-label Extension||433
374139|NCT00379236|911701|P2|STARTED|Open-label Extension||0
374140|NCT00379236|911702|P1|STARTED|Open-label Extension||0
374141|NCT00379236|911700|P3|NOT COMPLETED|Double-blind||0
374142|NCT00379236|911701|P2|NOT COMPLETED|Double-blind||36
374143|NCT00379236|911702|P1|NOT COMPLETED|Double-blind||36
374144|NCT00379236|911700|P3|COMPLETED|Double-blind||0
374145|NCT00379236|911701|P2|COMPLETED|Double-blind|Data could not be retrieved for two participants|259
374146|NCT00379236|911702|P1|COMPLETED|Double-blind|Data could not be retrieved for two participants|257
374147|NCT00379236|911700|P3|STARTED|Double-blind||0
374148|NCT00379236|911701|P2|STARTED|Double-blind||295
374149|NCT00379236|911702|P1|STARTED|Double-blind||293
374150|NCT00379210|911747|P2|NOT COMPLETED|Overall Study||7
374151|NCT00379210|911748|P1|NOT COMPLETED|Overall Study||10
374152|NCT00379210|911747|P2|COMPLETED|Overall Study||23
374153|NCT00379210|911748|P1|COMPLETED|Overall Study||20
374154|NCT00379210|911747|P2|STARTED|Overall Study||30
374155|NCT00379210|911748|P1|STARTED|Overall Study||30
374156|NCT00379197|911754|P1|NOT COMPLETED|Overall Study||5
374157|NCT00379197|911754|P1|COMPLETED|Overall Study||8
374158|NCT00379197|911754|P1|STARTED|Overall Study||13
374159|NCT00379145|911759|P1|NOT COMPLETED|Overall Study||0
374160|NCT00379145|911759|P1|COMPLETED|Overall Study||20
374161|NCT00379145|911759|P1|STARTED|Overall Study||20
374162|NCT00379080|911771|P3|NOT COMPLETED|Overall Study||0
374163|NCT00379080|911772|P2|NOT COMPLETED|Overall Study||4
374164|NCT00379080|911773|P1|NOT COMPLETED|Overall Study||0
374165|NCT00379080|911771|P3|COMPLETED|Overall Study||31
374166|NCT00379080|911772|P2|COMPLETED|Overall Study||15
374167|NCT00379080|911773|P1|COMPLETED|Overall Study||6
374168|NCT00379080|911771|P3|STARTED|Overall Study||31
374169|NCT00379080|911772|P2|STARTED|Overall Study||19
374170|NCT00379080|911773|P1|STARTED|Overall Study||6
374171|NCT00378898|911818|P2|NOT COMPLETED|Overall Study||6
374172|NCT00378898|911819|P1|NOT COMPLETED|Overall Study||11
374173|NCT00378898|911818|P2|COMPLETED|Overall Study||11
374174|NCT00378898|911819|P1|COMPLETED|Overall Study||11
374175|NCT00378898|911818|P2|STARTED|Overall Study||17
374176|NCT00378898|911819|P1|STARTED|Overall Study||22
374177|NCT00378703|911831|P4|NOT COMPLETED|Overall Study||91
374178|NCT00378703|911832|P3|NOT COMPLETED|Overall Study||90
374179|NCT00378703|911833|P2|NOT COMPLETED|Overall Study||91
374180|NCT00378703|911834|P1|NOT COMPLETED|Overall Study||89
374181|NCT00378703|911831|P4|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
374182|NCT00378703|911832|P3|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
374183|NCT00378703|911833|P2|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
374184|NCT00378703|911834|P1|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
374185|NCT00378703|911831|P4|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
374186|NCT00378703|911832|P3|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|83
374187|NCT00378703|911833|P2|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|80
374188|NCT00378703|911834|P1|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
374189|NCT00378703|911831|P4|Treated|Overall Study|Number of patients included in the toxicity analysis.|91
374190|NCT00378703|911832|P3|Treated|Overall Study|Number of patients included in the toxicity analysis.|90
374191|NCT00378703|911833|P2|Treated|Overall Study|Number of patients included in the toxicity analysis.|86
374192|NCT00378703|911834|P1|Treated|Overall Study|Number of patients included in the toxicity analysis.|88
374193|NCT00378703|911831|P4|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
374194|NCT00378703|911832|P3|STARTED|Overall Study|Number of patients randomized to this treatment arm.|90
374195|NCT00378703|911833|P2|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
374196|NCT00378703|911834|P1|STARTED|Overall Study|Number of patients randomized to this treatment arm.|89
374197|NCT00378599|911856|P1|NOT COMPLETED|Overall Study||52
374198|NCT00378599|911856|P1|COMPLETED|Overall Study||73
374199|NCT00378599|911856|P1|STARTED|Overall Study||125
374200|NCT00378573|911860|P1|NOT COMPLETED|Follow-up||14
374201|NCT00378573|911860|P1|COMPLETED|Follow-up||3
374202|NCT00378573|911860|P1|STARTED|Follow-up||17
374203|NCT00378573|911860|P1|NOT COMPLETED|Treatment Period||17
374204|NCT00378573|911860|P1|COMPLETED|Treatment Period|Patients who did not complete treatment moved directly to the follow-up phase of the study.|0
374205|NCT00378573|911860|P1|STARTED|Treatment Period||17
374206|NCT00378560|911868|P2|NOT COMPLETED|Overall Study||58
374207|NCT00378560|911869|P1|NOT COMPLETED|Overall Study||56
374208|NCT00378560|911868|P2|COMPLETED|Overall Study||454
374209|NCT00378560|911869|P1|COMPLETED|Overall Study||453
374210|NCT00378560|911868|P2|Vaccinated|Overall Study||512
374211|NCT00378560|911869|P1|Vaccinated|Overall Study||509
374212|NCT00378560|911868|P2|STARTED|Overall Study||512
374213|NCT00378560|911869|P1|STARTED|Overall Study||509
374214|NCT00378534|911883|P1|NOT COMPLETED|Overall Study||60
374215|NCT00378534|911883|P1|COMPLETED|Overall Study|Transplantation Recipients|55
374216|NCT00378534|911883|P1|STARTED|Overall Study||115
374217|NCT00378508|911889|P2|NOT COMPLETED|Overall Study||3
374218|NCT00378508|911890|P1|NOT COMPLETED|Overall Study||2
374219|NCT00378508|911889|P2|COMPLETED|Overall Study||31
374220|NCT00378508|911890|P1|COMPLETED|Overall Study||27
374221|NCT00378508|911889|P2|Received Intervention/Placebo|Overall Study||31
374222|NCT00378508|911890|P1|Received Intervention/Placebo|Overall Study||28
374223|NCT00378508|911889|P2|Randomized|Overall Study||34
374224|NCT00378508|911890|P1|Randomized|Overall Study||29
374225|NCT00378508|911889|P2|STARTED|Overall Study||34
374226|NCT00378508|911890|P1|STARTED|Overall Study||29
374227|NCT00378378|911909|P3|NOT COMPLETED|Overall Study||2
374228|NCT00378378|911910|P2|NOT COMPLETED|Overall Study||1
374229|NCT00378378|911911|P1|NOT COMPLETED|Overall Study||0
374230|NCT00378378|911909|P3|COMPLETED|Overall Study||24
374231|NCT00378378|911910|P2|COMPLETED|Overall Study||49
374232|NCT00378378|911911|P1|COMPLETED|Overall Study||51
374233|NCT00378378|911909|P3|STARTED|Overall Study||26
374234|NCT00378378|911910|P2|STARTED|Overall Study||50
374235|NCT00378378|911911|P1|STARTED|Overall Study||51
374236|NCT00378352|911924|P6|NOT COMPLETED|Efficacy Phase||7
374237|NCT00378352|911925|P5|NOT COMPLETED|Efficacy Phase||11
374238|NCT00378352|911926|P4|NOT COMPLETED|Efficacy Phase||0
374239|NCT00378352|911927|P3|NOT COMPLETED|Efficacy Phase||0
374240|NCT00378352|911928|P2|NOT COMPLETED|Efficacy Phase||0
374241|NCT00378352|911929|P1|NOT COMPLETED|Efficacy Phase||0
374242|NCT00378352|911924|P6|COMPLETED|Efficacy Phase||59
374243|NCT00378352|911925|P5|COMPLETED|Efficacy Phase||54
374244|NCT00378352|911926|P4|COMPLETED|Efficacy Phase||0
374245|NCT00378352|911927|P3|COMPLETED|Efficacy Phase||0
374246|NCT00378352|911928|P2|COMPLETED|Efficacy Phase||0
374247|NCT00378352|911929|P1|COMPLETED|Efficacy Phase||0
374248|NCT00378352|911924|P6|Safety Analysis|Efficacy Phase||64
374249|NCT00378352|911925|P5|Safety Analysis|Efficacy Phase|Two participants randomized to placebo received 60,000 units Epoetin alfa|67
374250|NCT00378352|911926|P4|Safety Analysis|Efficacy Phase||0
374251|NCT00378352|911927|P3|Safety Analysis|Efficacy Phase||0
374252|NCT00378352|911928|P2|Safety Analysis|Efficacy Phase||0
374253|NCT00378352|911929|P1|Safety Analysis|Efficacy Phase||0
374254|NCT00378352|911924|P6|STARTED|Efficacy Phase||66
374255|NCT00378352|911925|P5|STARTED|Efficacy Phase||65
374256|NCT00378352|911926|P4|STARTED|Efficacy Phase||0
374257|NCT00378352|911927|P3|STARTED|Efficacy Phase||0
374258|NCT00378352|911928|P2|STARTED|Efficacy Phase||0
374259|NCT00378352|911929|P1|STARTED|Efficacy Phase||0
374260|NCT00378352|911924|P6|NOT COMPLETED|Dose Escalation 60,000 Units||0
374261|NCT00378352|911925|P5|NOT COMPLETED|Dose Escalation 60,000 Units||0
374262|NCT00378352|911926|P4|NOT COMPLETED|Dose Escalation 60,000 Units||1
374263|NCT00378352|911927|P3|NOT COMPLETED|Dose Escalation 60,000 Units||3
374264|NCT00378352|911928|P2|NOT COMPLETED|Dose Escalation 60,000 Units||0
374265|NCT00378352|911929|P1|NOT COMPLETED|Dose Escalation 60,000 Units||0
374266|NCT00378352|911924|P6|COMPLETED|Dose Escalation 60,000 Units||0
374267|NCT00378352|911925|P5|COMPLETED|Dose Escalation 60,000 Units||0
374268|NCT00378352|911926|P4|COMPLETED|Dose Escalation 60,000 Units||10
374269|NCT00378352|911927|P3|COMPLETED|Dose Escalation 60,000 Units||17
374270|NCT00378352|911928|P2|COMPLETED|Dose Escalation 60,000 Units||0
374271|NCT00378352|911929|P1|COMPLETED|Dose Escalation 60,000 Units||0
374272|NCT00378352|911924|P6|Safety Analysis|Dose Escalation 60,000 Units||0
374273|NCT00378352|911925|P5|Safety Analysis|Dose Escalation 60,000 Units||0
374274|NCT00378352|911926|P4|Safety Analysis|Dose Escalation 60,000 Units||11
374275|NCT00378352|911927|P3|Safety Analysis|Dose Escalation 60,000 Units||19
374276|NCT00378352|911928|P2|Safety Analysis|Dose Escalation 60,000 Units||0
374277|NCT00378352|911929|P1|Safety Analysis|Dose Escalation 60,000 Units||0
374278|NCT00378352|911924|P6|STARTED|Dose Escalation 60,000 Units||0
374279|NCT00378352|911925|P5|STARTED|Dose Escalation 60,000 Units||0
374280|NCT00378352|911926|P4|STARTED|Dose Escalation 60,000 Units||11
374281|NCT00378352|911927|P3|STARTED|Dose Escalation 60,000 Units||20
374282|NCT00378352|911928|P2|STARTED|Dose Escalation 60,000 Units||0
374283|NCT00378352|911929|P1|STARTED|Dose Escalation 60,000 Units||0
374284|NCT00378352|911924|P6|NOT COMPLETED|Dose Escalation 30,000 Units||0
374285|NCT00378352|911925|P5|NOT COMPLETED|Dose Escalation 30,000 Units||0
374286|NCT00378352|911926|P4|NOT COMPLETED|Dose Escalation 30,000 Units||2
374287|NCT00378352|911927|P3|NOT COMPLETED|Dose Escalation 30,000 Units||0
374288|NCT00378352|911928|P2|NOT COMPLETED|Dose Escalation 30,000 Units||3
374289|NCT00378352|911929|P1|NOT COMPLETED|Dose Escalation 30,000 Units||0
374290|NCT00378352|911924|P6|COMPLETED|Dose Escalation 30,000 Units||0
374291|NCT00378352|911925|P5|COMPLETED|Dose Escalation 30,000 Units||0
374292|NCT00378352|911926|P4|COMPLETED|Dose Escalation 30,000 Units||9
374293|NCT00378352|911927|P3|COMPLETED|Dose Escalation 30,000 Units||0
374294|NCT00378352|911928|P2|COMPLETED|Dose Escalation 30,000 Units||16
374295|NCT00378352|911929|P1|COMPLETED|Dose Escalation 30,000 Units||0
374296|NCT00378352|911924|P6|Safety Analysis|Dose Escalation 30,000 Units||0
374297|NCT00378352|911925|P5|Safety Analysis|Dose Escalation 30,000 Units||0
374298|NCT00378352|911926|P4|Safety Analysis|Dose Escalation 30,000 Units||11
374299|NCT00378352|911927|P3|Safety Analysis|Dose Escalation 30,000 Units||0
374300|NCT00378352|911928|P2|Safety Analysis|Dose Escalation 30,000 Units|One participant randomized to 60,000 units received 30,000 units|20
374301|NCT00378352|911929|P1|Safety Analysis|Dose Escalation 30,000 Units||0
374302|NCT00378352|911924|P6|STARTED|Dose Escalation 30,000 Units||0
374303|NCT00378352|911925|P5|STARTED|Dose Escalation 30,000 Units||0
374304|NCT00378352|911926|P4|STARTED|Dose Escalation 30,000 Units||11
374305|NCT00378352|911927|P3|STARTED|Dose Escalation 30,000 Units||0
374306|NCT00378352|911928|P2|STARTED|Dose Escalation 30,000 Units||19
374307|NCT00378352|911929|P1|STARTED|Dose Escalation 30,000 Units||0
374308|NCT00378352|911924|P6|NOT COMPLETED|Dose Escalation 15,000 Units||0
374309|NCT00378352|911925|P5|NOT COMPLETED|Dose Escalation 15,000 Units||0
374310|NCT00378352|911926|P4|NOT COMPLETED|Dose Escalation 15,000 Units||1
374311|NCT00378352|911927|P3|NOT COMPLETED|Dose Escalation 15,000 Units||0
374312|NCT00378352|911928|P2|NOT COMPLETED|Dose Escalation 15,000 Units||0
374313|NCT00378352|911929|P1|NOT COMPLETED|Dose Escalation 15,000 Units||5
374314|NCT00378352|911924|P6|COMPLETED|Dose Escalation 15,000 Units||0
374315|NCT00378352|911925|P5|COMPLETED|Dose Escalation 15,000 Units||0
374316|NCT00378352|911926|P4|COMPLETED|Dose Escalation 15,000 Units||10
374317|NCT00378352|911927|P3|COMPLETED|Dose Escalation 15,000 Units||0
374318|NCT00378352|911928|P2|COMPLETED|Dose Escalation 15,000 Units||0
374319|NCT00378352|911929|P1|COMPLETED|Dose Escalation 15,000 Units||15
374320|NCT00378352|911924|P6|Safety Analysis|Dose Escalation 15,000 Units||0
374321|NCT00378352|911925|P5|Safety Analysis|Dose Escalation 15,000 Units||0
374322|NCT00378352|911926|P4|Safety Analysis|Dose Escalation 15,000 Units||11
374323|NCT00378352|911927|P3|Safety Analysis|Dose Escalation 15,000 Units||0
374324|NCT00378352|911928|P2|Safety Analysis|Dose Escalation 15,000 Units||0
374325|NCT00378352|911929|P1|Safety Analysis|Dose Escalation 15,000 Units||19
374326|NCT00378352|911924|P6|STARTED|Dose Escalation 15,000 Units||0
374327|NCT00378352|911925|P5|STARTED|Dose Escalation 15,000 Units||0
374328|NCT00378352|911926|P4|STARTED|Dose Escalation 15,000 Units||11
374329|NCT00378352|911927|P3|STARTED|Dose Escalation 15,000 Units||0
374330|NCT00378352|911928|P2|STARTED|Dose Escalation 15,000 Units||0
374331|NCT00378352|911929|P1|STARTED|Dose Escalation 15,000 Units||20
374332|NCT00378326|911951|P1|NOT COMPLETED|Overall Study||0
374333|NCT00378326|911951|P1|COMPLETED|Overall Study||26
374334|NCT00378326|911951|P1|STARTED|Overall Study||26
374335|NCT00378209|911957|P1|NOT COMPLETED|Overall Study||22
374336|NCT00378209|911957|P1|COMPLETED|Overall Study|This included patients who completed at least 8 cycles of combination therapy with all drugs.|42
374337|NCT00378209|911957|P1|STARTED|Overall Study|1 patient who never started treatment was excluded in the analysis.|64
374338|NCT00378105|911967|P2|NOT COMPLETED|Overall Study||30
374339|NCT00378105|911968|P1|NOT COMPLETED|Overall Study||20
374340|NCT00378105|911967|P2|COMPLETED|Overall Study||5
374341|NCT00378105|911968|P1|COMPLETED|Overall Study||11
374342|NCT00378105|911967|P2|STARTED|Overall Study||35
374343|NCT00378105|911968|P1|STARTED|Overall Study|Out of 33 enrolled, two patients went off study before start of therapy.|31
374344|NCT00378079|911980|P3|NOT COMPLETED|Overall Study||0
374345|NCT00378079|911981|P2|NOT COMPLETED|Overall Study||1
374346|NCT00378079|911982|P1|NOT COMPLETED|Overall Study||6
374347|NCT00378079|911980|P3|COMPLETED|Overall Study||71
374348|NCT00378079|911981|P2|COMPLETED|Overall Study||69
374349|NCT00378079|911982|P1|COMPLETED|Overall Study||64
374350|NCT00378079|911980|P3|STARTED|Overall Study||71
374351|NCT00378079|911981|P2|STARTED|Overall Study||70
374352|NCT00378079|911982|P1|STARTED|Overall Study||70
374353|NCT00378014|912004|P2|NOT COMPLETED|Extension (Month 12 to Month 59)||14
374354|NCT00378014|912005|P1|NOT COMPLETED|Extension (Month 12 to Month 59)||14
374355|NCT00378014|912004|P2|COMPLETED|Extension (Month 12 to Month 59)||26
374356|NCT00378014|912005|P1|COMPLETED|Extension (Month 12 to Month 59)||27
374357|NCT00378014|912004|P2|STARTED|Extension (Month 12 to Month 59)||40
374358|NCT00378014|912005|P1|STARTED|Extension (Month 12 to Month 59)||41
374359|NCT00378014|912004|P2|NOT COMPLETED|Core (Randomization to Month 11)||12
374360|NCT00378014|912005|P1|NOT COMPLETED|Core (Randomization to Month 11)||14
374361|NCT00378014|912004|P2|COMPLETED|Core (Randomization to Month 11)||90
374362|NCT00378014|912005|P1|COMPLETED|Core (Randomization to Month 11)||87
374363|NCT00378014|912004|P2|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|98
374364|NCT00378014|912005|P1|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|96
374365|NCT00378014|912004|P2|STARTED|Core (Randomization to Month 11)||102
374366|NCT00378014|912005|P1|STARTED|Core (Randomization to Month 11)||101
374367|NCT00377962|912031|P2|NOT COMPLETED|Extension Study: 12-24 Months||4
374368|NCT00377962|912032|P1|NOT COMPLETED|Extension Study: 12-24 Months||10
374369|NCT00377962|912031|P2|COMPLETED|Extension Study: 12-24 Months||123
374370|NCT00377962|912032|P1|COMPLETED|Extension Study: 12-24 Months||98
374371|NCT00377962|912031|P2|STARTED|Extension Study: 12-24 Months||127
374372|NCT00377962|912032|P1|STARTED|Extension Study: 12-24 Months||108
374373|NCT00377962|912031|P2|NOT COMPLETED|Core Study: 0-12 Months||9
374374|NCT00377962|912032|P1|NOT COMPLETED|Core Study: 0-12 Months||28
374375|NCT00377962|912031|P2|COMPLETED|Core Study: 0-12 Months||133
374376|NCT00377962|912032|P1|COMPLETED|Core Study: 0-12 Months||112
374377|NCT00377962|912031|P2|STARTED|Core Study: 0-12 Months||142
374378|NCT00377962|912032|P1|STARTED|Core Study: 0-12 Months||140
374379|NCT00377858|912068|P2|NOT COMPLETED|Overall Study||27
374380|NCT00377858|912069|P1|NOT COMPLETED|Overall Study||31
374381|NCT00377858|912068|P2|COMPLETED|Overall Study||215
374382|NCT00377858|912069|P1|COMPLETED|Overall Study||211
374383|NCT00377858|912068|P2|Had at Least One Post-Baseline Value|Overall Study||240
374384|NCT00377858|912069|P1|Had at Least One Post-Baseline Value|Overall Study||239
374385|NCT00377858|912068|P2|STARTED|Overall Study||242
374386|NCT00377858|912069|P1|STARTED|Overall Study||242
374387|NCT00377832|912099|P2|NOT COMPLETED|Overall Study||0
374388|NCT00377832|912100|P1|NOT COMPLETED|Overall Study||0
374389|NCT00377832|912099|P2|COMPLETED|Overall Study||6
374390|NCT00377832|912100|P1|COMPLETED|Overall Study||7
374391|NCT00377832|912099|P2|STARTED|Overall Study||6
374392|NCT00377832|912100|P1|STARTED|Overall Study||7
374393|NCT00377819|912122|P2|NOT COMPLETED|Overall Study||10
374394|NCT00377819|912123|P1|NOT COMPLETED|Overall Study||13
374395|NCT00377819|912122|P2|COMPLETED|Overall Study||243
374396|NCT00377819|912123|P1|COMPLETED|Overall Study||238
374397|NCT00377819|912122|P2|Received Study Medication|Overall Study||253
374398|NCT00377819|912123|P1|Received Study Medication|Overall Study||249
374399|NCT00377819|912122|P2|STARTED|Overall Study||253
374400|NCT00377819|912123|P1|STARTED|Overall Study||251
374401|NCT00377741|912135|P2|NOT COMPLETED|Overall Study||0
374402|NCT00377741|912136|P1|NOT COMPLETED|Overall Study||0
374403|NCT00377741|912135|P2|COMPLETED|Overall Study||15
374404|NCT00377741|912136|P1|COMPLETED|Overall Study||16
374405|NCT00377741|912135|P2|STARTED|Overall Study||15
374406|NCT00377741|912136|P1|STARTED|Overall Study||16
374407|NCT00377676|912152|P2|NOT COMPLETED|Overall Study||322
374408|NCT00377676|912153|P1|NOT COMPLETED|Overall Study||961
374409|NCT00377676|912152|P2|COMPLETED|Overall Study||694
374410|NCT00377676|912153|P1|COMPLETED|Overall Study||1093
374411|NCT00377676|912152|P2|STARTED|Overall Study||1016
374412|NCT00377676|912153|P1|STARTED|Overall Study|25 subjects did not receive study drug - thus 3070 were randomized and received drug|2054
374413|NCT00377637|912169|P4|NOT COMPLETED|Maintenance Phase||57
374414|NCT00377637|912170|P3|NOT COMPLETED|Maintenance Phase||43
374415|NCT00377637|912171|P2|NOT COMPLETED|Maintenance Phase||0
374416|NCT00377637|912172|P1|NOT COMPLETED|Maintenance Phase||0
374417|NCT00377637|912169|P4|COMPLETED|Maintenance Phase||54
374418|NCT00377637|912170|P3|COMPLETED|Maintenance Phase||73
374419|NCT00377637|912171|P2|COMPLETED|Maintenance Phase||0
374420|NCT00377637|912172|P1|COMPLETED|Maintenance Phase||0
374421|NCT00377637|912169|P4|STARTED|Maintenance Phase||111
374422|NCT00377637|912170|P3|STARTED|Maintenance Phase||116
374423|NCT00377637|912171|P2|STARTED|Maintenance Phase||0
374424|NCT00377637|912172|P1|STARTED|Maintenance Phase||0
374425|NCT00377637|912169|P4|NOT COMPLETED|Induction Phase||0
374426|NCT00377637|912170|P3|NOT COMPLETED|Induction Phase||0
374427|NCT00377637|912171|P2|NOT COMPLETED|Induction Phase||35
374428|NCT00377637|912172|P1|NOT COMPLETED|Induction Phase||29
374429|NCT00377637|912169|P4|COMPLETED|Induction Phase||0
374430|NCT00377637|912170|P3|COMPLETED|Induction Phase||0
374431|NCT00377637|912171|P2|COMPLETED|Induction Phase||150
374432|NCT00377637|912172|P1|COMPLETED|Induction Phase||156
374433|NCT00377637|912169|P4|Safety Population|Induction Phase||0
374434|NCT00377637|912170|P3|Safety Population|Induction Phase||0
374435|NCT00377637|912171|P2|Safety Population|Induction Phase||184
374436|NCT00377637|912172|P1|Safety Population|Induction Phase||180
374437|NCT00377637|912169|P4|STARTED|Induction Phase||0
374438|NCT00377637|912170|P3|STARTED|Induction Phase||0
374439|NCT00377637|912171|P2|STARTED|Induction Phase|Intent-To-Treat|185
374440|NCT00377637|912172|P1|STARTED|Induction Phase|Intent-To-Treat|185
374441|NCT00377611|912208|P2|NOT COMPLETED|Overall Study||33
374442|NCT00377611|912209|P1|NOT COMPLETED|Overall Study||22
374443|NCT00377611|912208|P2|COMPLETED|Overall Study||1974
374444|NCT00377611|912209|P1|COMPLETED|Overall Study||1025
374445|NCT00377611|912208|P2|STARTED|Overall Study||2007
374446|NCT00377611|912209|P1|STARTED|Overall Study||1047
374447|NCT00377572|912272|P2|NOT COMPLETED|Overall Study||54
374448|NCT00377572|912273|P1|NOT COMPLETED|Overall Study||53
374449|NCT00377572|912272|P2|COMPLETED|Overall Study||157
374450|NCT00377572|912273|P1|COMPLETED|Overall Study||155
374451|NCT00377572|912272|P2|STARTED|Overall Study||211
374452|NCT00377572|912273|P1|STARTED|Overall Study||208
374453|NCT00377520|912311|P1|NOT COMPLETED|Overall Study||1
374454|NCT00377520|912311|P1|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|26
374455|NCT00377520|912311|P1|STARTED|Overall Study||27
374456|NCT00377455|912316|P1|NOT COMPLETED|Overall Study||1
374457|NCT00377455|912316|P1|COMPLETED|Overall Study||4
374458|NCT00377455|912316|P1|STARTED|Overall Study||5
374459|NCT00377429|912324|P1|NOT COMPLETED|Overall Study||15
374460|NCT00377429|912324|P1|COMPLETED|Overall Study|Completed main study|32
374461|NCT00377429|912324|P1|STARTED|Overall Study|Treated|47
374462|NCT00377403|912335|P2|NOT COMPLETED|Overall Study||7
374463|NCT00377403|912336|P1|NOT COMPLETED|Overall Study||4
374464|NCT00377403|912335|P2|COMPLETED|Overall Study|The number varied by day of follow-up from 71 to 77 in the symptomatic treatment only group.|74
374465|NCT00377403|912336|P1|COMPLETED|Overall Study|The number varied by day of follow-up from 80 to 82 in the intervention group.|81
374466|NCT00377403|912335|P2|Day 28 Assessment|Overall Study||77
374467|NCT00377403|912336|P1|Day 28 Assessment|Overall Study||82
374468|NCT00377403|912335|P2|Day 10 Assessment|Overall Study||71
374469|NCT00377403|912336|P1|Day 10 Assessment|Overall Study||81
374470|NCT00377403|912335|P2|Day 7 Assessment|Overall Study||75
374471|NCT00377403|912336|P1|Day 7 Assessment|Overall Study||80
374472|NCT00377403|912335|P2|Day -3 Assessment|Overall Study||74
374473|NCT00377403|912336|P1|Day -3 Assessment|Overall Study||81
374474|NCT00377403|912335|P2|STARTED|Overall Study||81
374475|NCT00377403|912336|P1|STARTED|Overall Study||85
374476|NCT00377364|912344|P2|NOT COMPLETED|Overall Study||0
374477|NCT00377364|912345|P1|NOT COMPLETED|Overall Study||2
374478|NCT00377364|912344|P2|COMPLETED|Overall Study||14
374479|NCT00377364|912345|P1|COMPLETED|Overall Study||14
374480|NCT00377364|912344|P2|STARTED|Overall Study||14
374481|NCT00377364|912345|P1|STARTED|Overall Study||16
374482|NCT00377312|912371|P2|NOT COMPLETED|Overall Study||1
374483|NCT00377312|912372|P1|NOT COMPLETED|Overall Study||1
374484|NCT00377312|912371|P2|COMPLETED|Overall Study||4
374485|NCT00377312|912372|P1|COMPLETED|Overall Study||5
374486|NCT00377312|912371|P2|STARTED|Overall Study||5
374487|NCT00377312|912372|P1|STARTED|Overall Study||6
374488|NCT00377299|912404|P2|NOT COMPLETED|Overall Study||24
374489|NCT00377299|912405|P1|NOT COMPLETED|Overall Study||19
374490|NCT00377299|912404|P2|COMPLETED|Overall Study||4
374491|NCT00377299|912405|P1|COMPLETED|Overall Study||13
374492|NCT00377299|912404|P2|STARTED|Overall Study||28
374493|NCT00377299|912405|P1|STARTED|Overall Study||32
374494|NCT00377260|912421|P2|NOT COMPLETED|Overall Study||5
374495|NCT00377260|912422|P1|NOT COMPLETED|Overall Study||2
374496|NCT00377260|912421|P2|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
374497|NCT00377260|912422|P1|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
374498|NCT00377260|912421|P2|STARTED|Overall Study||147
374499|NCT00377260|912422|P1|STARTED|Overall Study||144
374500|NCT00377234|912476|P2|NOT COMPLETED|Overall Study||31
374501|NCT00377234|912477|P1|NOT COMPLETED|Overall Study||34
374502|NCT00377234|912476|P2|COMPLETED|Overall Study||145
374503|NCT00377234|912477|P1|COMPLETED|Overall Study||146
374504|NCT00377234|912476|P2|Safety Analysis Set: Risedronate|Overall Study||174
374505|NCT00377234|912477|P1|Safety Analysis Set: Risedronate|Overall Study||153
374506|NCT00377234|912476|P2|Safety Analysis Set: Ibandronate|Overall Study||150
374507|NCT00377234|912477|P1|Safety Analysis Set: Ibandronate|Overall Study||177
374508|NCT00377234|912476|P2|Safety Analysis Set: Period 2|Overall Study||150
374509|NCT00377234|912477|P1|Safety Analysis Set: Period 2|Overall Study||153
374510|NCT00377234|912476|P2|Safety Analysis Set: Period 1|Overall Study||174
374511|NCT00377234|912477|P1|Safety Analysis Set: Period 1|Overall Study||177
374512|NCT00377234|912476|P2|Received Treatment|Overall Study||174
374513|NCT00377234|912477|P1|Received Treatment|Overall Study||177
374514|NCT00377234|912476|P2|Did Not Receive Study Treatment|Overall Study||2
374515|NCT00377234|912477|P1|Did Not Receive Study Treatment|Overall Study||3
374516|NCT00377234|912476|P2|Randomized|Overall Study||176
374517|NCT00377234|912477|P1|Randomized|Overall Study||180
374518|NCT00377234|912476|P2|STARTED|Overall Study||176
374519|NCT00377234|912477|P1|STARTED|Overall Study||180
374520|NCT00377156|912495|P2|NOT COMPLETED|Overall Study||54
374521|NCT00377156|912496|P1|NOT COMPLETED|Overall Study||48
374522|NCT00377156|912495|P2|COMPLETED|Overall Study||48
374523|NCT00377156|912496|P1|COMPLETED|Overall Study||63
374524|NCT00377156|912495|P2|STARTED|Overall Study||102
374525|NCT00377156|912496|P1|STARTED|Overall Study||111
374526|NCT00376961|912510|P2|NOT COMPLETED|Maintenance||23
374527|NCT00376961|912511|P1|NOT COMPLETED|Maintenance||0
374528|NCT00376961|912510|P2|COMPLETED|Maintenance||27
374529|NCT00376961|912511|P1|COMPLETED|Maintenance||0
374530|NCT00376961|912510|P2|Eligible|Maintenance||47
374531|NCT00376961|912511|P1|Eligible|Maintenance||0
374532|NCT00376961|912510|P2|STARTED|Maintenance||50
374533|NCT00376961|912511|P1|STARTED|Maintenance||0
374534|NCT00376961|912510|P2|NOT COMPLETED|Initial Registration||0
374535|NCT00376961|912511|P1|NOT COMPLETED|Initial Registration||7
374536|NCT00376961|912510|P2|COMPLETED|Initial Registration||0
374537|NCT00376961|912511|P1|COMPLETED|Initial Registration||61
374538|NCT00376961|912510|P2|Eligible|Initial Registration||0
374539|NCT00376961|912511|P1|Eligible|Initial Registration||65
374540|NCT00376961|912510|P2|STARTED|Initial Registration||0
374541|NCT00376961|912511|P1|STARTED|Initial Registration||68
374542|NCT00376948|912520|P1|NOT COMPLETED|Overall Study||0
374543|NCT00376948|912520|P1|COMPLETED|Overall Study||20
374544|NCT00376948|912520|P1|STARTED|Overall Study||20
374545|NCT00376935|912529|P4|NOT COMPLETED|Overall Study||0
374546|NCT00376935|912530|P3|NOT COMPLETED|Overall Study||0
374547|NCT00376935|912531|P2|NOT COMPLETED|Overall Study||0
374548|NCT00376935|912532|P1|NOT COMPLETED|Overall Study||0
374549|NCT00376935|912529|P4|COMPLETED|Overall Study||24
374550|NCT00376935|912530|P3|COMPLETED|Overall Study||25
374551|NCT00376935|912531|P2|COMPLETED|Overall Study||25
374552|NCT00376935|912532|P1|COMPLETED|Overall Study||25
374553|NCT00376935|912529|P4|STARTED|Overall Study||24
374554|NCT00376935|912530|P3|STARTED|Overall Study||25
374555|NCT00376935|912531|P2|STARTED|Overall Study||25
374556|NCT00376935|912532|P1|STARTED|Overall Study||25
374557|NCT00376805|912570|P1|NOT COMPLETED|Overall Study||0
374558|NCT00376805|912570|P1|COMPLETED|Overall Study||6
374559|NCT00376805|912570|P1|STARTED|Overall Study||6
374560|NCT00376688|912577|P1|NOT COMPLETED|Overall Study||4
374561|NCT00376688|912577|P1|COMPLETED|Overall Study||27
374562|NCT00376688|912577|P1|STARTED|Overall Study||31
374563|NCT00376675|912583|P2|NOT COMPLETED|Overall Study||14
374564|NCT00376675|912584|P1|NOT COMPLETED|Overall Study||20
374565|NCT00376675|912583|P2|COMPLETED|Overall Study||56
374566|NCT00376675|912584|P1|COMPLETED|Overall Study||49
374567|NCT00376675|912583|P2|STARTED|Overall Study||70
374568|NCT00376675|912584|P1|STARTED|Overall Study||69
374569|NCT00376597|912608|P2|NOT COMPLETED|Overall Study||3
374570|NCT00376597|912609|P1|NOT COMPLETED|Overall Study||11
374571|NCT00376597|912608|P2|COMPLETED|Overall Study||312
374572|NCT00376597|912609|P1|COMPLETED|Overall Study||242
374573|NCT00376597|912608|P2|STARTED|Overall Study||315
374574|NCT00376597|912609|P1|STARTED|Overall Study||253
374575|NCT00376558|912623|P2|NOT COMPLETED|Overall Study||0
374576|NCT00376558|912624|P1|NOT COMPLETED|Overall Study||0
374577|NCT00376558|912623|P2|COMPLETED|Overall Study||25
374578|NCT00376558|912624|P1|COMPLETED|Overall Study||25
374579|NCT00376558|912623|P2|STARTED|Overall Study||25
374580|NCT00376558|912624|P1|STARTED|Overall Study||25
374581|NCT00376532|912633|P2|NOT COMPLETED|Overall Study||6
374582|NCT00376532|912634|P1|NOT COMPLETED|Overall Study||6
374583|NCT00376532|912633|P2|COMPLETED|Overall Study|Last non-event subject enrolled 3/18/2008.|26
374584|NCT00376532|912634|P1|COMPLETED|Overall Study|Last event subject enrolled 2/22/2008|25
374585|NCT00376532|912633|P2|STARTED|Overall Study|Subjects without an event were enrolled beginning 09/15/2006.|32
374586|NCT00376532|912634|P1|STARTED|Overall Study|Subjects with an event were enrolled beginning 09/14/2006.|31
374587|NCT00376506|912644|P2|NOT COMPLETED|Overall Study||2
374588|NCT00376506|912645|P1|NOT COMPLETED|Overall Study||0
374589|NCT00376506|912644|P2|COMPLETED|Overall Study||4
374590|NCT00376506|912645|P1|COMPLETED|Overall Study||4
374591|NCT00376506|912644|P2|STARTED|Overall Study||6
374592|NCT00376506|912645|P1|STARTED|Overall Study||4
374593|NCT00376363|912663|P2|NOT COMPLETED|Overall Study||46
374594|NCT00376363|912664|P1|NOT COMPLETED|Overall Study||56
374595|NCT00376363|912663|P2|COMPLETED|Overall Study||87
374596|NCT00376363|912664|P1|COMPLETED|Overall Study||87
374597|NCT00376363|912663|P2|STARTED|Overall Study||133
374598|NCT00376363|912664|P1|STARTED|Overall Study||143
374599|NCT00376259|912676|P2|NOT COMPLETED|Overall Study||21
374600|NCT00376259|912677|P1|NOT COMPLETED|Overall Study||22
374601|NCT00376259|912676|P2|COMPLETED|Overall Study||0
374602|NCT00376259|912677|P1|COMPLETED|Overall Study||0
374603|NCT00376259|912676|P2|Received Study Drug|Overall Study||21
374604|NCT00376259|912677|P1|Received Study Drug|Overall Study||21
374605|NCT00376259|912676|P2|STARTED|Overall Study||21
374606|NCT00376259|912677|P1|STARTED|Overall Study||22
374607|NCT00376220|912691|P2|NOT COMPLETED|Overall Study||12
374608|NCT00376220|912692|P1|NOT COMPLETED|Overall Study||10
374609|NCT00376220|912691|P2|COMPLETED|Overall Study||35
374610|NCT00376220|912692|P1|COMPLETED|Overall Study||37
374611|NCT00376220|912691|P2|STARTED|Overall Study||47
374612|NCT00376220|912692|P1|STARTED|Overall Study||47
374613|NCT00376168|912700|P2|NOT COMPLETED|Overall Study||1
374614|NCT00376168|912701|P1|NOT COMPLETED|Overall Study||2
374615|NCT00376168|912700|P2|COMPLETED|Overall Study||15
374616|NCT00376168|912701|P1|COMPLETED|Overall Study||14
374617|NCT00376168|912700|P2|STARTED|Overall Study|One patient randomized but not treated|16
374618|NCT00376168|912701|P1|STARTED|Overall Study||16
374619|NCT00375999|912715|P1|NOT COMPLETED|Overall Study||2
374620|NCT00375999|912715|P1|COMPLETED|Overall Study||32
374621|NCT00375999|912715|P1|STARTED|Overall Study||34
374622|NCT00375973|912721|P2|NOT COMPLETED|Overall Study||2
374623|NCT00375973|912722|P1|NOT COMPLETED|Overall Study||10
374624|NCT00375973|912721|P2|COMPLETED|Overall Study||28
374625|NCT00375973|912722|P1|COMPLETED|Overall Study||20
374626|NCT00375973|912721|P2|STARTED|Overall Study||30
374627|NCT00375973|912722|P1|STARTED|Overall Study||30
374628|NCT00375934|912742|P2|NOT COMPLETED|Overall Study||6
374629|NCT00375934|912743|P1|NOT COMPLETED|Overall Study||3
374630|NCT00375934|912742|P2|COMPLETED|Overall Study||95
374631|NCT00375934|912743|P1|COMPLETED|Overall Study||96
374632|NCT00375934|912742|P2|STARTED|Overall Study||101
374633|NCT00375934|912743|P1|STARTED|Overall Study||99
374634|NCT00375830|912772|P3|NOT COMPLETED|Overall Study||0
374635|NCT00375830|912773|P2|NOT COMPLETED|Overall Study||0
374636|NCT00375830|912774|P1|NOT COMPLETED|Overall Study||0
374637|NCT00375830|912772|P3|COMPLETED|Overall Study||74
374638|NCT00375830|912773|P2|COMPLETED|Overall Study||30
374639|NCT00375830|912774|P1|COMPLETED|Overall Study||10
374640|NCT00375830|912772|P3|STARTED|Overall Study||74
374641|NCT00375830|912773|P2|STARTED|Overall Study||30
374642|NCT00375830|912774|P1|STARTED|Overall Study||10
374643|NCT00375752|912801|P2|NOT COMPLETED|Overall Study||15
374644|NCT00375752|912802|P1|NOT COMPLETED|Overall Study||12
374645|NCT00375752|912801|P2|COMPLETED|Overall Study||74
374646|NCT00375752|912802|P1|COMPLETED|Overall Study||67
374647|NCT00375752|912801|P2|STARTED|Overall Study||89
374648|NCT00375752|912802|P1|STARTED|Overall Study||79
374649|NCT00375713|912818|P2|NOT COMPLETED|Overall Study||23
374650|NCT00375713|912819|P1|NOT COMPLETED|Overall Study||20
374651|NCT00375713|912818|P2|COMPLETED|Overall Study|23 Patients were not treated or discontinued after randomization in Cetirizine group.|211
374652|NCT00375713|912819|P1|COMPLETED|Overall Study|20 Patients were not treated or discontinued after randomization in Levocetirizine group.|212
374653|NCT00375713|912818|P2|STARTED|Overall Study|Randomized population (N=234).|234
374654|NCT00375713|912819|P1|STARTED|Overall Study|Randomized population (N=232).|232
374655|NCT00375674|912833|P2|NOT COMPLETED|Overall Study||141
374656|NCT00375674|912834|P1|NOT COMPLETED|Overall Study||144
374657|NCT00375674|912833|P2|COMPLETED|Overall Study||165
374658|NCT00375674|912834|P1|COMPLETED|Overall Study||165
374659|NCT00375674|912833|P2|As-Treated Population|Overall Study|2 were randomized but not treated: 1 was screening failure & 1 discontinued due to new liver lesions|304
374660|NCT00375674|912834|P1|As-Treated Population|Overall Study|3 were randomized but not treated: 2 refused treatment & 1 withdrew before receiving study drug|306
374661|NCT00375674|912833|P2|Intent-to-Treat Population|Overall Study||306
374662|NCT00375674|912834|P1|Intent-to-Treat Population|Overall Study||309
374663|NCT00375674|912833|P2|STARTED|Overall Study||306
374664|NCT00375674|912834|P1|STARTED|Overall Study||309
374665|NCT00375609|912863|P3|NOT COMPLETED|Overall Study||1
374666|NCT00375609|912864|P2|NOT COMPLETED|Overall Study||7
374667|NCT00375609|912865|P1|NOT COMPLETED|Overall Study||4
374668|NCT00375609|912863|P3|COMPLETED|Overall Study||42
374669|NCT00375609|912864|P2|COMPLETED|Overall Study||77
374670|NCT00375609|912865|P1|COMPLETED|Overall Study||84
374671|NCT00375609|912863|P3|STARTED|Overall Study||43
374672|NCT00375609|912864|P2|STARTED|Overall Study||84
374673|NCT00375609|912865|P1|STARTED|Overall Study||88
374674|NCT00375518|912881|P2|NOT COMPLETED|Overall Study||17
374675|NCT00375518|912882|P1|NOT COMPLETED|Overall Study||8
374676|NCT00375518|912881|P2|COMPLETED|Overall Study||65
374677|NCT00375518|912882|P1|COMPLETED|Overall Study||72
374678|NCT00375518|912881|P2|STARTED|Overall Study||82
374679|NCT00375518|912882|P1|STARTED|Overall Study||80
374680|NCT00375505|912890|P2|NOT COMPLETED|Overall Study||2
374681|NCT00375505|912891|P1|NOT COMPLETED|Overall Study||1
374682|NCT00375505|912890|P2|COMPLETED|Overall Study||32
374683|NCT00375505|912891|P1|COMPLETED|Overall Study||35
374684|NCT00375505|912890|P2|STARTED|Overall Study||34
374685|NCT00375505|912891|P1|STARTED|Overall Study||36
374686|NCT00375492|912935|P2|NOT COMPLETED|Overall Study||26
374687|NCT00375492|912936|P1|NOT COMPLETED|Overall Study||26
374688|NCT00375492|912935|P2|COMPLETED|Overall Study||72
374689|NCT00375492|912936|P1|COMPLETED|Overall Study||70
374690|NCT00375492|912935|P2|STARTED|Overall Study||98
374691|NCT00375492|912936|P1|STARTED|Overall Study||96
374692|NCT00375427|912966|P2|NOT COMPLETED|Overall Study||74
374693|NCT00375427|912967|P1|NOT COMPLETED|Overall Study||60
374694|NCT00375427|912966|P2|COMPLETED|Overall Study||142
374695|NCT00375427|912967|P1|COMPLETED|Overall Study||149
374696|NCT00375427|912966|P2|STARTED|Overall Study||216
374697|NCT00375427|912967|P1|STARTED|Overall Study|Total enrollment was 430 but five patients were screened but not treated.|209
374698|NCT00375219|912992|P3|NOT COMPLETED|Overall Study||21
374699|NCT00375219|912993|P2|NOT COMPLETED|Overall Study||20
374700|NCT00375219|912994|P1|NOT COMPLETED|Overall Study||59
374701|NCT00375219|912992|P3|COMPLETED|Overall Study||0
374702|NCT00375219|912993|P2|COMPLETED|Overall Study||0
374703|NCT00375219|912994|P1|COMPLETED|Overall Study||3
374704|NCT00375219|912992|P3|STARTED|Overall Study||21
374705|NCT00375219|912993|P2|STARTED|Overall Study||20
374706|NCT00375219|912994|P1|STARTED|Overall Study||62
374707|NCT00375167|913062|P2|NOT COMPLETED|Overall Study||0
374708|NCT00375167|913063|P1|NOT COMPLETED|Overall Study||0
374709|NCT00375167|913062|P2|COMPLETED|Overall Study||17
374710|NCT00375167|913063|P1|COMPLETED|Overall Study||16
374711|NCT00375167|913062|P2|STARTED|Overall Study|Participants were already clients of ACT and continued receiving services following this period|17
374712|NCT00375167|913063|P1|STARTED|Overall Study|Clients were already receiving ACT services and this continued after study completion|16
374713|NCT00374907|913077|P2|NOT COMPLETED|116-Week Short-term + Long-term Period||14
374714|NCT00374907|913078|P1|NOT COMPLETED|116-Week Short-term + Long-term Period||13
374715|NCT00374907|913077|P2|COMPLETED|116-Week Short-term + Long-term Period||2
374716|NCT00374907|913078|P1|COMPLETED|116-Week Short-term + Long-term Period||7
374717|NCT00374907|913077|P2|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||15
374718|NCT00374907|913078|P1|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||17
374719|NCT00374907|913077|P2|STARTED|116-Week Short-term + Long-term Period||16
374720|NCT00374907|913078|P1|STARTED|116-Week Short-term + Long-term Period||20
374721|NCT00374907|913077|P2|NOT COMPLETED|12-Week Short-term Period||1
374722|NCT00374907|913078|P1|NOT COMPLETED|12-Week Short-term Period||3
374723|NCT00374907|913077|P2|COMPLETED|12-Week Short-term Period||15
374724|NCT00374907|913078|P1|COMPLETED|12-Week Short-term Period||17
374725|NCT00374907|913077|P2|STARTED|12-Week Short-term Period||16
374726|NCT00374907|913078|P1|STARTED|12-Week Short-term Period||20
374727|NCT00374868|913090|P1|NOT COMPLETED|Overall Study||36
374728|NCT00374868|913090|P1|COMPLETED|Overall Study||2
374729|NCT00374868|913090|P1|STARTED|Overall Study||38
374730|NCT00374842|913104|P3|NOT COMPLETED|Overall Study||0
374731|NCT00374842|913105|P2|NOT COMPLETED|Overall Study||0
374732|NCT00374842|913106|P1|NOT COMPLETED|Overall Study||0
374733|NCT00374842|913104|P3|COMPLETED|Overall Study||100
374734|NCT00374842|913105|P2|COMPLETED|Overall Study||100
374735|NCT00374842|913106|P1|COMPLETED|Overall Study||100
374736|NCT00374842|913104|P3|STARTED|Overall Study||100
374737|NCT00374842|913105|P2|STARTED|Overall Study||100
374738|NCT00374842|913106|P1|STARTED|Overall Study||100
374739|NCT00374803|913137|P2|NOT COMPLETED|Overall Study||0
374740|NCT00374803|913138|P1|NOT COMPLETED|Overall Study||0
374741|NCT00374803|913137|P2|COMPLETED|Overall Study||23
374742|NCT00374803|913138|P1|COMPLETED|Overall Study||22
374743|NCT00374803|913137|P2|STARTED|Overall Study||23
374744|NCT00374803|913138|P1|STARTED|Overall Study||22
374745|NCT00374556|913154|P2|NOT COMPLETED|Overall Study||1
374746|NCT00374556|913155|P1|NOT COMPLETED|Overall Study||1
374747|NCT00374556|913154|P2|COMPLETED|Overall Study||15
374748|NCT00374556|913155|P1|COMPLETED|Overall Study||13
374749|NCT00374556|913154|P2|STARTED|Overall Study||16
374750|NCT00374556|913155|P1|STARTED|Overall Study||14
374751|NCT00374543|913207|P2|NOT COMPLETED|Overall Study||0
374752|NCT00374543|913208|P1|NOT COMPLETED|Overall Study||0
374753|NCT00374543|913207|P2|COMPLETED|Overall Study||1
374754|NCT00374543|913208|P1|COMPLETED|Overall Study||2
374755|NCT00374543|913207|P2|STARTED|Overall Study||1
374756|NCT00374543|913208|P1|STARTED|Overall Study||2
374757|NCT00374452|913216|P2|NOT COMPLETED|Overall Study||5
374758|NCT00374452|913217|P1|NOT COMPLETED|Overall Study||5
374759|NCT00374452|913216|P2|COMPLETED|Overall Study||43
374760|NCT00374452|913217|P1|COMPLETED|Overall Study||29
374761|NCT00374452|913216|P2|Intervention Started|Overall Study||46
374762|NCT00374452|913217|P1|Intervention Started|Overall Study||30
374763|NCT00374452|913216|P2|STARTED|Overall Study||48
374764|NCT00374452|913217|P1|STARTED|Overall Study||34
374765|NCT00374335|913223|P1|NOT COMPLETED|Overall Study||0
374766|NCT00374335|913223|P1|COMPLETED|Overall Study||261
374767|NCT00374335|913223|P1|STARTED|Overall Study||261
374768|NCT00374322|913230|P2|NOT COMPLETED|Overall Study||1304
374769|NCT00374322|913231|P1|NOT COMPLETED|Overall Study||1257
374770|NCT00374322|913230|P2|COMPLETED|Overall Study||278
374771|NCT00374322|913231|P1|COMPLETED|Overall Study||322
374772|NCT00374322|913230|P2|Received >=1 Dose of Study Treatment|Overall Study||1576
374773|NCT00374322|913231|P1|Received >=1 Dose of Study Treatment|Overall Study||1571
374774|NCT00374322|913230|P2|STARTED|Overall Study||1582
374775|NCT00374322|913231|P1|STARTED|Overall Study||1579
374776|NCT00374244|913269|P2|NOT COMPLETED|Overall Study||0
374777|NCT00374244|913270|P1|NOT COMPLETED|Overall Study||0
374778|NCT00374244|913269|P2|COMPLETED|Overall Study||14
374779|NCT00374244|913270|P1|COMPLETED|Overall Study||14
374780|NCT00374244|913269|P2|STARTED|Overall Study||14
374781|NCT00374244|913270|P1|STARTED|Overall Study||14
374782|NCT00374231|913316|P1|NOT COMPLETED|Overall Study||0
374783|NCT00374231|913316|P1|COMPLETED|Overall Study||40
374784|NCT00374231|913316|P1|STARTED|Overall Study||40
374785|NCT00374140|913322|P1|NOT COMPLETED|Overall Study||2
374786|NCT00374140|913322|P1|COMPLETED|Overall Study||38
374787|NCT00374140|913322|P1|STARTED|Overall Study||40
374788|NCT00374127|913329|P1|NOT COMPLETED|Overall Study||11
374789|NCT00374127|913329|P1|COMPLETED|Overall Study||24
374790|NCT00374127|913329|P1|STARTED|Overall Study||35
374791|NCT00374088|913365|P2|NOT COMPLETED|Overall Study||1
374792|NCT00374088|913366|P1|NOT COMPLETED|Overall Study||1
374793|NCT00374088|913365|P2|COMPLETED|Overall Study||10
374794|NCT00374088|913366|P1|COMPLETED|Overall Study||9
374795|NCT00374088|913365|P2|STARTED|Overall Study||11
374796|NCT00374088|913366|P1|STARTED|Overall Study||10
374797|NCT00373958|913378|P2|NOT COMPLETED|Toddler Dose||38
374798|NCT00373958|913379|P1|NOT COMPLETED|Toddler Dose||30
374799|NCT00373958|913378|P2|COMPLETED|Toddler Dose||252
374800|NCT00373958|913379|P1|COMPLETED|Toddler Dose||264
374801|NCT00373958|913378|P2|Vaccinated Toddler Dose|Toddler Dose||265
374802|NCT00373958|913379|P1|Vaccinated Toddler Dose|Toddler Dose||272
374803|NCT00373958|913378|P2|Withdrawn After Infant Series|Toddler Dose||25
374804|NCT00373958|913379|P1|Withdrawn After Infant Series|Toddler Dose||22
374805|NCT00373958|913378|P2|STARTED|Toddler Dose||290
374806|NCT00373958|913379|P1|STARTED|Toddler Dose||294
374807|NCT00373958|913378|P2|NOT COMPLETED|Infant Series||42
374808|NCT00373958|913379|P1|NOT COMPLETED|Infant Series||40
374809|NCT00373958|913378|P2|COMPLETED|Infant Series||290
374810|NCT00373958|913379|P1|COMPLETED|Infant Series||294
374811|NCT00373958|913378|P2|Vaccinated Dose 3|Infant Series||300
374812|NCT00373958|913379|P1|Vaccinated Dose 3|Infant Series||298
374813|NCT00373958|913378|P2|Vaccinated Dose 2|Infant Series||305
374814|NCT00373958|913379|P1|Vaccinated Dose 2|Infant Series||309
374815|NCT00373958|913378|P2|Vaccinated Dose 1|Infant Series||331
374816|NCT00373958|913379|P1|Vaccinated Dose 1|Infant Series||332
374817|NCT00373958|913378|P2|STARTED|Infant Series||332
374818|NCT00373958|913379|P1|STARTED|Infant Series|One participant was prerandomized but not consented.|334
374819|NCT00373880|913427|P1|NOT COMPLETED|Overall Study||18
374820|NCT00373880|913427|P1|COMPLETED|Overall Study||8
374821|NCT00373880|913427|P1|STARTED|Overall Study||26
374822|NCT00373698|913457|P2|NOT COMPLETED|Overall Study||0
374823|NCT00373698|913458|P1|NOT COMPLETED|Overall Study||11
374824|NCT00373698|913457|P2|COMPLETED|Overall Study||99
374825|NCT00373698|913458|P1|COMPLETED|Overall Study||85
374826|NCT00373698|913457|P2|STARTED|Overall Study||99
374827|NCT00373698|913458|P1|STARTED|Overall Study||96
374828|NCT00373685|913472|P2|NOT COMPLETED|Overall Study||1421
374829|NCT00373685|913473|P1|NOT COMPLETED|Overall Study||1439
374830|NCT00373685|913472|P2|COMPLETED|Overall Study||2611
374831|NCT00373685|913473|P1|COMPLETED|Overall Study||2596
374832|NCT00373685|913472|P2|Treated|Overall Study||3955
374833|NCT00373685|913473|P1|Treated|Overall Study||3984
374834|NCT00373685|913472|P2|STARTED|Overall Study||4032
374835|NCT00373685|913473|P1|STARTED|Overall Study||4035
374836|NCT00373529|913507|P1|NOT COMPLETED|Overall Study||108
374837|NCT00373529|913507|P1|COMPLETED|Overall Study|Completed: initiated full 6 cycles of treatment. Not Completed: initiated <6 cycles of treatment|8
374838|NCT00373529|913507|P1|Full Analysis Set|Overall Study|3 Failed Independent Confirmation of AML; 1 consent violation|112
374839|NCT00373529|913507|P1|STARTED|Overall Study||116
374840|NCT00373490|913519|P2|NOT COMPLETED|Overall Study||6
374841|NCT00373490|913520|P1|NOT COMPLETED|Overall Study||9
374842|NCT00373490|913519|P2|COMPLETED|Overall Study||0
374843|NCT00373490|913520|P1|COMPLETED|Overall Study||1
374844|NCT00373490|913519|P2|STARTED|Overall Study||6
374845|NCT00373490|913520|P1|STARTED|Overall Study||10
374846|NCT00373425|913543|P5|NOT COMPLETED|Overall Study||72
374847|NCT00373425|913544|P4|NOT COMPLETED|Overall Study||11
374848|NCT00373425|913545|P3|NOT COMPLETED|Overall Study||134
374849|NCT00373425|913546|P2|NOT COMPLETED|Overall Study||153
374850|NCT00373425|913547|P1|NOT COMPLETED|Overall Study||370
374851|NCT00373425|913543|P5|COMPLETED|Overall Study|Completed 2 years of study treatment|60
374852|NCT00373425|913544|P4|COMPLETED|Overall Study|Completed 2 years of study treatment|0
374853|NCT00373425|913545|P3|COMPLETED|Overall Study|Completed 2 years of study treatment|0
374854|NCT00373425|913546|P2|COMPLETED|Overall Study|Completed 2 years of study treatment|197
374855|NCT00373425|913547|P1|COMPLETED|Overall Study|Completed 2 years of study treatment|253
374856|NCT00373425|913543|P5|Received Treatment|Overall Study||132
374857|NCT00373425|913544|P4|Received Treatment|Overall Study||7
374858|NCT00373425|913545|P3|Received Treatment|Overall Study||134
374859|NCT00373425|913546|P2|Received Treatment|Overall Study||342
374860|NCT00373425|913547|P1|Received Treatment|Overall Study||612
374861|NCT00373425|913543|P5|STARTED|Overall Study||132
374862|NCT00373425|913544|P4|STARTED|Overall Study||11
374863|NCT00373425|913545|P3|STARTED|Overall Study||134
374864|NCT00373425|913546|P2|STARTED|Overall Study||350
374865|NCT00373425|913547|P1|STARTED|Overall Study||623
374866|NCT00373399|913572|P6|NOT COMPLETED|Overall Study||0
374867|NCT00373399|913573|P5|NOT COMPLETED|Overall Study||0
374868|NCT00373399|913574|P4|NOT COMPLETED|Overall Study||0
374869|NCT00373399|913575|P3|NOT COMPLETED|Overall Study||0
374870|NCT00373399|913576|P2|NOT COMPLETED|Overall Study||0
374871|NCT00373399|913577|P1|NOT COMPLETED|Overall Study||0
374872|NCT00373399|913572|P6|COMPLETED|Overall Study||7
374873|NCT00373399|913573|P5|COMPLETED|Overall Study||7
374874|NCT00373399|913574|P4|COMPLETED|Overall Study||6
374875|NCT00373399|913575|P3|COMPLETED|Overall Study||4
374876|NCT00373399|913576|P2|COMPLETED|Overall Study||7
374877|NCT00373399|913577|P1|COMPLETED|Overall Study||5
374878|NCT00373399|913572|P6|STARTED|Overall Study||7
374879|NCT00373399|913573|P5|STARTED|Overall Study||7
374880|NCT00373399|913574|P4|STARTED|Overall Study||6
374881|NCT00373399|913575|P3|STARTED|Overall Study||4
374882|NCT00373399|913576|P2|STARTED|Overall Study||7
374883|NCT00373399|913577|P1|STARTED|Overall Study||5
374884|NCT00373386|913585|P1|NOT COMPLETED|Overall Study||0
374885|NCT00373386|913585|P1|COMPLETED|Overall Study||9
374886|NCT00373386|913585|P1|STARTED|Overall Study||9
374887|NCT00373360|913595|P1|NOT COMPLETED|Overall Study||0
374888|NCT00373360|913595|P1|COMPLETED|Overall Study||10
374889|NCT00373360|913595|P1|STARTED|Overall Study||10
374890|NCT00373334|913626|P3|NOT COMPLETED|Overall Study||13
374891|NCT00373334|913627|P2|NOT COMPLETED|Overall Study||18
374892|NCT00373334|913628|P1|NOT COMPLETED|Overall Study||10
374893|NCT00373334|913626|P3|COMPLETED|Overall Study||32
374894|NCT00373334|913627|P2|COMPLETED|Overall Study||32
374895|NCT00373334|913628|P1|COMPLETED|Overall Study||33
374896|NCT00373334|913626|P3|STARTED|Overall Study||45
374897|NCT00373334|913627|P2|STARTED|Overall Study||50
374898|NCT00373334|913628|P1|STARTED|Overall Study||43
374899|NCT00373295|913642|P6|NOT COMPLETED|Intervention 3 (8 Days)||0
374900|NCT00373295|913643|P5|NOT COMPLETED|Intervention 3 (8 Days)||0
374901|NCT00373295|913644|P4|NOT COMPLETED|Intervention 3 (8 Days)||0
374902|NCT00373295|913645|P3|NOT COMPLETED|Intervention 3 (8 Days)||0
374903|NCT00373295|913646|P2|NOT COMPLETED|Intervention 3 (8 Days)||0
374904|NCT00373295|913647|P1|NOT COMPLETED|Intervention 3 (8 Days)||0
374905|NCT00373295|913642|P6|COMPLETED|Intervention 3 (8 Days)||2
374906|NCT00373295|913643|P5|COMPLETED|Intervention 3 (8 Days)||2
374907|NCT00373295|913644|P4|COMPLETED|Intervention 3 (8 Days)||2
374908|NCT00373295|913645|P3|COMPLETED|Intervention 3 (8 Days)||1
374909|NCT00373295|913646|P2|COMPLETED|Intervention 3 (8 Days)||1
374910|NCT00373295|913647|P1|COMPLETED|Intervention 3 (8 Days)||2
374911|NCT00373295|913642|P6|STARTED|Intervention 3 (8 Days)||2
374912|NCT00373295|913643|P5|STARTED|Intervention 3 (8 Days)||2
374913|NCT00373295|913644|P4|STARTED|Intervention 3 (8 Days)||2
374914|NCT00373295|913645|P3|STARTED|Intervention 3 (8 Days)||1
374915|NCT00373295|913646|P2|STARTED|Intervention 3 (8 Days)||1
374916|NCT00373295|913647|P1|STARTED|Intervention 3 (8 Days)||2
374917|NCT00373295|913642|P6|NOT COMPLETED|Intervention 2 (8 Days)||0
374918|NCT00373295|913643|P5|NOT COMPLETED|Intervention 2 (8 Days)||0
374919|NCT00373295|913644|P4|NOT COMPLETED|Intervention 2 (8 Days)||0
374920|NCT00373295|913645|P3|NOT COMPLETED|Intervention 2 (8 Days)||0
374921|NCT00373295|913646|P2|NOT COMPLETED|Intervention 2 (8 Days)||0
374922|NCT00373295|913647|P1|NOT COMPLETED|Intervention 2 (8 Days)||0
374923|NCT00373295|913642|P6|COMPLETED|Intervention 2 (8 Days)||2
374924|NCT00373295|913643|P5|COMPLETED|Intervention 2 (8 Days)||2
374925|NCT00373295|913644|P4|COMPLETED|Intervention 2 (8 Days)||2
374926|NCT00373295|913645|P3|COMPLETED|Intervention 2 (8 Days)||1
374927|NCT00373295|913646|P2|COMPLETED|Intervention 2 (8 Days)||1
374928|NCT00373295|913647|P1|COMPLETED|Intervention 2 (8 Days)||2
374929|NCT00373295|913642|P6|STARTED|Intervention 2 (8 Days)||2
374930|NCT00373295|913643|P5|STARTED|Intervention 2 (8 Days)||2
374931|NCT00373295|913644|P4|STARTED|Intervention 2 (8 Days)||2
374932|NCT00373295|913645|P3|STARTED|Intervention 2 (8 Days)||1
374933|NCT00373295|913646|P2|STARTED|Intervention 2 (8 Days)||1
374934|NCT00373295|913647|P1|STARTED|Intervention 2 (8 Days)||2
374935|NCT00373295|913642|P6|NOT COMPLETED|Intervention 1 (8 Days)||0
374936|NCT00373295|913643|P5|NOT COMPLETED|Intervention 1 (8 Days)||1
374937|NCT00373295|913644|P4|NOT COMPLETED|Intervention 1 (8 Days)||0
374938|NCT00373295|913645|P3|NOT COMPLETED|Intervention 1 (8 Days)||0
374939|NCT00373295|913646|P2|NOT COMPLETED|Intervention 1 (8 Days)||2
374940|NCT00373295|913647|P1|NOT COMPLETED|Intervention 1 (8 Days)||0
374941|NCT00373295|913642|P6|COMPLETED|Intervention 1 (8 Days)||2
374942|NCT00373295|913643|P5|COMPLETED|Intervention 1 (8 Days)||2
374943|NCT00373295|913644|P4|COMPLETED|Intervention 1 (8 Days)||2
374944|NCT00373295|913645|P3|COMPLETED|Intervention 1 (8 Days)||1
374945|NCT00373295|913646|P2|COMPLETED|Intervention 1 (8 Days)||1
374946|NCT00373295|913647|P1|COMPLETED|Intervention 1 (8 Days)||2
374947|NCT00373295|913642|P6|STARTED|Intervention 1 (8 Days)||2
374948|NCT00373295|913643|P5|STARTED|Intervention 1 (8 Days)||3
374949|NCT00373295|913644|P4|STARTED|Intervention 1 (8 Days)||2
374950|NCT00373295|913645|P3|STARTED|Intervention 1 (8 Days)||1
374951|NCT00373295|913646|P2|STARTED|Intervention 1 (8 Days)||3
374952|NCT00373295|913647|P1|STARTED|Intervention 1 (8 Days)||2
374953|NCT00373269|913657|P2|NOT COMPLETED|Overall Study||0
374954|NCT00373269|913658|P1|NOT COMPLETED|Overall Study||0
374955|NCT00373269|913657|P2|COMPLETED|Overall Study||10
374956|NCT00373269|913658|P1|COMPLETED|Overall Study||11
374957|NCT00373269|913657|P2|STARTED|Overall Study||10
374958|NCT00373269|913658|P1|STARTED|Overall Study||11
374959|NCT00373256|913668|P2|NOT COMPLETED|Overall Study||247
374960|NCT00373256|913669|P1|NOT COMPLETED|Overall Study||241
374961|NCT00373256|913668|P2|COMPLETED|Overall Study||0
374962|NCT00373256|913669|P1|COMPLETED|Overall Study||0
374963|NCT00373256|913668|P2|Treated|Overall Study||236
374964|NCT00373256|913669|P1|Treated|Overall Study||235
374965|NCT00373256|913668|P2|STARTED|Overall Study||247
374966|NCT00373256|913669|P1|STARTED|Overall Study||241
374967|NCT00373113|913695|P2|NOT COMPLETED|Overall Study||244
374968|NCT00373113|913696|P1|NOT COMPLETED|Overall Study||238
374969|NCT00373113|913695|P2|COMPLETED|Overall Study||0
374970|NCT00373113|913696|P1|COMPLETED|Overall Study||0
374971|NCT00373113|913695|P2|Received Treatment|Overall Study||240
374972|NCT00373113|913696|P1|Received Treatment|Overall Study||238
374973|NCT00373113|913695|P2|STARTED|Overall Study||244
374974|NCT00373113|913696|P1|STARTED|Overall Study||238
374975|NCT00372996|913718|P4|NOT COMPLETED|Overall Study||20
374976|NCT00372996|913719|P3|NOT COMPLETED|Overall Study||28
374977|NCT00372996|913720|P2|NOT COMPLETED|Overall Study||14
374978|NCT00372996|913721|P1|NOT COMPLETED|Overall Study||37
374979|NCT00372996|913718|P4|COMPLETED|Overall Study||23
374980|NCT00372996|913719|P3|COMPLETED|Overall Study||33
374981|NCT00372996|913720|P2|COMPLETED|Overall Study||22
374982|NCT00372996|913721|P1|COMPLETED|Overall Study||42
374983|NCT00372996|913718|P4|STARTED|Overall Study||43
374984|NCT00372996|913719|P3|STARTED|Overall Study||61
374985|NCT00372996|913720|P2|STARTED|Overall Study||36
374986|NCT00372996|913721|P1|STARTED|Overall Study||79
374987|NCT00372970|913747|P2|NOT COMPLETED|Overall Study||0
374988|NCT00372970|913748|P1|NOT COMPLETED|Overall Study||0
374989|NCT00372970|913747|P2|COMPLETED|Overall Study||16
374990|NCT00372970|913748|P1|COMPLETED|Overall Study||16
374991|NCT00372970|913747|P2|STARTED|Overall Study||16
374992|NCT00372970|913748|P1|STARTED|Overall Study||16
374993|NCT00372957|913757|P3|NOT COMPLETED|Overall Study||0
374994|NCT00372957|913758|P2|NOT COMPLETED|Overall Study||0
374995|NCT00372957|913759|P1|NOT COMPLETED|Overall Study||0
374996|NCT00372957|913757|P3|COMPLETED|Overall Study||10
374997|NCT00372957|913758|P2|COMPLETED|Overall Study||10
374998|NCT00372957|913759|P1|COMPLETED|Overall Study||10
374999|NCT00372957|913757|P3|STARTED|Overall Study||10
375000|NCT00372957|913758|P2|STARTED|Overall Study||10
375001|NCT00372957|913759|P1|STARTED|Overall Study||10
375002|NCT00372905|913806|P4|NOT COMPLETED|Follow up Until Relapse or Progression||3
375003|NCT00372905|913807|P3|NOT COMPLETED|Follow up Until Relapse or Progression||0
375004|NCT00372905|913808|P2|NOT COMPLETED|Follow up Until Relapse or Progression||1
375005|NCT00372905|913809|P1|NOT COMPLETED|Follow up Until Relapse or Progression||0
375006|NCT00372905|913806|P4|COMPLETED|Follow up Until Relapse or Progression||5
375007|NCT00372905|913807|P3|COMPLETED|Follow up Until Relapse or Progression||3
375008|NCT00372905|913808|P2|COMPLETED|Follow up Until Relapse or Progression||2
375009|NCT00372905|913809|P1|COMPLETED|Follow up Until Relapse or Progression||3
375010|NCT00372905|913806|P4|STARTED|Follow up Until Relapse or Progression||8
375011|NCT00372905|913807|P3|STARTED|Follow up Until Relapse or Progression||3
375012|NCT00372905|913808|P2|STARTED|Follow up Until Relapse or Progression||3
375086|NCT00372905|913806|P4|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
375013|NCT00372905|913809|P1|STARTED|Follow up Until Relapse or Progression|All patients that are treated on study move into the follow up phase at the completion of therapy.|3
375014|NCT00372905|913806|P4|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||2
375015|NCT00372905|913807|P3|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
375016|NCT00372905|913808|P2|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
375017|NCT00372905|913809|P1|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
375018|NCT00372905|913806|P4|COMPLETED|Expansion Phase at Dose 1.3mg/m2||6
375019|NCT00372905|913807|P3|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
375020|NCT00372905|913808|P2|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
375021|NCT00372905|913809|P1|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
375022|NCT00372905|913806|P4|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||6
375023|NCT00372905|913807|P3|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
375024|NCT00372905|913808|P2|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
375025|NCT00372905|913809|P1|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
375026|NCT00372905|913806|P4|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||8
375027|NCT00372905|913807|P3|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
375028|NCT00372905|913808|P2|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
375029|NCT00372905|913809|P1|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
375030|NCT00372905|913806|P4|Registration|Expansion Phase at Dose 1.3mg/m2||8
375031|NCT00372905|913807|P3|Registration|Expansion Phase at Dose 1.3mg/m2||0
375032|NCT00372905|913808|P2|Registration|Expansion Phase at Dose 1.3mg/m2||0
375033|NCT00372905|913809|P1|Registration|Expansion Phase at Dose 1.3mg/m2||0
375034|NCT00372905|913806|P4|STARTED|Expansion Phase at Dose 1.3mg/m2||8
375035|NCT00372905|913807|P3|STARTED|Expansion Phase at Dose 1.3mg/m2||0
375036|NCT00372905|913808|P2|STARTED|Expansion Phase at Dose 1.3mg/m2||0
375037|NCT00372905|913809|P1|STARTED|Expansion Phase at Dose 1.3mg/m2||0
375038|NCT00372905|913806|P4|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
375039|NCT00372905|913807|P3|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||3
375040|NCT00372905|913808|P2|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
375041|NCT00372905|913809|P1|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
375042|NCT00372905|913806|P4|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
375043|NCT00372905|913807|P3|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||1
375044|NCT00372905|913808|P2|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
375045|NCT00372905|913809|P1|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
375046|NCT00372905|913806|P4|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
375047|NCT00372905|913807|P3|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||1
375048|NCT00372905|913808|P2|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
375049|NCT00372905|913809|P1|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
375050|NCT00372905|913806|P4|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
375051|NCT00372905|913807|P3|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||3
375052|NCT00372905|913808|P2|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
375053|NCT00372905|913809|P1|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
375054|NCT00372905|913806|P4|Registered|Cohort 3: Dose Level 1.6mg/m2||0
375055|NCT00372905|913807|P3|Registered|Cohort 3: Dose Level 1.6mg/m2||4
375056|NCT00372905|913808|P2|Registered|Cohort 3: Dose Level 1.6mg/m2||0
375057|NCT00372905|913809|P1|Registered|Cohort 3: Dose Level 1.6mg/m2||0
375058|NCT00372905|913806|P4|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
375059|NCT00372905|913807|P3|STARTED|Cohort 3: Dose Level 1.6mg/m2||4
375060|NCT00372905|913808|P2|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
375061|NCT00372905|913809|P1|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
375062|NCT00372905|913806|P4|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
375063|NCT00372905|913807|P3|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
375064|NCT00372905|913808|P2|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
375065|NCT00372905|913809|P1|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
375066|NCT00372905|913806|P4|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
375067|NCT00372905|913807|P3|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
375068|NCT00372905|913808|P2|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||3
375069|NCT00372905|913809|P1|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
375070|NCT00372905|913806|P4|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
375071|NCT00372905|913807|P3|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
375072|NCT00372905|913808|P2|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||3
375073|NCT00372905|913809|P1|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
375074|NCT00372905|913806|P4|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
375075|NCT00372905|913807|P3|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
375076|NCT00372905|913808|P2|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||3
375077|NCT00372905|913809|P1|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
375078|NCT00372905|913806|P4|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
375079|NCT00372905|913807|P3|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
375080|NCT00372905|913808|P2|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||3
375081|NCT00372905|913809|P1|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
375082|NCT00372905|913806|P4|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
375083|NCT00372905|913807|P3|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
375084|NCT00372905|913808|P2|STARTED|Cohort 2: Dose Level 1.3mg/m2||3
375085|NCT00372905|913809|P1|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
375087|NCT00372905|913807|P3|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
375088|NCT00372905|913808|P2|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
375089|NCT00372905|913809|P1|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||2
375090|NCT00372905|913806|P4|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
375091|NCT00372905|913807|P3|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
375092|NCT00372905|913808|P2|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
375093|NCT00372905|913809|P1|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||1
375094|NCT00372905|913806|P4|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
375095|NCT00372905|913807|P3|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
375096|NCT00372905|913808|P2|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
375097|NCT00372905|913809|P1|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||1
375098|NCT00372905|913806|P4|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
375099|NCT00372905|913807|P3|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
375100|NCT00372905|913808|P2|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
375101|NCT00372905|913809|P1|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||3
375102|NCT00372905|913806|P4|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
375103|NCT00372905|913807|P3|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
375104|NCT00372905|913808|P2|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
375105|NCT00372905|913809|P1|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||3
375106|NCT00372905|913806|P4|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
375107|NCT00372905|913807|P3|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
375108|NCT00372905|913808|P2|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
375109|NCT00372905|913809|P1|STARTED|Cohort 1: Dose Level 1.0mg/m2||3
375110|NCT00372775|913821|P1|NOT COMPLETED|Overall Study||63
375111|NCT00372775|913821|P1|COMPLETED|Overall Study||3
375112|NCT00372775|913821|P1|Received Treatment|Overall Study||64
375113|NCT00372775|913821|P1|STARTED|Overall Study||66
375114|NCT00372697|913843|P2|NOT COMPLETED|Overall Study||1
375115|NCT00372697|913844|P1|NOT COMPLETED|Overall Study||1
375116|NCT00372697|913843|P2|COMPLETED|Overall Study||11
375117|NCT00372697|913844|P1|COMPLETED|Overall Study||15
375118|NCT00372697|913843|P2|STARTED|Overall Study||12
375119|NCT00372697|913844|P1|STARTED|Overall Study||16
375120|NCT00372619|913869|P7|NOT COMPLETED|Overall Study||0
375121|NCT00372619|913870|P6|NOT COMPLETED|Overall Study||3
375122|NCT00372619|913871|P5|NOT COMPLETED|Overall Study||0
375123|NCT00372619|913872|P4|NOT COMPLETED|Overall Study||0
375124|NCT00372619|913873|P3|NOT COMPLETED|Overall Study||0
375125|NCT00372619|913874|P2|NOT COMPLETED|Overall Study||0
375126|NCT00372619|913875|P1|NOT COMPLETED|Overall Study||0
375127|NCT00372619|913869|P7|COMPLETED|Overall Study||2
375128|NCT00372619|913870|P6|COMPLETED|Overall Study||39
375129|NCT00372619|913871|P5|COMPLETED|Overall Study||7
375130|NCT00372619|913872|P4|COMPLETED|Overall Study||10
375131|NCT00372619|913873|P3|COMPLETED|Overall Study||3
375132|NCT00372619|913874|P2|COMPLETED|Overall Study||2
375133|NCT00372619|913875|P1|COMPLETED|Overall Study||8
375134|NCT00372619|913869|P7|STARTED|Overall Study||2
375135|NCT00372619|913870|P6|STARTED|Overall Study||42
375136|NCT00372619|913871|P5|STARTED|Overall Study||7
375137|NCT00372619|913872|P4|STARTED|Overall Study||10
375138|NCT00372619|913873|P3|STARTED|Overall Study||3
375139|NCT00372619|913874|P2|STARTED|Overall Study||2
375140|NCT00372619|913875|P1|STARTED|Overall Study||8
375141|NCT00372593|913908|P3|NOT COMPLETED|Overall Study||4
375142|NCT00372593|913909|P2|NOT COMPLETED|Overall Study||198
375143|NCT00372593|913910|P1|NOT COMPLETED|Overall Study||204
375144|NCT00372593|913908|P3|COMPLETED|Overall Study||3
375145|NCT00372593|913909|P2|COMPLETED|Overall Study||334
375146|NCT00372593|913910|P1|COMPLETED|Overall Study||327
375147|NCT00372593|913908|P3|STARTED|Overall Study||7
375148|NCT00372593|913909|P2|STARTED|Overall Study||532
375149|NCT00372593|913910|P1|STARTED|Overall Study||531
375150|NCT00372567|913939|P3|NOT COMPLETED|Phase 3 Study||12
375151|NCT00372567|913940|P2|NOT COMPLETED|Phase 3 Study||26
375152|NCT00372567|913941|P1|NOT COMPLETED|Phase 3 Study||31
375153|NCT00372567|913939|P3|COMPLETED|Phase 3 Study||0
375154|NCT00372567|913940|P2|COMPLETED|Phase 3 Study||0
375155|NCT00372567|913941|P1|COMPLETED|Phase 3 Study||0
375156|NCT00372567|913939|P3|Received Treatment|Phase 3 Study||12
375157|NCT00372567|913940|P2|Received Treatment|Phase 3 Study||25
375158|NCT00372567|913941|P1|Received Treatment|Phase 3 Study||31
375159|NCT00372567|913939|P3|STARTED|Phase 3 Study||12
375160|NCT00372567|913940|P2|STARTED|Phase 3 Study||26
375161|NCT00372567|913941|P1|STARTED|Phase 3 Study||31
375162|NCT00372567|913939|P3|NOT COMPLETED|Phase 1 Sub-study||0
375163|NCT00372567|913940|P2|NOT COMPLETED|Phase 1 Sub-study||0
375164|NCT00372567|913941|P1|NOT COMPLETED|Phase 1 Sub-study||0
375165|NCT00372567|913939|P3|COMPLETED|Phase 1 Sub-study||12
375166|NCT00372567|913940|P2|COMPLETED|Phase 1 Sub-study||0
375167|NCT00372567|913941|P1|COMPLETED|Phase 1 Sub-study||0
375168|NCT00372567|913939|P3|STARTED|Phase 1 Sub-study||12
375169|NCT00372567|913940|P2|STARTED|Phase 1 Sub-study||0
375170|NCT00372567|913941|P1|STARTED|Phase 1 Sub-study||0
375171|NCT00372528|913969|P1|NOT COMPLETED|Overall Study||21
375172|NCT00372528|913969|P1|COMPLETED|Overall Study||0
375173|NCT00372528|913969|P1|STARTED|Overall Study||21
375174|NCT00372489|913974|P1|NOT COMPLETED|Overall Study||79
375175|NCT00372489|913974|P1|COMPLETED|Overall Study||2
375176|NCT00372489|913974|P1|STARTED|Overall Study||81
375177|NCT00372424|913978|P1|NOT COMPLETED|Overall Study||26
375178|NCT00372424|913978|P1|COMPLETED|Overall Study||0
375179|NCT00372424|913978|P1|Treated|Overall Study||25
375180|NCT00372424|913978|P1|STARTED|Overall Study||26
375181|NCT00372411|913992|P3|NOT COMPLETED|Overall Study||3
375182|NCT00372411|913993|P2|NOT COMPLETED|Overall Study||8
375183|NCT00372411|913994|P1|NOT COMPLETED|Overall Study||5
375184|NCT00372411|913992|P3|COMPLETED|Overall Study||25
375185|NCT00372411|913993|P2|COMPLETED|Overall Study||42
375186|NCT00372411|913994|P1|COMPLETED|Overall Study||44
375187|NCT00372411|913992|P3|STARTED|Overall Study||28
375188|NCT00372411|913993|P2|STARTED|Overall Study||50
375189|NCT00372411|913994|P1|STARTED|Overall Study||49
375190|NCT00372385|914018|P4|NOT COMPLETED|Overall Study||8
375191|NCT00372385|914019|P3|NOT COMPLETED|Overall Study||10
375192|NCT00372385|914020|P2|NOT COMPLETED|Overall Study||20
375193|NCT00372385|914021|P1|NOT COMPLETED|Overall Study||33
375194|NCT00372385|914018|P4|COMPLETED|Overall Study||70
375195|NCT00372385|914019|P3|COMPLETED|Overall Study||72
375196|NCT00372385|914020|P2|COMPLETED|Overall Study||61
375197|NCT00372385|914021|P1|COMPLETED|Overall Study||49
375198|NCT00372385|914018|P4|STARTED|Overall Study||78
375199|NCT00372385|914019|P3|STARTED|Overall Study||82
375200|NCT00372385|914020|P2|STARTED|Overall Study||81
375201|NCT00372385|914021|P1|STARTED|Overall Study||82
375202|NCT00372255|914050|P2|NOT COMPLETED|Overall Study||1
375203|NCT00372255|914051|P1|NOT COMPLETED|Overall Study||2
375204|NCT00372255|914050|P2|COMPLETED|Overall Study||113
375205|NCT00372255|914051|P1|COMPLETED|Overall Study||108
375206|NCT00372255|914050|P2|STARTED|Overall Study||114
375207|NCT00372255|914051|P1|STARTED|Overall Study||110
375208|NCT00372190|914073|P2|NOT COMPLETED|Overall Study||1
375209|NCT00372190|914074|P1|NOT COMPLETED|Overall Study||3
375210|NCT00372190|914073|P2|COMPLETED|Overall Study||96
375211|NCT00372190|914074|P1|COMPLETED|Overall Study||90
375212|NCT00372190|914073|P2|STARTED|Overall Study|99 were allocated to conventional arm, however 2 never underwent any surgery|97
375213|NCT00372190|914074|P1|STARTED|Overall Study|95 were allocated to mesh group, however 2 never underwent any surgery|93
375214|NCT00372112|914090|P4|NOT COMPLETED|Overall Study||4
375215|NCT00372112|914091|P3|NOT COMPLETED|Overall Study||4
375216|NCT00372112|914092|P2|NOT COMPLETED|Overall Study||1
375217|NCT00372112|914093|P1|NOT COMPLETED|Overall Study||1
375218|NCT00372112|914090|P4|COMPLETED|Overall Study||14
375219|NCT00372112|914091|P3|COMPLETED|Overall Study||13
375220|NCT00372112|914092|P2|COMPLETED|Overall Study||15
375221|NCT00372112|914093|P1|COMPLETED|Overall Study||16
375222|NCT00372112|914090|P4|STARTED|Overall Study||18
375223|NCT00372112|914091|P3|STARTED|Overall Study||17
375224|NCT00372112|914092|P2|STARTED|Overall Study||16
375225|NCT00372112|914093|P1|STARTED|Overall Study||17
375226|NCT00372060|914224|P2|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||8
375227|NCT00372060|914225|P1|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||14
375228|NCT00372060|914224|P2|COMPLETED|Period II - Open-label (Weeks 12-52)||59
375229|NCT00372060|914225|P1|COMPLETED|Period II - Open-label (Weeks 12-52)||49
375230|NCT00372060|914224|P2|STARTED|Period II - Open-label (Weeks 12-52)||67
375231|NCT00372060|914225|P1|STARTED|Period II - Open-label (Weeks 12-52)||63
375232|NCT00372060|914224|P2|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||1
375233|NCT00372060|914225|P1|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||3
375234|NCT00372060|914224|P2|COMPLETED|Period I - Double-blind (Weeks 0-12)||67
375235|NCT00372060|914225|P1|COMPLETED|Period I - Double-blind (Weeks 0-12)||63
375236|NCT00372060|914224|P2|STARTED|Period I - Double-blind (Weeks 0-12)||68
375237|NCT00372060|914225|P1|STARTED|Period I - Double-blind (Weeks 0-12)|The planned number of enrolled patients was 130. The actual number of enrolled patients was 134.|66
375238|NCT00371865|914240|P2|NOT COMPLETED|Overall Study||14
375239|NCT00371865|914241|P1|NOT COMPLETED|Overall Study||15
375240|NCT00371865|914240|P2|COMPLETED|Overall Study|8 withdrew before starting the intervention. 6 withdrew after starting the intervention.|43
375241|NCT00371865|914241|P1|COMPLETED|Overall Study|7 withdrew before starting the intervention. 8 withdrew after starting the intervention.|42
375242|NCT00371865|914240|P2|STARTED|Overall Study||57
375243|NCT00371865|914241|P1|STARTED|Overall Study||57
375244|NCT00371839|914258|P3|NOT COMPLETED|Overall Study||2
375245|NCT00371839|914259|P2|NOT COMPLETED|Overall Study||7
375246|NCT00371839|914260|P1|NOT COMPLETED|Overall Study||17
375247|NCT00371839|914258|P3|COMPLETED|Overall Study||7
375248|NCT00371839|914259|P2|COMPLETED|Overall Study||13
375249|NCT00371839|914260|P1|COMPLETED|Overall Study||32
375250|NCT00371839|914258|P3|STARTED|Overall Study||9
375251|NCT00371839|914259|P2|STARTED|Overall Study||20
375252|NCT00371839|914260|P1|STARTED|Overall Study||49
375253|NCT00371826|914269|P3|NOT COMPLETED|Extension Phase (24 Months)||2
375254|NCT00371826|914270|P2|NOT COMPLETED|Extension Phase (24 Months)||10
375255|NCT00371826|914271|P1|NOT COMPLETED|Extension Phase (24 Months)||5
375256|NCT00371826|914269|P3|COMPLETED|Extension Phase (24 Months)||3
375257|NCT00371826|914270|P2|COMPLETED|Extension Phase (24 Months)||29
375258|NCT00371826|914271|P1|COMPLETED|Extension Phase (24 Months)||18
375259|NCT00371826|914269|P3|Safety Set|Extension Phase (24 Months)|Patient withdrawn as per DMC suggestion had no efficacy data, but was included in safety set.|5
375260|NCT00371826|914270|P2|Safety Set|Extension Phase (24 Months)|One patient mis-randomised to 1st arm but treated in this arm, evaluated for safety in this arm.|40
375261|NCT00371826|914271|P1|Safety Set|Extension Phase (24 Months)|One patient randomized to this arm, was treated with the control regimen (CNI+MPA+Steroid)|22
375262|NCT00371826|914269|P3|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)|One patient entered extension, was withdrawn (no efficacy data in extension) due to DMC suggestion|4
375263|NCT00371826|914270|P2|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||39
375264|NCT00371826|914271|P1|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||23
375265|NCT00371826|914269|P3|STARTED|Extension Phase (24 Months)|One patient completed core, did not wish to continue to extension.|5
375266|NCT00371826|914270|P2|STARTED|Extension Phase (24 Months)||39
375267|NCT00371826|914271|P1|STARTED|Extension Phase (24 Months)|2 patients who completed 12 month core did not wish to continue in extension.|23
375268|NCT00371826|914269|P3|NOT COMPLETED|Core Phase (12 Months)||24
375269|NCT00371826|914270|P2|NOT COMPLETED|Core Phase (12 Months)||8
375270|NCT00371826|914271|P1|NOT COMPLETED|Core Phase (12 Months)||24
375271|NCT00371826|914269|P3|COMPLETED|Core Phase (12 Months)||6
375272|NCT00371826|914270|P2|COMPLETED|Core Phase (12 Months)||39
375273|NCT00371826|914271|P1|COMPLETED|Core Phase (12 Months)|"Completed means patients were still on study medication by month 12."|25
375274|NCT00371826|914269|P3|Modified Intent to Treat (mITT)|Core Phase (12 Months)||6
375275|NCT00371826|914270|P2|Modified Intent to Treat (mITT)|Core Phase (12 Months)||39
375276|NCT00371826|914271|P1|Modified Intent to Treat (mITT)|Core Phase (12 Months)||27
375277|NCT00371826|914269|P3|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||20
375278|NCT00371826|914270|P2|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||44
375279|NCT00371826|914271|P1|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||46
375280|NCT00371826|914269|P3|STARTED|Core Phase (12 Months)||30
375281|NCT00371826|914270|P2|STARTED|Core Phase (12 Months)||47
375282|NCT00371826|914271|P1|STARTED|Core Phase (12 Months)|"Started indicates patients in Randomized, Intent to treat (ITT) and Safety set."|49
375283|NCT00371787|914395|P2|NOT COMPLETED|Overall Study||1
375284|NCT00371787|914396|P1|NOT COMPLETED|Overall Study||3
375285|NCT00371787|914395|P2|COMPLETED|Overall Study||11
375286|NCT00371787|914396|P1|COMPLETED|Overall Study||23
375287|NCT00371787|914395|P2|STARTED|Overall Study||12
375288|NCT00371787|914396|P1|STARTED|Overall Study||26
375289|NCT00371761|914410|P2|NOT COMPLETED|Overall Study||10
375290|NCT00371761|914411|P1|NOT COMPLETED|Overall Study||8
375291|NCT00371761|914410|P2|COMPLETED|Overall Study||2
375292|NCT00371761|914411|P1|COMPLETED|Overall Study||5
375293|NCT00371761|914410|P2|STARTED|Overall Study||12
375294|NCT00371761|914411|P1|STARTED|Overall Study||13
375295|NCT00371683|914419|P2|NOT COMPLETED|Follow-Up Period - Randomized Patients||72
375296|NCT00371683|914420|P1|NOT COMPLETED|Follow-Up Period - Randomized Patients||61
375297|NCT00371683|914419|P2|COMPLETED|Follow-Up Period - Randomized Patients||1461
375298|NCT00371683|914420|P1|COMPLETED|Follow-Up Period - Randomized Patients||1492
375299|NCT00371683|914419|P2|STARTED|Follow-Up Period - Randomized Patients||1533
375300|NCT00371683|914420|P1|STARTED|Follow-Up Period - Randomized Patients||1553
375301|NCT00371683|914419|P2|NOT COMPLETED|DB Treatment Period-Randomized Patients||107
375302|NCT00371683|914420|P1|NOT COMPLETED|DB Treatment Period-Randomized Patients||90
375303|NCT00371683|914419|P2|COMPLETED|DB Treatment Period-Randomized Patients||1489
375304|NCT00371683|914420|P1|COMPLETED|DB Treatment Period-Randomized Patients||1509
375305|NCT00371683|914419|P2|STARTED|DB Treatment Period-Randomized Patients||1596
375306|NCT00371683|914420|P1|STARTED|DB Treatment Period-Randomized Patients||1599
375307|NCT00371644|914474|P2|NOT COMPLETED|Overall Study||13
375308|NCT00371644|914475|P1|NOT COMPLETED|Overall Study||28
375309|NCT00371644|914474|P2|COMPLETED|Overall Study||44
375310|NCT00371644|914475|P1|COMPLETED|Overall Study||44
375311|NCT00371644|914474|P2|STARTED|Overall Study||57
375312|NCT00371644|914475|P1|STARTED|Overall Study||72
375313|NCT00371631|914481|P1|NOT COMPLETED|Overall Study||0
375314|NCT00371631|914481|P1|COMPLETED|Overall Study||13
375315|NCT00371631|914481|P1|STARTED|Overall Study||13
375316|NCT00371566|914488|P2|NOT COMPLETED|Follow Up Phase||7
375317|NCT00371566|914489|P1|NOT COMPLETED|Follow Up Phase||3
375318|NCT00371566|914488|P2|COMPLETED|Follow Up Phase||58
375319|NCT00371566|914489|P1|COMPLETED|Follow Up Phase||28
375320|NCT00371566|914488|P2|STARTED|Follow Up Phase||65
375321|NCT00371566|914489|P1|STARTED|Follow Up Phase||31
375322|NCT00371566|914488|P2|NOT COMPLETED|Chemoradiation Phase||3
375323|NCT00371566|914489|P1|NOT COMPLETED|Chemoradiation Phase||5
375324|NCT00371566|914488|P2|COMPLETED|Chemoradiation Phase||65
375325|NCT00371566|914489|P1|COMPLETED|Chemoradiation Phase||31
375326|NCT00371566|914488|P2|STARTED|Chemoradiation Phase||68
375327|NCT00371566|914489|P1|STARTED|Chemoradiation Phase||36
375328|NCT00371566|914488|P2|NOT COMPLETED|Treatment Phase||3
375329|NCT00371566|914489|P1|NOT COMPLETED|Treatment Phase||0
375330|NCT00371566|914488|P2|COMPLETED|Treatment Phase|1 screen failure included in the ITT population|68
375331|NCT00371566|914489|P1|COMPLETED|Treatment Phase||36
375332|NCT00371566|914488|P2|STARTED|Treatment Phase||71
375333|NCT00371566|914489|P1|STARTED|Treatment Phase||36
375334|NCT00371540|914561|P2|NOT COMPLETED|Overall Study||9
375335|NCT00371540|914562|P1|NOT COMPLETED|Overall Study||10
375336|NCT00371540|914561|P2|COMPLETED|Overall Study||87
375337|NCT00371540|914562|P1|COMPLETED|Overall Study||102
375338|NCT00371540|914561|P2|STARTED|Overall Study||96
375339|NCT00371540|914562|P1|STARTED|Overall Study||112
375340|NCT00371462|914574|P2|NOT COMPLETED|Overall Study||8
375341|NCT00371462|914575|P1|NOT COMPLETED|Overall Study||8
375342|NCT00371462|914574|P2|COMPLETED|Overall Study||27
375343|NCT00371462|914575|P1|COMPLETED|Overall Study||27
375344|NCT00371462|914574|P2|STARTED|Overall Study||35
375345|NCT00371462|914575|P1|STARTED|Overall Study||35
375346|NCT00371449|914581|P1|NOT COMPLETED|Overall Study||0
375347|NCT00371449|914581|P1|COMPLETED|Overall Study||120
375348|NCT00371449|914581|P1|STARTED|Overall Study||120
375349|NCT00371436|914592|P2|NOT COMPLETED|Overall Study||21
375350|NCT00371436|914593|P1|NOT COMPLETED|Overall Study||34
375351|NCT00371436|914592|P2|COMPLETED|Overall Study||68
375352|NCT00371436|914593|P1|COMPLETED|Overall Study||58
375353|NCT00371436|914592|P2|STARTED|Overall Study||89
375354|NCT00371436|914593|P1|STARTED|Overall Study||92
375355|NCT00371397|914599|P12|NOT COMPLETED|Session 3||0
375356|NCT00371397|914600|P11|NOT COMPLETED|Session 3||0
375357|NCT00371397|914601|P10|NOT COMPLETED|Session 3||0
375358|NCT00371397|914602|P9|NOT COMPLETED|Session 3||0
375359|NCT00371397|914603|P8|NOT COMPLETED|Session 3||0
375360|NCT00371397|914604|P7|NOT COMPLETED|Session 3||0
375361|NCT00371397|914605|P6|NOT COMPLETED|Session 3||0
375362|NCT00371397|914606|P5|NOT COMPLETED|Session 3||0
375363|NCT00371397|914607|P4|NOT COMPLETED|Session 3||0
375364|NCT00371397|914608|P3|NOT COMPLETED|Session 3||0
375365|NCT00371397|914609|P2|NOT COMPLETED|Session 3||0
375366|NCT00371397|914610|P1|NOT COMPLETED|Session 3||0
375367|NCT00371397|914599|P12|COMPLETED|Session 3||2
375368|NCT00371397|914600|P11|COMPLETED|Session 3||4
375369|NCT00371397|914601|P10|COMPLETED|Session 3||5
375370|NCT00371397|914602|P9|COMPLETED|Session 3||6
375371|NCT00371397|914603|P8|COMPLETED|Session 3||4
375372|NCT00371397|914604|P7|COMPLETED|Session 3||4
375373|NCT00371397|914605|P6|COMPLETED|Session 3||4
375374|NCT00371397|914606|P5|COMPLETED|Session 3||3
375375|NCT00371397|914607|P4|COMPLETED|Session 3||2
375376|NCT00371397|914608|P3|COMPLETED|Session 3||5
375377|NCT00371397|914609|P2|COMPLETED|Session 3||7
375378|NCT00371397|914610|P1|COMPLETED|Session 3||4
375379|NCT00371397|914599|P12|STARTED|Session 3||2
375380|NCT00371397|914600|P11|STARTED|Session 3||4
375381|NCT00371397|914601|P10|STARTED|Session 3||5
375382|NCT00371397|914602|P9|STARTED|Session 3||6
375383|NCT00371397|914603|P8|STARTED|Session 3||4
375384|NCT00371397|914604|P7|STARTED|Session 3||4
375385|NCT00371397|914605|P6|STARTED|Session 3||4
375386|NCT00371397|914606|P5|STARTED|Session 3||3
375387|NCT00371397|914607|P4|STARTED|Session 3||2
375388|NCT00371397|914608|P3|STARTED|Session 3||5
375389|NCT00371397|914609|P2|STARTED|Session 3||7
375390|NCT00371397|914610|P1|STARTED|Session 3||4
375391|NCT00371397|914599|P12|NOT COMPLETED|Session 2||0
375392|NCT00371397|914600|P11|NOT COMPLETED|Session 2||0
375393|NCT00371397|914601|P10|NOT COMPLETED|Session 2||0
375394|NCT00371397|914602|P9|NOT COMPLETED|Session 2||0
375395|NCT00371397|914603|P8|NOT COMPLETED|Session 2||0
375396|NCT00371397|914604|P7|NOT COMPLETED|Session 2||0
375397|NCT00371397|914605|P6|NOT COMPLETED|Session 2||0
375398|NCT00371397|914606|P5|NOT COMPLETED|Session 2||0
375399|NCT00371397|914607|P4|NOT COMPLETED|Session 2||0
375400|NCT00371397|914608|P3|NOT COMPLETED|Session 2||0
375401|NCT00371397|914609|P2|NOT COMPLETED|Session 2||0
375402|NCT00371397|914610|P1|NOT COMPLETED|Session 2||0
375403|NCT00371397|914599|P12|COMPLETED|Session 2||2
375404|NCT00371397|914600|P11|COMPLETED|Session 2||4
375405|NCT00371397|914601|P10|COMPLETED|Session 2||5
375406|NCT00371397|914602|P9|COMPLETED|Session 2||6
375407|NCT00371397|914603|P8|COMPLETED|Session 2||4
375408|NCT00371397|914604|P7|COMPLETED|Session 2||4
375409|NCT00371397|914605|P6|COMPLETED|Session 2||4
375410|NCT00371397|914606|P5|COMPLETED|Session 2||3
375411|NCT00371397|914607|P4|COMPLETED|Session 2||2
375412|NCT00371397|914608|P3|COMPLETED|Session 2||5
375413|NCT00371397|914609|P2|COMPLETED|Session 2||7
375414|NCT00371397|914610|P1|COMPLETED|Session 2||4
375415|NCT00371397|914599|P12|STARTED|Session 2||2
375416|NCT00371397|914600|P11|STARTED|Session 2||4
375417|NCT00371397|914601|P10|STARTED|Session 2||5
375418|NCT00371397|914602|P9|STARTED|Session 2||6
375419|NCT00371397|914603|P8|STARTED|Session 2||4
375420|NCT00371397|914604|P7|STARTED|Session 2||4
375421|NCT00371397|914605|P6|STARTED|Session 2||4
375422|NCT00371397|914606|P5|STARTED|Session 2||3
375423|NCT00371397|914607|P4|STARTED|Session 2||2
375424|NCT00371397|914608|P3|STARTED|Session 2||5
375425|NCT00371397|914609|P2|STARTED|Session 2||7
375426|NCT00371397|914610|P1|STARTED|Session 2||4
375427|NCT00371397|914599|P12|NOT COMPLETED|Session 1||0
375428|NCT00371397|914600|P11|NOT COMPLETED|Session 1||0
375429|NCT00371397|914601|P10|NOT COMPLETED|Session 1||0
375430|NCT00371397|914602|P9|NOT COMPLETED|Session 1||0
375431|NCT00371397|914603|P8|NOT COMPLETED|Session 1||1
375432|NCT00371397|914604|P7|NOT COMPLETED|Session 1||0
375433|NCT00371397|914605|P6|NOT COMPLETED|Session 1||0
375434|NCT00371397|914606|P5|NOT COMPLETED|Session 1||0
375435|NCT00371397|914607|P4|NOT COMPLETED|Session 1||0
375436|NCT00371397|914608|P3|NOT COMPLETED|Session 1||0
375437|NCT00371397|914609|P2|NOT COMPLETED|Session 1||0
375438|NCT00371397|914610|P1|NOT COMPLETED|Session 1||1
375439|NCT00371397|914599|P12|COMPLETED|Session 1||2
375440|NCT00371397|914600|P11|COMPLETED|Session 1||4
375441|NCT00371397|914601|P10|COMPLETED|Session 1||5
375442|NCT00371397|914602|P9|COMPLETED|Session 1||6
375443|NCT00371397|914603|P8|COMPLETED|Session 1||4
375444|NCT00371397|914604|P7|COMPLETED|Session 1||4
375445|NCT00371397|914605|P6|COMPLETED|Session 1||4
375446|NCT00371397|914606|P5|COMPLETED|Session 1||3
375447|NCT00371397|914607|P4|COMPLETED|Session 1||2
375448|NCT00371397|914608|P3|COMPLETED|Session 1||5
375449|NCT00371397|914609|P2|COMPLETED|Session 1||7
375450|NCT00371397|914610|P1|COMPLETED|Session 1||4
375451|NCT00371397|914599|P12|STARTED|Session 1||2
375452|NCT00371397|914600|P11|STARTED|Session 1||4
375453|NCT00371397|914601|P10|STARTED|Session 1||5
375454|NCT00371397|914602|P9|STARTED|Session 1||6
375455|NCT00371397|914603|P8|STARTED|Session 1||5
375456|NCT00371397|914604|P7|STARTED|Session 1||4
375457|NCT00371397|914605|P6|STARTED|Session 1||4
375458|NCT00371397|914606|P5|STARTED|Session 1||3
375459|NCT00371397|914607|P4|STARTED|Session 1||2
375460|NCT00371397|914608|P3|STARTED|Session 1||5
375461|NCT00371397|914609|P2|STARTED|Session 1||7
375462|NCT00371397|914610|P1|STARTED|Session 1||5
375463|NCT00371345|914618|P2|NOT COMPLETED|Overall Study||46
375464|NCT00371345|914619|P1|NOT COMPLETED|Overall Study||24
375465|NCT00371345|914618|P2|COMPLETED|Overall Study||0
375466|NCT00371345|914619|P1|COMPLETED|Overall Study||0
375467|NCT00371345|914618|P2|STARTED|Overall Study||46
375468|NCT00371345|914619|P1|STARTED|Overall Study||24
375469|NCT00371293|914679|P3|NOT COMPLETED|Overall Study||16
375470|NCT00371293|914680|P2|NOT COMPLETED|Overall Study||19
375471|NCT00371293|914681|P1|NOT COMPLETED|Overall Study||10
375472|NCT00371293|914679|P3|COMPLETED|Overall Study||46
375473|NCT00371293|914680|P2|COMPLETED|Overall Study||42
375474|NCT00371293|914681|P1|COMPLETED|Overall Study||48
375475|NCT00371293|914679|P3|STARTED|Overall Study||62
375476|NCT00371293|914680|P2|STARTED|Overall Study||61
375477|NCT00371293|914681|P1|STARTED|Overall Study||58
375478|NCT00371267|914703|P2|NOT COMPLETED|Overall Study||18
375479|NCT00371267|914704|P1|NOT COMPLETED|Overall Study||9
375480|NCT00371267|914703|P2|COMPLETED|Overall Study||32
375481|NCT00371267|914704|P1|COMPLETED|Overall Study||39
375482|NCT00371267|914703|P2|STARTED|Overall Study||50
375483|NCT00371267|914704|P1|STARTED|Overall Study||48
375484|NCT00371254|914720|P2|NOT COMPLETED|Overall Study||21
375485|NCT00371254|914721|P1|NOT COMPLETED|Overall Study||23
375486|NCT00371254|914720|P2|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
375487|NCT00371254|914721|P1|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
375488|NCT00371254|914720|P2|STARTED|Overall Study|Number of participants treated|21
375489|NCT00371254|914721|P1|STARTED|Overall Study|Number of participants treated|23
375490|NCT00371176|914773|P2|NOT COMPLETED|Overall Study||8
375491|NCT00371176|914774|P1|NOT COMPLETED|Overall Study||5
375492|NCT00371176|914773|P2|COMPLETED|Overall Study||5
375493|NCT00371176|914774|P1|COMPLETED|Overall Study||8
375494|NCT00371176|914773|P2|Completed Treatment|Overall Study||9
375495|NCT00371176|914774|P1|Completed Treatment|Overall Study||10
375496|NCT00371176|914773|P2|STARTED|Overall Study||13
375497|NCT00371176|914774|P1|STARTED|Overall Study||13
375498|NCT00371150|914804|P2|NOT COMPLETED|Overall Study||2
375499|NCT00371150|914805|P1|NOT COMPLETED|Overall Study||3
375500|NCT00371150|914804|P2|COMPLETED|Overall Study|"Completion of treatment” means received treatment through Week 52"|4
375501|NCT00371150|914805|P1|COMPLETED|Overall Study|"Completion of treatment” means received treatment through Week 52"|37
375502|NCT00371150|914804|P2|Discontinued at or After Week 48 Visit|Overall Study||1
375503|NCT00371150|914805|P1|Discontinued at or After Week 48 Visit|Overall Study||2
375504|NCT00371150|914804|P2|Discontinued Prior to Week 48 Visit|Overall Study||1
375505|NCT00371150|914805|P1|Discontinued Prior to Week 48 Visit|Overall Study||1
375506|NCT00371150|914804|P2|STARTED|Overall Study||6
375507|NCT00371150|914805|P1|STARTED|Overall Study||40
375508|NCT00371137|914840|P3|NOT COMPLETED|Overall Study||79
375509|NCT00371137|914841|P2|NOT COMPLETED|Overall Study||63
375510|NCT00371137|914842|P1|NOT COMPLETED|Overall Study||72
375511|NCT00371137|914840|P3|COMPLETED|Overall Study||104
375512|NCT00371137|914841|P2|COMPLETED|Overall Study||119
375513|NCT00371137|914842|P1|COMPLETED|Overall Study||111
375514|NCT00371137|914840|P3|Treated|Overall Study||182
375515|NCT00371137|914841|P2|Treated|Overall Study||182
375516|NCT00371137|914842|P1|Treated|Overall Study||183
375517|NCT00371137|914840|P3|STARTED|Overall Study||183
375518|NCT00371137|914841|P2|STARTED|Overall Study||182
375519|NCT00371137|914842|P1|STARTED|Overall Study||183
375520|NCT00370994|914852|P2|NOT COMPLETED|Overall Study||0
375521|NCT00370994|914853|P1|NOT COMPLETED|Overall Study||0
375522|NCT00370994|914852|P2|COMPLETED|Overall Study||60
375523|NCT00370994|914853|P1|COMPLETED|Overall Study||60
375524|NCT00370994|914852|P2|STARTED|Overall Study||60
375525|NCT00370994|914853|P1|STARTED|Overall Study|Sample size was 200, due to the difficulties of recruiting we changed to 120|60
375526|NCT00370838|914863|P2|NOT COMPLETED|Taper||0
375527|NCT00370838|914864|P1|NOT COMPLETED|Taper||0
375528|NCT00370838|914863|P2|COMPLETED|Taper||3
375529|NCT00370838|914864|P1|COMPLETED|Taper||7
375530|NCT00370838|914863|P2|STARTED|Taper||3
375531|NCT00370838|914864|P1|STARTED|Taper||7
375532|NCT00370838|914863|P2|NOT COMPLETED|Period 2 (Days 65-107)||0
375533|NCT00370838|914864|P1|NOT COMPLETED|Period 2 (Days 65-107)||0
375534|NCT00370838|914863|P2|COMPLETED|Period 2 (Days 65-107)||3
375535|NCT00370838|914864|P1|COMPLETED|Period 2 (Days 65-107)||7
375536|NCT00370838|914863|P2|STARTED|Period 2 (Days 65-107)||3
375537|NCT00370838|914864|P1|STARTED|Period 2 (Days 65-107)||7
375538|NCT00370838|914863|P2|NOT COMPLETED|Washout (Days 51-64)||0
375539|NCT00370838|914864|P1|NOT COMPLETED|Washout (Days 51-64)||0
375540|NCT00370838|914863|P2|COMPLETED|Washout (Days 51-64)||3
375541|NCT00370838|914864|P1|COMPLETED|Washout (Days 51-64)||7
375542|NCT00370838|914863|P2|STARTED|Washout (Days 51-64)||3
375543|NCT00370838|914864|P1|STARTED|Washout (Days 51-64)||7
375544|NCT00370838|914863|P2|NOT COMPLETED|Period 1 (Days 8-50)||0
375545|NCT00370838|914864|P1|NOT COMPLETED|Period 1 (Days 8-50)||0
375546|NCT00370838|914863|P2|COMPLETED|Period 1 (Days 8-50)||3
375547|NCT00370838|914864|P1|COMPLETED|Period 1 (Days 8-50)||7
375548|NCT00370838|914863|P2|STARTED|Period 1 (Days 8-50)||3
375549|NCT00370838|914864|P1|STARTED|Period 1 (Days 8-50)||7
375550|NCT00370682|914885|P3|NOT COMPLETED|Overall Study||1
375551|NCT00370682|914886|P2|NOT COMPLETED|Overall Study||3
375552|NCT00370682|914887|P1|NOT COMPLETED|Overall Study||0
375553|NCT00370682|914885|P3|COMPLETED|Overall Study||39
375554|NCT00370682|914886|P2|COMPLETED|Overall Study||37
375555|NCT00370682|914887|P1|COMPLETED|Overall Study||40
375556|NCT00370682|914885|P3|STARTED|Overall Study||40
375557|NCT00370682|914886|P2|STARTED|Overall Study||40
375558|NCT00370682|914887|P1|STARTED|Overall Study||40
375559|NCT00370552|914929|P3|NOT COMPLETED|Overall Study||32
375560|NCT00370552|914930|P2|NOT COMPLETED|Overall Study||45
375561|NCT00370552|914931|P1|NOT COMPLETED|Overall Study||46
375562|NCT00370552|914929|P3|COMPLETED|Overall Study||0
375563|NCT00370552|914930|P2|COMPLETED|Overall Study||0
375564|NCT00370552|914931|P1|COMPLETED|Overall Study||0
375565|NCT00370552|914929|P3|STARTED|Overall Study|Randomized|32
375566|NCT00370552|914930|P2|STARTED|Overall Study|Randomized|45
375567|NCT00370552|914931|P1|STARTED|Overall Study|Randomized|46
375568|NCT00370396|914972|P3|NOT COMPLETED|Overall Study||1
375569|NCT00370396|914973|P2|NOT COMPLETED|Overall Study||1
375570|NCT00370396|914974|P1|NOT COMPLETED|Overall Study||11
375571|NCT00370396|914972|P3|COMPLETED|Overall Study||282
375572|NCT00370396|914973|P2|COMPLETED|Overall Study||91
375573|NCT00370396|914974|P1|COMPLETED|Overall Study||726
375574|NCT00370396|914972|P3|STARTED|Overall Study||283
375575|NCT00370396|914973|P2|STARTED|Overall Study||92
375576|NCT00370396|914974|P1|STARTED|Overall Study||737
375577|NCT00370331|915028|P2|NOT COMPLETED|Overall Study||23
375578|NCT00370331|915029|P1|NOT COMPLETED|Overall Study||7
375579|NCT00370331|915028|P2|COMPLETED|Overall Study||112
375580|NCT00370331|915029|P1|COMPLETED|Overall Study||55
375581|NCT00370331|915028|P2|STARTED|Overall Study||135
375582|NCT00370331|915029|P1|STARTED|Overall Study||62
375583|NCT00370292|915055|P1|NOT COMPLETED|Overall Study||13
375584|NCT00370292|915055|P1|COMPLETED|Overall Study||6
375585|NCT00370292|915055|P1|STARTED|Overall Study||19
375586|NCT00370149|915068|P2|NOT COMPLETED|Overall Study||19
375587|NCT00370149|915069|P1|NOT COMPLETED|Overall Study||19
375588|NCT00370149|915068|P2|COMPLETED|Overall Study||142
375589|NCT00370149|915069|P1|COMPLETED|Overall Study||146
375590|NCT00370149|915068|P2|STARTED|Overall Study||161
375591|NCT00370149|915069|P1|STARTED|Overall Study||165
375592|NCT00370071|915079|P1|NOT COMPLETED|Overall Study||2
375593|NCT00370071|915079|P1|COMPLETED|Overall Study||37
375594|NCT00370071|915079|P1|STARTED|Overall Study||39
375595|NCT00370032|915096|P2|NOT COMPLETED|Follow-up Period||0
375596|NCT00370032|915097|P1|NOT COMPLETED|Follow-up Period||1
375597|NCT00370032|915096|P2|COMPLETED|Follow-up Period||22
375598|NCT00370032|915097|P1|COMPLETED|Follow-up Period||22
375599|NCT00370032|915096|P2|STARTED|Follow-up Period||22
375600|NCT00370032|915097|P1|STARTED|Follow-up Period||23
375601|NCT00370032|915096|P2|NOT COMPLETED|Treatment Period 2||0
375602|NCT00370032|915097|P1|NOT COMPLETED|Treatment Period 2||0
375603|NCT00370032|915096|P2|COMPLETED|Treatment Period 2||22
375604|NCT00370032|915097|P1|COMPLETED|Treatment Period 2||23
375605|NCT00370032|915096|P2|STARTED|Treatment Period 2||22
375606|NCT00370032|915097|P1|STARTED|Treatment Period 2||23
375607|NCT00370032|915096|P2|NOT COMPLETED|Washout Period||2
375608|NCT00370032|915097|P1|NOT COMPLETED|Washout Period||1
375609|NCT00370032|915096|P2|COMPLETED|Washout Period||22
375610|NCT00370032|915097|P1|COMPLETED|Washout Period||23
375611|NCT00370032|915096|P2|STARTED|Washout Period||24
375612|NCT00370032|915097|P1|STARTED|Washout Period||24
375613|NCT00370032|915096|P2|NOT COMPLETED|Treatment Period 1||1
375614|NCT00370032|915097|P1|NOT COMPLETED|Treatment Period 1||0
375615|NCT00370032|915096|P2|COMPLETED|Treatment Period 1||24
375616|NCT00370032|915097|P1|COMPLETED|Treatment Period 1||24
375617|NCT00370032|915096|P2|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|25
375618|NCT00370032|915097|P1|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|24
375619|NCT00369967|915117|P2|NOT COMPLETED|Overall Study||12
375620|NCT00369967|915118|P1|NOT COMPLETED|Overall Study||23
375621|NCT00369967|915117|P2|COMPLETED|Overall Study||5
375622|NCT00369967|915118|P1|COMPLETED|Overall Study||8
375623|NCT00369967|915117|P2|STARTED|Overall Study||17
375624|NCT00369967|915118|P1|STARTED|Overall Study||31
375625|NCT00369941|915136|P2|NOT COMPLETED|Overall Study||100
375626|NCT00369941|915137|P1|NOT COMPLETED|Overall Study||72
375627|NCT00369941|915136|P2|COMPLETED|Overall Study||184
375628|NCT00369941|915137|P1|COMPLETED|Overall Study||210
375629|NCT00369941|915136|P2|Treated|Overall Study||282
375630|NCT00369941|915137|P1|Treated|Overall Study||281
375631|NCT00369941|915136|P2|STARTED|Overall Study||284
375632|NCT00369941|915137|P1|STARTED|Overall Study||282
375633|NCT00369928|915290|P3|NOT COMPLETED|Overall Study||20
375634|NCT00369928|915291|P2|NOT COMPLETED|Overall Study||16
375635|NCT00369928|915292|P1|NOT COMPLETED|Overall Study||8
375636|NCT00369928|915290|P3|COMPLETED|Overall Study||66
375637|NCT00369928|915291|P2|COMPLETED|Overall Study||69
375638|NCT00369928|915292|P1|COMPLETED|Overall Study||77
375639|NCT00369928|915290|P3|STARTED|Overall Study||86
375640|NCT00369928|915291|P2|STARTED|Overall Study||85
375641|NCT00369928|915292|P1|STARTED|Overall Study||85
375642|NCT00369915|915302|P2|NOT COMPLETED|Overall Study||3
375643|NCT00369915|915303|P1|NOT COMPLETED|Overall Study||6
375644|NCT00369915|915302|P2|COMPLETED|Overall Study||4
375645|NCT00369915|915303|P1|COMPLETED|Overall Study||4
375646|NCT00369915|915302|P2|STARTED|Overall Study||7
375647|NCT00369915|915303|P1|STARTED|Overall Study||10
375648|NCT00369824|915317|P6|NOT COMPLETED|Overall Study||11
375649|NCT00369824|915318|P5|NOT COMPLETED|Overall Study||18
375650|NCT00369824|915319|P4|NOT COMPLETED|Overall Study||15
375651|NCT00369824|915320|P3|NOT COMPLETED|Overall Study||12
375652|NCT00369824|915321|P2|NOT COMPLETED|Overall Study||19
375653|NCT00369824|915322|P1|NOT COMPLETED|Overall Study||15
375654|NCT00369824|915317|P6|COMPLETED|Overall Study||204
375655|NCT00369824|915318|P5|COMPLETED|Overall Study||196
375656|NCT00369824|915319|P4|COMPLETED|Overall Study||199
375657|NCT00369824|915320|P3|COMPLETED|Overall Study||202
375658|NCT00369824|915321|P2|COMPLETED|Overall Study||195
375659|NCT00369824|915322|P1|COMPLETED|Overall Study||197
375660|NCT00369824|915317|P6|STARTED|Overall Study||215
375661|NCT00369824|915318|P5|STARTED|Overall Study||214
375662|NCT00369824|915319|P4|STARTED|Overall Study||214
375663|NCT00369824|915320|P3|STARTED|Overall Study||214
375664|NCT00369824|915321|P2|STARTED|Overall Study||214
375665|NCT00369824|915322|P1|STARTED|Overall Study||212
375666|NCT00369785|915422|P2|NOT COMPLETED|Overall Study||25
375667|NCT00369785|915423|P1|NOT COMPLETED|Overall Study||27
375668|NCT00369785|915422|P2|COMPLETED|Overall Study||74
375669|NCT00369785|915423|P1|COMPLETED|Overall Study||72
375670|NCT00369785|915422|P2|STARTED|Overall Study||99
375671|NCT00369785|915423|P1|STARTED|Overall Study||99
375672|NCT00369746|915433|P2|NOT COMPLETED|Overall Study||0
375673|NCT00369746|915434|P1|NOT COMPLETED|Overall Study||0
375674|NCT00369746|915433|P2|COMPLETED|Overall Study||536
375675|NCT00369746|915434|P1|COMPLETED|Overall Study||138
375676|NCT00369746|915433|P2|STARTED|Overall Study||536
375677|NCT00369746|915434|P1|STARTED|Overall Study||138
375678|NCT00369707|915444|P1|NOT COMPLETED|Follow up for 2 Years After Treatment||3
375679|NCT00369707|915444|P1|COMPLETED|Follow up for 2 Years After Treatment||38
375680|NCT00369707|915444|P1|STARTED|Follow up for 2 Years After Treatment||41
375681|NCT00369707|915444|P1|NOT COMPLETED|Maintenance Period (up to 4 Cycles)||8
375682|NCT00369707|915444|P1|COMPLETED|Maintenance Period (up to 4 Cycles)||27
375683|NCT00369707|915444|P1|STARTED|Maintenance Period (up to 4 Cycles)||35
375684|NCT00369707|915444|P1|NOT COMPLETED|Induction Part B (2 Cycles)||7
375685|NCT00369707|915444|P1|COMPLETED|Induction Part B (2 Cycles)||35
375686|NCT00369707|915444|P1|STARTED|Induction Part B (2 Cycles)||42
375687|NCT00369707|915444|P1|NOT COMPLETED|Induction Part A (1 Cycle -35 Days)||0
375688|NCT00369707|915444|P1|COMPLETED|Induction Part A (1 Cycle -35 Days)||42
375689|NCT00369707|915444|P1|STARTED|Induction Part A (1 Cycle -35 Days)||42
375690|NCT00369681|915457|P1|NOT COMPLETED|Overall Study||1
375691|NCT00369681|915457|P1|COMPLETED|Overall Study||49
375692|NCT00369681|915457|P1|STARTED|Overall Study||50
375693|NCT00369668|915467|P3|NOT COMPLETED|Overall Study||7
375694|NCT00369668|915468|P2|NOT COMPLETED|Overall Study||5
375695|NCT00369668|915469|P1|NOT COMPLETED|Overall Study||4
375696|NCT00369668|915467|P3|COMPLETED|Overall Study||3
375697|NCT00369668|915468|P2|COMPLETED|Overall Study||5
375698|NCT00369668|915469|P1|COMPLETED|Overall Study||6
375699|NCT00369668|915467|P3|STARTED|Overall Study||10
375700|NCT00369668|915468|P2|STARTED|Overall Study||10
375701|NCT00369668|915469|P1|STARTED|Overall Study|Original number of participants to be recruited for each group.|10
375702|NCT00369655|915483|P1|NOT COMPLETED|Overall Study||2
375703|NCT00369655|915483|P1|COMPLETED|Overall Study||19
375704|NCT00369655|915483|P1|STARTED|Overall Study||21
375705|NCT00369629|915492|P4|NOT COMPLETED|Follow up for 1 Year||0
375706|NCT00369629|915493|P3|NOT COMPLETED|Follow up for 1 Year||3
375707|NCT00369629|915494|P2|NOT COMPLETED|Follow up for 1 Year||2
375708|NCT00369629|915495|P1|NOT COMPLETED|Follow up for 1 Year||2
375709|NCT00369629|915492|P4|COMPLETED|Follow up for 1 Year||0
375710|NCT00369629|915493|P3|COMPLETED|Follow up for 1 Year||2
375711|NCT00369629|915494|P2|COMPLETED|Follow up for 1 Year||1
375712|NCT00369629|915495|P1|COMPLETED|Follow up for 1 Year||4
375713|NCT00369629|915492|P4|STARTED|Follow up for 1 Year||0
375714|NCT00369629|915493|P3|STARTED|Follow up for 1 Year||5
375715|NCT00369629|915494|P2|STARTED|Follow up for 1 Year||3
375716|NCT00369629|915495|P1|STARTED|Follow up for 1 Year|All patients treated on study go into the follow up period|6
375717|NCT00369629|915492|P4|NOT COMPLETED|Completed 4 More Cycles||0
375718|NCT00369629|915493|P3|NOT COMPLETED|Completed 4 More Cycles||2
375719|NCT00369629|915494|P2|NOT COMPLETED|Completed 4 More Cycles||2
375720|NCT00369629|915495|P1|NOT COMPLETED|Completed 4 More Cycles||4
375721|NCT00369629|915492|P4|COMPLETED|Completed 4 More Cycles||0
375722|NCT00369629|915493|P3|COMPLETED|Completed 4 More Cycles||0
375723|NCT00369629|915494|P2|COMPLETED|Completed 4 More Cycles||0
375724|NCT00369629|915495|P1|COMPLETED|Completed 4 More Cycles||0
375725|NCT00369629|915492|P4|STARTED|Completed 4 More Cycles||0
375726|NCT00369629|915493|P3|STARTED|Completed 4 More Cycles||2
375727|NCT00369629|915494|P2|STARTED|Completed 4 More Cycles||2
375728|NCT00369629|915495|P1|STARTED|Completed 4 More Cycles||4
375729|NCT00369629|915492|P4|NOT COMPLETED|Moved on to 4 More Cycles||0
375730|NCT00369629|915493|P3|NOT COMPLETED|Moved on to 4 More Cycles||1
375731|NCT00369629|915494|P2|NOT COMPLETED|Moved on to 4 More Cycles||0
375732|NCT00369629|915495|P1|NOT COMPLETED|Moved on to 4 More Cycles||0
375733|NCT00369629|915492|P4|COMPLETED|Moved on to 4 More Cycles||0
375734|NCT00369629|915493|P3|COMPLETED|Moved on to 4 More Cycles||2
375735|NCT00369629|915494|P2|COMPLETED|Moved on to 4 More Cycles||2
375736|NCT00369629|915495|P1|COMPLETED|Moved on to 4 More Cycles||4
375737|NCT00369629|915492|P4|STARTED|Moved on to 4 More Cycles||0
375738|NCT00369629|915493|P3|STARTED|Moved on to 4 More Cycles||3
375739|NCT00369629|915494|P2|STARTED|Moved on to 4 More Cycles||2
375740|NCT00369629|915495|P1|STARTED|Moved on to 4 More Cycles||4
375741|NCT00369629|915492|P4|NOT COMPLETED|Treated 2 Cycles/Reached First Response||0
375742|NCT00369629|915493|P3|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2
375743|NCT00369629|915494|P2|NOT COMPLETED|Treated 2 Cycles/Reached First Response||1
375744|NCT00369629|915495|P1|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2
375745|NCT00369629|915492|P4|COMPLETED|Treated 2 Cycles/Reached First Response||0
375746|NCT00369629|915493|P3|COMPLETED|Treated 2 Cycles/Reached First Response||3
375747|NCT00369629|915494|P2|COMPLETED|Treated 2 Cycles/Reached First Response||2
375748|NCT00369629|915495|P1|COMPLETED|Treated 2 Cycles/Reached First Response||4
375749|NCT00369629|915492|P4|STARTED|Treated 2 Cycles/Reached First Response|No patients were enrolled at this dose level as the study closed early due to lack of funding.|0
375750|NCT00369629|915493|P3|STARTED|Treated 2 Cycles/Reached First Response||5
375751|NCT00369629|915494|P2|STARTED|Treated 2 Cycles/Reached First Response||3
375752|NCT00369629|915495|P1|STARTED|Treated 2 Cycles/Reached First Response||6
375753|NCT00369590|915507|P2|NOT COMPLETED|Overall Study||0
375754|NCT00369590|915508|P1|NOT COMPLETED|Overall Study||0
375755|NCT00369590|915507|P2|COMPLETED|Overall Study||42
375756|NCT00369590|915508|P1|COMPLETED|Overall Study||16
375757|NCT00369590|915507|P2|STARTED|Overall Study||42
375758|NCT00369590|915508|P1|STARTED|Overall Study||16
375759|NCT00369577|915526|P3|NOT COMPLETED|Overall Study||1
375760|NCT00369577|915527|P2|NOT COMPLETED|Overall Study||0
375761|NCT00369577|915528|P1|NOT COMPLETED|Overall Study||0
375762|NCT00369577|915526|P3|COMPLETED|Overall Study||40
375763|NCT00369577|915527|P2|COMPLETED|Overall Study||45
375764|NCT00369577|915528|P1|COMPLETED|Overall Study||43
375765|NCT00369577|915526|P3|STARTED|Overall Study||41
375766|NCT00369577|915527|P2|STARTED|Overall Study||45
375767|NCT00369577|915528|P1|STARTED|Overall Study||43
375768|NCT00369564|915547|P2|NOT COMPLETED|Overall Study||23
375769|NCT00369564|915548|P1|NOT COMPLETED|Overall Study||43
375770|NCT00369564|915547|P2|COMPLETED|Overall Study||100
375771|NCT00369564|915548|P1|COMPLETED|Overall Study||84
375772|NCT00369564|915547|P2|STARTED|Overall Study||123
375773|NCT00369564|915548|P1|STARTED|Overall Study||127
375774|NCT00369512|915554|P1|NOT COMPLETED|Overall Study||0
375775|NCT00369512|915554|P1|COMPLETED|Overall Study||15
375776|NCT00369512|915554|P1|STARTED|Overall Study||15
375777|NCT00369486|915565|P5|NOT COMPLETED|34-Week Visit||3
375778|NCT00369486|915566|P4|NOT COMPLETED|34-Week Visit||3
375779|NCT00369486|915567|P3|NOT COMPLETED|34-Week Visit||1
375780|NCT00369486|915568|P2|NOT COMPLETED|34-Week Visit||1
375781|NCT00369486|915569|P1|NOT COMPLETED|34-Week Visit||0
375782|NCT00369486|915565|P5|COMPLETED|34-Week Visit|Number of eyes|22
375783|NCT00369486|915566|P4|COMPLETED|34-Week Visit|Number of eyes|19
375784|NCT00369486|915567|P3|COMPLETED|34-Week Visit|Number of eyes|22
375785|NCT00369486|915568|P2|COMPLETED|34-Week Visit|Number of eyes|20
375786|NCT00369486|915569|P1|COMPLETED|34-Week Visit|Number of eyes|38
375787|NCT00369486|915565|P5|STARTED|34-Week Visit|Number of eyes that|25
375788|NCT00369486|915566|P4|STARTED|34-Week Visit|Number of eyes|22
375789|NCT00369486|915567|P3|STARTED|34-Week Visit|Number of eyes|23
375790|NCT00369486|915568|P2|STARTED|34-Week Visit|Number of eyes|21
375791|NCT00369486|915569|P1|STARTED|34-Week Visit|Number of eyes|38
375792|NCT00369486|915565|P5|NOT COMPLETED|17-Week Visit||1
375793|NCT00369486|915566|P4|NOT COMPLETED|17-Week Visit||1
375794|NCT00369486|915567|P3|NOT COMPLETED|17-Week Visit||1
375795|NCT00369486|915568|P2|NOT COMPLETED|17-Week Visit||0
375796|NCT00369486|915569|P1|NOT COMPLETED|17-Week Visit||0
375797|NCT00369486|915565|P5|COMPLETED|17-Week Visit|Number of eyes|24
375798|NCT00369486|915566|P4|COMPLETED|17-Week Visit|Number of eyes|21
375799|NCT00369486|915567|P3|COMPLETED|17-Week Visit|Number of eyes|22
375800|NCT00369486|915568|P2|COMPLETED|17-Week Visit|Number of eyes|21
375801|NCT00369486|915569|P1|COMPLETED|17-Week Visit|Number of eyes|38
375802|NCT00369486|915565|P5|STARTED|17-Week Visit|Number of eyes|25
375803|NCT00369486|915566|P4|STARTED|17-Week Visit|Number of eyes|22
375804|NCT00369486|915567|P3|STARTED|17-Week Visit|Number of eyes|23
375805|NCT00369486|915568|P2|STARTED|17-Week Visit|Number of eyes|21
375806|NCT00369486|915569|P1|STARTED|17-Week Visit|Number of eyes|38
375807|NCT00369486|915565|P5|NOT COMPLETED|8-Week Visit||1
375808|NCT00369486|915566|P4|NOT COMPLETED|8-Week Visit||1
375809|NCT00369486|915567|P3|NOT COMPLETED|8-Week Visit||0
375810|NCT00369486|915568|P2|NOT COMPLETED|8-Week Visit||1
375811|NCT00369486|915569|P1|NOT COMPLETED|8-Week Visit||0
375812|NCT00369486|915565|P5|COMPLETED|8-Week Visit|Number of eyes|24
375813|NCT00369486|915566|P4|COMPLETED|8-Week Visit|Number of eyes|21
375814|NCT00369486|915567|P3|COMPLETED|8-Week Visit|Number of eyes|22
375815|NCT00369486|915568|P2|COMPLETED|8-Week Visit|Number of eyes|20
375816|NCT00369486|915569|P1|COMPLETED|8-Week Visit|Number of eyes|38
375817|NCT00369486|915565|P5|STARTED|8-Week Visit|Number of eyes|25
375818|NCT00369486|915566|P4|STARTED|8-Week Visit|Number of eyes|22
375819|NCT00369486|915567|P3|STARTED|8-Week Visit|Number of eyes|22
375820|NCT00369486|915568|P2|STARTED|8-Week Visit|Number of eyes|21
375821|NCT00369486|915569|P1|STARTED|8-Week Visit|Number of eyes|38
375822|NCT00369486|915565|P5|NOT COMPLETED|4-Week Visit||1
375823|NCT00369486|915566|P4|NOT COMPLETED|4-Week Visit||2
375824|NCT00369486|915567|P3|NOT COMPLETED|4-Week Visit||1
375825|NCT00369486|915568|P2|NOT COMPLETED|4-Week Visit||2
375826|NCT00369486|915569|P1|NOT COMPLETED|4-Week Visit||2
375827|NCT00369486|915565|P5|COMPLETED|4-Week Visit|Number of eyes|24
375828|NCT00369486|915566|P4|COMPLETED|4-Week Visit|Number of eyes|20
375829|NCT00369486|915567|P3|COMPLETED|4-Week Visit|Number of eyes|22
375830|NCT00369486|915568|P2|COMPLETED|4-Week Visit|Number of eyes;|19
375831|NCT00369486|915569|P1|COMPLETED|4-Week Visit|Number of eyes|36
375832|NCT00369486|915565|P5|STARTED|4-Week Visit|Number of eyes|25
375833|NCT00369486|915566|P4|STARTED|4-Week Visit|Number of eyes|22
375834|NCT00369486|915567|P3|STARTED|4-Week Visit|Number of eyes|23
375835|NCT00369486|915568|P2|STARTED|4-Week Visit|Number of eyes|21
375836|NCT00369486|915569|P1|STARTED|4-Week Visit|Number of eyes|38
375837|NCT00369382|915608|P2|NOT COMPLETED|Overall Study||3
375838|NCT00369382|915609|P1|NOT COMPLETED|Overall Study||10
375839|NCT00369382|915608|P2|COMPLETED|Overall Study||54
375840|NCT00369382|915609|P1|COMPLETED|Overall Study||49
375841|NCT00369382|915608|P2|Completed Assigned Treatment Regimen|Overall Study||33
375842|NCT00369382|915609|P1|Completed Assigned Treatment Regimen|Overall Study||48
375843|NCT00369382|915608|P2|Received Treatment|Overall Study||57
375844|NCT00369382|915609|P1|Received Treatment|Overall Study||57
375845|NCT00369382|915608|P2|STARTED|Overall Study||57
375846|NCT00369382|915609|P1|STARTED|Overall Study||59
375847|NCT00369343|915642|P2|NOT COMPLETED|Open-label Phase||30
375848|NCT00369343|915643|P1|NOT COMPLETED|Open-label Phase||57
375849|NCT00369343|915642|P2|COMPLETED|Open-label Phase||79
375850|NCT00369343|915643|P1|COMPLETED|Open-label Phase||155
375851|NCT00369343|915642|P2|STARTED|Open-label Phase||109
375852|NCT00369343|915643|P1|STARTED|Open-label Phase||212
375853|NCT00369343|915642|P2|NOT COMPLETED|Double-blind Phase||16
375854|NCT00369343|915643|P1|NOT COMPLETED|Double-blind Phase||44
375855|NCT00369343|915642|P2|COMPLETED|Double-blind Phase||109
375856|NCT00369343|915643|P1|COMPLETED|Double-blind Phase||212
375857|NCT00369343|915642|P2|STARTED|Double-blind Phase||125
375858|NCT00369343|915643|P1|STARTED|Double-blind Phase||256
375859|NCT00369317|915676|P1|NOT COMPLETED|Overall Study||20
375860|NCT00369317|915676|P1|COMPLETED|Overall Study||185
375861|NCT00369317|915676|P1|STARTED|Overall Study||205
375862|NCT00369278|915692|P2|NOT COMPLETED|Overall Study||21
375863|NCT00369278|915693|P1|NOT COMPLETED|Overall Study||24
375864|NCT00369278|915692|P2|COMPLETED|Overall Study||44
375865|NCT00369278|915693|P1|COMPLETED|Overall Study||39
375866|NCT00369278|915692|P2|STARTED|Overall Study||65
375867|NCT00369278|915693|P1|STARTED|Overall Study||63
375868|NCT00369265|915709|P2|NOT COMPLETED|Overall Study||7
375869|NCT00369265|915710|P1|NOT COMPLETED|Overall Study||4
375870|NCT00369265|915709|P2|COMPLETED|Overall Study||0
375871|NCT00369265|915710|P1|COMPLETED|Overall Study||0
375872|NCT00369265|915709|P2|STARTED|Overall Study||7
375873|NCT00369265|915710|P1|STARTED|Overall Study||4
375874|NCT00369226|915718|P2|NOT COMPLETED|Phase II (45 Days)||0
375875|NCT00369226|915719|P1|NOT COMPLETED|Phase II (45 Days)||0
375876|NCT00369226|915718|P2|COMPLETED|Phase II (45 Days)|This includes 10 patients treated at candidate MTD in Phase I.|32
375877|NCT00369226|915719|P1|COMPLETED|Phase II (45 Days)||0
375878|NCT00369226|915718|P2|STARTED|Phase II (45 Days)||32
375879|NCT00369226|915719|P1|STARTED|Phase II (45 Days)||0
375880|NCT00369226|915718|P2|NOT COMPLETED|Phase I (45 Days)||0
375881|NCT00369226|915719|P1|NOT COMPLETED|Phase I (45 Days)||0
375882|NCT00369226|915718|P2|COMPLETED|Phase I (45 Days)||0
375883|NCT00369226|915719|P1|COMPLETED|Phase I (45 Days)|Once MTD established, additional 10 patients were accrued at MTD to better estimate toxicity.|13
375884|NCT00369226|915718|P2|STARTED|Phase I (45 Days)||0
375885|NCT00369226|915719|P1|STARTED|Phase I (45 Days)||13
375886|NCT00369161|915731|P2|NOT COMPLETED|Overall Study||24
375887|NCT00369161|915732|P1|NOT COMPLETED|Overall Study||27
375888|NCT00369161|915731|P2|COMPLETED|Overall Study||95
375889|NCT00369161|915732|P1|COMPLETED|Overall Study||82
375890|NCT00369161|915731|P2|Intention to Treat (ITT)|Overall Study||117
375891|NCT00369161|915732|P1|Intention to Treat (ITT)|Overall Study||107
375892|NCT00369161|915731|P2|STARTED|Overall Study||119
375893|NCT00369161|915732|P1|STARTED|Overall Study|"Started indicates randomized and safety population."|109
375894|NCT00369122|915742|P1|NOT COMPLETED|Overall Study||11
375895|NCT00369122|915742|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|49
375896|NCT00369122|915742|P1|STARTED|Overall Study||60
375897|NCT00368992|915749|P1|NOT COMPLETED|Overall Study||110
375898|NCT00368992|915749|P1|COMPLETED|Overall Study||0
375899|NCT00368992|915749|P1|STARTED|Overall Study||110
375900|NCT00368979|915758|P2|NOT COMPLETED|Overall Study||30
375901|NCT00368979|915759|P1|NOT COMPLETED|Overall Study||25
375902|NCT00368979|915758|P2|COMPLETED|Overall Study||163
375903|NCT00368979|915759|P1|COMPLETED|Overall Study||160
375904|NCT00368979|915758|P2|STARTED|Overall Study||193
375905|NCT00368979|915759|P1|STARTED|Overall Study||185
375906|NCT00368966|915775|P2|NOT COMPLETED|Toddler Dose||3
375907|NCT00368966|915776|P1|NOT COMPLETED|Toddler Dose||1
375908|NCT00368966|915775|P2|COMPLETED|Toddler Dose||286
375909|NCT00368966|915776|P1|COMPLETED|Toddler Dose||292
375910|NCT00368966|915775|P2|STARTED|Toddler Dose||289
375911|NCT00368966|915776|P1|STARTED|Toddler Dose||293
375912|NCT00368966|915775|P2|NOT COMPLETED|After Infant||5
375913|NCT00368966|915776|P1|NOT COMPLETED|After Infant||6
375914|NCT00368966|915775|P2|COMPLETED|After Infant||289
375915|NCT00368966|915776|P1|COMPLETED|After Infant||293
375916|NCT00368966|915775|P2|STARTED|After Infant||294
375917|NCT00368966|915776|P1|STARTED|After Infant||299
375918|NCT00368966|915775|P2|NOT COMPLETED|Infant Series||10
375919|NCT00368966|915776|P1|NOT COMPLETED|Infant Series||16
375920|NCT00368966|915775|P2|COMPLETED|Infant Series||294
375921|NCT00368966|915776|P1|COMPLETED|Infant Series||299
375922|NCT00368966|915775|P2|Vaccinated Dose 3|Infant Series|1 randomized but incorrectly given 13vPnC|296
375923|NCT00368966|915776|P1|Vaccinated Dose 3|Infant Series||301
375924|NCT00368966|915775|P2|Vaccinated Dose 2|Infant Series||298
375925|NCT00368966|915776|P1|Vaccinated Dose 2|Infant Series|1 randomized but incorrectly given 7vPnC|307
375926|NCT00368966|915775|P2|Vaccinated Dose 1|Infant Series|1 randomized to 7vPnC but given 13vPnC vaccine; 1 was withdrawn before receiving 7vPnC vaccine|302
375927|NCT00368966|915776|P1|Vaccinated Dose 1|Infant Series||314
375928|NCT00368966|915775|P2|STARTED|Infant Series||304
375929|NCT00368966|915776|P1|STARTED|Infant Series||315
375930|NCT00368940|915832|P2|NOT COMPLETED|Completed 12-wk Treatment||5
375931|NCT00368940|915833|P1|NOT COMPLETED|Completed 12-wk Treatment||6
375932|NCT00368940|915832|P2|COMPLETED|Completed 12-wk Treatment||32
375933|NCT00368940|915833|P1|COMPLETED|Completed 12-wk Treatment||31
375934|NCT00368940|915832|P2|STARTED|Completed 12-wk Treatment||37
375935|NCT00368940|915833|P1|STARTED|Completed 12-wk Treatment||37
375936|NCT00368940|915832|P2|NOT COMPLETED|Intention-to-Treat||0
375937|NCT00368940|915833|P1|NOT COMPLETED|Intention-to-Treat||0
375938|NCT00368940|915832|P2|COMPLETED|Intention-to-Treat||37
375939|NCT00368940|915833|P1|COMPLETED|Intention-to-Treat||37
375940|NCT00368940|915832|P2|STARTED|Intention-to-Treat||37
375941|NCT00368940|915833|P1|STARTED|Intention-to-Treat||37
375942|NCT00368927|915847|P2|NOT COMPLETED|Overall Study||3
375943|NCT00368927|915848|P1|NOT COMPLETED|Overall Study||5
375944|NCT00368927|915847|P2|COMPLETED|Overall Study||27
375945|NCT00368927|915848|P1|COMPLETED|Overall Study||26
375946|NCT00368927|915847|P2|STARTED|Overall Study||30
375947|NCT00368927|915848|P1|STARTED|Overall Study||31
375948|NCT00368875|915856|P2|NOT COMPLETED|Overall Study||48
375949|NCT00368875|915857|P1|NOT COMPLETED|Overall Study||6
375950|NCT00368875|915856|P2|COMPLETED|Overall Study||0
375951|NCT00368875|915857|P1|COMPLETED|Overall Study||0
375952|NCT00368875|915856|P2|STARTED|Overall Study||48
375953|NCT00368875|915857|P1|STARTED|Overall Study||6
375954|NCT00368849|915865|P2|NOT COMPLETED|Overall Study||2
375955|NCT00368849|915866|P1|NOT COMPLETED|Overall Study||0
375956|NCT00368849|915865|P2|COMPLETED|Overall Study||8
375957|NCT00368849|915866|P1|COMPLETED|Overall Study||10
375958|NCT00368849|915865|P2|STARTED|Overall Study||10
375959|NCT00368849|915866|P1|STARTED|Overall Study||10
375960|NCT00368745|915882|P2|NOT COMPLETED|Double-blind Treatment Period||31
375961|NCT00368745|915883|P1|NOT COMPLETED|Double-blind Treatment Period||26
375962|NCT00368745|915882|P2|COMPLETED|Double-blind Treatment Period||19
375963|NCT00368745|915883|P1|COMPLETED|Double-blind Treatment Period||30
375964|NCT00368745|915882|P2|STARTED|Double-blind Treatment Period||50
375965|NCT00368745|915883|P1|STARTED|Double-blind Treatment Period||56
375966|NCT00368745|915882|P2|NOT COMPLETED|Randomized to Double-blind Treatment||1
375967|NCT00368745|915883|P1|NOT COMPLETED|Randomized to Double-blind Treatment||1
375968|NCT00368745|915882|P2|COMPLETED|Randomized to Double-blind Treatment|One subject did not want to participate in study.|50
375969|NCT00368745|915883|P1|COMPLETED|Randomized to Double-blind Treatment|One subject did not return following randomization; study drug not dispensed.|56
375970|NCT00368745|915882|P2|STARTED|Randomized to Double-blind Treatment||51
375971|NCT00368745|915883|P1|STARTED|Randomized to Double-blind Treatment||57
375972|NCT00368654|915917|P4|NOT COMPLETED|Overall Study||3
375973|NCT00368654|915918|P3|NOT COMPLETED|Overall Study||3
375974|NCT00368654|915919|P2|NOT COMPLETED|Overall Study||3
375975|NCT00368654|915920|P1|NOT COMPLETED|Overall Study||3
375976|NCT00368654|915917|P4|COMPLETED|Overall Study||0
375977|NCT00368654|915918|P3|COMPLETED|Overall Study||0
375978|NCT00368654|915919|P2|COMPLETED|Overall Study||0
375979|NCT00368654|915920|P1|COMPLETED|Overall Study||0
375980|NCT00368654|915917|P4|STARTED|Overall Study||3
375981|NCT00368654|915918|P3|STARTED|Overall Study||3
375982|NCT00368654|915919|P2|STARTED|Overall Study||3
375983|NCT00368654|915920|P1|STARTED|Overall Study||3
375984|NCT00368641|915936|P2|NOT COMPLETED|Overall Study||6
375985|NCT00368641|915937|P1|NOT COMPLETED|Overall Study||6
375986|NCT00368641|915936|P2|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
375987|NCT00368641|915937|P1|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
375988|NCT00368641|915936|P2|STARTED|Overall Study||6
375989|NCT00368641|915937|P1|STARTED|Overall Study||6
375990|NCT00368550|915945|P2|NOT COMPLETED|Overall Study||23
375991|NCT00368550|915946|P1|NOT COMPLETED|Overall Study||28
375992|NCT00368550|915945|P2|COMPLETED|Overall Study||48
375993|NCT00368550|915946|P1|COMPLETED|Overall Study||35
375994|NCT00368550|915945|P2|STARTED|Overall Study||71
375995|NCT00368550|915946|P1|STARTED|Overall Study||63
375996|NCT00368537|915958|P2|NOT COMPLETED|Baseline Participants||24
375997|NCT00368537|915959|P1|NOT COMPLETED|Baseline Participants||24
375998|NCT00368537|915958|P2|COMPLETED|Baseline Participants||239
375999|NCT00368537|915959|P1|COMPLETED|Baseline Participants||244
376000|NCT00368537|915958|P2|STARTED|Baseline Participants||263
376001|NCT00368537|915959|P1|STARTED|Baseline Participants||268
376002|NCT00368537|915958|P2|NOT COMPLETED|Randomization||6
376003|NCT00368537|915959|P1|NOT COMPLETED|Randomization||13
376004|NCT00368537|915958|P2|COMPLETED|Randomization||263
376005|NCT00368537|915959|P1|COMPLETED|Randomization||268
376006|NCT00368537|915958|P2|STARTED|Randomization||269
376007|NCT00368537|915959|P1|STARTED|Randomization||281
376008|NCT00368472|915973|P1|NOT COMPLETED|Overall Study||105
376009|NCT00368472|915973|P1|COMPLETED|Overall Study||33
376010|NCT00368472|915973|P1|STARTED|Overall Study||138
376011|NCT00368459|915981|P2|NOT COMPLETED|Overall Study||1
376012|NCT00368459|915982|P1|NOT COMPLETED|Overall Study||2
376013|NCT00368459|915981|P2|COMPLETED|Overall Study||20
376014|NCT00368459|915982|P1|COMPLETED|Overall Study||19
376015|NCT00368459|915981|P2|STARTED|Overall Study||21
376016|NCT00368459|915982|P1|STARTED|Overall Study||21
376017|NCT00368316|916008|P2|NOT COMPLETED|Overall Study||46
376018|NCT00368316|916009|P1|NOT COMPLETED|Overall Study||42
376019|NCT00368316|916008|P2|COMPLETED|Overall Study||1319
376020|NCT00368316|916009|P1|COMPLETED|Overall Study||1392
376021|NCT00368316|916008|P2|STARTED|Overall Study||1365
376022|NCT00368316|916009|P1|STARTED|Overall Study||1434
376023|NCT00368290|916021|P2|NOT COMPLETED|Overall Study||10
376024|NCT00368290|916022|P1|NOT COMPLETED|Overall Study||13
376025|NCT00368290|916021|P2|COMPLETED|Overall Study||37
376026|NCT00368290|916022|P1|COMPLETED|Overall Study||34
376027|NCT00368290|916021|P2|STARTED|Overall Study||47
376028|NCT00368290|916022|P1|STARTED|Overall Study||47
376029|NCT00368277|916032|P2|NOT COMPLETED|Overall Study||108
376030|NCT00368277|916033|P1|NOT COMPLETED|Overall Study||113
376031|NCT00368277|916032|P2|COMPLETED|Overall Study||336
376032|NCT00368277|916033|P1|COMPLETED|Overall Study||344
376033|NCT00368277|916032|P2|STARTED|Overall Study||444
376034|NCT00368277|916033|P1|STARTED|Overall Study||457
376035|NCT00368251|916048|P3|NOT COMPLETED|Overall Study||1
376036|NCT00368251|916049|P2|NOT COMPLETED|Overall Study||0
376037|NCT00368251|916050|P1|NOT COMPLETED|Overall Study||1
376038|NCT00368251|916048|P3|COMPLETED|Overall Study||17
376039|NCT00368251|916049|P2|COMPLETED|Overall Study||20
376040|NCT00368251|916050|P1|COMPLETED|Overall Study||17
376041|NCT00368251|916048|P3|STARTED|Overall Study||18
376042|NCT00368251|916049|P2|STARTED|Overall Study||20
376043|NCT00368251|916050|P1|STARTED|Overall Study||18
376044|NCT00368108|916073|P3|NOT COMPLETED|Overall Study||68
376045|NCT00368108|916074|P2|NOT COMPLETED|Overall Study||53
376046|NCT00368108|916075|P1|NOT COMPLETED|Overall Study||64
376047|NCT00368108|916073|P3|COMPLETED|Overall Study||182
376048|NCT00368108|916074|P2|COMPLETED|Overall Study||198
376049|NCT00368108|916075|P1|COMPLETED|Overall Study||187
376050|NCT00368108|916073|P3|STARTED|Overall Study||250
376051|NCT00368108|916074|P2|STARTED|Overall Study||251
376052|NCT00368108|916075|P1|STARTED|Overall Study|One subject had stopped medication prior to notifying staff. Remaining results will have 250.|251
376053|NCT00368069|916094|P2|NOT COMPLETED|Overall Study||7
376054|NCT00368069|916095|P1|NOT COMPLETED|Overall Study||8
376055|NCT00368069|916094|P2|COMPLETED|Overall Study||72
376056|NCT00368069|916095|P1|COMPLETED|Overall Study||71
376057|NCT00368069|916094|P2|STARTED|Overall Study||79
376058|NCT00368069|916095|P1|STARTED|Overall Study||79
376059|NCT00367991|916113|P2|NOT COMPLETED|Overall Study||2
376060|NCT00367991|916114|P1|NOT COMPLETED|Overall Study||2
376061|NCT00367991|916113|P2|COMPLETED|Overall Study||13
376062|NCT00367991|916114|P1|COMPLETED|Overall Study||27
376063|NCT00367991|916113|P2|STARTED|Overall Study||15
376064|NCT00367991|916114|P1|STARTED|Overall Study||29
376065|NCT00367835|916132|P2|NOT COMPLETED|Overall Study||31
376066|NCT00367835|916133|P1|NOT COMPLETED|Overall Study||29
376067|NCT00367835|916132|P2|COMPLETED|Overall Study||48
376068|NCT00367835|916133|P1|COMPLETED|Overall Study||109
376069|NCT00367835|916132|P2|STARTED|Overall Study||79
376070|NCT00367835|916133|P1|STARTED|Overall Study||138
376071|NCT00367770|916159|P1|NOT COMPLETED|Overall Study||2
376072|NCT00367770|916159|P1|COMPLETED|Overall Study||35
376073|NCT00367770|916159|P1|STARTED|Overall Study||37
376074|NCT00367744|916167|P2|NOT COMPLETED|Overall Study||5
376075|NCT00367744|916168|P1|NOT COMPLETED|Overall Study||4
376076|NCT00367744|916167|P2|COMPLETED|Overall Study||32
376077|NCT00367744|916168|P1|COMPLETED|Overall Study||30
376078|NCT00367744|916167|P2|STARTED|Overall Study||37
376079|NCT00367744|916168|P1|STARTED|Overall Study||34
376080|NCT00367679|916176|P1|NOT COMPLETED|Overall Study||0
376081|NCT00367679|916176|P1|COMPLETED|Overall Study||35
376082|NCT00367679|916176|P1|STARTED|Overall Study||35
376083|NCT00367640|916197|P4|NOT COMPLETED|Overall Study||10
376084|NCT00367640|916198|P3|NOT COMPLETED|Overall Study||19
376085|NCT00367640|916199|P2|NOT COMPLETED|Overall Study||22
376086|NCT00367640|916200|P1|NOT COMPLETED|Overall Study||18
376087|NCT00367640|916197|P4|COMPLETED|Overall Study||146
376088|NCT00367640|916198|P3|COMPLETED|Overall Study||141
376089|NCT00367640|916199|P2|COMPLETED|Overall Study||133
376090|NCT00367640|916200|P1|COMPLETED|Overall Study||139
376091|NCT00367640|916197|P4|STARTED|Overall Study||156
376092|NCT00367640|916198|P3|STARTED|Overall Study||160
376093|NCT00367640|916199|P2|STARTED|Overall Study||155
376094|NCT00367640|916200|P1|STARTED|Overall Study||157
376095|NCT00367601|916210|P1|NOT COMPLETED|Overall Study||0
376096|NCT00367601|916210|P1|COMPLETED|Overall Study||25
376097|NCT00367601|916210|P1|STARTED|Overall Study||25
376098|NCT00367484|916216|P1|NOT COMPLETED|Overall Study||17
376099|NCT00367484|916216|P1|COMPLETED|Overall Study|Safety population = 460 Intent To Treat (ITT) population = 458|443
376100|NCT00367484|916216|P1|STARTED|Overall Study||460
376101|NCT00367432|916220|P2|NOT COMPLETED|Second Period (up to 54 Months)||16
376102|NCT00367432|916221|P1|NOT COMPLETED|Second Period (up to 54 Months)||87
376103|NCT00367432|916220|P2|COMPLETED|Second Period (up to 54 Months)||69
376104|NCT00367432|916221|P1|COMPLETED|Second Period (up to 54 Months)||188
376105|NCT00367432|916220|P2|STARTED|Second Period (up to 54 Months)|85 subjects from N01020 [NCT00160615] entered Second Period of N01222|85
376106|NCT00367432|916221|P1|STARTED|Second Period (up to 54 Months)|275 subjects from N01221 [NCT00280696] completed First Period and entered Second Period of N01222|275
376107|NCT00367432|916220|P2|NOT COMPLETED|First Period (16 Weeks)||0
376108|NCT00367432|916221|P1|NOT COMPLETED|First Period (16 Weeks)||38
376109|NCT00367432|916220|P2|COMPLETED|First Period (16 Weeks)||0
376110|NCT00367432|916221|P1|COMPLETED|First Period (16 Weeks)||275
376111|NCT00367432|916220|P2|STARTED|First Period (16 Weeks)||0
376112|NCT00367432|916221|P1|STARTED|First Period (16 Weeks)|Eligible subjects from preceding study N01221 [NCT00280696] entered the First Period of N01222|313
376113|NCT00367380|916236|P3|NOT COMPLETED|Overall Study||0
376114|NCT00367380|916237|P2|NOT COMPLETED|Overall Study||0
376115|NCT00367380|916238|P1|NOT COMPLETED|Overall Study||0
376116|NCT00367380|916236|P3|COMPLETED|Overall Study||6
376117|NCT00367380|916237|P2|COMPLETED|Overall Study||6
376118|NCT00367380|916238|P1|COMPLETED|Overall Study||6
376119|NCT00367380|916236|P3|STARTED|Overall Study||6
376120|NCT00367380|916237|P2|STARTED|Overall Study||6
376121|NCT00367380|916238|P1|STARTED|Overall Study||6
376122|NCT00367341|916248|P2|NOT COMPLETED|Overall Study||0
376123|NCT00367341|916249|P1|NOT COMPLETED|Overall Study||2
376124|NCT00367341|916248|P2|COMPLETED|Overall Study||40
376125|NCT00367341|916249|P1|COMPLETED|Overall Study||40
376126|NCT00367341|916248|P2|STARTED|Overall Study||40
376127|NCT00367341|916249|P1|STARTED|Overall Study||42
376128|NCT00367237|916259|P2|NOT COMPLETED|Overall Study||11
376129|NCT00367237|916260|P1|NOT COMPLETED|Overall Study||10
376130|NCT00367237|916259|P2|COMPLETED|Overall Study||47
376131|NCT00367237|916260|P1|COMPLETED|Overall Study||47
376132|NCT00367237|916259|P2|STARTED|Overall Study|Number of subjects randomized|58
376133|NCT00367237|916260|P1|STARTED|Overall Study|Number of subjects randomized|57
376134|NCT00367133|916269|P3|NOT COMPLETED|3 Years||18
376135|NCT00367133|916270|P2|NOT COMPLETED|3 Years||23
376136|NCT00367133|916271|P1|NOT COMPLETED|3 Years||28
376137|NCT00367133|916269|P3|COMPLETED|3 Years||98
376138|NCT00367133|916270|P2|COMPLETED|3 Years||93
376139|NCT00367133|916271|P1|COMPLETED|3 Years||115
376140|NCT00367133|916269|P3|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
376141|NCT00367133|916270|P2|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
376142|NCT00367133|916271|P1|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|143
376143|NCT00367133|916269|P3|NOT COMPLETED|2 Years||49
376144|NCT00367133|916270|P2|NOT COMPLETED|2 Years||36
376145|NCT00367133|916271|P1|NOT COMPLETED|2 Years||58
376146|NCT00367133|916269|P3|COMPLETED|2 Years||205
376147|NCT00367133|916270|P2|COMPLETED|2 Years||220
376148|NCT00367133|916271|P1|COMPLETED|2 Years||272
376149|NCT00367133|916269|P3|STARTED|2 Years|Number of Eyes|254
376150|NCT00367133|916270|P2|STARTED|2 Years|Number of Eyes|256
376151|NCT00367133|916271|P1|STARTED|2 Years|Number of Eyes|330
376152|NCT00367055|916323|P2|NOT COMPLETED|Overall Study||11
376153|NCT00367055|916324|P1|NOT COMPLETED|Overall Study||11
376154|NCT00367055|916323|P2|COMPLETED|Overall Study||30
376155|NCT00367055|916324|P1|COMPLETED|Overall Study||32
376156|NCT00367055|916323|P2|STARTED|Overall Study||41
376157|NCT00367055|916324|P1|STARTED|Overall Study||43
376158|NCT00366899|916340|P2|NOT COMPLETED|Toddler Dose||1
376159|NCT00366899|916341|P1|NOT COMPLETED|Toddler Dose||2
376160|NCT00366899|916340|P2|COMPLETED|Toddler Dose||281
376161|NCT00366899|916341|P1|COMPLETED|Toddler Dose||285
376162|NCT00366899|916340|P2|STARTED|Toddler Dose||282
376163|NCT00366899|916341|P1|STARTED|Toddler Dose||287
376164|NCT00366899|916340|P2|NOT COMPLETED|After Infant Series||9
376165|NCT00366899|916341|P1|NOT COMPLETED|After Infant Series||7
376166|NCT00366899|916340|P2|COMPLETED|After Infant Series||282
376167|NCT00366899|916341|P1|COMPLETED|After Infant Series||287
376168|NCT00366899|916340|P2|STARTED|After Infant Series||291
376169|NCT00366899|916341|P1|STARTED|After Infant Series||294
376170|NCT00366899|916340|P2|NOT COMPLETED|Infant Series||12
376171|NCT00366899|916341|P1|NOT COMPLETED|Infant Series||9
376172|NCT00366899|916340|P2|COMPLETED|Infant Series||291
376173|NCT00366899|916341|P1|COMPLETED|Infant Series||294
376174|NCT00366899|916340|P2|Vaccinated Dose 2|Infant Series||293
376175|NCT00366899|916341|P1|Vaccinated Dose 2|Infant Series|1 participant randomized to 13vPnC, incorrectly received 7vPnC|296
376176|NCT00366899|916340|P2|Vaccinated Dose 1|Infant Series||302
376177|NCT00366899|916341|P1|Vaccinated Dose 1|Infant Series|2 participants randomized to 13vPnC, incorrectly received 7vPnC|302
376178|NCT00366899|916340|P2|STARTED|Infant Series|1 participant randomized to 7vPnC but never vaccinated|303
376179|NCT00366899|916341|P1|STARTED|Infant Series|1 participant was counted twice, 1 participant randomized to 13vPnC, incorrectly received 7vPnC|303
376180|NCT00366678|916401|P3|NOT COMPLETED|Toddler Dose||0
376181|NCT00366678|916402|P2|NOT COMPLETED|Toddler Dose||1
376182|NCT00366678|916403|P1|NOT COMPLETED|Toddler Dose||5
376183|NCT00366678|916401|P3|COMPLETED|Toddler Dose||137
376184|NCT00366678|916402|P2|COMPLETED|Toddler Dose||151
376185|NCT00366678|916403|P1|COMPLETED|Toddler Dose||268
376186|NCT00366678|916401|P3|STARTED|Toddler Dose||137
376187|NCT00366678|916402|P2|STARTED|Toddler Dose||152
376188|NCT00366678|916403|P1|STARTED|Toddler Dose||273
376189|NCT00366678|916401|P3|NOT COMPLETED|After Infant||0
376190|NCT00366678|916402|P2|NOT COMPLETED|After Infant||10
376191|NCT00366678|916403|P1|NOT COMPLETED|After Infant||17
376192|NCT00366678|916401|P3|COMPLETED|After Infant||0
376193|NCT00366678|916402|P2|COMPLETED|After Infant||289
376194|NCT00366678|916403|P1|COMPLETED|After Infant||273
376195|NCT00366678|916401|P3|STARTED|After Infant||0
376196|NCT00366678|916402|P2|STARTED|After Infant||299
376197|NCT00366678|916403|P1|STARTED|After Infant||290
376198|NCT00366678|916401|P3|NOT COMPLETED|Infant Series||0
376199|NCT00366678|916402|P2|NOT COMPLETED|Infant Series||10
376200|NCT00366678|916403|P1|NOT COMPLETED|Infant Series||14
376201|NCT00366678|916401|P3|COMPLETED|Infant Series||0
376202|NCT00366678|916402|P2|COMPLETED|Infant Series||299
376203|NCT00366678|916403|P1|COMPLETED|Infant Series||290
376204|NCT00366678|916401|P3|Vaccinated Dose 3|Infant Series||0
376205|NCT00366678|916402|P2|Vaccinated Dose 3|Infant Series||302
376206|NCT00366678|916403|P1|Vaccinated Dose 3|Infant Series||291
376207|NCT00366678|916401|P3|Vaccinated Dose 2|Infant Series||0
376208|NCT00366678|916402|P2|Vaccinated Dose 2|Infant Series||304
376209|NCT00366678|916403|P1|Vaccinated Dose 2|Infant Series||295
376210|NCT00366678|916401|P3|Vaccinated Dose 1|Infant Series||0
376211|NCT00366678|916402|P2|Vaccinated Dose 1|Infant Series||309
376212|NCT00366678|916403|P1|Vaccinated Dose 1|Infant Series||302
376213|NCT00366678|916401|P3|STARTED|Infant Series||0
376214|NCT00366678|916402|P2|STARTED|Infant Series||309
376215|NCT00366678|916403|P1|STARTED|Infant Series||304
376216|NCT00366626|916470|P2|NOT COMPLETED|Overall Study||0
376217|NCT00366626|916471|P1|NOT COMPLETED|Overall Study||0
376218|NCT00366626|916470|P2|COMPLETED|Overall Study||45
376219|NCT00366626|916471|P1|COMPLETED|Overall Study||38
376220|NCT00366626|916470|P2|STARTED|Overall Study||45
376221|NCT00366626|916471|P1|STARTED|Overall Study||38
376222|NCT00366548|916485|P2|NOT COMPLETED|Toddler Dose||0
376223|NCT00366548|916486|P1|NOT COMPLETED|Toddler Dose||0
376224|NCT00366548|916485|P2|COMPLETED|Toddler Dose||244
376225|NCT00366548|916486|P1|COMPLETED|Toddler Dose||240
376226|NCT00366548|916485|P2|STARTED|Toddler Dose||244
376227|NCT00366548|916486|P1|STARTED|Toddler Dose||240
376228|NCT00366548|916485|P2|NOT COMPLETED|After Infant Series||1
376229|NCT00366548|916486|P1|NOT COMPLETED|After Infant Series||6
376230|NCT00366548|916485|P2|COMPLETED|After Infant Series||244
376231|NCT00366548|916486|P1|COMPLETED|After Infant Series||240
376232|NCT00366548|916485|P2|STARTED|After Infant Series||245
376233|NCT00366548|916486|P1|STARTED|After Infant Series||246
376234|NCT00366548|916485|P2|NOT COMPLETED|Infant Series||5
376235|NCT00366548|916486|P1|NOT COMPLETED|Infant Series||4
376236|NCT00366548|916485|P2|COMPLETED|Infant Series||245
376237|NCT00366548|916486|P1|COMPLETED|Infant Series||246
376238|NCT00366548|916485|P2|Vaccinated Dose 3|Infant Series||247
376239|NCT00366548|916486|P1|Vaccinated Dose 3|Infant Series||246
376240|NCT00366548|916485|P2|Vaccinated Dose 2|Infant Series||249
376241|NCT00366548|916486|P1|Vaccinated Dose 2|Infant Series||246
376242|NCT00366548|916485|P2|Vaccinated Dose 1|Infant Series||250
376243|NCT00366548|916486|P1|Vaccinated Dose 1|Infant Series||250
376244|NCT00366548|916485|P2|STARTED|Infant Series||250
376245|NCT00366548|916486|P1|STARTED|Infant Series||250
376246|NCT00366535|916522|P2|NOT COMPLETED|Second Phase: 12 Weeks||3
376247|NCT00366535|916523|P1|NOT COMPLETED|Second Phase: 12 Weeks||3
376248|NCT00366535|916522|P2|COMPLETED|Second Phase: 12 Weeks||18
376249|NCT00366535|916523|P1|COMPLETED|Second Phase: 12 Weeks||21
376250|NCT00366535|916522|P2|STARTED|Second Phase: 12 Weeks||21
376251|NCT00366535|916523|P1|STARTED|Second Phase: 12 Weeks||24
376252|NCT00366535|916522|P2|NOT COMPLETED|Washout Period (at Least a Week)||0
376253|NCT00366535|916523|P1|NOT COMPLETED|Washout Period (at Least a Week)||0
376254|NCT00366535|916522|P2|COMPLETED|Washout Period (at Least a Week)||21
376255|NCT00366535|916523|P1|COMPLETED|Washout Period (at Least a Week)||24
376256|NCT00366535|916522|P2|STARTED|Washout Period (at Least a Week)||21
376257|NCT00366535|916523|P1|STARTED|Washout Period (at Least a Week)||24
376258|NCT00366535|916522|P2|NOT COMPLETED|First Phase: 12 Weeks||8
376259|NCT00366535|916523|P1|NOT COMPLETED|First Phase: 12 Weeks||3
376260|NCT00366535|916522|P2|COMPLETED|First Phase: 12 Weeks||21
376261|NCT00366535|916523|P1|COMPLETED|First Phase: 12 Weeks||24
376262|NCT00366535|916522|P2|STARTED|First Phase: 12 Weeks||29
376263|NCT00366535|916523|P1|STARTED|First Phase: 12 Weeks||27
376264|NCT00366457|916537|P1|NOT COMPLETED|Overall Study||2
376265|NCT00366457|916537|P1|COMPLETED|Overall Study||30
376266|NCT00366457|916537|P1|STARTED|Overall Study||32
376267|NCT00366444|916546|P2|NOT COMPLETED|Overall Study||2
376268|NCT00366444|916547|P1|NOT COMPLETED|Overall Study||1
376269|NCT00366444|916546|P2|COMPLETED|Overall Study||97
376270|NCT00366444|916547|P1|COMPLETED|Overall Study||101
376271|NCT00366444|916546|P2|STARTED|Overall Study||99
376272|NCT00366444|916547|P1|STARTED|Overall Study||102
376273|NCT00366340|916575|P2|NOT COMPLETED|Toddler Dose||1
376274|NCT00366340|916576|P1|NOT COMPLETED|Toddler Dose||1
376275|NCT00366340|916575|P2|COMPLETED|Toddler Dose||286
376276|NCT00366340|916576|P1|COMPLETED|Toddler Dose||289
376277|NCT00366340|916575|P2|STARTED|Toddler Dose||287
376278|NCT00366340|916576|P1|STARTED|Toddler Dose||290
376279|NCT00366340|916575|P2|NOT COMPLETED|After the Infant Series||6
376280|NCT00366340|916576|P1|NOT COMPLETED|After the Infant Series||3
376281|NCT00366340|916575|P2|COMPLETED|After the Infant Series||287
376282|NCT00366340|916576|P1|COMPLETED|After the Infant Series||290
376283|NCT00366340|916575|P2|STARTED|After the Infant Series||293
376284|NCT00366340|916576|P1|STARTED|After the Infant Series||293
376285|NCT00366340|916575|P2|NOT COMPLETED|Infant Series||10
376286|NCT00366340|916576|P1|NOT COMPLETED|Infant Series||8
376287|NCT00366340|916575|P2|COMPLETED|Infant Series||293
376288|NCT00366340|916576|P1|COMPLETED|Infant Series||293
376289|NCT00366340|916575|P2|Vaccinated Dose 3|Infant Series||293
376290|NCT00366340|916576|P1|Vaccinated Dose 3|Infant Series||294
376291|NCT00366340|916575|P2|Vaccinated Dose 2|Infant Series||297
376292|NCT00366340|916576|P1|Vaccinated Dose 2|Infant Series||296
376293|NCT00366340|916575|P2|Vaccinated Dose 1|Infant Series||303
376294|NCT00366340|916576|P1|Vaccinated Dose 1|Infant Series||300
376295|NCT00366340|916575|P2|STARTED|Infant Series||303
376296|NCT00366340|916576|P1|STARTED|Infant Series||301
376297|NCT00366301|916634|P4|NOT COMPLETED|Overall Study||8
376298|NCT00366301|916635|P3|NOT COMPLETED|Overall Study||4
376299|NCT00366301|916636|P2|NOT COMPLETED|Overall Study||6
376300|NCT00366301|916637|P1|NOT COMPLETED|Overall Study||8
376301|NCT00366301|916634|P4|COMPLETED|Overall Study||116
376302|NCT00366301|916635|P3|COMPLETED|Overall Study||122
376303|NCT00366301|916636|P2|COMPLETED|Overall Study||120
376304|NCT00366301|916637|P1|COMPLETED|Overall Study||116
376305|NCT00366301|916634|P4|Either 6W or 14W CRP Obtained|Overall Study||119
376306|NCT00366301|916635|P3|Either 6W or 14W CRP Obtained|Overall Study||124
376307|NCT00366301|916636|P2|Either 6W or 14W CRP Obtained|Overall Study||124
376308|NCT00366301|916637|P1|Either 6W or 14W CRP Obtained|Overall Study||120
376309|NCT00366301|916634|P4|STARTED|Overall Study||124
376310|NCT00366301|916635|P3|STARTED|Overall Study||126
376311|NCT00366301|916636|P2|STARTED|Overall Study||126
376312|NCT00366301|916637|P1|STARTED|Overall Study||124
376313|NCT00366275|916647|P1|NOT COMPLETED|Overall Study||6
376314|NCT00366275|916647|P1|COMPLETED|Overall Study||58
376315|NCT00366275|916647|P1|STARTED|Overall Study||64
376316|NCT00366249|916653|P2|NOT COMPLETED|Overall Study||78
376317|NCT00366249|916654|P1|NOT COMPLETED|Overall Study||131
376318|NCT00366249|916653|P2|COMPLETED|Overall Study||430
376319|NCT00366249|916654|P1|COMPLETED|Overall Study||422
376320|NCT00366249|916653|P2|STARTED|Overall Study||508
376321|NCT00366249|916654|P1|STARTED|Overall Study||553
376322|NCT00366106|916668|P1|NOT COMPLETED|Overall Study||0
376323|NCT00366106|916668|P1|COMPLETED|Overall Study||32
376324|NCT00366106|916668|P1|STARTED|Overall Study||32
376325|NCT00366028|916677|P2|NOT COMPLETED|Overall Study||0
376326|NCT00366028|916678|P1|NOT COMPLETED|Overall Study||0
376327|NCT00366028|916677|P2|COMPLETED|Overall Study||735
376328|NCT00366028|916678|P1|COMPLETED|Overall Study||889
376329|NCT00366028|916677|P2|STARTED|Overall Study||735
376330|NCT00366028|916678|P1|STARTED|Overall Study||889
376331|NCT00365989|916686|P1|NOT COMPLETED|Overall Study||2
376332|NCT00365989|916686|P1|COMPLETED|Overall Study||48
376333|NCT00365989|916686|P1|STARTED|Overall Study||50
376334|NCT00365976|916694|P2|NOT COMPLETED|Overall Study||5
376335|NCT00365976|916695|P1|NOT COMPLETED|Overall Study||1
376336|NCT00365976|916694|P2|COMPLETED|Overall Study||20
376337|NCT00365976|916695|P1|COMPLETED|Overall Study||32
376338|NCT00365976|916694|P2|STARTED|Overall Study||25
376339|NCT00365976|916695|P1|STARTED|Overall Study||33
376340|NCT00365872|916726|P3|NOT COMPLETED|Overall Study||0
376341|NCT00365872|916727|P2|NOT COMPLETED|Overall Study||0
376342|NCT00365872|916728|P1|NOT COMPLETED|Overall Study||0
376343|NCT00365872|916726|P3|COMPLETED|Overall Study||6
376344|NCT00365872|916727|P2|COMPLETED|Overall Study||6
376345|NCT00365872|916728|P1|COMPLETED|Overall Study||5
376346|NCT00365872|916726|P3|STARTED|Overall Study||6
376347|NCT00365872|916727|P2|STARTED|Overall Study||6
376348|NCT00365872|916728|P1|STARTED|Overall Study||5
376349|NCT00365859|916741|P4|NOT COMPLETED|Overall Study||131
376350|NCT00365859|916742|P3|NOT COMPLETED|Overall Study||67
376351|NCT00365859|916743|P2|NOT COMPLETED|Overall Study||33
376352|NCT00365859|916744|P1|NOT COMPLETED|Overall Study||31
376353|NCT00365859|916741|P4|COMPLETED|Overall Study||199
376354|NCT00365859|916742|P3|COMPLETED|Overall Study||107
376355|NCT00365859|916743|P2|COMPLETED|Overall Study||37
376356|NCT00365859|916744|P1|COMPLETED|Overall Study||55
376357|NCT00365859|916741|P4|Efficacy Population|Overall Study||322
376358|NCT00365859|916742|P3|Efficacy Population|Overall Study|3 lost to follow-up, 1 not included due to mild increased appetite, 1 to family emergency (total=5)|169
376359|NCT00365859|916743|P2|Efficacy Population|Overall Study|1 not included due to increased alanine aminotransferase (ALT) prior to treatment with aripiprazole|69
376360|NCT00365859|916744|P1|Efficacy Population|Overall Study|1 patient was lost to follow-up and 1 not included due to moderate sedation (total=2)|84
376361|NCT00365859|916741|P4|Safety Population|Overall Study||330
376362|NCT00365859|916742|P3|Safety Population|Overall Study||174
376363|NCT00365859|916743|P2|Safety Population|Overall Study||70
376364|NCT00365859|916744|P1|Safety Population|Overall Study||86
376365|NCT00365859|916741|P4|STARTED|Overall Study||330
376366|NCT00365859|916742|P3|STARTED|Overall Study||174
376367|NCT00365859|916743|P2|STARTED|Overall Study||70
376368|NCT00365859|916744|P1|STARTED|Overall Study||86
376369|NCT00365846|916833|P1|NOT COMPLETED|Overall Study||1
376370|NCT00365846|916833|P1|COMPLETED|Overall Study||28
376371|NCT00365846|916833|P1|STARTED|Overall Study||29
376372|NCT00365794|916842|P1|NOT COMPLETED|Overall Study||2
376373|NCT00365794|916842|P1|COMPLETED|Overall Study||20
376374|NCT00365794|916842|P1|STARTED|Overall Study|22 subjects were enrolled since only 20 completed all post treatment measures.|22
376375|NCT00365768|916857|P2|NOT COMPLETED|Overall Study||0
376376|NCT00365768|916858|P1|NOT COMPLETED|Overall Study||0
376377|NCT00365768|916857|P2|COMPLETED|Overall Study||25
376378|NCT00365768|916858|P1|COMPLETED|Overall Study||24
376379|NCT00365768|916857|P2|STARTED|Overall Study||25
376380|NCT00365768|916858|P1|STARTED|Overall Study||24
376381|NCT00365716|916871|P7|NOT COMPLETED|Extension 2||10
376382|NCT00365716|916872|P6|NOT COMPLETED|Extension 2||0
376383|NCT00365716|916873|P5|NOT COMPLETED|Extension 2||0
376384|NCT00365716|916874|P4|NOT COMPLETED|Extension 2||0
376385|NCT00365716|916875|P3|NOT COMPLETED|Extension 2||0
376386|NCT00365716|916876|P2|NOT COMPLETED|Extension 2||0
376387|NCT00365716|916877|P1|NOT COMPLETED|Extension 2||0
376388|NCT00365716|916871|P7|COMPLETED|Extension 2||7
376389|NCT00365716|916872|P6|COMPLETED|Extension 2||0
376390|NCT00365716|916873|P5|COMPLETED|Extension 2||0
376391|NCT00365716|916874|P4|COMPLETED|Extension 2||0
376392|NCT00365716|916875|P3|COMPLETED|Extension 2||0
376393|NCT00365716|916876|P2|COMPLETED|Extension 2||0
376394|NCT00365716|916877|P1|COMPLETED|Extension 2||0
376395|NCT00365716|916871|P7|STARTED|Extension 2|17 Participants continued into Extension 2 from Extension 1|17
376396|NCT00365716|916872|P6|STARTED|Extension 2||0
376397|NCT00365716|916873|P5|STARTED|Extension 2||0
376398|NCT00365716|916874|P4|STARTED|Extension 2||0
376399|NCT00365716|916875|P3|STARTED|Extension 2||0
376400|NCT00365716|916876|P2|STARTED|Extension 2||0
376401|NCT00365716|916877|P1|STARTED|Extension 2||0
376402|NCT00365716|916871|P7|NOT COMPLETED|Extension 1||0
376403|NCT00365716|916872|P6|NOT COMPLETED|Extension 1||22
376404|NCT00365716|916873|P5|NOT COMPLETED|Extension 1||0
376405|NCT00365716|916874|P4|NOT COMPLETED|Extension 1||0
376406|NCT00365716|916875|P3|NOT COMPLETED|Extension 1||0
376407|NCT00365716|916876|P2|NOT COMPLETED|Extension 1||0
376408|NCT00365716|916877|P1|NOT COMPLETED|Extension 1||0
376409|NCT00365716|916871|P7|COMPLETED|Extension 1||0
376410|NCT00365716|916872|P6|COMPLETED|Extension 1||219
376411|NCT00365716|916873|P5|COMPLETED|Extension 1||0
376412|NCT00365716|916874|P4|COMPLETED|Extension 1||0
376413|NCT00365716|916875|P3|COMPLETED|Extension 1||0
376414|NCT00365716|916876|P2|COMPLETED|Extension 1||0
376415|NCT00365716|916877|P1|COMPLETED|Extension 1||0
376416|NCT00365716|916871|P7|STARTED|Extension 1||0
376417|NCT00365716|916872|P6|STARTED|Extension 1||241
376418|NCT00365716|916873|P5|STARTED|Extension 1||0
376419|NCT00365716|916874|P4|STARTED|Extension 1||0
376420|NCT00365716|916875|P3|STARTED|Extension 1||0
376421|NCT00365716|916876|P2|STARTED|Extension 1||0
376422|NCT00365716|916877|P1|STARTED|Extension 1||0
376423|NCT00365716|916871|P7|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
376424|NCT00365716|916872|P6|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
376425|NCT00365716|916873|P5|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||82
376426|NCT00365716|916874|P4|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||79
376427|NCT00365716|916875|P3|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||20
376428|NCT00365716|916876|P2|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||15
376429|NCT00365716|916877|P1|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||132
376430|NCT00365716|916871|P7|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
376431|NCT00365716|916872|P6|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
376432|NCT00365716|916873|P5|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
376433|NCT00365716|916874|P4|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
376434|NCT00365716|916875|P3|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||251
376435|NCT00365716|916876|P2|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||245
376436|NCT00365716|916877|P1|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||137
376437|NCT00365716|916871|P7|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
376438|NCT00365716|916872|P6|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
376439|NCT00365716|916873|P5|STARTED|Long Term Follow-up (Month 7 toMonth 36)||139
376440|NCT00365716|916874|P4|STARTED|Long Term Follow-up (Month 7 toMonth 36)||136
376441|NCT00365716|916875|P3|STARTED|Long Term Follow-up (Month 7 toMonth 36)||271
376442|NCT00365716|916876|P2|STARTED|Long Term Follow-up (Month 7 toMonth 36)||260
376443|NCT00365716|916877|P1|STARTED|Long Term Follow-up (Month 7 toMonth 36)||269
376444|NCT00365716|916871|P7|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
376445|NCT00365716|916872|P6|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
376446|NCT00365716|916873|P5|NOT COMPLETED|Base Study (Day 1 to Month 7)||7
376447|NCT00365716|916874|P4|NOT COMPLETED|Base Study (Day 1 to Month 7)||10
376448|NCT00365716|916875|P3|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
376449|NCT00365716|916876|P2|NOT COMPLETED|Base Study (Day 1 to Month 7)||24
376450|NCT00365716|916877|P1|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
376451|NCT00365716|916871|P7|COMPLETED|Base Study (Day 1 to Month 7)||0
376452|NCT00365716|916872|P6|COMPLETED|Base Study (Day 1 to Month 7)||0
376453|NCT00365716|916873|P5|COMPLETED|Base Study (Day 1 to Month 7)||139
376454|NCT00365716|916874|P4|COMPLETED|Base Study (Day 1 to Month 7)||136
376455|NCT00365716|916875|P3|COMPLETED|Base Study (Day 1 to Month 7)||271
376456|NCT00365716|916876|P2|COMPLETED|Base Study (Day 1 to Month 7)||260
376457|NCT00365716|916877|P1|COMPLETED|Base Study (Day 1 to Month 7)||269
376458|NCT00365716|916871|P7|STARTED|Base Study (Day 1 to Month 7)||0
376459|NCT00365716|916872|P6|STARTED|Base Study (Day 1 to Month 7)||0
376460|NCT00365716|916873|P5|STARTED|Base Study (Day 1 to Month 7)||146
376461|NCT00365716|916874|P4|STARTED|Base Study (Day 1 to Month 7)||146
376462|NCT00365716|916875|P3|STARTED|Base Study (Day 1 to Month 7)||292
376463|NCT00365716|916876|P2|STARTED|Base Study (Day 1 to Month 7)||284
376464|NCT00365716|916877|P1|STARTED|Base Study (Day 1 to Month 7)||290
376465|NCT00365599|916892|P1|NOT COMPLETED|Overall Study||0
376466|NCT00365599|916892|P1|COMPLETED|Overall Study||43
376467|NCT00365599|916892|P1|STARTED|Overall Study||43
376468|NCT00365547|916898|P1|NOT COMPLETED|Overall Study||3
376469|NCT00365547|916898|P1|COMPLETED|Overall Study||43
376470|NCT00365547|916898|P1|STARTED|Overall Study||46
376471|NCT00365508|916908|P2|NOT COMPLETED|Overall Study||154
376472|NCT00365508|916909|P1|NOT COMPLETED|Overall Study||139
376473|NCT00365508|916908|P2|COMPLETED|Overall Study||167
376474|NCT00365508|916909|P1|COMPLETED|Overall Study||182
376475|NCT00365508|916908|P2|STARTED|Overall Study||321
376476|NCT00365508|916909|P1|STARTED|Overall Study||321
376477|NCT00365456|916917|P2|NOT COMPLETED|Trial Period III (12 Months)||5
376478|NCT00365456|916918|P1|NOT COMPLETED|Trial Period III (12 Months)||18
376479|NCT00365456|916917|P2|COMPLETED|Trial Period III (12 Months)||127
376480|NCT00365456|916918|P1|COMPLETED|Trial Period III (12 Months)||118
376481|NCT00365456|916917|P2|STARTED|Trial Period III (12 Months)||132
376482|NCT00365456|916918|P1|STARTED|Trial Period III (12 Months)||136
376483|NCT00365456|916917|P2|NOT COMPLETED|Trial Period II (12 Months)||14
376484|NCT00365456|916918|P1|NOT COMPLETED|Trial Period II (12 Months)||0
376485|NCT00365456|916917|P2|COMPLETED|Trial Period II (12 Months)||268
376486|NCT00365456|916918|P1|COMPLETED|Trial Period II (12 Months)||0
376487|NCT00365456|916917|P2|STARTED|Trial Period II (12 Months)||282
376488|NCT00365456|916918|P1|STARTED|Trial Period II (12 Months)||0
376489|NCT00365456|916917|P2|NOT COMPLETED|Trial Period I (12 Months)||0
376490|NCT00365456|916918|P1|NOT COMPLETED|Trial Period I (12 Months)||125
376491|NCT00365456|916917|P2|COMPLETED|Trial Period I (12 Months)||0
376492|NCT00365456|916918|P1|COMPLETED|Trial Period I (12 Months)||282
376493|NCT00365456|916917|P2|STARTED|Trial Period I (12 Months)||0
376494|NCT00365456|916918|P1|STARTED|Trial Period I (12 Months)||407
376495|NCT00365417|916924|P1|NOT COMPLETED|Overall Study||0
376496|NCT00365417|916924|P1|COMPLETED|Overall Study||45
376497|NCT00365417|916924|P1|STARTED|Overall Study||45
376498|NCT00365391|916935|P1|NOT COMPLETED|Overall Study||0
376499|NCT00365391|916935|P1|COMPLETED|Overall Study||27
376500|NCT00365391|916935|P1|STARTED|Overall Study||27
376501|NCT00365378|916945|P3|NOT COMPLETED|Extension||197
376502|NCT00365378|916946|P2|NOT COMPLETED|Extension||0
376503|NCT00365378|916947|P1|NOT COMPLETED|Extension||0
376504|NCT00365378|916945|P3|COMPLETED|Extension||203
376505|NCT00365378|916946|P2|COMPLETED|Extension||0
376506|NCT00365378|916947|P1|COMPLETED|Extension||0
376507|NCT00365378|916945|P3|STARTED|Extension||400
376508|NCT00365378|916946|P2|STARTED|Extension||0
376509|NCT00365378|916947|P1|STARTED|Extension||0
376510|NCT00365378|916945|P3|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||0
376511|NCT00365378|916946|P2|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||202
376512|NCT00365378|916947|P1|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||158
376513|NCT00365378|916945|P3|COMPLETED|Follow-up (Month 7 Though Month 48)||0
376514|NCT00365378|916946|P2|COMPLETED|Follow-up (Month 7 Though Month 48)||836
376515|NCT00365378|916947|P1|COMPLETED|Follow-up (Month 7 Though Month 48)||835
376516|NCT00365378|916945|P3|STARTED|Follow-up (Month 7 Though Month 48)||0
376517|NCT00365378|916946|P2|STARTED|Follow-up (Month 7 Though Month 48)||1038
376518|NCT00365378|916947|P1|STARTED|Follow-up (Month 7 Though Month 48)||993
376519|NCT00365378|916945|P3|NOT COMPLETED|Vaccination (Day 1 to Month 7)||0
376520|NCT00365378|916946|P2|NOT COMPLETED|Vaccination (Day 1 to Month 7)||167
376521|NCT00365378|916947|P1|NOT COMPLETED|Vaccination (Day 1 to Month 7)||211
376522|NCT00365378|916945|P3|COMPLETED|Vaccination (Day 1 to Month 7)||0
376523|NCT00365378|916946|P2|COMPLETED|Vaccination (Day 1 to Month 7)||1038
376524|NCT00365378|916947|P1|COMPLETED|Vaccination (Day 1 to Month 7)||993
376525|NCT00365378|916945|P3|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||0
376526|NCT00365378|916946|P2|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1198
376527|NCT00365378|916947|P1|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1193
376528|NCT00365378|916945|P3|STARTED|Vaccination (Day 1 to Month 7)||0
376529|NCT00365378|916946|P2|STARTED|Vaccination (Day 1 to Month 7)||1205
376530|NCT00365378|916947|P1|STARTED|Vaccination (Day 1 to Month 7)||1204
376531|NCT00365365|916961|P3|NOT COMPLETED|Overall Study||15
376532|NCT00365365|916962|P2|NOT COMPLETED|Overall Study||36
376533|NCT00365365|916963|P1|NOT COMPLETED|Overall Study||34
376534|NCT00365365|916961|P3|COMPLETED|Overall Study||44
376535|NCT00365365|916962|P2|COMPLETED|Overall Study||41
376536|NCT00365365|916963|P1|COMPLETED|Overall Study||44
376537|NCT00365365|916961|P3|COMPLETED TREATMENT|Overall Study||45
376538|NCT00365365|916962|P2|COMPLETED TREATMENT|Overall Study||36
376539|NCT00365365|916963|P1|COMPLETED TREATMENT|Overall Study||38
376540|NCT00365365|916961|P3|TREATED (SAFETY POPULATION)|Overall Study||59
376541|NCT00365365|916962|P2|TREATED (SAFETY POPULATION)|Overall Study||75
376542|NCT00365365|916963|P1|TREATED (SAFETY POPULATION)|Overall Study||78
376543|NCT00365365|916961|P3|STARTED|Overall Study||59
376544|NCT00365365|916962|P2|STARTED|Overall Study||77
376545|NCT00365365|916963|P1|STARTED|Overall Study||78
376546|NCT00365352|916980|P3|NOT COMPLETED|Overall Study||15
376547|NCT00365352|916981|P2|NOT COMPLETED|Overall Study||11
376548|NCT00365352|916982|P1|NOT COMPLETED|Overall Study||20
376549|NCT00365352|916980|P3|COMPLETED|Overall Study||98
376550|NCT00365352|916981|P2|COMPLETED|Overall Study||104
376551|NCT00365352|916982|P1|COMPLETED|Overall Study||77
376552|NCT00365352|916980|P3|Modified Intent-to-Treat Population|Overall Study||111
376553|NCT00365352|916981|P2|Modified Intent-to-Treat Population|Overall Study||114
376554|NCT00365352|916982|P1|Modified Intent-to-Treat Population|Overall Study||96
376555|NCT00365352|916980|P3|Safety Population|Overall Study||111
376556|NCT00365352|916981|P2|Safety Population|Overall Study||115
376557|NCT00365352|916982|P1|Safety Population|Overall Study||96
376558|NCT00365352|916980|P3|STARTED|Overall Study||113
376559|NCT00365352|916981|P2|STARTED|Overall Study||115
376560|NCT00365352|916982|P1|STARTED|Overall Study||97
376561|NCT00365300|917066|P2|NOT COMPLETED|Double-blind Phase||9
376562|NCT00365300|917067|P1|NOT COMPLETED|Double-blind Phase||11
376563|NCT00365300|917066|P2|COMPLETED|Double-blind Phase||45
376564|NCT00365300|917067|P1|COMPLETED|Double-blind Phase||43
376565|NCT00365300|917066|P2|STARTED|Double-blind Phase||54
376566|NCT00365300|917067|P1|STARTED|Double-blind Phase||54
376567|NCT00365300|917066|P2|NOT COMPLETED|Open-label Phase||0
376568|NCT00365300|917067|P1|NOT COMPLETED|Open-label Phase||22
376569|NCT00365300|917066|P2|COMPLETED|Open-label Phase||0
376570|NCT00365300|917067|P1|COMPLETED|Open-label Phase||107
376571|NCT00365300|917066|P2|STARTED|Open-label Phase||0
376572|NCT00365300|917067|P1|STARTED|Open-label Phase||129
376573|NCT00365274|917076|P1|NOT COMPLETED|Overall Study||0
376574|NCT00365274|917076|P1|COMPLETED|Overall Study||6
376575|NCT00365274|917076|P1|STARTED|Overall Study||6
376576|NCT00365261|917082|P2|NOT COMPLETED|Overall Study||3
376577|NCT00365261|917083|P1|NOT COMPLETED|Overall Study||3
376578|NCT00365261|917082|P2|COMPLETED|Overall Study||19
376579|NCT00365261|917083|P1|COMPLETED|Overall Study||20
376580|NCT00365261|917082|P2|STARTED|Overall Study||22
376581|NCT00365261|917083|P1|STARTED|Overall Study||23
376582|NCT00365209|917093|P1|NOT COMPLETED|Stage 2: Receiving 4g Curcumin||2
376583|NCT00365209|917093|P1|COMPLETED|Stage 2: Receiving 4g Curcumin||19
376584|NCT00365209|917093|P1|STARTED|Stage 2: Receiving 4g Curcumin||21
376585|NCT00365209|917093|P1|NOT COMPLETED|Stage 1: Receiving 2g Curcumin||2
376586|NCT00365209|917093|P1|COMPLETED|Stage 1: Receiving 2g Curcumin||21
376587|NCT00365209|917093|P1|STARTED|Stage 1: Receiving 2g Curcumin||23
376588|NCT00365144|917122|P1|NOT COMPLETED|Overall Study||0
376589|NCT00365144|917122|P1|COMPLETED|Overall Study||36
376590|NCT00365144|917122|P1|STARTED|Overall Study||36
376591|NCT00365105|917132|P2|NOT COMPLETED|Overall Study||8
376592|NCT00365105|917133|P1|NOT COMPLETED|Overall Study||5
376593|NCT00365105|917132|P2|COMPLETED|Overall Study||124
376594|NCT00365105|917133|P1|COMPLETED|Overall Study||124
376595|NCT00365105|917132|P2|Eligible With Adverse Event Data|Overall Study||124
376596|NCT00365105|917133|P1|Eligible With Adverse Event Data|Overall Study||123
376597|NCT00365105|917132|P2|Eligible|Overall Study||124
376598|NCT00365105|917133|P1|Eligible|Overall Study||124
376599|NCT00365105|917132|P2|STARTED|Overall Study||132
376600|NCT00365105|917133|P1|STARTED|Overall Study||129
376601|NCT00365053|917149|P1|NOT COMPLETED|Overall Study||0
376602|NCT00365053|917149|P1|COMPLETED|Overall Study||13
376603|NCT00365053|917149|P1|STARTED|Overall Study||13
376604|NCT00364949|917160|P2|NOT COMPLETED|Overall Study||0
376605|NCT00364949|917161|P1|NOT COMPLETED|Overall Study||0
376606|NCT00364949|917160|P2|COMPLETED|Overall Study||39
376607|NCT00364949|917161|P1|COMPLETED|Overall Study||31
376608|NCT00364949|917160|P2|STARTED|Overall Study||39
376609|NCT00364949|917161|P1|STARTED|Overall Study||31
376610|NCT00364923|917179|P1|NOT COMPLETED|Survival Follow-up, After Pralatrexate||24
376611|NCT00364923|917179|P1|COMPLETED|Survival Follow-up, After Pralatrexate|Pts who completed follow-up either died, were followed for 24 months, or withdrew|83
376612|NCT00364923|917179|P1|STARTED|Survival Follow-up, After Pralatrexate|Patients (pts) who stop treatment with pralatrexate are followed for survival|107
376613|NCT00364923|917179|P1|NOT COMPLETED|Treatment With Pralatrexate||4
376614|NCT00364923|917179|P1|COMPLETED|Treatment With Pralatrexate|Treatment duration not limited. After treatment ends, patients attend survival follow-up visits.|107
376615|NCT00364923|917179|P1|STARTED|Treatment With Pralatrexate|Received at least one dose of pralatrexate.|111
376616|NCT00364858|917188|P2|NOT COMPLETED|Overall Study||22
376617|NCT00364858|917189|P1|NOT COMPLETED|Overall Study||7
376618|NCT00364858|917188|P2|COMPLETED|Overall Study||40
376619|NCT00364858|917189|P1|COMPLETED|Overall Study||26
376620|NCT00364858|917188|P2|STARTED|Overall Study||62
376621|NCT00364858|917189|P1|STARTED|Overall Study||33
376622|NCT00364845|917204|P2|NOT COMPLETED|Overall Study||11
376623|NCT00364845|917205|P1|NOT COMPLETED|Overall Study||11
376624|NCT00364845|917204|P2|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|12
376625|NCT00364845|917205|P1|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|17
376626|NCT00364845|917204|P2|STARTED|Overall Study||23
376627|NCT00364845|917205|P1|STARTED|Overall Study||28
376628|NCT00364832|917226|P12|NOT COMPLETED|Extension Year 2||3
376629|NCT00364832|917227|P11|NOT COMPLETED|Extension Year 2||5
376630|NCT00364832|917228|P10|NOT COMPLETED|Extension Year 2||5
376631|NCT00364832|917229|P9|NOT COMPLETED|Extension Year 2||0
376632|NCT00364832|917230|P8|NOT COMPLETED|Extension Year 2||0
376633|NCT00364832|917231|P7|NOT COMPLETED|Extension Year 2||0
376634|NCT00364832|917232|P6|NOT COMPLETED|Extension Year 2||0
376635|NCT00364832|917233|P5|NOT COMPLETED|Extension Year 2||0
376636|NCT00364832|917234|P4|NOT COMPLETED|Extension Year 2||0
376637|NCT00364832|917235|P3|NOT COMPLETED|Extension Year 2||0
376638|NCT00364832|917236|P2|NOT COMPLETED|Extension Year 2||0
376639|NCT00364832|917237|P1|NOT COMPLETED|Extension Year 2||0
376640|NCT00364832|917226|P12|COMPLETED|Extension Year 2||11
376641|NCT00364832|917227|P11|COMPLETED|Extension Year 2||9
376642|NCT00364832|917228|P10|COMPLETED|Extension Year 2||9
376643|NCT00364832|917229|P9|COMPLETED|Extension Year 2||0
376644|NCT00364832|917230|P8|COMPLETED|Extension Year 2||0
376645|NCT00364832|917231|P7|COMPLETED|Extension Year 2||0
376646|NCT00364832|917232|P6|COMPLETED|Extension Year 2||0
376647|NCT00364832|917233|P5|COMPLETED|Extension Year 2||0
376648|NCT00364832|917234|P4|COMPLETED|Extension Year 2||0
376649|NCT00364832|917235|P3|COMPLETED|Extension Year 2||0
376650|NCT00364832|917236|P2|COMPLETED|Extension Year 2||0
376651|NCT00364832|917237|P1|COMPLETED|Extension Year 2||0
376652|NCT00364832|917226|P12|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
376653|NCT00364832|917227|P11|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
376654|NCT00364832|917228|P10|STARTED|Extension Year 2||14
376655|NCT00364832|917229|P9|STARTED|Extension Year 2||0
376656|NCT00364832|917230|P8|STARTED|Extension Year 2||0
376657|NCT00364832|917231|P7|STARTED|Extension Year 2||0
376658|NCT00364832|917232|P6|STARTED|Extension Year 2||0
376659|NCT00364832|917233|P5|STARTED|Extension Year 2||0
376660|NCT00364832|917234|P4|STARTED|Extension Year 2||0
376661|NCT00364832|917235|P3|STARTED|Extension Year 2||0
376662|NCT00364832|917236|P2|STARTED|Extension Year 2||0
376663|NCT00364832|917237|P1|STARTED|Extension Year 2||0
376664|NCT00364832|917226|P12|NOT COMPLETED|Extension Year 1||10
376665|NCT00364832|917227|P11|NOT COMPLETED|Extension Year 1||2
376666|NCT00364832|917228|P10|NOT COMPLETED|Extension Year 1||4
376667|NCT00364832|917229|P9|NOT COMPLETED|Extension Year 1||0
376668|NCT00364832|917230|P8|NOT COMPLETED|Extension Year 1||0
376669|NCT00364832|917231|P7|NOT COMPLETED|Extension Year 1||0
376670|NCT00364832|917232|P6|NOT COMPLETED|Extension Year 1||0
376671|NCT00364832|917233|P5|NOT COMPLETED|Extension Year 1||0
376672|NCT00364832|917234|P4|NOT COMPLETED|Extension Year 1||0
376673|NCT00364832|917235|P3|NOT COMPLETED|Extension Year 1||0
376674|NCT00364832|917236|P2|NOT COMPLETED|Extension Year 1||0
376675|NCT00364832|917237|P1|NOT COMPLETED|Extension Year 1||0
376676|NCT00364832|917226|P12|COMPLETED|Extension Year 1||17
376677|NCT00364832|917227|P11|COMPLETED|Extension Year 1||15
376678|NCT00364832|917228|P10|COMPLETED|Extension Year 1||14
376679|NCT00364832|917229|P9|COMPLETED|Extension Year 1||0
376680|NCT00364832|917230|P8|COMPLETED|Extension Year 1||0
376681|NCT00364832|917231|P7|COMPLETED|Extension Year 1||0
376682|NCT00364832|917232|P6|COMPLETED|Extension Year 1||0
376683|NCT00364832|917233|P5|COMPLETED|Extension Year 1||0
376684|NCT00364832|917234|P4|COMPLETED|Extension Year 1||0
376685|NCT00364832|917235|P3|COMPLETED|Extension Year 1||0
376686|NCT00364832|917236|P2|COMPLETED|Extension Year 1||0
376687|NCT00364832|917237|P1|COMPLETED|Extension Year 1||0
376688|NCT00364832|917226|P12|STARTED|Extension Year 1|Participants (Cohorts C, F, and I) who completed core, entered extension period (entry optional).|27
376689|NCT00364832|917227|P11|STARTED|Extension Year 1|Participants (Cohorts B, E, and H) who completed core, entered extension period (entry optional).|17
376690|NCT00364832|917228|P10|STARTED|Extension Year 1|Participants (Cohorts A, D, and G) who completed core, entered extension period (entry optional).|18
376691|NCT00364832|917229|P9|STARTED|Extension Year 1||0
376692|NCT00364832|917230|P8|STARTED|Extension Year 1||0
376693|NCT00364832|917231|P7|STARTED|Extension Year 1||0
376694|NCT00364832|917232|P6|STARTED|Extension Year 1||0
376695|NCT00364832|917233|P5|STARTED|Extension Year 1||0
376696|NCT00364832|917234|P4|STARTED|Extension Year 1||0
376697|NCT00364832|917235|P3|STARTED|Extension Year 1||0
376698|NCT00364832|917236|P2|STARTED|Extension Year 1||0
376699|NCT00364832|917237|P1|STARTED|Extension Year 1||0
376700|NCT00364832|917226|P12|NOT COMPLETED|Core Period||0
376701|NCT00364832|917227|P11|NOT COMPLETED|Core Period||0
376702|NCT00364832|917228|P10|NOT COMPLETED|Core Period||0
376703|NCT00364832|917229|P9|NOT COMPLETED|Core Period||0
376704|NCT00364832|917230|P8|NOT COMPLETED|Core Period||1
376705|NCT00364832|917231|P7|NOT COMPLETED|Core Period||4
376706|NCT00364832|917232|P6|NOT COMPLETED|Core Period||0
376707|NCT00364832|917233|P5|NOT COMPLETED|Core Period||0
376708|NCT00364832|917234|P4|NOT COMPLETED|Core Period||1
376709|NCT00364832|917235|P3|NOT COMPLETED|Core Period||1
376710|NCT00364832|917236|P2|NOT COMPLETED|Core Period||2
376711|NCT00364832|917237|P1|NOT COMPLETED|Core Period||2
376712|NCT00364832|917226|P12|COMPLETED|Core Period||0
376713|NCT00364832|917227|P11|COMPLETED|Core Period||0
376714|NCT00364832|917228|P10|COMPLETED|Core Period||0
376715|NCT00364832|917229|P9|COMPLETED|Core Period||16
376716|NCT00364832|917230|P8|COMPLETED|Core Period||14
376717|NCT00364832|917231|P7|COMPLETED|Core Period||12
376718|NCT00364832|917232|P6|COMPLETED|Core Period||12
376719|NCT00364832|917233|P5|COMPLETED|Core Period||16
376720|NCT00364832|917234|P4|COMPLETED|Core Period||15
376721|NCT00364832|917235|P3|COMPLETED|Core Period||14
376722|NCT00364832|917236|P2|COMPLETED|Core Period||13
376723|NCT00364832|917237|P1|COMPLETED|Core Period||14
376724|NCT00364832|917226|P12|STARTED|Core Period||0
376725|NCT00364832|917227|P11|STARTED|Core Period||0
376726|NCT00364832|917228|P10|STARTED|Core Period||0
376727|NCT00364832|917229|P9|STARTED|Core Period||16
376728|NCT00364832|917230|P8|STARTED|Core Period||15
376729|NCT00364832|917231|P7|STARTED|Core Period||16
376730|NCT00364832|917232|P6|STARTED|Core Period||12
376731|NCT00364832|917233|P5|STARTED|Core Period||16
376732|NCT00364832|917234|P4|STARTED|Core Period||16
376733|NCT00364832|917235|P3|STARTED|Core Period||15
376734|NCT00364832|917236|P2|STARTED|Core Period||15
376735|NCT00364832|917237|P1|STARTED|Core Period||16
376736|NCT00364819|917290|P1|NOT COMPLETED|Overall Study||0
376737|NCT00364819|917290|P1|COMPLETED|Overall Study||6
376738|NCT00364819|917290|P1|STARTED|Overall Study||6
376739|NCT00364793|917302|P4|NOT COMPLETED|Overall Study||3
376740|NCT00364793|917303|P3|NOT COMPLETED|Overall Study||4
376741|NCT00364793|917304|P2|NOT COMPLETED|Overall Study||5
376742|NCT00364793|917305|P1|NOT COMPLETED|Overall Study||8
376743|NCT00364793|917302|P4|COMPLETED|Overall Study||5
376744|NCT00364793|917303|P3|COMPLETED|Overall Study||0
376745|NCT00364793|917304|P2|COMPLETED|Overall Study||5
376746|NCT00364793|917305|P1|COMPLETED|Overall Study||7
376747|NCT00364793|917302|P4|STARTED|Overall Study||8
376748|NCT00364793|917303|P3|STARTED|Overall Study||4
376749|NCT00364793|917304|P2|STARTED|Overall Study||10
376750|NCT00364793|917305|P1|STARTED|Overall Study||15
376751|NCT00364689|917442|P1|NOT COMPLETED|Overall Study||1
376752|NCT00364689|917442|P1|COMPLETED|Overall Study||12
376753|NCT00364689|917442|P1|STARTED|Overall Study||13
376754|NCT00364611|917462|P2|NOT COMPLETED|Overall Study||21
376755|NCT00364611|917463|P1|NOT COMPLETED|Overall Study||51
376756|NCT00364611|917462|P2|COMPLETED|Overall Study||0
376757|NCT00364611|917463|P1|COMPLETED|Overall Study|Ongoing treatment (June 2011-initial analysis). Continued treatment till March 2012 (study closed).|1
376758|NCT00364611|917462|P2|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|20
376759|NCT00364611|917463|P1|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|52
376760|NCT00364611|917462|P2|STARTED|Overall Study||21
376761|NCT00364611|917463|P1|STARTED|Overall Study||52
376762|NCT00364533|917486|P5|NOT COMPLETED|Overall Study||51
376763|NCT00364533|917487|P4|NOT COMPLETED|Overall Study||31
376764|NCT00364533|917488|P3|NOT COMPLETED|Overall Study||45
376765|NCT00364533|917489|P2|NOT COMPLETED|Overall Study||40
376766|NCT00364533|917490|P1|NOT COMPLETED|Overall Study||42
376767|NCT00364533|917486|P5|COMPLETED|Overall Study||24
376768|NCT00364533|917487|P4|COMPLETED|Overall Study||36
376769|NCT00364533|917488|P3|COMPLETED|Overall Study||30
376770|NCT00364533|917489|P2|COMPLETED|Overall Study||31
376771|NCT00364533|917490|P1|COMPLETED|Overall Study||35
376772|NCT00364533|917486|P5|STARTED|Overall Study||75
376773|NCT00364533|917487|P4|STARTED|Overall Study||67
376774|NCT00364533|917488|P3|STARTED|Overall Study||75
376775|NCT00364533|917489|P2|STARTED|Overall Study||71
376776|NCT00364533|917490|P1|STARTED|Overall Study||77
376777|NCT00364377|917514|P2|NOT COMPLETED|Overall Study||0
376778|NCT00364377|917515|P1|NOT COMPLETED|Overall Study||0
376779|NCT00364377|917514|P2|COMPLETED|Overall Study||11
376780|NCT00364377|917515|P1|COMPLETED|Overall Study||11
376781|NCT00364377|917514|P2|STARTED|Overall Study||11
376782|NCT00364377|917515|P1|STARTED|Overall Study||11
376783|NCT00364351|917523|P2|NOT COMPLETED|Overall Study||583
376784|NCT00364351|917524|P1|NOT COMPLETED|Overall Study||592
376785|NCT00364351|917523|P2|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|34
376786|NCT00364351|917524|P1|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|31
376787|NCT00364351|917523|P2|STARTED|Overall Study|randomised patients|617
376788|NCT00364351|917524|P1|STARTED|Overall Study|randomised patients|623
376789|NCT00364286|917542|P1|NOT COMPLETED|Overall Study||3
376790|NCT00364286|917542|P1|COMPLETED|Overall Study||14
376791|NCT00364286|917542|P1|STARTED|Overall Study||17
376792|NCT00364182|917549|P3|NOT COMPLETED|Fourth Intervention||0
376793|NCT00364182|917550|P2|NOT COMPLETED|Fourth Intervention||0
376794|NCT00364182|917551|P1|NOT COMPLETED|Fourth Intervention||0
376795|NCT00364182|917549|P3|COMPLETED|Fourth Intervention||22
376796|NCT00364182|917550|P2|COMPLETED|Fourth Intervention||19
376797|NCT00364182|917551|P1|COMPLETED|Fourth Intervention||0
376798|NCT00364182|917549|P3|STARTED|Fourth Intervention||22
376799|NCT00364182|917550|P2|STARTED|Fourth Intervention||19
376800|NCT00364182|917551|P1|STARTED|Fourth Intervention||0
376801|NCT00364182|917549|P3|NOT COMPLETED|Third Intervention||1
376802|NCT00364182|917550|P2|NOT COMPLETED|Third Intervention||1
376803|NCT00364182|917551|P1|NOT COMPLETED|Third Intervention||0
376804|NCT00364182|917549|P3|COMPLETED|Third Intervention||22
376805|NCT00364182|917550|P2|COMPLETED|Third Intervention||19
376806|NCT00364182|917551|P1|COMPLETED|Third Intervention||0
376807|NCT00364182|917549|P3|STARTED|Third Intervention||23
376808|NCT00364182|917550|P2|STARTED|Third Intervention||20
376809|NCT00364182|917551|P1|STARTED|Third Intervention||0
376810|NCT00364182|917549|P3|NOT COMPLETED|Second Intervention||2
376811|NCT00364182|917550|P2|NOT COMPLETED|Second Intervention||2
376812|NCT00364182|917551|P1|NOT COMPLETED|Second Intervention||0
376813|NCT00364182|917549|P3|COMPLETED|Second Intervention||23
376814|NCT00364182|917550|P2|COMPLETED|Second Intervention||20
376815|NCT00364182|917551|P1|COMPLETED|Second Intervention||0
376816|NCT00364182|917549|P3|Randomized|Second Intervention||25
376817|NCT00364182|917550|P2|Randomized|Second Intervention||22
376818|NCT00364182|917551|P1|Randomized|Second Intervention||0
376819|NCT00364182|917549|P3|STARTED|Second Intervention||25
376820|NCT00364182|917550|P2|STARTED|Second Intervention||22
376821|NCT00364182|917551|P1|STARTED|Second Intervention||0
376822|NCT00364182|917549|P3|NOT COMPLETED|First Intervention||0
376823|NCT00364182|917550|P2|NOT COMPLETED|First Intervention||0
376824|NCT00364182|917551|P1|NOT COMPLETED|First Intervention||3
376825|NCT00364182|917549|P3|COMPLETED|First Intervention||25
376826|NCT00364182|917550|P2|COMPLETED|First Intervention||22
376827|NCT00364182|917551|P1|COMPLETED|First Intervention||0
376828|NCT00364182|917549|P3|STARTED|First Intervention||25
376829|NCT00364182|917550|P2|STARTED|First Intervention||22
376830|NCT00364182|917551|P1|STARTED|First Intervention||3
376831|NCT00364156|917585|P2|NOT COMPLETED|Overall Study||81
376832|NCT00364156|917586|P1|NOT COMPLETED|Overall Study||79
376833|NCT00364156|917585|P2|COMPLETED|Overall Study||205
376834|NCT00364156|917586|P1|COMPLETED|Overall Study||203
376835|NCT00364156|917585|P2|STARTED|Overall Study||286
376836|NCT00364156|917586|P1|STARTED|Overall Study||282
376837|NCT00364130|917594|P2|NOT COMPLETED|Post Intervention Follow-up Period||11
376838|NCT00364130|917595|P1|NOT COMPLETED|Post Intervention Follow-up Period||5
376839|NCT00364130|917594|P2|COMPLETED|Post Intervention Follow-up Period||50
376840|NCT00364130|917595|P1|COMPLETED|Post Intervention Follow-up Period||55
376841|NCT00364130|917594|P2|STARTED|Post Intervention Follow-up Period||61
376842|NCT00364130|917595|P1|STARTED|Post Intervention Follow-up Period||60
376843|NCT00364130|917594|P2|NOT COMPLETED|Intervention Period||8
376844|NCT00364130|917595|P1|NOT COMPLETED|Intervention Period||9
376845|NCT00364130|917594|P2|COMPLETED|Intervention Period||61
376846|NCT00364130|917595|P1|COMPLETED|Intervention Period||60
376847|NCT00364130|917594|P2|STARTED|Intervention Period||69
376848|NCT00364130|917595|P1|STARTED|Intervention Period||69
376849|NCT00364013|917617|P2|NOT COMPLETED|Overall Study||95
376850|NCT00364013|917618|P1|NOT COMPLETED|Overall Study||101
376851|NCT00364013|917617|P2|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|495
376852|NCT00364013|917618|P1|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|492
376853|NCT00364013|917617|P2|Received Study Drug|Overall Study||583
376854|NCT00364013|917618|P1|Received Study Drug|Overall Study|One participant randomized to this group did not receive any panitumumab|586
376855|NCT00364013|917617|P2|STARTED|Overall Study||590
376856|NCT00364013|917618|P1|STARTED|Overall Study||593
376857|NCT00363896|917646|P2|NOT COMPLETED|Overall Study||47
376858|NCT00363896|917647|P1|NOT COMPLETED|Overall Study||89
376859|NCT00363896|917646|P2|COMPLETED|Overall Study||169
376860|NCT00363896|917647|P1|COMPLETED|Overall Study||538
376861|NCT00363896|917646|P2|STARTED|Overall Study||216
376862|NCT00363896|917647|P1|STARTED|Overall Study||627
376863|NCT00363883|917659|P1|NOT COMPLETED|Overall Study||0
376864|NCT00363883|917659|P1|COMPLETED|Overall Study||14
376865|NCT00363883|917659|P1|STARTED|Overall Study||14
376866|NCT00363805|917668|P3|NOT COMPLETED|Overall Study||3
376867|NCT00363805|917669|P2|NOT COMPLETED|Overall Study||6
376868|NCT00363805|917670|P1|NOT COMPLETED|Overall Study||4
376869|NCT00363805|917668|P3|COMPLETED|Overall Study||70
376870|NCT00363805|917669|P2|COMPLETED|Overall Study||57
376871|NCT00363805|917670|P1|COMPLETED|Overall Study||38
376872|NCT00363805|917668|P3|STARTED|Overall Study||73
376873|NCT00363805|917669|P2|STARTED|Overall Study||63
376874|NCT00363805|917670|P1|STARTED|Overall Study||42
376875|NCT00363779|917681|P1|NOT COMPLETED|Overall Study||0
376876|NCT00363779|917681|P1|COMPLETED|Overall Study||5
376877|NCT00363779|917681|P1|STARTED|Overall Study||5
376878|NCT00363766|917688|P2|NOT COMPLETED|Overall Study||20
376879|NCT00363766|917689|P1|NOT COMPLETED|Overall Study||32
376880|NCT00363766|917688|P2|COMPLETED|Overall Study||0
376881|NCT00363766|917689|P1|COMPLETED|Overall Study||0
376882|NCT00363766|917688|P2|STARTED|Overall Study||20
376883|NCT00363766|917689|P1|STARTED|Overall Study||32
376884|NCT00363675|917709|P1|NOT COMPLETED|Overall Study||0
376885|NCT00363675|917709|P1|COMPLETED|Overall Study||3
376886|NCT00363675|917709|P1|Completed Testing|Overall Study||3
376887|NCT00363675|917709|P1|STARTED|Overall Study||3
376888|NCT00363649|917718|P2|NOT COMPLETED|Overall Study||1
376889|NCT00363649|917719|P1|NOT COMPLETED|Overall Study||7
376890|NCT00363649|917718|P2|COMPLETED|Overall Study||15
376891|NCT00363649|917719|P1|COMPLETED|Overall Study||11
376892|NCT00363649|917718|P2|Did Not Cross Over|Overall Study||3
376893|NCT00363649|917719|P1|Did Not Cross Over|Overall Study||2
376894|NCT00363649|917718|P2|Crossed Over to Arm A|Overall Study||12
376895|NCT00363649|917719|P1|Crossed Over to Arm A|Overall Study||0
376896|NCT00363649|917718|P2|Crossed Over to Arm B|Overall Study||0
376897|NCT00363649|917719|P1|Crossed Over to Arm B|Overall Study||9
376898|NCT00363649|917718|P2|STARTED|Overall Study||16
376899|NCT00363649|917719|P1|STARTED|Overall Study||18
376900|NCT00363545|917735|P2|NOT COMPLETED|Overall Study||57
376901|NCT00363545|917736|P1|NOT COMPLETED|Overall Study||44
376902|NCT00363545|917735|P2|COMPLETED|Overall Study||581
376903|NCT00363545|917736|P1|COMPLETED|Overall Study||592
376904|NCT00363545|917735|P2|STARTED|Overall Study||638
376905|NCT00363545|917736|P1|STARTED|Overall Study||636
376906|NCT00363480|917754|P1|NOT COMPLETED|Overall Study||17
376907|NCT00363480|917754|P1|COMPLETED|Overall Study||204
376908|NCT00363480|917754|P1|STARTED|Overall Study||221
376909|NCT00363467|917774|P1|NOT COMPLETED|Overall Study||1
376910|NCT00363467|917774|P1|COMPLETED|Overall Study||2
376911|NCT00363467|917774|P1|STARTED|Overall Study||3
376912|NCT00363415|917784|P2|NOT COMPLETED|Overall Study||249
376913|NCT00363415|917785|P1|NOT COMPLETED|Overall Study||361
376914|NCT00363415|917784|P2|COMPLETED|Overall Study||206
376915|NCT00363415|917785|P1|COMPLETED|Overall Study||92
376916|NCT00363415|917784|P2|Received at Least One Dose of Study Drug|Overall Study||447
376917|NCT00363415|917785|P1|Received at Least One Dose of Study Drug|Overall Study||433
376918|NCT00363415|917784|P2|STARTED|Overall Study||455
376919|NCT00363415|917785|P1|STARTED|Overall Study||453
376920|NCT00363311|917803|P2|NOT COMPLETED|Overall Study||45
376921|NCT00363311|917804|P1|NOT COMPLETED|Overall Study||76
376922|NCT00363311|917803|P2|COMPLETED|Overall Study||102
376923|NCT00363311|917804|P1|COMPLETED|Overall Study||79
376924|NCT00363311|917803|P2|STARTED|Overall Study||147
376925|NCT00363311|917804|P1|STARTED|Overall Study||155
376926|NCT00363298|917870|P2|NOT COMPLETED|4-week Study Continuation Phase||0
376927|NCT00363298|917871|P1|NOT COMPLETED|4-week Study Continuation Phase||1
376928|NCT00363298|917870|P2|COMPLETED|4-week Study Continuation Phase||7
376929|NCT00363298|917871|P1|COMPLETED|4-week Study Continuation Phase||5
376930|NCT00363298|917870|P2|STARTED|4-week Study Continuation Phase||7
376931|NCT00363298|917871|P1|STARTED|4-week Study Continuation Phase||6
376932|NCT00363298|917870|P2|NOT COMPLETED|First Study Week||5
376933|NCT00363298|917871|P1|NOT COMPLETED|First Study Week||6
376934|NCT00363298|917870|P2|COMPLETED|First Study Week|At end of week 1, 7/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|7
376935|NCT00363298|917871|P1|COMPLETED|First Study Week|At end of week 1, 6/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|6
376936|NCT00363298|917870|P2|STARTED|First Study Week||12
376937|NCT00363298|917871|P1|STARTED|First Study Week||12
376938|NCT00363246|917879|P1|NOT COMPLETED|Overall Study||97
376939|NCT00363246|917879|P1|COMPLETED|Overall Study||669
376940|NCT00363246|917879|P1|STARTED|Overall Study||766
376941|NCT00363168|917886|P2|NOT COMPLETED|Overall Study||0
376942|NCT00363168|917887|P1|NOT COMPLETED|Overall Study||0
376943|NCT00363168|917886|P2|COMPLETED|Overall Study||2
376944|NCT00363168|917887|P1|COMPLETED|Overall Study||5
376945|NCT00363168|917886|P2|STARTED|Overall Study||2
376946|NCT00363168|917887|P1|STARTED|Overall Study||5
376947|NCT00363142|917897|P2|NOT COMPLETED|Overall Study||3
376948|NCT00363142|917898|P1|NOT COMPLETED|Overall Study||7
376949|NCT00363142|917897|P2|COMPLETED|Overall Study||66
376950|NCT00363142|917898|P1|COMPLETED|Overall Study||133
376951|NCT00363142|917897|P2|STARTED|Overall Study||69
376952|NCT00363142|917898|P1|STARTED|Overall Study||140
376953|NCT00363129|917927|P2|NOT COMPLETED|Overall Study||33
376954|NCT00363129|917928|P1|NOT COMPLETED|Overall Study||29
376955|NCT00363129|917927|P2|COMPLETED|Overall Study||60
376956|NCT00363129|917928|P1|COMPLETED|Overall Study||67
376957|NCT00363129|917927|P2|STARTED|Overall Study||93
376958|NCT00363129|917928|P1|STARTED|Overall Study||96
376959|NCT00363077|917944|P2|NOT COMPLETED|Overall Study||0
376960|NCT00363077|917945|P1|NOT COMPLETED|Overall Study||0
376961|NCT00363077|917944|P2|COMPLETED|Overall Study||75
376962|NCT00363077|917945|P1|COMPLETED|Overall Study||75
376963|NCT00363077|917944|P2|STARTED|Overall Study||75
376964|NCT00363077|917945|P1|STARTED|Overall Study||75
376965|NCT00363051|917971|P2|NOT COMPLETED|Overall Study||22
376966|NCT00363051|917972|P1|NOT COMPLETED|Overall Study||38
376967|NCT00363051|917971|P2|COMPLETED|Overall Study||23
376968|NCT00363051|917972|P1|COMPLETED|Overall Study|Patients with documented disease progression per RECIST criteria|77
376969|NCT00363051|917971|P2|STARTED|Overall Study||45
376970|NCT00363051|917972|P1|STARTED|Overall Study||115
376971|NCT00363038|917989|P1|NOT COMPLETED|Overall Study||0
376972|NCT00363038|917989|P1|COMPLETED|Overall Study||16
376973|NCT00363038|917989|P1|STARTED|Overall Study||16
376974|NCT00362882|917995|P2|NOT COMPLETED|Overall Study||0
376975|NCT00362882|917996|P1|NOT COMPLETED|Overall Study||0
376976|NCT00362882|917995|P2|COMPLETED|Overall Study||41
376977|NCT00362882|917996|P1|COMPLETED|Overall Study||40
376978|NCT00362882|917995|P2|STARTED|Overall Study||41
376979|NCT00362882|917996|P1|STARTED|Overall Study||40
376980|NCT00362817|918008|P1|NOT COMPLETED|Overall Study||0
376981|NCT00362817|918008|P1|COMPLETED|Overall Study||17
376982|NCT00362817|918008|P1|STARTED|Overall Study||17
376983|NCT00362648|918021|P4|NOT COMPLETED|Overall Study||11
376984|NCT00362648|918022|P3|NOT COMPLETED|Overall Study||9
376985|NCT00362648|918023|P2|NOT COMPLETED|Overall Study||134
376986|NCT00362648|918024|P1|NOT COMPLETED|Overall Study||126
376987|NCT00362648|918021|P4|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1007
376988|NCT00362648|918022|P3|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1009
376989|NCT00362648|918023|P2|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2601
376990|NCT00362648|918024|P1|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2607
376991|NCT00362648|918021|P4|Vaccinated at Visit 3|Overall Study||1007
376992|NCT00362648|918022|P3|Vaccinated at Visit 3|Overall Study||1009
376993|NCT00362648|918023|P2|Vaccinated at Visit 3|Overall Study||2612
376994|NCT00362648|918024|P1|Vaccinated at Visit 3|Overall Study||2613
376995|NCT00362648|918021|P4|Vaccinated at Visit 2|Overall Study||1009
376996|NCT00362648|918022|P3|Vaccinated at Visit 2|Overall Study||1013
376997|NCT00362648|918023|P2|Vaccinated at Visit 2|Overall Study||2666
376998|NCT00362648|918024|P1|Vaccinated at Visit 2|Overall Study||2657
376999|NCT00362648|918021|P4|Vaccinated at Visit 1|Overall Study||1018
377000|NCT00362648|918022|P3|Vaccinated at Visit 1|Overall Study||1018
377001|NCT00362648|918023|P2|Vaccinated at Visit 1|Overall Study||2735
377002|NCT00362648|918024|P1|Vaccinated at Visit 1|Overall Study||2733
377003|NCT00362648|918021|P4|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
377004|NCT00362648|918022|P3|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
377005|NCT00362648|918023|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2735
377006|NCT00362648|918024|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2733
377007|NCT00362609|918042|P2|NOT COMPLETED|Overall Study||2
377008|NCT00362609|918043|P1|NOT COMPLETED|Overall Study||0
377009|NCT00362609|918042|P2|COMPLETED|Overall Study||38
377010|NCT00362609|918043|P1|COMPLETED|Overall Study||19
377011|NCT00362609|918042|P2|STARTED|Overall Study||40
377012|NCT00362609|918043|P1|STARTED|Overall Study||19
377013|NCT00362466|918057|P2|NOT COMPLETED|Overall Study||0
377014|NCT00362466|918058|P1|NOT COMPLETED|Overall Study||0
377015|NCT00362466|918057|P2|COMPLETED|Overall Study||1
377016|NCT00362466|918058|P1|COMPLETED|Overall Study||2
377017|NCT00362466|918057|P2|STARTED|Overall Study||1
377018|NCT00362466|918058|P1|STARTED|Overall Study||2
377019|NCT00362453|918080|P2|NOT COMPLETED|Overall Study||0
377020|NCT00362453|918081|P1|NOT COMPLETED|Overall Study||0
377021|NCT00362453|918080|P2|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
377022|NCT00362453|918081|P1|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
377023|NCT00362453|918080|P2|STARTED|Overall Study||20
377024|NCT00362453|918081|P1|STARTED|Overall Study||20
377025|NCT00362440|918113|P2|NOT COMPLETED|Overall Study||1
377026|NCT00362440|918114|P1|NOT COMPLETED|Overall Study||2
377027|NCT00362440|918113|P2|COMPLETED|Overall Study||3
377028|NCT00362440|918114|P1|COMPLETED|Overall Study||3
377029|NCT00362440|918113|P2|STARTED|Overall Study||4
377030|NCT00362440|918114|P1|STARTED|Overall Study||5
377031|NCT00362414|918124|P1|NOT COMPLETED|Overall Study||3
377032|NCT00362414|918124|P1|COMPLETED|Overall Study||12
377033|NCT00362414|918124|P1|STARTED|Overall Study||15
377034|NCT00362401|918144|P3|NOT COMPLETED|Overall Study||0
377035|NCT00362401|918145|P2|NOT COMPLETED|Overall Study||0
377036|NCT00362401|918146|P1|NOT COMPLETED|Overall Study||0
377037|NCT00362401|918144|P3|COMPLETED|Overall Study||40
377038|NCT00362401|918145|P2|COMPLETED|Overall Study||29
377039|NCT00362401|918146|P1|COMPLETED|Overall Study||15
377040|NCT00362401|918144|P3|STARTED|Overall Study||40
377041|NCT00362401|918145|P2|STARTED|Overall Study||29
377042|NCT00362401|918146|P1|STARTED|Overall Study||15
377043|NCT00362375|918153|P2|NOT COMPLETED|Overall Study||35
377044|NCT00362375|918154|P1|NOT COMPLETED|Overall Study||40
377045|NCT00362375|918153|P2|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|117
377046|NCT00362375|918154|P1|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|121
377047|NCT00362375|918153|P2|STARTED|Overall Study|Number eligible and randomized|152
377048|NCT00362375|918154|P1|STARTED|Overall Study|Number eligible and randomized|161
377049|NCT00362336|918171|P3|NOT COMPLETED|Overall Study||3
377050|NCT00362336|918172|P2|NOT COMPLETED|Overall Study||7
377051|NCT00362336|918173|P1|NOT COMPLETED|Overall Study||10
377052|NCT00362336|918171|P3|COMPLETED|Overall Study||134
377053|NCT00362336|918172|P2|COMPLETED|Overall Study||235
377054|NCT00362336|918173|P1|COMPLETED|Overall Study||233
377055|NCT00362336|918171|P3|STARTED|Overall Study||137
377056|NCT00362336|918172|P2|STARTED|Overall Study||242
377057|NCT00362336|918173|P1|STARTED|Overall Study||243
377058|NCT00362297|918201|P2|NOT COMPLETED|Arm 2 (Cross-over to Other Dose)||0
377059|NCT00362297|918202|P1|NOT COMPLETED|Arm 2 (Cross-over to Other Dose)||0
377060|NCT00362297|918201|P2|COMPLETED|Arm 2 (Cross-over to Other Dose)||11
377061|NCT00362297|918202|P1|COMPLETED|Arm 2 (Cross-over to Other Dose)||16
377062|NCT00362297|918201|P2|STARTED|Arm 2 (Cross-over to Other Dose)||11
377063|NCT00362297|918202|P1|STARTED|Arm 2 (Cross-over to Other Dose)||16
377064|NCT00362297|918201|P2|NOT COMPLETED|Arm 1 (Initial Drug Assignment)||4
377065|NCT00362297|918202|P1|NOT COMPLETED|Arm 1 (Initial Drug Assignment)||0
377066|NCT00362297|918201|P2|COMPLETED|Arm 1 (Initial Drug Assignment)||11
377067|NCT00362297|918202|P1|COMPLETED|Arm 1 (Initial Drug Assignment)||16
377068|NCT00362297|918201|P2|STARTED|Arm 1 (Initial Drug Assignment)||15
377069|NCT00362297|918202|P1|STARTED|Arm 1 (Initial Drug Assignment)||16
377070|NCT00362232|918210|P2|NOT COMPLETED|Follow-up (30 (+ 5) Days)||39
377071|NCT00362232|918211|P1|NOT COMPLETED|Follow-up (30 (+ 5) Days)||38
377072|NCT00362232|918210|P2|COMPLETED|Follow-up (30 (+ 5) Days)||1416
377073|NCT00362232|918211|P1|COMPLETED|Follow-up (30 (+ 5) Days)||1433
377074|NCT00362232|918210|P2|STARTED|Follow-up (30 (+ 5) Days)||1455
377075|NCT00362232|918211|P1|STARTED|Follow-up (30 (+ 5) Days)||1471
377076|NCT00362232|918210|P2|NOT COMPLETED|Treatment (12 +/- 2 Days)||151
377077|NCT00362232|918211|P1|NOT COMPLETED|Treatment (12 +/- 2 Days)||159
377078|NCT00362232|918210|P2|COMPLETED|Treatment (12 +/- 2 Days)||1413
377079|NCT00362232|918211|P1|COMPLETED|Treatment (12 +/- 2 Days)||1425
377080|NCT00362232|918210|P2|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1508
377081|NCT00362232|918211|P1|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1526
377082|NCT00362232|918210|P2|STARTED|Treatment (12 +/- 2 Days)||1564
377083|NCT00362232|918211|P1|STARTED|Treatment (12 +/- 2 Days)||1584
377084|NCT00362180|918256|P9|NOT COMPLETED|20 Week Safety Follow-up||0
377085|NCT00362180|918257|P8|NOT COMPLETED|20 Week Safety Follow-up||0
377086|NCT00362180|918258|P7|NOT COMPLETED|20 Week Safety Follow-up||0
377087|NCT00362180|918259|P6|NOT COMPLETED|20 Week Safety Follow-up||0
377088|NCT00362180|918260|P5|NOT COMPLETED|20 Week Safety Follow-up||0
377089|NCT00362180|918261|P4|NOT COMPLETED|20 Week Safety Follow-up||0
377090|NCT00362180|918262|P3|NOT COMPLETED|20 Week Safety Follow-up||0
377091|NCT00362180|918263|P2|NOT COMPLETED|20 Week Safety Follow-up||0
377092|NCT00362180|918264|P1|NOT COMPLETED|20 Week Safety Follow-up||0
377093|NCT00362180|918256|P9|COMPLETED|20 Week Safety Follow-up||1
377094|NCT00362180|918257|P8|COMPLETED|20 Week Safety Follow-up||3
377095|NCT00362180|918258|P7|COMPLETED|20 Week Safety Follow-up||0
377096|NCT00362180|918259|P6|COMPLETED|20 Week Safety Follow-up||9
377097|NCT00362180|918260|P5|COMPLETED|20 Week Safety Follow-up||11
377098|NCT00362180|918261|P4|COMPLETED|20 Week Safety Follow-up||0
377099|NCT00362180|918262|P3|COMPLETED|20 Week Safety Follow-up||1
377100|NCT00362180|918263|P2|COMPLETED|20 Week Safety Follow-up||2
377101|NCT00362180|918264|P1|COMPLETED|20 Week Safety Follow-up||3
377102|NCT00362180|918256|P9|STARTED|20 Week Safety Follow-up||1
377103|NCT00362180|918257|P8|STARTED|20 Week Safety Follow-up||3
377104|NCT00362180|918258|P7|STARTED|20 Week Safety Follow-up|This observational cohort did not include a safety follow-up period.|0
377105|NCT00362180|918259|P6|STARTED|20 Week Safety Follow-up||9
377106|NCT00362180|918260|P5|STARTED|20 Week Safety Follow-up||11
377107|NCT00362180|918261|P4|STARTED|20 Week Safety Follow-up||0
377108|NCT00362180|918262|P3|STARTED|20 Week Safety Follow-up||1
377109|NCT00362180|918263|P2|STARTED|20 Week Safety Follow-up||2
377110|NCT00362180|918264|P1|STARTED|20 Week Safety Follow-up||3
377111|NCT00362180|918256|P9|NOT COMPLETED|Treated Period||0
377112|NCT00362180|918257|P8|NOT COMPLETED|Treated Period||1
377113|NCT00362180|918258|P7|NOT COMPLETED|Treated Period||0
377114|NCT00362180|918259|P6|NOT COMPLETED|Treated Period||1
377115|NCT00362180|918260|P5|NOT COMPLETED|Treated Period||0
377116|NCT00362180|918261|P4|NOT COMPLETED|Treated Period||0
377117|NCT00362180|918262|P3|NOT COMPLETED|Treated Period||0
377118|NCT00362180|918263|P2|NOT COMPLETED|Treated Period||0
377119|NCT00362180|918264|P1|NOT COMPLETED|Treated Period||1
377120|NCT00362180|918256|P9|COMPLETED|Treated Period||1
377121|NCT00362180|918257|P8|COMPLETED|Treated Period||2
377122|NCT00362180|918258|P7|COMPLETED|Treated Period||6
377123|NCT00362180|918259|P6|COMPLETED|Treated Period||9
377124|NCT00362180|918260|P5|COMPLETED|Treated Period||11
377125|NCT00362180|918261|P4|COMPLETED|Treated Period||0
377126|NCT00362180|918262|P3|COMPLETED|Treated Period||1
377127|NCT00362180|918263|P2|COMPLETED|Treated Period||2
377128|NCT00362180|918264|P1|COMPLETED|Treated Period||3
377129|NCT00362180|918256|P9|STARTED|Treated Period||1
377130|NCT00362180|918257|P8|STARTED|Treated Period||3
377131|NCT00362180|918258|P7|STARTED|Treated Period||6
377132|NCT00362180|918259|P6|STARTED|Treated Period||10
377133|NCT00362180|918260|P5|STARTED|Treated Period||11
377134|NCT00362180|918261|P4|STARTED|Treated Period||0
377135|NCT00362180|918262|P3|STARTED|Treated Period||1
377136|NCT00362180|918263|P2|STARTED|Treated Period||2
377137|NCT00362180|918264|P1|STARTED|Treated Period||4
377138|NCT00362128|918325|P1|NOT COMPLETED|Overall Study||0
377139|NCT00362128|918325|P1|COMPLETED|Overall Study|Enrollment was completed in October 2009.|2072
377140|NCT00362128|918325|P1|STARTED|Overall Study|Enrollment was initiated in 2007.|2072
377141|NCT00362115|918336|P7|NOT COMPLETED|Overall Study||12
377142|NCT00362115|918337|P6|NOT COMPLETED|Overall Study||7
377143|NCT00362115|918338|P5|NOT COMPLETED|Overall Study||7
377144|NCT00362115|918339|P4|NOT COMPLETED|Overall Study||4
377145|NCT00362115|918340|P3|NOT COMPLETED|Overall Study||7
377146|NCT00362115|918341|P2|NOT COMPLETED|Overall Study||6
377147|NCT00362115|918342|P1|NOT COMPLETED|Overall Study||2
377148|NCT00362115|918336|P7|COMPLETED|Overall Study||52
377149|NCT00362115|918337|P6|COMPLETED|Overall Study||57
377150|NCT00362115|918338|P5|COMPLETED|Overall Study||57
377151|NCT00362115|918339|P4|COMPLETED|Overall Study||59
377152|NCT00362115|918340|P3|COMPLETED|Overall Study||57
377153|NCT00362115|918341|P2|COMPLETED|Overall Study||59
377154|NCT00362115|918342|P1|COMPLETED|Overall Study||63
377155|NCT00362115|918336|P7|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
377156|NCT00362115|918337|P6|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
377157|NCT00362115|918338|P5|STARTED|Overall Study||64
377158|NCT00362115|918339|P4|STARTED|Overall Study|1 participant failed to receive double-blind medication.|63
377159|NCT00362115|918340|P3|STARTED|Overall Study||64
377160|NCT00362115|918341|P2|STARTED|Overall Study|1 participant failed to receive double-blind medication.|65
377161|NCT00362115|918342|P1|STARTED|Overall Study||65
377162|NCT00361972|918493|P2|NOT COMPLETED|Overall Study||0
377163|NCT00361972|918494|P1|NOT COMPLETED|Overall Study||0
377164|NCT00361972|918493|P2|COMPLETED|Overall Study||9
377165|NCT00361972|918494|P1|COMPLETED|Overall Study||8
377166|NCT00361972|918493|P2|STARTED|Overall Study||9
377167|NCT00361972|918494|P1|STARTED|Overall Study||8
377168|NCT00361712|918504|P2|NOT COMPLETED|Overall Study||0
377169|NCT00361712|918505|P1|NOT COMPLETED|Overall Study||0
377170|NCT00361712|918504|P2|COMPLETED|Overall Study||21
377171|NCT00361712|918505|P1|COMPLETED|Overall Study||20
377172|NCT00361712|918504|P2|STARTED|Overall Study||21
377173|NCT00361712|918505|P1|STARTED|Overall Study||20
377174|NCT00361634|918515|P1|NOT COMPLETED|Overall Study||2
377175|NCT00361634|918515|P1|COMPLETED|Overall Study||12
377176|NCT00361634|918515|P1|Treated|Overall Study|The safety analysis set consisted of all patients who received at least one dose of etanercept.|13
377177|NCT00361634|918515|P1|STARTED|Overall Study||14
377178|NCT00361595|918533|P1|NOT COMPLETED|Overall Study||0
377179|NCT00361595|918533|P1|COMPLETED|Overall Study||35
377180|NCT00361595|918533|P1|STARTED|Overall Study||35
377181|NCT00361569|918544|P4|NOT COMPLETED|Overall Study||21
377182|NCT00361569|918545|P3|NOT COMPLETED|Overall Study||18
377183|NCT00361569|918546|P2|NOT COMPLETED|Overall Study||11
377184|NCT00361569|918547|P1|NOT COMPLETED|Overall Study||12
377185|NCT00361569|918544|P4|COMPLETED|Overall Study||135
377186|NCT00361569|918545|P3|COMPLETED|Overall Study||137
377187|NCT00361569|918546|P2|COMPLETED|Overall Study||150
377188|NCT00361569|918547|P1|COMPLETED|Overall Study||138
377189|NCT00361569|918544|P4|STARTED|Overall Study||156
377190|NCT00361569|918545|P3|STARTED|Overall Study||155
377191|NCT00361569|918546|P2|STARTED|Overall Study||161
377192|NCT00361569|918547|P1|STARTED|Overall Study||150
377193|NCT00361504|918571|P2|NOT COMPLETED|Overall Study||145
377194|NCT00361504|918572|P1|NOT COMPLETED|Overall Study||481
377195|NCT00361504|918571|P2|COMPLETED|Overall Study||78
377196|NCT00361504|918572|P1|COMPLETED|Overall Study||413
377197|NCT00361504|918571|P2|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|223
377198|NCT00361504|918572|P1|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|894
377199|NCT00361439|918582|P2|NOT COMPLETED|Overall Study||0
377200|NCT00361439|918583|P1|NOT COMPLETED|Overall Study||0
377201|NCT00361439|918582|P2|COMPLETED|Overall Study||9
377202|NCT00361439|918583|P1|COMPLETED|Overall Study||8
377203|NCT00361439|918582|P2|STARTED|Overall Study||9
377204|NCT00361439|918583|P1|STARTED|Overall Study||8
377205|NCT00361374|918598|P3|NOT COMPLETED|Overall Study||12
377206|NCT00361374|918599|P2|NOT COMPLETED|Overall Study||15
377207|NCT00361374|918600|P1|NOT COMPLETED|Overall Study||15
377208|NCT00361374|918598|P3|COMPLETED|Overall Study||53
377209|NCT00361374|918599|P2|COMPLETED|Overall Study||50
377210|NCT00361374|918600|P1|COMPLETED|Overall Study||51
377211|NCT00361374|918598|P3|STARTED|Overall Study||65
377212|NCT00361374|918599|P2|STARTED|Overall Study||65
377213|NCT00361374|918600|P1|STARTED|Overall Study||66
377214|NCT00361335|918613|P7|NOT COMPLETED|SC Period: Week E0 to Week E24||9
377215|NCT00361335|918614|P6|NOT COMPLETED|SC Period: Week E0 to Week E24||1
377216|NCT00361335|918615|P5|NOT COMPLETED|SC Period: Week E0 to Week E24||0
377217|NCT00361335|918616|P4|NOT COMPLETED|SC Period: Week E0 to Week E24||4
377218|NCT00361335|918617|P3|NOT COMPLETED|SC Period: Week E0 to Week E24||5
377219|NCT00361335|918618|P2|NOT COMPLETED|SC Period: Week E0 to Week E24||3
377220|NCT00361335|918619|P1|NOT COMPLETED|SC Period: Week E0 to Week E24||2
377221|NCT00361335|918613|P7|COMPLETED|SC Period: Week E0 to Week E24||164
377222|NCT00361335|918614|P6|COMPLETED|SC Period: Week E0 to Week E24||23
377223|NCT00361335|918615|P5|COMPLETED|SC Period: Week E0 to Week E24||3
377224|NCT00361335|918616|P4|COMPLETED|SC Period: Week E0 to Week E24||59
377225|NCT00361335|918617|P3|COMPLETED|SC Period: Week E0 to Week E24||99
377226|NCT00361335|918618|P2|COMPLETED|SC Period: Week E0 to Week E24||56
377227|NCT00361335|918619|P1|COMPLETED|SC Period: Week E0 to Week E24||80
377228|NCT00361335|918613|P7|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|173
377229|NCT00361335|918614|P6|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|24
377230|NCT00361335|918615|P5|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|3
377231|NCT00361335|918616|P4|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|63
377232|NCT00361335|918617|P3|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|104
377233|NCT00361335|918618|P2|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|59
377234|NCT00361335|918619|P1|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|82
377235|NCT00361335|918613|P7|NOT COMPLETED|IV Period: Baseline to E0||0
377236|NCT00361335|918614|P6|NOT COMPLETED|IV Period: Baseline to E0||0
377237|NCT00361335|918615|P5|NOT COMPLETED|IV Period: Baseline to E0||24
377238|NCT00361335|918616|P4|NOT COMPLETED|IV Period: Baseline to E0||27
377239|NCT00361335|918617|P3|NOT COMPLETED|IV Period: Baseline to E0||21
377240|NCT00361335|918618|P2|NOT COMPLETED|IV Period: Baseline to E0||29
377241|NCT00361335|918619|P1|NOT COMPLETED|IV Period: Baseline to E0||20
377242|NCT00361335|918613|P7|COMPLETED|IV Period: Baseline to E0||0
377243|NCT00361335|918614|P6|COMPLETED|IV Period: Baseline to E0||0
377244|NCT00361335|918615|P5|COMPLETED|IV Period: Baseline to E0||105
377245|NCT00361335|918616|P4|COMPLETED|IV Period: Baseline to E0||102
377246|NCT00361335|918617|P3|COMPLETED|IV Period: Baseline to E0||107
377247|NCT00361335|918618|P2|COMPLETED|IV Period: Baseline to E0||99
377248|NCT00361335|918619|P1|COMPLETED|IV Period: Baseline to E0||109
377249|NCT00361335|918613|P7|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
377250|NCT00361335|918614|P6|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
377251|NCT00361335|918615|P5|STARTED|IV Period: Baseline to E0||129
377252|NCT00361335|918616|P4|STARTED|IV Period: Baseline to E0||129
377253|NCT00361335|918617|P3|STARTED|IV Period: Baseline to E0||128
377254|NCT00361335|918618|P2|STARTED|IV Period: Baseline to E0||128
377255|NCT00361335|918619|P1|STARTED|IV Period: Baseline to E0||129
377256|NCT00361296|918663|P1|NOT COMPLETED|Overall Study||3
377257|NCT00361296|918663|P1|COMPLETED|Overall Study||2
377258|NCT00361296|918663|P1|STARTED|Overall Study||5
377259|NCT00361283|918670|P1|NOT COMPLETED|Overall Study||27
377260|NCT00361283|918670|P1|COMPLETED|Overall Study||81
377261|NCT00361283|918670|P1|STARTED|Overall Study||108
377262|NCT00361270|918678|P4|NOT COMPLETED|Overall Study||13
377263|NCT00361270|918679|P3|NOT COMPLETED|Overall Study||10
377264|NCT00361270|918680|P2|NOT COMPLETED|Overall Study||14
377265|NCT00361270|918681|P1|NOT COMPLETED|Overall Study||24
377266|NCT00361270|918678|P4|COMPLETED|Overall Study||25
377267|NCT00361270|918679|P3|COMPLETED|Overall Study||25
377268|NCT00361270|918680|P2|COMPLETED|Overall Study||25
377269|NCT00361270|918681|P1|COMPLETED|Overall Study||25
377270|NCT00361270|918678|P4|STARTED|Overall Study||38
377271|NCT00361270|918679|P3|STARTED|Overall Study||35
377272|NCT00361270|918680|P2|STARTED|Overall Study||39
377273|NCT00361270|918681|P1|STARTED|Overall Study||49
377274|NCT00361257|918701|P2|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
377275|NCT00361257|918702|P1|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
377276|NCT00361257|918701|P2|COMPLETED|Step 2: Minocycline(Open Label) for All||19
377277|NCT00361257|918702|P1|COMPLETED|Step 2: Minocycline(Open Label) for All||13
377278|NCT00361257|918701|P2|STARTED|Step 2: Minocycline(Open Label) for All|43 participants completed Step 1; however, 9 decided not to enroll Step 2,so 43-9=34 started Step 2.|34
377279|NCT00361257|918702|P1|STARTED|Step 2: Minocycline(Open Label) for All|40 participants completed Step 1; however,12 decided not to enroll Step 2,so 40-12=28 started Step 2|28
377280|NCT00361257|918701|P2|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
377281|NCT00361257|918702|P1|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
377282|NCT00361257|918701|P2|COMPLETED|Step 1: Minocycline vs. Placebo||43
377283|NCT00361257|918702|P1|COMPLETED|Step 1: Minocycline vs. Placebo||40
377284|NCT00361257|918701|P2|STARTED|Step 1: Minocycline vs. Placebo||55
377285|NCT00361257|918702|P1|STARTED|Step 1: Minocycline vs. Placebo||52
377286|NCT00361231|918754|P1|NOT COMPLETED|Overall Study||34
377287|NCT00361231|918754|P1|COMPLETED|Overall Study||1
377288|NCT00361231|918754|P1|STARTED|Overall Study||35
377289|NCT00361218|918759|P1|NOT COMPLETED|Overall Study||23
377290|NCT00361218|918759|P1|COMPLETED|Overall Study||30
377291|NCT00361218|918759|P1|Completed Baseline Assessment|Overall Study||47
377292|NCT00361218|918759|P1|STARTED|Overall Study|met eligibility criteria and enrolled in the study|53
377293|NCT00361140|918767|P3|NOT COMPLETED|Overall Study||0
377294|NCT00361140|918768|P2|NOT COMPLETED|Overall Study||0
377295|NCT00361140|918769|P1|NOT COMPLETED|Overall Study||0
377296|NCT00361140|918767|P3|COMPLETED|Overall Study||3
377297|NCT00361140|918768|P2|COMPLETED|Overall Study||29
377298|NCT00361140|918769|P1|COMPLETED|Overall Study||40
377299|NCT00361140|918767|P3|STARTED|Overall Study||3
377300|NCT00361140|918768|P2|STARTED|Overall Study||29
377301|NCT00361140|918769|P1|STARTED|Overall Study||40
377302|NCT00360971|918782|P2|NOT COMPLETED|Overall Study||0
377303|NCT00360971|918783|P1|NOT COMPLETED|Overall Study||0
377304|NCT00360971|918782|P2|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|11
377305|NCT00360971|918783|P1|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|10
377306|NCT00360971|918782|P2|STARTED|Overall Study||11
377307|NCT00360971|918783|P1|STARTED|Overall Study||10
377308|NCT00360828|918799|P1|NOT COMPLETED|Overall Study||1
377309|NCT00360828|918799|P1|COMPLETED|Overall Study||9
377310|NCT00360828|918799|P1|STARTED|Overall Study||10
377311|NCT00360724|918809|P2|NOT COMPLETED|Overall Study||4
377312|NCT00360724|918810|P1|NOT COMPLETED|Overall Study||4
377313|NCT00360724|918809|P2|COMPLETED|Overall Study||28
377314|NCT00360724|918810|P1|COMPLETED|Overall Study||29
377315|NCT00360724|918809|P2|STARTED|Overall Study||32
377316|NCT00360724|918810|P1|STARTED|Overall Study||33
377317|NCT00360698|918838|P2|NOT COMPLETED|Treatment Period||1
377318|NCT00360698|918839|P1|NOT COMPLETED|Treatment Period||1
377319|NCT00360698|918838|P2|COMPLETED|Treatment Period||56
377320|NCT00360698|918839|P1|COMPLETED|Treatment Period||48
377321|NCT00360698|918838|P2|STARTED|Treatment Period||57
377322|NCT00360698|918839|P1|STARTED|Treatment Period||49
377323|NCT00360698|918838|P2|NOT COMPLETED|Run-In||10
377324|NCT00360698|918839|P1|NOT COMPLETED|Run-In||0
377325|NCT00360698|918838|P2|COMPLETED|Run-In|19 patients completed the run-in but were not eligible for randomization in the treatment period|125
377326|NCT00360698|918839|P1|COMPLETED|Run-In||0
377327|NCT00360698|918838|P2|STARTED|Run-In||135
377328|NCT00360698|918839|P1|STARTED|Run-In||0
377329|NCT00360685|918867|P2|NOT COMPLETED|Overall Study||0
377330|NCT00360685|918868|P1|NOT COMPLETED|Overall Study||0
377331|NCT00360685|918867|P2|COMPLETED|Overall Study||42
377332|NCT00360685|918868|P1|COMPLETED|Overall Study||47
377333|NCT00360685|918867|P2|STARTED|Overall Study||42
377334|NCT00360685|918868|P1|STARTED|Overall Study||47
377335|NCT00360672|918878|P1|NOT COMPLETED|Overall Study||0
377336|NCT00360672|918878|P1|COMPLETED|Overall Study||27
377337|NCT00360672|918878|P1|STARTED|Overall Study||27
377338|NCT00360568|918884|P2|NOT COMPLETED|Overall Study||5
377339|NCT00360568|918885|P1|NOT COMPLETED|Overall Study||2
377340|NCT00360568|918884|P2|COMPLETED|Overall Study||24
377341|NCT00360568|918885|P1|COMPLETED|Overall Study||31
377342|NCT00360568|918884|P2|STARTED|Overall Study||29
377343|NCT00360568|918885|P1|STARTED|Overall Study||33
377344|NCT00360555|918996|P4|NOT COMPLETED|Overall Study||112
377345|NCT00360555|918997|P3|NOT COMPLETED|Overall Study||145
377346|NCT00360555|918998|P2|NOT COMPLETED|Overall Study||134
377347|NCT00360555|918999|P1|NOT COMPLETED|Overall Study||122
377348|NCT00360555|918996|P4|COMPLETED|Overall Study||287
377349|NCT00360555|918997|P3|COMPLETED|Overall Study||251
377350|NCT00360555|918998|P2|COMPLETED|Overall Study||259
377351|NCT00360555|918999|P1|COMPLETED|Overall Study||274
377352|NCT00360555|918996|P4|STARTED|Overall Study||399
377353|NCT00360555|918997|P3|STARTED|Overall Study||396
377354|NCT00360555|918998|P2|STARTED|Overall Study||393
377355|NCT00360555|918999|P1|STARTED|Overall Study||396
377356|NCT00360529|919016|P3|NOT COMPLETED|Overall Study||91
377357|NCT00360529|919017|P2|NOT COMPLETED|Overall Study||65
377358|NCT00360529|919018|P1|NOT COMPLETED|Overall Study||61
377359|NCT00360529|919016|P3|COMPLETED|Overall Study||199
377360|NCT00360529|919017|P2|COMPLETED|Overall Study||230
377361|NCT00360529|919018|P1|COMPLETED|Overall Study||234
377362|NCT00360529|919016|P3|STARTED|Overall Study||290
377363|NCT00360529|919017|P2|STARTED|Overall Study||295
377364|NCT00360529|919018|P1|STARTED|Overall Study||295
377365|NCT00360490|919046|P2|NOT COMPLETED|Overall Study||11
377366|NCT00360490|919047|P1|NOT COMPLETED|Overall Study||9
377367|NCT00360490|919046|P2|COMPLETED|Overall Study||72
377368|NCT00360490|919047|P1|COMPLETED|Overall Study||73
377369|NCT00360490|919046|P2|STARTED|Overall Study||83
377370|NCT00360490|919047|P1|STARTED|Overall Study||82
377371|NCT00360412|919082|P2|NOT COMPLETED|Overall Study||662
377372|NCT00360412|919083|P1|NOT COMPLETED|Overall Study||333
377373|NCT00360412|919082|P2|COMPLETED|Overall Study||2
377374|NCT00360412|919083|P1|COMPLETED|Overall Study||0
377375|NCT00360412|919082|P2|STARTED|Overall Study||664
377376|NCT00360412|919083|P1|STARTED|Overall Study||333
377377|NCT00360399|919098|P3|NOT COMPLETED|Overall Study||46
377378|NCT00360399|919099|P2|NOT COMPLETED|Overall Study||36
377379|NCT00360399|919100|P1|NOT COMPLETED|Overall Study||28
377380|NCT00360399|919098|P3|COMPLETED|Overall Study||69
377381|NCT00360399|919099|P2|COMPLETED|Overall Study||79
377382|NCT00360399|919100|P1|COMPLETED|Overall Study||86
377383|NCT00360399|919098|P3|Had Post-randomization Assessment|Overall Study||105
377384|NCT00360399|919099|P2|Had Post-randomization Assessment|Overall Study||106
377385|NCT00360399|919100|P1|Had Post-randomization Assessment|Overall Study||105
377386|NCT00360399|919098|P3|STARTED|Overall Study||115
377387|NCT00360399|919099|P2|STARTED|Overall Study||115
377388|NCT00360399|919100|P1|STARTED|Overall Study||114
377389|NCT00360360|919123|P1|NOT COMPLETED|Overall Study||6
377390|NCT00360360|919123|P1|COMPLETED|Overall Study||54
377391|NCT00360360|919123|P1|STARTED|Overall Study||60
377392|NCT00360334|919130|P2|NOT COMPLETED|Overall Study||13
377393|NCT00360334|919131|P1|NOT COMPLETED|Overall Study||19
377394|NCT00360334|919130|P2|COMPLETED|Overall Study||104
377395|NCT00360334|919131|P1|COMPLETED|Overall Study||99
377396|NCT00360334|919130|P2|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|116
377397|NCT00360334|919131|P1|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|118
377398|NCT00360334|919130|P2|STARTED|Overall Study||117
377399|NCT00360334|919131|P1|STARTED|Overall Study||118
377400|NCT00360308|919194|P3|NOT COMPLETED|Overall Study||88
377401|NCT00360308|919195|P2|NOT COMPLETED|Overall Study||79
377402|NCT00360308|919196|P1|NOT COMPLETED|Overall Study||76
377403|NCT00360308|919194|P3|COMPLETED|Overall Study||154
377404|NCT00360308|919195|P2|COMPLETED|Overall Study||155
377405|NCT00360308|919196|P1|COMPLETED|Overall Study||171
377406|NCT00360308|919194|P3|STARTED|Overall Study||242
377407|NCT00360308|919195|P2|STARTED|Overall Study||234
377408|NCT00360308|919196|P1|STARTED|Overall Study||247
377409|NCT00360282|919213|P4|NOT COMPLETED|Second Intervention||0
377410|NCT00360282|919214|P3|NOT COMPLETED|Second Intervention||0
377411|NCT00360282|919215|P2|NOT COMPLETED|Second Intervention||1
377412|NCT00360282|919216|P1|NOT COMPLETED|Second Intervention||0
377413|NCT00360282|919213|P4|COMPLETED|Second Intervention||6
377414|NCT00360282|919214|P3|COMPLETED|Second Intervention||6
377415|NCT00360282|919215|P2|COMPLETED|Second Intervention||7
377416|NCT00360282|919216|P1|COMPLETED|Second Intervention||6
377417|NCT00360282|919213|P4|STARTED|Second Intervention||6
377418|NCT00360282|919214|P3|STARTED|Second Intervention||6
377419|NCT00360282|919215|P2|STARTED|Second Intervention||8
377420|NCT00360282|919216|P1|STARTED|Second Intervention||6
377421|NCT00360282|919213|P4|NOT COMPLETED|Washout 1-3 Weeks||0
377422|NCT00360282|919214|P3|NOT COMPLETED|Washout 1-3 Weeks||1
377423|NCT00360282|919215|P2|NOT COMPLETED|Washout 1-3 Weeks||0
377424|NCT00360282|919216|P1|NOT COMPLETED|Washout 1-3 Weeks||0
377425|NCT00360282|919213|P4|COMPLETED|Washout 1-3 Weeks||6
377426|NCT00360282|919214|P3|COMPLETED|Washout 1-3 Weeks||6
377427|NCT00360282|919215|P2|COMPLETED|Washout 1-3 Weeks||8
377428|NCT00360282|919216|P1|COMPLETED|Washout 1-3 Weeks||6
377429|NCT00360282|919213|P4|STARTED|Washout 1-3 Weeks||6
377430|NCT00360282|919214|P3|STARTED|Washout 1-3 Weeks||7
377431|NCT00360282|919215|P2|STARTED|Washout 1-3 Weeks||8
377432|NCT00360282|919216|P1|STARTED|Washout 1-3 Weeks||6
377433|NCT00360282|919213|P4|NOT COMPLETED|First Intervention||0
377434|NCT00360282|919214|P3|NOT COMPLETED|First Intervention||0
377435|NCT00360282|919215|P2|NOT COMPLETED|First Intervention||0
377436|NCT00360282|919216|P1|NOT COMPLETED|First Intervention||0
377437|NCT00360282|919213|P4|COMPLETED|First Intervention||6
377438|NCT00360282|919214|P3|COMPLETED|First Intervention||7
377439|NCT00360282|919215|P2|COMPLETED|First Intervention||8
377440|NCT00360282|919216|P1|COMPLETED|First Intervention||6
377441|NCT00360282|919213|P4|STARTED|First Intervention||6
377442|NCT00360282|919214|P3|STARTED|First Intervention||7
377443|NCT00360282|919215|P2|STARTED|First Intervention||8
377444|NCT00360282|919216|P1|STARTED|First Intervention||6
377445|NCT00360269|919228|P2|NOT COMPLETED|Overall Study||12
377446|NCT00360269|919229|P1|NOT COMPLETED|Overall Study||10
377447|NCT00360269|919228|P2|COMPLETED|Overall Study||7
377448|NCT00360269|919229|P1|COMPLETED|Overall Study||9
377449|NCT00360269|919228|P2|STARTED|Overall Study||19
377450|NCT00360269|919229|P1|STARTED|Overall Study||19
377451|NCT00360243|919247|P4|NOT COMPLETED|Overall Study||125
377452|NCT00360243|919248|P3|NOT COMPLETED|Overall Study||156
377453|NCT00360243|919249|P2|NOT COMPLETED|Overall Study||120
377454|NCT00360243|919250|P1|NOT COMPLETED|Overall Study||102
377455|NCT00360243|919247|P4|COMPLETED|Overall Study||224
377456|NCT00360243|919248|P3|COMPLETED|Overall Study||180
377457|NCT00360243|919249|P2|COMPLETED|Overall Study||243
377458|NCT00360243|919250|P1|COMPLETED|Overall Study||235
377459|NCT00360243|919247|P4|STARTED|Overall Study||349
377460|NCT00360243|919248|P3|STARTED|Overall Study||336
377461|NCT00360243|919249|P2|STARTED|Overall Study||363
377462|NCT00360243|919250|P1|STARTED|Overall Study||337
377463|NCT00360230|919271|P7|NOT COMPLETED|Overall Study||2
377464|NCT00360230|919272|P6|NOT COMPLETED|Overall Study||4
377465|NCT00360230|919273|P5|NOT COMPLETED|Overall Study||5
377466|NCT00360230|919274|P4|NOT COMPLETED|Overall Study||2
377467|NCT00360230|919275|P3|NOT COMPLETED|Overall Study||3
377468|NCT00360230|919276|P2|NOT COMPLETED|Overall Study||3
377469|NCT00360230|919277|P1|NOT COMPLETED|Overall Study||6
377470|NCT00360230|919271|P7|COMPLETED|Overall Study||43
377471|NCT00360230|919272|P6|COMPLETED|Overall Study||86
377472|NCT00360230|919273|P5|COMPLETED|Overall Study||85
377473|NCT00360230|919274|P4|COMPLETED|Overall Study||88
377474|NCT00360230|919275|P3|COMPLETED|Overall Study||42
377475|NCT00360230|919276|P2|COMPLETED|Overall Study||87
377476|NCT00360230|919277|P1|COMPLETED|Overall Study||84
377477|NCT00360230|919271|P7|STARTED|Overall Study||45
377478|NCT00360230|919272|P6|STARTED|Overall Study||90
377479|NCT00360230|919273|P5|STARTED|Overall Study||90
377480|NCT00360230|919274|P4|STARTED|Overall Study||90
377481|NCT00360230|919275|P3|STARTED|Overall Study||45
377482|NCT00360230|919276|P2|STARTED|Overall Study||90
377483|NCT00360230|919277|P1|STARTED|Overall Study||90
377484|NCT00360126|919328|P1|NOT COMPLETED|Overall Study||0
377485|NCT00360126|919328|P1|COMPLETED|Overall Study||11
377486|NCT00360126|919328|P1|STARTED|Overall Study||11
377487|NCT00360009|919335|P3|NOT COMPLETED|Overall Study||3
377488|NCT00360009|919336|P2|NOT COMPLETED|Overall Study||4
377489|NCT00360009|919337|P1|NOT COMPLETED|Overall Study||0
377490|NCT00360009|919335|P3|COMPLETED|Overall Study||23
377491|NCT00360009|919336|P2|COMPLETED|Overall Study||22
377492|NCT00360009|919337|P1|COMPLETED|Overall Study||10
377493|NCT00360009|919335|P3|STARTED|Overall Study||26
377494|NCT00360009|919336|P2|STARTED|Overall Study||26
377495|NCT00360009|919337|P1|STARTED|Overall Study||10
377496|NCT00359983|919378|P3|NOT COMPLETED|Year 5 Persistence Follow-up||0
377497|NCT00359983|919379|P2|NOT COMPLETED|Year 5 Persistence Follow-up||0
377498|NCT00359983|919380|P1|NOT COMPLETED|Year 5 Persistence Follow-up||0
377499|NCT00359983|919378|P3|COMPLETED|Year 5 Persistence Follow-up||42
377500|NCT00359983|919379|P2|COMPLETED|Year 5 Persistence Follow-up||44
377501|NCT00359983|919380|P1|COMPLETED|Year 5 Persistence Follow-up||95
377502|NCT00359983|919378|P3|STARTED|Year 5 Persistence Follow-up||42
377503|NCT00359983|919379|P2|STARTED|Year 5 Persistence Follow-up||44
377504|NCT00359983|919380|P1|STARTED|Year 5 Persistence Follow-up||95
377505|NCT00359983|919378|P3|NOT COMPLETED|Year 3 Persistence Follow-up||0
377506|NCT00359983|919379|P2|NOT COMPLETED|Year 3 Persistence Follow-up||0
377507|NCT00359983|919380|P1|NOT COMPLETED|Year 3 Persistence Follow-up||0
377508|NCT00359983|919378|P3|COMPLETED|Year 3 Persistence Follow-up||51
377509|NCT00359983|919379|P2|COMPLETED|Year 3 Persistence Follow-up||47
377510|NCT00359983|919380|P1|COMPLETED|Year 3 Persistence Follow-up||103
377511|NCT00359983|919378|P3|STARTED|Year 3 Persistence Follow-up||51
377512|NCT00359983|919379|P2|STARTED|Year 3 Persistence Follow-up||47
377513|NCT00359983|919380|P1|STARTED|Year 3 Persistence Follow-up||103
377514|NCT00359983|919378|P3|NOT COMPLETED|Year 1 Persistence Follow-up||0
377515|NCT00359983|919379|P2|NOT COMPLETED|Year 1 Persistence Follow-up||0
377516|NCT00359983|919380|P1|NOT COMPLETED|Year 1 Persistence Follow-up||0
377517|NCT00359983|919378|P3|COMPLETED|Year 1 Persistence Follow-up||62
377518|NCT00359983|919379|P2|COMPLETED|Year 1 Persistence Follow-up||70
377519|NCT00359983|919380|P1|COMPLETED|Year 1 Persistence Follow-up||138
377520|NCT00359983|919378|P3|STARTED|Year 1 Persistence Follow-up||62
377521|NCT00359983|919379|P2|STARTED|Year 1 Persistence Follow-up||70
377522|NCT00359983|919380|P1|STARTED|Year 1 Persistence Follow-up||138
377523|NCT00359944|919415|P3|NOT COMPLETED|Overall Study||19
377524|NCT00359944|919416|P2|NOT COMPLETED|Overall Study||19
377525|NCT00359944|919417|P1|NOT COMPLETED|Overall Study||16
377526|NCT00359944|919415|P3|COMPLETED|Overall Study||38
377527|NCT00359944|919416|P2|COMPLETED|Overall Study||28
377528|NCT00359944|919417|P1|COMPLETED|Overall Study||34
377529|NCT00359944|919415|P3|STARTED|Overall Study||57
377530|NCT00359944|919416|P2|STARTED|Overall Study||47
377531|NCT00359944|919417|P1|STARTED|Overall Study||50
377532|NCT00359801|919433|P2|NOT COMPLETED|Overall Study||220
377533|NCT00359801|919434|P1|NOT COMPLETED|Overall Study||305
377534|NCT00359801|919433|P2|COMPLETED|Overall Study|4 additional subjects had missing data and final status (completed/discontinued) is unknown.|769
377535|NCT00359801|919434|P1|COMPLETED|Overall Study|7 additional subjects had missing data and final status (completed/discontinued) is unknown.|682
377536|NCT00359801|919433|P2|STARTED|Overall Study||989
377537|NCT00359801|919434|P1|STARTED|Overall Study||987
377538|NCT00359788|919468|P2|NOT COMPLETED|Overall Study||17
377539|NCT00359788|919469|P1|NOT COMPLETED|Overall Study||23
377540|NCT00359788|919468|P2|COMPLETED|Overall Study||159
377541|NCT00359788|919469|P1|COMPLETED|Overall Study||150
377542|NCT00359788|919468|P2|STARTED|Overall Study||176
377543|NCT00359788|919469|P1|STARTED|Overall Study||173
377544|NCT00359762|919703|P5|NOT COMPLETED|Period I||0
377545|NCT00359762|919704|P4|NOT COMPLETED|Period I||0
377546|NCT00359762|919705|P3|NOT COMPLETED|Period I||0
377547|NCT00359762|919706|P2|NOT COMPLETED|Period I||0
377548|NCT00359762|919707|P1|NOT COMPLETED|Period I||0
377549|NCT00359762|919703|P5|COMPLETED|Period I||0
377550|NCT00359762|919704|P4|COMPLETED|Period I||0
377551|NCT00359762|919705|P3|COMPLETED|Period I||0
377552|NCT00359762|919706|P2|COMPLETED|Period I||0
377553|NCT00359762|919707|P1|COMPLETED|Period I||0
377554|NCT00359762|919703|P5|STARTED|Period I||0
377555|NCT00359762|919704|P4|STARTED|Period I||0
377556|NCT00359762|919705|P3|STARTED|Period I||0
377557|NCT00359762|919706|P2|STARTED|Period I||0
377558|NCT00359762|919707|P1|STARTED|Period I||0
377559|NCT00359762|919703|P5|NOT COMPLETED|Period III||0
377560|NCT00359762|919704|P4|NOT COMPLETED|Period III||65
377561|NCT00359762|919705|P3|NOT COMPLETED|Period III||30
377562|NCT00359762|919706|P2|NOT COMPLETED|Period III||29
377563|NCT00359762|919707|P1|NOT COMPLETED|Period III||0
377564|NCT00359762|919703|P5|COMPLETED|Period III||0
377565|NCT00359762|919704|P4|COMPLETED|Period III||101
377566|NCT00359762|919705|P3|COMPLETED|Period III||47
377567|NCT00359762|919706|P2|COMPLETED|Period III||48
377568|NCT00359762|919707|P1|COMPLETED|Period III||0
377569|NCT00359762|919703|P5|Extension ITT Efficacy Population|Period III||0
377570|NCT00359762|919704|P4|Extension ITT Efficacy Population|Period III||164
377571|NCT00359762|919705|P3|Extension ITT Efficacy Population|Period III||75
377572|NCT00359762|919706|P2|Extension ITT Efficacy Population|Period III||73
377573|NCT00359762|919707|P1|Extension ITT Efficacy Population|Period III||0
377574|NCT00359762|919703|P5|Extension ITT Safety Population|Period III||0
377575|NCT00359762|919704|P4|Extension ITT Safety Population|Period III||166
377576|NCT00359762|919705|P3|Extension ITT Safety Population|Period III||76
377577|NCT00359762|919706|P2|Extension ITT Safety Population|Period III||74
377578|NCT00359762|919707|P1|Extension ITT Safety Population|Period III||0
377579|NCT00359762|919703|P5|STARTED|Period III||0
377580|NCT00359762|919704|P4|STARTED|Period III||166
377581|NCT00359762|919705|P3|STARTED|Period III||77
377582|NCT00359762|919706|P2|STARTED|Period III||77
377583|NCT00359762|919707|P1|STARTED|Period III||0
377584|NCT00359762|919703|P5|NOT COMPLETED|Period II||174
377585|NCT00359762|919704|P4|NOT COMPLETED|Period II||0
377586|NCT00359762|919705|P3|NOT COMPLETED|Period II||0
377587|NCT00359762|919706|P2|NOT COMPLETED|Period II||0
377588|NCT00359762|919707|P1|NOT COMPLETED|Period II||128
377589|NCT00359762|919703|P5|COMPLETED|Period II||341
377590|NCT00359762|919704|P4|COMPLETED|Period II||0
377591|NCT00359762|919705|P3|COMPLETED|Period II||0
377592|NCT00359762|919706|P2|COMPLETED|Period II||0
377593|NCT00359762|919707|P1|COMPLETED|Period II||386
377594|NCT00359762|919703|P5|Without Treatment Failure|Period II||138
377595|NCT00359762|919704|P4|Without Treatment Failure|Period II||0
377596|NCT00359762|919705|P3|Without Treatment Failure|Period II||0
377597|NCT00359762|919706|P2|Without Treatment Failure|Period II||0
377598|NCT00359762|919707|P1|Without Treatment Failure|Period II||124
377599|NCT00359762|919703|P5|Met Primary Endpoint|Period II||203
377600|NCT00359762|919704|P4|Met Primary Endpoint|Period II||0
377601|NCT00359762|919705|P3|Met Primary Endpoint|Period II||0
377602|NCT00359762|919706|P2|Met Primary Endpoint|Period II||0
377603|NCT00359762|919707|P1|Met Primary Endpoint|Period II||262
377604|NCT00359762|919703|P5|ITT Efficacy Population|Period II||490
377605|NCT00359762|919704|P4|ITT Efficacy Population|Period II||0
377606|NCT00359762|919705|P3|ITT Efficacy Population|Period II||0
377607|NCT00359762|919706|P2|ITT Efficacy Population|Period II||0
377608|NCT00359762|919707|P1|ITT Efficacy Population|Period II||487
377609|NCT00359762|919703|P5|Intent to Treat (ITT) Safety Population|Period II||511
377610|NCT00359762|919704|P4|Intent to Treat (ITT) Safety Population|Period II||0
377611|NCT00359762|919705|P3|Intent to Treat (ITT) Safety Population|Period II||0
377612|NCT00359762|919706|P2|Intent to Treat (ITT) Safety Population|Period II||0
377613|NCT00359762|919707|P1|Intent to Treat (ITT) Safety Population|Period II||508
377614|NCT00359762|919703|P5|STARTED|Period II||515
377615|NCT00359762|919704|P4|STARTED|Period II||0
377616|NCT00359762|919705|P3|STARTED|Period II||0
377617|NCT00359762|919706|P2|STARTED|Period II||0
377618|NCT00359762|919707|P1|STARTED|Period II||514
377619|NCT00359736|919770|P2|NOT COMPLETED|Overall Study||0
377620|NCT00359736|919771|P1|NOT COMPLETED|Overall Study||0
377621|NCT00359736|919770|P2|COMPLETED|Overall Study||15
377622|NCT00359736|919771|P1|COMPLETED|Overall Study||14
377623|NCT00359736|919770|P2|STARTED|Overall Study||15
377624|NCT00359736|919771|P1|STARTED|Overall Study||14
377625|NCT00359632|919781|P2|NOT COMPLETED|Overall Study||0
377626|NCT00359632|919782|P1|NOT COMPLETED|Overall Study||4
377627|NCT00359632|919781|P2|COMPLETED|Overall Study||9
377628|NCT00359632|919782|P1|COMPLETED|Overall Study||20
377629|NCT00359632|919781|P2|STARTED|Overall Study||9
377630|NCT00359632|919782|P1|STARTED|Overall Study||24
377631|NCT00359619|919796|P7|NOT COMPLETED|Overall Study||4
377632|NCT00359619|919797|P6|NOT COMPLETED|Overall Study||5
377633|NCT00359619|919798|P5|NOT COMPLETED|Overall Study||3
377634|NCT00359619|919799|P4|NOT COMPLETED|Overall Study||3
377635|NCT00359619|919800|P3|NOT COMPLETED|Overall Study||7
377636|NCT00359619|919801|P2|NOT COMPLETED|Overall Study||5
377637|NCT00359619|919802|P1|NOT COMPLETED|Overall Study||8
377638|NCT00359619|919796|P7|COMPLETED|Overall Study||46
377639|NCT00359619|919797|P6|COMPLETED|Overall Study||45
377640|NCT00359619|919798|P5|COMPLETED|Overall Study||45
377641|NCT00359619|919799|P4|COMPLETED|Overall Study||45
377642|NCT00359619|919800|P3|COMPLETED|Overall Study||42
377643|NCT00359619|919801|P2|COMPLETED|Overall Study||45
377644|NCT00359619|919802|P1|COMPLETED|Overall Study||80
377645|NCT00359619|919796|P7|STARTED|Overall Study||50
377646|NCT00359619|919797|P6|STARTED|Overall Study||50
377647|NCT00359619|919798|P5|STARTED|Overall Study||48
377648|NCT00359619|919799|P4|STARTED|Overall Study||48
377649|NCT00359619|919800|P3|STARTED|Overall Study||49
377650|NCT00359619|919801|P2|STARTED|Overall Study||50
377651|NCT00359619|919802|P1|STARTED|Overall Study||88
377652|NCT00359424|919932|P2|NOT COMPLETED|Overall Study||67
377653|NCT00359424|919933|P1|NOT COMPLETED|Overall Study||130
377654|NCT00359424|919932|P2|COMPLETED|Overall Study||155
377655|NCT00359424|919933|P1|COMPLETED|Overall Study||304
377656|NCT00359424|919932|P2|270 Day Follow up|Overall Study||159
377657|NCT00359424|919933|P1|270 Day Follow up|Overall Study||313
377658|NCT00359424|919932|P2|180 Day Follow up|Overall Study||167
377659|NCT00359424|919933|P1|180 Day Follow up|Overall Study||325
377660|NCT00359424|919932|P2|90 Day Follow up|Overall Study||172
377661|NCT00359424|919933|P1|90 Day Follow up|Overall Study||343
377662|NCT00359424|919932|P2|STARTED|Overall Study||222
377663|NCT00359424|919933|P1|STARTED|Overall Study||434
377664|NCT00359281|919972|P9|NOT COMPLETED|Overall Study||0
377665|NCT00359281|919973|P8|NOT COMPLETED|Overall Study||0
377666|NCT00359281|919974|P7|NOT COMPLETED|Overall Study||2
377667|NCT00359281|919975|P6|NOT COMPLETED|Overall Study||0
377668|NCT00359281|919976|P5|NOT COMPLETED|Overall Study||0
377669|NCT00359281|919977|P4|NOT COMPLETED|Overall Study||0
377670|NCT00359281|919978|P3|NOT COMPLETED|Overall Study||0
377671|NCT00359281|919979|P2|NOT COMPLETED|Overall Study||0
377672|NCT00359281|919980|P1|NOT COMPLETED|Overall Study||1
377673|NCT00359281|919972|P9|COMPLETED|Overall Study||20
377674|NCT00359281|919973|P8|COMPLETED|Overall Study||15
377675|NCT00359281|919974|P7|COMPLETED|Overall Study||16
377676|NCT00359281|919975|P6|COMPLETED|Overall Study||15
377677|NCT00359281|919976|P5|COMPLETED|Overall Study||10
377678|NCT00359281|919977|P4|COMPLETED|Overall Study||10
377679|NCT00359281|919978|P3|COMPLETED|Overall Study||10
377680|NCT00359281|919979|P2|COMPLETED|Overall Study||15
377681|NCT00359281|919980|P1|COMPLETED|Overall Study||15
377682|NCT00359281|919972|P9|STARTED|Overall Study||20
377683|NCT00359281|919973|P8|STARTED|Overall Study||15
377684|NCT00359281|919974|P7|STARTED|Overall Study||18
377685|NCT00359281|919975|P6|STARTED|Overall Study||15
377686|NCT00359281|919976|P5|STARTED|Overall Study||10
377687|NCT00359281|919977|P4|STARTED|Overall Study||10
377688|NCT00359281|919978|P3|STARTED|Overall Study||10
377689|NCT00359281|919979|P2|STARTED|Overall Study||15
377690|NCT00359281|919980|P1|STARTED|Overall Study||16
377691|NCT00359216|920012|P2|NOT COMPLETED|Overall Study||1
377692|NCT00359216|920013|P1|NOT COMPLETED|Overall Study||0
377693|NCT00359216|920012|P2|COMPLETED|Overall Study|Completed treatment but simultaneously partaking in other study,final study procedures not performed|9
377694|NCT00359216|920013|P1|COMPLETED|Overall Study||20
377695|NCT00359216|920012|P2|STARTED|Overall Study||10
377696|NCT00359216|920013|P1|STARTED|Overall Study||20
377697|NCT00359203|920021|P2|NOT COMPLETED|Overall Study||0
377698|NCT00359203|920022|P1|NOT COMPLETED|Overall Study||0
377699|NCT00359203|920021|P2|COMPLETED|Overall Study||38
377700|NCT00359203|920022|P1|COMPLETED|Overall Study||39
377701|NCT00359203|920021|P2|STARTED|Overall Study||38
377702|NCT00359203|920022|P1|STARTED|Overall Study||39
377703|NCT00359138|920031|P3|NOT COMPLETED|Overall Study||0
377704|NCT00359138|920032|P2|NOT COMPLETED|Overall Study||0
377705|NCT00359138|920033|P1|NOT COMPLETED|Overall Study||0
377706|NCT00359138|920031|P3|COMPLETED|Overall Study||12
377707|NCT00359138|920032|P2|COMPLETED|Overall Study||12
377708|NCT00359138|920033|P1|COMPLETED|Overall Study||12
377709|NCT00359138|920031|P3|STARTED|Overall Study||12
377710|NCT00359138|920032|P2|STARTED|Overall Study||12
377711|NCT00359138|920033|P1|STARTED|Overall Study||12
377712|NCT00359073|920043|P2|NOT COMPLETED|Overall Study||2
377713|NCT00359073|920044|P1|NOT COMPLETED|Overall Study||4
377714|NCT00359073|920043|P2|COMPLETED|Overall Study||11
377715|NCT00359073|920044|P1|COMPLETED|Overall Study||8
377716|NCT00359073|920043|P2|STARTED|Overall Study||13
377717|NCT00359073|920044|P1|STARTED|Overall Study||12
377718|NCT00359021|920056|P2|NOT COMPLETED|Overall Study||52
377719|NCT00359021|920057|P1|NOT COMPLETED|Overall Study||81
377720|NCT00359021|920056|P2|COMPLETED|Overall Study||195
377721|NCT00359021|920057|P1|COMPLETED|Overall Study||175
377722|NCT00359021|920056|P2|STARTED|Overall Study||247
377723|NCT00359021|920057|P1|STARTED|Overall Study||256
377724|NCT00358956|920069|P1|NOT COMPLETED|Overall Study||8
377725|NCT00358956|920069|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|11
377726|NCT00358956|920069|P1|STARTED|Overall Study||19
377727|NCT00358917|920081|P2|NOT COMPLETED|Overall Study||69
377728|NCT00358917|920082|P1|NOT COMPLETED|Overall Study||66
377729|NCT00358917|920081|P2|COMPLETED|Overall Study||230
377730|NCT00358917|920082|P1|COMPLETED|Overall Study||234
377731|NCT00358917|920081|P2|STARTED|Overall Study||299
377732|NCT00358917|920082|P1|STARTED|Overall Study||300
377733|NCT00358826|920100|P8|NOT COMPLETED|MDCT Substudy||0
377734|NCT00358826|920101|P7|NOT COMPLETED|MDCT Substudy||0
377735|NCT00358826|920102|P6|NOT COMPLETED|MDCT Substudy||2
377736|NCT00358826|920103|P5|NOT COMPLETED|MDCT Substudy||1
377737|NCT00358826|920104|P4|NOT COMPLETED|MDCT Substudy||0
377738|NCT00358826|920105|P3|NOT COMPLETED|MDCT Substudy||0
377739|NCT00358826|920106|P2|NOT COMPLETED|MDCT Substudy||0
377740|NCT00358826|920107|P1|NOT COMPLETED|MDCT Substudy||0
377741|NCT00358826|920100|P8|COMPLETED|MDCT Substudy||27
377742|NCT00358826|920101|P7|COMPLETED|MDCT Substudy||19
377743|NCT00358826|920102|P6|COMPLETED|MDCT Substudy||20
377744|NCT00358826|920103|P5|COMPLETED|MDCT Substudy||24
377745|NCT00358826|920104|P4|COMPLETED|MDCT Substudy||0
377746|NCT00358826|920105|P3|COMPLETED|MDCT Substudy||0
377747|NCT00358826|920106|P2|COMPLETED|MDCT Substudy||0
377748|NCT00358826|920107|P1|COMPLETED|MDCT Substudy||0
377749|NCT00358826|920100|P8|STARTED|MDCT Substudy||27
377750|NCT00358826|920101|P7|STARTED|MDCT Substudy||19
377751|NCT00358826|920102|P6|STARTED|MDCT Substudy||22
377752|NCT00358826|920103|P5|STARTED|MDCT Substudy||25
377753|NCT00358826|920104|P4|STARTED|MDCT Substudy||0
377754|NCT00358826|920105|P3|STARTED|MDCT Substudy||0
377755|NCT00358826|920106|P2|STARTED|MDCT Substudy||0
377756|NCT00358826|920107|P1|STARTED|MDCT Substudy||0
377757|NCT00358826|920100|P8|NOT COMPLETED|Core Study||0
377758|NCT00358826|920101|P7|NOT COMPLETED|Core Study||0
377759|NCT00358826|920102|P6|NOT COMPLETED|Core Study||0
377760|NCT00358826|920103|P5|NOT COMPLETED|Core Study||0
377761|NCT00358826|920104|P4|NOT COMPLETED|Core Study||2
377762|NCT00358826|920105|P3|NOT COMPLETED|Core Study||2
377763|NCT00358826|920106|P2|NOT COMPLETED|Core Study||5
377764|NCT00358826|920107|P1|NOT COMPLETED|Core Study||3
377765|NCT00358826|920100|P8|COMPLETED|Core Study||0
377766|NCT00358826|920101|P7|COMPLETED|Core Study||0
377767|NCT00358826|920102|P6|COMPLETED|Core Study||0
377768|NCT00358826|920103|P5|COMPLETED|Core Study||0
377769|NCT00358826|920104|P4|COMPLETED|Core Study||50
377770|NCT00358826|920105|P3|COMPLETED|Core Study||42
377771|NCT00358826|920106|P2|COMPLETED|Core Study||41
377772|NCT00358826|920107|P1|COMPLETED|Core Study||46
377773|NCT00358826|920100|P8|STARTED|Core Study||0
377774|NCT00358826|920101|P7|STARTED|Core Study||0
377775|NCT00358826|920102|P6|STARTED|Core Study||0
377776|NCT00358826|920103|P5|STARTED|Core Study||0
377777|NCT00358826|920104|P4|STARTED|Core Study||52
377778|NCT00358826|920105|P3|STARTED|Core Study||44
377779|NCT00358826|920106|P2|STARTED|Core Study||46
377780|NCT00358826|920107|P1|STARTED|Core Study||49
377781|NCT00358735|920143|P2|NOT COMPLETED|Overall Study||17
377782|NCT00358735|920144|P1|NOT COMPLETED|Overall Study||8
377783|NCT00358735|920143|P2|COMPLETED|Overall Study|Efficacy|190
377784|NCT00358735|920144|P1|COMPLETED|Overall Study|Efficacy|196
377785|NCT00358735|920143|P2|Not Completed Safety|Overall Study||13
377786|NCT00358735|920144|P1|Not Completed Safety|Overall Study||6
377787|NCT00358735|920143|P2|Completed Safety|Overall Study||194
377788|NCT00358735|920144|P1|Completed Safety|Overall Study||198
377789|NCT00358735|920143|P2|STARTED|Overall Study||207
377790|NCT00358735|920144|P1|STARTED|Overall Study||204
377791|NCT00358670|920174|P2|NOT COMPLETED|Overall Study||219
377792|NCT00358670|920175|P1|NOT COMPLETED|Overall Study||222
377793|NCT00358670|920174|P2|COMPLETED|Overall Study||0
377794|NCT00358670|920175|P1|COMPLETED|Overall Study||0
377795|NCT00358670|920174|P2|STARTED|Overall Study||219
377796|NCT00358670|920175|P1|STARTED|Overall Study||222
377797|NCT00358644|920189|P1|NOT COMPLETED|Overall Study||50
377798|NCT00358644|920189|P1|COMPLETED|Overall Study||5
377799|NCT00358644|920189|P1|STARTED|Overall Study||55
377800|NCT00358579|920195|P2|NOT COMPLETED|Overall Study||0
377801|NCT00358579|920196|P1|NOT COMPLETED|Overall Study||0
377802|NCT00358579|920195|P2|COMPLETED|Overall Study||374
377803|NCT00358579|920196|P1|COMPLETED|Overall Study||353
377804|NCT00358579|920195|P2|STARTED|Overall Study||374
377805|NCT00358579|920196|P1|STARTED|Overall Study||353
377806|NCT00358527|920212|P2|NOT COMPLETED|Overall Study||3
377807|NCT00358527|920213|P1|NOT COMPLETED|Overall Study||13
377808|NCT00358527|920212|P2|COMPLETED|Overall Study||131
377809|NCT00358527|920213|P1|COMPLETED|Overall Study||254
377810|NCT00358527|920212|P2|STARTED|Overall Study||134
377811|NCT00358527|920213|P1|STARTED|Overall Study||267
377812|NCT00358501|920223|P2|NOT COMPLETED|Overall Study||0
377813|NCT00358501|920224|P1|NOT COMPLETED|Overall Study||0
377814|NCT00358501|920223|P2|COMPLETED|Overall Study||32
377815|NCT00358501|920224|P1|COMPLETED|Overall Study||102
377816|NCT00358501|920223|P2|STARTED|Overall Study||32
377817|NCT00358501|920224|P1|STARTED|Overall Study||102
377818|NCT00358462|920239|P2|NOT COMPLETED|Overall Study||64
377819|NCT00358462|920240|P1|NOT COMPLETED|Overall Study||59
377820|NCT00358462|920239|P2|COMPLETED|Overall Study||238
377821|NCT00358462|920240|P1|COMPLETED|Overall Study||245
377822|NCT00358462|920239|P2|STARTED|Overall Study||302
377823|NCT00358462|920240|P1|STARTED|Overall Study||304
377824|NCT00358449|920263|P3|NOT COMPLETED|Overall Study||2
377825|NCT00358449|920264|P2|NOT COMPLETED|Overall Study||1
377826|NCT00358449|920265|P1|NOT COMPLETED|Overall Study||4
377827|NCT00358449|920263|P3|COMPLETED|Overall Study||18
377828|NCT00358449|920264|P2|COMPLETED|Overall Study||19
377829|NCT00358449|920265|P1|COMPLETED|Overall Study||15
377830|NCT00358449|920263|P3|STARTED|Overall Study||20
377831|NCT00358449|920264|P2|STARTED|Overall Study||20
377832|NCT00358449|920265|P1|STARTED|Overall Study||19
377833|NCT00358436|920368|P2|NOT COMPLETED|Overall Study||86
377834|NCT00358436|920369|P1|NOT COMPLETED|Overall Study||154
377835|NCT00358436|920368|P2|COMPLETED|Overall Study||118
377836|NCT00358436|920369|P1|COMPLETED|Overall Study||446
377837|NCT00358436|920368|P2|STARTED|Overall Study||204
377838|NCT00358436|920369|P1|STARTED|Overall Study||600
377839|NCT00358332|920385|P4|NOT COMPLETED|Overall Study||0
377840|NCT00358332|920386|P3|NOT COMPLETED|Overall Study||1
377841|NCT00358332|920387|P2|NOT COMPLETED|Overall Study||3
377842|NCT00358332|920388|P1|NOT COMPLETED|Overall Study||0
377843|NCT00358332|920385|P4|COMPLETED|Overall Study||25
377844|NCT00358332|920386|P3|COMPLETED|Overall Study||29
377845|NCT00358332|920387|P2|COMPLETED|Overall Study||27
377846|NCT00358332|920388|P1|COMPLETED|Overall Study||15
377847|NCT00358332|920385|P4|STARTED|Overall Study||25
377848|NCT00358332|920386|P3|STARTED|Overall Study||30
377849|NCT00358332|920387|P2|STARTED|Overall Study||30
377850|NCT00358332|920388|P1|STARTED|Overall Study||15
377851|NCT00358215|920440|P2|NOT COMPLETED|Overall Study||652
377852|NCT00358215|920441|P1|NOT COMPLETED|Overall Study||679
377853|NCT00358215|920440|P2|COMPLETED|Overall Study|Participants who completed investigational product|484
377854|NCT00358215|920441|P1|COMPLETED|Overall Study|Participants who completed investigational product|463
377855|NCT00358215|920440|P2|Received Investigational Product|Overall Study||1133
377856|NCT00358215|920441|P1|Received Investigational Product|Overall Study||1140
377857|NCT00358215|920440|P2|STARTED|Overall Study||1136
377858|NCT00358215|920441|P1|STARTED|Overall Study||1142
377859|NCT00358150|920455|P1|NOT COMPLETED|Overall Study||7
377860|NCT00358150|920455|P1|COMPLETED|Overall Study||19
377861|NCT00358150|920455|P1|STARTED|Overall Study||26
377862|NCT00358007|920477|P1|NOT COMPLETED|Overall Study||2
377863|NCT00358007|920477|P1|COMPLETED|Overall Study||28
377864|NCT00358007|920477|P1|STARTED|Overall Study||30
377865|NCT00357994|920484|P2|NOT COMPLETED|Overall Study||3
377866|NCT00357994|920485|P1|NOT COMPLETED|Overall Study||2
377867|NCT00357994|920484|P2|COMPLETED|Overall Study||31
377868|NCT00357994|920485|P1|COMPLETED|Overall Study||35
377869|NCT00357994|920484|P2|STARTED|Overall Study||34
377870|NCT00357994|920485|P1|STARTED|Overall Study||37
377871|NCT00357968|920539|P2|NOT COMPLETED|Crossover Maintenance Dose Phase||0
377872|NCT00357968|920540|P1|NOT COMPLETED|Crossover Maintenance Dose Phase||0
377873|NCT00357968|920539|P2|COMPLETED|Crossover Maintenance Dose Phase||55
377874|NCT00357968|920540|P1|COMPLETED|Crossover Maintenance Dose Phase||54
377875|NCT00357968|920539|P2|STARTED|Crossover Maintenance Dose Phase||55
377876|NCT00357968|920540|P1|STARTED|Crossover Maintenance Dose Phase|1 subject discontinued study drug-did not take clopidogrel during the 2nd phase but completed study|54
377877|NCT00357968|920539|P2|NOT COMPLETED|First Maintenance Dose Phase||44
377878|NCT00357968|920540|P1|NOT COMPLETED|First Maintenance Dose Phase||48
377879|NCT00357968|920539|P2|COMPLETED|First Maintenance Dose Phase||55
377880|NCT00357968|920540|P1|COMPLETED|First Maintenance Dose Phase||54
377881|NCT00357968|920539|P2|Started Maintenance Dose|First Maintenance Dose Phase||55
377882|NCT00357968|920540|P1|Started Maintenance Dose|First Maintenance Dose Phase||55
377883|NCT00357968|920539|P2|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||57
377884|NCT00357968|920540|P1|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||55
377885|NCT00357968|920539|P2|Received Loading Dose|First Maintenance Dose Phase||99
377886|NCT00357968|920540|P1|Received Loading Dose|First Maintenance Dose Phase||102
377887|NCT00357968|920539|P2|STARTED|First Maintenance Dose Phase||99
377888|NCT00357968|920540|P1|STARTED|First Maintenance Dose Phase||102
377889|NCT00357955|920584|P2|NOT COMPLETED|Overall Study||3
377890|NCT00357955|920585|P1|NOT COMPLETED|Overall Study||6
377891|NCT00357955|920584|P2|COMPLETED|Overall Study||51
377892|NCT00357955|920585|P1|COMPLETED|Overall Study||58
377893|NCT00357955|920584|P2|STARTED|Overall Study||54
377894|NCT00357955|920585|P1|STARTED|Overall Study||64
377895|NCT00357903|920593|P2|NOT COMPLETED|Overall Study||43
377896|NCT00357903|920594|P1|NOT COMPLETED|Overall Study||363
377897|NCT00357903|920593|P2|COMPLETED|Overall Study||15
377898|NCT00357903|920594|P1|COMPLETED|Overall Study||218
377899|NCT00357903|920593|P2|STARTED|Overall Study||58
377900|NCT00357903|920594|P1|STARTED|Overall Study||581
377901|NCT00357877|920634|P2|NOT COMPLETED|Overall Study||30
377902|NCT00357877|920635|P1|NOT COMPLETED|Overall Study||26
377903|NCT00357877|920634|P2|COMPLETED|Overall Study||460
377904|NCT00357877|920635|P1|COMPLETED|Overall Study||467
377905|NCT00357877|920634|P2|STARTED|Overall Study||490
377906|NCT00357877|920635|P1|STARTED|Overall Study||493
377907|NCT00357760|920649|P2|NOT COMPLETED|Overall Study||35
377908|NCT00357760|920650|P1|NOT COMPLETED|Overall Study||59
377909|NCT00357760|920649|P2|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
377910|NCT00357760|920650|P1|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
377911|NCT00357760|920649|P2|Patients Who Undergo Dose Escalation|Overall Study||16
377912|NCT00357760|920650|P1|Patients Who Undergo Dose Escalation|Overall Study|Only patients who progressed on the low dose (Arm B) had the opportunity to undergo dose escalation.|0
377913|NCT00357760|920649|P2|Eligible and Treated Patients|Overall Study||32
377914|NCT00357760|920650|P1|Eligible and Treated Patients|Overall Study||57
377915|NCT00357760|920649|P2|Patients Who Started Treatment|Overall Study||34
377916|NCT00357760|920650|P1|Patients Who Started Treatment|Overall Study||57
377917|NCT00357760|920649|P2|STARTED|Overall Study||35
377918|NCT00357760|920650|P1|STARTED|Overall Study||59
377919|NCT00357734|920660|P1|NOT COMPLETED|Overall Study||4
377920|NCT00357734|920660|P1|COMPLETED|Overall Study||10
377921|NCT00357734|920660|P1|Patient Received 500 mg of ZD1839|Overall Study||1
377922|NCT00357734|920660|P1|Patients Received 250 mg of ZD1839|Overall Study||13
377923|NCT00357734|920660|P1|STARTED|Overall Study||14
377924|NCT00357656|920671|P2|NOT COMPLETED|Overall Study||3
377925|NCT00357656|920672|P1|NOT COMPLETED|Overall Study||0
377926|NCT00357656|920671|P2|COMPLETED|Overall Study||29
377927|NCT00357656|920672|P1|COMPLETED|Overall Study||31
377928|NCT00357656|920671|P2|STARTED|Overall Study||32
377929|NCT00357656|920672|P1|STARTED|Overall Study||31
377930|NCT00357552|920723|P1|NOT COMPLETED|Weeks 24 to 104||5
377931|NCT00357552|920723|P1|COMPLETED|Weeks 24 to 104||117
377932|NCT00357552|920723|P1|STARTED|Weeks 24 to 104||122
377933|NCT00357552|920723|P1|NOT COMPLETED|Weeks 0 to 24||1
377934|NCT00357552|920723|P1|COMPLETED|Weeks 0 to 24|One subject died prior to week 24.|122
377935|NCT00357552|920723|P1|STARTED|Weeks 0 to 24||123
377936|NCT00357552|920723|P1|NOT COMPLETED|Screening||84
377937|NCT00357552|920723|P1|COMPLETED|Screening|The number of participants who completed this period, is the number of participants who enrolled.|123
377938|NCT00357552|920723|P1|STARTED|Screening|The number of participants who started this period, is the number of participants who screened.|207
377939|NCT00357500|920738|P1|NOT COMPLETED|Overall Study||77
377940|NCT00357500|920738|P1|COMPLETED|Overall Study||24
377941|NCT00357500|920738|P1|Began Protocol Therapy|Overall Study|4 pts did not start treatment due either to removal of consent or inability to get insurance.|97
377942|NCT00357500|920738|P1|STARTED|Overall Study||101
377943|NCT00357396|920747|P2|NOT COMPLETED|Overall Study||0
377944|NCT00357396|920748|P1|NOT COMPLETED|Overall Study||1
377945|NCT00357396|920747|P2|COMPLETED|Overall Study||4
377946|NCT00357396|920748|P1|COMPLETED|Overall Study||5
377947|NCT00357396|920747|P2|STARTED|Overall Study||4
377948|NCT00357396|920748|P1|STARTED|Overall Study||6
377949|NCT00357370|920756|P3|NOT COMPLETED|Cohort 2||2
377950|NCT00357370|920757|P2|NOT COMPLETED|Cohort 2||7
377951|NCT00357370|920758|P1|NOT COMPLETED|Cohort 2||2
377952|NCT00357370|920756|P3|COMPLETED|Cohort 2||22
377953|NCT00357370|920757|P2|COMPLETED|Cohort 2||16
377954|NCT00357370|920758|P1|COMPLETED|Cohort 2||22
377955|NCT00357370|920756|P3|STARTED|Cohort 2||24
377956|NCT00357370|920757|P2|STARTED|Cohort 2||23
377957|NCT00357370|920758|P1|STARTED|Cohort 2||24
377958|NCT00357370|920756|P3|NOT COMPLETED|Cohort 1||0
377959|NCT00357370|920757|P2|NOT COMPLETED|Cohort 1||0
377960|NCT00357370|920758|P1|NOT COMPLETED|Cohort 1||0
377961|NCT00357370|920756|P3|COMPLETED|Cohort 1||0
377962|NCT00357370|920757|P2|COMPLETED|Cohort 1||0
377963|NCT00357370|920758|P1|COMPLETED|Cohort 1||4
377964|NCT00357370|920756|P3|STARTED|Cohort 1||0
377965|NCT00357370|920757|P2|STARTED|Cohort 1||0
377966|NCT00357370|920758|P1|STARTED|Cohort 1||4
377967|NCT00357331|920783|P2|NOT COMPLETED|Overall Study||0
377968|NCT00357331|920784|P1|NOT COMPLETED|Overall Study||0
377969|NCT00357331|920783|P2|COMPLETED|Overall Study||41
377970|NCT00357331|920784|P1|COMPLETED|Overall Study||42
377971|NCT00357331|920783|P2|STARTED|Overall Study||41
377972|NCT00357331|920784|P1|STARTED|Overall Study||42
377973|NCT00357162|920794|P1|NOT COMPLETED|Overall Study||0
377974|NCT00357162|920794|P1|COMPLETED|Overall Study||21
377975|NCT00357162|920794|P1|STARTED|Overall Study||21
377976|NCT00357110|920804|P2|NOT COMPLETED|Overall Study||5
377977|NCT00357110|920805|P1|NOT COMPLETED|Overall Study||5
377978|NCT00357110|920804|P2|COMPLETED|Overall Study||2
377979|NCT00357110|920805|P1|COMPLETED|Overall Study||1
377980|NCT00357110|920804|P2|STARTED|Overall Study||7
377981|NCT00357110|920805|P1|STARTED|Overall Study||6
377982|NCT00357097|920813|P2|NOT COMPLETED|Overall Study||29
377983|NCT00357097|920814|P1|NOT COMPLETED|Overall Study||54
377984|NCT00357097|920813|P2|COMPLETED|Overall Study||38
377985|NCT00357097|920814|P1|COMPLETED|Overall Study||145
377986|NCT00357097|920813|P2|STARTED|Overall Study||67
377987|NCT00357097|920814|P1|STARTED|Overall Study|199 were randomized. Only 198 took investigational product.|199
377988|NCT00357032|920858|P1|NOT COMPLETED|Overall Study||0
377989|NCT00357032|920858|P1|COMPLETED|Overall Study||12
377990|NCT00357032|920858|P1|STARTED|Overall Study||12
377991|NCT00357006|920868|P3|NOT COMPLETED|Overall Study||3
377992|NCT00357006|920869|P2|NOT COMPLETED|Overall Study||5
377993|NCT00357006|920870|P1|NOT COMPLETED|Overall Study||2
377994|NCT00357006|920868|P3|COMPLETED|Overall Study||59
377995|NCT00357006|920869|P2|COMPLETED|Overall Study||51
377996|NCT00357006|920870|P1|COMPLETED|Overall Study||60
377997|NCT00357006|920868|P3|STARTED|Overall Study||62
377998|NCT00357006|920869|P2|STARTED|Overall Study||56
377999|NCT00357006|920870|P1|STARTED|Overall Study||62
378000|NCT00356993|920878|P1|NOT COMPLETED|Overall Study||3921
378001|NCT00356993|920878|P1|COMPLETED|Overall Study||2088
378002|NCT00356993|920878|P1|STARTED|Overall Study||6009
378003|NCT00356915|920885|P3|NOT COMPLETED|Overall Study||42
378004|NCT00356915|920886|P2|NOT COMPLETED|Overall Study||94
378005|NCT00356915|920887|P1|NOT COMPLETED|Overall Study||76
378006|NCT00356915|920885|P3|COMPLETED|Overall Study||156
378007|NCT00356915|920886|P2|COMPLETED|Overall Study||496
378008|NCT00356915|920887|P1|COMPLETED|Overall Study||517
378009|NCT00356915|920885|P3|STARTED|Overall Study||198
378010|NCT00356915|920886|P2|STARTED|Overall Study||590
378011|NCT00356915|920887|P1|STARTED|Overall Study||593
378012|NCT00356889|920904|P1|NOT COMPLETED|Overall Study||3
378013|NCT00356889|920904|P1|COMPLETED|Overall Study||53
378014|NCT00356889|920904|P1|STARTED|Overall Study||56
378015|NCT00356863|920913|P2|NOT COMPLETED|Overall Study||75
378016|NCT00356863|920914|P1|NOT COMPLETED|Overall Study||92
378017|NCT00356863|920913|P2|COMPLETED|Overall Study||445
378018|NCT00356863|920914|P1|COMPLETED|Overall Study||412
378019|NCT00356863|920913|P2|STARTED|Overall Study||520
378020|NCT00356863|920914|P1|STARTED|Overall Study||504
378021|NCT00356811|920940|P1|NOT COMPLETED|Overall Study||49
378022|NCT00356811|920940|P1|COMPLETED|Overall Study||8
378023|NCT00356811|920940|P1|STARTED|Overall Study||57
378024|NCT00356759|920955|P2|NOT COMPLETED|Overall Study||10
378025|NCT00356759|920956|P1|NOT COMPLETED|Overall Study||14
378026|NCT00356759|920955|P2|COMPLETED|Overall Study||114
378027|NCT00356759|920956|P1|COMPLETED|Overall Study||112
378028|NCT00356759|920955|P2|STARTED|Overall Study||124
378029|NCT00356759|920956|P1|STARTED|Overall Study||126
378030|NCT00356603|920974|P2|NOT COMPLETED|Overall Study||3
378031|NCT00356603|920975|P1|NOT COMPLETED|Overall Study||6
378032|NCT00356603|920974|P2|COMPLETED|Overall Study||33
378033|NCT00356603|920975|P1|COMPLETED|Overall Study||33
378034|NCT00356603|920974|P2|STARTED|Overall Study||36
378035|NCT00356603|920975|P1|STARTED|Overall Study||39
378036|NCT00356590|920989|P1|NOT COMPLETED|Overall Study||274
378037|NCT00356590|920989|P1|COMPLETED|Overall Study||194
378038|NCT00356590|920989|P1|STARTED|Overall Study||468
378039|NCT00356525|921025|P4|NOT COMPLETED|Overall Study||9
378040|NCT00356525|921026|P3|NOT COMPLETED|Overall Study||7
378041|NCT00356525|921027|P2|NOT COMPLETED|Overall Study||11
378042|NCT00356525|921028|P1|NOT COMPLETED|Overall Study||14
378043|NCT00356525|921025|P4|COMPLETED|Overall Study||0
378044|NCT00356525|921026|P3|COMPLETED|Overall Study||0
378045|NCT00356525|921027|P2|COMPLETED|Overall Study||0
378046|NCT00356525|921028|P1|COMPLETED|Overall Study||0
378047|NCT00356525|921025|P4|STARTED|Overall Study||9
378048|NCT00356525|921026|P3|STARTED|Overall Study||7
378049|NCT00356525|921027|P2|STARTED|Overall Study||11
378050|NCT00356525|921028|P1|STARTED|Overall Study||14
378051|NCT00356434|921056|P2|NOT COMPLETED|Overall Study||0
378052|NCT00356434|921057|P1|NOT COMPLETED|Overall Study||0
378053|NCT00356434|921056|P2|COMPLETED|Overall Study||7
378054|NCT00356434|921057|P1|COMPLETED|Overall Study||4
378055|NCT00356434|921056|P2|STARTED|Overall Study||7
378056|NCT00356434|921057|P1|STARTED|Overall Study||4
378057|NCT00356421|921069|P2|NOT COMPLETED|Overall Study||17
378058|NCT00356421|921070|P1|NOT COMPLETED|Overall Study||32
378059|NCT00356421|921069|P2|COMPLETED|Overall Study||3
378060|NCT00356421|921070|P1|COMPLETED|Overall Study||6
378061|NCT00356421|921069|P2|STARTED|Overall Study||20
378062|NCT00356421|921070|P1|STARTED|Overall Study||38
378063|NCT00356408|921110|P1|NOT COMPLETED|Overall Study||60
378064|NCT00356408|921110|P1|COMPLETED|Overall Study||43
378065|NCT00356408|921110|P1|STARTED|Overall Study|106 subjects enrolled, however only 103 were included in the Intent to Treat (ITT) population.|103
378066|NCT00356369|921127|P2|NOT COMPLETED|Year 5||0
378067|NCT00356369|921128|P1|NOT COMPLETED|Year 5||0
378068|NCT00356369|921127|P2|COMPLETED|Year 5||105
378069|NCT00356369|921128|P1|COMPLETED|Year 5||299
378070|NCT00356369|921127|P2|STARTED|Year 5||105
378071|NCT00356369|921128|P1|STARTED|Year 5||299
378072|NCT00356369|921127|P2|NOT COMPLETED|Year 4||0
378073|NCT00356369|921128|P1|NOT COMPLETED|Year 4||0
378074|NCT00356369|921127|P2|COMPLETED|Year 4||109
378075|NCT00356369|921128|P1|COMPLETED|Year 4||317
378076|NCT00356369|921127|P2|STARTED|Year 4||109
378077|NCT00356369|921128|P1|STARTED|Year 4||317
378078|NCT00356369|921127|P2|NOT COMPLETED|Year 3||0
378079|NCT00356369|921128|P1|NOT COMPLETED|Year 3||0
378080|NCT00356369|921127|P2|COMPLETED|Year 3||116
378081|NCT00356369|921128|P1|COMPLETED|Year 3||344
378082|NCT00356369|921127|P2|STARTED|Year 3||116
378083|NCT00356369|921128|P1|STARTED|Year 3||344
378084|NCT00356369|921127|P2|NOT COMPLETED|Year 2||0
378085|NCT00356369|921128|P1|NOT COMPLETED|Year 2||0
378086|NCT00356369|921127|P2|COMPLETED|Year 2||117
378087|NCT00356369|921128|P1|COMPLETED|Year 2||354
378088|NCT00356369|921127|P2|STARTED|Year 2||117
378089|NCT00356369|921128|P1|STARTED|Year 2||354
378090|NCT00356369|921127|P2|NOT COMPLETED|Year 1||0
378091|NCT00356369|921128|P1|NOT COMPLETED|Year 1||0
378092|NCT00356369|921127|P2|COMPLETED|Year 1||121
378093|NCT00356369|921128|P1|COMPLETED|Year 1||364
378094|NCT00356369|921127|P2|STARTED|Year 1||121
378095|NCT00356369|921128|P1|STARTED|Year 1||364
378096|NCT00356369|921127|P2|NOT COMPLETED|Active Phase||1
378097|NCT00356369|921128|P1|NOT COMPLETED|Active Phase||2
378098|NCT00356369|921127|P2|COMPLETED|Active Phase||125
378099|NCT00356369|921128|P1|COMPLETED|Active Phase||372
378100|NCT00356369|921127|P2|STARTED|Active Phase||126
378101|NCT00356369|921128|P1|STARTED|Active Phase||374
378102|NCT00356304|921198|P2|NOT COMPLETED|Overall Study||4
378103|NCT00356304|921199|P1|NOT COMPLETED|Overall Study||2
378104|NCT00356304|921198|P2|COMPLETED|Overall Study||20
378105|NCT00356304|921199|P1|COMPLETED|Overall Study||24
378106|NCT00356304|921198|P2|STARTED|Overall Study||24
378107|NCT00356304|921199|P1|STARTED|Overall Study||26
378108|NCT00356278|921210|P3|NOT COMPLETED|Overall Study||19
378109|NCT00356278|921211|P2|NOT COMPLETED|Overall Study||15
378110|NCT00356278|921212|P1|NOT COMPLETED|Overall Study||25
378111|NCT00356278|921210|P3|COMPLETED|Overall Study||34
378112|NCT00356278|921211|P2|COMPLETED|Overall Study||35
378113|NCT00356278|921212|P1|COMPLETED|Overall Study||28
378114|NCT00356278|921210|P3|STARTED|Overall Study||53
378115|NCT00356278|921211|P2|STARTED|Overall Study||50
378116|NCT00356278|921212|P1|STARTED|Overall Study||53
378117|NCT00356265|921250|P3|NOT COMPLETED|Overall Study||1
378118|NCT00356265|921251|P2|NOT COMPLETED|Overall Study||0
378119|NCT00356265|921252|P1|NOT COMPLETED|Overall Study||0
378120|NCT00356265|921250|P3|COMPLETED|Overall Study||5
378121|NCT00356265|921251|P2|COMPLETED|Overall Study||2
378122|NCT00356265|921252|P1|COMPLETED|Overall Study||7
378123|NCT00356265|921250|P3|STARTED|Overall Study||6
378124|NCT00356265|921251|P2|STARTED|Overall Study||2
378125|NCT00356265|921252|P1|STARTED|Overall Study||7
378126|NCT00356200|921264|P2|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||2
378127|NCT00356200|921265|P1|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
378128|NCT00356200|921264|P2|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||3
378129|NCT00356200|921265|P1|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
378130|NCT00356200|921264|P2|STARTED|Cohort 2: 100 ug/ml (New Patients)||5
378131|NCT00356200|921265|P1|STARTED|Cohort 2: 100 ug/ml (New Patients)||0
378132|NCT00356200|921264|P2|NOT COMPLETED|Cohort 1: 10 ug/ml||0
378133|NCT00356200|921265|P1|NOT COMPLETED|Cohort 1: 10 ug/ml||1
378134|NCT00356200|921264|P2|COMPLETED|Cohort 1: 10 ug/ml||0
378135|NCT00356200|921265|P1|COMPLETED|Cohort 1: 10 ug/ml||4
378136|NCT00356200|921264|P2|STARTED|Cohort 1: 10 ug/ml||0
378137|NCT00356200|921265|P1|STARTED|Cohort 1: 10 ug/ml||5
378138|NCT00356187|921279|P2|NOT COMPLETED|Overall Study||0
378139|NCT00356187|921280|P1|NOT COMPLETED|Overall Study||0
378140|NCT00356187|921279|P2|COMPLETED|Overall Study||0
378141|NCT00356187|921280|P1|COMPLETED|Overall Study||0
378142|NCT00356187|921279|P2|STARTED|Overall Study||0
378143|NCT00356187|921280|P1|STARTED|Overall Study||0
378144|NCT00356148|921294|P2|NOT COMPLETED|Overall Study||1
378145|NCT00356148|921295|P1|NOT COMPLETED|Overall Study||2
378146|NCT00356148|921294|P2|COMPLETED|Overall Study||182
378147|NCT00356148|921295|P1|COMPLETED|Overall Study||187
378148|NCT00356148|921294|P2|STARTED|Overall Study||183
378149|NCT00356148|921295|P1|STARTED|Overall Study||189
378150|NCT00356135|921306|P3|NOT COMPLETED|Overall Study||5
378151|NCT00356135|921307|P2|NOT COMPLETED|Overall Study||2
378152|NCT00356135|921308|P1|NOT COMPLETED|Overall Study||4
378153|NCT00356135|921306|P3|COMPLETED|Overall Study||39
378154|NCT00356135|921307|P2|COMPLETED|Overall Study||46
378155|NCT00356135|921308|P1|COMPLETED|Overall Study||43
378156|NCT00356135|921306|P3|STARTED|Overall Study||44
378157|NCT00356135|921307|P2|STARTED|Overall Study||48
378158|NCT00356135|921308|P1|STARTED|Overall Study||47
378159|NCT00356122|921330|P1|NOT COMPLETED|FOLLOW-UP||41
378160|NCT00356122|921330|P1|COMPLETED|FOLLOW-UP||12
378161|NCT00356122|921330|P1|STARTED|FOLLOW-UP||53
378162|NCT00356122|921330|P1|NOT COMPLETED|TREATMENT||45
378163|NCT00356122|921330|P1|COMPLETED|TREATMENT||8
378164|NCT00356122|921330|P1|STARTED|TREATMENT||53
378165|NCT00356057|921341|P3|NOT COMPLETED|Overall Study||12
378166|NCT00356057|921342|P2|NOT COMPLETED|Overall Study||14
378167|NCT00356057|921343|P1|NOT COMPLETED|Overall Study||13
378168|NCT00356057|921341|P3|COMPLETED|Overall Study||22
378169|NCT00356057|921342|P2|COMPLETED|Overall Study||47
378170|NCT00356057|921343|P1|COMPLETED|Overall Study||45
378171|NCT00356057|921341|P3|IMPLANTED|Overall Study||25
378172|NCT00356057|921342|P2|IMPLANTED|Overall Study||52
378173|NCT00356057|921343|P1|IMPLANTED|Overall Study||49
378174|NCT00356057|921341|P3|STARTED|Overall Study||34
378175|NCT00356057|921342|P2|STARTED|Overall Study||61
378176|NCT00356057|921343|P1|STARTED|Overall Study||58
378177|NCT00356031|921381|P1|NOT COMPLETED|Overall Study||0
378178|NCT00356031|921381|P1|COMPLETED|Overall Study||20
378179|NCT00356031|921381|P1|STARTED|Overall Study||20
378180|NCT00355914|921392|P2|NOT COMPLETED|Overall Study||0
378181|NCT00355914|921393|P1|NOT COMPLETED|Overall Study||0
378182|NCT00355914|921392|P2|COMPLETED|Overall Study||60
378183|NCT00355914|921393|P1|COMPLETED|Overall Study||60
378184|NCT00355914|921392|P2|STARTED|Overall Study||60
378185|NCT00355914|921393|P1|STARTED|Overall Study||60
378186|NCT00355797|921404|P3|NOT COMPLETED|Overall Study||142
378187|NCT00355797|921405|P2|NOT COMPLETED|Overall Study||148
378188|NCT00355797|921406|P1|NOT COMPLETED|Overall Study||240
378189|NCT00355797|921404|P3|COMPLETED|Overall Study||239
378190|NCT00355797|921405|P2|COMPLETED|Overall Study||221
378191|NCT00355797|921406|P1|COMPLETED|Overall Study||501
378192|NCT00355797|921404|P3|STARTED|Overall Study||381
378193|NCT00355797|921405|P2|STARTED|Overall Study||369
378194|NCT00355797|921406|P1|STARTED|Overall Study||741
378195|NCT00355784|921438|P3|NOT COMPLETED|Overall Study||2
378196|NCT00355784|921439|P2|NOT COMPLETED|Overall Study||0
378197|NCT00355784|921440|P1|NOT COMPLETED|Overall Study||0
378198|NCT00355784|921438|P3|COMPLETED|Overall Study||5
378199|NCT00355784|921439|P2|COMPLETED|Overall Study||8
378200|NCT00355784|921440|P1|COMPLETED|Overall Study||9
378201|NCT00355784|921438|P3|STARTED|Overall Study||7
378202|NCT00355784|921439|P2|STARTED|Overall Study||8
378203|NCT00355784|921440|P1|STARTED|Overall Study||9
378204|NCT00355706|921474|P2|NOT COMPLETED|Overall Study||0
378205|NCT00355706|921475|P1|NOT COMPLETED|Overall Study||0
378206|NCT00355706|921474|P2|COMPLETED|Overall Study||50
378207|NCT00355706|921475|P1|COMPLETED|Overall Study||50
378208|NCT00355706|921474|P2|STARTED|Overall Study||50
378209|NCT00355706|921475|P1|STARTED|Overall Study||50
378210|NCT00355615|921489|P5|NOT COMPLETED|40-week Rosuvastatin Open Label Period||9
378211|NCT00355615|921490|P4|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
378212|NCT00355615|921491|P3|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
378213|NCT00355615|921492|P2|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
378214|NCT00355615|921493|P1|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
378215|NCT00355615|921489|P5|COMPLETED|40-week Rosuvastatin Open Label Period||164
378216|NCT00355615|921490|P4|COMPLETED|40-week Rosuvastatin Open Label Period||0
378217|NCT00355615|921491|P3|COMPLETED|40-week Rosuvastatin Open Label Period||0
378218|NCT00355615|921492|P2|COMPLETED|40-week Rosuvastatin Open Label Period||0
378219|NCT00355615|921493|P1|COMPLETED|40-week Rosuvastatin Open Label Period||0
378220|NCT00355615|921489|P5|STARTED|40-week Rosuvastatin Open Label Period||173
378221|NCT00355615|921490|P4|STARTED|40-week Rosuvastatin Open Label Period||0
378222|NCT00355615|921491|P3|STARTED|40-week Rosuvastatin Open Label Period||0
378223|NCT00355615|921492|P2|STARTED|40-week Rosuvastatin Open Label Period||0
378224|NCT00355615|921493|P1|STARTED|40-week Rosuvastatin Open Label Period||0
378225|NCT00355615|921489|P5|NOT COMPLETED|Randomized Double Blind Period||0
378226|NCT00355615|921490|P4|NOT COMPLETED|Randomized Double Blind Period||1
378227|NCT00355615|921491|P3|NOT COMPLETED|Randomized Double Blind Period||1
378228|NCT00355615|921492|P2|NOT COMPLETED|Randomized Double Blind Period||0
378229|NCT00355615|921493|P1|NOT COMPLETED|Randomized Double Blind Period||1
378230|NCT00355615|921489|P5|COMPLETED|Randomized Double Blind Period||0
378231|NCT00355615|921490|P4|COMPLETED|Randomized Double Blind Period|1 dropped out due to an adverse event|45
378232|NCT00355615|921491|P3|COMPLETED|Randomized Double Blind Period|45 were randomized but 1 never received drug|44
378233|NCT00355615|921492|P2|COMPLETED|Randomized Double Blind Period||44
378234|NCT00355615|921493|P1|COMPLETED|Randomized Double Blind Period|1 dropped out due to adverse event|41
378235|NCT00355615|921489|P5|STARTED|Randomized Double Blind Period|open label phase followed the randomized phase|0
378236|NCT00355615|921490|P4|STARTED|Randomized Double Blind Period||46
378237|NCT00355615|921491|P3|STARTED|Randomized Double Blind Period||45
378238|NCT00355615|921492|P2|STARTED|Randomized Double Blind Period||44
378239|NCT00355615|921493|P1|STARTED|Randomized Double Blind Period||42
378240|NCT00355472|921552|P1|NOT COMPLETED|Overall Study||1
378241|NCT00355472|921552|P1|COMPLETED|Overall Study||15
378242|NCT00355472|921552|P1|STARTED|Overall Study||16
378243|NCT00355394|921579|P2|NOT COMPLETED|Overall Study||0
378244|NCT00355394|921580|P1|NOT COMPLETED|Overall Study||0
378245|NCT00355394|921579|P2|COMPLETED|Overall Study||16
378246|NCT00355394|921580|P1|COMPLETED|Overall Study||15
378247|NCT00355394|921579|P2|STARTED|Overall Study||16
378248|NCT00355394|921580|P1|STARTED|Overall Study||15
378249|NCT00355368|921598|P2|NOT COMPLETED|Overall Study||9
378250|NCT00355368|921599|P1|NOT COMPLETED|Overall Study||10
378251|NCT00355368|921598|P2|COMPLETED|Overall Study||201
378252|NCT00355368|921599|P1|COMPLETED|Overall Study||200
378253|NCT00355368|921598|P2|STARTED|Overall Study||210
378254|NCT00355368|921599|P1|STARTED|Overall Study||210
378255|NCT00355342|921613|P2|NOT COMPLETED|Overall Study||36
378256|NCT00355342|921614|P1|NOT COMPLETED|Overall Study||39
378257|NCT00355342|921613|P2|COMPLETED|Overall Study||56
378258|NCT00355342|921614|P1|COMPLETED|Overall Study||55
378259|NCT00355342|921613|P2|STARTED|Overall Study||92
378260|NCT00355342|921614|P1|STARTED|Overall Study||94
378261|NCT00355199|921624|P2|NOT COMPLETED|Overall Study||4
378262|NCT00355199|921625|P1|NOT COMPLETED|Overall Study||7
378263|NCT00355199|921624|P2|COMPLETED|Overall Study||122
378264|NCT00355199|921625|P1|COMPLETED|Overall Study||113
378265|NCT00355199|921624|P2|STARTED|Overall Study||126
378266|NCT00355199|921625|P1|STARTED|Overall Study||120
378267|NCT00355147|921641|P2|NOT COMPLETED|Overall Study||20
378268|NCT00355147|921642|P1|NOT COMPLETED|Overall Study||18
378269|NCT00355147|921641|P2|COMPLETED|Overall Study||67
378270|NCT00355147|921642|P1|COMPLETED|Overall Study||69
378271|NCT00355147|921641|P2|STARTED|Overall Study||87
378272|NCT00355147|921642|P1|STARTED|Overall Study||87
378273|NCT00355134|921661|P5|NOT COMPLETED|Extension Phase||19
378274|NCT00355134|921662|P4|NOT COMPLETED|Extension Phase||16
378275|NCT00355134|921663|P3|NOT COMPLETED|Extension Phase||0
378276|NCT00355134|921664|P2|NOT COMPLETED|Extension Phase||37
378277|NCT00355134|921665|P1|NOT COMPLETED|Extension Phase||31
378278|NCT00355134|921661|P5|COMPLETED|Extension Phase||88
378279|NCT00355134|921662|P4|COMPLETED|Extension Phase||89
378280|NCT00355134|921663|P3|COMPLETED|Extension Phase||0
378281|NCT00355134|921664|P2|COMPLETED|Extension Phase||180
378282|NCT00355134|921665|P1|COMPLETED|Extension Phase||172
378283|NCT00355134|921661|P5|STARTED|Extension Phase||107
378284|NCT00355134|921662|P4|STARTED|Extension Phase||105
378285|NCT00355134|921663|P3|STARTED|Extension Phase||0
378286|NCT00355134|921664|P2|STARTED|Extension Phase||217
378287|NCT00355134|921665|P1|STARTED|Extension Phase||203
378288|NCT00355134|921661|P5|NOT COMPLETED|Core Phase||0
378289|NCT00355134|921662|P4|NOT COMPLETED|Core Phase||0
378290|NCT00355134|921663|P3|NOT COMPLETED|Core Phase||100
378291|NCT00355134|921664|P2|NOT COMPLETED|Core Phase||86
378292|NCT00355134|921665|P1|NOT COMPLETED|Core Phase||119
378293|NCT00355134|921661|P5|COMPLETED|Core Phase||0
378294|NCT00355134|921662|P4|COMPLETED|Core Phase||0
378295|NCT00355134|921663|P3|COMPLETED|Core Phase||255
378296|NCT00355134|921664|P2|COMPLETED|Core Phase||272
378297|NCT00355134|921665|P1|COMPLETED|Core Phase||251
378298|NCT00355134|921661|P5|STARTED|Core Phase||0
378299|NCT00355134|921662|P4|STARTED|Core Phase||0
378300|NCT00355134|921663|P3|STARTED|Core Phase||355
378301|NCT00355134|921664|P2|STARTED|Core Phase||358
378302|NCT00355134|921665|P1|STARTED|Core Phase||370
378303|NCT00355121|921708|P3|NOT COMPLETED|Overall Study||5
378304|NCT00355121|921709|P2|NOT COMPLETED|Overall Study||29
378305|NCT00355121|921710|P1|NOT COMPLETED|Overall Study||21
378306|NCT00355121|921708|P3|COMPLETED|Overall Study||170
378307|NCT00355121|921709|P2|COMPLETED|Overall Study||324
378308|NCT00355121|921710|P1|COMPLETED|Overall Study||332
378309|NCT00355121|921708|P3|STARTED|Overall Study||175
378310|NCT00355121|921709|P2|STARTED|Overall Study||353
378311|NCT00355121|921710|P1|STARTED|Overall Study||353
378312|NCT00355082|921741|P3|NOT COMPLETED|Continuation Phase||3
378313|NCT00355082|921742|P2|NOT COMPLETED|Continuation Phase||0
378314|NCT00355082|921743|P1|NOT COMPLETED|Continuation Phase||24
378315|NCT00355082|921741|P3|COMPLETED|Continuation Phase||8
378316|NCT00355082|921742|P2|COMPLETED|Continuation Phase||0
378317|NCT00355082|921743|P1|COMPLETED|Continuation Phase||160
378318|NCT00355082|921741|P3|STARTED|Continuation Phase|"See Pre-assign. Details for reasons why number starting CP does not equal number completing TP."|11
378319|NCT00355082|921742|P2|STARTED|Continuation Phase||0
378320|NCT00355082|921743|P1|STARTED|Continuation Phase|83 and 101 participants from the 250 and 300 mg groups (DB Phase), respectively, entered the CP.|184
378321|NCT00355082|921741|P3|NOT COMPLETED|Double-Blind (DB) Treatment Phase||0
378322|NCT00355082|921742|P2|NOT COMPLETED|Double-Blind (DB) Treatment Phase||34
378323|NCT00355082|921743|P1|NOT COMPLETED|Double-Blind (DB) Treatment Phase||19
378324|NCT00355082|921741|P3|COMPLETED|Double-Blind (DB) Treatment Phase||0
378325|NCT00355082|921742|P2|COMPLETED|Double-Blind (DB) Treatment Phase||79
378326|NCT00355082|921743|P1|COMPLETED|Double-Blind (DB) Treatment Phase||94
378327|NCT00355082|921741|P3|STARTED|Double-Blind (DB) Treatment Phase||0
378328|NCT00355082|921742|P2|STARTED|Double-Blind (DB) Treatment Phase|111 participants have baseline data; 2 participants did not receive study drug.|113
378329|NCT00355082|921743|P1|STARTED|Double-Blind (DB) Treatment Phase|112 participants have baseline data; 1 participant did not receive study drug.|113
378330|NCT00355030|921765|P2|NOT COMPLETED|Study Period 2 Long Term Follow-Up||2
378331|NCT00355030|921766|P1|NOT COMPLETED|Study Period 2 Long Term Follow-Up||1
378332|NCT00355030|921765|P2|COMPLETED|Study Period 2 Long Term Follow-Up||17
378333|NCT00355030|921766|P1|COMPLETED|Study Period 2 Long Term Follow-Up||19
378334|NCT00355030|921765|P2|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|19
378335|NCT00355030|921766|P1|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|20
378336|NCT00355030|921765|P2|NOT COMPLETED|Study Period 1 Treatment||44
378337|NCT00355030|921766|P1|NOT COMPLETED|Study Period 1 Treatment||45
378338|NCT00355030|921765|P2|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
378339|NCT00355030|921766|P1|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
378340|NCT00355030|921765|P2|Received At Least One Dose of Study Drug|Study Period 1 Treatment|2 non-eligible participants received somatropin from previous control group|43
378341|NCT00355030|921766|P1|Received At Least One Dose of Study Drug|Study Period 1 Treatment|1 non-eligible participant received somatropin from previous control group|45
378342|NCT00355030|921765|P2|STARTED|Study Period 1 Treatment||45
378343|NCT00355030|921766|P1|STARTED|Study Period 1 Treatment||46
378344|NCT00354978|921788|P1|NOT COMPLETED|Overall Study||0
378345|NCT00354978|921788|P1|COMPLETED|Overall Study||43
378346|NCT00354978|921788|P1|STARTED|Overall Study||43
378347|NCT00354913|921792|P1|NOT COMPLETED|Overall Study||0
378348|NCT00354913|921792|P1|COMPLETED|Overall Study||21
378349|NCT00354913|921792|P1|STARTED|Overall Study||21
378350|NCT00354887|921799|P1|NOT COMPLETED|Overall Study||1
378351|NCT00354887|921799|P1|COMPLETED|Overall Study||29
378352|NCT00354887|921799|P1|STARTED|Overall Study||30
378353|NCT00354835|921805|P2|NOT COMPLETED|Overall Study||61
378354|NCT00354835|921806|P1|NOT COMPLETED|Overall Study||52
378355|NCT00354835|921805|P2|COMPLETED|Overall Study||181
378356|NCT00354835|921806|P1|COMPLETED|Overall Study||187
378357|NCT00354835|921805|P2|STARTED|Overall Study||242
378358|NCT00354835|921806|P1|STARTED|Overall Study||239
378359|NCT00354770|921838|P2|NOT COMPLETED|Overall Study||3
378360|NCT00354770|921839|P1|NOT COMPLETED|Overall Study||3
378361|NCT00354770|921838|P2|COMPLETED|Overall Study||22
378362|NCT00354770|921839|P1|COMPLETED|Overall Study||22
378363|NCT00354770|921838|P2|STARTED|Overall Study||25
378364|NCT00354770|921839|P1|STARTED|Overall Study||25
378365|NCT00354744|921845|P1|NOT COMPLETED|Overall Study||42
378366|NCT00354744|921845|P1|COMPLETED|Overall Study||67
378367|NCT00354744|921845|P1|STARTED|Overall Study||109
378368|NCT00354679|921850|P1|NOT COMPLETED|Overall Study||1
378369|NCT00354679|921850|P1|COMPLETED|Overall Study||33
378370|NCT00354679|921850|P1|STARTED|Overall Study||34
378371|NCT00354640|921854|P1|NOT COMPLETED|Overall Study||0
378372|NCT00354640|921854|P1|COMPLETED|Overall Study||11
378373|NCT00354640|921854|P1|STARTED|Overall Study||11
378374|NCT00354614|921859|P1|NOT COMPLETED|Overall Study||28
378375|NCT00354614|921859|P1|COMPLETED|Overall Study||53
378376|NCT00354614|921859|P1|STARTED|Overall Study||81
378377|NCT00354601|921863|P1|NOT COMPLETED|Overall Study||2
378378|NCT00354601|921863|P1|COMPLETED|Overall Study||0
378379|NCT00354601|921863|P1|STARTED|Overall Study||2
378380|NCT00354484|921872|P2|NOT COMPLETED|Overall Study||3
378381|NCT00354484|921873|P1|NOT COMPLETED|Overall Study||4
378382|NCT00354484|921872|P2|COMPLETED|Overall Study||144
378383|NCT00354484|921873|P1|COMPLETED|Overall Study||138
378384|NCT00354484|921872|P2|STARTED|Overall Study||147
378385|NCT00354484|921873|P1|STARTED|Overall Study||142
378386|NCT00354432|921883|P4|NOT COMPLETED|Overall Study||10
378387|NCT00354432|921884|P3|NOT COMPLETED|Overall Study||10
378388|NCT00354432|921885|P2|NOT COMPLETED|Overall Study||8
378389|NCT00354432|921886|P1|NOT COMPLETED|Overall Study||6
378390|NCT00354432|921883|P4|COMPLETED|Overall Study||20
378391|NCT00354432|921884|P3|COMPLETED|Overall Study||20
378392|NCT00354432|921885|P2|COMPLETED|Overall Study||22
378393|NCT00354432|921886|P1|COMPLETED|Overall Study||24
378394|NCT00354432|921883|P4|STARTED|Overall Study||30
378395|NCT00354432|921884|P3|STARTED|Overall Study||30
378396|NCT00354432|921885|P2|STARTED|Overall Study||30
378397|NCT00354432|921886|P1|STARTED|Overall Study||30
378398|NCT00354341|921902|P2|NOT COMPLETED|Overall Study||7
378399|NCT00354341|921903|P1|NOT COMPLETED|Overall Study||3
378400|NCT00354341|921902|P2|COMPLETED|Overall Study||75
378401|NCT00354341|921903|P1|COMPLETED|Overall Study||85
378402|NCT00354341|921902|P2|STARTED|Overall Study||82
378403|NCT00354341|921903|P1|STARTED|Overall Study||88
378404|NCT00354224|921919|P1|NOT COMPLETED|Overall Study||0
378405|NCT00354224|921919|P1|COMPLETED|Overall Study||10
378406|NCT00354224|921919|P1|STARTED|Overall Study||10
378407|NCT00354172|921925|P1|NOT COMPLETED|Overall Study||1
378408|NCT00354172|921925|P1|COMPLETED|Overall Study|1 patient did not reach umbilical cord blood transplant|15
378409|NCT00354172|921925|P1|STARTED|Overall Study||16
378410|NCT00354159|921945|P2|NOT COMPLETED|Long-term Follow-up||176
378411|NCT00354159|921946|P1|NOT COMPLETED|Long-term Follow-up||180
378412|NCT00354159|921945|P2|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
378413|NCT00354159|921946|P1|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
378414|NCT00354159|921945|P2|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|176
378415|NCT00354159|921946|P1|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|180
378416|NCT00354159|921945|P2|NOT COMPLETED|Randomized Study Period||22
378417|NCT00354159|921946|P1|NOT COMPLETED|Randomized Study Period||22
378418|NCT00354159|921945|P2|COMPLETED|Randomized Study Period||176
378419|NCT00354159|921946|P1|COMPLETED|Randomized Study Period||180
378420|NCT00354159|921945|P2|STARTED|Randomized Study Period||198
378421|NCT00354159|921946|P1|STARTED|Randomized Study Period||202
378422|NCT00354107|921989|P1|NOT COMPLETED|Overall Study||5
378423|NCT00354107|921989|P1|COMPLETED|Overall Study||0
378424|NCT00354107|921989|P1|STARTED|Overall Study||5
378425|NCT00354029|921999|P2|NOT COMPLETED|Overall Study||2
378426|NCT00354029|922000|P1|NOT COMPLETED|Overall Study||4
378427|NCT00354029|921999|P2|COMPLETED|Overall Study||38
378428|NCT00354029|922000|P1|COMPLETED|Overall Study||39
378429|NCT00354029|921999|P2|STARTED|Overall Study||40
378430|NCT00354029|922000|P1|STARTED|Overall Study||43
378431|NCT00353977|922006|P1|NOT COMPLETED|Overall Study||0
378432|NCT00353977|922006|P1|COMPLETED|Overall Study||38
378433|NCT00353977|922006|P1|STARTED|Overall Study||38
378434|NCT00353873|922012|P2|NOT COMPLETED|Overall Study||3
378435|NCT00353873|922013|P1|NOT COMPLETED|Overall Study||6
378436|NCT00353873|922012|P2|COMPLETED|Overall Study||147
378437|NCT00353873|922013|P1|COMPLETED|Overall Study||147
378438|NCT00353873|922012|P2|STARTED|Overall Study||150
378439|NCT00353873|922013|P1|STARTED|Overall Study||153
378440|NCT00353834|922027|P2|NOT COMPLETED|Overall Study||0
378441|NCT00353834|922028|P1|NOT COMPLETED|Overall Study||0
378442|NCT00353834|922027|P2|COMPLETED|Overall Study||27
378443|NCT00353834|922028|P1|COMPLETED|Overall Study||26
378444|NCT00353834|922027|P2|STARTED|Overall Study||27
378445|NCT00353834|922028|P1|STARTED|Overall Study||26
378446|NCT00353795|922036|P1|NOT COMPLETED|Overall Study||0
378447|NCT00353795|922036|P1|COMPLETED|Overall Study||179
378448|NCT00353795|922036|P1|STARTED|Overall Study||179
378449|NCT00353704|922042|P2|NOT COMPLETED|Overall Study||1
378450|NCT00353704|922043|P1|NOT COMPLETED|Overall Study||3
378451|NCT00353704|922042|P2|COMPLETED|Overall Study||24
378452|NCT00353704|922043|P1|COMPLETED|Overall Study||22
378453|NCT00353704|922042|P2|STARTED|Overall Study||25
378454|NCT00353704|922043|P1|STARTED|Overall Study||25
378455|NCT00353652|922053|P8|NOT COMPLETED|Third Intervention – 3 Months||0
378456|NCT00353652|922054|P7|NOT COMPLETED|Third Intervention – 3 Months||0
378457|NCT00353652|922055|P6|NOT COMPLETED|Third Intervention – 3 Months||0
378458|NCT00353652|922056|P5|NOT COMPLETED|Third Intervention – 3 Months||0
378459|NCT00353652|922057|P4|NOT COMPLETED|Third Intervention – 3 Months||1
378460|NCT00353652|922058|P3|NOT COMPLETED|Third Intervention – 3 Months||0
378461|NCT00353652|922059|P2|NOT COMPLETED|Third Intervention – 3 Months||0
378462|NCT00353652|922060|P1|NOT COMPLETED|Third Intervention – 3 Months||0
378463|NCT00353652|922053|P8|COMPLETED|Third Intervention – 3 Months||0
378464|NCT00353652|922054|P7|COMPLETED|Third Intervention – 3 Months||1
378465|NCT00353652|922055|P6|COMPLETED|Third Intervention – 3 Months||0
378466|NCT00353652|922056|P5|COMPLETED|Third Intervention – 3 Months||3
378467|NCT00353652|922057|P4|COMPLETED|Third Intervention – 3 Months||6
378468|NCT00353652|922058|P3|COMPLETED|Third Intervention – 3 Months||6
378469|NCT00353652|922059|P2|COMPLETED|Third Intervention – 3 Months||0
378470|NCT00353652|922060|P1|COMPLETED|Third Intervention – 3 Months||0
378471|NCT00353652|922053|P8|STARTED|Third Intervention – 3 Months||0
378472|NCT00353652|922054|P7|STARTED|Third Intervention – 3 Months||1
378473|NCT00353652|922055|P6|STARTED|Third Intervention – 3 Months||0
378474|NCT00353652|922056|P5|STARTED|Third Intervention – 3 Months||3
378475|NCT00353652|922057|P4|STARTED|Third Intervention – 3 Months||7
378476|NCT00353652|922058|P3|STARTED|Third Intervention – 3 Months||6
378477|NCT00353652|922059|P2|STARTED|Third Intervention – 3 Months||0
378478|NCT00353652|922060|P1|STARTED|Third Intervention – 3 Months||0
378479|NCT00353652|922053|P8|NOT COMPLETED|Second Intervention – 3 Months||0
378480|NCT00353652|922054|P7|NOT COMPLETED|Second Intervention – 3 Months||0
378481|NCT00353652|922055|P6|NOT COMPLETED|Second Intervention – 3 Months||0
378482|NCT00353652|922056|P5|NOT COMPLETED|Second Intervention – 3 Months||0
378483|NCT00353652|922057|P4|NOT COMPLETED|Second Intervention – 3 Months||0
378484|NCT00353652|922058|P3|NOT COMPLETED|Second Intervention – 3 Months||0
378485|NCT00353652|922059|P2|NOT COMPLETED|Second Intervention – 3 Months||0
378486|NCT00353652|922060|P1|NOT COMPLETED|Second Intervention – 3 Months||0
378487|NCT00353652|922053|P8|COMPLETED|Second Intervention – 3 Months||0
378488|NCT00353652|922054|P7|COMPLETED|Second Intervention – 3 Months||1
378489|NCT00353652|922055|P6|COMPLETED|Second Intervention – 3 Months||0
378490|NCT00353652|922056|P5|COMPLETED|Second Intervention – 3 Months||3
378491|NCT00353652|922057|P4|COMPLETED|Second Intervention – 3 Months||7
378492|NCT00353652|922058|P3|COMPLETED|Second Intervention – 3 Months||6
378493|NCT00353652|922059|P2|COMPLETED|Second Intervention – 3 Months||11
378494|NCT00353652|922060|P1|COMPLETED|Second Intervention – 3 Months||12
378495|NCT00353652|922053|P8|STARTED|Second Intervention – 3 Months||0
378496|NCT00353652|922054|P7|STARTED|Second Intervention – 3 Months||1
378497|NCT00353652|922055|P6|STARTED|Second Intervention – 3 Months||0
378498|NCT00353652|922056|P5|STARTED|Second Intervention – 3 Months||3
378499|NCT00353652|922057|P4|STARTED|Second Intervention – 3 Months||7
378500|NCT00353652|922058|P3|STARTED|Second Intervention – 3 Months||6
378501|NCT00353652|922059|P2|STARTED|Second Intervention – 3 Months||11
378502|NCT00353652|922060|P1|STARTED|Second Intervention – 3 Months||12
378503|NCT00353652|922053|P8|NOT COMPLETED|First Intervention – 3 Months||0
378504|NCT00353652|922054|P7|NOT COMPLETED|First Intervention – 3 Months||0
378505|NCT00353652|922055|P6|NOT COMPLETED|First Intervention – 3 Months||0
378506|NCT00353652|922056|P5|NOT COMPLETED|First Intervention – 3 Months||0
378507|NCT00353652|922057|P4|NOT COMPLETED|First Intervention – 3 Months||0
378508|NCT00353652|922058|P3|NOT COMPLETED|First Intervention – 3 Months||0
378509|NCT00353652|922059|P2|NOT COMPLETED|First Intervention – 3 Months||4
378510|NCT00353652|922060|P1|NOT COMPLETED|First Intervention – 3 Months||3
378511|NCT00353652|922053|P8|COMPLETED|First Intervention – 3 Months||0
378512|NCT00353652|922054|P7|COMPLETED|First Intervention – 3 Months||1
378513|NCT00353652|922055|P6|COMPLETED|First Intervention – 3 Months||0
378514|NCT00353652|922056|P5|COMPLETED|First Intervention – 3 Months||3
378515|NCT00353652|922057|P4|COMPLETED|First Intervention – 3 Months||7
378516|NCT00353652|922058|P3|COMPLETED|First Intervention – 3 Months||6
378517|NCT00353652|922059|P2|COMPLETED|First Intervention – 3 Months||11
378518|NCT00353652|922060|P1|COMPLETED|First Intervention – 3 Months||12
378519|NCT00353652|922053|P8|STARTED|First Intervention – 3 Months||0
378520|NCT00353652|922054|P7|STARTED|First Intervention – 3 Months||1
378521|NCT00353652|922055|P6|STARTED|First Intervention – 3 Months||0
378522|NCT00353652|922056|P5|STARTED|First Intervention – 3 Months||3
378523|NCT00353652|922057|P4|STARTED|First Intervention – 3 Months||7
378524|NCT00353652|922058|P3|STARTED|First Intervention – 3 Months||6
378525|NCT00353652|922059|P2|STARTED|First Intervention – 3 Months||15
378526|NCT00353652|922060|P1|STARTED|First Intervention – 3 Months||15
378527|NCT00353496|922094|P2|NOT COMPLETED|Overall Study||17
378528|NCT00353496|922095|P1|NOT COMPLETED|Overall Study||16
378529|NCT00353496|922094|P2|COMPLETED|Overall Study||86
378530|NCT00353496|922095|P1|COMPLETED|Overall Study|Patients who completed specified assessments or met primary efficacy endpoint criteria for an event.|85
378531|NCT00353496|922094|P2|STARTED|Overall Study||103
378532|NCT00353496|922095|P1|STARTED|Overall Study||101
378533|NCT00353431|922112|P2|NOT COMPLETED|Overall Study||0
378534|NCT00353431|922113|P1|NOT COMPLETED|Overall Study||0
378535|NCT00353431|922112|P2|COMPLETED|Overall Study||67
378536|NCT00353431|922113|P1|COMPLETED|Overall Study||63
378537|NCT00353431|922112|P2|STARTED|Overall Study||67
378538|NCT00353431|922113|P1|STARTED|Overall Study||63
378539|NCT00353418|922129|P2|NOT COMPLETED|Overall Study||158
378540|NCT00353418|922130|P1|NOT COMPLETED|Overall Study||83
378541|NCT00353418|922129|P2|COMPLETED|Overall Study||119
378542|NCT00353418|922130|P1|COMPLETED|Overall Study||55
378543|NCT00353418|922129|P2|STARTED|Overall Study||277
378544|NCT00353418|922130|P1|STARTED|Overall Study||138
378545|NCT00353366|922148|P1|NOT COMPLETED|Overall Study||143
378546|NCT00353366|922148|P1|COMPLETED|Overall Study||1289
378547|NCT00353366|922148|P1|STARTED|Overall Study||1432
378548|NCT00353301|922155|P1|NOT COMPLETED|Overall Study||0
378549|NCT00353301|922155|P1|COMPLETED|Overall Study||25
378550|NCT00353301|922155|P1|STARTED|Overall Study||25
378551|NCT00353275|922162|P2|NOT COMPLETED|Overall Study||0
378552|NCT00353275|922163|P1|NOT COMPLETED|Overall Study||0
378553|NCT00353275|922162|P2|COMPLETED|Overall Study||3
378554|NCT00353275|922163|P1|COMPLETED|Overall Study||2
378555|NCT00353275|922162|P2|STARTED|Overall Study||3
378556|NCT00353275|922163|P1|STARTED|Overall Study||2
378557|NCT00353262|922175|P1|NOT COMPLETED|Overall Study||29
378558|NCT00353262|922175|P1|COMPLETED|Overall Study||7
378559|NCT00353262|922175|P1|STARTED|Overall Study||36
378560|NCT00353119|922194|P2|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
378561|NCT00353119|922195|P1|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
378562|NCT00353119|922194|P2|COMPLETED|Second Intervention Week 12 to Week 28||10
378563|NCT00353119|922195|P1|COMPLETED|Second Intervention Week 12 to Week 28||5
378564|NCT00353119|922194|P2|STARTED|Second Intervention Week 12 to Week 28||10
378565|NCT00353119|922195|P1|STARTED|Second Intervention Week 12 to Week 28||5
378566|NCT00353119|922194|P2|NOT COMPLETED|First Intervention Day 0 to Week 12||0
378567|NCT00353119|922195|P1|NOT COMPLETED|First Intervention Day 0 to Week 12||0
378568|NCT00353119|922194|P2|COMPLETED|First Intervention Day 0 to Week 12||10
378569|NCT00353119|922195|P1|COMPLETED|First Intervention Day 0 to Week 12||5
378570|NCT00353119|922194|P2|STARTED|First Intervention Day 0 to Week 12||10
378571|NCT00353119|922195|P1|STARTED|First Intervention Day 0 to Week 12||5
378572|NCT00352911|922207|P2|NOT COMPLETED|300mg Twice Daily (14 Days)||0
378573|NCT00352911|922208|P1|NOT COMPLETED|300mg Twice Daily (14 Days)||1
378574|NCT00352911|922207|P2|COMPLETED|300mg Twice Daily (14 Days)||3
378575|NCT00352911|922208|P1|COMPLETED|300mg Twice Daily (14 Days)||15
378576|NCT00352911|922207|P2|STARTED|300mg Twice Daily (14 Days)||3
378577|NCT00352911|922208|P1|STARTED|300mg Twice Daily (14 Days)||16
378578|NCT00352911|922207|P2|NOT COMPLETED|150mg Twice Daily (14 Days)||0
378579|NCT00352911|922208|P1|NOT COMPLETED|150mg Twice Daily (14 Days)||0
378580|NCT00352911|922207|P2|COMPLETED|150mg Twice Daily (14 Days)||3
378581|NCT00352911|922208|P1|COMPLETED|150mg Twice Daily (14 Days)||16
378582|NCT00352911|922207|P2|STARTED|150mg Twice Daily (14 Days)||3
378583|NCT00352911|922208|P1|STARTED|150mg Twice Daily (14 Days)||16
378584|NCT00352885|922216|P2|NOT COMPLETED|Overall Study||7
378585|NCT00352885|922217|P1|NOT COMPLETED|Overall Study||6
378586|NCT00352885|922216|P2|COMPLETED|Overall Study||4
378587|NCT00352885|922217|P1|COMPLETED|Overall Study||3
378588|NCT00352885|922216|P2|Completed Cycle 3 of IL-2 Treatment|Overall Study||7
378589|NCT00352885|922217|P1|Completed Cycle 3 of IL-2 Treatment|Overall Study||4
378590|NCT00352885|922216|P2|Completed Cycle 2 of IL-2 Treatment|Overall Study||9
378591|NCT00352885|922217|P1|Completed Cycle 2 of IL-2 Treatment|Overall Study||8
378592|NCT00352885|922216|P2|Completed Cycle 1 of IL-2 Treatment|Overall Study||11
378593|NCT00352885|922217|P1|Completed Cycle 1 of IL-2 Treatment|Overall Study||9
378594|NCT00352885|922216|P2|STARTED|Overall Study||11
378595|NCT00352885|922217|P1|STARTED|Overall Study||9
378596|NCT00352846|922235|P2|NOT COMPLETED|Overall Study||13
378597|NCT00352846|922236|P1|NOT COMPLETED|Overall Study||8
378598|NCT00352846|922235|P2|COMPLETED|Overall Study||24
378599|NCT00352846|922236|P1|COMPLETED|Overall Study||29
378600|NCT00352846|922235|P2|STARTED|Overall Study||37
378601|NCT00352846|922236|P1|STARTED|Overall Study||37
378602|NCT00352794|922242|P1|NOT COMPLETED|Overall Study||0
378603|NCT00352794|922242|P1|COMPLETED|Overall Study||40
378604|NCT00352794|922242|P1|STARTED|Overall Study||40
378605|NCT00352781|922246|P1|NOT COMPLETED|Overall Study||883
378606|NCT00352781|922246|P1|COMPLETED|Overall Study||884
378607|NCT00352781|922246|P1|STARTED|Overall Study||1767
378608|NCT00352755|922251|P1|NOT COMPLETED|Overall Study||2
378609|NCT00352755|922251|P1|COMPLETED|Overall Study||16
378610|NCT00352755|922251|P1|STARTED|Overall Study||18
378611|NCT00352690|922261|P2|NOT COMPLETED|Overall Study||0
378612|NCT00352690|922262|P1|NOT COMPLETED|Overall Study||2
378613|NCT00352690|922261|P2|COMPLETED|Overall Study||0
378614|NCT00352690|922262|P1|COMPLETED|Overall Study||8
378615|NCT00352690|922261|P2|STARTED|Overall Study||0
378616|NCT00352690|922262|P1|STARTED|Overall Study||10
378617|NCT00352664|922282|P2|NOT COMPLETED|Overall Study||0
378618|NCT00352664|922283|P1|NOT COMPLETED|Overall Study||7
378619|NCT00352664|922282|P2|COMPLETED|Overall Study||0
378620|NCT00352664|922283|P1|COMPLETED|Overall Study||20
378621|NCT00352664|922282|P2|STARTED|Overall Study||0
378622|NCT00352664|922283|P1|STARTED|Overall Study||27
378623|NCT00352612|922291|P2|NOT COMPLETED|Overall Study||0
378624|NCT00352612|922292|P1|NOT COMPLETED|Overall Study||0
378625|NCT00352612|922291|P2|COMPLETED|Overall Study||100
378626|NCT00352612|922292|P1|COMPLETED|Overall Study||100
378627|NCT00352612|922291|P2|STARTED|Overall Study||100
378628|NCT00352612|922292|P1|STARTED|Overall Study||100
378629|NCT00352534|922300|P7|NOT COMPLETED|Final Risk Group Assignment||39
378630|NCT00352534|922301|P6|NOT COMPLETED|Final Risk Group Assignment||45
378631|NCT00352534|922302|P5|NOT COMPLETED|Final Risk Group Assignment||1
378632|NCT00352534|922303|P4|NOT COMPLETED|Final Risk Group Assignment||3
378633|NCT00352534|922304|P3|NOT COMPLETED|Final Risk Group Assignment||3
378634|NCT00352534|922305|P2|NOT COMPLETED|Final Risk Group Assignment||0
378635|NCT00352534|922306|P1|NOT COMPLETED|Final Risk Group Assignment||0
378636|NCT00352534|922300|P7|COMPLETED|Final Risk Group Assignment||1
378637|NCT00352534|922301|P6|COMPLETED|Final Risk Group Assignment||503
378638|NCT00352534|922302|P5|COMPLETED|Final Risk Group Assignment||31
378639|NCT00352534|922303|P4|COMPLETED|Final Risk Group Assignment||49
378640|NCT00352534|922304|P3|COMPLETED|Final Risk Group Assignment||116
378641|NCT00352534|922305|P2|COMPLETED|Final Risk Group Assignment||0
378642|NCT00352534|922306|P1|COMPLETED|Final Risk Group Assignment||0
378643|NCT00352534|922300|P7|STARTED|Final Risk Group Assignment||40
378644|NCT00352534|922301|P6|STARTED|Final Risk Group Assignment||548
378645|NCT00352534|922302|P5|STARTED|Final Risk Group Assignment||32
378646|NCT00352534|922303|P4|STARTED|Final Risk Group Assignment||52
378647|NCT00352534|922304|P3|STARTED|Final Risk Group Assignment||119
378648|NCT00352534|922305|P2|STARTED|Final Risk Group Assignment||0
378649|NCT00352534|922306|P1|STARTED|Final Risk Group Assignment||0
378650|NCT00352534|922300|P7|NOT COMPLETED|Initial Staging||0
378651|NCT00352534|922301|P6|NOT COMPLETED|Initial Staging||0
378652|NCT00352534|922302|P5|NOT COMPLETED|Initial Staging||0
378653|NCT00352534|922303|P4|NOT COMPLETED|Initial Staging||0
378654|NCT00352534|922304|P3|NOT COMPLETED|Initial Staging||0
378655|NCT00352534|922305|P2|NOT COMPLETED|Initial Staging||9
378656|NCT00352534|922306|P1|NOT COMPLETED|Initial Staging||8
378657|NCT00352534|922300|P7|COMPLETED|Initial Staging||0
378658|NCT00352534|922301|P6|COMPLETED|Initial Staging||0
378659|NCT00352534|922302|P5|COMPLETED|Initial Staging||0
378660|NCT00352534|922303|P4|COMPLETED|Initial Staging||0
378661|NCT00352534|922304|P3|COMPLETED|Initial Staging||0
378662|NCT00352534|922305|P2|COMPLETED|Initial Staging||588
378663|NCT00352534|922306|P1|COMPLETED|Initial Staging||203
378664|NCT00352534|922300|P7|STARTED|Initial Staging||0
378665|NCT00352534|922301|P6|STARTED|Initial Staging||0
378666|NCT00352534|922302|P5|STARTED|Initial Staging||0
378667|NCT00352534|922303|P4|STARTED|Initial Staging||0
378668|NCT00352534|922304|P3|STARTED|Initial Staging||0
378669|NCT00352534|922305|P2|STARTED|Initial Staging||597
378670|NCT00352534|922306|P1|STARTED|Initial Staging||211
378671|NCT00352417|922323|P2|NOT COMPLETED|Overall Study||5
378672|NCT00352417|922324|P1|NOT COMPLETED|Overall Study||5
378673|NCT00352417|922323|P2|COMPLETED|Overall Study||21
378674|NCT00352417|922324|P1|COMPLETED|Overall Study||19
378675|NCT00352417|922323|P2|STARTED|Overall Study||26
378676|NCT00352417|922324|P1|STARTED|Overall Study||24
378677|NCT00352365|922338|P1|NOT COMPLETED|Maintenance Therapy||12
378678|NCT00352365|922338|P1|COMPLETED|Maintenance Therapy||0
378679|NCT00352365|922338|P1|Eligible and Began Protocol Therapy|Maintenance Therapy||8
378680|NCT00352365|922338|P1|STARTED|Maintenance Therapy||12
378681|NCT00352365|922338|P1|NOT COMPLETED|Induction Therapy||27
378682|NCT00352365|922338|P1|COMPLETED|Induction Therapy||14
378683|NCT00352365|922338|P1|Eligible and Began Protocol Therapy|Induction Therapy||37
378684|NCT00352365|922338|P1|Eligible|Induction Therapy||38
378685|NCT00352365|922338|P1|STARTED|Induction Therapy||41
378686|NCT00352118|922348|P1|NOT COMPLETED|Overall Study||4
378687|NCT00352118|922348|P1|COMPLETED|Overall Study||0
378688|NCT00352118|922348|P1|STARTED|Overall Study||4
378689|NCT00352105|922358|P1|NOT COMPLETED|Overall Study||40
378690|NCT00352105|922358|P1|COMPLETED|Overall Study||20
378691|NCT00352105|922358|P1|STARTED|Overall Study||60
378692|NCT00352053|922369|P2|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||2
378693|NCT00352053|922370|P1|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||1
378694|NCT00352053|922369|P2|COMPLETED|Third Extension Phase (Weeks 240-294)||2
378695|NCT00352053|922370|P1|COMPLETED|Third Extension Phase (Weeks 240-294)||0
378696|NCT00352053|922369|P2|STARTED|Third Extension Phase (Weeks 240-294)|5 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|4
378697|NCT00352053|922370|P1|STARTED|Third Extension Phase (Weeks 240-294)|3 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|1
378698|NCT00352053|922369|P2|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
378699|NCT00352053|922370|P1|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
378700|NCT00352053|922369|P2|COMPLETED|Second Extension Phase (Weeks 144-240)||9
378701|NCT00352053|922370|P1|COMPLETED|Second Extension Phase (Weeks 144-240)||4
378702|NCT00352053|922369|P2|STARTED|Second Extension Phase (Weeks 144-240)|5 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|14
378703|NCT00352053|922370|P1|STARTED|Second Extension Phase (Weeks 144-240)|3 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|9
378704|NCT00352053|922369|P2|NOT COMPLETED|First Extension Phase (Weeks 48-144)||17
378705|NCT00352053|922370|P1|NOT COMPLETED|First Extension Phase (Weeks 48-144)||12
378706|NCT00352053|922369|P2|COMPLETED|First Extension Phase (Weeks 48-144)||19
378707|NCT00352053|922370|P1|COMPLETED|First Extension Phase (Weeks 48-144)||12
378708|NCT00352053|922369|P2|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|36
378709|NCT00352053|922370|P1|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|24
378710|NCT00352053|922369|P2|NOT COMPLETED|Double-Blind Phase (Through Week 48)||13
378711|NCT00352053|922370|P1|NOT COMPLETED|Double-Blind Phase (Through Week 48)||18
378712|NCT00352053|922369|P2|COMPLETED|Double-Blind Phase (Through Week 48)|The 10 participants discontinued for virologic failure enrolled early in the open-label extension.|29
378713|NCT00352053|922370|P1|COMPLETED|Double-Blind Phase (Through Week 48)||27
378714|NCT00352053|922369|P2|STARTED|Double-Blind Phase (Through Week 48)||42
378715|NCT00352053|922370|P1|STARTED|Double-Blind Phase (Through Week 48)||45
378716|NCT00352027|922537|P1|NOT COMPLETED|Overall Study||3
378717|NCT00352027|922537|P1|COMPLETED|Overall Study||77
378718|NCT00352027|922537|P1|STARTED|Overall Study||80
378719|NCT00352001|922806|P1|NOT COMPLETED|Overall Study||0
378720|NCT00352001|922806|P1|COMPLETED|Overall Study||37
378721|NCT00352001|922806|P1|Azacitidine 75mg/Lenalidomide 10mg-14day|Overall Study||3
378722|NCT00352001|922806|P1|Azacitidine 75mg/Lenalidomide 5mg-21 Day|Overall Study||3
378723|NCT00352001|922806|P1|Azacitidine 75mg/Lenalidomide 5mg-14 Day|Overall Study||3
378724|NCT00352001|922806|P1|STARTED|Overall Study||37
378725|NCT00351936|922817|P1|NOT COMPLETED|Overall Study||0
378726|NCT00351936|922817|P1|COMPLETED|Overall Study||15
378727|NCT00351936|922817|P1|STARTED|Overall Study||15
378728|NCT00351819|922836|P2|NOT COMPLETED|Overall Study||12
378729|NCT00351819|922837|P1|NOT COMPLETED|Overall Study||7
378730|NCT00351819|922836|P2|COMPLETED|Overall Study||29
378731|NCT00351819|922837|P1|COMPLETED|Overall Study||36
378732|NCT00351819|922836|P2|STARTED|Overall Study||41
378733|NCT00351819|922837|P1|STARTED|Overall Study||43
378734|NCT00351741|922887|P2|NOT COMPLETED|Overall Study||0
378735|NCT00351741|922888|P1|NOT COMPLETED|Overall Study||0
378736|NCT00351741|922887|P2|COMPLETED|Overall Study||31
378737|NCT00351741|922888|P1|COMPLETED|Overall Study||31
378738|NCT00351741|922887|P2|STARTED|Overall Study||31
378739|NCT00351741|922888|P1|STARTED|Overall Study||31
378740|NCT00351533|922908|P2|NOT COMPLETED|Overall Study||5
378741|NCT00351533|922909|P1|NOT COMPLETED|Overall Study||2
378742|NCT00351533|922908|P2|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|44
378743|NCT00351533|922909|P1|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|39
378744|NCT00351533|922908|P2|STARTED|Overall Study||49
378745|NCT00351533|922909|P1|STARTED|Overall Study||41
378746|NCT00351468|922969|P1|NOT COMPLETED|Overall Study||167
378747|NCT00351468|922969|P1|COMPLETED|Overall Study||135
378748|NCT00351468|922969|P1|Unknown - Not From Previous Trial|Overall Study|Mistakenly enrolled (not in any of the 3 trials) On 50 mg/d eltrombopag for 18 days and withdrawn|1
378749|NCT00351468|922969|P1|Subjects From TRA108057 Repeat|Overall Study||43
378750|NCT00351468|922969|P1|Subjects From TRA102537 Raise|Overall Study||146
378751|NCT00351468|922969|P1|Subjects From TRA100773B|Overall Study||61
378752|NCT00351468|922969|P1|Subjects From TRA100773A|Overall Study||51
378753|NCT00351468|922969|P1|STARTED|Overall Study||302
378754|NCT00351416|922986|P2|NOT COMPLETED|Overall Study||0
378755|NCT00351416|922987|P1|NOT COMPLETED|Overall Study||0
378756|NCT00351416|922986|P2|COMPLETED|Overall Study||9
378757|NCT00351416|922987|P1|COMPLETED|Overall Study||6
378758|NCT00351416|922986|P2|STARTED|Overall Study||9
378759|NCT00351416|922987|P1|STARTED|Overall Study||6
378760|NCT00351377|922993|P1|NOT COMPLETED|Overall Study||7
378761|NCT00351377|922993|P1|COMPLETED|Overall Study||104
378762|NCT00351377|922993|P1|STARTED|Overall Study||111
378763|NCT00351351|923007|P2|NOT COMPLETED|Overall Study||4
378764|NCT00351351|923008|P1|NOT COMPLETED|Overall Study||9
378765|NCT00351351|923007|P2|COMPLETED|Overall Study||32
378766|NCT00351351|923008|P1|COMPLETED|Overall Study||25
378767|NCT00351351|923007|P2|STARTED|Overall Study||36
378768|NCT00351351|923008|P1|STARTED|Overall Study||34
378769|NCT00351299|923016|P2|NOT COMPLETED|Overall Study||0
378770|NCT00351299|923017|P1|NOT COMPLETED|Overall Study||0
378771|NCT00351299|923016|P2|COMPLETED|Overall Study||28
378772|NCT00351299|923017|P1|COMPLETED|Overall Study||25
378773|NCT00351299|923016|P2|STARTED|Overall Study||28
378774|NCT00351299|923017|P1|STARTED|Overall Study||25
378775|NCT00351273|923034|P3|NOT COMPLETED|Overall Study||5
378776|NCT00351273|923035|P2|NOT COMPLETED|Overall Study||2
378777|NCT00351273|923036|P1|NOT COMPLETED|Overall Study||1
378778|NCT00351273|923034|P3|COMPLETED|Overall Study||10
378779|NCT00351273|923035|P2|COMPLETED|Overall Study||10
378780|NCT00351273|923036|P1|COMPLETED|Overall Study||14
378781|NCT00351273|923034|P3|STARTED|Overall Study||15
378782|NCT00351273|923035|P2|STARTED|Overall Study||12
378783|NCT00351273|923036|P1|STARTED|Overall Study||15
378784|NCT00351039|923059|P1|NOT COMPLETED|Overall Study||0
378785|NCT00351039|923059|P1|COMPLETED|Overall Study|The study was halted before Phase II was initiated.|8
378786|NCT00351039|923059|P1|STARTED|Overall Study||8
378787|NCT00351000|923068|P1|NOT COMPLETED|Overall Study||3
378788|NCT00351000|923068|P1|COMPLETED|Overall Study||21
378789|NCT00351000|923068|P1|STARTED|Overall Study||24
378790|NCT00350870|923079|P4|NOT COMPLETED|Overall Study||15
378791|NCT00350870|923080|P3|NOT COMPLETED|Overall Study||16
378792|NCT00350870|923081|P2|NOT COMPLETED|Overall Study||17
378793|NCT00350870|923082|P1|NOT COMPLETED|Overall Study||22
378794|NCT00350870|923079|P4|COMPLETED|Overall Study||7
378795|NCT00350870|923080|P3|COMPLETED|Overall Study||6
378796|NCT00350870|923081|P2|COMPLETED|Overall Study||11
378797|NCT00350870|923082|P1|COMPLETED|Overall Study||5
378798|NCT00350870|923079|P4|Had at Least 1 Day of Med|Overall Study||19
378799|NCT00350870|923080|P3|Had at Least 1 Day of Med|Overall Study||18
378800|NCT00350870|923081|P2|Had at Least 1 Day of Med|Overall Study||24
378801|NCT00350870|923082|P1|Had at Least 1 Day of Med|Overall Study||19
378802|NCT00350870|923079|P4|STARTED|Overall Study||22
378803|NCT00350870|923080|P3|STARTED|Overall Study||22
378804|NCT00350870|923081|P2|STARTED|Overall Study||28
378805|NCT00350870|923082|P1|STARTED|Overall Study||27
378806|NCT00350844|923096|P1|NOT COMPLETED|Overall Study||1
378807|NCT00350844|923096|P1|COMPLETED|Overall Study||5
378808|NCT00350844|923096|P1|STARTED|Overall Study||6
378809|NCT00350792|923100|P1|NOT COMPLETED|Overall Study||33
378810|NCT00350792|923100|P1|COMPLETED|Overall Study||29
378811|NCT00350792|923100|P1|STARTED|Overall Study||62
378812|NCT00350779|923110|P2|NOT COMPLETED|Overall Study||21
378813|NCT00350779|923111|P1|NOT COMPLETED|Overall Study||22
378814|NCT00350779|923110|P2|COMPLETED|Overall Study||71
378815|NCT00350779|923111|P1|COMPLETED|Overall Study||148
378816|NCT00350779|923110|P2|STARTED|Overall Study||92
378817|NCT00350779|923111|P1|STARTED|Overall Study||170
378818|NCT00350727|923132|P3|NOT COMPLETED|Phase II||22
378819|NCT00350727|923133|P2|NOT COMPLETED|Phase II||19
378820|NCT00350727|923134|P1|NOT COMPLETED|Phase II||0
378821|NCT00350727|923132|P3|COMPLETED|Phase II||0
378822|NCT00350727|923133|P2|COMPLETED|Phase II||0
378823|NCT00350727|923134|P1|COMPLETED|Phase II||0
378824|NCT00350727|923132|P3|STARTED|Phase II||22
378825|NCT00350727|923133|P2|STARTED|Phase II||19
378826|NCT00350727|923134|P1|STARTED|Phase II||0
378827|NCT00350727|923132|P3|NOT COMPLETED|Phase I: Dose Escalation||0
378828|NCT00350727|923133|P2|NOT COMPLETED|Phase I: Dose Escalation||0
378829|NCT00350727|923134|P1|NOT COMPLETED|Phase I: Dose Escalation||34
378830|NCT00350727|923132|P3|COMPLETED|Phase I: Dose Escalation||0
378831|NCT00350727|923133|P2|COMPLETED|Phase I: Dose Escalation||0
378832|NCT00350727|923134|P1|COMPLETED|Phase I: Dose Escalation||0
378833|NCT00350727|923132|P3|STARTED|Phase I: Dose Escalation||0
378834|NCT00350727|923133|P2|STARTED|Phase I: Dose Escalation||0
378835|NCT00350727|923134|P1|STARTED|Phase I: Dose Escalation||34
378836|NCT00350636|923278|P2|NOT COMPLETED|Overall Study||45
378837|NCT00350636|923279|P1|NOT COMPLETED|Overall Study||43
378838|NCT00350636|923278|P2|COMPLETED|Overall Study||355
378839|NCT00350636|923279|P1|COMPLETED|Overall Study||346
378840|NCT00350636|923278|P2|STARTED|Overall Study||400
378841|NCT00350636|923279|P1|STARTED|Overall Study||389
378842|NCT00350623|923298|P3|NOT COMPLETED|Overall Study||6
378843|NCT00350623|923299|P2|NOT COMPLETED|Overall Study||4
378844|NCT00350623|923300|P1|NOT COMPLETED|Overall Study||8
378845|NCT00350623|923298|P3|COMPLETED|Overall Study||62
378846|NCT00350623|923299|P2|COMPLETED|Overall Study||67
378847|NCT00350623|923300|P1|COMPLETED|Overall Study||63
378848|NCT00350623|923298|P3|STARTED|Overall Study||68
378849|NCT00350623|923299|P2|STARTED|Overall Study||71
378850|NCT00350623|923300|P1|STARTED|Overall Study||71
378851|NCT00350545|923308|P1|NOT COMPLETED|Overall Study||2
378852|NCT00350545|923308|P1|COMPLETED|Overall Study||35
378853|NCT00350545|923308|P1|STARTED|Overall Study||37
378854|NCT00350532|923318|P2|NOT COMPLETED|Overall Study||0
378855|NCT00350532|923319|P1|NOT COMPLETED|Overall Study||0
378856|NCT00350532|923318|P2|COMPLETED|Overall Study||19
378857|NCT00350532|923319|P1|COMPLETED|Overall Study||24
378858|NCT00350532|923318|P2|STARTED|Overall Study||19
378859|NCT00350532|923319|P1|STARTED|Overall Study||24
378860|NCT00350519|923327|P2|NOT COMPLETED|Overall Study||6
378861|NCT00350519|923328|P1|NOT COMPLETED|Overall Study||4
378862|NCT00350519|923327|P2|COMPLETED|Overall Study||13
378863|NCT00350519|923328|P1|COMPLETED|Overall Study||14
378864|NCT00350519|923327|P2|STARTED|Overall Study||19
378865|NCT00350519|923328|P1|STARTED|Overall Study||18
378866|NCT00350402|923342|P2|NOT COMPLETED|Overall Study||1
378867|NCT00350402|923343|P1|NOT COMPLETED|Overall Study||1
378868|NCT00350402|923342|P2|COMPLETED|Overall Study||20
378869|NCT00350402|923343|P1|COMPLETED|Overall Study||20
378870|NCT00350402|923342|P2|STARTED|Overall Study||21
378871|NCT00350402|923343|P1|STARTED|Overall Study||21
378872|NCT00350363|923355|P1|NOT COMPLETED|Overall Study||0
378873|NCT00350363|923355|P1|COMPLETED|Overall Study||60
378874|NCT00350363|923355|P1|STARTED|Overall Study||60
378875|NCT00350337|923363|P4|NOT COMPLETED|Overall Study||0
378876|NCT00350337|923364|P3|NOT COMPLETED|Overall Study||3
378877|NCT00350337|923365|P2|NOT COMPLETED|Overall Study||3
378878|NCT00350337|923366|P1|NOT COMPLETED|Overall Study||5
378879|NCT00350337|923363|P4|COMPLETED|Overall Study||21
378880|NCT00350337|923364|P3|COMPLETED|Overall Study||18
378881|NCT00350337|923365|P2|COMPLETED|Overall Study||19
378882|NCT00350337|923366|P1|COMPLETED|Overall Study||17
378883|NCT00350337|923363|P4|STARTED|Overall Study||21
378884|NCT00350337|923364|P3|STARTED|Overall Study||21
378885|NCT00350337|923365|P2|STARTED|Overall Study||22
378886|NCT00350337|923366|P1|STARTED|Overall Study||22
378887|NCT00350272|923416|P2|NOT COMPLETED|Open-Label 84 Week Treatment||8
378888|NCT00350272|923417|P1|NOT COMPLETED|Open-Label 84 Week Treatment||9
378889|NCT00350272|923416|P2|COMPLETED|Open-Label 84 Week Treatment||27
378890|NCT00350272|923417|P1|COMPLETED|Open-Label 84 Week Treatment||21
378891|NCT00350272|923416|P2|STARTED|Open-Label 84 Week Treatment||35
378892|NCT00350272|923417|P1|STARTED|Open-Label 84 Week Treatment||30
378893|NCT00350272|923416|P2|NOT COMPLETED|Blinded 12 Week Treatment||2
378894|NCT00350272|923417|P1|NOT COMPLETED|Blinded 12 Week Treatment||9
378895|NCT00350272|923416|P2|COMPLETED|Blinded 12 Week Treatment||35
378896|NCT00350272|923417|P1|COMPLETED|Blinded 12 Week Treatment||30
378897|NCT00350272|923416|P2|STARTED|Blinded 12 Week Treatment||37
378898|NCT00350272|923417|P1|STARTED|Blinded 12 Week Treatment||39
378899|NCT00350220|923427|P2|NOT COMPLETED|Overall Study||0
378900|NCT00350220|923428|P1|NOT COMPLETED|Overall Study||0
378901|NCT00350220|923427|P2|COMPLETED|Overall Study||30
378902|NCT00350220|923428|P1|COMPLETED|Overall Study||30
378903|NCT00350220|923427|P2|STARTED|Overall Study||30
378904|NCT00350220|923428|P1|STARTED|Overall Study||30
378905|NCT00350207|923439|P3|NOT COMPLETED|Overall Study||7
378906|NCT00350207|923440|P2|NOT COMPLETED|Overall Study||6
378907|NCT00350207|923441|P1|NOT COMPLETED|Overall Study||8
378908|NCT00350207|923439|P3|COMPLETED|Overall Study||119
378909|NCT00350207|923440|P2|COMPLETED|Overall Study||128
378910|NCT00350207|923441|P1|COMPLETED|Overall Study||120
378911|NCT00350207|923439|P3|STARTED|Overall Study||126
378912|NCT00350207|923440|P2|STARTED|Overall Study||134
378913|NCT00350207|923441|P1|STARTED|Overall Study||128
378914|NCT00350142|923635|P1|NOT COMPLETED|Overall Study||0
378915|NCT00350142|923635|P1|COMPLETED|Overall Study||20
378916|NCT00350142|923635|P1|STARTED|Overall Study||20
378917|NCT00350025|923642|P2|NOT COMPLETED|Overall Study||2
378918|NCT00350025|923643|P1|NOT COMPLETED|Overall Study||0
378919|NCT00350025|923642|P2|COMPLETED|Overall Study||28
378920|NCT00350025|923643|P1|COMPLETED|Overall Study||11
378921|NCT00350025|923642|P2|STARTED|Overall Study||30
378922|NCT00350025|923643|P1|STARTED|Overall Study||11
378923|NCT00349973|923653|P2|NOT COMPLETED|Overall Study||3
378924|NCT00349973|923654|P1|NOT COMPLETED|Overall Study||4
378925|NCT00349973|923653|P2|COMPLETED|Overall Study||5
378926|NCT00349973|923654|P1|COMPLETED|Overall Study||8
378927|NCT00349973|923653|P2|STARTED|Overall Study||8
378928|NCT00349973|923654|P1|STARTED|Overall Study||12
378929|NCT00349921|923668|P4|NOT COMPLETED|Second Spinal Injection||0
378930|NCT00349921|923669|P3|NOT COMPLETED|Second Spinal Injection||0
378931|NCT00349921|923670|P2|NOT COMPLETED|Second Spinal Injection||0
378932|NCT00349921|923671|P1|NOT COMPLETED|Second Spinal Injection||0
378933|NCT00349921|923668|P4|COMPLETED|Second Spinal Injection||1
378934|NCT00349921|923669|P3|COMPLETED|Second Spinal Injection||0
378935|NCT00349921|923670|P2|COMPLETED|Second Spinal Injection||10
378936|NCT00349921|923671|P1|COMPLETED|Second Spinal Injection||9
378937|NCT00349921|923668|P4|STARTED|Second Spinal Injection||1
378938|NCT00349921|923669|P3|STARTED|Second Spinal Injection||0
378939|NCT00349921|923670|P2|STARTED|Second Spinal Injection||10
378940|NCT00349921|923671|P1|STARTED|Second Spinal Injection|One patient experienced an adverse event after period one and did not participate in period two|9
378941|NCT00349921|923668|P4|NOT COMPLETED|First Spinal Injection||0
378942|NCT00349921|923669|P3|NOT COMPLETED|First Spinal Injection||1
378943|NCT00349921|923670|P2|NOT COMPLETED|First Spinal Injection||0
378944|NCT00349921|923671|P1|NOT COMPLETED|First Spinal Injection||1
378945|NCT00349921|923668|P4|COMPLETED|First Spinal Injection||1
378946|NCT00349921|923669|P3|COMPLETED|First Spinal Injection||0
378947|NCT00349921|923670|P2|COMPLETED|First Spinal Injection||10
378948|NCT00349921|923671|P1|COMPLETED|First Spinal Injection||9
378949|NCT00349921|923668|P4|STARTED|First Spinal Injection||1
378950|NCT00349921|923669|P3|STARTED|First Spinal Injection||1
378951|NCT00349921|923670|P2|STARTED|First Spinal Injection||10
378952|NCT00349921|923671|P1|STARTED|First Spinal Injection||10
378953|NCT00349908|923682|P2|NOT COMPLETED|Overall Study||4
378954|NCT00349908|923683|P1|NOT COMPLETED|Overall Study||0
378955|NCT00349908|923682|P2|COMPLETED|Overall Study|9 returned for 30 day follow-up, 7 returned for 6 month and 6/7 had 6 month angiogram|6
378956|NCT00349908|923683|P1|COMPLETED|Overall Study||10
378957|NCT00349908|923682|P2|STARTED|Overall Study||10
378958|NCT00349908|923683|P1|STARTED|Overall Study||10
378959|NCT00349778|923701|P1|NOT COMPLETED|Overall Study||0
378960|NCT00349778|923701|P1|COMPLETED|Overall Study||102
378961|NCT00349778|923701|P1|STARTED|Overall Study||102
378962|NCT00349752|923709|P2|NOT COMPLETED|Overall Study||64
378963|NCT00349752|923710|P1|NOT COMPLETED|Overall Study||59
378964|NCT00349752|923709|P2|COMPLETED|Overall Study||23
378965|NCT00349752|923710|P1|COMPLETED|Overall Study||28
378966|NCT00349752|923709|P2|STARTED|Overall Study||87
378967|NCT00349752|923710|P1|STARTED|Overall Study||87
378968|NCT00349713|923739|P3|NOT COMPLETED|Overall Study||0
378969|NCT00349713|923740|P2|NOT COMPLETED|Overall Study||0
378970|NCT00349713|923741|P1|NOT COMPLETED|Overall Study||0
378971|NCT00349713|923739|P3|COMPLETED|Overall Study||20
378972|NCT00349713|923740|P2|COMPLETED|Overall Study||20
378973|NCT00349713|923741|P1|COMPLETED|Overall Study||20
378974|NCT00349713|923739|P3|STARTED|Overall Study||20
378975|NCT00349713|923740|P2|STARTED|Overall Study||20
378976|NCT00349713|923741|P1|STARTED|Overall Study||20
378977|NCT00349622|923763|P2|NOT COMPLETED|Overall Study||96
378978|NCT00349622|923764|P1|NOT COMPLETED|Overall Study||178
378979|NCT00349622|923763|P2|COMPLETED|Overall Study||77
378980|NCT00349622|923764|P1|COMPLETED|Overall Study||162
378981|NCT00349622|923763|P2|STARTED|Overall Study||173
378982|NCT00349622|923764|P1|STARTED|Overall Study||340
378983|NCT00349466|923782|P2|NOT COMPLETED|Overall Study||3
378984|NCT00349466|923783|P1|NOT COMPLETED|Overall Study||9
378985|NCT00349466|923782|P2|COMPLETED|Overall Study||35
378986|NCT00349466|923783|P1|COMPLETED|Overall Study||33
378987|NCT00349466|923782|P2|STARTED|Overall Study||38
378988|NCT00349466|923783|P1|STARTED|Overall Study||42
378989|NCT00349388|923791|P2|NOT COMPLETED|Overall Study||0
378990|NCT00349388|923792|P1|NOT COMPLETED|Overall Study||0
378991|NCT00349388|923791|P2|COMPLETED|Overall Study||1
378992|NCT00349388|923792|P1|COMPLETED|Overall Study|no patients enrolled , therefore no patients completed|0
378993|NCT00349388|923791|P2|STARTED|Overall Study||1
378994|NCT00349388|923792|P1|STARTED|Overall Study|no patients enrolled|0
378995|NCT00349349|923803|P3|NOT COMPLETED|Overall Study||6
378996|NCT00349349|923804|P2|NOT COMPLETED|Overall Study||62
378997|NCT00349349|923805|P1|NOT COMPLETED|Overall Study||53
378998|NCT00349349|923803|P3|COMPLETED|Overall Study||10
378999|NCT00349349|923804|P2|COMPLETED|Overall Study||50
379000|NCT00349349|923805|P1|COMPLETED|Overall Study||42
379001|NCT00349349|923803|P3|STARTED|Overall Study||16
379002|NCT00349349|923804|P2|STARTED|Overall Study||112
379003|NCT00349349|923805|P1|STARTED|Overall Study||95
379004|NCT00349336|923871|P2|NOT COMPLETED|Overall Study||14
379005|NCT00349336|923872|P1|NOT COMPLETED|Overall Study||13
379006|NCT00349336|923871|P2|COMPLETED|Overall Study||18
379007|NCT00349336|923872|P1|COMPLETED|Overall Study||19
379008|NCT00349336|923871|P2|STARTED|Overall Study||32
379009|NCT00349336|923872|P1|STARTED|Overall Study||32
379010|NCT00348933|923894|P1|NOT COMPLETED|Overall Study||25
379011|NCT00348933|923894|P1|COMPLETED|Overall Study||65
379012|NCT00348933|923894|P1|STARTED|Overall Study||90
379013|NCT00348881|923902|P2|NOT COMPLETED|Overall Study||12
379014|NCT00348881|923903|P1|NOT COMPLETED|Overall Study||17
379015|NCT00348881|923902|P2|COMPLETED|Overall Study||697
379016|NCT00348881|923903|P1|COMPLETED|Overall Study||1407
379017|NCT00348881|923902|P2|STARTED|Overall Study||709
379018|NCT00348881|923903|P1|STARTED|Overall Study||1424
379019|NCT00348816|923915|P1|NOT COMPLETED|Overall Study||1
379020|NCT00348816|923915|P1|COMPLETED|Overall Study||19
379021|NCT00348816|923915|P1|STARTED|Overall Study||20
379022|NCT00348790|923922|P1|NOT COMPLETED|Completed Treatment||25
379023|NCT00348790|923922|P1|COMPLETED|Completed Treatment||0
379024|NCT00348790|923922|P1|STARTED|Completed Treatment||25
379025|NCT00348790|923922|P1|NOT COMPLETED|Began Treatment||0
379026|NCT00348790|923922|P1|COMPLETED|Began Treatment||25
379027|NCT00348790|923922|P1|STARTED|Began Treatment||25
379028|NCT00348686|923934|P1|NOT COMPLETED|Overall Study||66
379029|NCT00348686|923934|P1|COMPLETED|Overall Study||249
379030|NCT00348686|923934|P1|STARTED|Overall Study||315
379031|NCT00348673|923951|P9|NOT COMPLETED|Stage 2||0
379032|NCT00348673|923952|P8|NOT COMPLETED|Stage 2||0
379033|NCT00348673|923953|P7|NOT COMPLETED|Stage 2||0
379034|NCT00348673|923954|P6|NOT COMPLETED|Stage 2||0
379035|NCT00348673|923955|P5|NOT COMPLETED|Stage 2||0
379036|NCT00348673|923956|P4|NOT COMPLETED|Stage 2||0
379037|NCT00348673|923957|P3|NOT COMPLETED|Stage 2||0
379038|NCT00348673|923958|P2|NOT COMPLETED|Stage 2||0
379039|NCT00348673|923959|P1|NOT COMPLETED|Stage 2||0
379040|NCT00348673|923951|P9|COMPLETED|Stage 2||2
379041|NCT00348673|923952|P8|COMPLETED|Stage 2||6
379042|NCT00348673|923953|P7|COMPLETED|Stage 2||6
379043|NCT00348673|923954|P6|COMPLETED|Stage 2||6
379044|NCT00348673|923955|P5|COMPLETED|Stage 2||0
379045|NCT00348673|923956|P4|COMPLETED|Stage 2||0
379046|NCT00348673|923957|P3|COMPLETED|Stage 2||0
379047|NCT00348673|923958|P2|COMPLETED|Stage 2||0
379048|NCT00348673|923959|P1|COMPLETED|Stage 2||0
379049|NCT00348673|923951|P9|STARTED|Stage 2||2
379050|NCT00348673|923952|P8|STARTED|Stage 2||6
379051|NCT00348673|923953|P7|STARTED|Stage 2||6
379052|NCT00348673|923954|P6|STARTED|Stage 2||6
379053|NCT00348673|923955|P5|STARTED|Stage 2||0
379054|NCT00348673|923956|P4|STARTED|Stage 2||0
379055|NCT00348673|923957|P3|STARTED|Stage 2||0
379056|NCT00348673|923958|P2|STARTED|Stage 2||0
379057|NCT00348673|923959|P1|STARTED|Stage 2||0
379058|NCT00348673|923951|P9|NOT COMPLETED|Stage 1||0
379059|NCT00348673|923952|P8|NOT COMPLETED|Stage 1||0
379060|NCT00348673|923953|P7|NOT COMPLETED|Stage 1||0
379061|NCT00348673|923954|P6|NOT COMPLETED|Stage 1||0
379062|NCT00348673|923955|P5|NOT COMPLETED|Stage 1||0
379063|NCT00348673|923956|P4|NOT COMPLETED|Stage 1||0
379064|NCT00348673|923957|P3|NOT COMPLETED|Stage 1||1
379065|NCT00348673|923958|P2|NOT COMPLETED|Stage 1||0
379066|NCT00348673|923959|P1|NOT COMPLETED|Stage 1||0
379067|NCT00348673|923951|P9|COMPLETED|Stage 1||0
379068|NCT00348673|923952|P8|COMPLETED|Stage 1||0
379069|NCT00348673|923953|P7|COMPLETED|Stage 1||0
379070|NCT00348673|923954|P6|COMPLETED|Stage 1||0
379071|NCT00348673|923955|P5|COMPLETED|Stage 1||4
379072|NCT00348673|923956|P4|COMPLETED|Stage 1||6
379073|NCT00348673|923957|P3|COMPLETED|Stage 1||6
379074|NCT00348673|923958|P2|COMPLETED|Stage 1||6
379075|NCT00348673|923959|P1|COMPLETED|Stage 1||6
379076|NCT00348673|923951|P9|Treated|Stage 1||0
379077|NCT00348673|923952|P8|Treated|Stage 1||0
379078|NCT00348673|923953|P7|Treated|Stage 1||0
379079|NCT00348673|923954|P6|Treated|Stage 1||0
379080|NCT00348673|923955|P5|Treated|Stage 1||4
379081|NCT00348673|923956|P4|Treated|Stage 1||6
379082|NCT00348673|923957|P3|Treated|Stage 1||6
379083|NCT00348673|923958|P2|Treated|Stage 1||6
379084|NCT00348673|923959|P1|Treated|Stage 1||6
379085|NCT00348673|923951|P9|STARTED|Stage 1||0
379086|NCT00348673|923952|P8|STARTED|Stage 1||0
379087|NCT00348673|923953|P7|STARTED|Stage 1||0
379088|NCT00348673|923954|P6|STARTED|Stage 1||0
379089|NCT00348673|923955|P5|STARTED|Stage 1||4
379090|NCT00348673|923956|P4|STARTED|Stage 1||6
379091|NCT00348673|923957|P3|STARTED|Stage 1||7
379092|NCT00348673|923958|P2|STARTED|Stage 1||6
379093|NCT00348673|923959|P1|STARTED|Stage 1||6
379094|NCT00348595|924008|P2|NOT COMPLETED|Overall Study||8
379095|NCT00348595|924009|P1|NOT COMPLETED|Overall Study||5
379096|NCT00348595|924008|P2|COMPLETED|Overall Study||26
379097|NCT00348595|924009|P1|COMPLETED|Overall Study||21
379098|NCT00348595|924008|P2|STARTED|Overall Study||34
379099|NCT00348595|924009|P1|STARTED|Overall Study||26
379100|NCT00348556|924021|P1|NOT COMPLETED|Overall Study||1
379101|NCT00348556|924021|P1|COMPLETED|Overall Study||3
379102|NCT00348556|924021|P1|STARTED|Overall Study||4
379103|NCT00348374|924028|P2|NOT COMPLETED|Overall Study||32
379104|NCT00348374|924029|P1|NOT COMPLETED|Overall Study||19
379105|NCT00348374|924028|P2|COMPLETED|Overall Study||71
379106|NCT00348374|924029|P1|COMPLETED|Overall Study||69
379107|NCT00348374|924028|P2|Received Study Treatment|Overall Study||96
379108|NCT00348374|924029|P1|Received Study Treatment|Overall Study||88
379109|NCT00348374|924028|P2|STARTED|Overall Study||103
379110|NCT00348374|924029|P1|STARTED|Overall Study||88
379111|NCT00348348|924076|P2|NOT COMPLETED|Overall Study||27
379112|NCT00348348|924077|P1|NOT COMPLETED|Overall Study||25
379113|NCT00348348|924076|P2|COMPLETED|Overall Study||555
379114|NCT00348348|924077|P1|COMPLETED|Overall Study||554
379115|NCT00348348|924076|P2|STARTED|Overall Study|Received at least one drop of study medication(Safety Population)|582
379116|NCT00348348|924077|P1|STARTED|Overall Study|Received at least one drop of study medication (Safety Population)|579
379117|NCT00348309|924092|P3|NOT COMPLETED|Overall Study||143
379118|NCT00348309|924093|P2|NOT COMPLETED|Overall Study||98
379119|NCT00348309|924094|P1|NOT COMPLETED|Overall Study||134
379120|NCT00348309|924092|P3|COMPLETED|Overall Study||346
379121|NCT00348309|924093|P2|COMPLETED|Overall Study||396
379122|NCT00348309|924094|P1|COMPLETED|Overall Study||362
379123|NCT00348309|924092|P3|STARTED|Overall Study||489
379124|NCT00348309|924093|P2|STARTED|Overall Study||494
379125|NCT00348309|924094|P1|STARTED|Overall Study||496
379126|NCT00348283|924167|P2|NOT COMPLETED|Open Label||34
379127|NCT00348283|924168|P1|NOT COMPLETED|Open Label||0
379128|NCT00348283|924167|P2|COMPLETED|Open Label||66
379129|NCT00348283|924168|P1|COMPLETED|Open Label||0
379130|NCT00348283|924167|P2|STARTED|Open Label|14 subjects completed the Double Blind portion of the study but did not enter the Open Label period.|100
379131|NCT00348283|924168|P1|STARTED|Open Label|No comparator was used in the Open Label portion of the study.|0
379132|NCT00348283|924167|P2|NOT COMPLETED|Double Blind||10
379133|NCT00348283|924168|P1|NOT COMPLETED|Double Blind||5
379134|NCT00348283|924167|P2|COMPLETED|Double Blind||54
379135|NCT00348283|924168|P1|COMPLETED|Double Blind||60
379136|NCT00348283|924167|P2|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|64
379137|NCT00348283|924168|P1|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|65
379138|NCT00348283|924167|P2|NOT COMPLETED|Induction||6
379139|NCT00348283|924168|P1|NOT COMPLETED|Induction||0
379140|NCT00348283|924167|P2|COMPLETED|Induction|Subjects provided more than one reason for discontinuing during induction.|129
379141|NCT00348283|924168|P1|COMPLETED|Induction||0
379142|NCT00348283|924167|P2|STARTED|Induction|Subjects received an open- label dose of 80 mg adalimumab at Week 2 (induction dose).|135
379143|NCT00348283|924168|P1|STARTED|Induction||0
379144|NCT00348140|924187|P3|NOT COMPLETED|Overall Study||163
379145|NCT00348140|924188|P2|NOT COMPLETED|Overall Study||139
379146|NCT00348140|924189|P1|NOT COMPLETED|Overall Study||126
379147|NCT00348140|924187|P3|COMPLETED|Overall Study||328
379148|NCT00348140|924188|P2|COMPLETED|Overall Study||351
379149|NCT00348140|924189|P1|COMPLETED|Overall Study||361
379150|NCT00348140|924187|P3|STARTED|Overall Study||491
379151|NCT00348140|924188|P2|STARTED|Overall Study||490
379152|NCT00348140|924189|P1|STARTED|Overall Study||487
379153|NCT00347958|924287|P1|NOT COMPLETED|Overall Study||4
379154|NCT00347958|924287|P1|COMPLETED|Overall Study||540
379155|NCT00347958|924287|P1|STARTED|Overall Study||544
379156|NCT00347932|924296|P2|NOT COMPLETED|Overall Study||52
379157|NCT00347932|924297|P1|NOT COMPLETED|Overall Study||31
379158|NCT00347932|924296|P2|COMPLETED|Overall Study||430
379159|NCT00347932|924297|P1|COMPLETED|Overall Study||444
379160|NCT00347932|924296|P2|STARTED|Overall Study|As Randomized Population - received at least one dose of study medication|482
379161|NCT00347932|924297|P1|STARTED|Overall Study|As Randomized population - received at least one dose of study medication|475
379162|NCT00347919|924312|P3|NOT COMPLETED|Overall Study||38
379163|NCT00347919|924313|P2|NOT COMPLETED|Overall Study||76
379164|NCT00347919|924314|P1|NOT COMPLETED|Overall Study||71
379165|NCT00347919|924312|P3|COMPLETED|Overall Study||2
379166|NCT00347919|924313|P2|COMPLETED|Overall Study||0
379167|NCT00347919|924314|P1|COMPLETED|Overall Study||2
379168|NCT00347919|924312|P3|STARTED|Overall Study|Safety Population|40
379169|NCT00347919|924313|P2|STARTED|Overall Study|Safety Population|76
379170|NCT00347919|924314|P1|STARTED|Overall Study|Safety Population|73
379171|NCT00347776|924337|P3|NOT COMPLETED|12 Month Follow-up||19
379172|NCT00347776|924338|P2|NOT COMPLETED|12 Month Follow-up||16
379173|NCT00347776|924339|P1|NOT COMPLETED|12 Month Follow-up||23
379174|NCT00347776|924337|P3|COMPLETED|12 Month Follow-up||436
379175|NCT00347776|924338|P2|COMPLETED|12 Month Follow-up||446
379176|NCT00347776|924339|P1|COMPLETED|12 Month Follow-up||425
379177|NCT00347776|924337|P3|STARTED|12 Month Follow-up||455
379178|NCT00347776|924338|P2|STARTED|12 Month Follow-up||462
379179|NCT00347776|924339|P1|STARTED|12 Month Follow-up||448
379180|NCT00347776|924337|P3|NOT COMPLETED|6 Month Follow-up||18
379181|NCT00347776|924338|P2|NOT COMPLETED|6 Month Follow-up||13
379182|NCT00347776|924339|P1|NOT COMPLETED|6 Month Follow-up||22
379183|NCT00347776|924337|P3|COMPLETED|6 Month Follow-up|452 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|455
379184|NCT00347776|924338|P2|COMPLETED|6 Month Follow-up|459 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|462
379185|NCT00347776|924339|P1|COMPLETED|6 Month Follow-up|440 had no recurrence.8 were lost to follow-up but were still eligible for follow-up at next visits|448
379186|NCT00347776|924337|P3|STARTED|6 Month Follow-up||473
379187|NCT00347776|924338|P2|STARTED|6 Month Follow-up||475
379188|NCT00347776|924339|P1|STARTED|6 Month Follow-up||470
379189|NCT00347776|924337|P3|NOT COMPLETED|1.5 Month Follow-up||12
379190|NCT00347776|924338|P2|NOT COMPLETED|1.5 Month Follow-up||8
379191|NCT00347776|924339|P1|NOT COMPLETED|1.5 Month Follow-up||14
379192|NCT00347776|924337|P3|COMPLETED|1.5 Month Follow-up|472 had no recurrence.1 was lost to follow-up but was still eligible for follow-up at next visits|473
379284|NCT00346775|924613|P1|STARTED|Period 1: Intervention Period 1||49
379193|NCT00347776|924338|P2|COMPLETED|1.5 Month Follow-up|473 had no recurrence.2 were lost to follow-up but were still eligible for follow-up at next visits|475
379194|NCT00347776|924339|P1|COMPLETED|1.5 Month Follow-up||470
379195|NCT00347776|924337|P3|STARTED|1.5 Month Follow-up||485
379196|NCT00347776|924338|P2|STARTED|1.5 Month Follow-up||483
379197|NCT00347776|924339|P1|STARTED|1.5 Month Follow-up||484
379198|NCT00347438|924351|P1|NOT COMPLETED|Overall Study||2
379199|NCT00347438|924351|P1|COMPLETED|Overall Study||16
379200|NCT00347438|924351|P1|STARTED|Overall Study||18
379201|NCT00347360|924373|P15|NOT COMPLETED|Overall Study||4
379202|NCT00347360|924374|P14|NOT COMPLETED|Overall Study||8
379203|NCT00347360|924375|P13|NOT COMPLETED|Overall Study||10
379204|NCT00347360|924376|P12|NOT COMPLETED|Overall Study||6
379205|NCT00347360|924377|P11|NOT COMPLETED|Overall Study||5
379206|NCT00347360|924378|P10|NOT COMPLETED|Overall Study||9
379207|NCT00347360|924379|P9|NOT COMPLETED|Overall Study||6
379208|NCT00347360|924380|P8|NOT COMPLETED|Overall Study||3
379209|NCT00347360|924381|P7|NOT COMPLETED|Overall Study||7
379210|NCT00347360|924382|P6|NOT COMPLETED|Overall Study||8
379211|NCT00347360|924383|P5|NOT COMPLETED|Overall Study||5
379212|NCT00347360|924384|P4|NOT COMPLETED|Overall Study||13
379213|NCT00347360|924385|P3|NOT COMPLETED|Overall Study||6
379214|NCT00347360|924386|P2|NOT COMPLETED|Overall Study||8
379215|NCT00347360|924387|P1|NOT COMPLETED|Overall Study||5
379216|NCT00347360|924373|P15|COMPLETED|Overall Study||39
379217|NCT00347360|924374|P14|COMPLETED|Overall Study||36
379218|NCT00347360|924375|P13|COMPLETED|Overall Study||34
379219|NCT00347360|924376|P12|COMPLETED|Overall Study||37
379220|NCT00347360|924377|P11|COMPLETED|Overall Study||39
379221|NCT00347360|924378|P10|COMPLETED|Overall Study||35
379222|NCT00347360|924379|P9|COMPLETED|Overall Study||38
379223|NCT00347360|924380|P8|COMPLETED|Overall Study||40
379224|NCT00347360|924381|P7|COMPLETED|Overall Study||37
379225|NCT00347360|924382|P6|COMPLETED|Overall Study||36
379226|NCT00347360|924383|P5|COMPLETED|Overall Study||39
379227|NCT00347360|924384|P4|COMPLETED|Overall Study||30
379228|NCT00347360|924385|P3|COMPLETED|Overall Study||37
379229|NCT00347360|924386|P2|COMPLETED|Overall Study||35
379230|NCT00347360|924387|P1|COMPLETED|Overall Study||39
379231|NCT00347360|924373|P15|STARTED|Overall Study||43
379232|NCT00347360|924374|P14|STARTED|Overall Study||44
379233|NCT00347360|924375|P13|STARTED|Overall Study||44
379234|NCT00347360|924376|P12|STARTED|Overall Study||43
379235|NCT00347360|924377|P11|STARTED|Overall Study||44
379236|NCT00347360|924378|P10|STARTED|Overall Study||44
379237|NCT00347360|924379|P9|STARTED|Overall Study||44
379238|NCT00347360|924380|P8|STARTED|Overall Study||43
379239|NCT00347360|924381|P7|STARTED|Overall Study||44
379240|NCT00347360|924382|P6|STARTED|Overall Study||44
379241|NCT00347360|924383|P5|STARTED|Overall Study||44
379242|NCT00347360|924384|P4|STARTED|Overall Study||43
379243|NCT00347360|924385|P3|STARTED|Overall Study||43
379244|NCT00347360|924386|P2|STARTED|Overall Study||43
379245|NCT00347360|924387|P1|STARTED|Overall Study||44
379246|NCT00347308|924569|P1|NOT COMPLETED|Overall Study||0
379247|NCT00347308|924569|P1|COMPLETED|Overall Study||40
379248|NCT00347308|924569|P1|STARTED|Overall Study||40
379249|NCT00347269|924575|P2|NOT COMPLETED|Overall Study||106
379250|NCT00347269|924576|P1|NOT COMPLETED|Overall Study||94
379251|NCT00347269|924575|P2|COMPLETED|Overall Study||395
379252|NCT00347269|924576|P1|COMPLETED|Overall Study||409
379253|NCT00347269|924575|P2|STARTED|Overall Study||501
379254|NCT00347269|924576|P1|STARTED|Overall Study||503
379255|NCT00347022|924584|P2|NOT COMPLETED|Overall Study||5
379256|NCT00347022|924585|P1|NOT COMPLETED|Overall Study||12
379257|NCT00347022|924584|P2|COMPLETED|Overall Study||66
379258|NCT00347022|924585|P1|COMPLETED|Overall Study||62
379259|NCT00347022|924584|P2|STARTED|Overall Study||71
379260|NCT00347022|924585|P1|STARTED|Overall Study||74
379261|NCT00347009|924591|P1|NOT COMPLETED|Overall Study||27
379262|NCT00347009|924591|P1|COMPLETED|Overall Study||128
379263|NCT00347009|924591|P1|STARTED|Overall Study||155
379264|NCT00346905|924608|P1|NOT COMPLETED|Overall Study||4
379265|NCT00346905|924608|P1|COMPLETED|Overall Study||12
379266|NCT00346905|924608|P1|STARTED|Overall Study||16
379267|NCT00346775|924612|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
379268|NCT00346775|924613|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
379269|NCT00346775|924612|P2|COMPLETED|Period 3: Intervention Period 2||45
379270|NCT00346775|924613|P1|COMPLETED|Period 3: Intervention Period 2||44
379271|NCT00346775|924612|P2|STARTED|Period 3: Intervention Period 2||45
379272|NCT00346775|924613|P1|STARTED|Period 3: Intervention Period 2||44
379273|NCT00346775|924612|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
379274|NCT00346775|924613|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
379275|NCT00346775|924612|P2|COMPLETED|Period 2: Washout Period (7 Days)||45
379276|NCT00346775|924613|P1|COMPLETED|Period 2: Washout Period (7 Days)||44
379277|NCT00346775|924612|P2|STARTED|Period 2: Washout Period (7 Days)||45
379278|NCT00346775|924613|P1|STARTED|Period 2: Washout Period (7 Days)||44
379279|NCT00346775|924612|P2|NOT COMPLETED|Period 1: Intervention Period 1||3
379280|NCT00346775|924613|P1|NOT COMPLETED|Period 1: Intervention Period 1||5
379281|NCT00346775|924612|P2|COMPLETED|Period 1: Intervention Period 1||45
379282|NCT00346775|924613|P1|COMPLETED|Period 1: Intervention Period 1||44
379283|NCT00346775|924612|P2|STARTED|Period 1: Intervention Period 1||48
379285|NCT00346697|924625|P2|NOT COMPLETED|Overall Study||1
379286|NCT00346697|924626|P1|NOT COMPLETED|Overall Study||0
379287|NCT00346697|924625|P2|COMPLETED|Overall Study||23
379288|NCT00346697|924626|P1|COMPLETED|Overall Study||24
379289|NCT00346697|924625|P2|STARTED|Overall Study||24
379290|NCT00346697|924626|P1|STARTED|Overall Study||24
379291|NCT00346632|924662|P10|NOT COMPLETED|Overall Study||3
379292|NCT00346632|924663|P9|NOT COMPLETED|Overall Study||4
379293|NCT00346632|924664|P8|NOT COMPLETED|Overall Study||4
379294|NCT00346632|924665|P7|NOT COMPLETED|Overall Study||5
379295|NCT00346632|924666|P6|NOT COMPLETED|Overall Study||2
379296|NCT00346632|924667|P5|NOT COMPLETED|Overall Study||4
379297|NCT00346632|924668|P4|NOT COMPLETED|Overall Study||3
379298|NCT00346632|924669|P3|NOT COMPLETED|Overall Study||6
379299|NCT00346632|924670|P2|NOT COMPLETED|Overall Study||3
379300|NCT00346632|924671|P1|NOT COMPLETED|Overall Study||3
379301|NCT00346632|924662|P10|COMPLETED|Overall Study||0
379302|NCT00346632|924663|P9|COMPLETED|Overall Study||0
379303|NCT00346632|924664|P8|COMPLETED|Overall Study||0
379304|NCT00346632|924665|P7|COMPLETED|Overall Study||0
379305|NCT00346632|924666|P6|COMPLETED|Overall Study||0
379306|NCT00346632|924667|P5|COMPLETED|Overall Study||0
379307|NCT00346632|924668|P4|COMPLETED|Overall Study||0
379308|NCT00346632|924669|P3|COMPLETED|Overall Study||0
379309|NCT00346632|924670|P2|COMPLETED|Overall Study||0
379310|NCT00346632|924671|P1|COMPLETED|Overall Study||0
379311|NCT00346632|924662|P10|STARTED|Overall Study||3
379312|NCT00346632|924663|P9|STARTED|Overall Study||4
379313|NCT00346632|924664|P8|STARTED|Overall Study||4
379314|NCT00346632|924665|P7|STARTED|Overall Study||5
379315|NCT00346632|924666|P6|STARTED|Overall Study||2
379316|NCT00346632|924667|P5|STARTED|Overall Study||4
379317|NCT00346632|924668|P4|STARTED|Overall Study||3
379318|NCT00346632|924669|P3|STARTED|Overall Study||6
379319|NCT00346632|924670|P2|STARTED|Overall Study||3
379320|NCT00346632|924671|P1|STARTED|Overall Study||3
379321|NCT00346476|924814|P1|NOT COMPLETED|Overall Study||0
379322|NCT00346476|924814|P1|COMPLETED|Overall Study||1250
379323|NCT00346476|924814|P1|STARTED|Overall Study||1250
379324|NCT00346398|924821|P2|NOT COMPLETED|Overall Study||2
379325|NCT00346398|924822|P1|NOT COMPLETED|Overall Study||3
379326|NCT00346398|924821|P2|COMPLETED|Overall Study||24
379327|NCT00346398|924822|P1|COMPLETED|Overall Study||22
379328|NCT00346398|924821|P2|STARTED|Overall Study||26
379329|NCT00346398|924822|P1|STARTED|Overall Study||25
379330|NCT00346333|924834|P2|NOT COMPLETED|Overall Study||8
379331|NCT00346333|924835|P1|NOT COMPLETED|Overall Study||5
379332|NCT00346333|924834|P2|COMPLETED|Overall Study||111
379333|NCT00346333|924835|P1|COMPLETED|Overall Study||116
379334|NCT00346333|924834|P2|STARTED|Overall Study||119
379335|NCT00346333|924835|P1|STARTED|Overall Study||121
379336|NCT00346268|924851|P2|NOT COMPLETED|Overall Study||3
379337|NCT00346268|924852|P1|NOT COMPLETED|Overall Study||2
379338|NCT00346268|924851|P2|COMPLETED|Overall Study||50
379339|NCT00346268|924852|P1|COMPLETED|Overall Study||50
379340|NCT00346268|924851|P2|STARTED|Overall Study||53
379341|NCT00346268|924852|P1|STARTED|Overall Study||52
379342|NCT00346216|924887|P3|NOT COMPLETED|Overall Study||2348
379343|NCT00346216|924888|P2|NOT COMPLETED|Overall Study||2460
379344|NCT00346216|924889|P1|NOT COMPLETED|Overall Study||2408
379345|NCT00346216|924887|P3|COMPLETED|Overall Study||5621
379346|NCT00346216|924888|P2|COMPLETED|Overall Study||5580
379347|NCT00346216|924889|P1|COMPLETED|Overall Study||5664
379348|NCT00346216|924887|P3|STARTED|Overall Study||7969
379349|NCT00346216|924888|P2|STARTED|Overall Study||8040
379350|NCT00346216|924889|P1|STARTED|Overall Study||8072
379351|NCT00346164|924910|P4|NOT COMPLETED|Overall Study||106
379352|NCT00346164|924911|P3|NOT COMPLETED|Overall Study||26
379353|NCT00346164|924912|P2|NOT COMPLETED|Overall Study||7
379354|NCT00346164|924913|P1|NOT COMPLETED|Overall Study||17
379355|NCT00346164|924910|P4|COMPLETED|Overall Study||117
379356|NCT00346164|924911|P3|COMPLETED|Overall Study||96
379357|NCT00346164|924912|P2|COMPLETED|Overall Study||14
379358|NCT00346164|924913|P1|COMPLETED|Overall Study||205
379359|NCT00346164|924910|P4|STARTED|Overall Study||223
379360|NCT00346164|924911|P3|STARTED|Overall Study||122
379361|NCT00346164|924912|P2|STARTED|Overall Study||21
379362|NCT00346164|924913|P1|STARTED|Overall Study||222
379363|NCT00346151|924948|P1|NOT COMPLETED|Overall Study||3
379364|NCT00346151|924948|P1|COMPLETED|Overall Study||2
379365|NCT00346151|924948|P1|STARTED|Overall Study||5
379366|NCT00346073|924968|P2|NOT COMPLETED|Overall Study||24
379367|NCT00346073|924969|P1|NOT COMPLETED|Overall Study||41
379368|NCT00346073|924968|P2|COMPLETED|Overall Study||738
379369|NCT00346073|924969|P1|COMPLETED|Overall Study||1481
379370|NCT00346073|924968|P2|STARTED|Overall Study||762
379371|NCT00346073|924969|P1|STARTED|Overall Study||1522
379372|NCT00346034|925003|P1|NOT COMPLETED|Overall Study||57
379373|NCT00346034|925003|P1|COMPLETED|Overall Study||300
379374|NCT00346034|925003|P1|STARTED|Overall Study||357
379375|NCT00345969|925010|P2|NOT COMPLETED|Overall Study||2
379376|NCT00345969|925011|P1|NOT COMPLETED|Overall Study||1
379377|NCT00345969|925010|P2|COMPLETED|Overall Study||11
379378|NCT00345969|925011|P1|COMPLETED|Overall Study||11
379379|NCT00345969|925010|P2|STARTED|Overall Study||13
379380|NCT00345969|925011|P1|STARTED|Overall Study||12
379381|NCT00345878|925043|P2|NOT COMPLETED|Overall Study||1
379382|NCT00345878|925044|P1|NOT COMPLETED|Overall Study||4
379383|NCT00345878|925043|P2|COMPLETED|Overall Study||135
379384|NCT00345878|925044|P1|COMPLETED|Overall Study||131
379385|NCT00345878|925043|P2|STARTED|Overall Study||136
379386|NCT00345878|925044|P1|STARTED|Overall Study||135
379387|NCT00345839|925062|P2|NOT COMPLETED|Overall Study||159
379388|NCT00345839|925063|P1|NOT COMPLETED|Overall Study||149
379389|NCT00345839|925062|P2|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1776
379390|NCT00345839|925063|P1|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1799
379391|NCT00345839|925062|P2|STARTED|Overall Study|Randomized to placebo|1935
379392|NCT00345839|925063|P1|STARTED|Overall Study|Randomized to cinacalcet|1948
379393|NCT00345683|925089|P2|NOT COMPLETED|Overall Study||9
379394|NCT00345683|925090|P1|NOT COMPLETED|Overall Study||25
379395|NCT00345683|925089|P2|COMPLETED|Overall Study||1001
379396|NCT00345683|925090|P1|COMPLETED|Overall Study||2985
379397|NCT00345683|925089|P2|STARTED|Overall Study||1010
379398|NCT00345683|925090|P1|STARTED|Overall Study||3010
379399|NCT00345631|925113|P3|NOT COMPLETED|Overall Study||6
379400|NCT00345631|925114|P2|NOT COMPLETED|Overall Study||8
379401|NCT00345631|925115|P1|NOT COMPLETED|Overall Study||4
379402|NCT00345631|925113|P3|COMPLETED|Overall Study||128
379403|NCT00345631|925114|P2|COMPLETED|Overall Study||259
379404|NCT00345631|925115|P1|COMPLETED|Overall Study||83
379405|NCT00345631|925113|P3|STARTED|Overall Study||134
379406|NCT00345631|925114|P2|STARTED|Overall Study||267
379407|NCT00345631|925115|P1|STARTED|Overall Study||87
379408|NCT00345605|925147|P2|NOT COMPLETED|Arm 2, Opposite Treatment||0
379409|NCT00345605|925148|P1|NOT COMPLETED|Arm 2, Opposite Treatment||1
379410|NCT00345605|925147|P2|COMPLETED|Arm 2, Opposite Treatment||6
379411|NCT00345605|925148|P1|COMPLETED|Arm 2, Opposite Treatment||5
379412|NCT00345605|925147|P2|STARTED|Arm 2, Opposite Treatment||6
379413|NCT00345605|925148|P1|STARTED|Arm 2, Opposite Treatment||6
379414|NCT00345605|925147|P2|NOT COMPLETED|Crossover Wash-out||0
379415|NCT00345605|925148|P1|NOT COMPLETED|Crossover Wash-out||0
379416|NCT00345605|925147|P2|COMPLETED|Crossover Wash-out||6
379417|NCT00345605|925148|P1|COMPLETED|Crossover Wash-out||6
379418|NCT00345605|925147|P2|STARTED|Crossover Wash-out||6
379419|NCT00345605|925148|P1|STARTED|Crossover Wash-out||6
379420|NCT00345605|925147|P2|NOT COMPLETED|Interval||0
379421|NCT00345605|925148|P1|NOT COMPLETED|Interval||0
379422|NCT00345605|925147|P2|COMPLETED|Interval||6
379423|NCT00345605|925148|P1|COMPLETED|Interval||6
379424|NCT00345605|925147|P2|STARTED|Interval||6
379425|NCT00345605|925148|P1|STARTED|Interval||6
379426|NCT00345605|925147|P2|NOT COMPLETED|Arm 1||1
379427|NCT00345605|925148|P1|NOT COMPLETED|Arm 1||0
379428|NCT00345605|925147|P2|COMPLETED|Arm 1||5
379429|NCT00345605|925148|P1|COMPLETED|Arm 1||6
379430|NCT00345605|925147|P2|STARTED|Arm 1||6
379431|NCT00345605|925148|P1|STARTED|Arm 1||6
379432|NCT00345605|925147|P2|NOT COMPLETED|Initial Washout||0
379433|NCT00345605|925148|P1|NOT COMPLETED|Initial Washout||0
379434|NCT00345605|925147|P2|COMPLETED|Initial Washout||6
379435|NCT00345605|925148|P1|COMPLETED|Initial Washout||6
379436|NCT00345605|925147|P2|STARTED|Initial Washout||6
379437|NCT00345605|925148|P1|STARTED|Initial Washout||6
379438|NCT00345592|925168|P2|NOT COMPLETED|Overall Study||24
379439|NCT00345592|925169|P1|NOT COMPLETED|Overall Study||25
379440|NCT00345592|925168|P2|COMPLETED|Overall Study||173
379441|NCT00345592|925169|P1|COMPLETED|Overall Study||174
379442|NCT00345592|925168|P2|STARTED|Overall Study||197
379443|NCT00345592|925169|P1|STARTED|Overall Study||199
379444|NCT00345579|925177|P2|NOT COMPLETED|Overall Study||65
379445|NCT00345579|925178|P1|NOT COMPLETED|Overall Study||164
379446|NCT00345579|925177|P2|COMPLETED|Overall Study||1048
379447|NCT00345579|925178|P1|COMPLETED|Overall Study||3114
379448|NCT00345579|925177|P2|STARTED|Overall Study||1113
379449|NCT00345579|925178|P1|STARTED|Overall Study||3278
379450|NCT00345540|925198|P1|NOT COMPLETED|Overall Study||1
379451|NCT00345540|925198|P1|COMPLETED|Overall Study||15
379452|NCT00345540|925198|P1|STARTED|Overall Study|1 subject enrolled but not treated (off-trial for patient discretion)|16
379453|NCT00345397|925204|P1|NOT COMPLETED|Overall Study||1
379454|NCT00345397|925204|P1|COMPLETED|Overall Study||6
379455|NCT00345397|925204|P1|STARTED|Overall Study||7
379456|NCT00345384|925211|P2|NOT COMPLETED|Overall Study||0
379457|NCT00345384|925212|P1|NOT COMPLETED|Overall Study||0
379458|NCT00345384|925211|P2|COMPLETED|Overall Study||19
379459|NCT00345384|925212|P1|COMPLETED|Overall Study||19
379460|NCT00345384|925211|P2|STARTED|Overall Study||19
379461|NCT00345384|925212|P1|STARTED|Overall Study||19
379462|NCT00345371|925222|P2|NOT COMPLETED|Overall Study||33
379463|NCT00345371|925223|P1|NOT COMPLETED|Overall Study||30
379464|NCT00345371|925222|P2|COMPLETED|Overall Study||38
379465|NCT00345371|925223|P1|COMPLETED|Overall Study||39
379466|NCT00345371|925222|P2|STARTED|Overall Study||71
379467|NCT00345371|925223|P1|STARTED|Overall Study||69
379468|NCT00345358|925235|P4|NOT COMPLETED|Booster Vaccination Phase||0
379469|NCT00345358|925236|P3|NOT COMPLETED|Booster Vaccination Phase||0
379470|NCT00345358|925237|P2|NOT COMPLETED|Booster Vaccination Phase||0
379471|NCT00345358|925238|P1|NOT COMPLETED|Booster Vaccination Phase||4
379472|NCT00345358|925235|P4|COMPLETED|Booster Vaccination Phase||0
379473|NCT00345358|925236|P3|COMPLETED|Booster Vaccination Phase||0
379474|NCT00345358|925237|P2|COMPLETED|Booster Vaccination Phase||145
379475|NCT00345358|925238|P1|COMPLETED|Booster Vaccination Phase||141
379476|NCT00345358|925235|P4|STARTED|Booster Vaccination Phase||0
379477|NCT00345358|925236|P3|STARTED|Booster Vaccination Phase||0
379478|NCT00345358|925237|P2|STARTED|Booster Vaccination Phase||145
379479|NCT00345358|925238|P1|STARTED|Booster Vaccination Phase||145
379480|NCT00345358|925235|P4|NOT COMPLETED|Primary Vaccination Phase||2
379481|NCT00345358|925236|P3|NOT COMPLETED|Primary Vaccination Phase||8
379482|NCT00345358|925237|P2|NOT COMPLETED|Primary Vaccination Phase||4
379483|NCT00345358|925238|P1|NOT COMPLETED|Primary Vaccination Phase||5
379484|NCT00345358|925235|P4|COMPLETED|Primary Vaccination Phase||148
379485|NCT00345358|925236|P3|COMPLETED|Primary Vaccination Phase||142
379486|NCT00345358|925237|P2|COMPLETED|Primary Vaccination Phase||146
379487|NCT00345358|925238|P1|COMPLETED|Primary Vaccination Phase||145
379488|NCT00345358|925235|P4|STARTED|Primary Vaccination Phase||150
379489|NCT00345358|925236|P3|STARTED|Primary Vaccination Phase||150
379490|NCT00345358|925237|P2|STARTED|Primary Vaccination Phase||150
379491|NCT00345358|925238|P1|STARTED|Primary Vaccination Phase||150
379492|NCT00345345|925313|P1|NOT COMPLETED|Overall Study||2
379493|NCT00345345|925313|P1|COMPLETED|Overall Study||27
379494|NCT00345345|925313|P1|STARTED|Overall Study||29
379495|NCT00345332|925319|P2|NOT COMPLETED|Overall Study||0
379496|NCT00345332|925320|P1|NOT COMPLETED|Overall Study||0
379497|NCT00345332|925319|P2|COMPLETED|Overall Study||20
379498|NCT00345332|925320|P1|COMPLETED|Overall Study||11
379499|NCT00345332|925319|P2|STARTED|Overall Study||20
379500|NCT00345332|925320|P1|STARTED|Overall Study||11
379501|NCT00345293|925328|P2|NOT COMPLETED|Overall Study||0
379502|NCT00345293|925329|P1|NOT COMPLETED|Overall Study||2
379503|NCT00345293|925328|P2|COMPLETED|Overall Study||3
379504|NCT00345293|925329|P1|COMPLETED|Overall Study||8
379505|NCT00345293|925328|P2|STARTED|Overall Study||3
379506|NCT00345293|925329|P1|STARTED|Overall Study||10
379507|NCT00345254|925338|P2|NOT COMPLETED|Overall Study||0
379508|NCT00345254|925339|P1|NOT COMPLETED|Overall Study||0
379509|NCT00345254|925338|P2|COMPLETED|Overall Study||30
379510|NCT00345254|925339|P1|COMPLETED|Overall Study||30
379511|NCT00345254|925338|P2|STARTED|Overall Study||30
379512|NCT00345254|925339|P1|STARTED|Overall Study||30
379513|NCT00345176|925349|P4|NOT COMPLETED|Overall Study||10
379514|NCT00345176|925350|P3|NOT COMPLETED|Overall Study||6
379515|NCT00345176|925351|P2|NOT COMPLETED|Overall Study||6
379516|NCT00345176|925352|P1|NOT COMPLETED|Overall Study||5
379517|NCT00345176|925349|P4|COMPLETED|Overall Study||1069
379518|NCT00345176|925350|P3|COMPLETED|Overall Study||1062
379519|NCT00345176|925351|P2|COMPLETED|Overall Study||1038
379520|NCT00345176|925352|P1|COMPLETED|Overall Study||1007
379521|NCT00345176|925349|P4|STARTED|Overall Study||1079
379522|NCT00345176|925350|P3|STARTED|Overall Study||1068
379523|NCT00345176|925351|P2|STARTED|Overall Study||1044
379524|NCT00345176|925352|P1|STARTED|Overall Study||1012
379525|NCT00345046|925375|P3|NOT COMPLETED|Overall Study||2
379526|NCT00345046|925376|P2|NOT COMPLETED|Overall Study||1
379527|NCT00345046|925377|P1|NOT COMPLETED|Overall Study||1
379528|NCT00345046|925375|P3|COMPLETED|Overall Study||14
379529|NCT00345046|925376|P2|COMPLETED|Overall Study||21
379530|NCT00345046|925377|P1|COMPLETED|Overall Study||17
379531|NCT00345046|925375|P3|STARTED|Overall Study||16
379532|NCT00345046|925376|P2|STARTED|Overall Study||22
379533|NCT00345046|925377|P1|STARTED|Overall Study||18
379534|NCT00345033|925387|P2|NOT COMPLETED|Overall Study||4
379535|NCT00345033|925388|P1|NOT COMPLETED|Overall Study||4
379536|NCT00345033|925387|P2|COMPLETED|Overall Study||14
379537|NCT00345033|925388|P1|COMPLETED|Overall Study||16
379538|NCT00345033|925387|P2|STARTED|Overall Study||18
379539|NCT00345033|925388|P1|STARTED|Overall Study||20
379540|NCT00344968|925407|P3|NOT COMPLETED|Overall Study||116
379541|NCT00344968|925408|P2|NOT COMPLETED|Overall Study||102
379542|NCT00344968|925409|P1|NOT COMPLETED|Overall Study||59
379543|NCT00344968|925407|P3|COMPLETED|Overall Study||279
379544|NCT00344968|925408|P2|COMPLETED|Overall Study||274
379545|NCT00344968|925409|P1|COMPLETED|Overall Study||126
379546|NCT00344968|925407|P3|STARTED|Overall Study||395
379547|NCT00344968|925408|P2|STARTED|Overall Study||376
379548|NCT00344968|925409|P1|STARTED|Overall Study||185
379549|NCT00344773|925420|P1|NOT COMPLETED|Overall Study||21
379550|NCT00344773|925420|P1|COMPLETED|Overall Study||25
379551|NCT00344773|925420|P1|STARTED|Overall Study||46
379552|NCT00344682|925428|P2|NOT COMPLETED|Overall Study||1
379553|NCT00344682|925429|P1|NOT COMPLETED|Overall Study||4
379554|NCT00344682|925428|P2|COMPLETED|Overall Study||14
379555|NCT00344682|925429|P1|COMPLETED|Overall Study||12
379556|NCT00344682|925428|P2|STARTED|Overall Study||15
379557|NCT00344682|925429|P1|STARTED|Overall Study||16
379558|NCT00344500|925443|P3|NOT COMPLETED|Overall Study||2
379559|NCT00344500|925444|P2|NOT COMPLETED|Overall Study||35
379560|NCT00344500|925445|P1|NOT COMPLETED|Overall Study||23
379561|NCT00344500|925443|P3|COMPLETED|Overall Study||12
379562|NCT00344500|925444|P2|COMPLETED|Overall Study||25
379563|NCT00344500|925445|P1|COMPLETED|Overall Study||25
379564|NCT00344500|925443|P3|STARTED|Overall Study||14
379565|NCT00344500|925444|P2|STARTED|Overall Study||60
379566|NCT00344500|925445|P1|STARTED|Overall Study||48
379567|NCT00344487|925456|P1|NOT COMPLETED|Overall Study||1
379568|NCT00344487|925456|P1|COMPLETED|Overall Study|One subject was withdrawn at month 9 because he was considered an immunologic failure on study.|2
379569|NCT00344487|925456|P1|STARTED|Overall Study||3
379570|NCT00344461|925460|P1|NOT COMPLETED|Overall Study||21
379571|NCT00344461|925460|P1|COMPLETED|Overall Study||33
379572|NCT00344461|925460|P1|STARTED|Overall Study||54
379573|NCT00344448|925471|P2|NOT COMPLETED|Open Label||1
379574|NCT00344448|925472|P1|NOT COMPLETED|Open Label||2
379575|NCT00344448|925471|P2|COMPLETED|Open Label||2
379576|NCT00344448|925472|P1|COMPLETED|Open Label||2
379577|NCT00344448|925471|P2|STARTED|Open Label||3
379578|NCT00344448|925472|P1|STARTED|Open Label||4
379579|NCT00344448|925471|P2|NOT COMPLETED|Double Blind, Placebo Controlled||0
379580|NCT00344448|925472|P1|NOT COMPLETED|Double Blind, Placebo Controlled||2
379581|NCT00344448|925471|P2|COMPLETED|Double Blind, Placebo Controlled||3
379582|NCT00344448|925472|P1|COMPLETED|Double Blind, Placebo Controlled||4
379583|NCT00344448|925471|P2|STARTED|Double Blind, Placebo Controlled||3
379584|NCT00344448|925472|P1|STARTED|Double Blind, Placebo Controlled||6
379585|NCT00344448|925471|P2|NOT COMPLETED|Screening||1
379586|NCT00344448|925472|P1|NOT COMPLETED|Screening||0
379587|NCT00344448|925471|P2|COMPLETED|Screening||3
379588|NCT00344448|925472|P1|COMPLETED|Screening||6
379589|NCT00344448|925471|P2|STARTED|Screening||4
379590|NCT00344448|925472|P1|STARTED|Screening|No randomization during the screening phase|6
379591|NCT00344370|925480|P2|NOT COMPLETED|Overall Study||3
379592|NCT00344370|925481|P1|NOT COMPLETED|Overall Study||15
379593|NCT00344370|925480|P2|COMPLETED|Overall Study||68
379594|NCT00344370|925481|P1|COMPLETED|Overall Study||128
379595|NCT00344370|925480|P2|STARTED|Overall Study||71
379596|NCT00344370|925481|P1|STARTED|Overall Study||143
379597|NCT00344318|925493|P4|NOT COMPLETED|Overall Study||3
379598|NCT00344318|925494|P3|NOT COMPLETED|Overall Study||1
379599|NCT00344318|925495|P2|NOT COMPLETED|Overall Study||5
379600|NCT00344318|925496|P1|NOT COMPLETED|Overall Study||4
379601|NCT00344318|925493|P4|COMPLETED|Overall Study||100
379602|NCT00344318|925494|P3|COMPLETED|Overall Study||99
379603|NCT00344318|925495|P2|COMPLETED|Overall Study||298
379604|NCT00344318|925496|P1|COMPLETED|Overall Study||296
379605|NCT00344318|925493|P4|STARTED|Overall Study||103
379606|NCT00344318|925494|P3|STARTED|Overall Study||100
379607|NCT00344318|925495|P2|STARTED|Overall Study||303
379608|NCT00344318|925496|P1|STARTED|Overall Study||300
379609|NCT00344305|925618|P2|NOT COMPLETED|Overall Study||1
379610|NCT00344305|925619|P1|NOT COMPLETED|Overall Study||2
379611|NCT00344305|925618|P2|COMPLETED|Overall Study||99
379612|NCT00344305|925619|P1|COMPLETED|Overall Study||98
379613|NCT00344305|925618|P2|STARTED|Overall Study||100
379614|NCT00344305|925619|P1|STARTED|Overall Study||100
379615|NCT00344175|925656|P2|NOT COMPLETED|Overall Study||10
379616|NCT00344175|925657|P1|NOT COMPLETED|Overall Study||12
379617|NCT00344175|925656|P2|COMPLETED|Overall Study||47
379618|NCT00344175|925657|P1|COMPLETED|Overall Study||109
379619|NCT00344175|925656|P2|STARTED|Overall Study||57
379620|NCT00344175|925657|P1|STARTED|Overall Study||121
379621|NCT00344032|925669|P2|NOT COMPLETED|Overall Study||10
379622|NCT00344032|925670|P1|NOT COMPLETED|Overall Study||14
379623|NCT00344032|925669|P2|COMPLETED|Overall Study||168
379624|NCT00344032|925670|P1|COMPLETED|Overall Study||162
379625|NCT00344032|925669|P2|STARTED|Overall Study||178
379626|NCT00344032|925670|P1|STARTED|Overall Study||176
379627|NCT00344019|925689|P3|NOT COMPLETED|Overall Study||74
379628|NCT00344019|925690|P2|NOT COMPLETED|Overall Study||0
379629|NCT00344019|925691|P1|NOT COMPLETED|Overall Study||0
379630|NCT00344019|925689|P3|COMPLETED|Overall Study||0
379631|NCT00344019|925690|P2|COMPLETED|Overall Study||11
379632|NCT00344019|925691|P1|COMPLETED|Overall Study||12
379633|NCT00344019|925689|P3|STARTED|Overall Study||74
379634|NCT00344019|925690|P2|STARTED|Overall Study||11
379635|NCT00344019|925691|P1|STARTED|Overall Study||12
379636|NCT00343915|925709|P2|NOT COMPLETED|Month 66 Follow-up||0
379637|NCT00343915|925710|P1|NOT COMPLETED|Month 66 Follow-up||0
379638|NCT00343915|925709|P2|COMPLETED|Month 66 Follow-up||76
379639|NCT00343915|925710|P1|COMPLETED|Month 66 Follow-up||158
379640|NCT00343915|925709|P2|STARTED|Month 66 Follow-up||76
379641|NCT00343915|925710|P1|STARTED|Month 66 Follow-up|Subjects, previously vaccinated, that returned for the Month 66 follow-up.|158
379642|NCT00343915|925709|P2|NOT COMPLETED|Month 54 Follow-up||0
379643|NCT00343915|925710|P1|NOT COMPLETED|Month 54 Follow-up||0
379644|NCT00343915|925709|P2|COMPLETED|Month 54 Follow-up||79
379645|NCT00343915|925710|P1|COMPLETED|Month 54 Follow-up||166
379646|NCT00343915|925709|P2|STARTED|Month 54 Follow-up||79
379647|NCT00343915|925710|P1|STARTED|Month 54 Follow-up|Subjects, previously vaccinated, that returned for the Month 54 follow-up.|166
379648|NCT00343915|925709|P2|NOT COMPLETED|Month 42 Follow-up||0
379649|NCT00343915|925710|P1|NOT COMPLETED|Month 42 Follow-up||0
379650|NCT00343915|925709|P2|COMPLETED|Month 42 Follow-up||84
379651|NCT00343915|925710|P1|COMPLETED|Month 42 Follow-up||174
379652|NCT00343915|925709|P2|STARTED|Month 42 Follow-up||84
379653|NCT00343915|925710|P1|STARTED|Month 42 Follow-up|Subjects, previously vaccinated, that returned for the Month 42 follow-up.|174
379654|NCT00343915|925709|P2|NOT COMPLETED|Month 30 Follow-up||0
379655|NCT00343915|925710|P1|NOT COMPLETED|Month 30 Follow-up||0
379656|NCT00343915|925709|P2|COMPLETED|Month 30 Follow-up||88
379657|NCT00343915|925710|P1|COMPLETED|Month 30 Follow-up||179
379658|NCT00343915|925709|P2|STARTED|Month 30 Follow-up||88
379659|NCT00343915|925710|P1|STARTED|Month 30 Follow-up|Subjects, previously vaccinated, that returned for the Month 30 follow-up.|179
379660|NCT00343915|925709|P2|NOT COMPLETED|Primary Study||3
379661|NCT00343915|925710|P1|NOT COMPLETED|Primary Study||4
379662|NCT00343915|925709|P2|COMPLETED|Primary Study||123
379663|NCT00343915|925710|P1|COMPLETED|Primary Study||254
379664|NCT00343915|925709|P2|STARTED|Primary Study||126
379665|NCT00343915|925710|P1|STARTED|Primary Study||258
379666|NCT00343889|925736|P2|NOT COMPLETED|Overall Study||1
379667|NCT00343889|925737|P1|NOT COMPLETED|Overall Study||3
379668|NCT00343889|925736|P2|COMPLETED|Overall Study||188
379669|NCT00343889|925737|P1|COMPLETED|Overall Study||187
379670|NCT00343889|925736|P2|STARTED|Overall Study||189
379671|NCT00343889|925737|P1|STARTED|Overall Study||190
379672|NCT00343863|925755|P2|NOT COMPLETED|Overall Study||0
379673|NCT00343863|925756|P1|NOT COMPLETED|Overall Study||0
379674|NCT00343863|925755|P2|COMPLETED|Overall Study||34
379675|NCT00343863|925756|P1|COMPLETED|Overall Study||7
379676|NCT00343863|925755|P2|STARTED|Overall Study||34
379677|NCT00343863|925756|P1|STARTED|Overall Study||7
379678|NCT00343785|925778|P1|NOT COMPLETED|Overall Study||0
379679|NCT00343785|925778|P1|COMPLETED|Overall Study||21
379680|NCT00343785|925778|P1|STARTED|Overall Study||21
379681|NCT00343564|925795|P11|NOT COMPLETED|Overall Study||0
379682|NCT00343564|925796|P10|NOT COMPLETED|Overall Study||0
379683|NCT00343564|925797|P9|NOT COMPLETED|Overall Study||0
379684|NCT00343564|925798|P8|NOT COMPLETED|Overall Study||0
379685|NCT00343564|925799|P7|NOT COMPLETED|Overall Study||0
379686|NCT00343564|925800|P6|NOT COMPLETED|Overall Study||0
379687|NCT00343564|925801|P5|NOT COMPLETED|Overall Study||0
379688|NCT00343564|925802|P4|NOT COMPLETED|Overall Study||0
379689|NCT00343564|925803|P3|NOT COMPLETED|Overall Study||0
379690|NCT00343564|925804|P2|NOT COMPLETED|Overall Study||0
379691|NCT00343564|925805|P1|NOT COMPLETED|Overall Study||0
379692|NCT00343564|925795|P11|COMPLETED|Overall Study||8
379693|NCT00343564|925796|P10|COMPLETED|Overall Study||8
379694|NCT00343564|925797|P9|COMPLETED|Overall Study||3
379695|NCT00343564|925798|P8|COMPLETED|Overall Study||3
379696|NCT00343564|925799|P7|COMPLETED|Overall Study||4
379697|NCT00343564|925800|P6|COMPLETED|Overall Study||9
379698|NCT00343564|925801|P5|COMPLETED|Overall Study||10
379699|NCT00343564|925802|P4|COMPLETED|Overall Study||7
379700|NCT00343564|925803|P3|COMPLETED|Overall Study||3
379701|NCT00343564|925804|P2|COMPLETED|Overall Study||7
379702|NCT00343564|925805|P1|COMPLETED|Overall Study||6
379703|NCT00343564|925795|P11|STARTED|Overall Study||8
379704|NCT00343564|925796|P10|STARTED|Overall Study||8
379705|NCT00343564|925797|P9|STARTED|Overall Study||3
379706|NCT00343564|925798|P8|STARTED|Overall Study||3
379707|NCT00343564|925799|P7|STARTED|Overall Study||4
379708|NCT00343564|925800|P6|STARTED|Overall Study||9
379709|NCT00343564|925801|P5|STARTED|Overall Study||10
379710|NCT00343564|925802|P4|STARTED|Overall Study||7
379711|NCT00343564|925803|P3|STARTED|Overall Study||3
379712|NCT00343564|925804|P2|STARTED|Overall Study||7
379713|NCT00343564|925805|P1|STARTED|Overall Study||6
379714|NCT00343512|925820|P1|NOT COMPLETED|Overall Study||2
379715|NCT00343512|925820|P1|COMPLETED|Overall Study||32
379716|NCT00343512|925820|P1|STARTED|Overall Study||34
379717|NCT00343460|925832|P3|NOT COMPLETED|Cycle 2 - 4||0
379718|NCT00343460|925833|P2|NOT COMPLETED|Cycle 2 - 4||50
379719|NCT00343460|925834|P1|NOT COMPLETED|Cycle 2 - 4||56
379720|NCT00343460|925832|P3|COMPLETED|Cycle 2 - 4||0
379721|NCT00343460|925833|P2|COMPLETED|Cycle 2 - 4||515
379722|NCT00343460|925834|P1|COMPLETED|Cycle 2 - 4||528
379723|NCT00343460|925832|P3|STARTED|Cycle 2 - 4||0
379724|NCT00343460|925833|P2|STARTED|Cycle 2 - 4||565
379725|NCT00343460|925834|P1|STARTED|Cycle 2 - 4||584
379726|NCT00343460|925832|P3|NOT COMPLETED|Cycle 1||18
379727|NCT00343460|925833|P2|NOT COMPLETED|Cycle 1||22
379728|NCT00343460|925834|P1|NOT COMPLETED|Cycle 1||22
379729|NCT00343460|925832|P3|COMPLETED|Cycle 1||454
379730|NCT00343460|925833|P2|COMPLETED|Cycle 1||459
379731|NCT00343460|925834|P1|COMPLETED|Cycle 1||453
379732|NCT00343460|925832|P3|STARTED|Cycle 1||472
379733|NCT00343460|925833|P2|STARTED|Cycle 1||481
379734|NCT00343460|925834|P1|STARTED|Cycle 1||475
379735|NCT00343382|925908|P3|NOT COMPLETED|Overall Study||17
379736|NCT00343382|925909|P2|NOT COMPLETED|Overall Study||14
379737|NCT00343382|925910|P1|NOT COMPLETED|Overall Study||4
379738|NCT00343382|925908|P3|COMPLETED|Overall Study||49
379739|NCT00343382|925909|P2|COMPLETED|Overall Study||51
379740|NCT00343382|925910|P1|COMPLETED|Overall Study||60
379741|NCT00343382|925908|P3|STARTED|Overall Study||66
379742|NCT00343382|925909|P2|STARTED|Overall Study||65
379743|NCT00343382|925910|P1|STARTED|Overall Study||64
379744|NCT00343291|925929|P2|NOT COMPLETED|Overall Study||56
379745|NCT00343291|925930|P1|NOT COMPLETED|Overall Study||57
379746|NCT00343291|925929|P2|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|5
379747|NCT00343291|925930|P1|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|3
379748|NCT00343291|925929|P2|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
379749|NCT00343291|925930|P1|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
379750|NCT00343291|925929|P2|STARTED|Overall Study||61
379751|NCT00343291|925930|P1|STARTED|Overall Study||60
379752|NCT00343252|925946|P2|NOT COMPLETED|18 Months (All Treated Participants)||81
379753|NCT00343252|925947|P1|NOT COMPLETED|18 Months (All Treated Participants)||101
379754|NCT00343252|925946|P2|COMPLETED|18 Months (All Treated Participants)||269
379755|NCT00343252|925947|P1|COMPLETED|18 Months (All Treated Participants)||259
379756|NCT00343252|925946|P2|STARTED|18 Months (All Treated Participants)||350
379757|NCT00343252|925947|P1|STARTED|18 Months (All Treated Participants)||360
379758|NCT00343252|925946|P2|NOT COMPLETED|12 Months (All Treated Participants)||69
379759|NCT00343252|925947|P1|NOT COMPLETED|12 Months (All Treated Participants)||86
379760|NCT00343252|925946|P2|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|281
379761|NCT00343252|925947|P1|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|274
379762|NCT00343252|925946|P2|STARTED|12 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
379763|NCT00343252|925947|P1|STARTED|12 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
379764|NCT00343252|925946|P2|NOT COMPLETED|6 Months (All Treated Participants)||44
379765|NCT00343252|925947|P1|NOT COMPLETED|6 Months (All Treated Participants)||56
379766|NCT00343252|925946|P2|COMPLETED|6 Months (All Treated Participants)||306
379767|NCT00343252|925947|P1|COMPLETED|6 Months (All Treated Participants)||304
379768|NCT00343252|925946|P2|STARTED|6 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
379769|NCT00343252|925947|P1|STARTED|6 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
379770|NCT00343252|925946|P2|NOT COMPLETED|All Randomized Participants||82
379771|NCT00343252|925947|P1|NOT COMPLETED|All Randomized Participants||102
379772|NCT00343252|925946|P2|COMPLETED|All Randomized Participants||269
379773|NCT00343252|925947|P1|COMPLETED|All Randomized Participants||259
379774|NCT00343252|925946|P2|STARTED|All Randomized Participants||351
379775|NCT00343252|925947|P1|STARTED|All Randomized Participants||361
379776|NCT00343083|925993|P1|NOT COMPLETED|Overall Study||21
379777|NCT00343083|925993|P1|COMPLETED|Overall Study||22
379778|NCT00343083|925993|P1|STARTED|Overall Study||43
379779|NCT00343044|926002|P1|NOT COMPLETED|Overall Study||0
379780|NCT00343044|926002|P1|COMPLETED|Overall Study||40
379781|NCT00343044|926002|P1|STARTED|Overall Study||40
379782|NCT00342628|926012|P3|NOT COMPLETED|Overall Study||19
379783|NCT00342628|926013|P2|NOT COMPLETED|Overall Study||21
379784|NCT00342628|926014|P1|NOT COMPLETED|Overall Study||20
379785|NCT00342628|926012|P3|COMPLETED|Overall Study|97 completed 3 injections of DTP alone, 16 were lost-to-followup for blood drawing at 12 months.|81
379786|NCT00342628|926013|P2|COMPLETED|Overall Study|83 completed 4 injections, 3 were lost-to-followup after 4th injection|80
379787|NCT00342628|926014|P1|COMPLETED|Overall Study|84 completed 4 injections, 4 were lost-to-followup after the 4th injection|80
379788|NCT00342628|926012|P3|STARTED|Overall Study||100
379789|NCT00342628|926013|P2|STARTED|Overall Study||101
379790|NCT00342628|926014|P1|STARTED|Overall Study||100
379791|NCT00342563|926035|P4|NOT COMPLETED|Overall Study||6
379792|NCT00342563|926036|P3|NOT COMPLETED|Overall Study||14
379793|NCT00342563|926037|P2|NOT COMPLETED|Overall Study||8
379794|NCT00342563|926038|P1|NOT COMPLETED|Overall Study||6
379795|NCT00342563|926035|P4|COMPLETED|Overall Study||22
379796|NCT00342563|926036|P3|COMPLETED|Overall Study||26
379797|NCT00342563|926037|P2|COMPLETED|Overall Study||19
379798|NCT00342563|926038|P1|COMPLETED|Overall Study||35
379799|NCT00342563|926035|P4|STARTED|Overall Study||28
379800|NCT00342563|926036|P3|STARTED|Overall Study||40
379801|NCT00342563|926037|P2|STARTED|Overall Study||27
379802|NCT00342563|926038|P1|STARTED|Overall Study||41
379803|NCT00342355|926058|P4|NOT COMPLETED|Overall Study||0
379804|NCT00342355|926059|P3|NOT COMPLETED|Overall Study||0
379805|NCT00342355|926060|P2|NOT COMPLETED|Overall Study||0
379806|NCT00342355|926061|P1|NOT COMPLETED|Overall Study||0
379807|NCT00342355|926058|P4|COMPLETED|Overall Study||443
379808|NCT00342355|926059|P3|COMPLETED|Overall Study||444
379809|NCT00342355|926060|P2|COMPLETED|Overall Study||440
379810|NCT00342355|926061|P1|COMPLETED|Overall Study||444
379811|NCT00342355|926058|P4|STARTED|Overall Study||443
379812|NCT00342355|926059|P3|STARTED|Overall Study||444
379813|NCT00342355|926060|P2|STARTED|Overall Study||440
379814|NCT00342355|926061|P1|STARTED|Overall Study||444
379815|NCT00340834|926080|P5|NOT COMPLETED|Extension Phase of Study||44
379816|NCT00340834|926081|P4|NOT COMPLETED|Extension Phase of Study||53
379817|NCT00340834|926082|P3|NOT COMPLETED|Extension Phase of Study||0
379818|NCT00340834|926083|P2|NOT COMPLETED|Extension Phase of Study||76
379819|NCT00340834|926084|P1|NOT COMPLETED|Extension Phase of Study||85
379820|NCT00340834|926080|P5|COMPLETED|Extension Phase of Study||123
379821|NCT00340834|926081|P4|COMPLETED|Extension Phase of Study||123
379822|NCT00340834|926082|P3|COMPLETED|Extension Phase of Study||0
379823|NCT00340834|926083|P2|COMPLETED|Extension Phase of Study||281
379824|NCT00340834|926084|P1|COMPLETED|Extension Phase of Study||245
379825|NCT00340834|926080|P5|Received Study Drug|Extension Phase of Study||167
379826|NCT00340834|926081|P4|Received Study Drug|Extension Phase of Study||174
379827|NCT00340834|926082|P3|Received Study Drug|Extension Phase of Study||0
379828|NCT00340834|926083|P2|Received Study Drug|Extension Phase of Study||356
379829|NCT00340834|926084|P1|Received Study Drug|Extension Phase of Study||330
379830|NCT00340834|926080|P5|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|167
379831|NCT00340834|926081|P4|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|176
379832|NCT00340834|926082|P3|STARTED|Extension Phase of Study|This group did not exist in the extension phase of the study.|0
379833|NCT00340834|926083|P2|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|357
379834|NCT00340834|926084|P1|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|330
379835|NCT00340834|926080|P5|NOT COMPLETED|Core Phase of Study||0
379836|NCT00340834|926081|P4|NOT COMPLETED|Core Phase of Study||0
379837|NCT00340834|926082|P3|NOT COMPLETED|Core Phase of Study||49
379838|NCT00340834|926083|P2|NOT COMPLETED|Core Phase of Study||33
379839|NCT00340834|926084|P1|NOT COMPLETED|Core Phase of Study||57
379840|NCT00340834|926080|P5|COMPLETED|Core Phase of Study||0
379841|NCT00340834|926081|P4|COMPLETED|Core Phase of Study||0
379842|NCT00340834|926082|P3|COMPLETED|Core Phase of Study|On study drug: 380, Off study drug: 6|386
379843|NCT00340834|926083|P2|COMPLETED|Core Phase of Study|On study drug: 385, Off study drug: 13|398
379844|NCT00340834|926084|P1|COMPLETED|Core Phase of Study|On study drug: 358, Off study drug: 11|369
379845|NCT00340834|926080|P5|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
379846|NCT00340834|926081|P4|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
379847|NCT00340834|926082|P3|STARTED|Core Phase of Study||435
379848|NCT00340834|926083|P2|STARTED|Core Phase of Study||431
379849|NCT00340834|926084|P1|STARTED|Core Phase of Study||426
379850|NCT00340704|926118|P9|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||29
379851|NCT00340704|926119|P8|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||12
379852|NCT00340704|926120|P7|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||53
379853|NCT00340704|926121|P6|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||7
379854|NCT00340704|926122|P5|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||5
379855|NCT00340704|926123|P4|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||2
379856|NCT00340704|926124|P3|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
379857|NCT00340704|926125|P2|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
379858|NCT00340704|926126|P1|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
379859|NCT00340704|926118|P9|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
379860|NCT00340704|926119|P8|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
379861|NCT00340704|926120|P7|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
379862|NCT00340704|926121|P6|COMPLETED|Group D- Denovo & 527.51 Rollover Study||30
379863|NCT00340704|926122|P5|COMPLETED|Group D- Denovo & 527.51 Rollover Study||16
379864|NCT00340704|926123|P4|COMPLETED|Group D- Denovo & 527.51 Rollover Study||27
379865|NCT00340704|926124|P3|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
379866|NCT00340704|926125|P2|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
379867|NCT00340704|926126|P1|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
379868|NCT00340704|926118|P9|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
379869|NCT00340704|926119|P8|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
379870|NCT00340704|926120|P7|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
379871|NCT00340704|926121|P6|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||18
379872|NCT00340704|926122|P5|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||5
379873|NCT00340704|926123|P4|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||7
379874|NCT00340704|926124|P3|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
379875|NCT00340704|926125|P2|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
379876|NCT00340704|926126|P1|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
379877|NCT00340704|926118|P9|STARTED|Group D- Denovo & 527.51 Rollover Study||29
379878|NCT00340704|926119|P8|STARTED|Group D- Denovo & 527.51 Rollover Study||13
379879|NCT00340704|926120|P7|STARTED|Group D- Denovo & 527.51 Rollover Study||54
379880|NCT00340704|926121|P6|STARTED|Group D- Denovo & 527.51 Rollover Study||37
379881|NCT00340704|926122|P5|STARTED|Group D- Denovo & 527.51 Rollover Study||21
379882|NCT00340704|926123|P4|STARTED|Group D- Denovo & 527.51 Rollover Study||29
379883|NCT00340704|926124|P3|STARTED|Group D- Denovo & 527.51 Rollover Study||0
379884|NCT00340704|926125|P2|STARTED|Group D- Denovo & 527.51 Rollover Study||0
379885|NCT00340704|926126|P1|STARTED|Group D- Denovo & 527.51 Rollover Study||0
379886|NCT00340704|926118|P9|NOT COMPLETED|PK Study||0
379887|NCT00340704|926119|P8|NOT COMPLETED|PK Study||0
379888|NCT00340704|926120|P7|NOT COMPLETED|PK Study||0
379889|NCT00340704|926121|P6|NOT COMPLETED|PK Study||0
379890|NCT00340704|926122|P5|NOT COMPLETED|PK Study||0
379891|NCT00340704|926123|P4|NOT COMPLETED|PK Study||0
379892|NCT00340704|926124|P3|NOT COMPLETED|PK Study||1
379893|NCT00340704|926125|P2|NOT COMPLETED|PK Study||1
379894|NCT00340704|926126|P1|NOT COMPLETED|PK Study||0
379895|NCT00340704|926118|P9|COMPLETED|PK Study||0
379896|NCT00340704|926119|P8|COMPLETED|PK Study||0
379897|NCT00340704|926120|P7|COMPLETED|PK Study||0
379898|NCT00340704|926121|P6|COMPLETED|PK Study||0
379899|NCT00340704|926122|P5|COMPLETED|PK Study||0
379900|NCT00340704|926123|P4|COMPLETED|PK Study||0
379901|NCT00340704|926124|P3|COMPLETED|PK Study||10
379902|NCT00340704|926125|P2|COMPLETED|PK Study||9
379903|NCT00340704|926126|P1|COMPLETED|PK Study||10
379904|NCT00340704|926118|P9|STARTED|PK Study||0
379905|NCT00340704|926119|P8|STARTED|PK Study||0
379906|NCT00340704|926120|P7|STARTED|PK Study||0
379907|NCT00340704|926121|P6|STARTED|PK Study||0
379908|NCT00340704|926122|P5|STARTED|PK Study||0
379909|NCT00340704|926123|P4|STARTED|PK Study||0
379910|NCT00340704|926124|P3|STARTED|PK Study||11
379911|NCT00340704|926125|P2|STARTED|PK Study||10
379912|NCT00340704|926126|P1|STARTED|PK Study||10
379913|NCT00340678|926232|P4|NOT COMPLETED|Overall Study||0
379914|NCT00340678|926233|P3|NOT COMPLETED|Overall Study||0
379915|NCT00340678|926234|P2|NOT COMPLETED|Overall Study||0
379916|NCT00340678|926235|P1|NOT COMPLETED|Overall Study||1
379917|NCT00340678|926232|P4|COMPLETED|Overall Study||39
379918|NCT00340678|926233|P3|COMPLETED|Overall Study||39
379919|NCT00340678|926234|P2|COMPLETED|Overall Study||46
379920|NCT00340678|926235|P1|COMPLETED|Overall Study||45
379921|NCT00340678|926232|P4|STARTED|Overall Study||39
379922|NCT00340678|926233|P3|STARTED|Overall Study||39
379923|NCT00340678|926234|P2|STARTED|Overall Study||46
379924|NCT00340678|926235|P1|STARTED|Overall Study||46
379925|NCT00340379|926249|P2|NOT COMPLETED|Overall Study||9
379926|NCT00340379|926250|P1|NOT COMPLETED|Overall Study||8
379927|NCT00340379|926249|P2|COMPLETED|Overall Study||28
379928|NCT00340379|926250|P1|COMPLETED|Overall Study||27
379929|NCT00340379|926249|P2|STARTED|Overall Study||37
379930|NCT00340379|926250|P1|STARTED|Overall Study||35
379931|NCT00339833|926262|P2|NOT COMPLETED|Overall Study||8
379932|NCT00339833|926263|P1|NOT COMPLETED|Overall Study||6
379933|NCT00339833|926262|P2|COMPLETED|Overall Study||18
379934|NCT00339833|926263|P1|COMPLETED|Overall Study||22
379935|NCT00339833|926262|P2|STARTED|Overall Study||26
379936|NCT00339833|926263|P1|STARTED|Overall Study||28
379937|NCT00339183|926273|P2|NOT COMPLETED|Overall Study||105
379938|NCT00339183|926274|P1|NOT COMPLETED|Overall Study||121
379939|NCT00339183|926273|P2|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|490
379940|NCT00339183|926274|P1|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|470
379941|NCT00339183|926273|P2|Received Study Drug|Overall Study||593
379942|NCT00339183|926274|P1|Received Study Drug|Overall Study|Includes one participant who received FOLFIRI Alone|588
379943|NCT00339183|926273|P2|STARTED|Overall Study||595
379944|NCT00339183|926274|P1|STARTED|Overall Study||591
379945|NCT00339144|926303|P3|NOT COMPLETED|Overall Study||4
379946|NCT00339144|926304|P2|NOT COMPLETED|Overall Study||3
379947|NCT00339144|926305|P1|NOT COMPLETED|Overall Study||9
379948|NCT00339144|926303|P3|COMPLETED|Overall Study||0
379949|NCT00339144|926304|P2|COMPLETED|Overall Study||0
379950|NCT00339144|926305|P1|COMPLETED|Overall Study||0
379951|NCT00339144|926303|P3|STARTED|Overall Study|Number of participants enrolled and treated|4
379952|NCT00339144|926304|P2|STARTED|Overall Study|Number of participants enrolled and treated|3
379953|NCT00339144|926305|P1|STARTED|Overall Study|Number of participants enrolled and treated|9
379954|NCT00339079|926391|P4|NOT COMPLETED|Overall Study||24
379955|NCT00339079|926392|P3|NOT COMPLETED|Overall Study||18
379956|NCT00339079|926393|P2|NOT COMPLETED|Overall Study||23
379957|NCT00339079|926394|P1|NOT COMPLETED|Overall Study||33
379958|NCT00339079|926391|P4|COMPLETED|Overall Study||29
379959|NCT00339079|926392|P3|COMPLETED|Overall Study||27
379960|NCT00339079|926393|P2|COMPLETED|Overall Study||21
379961|NCT00339079|926394|P1|COMPLETED|Overall Study||20
379962|NCT00339079|926391|P4|STARTED|Overall Study||53
379963|NCT00339079|926392|P3|STARTED|Overall Study||45
379964|NCT00339079|926393|P2|STARTED|Overall Study||44
379965|NCT00339079|926394|P1|STARTED|Overall Study||53
379966|NCT00339040|926410|P2|NOT COMPLETED|Stage II||2
379967|NCT00339040|926411|P1|NOT COMPLETED|Stage II||10
379968|NCT00339040|926410|P2|COMPLETED|Stage II||27
379969|NCT00339040|926411|P1|COMPLETED|Stage II||84
379970|NCT00339040|926410|P2|Vaccination 6 at Week 120|Stage II||27
379971|NCT00339040|926411|P1|Vaccination 6 at Week 120|Stage II||0
379972|NCT00339040|926410|P2|Vaccination 5 at Week 104|Stage II||28
379973|NCT00339040|926411|P1|Vaccination 5 at Week 104|Stage II||0
379974|NCT00339040|926410|P2|Vaccination 4 at Week 96|Stage II||29
379975|NCT00339040|926411|P1|Vaccination 4 at Week 96|Stage II||84
379976|NCT00339040|926410|P2|STARTED|Stage II||29
379977|NCT00339040|926411|P1|STARTED|Stage II||94
379978|NCT00339040|926410|P2|NOT COMPLETED|Stage I||1
379979|NCT00339040|926411|P1|NOT COMPLETED|Stage I||2
379980|NCT00339040|926410|P2|COMPLETED|Stage I||29
379981|NCT00339040|926411|P1|COMPLETED|Stage I||94
379982|NCT00339040|926410|P2|Vaccination 3 at Week 24|Stage I||30
379983|NCT00339040|926411|P1|Vaccination 3 at Week 24|Stage I||94
379984|NCT00339040|926410|P2|Vaccination 2 at Week 8|Stage I||30
379985|NCT00339040|926411|P1|Vaccination 2 at Week 8|Stage I||95
379986|NCT00339040|926410|P2|Vaccination 1 at Week 0|Stage I||30
379987|NCT00339040|926411|P1|Vaccination 1 at Week 0|Stage I||96
379988|NCT00339040|926410|P2|STARTED|Stage I||30
379989|NCT00339040|926411|P1|STARTED|Stage I||96
379990|NCT00338988|926429|P1|NOT COMPLETED|Overall Study||1
379991|NCT00338988|926429|P1|COMPLETED|Overall Study||43
379992|NCT00338988|926429|P1|STARTED|Overall Study||44
379993|NCT00338962|926438|P4|NOT COMPLETED|Overall Study||3
379994|NCT00338962|926439|P3|NOT COMPLETED|Overall Study||6
379995|NCT00338962|926440|P2|NOT COMPLETED|Overall Study||4
379996|NCT00338962|926441|P1|NOT COMPLETED|Overall Study||8
379997|NCT00338962|926438|P4|COMPLETED|Overall Study||21
379998|NCT00338962|926439|P3|COMPLETED|Overall Study||16
379999|NCT00338962|926440|P2|COMPLETED|Overall Study||16
380000|NCT00338962|926441|P1|COMPLETED|Overall Study||14
380001|NCT00338962|926438|P4|STARTED|Overall Study||24
380002|NCT00338962|926439|P3|STARTED|Overall Study||22
380003|NCT00338962|926440|P2|STARTED|Overall Study||20
380004|NCT00338962|926441|P1|STARTED|Overall Study||22
380005|NCT00338884|926463|P1|NOT COMPLETED|Overall Study||78
380006|NCT00338884|926463|P1|COMPLETED|Overall Study||42
380007|NCT00338884|926463|P1|Received Treatment|Overall Study||119
380008|NCT00338884|926463|P1|STARTED|Overall Study||120
380009|NCT00338806|926497|P2|NOT COMPLETED|Follow-up||3
380010|NCT00338806|926498|P1|NOT COMPLETED|Follow-up||1
380011|NCT00338806|926497|P2|COMPLETED|Follow-up||1
380012|NCT00338806|926498|P1|COMPLETED|Follow-up||1
380013|NCT00338806|926497|P2|STARTED|Follow-up||4
380014|NCT00338806|926498|P1|STARTED|Follow-up||2
380015|NCT00338806|926497|P2|NOT COMPLETED|Acute Phase||1
380016|NCT00338806|926498|P1|NOT COMPLETED|Acute Phase||0
380017|NCT00338806|926497|P2|COMPLETED|Acute Phase||4
380018|NCT00338806|926498|P1|COMPLETED|Acute Phase||2
380019|NCT00338806|926497|P2|STARTED|Acute Phase||5
380020|NCT00338806|926498|P1|STARTED|Acute Phase||2
380021|NCT00338741|926560|P2|NOT COMPLETED|Overall Study||0
380022|NCT00338741|926561|P1|NOT COMPLETED|Overall Study||2
380023|NCT00338741|926560|P2|COMPLETED|Overall Study||2
380024|NCT00338741|926561|P1|COMPLETED|Overall Study||32
380025|NCT00338741|926560|P2|STARTED|Overall Study||2
380026|NCT00338741|926561|P1|STARTED|Overall Study|2 subjects signed a consent form but no data were received for either subject|34
380027|NCT00338598|926571|P2|NOT COMPLETED|Overall Study||2
380028|NCT00338598|926572|P1|NOT COMPLETED|Overall Study||0
380029|NCT00338598|926571|P2|COMPLETED|Overall Study||8
380030|NCT00338598|926572|P1|COMPLETED|Overall Study||10
380031|NCT00338598|926571|P2|STARTED|Overall Study||10
380032|NCT00338598|926572|P1|STARTED|Overall Study||10
380033|NCT00338455|926592|P2|NOT COMPLETED|Overall Study||1
380034|NCT00338455|926593|P1|NOT COMPLETED|Overall Study||3
380035|NCT00338455|926592|P2|COMPLETED|Overall Study||6
380036|NCT00338455|926593|P1|COMPLETED|Overall Study||6
380037|NCT00338455|926592|P2|Administered Study Drug|Overall Study||7
380038|NCT00338455|926593|P1|Administered Study Drug|Overall Study||8
380039|NCT00338455|926592|P2|STARTED|Overall Study||7
380040|NCT00338455|926593|P1|STARTED|Overall Study||9
380041|NCT00338286|926607|P2|NOT COMPLETED|Overall Study||213
380042|NCT00338286|926608|P1|NOT COMPLETED|Overall Study||233
380043|NCT00338286|926607|P2|COMPLETED|Overall Study||837
380044|NCT00338286|926608|P1|COMPLETED|Overall Study||815
380045|NCT00338286|926607|P2|STARTED|Overall Study||1050
380046|NCT00338286|926608|P1|STARTED|Overall Study||1048
380047|NCT00338104|926625|P3|NOT COMPLETED|Overall Study||3
380048|NCT00338104|926626|P2|NOT COMPLETED|Overall Study||1
380049|NCT00338104|926627|P1|NOT COMPLETED|Overall Study||2
380050|NCT00338104|926625|P3|COMPLETED|Overall Study||22
380051|NCT00338104|926626|P2|COMPLETED|Overall Study||24
380052|NCT00338104|926627|P1|COMPLETED|Overall Study||23
380053|NCT00338104|926625|P3|STARTED|Overall Study||25
380054|NCT00338104|926626|P2|STARTED|Overall Study||25
380055|NCT00338104|926627|P1|STARTED|Overall Study||25
380056|NCT00338039|926638|P1|NOT COMPLETED|Overall Study||0
380057|NCT00338039|926638|P1|COMPLETED|Overall Study||69
380058|NCT00338039|926638|P1|STARTED|Overall Study||69
380059|NCT00337987|926643|P1|NOT COMPLETED|Overall Study||0
380060|NCT00337987|926643|P1|COMPLETED|Overall Study||49
380061|NCT00337987|926643|P1|STARTED|Overall Study||49
380062|NCT00337935|926650|P2|NOT COMPLETED|Overall Study||27
380063|NCT00337935|926651|P1|NOT COMPLETED|Overall Study||10
380064|NCT00337935|926650|P2|COMPLETED|Overall Study||91
380065|NCT00337935|926651|P1|COMPLETED|Overall Study||29
380066|NCT00337935|926650|P2|STARTED|Overall Study||118
380067|NCT00337935|926651|P1|STARTED|Overall Study||39
380068|NCT00337818|926664|P3|NOT COMPLETED|Overall Study||107
380069|NCT00337818|926665|P2|NOT COMPLETED|Overall Study||91
380070|NCT00337818|926666|P1|NOT COMPLETED|Overall Study||289
380071|NCT00337818|926664|P3|COMPLETED|Overall Study||51
380072|NCT00337818|926665|P2|COMPLETED|Overall Study||63
380073|NCT00337818|926666|P1|COMPLETED|Overall Study||169
380074|NCT00337818|926664|P3|STARTED|Overall Study||158
380075|NCT00337818|926665|P2|STARTED|Overall Study||154
380076|NCT00337818|926666|P1|STARTED|Overall Study||458
380077|NCT00337779|926688|P2|NOT COMPLETED|Overall Study||79
380078|NCT00337779|926689|P1|NOT COMPLETED|Overall Study||52
380079|NCT00337779|926688|P2|COMPLETED|Overall Study||490
380080|NCT00337779|926689|P1|COMPLETED|Overall Study||534
380081|NCT00337779|926688|P2|STARTED|Overall Study||569
380082|NCT00337779|926689|P1|STARTED|Overall Study||586
380083|NCT00337727|926701|P2|NOT COMPLETED|Overall Study||12
380084|NCT00337727|926702|P1|NOT COMPLETED|Overall Study||18
380085|NCT00337727|926701|P2|COMPLETED|Overall Study||406
380086|NCT00337727|926702|P1|COMPLETED|Overall Study||412
380087|NCT00337727|926701|P2|STARTED|Overall Study||418
380088|NCT00337727|926702|P1|STARTED|Overall Study||430
380089|NCT00337675|926713|P3|NOT COMPLETED|Overall Study||99
380090|NCT00337675|926714|P2|NOT COMPLETED|Overall Study||103
380091|NCT00337675|926715|P1|NOT COMPLETED|Overall Study||97
380092|NCT00337675|926713|P3|COMPLETED|Overall Study||492
380093|NCT00337675|926714|P2|COMPLETED|Overall Study||488
380094|NCT00337675|926715|P1|COMPLETED|Overall Study||492
380095|NCT00337675|926713|P3|STARTED|Overall Study||591
380096|NCT00337675|926714|P2|STARTED|Overall Study||591
380097|NCT00337675|926715|P1|STARTED|Overall Study||589
380098|NCT00337662|926732|P4|NOT COMPLETED|Study Period III||0
380099|NCT00337662|926733|P3|NOT COMPLETED|Study Period III||44
380100|NCT00337662|926734|P2|NOT COMPLETED|Study Period III||58
380101|NCT00337662|926735|P1|NOT COMPLETED|Study Period III||60
380102|NCT00337662|926732|P4|COMPLETED|Study Period III||0
380103|NCT00337662|926733|P3|COMPLETED|Study Period III||100
380104|NCT00337662|926734|P2|COMPLETED|Study Period III||134
380105|NCT00337662|926735|P1|COMPLETED|Study Period III||126
380106|NCT00337662|926732|P4|STARTED|Study Period III||0
380107|NCT00337662|926733|P3|STARTED|Study Period III||144
380108|NCT00337662|926734|P2|STARTED|Study Period III||192
380109|NCT00337662|926735|P1|STARTED|Study Period III||186
380110|NCT00337662|926732|P4|NOT COMPLETED|Study Period II||106
380111|NCT00337662|926733|P3|NOT COMPLETED|Study Period II||0
380112|NCT00337662|926734|P2|NOT COMPLETED|Study Period II||0
380113|NCT00337662|926735|P1|NOT COMPLETED|Study Period II||0
380114|NCT00337662|926732|P4|COMPLETED|Study Period II||522
380115|NCT00337662|926733|P3|COMPLETED|Study Period II||0
380116|NCT00337662|926734|P2|COMPLETED|Study Period II||0
380117|NCT00337662|926735|P1|COMPLETED|Study Period II||0
380118|NCT00337662|926732|P4|STARTED|Study Period II||628
380119|NCT00337662|926733|P3|STARTED|Study Period II||0
380120|NCT00337662|926734|P2|STARTED|Study Period II||0
380121|NCT00337662|926735|P1|STARTED|Study Period II||0
380122|NCT00337610|926789|P2|NOT COMPLETED|Overall Study||14
380123|NCT00337610|926790|P1|NOT COMPLETED|Overall Study||17
380124|NCT00337610|926789|P2|COMPLETED|Overall Study||80
380125|NCT00337610|926790|P1|COMPLETED|Overall Study||79
380126|NCT00337610|926789|P2|Completed Week 18|Overall Study||82
380127|NCT00337610|926790|P1|Completed Week 18|Overall Study||89
380128|NCT00337610|926789|P2|STARTED|Overall Study||94
380129|NCT00337610|926790|P1|STARTED|Overall Study||96
380130|NCT00337571|926806|P4|NOT COMPLETED|Overall Study||7
380131|NCT00337571|926807|P3|NOT COMPLETED|Overall Study||10
380132|NCT00337571|926808|P2|NOT COMPLETED|Overall Study||9
380133|NCT00337571|926809|P1|NOT COMPLETED|Overall Study||14
380134|NCT00337571|926806|P4|COMPLETED|Overall Study||47
380135|NCT00337571|926807|P3|COMPLETED|Overall Study||49
380136|NCT00337571|926808|P2|COMPLETED|Overall Study||44
380137|NCT00337571|926809|P1|COMPLETED|Overall Study||38
380138|NCT00337571|926806|P4|STARTED|Overall Study||54
380139|NCT00337571|926807|P3|STARTED|Overall Study||59
380140|NCT00337571|926808|P2|STARTED|Overall Study||53
380141|NCT00337571|926809|P1|STARTED|Overall Study||52
380142|NCT00337467|926847|P1|NOT COMPLETED|Overall Study||10
380143|NCT00337467|926847|P1|COMPLETED|Overall Study||51
380144|NCT00337467|926847|P1|Discontinued Prior to Week 96|Overall Study|5 of these participants discontinued prior to Week 48|10
380145|NCT00337467|926847|P1|STARTED|Overall Study||61
380146|NCT00337428|926866|P2|NOT COMPLETED|Overall Study||3
380147|NCT00337428|926867|P1|NOT COMPLETED|Overall Study||4
380148|NCT00337428|926866|P2|COMPLETED|Overall Study||421
380149|NCT00337428|926867|P1|COMPLETED|Overall Study||415
380150|NCT00337428|926866|P2|STARTED|Overall Study||424
380151|NCT00337428|926867|P1|STARTED|Overall Study||419
380152|NCT00337350|926907|P2|NOT COMPLETED|Overall Study||1
380153|NCT00337350|926908|P1|NOT COMPLETED|Overall Study||1
380154|NCT00337350|926907|P2|COMPLETED|Overall Study||10
380155|NCT00337350|926908|P1|COMPLETED|Overall Study||8
380156|NCT00337350|926907|P2|STARTED|Overall Study||11
380157|NCT00337350|926908|P1|STARTED|Overall Study||9
380158|NCT00337285|926918|P1|NOT COMPLETED|Overall Study||158
380159|NCT00337285|926918|P1|COMPLETED|Overall Study||191
380160|NCT00337285|926918|P1|STARTED|Overall Study||349
380161|NCT00337272|926926|P2|NOT COMPLETED|Withdrawal Period||1
380162|NCT00337272|926927|P1|NOT COMPLETED|Withdrawal Period||0
380163|NCT00337272|926926|P2|COMPLETED|Withdrawal Period||6
380164|NCT00337272|926927|P1|COMPLETED|Withdrawal Period||6
380165|NCT00337272|926926|P2|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|7
380166|NCT00337272|926927|P1|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|6
380167|NCT00337272|926926|P2|NOT COMPLETED|Treatment Period||2
380168|NCT00337272|926927|P1|NOT COMPLETED|Treatment Period||1
380169|NCT00337272|926926|P2|COMPLETED|Treatment Period||7
380170|NCT00337272|926927|P1|COMPLETED|Treatment Period||6
380171|NCT00337272|926926|P2|Randomization|Treatment Period||9
380172|NCT00337272|926927|P1|Randomization|Treatment Period||7
380173|NCT00337272|926926|P2|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|9
380174|NCT00337272|926927|P1|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|7
380175|NCT00337272|926926|P2|NOT COMPLETED|Screening Period (Pre-randomization)||0
380176|NCT00337272|926927|P1|NOT COMPLETED|Screening Period (Pre-randomization)||6
380177|NCT00337272|926926|P2|COMPLETED|Screening Period (Pre-randomization)||0
380178|NCT00337272|926927|P1|COMPLETED|Screening Period (Pre-randomization)|16 subjects completed the screening period and were eligible for randomization.|16
380179|NCT00337272|926926|P2|STARTED|Screening Period (Pre-randomization)||0
380180|NCT00337272|926927|P1|STARTED|Screening Period (Pre-randomization)|22 subjects were consented. All subjects received placebo during the 2 week screening period.|22
380181|NCT00337207|926947|P1|NOT COMPLETED|Overall Study||3
380182|NCT00337207|926947|P1|COMPLETED|Overall Study||52
380183|NCT00337207|926947|P1|STARTED|Overall Study||55
380184|NCT00337194|926955|P2|NOT COMPLETED|Overall Study||4
380185|NCT00337194|926956|P1|NOT COMPLETED|Overall Study||12
380186|NCT00337194|926955|P2|COMPLETED|Overall Study||3
380187|NCT00337194|926956|P1|COMPLETED|Overall Study||11
380188|NCT00337194|926955|P2|STARTED|Overall Study||7
380189|NCT00337194|926956|P1|STARTED|Overall Study||23
380190|NCT00337181|926973|P2|NOT COMPLETED|Overall Study||0
380191|NCT00337181|926974|P1|NOT COMPLETED|Overall Study||0
380192|NCT00337181|926973|P2|COMPLETED|Overall Study||65
380193|NCT00337181|926974|P1|COMPLETED|Overall Study||49
380194|NCT00337181|926973|P2|STARTED|Overall Study||65
380195|NCT00337181|926974|P1|STARTED|Overall Study||49
380196|NCT00337168|926980|P1|NOT COMPLETED|Overall Study||8
380197|NCT00337168|926980|P1|COMPLETED|Overall Study||29
380198|NCT00337168|926980|P1|Eligible and Treated|Overall Study||36
380199|NCT00337168|926980|P1|Eligible|Overall Study||37
380200|NCT00337168|926980|P1|STARTED|Overall Study||37
380201|NCT00337129|926987|P1|NOT COMPLETED|Overall Study||40
380202|NCT00337129|926987|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until discontinuation criterion is met.|0
380203|NCT00337129|926987|P1|STARTED|Overall Study||40
380204|NCT00337103|926996|P2|NOT COMPLETED|Overall Study||543
380205|NCT00337103|926997|P1|NOT COMPLETED|Overall Study||549
380206|NCT00337103|926996|P2|COMPLETED|Overall Study||5
380207|NCT00337103|926997|P1|COMPLETED|Overall Study||5
380208|NCT00337103|926996|P2|STARTED|Overall Study||548
380209|NCT00337103|926997|P1|STARTED|Overall Study||554
380210|NCT00337077|927008|P3|NOT COMPLETED|Overall Study||25
380211|NCT00337077|927009|P2|NOT COMPLETED|Overall Study||53
380212|NCT00337077|927010|P1|NOT COMPLETED|Overall Study||43
380213|NCT00337077|927008|P3|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
380214|NCT00337077|927009|P2|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
380215|NCT00337077|927010|P1|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
380216|NCT00337077|927008|P3|Patients With Measurable Disease|Overall Study||13
380217|NCT00337077|927009|P2|Patients With Measurable Disease|Overall Study||38
380218|NCT00337077|927010|P1|Patients With Measurable Disease|Overall Study||26
380219|NCT00337077|927008|P3|Eligible and Treated|Overall Study||24
380220|NCT00337077|927009|P2|Eligible and Treated|Overall Study||51
380221|NCT00337077|927010|P1|Eligible and Treated|Overall Study||41
380222|NCT00337077|927008|P3|Toxicity Assessed|Overall Study||25
380223|NCT00337077|927009|P2|Toxicity Assessed|Overall Study||51
380224|NCT00337077|927010|P1|Toxicity Assessed|Overall Study||42
380225|NCT00337077|927008|P3|Treated|Overall Study||25
380226|NCT00337077|927009|P2|Treated|Overall Study||52
380227|NCT00337077|927010|P1|Treated|Overall Study||42
380228|NCT00337077|927008|P3|STARTED|Overall Study||25
380229|NCT00337077|927009|P2|STARTED|Overall Study||53
380230|NCT00337077|927010|P1|STARTED|Overall Study||43
380231|NCT00336973|927019|P1|NOT COMPLETED|Overall Study||33
380232|NCT00336973|927019|P1|COMPLETED|Overall Study||33
380233|NCT00336973|927019|P1|STARTED|Overall Study||66
380234|NCT00336895|927025|P1|NOT COMPLETED|Overall Study||4
380235|NCT00336895|927025|P1|COMPLETED|Overall Study||26
380236|NCT00336895|927025|P1|STARTED|Overall Study||30
380237|NCT00336856|927031|P1|NOT COMPLETED|Overall Study||4
380238|NCT00336856|927031|P1|COMPLETED|Overall Study||31
380239|NCT00336856|927031|P1|STARTED|Overall Study|Number of patients consented and registered for the study|35
380240|NCT00336817|927039|P2|NOT COMPLETED|Overall Study||2
380241|NCT00336817|927040|P1|NOT COMPLETED|Overall Study||1
380242|NCT00336817|927039|P2|COMPLETED|Overall Study||13
380243|NCT00336817|927040|P1|COMPLETED|Overall Study||14
380244|NCT00336817|927039|P2|STARTED|Overall Study||15
380245|NCT00336817|927040|P1|STARTED|Overall Study||15
380246|NCT00336700|927070|P1|NOT COMPLETED|Overall Study||0
380247|NCT00336700|927070|P1|COMPLETED|Overall Study||25
380248|NCT00336700|927070|P1|STARTED|Overall Study||25
380249|NCT00336583|927079|P1|NOT COMPLETED|Overall Study||2
380250|NCT00336583|927079|P1|COMPLETED|Overall Study||25
380251|NCT00336583|927079|P1|STARTED|Overall Study||27
380252|NCT00336544|927086|P2|NOT COMPLETED|Overall Study||22
380253|NCT00336544|927087|P1|NOT COMPLETED|Overall Study||19
380254|NCT00336544|927086|P2|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|238
380255|NCT00336544|927087|P1|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|242
380256|NCT00336544|927086|P2|STARTED|Overall Study|All subjects who were randomized and dosed.|260
380257|NCT00336544|927087|P1|STARTED|Overall Study|All subjects who were randomized and dosed.|261
380258|NCT00336505|927101|P2|NOT COMPLETED|Overall Study||27
380259|NCT00336505|927102|P1|NOT COMPLETED|Overall Study||37
380260|NCT00336505|927101|P2|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|264
380261|NCT00336505|927102|P1|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|254
380262|NCT00336505|927101|P2|STARTED|Overall Study|All subjects who were randomized and dosed.|291
380263|NCT00336505|927102|P1|STARTED|Overall Study|All subjects who were randomized and dosed.|291
380264|NCT00336492|927117|P3|NOT COMPLETED|Overall Study||11
380265|NCT00336492|927118|P2|NOT COMPLETED|Overall Study||4
380266|NCT00336492|927119|P1|NOT COMPLETED|Overall Study||15
380267|NCT00336492|927117|P3|COMPLETED|Overall Study||12
380268|NCT00336492|927118|P2|COMPLETED|Overall Study||18
380269|NCT00336492|927119|P1|COMPLETED|Overall Study||0
380270|NCT00336492|927117|P3|STARTED|Overall Study||23
380271|NCT00336492|927118|P2|STARTED|Overall Study||22
380272|NCT00336492|927119|P1|STARTED|Overall Study||15
380273|NCT00336479|927131|P4|NOT COMPLETED|Overall Study||4
380274|NCT00336479|927132|P3|NOT COMPLETED|Overall Study||26
380275|NCT00336479|927133|P2|NOT COMPLETED|Overall Study||25
380276|NCT00336479|927134|P1|NOT COMPLETED|Overall Study||37
380277|NCT00336479|927131|P4|COMPLETED|Overall Study||13
380278|NCT00336479|927132|P3|COMPLETED|Overall Study||53
380279|NCT00336479|927133|P2|COMPLETED|Overall Study||54
380280|NCT00336479|927134|P1|COMPLETED|Overall Study||38
380281|NCT00336479|927131|P4|STARTED|Overall Study||17
380282|NCT00336479|927132|P3|STARTED|Overall Study||79
380283|NCT00336479|927133|P2|STARTED|Overall Study||79
380284|NCT00336479|927134|P1|STARTED|Overall Study||75
380285|NCT00336323|927162|P5|NOT COMPLETED|Overall Study||3
380286|NCT00336323|927163|P4|NOT COMPLETED|Overall Study||0
380287|NCT00336323|927164|P3|NOT COMPLETED|Overall Study||1
380288|NCT00336323|927165|P2|NOT COMPLETED|Overall Study||1
380289|NCT00336323|927166|P1|NOT COMPLETED|Overall Study||0
380290|NCT00336323|927162|P5|COMPLETED|Overall Study||19
380291|NCT00336323|927163|P4|COMPLETED|Overall Study||22
380292|NCT00336323|927164|P3|COMPLETED|Overall Study||23
380293|NCT00336323|927165|P2|COMPLETED|Overall Study||21
380294|NCT00336323|927166|P1|COMPLETED|Overall Study||19
380295|NCT00336323|927162|P5|24 Week Visit|Overall Study||19
380296|NCT00336323|927163|P4|24 Week Visit|Overall Study||22
380297|NCT00336323|927164|P3|24 Week Visit|Overall Study|1 patient was dropped from the study|22
380298|NCT00336323|927165|P2|24 Week Visit|Overall Study|1 patient was dropped from the study|20
380299|NCT00336323|927166|P1|24 Week Visit|Overall Study||18
380300|NCT00336323|927162|P5|18 Week Visit|Overall Study|1 patient was dropped from the study|18
380301|NCT00336323|927163|P4|18 Week Visit|Overall Study||21
380302|NCT00336323|927164|P3|18 Week Visit|Overall Study||23
380303|NCT00336323|927165|P2|18 Week Visit|Overall Study||22
380304|NCT00336323|927166|P1|18 Week Visit|Overall Study||19
380305|NCT00336323|927162|P5|12 Week Visit|Overall Study|1 patient was dropped from study|20
380306|NCT00336323|927163|P4|12 Week Visit|Overall Study||22
380307|NCT00336323|927164|P3|12 Week Visit|Overall Study||24
380308|NCT00336323|927165|P2|12 Week Visit|Overall Study||21
380309|NCT00336323|927166|P1|12 Week Visit|Overall Study||19
380310|NCT00336323|927162|P5|9 Week Visit|Overall Study||19
380311|NCT00336323|927163|P4|9 Week Visit|Overall Study||21
380312|NCT00336323|927164|P3|9 Week Visit|Overall Study||23
380313|NCT00336323|927165|P2|9 Week Visit|Overall Study||21
380314|NCT00336323|927166|P1|9 Week Visit|Overall Study||18
380315|NCT00336323|927162|P5|6 Week Visit|Overall Study|1 patient was dropped - injection was given late at 9 wks for one patient|20
380316|NCT00336323|927163|P4|6 Week Visit|Overall Study||22
380317|NCT00336323|927164|P3|6 Week Visit|Overall Study||24
380318|NCT00336323|927165|P2|6 Week Visit|Overall Study||22
380319|NCT00336323|927166|P1|6 Week Visit|Overall Study||18
380320|NCT00336323|927162|P5|3 Week Visit|Overall Study|Laser given late at six weeks for one patient|20
380321|NCT00336323|927163|P4|3 Week Visit|Overall Study||22
380322|NCT00336323|927164|P3|3 Week Visit|Overall Study||24
380323|NCT00336323|927165|P2|3 Week Visit|Overall Study||21
380324|NCT00336323|927166|P1|3 Week Visit|Overall Study||18
380325|NCT00336323|927162|P5|STARTED|Overall Study||22
380326|NCT00336323|927163|P4|STARTED|Overall Study||22
380327|NCT00336323|927164|P3|STARTED|Overall Study||24
380328|NCT00336323|927165|P2|STARTED|Overall Study||22
380329|NCT00336323|927166|P1|STARTED|Overall Study||19
380330|NCT00336284|927223|P2|NOT COMPLETED|Overall Study||151
380331|NCT00336284|927224|P1|NOT COMPLETED|Overall Study||236
380332|NCT00336284|927223|P2|COMPLETED|Overall Study||322
380333|NCT00336284|927224|P1|COMPLETED|Overall Study||741
380334|NCT00336284|927223|P2|STARTED|Overall Study||473
380335|NCT00336284|927224|P1|STARTED|Overall Study||977
380336|NCT00336232|927236|P1|NOT COMPLETED|High Vitamin K (500mcg Daily)||0
380337|NCT00336232|927236|P1|COMPLETED|High Vitamin K (500mcg Daily)||42
380338|NCT00336232|927236|P1|STARTED|High Vitamin K (500mcg Daily)||42
380339|NCT00336232|927236|P1|NOT COMPLETED|Low Vitamin K (10mcg Daily)||0
380340|NCT00336232|927236|P1|COMPLETED|Low Vitamin K (10mcg Daily)||42
380341|NCT00336232|927236|P1|STARTED|Low Vitamin K (10mcg Daily)||42
380342|NCT00336232|927236|P1|NOT COMPLETED|Baseline (200mcg Daily)||17
380343|NCT00336232|927236|P1|COMPLETED|Baseline (200mcg Daily)||42
380344|NCT00336232|927236|P1|STARTED|Baseline (200mcg Daily)||59
380345|NCT00336024|927242|P2|NOT COMPLETED|Overall Study||19
380346|NCT00336024|927243|P1|NOT COMPLETED|Overall Study||20
380347|NCT00336024|927242|P2|COMPLETED|Overall Study||26
380348|NCT00336024|927243|P1|COMPLETED|Overall Study||26
380349|NCT00336024|927242|P2|STARTED|Overall Study||45
380350|NCT00336024|927243|P1|STARTED|Overall Study||46
380351|NCT00335972|927277|P2|NOT COMPLETED|Overall Study||3
380352|NCT00335972|927278|P1|NOT COMPLETED|Overall Study||0
380353|NCT00335972|927277|P2|COMPLETED|Overall Study||68
380354|NCT00335972|927278|P1|COMPLETED|Overall Study||71
380355|NCT00335972|927277|P2|STARTED|Overall Study||71
380356|NCT00335972|927278|P1|STARTED|Overall Study||71
380357|NCT00335959|927288|P1|NOT COMPLETED|Overall Study||3
380358|NCT00335959|927288|P1|COMPLETED|Overall Study||4
380359|NCT00335959|927288|P1|Eligible and Began Protocol Therapy|Overall Study||6
380360|NCT00335959|927288|P1|Eligible|Overall Study||6
380361|NCT00335959|927288|P1|STARTED|Overall Study||7
380362|NCT00335829|927293|P1|NOT COMPLETED|Overall Study||3
380363|NCT00335829|927293|P1|COMPLETED|Overall Study||23
380364|NCT00335829|927293|P1|Received First TACE|Overall Study|1 patient left after receiving bevacizumab but prior to first TACE|25
380365|NCT00335829|927293|P1|Received Bevacizumab|Overall Study||26
380366|NCT00335829|927293|P1|STARTED|Overall Study||26
380367|NCT00335777|927307|P1|NOT COMPLETED|Treated 2 Headaches Per Protocol||13
380368|NCT00335777|927307|P1|COMPLETED|Treated 2 Headaches Per Protocol||22
380369|NCT00335777|927307|P1|STARTED|Treated 2 Headaches Per Protocol||35
380370|NCT00335777|927307|P1|NOT COMPLETED|Enrolled and Dispensed Study Medication||29
380371|NCT00335777|927307|P1|COMPLETED|Enrolled and Dispensed Study Medication||35
380372|NCT00335777|927307|P1|STARTED|Enrolled and Dispensed Study Medication|64 subjects enrolled. 35 treated 2 headaches, but 22/35 at appropriate times, as per protocol.|64
380373|NCT00335764|927317|P5|NOT COMPLETED|Overall Study||1
380374|NCT00335764|927318|P4|NOT COMPLETED|Overall Study||0
380375|NCT00335764|927319|P3|NOT COMPLETED|Overall Study||0
380376|NCT00335764|927320|P2|NOT COMPLETED|Overall Study||0
380377|NCT00335764|927321|P1|NOT COMPLETED|Overall Study||1
380378|NCT00335764|927317|P5|COMPLETED|Overall Study||18
380379|NCT00335764|927318|P4|COMPLETED|Overall Study||19
380380|NCT00335764|927319|P3|COMPLETED|Overall Study||24
380381|NCT00335764|927320|P2|COMPLETED|Overall Study||13
380382|NCT00335764|927321|P1|COMPLETED|Overall Study||16
380383|NCT00335764|927317|P5|STARTED|Overall Study||19
380384|NCT00335764|927318|P4|STARTED|Overall Study||19
380385|NCT00335764|927319|P3|STARTED|Overall Study||24
380386|NCT00335764|927320|P2|STARTED|Overall Study||13
380387|NCT00335764|927321|P1|STARTED|Overall Study||17
380388|NCT00335738|927370|P2|NOT COMPLETED|Overall Study||4
380389|NCT00335738|927371|P1|NOT COMPLETED|Overall Study||11
380390|NCT00335738|927370|P2|COMPLETED|Overall Study||219
380391|NCT00335738|927371|P1|COMPLETED|Overall Study||97
380392|NCT00335738|927370|P2|STARTED|Overall Study||223
380393|NCT00335738|927371|P1|STARTED|Overall Study||108
380394|NCT00335725|927388|P2|NOT COMPLETED|Overall Study||5
380395|NCT00335725|927389|P1|NOT COMPLETED|Overall Study||4
380396|NCT00335725|927388|P2|COMPLETED|Overall Study||71
380397|NCT00335725|927389|P1|COMPLETED|Overall Study||71
380398|NCT00335725|927388|P2|STARTED|Overall Study||76
380399|NCT00335725|927389|P1|STARTED|Overall Study||75
380400|NCT00335556|927403|P6|NOT COMPLETED|Overall Study||1
380401|NCT00335556|927404|P5|NOT COMPLETED|Overall Study||1
380402|NCT00335556|927405|P4|NOT COMPLETED|Overall Study||5
380403|NCT00335556|927406|P3|NOT COMPLETED|Overall Study||5
380404|NCT00335556|927407|P2|NOT COMPLETED|Overall Study||34
380405|NCT00335556|927408|P1|NOT COMPLETED|Overall Study||2
380406|NCT00335556|927403|P6|COMPLETED|Overall Study||29
380407|NCT00335556|927404|P5|COMPLETED|Overall Study||77
380408|NCT00335556|927405|P4|COMPLETED|Overall Study||5
380409|NCT00335556|927406|P3|COMPLETED|Overall Study||2
380410|NCT00335556|927407|P2|COMPLETED|Overall Study||64
380411|NCT00335556|927408|P1|COMPLETED|Overall Study||66
380412|NCT00335556|927403|P6|STARTED|Overall Study||30
380413|NCT00335556|927404|P5|STARTED|Overall Study||78
380414|NCT00335556|927405|P4|STARTED|Overall Study||10
380415|NCT00335556|927406|P3|STARTED|Overall Study||7
380416|NCT00335556|927407|P2|STARTED|Overall Study||98
380417|NCT00335556|927408|P1|STARTED|Overall Study||68
380418|NCT00335517|927429|P1|NOT COMPLETED|Overall Study||2
380419|NCT00335517|927429|P1|COMPLETED|Overall Study|Due to pharmacy error two patients were enolled and recieved EREM, but were not included in analysis|98
380420|NCT00335517|927429|P1|STARTED|Overall Study||100
380421|NCT00335504|927437|P4|NOT COMPLETED|Overall Study||0
380422|NCT00335504|927438|P3|NOT COMPLETED|Overall Study||0
380423|NCT00335504|927439|P2|NOT COMPLETED|Overall Study||0
380424|NCT00335504|927440|P1|NOT COMPLETED|Overall Study||0
380425|NCT00335504|927437|P4|COMPLETED|Overall Study||22
380426|NCT00335504|927438|P3|COMPLETED|Overall Study||20
380427|NCT00335504|927439|P2|COMPLETED|Overall Study||21
380428|NCT00335504|927440|P1|COMPLETED|Overall Study||22
380429|NCT00335504|927437|P4|STARTED|Overall Study||22
380430|NCT00335504|927438|P3|STARTED|Overall Study||20
380431|NCT00335504|927439|P2|STARTED|Overall Study||21
380432|NCT00335504|927440|P1|STARTED|Overall Study||22
380433|NCT00335478|927462|P1|NOT COMPLETED|Overall Study||24
380434|NCT00335478|927462|P1|COMPLETED|Overall Study||30
380435|NCT00335478|927462|P1|STARTED|Overall Study||54
380436|NCT00335452|927470|P4|NOT COMPLETED|Overall Study||131
380437|NCT00335452|927471|P3|NOT COMPLETED|Overall Study||159
380438|NCT00335452|927472|P2|NOT COMPLETED|Overall Study||147
380439|NCT00335452|927473|P1|NOT COMPLETED|Overall Study||158
380440|NCT00335452|927470|P4|COMPLETED|Overall Study|Completed 30 days follow-up period|6122
380441|NCT00335452|927471|P3|COMPLETED|Overall Study|Completed 30 days follow-up period|6108
380442|NCT00335452|927472|P2|COMPLETED|Overall Study|Completed 30 days follow-up period|6107
380443|NCT00335452|927473|P1|COMPLETED|Overall Study|Completed 30 days follow-up period|6154
380444|NCT00335452|927470|P4|TREATED WITH ASA|Overall Study||6247
380445|NCT00335452|927471|P3|TREATED WITH ASA|Overall Study||6261
380446|NCT00335452|927472|P2|TREATED WITH ASA|Overall Study||6251
380447|NCT00335452|927473|P1|TREATED WITH ASA|Overall Study||6302
380448|NCT00335452|927470|P4|TREATED WITH CLOPIDOGREL|Overall Study||6217
380449|NCT00335452|927471|P3|TREATED WITH CLOPIDOGREL|Overall Study||6228
380450|NCT00335452|927472|P2|TREATED WITH CLOPIDOGREL|Overall Study||6218
380451|NCT00335452|927473|P1|TREATED WITH CLOPIDOGREL|Overall Study||6271
380452|NCT00335452|927470|P4|STARTED|Overall Study|Randomized|6253
380453|NCT00335452|927471|P3|STARTED|Overall Study|Randomized|6267
380454|NCT00335452|927472|P2|STARTED|Overall Study|Randomized|6254
380455|NCT00335452|927473|P1|STARTED|Overall Study|Randomized|6312
380456|NCT00335322|927498|P3|NOT COMPLETED|Overall Study||2
380457|NCT00335322|927499|P2|NOT COMPLETED|Overall Study||2
380458|NCT00335322|927500|P1|NOT COMPLETED|Overall Study||1
380459|NCT00335322|927498|P3|COMPLETED|Overall Study||103
380460|NCT00335322|927499|P2|COMPLETED|Overall Study||105
380461|NCT00335322|927500|P1|COMPLETED|Overall Study||114
380462|NCT00335322|927498|P3|STARTED|Overall Study||105
380463|NCT00335322|927499|P2|STARTED|Overall Study||107
380464|NCT00335322|927500|P1|STARTED|Overall Study||115
380465|NCT00335283|927513|P2|NOT COMPLETED|Overall Study||5
380466|NCT00335283|927514|P1|NOT COMPLETED|Overall Study||6
380467|NCT00335283|927513|P2|COMPLETED|Overall Study||34
380468|NCT00335283|927514|P1|COMPLETED|Overall Study||30
380469|NCT00335283|927513|P2|STARTED|Overall Study||39
380470|NCT00335283|927514|P1|STARTED|Overall Study||36
380471|NCT00335257|927529|P3|NOT COMPLETED|Overall Study||0
380472|NCT00335257|927530|P2|NOT COMPLETED|Overall Study||0
380473|NCT00335257|927531|P1|NOT COMPLETED|Overall Study||0
380474|NCT00335257|927529|P3|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|60190
380475|NCT00335257|927530|P2|COMPLETED|Overall Study||9377
380476|NCT00335257|927531|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|15542
380477|NCT00335257|927529|P3|STARTED|Overall Study||60190
380478|NCT00335257|927530|P2|STARTED|Overall Study||9377
380479|NCT00335257|927531|P1|STARTED|Overall Study||15542
380480|NCT00335153|927548|P1|NOT COMPLETED|Post-PEG-J Long-Term Treatment Period||52
380481|NCT00335153|927548|P1|COMPLETED|Post-PEG-J Long-Term Treatment Period||272
380482|NCT00335153|927548|P1|STARTED|Post-PEG-J Long-Term Treatment Period||324
380483|NCT00335153|927548|P1|NOT COMPLETED|Nasojejunal (NJ) Test Period||30
380484|NCT00335153|927548|P1|COMPLETED|Nasojejunal (NJ) Test Period||324
380485|NCT00335153|927548|P1|STARTED|Nasojejunal (NJ) Test Period||354
380486|NCT00335140|927585|P1|NOT COMPLETED|Overall Study||1
380487|NCT00335140|927585|P1|COMPLETED|Overall Study||25
380488|NCT00335140|927585|P1|Treated|Overall Study||25
380489|NCT00335140|927585|P1|Eligible|Overall Study||25
380490|NCT00335140|927585|P1|STARTED|Overall Study||26
380491|NCT00334958|927591|P2|NOT COMPLETED|Overall Study||24
380492|NCT00334958|927592|P1|NOT COMPLETED|Overall Study||37
380493|NCT00334958|927591|P2|COMPLETED|Overall Study||156
380494|NCT00334958|927592|P1|COMPLETED|Overall Study||139
380495|NCT00334958|927591|P2|STARTED|Overall Study|1 subject withdrawn prior to study drug dosing due to not obtaining labs|180
380496|NCT00334958|927592|P1|STARTED|Overall Study||176
380497|NCT00334893|927606|P2|NOT COMPLETED|Overall Study||0
380498|NCT00334893|927607|P1|NOT COMPLETED|Overall Study||1
380499|NCT00334893|927606|P2|COMPLETED|Overall Study||37
380500|NCT00334893|927607|P1|COMPLETED|Overall Study||36
380501|NCT00334893|927606|P2|STARTED|Overall Study||37
380502|NCT00334893|927607|P1|STARTED|Overall Study||37
380503|NCT00334815|927617|P2|NOT COMPLETED|Overall Study||10
380504|NCT00334815|927618|P1|NOT COMPLETED|Overall Study||7
380505|NCT00334815|927617|P2|COMPLETED|Overall Study||3
380506|NCT00334815|927618|P1|COMPLETED|Overall Study||9
380507|NCT00334815|927617|P2|STARTED|Overall Study||13
380508|NCT00334815|927618|P1|STARTED|Overall Study||16
380509|NCT00334802|927632|P2|NOT COMPLETED|Overall Study||40
380510|NCT00334802|927633|P1|NOT COMPLETED|Overall Study||6
380511|NCT00334802|927632|P2|COMPLETED|Overall Study||16
380512|NCT00334802|927633|P1|COMPLETED|Overall Study||0
380513|NCT00334802|927632|P2|STARTED|Overall Study||56
380514|NCT00334802|927633|P1|STARTED|Overall Study||6
380515|NCT00334737|927653|P3|NOT COMPLETED|Follow up Phase||6
380516|NCT00334737|927654|P2|NOT COMPLETED|Follow up Phase||3
380517|NCT00334737|927655|P1|NOT COMPLETED|Follow up Phase||5
380518|NCT00334737|927653|P3|COMPLETED|Follow up Phase||24
380519|NCT00334737|927654|P2|COMPLETED|Follow up Phase||29
380520|NCT00334737|927655|P1|COMPLETED|Follow up Phase||27
380521|NCT00334737|927653|P3|STARTED|Follow up Phase||30
380522|NCT00334737|927654|P2|STARTED|Follow up Phase||32
380523|NCT00334737|927655|P1|STARTED|Follow up Phase||32
380524|NCT00334737|927653|P3|NOT COMPLETED|Hospital Phase||4
380525|NCT00334737|927654|P2|NOT COMPLETED|Hospital Phase||2
380526|NCT00334737|927655|P1|NOT COMPLETED|Hospital Phase||2
380527|NCT00334737|927653|P3|COMPLETED|Hospital Phase||30
380528|NCT00334737|927654|P2|COMPLETED|Hospital Phase||32
380529|NCT00334737|927655|P1|COMPLETED|Hospital Phase||32
380530|NCT00334737|927653|P3|STARTED|Hospital Phase||34
380531|NCT00334737|927654|P2|STARTED|Hospital Phase||34
380532|NCT00334737|927655|P1|STARTED|Hospital Phase||34
380533|NCT00334633|927690|P3|NOT COMPLETED|Overall Study||82
380534|NCT00334633|927691|P2|NOT COMPLETED|Overall Study||82
380535|NCT00334633|927692|P1|NOT COMPLETED|Overall Study||80
380536|NCT00334633|927690|P3|COMPLETED|Overall Study||114
380537|NCT00334633|927691|P2|COMPLETED|Overall Study||118
380538|NCT00334633|927692|P1|COMPLETED|Overall Study||117
380539|NCT00334633|927690|P3|STARTED|Overall Study||196
380540|NCT00334633|927691|P2|STARTED|Overall Study||200
380541|NCT00334633|927692|P1|STARTED|Overall Study||197
380542|NCT00334542|927703|P1|NOT COMPLETED|Overall Study||5
380543|NCT00334542|927703|P1|COMPLETED|Overall Study||45
380544|NCT00334542|927703|P1|STARTED|Overall Study||50
380545|NCT00334295|927710|P1|NOT COMPLETED|Overall Study||5
380546|NCT00334295|927710|P1|COMPLETED|Overall Study||30
380547|NCT00334295|927710|P1|STARTED|Overall Study||35
380548|NCT00334282|927720|P2|NOT COMPLETED|Overall Study||108
380549|NCT00334282|927721|P1|NOT COMPLETED|Overall Study||222
380550|NCT00334282|927720|P2|COMPLETED|Overall Study||37
380551|NCT00334282|927721|P1|COMPLETED|Overall Study||68
380552|NCT00334282|927720|P2|STARTED|Overall Study||145
380553|NCT00334282|927721|P1|STARTED|Overall Study||290
380554|NCT00334204|927744|P1|NOT COMPLETED|Overall Study||2
380555|NCT00334204|927744|P1|COMPLETED|Overall Study||56
380556|NCT00334204|927744|P1|STARTED|Overall Study||58
380557|NCT00334113|927752|P2|NOT COMPLETED|Overall Study||3
380558|NCT00334113|927753|P1|NOT COMPLETED|Overall Study||2
380559|NCT00334113|927752|P2|COMPLETED|Overall Study||31
380560|NCT00334113|927753|P1|COMPLETED|Overall Study||30
380561|NCT00334113|927752|P2|STARTED|Overall Study||34
380562|NCT00334113|927753|P1|STARTED|Overall Study||32
380563|NCT00334074|927759|P1|NOT COMPLETED|Overall Study||0
380564|NCT00334074|927759|P1|COMPLETED|Overall Study||30
380565|NCT00334074|927759|P1|STARTED|Overall Study||30
380566|NCT00334061|927764|P1|NOT COMPLETED|Overall Study||0
380567|NCT00334061|927764|P1|COMPLETED|Overall Study|November 2007|125
380568|NCT00334061|927764|P1|STARTED|Overall Study|June 2006|125
380569|NCT00333983|927776|P3|NOT COMPLETED|Overall Study||2
380570|NCT00333983|927777|P2|NOT COMPLETED|Overall Study||5
380571|NCT00333983|927778|P1|NOT COMPLETED|Overall Study||3
380572|NCT00333983|927776|P3|COMPLETED|Overall Study||19
380573|NCT00333983|927777|P2|COMPLETED|Overall Study||16
380574|NCT00333983|927778|P1|COMPLETED|Overall Study||17
380575|NCT00333983|927776|P3|STARTED|Overall Study||21
380576|NCT00333983|927777|P2|STARTED|Overall Study||21
380577|NCT00333983|927778|P1|STARTED|Overall Study||20
380578|NCT00333970|927788|P2|NOT COMPLETED|Overall Study||7
380579|NCT00333970|927789|P1|NOT COMPLETED|Overall Study||13
380580|NCT00333970|927788|P2|COMPLETED|Overall Study||18
380581|NCT00333970|927789|P1|COMPLETED|Overall Study||37
380582|NCT00333970|927788|P2|STARTED|Overall Study||25
380583|NCT00333970|927789|P1|STARTED|Overall Study||50
380584|NCT00333879|927795|P1|NOT COMPLETED|Overall Study||0
380585|NCT00333879|927795|P1|COMPLETED|Overall Study||4
380586|NCT00333879|927795|P1|STARTED|Overall Study||4
380587|NCT00333866|927804|P4|NOT COMPLETED|Overall Study||66
380588|NCT00333866|927805|P3|NOT COMPLETED|Overall Study||51
380589|NCT00333866|927806|P2|NOT COMPLETED|Overall Study||64
380590|NCT00333866|927807|P1|NOT COMPLETED|Overall Study||48
380591|NCT00333866|927804|P4|COMPLETED|Overall Study||121
380592|NCT00333866|927805|P3|COMPLETED|Overall Study||133
380593|NCT00333866|927806|P2|COMPLETED|Overall Study||123
380594|NCT00333866|927807|P1|COMPLETED|Overall Study||141
380595|NCT00333866|927804|P4|TREATED|Overall Study||186
380596|NCT00333866|927805|P3|TREATED|Overall Study||182
380597|NCT00333866|927806|P2|TREATED|Overall Study||184
380598|NCT00333866|927807|P1|TREATED|Overall Study||184
380599|NCT00333866|927804|P4|STARTED|Overall Study||187
380600|NCT00333866|927805|P3|STARTED|Overall Study||184
380601|NCT00333866|927806|P2|STARTED|Overall Study||187
380602|NCT00333866|927807|P1|STARTED|Overall Study||189
380603|NCT00333840|927867|P4|NOT COMPLETED|Second-line Treatment Period||188
380604|NCT00333840|927868|P3|NOT COMPLETED|Second-line Treatment Period||14
380605|NCT00333840|927869|P2|NOT COMPLETED|Second-line Treatment Period||0
380606|NCT00333840|927870|P1|NOT COMPLETED|Second-line Treatment Period||0
380607|NCT00333840|927867|P4|COMPLETED|Second-line Treatment Period||175
380608|NCT00333840|927868|P3|COMPLETED|Second-line Treatment Period||0
380609|NCT00333840|927869|P2|COMPLETED|Second-line Treatment Period||0
380610|NCT00333840|927870|P1|COMPLETED|Second-line Treatment Period||0
380611|NCT00333840|927867|P4|STARTED|Second-line Treatment Period||363
380612|NCT00333840|927868|P3|STARTED|Second-line Treatment Period||14
380613|NCT00333840|927869|P2|STARTED|Second-line Treatment Period||0
380614|NCT00333840|927870|P1|STARTED|Second-line Treatment Period||0
380615|NCT00333840|927867|P4|NOT COMPLETED|First-line Treatment Period||0
380616|NCT00333840|927868|P3|NOT COMPLETED|First-line Treatment Period||0
380617|NCT00333840|927869|P2|NOT COMPLETED|First-line Treatment Period||546
380618|NCT00333840|927870|P1|NOT COMPLETED|First-line Treatment Period||286
380619|NCT00333840|927867|P4|COMPLETED|First-line Treatment Period||0
380620|NCT00333840|927868|P3|COMPLETED|First-line Treatment Period||0
380621|NCT00333840|927869|P2|COMPLETED|First-line Treatment Period||7
380622|NCT00333840|927870|P1|COMPLETED|First-line Treatment Period||267
380623|NCT00333840|927867|P4|Safety Population; Received Study Drug|First-line Treatment Period||0
380624|NCT00333840|927868|P3|Safety Population; Received Study Drug|First-line Treatment Period||0
380625|NCT00333840|927869|P2|Safety Population; Received Study Drug|First-line Treatment Period||533
380626|NCT00333840|927870|P1|Safety Population; Received Study Drug|First-line Treatment Period||551
380627|NCT00333840|927867|P4|STARTED|First-line Treatment Period||0
380628|NCT00333840|927868|P3|STARTED|First-line Treatment Period||0
380629|NCT00333840|927869|P2|STARTED|First-line Treatment Period||553
380630|NCT00333840|927870|P1|STARTED|First-line Treatment Period||553
380631|NCT00333814|927898|P3|NOT COMPLETED|Overall Study||5
380632|NCT00333814|927899|P2|NOT COMPLETED|Overall Study||4
380633|NCT00333814|927900|P1|NOT COMPLETED|Overall Study||3
380634|NCT00333814|927898|P3|COMPLETED|Overall Study||71
380635|NCT00333814|927899|P2|COMPLETED|Overall Study||73
380636|NCT00333814|927900|P1|COMPLETED|Overall Study||73
380637|NCT00333814|927898|P3|STARTED|Overall Study||76
380638|NCT00333814|927899|P2|STARTED|Overall Study||77
380639|NCT00333814|927900|P1|STARTED|Overall Study||76
380640|NCT00333801|927916|P2|NOT COMPLETED|Overall Study||6
380641|NCT00333801|927917|P1|NOT COMPLETED|Overall Study||8
380642|NCT00333801|927916|P2|COMPLETED|Overall Study||36
380643|NCT00333801|927917|P1|COMPLETED|Overall Study||35
380644|NCT00333801|927916|P2|STARTED|Overall Study||42
380645|NCT00333801|927917|P1|STARTED|Overall Study||43
380646|NCT00333788|927935|P1|NOT COMPLETED|Overall Study||162
380647|NCT00333788|927935|P1|COMPLETED|Overall Study||71
380648|NCT00333788|927935|P1|STARTED|Overall Study|Participant flow based on All Subjects population; Baseline characteristics based on ITT population.|233
380649|NCT00333775|927965|P3|NOT COMPLETED|Overall Study||247
380650|NCT00333775|927966|P2|NOT COMPLETED|Overall Study||248
380651|NCT00333775|927967|P1|NOT COMPLETED|Overall Study||241
380652|NCT00333775|927965|P3|COMPLETED|Overall Study||0
380653|NCT00333775|927966|P2|COMPLETED|Overall Study||0
380654|NCT00333775|927967|P1|COMPLETED|Overall Study||0
380655|NCT00333775|927965|P3|Received Treatment|Overall Study||245
380656|NCT00333775|927966|P2|Received Treatment|Overall Study||247
380657|NCT00333775|927967|P1|Received Treatment|Overall Study||238
380658|NCT00333775|927965|P3|STARTED|Overall Study||247
380659|NCT00333775|927966|P2|STARTED|Overall Study||248
380660|NCT00333775|927967|P1|STARTED|Overall Study||241
380661|NCT00333762|927987|P1|NOT COMPLETED|Overall Study||4
380662|NCT00333762|927987|P1|COMPLETED|Overall Study||0
380663|NCT00333762|927987|P1|STARTED|Overall Study||4
380664|NCT00333710|927994|P3|NOT COMPLETED|Overall Study||1
380665|NCT00333710|927995|P2|NOT COMPLETED|Overall Study||4
380666|NCT00333710|927996|P1|NOT COMPLETED|Overall Study||11
380667|NCT00333710|927994|P3|COMPLETED|Overall Study||15
380668|NCT00333710|927995|P2|COMPLETED|Overall Study||14
380669|NCT00333710|927996|P1|COMPLETED|Overall Study||8
380670|NCT00333710|927994|P3|STARTED|Overall Study||16
380671|NCT00333710|927995|P2|STARTED|Overall Study||18
380672|NCT00333710|927996|P1|STARTED|Overall Study||19
380673|NCT00333619|928006|P2|NOT COMPLETED|Overall Study||10
380674|NCT00333619|928007|P1|NOT COMPLETED|Overall Study||21
380675|NCT00333619|928006|P2|COMPLETED|Overall Study||99
380676|NCT00333619|928007|P1|COMPLETED|Overall Study||89
380677|NCT00333619|928006|P2|3-month Follow-up|Overall Study||105
380678|NCT00333619|928007|P1|3-month Follow-up|Overall Study||101
380679|NCT00333619|928006|P2|Post-treatment|Overall Study||109
380680|NCT00333619|928007|P1|Post-treatment|Overall Study||109
380681|NCT00333619|928006|P2|STARTED|Overall Study||109
380682|NCT00333619|928007|P1|STARTED|Overall Study||110
380683|NCT00333606|928017|P2|NOT COMPLETED|Overall Study||0
380684|NCT00333606|928018|P1|NOT COMPLETED|Overall Study||0
380685|NCT00333606|928017|P2|COMPLETED|Overall Study||30
380686|NCT00333606|928018|P1|COMPLETED|Overall Study||30
380687|NCT00333606|928017|P2|STARTED|Overall Study||30
380688|NCT00333606|928018|P1|STARTED|Overall Study||30
380689|NCT00333437|928026|P1|NOT COMPLETED|Overall Study||0
380690|NCT00333437|928026|P1|COMPLETED|Overall Study||7
380691|NCT00333437|928026|P1|STARTED|Overall Study||7
380692|NCT00333359|928036|P2|NOT COMPLETED|Overall Study||122
380693|NCT00333359|928037|P1|NOT COMPLETED|Overall Study||73
380694|NCT00333359|928036|P2|COMPLETED|Overall Study||260
380695|NCT00333359|928037|P1|COMPLETED|Overall Study||126
380696|NCT00333359|928036|P2|STARTED|Overall Study||382
380697|NCT00333359|928037|P1|STARTED|Overall Study||199
380698|NCT00333229|928080|P2|NOT COMPLETED|Overall Study||1
380699|NCT00333229|928081|P1|NOT COMPLETED|Overall Study||0
380700|NCT00333229|928080|P2|COMPLETED|Overall Study||4
380701|NCT00333229|928081|P1|COMPLETED|Overall Study||6
380702|NCT00333229|928080|P2|STARTED|Overall Study||5
380703|NCT00333229|928081|P1|STARTED|Overall Study||6
380704|NCT00333138|928098|P3|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
380705|NCT00333138|928099|P2|NOT COMPLETED|Extension Study (Month6 to End of Study)||42
380706|NCT00333138|928100|P1|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
380707|NCT00333138|928098|P3|COMPLETED|Extension Study (Month6 to End of Study)||37
380708|NCT00333138|928099|P2|COMPLETED|Extension Study (Month6 to End of Study)||45
380709|NCT00333138|928100|P1|COMPLETED|Extension Study (Month6 to End of Study)||40
380710|NCT00333138|928098|P3|STARTED|Extension Study (Month6 to End of Study)||80
380711|NCT00333138|928099|P2|STARTED|Extension Study (Month6 to End of Study)||87
380712|NCT00333138|928100|P1|STARTED|Extension Study (Month6 to End of Study)||83
380713|NCT00333138|928098|P3|NOT COMPLETED|Core Study (6 Months)||12
380714|NCT00333138|928099|P2|NOT COMPLETED|Core Study (6 Months)||6
380715|NCT00333138|928100|P1|NOT COMPLETED|Core Study (6 Months)||7
380716|NCT00333138|928098|P3|COMPLETED|Core Study (6 Months)||82
380717|NCT00333138|928099|P2|COMPLETED|Core Study (6 Months)||88
380718|NCT00333138|928100|P1|COMPLETED|Core Study (6 Months)||86
380719|NCT00333138|928098|P3|STARTED|Core Study (6 Months)||94
380720|NCT00333138|928099|P2|STARTED|Core Study (6 Months)||94
380721|NCT00333138|928100|P1|STARTED|Core Study (6 Months)||93
380722|NCT00332839|928139|P2|NOT COMPLETED|Follow-up (Months 12 - 60)||3
380723|NCT00332839|928140|P1|NOT COMPLETED|Follow-up (Months 12 - 60)||4
380724|NCT00332839|928139|P2|COMPLETED|Follow-up (Months 12 - 60)||31
380725|NCT00332839|928140|P1|COMPLETED|Follow-up (Months 12 - 60)||29
380726|NCT00332839|928139|P2|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|34
380727|NCT00332839|928140|P1|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|33
380728|NCT00332839|928139|P2|NOT COMPLETED|Core (Months 0 - 12)||18
380729|NCT00332839|928140|P1|NOT COMPLETED|Core (Months 0 - 12)||10
380730|NCT00332839|928139|P2|COMPLETED|Core (Months 0 - 12)||28
380731|NCT00332839|928140|P1|COMPLETED|Core (Months 0 - 12)||37
380732|NCT00332839|928139|P2|Safety Set|Core (Months 0 - 12)||46
380733|NCT00332839|928140|P1|Safety Set|Core (Months 0 - 12)||47
380734|NCT00332839|928139|P2|STARTED|Core (Months 0 - 12)||46
380735|NCT00332839|928140|P1|STARTED|Core (Months 0 - 12)||47
380736|NCT00332722|928160|P2|NOT COMPLETED|Overall Study||0
380737|NCT00332722|928161|P1|NOT COMPLETED|Overall Study||0
380738|NCT00332722|928160|P2|COMPLETED|Overall Study||60
380739|NCT00332722|928161|P1|COMPLETED|Overall Study||60
380740|NCT00332722|928160|P2|STARTED|Overall Study||60
380741|NCT00332722|928161|P1|STARTED|Overall Study||60
380742|NCT00332709|928171|P2|NOT COMPLETED|Overall Study||20
380743|NCT00332709|928172|P1|NOT COMPLETED|Overall Study||16
380744|NCT00332709|928171|P2|COMPLETED|Overall Study||21
380745|NCT00332709|928172|P1|COMPLETED|Overall Study||24
380746|NCT00332709|928171|P2|STARTED|Overall Study||41
380747|NCT00332709|928172|P1|STARTED|Overall Study||40
380748|NCT00332696|928196|P2|NOT COMPLETED|Overall Study||30
380749|NCT00332696|928197|P1|NOT COMPLETED|Overall Study||30
380750|NCT00332696|928196|P2|COMPLETED|Overall Study||2
380751|NCT00332696|928197|P1|COMPLETED|Overall Study|Completed Month 3 Visit|2
380752|NCT00332696|928196|P2|Completed Day 14 Visit|Overall Study||15
380753|NCT00332696|928197|P1|Completed Day 14 Visit|Overall Study|Primary Endpoint|21
380754|NCT00332696|928196|P2|STARTED|Overall Study||32
380755|NCT00332696|928197|P1|STARTED|Overall Study||32
380756|NCT00332644|928229|P6|NOT COMPLETED|Overall Study||15
380757|NCT00332644|928230|P5|NOT COMPLETED|Overall Study||12
380758|NCT00332644|928231|P4|NOT COMPLETED|Overall Study||20
380759|NCT00332644|928232|P3|NOT COMPLETED|Overall Study||9
380760|NCT00332644|928233|P2|NOT COMPLETED|Overall Study||22
380761|NCT00332644|928234|P1|NOT COMPLETED|Overall Study||12
380762|NCT00332644|928229|P6|COMPLETED|Overall Study||174
380763|NCT00332644|928230|P5|COMPLETED|Overall Study||250
380764|NCT00332644|928231|P4|COMPLETED|Overall Study||244
380765|NCT00332644|928232|P3|COMPLETED|Overall Study||258
380766|NCT00332644|928233|P2|COMPLETED|Overall Study||238
380767|NCT00332644|928234|P1|COMPLETED|Overall Study||250
380768|NCT00332644|928229|P6|STARTED|Overall Study||189
380769|NCT00332644|928230|P5|STARTED|Overall Study||262
380770|NCT00332644|928231|P4|STARTED|Overall Study||264
380771|NCT00332644|928232|P3|STARTED|Overall Study||267
380772|NCT00332644|928233|P2|STARTED|Overall Study||260
380773|NCT00332644|928234|P1|STARTED|Overall Study||262
380774|NCT00332605|928251|P3|NOT COMPLETED|Overall Study||8
380775|NCT00332605|928252|P2|NOT COMPLETED|Overall Study||2
380776|NCT00332605|928253|P1|NOT COMPLETED|Overall Study||2
380777|NCT00332605|928251|P3|COMPLETED|Overall Study||9
380778|NCT00332605|928252|P2|COMPLETED|Overall Study||12
380779|NCT00332605|928253|P1|COMPLETED|Overall Study||12
380780|NCT00332605|928251|P3|STARTED|Overall Study||17
380781|NCT00332605|928252|P2|STARTED|Overall Study||14
380782|NCT00332605|928253|P1|STARTED|Overall Study||14
380783|NCT00332579|928263|P2|NOT COMPLETED|Overall Study||1
380784|NCT00332579|928264|P1|NOT COMPLETED|Overall Study||1
380785|NCT00332579|928263|P2|COMPLETED|Overall Study||12
380786|NCT00332579|928264|P1|COMPLETED|Overall Study||11
380787|NCT00332579|928263|P2|STARTED|Overall Study||13
380788|NCT00332579|928264|P1|STARTED|Overall Study||12
380789|NCT00332488|928273|P3|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||21
380790|NCT00332488|928274|P2|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||2
380791|NCT00332488|928275|P1|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||2
380792|NCT00332488|928273|P3|COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||233
380793|NCT00332488|928274|P2|COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||70
380794|NCT00332488|928275|P1|COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||27
380795|NCT00332488|928273|P3|STARTED|Transfer Treatment Phase (Weeks 12 – 24)|Subjects in this arm who met HbA1c criteria + subjects from other arms who did not|254
380796|NCT00332488|928274|P2|STARTED|Transfer Treatment Phase (Weeks 12 – 24)|Subjects on treatment who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|72
380797|NCT00332488|928275|P1|STARTED|Transfer Treatment Phase (Weeks 12 – 24)|Subjects on TI who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|29
380798|NCT00332488|928273|P3|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||56
380799|NCT00332488|928274|P2|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||18
380800|NCT00332488|928275|P1|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||50
380801|NCT00332488|928273|P3|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||119
380802|NCT00332488|928274|P2|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||152
380803|NCT00332488|928275|P1|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||133
380804|NCT00332488|928273|P3|STARTED|Initial Treatment Phase (Weeks 0 - 12)||175
380805|NCT00332488|928274|P2|STARTED|Initial Treatment Phase (Weeks 0 - 12)||170
380806|NCT00332488|928275|P1|STARTED|Initial Treatment Phase (Weeks 0 - 12)||183
380807|NCT00332462|928287|P1|NOT COMPLETED|Overall Study||16
380808|NCT00332462|928287|P1|COMPLETED|Overall Study||18
380809|NCT00332462|928287|P1|Patients Treated With Sandimmun® Optoral|Overall Study||29
380810|NCT00332462|928287|P1|Patients Treated With Sandimmun® i.v.|Overall Study||34
380811|NCT00332462|928287|P1|STARTED|Overall Study|Safety and Intention to treat population.|34
380812|NCT00332332|928294|P1|NOT COMPLETED|Overall Study||68
380813|NCT00332332|928294|P1|COMPLETED|Overall Study||178
380814|NCT00332332|928294|P1|Received Study Medication|Overall Study||230
380815|NCT00332332|928294|P1|STARTED|Overall Study||246
380816|NCT00332241|928303|P2|NOT COMPLETED|Overall Study||8
380817|NCT00332241|928304|P1|NOT COMPLETED|Overall Study||15
380818|NCT00332241|928303|P2|COMPLETED|Overall Study||39
380819|NCT00332241|928304|P1|COMPLETED|Overall Study||36
380820|NCT00332241|928303|P2|STARTED|Overall Study||47
380821|NCT00332241|928304|P1|STARTED|Overall Study||51
380822|NCT00332202|928326|P2|NOT COMPLETED|Overall Study||125
380823|NCT00332202|928327|P1|NOT COMPLETED|Overall Study||241
380824|NCT00332202|928326|P2|COMPLETED|Overall Study||129
380825|NCT00332202|928327|P1|COMPLETED|Overall Study||263
380826|NCT00332202|928326|P2|Received At Least One Dose of Study Drug|Overall Study||249
380827|NCT00332202|928327|P1|Received At Least One Dose of Study Drug|Overall Study||493
380828|NCT00332202|928326|P2|STARTED|Overall Study||254
380829|NCT00332202|928327|P1|STARTED|Overall Study||504
380830|NCT00332189|928356|P1|NOT COMPLETED|Overall Study||21
380831|NCT00332189|928356|P1|COMPLETED|Overall Study|Subjects in this extension study continued until there was market approval in their region.|90
380832|NCT00332189|928356|P1|STARTED|Overall Study||111
380833|NCT00332163|928363|P2|NOT COMPLETED|Overall Study||0
380834|NCT00332163|928364|P1|NOT COMPLETED|Overall Study||0
380835|NCT00332163|928363|P2|COMPLETED|Overall Study||47
380836|NCT00332163|928364|P1|COMPLETED|Overall Study||48
380837|NCT00332163|928363|P2|Received Treatment|Overall Study||47
380838|NCT00332163|928364|P1|Received Treatment|Overall Study||48
380839|NCT00332163|928363|P2|STARTED|Overall Study||47
380840|NCT00332163|928364|P1|STARTED|Overall Study||48
380841|NCT00331864|928398|P2|NOT COMPLETED|Overall Study||4
380842|NCT00331864|928399|P1|NOT COMPLETED|Overall Study||58
380843|NCT00331864|928398|P2|COMPLETED|Overall Study||14
380844|NCT00331864|928399|P1|COMPLETED|Overall Study||455
380845|NCT00331864|928398|P2|STARTED|Overall Study||18
380846|NCT00331864|928399|P1|STARTED|Overall Study||513
380847|NCT00331799|928418|P1|NOT COMPLETED|Overall Study||3
380848|NCT00331799|928418|P1|COMPLETED|Overall Study||15
380849|NCT00331799|928418|P1|STARTED|Overall Study||18
380850|NCT00331773|928424|P2|NOT COMPLETED|Overall Study||7
380851|NCT00331773|928425|P1|NOT COMPLETED|Overall Study||16
380852|NCT00331773|928424|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|550
380853|NCT00331773|928425|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|542
380854|NCT00331773|928424|P2|STARTED|Overall Study||557
380855|NCT00331773|928425|P1|STARTED|Overall Study||558
380856|NCT00331760|928453|P2|NOT COMPLETED|Overall Study||8
380857|NCT00331760|928454|P1|NOT COMPLETED|Overall Study||15
380858|NCT00331760|928453|P2|COMPLETED|Overall Study||40
380859|NCT00331760|928454|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|43
380860|NCT00331760|928453|P2|STARTED|Overall Study||48
380861|NCT00331760|928454|P1|STARTED|Overall Study||58
380862|NCT00331682|928475|P1|NOT COMPLETED|Overall Study||1
380863|NCT00331682|928475|P1|COMPLETED|Overall Study||9
380864|NCT00331682|928475|P1|STARTED|Overall Study||10
380865|NCT00331552|928483|P2|NOT COMPLETED|Period 3: Phase II||0
380866|NCT00331552|928484|P1|NOT COMPLETED|Period 3: Phase II||2
380867|NCT00331552|928483|P2|COMPLETED|Period 3: Phase II||0
380868|NCT00331552|928484|P1|COMPLETED|Period 3: Phase II||22
380869|NCT00331552|928483|P2|STARTED|Period 3: Phase II||0
380870|NCT00331552|928484|P1|STARTED|Period 3: Phase II||24
380871|NCT00331552|928483|P2|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
380872|NCT00331552|928484|P1|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
380873|NCT00331552|928483|P2|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
380874|NCT00331552|928484|P1|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
380875|NCT00331552|928483|P2|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
380876|NCT00331552|928484|P1|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
380877|NCT00331552|928483|P2|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
380878|NCT00331552|928484|P1|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
380879|NCT00331552|928483|P2|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
380880|NCT00331552|928484|P1|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
380881|NCT00331552|928483|P2|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
380882|NCT00331552|928484|P1|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
380883|NCT00331422|928498|P1|NOT COMPLETED|Overall Study||5
380884|NCT00331422|928498|P1|COMPLETED|Overall Study|Completed all 6 courses of chemotherapy and had surgery to remove all tumor lesions.|2
380885|NCT00331422|928498|P1|STARTED|Overall Study|Patients who met study criteria and received at least one dose of study drug.|7
380886|NCT00331409|928507|P1|NOT COMPLETED|Overall Study||4
380887|NCT00331409|928507|P1|COMPLETED|Overall Study|15 patients accrued to the first stage;if>9 were progression-free at 3 months,enrollment continued.|15
380888|NCT00331409|928507|P1|STARTED|Overall Study|19 patients were enrolled in the first stage due to 4 patients who withdrew early.|19
380889|NCT00331344|928515|P9|NOT COMPLETED|Phase II||4
380890|NCT00331344|928516|P8|NOT COMPLETED|Phase II||0
380891|NCT00331344|928517|P7|NOT COMPLETED|Phase II||0
380892|NCT00331344|928518|P6|NOT COMPLETED|Phase II||0
380893|NCT00331344|928519|P5|NOT COMPLETED|Phase II||0
380894|NCT00331344|928520|P4|NOT COMPLETED|Phase II||0
380895|NCT00331344|928521|P3|NOT COMPLETED|Phase II||0
380896|NCT00331344|928522|P2|NOT COMPLETED|Phase II||0
380897|NCT00331344|928523|P1|NOT COMPLETED|Phase II||0
380898|NCT00331344|928515|P9|COMPLETED|Phase II||48
380899|NCT00331344|928516|P8|COMPLETED|Phase II||6
380900|NCT00331344|928517|P7|COMPLETED|Phase II||0
380901|NCT00331344|928518|P6|COMPLETED|Phase II||0
380902|NCT00331344|928519|P5|COMPLETED|Phase II||0
380903|NCT00331344|928520|P4|COMPLETED|Phase II||0
380904|NCT00331344|928521|P3|COMPLETED|Phase II||0
380905|NCT00331344|928522|P2|COMPLETED|Phase II||0
380906|NCT00331344|928523|P1|COMPLETED|Phase II||0
380907|NCT00331344|928515|P9|STARTED|Phase II|Protocol enrollment (63) minus 11 ineligible prior to receiving treatment.|52
380908|NCT00331344|928516|P8|STARTED|Phase II|6 patients in Phase I Group VIa continued to the Phase II period.|6
380909|NCT00331344|928517|P7|STARTED|Phase II||0
380910|NCT00331344|928518|P6|STARTED|Phase II||0
380911|NCT00331344|928519|P5|STARTED|Phase II||0
380912|NCT00331344|928520|P4|STARTED|Phase II||0
380913|NCT00331344|928521|P3|STARTED|Phase II||0
380914|NCT00331344|928522|P2|STARTED|Phase II||0
380915|NCT00331344|928523|P1|STARTED|Phase II||0
380916|NCT00331344|928515|P9|NOT COMPLETED|Phase I||0
380917|NCT00331344|928516|P8|NOT COMPLETED|Phase I||1
380918|NCT00331344|928517|P7|NOT COMPLETED|Phase I||0
380919|NCT00331344|928518|P6|NOT COMPLETED|Phase I||2
380920|NCT00331344|928519|P5|NOT COMPLETED|Phase I||2
380921|NCT00331344|928520|P4|NOT COMPLETED|Phase I||1
380922|NCT00331344|928521|P3|NOT COMPLETED|Phase I||0
380923|NCT00331344|928522|P2|NOT COMPLETED|Phase I||0
380924|NCT00331344|928523|P1|NOT COMPLETED|Phase I||0
380925|NCT00331344|928515|P9|COMPLETED|Phase I||0
380926|NCT00331344|928516|P8|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
380927|NCT00331344|928517|P7|COMPLETED|Phase I||4
380928|NCT00331344|928518|P6|COMPLETED|Phase I|2 participants reached dose limiting toxicity|3
380929|NCT00331344|928519|P5|COMPLETED|Phase I|2 participants reached dose limiting toxicity|4
380930|NCT00331344|928520|P4|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
380931|NCT00331344|928521|P3|COMPLETED|Phase I||3
380932|NCT00331344|928522|P2|COMPLETED|Phase I||3
380933|NCT00331344|928523|P1|COMPLETED|Phase I||3
380934|NCT00331344|928515|P9|STARTED|Phase I||0
380935|NCT00331344|928516|P8|STARTED|Phase I|1 participant who was enrolled died prior to initiating protocol therapy.|6
380936|NCT00331344|928517|P7|STARTED|Phase I||4
380937|NCT00331344|928518|P6|STARTED|Phase I||5
380938|NCT00331344|928519|P5|STARTED|Phase I||6
380939|NCT00331344|928520|P4|STARTED|Phase I||6
380940|NCT00331344|928521|P3|STARTED|Phase I||3
380941|NCT00331344|928522|P2|STARTED|Phase I||3
380942|NCT00331344|928523|P1|STARTED|Phase I||3
380943|NCT00331162|928539|P2|NOT COMPLETED|Overall Study||0
380944|NCT00331162|928540|P1|NOT COMPLETED|Overall Study||0
380945|NCT00331162|928539|P2|COMPLETED|Overall Study||109
380946|NCT00331162|928540|P1|COMPLETED|Overall Study||113
380947|NCT00331162|928539|P2|STARTED|Overall Study||109
380948|NCT00331162|928540|P1|STARTED|Overall Study||113
380949|NCT00331006|928560|P1|NOT COMPLETED|Follow-Up Phase II||3
380950|NCT00331006|928560|P1|COMPLETED|Follow-Up Phase II||11
380951|NCT00331006|928560|P1|STARTED|Follow-Up Phase II||14
380952|NCT00331006|928560|P1|NOT COMPLETED|Follow-Up Phase I||1
380953|NCT00331006|928560|P1|COMPLETED|Follow-Up Phase I||14
380954|NCT00331006|928560|P1|STARTED|Follow-Up Phase I||15
380955|NCT00331006|928560|P1|NOT COMPLETED|Treatment Phase||1
380956|NCT00331006|928560|P1|COMPLETED|Treatment Phase||15
380957|NCT00331006|928560|P1|STARTED|Treatment Phase||16
380958|NCT00331006|928560|P1|NOT COMPLETED|Screening Phase||7
380959|NCT00331006|928560|P1|COMPLETED|Screening Phase|subjects eligible for the treatment phase if inhibitor titer following Factor VIII was at least 5 BU|16
380960|NCT00331006|928560|P1|STARTED|Screening Phase||23
380961|NCT00330967|928573|P2|NOT COMPLETED|Overall Study||14
380962|NCT00330967|928574|P1|NOT COMPLETED|Overall Study||0
380963|NCT00330967|928573|P2|COMPLETED|Overall Study||11
380964|NCT00330967|928574|P1|COMPLETED|Overall Study||0
380965|NCT00330967|928573|P2|STARTED|Overall Study||25
380966|NCT00330967|928574|P1|STARTED|Overall Study||0
380967|NCT00330928|928585|P1|NOT COMPLETED|Overall Study||17
380968|NCT00330928|928585|P1|COMPLETED|Overall Study||89
380969|NCT00330928|928585|P1|1 Year Phone Contact|Overall Study||89
380970|NCT00330928|928585|P1|7 Day Phone Contact|Overall Study||99
380971|NCT00330928|928585|P1|STARTED|Overall Study|Subjects that signed consent and were subject to research procedures.|106
380972|NCT00330915|928590|P1|NOT COMPLETED|Overall Study||0
380973|NCT00330915|928590|P1|COMPLETED|Overall Study||37
380974|NCT00330915|928590|P1|STARTED|Overall Study||37
380975|NCT00330876|928597|P2|NOT COMPLETED|Overall Study||13
380976|NCT00330876|928598|P1|NOT COMPLETED|Overall Study||71
380977|NCT00330876|928597|P2|COMPLETED|Overall Study||77
380978|NCT00330876|928598|P1|COMPLETED|Overall Study||378
380979|NCT00330876|928597|P2|STARTED|Overall Study||90
380980|NCT00330876|928598|P1|STARTED|Overall Study||449
380981|NCT00330863|928608|P2|NOT COMPLETED|Overall Study||80
380982|NCT00330863|928609|P1|NOT COMPLETED|Overall Study||81
380983|NCT00330863|928608|P2|COMPLETED|Overall Study||72
380984|NCT00330863|928609|P1|COMPLETED|Overall Study||72
380985|NCT00330863|928608|P2|STARTED|Overall Study||152
380986|NCT00330863|928609|P1|STARTED|Overall Study||153
380987|NCT00330759|928627|P2|NOT COMPLETED|Overall Study||706
380988|NCT00330759|928628|P1|NOT COMPLETED|Overall Study||712
380989|NCT00330759|928627|P2|COMPLETED|Overall Study||180
380990|NCT00330759|928628|P1|COMPLETED|Overall Study||178
380991|NCT00330759|928627|P2|Received Investigational Product|Overall Study||878
380992|NCT00330759|928628|P1|Received Investigational Product|Overall Study||878
380993|NCT00330759|928627|P2|STARTED|Overall Study||886
380994|NCT00330759|928628|P1|STARTED|Overall Study||890
380995|NCT00330733|928640|P2|NOT COMPLETED|Overall Study||5
380996|NCT00330733|928641|P1|NOT COMPLETED|Overall Study||7
380997|NCT00330733|928640|P2|COMPLETED|Overall Study||29
380998|NCT00330733|928641|P1|COMPLETED|Overall Study||30
380999|NCT00330733|928640|P2|Received Study Medication|Overall Study||34
381000|NCT00330733|928641|P1|Received Study Medication|Overall Study||36
381001|NCT00330733|928640|P2|STARTED|Overall Study||34
381002|NCT00330733|928641|P1|STARTED|Overall Study||37
381003|NCT00330681|928649|P2|NOT COMPLETED|Overall Study||14
381004|NCT00330681|928650|P1|NOT COMPLETED|Overall Study||9
381005|NCT00330681|928649|P2|COMPLETED|Overall Study||90
381006|NCT00330681|928650|P1|COMPLETED|Overall Study||93
381007|NCT00330681|928649|P2|STARTED|Overall Study||104
381008|NCT00330681|928650|P1|STARTED|Overall Study||102
381009|NCT00330668|928672|P1|NOT COMPLETED|Overall Study||114
381010|NCT00330668|928672|P1|COMPLETED|Overall Study||0
381011|NCT00330668|928672|P1|STARTED|Overall Study||114
381012|NCT00330616|928679|P1|NOT COMPLETED|Overall Study||21
381013|NCT00330616|928679|P1|COMPLETED|Overall Study||14
381014|NCT00330616|928679|P1|STARTED|Overall Study||35
381015|NCT00330564|928698|P1|NOT COMPLETED|Overall Study||0
381016|NCT00330564|928698|P1|COMPLETED|Overall Study||15
381017|NCT00330564|928698|P1|STARTED|Overall Study||15
381018|NCT00330460|928705|P2|NOT COMPLETED|Overall Study||33
381019|NCT00330460|928706|P1|NOT COMPLETED|Overall Study||42
381020|NCT00330460|928705|P2|COMPLETED|Overall Study||561
381021|NCT00330460|928706|P1|COMPLETED|Overall Study||553
381022|NCT00330460|928705|P2|STARTED|Overall Study||594
381023|NCT00330460|928706|P1|STARTED|Overall Study||595
381024|NCT00330421|928720|P2|NOT COMPLETED|Overall Study||0
381025|NCT00330421|928721|P1|NOT COMPLETED|Overall Study||0
381026|NCT00330421|928720|P2|COMPLETED|Overall Study||0
381027|NCT00330421|928721|P1|COMPLETED|Overall Study||15
381028|NCT00330421|928720|P2|STARTED|Overall Study||0
381029|NCT00330421|928721|P1|STARTED|Overall Study||15
381030|NCT00330382|928727|P2|NOT COMPLETED|Overall Study||17
381031|NCT00330382|928728|P1|NOT COMPLETED|Overall Study||24
381032|NCT00330382|928727|P2|COMPLETED|Overall Study||48
381033|NCT00330382|928728|P1|COMPLETED|Overall Study||43
381034|NCT00330382|928727|P2|STARTED|Overall Study||65
381035|NCT00330382|928728|P1|STARTED|Overall Study||67
381036|NCT00330343|928749|P1|NOT COMPLETED|Overall Study||5
381037|NCT00330343|928749|P1|COMPLETED|Overall Study||59
381038|NCT00330343|928749|P1|STARTED|Overall Study||64
381039|NCT00330187|928757|P4|NOT COMPLETED|Overall Study||14
381040|NCT00330187|928758|P3|NOT COMPLETED|Overall Study||18
381041|NCT00330187|928759|P2|NOT COMPLETED|Overall Study||18
381042|NCT00330187|928760|P1|NOT COMPLETED|Overall Study||20
381043|NCT00330187|928757|P4|COMPLETED|Overall Study||18
381044|NCT00330187|928758|P3|COMPLETED|Overall Study||11
381045|NCT00330187|928759|P2|COMPLETED|Overall Study||18
381046|NCT00330187|928760|P1|COMPLETED|Overall Study||17
381047|NCT00330187|928757|P4|STARTED|Overall Study||32
381048|NCT00330187|928758|P3|STARTED|Overall Study||29
381049|NCT00330187|928759|P2|STARTED|Overall Study||36
381050|NCT00330187|928760|P1|STARTED|Overall Study||37
381051|NCT00330174|928772|P2|NOT COMPLETED|Overall Study||19
381052|NCT00330174|928773|P1|NOT COMPLETED|Overall Study||22
381053|NCT00330174|928772|P2|COMPLETED|Overall Study||26
381054|NCT00330174|928773|P1|COMPLETED|Overall Study||23
381055|NCT00330174|928772|P2|STARTED|Overall Study||45
381056|NCT00330174|928773|P1|STARTED|Overall Study||45
381057|NCT00330161|928785|P1|NOT COMPLETED|Overall Study||0
381058|NCT00330161|928785|P1|COMPLETED|Overall Study||29
381059|NCT00330161|928785|P1|STARTED|Overall Study||29
381060|NCT00329901|928797|P3|NOT COMPLETED|Overall Study||4
381061|NCT00329901|928798|P2|NOT COMPLETED|Overall Study||5
381062|NCT00329901|928799|P1|NOT COMPLETED|Overall Study||9
381063|NCT00329901|928797|P3|COMPLETED|Overall Study||353
381064|NCT00329901|928798|P2|COMPLETED|Overall Study||349
381065|NCT00329901|928799|P1|COMPLETED|Overall Study||352
381066|NCT00329901|928797|P3|STARTED|Overall Study||357
381067|NCT00329901|928798|P2|STARTED|Overall Study||354
381068|NCT00329901|928799|P1|STARTED|Overall Study||361
381069|NCT00329849|928829|P2|NOT COMPLETED|Overall Study||4
381070|NCT00329849|928830|P1|NOT COMPLETED|Overall Study||6
381071|NCT00329849|928829|P2|COMPLETED|Overall Study||546
381072|NCT00329849|928830|P1|COMPLETED|Overall Study||944
381073|NCT00329849|928829|P2|STARTED|Overall Study||550
381074|NCT00329849|928830|P1|STARTED|Overall Study||950
381075|NCT00329836|928850|P1|NOT COMPLETED|Overall Study||0
381076|NCT00329836|928850|P1|COMPLETED|Overall Study||41
381077|NCT00329836|928850|P1|STARTED|Overall Study||41
381078|NCT00329797|928856|P2|NOT COMPLETED|Overall Study||6
381079|NCT00329797|928857|P1|NOT COMPLETED|Overall Study||7
381080|NCT00329797|928856|P2|COMPLETED|Overall Study||46
381081|NCT00329797|928857|P1|COMPLETED|Overall Study||50
381082|NCT00329797|928856|P2|STARTED|Overall Study||52
381083|NCT00329797|928857|P1|STARTED|Overall Study||57
381084|NCT00329784|928873|P4|NOT COMPLETED|Overall Study||0
381085|NCT00329784|928874|P3|NOT COMPLETED|Overall Study||0
381086|NCT00329784|928875|P2|NOT COMPLETED|Overall Study||5
381087|NCT00329784|928876|P1|NOT COMPLETED|Overall Study||5
381088|NCT00329784|928873|P4|COMPLETED|Overall Study||47
381089|NCT00329784|928874|P3|COMPLETED|Overall Study||51
381090|NCT00329784|928875|P2|COMPLETED|Overall Study||267
381091|NCT00329784|928876|P1|COMPLETED|Overall Study||265
381092|NCT00329784|928873|P4|STARTED|Overall Study||47
381093|NCT00329784|928874|P3|STARTED|Overall Study||51
381094|NCT00329784|928875|P2|STARTED|Overall Study||272
381095|NCT00329784|928876|P1|STARTED|Overall Study||270
381096|NCT00329771|928898|P1|NOT COMPLETED|Overall Study||3
381097|NCT00329771|928898|P1|COMPLETED|Overall Study|3 subjects withdrew or were lost to follow-up|25
381098|NCT00329771|928898|P1|STARTED|Overall Study||28
381099|NCT00329745|928904|P2|NOT COMPLETED|Overall Study||102
381100|NCT00329745|928905|P1|NOT COMPLETED|Overall Study||87
381101|NCT00329745|928904|P2|COMPLETED|Overall Study||4226
381102|NCT00329745|928905|P1|COMPLETED|Overall Study||4272
381103|NCT00329745|928904|P2|STARTED|Overall Study||4328
381104|NCT00329745|928905|P1|STARTED|Overall Study||4359
381105|NCT00329732|928915|P2|NOT COMPLETED|Overall Study||0
381106|NCT00329732|928916|P1|NOT COMPLETED|Overall Study||0
381107|NCT00329732|928915|P2|COMPLETED|Overall Study||0
381108|NCT00329732|928916|P1|COMPLETED|Overall Study||2
381109|NCT00329732|928915|P2|STARTED|Overall Study||0
381110|NCT00329732|928916|P1|STARTED|Overall Study||2
381111|NCT00329719|928925|P4|NOT COMPLETED|Overall Study||1
381112|NCT00329719|928926|P3|NOT COMPLETED|Overall Study||0
381113|NCT00329719|928927|P2|NOT COMPLETED|Overall Study||0
381114|NCT00329719|928928|P1|NOT COMPLETED|Overall Study||0
381115|NCT00329719|928925|P4|COMPLETED|Overall Study||44
381116|NCT00329719|928926|P3|COMPLETED|Overall Study||9
381117|NCT00329719|928927|P2|COMPLETED|Overall Study||49
381118|NCT00329719|928928|P1|COMPLETED|Overall Study||12
381119|NCT00329719|928925|P4|STARTED|Overall Study||45
381120|NCT00329719|928926|P3|STARTED|Overall Study||9
381121|NCT00329719|928927|P2|STARTED|Overall Study||49
381122|NCT00329719|928928|P1|STARTED|Overall Study||12
381123|NCT00329641|928950|P1|NOT COMPLETED|Overall Study||6
381124|NCT00329641|928950|P1|COMPLETED|Overall Study||19
381125|NCT00329641|928950|P1|Eligible and Received Treatment|Overall Study||24
381126|NCT00329641|928950|P1|Eligible|Overall Study||25
381127|NCT00329641|928950|P1|STARTED|Overall Study||25
381128|NCT00329602|928959|P3|NOT COMPLETED|40-Week Open-Label Treatment Phase||36
381129|NCT00329602|928960|P2|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
381130|NCT00329602|928961|P1|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
381131|NCT00329602|928959|P3|COMPLETED|40-Week Open-Label Treatment Phase||233
381132|NCT00329602|928960|P2|COMPLETED|40-Week Open-Label Treatment Phase||0
381133|NCT00329602|928961|P1|COMPLETED|40-Week Open-Label Treatment Phase||0
381134|NCT00329602|928959|P3|STARTED|40-Week Open-Label Treatment Phase|148 and 121 par. randomized to DB placebo and ropinirole IR, respectively, entered the OL phase.|269
381135|NCT00329602|928960|P2|STARTED|40-Week Open-Label Treatment Phase||0
381136|NCT00329602|928961|P1|STARTED|40-Week Open-Label Treatment Phase||0
381137|NCT00329602|928959|P3|NOT COMPLETED|26-Week Double-Blind Treatment Phase||0
381138|NCT00329602|928960|P2|NOT COMPLETED|26-Week Double-Blind Treatment Phase||99
381139|NCT00329602|928961|P1|NOT COMPLETED|26-Week Double-Blind Treatment Phase||119
381140|NCT00329602|928959|P3|COMPLETED|26-Week Double-Blind Treatment Phase||0
381141|NCT00329602|928960|P2|COMPLETED|26-Week Double-Blind Treatment Phase||98
381142|NCT00329602|928961|P1|COMPLETED|26-Week Double-Blind Treatment Phase||88
381143|NCT00329602|928959|P3|STARTED|26-Week Double-Blind Treatment Phase||0
381144|NCT00329602|928960|P2|STARTED|26-Week Double-Blind Treatment Phase||197
381145|NCT00329602|928961|P1|STARTED|26-Week Double-Blind Treatment Phase|"Numbers of participants in the Participant Flow section are based on the Safety Population."|207
381146|NCT00329550|928999|P3|NOT COMPLETED|Overall Study||4
381147|NCT00329550|929000|P2|NOT COMPLETED|Overall Study||4
381148|NCT00329550|929001|P1|NOT COMPLETED|Overall Study||4
381149|NCT00329550|928999|P3|COMPLETED|Overall Study||12
381150|NCT00329550|929000|P2|COMPLETED|Overall Study||11
381151|NCT00329550|929001|P1|COMPLETED|Overall Study||5
381152|NCT00329550|928999|P3|STARTED|Overall Study|1 subject in Safety Set is not in Full Analysis Set due to Good Clinical Practice non-compliance.|16
381153|NCT00329550|929000|P2|STARTED|Overall Study||15
381154|NCT00329550|929001|P1|STARTED|Overall Study||9
381155|NCT00329524|929248|P1|NOT COMPLETED|Overall Study||0
381156|NCT00329524|929248|P1|COMPLETED|Overall Study||5
381157|NCT00329524|929248|P1|STARTED|Overall Study||5
381158|NCT00329433|929256|P2|NOT COMPLETED|Overall Study||0
381159|NCT00329433|929257|P1|NOT COMPLETED|Overall Study||0
381160|NCT00329433|929256|P2|COMPLETED|Overall Study||59
381161|NCT00329433|929257|P1|COMPLETED|Overall Study||61
381162|NCT00329433|929256|P2|STARTED|Overall Study||59
381163|NCT00329433|929257|P1|STARTED|Overall Study||61
381164|NCT00329420|929270|P3|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||1
381165|NCT00329420|929271|P2|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||2
381166|NCT00329420|929272|P1|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||4
381167|NCT00329420|929270|P3|COMPLETED|4-weekly Dosing Phase (Responders Only)||6
381168|NCT00329420|929271|P2|COMPLETED|4-weekly Dosing Phase (Responders Only)||5
381169|NCT00329420|929272|P1|COMPLETED|4-weekly Dosing Phase (Responders Only)||8
381170|NCT00329420|929270|P3|STARTED|4-weekly Dosing Phase (Responders Only)||7
381171|NCT00329420|929271|P2|STARTED|4-weekly Dosing Phase (Responders Only)||7
381172|NCT00329420|929272|P1|STARTED|4-weekly Dosing Phase (Responders Only)||12
381173|NCT00329420|929270|P3|NOT COMPLETED|Re-induction Phase||8
381174|NCT00329420|929271|P2|NOT COMPLETED|Re-induction Phase||6
381175|NCT00329420|929272|P1|NOT COMPLETED|Re-induction Phase||6
381176|NCT00329420|929270|P3|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
381177|NCT00329420|929271|P2|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
381178|NCT00329420|929272|P1|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|12
381179|NCT00329420|929270|P3|STARTED|Re-induction Phase||15
381180|NCT00329420|929271|P2|STARTED|Re-induction Phase||13
381181|NCT00329420|929272|P1|STARTED|Re-induction Phase||18
381182|NCT00329407|929651|P1|NOT COMPLETED|Overall Study||1
381183|NCT00329407|929651|P1|COMPLETED|Overall Study||9
381184|NCT00329407|929651|P1|STARTED|Overall Study||10
381185|NCT00329303|929658|P2|NOT COMPLETED|Overall Study||2
381186|NCT00329303|929659|P1|NOT COMPLETED|Overall Study||2
381187|NCT00329303|929658|P2|COMPLETED|Overall Study||35
381188|NCT00329303|929659|P1|COMPLETED|Overall Study||32
381189|NCT00329303|929658|P2|STARTED|Overall Study||37
381190|NCT00329303|929659|P1|STARTED|Overall Study||34
381191|NCT00329238|929821|P2|NOT COMPLETED|Overall Study||281
381192|NCT00329238|929822|P1|NOT COMPLETED|Overall Study||276
381193|NCT00329238|929821|P2|COMPLETED|Overall Study||1145
381194|NCT00329238|929822|P1|COMPLETED|Overall Study||1154
381195|NCT00329238|929821|P2|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1426
381196|NCT00329238|929822|P1|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1430
381197|NCT00329160|929858|P1|NOT COMPLETED|Overall Study||88
381198|NCT00329160|929858|P1|COMPLETED|Overall Study||126
381199|NCT00329160|929858|P1|Treatment Period|Overall Study||214
381200|NCT00329160|929858|P1|Observation Period|Overall Study||214
381201|NCT00329160|929858|P1|STARTED|Overall Study||214
381202|NCT00329108|929867|P2|NOT COMPLETED|Overall Study||12
381203|NCT00329108|929868|P1|NOT COMPLETED|Overall Study||10
381204|NCT00329108|929867|P2|COMPLETED|Overall Study||2
381205|NCT00329108|929868|P1|COMPLETED|Overall Study||5
381206|NCT00329108|929867|P2|STARTED|Overall Study|study terminated due to poor recruitment|14
381207|NCT00329108|929868|P1|STARTED|Overall Study|study terminated due to poor recruitment|15
381208|NCT00329030|929876|P2|NOT COMPLETED|Overall Study||6
381209|NCT00329030|929877|P1|NOT COMPLETED|Overall Study||8
381210|NCT00329030|929876|P2|COMPLETED|Overall Study||107
381211|NCT00329030|929877|P1|COMPLETED|Overall Study||103
381212|NCT00329030|929876|P2|STARTED|Overall Study||113
381213|NCT00329030|929877|P1|STARTED|Overall Study||111
381214|NCT00328926|929908|P3|NOT COMPLETED|Overall Study||2
381215|NCT00328926|929909|P2|NOT COMPLETED|Overall Study||3
381216|NCT00328926|929910|P1|NOT COMPLETED|Overall Study||2
381217|NCT00328926|929908|P3|COMPLETED|Overall Study||1
381218|NCT00328926|929909|P2|COMPLETED|Overall Study||0
381219|NCT00328926|929910|P1|COMPLETED|Overall Study||3
381220|NCT00328926|929908|P3|STARTED|Overall Study||3
381221|NCT00328926|929909|P2|STARTED|Overall Study||3
381222|NCT00328926|929910|P1|STARTED|Overall Study||5
381223|NCT00328861|929926|P2|NOT COMPLETED|Overall Study||0
381224|NCT00328861|929927|P1|NOT COMPLETED|Overall Study||0
381225|NCT00328861|929926|P2|COMPLETED|Overall Study||1
381226|NCT00328861|929927|P1|COMPLETED|Overall Study||7
381227|NCT00328861|929926|P2|STARTED|Overall Study||1
381228|NCT00328861|929927|P1|STARTED|Overall Study||7
381229|NCT00328783|929935|P1|NOT COMPLETED|Overall Study||26
381230|NCT00328783|929935|P1|COMPLETED|Overall Study||86
381231|NCT00328783|929935|P1|STARTED|Overall Study||112
381232|NCT00328770|929943|P1|NOT COMPLETED|Overall Study||0
381233|NCT00328770|929943|P1|COMPLETED|Overall Study||70
381234|NCT00328770|929943|P1|STARTED|Overall Study||70
381235|NCT00328627|929961|P12|NOT COMPLETED|Overall Study||16
381236|NCT00328627|929962|P11|NOT COMPLETED|Overall Study||18
381237|NCT00328627|929963|P10|NOT COMPLETED|Overall Study||32
381238|NCT00328627|929964|P9|NOT COMPLETED|Overall Study||17
381239|NCT00328627|929965|P8|NOT COMPLETED|Overall Study||14
381240|NCT00328627|929966|P7|NOT COMPLETED|Overall Study||35
381241|NCT00328627|929967|P6|NOT COMPLETED|Overall Study||20
381242|NCT00328627|929968|P5|NOT COMPLETED|Overall Study||15
381243|NCT00328627|929969|P4|NOT COMPLETED|Overall Study||37
381244|NCT00328627|929970|P3|NOT COMPLETED|Overall Study||28
381245|NCT00328627|929971|P2|NOT COMPLETED|Overall Study||31
381246|NCT00328627|929972|P1|NOT COMPLETED|Overall Study||59
381247|NCT00328627|929961|P12|COMPLETED|Overall Study||114
381248|NCT00328627|929962|P11|COMPLETED|Overall Study||112
381249|NCT00328627|929963|P10|COMPLETED|Overall Study||97
381250|NCT00328627|929964|P9|COMPLETED|Overall Study||113
381251|NCT00328627|929965|P8|COMPLETED|Overall Study||116
381252|NCT00328627|929966|P7|COMPLETED|Overall Study||94
381253|NCT00328627|929967|P6|COMPLETED|Overall Study||110
381254|NCT00328627|929968|P5|COMPLETED|Overall Study||115
381255|NCT00328627|929969|P4|COMPLETED|Overall Study||93
381256|NCT00328627|929970|P3|COMPLETED|Overall Study||101
381257|NCT00328627|929971|P2|COMPLETED|Overall Study||97
381258|NCT00328627|929972|P1|COMPLETED|Overall Study||70
381259|NCT00328627|929961|P12|Safety Set|Overall Study||130
381260|NCT00328627|929962|P11|Safety Set|Overall Study||130
381261|NCT00328627|929963|P10|Safety Set|Overall Study||129
381262|NCT00328627|929964|P9|Safety Set|Overall Study||130
381263|NCT00328627|929965|P8|Safety Set|Overall Study||130
381264|NCT00328627|929966|P7|Safety Set|Overall Study||129
381265|NCT00328627|929967|P6|Safety Set|Overall Study||130
381266|NCT00328627|929968|P5|Safety Set|Overall Study||130
381267|NCT00328627|929969|P4|Safety Set|Overall Study||129
381268|NCT00328627|929970|P3|Safety Set|Overall Study||129
381269|NCT00328627|929971|P2|Safety Set|Overall Study||128
381270|NCT00328627|929972|P1|Safety Set|Overall Study|All patients who took at least 1 dose of double-blind study drug.|129
381271|NCT00328627|929961|P12|STARTED|Overall Study||130
381272|NCT00328627|929962|P11|STARTED|Overall Study||130
381273|NCT00328627|929963|P10|STARTED|Overall Study||129
381274|NCT00328627|929964|P9|STARTED|Overall Study||130
381275|NCT00328627|929965|P8|STARTED|Overall Study||130
381276|NCT00328627|929966|P7|STARTED|Overall Study||129
381277|NCT00328627|929967|P6|STARTED|Overall Study||130
381278|NCT00328627|929968|P5|STARTED|Overall Study||130
381279|NCT00328627|929969|P4|STARTED|Overall Study||130
381280|NCT00328627|929970|P3|STARTED|Overall Study||129
381281|NCT00328627|929971|P2|STARTED|Overall Study||128
381282|NCT00328627|929972|P1|STARTED|Overall Study||129
381283|NCT00328614|931495|P6|NOT COMPLETED|Overall Study||1
381284|NCT00328614|931496|P5|NOT COMPLETED|Overall Study||1
381285|NCT00328614|931497|P4|NOT COMPLETED|Overall Study||1
381286|NCT00328614|931498|P3|NOT COMPLETED|Overall Study||0
381287|NCT00328614|931499|P2|NOT COMPLETED|Overall Study||0
381288|NCT00328614|931500|P1|NOT COMPLETED|Overall Study||0
381289|NCT00328614|931495|P6|COMPLETED|Overall Study||5
381290|NCT00328614|931496|P5|COMPLETED|Overall Study||5
381291|NCT00328614|931497|P4|COMPLETED|Overall Study||5
381292|NCT00328614|931498|P3|COMPLETED|Overall Study||6
381293|NCT00328614|931499|P2|COMPLETED|Overall Study||4
381294|NCT00328614|931500|P1|COMPLETED|Overall Study||4
381295|NCT00328614|931495|P6|STARTED|Overall Study||6
381296|NCT00328614|931496|P5|STARTED|Overall Study||6
381297|NCT00328614|931497|P4|STARTED|Overall Study||6
381298|NCT00328614|931498|P3|STARTED|Overall Study||6
381299|NCT00328614|931499|P2|STARTED|Overall Study||4
381300|NCT00328614|931500|P1|STARTED|Overall Study||4
381301|NCT00328562|931509|P1|NOT COMPLETED|Overall Study||1
381302|NCT00328562|931509|P1|COMPLETED|Overall Study||12
381303|NCT00328562|931509|P1|STARTED|Overall Study||13
381304|NCT00328510|931518|P2|NOT COMPLETED|Overall Study||4
381305|NCT00328510|931519|P1|NOT COMPLETED|Overall Study||10
381306|NCT00328510|931518|P2|COMPLETED|Overall Study||37
381307|NCT00328510|931519|P1|COMPLETED|Overall Study||32
381308|NCT00328510|931518|P2|STARTED|Overall Study||41
381309|NCT00328510|931519|P1|STARTED|Overall Study||42
381310|NCT00328263|931527|P2|NOT COMPLETED|Overall Study||4
381311|NCT00328263|931528|P1|NOT COMPLETED|Overall Study||3
381312|NCT00328263|931527|P2|COMPLETED|Overall Study|4 deaths occured during the study. None of the deaths were causally related to the study product.|217
381313|NCT00328263|931528|P1|COMPLETED|Overall Study|3 deaths occured during the study. None of the deaths were causally related to the study product.|213
381314|NCT00328263|931527|P2|STARTED|Overall Study||221
381315|NCT00328263|931528|P1|STARTED|Overall Study||216
381316|NCT00328198|931534|P1|NOT COMPLETED|Follow-up||35
381317|NCT00328198|931534|P1|COMPLETED|Follow-up||43
381318|NCT00328198|931534|P1|STARTED|Follow-up|Eight participants did not enter Follow-up|78
381319|NCT00328198|931534|P1|NOT COMPLETED|Treatment||38
381320|NCT00328198|931534|P1|COMPLETED|Treatment|Depending upon protocol version, completed treatment was either 12 or 18 weeks in duration.|48
381321|NCT00328198|931534|P1|STARTED|Treatment|16 participants escalated the dose. 70 participants started at the 30 mg target dose.|86
381322|NCT00328172|931549|P5|NOT COMPLETED|Overall Study||5
381323|NCT00328172|931550|P4|NOT COMPLETED|Overall Study||13
381324|NCT00328172|931551|P3|NOT COMPLETED|Overall Study||10
381325|NCT00328172|931552|P2|NOT COMPLETED|Overall Study||14
381326|NCT00328172|931553|P1|NOT COMPLETED|Overall Study||22
381327|NCT00328172|931549|P5|COMPLETED|Overall Study||60
381328|NCT00328172|931550|P4|COMPLETED|Overall Study||42
381329|NCT00328172|931551|P3|COMPLETED|Overall Study||47
381330|NCT00328172|931552|P2|COMPLETED|Overall Study||44
381331|NCT00328172|931553|P1|COMPLETED|Overall Study||45
381332|NCT00328172|931549|P5|STARTED|Overall Study||65
381333|NCT00328172|931550|P4|STARTED|Overall Study||55
381334|NCT00328172|931551|P3|STARTED|Overall Study||57
381335|NCT00328172|931552|P2|STARTED|Overall Study||58
381336|NCT00328172|931553|P1|STARTED|Overall Study||67
381337|NCT00328094|931577|P2|NOT COMPLETED|Overall Study||3
381338|NCT00328094|931578|P1|NOT COMPLETED|Overall Study||3
381339|NCT00328094|931577|P2|COMPLETED|Overall Study|3 did not receive interevention. 1 post induction arrest. 1 case cancelled.|122
381340|NCT00328094|931578|P1|COMPLETED|Overall Study|2 did not receive intervention. 1 patient refusal|114
381341|NCT00328094|931577|P2|STARTED|Overall Study||125
381342|NCT00328094|931578|P1|STARTED|Overall Study||117
381343|NCT00328042|931588|P2|NOT COMPLETED|Overall Study||2
381344|NCT00328042|931589|P1|NOT COMPLETED|Overall Study||0
381345|NCT00328042|931588|P2|COMPLETED|Overall Study||63
381346|NCT00328042|931589|P1|COMPLETED|Overall Study||69
381347|NCT00328042|931588|P2|STARTED|Overall Study||65
381348|NCT00328042|931589|P1|STARTED|Overall Study||69
381349|NCT00328016|931599|P2|NOT COMPLETED|Overall Study||0
381350|NCT00328016|931600|P1|NOT COMPLETED|Overall Study||0
381351|NCT00328016|931599|P2|COMPLETED|Overall Study||21
381352|NCT00328016|931600|P1|COMPLETED|Overall Study||23
381353|NCT00328016|931599|P2|STARTED|Overall Study||21
381354|NCT00328016|931600|P1|STARTED|Overall Study||23
381355|NCT00327717|931612|P2|NOT COMPLETED|Overall Study||14
381356|NCT00327717|931613|P1|NOT COMPLETED|Overall Study||9
381357|NCT00327717|931612|P2|COMPLETED|Overall Study||106
381358|NCT00327717|931613|P1|COMPLETED|Overall Study||111
381359|NCT00327717|931612|P2|STARTED|Overall Study||120
381360|NCT00327717|931613|P1|STARTED|Overall Study||120
381361|NCT00327470|931639|P2|NOT COMPLETED|Overall Study||63
381362|NCT00327470|931640|P1|NOT COMPLETED|Overall Study||29
381363|NCT00327470|931639|P2|COMPLETED|Overall Study||118
381364|NCT00327470|931640|P1|COMPLETED|Overall Study||78
381365|NCT00327470|931639|P2|Treated|Overall Study||179
381366|NCT00327470|931640|P1|Treated|Overall Study||107
381367|NCT00327470|931639|P2|STARTED|Overall Study||181
381368|NCT00327470|931640|P1|STARTED|Overall Study||107
381369|NCT00327444|931660|P2|NOT COMPLETED|Open Label Treatment (OL) Period||10
381370|NCT00327444|931661|P1|NOT COMPLETED|Open Label Treatment (OL) Period||11
381371|NCT00327444|931660|P2|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
381372|NCT00327444|931661|P1|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
381373|NCT00327444|931660|P2|ONGOING TREATMENT|Open Label Treatment (OL) Period||0
381374|NCT00327444|931661|P1|ONGOING TREATMENT|Open Label Treatment (OL) Period||1
381375|NCT00327444|931660|P2|STARTED|Open Label Treatment (OL) Period||10
381376|NCT00327444|931661|P1|STARTED|Open Label Treatment (OL) Period||11
381377|NCT00327444|931660|P2|NOT COMPLETED|Double Blind Treatment (DB) Period||29
381378|NCT00327444|931661|P1|NOT COMPLETED|Double Blind Treatment (DB) Period||26
381379|NCT00327444|931660|P2|COMPLETED|Double Blind Treatment (DB) Period||0
381380|NCT00327444|931661|P1|COMPLETED|Double Blind Treatment (DB) Period||0
381381|NCT00327444|931660|P2|SAFETY|Double Blind Treatment (DB) Period|Includes 1 from Placebo who received aflibercept in DB period|30
381382|NCT00327444|931661|P1|SAFETY|Double Blind Treatment (DB) Period|Excludes one participant from the Placebo arm who received aflibercept in error in the DB period.|25
381383|NCT00327444|931660|P2|STARTED|Double Blind Treatment (DB) Period||29
381384|NCT00327444|931661|P1|STARTED|Double Blind Treatment (DB) Period||26
381385|NCT00327392|931673|P1|NOT COMPLETED|Overall Study||0
381386|NCT00327392|931673|P1|COMPLETED|Overall Study||123
381387|NCT00327392|931673|P1|STARTED|Overall Study||123
381388|NCT00327340|931679|P2|NOT COMPLETED|Overall Study||30
381389|NCT00327340|931680|P1|NOT COMPLETED|Overall Study||15
381390|NCT00327340|931679|P2|COMPLETED|Overall Study||16
381391|NCT00327340|931680|P1|COMPLETED|Overall Study||8
381392|NCT00327340|931679|P2|STARTED|Overall Study||46
381393|NCT00327340|931680|P1|STARTED|Overall Study||23
381394|NCT00327171|931694|P2|NOT COMPLETED|Overall Study||109
381395|NCT00327171|931695|P1|NOT COMPLETED|Overall Study||108
381396|NCT00327171|931694|P2|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|0
381397|NCT00327171|931695|P1|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|1
381398|NCT00327171|931694|P2|STARTED|Overall Study||109
381399|NCT00327171|931695|P1|STARTED|Overall Study||109
381400|NCT00327015|931727|P4|NOT COMPLETED|Overall Study||109
381401|NCT00327015|931728|P3|NOT COMPLETED|Overall Study||126
381402|NCT00327015|931729|P2|NOT COMPLETED|Overall Study||92
381403|NCT00327015|931730|P1|NOT COMPLETED|Overall Study||91
381404|NCT00327015|931727|P4|COMPLETED|Overall Study||219
381405|NCT00327015|931728|P3|COMPLETED|Overall Study||209
381406|NCT00327015|931729|P2|COMPLETED|Overall Study||231
381407|NCT00327015|931730|P1|COMPLETED|Overall Study||229
381408|NCT00327015|931727|P4|Completed Study Without Being Rescued|Overall Study||144
381409|NCT00327015|931728|P3|Completed Study Without Being Rescued|Overall Study||113
381410|NCT00327015|931729|P2|Completed Study Without Being Rescued|Overall Study||177
381411|NCT00327015|931730|P1|Completed Study Without Being Rescued|Overall Study||179
381412|NCT00327015|931727|P4|STARTED|Overall Study||328
381413|NCT00327015|931728|P3|STARTED|Overall Study||335
381414|NCT00327015|931729|P2|STARTED|Overall Study||323
381415|NCT00327015|931730|P1|STARTED|Overall Study||320
381416|NCT00326963|931772|P1|NOT COMPLETED|Overall Study||33
381417|NCT00326963|931772|P1|COMPLETED|Overall Study||107
381418|NCT00326963|931772|P1|STARTED|Overall Study||140
381419|NCT00326950|931792|P1|NOT COMPLETED|Overall Study||1
381420|NCT00326950|931792|P1|COMPLETED|Overall Study||14
381421|NCT00326950|931792|P1|STARTED|Overall Study||15
381422|NCT00326924|931799|P2|NOT COMPLETED|Overall Study||1
381423|NCT00326924|931800|P1|NOT COMPLETED|Overall Study||1
381424|NCT00326924|931799|P2|COMPLETED|Overall Study||188
381425|NCT00326924|931800|P1|COMPLETED|Overall Study||187
381426|NCT00326924|931799|P2|STARTED|Overall Study||189
381427|NCT00326924|931800|P1|STARTED|Overall Study||188
381428|NCT00326911|931814|P2|NOT COMPLETED|Overall Study||2
381429|NCT00326911|931815|P1|NOT COMPLETED|Overall Study||1
381430|NCT00326911|931814|P2|COMPLETED|Overall Study|This number reflects all treated patients.|29
381431|NCT00326911|931815|P1|COMPLETED|Overall Study|This number reflects all treated patients.|29
381432|NCT00326911|931814|P2|STARTED|Overall Study|This number reflects all randomized patients.|31
381433|NCT00326911|931815|P1|STARTED|Overall Study|This number reflects all randomized patients.|30
381434|NCT00326898|931868|P3|NOT COMPLETED|Overall Study||203
381435|NCT00326898|931869|P2|NOT COMPLETED|Overall Study||343
381436|NCT00326898|931870|P1|NOT COMPLETED|Overall Study||351
381437|NCT00326898|931868|P3|COMPLETED|Overall Study||444
381438|NCT00326898|931869|P2|COMPLETED|Overall Study||306
381439|NCT00326898|931870|P1|COMPLETED|Overall Study||296
381440|NCT00326898|931868|P3|Patients With >=1 Follow-up MUGA Scan|Overall Study||580
381441|NCT00326898|931869|P2|Patients With >=1 Follow-up MUGA Scan|Overall Study||510
381442|NCT00326898|931870|P1|Patients With >=1 Follow-up MUGA Scan|Overall Study||513
381443|NCT00326898|931868|P3|Patients With Clear Cell Histology|Overall Study||540
381444|NCT00326898|931869|P2|Patients With Clear Cell Histology|Overall Study||540
381445|NCT00326898|931870|P1|Patients With Clear Cell Histology|Overall Study||542
381446|NCT00326898|931868|P3|Patients With Toxicity Data|Overall Study||626
381447|NCT00326898|931869|P2|Patients With Toxicity Data|Overall Study||628
381448|NCT00326898|931870|P1|Patients With Toxicity Data|Overall Study||625
381449|NCT00326898|931868|P3|STARTED|Overall Study||647
381450|NCT00326898|931869|P2|STARTED|Overall Study||649
381451|NCT00326898|931870|P1|STARTED|Overall Study||647
381452|NCT00326885|931887|P1|NOT COMPLETED|Overall Study||7
381453|NCT00326885|931887|P1|COMPLETED|Overall Study||25
381454|NCT00326885|931887|P1|STARTED|Overall Study||32
381455|NCT00326872|931896|P1|NOT COMPLETED|Overall Study||0
381456|NCT00326872|931896|P1|COMPLETED|Overall Study||26
381457|NCT00326872|931896|P1|STARTED|Overall Study||26
381458|NCT00326781|931907|P2|NOT COMPLETED|Overall Study||32
381459|NCT00326781|931908|P1|NOT COMPLETED|Overall Study||42
381460|NCT00326781|931907|P2|COMPLETED|Overall Study||298
381461|NCT00326781|931908|P1|COMPLETED|Overall Study||302
381462|NCT00326781|931907|P2|STARTED|Overall Study||330
381463|NCT00326781|931908|P1|STARTED|Overall Study||344
381464|NCT00326716|931918|P4|NOT COMPLETED|Infants||0
381465|NCT00326716|931919|P3|NOT COMPLETED|Infants||0
381466|NCT00326716|931920|P2|NOT COMPLETED|Infants||0
381467|NCT00326716|931921|P1|NOT COMPLETED|Infants||0
381468|NCT00326716|931918|P4|COMPLETED|Infants||20
381469|NCT00326716|931919|P3|COMPLETED|Infants||20
381470|NCT00326716|931920|P2|COMPLETED|Infants||0
381471|NCT00326716|931921|P1|COMPLETED|Infants||0
381472|NCT00326716|931918|P4|STARTED|Infants|All infants were followed. One mother withdrew consent pre-delivery and her infant was not followed.|20
381473|NCT00326716|931919|P3|STARTED|Infants|All infants were followed.|20
381474|NCT00326716|931920|P2|STARTED|Infants||0
381475|NCT00326716|931921|P1|STARTED|Infants||0
381476|NCT00326716|931918|P4|NOT COMPLETED|Pre-Natal Mothers||0
381477|NCT00326716|931919|P3|NOT COMPLETED|Pre-Natal Mothers||0
381478|NCT00326716|931920|P2|NOT COMPLETED|Pre-Natal Mothers||2
381479|NCT00326716|931921|P1|NOT COMPLETED|Pre-Natal Mothers||1
381480|NCT00326716|931918|P4|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
381481|NCT00326716|931919|P3|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
381482|NCT00326716|931920|P2|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
381483|NCT00326716|931921|P1|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
381484|NCT00326716|931918|P4|STARTED|Pre-Natal Mothers||0
381485|NCT00326716|931919|P3|STARTED|Pre-Natal Mothers||0
381486|NCT00326716|931920|P2|STARTED|Pre-Natal Mothers||21
381487|NCT00326716|931921|P1|STARTED|Pre-Natal Mothers||20
381488|NCT00326612|931993|P2|NOT COMPLETED|Overall Study||137
381489|NCT00326612|931994|P1|NOT COMPLETED|Overall Study||129
381490|NCT00326612|931993|P2|COMPLETED|Overall Study||42
381491|NCT00326612|931994|P1|COMPLETED|Overall Study||50
381492|NCT00326612|931993|P2|STARTED|Overall Study||179
381493|NCT00326612|931994|P1|STARTED|Overall Study||179
381494|NCT00326599|932016|P4|NOT COMPLETED|Overall Study||19
381495|NCT00326599|932017|P3|NOT COMPLETED|Overall Study||53
381496|NCT00326599|932018|P2|NOT COMPLETED|Overall Study||1
381497|NCT00326599|932019|P1|NOT COMPLETED|Overall Study||6
381498|NCT00326599|932016|P4|COMPLETED|Overall Study||10
381499|NCT00326599|932017|P3|COMPLETED|Overall Study||5
381500|NCT00326599|932018|P2|COMPLETED|Overall Study||2
381501|NCT00326599|932019|P1|COMPLETED|Overall Study||0
381502|NCT00326599|932016|P4|STARTED|Overall Study||29
381503|NCT00326599|932017|P3|STARTED|Overall Study||58
381504|NCT00326599|932018|P2|STARTED|Overall Study||3
381505|NCT00326599|932019|P1|STARTED|Overall Study||6
381506|NCT00326495|932038|P1|NOT COMPLETED|Overall Study||5
381507|NCT00326495|932038|P1|COMPLETED|Overall Study||46
381508|NCT00326495|932038|P1|STARTED|Overall Study||51
381509|NCT00326417|932045|P4|NOT COMPLETED|Overall Study||3
381510|NCT00326417|932046|P3|NOT COMPLETED|Overall Study||1
381511|NCT00326417|932047|P2|NOT COMPLETED|Overall Study||0
381512|NCT00326417|932048|P1|NOT COMPLETED|Overall Study||14
381513|NCT00326417|932045|P4|COMPLETED|Overall Study|Arm was closed to accrual after 3 patients experienced graft failure.|0
381514|NCT00326417|932046|P3|COMPLETED|Overall Study||38
381515|NCT00326417|932047|P2|COMPLETED|Overall Study||41
381516|NCT00326417|932048|P1|COMPLETED|Overall Study|Dose level was closed for excessive toxicity after 8 patients in Phase II accrued.|0
381517|NCT00326417|932045|P4|Phase II|Overall Study||0
381518|NCT00326417|932046|P3|Phase II|Overall Study||33
381519|NCT00326417|932047|P2|Phase II|Overall Study||35
381520|NCT00326417|932048|P1|Phase II|Overall Study||8
381521|NCT00326417|932045|P4|Phase I|Overall Study||3
381522|NCT00326417|932046|P3|Phase I|Overall Study||6
381523|NCT00326417|932047|P2|Phase I|Overall Study||6
381524|NCT00326417|932048|P1|Phase I|Overall Study||6
381525|NCT00326417|932045|P4|STARTED|Overall Study||3
381526|NCT00326417|932046|P3|STARTED|Overall Study||39
381527|NCT00326417|932047|P2|STARTED|Overall Study||41
381528|NCT00326417|932048|P1|STARTED|Overall Study||14
381529|NCT00326209|932064|P1|NOT COMPLETED|Overall Study||282
381530|NCT00326209|932064|P1|COMPLETED|Overall Study||111
381531|NCT00326209|932064|P1|Safety Population|Overall Study||388
381532|NCT00326209|932064|P1|STARTED|Overall Study||393
381533|NCT00326196|932073|P2|NOT COMPLETED|Overall Study||0
381534|NCT00326196|932074|P1|NOT COMPLETED|Overall Study||0
381535|NCT00326196|932073|P2|COMPLETED|Overall Study||97
381536|NCT00326196|932074|P1|COMPLETED|Overall Study||101
381537|NCT00326196|932073|P2|STARTED|Overall Study||97
381538|NCT00326196|932074|P1|STARTED|Overall Study||101
381539|NCT00326183|932082|P2|NOT COMPLETED|Overall Study||83
381540|NCT00326183|932083|P1|NOT COMPLETED|Overall Study||200
381541|NCT00326183|932082|P2|COMPLETED|Overall Study||264
381542|NCT00326183|932083|P1|COMPLETED|Overall Study||1253
381543|NCT00326183|932082|P2|Postvaccination 2 Post-safety Follow-up|Overall Study||271
381544|NCT00326183|932083|P1|Postvaccination 2 Post-safety Follow-up|Overall Study||1265
381545|NCT00326183|932082|P2|Vaccination 2 + Safety Follow-up|Overall Study||292
381546|NCT00326183|932083|P1|Vaccination 2 + Safety Follow-up|Overall Study||1301
381547|NCT00326183|932082|P2|Postvaccination 1 Post-safety Follow-up|Overall Study||325
381548|NCT00326183|932083|P1|Postvaccination 1 Post-safety Follow-up|Overall Study||1393
381549|NCT00326183|932082|P2|Vaccination 1 + Safety Follow-up|Overall Study||347
381550|NCT00326183|932083|P1|Vaccination 1 + Safety Follow-up|Overall Study||1453
381551|NCT00326183|932082|P2|STARTED|Overall Study||347
381552|NCT00326183|932083|P1|STARTED|Overall Study||1453
381553|NCT00326170|932109|P1|NOT COMPLETED|Overall Study||0
381554|NCT00326170|932109|P1|COMPLETED|Overall Study||34
381555|NCT00326170|932109|P1|STARTED|Overall Study||34
381556|NCT00326118|932115|P2|NOT COMPLETED|Year 5 Follow up||0
381557|NCT00326118|932116|P1|NOT COMPLETED|Year 5 Follow up||0
381558|NCT00326118|932115|P2|COMPLETED|Year 5 Follow up||78
381559|NCT00326118|932116|P1|COMPLETED|Year 5 Follow up||217
381560|NCT00326118|932115|P2|STARTED|Year 5 Follow up||78
381561|NCT00326118|932116|P1|STARTED|Year 5 Follow up||217
381562|NCT00326118|932115|P2|NOT COMPLETED|Year 4 Follow-up||0
381563|NCT00326118|932116|P1|NOT COMPLETED|Year 4 Follow-up||0
381564|NCT00326118|932115|P2|COMPLETED|Year 4 Follow-up||80
381565|NCT00326118|932116|P1|COMPLETED|Year 4 Follow-up||228
381566|NCT00326118|932115|P2|STARTED|Year 4 Follow-up||80
381567|NCT00326118|932116|P1|STARTED|Year 4 Follow-up||228
381568|NCT00326118|932115|P2|NOT COMPLETED|Year 3 Follow-up||0
381569|NCT00326118|932116|P1|NOT COMPLETED|Year 3 Follow-up||0
381570|NCT00326118|932115|P2|COMPLETED|Year 3 Follow-up||89
381571|NCT00326118|932116|P1|COMPLETED|Year 3 Follow-up||256
381572|NCT00326118|932115|P2|STARTED|Year 3 Follow-up||89
381573|NCT00326118|932116|P1|STARTED|Year 3 Follow-up||256
381574|NCT00326118|932115|P2|NOT COMPLETED|Year 2 Follow-up||0
381575|NCT00326118|932116|P1|NOT COMPLETED|Year 2 Follow-up||0
381576|NCT00326118|932115|P2|COMPLETED|Year 2 Follow-up||92
381577|NCT00326118|932116|P1|COMPLETED|Year 2 Follow-up||270
381578|NCT00326118|932115|P2|STARTED|Year 2 Follow-up||92
381579|NCT00326118|932116|P1|STARTED|Year 2 Follow-up||270
381580|NCT00326118|932115|P2|NOT COMPLETED|Year 1 Follow-up||0
381581|NCT00326118|932116|P1|NOT COMPLETED|Year 1 Follow-up||0
381582|NCT00326118|932115|P2|COMPLETED|Year 1 Follow-up||100
381583|NCT00326118|932116|P1|COMPLETED|Year 1 Follow-up||295
381584|NCT00326118|932115|P2|STARTED|Year 1 Follow-up||100
381585|NCT00326118|932116|P1|STARTED|Year 1 Follow-up||295
381586|NCT00326118|932115|P2|NOT COMPLETED|Active Phase||1
381587|NCT00326118|932116|P1|NOT COMPLETED|Active Phase||4
381588|NCT00326118|932115|P2|COMPLETED|Active Phase||108
381589|NCT00326118|932116|P1|COMPLETED|Active Phase||320
381590|NCT00326118|932115|P2|STARTED|Active Phase||109
381591|NCT00326118|932116|P1|STARTED|Active Phase||324
381592|NCT00326001|932152|P2|NOT COMPLETED|Overall Study||8
381593|NCT00326001|932153|P1|NOT COMPLETED|Overall Study||7
381594|NCT00326001|932152|P2|COMPLETED|Overall Study||219
381595|NCT00326001|932153|P1|COMPLETED|Overall Study||229
381596|NCT00326001|932152|P2|STARTED|Overall Study||227
381597|NCT00326001|932153|P1|STARTED|Overall Study||236
381598|NCT00325897|932167|P2|NOT COMPLETED|Overall Study||13
381599|NCT00325897|932168|P1|NOT COMPLETED|Overall Study||12
381600|NCT00325897|932167|P2|COMPLETED|Overall Study||559
381601|NCT00325897|932168|P1|COMPLETED|Overall Study||558
381602|NCT00325897|932167|P2|STARTED|Overall Study||572
381603|NCT00325897|932168|P1|STARTED|Overall Study||570
381604|NCT00325819|932188|P2|NOT COMPLETED|Overall Study||13
381605|NCT00325819|932189|P1|NOT COMPLETED|Overall Study||9
381606|NCT00325819|932188|P2|COMPLETED|Overall Study||176
381607|NCT00325819|932189|P1|COMPLETED|Overall Study||176
381608|NCT00325819|932188|P2|STARTED|Overall Study||189
381609|NCT00325819|932189|P1|STARTED|Overall Study||185
381610|NCT00325780|932209|P1|NOT COMPLETED|Overall Study||155
381611|NCT00325780|932209|P1|COMPLETED|Overall Study||1200
381612|NCT00325780|932209|P1|Safety Population|Overall Study|Patients who received at least one dose of study treatment in this extension study.|1353
381613|NCT00325780|932209|P1|STARTED|Overall Study||1355
381614|NCT00325754|932216|P2|NOT COMPLETED|Overall Study||1
381615|NCT00325754|932217|P1|NOT COMPLETED|Overall Study||4
381616|NCT00325754|932216|P2|COMPLETED|Overall Study||10
381617|NCT00325754|932217|P1|COMPLETED|Overall Study||7
381618|NCT00325754|932216|P2|STARTED|Overall Study||11
381619|NCT00325754|932217|P1|STARTED|Overall Study||11
381620|NCT00325598|932233|P2|NOT COMPLETED|Overall Study||0
381621|NCT00325598|932234|P1|NOT COMPLETED|Overall Study||0
381622|NCT00325598|932233|P2|COMPLETED|Overall Study||50
381623|NCT00325598|932234|P1|COMPLETED|Overall Study||50
381624|NCT00325598|932233|P2|STARTED|Overall Study||50
381625|NCT00325598|932234|P1|STARTED|Overall Study||50
381626|NCT00325572|932260|P2|NOT COMPLETED|PHASE ii||0
381627|NCT00325572|932261|P1|NOT COMPLETED|PHASE ii||0
381628|NCT00325572|932260|P2|COMPLETED|PHASE ii||0
381629|NCT00325572|932261|P1|COMPLETED|PHASE ii||0
381630|NCT00325572|932260|P2|STARTED|PHASE ii||0
381631|NCT00325572|932261|P1|STARTED|PHASE ii||0
381632|NCT00325572|932260|P2|NOT COMPLETED|PHASE I||0
381633|NCT00325572|932261|P1|NOT COMPLETED|PHASE I||0
381634|NCT00325572|932260|P2|COMPLETED|PHASE I||44
381635|NCT00325572|932261|P1|COMPLETED|PHASE I||45
381636|NCT00325572|932260|P2|STARTED|PHASE I||44
381637|NCT00325572|932261|P1|STARTED|PHASE I||45
381638|NCT00325468|932272|P5|NOT COMPLETED|Overall Study||8
381639|NCT00325468|932273|P4|NOT COMPLETED|Overall Study||34
381640|NCT00325468|932274|P3|NOT COMPLETED|Overall Study||4
381641|NCT00325468|932275|P2|NOT COMPLETED|Overall Study||5
381642|NCT00325468|932276|P1|NOT COMPLETED|Overall Study||11
381643|NCT00325468|932272|P5|COMPLETED|Overall Study||14
381644|NCT00325468|932273|P4|COMPLETED|Overall Study||90
381645|NCT00325468|932274|P3|COMPLETED|Overall Study||10
381646|NCT00325468|932275|P2|COMPLETED|Overall Study||12
381647|NCT00325468|932276|P1|COMPLETED|Overall Study||12
381648|NCT00325468|932272|P5|STARTED|Overall Study||22
381649|NCT00325468|932273|P4|STARTED|Overall Study||124
381650|NCT00325468|932274|P3|STARTED|Overall Study||14
381651|NCT00325468|932275|P2|STARTED|Overall Study||17
381652|NCT00325468|932276|P1|STARTED|Overall Study||23
381653|NCT00325442|932311|P2|NOT COMPLETED|Overall Study||21
381654|NCT00325442|932312|P1|NOT COMPLETED|Overall Study||9
381655|NCT00325442|932311|P2|COMPLETED|Overall Study||153
381656|NCT00325442|932312|P1|COMPLETED|Overall Study||167
381657|NCT00325442|932311|P2|STARTED|Overall Study||174
381658|NCT00325442|932312|P1|STARTED|Overall Study||176
381659|NCT00325416|932359|P2|NOT COMPLETED|Phase II: Treatment at MTD||2
381660|NCT00325416|932360|P1|NOT COMPLETED|Phase II: Treatment at MTD||0
381661|NCT00325416|932359|P2|COMPLETED|Phase II: Treatment at MTD||40
381662|NCT00325416|932360|P1|COMPLETED|Phase II: Treatment at MTD||78
381663|NCT00325416|932359|P2|Enrolled During Phase II|Phase II: Treatment at MTD||8
381664|NCT00325416|932360|P1|Enrolled During Phase II|Phase II: Treatment at MTD||40
381665|NCT00325416|932359|P2|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||34
381666|NCT00325416|932360|P1|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||38
381667|NCT00325416|932359|P2|STARTED|Phase II: Treatment at MTD||42
381668|NCT00325416|932360|P1|STARTED|Phase II: Treatment at MTD||78
381669|NCT00325416|932359|P2|NOT COMPLETED|Phase I: Dose Escalation||16
381670|NCT00325416|932360|P1|NOT COMPLETED|Phase I: Dose Escalation||22
381671|NCT00325416|932359|P2|COMPLETED|Phase I: Dose Escalation||44
381672|NCT00325416|932360|P1|COMPLETED|Phase I: Dose Escalation||48
381673|NCT00325416|932359|P2|STARTED|Phase I: Dose Escalation||60
381674|NCT00325416|932360|P1|STARTED|Phase I: Dose Escalation||70
381675|NCT00325403|932374|P2|NOT COMPLETED|Overall Study||51
381676|NCT00325403|932375|P1|NOT COMPLETED|Overall Study||18
381677|NCT00325403|932374|P2|COMPLETED|Overall Study|182 subjects receiving oral treprostinil completed the study on study drug|182
381678|NCT00325403|932375|P1|COMPLETED|Overall Study|98 subjects receiving placebo completed the study on study drug|98
381679|NCT00325403|932374|P2|STARTED|Overall Study||233
381680|NCT00325403|932375|P1|STARTED|Overall Study||116
381681|NCT00325234|932413|P2|NOT COMPLETED|Overall Study||66
381682|NCT00325234|932414|P1|NOT COMPLETED|Overall Study||69
381683|NCT00325234|932413|P2|COMPLETED|Overall Study||0
381684|NCT00325234|932414|P1|COMPLETED|Overall Study||0
381685|NCT00325234|932413|P2|Received At Least 1 Dose of Study Drug|Overall Study||66
381686|NCT00325234|932414|P1|Received At Least 1 Dose of Study Drug|Overall Study||65
381687|NCT00325234|932413|P2|STARTED|Overall Study||66
381688|NCT00325234|932414|P1|STARTED|Overall Study||69
381689|NCT00325195|932433|P3|NOT COMPLETED|Received Intervention: ITT Population||4
381690|NCT00325195|932434|P2|NOT COMPLETED|Received Intervention: ITT Population||25
381691|NCT00325195|932435|P1|NOT COMPLETED|Received Intervention: ITT Population||26
381692|NCT00325195|932433|P3|COMPLETED|Received Intervention: ITT Population||39
381693|NCT00325195|932434|P2|COMPLETED|Received Intervention: ITT Population||59
381694|NCT00325195|932435|P1|COMPLETED|Received Intervention: ITT Population||59
381695|NCT00325195|932433|P3|STARTED|Received Intervention: ITT Population||43
381696|NCT00325195|932434|P2|STARTED|Received Intervention: ITT Population||84
381697|NCT00325195|932435|P1|STARTED|Received Intervention: ITT Population||85
381698|NCT00325195|932433|P3|NOT COMPLETED|Randomized||3
381699|NCT00325195|932434|P2|NOT COMPLETED|Randomized||5
381700|NCT00325195|932435|P1|NOT COMPLETED|Randomized||5
381701|NCT00325195|932433|P3|COMPLETED|Randomized||43
381702|NCT00325195|932434|P2|COMPLETED|Randomized||84
381703|NCT00325195|932435|P1|COMPLETED|Randomized||85
381704|NCT00325195|932433|P3|STARTED|Randomized||46
381705|NCT00325195|932434|P2|STARTED|Randomized||89
381706|NCT00325195|932435|P1|STARTED|Randomized||90
381707|NCT00325156|932458|P1|NOT COMPLETED|Overall Study||112
381708|NCT00325156|932458|P1|COMPLETED|Overall Study||2478
381709|NCT00325156|932458|P1|STARTED|Overall Study||2590
381710|NCT00325143|932465|P1|NOT COMPLETED|Overall Study||26
381711|NCT00325143|932465|P1|COMPLETED|Overall Study||676
381712|NCT00325143|932465|P1|STARTED|Overall Study||702
381713|NCT00325130|932475|P2|NOT COMPLETED|Overall Study||30
381714|NCT00325130|932476|P1|NOT COMPLETED|Overall Study||19
381715|NCT00325130|932475|P2|COMPLETED|Overall Study||494
381716|NCT00325130|932476|P1|COMPLETED|Overall Study||499
381717|NCT00325130|932475|P2|STARTED|Overall Study||524
381718|NCT00325130|932476|P1|STARTED|Overall Study||518
381719|NCT00325078|932519|P3|NOT COMPLETED|Overall Study||2
381720|NCT00325078|932520|P2|NOT COMPLETED|Overall Study||5
381721|NCT00325078|932521|P1|NOT COMPLETED|Overall Study||5
381722|NCT00325078|932519|P3|COMPLETED|Overall Study||23
381723|NCT00325078|932520|P2|COMPLETED|Overall Study||2
381724|NCT00325078|932521|P1|COMPLETED|Overall Study||3
381725|NCT00325078|932519|P3|STARTED|Overall Study||25
381726|NCT00325078|932520|P2|STARTED|Overall Study||7
381727|NCT00325078|932521|P1|STARTED|Overall Study||8
381728|NCT00325039|932533|P2|NOT COMPLETED|Overall Study||14
381729|NCT00325039|932534|P1|NOT COMPLETED|Overall Study||18
381730|NCT00325039|932533|P2|COMPLETED|Overall Study||285
381731|NCT00325039|932534|P1|COMPLETED|Overall Study||280
381732|NCT00325039|932533|P2|STARTED|Overall Study||299
381733|NCT00325039|932534|P1|STARTED|Overall Study||298
381734|NCT00324987|932550|P2|NOT COMPLETED|Overall Study||6
381735|NCT00324987|932551|P1|NOT COMPLETED|Overall Study||6
381736|NCT00324987|932550|P2|COMPLETED|Overall Study|Patients were to be treated until progression|0
381737|NCT00324987|932551|P1|COMPLETED|Overall Study|Patients were to be treated until progression|0
381738|NCT00324987|932550|P2|STARTED|Overall Study||6
381739|NCT00324987|932551|P1|STARTED|Overall Study||6
381740|NCT00324961|932565|P1|NOT COMPLETED|Overall Study||43
381741|NCT00324961|932565|P1|COMPLETED|Overall Study||490
381742|NCT00324961|932565|P1|STARTED|Overall Study||533
381743|NCT00324896|932580|P2|NOT COMPLETED|Overall Study||8
381744|NCT00324896|932581|P1|NOT COMPLETED|Overall Study||3
381745|NCT00324896|932580|P2|COMPLETED|Overall Study||7
381746|NCT00324896|932581|P1|COMPLETED|Overall Study||12
381747|NCT00324896|932580|P2|STARTED|Overall Study||15
381748|NCT00324896|932581|P1|STARTED|Overall Study||15
381749|NCT00324870|932589|P1|NOT COMPLETED|Overall Study||0
381750|NCT00324870|932589|P1|COMPLETED|Overall Study||37
381751|NCT00324870|932589|P1|STARTED|Overall Study||37
381752|NCT00324857|932597|P4|NOT COMPLETED|Overall Study||5
381753|NCT00324857|932598|P3|NOT COMPLETED|Overall Study||7
381754|NCT00324857|932599|P2|NOT COMPLETED|Overall Study||6
381755|NCT00324857|932600|P1|NOT COMPLETED|Overall Study||6
381756|NCT00324857|932597|P4|COMPLETED|Overall Study||158
381757|NCT00324857|932598|P3|COMPLETED|Overall Study||158
381758|NCT00324857|932599|P2|COMPLETED|Overall Study||162
381759|NCT00324857|932600|P1|COMPLETED|Overall Study||161
381760|NCT00324857|932597|P4|STARTED|Overall Study||163
381761|NCT00324857|932598|P3|STARTED|Overall Study||165
381762|NCT00324857|932599|P2|STARTED|Overall Study||168
381763|NCT00324857|932600|P1|STARTED|Overall Study||167
381764|NCT00324805|932616|P2|NOT COMPLETED|Overall Study||483
381765|NCT00324805|932617|P1|NOT COMPLETED|Overall Study||150
381766|NCT00324805|932616|P2|COMPLETED|Overall Study||269
381767|NCT00324805|932617|P1|COMPLETED|Overall Study||599
381768|NCT00324805|932616|P2|Started Assigned Therapy|Overall Study||735
381769|NCT00324805|932617|P1|Started Assigned Therapy|Overall Study||737
381770|NCT00324805|932616|P2|STARTED|Overall Study||752
381771|NCT00324805|932617|P1|STARTED|Overall Study||749
381772|NCT00324753|932631|P2|NOT COMPLETED|Overall Study||0
381773|NCT00324753|932632|P1|NOT COMPLETED|Overall Study||0
381774|NCT00324753|932631|P2|COMPLETED|Overall Study||264
381775|NCT00324753|932632|P1|COMPLETED|Overall Study||190
381776|NCT00324753|932631|P2|STARTED|Overall Study||264
381777|NCT00324753|932632|P1|STARTED|Overall Study||190
381778|NCT00324740|932642|P3|NOT COMPLETED|Overall Study||1
381779|NCT00324740|932643|P2|NOT COMPLETED|Overall Study||0
381780|NCT00324740|932644|P1|NOT COMPLETED|Overall Study||1
381781|NCT00324740|932642|P3|COMPLETED|Overall Study||3
381782|NCT00324740|932643|P2|COMPLETED|Overall Study||3
381783|NCT00324740|932644|P1|COMPLETED|Overall Study||6
381784|NCT00324740|932642|P3|STARTED|Overall Study||4
381785|NCT00324740|932643|P2|STARTED|Overall Study||3
381786|NCT00324740|932644|P1|STARTED|Overall Study||7
381787|NCT00324701|932653|P2|NOT COMPLETED|Overall Study||17
381788|NCT00324701|932654|P1|NOT COMPLETED|Overall Study||20
381789|NCT00324701|932653|P2|COMPLETED|Overall Study||104
381790|NCT00324701|932654|P1|COMPLETED|Overall Study||100
381791|NCT00324701|932653|P2|Week 8 Assessment|Overall Study||107
381792|NCT00324701|932654|P1|Week 8 Assessment|Overall Study||108
381793|NCT00324701|932653|P2|STARTED|Overall Study||121
381794|NCT00324701|932654|P1|STARTED|Overall Study||120
381795|NCT00324675|932664|P2|NOT COMPLETED|Overall Study||0
381796|NCT00324675|932665|P1|NOT COMPLETED|Overall Study||1
381797|NCT00324675|932664|P2|COMPLETED|Overall Study||14
381798|NCT00324675|932665|P1|COMPLETED|Overall Study||13
381799|NCT00324675|932664|P2|STARTED|Overall Study||14
381800|NCT00324675|932665|P1|STARTED|Overall Study||14
381801|NCT00324649|932673|P2|NOT COMPLETED|Overall Study||5
381802|NCT00324649|932674|P1|NOT COMPLETED|Overall Study||2
381803|NCT00324649|932673|P2|COMPLETED|Overall Study||36
381804|NCT00324649|932674|P1|COMPLETED|Overall Study||37
381805|NCT00324649|932673|P2|STARTED|Overall Study||41
381806|NCT00324649|932674|P1|STARTED|Overall Study||39
381807|NCT00324415|932714|P1|NOT COMPLETED|Overall Study||0
381808|NCT00324415|932714|P1|COMPLETED|Overall Study||45
381809|NCT00324415|932714|P1|STARTED|Overall Study||45
381810|NCT00324350|932729|P2|NOT COMPLETED|Overall Study||0
381811|NCT00324350|932730|P1|NOT COMPLETED|Overall Study||0
381812|NCT00324350|932729|P2|COMPLETED|Overall Study||3632
381813|NCT00324350|932730|P1|COMPLETED|Overall Study||3655
381814|NCT00324350|932729|P2|Falls Follow-Up|Overall Study||3418
381815|NCT00324350|932730|P1|Falls Follow-Up|Overall Study||3364
381816|NCT00324350|932729|P2|Non-Vertebral Fracture Follow-Up|Overall Study||3632
381817|NCT00324350|932730|P1|Non-Vertebral Fracture Follow-Up|Overall Study||3655
381818|NCT00324350|932729|P2|STARTED|Overall Study||3632
381819|NCT00324350|932730|P1|STARTED|Overall Study||3655
381820|NCT00324272|932744|P4|NOT COMPLETED|Overall Study||0
381821|NCT00324272|932745|P3|NOT COMPLETED|Overall Study||0
381822|NCT00324272|932746|P2|NOT COMPLETED|Overall Study||0
381823|NCT00324272|932747|P1|NOT COMPLETED|Overall Study||0
381824|NCT00324272|932744|P4|COMPLETED|Overall Study||18
381825|NCT00324272|932745|P3|COMPLETED|Overall Study||18
381826|NCT00324272|932746|P2|COMPLETED|Overall Study||20
381827|NCT00324272|932747|P1|COMPLETED|Overall Study||18
381828|NCT00324272|932744|P4|STARTED|Overall Study||18
381829|NCT00324272|932745|P3|STARTED|Overall Study||18
381830|NCT00324272|932746|P2|STARTED|Overall Study||20
381831|NCT00324272|932747|P1|STARTED|Overall Study||18
381832|NCT00324259|932783|P2|NOT COMPLETED|Overall Study||0
381833|NCT00324259|932784|P1|NOT COMPLETED|Overall Study||0
381834|NCT00324259|932783|P2|COMPLETED|Overall Study||32
381835|NCT00324259|932784|P1|COMPLETED|Overall Study||34
381836|NCT00324259|932783|P2|STARTED|Overall Study||32
381837|NCT00324259|932784|P1|STARTED|Overall Study||34
381838|NCT00324233|932805|P2|NOT COMPLETED|Second Period||7
381839|NCT00324233|932806|P1|NOT COMPLETED|Second Period||5
381840|NCT00324233|932805|P2|COMPLETED|Second Period||11
381841|NCT00324233|932806|P1|COMPLETED|Second Period||12
381842|NCT00324233|932805|P2|STARTED|Second Period||18
381843|NCT00324233|932806|P1|STARTED|Second Period||17
381844|NCT00324233|932805|P2|NOT COMPLETED|First Period||0
381845|NCT00324233|932806|P1|NOT COMPLETED|First Period||1
381846|NCT00324233|932805|P2|COMPLETED|First Period||18
381847|NCT00324233|932806|P1|COMPLETED|First Period||17
381848|NCT00324233|932805|P2|STARTED|First Period||18
381849|NCT00324233|932806|P1|STARTED|First Period||18
381850|NCT00324168|932814|P2|NOT COMPLETED|Overall Study||30
381851|NCT00324168|932815|P1|NOT COMPLETED|Overall Study||28
381852|NCT00324168|932814|P2|COMPLETED|Overall Study||220
381853|NCT00324168|932815|P1|COMPLETED|Overall Study||222
381854|NCT00324168|932814|P2|STARTED|Overall Study||250
381855|NCT00324168|932815|P1|STARTED|Overall Study||250
381856|NCT00324155|932843|P2|NOT COMPLETED|Follow-up Phase||6
381857|NCT00324155|932844|P1|NOT COMPLETED|Follow-up Phase||11
381858|NCT00324155|932843|P2|COMPLETED|Follow-up Phase||245
381859|NCT00324155|932844|P1|COMPLETED|Follow-up Phase||236
381860|NCT00324155|932843|P2|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|251
381861|NCT00324155|932844|P1|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|247
381862|NCT00324155|932843|P2|NOT COMPLETED|Received Treatment in Maintenance Phase||47
381863|NCT00324155|932844|P1|NOT COMPLETED|Received Treatment in Maintenance Phase||32
381864|NCT00324155|932843|P2|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure. 6 participants in Maintenance Phase not yet summarized.|6
381865|NCT00324155|932844|P1|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure at this time. 11 in Maintenance Phase not yet summarized.|11
381866|NCT00324155|932843|P2|STARTED|Received Treatment in Maintenance Phase|1 completed Induction Phase but did not enter Maintenance Phase|53
381867|NCT00324155|932844|P1|STARTED|Received Treatment in Maintenance Phase|2 completed Induction Phase but did not enter Maintenance Phase|43
381868|NCT00324155|932843|P2|NOT COMPLETED|Received Treatment in Induction Phase||197
381869|NCT00324155|932844|P1|NOT COMPLETED|Received Treatment in Induction Phase||202
381870|NCT00324155|932843|P2|COMPLETED|Received Treatment in Induction Phase|54 participants on treatment at end of Induction Phase. Study undergoing closure.|54
381871|NCT00324155|932844|P1|COMPLETED|Received Treatment in Induction Phase|45 participants on treatment at end of Induction Phase. Study undergoing closure.|45
381872|NCT00324155|932843|P2|STARTED|Received Treatment in Induction Phase||251
381873|NCT00324155|932844|P1|STARTED|Received Treatment in Induction Phase||247
381874|NCT00324155|932843|P2|NOT COMPLETED|Enrolled and Randomized||1
381875|NCT00324155|932844|P1|NOT COMPLETED|Enrolled and Randomized||3
381876|NCT00324155|932843|P2|COMPLETED|Enrolled and Randomized|1 randomized but who did not receive treatment (lost to follow-up).|251
381877|NCT00324155|932844|P1|COMPLETED|Enrolled and Randomized|3 randomized but who did not receive treatment (no longer met study criteria).|247
381878|NCT00324155|932843|P2|STARTED|Enrolled and Randomized||252
381879|NCT00324155|932844|P1|STARTED|Enrolled and Randomized||250
381880|NCT00324116|932874|P1|NOT COMPLETED|Overall Study||32
381881|NCT00324116|932874|P1|COMPLETED|Overall Study||49
381882|NCT00324116|932874|P1|STARTED|Overall Study|subjects received treatment|81
381883|NCT00324038|932886|P2|NOT COMPLETED|Overall Study||51
381884|NCT00324038|932887|P1|NOT COMPLETED|Overall Study||49
381885|NCT00324038|932886|P2|COMPLETED|Overall Study||58
381886|NCT00324038|932887|P1|COMPLETED|Overall Study||61
381887|NCT00324038|932886|P2|STARTED|Overall Study||109
381888|NCT00324038|932887|P1|STARTED|Overall Study||110
381889|NCT00323882|932898|P5|NOT COMPLETED|Overall Study||32
381890|NCT00323882|932899|P4|NOT COMPLETED|Overall Study||7
381891|NCT00323882|932900|P3|NOT COMPLETED|Overall Study||13
381892|NCT00323882|932901|P2|NOT COMPLETED|Overall Study||6
381893|NCT00323882|932902|P1|NOT COMPLETED|Overall Study||8
381894|NCT00323882|932898|P5|COMPLETED|Overall Study||2
381895|NCT00323882|932899|P4|COMPLETED|Overall Study||0
381896|NCT00323882|932900|P3|COMPLETED|Overall Study||3
381897|NCT00323882|932901|P2|COMPLETED|Overall Study||0
381898|NCT00323882|932902|P1|COMPLETED|Overall Study||0
381899|NCT00323882|932898|P5|STARTED|Overall Study||34
381900|NCT00323882|932899|P4|STARTED|Overall Study||7
381901|NCT00323882|932900|P3|STARTED|Overall Study||16
381902|NCT00323882|932901|P2|STARTED|Overall Study||6
381903|NCT00323882|932902|P1|STARTED|Overall Study||8
381904|NCT00323869|932973|P1|NOT COMPLETED|Overall Study||1
381905|NCT00323869|932973|P1|COMPLETED|Overall Study||47
381906|NCT00323869|932973|P1|Treatment Initiation|Overall Study|One participant died before receiving therapy, not included in analysis|47
381907|NCT00323869|932973|P1|STARTED|Overall Study|Enrollment|48
381908|NCT00323739|932985|P1|NOT COMPLETED|Overall Study||0
381909|NCT00323739|932985|P1|COMPLETED|Overall Study||80
381910|NCT00323739|932985|P1|STARTED|Overall Study||80
381911|NCT00323635|932992|P2|NOT COMPLETED|Overall Study||0
381912|NCT00323635|932993|P1|NOT COMPLETED|Overall Study||0
381913|NCT00323635|932992|P2|COMPLETED|Overall Study||9
381914|NCT00323635|932993|P1|COMPLETED|Overall Study||10
381915|NCT00323635|932992|P2|STARTED|Overall Study||9
381916|NCT00323635|932993|P1|STARTED|Overall Study||10
381917|NCT00323622|933029|P8|NOT COMPLETED|Overall Study||15
381918|NCT00323622|933030|P7|NOT COMPLETED|Overall Study||5
381919|NCT00323622|933031|P6|NOT COMPLETED|Overall Study||74
381920|NCT00323622|933032|P5|NOT COMPLETED|Overall Study||39
381921|NCT00323622|933033|P4|NOT COMPLETED|Overall Study||12
381922|NCT00323622|933034|P3|NOT COMPLETED|Overall Study||4
381923|NCT00323622|933035|P2|NOT COMPLETED|Overall Study||92
381924|NCT00323622|933036|P1|NOT COMPLETED|Overall Study||31
381925|NCT00323622|933029|P8|COMPLETED|Overall Study||125
381926|NCT00323622|933030|P7|COMPLETED|Overall Study||38
381927|NCT00323622|933031|P6|COMPLETED|Overall Study||454
381928|NCT00323622|933032|P5|COMPLETED|Overall Study||120
381929|NCT00323622|933033|P4|COMPLETED|Overall Study||122
381930|NCT00323622|933034|P3|COMPLETED|Overall Study||38
381931|NCT00323622|933035|P2|COMPLETED|Overall Study||423
381932|NCT00323622|933036|P1|COMPLETED|Overall Study||145
381933|NCT00323622|933029|P8|STARTED|Overall Study||140
381934|NCT00323622|933030|P7|STARTED|Overall Study||43
381935|NCT00323622|933031|P6|STARTED|Overall Study||528
381936|NCT00323622|933032|P5|STARTED|Overall Study||159
381937|NCT00323622|933033|P4|STARTED|Overall Study||134
381938|NCT00323622|933034|P3|STARTED|Overall Study||42
381939|NCT00323622|933035|P2|STARTED|Overall Study||515
381940|NCT00323622|933036|P1|STARTED|Overall Study||176
381941|NCT00323609|933078|P4|NOT COMPLETED|Overall Study||15
381942|NCT00323609|933079|P3|NOT COMPLETED|Overall Study||8
381943|NCT00323609|933080|P2|NOT COMPLETED|Overall Study||99
381944|NCT00323609|933081|P1|NOT COMPLETED|Overall Study||91
381945|NCT00323609|933078|P4|COMPLETED|Overall Study||0
381946|NCT00323609|933079|P3|COMPLETED|Overall Study||0
381947|NCT00323609|933080|P2|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|91
381948|NCT00323609|933081|P1|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|100
381949|NCT00323609|933078|P4|STARTED|Overall Study||15
381950|NCT00323609|933079|P3|STARTED|Overall Study||8
381951|NCT00323609|933080|P2|STARTED|Overall Study||190
381952|NCT00323609|933081|P1|STARTED|Overall Study||191
381953|NCT00323557|933117|P2|NOT COMPLETED|Overall Study||0
381954|NCT00323557|933118|P1|NOT COMPLETED|Overall Study||1
381955|NCT00323557|933117|P2|COMPLETED|Overall Study||7
381956|NCT00323557|933118|P1|COMPLETED|Overall Study||24
381957|NCT00323557|933117|P2|STARTED|Overall Study||7
381958|NCT00323557|933118|P1|STARTED|Overall Study|GM-CSF pre and post vaccine.|25
381959|NCT00323492|933127|P3|NOT COMPLETED|Study Phase 2||1
381960|NCT00323492|933128|P2|NOT COMPLETED|Study Phase 2||1
381961|NCT00323492|933129|P1|NOT COMPLETED|Study Phase 2||4
381962|NCT00323492|933127|P3|COMPLETED|Study Phase 2||24
381963|NCT00323492|933128|P2|COMPLETED|Study Phase 2||17
381964|NCT00323492|933129|P1|COMPLETED|Study Phase 2||40
381965|NCT00323492|933127|P3|STARTED|Study Phase 2|N=25 switched to Truvada in Phase 2.|25
381966|NCT00323492|933128|P2|STARTED|Study Phase 2|2/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=20 (no switch to Truvada)|18
381967|NCT00323492|933129|P1|STARTED|Study Phase 2|1/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=46|44
381968|NCT00323492|933127|P3|NOT COMPLETED|Study Phase 1||0
381969|NCT00323492|933128|P2|NOT COMPLETED|Study Phase 1||0
381970|NCT00323492|933129|P1|NOT COMPLETED|Study Phase 1||2
381971|NCT00323492|933127|P3|COMPLETED|Study Phase 1||0
381972|NCT00323492|933128|P2|COMPLETED|Study Phase 1||45
381973|NCT00323492|933129|P1|COMPLETED|Study Phase 1||45
381974|NCT00323492|933127|P3|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||0
381975|NCT00323492|933128|P2|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||45
381976|NCT00323492|933129|P1|Intent-to-Treat (ITT) Analysis Set|Study Phase 1|One subject was excluded from ITT analysis set due to protocol violation.|46
381977|NCT00323492|933127|P3|STARTED|Study Phase 1|Not applicable to Phase 1.|0
381978|NCT00323492|933128|P2|STARTED|Study Phase 1||45
381979|NCT00323492|933129|P1|STARTED|Study Phase 1||47
381980|NCT00323479|933160|P1|NOT COMPLETED|Overall Study||8
381981|NCT00323479|933160|P1|COMPLETED|Overall Study|with at least 1 evaluation for primary efficacy endpoint|106
381982|NCT00323479|933160|P1|Safety Population|Overall Study|Patients who taken at least one dose of treatment|110
381983|NCT00323479|933160|P1|STARTED|Overall Study||114
381984|NCT00323453|933171|P2|NOT COMPLETED|Overall Study||0
381985|NCT00323453|933172|P1|NOT COMPLETED|Overall Study||0
381986|NCT00323453|933171|P2|COMPLETED|Overall Study||48
381987|NCT00323453|933172|P1|COMPLETED|Overall Study||61
381988|NCT00323453|933171|P2|STARTED|Overall Study||48
381989|NCT00323453|933172|P1|STARTED|Overall Study||61
381990|NCT00323427|933180|P2|NOT COMPLETED|Overall Study||23
381991|NCT00323427|933181|P1|NOT COMPLETED|Overall Study||31
381992|NCT00323427|933180|P2|COMPLETED|Overall Study||43
381993|NCT00323427|933181|P1|COMPLETED|Overall Study||38
381994|NCT00323427|933180|P2|STARTED|Overall Study||66
381995|NCT00323427|933181|P1|STARTED|Overall Study||69
381996|NCT00323414|933193|P2|NOT COMPLETED|Overall Study||1
381997|NCT00323414|933194|P1|NOT COMPLETED|Overall Study||0
381998|NCT00323414|933193|P2|COMPLETED|Overall Study||18
381999|NCT00323414|933194|P1|COMPLETED|Overall Study||18
382000|NCT00323414|933193|P2|STARTED|Overall Study||19
382001|NCT00323414|933194|P1|STARTED|Overall Study||18
382002|NCT00323362|933210|P1|NOT COMPLETED|Overall Study||0
382003|NCT00323362|933210|P1|COMPLETED|Overall Study||17
382004|NCT00323362|933210|P1|STARTED|Overall Study||17
382005|NCT00323310|933216|P1|NOT COMPLETED|Overall Study||3
382006|NCT00323310|933216|P1|COMPLETED|Overall Study||89
382007|NCT00323310|933216|P1|STARTED|Overall Study||92
382008|NCT00323297|933231|P2|NOT COMPLETED|Part B (Open-label)||12
382009|NCT00323297|933232|P1|NOT COMPLETED|Part B (Open-label)||9
382010|NCT00323297|933231|P2|COMPLETED|Part B (Open-label)||31
382011|NCT00323297|933232|P1|COMPLETED|Part B (Open-label)||39
382012|NCT00323297|933231|P2|STARTED|Part B (Open-label)||43
382013|NCT00323297|933232|P1|STARTED|Part B (Open-label)||48
382014|NCT00323297|933231|P2|NOT COMPLETED|Part A (Double Blind Randomized)||7
382015|NCT00323297|933232|P1|NOT COMPLETED|Part A (Double Blind Randomized)||5
382016|NCT00323297|933231|P2|COMPLETED|Part A (Double Blind Randomized)||43
382017|NCT00323297|933232|P1|COMPLETED|Part A (Double Blind Randomized)||48
382018|NCT00323297|933231|P2|STARTED|Part A (Double Blind Randomized)||50
382019|NCT00323297|933232|P1|STARTED|Part A (Double Blind Randomized)||53
382020|NCT00323284|933250|P2|NOT COMPLETED|24 Months Follow-up||22
382021|NCT00323284|933251|P1|NOT COMPLETED|24 Months Follow-up||18
382022|NCT00323284|933250|P2|COMPLETED|24 Months Follow-up||101
382023|NCT00323284|933251|P1|COMPLETED|24 Months Follow-up||98
382024|NCT00323284|933250|P2|STARTED|24 Months Follow-up||123
382025|NCT00323284|933251|P1|STARTED|24 Months Follow-up||116
382026|NCT00323284|933250|P2|NOT COMPLETED|12 Months Follow-up||9
382027|NCT00323284|933251|P1|NOT COMPLETED|12 Months Follow-up||5
382028|NCT00323284|933250|P2|COMPLETED|12 Months Follow-up||114
382029|NCT00323284|933251|P1|COMPLETED|12 Months Follow-up||111
382030|NCT00323284|933250|P2|STARTED|12 Months Follow-up||123
382031|NCT00323284|933251|P1|STARTED|12 Months Follow-up||116
382032|NCT00323271|933261|P2|NOT COMPLETED|Overall Study||3
382033|NCT00323271|933262|P1|NOT COMPLETED|Overall Study||2
382034|NCT00323271|933261|P2|COMPLETED|Overall Study||9
382035|NCT00323271|933262|P1|COMPLETED|Overall Study||11
382036|NCT00323271|933261|P2|STARTED|Overall Study||12
382037|NCT00323271|933262|P1|STARTED|Overall Study||13
382038|NCT00323258|933272|P2|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
382039|NCT00323258|933273|P1|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
382040|NCT00323258|933272|P2|COMPLETED|Secondary Outcome (6 Mon Refill Records)||58
382041|NCT00323258|933273|P1|COMPLETED|Secondary Outcome (6 Mon Refill Records)||57
382042|NCT00323258|933272|P2|STARTED|Secondary Outcome (6 Mon Refill Records)||72
382043|NCT00323258|933273|P1|STARTED|Secondary Outcome (6 Mon Refill Records)||71
382044|NCT00323258|933272|P2|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||19
382045|NCT00323258|933273|P1|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||16
382046|NCT00323258|933272|P2|COMPLETED|Primary Outcome (Phone Call at 6 Months)||53
382047|NCT00323258|933273|P1|COMPLETED|Primary Outcome (Phone Call at 6 Months)||55
382048|NCT00323258|933272|P2|STARTED|Primary Outcome (Phone Call at 6 Months)||72
382049|NCT00323258|933273|P1|STARTED|Primary Outcome (Phone Call at 6 Months)||71
382050|NCT00323193|933289|P2|NOT COMPLETED|Overall Study||15
382051|NCT00323193|933290|P1|NOT COMPLETED|Overall Study||23
382052|NCT00323193|933289|P2|COMPLETED|Overall Study||41
382053|NCT00323193|933290|P1|COMPLETED|Overall Study||30
382054|NCT00323193|933289|P2|STARTED|Overall Study||56
382055|NCT00323193|933290|P1|STARTED|Overall Study||53
382056|NCT00323115|933298|P1|NOT COMPLETED|Adjuvant Therapy & Survival Follow-Up||8
382057|NCT00323115|933298|P1|COMPLETED|Adjuvant Therapy & Survival Follow-Up||2
382058|NCT00323115|933298|P1|STARTED|Adjuvant Therapy & Survival Follow-Up||10
382059|NCT00323115|933298|P1|NOT COMPLETED|Vaccine Administration||1
382060|NCT00323115|933298|P1|COMPLETED|Vaccine Administration||10
382061|NCT00323115|933298|P1|STARTED|Vaccine Administration||11
382062|NCT00323063|933325|P2|NOT COMPLETED|Overall Study||0
382063|NCT00323063|933326|P1|NOT COMPLETED|Overall Study||2
382064|NCT00323063|933325|P2|COMPLETED|Overall Study||23
382065|NCT00323063|933326|P1|COMPLETED|Overall Study||24
382066|NCT00323063|933325|P2|STARTED|Overall Study||23
382067|NCT00323063|933326|P1|STARTED|Overall Study||26
382068|NCT00323037|933338|P2|NOT COMPLETED|Overall Study||27
382069|NCT00323037|933339|P1|NOT COMPLETED|Overall Study||33
382070|NCT00323037|933338|P2|COMPLETED|Overall Study||126
382071|NCT00323037|933339|P1|COMPLETED|Overall Study||132
382072|NCT00323037|933338|P2|STARTED|Overall Study|Number randomized|153
382073|NCT00323037|933339|P1|STARTED|Overall Study|Number randomized|165
382074|NCT00322881|933343|P1|NOT COMPLETED|Overall Study||5
382075|NCT00322881|933343|P1|COMPLETED|Overall Study||7
382076|NCT00322881|933343|P1|STARTED|Overall Study||12
382077|NCT00322868|933347|P1|NOT COMPLETED|Overall Study||1
382078|NCT00322868|933347|P1|COMPLETED|Overall Study||20
382079|NCT00322868|933347|P1|STARTED|Overall Study||21
382080|NCT00322855|933366|P1|NOT COMPLETED|Overall Study||0
382081|NCT00322855|933366|P1|COMPLETED|Overall Study||1
382082|NCT00322855|933366|P1|STARTED|Overall Study||1
382083|NCT00322842|933372|P2|NOT COMPLETED|Overall Study||2
382084|NCT00322842|933373|P1|NOT COMPLETED|Overall Study||2
382085|NCT00322842|933372|P2|COMPLETED|Overall Study|One participant d/c treatment early, received a transplant, and was lost to follow-up after 6 months|29
382086|NCT00322842|933373|P1|COMPLETED|Overall Study|One participant discontinued (d/c) treatment early, received a transplant, and completed the study.|2
382087|NCT00322842|933372|P2|STARTED|Overall Study||31
382088|NCT00322842|933373|P1|STARTED|Overall Study||4
382089|NCT00322777|933400|P2|NOT COMPLETED|Overall Study||0
382090|NCT00322777|933401|P1|NOT COMPLETED|Overall Study||0
382091|NCT00322777|933400|P2|COMPLETED|Overall Study||45
382092|NCT00322777|933401|P1|COMPLETED|Overall Study||39
382093|NCT00322777|933400|P2|Data Collection at Week 24|Overall Study||45
382094|NCT00322777|933401|P1|Data Collection at Week 24|Overall Study||39
382095|NCT00322777|933400|P2|Data Collection at Week 16|Overall Study||45
382096|NCT00322777|933401|P1|Data Collection at Week 16|Overall Study||39
382097|NCT00322777|933400|P2|Data Collection at Week 8|Overall Study||45
382098|NCT00322777|933401|P1|Data Collection at Week 8|Overall Study||39
382099|NCT00322777|933400|P2|"Data Collection at BASELINE|"|Overall Study||45
382100|NCT00322777|933401|P1|"Data Collection at BASELINE|"|Overall Study||39
382101|NCT00322777|933400|P2|STARTED|Overall Study||45
382102|NCT00322777|933401|P1|STARTED|Overall Study||39
382103|NCT00322712|933411|P1|NOT COMPLETED|Overall Study||1
382104|NCT00322712|933411|P1|COMPLETED|Overall Study||11
382105|NCT00322712|933411|P1|STARTED|Overall Study||12
382106|NCT00322621|933415|P3|NOT COMPLETED|Period III - Maintenance / Rescue Phase||36
382107|NCT00322621|933416|P2|NOT COMPLETED|Period III - Maintenance / Rescue Phase||29
382108|NCT00322621|933417|P1|NOT COMPLETED|Period III - Maintenance / Rescue Phase||0
382109|NCT00322621|933415|P3|COMPLETED|Period III - Maintenance / Rescue Phase||33
382110|NCT00322621|933416|P2|COMPLETED|Period III - Maintenance / Rescue Phase||86
382111|NCT00322621|933417|P1|COMPLETED|Period III - Maintenance / Rescue Phase||0
382112|NCT00322621|933415|P3|STARTED|Period III - Maintenance / Rescue Phase||69
382113|NCT00322621|933416|P2|STARTED|Period III - Maintenance / Rescue Phase||115
382114|NCT00322621|933417|P1|STARTED|Period III - Maintenance / Rescue Phase||0
382115|NCT00322621|933415|P3|NOT COMPLETED|Period II - Acute Therapy Phase||0
382116|NCT00322621|933416|P2|NOT COMPLETED|Period II - Acute Therapy Phase||0
382117|NCT00322621|933417|P1|NOT COMPLETED|Period II - Acute Therapy Phase||32
382118|NCT00322621|933415|P3|COMPLETED|Period II - Acute Therapy Phase||0
382119|NCT00322621|933416|P2|COMPLETED|Period II - Acute Therapy Phase||0
382120|NCT00322621|933417|P1|COMPLETED|Period II - Acute Therapy Phase||184
382121|NCT00322621|933415|P3|STARTED|Period II - Acute Therapy Phase||0
382122|NCT00322621|933416|P2|STARTED|Period II - Acute Therapy Phase||0
382123|NCT00322621|933417|P1|STARTED|Period II - Acute Therapy Phase||216
382124|NCT00322556|933469|P1|NOT COMPLETED|Overall Study||12
382125|NCT00322556|933469|P1|COMPLETED|Overall Study||43
382126|NCT00322556|933469|P1|STARTED|Overall Study||55
382127|NCT00322491|933485|P2|NOT COMPLETED|Overall Study||2
382128|NCT00322491|933486|P1|NOT COMPLETED|Overall Study||2
382129|NCT00322491|933485|P2|COMPLETED|Overall Study||24
382130|NCT00322491|933486|P1|COMPLETED|Overall Study||21
382131|NCT00322491|933485|P2|STARTED|Overall Study||26
382132|NCT00322491|933486|P1|STARTED|Overall Study||23
382133|NCT00322465|933512|P4|NOT COMPLETED|Overall Study||26
382134|NCT00322465|933513|P3|NOT COMPLETED|Overall Study||26
382135|NCT00322465|933514|P2|NOT COMPLETED|Overall Study||24
382136|NCT00322465|933515|P1|NOT COMPLETED|Overall Study||20
382137|NCT00322465|933512|P4|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|53
382138|NCT00322465|933513|P3|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|51
382139|NCT00322465|933514|P2|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|49
382140|NCT00322465|933515|P1|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|56
382141|NCT00322465|933512|P4|STARTED|Overall Study|Randomized|79
382142|NCT00322465|933513|P3|STARTED|Overall Study|Randomized|77
382143|NCT00322465|933514|P2|STARTED|Overall Study|Randomized|73
382144|NCT00322465|933515|P1|STARTED|Overall Study|Randomized|76
382145|NCT00322452|933576|P2|NOT COMPLETED|Overall Study||276
382146|NCT00322452|933577|P1|NOT COMPLETED|Overall Study||247
382147|NCT00322452|933576|P2|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 84 remained at OS DCO (14 June 2010)|332
382148|NCT00322452|933577|P1|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 97 remained at OS DCO (14 June 2010)|362
382149|NCT00322452|933576|P2|STARTED|Overall Study|Number of patients randomized|608
382150|NCT00322452|933577|P1|STARTED|Overall Study|Number of patients randomized|609
382151|NCT00322439|933613|P1|NOT COMPLETED|Overall Study||1056
382152|NCT00322439|933613|P1|COMPLETED|Overall Study||1455
382153|NCT00322439|933613|P1|Received at Least 1 Dose of Etanercept|Overall Study||2510
382154|NCT00322439|933613|P1|STARTED|Overall Study||2511
382155|NCT00322387|933628|P2|NOT COMPLETED|Follow-up Period||3
382156|NCT00322387|933629|P1|NOT COMPLETED|Follow-up Period||2
382157|NCT00322387|933628|P2|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|23
382158|NCT00322387|933629|P1|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|12
382159|NCT00322387|933628|P2|STARTED|Follow-up Period|Participants who had transplants. One participant did not complete therapy but had a transplant.|26
382160|NCT00322387|933629|P1|STARTED|Follow-up Period|Participants who had transplants|14
382161|NCT00322387|933628|P2|NOT COMPLETED|Treatment Period||1
382162|NCT00322387|933629|P1|NOT COMPLETED|Treatment Period||0
382163|NCT00322387|933628|P2|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|25
382164|NCT00322387|933629|P1|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|14
382165|NCT00322387|933628|P2|STARTED|Treatment Period|Plerixafor PM=12, Plerixafor AM=9, Low CD34+ Count/Plerixafor PM=1, and Plerixafor After Chemo=4|26
382166|NCT00322387|933629|P1|STARTED|Treatment Period|Plerixafor PM=7, Plerixafor AM=6, Low CD34+ Count/Plerixafor PM=0, and Plerixafor After Chemo=1|14
382167|NCT00322374|933663|P4|NOT COMPLETED|Second Escalation||0
382168|NCT00322374|933664|P3|NOT COMPLETED|Second Escalation||6
382169|NCT00322374|933665|P2|NOT COMPLETED|Second Escalation||0
382170|NCT00322374|933666|P1|NOT COMPLETED|Second Escalation||0
382171|NCT00322374|933663|P4|COMPLETED|Second Escalation||0
382172|NCT00322374|933664|P3|COMPLETED|Second Escalation||0
382173|NCT00322374|933665|P2|COMPLETED|Second Escalation||0
382174|NCT00322374|933666|P1|COMPLETED|Second Escalation||0
382175|NCT00322374|933663|P4|STARTED|Second Escalation||0
382176|NCT00322374|933664|P3|STARTED|Second Escalation||6
382177|NCT00322374|933665|P2|STARTED|Second Escalation||0
382178|NCT00322374|933666|P1|STARTED|Second Escalation||0
382179|NCT00322374|933663|P4|NOT COMPLETED|First Escalation||0
382180|NCT00322374|933664|P3|NOT COMPLETED|First Escalation||0
382181|NCT00322374|933665|P2|NOT COMPLETED|First Escalation||30
382182|NCT00322374|933666|P1|NOT COMPLETED|First Escalation||0
382183|NCT00322374|933663|P4|COMPLETED|First Escalation||0
382184|NCT00322374|933664|P3|COMPLETED|First Escalation||0
382185|NCT00322374|933665|P2|COMPLETED|First Escalation||0
382186|NCT00322374|933666|P1|COMPLETED|First Escalation||0
382187|NCT00322374|933663|P4|STARTED|First Escalation||0
382188|NCT00322374|933664|P3|STARTED|First Escalation||0
382189|NCT00322374|933665|P2|STARTED|First Escalation||30
382190|NCT00322374|933666|P1|STARTED|First Escalation||0
382191|NCT00322374|933663|P4|NOT COMPLETED|Starting Dose||0
382192|NCT00322374|933664|P3|NOT COMPLETED|Starting Dose||0
382193|NCT00322374|933665|P2|NOT COMPLETED|Starting Dose||0
382194|NCT00322374|933666|P1|NOT COMPLETED|Starting Dose||6
382195|NCT00322374|933663|P4|COMPLETED|Starting Dose||0
382196|NCT00322374|933664|P3|COMPLETED|Starting Dose||0
382197|NCT00322374|933665|P2|COMPLETED|Starting Dose||0
382198|NCT00322374|933666|P1|COMPLETED|Starting Dose||0
382199|NCT00322374|933663|P4|STARTED|Starting Dose||0
382200|NCT00322374|933664|P3|STARTED|Starting Dose||0
382201|NCT00322374|933665|P2|STARTED|Starting Dose||0
382202|NCT00322374|933666|P1|STARTED|Starting Dose||6
382203|NCT00322374|933663|P4|NOT COMPLETED|Enrollment||0
382204|NCT00322374|933664|P3|NOT COMPLETED|Enrollment||0
382205|NCT00322374|933665|P2|NOT COMPLETED|Enrollment||0
382206|NCT00322374|933666|P1|NOT COMPLETED|Enrollment||0
382207|NCT00322374|933663|P4|COMPLETED|Enrollment||42
382208|NCT00322374|933664|P3|COMPLETED|Enrollment||0
382209|NCT00322374|933665|P2|COMPLETED|Enrollment||0
382210|NCT00322374|933666|P1|COMPLETED|Enrollment||0
382211|NCT00322374|933663|P4|STARTED|Enrollment||42
382212|NCT00322374|933664|P3|STARTED|Enrollment||0
382213|NCT00322374|933665|P2|STARTED|Enrollment||0
382214|NCT00322374|933666|P1|STARTED|Enrollment||0
382215|NCT00322348|933716|P2|NOT COMPLETED|Overall Study||33
382216|NCT00322348|933717|P1|NOT COMPLETED|Overall Study||37
382217|NCT00322348|933716|P2|COMPLETED|Overall Study|Number of participants completed up to Week 96|16
382218|NCT00322348|933717|P1|COMPLETED|Overall Study|Number of participants completed up to Week 96|12
382219|NCT00322348|933716|P2|Received Study Treatment|Overall Study||48
382220|NCT00322348|933717|P1|Received Study Treatment|Overall Study||50
382221|NCT00322348|933716|P2|STARTED|Overall Study||49
382222|NCT00322348|933717|P1|STARTED|Overall Study||49
382223|NCT00322335|933736|P3|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
382224|NCT00322335|933737|P2|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
382225|NCT00322335|933738|P1|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
382226|NCT00322335|933736|P3|COMPLETED|Subjects 66 Months After Booster Dose||53
382227|NCT00322335|933737|P2|COMPLETED|Subjects 66 Months After Booster Dose||104
382228|NCT00322335|933738|P1|COMPLETED|Subjects 66 Months After Booster Dose||48
382229|NCT00322335|933736|P3|STARTED|Subjects 66 Months After Booster Dose||53
382230|NCT00322335|933737|P2|STARTED|Subjects 66 Months After Booster Dose||104
382231|NCT00322335|933738|P1|STARTED|Subjects 66 Months After Booster Dose||48
382232|NCT00322335|933736|P3|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
382233|NCT00322335|933737|P2|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
382234|NCT00322335|933738|P1|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
382235|NCT00322335|933736|P3|COMPLETED|Subjects 54 Months After Booster Dose||56
382236|NCT00322335|933737|P2|COMPLETED|Subjects 54 Months After Booster Dose||108
382237|NCT00322335|933738|P1|COMPLETED|Subjects 54 Months After Booster Dose||50
382238|NCT00322335|933736|P3|STARTED|Subjects 54 Months After Booster Dose||56
382239|NCT00322335|933737|P2|STARTED|Subjects 54 Months After Booster Dose||108
382240|NCT00322335|933738|P1|STARTED|Subjects 54 Months After Booster Dose||50
382241|NCT00322335|933736|P3|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
382242|NCT00322335|933737|P2|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
382243|NCT00322335|933738|P1|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
382244|NCT00322335|933736|P3|COMPLETED|Subjects 42 Months After Booster Dose||56
382245|NCT00322335|933737|P2|COMPLETED|Subjects 42 Months After Booster Dose||113
382246|NCT00322335|933738|P1|COMPLETED|Subjects 42 Months After Booster Dose||51
382247|NCT00322335|933736|P3|STARTED|Subjects 42 Months After Booster Dose||56
382248|NCT00322335|933737|P2|STARTED|Subjects 42 Months After Booster Dose||113
382249|NCT00322335|933738|P1|STARTED|Subjects 42 Months After Booster Dose||51
382250|NCT00322335|933736|P3|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
382251|NCT00322335|933737|P2|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
382252|NCT00322335|933738|P1|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
382253|NCT00322335|933736|P3|COMPLETED|Subjects 30 Months After Booster Dose||57
382254|NCT00322335|933737|P2|COMPLETED|Subjects 30 Months After Booster Dose||119
382255|NCT00322335|933738|P1|COMPLETED|Subjects 30 Months After Booster Dose||54
382256|NCT00322335|933736|P3|STARTED|Subjects 30 Months After Booster Dose|Subjects eliminated from previous timepoint were included again from this timepoint onwards|57
382257|NCT00322335|933737|P2|STARTED|Subjects 30 Months After Booster Dose||119
382258|NCT00322335|933738|P1|STARTED|Subjects 30 Months After Booster Dose||54
382259|NCT00322335|933736|P3|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
382260|NCT00322335|933737|P2|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
382261|NCT00322335|933738|P1|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
382262|NCT00322335|933736|P3|COMPLETED|Subjects 18 Months After Booster Dose||3
382263|NCT00322335|933737|P2|COMPLETED|Subjects 18 Months After Booster Dose||123
382264|NCT00322335|933738|P1|COMPLETED|Subjects 18 Months After Booster Dose||58
382265|NCT00322335|933736|P3|STARTED|Subjects 18 Months After Booster Dose|Subjects who received Meningitec booster outside scope study NCT00323050 eliminated from this period|3
382266|NCT00322335|933737|P2|STARTED|Subjects 18 Months After Booster Dose||123
382267|NCT00322335|933738|P1|STARTED|Subjects 18 Months After Booster Dose||58
382268|NCT00322309|933778|P2|NOT COMPLETED|Overall Study||4
382269|NCT00322309|933779|P1|NOT COMPLETED|Overall Study||2
382270|NCT00322309|933778|P2|COMPLETED|Overall Study||9
382271|NCT00322309|933779|P1|COMPLETED|Overall Study||9
382272|NCT00322309|933778|P2|STARTED|Overall Study||13
382273|NCT00322309|933779|P1|STARTED|Overall Study||11
382274|NCT00322231|933795|P2|NOT COMPLETED|Period 2||0
382275|NCT00322231|933796|P1|NOT COMPLETED|Period 2||0
382276|NCT00322231|933795|P2|COMPLETED|Period 2||49
382277|NCT00322231|933796|P1|COMPLETED|Period 2||51
382278|NCT00322231|933795|P2|STARTED|Period 2|One participant was lost between Period 1 and Period 2|49
382279|NCT00322231|933796|P1|STARTED|Period 2||51
382280|NCT00322231|933795|P2|NOT COMPLETED|Period 1||0
382281|NCT00322231|933796|P1|NOT COMPLETED|Period 1||0
382282|NCT00322231|933795|P2|COMPLETED|Period 1||50
382283|NCT00322231|933796|P1|COMPLETED|Period 1||51
382284|NCT00322231|933795|P2|STARTED|Period 1||50
382285|NCT00322231|933796|P1|STARTED|Period 1||51
382286|NCT00322153|933808|P2|NOT COMPLETED|Overall Study||69
382287|NCT00322153|933809|P1|NOT COMPLETED|Overall Study||63
382288|NCT00322153|933808|P2|COMPLETED|Overall Study||273
382289|NCT00322153|933809|P1|COMPLETED|Overall Study||272
382290|NCT00322153|933808|P2|SAFETY POPULATION|Overall Study|Safety population: one patient was randomized but did not receive double-blind study drug.|341
382291|NCT00322153|933809|P1|SAFETY POPULATION|Overall Study|Safety population defined as all patients who took at least one dose of double-blind study drug.|335
382292|NCT00322153|933808|P2|STARTED|Overall Study|Randomized to Memantine ER|342
382293|NCT00322153|933809|P1|STARTED|Overall Study|Randomized to placebo|335
382294|NCT00322101|933821|P2|NOT COMPLETED|Overall Study||0
382295|NCT00322101|933822|P1|NOT COMPLETED|Overall Study||0
382296|NCT00322101|933821|P2|COMPLETED|Overall Study||11
382297|NCT00322101|933822|P1|COMPLETED|Overall Study||14
382298|NCT00322101|933821|P2|STARTED|Overall Study||11
382299|NCT00322101|933822|P1|STARTED|Overall Study||14
382300|NCT00322049|933842|P4|NOT COMPLETED|Overall Study||1
382301|NCT00322049|933843|P3|NOT COMPLETED|Overall Study||0
382302|NCT00322049|933844|P2|NOT COMPLETED|Overall Study||1
382303|NCT00322049|933845|P1|NOT COMPLETED|Overall Study||0
382304|NCT00322049|933842|P4|COMPLETED|Overall Study||16
382305|NCT00322049|933843|P3|COMPLETED|Overall Study||20
382306|NCT00322049|933844|P2|COMPLETED|Overall Study||9
382307|NCT00322049|933845|P1|COMPLETED|Overall Study||4
382308|NCT00322049|933842|P4|STARTED|Overall Study||17
382309|NCT00322049|933843|P3|STARTED|Overall Study||20
382310|NCT00322049|933844|P2|STARTED|Overall Study||10
382311|NCT00322049|933845|P1|STARTED|Overall Study||4
382312|NCT00321984|933878|P3|NOT COMPLETED|Overall Study||26
382313|NCT00321984|933879|P2|NOT COMPLETED|Overall Study||21
382314|NCT00321984|933880|P1|NOT COMPLETED|Overall Study||27
382315|NCT00321984|933878|P3|COMPLETED|Overall Study||289
382316|NCT00321984|933879|P2|COMPLETED|Overall Study||294
382317|NCT00321984|933880|P1|COMPLETED|Overall Study||290
382318|NCT00321984|933878|P3|STARTED|Overall Study||315
382319|NCT00321984|933879|P2|STARTED|Overall Study||315
382320|NCT00321984|933880|P1|STARTED|Overall Study||317
382321|NCT00321971|933899|P2|NOT COMPLETED|Overall Study||11
382322|NCT00321971|933900|P1|NOT COMPLETED|Overall Study||8
382323|NCT00321971|933899|P2|COMPLETED|Overall Study||26
382324|NCT00321971|933900|P1|COMPLETED|Overall Study||28
382325|NCT00321971|933899|P2|STARTED|Overall Study||37
382326|NCT00321971|933900|P1|STARTED|Overall Study|Subject recruitment began in February 2007 and ended in December 2011|36
382327|NCT00321932|933908|P2|NOT COMPLETED|Overall Study||21
382328|NCT00321932|933909|P1|NOT COMPLETED|Overall Study||10
382329|NCT00321932|933908|P2|COMPLETED|Overall Study||11
382330|NCT00321932|933909|P1|COMPLETED|Overall Study||19
382331|NCT00321932|933908|P2|STARTED|Overall Study||32
382332|NCT00321932|933909|P1|STARTED|Overall Study||29
382333|NCT00321919|933933|P2|NOT COMPLETED|Overall Study||52
382334|NCT00321919|933934|P1|NOT COMPLETED|Overall Study||75
382335|NCT00321919|933933|P2|COMPLETED|Overall Study||250
382336|NCT00321919|933934|P1|COMPLETED|Overall Study||226
382337|NCT00321919|933933|P2|STARTED|Overall Study||302
382338|NCT00321919|933934|P1|STARTED|Overall Study||301
382339|NCT00321906|933976|P2|NOT COMPLETED|Overall Study||56
382340|NCT00321906|933977|P1|NOT COMPLETED|Overall Study||46
382341|NCT00321906|933976|P2|COMPLETED|Overall Study||31
382342|NCT00321906|933977|P1|COMPLETED|Overall Study||48
382343|NCT00321906|933976|P2|STARTED|Overall Study||87
382344|NCT00321906|933977|P1|STARTED|Overall Study||94
382345|NCT00321893|933999|P2|NOT COMPLETED|Overall Study||14
382346|NCT00321893|934000|P1|NOT COMPLETED|Overall Study||24
382347|NCT00321893|933999|P2|COMPLETED|Overall Study||87
382348|NCT00321893|934000|P1|COMPLETED|Overall Study||77
382349|NCT00321893|933999|P2|STARTED|Overall Study||101
382350|NCT00321893|934000|P1|STARTED|Overall Study||101
382351|NCT00321854|934014|P2|NOT COMPLETED|Overall Study||82
382352|NCT00321854|934015|P1|NOT COMPLETED|Overall Study||63
382353|NCT00321854|934014|P2|COMPLETED|Overall Study||192
382354|NCT00321854|934015|P1|COMPLETED|Overall Study||198
382355|NCT00321854|934014|P2|STARTED|Overall Study||274
382356|NCT00321854|934015|P1|STARTED|Overall Study||261
382357|NCT00321828|934133|P1|NOT COMPLETED|Overall Study||4
382358|NCT00321828|934133|P1|COMPLETED|Overall Study||86
382359|NCT00321828|934133|P1|STARTED|Overall Study||90
382360|NCT00321789|934139|P2|NOT COMPLETED|Overall Study||16
382361|NCT00321789|934140|P1|NOT COMPLETED|Overall Study||15
382362|NCT00321789|934139|P2|COMPLETED|Overall Study||112
382363|NCT00321789|934140|P1|COMPLETED|Overall Study||112
382364|NCT00321789|934139|P2|STARTED|Overall Study||128
382365|NCT00321789|934140|P1|STARTED|Overall Study||127
382366|NCT00321763|934172|P4|NOT COMPLETED|Overall Study||5
382367|NCT00321763|934173|P3|NOT COMPLETED|Overall Study||6
382368|NCT00321763|934174|P2|NOT COMPLETED|Overall Study||2
382369|NCT00321763|934175|P1|NOT COMPLETED|Overall Study||6
382370|NCT00321763|934172|P4|COMPLETED|Overall Study||565
382371|NCT00321763|934173|P3|COMPLETED|Overall Study||848
382372|NCT00321763|934174|P2|COMPLETED|Overall Study||848
382373|NCT00321763|934175|P1|COMPLETED|Overall Study||844
382374|NCT00321763|934172|P4|STARTED|Overall Study||570
382375|NCT00321763|934173|P3|STARTED|Overall Study||854
382376|NCT00321763|934174|P2|STARTED|Overall Study||850
382377|NCT00321763|934175|P1|STARTED|Overall Study||850
382378|NCT00321737|934235|P3|NOT COMPLETED|Overall Study||54
382379|NCT00321737|934236|P2|NOT COMPLETED|Overall Study||48
382380|NCT00321737|934237|P1|NOT COMPLETED|Overall Study||122
382381|NCT00321737|934235|P3|COMPLETED|Overall Study||104
382382|NCT00321737|934236|P2|COMPLETED|Overall Study||92
382383|NCT00321737|934237|P1|COMPLETED|Overall Study||25
382384|NCT00321737|934235|P3|STARTED|Overall Study||158
382385|NCT00321737|934236|P2|STARTED|Overall Study||140
382386|NCT00321737|934237|P1|STARTED|Overall Study||147
382387|NCT00321711|934265|P5|NOT COMPLETED|Part B||5
382388|NCT00321711|934266|P4|NOT COMPLETED|Part B||6
382389|NCT00321711|934267|P3|NOT COMPLETED|Part B||0
382390|NCT00321711|934268|P2|NOT COMPLETED|Part B||0
382391|NCT00321711|934269|P1|NOT COMPLETED|Part B||0
382392|NCT00321711|934265|P5|COMPLETED|Part B||10
382393|NCT00321711|934266|P4|COMPLETED|Part B||8
382394|NCT00321711|934267|P3|COMPLETED|Part B||0
382395|NCT00321711|934268|P2|COMPLETED|Part B||0
382396|NCT00321711|934269|P1|COMPLETED|Part B||0
382397|NCT00321711|934265|P5|STARTED|Part B||15
382398|NCT00321711|934266|P4|STARTED|Part B||14
382399|NCT00321711|934267|P3|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
382400|NCT00321711|934268|P2|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
382401|NCT00321711|934269|P1|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
382402|NCT00321711|934265|P5|NOT COMPLETED|Part A||0
382403|NCT00321711|934266|P4|NOT COMPLETED|Part A||0
382404|NCT00321711|934267|P3|NOT COMPLETED|Part A||11
382405|NCT00321711|934268|P2|NOT COMPLETED|Part A||10
382406|NCT00321711|934269|P1|NOT COMPLETED|Part A||5
382407|NCT00321711|934265|P5|COMPLETED|Part A||0
382408|NCT00321711|934266|P4|COMPLETED|Part A||0
382409|NCT00321711|934267|P3|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
382410|NCT00321711|934268|P2|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
382411|NCT00321711|934269|P1|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|8
382412|NCT00321711|934265|P5|STARTED|Part A||0
382413|NCT00321711|934266|P4|STARTED|Part A||0
382414|NCT00321711|934267|P3|STARTED|Part A||14
382415|NCT00321711|934268|P2|STARTED|Part A||13
382416|NCT00321711|934269|P1|STARTED|Part A||13
382417|NCT00321698|934301|P5|NOT COMPLETED|Phase II, MTD Dose||0
382418|NCT00321698|934302|P4|NOT COMPLETED|Phase II, MTD Dose||0
382419|NCT00321698|934303|P3|NOT COMPLETED|Phase II, MTD Dose||0
382420|NCT00321698|934304|P2|NOT COMPLETED|Phase II, MTD Dose||0
382421|NCT00321698|934305|P1|NOT COMPLETED|Phase II, MTD Dose||0
382422|NCT00321698|934301|P5|COMPLETED|Phase II, MTD Dose||13
382423|NCT00321698|934302|P4|COMPLETED|Phase II, MTD Dose||0
382424|NCT00321698|934303|P3|COMPLETED|Phase II, MTD Dose||0
382425|NCT00321698|934304|P2|COMPLETED|Phase II, MTD Dose||0
382426|NCT00321698|934305|P1|COMPLETED|Phase II, MTD Dose||0
382427|NCT00321698|934301|P5|STARTED|Phase II, MTD Dose|+1 screen failure|13
382428|NCT00321698|934302|P4|STARTED|Phase II, MTD Dose||0
382429|NCT00321698|934303|P3|STARTED|Phase II, MTD Dose||0
382430|NCT00321698|934304|P2|STARTED|Phase II, MTD Dose||0
382431|NCT00321698|934305|P1|STARTED|Phase II, MTD Dose||0
382432|NCT00321698|934301|P5|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
382433|NCT00321698|934302|P4|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
382434|NCT00321698|934303|P3|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
382435|NCT00321698|934304|P2|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
382436|NCT00321698|934305|P1|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
382437|NCT00321698|934301|P5|COMPLETED|Phase I, Rad Only & Dose 1-3||0
382438|NCT00321698|934302|P4|COMPLETED|Phase I, Rad Only & Dose 1-3||3
382439|NCT00321698|934303|P3|COMPLETED|Phase I, Rad Only & Dose 1-3||3
382440|NCT00321698|934304|P2|COMPLETED|Phase I, Rad Only & Dose 1-3||3
382441|NCT00321698|934305|P1|COMPLETED|Phase I, Rad Only & Dose 1-3||3
382442|NCT00321698|934301|P5|STARTED|Phase I, Rad Only & Dose 1-3||0
382443|NCT00321698|934302|P4|STARTED|Phase I, Rad Only & Dose 1-3||3
382444|NCT00321698|934303|P3|STARTED|Phase I, Rad Only & Dose 1-3||3
382445|NCT00321698|934304|P2|STARTED|Phase I, Rad Only & Dose 1-3||3
382446|NCT00321698|934305|P1|STARTED|Phase I, Rad Only & Dose 1-3||3
382447|NCT00321685|934319|P1|NOT COMPLETED|Overall Study||39
382448|NCT00321685|934319|P1|COMPLETED|Overall Study||18
382449|NCT00321685|934319|P1|Eligible and Treated|Overall Study||53
382450|NCT00321685|934319|P1|Started Protocol Therapy|Overall Study||55
382451|NCT00321685|934319|P1|Eligible|Overall Study||55
382452|NCT00321685|934319|P1|STARTED|Overall Study||57
382453|NCT00321672|934331|P4|NOT COMPLETED|Overall Study||2
382454|NCT00321672|934332|P3|NOT COMPLETED|Overall Study||11
382455|NCT00321672|934333|P2|NOT COMPLETED|Overall Study||8
382456|NCT00321672|934334|P1|NOT COMPLETED|Overall Study||12
382457|NCT00321672|934331|P4|COMPLETED|Overall Study||71
382458|NCT00321672|934332|P3|COMPLETED|Overall Study||156
382459|NCT00321672|934333|P2|COMPLETED|Overall Study||81
382460|NCT00321672|934334|P1|COMPLETED|Overall Study||153
382461|NCT00321672|934331|P4|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|73
382462|NCT00321672|934332|P3|STARTED|Overall Study||167
382463|NCT00321672|934333|P2|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|89
382464|NCT00321672|934334|P1|STARTED|Overall Study||165
382465|NCT00321646|934360|P1|NOT COMPLETED|Prostatectomy||0
382466|NCT00321646|934360|P1|COMPLETED|Prostatectomy||37
382467|NCT00321646|934360|P1|STARTED|Prostatectomy||37
382468|NCT00321646|934360|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||4
382469|NCT00321646|934360|P1|COMPLETED|Neoadjuvant Chemotherapy|1 pt withdrew before start of therapy, 38 completed 6 cycles neoadjuvant therapy.|38
382470|NCT00321646|934360|P1|STARTED|Neoadjuvant Chemotherapy||42
382471|NCT00321620|934367|P2|NOT COMPLETED|Overall Study||722
382472|NCT00321620|934368|P1|NOT COMPLETED|Overall Study||743
382473|NCT00321620|934367|P2|COMPLETED|Overall Study||228
382474|NCT00321620|934368|P1|COMPLETED|Overall Study||208
382475|NCT00321620|934367|P2|Received Investigational Product|Overall Study||942
382476|NCT00321620|934368|P1|Received Investigational Product|Overall Study||946
382477|NCT00321620|934367|P2|STARTED|Overall Study||950
382478|NCT00321620|934368|P1|STARTED|Overall Study||951
382479|NCT00321594|934380|P5|NOT COMPLETED|Phase II, MTD Dose||0
382480|NCT00321594|934381|P4|NOT COMPLETED|Phase II, MTD Dose||0
382481|NCT00321594|934382|P3|NOT COMPLETED|Phase II, MTD Dose||0
382482|NCT00321594|934383|P2|NOT COMPLETED|Phase II, MTD Dose||0
382483|NCT00321594|934384|P1|NOT COMPLETED|Phase II, MTD Dose||0
382484|NCT00321594|934380|P5|COMPLETED|Phase II, MTD Dose||36
382485|NCT00321594|934381|P4|COMPLETED|Phase II, MTD Dose||6
382486|NCT00321594|934382|P3|COMPLETED|Phase II, MTD Dose||0
382487|NCT00321594|934383|P2|COMPLETED|Phase II, MTD Dose||0
382488|NCT00321594|934384|P1|COMPLETED|Phase II, MTD Dose||0
382489|NCT00321594|934380|P5|STARTED|Phase II, MTD Dose|last six patients in Phase I, Level 4 include in Phase II MTD Dose total number = 6 + 36 = 42|36
382490|NCT00321594|934381|P4|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|6
382491|NCT00321594|934382|P3|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
382492|NCT00321594|934383|P2|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
382493|NCT00321594|934384|P1|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
382494|NCT00321594|934380|P5|NOT COMPLETED|Phase I, Level 1-4||0
382495|NCT00321594|934381|P4|NOT COMPLETED|Phase I, Level 1-4||0
382496|NCT00321594|934382|P3|NOT COMPLETED|Phase I, Level 1-4||0
382497|NCT00321594|934383|P2|NOT COMPLETED|Phase I, Level 1-4||0
382498|NCT00321594|934384|P1|NOT COMPLETED|Phase I, Level 1-4||0
382499|NCT00321594|934380|P5|COMPLETED|Phase I, Level 1-4||0
382500|NCT00321594|934381|P4|COMPLETED|Phase I, Level 1-4||6
382501|NCT00321594|934382|P3|COMPLETED|Phase I, Level 1-4||6
382502|NCT00321594|934383|P2|COMPLETED|Phase I, Level 1-4||3
382503|NCT00321594|934384|P1|COMPLETED|Phase I, Level 1-4||3
382504|NCT00321594|934380|P5|STARTED|Phase I, Level 1-4||0
382505|NCT00321594|934381|P4|STARTED|Phase I, Level 1-4||6
382506|NCT00321594|934382|P3|STARTED|Phase I, Level 1-4||6
382507|NCT00321594|934383|P2|STARTED|Phase I, Level 1-4||3
382508|NCT00321594|934384|P1|STARTED|Phase I, Level 1-4||3
382509|NCT00321555|934396|P1|NOT COMPLETED|Overall Study||6
382510|NCT00321555|934396|P1|COMPLETED|Overall Study||9
382511|NCT00321555|934396|P1|STARTED|Overall Study||15
382512|NCT00321464|934404|P2|NOT COMPLETED|Overall Study||558
382513|NCT00321464|934405|P1|NOT COMPLETED|Overall Study||559
382514|NCT00321464|934404|P2|COMPLETED|Overall Study||468
382515|NCT00321464|934405|P1|COMPLETED|Overall Study||461
382516|NCT00321464|934404|P2|Received Investigational Product|Overall Study||1019
382517|NCT00321464|934405|P1|Received Investigational Product|Overall Study||1014
382518|NCT00321464|934404|P2|STARTED|Overall Study||1026
382519|NCT00321464|934405|P1|STARTED|Overall Study||1020
382520|NCT00321373|934418|P3|NOT COMPLETED|Overall Study||3
382521|NCT00321373|934419|P2|NOT COMPLETED|Overall Study||0
382522|NCT00321373|934420|P1|NOT COMPLETED|Overall Study||2
382523|NCT00321373|934418|P3|COMPLETED|Overall Study||404
382524|NCT00321373|934419|P2|COMPLETED|Overall Study||406
382525|NCT00321373|934420|P1|COMPLETED|Overall Study||405
382526|NCT00321373|934418|P3|STARTED|Overall Study||407
382527|NCT00321373|934419|P2|STARTED|Overall Study||406
382528|NCT00321373|934420|P1|STARTED|Overall Study||407
382529|NCT00321321|934443|P1|NOT COMPLETED|Overall Study||0
382530|NCT00321321|934443|P1|COMPLETED|Overall Study||12
382531|NCT00321321|934443|P1|STARTED|Overall Study||12
382532|NCT00321269|934449|P2|NOT COMPLETED|Overall Study||6
382533|NCT00321269|934450|P1|NOT COMPLETED|Overall Study||8
382534|NCT00321269|934449|P2|COMPLETED|Overall Study||68
382535|NCT00321269|934450|P1|COMPLETED|Overall Study||66
382536|NCT00321269|934449|P2|STARTED|Overall Study||74
382537|NCT00321269|934450|P1|STARTED|Overall Study||74
382538|NCT00321048|934460|P2|NOT COMPLETED|Overall Study||8
382539|NCT00321048|934461|P1|NOT COMPLETED|Overall Study||6
382540|NCT00321048|934460|P2|COMPLETED|Overall Study||21
382541|NCT00321048|934461|P1|COMPLETED|Overall Study||22
382542|NCT00321048|934460|P2|STARTED|Overall Study||29
382543|NCT00321048|934461|P1|STARTED|Overall Study||28
382544|NCT00320801|934469|P4|NOT COMPLETED|Extension Phase||48
382545|NCT00320801|934470|P3|NOT COMPLETED|Extension Phase||0
382546|NCT00320801|934471|P2|NOT COMPLETED|Extension Phase||0
382547|NCT00320801|934472|P1|NOT COMPLETED|Extension Phase||0
382548|NCT00320801|934469|P4|COMPLETED|Extension Phase||7
382549|NCT00320801|934470|P3|COMPLETED|Extension Phase||0
382550|NCT00320801|934471|P2|COMPLETED|Extension Phase||0
382551|NCT00320801|934472|P1|COMPLETED|Extension Phase||0
382552|NCT00320801|934469|P4|STARTED|Extension Phase||55
382553|NCT00320801|934470|P3|STARTED|Extension Phase||0
382554|NCT00320801|934471|P2|STARTED|Extension Phase||0
382555|NCT00320801|934472|P1|STARTED|Extension Phase||0
382556|NCT00320801|934469|P4|NOT COMPLETED|Double-blind Phase||0
382557|NCT00320801|934470|P3|NOT COMPLETED|Double-blind Phase||14
382558|NCT00320801|934471|P2|NOT COMPLETED|Double-blind Phase||11
382559|NCT00320801|934472|P1|NOT COMPLETED|Double-blind Phase||0
382560|NCT00320801|934469|P4|COMPLETED|Double-blind Phase||0
382561|NCT00320801|934470|P3|COMPLETED|Double-blind Phase||35
382562|NCT00320801|934471|P2|COMPLETED|Double-blind Phase||36
382563|NCT00320801|934472|P1|COMPLETED|Double-blind Phase||0
382564|NCT00320801|934469|P4|STARTED|Double-blind Phase||0
382565|NCT00320801|934470|P3|STARTED|Double-blind Phase||49
382566|NCT00320801|934471|P2|STARTED|Double-blind Phase||47
382567|NCT00320801|934472|P1|STARTED|Double-blind Phase||0
382568|NCT00320801|934469|P4|NOT COMPLETED|Open-label Run-in Period||0
382569|NCT00320801|934470|P3|NOT COMPLETED|Open-label Run-in Period||0
382570|NCT00320801|934471|P2|NOT COMPLETED|Open-label Run-in Period||0
382571|NCT00320801|934472|P1|NOT COMPLETED|Open-label Run-in Period||92
382572|NCT00320801|934469|P4|COMPLETED|Open-label Run-in Period||0
382573|NCT00320801|934470|P3|COMPLETED|Open-label Run-in Period||0
382574|NCT00320801|934471|P2|COMPLETED|Open-label Run-in Period||0
382575|NCT00320801|934472|P1|COMPLETED|Open-label Run-in Period||96
382576|NCT00320801|934469|P4|STARTED|Open-label Run-in Period||0
382577|NCT00320801|934470|P3|STARTED|Open-label Run-in Period||0
382578|NCT00320801|934471|P2|STARTED|Open-label Run-in Period||0
382579|NCT00320801|934472|P1|STARTED|Open-label Run-in Period||188
382580|NCT00320788|934487|P5|NOT COMPLETED|Overall Study||5
382581|NCT00320788|934488|P4|NOT COMPLETED|Overall Study||5
382582|NCT00320788|934489|P3|NOT COMPLETED|Overall Study||3
382583|NCT00320788|934490|P2|NOT COMPLETED|Overall Study||6
382584|NCT00320788|934491|P1|NOT COMPLETED|Overall Study||6
382585|NCT00320788|934487|P5|COMPLETED|Overall Study||26
382586|NCT00320788|934488|P4|COMPLETED|Overall Study||27
382587|NCT00320788|934489|P3|COMPLETED|Overall Study||29
382588|NCT00320788|934490|P2|COMPLETED|Overall Study||26
382589|NCT00320788|934491|P1|COMPLETED|Overall Study||26
382590|NCT00320788|934487|P5|Participants Received Treatment (SAF)|Overall Study||31
382591|NCT00320788|934488|P4|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
382592|NCT00320788|934489|P3|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
382593|NCT00320788|934490|P2|Participants Received Treatment (SAF)|Overall Study||32
382594|NCT00320788|934491|P1|Participants Received Treatment (SAF)|Overall Study||32
382595|NCT00320788|934487|P5|STARTED|Overall Study||31
382596|NCT00320788|934488|P4|STARTED|Overall Study|Participants Randomized|32
382597|NCT00320788|934489|P3|STARTED|Overall Study||32
382598|NCT00320788|934490|P2|STARTED|Overall Study||32
382599|NCT00320788|934491|P1|STARTED|Overall Study||32
382600|NCT00320749|934534|P3|NOT COMPLETED|Overall Study||9
382601|NCT00320749|934535|P2|NOT COMPLETED|Overall Study||2
382602|NCT00320749|934536|P1|NOT COMPLETED|Overall Study||0
382603|NCT00320749|934534|P3|COMPLETED|Overall Study||1
382604|NCT00320749|934535|P2|COMPLETED|Overall Study||6
382605|NCT00320749|934536|P1|COMPLETED|Overall Study||3
382606|NCT00320749|934534|P3|STARTED|Overall Study||10
382607|NCT00320749|934535|P2|STARTED|Overall Study||8
382608|NCT00320749|934536|P1|STARTED|Overall Study||3
382609|NCT00320710|934545|P3|NOT COMPLETED|Overall Study||5
382610|NCT00320710|934546|P2|NOT COMPLETED|Overall Study||76
382611|NCT00320710|934547|P1|NOT COMPLETED|Overall Study||94
382612|NCT00320710|934545|P3|COMPLETED|Overall Study||8
382613|NCT00320710|934546|P2|COMPLETED|Overall Study||127
382614|NCT00320710|934547|P1|COMPLETED|Overall Study||106
382615|NCT00320710|934545|P3|Treated (Safety Set)|Overall Study||13
382616|NCT00320710|934546|P2|Treated (Safety Set)|Overall Study||202
382617|NCT00320710|934547|P1|Treated (Safety Set)|Overall Study||198
382618|NCT00320710|934545|P3|STARTED|Overall Study||13
382619|NCT00320710|934546|P2|STARTED|Overall Study||203
382620|NCT00320710|934547|P1|STARTED|Overall Study||200
382621|NCT00320671|934570|P2|NOT COMPLETED|Overall Study||38
382622|NCT00320671|934571|P1|NOT COMPLETED|Overall Study||33
382623|NCT00320671|934570|P2|COMPLETED|Overall Study||58
382624|NCT00320671|934571|P1|COMPLETED|Overall Study||69
382625|NCT00320671|934570|P2|STARTED|Overall Study||96
382626|NCT00320671|934571|P1|STARTED|Overall Study||102
382627|NCT00320606|934577|P1|NOT COMPLETED|Overall Study||3
382628|NCT00320606|934577|P1|COMPLETED|Overall Study||17
382629|NCT00320606|934577|P1|STARTED|Overall Study||20
382630|NCT00320593|934593|P2|NOT COMPLETED|Overall Study||1
382631|NCT00320593|934594|P1|NOT COMPLETED|Overall Study||7
382632|NCT00320593|934593|P2|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|58
382633|NCT00320593|934594|P1|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|52
382634|NCT00320593|934593|P2|STARTED|Overall Study||59
382635|NCT00320593|934594|P1|STARTED|Overall Study||59
382636|NCT00320541|934618|P2|NOT COMPLETED|Overall Study||57
382637|NCT00320541|934619|P1|NOT COMPLETED|Overall Study||50
382638|NCT00320541|934618|P2|COMPLETED|Overall Study||36
382639|NCT00320541|934619|P1|COMPLETED|Overall Study||44
382640|NCT00320541|934618|P2|STARTED|Overall Study||93
382641|NCT00320541|934619|P1|STARTED|Overall Study||94
382642|NCT00320528|934646|P3|NOT COMPLETED|Study Period III||106
382643|NCT00320528|934647|P2|NOT COMPLETED|Study Period III||31
382644|NCT00320528|934648|P1|NOT COMPLETED|Study Period III||87
382645|NCT00320528|934646|P3|COMPLETED|Study Period III||2
382646|NCT00320528|934647|P2|COMPLETED|Study Period III||0
382647|NCT00320528|934648|P1|COMPLETED|Study Period III||0
382648|NCT00320528|934646|P3|STARTED|Study Period III||108
382649|NCT00320528|934647|P2|STARTED|Study Period III||31
382650|NCT00320528|934648|P1|STARTED|Study Period III||87
382651|NCT00320528|934646|P3|NOT COMPLETED|Study Period II||22
382652|NCT00320528|934647|P2|NOT COMPLETED|Study Period II||10
382653|NCT00320528|934648|P1|NOT COMPLETED|Study Period II||11
382654|NCT00320528|934646|P3|COMPLETED|Study Period II||108
382655|NCT00320528|934647|P2|COMPLETED|Study Period II||31
382656|NCT00320528|934648|P1|COMPLETED|Study Period II||87
382657|NCT00320528|934646|P3|Received at Least One Dose of Study Drug|Study Period II||128
382658|NCT00320528|934647|P2|Received at Least One Dose of Study Drug|Study Period II||38
382659|NCT00320528|934648|P1|Received at Least One Dose of Study Drug|Study Period II||97
382660|NCT00320528|934646|P3|STARTED|Study Period II||130
382661|NCT00320528|934647|P2|STARTED|Study Period II||41
382662|NCT00320528|934648|P1|STARTED|Study Period II||98
382663|NCT00320515|934683|P1|NOT COMPLETED|Overall Study||49
382664|NCT00320515|934683|P1|COMPLETED|Overall Study||20
382665|NCT00320515|934683|P1|STARTED|Overall Study||69
382666|NCT00320489|934692|P2|NOT COMPLETED|Overall Study||136
382667|NCT00320489|934693|P1|NOT COMPLETED|Overall Study||145
382668|NCT00320489|934692|P2|COMPLETED|Overall Study||124
382669|NCT00320489|934693|P1|COMPLETED|Overall Study||119
382670|NCT00320489|934692|P2|STARTED|Overall Study||260
382671|NCT00320489|934693|P1|STARTED|Overall Study||264
382672|NCT00320424|934749|P1|NOT COMPLETED|Overall Study||6
382673|NCT00320424|934749|P1|COMPLETED|Overall Study||42
382674|NCT00320424|934749|P1|STARTED|Overall Study||48
382675|NCT00320411|934763|P1|NOT COMPLETED|Overall Study||4
382676|NCT00320411|934763|P1|COMPLETED|Overall Study||58
382677|NCT00320411|934763|P1|STARTED|Overall Study||62
382678|NCT00320398|934786|P2|NOT COMPLETED|Overall Study||4
382679|NCT00320398|934787|P1|NOT COMPLETED|Overall Study||2
382680|NCT00320398|934786|P2|COMPLETED|Overall Study||52
382681|NCT00320398|934787|P1|COMPLETED|Overall Study||56
382682|NCT00320398|934786|P2|STARTED|Overall Study||56
382683|NCT00320398|934787|P1|STARTED|Overall Study||58
382684|NCT00320385|934815|P2|NOT COMPLETED|Overall Study||22
382685|NCT00320385|934816|P1|NOT COMPLETED|Overall Study||18
382686|NCT00320385|934815|P2|COMPLETED|Overall Study||126
382687|NCT00320385|934816|P1|COMPLETED|Overall Study||130
382688|NCT00320385|934815|P2|STARTED|Overall Study||148
382689|NCT00320385|934816|P1|STARTED|Overall Study||148
382690|NCT00320372|934839|P2|NOT COMPLETED|Overall Study||163
382691|NCT00320372|934840|P1|NOT COMPLETED|Overall Study||195
382692|NCT00320372|934839|P2|COMPLETED|Overall Study||138
382693|NCT00320372|934840|P1|COMPLETED|Overall Study||299
382694|NCT00320372|934839|P2|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||0
382695|NCT00320372|934840|P1|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||159
382696|NCT00320372|934839|P2|VNS Therapy D-23 Original|Overall Study||0
382697|NCT00320372|934840|P1|VNS Therapy D-23 Original|Overall Study||335
382698|NCT00320372|934839|P2|STARTED|Overall Study||301
382699|NCT00320372|934840|P1|STARTED|Overall Study||494
382700|NCT00320281|934867|P2|NOT COMPLETED|Overall Study||0
382701|NCT00320281|934868|P1|NOT COMPLETED|Overall Study||0
382702|NCT00320281|934867|P2|COMPLETED|Overall Study||9
382703|NCT00320281|934868|P1|COMPLETED|Overall Study||10
382704|NCT00320281|934867|P2|STARTED|Overall Study||9
382705|NCT00320281|934868|P1|STARTED|Overall Study||10
382706|NCT00320255|934880|P6|NOT COMPLETED|Overall Study||0
382707|NCT00320255|934881|P5|NOT COMPLETED|Overall Study||0
382708|NCT00320255|934882|P4|NOT COMPLETED|Overall Study||8
382709|NCT00320255|934883|P3|NOT COMPLETED|Overall Study||6
382710|NCT00320255|934884|P2|NOT COMPLETED|Overall Study||7
382711|NCT00320255|934885|P1|NOT COMPLETED|Overall Study||11
382712|NCT00320255|934880|P6|COMPLETED|Overall Study||3
382713|NCT00320255|934881|P5|COMPLETED|Overall Study||2
382714|NCT00320255|934882|P4|COMPLETED|Overall Study||25
382715|NCT00320255|934883|P3|COMPLETED|Overall Study||24
382716|NCT00320255|934884|P2|COMPLETED|Overall Study||25
382717|NCT00320255|934885|P1|COMPLETED|Overall Study||19
382718|NCT00320255|934880|P6|Received Treatment|Overall Study||3
382719|NCT00320255|934881|P5|Received Treatment|Overall Study||2
382720|NCT00320255|934882|P4|Received Treatment|Overall Study||32
382721|NCT00320255|934883|P3|Received Treatment|Overall Study||29
382722|NCT00320255|934884|P2|Received Treatment|Overall Study||32
382723|NCT00320255|934885|P1|Received Treatment|Overall Study||29
382724|NCT00320255|934880|P6|STARTED|Overall Study||3
382725|NCT00320255|934881|P5|STARTED|Overall Study||2
382726|NCT00320255|934882|P4|STARTED|Overall Study||33
382727|NCT00320255|934883|P3|STARTED|Overall Study||30
382728|NCT00320255|934884|P2|STARTED|Overall Study||32
382729|NCT00320255|934885|P1|STARTED|Overall Study||30
382730|NCT00320242|934965|P2|NOT COMPLETED|Overall Study||4
382731|NCT00320242|934966|P1|NOT COMPLETED|Overall Study||2
382732|NCT00320242|934965|P2|COMPLETED|Overall Study||12
382733|NCT00320242|934966|P1|COMPLETED|Overall Study||14
382734|NCT00320242|934965|P2|STARTED|Overall Study||16
382735|NCT00320242|934966|P1|STARTED|Overall Study||16
382736|NCT00320216|934978|P5|NOT COMPLETED|Overall Study||6
382737|NCT00320216|934979|P4|NOT COMPLETED|Overall Study||3
382738|NCT00320216|934980|P3|NOT COMPLETED|Overall Study||6
382739|NCT00320216|934981|P2|NOT COMPLETED|Overall Study||10
382740|NCT00320216|934982|P1|NOT COMPLETED|Overall Study||16
382741|NCT00320216|934978|P5|COMPLETED|Overall Study||58
382742|NCT00320216|934979|P4|COMPLETED|Overall Study||61
382743|NCT00320216|934980|P3|COMPLETED|Overall Study||58
382744|NCT00320216|934981|P2|COMPLETED|Overall Study||54
382745|NCT00320216|934982|P1|COMPLETED|Overall Study||48
382746|NCT00320216|934978|P5|STARTED|Overall Study||64
382747|NCT00320216|934979|P4|STARTED|Overall Study||64
382748|NCT00320216|934980|P3|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
382749|NCT00320216|934981|P2|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
382750|NCT00320216|934982|P1|STARTED|Overall Study||64
382751|NCT00320190|935016|P2|NOT COMPLETED|Long-term (12-month) Extension||2
382752|NCT00320190|935017|P1|NOT COMPLETED|Long-term (12-month) Extension||9
382753|NCT00320190|935016|P2|COMPLETED|Long-term (12-month) Extension||1
382754|NCT00320190|935017|P1|COMPLETED|Long-term (12-month) Extension||2
382755|NCT00320190|935016|P2|STARTED|Long-term (12-month) Extension||3
382756|NCT00320190|935017|P1|STARTED|Long-term (12-month) Extension||11
382757|NCT00320190|935016|P2|NOT COMPLETED|First 12 Months||10
382758|NCT00320190|935017|P1|NOT COMPLETED|First 12 Months||8
382759|NCT00320190|935016|P2|COMPLETED|First 12 Months||3
382760|NCT00320190|935017|P1|COMPLETED|First 12 Months||11
382761|NCT00320190|935016|P2|STARTED|First 12 Months||13
382762|NCT00320190|935017|P1|STARTED|First 12 Months||19
382763|NCT00320112|935037|P2|NOT COMPLETED|Overall Study||5
382764|NCT00320112|935038|P1|NOT COMPLETED|Overall Study||8
382765|NCT00320112|935037|P2|COMPLETED|Overall Study||114
382766|NCT00320112|935038|P1|COMPLETED|Overall Study||117
382767|NCT00320112|935037|P2|STARTED|Overall Study||119
382768|NCT00320112|935038|P1|STARTED|Overall Study||125
382769|NCT00319982|935052|P2|NOT COMPLETED|Overall Study||0
382770|NCT00319982|935053|P1|NOT COMPLETED|Overall Study||1
382771|NCT00319982|935052|P2|COMPLETED|Overall Study||20
382772|NCT00319982|935053|P1|COMPLETED|Overall Study||18
382773|NCT00319982|935052|P2|STARTED|Overall Study||20
382774|NCT00319982|935053|P1|STARTED|Overall Study||19
382775|NCT00319956|935073|P2|NOT COMPLETED|Overall Study||24
382776|NCT00319956|935074|P1|NOT COMPLETED|Overall Study||20
382777|NCT00319956|935073|P2|COMPLETED|Overall Study||85
382778|NCT00319956|935074|P1|COMPLETED|Overall Study||91
382779|NCT00319956|935073|P2|STARTED|Overall Study||109
382780|NCT00319956|935074|P1|STARTED|Overall Study||111
382781|NCT00319839|935086|P1|NOT COMPLETED|Overall Study||6
382782|NCT00319839|935086|P1|COMPLETED|Overall Study||1
382783|NCT00319839|935086|P1|STARTED|Overall Study||7
382784|NCT00319748|935092|P1|NOT COMPLETED|Overall Study||0
382785|NCT00319748|935092|P1|COMPLETED|Overall Study||13
382786|NCT00319748|935092|P1|STARTED|Overall Study||13
382787|NCT00319735|935102|P1|NOT COMPLETED|Overall Study||2
382788|NCT00319735|935102|P1|COMPLETED|Overall Study||39
382789|NCT00319735|935102|P1|STARTED|Overall Study||41
382790|NCT00319696|935115|P1|NOT COMPLETED|Overall Study||60
382791|NCT00319696|935115|P1|COMPLETED|Overall Study||56
382792|NCT00319696|935115|P1|STARTED|Overall Study||116
382793|NCT00319644|935141|P2|NOT COMPLETED|Overall Study||0
382794|NCT00319644|935142|P1|NOT COMPLETED|Overall Study||0
382795|NCT00319644|935141|P2|COMPLETED|Overall Study||16
382796|NCT00319644|935142|P1|COMPLETED|Overall Study||21
382797|NCT00319644|935141|P2|STARTED|Overall Study||16
382798|NCT00319644|935142|P1|STARTED|Overall Study||21
382799|NCT00319592|935152|P2|NOT COMPLETED|Overall Study||1
382800|NCT00319592|935153|P1|NOT COMPLETED|Overall Study||1
382801|NCT00319592|935152|P2|COMPLETED|Overall Study||29
382802|NCT00319592|935153|P1|COMPLETED|Overall Study||29
382803|NCT00319592|935152|P2|STARTED|Overall Study||30
382804|NCT00319592|935153|P1|STARTED|Overall Study||30
382805|NCT00319553|935169|P2|NOT COMPLETED|Overall Study||4
382806|NCT00319553|935170|P1|NOT COMPLETED|Overall Study||4
382807|NCT00319553|935169|P2|COMPLETED|Overall Study||317
382808|NCT00319553|935170|P1|COMPLETED|Overall Study||319
382809|NCT00319553|935169|P2|STARTED|Overall Study||321
382810|NCT00319553|935170|P1|STARTED|Overall Study||323
382811|NCT00319501|935184|P2|NOT COMPLETED|Open-label Extension Period||0
382812|NCT00319501|935185|P1|NOT COMPLETED|Open-label Extension Period||51
382813|NCT00319501|935184|P2|COMPLETED|Open-label Extension Period||0
382814|NCT00319501|935185|P1|COMPLETED|Open-label Extension Period||0
382815|NCT00319501|935184|P2|Received Treatment|Open-label Extension Period||0
382816|NCT00319501|935185|P1|Received Treatment|Open-label Extension Period||33
382817|NCT00319501|935184|P2|STARTED|Open-label Extension Period||0
382818|NCT00319501|935185|P1|STARTED|Open-label Extension Period|Eligible participants who chose to continue treatment|51
382819|NCT00319501|935184|P2|NOT COMPLETED|Open-label Period||0
382820|NCT00319501|935185|P1|NOT COMPLETED|Open-label Period||116
382821|NCT00319501|935184|P2|COMPLETED|Open-label Period||0
382822|NCT00319501|935185|P1|COMPLETED|Open-label Period|Competed=continuing treatment|45
382823|NCT00319501|935184|P2|Received Treatment|Open-label Period||0
382824|NCT00319501|935185|P1|Received Treatment|Open-label Period||128
382825|NCT00319501|935184|P2|STARTED|Open-label Period||0
382826|NCT00319501|935185|P1|STARTED|Open-label Period|Participants who continued to meet eligibility requirements|161
382827|NCT00319501|935184|P2|NOT COMPLETED|Double-blind Period||32
382828|NCT00319501|935185|P1|NOT COMPLETED|Double-blind Period||43
382829|NCT00319501|935184|P2|COMPLETED|Double-blind Period||78
382830|NCT00319501|935185|P1|COMPLETED|Double-blind Period||81
382831|NCT00319501|935184|P2|Received Treatment|Double-blind Period||81
382832|NCT00319501|935185|P1|Received Treatment|Double-blind Period||82
382833|NCT00319501|935184|P2|STARTED|Double-blind Period|Randomized participants|110
382834|NCT00319501|935185|P1|STARTED|Double-blind Period|Randomized participants|124
382835|NCT00319449|935211|P2|NOT COMPLETED|Overall Study||0
382836|NCT00319449|935212|P1|NOT COMPLETED|Overall Study||2
382837|NCT00319449|935211|P2|COMPLETED|Overall Study||12
382838|NCT00319449|935212|P1|COMPLETED|Overall Study||8
382839|NCT00319449|935211|P2|STARTED|Overall Study||12
382840|NCT00319449|935212|P1|STARTED|Overall Study||10
382841|NCT00319436|935224|P2|NOT COMPLETED|Overall Study||7
382842|NCT00319436|935225|P1|NOT COMPLETED|Overall Study||6
382843|NCT00319436|935224|P2|COMPLETED|Overall Study||17
382844|NCT00319436|935225|P1|COMPLETED|Overall Study||17
382845|NCT00319436|935224|P2|STARTED|Overall Study||24
382846|NCT00319436|935225|P1|STARTED|Overall Study||23
382847|NCT00319254|935243|P1|NOT COMPLETED|Overall Study||54
382848|NCT00319254|935243|P1|COMPLETED|Overall Study||21
382849|NCT00319254|935243|P1|Treated|Overall Study||73
382850|NCT00319254|935243|P1|STARTED|Overall Study||75
382851|NCT00319111|935256|P1|NOT COMPLETED|Overall Study||47
382852|NCT00319111|935256|P1|COMPLETED|Overall Study||104
382853|NCT00319111|935256|P1|STARTED|Overall Study|148 patients enrolled in BENEFIT OL & 3 prematurely discontinued from BENEFIT (NCT00313222)|151
382854|NCT00319098|935270|P2|NOT COMPLETED|Overall Study||32
382855|NCT00319098|935271|P1|NOT COMPLETED|Overall Study||135
382856|NCT00319098|935270|P2|COMPLETED|Overall Study||1237
382857|NCT00319098|935271|P1|COMPLETED|Overall Study||3667
382858|NCT00319098|935270|P2|STARTED|Overall Study||1269
382859|NCT00319098|935271|P1|STARTED|Overall Study||3802
382860|NCT00319046|935329|P1|NOT COMPLETED|Overall Study||8
382861|NCT00319046|935329|P1|COMPLETED|Overall Study||34
382862|NCT00319046|935329|P1|STARTED|Overall Study|One patient was excluded from analysis as the baseline liver volume not available|42
382863|NCT00319020|935338|P2|NOT COMPLETED|Overall Study||13
382864|NCT00319020|935339|P1|NOT COMPLETED|Overall Study||7
382865|NCT00319020|935338|P2|COMPLETED|Overall Study||8
382866|NCT00319020|935339|P1|COMPLETED|Overall Study||8
382867|NCT00319020|935338|P2|Enrollment in FUTURE 2 (F-2)|Overall Study||20
382868|NCT00319020|935339|P1|Enrollment in FUTURE 2 (F-2)|Overall Study||13
382869|NCT00319020|935338|P2|STARTED|Overall Study||21
382870|NCT00319020|935339|P1|STARTED|Overall Study||15
382871|NCT00318929|935368|P1|NOT COMPLETED|Overall Study||0
382872|NCT00318929|935368|P1|COMPLETED|Overall Study||14
382873|NCT00318929|935368|P1|STARTED|Overall Study||14
382874|NCT00318812|935377|P2|NOT COMPLETED|Overall Study||0
382875|NCT00318812|935378|P1|NOT COMPLETED|Overall Study||0
382876|NCT00318812|935377|P2|COMPLETED|Overall Study||22
382877|NCT00318812|935378|P1|COMPLETED|Overall Study||18
382878|NCT00318812|935377|P2|STARTED|Overall Study||22
382879|NCT00318812|935378|P1|STARTED|Overall Study||18
382880|NCT00318708|935390|P2|NOT COMPLETED|Overall Study||5
382881|NCT00318708|935391|P1|NOT COMPLETED|Overall Study||8
382882|NCT00318708|935390|P2|COMPLETED|Overall Study||40
382883|NCT00318708|935391|P1|COMPLETED|Overall Study||39
382884|NCT00318708|935390|P2|8-week Milestone|Overall Study||42
382885|NCT00318708|935391|P1|8-week Milestone|Overall Study||42
382886|NCT00318708|935390|P2|STARTED|Overall Study||45
382887|NCT00318708|935391|P1|STARTED|Overall Study||47
382888|NCT00318656|935411|P2|NOT COMPLETED|Overall Study||2
382889|NCT00318656|935412|P1|NOT COMPLETED|Overall Study||0
382890|NCT00318656|935411|P2|COMPLETED|Overall Study|1 patient received by error avandamet treatment and 1 patient did not receive any treatment.|9
382891|NCT00318656|935412|P1|COMPLETED|Overall Study||12
382892|NCT00318656|935411|P2|STARTED|Overall Study||11
382893|NCT00318656|935412|P1|STARTED|Overall Study||12
382894|NCT00318591|935450|P2|NOT COMPLETED|Overall Study||45
382895|NCT00318591|935451|P1|NOT COMPLETED|Overall Study||60
382896|NCT00318591|935450|P2|COMPLETED|Overall Study||69
382897|NCT00318591|935451|P1|COMPLETED|Overall Study||45
382898|NCT00318591|935450|P2|STARTED|Overall Study||114
382899|NCT00318591|935451|P1|STARTED|Overall Study||105
382900|NCT00318565|935469|P1|NOT COMPLETED|Overall Study||24
382901|NCT00318565|935469|P1|COMPLETED|Overall Study||267
382902|NCT00318565|935469|P1|STARTED|Overall Study||291
382903|NCT00318474|935476|P2|NOT COMPLETED|Overall Study||17
382904|NCT00318474|935477|P1|NOT COMPLETED|Overall Study||18
382905|NCT00318474|935476|P2|COMPLETED|Overall Study||10
382906|NCT00318474|935477|P1|COMPLETED|Overall Study||7
382907|NCT00318474|935476|P2|STARTED|Overall Study||27
382908|NCT00318474|935477|P1|STARTED|Overall Study||25
382909|NCT00318461|935488|P5|NOT COMPLETED|Open-Label Extension, 18 Months||97
382910|NCT00318461|935489|P4|NOT COMPLETED|Open-Label Extension, 18 Months||43
382911|NCT00318461|935490|P3|NOT COMPLETED|Open-Label Extension, 18 Months||73
382912|NCT00318461|935491|P2|NOT COMPLETED|Open-Label Extension, 18 Months||60
382913|NCT00318461|935492|P1|NOT COMPLETED|Open-Label Extension, 18 Months||78
382914|NCT00318461|935488|P5|COMPLETED|Open-Label Extension, 18 Months||113
382915|NCT00318461|935489|P4|COMPLETED|Open-Label Extension, 18 Months||31
382916|NCT00318461|935490|P3|COMPLETED|Open-Label Extension, 18 Months||118
382917|NCT00318461|935491|P2|COMPLETED|Open-Label Extension, 18 Months||137
382918|NCT00318461|935492|P1|COMPLETED|Open-Label Extension, 18 Months||130
382919|NCT00318461|935488|P5|STARTED|Open-Label Extension, 18 Months||210
382920|NCT00318461|935489|P4|STARTED|Open-Label Extension, 18 Months||74
382921|NCT00318461|935490|P3|STARTED|Open-Label Extension, 18 Months||191
382922|NCT00318461|935491|P2|STARTED|Open-Label Extension, 18 Months||197
382923|NCT00318461|935492|P1|STARTED|Open-Label Extension, 18 Months||208
382924|NCT00318461|935488|P5|NOT COMPLETED|Double-Blind, 6 Months||34
382925|NCT00318461|935489|P4|NOT COMPLETED|Double-Blind, 6 Months||48
382926|NCT00318461|935490|P3|NOT COMPLETED|Double-Blind, 6 Months||51
382927|NCT00318461|935491|P2|NOT COMPLETED|Double-Blind, 6 Months||44
382928|NCT00318461|935492|P1|NOT COMPLETED|Double-Blind, 6 Months||34
382929|NCT00318461|935488|P5|COMPLETED|Double-Blind, 6 Months||210
382930|NCT00318461|935489|P4|COMPLETED|Double-Blind, 6 Months||74
382931|NCT00318461|935490|P3|COMPLETED|Double-Blind, 6 Months||191
382932|NCT00318461|935491|P2|COMPLETED|Double-Blind, 6 Months||197
382933|NCT00318461|935492|P1|COMPLETED|Double-Blind, 6 Months||208
382934|NCT00318461|935488|P5|Exposed to Study Drug|Double-Blind, 6 Months|Subjects withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|242
382935|NCT00318461|935489|P4|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|121
382936|NCT00318461|935490|P3|Exposed to Study Drug|Double-Blind, 6 Months||242
382937|NCT00318461|935491|P2|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|240
382938|NCT00318461|935492|P1|Exposed to Study Drug|Double-Blind, 6 Months||242
382939|NCT00318461|935488|P5|STARTED|Double-Blind, 6 Months|Randomised|244
382940|NCT00318461|935489|P4|STARTED|Double-Blind, 6 Months|Randomised|122
382941|NCT00318461|935490|P3|STARTED|Double-Blind, 6 Months|Randomised|242
382942|NCT00318461|935491|P2|STARTED|Double-Blind, 6 Months|Randomised|241
382943|NCT00318461|935492|P1|STARTED|Double-Blind, 6 Months|Randomised|242
382944|NCT00318409|935571|P2|NOT COMPLETED|Overall Study||1
382945|NCT00318409|935572|P1|NOT COMPLETED|Overall Study||2
382946|NCT00318409|935571|P2|COMPLETED|Overall Study||9
382947|NCT00318409|935572|P1|COMPLETED|Overall Study||18
382948|NCT00318409|935571|P2|STARTED|Overall Study||10
382949|NCT00318409|935572|P1|STARTED|Overall Study||20
382950|NCT00318370|935591|P3|NOT COMPLETED|Period 3||33
382951|NCT00318370|935592|P2|NOT COMPLETED|Period 3||0
382952|NCT00318370|935593|P1|NOT COMPLETED|Period 3||0
382953|NCT00318370|935591|P3|COMPLETED|Period 3||3
382954|NCT00318370|935592|P2|COMPLETED|Period 3||0
382955|NCT00318370|935593|P1|COMPLETED|Period 3||0
382956|NCT00318370|935591|P3|STARTED|Period 3||36
382957|NCT00318370|935592|P2|STARTED|Period 3||0
382958|NCT00318370|935593|P1|STARTED|Period 3||0
382959|NCT00318370|935591|P3|NOT COMPLETED|Period 2||0
382960|NCT00318370|935592|P2|NOT COMPLETED|Period 2||11
382961|NCT00318370|935593|P1|NOT COMPLETED|Period 2||0
382962|NCT00318370|935591|P3|COMPLETED|Period 2||0
382963|NCT00318370|935592|P2|COMPLETED|Period 2||36
382964|NCT00318370|935593|P1|COMPLETED|Period 2||0
382965|NCT00318370|935591|P3|STARTED|Period 2||0
382966|NCT00318370|935592|P2|STARTED|Period 2|26 participants enrolled directly into Chemo Plus Far plus 21 participants from Far Only.|47
382967|NCT00318370|935593|P1|STARTED|Period 2||0
382968|NCT00318370|935591|P3|NOT COMPLETED|Period 1||0
382969|NCT00318370|935592|P2|NOT COMPLETED|Period 1||0
382970|NCT00318370|935593|P1|NOT COMPLETED|Period 1||7
382971|NCT00318370|935591|P3|COMPLETED|Period 1||0
382972|NCT00318370|935592|P2|COMPLETED|Period 1||0
382973|NCT00318370|935593|P1|COMPLETED|Period 1|21 participants proceeded from Far Only to Chemo Plus Far.|21
382974|NCT00318370|935591|P3|STARTED|Period 1||0
382975|NCT00318370|935592|P2|STARTED|Period 1||0
382976|NCT00318370|935593|P1|STARTED|Period 1||28
382977|NCT00318357|935605|P2|NOT COMPLETED|Overall Study||32
382978|NCT00318357|935606|P1|NOT COMPLETED|Overall Study||39
382979|NCT00318357|935605|P2|COMPLETED|Overall Study||104
382980|NCT00318357|935606|P1|COMPLETED|Overall Study||134
382981|NCT00318357|935605|P2|STARTED|Overall Study||136
382982|NCT00318357|935606|P1|STARTED|Overall Study||173
382983|NCT00318292|935614|P2|NOT COMPLETED|Overall Study||0
382984|NCT00318292|935615|P1|NOT COMPLETED|Overall Study||0
382985|NCT00318292|935614|P2|COMPLETED|Overall Study||45
382986|NCT00318292|935615|P1|COMPLETED|Overall Study||45
382987|NCT00318292|935614|P2|STARTED|Overall Study||45
382988|NCT00318292|935615|P1|STARTED|Overall Study||45
382989|NCT00318149|935627|P6|NOT COMPLETED|Overall Study||2
382990|NCT00318149|935628|P5|NOT COMPLETED|Overall Study||0
382991|NCT00318149|935629|P4|NOT COMPLETED|Overall Study||0
382992|NCT00318149|935630|P3|NOT COMPLETED|Overall Study||0
382993|NCT00318149|935631|P2|NOT COMPLETED|Overall Study||0
382994|NCT00318149|935632|P1|NOT COMPLETED|Overall Study||0
382995|NCT00318149|935627|P6|COMPLETED|Overall Study||73
382996|NCT00318149|935628|P5|COMPLETED|Overall Study||75
382997|NCT00318149|935629|P4|COMPLETED|Overall Study||75
382998|NCT00318149|935630|P3|COMPLETED|Overall Study||75
382999|NCT00318149|935631|P2|COMPLETED|Overall Study||50
383000|NCT00318149|935632|P1|COMPLETED|Overall Study||75
383001|NCT00318149|935627|P6|STARTED|Overall Study||75
383002|NCT00318149|935628|P5|STARTED|Overall Study||75
383003|NCT00318149|935629|P4|STARTED|Overall Study||75
383004|NCT00318149|935630|P3|STARTED|Overall Study||75
383005|NCT00318149|935631|P2|STARTED|Overall Study||50
383006|NCT00318149|935632|P1|STARTED|Overall Study||75
383007|NCT00318136|935718|P1|NOT COMPLETED|Overall Study||45
383008|NCT00318136|935718|P1|COMPLETED|Overall Study||2
383009|NCT00318136|935718|P1|STARTED|Overall Study||47
383010|NCT00317941|935727|P3|NOT COMPLETED|Overall Study||8
383011|NCT00317941|935728|P2|NOT COMPLETED|Overall Study||5
383012|NCT00317941|935729|P1|NOT COMPLETED|Overall Study||7
383013|NCT00317941|935727|P3|COMPLETED|Overall Study||60
383014|NCT00317941|935728|P2|COMPLETED|Overall Study||74
383015|NCT00317941|935729|P1|COMPLETED|Overall Study||66
383016|NCT00317941|935727|P3|Fulfilled Requirements PP Population|Overall Study||63
383017|NCT00317941|935728|P2|Fulfilled Requirements PP Population|Overall Study||76
383018|NCT00317941|935729|P1|Fulfilled Requirements PP Population|Overall Study||66
383019|NCT00317941|935727|P3|Fulfilled Requirement Safety Population|Overall Study||65
383020|NCT00317941|935728|P2|Fulfilled Requirement Safety Population|Overall Study||77
383021|NCT00317941|935729|P1|Fulfilled Requirement Safety Population|Overall Study||73
383022|NCT00317941|935727|P3|Participants Received Treatment|Overall Study||68
383023|NCT00317941|935728|P2|Participants Received Treatment|Overall Study||79
383024|NCT00317941|935729|P1|Participants Received Treatment|Overall Study||73
383025|NCT00317941|935727|P3|STARTED|Overall Study||68
383026|NCT00317941|935728|P2|STARTED|Overall Study||79
383027|NCT00317941|935729|P1|STARTED|Overall Study||73
383028|NCT00317720|935770|P2|NOT COMPLETED|Overall Study||0
383029|NCT00317720|935771|P1|NOT COMPLETED|Overall Study||0
383030|NCT00317720|935770|P2|COMPLETED|Overall Study||7
383031|NCT00317720|935771|P1|COMPLETED|Overall Study||40
383032|NCT00317720|935770|P2|STARTED|Overall Study||7
383033|NCT00317720|935771|P1|STARTED|Overall Study||40
383034|NCT00317642|935778|P2|NOT COMPLETED|Overall Study||135
383035|NCT00317642|935779|P1|NOT COMPLETED|Overall Study||122
383036|NCT00317642|935778|P2|COMPLETED|Overall Study|achieved remission and completed consolidation|28
383037|NCT00317642|935779|P1|COMPLETED|Overall Study|achieved remission and completed consolidation|41
383038|NCT00317642|935778|P2|Received >= 1 Study Drug (Safety Set)|Overall Study||155
383039|NCT00317642|935779|P1|Received >= 1 Study Drug (Safety Set)|Overall Study||161
383040|NCT00317642|935778|P2|Full Analysis Set|Overall Study|AML Centrally Confirmed|158
383041|NCT00317642|935779|P1|Full Analysis Set|Overall Study|AML Centrally Confirmed|162
383042|NCT00317642|935778|P2|STARTED|Overall Study||163
383043|NCT00317642|935779|P1|STARTED|Overall Study||163
383044|NCT00317473|935858|P6|NOT COMPLETED|Overall Study||3
383045|NCT00317473|935859|P5|NOT COMPLETED|Overall Study||8
383046|NCT00317473|935860|P4|NOT COMPLETED|Overall Study||2
383047|NCT00317473|935861|P3|NOT COMPLETED|Overall Study||3
383048|NCT00317473|935862|P2|NOT COMPLETED|Overall Study||3
383049|NCT00317473|935863|P1|NOT COMPLETED|Overall Study||4
383050|NCT00317473|935858|P6|COMPLETED|Overall Study||12
383051|NCT00317473|935859|P5|COMPLETED|Overall Study||22
383052|NCT00317473|935860|P4|COMPLETED|Overall Study||13
383053|NCT00317473|935861|P3|COMPLETED|Overall Study||27
383054|NCT00317473|935862|P2|COMPLETED|Overall Study||12
383055|NCT00317473|935863|P1|COMPLETED|Overall Study||26
383056|NCT00317473|935858|P6|STARTED|Overall Study||15
383057|NCT00317473|935859|P5|STARTED|Overall Study||30
383058|NCT00317473|935860|P4|STARTED|Overall Study||15
383059|NCT00317473|935861|P3|STARTED|Overall Study||30
383060|NCT00317473|935862|P2|STARTED|Overall Study||15
383061|NCT00317473|935863|P1|STARTED|Overall Study||30
383062|NCT00317239|935889|P2|NOT COMPLETED|Overall Study||19
383063|NCT00317239|935890|P1|NOT COMPLETED|Overall Study||13
383064|NCT00317239|935889|P2|COMPLETED|Overall Study||84
383065|NCT00317239|935890|P1|COMPLETED|Overall Study||134
383066|NCT00317239|935889|P2|STARTED|Overall Study||103
383067|NCT00317239|935890|P1|STARTED|Overall Study||147
383068|NCT00317226|935896|P1|NOT COMPLETED|Overall Study||23
383069|NCT00317226|935896|P1|COMPLETED|Overall Study||104
383070|NCT00317226|935896|P1|STARTED|Overall Study||127
383071|NCT00317109|935902|P2|NOT COMPLETED|Overall Study||0
383072|NCT00317109|935903|P1|NOT COMPLETED|Overall Study||3
383073|NCT00317109|935902|P2|COMPLETED|Overall Study||84
383074|NCT00317109|935903|P1|COMPLETED|Overall Study||81
383075|NCT00317109|935902|P2|STARTED|Overall Study||84
383076|NCT00317109|935903|P1|STARTED|Overall Study||84
383077|NCT00317044|935940|P3|NOT COMPLETED|Overall Study||45
383078|NCT00317044|935941|P2|NOT COMPLETED|Overall Study||40
383079|NCT00317044|935942|P1|NOT COMPLETED|Overall Study||48
383080|NCT00317044|935940|P3|COMPLETED|Overall Study||283
383081|NCT00317044|935941|P2|COMPLETED|Overall Study||273
383082|NCT00317044|935942|P1|COMPLETED|Overall Study||272
383083|NCT00317044|935940|P3|STARTED|Overall Study||328
383084|NCT00317044|935941|P2|STARTED|Overall Study||313
383085|NCT00317044|935942|P1|STARTED|Overall Study||320
383086|NCT00316914|935988|P2|NOT COMPLETED|Overall Study||36
383087|NCT00316914|935989|P1|NOT COMPLETED|Overall Study||33
383088|NCT00316914|935988|P2|COMPLETED|Overall Study||16
383089|NCT00316914|935989|P1|COMPLETED|Overall Study||17
383090|NCT00316914|935988|P2|STARTED|Overall Study||52
383091|NCT00316914|935989|P1|STARTED|Overall Study||50
383092|NCT00316888|936019|P2|NOT COMPLETED|Overall Study||8
383093|NCT00316888|936020|P1|NOT COMPLETED|Overall Study||6
383094|NCT00316888|936019|P2|COMPLETED|Overall Study||27
383095|NCT00316888|936020|P1|COMPLETED|Overall Study||22
383096|NCT00316888|936019|P2|Started Chemo+Radiation+Cetuximab|Overall Study||34
383097|NCT00316888|936020|P1|Started Chemo+Radiation+Cetuximab|Overall Study|One patient did not start chemo+radiation therapy after completing induction therapy|27
383098|NCT00316888|936019|P2|Started Induction Chemotherapy|Overall Study|Induction chemotherapy was removed for patients on this arm|0
383099|NCT00316888|936020|P1|Started Induction Chemotherapy|Overall Study||28
383100|NCT00316888|936019|P2|Treated|Overall Study||34
383101|NCT00316888|936020|P1|Treated|Overall Study|Received induction and/or chemo+radiation therapy|28
383102|NCT00316888|936019|P2|Eligible|Overall Study||35
383103|NCT00316888|936020|P1|Eligible|Overall Study||28
383104|NCT00316888|936019|P2|STARTED|Overall Study||35
383105|NCT00316888|936020|P1|STARTED|Overall Study||28
383106|NCT00316862|936034|P1|NOT COMPLETED|Overall Study||0
383107|NCT00316862|936034|P1|COMPLETED|Overall Study||82
383108|NCT00316862|936034|P1|STARTED|Overall Study||82
383109|NCT00316719|936042|P2|NOT COMPLETED|Overall Study||6
383110|NCT00316719|936043|P1|NOT COMPLETED|Overall Study||2
383111|NCT00316719|936042|P2|COMPLETED|Overall Study||47
383112|NCT00316719|936043|P1|COMPLETED|Overall Study||50
383113|NCT00316719|936042|P2|STARTED|Overall Study||53
383114|NCT00316719|936043|P1|STARTED|Overall Study||52
383115|NCT00316706|936069|P2|NOT COMPLETED|Overall Study||48
383116|NCT00316706|936070|P1|NOT COMPLETED|Overall Study||38
383117|NCT00316706|936069|P2|COMPLETED|Overall Study|Subjects in Havrix group that completed the study at Month 24|571
383118|NCT00316706|936070|P1|COMPLETED|Overall Study|Subjects in Cervarix group that completed the study at Month 48|588
383119|NCT00316706|936069|P2|STARTED|Overall Study||619
383120|NCT00316706|936070|P1|STARTED|Overall Study||626
383121|NCT00316693|936086|P2|NOT COMPLETED|Overall Study||85
383122|NCT00316693|936087|P1|NOT COMPLETED|Overall Study||77
383123|NCT00316693|936086|P2|COMPLETED|Overall Study||436
383124|NCT00316693|936087|P1|COMPLETED|Overall Study||442
383125|NCT00316693|936086|P2|STARTED|Overall Study||521
383126|NCT00316693|936087|P1|STARTED|Overall Study||519
383127|NCT00316602|936129|P2|NOT COMPLETED|Overall Study||25
383128|NCT00316602|936130|P1|NOT COMPLETED|Overall Study||10
383129|NCT00316602|936129|P2|COMPLETED|Overall Study||325
383130|NCT00316602|936130|P1|COMPLETED|Overall Study||272
383131|NCT00316602|936129|P2|STARTED|Overall Study||350
383132|NCT00316602|936130|P1|STARTED|Overall Study||282
383133|NCT00316589|936162|P4|NOT COMPLETED|Overall Study||5
383134|NCT00316589|936163|P3|NOT COMPLETED|Overall Study||1
383135|NCT00316589|936164|P2|NOT COMPLETED|Overall Study||24
383136|NCT00316589|936165|P1|NOT COMPLETED|Overall Study||1
383137|NCT00316589|936162|P4|COMPLETED|Overall Study||127
383138|NCT00316589|936163|P3|COMPLETED|Overall Study||8
383139|NCT00316589|936164|P2|COMPLETED|Overall Study||328
383140|NCT00316589|936165|P1|COMPLETED|Overall Study||87
383141|NCT00316589|936162|P4|STARTED|Overall Study||132
383142|NCT00316589|936163|P3|STARTED|Overall Study||9
383143|NCT00316589|936164|P2|STARTED|Overall Study||352
383144|NCT00316589|936165|P1|STARTED|Overall Study||88
383145|NCT00316524|936233|P4|NOT COMPLETED|Overall Study||0
383146|NCT00316524|936234|P3|NOT COMPLETED|Overall Study||6
383147|NCT00316524|936235|P2|NOT COMPLETED|Overall Study||8
383148|NCT00316524|936236|P1|NOT COMPLETED|Overall Study||8
383149|NCT00316524|936233|P4|COMPLETED|Overall Study||200
383150|NCT00316524|936234|P3|COMPLETED|Overall Study||175
383151|NCT00316524|936235|P2|COMPLETED|Overall Study||173
383152|NCT00316524|936236|P1|COMPLETED|Overall Study||175
383153|NCT00316524|936233|P4|STARTED|Overall Study||200
383154|NCT00316524|936234|P3|STARTED|Overall Study||181
383155|NCT00316524|936235|P2|STARTED|Overall Study||181
383156|NCT00316524|936236|P1|STARTED|Overall Study||183
383157|NCT00316355|936288|P2|NOT COMPLETED|Overall Study||7
383158|NCT00316355|936289|P1|NOT COMPLETED|Overall Study||5
383159|NCT00316355|936288|P2|COMPLETED|Overall Study||12
383160|NCT00316355|936289|P1|COMPLETED|Overall Study||10
383161|NCT00316355|936288|P2|Started Treatment|Overall Study||18
383162|NCT00316355|936289|P1|Started Treatment|Overall Study||12
383163|NCT00316355|936288|P2|STARTED|Overall Study||19
383164|NCT00316355|936289|P1|STARTED|Overall Study||15
383165|NCT00316303|936299|P2|NOT COMPLETED|Overall Study||16
383166|NCT00316303|936300|P1|NOT COMPLETED|Overall Study||11
383167|NCT00316303|936299|P2|COMPLETED|Overall Study||102
383168|NCT00316303|936300|P1|COMPLETED|Overall Study||107
383169|NCT00316303|936299|P2|STARTED|Overall Study||118
383170|NCT00316303|936300|P1|STARTED|Overall Study||118
383171|NCT00316277|936316|P2|NOT COMPLETED|Phase 2 (24 Weeks)||19
383172|NCT00316277|936317|P1|NOT COMPLETED|Phase 2 (24 Weeks)||19
383173|NCT00316277|936316|P2|COMPLETED|Phase 2 (24 Weeks)||161
383174|NCT00316277|936317|P1|COMPLETED|Phase 2 (24 Weeks)||161
383175|NCT00316277|936316|P2|STARTED|Phase 2 (24 Weeks)||180
383176|NCT00316277|936317|P1|STARTED|Phase 2 (24 Weeks)||180
383177|NCT00316277|936316|P2|NOT COMPLETED|Phase 1 (12 Weeks)||300
383178|NCT00316277|936317|P1|NOT COMPLETED|Phase 1 (12 Weeks)||310
383179|NCT00316277|936316|P2|COMPLETED|Phase 1 (12 Weeks)||24
383180|NCT00316277|936317|P1|COMPLETED|Phase 1 (12 Weeks)||19
383181|NCT00316277|936316|P2|STARTED|Phase 1 (12 Weeks)||324
383182|NCT00316277|936317|P1|STARTED|Phase 1 (12 Weeks)||329
383183|NCT00316264|936338|P3|NOT COMPLETED|Overall Study||6
383184|NCT00316264|936339|P2|NOT COMPLETED|Overall Study||7
383185|NCT00316264|936340|P1|NOT COMPLETED|Overall Study||6
383186|NCT00316264|936338|P3|COMPLETED|Overall Study||87
383187|NCT00316264|936339|P2|COMPLETED|Overall Study||77
383188|NCT00316264|936340|P1|COMPLETED|Overall Study||77
383189|NCT00316264|936338|P3|STARTED|Overall Study||93
383190|NCT00316264|936339|P2|STARTED|Overall Study||84
383191|NCT00316264|936340|P1|STARTED|Overall Study||83
383192|NCT00316225|936408|P1|NOT COMPLETED|Overall Study||25
383193|NCT00316225|936408|P1|COMPLETED|Overall Study||6
383194|NCT00316225|936408|P1|STARTED|Overall Study||31
383195|NCT00316199|936417|P1|NOT COMPLETED|Overall Study||12
383196|NCT00316199|936417|P1|COMPLETED|Overall Study||48
383197|NCT00316199|936417|P1|STARTED|Overall Study||60
383198|NCT00316186|936425|P1|NOT COMPLETED|Overall Study||12
383199|NCT00316186|936425|P1|COMPLETED|Overall Study||21
383200|NCT00316186|936425|P1|STARTED|Overall Study||33
383201|NCT00316173|936439|P2|NOT COMPLETED|Treatment Phase||42
383202|NCT00316173|936440|P1|NOT COMPLETED|Treatment Phase||0
383203|NCT00316173|936439|P2|COMPLETED|Treatment Phase||13
383204|NCT00316173|936440|P1|COMPLETED|Treatment Phase||0
383205|NCT00316173|936439|P2|STARTED|Treatment Phase||55
383206|NCT00316173|936440|P1|STARTED|Treatment Phase||0
383207|NCT00316173|936439|P2|NOT COMPLETED|Run-in Phase||0
383208|NCT00316173|936440|P1|NOT COMPLETED|Run-in Phase||7
383209|NCT00316173|936439|P2|COMPLETED|Run-in Phase||0
383210|NCT00316173|936440|P1|COMPLETED|Run-in Phase||15
383211|NCT00316173|936439|P2|STARTED|Run-in Phase||0
383212|NCT00316173|936440|P1|STARTED|Run-in Phase||22
383213|NCT00316121|936453|P2|NOT COMPLETED|Overall Study||9
383214|NCT00316121|936454|P1|NOT COMPLETED|Overall Study||22
383215|NCT00316121|936453|P2|COMPLETED|Overall Study||37
383216|NCT00316121|936454|P1|COMPLETED|Overall Study||70
383217|NCT00316121|936453|P2|STARTED|Overall Study||46
383218|NCT00316121|936454|P1|STARTED|Overall Study||92
383219|NCT00316082|936465|P5|NOT COMPLETED|Overall Study||26
383220|NCT00316082|936466|P4|NOT COMPLETED|Overall Study||26
383221|NCT00316082|936467|P3|NOT COMPLETED|Overall Study||27
383222|NCT00316082|936468|P2|NOT COMPLETED|Overall Study||22
383223|NCT00316082|936469|P1|NOT COMPLETED|Overall Study||33
383224|NCT00316082|936465|P5|COMPLETED|Overall Study||48
383225|NCT00316082|936466|P4|COMPLETED|Overall Study||46
383226|NCT00316082|936467|P3|COMPLETED|Overall Study||44
383227|NCT00316082|936468|P2|COMPLETED|Overall Study||52
383228|NCT00316082|936469|P1|COMPLETED|Overall Study||41
383229|NCT00316082|936465|P5|Completed Study Without Being Rescued|Overall Study||31
383230|NCT00316082|936466|P4|Completed Study Without Being Rescued|Overall Study||27
383231|NCT00316082|936467|P3|Completed Study Without Being Rescued|Overall Study||29
383232|NCT00316082|936468|P2|Completed Study Without Being Rescued|Overall Study||35
383233|NCT00316082|936469|P1|Completed Study Without Being Rescued|Overall Study||25
383234|NCT00316082|936465|P5|STARTED|Overall Study||74
383235|NCT00316082|936466|P4|STARTED|Overall Study||72
383236|NCT00316082|936467|P3|STARTED|Overall Study||71
383237|NCT00316082|936468|P2|STARTED|Overall Study||74
383238|NCT00316082|936469|P1|STARTED|Overall Study||74
383239|NCT00316017|936500|P3|NOT COMPLETED|Overall Study||19
383240|NCT00316017|936501|P2|NOT COMPLETED|Overall Study||13
383241|NCT00316017|936502|P1|NOT COMPLETED|Overall Study||11
383242|NCT00316017|936500|P3|COMPLETED|Overall Study||376
383243|NCT00316017|936501|P2|COMPLETED|Overall Study||256
383244|NCT00316017|936502|P1|COMPLETED|Overall Study||220
383245|NCT00316017|936500|P3|STARTED|Overall Study|19 of 19 not complete due to BONG|395
383246|NCT00316017|936501|P2|STARTED|Overall Study|12 of 13 not completed due to BONG; 1 not completed was a prisoner who was excluded|269
383247|NCT00316017|936502|P1|STARTED|Overall Study|"11 of 11 not completed due to Bag Opened Not Given (BONG)"|231
383248|NCT00316004|936576|P3|NOT COMPLETED|Overall Study||21
383249|NCT00316004|936577|P2|NOT COMPLETED|Overall Study||14
383250|NCT00316004|936578|P1|NOT COMPLETED|Overall Study||14
383251|NCT00316004|936576|P3|COMPLETED|Overall Study||582
383252|NCT00316004|936577|P2|COMPLETED|Overall Study||341
383253|NCT00316004|936578|P1|COMPLETED|Overall Study||359
383254|NCT00316004|936576|P3|STARTED|Overall Study||603
383255|NCT00316004|936577|P2|STARTED|Overall Study||355
383256|NCT00316004|936578|P1|STARTED|Overall Study||373
383257|NCT00315939|936633|P2|NOT COMPLETED|Admission 3 (3 Months)||2
383258|NCT00315939|936634|P1|NOT COMPLETED|Admission 3 (3 Months)||4
383259|NCT00315939|936633|P2|COMPLETED|Admission 3 (3 Months)||49
383260|NCT00315939|936634|P1|COMPLETED|Admission 3 (3 Months)||48
383261|NCT00315939|936633|P2|STARTED|Admission 3 (3 Months)||51
383262|NCT00315939|936634|P1|STARTED|Admission 3 (3 Months)||52
383263|NCT00315939|936633|P2|NOT COMPLETED|Admission 2 (3 Months)||4
383264|NCT00315939|936634|P1|NOT COMPLETED|Admission 2 (3 Months)||4
383265|NCT00315939|936633|P2|COMPLETED|Admission 2 (3 Months)||51
383266|NCT00315939|936634|P1|COMPLETED|Admission 2 (3 Months)||52
383267|NCT00315939|936633|P2|STARTED|Admission 2 (3 Months)||55
383268|NCT00315939|936634|P1|STARTED|Admission 2 (3 Months)||56
383269|NCT00315939|936633|P2|NOT COMPLETED|Admission 1 (3 Months)||6
383270|NCT00315939|936634|P1|NOT COMPLETED|Admission 1 (3 Months)||3
383271|NCT00315939|936633|P2|COMPLETED|Admission 1 (3 Months)||55
383272|NCT00315939|936634|P1|COMPLETED|Admission 1 (3 Months)||56
383273|NCT00315939|936633|P2|STARTED|Admission 1 (3 Months)||61
383274|NCT00315939|936634|P1|STARTED|Admission 1 (3 Months)||59
383275|NCT00315822|936642|P2|NOT COMPLETED|Overall Study||0
383276|NCT00315822|936643|P1|NOT COMPLETED|Overall Study||0
383277|NCT00315822|936642|P2|COMPLETED|Overall Study||202
383278|NCT00315822|936643|P1|COMPLETED|Overall Study||198
383279|NCT00315822|936642|P2|STARTED|Overall Study||202
383280|NCT00315822|936643|P1|STARTED|Overall Study||198
383281|NCT00315731|936649|P1|NOT COMPLETED|Overall Study||6
383282|NCT00315731|936649|P1|COMPLETED|Overall Study||9
383283|NCT00315731|936649|P1|STARTED|Overall Study||15
383284|NCT00315705|936677|P1|NOT COMPLETED|Phase 2||25
383285|NCT00315705|936677|P1|COMPLETED|Phase 2|No Phase 2 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
383286|NCT00315705|936677|P1|STARTED|Phase 2|Phase 1 and phase 2 are separate populations|25
383287|NCT00315705|936677|P1|NOT COMPLETED|Phase 1||25
383288|NCT00315705|936677|P1|COMPLETED|Phase 1|No Phase 1 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
383289|NCT00315705|936677|P1|STARTED|Phase 1||25
383290|NCT00315627|936714|P1|NOT COMPLETED|Overall Study||0
383291|NCT00315627|936714|P1|COMPLETED|Overall Study||3
383292|NCT00315627|936714|P1|STARTED|Overall Study||3
383293|NCT00315614|936722|P1|NOT COMPLETED|Overall Study||0
383294|NCT00315614|936722|P1|COMPLETED|Overall Study||3
383295|NCT00315614|936722|P1|STARTED|Overall Study||3
383296|NCT00315588|936729|P1|NOT COMPLETED|Overall Study||0
383297|NCT00315588|936729|P1|COMPLETED|Overall Study||7
383298|NCT00315588|936729|P1|STARTED|Overall Study||7
383299|NCT00315458|936738|P4|NOT COMPLETED|Overall Study||29
383300|NCT00315458|936739|P3|NOT COMPLETED|Overall Study||52
383301|NCT00315458|936740|P2|NOT COMPLETED|Overall Study||12
383302|NCT00315458|936741|P1|NOT COMPLETED|Overall Study||3
383303|NCT00315458|936738|P4|COMPLETED|Overall Study||10
383304|NCT00315458|936739|P3|COMPLETED|Overall Study||107
383305|NCT00315458|936740|P2|COMPLETED|Overall Study||44
383306|NCT00315458|936741|P1|COMPLETED|Overall Study||48
383307|NCT00315458|936738|P4|STARTED|Overall Study||39
383308|NCT00315458|936739|P3|STARTED|Overall Study||159
383309|NCT00315458|936740|P2|STARTED|Overall Study||56
383310|NCT00315458|936741|P1|STARTED|Overall Study||51
383311|NCT00315445|936754|P3|NOT COMPLETED|Overall Study||24
383312|NCT00315445|936755|P2|NOT COMPLETED|Overall Study||16
383313|NCT00315445|936756|P1|NOT COMPLETED|Overall Study||27
383314|NCT00315445|936754|P3|COMPLETED|Overall Study||22
383315|NCT00315445|936755|P2|COMPLETED|Overall Study||27
383316|NCT00315445|936756|P1|COMPLETED|Overall Study||18
383317|NCT00315445|936754|P3|STARTED|Overall Study||46
383318|NCT00315445|936755|P2|STARTED|Overall Study||43
383319|NCT00315445|936756|P1|STARTED|Overall Study||45
383320|NCT00315341|936829|P2|NOT COMPLETED|Overall Study||138
383321|NCT00315341|936830|P1|NOT COMPLETED|Overall Study||400
383322|NCT00315341|936829|P2|COMPLETED|Overall Study||391
383323|NCT00315341|936830|P1|COMPLETED|Overall Study||340
383324|NCT00315341|936829|P2|STARTED|Overall Study||529
383325|NCT00315341|936830|P1|STARTED|Overall Study||740
383326|NCT00315328|936840|P4|NOT COMPLETED|Overall Study||2
383327|NCT00315328|936841|P3|NOT COMPLETED|Overall Study||5
383328|NCT00315328|936842|P2|NOT COMPLETED|Overall Study||7
383329|NCT00315328|936843|P1|NOT COMPLETED|Overall Study||14
383330|NCT00315328|936840|P4|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|20
383331|NCT00315328|936841|P3|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|13
383332|NCT00315328|936842|P2|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|88
383333|NCT00315328|936843|P1|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|84
383334|NCT00315328|936840|P4|5 Week Visit|Overall Study||19
383335|NCT00315328|936841|P3|5 Week Visit|Overall Study||17
383336|NCT00315328|936842|P2|5 Week Visit|Overall Study||89
383337|NCT00315328|936843|P1|5 Week Visit|Overall Study||91
383338|NCT00315328|936840|P4|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|22
383339|NCT00315328|936841|P3|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|18
383340|NCT00315328|936842|P2|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|95
383341|NCT00315328|936843|P1|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|98
383342|NCT00315302|936913|P4|NOT COMPLETED|Overall Study||3
383343|NCT00315302|936914|P3|NOT COMPLETED|Overall Study||2
383344|NCT00315302|936915|P2|NOT COMPLETED|Overall Study||2
383345|NCT00315302|936916|P1|NOT COMPLETED|Overall Study||6
383346|NCT00315302|936913|P4|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|31
383347|NCT00315302|936914|P3|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|24
383348|NCT00315302|936915|P2|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|88
383349|NCT00315302|936916|P1|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|84
383350|NCT00315302|936913|P4|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|11
383351|NCT00315302|936914|P3|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|9
383352|NCT00315302|936915|P2|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|13
383353|NCT00315302|936916|P1|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|16
383354|NCT00315302|936913|P4|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|31
383355|NCT00315302|936914|P3|18 Week Primary Outcome Visit|Overall Study||24
383356|NCT00315302|936915|P2|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|88
383357|NCT00315302|936916|P1|18 Week Primary Outcome Visit|Overall Study||84
383358|NCT00315302|936913|P4|10 Week Visit|Overall Study||29
383359|NCT00315302|936914|P3|10 Week Visit|Overall Study||24
383360|NCT00315302|936915|P2|10 Week Visit|Overall Study||85
383361|NCT00315302|936916|P1|10 Week Visit|Overall Study|Can be higher as includes subjects who may have missed the 5 week visit|86
383362|NCT00315302|936913|P4|5 Week Visit|Overall Study||30
383363|NCT00315302|936914|P3|5 Week Visit|Overall Study||26
383364|NCT00315302|936915|P2|5 Week Visit|Overall Study||86
383365|NCT00315302|936916|P1|5 Week Visit|Overall Study||85
383366|NCT00315302|936913|P4|STARTED|Overall Study||34
383367|NCT00315302|936914|P3|STARTED|Overall Study||26
383368|NCT00315302|936915|P2|STARTED|Overall Study||90
383369|NCT00315302|936916|P1|STARTED|Overall Study||90
383370|NCT00315146|936962|P4|NOT COMPLETED|Overall Study||0
383371|NCT00315146|936963|P3|NOT COMPLETED|Overall Study||2
383372|NCT00315146|936964|P2|NOT COMPLETED|Overall Study||3
383373|NCT00315146|936965|P1|NOT COMPLETED|Overall Study||2
383374|NCT00315146|936962|P4|COMPLETED|Overall Study||22
383375|NCT00315146|936963|P3|COMPLETED|Overall Study||20
383376|NCT00315146|936964|P2|COMPLETED|Overall Study||19
383377|NCT00315146|936965|P1|COMPLETED|Overall Study||20
383378|NCT00315146|936962|P4|STARTED|Overall Study||22
383379|NCT00315146|936963|P3|STARTED|Overall Study||22
383380|NCT00315146|936964|P2|STARTED|Overall Study||22
383381|NCT00315146|936965|P1|STARTED|Overall Study||22
383382|NCT00315120|936983|P4|NOT COMPLETED|Overall Study||0
383383|NCT00315120|936984|P3|NOT COMPLETED|Overall Study||0
383384|NCT00315120|936985|P2|NOT COMPLETED|Overall Study||0
383385|NCT00315120|936986|P1|NOT COMPLETED|Overall Study||0
383386|NCT00315120|936983|P4|COMPLETED|Overall Study||107
383387|NCT00315120|936984|P3|COMPLETED|Overall Study||115
383388|NCT00315120|936985|P2|COMPLETED|Overall Study||118
383389|NCT00315120|936986|P1|COMPLETED|Overall Study||115
383390|NCT00315120|936983|P4|STARTED|Overall Study||107
383391|NCT00315120|936984|P3|STARTED|Overall Study||115
383392|NCT00315120|936985|P2|STARTED|Overall Study||118
383393|NCT00315120|936986|P1|STARTED|Overall Study||115
383394|NCT00315055|937046|P2|NOT COMPLETED|Overall Study||5
383395|NCT00315055|937047|P1|NOT COMPLETED|Overall Study||3
383396|NCT00315055|937046|P2|COMPLETED|Overall Study||150
383397|NCT00315055|937047|P1|COMPLETED|Overall Study||152
383398|NCT00315055|937046|P2|STARTED|Overall Study||155
383399|NCT00315055|937047|P1|STARTED|Overall Study||155
383400|NCT00314951|937065|P2|NOT COMPLETED|Follow-up||34
383401|NCT00314951|937066|P1|NOT COMPLETED|Follow-up||44
383402|NCT00314951|937065|P2|COMPLETED|Follow-up||255
383403|NCT00314951|937066|P1|COMPLETED|Follow-up||263
383404|NCT00314951|937065|P2|STARTED|Follow-up||289
383405|NCT00314951|937066|P1|STARTED|Follow-up||307
383406|NCT00314951|937065|P2|NOT COMPLETED|Treatment||11
383407|NCT00314951|937066|P1|NOT COMPLETED|Treatment||16
383408|NCT00314951|937065|P2|COMPLETED|Treatment||289
383409|NCT00314951|937066|P1|COMPLETED|Treatment||307
383410|NCT00314951|937065|P2|STARTED|Treatment||300
383411|NCT00314951|937066|P1|STARTED|Treatment||323
383412|NCT00314951|937065|P2|NOT COMPLETED|Enrollment||6
383413|NCT00314951|937066|P1|NOT COMPLETED|Enrollment||0
383414|NCT00314951|937065|P2|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|300
383415|NCT00314951|937066|P1|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|323
383416|NCT00314951|937065|P2|STARTED|Enrollment||306
383417|NCT00314951|937066|P1|STARTED|Enrollment||323
383418|NCT00314808|937076|P1|NOT COMPLETED|Overall Study||8
383419|NCT00314808|937076|P1|COMPLETED|Overall Study|Completed 2 cycles of Dronabinol or terminated early due to treatment-related adverse events (AE)|25
383420|NCT00314808|937076|P1|STARTED|Overall Study||33
383421|NCT00314795|937084|P1|NOT COMPLETED|Overall Study||20
383422|NCT00314795|937084|P1|COMPLETED|Overall Study||2
383423|NCT00314795|937084|P1|STARTED|Overall Study||22
383424|NCT00314574|937094|P2|NOT COMPLETED|Overall Study||83
383425|NCT00314574|937095|P1|NOT COMPLETED|Overall Study||94
383426|NCT00314574|937094|P2|COMPLETED|Overall Study||344
383427|NCT00314574|937095|P1|COMPLETED|Overall Study||329
383428|NCT00314574|937094|P2|Safety Population|Overall Study||428
383429|NCT00314574|937095|P1|Safety Population|Overall Study|1 patient in the placebo arm received Xolair and was added to the Xolair arm for Safety analyses.|420
383430|NCT00314574|937094|P2|Received at Least One Dose of Study Drug|Overall Study||427
383431|NCT00314574|937095|P1|Received at Least One Dose of Study Drug|Overall Study||421
383432|NCT00314574|937094|P2|STARTED|Overall Study||427
383433|NCT00314574|937095|P1|STARTED|Overall Study||423
383434|NCT00314366|937111|P2|NOT COMPLETED|Overall Study||0
383435|NCT00314366|937112|P1|NOT COMPLETED|Overall Study||1
383436|NCT00314366|937111|P2|COMPLETED|Overall Study||10
383437|NCT00314366|937112|P1|COMPLETED|Overall Study||10
383438|NCT00314366|937111|P2|STARTED|Overall Study||10
383439|NCT00314366|937112|P1|STARTED|Overall Study||11
383440|NCT00314353|937142|P2|NOT COMPLETED|Follow-up||0
383441|NCT00314353|937143|P1|NOT COMPLETED|Follow-up||0
383442|NCT00314353|937142|P2|COMPLETED|Follow-up||0
383443|NCT00314353|937143|P1|COMPLETED|Follow-up||3
383444|NCT00314353|937142|P2|STARTED|Follow-up||0
383445|NCT00314353|937143|P1|STARTED|Follow-up|2 participants who completed 8 cycles plus 1 participant who did not complete 8 cycles therapy.|3
383446|NCT00314353|937142|P2|NOT COMPLETED|Protocol Therapy (8 Cycles)||3
383447|NCT00314353|937143|P1|NOT COMPLETED|Protocol Therapy (8 Cycles)||2
383448|NCT00314353|937142|P2|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|0
383449|NCT00314353|937143|P1|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|2
383450|NCT00314353|937142|P2|STARTED|Protocol Therapy (8 Cycles)||3
383451|NCT00314353|937143|P1|STARTED|Protocol Therapy (8 Cycles)||4
383452|NCT00314340|937157|P1|NOT COMPLETED|Overall Study||1
383453|NCT00314340|937157|P1|COMPLETED|Overall Study||11
383454|NCT00314340|937157|P1|Placebo|Overall Study||12
383455|NCT00314340|937157|P1|Hydrocodone Plus APAP|Overall Study||12
383456|NCT00314340|937157|P1|ER Morphine|Overall Study||11
383457|NCT00314340|937157|P1|STARTED|Overall Study||12
383458|NCT00314327|937163|P1|NOT COMPLETED|Overall Study||1
383459|NCT00314327|937163|P1|COMPLETED|Overall Study||0
383460|NCT00314327|937163|P1|STARTED|Overall Study||1
383461|NCT00314262|937168|P1|NOT COMPLETED|Overall Study||5
383462|NCT00314262|937168|P1|COMPLETED|Overall Study||7
383463|NCT00314262|937168|P1|STARTED|Overall Study||12
383464|NCT00314249|937176|P2|NOT COMPLETED|Overall Study||163
383465|NCT00314249|937177|P1|NOT COMPLETED|Overall Study||152
383466|NCT00314249|937176|P2|COMPLETED|Overall Study||353
383467|NCT00314249|937177|P1|COMPLETED|Overall Study||357
383468|NCT00314249|937176|P2|STARTED|Overall Study||516
383469|NCT00314249|937177|P1|STARTED|Overall Study||509
383470|NCT00314236|937195|P2|NOT COMPLETED|Overall Study||2
383471|NCT00314236|937196|P1|NOT COMPLETED|Overall Study||0
383472|NCT00314236|937195|P2|COMPLETED|Overall Study||37
383473|NCT00314236|937196|P1|COMPLETED|Overall Study||41
383474|NCT00314236|937195|P2|STARTED|Overall Study||39
383475|NCT00314236|937196|P1|STARTED|Overall Study||41
383476|NCT00314145|937210|P2|NOT COMPLETED|Overall Study||29
383477|NCT00314145|937211|P1|NOT COMPLETED|Overall Study||21
383478|NCT00314145|937210|P2|COMPLETED|Overall Study||381
383479|NCT00314145|937211|P1|COMPLETED|Overall Study||389
383480|NCT00314145|937210|P2|STARTED|Overall Study||410
383481|NCT00314145|937211|P1|STARTED|Overall Study||410
383482|NCT00314132|937225|P2|NOT COMPLETED|Overall Study||18
383483|NCT00314132|937226|P1|NOT COMPLETED|Overall Study||8
383484|NCT00314132|937225|P2|COMPLETED|Overall Study||1583
383485|NCT00314132|937226|P1|COMPLETED|Overall Study||395
383486|NCT00314132|937225|P2|STARTED|Overall Study||1601
383487|NCT00314132|937226|P1|STARTED|Overall Study||403
383488|NCT00314106|937236|P2|NOT COMPLETED|Overall Study||0
383489|NCT00314106|937237|P1|NOT COMPLETED|Overall Study||0
383490|NCT00314106|937236|P2|COMPLETED|Overall Study||8
383491|NCT00314106|937237|P1|COMPLETED|Overall Study||18
383492|NCT00314106|937236|P2|STARTED|Overall Study||8
383493|NCT00314106|937237|P1|STARTED|Overall Study||18
383494|NCT00314093|937245|P1|NOT COMPLETED|Overall Study||0
383495|NCT00314093|937245|P1|COMPLETED|Overall Study||0
383496|NCT00314093|937245|P1|STARTED|Overall Study||0
383497|NCT00313911|937253|P2|NOT COMPLETED|Overall Study||41
383498|NCT00313911|937254|P1|NOT COMPLETED|Overall Study||94
383499|NCT00313911|937253|P2|COMPLETED|Overall Study||670
383500|NCT00313911|937254|P1|COMPLETED|Overall Study||1328
383501|NCT00313911|937253|P2|STARTED|Overall Study|A participant in this group mistakenly got Group 1 vaccine. N in outcomes adjusted accordingly.|711
383502|NCT00313911|937254|P1|STARTED|Overall Study|N for outcomes adjusted to include participant in Group 2 that got vaccine assigned to this group.|1422
383503|NCT00313846|937268|P2|NOT COMPLETED|Overall Study||11
383504|NCT00313846|937269|P1|NOT COMPLETED|Overall Study||5
383505|NCT00313846|937268|P2|COMPLETED|Overall Study||153
383506|NCT00313846|937269|P1|COMPLETED|Overall Study||157
383507|NCT00313846|937268|P2|STARTED|Overall Study|327 subjects were randomized: 1 subject was lost to follow-up (N = 326).|164
383508|NCT00313846|937269|P1|STARTED|Overall Study||162
383509|NCT00313820|937280|P2|NOT COMPLETED|Pregabalin or Placebo Treatment Period||19
383510|NCT00313820|937281|P1|NOT COMPLETED|Pregabalin or Placebo Treatment Period||17
383511|NCT00313820|937280|P2|COMPLETED|Pregabalin or Placebo Treatment Period||90
383512|NCT00313820|937281|P1|COMPLETED|Pregabalin or Placebo Treatment Period||93
383513|NCT00313820|937280|P2|STARTED|Pregabalin or Placebo Treatment Period||109
383514|NCT00313820|937281|P1|STARTED|Pregabalin or Placebo Treatment Period||110
383515|NCT00313820|937280|P2|NOT COMPLETED|Assigned to Treatment||0
383516|NCT00313820|937281|P1|NOT COMPLETED|Assigned to Treatment||1
383517|NCT00313820|937280|P2|COMPLETED|Assigned to Treatment||109
383518|NCT00313820|937281|P1|COMPLETED|Assigned to Treatment||110
383519|NCT00313820|937280|P2|STARTED|Assigned to Treatment||109
383520|NCT00313820|937281|P1|STARTED|Assigned to Treatment||111
383521|NCT00313781|937319|P3|NOT COMPLETED|After Crossover||27
383522|NCT00313781|937320|P2|NOT COMPLETED|After Crossover||0
383523|NCT00313781|937321|P1|NOT COMPLETED|After Crossover||0
383524|NCT00313781|937319|P3|COMPLETED|After Crossover||10
383525|NCT00313781|937320|P2|COMPLETED|After Crossover||0
383526|NCT00313781|937321|P1|COMPLETED|After Crossover||0
383527|NCT00313781|937319|P3|STARTED|After Crossover||37
383528|NCT00313781|937320|P2|STARTED|After Crossover||0
383529|NCT00313781|937321|P1|STARTED|After Crossover||0
383530|NCT00313781|937319|P3|NOT COMPLETED|Before Crossover||0
383531|NCT00313781|937320|P2|NOT COMPLETED|Before Crossover||79
383532|NCT00313781|937321|P1|NOT COMPLETED|Before Crossover||75
383533|NCT00313781|937319|P3|COMPLETED|Before Crossover||0
383534|NCT00313781|937320|P2|COMPLETED|Before Crossover||23
383535|NCT00313781|937321|P1|COMPLETED|Before Crossover||27
383536|NCT00313781|937319|P3|Treated|Before Crossover||0
383537|NCT00313781|937320|P2|Treated|Before Crossover||102
383538|NCT00313781|937321|P1|Treated|Before Crossover||97
383539|NCT00313781|937319|P3|STARTED|Before Crossover||0
383540|NCT00313781|937320|P2|STARTED|Before Crossover||102
383541|NCT00313781|937321|P1|STARTED|Before Crossover||102
383542|NCT00313729|937355|P1|NOT COMPLETED|Overall Study||0
383543|NCT00313729|937355|P1|COMPLETED|Overall Study||120
383544|NCT00313729|937355|P1|STARTED|Overall Study||120
383545|NCT00313716|937367|P6|NOT COMPLETED|Overall Study||13
383546|NCT00313716|937368|P5|NOT COMPLETED|Overall Study||6
383547|NCT00313716|937369|P4|NOT COMPLETED|Overall Study||4
383548|NCT00313716|937370|P3|NOT COMPLETED|Overall Study||12
383549|NCT00313716|937371|P2|NOT COMPLETED|Overall Study||8
383550|NCT00313716|937372|P1|NOT COMPLETED|Overall Study||5
383551|NCT00313716|937367|P6|COMPLETED|Overall Study||35
383552|NCT00313716|937368|P5|COMPLETED|Overall Study||27
383553|NCT00313716|937369|P4|COMPLETED|Overall Study||16
383554|NCT00313716|937370|P3|COMPLETED|Overall Study||38
383555|NCT00313716|937371|P2|COMPLETED|Overall Study||23
383556|NCT00313716|937372|P1|COMPLETED|Overall Study||13
383557|NCT00313716|937367|P6|STARTED|Overall Study||48
383558|NCT00313716|937368|P5|STARTED|Overall Study||33
383559|NCT00313716|937369|P4|STARTED|Overall Study||20
383560|NCT00313716|937370|P3|STARTED|Overall Study||50
383561|NCT00313716|937371|P2|STARTED|Overall Study||31
383562|NCT00313716|937372|P1|STARTED|Overall Study||18
383563|NCT00313703|937399|P4|NOT COMPLETED|Overall Study||12
383564|NCT00313703|937400|P3|NOT COMPLETED|Overall Study||5
383565|NCT00313703|937401|P2|NOT COMPLETED|Overall Study||2
383566|NCT00313703|937402|P1|NOT COMPLETED|Overall Study||11
383567|NCT00313703|937399|P4|COMPLETED|Overall Study|Outcomes not reported due to heterogeneity of this group|0
383568|NCT00313703|937400|P3|COMPLETED|Overall Study|Some subjects lost-to-follow-up|72
383569|NCT00313703|937401|P2|COMPLETED|Overall Study|Some subjects lost-to follow-up|32
383570|NCT00313703|937402|P1|COMPLETED|Overall Study|Some subjects lost to follow-up|175
383571|NCT00313703|937399|P4|STARTED|Overall Study||12
383572|NCT00313703|937400|P3|STARTED|Overall Study||77
383573|NCT00313703|937401|P2|STARTED|Overall Study||34
383574|NCT00313703|937402|P1|STARTED|Overall Study||186
383575|NCT00313612|937418|P2|NOT COMPLETED|Overall Study||1
383576|NCT00313612|937419|P1|NOT COMPLETED|Overall Study||0
383577|NCT00313612|937418|P2|COMPLETED|Overall Study||19
383578|NCT00313612|937419|P1|COMPLETED|Overall Study||19
383579|NCT00313612|937418|P2|STARTED|Overall Study||20
383580|NCT00313612|937419|P1|STARTED|Overall Study||19
383581|NCT00313586|937431|P4|NOT COMPLETED|Overall Study||23
383582|NCT00313586|937432|P3|NOT COMPLETED|Overall Study||24
383583|NCT00313586|937433|P2|NOT COMPLETED|Overall Study||70
383584|NCT00313586|937434|P1|NOT COMPLETED|Overall Study||70
383585|NCT00313586|937431|P4|COMPLETED|Overall Study||0
383586|NCT00313586|937432|P3|COMPLETED|Overall Study||0
383587|NCT00313586|937433|P2|COMPLETED|Overall Study||5
383588|NCT00313586|937434|P1|COMPLETED|Overall Study||5
383589|NCT00313586|937431|P4|Treated|Overall Study||23
383590|NCT00313586|937432|P3|Treated|Overall Study||24
383591|NCT00313586|937433|P2|Treated|Overall Study||75
383592|NCT00313586|937434|P1|Treated|Overall Study||74
383593|NCT00313586|937431|P4|STARTED|Overall Study||23
383594|NCT00313586|937432|P3|STARTED|Overall Study||24
383595|NCT00313586|937433|P2|STARTED|Overall Study||75
383596|NCT00313586|937434|P1|STARTED|Overall Study||75
383597|NCT00313560|937442|P1|NOT COMPLETED|Overall Study||0
383598|NCT00313560|937442|P1|COMPLETED|Overall Study||48
383599|NCT00313560|937442|P1|STARTED|Overall Study||48
383600|NCT00313443|937446|P1|NOT COMPLETED|Overall Study||0
383601|NCT00313443|937446|P1|COMPLETED|Overall Study||30
383602|NCT00313443|937446|P1|STARTED|Overall Study||30
383603|NCT00313313|937457|P3|NOT COMPLETED|Overall Study||82
383604|NCT00313313|937458|P2|NOT COMPLETED|Overall Study||66
383605|NCT00313313|937459|P1|NOT COMPLETED|Overall Study||63
383606|NCT00313313|937457|P3|COMPLETED|Overall Study|26 subjects completed the study without being rescued|185
383607|NCT00313313|937458|P2|COMPLETED|Overall Study|55 subjects completed the study without being rescued|187
383608|NCT00313313|937459|P1|COMPLETED|Overall Study|61 subjects completed the study without being rescued|185
383609|NCT00313313|937457|P3|STARTED|Overall Study||267
383610|NCT00313313|937458|P2|STARTED|Overall Study||253
383611|NCT00313313|937459|P1|STARTED|Overall Study||248
383612|NCT00313300|937481|P5|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
383613|NCT00313300|937482|P4|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||5
383614|NCT00313300|937483|P3|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
383615|NCT00313300|937484|P2|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||0
383616|NCT00313300|937485|P1|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||3
383617|NCT00313300|937481|P5|COMPLETED|Follow-Up(30days)-Randomized Phase B||199
383618|NCT00313300|937482|P4|COMPLETED|Follow-Up(30days)-Randomized Phase B||217
383619|NCT00313300|937483|P3|COMPLETED|Follow-Up(30days)-Randomized Phase B||117
383620|NCT00313300|937484|P2|COMPLETED|Follow-Up(30days)-Randomized Phase B||123
383621|NCT00313300|937485|P1|COMPLETED|Follow-Up(30days)-Randomized Phase B||380
383622|NCT00313300|937481|P5|STARTED|Follow-Up(30days)-Randomized Phase B||201
383623|NCT00313300|937482|P4|STARTED|Follow-Up(30days)-Randomized Phase B||222
383624|NCT00313300|937483|P3|STARTED|Follow-Up(30days)-Randomized Phase B||119
383625|NCT00313300|937484|P2|STARTED|Follow-Up(30days)-Randomized Phase B||123
383626|NCT00313300|937485|P1|STARTED|Follow-Up(30days)-Randomized Phase B||383
383627|NCT00313300|937481|P5|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
383628|NCT00313300|937482|P4|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
383629|NCT00313300|937483|P3|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||2
383630|NCT00313300|937484|P2|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||6
383631|NCT00313300|937485|P1|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||5
383632|NCT00313300|937481|P5|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
383633|NCT00313300|937482|P4|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
383634|NCT00313300|937483|P3|COMPLETED|Follow-Up(30days)-Randomized Phase A||172
383635|NCT00313300|937484|P2|COMPLETED|Follow-Up(30days)-Randomized Phase A||156
383636|NCT00313300|937485|P1|COMPLETED|Follow-Up(30days)-Randomized Phase A||158
383637|NCT00313300|937481|P5|STARTED|Follow-Up(30days)-Randomized Phase A||0
383638|NCT00313300|937482|P4|STARTED|Follow-Up(30days)-Randomized Phase A||0
383639|NCT00313300|937483|P3|STARTED|Follow-Up(30days)-Randomized Phase A||174
383640|NCT00313300|937484|P2|STARTED|Follow-Up(30days)-Randomized Phase A||162
383641|NCT00313300|937485|P1|STARTED|Follow-Up(30days)-Randomized Phase A||163
383642|NCT00313300|937481|P5|NOT COMPLETED|Randomized in Phase B (26 Weeks)||208
383643|NCT00313300|937482|P4|NOT COMPLETED|Randomized in Phase B (26 Weeks)||233
383644|NCT00313300|937483|P3|NOT COMPLETED|Randomized in Phase B (26 Weeks)||40
383645|NCT00313300|937484|P2|NOT COMPLETED|Randomized in Phase B (26 Weeks)||33
383646|NCT00313300|937485|P1|NOT COMPLETED|Randomized in Phase B (26 Weeks)||94
383647|NCT00313300|937481|P5|COMPLETED|Randomized in Phase B (26 Weeks)||13
383648|NCT00313300|937482|P4|COMPLETED|Randomized in Phase B (26 Weeks)||15
383649|NCT00313300|937483|P3|COMPLETED|Randomized in Phase B (26 Weeks)||94
383650|NCT00313300|937484|P2|COMPLETED|Randomized in Phase B (26 Weeks)||105
383651|NCT00313300|937485|P1|COMPLETED|Randomized in Phase B (26 Weeks)||333
383652|NCT00313300|937481|P5|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||221
383653|NCT00313300|937482|P4|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||248
383654|NCT00313300|937483|P3|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||110
383655|NCT00313300|937484|P2|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||120
383656|NCT00313300|937485|P1|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||368
383657|NCT00313300|937481|P5|STARTED|Randomized in Phase B (26 Weeks)||221
383658|NCT00313300|937482|P4|STARTED|Randomized in Phase B (26 Weeks)||248
383659|NCT00313300|937483|P3|STARTED|Randomized in Phase B (26 Weeks)||134
383660|NCT00313300|937484|P2|STARTED|Randomized in Phase B (26 Weeks)||138
383661|NCT00313300|937485|P1|STARTED|Randomized in Phase B (26 Weeks)||427
383662|NCT00313300|937481|P5|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
383663|NCT00313300|937482|P4|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
383664|NCT00313300|937483|P3|NOT COMPLETED|Randomized in Phase A (26 Weeks)||35
383665|NCT00313300|937484|P2|NOT COMPLETED|Randomized in Phase A (26 Weeks)||39
383666|NCT00313300|937485|P1|NOT COMPLETED|Randomized in Phase A (26 Weeks)||54
383667|NCT00313300|937481|P5|COMPLETED|Randomized in Phase A (26 Weeks)||0
383668|NCT00313300|937482|P4|COMPLETED|Randomized in Phase A (26 Weeks)||0
383669|NCT00313300|937483|P3|COMPLETED|Randomized in Phase A (26 Weeks)||149
383670|NCT00313300|937484|P2|COMPLETED|Randomized in Phase A (26 Weeks)||140
383671|NCT00313300|937485|P1|COMPLETED|Randomized in Phase A (26 Weeks)||130
383672|NCT00313300|937481|P5|STARTED|Randomized in Phase A (26 Weeks)||0
383673|NCT00313300|937482|P4|STARTED|Randomized in Phase A (26 Weeks)||0
383674|NCT00313300|937483|P3|STARTED|Randomized in Phase A (26 Weeks)||184
383675|NCT00313300|937484|P2|STARTED|Randomized in Phase A (26 Weeks)||179
383676|NCT00313300|937485|P1|STARTED|Randomized in Phase A (26 Weeks)||184
383677|NCT00313209|937537|P2|NOT COMPLETED|Overall Study||82
383678|NCT00313209|937538|P1|NOT COMPLETED|Overall Study||107
383679|NCT00313209|937537|P2|COMPLETED|Overall Study||385
383680|NCT00313209|937538|P1|COMPLETED|Overall Study||359
383681|NCT00313209|937537|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|467
383682|NCT00313209|937538|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|466
383683|NCT00313170|937555|P3|NOT COMPLETED|Overall Study||32
383684|NCT00313170|937556|P2|NOT COMPLETED|Overall Study||34
383685|NCT00313170|937557|P1|NOT COMPLETED|Overall Study||36
383686|NCT00313170|937555|P3|COMPLETED|Overall Study||14
383687|NCT00313170|937556|P2|COMPLETED|Overall Study||16
383688|NCT00313170|937557|P1|COMPLETED|Overall Study||11
383689|NCT00313170|937555|P3|STARTED|Overall Study||46
383690|NCT00313170|937556|P2|STARTED|Overall Study||50
383691|NCT00313170|937557|P1|STARTED|Overall Study||47
383692|NCT00313144|937573|P1|NOT COMPLETED|Overall Study||110
383693|NCT00313144|937573|P1|COMPLETED|Overall Study||17
383694|NCT00313144|937573|P1|STARTED|Overall Study||127
383695|NCT00313014|937660|P3|NOT COMPLETED|Overall Study||61
383696|NCT00313014|937661|P2|NOT COMPLETED|Overall Study||73
383697|NCT00313014|937662|P1|NOT COMPLETED|Overall Study||93
383698|NCT00313014|937660|P3|COMPLETED|Overall Study||159
383699|NCT00313014|937661|P2|COMPLETED|Overall Study||146
383700|NCT00313014|937662|P1|COMPLETED|Overall Study||128
383701|NCT00313014|937660|P3|STARTED|Overall Study||220
383702|NCT00313014|937661|P2|STARTED|Overall Study||219
383703|NCT00313014|937662|P1|STARTED|Overall Study||221
383704|NCT00312923|937682|P2|NOT COMPLETED|Overall Study||6
383705|NCT00312923|937683|P1|NOT COMPLETED|Overall Study||9
383706|NCT00312923|937682|P2|COMPLETED|Overall Study||20
383707|NCT00312923|937683|P1|COMPLETED|Overall Study||19
383708|NCT00312923|937682|P2|STARTED|Overall Study||26
383709|NCT00312923|937683|P1|STARTED|Overall Study||28
383710|NCT00312897|937693|P2|NOT COMPLETED|Overall Study||6
383711|NCT00312897|937694|P1|NOT COMPLETED|Overall Study||6
383712|NCT00312897|937693|P2|COMPLETED|Overall Study||18
383713|NCT00312897|937694|P1|COMPLETED|Overall Study||21
383714|NCT00312897|937693|P2|STARTED|Overall Study||24
383715|NCT00312897|937694|P1|STARTED|Overall Study||27
383716|NCT00312884|937704|P2|NOT COMPLETED|Overall Study||12
383717|NCT00312884|937705|P1|NOT COMPLETED|Overall Study||17
383718|NCT00312884|937704|P2|COMPLETED|Overall Study||79
383719|NCT00312884|937705|P1|COMPLETED|Overall Study||74
383720|NCT00312884|937704|P2|STARTED|Overall Study||91
383721|NCT00312884|937705|P1|STARTED|Overall Study||91
383722|NCT00312858|937719|P2|NOT COMPLETED|Overall Study||93
383723|NCT00312858|937720|P1|NOT COMPLETED|Overall Study||68
383724|NCT00312858|937719|P2|COMPLETED|Overall Study||230
383725|NCT00312858|937720|P1|COMPLETED|Overall Study||262
383726|NCT00312858|937719|P2|Visit 4|Overall Study||240
383727|NCT00312858|937720|P1|Visit 4|Overall Study||262
383728|NCT00312858|937719|P2|Visit 3|Overall Study||261
383729|NCT00312858|937720|P1|Visit 3|Overall Study||273
383730|NCT00312858|937719|P2|Visit 2|Overall Study||294
383731|NCT00312858|937720|P1|Visit 2|Overall Study||305
383732|NCT00312858|937719|P2|Visit 1|Overall Study||323
383733|NCT00312858|937720|P1|Visit 1|Overall Study||330
383734|NCT00312858|937719|P2|STARTED|Overall Study||323
383735|NCT00312858|937720|P1|STARTED|Overall Study||330
383736|NCT00312845|937774|P2|NOT COMPLETED|Overall Study||95
383737|NCT00312845|937775|P1|NOT COMPLETED|Overall Study||99
383738|NCT00312845|937774|P2|COMPLETED|Overall Study||245
383739|NCT00312845|937775|P1|COMPLETED|Overall Study||237
383740|NCT00312845|937774|P2|STARTED|Overall Study||340
383741|NCT00312845|937775|P1|STARTED|Overall Study||336
383742|NCT00312728|937783|P1|NOT COMPLETED|Overall Study||110
383743|NCT00312728|937783|P1|COMPLETED|Overall Study||5
383744|NCT00312728|937783|P1|STARTED|Overall Study||115
383745|NCT00312702|937795|P3|NOT COMPLETED|Challenge Phase||0
383746|NCT00312702|937796|P2|NOT COMPLETED|Challenge Phase||0
383747|NCT00312702|937797|P1|NOT COMPLETED|Challenge Phase||0
383748|NCT00312702|937795|P3|COMPLETED|Challenge Phase||1
383749|NCT00312702|937796|P2|COMPLETED|Challenge Phase||12
383750|NCT00312702|937797|P1|COMPLETED|Challenge Phase||0
383751|NCT00312702|937795|P3|STARTED|Challenge Phase|1 non-immunized subjects participated in the challenge phase.|1
383752|NCT00312702|937796|P2|STARTED|Challenge Phase|12 subjects from the high dose group participated in the challenge phase|12
383753|NCT00312702|937797|P1|STARTED|Challenge Phase|low dose subjects didn't participate in the challenge phase|0
383754|NCT00312702|937795|P3|NOT COMPLETED|Immunization Phase||0
383755|NCT00312702|937796|P2|NOT COMPLETED|Immunization Phase||1
383756|NCT00312702|937797|P1|NOT COMPLETED|Immunization Phase||0
383757|NCT00312702|937795|P3|COMPLETED|Immunization Phase||0
383758|NCT00312702|937796|P2|COMPLETED|Immunization Phase||12
383759|NCT00312702|937797|P1|COMPLETED|Immunization Phase||5
383760|NCT00312702|937795|P3|STARTED|Immunization Phase||0
383761|NCT00312702|937796|P2|STARTED|Immunization Phase||13
383762|NCT00312702|937797|P1|STARTED|Immunization Phase||5
383763|NCT00312663|937810|P3|NOT COMPLETED|Challenge Phase||0
383764|NCT00312663|937811|P2|NOT COMPLETED|Challenge Phase||0
383765|NCT00312663|937812|P1|NOT COMPLETED|Challenge Phase||0
383766|NCT00312663|937810|P3|COMPLETED|Challenge Phase||6
383767|NCT00312663|937811|P2|COMPLETED|Challenge Phase||10
383768|NCT00312663|937812|P1|COMPLETED|Challenge Phase||0
383769|NCT00312663|937810|P3|STARTED|Challenge Phase|6 non-immunized subjects participated in the challenge phase|6
383770|NCT00312663|937811|P2|STARTED|Challenge Phase|10 subjects from the high dose group participated in the challenge phase|10
383771|NCT00312663|937812|P1|STARTED|Challenge Phase|low dose subjects didn't participate in the challenge phase|0
383772|NCT00312663|937810|P3|NOT COMPLETED|Immunization Phase||0
383773|NCT00312663|937811|P2|NOT COMPLETED|Immunization Phase||1
383774|NCT00312663|937812|P1|NOT COMPLETED|Immunization Phase||0
383775|NCT00312663|937810|P3|COMPLETED|Immunization Phase||0
383776|NCT00312663|937811|P2|COMPLETED|Immunization Phase||12
383777|NCT00312663|937812|P1|COMPLETED|Immunization Phase||5
383778|NCT00312663|937810|P3|STARTED|Immunization Phase||0
383779|NCT00312663|937811|P2|STARTED|Immunization Phase||13
383780|NCT00312663|937812|P1|STARTED|Immunization Phase||5
383781|NCT00312572|937825|P2|NOT COMPLETED|Overall Study||21
383782|NCT00312572|937826|P1|NOT COMPLETED|Overall Study||16
383783|NCT00312572|937825|P2|COMPLETED|Overall Study||82
383784|NCT00312572|937826|P1|COMPLETED|Overall Study||85
383785|NCT00312572|937825|P2|STARTED|Overall Study||103
383786|NCT00312572|937826|P1|STARTED|Overall Study||101
383787|NCT00312494|937837|P3|NOT COMPLETED|Overall Study||43
383788|NCT00312494|937838|P2|NOT COMPLETED|Overall Study||58
383789|NCT00312494|937839|P1|NOT COMPLETED|Overall Study||71
383790|NCT00312494|937837|P3|COMPLETED|Overall Study||179
383791|NCT00312494|937838|P2|COMPLETED|Overall Study||168
383792|NCT00312494|937839|P1|COMPLETED|Overall Study|1 subject randomized to higher dose; received lower dose baseline and/or week 1; higher dose week 2.|161
383793|NCT00312494|937837|P3|Received Study Treatment|Overall Study||217
383794|NCT00312494|937838|P2|Received Study Treatment|Overall Study||216
383795|NCT00312494|937839|P1|Received Study Treatment|Overall Study|1 subject randomized to higher dose; received lower dose at baseline, higher dose weeks 1 and 2.|223
383796|NCT00312494|937837|P3|STARTED|Overall Study||222
383797|NCT00312494|937838|P2|STARTED|Overall Study||226
383798|NCT00312494|937839|P1|STARTED|Overall Study||232
383799|NCT00312377|937873|P2|NOT COMPLETED|Overall Study||668
383800|NCT00312377|937874|P1|NOT COMPLETED|Overall Study||644
383890|NCT00311376|938057|P2|STARTED|Treatment Cycle 1||135
383801|NCT00312377|937873|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|29
383802|NCT00312377|937874|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|50
383803|NCT00312377|937873|P2|STARTED|Overall Study|randomised patients|697
383804|NCT00312377|937874|P1|STARTED|Overall Study|randomised patients|694
383805|NCT00312338|937898|P2|NOT COMPLETED|Overall Study||3
383806|NCT00312338|937899|P1|NOT COMPLETED|Overall Study||22
383807|NCT00312338|937898|P2|COMPLETED|Overall Study||54
383808|NCT00312338|937899|P1|COMPLETED|Overall Study||83
383809|NCT00312338|937898|P2|STARTED|Overall Study||57
383810|NCT00312338|937899|P1|STARTED|Overall Study||105
383811|NCT00312221|937912|P4|NOT COMPLETED|Double-blind Phase||70
383812|NCT00312221|937913|P3|NOT COMPLETED|Double-blind Phase||72
383813|NCT00312221|937914|P2|NOT COMPLETED|Double-blind Phase||59
383814|NCT00312221|937915|P1|NOT COMPLETED|Double-blind Phase||0
383815|NCT00312221|937912|P4|COMPLETED|Double-blind Phase||63
383816|NCT00312221|937913|P3|COMPLETED|Double-blind Phase||77
383817|NCT00312221|937914|P2|COMPLETED|Double-blind Phase||77
383818|NCT00312221|937915|P1|COMPLETED|Double-blind Phase||0
383819|NCT00312221|937912|P4|STARTED|Double-blind Phase||133
383820|NCT00312221|937913|P3|STARTED|Double-blind Phase||149
383821|NCT00312221|937914|P2|STARTED|Double-blind Phase||136
383822|NCT00312221|937915|P1|STARTED|Double-blind Phase||0
383823|NCT00312221|937912|P4|NOT COMPLETED|Open-label Run-in Period||0
383824|NCT00312221|937913|P3|NOT COMPLETED|Open-label Run-in Period||0
383825|NCT00312221|937914|P2|NOT COMPLETED|Open-label Run-in Period||0
383826|NCT00312221|937915|P1|NOT COMPLETED|Open-label Run-in Period||234
383827|NCT00312221|937912|P4|COMPLETED|Open-label Run-in Period||0
383828|NCT00312221|937913|P3|COMPLETED|Open-label Run-in Period||0
383829|NCT00312221|937914|P2|COMPLETED|Open-label Run-in Period||0
383830|NCT00312221|937915|P1|COMPLETED|Open-label Run-in Period||418
383831|NCT00312221|937912|P4|STARTED|Open-label Run-in Period||0
383832|NCT00312221|937913|P3|STARTED|Open-label Run-in Period||0
383833|NCT00312221|937914|P2|STARTED|Open-label Run-in Period||0
383834|NCT00312221|937915|P1|STARTED|Open-label Run-in Period||652
383835|NCT00312208|937935|P2|NOT COMPLETED|Overall Study||123
383836|NCT00312208|937936|P1|NOT COMPLETED|Overall Study||172
383837|NCT00312208|937935|P2|COMPLETED|Overall Study||1526
383838|NCT00312208|937936|P1|COMPLETED|Overall Study||1477
383839|NCT00312208|937935|P2|STARTED|Overall Study|1649 patients randomized 1635 patients treated|1649
383840|NCT00312208|937936|P1|STARTED|Overall Study|1649 patients randomized, 1634 patients treated|1649
383841|NCT00312195|937946|P2|NOT COMPLETED|Overall Study||6
383842|NCT00312195|937947|P1|NOT COMPLETED|Overall Study||6
383843|NCT00312195|937946|P2|COMPLETED|Overall Study||123
383844|NCT00312195|937947|P1|COMPLETED|Overall Study||132
383845|NCT00312195|937946|P2|STARTED|Overall Study||129
383846|NCT00312195|937947|P1|STARTED|Overall Study||138
383847|NCT00311766|937963|P2|NOT COMPLETED|Overall Study||5
383848|NCT00311766|937964|P1|NOT COMPLETED|Overall Study||0
383849|NCT00311766|937963|P2|COMPLETED|Overall Study||17
383850|NCT00311766|937964|P1|COMPLETED|Overall Study||8
383851|NCT00311766|937963|P2|STARTED|Overall Study||22
383852|NCT00311766|937964|P1|STARTED|Overall Study||8
383853|NCT00311623|937975|P3|NOT COMPLETED|Overall Study||2
383854|NCT00311623|937976|P2|NOT COMPLETED|Overall Study||0
383855|NCT00311623|937977|P1|NOT COMPLETED|Overall Study||0
383856|NCT00311623|937975|P3|COMPLETED|Overall Study||0
383857|NCT00311623|937976|P2|COMPLETED|Overall Study||20
383858|NCT00311623|937977|P1|COMPLETED|Overall Study||10
383859|NCT00311623|937975|P3|STARTED|Overall Study||2
383860|NCT00311623|937976|P2|STARTED|Overall Study||20
383861|NCT00311623|937977|P1|STARTED|Overall Study||10
383862|NCT00311584|938019|P2|NOT COMPLETED|Overall Study||23
383863|NCT00311584|938020|P1|NOT COMPLETED|Overall Study||20
383864|NCT00311584|938019|P2|COMPLETED|Overall Study||7
383865|NCT00311584|938020|P1|COMPLETED|Overall Study||9
383866|NCT00311584|938019|P2|STARTED|Overall Study||30
383867|NCT00311584|938020|P1|STARTED|Overall Study||29
383868|NCT00311402|938028|P2|NOT COMPLETED|Overall Study||177
383869|NCT00311402|938029|P1|NOT COMPLETED|Overall Study||210
383870|NCT00311402|938028|P2|COMPLETED|Overall Study||462
383871|NCT00311402|938029|P1|COMPLETED|Overall Study||445
383872|NCT00311402|938028|P2|STARTED|Overall Study||639
383873|NCT00311402|938029|P1|STARTED|Overall Study||655
383874|NCT00311376|938056|P3|NOT COMPLETED|Treatment Cycle 2||0
383875|NCT00311376|938057|P2|NOT COMPLETED|Treatment Cycle 2||13
383876|NCT00311376|938058|P1|NOT COMPLETED|Treatment Cycle 2||9
383877|NCT00311376|938056|P3|COMPLETED|Treatment Cycle 2||0
383878|NCT00311376|938057|P2|COMPLETED|Treatment Cycle 2||112
383879|NCT00311376|938058|P1|COMPLETED|Treatment Cycle 2||106
383880|NCT00311376|938056|P3|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200U in Cycle 2|0
383881|NCT00311376|938057|P2|STARTED|Treatment Cycle 2|74 from the 200U group + 51 from the Placebo group entered Cycle 2|125
383882|NCT00311376|938058|P1|STARTED|Treatment Cycle 2|69 from the 300U group + 46 from the Placebo group entered Cycle 2|115
383883|NCT00311376|938056|P3|NOT COMPLETED|Treatment Cycle 1||17
383884|NCT00311376|938057|P2|NOT COMPLETED|Treatment Cycle 1||17
383885|NCT00311376|938058|P1|NOT COMPLETED|Treatment Cycle 1||27
383886|NCT00311376|938056|P3|COMPLETED|Treatment Cycle 1||132
383887|NCT00311376|938057|P2|COMPLETED|Treatment Cycle 1||118
383888|NCT00311376|938058|P1|COMPLETED|Treatment Cycle 1||105
383889|NCT00311376|938056|P3|STARTED|Treatment Cycle 1||149
383891|NCT00311376|938058|P1|STARTED|Treatment Cycle 1||132
383892|NCT00311363|938078|P3|NOT COMPLETED|12-Week Double-Blind Treatment Period||12
383893|NCT00311363|938079|P2|NOT COMPLETED|12-Week Double-Blind Treatment Period||14
383894|NCT00311363|938080|P1|NOT COMPLETED|12-Week Double-Blind Treatment Period||0
383895|NCT00311363|938078|P3|COMPLETED|12-Week Double-Blind Treatment Period||84
383896|NCT00311363|938079|P2|COMPLETED|12-Week Double-Blind Treatment Period||84
383897|NCT00311363|938080|P1|COMPLETED|12-Week Double-Blind Treatment Period||0
383898|NCT00311363|938078|P3|STARTED|12-Week Double-Blind Treatment Period||96
383899|NCT00311363|938079|P2|STARTED|12-Week Double-Blind Treatment Period||98
383900|NCT00311363|938080|P1|STARTED|12-Week Double-Blind Treatment Period||0
383901|NCT00311363|938078|P3|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
383902|NCT00311363|938079|P2|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
383903|NCT00311363|938080|P1|NOT COMPLETED|24-Week Single-Blind Treatment Period||106
383904|NCT00311363|938078|P3|COMPLETED|24-Week Single-Blind Treatment Period||0
383905|NCT00311363|938079|P2|COMPLETED|24-Week Single-Blind Treatment Period||0
383906|NCT00311363|938080|P1|COMPLETED|24-Week Single-Blind Treatment Period||221
383907|NCT00311363|938078|P3|STARTED|24-Week Single-Blind Treatment Period||0
383908|NCT00311363|938079|P2|STARTED|24-Week Single-Blind Treatment Period||0
383909|NCT00311363|938080|P1|STARTED|24-Week Single-Blind Treatment Period||327
383910|NCT00311311|938140|P2|NOT COMPLETED|Overall Study||9
383911|NCT00311311|938141|P1|NOT COMPLETED|Overall Study||8
383912|NCT00311311|938140|P2|COMPLETED|Overall Study||26
383913|NCT00311311|938141|P1|COMPLETED|Overall Study||29
383914|NCT00311311|938140|P2|STARTED|Overall Study||35
383915|NCT00311311|938141|P1|STARTED|Overall Study||37
383916|NCT00311181|938191|P1|NOT COMPLETED|Overall Study||96
383917|NCT00311181|938191|P1|COMPLETED|Overall Study||121
383918|NCT00311181|938191|P1|STARTED|Overall Study||217
383919|NCT00311155|938197|P1|NOT COMPLETED|Overall Study||93
383920|NCT00311155|938197|P1|COMPLETED|Overall Study|Some participants had multiple reasons for discontinuation|601
383921|NCT00311155|938197|P1|STARTED|Overall Study||694
383922|NCT00310856|938209|P3|NOT COMPLETED|Overall Study||8
383923|NCT00310856|938210|P2|NOT COMPLETED|Overall Study||5
383924|NCT00310856|938211|P1|NOT COMPLETED|Overall Study||5
383925|NCT00310856|938209|P3|COMPLETED|Overall Study||42
383926|NCT00310856|938210|P2|COMPLETED|Overall Study||56
383927|NCT00310856|938211|P1|COMPLETED|Overall Study||59
383928|NCT00310856|938209|P3|STARTED|Overall Study||50
383929|NCT00310856|938210|P2|STARTED|Overall Study||61
383930|NCT00310856|938211|P1|STARTED|Overall Study||64
383931|NCT00310817|938235|P4|NOT COMPLETED|Overall Study||8
383932|NCT00310817|938236|P3|NOT COMPLETED|Overall Study||8
383933|NCT00310817|938237|P2|NOT COMPLETED|Overall Study||8
383934|NCT00310817|938238|P1|NOT COMPLETED|Overall Study||11
383935|NCT00310817|938235|P4|COMPLETED|Overall Study||74
383936|NCT00310817|938236|P3|COMPLETED|Overall Study||120
383937|NCT00310817|938237|P2|COMPLETED|Overall Study||198
383938|NCT00310817|938238|P1|COMPLETED|Overall Study||196
383939|NCT00310817|938235|P4|STARTED|Overall Study||82
383940|NCT00310817|938236|P3|STARTED|Overall Study||128
383941|NCT00310817|938237|P2|STARTED|Overall Study||206
383942|NCT00310817|938238|P1|STARTED|Overall Study||207
383943|NCT00310804|938326|P2|NOT COMPLETED|Overall Study||0
383944|NCT00310804|938327|P1|NOT COMPLETED|Overall Study||5
383945|NCT00310804|938326|P2|COMPLETED|Overall Study||171
383946|NCT00310804|938327|P1|COMPLETED|Overall Study||1024
383947|NCT00310804|938326|P2|STARTED|Overall Study||171
383948|NCT00310804|938327|P1|STARTED|Overall Study||1029
383949|NCT00310791|938362|P2|NOT COMPLETED|Overall Study||10
383950|NCT00310791|938363|P1|NOT COMPLETED|Overall Study||10
383951|NCT00310791|938362|P2|COMPLETED|Overall Study||30
383952|NCT00310791|938363|P1|COMPLETED|Overall Study||30
383953|NCT00310791|938362|P2|STARTED|Overall Study||40
383954|NCT00310791|938363|P1|STARTED|Overall Study||40
383955|NCT00310466|938371|P2|NOT COMPLETED|Overall Study||12
383956|NCT00310466|938372|P1|NOT COMPLETED|Overall Study||18
383957|NCT00310466|938371|P2|COMPLETED|Overall Study||101
383958|NCT00310466|938372|P1|COMPLETED|Overall Study||95
383959|NCT00310466|938371|P2|STARTED|Overall Study||113
383960|NCT00310466|938372|P1|STARTED|Overall Study||113
383961|NCT00310440|938386|P2|NOT COMPLETED|Overall Study||13
383962|NCT00310440|938387|P1|NOT COMPLETED|Overall Study||26
383963|NCT00310440|938386|P2|COMPLETED|Overall Study||141
383964|NCT00310440|938387|P1|COMPLETED|Overall Study||139
383965|NCT00310440|938386|P2|STARTED|Overall Study||154
383966|NCT00310440|938387|P1|STARTED|Overall Study||165
383967|NCT00310427|938413|P2|NOT COMPLETED|Overall Study||1
383968|NCT00310427|938414|P1|NOT COMPLETED|Overall Study||2
383969|NCT00310427|938413|P2|COMPLETED|Overall Study||25
383970|NCT00310427|938414|P1|COMPLETED|Overall Study||25
383971|NCT00310427|938413|P2|STARTED|Overall Study||26
383972|NCT00310427|938414|P1|STARTED|Overall Study||27
383973|NCT00310401|938436|P2|NOT COMPLETED|Overall Study||0
383974|NCT00310401|938437|P1|NOT COMPLETED|Overall Study||0
383975|NCT00310401|938436|P2|COMPLETED|Overall Study||246
383976|NCT00310401|938437|P1|COMPLETED|Overall Study||260
383977|NCT00310401|938436|P2|STARTED|Overall Study||246
383978|NCT00310401|938437|P1|STARTED|Overall Study||260
383979|NCT00310388|938451|P2|NOT COMPLETED|Safety Follow-up Continuation Phase||13
383980|NCT00310388|938452|P1|NOT COMPLETED|Safety Follow-up Continuation Phase||0
383981|NCT00310388|938451|P2|COMPLETED|Safety Follow-up Continuation Phase||13
383982|NCT00310388|938452|P1|COMPLETED|Safety Follow-up Continuation Phase||0
383983|NCT00310388|938451|P2|STARTED|Safety Follow-up Continuation Phase||26
383984|NCT00310388|938452|P1|STARTED|Safety Follow-up Continuation Phase||0
383985|NCT00310388|938451|P2|NOT COMPLETED|Primary Reporting Phase||0
383986|NCT00310388|938452|P1|NOT COMPLETED|Primary Reporting Phase||346
383987|NCT00310388|938451|P2|COMPLETED|Primary Reporting Phase||0
383988|NCT00310388|938452|P1|COMPLETED|Primary Reporting Phase||30
383989|NCT00310388|938451|P2|STARTED|Primary Reporting Phase||0
383990|NCT00310388|938452|P1|STARTED|Primary Reporting Phase||376
383991|NCT00310375|938494|P3|NOT COMPLETED|Safety Follow-up Continuation Phase||1
383992|NCT00310375|938495|P2|NOT COMPLETED|Safety Follow-up Continuation Phase||0
383993|NCT00310375|938496|P1|NOT COMPLETED|Safety Follow-up Continuation Phase||0
383994|NCT00310375|938494|P3|COMPLETED|Safety Follow-up Continuation Phase|Met the protocol defined stopping criteria|18
383995|NCT00310375|938495|P2|COMPLETED|Safety Follow-up Continuation Phase||0
383996|NCT00310375|938496|P1|COMPLETED|Safety Follow-up Continuation Phase||0
383997|NCT00310375|938494|P3|STARTED|Safety Follow-up Continuation Phase||19
383998|NCT00310375|938495|P2|STARTED|Safety Follow-up Continuation Phase||0
383999|NCT00310375|938496|P1|STARTED|Safety Follow-up Continuation Phase||0
384000|NCT00310375|938494|P3|NOT COMPLETED|Primary Reporting Phase||0
384001|NCT00310375|938495|P2|NOT COMPLETED|Primary Reporting Phase||68
384002|NCT00310375|938496|P1|NOT COMPLETED|Primary Reporting Phase||91
384003|NCT00310375|938494|P3|COMPLETED|Primary Reporting Phase||0
384004|NCT00310375|938495|P2|COMPLETED|Primary Reporting Phase||11
384005|NCT00310375|938496|P1|COMPLETED|Primary Reporting Phase||11
384006|NCT00310375|938494|P3|STARTED|Primary Reporting Phase||0
384007|NCT00310375|938495|P2|STARTED|Primary Reporting Phase||79
384008|NCT00310375|938496|P1|STARTED|Primary Reporting Phase||102
384009|NCT00310362|938541|P3|NOT COMPLETED|Overall Study||0
384010|NCT00310362|938542|P2|NOT COMPLETED|Overall Study||0
384011|NCT00310362|938543|P1|NOT COMPLETED|Overall Study||0
384012|NCT00310362|938541|P3|COMPLETED|Overall Study||1206
384013|NCT00310362|938542|P2|COMPLETED|Overall Study||1205
384014|NCT00310362|938543|P1|COMPLETED|Overall Study||1199
384015|NCT00310362|938541|P3|STARTED|Overall Study||1206
384016|NCT00310362|938542|P2|STARTED|Overall Study||1205
384017|NCT00310362|938543|P1|STARTED|Overall Study||1199
384018|NCT00310310|938553|P2|NOT COMPLETED|Overall Study||20
384019|NCT00310310|938554|P1|NOT COMPLETED|Overall Study||30
384020|NCT00310310|938553|P2|COMPLETED|Overall Study||100
384021|NCT00310310|938554|P1|COMPLETED|Overall Study||90
384022|NCT00310310|938553|P2|STARTED|Overall Study||120
384023|NCT00310310|938554|P1|STARTED|Overall Study||120
384024|NCT00310180|938582|P4|NOT COMPLETED|Overall Study||348
384025|NCT00310180|938583|P3|NOT COMPLETED|Overall Study||137
384026|NCT00310180|938584|P2|NOT COMPLETED|Overall Study||59
384027|NCT00310180|938585|P1|NOT COMPLETED|Overall Study||10
384028|NCT00310180|938582|P4|COMPLETED|Overall Study||1389
384029|NCT00310180|938583|P3|COMPLETED|Overall Study||3312
384030|NCT00310180|938584|P2|COMPLETED|Overall Study||3399
384031|NCT00310180|938585|P1|COMPLETED|Overall Study||1619
384032|NCT00310180|938582|P4|No Follow-up Data|Overall Study||245
384033|NCT00310180|938583|P3|No Follow-up Data|Overall Study||131
384034|NCT00310180|938584|P2|No Follow-up Data|Overall Study||55
384035|NCT00310180|938585|P1|No Follow-up Data|Overall Study||7
384036|NCT00310180|938582|P4|Ineligible|Overall Study||7
384037|NCT00310180|938583|P3|Ineligible|Overall Study||6
384038|NCT00310180|938584|P2|Ineligible|Overall Study||4
384039|NCT00310180|938585|P1|Ineligible|Overall Study||3
384040|NCT00310180|938582|P4|No On-study Data|Overall Study||172
384041|NCT00310180|938583|P3|No On-study Data|Overall Study||10
384042|NCT00310180|938584|P2|No On-study Data|Overall Study||2
384043|NCT00310180|938585|P1|No On-study Data|Overall Study||0
384044|NCT00310180|938582|P4|STARTED|Overall Study||1737
384045|NCT00310180|938583|P3|STARTED|Overall Study||3449
384046|NCT00310180|938584|P2|STARTED|Overall Study||3458
384047|NCT00310180|938585|P1|STARTED|Overall Study||1629
384048|NCT00310076|938615|P1|NOT COMPLETED|Overall Study||3
384049|NCT00310076|938615|P1|COMPLETED|Overall Study||26
384050|NCT00310076|938615|P1|STARTED|Overall Study||29
384051|NCT00310050|938621|P1|NOT COMPLETED|Overall Study||1
384052|NCT00310050|938621|P1|COMPLETED|Overall Study||3
384053|NCT00310050|938621|P1|STARTED|Overall Study||4
384054|NCT00310037|938632|P2|NOT COMPLETED|Overall Study||17
384055|NCT00310037|938633|P1|NOT COMPLETED|Overall Study||18
384056|NCT00310037|938632|P2|COMPLETED|Overall Study||33
384057|NCT00310037|938633|P1|COMPLETED|Overall Study||34
384058|NCT00310037|938632|P2|STARTED|Overall Study||50
384059|NCT00310037|938633|P1|STARTED|Overall Study||52
384060|NCT00309985|938647|P2|NOT COMPLETED|Overall Study||1
384061|NCT00309985|938648|P1|NOT COMPLETED|Overall Study||62
384062|NCT00309985|938647|P2|COMPLETED|Overall Study|"Arm B tx info was not collected so only 1 patient w/o follow-up data was considered not completed."|392
384063|NCT00309985|938648|P1|COMPLETED|Overall Study||335
384064|NCT00309985|938647|P2|Both Baseline and 3-month FACT-P Evals|Overall Study||299
384065|NCT00309985|938648|P1|Both Baseline and 3-month FACT-P Evals|Overall Study||334
384066|NCT00309985|938647|P2|Toxicity Analysis|Overall Study||392
384067|NCT00309985|938648|P1|Toxicity Analysis|Overall Study||390
384068|NCT00309985|938647|P2|STARTED|Overall Study||393
384069|NCT00309985|938648|P1|STARTED|Overall Study||397
384070|NCT00309959|938664|P1|NOT COMPLETED|Overall Study||2
384071|NCT00309959|938664|P1|COMPLETED|Overall Study||35
384072|NCT00309959|938664|P1|STARTED|Overall Study||37
384073|NCT00309946|938673|P1|NOT COMPLETED|Overall Study||1
384074|NCT00309946|938673|P1|COMPLETED|Overall Study||50
384075|NCT00309946|938673|P1|STARTED|Overall Study||51
384076|NCT00309907|938679|P1|NOT COMPLETED|Overall Study||20
384077|NCT00309907|938679|P1|COMPLETED|Overall Study||19
384078|NCT00309907|938679|P1|STARTED|Overall Study||39
384079|NCT00309777|938692|P4|NOT COMPLETED|Overall Study||4
384080|NCT00309777|938693|P3|NOT COMPLETED|Overall Study||19
384081|NCT00309777|938694|P2|NOT COMPLETED|Overall Study||9
384082|NCT00309777|938695|P1|NOT COMPLETED|Overall Study||23
384083|NCT00309777|938692|P4|COMPLETED|Overall Study||107
384084|NCT00309777|938693|P3|COMPLETED|Overall Study||304
384085|NCT00309777|938694|P2|COMPLETED|Overall Study||99
384086|NCT00309777|938695|P1|COMPLETED|Overall Study||292
384087|NCT00309777|938692|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|110
384088|NCT00309777|938693|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|320
384089|NCT00309777|938694|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|107
384090|NCT00309777|938695|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|311
384091|NCT00309777|938692|P4|STARTED|Overall Study||111
384092|NCT00309777|938693|P3|STARTED|Overall Study||323
384093|NCT00309777|938694|P2|STARTED|Overall Study||108
384094|NCT00309777|938695|P1|STARTED|Overall Study||315
384095|NCT00309751|938711|P2|NOT COMPLETED|Overall Study||15
384096|NCT00309751|938712|P1|NOT COMPLETED|Overall Study||31
384097|NCT00309751|938711|P2|COMPLETED|Overall Study||124
384098|NCT00309751|938712|P1|COMPLETED|Overall Study||248
384099|NCT00309751|938711|P2|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|137
384100|NCT00309751|938712|P1|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|275
384101|NCT00309751|938711|P2|STARTED|Overall Study||139
384102|NCT00309751|938712|P1|STARTED|Overall Study||279
384103|NCT00309738|938722|P2|NOT COMPLETED|Overall Study||12
384104|NCT00309738|938723|P1|NOT COMPLETED|Overall Study||13
384105|NCT00309738|938722|P2|COMPLETED|Overall Study||107
384106|NCT00309738|938723|P1|COMPLETED|Overall Study||223
384107|NCT00309738|938722|P2|Safety Population|Overall Study|Subjects who received at least one dose of study medication|119
384108|NCT00309738|938723|P1|Safety Population|Overall Study|Subjects who received at least one dose of study medication|233
384109|NCT00309738|938722|P2|STARTED|Overall Study||119
384110|NCT00309738|938723|P1|STARTED|Overall Study||236
384111|NCT00309608|938736|P5|NOT COMPLETED|Overall Study||4
384112|NCT00309608|938737|P4|NOT COMPLETED|Overall Study||6
384113|NCT00309608|938738|P3|NOT COMPLETED|Overall Study||10
384114|NCT00309608|938739|P2|NOT COMPLETED|Overall Study||13
384115|NCT00309608|938740|P1|NOT COMPLETED|Overall Study||14
384116|NCT00309608|938736|P5|COMPLETED|Overall Study||61
384117|NCT00309608|938737|P4|COMPLETED|Overall Study||60
384118|NCT00309608|938738|P3|COMPLETED|Overall Study||56
384119|NCT00309608|938739|P2|COMPLETED|Overall Study||52
384120|NCT00309608|938740|P1|COMPLETED|Overall Study||57
384121|NCT00309608|938736|P5|STARTED|Overall Study||65
384122|NCT00309608|938737|P4|STARTED|Overall Study||66
384123|NCT00309608|938738|P3|STARTED|Overall Study||66
384124|NCT00309608|938739|P2|STARTED|Overall Study||65
384125|NCT00309608|938740|P1|STARTED|Overall Study||71
384126|NCT00309465|938767|P6|NOT COMPLETED|Overall Study||0
384127|NCT00309465|938768|P5|NOT COMPLETED|Overall Study||0
384128|NCT00309465|938769|P4|NOT COMPLETED|Overall Study||1
384129|NCT00309465|938770|P3|NOT COMPLETED|Overall Study||0
384130|NCT00309465|938771|P2|NOT COMPLETED|Overall Study||0
384131|NCT00309465|938772|P1|NOT COMPLETED|Overall Study||0
384132|NCT00309465|938767|P6|COMPLETED|Overall Study||76
384133|NCT00309465|938768|P5|COMPLETED|Overall Study||76
384134|NCT00309465|938769|P4|COMPLETED|Overall Study|One subject was excluded due to eligibility error.|75
384135|NCT00309465|938770|P3|COMPLETED|Overall Study||58
384136|NCT00309465|938771|P2|COMPLETED|Overall Study||58
384137|NCT00309465|938772|P1|COMPLETED|Overall Study||58
384138|NCT00309465|938767|P6|STARTED|Overall Study||76
384139|NCT00309465|938768|P5|STARTED|Overall Study||76
384140|NCT00309465|938769|P4|STARTED|Overall Study||76
384141|NCT00309465|938770|P3|STARTED|Overall Study||58
384142|NCT00309465|938771|P2|STARTED|Overall Study||58
384143|NCT00309465|938772|P1|STARTED|Overall Study||58
384144|NCT00309452|938788|P2|NOT COMPLETED|Overall Study||0
384145|NCT00309452|938789|P1|NOT COMPLETED|Overall Study||3
384146|NCT00309452|938788|P2|COMPLETED|Overall Study||60
384147|NCT00309452|938789|P1|COMPLETED|Overall Study||57
384148|NCT00309452|938788|P2|STARTED|Overall Study||60
384149|NCT00309452|938789|P1|STARTED|Overall Study||60
384150|NCT00309387|938817|P2|NOT COMPLETED|Overall Study||159
384151|NCT00309387|938818|P1|NOT COMPLETED|Overall Study||142
384152|NCT00309387|938817|P2|COMPLETED|Overall Study||351
384153|NCT00309387|938818|P1|COMPLETED|Overall Study||368
384154|NCT00309387|938817|P2|STARTED|Overall Study||510
384155|NCT00309387|938818|P1|STARTED|Overall Study||510
384156|NCT00309244|938836|P2|NOT COMPLETED|Overall Study||97
384157|NCT00309244|938837|P1|NOT COMPLETED|Overall Study||118
384158|NCT00309244|938836|P2|COMPLETED|Overall Study||246
384159|NCT00309244|938837|P1|COMPLETED|Overall Study||216
384160|NCT00309244|938836|P2|STARTED|Overall Study||343
384161|NCT00309244|938837|P1|STARTED|Overall Study||334
384162|NCT00309166|938859|P2|NOT COMPLETED|Overall Study||3
384163|NCT00309166|938860|P1|NOT COMPLETED|Overall Study||5
384164|NCT00309166|938859|P2|COMPLETED|Overall Study||86
384165|NCT00309166|938860|P1|COMPLETED|Overall Study||176
384166|NCT00309166|938859|P2|STARTED|Overall Study||89
384167|NCT00309166|938860|P1|STARTED|Overall Study||181
384168|NCT00308997|938888|P2|NOT COMPLETED|Overall Study||1
384169|NCT00308997|938889|P1|NOT COMPLETED|Overall Study||1
384170|NCT00308997|938888|P2|COMPLETED|Overall Study||28
384171|NCT00308997|938889|P1|COMPLETED|Overall Study||55
384172|NCT00308997|938888|P2|STARTED|Overall Study||29
384173|NCT00308997|938889|P1|STARTED|Overall Study||56
384174|NCT00308737|938908|P3|NOT COMPLETED|Overall Study||37
384175|NCT00308737|938909|P2|NOT COMPLETED|Overall Study||289
384176|NCT00308737|938910|P1|NOT COMPLETED|Overall Study||463
384177|NCT00308737|938908|P3|COMPLETED|Overall Study||127
384178|NCT00308737|938909|P2|COMPLETED|Overall Study||662
384179|NCT00308737|938910|P1|COMPLETED|Overall Study||475
384180|NCT00308737|938908|P3|STARTED|Overall Study||164
384181|NCT00308737|938909|P2|STARTED|Overall Study||951
384182|NCT00308737|938910|P1|STARTED|Overall Study||938
384183|NCT00308711|938950|P3|NOT COMPLETED|Overall Study||5
384184|NCT00308711|938951|P2|NOT COMPLETED|Overall Study||4
384185|NCT00308711|938952|P1|NOT COMPLETED|Overall Study||2
384186|NCT00308711|938950|P3|COMPLETED|Overall Study||431
384187|NCT00308711|938951|P2|COMPLETED|Overall Study||440
384188|NCT00308711|938952|P1|COMPLETED|Overall Study||426
384189|NCT00308711|938950|P3|STARTED|Overall Study||436
384190|NCT00308711|938951|P2|STARTED|Overall Study||444
384191|NCT00308711|938952|P1|STARTED|Overall Study||428
384192|NCT00308620|938987|P3|NOT COMPLETED|Overall Study||1
384193|NCT00308620|938988|P2|NOT COMPLETED|Overall Study||1
384194|NCT00308620|938989|P1|NOT COMPLETED|Overall Study||1
384195|NCT00308620|938987|P3|COMPLETED|Overall Study||5
384196|NCT00308620|938988|P2|COMPLETED|Overall Study||3
384197|NCT00308620|938989|P1|COMPLETED|Overall Study||2
384198|NCT00308620|938987|P3|STARTED|Overall Study||6
384199|NCT00308620|938988|P2|STARTED|Overall Study||4
384200|NCT00308620|938989|P1|STARTED|Overall Study||3
384201|NCT00308581|938998|P3|NOT COMPLETED|Randomized Maintenance Phase||0
384202|NCT00308581|938999|P2|NOT COMPLETED|Randomized Maintenance Phase||103
384203|NCT00308581|939000|P1|NOT COMPLETED|Randomized Maintenance Phase||105
384204|NCT00308581|938998|P3|COMPLETED|Randomized Maintenance Phase||0
384205|NCT00308581|938999|P2|COMPLETED|Randomized Maintenance Phase||83
384206|NCT00308581|939000|P1|COMPLETED|Randomized Maintenance Phase||82
384207|NCT00308581|938998|P3|STARTED|Randomized Maintenance Phase||0
384208|NCT00308581|938999|P2|STARTED|Randomized Maintenance Phase||186
384209|NCT00308581|939000|P1|STARTED|Randomized Maintenance Phase||187
384210|NCT00308581|938998|P3|NOT COMPLETED|Induction Phase||166
384211|NCT00308581|938999|P2|NOT COMPLETED|Induction Phase||0
384212|NCT00308581|939000|P1|NOT COMPLETED|Induction Phase||0
384213|NCT00308581|938998|P3|COMPLETED|Induction Phase||373
384214|NCT00308581|938999|P2|COMPLETED|Induction Phase|Not applicable in this period|0
384215|NCT00308581|939000|P1|COMPLETED|Induction Phase|Not applicable in this period|0
384216|NCT00308581|938998|P3|STARTED|Induction Phase||539
384217|NCT00308581|938999|P2|STARTED|Induction Phase|Not applicable in this period|0
384218|NCT00308581|939000|P1|STARTED|Induction Phase|Not applicable in this period|0
384219|NCT00308555|939126|P2|NOT COMPLETED|Overall Study||0
384220|NCT00308555|939127|P1|NOT COMPLETED|Overall Study||3
384221|NCT00308555|939126|P2|COMPLETED|Overall Study||11
384222|NCT00308555|939127|P1|COMPLETED|Overall Study||10
384223|NCT00308555|939126|P2|STARTED|Overall Study||11
384224|NCT00308555|939127|P1|STARTED|Overall Study||13
384225|NCT00308516|939135|P2|NOT COMPLETED|Overall Study||21
384226|NCT00308516|939136|P1|NOT COMPLETED|Overall Study||29
384227|NCT00308516|939135|P2|COMPLETED|Overall Study||10
384228|NCT00308516|939136|P1|COMPLETED|Overall Study||6
384229|NCT00308516|939135|P2|STARTED|Overall Study||31
384230|NCT00308516|939136|P1|STARTED|Overall Study||35
384231|NCT00308308|939144|P2|NOT COMPLETED|Overall Study||68
384232|NCT00308308|939145|P1|NOT COMPLETED|Overall Study||103
384233|NCT00308308|939144|P2|COMPLETED|Overall Study||220
384234|NCT00308308|939145|P1|COMPLETED|Overall Study||198
384235|NCT00308308|939144|P2|STARTED|Overall Study||288
384236|NCT00308308|939145|P1|STARTED|Overall Study||301
384237|NCT00308282|939169|P4|NOT COMPLETED|Overall Study||2
384238|NCT00308282|939170|P3|NOT COMPLETED|Overall Study||1
384239|NCT00308282|939171|P2|NOT COMPLETED|Overall Study||4
384240|NCT00308282|939172|P1|NOT COMPLETED|Overall Study||3
384241|NCT00308282|939169|P4|COMPLETED|Overall Study||32
384242|NCT00308282|939170|P3|COMPLETED|Overall Study||33
384243|NCT00308282|939171|P2|COMPLETED|Overall Study||30
384244|NCT00308282|939172|P1|COMPLETED|Overall Study||31
384245|NCT00308282|939169|P4|Received at Least One Dose of Study Drug|Overall Study||34
384246|NCT00308282|939170|P3|Received at Least One Dose of Study Drug|Overall Study||34
384247|NCT00308282|939171|P2|Received at Least One Dose of Study Drug|Overall Study||34
384248|NCT00308282|939172|P1|Received at Least One Dose of Study Drug|Overall Study||34
384249|NCT00308282|939169|P4|STARTED|Overall Study||34
384250|NCT00308282|939170|P3|STARTED|Overall Study||34
384251|NCT00308282|939171|P2|STARTED|Overall Study||34
384252|NCT00308282|939172|P1|STARTED|Overall Study||34
384253|NCT00308230|939212|P3|NOT COMPLETED|Overall Study||0
384254|NCT00308230|939213|P2|NOT COMPLETED|Overall Study||0
384255|NCT00308230|939214|P1|NOT COMPLETED|Overall Study||0
384256|NCT00308230|939212|P3|COMPLETED|Overall Study||20
384257|NCT00308230|939213|P2|COMPLETED|Overall Study||8
384258|NCT00308230|939214|P1|COMPLETED|Overall Study||6
384259|NCT00308230|939212|P3|STARTED|Overall Study||20
384260|NCT00308230|939213|P2|STARTED|Overall Study||8
384261|NCT00308230|939214|P1|STARTED|Overall Study||6
384262|NCT00308139|939224|P2|NOT COMPLETED|Overall Study||87
384263|NCT00308139|939225|P1|NOT COMPLETED|Overall Study||94
384264|NCT00308139|939224|P2|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|64
384265|NCT00308139|939225|P1|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|58
384266|NCT00308139|939224|P2|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|130
384267|NCT00308139|939225|P1|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|128
384268|NCT00308139|939224|P2|Evaluable Meal Tolerance Cohort|Overall Study||24
384269|NCT00308139|939225|P1|Evaluable Meal Tolerance Cohort|Overall Study||27
384270|NCT00308139|939224|P2|Pharmacokinetics Population|Overall Study||0
384271|NCT00308139|939225|P1|Pharmacokinetics Population|Overall Study||129
384272|NCT00308139|939224|P2|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|145
384273|NCT00308139|939225|P1|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|148
384274|NCT00308139|939224|P2|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|147
384275|NCT00308139|939225|P1|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|148
384276|NCT00308139|939224|P2|STARTED|Overall Study||151
384277|NCT00308139|939225|P1|STARTED|Overall Study||152
384278|NCT00308113|939299|P4|NOT COMPLETED|Overall Study||1
384279|NCT00308113|939300|P3|NOT COMPLETED|Overall Study||0
384280|NCT00308113|939301|P2|NOT COMPLETED|Overall Study||0
384281|NCT00308113|939302|P1|NOT COMPLETED|Overall Study||0
384282|NCT00308113|939299|P4|COMPLETED|Overall Study||1
384283|NCT00308113|939300|P3|COMPLETED|Overall Study||1
384284|NCT00308113|939301|P2|COMPLETED|Overall Study||0
384285|NCT00308113|939302|P1|COMPLETED|Overall Study||0
384286|NCT00308113|939299|P4|STARTED|Overall Study||2
384287|NCT00308113|939300|P3|STARTED|Overall Study||1
384288|NCT00308113|939301|P2|STARTED|Overall Study||0
384289|NCT00308113|939302|P1|STARTED|Overall Study||0
384290|NCT00308087|939322|P2|NOT COMPLETED|Overall Study||37
384291|NCT00308087|939323|P1|NOT COMPLETED|Overall Study||36
384292|NCT00308087|939322|P2|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
384293|NCT00308087|939323|P1|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
384294|NCT00308087|939322|P2|STARTED|Overall Study||38
384295|NCT00308087|939323|P1|STARTED|Overall Study||37
384296|NCT00308074|939339|P1|NOT COMPLETED|Overall Study||1
384297|NCT00308074|939339|P1|COMPLETED|Overall Study||13
384298|NCT00308074|939339|P1|STARTED|Overall Study||14
384299|NCT00308061|939348|P2|NOT COMPLETED|Overall Study||0
384300|NCT00308061|939349|P1|NOT COMPLETED|Overall Study||0
384301|NCT00308061|939348|P2|COMPLETED|Overall Study||20
384302|NCT00308061|939349|P1|COMPLETED|Overall Study||20
384303|NCT00308061|939348|P2|STARTED|Overall Study||20
384304|NCT00308061|939349|P1|STARTED|Overall Study||20
384305|NCT00307931|939356|P1|NOT COMPLETED|Overall Study||1
384306|NCT00307931|939356|P1|COMPLETED|Overall Study|Number of subjects who completed the Week 12 visit|15
384307|NCT00307931|939356|P1|STARTED|Overall Study|Number of subjects who entered the study and have been treated|16
384308|NCT00307801|939373|P2|NOT COMPLETED|Overall Study||17
384309|NCT00307801|939374|P1|NOT COMPLETED|Overall Study||32
384310|NCT00307801|939373|P2|COMPLETED|Overall Study||65
384311|NCT00307801|939374|P1|COMPLETED|Overall Study||117
384312|NCT00307801|939373|P2|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|77
384313|NCT00307801|939374|P1|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|141
384314|NCT00307801|939373|P2|Cycle 3, Visit 7, Treatment Day 84|Overall Study||71
384315|NCT00307801|939374|P1|Cycle 3, Visit 7, Treatment Day 84|Overall Study||130
384316|NCT00307801|939373|P2|Cycle 1, Visit 5, Baseline|Overall Study||81
384317|NCT00307801|939374|P1|Cycle 1, Visit 5, Baseline|Overall Study||145
384318|NCT00307801|939373|P2|Subjects Received Treatment|Overall Study||81
384319|NCT00307801|939374|P1|Subjects Received Treatment|Overall Study||145
384320|NCT00307801|939373|P2|STARTED|Overall Study||82
384321|NCT00307801|939374|P1|STARTED|Overall Study||149
384322|NCT00307736|939486|P4|NOT COMPLETED|Overall Study||3
384323|NCT00307736|939487|P3|NOT COMPLETED|Overall Study||3
384324|NCT00307736|939488|P2|NOT COMPLETED|Overall Study||0
384325|NCT00307736|939489|P1|NOT COMPLETED|Overall Study||0
384326|NCT00307736|939486|P4|COMPLETED|Overall Study||20
384327|NCT00307736|939487|P3|COMPLETED|Overall Study||0
384328|NCT00307736|939488|P2|COMPLETED|Overall Study||3
384329|NCT00307736|939489|P1|COMPLETED|Overall Study||3
384330|NCT00307736|939486|P4|STARTED|Overall Study||23
384331|NCT00307736|939487|P3|STARTED|Overall Study||3
384332|NCT00307736|939488|P2|STARTED|Overall Study||3
384333|NCT00307736|939489|P1|STARTED|Overall Study||3
384334|NCT00307684|939500|P3|NOT COMPLETED|Double Blind Phase||0
384335|NCT00307684|939501|P2|NOT COMPLETED|Double Blind Phase||5
384336|NCT00307684|939502|P1|NOT COMPLETED|Double Blind Phase||2
384337|NCT00307684|939500|P3|COMPLETED|Double Blind Phase||0
384338|NCT00307684|939501|P2|COMPLETED|Double Blind Phase||17
384339|NCT00307684|939502|P1|COMPLETED|Double Blind Phase||21
384340|NCT00307684|939500|P3|STARTED|Double Blind Phase||0
384341|NCT00307684|939501|P2|STARTED|Double Blind Phase||22
384342|NCT00307684|939502|P1|STARTED|Double Blind Phase||23
384343|NCT00307684|939500|P3|NOT COMPLETED|Open Label Phase||56
384344|NCT00307684|939501|P2|NOT COMPLETED|Open Label Phase||0
384345|NCT00307684|939502|P1|NOT COMPLETED|Open Label Phase||0
384346|NCT00307684|939500|P3|COMPLETED|Open Label Phase||99
384347|NCT00307684|939501|P2|COMPLETED|Open Label Phase||0
384348|NCT00307684|939502|P1|COMPLETED|Open Label Phase||0
384349|NCT00307684|939500|P3|STARTED|Open Label Phase|1 screening failure|155
384350|NCT00307684|939501|P2|STARTED|Open Label Phase||0
384351|NCT00307684|939502|P1|STARTED|Open Label Phase||0
384352|NCT00307489|939530|P2|NOT COMPLETED|Week 48 Through Week 168||6
384353|NCT00307489|939531|P1|NOT COMPLETED|Week 48 Through Week 168||6
384354|NCT00307489|939530|P2|COMPLETED|Week 48 Through Week 168|5 of the 44 subjects switched to open-label FTC/TDF prior to Week 168.|44
384355|NCT00307489|939531|P1|COMPLETED|Week 48 Through Week 168|11 of the 46 subjects switched to open-label FTC/TDF prior to Week 168.|46
384356|NCT00307489|939530|P2|STARTED|Week 48 Through Week 168||50
384357|NCT00307489|939531|P1|STARTED|Week 48 Through Week 168||52
384358|NCT00307489|939530|P2|NOT COMPLETED|Baseline Through Week 48||2
384359|NCT00307489|939531|P1|NOT COMPLETED|Baseline Through Week 48||1
384360|NCT00307489|939530|P2|COMPLETED|Baseline Through Week 48|9 of the 50 subjects switched to open-label FTC/TDF prior to Week 48.|50
384361|NCT00307489|939531|P1|COMPLETED|Baseline Through Week 48|16 of the 52 subjects switched to open-label FTC/TDF prior to Week 48.|52
384362|NCT00307489|939530|P2|STARTED|Baseline Through Week 48||52
384363|NCT00307489|939531|P1|STARTED|Baseline Through Week 48||53
384364|NCT00307437|939576|P7|NOT COMPLETED|After Controlled Period||113
384365|NCT00307437|939577|P6|NOT COMPLETED|After Controlled Period||122
384366|NCT00307437|939578|P5|NOT COMPLETED|After Controlled Period||55
384367|NCT00307437|939579|P4|NOT COMPLETED|After Controlled Period||58
384368|NCT00307437|939580|P3|NOT COMPLETED|After Controlled Period||0
384369|NCT00307437|939581|P2|NOT COMPLETED|After Controlled Period||0
384370|NCT00307437|939582|P1|NOT COMPLETED|After Controlled Period||0
384371|NCT00307437|939576|P7|COMPLETED|After Controlled Period||289
384372|NCT00307437|939577|P6|COMPLETED|After Controlled Period||281
384373|NCT00307437|939578|P5|COMPLETED|After Controlled Period||140
384374|NCT00307437|939579|P4|COMPLETED|After Controlled Period||139
384375|NCT00307437|939580|P3|COMPLETED|After Controlled Period||0
384376|NCT00307437|939581|P2|COMPLETED|After Controlled Period||0
384377|NCT00307437|939582|P1|COMPLETED|After Controlled Period||0
384378|NCT00307437|939576|P7|STARTED|After Controlled Period||402
384379|NCT00307437|939577|P6|STARTED|After Controlled Period||403
384380|NCT00307437|939578|P5|STARTED|After Controlled Period|2 participants from placebo group in CP did not crossover to this group after CP.|195
384381|NCT00307437|939579|P4|STARTED|After Controlled Period||197
384382|NCT00307437|939580|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
384383|NCT00307437|939581|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
384384|NCT00307437|939582|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
384385|NCT00307437|939576|P7|NOT COMPLETED|Controlled Period||0
384386|NCT00307437|939577|P6|NOT COMPLETED|Controlled Period||0
384387|NCT00307437|939578|P5|NOT COMPLETED|Controlled Period||0
384388|NCT00307437|939579|P4|NOT COMPLETED|Controlled Period||0
384389|NCT00307437|939580|P3|NOT COMPLETED|Controlled Period||9
384390|NCT00307437|939581|P2|NOT COMPLETED|Controlled Period||6
384391|NCT00307437|939582|P1|NOT COMPLETED|Controlled Period||16
384392|NCT00307437|939576|P7|COMPLETED|Controlled Period||0
384393|NCT00307437|939577|P6|COMPLETED|Controlled Period||0
384394|NCT00307437|939578|P5|COMPLETED|Controlled Period||0
384395|NCT00307437|939579|P4|COMPLETED|Controlled Period||0
384396|NCT00307437|939580|P3|COMPLETED|Controlled Period||402
384397|NCT00307437|939581|P2|COMPLETED|Controlled Period||403
384398|NCT00307437|939582|P1|COMPLETED|Controlled Period||394
384399|NCT00307437|939576|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
384400|NCT00307437|939577|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
384401|NCT00307437|939578|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
384402|NCT00307437|939579|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
384403|NCT00307437|939580|P3|STARTED|Controlled Period||411
384404|NCT00307437|939581|P2|STARTED|Controlled Period||409
384405|NCT00307437|939582|P1|STARTED|Controlled Period||410
384406|NCT00307333|939608|P2|NOT COMPLETED|Overall Study||3
384407|NCT00307333|939609|P1|NOT COMPLETED|Overall Study||11
384408|NCT00307333|939608|P2|COMPLETED|Overall Study||1489
384409|NCT00307333|939609|P1|COMPLETED|Overall Study||1500
384410|NCT00307333|939608|P2|STARTED|Overall Study||1492
384411|NCT00307333|939609|P1|STARTED|Overall Study||1511
384412|NCT00307294|939621|P1|NOT COMPLETED|Overall Study||1
384413|NCT00307294|939621|P1|COMPLETED|Overall Study||39
384414|NCT00307294|939621|P1|STARTED|Overall Study||40
384415|NCT00307164|939630|P2|NOT COMPLETED|Overall Study||14
384416|NCT00307164|939631|P1|NOT COMPLETED|Overall Study||15
384417|NCT00307164|939630|P2|COMPLETED|Overall Study||68
384418|NCT00307164|939631|P1|COMPLETED|Overall Study||68
384419|NCT00307164|939630|P2|STARTED|Overall Study||82
384420|NCT00307164|939631|P1|STARTED|Overall Study||83
384421|NCT00307151|939671|P4|NOT COMPLETED|Overall Study||11
384422|NCT00307151|939672|P3|NOT COMPLETED|Overall Study||20
384423|NCT00307151|939673|P2|NOT COMPLETED|Overall Study||7
384424|NCT00307151|939674|P1|NOT COMPLETED|Overall Study||11
384425|NCT00307151|939671|P4|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|129
384426|NCT00307151|939672|P3|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|127
384427|NCT00307151|939673|P2|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|75
384428|NCT00307151|939674|P1|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|71
384429|NCT00307151|939671|P4|STARTED|Overall Study|One participant never started treatment, were not followed and not included in analysis.|140
384430|NCT00307151|939672|P3|STARTED|Overall Study||147
384431|NCT00307151|939673|P2|STARTED|Overall Study||82
384432|NCT00307151|939674|P1|STARTED|Overall Study||82
384433|NCT00307125|939718|P3|NOT COMPLETED|Pilot Phase||1
384434|NCT00307125|939719|P2|NOT COMPLETED|Pilot Phase||2
384435|NCT00307125|939720|P1|NOT COMPLETED|Pilot Phase||0
384436|NCT00307125|939718|P3|COMPLETED|Pilot Phase|1 participant had reduced follow-up|6
384437|NCT00307125|939719|P2|COMPLETED|Pilot Phase|2 participants had reduced follow-up|13
384438|NCT00307125|939720|P1|COMPLETED|Pilot Phase||0
384439|NCT00307125|939718|P3|STARTED|Pilot Phase||7
384440|NCT00307125|939719|P2|STARTED|Pilot Phase||15
384441|NCT00307125|939720|P1|STARTED|Pilot Phase||0
384442|NCT00307125|939718|P3|NOT COMPLETED|Screening Phase||0
384443|NCT00307125|939719|P2|NOT COMPLETED|Screening Phase||0
384444|NCT00307125|939720|P1|NOT COMPLETED|Screening Phase||454
384445|NCT00307125|939718|P3|COMPLETED|Screening Phase||0
384446|NCT00307125|939719|P2|COMPLETED|Screening Phase||0
384447|NCT00307125|939720|P1|COMPLETED|Screening Phase||303
384448|NCT00307125|939718|P3|STARTED|Screening Phase||0
384449|NCT00307125|939719|P2|STARTED|Screening Phase||0
384450|NCT00307125|939720|P1|STARTED|Screening Phase||757
384451|NCT00307086|939742|P1|NOT COMPLETED|Overall Study||5
384452|NCT00307086|939742|P1|COMPLETED|Overall Study||25
384453|NCT00307086|939742|P1|STARTED|Overall Study||30
384454|NCT00307047|939748|P2|NOT COMPLETED|Overall Study||49
384455|NCT00307047|939749|P1|NOT COMPLETED|Overall Study||69
384456|NCT00307047|939748|P2|COMPLETED|Overall Study||1180
384457|NCT00307047|939749|P1|COMPLETED|Overall Study||2389
384458|NCT00307047|939748|P2|STARTED|Overall Study||1229
384459|NCT00307047|939749|P1|STARTED|Overall Study||2458
384460|NCT00307034|939887|P2|NOT COMPLETED|Overall Study||7
384461|NCT00307034|939888|P1|NOT COMPLETED|Overall Study||2
384462|NCT00307034|939887|P2|COMPLETED|Overall Study||169
384463|NCT00307034|939888|P1|COMPLETED|Overall Study||173
384464|NCT00307034|939887|P2|STARTED|Overall Study||176
384465|NCT00307034|939888|P1|STARTED|Overall Study||175
384466|NCT00306917|939928|P2|NOT COMPLETED|Overall Study||109
384467|NCT00306917|939929|P1|NOT COMPLETED|Overall Study||108
384468|NCT00306917|939928|P2|COMPLETED|Overall Study||15
384469|NCT00306917|939929|P1|COMPLETED|Overall Study||13
384470|NCT00306917|939928|P2|60 Month Follow up|Overall Study||15
384471|NCT00306917|939929|P1|60 Month Follow up|Overall Study||13
384472|NCT00306917|939928|P2|48 Month Follow up|Overall Study||22
384473|NCT00306917|939929|P1|48 Month Follow up|Overall Study||29
384474|NCT00306917|939928|P2|36 Month Follow up|Overall Study||42
384475|NCT00306917|939929|P1|36 Month Follow up|Overall Study||56
384476|NCT00306917|939928|P2|24 Month Follow up|Overall Study||71
384477|NCT00306917|939929|P1|24 Month Follow up|Overall Study||60
384478|NCT00306917|939928|P2|12 Month Follow|Overall Study||94
384479|NCT00306917|939929|P1|12 Month Follow|Overall Study||86
384480|NCT00306917|939928|P2|Postoperative to 6 Month Follow up|Overall Study||100
384481|NCT00306917|939929|P1|Postoperative to 6 Month Follow up|Overall Study||93
384482|NCT00306917|939928|P2|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|124
384483|NCT00306917|939929|P1|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|121
384484|NCT00306891|939939|P4|NOT COMPLETED|Part B||17
384485|NCT00306891|939940|P3|NOT COMPLETED|Part B||11
384486|NCT00306891|939941|P2|NOT COMPLETED|Part B||0
384487|NCT00306891|939942|P1|NOT COMPLETED|Part B||0
384488|NCT00306891|939939|P4|COMPLETED|Part B||14
384489|NCT00306891|939940|P3|COMPLETED|Part B||5
384490|NCT00306891|939941|P2|COMPLETED|Part B||0
384491|NCT00306891|939942|P1|COMPLETED|Part B||0
384492|NCT00306891|939939|P4|STARTED|Part B|in Part B: Cediranib Dose Escalation 11 new patients were randomized.|31
384493|NCT00306891|939940|P3|STARTED|Part B|In Part B: Cediranib 45 mg Fixed Dose 4 new patients were randomized|16
384494|NCT00306891|939941|P2|STARTED|Part B||0
384495|NCT00306891|939942|P1|STARTED|Part B||0
384496|NCT00306891|939939|P4|NOT COMPLETED|Part A||0
384497|NCT00306891|939940|P3|NOT COMPLETED|Part A||0
384498|NCT00306891|939941|P2|NOT COMPLETED|Part A||6
384499|NCT00306891|939942|P1|NOT COMPLETED|Part A||5
384500|NCT00306891|939939|P4|COMPLETED|Part A||0
384501|NCT00306891|939940|P3|COMPLETED|Part A||0
384502|NCT00306891|939941|P2|COMPLETED|Part A||16
384503|NCT00306891|939942|P1|COMPLETED|Part A||18
384504|NCT00306891|939939|P4|STARTED|Part A||0
384505|NCT00306891|939940|P3|STARTED|Part A||0
384506|NCT00306891|939941|P2|STARTED|Part A||22
384507|NCT00306891|939942|P1|STARTED|Part A||23
384508|NCT00306852|939965|P2|NOT COMPLETED|Overall Study||38
384509|NCT00306852|939966|P1|NOT COMPLETED|Overall Study||29
384510|NCT00306852|939965|P2|COMPLETED|Overall Study||69
384511|NCT00306852|939966|P1|COMPLETED|Overall Study||76
384512|NCT00306852|939965|P2|STARTED|Overall Study||107
384513|NCT00306852|939966|P1|STARTED|Overall Study||105
384514|NCT00306787|939984|P2|NOT COMPLETED|Overall Study||241
384515|NCT00306787|939985|P1|NOT COMPLETED|Overall Study||234
384516|NCT00306787|939984|P2|COMPLETED|Overall Study||359
384517|NCT00306787|939985|P1|COMPLETED|Overall Study||345
384518|NCT00306787|939984|P2|Intent to Treat (ITT) Population|Overall Study||381
384519|NCT00306787|939985|P1|Intent to Treat (ITT) Population|Overall Study||370
384520|NCT00306787|939984|P2|Received Study Drug (Safety Population)|Overall Study||385
384521|NCT00306787|939985|P1|Received Study Drug (Safety Population)|Overall Study||371
384522|NCT00306787|939984|P2|STARTED|Overall Study||600
384523|NCT00306787|939985|P1|STARTED|Overall Study||579
384524|NCT00306670|940003|P2|NOT COMPLETED|Overall Study||2
384525|NCT00306670|940004|P1|NOT COMPLETED|Overall Study||0
384526|NCT00306670|940003|P2|COMPLETED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued study before treatment initiated|0
384527|NCT00306670|940004|P1|COMPLETED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
384528|NCT00306670|940003|P2|STARTED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued trial before treatment started|2
384529|NCT00306670|940004|P1|STARTED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
384530|NCT00306592|940010|P2|NOT COMPLETED|Overall Study||58
384531|NCT00306592|940011|P1|NOT COMPLETED|Overall Study||31
384532|NCT00306592|940010|P2|COMPLETED|Overall Study||632
384533|NCT00306592|940011|P1|COMPLETED|Overall Study||373
384534|NCT00306592|940010|P2|Entered 101-MS-321 Extension Study|Overall Study|pertains to participants transitioning from 101-MS-322 (NCT00306592) study only|0
384535|NCT00306592|940011|P1|Entered 101-MS-321 Extension Study|Overall Study||22
384536|NCT00306592|940010|P2|Completed at 48 Weeks|Overall Study||632
384537|NCT00306592|940011|P1|Completed at 48 Weeks|Overall Study||81
384538|NCT00306592|940010|P2|Completed Between 24 and 48 Weeks|Overall Study||0
384539|NCT00306592|940011|P1|Completed Between 24 and 48 Weeks|Overall Study||85
384540|NCT00306592|940010|P2|Completed at 24 Weeks|Overall Study||0
384541|NCT00306592|940011|P1|Completed at 24 Weeks|Overall Study||207
384542|NCT00306592|940010|P2|STARTED|Overall Study||690
384543|NCT00306592|940011|P1|STARTED|Overall Study||404
384544|NCT00306527|940021|P4|NOT COMPLETED|Overall Study||6
384545|NCT00306527|940022|P3|NOT COMPLETED|Overall Study||5
384546|NCT00306527|940023|P2|NOT COMPLETED|Overall Study||7
384547|NCT00306527|940024|P1|NOT COMPLETED|Overall Study||6
384548|NCT00306527|940021|P4|COMPLETED|Overall Study||590
384549|NCT00306527|940022|P3|COMPLETED|Overall Study|3 of 4 deaths in the elderly subjects resulted in premature discontinuation. Refer to OM2 .|567
384550|NCT00306527|940023|P2|COMPLETED|Overall Study||527
384551|NCT00306527|940024|P1|COMPLETED|Overall Study||527
384552|NCT00306527|940021|P4|STARTED|Overall Study||596
384553|NCT00306527|940022|P3|STARTED|Overall Study||572
384554|NCT00306527|940023|P2|STARTED|Overall Study||534
384555|NCT00306527|940024|P1|STARTED|Overall Study||533
384556|NCT00306488|940078|P2|NOT COMPLETED|Overall Study||1
384557|NCT00306488|940079|P1|NOT COMPLETED|Overall Study||1
384558|NCT00306488|940078|P2|COMPLETED|Overall Study||10
384559|NCT00306488|940079|P1|COMPLETED|Overall Study||10
384560|NCT00306488|940078|P2|STARTED|Overall Study||11
384561|NCT00306488|940079|P1|STARTED|Overall Study||11
384562|NCT00306384|940093|P3|NOT COMPLETED|Overall Study||277
384563|NCT00306384|940094|P2|NOT COMPLETED|Overall Study||508
384564|NCT00306384|940095|P1|NOT COMPLETED|Overall Study||542
384565|NCT00306384|940093|P3|COMPLETED|Overall Study||251
384566|NCT00306384|940094|P2|COMPLETED|Overall Study||891
384567|NCT00306384|940095|P1|COMPLETED|Overall Study||854
384568|NCT00306384|940093|P3|Safety Set|Overall Study|Patients who received at least one dose of study drug|527
384569|NCT00306384|940094|P2|Safety Set|Overall Study|Patients who received at least one dose of study drug|1398
384570|NCT00306384|940095|P1|Safety Set|Overall Study|Patients who received at least one dose of study drug|1395
384571|NCT00306384|940093|P3|STARTED|Overall Study||528
384572|NCT00306384|940094|P2|STARTED|Overall Study||1399
384573|NCT00306384|940095|P1|STARTED|Overall Study||1396
384574|NCT00306293|940127|P2|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||1
384575|NCT00306293|940128|P1|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||3
384576|NCT00306293|940127|P2|COMPLETED|Period 2 (Day 67 to Day 126 )||26
384577|NCT00306293|940128|P1|COMPLETED|Period 2 (Day 67 to Day 126 )||24
384578|NCT00306293|940127|P2|STARTED|Period 2 (Day 67 to Day 126 )||27
384579|NCT00306293|940128|P1|STARTED|Period 2 (Day 67 to Day 126 )||27
384580|NCT00306293|940127|P2|NOT COMPLETED|Washout (Day 61 to Day 66)||0
384581|NCT00306293|940128|P1|NOT COMPLETED|Washout (Day 61 to Day 66)||0
384582|NCT00306293|940127|P2|COMPLETED|Washout (Day 61 to Day 66)||27
384583|NCT00306293|940128|P1|COMPLETED|Washout (Day 61 to Day 66)||27
384584|NCT00306293|940127|P2|STARTED|Washout (Day 61 to Day 66)||27
384585|NCT00306293|940128|P1|STARTED|Washout (Day 61 to Day 66)||27
384586|NCT00306293|940127|P2|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
384587|NCT00306293|940128|P1|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
384588|NCT00306293|940127|P2|COMPLETED|Period 1 (Day 1 to Day 60)||27
384589|NCT00306293|940128|P1|COMPLETED|Period 1 (Day 1 to Day 60)||27
384590|NCT00306293|940127|P2|STARTED|Period 1 (Day 1 to Day 60)||35
384591|NCT00306293|940128|P1|STARTED|Period 1 (Day 1 to Day 60)||35
384592|NCT00306202|940149|P3|NOT COMPLETED|Overall Study||0
384593|NCT00306202|940150|P2|NOT COMPLETED|Overall Study||1
384594|NCT00306202|940151|P1|NOT COMPLETED|Overall Study||6
384595|NCT00306202|940149|P3|COMPLETED|Overall Study|Completed = Off-treatment|24
384596|NCT00306202|940150|P2|COMPLETED|Overall Study|Completed = Off-treatment|16
384597|NCT00306202|940151|P1|COMPLETED|Overall Study|Completed = Off-treatment|11
384598|NCT00306202|940149|P3|STARTED|Overall Study|Started = Treated. 24 were enrolled; 1 no longer met study criteria and was never treated|24
384599|NCT00306202|940150|P2|STARTED|Overall Study|Started=Treated. 20 were enrolled;3 never treated(2 no longer met study criteria;1 withdrew consent)|17
384600|NCT00306202|940151|P1|STARTED|Overall Study|Started = Treated. 18 were enrolled; 1 no longer met study criteria and was never treated|17
384601|NCT00306189|940311|P4|NOT COMPLETED|Overall Study||5
384602|NCT00306189|940312|P3|NOT COMPLETED|Overall Study||11
384603|NCT00306189|940313|P2|NOT COMPLETED|Overall Study||6
384604|NCT00306189|940314|P1|NOT COMPLETED|Overall Study||9
384605|NCT00306189|940311|P4|COMPLETED|Overall Study||52
384606|NCT00306189|940312|P3|COMPLETED|Overall Study||45
384607|NCT00306189|940313|P2|COMPLETED|Overall Study||50
384608|NCT00306189|940314|P1|COMPLETED|Overall Study||48
384609|NCT00306189|940311|P4|STARTED|Overall Study||57
384610|NCT00306189|940312|P3|STARTED|Overall Study||56
384611|NCT00306189|940313|P2|STARTED|Overall Study||56
384612|NCT00306189|940314|P1|STARTED|Overall Study||57
384613|NCT00306163|940326|P2|NOT COMPLETED|Overall Study||0
384614|NCT00306163|940327|P1|NOT COMPLETED|Overall Study||0
384615|NCT00306163|940326|P2|COMPLETED|Overall Study||18
384616|NCT00306163|940327|P1|COMPLETED|Overall Study||19
384617|NCT00306163|940326|P2|STARTED|Overall Study||18
384618|NCT00306163|940327|P1|STARTED|Overall Study||19
384619|NCT00305942|940333|P1|NOT COMPLETED|Overall Study||38
384620|NCT00305942|940333|P1|COMPLETED|Overall Study||23
384621|NCT00305942|940333|P1|STARTED|Overall Study||61
384622|NCT00305877|940341|P2|NOT COMPLETED|Overall Study||34
384623|NCT00305877|940342|P1|NOT COMPLETED|Overall Study||24
384624|NCT00305877|940341|P2|COMPLETED|Overall Study||34
384625|NCT00305877|940342|P1|COMPLETED|Overall Study||45
384626|NCT00305877|940341|P2|Included in Efficacy Analysis|Overall Study||62
384627|NCT00305877|940342|P1|Included in Efficacy Analysis|Overall Study||65
384628|NCT00305877|940341|P2|Eligible|Overall Study||66
384629|NCT00305877|940342|P1|Eligible|Overall Study||66
384630|NCT00305877|940341|P2|Treated|Overall Study||63
384631|NCT00305877|940342|P1|Treated|Overall Study||67
384632|NCT00305877|940341|P2|STARTED|Overall Study||68
384633|NCT00305877|940342|P1|STARTED|Overall Study||69
384634|NCT00305864|940356|P4|NOT COMPLETED|Overall Study||13
384635|NCT00305864|940357|P3|NOT COMPLETED|Overall Study||1
384636|NCT00305864|940358|P2|NOT COMPLETED|Overall Study||1
384637|NCT00305864|940359|P1|NOT COMPLETED|Overall Study||0
384638|NCT00305864|940356|P4|COMPLETED|Overall Study||81
384639|NCT00305864|940357|P3|COMPLETED|Overall Study||6
384640|NCT00305864|940358|P2|COMPLETED|Overall Study||9
384641|NCT00305864|940359|P1|COMPLETED|Overall Study||7
384642|NCT00305864|940356|P4|STARTED|Overall Study||94
384643|NCT00305864|940357|P3|STARTED|Overall Study||7
384644|NCT00305864|940358|P2|STARTED|Overall Study||10
384645|NCT00305864|940359|P1|STARTED|Overall Study||7
384646|NCT00305773|940372|P2|NOT COMPLETED|Overall Study||18
384647|NCT00305773|940373|P1|NOT COMPLETED|Overall Study||14
384648|NCT00305773|940372|P2|COMPLETED|Overall Study||4
384649|NCT00305773|940373|P1|COMPLETED|Overall Study||1
384650|NCT00305773|940372|P2|STARTED|Overall Study||22
384651|NCT00305773|940373|P1|STARTED|Overall Study||15
384652|NCT00305760|940387|P1|NOT COMPLETED|Overall Study||47
384653|NCT00305760|940387|P1|COMPLETED|Overall Study||13
384654|NCT00305760|940387|P1|STARTED|Overall Study||60
384655|NCT00305643|940393|P2|NOT COMPLETED|Overall Study||0
384656|NCT00305643|940394|P1|NOT COMPLETED|Overall Study||0
384657|NCT00305643|940393|P2|COMPLETED|Overall Study||5
384658|NCT00305643|940394|P1|COMPLETED|Overall Study||6
384659|NCT00305643|940393|P2|STARTED|Overall Study||5
384660|NCT00305643|940394|P1|STARTED|Overall Study||6
384661|NCT00305604|940404|P2|NOT COMPLETED|Overall Study||47
384662|NCT00305604|940405|P1|NOT COMPLETED|Overall Study||32
384663|NCT00305604|940404|P2|COMPLETED|Overall Study||57
384664|NCT00305604|940405|P1|COMPLETED|Overall Study||70
384665|NCT00305604|940404|P2|STARTED|Overall Study||104
384666|NCT00305604|940405|P1|STARTED|Overall Study||102
384667|NCT00305578|940419|P2|NOT COMPLETED|Overall Study||2
384668|NCT00305578|940420|P1|NOT COMPLETED|Overall Study||3
384669|NCT00305578|940419|P2|COMPLETED|Overall Study||12
384670|NCT00305578|940420|P1|COMPLETED|Overall Study||12
384671|NCT00305578|940419|P2|STARTED|Overall Study||14
384672|NCT00305578|940420|P1|STARTED|Overall Study||15
384673|NCT00305565|940429|P3|NOT COMPLETED|Overall Study (ITT Population)||5
384674|NCT00305565|940430|P2|NOT COMPLETED|Overall Study (ITT Population)||11
384675|NCT00305565|940431|P1|NOT COMPLETED|Overall Study (ITT Population)||13
384676|NCT00305565|940429|P3|COMPLETED|Overall Study (ITT Population)||102
384677|NCT00305565|940430|P2|COMPLETED|Overall Study (ITT Population)||90
384678|NCT00305565|940431|P1|COMPLETED|Overall Study (ITT Population)||89
384679|NCT00305565|940429|P3|STARTED|Overall Study (ITT Population)||107
384680|NCT00305565|940430|P2|STARTED|Overall Study (ITT Population)||101
384681|NCT00305565|940431|P1|STARTED|Overall Study (ITT Population)||102
384682|NCT00305565|940429|P3|NOT COMPLETED|Overall Study (Safety Population)||7
384683|NCT00305565|940430|P2|NOT COMPLETED|Overall Study (Safety Population)||12
384684|NCT00305565|940431|P1|NOT COMPLETED|Overall Study (Safety Population)||14
384685|NCT00305565|940429|P3|COMPLETED|Overall Study (Safety Population)||106
384686|NCT00305565|940430|P2|COMPLETED|Overall Study (Safety Population)||95
384687|NCT00305565|940431|P1|COMPLETED|Overall Study (Safety Population)||97
384688|NCT00305565|940429|P3|STARTED|Overall Study (Safety Population)||113
384689|NCT00305565|940430|P2|STARTED|Overall Study (Safety Population)||107
384690|NCT00305565|940431|P1|STARTED|Overall Study (Safety Population)||111
384691|NCT00305448|940549|P3|NOT COMPLETED|Overall Study||33
384692|NCT00305448|940550|P2|NOT COMPLETED|Overall Study||34
384693|NCT00305448|940551|P1|NOT COMPLETED|Overall Study||31
384694|NCT00305448|940549|P3|COMPLETED|Overall Study||14
384695|NCT00305448|940550|P2|COMPLETED|Overall Study||17
384696|NCT00305448|940551|P1|COMPLETED|Overall Study||14
384697|NCT00305448|940549|P3|STARTED|Overall Study||47
384698|NCT00305448|940550|P2|STARTED|Overall Study||51
384699|NCT00305448|940551|P1|STARTED|Overall Study||45
384700|NCT00305344|940567|P1|NOT COMPLETED|Overall Study||0
384701|NCT00305344|940567|P1|COMPLETED|Overall Study||23
384702|NCT00305344|940567|P1|STARTED|Overall Study||23
384703|NCT00305253|940573|P2|NOT COMPLETED|Overall Study||1
384704|NCT00305253|940574|P1|NOT COMPLETED|Overall Study||0
384705|NCT00305253|940573|P2|COMPLETED|Overall Study||558
384706|NCT00305253|940574|P1|COMPLETED|Overall Study||432
384707|NCT00305253|940573|P2|STARTED|Overall Study||559
384708|NCT00305253|940574|P1|STARTED|Overall Study||432
384709|NCT00305227|940586|P2|NOT COMPLETED|Overall Study||6
384710|NCT00305227|940587|P1|NOT COMPLETED|Overall Study||7
384711|NCT00305227|940586|P2|COMPLETED|Overall Study|with at least 8 weeks of observation|44
384712|NCT00305227|940587|P1|COMPLETED|Overall Study|with at least 8 weeks of observation|43
384713|NCT00305227|940586|P2|STARTED|Overall Study||50
384714|NCT00305227|940587|P1|STARTED|Overall Study||50
384715|NCT00305162|940595|P2|NOT COMPLETED|1 Year Follow-up Period||65
384716|NCT00305162|940596|P1|NOT COMPLETED|1 Year Follow-up Period||55
384717|NCT00305162|940595|P2|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4382
384718|NCT00305162|940596|P1|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4380
384719|NCT00305162|940595|P2|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|444
384720|NCT00305162|940596|P1|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|446
384721|NCT00305162|940595|P2|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3818
384722|NCT00305162|940596|P1|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3851
384723|NCT00305162|940595|P2|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|504
384724|NCT00305162|940596|P1|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|480
384725|NCT00305162|940595|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3878
384726|NCT00305162|940596|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3900
384727|NCT00305162|940595|P2|STARTED|1 Year Follow-up Period||4447
384728|NCT00305162|940596|P1|STARTED|1 Year Follow-up Period||4435
384729|NCT00305162|940595|P2|NOT COMPLETED|30-day Follow-up Period||63
384730|NCT00305162|940596|P1|NOT COMPLETED|30-day Follow-up Period||62
384731|NCT00305162|940595|P2|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4384
384732|NCT00305162|940596|P1|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4373
384733|NCT00305162|940595|P2|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|444
384734|NCT00305162|940596|P1|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|438
384735|NCT00305162|940595|P2|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3827
384736|NCT00305162|940596|P1|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3860
384737|NCT00305162|940595|P2|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|501
384738|NCT00305162|940596|P1|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|471
384739|NCT00305162|940595|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3883
384740|NCT00305162|940596|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3902
384741|NCT00305162|940595|P2|STARTED|30-day Follow-up Period||4447
384742|NCT00305162|940596|P1|STARTED|30-day Follow-up Period||4435
384743|NCT00305162|940595|P2|NOT COMPLETED|48 Hour Follow-up Period||16
384744|NCT00305162|940596|P1|NOT COMPLETED|48 Hour Follow-up Period||20
384745|NCT00305162|940595|P2|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4431
384746|NCT00305162|940596|P1|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4415
384747|NCT00305162|940595|P2|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4365
384748|NCT00305162|940596|P1|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4374
384749|NCT00305162|940595|P2|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|447
384750|NCT00305162|940596|P1|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|446
384751|NCT00305162|940595|P2|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3865
384752|NCT00305162|940596|P1|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3889
384753|NCT00305162|940595|P2|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|507
384754|NCT00305162|940596|P1|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|482
384755|NCT00305162|940595|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3924
384756|NCT00305162|940596|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3933
384757|NCT00305162|940595|P2|STARTED|48 Hour Follow-up Period||4447
384758|NCT00305162|940596|P1|STARTED|48 Hour Follow-up Period||4435
384759|NCT00305110|940634|P1|NOT COMPLETED|Overall Study||29
384760|NCT00305110|940634|P1|COMPLETED|Overall Study||269
384761|NCT00305110|940634|P1|All Necessary Data Collected|Overall Study||269
384762|NCT00305110|940634|P1|STARTED|Overall Study||298
384763|NCT00305084|940648|P5|NOT COMPLETED|Overall Study||0
384764|NCT00305084|940649|P4|NOT COMPLETED|Overall Study||0
384765|NCT00305084|940650|P3|NOT COMPLETED|Overall Study||0
384766|NCT00305084|940651|P2|NOT COMPLETED|Overall Study||0
384767|NCT00305084|940652|P1|NOT COMPLETED|Overall Study||0
384768|NCT00305084|940648|P5|COMPLETED|Overall Study||3
384769|NCT00305084|940649|P4|COMPLETED|Overall Study||3
384770|NCT00305084|940650|P3|COMPLETED|Overall Study||3
384771|NCT00305084|940651|P2|COMPLETED|Overall Study||3
384772|NCT00305084|940652|P1|COMPLETED|Overall Study||3
384773|NCT00305084|940648|P5|STARTED|Overall Study||3
384774|NCT00305084|940649|P4|STARTED|Overall Study||3
384775|NCT00305084|940650|P3|STARTED|Overall Study||3
384776|NCT00305084|940651|P2|STARTED|Overall Study||3
384777|NCT00305084|940652|P1|STARTED|Overall Study||3
384778|NCT00305058|940707|P2|NOT COMPLETED|Overall Study||4
384779|NCT00305058|940708|P1|NOT COMPLETED|Overall Study||7
384780|NCT00305058|940707|P2|COMPLETED|Overall Study||93
384781|NCT00305058|940708|P1|COMPLETED|Overall Study||90
384782|NCT00305058|940707|P2|Data Collection Forms Filed for Analysis|Overall Study||93
384783|NCT00305058|940708|P1|Data Collection Forms Filed for Analysis|Overall Study||90
384784|NCT00305058|940707|P2|All Outcome Data Collected|Overall Study||95
384785|NCT00305058|940708|P1|All Outcome Data Collected|Overall Study||93
384786|NCT00305058|940707|P2|Inclusion/Exclusion Verification|Overall Study||97
384787|NCT00305058|940708|P1|Inclusion/Exclusion Verification|Overall Study||96
384788|NCT00305058|940707|P2|STARTED|Overall Study||97
384789|NCT00305058|940708|P1|STARTED|Overall Study||97
384790|NCT00304954|940724|P4|NOT COMPLETED|Overall Study||0
384791|NCT00304954|940725|P3|NOT COMPLETED|Overall Study||1
384792|NCT00304954|940726|P2|NOT COMPLETED|Overall Study||0
384793|NCT00304954|940727|P1|NOT COMPLETED|Overall Study||1
384794|NCT00304954|940724|P4|COMPLETED|Overall Study||3
384795|NCT00304954|940725|P3|COMPLETED|Overall Study||2
384796|NCT00304954|940726|P2|COMPLETED|Overall Study||3
384797|NCT00304954|940727|P1|COMPLETED|Overall Study||3
384798|NCT00304954|940724|P4|STARTED|Overall Study||3
384799|NCT00304954|940725|P3|STARTED|Overall Study||3
384800|NCT00304954|940726|P2|STARTED|Overall Study||3
384801|NCT00304954|940727|P1|STARTED|Overall Study||4
384802|NCT00304915|940747|P2|NOT COMPLETED|Overall Study||16
384803|NCT00304915|940748|P1|NOT COMPLETED|Overall Study||18
384804|NCT00304915|940747|P2|COMPLETED|Overall Study||110
384805|NCT00304915|940748|P1|COMPLETED|Overall Study||105
384806|NCT00304915|940747|P2|STARTED|Overall Study||126
384807|NCT00304915|940748|P1|STARTED|Overall Study||123
384808|NCT00304746|940756|P2|NOT COMPLETED|Overall Study||0
384809|NCT00304746|940757|P1|NOT COMPLETED|Overall Study||0
384810|NCT00304746|940756|P2|COMPLETED|Overall Study||50
384811|NCT00304746|940757|P1|COMPLETED|Overall Study||50
384812|NCT00304746|940756|P2|STARTED|Overall Study||50
384813|NCT00304746|940757|P1|STARTED|Overall Study||50
384814|NCT00304707|940767|P2|NOT COMPLETED|Overall Study||6
384815|NCT00304707|940768|P1|NOT COMPLETED|Overall Study||7
384816|NCT00304707|940767|P2|COMPLETED|Overall Study||64
384817|NCT00304707|940768|P1|COMPLETED|Overall Study||66
384818|NCT00304707|940767|P2|STARTED|Overall Study||70
384819|NCT00304707|940768|P1|STARTED|Overall Study||73
384820|NCT00304512|940777|P3|NOT COMPLETED|Extension Period||0
384821|NCT00304512|940778|P2|NOT COMPLETED|Extension Period||0
384822|NCT00304512|940779|P1|NOT COMPLETED|Extension Period||0
384823|NCT00304512|940777|P3|COMPLETED|Extension Period||3
384824|NCT00304512|940778|P2|COMPLETED|Extension Period||4
384825|NCT00304512|940779|P1|COMPLETED|Extension Period||2
384826|NCT00304512|940777|P3|STARTED|Extension Period||3
384827|NCT00304512|940778|P2|STARTED|Extension Period||4
384828|NCT00304512|940779|P1|STARTED|Extension Period||2
384829|NCT00304512|940777|P3|NOT COMPLETED|Treatment Period||0
384830|NCT00304512|940778|P2|NOT COMPLETED|Treatment Period||0
384831|NCT00304512|940779|P1|NOT COMPLETED|Treatment Period||0
384832|NCT00304512|940777|P3|COMPLETED|Treatment Period||3
384833|NCT00304512|940778|P2|COMPLETED|Treatment Period||4
384834|NCT00304512|940779|P1|COMPLETED|Treatment Period||2
384835|NCT00304512|940777|P3|Pharmacodynamic (PD) Population|Treatment Period||3
384836|NCT00304512|940778|P2|Pharmacodynamic (PD) Population|Treatment Period||4
384837|NCT00304512|940779|P1|Pharmacodynamic (PD) Population|Treatment Period||2
384838|NCT00304512|940777|P3|Pharmacokinetic (PK) Population|Treatment Period||3
384839|NCT00304512|940778|P2|Pharmacokinetic (PK) Population|Treatment Period||4
384840|NCT00304512|940779|P1|Pharmacokinetic (PK) Population|Treatment Period||2
384841|NCT00304512|940777|P3|Safety Population|Treatment Period||3
384842|NCT00304512|940778|P2|Safety Population|Treatment Period||4
384843|NCT00304512|940779|P1|Safety Population|Treatment Period||2
384844|NCT00304512|940777|P3|STARTED|Treatment Period||3
384845|NCT00304512|940778|P2|STARTED|Treatment Period||4
384846|NCT00304512|940779|P1|STARTED|Treatment Period||2
384847|NCT00304356|940793|P1|NOT COMPLETED|Nitazoxanide||5
384848|NCT00304356|940793|P1|COMPLETED|Nitazoxanide||22
384849|NCT00304356|940793|P1|STARTED|Nitazoxanide||27
384850|NCT00304356|940793|P1|NOT COMPLETED|Nitazoxanide||5
384851|NCT00304356|940793|P1|COMPLETED|Nitazoxanide||22
384852|NCT00304356|940793|P1|STARTED|Nitazoxanide||27
384853|NCT00304278|940797|P1|NOT COMPLETED|Overall Study||2
384854|NCT00304278|940797|P1|COMPLETED|Overall Study||19
384855|NCT00304278|940797|P1|STARTED|Overall Study||21
384856|NCT00304265|940804|P2|NOT COMPLETED|Overall Study||0
384857|NCT00304265|940805|P1|NOT COMPLETED|Overall Study||0
384858|NCT00304265|940804|P2|COMPLETED|Overall Study||98
384859|NCT00304265|940805|P1|COMPLETED|Overall Study||117
384860|NCT00304265|940804|P2|STARTED|Overall Study||98
384861|NCT00304265|940805|P1|STARTED|Overall Study||117
384862|NCT00304187|940813|P2|NOT COMPLETED|Overall Study||1
384863|NCT00304187|940814|P1|NOT COMPLETED|Overall Study||2
384864|NCT00304187|940813|P2|COMPLETED|Overall Study||13
384865|NCT00304187|940814|P1|COMPLETED|Overall Study||13
384866|NCT00304187|940813|P2|STARTED|Overall Study||14
384867|NCT00304187|940814|P1|STARTED|Overall Study||15
384868|NCT00304161|940824|P2|NOT COMPLETED|Overall Study||6
384869|NCT00304161|940825|P1|NOT COMPLETED|Overall Study||6
384870|NCT00304161|940824|P2|COMPLETED|Overall Study||21
384871|NCT00304161|940825|P1|COMPLETED|Overall Study||22
384872|NCT00304161|940824|P2|STARTED|Overall Study||27
384873|NCT00304161|940825|P1|STARTED|Overall Study||28
384874|NCT00304096|940835|P2|NOT COMPLETED|Overall Study||0
384875|NCT00304096|940836|P1|NOT COMPLETED|Overall Study||0
384876|NCT00304096|940835|P2|COMPLETED|Overall Study|6 patients enrolled, 1 not treated|5
384877|NCT00304096|940836|P1|COMPLETED|Overall Study||6
384878|NCT00304096|940835|P2|STARTED|Overall Study||5
384879|NCT00304096|940836|P1|STARTED|Overall Study||6
384880|NCT00304083|940846|P2|NOT COMPLETED|Overall Study||8
384881|NCT00304083|940847|P1|NOT COMPLETED|Overall Study||22
384882|NCT00304083|940846|P2|COMPLETED|Overall Study||6
384883|NCT00304083|940847|P1|COMPLETED|Overall Study||12
384884|NCT00304083|940846|P2|Patients Had Neither RT or Surgery|Overall Study||1
384885|NCT00304083|940847|P1|Patients Had Neither RT or Surgery|Overall Study||6
384886|NCT00304083|940846|P2|Patients Treated With RT Only|Overall Study||2
384887|NCT00304083|940847|P1|Patients Treated With RT Only|Overall Study||4
384888|NCT00304083|940846|P2|Patients Treated With Surgery and RT|Overall Study||1
384889|NCT00304083|940847|P1|Patients Treated With Surgery and RT|Overall Study||5
384890|NCT00304083|940846|P2|Patients Treated With Surgery|Overall Study||3
384891|NCT00304083|940847|P1|Patients Treated With Surgery|Overall Study||7
384892|NCT00304083|940846|P2|Completed 4 Cycles|Overall Study||7
384893|NCT00304083|940847|P1|Completed 4 Cycles|Overall Study||22
384894|NCT00304083|940846|P2|STARTED|Overall Study||14
384895|NCT00304083|940847|P1|STARTED|Overall Study||34
384896|NCT00304070|940866|P3|NOT COMPLETED|Overall Study||12
384897|NCT00304070|940867|P2|NOT COMPLETED|Overall Study||7
384898|NCT00304070|940868|P1|NOT COMPLETED|Overall Study||3
384899|NCT00304070|940866|P3|COMPLETED|Overall Study||27
384900|NCT00304070|940867|P2|COMPLETED|Overall Study||8
384901|NCT00304070|940868|P1|COMPLETED|Overall Study||21
384902|NCT00304070|940866|P3|STARTED|Overall Study||39
384903|NCT00304070|940867|P2|STARTED|Overall Study||15
384904|NCT00304070|940868|P1|STARTED|Overall Study||24
384905|NCT00304031|940883|P3|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||2
384906|NCT00304031|940884|P2|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
384907|NCT00304031|940885|P1|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
384908|NCT00304031|940883|P3|COMPLETED|Randomization to Adjuvant TMZ Arm|Subjects contributing data to the primary analysis are considered to have completed the study|420
384909|NCT00304031|940884|P2|COMPLETED|Randomization to Adjuvant TMZ Arm|Subjects contributing data to the primary analysis are considered to have completed the study.|411
384910|NCT00304031|940885|P1|COMPLETED|Randomization to Adjuvant TMZ Arm||0
384911|NCT00304031|940883|P3|STARTED|Randomization to Adjuvant TMZ Arm|Patients who met requirements were randomized to an adjuvant TMZ arm after concomitant treatment.|422
385084|NCT00302952|941319|P2|COMPLETED|Overall Study||25
384912|NCT00304031|940884|P2|STARTED|Randomization to Adjuvant TMZ Arm|Patients who met requirements were randomized to an adjuvant TMZ arm after concomitant treatment.|411
384913|NCT00304031|940885|P1|STARTED|Randomization to Adjuvant TMZ Arm|Patients who met requirements were randomized to an adjuvant TMZ arm after concomitant treatment.|0
384914|NCT00304031|940883|P3|NOT COMPLETED|Concomitant Radiation Therapy and TMZ||0
384915|NCT00304031|940884|P2|NOT COMPLETED|Concomitant Radiation Therapy and TMZ||0
384916|NCT00304031|940885|P1|NOT COMPLETED|Concomitant Radiation Therapy and TMZ||292
384917|NCT00304031|940883|P3|COMPLETED|Concomitant Radiation Therapy and TMZ||0
384918|NCT00304031|940884|P2|COMPLETED|Concomitant Radiation Therapy and TMZ||0
384919|NCT00304031|940885|P1|COMPLETED|Concomitant Radiation Therapy and TMZ|These patients successfully completed concomitant treatment and met requirements for randomization.|833
384920|NCT00304031|940883|P3|STARTED|Concomitant Radiation Therapy and TMZ|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
384921|NCT00304031|940884|P2|STARTED|Concomitant Radiation Therapy and TMZ|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
384922|NCT00304031|940885|P1|STARTED|Concomitant Radiation Therapy and TMZ|All patients were registered to concomitant treatment; randomized after completing this treatment.|1125
384923|NCT00304031|940883|P3|NOT COMPLETED|Registration||0
384924|NCT00304031|940884|P2|NOT COMPLETED|Registration||0
384925|NCT00304031|940885|P1|NOT COMPLETED|Registration||48
384926|NCT00304031|940883|P3|COMPLETED|Registration||0
384927|NCT00304031|940884|P2|COMPLETED|Registration||0
384928|NCT00304031|940885|P1|COMPLETED|Registration|Patients determined to be ineligible after registration were excluded.|1125
384929|NCT00304031|940883|P3|STARTED|Registration|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
384930|NCT00304031|940884|P2|STARTED|Registration|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
384931|NCT00304031|940885|P1|STARTED|Registration|All patients were registered to concomitant treatment; randomized after completing this treatment.|1173
384932|NCT00303979|940895|P3|NOT COMPLETED|Overall Study||0
384933|NCT00303979|940896|P2|NOT COMPLETED|Overall Study||0
384934|NCT00303979|940897|P1|NOT COMPLETED|Overall Study||7572
384935|NCT00303979|940895|P3|COMPLETED|Overall Study|at 18 months|9641
384936|NCT00303979|940896|P2|COMPLETED|Overall Study|at 6 months|9992
384937|NCT00303979|940897|P1|COMPLETED|Overall Study|at 24 Months|7605
384938|NCT00303979|940895|P3|STARTED|Overall Study|at 18 months|9641
384939|NCT00303979|940896|P2|STARTED|Overall Study|at 6 months|9992
384940|NCT00303979|940897|P1|STARTED|Overall Study|at baseline|15177
384941|NCT00303966|940915|P1|NOT COMPLETED|Overall Study||0
384942|NCT00303966|940915|P1|COMPLETED|Overall Study||5
384943|NCT00303966|940915|P1|STARTED|Overall Study||5
384944|NCT00303953|940924|P1|NOT COMPLETED|Overall Study||19
384945|NCT00303953|940924|P1|COMPLETED|Overall Study||3
384946|NCT00303953|940924|P1|Eligible and Treated|Overall Study||20
384947|NCT00303953|940924|P1|Eligible|Overall Study||21
384948|NCT00303953|940924|P1|STARTED|Overall Study||22
384949|NCT00303901|940930|P1|NOT COMPLETED|Overall Study||0
384950|NCT00303901|940930|P1|COMPLETED|Overall Study||40
384951|NCT00303901|940930|P1|STARTED|Overall Study||40
384952|NCT00303862|940935|P1|NOT COMPLETED|Overall Study||0
384953|NCT00303862|940935|P1|COMPLETED|Overall Study||10
384954|NCT00303862|940935|P1|STARTED|Overall Study||10
384955|NCT00303823|940944|P2|NOT COMPLETED|Overall Study||10
384956|NCT00303823|940945|P1|NOT COMPLETED|Overall Study||15
384957|NCT00303823|940944|P2|COMPLETED|Overall Study||38
384958|NCT00303823|940945|P1|COMPLETED|Overall Study||35
384959|NCT00303823|940944|P2|STARTED|Overall Study||48
384960|NCT00303823|940945|P1|STARTED|Overall Study||50
384961|NCT00303667|940959|P2|NOT COMPLETED|Overall Study||4
384962|NCT00303667|940960|P1|NOT COMPLETED|Overall Study||0
384963|NCT00303667|940959|P2|COMPLETED|Overall Study|Completed = remained alive and on study through Day 0 (day of transplant)|35
384964|NCT00303667|940960|P1|COMPLETED|Overall Study||8
384965|NCT00303667|940959|P2|STARTED|Overall Study||39
384966|NCT00303667|940960|P1|STARTED|Overall Study||8
384967|NCT00303628|940984|P2|NOT COMPLETED|Overall Study||73
384968|NCT00303628|940985|P1|NOT COMPLETED|Overall Study||50
384969|NCT00303628|940984|P2|COMPLETED|Overall Study||106
384970|NCT00303628|940985|P1|COMPLETED|Overall Study||126
384971|NCT00303628|940984|P2|Treated|Overall Study||174
384972|NCT00303628|940985|P1|Treated|Overall Study||173
384973|NCT00303628|940984|P2|Eligible|Overall Study||177
384974|NCT00303628|940985|P1|Eligible|Overall Study||171
384975|NCT00303628|940984|P2|STARTED|Overall Study||179
384976|NCT00303628|940985|P1|STARTED|Overall Study||176
384977|NCT00303602|941003|P2|NOT COMPLETED|Overall Study||15
384978|NCT00303602|941004|P1|NOT COMPLETED|Overall Study||19
384979|NCT00303602|941003|P2|COMPLETED|Overall Study||50
384980|NCT00303602|941004|P1|COMPLETED|Overall Study||65
384981|NCT00303602|941003|P2|STARTED|Overall Study||65
384982|NCT00303602|941004|P1|STARTED|Overall Study||84
384983|NCT00303511|941044|P1|NOT COMPLETED|Overall Study||0
384984|NCT00303511|941044|P1|COMPLETED|Overall Study||10
384985|NCT00303511|941044|P1|STARTED|Overall Study||10
384986|NCT00303485|941050|P2|NOT COMPLETED|Overall Study||2
384987|NCT00303485|941051|P1|NOT COMPLETED|Overall Study||1
384988|NCT00303485|941050|P2|COMPLETED|Overall Study||15
384989|NCT00303485|941051|P1|COMPLETED|Overall Study||48
384990|NCT00303485|941050|P2|STARTED|Overall Study||17
384991|NCT00303485|941051|P1|STARTED|Overall Study||49
384992|NCT00303472|941082|P7|NOT COMPLETED|Treatment Extension (Optional)||0
384993|NCT00303472|941083|P6|NOT COMPLETED|Treatment Extension (Optional)||1
384994|NCT00303472|941084|P5|NOT COMPLETED|Treatment Extension (Optional)||4
384995|NCT00303472|941085|P4|NOT COMPLETED|Treatment Extension (Optional)||8
384996|NCT00303472|941086|P3|NOT COMPLETED|Treatment Extension (Optional)||9
384997|NCT00303472|941087|P2|NOT COMPLETED|Treatment Extension (Optional)||6
384998|NCT00303472|941088|P1|NOT COMPLETED|Treatment Extension (Optional)||5
384999|NCT00303472|941082|P7|COMPLETED|Treatment Extension (Optional)||1
385000|NCT00303472|941083|P6|COMPLETED|Treatment Extension (Optional)||4
385001|NCT00303472|941084|P5|COMPLETED|Treatment Extension (Optional)||1
385002|NCT00303472|941085|P4|COMPLETED|Treatment Extension (Optional)||5
385003|NCT00303472|941086|P3|COMPLETED|Treatment Extension (Optional)||2
385004|NCT00303472|941087|P2|COMPLETED|Treatment Extension (Optional)||5
385005|NCT00303472|941088|P1|COMPLETED|Treatment Extension (Optional)||1
385006|NCT00303472|941082|P7|STARTED|Treatment Extension (Optional)||1
385007|NCT00303472|941083|P6|STARTED|Treatment Extension (Optional)||5
385008|NCT00303472|941084|P5|STARTED|Treatment Extension (Optional)||5
385009|NCT00303472|941085|P4|STARTED|Treatment Extension (Optional)||13
385010|NCT00303472|941086|P3|STARTED|Treatment Extension (Optional)||11
385011|NCT00303472|941087|P2|STARTED|Treatment Extension (Optional)||11
385012|NCT00303472|941088|P1|STARTED|Treatment Extension (Optional)||6
385013|NCT00303472|941082|P7|NOT COMPLETED|Treatment Period||2
385014|NCT00303472|941083|P6|NOT COMPLETED|Treatment Period||1
385015|NCT00303472|941084|P5|NOT COMPLETED|Treatment Period||3
385016|NCT00303472|941085|P4|NOT COMPLETED|Treatment Period||2
385017|NCT00303472|941086|P3|NOT COMPLETED|Treatment Period||0
385018|NCT00303472|941087|P2|NOT COMPLETED|Treatment Period||0
385019|NCT00303472|941088|P1|NOT COMPLETED|Treatment Period||0
385020|NCT00303472|941082|P7|COMPLETED|Treatment Period||3
385021|NCT00303472|941083|P6|COMPLETED|Treatment Period||11
385022|NCT00303472|941084|P5|COMPLETED|Treatment Period||8
385023|NCT00303472|941085|P4|COMPLETED|Treatment Period||14
385024|NCT00303472|941086|P3|COMPLETED|Treatment Period||11
385025|NCT00303472|941087|P2|COMPLETED|Treatment Period||11
385026|NCT00303472|941088|P1|COMPLETED|Treatment Period||6
385027|NCT00303472|941082|P7|STARTED|Treatment Period||5
385028|NCT00303472|941083|P6|STARTED|Treatment Period||12
385029|NCT00303472|941084|P5|STARTED|Treatment Period||11
385030|NCT00303472|941085|P4|STARTED|Treatment Period||16
385031|NCT00303472|941086|P3|STARTED|Treatment Period||11
385032|NCT00303472|941087|P2|STARTED|Treatment Period||11
385033|NCT00303472|941088|P1|STARTED|Treatment Period||6
385034|NCT00303459|941148|P2|NOT COMPLETED|Overall Study||89
385035|NCT00303459|941149|P1|NOT COMPLETED|Overall Study||83
385036|NCT00303459|941148|P2|COMPLETED|Overall Study||86
385037|NCT00303459|941149|P1|COMPLETED|Overall Study||76
385038|NCT00303459|941148|P2|STARTED|Overall Study|One subject randomized to placebo did not receive study treatment|175
385039|NCT00303459|941149|P1|STARTED|Overall Study||159
385040|NCT00303446|941175|P2|NOT COMPLETED|Overall Study||4
385041|NCT00303446|941176|P1|NOT COMPLETED|Overall Study||2
385042|NCT00303446|941175|P2|COMPLETED|Overall Study||21
385043|NCT00303446|941176|P1|COMPLETED|Overall Study||23
385044|NCT00303446|941175|P2|STARTED|Overall Study||25
385045|NCT00303446|941176|P1|STARTED|Overall Study||25
385046|NCT00303329|941212|P2|NOT COMPLETED|Overall Study||62
385047|NCT00303329|941213|P1|NOT COMPLETED|Overall Study||35
385048|NCT00303329|941212|P2|COMPLETED|Overall Study||37
385049|NCT00303329|941213|P1|COMPLETED|Overall Study||50
385050|NCT00303329|941212|P2|STARTED|Overall Study||99
385051|NCT00303329|941213|P1|STARTED|Overall Study||85
385052|NCT00303316|941227|P2|NOT COMPLETED|Overall Study||3
385053|NCT00303316|941228|P1|NOT COMPLETED|Overall Study||2
385054|NCT00303316|941227|P2|COMPLETED|Overall Study||223
385055|NCT00303316|941228|P1|COMPLETED|Overall Study||230
385056|NCT00303316|941227|P2|STARTED|Overall Study||226
385057|NCT00303316|941228|P1|STARTED|Overall Study||232
385058|NCT00303186|941240|P1|NOT COMPLETED|Overall Study||52
385059|NCT00303186|941240|P1|COMPLETED|Overall Study||55
385060|NCT00303186|941240|P1|STARTED|Overall Study||107
385061|NCT00303108|941274|P3|NOT COMPLETED|Overall Study||16
385062|NCT00303108|941275|P2|NOT COMPLETED|Overall Study||9
385063|NCT00303108|941276|P1|NOT COMPLETED|Overall Study||12
385064|NCT00303108|941274|P3|COMPLETED|Overall Study||31
385065|NCT00303108|941275|P2|COMPLETED|Overall Study||37
385066|NCT00303108|941276|P1|COMPLETED|Overall Study||31
385067|NCT00303108|941274|P3|STARTED|Overall Study||47
385068|NCT00303108|941275|P2|STARTED|Overall Study||46
385069|NCT00303108|941276|P1|STARTED|Overall Study||43
385070|NCT00303069|941296|P4|NOT COMPLETED|Overall Study||2
385071|NCT00303069|941297|P3|NOT COMPLETED|Overall Study||1
385072|NCT00303069|941298|P2|NOT COMPLETED|Overall Study||0
385073|NCT00303069|941299|P1|NOT COMPLETED|Overall Study||2
385074|NCT00303069|941296|P4|COMPLETED|Overall Study||29
385075|NCT00303069|941297|P3|COMPLETED|Overall Study||33
385076|NCT00303069|941298|P2|COMPLETED|Overall Study||28
385077|NCT00303069|941299|P1|COMPLETED|Overall Study||29
385078|NCT00303069|941296|P4|STARTED|Overall Study||31
385079|NCT00303069|941297|P3|STARTED|Overall Study||34
385080|NCT00303069|941298|P2|STARTED|Overall Study||28
385081|NCT00303069|941299|P1|STARTED|Overall Study||31
385082|NCT00302952|941319|P2|NOT COMPLETED|Overall Study||5
385083|NCT00302952|941320|P1|NOT COMPLETED|Overall Study||3
385085|NCT00302952|941320|P1|COMPLETED|Overall Study||31
385086|NCT00302952|941319|P2|Completed Intent-to-Treat (ITT)|Overall Study|One participant did not have a baseline C-reactive Protein and was excluded from the ITT population.|29
385087|NCT00302952|941320|P1|Completed Intent-to-Treat (ITT)|Overall Study||34
385088|NCT00302952|941319|P2|Started Intent-to-Treat (ITT)|Overall Study||30
385089|NCT00302952|941320|P1|Started Intent-to-Treat (ITT)|Overall Study||34
385090|NCT00302952|941319|P2|STARTED|Overall Study||30
385091|NCT00302952|941320|P1|STARTED|Overall Study||34
385092|NCT00302848|941357|P3|NOT COMPLETED|Overall Study||579
385093|NCT00302848|941358|P2|NOT COMPLETED|Overall Study||419
385094|NCT00302848|941359|P1|NOT COMPLETED|Overall Study||401
385095|NCT00302848|941357|P3|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|25762
385096|NCT00302848|941358|P2|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|15009
385097|NCT00302848|941359|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|16133
385098|NCT00302848|941357|P3|STARTED|Overall Study||26341
385099|NCT00302848|941358|P2|STARTED|Overall Study||15428
385100|NCT00302848|941359|P1|STARTED|Overall Study||16534
385101|NCT00302731|941370|P4|NOT COMPLETED|Overall Study||0
385102|NCT00302731|941371|P3|NOT COMPLETED|Overall Study||3
385103|NCT00302731|941372|P2|NOT COMPLETED|Overall Study||5
385104|NCT00302731|941373|P1|NOT COMPLETED|Overall Study||4
385105|NCT00302731|941370|P4|COMPLETED|Overall Study||4
385106|NCT00302731|941371|P3|COMPLETED|Overall Study||2
385107|NCT00302731|941372|P2|COMPLETED|Overall Study||1
385108|NCT00302731|941373|P1|COMPLETED|Overall Study||2
385109|NCT00302731|941370|P4|STARTED|Overall Study||4
385110|NCT00302731|941371|P3|STARTED|Overall Study||5
385111|NCT00302731|941372|P2|STARTED|Overall Study||6
385112|NCT00302731|941373|P1|STARTED|Overall Study||6
385113|NCT00302718|941399|P4|NOT COMPLETED|Overall Study||2
385114|NCT00302718|941400|P3|NOT COMPLETED|Overall Study||2
385115|NCT00302718|941401|P2|NOT COMPLETED|Overall Study||1
385116|NCT00302718|941402|P1|NOT COMPLETED|Overall Study||1
385117|NCT00302718|941399|P4|COMPLETED|Overall Study||19
385118|NCT00302718|941400|P3|COMPLETED|Overall Study||19
385119|NCT00302718|941401|P2|COMPLETED|Overall Study||20
385120|NCT00302718|941402|P1|COMPLETED|Overall Study||19
385121|NCT00302718|941399|P4|STARTED|Overall Study||21
385122|NCT00302718|941400|P3|STARTED|Overall Study||21
385123|NCT00302718|941401|P2|STARTED|Overall Study||21
385124|NCT00302718|941402|P1|STARTED|Overall Study||20
385125|NCT00302458|941468|P1|NOT COMPLETED|Overall Study||3
385126|NCT00302458|941468|P1|COMPLETED|Overall Study||26
385127|NCT00302458|941468|P1|STARTED|Overall Study||29
385128|NCT00302328|941479|P3|NOT COMPLETED|Overall Study||0
385129|NCT00302328|941480|P2|NOT COMPLETED|Overall Study||1
385130|NCT00302328|941481|P1|NOT COMPLETED|Overall Study||0
385131|NCT00302328|941479|P3|COMPLETED|Overall Study||18
385132|NCT00302328|941480|P2|COMPLETED|Overall Study|developed cancer during the study|34
385133|NCT00302328|941481|P1|COMPLETED|Overall Study||25
385134|NCT00302328|941479|P3|STARTED|Overall Study||18
385135|NCT00302328|941480|P2|STARTED|Overall Study||35
385136|NCT00302328|941481|P1|STARTED|Overall Study||25
385137|NCT00302211|941498|P5|NOT COMPLETED|Open Label-Patients From Double-Blind||8
385138|NCT00302211|941499|P4|NOT COMPLETED|Open Label-Patients From Double-Blind||8
385139|NCT00302211|941500|P3|NOT COMPLETED|Open Label-Patients From Double-Blind||0
385140|NCT00302211|941501|P2|NOT COMPLETED|Open Label-Patients From Double-Blind||0
385141|NCT00302211|941502|P1|NOT COMPLETED|Open Label-Patients From Double-Blind||0
385142|NCT00302211|941498|P5|COMPLETED|Open Label-Patients From Double-Blind||24
385143|NCT00302211|941499|P4|COMPLETED|Open Label-Patients From Double-Blind||18
385144|NCT00302211|941500|P3|COMPLETED|Open Label-Patients From Double-Blind||0
385145|NCT00302211|941501|P2|COMPLETED|Open Label-Patients From Double-Blind||0
385146|NCT00302211|941502|P1|COMPLETED|Open Label-Patients From Double-Blind||0
385147|NCT00302211|941498|P5|STARTED|Open Label-Patients From Double-Blind|26 pts in 4x/day + placebo 2x/day DB phase & 6 pts in placebo 6x/day DB phase enrolled in OL 4x/day|32
385148|NCT00302211|941499|P4|STARTED|Open Label-Patients From Double-Blind|21 patients (pts) in 6x/day DB phase & 5 patients in placebo 6x/day DB phase enrolled in OL 6x/day|26
385149|NCT00302211|941500|P3|STARTED|Open Label-Patients From Double-Blind||0
385150|NCT00302211|941501|P2|STARTED|Open Label-Patients From Double-Blind||0
385151|NCT00302211|941502|P1|STARTED|Open Label-Patients From Double-Blind||0
385152|NCT00302211|941498|P5|NOT COMPLETED|Double Blind Period (New Patients)||0
385153|NCT00302211|941499|P4|NOT COMPLETED|Double Blind Period (New Patients)||0
385154|NCT00302211|941500|P3|NOT COMPLETED|Double Blind Period (New Patients)||4
385155|NCT00302211|941501|P2|NOT COMPLETED|Double Blind Period (New Patients)||2
385156|NCT00302211|941502|P1|NOT COMPLETED|Double Blind Period (New Patients)||3
385157|NCT00302211|941498|P5|COMPLETED|Double Blind Period (New Patients)||0
385158|NCT00302211|941499|P4|COMPLETED|Double Blind Period (New Patients)||0
385159|NCT00302211|941500|P3|COMPLETED|Double Blind Period (New Patients)||10
385160|NCT00302211|941501|P2|COMPLETED|Double Blind Period (New Patients)||25
385161|NCT00302211|941502|P1|COMPLETED|Double Blind Period (New Patients)||23
385162|NCT00302211|941498|P5|STARTED|Double Blind Period (New Patients)||0
385163|NCT00302211|941499|P4|STARTED|Double Blind Period (New Patients)||0
385164|NCT00302211|941500|P3|STARTED|Double Blind Period (New Patients)|These subjects could receive either iloprost 4x/day or 6x/day in the OL period|14
385165|NCT00302211|941501|P2|STARTED|Double Blind Period (New Patients)|These subjects had the option to continue with the same dose of iloprost during the OL period|27
385166|NCT00302211|941502|P1|STARTED|Double Blind Period (New Patients)|These subjects had the option to continue with the same dose of iloprost during the OL period|26
385167|NCT00302159|941528|P1|NOT COMPLETED|Overall Study||2
385168|NCT00302159|941528|P1|COMPLETED|Overall Study||41
385169|NCT00302159|941528|P1|STARTED|Overall Study||43
385170|NCT00302133|941539|P2|NOT COMPLETED|Overall Study||4
385171|NCT00302133|941540|P1|NOT COMPLETED|Overall Study||4
385172|NCT00302133|941539|P2|COMPLETED|Overall Study||5
385173|NCT00302133|941540|P1|COMPLETED|Overall Study||5
385174|NCT00302133|941539|P2|STARTED|Overall Study||9
385175|NCT00302133|941540|P1|STARTED|Overall Study||9
385176|NCT00302107|941550|P2|NOT COMPLETED|Overall Study||9
385177|NCT00302107|941551|P1|NOT COMPLETED|Overall Study||8
385178|NCT00302107|941550|P2|COMPLETED|Overall Study||30
385179|NCT00302107|941551|P1|COMPLETED|Overall Study||31
385180|NCT00302107|941550|P2|STARTED|Overall Study||39
385181|NCT00302107|941551|P1|STARTED|Overall Study||39
385182|NCT00302081|941560|P3|NOT COMPLETED|Overall Study||52
385183|NCT00302081|941561|P2|NOT COMPLETED|Overall Study||43
385184|NCT00302081|941562|P1|NOT COMPLETED|Overall Study||56
385185|NCT00302081|941560|P3|COMPLETED|Overall Study||178
385186|NCT00302081|941561|P2|COMPLETED|Overall Study||186
385187|NCT00302081|941562|P1|COMPLETED|Overall Study||181
385188|NCT00302081|941560|P3|STARTED|Overall Study||230
385189|NCT00302081|941561|P2|STARTED|Overall Study||229
385190|NCT00302081|941562|P1|STARTED|Overall Study||237
385191|NCT00302068|941573|P3|NOT COMPLETED|Overall Study||1
385192|NCT00302068|941574|P2|NOT COMPLETED|Overall Study||4
385193|NCT00302068|941575|P1|NOT COMPLETED|Overall Study||1
385194|NCT00302068|941573|P3|COMPLETED|Overall Study||23
385195|NCT00302068|941574|P2|COMPLETED|Overall Study||36
385196|NCT00302068|941575|P1|COMPLETED|Overall Study||36
385197|NCT00302068|941573|P3|STARTED|Overall Study||24
385198|NCT00302068|941574|P2|STARTED|Overall Study||40
385199|NCT00302068|941575|P1|STARTED|Overall Study||37
385200|NCT00302055|941603|P2|NOT COMPLETED|Overall Study||13
385201|NCT00302055|941604|P1|NOT COMPLETED|Overall Study||9
385202|NCT00302055|941603|P2|COMPLETED|Overall Study||36
385203|NCT00302055|941604|P1|COMPLETED|Overall Study||14
385204|NCT00302055|941603|P2|STARTED|Overall Study||49
385205|NCT00302055|941604|P1|STARTED|Overall Study||23
385206|NCT00302042|941612|P2|NOT COMPLETED|Overall Study||8
385207|NCT00302042|941613|P1|NOT COMPLETED|Overall Study||7
385208|NCT00302042|941612|P2|COMPLETED|Overall Study||38
385209|NCT00302042|941613|P1|COMPLETED|Overall Study||39
385210|NCT00302042|941612|P2|STARTED|Overall Study||46
385211|NCT00302042|941613|P1|STARTED|Overall Study||46
385212|NCT00302003|941619|P1|NOT COMPLETED|Overall Study||80
385213|NCT00302003|941619|P1|COMPLETED|Overall Study||207
385214|NCT00302003|941619|P1|STARTED|Overall Study||287
385215|NCT00301964|941626|P1|NOT COMPLETED|Overall Study||4
385216|NCT00301964|941626|P1|COMPLETED|Overall Study|Total number of eligible and evaluable participants|52
385217|NCT00301964|941626|P1|STARTED|Overall Study||56
385218|NCT00301873|941641|P1|NOT COMPLETED|Overall Study||0
385219|NCT00301873|941641|P1|COMPLETED|Overall Study||59
385220|NCT00301873|941641|P1|STARTED|Overall Study||59
385221|NCT00301834|941647|P1|NOT COMPLETED|Overall Study||1
385222|NCT00301834|941647|P1|COMPLETED|Overall Study||34
385223|NCT00301834|941647|P1|STARTED|Overall Study||35
385224|NCT00301821|941656|P1|NOT COMPLETED|Overall Study||26
385225|NCT00301821|941656|P1|COMPLETED|Overall Study||81
385226|NCT00301821|941656|P1|STARTED|Overall Study||107
385227|NCT00301808|941663|P1|NOT COMPLETED|Overall Study||12
385228|NCT00301808|941663|P1|COMPLETED|Overall Study||17
385229|NCT00301808|941663|P1|STARTED|Overall Study||29
385230|NCT00301756|941670|P1|NOT COMPLETED|Overall Study||0
385231|NCT00301756|941670|P1|COMPLETED|Overall Study||32
385232|NCT00301756|941670|P1|STARTED|Overall Study||32
385233|NCT00301418|941682|P1|NOT COMPLETED|Overall Study||0
385234|NCT00301418|941682|P1|COMPLETED|Overall Study||11
385235|NCT00301418|941682|P1|STARTED|Overall Study||11
385236|NCT00301366|941688|P1|NOT COMPLETED|Overall Study||1
385237|NCT00301366|941688|P1|COMPLETED|Overall Study||37
385238|NCT00301366|941688|P1|STARTED|Overall Study||38
385239|NCT00301262|941694|P2|NOT COMPLETED|Open Label Phase (OL)||2
385240|NCT00301262|941695|P1|NOT COMPLETED|Open Label Phase (OL)||4
385241|NCT00301262|941694|P2|COMPLETED|Open Label Phase (OL)||67
385242|NCT00301262|941695|P1|COMPLETED|Open Label Phase (OL)||79
385243|NCT00301262|941694|P2|STARTED|Open Label Phase (OL)||69
385244|NCT00301262|941695|P1|STARTED|Open Label Phase (OL)||83
385245|NCT00301262|941694|P2|NOT COMPLETED|Double Blind Phase (DB)||13
385246|NCT00301262|941695|P1|NOT COMPLETED|Double Blind Phase (DB)||10
385247|NCT00301262|941694|P2|COMPLETED|Double Blind Phase (DB)||69
385248|NCT00301262|941695|P1|COMPLETED|Double Blind Phase (DB)||84
385249|NCT00301262|941694|P2|STARTED|Double Blind Phase (DB)||82
385250|NCT00301262|941695|P1|STARTED|Double Blind Phase (DB)||94
385251|NCT00301080|941853|P5|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
385252|NCT00301080|941854|P4|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
385253|NCT00301080|941855|P3|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
385254|NCT00301080|941856|P2|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
385255|NCT00301080|941857|P1|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
385256|NCT00301080|941853|P5|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
385257|NCT00301080|941854|P4|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
385258|NCT00301080|941855|P3|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
385259|NCT00301080|941856|P2|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
385260|NCT00301080|941857|P1|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
385261|NCT00301080|941853|P5|STARTED|Revised Version (3 Arms & 12 Weeks)||0
385262|NCT00301080|941854|P4|STARTED|Revised Version (3 Arms & 12 Weeks)||0
385263|NCT00301080|941855|P3|STARTED|Revised Version (3 Arms & 12 Weeks)||0
385264|NCT00301080|941856|P2|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
385265|NCT00301080|941857|P1|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
385266|NCT00301080|941853|P5|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
385267|NCT00301080|941854|P4|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
385268|NCT00301080|941855|P3|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
385269|NCT00301080|941856|P2|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
385270|NCT00301080|941857|P1|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||1
385271|NCT00301080|941853|P5|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
385272|NCT00301080|941854|P4|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
385273|NCT00301080|941855|P3|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
385274|NCT00301080|941856|P2|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
385275|NCT00301080|941857|P1|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
385276|NCT00301080|941853|P5|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
385277|NCT00301080|941854|P4|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
385278|NCT00301080|941855|P3|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
385279|NCT00301080|941856|P2|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
385280|NCT00301080|941857|P1|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
385281|NCT00301080|941853|P5|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
385282|NCT00301080|941854|P4|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
385283|NCT00301080|941855|P3|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
385284|NCT00301080|941856|P2|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
385285|NCT00301080|941857|P1|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
385286|NCT00301080|941853|P5|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
385287|NCT00301080|941854|P4|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
385288|NCT00301080|941855|P3|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
385289|NCT00301080|941856|P2|STARTED|Original Version (2 Arms & 4 Weeks)||3
385290|NCT00301080|941857|P1|STARTED|Original Version (2 Arms & 4 Weeks)||4
385291|NCT00301067|941886|P4|NOT COMPLETED|Follow up Until Death||1
385292|NCT00301067|941887|P3|NOT COMPLETED|Follow up Until Death||0
385293|NCT00301067|941888|P2|NOT COMPLETED|Follow up Until Death||0
385294|NCT00301067|941889|P1|NOT COMPLETED|Follow up Until Death||1
385295|NCT00301067|941886|P4|COMPLETED|Follow up Until Death||2
385296|NCT00301067|941887|P3|COMPLETED|Follow up Until Death||3
385297|NCT00301067|941888|P2|COMPLETED|Follow up Until Death||3
385298|NCT00301067|941889|P1|COMPLETED|Follow up Until Death||3
385299|NCT00301067|941886|P4|STARTED|Follow up Until Death||3
385300|NCT00301067|941887|P3|STARTED|Follow up Until Death||3
385301|NCT00301067|941888|P2|STARTED|Follow up Until Death||3
385302|NCT00301067|941889|P1|STARTED|Follow up Until Death||4
385303|NCT00301067|941886|P4|NOT COMPLETED|Completed 12 Cycles of Treatment||2
385304|NCT00301067|941887|P3|NOT COMPLETED|Completed 12 Cycles of Treatment||0
385305|NCT00301067|941888|P2|NOT COMPLETED|Completed 12 Cycles of Treatment||1
385306|NCT00301067|941889|P1|NOT COMPLETED|Completed 12 Cycles of Treatment||0
385307|NCT00301067|941886|P4|COMPLETED|Completed 12 Cycles of Treatment||0
385308|NCT00301067|941887|P3|COMPLETED|Completed 12 Cycles of Treatment||0
385309|NCT00301067|941888|P2|COMPLETED|Completed 12 Cycles of Treatment||0
385310|NCT00301067|941889|P1|COMPLETED|Completed 12 Cycles of Treatment||0
385311|NCT00301067|941886|P4|STARTED|Completed 12 Cycles of Treatment||2
385312|NCT00301067|941887|P3|STARTED|Completed 12 Cycles of Treatment||0
385313|NCT00301067|941888|P2|STARTED|Completed 12 Cycles of Treatment||1
385314|NCT00301067|941889|P1|STARTED|Completed 12 Cycles of Treatment||0
385315|NCT00301067|941886|P4|NOT COMPLETED|Completed 4 Cycles of Treatment||5
385316|NCT00301067|941887|P3|NOT COMPLETED|Completed 4 Cycles of Treatment||2
385317|NCT00301067|941888|P2|NOT COMPLETED|Completed 4 Cycles of Treatment||1
385318|NCT00301067|941889|P1|NOT COMPLETED|Completed 4 Cycles of Treatment||1
385319|NCT00301067|941886|P4|COMPLETED|Completed 4 Cycles of Treatment||2
385320|NCT00301067|941887|P3|COMPLETED|Completed 4 Cycles of Treatment||0
385321|NCT00301067|941888|P2|COMPLETED|Completed 4 Cycles of Treatment||1
385322|NCT00301067|941889|P1|COMPLETED|Completed 4 Cycles of Treatment||0
385323|NCT00301067|941886|P4|STARTED|Completed 4 Cycles of Treatment||7
385324|NCT00301067|941887|P3|STARTED|Completed 4 Cycles of Treatment||2
385325|NCT00301067|941888|P2|STARTED|Completed 4 Cycles of Treatment||2
385326|NCT00301067|941889|P1|STARTED|Completed 4 Cycles of Treatment||1
385327|NCT00301067|941886|P4|NOT COMPLETED|Reached 1st Response/2 Cycles||2
385328|NCT00301067|941887|P3|NOT COMPLETED|Reached 1st Response/2 Cycles||1
385329|NCT00301067|941888|P2|NOT COMPLETED|Reached 1st Response/2 Cycles||1
385330|NCT00301067|941889|P1|NOT COMPLETED|Reached 1st Response/2 Cycles||2
385331|NCT00301067|941886|P4|COMPLETED|Reached 1st Response/2 Cycles||7
385332|NCT00301067|941887|P3|COMPLETED|Reached 1st Response/2 Cycles||2
385333|NCT00301067|941888|P2|COMPLETED|Reached 1st Response/2 Cycles||2
385334|NCT00301067|941889|P1|COMPLETED|Reached 1st Response/2 Cycles||1
385335|NCT00301067|941886|P4|STARTED|Reached 1st Response/2 Cycles||9
385336|NCT00301067|941887|P3|STARTED|Reached 1st Response/2 Cycles||3
385337|NCT00301067|941888|P2|STARTED|Reached 1st Response/2 Cycles||3
385338|NCT00301067|941889|P1|STARTED|Reached 1st Response/2 Cycles||3
385339|NCT00301067|941886|P4|NOT COMPLETED|Completed DLT Period/1st Cycle||1
385340|NCT00301067|941887|P3|NOT COMPLETED|Completed DLT Period/1st Cycle||0
385341|NCT00301067|941888|P2|NOT COMPLETED|Completed DLT Period/1st Cycle||0
385342|NCT00301067|941889|P1|NOT COMPLETED|Completed DLT Period/1st Cycle||1
385343|NCT00301067|941886|P4|COMPLETED|Completed DLT Period/1st Cycle||9
385344|NCT00301067|941887|P3|COMPLETED|Completed DLT Period/1st Cycle||3
385345|NCT00301067|941888|P2|COMPLETED|Completed DLT Period/1st Cycle||3
385346|NCT00301067|941889|P1|COMPLETED|Completed DLT Period/1st Cycle||3
385347|NCT00301067|941886|P4|STARTED|Completed DLT Period/1st Cycle|Patients did not participate in the DLT portion of the trial, they completed 1st cycle of treatment.|10
385348|NCT00301067|941887|P3|STARTED|Completed DLT Period/1st Cycle||3
385349|NCT00301067|941888|P2|STARTED|Completed DLT Period/1st Cycle||3
385350|NCT00301067|941889|P1|STARTED|Completed DLT Period/1st Cycle||4
385351|NCT00301028|941908|P1|NOT COMPLETED|Overall Study||0
385352|NCT00301028|941908|P1|COMPLETED|Overall Study||47
385353|NCT00301028|941908|P1|STARTED|Overall Study||47
385354|NCT00300885|941914|P2|NOT COMPLETED|Follow-up||195
385355|NCT00300885|941915|P1|NOT COMPLETED|Follow-up||178
385356|NCT00300885|941914|P2|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|174
385357|NCT00300885|941915|P1|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|176
385358|NCT00300885|941914|P2|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|369
385359|NCT00300885|941915|P1|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|354
385360|NCT00300885|941914|P2|NOT COMPLETED|Treatment||374
385361|NCT00300885|941915|P1|NOT COMPLETED|Treatment||373
385362|NCT00300885|941914|P2|COMPLETED|Treatment||88
385363|NCT00300885|941915|P1|COMPLETED|Treatment||91
385364|NCT00300885|941914|P2|Received Treatment|Treatment||459
385365|NCT00300885|941915|P1|Received Treatment|Treatment||463
385366|NCT00300885|941914|P2|STARTED|Treatment|ongoing in double -blind treatment at data cut-off|462
385367|NCT00300885|941915|P1|STARTED|Treatment||464
385368|NCT00300781|941933|P2|NOT COMPLETED|Overall Study||62
385369|NCT00300781|941934|P1|NOT COMPLETED|Overall Study||63
385370|NCT00300781|941933|P2|COMPLETED|Overall Study||8
385371|NCT00300781|941934|P1|COMPLETED|Overall Study||3
385372|NCT00300781|941933|P2|STARTED|Overall Study||70
385373|NCT00300781|941934|P1|STARTED|Overall Study||66
385374|NCT00300755|941949|P3|NOT COMPLETED|Overall Study||2
385375|NCT00300755|941950|P2|NOT COMPLETED|Overall Study||4
385376|NCT00300755|941951|P1|NOT COMPLETED|Overall Study||1
385377|NCT00300755|941949|P3|COMPLETED|Overall Study||19
385378|NCT00300755|941950|P2|COMPLETED|Overall Study||17
385379|NCT00300755|941951|P1|COMPLETED|Overall Study||17
385380|NCT00300755|941949|P3|STARTED|Overall Study||21
385381|NCT00300755|941950|P2|STARTED|Overall Study||21
385382|NCT00300755|941951|P1|STARTED|Overall Study||18
385383|NCT00300742|941968|P1|NOT COMPLETED|Overall Study||2
385384|NCT00300742|941968|P1|COMPLETED|Overall Study||3
385385|NCT00300742|941968|P1|STARTED|Overall Study||5
385386|NCT00300677|941976|P1|NOT COMPLETED|Overall Study||0
385387|NCT00300677|941976|P1|COMPLETED|Overall Study||12
385388|NCT00300677|941976|P1|STARTED|Overall Study||12
385389|NCT00300495|941985|P2|NOT COMPLETED|Overall Study||1
385390|NCT00300495|941986|P1|NOT COMPLETED|Overall Study||4
385391|NCT00300495|941985|P2|COMPLETED|Overall Study||8
385392|NCT00300495|941986|P1|COMPLETED|Overall Study||6
385393|NCT00300495|941985|P2|STARTED|Overall Study||9
385394|NCT00300495|941986|P1|STARTED|Overall Study||10
385395|NCT00300482|942000|P6|NOT COMPLETED|Overall Study||16
385396|NCT00300482|942001|P5|NOT COMPLETED|Overall Study||23
385397|NCT00300482|942002|P4|NOT COMPLETED|Overall Study||24
385398|NCT00300482|942003|P3|NOT COMPLETED|Overall Study||51
385399|NCT00300482|942004|P2|NOT COMPLETED|Overall Study||41
385400|NCT00300482|942005|P1|NOT COMPLETED|Overall Study||41
385401|NCT00300482|942000|P6|COMPLETED|Overall Study||115
385402|NCT00300482|942001|P5|COMPLETED|Overall Study||243
385403|NCT00300482|942002|P4|COMPLETED|Overall Study||237
385404|NCT00300482|942003|P3|COMPLETED|Overall Study||208
385405|NCT00300482|942004|P2|COMPLETED|Overall Study||220
385406|NCT00300482|942005|P1|COMPLETED|Overall Study||220
385407|NCT00300482|942000|P6|STARTED|Overall Study||131
385408|NCT00300482|942001|P5|STARTED|Overall Study||266
385409|NCT00300482|942002|P4|STARTED|Overall Study||261
385410|NCT00300482|942003|P3|STARTED|Overall Study||259
385411|NCT00300482|942004|P2|STARTED|Overall Study||261
385412|NCT00300482|942005|P1|STARTED|Overall Study|"For all arms, started means treated."|261
385413|NCT00300469|942067|P6|NOT COMPLETED|Overall Study||9
385414|NCT00300469|942068|P5|NOT COMPLETED|Overall Study||14
385415|NCT00300469|942069|P4|NOT COMPLETED|Overall Study||9
385416|NCT00300469|942070|P3|NOT COMPLETED|Overall Study||17
385417|NCT00300469|942071|P2|NOT COMPLETED|Overall Study||21
385418|NCT00300469|942072|P1|NOT COMPLETED|Overall Study||21
385419|NCT00300469|942067|P6|COMPLETED|Overall Study||46
385420|NCT00300469|942068|P5|COMPLETED|Overall Study||95
385421|NCT00300469|942069|P4|COMPLETED|Overall Study||104
385422|NCT00300469|942070|P3|COMPLETED|Overall Study||95
385423|NCT00300469|942071|P2|COMPLETED|Overall Study||89
385424|NCT00300469|942072|P1|COMPLETED|Overall Study||89
385425|NCT00300469|942067|P6|STARTED|Overall Study||55
385426|NCT00300469|942068|P5|STARTED|Overall Study||109
385427|NCT00300469|942069|P4|STARTED|Overall Study||113
385428|NCT00300469|942070|P3|STARTED|Overall Study||112
385429|NCT00300469|942071|P2|STARTED|Overall Study||110
385430|NCT00300469|942072|P1|STARTED|Overall Study|"For all arms, started means treated."|110
385431|NCT00300456|942134|P6|NOT COMPLETED|Overall Study||11
385432|NCT00300456|942135|P5|NOT COMPLETED|Overall Study||17
385433|NCT00300456|942136|P4|NOT COMPLETED|Overall Study||14
385434|NCT00300456|942137|P3|NOT COMPLETED|Overall Study||21
385435|NCT00300456|942138|P2|NOT COMPLETED|Overall Study||16
385436|NCT00300456|942139|P1|NOT COMPLETED|Overall Study||16
385437|NCT00300456|942134|P6|COMPLETED|Overall Study||48
385438|NCT00300456|942135|P5|COMPLETED|Overall Study||99
385439|NCT00300456|942136|P4|COMPLETED|Overall Study||105
385440|NCT00300456|942137|P3|COMPLETED|Overall Study||98
385441|NCT00300456|942138|P2|COMPLETED|Overall Study||102
385442|NCT00300456|942139|P1|COMPLETED|Overall Study||103
385443|NCT00300456|942134|P6|STARTED|Overall Study||59
385444|NCT00300456|942135|P5|STARTED|Overall Study||116
385445|NCT00300456|942136|P4|STARTED|Overall Study||119
385446|NCT00300456|942137|P3|STARTED|Overall Study||119
385447|NCT00300456|942138|P2|STARTED|Overall Study||118
385448|NCT00300456|942139|P1|STARTED|Overall Study|"For all arms, started means treated."|119
385449|NCT00300430|942198|P3|NOT COMPLETED|Overall Study||151
385450|NCT00300430|942199|P2|NOT COMPLETED|Overall Study||169
385451|NCT00300430|942200|P1|NOT COMPLETED|Overall Study||367
385452|NCT00300430|942198|P3|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|350
385453|NCT00300430|942199|P2|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|345
385454|NCT00300430|942200|P1|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|819
385455|NCT00300430|942198|P3|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|501
385456|NCT00300430|942199|P2|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|514
385457|NCT00300430|942200|P1|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|1186
385458|NCT00300391|942234|P2|NOT COMPLETED|Overall Study||0
385459|NCT00300391|942235|P1|NOT COMPLETED|Overall Study||0
385460|NCT00300391|942234|P2|COMPLETED|Overall Study||14
385461|NCT00300391|942235|P1|COMPLETED|Overall Study||16
385462|NCT00300391|942234|P2|STARTED|Overall Study||14
385463|NCT00300391|942235|P1|STARTED|Overall Study||16
385464|NCT00300365|942253|P2|NOT COMPLETED|Overall Study||2
385465|NCT00300365|942254|P1|NOT COMPLETED|Overall Study||4
385466|NCT00300365|942253|P2|COMPLETED|Overall Study||38
385467|NCT00300365|942254|P1|COMPLETED|Overall Study||34
385468|NCT00300365|942253|P2|STARTED|Overall Study||40
385469|NCT00300365|942254|P1|STARTED|Overall Study||38
385470|NCT00300274|942263|P3|NOT COMPLETED|Overall Study||45
385471|NCT00300274|942264|P2|NOT COMPLETED|Overall Study||27
385472|NCT00300274|942265|P1|NOT COMPLETED|Overall Study||46
385473|NCT00300274|942263|P3|COMPLETED|Overall Study||226
385474|NCT00300274|942264|P2|COMPLETED|Overall Study||141
385475|NCT00300274|942265|P1|COMPLETED|Overall Study||236
385476|NCT00300274|942263|P3|Completed 12 Month|Overall Study||248
385477|NCT00300274|942264|P2|Completed 12 Month|Overall Study||149
385478|NCT00300274|942265|P1|Completed 12 Month|Overall Study||250
385479|NCT00300274|942263|P3|STARTED|Overall Study||271
385480|NCT00300274|942264|P2|STARTED|Overall Study||168
385481|NCT00300274|942265|P1|STARTED|Overall Study||282
385482|NCT00300235|942305|P5|NOT COMPLETED|Overall Study||0
385483|NCT00300235|942306|P4|NOT COMPLETED|Overall Study||0
385484|NCT00300235|942307|P3|NOT COMPLETED|Overall Study||0
385485|NCT00300235|942308|P2|NOT COMPLETED|Overall Study||0
385486|NCT00300235|942309|P1|NOT COMPLETED|Overall Study||0
385487|NCT00300235|942305|P5|COMPLETED|Overall Study||251
385488|NCT00300235|942306|P4|COMPLETED|Overall Study||362
385489|NCT00300235|942307|P3|COMPLETED|Overall Study||398
385490|NCT00300235|942308|P2|COMPLETED|Overall Study||240
385491|NCT00300235|942309|P1|COMPLETED|Overall Study||208
385492|NCT00300235|942305|P5|STARTED|Overall Study||251
385493|NCT00300235|942306|P4|STARTED|Overall Study||362
385494|NCT00300235|942307|P3|STARTED|Overall Study||398
385495|NCT00300235|942308|P2|STARTED|Overall Study||240
385496|NCT00300235|942309|P1|STARTED|Overall Study||208
385497|NCT00299975|942324|P3|NOT COMPLETED|Overall Study||8
385498|NCT00299975|942325|P2|NOT COMPLETED|Overall Study||1
385499|NCT00299975|942326|P1|NOT COMPLETED|Overall Study||3
385500|NCT00299975|942324|P3|COMPLETED|Overall Study||25
385501|NCT00299975|942325|P2|COMPLETED|Overall Study||31
385502|NCT00299975|942326|P1|COMPLETED|Overall Study||29
385503|NCT00299975|942324|P3|Received Allocated Intervention|Overall Study||32
385504|NCT00299975|942325|P2|Received Allocated Intervention|Overall Study||32
385505|NCT00299975|942326|P1|Received Allocated Intervention|Overall Study||32
385506|NCT00299975|942324|P3|STARTED|Overall Study||33
385507|NCT00299975|942325|P2|STARTED|Overall Study||32
385508|NCT00299975|942326|P1|STARTED|Overall Study||32
385509|NCT00299741|942376|P1|NOT COMPLETED|Overall Study||0
385510|NCT00299741|942376|P1|COMPLETED|Overall Study||36
385511|NCT00299741|942376|P1|STARTED|Overall Study||36
385512|NCT00299702|942383|P2|NOT COMPLETED|Overall Study||50
385513|NCT00299702|942384|P1|NOT COMPLETED|Overall Study||53
385514|NCT00299702|942383|P2|COMPLETED|Overall Study||126
385515|NCT00299702|942384|P1|COMPLETED|Overall Study||126
385516|NCT00299702|942383|P2|STARTED|Overall Study||176
385517|NCT00299702|942384|P1|STARTED|Overall Study||179
385518|NCT00299689|942392|P1|NOT COMPLETED|Overall Study||0
385519|NCT00299689|942392|P1|COMPLETED|Overall Study||69
385520|NCT00299689|942392|P1|STARTED|Overall Study||69
385521|NCT00299546|942399|P3|NOT COMPLETED|Overall Study||86
385522|NCT00299546|942400|P2|NOT COMPLETED|Overall Study||92
385523|NCT00299546|942401|P1|NOT COMPLETED|Overall Study||100
385524|NCT00299546|942399|P3|COMPLETED|Overall Study||67
385525|NCT00299546|942400|P2|COMPLETED|Overall Study||61
385526|NCT00299546|942401|P1|COMPLETED|Overall Study||55
385527|NCT00299546|942399|P3|STARTED|Overall Study||153
385528|NCT00299546|942400|P2|STARTED|Overall Study||153
385529|NCT00299546|942401|P1|STARTED|Overall Study||155
385530|NCT00299494|942432|P6|NOT COMPLETED|Overall Study||26
385531|NCT00299494|942433|P5|NOT COMPLETED|Overall Study||27
385532|NCT00299494|942434|P4|NOT COMPLETED|Overall Study||10
385533|NCT00299494|942435|P3|NOT COMPLETED|Overall Study||4
385534|NCT00299494|942436|P2|NOT COMPLETED|Overall Study||1
385535|NCT00299494|942437|P1|NOT COMPLETED|Overall Study||3
385536|NCT00299494|942432|P6|COMPLETED|Overall Study||4
385537|NCT00299494|942433|P5|COMPLETED|Overall Study||13
385538|NCT00299494|942434|P4|COMPLETED|Overall Study||24
385539|NCT00299494|942435|P3|COMPLETED|Overall Study||3
385540|NCT00299494|942436|P2|COMPLETED|Overall Study||2
385541|NCT00299494|942437|P1|COMPLETED|Overall Study||2
385542|NCT00299494|942432|P6|STARTED|Overall Study||30
385543|NCT00299494|942433|P5|STARTED|Overall Study|1 participant received rituximab only, and did not receive inotuzumab ozogamicin|40
385544|NCT00299494|942434|P4|STARTED|Overall Study||34
385545|NCT00299494|942435|P3|STARTED|Overall Study||7
385546|NCT00299494|942436|P2|STARTED|Overall Study||3
385547|NCT00299494|942437|P1|STARTED|Overall Study||5
385548|NCT00299416|942540|P1|NOT COMPLETED|Overall Study||0
385549|NCT00299416|942540|P1|COMPLETED|Overall Study||30
385550|NCT00299416|942540|P1|STARTED|Overall Study||30
385551|NCT00299221|942548|P2|NOT COMPLETED|Overall Study||0
385552|NCT00299221|942549|P1|NOT COMPLETED|Overall Study||0
385553|NCT00299221|942548|P2|COMPLETED|Overall Study||71
385554|NCT00299221|942549|P1|COMPLETED|Overall Study||79
385555|NCT00299221|942548|P2|STARTED|Overall Study||71
385556|NCT00299221|942549|P1|STARTED|Overall Study||79
385557|NCT00299156|942566|P3|NOT COMPLETED|Period 2 (Randomized)||0
385558|NCT00299156|942567|P2|NOT COMPLETED|Period 2 (Randomized)||1
385559|NCT00299156|942568|P1|NOT COMPLETED|Period 2 (Randomized)||0
385560|NCT00299156|942566|P3|COMPLETED|Period 2 (Randomized)||16
385561|NCT00299156|942567|P2|COMPLETED|Period 2 (Randomized)||16
385562|NCT00299156|942568|P1|COMPLETED|Period 2 (Randomized)||0
385563|NCT00299156|942566|P3|STARTED|Period 2 (Randomized)||16
385564|NCT00299156|942567|P2|STARTED|Period 2 (Randomized)||17
385565|NCT00299156|942568|P1|STARTED|Period 2 (Randomized)||0
385566|NCT00299156|942566|P3|NOT COMPLETED|Period 1 (Non-Randomized)||0
385567|NCT00299156|942567|P2|NOT COMPLETED|Period 1 (Non-Randomized)||0
385568|NCT00299156|942568|P1|NOT COMPLETED|Period 1 (Non-Randomized)||0
385569|NCT00299156|942566|P3|COMPLETED|Period 1 (Non-Randomized)||0
385570|NCT00299156|942567|P2|COMPLETED|Period 1 (Non-Randomized)||0
385571|NCT00299156|942568|P1|COMPLETED|Period 1 (Non-Randomized)||32
385572|NCT00299156|942566|P3|STARTED|Period 1 (Non-Randomized)||0
385573|NCT00299156|942567|P2|STARTED|Period 1 (Non-Randomized)||0
385574|NCT00299156|942568|P1|STARTED|Period 1 (Non-Randomized)||32
385575|NCT00299130|942579|P3|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||6
385576|NCT00299130|942580|P2|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||8
385577|NCT00299130|942581|P1|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
385578|NCT00299130|942579|P3|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||38
385579|NCT00299130|942580|P2|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||74
385580|NCT00299130|942581|P1|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
385581|NCT00299130|942579|P3|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||44
385582|NCT00299130|942580|P2|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||82
385583|NCT00299130|942581|P1|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||0
385584|NCT00299130|942579|P3|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
385585|NCT00299130|942580|P2|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
385586|NCT00299130|942581|P1|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
385587|NCT00299130|942579|P3|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||123
385588|NCT00299130|942580|P2|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||120
385589|NCT00299130|942581|P1|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||122
385590|NCT00299130|942579|P3|STARTED|Safety Follow-up (SFU) (48 Weeks)||168
385591|NCT00299130|942580|P2|STARTED|Safety Follow-up (SFU) (48 Weeks)||165
385592|NCT00299130|942581|P1|STARTED|Safety Follow-up (SFU) (48 Weeks)||167
385593|NCT00299130|942579|P3|NOT COMPLETED|Treatment Period (up to 5 Years)||50
385594|NCT00299130|942580|P2|NOT COMPLETED|Treatment Period (up to 5 Years)||43
385595|NCT00299130|942581|P1|NOT COMPLETED|Treatment Period (up to 5 Years)||53
385596|NCT00299130|942579|P3|COMPLETED|Treatment Period (up to 5 Years)||121
385597|NCT00299130|942580|P2|COMPLETED|Treatment Period (up to 5 Years)||125
385598|NCT00299130|942581|P1|COMPLETED|Treatment Period (up to 5 Years)||119
385599|NCT00299130|942579|P3|Completed 144 Weeks|Treatment Period (up to 5 Years)||132
385600|NCT00299130|942580|P2|Completed 144 Weeks|Treatment Period (up to 5 Years)||138
385601|NCT00299130|942581|P1|Completed 144 Weeks|Treatment Period (up to 5 Years)||133
385602|NCT00299130|942579|P3|Completed 48 Weeks|Treatment Period (up to 5 Years)||158
385603|NCT00299130|942580|P2|Completed 48 Weeks|Treatment Period (up to 5 Years)||157
385604|NCT00299130|942581|P1|Completed 48 Weeks|Treatment Period (up to 5 Years)||155
385605|NCT00299130|942579|P3|Completed 24 Weeks|Treatment Period (up to 5 Years)||166
385606|NCT00299130|942580|P2|Completed 24 Weeks|Treatment Period (up to 5 Years)||162
385607|NCT00299130|942581|P1|Completed 24 Weeks|Treatment Period (up to 5 Years)||159
385608|NCT00299130|942579|P3|Treated|Treatment Period (up to 5 Years)||170
385609|NCT00299130|942580|P2|Treated|Treatment Period (up to 5 Years)||167
385610|NCT00299130|942581|P1|Treated|Treatment Period (up to 5 Years)|155 participants in placebo arm switched to active therapy (rituximab 2 x 0.5g) between Weeks 16-48.|172
385611|NCT00299130|942579|P3|STARTED|Treatment Period (up to 5 Years)||171
385612|NCT00299130|942580|P2|STARTED|Treatment Period (up to 5 Years)||168
385613|NCT00299130|942581|P1|STARTED|Treatment Period (up to 5 Years)||172
385614|NCT00299104|942686|P3|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||12
385615|NCT00299104|942687|P2|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||9
385616|NCT00299104|942688|P1|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||5
385617|NCT00299104|942686|P3|COMPLETED|Extended Safety Follow-Up (ESFU) Period||39
385618|NCT00299104|942687|P2|COMPLETED|Extended Safety Follow-Up (ESFU) Period||31
385619|NCT00299104|942688|P1|COMPLETED|Extended Safety Follow-Up (ESFU) Period||29
385620|NCT00299104|942686|P3|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|51
385621|NCT00299104|942687|P2|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|40
385622|NCT00299104|942688|P1|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|34
385623|NCT00299104|942686|P3|NOT COMPLETED|Safety Follow-Up (SFU) Period||37
385624|NCT00299104|942687|P2|NOT COMPLETED|Safety Follow-Up (SFU) Period||41
385625|NCT00299104|942688|P1|NOT COMPLETED|Safety Follow-Up (SFU) Period||55
385626|NCT00299104|942686|P3|COMPLETED|Safety Follow-Up (SFU) Period||176
385627|NCT00299104|942687|P2|COMPLETED|Safety Follow-Up (SFU) Period||171
385628|NCT00299104|942688|P1|COMPLETED|Safety Follow-Up (SFU) Period||129
385629|NCT00299104|942686|P3|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|213
385630|NCT00299104|942687|P2|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|212
385631|NCT00299104|942688|P1|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|184
385632|NCT00299104|942686|P3|NOT COMPLETED|Treatment Period||172
385633|NCT00299104|942687|P2|NOT COMPLETED|Treatment Period||175
385634|NCT00299104|942688|P1|NOT COMPLETED|Treatment Period||189
385635|NCT00299104|942686|P3|COMPLETED|Treatment Period||80
385636|NCT00299104|942687|P2|COMPLETED|Treatment Period||77
385637|NCT00299104|942688|P1|COMPLETED|Treatment Period|Completed Week 152|62
385638|NCT00299104|942686|P3|Completed Week 104|Treatment Period||216
385639|NCT00299104|942687|P2|Completed Week 104|Treatment Period||213
385640|NCT00299104|942688|P1|Completed Week 104|Treatment Period||178
385641|NCT00299104|942686|P3|Completed Week 52|Treatment Period||232
385642|NCT00299104|942687|P2|Completed Week 52|Treatment Period||227
385643|NCT00299104|942688|P1|Completed Week 52|Treatment Period||213
385644|NCT00299104|942686|P3|Completed Week 24|Treatment Period||241
385645|NCT00299104|942687|P2|Completed Week 24|Treatment Period||240
385646|NCT00299104|942688|P1|Completed Week 24|Treatment Period||227
385647|NCT00299104|942686|P3|Safety/ITT: Received Study Drug|Treatment Period||250
385648|NCT00299104|942687|P2|Safety/ITT: Received Study Drug|Treatment Period||249
385649|NCT00299104|942688|P1|Safety/ITT: Received Study Drug|Treatment Period||249
385650|NCT00299104|942686|P3|STARTED|Treatment Period||252
385651|NCT00299104|942687|P2|STARTED|Treatment Period||252
385652|NCT00299104|942688|P1|STARTED|Treatment Period||251
385653|NCT00299000|942785|P2|NOT COMPLETED|Overall Study||0
385654|NCT00299000|942786|P1|NOT COMPLETED|Overall Study||0
385655|NCT00299000|942785|P2|COMPLETED|Overall Study||2
385656|NCT00299000|942786|P1|COMPLETED|Overall Study||2
385657|NCT00299000|942785|P2|STARTED|Overall Study||2
385658|NCT00299000|942786|P1|STARTED|Overall Study||2
385659|NCT00298896|942798|P1|NOT COMPLETED|Overall Study||50
385660|NCT00298896|942798|P1|COMPLETED|Overall Study||5
385661|NCT00298896|942798|P1|STARTED|Overall Study||55
385662|NCT00298831|942803|P1|NOT COMPLETED|Overall Study||32
385663|NCT00298831|942803|P1|COMPLETED|Overall Study||192
385664|NCT00298831|942803|P1|Treated|Overall Study||197
385665|NCT00298831|942803|P1|STARTED|Overall Study||224
385666|NCT00298766|942812|P1|NOT COMPLETED|Overall Study||46
385667|NCT00298766|942812|P1|COMPLETED|Overall Study||24
385668|NCT00298766|942812|P1|STARTED|Overall Study||70
385669|NCT00298740|942821|P1|NOT COMPLETED|Overall Study||9
385670|NCT00298740|942821|P1|COMPLETED|Overall Study||3
385671|NCT00298740|942821|P1|STARTED|Overall Study||12
385672|NCT00298610|942825|P1|NOT COMPLETED|Overall Study||0
385673|NCT00298610|942825|P1|COMPLETED|Overall Study||30
385674|NCT00298610|942825|P1|STARTED|Overall Study||30
385675|NCT00298558|942839|P4|NOT COMPLETED|10th Annual (A10)||163
385676|NCT00298558|942840|P3|NOT COMPLETED|10th Annual (A10)||171
385677|NCT00298558|942841|P2|NOT COMPLETED|10th Annual (A10)||153
385678|NCT00298558|942842|P1|NOT COMPLETED|10th Annual (A10)||172
385679|NCT00298558|942839|P4|COMPLETED|10th Annual (A10)||285
385680|NCT00298558|942840|P3|COMPLETED|10th Annual (A10)||319
385681|NCT00298558|942841|P2|COMPLETED|10th Annual (A10)||316
385682|NCT00298558|942842|P1|COMPLETED|10th Annual (A10)||300
385683|NCT00298558|942839|P4|STARTED|10th Annual (A10)||448
385684|NCT00298558|942840|P3|STARTED|10th Annual (A10)||490
385685|NCT00298558|942841|P2|STARTED|10th Annual (A10)||469
385686|NCT00298558|942842|P1|STARTED|10th Annual (A10)||472
385687|NCT00298558|942839|P4|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||104
385688|NCT00298558|942840|P3|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||84
385689|NCT00298558|942841|P2|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||86
385690|NCT00298558|942842|P1|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||91
385691|NCT00298558|942839|P4|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||448
385692|NCT00298558|942840|P3|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||490
385693|NCT00298558|942841|P2|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||469
385694|NCT00298558|942842|P1|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||472
385695|NCT00298558|942839|P4|STARTED|3rd Annual (A3) and 5th Annual (A5)||552
385696|NCT00298558|942840|P3|STARTED|3rd Annual (A3) and 5th Annual (A5)||574
385697|NCT00298558|942841|P2|STARTED|3rd Annual (A3) and 5th Annual (A5)||555
385698|NCT00298558|942842|P1|STARTED|3rd Annual (A3) and 5th Annual (A5)||563
385699|NCT00298558|942839|P4|NOT COMPLETED|3rd Annual Booster||0
385700|NCT00298558|942840|P3|NOT COMPLETED|3rd Annual Booster||140
385701|NCT00298558|942841|P2|NOT COMPLETED|3rd Annual Booster||128
385702|NCT00298558|942842|P1|NOT COMPLETED|3rd Annual Booster||122
385703|NCT00298558|942839|P4|COMPLETED|3rd Annual Booster||0
385704|NCT00298558|942840|P3|COMPLETED|3rd Annual Booster||230
385705|NCT00298558|942841|P2|COMPLETED|3rd Annual Booster||243
385706|NCT00298558|942842|P1|COMPLETED|3rd Annual Booster||250
385707|NCT00298558|942839|P4|STARTED|3rd Annual Booster||0
385708|NCT00298558|942840|P3|STARTED|3rd Annual Booster||370
385709|NCT00298558|942841|P2|STARTED|3rd Annual Booster||371
385710|NCT00298558|942842|P1|STARTED|3rd Annual Booster||372
385711|NCT00298558|942839|P4|NOT COMPLETED|2nd Annual (A2)||32
385712|NCT00298558|942840|P3|NOT COMPLETED|2nd Annual (A2)||27
385713|NCT00298558|942841|P2|NOT COMPLETED|2nd Annual (A2)||11
385714|NCT00298558|942842|P1|NOT COMPLETED|2nd Annual (A2)||22
385715|NCT00298558|942839|P4|COMPLETED|2nd Annual (A2)||552
385716|NCT00298558|942840|P3|COMPLETED|2nd Annual (A2)||574
385717|NCT00298558|942841|P2|COMPLETED|2nd Annual (A2)||555
385718|NCT00298558|942842|P1|COMPLETED|2nd Annual (A2)||563
385719|NCT00298558|942839|P4|STARTED|2nd Annual (A2)||584
385720|NCT00298558|942840|P3|STARTED|2nd Annual (A2)||601
385721|NCT00298558|942841|P2|STARTED|2nd Annual (A2)||566
385722|NCT00298558|942842|P1|STARTED|2nd Annual (A2)||585
385723|NCT00298558|942839|P4|NOT COMPLETED|1st Annual (A1)||55
385724|NCT00298558|942840|P3|NOT COMPLETED|1st Annual (A1)||52
385725|NCT00298558|942841|P2|NOT COMPLETED|1st Annual (A1)||63
385726|NCT00298558|942842|P1|NOT COMPLETED|1st Annual (A1)||55
385727|NCT00298558|942839|P4|COMPLETED|1st Annual (A1)||584
385728|NCT00298558|942840|P3|COMPLETED|1st Annual (A1)||601
385729|NCT00298558|942841|P2|COMPLETED|1st Annual (A1)||566
385730|NCT00298558|942842|P1|COMPLETED|1st Annual (A1)||585
385731|NCT00298558|942839|P4|STARTED|1st Annual (A1)||639
385732|NCT00298558|942840|P3|STARTED|1st Annual (A1)||653
385733|NCT00298558|942841|P2|STARTED|1st Annual (A1)||629
385734|NCT00298558|942842|P1|STARTED|1st Annual (A1)||640
385735|NCT00298558|942839|P4|NOT COMPLETED|Booster||0
385736|NCT00298558|942840|P3|NOT COMPLETED|Booster||75
385737|NCT00298558|942841|P2|NOT COMPLETED|Booster||70
385738|NCT00298558|942842|P1|NOT COMPLETED|Booster||89
385739|NCT00298558|942839|P4|COMPLETED|Booster||0
385740|NCT00298558|942840|P3|COMPLETED|Booster||295
385741|NCT00298558|942841|P2|COMPLETED|Booster||301
385742|NCT00298558|942842|P1|COMPLETED|Booster||283
385743|NCT00298558|942839|P4|STARTED|Booster||0
385744|NCT00298558|942840|P3|STARTED|Booster||370
385745|NCT00298558|942841|P2|STARTED|Booster||371
385746|NCT00298558|942842|P1|STARTED|Booster||372
385747|NCT00298558|942839|P4|NOT COMPLETED|Immediate Post Test||65
385748|NCT00298558|942840|P3|NOT COMPLETED|Immediate Post Test||59
385749|NCT00298558|942841|P2|NOT COMPLETED|Immediate Post Test||76
385750|NCT00298558|942842|P1|NOT COMPLETED|Immediate Post Test||71
385751|NCT00298558|942839|P4|COMPLETED|Immediate Post Test||639
385752|NCT00298558|942840|P3|COMPLETED|Immediate Post Test||653
385753|NCT00298558|942841|P2|COMPLETED|Immediate Post Test||629
385754|NCT00298558|942842|P1|COMPLETED|Immediate Post Test||640
385755|NCT00298558|942839|P4|STARTED|Immediate Post Test||704
385756|NCT00298558|942840|P3|STARTED|Immediate Post Test||712
385757|NCT00298558|942841|P2|STARTED|Immediate Post Test||705
385758|NCT00298558|942842|P1|STARTED|Immediate Post Test||711
385759|NCT00298558|942839|P4|NOT COMPLETED|Intervention||419
385760|NCT00298558|942840|P3|NOT COMPLETED|Intervention||75
385761|NCT00298558|942841|P2|NOT COMPLETED|Intervention||78
385762|NCT00298558|942842|P1|NOT COMPLETED|Intervention||91
385763|NCT00298558|942839|P4|COMPLETED|Intervention||285
385764|NCT00298558|942840|P3|COMPLETED|Intervention||637
385765|NCT00298558|942841|P2|COMPLETED|Intervention||627
385766|NCT00298558|942842|P1|COMPLETED|Intervention||620
385767|NCT00298558|942839|P4|STARTED|Intervention||704
385768|NCT00298558|942840|P3|STARTED|Intervention||712
385769|NCT00298558|942841|P2|STARTED|Intervention||705
385770|NCT00298558|942842|P1|STARTED|Intervention||711
385771|NCT00298558|942839|P4|NOT COMPLETED|Baseline||0
385772|NCT00298558|942840|P3|NOT COMPLETED|Baseline||0
385773|NCT00298558|942841|P2|NOT COMPLETED|Baseline||0
385774|NCT00298558|942842|P1|NOT COMPLETED|Baseline||0
385775|NCT00298558|942839|P4|COMPLETED|Baseline||704
385776|NCT00298558|942840|P3|COMPLETED|Baseline||712
385777|NCT00298558|942841|P2|COMPLETED|Baseline||705
385778|NCT00298558|942842|P1|COMPLETED|Baseline||711
385779|NCT00298558|942839|P4|STARTED|Baseline||704
385780|NCT00298558|942840|P3|STARTED|Baseline||712
385781|NCT00298558|942841|P2|STARTED|Baseline||705
385782|NCT00298558|942842|P1|STARTED|Baseline||711
385783|NCT00298389|942875|P3|NOT COMPLETED|Overall Study||0
385784|NCT00298389|942876|P2|NOT COMPLETED|Overall Study||0
385785|NCT00298389|942877|P1|NOT COMPLETED|Overall Study||0
385786|NCT00298389|942875|P3|COMPLETED|Overall Study||19
385787|NCT00298389|942876|P2|COMPLETED|Overall Study||17
385788|NCT00298389|942877|P1|COMPLETED|Overall Study||20
385789|NCT00298389|942875|P3|STARTED|Overall Study||19
385790|NCT00298389|942876|P2|STARTED|Overall Study||17
385791|NCT00298389|942877|P1|STARTED|Overall Study||20
385792|NCT00298363|942891|P3|NOT COMPLETED|Overall Study||6
385793|NCT00298363|942892|P2|NOT COMPLETED|Overall Study||8
385794|NCT00298363|942893|P1|NOT COMPLETED|Overall Study||17
385795|NCT00298363|942891|P3|COMPLETED|Overall Study|13 completed while taking DB ETV; 3 completed following switch from DB ETV to OL FTC/TDF.|16
385796|NCT00298363|942892|P2|COMPLETED|Overall Study|34 completed while taking DB FTC/TDF; 3 completed following switch from DB TDF to OL FTC/TDF.|37
385797|NCT00298363|942893|P1|COMPLETED|Overall Study|22 completed while taking DB TDF; 6 completed following switch from DB TDF to OL FTC/TDF.|28
385798|NCT00298363|942891|P3|STARTED|Overall Study||22
385799|NCT00298363|942892|P2|STARTED|Overall Study||45
385800|NCT00298363|942893|P1|STARTED|Overall Study||45
385801|NCT00298272|943051|P2|NOT COMPLETED|Safety Follow-up Phase||4
385802|NCT00298272|943052|P1|NOT COMPLETED|Safety Follow-up Phase||4
385803|NCT00298272|943051|P2|COMPLETED|Safety Follow-up Phase||13
385804|NCT00298272|943052|P1|COMPLETED|Safety Follow-up Phase||18
385805|NCT00298272|943051|P2|STARTED|Safety Follow-up Phase||17
385806|NCT00298272|943052|P1|STARTED|Safety Follow-up Phase||22
385807|NCT00298272|943051|P2|NOT COMPLETED|Open Label Retreatment Phase||4
385808|NCT00298272|943052|P1|NOT COMPLETED|Open Label Retreatment Phase||9
385809|NCT00298272|943051|P2|COMPLETED|Open Label Retreatment Phase||12
385810|NCT00298272|943052|P1|COMPLETED|Open Label Retreatment Phase||13
385811|NCT00298272|943051|P2|Completed to Week 56|Open Label Retreatment Phase||12
385812|NCT00298272|943052|P1|Completed to Week 56|Open Label Retreatment Phase||13
385813|NCT00298272|943051|P2|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|15
385814|NCT00298272|943052|P1|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|22
385815|NCT00298272|943051|P2|STARTED|Open Label Retreatment Phase||16
385816|NCT00298272|943052|P1|STARTED|Open Label Retreatment Phase||22
385817|NCT00298272|943051|P2|NOT COMPLETED|Double-blind Phase||0
385818|NCT00298272|943052|P1|NOT COMPLETED|Double-blind Phase||8
385819|NCT00298272|943051|P2|COMPLETED|Double-blind Phase||18
385820|NCT00298272|943052|P1|COMPLETED|Double-blind Phase||28
385821|NCT00298272|943051|P2|Completed to Week 56|Double-blind Phase||3
385822|NCT00298272|943052|P1|Completed to Week 56|Double-blind Phase||8
385823|NCT00298272|943051|P2|Completed to Week 24|Double-blind Phase|received full course of placebo therapy|18
385824|NCT00298272|943052|P1|Completed to Week 24|Double-blind Phase|received full course of rituximab therapy|31
385825|NCT00298272|943051|P2|Safety Population|Double-blind Phase||18
385826|NCT00298272|943052|P1|Safety Population|Double-blind Phase|received treatment|33
385827|NCT00298272|943051|P2|STARTED|Double-blind Phase||18
385828|NCT00298272|943052|P1|STARTED|Double-blind Phase|enrolled and randomized (2:1 scheme)|36
385829|NCT00298233|943075|P4|NOT COMPLETED|Overall Study||0
385830|NCT00298233|943076|P3|NOT COMPLETED|Overall Study||0
385831|NCT00298233|943077|P2|NOT COMPLETED|Overall Study||0
385832|NCT00298233|943078|P1|NOT COMPLETED|Overall Study||0
385833|NCT00298233|943075|P4|COMPLETED|Overall Study||124
385834|NCT00298233|943076|P3|COMPLETED|Overall Study||122
385835|NCT00298233|943077|P2|COMPLETED|Overall Study||41
385836|NCT00298233|943078|P1|COMPLETED|Overall Study||39
385837|NCT00298233|943075|P4|STARTED|Overall Study||124
385838|NCT00298233|943076|P3|STARTED|Overall Study||122
385839|NCT00298233|943077|P2|STARTED|Overall Study||41
385840|NCT00298233|943078|P1|STARTED|Overall Study||39
385841|NCT00298155|943097|P3|NOT COMPLETED|Overall Study||0
385842|NCT00298155|943098|P2|NOT COMPLETED|Overall Study||0
385843|NCT00298155|943099|P1|NOT COMPLETED|Overall Study||0
385844|NCT00298155|943097|P3|COMPLETED|Overall Study||13
385845|NCT00298155|943098|P2|COMPLETED|Overall Study||10
385846|NCT00298155|943099|P1|COMPLETED|Overall Study||12
385847|NCT00298155|943097|P3|STARTED|Overall Study||13
385848|NCT00298155|943098|P2|STARTED|Overall Study||10
385849|NCT00298155|943099|P1|STARTED|Overall Study||12
385850|NCT00298090|943110|P1|NOT COMPLETED|Overall Study||18
385851|NCT00298090|943110|P1|COMPLETED|Overall Study|Eighteen subjects were not included in final analysis due to incomplete data sets|29
385852|NCT00298090|943110|P1|STARTED|Overall Study||47
385853|NCT00298038|943116|P2|NOT COMPLETED|Overall Study||93
385854|NCT00298038|943117|P1|NOT COMPLETED|Overall Study||52
385855|NCT00298038|943116|P2|COMPLETED|Overall Study||66
385856|NCT00298038|943117|P1|COMPLETED|Overall Study||88
385857|NCT00298038|943116|P2|Received At Least 1 Dose Of Study Drug|Overall Study||159
385858|NCT00298038|943117|P1|Received At Least 1 Dose Of Study Drug|Overall Study||140
385859|NCT00298038|943116|P2|STARTED|Overall Study||159
385860|NCT00298038|943117|P1|STARTED|Overall Study||140
385861|NCT00297830|943136|P3|NOT COMPLETED|12 Month Visit||0
385862|NCT00297830|943137|P2|NOT COMPLETED|12 Month Visit||6
385863|NCT00297830|943138|P1|NOT COMPLETED|12 Month Visit||1
385864|NCT00297830|943136|P3|COMPLETED|12 Month Visit||24
385865|NCT00297830|943137|P2|COMPLETED|12 Month Visit||35
385866|NCT00297830|943138|P1|COMPLETED|12 Month Visit||37
385867|NCT00297830|943136|P3|STARTED|12 Month Visit||24
385868|NCT00297830|943137|P2|STARTED|12 Month Visit||41
385869|NCT00297830|943138|P1|STARTED|12 Month Visit||38
385870|NCT00297830|943136|P3|NOT COMPLETED|6 Month Visit||3
385871|NCT00297830|943137|P2|NOT COMPLETED|6 Month Visit||2
385872|NCT00297830|943138|P1|NOT COMPLETED|6 Month Visit||3
385873|NCT00297830|943136|P3|COMPLETED|6 Month Visit||24
385874|NCT00297830|943137|P2|COMPLETED|6 Month Visit||41
385875|NCT00297830|943138|P1|COMPLETED|6 Month Visit||38
385876|NCT00297830|943136|P3|STARTED|6 Month Visit||27
385877|NCT00297830|943137|P2|STARTED|6 Month Visit||43
385878|NCT00297830|943138|P1|STARTED|6 Month Visit||41
385879|NCT00297830|943136|P3|NOT COMPLETED|Baseline||0
385880|NCT00297830|943137|P2|NOT COMPLETED|Baseline||0
385881|NCT00297830|943138|P1|NOT COMPLETED|Baseline||0
385882|NCT00297830|943136|P3|COMPLETED|Baseline||27
385883|NCT00297830|943137|P2|COMPLETED|Baseline||43
385884|NCT00297830|943138|P1|COMPLETED|Baseline||41
385885|NCT00297830|943136|P3|STARTED|Baseline||27
385886|NCT00297830|943137|P2|STARTED|Baseline||43
385887|NCT00297830|943138|P1|STARTED|Baseline||41
385888|NCT00297778|943157|P2|NOT COMPLETED|Overall Study||20
385889|NCT00297778|943158|P1|NOT COMPLETED|Overall Study||19
385890|NCT00297778|943157|P2|COMPLETED|Overall Study||124
385891|NCT00297778|943158|P1|COMPLETED|Overall Study||133
385892|NCT00297778|943157|P2|STARTED|Overall Study||144
385893|NCT00297778|943158|P1|STARTED|Overall Study||152
385894|NCT00297648|943192|P1|NOT COMPLETED|Overall Study||36
385895|NCT00297648|943192|P1|COMPLETED|Overall Study||53
385896|NCT00297648|943192|P1|STARTED|Overall Study||89
385897|NCT00297596|943231|P1|NOT COMPLETED|Overall Study||0
385898|NCT00297596|943231|P1|COMPLETED|Overall Study||25
385899|NCT00297596|943231|P1|STARTED|Overall Study||25
385900|NCT00297492|943238|P3|NOT COMPLETED|6 Month Follow-up||27
385901|NCT00297492|943239|P2|NOT COMPLETED|6 Month Follow-up||49
385902|NCT00297492|943240|P1|NOT COMPLETED|6 Month Follow-up||63
385903|NCT00297492|943238|P3|COMPLETED|6 Month Follow-up||118
385904|NCT00297492|943239|P2|COMPLETED|6 Month Follow-up||237
385905|NCT00297492|943240|P1|COMPLETED|6 Month Follow-up||227
385906|NCT00297492|943238|P3|STARTED|6 Month Follow-up||145
385907|NCT00297492|943239|P2|STARTED|6 Month Follow-up||286
385908|NCT00297492|943240|P1|STARTED|6 Month Follow-up||290
385909|NCT00297492|943238|P3|NOT COMPLETED|Set Quit Date||5
385910|NCT00297492|943239|P2|NOT COMPLETED|Set Quit Date||13
385911|NCT00297492|943240|P1|NOT COMPLETED|Set Quit Date||7
385912|NCT00297492|943238|P3|COMPLETED|Set Quit Date||145
385913|NCT00297492|943239|P2|COMPLETED|Set Quit Date||286
385914|NCT00297492|943240|P1|COMPLETED|Set Quit Date||290
385915|NCT00297492|943238|P3|STARTED|Set Quit Date||150
385916|NCT00297492|943239|P2|STARTED|Set Quit Date||299
385917|NCT00297492|943240|P1|STARTED|Set Quit Date||297
385918|NCT00297427|943250|P2|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||0
385919|NCT00297427|943251|P1|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||34
385920|NCT00297427|943250|P2|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
385921|NCT00297427|943251|P1|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Subjects who completed=/>1 follow-up visits and were evaluated for booster acupuncture|60
385922|NCT00297427|943250|P2|STARTED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
385923|NCT00297427|943251|P1|STARTED|Phase 3: Follow-up Post-True Acupuncture||94
385924|NCT00297427|943250|P2|NOT COMPLETED|Phase 2: Optional Crossover for Sham||0
385925|NCT00297427|943251|P1|NOT COMPLETED|Phase 2: Optional Crossover for Sham||16
385926|NCT00297427|943250|P2|COMPLETED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
385927|NCT00297427|943251|P1|COMPLETED|Phase 2: Optional Crossover for Sham||38
385928|NCT00297427|943250|P2|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
385929|NCT00297427|943251|P1|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|54 subjects completed the sham acupuncture & were offered the opportunity to cross-over; 12 declined|42
385930|NCT00297427|943250|P2|STARTED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
385931|NCT00297427|943251|P1|STARTED|Phase 2: Optional Crossover for Sham||54
385932|NCT00297427|943250|P2|NOT COMPLETED|Phase 1: Initial Intervention||9
385933|NCT00297427|943251|P1|NOT COMPLETED|Phase 1: Initial Intervention||8
385934|NCT00297427|943250|P2|COMPLETED|Phase 1: Initial Intervention||54
385935|NCT00297427|943251|P1|COMPLETED|Phase 1: Initial Intervention||56
385936|NCT00297427|943250|P2|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|63
385937|NCT00297427|943251|P1|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|64
385938|NCT00297258|943292|P1|NOT COMPLETED|Overall Study||142
385939|NCT00297258|943292|P1|COMPLETED|Overall Study||0
385940|NCT00297258|943292|P1|STARTED|Overall Study||142
385941|NCT00297232|943311|P1|NOT COMPLETED|Overall Study||605
385942|NCT00297232|943311|P1|COMPLETED|Overall Study||489
385943|NCT00297232|943311|P1|STARTED|Overall Study||1094
385944|NCT00297167|943317|P3|NOT COMPLETED|Open-label Dose Normalization Period 2||0
385945|NCT00297167|943318|P2|NOT COMPLETED|Open-label Dose Normalization Period 2||0
385946|NCT00297167|943319|P1|NOT COMPLETED|Open-label Dose Normalization Period 2||0
385947|NCT00297167|943317|P3|COMPLETED|Open-label Dose Normalization Period 2||31
385948|NCT00297167|943318|P2|COMPLETED|Open-label Dose Normalization Period 2||0
385949|NCT00297167|943319|P1|COMPLETED|Open-label Dose Normalization Period 2||0
385950|NCT00297167|943317|P3|STARTED|Open-label Dose Normalization Period 2||31
385951|NCT00297167|943318|P2|STARTED|Open-label Dose Normalization Period 2||0
385952|NCT00297167|943319|P1|STARTED|Open-label Dose Normalization Period 2||0
385953|NCT00297167|943317|P3|NOT COMPLETED|Second Double-blind Intervention Period||0
385954|NCT00297167|943318|P2|NOT COMPLETED|Second Double-blind Intervention Period||0
385955|NCT00297167|943319|P1|NOT COMPLETED|Second Double-blind Intervention Period||1
385956|NCT00297167|943317|P3|COMPLETED|Second Double-blind Intervention Period||0
385957|NCT00297167|943318|P2|COMPLETED|Second Double-blind Intervention Period||15
385958|NCT00297167|943319|P1|COMPLETED|Second Double-blind Intervention Period||16
385959|NCT00297167|943317|P3|STARTED|Second Double-blind Intervention Period||0
385960|NCT00297167|943318|P2|STARTED|Second Double-blind Intervention Period||15
385961|NCT00297167|943319|P1|STARTED|Second Double-blind Intervention Period||17
385962|NCT00297167|943317|P3|NOT COMPLETED|Open-label Dose Normalization Period 1||1
385963|NCT00297167|943318|P2|NOT COMPLETED|Open-label Dose Normalization Period 1||0
385964|NCT00297167|943319|P1|NOT COMPLETED|Open-label Dose Normalization Period 1||0
385965|NCT00297167|943317|P3|COMPLETED|Open-label Dose Normalization Period 1||32
385966|NCT00297167|943318|P2|COMPLETED|Open-label Dose Normalization Period 1||0
385967|NCT00297167|943319|P1|COMPLETED|Open-label Dose Normalization Period 1||0
385968|NCT00297167|943317|P3|STARTED|Open-label Dose Normalization Period 1||33
385969|NCT00297167|943318|P2|STARTED|Open-label Dose Normalization Period 1||0
385970|NCT00297167|943319|P1|STARTED|Open-label Dose Normalization Period 1||0
385971|NCT00297167|943317|P3|NOT COMPLETED|First Double-blind Intervention Period||0
385972|NCT00297167|943318|P2|NOT COMPLETED|First Double-blind Intervention Period||0
385973|NCT00297167|943319|P1|NOT COMPLETED|First Double-blind Intervention Period||0
385974|NCT00297167|943317|P3|COMPLETED|First Double-blind Intervention Period||0
385975|NCT00297167|943318|P2|COMPLETED|First Double-blind Intervention Period||16
385976|NCT00297167|943319|P1|COMPLETED|First Double-blind Intervention Period||17
385977|NCT00297167|943317|P3|STARTED|First Double-blind Intervention Period||0
385978|NCT00297167|943318|P2|STARTED|First Double-blind Intervention Period||16
385979|NCT00297167|943319|P1|STARTED|First Double-blind Intervention Period||17
385980|NCT00297115|943345|P2|NOT COMPLETED|Overall Study||246
385981|NCT00297115|943346|P1|NOT COMPLETED|Overall Study||245
385982|NCT00297115|943345|P2|COMPLETED|Overall Study||550
385983|NCT00297115|943346|P1|COMPLETED|Overall Study||527
385984|NCT00297115|943345|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|796
385985|NCT00297115|943346|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|772
385986|NCT00297102|943364|P2|NOT COMPLETED|Overall Study||233
385987|NCT00297102|943365|P1|NOT COMPLETED|Overall Study||263
385988|NCT00297102|943364|P2|COMPLETED|Overall Study||525
385989|NCT00297102|943365|P1|COMPLETED|Overall Study||502
385990|NCT00297102|943364|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|758
385991|NCT00297102|943365|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|765
385992|NCT00297037|943383|P2|NOT COMPLETED|Overall Study||0
385993|NCT00297037|943384|P1|NOT COMPLETED|Overall Study||2
385994|NCT00297037|943383|P2|COMPLETED|Overall Study||11
385995|NCT00297037|943384|P1|COMPLETED|Overall Study||8
385996|NCT00297037|943383|P2|STARTED|Overall Study||11
385997|NCT00297037|943384|P1|STARTED|Overall Study||10
385998|NCT00296816|943396|P1|NOT COMPLETED|Overall Study||74
385999|NCT00296816|943396|P1|COMPLETED|Overall Study|Completed study treatment for a minimum of three years|58
386000|NCT00296816|943396|P1|STARTED|Overall Study||132
386001|NCT00296725|943408|P1|NOT COMPLETED|Phase 2: Imipramine (1-6 Weeks)||1
386002|NCT00296725|943408|P1|COMPLETED|Phase 2: Imipramine (1-6 Weeks)||7
386003|NCT00296725|943408|P1|STARTED|Phase 2: Imipramine (1-6 Weeks)||8
386004|NCT00296725|943408|P1|NOT COMPLETED|Phase 1: Fluoxetine (1-12 Weeks)||5
386005|NCT00296725|943408|P1|COMPLETED|Phase 1: Fluoxetine (1-12 Weeks)||12
386006|NCT00296725|943408|P1|STARTED|Phase 1: Fluoxetine (1-12 Weeks)||17
386007|NCT00296647|943421|P5|NOT COMPLETED|Overall Study||20
386008|NCT00296647|943422|P4|NOT COMPLETED|Overall Study||17
386009|NCT00296647|943423|P3|NOT COMPLETED|Overall Study||34
386010|NCT00296647|943424|P2|NOT COMPLETED|Overall Study||28
386011|NCT00296647|943425|P1|NOT COMPLETED|Overall Study||32
386012|NCT00296647|943421|P5|COMPLETED|Overall Study||248
386013|NCT00296647|943422|P4|COMPLETED|Overall Study||262
386014|NCT00296647|943423|P3|COMPLETED|Overall Study||222
386015|NCT00296647|943424|P2|COMPLETED|Overall Study||233
386016|NCT00296647|943425|P1|COMPLETED|Overall Study||250
386017|NCT00296647|943421|P5|STARTED|Overall Study||268
386018|NCT00296647|943422|P4|STARTED|Overall Study||279
386019|NCT00296647|943423|P3|STARTED|Overall Study||256
386020|NCT00296647|943424|P2|STARTED|Overall Study||261
386021|NCT00296647|943425|P1|STARTED|Overall Study||282
386022|NCT00296517|943439|P2|NOT COMPLETED|Dose Level 3 - Weeks 3-12||62
386023|NCT00296517|943440|P1|NOT COMPLETED|Dose Level 3 - Weeks 3-12||45
386024|NCT00296517|943439|P2|COMPLETED|Dose Level 3 - Weeks 3-12||99
386025|NCT00296517|943440|P1|COMPLETED|Dose Level 3 - Weeks 3-12||112
386026|NCT00296517|943439|P2|STARTED|Dose Level 3 - Weeks 3-12||161
386027|NCT00296517|943440|P1|STARTED|Dose Level 3 - Weeks 3-12||157
386028|NCT00296517|943439|P2|NOT COMPLETED|Dose Level 2 - Week 2||5
386029|NCT00296517|943440|P1|NOT COMPLETED|Dose Level 2 - Week 2||2
386030|NCT00296517|943439|P2|COMPLETED|Dose Level 2 - Week 2||161
386031|NCT00296517|943440|P1|COMPLETED|Dose Level 2 - Week 2||157
386032|NCT00296517|943439|P2|STARTED|Dose Level 2 - Week 2||166
386033|NCT00296517|943440|P1|STARTED|Dose Level 2 - Week 2||159
386034|NCT00296517|943439|P2|NOT COMPLETED|Dose Level 1 - Week 1||0
386035|NCT00296517|943440|P1|NOT COMPLETED|Dose Level 1 - Week 1||0
386036|NCT00296517|943439|P2|COMPLETED|Dose Level 1 - Week 1||166
386037|NCT00296517|943440|P1|COMPLETED|Dose Level 1 - Week 1||159
386038|NCT00296517|943439|P2|STARTED|Dose Level 1 - Week 1||166
386039|NCT00296517|943440|P1|STARTED|Dose Level 1 - Week 1||159
386040|NCT00296504|943476|P9|NOT COMPLETED|Final Analysis||21
386041|NCT00296504|943477|P8|NOT COMPLETED|Final Analysis||0
386042|NCT00296504|943478|P7|NOT COMPLETED|Final Analysis||0
386043|NCT00296504|943479|P6|NOT COMPLETED|Final Analysis||0
386044|NCT00296504|943480|P5|NOT COMPLETED|Final Analysis||0
386045|NCT00296504|943481|P4|NOT COMPLETED|Final Analysis||0
386046|NCT00296504|943482|P3|NOT COMPLETED|Final Analysis||0
386047|NCT00296504|943483|P2|NOT COMPLETED|Final Analysis||0
386048|NCT00296504|943484|P1|NOT COMPLETED|Final Analysis||0
386049|NCT00296504|943476|P9|COMPLETED|Final Analysis||90
386050|NCT00296504|943477|P8|COMPLETED|Final Analysis||0
386051|NCT00296504|943478|P7|COMPLETED|Final Analysis||0
386052|NCT00296504|943479|P6|COMPLETED|Final Analysis||0
386053|NCT00296504|943480|P5|COMPLETED|Final Analysis||0
386054|NCT00296504|943481|P4|COMPLETED|Final Analysis||0
386055|NCT00296504|943482|P3|COMPLETED|Final Analysis||0
386056|NCT00296504|943483|P2|COMPLETED|Final Analysis||0
386057|NCT00296504|943484|P1|COMPLETED|Final Analysis||0
386058|NCT00296504|943476|P9|STARTED|Final Analysis|Continued in study; commercial supplies of FPV were unavailable locally at end of Interim Analysis.|111
386059|NCT00296504|943477|P8|STARTED|Final Analysis||0
386060|NCT00296504|943478|P7|STARTED|Final Analysis||0
386061|NCT00296504|943479|P6|STARTED|Final Analysis||0
386062|NCT00296504|943480|P5|STARTED|Final Analysis||0
386063|NCT00296504|943481|P4|STARTED|Final Analysis||0
386064|NCT00296504|943482|P3|STARTED|Final Analysis||0
386065|NCT00296504|943483|P2|STARTED|Final Analysis||0
386066|NCT00296504|943484|P1|STARTED|Final Analysis||0
386067|NCT00296504|943476|P9|NOT COMPLETED|Interim Analysis||0
386068|NCT00296504|943477|P8|NOT COMPLETED|Interim Analysis||49
386069|NCT00296504|943478|P7|NOT COMPLETED|Interim Analysis||74
386070|NCT00296504|943479|P6|NOT COMPLETED|Interim Analysis||37
386071|NCT00296504|943480|P5|NOT COMPLETED|Interim Analysis||37
386072|NCT00296504|943481|P4|NOT COMPLETED|Interim Analysis||43
386073|NCT00296504|943482|P3|NOT COMPLETED|Interim Analysis||105
386074|NCT00296504|943483|P2|NOT COMPLETED|Interim Analysis||18
386075|NCT00296504|943484|P1|NOT COMPLETED|Interim Analysis||76
386076|NCT00296504|943476|P9|COMPLETED|Interim Analysis||0
386077|NCT00296504|943477|P8|COMPLETED|Interim Analysis||37
386078|NCT00296504|943478|P7|COMPLETED|Interim Analysis||30
386079|NCT00296504|943479|P6|COMPLETED|Interim Analysis||41
386080|NCT00296504|943480|P5|COMPLETED|Interim Analysis||36
386081|NCT00296504|943481|P4|COMPLETED|Interim Analysis||11
386082|NCT00296504|943482|P3|COMPLETED|Interim Analysis||116
386083|NCT00296504|943483|P2|COMPLETED|Interim Analysis||0
386084|NCT00296504|943484|P1|COMPLETED|Interim Analysis||43
386085|NCT00296504|943476|P9|Ongoing|Interim Analysis||0
386086|NCT00296504|943477|P8|Ongoing|Interim Analysis||1
386087|NCT00296504|943478|P7|Ongoing|Interim Analysis||30
386088|NCT00296504|943479|P6|Ongoing|Interim Analysis||0
386089|NCT00296504|943480|P5|Ongoing|Interim Analysis||0
386090|NCT00296504|943481|P4|Ongoing|Interim Analysis||22
386091|NCT00296504|943482|P3|Ongoing|Interim Analysis||16
386092|NCT00296504|943483|P2|Ongoing|Interim Analysis||12
386093|NCT00296504|943484|P1|Ongoing|Interim Analysis||32
386094|NCT00296504|943476|P9|STARTED|Interim Analysis||0
386095|NCT00296504|943477|P8|STARTED|Interim Analysis||86
386096|NCT00296504|943478|P7|STARTED|Interim Analysis||104
386097|NCT00296504|943479|P6|STARTED|Interim Analysis||78
386098|NCT00296504|943480|P5|STARTED|Interim Analysis||73
386099|NCT00296504|943481|P4|STARTED|Interim Analysis||54
386100|NCT00296504|943482|P3|STARTED|Interim Analysis||221
386101|NCT00296504|943483|P2|STARTED|Interim Analysis||18
386102|NCT00296504|943484|P1|STARTED|Interim Analysis||119
386103|NCT00296491|943577|P4|NOT COMPLETED|Overall Study||43
386104|NCT00296491|943578|P3|NOT COMPLETED|Overall Study||43
386105|NCT00296491|943579|P2|NOT COMPLETED|Overall Study||53
386106|NCT00296491|943580|P1|NOT COMPLETED|Overall Study||42
386107|NCT00296491|943577|P4|COMPLETED|Overall Study||138
386108|NCT00296491|943578|P3|COMPLETED|Overall Study||137
386109|NCT00296491|943579|P2|COMPLETED|Overall Study||129
386110|NCT00296491|943580|P1|COMPLETED|Overall Study||140
386111|NCT00296491|943577|P4|STARTED|Overall Study||181
386112|NCT00296491|943578|P3|STARTED|Overall Study||180
386113|NCT00296491|943579|P2|STARTED|Overall Study||182
386114|NCT00296491|943580|P1|STARTED|Overall Study|Please note: Outcome Measures generally conducts analysis of 2 of the 4 Arms at a time.|182
386115|NCT00296400|943609|P3|NOT COMPLETED|Overall Study||13
386116|NCT00296400|943610|P2|NOT COMPLETED|Overall Study||18
386117|NCT00296400|943611|P1|NOT COMPLETED|Overall Study||17
386118|NCT00296400|943609|P3|COMPLETED|Overall Study||67
386119|NCT00296400|943610|P2|COMPLETED|Overall Study||69
386120|NCT00296400|943611|P1|COMPLETED|Overall Study||53
386121|NCT00296400|943609|P3|STARTED|Overall Study||80
386122|NCT00296400|943610|P2|STARTED|Overall Study||87
386123|NCT00296400|943611|P1|STARTED|Overall Study||70
386124|NCT00296374|943835|P3|NOT COMPLETED|Overall Study||29
386125|NCT00296374|943836|P2|NOT COMPLETED|Overall Study||23
386126|NCT00296374|943837|P1|NOT COMPLETED|Overall Study||25
386127|NCT00296374|943835|P3|COMPLETED|Overall Study||82
386128|NCT00296374|943836|P2|COMPLETED|Overall Study||101
386129|NCT00296374|943837|P1|COMPLETED|Overall Study||93
386130|NCT00296374|943835|P3|STARTED|Overall Study||111
386131|NCT00296374|943836|P2|STARTED|Overall Study||124
386132|NCT00296374|943837|P1|STARTED|Overall Study||118
386133|NCT00296335|944060|P2|NOT COMPLETED|Overall Study||122
386134|NCT00296335|944061|P1|NOT COMPLETED|Overall Study||30
386135|NCT00296335|944060|P2|COMPLETED|Overall Study||309
386136|NCT00296335|944061|P1|COMPLETED|Overall Study||394
386137|NCT00296335|944060|P2|STARTED|Overall Study||431
386138|NCT00296335|944061|P1|STARTED|Overall Study||424
386139|NCT00296322|944073|P2|NOT COMPLETED|Overall Study||79
386140|NCT00296322|944074|P1|NOT COMPLETED|Overall Study||21
386141|NCT00296322|944073|P2|COMPLETED|Overall Study||184
386142|NCT00296322|944074|P1|COMPLETED|Overall Study||237
386143|NCT00296322|944073|P2|STARTED|Overall Study||263
386144|NCT00296322|944074|P1|STARTED|Overall Study||258
386145|NCT00296296|944086|P2|NOT COMPLETED|Overall Study||13
386146|NCT00296296|944087|P1|NOT COMPLETED|Overall Study||2
386147|NCT00296296|944086|P2|COMPLETED|Overall Study||5
386148|NCT00296296|944087|P1|COMPLETED|Overall Study||9
386149|NCT00296296|944086|P2|STARTED|Overall Study||18
386150|NCT00296296|944087|P1|STARTED|Overall Study||11
386151|NCT00296244|944101|P2|NOT COMPLETED|Overall Study||1
386152|NCT00296244|944102|P1|NOT COMPLETED|Overall Study||0
386153|NCT00296244|944101|P2|COMPLETED|Overall Study||19
386154|NCT00296244|944102|P1|COMPLETED|Overall Study||20
386155|NCT00296244|944101|P2|STARTED|Overall Study||20
386156|NCT00296244|944102|P1|STARTED|Overall Study||20
386157|NCT00296231|944118|P1|NOT COMPLETED|Overall Study||0
386158|NCT00296231|944118|P1|COMPLETED|Overall Study||14
386159|NCT00296231|944118|P1|STARTED|Overall Study||14
386160|NCT00296192|944128|P5|NOT COMPLETED|Overall Study||0
386161|NCT00296192|944129|P4|NOT COMPLETED|Overall Study||0
386162|NCT00296192|944130|P3|NOT COMPLETED|Overall Study||0
386163|NCT00296192|944131|P2|NOT COMPLETED|Overall Study||0
386164|NCT00296192|944132|P1|NOT COMPLETED|Overall Study||0
386165|NCT00296192|944128|P5|COMPLETED|Overall Study||16
386166|NCT00296192|944129|P4|COMPLETED|Overall Study||17
386167|NCT00296192|944130|P3|COMPLETED|Overall Study||16
386168|NCT00296192|944131|P2|COMPLETED|Overall Study||16
386169|NCT00296192|944132|P1|COMPLETED|Overall Study||17
386170|NCT00296192|944128|P5|STARTED|Overall Study||16
386171|NCT00296192|944129|P4|STARTED|Overall Study||17
386172|NCT00296192|944130|P3|STARTED|Overall Study||16
386173|NCT00296192|944131|P2|STARTED|Overall Study||16
386174|NCT00296192|944132|P1|STARTED|Overall Study||17
386175|NCT00296140|944166|P2|NOT COMPLETED|Overall Study||0
386176|NCT00296140|944167|P1|NOT COMPLETED|Overall Study||3
386177|NCT00296140|944166|P2|COMPLETED|Overall Study||33
386178|NCT00296140|944167|P1|COMPLETED|Overall Study||30
386179|NCT00296140|944166|P2|STARTED|Overall Study||33
386180|NCT00296140|944167|P1|STARTED|Overall Study||33
386181|NCT00296036|944179|P6|NOT COMPLETED|Overall Study||4
386182|NCT00296036|944180|P5|NOT COMPLETED|Overall Study||2
386183|NCT00296036|944181|P4|NOT COMPLETED|Overall Study||1
386184|NCT00296036|944182|P3|NOT COMPLETED|Overall Study||2
386185|NCT00296036|944183|P2|NOT COMPLETED|Overall Study||0
386186|NCT00296036|944184|P1|NOT COMPLETED|Overall Study||1
386187|NCT00296036|944179|P6|COMPLETED|Overall Study||28
386188|NCT00296036|944180|P5|COMPLETED|Overall Study||31
386189|NCT00296036|944181|P4|COMPLETED|Overall Study||16
386190|NCT00296036|944182|P3|COMPLETED|Overall Study||16
386191|NCT00296036|944183|P2|COMPLETED|Overall Study||18
386192|NCT00296036|944184|P1|COMPLETED|Overall Study||18
386193|NCT00296036|944179|P6|STARTED|Overall Study||32
386194|NCT00296036|944180|P5|STARTED|Overall Study||33
386195|NCT00296036|944181|P4|STARTED|Overall Study||17
386196|NCT00296036|944182|P3|STARTED|Overall Study||18
386197|NCT00296036|944183|P2|STARTED|Overall Study||18
386198|NCT00296036|944184|P1|STARTED|Overall Study||19
386199|NCT00295932|944221|P11|NOT COMPLETED|Overall Study||1
386200|NCT00295932|944222|P10|NOT COMPLETED|Overall Study||0
386201|NCT00295932|944223|P9|NOT COMPLETED|Overall Study||0
386202|NCT00295932|944224|P8|NOT COMPLETED|Overall Study||0
386203|NCT00295932|944225|P7|NOT COMPLETED|Overall Study||0
386204|NCT00295932|944226|P6|NOT COMPLETED|Overall Study||0
386205|NCT00295932|944227|P5|NOT COMPLETED|Overall Study||0
386206|NCT00295932|944228|P4|NOT COMPLETED|Overall Study||0
386207|NCT00295932|944229|P3|NOT COMPLETED|Overall Study||0
386208|NCT00295932|944230|P2|NOT COMPLETED|Overall Study||0
386209|NCT00295932|944231|P1|NOT COMPLETED|Overall Study||0
386210|NCT00295932|944221|P11|COMPLETED|Overall Study||12
386211|NCT00295932|944222|P10|COMPLETED|Overall Study||12
386212|NCT00295932|944223|P9|COMPLETED|Overall Study||10
386213|NCT00295932|944224|P8|COMPLETED|Overall Study||4
386214|NCT00295932|944225|P7|COMPLETED|Overall Study||3
386215|NCT00295932|944226|P6|COMPLETED|Overall Study||18
386216|NCT00295932|944227|P5|COMPLETED|Overall Study||2
386217|NCT00295932|944228|P4|COMPLETED|Overall Study||4
386218|NCT00295932|944229|P3|COMPLETED|Overall Study||3
386219|NCT00295932|944230|P2|COMPLETED|Overall Study||6
386220|NCT00295932|944231|P1|COMPLETED|Overall Study||4
386221|NCT00295932|944221|P11|STARTED|Overall Study||13
386222|NCT00295932|944222|P10|STARTED|Overall Study||12
386223|NCT00295932|944223|P9|STARTED|Overall Study||10
386224|NCT00295932|944224|P8|STARTED|Overall Study||4
386225|NCT00295932|944225|P7|STARTED|Overall Study||3
386226|NCT00295932|944226|P6|STARTED|Overall Study||18
386227|NCT00295932|944227|P5|STARTED|Overall Study||2
386228|NCT00295932|944228|P4|STARTED|Overall Study||4
386229|NCT00295932|944229|P3|STARTED|Overall Study||3
386230|NCT00295932|944230|P2|STARTED|Overall Study||6
386231|NCT00295932|944231|P1|STARTED|Overall Study||4
386232|NCT00295880|944265|P1|NOT COMPLETED|Overall Study||2
386233|NCT00295880|944265|P1|COMPLETED|Overall Study||10
386234|NCT00295880|944265|P1|STARTED|Overall Study||12
386235|NCT00295854|944279|P3|NOT COMPLETED|Overall Study||15
386236|NCT00295854|944280|P2|NOT COMPLETED|Overall Study||21
386237|NCT00295854|944281|P1|NOT COMPLETED|Overall Study||18
386238|NCT00295854|944279|P3|COMPLETED|Overall Study||87
386239|NCT00295854|944280|P2|COMPLETED|Overall Study||87
386240|NCT00295854|944281|P1|COMPLETED|Overall Study||77
386241|NCT00295854|944279|P3|ITT Population (N=296)|Overall Study||99
386242|NCT00295854|944280|P2|ITT Population (N=296)|Overall Study||105
386243|NCT00295854|944281|P1|ITT Population (N=296)|Overall Study||92
386244|NCT00295854|944279|P3|Safety Population (N=304)|Overall Study||101
386245|NCT00295854|944280|P2|Safety Population (N=304)|Overall Study||108
386246|NCT00295854|944281|P1|Safety Population (N=304)|Overall Study||95
386247|NCT00295854|944279|P3|STARTED|Overall Study||102
386248|NCT00295854|944280|P2|STARTED|Overall Study||108
386249|NCT00295854|944281|P1|STARTED|Overall Study||95
386250|NCT00295750|944295|P3|NOT COMPLETED|Overall Study||32
386251|NCT00295750|944296|P2|NOT COMPLETED|Overall Study||41
386252|NCT00295750|944297|P1|NOT COMPLETED|Overall Study||43
386253|NCT00295750|944295|P3|COMPLETED|Overall Study||172
386254|NCT00295750|944296|P2|COMPLETED|Overall Study||169
386255|NCT00295750|944297|P1|COMPLETED|Overall Study||163
386256|NCT00295750|944295|P3|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|201
386257|NCT00295750|944296|P2|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|207
386258|NCT00295750|944297|P1|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|202
386259|NCT00295750|944295|P3|STARTED|Overall Study|randomized|204
386260|NCT00295750|944296|P2|STARTED|Overall Study|randomized|210
386261|NCT00295750|944297|P1|STARTED|Overall Study|randomized|206
386262|NCT00295633|944332|P3|NOT COMPLETED|Overall Study||76
386263|NCT00295633|944333|P2|NOT COMPLETED|Overall Study||67
386264|NCT00295633|944334|P1|NOT COMPLETED|Overall Study||62
386265|NCT00295633|944332|P3|COMPLETED|Overall Study||108
386266|NCT00295633|944333|P2|COMPLETED|Overall Study||119
386267|NCT00295633|944334|P1|COMPLETED|Overall Study||133
386268|NCT00295633|944332|P3|Completed Study Without Being Rescued|Overall Study||51
386269|NCT00295633|944333|P2|Completed Study Without Being Rescued|Overall Study||82
386270|NCT00295633|944334|P1|Completed Study Without Being Rescued|Overall Study||88
386271|NCT00295633|944332|P3|STARTED|Overall Study||184
386272|NCT00295633|944333|P2|STARTED|Overall Study||186
386273|NCT00295633|944334|P1|STARTED|Overall Study||195
386274|NCT00295620|944353|P2|NOT COMPLETED|Overall Study||896
386275|NCT00295620|944354|P1|NOT COMPLETED|Overall Study||872
386276|NCT00295620|944353|P2|COMPLETED|Overall Study||842
386277|NCT00295620|944354|P1|COMPLETED|Overall Study||860
386278|NCT00295620|944353|P2|Safety Analysis Set|Overall Study||1710
386279|NCT00295620|944354|P1|Safety Analysis Set|Overall Study||1705
386280|NCT00295620|944353|P2|STARTED|Overall Study||1738
386281|NCT00295620|944354|P1|STARTED|Overall Study||1732
386282|NCT00295503|944368|P1|NOT COMPLETED|Overall Study||0
386283|NCT00295503|944368|P1|COMPLETED|Overall Study||53
386284|NCT00295503|944368|P1|STARTED|Overall Study||53
386285|NCT00295490|944378|P4|NOT COMPLETED|Overall Study||5
386286|NCT00295490|944379|P3|NOT COMPLETED|Overall Study||4
386287|NCT00295490|944380|P2|NOT COMPLETED|Overall Study||4
386288|NCT00295490|944381|P1|NOT COMPLETED|Overall Study||1
386289|NCT00295490|944378|P4|COMPLETED|Overall Study||12
386290|NCT00295490|944379|P3|COMPLETED|Overall Study||12
386291|NCT00295490|944380|P2|COMPLETED|Overall Study||15
386292|NCT00295490|944381|P1|COMPLETED|Overall Study||14
386293|NCT00295490|944378|P4|STARTED|Overall Study||17
386294|NCT00295490|944379|P3|STARTED|Overall Study||16
386295|NCT00295490|944380|P2|STARTED|Overall Study||19
386296|NCT00295490|944381|P1|STARTED|Overall Study||15
386297|NCT00295061|944421|P2|NOT COMPLETED|Overall Study||0
386298|NCT00295061|944422|P1|NOT COMPLETED|Overall Study||0
386299|NCT00295061|944421|P2|COMPLETED|Overall Study||12
386300|NCT00295061|944422|P1|COMPLETED|Overall Study||12
386301|NCT00295061|944421|P2|STARTED|Overall Study||12
386302|NCT00295061|944422|P1|STARTED|Overall Study||12
386303|NCT00295022|944431|P3|NOT COMPLETED|Overall Study||5
386304|NCT00295022|944432|P2|NOT COMPLETED|Overall Study||1
386305|NCT00295022|944433|P1|NOT COMPLETED|Overall Study||1
386306|NCT00295022|944431|P3|COMPLETED|Overall Study||151
386307|NCT00295022|944432|P2|COMPLETED|Overall Study||156
386308|NCT00295022|944433|P1|COMPLETED|Overall Study||104
386309|NCT00295022|944431|P3|STARTED|Overall Study||156
386310|NCT00295022|944432|P2|STARTED|Overall Study||157
386311|NCT00295022|944433|P1|STARTED|Overall Study||105
386312|NCT00295009|944522|P6|NOT COMPLETED|Overall Study||269
386313|NCT00295009|944523|P5|NOT COMPLETED|Overall Study||58
386314|NCT00295009|944524|P4|NOT COMPLETED|Overall Study||25
386315|NCT00295009|944525|P3|NOT COMPLETED|Overall Study||12
386316|NCT00295009|944526|P2|NOT COMPLETED|Overall Study||49
386317|NCT00295009|944527|P1|NOT COMPLETED|Overall Study||41
386318|NCT00295009|944522|P6|COMPLETED|Overall Study|Continued Access patients were only followed out to 24 months|0
386319|NCT00295009|944523|P5|COMPLETED|Overall Study|Completed 60 month visit|116
386320|NCT00295009|944524|P4|COMPLETED|Overall Study|Completed 60 month visit|57
386321|NCT00295009|944525|P3|COMPLETED|Overall Study|Completed 60 month visit|39
386322|NCT00295009|944526|P2|COMPLETED|Overall Study|Completed 60 month visit|134
386323|NCT00295009|944527|P1|COMPLETED|Overall Study|Completed 60 month visit|52
386324|NCT00295009|944522|P6|Completed 24 Month Analysis|Overall Study||198
386325|NCT00295009|944523|P5|Completed 24 Month Analysis|Overall Study||133
386326|NCT00295009|944524|P4|Completed 24 Month Analysis|Overall Study||60
386327|NCT00295009|944525|P3|Completed 24 Month Analysis|Overall Study||45
386328|NCT00295009|944526|P2|Completed 24 Month Analysis|Overall Study||148
386329|NCT00295009|944527|P1|Completed 24 Month Analysis|Overall Study||71
386330|NCT00295009|944522|P6|Treated|Overall Study||259
386331|NCT00295009|944523|P5|Treated|Overall Study||165
386332|NCT00295009|944524|P4|Treated|Overall Study||72
386333|NCT00295009|944525|P3|Treated|Overall Study||50
386334|NCT00295009|944526|P2|Treated|Overall Study||162
386335|NCT00295009|944527|P1|Treated|Overall Study||80
386336|NCT00295009|944522|P6|STARTED|Overall Study||269
386337|NCT00295009|944523|P5|STARTED|Overall Study||174
386338|NCT00295009|944524|P4|STARTED|Overall Study||82
386339|NCT00295009|944525|P3|STARTED|Overall Study||51
386340|NCT00295009|944526|P2|STARTED|Overall Study||183
386341|NCT00295009|944527|P1|STARTED|Overall Study||93
386342|NCT00294762|944549|P2|NOT COMPLETED|Overall Study||3
386343|NCT00294762|944550|P1|NOT COMPLETED|Overall Study||3
386344|NCT00294762|944549|P2|COMPLETED|Overall Study||68
386345|NCT00294762|944550|P1|COMPLETED|Overall Study||69
386346|NCT00294762|944549|P2|STARTED|Overall Study||71
386347|NCT00294762|944550|P1|STARTED|Overall Study||72
386348|NCT00294723|944569|P3|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||20
386349|NCT00294723|944570|P2|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||21
386350|NCT00294723|944571|P1|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||28
386351|NCT00294723|944569|P3|COMPLETED|Additional Open-Label Extension 91 Weeks||8
386352|NCT00294723|944570|P2|COMPLETED|Additional Open-Label Extension 91 Weeks||32
386353|NCT00294723|944571|P1|COMPLETED|Additional Open-Label Extension 91 Weeks||34
386354|NCT00294723|944569|P3|STARTED|Additional Open-Label Extension 91 Weeks|69 subjects did not continue into the extension period|28
386355|NCT00294723|944570|P2|STARTED|Additional Open-Label Extension 91 Weeks|57 subjects did not continue into the extension period|53
386356|NCT00294723|944571|P1|STARTED|Additional Open-Label Extension 91 Weeks|52 subjects did not continue into the extension period|62
386357|NCT00294723|944569|P3|NOT COMPLETED|Open-Label Extension 52 Weeks||40
386358|NCT00294723|944570|P2|NOT COMPLETED|Open-Label Extension 52 Weeks||39
386359|NCT00294723|944571|P1|NOT COMPLETED|Open-Label Extension 52 Weeks||40
386360|NCT00294723|944569|P3|COMPLETED|Open-Label Extension 52 Weeks||97
386361|NCT00294723|944570|P2|COMPLETED|Open-Label Extension 52 Weeks||110
386362|NCT00294723|944571|P1|COMPLETED|Open-Label Extension 52 Weeks||114
386363|NCT00294723|944569|P3|STARTED|Open-Label Extension 52 Weeks|15 subjects did not continue into the extension period|137
386364|NCT00294723|944570|P2|STARTED|Open-Label Extension 52 Weeks|13 subjects did not continue into the extension period|149
386365|NCT00294723|944571|P1|STARTED|Open-Label Extension 52 Weeks|19 subjects did not continue into the extension period|154
386366|NCT00294723|944569|P3|NOT COMPLETED|Double-Blind Period 52 Weeks||96
386367|NCT00294723|944570|P2|NOT COMPLETED|Double-Blind Period 52 Weeks||89
386368|NCT00294723|944571|P1|NOT COMPLETED|Double-Blind Period 52 Weeks||74
386369|NCT00294723|944569|P3|COMPLETED|Double-Blind Period 52 Weeks||152
386370|NCT00294723|944570|P2|COMPLETED|Double-Blind Period 52 Weeks||162
386371|NCT00294723|944571|P1|COMPLETED|Double-Blind Period 52 Weeks||173
386372|NCT00294723|944569|P3|Exposed to Study Drug|Double-Blind Period 52 Weeks||248
386373|NCT00294723|944570|P2|Exposed to Study Drug|Double-Blind Period 52 Weeks||251
386465|NCT00293462|945002|P2|COMPLETED|Overall Study||21
386374|NCT00294723|944571|P1|Exposed to Study Drug|Double-Blind Period 52 Weeks|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|246
386375|NCT00294723|944569|P3|STARTED|Double-Blind Period 52 Weeks|Randomised|248
386376|NCT00294723|944570|P2|STARTED|Double-Blind Period 52 Weeks|Randomised|251
386377|NCT00294723|944571|P1|STARTED|Double-Blind Period 52 Weeks|Randomised|247
386378|NCT00294684|944632|P2|NOT COMPLETED|Overall Study||8
386379|NCT00294684|944633|P1|NOT COMPLETED|Overall Study||5
386380|NCT00294684|944632|P2|COMPLETED|Overall Study||62
386381|NCT00294684|944633|P1|COMPLETED|Overall Study||65
386382|NCT00294684|944632|P2|STARTED|Overall Study||70
386383|NCT00294684|944633|P1|STARTED|Overall Study||70
386384|NCT00294671|944673|P2|NOT COMPLETED|Overall Study||40
386385|NCT00294671|944674|P1|NOT COMPLETED|Overall Study||27
386386|NCT00294671|944673|P2|COMPLETED|Overall Study||26
386387|NCT00294671|944674|P1|COMPLETED|Overall Study||37
386388|NCT00294671|944673|P2|STARTED|Overall Study||66
386389|NCT00294671|944674|P1|STARTED|Overall Study||64
386390|NCT00294658|944690|P2|NOT COMPLETED|Overall Study||9
386391|NCT00294658|944691|P1|NOT COMPLETED|Overall Study||6
386392|NCT00294658|944690|P2|COMPLETED|Overall Study||51
386393|NCT00294658|944691|P1|COMPLETED|Overall Study||60
386394|NCT00294658|944690|P2|STARTED|Overall Study||60
386395|NCT00294658|944691|P1|STARTED|Overall Study||66
386396|NCT00294645|944755|P2|NOT COMPLETED|Overall Study||92
386397|NCT00294645|944756|P1|NOT COMPLETED|Overall Study||48
386398|NCT00294645|944755|P2|COMPLETED|Overall Study||510
386399|NCT00294645|944756|P1|COMPLETED|Overall Study||247
386400|NCT00294645|944755|P2|STARTED|Overall Study||602
386401|NCT00294645|944756|P1|STARTED|Overall Study||295
386402|NCT00294554|944790|P2|NOT COMPLETED|Overall Study||2
386403|NCT00294554|944791|P1|NOT COMPLETED|Overall Study||0
386404|NCT00294554|944790|P2|COMPLETED|Overall Study|"1 S withdrew @ 20 wks for lack perceived benefit~1 S withdrawn @ 13 wks b/o extreme agitation"|8
386405|NCT00294554|944791|P1|COMPLETED|Overall Study||10
386406|NCT00294554|944790|P2|STARTED|Overall Study||10
386407|NCT00294554|944791|P1|STARTED|Overall Study||10
386408|NCT00294515|944801|P2|NOT COMPLETED|Overall Study||28
386409|NCT00294515|944802|P1|NOT COMPLETED|Overall Study||34
386410|NCT00294515|944801|P2|COMPLETED|Overall Study||132
386411|NCT00294515|944802|P1|COMPLETED|Overall Study||132
386412|NCT00294515|944801|P2|STARTED|Overall Study|Randomized|160
386413|NCT00294515|944802|P1|STARTED|Overall Study|Randomized|166
386414|NCT00294398|944818|P2|NOT COMPLETED|Overall Study||26
386415|NCT00294398|944819|P1|NOT COMPLETED|Overall Study||21
386416|NCT00294398|944818|P2|COMPLETED|Overall Study||48
386417|NCT00294398|944819|P1|COMPLETED|Overall Study||57
386418|NCT00294398|944818|P2|STARTED|Overall Study||74
386419|NCT00294398|944819|P1|STARTED|Overall Study||78
386420|NCT00294060|944827|P1|NOT COMPLETED|Overall Study||1173
386421|NCT00294060|944827|P1|COMPLETED|Overall Study||840
386422|NCT00294060|944827|P1|STARTED|Overall Study||2013
386423|NCT00294047|944835|P2|NOT COMPLETED|Month 84||989
386424|NCT00294047|944836|P1|NOT COMPLETED|Month 84||973
386425|NCT00294047|944835|P2|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Aluminium Hydroxide Group = 2116|1881
386426|NCT00294047|944836|P1|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Cervarix Group = 2146|1904
386427|NCT00294047|944835|P2|STARTED|Month 84||2870
386428|NCT00294047|944836|P1|STARTED|Month 84||2877
386429|NCT00294047|944835|P2|NOT COMPLETED|Month 48||433
386430|NCT00294047|944836|P1|NOT COMPLETED|Month 48||425
386431|NCT00294047|944835|P2|COMPLETED|Month 48||2438
386432|NCT00294047|944836|P1|COMPLETED|Month 48||2456
386433|NCT00294047|944835|P2|Participated up to Month 48|Month 48||2281
386434|NCT00294047|944836|P1|Participated up to Month 48|Month 48||2305
386435|NCT00294047|944835|P2|STARTED|Month 48||2871
386436|NCT00294047|944836|P1|STARTED|Month 48||2881
386437|NCT00293813|944941|P3|NOT COMPLETED|Overall Study||8
386438|NCT00293813|944942|P2|NOT COMPLETED|Overall Study||9
386439|NCT00293813|944943|P1|NOT COMPLETED|Overall Study||13
386440|NCT00293813|944941|P3|COMPLETED|Overall Study||74
386441|NCT00293813|944942|P2|COMPLETED|Overall Study||74
386442|NCT00293813|944943|P1|COMPLETED|Overall Study||69
386443|NCT00293813|944941|P3|STARTED|Overall Study||82
386444|NCT00293813|944942|P2|STARTED|Overall Study||83
386445|NCT00293813|944943|P1|STARTED|Overall Study||82
386446|NCT00293722|944954|P1|NOT COMPLETED|Overall Study||427
386447|NCT00293722|944954|P1|COMPLETED|Overall Study||864
386448|NCT00293722|944954|P1|STARTED|Overall Study||1291
386449|NCT00293709|944968|P1|NOT COMPLETED|Overall Study||47
386450|NCT00293709|944968|P1|COMPLETED|Overall Study||102
386451|NCT00293709|944968|P1|STARTED|Overall Study||149
386452|NCT00293579|944982|P1|NOT COMPLETED|Overall Study||1
386453|NCT00293579|944982|P1|COMPLETED|Overall Study||4
386454|NCT00293579|944982|P1|STARTED|Overall Study||5
386455|NCT00293540|944991|P2|NOT COMPLETED|Overall Study||8
386456|NCT00293540|944992|P1|NOT COMPLETED|Overall Study||7
386457|NCT00293540|944991|P2|COMPLETED|Overall Study||119
386458|NCT00293540|944992|P1|COMPLETED|Overall Study||115
386459|NCT00293540|944991|P2|STARTED|Overall Study||127
386460|NCT00293540|944992|P1|STARTED|Overall Study||122
386461|NCT00293462|945001|P3|NOT COMPLETED|Overall Study||10
386462|NCT00293462|945002|P2|NOT COMPLETED|Overall Study||8
386463|NCT00293462|945003|P1|NOT COMPLETED|Overall Study||7
386464|NCT00293462|945001|P3|COMPLETED|Overall Study||21
386466|NCT00293462|945003|P1|COMPLETED|Overall Study||24
386467|NCT00293462|945001|P3|STARTED|Overall Study||31
386468|NCT00293462|945002|P2|STARTED|Overall Study||29
386469|NCT00293462|945003|P1|STARTED|Overall Study||31
386470|NCT00293397|945022|P1|NOT COMPLETED|Overall Study||2
386471|NCT00293397|945022|P1|COMPLETED|Overall Study|1 patient death within 30 days post-TACE - not attributed to TACE procedure|18
386472|NCT00293397|945022|P1|Received First DEB-TACE|Overall Study|1 patient death after baseline inclusion screening and before first treatment|19
386473|NCT00293397|945022|P1|STARTED|Overall Study||20
386474|NCT00293384|945032|P1|NOT COMPLETED|Overall Study||5
386475|NCT00293384|945032|P1|COMPLETED|Overall Study||35
386476|NCT00293384|945032|P1|STARTED|Overall Study||40
386477|NCT00293293|945041|P2|NOT COMPLETED|Overall Study||2
386478|NCT00293293|945042|P1|NOT COMPLETED|Overall Study||2
386479|NCT00293293|945041|P2|COMPLETED|Overall Study||21
386480|NCT00293293|945042|P1|COMPLETED|Overall Study||18
386481|NCT00293293|945041|P2|STARTED|Overall Study||23
386482|NCT00293293|945042|P1|STARTED|Overall Study||20
386483|NCT00293267|945070|P2|NOT COMPLETED|Open-Label Post Virologic Failure Phase||37
386484|NCT00293267|945071|P1|NOT COMPLETED|Open-Label Post Virologic Failure Phase||33
386485|NCT00293267|945070|P2|COMPLETED|Open-Label Post Virologic Failure Phase||29
386486|NCT00293267|945071|P1|COMPLETED|Open-Label Post Virologic Failure Phase||15
386487|NCT00293267|945070|P2|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|66
386488|NCT00293267|945071|P1|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|48
386489|NCT00293267|945070|P2|NOT COMPLETED|Extension - Open-Label Week 157-240||2
386490|NCT00293267|945071|P1|NOT COMPLETED|Extension - Open-Label Week 157-240||20
386491|NCT00293267|945070|P2|COMPLETED|Extension - Open-Label Week 157-240||26
386492|NCT00293267|945071|P1|COMPLETED|Extension - Open-Label Week 157-240||111
386493|NCT00293267|945070|P2|STARTED|Extension - Open-Label Week 157-240|7 of 35 participants who completed the double-blind phase did not enter this open-label phase|28
386494|NCT00293267|945071|P1|STARTED|Extension - Open-Label Week 157-240|8 of 139 participants who completed the double-blind phase did not enter this open-label phase|131
386495|NCT00293267|945070|P2|NOT COMPLETED|Extension - Double-Blind Week 49-156||15
386496|NCT00293267|945071|P1|NOT COMPLETED|Extension - Double-Blind Week 49-156||52
386497|NCT00293267|945070|P2|COMPLETED|Extension - Double-Blind Week 49-156||35
386498|NCT00293267|945071|P1|COMPLETED|Extension - Double-Blind Week 49-156||139
386499|NCT00293267|945070|P2|STARTED|Extension - Double-Blind Week 49-156||50
386500|NCT00293267|945071|P1|STARTED|Extension - Double-Blind Week 49-156|2 participants who completed Week 48 did not enter the extension study|191
386501|NCT00293267|945070|P2|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||68
386502|NCT00293267|945071|P1|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||41
386503|NCT00293267|945070|P2|COMPLETED|Primary Study - Double-Blind Week 0-48||50
386504|NCT00293267|945071|P1|COMPLETED|Primary Study - Double-Blind Week 0-48||193
386505|NCT00293267|945070|P2|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48||50
386506|NCT00293267|945071|P1|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the open-label post virological failure (OLPVF) phase|193
386507|NCT00293267|945070|P2|Treated|Primary Study - Double-Blind Week 0-48||118
386508|NCT00293267|945071|P1|Treated|Primary Study - Double-Blind Week 0-48||232
386509|NCT00293267|945070|P2|STARTED|Primary Study - Double-Blind Week 0-48||118
386510|NCT00293267|945071|P1|STARTED|Primary Study - Double-Blind Week 0-48||234
386511|NCT00293254|945111|P2|NOT COMPLETED|Open-Label Post Virologic Failure Phase||27
386512|NCT00293254|945112|P1|NOT COMPLETED|Open-Label Post Virologic Failure Phase||31
386513|NCT00293254|945111|P2|COMPLETED|Open-Label Post Virologic Failure Phase||37
386514|NCT00293254|945112|P1|COMPLETED|Open-Label Post Virologic Failure Phase||19
386515|NCT00293254|945111|P2|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|64
386516|NCT00293254|945112|P1|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|50
386517|NCT00293254|945111|P2|NOT COMPLETED|Extension - Open-Label Week 157-240||1
386518|NCT00293254|945112|P1|NOT COMPLETED|Extension - Open-Label Week 157-240||10
386519|NCT00293254|945111|P2|COMPLETED|Extension - Open-Label Week 157-240||18
386520|NCT00293254|945112|P1|COMPLETED|Extension - Open-Label Week 157-240||110
386521|NCT00293254|945111|P2|STARTED|Extension - Open-Label Week 157-240|6 of 25 participants who completed the double-blind phase did not enter this open-label phase.|19
386522|NCT00293254|945112|P1|STARTED|Extension - Open-Label Week 157-240||120
386523|NCT00293254|945111|P2|NOT COMPLETED|Extension - Double-Blind Week 49-156||29
386524|NCT00293254|945112|P1|NOT COMPLETED|Extension - Double-Blind Week 49-156||57
386525|NCT00293254|945111|P2|COMPLETED|Extension - Double-Blind Week 49-156||25
386526|NCT00293254|945112|P1|COMPLETED|Extension - Double-Blind Week 49-156||120
386527|NCT00293254|945111|P2|STARTED|Extension - Double-Blind Week 49-156|1 of 55 participants who completed Week 48 did not enter the extension study.|54
386528|NCT00293254|945112|P1|STARTED|Extension - Double-Blind Week 49-156||177
386529|NCT00293254|945111|P2|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||64
386530|NCT00293254|945112|P1|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||55
386531|NCT00293254|945111|P2|COMPLETED|Primary Study - Double-Blind Week 0-48||55
386532|NCT00293254|945112|P1|COMPLETED|Primary Study - Double-Blind Week 0-48||177
386533|NCT00293254|945111|P2|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the OLPVF phase|55
386708|NCT00291694|945709|P2|COMPLETED|Overall Study||43
386534|NCT00293254|945112|P1|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the Open-Label Post-Virologic Failure (OLPVF) Phase|177
386535|NCT00293254|945111|P2|Treated|Primary Study - Double-Blind Week 0-48||119
386536|NCT00293254|945112|P1|Treated|Primary Study - Double-Blind Week 0-48||230
386537|NCT00293254|945111|P2|STARTED|Primary Study - Double-Blind Week 0-48||119
386538|NCT00293254|945112|P1|STARTED|Primary Study - Double-Blind Week 0-48||232
386539|NCT00293241|945152|P2|NOT COMPLETED|Overall Study||41
386540|NCT00293241|945153|P1|NOT COMPLETED|Overall Study||36
386541|NCT00293241|945152|P2|COMPLETED|Overall Study||265
386542|NCT00293241|945153|P1|COMPLETED|Overall Study||263
386543|NCT00293241|945152|P2|STARTED|Overall Study||306
386544|NCT00293241|945153|P1|STARTED|Overall Study||299
386545|NCT00293059|945197|P2|NOT COMPLETED|Overall Study||19
386546|NCT00293059|945198|P1|NOT COMPLETED|Overall Study||35
386547|NCT00293059|945197|P2|COMPLETED|Overall Study||51
386548|NCT00293059|945198|P1|COMPLETED|Overall Study||85
386549|NCT00293059|945197|P2|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|62
386550|NCT00293059|945198|P1|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|113
386551|NCT00293059|945197|P2|Cycle 3/Treatment Day 84|Overall Study||55
386552|NCT00293059|945198|P1|Cycle 3/Treatment Day 84|Overall Study||100
386553|NCT00293059|945197|P2|Cycle 1/Treatment Day 28|Overall Study||64
386554|NCT00293059|945198|P1|Cycle 1/Treatment Day 28|Overall Study||115
386555|NCT00293059|945197|P2|Subjects Received Treatment|Overall Study||66
386556|NCT00293059|945198|P1|Subjects Received Treatment|Overall Study||119
386557|NCT00293059|945197|P2|STARTED|Overall Study||70
386558|NCT00293059|945198|P1|STARTED|Overall Study||120
386559|NCT00293033|945310|P1|NOT COMPLETED|Double-blind Treatment Period||12
386560|NCT00293033|945310|P1|COMPLETED|Double-blind Treatment Period||70
386561|NCT00293033|945310|P1|STARTED|Double-blind Treatment Period|82 randomized; 1 didn't take double-blind drug; 1 didn't report a pain assessment within 30 minutes|82
386562|NCT00293033|945310|P1|NOT COMPLETED|Open-label Titration Period||69
386563|NCT00293033|945310|P1|COMPLETED|Open-label Titration Period||82
386564|NCT00293033|945310|P1|STARTED|Open-label Titration Period|152 subjects enrolled; 151 subjects received at least one dose of study drug|151
386565|NCT00293020|945413|P1|NOT COMPLETED|Overall Study||162
386566|NCT00293020|945413|P1|COMPLETED|Overall Study||82
386567|NCT00293020|945413|P1|STARTED|Overall Study||244
386568|NCT00292981|945417|P1|NOT COMPLETED|Overall Study||39
386569|NCT00292981|945417|P1|COMPLETED|Overall Study||18
386570|NCT00292981|945417|P1|STARTED|Overall Study||57
386571|NCT00292942|945428|P4|NOT COMPLETED|Overall Study||1
386572|NCT00292942|945429|P3|NOT COMPLETED|Overall Study||1
386573|NCT00292942|945430|P2|NOT COMPLETED|Overall Study||0
386574|NCT00292942|945431|P1|NOT COMPLETED|Overall Study||0
386575|NCT00292942|945428|P4|COMPLETED|Overall Study||6
386576|NCT00292942|945429|P3|COMPLETED|Overall Study||6
386577|NCT00292942|945430|P2|COMPLETED|Overall Study||6
386578|NCT00292942|945431|P1|COMPLETED|Overall Study||6
386579|NCT00292942|945428|P4|STARTED|Overall Study||7
386580|NCT00292942|945429|P3|STARTED|Overall Study||7
386581|NCT00292942|945430|P2|STARTED|Overall Study||6
386582|NCT00292942|945431|P1|STARTED|Overall Study||6
386583|NCT00292591|945465|P3|NOT COMPLETED|Overall Study||58
386584|NCT00292591|945466|P2|NOT COMPLETED|Overall Study||56
386585|NCT00292591|945467|P1|NOT COMPLETED|Overall Study||64
386586|NCT00292591|945465|P3|COMPLETED|Overall Study||110
386587|NCT00292591|945466|P2|COMPLETED|Overall Study||111
386588|NCT00292591|945467|P1|COMPLETED|Overall Study||102
386589|NCT00292591|945465|P3|STARTED|Overall Study||168
386590|NCT00292591|945466|P2|STARTED|Overall Study||167
386591|NCT00292591|945467|P1|STARTED|Overall Study||166
386592|NCT00292461|945477|P2|NOT COMPLETED|Overall Study||6
386593|NCT00292461|945478|P1|NOT COMPLETED|Overall Study||10
386594|NCT00292461|945477|P2|COMPLETED|Overall Study||24
386595|NCT00292461|945478|P1|COMPLETED|Overall Study||24
386596|NCT00292461|945477|P2|STARTED|Overall Study||30
386597|NCT00292461|945478|P1|STARTED|Overall Study||34
386598|NCT00292370|945493|P3|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||7
386599|NCT00292370|945494|P2|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||4
386600|NCT00292370|945495|P1|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
386601|NCT00292370|945493|P3|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||18
386602|NCT00292370|945494|P2|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||21
386603|NCT00292370|945495|P1|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
386604|NCT00292370|945493|P3|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
386605|NCT00292370|945494|P2|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
386606|NCT00292370|945495|P1|STARTED|Phase II: OLP + DB Quetiapine or Placebo|"78 Completed Ph I~28 Excluded Ph II:~20 responded~7 declined~1 medical~50 to Arm 2 & 3"|0
386607|NCT00292370|945493|P3|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
386608|NCT00292370|945494|P2|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
386609|NCT00292370|945495|P1|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||46
386610|NCT00292370|945493|P3|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
386611|NCT00292370|945494|P2|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
386612|NCT00292370|945495|P1|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||78
386613|NCT00292370|945493|P3|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
386614|NCT00292370|945494|P2|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
386615|NCT00292370|945495|P1|STARTED|Phase I - Open-Label Paroxetine (OLP)||124
386616|NCT00292318|945520|P2|NOT COMPLETED|Overall Study||1
386617|NCT00292318|945521|P1|NOT COMPLETED|Overall Study||2
386618|NCT00292318|945520|P2|COMPLETED|Overall Study||2
386619|NCT00292318|945521|P1|COMPLETED|Overall Study||2
386620|NCT00292318|945520|P2|STARTED|Overall Study||3
386621|NCT00292318|945521|P1|STARTED|Overall Study||4
386622|NCT00292227|945531|P3|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
386623|NCT00292227|945532|P2|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
386624|NCT00292227|945533|P1|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
386625|NCT00292227|945531|P3|COMPLETED|Cross-over Period 2 (Day 39)||30
386626|NCT00292227|945532|P2|COMPLETED|Cross-over Period 2 (Day 39)||31
386627|NCT00292227|945533|P1|COMPLETED|Cross-over Period 2 (Day 39)||65
386628|NCT00292227|945531|P3|STARTED|Cross-over Period 2 (Day 39)||30
386629|NCT00292227|945532|P2|STARTED|Cross-over Period 2 (Day 39)||31
386630|NCT00292227|945533|P1|STARTED|Cross-over Period 2 (Day 39)||65
386631|NCT00292227|945531|P3|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
386632|NCT00292227|945532|P2|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
386633|NCT00292227|945533|P1|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
386634|NCT00292227|945531|P3|COMPLETED|Cross-over Period 1 (Day 32)||30
386635|NCT00292227|945532|P2|COMPLETED|Cross-over Period 1 (Day 32)||31
386636|NCT00292227|945533|P1|COMPLETED|Cross-over Period 1 (Day 32)||65
386637|NCT00292227|945531|P3|STARTED|Cross-over Period 1 (Day 32)||30
386638|NCT00292227|945532|P2|STARTED|Cross-over Period 1 (Day 32)||31
386639|NCT00292227|945533|P1|STARTED|Cross-over Period 1 (Day 32)||65
386640|NCT00292227|945531|P3|NOT COMPLETED|Patch Period||3
386641|NCT00292227|945532|P2|NOT COMPLETED|Patch Period||0
386642|NCT00292227|945533|P1|NOT COMPLETED|Patch Period||1
386643|NCT00292227|945531|P3|COMPLETED|Patch Period||30
386644|NCT00292227|945532|P2|COMPLETED|Patch Period||31
386645|NCT00292227|945533|P1|COMPLETED|Patch Period||65
386646|NCT00292227|945531|P3|STARTED|Patch Period||33
386647|NCT00292227|945532|P2|STARTED|Patch Period||31
386648|NCT00292227|945533|P1|STARTED|Patch Period||66
386649|NCT00292188|945615|P3|NOT COMPLETED|Double-Blind||29
386650|NCT00292188|945616|P2|NOT COMPLETED|Double-Blind||31
386651|NCT00292188|945617|P1|NOT COMPLETED|Double-Blind||0
386652|NCT00292188|945615|P3|COMPLETED|Double-Blind||98
386653|NCT00292188|945616|P2|COMPLETED|Double-Blind||96
386654|NCT00292188|945617|P1|COMPLETED|Double-Blind||0
386655|NCT00292188|945615|P3|STARTED|Double-Blind||127
386656|NCT00292188|945616|P2|STARTED|Double-Blind||127
386657|NCT00292188|945617|P1|STARTED|Double-Blind||0
386658|NCT00292188|945615|P3|NOT COMPLETED|Single-Blind||0
386659|NCT00292188|945616|P2|NOT COMPLETED|Single-Blind||0
386660|NCT00292188|945617|P1|NOT COMPLETED|Single-Blind||114
386661|NCT00292188|945615|P3|COMPLETED|Single-Blind||0
386662|NCT00292188|945616|P2|COMPLETED|Single-Blind||0
386663|NCT00292188|945617|P1|COMPLETED|Single-Blind||254
386664|NCT00292188|945615|P3|Received Treatment|Single-Blind||0
386665|NCT00292188|945616|P2|Received Treatment|Single-Blind||0
386666|NCT00292188|945617|P1|Received Treatment|Single-Blind||367
386667|NCT00292188|945615|P3|STARTED|Single-Blind||0
386668|NCT00292188|945616|P2|STARTED|Single-Blind||0
386669|NCT00292188|945617|P1|STARTED|Single-Blind||368
386670|NCT00292162|945678|P2|NOT COMPLETED|Overall Study||2
386671|NCT00292162|945679|P1|NOT COMPLETED|Overall Study||1
386672|NCT00292162|945678|P2|COMPLETED|Overall Study||20
386673|NCT00292162|945679|P1|COMPLETED|Overall Study||18
386674|NCT00292162|945678|P2|STARTED|Overall Study||22
386675|NCT00292162|945679|P1|STARTED|Overall Study||19
386676|NCT00291876|945695|P1|NOT COMPLETED|Month 246||0
386677|NCT00291876|945695|P1|COMPLETED|Month 246||116
386678|NCT00291876|945695|P1|STARTED|Month 246||116
386679|NCT00291876|945695|P1|NOT COMPLETED|Month 234||0
386680|NCT00291876|945695|P1|COMPLETED|Month 234||110
386681|NCT00291876|945695|P1|STARTED|Month 234||110
386682|NCT00291876|945695|P1|NOT COMPLETED|Month 222||0
386683|NCT00291876|945695|P1|COMPLETED|Month 222||114
386684|NCT00291876|945695|P1|STARTED|Month 222||114
386685|NCT00291876|945695|P1|NOT COMPLETED|Month 210||0
386686|NCT00291876|945695|P1|COMPLETED|Month 210||124
386687|NCT00291876|945695|P1|STARTED|Month 210||124
386688|NCT00291876|945695|P1|NOT COMPLETED|Month 198||0
386689|NCT00291876|945695|P1|COMPLETED|Month 198||135
386690|NCT00291876|945695|P1|STARTED|Month 198||135
386691|NCT00291876|945695|P1|NOT COMPLETED|Month 186||0
386692|NCT00291876|945695|P1|COMPLETED|Month 186||129
386693|NCT00291876|945695|P1|STARTED|Month 186||129
386694|NCT00291876|945695|P1|NOT COMPLETED|Month 174||0
386695|NCT00291876|945695|P1|COMPLETED|Month 174||127
386696|NCT00291876|945695|P1|STARTED|Month 174||127
386697|NCT00291876|945695|P1|NOT COMPLETED|Month 162||0
386698|NCT00291876|945695|P1|COMPLETED|Month 162||127
386699|NCT00291876|945695|P1|STARTED|Month 162||127
386700|NCT00291876|945695|P1|NOT COMPLETED|Month 150||0
386701|NCT00291876|945695|P1|COMPLETED|Month 150||117
386702|NCT00291876|945695|P1|STARTED|Month 150||117
386703|NCT00291876|945695|P1|NOT COMPLETED|Month 138||0
386704|NCT00291876|945695|P1|COMPLETED|Month 138||107
386705|NCT00291876|945695|P1|STARTED|Month 138||107
386706|NCT00291694|945709|P2|NOT COMPLETED|Overall Study||5
386707|NCT00291694|945710|P1|NOT COMPLETED|Overall Study||3
386709|NCT00291694|945710|P1|COMPLETED|Overall Study||21
386710|NCT00291694|945709|P2|STARTED|Overall Study||48
386711|NCT00291694|945710|P1|STARTED|Overall Study||24
386712|NCT00291655|945724|P1|NOT COMPLETED|Overall Study||15
386713|NCT00291655|945724|P1|COMPLETED|Overall Study||115
386714|NCT00291655|945724|P1|STARTED|Overall Study||130
386715|NCT00291642|945734|P5|NOT COMPLETED|Overall Study||1
386716|NCT00291642|945735|P4|NOT COMPLETED|Overall Study||0
386717|NCT00291642|945736|P3|NOT COMPLETED|Overall Study||2
386718|NCT00291642|945737|P2|NOT COMPLETED|Overall Study||0
386719|NCT00291642|945738|P1|NOT COMPLETED|Overall Study||2
386720|NCT00291642|945734|P5|COMPLETED|Overall Study||118
386721|NCT00291642|945735|P4|COMPLETED|Overall Study||119
386722|NCT00291642|945736|P3|COMPLETED|Overall Study||117
386723|NCT00291642|945737|P2|COMPLETED|Overall Study||116
386724|NCT00291642|945738|P1|COMPLETED|Overall Study||76
386725|NCT00291642|945734|P5|STARTED|Overall Study||119
386726|NCT00291642|945735|P4|STARTED|Overall Study||119
386727|NCT00291642|945736|P3|STARTED|Overall Study||119
386728|NCT00291642|945737|P2|STARTED|Overall Study||116
386729|NCT00291642|945738|P1|STARTED|Overall Study||78
386730|NCT00291577|945790|P1|NOT COMPLETED|Overall Study||21
386731|NCT00291577|945790|P1|COMPLETED|Overall Study|Subject End of Study=Completed; not per protocol reason. PI reason=withdrawn during active treatment|1
386732|NCT00291577|945790|P1|STARTED|Overall Study||22
386733|NCT00291551|945809|P1|NOT COMPLETED|Overall Study||13
386734|NCT00291551|945809|P1|COMPLETED|Overall Study||26
386735|NCT00291551|945809|P1|STARTED|Overall Study||39
386736|NCT00291343|945826|P2|NOT COMPLETED|Overall Study||0
386737|NCT00291343|945827|P1|NOT COMPLETED|Overall Study||0
386738|NCT00291343|945826|P2|COMPLETED|Overall Study||93
386739|NCT00291343|945827|P1|COMPLETED|Overall Study||203
386740|NCT00291343|945826|P2|STARTED|Overall Study||93
386741|NCT00291343|945827|P1|STARTED|Overall Study||203
386742|NCT00291330|945857|P2|NOT COMPLETED|Overall Study||97
386743|NCT00291330|945858|P1|NOT COMPLETED|Overall Study||101
386744|NCT00291330|945857|P2|COMPLETED|Overall Study|Completed planned observation time|1169
386745|NCT00291330|945858|P1|COMPLETED|Overall Study|Completed planned observation time|1172
386746|NCT00291330|945857|P2|STARTED|Overall Study|Started Treatment|1266
386747|NCT00291330|945858|P1|STARTED|Overall Study|Started Treatment|1273
386748|NCT00291317|945880|P1|NOT COMPLETED|Overall Study||0
386749|NCT00291317|945880|P1|COMPLETED|Overall Study||6
386750|NCT00291317|945880|P1|STARTED|Overall Study||6
386751|NCT00291226|945887|P2|NOT COMPLETED|Overall Study||1
386752|NCT00291226|945888|P1|NOT COMPLETED|Overall Study||1
386753|NCT00291226|945887|P2|COMPLETED|Overall Study||3
386754|NCT00291226|945888|P1|COMPLETED|Overall Study||3
386755|NCT00291226|945887|P2|STARTED|Overall Study||4
386756|NCT00291226|945888|P1|STARTED|Overall Study||4
386757|NCT00291187|945900|P4|NOT COMPLETED|Overall Study||0
386758|NCT00291187|945901|P3|NOT COMPLETED|Overall Study||1
386759|NCT00291187|945902|P2|NOT COMPLETED|Overall Study||0
386760|NCT00291187|945903|P1|NOT COMPLETED|Overall Study||0
386761|NCT00291187|945900|P4|COMPLETED|Overall Study||106
386762|NCT00291187|945901|P3|COMPLETED|Overall Study||102
386763|NCT00291187|945902|P2|COMPLETED|Overall Study||100
386764|NCT00291187|945903|P1|COMPLETED|Overall Study||103
386765|NCT00291187|945900|P4|STARTED|Overall Study||106
386766|NCT00291187|945901|P3|STARTED|Overall Study||103
386767|NCT00291187|945902|P2|STARTED|Overall Study||100
386768|NCT00291187|945903|P1|STARTED|Overall Study||103
386769|NCT00291161|945929|P4|NOT COMPLETED|Overall Study||65
386770|NCT00291161|945930|P3|NOT COMPLETED|Overall Study||93
386771|NCT00291161|945931|P2|NOT COMPLETED|Overall Study||58
386772|NCT00291161|945932|P1|NOT COMPLETED|Overall Study||81
386773|NCT00291161|945929|P4|COMPLETED|Overall Study||122
386774|NCT00291161|945930|P3|COMPLETED|Overall Study||206
386775|NCT00291161|945931|P2|COMPLETED|Overall Study||134
386776|NCT00291161|945932|P1|COMPLETED|Overall Study||235
386777|NCT00291161|945929|P4|STARTED|Overall Study||187
386778|NCT00291161|945930|P3|STARTED|Overall Study||299
386779|NCT00291161|945931|P2|STARTED|Overall Study||192
386780|NCT00291161|945932|P1|STARTED|Overall Study||316
386781|NCT00291135|945940|P1|NOT COMPLETED|Overall Study||0
386782|NCT00291135|945940|P1|COMPLETED|Overall Study||42
386783|NCT00291135|945940|P1|STARTED|Overall Study||42
386784|NCT00291018|945947|P3|NOT COMPLETED|Overall Study||43
386785|NCT00291018|945948|P2|NOT COMPLETED|Overall Study||42
386786|NCT00291018|945949|P1|NOT COMPLETED|Overall Study||25
386787|NCT00291018|945947|P3|COMPLETED|Overall Study|Evaluated at 84 Months|93
386788|NCT00291018|945948|P2|COMPLETED|Overall Study|Evaluated at 84 Months|64
386789|NCT00291018|945949|P1|COMPLETED|Overall Study|Evaluated at 84 Months|78
386790|NCT00291018|945947|P3|Evaluated at 24 Months|Overall Study||105
386791|NCT00291018|945948|P2|Evaluated at 24 Months|Overall Study||92
386792|NCT00291018|945949|P1|Evaluated at 24 Months|Overall Study||99
386793|NCT00291018|945947|P3|STARTED|Overall Study|Enrolled and Treated. 140 PDC-CA subjects were Enrolled but only 136 were Treated.|136
386794|NCT00291018|945948|P2|STARTED|Overall Study|Enrolled and Treated. 117 ACDF subjects were Enrolled but only 106 were Treated.|106
386795|NCT00291018|945949|P1|STARTED|Overall Study|Enrolled and Treated. 111 PDC subjects were Enrolled but only 103 were Treated.|103
386796|NCT00290888|945989|P2|NOT COMPLETED|Overall Study||1
386797|NCT00290888|945990|P1|NOT COMPLETED|Overall Study||3
386798|NCT00290888|945989|P2|COMPLETED|Overall Study||44
386799|NCT00290888|945990|P1|COMPLETED|Overall Study||38
386800|NCT00290888|945989|P2|STARTED|Overall Study||45
386801|NCT00290888|945990|P1|STARTED|Overall Study||41
386802|NCT00290810|945998|P1|NOT COMPLETED|Overall Study||0
386803|NCT00290810|945998|P1|COMPLETED|Overall Study||12
386804|NCT00290810|945998|P1|STARTED|Overall Study||12
386805|NCT00290771|946007|P2|NOT COMPLETED|Overall Study||97
386806|NCT00290771|946008|P1|NOT COMPLETED|Overall Study||127
386807|NCT00290771|946007|P2|COMPLETED|Overall Study||3
386808|NCT00290771|946008|P1|COMPLETED|Overall Study||4
386809|NCT00290771|946007|P2|STARTED|Overall Study||100
386810|NCT00290771|946008|P1|STARTED|Overall Study||131
386811|NCT00290758|946032|P2|NOT COMPLETED|Post Intervention rFNA||5
386812|NCT00290758|946033|P1|NOT COMPLETED|Post Intervention rFNA||6
386813|NCT00290758|946032|P2|COMPLETED|Post Intervention rFNA||49
386814|NCT00290758|946033|P1|COMPLETED|Post Intervention rFNA||49
386815|NCT00290758|946032|P2|STARTED|Post Intervention rFNA||54
386816|NCT00290758|946033|P1|STARTED|Post Intervention rFNA||55
386817|NCT00290758|946032|P2|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||10
386818|NCT00290758|946033|P1|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||7
386819|NCT00290758|946032|P2|COMPLETED|Pre-Intervention rFNA Through Follow-Up||54
386820|NCT00290758|946033|P1|COMPLETED|Pre-Intervention rFNA Through Follow-Up||55
386821|NCT00290758|946032|P2|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||54
386822|NCT00290758|946033|P1|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||55
386823|NCT00290758|946032|P2|Treatment|Pre-Intervention rFNA Through Follow-Up||64
386824|NCT00290758|946033|P1|Treatment|Pre-Intervention rFNA Through Follow-Up||61
386825|NCT00290758|946032|P2|Randomization|Pre-Intervention rFNA Through Follow-Up||62
386826|NCT00290758|946033|P1|Randomization|Pre-Intervention rFNA Through Follow-Up||62
386827|NCT00290758|946032|P2|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||64
386828|NCT00290758|946033|P1|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||62
386829|NCT00290758|946032|P2|STARTED|Pre-Intervention rFNA Through Follow-Up||64
386830|NCT00290758|946033|P1|STARTED|Pre-Intervention rFNA Through Follow-Up||62
386831|NCT00290732|946055|P5|NOT COMPLETED|Overall Study||0
386832|NCT00290732|946056|P4|NOT COMPLETED|Overall Study||0
386833|NCT00290732|946057|P3|NOT COMPLETED|Overall Study||1
386834|NCT00290732|946058|P2|NOT COMPLETED|Overall Study||1
386835|NCT00290732|946059|P1|NOT COMPLETED|Overall Study||0
386836|NCT00290732|946055|P5|COMPLETED|Overall Study||3
386837|NCT00290732|946056|P4|COMPLETED|Overall Study||6
386838|NCT00290732|946057|P3|COMPLETED|Overall Study||3
386839|NCT00290732|946058|P2|COMPLETED|Overall Study||3
386840|NCT00290732|946059|P1|COMPLETED|Overall Study||3
386841|NCT00290732|946055|P5|STARTED|Overall Study||3
386842|NCT00290732|946056|P4|STARTED|Overall Study||6
386843|NCT00290732|946057|P3|STARTED|Overall Study||4
386844|NCT00290732|946058|P2|STARTED|Overall Study||4
386845|NCT00290732|946059|P1|STARTED|Overall Study||3
386846|NCT00290706|946081|P4|NOT COMPLETED|Overall Study||12
386847|NCT00290706|946082|P3|NOT COMPLETED|Overall Study||6
386848|NCT00290706|946083|P2|NOT COMPLETED|Overall Study||6
386849|NCT00290706|946084|P1|NOT COMPLETED|Overall Study||5
386850|NCT00290706|946081|P4|COMPLETED|Overall Study||2
386851|NCT00290706|946082|P3|COMPLETED|Overall Study||1
386852|NCT00290706|946083|P2|COMPLETED|Overall Study||0
386853|NCT00290706|946084|P1|COMPLETED|Overall Study||0
386854|NCT00290706|946081|P4|Reached 1st Response/Cycle 3|Overall Study||2
386855|NCT00290706|946082|P3|Reached 1st Response/Cycle 3|Overall Study||1
386856|NCT00290706|946083|P2|Reached 1st Response/Cycle 3|Overall Study||0
386857|NCT00290706|946084|P1|Reached 1st Response/Cycle 3|Overall Study||0
386858|NCT00290706|946081|P4|Attempted1st Cycle|Overall Study||14
386859|NCT00290706|946082|P3|Attempted1st Cycle|Overall Study||7
386860|NCT00290706|946083|P2|Attempted1st Cycle|Overall Study||6
386861|NCT00290706|946084|P1|Attempted1st Cycle|Overall Study||5
386862|NCT00290706|946081|P4|STARTED|Overall Study||14
386863|NCT00290706|946082|P3|STARTED|Overall Study||7
386864|NCT00290706|946083|P2|STARTED|Overall Study||6
386865|NCT00290706|946084|P1|STARTED|Overall Study||5
386866|NCT00290693|946103|P1|NOT COMPLETED|Overall Study||2
386867|NCT00290693|946103|P1|COMPLETED|Overall Study||43
386868|NCT00290693|946103|P1|STARTED|Overall Study||45
386869|NCT00290654|946111|P1|NOT COMPLETED|Overall Study||0
386870|NCT00290654|946111|P1|COMPLETED|Overall Study||41
386871|NCT00290654|946111|P1|STARTED|Overall Study||41
386872|NCT00290615|946122|P1|NOT COMPLETED|Overall Study||0
386873|NCT00290615|946122|P1|COMPLETED|Overall Study||30
386874|NCT00290615|946122|P1|STARTED|Overall Study||30
386875|NCT00290589|946131|P2|NOT COMPLETED|Overall Study||2
386876|NCT00290589|946132|P1|NOT COMPLETED|Overall Study||2
386877|NCT00290589|946131|P2|COMPLETED|Overall Study||41
386878|NCT00290589|946132|P1|COMPLETED|Overall Study||37
386879|NCT00290589|946131|P2|STARTED|Overall Study||43
386880|NCT00290589|946132|P1|STARTED|Overall Study||39
386881|NCT00290537|946142|P2|NOT COMPLETED|Overall Study||0
386882|NCT00290537|946143|P1|NOT COMPLETED|Overall Study||0
386883|NCT00290537|946142|P2|COMPLETED|Overall Study||0
386884|NCT00290537|946143|P1|COMPLETED|Overall Study||4
386885|NCT00290537|946142|P2|STARTED|Overall Study||0
386886|NCT00290537|946143|P1|STARTED|Overall Study||4
386887|NCT00290472|946151|P3|NOT COMPLETED|Overall Study||0
386888|NCT00290472|946152|P2|NOT COMPLETED|Overall Study||0
386889|NCT00290472|946153|P1|NOT COMPLETED|Overall Study||0
386890|NCT00290472|946151|P3|COMPLETED|Overall Study||18
386891|NCT00290472|946152|P2|COMPLETED|Overall Study||39
386892|NCT00290472|946153|P1|COMPLETED|Overall Study||32
386893|NCT00290472|946151|P3|STARTED|Overall Study||18
386894|NCT00290472|946152|P2|STARTED|Overall Study||39
386895|NCT00290472|946153|P1|STARTED|Overall Study||32
386896|NCT00290407|946165|P1|NOT COMPLETED|Overall Study||2
386897|NCT00290407|946165|P1|COMPLETED|Overall Study||0
386898|NCT00290407|946165|P1|STARTED|Overall Study||2
386899|NCT00290355|946172|P2|NOT COMPLETED|Overall Study||5
386900|NCT00290355|946173|P1|NOT COMPLETED|Overall Study||17
386901|NCT00290355|946172|P2|COMPLETED|Overall Study||55
386902|NCT00290355|946173|P1|COMPLETED|Overall Study||105
386903|NCT00290355|946172|P2|STARTED|Overall Study||60
386904|NCT00290355|946173|P1|STARTED|Overall Study||122
386905|NCT00290342|946217|P2|NOT COMPLETED|Overall Study||5
386906|NCT00290342|946218|P1|NOT COMPLETED|Overall Study||7
386907|NCT00290342|946217|P2|COMPLETED|Overall Study||223
386908|NCT00290342|946218|P1|COMPLETED|Overall Study||217
386909|NCT00290342|946217|P2|STARTED|Overall Study||228
386910|NCT00290342|946218|P1|STARTED|Overall Study||224
386911|NCT00290329|946249|P3|NOT COMPLETED|Overall Study||0
386912|NCT00290329|946250|P2|NOT COMPLETED|Overall Study||0
386913|NCT00290329|946251|P1|NOT COMPLETED|Overall Study||0
386914|NCT00290329|946249|P3|COMPLETED|Overall Study||61
386915|NCT00290329|946250|P2|COMPLETED|Overall Study||86
386916|NCT00290329|946251|P1|COMPLETED|Overall Study||102
386917|NCT00290329|946249|P3|STARTED|Overall Study||61
386918|NCT00290329|946250|P2|STARTED|Overall Study||86
386919|NCT00290329|946251|P1|STARTED|Overall Study||102
386920|NCT00290290|946273|P2|NOT COMPLETED|Overall Study||18
386921|NCT00290290|946274|P1|NOT COMPLETED|Overall Study||18
386922|NCT00290290|946273|P2|COMPLETED|Overall Study||391
386923|NCT00290290|946274|P1|COMPLETED|Overall Study||422
386924|NCT00290290|946273|P2|STARTED|Overall Study||409
386925|NCT00290290|946274|P1|STARTED|Overall Study||440
386926|NCT00290251|946280|P3|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
386927|NCT00290251|946281|P2|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
386928|NCT00290251|946282|P1|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
386929|NCT00290251|946280|P3|COMPLETED|Elective Extension (to 12 Months no Rx)||5
386930|NCT00290251|946281|P2|COMPLETED|Elective Extension (to 12 Months no Rx)||3
386931|NCT00290251|946282|P1|COMPLETED|Elective Extension (to 12 Months no Rx)||5
386932|NCT00290251|946280|P3|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|5
386933|NCT00290251|946281|P2|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|3
386934|NCT00290251|946282|P1|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|5
386935|NCT00290251|946280|P3|NOT COMPLETED|Treatment 2 (Months 4 - 6)||0
386936|NCT00290251|946281|P2|NOT COMPLETED|Treatment 2 (Months 4 - 6)||0
386937|NCT00290251|946282|P1|NOT COMPLETED|Treatment 2 (Months 4 - 6)||2
386938|NCT00290251|946280|P3|COMPLETED|Treatment 2 (Months 4 - 6)||0
386939|NCT00290251|946281|P2|COMPLETED|Treatment 2 (Months 4 - 6)||5
386940|NCT00290251|946282|P1|COMPLETED|Treatment 2 (Months 4 - 6)||6
386941|NCT00290251|946280|P3|STARTED|Treatment 2 (Months 4 - 6)|Women were randomized from PLC to ulipristal acetate or continued same dose ulipristal acetate|0
386942|NCT00290251|946281|P2|STARTED|Treatment 2 (Months 4 - 6)|2 crossed over from placebo; others in treatment 1 PLC or ulipristal acetate 10 grp did not continue|5
386943|NCT00290251|946282|P1|STARTED|Treatment 2 (Months 4 - 6)|2 crossed over from placebo; others in treatment 1 PLC or ulipristal acetate 20 did not continue|8
386944|NCT00290251|946280|P3|NOT COMPLETED|Treatment 1 (Months 1 - 3)||2
386945|NCT00290251|946281|P2|NOT COMPLETED|Treatment 1 (Months 1 - 3)||1
386946|NCT00290251|946282|P1|NOT COMPLETED|Treatment 1 (Months 1 - 3)||1
386947|NCT00290251|946280|P3|COMPLETED|Treatment 1 (Months 1 - 3)||12
386948|NCT00290251|946281|P2|COMPLETED|Treatment 1 (Months 1 - 3)||13
386949|NCT00290251|946282|P1|COMPLETED|Treatment 1 (Months 1 - 3)||13
386950|NCT00290251|946280|P3|STARTED|Treatment 1 (Months 1 - 3)||14
386951|NCT00290251|946281|P2|STARTED|Treatment 1 (Months 1 - 3)||14
386952|NCT00290251|946282|P1|STARTED|Treatment 1 (Months 1 - 3)||14
386953|NCT00290238|946294|P2|NOT COMPLETED|Overall Study||41
386954|NCT00290238|946295|P1|NOT COMPLETED|Overall Study||42
386955|NCT00290238|946294|P2|COMPLETED|Overall Study||24
386956|NCT00290238|946295|P1|COMPLETED|Overall Study||15
386957|NCT00290238|946294|P2|STARTED|Overall Study|One subject had an invalid birth date and was excluded from the Age Categorical counts.|65
386958|NCT00290238|946295|P1|STARTED|Overall Study||57
386959|NCT00290199|946305|P2|NOT COMPLETED|Overall Study||0
386960|NCT00290199|946306|P1|NOT COMPLETED|Overall Study||0
386961|NCT00290199|946305|P2|COMPLETED|Overall Study||82
386962|NCT00290199|946306|P1|COMPLETED|Overall Study||87
386963|NCT00290199|946305|P2|STARTED|Overall Study||82
386964|NCT00290199|946306|P1|STARTED|Overall Study||87
386965|NCT00290186|946320|P2|NOT COMPLETED|Overall Study||5
386966|NCT00290186|946321|P1|NOT COMPLETED|Overall Study||5
386967|NCT00290186|946320|P2|COMPLETED|Overall Study||19
386968|NCT00290186|946321|P1|COMPLETED|Overall Study||20
386969|NCT00290186|946320|P2|Completed 6-month Followup Assessments|Overall Study||19
386970|NCT00290186|946321|P1|Completed 6-month Followup Assessments|Overall Study||20
386971|NCT00290186|946320|P2|Completed 3-month Followup Assessments|Overall Study||21
386972|NCT00290186|946321|P1|Completed 3-month Followup Assessments|Overall Study||20
386973|NCT00290186|946320|P2|Completed Post-treatment Assessments|Overall Study||22
386974|NCT00290186|946321|P1|Completed Post-treatment Assessments|Overall Study||24
386975|NCT00290186|946320|P2|Completed 8 Weeks of Treatment|Overall Study||22
386976|NCT00290186|946321|P1|Completed 8 Weeks of Treatment|Overall Study||24
386977|NCT00290186|946320|P2|Completed Baseline Assessments|Overall Study||24
386978|NCT00290186|946321|P1|Completed Baseline Assessments|Overall Study||25
386979|NCT00290186|946320|P2|STARTED|Overall Study||24
386980|NCT00290186|946321|P1|STARTED|Overall Study||25
386981|NCT00290147|946361|P2|NOT COMPLETED|Overall Study||0
386982|NCT00290147|946362|P1|NOT COMPLETED|Overall Study||0
386983|NCT00290147|946361|P2|COMPLETED|Overall Study||12
386984|NCT00290147|946362|P1|COMPLETED|Overall Study||10
386985|NCT00290147|946361|P2|STARTED|Overall Study||12
386986|NCT00290147|946362|P1|STARTED|Overall Study||10
386987|NCT00289991|946372|P2|NOT COMPLETED|Overall Study||80
386988|NCT00289991|946373|P1|NOT COMPLETED|Overall Study||58
386989|NCT00289991|946372|P2|COMPLETED|Overall Study||175
386990|NCT00289991|946373|P1|COMPLETED|Overall Study||176
386991|NCT00289991|946372|P2|STARTED|Overall Study||255
386992|NCT00289991|946373|P1|STARTED|Overall Study||234
386993|NCT00289978|946398|P3|NOT COMPLETED|Overall Study||86
386994|NCT00289978|946399|P2|NOT COMPLETED|Overall Study||56
386995|NCT00289978|946400|P1|NOT COMPLETED|Overall Study||97
386996|NCT00289978|946398|P3|COMPLETED|Overall Study|303 completed on study drug, 29 completed off study drug.|332
386997|NCT00289978|946399|P2|COMPLETED|Overall Study|345 completed on study drug, 24 completed off study drug.|369
386998|NCT00289978|946400|P1|COMPLETED|Overall Study|296 completed on study drug, 35 completed off study drug.|332
386999|NCT00289978|946398|P3|STARTED|Overall Study||418
387000|NCT00289978|946399|P2|STARTED|Overall Study||425
387001|NCT00289978|946400|P1|STARTED|Overall Study||429
387002|NCT00289913|946419|P5|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
387003|NCT00289913|946420|P4|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
387004|NCT00289913|946421|P3|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
387005|NCT00289913|946422|P2|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
387006|NCT00289913|946423|P1|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
387007|NCT00289913|946419|P5|COMPLETED|Visit 4 (Stage I and Stage II)||597
387008|NCT00289913|946420|P4|COMPLETED|Visit 4 (Stage I and Stage II)||131
387009|NCT00289913|946421|P3|COMPLETED|Visit 4 (Stage I and Stage II)||138
387010|NCT00289913|946422|P2|COMPLETED|Visit 4 (Stage I and Stage II)||106
387011|NCT00289913|946423|P1|COMPLETED|Visit 4 (Stage I and Stage II)||122
387012|NCT00289913|946419|P5|STARTED|Visit 4 (Stage I and Stage II)||597
387013|NCT00289913|946420|P4|STARTED|Visit 4 (Stage I and Stage II)||131
387014|NCT00289913|946421|P3|STARTED|Visit 4 (Stage I and Stage II)||138
387015|NCT00289913|946422|P2|STARTED|Visit 4 (Stage I and Stage II)||106
387016|NCT00289913|946423|P1|STARTED|Visit 4 (Stage I and Stage II)||122
387017|NCT00289913|946419|P5|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
387018|NCT00289913|946420|P4|NOT COMPLETED|Visit 3 (Stage I and Stage II)||4
387019|NCT00289913|946421|P3|NOT COMPLETED|Visit 3 (Stage I and Stage II)||2
387020|NCT00289913|946422|P2|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
387021|NCT00289913|946423|P1|NOT COMPLETED|Visit 3 (Stage I and Stage II)||9
387022|NCT00289913|946419|P5|COMPLETED|Visit 3 (Stage I and Stage II)||597
387023|NCT00289913|946420|P4|COMPLETED|Visit 3 (Stage I and Stage II)||131
387024|NCT00289913|946421|P3|COMPLETED|Visit 3 (Stage I and Stage II)||138
387025|NCT00289913|946422|P2|COMPLETED|Visit 3 (Stage I and Stage II)||106
387026|NCT00289913|946423|P1|COMPLETED|Visit 3 (Stage I and Stage II)||122
387027|NCT00289913|946419|P5|STARTED|Visit 3 (Stage I and Stage II)||605
387028|NCT00289913|946420|P4|STARTED|Visit 3 (Stage I and Stage II)||135
387029|NCT00289913|946421|P3|STARTED|Visit 3 (Stage I and Stage II)||140
387030|NCT00289913|946422|P2|STARTED|Visit 3 (Stage I and Stage II)||114
387031|NCT00289913|946423|P1|STARTED|Visit 3 (Stage I and Stage II)||131
387032|NCT00289913|946419|P5|NOT COMPLETED|Visit 2 (Stage I and Stage II)||40
387033|NCT00289913|946420|P4|NOT COMPLETED|Visit 2 (Stage I and Stage II)||6
387034|NCT00289913|946421|P3|NOT COMPLETED|Visit 2 (Stage I and Stage II)||10
387035|NCT00289913|946422|P2|NOT COMPLETED|Visit 2 (Stage I and Stage II)||21
387036|NCT00289913|946423|P1|NOT COMPLETED|Visit 2 (Stage I and Stage II)||15
387037|NCT00289913|946419|P5|COMPLETED|Visit 2 (Stage I and Stage II)||605
387038|NCT00289913|946420|P4|COMPLETED|Visit 2 (Stage I and Stage II)||135
387039|NCT00289913|946421|P3|COMPLETED|Visit 2 (Stage I and Stage II)||140
387040|NCT00289913|946422|P2|COMPLETED|Visit 2 (Stage I and Stage II)||114
387041|NCT00289913|946423|P1|COMPLETED|Visit 2 (Stage I and Stage II)||131
387042|NCT00289913|946419|P5|STARTED|Visit 2 (Stage I and Stage II)|No vaccine administered at Visit 2 (Stage II), therefore there was no safety F/U period.|645
387043|NCT00289913|946420|P4|STARTED|Visit 2 (Stage I and Stage II)||141
387044|NCT00289913|946421|P3|STARTED|Visit 2 (Stage I and Stage II)||150
387045|NCT00289913|946422|P2|STARTED|Visit 2 (Stage I and Stage II)||135
387046|NCT00289913|946423|P1|STARTED|Visit 2 (Stage I and Stage II)||146
387047|NCT00289913|946419|P5|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
387048|NCT00289913|946420|P4|NOT COMPLETED|Visit 1 (Stage I and Stage II)||11
387049|NCT00289913|946421|P3|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
387050|NCT00289913|946422|P2|NOT COMPLETED|Visit 1 (Stage I and Stage II)||16
387051|NCT00289913|946423|P1|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
387052|NCT00289913|946419|P5|COMPLETED|Visit 1 (Stage I and Stage II)||645
387053|NCT00289913|946420|P4|COMPLETED|Visit 1 (Stage I and Stage II)||141
387054|NCT00289913|946421|P3|COMPLETED|Visit 1 (Stage I and Stage II)||150
387055|NCT00289913|946422|P2|COMPLETED|Visit 1 (Stage I and Stage II)||135
387056|NCT00289913|946423|P1|COMPLETED|Visit 1 (Stage I and Stage II)||146
387057|NCT00289913|946419|P5|STARTED|Visit 1 (Stage I and Stage II)|Participants were enrolled during Stage II.|654
387058|NCT00289913|946420|P4|STARTED|Visit 1 (Stage I and Stage II)||152
387059|NCT00289913|946421|P3|STARTED|Visit 1 (Stage I and Stage II)||159
387060|NCT00289913|946422|P2|STARTED|Visit 1 (Stage I and Stage II)||151
387061|NCT00289913|946423|P1|STARTED|Visit 1 (Stage I and Stage II)||155
387062|NCT00289900|946454|P6|NOT COMPLETED|Overall Study||61
387063|NCT00289900|946455|P5|NOT COMPLETED|Overall Study||45
387064|NCT00289900|946456|P4|NOT COMPLETED|Overall Study||59
387065|NCT00289900|946457|P3|NOT COMPLETED|Overall Study||33
387066|NCT00289900|946458|P2|NOT COMPLETED|Overall Study||120
387067|NCT00289900|946459|P1|NOT COMPLETED|Overall Study||68
387068|NCT00289900|946454|P6|COMPLETED|Overall Study||372
387069|NCT00289900|946455|P5|COMPLETED|Overall Study||392
387070|NCT00289900|946456|P4|COMPLETED|Overall Study||380
387071|NCT00289900|946457|P3|COMPLETED|Overall Study||265
387072|NCT00289900|946458|P2|COMPLETED|Overall Study||316
387073|NCT00289900|946459|P1|COMPLETED|Overall Study||229
387074|NCT00289900|946454|P6|Treated|Overall Study||433
387075|NCT00289900|946455|P5|Treated|Overall Study||437
387076|NCT00289900|946456|P4|Treated|Overall Study||439
387077|NCT00289900|946457|P3|Treated|Overall Study||298
387078|NCT00289900|946458|P2|Treated|Overall Study||435
387079|NCT00289900|946459|P1|Treated|Overall Study||297
387080|NCT00289900|946454|P6|STARTED|Overall Study||433
387081|NCT00289900|946455|P5|STARTED|Overall Study||437
387082|NCT00289900|946456|P4|STARTED|Overall Study||439
387083|NCT00289900|946457|P3|STARTED|Overall Study||298
387084|NCT00289900|946458|P2|STARTED|Overall Study||436
387085|NCT00289900|946459|P1|STARTED|Overall Study||297
387086|NCT00289887|946563|P2|NOT COMPLETED|Overall Study||29
387087|NCT00289887|946564|P1|NOT COMPLETED|Overall Study||22
387088|NCT00289887|946563|P2|COMPLETED|Overall Study||105
387089|NCT00289887|946564|P1|COMPLETED|Overall Study||105
387090|NCT00289887|946563|P2|STARTED|Overall Study||134
387091|NCT00289887|946564|P1|STARTED|Overall Study||127
387092|NCT00289874|946582|P2|NOT COMPLETED|Overall Study||8
387093|NCT00289874|946583|P1|NOT COMPLETED|Overall Study||6
387094|NCT00289874|946582|P2|COMPLETED|Overall Study||210
387095|NCT00289874|946583|P1|COMPLETED|Overall Study||197
387096|NCT00289874|946582|P2|STARTED|Overall Study||218
387097|NCT00289874|946583|P1|STARTED|Overall Study||203
387098|NCT00289848|946593|P2|NOT COMPLETED|Overall Study||45
387099|NCT00289848|946594|P1|NOT COMPLETED|Overall Study||46
387100|NCT00289848|946593|P2|COMPLETED|Overall Study||133
387101|NCT00289848|946594|P1|COMPLETED|Overall Study||306
387102|NCT00289848|946593|P2|STARTED|Overall Study||178
387103|NCT00289848|946594|P1|STARTED|Overall Study||352
387104|NCT00289783|946606|P2|NOT COMPLETED|Fourth Dose Phase||24
387105|NCT00289783|946607|P1|NOT COMPLETED|Fourth Dose Phase||87
387106|NCT00289783|946606|P2|COMPLETED|Fourth Dose Phase||899
387107|NCT00289783|946607|P1|COMPLETED|Fourth Dose Phase||2682
387108|NCT00289783|946606|P2|STARTED|Fourth Dose Phase||923
387109|NCT00289783|946607|P1|STARTED|Fourth Dose Phase||2769
387110|NCT00289783|946606|P2|NOT COMPLETED|Primary Phase||83
387111|NCT00289783|946607|P1|NOT COMPLETED|Primary Phase||248
387112|NCT00289783|946606|P2|COMPLETED|Primary Phase||961
387113|NCT00289783|946607|P1|COMPLETED|Primary Phase||2888
387114|NCT00289783|946606|P2|STARTED|Primary Phase||1044
387115|NCT00289783|946607|P1|STARTED|Primary Phase||3136
387116|NCT00289770|946785|P1|NOT COMPLETED|Year 15||1
387117|NCT00289770|946785|P1|COMPLETED|Year 15||49
387118|NCT00289770|946785|P1|STARTED|Year 15||50
387119|NCT00289770|946785|P1|NOT COMPLETED|Year 14||0
387120|NCT00289770|946785|P1|COMPLETED|Year 14||43
387121|NCT00289770|946785|P1|STARTED|Year 14||43
387122|NCT00289770|946785|P1|NOT COMPLETED|Year 13||0
387123|NCT00289770|946785|P1|COMPLETED|Year 13||37
387124|NCT00289770|946785|P1|STARTED|Year 13||37
387125|NCT00289770|946785|P1|NOT COMPLETED|Year 12||0
387126|NCT00289770|946785|P1|COMPLETED|Year 12||40
387127|NCT00289770|946785|P1|STARTED|Year 12||40
387128|NCT00289770|946785|P1|NOT COMPLETED|Year 11||0
387129|NCT00289770|946785|P1|COMPLETED|Year 11||37
387130|NCT00289770|946785|P1|STARTED|Year 11||37
387131|NCT00289757|946797|P1|NOT COMPLETED|Overall Study||0
387132|NCT00289757|946797|P1|COMPLETED|Overall Study||78
387133|NCT00289757|946797|P1|STARTED|Overall Study||78
387134|NCT00289744|946808|P3|NOT COMPLETED|Additional Dose Phase||0
387135|NCT00289744|946809|P2|NOT COMPLETED|Additional Dose Phase||0
387136|NCT00289744|946810|P1|NOT COMPLETED|Additional Dose Phase||0
387137|NCT00289744|946808|P3|COMPLETED|Additional Dose Phase||6
387138|NCT00289744|946809|P2|COMPLETED|Additional Dose Phase||19
387139|NCT00289744|946810|P1|COMPLETED|Additional Dose Phase||0
387140|NCT00289744|946808|P3|STARTED|Additional Dose Phase||6
387141|NCT00289744|946809|P2|STARTED|Additional Dose Phase||19
387142|NCT00289744|946810|P1|STARTED|Additional Dose Phase||0
387143|NCT00289744|946808|P3|NOT COMPLETED|Year 10 Long-term Follow-up||0
387144|NCT00289744|946809|P2|NOT COMPLETED|Year 10 Long-term Follow-up||0
387145|NCT00289744|946810|P1|NOT COMPLETED|Year 10 Long-term Follow-up||0
387146|NCT00289744|946808|P3|COMPLETED|Year 10 Long-term Follow-up||0
387147|NCT00289744|946809|P2|COMPLETED|Year 10 Long-term Follow-up||0
387148|NCT00289744|946810|P1|COMPLETED|Year 10 Long-term Follow-up||171
387149|NCT00289744|946808|P3|STARTED|Year 10 Long-term Follow-up||0
387150|NCT00289744|946809|P2|STARTED|Year 10 Long-term Follow-up||0
387151|NCT00289744|946810|P1|STARTED|Year 10 Long-term Follow-up|Subjects who came back at Year 10 blood sampling time-point|171
387152|NCT00289744|946808|P3|NOT COMPLETED|Year 9 Long-term Follow-up||0
387153|NCT00289744|946809|P2|NOT COMPLETED|Year 9 Long-term Follow-up||0
387154|NCT00289744|946810|P1|NOT COMPLETED|Year 9 Long-term Follow-up||0
387155|NCT00289744|946808|P3|COMPLETED|Year 9 Long-term Follow-up||0
387156|NCT00289744|946809|P2|COMPLETED|Year 9 Long-term Follow-up||0
387157|NCT00289744|946810|P1|COMPLETED|Year 9 Long-term Follow-up||173
387158|NCT00289744|946808|P3|STARTED|Year 9 Long-term Follow-up||0
387159|NCT00289744|946809|P2|STARTED|Year 9 Long-term Follow-up||0
387160|NCT00289744|946810|P1|STARTED|Year 9 Long-term Follow-up|Subjects who came back at Year 9 blood sampling time-point|173
387161|NCT00289744|946808|P3|NOT COMPLETED|Year 8 Long-term Follow-up||0
387162|NCT00289744|946809|P2|NOT COMPLETED|Year 8 Long-term Follow-up||0
387163|NCT00289744|946810|P1|NOT COMPLETED|Year 8 Long-term Follow-up||0
387164|NCT00289744|946808|P3|COMPLETED|Year 8 Long-term Follow-up||0
387165|NCT00289744|946809|P2|COMPLETED|Year 8 Long-term Follow-up||0
387166|NCT00289744|946810|P1|COMPLETED|Year 8 Long-term Follow-up||174
387167|NCT00289744|946808|P3|STARTED|Year 8 Long-term Follow-up||0
387168|NCT00289744|946809|P2|STARTED|Year 8 Long-term Follow-up||0
387169|NCT00289744|946810|P1|STARTED|Year 8 Long-term Follow-up|Subjects who came back at Year 8 blood sampling time-point|174
387170|NCT00289744|946808|P3|NOT COMPLETED|Year 7 Long-term Follow-up||0
387171|NCT00289744|946809|P2|NOT COMPLETED|Year 7 Long-term Follow-up||0
387172|NCT00289744|946810|P1|NOT COMPLETED|Year 7 Long-term Follow-up||0
387173|NCT00289744|946808|P3|COMPLETED|Year 7 Long-term Follow-up||0
387174|NCT00289744|946809|P2|COMPLETED|Year 7 Long-term Follow-up||0
387175|NCT00289744|946810|P1|COMPLETED|Year 7 Long-term Follow-up||175
387176|NCT00289744|946808|P3|STARTED|Year 7 Long-term Follow-up||0
387177|NCT00289744|946809|P2|STARTED|Year 7 Long-term Follow-up||0
387178|NCT00289744|946810|P1|STARTED|Year 7 Long-term Follow-up|Subjects who came back at Year 7 blood sampling time-point|175
387179|NCT00289744|946808|P3|NOT COMPLETED|Year 6 Long-term Follow-up||0
387180|NCT00289744|946809|P2|NOT COMPLETED|Year 6 Long-term Follow-up||0
387181|NCT00289744|946810|P1|NOT COMPLETED|Year 6 Long-term Follow-up||0
387182|NCT00289744|946808|P3|COMPLETED|Year 6 Long-term Follow-up||0
387183|NCT00289744|946809|P2|COMPLETED|Year 6 Long-term Follow-up||0
387184|NCT00289744|946810|P1|COMPLETED|Year 6 Long-term Follow-up||178
387185|NCT00289744|946808|P3|STARTED|Year 6 Long-term Follow-up||0
387186|NCT00289744|946809|P2|STARTED|Year 6 Long-term Follow-up||0
387187|NCT00289744|946810|P1|STARTED|Year 6 Long-term Follow-up|Number of subjects who come back at Year 6 blood sampling time-point|178
387188|NCT00289731|946831|P3|NOT COMPLETED|Overall Study||2
387189|NCT00289731|946832|P2|NOT COMPLETED|Overall Study||2
387190|NCT00289731|946833|P1|NOT COMPLETED|Overall Study||2
387191|NCT00289731|946831|P3|COMPLETED|Overall Study||195
387192|NCT00289731|946832|P2|COMPLETED|Overall Study||198
387193|NCT00289731|946833|P1|COMPLETED|Overall Study||197
387194|NCT00289731|946831|P3|STARTED|Overall Study||197
387195|NCT00289731|946832|P2|STARTED|Overall Study||200
387196|NCT00289731|946833|P1|STARTED|Overall Study||199
387197|NCT00289718|946925|P1|NOT COMPLETED|Overall Study||0
387198|NCT00289718|946925|P1|COMPLETED|Overall Study||51
387199|NCT00289718|946925|P1|STARTED|Overall Study||51
387200|NCT00289653|946940|P1|NOT COMPLETED|Overall Study||11
387201|NCT00289653|946940|P1|COMPLETED|Overall Study||12
387202|NCT00289653|946940|P1|STARTED|Overall Study||23
387203|NCT00289536|946945|P3|NOT COMPLETED|Period 3||1
387204|NCT00289536|946946|P2|NOT COMPLETED|Period 3||0
387205|NCT00289536|946947|P1|NOT COMPLETED|Period 3||0
387206|NCT00289536|946945|P3|COMPLETED|Period 3||9
387207|NCT00289536|946946|P2|COMPLETED|Period 3||9
387208|NCT00289536|946947|P1|COMPLETED|Period 3||7
387209|NCT00289536|946945|P3|STARTED|Period 3|5 participants received Low Dose and 5 participants received Medium Dose in Period 2|10
387210|NCT00289536|946946|P2|STARTED|Period 3|5 participants received Low Dose and 4 participants received High Dose in Period 2|9
387211|NCT00289536|946947|P1|STARTED|Period 3|3 participants received Medium Dose and 4 participants received High Dose in Period 2|7
387212|NCT00289536|946945|P3|NOT COMPLETED|Period 2||0
387213|NCT00289536|946946|P2|NOT COMPLETED|Period 2||0
387214|NCT00289536|946947|P1|NOT COMPLETED|Period 2||0
387215|NCT00289536|946945|P3|COMPLETED|Period 2||7
387216|NCT00289536|946946|P2|COMPLETED|Period 2||9
387217|NCT00289536|946947|P1|COMPLETED|Period 2||10
387218|NCT00289536|946945|P3|STARTED|Period 2|4 participants received Low Dose and 3 participants received Medium Dose in Period 1|7
387219|NCT00289536|946946|P2|STARTED|Period 2|5 participants received Low Dose and 4 participants received High Dose in Period 1|9
387220|NCT00289536|946947|P1|STARTED|Period 2|5 participants received Medium Dose and 5 participants received High Dose in Period 1|10
387221|NCT00289536|946945|P3|NOT COMPLETED|Period 1||0
387222|NCT00289536|946946|P2|NOT COMPLETED|Period 1||0
387223|NCT00289536|946947|P1|NOT COMPLETED|Period 1||0
387224|NCT00289536|946945|P3|COMPLETED|Period 1||9
387225|NCT00289536|946946|P2|COMPLETED|Period 1||8
387226|NCT00289536|946947|P1|COMPLETED|Period 1||9
387227|NCT00289536|946945|P3|STARTED|Period 1||9
387228|NCT00289536|946946|P2|STARTED|Period 1||8
387229|NCT00289536|946947|P1|STARTED|Period 1||9
387230|NCT00289471|946986|P1|NOT COMPLETED|Overall Study||0
387231|NCT00289471|946986|P1|COMPLETED|Overall Study||630
387232|NCT00289471|946986|P1|STARTED|Overall Study||630
387233|NCT00289458|946993|P3|NOT COMPLETED|Overall Study||6
387234|NCT00289458|946994|P2|NOT COMPLETED|Overall Study||6
387235|NCT00289458|946995|P1|NOT COMPLETED|Overall Study||6
387236|NCT00289458|946993|P3|COMPLETED|Overall Study||22
387237|NCT00289458|946994|P2|COMPLETED|Overall Study||20
387238|NCT00289458|946995|P1|COMPLETED|Overall Study||19
387239|NCT00289458|946993|P3|STARTED|Overall Study||28
387240|NCT00289458|946994|P2|STARTED|Overall Study||26
387241|NCT00289458|946995|P1|STARTED|Overall Study||25
387242|NCT00289341|947020|P2|NOT COMPLETED|Overall Study||0
387243|NCT00289341|947021|P1|NOT COMPLETED|Overall Study||0
387244|NCT00289341|947020|P2|COMPLETED|Overall Study||12
387245|NCT00289341|947021|P1|COMPLETED|Overall Study||12
387246|NCT00289341|947020|P2|STARTED|Overall Study||12
387247|NCT00289341|947021|P1|STARTED|Overall Study||12
387248|NCT00289315|947034|P3|NOT COMPLETED|Overall Study||140
387249|NCT00289315|947035|P2|NOT COMPLETED|Overall Study||122
387250|NCT00289315|947036|P1|NOT COMPLETED|Overall Study||101
387251|NCT00289315|947034|P3|COMPLETED|Overall Study||447
387252|NCT00289315|947035|P2|COMPLETED|Overall Study||638
387253|NCT00289315|947036|P1|COMPLETED|Overall Study||612
387254|NCT00289315|947034|P3|STARTED|Overall Study||587
387255|NCT00289315|947035|P2|STARTED|Overall Study||760
387256|NCT00289315|947036|P1|STARTED|Overall Study||713
387257|NCT00289289|947056|P3|NOT COMPLETED|Overall Study||49
387258|NCT00289289|947057|P2|NOT COMPLETED|Overall Study||10
387259|NCT00289289|947058|P1|NOT COMPLETED|Overall Study||19
387260|NCT00289289|947056|P3|COMPLETED|Overall Study||95
387261|NCT00289289|947057|P2|COMPLETED|Overall Study||114
387262|NCT00289289|947058|P1|COMPLETED|Overall Study||113
387263|NCT00289289|947056|P3|STARTED|Overall Study||144
387264|NCT00289289|947057|P2|STARTED|Overall Study||124
387265|NCT00289289|947058|P1|STARTED|Overall Study||132
387266|NCT00289276|947073|P2|NOT COMPLETED|Second Part of FAST Study (Expansion)||3
387267|NCT00289276|947074|P1|NOT COMPLETED|Second Part of FAST Study (Expansion)||0
387268|NCT00289276|947073|P2|COMPLETED|Second Part of FAST Study (Expansion)||106
387269|NCT00289276|947074|P1|COMPLETED|Second Part of FAST Study (Expansion)||0
387270|NCT00289276|947073|P2|STARTED|Second Part of FAST Study (Expansion)||109
387271|NCT00289276|947074|P1|STARTED|Second Part of FAST Study (Expansion)||0
387272|NCT00289276|947073|P2|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
387273|NCT00289276|947074|P1|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
387274|NCT00289276|947073|P2|COMPLETED|First Part of FAST Study (Pivotal)||0
387275|NCT00289276|947074|P1|COMPLETED|First Part of FAST Study (Pivotal)||47
387276|NCT00289276|947073|P2|STARTED|First Part of FAST Study (Pivotal)||0
387277|NCT00289276|947074|P1|STARTED|First Part of FAST Study (Pivotal)|11 patients were re-consented under version 7 of the CIP, but are included in Pivotal results only|47
387278|NCT00289211|947089|P3|NOT COMPLETED|Overall Study||10
387279|NCT00289211|947090|P2|NOT COMPLETED|Overall Study||1
387280|NCT00289211|947091|P1|NOT COMPLETED|Overall Study||0
387281|NCT00289211|947089|P3|COMPLETED|Overall Study||2
387282|NCT00289211|947090|P2|COMPLETED|Overall Study||34
387283|NCT00289211|947091|P1|COMPLETED|Overall Study||36
387284|NCT00289211|947089|P3|STARTED|Overall Study||12
387285|NCT00289211|947090|P2|STARTED|Overall Study||35
387286|NCT00289211|947091|P1|STARTED|Overall Study||36
387287|NCT00289198|947109|P2|NOT COMPLETED|Overall Study||30
387288|NCT00289198|947110|P1|NOT COMPLETED|Overall Study||31
387289|NCT00289198|947109|P2|COMPLETED|Overall Study||121
387290|NCT00289198|947110|P1|COMPLETED|Overall Study||120
387291|NCT00289198|947109|P2|STARTED|Overall Study||151
387292|NCT00289198|947110|P1|STARTED|Overall Study||151
387293|NCT00289185|947160|P2|NOT COMPLETED|Overall Study||26
387294|NCT00289185|947161|P1|NOT COMPLETED|Overall Study||28
387295|NCT00289185|947160|P2|COMPLETED|Overall Study||144
387296|NCT00289185|947161|P1|COMPLETED|Overall Study||142
387297|NCT00289185|947160|P2|STARTED|Overall Study||170
387298|NCT00289185|947161|P1|STARTED|Overall Study||170
387299|NCT00289133|947208|P2|NOT COMPLETED|Overall Study||298
387300|NCT00289133|947209|P1|NOT COMPLETED|Overall Study||272
387301|NCT00289133|947208|P2|COMPLETED|Overall Study||179
387302|NCT00289133|947209|P1|COMPLETED|Overall Study||189
387303|NCT00289133|947208|P2|STARTED|Overall Study||477
387304|NCT00289133|947209|P1|STARTED|Overall Study||461
387305|NCT00289120|947231|P1|NOT COMPLETED|Overall Study||0
387306|NCT00289120|947231|P1|COMPLETED|Overall Study||13
387307|NCT00289120|947231|P1|STARTED|Overall Study||13
387308|NCT00289107|947249|P2|NOT COMPLETED|Overall Study||44
387309|NCT00289107|947250|P1|NOT COMPLETED|Overall Study||53
387310|NCT00289107|947249|P2|COMPLETED|Overall Study||28
387311|NCT00289107|947250|P1|COMPLETED|Overall Study||24
387312|NCT00289107|947249|P2|STARTED|Overall Study||72
387313|NCT00289107|947250|P1|STARTED|Overall Study||77
387314|NCT00289094|947258|P2|NOT COMPLETED|Overall Study||47
387315|NCT00289094|947259|P1|NOT COMPLETED|Overall Study||47
387316|NCT00289094|947258|P2|COMPLETED|Overall Study||2
387317|NCT00289094|947259|P1|COMPLETED|Overall Study||3
387318|NCT00289094|947258|P2|STARTED|Overall Study||49
387319|NCT00289094|947259|P1|STARTED|Overall Study||50
387320|NCT00289016|947265|P1|NOT COMPLETED|Overall Study||37
387321|NCT00289016|947265|P1|COMPLETED|Overall Study||13
387322|NCT00289016|947265|P1|STARTED|Overall Study||50
387323|NCT00288912|947277|P3|NOT COMPLETED|Overall Study||28
387324|NCT00288912|947278|P2|NOT COMPLETED|Overall Study||17
387325|NCT00288912|947279|P1|NOT COMPLETED|Overall Study||17
387326|NCT00288912|947277|P3|COMPLETED|Overall Study||146
387327|NCT00288912|947278|P2|COMPLETED|Overall Study||157
387328|NCT00288912|947279|P1|COMPLETED|Overall Study||158
387329|NCT00288912|947277|P3|STARTED|Overall Study||174
387330|NCT00288912|947278|P2|STARTED|Overall Study||174
387331|NCT00288912|947279|P1|STARTED|Overall Study||175
387332|NCT00288886|947298|P2|NOT COMPLETED|Overall Study||11
387333|NCT00288886|947299|P1|NOT COMPLETED|Overall Study||11
387334|NCT00288886|947298|P2|COMPLETED|Overall Study||81
387335|NCT00288886|947299|P1|COMPLETED|Overall Study||80
387336|NCT00288886|947298|P2|12-month Follow Up|Overall Study||81
387337|NCT00288886|947299|P1|12-month Follow Up|Overall Study||80
387338|NCT00288886|947298|P2|6-month Follow Up|Overall Study||84
387339|NCT00288886|947299|P1|6-month Follow Up|Overall Study||85
387340|NCT00288886|947298|P2|3-month Follow Up|Overall Study||85
387341|NCT00288886|947299|P1|3-month Follow Up|Overall Study||82
387342|NCT00288886|947298|P2|STARTED|Overall Study||92
387343|NCT00288886|947299|P1|STARTED|Overall Study||91
387344|NCT00288860|947319|P2|NOT COMPLETED|Overall Study||97
387345|NCT00288860|947320|P1|NOT COMPLETED|Overall Study||102
387346|NCT00288860|947319|P2|COMPLETED|Overall Study|328 completed 4 or 12 month survey. Used all with intake (n=417) in intent to treat.|328
387347|NCT00288860|947320|P1|COMPLETED|Overall Study|310 completed either 4 or 12 month survey. Used all with intake (n = 408) in intent-to-treat.|310
387348|NCT00288860|947319|P2|Completed 12 Month fu Survey|Overall Study||281
387349|NCT00288860|947320|P1|Completed 12 Month fu Survey|Overall Study||257
387350|NCT00288860|947319|P2|Completed 4 Month fu Survey|Overall Study||299
387351|NCT00288860|947320|P1|Completed 4 Month fu Survey|Overall Study||275
387352|NCT00288860|947319|P2|Completed Intake Survey|Overall Study||417
387353|NCT00288860|947320|P1|Completed Intake Survey|Overall Study||408
387354|NCT00288860|947319|P2|STARTED|Overall Study||425
387355|NCT00288860|947320|P1|STARTED|Overall Study||412
387356|NCT00288704|947333|P3|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||20
387357|NCT00288704|947334|P2|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
387358|NCT00288704|947335|P1|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
387359|NCT00288704|947333|P3|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||81
387360|NCT00288704|947334|P2|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
387361|NCT00288704|947335|P1|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
387362|NCT00288704|947333|P3|STARTED|Open-Label Extension (OLE) Weeks 24-117||101
387363|NCT00288704|947334|P2|STARTED|Open-Label Extension (OLE) Weeks 24-117||0
387364|NCT00288704|947335|P1|STARTED|Open-Label Extension (OLE) Weeks 24-117|After week 24, all subjects are treated with Open label rilonacept.|0
387365|NCT00288704|947333|P3|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
387366|NCT00288704|947334|P2|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||1
387367|NCT00288704|947335|P1|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
387368|NCT00288704|947333|P3|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
387369|NCT00288704|947334|P2|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||21
387370|NCT00288704|947335|P1|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||23
387371|NCT00288704|947333|P3|STARTED|Part B, Randomized Withdrawal, Wks 15-24||0
387372|NCT00288704|947334|P2|STARTED|Part B, Randomized Withdrawal, Wks 15-24||22
387373|NCT00288704|947335|P1|STARTED|Part B, Randomized Withdrawal, Wks 15-24|1 subject discontinued during weeks 6-14 due to non-compliance with study drug dosing procedures.|23
387374|NCT00288704|947333|P3|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
387375|NCT00288704|947334|P2|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||1
387376|NCT00288704|947335|P1|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
387377|NCT00288704|947333|P3|COMPLETED|Part A, Double Blind, Weeks 1-6||0
387378|NCT00288704|947334|P2|COMPLETED|Part A, Double Blind, Weeks 1-6||22
387379|NCT00288704|947335|P1|COMPLETED|Part A, Double Blind, Weeks 1-6||24
387380|NCT00288704|947333|P3|STARTED|Part A, Double Blind, Weeks 1-6|Subjects enrolled into the open-label phase do not complete this part of the study.|0
387381|NCT00288704|947334|P2|STARTED|Part A, Double Blind, Weeks 1-6||23
387382|NCT00288704|947335|P1|STARTED|Part A, Double Blind, Weeks 1-6||24
387383|NCT00288639|947362|P1|NOT COMPLETED|Overall Study||12
387384|NCT00288639|947362|P1|COMPLETED|Overall Study||86
387385|NCT00288639|947362|P1|STARTED|Overall Study||98
387386|NCT00288626|947379|P1|NOT COMPLETED|Overall Study||7
387387|NCT00288626|947379|P1|COMPLETED|Overall Study||17
387388|NCT00288626|947379|P1|STARTED|Overall Study||24
387389|NCT00288600|947404|P2|NOT COMPLETED|Overall Study||0
387390|NCT00288600|947405|P1|NOT COMPLETED|Overall Study||0
387391|NCT00288600|947404|P2|COMPLETED|Overall Study||46
387392|NCT00288600|947405|P1|COMPLETED|Overall Study||46
387393|NCT00288600|947404|P2|STARTED|Overall Study||46
387394|NCT00288600|947405|P1|STARTED|Overall Study||46
387395|NCT00288587|947413|P2|NOT COMPLETED|Overall Study||10
387396|NCT00288587|947414|P1|NOT COMPLETED|Overall Study||5
387397|NCT00288587|947413|P2|COMPLETED|Overall Study||7
387398|NCT00288587|947414|P1|COMPLETED|Overall Study||14
387399|NCT00288587|947413|P2|STARTED|Overall Study||17
387400|NCT00288587|947414|P1|STARTED|Overall Study||19
387401|NCT00288574|947430|P2|NOT COMPLETED|Overall Study||0
387402|NCT00288574|947431|P1|NOT COMPLETED|Overall Study||0
387403|NCT00288574|947430|P2|COMPLETED|Overall Study||44
387404|NCT00288574|947431|P1|COMPLETED|Overall Study||49
387405|NCT00288574|947430|P2|STARTED|Overall Study||44
387406|NCT00288574|947431|P1|STARTED|Overall Study||49
387407|NCT00288509|947457|P1|NOT COMPLETED|Treatment Cycle 4||8
387408|NCT00288509|947457|P1|COMPLETED|Treatment Cycle 4||80
387409|NCT00288509|947457|P1|STARTED|Treatment Cycle 4|3 subjects completed Cycle 3 but withdrew before Cycle 4, treatment stopped according to protocol|88
387410|NCT00288509|947457|P1|NOT COMPLETED|Treatment Cycle 3||5
387411|NCT00288509|947457|P1|COMPLETED|Treatment Cycle 3||91
387412|NCT00288509|947457|P1|STARTED|Treatment Cycle 3|One subject completed Cycle 2 but withdrew before Cycle 3 due to insufficient clinical response|96
387413|NCT00288509|947457|P1|NOT COMPLETED|Treatment Cycle 2||3
387414|NCT00288509|947457|P1|COMPLETED|Treatment Cycle 2||97
387415|NCT00288509|947457|P1|STARTED|Treatment Cycle 2|2 subjects completed Cycle 1 but withdrew before Cycle 2 due to insufficient clinical response|100
387416|NCT00288509|947457|P1|NOT COMPLETED|Treatment Cycle 1||6
387417|NCT00288509|947457|P1|COMPLETED|Treatment Cycle 1||102
387418|NCT00288509|947457|P1|STARTED|Treatment Cycle 1||108
387419|NCT00288366|947466|P2|NOT COMPLETED|Overall Study||0
387420|NCT00288366|947467|P1|NOT COMPLETED|Overall Study||0
387421|NCT00288366|947466|P2|COMPLETED|Overall Study||26
387422|NCT00288366|947467|P1|COMPLETED|Overall Study||23
387423|NCT00288366|947466|P2|STARTED|Overall Study||26
387424|NCT00288366|947467|P1|STARTED|Overall Study||23
387425|NCT00288080|947475|P2|NOT COMPLETED|Overall Study||23
387426|NCT00288080|947476|P1|NOT COMPLETED|Overall Study||26
387427|NCT00288080|947475|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|282
387428|NCT00288080|947476|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|281
387429|NCT00288080|947475|P2|STARTED|Overall Study||305
387430|NCT00288080|947476|P1|STARTED|Overall Study||307
387431|NCT00288067|947492|P1|NOT COMPLETED|Overall Study||0
387432|NCT00288067|947492|P1|COMPLETED|Overall Study||32
387433|NCT00288067|947492|P1|STARTED|Overall Study||32
387434|NCT00288054|947498|P1|NOT COMPLETED|Overall Study||24
387435|NCT00288054|947498|P1|COMPLETED|Overall Study||0
387436|NCT00288054|947498|P1|STARTED|Overall Study||24
387437|NCT00288015|947506|P1|NOT COMPLETED|Follow up for Survival x 2 Years||26
387438|NCT00288015|947506|P1|COMPLETED|Follow up for Survival x 2 Years||3
387439|NCT00288015|947506|P1|STARTED|Follow up for Survival x 2 Years||29
387440|NCT00288015|947506|P1|NOT COMPLETED|Continued Bevacizumab Cycle 3+||7
387441|NCT00288015|947506|P1|COMPLETED|Continued Bevacizumab Cycle 3+||19
387442|NCT00288015|947506|P1|STARTED|Continued Bevacizumab Cycle 3+||26
387443|NCT00288015|947506|P1|NOT COMPLETED|First Response Assessment||4
387444|NCT00288015|947506|P1|COMPLETED|First Response Assessment||26
387445|NCT00288015|947506|P1|STARTED|First Response Assessment||30
387446|NCT00288015|947506|P1|NOT COMPLETED|Bevacizumab Treatment Cycles 1-2||2
387447|NCT00288015|947506|P1|COMPLETED|Bevacizumab Treatment Cycles 1-2||30
387448|NCT00288015|947506|P1|STARTED|Bevacizumab Treatment Cycles 1-2||32
387449|NCT00288015|947506|P1|NOT COMPLETED|Registered to Study||0
387450|NCT00288015|947506|P1|COMPLETED|Registered to Study||32
387451|NCT00288015|947506|P1|STARTED|Registered to Study||32
387452|NCT00287989|947518|P3|NOT COMPLETED|Overall Study||0
387453|NCT00287989|947519|P2|NOT COMPLETED|Overall Study||0
387454|NCT00287989|947520|P1|NOT COMPLETED|Overall Study||0
387455|NCT00287989|947518|P3|COMPLETED|Overall Study||29
387456|NCT00287989|947519|P2|COMPLETED|Overall Study||29
387457|NCT00287989|947520|P1|COMPLETED|Overall Study||28
387458|NCT00287989|947518|P3|STARTED|Overall Study||29
387459|NCT00287989|947519|P2|STARTED|Overall Study||29
387460|NCT00287989|947520|P1|STARTED|Overall Study||28
387461|NCT00287872|947531|P1|NOT COMPLETED|Overall Study||0
387462|NCT00287872|947531|P1|COMPLETED|Overall Study||30
387463|NCT00287872|947531|P1|STARTED|Overall Study||30
387464|NCT00287729|947541|P2|NOT COMPLETED|Overall Study||31
387465|NCT00287729|947542|P1|NOT COMPLETED|Overall Study||34
387466|NCT00287729|947541|P2|COMPLETED|Overall Study||142
387467|NCT00287729|947542|P1|COMPLETED|Overall Study||137
387468|NCT00287729|947541|P2|STARTED|Overall Study||173
387469|NCT00287729|947542|P1|STARTED|Overall Study||171
387470|NCT00287716|947565|P3|NOT COMPLETED|Overall Study||31
387471|NCT00287716|947566|P2|NOT COMPLETED|Overall Study||17
387472|NCT00287716|947567|P1|NOT COMPLETED|Overall Study||38
387473|NCT00287716|947565|P3|COMPLETED|Overall Study||143
387474|NCT00287716|947566|P2|COMPLETED|Overall Study||70
387475|NCT00287716|947567|P1|COMPLETED|Overall Study||136
387476|NCT00287716|947565|P3|STARTED|Overall Study||174
387477|NCT00287716|947566|P2|STARTED|Overall Study||87
387478|NCT00287716|947567|P1|STARTED|Overall Study||174
387479|NCT00287690|947598|P2|NOT COMPLETED|Overall Study||26
387480|NCT00287690|947599|P1|NOT COMPLETED|Overall Study||20
387481|NCT00287690|947598|P2|COMPLETED|Overall Study||12
387482|NCT00287690|947599|P1|COMPLETED|Overall Study||13
387483|NCT00287690|947598|P2|STARTED|Overall Study||38
387484|NCT00287690|947599|P1|STARTED|Overall Study||33
387485|NCT00287586|947611|P2|NOT COMPLETED|Overall Study||52
387486|NCT00287586|947612|P1|NOT COMPLETED|Overall Study||45
387487|NCT00287586|947611|P2|COMPLETED|Overall Study||100
387488|NCT00287586|947612|P1|COMPLETED|Overall Study||111
387489|NCT00287586|947611|P2|Intent-to-treat: Received Study Drug|Overall Study||151
387490|NCT00287586|947612|P1|Intent-to-treat: Received Study Drug|Overall Study||155
387491|NCT00287586|947611|P2|STARTED|Overall Study||152
387492|NCT00287586|947612|P1|STARTED|Overall Study||156
387493|NCT00287469|947650|P2|NOT COMPLETED|Overall Study||214
387494|NCT00287469|947651|P1|NOT COMPLETED|Overall Study||220
387495|NCT00287469|947650|P2|COMPLETED|Overall Study||786
387496|NCT00287469|947651|P1|COMPLETED|Overall Study||780
387497|NCT00287469|947650|P2|STARTED|Overall Study||1000
387498|NCT00287469|947651|P1|STARTED|Overall Study||1000
387499|NCT00287365|947661|P1|NOT COMPLETED|Overall Study||13
387500|NCT00287365|947661|P1|COMPLETED|Overall Study||12
387501|NCT00287365|947661|P1|STARTED|Overall Study||25
387502|NCT00287339|947672|P2|NOT COMPLETED|Overall Study||0
387503|NCT00287339|947673|P1|NOT COMPLETED|Overall Study||0
387504|NCT00287339|947672|P2|COMPLETED|Overall Study||18
387505|NCT00287339|947673|P1|COMPLETED|Overall Study||22
387506|NCT00287339|947672|P2|STARTED|Overall Study||18
387507|NCT00287339|947673|P1|STARTED|Overall Study||22
387508|NCT00287222|947679|P1|NOT COMPLETED|Overall Study||0
387509|NCT00287222|947679|P1|COMPLETED|Overall Study||21
387510|NCT00287222|947679|P1|STARTED|Overall Study||21
387511|NCT00287118|947683|P1|NOT COMPLETED|Overall Study||52
387512|NCT00287118|947683|P1|COMPLETED|Overall Study||137
387513|NCT00287118|947683|P1|STARTED|Overall Study||189
387514|NCT00287079|947689|P2|NOT COMPLETED|Overall Study||1
387515|NCT00287079|947690|P1|NOT COMPLETED|Overall Study||22
387516|NCT00287079|947689|P2|COMPLETED|Overall Study||2
387517|NCT00287079|947690|P1|COMPLETED|Overall Study||10
387518|NCT00287079|947689|P2|STARTED|Overall Study||3
387519|NCT00287079|947690|P1|STARTED|Overall Study||32
387520|NCT00287053|947702|P2|NOT COMPLETED|Overall Study||1
387521|NCT00287053|947703|P1|NOT COMPLETED|Overall Study||4
387522|NCT00287053|947702|P2|COMPLETED|Overall Study||26
387523|NCT00287053|947703|P1|COMPLETED|Overall Study||26
387524|NCT00287053|947702|P2|STARTED|Overall Study||27
387525|NCT00287053|947703|P1|STARTED|Overall Study||30
387526|NCT00286949|947709|P1|NOT COMPLETED|Overall Study||0
387527|NCT00286949|947709|P1|COMPLETED|Overall Study||12
387528|NCT00286949|947709|P1|STARTED|Overall Study||12
387529|NCT00286754|947718|P3|NOT COMPLETED|Overall Study||10
387530|NCT00286754|947719|P2|NOT COMPLETED|Overall Study||18
387531|NCT00286754|947720|P1|NOT COMPLETED|Overall Study||20
387532|NCT00286754|947718|P3|COMPLETED|Overall Study||170
387533|NCT00286754|947719|P2|COMPLETED|Overall Study||159
387534|NCT00286754|947720|P1|COMPLETED|Overall Study||156
387535|NCT00286754|947718|P3|STARTED|Overall Study||180
387536|NCT00286754|947719|P2|STARTED|Overall Study||177
387537|NCT00286754|947720|P1|STARTED|Overall Study||176
387538|NCT00286741|947754|P2|NOT COMPLETED|Overall Study||17
387539|NCT00286741|947755|P1|NOT COMPLETED|Overall Study||11
387540|NCT00286741|947754|P2|COMPLETED|Overall Study||89
387541|NCT00286741|947755|P1|COMPLETED|Overall Study||122
387542|NCT00286741|947754|P2|STARTED|Overall Study||106
387543|NCT00286741|947755|P1|STARTED|Overall Study||133
387544|NCT00286728|947767|P2|NOT COMPLETED|Overall Study||29
387545|NCT00286728|947768|P1|NOT COMPLETED|Overall Study||36
387546|NCT00286728|947767|P2|COMPLETED|Overall Study||116
387547|NCT00286728|947768|P1|COMPLETED|Overall Study||106
387548|NCT00286728|947767|P2|STARTED|Overall Study||145
387549|NCT00286728|947768|P1|STARTED|Overall Study||142
387550|NCT00286494|947779|P3|NOT COMPLETED|Overall Study||39
387551|NCT00286494|947780|P2|NOT COMPLETED|Overall Study||44
387552|NCT00286494|947781|P1|NOT COMPLETED|Overall Study||26
387553|NCT00286494|947779|P3|COMPLETED|Overall Study||160
387554|NCT00286494|947780|P2|COMPLETED|Overall Study||153
387555|NCT00286494|947781|P1|COMPLETED|Overall Study||71
387556|NCT00286494|947779|P3|STARTED|Overall Study||199
387557|NCT00286494|947780|P2|STARTED|Overall Study||197
387558|NCT00286494|947781|P1|STARTED|Overall Study||97
387559|NCT00286468|947942|P3|NOT COMPLETED|Overall Study||50
387560|NCT00286468|947943|P2|NOT COMPLETED|Overall Study||50
387561|NCT00286468|947944|P1|NOT COMPLETED|Overall Study||37
387562|NCT00286468|947942|P3|COMPLETED|Overall Study||148
387563|NCT00286468|947943|P2|COMPLETED|Overall Study||153
387564|NCT00286468|947944|P1|COMPLETED|Overall Study||62
387565|NCT00286468|947942|P3|STARTED|Overall Study||198
387566|NCT00286468|947943|P2|STARTED|Overall Study||203
387567|NCT00286468|947944|P1|STARTED|Overall Study||99
387568|NCT00286455|948105|P3|NOT COMPLETED|Overall Study||24
387569|NCT00286455|948106|P2|NOT COMPLETED|Overall Study||28
387570|NCT00286455|948107|P1|NOT COMPLETED|Overall Study||25
387571|NCT00286455|948105|P3|COMPLETED|Overall Study||107
387572|NCT00286455|948106|P2|COMPLETED|Overall Study||105
387573|NCT00286455|948107|P1|COMPLETED|Overall Study||40
387574|NCT00286455|948105|P3|STARTED|Overall Study||131
387575|NCT00286455|948106|P2|STARTED|Overall Study||133
387576|NCT00286455|948107|P1|STARTED|Overall Study||65
387577|NCT00286442|948286|P3|NOT COMPLETED|Overall Study||32
387578|NCT00286442|948287|P2|NOT COMPLETED|Overall Study||45
387579|NCT00286442|948288|P1|NOT COMPLETED|Overall Study||37
387580|NCT00286442|948286|P3|COMPLETED|Overall Study||72
387581|NCT00286442|948287|P2|COMPLETED|Overall Study||165
387582|NCT00286442|948288|P1|COMPLETED|Overall Study||176
387583|NCT00286442|948286|P3|STARTED|Overall Study||104
387584|NCT00286442|948287|P2|STARTED|Overall Study||210
387585|NCT00286442|948288|P1|STARTED|Overall Study||213
387586|NCT00286429|948449|P3|NOT COMPLETED|Overall Study||52
387587|NCT00286429|948450|P2|NOT COMPLETED|Overall Study||48
387588|NCT00286429|948451|P1|NOT COMPLETED|Overall Study||75
387589|NCT00286429|948449|P3|COMPLETED|Overall Study||77
387590|NCT00286429|948450|P2|COMPLETED|Overall Study||83
387591|NCT00286429|948451|P1|COMPLETED|Overall Study||55
387592|NCT00286429|948449|P3|STARTED|Overall Study||129
387593|NCT00286429|948450|P2|STARTED|Overall Study||131
387594|NCT00286429|948451|P1|STARTED|Overall Study||130
387595|NCT00286325|948555|P1|NOT COMPLETED|Overall Study||0
387596|NCT00286325|948555|P1|COMPLETED|Overall Study||8
387597|NCT00286325|948555|P1|STARTED|Overall Study||8
387598|NCT00286221|948567|P4|NOT COMPLETED|Overall Study||6
387599|NCT00286221|948568|P3|NOT COMPLETED|Overall Study||9
387600|NCT00286221|948569|P2|NOT COMPLETED|Overall Study||5
387601|NCT00286221|948570|P1|NOT COMPLETED|Overall Study||10
387602|NCT00286221|948567|P4|COMPLETED|Overall Study||34
387603|NCT00286221|948568|P3|COMPLETED|Overall Study||31
387604|NCT00286221|948569|P2|COMPLETED|Overall Study||35
387605|NCT00286221|948570|P1|COMPLETED|Overall Study||29
387606|NCT00286221|948567|P4|STARTED|Overall Study||40
387607|NCT00286221|948568|P3|STARTED|Overall Study||40
387608|NCT00286221|948569|P2|STARTED|Overall Study||40
387609|NCT00286221|948570|P1|STARTED|Overall Study||39
387610|NCT00286182|948586|P2|NOT COMPLETED|Overall Study||3
387611|NCT00286182|948587|P1|NOT COMPLETED|Overall Study||5
387612|NCT00286182|948586|P2|COMPLETED|Overall Study||25
387613|NCT00286182|948587|P1|COMPLETED|Overall Study||23
387614|NCT00286182|948586|P2|STARTED|Overall Study||28
387615|NCT00286182|948587|P1|STARTED|Overall Study||28
387616|NCT00286156|948596|P3|NOT COMPLETED|Overall Study||1
387617|NCT00286156|948597|P2|NOT COMPLETED|Overall Study||1
387618|NCT00286156|948598|P1|NOT COMPLETED|Overall Study||2
387619|NCT00286156|948596|P3|COMPLETED|Overall Study||9
387620|NCT00286156|948597|P2|COMPLETED|Overall Study||9
387621|NCT00286156|948598|P1|COMPLETED|Overall Study||8
387622|NCT00286156|948596|P3|STARTED|Overall Study||10
387623|NCT00286156|948597|P2|STARTED|Overall Study||10
387624|NCT00286156|948598|P1|STARTED|Overall Study||10
387625|NCT00286091|948611|P2|NOT COMPLETED|Open-label Treatment Phase||71
387626|NCT00286091|948612|P1|NOT COMPLETED|Open-label Treatment Phase||77
387627|NCT00286091|948611|P2|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
387628|NCT00286091|948612|P1|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
387629|NCT00286091|948611|P2|Received Treatment|Open-label Treatment Phase||101
387630|NCT00286091|948612|P1|Received Treatment|Open-label Treatment Phase||109
387631|NCT00286091|948611|P2|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|104
387632|NCT00286091|948612|P1|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|110
387633|NCT00286091|948611|P2|NOT COMPLETED|Double-blind Treatment Phase||593
387634|NCT00286091|948612|P1|NOT COMPLETED|Double-blind Treatment Phase||584
387635|NCT00286091|948611|P2|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|123
387636|NCT00286091|948612|P1|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|132
387637|NCT00286091|948611|P2|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|174
387638|NCT00286091|948612|P1|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|164
387639|NCT00286091|948611|P2|Received Treatment|Double-blind Treatment Phase||716
387640|NCT00286091|948612|P1|Received Treatment|Double-blind Treatment Phase|4 participants received ≥ 1 dose of denosumab in error|709
387641|NCT00286091|948611|P2|STARTED|Double-blind Treatment Phase||716
387642|NCT00286091|948612|P1|STARTED|Double-blind Treatment Phase||716
387643|NCT00286078|948626|P2|NOT COMPLETED|Overall Study||34
387644|NCT00286078|948627|P1|NOT COMPLETED|Overall Study||32
387645|NCT00286078|948626|P2|COMPLETED|Overall Study||34
387646|NCT00286078|948627|P1|COMPLETED|Overall Study||40
387647|NCT00286078|948626|P2|12 Weeks|Overall Study||62
387648|NCT00286078|948627|P1|12 Weeks|Overall Study||63
387649|NCT00286078|948626|P2|STARTED|Overall Study||68
387650|NCT00286078|948627|P1|STARTED|Overall Study||72
387651|NCT00285857|948635|P1|NOT COMPLETED|Overall Study||4
387652|NCT00285857|948635|P1|COMPLETED|Overall Study||26
387653|NCT00285857|948635|P1|STARTED|Overall Study||30
387654|NCT00285818|948648|P2|NOT COMPLETED|Overall Study||2
387655|NCT00285818|948649|P1|NOT COMPLETED|Overall Study||4
387656|NCT00285818|948648|P2|COMPLETED|Overall Study||3
387657|NCT00285818|948649|P1|COMPLETED|Overall Study||2
387658|NCT00285818|948648|P2|STARTED|Overall Study||5
387659|NCT00285818|948649|P1|STARTED|Overall Study||6
387660|NCT00285779|948657|P2|NOT COMPLETED|Follow-up Period (wk 24-32)||0
387661|NCT00285779|948658|P1|NOT COMPLETED|Follow-up Period (wk 24-32)||1
387662|NCT00285779|948657|P2|COMPLETED|Follow-up Period (wk 24-32)||10
387663|NCT00285779|948658|P1|COMPLETED|Follow-up Period (wk 24-32)||8
387664|NCT00285779|948657|P2|STARTED|Follow-up Period (wk 24-32)||10
387665|NCT00285779|948658|P1|STARTED|Follow-up Period (wk 24-32)||9
387666|NCT00285779|948657|P2|NOT COMPLETED|Open Label Period (wk 12-24)||2
387667|NCT00285779|948658|P1|NOT COMPLETED|Open Label Period (wk 12-24)||2
387668|NCT00285779|948657|P2|COMPLETED|Open Label Period (wk 12-24)||10
387669|NCT00285779|948658|P1|COMPLETED|Open Label Period (wk 12-24)||9
387670|NCT00285779|948657|P2|STARTED|Open Label Period (wk 12-24)||12
387671|NCT00285779|948658|P1|STARTED|Open Label Period (wk 12-24)||11
387672|NCT00285779|948657|P2|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||1
387673|NCT00285779|948658|P1|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||3
387674|NCT00285779|948657|P2|COMPLETED|Placebo-controlled Period (wk 1-12)||12
387675|NCT00285779|948658|P1|COMPLETED|Placebo-controlled Period (wk 1-12)||11
387676|NCT00285779|948657|P2|STARTED|Placebo-controlled Period (wk 1-12)||13
387677|NCT00285779|948658|P1|STARTED|Placebo-controlled Period (wk 1-12)||14
387678|NCT00285649|948694|P3|NOT COMPLETED|Overall Study||6
387679|NCT00285649|948695|P2|NOT COMPLETED|Overall Study||6
387680|NCT00285649|948696|P1|NOT COMPLETED|Overall Study||9
387681|NCT00285649|948694|P3|COMPLETED|Overall Study||42
387682|NCT00285649|948695|P2|COMPLETED|Overall Study||66
387683|NCT00285649|948696|P1|COMPLETED|Overall Study||63
387684|NCT00285649|948694|P3|STARTED|Overall Study||48
387685|NCT00285649|948695|P2|STARTED|Overall Study||72
387686|NCT00285649|948696|P1|STARTED|Overall Study||72
387687|NCT00285584|948706|P2|NOT COMPLETED|Month 9||3
387688|NCT00285584|948707|P1|NOT COMPLETED|Month 9||1
387689|NCT00285584|948706|P2|COMPLETED|Month 9||14
387690|NCT00285584|948707|P1|COMPLETED|Month 9||15
387691|NCT00285584|948706|P2|STARTED|Month 9||17
387692|NCT00285584|948707|P1|STARTED|Month 9||16
387693|NCT00285584|948706|P2|NOT COMPLETED|Month 6||1
387694|NCT00285584|948707|P1|NOT COMPLETED|Month 6||0
387695|NCT00285584|948706|P2|COMPLETED|Month 6||17
387696|NCT00285584|948707|P1|COMPLETED|Month 6||16
387697|NCT00285584|948706|P2|STARTED|Month 6||18
387698|NCT00285584|948707|P1|STARTED|Month 6||16
387699|NCT00285584|948706|P2|NOT COMPLETED|Month 3||3
387700|NCT00285584|948707|P1|NOT COMPLETED|Month 3||4
387701|NCT00285584|948706|P2|COMPLETED|Month 3||18
387702|NCT00285584|948707|P1|COMPLETED|Month 3||16
387703|NCT00285584|948706|P2|STARTED|Month 3||21
387704|NCT00285584|948707|P1|STARTED|Month 3||20
387705|NCT00285584|948706|P2|NOT COMPLETED|Enrollment (Month 0)||0
387706|NCT00285584|948707|P1|NOT COMPLETED|Enrollment (Month 0)||0
387707|NCT00285584|948706|P2|COMPLETED|Enrollment (Month 0)||21
387708|NCT00285584|948707|P1|COMPLETED|Enrollment (Month 0)||20
387709|NCT00285584|948706|P2|STARTED|Enrollment (Month 0)||21
387710|NCT00285584|948707|P1|STARTED|Enrollment (Month 0)||20
387711|NCT00285467|948721|P2|NOT COMPLETED|Overall Study||0
387712|NCT00285467|948722|P1|NOT COMPLETED|Overall Study||0
387713|NCT00285467|948721|P2|COMPLETED|Overall Study||22
387714|NCT00285467|948722|P1|COMPLETED|Overall Study||25
387715|NCT00285467|948721|P2|STARTED|Overall Study||22
387716|NCT00285467|948722|P1|STARTED|Overall Study||25
387717|NCT00285246|948730|P1|NOT COMPLETED|Overall Study||48
387718|NCT00285246|948730|P1|COMPLETED|Overall Study|Number of participants who were eligible and completed at least one phase of data collection|790
387719|NCT00285246|948730|P1|STARTED|Overall Study||838
387720|NCT00285207|948739|P2|NOT COMPLETED|Overall Study||6
387721|NCT00285207|948740|P1|NOT COMPLETED|Overall Study||9
387722|NCT00285207|948739|P2|COMPLETED|Overall Study||71
387723|NCT00285207|948740|P1|COMPLETED|Overall Study||61
387724|NCT00285207|948739|P2|Treated|Overall Study||75
387725|NCT00285207|948740|P1|Treated|Overall Study||63
387726|NCT00285207|948739|P2|STARTED|Overall Study||77
387727|NCT00285207|948740|P1|STARTED|Overall Study||70
387728|NCT00285012|948748|P2|NOT COMPLETED|Received Study Tx||94
387729|NCT00285012|948749|P1|NOT COMPLETED|Received Study Tx||72
387730|NCT00285012|948748|P2|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|157
387731|NCT00285012|948749|P1|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|176
387732|NCT00285012|948748|P2|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=14 AE;3 Lack of efficacy;10 Lost to follow up;25 subject withdrawal;6 other, unknown|58
387733|NCT00285012|948749|P1|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=12 Adverse Event (AE); 10 Lost to follow up; 13 subject withdrawal; 6 other, unknown|41
387734|NCT00285012|948748|P2|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|193
387735|NCT00285012|948749|P1|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|207
387736|NCT00285012|948748|P2|STARTED|Received Study Tx||251
387737|NCT00285012|948749|P1|STARTED|Received Study Tx||248
387738|NCT00285012|948748|P2|NOT COMPLETED|Assigned to Study Treatment (Tx)||3
387739|NCT00285012|948749|P1|NOT COMPLETED|Assigned to Study Treatment (Tx)||2
387740|NCT00285012|948748|P2|COMPLETED|Assigned to Study Treatment (Tx)||251
387741|NCT00285012|948749|P1|COMPLETED|Assigned to Study Treatment (Tx)||248
387742|NCT00285012|948748|P2|STARTED|Assigned to Study Treatment (Tx)||254
387743|NCT00285012|948749|P1|STARTED|Assigned to Study Treatment (Tx)||250
387744|NCT00284934|948775|P2|NOT COMPLETED|Overall Study||3
387745|NCT00284934|948776|P1|NOT COMPLETED|Overall Study||4
387746|NCT00284934|948775|P2|COMPLETED|Overall Study||43
387747|NCT00284934|948776|P1|COMPLETED|Overall Study||44
387748|NCT00284934|948775|P2|Intent-to-treat Population (ITT)|Overall Study||45
387749|NCT00284934|948776|P1|Intent-to-treat Population (ITT)|Overall Study||47
387750|NCT00284934|948775|P2|STARTED|Overall Study||46
387751|NCT00284934|948776|P1|STARTED|Overall Study||48
387752|NCT00284856|948791|P3|NOT COMPLETED|Overall Study||60
387753|NCT00284856|948792|P2|NOT COMPLETED|Overall Study||50
387754|NCT00284856|948793|P1|NOT COMPLETED|Overall Study||51
387755|NCT00284856|948791|P3|COMPLETED|Overall Study||276
387756|NCT00284856|948792|P2|COMPLETED|Overall Study||286
387757|NCT00284856|948793|P1|COMPLETED|Overall Study||296
387758|NCT00284856|948791|P3|STARTED|Overall Study||336
387759|NCT00284856|948792|P2|STARTED|Overall Study||336
387760|NCT00284856|948793|P1|STARTED|Overall Study||347
387761|NCT00284739|948809|P2|NOT COMPLETED|Overall Study||0
387762|NCT00284739|948810|P1|NOT COMPLETED|Overall Study||0
387763|NCT00284739|948809|P2|COMPLETED|Overall Study||9
387764|NCT00284739|948810|P1|COMPLETED|Overall Study||11
387765|NCT00284739|948809|P2|STARTED|Overall Study||9
387766|NCT00284739|948810|P1|STARTED|Overall Study||11
387767|NCT00284557|948822|P2|NOT COMPLETED|Overall Study||13
387768|NCT00284557|948823|P1|NOT COMPLETED|Overall Study||9
387769|NCT00284557|948822|P2|COMPLETED|Overall Study||50
387770|NCT00284557|948823|P1|COMPLETED|Overall Study||58
387771|NCT00284557|948822|P2|STARTED|Overall Study||63
387772|NCT00284557|948823|P1|STARTED|Overall Study||67
387773|NCT00284518|948835|P4|NOT COMPLETED|Overall Study||33
387774|NCT00284518|948836|P3|NOT COMPLETED|Overall Study||28
387775|NCT00284518|948837|P2|NOT COMPLETED|Overall Study||28
387776|NCT00284518|948838|P1|NOT COMPLETED|Overall Study||26
387777|NCT00284518|948835|P4|COMPLETED|Overall Study||61
387778|NCT00284518|948836|P3|COMPLETED|Overall Study||67
387779|NCT00284518|948837|P2|COMPLETED|Overall Study||66
387780|NCT00284518|948838|P1|COMPLETED|Overall Study||71
387781|NCT00284518|948835|P4|STARTED|Overall Study||94
387782|NCT00284518|948836|P3|STARTED|Overall Study||95
387783|NCT00284518|948837|P2|STARTED|Overall Study||94
387784|NCT00284518|948838|P1|STARTED|Overall Study||97
387785|NCT00284180|948878|P2|NOT COMPLETED|Overall Study||4
387786|NCT00284180|948879|P1|NOT COMPLETED|Overall Study||0
387787|NCT00284180|948878|P2|COMPLETED|Overall Study||17
387788|NCT00284180|948879|P1|COMPLETED|Overall Study||11
387789|NCT00284180|948878|P2|STARTED|Overall Study||21
387790|NCT00284180|948879|P1|STARTED|Overall Study||11
387791|NCT00284154|948885|P1|NOT COMPLETED|Overall Study||42
387792|NCT00284154|948885|P1|COMPLETED|Overall Study||9
387793|NCT00284154|948885|P1|STARTED|Overall Study||51
387794|NCT00284141|948892|P1|NOT COMPLETED|Overall Study||98
387795|NCT00284141|948892|P1|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were still ongoing treatment.|0
387796|NCT00284141|948892|P1|ONGOING TREATMENT|Overall Study|Participants were still on study treatment at the clinical database cut-off date.|2
387797|NCT00284141|948892|P1|TREATED|Overall Study|Participants received at least part of one dose of Aflibercept.|96
387798|NCT00284141|948892|P1|STARTED|Overall Study||98
387799|NCT00284089|948915|P4|NOT COMPLETED|Extension Phase||12
387800|NCT00284089|948916|P3|NOT COMPLETED|Extension Phase||6
387801|NCT00284089|948917|P2|NOT COMPLETED|Extension Phase||0
387802|NCT00284089|948918|P1|NOT COMPLETED|Extension Phase||2
387803|NCT00284089|948915|P4|COMPLETED|Extension Phase||21
387804|NCT00284089|948916|P3|COMPLETED|Extension Phase||22
387805|NCT00284089|948917|P2|COMPLETED|Extension Phase||6
387806|NCT00284089|948918|P1|COMPLETED|Extension Phase||1
387807|NCT00284089|948915|P4|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|33
387808|NCT00284089|948916|P3|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|28
387809|NCT00284089|948917|P2|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|6
387810|NCT00284089|948918|P1|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|3
387811|NCT00284089|948915|P4|NOT COMPLETED|Multiple Dose Phase||4
387812|NCT00284089|948916|P3|NOT COMPLETED|Multiple Dose Phase||4
387813|NCT00284089|948917|P2|NOT COMPLETED|Multiple Dose Phase||0
387814|NCT00284089|948918|P1|NOT COMPLETED|Multiple Dose Phase||1
387815|NCT00284089|948915|P4|COMPLETED|Multiple Dose Phase||37
387816|NCT00284089|948916|P3|COMPLETED|Multiple Dose Phase||31
387817|NCT00284089|948917|P2|COMPLETED|Multiple Dose Phase||6
387818|NCT00284089|948918|P1|COMPLETED|Multiple Dose Phase||4
387819|NCT00284089|948915|P4|STARTED|Multiple Dose Phase||41
387820|NCT00284089|948916|P3|STARTED|Multiple Dose Phase||35
387821|NCT00284089|948917|P2|STARTED|Multiple Dose Phase||6
387822|NCT00284089|948918|P1|STARTED|Multiple Dose Phase|1 subject chose to receive other treatment & discontinued before starting the multiple dose phase.|5
387823|NCT00284089|948915|P4|NOT COMPLETED|Single Dose Phase||0
387824|NCT00284089|948916|P3|NOT COMPLETED|Single Dose Phase||0
387825|NCT00284089|948917|P2|NOT COMPLETED|Single Dose Phase||0
387826|NCT00284089|948918|P1|NOT COMPLETED|Single Dose Phase||0
387827|NCT00284089|948915|P4|COMPLETED|Single Dose Phase||0
387828|NCT00284089|948916|P3|COMPLETED|Single Dose Phase||0
387829|NCT00284089|948917|P2|COMPLETED|Single Dose Phase||6
387830|NCT00284089|948918|P1|COMPLETED|Single Dose Phase||6
387831|NCT00284089|948915|P4|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
387832|NCT00284089|948916|P3|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
387833|NCT00284089|948917|P2|STARTED|Single Dose Phase||6
387834|NCT00284089|948918|P1|STARTED|Single Dose Phase||6
387835|NCT00284050|948947|P3|NOT COMPLETED|Overall Study||9
387836|NCT00284050|948948|P2|NOT COMPLETED|Overall Study||5
387837|NCT00284050|948949|P1|NOT COMPLETED|Overall Study||5
387838|NCT00284050|948947|P3|COMPLETED|Overall Study||40
387839|NCT00284050|948948|P2|COMPLETED|Overall Study||46
387840|NCT00284050|948949|P1|COMPLETED|Overall Study||46
387841|NCT00284050|948947|P3|STARTED|Overall Study||49
387842|NCT00284050|948948|P2|STARTED|Overall Study||51
387843|NCT00284050|948949|P1|STARTED|Overall Study||51
387844|NCT00283959|948963|P1|NOT COMPLETED|Extension Period||1
387845|NCT00283959|948963|P1|COMPLETED|Extension Period||3
387846|NCT00283959|948963|P1|STARTED|Extension Period||4
387847|NCT00283959|948963|P1|NOT COMPLETED|Treatment Period||0
387848|NCT00283959|948963|P1|COMPLETED|Treatment Period||4
387849|NCT00283959|948963|P1|Pharmacodynamics (PD) Population|Treatment Period||4
387850|NCT00283959|948963|P1|Safety Population|Treatment Period||4
387851|NCT00283959|948963|P1|STARTED|Treatment Period||4
387852|NCT00283933|948968|P1|NOT COMPLETED|Extension Period||0
387853|NCT00283933|948968|P1|COMPLETED|Extension Period||5
387854|NCT00283933|948968|P1|STARTED|Extension Period||5
387855|NCT00283933|948968|P1|NOT COMPLETED|Treatment Period||0
387856|NCT00283933|948968|P1|COMPLETED|Treatment Period||5
387857|NCT00283933|948968|P1|Pharmacodynamic (PD) Population|Treatment Period||5
387858|NCT00283933|948968|P1|Safety Population|Treatment Period||5
387859|NCT00283933|948968|P1|STARTED|Treatment Period||5
387860|NCT00283868|948975|P2|NOT COMPLETED|Overall Study||8
387861|NCT00283868|948976|P1|NOT COMPLETED|Overall Study||7
387862|NCT00283868|948975|P2|COMPLETED|Overall Study||103
387863|NCT00283868|948976|P1|COMPLETED|Overall Study||104
387864|NCT00283868|948975|P2|STARTED|Overall Study||111
387865|NCT00283868|948976|P1|STARTED|Overall Study||111
387866|NCT00283842|948993|P5|NOT COMPLETED|Overall Study||15
387867|NCT00283842|948994|P4|NOT COMPLETED|Overall Study||27
387868|NCT00283842|948995|P3|NOT COMPLETED|Overall Study||31
387869|NCT00283842|948996|P2|NOT COMPLETED|Overall Study||18
387870|NCT00283842|948997|P1|NOT COMPLETED|Overall Study||12
387871|NCT00283842|948993|P5|COMPLETED|Overall Study||75
387872|NCT00283842|948994|P4|COMPLETED|Overall Study||42
387873|NCT00283842|948995|P3|COMPLETED|Overall Study||68
387874|NCT00283842|948996|P2|COMPLETED|Overall Study||69
387875|NCT00283842|948997|P1|COMPLETED|Overall Study||51
387876|NCT00283842|948993|P5|STARTED|Overall Study||90
387877|NCT00283842|948994|P4|STARTED|Overall Study||69
387878|NCT00283842|948995|P3|STARTED|Overall Study||99
387879|NCT00283842|948996|P2|STARTED|Overall Study||87
387880|NCT00283842|948997|P1|STARTED|Overall Study||63
387881|NCT00283816|949016|P2|NOT COMPLETED|Overall Study||2
387882|NCT00283816|949017|P1|NOT COMPLETED|Overall Study||2
387883|NCT00283816|949016|P2|COMPLETED|Overall Study||16
387884|NCT00283816|949017|P1|COMPLETED|Overall Study||16
387885|NCT00283816|949016|P2|STARTED|Overall Study||18
387886|NCT00283816|949017|P1|STARTED|Overall Study||18
387887|NCT00283803|949029|P1|NOT COMPLETED|Overall Study||13
387888|NCT00283803|949029|P1|COMPLETED|Overall Study||19
387889|NCT00283803|949029|P1|STARTED|Overall Study||32
387890|NCT00283712|949037|P2|NOT COMPLETED|Overall Study||1
387891|NCT00283712|949038|P1|NOT COMPLETED|Overall Study||0
387892|NCT00283712|949037|P2|COMPLETED|Overall Study|One subject in placebo arm died prior to study completion.|9
387893|NCT00283712|949038|P1|COMPLETED|Overall Study||10
387894|NCT00283712|949037|P2|Per-Protocol Sample|Overall Study||7
387895|NCT00283712|949038|P1|Per-Protocol Sample|Overall Study||6
387896|NCT00283712|949037|P2|Safety Sample|Overall Study||10
387897|NCT00283712|949038|P1|Safety Sample|Overall Study||10
387898|NCT00283712|949037|P2|Intent-to-treat Sample|Overall Study||10
387899|NCT00283712|949038|P1|Intent-to-treat Sample|Overall Study||10
387900|NCT00283712|949037|P2|STARTED|Overall Study||10
387901|NCT00283712|949038|P1|STARTED|Overall Study||10
387902|NCT00283686|949076|P4|NOT COMPLETED|Overall Study||32
387903|NCT00283686|949077|P3|NOT COMPLETED|Overall Study||33
387904|NCT00283686|949078|P2|NOT COMPLETED|Overall Study||41
387905|NCT00283686|949079|P1|NOT COMPLETED|Overall Study||29
387906|NCT00283686|949076|P4|COMPLETED|Overall Study||109
387907|NCT00283686|949077|P3|COMPLETED|Overall Study||111
387908|NCT00283686|949078|P2|COMPLETED|Overall Study||92
387909|NCT00283686|949079|P1|COMPLETED|Overall Study||111
387910|NCT00283686|949076|P4|STARTED|Overall Study||141
387911|NCT00283686|949077|P3|STARTED|Overall Study||144
387912|NCT00283686|949078|P2|STARTED|Overall Study||133
387913|NCT00283686|949079|P1|STARTED|Overall Study||140
387914|NCT00283595|949123|P2|NOT COMPLETED|Overall Study||2
387915|NCT00283595|949124|P1|NOT COMPLETED|Overall Study||1
387916|NCT00283595|949123|P2|COMPLETED|Overall Study||9
387917|NCT00283595|949124|P1|COMPLETED|Overall Study||9
387918|NCT00283595|949123|P2|STARTED|Overall Study||11
387919|NCT00283595|949124|P1|STARTED|Overall Study||10
387920|NCT00283504|949134|P2|NOT COMPLETED|Overall Study||0
387921|NCT00283504|949135|P1|NOT COMPLETED|Overall Study||0
387922|NCT00283504|949134|P2|COMPLETED|Overall Study||6
387923|NCT00283504|949135|P1|COMPLETED|Overall Study||7
387924|NCT00283504|949134|P2|STARTED|Overall Study||6
387925|NCT00283504|949135|P1|STARTED|Overall Study||7
387926|NCT00283439|949149|P4|NOT COMPLETED|Overall Study||9
387927|NCT00283439|949150|P3|NOT COMPLETED|Overall Study||11
387928|NCT00283439|949151|P2|NOT COMPLETED|Overall Study||11
387929|NCT00283439|949152|P1|NOT COMPLETED|Overall Study||8
387930|NCT00283439|949149|P4|COMPLETED|Overall Study||0
387931|NCT00283439|949150|P3|COMPLETED|Overall Study||0
387932|NCT00283439|949151|P2|COMPLETED|Overall Study||0
387933|NCT00283439|949152|P1|COMPLETED|Overall Study||0
387934|NCT00283439|949149|P4|STARTED|Overall Study||9
387935|NCT00283439|949150|P3|STARTED|Overall Study||11
387936|NCT00283439|949151|P2|STARTED|Overall Study||11
387937|NCT00283439|949152|P1|STARTED|Overall Study||8
387938|NCT00283400|949178|P4|NOT COMPLETED|Overall Study||0
387939|NCT00283400|949179|P3|NOT COMPLETED|Overall Study||1
387940|NCT00283400|949180|P2|NOT COMPLETED|Overall Study||1
387941|NCT00283400|949181|P1|NOT COMPLETED|Overall Study||2
387942|NCT00283400|949178|P4|COMPLETED|Overall Study||0
387943|NCT00283400|949179|P3|COMPLETED|Overall Study||6
387944|NCT00283400|949180|P2|COMPLETED|Overall Study||19
387945|NCT00283400|949181|P1|COMPLETED|Overall Study||18
387946|NCT00283400|949178|P4|STARTED|Overall Study||0
387947|NCT00283400|949179|P3|STARTED|Overall Study||7
387948|NCT00283400|949180|P2|STARTED|Overall Study||20
387949|NCT00283400|949181|P1|STARTED|Overall Study||20
387950|NCT00283387|949199|P2|NOT COMPLETED|Second Intervention||0
387951|NCT00283387|949200|P1|NOT COMPLETED|Second Intervention||0
387952|NCT00283387|949199|P2|COMPLETED|Second Intervention||5
387953|NCT00283387|949200|P1|COMPLETED|Second Intervention||5
387954|NCT00283387|949199|P2|STARTED|Second Intervention||5
387955|NCT00283387|949200|P1|STARTED|Second Intervention||5
387956|NCT00283387|949199|P2|NOT COMPLETED|Washout Period of 2 Months||0
387957|NCT00283387|949200|P1|NOT COMPLETED|Washout Period of 2 Months||0
387958|NCT00283387|949199|P2|COMPLETED|Washout Period of 2 Months||5
387959|NCT00283387|949200|P1|COMPLETED|Washout Period of 2 Months||5
387960|NCT00283387|949199|P2|STARTED|Washout Period of 2 Months||5
387961|NCT00283387|949200|P1|STARTED|Washout Period of 2 Months||5
387962|NCT00283387|949199|P2|NOT COMPLETED|First Intervention||2
387963|NCT00283387|949200|P1|NOT COMPLETED|First Intervention||1
387964|NCT00283387|949199|P2|COMPLETED|First Intervention||5
387965|NCT00283387|949200|P1|COMPLETED|First Intervention||5
387966|NCT00283387|949199|P2|STARTED|First Intervention||7
387967|NCT00283387|949200|P1|STARTED|First Intervention||6
387968|NCT00283296|949206|P1|NOT COMPLETED|Overall Study||5
387969|NCT00283296|949206|P1|COMPLETED|Overall Study|Completed in-lab and in-home trial.|9
387970|NCT00283296|949206|P1|STARTED|Overall Study||14
387971|NCT00283244|949215|P3|NOT COMPLETED|Overall Study||51
387972|NCT00283244|949216|P2|NOT COMPLETED|Overall Study||51
387973|NCT00283244|949217|P1|NOT COMPLETED|Overall Study||18
387974|NCT00283244|949215|P3|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 9 patients received 2nd line therapy|0
387975|NCT00283244|949216|P2|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 12 patients received 2nd line therapy|0
387976|NCT00283244|949217|P1|COMPLETED|Overall Study|19 patients went on to receive second line Erlotinib|26
387977|NCT00283244|949215|P3|STARTED|Overall Study||51
387978|NCT00283244|949216|P2|STARTED|Overall Study||51
387979|NCT00283244|949217|P1|STARTED|Overall Study||44
387980|NCT00283075|949237|P2|NOT COMPLETED|Overall Study||0
387981|NCT00283075|949238|P1|NOT COMPLETED|Overall Study||0
387982|NCT00283075|949237|P2|COMPLETED|Overall Study||6
387983|NCT00283075|949238|P1|COMPLETED|Overall Study||25
387984|NCT00283075|949237|P2|STARTED|Overall Study||6
387985|NCT00283075|949238|P1|STARTED|Overall Study||25
387986|NCT00283062|949253|P4|NOT COMPLETED|Overall Study||49
387987|NCT00283062|949254|P3|NOT COMPLETED|Overall Study||41
387988|NCT00283062|949255|P2|NOT COMPLETED|Overall Study||7
387989|NCT00283062|949256|P1|NOT COMPLETED|Overall Study||12
387990|NCT00283062|949253|P4|COMPLETED|Overall Study||13
387991|NCT00283062|949254|P3|COMPLETED|Overall Study||15
387992|NCT00283062|949255|P2|COMPLETED|Overall Study||48
387993|NCT00283062|949256|P1|COMPLETED|Overall Study||43
387994|NCT00283062|949253|P4|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
387995|NCT00283062|949254|P3|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||15
387996|NCT00283062|949255|P2|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
387997|NCT00283062|949256|P1|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||43
387998|NCT00283062|949253|P4|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||13
387999|NCT00283062|949254|P3|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||15
388000|NCT00283062|949255|P2|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||48
388001|NCT00283062|949256|P1|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||44
388002|NCT00283062|949253|P4|ADMINISTERED STUDY TREATMENT|Overall Study||17
388003|NCT00283062|949254|P3|ADMINISTERED STUDY TREATMENT|Overall Study||20
388004|NCT00283062|949255|P2|ADMINISTERED STUDY TREATMENT|Overall Study||51
388005|NCT00283062|949256|P1|ADMINISTERED STUDY TREATMENT|Overall Study||50
388006|NCT00283062|949253|P4|STARTED|Overall Study||62
388007|NCT00283062|949254|P3|STARTED|Overall Study||56
388008|NCT00283062|949255|P2|STARTED|Overall Study||55
388009|NCT00283062|949256|P1|STARTED|Overall Study||55
388010|NCT00283049|949289|P3|NOT COMPLETED|Overall Study||54
388011|NCT00283049|949290|P2|NOT COMPLETED|Overall Study||45
388012|NCT00283049|949291|P1|NOT COMPLETED|Overall Study||58
388013|NCT00283049|949289|P3|COMPLETED|Overall Study||76
388014|NCT00283049|949290|P2|COMPLETED|Overall Study||83
388015|NCT00283049|949291|P1|COMPLETED|Overall Study||70
388016|NCT00283049|949289|P3|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|130
388104|NCT00282568|949476|P1|STARTED|Pharmacokinetic Treatment Period||70
388017|NCT00283049|949290|P2|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|128
388018|NCT00283049|949291|P1|STARTED|Overall Study|2 randomized patients did not receive study drug and were not included in the safety population|128
388019|NCT00282984|949319|P2|NOT COMPLETED|Overall Study||61
388020|NCT00282984|949320|P1|NOT COMPLETED|Overall Study||51
388021|NCT00282984|949319|P2|COMPLETED|Overall Study||289
388022|NCT00282984|949320|P1|COMPLETED|Overall Study||302
388023|NCT00282984|949319|P2|STARTED|Overall Study||350
388024|NCT00282984|949320|P1|STARTED|Overall Study||353
388025|NCT00282971|949346|P2|NOT COMPLETED|Overall Study||22
388026|NCT00282971|949347|P1|NOT COMPLETED|Overall Study||34
388027|NCT00282971|949346|P2|COMPLETED|Overall Study||149
388028|NCT00282971|949347|P1|COMPLETED|Overall Study||146
388029|NCT00282971|949346|P2|STARTED|Overall Study||171
388030|NCT00282971|949347|P1|STARTED|Overall Study||180
388031|NCT00282919|949357|P1|NOT COMPLETED|Overall Study||7
388032|NCT00282919|949357|P1|COMPLETED|Overall Study||103
388033|NCT00282919|949357|P1|STARTED|Overall Study||110
388034|NCT00282867|949372|P3|NOT COMPLETED|Overall Study||0
388035|NCT00282867|949373|P2|NOT COMPLETED|Overall Study||1
388036|NCT00282867|949374|P1|NOT COMPLETED|Overall Study||1
388037|NCT00282867|949372|P3|COMPLETED|Overall Study||25
388038|NCT00282867|949373|P2|COMPLETED|Overall Study||24
388039|NCT00282867|949374|P1|COMPLETED|Overall Study||23
388040|NCT00282867|949372|P3|STARTED|Overall Study||25
388041|NCT00282867|949373|P2|STARTED|Overall Study||25
388042|NCT00282867|949374|P1|STARTED|Overall Study||24
388043|NCT00282841|949388|P1|NOT COMPLETED|Overall Study||0
388044|NCT00282841|949388|P1|COMPLETED|Overall Study||61
388045|NCT00282841|949388|P1|STARTED|Overall Study|Anticipated recruitment 400; stopped due to funding and poor recruitment.|61
388046|NCT00282828|949396|P3|NOT COMPLETED|Overall Study||9
388047|NCT00282828|949397|P2|NOT COMPLETED|Overall Study||12
388048|NCT00282828|949398|P1|NOT COMPLETED|Overall Study||6
388049|NCT00282828|949396|P3|COMPLETED|Overall Study||50
388050|NCT00282828|949397|P2|COMPLETED|Overall Study||47
388051|NCT00282828|949398|P1|COMPLETED|Overall Study||57
388052|NCT00282828|949396|P3|STARTED|Overall Study||59
388053|NCT00282828|949397|P2|STARTED|Overall Study||59
388054|NCT00282828|949398|P1|STARTED|Overall Study||63
388055|NCT00282815|949411|P2|NOT COMPLETED|Overall Study||6
388056|NCT00282815|949412|P1|NOT COMPLETED|Overall Study||7
388057|NCT00282815|949411|P2|COMPLETED|Overall Study||11
388058|NCT00282815|949412|P1|COMPLETED|Overall Study||8
388059|NCT00282815|949411|P2|STARTED|Overall Study||17
388060|NCT00282815|949412|P1|STARTED|Overall Study||15
388061|NCT00282672|949425|P4|NOT COMPLETED|5 Year: Follow up||5
388062|NCT00282672|949426|P3|NOT COMPLETED|5 Year: Follow up||0
388063|NCT00282672|949427|P2|NOT COMPLETED|5 Year: Follow up||5
388064|NCT00282672|949428|P1|NOT COMPLETED|5 Year: Follow up||1
388065|NCT00282672|949425|P4|COMPLETED|5 Year: Follow up||20
388066|NCT00282672|949426|P3|COMPLETED|5 Year: Follow up||12
388067|NCT00282672|949427|P2|COMPLETED|5 Year: Follow up||27
388068|NCT00282672|949428|P1|COMPLETED|5 Year: Follow up||14
388069|NCT00282672|949425|P4|STARTED|5 Year: Follow up|11 withdrew|25
388070|NCT00282672|949426|P3|STARTED|5 Year: Follow up|3 withdrew|12
388071|NCT00282672|949427|P2|STARTED|5 Year: Follow up|7 withdrew|32
388072|NCT00282672|949428|P1|STARTED|5 Year: Follow up|1 withdrew|15
388073|NCT00282672|949425|P4|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||2
388074|NCT00282672|949426|P3|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
388075|NCT00282672|949427|P2|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
388076|NCT00282672|949428|P1|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||3
388077|NCT00282672|949425|P4|COMPLETED|2 Year: Sham Crossed Over to RFA||36
388078|NCT00282672|949426|P3|COMPLETED|2 Year: Sham Crossed Over to RFA||15
388079|NCT00282672|949427|P2|COMPLETED|2 Year: Sham Crossed Over to RFA||39
388080|NCT00282672|949428|P1|COMPLETED|2 Year: Sham Crossed Over to RFA||16
388081|NCT00282672|949425|P4|STARTED|2 Year: Sham Crossed Over to RFA||38
388082|NCT00282672|949426|P3|STARTED|2 Year: Sham Crossed Over to RFA|16 Crossed over to RFA treatment|16
388083|NCT00282672|949427|P2|STARTED|2 Year: Sham Crossed Over to RFA||40
388084|NCT00282672|949428|P1|STARTED|2 Year: Sham Crossed Over to RFA|19 crossed over to RFA treatment|19
388085|NCT00282672|949425|P4|NOT COMPLETED|1 Year||4
388086|NCT00282672|949426|P3|NOT COMPLETED|1 Year||1
388087|NCT00282672|949427|P2|NOT COMPLETED|1 Year||2
388088|NCT00282672|949428|P1|NOT COMPLETED|1 Year||3
388089|NCT00282672|949425|P4|COMPLETED|1 Year||38
388090|NCT00282672|949426|P3|COMPLETED|1 Year||20
388091|NCT00282672|949427|P2|COMPLETED|1 Year||40
388092|NCT00282672|949428|P1|COMPLETED|1 Year||19
388093|NCT00282672|949425|P4|STARTED|1 Year||42
388094|NCT00282672|949426|P3|STARTED|1 Year||21
388095|NCT00282672|949427|P2|STARTED|1 Year||42
388096|NCT00282672|949428|P1|STARTED|1 Year||22
388097|NCT00282568|949476|P1|NOT COMPLETED|Extended Treatment Period||24
388098|NCT00282568|949476|P1|COMPLETED|Extended Treatment Period||42
388099|NCT00282568|949476|P1|STARTED|Extended Treatment Period|One patient who completed the PK period did not enter the extended treatment period.|66
388100|NCT00282568|949476|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||3
388101|NCT00282568|949476|P1|COMPLETED|Pharmacokinetic Treatment Period||67
388102|NCT00282568|949476|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||67
388103|NCT00282568|949476|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||68
388105|NCT00282464|949502|P2|NOT COMPLETED|Overall Study||62
388106|NCT00282464|949503|P1|NOT COMPLETED|Overall Study||73
388107|NCT00282464|949502|P2|COMPLETED|Overall Study||134
388108|NCT00282464|949503|P1|COMPLETED|Overall Study||112
388109|NCT00282464|949502|P2|STARTED|Overall Study||196
388110|NCT00282464|949503|P1|STARTED|Overall Study||185
388111|NCT00282438|949553|P2|NOT COMPLETED|Overall Study||1
388112|NCT00282438|949554|P1|NOT COMPLETED|Overall Study||1
388113|NCT00282438|949553|P2|COMPLETED|Overall Study||0
388114|NCT00282438|949554|P1|COMPLETED|Overall Study||0
388115|NCT00282438|949553|P2|STARTED|Overall Study||1
388116|NCT00282438|949554|P1|STARTED|Overall Study||1
388117|NCT00282412|949564|P1|NOT COMPLETED|Overall Study||2
388118|NCT00282412|949564|P1|COMPLETED|Overall Study|Two late deaths non-treatment related. One from pulmonary embolism and one from late leukemia.|2
388119|NCT00282412|949564|P1|STARTED|Overall Study||4
388120|NCT00282347|949570|P2|NOT COMPLETED|B Cell Follow-up Period||0
388121|NCT00282347|949571|P1|NOT COMPLETED|B Cell Follow-up Period||5
388122|NCT00282347|949570|P2|COMPLETED|B Cell Follow-up Period||4
388123|NCT00282347|949571|P1|COMPLETED|B Cell Follow-up Period||15
388124|NCT00282347|949570|P2|STARTED|B Cell Follow-up Period||4
388125|NCT00282347|949571|P1|STARTED|B Cell Follow-up Period||20
388126|NCT00282347|949570|P2|NOT COMPLETED|Safety Follow-up Period||6
388127|NCT00282347|949571|P1|NOT COMPLETED|Safety Follow-up Period||3
388128|NCT00282347|949570|P2|COMPLETED|Safety Follow-up Period||57
388129|NCT00282347|949571|P1|COMPLETED|Safety Follow-up Period||64
388130|NCT00282347|949570|P2|STARTED|Safety Follow-up Period||63
388131|NCT00282347|949571|P1|STARTED|Safety Follow-up Period||67
388132|NCT00282347|949570|P2|NOT COMPLETED|Treatment Period||9
388133|NCT00282347|949571|P1|NOT COMPLETED|Treatment Period||5
388134|NCT00282347|949570|P2|COMPLETED|Treatment Period||63
388135|NCT00282347|949571|P1|COMPLETED|Treatment Period||67
388136|NCT00282347|949570|P2|STARTED|Treatment Period||72
388137|NCT00282347|949571|P1|STARTED|Treatment Period||72
388138|NCT00282334|949597|P2|NOT COMPLETED|Overall Study||5
388139|NCT00282334|949598|P1|NOT COMPLETED|Overall Study||8
388140|NCT00282334|949597|P2|COMPLETED|Overall Study||118
388141|NCT00282334|949598|P1|COMPLETED|Overall Study||105
388142|NCT00282334|949597|P2|STARTED|Overall Study||123
388143|NCT00282334|949598|P1|STARTED|Overall Study||113
388144|NCT00282308|949606|P3|NOT COMPLETED|Safety Follow-up Period||19
388145|NCT00282308|949607|P2|NOT COMPLETED|Safety Follow-up Period||0
388146|NCT00282308|949608|P1|NOT COMPLETED|Safety Follow-up Period||0
388147|NCT00282308|949606|P3|COMPLETED|Safety Follow-up Period||81
388148|NCT00282308|949607|P2|COMPLETED|Safety Follow-up Period||0
388149|NCT00282308|949608|P1|COMPLETED|Safety Follow-up Period||0
388150|NCT00282308|949606|P3|STARTED|Safety Follow-up Period|Some patients entered this Safety Follow-up Period directly from the Treatment Period.|100
388151|NCT00282308|949607|P2|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
388152|NCT00282308|949608|P1|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
388153|NCT00282308|949606|P3|NOT COMPLETED|Optional Extension Re-treatment Period||6
388154|NCT00282308|949607|P2|NOT COMPLETED|Optional Extension Re-treatment Period||0
388155|NCT00282308|949608|P1|NOT COMPLETED|Optional Extension Re-treatment Period||0
388156|NCT00282308|949606|P3|COMPLETED|Optional Extension Re-treatment Period||72
388157|NCT00282308|949607|P2|COMPLETED|Optional Extension Re-treatment Period||0
388158|NCT00282308|949608|P1|COMPLETED|Optional Extension Re-treatment Period||0
388159|NCT00282308|949606|P3|STARTED|Optional Extension Re-treatment Period|Not all patients who completed the Treatment Period entered this Optional Re-treatment Period.|78
388160|NCT00282308|949607|P2|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
388161|NCT00282308|949608|P1|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
388162|NCT00282308|949606|P3|NOT COMPLETED|Treatment Period||0
388163|NCT00282308|949607|P2|NOT COMPLETED|Treatment Period||6
388164|NCT00282308|949608|P1|NOT COMPLETED|Treatment Period||4
388165|NCT00282308|949606|P3|COMPLETED|Treatment Period||0
388166|NCT00282308|949607|P2|COMPLETED|Treatment Period||28
388167|NCT00282308|949608|P1|COMPLETED|Treatment Period||65
388168|NCT00282308|949606|P3|STARTED|Treatment Period|Participant Flow is reported separately for the treatment groups for this Period.|0
388169|NCT00282308|949607|P2|STARTED|Treatment Period||34
388170|NCT00282308|949608|P1|STARTED|Treatment Period||69
388171|NCT00282295|949638|P3|NOT COMPLETED|Overall Study||8
388172|NCT00282295|949639|P2|NOT COMPLETED|Overall Study||17
388173|NCT00282295|949640|P1|NOT COMPLETED|Overall Study||3
388174|NCT00282295|949638|P3|COMPLETED|Overall Study||441
388175|NCT00282295|949639|P2|COMPLETED|Overall Study||429
388176|NCT00282295|949640|P1|COMPLETED|Overall Study||443
388177|NCT00282295|949638|P3|STARTED|Overall Study||449
388178|NCT00282295|949639|P2|STARTED|Overall Study||446
388179|NCT00282295|949640|P1|STARTED|Overall Study||446
388180|NCT00282282|949689|P1|NOT COMPLETED|Overall Study||0
388181|NCT00282282|949689|P1|COMPLETED|Overall Study||29
388182|NCT00282282|949689|P1|STARTED|Overall Study|31 patients enrolled but 2 patients did not go through with transplant|29
388183|NCT00282256|949695|P1|NOT COMPLETED|Extension Treatment Period||2
388184|NCT00282256|949695|P1|COMPLETED|Extension Treatment Period||16
388185|NCT00282256|949695|P1|STARTED|Extension Treatment Period||18
388186|NCT00282256|949695|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||1
388187|NCT00282256|949695|P1|COMPLETED|Pharmacokinetic Treatment Period||18
388188|NCT00282256|949695|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||18
388189|NCT00282256|949695|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||19
388190|NCT00282256|949695|P1|STARTED|Pharmacokinetic Treatment Period||19
388191|NCT00282243|949716|P1|NOT COMPLETED|Extension Treatment Period||22
388192|NCT00282243|949716|P1|COMPLETED|Extension Treatment Period||43
388193|NCT00282243|949716|P1|STARTED|Extension Treatment Period||65
388194|NCT00282243|949716|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||5
388195|NCT00282243|949716|P1|COMPLETED|Pharmacokinetic Treatment Period||65
388196|NCT00282243|949716|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||69
388197|NCT00282243|949716|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||70
388198|NCT00282243|949716|P1|STARTED|Pharmacokinetic Treatment Period||70
388199|NCT00282152|949742|P2|NOT COMPLETED|Overall Study||0
388200|NCT00282152|949743|P1|NOT COMPLETED|Overall Study||1
388201|NCT00282152|949742|P2|COMPLETED|Overall Study||15
388202|NCT00282152|949743|P1|COMPLETED|Overall Study||14
388203|NCT00282152|949742|P2|STARTED|Overall Study||15
388204|NCT00282152|949743|P1|STARTED|Overall Study||15
388205|NCT00282113|949764|P3|NOT COMPLETED|Overall Study||0
388206|NCT00282113|949765|P2|NOT COMPLETED|Overall Study||0
388207|NCT00282113|949766|P1|NOT COMPLETED|Overall Study||1
388208|NCT00282113|949764|P3|COMPLETED|Overall Study||29
388209|NCT00282113|949765|P2|COMPLETED|Overall Study||30
388210|NCT00282113|949766|P1|COMPLETED|Overall Study||30
388211|NCT00282113|949764|P3|STARTED|Overall Study||29
388212|NCT00282113|949765|P2|STARTED|Overall Study||30
388213|NCT00282113|949766|P1|STARTED|Overall Study||31
388214|NCT00282087|949780|P1|NOT COMPLETED|Overall Study||1
388215|NCT00282087|949780|P1|COMPLETED|Overall Study|One patient died during cycle 1 of treatment because of infectious complications of AIDS.|46
388216|NCT00282087|949780|P1|STARTED|Overall Study||47
388217|NCT00282048|949793|P1|NOT COMPLETED|Overall Study||62
388218|NCT00282048|949793|P1|COMPLETED|Overall Study||0
388219|NCT00282048|949793|P1|STARTED|Overall Study||62
388220|NCT00281957|949807|P2|NOT COMPLETED|Overall Study||42
388221|NCT00281957|949808|P1|NOT COMPLETED|Overall Study||67
388222|NCT00281957|949807|P2|COMPLETED|Overall Study||0
388223|NCT00281957|949808|P1|COMPLETED|Overall Study||0
388224|NCT00281957|949807|P2|Eligible and Received Treatment|Overall Study||39
388225|NCT00281957|949808|P1|Eligible and Received Treatment|Overall Study||63
388226|NCT00281957|949807|P2|Eligible|Overall Study||40
388227|NCT00281957|949808|P1|Eligible|Overall Study||66
388228|NCT00281957|949807|P2|STARTED|Overall Study||42
388229|NCT00281957|949808|P1|STARTED|Overall Study||67
388230|NCT00281918|949822|P2|NOT COMPLETED|Overall Study||108
388231|NCT00281918|949823|P1|NOT COMPLETED|Overall Study||142
388232|NCT00281918|949822|P2|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|300
388233|NCT00281918|949823|P1|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|267
388234|NCT00281918|949822|P2|Safety Population; Received Study Drug|Overall Study||402
388235|NCT00281918|949823|P1|Safety Population; Received Study Drug|Overall Study||398
388236|NCT00281918|949822|P2|STARTED|Overall Study|Informed consent unavailable for 5 patients at time of analysis; intent-to-treat population was 403.|408
388237|NCT00281918|949823|P1|STARTED|Overall Study|Informed consent unavailable for 2 patients at time of analysis; intent-to-treat population was 407.|409
388238|NCT00281879|949857|P8|NOT COMPLETED|Overall Study||1
388239|NCT00281879|949858|P7|NOT COMPLETED|Overall Study||0
388240|NCT00281879|949859|P6|NOT COMPLETED|Overall Study||9
388241|NCT00281879|949860|P5|NOT COMPLETED|Overall Study||6
388242|NCT00281879|949861|P4|NOT COMPLETED|Overall Study||0
388243|NCT00281879|949862|P3|NOT COMPLETED|Overall Study||20
388244|NCT00281879|949863|P2|NOT COMPLETED|Overall Study||36
388245|NCT00281879|949864|P1|NOT COMPLETED|Overall Study||128
388246|NCT00281879|949857|P8|COMPLETED|Overall Study||0
388247|NCT00281879|949858|P7|COMPLETED|Overall Study||0
388248|NCT00281879|949859|P6|COMPLETED|Overall Study||0
388249|NCT00281879|949860|P5|COMPLETED|Overall Study||0
388250|NCT00281879|949861|P4|COMPLETED|Overall Study||0
388251|NCT00281879|949862|P3|COMPLETED|Overall Study||0
388252|NCT00281879|949863|P2|COMPLETED|Overall Study||0
388253|NCT00281879|949864|P1|COMPLETED|Overall Study||0
388254|NCT00281879|949857|P8|STARTED|Overall Study||1
388255|NCT00281879|949858|P7|STARTED|Overall Study||0
388256|NCT00281879|949859|P6|STARTED|Overall Study||9
388257|NCT00281879|949860|P5|STARTED|Overall Study||6
388258|NCT00281879|949861|P4|STARTED|Overall Study||0
388259|NCT00281879|949862|P3|STARTED|Overall Study||20
388260|NCT00281879|949863|P2|STARTED|Overall Study||36
388261|NCT00281879|949864|P1|STARTED|Overall Study||128
388262|NCT00281840|949882|P1|NOT COMPLETED|Overall Study||25
388263|NCT00281840|949882|P1|COMPLETED|Overall Study||5
388264|NCT00281840|949882|P1|STARTED|Overall Study||30
388265|NCT00281827|949887|P1|NOT COMPLETED|Overall Study||0
388266|NCT00281827|949887|P1|COMPLETED|Overall Study|All patients received 3 cycles of therapy; 2 did not receive all 3 thalidomide cycles|22
388267|NCT00281827|949887|P1|STARTED|Overall Study||22
388268|NCT00281697|949898|P2|NOT COMPLETED|Overall Study||197
388269|NCT00281697|949899|P1|NOT COMPLETED|Overall Study||401
388270|NCT00281697|949898|P2|COMPLETED|Overall Study||28
388271|NCT00281697|949899|P1|COMPLETED|Overall Study||58
388272|NCT00281697|949898|P2|STARTED|Overall Study||225
388273|NCT00281697|949899|P1|STARTED|Overall Study||459
388274|NCT00281684|949919|P4|NOT COMPLETED|Overall Study||0
388275|NCT00281684|949920|P3|NOT COMPLETED|Overall Study||1
388276|NCT00281684|949921|P2|NOT COMPLETED|Overall Study||0
388277|NCT00281684|949922|P1|NOT COMPLETED|Overall Study||1
388278|NCT00281684|949919|P4|COMPLETED|Overall Study||38
388279|NCT00281684|949920|P3|COMPLETED|Overall Study||33
388280|NCT00281684|949921|P2|COMPLETED|Overall Study||36
388281|NCT00281684|949922|P1|COMPLETED|Overall Study||36
388282|NCT00281684|949919|P4|STARTED|Overall Study||38
388283|NCT00281684|949920|P3|STARTED|Overall Study||34
388284|NCT00281684|949921|P2|STARTED|Overall Study||36
388285|NCT00281684|949922|P1|STARTED|Overall Study||37
388286|NCT00281658|949996|P3|NOT COMPLETED|Open-label Monotherapy Extension Phase||101
388287|NCT00281658|949997|P2|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
388288|NCT00281658|949998|P1|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
388289|NCT00281658|949996|P3|COMPLETED|Open-label Monotherapy Extension Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|48
388290|NCT00281658|949997|P2|COMPLETED|Open-label Monotherapy Extension Phase||0
388291|NCT00281658|949998|P1|COMPLETED|Open-label Monotherapy Extension Phase||0
388292|NCT00281658|949996|P3|STARTED|Open-label Monotherapy Extension Phase||149
388293|NCT00281658|949997|P2|STARTED|Open-label Monotherapy Extension Phase||0
388294|NCT00281658|949998|P1|STARTED|Open-label Monotherapy Extension Phase||0
388295|NCT00281658|949996|P3|NOT COMPLETED|Double-blind, Randomized Phase||0
388296|NCT00281658|949997|P2|NOT COMPLETED|Double-blind, Randomized Phase||54
388297|NCT00281658|949998|P1|NOT COMPLETED|Double-blind, Randomized Phase||137
388298|NCT00281658|949996|P3|COMPLETED|Double-blind, Randomized Phase||0
388299|NCT00281658|949997|P2|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|168
388300|NCT00281658|949998|P1|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|85
388301|NCT00281658|949996|P3|STARTED|Double-blind, Randomized Phase||0
388302|NCT00281658|949997|P2|STARTED|Double-blind, Randomized Phase|Of these participants, 149 entered the open-label extension phase.|222
388303|NCT00281658|949998|P1|STARTED|Double-blind, Randomized Phase||222
388304|NCT00281632|950015|P1|NOT COMPLETED|Overall Study||36
388305|NCT00281632|950015|P1|COMPLETED|Overall Study|Three participants were ongoing in the study at the time of the data cut-off (30 Apr 2008).|0
388306|NCT00281632|950015|P1|STARTED|Overall Study||36
388307|NCT00281580|950057|P16|NOT COMPLETED|Overall Study||13
388308|NCT00281580|950058|P15|NOT COMPLETED|Overall Study||7
388309|NCT00281580|950059|P14|NOT COMPLETED|Overall Study||7
388310|NCT00281580|950060|P13|NOT COMPLETED|Overall Study||13
388311|NCT00281580|950061|P12|NOT COMPLETED|Overall Study||10
388312|NCT00281580|950062|P11|NOT COMPLETED|Overall Study||4
388313|NCT00281580|950063|P10|NOT COMPLETED|Overall Study||12
388314|NCT00281580|950064|P9|NOT COMPLETED|Overall Study||8
388315|NCT00281580|950065|P8|NOT COMPLETED|Overall Study||1
388316|NCT00281580|950066|P7|NOT COMPLETED|Overall Study||5
388317|NCT00281580|950067|P6|NOT COMPLETED|Overall Study||3
388318|NCT00281580|950068|P5|NOT COMPLETED|Overall Study||4
388319|NCT00281580|950069|P4|NOT COMPLETED|Overall Study||17
388320|NCT00281580|950070|P3|NOT COMPLETED|Overall Study||5
388321|NCT00281580|950071|P2|NOT COMPLETED|Overall Study||1
388322|NCT00281580|950072|P1|NOT COMPLETED|Overall Study||7
388323|NCT00281580|950057|P16|COMPLETED|Overall Study||116
388324|NCT00281580|950058|P15|COMPLETED|Overall Study||133
388325|NCT00281580|950059|P14|COMPLETED|Overall Study||43
388326|NCT00281580|950060|P13|COMPLETED|Overall Study||129
388327|NCT00281580|950061|P12|COMPLETED|Overall Study||136
388328|NCT00281580|950062|P11|COMPLETED|Overall Study||44
388329|NCT00281580|950063|P10|COMPLETED|Overall Study||117
388330|NCT00281580|950064|P9|COMPLETED|Overall Study||135
388331|NCT00281580|950065|P8|COMPLETED|Overall Study||46
388332|NCT00281580|950066|P7|COMPLETED|Overall Study||39
388333|NCT00281580|950067|P6|COMPLETED|Overall Study||43
388334|NCT00281580|950068|P5|COMPLETED|Overall Study||40
388335|NCT00281580|950069|P4|COMPLETED|Overall Study||118
388336|NCT00281580|950070|P3|COMPLETED|Overall Study||125
388337|NCT00281580|950071|P2|COMPLETED|Overall Study||41
388338|NCT00281580|950072|P1|COMPLETED|Overall Study||39
388339|NCT00281580|950057|P16|STARTED|Overall Study||129
388340|NCT00281580|950058|P15|STARTED|Overall Study||140
388341|NCT00281580|950059|P14|STARTED|Overall Study||50
388342|NCT00281580|950060|P13|STARTED|Overall Study||142
388343|NCT00281580|950061|P12|STARTED|Overall Study||146
388344|NCT00281580|950062|P11|STARTED|Overall Study||48
388345|NCT00281580|950063|P10|STARTED|Overall Study||129
388346|NCT00281580|950064|P9|STARTED|Overall Study||143
388347|NCT00281580|950065|P8|STARTED|Overall Study||47
388348|NCT00281580|950066|P7|STARTED|Overall Study||44
388349|NCT00281580|950067|P6|STARTED|Overall Study||46
388350|NCT00281580|950068|P5|STARTED|Overall Study||44
388351|NCT00281580|950069|P4|STARTED|Overall Study||135
388352|NCT00281580|950070|P3|STARTED|Overall Study||130
388353|NCT00281580|950071|P2|STARTED|Overall Study||42
388354|NCT00281580|950072|P1|STARTED|Overall Study||46
388355|NCT00281528|950419|P3|NOT COMPLETED|Overall Study||79
388356|NCT00281528|950420|P2|NOT COMPLETED|Overall Study||54
388357|NCT00281528|950421|P1|NOT COMPLETED|Overall Study||75
388444|NCT00280384|950647|P7|COMPLETED|Overall Study||6
388358|NCT00281528|950419|P3|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
388359|NCT00281528|950420|P2|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
388360|NCT00281528|950421|P1|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
388361|NCT00281528|950419|P3|STARTED|Overall Study||79
388362|NCT00281528|950420|P2|STARTED|Overall Study||54
388363|NCT00281528|950421|P1|STARTED|Overall Study||75
388364|NCT00281463|950465|P1|NOT COMPLETED|Overall Study||0
388365|NCT00281463|950465|P1|COMPLETED|Overall Study||45
388366|NCT00281463|950465|P1|STARTED|Overall Study||45
388367|NCT00281320|950472|P2|NOT COMPLETED|Overall Study||21
388368|NCT00281320|950473|P1|NOT COMPLETED|Overall Study||25
388369|NCT00281320|950472|P2|COMPLETED|Overall Study||40
388370|NCT00281320|950473|P1|COMPLETED|Overall Study||36
388371|NCT00281320|950472|P2|STARTED|Overall Study||61
388372|NCT00281320|950473|P1|STARTED|Overall Study||61
388373|NCT00281099|950495|P2|NOT COMPLETED|Overall Study||222
388374|NCT00281099|950496|P1|NOT COMPLETED|Overall Study||205
388375|NCT00281099|950495|P2|COMPLETED|Overall Study||296
388376|NCT00281099|950496|P1|COMPLETED|Overall Study||308
388377|NCT00281099|950495|P2|STARTED|Overall Study||518
388378|NCT00281099|950496|P1|STARTED|Overall Study||513
388379|NCT00281021|950537|P1|NOT COMPLETED|Overall Study||2
388380|NCT00281021|950537|P1|COMPLETED|Overall Study||24
388381|NCT00281021|950537|P1|STARTED|Overall Study||26
388382|NCT00280917|950545|P4|NOT COMPLETED|Overall Study||2
388383|NCT00280917|950546|P3|NOT COMPLETED|Overall Study||6
388384|NCT00280917|950547|P2|NOT COMPLETED|Overall Study||6
388385|NCT00280917|950548|P1|NOT COMPLETED|Overall Study||2
388386|NCT00280917|950545|P4|COMPLETED|Overall Study||61
388387|NCT00280917|950546|P3|COMPLETED|Overall Study||57
388388|NCT00280917|950547|P2|COMPLETED|Overall Study||57
388389|NCT00280917|950548|P1|COMPLETED|Overall Study||63
388390|NCT00280917|950545|P4|STARTED|Overall Study||63
388391|NCT00280917|950546|P3|STARTED|Overall Study||63
388392|NCT00280917|950547|P2|STARTED|Overall Study||63
388393|NCT00280917|950548|P1|STARTED|Overall Study||65
388394|NCT00280904|950558|P1|NOT COMPLETED|Overall Study||0
388395|NCT00280904|950558|P1|COMPLETED|Overall Study||433
388396|NCT00280904|950558|P1|STARTED|Overall Study||433
388397|NCT00280826|950563|P1|NOT COMPLETED|Overall Study||0
388398|NCT00280826|950563|P1|COMPLETED|Overall Study||6
388399|NCT00280826|950563|P1|STARTED|Overall Study||6
388400|NCT00280748|950571|P1|NOT COMPLETED|Overall Study||4
388401|NCT00280748|950571|P1|COMPLETED|Overall Study||6
388402|NCT00280748|950571|P1|STARTED|Overall Study||10
388403|NCT00280735|950581|P1|NOT COMPLETED|Overall Study||18
388404|NCT00280735|950581|P1|COMPLETED|Overall Study||57
388405|NCT00280735|950581|P1|Received Adequate Exposure|Overall Study||57
388406|NCT00280735|950581|P1|Received Treatment|Overall Study||72
388407|NCT00280735|950581|P1|STARTED|Overall Study||75
388408|NCT00280683|950593|P2|NOT COMPLETED|Overall Study||3
388409|NCT00280683|950594|P1|NOT COMPLETED|Overall Study||2
388410|NCT00280683|950593|P2|COMPLETED|Overall Study||7
388411|NCT00280683|950594|P1|COMPLETED|Overall Study|Reasons for subjects discontinuing included inability to adhere to the schedule or adverse event.|8
388412|NCT00280683|950593|P2|STARTED|Overall Study||10
388413|NCT00280683|950594|P1|STARTED|Overall Study||10
388414|NCT00280566|950604|P3|NOT COMPLETED|Period 2 Double Blind||57
388415|NCT00280566|950605|P2|NOT COMPLETED|Period 2 Double Blind||43
388416|NCT00280566|950606|P1|NOT COMPLETED|Period 2 Double Blind||0
388417|NCT00280566|950604|P3|COMPLETED|Period 2 Double Blind||54
388418|NCT00280566|950605|P2|COMPLETED|Period 2 Double Blind||84
388419|NCT00280566|950606|P1|COMPLETED|Period 2 Double Blind||0
388420|NCT00280566|950604|P3|STARTED|Period 2 Double Blind||111
388421|NCT00280566|950605|P2|STARTED|Period 2 Double Blind||127
388422|NCT00280566|950606|P1|STARTED|Period 2 Double Blind|1 subject in Period 1 did not want to be randomized into Period 2|0
388423|NCT00280566|950604|P3|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
388424|NCT00280566|950605|P2|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
388425|NCT00280566|950606|P1|NOT COMPLETED|Period 1 Open Label Ziprasidone||343
388426|NCT00280566|950604|P3|COMPLETED|Period 1 Open Label Ziprasidone||0
388427|NCT00280566|950605|P2|COMPLETED|Period 1 Open Label Ziprasidone||0
388428|NCT00280566|950606|P1|COMPLETED|Period 1 Open Label Ziprasidone|Subject excluded as described above is counted as 2; enrolled in 2 sites (2 identification numbers)|241
388429|NCT00280566|950604|P3|STARTED|Period 1 Open Label Ziprasidone||0
388430|NCT00280566|950605|P2|STARTED|Period 1 Open Label Ziprasidone||0
388431|NCT00280566|950606|P1|STARTED|Period 1 Open Label Ziprasidone|1 subject inappropriately randomized into 2 different sites. Data from this subject was excluded.|584
388432|NCT00280397|950631|P1|NOT COMPLETED|Overall Study||1
388433|NCT00280397|950631|P1|COMPLETED|Overall Study||26
388434|NCT00280397|950631|P1|STARTED|Overall Study||27
388435|NCT00280384|950646|P8|NOT COMPLETED|Overall Study||0
388436|NCT00280384|950647|P7|NOT COMPLETED|Overall Study||0
388437|NCT00280384|950648|P6|NOT COMPLETED|Overall Study||0
388438|NCT00280384|950649|P5|NOT COMPLETED|Overall Study||0
388439|NCT00280384|950650|P4|NOT COMPLETED|Overall Study||0
388440|NCT00280384|950651|P3|NOT COMPLETED|Overall Study||0
388441|NCT00280384|950652|P2|NOT COMPLETED|Overall Study||0
388442|NCT00280384|950653|P1|NOT COMPLETED|Overall Study||0
388443|NCT00280384|950646|P8|COMPLETED|Overall Study||6
388445|NCT00280384|950648|P6|COMPLETED|Overall Study||6
388446|NCT00280384|950649|P5|COMPLETED|Overall Study||6
388447|NCT00280384|950650|P4|COMPLETED|Overall Study||6
388448|NCT00280384|950651|P3|COMPLETED|Overall Study||6
388449|NCT00280384|950652|P2|COMPLETED|Overall Study||6
388450|NCT00280384|950653|P1|COMPLETED|Overall Study||6
388451|NCT00280384|950646|P8|STARTED|Overall Study||6
388452|NCT00280384|950647|P7|STARTED|Overall Study||6
388453|NCT00280384|950648|P6|STARTED|Overall Study||6
388454|NCT00280384|950649|P5|STARTED|Overall Study||6
388455|NCT00280384|950650|P4|STARTED|Overall Study||6
388456|NCT00280384|950651|P3|STARTED|Overall Study||6
388457|NCT00280384|950652|P2|STARTED|Overall Study||6
388458|NCT00280384|950653|P1|STARTED|Overall Study||6
388459|NCT00280293|950697|P2|NOT COMPLETED|Overall Study||23
388460|NCT00280293|950698|P1|NOT COMPLETED|Overall Study||26
388461|NCT00280293|950697|P2|COMPLETED|Overall Study||34
388462|NCT00280293|950698|P1|COMPLETED|Overall Study||29
388463|NCT00280293|950697|P2|STARTED|Overall Study||57
388464|NCT00280293|950698|P1|STARTED|Overall Study||55
388465|NCT00280241|950710|P1|NOT COMPLETED|Overall Study||10
388466|NCT00280241|950710|P1|COMPLETED|Overall Study||55
388467|NCT00280241|950710|P1|STARTED|Overall Study||65
388468|NCT00280150|950721|P4|NOT COMPLETED|Overall Study||10
388469|NCT00280150|950722|P3|NOT COMPLETED|Overall Study||5
388470|NCT00280150|950723|P2|NOT COMPLETED|Overall Study||1
388471|NCT00280150|950724|P1|NOT COMPLETED|Overall Study||3
388472|NCT00280150|950721|P4|COMPLETED|Overall Study||20
388473|NCT00280150|950722|P3|COMPLETED|Overall Study||1
388474|NCT00280150|950723|P2|COMPLETED|Overall Study||4
388475|NCT00280150|950724|P1|COMPLETED|Overall Study||2
388476|NCT00280150|950721|P4|Consolidation Therapy|Overall Study|Phase II participants did not receive consolidation therapy.|0
388477|NCT00280150|950722|P3|Consolidation Therapy|Overall Study||3
388478|NCT00280150|950723|P2|Consolidation Therapy|Overall Study||5
388479|NCT00280150|950724|P1|Consolidation Therapy|Overall Study||2
388480|NCT00280150|950721|P4|Cohort Induction|Overall Study||30
388481|NCT00280150|950722|P3|Cohort Induction|Overall Study||6
388482|NCT00280150|950723|P2|Cohort Induction|Overall Study||5
388483|NCT00280150|950724|P1|Cohort Induction|Overall Study||5
388484|NCT00280150|950721|P4|STARTED|Overall Study||30
388485|NCT00280150|950722|P3|STARTED|Overall Study||6
388486|NCT00280150|950723|P2|STARTED|Overall Study||5
388487|NCT00280150|950724|P1|STARTED|Overall Study||5
388488|NCT00280059|950739|P2|NOT COMPLETED|Extension Phase||38
388489|NCT00280059|950740|P1|NOT COMPLETED|Extension Phase||49
388490|NCT00280059|950739|P2|COMPLETED|Extension Phase||177
388491|NCT00280059|950740|P1|COMPLETED|Extension Phase||145
388492|NCT00280059|950739|P2|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|215
388493|NCT00280059|950740|P1|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|194
388494|NCT00280059|950739|P2|NOT COMPLETED|Efficacy Assessment Phase||80
388495|NCT00280059|950740|P1|NOT COMPLETED|Efficacy Assessment Phase||94
388496|NCT00280059|950739|P2|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|250
388497|NCT00280059|950740|P1|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|236
388498|NCT00280059|950739|P2|STARTED|Efficacy Assessment Phase||330
388499|NCT00280059|950740|P1|STARTED|Efficacy Assessment Phase||330
388500|NCT00279955|950789|P3|NOT COMPLETED|Overall Study||0
388501|NCT00279955|950790|P2|NOT COMPLETED|Overall Study||0
388502|NCT00279955|950791|P1|NOT COMPLETED|Overall Study||0
388503|NCT00279955|950789|P3|COMPLETED|Overall Study|They are still counted as completes, though they are never used for the analyses of objectives.|358
388504|NCT00279955|950790|P2|COMPLETED|Overall Study||486
388505|NCT00279955|950791|P1|COMPLETED|Overall Study||157
388506|NCT00279955|950789|P3|STARTED|Overall Study||358
388507|NCT00279955|950790|P2|STARTED|Overall Study||486
388508|NCT00279955|950791|P1|STARTED|Overall Study||157
388509|NCT00279916|950804|P2|NOT COMPLETED|Overall Study||5
388510|NCT00279916|950805|P1|NOT COMPLETED|Overall Study||7
388511|NCT00279916|950804|P2|COMPLETED|Overall Study||41
388512|NCT00279916|950805|P1|COMPLETED|Overall Study||38
388513|NCT00279916|950804|P2|STARTED|Overall Study||46
388514|NCT00279916|950805|P1|STARTED|Overall Study||45
388515|NCT00279812|950831|P6|NOT COMPLETED|Overall Study||1
388516|NCT00279812|950832|P5|NOT COMPLETED|Overall Study||3
388517|NCT00279812|950833|P4|NOT COMPLETED|Overall Study||0
388518|NCT00279812|950834|P3|NOT COMPLETED|Overall Study||3
388519|NCT00279812|950835|P2|NOT COMPLETED|Overall Study||6
388520|NCT00279812|950836|P1|NOT COMPLETED|Overall Study||1
388521|NCT00279812|950831|P6|COMPLETED|Overall Study||18
388522|NCT00279812|950832|P5|COMPLETED|Overall Study||17
388523|NCT00279812|950833|P4|COMPLETED|Overall Study||23
388524|NCT00279812|950834|P3|COMPLETED|Overall Study||21
388525|NCT00279812|950835|P2|COMPLETED|Overall Study||20
388526|NCT00279812|950836|P1|COMPLETED|Overall Study||20
388527|NCT00279812|950831|P6|STARTED|Overall Study||19
388528|NCT00279812|950832|P5|STARTED|Overall Study||20
388529|NCT00279812|950833|P4|STARTED|Overall Study||23
388530|NCT00279812|950834|P3|STARTED|Overall Study||24
388531|NCT00279812|950835|P2|STARTED|Overall Study||26
388532|NCT00279812|950836|P1|STARTED|Overall Study||21
388533|NCT00279708|950864|P2|NOT COMPLETED|Overall Study||4
388534|NCT00279708|950865|P1|NOT COMPLETED|Overall Study||3
388535|NCT00279708|950864|P2|COMPLETED|Overall Study||24
388536|NCT00279708|950865|P1|COMPLETED|Overall Study||24
388537|NCT00279708|950864|P2|STARTED|Overall Study||28
388538|NCT00279708|950865|P1|STARTED|Overall Study|"Started meaning randomized"|27
388539|NCT00279591|950873|P2|NOT COMPLETED|Overall Study||0
388540|NCT00279591|950874|P1|NOT COMPLETED|Overall Study||0
388541|NCT00279591|950873|P2|COMPLETED|Overall Study||46
388542|NCT00279591|950874|P1|COMPLETED|Overall Study||48
388543|NCT00279591|950873|P2|STARTED|Overall Study||46
388544|NCT00279591|950874|P1|STARTED|Overall Study||48
388545|NCT00279500|950888|P1|NOT COMPLETED|Overall Study||0
388546|NCT00279500|950888|P1|COMPLETED|Overall Study|6 patients treated|6
388547|NCT00279500|950888|P1|STARTED|Overall Study|6 patients treated|6
388548|NCT00279305|950894|P2|NOT COMPLETED|Overall Study||1
388549|NCT00279305|950895|P1|NOT COMPLETED|Overall Study||8
388550|NCT00279305|950894|P2|COMPLETED|Overall Study||29
388551|NCT00279305|950895|P1|COMPLETED|Overall Study||49
388552|NCT00279305|950894|P2|STARTED|Overall Study||30
388553|NCT00279305|950895|P1|STARTED|Overall Study||57
388554|NCT00279214|950903|P2|NOT COMPLETED|Overall Study||2
388555|NCT00279214|950904|P1|NOT COMPLETED|Overall Study||3
388556|NCT00279214|950903|P2|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
388557|NCT00279214|950904|P1|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
388558|NCT00279214|950903|P2|STARTED|Overall Study||21
388559|NCT00279214|950904|P1|STARTED|Overall Study||22
388560|NCT00279201|950934|P6|NOT COMPLETED|Intensification Addendum||37
388561|NCT00279201|950935|P5|NOT COMPLETED|Intensification Addendum||29
388562|NCT00279201|950936|P4|NOT COMPLETED|Intensification Addendum||28
388563|NCT00279201|950937|P3|NOT COMPLETED|Intensification Addendum||23
388564|NCT00279201|950938|P2|NOT COMPLETED|Intensification Addendum||0
388565|NCT00279201|950939|P1|NOT COMPLETED|Intensification Addendum||0
388566|NCT00279201|950934|P6|COMPLETED|Intensification Addendum||162
388567|NCT00279201|950935|P5|COMPLETED|Intensification Addendum||142
388568|NCT00279201|950936|P4|COMPLETED|Intensification Addendum||172
388569|NCT00279201|950937|P3|COMPLETED|Intensification Addendum||151
388570|NCT00279201|950938|P2|COMPLETED|Intensification Addendum||0
388571|NCT00279201|950939|P1|COMPLETED|Intensification Addendum||0
388572|NCT00279201|950934|P6|STARTED|Intensification Addendum||199
388573|NCT00279201|950935|P5|STARTED|Intensification Addendum||171
388574|NCT00279201|950936|P4|STARTED|Intensification Addendum||200
388575|NCT00279201|950937|P3|STARTED|Intensification Addendum||174
388576|NCT00279201|950938|P2|STARTED|Intensification Addendum||0
388577|NCT00279201|950939|P1|STARTED|Intensification Addendum||0
388578|NCT00279201|950934|P6|NOT COMPLETED|Maintenance||0
388579|NCT00279201|950935|P5|NOT COMPLETED|Maintenance||0
388580|NCT00279201|950936|P4|NOT COMPLETED|Maintenance||0
388581|NCT00279201|950937|P3|NOT COMPLETED|Maintenance||0
388582|NCT00279201|950938|P2|NOT COMPLETED|Maintenance||234
388583|NCT00279201|950939|P1|NOT COMPLETED|Maintenance||231
388584|NCT00279201|950934|P6|COMPLETED|Maintenance||0
388585|NCT00279201|950935|P5|COMPLETED|Maintenance||0
388586|NCT00279201|950936|P4|COMPLETED|Maintenance||0
388587|NCT00279201|950937|P3|COMPLETED|Maintenance||0
388588|NCT00279201|950938|P2|COMPLETED|Maintenance||239
388589|NCT00279201|950939|P1|COMPLETED|Maintenance||188
388590|NCT00279201|950934|P6|STARTED|Maintenance||0
388591|NCT00279201|950935|P5|STARTED|Maintenance||0
388592|NCT00279201|950936|P4|STARTED|Maintenance||0
388593|NCT00279201|950937|P3|STARTED|Maintenance||0
388594|NCT00279201|950938|P2|STARTED|Maintenance|82 left the study after initiation. 345 had HbA1c>7% and enrolled in intensification addendum.|473
388595|NCT00279201|950939|P1|STARTED|Maintenance|100 left the study after initiation. 399 had HbA1c>7% and enrolled in intensification addendum.|419
388596|NCT00279201|950934|P6|NOT COMPLETED|Initiation||0
388597|NCT00279201|950935|P5|NOT COMPLETED|Initiation||0
388598|NCT00279201|950936|P4|NOT COMPLETED|Initiation||0
388599|NCT00279201|950937|P3|NOT COMPLETED|Initiation||0
388600|NCT00279201|950938|P2|NOT COMPLETED|Initiation||145
388601|NCT00279201|950939|P1|NOT COMPLETED|Initiation||128
388602|NCT00279201|950934|P6|COMPLETED|Initiation||0
388603|NCT00279201|950935|P5|COMPLETED|Initiation||0
388604|NCT00279201|950936|P4|COMPLETED|Initiation||0
388605|NCT00279201|950937|P3|COMPLETED|Initiation||0
388606|NCT00279201|950938|P2|COMPLETED|Initiation||900
388607|NCT00279201|950939|P1|COMPLETED|Initiation||918
388608|NCT00279201|950934|P6|STARTED|Initiation||0
388609|NCT00279201|950935|P5|STARTED|Initiation||0
388610|NCT00279201|950936|P4|STARTED|Initiation||0
388611|NCT00279201|950937|P3|STARTED|Initiation||0
388612|NCT00279201|950938|P2|STARTED|Initiation||1045
388613|NCT00279201|950939|P1|STARTED|Initiation||1046
388614|NCT00278993|951083|P1|NOT COMPLETED|Overall Study||107
388615|NCT00278993|951083|P1|COMPLETED|Overall Study||1
388616|NCT00278993|951083|P1|STARTED|Overall Study||108
388617|NCT00278954|951091|P1|NOT COMPLETED|Overall Study||5
388618|NCT00278954|951091|P1|COMPLETED|Overall Study||45
388619|NCT00278954|951091|P1|STARTED|Overall Study||50
388620|NCT00278915|951099|P1|NOT COMPLETED|Overall Study||1
388621|NCT00278915|951099|P1|COMPLETED|Overall Study||29
388622|NCT00278915|951099|P1|STARTED|Overall Study|First 6 patients were dosed at 2mg/kg then increased to 4 mg/kg. Remaining 24 were dosed at 4mg/kg.|30
388623|NCT00278889|951135|P3|NOT COMPLETED|Overall Study||20
388624|NCT00278889|951136|P2|NOT COMPLETED|Overall Study||27
388625|NCT00278889|951137|P1|NOT COMPLETED|Overall Study||25
388626|NCT00278889|951135|P3|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
388627|NCT00278889|951136|P2|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|47
388628|NCT00278889|951137|P1|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
388629|NCT00278889|951135|P3|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|19
388630|NCT00278889|951136|P2|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|20
388631|NCT00278889|951137|P1|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|16
388632|NCT00278889|951135|P3|STARTED|Overall Study|Randomised|68
388633|NCT00278889|951136|P2|STARTED|Overall Study|Randomised|74
388634|NCT00278889|951137|P1|STARTED|Overall Study|Randomised|73
388635|NCT00278876|951163|P1|NOT COMPLETED|Overall Study||9
388636|NCT00278876|951163|P1|COMPLETED|Overall Study||38
388637|NCT00278876|951163|P1|STARTED|Overall Study||47
388638|NCT00278863|951171|P2|NOT COMPLETED|Overall Study||2
388639|NCT00278863|951172|P1|NOT COMPLETED|Overall Study||5
388640|NCT00278863|951171|P2|COMPLETED|Overall Study||45
388641|NCT00278863|951172|P1|COMPLETED|Overall Study||44
388642|NCT00278863|951171|P2|STARTED|Overall Study||47
388643|NCT00278863|951172|P1|STARTED|Overall Study||49
388644|NCT00278655|951180|P1|NOT COMPLETED|Overall Study||0
388645|NCT00278655|951180|P1|COMPLETED|Overall Study||21
388646|NCT00278655|951180|P1|STARTED|Overall Study||21
388647|NCT00278564|951185|P1|NOT COMPLETED|Overall Study||4
388648|NCT00278564|951185|P1|COMPLETED|Overall Study||3
388649|NCT00278564|951185|P1|STARTED|Overall Study||7
388650|NCT00278525|951191|P2|NOT COMPLETED|Overall Study||0
388651|NCT00278525|951192|P1|NOT COMPLETED|Overall Study||0
388652|NCT00278525|951191|P2|COMPLETED|Overall Study|7 participant crossed over to the HSCT arm and underwent HSCT, in accordance with the protocol.|10
388653|NCT00278525|951192|P1|COMPLETED|Overall Study|7 participants crossed to HSCT arm in accordance with the protocol|9
388654|NCT00278525|951191|P2|STARTED|Overall Study||10
388655|NCT00278525|951192|P1|STARTED|Overall Study||9
388656|NCT00278512|951202|P2|NOT COMPLETED|Overall Study||0
388657|NCT00278512|951203|P1|NOT COMPLETED|Overall Study||1
388658|NCT00278512|951202|P2|COMPLETED|Overall Study||0
388659|NCT00278512|951203|P1|COMPLETED|Overall Study||6
388660|NCT00278512|951202|P2|STARTED|Overall Study||0
388661|NCT00278512|951203|P1|STARTED|Overall Study||7
388662|NCT00278473|951211|P2|NOT COMPLETED|Overall Study||3
388663|NCT00278473|951212|P1|NOT COMPLETED|Overall Study||4
388664|NCT00278473|951211|P2|COMPLETED|Overall Study||40
388665|NCT00278473|951212|P1|COMPLETED|Overall Study||41
388666|NCT00278473|951211|P2|STARTED|Overall Study||43
388667|NCT00278473|951212|P1|STARTED|Overall Study||45
388668|NCT00278395|951228|P1|NOT COMPLETED|Overall Study||3
388669|NCT00278395|951228|P1|COMPLETED|Overall Study||11
388670|NCT00278395|951228|P1|STARTED|Overall Study||14
388671|NCT00278343|951235|P1|NOT COMPLETED|Overall Study||0
388672|NCT00278343|951235|P1|COMPLETED|Overall Study||74
388673|NCT00278343|951235|P1|STARTED|Overall Study||74
388674|NCT00278200|951246|P2|NOT COMPLETED|Overall Study||4
388675|NCT00278200|951247|P1|NOT COMPLETED|Overall Study||1
388676|NCT00278200|951246|P2|COMPLETED|Overall Study||8
388677|NCT00278200|951247|P1|COMPLETED|Overall Study||1
388678|NCT00278200|951246|P2|STARTED|Overall Study||12
388679|NCT00278200|951247|P1|STARTED|Overall Study||2
388680|NCT00278161|951256|P1|NOT COMPLETED|Overall Study||11
388681|NCT00278161|951256|P1|COMPLETED|Overall Study||70
388682|NCT00278161|951256|P1|STARTED|Overall Study||81
388683|NCT00278109|951262|P1|NOT COMPLETED|Overall Study||4
388684|NCT00278109|951262|P1|COMPLETED|Overall Study||21
388685|NCT00278109|951262|P1|Completed 3 Cycles of Chemotherapy|Overall Study||25
388686|NCT00278109|951262|P1|STARTED|Overall Study||25
388687|NCT00277524|951266|P4|NOT COMPLETED|Overall Study||0
388688|NCT00277524|951267|P3|NOT COMPLETED|Overall Study||0
388689|NCT00277524|951268|P2|NOT COMPLETED|Overall Study||0
388690|NCT00277524|951269|P1|NOT COMPLETED|Overall Study||0
388691|NCT00277524|951266|P4|COMPLETED|Overall Study||850
388692|NCT00277524|951267|P3|COMPLETED|Overall Study||1088
388693|NCT00277524|951268|P2|COMPLETED|Overall Study||324
388694|NCT00277524|951269|P1|COMPLETED|Overall Study||621
388695|NCT00277524|951266|P4|STARTED|Overall Study||850
388696|NCT00277524|951267|P3|STARTED|Overall Study||1088
388697|NCT00277524|951268|P2|STARTED|Overall Study||324
388698|NCT00277524|951269|P1|STARTED|Overall Study||621
388699|NCT00277446|951287|P1|NOT COMPLETED|Overall Study||0
388700|NCT00277446|951287|P1|COMPLETED|Overall Study||13
388701|NCT00277446|951287|P1|STARTED|Overall Study||13
388702|NCT00277394|951295|P2|NOT COMPLETED|Overall Study||24
388703|NCT00277394|951296|P1|NOT COMPLETED|Overall Study||37
388704|NCT00277394|951295|P2|COMPLETED|Overall Study||246
388705|NCT00277394|951296|P1|COMPLETED|Overall Study||232
388706|NCT00277394|951295|P2|STARTED|Overall Study||270
388707|NCT00277394|951296|P1|STARTED|Overall Study||269
388708|NCT00277355|951308|P2|NOT COMPLETED|Overall Study||5
388709|NCT00277355|951309|P1|NOT COMPLETED|Overall Study||14
388710|NCT00277355|951308|P2|COMPLETED|Overall Study||22
388711|NCT00277355|951309|P1|COMPLETED|Overall Study||73
388712|NCT00277355|951308|P2|STARTED|Overall Study||27
388713|NCT00277355|951309|P1|STARTED|Overall Study||87
388714|NCT00277212|951317|P3|NOT COMPLETED|Phase 2 - Double-Blind Treatment||113
388715|NCT00277212|951318|P2|NOT COMPLETED|Phase 2 - Double-Blind Treatment||120
388716|NCT00277212|951319|P1|NOT COMPLETED|Phase 2 - Double-Blind Treatment||0
388717|NCT00277212|951317|P3|COMPLETED|Phase 2 - Double-Blind Treatment||65
388718|NCT00277212|951318|P2|COMPLETED|Phase 2 - Double-Blind Treatment||53
388719|NCT00277212|951319|P1|COMPLETED|Phase 2 - Double-Blind Treatment||0
388720|NCT00277212|951317|P3|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||174
388721|NCT00277212|951318|P2|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||164
388722|NCT00277212|951319|P1|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||0
388723|NCT00277212|951317|P3|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||176
388724|NCT00277212|951318|P2|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||165
388725|NCT00277212|951319|P1|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||0
388726|NCT00277212|951317|P3|STARTED|Phase 2 - Double-Blind Treatment|1 participant did not want to continue in the study for personal reasons, and did not enter Phase 2.|178
388727|NCT00277212|951318|P2|STARTED|Phase 2 - Double-Blind Treatment||173
388728|NCT00277212|951319|P1|STARTED|Phase 2 - Double-Blind Treatment||0
388729|NCT00277212|951317|P3|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
388730|NCT00277212|951318|P2|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
388731|NCT00277212|951319|P1|NOT COMPLETED|Phase 1 - Single-Blind Treatment||435
388732|NCT00277212|951317|P3|COMPLETED|Phase 1 - Single-Blind Treatment||0
388733|NCT00277212|951318|P2|COMPLETED|Phase 1 - Single-Blind Treatment||0
388734|NCT00277212|951319|P1|COMPLETED|Phase 1 - Single-Blind Treatment||352
388735|NCT00277212|951317|P3|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
388736|NCT00277212|951318|P2|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
388737|NCT00277212|951319|P1|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||756
388738|NCT00277212|951317|P3|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
388739|NCT00277212|951318|P2|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
388740|NCT00277212|951319|P1|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||787
388741|NCT00277212|951317|P3|STARTED|Phase 1 - Single-Blind Treatment||0
388742|NCT00277212|951318|P2|STARTED|Phase 1 - Single-Blind Treatment||0
388743|NCT00277212|951319|P1|STARTED|Phase 1 - Single-Blind Treatment||787
388744|NCT00277095|951357|P1|NOT COMPLETED|Overall Study||21
388745|NCT00277095|951357|P1|COMPLETED|Overall Study|Details of patients who did not complete study are given below.|103
388746|NCT00277095|951357|P1|STARTED|Overall Study|Anatomy of 1 patient did not allow ProACT to be implanted, hence only 123 patients were implanted.|124
388747|NCT00276861|951361|P1|NOT COMPLETED|Overall Study||0
388748|NCT00276861|951361|P1|COMPLETED|Overall Study||10
388749|NCT00276861|951361|P1|STARTED|Overall Study||10
388750|NCT00276744|951366|P1|NOT COMPLETED|PART B||0
388751|NCT00276744|951366|P1|COMPLETED|PART B||0
388752|NCT00276744|951366|P1|STARTED|PART B|This study was terminated before participants could reach this stage of the study.|0
388753|NCT00276744|951366|P1|NOT COMPLETED|PART A||98
388754|NCT00276744|951366|P1|COMPLETED|PART A||142
388755|NCT00276744|951366|P1|STARTED|PART A||240
388756|NCT00276614|951370|P1|NOT COMPLETED|Overall Study||3
388757|NCT00276614|951370|P1|COMPLETED|Overall Study||1
388758|NCT00276614|951370|P1|STARTED|Overall Study||4
388759|NCT00276549|951374|P1|NOT COMPLETED|Overall Study||0
388760|NCT00276549|951374|P1|COMPLETED|Overall Study||35
388761|NCT00276549|951374|P1|STARTED|Overall Study||35
388762|NCT00276484|951381|P2|NOT COMPLETED|Overall Study||13
388763|NCT00276484|951382|P1|NOT COMPLETED|Overall Study||9
388764|NCT00276484|951381|P2|COMPLETED|Overall Study||278
388765|NCT00276484|951382|P1|COMPLETED|Overall Study||279
388766|NCT00276484|951381|P2|STARTED|Overall Study||291
388767|NCT00276484|951382|P1|STARTED|Overall Study||288
388768|NCT00276458|951414|P2|NOT COMPLETED|Overall Study||7
388769|NCT00276458|951415|P1|NOT COMPLETED|Overall Study||6
388770|NCT00276458|951414|P2|COMPLETED|Overall Study||91
388771|NCT00276458|951415|P1|COMPLETED|Overall Study||92
388772|NCT00276458|951414|P2|STARTED|Overall Study||98
388773|NCT00276458|951415|P1|STARTED|Overall Study||98
388774|NCT00276419|951449|P2|NOT COMPLETED|Second Intervention||0
388775|NCT00276419|951450|P1|NOT COMPLETED|Second Intervention||0
388776|NCT00276419|951449|P2|COMPLETED|Second Intervention||8
388777|NCT00276419|951450|P1|COMPLETED|Second Intervention||7
388778|NCT00276419|951449|P2|STARTED|Second Intervention||8
388779|NCT00276419|951450|P1|STARTED|Second Intervention||7
388780|NCT00276419|951449|P2|NOT COMPLETED|Wash-out Phase||0
388781|NCT00276419|951450|P1|NOT COMPLETED|Wash-out Phase||0
388782|NCT00276419|951449|P2|COMPLETED|Wash-out Phase||8
388783|NCT00276419|951450|P1|COMPLETED|Wash-out Phase||7
388784|NCT00276419|951449|P2|STARTED|Wash-out Phase||8
388785|NCT00276419|951450|P1|STARTED|Wash-out Phase||7
388786|NCT00276419|951449|P2|NOT COMPLETED|First Intervention||2
388787|NCT00276419|951450|P1|NOT COMPLETED|First Intervention||1
388788|NCT00276419|951449|P2|COMPLETED|First Intervention||8
388789|NCT00276419|951450|P1|COMPLETED|First Intervention||7
388790|NCT00276419|951449|P2|STARTED|First Intervention||10
388791|NCT00276419|951450|P1|STARTED|First Intervention||8
388792|NCT00276406|951462|P2|NOT COMPLETED|Overall Study||0
388793|NCT00276406|951463|P1|NOT COMPLETED|Overall Study||0
388794|NCT00276406|951462|P2|COMPLETED|Overall Study||14
388795|NCT00276406|951463|P1|COMPLETED|Overall Study|14 of 16 subjects tolerated 360mg daily, while 2 of 16 tolerated 180mg daily.|16
388796|NCT00276406|951462|P2|STARTED|Overall Study||14
388797|NCT00276406|951463|P1|STARTED|Overall Study||16
388798|NCT00276380|951493|P2|NOT COMPLETED|Overall Study||14
388799|NCT00276380|951494|P1|NOT COMPLETED|Overall Study||14
388800|NCT00276380|951493|P2|COMPLETED|Overall Study||88
388801|NCT00276380|951494|P1|COMPLETED|Overall Study||88
388802|NCT00276380|951493|P2|STARTED|Overall Study||102
388803|NCT00276380|951494|P1|STARTED|Overall Study||102
388804|NCT00276250|951515|P3|NOT COMPLETED|Overall Study||0
388805|NCT00276250|951516|P2|NOT COMPLETED|Overall Study||0
388806|NCT00276250|951517|P1|NOT COMPLETED|Overall Study||0
388807|NCT00276250|951515|P3|COMPLETED|Overall Study||0
388808|NCT00276250|951516|P2|COMPLETED|Overall Study||1
388809|NCT00276250|951517|P1|COMPLETED|Overall Study||4
388810|NCT00276250|951515|P3|STARTED|Overall Study||0
388811|NCT00276250|951516|P2|STARTED|Overall Study||1
388812|NCT00276250|951517|P1|STARTED|Overall Study||4
388813|NCT00276159|951549|P1|NOT COMPLETED|Overall Study||6
388814|NCT00276159|951549|P1|COMPLETED|Overall Study||0
388815|NCT00276159|951549|P1|STARTED|Overall Study||6
388816|NCT00276094|951559|P3|NOT COMPLETED|Overall Study||38
388817|NCT00276094|951560|P2|NOT COMPLETED|Overall Study||42
388818|NCT00276094|951561|P1|NOT COMPLETED|Overall Study||57
388819|NCT00276094|951559|P3|COMPLETED|Overall Study||230
388820|NCT00276094|951560|P2|COMPLETED|Overall Study||234
388821|NCT00276094|951561|P1|COMPLETED|Overall Study||225
388822|NCT00276094|951559|P3|STARTED|Overall Study||268
388823|NCT00276094|951560|P2|STARTED|Overall Study||276
388824|NCT00276094|951561|P1|STARTED|Overall Study||282
388825|NCT00276016|951614|P6|NOT COMPLETED|Intervention 3||0
388826|NCT00276016|951615|P5|NOT COMPLETED|Intervention 3||0
388827|NCT00276016|951616|P4|NOT COMPLETED|Intervention 3||0
388828|NCT00276016|951617|P3|NOT COMPLETED|Intervention 3||0
388829|NCT00276016|951618|P2|NOT COMPLETED|Intervention 3||0
388830|NCT00276016|951619|P1|NOT COMPLETED|Intervention 3||0
388831|NCT00276016|951614|P6|COMPLETED|Intervention 3||6
388832|NCT00276016|951615|P5|COMPLETED|Intervention 3||6
388833|NCT00276016|951616|P4|COMPLETED|Intervention 3||6
388834|NCT00276016|951617|P3|COMPLETED|Intervention 3||7
388835|NCT00276016|951618|P2|COMPLETED|Intervention 3||6
388836|NCT00276016|951619|P1|COMPLETED|Intervention 3||7
388837|NCT00276016|951614|P6|STARTED|Intervention 3||6
388838|NCT00276016|951615|P5|STARTED|Intervention 3||6
388839|NCT00276016|951616|P4|STARTED|Intervention 3||6
388840|NCT00276016|951617|P3|STARTED|Intervention 3||7
388841|NCT00276016|951618|P2|STARTED|Intervention 3||6
388842|NCT00276016|951619|P1|STARTED|Intervention 3||7
388843|NCT00276016|951614|P6|NOT COMPLETED|Wash Out 2||0
388844|NCT00276016|951615|P5|NOT COMPLETED|Wash Out 2||0
388845|NCT00276016|951616|P4|NOT COMPLETED|Wash Out 2||0
388846|NCT00276016|951617|P3|NOT COMPLETED|Wash Out 2||0
388847|NCT00276016|951618|P2|NOT COMPLETED|Wash Out 2||0
388848|NCT00276016|951619|P1|NOT COMPLETED|Wash Out 2||0
388849|NCT00276016|951614|P6|COMPLETED|Wash Out 2||6
388850|NCT00276016|951615|P5|COMPLETED|Wash Out 2||6
388851|NCT00276016|951616|P4|COMPLETED|Wash Out 2||6
388852|NCT00276016|951617|P3|COMPLETED|Wash Out 2||7
388853|NCT00276016|951618|P2|COMPLETED|Wash Out 2||6
388854|NCT00276016|951619|P1|COMPLETED|Wash Out 2||7
388855|NCT00276016|951614|P6|STARTED|Wash Out 2||6
388856|NCT00276016|951615|P5|STARTED|Wash Out 2||6
388857|NCT00276016|951616|P4|STARTED|Wash Out 2||6
388858|NCT00276016|951617|P3|STARTED|Wash Out 2||7
388859|NCT00276016|951618|P2|STARTED|Wash Out 2||6
388860|NCT00276016|951619|P1|STARTED|Wash Out 2||7
388861|NCT00276016|951614|P6|NOT COMPLETED|Intervention 2||0
388862|NCT00276016|951615|P5|NOT COMPLETED|Intervention 2||0
388863|NCT00276016|951616|P4|NOT COMPLETED|Intervention 2||0
388864|NCT00276016|951617|P3|NOT COMPLETED|Intervention 2||0
388865|NCT00276016|951618|P2|NOT COMPLETED|Intervention 2||0
388866|NCT00276016|951619|P1|NOT COMPLETED|Intervention 2||0
388867|NCT00276016|951614|P6|COMPLETED|Intervention 2||6
388868|NCT00276016|951615|P5|COMPLETED|Intervention 2||6
388869|NCT00276016|951616|P4|COMPLETED|Intervention 2||6
388870|NCT00276016|951617|P3|COMPLETED|Intervention 2||7
388871|NCT00276016|951618|P2|COMPLETED|Intervention 2||6
388872|NCT00276016|951619|P1|COMPLETED|Intervention 2||7
388873|NCT00276016|951614|P6|STARTED|Intervention 2||6
388874|NCT00276016|951615|P5|STARTED|Intervention 2||6
388875|NCT00276016|951616|P4|STARTED|Intervention 2||6
388876|NCT00276016|951617|P3|STARTED|Intervention 2||7
388877|NCT00276016|951618|P2|STARTED|Intervention 2||6
388878|NCT00276016|951619|P1|STARTED|Intervention 2||7
388879|NCT00276016|951614|P6|NOT COMPLETED|Wash Out 1||0
388880|NCT00276016|951615|P5|NOT COMPLETED|Wash Out 1||0
388881|NCT00276016|951616|P4|NOT COMPLETED|Wash Out 1||0
388882|NCT00276016|951617|P3|NOT COMPLETED|Wash Out 1||0
388883|NCT00276016|951618|P2|NOT COMPLETED|Wash Out 1||0
388884|NCT00276016|951619|P1|NOT COMPLETED|Wash Out 1||0
388885|NCT00276016|951614|P6|COMPLETED|Wash Out 1||6
388886|NCT00276016|951615|P5|COMPLETED|Wash Out 1||6
388887|NCT00276016|951616|P4|COMPLETED|Wash Out 1||6
388888|NCT00276016|951617|P3|COMPLETED|Wash Out 1||7
388889|NCT00276016|951618|P2|COMPLETED|Wash Out 1||6
388890|NCT00276016|951619|P1|COMPLETED|Wash Out 1||7
388891|NCT00276016|951614|P6|STARTED|Wash Out 1||6
388892|NCT00276016|951615|P5|STARTED|Wash Out 1||6
388893|NCT00276016|951616|P4|STARTED|Wash Out 1||6
388894|NCT00276016|951617|P3|STARTED|Wash Out 1||7
388895|NCT00276016|951618|P2|STARTED|Wash Out 1||6
388896|NCT00276016|951619|P1|STARTED|Wash Out 1||7
388897|NCT00276016|951614|P6|NOT COMPLETED|Intervention 1||0
388898|NCT00276016|951615|P5|NOT COMPLETED|Intervention 1||0
388899|NCT00276016|951616|P4|NOT COMPLETED|Intervention 1||0
388900|NCT00276016|951617|P3|NOT COMPLETED|Intervention 1||0
388901|NCT00276016|951618|P2|NOT COMPLETED|Intervention 1||1
388902|NCT00276016|951619|P1|NOT COMPLETED|Intervention 1||0
388903|NCT00276016|951614|P6|COMPLETED|Intervention 1||6
388904|NCT00276016|951615|P5|COMPLETED|Intervention 1||6
388905|NCT00276016|951616|P4|COMPLETED|Intervention 1||6
388906|NCT00276016|951617|P3|COMPLETED|Intervention 1||7
388907|NCT00276016|951618|P2|COMPLETED|Intervention 1||6
388908|NCT00276016|951619|P1|COMPLETED|Intervention 1||7
388909|NCT00276016|951614|P6|STARTED|Intervention 1||6
388910|NCT00276016|951615|P5|STARTED|Intervention 1||6
388911|NCT00276016|951616|P4|STARTED|Intervention 1||6
388912|NCT00276016|951617|P3|STARTED|Intervention 1||7
388913|NCT00276016|951618|P2|STARTED|Intervention 1||7
388914|NCT00276016|951619|P1|STARTED|Intervention 1||7
388915|NCT00275834|951631|P3|NOT COMPLETED|Overall Study||1
388916|NCT00275834|951632|P2|NOT COMPLETED|Overall Study||3
388917|NCT00275834|951633|P1|NOT COMPLETED|Overall Study||3
388918|NCT00275834|951631|P3|COMPLETED|Overall Study||74
388919|NCT00275834|951632|P2|COMPLETED|Overall Study||73
388920|NCT00275834|951633|P1|COMPLETED|Overall Study||71
388921|NCT00275834|951631|P3|Completed Study While on Study Drug|Overall Study||62
388922|NCT00275834|951632|P2|Completed Study While on Study Drug|Overall Study||51
388923|NCT00275834|951633|P1|Completed Study While on Study Drug|Overall Study||54
388924|NCT00275834|951631|P3|STARTED|Overall Study||75
388925|NCT00275834|951632|P2|STARTED|Overall Study||76
388926|NCT00275834|951633|P1|STARTED|Overall Study||74
388927|NCT00275821|951665|P3|NOT COMPLETED|Overall Study||12
388928|NCT00275821|951666|P2|NOT COMPLETED|Overall Study||23
388929|NCT00275821|951667|P1|NOT COMPLETED|Overall Study||14
388930|NCT00275821|951665|P3|COMPLETED|Overall Study||103
388931|NCT00275821|951666|P2|COMPLETED|Overall Study||95
388932|NCT00275821|951667|P1|COMPLETED|Overall Study||106
388933|NCT00275821|951665|P3|STARTED|Overall Study||115
388934|NCT00275821|951666|P2|STARTED|Overall Study||118
388935|NCT00275821|951667|P1|STARTED|Overall Study||120
388936|NCT00275561|951686|P2|NOT COMPLETED|Overall Study||6
388937|NCT00275561|951687|P1|NOT COMPLETED|Overall Study||2
388938|NCT00275561|951686|P2|COMPLETED|Overall Study||15
388939|NCT00275561|951687|P1|COMPLETED|Overall Study||19
388940|NCT00275561|951686|P2|STARTED|Overall Study||21
388941|NCT00275561|951687|P1|STARTED|Overall Study||21
388942|NCT00275509|951699|P2|NOT COMPLETED|Overall Study||1
388943|NCT00275509|951700|P1|NOT COMPLETED|Overall Study||0
388944|NCT00275509|951699|P2|COMPLETED|Overall Study||25
388945|NCT00275509|951700|P1|COMPLETED|Overall Study||30
388946|NCT00275509|951699|P2|STARTED|Overall Study||26
388947|NCT00275509|951700|P1|STARTED|Overall Study||30
388948|NCT00275392|951712|P2|NOT COMPLETED|Overall Study||2
388949|NCT00275392|951713|P1|NOT COMPLETED|Overall Study||0
388950|NCT00275392|951712|P2|COMPLETED|Overall Study||17
388951|NCT00275392|951713|P1|COMPLETED|Overall Study||20
388952|NCT00275392|951712|P2|STARTED|Overall Study||19
388953|NCT00275392|951713|P1|STARTED|Overall Study||20
388954|NCT00275340|951723|P2|NOT COMPLETED|Overall Study||4
388955|NCT00275340|951724|P1|NOT COMPLETED|Overall Study||2
388956|NCT00275340|951723|P2|COMPLETED|Overall Study||45
388957|NCT00275340|951724|P1|COMPLETED|Overall Study||50
388958|NCT00275340|951723|P2|STARTED|Overall Study||49
388959|NCT00275340|951724|P1|STARTED|Overall Study||52
388960|NCT00275301|951728|P1|NOT COMPLETED|Overall Study||5
388961|NCT00275301|951728|P1|COMPLETED|Overall Study||14
388962|NCT00275301|951728|P1|STARTED|Overall Study||19
388963|NCT00275275|951735|P3|NOT COMPLETED|Overall Study||6
388964|NCT00275275|951736|P2|NOT COMPLETED|Overall Study||2
388965|NCT00275275|951737|P1|NOT COMPLETED|Overall Study||6
388966|NCT00275275|951735|P3|COMPLETED|Overall Study||15
388967|NCT00275275|951736|P2|COMPLETED|Overall Study||18
388968|NCT00275275|951737|P1|COMPLETED|Overall Study||14
388969|NCT00275275|951735|P3|STARTED|Overall Study|One participant was removed after enrollment and before any data was collected for him.|21
388970|NCT00275275|951736|P2|STARTED|Overall Study||20
388971|NCT00275275|951737|P1|STARTED|Overall Study||20
388972|NCT00275262|951747|P2|NOT COMPLETED|Overall Study||9
388973|NCT00275262|951748|P1|NOT COMPLETED|Overall Study||6
388974|NCT00275262|951747|P2|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|4
388975|NCT00275262|951748|P1|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|6
388976|NCT00275262|951747|P2|STARTED|Overall Study||13
388977|NCT00275262|951748|P1|STARTED|Overall Study||12
388978|NCT00275028|951762|P1|NOT COMPLETED|Overall Study||47
388979|NCT00275028|951762|P1|COMPLETED|Overall Study|Participants are treated until one of the below milestones is reached. Completion is N/A.|0
388980|NCT00275028|951762|P1|STARTED|Overall Study||47
388981|NCT00275002|951769|P2|NOT COMPLETED|Overall Study||16
388982|NCT00275002|951770|P1|NOT COMPLETED|Overall Study||22
388983|NCT00275002|951769|P2|COMPLETED|Overall Study||0
388984|NCT00275002|951770|P1|COMPLETED|Overall Study||3
388985|NCT00275002|951769|P2|STARTED|Overall Study||16
388986|NCT00275002|951770|P1|STARTED|Overall Study||25
388987|NCT00274937|951778|P1|NOT COMPLETED|Overall Study||20
388988|NCT00274937|951778|P1|COMPLETED|Overall Study||91
388989|NCT00274937|951778|P1|STARTED|Overall Study||111
388990|NCT00274924|951790|P3|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
388991|NCT00274924|951791|P2|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||18
388992|NCT00274924|951792|P1|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||7
388993|NCT00274924|951790|P3|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
388994|NCT00274924|951791|P2|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||58
388995|NCT00274924|951792|P1|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||10
388996|NCT00274924|951790|P3|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||0
388997|NCT00274924|951791|P2|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||61
388998|NCT00274924|951792|P1|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||13
388999|NCT00274924|951790|P3|STARTED|Step 2 (Tx Based on Mid-treatment PET)||0
389000|NCT00274924|951791|P2|STARTED|Step 2 (Tx Based on Mid-treatment PET)|One patient withdrew from the study after step 1 treatment.|76
389001|NCT00274924|951792|P1|STARTED|Step 2 (Tx Based on Mid-treatment PET)|All patients who started step 2 therapy were included regardless of eligibility.|17
389002|NCT00274924|951790|P3|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||6
389003|NCT00274924|951791|P2|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||14
389004|NCT00274924|951792|P1|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||4
389005|NCT00274924|951790|P3|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||0
389006|NCT00274924|951791|P2|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||63
389007|NCT00274924|951792|P1|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||13
389008|NCT00274924|951790|P3|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||4
389009|NCT00274924|951791|P2|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||63
389010|NCT00274924|951792|P1|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||13
389011|NCT00274924|951790|P3|Treated|Step 1 (R-CHOP X 3 Cycles)||5
389012|NCT00274924|951791|P2|Treated|Step 1 (R-CHOP X 3 Cycles)||77
389013|NCT00274924|951792|P1|Treated|Step 1 (R-CHOP X 3 Cycles)||17
389014|NCT00274924|951790|P3|STARTED|Step 1 (R-CHOP X 3 Cycles)||6
389015|NCT00274924|951791|P2|STARTED|Step 1 (R-CHOP X 3 Cycles)||77
389016|NCT00274924|951792|P1|STARTED|Step 1 (R-CHOP X 3 Cycles)||17
389017|NCT00274846|951801|P1|NOT COMPLETED|Overall Study||1
389018|NCT00274846|951801|P1|COMPLETED|Overall Study|Evaluable patients - received adequate natural killer (NK) cells|20
389019|NCT00274846|951801|P1|STARTED|Overall Study||21
389020|NCT00274781|951809|P1|NOT COMPLETED|Overall Study||0
389021|NCT00274781|951809|P1|COMPLETED|Overall Study||30
389022|NCT00274781|951809|P1|STARTED|Overall Study||30
389023|NCT00274768|951815|P1|NOT COMPLETED|Overall Study||0
389024|NCT00274768|951815|P1|COMPLETED|Overall Study||26
389025|NCT00274768|951815|P1|STARTED|Overall Study||26
389026|NCT00274742|951825|P6|NOT COMPLETED|Overall Study||3
389027|NCT00274742|951826|P5|NOT COMPLETED|Overall Study||16
389028|NCT00274742|951827|P4|NOT COMPLETED|Overall Study||5
389029|NCT00274742|951828|P3|NOT COMPLETED|Overall Study||2
389030|NCT00274742|951829|P2|NOT COMPLETED|Overall Study||8
389031|NCT00274742|951830|P1|NOT COMPLETED|Overall Study||0
389032|NCT00274742|951825|P6|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|1
389033|NCT00274742|951826|P5|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|16
389034|NCT00274742|951827|P4|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
389035|NCT00274742|951828|P3|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
389036|NCT00274742|951829|P2|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|5
389037|NCT00274742|951830|P1|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|12
389038|NCT00274742|951825|P6|STARTED|Overall Study||4
389039|NCT00274742|951826|P5|STARTED|Overall Study||32
389040|NCT00274742|951827|P4|STARTED|Overall Study||9
389041|NCT00274742|951828|P3|STARTED|Overall Study||6
389042|NCT00274742|951829|P2|STARTED|Overall Study||13
389043|NCT00274742|951830|P1|STARTED|Overall Study||12
389044|NCT00274716|951868|P6|NOT COMPLETED|Phase B||1
389045|NCT00274716|951869|P5|NOT COMPLETED|Phase B||0
389046|NCT00274716|951870|P4|NOT COMPLETED|Phase B||1
389047|NCT00274716|951871|P3|NOT COMPLETED|Phase B||3
389048|NCT00274716|951872|P2|NOT COMPLETED|Phase B||4
389049|NCT00274716|951873|P1|NOT COMPLETED|Phase B||1
389050|NCT00274716|951868|P6|COMPLETED|Phase B||14
389051|NCT00274716|951869|P5|COMPLETED|Phase B||16
389052|NCT00274716|951870|P4|COMPLETED|Phase B||41
389053|NCT00274716|951871|P3|COMPLETED|Phase B||41
389054|NCT00274716|951872|P2|COMPLETED|Phase B||40
389055|NCT00274716|951873|P1|COMPLETED|Phase B||42
389056|NCT00274716|951868|P6|STARTED|Phase B||15
389057|NCT00274716|951869|P5|STARTED|Phase B||16
389058|NCT00274716|951870|P4|STARTED|Phase B||42
389059|NCT00274716|951871|P3|STARTED|Phase B||44
389060|NCT00274716|951872|P2|STARTED|Phase B||44
389061|NCT00274716|951873|P1|STARTED|Phase B||43
389062|NCT00274716|951868|P6|NOT COMPLETED|Phase A||4
389063|NCT00274716|951869|P5|NOT COMPLETED|Phase A||3
389064|NCT00274716|951870|P4|NOT COMPLETED|Phase A||9
389065|NCT00274716|951871|P3|NOT COMPLETED|Phase A||8
389066|NCT00274716|951872|P2|NOT COMPLETED|Phase A||10
389067|NCT00274716|951873|P1|NOT COMPLETED|Phase A||11
389068|NCT00274716|951868|P6|COMPLETED|Phase A||15
389069|NCT00274716|951869|P5|COMPLETED|Phase A||16
389070|NCT00274716|951870|P4|COMPLETED|Phase A||42
389071|NCT00274716|951871|P3|COMPLETED|Phase A||44
389072|NCT00274716|951872|P2|COMPLETED|Phase A||44
389073|NCT00274716|951873|P1|COMPLETED|Phase A||43
389074|NCT00274716|951868|P6|STARTED|Phase A||19
389075|NCT00274716|951869|P5|STARTED|Phase A||19
389076|NCT00274716|951870|P4|STARTED|Phase A||51
389077|NCT00274716|951871|P3|STARTED|Phase A||52
389078|NCT00274716|951872|P2|STARTED|Phase A||54
389079|NCT00274716|951873|P1|STARTED|Phase A||54
389080|NCT00274651|951935|P2|NOT COMPLETED|Overall Study||20
389081|NCT00274651|951936|P1|NOT COMPLETED|Overall Study||28
389082|NCT00274651|951935|P2|COMPLETED|Overall Study||4
389083|NCT00274651|951936|P1|COMPLETED|Overall Study||1
389084|NCT00274651|951935|P2|STARTED|Overall Study||24
389085|NCT00274651|951936|P1|STARTED|Overall Study||29
389086|NCT00274625|951951|P2|NOT COMPLETED|Overall Study||62
389087|NCT00274625|951952|P1|NOT COMPLETED|Overall Study||60
389088|NCT00274625|951951|P2|COMPLETED|Overall Study||141
389089|NCT00274625|951952|P1|COMPLETED|Overall Study||139
389090|NCT00274625|951951|P2|STARTED|Overall Study||203
389091|NCT00274625|951952|P1|STARTED|Overall Study||199
389092|NCT00274469|951960|P2|NOT COMPLETED|Overall Study||93
389093|NCT00274469|951961|P1|NOT COMPLETED|Overall Study||79
389094|NCT00274469|951960|P2|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|10
389095|NCT00274469|951961|P1|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|23
389096|NCT00274469|951960|P2|STARTED|Overall Study|Number of patients randomized|103
389097|NCT00274469|951961|P1|STARTED|Overall Study|Number of patients randomized|102
389098|NCT00274456|951981|P4|NOT COMPLETED|Overall Study||45
389099|NCT00274456|951982|P3|NOT COMPLETED|Overall Study||35
389100|NCT00274456|951983|P2|NOT COMPLETED|Overall Study||27
389101|NCT00274456|951984|P1|NOT COMPLETED|Overall Study||37
389102|NCT00274456|951981|P4|COMPLETED|Overall Study|Treatment completed upon progressive disease|29
389103|NCT00274456|951982|P3|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
389104|NCT00274456|951983|P2|COMPLETED|Overall Study|Treatment completed upon progressive disease|49
389105|NCT00274456|951984|P1|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
389106|NCT00274456|951981|P4|At Least One Response Assessment|Overall Study||70
389107|NCT00274456|951982|P3|At Least One Response Assessment|Overall Study||73
389108|NCT00274456|951983|P2|At Least One Response Assessment|Overall Study||76
389109|NCT00274456|951984|P1|At Least One Response Assessment|Overall Study||73
389110|NCT00274456|951981|P4|STARTED|Overall Study||74
389111|NCT00274456|951982|P3|STARTED|Overall Study||74
389112|NCT00274456|951983|P2|STARTED|Overall Study||76
389113|NCT00274456|951984|P1|STARTED|Overall Study||76
389114|NCT00274287|952026|P1|NOT COMPLETED|Overall Study||2
389115|NCT00274287|952026|P1|COMPLETED|Overall Study||13
389116|NCT00274287|952026|P1|STARTED|Overall Study||15
389117|NCT00274261|952036|P2|NOT COMPLETED|Overall Study||337
389118|NCT00274261|952037|P1|NOT COMPLETED|Overall Study||489
389119|NCT00274261|952036|P2|COMPLETED|Overall Study||296
389120|NCT00274261|952037|P1|COMPLETED|Overall Study||443
389121|NCT00274261|952036|P2|STARTED|Overall Study||633
389122|NCT00274261|952037|P1|STARTED|Overall Study||932
389123|NCT00273910|952051|P6|NOT COMPLETED|Overall Study||0
389124|NCT00273910|952052|P5|NOT COMPLETED|Overall Study||0
389125|NCT00273910|952053|P4|NOT COMPLETED|Overall Study||0
389126|NCT00273910|952054|P3|NOT COMPLETED|Overall Study||0
389127|NCT00273910|952055|P2|NOT COMPLETED|Overall Study||0
389128|NCT00273910|952056|P1|NOT COMPLETED|Overall Study||0
389129|NCT00273910|952051|P6|COMPLETED|Overall Study||14
389130|NCT00273910|952052|P5|COMPLETED|Overall Study||15
389131|NCT00273910|952053|P4|COMPLETED|Overall Study||19
389132|NCT00273910|952054|P3|COMPLETED|Overall Study||18
389133|NCT00273910|952055|P2|COMPLETED|Overall Study||19
389134|NCT00273910|952056|P1|COMPLETED|Overall Study||19
389135|NCT00273910|952051|P6|STARTED|Overall Study||14
389136|NCT00273910|952052|P5|STARTED|Overall Study||15
389137|NCT00273910|952053|P4|STARTED|Overall Study||19
389138|NCT00273910|952054|P3|STARTED|Overall Study||18
389139|NCT00273910|952055|P2|STARTED|Overall Study||19
389140|NCT00273910|952056|P1|STARTED|Overall Study||19
389141|NCT00273858|952076|P1|NOT COMPLETED|Overall Study||537
389142|NCT00273858|952076|P1|COMPLETED|Overall Study||343
389143|NCT00273858|952076|P1|STARTED|Overall Study||880
389144|NCT00273793|952091|P6|NOT COMPLETED|Overall Study||0
389145|NCT00273793|952092|P5|NOT COMPLETED|Overall Study||0
389146|NCT00273793|952093|P4|NOT COMPLETED|Overall Study||0
389147|NCT00273793|952094|P3|NOT COMPLETED|Overall Study||0
389148|NCT00273793|952095|P2|NOT COMPLETED|Overall Study||0
389149|NCT00273793|952096|P1|NOT COMPLETED|Overall Study||0
389150|NCT00273793|952091|P6|COMPLETED|Overall Study||29
389151|NCT00273793|952092|P5|COMPLETED|Overall Study||58
389152|NCT00273793|952093|P4|COMPLETED|Overall Study||60
389153|NCT00273793|952094|P3|COMPLETED|Overall Study||18
389154|NCT00273793|952095|P2|COMPLETED|Overall Study||38
389155|NCT00273793|952096|P1|COMPLETED|Overall Study||36
389156|NCT00273793|952091|P6|STARTED|Overall Study||29
389157|NCT00273793|952092|P5|STARTED|Overall Study||58
389158|NCT00273793|952093|P4|STARTED|Overall Study||60
389159|NCT00273793|952094|P3|STARTED|Overall Study||18
389160|NCT00273793|952095|P2|STARTED|Overall Study||38
389161|NCT00273793|952096|P1|STARTED|Overall Study||36
389162|NCT00273754|952118|P2|NOT COMPLETED|Overall Study||0
389163|NCT00273754|952119|P1|NOT COMPLETED|Overall Study||0
389164|NCT00273754|952118|P2|COMPLETED|Overall Study||36
389165|NCT00273754|952119|P1|COMPLETED|Overall Study||36
389166|NCT00273754|952118|P2|STARTED|Overall Study||36
389167|NCT00273754|952119|P1|STARTED|Overall Study||36
389168|NCT00273182|952135|P1|NOT COMPLETED|Overall Study||985
389169|NCT00273182|952135|P1|COMPLETED|Overall Study||1014
389170|NCT00273182|952135|P1|STARTED|Overall Study||1999
389171|NCT00273052|952145|P2|NOT COMPLETED|Overall Study||88
389172|NCT00273052|952146|P1|NOT COMPLETED|Overall Study||69
389173|NCT00273052|952145|P2|COMPLETED|Overall Study||190
389174|NCT00273052|952146|P1|COMPLETED|Overall Study||221
389175|NCT00273052|952145|P2|STARTED|Overall Study||278
389176|NCT00273052|952146|P1|STARTED|Overall Study||290
389177|NCT00272987|952181|P3|NOT COMPLETED|Overall Study||19
389178|NCT00272987|952182|P2|NOT COMPLETED|Overall Study||14
389179|NCT00272987|952183|P1|NOT COMPLETED|Overall Study||21
389180|NCT00272987|952181|P3|COMPLETED|Overall Study||1
389181|NCT00272987|952182|P2|COMPLETED|Overall Study||0
389182|NCT00272987|952183|P1|COMPLETED|Overall Study||8
389183|NCT00272987|952181|P3|Ongoing|Overall Study||15
389184|NCT00272987|952182|P2|Ongoing|Overall Study||14
389185|NCT00272987|952183|P1|Ongoing|Overall Study||20
389186|NCT00272987|952181|P3|STARTED|Overall Study||20
389187|NCT00272987|952182|P2|STARTED|Overall Study||14
389188|NCT00272987|952183|P1|STARTED|Overall Study||29
389189|NCT00272961|952247|P5|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
389190|NCT00272961|952248|P4|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||3
389191|NCT00272961|952249|P3|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
389192|NCT00272961|952250|P2|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
389193|NCT00272961|952251|P1|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||2
389194|NCT00272961|952247|P5|COMPLETED|Treatment Phase: Week 3 Up to Week 12||6
389195|NCT00272961|952248|P4|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
389196|NCT00272961|952249|P3|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
389197|NCT00272961|952250|P2|COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
389198|NCT00272961|952251|P1|COMPLETED|Treatment Phase: Week 3 Up to Week 12||8
389199|NCT00272961|952247|P5|STARTED|Treatment Phase: Week 3 Up to Week 12||10
389200|NCT00272961|952248|P4|STARTED|Treatment Phase: Week 3 Up to Week 12||10
389201|NCT00272961|952249|P3|STARTED|Treatment Phase: Week 3 Up to Week 12||11
389202|NCT00272961|952250|P2|STARTED|Treatment Phase: Week 3 Up to Week 12||8
389203|NCT00272961|952251|P1|STARTED|Treatment Phase: Week 3 Up to Week 12||10
389204|NCT00272961|952247|P5|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
389205|NCT00272961|952248|P4|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
389206|NCT00272961|952249|P3|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
389207|NCT00272961|952250|P2|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
389208|NCT00272961|952251|P1|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||11
389209|NCT00272961|952247|P5|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
389210|NCT00272961|952248|P4|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
389211|NCT00272961|952249|P3|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
389212|NCT00272961|952250|P2|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
389213|NCT00272961|952251|P1|COMPLETED|Placebo Run-in Phase: Up to Week 2||49
389214|NCT00272961|952247|P5|STARTED|Placebo Run-in Phase: Up to Week 2||0
389215|NCT00272961|952248|P4|STARTED|Placebo Run-in Phase: Up to Week 2||0
389216|NCT00272961|952249|P3|STARTED|Placebo Run-in Phase: Up to Week 2||0
389217|NCT00272961|952250|P2|STARTED|Placebo Run-in Phase: Up to Week 2||0
389218|NCT00272961|952251|P1|STARTED|Placebo Run-in Phase: Up to Week 2||60
389219|NCT00272844|952308|P1|NOT COMPLETED|Overall Study||5
389220|NCT00272844|952308|P1|COMPLETED|Overall Study||18
389221|NCT00272844|952308|P1|STARTED|Overall Study||23
389222|NCT00272792|952316|P2|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||3
389223|NCT00272792|952317|P1|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||1
389224|NCT00272792|952316|P2|COMPLETED|Part 2: Blinded, Placebo Control Period||9
389225|NCT00272792|952317|P1|COMPLETED|Part 2: Blinded, Placebo Control Period||32
389226|NCT00272792|952316|P2|STARTED|Part 2: Blinded, Placebo Control Period||12
389227|NCT00272792|952317|P1|STARTED|Part 2: Blinded, Placebo Control Period||33
389228|NCT00272792|952316|P2|NOT COMPLETED|Part 1: Responsiveness||0
389229|NCT00272792|952317|P1|NOT COMPLETED|Part 1: Responsiveness||1
389230|NCT00272792|952316|P2|COMPLETED|Part 1: Responsiveness||0
389231|NCT00272792|952317|P1|COMPLETED|Part 1: Responsiveness||89
389232|NCT00272792|952316|P2|STARTED|Part 1: Responsiveness||0
389233|NCT00272792|952317|P1|STARTED|Part 1: Responsiveness||90
389234|NCT00272779|952327|P2|NOT COMPLETED|Baseline Through Week 96||136
389235|NCT00272779|952328|P1|NOT COMPLETED|Baseline Through Week 96||139
389236|NCT00272779|952327|P2|COMPLETED|Baseline Through Week 96||307
389237|NCT00272779|952328|P1|COMPLETED|Baseline Through Week 96||301
389238|NCT00272779|952327|P2|RECEIVED ANY TREATMENT|Baseline Through Week 96|3 participants received ATV instead of LPV (treatment error) and 3 participants never treated|437
389239|NCT00272779|952328|P1|RECEIVED ANY TREATMENT|Baseline Through Week 96|1 participant randomized to LPV received ATV instead (treatment error)|441
389240|NCT00272779|952327|P2|STARTED|Baseline Through Week 96|Number randomized to LPV|443
389241|NCT00272779|952328|P1|STARTED|Baseline Through Week 96|Number randomized to ATV|440
389242|NCT00272779|952327|P2|NOT COMPLETED|Baseline Through Week 48||443
389243|NCT00272779|952328|P1|NOT COMPLETED|Baseline Through Week 48||440
389244|NCT00272779|952327|P2|COMPLETED|Baseline Through Week 48||0
389245|NCT00272779|952328|P1|COMPLETED|Baseline Through Week 48||0
389246|NCT00272779|952327|P2|STILL ON TREATMENT|Baseline Through Week 48||368
389247|NCT00272779|952328|P1|STILL ON TREATMENT|Baseline Through Week 48||385
389248|NCT00272779|952327|P2|Discontinued on or After Week 48|Baseline Through Week 48||14
389249|NCT00272779|952328|P1|Discontinued on or After Week 48|Baseline Through Week 48||14
389250|NCT00272779|952327|P2|Discontinued Before Week 48|Baseline Through Week 48||58
389251|NCT00272779|952328|P1|Discontinued Before Week 48|Baseline Through Week 48||39
389252|NCT00272779|952327|P2|TREATED AS RANDOMIZED|Baseline Through Week 48||440
389253|NCT00272779|952328|P1|TREATED AS RANDOMIZED|Baseline Through Week 48||438
389254|NCT00272779|952327|P2|RECEIVED ANY TREATMENT|Baseline Through Week 48|3 participants received ATV instead of LPV (treatment error), 3 participants never treated with LPV|437
389255|NCT00272779|952328|P1|RECEIVED ANY TREATMENT|Baseline Through Week 48|1 participant randomized to LPV received ATV instead (treatment error)|441
389256|NCT00272779|952327|P2|STARTED|Baseline Through Week 48|Number of participants randomized to LPV|443
389257|NCT00272779|952328|P1|STARTED|Baseline Through Week 48|Number of participants randomized to ATV|440
389258|NCT00272337|952512|P5|NOT COMPLETED|Overall Study||0
389259|NCT00272337|952513|P4|NOT COMPLETED|Overall Study||0
389260|NCT00272337|952514|P3|NOT COMPLETED|Overall Study||0
389261|NCT00272337|952515|P2|NOT COMPLETED|Overall Study||0
389262|NCT00272337|952516|P1|NOT COMPLETED|Overall Study||0
389263|NCT00272337|952512|P5|COMPLETED|Overall Study||8
389264|NCT00272337|952513|P4|COMPLETED|Overall Study||7
389265|NCT00272337|952514|P3|COMPLETED|Overall Study||7
389266|NCT00272337|952515|P2|COMPLETED|Overall Study||7
389267|NCT00272337|952516|P1|COMPLETED|Overall Study||8
389268|NCT00272337|952512|P5|STARTED|Overall Study||8
389269|NCT00272337|952513|P4|STARTED|Overall Study||7
389270|NCT00272337|952514|P3|STARTED|Overall Study||7
389271|NCT00272337|952515|P2|STARTED|Overall Study||7
389272|NCT00272337|952516|P1|STARTED|Overall Study||8
389273|NCT00272311|952543|P5|NOT COMPLETED|Overall Study||0
389274|NCT00272311|952544|P4|NOT COMPLETED|Overall Study||0
389275|NCT00272311|952545|P3|NOT COMPLETED|Overall Study||0
389276|NCT00272311|952546|P2|NOT COMPLETED|Overall Study||0
389277|NCT00272311|952547|P1|NOT COMPLETED|Overall Study||0
389278|NCT00272311|952543|P5|COMPLETED|Overall Study||14
389279|NCT00272311|952544|P4|COMPLETED|Overall Study||14
389280|NCT00272311|952545|P3|COMPLETED|Overall Study||14
389281|NCT00272311|952546|P2|COMPLETED|Overall Study||14
389282|NCT00272311|952547|P1|COMPLETED|Overall Study||14
389283|NCT00272311|952543|P5|STARTED|Overall Study||14
389284|NCT00272311|952544|P4|STARTED|Overall Study||14
389285|NCT00272311|952545|P3|STARTED|Overall Study||14
389286|NCT00272311|952546|P2|STARTED|Overall Study||14
389287|NCT00272311|952547|P1|STARTED|Overall Study||14
389288|NCT00272168|952571|P2|NOT COMPLETED|Overall Study||10
389289|NCT00272168|952572|P1|NOT COMPLETED|Overall Study||10
389290|NCT00272168|952571|P2|COMPLETED|Overall Study||31
389291|NCT00272168|952572|P1|COMPLETED|Overall Study||37
389292|NCT00272168|952571|P2|STARTED|Overall Study||41
389293|NCT00272168|952572|P1|STARTED|Overall Study||47
389294|NCT00272038|952588|P1|NOT COMPLETED|Overall Study||7
389295|NCT00272038|952588|P1|COMPLETED|Overall Study||22
389296|NCT00272038|952588|P1|STARTED|Overall Study||29
389297|NCT00271947|952594|P1|NOT COMPLETED|Overall Study||1
389298|NCT00271947|952594|P1|COMPLETED|Overall Study||0
389299|NCT00271947|952594|P1|STARTED|Overall Study||1
389300|NCT00271856|952600|P2|NOT COMPLETED|Overall Study||18
389301|NCT00271856|952601|P1|NOT COMPLETED|Overall Study||11
389302|NCT00271856|952600|P2|COMPLETED|Overall Study||70
389303|NCT00271856|952601|P1|COMPLETED|Overall Study||78
389304|NCT00271856|952600|P2|STARTED|Overall Study||88
389305|NCT00271856|952601|P1|STARTED|Overall Study||89
389306|NCT00271817|952620|P3|NOT COMPLETED|Part 2||84
389307|NCT00271817|952621|P2|NOT COMPLETED|Part 2||32
389308|NCT00271817|952622|P1|NOT COMPLETED|Part 2||0
389309|NCT00271817|952620|P3|COMPLETED|Part 2||401
389310|NCT00271817|952621|P2|COMPLETED|Part 2||234
389311|NCT00271817|952622|P1|COMPLETED|Part 2||0
389312|NCT00271817|952620|P3|STARTED|Part 2|Includes 105 patients re-allocated from the niacin group in Part 1|485
389313|NCT00271817|952621|P2|STARTED|Part 2|Includes 54 patients re-allocated from the niacin group in Part 1|266
389314|NCT00271817|952622|P1|STARTED|Part 2|Patients completing the niacin group in Part 1, were re-allocated to one of the two arms in Part 2|0
389315|NCT00271817|952620|P3|NOT COMPLETED|Part 1||285
389316|NCT00271817|952621|P2|NOT COMPLETED|Part 1||59
389317|NCT00271817|952622|P1|NOT COMPLETED|Part 1||106
389318|NCT00271817|952620|P3|COMPLETED|Part 1|11 patients who completed Part 1 did not continue to Part 2|391
389319|NCT00271817|952621|P2|COMPLETED|Part 1|1 patient who completed Part 1 did not continue to Part 2|213
389320|NCT00271817|952622|P1|COMPLETED|Part 1|6 patients who completed Part 1 did not continue to Part 2; 1 patient never received drug in Part 2|166
389321|NCT00271817|952620|P3|STARTED|Part 1||676
389322|NCT00271817|952621|P2|STARTED|Part 1||272
389323|NCT00271817|952622|P1|STARTED|Part 1||272
389324|NCT00271739|952651|P2|NOT COMPLETED|Overall Study||105
389325|NCT00271739|952652|P1|NOT COMPLETED|Overall Study||115
389326|NCT00271739|952651|P2|COMPLETED|Overall Study||716
389327|NCT00271739|952652|P1|COMPLETED|Overall Study||729
389328|NCT00271739|952651|P2|STARTED|Overall Study||821
389329|NCT00271739|952652|P1|STARTED|Overall Study||844
389330|NCT00271609|952664|P2|NOT COMPLETED|Overall Study||3
389331|NCT00271609|952665|P1|NOT COMPLETED|Overall Study||13
389332|NCT00271609|952664|P2|COMPLETED|Overall Study||29
389333|NCT00271609|952665|P1|COMPLETED|Overall Study||43
389334|NCT00271609|952664|P2|STARTED|Overall Study||32
389335|NCT00271609|952665|P1|STARTED|Overall Study||56
389336|NCT00271596|952675|P2|NOT COMPLETED|Overall Study||1
389337|NCT00271596|952676|P1|NOT COMPLETED|Overall Study||1
389338|NCT00271596|952675|P2|COMPLETED|Overall Study||15
389339|NCT00271596|952676|P1|COMPLETED|Overall Study||16
389340|NCT00271596|952675|P2|STARTED|Overall Study||16
389341|NCT00271596|952676|P1|STARTED|Overall Study||17
389342|NCT00271570|952702|P2|NOT COMPLETED|Overall Study||0
389343|NCT00271570|952703|P1|NOT COMPLETED|Overall Study||0
389344|NCT00271570|952702|P2|COMPLETED|Overall Study||12
389345|NCT00271570|952703|P1|COMPLETED|Overall Study||12
389346|NCT00271570|952702|P2|STARTED|Overall Study||12
389347|NCT00271570|952703|P1|STARTED|Overall Study||12
389348|NCT00271544|952711|P1|NOT COMPLETED|Overall Study||20
389349|NCT00271544|952711|P1|COMPLETED|Overall Study|Total number subjects successfully implanted 4196 lead.|170
389350|NCT00271544|952711|P1|Model 4196 Lead Attempted|Overall Study|Total number of subjects attempted Model 4196 lead.|177
389351|NCT00271544|952711|P1|Implant Attempted|Overall Study|Total number of subjects completed baseline and underwent system implant attempt.|186
389352|NCT00271544|952711|P1|STARTED|Overall Study|Total number of subjects enrolled.|190
389353|NCT00271375|952735|P3|NOT COMPLETED|Overall Study||0
389354|NCT00271375|952736|P2|NOT COMPLETED|Overall Study||0
389355|NCT00271375|952737|P1|NOT COMPLETED|Overall Study||0
389356|NCT00271375|952735|P3|COMPLETED|Overall Study||57
389357|NCT00271375|952736|P2|COMPLETED|Overall Study||83
389358|NCT00271375|952737|P1|COMPLETED|Overall Study||114
389359|NCT00271375|952735|P3|STARTED|Overall Study||57
389360|NCT00271375|952736|P2|STARTED|Overall Study||83
389361|NCT00271375|952737|P1|STARTED|Overall Study||114
389362|NCT00271219|952775|P2|NOT COMPLETED|Overall Study||28
389363|NCT00271219|952776|P1|NOT COMPLETED|Overall Study||16
389364|NCT00271219|952775|P2|COMPLETED|Overall Study||58
389365|NCT00271219|952776|P1|COMPLETED|Overall Study||73
389366|NCT00271219|952775|P2|STARTED|Overall Study||86
389367|NCT00271219|952776|P1|STARTED|Overall Study||89
389368|NCT00271154|952802|P2|NOT COMPLETED|Overall Study||0
389369|NCT00271154|952803|P1|NOT COMPLETED|Overall Study||0
389370|NCT00271154|952802|P2|COMPLETED|Overall Study||419
389371|NCT00271154|952803|P1|COMPLETED|Overall Study||191
389372|NCT00271154|952802|P2|STARTED|Overall Study||419
389373|NCT00271154|952803|P1|STARTED|Overall Study||191
389374|NCT00271102|952814|P2|NOT COMPLETED|Overall Study||5
389375|NCT00271102|952815|P1|NOT COMPLETED|Overall Study||5
389376|NCT00271102|952814|P2|COMPLETED|Overall Study||30
389377|NCT00271102|952815|P1|COMPLETED|Overall Study||30
389378|NCT00271102|952814|P2|STARTED|Overall Study||35
389379|NCT00271102|952815|P1|STARTED|Overall Study||35
389380|NCT00271024|952825|P4|NOT COMPLETED|Overall Study||24
389381|NCT00271024|952826|P3|NOT COMPLETED|Overall Study||23
389382|NCT00271024|952827|P2|NOT COMPLETED|Overall Study||26
389383|NCT00271024|952828|P1|NOT COMPLETED|Overall Study||22
389384|NCT00271024|952825|P4|COMPLETED|Overall Study|Discontinued: 9 smoking related, 2 reaction to tablet, 4 time commitment, 1 other, 3 unspecified|64
389385|NCT00271024|952826|P3|COMPLETED|Overall Study|Discontinued: 5 smoking related, 4 reaction to tablet, 4 time commitment, 3 other, 4 unspecified|65
389386|NCT00271024|952827|P2|COMPLETED|Overall Study|Discontinued: 5 smoking related, 3 reaction to tablet, 2 time commitment, 1 other, 9 unspecified|51
389387|NCT00271024|952828|P1|COMPLETED|Overall Study|Discontinued: 1 smoking related, 1 reaction to tablet, 6 time commitment, 2 other, 8 unspecified|58
389388|NCT00271024|952825|P4|Received Study Treatment|Overall Study|n=5 did not start treatment (2 health problems, 1 wanted diff. treatment method, 2 lost interest)|83
389389|NCT00271024|952826|P3|Received Study Treatment|Overall Study|n=3 did not start treatment (2 lost interest, 1 unknown)|85
389390|NCT00271024|952827|P2|Received Study Treatment|Overall Study|n=6 did not start treatment (1 diff treat. desired, 3 lost interest, 1 began psych meds, 1 unknown)|71
389391|NCT00271024|952828|P1|Received Study Treatment|Overall Study|n=4 did not start treatment (3 lost interest, 1 unknown)|76
389392|NCT00271024|952825|P4|STARTED|Overall Study||88
389393|NCT00271024|952826|P3|STARTED|Overall Study||88
389394|NCT00271024|952827|P2|STARTED|Overall Study||77
389395|NCT00271024|952828|P1|STARTED|Overall Study||80
389396|NCT00271011|952870|P1|NOT COMPLETED|Overall Study||0
389397|NCT00271011|952870|P1|COMPLETED|Overall Study||13
389398|NCT00271011|952870|P1|STARTED|Overall Study||13
389399|NCT00270998|952878|P3|NOT COMPLETED|12 Month Follow-up||21
389400|NCT00270998|952879|P2|NOT COMPLETED|12 Month Follow-up||25
389401|NCT00270998|952880|P1|NOT COMPLETED|12 Month Follow-up||14
389402|NCT00270998|952878|P3|COMPLETED|12 Month Follow-up||111
389403|NCT00270998|952879|P2|COMPLETED|12 Month Follow-up||99
389404|NCT00270998|952880|P1|COMPLETED|12 Month Follow-up||96
389405|NCT00270998|952878|P3|STARTED|12 Month Follow-up||132
389406|NCT00270998|952879|P2|STARTED|12 Month Follow-up||124
389407|NCT00270998|952880|P1|STARTED|12 Month Follow-up||110
389408|NCT00270998|952878|P3|NOT COMPLETED|3 Month Follow-up||18
389409|NCT00270998|952879|P2|NOT COMPLETED|3 Month Follow-up||22
389410|NCT00270998|952880|P1|NOT COMPLETED|3 Month Follow-up||39
389411|NCT00270998|952878|P3|COMPLETED|3 Month Follow-up||132
389412|NCT00270998|952879|P2|COMPLETED|3 Month Follow-up||124
389413|NCT00270998|952880|P1|COMPLETED|3 Month Follow-up||110
389506|NCT00269919|953209|P1|COMPLETED|Overall Study||13
389414|NCT00270998|952878|P3|STARTED|3 Month Follow-up|1 participant randomized to combined found ineligible at first treatment visit, removed from study.|150
389415|NCT00270998|952879|P2|STARTED|3 Month Follow-up||146
389416|NCT00270998|952880|P1|STARTED|3 Month Follow-up||149
389417|NCT00270894|952909|P1|NOT COMPLETED|Overall Study||2
389418|NCT00270894|952909|P1|COMPLETED|Overall Study||28
389419|NCT00270894|952909|P1|STARTED|Overall Study||30
389420|NCT00270855|952921|P2|NOT COMPLETED|Overall Study||8
389421|NCT00270855|952922|P1|NOT COMPLETED|Overall Study||8
389422|NCT00270855|952921|P2|COMPLETED|Overall Study||6
389423|NCT00270855|952922|P1|COMPLETED|Overall Study||7
389424|NCT00270855|952921|P2|STARTED|Overall Study||14
389425|NCT00270855|952922|P1|STARTED|Overall Study||15
389426|NCT00270842|952981|P3|NOT COMPLETED|Overall Study||16
389427|NCT00270842|952982|P2|NOT COMPLETED|Overall Study||16
389428|NCT00270842|952983|P1|NOT COMPLETED|Overall Study||15
389429|NCT00270842|952981|P3|COMPLETED|Overall Study||18
389430|NCT00270842|952982|P2|COMPLETED|Overall Study||18
389431|NCT00270842|952983|P1|COMPLETED|Overall Study||18
389432|NCT00270842|952981|P3|STARTED|Overall Study||34
389433|NCT00270842|952982|P2|STARTED|Overall Study||34
389434|NCT00270842|952983|P1|STARTED|Overall Study||33
389435|NCT00270790|952994|P1|NOT COMPLETED|Overall Study||5
389436|NCT00270790|952994|P1|COMPLETED|Overall Study||16
389437|NCT00270790|952994|P1|STARTED|Overall Study||21
389438|NCT00270634|953003|P4|NOT COMPLETED|Overall Study||5
389439|NCT00270634|953004|P3|NOT COMPLETED|Overall Study||22
389440|NCT00270634|953005|P2|NOT COMPLETED|Overall Study||13
389441|NCT00270634|953006|P1|NOT COMPLETED|Overall Study||17
389442|NCT00270634|953003|P4|COMPLETED|Overall Study||81
389443|NCT00270634|953004|P3|COMPLETED|Overall Study||62
389444|NCT00270634|953005|P2|COMPLETED|Overall Study||64
389445|NCT00270634|953006|P1|COMPLETED|Overall Study||70
389446|NCT00270634|953003|P4|STARTED|Overall Study||86
389447|NCT00270634|953004|P3|STARTED|Overall Study||84
389448|NCT00270634|953005|P2|STARTED|Overall Study||77
389449|NCT00270634|953006|P1|STARTED|Overall Study||87
389450|NCT00270296|953043|P3|NOT COMPLETED|Overall Study||61
389451|NCT00270296|953044|P2|NOT COMPLETED|Overall Study||90
389452|NCT00270296|953045|P1|NOT COMPLETED|Overall Study||99
389453|NCT00270296|953043|P3|COMPLETED|Overall Study||109
389454|NCT00270296|953044|P2|COMPLETED|Overall Study||185
389455|NCT00270296|953045|P1|COMPLETED|Overall Study||186
389456|NCT00270296|953043|P3|STARTED|Overall Study||170
389457|NCT00270296|953044|P2|STARTED|Overall Study||275
389458|NCT00270296|953045|P1|STARTED|Overall Study||285
389459|NCT00270257|953058|P2|NOT COMPLETED|Overall Study||424
389460|NCT00270257|953059|P1|NOT COMPLETED|Overall Study||412
389461|NCT00270257|953058|P2|COMPLETED|Overall Study||204
389462|NCT00270257|953059|P1|COMPLETED|Overall Study||211
389463|NCT00270257|953058|P2|Visit 104|Overall Study||204
389464|NCT00270257|953059|P1|Visit 104|Overall Study||211
389465|NCT00270257|953058|P2|Week 78|Overall Study||285
389466|NCT00270257|953059|P1|Week 78|Overall Study||283
389467|NCT00270257|953058|P2|Week 52|Overall Study||340
389468|NCT00270257|953059|P1|Week 52|Overall Study||362
389469|NCT00270257|953058|P2|Week 26|Overall Study||440
389470|NCT00270257|953059|P1|Week 26|Overall Study||460
389471|NCT00270257|953058|P2|Week 8|Overall Study||443
389472|NCT00270257|953059|P1|Week 8|Overall Study||510
389473|NCT00270257|953058|P2|STARTED|Overall Study|1 excluded from analysis (enrollment date exceeded eligibility window by 13 days)|628
389474|NCT00270257|953059|P1|STARTED|Overall Study||623
389475|NCT00270231|953077|P2|NOT COMPLETED|Second Intervention||1
389476|NCT00270231|953078|P1|NOT COMPLETED|Second Intervention||0
389477|NCT00270231|953077|P2|COMPLETED|Second Intervention||30
389478|NCT00270231|953078|P1|COMPLETED|Second Intervention||30
389479|NCT00270231|953077|P2|STARTED|Second Intervention||31
389480|NCT00270231|953078|P1|STARTED|Second Intervention||30
389481|NCT00270231|953077|P2|NOT COMPLETED|Washout Period||0
389482|NCT00270231|953078|P1|NOT COMPLETED|Washout Period||1
389483|NCT00270231|953077|P2|COMPLETED|Washout Period||31
389484|NCT00270231|953078|P1|COMPLETED|Washout Period||30
389485|NCT00270231|953077|P2|STARTED|Washout Period||31
389486|NCT00270231|953078|P1|STARTED|Washout Period||31
389487|NCT00270231|953077|P2|NOT COMPLETED|First Intervention||1
389488|NCT00270231|953078|P1|NOT COMPLETED|First Intervention||1
389489|NCT00270231|953077|P2|COMPLETED|First Intervention||31
389490|NCT00270231|953078|P1|COMPLETED|First Intervention||31
389491|NCT00270231|953077|P2|STARTED|First Intervention||32
389492|NCT00270231|953078|P1|STARTED|First Intervention||32
389493|NCT00270205|953088|P4|NOT COMPLETED|Overall Study||1
389494|NCT00270205|953089|P3|NOT COMPLETED|Overall Study||0
389495|NCT00270205|953090|P2|NOT COMPLETED|Overall Study||0
389496|NCT00270205|953091|P1|NOT COMPLETED|Overall Study||1
389497|NCT00270205|953088|P4|COMPLETED|Overall Study||6
389498|NCT00270205|953089|P3|COMPLETED|Overall Study||6
389499|NCT00270205|953090|P2|COMPLETED|Overall Study||6
389500|NCT00270205|953091|P1|COMPLETED|Overall Study||5
389501|NCT00270205|953088|P4|STARTED|Overall Study||7
389502|NCT00270205|953089|P3|STARTED|Overall Study||6
389503|NCT00270205|953090|P2|STARTED|Overall Study|7 participants enrolled. One never started study vaccination and was excluded from all analyses.|6
389504|NCT00270205|953091|P1|STARTED|Overall Study||6
389505|NCT00269919|953209|P1|NOT COMPLETED|Overall Study||27
389507|NCT00269919|953209|P1|Treated|Overall Study||39
389508|NCT00269919|953209|P1|STARTED|Overall Study||40
389509|NCT00269633|953228|P2|NOT COMPLETED|Overall Study||0
389510|NCT00269633|953229|P1|NOT COMPLETED|Overall Study||1
389511|NCT00269633|953228|P2|COMPLETED|Overall Study||5
389512|NCT00269633|953229|P1|COMPLETED|Overall Study||3
389513|NCT00269633|953228|P2|STARTED|Overall Study||5
389514|NCT00269633|953229|P1|STARTED|Overall Study||4
389515|NCT00269477|953239|P4|NOT COMPLETED|Overall Study||0
389516|NCT00269477|953240|P3|NOT COMPLETED|Overall Study||1
389517|NCT00269477|953241|P2|NOT COMPLETED|Overall Study||6
389518|NCT00269477|953242|P1|NOT COMPLETED|Overall Study||5
389519|NCT00269477|953239|P4|COMPLETED|Overall Study||60
389520|NCT00269477|953240|P3|COMPLETED|Overall Study||57
389521|NCT00269477|953241|P2|COMPLETED|Overall Study||12
389522|NCT00269477|953242|P1|COMPLETED|Overall Study||4
389523|NCT00269477|953239|P4|STARTED|Overall Study||60
389524|NCT00269477|953240|P3|STARTED|Overall Study||58
389525|NCT00269477|953241|P2|STARTED|Overall Study||18
389526|NCT00269477|953242|P1|STARTED|Overall Study||9
389527|NCT00269399|953258|P2|NOT COMPLETED|Overall Study||27
389528|NCT00269399|953259|P1|NOT COMPLETED|Overall Study||41
389529|NCT00269399|953258|P2|COMPLETED|Overall Study||91
389530|NCT00269399|953259|P1|COMPLETED|Overall Study||78
389531|NCT00269399|953258|P2|STARTED|Overall Study||118
389532|NCT00269399|953259|P1|STARTED|Overall Study||119
389533|NCT00269152|953269|P2|NOT COMPLETED|Overall Study||10
389534|NCT00269152|953270|P1|NOT COMPLETED|Overall Study||18
389535|NCT00269152|953269|P2|COMPLETED|Overall Study||49
389536|NCT00269152|953270|P1|COMPLETED|Overall Study||45
389537|NCT00269152|953269|P2|STARTED|Overall Study|4 were randomized without receiving any study drug.|59
389538|NCT00269152|953270|P1|STARTED|Overall Study|One participant in Pemetrexed+Carboplatin actually received Pemetrexed+Cisplatin|63
389539|NCT00269113|953286|P2|NOT COMPLETED|Overall Study||37
389540|NCT00269113|953287|P1|NOT COMPLETED|Overall Study||74
389541|NCT00269113|953286|P2|COMPLETED|Overall Study||146
389542|NCT00269113|953287|P1|COMPLETED|Overall Study||103
389543|NCT00269113|953286|P2|STARTED|Overall Study||183
389544|NCT00269113|953287|P1|STARTED|Overall Study||177
389545|NCT00269087|953305|P1|NOT COMPLETED|Overall Study||34
389546|NCT00269087|953305|P1|COMPLETED|Overall Study||88
389547|NCT00269087|953305|P1|STARTED|Overall Study||122
389548|NCT00268996|953335|P2|NOT COMPLETED|Overall Study||20
389549|NCT00268996|953336|P1|NOT COMPLETED|Overall Study||21
389550|NCT00268996|953335|P2|COMPLETED|Overall Study||152
389551|NCT00268996|953336|P1|COMPLETED|Overall Study||130
389552|NCT00268996|953335|P2|STARTED|Overall Study||172
389553|NCT00268996|953336|P1|STARTED|Overall Study||151
389554|NCT00268983|953380|P2|NOT COMPLETED|Overall Study||0
389555|NCT00268983|953381|P1|NOT COMPLETED|Overall Study||3
389556|NCT00268983|953380|P2|COMPLETED|Overall Study||8
389557|NCT00268983|953381|P1|COMPLETED|Overall Study||3
389558|NCT00268983|953380|P2|STARTED|Overall Study||8
389559|NCT00268983|953381|P1|STARTED|Overall Study||6
389560|NCT00268905|953424|P3|NOT COMPLETED|Overall Study||12
389561|NCT00268905|953425|P2|NOT COMPLETED|Overall Study||9
389562|NCT00268905|953426|P1|NOT COMPLETED|Overall Study||43
389563|NCT00268905|953424|P3|COMPLETED|Overall Study||0
389564|NCT00268905|953425|P2|COMPLETED|Overall Study||0
389565|NCT00268905|953426|P1|COMPLETED|Overall Study||0
389566|NCT00268905|953424|P3|STARTED|Overall Study||12
389567|NCT00268905|953425|P2|STARTED|Overall Study||9
389568|NCT00268905|953426|P1|STARTED|Overall Study||43
389569|NCT00268892|953443|P3|NOT COMPLETED|Overall Study||39
389570|NCT00268892|953444|P2|NOT COMPLETED|Overall Study||42
389571|NCT00268892|953445|P1|NOT COMPLETED|Overall Study||39
389572|NCT00268892|953443|P3|COMPLETED|Overall Study||54
389573|NCT00268892|953444|P2|COMPLETED|Overall Study||53
389574|NCT00268892|953445|P1|COMPLETED|Overall Study||51
389575|NCT00268892|953443|P3|Switched to Higher Dose|Overall Study||76
389576|NCT00268892|953444|P2|Switched to Higher Dose|Overall Study||68
389577|NCT00268892|953445|P1|Switched to Higher Dose|Overall Study||59
389578|NCT00268892|953443|P3|STARTED|Overall Study||93
389579|NCT00268892|953444|P2|STARTED|Overall Study||95
389580|NCT00268892|953445|P1|STARTED|Overall Study||90
389581|NCT00268762|953456|P1|NOT COMPLETED|Overall Study||0
389582|NCT00268762|953456|P1|COMPLETED|Overall Study||65
389583|NCT00268762|953456|P1|STARTED|Overall Study||65
389584|NCT00268463|953464|P2|NOT COMPLETED|Overall Study||12
389585|NCT00268463|953465|P1|NOT COMPLETED|Overall Study||10
389586|NCT00268463|953464|P2|COMPLETED|Overall Study||0
389587|NCT00268463|953465|P1|COMPLETED|Overall Study||0
389588|NCT00268463|953464|P2|STARTED|Overall Study||12
389589|NCT00268463|953465|P1|STARTED|Overall Study||10
389590|NCT00268450|953471|P1|NOT COMPLETED|Overall Study||0
389591|NCT00268450|953471|P1|COMPLETED|Overall Study||21
389592|NCT00268450|953471|P1|STARTED|Overall Study||21
389593|NCT00268437|953481|P1|NOT COMPLETED|Overall Study||1
389594|NCT00268437|953481|P1|COMPLETED|Overall Study||26
389595|NCT00268437|953481|P1|STARTED|Overall Study||27
389596|NCT00268346|953488|P2|NOT COMPLETED|Overall Study||3
389597|NCT00268346|953489|P1|NOT COMPLETED|Overall Study||0
389598|NCT00268346|953488|P2|COMPLETED|Overall Study||37
389599|NCT00268346|953489|P1|COMPLETED|Overall Study||18
389600|NCT00268346|953488|P2|Started Treatment|Overall Study||40
389601|NCT00268346|953489|P1|Started Treatment|Overall Study||18
389602|NCT00268346|953488|P2|STARTED|Overall Study||40
389603|NCT00268346|953489|P1|STARTED|Overall Study||18
389604|NCT00268242|953495|P1|NOT COMPLETED|Overall Study||1
389605|NCT00268242|953495|P1|COMPLETED|Overall Study||23
389606|NCT00268242|953495|P1|STARTED|Overall Study||24
389607|NCT00268203|953504|P1|NOT COMPLETED|Overall Study||647
389608|NCT00268203|953504|P1|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|118
389609|NCT00268203|953504|P1|Completed 2 Years of Follow-up|Overall Study||62
389610|NCT00268203|953504|P1|STARTED|Overall Study||765
389611|NCT00267969|953518|P7|NOT COMPLETED|After Controlled Period||72
389612|NCT00267969|953519|P6|NOT COMPLETED|After Controlled Period||82
389613|NCT00267969|953520|P5|NOT COMPLETED|After Controlled Period||35
389614|NCT00267969|953521|P4|NOT COMPLETED|After Controlled Period||36
389615|NCT00267969|953522|P3|NOT COMPLETED|After Controlled Period||0
389616|NCT00267969|953523|P2|NOT COMPLETED|After Controlled Period||0
389617|NCT00267969|953524|P1|NOT COMPLETED|After Controlled Period||0
389618|NCT00267969|953518|P7|COMPLETED|After Controlled Period||173
389619|NCT00267969|953519|P6|COMPLETED|After Controlled Period||172
389620|NCT00267969|953520|P5|COMPLETED|After Controlled Period||85
389621|NCT00267969|953521|P4|COMPLETED|After Controlled Period||87
389622|NCT00267969|953522|P3|COMPLETED|After Controlled Period||0
389623|NCT00267969|953523|P2|COMPLETED|After Controlled Period||0
389624|NCT00267969|953524|P1|COMPLETED|After Controlled Period||0
389625|NCT00267969|953518|P7|STARTED|After Controlled Period||245
389626|NCT00267969|953519|P6|STARTED|After Controlled Period||254
389627|NCT00267969|953520|P5|STARTED|After Controlled Period||120
389628|NCT00267969|953521|P4|STARTED|After Controlled Period||123
389629|NCT00267969|953522|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
389630|NCT00267969|953523|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
389631|NCT00267969|953524|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
389632|NCT00267969|953518|P7|NOT COMPLETED|Controlled Period||0
389633|NCT00267969|953519|P6|NOT COMPLETED|Controlled Period||0
389634|NCT00267969|953520|P5|NOT COMPLETED|Controlled Period||0
389635|NCT00267969|953521|P4|NOT COMPLETED|Controlled Period||0
389636|NCT00267969|953522|P3|NOT COMPLETED|Controlled Period||11
389637|NCT00267969|953523|P2|NOT COMPLETED|Controlled Period||1
389638|NCT00267969|953524|P1|NOT COMPLETED|Controlled Period||12
389639|NCT00267969|953518|P7|COMPLETED|Controlled Period||0
389640|NCT00267969|953519|P6|COMPLETED|Controlled Period||0
389641|NCT00267969|953520|P5|COMPLETED|Controlled Period||0
389642|NCT00267969|953521|P4|COMPLETED|Controlled Period||0
389643|NCT00267969|953522|P3|COMPLETED|Controlled Period||245
389644|NCT00267969|953523|P2|COMPLETED|Controlled Period||254
389645|NCT00267969|953524|P1|COMPLETED|Controlled Period||243
389646|NCT00267969|953518|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
389647|NCT00267969|953519|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
389648|NCT00267969|953520|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
389649|NCT00267969|953521|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
389650|NCT00267969|953522|P3|STARTED|Controlled Period|Number of patients randomized|256
389651|NCT00267969|953523|P2|STARTED|Controlled Period|Number of patients randomized|255
389652|NCT00267969|953524|P1|STARTED|Controlled Period|Number of patients randomized|255
389653|NCT00267956|953550|P4|NOT COMPLETED|After Controlled Period||2
389654|NCT00267956|953551|P3|NOT COMPLETED|After Controlled Period||5
389655|NCT00267956|953552|P2|NOT COMPLETED|After Controlled Period||0
389656|NCT00267956|953553|P1|NOT COMPLETED|After Controlled Period||0
389657|NCT00267956|953550|P4|COMPLETED|After Controlled Period||70
389658|NCT00267956|953551|P3|COMPLETED|After Controlled Period||52
389659|NCT00267956|953552|P2|COMPLETED|After Controlled Period||0
389660|NCT00267956|953553|P1|COMPLETED|After Controlled Period||0
389661|NCT00267956|953550|P4|STARTED|After Controlled Period||72
389662|NCT00267956|953551|P3|STARTED|After Controlled Period||57
389663|NCT00267956|953552|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
389664|NCT00267956|953553|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
389665|NCT00267956|953550|P4|NOT COMPLETED|Controlled Period||0
389666|NCT00267956|953551|P3|NOT COMPLETED|Controlled Period||0
389667|NCT00267956|953552|P2|NOT COMPLETED|Controlled Period||4
389668|NCT00267956|953553|P1|NOT COMPLETED|Controlled Period||13
389669|NCT00267956|953550|P4|COMPLETED|Controlled Period||0
389670|NCT00267956|953551|P3|COMPLETED|Controlled Period||0
389671|NCT00267956|953552|P2|COMPLETED|Controlled Period||72
389672|NCT00267956|953553|P1|COMPLETED|Controlled Period||57
389673|NCT00267956|953550|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
389674|NCT00267956|953551|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
389675|NCT00267956|953552|P2|STARTED|Controlled Period||76
389676|NCT00267956|953553|P1|STARTED|Controlled Period||70
389677|NCT00267774|953573|P2|NOT COMPLETED|Overall Study||0
389678|NCT00267774|953574|P1|NOT COMPLETED|Overall Study||0
389679|NCT00267774|953573|P2|COMPLETED|Overall Study||496
389680|NCT00267774|953574|P1|COMPLETED|Overall Study||509
389681|NCT00267774|953573|P2|STARTED|Overall Study||496
389682|NCT00267774|953574|P1|STARTED|Overall Study||509
389683|NCT00267748|953585|P3|NOT COMPLETED|Randomized Period||132
389684|NCT00267748|953586|P2|NOT COMPLETED|Randomized Period||127
389685|NCT00267748|953587|P1|NOT COMPLETED|Randomized Period||0
389686|NCT00267748|953585|P3|COMPLETED|Randomized Period||14
389687|NCT00267748|953586|P2|COMPLETED|Randomized Period||19
389688|NCT00267748|953587|P1|COMPLETED|Randomized Period||0
389689|NCT00267748|953585|P3|Treated|Randomized Period||143
389690|NCT00267748|953586|P2|Treated|Randomized Period||146
389691|NCT00267748|953587|P1|Treated|Randomized Period||0
389692|NCT00267748|953585|P3|STARTED|Randomized Period||146
389693|NCT00267748|953586|P2|STARTED|Randomized Period||146
389694|NCT00267748|953587|P1|STARTED|Randomized Period||0
389695|NCT00267748|953585|P3|NOT COMPLETED|Non-randomized Period||0
389696|NCT00267748|953586|P2|NOT COMPLETED|Non-randomized Period||0
389697|NCT00267748|953587|P1|NOT COMPLETED|Non-randomized Period||23
389698|NCT00267748|953585|P3|COMPLETED|Non-randomized Period||0
389699|NCT00267748|953586|P2|COMPLETED|Non-randomized Period||0
389700|NCT00267748|953587|P1|COMPLETED|Non-randomized Period||2
389701|NCT00267748|953585|P3|STARTED|Non-randomized Period||0
389702|NCT00267748|953586|P2|STARTED|Non-randomized Period||0
389703|NCT00267748|953587|P1|STARTED|Non-randomized Period||25
389704|NCT00267696|953604|P1|NOT COMPLETED|Overall Study||0
389705|NCT00267696|953604|P1|COMPLETED|Overall Study||45
389706|NCT00267696|953604|P1|STARTED|Overall Study||45
389707|NCT00267670|953611|P2|NOT COMPLETED|Overall Study||0
389708|NCT00267670|953612|P1|NOT COMPLETED|Overall Study||4
389709|NCT00267670|953611|P2|COMPLETED|Overall Study||7
389710|NCT00267670|953612|P1|COMPLETED|Overall Study||15
389711|NCT00267670|953611|P2|STARTED|Overall Study||7
389712|NCT00267670|953612|P1|STARTED|Overall Study||19
389713|NCT00267644|953626|P2|NOT COMPLETED|Overall Study||0
389714|NCT00267644|953627|P1|NOT COMPLETED|Overall Study||0
389715|NCT00267644|953626|P2|COMPLETED|Overall Study||63
389716|NCT00267644|953627|P1|COMPLETED|Overall Study||13
389717|NCT00267644|953626|P2|STARTED|Overall Study||63
389718|NCT00267644|953627|P1|STARTED|Overall Study||13
389719|NCT00267631|953637|P2|NOT COMPLETED|Overall Study||0
389720|NCT00267631|953638|P1|NOT COMPLETED|Overall Study||0
389721|NCT00267631|953637|P2|COMPLETED|Overall Study||3031
389722|NCT00267631|953638|P1|COMPLETED|Overall Study||2361
389723|NCT00267631|953637|P2|STARTED|Overall Study||3031
389724|NCT00267631|953638|P1|STARTED|Overall Study||2361
389725|NCT00267488|953644|P1|NOT COMPLETED|Overall Study||11
389726|NCT00267488|953644|P1|COMPLETED|Overall Study||26
389727|NCT00267488|953644|P1|STARTED|Overall Study||37
389728|NCT00267293|953656|P3|NOT COMPLETED|Overall Study||0
389729|NCT00267293|953657|P2|NOT COMPLETED|Overall Study||0
389730|NCT00267293|953658|P1|NOT COMPLETED|Overall Study||0
389731|NCT00267293|953656|P3|COMPLETED|Overall Study||20
389732|NCT00267293|953657|P2|COMPLETED|Overall Study||20
389733|NCT00267293|953658|P1|COMPLETED|Overall Study||20
389734|NCT00267293|953656|P3|STARTED|Overall Study||20
389735|NCT00267293|953657|P2|STARTED|Overall Study||20
389736|NCT00267293|953658|P1|STARTED|Overall Study||20
389737|NCT00267202|953668|P2|NOT COMPLETED|Overall Study||34
389738|NCT00267202|953669|P1|NOT COMPLETED|Overall Study||53
389739|NCT00267202|953668|P2|COMPLETED|Overall Study||105
389740|NCT00267202|953669|P1|COMPLETED|Overall Study||83
389741|NCT00267202|953668|P2|STARTED|Overall Study||139
389742|NCT00267202|953669|P1|STARTED|Overall Study||136
389743|NCT00267189|953690|P2|NOT COMPLETED|Overall Study||1
389744|NCT00267189|953691|P1|NOT COMPLETED|Overall Study||5
389745|NCT00267189|953690|P2|COMPLETED|Overall Study||72
389746|NCT00267189|953691|P1|COMPLETED|Overall Study|"Completed indicates completed study."|67
389747|NCT00267189|953690|P2|Completed Study Medication|Overall Study||72
389748|NCT00267189|953691|P1|Completed Study Medication|Overall Study||54
389749|NCT00267189|953690|P2|STARTED|Overall Study||73
389750|NCT00267189|953691|P1|STARTED|Overall Study|Intention to treat (ITT) population.|72
389751|NCT00267150|953701|P1|NOT COMPLETED|Overall Study||1
389752|NCT00267150|953701|P1|COMPLETED|Overall Study||30
389753|NCT00267150|953701|P1|STARTED|Overall Study||31
389754|NCT00267111|953708|P2|NOT COMPLETED|Overall Study||0
389755|NCT00267111|953709|P1|NOT COMPLETED|Overall Study||0
389756|NCT00267111|953708|P2|COMPLETED|Overall Study||55
389757|NCT00267111|953709|P1|COMPLETED|Overall Study||55
389758|NCT00267111|953708|P2|STARTED|Overall Study||55
389759|NCT00267111|953709|P1|STARTED|Overall Study||55
389760|NCT00267098|953725|P8|NOT COMPLETED|Overall Study||15
389761|NCT00267098|953726|P7|NOT COMPLETED|Overall Study||46
389762|NCT00267098|953727|P6|NOT COMPLETED|Overall Study||40
389763|NCT00267098|953728|P5|NOT COMPLETED|Overall Study||37
389764|NCT00267098|953729|P4|NOT COMPLETED|Overall Study||106
389765|NCT00267098|953730|P3|NOT COMPLETED|Overall Study||94
389766|NCT00267098|953731|P2|NOT COMPLETED|Overall Study||51
389767|NCT00267098|953732|P1|NOT COMPLETED|Overall Study||109
389768|NCT00267098|953725|P8|COMPLETED|Overall Study||5
389769|NCT00267098|953726|P7|COMPLETED|Overall Study||55
389770|NCT00267098|953727|P6|COMPLETED|Overall Study||66
389771|NCT00267098|953728|P5|COMPLETED|Overall Study||10
389772|NCT00267098|953729|P4|COMPLETED|Overall Study||135
389773|NCT00267098|953730|P3|COMPLETED|Overall Study||149
389774|NCT00267098|953731|P2|COMPLETED|Overall Study||0
389775|NCT00267098|953732|P1|COMPLETED|Overall Study||0
389776|NCT00267098|953725|P8|STARTED|Overall Study||20
389777|NCT00267098|953726|P7|STARTED|Overall Study||101
389778|NCT00267098|953727|P6|STARTED|Overall Study||106
389779|NCT00267098|953728|P5|STARTED|Overall Study||47
389780|NCT00267098|953729|P4|STARTED|Overall Study||241
389781|NCT00267098|953730|P3|STARTED|Overall Study||243
389782|NCT00267098|953731|P2|STARTED|Overall Study||51
389783|NCT00267098|953732|P1|STARTED|Overall Study||109
389784|NCT00267085|953865|P1|NOT COMPLETED|Overall Study||0
389785|NCT00267085|953865|P1|COMPLETED|Overall Study||10
389786|NCT00267085|953865|P1|STARTED|Overall Study||10
389787|NCT00267059|953869|P1|NOT COMPLETED|Overall Study||0
389788|NCT00267059|953869|P1|COMPLETED|Overall Study||44
389789|NCT00267059|953869|P1|STARTED|Overall Study||44
389790|NCT00267046|953875|P2|NOT COMPLETED|Overall Study||11
389791|NCT00267046|953876|P1|NOT COMPLETED|Overall Study||12
389792|NCT00267046|953875|P2|COMPLETED|Overall Study||5
389793|NCT00267046|953876|P1|COMPLETED|Overall Study||20
389794|NCT00267046|953875|P2|STARTED|Overall Study||16
389795|NCT00267046|953876|P1|STARTED|Overall Study||32
389796|NCT00267007|953886|P2|NOT COMPLETED|Overall Study||1
389797|NCT00267007|953887|P1|NOT COMPLETED|Overall Study||8
389798|NCT00267007|953886|P2|COMPLETED|Overall Study||10
389799|NCT00267007|953887|P1|COMPLETED|Overall Study||11
389800|NCT00267007|953886|P2|STARTED|Overall Study||11
389801|NCT00267007|953887|P1|STARTED|Overall Study|2 additional patients were randomized but never received study medication and no data were collected|19
389802|NCT00266877|953898|P3|NOT COMPLETED|Overall Study||28
389803|NCT00266877|953899|P2|NOT COMPLETED|Overall Study||48
389804|NCT00266877|953900|P1|NOT COMPLETED|Overall Study||91
389805|NCT00266877|953898|P3|COMPLETED|Overall Study||0
389806|NCT00266877|953899|P2|COMPLETED|Overall Study||0
389807|NCT00266877|953900|P1|COMPLETED|Overall Study||0
389808|NCT00266877|953898|P3|STARTED|Overall Study||28
389809|NCT00266877|953899|P2|STARTED|Overall Study||48
389810|NCT00266877|953900|P1|STARTED|Overall Study||91
389811|NCT00266864|953919|P2|NOT COMPLETED|Overall Study||2
389812|NCT00266864|953920|P1|NOT COMPLETED|Overall Study||5
389813|NCT00266864|953919|P2|COMPLETED|Overall Study||11
389814|NCT00266864|953920|P1|COMPLETED|Overall Study||13
389815|NCT00266864|953919|P2|STARTED|Overall Study||13
389816|NCT00266864|953920|P1|STARTED|Overall Study||18
389817|NCT00266851|953930|P3|NOT COMPLETED|Overall Study||0
389818|NCT00266851|953931|P2|NOT COMPLETED|Overall Study||0
389819|NCT00266851|953932|P1|NOT COMPLETED|Overall Study||0
389820|NCT00266851|953930|P3|COMPLETED|Overall Study||22
389821|NCT00266851|953931|P2|COMPLETED|Overall Study||38
389822|NCT00266851|953932|P1|COMPLETED|Overall Study||37
389823|NCT00266851|953930|P3|Completed 12 Month Follow up|Overall Study||13
389824|NCT00266851|953931|P2|Completed 12 Month Follow up|Overall Study||19
389825|NCT00266851|953932|P1|Completed 12 Month Follow up|Overall Study||25
389826|NCT00266851|953930|P3|Completed 9 Month Follow up|Overall Study||15
389827|NCT00266851|953931|P2|Completed 9 Month Follow up|Overall Study||23
389828|NCT00266851|953932|P1|Completed 9 Month Follow up|Overall Study||22
389829|NCT00266851|953930|P3|Completed 6 Month Follow up|Overall Study||17
389830|NCT00266851|953931|P2|Completed 6 Month Follow up|Overall Study||22
389831|NCT00266851|953932|P1|Completed 6 Month Follow up|Overall Study||27
389832|NCT00266851|953930|P3|Completed 3 Month Follow up|Overall Study||15
389833|NCT00266851|953931|P2|Completed 3 Month Follow up|Overall Study||22
389834|NCT00266851|953932|P1|Completed 3 Month Follow up|Overall Study||26
389835|NCT00266851|953930|P3|STARTED|Overall Study||22
389836|NCT00266851|953931|P2|STARTED|Overall Study||38
389837|NCT00266851|953932|P1|STARTED|Overall Study||37
389838|NCT00266825|953951|P2|NOT COMPLETED|Completed Follow-Up||24
389839|NCT00266825|953952|P1|NOT COMPLETED|Completed Follow-Up||25
389840|NCT00266825|953951|P2|COMPLETED|Completed Follow-Up||154
389841|NCT00266825|953952|P1|COMPLETED|Completed Follow-Up||147
389842|NCT00266825|953951|P2|STARTED|Completed Follow-Up||178
389843|NCT00266825|953952|P1|STARTED|Completed Follow-Up||172
389844|NCT00266825|953951|P2|NOT COMPLETED|Enrolled and Allocated Intervention||0
389845|NCT00266825|953952|P1|NOT COMPLETED|Enrolled and Allocated Intervention||0
389846|NCT00266825|953951|P2|COMPLETED|Enrolled and Allocated Intervention||178
389847|NCT00266825|953952|P1|COMPLETED|Enrolled and Allocated Intervention||172
389848|NCT00266825|953951|P2|STARTED|Enrolled and Allocated Intervention||178
389849|NCT00266825|953952|P1|STARTED|Enrolled and Allocated Intervention||172
389850|NCT00266812|953978|P2|NOT COMPLETED|Overall Study||11
389851|NCT00266812|953979|P1|NOT COMPLETED|Overall Study||21
389852|NCT00266812|953978|P2|COMPLETED|Overall Study||2
389853|NCT00266812|953979|P1|COMPLETED|Overall Study||1
389854|NCT00266812|953978|P2|STARTED|Overall Study||13
389855|NCT00266812|953979|P1|STARTED|Overall Study||22
389856|NCT00266799|953987|P2|NOT COMPLETED|Overall Study||34
389857|NCT00266799|953988|P1|NOT COMPLETED|Overall Study||36
389858|NCT00266799|953987|P2|COMPLETED|Overall Study||68
389859|NCT00266799|953988|P1|COMPLETED|Overall Study||62
389860|NCT00266799|953987|P2|STARTED|Overall Study||102
389861|NCT00266799|953988|P1|STARTED|Overall Study||98
389862|NCT00266708|954004|P2|NOT COMPLETED|Overall Study||9
389863|NCT00266708|954005|P1|NOT COMPLETED|Overall Study||4
389864|NCT00266708|954004|P2|COMPLETED|Overall Study||13
389865|NCT00266708|954005|P1|COMPLETED|Overall Study||16
389866|NCT00266708|954004|P2|STARTED|Overall Study||22
389867|NCT00266708|954005|P1|STARTED|Overall Study||20
389868|NCT00266695|954045|P1|NOT COMPLETED|Overall Study||29
389869|NCT00266695|954045|P1|COMPLETED|Overall Study||174
389870|NCT00266695|954045|P1|STARTED|Overall Study||203
389871|NCT00266656|954057|P2|NOT COMPLETED|Overall Study||13
389872|NCT00266656|954058|P1|NOT COMPLETED|Overall Study||14
389873|NCT00266656|954057|P2|COMPLETED|Overall Study||20
389874|NCT00266656|954058|P1|COMPLETED|Overall Study||22
389875|NCT00266656|954057|P2|STARTED|Overall Study||33
389876|NCT00266656|954058|P1|STARTED|Overall Study||36
389877|NCT00266630|954082|P2|NOT COMPLETED|Overall Study||28
389878|NCT00266630|954083|P1|NOT COMPLETED|Overall Study||42
389879|NCT00266630|954082|P2|COMPLETED|Overall Study||11
389880|NCT00266630|954083|P1|COMPLETED|Overall Study||58
389881|NCT00266630|954082|P2|STARTED|Overall Study||39
389882|NCT00266630|954083|P1|STARTED|Overall Study||100
389883|NCT00266409|954125|P4|NOT COMPLETED|Overall Study||22
389884|NCT00266409|954126|P3|NOT COMPLETED|Overall Study||17
389885|NCT00266409|954127|P2|NOT COMPLETED|Overall Study||46
389886|NCT00266409|954128|P1|NOT COMPLETED|Overall Study||45
389887|NCT00266409|954125|P4|COMPLETED|Overall Study||49
389888|NCT00266409|954126|P3|COMPLETED|Overall Study||55
389889|NCT00266409|954127|P2|COMPLETED|Overall Study||92
389890|NCT00266409|954128|P1|COMPLETED|Overall Study||92
389891|NCT00266409|954125|P4|STARTED|Overall Study||71
389892|NCT00266409|954126|P3|STARTED|Overall Study||72
389893|NCT00266409|954127|P2|STARTED|Overall Study||138
389894|NCT00266409|954128|P1|STARTED|Overall Study||137
389895|NCT00266279|954410|P1|NOT COMPLETED|Overall Study||2
389896|NCT00266279|954410|P1|COMPLETED|Overall Study||15
389897|NCT00266279|954410|P1|STARTED|Overall Study||17
389898|NCT00266227|954416|P3|NOT COMPLETED|Retreatment: Week 48 to Week 72||0
389899|NCT00266227|954417|P2|NOT COMPLETED|Retreatment: Week 48 to Week 72||42
389900|NCT00266227|954418|P1|NOT COMPLETED|Retreatment: Week 48 to Week 72||64
389901|NCT00266227|954416|P3|COMPLETED|Retreatment: Week 48 to Week 72||0
389902|NCT00266227|954417|P2|COMPLETED|Retreatment: Week 48 to Week 72||92
389903|NCT00266227|954418|P1|COMPLETED|Retreatment: Week 48 to Week 72||227
389904|NCT00266227|954416|P3|STARTED|Retreatment: Week 48 to Week 72||0
389905|NCT00266227|954417|P2|STARTED|Retreatment: Week 48 to Week 72||134
389906|NCT00266227|954418|P1|STARTED|Retreatment: Week 48 to Week 72||291
389907|NCT00266227|954416|P3|NOT COMPLETED|Retreatment: Up to Week 48||0
389908|NCT00266227|954417|P2|NOT COMPLETED|Retreatment: Up to Week 48||23
389909|NCT00266227|954418|P1|NOT COMPLETED|Retreatment: Up to Week 48||27
389910|NCT00266227|954416|P3|COMPLETED|Retreatment: Up to Week 48||0
389911|NCT00266227|954417|P2|COMPLETED|Retreatment: Up to Week 48||134
389912|NCT00266227|954418|P1|COMPLETED|Retreatment: Up to Week 48||291
389913|NCT00266227|954416|P3|STARTED|Retreatment: Up to Week 48||0
389914|NCT00266227|954417|P2|STARTED|Retreatment: Up to Week 48||157
389915|NCT00266227|954418|P1|STARTED|Retreatment: Up to Week 48||318
389916|NCT00266227|954416|P3|NOT COMPLETED|Initial Treatment||77
389917|NCT00266227|954417|P2|NOT COMPLETED|Initial Treatment||0
389918|NCT00266227|954418|P1|NOT COMPLETED|Initial Treatment||0
389919|NCT00266227|954416|P3|COMPLETED|Initial Treatment||482
389920|NCT00266227|954417|P2|COMPLETED|Initial Treatment||0
389921|NCT00266227|954418|P1|COMPLETED|Initial Treatment||0
389922|NCT00266227|954416|P3|STARTED|Initial Treatment||559
389923|NCT00266227|954417|P2|STARTED|Initial Treatment||0
389924|NCT00266227|954418|P1|STARTED|Initial Treatment||0
389925|NCT00266110|954463|P1|NOT COMPLETED|Overall Study||7
389926|NCT00266110|954463|P1|COMPLETED|Overall Study||10
389927|NCT00266110|954463|P1|STARTED|Overall Study||17
389928|NCT00266032|954472|P3|NOT COMPLETED|Open-label Safety Extension||25
389929|NCT00266032|954473|P2|NOT COMPLETED|Open-label Safety Extension||14
389930|NCT00266032|954474|P1|NOT COMPLETED|Open-label Safety Extension||41
389931|NCT00266032|954472|P3|COMPLETED|Open-label Safety Extension||140
389932|NCT00266032|954473|P2|COMPLETED|Open-label Safety Extension||115
389933|NCT00266032|954474|P1|COMPLETED|Open-label Safety Extension||448
389934|NCT00266032|954472|P3|STARTED|Open-label Safety Extension|21 subjects continued their treatment in second period (safety extension)|165
389935|NCT00266032|954473|P2|STARTED|Open-label Safety Extension|7 subjects continued their treatment in second period (safety extension)|129
389936|NCT00266032|954474|P1|STARTED|Open-label Safety Extension|treatment for subjects of all 3 treatment groups in 2nd period, except for 28 in subgroups|489
389937|NCT00266032|954472|P3|NOT COMPLETED|Treatment||47
389938|NCT00266032|954473|P2|NOT COMPLETED|Treatment||64
389939|NCT00266032|954474|P1|NOT COMPLETED|Treatment||111
389940|NCT00266032|954472|P3|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|192
389941|NCT00266032|954473|P2|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|172
389942|NCT00266032|954474|P1|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|580
389943|NCT00266032|954472|P3|Patients Treated and in FAS|Treatment|FAS|216
389944|NCT00266032|954473|P2|Patients Treated and in FAS|Treatment|FAS|209
389945|NCT00266032|954474|P1|Patients Treated and in FAS|Treatment|FAS|642
389946|NCT00266032|954472|P3|Patients Treated|Treatment||229
389947|NCT00266032|954473|P2|Patients Treated|Treatment||221
389948|NCT00266032|954474|P1|Patients Treated|Treatment||684
389949|NCT00266032|954472|P3|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|239
389950|NCT00266032|954473|P2|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|236
389951|NCT00266032|954474|P1|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|691
389952|NCT00265980|954502|P1|NOT COMPLETED|Overall Study||0
389953|NCT00265980|954502|P1|COMPLETED|Overall Study||22
389954|NCT00265980|954502|P1|Weight -10% Leptin|Overall Study||22
389955|NCT00265980|954502|P1|Weight -10% Placebo|Overall Study||22
389956|NCT00265980|954502|P1|Weight Initial|Overall Study||22
389957|NCT00265980|954502|P1|STARTED|Overall Study||22
389958|NCT00265941|954509|P2|NOT COMPLETED|Overall Study||26
389959|NCT00265941|954510|P1|NOT COMPLETED|Overall Study||23
389960|NCT00265941|954509|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|444
389961|NCT00265941|954510|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|447
389962|NCT00265941|954509|P2|STARTED|Overall Study||470
389963|NCT00265941|954510|P1|STARTED|Overall Study||470
389964|NCT00265889|954542|P1|NOT COMPLETED|Overall Study||5
389965|NCT00265889|954542|P1|COMPLETED|Overall Study||37
389966|NCT00265889|954542|P1|Cycle 2: 2nd Regimen/Transplant|Overall Study||37
389967|NCT00265889|954542|P1|Cycle 1: 1st Regimen/Transplant|Overall Study||37
389968|NCT00265889|954542|P1|STARTED|Overall Study||42
389969|NCT00265850|954551|P3|NOT COMPLETED|Overall Study||0
389970|NCT00265850|954552|P2|NOT COMPLETED|Overall Study||0
389971|NCT00265850|954553|P1|NOT COMPLETED|Overall Study||0
389972|NCT00265850|954551|P3|COMPLETED|Overall Study||533
389973|NCT00265850|954552|P2|COMPLETED|Overall Study||902
389974|NCT00265850|954553|P1|COMPLETED|Overall Study||899
389975|NCT00265850|954551|P3|STARTED|Overall Study||533
389976|NCT00265850|954552|P2|STARTED|Overall Study||902
389977|NCT00265850|954553|P1|STARTED|Overall Study||899
389978|NCT00265798|954563|P1|NOT COMPLETED|Overall Study||0
389979|NCT00265798|954563|P1|COMPLETED|Overall Study||38
389980|NCT00265798|954563|P1|STARTED|Overall Study||38
389981|NCT00265785|954569|P1|NOT COMPLETED|Overall Study||27
389982|NCT00265785|954569|P1|COMPLETED|Overall Study||0
389983|NCT00265785|954569|P1|Eligible and Began Protocol Treatment|Overall Study||24
389984|NCT00265785|954569|P1|Eligible|Overall Study||26
389985|NCT00265785|954569|P1|STARTED|Overall Study||27
389986|NCT00265759|954582|P4|NOT COMPLETED|Overall Study||9
389987|NCT00265759|954583|P3|NOT COMPLETED|Overall Study||2
389988|NCT00265759|954584|P2|NOT COMPLETED|Overall Study||1
389989|NCT00265759|954585|P1|NOT COMPLETED|Overall Study||0
389990|NCT00265759|954582|P4|COMPLETED|Overall Study||236
389991|NCT00265759|954583|P3|COMPLETED|Overall Study||123
389992|NCT00265759|954584|P2|COMPLETED|Overall Study||127
389993|NCT00265759|954585|P1|COMPLETED|Overall Study||124
389994|NCT00265759|954582|P4|STARTED|Overall Study||245
389995|NCT00265759|954583|P3|STARTED|Overall Study||125
389996|NCT00265759|954584|P2|STARTED|Overall Study||128
389997|NCT00265759|954585|P1|STARTED|Overall Study||124
389998|NCT00265616|954616|P2|NOT COMPLETED|Overall Study||0
389999|NCT00265616|954617|P1|NOT COMPLETED|Overall Study||0
390000|NCT00265616|954616|P2|COMPLETED|Overall Study||9
390001|NCT00265616|954617|P1|COMPLETED|Overall Study||14
390002|NCT00265616|954616|P2|STARTED|Overall Study||9
390003|NCT00265616|954617|P1|STARTED|Overall Study||14
390004|NCT00265512|954635|P2|NOT COMPLETED|Overall Study||95
390005|NCT00265512|954636|P1|NOT COMPLETED|Overall Study||45
390006|NCT00265512|954635|P2|COMPLETED|Overall Study||359
390007|NCT00265512|954636|P1|COMPLETED|Overall Study||168
390008|NCT00265512|954635|P2|STARTED|Overall Study||454
390009|NCT00265512|954636|P1|STARTED|Overall Study||213
390010|NCT00265473|954646|P1|NOT COMPLETED|Overall Study||0
390011|NCT00265473|954646|P1|COMPLETED|Overall Study||5
390012|NCT00265473|954646|P1|STARTED|Overall Study||5
390013|NCT00265395|954656|P2|NOT COMPLETED|Overall Study||17
390014|NCT00265395|954657|P1|NOT COMPLETED|Overall Study||8
390015|NCT00265395|954656|P2|COMPLETED|Overall Study||56
390016|NCT00265395|954657|P1|COMPLETED|Overall Study||78
390017|NCT00265395|954656|P2|STARTED|Overall Study||73
390018|NCT00265395|954657|P1|STARTED|Overall Study||86
390019|NCT00265382|954662|P1|NOT COMPLETED|Overall Study||145
390020|NCT00265382|954662|P1|COMPLETED|Overall Study||76
390021|NCT00265382|954662|P1|STARTED|Overall Study||221
390022|NCT00265343|954682|P2|NOT COMPLETED|Overall Study||19
390023|NCT00265343|954683|P1|NOT COMPLETED|Overall Study||21
390024|NCT00265343|954682|P2|COMPLETED|Overall Study||153
390025|NCT00265343|954683|P1|COMPLETED|Overall Study||113
390026|NCT00265343|954682|P2|STARTED|Overall Study||172
390027|NCT00265343|954683|P1|STARTED|Overall Study||134
390028|NCT00265330|954691|P1|NOT COMPLETED|Overall Study||95
390029|NCT00265330|954691|P1|COMPLETED|Overall Study||67
390030|NCT00265330|954691|P1|STARTED|Overall Study||162
390031|NCT00265317|954717|P4|NOT COMPLETED|Phase 2||65
390032|NCT00265317|954718|P3|NOT COMPLETED|Phase 2||64
390033|NCT00265317|954719|P2|NOT COMPLETED|Phase 2||0
390034|NCT00265317|954720|P1|NOT COMPLETED|Phase 2||0
390035|NCT00265317|954717|P4|COMPLETED|Phase 2||2
390036|NCT00265317|954718|P3|COMPLETED|Phase 2||1
390037|NCT00265317|954719|P2|COMPLETED|Phase 2||0
390038|NCT00265317|954720|P1|COMPLETED|Phase 2||0
390039|NCT00265317|954717|P4|STARTED|Phase 2||67
390040|NCT00265317|954718|P3|STARTED|Phase 2||65
390041|NCT00265317|954719|P2|STARTED|Phase 2||0
390042|NCT00265317|954720|P1|STARTED|Phase 2||0
390043|NCT00265317|954717|P4|NOT COMPLETED|Lead-In||0
390044|NCT00265317|954718|P3|NOT COMPLETED|Lead-In||0
390045|NCT00265317|954719|P2|NOT COMPLETED|Lead-In||17
390046|NCT00265317|954720|P1|NOT COMPLETED|Lead-In||12
390047|NCT00265317|954717|P4|COMPLETED|Lead-In||0
390048|NCT00265317|954718|P3|COMPLETED|Lead-In||0
390049|NCT00265317|954719|P2|COMPLETED|Lead-In||0
390050|NCT00265317|954720|P1|COMPLETED|Lead-In||1
390051|NCT00265317|954717|P4|STARTED|Lead-In||0
390052|NCT00265317|954718|P3|STARTED|Lead-In||0
390053|NCT00265317|954719|P2|STARTED|Lead-In||17
390054|NCT00265317|954720|P1|STARTED|Lead-In||13
390055|NCT00265239|954835|P2|NOT COMPLETED|Overall Study||1
390056|NCT00265239|954836|P1|NOT COMPLETED|Overall Study||2
390057|NCT00265239|954835|P2|COMPLETED|Overall Study||51
390058|NCT00265239|954836|P1|COMPLETED|Overall Study||50
390059|NCT00265239|954835|P2|STARTED|Overall Study||52
390060|NCT00265239|954836|P1|STARTED|Overall Study||52
390061|NCT00265200|954848|P1|NOT COMPLETED|Overall Study||4
390062|NCT00265200|954848|P1|COMPLETED|Overall Study||24
390063|NCT00265200|954848|P1|STARTED|Overall Study||28
390064|NCT00265122|954858|P6|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
390065|NCT00265122|954859|P5|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||5
390066|NCT00265122|954860|P4|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
390067|NCT00265122|954861|P3|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
390068|NCT00265122|954862|P2|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
390069|NCT00265122|954863|P1|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||7
390070|NCT00265122|954858|P6|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||12
390071|NCT00265122|954859|P5|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||8
390072|NCT00265122|954860|P4|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||20
390073|NCT00265122|954861|P3|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||18
390074|NCT00265122|954862|P2|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||22
390075|NCT00265122|954863|P1|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||17
390076|NCT00265122|954858|P6|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
390077|NCT00265122|954859|P5|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
390078|NCT00265122|954860|P4|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
390079|NCT00265122|954861|P3|STARTED|Intervention Period 2 (Weeks 8 to 28):||22
390080|NCT00265122|954862|P2|STARTED|Intervention Period 2 (Weeks 8 to 28):||23
390081|NCT00265122|954863|P1|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
390082|NCT00265122|954858|P6|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||0
390083|NCT00265122|954859|P5|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||1
390084|NCT00265122|954860|P4|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
390085|NCT00265122|954861|P3|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||5
390086|NCT00265122|954862|P2|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
390087|NCT00265122|954863|P1|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
390088|NCT00265122|954858|P6|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
390089|NCT00265122|954859|P5|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
390090|NCT00265122|954860|P4|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
390091|NCT00265122|954861|P3|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||22
390092|NCT00265122|954862|P2|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||23
390093|NCT00265122|954863|P1|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
390094|NCT00265122|954858|P6|STARTED|Intervention Period 1 (Weeks 0 to 8):||13
390095|NCT00265122|954859|P5|STARTED|Intervention Period 1 (Weeks 0 to 8):||14
390096|NCT00265122|954860|P4|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
390097|NCT00265122|954861|P3|STARTED|Intervention Period 1 (Weeks 0 to 8):||27
390098|NCT00265122|954862|P2|STARTED|Intervention Period 1 (Weeks 0 to 8):||25
390099|NCT00265122|954863|P1|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
390100|NCT00265109|954885|P1|NOT COMPLETED|Overall Study||6
390101|NCT00265109|954885|P1|COMPLETED|Overall Study||11
390102|NCT00265109|954885|P1|STARTED|Overall Study||17
390103|NCT00265096|954904|P3|NOT COMPLETED|Overall Study||39
390104|NCT00265096|954905|P2|NOT COMPLETED|Overall Study||51
390105|NCT00265096|954906|P1|NOT COMPLETED|Overall Study||36
390106|NCT00265096|954904|P3|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|107
390107|NCT00265096|954905|P2|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|95
390108|NCT00265096|954906|P1|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|77
390109|NCT00265096|954904|P3|STARTED|Overall Study||146
390110|NCT00265096|954905|P2|STARTED|Overall Study||146
390111|NCT00265096|954906|P1|STARTED|Overall Study||113
390112|NCT00265083|954938|P3|NOT COMPLETED|Overall Study||42
390113|NCT00265083|954939|P2|NOT COMPLETED|Overall Study||42
390114|NCT00265083|954940|P1|NOT COMPLETED|Overall Study||17
390115|NCT00265083|954938|P3|COMPLETED|Overall Study||98
390116|NCT00265083|954939|P2|COMPLETED|Overall Study|One patient did not receive study agent.|96
390117|NCT00265083|954940|P1|COMPLETED|Overall Study||61
390118|NCT00265083|954938|P3|STARTED|Overall Study||140
390119|NCT00265083|954939|P2|STARTED|Overall Study|One patient did not receive study agent.|138
390120|NCT00265083|954940|P1|STARTED|Overall Study||78
390121|NCT00264875|954961|P1|NOT COMPLETED|Overall Study||30
390122|NCT00264875|954961|P1|COMPLETED|Overall Study||190
390123|NCT00264875|954961|P1|STARTED|Overall Study||220
390124|NCT00264849|954967|P2|NOT COMPLETED|Overall Study||25
390125|NCT00264849|954968|P1|NOT COMPLETED|Overall Study||22
390126|NCT00264849|954967|P2|COMPLETED|Overall Study||106
390127|NCT00264849|954968|P1|COMPLETED|Overall Study||253
390128|NCT00264849|954967|P2|STARTED|Overall Study||131
390129|NCT00264849|954968|P1|STARTED|Overall Study||275
390130|NCT00264810|955002|P2|NOT COMPLETED|Open Label Evaluation Period||6
390131|NCT00264810|955003|P1|NOT COMPLETED|Open Label Evaluation Period||6
390132|NCT00264810|955002|P2|COMPLETED|Open Label Evaluation Period||86
390133|NCT00264810|955003|P1|COMPLETED|Open Label Evaluation Period||89
390134|NCT00264810|955002|P2|1-year Post-implant|Open Label Evaluation Period||90
390135|NCT00264810|955003|P1|1-year Post-implant|Open Label Evaluation Period||92
390136|NCT00264810|955002|P2|STARTED|Open Label Evaluation Period||92
390137|NCT00264810|955003|P1|STARTED|Open Label Evaluation Period||95
390138|NCT00264810|955002|P2|NOT COMPLETED|Blinded Evaluation Period||1
390139|NCT00264810|955003|P1|NOT COMPLETED|Blinded Evaluation Period||1
390140|NCT00264810|955002|P2|COMPLETED|Blinded Evaluation Period||92
390141|NCT00264810|955003|P1|COMPLETED|Blinded Evaluation Period||95
390142|NCT00264810|955002|P2|STARTED|Blinded Evaluation Period||93
390143|NCT00264810|955003|P1|STARTED|Blinded Evaluation Period||96
390144|NCT00264810|955002|P2|NOT COMPLETED|Stimulation Optimization Period||1
390145|NCT00264810|955003|P1|NOT COMPLETED|Stimulation Optimization Period||1
390146|NCT00264810|955002|P2|COMPLETED|Stimulation Optimization Period||93
390147|NCT00264810|955003|P1|COMPLETED|Stimulation Optimization Period||96
390148|NCT00264810|955002|P2|STARTED|Stimulation Optimization Period||94
390149|NCT00264810|955003|P1|STARTED|Stimulation Optimization Period||97
390150|NCT00264810|955002|P2|NOT COMPLETED|Post-Operative Stabilization Period||0
390151|NCT00264810|955003|P1|NOT COMPLETED|Post-Operative Stabilization Period||0
390152|NCT00264810|955002|P2|COMPLETED|Post-Operative Stabilization Period||94
390153|NCT00264810|955003|P1|COMPLETED|Post-Operative Stabilization Period||97
390154|NCT00264810|955002|P2|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
390155|NCT00264810|955003|P1|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
390156|NCT00264810|955002|P2|NOT COMPLETED|Baseline||26
390157|NCT00264810|955003|P1|NOT COMPLETED|Baseline||23
390158|NCT00264810|955002|P2|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
390159|NCT00264810|955003|P1|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
390160|NCT00264810|955002|P2|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
390161|NCT00264810|955003|P1|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
390162|NCT00264797|955013|P2|NOT COMPLETED|Overall Study||43
390163|NCT00264797|955014|P1|NOT COMPLETED|Overall Study||33
390164|NCT00264797|955013|P2|COMPLETED|Overall Study||109
390165|NCT00264797|955014|P1|COMPLETED|Overall Study||118
390166|NCT00264797|955013|P2|STARTED|Overall Study||152
390167|NCT00264797|955014|P1|STARTED|Overall Study||151
390168|NCT00264641|955028|P2|NOT COMPLETED|Overall Study||0
390169|NCT00264641|955029|P1|NOT COMPLETED|Overall Study||0
390170|NCT00264641|955028|P2|COMPLETED|Overall Study||10
390171|NCT00264641|955029|P1|COMPLETED|Overall Study||10
390172|NCT00264641|955028|P2|Initiation of the Study|Overall Study||10
390173|NCT00264641|955029|P1|Initiation of the Study|Overall Study||10
390174|NCT00264641|955028|P2|STARTED|Overall Study||10
390175|NCT00264641|955029|P1|STARTED|Overall Study||10
390176|NCT00264576|955036|P2|NOT COMPLETED|Overall Study||1
390177|NCT00264576|955037|P1|NOT COMPLETED|Overall Study||1
390178|NCT00264576|955036|P2|COMPLETED|Overall Study||304
390179|NCT00264576|955037|P1|COMPLETED|Overall Study||307
390180|NCT00264576|955036|P2|STARTED|Overall Study||305
390181|NCT00264576|955037|P1|STARTED|Overall Study||308
390182|NCT00264550|955061|P4|NOT COMPLETED|Overall Study||30
390183|NCT00264550|955062|P3|NOT COMPLETED|Overall Study||17
390184|NCT00264550|955063|P2|NOT COMPLETED|Overall Study||41
390185|NCT00264550|955064|P1|NOT COMPLETED|Overall Study||43
390186|NCT00264550|955061|P4|COMPLETED|Overall Study||59
390187|NCT00264550|955062|P3|COMPLETED|Overall Study||72
390188|NCT00264550|955063|P2|COMPLETED|Overall Study||92
390189|NCT00264550|955064|P1|COMPLETED|Overall Study||90
390190|NCT00264550|955061|P4|STARTED|Overall Study||89
390191|NCT00264550|955062|P3|STARTED|Overall Study||89
390192|NCT00264550|955063|P2|STARTED|Overall Study||133
390193|NCT00264550|955064|P1|STARTED|Overall Study||133
390194|NCT00264537|955103|P4|NOT COMPLETED|Overall Study||60
390195|NCT00264537|955104|P3|NOT COMPLETED|Overall Study||50
390196|NCT00264537|955105|P2|NOT COMPLETED|Overall Study||58
390197|NCT00264537|955106|P1|NOT COMPLETED|Overall Study||50
390198|NCT00264537|955103|P4|COMPLETED|Overall Study||99
390199|NCT00264537|955104|P3|COMPLETED|Overall Study||109
390200|NCT00264537|955105|P2|COMPLETED|Overall Study||101
390201|NCT00264537|955106|P1|COMPLETED|Overall Study||110
390202|NCT00264537|955103|P4|STARTED|Overall Study||159
390203|NCT00264537|955104|P3|STARTED|Overall Study||159
390204|NCT00264537|955105|P2|STARTED|Overall Study||159
390205|NCT00264537|955106|P1|STARTED|Overall Study||160
390206|NCT00264498|955138|P2|NOT COMPLETED|Crossover Treatment||9
390207|NCT00264498|955139|P1|NOT COMPLETED|Crossover Treatment||6
390208|NCT00264498|955138|P2|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
390209|NCT00264498|955139|P1|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
390210|NCT00264498|955138|P2|STARTED|Crossover Treatment||9
390211|NCT00264498|955139|P1|STARTED|Crossover Treatment||6
390212|NCT00264498|955138|P2|NOT COMPLETED|Randomized Treatment||18
390213|NCT00264498|955139|P1|NOT COMPLETED|Randomized Treatment||17
390214|NCT00264498|955138|P2|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
390215|NCT00264498|955139|P1|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
390216|NCT00264498|955138|P2|STARTED|Randomized Treatment||18
390217|NCT00264498|955139|P1|STARTED|Randomized Treatment||17
390218|NCT00264381|955147|P2|NOT COMPLETED|Overall Study||0
390219|NCT00264381|955148|P1|NOT COMPLETED|Overall Study||0
390220|NCT00264381|955147|P2|COMPLETED|Overall Study||37
390221|NCT00264381|955148|P1|COMPLETED|Overall Study||35
390222|NCT00264381|955147|P2|STARTED|Overall Study||37
390223|NCT00264381|955148|P1|STARTED|Overall Study||35
390224|NCT00264303|955162|P2|NOT COMPLETED|Overall Study||29
390225|NCT00264303|955163|P1|NOT COMPLETED|Overall Study||25
390226|NCT00264303|955162|P2|COMPLETED|Overall Study||419
390227|NCT00264303|955163|P1|COMPLETED|Overall Study||413
390228|NCT00264303|955162|P2|STARTED|Overall Study||448
390229|NCT00264303|955163|P1|STARTED|Overall Study||438
390230|NCT00264290|955181|P2|NOT COMPLETED|Observation (4 Weeks)||0
390231|NCT00264290|955182|P1|NOT COMPLETED|Observation (4 Weeks)||0
390232|NCT00264290|955181|P2|COMPLETED|Observation (4 Weeks)||14
390233|NCT00264290|955182|P1|COMPLETED|Observation (4 Weeks)||15
390234|NCT00264290|955181|P2|STARTED|Observation (4 Weeks)||14
390235|NCT00264290|955182|P1|STARTED|Observation (4 Weeks)||15
390236|NCT00264290|955181|P2|NOT COMPLETED|Intervention (8 Weeks)||0
390237|NCT00264290|955182|P1|NOT COMPLETED|Intervention (8 Weeks)||1
390238|NCT00264290|955181|P2|COMPLETED|Intervention (8 Weeks)||14
390239|NCT00264290|955182|P1|COMPLETED|Intervention (8 Weeks)||15
390240|NCT00264290|955181|P2|STARTED|Intervention (8 Weeks)||14
390241|NCT00264290|955182|P1|STARTED|Intervention (8 Weeks)||16
390242|NCT00264238|955188|P1|NOT COMPLETED|Overall Study||1
390243|NCT00264238|955188|P1|COMPLETED|Overall Study||14
390244|NCT00264238|955188|P1|STARTED|Overall Study||15
390245|NCT00264147|955200|P6|NOT COMPLETED|Treatment II Period||33
390246|NCT00264147|955201|P5|NOT COMPLETED|Treatment II Period||33
390247|NCT00264147|955202|P4|NOT COMPLETED|Treatment II Period||0
390248|NCT00264147|955203|P3|NOT COMPLETED|Treatment II Period||0
390249|NCT00264147|955204|P2|NOT COMPLETED|Treatment II Period||0
390250|NCT00264147|955205|P1|NOT COMPLETED|Treatment II Period||0
390251|NCT00264147|955200|P6|COMPLETED|Treatment II Period||116
390252|NCT00264147|955201|P5|COMPLETED|Treatment II Period||147
390253|NCT00264147|955202|P4|COMPLETED|Treatment II Period||0
390254|NCT00264147|955203|P3|COMPLETED|Treatment II Period||0
390255|NCT00264147|955204|P2|COMPLETED|Treatment II Period||0
390256|NCT00264147|955205|P1|COMPLETED|Treatment II Period||0
390257|NCT00264147|955200|P6|STARTED|Treatment II Period|Etoricoxib 10 mg (34), 30 mg (37), 60 mg (29), and placebo (49) reassigned to diclofenac (149)|149
390258|NCT00264147|955201|P5|STARTED|Treatment II Period|Etoricoxib 10 mg (38), 30 mg (28), 60 mg (33), 90 mg (45) and placebo (36) reassigned to 90 mg (180)|180
390259|NCT00264147|955202|P4|STARTED|Treatment II Period||0
390260|NCT00264147|955203|P3|STARTED|Treatment II Period||0
390261|NCT00264147|955204|P2|STARTED|Treatment II Period||0
390262|NCT00264147|955205|P1|STARTED|Treatment II Period||0
390263|NCT00264147|955200|P6|NOT COMPLETED|Treatment I Period||0
390264|NCT00264147|955201|P5|NOT COMPLETED|Treatment I Period||56
390265|NCT00264147|955202|P4|NOT COMPLETED|Treatment I Period||72
390266|NCT00264147|955203|P3|NOT COMPLETED|Treatment I Period||77
390267|NCT00264147|955204|P2|NOT COMPLETED|Treatment I Period||83
390268|NCT00264147|955205|P1|NOT COMPLETED|Treatment I Period||98
390269|NCT00264147|955200|P6|COMPLETED|Treatment I Period||0
390270|NCT00264147|955201|P5|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|99
390271|NCT00264147|955202|P4|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|68
390272|NCT00264147|955203|P3|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|74
390273|NCT00264147|955204|P2|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|71
390274|NCT00264147|955205|P1|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|63
390275|NCT00264147|955200|P6|STARTED|Treatment I Period||0
390276|NCT00264147|955201|P5|STARTED|Treatment I Period||155
390277|NCT00264147|955202|P4|STARTED|Treatment I Period||140
390278|NCT00264147|955203|P3|STARTED|Treatment I Period||151
390279|NCT00264147|955204|P2|STARTED|Treatment I Period||154
390280|NCT00264147|955205|P1|STARTED|Treatment I Period||161
390281|NCT00264004|955248|P4|NOT COMPLETED|Overall Study||15
390282|NCT00264004|955249|P3|NOT COMPLETED|Overall Study||14
390283|NCT00264004|955250|P2|NOT COMPLETED|Overall Study||11
390284|NCT00264004|955251|P1|NOT COMPLETED|Overall Study||17
390285|NCT00264004|955248|P4|COMPLETED|Overall Study|Completed 12 weeks treatment|19
390286|NCT00264004|955249|P3|COMPLETED|Overall Study|Completed 12 weeks treatment|16
390287|NCT00264004|955250|P2|COMPLETED|Overall Study|Completed 12 weeks treatment|21
390288|NCT00264004|955251|P1|COMPLETED|Overall Study|Completed 12 weeks treatment|13
390289|NCT00264004|955248|P4|STARTED|Overall Study|Randomised|34
390290|NCT00264004|955249|P3|STARTED|Overall Study|Randomised|30
390291|NCT00264004|955250|P2|STARTED|Overall Study|Randomised|32
390292|NCT00264004|955251|P1|STARTED|Overall Study|Randomised|30
390293|NCT00263887|955279|P2|NOT COMPLETED|Overall Study||7
390294|NCT00263887|955280|P1|NOT COMPLETED|Overall Study||3
390295|NCT00263887|955279|P2|COMPLETED|Overall Study||32
390296|NCT00263887|955280|P1|COMPLETED|Overall Study||35
390297|NCT00263887|955279|P2|STARTED|Overall Study||39
390298|NCT00263887|955280|P1|STARTED|Overall Study||38
390299|NCT00263757|955288|P2|NOT COMPLETED|Overall Study||8
390300|NCT00263757|955289|P1|NOT COMPLETED|Overall Study||8
390301|NCT00263757|955288|P2|COMPLETED|Overall Study||5
390302|NCT00263757|955289|P1|COMPLETED|Overall Study||4
390303|NCT00263757|955288|P2|STARTED|Overall Study||13
390304|NCT00263757|955289|P1|STARTED|Overall Study||12
390305|NCT00263666|955301|P2|NOT COMPLETED|Overall Study||11
390306|NCT00263666|955302|P1|NOT COMPLETED|Overall Study||7
390307|NCT00263666|955301|P2|COMPLETED|Overall Study||39
390308|NCT00263666|955302|P1|COMPLETED|Overall Study||43
390309|NCT00263666|955301|P2|STARTED|Overall Study||50
390310|NCT00263666|955302|P1|STARTED|Overall Study||50
390311|NCT00263328|955356|P3|NOT COMPLETED|Overall Study||7
390312|NCT00263328|955357|P2|NOT COMPLETED|Overall Study||2
390313|NCT00263328|955358|P1|NOT COMPLETED|Overall Study||8
390314|NCT00263328|955356|P3|COMPLETED|Overall Study||6
390315|NCT00263328|955357|P2|COMPLETED|Overall Study||12
390316|NCT00263328|955358|P1|COMPLETED|Overall Study||10
390317|NCT00263328|955356|P3|STARTED|Overall Study||13
390318|NCT00263328|955357|P2|STARTED|Overall Study||14
390319|NCT00263328|955358|P1|STARTED|Overall Study||18
390320|NCT00263211|955516|P2|NOT COMPLETED|Overall Study||1
390321|NCT00263211|955517|P1|NOT COMPLETED|Overall Study||5
390322|NCT00263211|955516|P2|COMPLETED|Overall Study||23
390323|NCT00263211|955517|P1|COMPLETED|Overall Study||19
390324|NCT00263211|955516|P2|STARTED|Overall Study||24
390325|NCT00263211|955517|P1|STARTED|Overall Study||24
390326|NCT00262964|955535|P4|NOT COMPLETED|Overall Study||0
390327|NCT00262964|955536|P3|NOT COMPLETED|Overall Study||0
390328|NCT00262964|955537|P2|NOT COMPLETED|Overall Study||0
390329|NCT00262964|955538|P1|NOT COMPLETED|Overall Study||0
390330|NCT00262964|955535|P4|COMPLETED|Overall Study||12
390331|NCT00262964|955536|P3|COMPLETED|Overall Study||17
390332|NCT00262964|955537|P2|COMPLETED|Overall Study||11
390333|NCT00262964|955538|P1|COMPLETED|Overall Study||11
390334|NCT00262964|955535|P4|STARTED|Overall Study||12
390335|NCT00262964|955536|P3|STARTED|Overall Study||17
390336|NCT00262964|955537|P2|STARTED|Overall Study||11
390337|NCT00262964|955538|P1|STARTED|Overall Study||11
390338|NCT00262951|955568|P1|NOT COMPLETED|Overall Study||16
390339|NCT00262951|955568|P1|COMPLETED|Overall Study||7
390340|NCT00262951|955568|P1|STARTED|Overall Study||23
390341|NCT00262925|955573|P1|NOT COMPLETED|Overall Study||11
390342|NCT00262925|955573|P1|COMPLETED|Overall Study||1
390343|NCT00262925|955573|P1|STARTED|Overall Study|7 patients were enrolled to step 1, and 5 patients were enrolled to step 2|12
390344|NCT00262873|955579|P1|NOT COMPLETED|Overall Study||8
390345|NCT00262873|955579|P1|COMPLETED|Overall Study||0
390346|NCT00262873|955579|P1|STARTED|Overall Study||8
390347|NCT00262860|955590|P1|NOT COMPLETED|Overall Study||2
390348|NCT00262860|955590|P1|COMPLETED|Overall Study||16
390349|NCT00262860|955590|P1|STARTED|Overall Study||18
390350|NCT00262847|955599|P3|NOT COMPLETED|Overall Study||396
390351|NCT00262847|955600|P2|NOT COMPLETED|Overall Study||513
390352|NCT00262847|955601|P1|NOT COMPLETED|Overall Study||518
390353|NCT00262847|955599|P3|COMPLETED|Overall Study||227
390354|NCT00262847|955600|P2|COMPLETED|Overall Study||112
390355|NCT00262847|955601|P1|COMPLETED|Overall Study||107
390356|NCT00262847|955599|P3|STARTED|Overall Study|Total enrolled and included in efficacy analysis|623
390357|NCT00262847|955600|P2|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
390358|NCT00262847|955601|P1|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
390359|NCT00262834|955620|P2|NOT COMPLETED|Overall Study||4
390360|NCT00262834|955621|P1|NOT COMPLETED|Overall Study||1
390361|NCT00262834|955620|P2|COMPLETED|Overall Study||25
390362|NCT00262834|955621|P1|COMPLETED|Overall Study||24
390363|NCT00262834|955620|P2|STARTED|Overall Study||29
390364|NCT00262834|955621|P1|STARTED|Overall Study||25
390365|NCT00262821|955634|P2|NOT COMPLETED|Overall Study||19
390366|NCT00262821|955635|P1|NOT COMPLETED|Overall Study||4
390367|NCT00262821|955634|P2|COMPLETED|Overall Study||185
390368|NCT00262821|955635|P1|COMPLETED|Overall Study||194
390369|NCT00262821|955634|P2|STARTED|Overall Study||204
390370|NCT00262821|955635|P1|STARTED|Overall Study||198
390371|NCT00262743|955647|P2|NOT COMPLETED|Overall Study||12
390372|NCT00262743|955648|P1|NOT COMPLETED|Overall Study||0
390373|NCT00262743|955647|P2|COMPLETED|Overall Study||30
390374|NCT00262743|955648|P1|COMPLETED|Overall Study||27
390375|NCT00262743|955647|P2|STARTED|Overall Study||42
390376|NCT00262743|955648|P1|STARTED|Overall Study||27
390377|NCT00262730|955655|P1|NOT COMPLETED|Overall Study||0
390378|NCT00262730|955655|P1|COMPLETED|Overall Study||97
390379|NCT00262730|955655|P1|STARTED|Overall Study||97
390380|NCT00262639|955663|P4|NOT COMPLETED|Overall Study||0
390381|NCT00262639|955664|P3|NOT COMPLETED|Overall Study||0
390382|NCT00262639|955665|P2|NOT COMPLETED|Overall Study||0
390383|NCT00262639|955666|P1|NOT COMPLETED|Overall Study||0
390384|NCT00262639|955663|P4|COMPLETED|Overall Study||7
390385|NCT00262639|955664|P3|COMPLETED|Overall Study||9
390386|NCT00262639|955665|P2|COMPLETED|Overall Study||26
390387|NCT00262639|955666|P1|COMPLETED|Overall Study||18
390388|NCT00262639|955663|P4|STARTED|Overall Study||7
390389|NCT00262639|955664|P3|STARTED|Overall Study||9
390390|NCT00262639|955665|P2|STARTED|Overall Study||26
390391|NCT00262639|955666|P1|STARTED|Overall Study||18
390392|NCT00262600|955683|P3|NOT COMPLETED|Overall Study||266
390393|NCT00262600|955684|P2|NOT COMPLETED|Overall Study||252
390394|NCT00262600|955685|P1|NOT COMPLETED|Overall Study||235
390395|NCT00262600|955683|P3|COMPLETED|Overall Study||5756
390396|NCT00262600|955684|P2|COMPLETED|Overall Study||5824
390397|NCT00262600|955685|P1|COMPLETED|Overall Study||5780
390398|NCT00262600|955683|P3|STARTED|Overall Study||6022
390399|NCT00262600|955684|P2|STARTED|Overall Study||6076
390400|NCT00262600|955685|P1|STARTED|Overall Study||6015
390401|NCT00262522|955712|P4|NOT COMPLETED|Study Start Through 96 Weeks||0
390402|NCT00262522|955713|P3|NOT COMPLETED|Study Start Through 96 Weeks||77
390403|NCT00262522|955714|P2|NOT COMPLETED|Study Start Through 96 Weeks||0
390404|NCT00262522|955715|P1|NOT COMPLETED|Study Start Through 96 Weeks||77
390405|NCT00262522|955712|P4|COMPLETED|Study Start Through 96 Weeks||0
390406|NCT00262522|955713|P3|COMPLETED|Study Start Through 96 Weeks||254
390407|NCT00262522|955714|P2|COMPLETED|Study Start Through 96 Weeks||0
390408|NCT00262522|955715|P1|COMPLETED|Study Start Through 96 Weeks||256
390409|NCT00262522|955712|P4|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
390410|NCT00262522|955713|P3|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|331
390411|NCT00262522|955714|P2|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
390412|NCT00262522|955715|P1|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|333
390413|NCT00262522|955712|P4|NOT COMPLETED|Study Start Through 48 Weeks||0
390414|NCT00262522|955713|P3|NOT COMPLETED|Study Start Through 48 Weeks||55
390415|NCT00262522|955714|P2|NOT COMPLETED|Study Start Through 48 Weeks||0
390416|NCT00262522|955715|P1|NOT COMPLETED|Study Start Through 48 Weeks||49
390417|NCT00262522|955712|P4|COMPLETED|Study Start Through 48 Weeks||0
390418|NCT00262522|955713|P3|COMPLETED|Study Start Through 48 Weeks||276
390419|NCT00262522|955714|P2|COMPLETED|Study Start Through 48 Weeks||0
390420|NCT00262522|955715|P1|COMPLETED|Study Start Through 48 Weeks||284
390421|NCT00262522|955712|P4|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
390422|NCT00262522|955713|P3|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|331
390423|NCT00262522|955714|P2|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
390424|NCT00262522|955715|P1|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|333
390425|NCT00262522|955712|P4|NOT COMPLETED|Study Start Through 8 Weeks||5
390426|NCT00262522|955713|P3|NOT COMPLETED|Study Start Through 8 Weeks||11
390427|NCT00262522|955714|P2|NOT COMPLETED|Study Start Through 8 Weeks||5
390428|NCT00262522|955715|P1|NOT COMPLETED|Study Start Through 8 Weeks||4
390429|NCT00262522|955712|P4|COMPLETED|Study Start Through 8 Weeks||160
390430|NCT00262522|955713|P3|COMPLETED|Study Start Through 8 Weeks||155
390431|NCT00262522|955714|P2|COMPLETED|Study Start Through 8 Weeks||161
390432|NCT00262522|955715|P1|COMPLETED|Study Start Through 8 Weeks||163
390433|NCT00262522|955712|P4|STARTED|Study Start Through 8 Weeks||165
390434|NCT00262522|955713|P3|STARTED|Study Start Through 8 Weeks||166
390435|NCT00262522|955714|P2|STARTED|Study Start Through 8 Weeks||166
390436|NCT00262522|955715|P1|STARTED|Study Start Through 8 Weeks||167
390437|NCT00262509|955737|P2|NOT COMPLETED|Overall Study||0
390438|NCT00262509|955738|P1|NOT COMPLETED|Overall Study||0
390439|NCT00262509|955737|P2|COMPLETED|Overall Study||9
390440|NCT00262509|955738|P1|COMPLETED|Overall Study||8
390441|NCT00262509|955737|P2|STARTED|Overall Study||9
390442|NCT00262509|955738|P1|STARTED|Overall Study||8
390443|NCT00262314|955744|P1|NOT COMPLETED|Overall Study||337
390444|NCT00262314|955744|P1|COMPLETED|Overall Study|Patients in the study for 5 years +/-3 months are considered to have completed the 5-year study|172
390445|NCT00262314|955744|P1|STARTED|Overall Study|Patients with validated data who received at least 1 dose of Novantrone®|509
390446|NCT00262301|955762|P3|NOT COMPLETED|Open-label Phase||0
390447|NCT00262301|955763|P2|NOT COMPLETED|Open-label Phase||0
390448|NCT00262301|955764|P1|NOT COMPLETED|Open-label Phase||0
390449|NCT00262301|955762|P3|COMPLETED|Open-label Phase||57
390450|NCT00262301|955763|P2|COMPLETED|Open-label Phase||0
390451|NCT00262301|955764|P1|COMPLETED|Open-label Phase||0
390452|NCT00262301|955762|P3|STARTED|Open-label Phase|"14/57 patients crossed over from the double-blind phase (7/14 were treated with 100 U/kg rhC1INH)"|57
390453|NCT00262301|955763|P2|STARTED|Open-label Phase||0
390454|NCT00262301|955764|P1|STARTED|Open-label Phase||0
390455|NCT00262301|955762|P3|NOT COMPLETED|Double-blind Phase||0
390456|NCT00262301|955763|P2|NOT COMPLETED|Double-blind Phase||1
390457|NCT00262301|955764|P1|NOT COMPLETED|Double-blind Phase||1
390458|NCT00262301|955762|P3|COMPLETED|Double-blind Phase||0
390459|NCT00262301|955763|P2|COMPLETED|Double-blind Phase||15
390460|NCT00262301|955764|P1|COMPLETED|Double-blind Phase||15
390461|NCT00262301|955762|P3|STARTED|Double-blind Phase||0
390462|NCT00262301|955763|P2|STARTED|Double-blind Phase||16
390463|NCT00262301|955764|P1|STARTED|Double-blind Phase||16
390464|NCT00262223|955777|P2|NOT COMPLETED|12-month Post-treatment Follow-up||7
390465|NCT00262223|955778|P1|NOT COMPLETED|12-month Post-treatment Follow-up||7
390466|NCT00262223|955777|P2|COMPLETED|12-month Post-treatment Follow-up||22
390467|NCT00262223|955778|P1|COMPLETED|12-month Post-treatment Follow-up||21
390468|NCT00262223|955777|P2|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
390469|NCT00262223|955778|P1|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
390470|NCT00262223|955777|P2|NOT COMPLETED|6-month Post-treatment Follow-up||1
390471|NCT00262223|955778|P1|NOT COMPLETED|6-month Post-treatment Follow-up||6
390472|NCT00262223|955777|P2|COMPLETED|6-month Post-treatment Follow-up||28
390473|NCT00262223|955778|P1|COMPLETED|6-month Post-treatment Follow-up||22
390474|NCT00262223|955777|P2|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
390475|NCT00262223|955778|P1|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
390476|NCT00262223|955777|P2|NOT COMPLETED|1-week Post-treatment Follow-up||4
390477|NCT00262223|955778|P1|NOT COMPLETED|1-week Post-treatment Follow-up||4
390478|NCT00262223|955777|P2|COMPLETED|1-week Post-treatment Follow-up||25
390479|NCT00262223|955778|P1|COMPLETED|1-week Post-treatment Follow-up||24
390480|NCT00262223|955777|P2|STARTED|1-week Post-treatment Follow-up||29
390481|NCT00262223|955778|P1|STARTED|1-week Post-treatment Follow-up||28
390482|NCT00262223|955777|P2|NOT COMPLETED|Treatment Phase||8
390483|NCT00262223|955778|P1|NOT COMPLETED|Treatment Phase||4
390484|NCT00262223|955777|P2|COMPLETED|Treatment Phase||29
390485|NCT00262223|955778|P1|COMPLETED|Treatment Phase||28
390486|NCT00262223|955777|P2|STARTED|Treatment Phase||37
390487|NCT00262223|955778|P1|STARTED|Treatment Phase||32
390488|NCT00262119|955789|P3|NOT COMPLETED|Overall Study||58
390489|NCT00262119|955790|P2|NOT COMPLETED|Overall Study||70
390490|NCT00262119|955791|P1|NOT COMPLETED|Overall Study||58
390491|NCT00262119|955789|P3|COMPLETED|Overall Study||325
390492|NCT00262119|955790|P2|COMPLETED|Overall Study||328
390493|NCT00262119|955791|P1|COMPLETED|Overall Study||327
390494|NCT00262119|955789|P3|STARTED|Overall Study||383
390495|NCT00262119|955790|P2|STARTED|Overall Study||398
390496|NCT00262119|955791|P1|STARTED|Overall Study||385
390497|NCT00262080|955811|P3|NOT COMPLETED|Repeat Dose Treatment Period||5
390498|NCT00262080|955812|P2|NOT COMPLETED|Repeat Dose Treatment Period||1
390499|NCT00262080|955813|P1|NOT COMPLETED|Repeat Dose Treatment Period||4
390500|NCT00262080|955811|P3|COMPLETED|Repeat Dose Treatment Period||14
390501|NCT00262080|955812|P2|COMPLETED|Repeat Dose Treatment Period||25
390502|NCT00262080|955813|P1|COMPLETED|Repeat Dose Treatment Period|Some patients participated in only the double-blind or the open label phase.|18
390503|NCT00262080|955811|P3|STARTED|Repeat Dose Treatment Period|This arm represents new patients, not treated in the double-blind part of the study.|19
390504|NCT00262080|955812|P2|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|26
390505|NCT00262080|955813|P1|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|22
390506|NCT00262080|955811|P3|NOT COMPLETED|Double Blind Treatment Period||0
390507|NCT00262080|955812|P2|NOT COMPLETED|Double Blind Treatment Period||0
390508|NCT00262080|955813|P1|NOT COMPLETED|Double Blind Treatment Period||1
390509|NCT00262080|955811|P3|COMPLETED|Double Blind Treatment Period||0
390510|NCT00262080|955812|P2|COMPLETED|Double Blind Treatment Period||36
390511|NCT00262080|955813|P1|COMPLETED|Double Blind Treatment Period||35
390512|NCT00262080|955811|P3|STARTED|Double Blind Treatment Period||0
390513|NCT00262080|955812|P2|STARTED|Double Blind Treatment Period|One patient was randomized to receive placebo but was treated with ecallantide.|36
390514|NCT00262080|955813|P1|STARTED|Double Blind Treatment Period|One patient was randomized to receive ecallantide but was treated with placebo.|36
390515|NCT00262067|955833|P4|NOT COMPLETED|Overall Study||113
390516|NCT00262067|955834|P3|NOT COMPLETED|Overall Study||216
390517|NCT00262067|955835|P2|NOT COMPLETED|Overall Study||100
390518|NCT00262067|955836|P1|NOT COMPLETED|Overall Study||219
390519|NCT00262067|955833|P4|COMPLETED|Overall Study||93
390520|NCT00262067|955834|P3|COMPLETED|Overall Study||193
390521|NCT00262067|955835|P2|COMPLETED|Overall Study||107
390522|NCT00262067|955836|P1|COMPLETED|Overall Study||196
390523|NCT00262067|955833|P4|STARTED|Overall Study||206
390524|NCT00262067|955834|P3|STARTED|Overall Study||409
390525|NCT00262067|955835|P2|STARTED|Overall Study||207
390526|NCT00262067|955836|P1|STARTED|Overall Study||415
390527|NCT00262041|955870|P3|NOT COMPLETED|Overall Study||6
390528|NCT00262041|955871|P2|NOT COMPLETED|Overall Study||4
390529|NCT00262041|955872|P1|NOT COMPLETED|Overall Study||2
390530|NCT00262041|955870|P3|COMPLETED|Overall Study||203
390531|NCT00262041|955871|P2|COMPLETED|Overall Study||147
390532|NCT00262041|955872|P1|COMPLETED|Overall Study||162
390533|NCT00262041|955870|P3|STARTED|Overall Study||209
390534|NCT00262041|955871|P2|STARTED|Overall Study||151
390535|NCT00262041|955872|P1|STARTED|Overall Study||164
390536|NCT00262028|955901|P9|NOT COMPLETED|Overall Study||19
390537|NCT00262028|955902|P8|NOT COMPLETED|Overall Study||18
390538|NCT00262028|955903|P7|NOT COMPLETED|Overall Study||12
390539|NCT00262028|955904|P6|NOT COMPLETED|Overall Study||13
390540|NCT00262028|955905|P5|NOT COMPLETED|Overall Study||12
390541|NCT00262028|955906|P4|NOT COMPLETED|Overall Study||23
390542|NCT00262028|955907|P3|NOT COMPLETED|Overall Study||20
390543|NCT00262028|955908|P2|NOT COMPLETED|Overall Study||27
390544|NCT00262028|955909|P1|NOT COMPLETED|Overall Study||24
390545|NCT00262028|955901|P9|COMPLETED|Overall Study||81
390546|NCT00262028|955902|P8|COMPLETED|Overall Study||55
390547|NCT00262028|955903|P7|COMPLETED|Overall Study||59
390548|NCT00262028|955904|P6|COMPLETED|Overall Study||60
390549|NCT00262028|955905|P5|COMPLETED|Overall Study||62
390550|NCT00262028|955906|P4|COMPLETED|Overall Study||134
390551|NCT00262028|955907|P3|COMPLETED|Overall Study||137
390552|NCT00262028|955908|P2|COMPLETED|Overall Study||126
390553|NCT00262028|955909|P1|COMPLETED|Overall Study||128
390554|NCT00262028|955901|P9|STARTED|Overall Study||100
390555|NCT00262028|955902|P8|STARTED|Overall Study||73
390556|NCT00262028|955903|P7|STARTED|Overall Study||71
390557|NCT00262028|955904|P6|STARTED|Overall Study||73
390558|NCT00262028|955905|P5|STARTED|Overall Study||74
390559|NCT00262028|955906|P4|STARTED|Overall Study||157
390560|NCT00262028|955907|P3|STARTED|Overall Study||157
390561|NCT00262028|955908|P2|STARTED|Overall Study||153
390562|NCT00262028|955909|P1|STARTED|Overall Study||152
390563|NCT00262002|955971|P7|NOT COMPLETED|Overall Study||6
390564|NCT00262002|955972|P6|NOT COMPLETED|Overall Study||7
390565|NCT00262002|955973|P5|NOT COMPLETED|Overall Study||7
390566|NCT00262002|955974|P4|NOT COMPLETED|Overall Study||5
390567|NCT00262002|955975|P3|NOT COMPLETED|Overall Study||0
390568|NCT00262002|955976|P2|NOT COMPLETED|Overall Study||6
390569|NCT00262002|955977|P1|NOT COMPLETED|Overall Study||11
390570|NCT00262002|955971|P7|COMPLETED|Overall Study||84
390571|NCT00262002|955972|P6|COMPLETED|Overall Study||83
390572|NCT00262002|955973|P5|COMPLETED|Overall Study||91
390573|NCT00262002|955974|P4|COMPLETED|Overall Study||93
390574|NCT00262002|955975|P3|COMPLETED|Overall Study||45
390575|NCT00262002|955976|P2|COMPLETED|Overall Study||84
390576|NCT00262002|955977|P1|COMPLETED|Overall Study||79
390577|NCT00262002|955971|P7|STARTED|Overall Study||90
390578|NCT00262002|955972|P6|STARTED|Overall Study||90
390579|NCT00262002|955973|P5|STARTED|Overall Study||98
390580|NCT00262002|955974|P4|STARTED|Overall Study||98
390581|NCT00262002|955975|P3|STARTED|Overall Study||45
390582|NCT00262002|955976|P2|STARTED|Overall Study||90
390583|NCT00262002|955977|P1|STARTED|Overall Study||90
390584|NCT00261950|956070|P1|NOT COMPLETED|Overall Study||26
390585|NCT00261950|956070|P1|COMPLETED|Overall Study||84
390586|NCT00261950|956070|P1|STARTED|Overall Study||110
390587|NCT00261846|956095|P12|NOT COMPLETED|Period 2: Part 2 (Efficacy)||23
390588|NCT00261846|956096|P11|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
390589|NCT00261846|956097|P10|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
390590|NCT00261846|956098|P9|NOT COMPLETED|Period 2: Part 2 (Efficacy)||14
390591|NCT00261846|956099|P8|NOT COMPLETED|Period 2: Part 2 (Efficacy)||29
390592|NCT00261846|956100|P7|NOT COMPLETED|Period 2: Part 2 (Efficacy)||22
390593|NCT00261846|956101|P6|NOT COMPLETED|Period 2: Part 2 (Efficacy)||2
390594|NCT00261846|956102|P5|NOT COMPLETED|Period 2: Part 2 (Efficacy)||50
390595|NCT00261846|956103|P4|NOT COMPLETED|Period 2: Part 2 (Efficacy)||135
390596|NCT00261846|956104|P3|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
390597|NCT00261846|956105|P2|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
390598|NCT00261846|956106|P1|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
390599|NCT00261846|956095|P12|COMPLETED|Period 2: Part 2 (Efficacy)||1
390600|NCT00261846|956096|P11|COMPLETED|Period 2: Part 2 (Efficacy)||15
390601|NCT00261846|956097|P10|COMPLETED|Period 2: Part 2 (Efficacy)||30
390602|NCT00261846|956098|P9|COMPLETED|Period 2: Part 2 (Efficacy)||12
390603|NCT00261846|956099|P8|COMPLETED|Period 2: Part 2 (Efficacy)||21
390604|NCT00261846|956100|P7|COMPLETED|Period 2: Part 2 (Efficacy)||16
390605|NCT00261846|956101|P6|COMPLETED|Period 2: Part 2 (Efficacy)||3
390606|NCT00261846|956102|P5|COMPLETED|Period 2: Part 2 (Efficacy)||39
390607|NCT00261846|956103|P4|COMPLETED|Period 2: Part 2 (Efficacy)||60
390608|NCT00261846|956104|P3|COMPLETED|Period 2: Part 2 (Efficacy)||0
390609|NCT00261846|956105|P2|COMPLETED|Period 2: Part 2 (Efficacy)||0
390610|NCT00261846|956106|P1|COMPLETED|Period 2: Part 2 (Efficacy)||0
390611|NCT00261846|956095|P12|STARTED|Period 2: Part 2 (Efficacy)||24
390612|NCT00261846|956096|P11|STARTED|Period 2: Part 2 (Efficacy)||64
390613|NCT00261846|956097|P10|STARTED|Period 2: Part 2 (Efficacy)|1 participant from Part 1 (Bosutinib 600mg cohort) continued in Part 2 of the study.|79
390614|NCT00261846|956098|P9|STARTED|Period 2: Part 2 (Efficacy)||26
390615|NCT00261846|956099|P8|STARTED|Period 2: Part 2 (Efficacy)||50
390616|NCT00261846|956100|P7|STARTED|Period 2: Part 2 (Efficacy)||38
390617|NCT00261846|956101|P6|STARTED|Period 2: Part 2 (Efficacy)||5
390618|NCT00261846|956102|P5|STARTED|Period 2: Part 2 (Efficacy)||89
390619|NCT00261846|956103|P4|STARTED|Period 2: Part 2 (Efficacy)|17 participants from Part 1 (Bosutinib 400mg, 500mg, 600mg cohort) continued in Part 2 of the study.|195
390620|NCT00261846|956104|P3|STARTED|Period 2: Part 2 (Efficacy)||0
390621|NCT00261846|956105|P2|STARTED|Period 2: Part 2 (Efficacy)||0
390622|NCT00261846|956106|P1|STARTED|Period 2: Part 2 (Efficacy)||0
390623|NCT00261846|956095|P12|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
390624|NCT00261846|956096|P11|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
390625|NCT00261846|956097|P10|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
390626|NCT00261846|956098|P9|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
390627|NCT00261846|956099|P8|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
390628|NCT00261846|956100|P7|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
390629|NCT00261846|956101|P6|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
390630|NCT00261846|956102|P5|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
390631|NCT00261846|956103|P4|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
390632|NCT00261846|956104|P3|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||12
390633|NCT00261846|956105|P2|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
390634|NCT00261846|956106|P1|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
390635|NCT00261846|956095|P12|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
390636|NCT00261846|956096|P11|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
390637|NCT00261846|956097|P10|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
390638|NCT00261846|956098|P9|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
390639|NCT00261846|956099|P8|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
390640|NCT00261846|956100|P7|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
390641|NCT00261846|956101|P6|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
390642|NCT00261846|956102|P5|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
390643|NCT00261846|956103|P4|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
390644|NCT00261846|956104|P3|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
390645|NCT00261846|956105|P2|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
390646|NCT00261846|956106|P1|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
390647|NCT00261846|956095|P12|STARTED|Period 1: Part 1 (Dose Escalation)||0
390648|NCT00261846|956096|P11|STARTED|Period 1: Part 1 (Dose Escalation)||0
390649|NCT00261846|956097|P10|STARTED|Period 1: Part 1 (Dose Escalation)||0
390650|NCT00261846|956098|P9|STARTED|Period 1: Part 1 (Dose Escalation)||0
390651|NCT00261846|956099|P8|STARTED|Period 1: Part 1 (Dose Escalation)||0
390652|NCT00261846|956100|P7|STARTED|Period 1: Part 1 (Dose Escalation)||0
390653|NCT00261846|956101|P6|STARTED|Period 1: Part 1 (Dose Escalation)||0
390654|NCT00261846|956102|P5|STARTED|Period 1: Part 1 (Dose Escalation)||0
390655|NCT00261846|956103|P4|STARTED|Period 1: Part 1 (Dose Escalation)||0
390656|NCT00261846|956104|P3|STARTED|Period 1: Part 1 (Dose Escalation)||12
390657|NCT00261846|956105|P2|STARTED|Period 1: Part 1 (Dose Escalation)||3
390658|NCT00261846|956106|P1|STARTED|Period 1: Part 1 (Dose Escalation)||3
390659|NCT00261833|956365|P2|NOT COMPLETED|Overall Study||18
390660|NCT00261833|956366|P1|NOT COMPLETED|Overall Study||9
390661|NCT00261833|956365|P2|COMPLETED|Overall Study||69
390662|NCT00261833|956366|P1|COMPLETED|Overall Study||84
390663|NCT00261833|956365|P2|STARTED|Overall Study||87
390664|NCT00261833|956366|P1|STARTED|Overall Study||93
390665|NCT00261716|956400|P2|NOT COMPLETED|Overall Study||10
390666|NCT00261716|956401|P1|NOT COMPLETED|Overall Study||6
390667|NCT00261716|956400|P2|COMPLETED|Overall Study||11
390668|NCT00261716|956401|P1|COMPLETED|Overall Study||11
390669|NCT00261716|956400|P2|STARTED|Overall Study||21
390670|NCT00261716|956401|P1|STARTED|Overall Study||17
390671|NCT00261495|956421|P2|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
390672|NCT00261495|956422|P1|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||10
390673|NCT00261495|956421|P2|COMPLETED|Extension Phase (Weeks 24 to 52)||47
390674|NCT00261495|956422|P1|COMPLETED|Extension Phase (Weeks 24 to 52)||50
390675|NCT00261495|956421|P2|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (85 subjects).|52
390676|NCT00261495|956422|P1|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (80 subjects).|60
390677|NCT00261495|956421|P2|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||48
390678|NCT00261495|956422|P1|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||66
390679|NCT00261495|956421|P2|COMPLETED|Maintenance Phase (Weeks 4 to 24)||137
390680|NCT00261495|956422|P1|COMPLETED|Maintenance Phase (Weeks 4 to 24)||140
390681|NCT00261495|956421|P2|STARTED|Maintenance Phase (Weeks 4 to 24)||185
390682|NCT00261495|956422|P1|STARTED|Maintenance Phase (Weeks 4 to 24)||206
390683|NCT00261495|956421|P2|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||65
390684|NCT00261495|956422|P1|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||48
390685|NCT00261495|956421|P2|COMPLETED|Titration Phase (Weeks 0 to 4)||185
390686|NCT00261495|956422|P1|COMPLETED|Titration Phase (Weeks 0 to 4)||206
390687|NCT00261495|956421|P2|STARTED|Titration Phase (Weeks 0 to 4)||250
390688|NCT00261495|956422|P1|STARTED|Titration Phase (Weeks 0 to 4)||254
390689|NCT00261443|956586|P3|NOT COMPLETED|4: Extension Phase||2
390690|NCT00261443|956587|P2|NOT COMPLETED|4: Extension Phase||3
390691|NCT00261443|956588|P1|NOT COMPLETED|4: Extension Phase||0
390692|NCT00261443|956586|P3|COMPLETED|4: Extension Phase||21
390693|NCT00261443|956587|P2|COMPLETED|4: Extension Phase||16
390694|NCT00261443|956588|P1|COMPLETED|4: Extension Phase||0
390695|NCT00261443|956586|P3|STARTED|4: Extension Phase||23
390696|NCT00261443|956587|P2|STARTED|4: Extension Phase||19
390697|NCT00261443|956588|P1|STARTED|4: Extension Phase||0
390698|NCT00261443|956586|P3|NOT COMPLETED|3: Assessment of Relapse||65
390699|NCT00261443|956587|P2|NOT COMPLETED|3: Assessment of Relapse||80
390700|NCT00261443|956588|P1|NOT COMPLETED|3: Assessment of Relapse||0
390701|NCT00261443|956586|P3|COMPLETED|3: Assessment of Relapse||103
390702|NCT00261443|956587|P2|COMPLETED|3: Assessment of Relapse||89
390703|NCT00261443|956588|P1|COMPLETED|3: Assessment of Relapse||0
390704|NCT00261443|956586|P3|STARTED|3: Assessment of Relapse||168
390705|NCT00261443|956587|P2|STARTED|3: Assessment of Relapse||169
390706|NCT00261443|956588|P1|STARTED|3: Assessment of Relapse||0
390794|NCT00259740|956975|P1|Received Study Medication|Overall Study||42
390707|NCT00261443|956586|P3|NOT COMPLETED|2: Stability & Maintenance of Stability||0
390708|NCT00261443|956587|P2|NOT COMPLETED|2: Stability & Maintenance of Stability||0
390709|NCT00261443|956588|P1|NOT COMPLETED|2: Stability & Maintenance of Stability||340
390710|NCT00261443|956586|P3|COMPLETED|2: Stability & Maintenance of Stability||0
390711|NCT00261443|956587|P2|COMPLETED|2: Stability & Maintenance of Stability||0
390712|NCT00261443|956588|P1|COMPLETED|2: Stability & Maintenance of Stability||346
390713|NCT00261443|956586|P3|STARTED|2: Stability & Maintenance of Stability||0
390714|NCT00261443|956587|P2|STARTED|2: Stability & Maintenance of Stability||0
390715|NCT00261443|956588|P1|STARTED|2: Stability & Maintenance of Stability||686
390716|NCT00261443|956586|P3|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
390717|NCT00261443|956587|P2|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
390718|NCT00261443|956588|P1|NOT COMPLETED|1: Confirmation of Partial Nonresponse||584
390719|NCT00261443|956586|P3|COMPLETED|1: Confirmation of Partial Nonresponse||0
390720|NCT00261443|956587|P2|COMPLETED|1: Confirmation of Partial Nonresponse||0
390721|NCT00261443|956588|P1|COMPLETED|1: Confirmation of Partial Nonresponse||686
390722|NCT00261443|956586|P3|STARTED|1: Confirmation of Partial Nonresponse||0
390723|NCT00261443|956587|P2|STARTED|1: Confirmation of Partial Nonresponse||0
390724|NCT00261443|956588|P1|STARTED|1: Confirmation of Partial Nonresponse||1270
390725|NCT00260962|956845|P2|NOT COMPLETED|Overall Study||2
390726|NCT00260962|956846|P1|NOT COMPLETED|Overall Study||4
390727|NCT00260962|956845|P2|COMPLETED|Overall Study||14
390728|NCT00260962|956846|P1|COMPLETED|Overall Study||14
390729|NCT00260962|956845|P2|STARTED|Overall Study||16
390730|NCT00260962|956846|P1|STARTED|Overall Study||18
390731|NCT00260832|956856|P2|NOT COMPLETED|Overall Study||211
390732|NCT00260832|956857|P1|NOT COMPLETED|Overall Study||228
390733|NCT00260832|956856|P2|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|31
390734|NCT00260832|956857|P1|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|15
390735|NCT00260832|956856|P2|STARTED|Overall Study||242
390736|NCT00260832|956857|P1|STARTED|Overall Study||243
390737|NCT00260689|956868|P3|NOT COMPLETED|Overall Study||15
390738|NCT00260689|956869|P2|NOT COMPLETED|Overall Study||49
390739|NCT00260689|956870|P1|NOT COMPLETED|Overall Study||41
390740|NCT00260689|956868|P3|COMPLETED|Overall Study||1
390741|NCT00260689|956869|P2|COMPLETED|Overall Study||11
390742|NCT00260689|956870|P1|COMPLETED|Overall Study||19
390743|NCT00260689|956868|P3|STARTED|Overall Study||16
390744|NCT00260689|956869|P2|STARTED|Overall Study||60
390745|NCT00260689|956870|P1|STARTED|Overall Study||60
390746|NCT00260533|956886|P2|NOT COMPLETED|Overall Study||3
390747|NCT00260533|956887|P1|NOT COMPLETED|Overall Study||3
390748|NCT00260533|956886|P2|COMPLETED|Overall Study||10
390749|NCT00260533|956887|P1|COMPLETED|Overall Study||11
390750|NCT00260533|956886|P2|STARTED|Overall Study||13
390751|NCT00260533|956887|P1|STARTED|Overall Study||14
390752|NCT00260429|956895|P2|NOT COMPLETED|Overall Study||0
390753|NCT00260429|956896|P1|NOT COMPLETED|Overall Study||2
390754|NCT00260429|956895|P2|COMPLETED|Overall Study||12
390755|NCT00260429|956896|P1|COMPLETED|Overall Study||21
390756|NCT00260429|956895|P2|STARTED|Overall Study||12
390757|NCT00260429|956896|P1|STARTED|Overall Study||23
390758|NCT00260208|956904|P2|NOT COMPLETED|Overall Study||34
390759|NCT00260208|956905|P1|NOT COMPLETED|Overall Study||47
390760|NCT00260208|956904|P2|COMPLETED|Overall Study||138
390761|NCT00260208|956905|P1|COMPLETED|Overall Study||137
390762|NCT00260208|956904|P2|Modified ITT|Overall Study||96
390763|NCT00260208|956905|P1|Modified ITT|Overall Study||101
390764|NCT00260208|956904|P2|Intent to Treat (ITT) Population|Overall Study||169
390765|NCT00260208|956905|P1|Intent to Treat (ITT) Population|Overall Study||182
390766|NCT00260208|956904|P2|STARTED|Overall Study||172
390767|NCT00260208|956905|P1|STARTED|Overall Study|"Started indicates safety population."|184
390768|NCT00260195|956935|P2|NOT COMPLETED|Overall Study||0
390769|NCT00260195|956936|P1|NOT COMPLETED|Overall Study||0
390770|NCT00260195|956935|P2|COMPLETED|Overall Study||37
390771|NCT00260195|956936|P1|COMPLETED|Overall Study||39
390772|NCT00260195|956935|P2|STARTED|Overall Study||37
390773|NCT00260195|956936|P1|STARTED|Overall Study||39
390774|NCT00260065|956948|P1|NOT COMPLETED|Overall Study||93
390775|NCT00260065|956948|P1|COMPLETED|Overall Study||6
390776|NCT00260065|956948|P1|STARTED|Overall Study||99
390777|NCT00259857|956955|P2|NOT COMPLETED|24 Months Treatment||3
390778|NCT00259857|956956|P1|NOT COMPLETED|24 Months Treatment||0
390779|NCT00259857|956955|P2|COMPLETED|24 Months Treatment||6
390780|NCT00259857|956956|P1|COMPLETED|24 Months Treatment||10
390781|NCT00259857|956955|P2|STARTED|24 Months Treatment||9
390782|NCT00259857|956956|P1|STARTED|24 Months Treatment||10
390783|NCT00259857|956955|P2|NOT COMPLETED|12 Months Treatment||2
390784|NCT00259857|956956|P1|NOT COMPLETED|12 Months Treatment||1
390785|NCT00259857|956955|P2|COMPLETED|12 Months Treatment||9
390786|NCT00259857|956956|P1|COMPLETED|12 Months Treatment||10
390787|NCT00259857|956955|P2|STARTED|12 Months Treatment||11
390788|NCT00259857|956956|P1|STARTED|12 Months Treatment||11
390789|NCT00259740|956974|P2|NOT COMPLETED|Overall Study||53
390790|NCT00259740|956975|P1|NOT COMPLETED|Overall Study||43
390791|NCT00259740|956974|P2|COMPLETED|Overall Study||0
390792|NCT00259740|956975|P1|COMPLETED|Overall Study||0
390793|NCT00259740|956974|P2|Received Study Medication|Overall Study||53
390795|NCT00259740|956974|P2|STARTED|Overall Study||53
390796|NCT00259740|956975|P1|STARTED|Overall Study||43
390797|NCT00259649|956985|P1|NOT COMPLETED|Overall Study||10
390798|NCT00259649|956985|P1|COMPLETED|Overall Study||61
390799|NCT00259649|956985|P1|STARTED|Overall Study||71
390800|NCT00259610|956993|P4|NOT COMPLETED|Overall Study||43
390801|NCT00259610|956994|P3|NOT COMPLETED|Overall Study||73
390802|NCT00259610|956995|P2|NOT COMPLETED|Overall Study||46
390803|NCT00259610|956996|P1|NOT COMPLETED|Overall Study||76
390804|NCT00259610|956993|P4|COMPLETED|Overall Study||81
390805|NCT00259610|956994|P3|COMPLETED|Overall Study||182
390806|NCT00259610|956995|P2|COMPLETED|Overall Study||86
390807|NCT00259610|956996|P1|COMPLETED|Overall Study||168
390808|NCT00259610|956993|P4|STARTED|Overall Study||124
390809|NCT00259610|956994|P3|STARTED|Overall Study||255
390810|NCT00259610|956995|P2|STARTED|Overall Study||132
390811|NCT00259610|956996|P1|STARTED|Overall Study||244
390812|NCT00259298|957010|P1|NOT COMPLETED|Overall Study||3
390813|NCT00259298|957010|P1|COMPLETED|Overall Study||9
390814|NCT00259298|957010|P1|Received at Least 1 Dose of Study Drug|Overall Study||10
390815|NCT00259298|957010|P1|STARTED|Overall Study||12
390816|NCT00259285|957018|P1|NOT COMPLETED|Overall Study||0
390817|NCT00259285|957018|P1|COMPLETED|Overall Study||10
390818|NCT00259285|957018|P1|STARTED|Overall Study||10
390819|NCT00259272|957028|P4|NOT COMPLETED|Overall Study||21
390820|NCT00259272|957029|P3|NOT COMPLETED|Overall Study||5
390821|NCT00259272|957030|P2|NOT COMPLETED|Overall Study||7
390822|NCT00259272|957031|P1|NOT COMPLETED|Overall Study||15
390823|NCT00259272|957028|P4|COMPLETED|Overall Study||27
390824|NCT00259272|957029|P3|COMPLETED|Overall Study||21
390825|NCT00259272|957030|P2|COMPLETED|Overall Study||24
390826|NCT00259272|957031|P1|COMPLETED|Overall Study||21
390827|NCT00259272|957028|P4|STARTED|Overall Study||48
390828|NCT00259272|957029|P3|STARTED|Overall Study||26
390829|NCT00259272|957030|P2|STARTED|Overall Study||31
390830|NCT00259272|957031|P1|STARTED|Overall Study||36
390831|NCT00259090|957109|P3|NOT COMPLETED|Overall Study||0
390832|NCT00259090|957110|P2|NOT COMPLETED|Overall Study||0
390833|NCT00259090|957111|P1|NOT COMPLETED|Overall Study||0
390834|NCT00259090|957109|P3|COMPLETED|Overall Study||37
390835|NCT00259090|957110|P2|COMPLETED|Overall Study||31
390836|NCT00259090|957111|P1|COMPLETED|Overall Study||35
390837|NCT00259090|957109|P3|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|37
390838|NCT00259090|957110|P2|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|31
390839|NCT00259090|957111|P1|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|35
390840|NCT00259012|957127|P2|NOT COMPLETED|Overall Study||4
390841|NCT00259012|957128|P1|NOT COMPLETED|Overall Study||2
390842|NCT00259012|957127|P2|COMPLETED|Overall Study||30
390843|NCT00259012|957128|P1|COMPLETED|Overall Study||31
390844|NCT00259012|957127|P2|STARTED|Overall Study||34
390845|NCT00259012|957128|P1|STARTED|Overall Study||33
390846|NCT00258960|957160|P1|NOT COMPLETED|Overall Study||17
390847|NCT00258960|957160|P1|COMPLETED|Overall Study||32
390848|NCT00258960|957160|P1|STARTED|Overall Study|49 patients included but 1 is not considered due to not receive any treatment and died before start|49
390849|NCT00258908|957168|P1|NOT COMPLETED|Overall Study||0
390850|NCT00258908|957168|P1|COMPLETED|Overall Study||112
390851|NCT00258908|957168|P1|STARTED|Overall Study|3 participants were not vaccinated and were not included in the final analysis and in this report.|112
390852|NCT00258895|957176|P2|NOT COMPLETED|Overall Study||3
390853|NCT00258895|957177|P1|NOT COMPLETED|Overall Study||10
390854|NCT00258895|957176|P2|COMPLETED|Overall Study||159
390855|NCT00258895|957177|P1|COMPLETED|Overall Study||477
390856|NCT00258895|957176|P2|STARTED|Overall Study||162
390857|NCT00258895|957177|P1|STARTED|Overall Study||487
390858|NCT00258882|957193|P2|NOT COMPLETED|Pregnancy Surveillance||0
390859|NCT00258882|957194|P1|NOT COMPLETED|Pregnancy Surveillance||0
390860|NCT00258882|957193|P2|COMPLETED|Pregnancy Surveillance||675
390861|NCT00258882|957194|P1|COMPLETED|Pregnancy Surveillance||225
390862|NCT00258882|957193|P2|STARTED|Pregnancy Surveillance|Non-vaccinated age-matched subjects with first positive pregnancy test in the same month (± 1 month)|675
390863|NCT00258882|957194|P1|STARTED|Pregnancy Surveillance|Adacel recipients who were pregnant at the time of vaccination or within 28 days thereafter.|225
390864|NCT00258882|957193|P2|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
390865|NCT00258882|957194|P1|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
390866|NCT00258882|957193|P2|COMPLETED|Adacel Recipients-Risk Interval Method||0
390867|NCT00258882|957194|P1|COMPLETED|Adacel Recipients-Risk Interval Method||124139
390868|NCT00258882|957193|P2|STARTED|Adacel Recipients-Risk Interval Method|Study participants served as their own controls for this analysis|0
390869|NCT00258882|957194|P1|STARTED|Adacel Recipients-Risk Interval Method||124139
390870|NCT00258882|957193|P2|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
390871|NCT00258882|957194|P1|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
390872|NCT00258882|957193|P2|COMPLETED|Adacel Recipients Historic Cohort Method||203154
390873|NCT00258882|957194|P1|COMPLETED|Adacel Recipients Historic Cohort Method||124139
390874|NCT00258882|957193|P2|STARTED|Adacel Recipients Historic Cohort Method||203154
390875|NCT00258882|957194|P1|STARTED|Adacel Recipients Historic Cohort Method||124139
390876|NCT00258856|957213|P4|NOT COMPLETED|Overall Study||1
390877|NCT00258856|957214|P3|NOT COMPLETED|Overall Study||2
390878|NCT00258856|957215|P2|NOT COMPLETED|Overall Study||0
390879|NCT00258856|957216|P1|NOT COMPLETED|Overall Study||3
390880|NCT00258856|957213|P4|COMPLETED|Overall Study||58
390881|NCT00258856|957214|P3|COMPLETED|Overall Study||56
390882|NCT00258856|957215|P2|COMPLETED|Overall Study||58
390883|NCT00258856|957216|P1|COMPLETED|Overall Study||56
390884|NCT00258856|957213|P4|STARTED|Overall Study||59
390885|NCT00258856|957214|P3|STARTED|Overall Study||58
390886|NCT00258856|957215|P2|STARTED|Overall Study||58
390887|NCT00258856|957216|P1|STARTED|Overall Study||59
390888|NCT00258830|957228|P2|NOT COMPLETED|Overall Study||0
390889|NCT00258830|957229|P1|NOT COMPLETED|Overall Study||0
390890|NCT00258830|957228|P2|COMPLETED|Overall Study||60
390891|NCT00258830|957229|P1|COMPLETED|Overall Study||60
390892|NCT00258830|957228|P2|STARTED|Overall Study||60
390893|NCT00258830|957229|P1|STARTED|Overall Study||60
390894|NCT00258817|957243|P2|NOT COMPLETED|Overall Study||0
390895|NCT00258817|957244|P1|NOT COMPLETED|Overall Study||0
390896|NCT00258817|957243|P2|COMPLETED|Overall Study||15
390897|NCT00258817|957244|P1|COMPLETED|Overall Study||15
390898|NCT00258817|957243|P2|STARTED|Overall Study||15
390899|NCT00258817|957244|P1|STARTED|Overall Study||15
390900|NCT00258674|957257|P3|NOT COMPLETED|Overall Study||34
390901|NCT00258674|957258|P2|NOT COMPLETED|Overall Study||53
390902|NCT00258674|957259|P1|NOT COMPLETED|Overall Study||32
390903|NCT00258674|957257|P3|COMPLETED|Overall Study||568
390904|NCT00258674|957258|P2|COMPLETED|Overall Study||758
390905|NCT00258674|957259|P1|COMPLETED|Overall Study||565
390906|NCT00258674|957257|P3|STARTED|Overall Study||602
390907|NCT00258674|957258|P2|STARTED|Overall Study||811
390908|NCT00258674|957259|P1|STARTED|Overall Study||597
390909|NCT00258440|957318|P3|NOT COMPLETED|Overall Study||1
390910|NCT00258440|957319|P2|NOT COMPLETED|Overall Study||0
390911|NCT00258440|957320|P1|NOT COMPLETED|Overall Study||0
390912|NCT00258440|957318|P3|COMPLETED|Overall Study||5
390913|NCT00258440|957319|P2|COMPLETED|Overall Study||0
390914|NCT00258440|957320|P1|COMPLETED|Overall Study||1
390915|NCT00258440|957318|P3|STARTED|Overall Study||6
390916|NCT00258440|957319|P2|STARTED|Overall Study||0
390917|NCT00258440|957320|P1|STARTED|Overall Study||1
390918|NCT00258362|957331|P1|NOT COMPLETED|Overall Study||0
390919|NCT00258362|957331|P1|COMPLETED|Overall Study||41
390920|NCT00258362|957331|P1|STARTED|Overall Study||41
390921|NCT00258349|957336|P1|NOT COMPLETED|Overall Study||0
390922|NCT00258349|957336|P1|COMPLETED|Overall Study||16
390923|NCT00258349|957336|P1|HER2-positive by Central Review|Overall Study||10
390924|NCT00258349|957336|P1|STARTED|Overall Study||16
390925|NCT00258310|957343|P1|NOT COMPLETED|Overall Study||0
390926|NCT00258310|957343|P1|COMPLETED|Overall Study||35
390927|NCT00258310|957343|P1|STARTED|Overall Study||35
390928|NCT00258206|957347|P1|NOT COMPLETED|Overall Study||0
390929|NCT00258206|957347|P1|COMPLETED|Overall Study||21
390930|NCT00258206|957347|P1|STARTED|Overall Study||21
390931|NCT00258180|957351|P1|NOT COMPLETED|Overall Study||0
390932|NCT00258180|957351|P1|COMPLETED|Overall Study||2
390933|NCT00258180|957351|P1|STARTED|Overall Study||2
390934|NCT00258154|957358|P2|NOT COMPLETED|Overall Study||7
390935|NCT00258154|957359|P1|NOT COMPLETED|Overall Study||9
390936|NCT00258154|957358|P2|COMPLETED|Overall Study|Subjects who completed the study.|195
390937|NCT00258154|957359|P1|COMPLETED|Overall Study|Subjects who completed the study.|192
390938|NCT00258154|957358|P2|Vaccinated at Visit 3|Overall Study||197
390939|NCT00258154|957359|P1|Vaccinated at Visit 3|Overall Study||195
390940|NCT00258154|957358|P2|Vaccinated at Visit 2|Overall Study||198
390941|NCT00258154|957359|P1|Vaccinated at Visit 2|Overall Study||198
390942|NCT00258154|957358|P2|Vaccinated at Visit 1|Overall Study||202
390943|NCT00258154|957359|P1|Vaccinated at Visit 1|Overall Study||201
390944|NCT00258154|957358|P2|STARTED|Overall Study|Healthy infants who started in the Placebo concomitantly with INFANRIX™ hexa group.|202
390945|NCT00258154|957359|P1|STARTED|Overall Study|Healthy infants who started in the RotaTeq™ concomitantly with INFANRIX™ hexa group.|201
390946|NCT00258128|957429|P2|NOT COMPLETED|Overall Study||0
390947|NCT00258128|957430|P1|NOT COMPLETED|Overall Study||0
390948|NCT00258128|957429|P2|COMPLETED|Overall Study||9
390949|NCT00258128|957430|P1|COMPLETED|Overall Study||8
390950|NCT00258128|957429|P2|STARTED|Overall Study||9
390951|NCT00258128|957430|P1|STARTED|Overall Study||8
390952|NCT00258011|957438|P1|NOT COMPLETED|Overall Study||0
390953|NCT00258011|957438|P1|COMPLETED|Overall Study||3
390954|NCT00258011|957438|P1|STARTED|Overall Study||3
390955|NCT00257933|957445|P2|NOT COMPLETED|Overall Study||0
390956|NCT00257933|957446|P1|NOT COMPLETED|Overall Study||0
390957|NCT00257933|957445|P2|COMPLETED|Overall Study||78
390958|NCT00257933|957446|P1|COMPLETED|Overall Study||74
390959|NCT00257933|957445|P2|STARTED|Overall Study||78
390960|NCT00257933|957446|P1|STARTED|Overall Study||74
390961|NCT00257920|957454|P2|NOT COMPLETED|Period: Second Intervention||1
390962|NCT00257920|957455|P1|NOT COMPLETED|Period: Second Intervention||2
390963|NCT00257920|957454|P2|COMPLETED|Period: Second Intervention||18
390964|NCT00257920|957455|P1|COMPLETED|Period: Second Intervention||19
390965|NCT00257920|957454|P2|STARTED|Period: Second Intervention||19
390966|NCT00257920|957455|P1|STARTED|Period: Second Intervention||21
390967|NCT00257920|957454|P2|NOT COMPLETED|Period: Washout Period of Two Weeks||1
390968|NCT00257920|957455|P1|NOT COMPLETED|Period: Washout Period of Two Weeks||0
390969|NCT00257920|957454|P2|COMPLETED|Period: Washout Period of Two Weeks||19
390970|NCT00257920|957455|P1|COMPLETED|Period: Washout Period of Two Weeks||21
390971|NCT00257920|957454|P2|STARTED|Period: Washout Period of Two Weeks||20
390972|NCT00257920|957455|P1|STARTED|Period: Washout Period of Two Weeks||21
390973|NCT00257920|957454|P2|NOT COMPLETED|Period: First Intervention||0
390974|NCT00257920|957455|P1|NOT COMPLETED|Period: First Intervention||0
390975|NCT00257920|957454|P2|COMPLETED|Period: First Intervention||20
390976|NCT00257920|957455|P1|COMPLETED|Period: First Intervention||21
390977|NCT00257920|957454|P2|STARTED|Period: First Intervention||20
390978|NCT00257920|957455|P1|STARTED|Period: First Intervention||21
390979|NCT00257894|957465|P2|NOT COMPLETED|Overall Study||5
390980|NCT00257894|957466|P1|NOT COMPLETED|Overall Study||4
390981|NCT00257894|957465|P2|COMPLETED|Overall Study||15
390982|NCT00257894|957466|P1|COMPLETED|Overall Study||17
390983|NCT00257894|957465|P2|STARTED|Overall Study||20
390984|NCT00257894|957466|P1|STARTED|Overall Study||21
390985|NCT00257686|957484|P6|NOT COMPLETED|Overall Study||9
390986|NCT00257686|957485|P5|NOT COMPLETED|Overall Study||22
390987|NCT00257686|957486|P4|NOT COMPLETED|Overall Study||11
390988|NCT00257686|957487|P3|NOT COMPLETED|Overall Study||18
390989|NCT00257686|957488|P2|NOT COMPLETED|Overall Study||19
390990|NCT00257686|957489|P1|NOT COMPLETED|Overall Study||21
390991|NCT00257686|957484|P6|COMPLETED|Overall Study||95
390992|NCT00257686|957485|P5|COMPLETED|Overall Study||194
390993|NCT00257686|957486|P4|COMPLETED|Overall Study||88
390994|NCT00257686|957487|P3|COMPLETED|Overall Study||208
390995|NCT00257686|957488|P2|COMPLETED|Overall Study||89
390996|NCT00257686|957489|P1|COMPLETED|Overall Study||188
390997|NCT00257686|957484|P6|Safety Population|Overall Study|Subjects who received at least one dose of study medication|102
390998|NCT00257686|957485|P5|Safety Population|Overall Study|Subjects who received at least one dose of study medication|210
390999|NCT00257686|957486|P4|Safety Population|Overall Study|Subjects who received at least one dose of study medication|96
391000|NCT00257686|957487|P3|Safety Population|Overall Study|Subjects who received at least one dose of study medication|224
391001|NCT00257686|957488|P2|Safety Population|Overall Study|Subjects who received at least one dose of study medication|103
391002|NCT00257686|957489|P1|Safety Population|Overall Study|Subjects who received at least one dose of study medication|207
391003|NCT00257686|957484|P6|STARTED|Overall Study||104
391004|NCT00257686|957485|P5|STARTED|Overall Study||216
391005|NCT00257686|957486|P4|STARTED|Overall Study||99
391006|NCT00257686|957487|P3|STARTED|Overall Study||226
391007|NCT00257686|957488|P2|STARTED|Overall Study||108
391008|NCT00257686|957489|P1|STARTED|Overall Study||209
391009|NCT00257660|957511|P2|NOT COMPLETED|Overall Study||23
391010|NCT00257660|957512|P1|NOT COMPLETED|Overall Study||10
391011|NCT00257660|957511|P2|COMPLETED|Overall Study||38
391012|NCT00257660|957512|P1|COMPLETED|Overall Study||45
391013|NCT00257660|957511|P2|STARTED|Overall Study||61
391014|NCT00257660|957512|P1|STARTED|Overall Study||55
391015|NCT00257608|957542|P3|NOT COMPLETED|Post Chemotherapy Phase||244
391016|NCT00257608|957543|P2|NOT COMPLETED|Post Chemotherapy Phase||264
391017|NCT00257608|957544|P1|NOT COMPLETED|Post Chemotherapy Phase||0
391018|NCT00257608|957542|P3|COMPLETED|Post Chemotherapy Phase||126
391019|NCT00257608|957543|P2|COMPLETED|Post Chemotherapy Phase||109
391020|NCT00257608|957544|P1|COMPLETED|Post Chemotherapy Phase||0
391021|NCT00257608|957542|P3|STARTED|Post Chemotherapy Phase||370
391022|NCT00257608|957543|P2|STARTED|Post Chemotherapy Phase||373
391023|NCT00257608|957544|P1|STARTED|Post Chemotherapy Phase||0
391024|NCT00257608|957542|P3|NOT COMPLETED|Chemotherapy Phase||0
391025|NCT00257608|957543|P2|NOT COMPLETED|Chemotherapy Phase||0
391026|NCT00257608|957544|P1|NOT COMPLETED|Chemotherapy Phase||376
391027|NCT00257608|957542|P3|COMPLETED|Chemotherapy Phase||0
391028|NCT00257608|957543|P2|COMPLETED|Chemotherapy Phase||0
391029|NCT00257608|957544|P1|COMPLETED|Chemotherapy Phase||769
391030|NCT00257608|957542|P3|STARTED|Chemotherapy Phase||0
391031|NCT00257608|957543|P2|STARTED|Chemotherapy Phase||0
391032|NCT00257608|957544|P1|STARTED|Chemotherapy Phase||1145
391033|NCT00257556|957570|P2|NOT COMPLETED|Overall Study||10
391034|NCT00257556|957571|P1|NOT COMPLETED|Overall Study||14
391035|NCT00257556|957570|P2|COMPLETED|Overall Study||32
391036|NCT00257556|957571|P1|COMPLETED|Overall Study||24
391037|NCT00257556|957570|P2|All Patients Treated Population|Overall Study|Also the safety population. Three randomized patients did not receive study medication.|39
391038|NCT00257556|957571|P1|All Patients Treated Population|Overall Study|Also the safety population. One randomized patient did not receive study medication.|37
391039|NCT00257556|957570|P2|STARTED|Overall Study||42
391040|NCT00257556|957571|P1|STARTED|Overall Study||38
391041|NCT00257322|957597|P1|NOT COMPLETED|Overall Study||4
391042|NCT00257322|957597|P1|COMPLETED|Overall Study|4 subjects withdrew from this study.|16
391043|NCT00257322|957597|P1|STARTED|Overall Study|20 subjects accrued.|20
391044|NCT00257309|957604|P2|NOT COMPLETED|Overall Study||2
391045|NCT00257309|957605|P1|NOT COMPLETED|Overall Study||2
391046|NCT00257309|957604|P2|COMPLETED|Overall Study||130
391047|NCT00257309|957605|P1|COMPLETED|Overall Study||132
391048|NCT00257309|957604|P2|STARTED|Overall Study||132
391049|NCT00257309|957605|P1|STARTED|Overall Study||134
391050|NCT00257192|957615|P2|NOT COMPLETED|Overall Study||39
391051|NCT00257192|957616|P1|NOT COMPLETED|Overall Study||58
391052|NCT00257192|957615|P2|COMPLETED|Overall Study||52
391053|NCT00257192|957616|P1|COMPLETED|Overall Study||135
391054|NCT00257192|957615|P2|Received Study Treatment|Overall Study||90
391055|NCT00257192|957616|P1|Received Study Treatment|Overall Study||193
391056|NCT00257192|957615|P2|STARTED|Overall Study|Includes 1 subject randomized but not treated|91
391057|NCT00257192|957616|P1|STARTED|Overall Study||193
391058|NCT00257166|957660|P2|NOT COMPLETED|Overall Study||37
391059|NCT00257166|957661|P1|NOT COMPLETED|Overall Study||53
391060|NCT00257166|957660|P2|COMPLETED|Overall Study||51
391061|NCT00257166|957661|P1|COMPLETED|Overall Study||97
391062|NCT00257166|957660|P2|Treated|Overall Study||88
391063|NCT00257166|957661|P1|Treated|Overall Study||149
391064|NCT00257166|957660|P2|STARTED|Overall Study||88
391065|NCT00257166|957661|P1|STARTED|Overall Study||150
391066|NCT00257010|957673|P1|NOT COMPLETED|Overall Study||128
391067|NCT00257010|957673|P1|COMPLETED|Overall Study||319
391068|NCT00257010|957673|P1|STARTED|Overall Study||447
391069|NCT00256997|957684|P2|NOT COMPLETED|Overall Study||55
391070|NCT00256997|957685|P1|NOT COMPLETED|Overall Study||48
391071|NCT00256997|957684|P2|COMPLETED|Overall Study||31
391072|NCT00256997|957685|P1|COMPLETED|Overall Study||33
391073|NCT00256997|957684|P2|Treated|Overall Study||86
391074|NCT00256997|957685|P1|Treated|Overall Study||79
391075|NCT00256997|957684|P2|STARTED|Overall Study||86
391076|NCT00256997|957685|P1|STARTED|Overall Study||81
391077|NCT00256984|957709|P1|NOT COMPLETED|Overall Study||16
391078|NCT00256984|957709|P1|COMPLETED|Overall Study||59
391079|NCT00256984|957709|P1|STARTED|Overall Study||75
391080|NCT00256867|957727|P8|NOT COMPLETED|Overall Study||11
391081|NCT00256867|957728|P7|NOT COMPLETED|Overall Study||5
391082|NCT00256867|957729|P6|NOT COMPLETED|Overall Study||6
391083|NCT00256867|957730|P5|NOT COMPLETED|Overall Study||7
391084|NCT00256867|957731|P4|NOT COMPLETED|Overall Study||6
391085|NCT00256867|957732|P3|NOT COMPLETED|Overall Study||5
391086|NCT00256867|957733|P2|NOT COMPLETED|Overall Study||5
391087|NCT00256867|957734|P1|NOT COMPLETED|Overall Study||2
391088|NCT00256867|957727|P8|COMPLETED|Overall Study||36
391089|NCT00256867|957728|P7|COMPLETED|Overall Study||41
391090|NCT00256867|957729|P6|COMPLETED|Overall Study||40
391091|NCT00256867|957730|P5|COMPLETED|Overall Study||41
391092|NCT00256867|957731|P4|COMPLETED|Overall Study||40
391093|NCT00256867|957732|P3|COMPLETED|Overall Study||40
391094|NCT00256867|957733|P2|COMPLETED|Overall Study||39
391095|NCT00256867|957734|P1|COMPLETED|Overall Study||45
391096|NCT00256867|957727|P8|STARTED|Overall Study||47
391097|NCT00256867|957728|P7|STARTED|Overall Study||46
391098|NCT00256867|957729|P6|STARTED|Overall Study||46
391099|NCT00256867|957730|P5|STARTED|Overall Study||48
391100|NCT00256867|957731|P4|STARTED|Overall Study||46
391101|NCT00256867|957732|P3|STARTED|Overall Study||45
391102|NCT00256867|957733|P2|STARTED|Overall Study||44
391103|NCT00256867|957734|P1|STARTED|Overall Study||47
391104|NCT00256854|957824|P6|NOT COMPLETED|Overall Study||1
391105|NCT00256854|957825|P5|NOT COMPLETED|Overall Study||1
391106|NCT00256854|957826|P4|NOT COMPLETED|Overall Study||3
391107|NCT00256854|957827|P3|NOT COMPLETED|Overall Study||3
391108|NCT00256854|957828|P2|NOT COMPLETED|Overall Study||4
391109|NCT00256854|957829|P1|NOT COMPLETED|Overall Study||3
391110|NCT00256854|957824|P6|COMPLETED|Overall Study||13
391111|NCT00256854|957825|P5|COMPLETED|Overall Study||15
391112|NCT00256854|957826|P4|COMPLETED|Overall Study||24
391113|NCT00256854|957827|P3|COMPLETED|Overall Study||23
391114|NCT00256854|957828|P2|COMPLETED|Overall Study||22
391115|NCT00256854|957829|P1|COMPLETED|Overall Study||23
391116|NCT00256854|957824|P6|STARTED|Overall Study||14
391117|NCT00256854|957825|P5|STARTED|Overall Study||16
391118|NCT00256854|957826|P4|STARTED|Overall Study||27
391119|NCT00256854|957827|P3|STARTED|Overall Study||26
391120|NCT00256854|957828|P2|STARTED|Overall Study||26
391121|NCT00256854|957829|P1|STARTED|Overall Study||26
391122|NCT00256750|957888|P3|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||28
391123|NCT00256750|957889|P2|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||30
391124|NCT00256750|957890|P1|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||47
391125|NCT00256750|957888|P3|COMPLETED|Long Term Extension (LTE; 84 Months)||127
391126|NCT00256750|957889|P2|COMPLETED|Long Term Extension (LTE; 84 Months)||136
391127|NCT00256750|957890|P1|COMPLETED|Long Term Extension (LTE; 84 Months)||89
391128|NCT00256750|957888|P3|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 3 withdrew or refused.|155
391129|NCT00256750|957889|P2|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 4 withdrew or refused.|166
391130|NCT00256750|957890|P1|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 eligible to enroll in LTE; 2 ineligible, 5 withdrew or refused|136
391131|NCT00256750|957888|P3|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
391132|NCT00256750|957889|P2|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
391133|NCT00256750|957890|P1|NOT COMPLETED|Post-Transplant Treated (36 Months)||10
391134|NCT00256750|957888|P3|COMPLETED|Post-Transplant Treated (36 Months)||158
391135|NCT00256750|957889|P2|COMPLETED|Post-Transplant Treated (36 Months)||170
391136|NCT00256750|957890|P1|COMPLETED|Post-Transplant Treated (36 Months)||143
391137|NCT00256750|957888|P3|STARTED|Post-Transplant Treated (36 Months)||164
391138|NCT00256750|957889|P2|STARTED|Post-Transplant Treated (36 Months)||176
391139|NCT00256750|957890|P1|STARTED|Post-Transplant Treated (36 Months)||153
391140|NCT00256750|957888|P3|NOT COMPLETED|Post-Transplant Treated (24 Months)||9
391141|NCT00256750|957889|P2|NOT COMPLETED|Post-Transplant Treated (24 Months)||7
391142|NCT00256750|957890|P1|NOT COMPLETED|Post-Transplant Treated (24 Months)||21
391143|NCT00256750|957888|P3|COMPLETED|Post-Transplant Treated (24 Months)||164
391144|NCT00256750|957889|P2|COMPLETED|Post-Transplant Treated (24 Months)||176
391145|NCT00256750|957890|P1|COMPLETED|Post-Transplant Treated (24 Months)||153
391146|NCT00256750|957888|P3|STARTED|Post-Transplant Treated (24 Months)||173
391147|NCT00256750|957889|P2|STARTED|Post-Transplant Treated (24 Months)||183
391148|NCT00256750|957890|P1|STARTED|Post-Transplant Treated (24 Months)||174
391149|NCT00256750|957888|P3|NOT COMPLETED|Post-Transplant Treated (12 Months)||46
391150|NCT00256750|957889|P2|NOT COMPLETED|Post-Transplant Treated (12 Months)||43
391151|NCT00256750|957890|P1|NOT COMPLETED|Post-Transplant Treated (12 Months)||41
391152|NCT00256750|957888|P3|COMPLETED|Post-Transplant Treated (12 Months)||173
391153|NCT00256750|957889|P2|COMPLETED|Post-Transplant Treated (12 Months)||183
391154|NCT00256750|957890|P1|COMPLETED|Post-Transplant Treated (12 Months)||174
391155|NCT00256750|957888|P3|STARTED|Post-Transplant Treated (12 Months)||219
391156|NCT00256750|957889|P2|STARTED|Post-Transplant Treated (12 Months)||226
391157|NCT00256750|957890|P1|STARTED|Post-Transplant Treated (12 Months)||215
391158|NCT00256750|957888|P3|NOT COMPLETED|Transplanted Pre-Treatment||0
391159|NCT00256750|957889|P2|NOT COMPLETED|Transplanted Pre-Treatment||0
391160|NCT00256750|957890|P1|NOT COMPLETED|Transplanted Pre-Treatment||6
391161|NCT00256750|957888|P3|COMPLETED|Transplanted Pre-Treatment||219
391162|NCT00256750|957889|P2|COMPLETED|Transplanted Pre-Treatment||226
391163|NCT00256750|957890|P1|COMPLETED|Transplanted Pre-Treatment||215
391164|NCT00256750|957888|P3|STARTED|Transplanted Pre-Treatment||219
391165|NCT00256750|957889|P2|STARTED|Transplanted Pre-Treatment||226
391166|NCT00256750|957890|P1|STARTED|Transplanted Pre-Treatment||221
391167|NCT00256724|958026|P2|NOT COMPLETED|Overall Study||8
391168|NCT00256724|958027|P1|NOT COMPLETED|Overall Study||5
391169|NCT00256724|958026|P2|COMPLETED|Overall Study||16
391170|NCT00256724|958027|P1|COMPLETED|Overall Study||18
391171|NCT00256724|958026|P2|STARTED|Overall Study||24
391172|NCT00256724|958027|P1|STARTED|Overall Study||23
391173|NCT00256698|958037|P2|NOT COMPLETED|Overall Study||172
391174|NCT00256698|958038|P1|NOT COMPLETED|Overall Study||167
391175|NCT00256698|958037|P2|COMPLETED|Overall Study||84
391176|NCT00256698|958038|P1|COMPLETED|Overall Study||91
391177|NCT00256698|958037|P2|STARTED|Overall Study||256
391178|NCT00256698|958038|P1|STARTED|Overall Study||258
391179|NCT00256451|958056|P4|NOT COMPLETED|Session4||0
391180|NCT00256451|958057|P3|NOT COMPLETED|Session4||0
391181|NCT00256451|958058|P2|NOT COMPLETED|Session4||0
391182|NCT00256451|958059|P1|NOT COMPLETED|Session4||0
391183|NCT00256451|958056|P4|COMPLETED|Session4||8
391184|NCT00256451|958057|P3|COMPLETED|Session4||10
391185|NCT00256451|958058|P2|COMPLETED|Session4||8
391186|NCT00256451|958059|P1|COMPLETED|Session4||9
391187|NCT00256451|958056|P4|STARTED|Session4||8
391188|NCT00256451|958057|P3|STARTED|Session4||10
391189|NCT00256451|958058|P2|STARTED|Session4||8
391190|NCT00256451|958059|P1|STARTED|Session4||9
391191|NCT00256451|958056|P4|NOT COMPLETED|Session3||0
391192|NCT00256451|958057|P3|NOT COMPLETED|Session3||0
391193|NCT00256451|958058|P2|NOT COMPLETED|Session3||0
391194|NCT00256451|958059|P1|NOT COMPLETED|Session3||0
391195|NCT00256451|958056|P4|COMPLETED|Session3||9
391196|NCT00256451|958057|P3|COMPLETED|Session3||10
391197|NCT00256451|958058|P2|COMPLETED|Session3||9
391198|NCT00256451|958059|P1|COMPLETED|Session3||9
391199|NCT00256451|958056|P4|STARTED|Session3||9
391200|NCT00256451|958057|P3|STARTED|Session3||10
391201|NCT00256451|958058|P2|STARTED|Session3||9
391202|NCT00256451|958059|P1|STARTED|Session3||9
391203|NCT00256451|958056|P4|NOT COMPLETED|Session2||0
391204|NCT00256451|958057|P3|NOT COMPLETED|Session2||0
391205|NCT00256451|958058|P2|NOT COMPLETED|Session2||0
391206|NCT00256451|958059|P1|NOT COMPLETED|Session2||0
391207|NCT00256451|958056|P4|COMPLETED|Session2||10
391208|NCT00256451|958057|P3|COMPLETED|Session2||10
391209|NCT00256451|958058|P2|COMPLETED|Session2||11
391210|NCT00256451|958059|P1|COMPLETED|Session2||9
391211|NCT00256451|958056|P4|STARTED|Session2||10
391212|NCT00256451|958057|P3|STARTED|Session2||10
391213|NCT00256451|958058|P2|STARTED|Session2||11
391214|NCT00256451|958059|P1|STARTED|Session2||9
391215|NCT00256451|958056|P4|NOT COMPLETED|Session1||0
391216|NCT00256451|958057|P3|NOT COMPLETED|Session1||0
391217|NCT00256451|958058|P2|NOT COMPLETED|Session1||0
391218|NCT00256451|958059|P1|NOT COMPLETED|Session1||0
391219|NCT00256451|958056|P4|COMPLETED|Session1||11
391220|NCT00256451|958057|P3|COMPLETED|Session1||11
391221|NCT00256451|958058|P2|COMPLETED|Session1||11
391222|NCT00256451|958059|P1|COMPLETED|Session1||10
391223|NCT00256451|958056|P4|STARTED|Session1||11
391224|NCT00256451|958057|P3|STARTED|Session1||11
391225|NCT00256451|958058|P2|STARTED|Session1||11
391226|NCT00256451|958059|P1|STARTED|Session1||10
391227|NCT00256308|958085|P1|NOT COMPLETED|Overall Study||2
391228|NCT00256308|958085|P1|COMPLETED|Overall Study||4
391229|NCT00256308|958085|P1|STARTED|Overall Study||6
391230|NCT00256295|958093|P1|NOT COMPLETED|Overall Study||4
391231|NCT00256295|958093|P1|COMPLETED|Overall Study||3
391232|NCT00256295|958093|P1|STARTED|Overall Study|Of the 8 subjects consented, 1 withdrew prior to treatment.|7
391233|NCT00256282|958099|P1|NOT COMPLETED|Overall Study||16
391234|NCT00256282|958099|P1|COMPLETED|Overall Study||36
391235|NCT00256282|958099|P1|STARTED|Overall Study||52
391236|NCT00256243|958104|P1|NOT COMPLETED|Overall Study||10
391237|NCT00256243|958104|P1|COMPLETED|Overall Study||38
391238|NCT00256243|958104|P1|STARTED|Overall Study||48
391239|NCT00256204|958113|P4|NOT COMPLETED|Overall Study||49
391240|NCT00256204|958114|P3|NOT COMPLETED|Overall Study||54
391241|NCT00256204|958115|P2|NOT COMPLETED|Overall Study||50
391242|NCT00256204|958116|P1|NOT COMPLETED|Overall Study||67
391243|NCT00256204|958113|P4|COMPLETED|Overall Study||244
391244|NCT00256204|958114|P3|COMPLETED|Overall Study||241
391245|NCT00256204|958115|P2|COMPLETED|Overall Study||238
391246|NCT00256204|958116|P1|COMPLETED|Overall Study||231
391247|NCT00256204|958113|P4|STARTED|Overall Study||293
391248|NCT00256204|958114|P3|STARTED|Overall Study||295
391249|NCT00256204|958115|P2|STARTED|Overall Study||288
391250|NCT00256204|958116|P1|STARTED|Overall Study||298
391251|NCT00256126|958131|P2|NOT COMPLETED|Overall Study||2
391252|NCT00256126|958132|P1|NOT COMPLETED|Overall Study||2
391253|NCT00256126|958131|P2|COMPLETED|Overall Study||167
391254|NCT00256126|958132|P1|COMPLETED|Overall Study||147
391255|NCT00256126|958131|P2|STARTED|Overall Study||169
391256|NCT00256126|958132|P1|STARTED|Overall Study||149
391257|NCT00255970|958150|P2|NOT COMPLETED|Overall Study||0
391258|NCT00255970|958151|P1|NOT COMPLETED|Overall Study||0
391259|NCT00255970|958150|P2|COMPLETED|Overall Study||19
391260|NCT00255970|958151|P1|COMPLETED|Overall Study||21
391261|NCT00255970|958150|P2|Final Visit Week 24|Overall Study||19
391262|NCT00255970|958151|P1|Final Visit Week 24|Overall Study||21
391263|NCT00255970|958150|P2|Screening Visit|Overall Study||19
391264|NCT00255970|958151|P1|Screening Visit|Overall Study||21
391265|NCT00255970|958150|P2|STARTED|Overall Study||19
391266|NCT00255970|958151|P1|STARTED|Overall Study||21
391267|NCT00255840|958171|P2|NOT COMPLETED|Overall Study||70
391268|NCT00255840|958172|P1|NOT COMPLETED|Overall Study||63
391269|NCT00255840|958171|P2|COMPLETED|Overall Study||334
391270|NCT00255840|958172|P1|COMPLETED|Overall Study||345
391271|NCT00255840|958171|P2|STARTED|Overall Study||404
391272|NCT00255840|958172|P1|STARTED|Overall Study||408
391273|NCT00255801|958178|P1|NOT COMPLETED|Overall Study||0
391274|NCT00255801|958178|P1|COMPLETED|Overall Study||37
391275|NCT00255801|958178|P1|STARTED|Overall Study||37
391276|NCT00255723|958185|P2|NOT COMPLETED|Overall Study||2
391277|NCT00255723|958186|P1|NOT COMPLETED|Overall Study||2
391278|NCT00255723|958185|P2|COMPLETED|Overall Study||39
391279|NCT00255723|958186|P1|COMPLETED|Overall Study||54
391280|NCT00255723|958185|P2|STARTED|Overall Study||41
391281|NCT00255723|958186|P1|STARTED|Overall Study||56
391282|NCT00255684|958192|P1|NOT COMPLETED|Overall Study||0
391283|NCT00255684|958192|P1|COMPLETED|Overall Study||16
391284|NCT00255684|958192|P1|STARTED|Overall Study||16
391285|NCT00255346|958202|P5|NOT COMPLETED|Overall Study||0
391286|NCT00255346|958203|P4|NOT COMPLETED|Overall Study||0
391287|NCT00255346|958204|P3|NOT COMPLETED|Overall Study||0
391288|NCT00255346|958205|P2|NOT COMPLETED|Overall Study||0
391289|NCT00255346|958206|P1|NOT COMPLETED|Overall Study||1
391290|NCT00255346|958202|P5|COMPLETED|Overall Study||33
391291|NCT00255346|958203|P4|COMPLETED|Overall Study||11
391292|NCT00255346|958204|P3|COMPLETED|Overall Study||8
391293|NCT00255346|958205|P2|COMPLETED|Overall Study||6
391294|NCT00255346|958206|P1|COMPLETED|Overall Study||9
391295|NCT00255346|958202|P5|STARTED|Overall Study||33
391296|NCT00255346|958203|P4|STARTED|Overall Study||11
391297|NCT00255346|958204|P3|STARTED|Overall Study||8
391298|NCT00255346|958205|P2|STARTED|Overall Study||6
391299|NCT00255346|958206|P1|STARTED|Overall Study||10
391300|NCT00255190|958221|P2|NOT COMPLETED|Overall Study||157
391301|NCT00255190|958222|P1|NOT COMPLETED|Overall Study||50
391302|NCT00255190|958221|P2|COMPLETED|Overall Study||281
391303|NCT00255190|958222|P1|COMPLETED|Overall Study||103
391304|NCT00255190|958221|P2|STARTED|Overall Study||438
391305|NCT00255190|958222|P1|STARTED|Overall Study||153
391306|NCT00255177|958290|P4|NOT COMPLETED|Overall Study||2
391307|NCT00255177|958291|P3|NOT COMPLETED|Overall Study||1
391308|NCT00255177|958292|P2|NOT COMPLETED|Overall Study||1
391309|NCT00255177|958293|P1|NOT COMPLETED|Overall Study||2
391310|NCT00255177|958290|P4|COMPLETED|Overall Study||4
391311|NCT00255177|958291|P3|COMPLETED|Overall Study||12
391312|NCT00255177|958292|P2|COMPLETED|Overall Study||13
391313|NCT00255177|958293|P1|COMPLETED|Overall Study||9
391314|NCT00255177|958290|P4|STARTED|Overall Study||6
391315|NCT00255177|958291|P3|STARTED|Overall Study||13
391316|NCT00255177|958292|P2|STARTED|Overall Study||14
391317|NCT00255177|958293|P1|STARTED|Overall Study||11
391318|NCT00255164|958306|P3|NOT COMPLETED|Overall Study||49
391319|NCT00255164|958307|P2|NOT COMPLETED|Overall Study||49
391320|NCT00255164|958308|P1|NOT COMPLETED|Overall Study||123
391321|NCT00255164|958306|P3|COMPLETED|Overall Study||103
391322|NCT00255164|958307|P2|COMPLETED|Overall Study||110
391323|NCT00255164|958308|P1|COMPLETED|Overall Study||17
391324|NCT00255164|958306|P3|STARTED|Overall Study||152
391325|NCT00255164|958307|P2|STARTED|Overall Study||159
391326|NCT00255164|958308|P1|STARTED|Overall Study||140
391327|NCT00255151|958334|P3|NOT COMPLETED|Overall Study||49
391328|NCT00255151|958335|P2|NOT COMPLETED|Overall Study||49
391329|NCT00255151|958336|P1|NOT COMPLETED|Overall Study||123
391330|NCT00255151|958334|P3|COMPLETED|Overall Study||103
391331|NCT00255151|958335|P2|COMPLETED|Overall Study||110
391332|NCT00255151|958336|P1|COMPLETED|Overall Study||17
391333|NCT00255151|958334|P3|STARTED|Overall Study||152
391334|NCT00255151|958335|P2|STARTED|Overall Study||159
391335|NCT00255151|958336|P1|STARTED|Overall Study||140
391336|NCT00255125|958361|P2|NOT COMPLETED|Overall Study||0
391337|NCT00255125|958362|P1|NOT COMPLETED|Overall Study||0
391338|NCT00255125|958361|P2|COMPLETED|Overall Study||44
391339|NCT00255125|958362|P1|COMPLETED|Overall Study||42
391340|NCT00255125|958361|P2|STARTED|Overall Study||44
391341|NCT00255125|958362|P1|STARTED|Overall Study||42
391342|NCT00255086|958374|P2|NOT COMPLETED|Overall Study||2
391343|NCT00255086|958375|P1|NOT COMPLETED|Overall Study||2
391344|NCT00255086|958374|P2|COMPLETED|Overall Study||6
391345|NCT00255086|958375|P1|COMPLETED|Overall Study||7
391346|NCT00255086|958374|P2|STARTED|Overall Study||8
391347|NCT00255086|958375|P1|STARTED|Overall Study||9
391348|NCT00255047|958387|P4|NOT COMPLETED|Overall Study||46
391349|NCT00255047|958388|P3|NOT COMPLETED|Overall Study||50
391350|NCT00255047|958389|P2|NOT COMPLETED|Overall Study||48
391351|NCT00255047|958390|P1|NOT COMPLETED|Overall Study||48
391352|NCT00255047|958387|P4|COMPLETED|Overall Study||502
391353|NCT00255047|958388|P3|COMPLETED|Overall Study||496
391354|NCT00255047|958389|P2|COMPLETED|Overall Study||487
391355|NCT00255047|958390|P1|COMPLETED|Overall Study||490
391356|NCT00255047|958387|P4|STARTED|Overall Study||548
391357|NCT00255047|958388|P3|STARTED|Overall Study||546
391358|NCT00255047|958389|P2|STARTED|Overall Study||535
391359|NCT00255047|958390|P1|STARTED|Overall Study||538
391360|NCT00255034|958414|P2|NOT COMPLETED|Overall Study||38
391361|NCT00255034|958415|P1|NOT COMPLETED|Overall Study||15
391362|NCT00255034|958414|P2|COMPLETED|Overall Study||26
391363|NCT00255034|958415|P1|COMPLETED|Overall Study||64
391364|NCT00255034|958414|P2|STARTED|Overall Study||64
391365|NCT00255034|958415|P1|STARTED|Overall Study||79
391366|NCT00255008|958425|P4|NOT COMPLETED|Overall Study||22
391367|NCT00255008|958426|P3|NOT COMPLETED|Overall Study||16
391368|NCT00255008|958427|P2|NOT COMPLETED|Overall Study||9
391369|NCT00255008|958428|P1|NOT COMPLETED|Overall Study||32
391370|NCT00255008|958425|P4|COMPLETED|Overall Study||12
391371|NCT00255008|958426|P3|COMPLETED|Overall Study||17
391372|NCT00255008|958427|P2|COMPLETED|Overall Study||0
391373|NCT00255008|958428|P1|COMPLETED|Overall Study|The study was terminated early and as a result only 42 patients completed the study.|13
391374|NCT00255008|958425|P4|STARTED|Overall Study||34
391375|NCT00255008|958426|P3|STARTED|Overall Study||33
391376|NCT00255008|958427|P2|STARTED|Overall Study||9
391377|NCT00255008|958428|P1|STARTED|Overall Study||45
391378|NCT00254995|958440|P2|NOT COMPLETED|Overall Study||0
391379|NCT00254995|958441|P1|NOT COMPLETED|Overall Study||0
391380|NCT00254995|958440|P2|COMPLETED|Overall Study||31065
391381|NCT00254995|958441|P1|COMPLETED|Overall Study||31561
391382|NCT00254995|958440|P2|STARTED|Overall Study||31065
391383|NCT00254995|958441|P1|STARTED|Overall Study||31561
391384|NCT00254982|958464|P2|NOT COMPLETED|Overall Study||31
391385|NCT00254982|958465|P1|NOT COMPLETED|Overall Study||36
391386|NCT00254982|958464|P2|COMPLETED|Overall Study||265
391387|NCT00254982|958465|P1|COMPLETED|Overall Study||261
391388|NCT00254982|958464|P2|STARTED|Overall Study||296
391389|NCT00254982|958465|P1|STARTED|Overall Study||297
391390|NCT00254592|958471|P1|NOT COMPLETED|Overall Study||2
391391|NCT00254592|958471|P1|COMPLETED|Overall Study||41
391392|NCT00254592|958471|P1|STARTED|Overall Study||43
391393|NCT00254566|958477|P2|NOT COMPLETED|Overall Study||26
391394|NCT00254566|958478|P1|NOT COMPLETED|Overall Study||31
391395|NCT00254566|958477|P2|COMPLETED|Overall Study||172
391396|NCT00254566|958478|P1|COMPLETED|Overall Study||167
391397|NCT00254566|958477|P2|STARTED|Overall Study||198
391398|NCT00254566|958478|P1|STARTED|Overall Study||198
391399|NCT00254540|958502|P2|NOT COMPLETED|Overall Study||22
391400|NCT00254540|958503|P1|NOT COMPLETED|Overall Study||19
391401|NCT00254540|958502|P2|COMPLETED|Overall Study||4
391402|NCT00254540|958503|P1|COMPLETED|Overall Study||6
391403|NCT00254540|958502|P2|STARTED|Overall Study|All 26 subjects enrolled were included in Intent-To Treat population.|26
391404|NCT00254540|958503|P1|STARTED|Overall Study|All 25 subjects enrolled were included in Intent-To Treat population.|25
391405|NCT00254501|958532|P2|NOT COMPLETED|Overall Study||1
391406|NCT00254501|958533|P1|NOT COMPLETED|Overall Study||1
391407|NCT00254501|958532|P2|COMPLETED|Overall Study||36
391408|NCT00254501|958533|P1|COMPLETED|Overall Study||31
391409|NCT00254501|958532|P2|STARTED|Overall Study||37
391410|NCT00254501|958533|P1|STARTED|Overall Study||32
391411|NCT00254488|958547|P2|NOT COMPLETED|Overall Study||49
391412|NCT00254488|958548|P1|NOT COMPLETED|Overall Study||57
391413|NCT00254488|958547|P2|COMPLETED|Overall Study||63
391414|NCT00254488|958548|P1|COMPLETED|Overall Study||55
391415|NCT00254488|958547|P2|STARTED|Overall Study||112
391416|NCT00254488|958548|P1|STARTED|Overall Study||112
391417|NCT00254462|958558|P2|NOT COMPLETED|Overall Study||10
391418|NCT00254462|958559|P1|NOT COMPLETED|Overall Study||8
391419|NCT00254462|958558|P2|COMPLETED|Overall Study||39
391420|NCT00254462|958559|P1|COMPLETED|Overall Study||36
391421|NCT00254462|958558|P2|STARTED|Overall Study||49
391422|NCT00254462|958559|P1|STARTED|Overall Study||44
391423|NCT00254410|958567|P1|NOT COMPLETED|Overall Study||0
391424|NCT00254410|958567|P1|COMPLETED|Overall Study||30
391425|NCT00254410|958567|P1|STARTED|Overall Study||30
391426|NCT00254397|958578|P4|NOT COMPLETED|Overall Study||25
391427|NCT00254397|958579|P3|NOT COMPLETED|Overall Study||19
391428|NCT00254397|958580|P2|NOT COMPLETED|Overall Study||1
391429|NCT00254397|958581|P1|NOT COMPLETED|Overall Study||6
391430|NCT00254397|958578|P4|COMPLETED|Overall Study||20
391431|NCT00254397|958579|P3|COMPLETED|Overall Study||18
391432|NCT00254397|958580|P2|COMPLETED|Overall Study||5
391433|NCT00254397|958581|P1|COMPLETED|Overall Study||4
391434|NCT00254397|958578|P4|STARTED|Overall Study||45
391435|NCT00254397|958579|P3|STARTED|Overall Study||37
391436|NCT00254397|958580|P2|STARTED|Overall Study||6
391437|NCT00254397|958581|P1|STARTED|Overall Study||10
391438|NCT00254293|958605|P7|NOT COMPLETED|LTE Open Label Fixed Dosing||13
391439|NCT00254293|958606|P6|NOT COMPLETED|LTE Open Label Fixed Dosing||0
391440|NCT00254293|958607|P5|NOT COMPLETED|LTE Open Label Fixed Dosing||0
391441|NCT00254293|958608|P4|NOT COMPLETED|LTE Open Label Fixed Dosing||0
391442|NCT00254293|958609|P3|NOT COMPLETED|LTE Open Label Fixed Dosing||0
391443|NCT00254293|958610|P2|NOT COMPLETED|LTE Open Label Fixed Dosing||0
391444|NCT00254293|958611|P1|NOT COMPLETED|LTE Open Label Fixed Dosing||0
391445|NCT00254293|958605|P7|COMPLETED|LTE Open Label Fixed Dosing||35
391446|NCT00254293|958606|P6|COMPLETED|LTE Open Label Fixed Dosing||0
391447|NCT00254293|958607|P5|COMPLETED|LTE Open Label Fixed Dosing||0
391448|NCT00254293|958608|P4|COMPLETED|LTE Open Label Fixed Dosing||0
391449|NCT00254293|958609|P3|COMPLETED|LTE Open Label Fixed Dosing||0
391450|NCT00254293|958610|P2|COMPLETED|LTE Open Label Fixed Dosing||0
391451|NCT00254293|958611|P1|COMPLETED|LTE Open Label Fixed Dosing||0
391452|NCT00254293|958605|P7|STARTED|LTE Open Label Fixed Dosing||48
391453|NCT00254293|958606|P6|STARTED|LTE Open Label Fixed Dosing||0
391454|NCT00254293|958607|P5|STARTED|LTE Open Label Fixed Dosing||0
391455|NCT00254293|958608|P4|STARTED|LTE Open Label Fixed Dosing||0
391456|NCT00254293|958609|P3|STARTED|LTE Open Label Fixed Dosing||0
391457|NCT00254293|958610|P2|STARTED|LTE Open Label Fixed Dosing||0
391458|NCT00254293|958611|P1|STARTED|LTE Open Label Fixed Dosing||0
391459|NCT00254293|958605|P7|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
391460|NCT00254293|958606|P6|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
391461|NCT00254293|958607|P5|NOT COMPLETED|LTE Open Label Variable SC Dosing||2
391462|NCT00254293|958608|P4|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
391463|NCT00254293|958609|P3|NOT COMPLETED|LTE Open Label Variable SC Dosing||10
391464|NCT00254293|958610|P2|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
391465|NCT00254293|958611|P1|NOT COMPLETED|LTE Open Label Variable SC Dosing||3
391466|NCT00254293|958605|P7|COMPLETED|LTE Open Label Variable SC Dosing||0
391467|NCT00254293|958606|P6|COMPLETED|LTE Open Label Variable SC Dosing||0
391468|NCT00254293|958607|P5|COMPLETED|LTE Open Label Variable SC Dosing||8
391469|NCT00254293|958608|P4|COMPLETED|LTE Open Label Variable SC Dosing||0
391470|NCT00254293|958609|P3|COMPLETED|LTE Open Label Variable SC Dosing||32
391471|NCT00254293|958610|P2|COMPLETED|LTE Open Label Variable SC Dosing||0
391472|NCT00254293|958611|P1|COMPLETED|LTE Open Label Variable SC Dosing||8
391473|NCT00254293|958605|P7|STARTED|LTE Open Label Variable SC Dosing|Participant rolled over from LTE (Variable Dose Period) to LTE (Fixed Dose Period).|0
391474|NCT00254293|958606|P6|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to a variable SC dose group of 75, 125 or 200 mg Weekly by body weight.|0
391475|NCT00254293|958607|P5|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to variable SC dose group (by body weight, >100kg).|10
391476|NCT00254293|958608|P4|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
391477|NCT00254293|958609|P3|STARTED|LTE Open Label Variable SC Dosing|Variable SC dose group: 125 mg Weekly, body weight <60 to >100kg (Groups 2, 3, 4 in ST Period).|42
391478|NCT00254293|958610|P2|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
391479|NCT00254293|958611|P1|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to 75mg SC dose group (by body weight, <60kg).|11
391480|NCT00254293|958605|P7|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
391481|NCT00254293|958606|P6|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
391482|NCT00254293|958607|P5|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
391483|NCT00254293|958608|P4|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
391484|NCT00254293|958609|P3|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||3
391485|NCT00254293|958610|P2|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
391486|NCT00254293|958611|P1|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
391487|NCT00254293|958605|P7|COMPLETED|Short Term (12 Week) Randomized Dosing||0
391488|NCT00254293|958606|P6|COMPLETED|Short Term (12 Week) Randomized Dosing||17
391489|NCT00254293|958607|P5|COMPLETED|Short Term (12 Week) Randomized Dosing||5
391490|NCT00254293|958608|P4|COMPLETED|Short Term (12 Week) Randomized Dosing||5
391491|NCT00254293|958609|P3|COMPLETED|Short Term (12 Week) Randomized Dosing||26
391492|NCT00254293|958610|P2|COMPLETED|Short Term (12 Week) Randomized Dosing||3
391493|NCT00254293|958611|P1|COMPLETED|Short Term (12 Week) Randomized Dosing||7
391494|NCT00254293|958605|P7|STARTED|Short Term (12 Week) Randomized Dosing||0
391495|NCT00254293|958606|P6|STARTED|Short Term (12 Week) Randomized Dosing|2, 2, 9, 2, and 2 were randomized to placebo in body weight Groups 1, 2, 3, 4, 5, respectively.|17
391496|NCT00254293|958607|P5|STARTED|Short Term (12 Week) Randomized Dosing||5
391497|NCT00254293|958608|P4|STARTED|Short Term (12 Week) Randomized Dosing||6
391498|NCT00254293|958609|P3|STARTED|Short Term (12 Week) Randomized Dosing||29
391499|NCT00254293|958610|P2|STARTED|Short Term (12 Week) Randomized Dosing||4
391500|NCT00254293|958611|P1|STARTED|Short Term (12 Week) Randomized Dosing||7
391501|NCT00254163|958694|P2|NOT COMPLETED|Overall Study||46
391502|NCT00254163|958695|P1|NOT COMPLETED|Overall Study||45
391503|NCT00254163|958694|P2|COMPLETED|Overall Study||46
391504|NCT00254163|958695|P1|COMPLETED|Overall Study||47
391505|NCT00254163|958694|P2|STARTED|Overall Study||92
391506|NCT00254163|958695|P1|STARTED|Overall Study||92
391507|NCT00254072|958719|P2|NOT COMPLETED|Overall Study||0
391508|NCT00254072|958720|P1|NOT COMPLETED|Overall Study||0
391509|NCT00254072|958719|P2|COMPLETED|Overall Study||175
391510|NCT00254072|958720|P1|COMPLETED|Overall Study||180
391511|NCT00254072|958719|P2|STARTED|Overall Study||175
391512|NCT00254072|958720|P1|STARTED|Overall Study||180
391513|NCT00253981|958728|P2|NOT COMPLETED|Overall Study||0
391514|NCT00253981|958729|P1|NOT COMPLETED|Overall Study||0
391515|NCT00253981|958728|P2|COMPLETED|Overall Study||14
391516|NCT00253981|958729|P1|COMPLETED|Overall Study||16
391517|NCT00253981|958728|P2|STARTED|Overall Study||14
391518|NCT00253981|958729|P1|STARTED|Overall Study||16
391519|NCT00253890|958737|P2|NOT COMPLETED|Overall Study||7
391520|NCT00253890|958738|P1|NOT COMPLETED|Overall Study||7
391521|NCT00253890|958737|P2|COMPLETED|Overall Study||61
391522|NCT00253890|958738|P1|COMPLETED|Overall Study||62
391523|NCT00253890|958737|P2|STARTED|Overall Study||68
391524|NCT00253890|958738|P1|STARTED|Overall Study||69
391525|NCT00253747|958746|P2|NOT COMPLETED|Overall Study||27
391526|NCT00253747|958747|P1|NOT COMPLETED|Overall Study||24
391527|NCT00253747|958746|P2|COMPLETED|Overall Study||101
391528|NCT00253747|958747|P1|COMPLETED|Overall Study||103
391529|NCT00253747|958746|P2|STARTED|Overall Study||128
391530|NCT00253747|958747|P1|STARTED|Overall Study||127
391531|NCT00253708|958768|P3|NOT COMPLETED|Overall Study||1
391532|NCT00253708|958769|P2|NOT COMPLETED|Overall Study||0
391533|NCT00253708|958770|P1|NOT COMPLETED|Overall Study||0
391534|NCT00253708|958768|P3|COMPLETED|Overall Study||8
391535|NCT00253708|958769|P2|COMPLETED|Overall Study||10
391536|NCT00253708|958770|P1|COMPLETED|Overall Study||20
391537|NCT00253708|958768|P3|STARTED|Overall Study||9
391538|NCT00253708|958769|P2|STARTED|Overall Study||10
391539|NCT00253708|958770|P1|STARTED|Overall Study||20
391540|NCT00253643|958800|P4|NOT COMPLETED|Overall Study||3
391541|NCT00253643|958801|P3|NOT COMPLETED|Overall Study||1
391542|NCT00253643|958802|P2|NOT COMPLETED|Overall Study||0
391543|NCT00253643|958803|P1|NOT COMPLETED|Overall Study||0
391544|NCT00253643|958800|P4|COMPLETED|Overall Study||28
391545|NCT00253643|958801|P3|COMPLETED|Overall Study||28
391546|NCT00253643|958802|P2|COMPLETED|Overall Study||15
391547|NCT00253643|958803|P1|COMPLETED|Overall Study||14
391548|NCT00253643|958800|P4|STARTED|Overall Study||31
391549|NCT00253643|958801|P3|STARTED|Overall Study||29
391550|NCT00253643|958802|P2|STARTED|Overall Study||15
391551|NCT00253643|958803|P1|STARTED|Overall Study||14
391552|NCT00253630|958817|P1|NOT COMPLETED|Overall Study||2
391553|NCT00253630|958817|P1|COMPLETED|Overall Study||35
391554|NCT00253630|958817|P1|STARTED|Overall Study||37
391555|NCT00253513|958826|P1|NOT COMPLETED|Overall Study||0
391556|NCT00253513|958826|P1|COMPLETED|Overall Study||60
391557|NCT00253513|958826|P1|STARTED|Overall Study||60
391558|NCT00253448|958833|P1|NOT COMPLETED|Overall Study||1
391559|NCT00253448|958833|P1|COMPLETED|Overall Study||34
391560|NCT00253448|958833|P1|STARTED|Overall Study||35
391561|NCT00253435|958839|P2|NOT COMPLETED|Overall Study||0
391562|NCT00253435|958840|P1|NOT COMPLETED|Overall Study||0
391563|NCT00253435|958839|P2|COMPLETED|Overall Study|Eight evaluable patients enrolled.|8
391564|NCT00253435|958840|P1|COMPLETED|Overall Study|Forty-two evaluable poor risk patients enrolled.|42
391565|NCT00253435|958839|P2|3rd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
391566|NCT00253435|958840|P1|3rd Interim Analysis|Overall Study|Third interim analysis: need 4+ responses in first 35 patients. Goal met study continued.|10
391567|NCT00253435|958839|P2|2nd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
391568|NCT00253435|958840|P1|2nd Interim Analysis|Overall Study|Second interim analysis: need 3+ responses in first 25 patients. Goal met study continued.|10
391569|NCT00253435|958839|P2|1st Interim Analysis|Overall Study|Only interim analysis: need 1+ response in first 10 patients.|8
391570|NCT00253435|958840|P1|1st Interim Analysis|Overall Study|First interim analysis: need 2+ responses in first 15 patients. Goal met study continued.|15
391571|NCT00253435|958839|P2|STARTED|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|8
391572|NCT00253435|958840|P1|STARTED|Overall Study|Total number is 42|42
391573|NCT00253370|958852|P1|NOT COMPLETED|Overall Study||43
391574|NCT00253370|958852|P1|COMPLETED|Overall Study||1
391575|NCT00253370|958852|P1|STARTED|Overall Study||44
391576|NCT00253019|958861|P3|NOT COMPLETED|Overall Study||18
391577|NCT00253019|958862|P2|NOT COMPLETED|Overall Study||31
391578|NCT00253019|958863|P1|NOT COMPLETED|Overall Study||29
391579|NCT00253019|958861|P3|COMPLETED|Overall Study||83
391580|NCT00253019|958862|P2|COMPLETED|Overall Study||78
391581|NCT00253019|958863|P1|COMPLETED|Overall Study||82
391582|NCT00253019|958861|P3|STARTED|Overall Study||101
391583|NCT00253019|958862|P2|STARTED|Overall Study||109
391584|NCT00253019|958863|P1|STARTED|Overall Study||111
391585|NCT00252967|958873|P2|NOT COMPLETED|Overall Study||0
391586|NCT00252967|958874|P1|NOT COMPLETED|Overall Study||0
391587|NCT00252967|958873|P2|COMPLETED|Overall Study||33
391588|NCT00252967|958874|P1|COMPLETED|Overall Study||31
391589|NCT00252967|958873|P2|STARTED|Overall Study||33
391590|NCT00252967|958874|P1|STARTED|Overall Study||31
391591|NCT00252733|958898|P2|NOT COMPLETED|Overall Study||92
391592|NCT00252733|958899|P1|NOT COMPLETED|Overall Study||106
391593|NCT00252733|958898|P2|COMPLETED|Overall Study||618
391594|NCT00252733|958899|P1|COMPLETED|Overall Study||605
391595|NCT00252733|958898|P2|STARTED|Overall Study||710
391596|NCT00252733|958899|P1|STARTED|Overall Study||711
391597|NCT00252720|958909|P2|NOT COMPLETED|Overall Study||165
391598|NCT00252720|958910|P1|NOT COMPLETED|Overall Study||132
391599|NCT00252720|958909|P2|COMPLETED|Overall Study||789
391600|NCT00252720|958910|P1|COMPLETED|Overall Study||819
391601|NCT00252720|958909|P2|STARTED|Overall Study||954
391602|NCT00252720|958910|P1|STARTED|Overall Study||951
391603|NCT00252694|958924|P2|NOT COMPLETED|Overall Study||154
391604|NCT00252694|958925|P1|NOT COMPLETED|Overall Study||144
391605|NCT00252694|958924|P2|COMPLETED|Overall Study||800
391606|NCT00252694|958925|P1|COMPLETED|Overall Study||807
391607|NCT00252694|958924|P2|STARTED|Overall Study||954
391608|NCT00252694|958925|P1|STARTED|Overall Study||951
391609|NCT00252629|958940|P3|NOT COMPLETED|Overall Study||0
391610|NCT00252629|958941|P2|NOT COMPLETED|Overall Study||0
391611|NCT00252629|958942|P1|NOT COMPLETED|Overall Study||1
391612|NCT00252629|958940|P3|COMPLETED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
391613|NCT00252629|958941|P2|COMPLETED|Overall Study||9
391614|NCT00252629|958942|P1|COMPLETED|Overall Study|One participant assigned to therapeutic CPAP was excluded from the trial before starting treatment.|8
391615|NCT00252629|958940|P3|STARTED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
391616|NCT00252629|958941|P2|STARTED|Overall Study||9
391617|NCT00252629|958942|P1|STARTED|Overall Study||9
391618|NCT00252590|958958|P3|NOT COMPLETED|Overall Study||3
391619|NCT00252590|958959|P2|NOT COMPLETED|Overall Study||2
391620|NCT00252590|958960|P1|NOT COMPLETED|Overall Study||2
391621|NCT00252590|958958|P3|COMPLETED|Overall Study||31
391622|NCT00252590|958959|P2|COMPLETED|Overall Study||28
391623|NCT00252590|958960|P1|COMPLETED|Overall Study||33
391624|NCT00252590|958958|P3|STARTED|Overall Study||34
391625|NCT00252590|958959|P2|STARTED|Overall Study||30
391626|NCT00252590|958960|P1|STARTED|Overall Study||35
391627|NCT00252564|958973|P2|NOT COMPLETED|Overall Study||44
391628|NCT00252564|958974|P1|NOT COMPLETED|Overall Study||39
391629|NCT00252564|958973|P2|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|79
391630|NCT00252564|958974|P1|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|85
391631|NCT00252564|958973|P2|STARTED|Overall Study|From randomization|123
391632|NCT00252564|958974|P1|STARTED|Overall Study|From randomization|124
391633|NCT00252538|958986|P2|NOT COMPLETED|Overall Study||0
391634|NCT00252538|958987|P1|NOT COMPLETED|Overall Study||0
391635|NCT00252538|958986|P2|COMPLETED|Overall Study||114
391636|NCT00252538|958987|P1|COMPLETED|Overall Study||19
391637|NCT00252538|958986|P2|STARTED|Overall Study||114
391638|NCT00252538|958987|P1|STARTED|Overall Study||19
391639|NCT00252512|958994|P2|NOT COMPLETED|12 Month Follow up||1
391640|NCT00252512|958995|P1|NOT COMPLETED|12 Month Follow up||9
391641|NCT00252512|958994|P2|COMPLETED|12 Month Follow up||121
391642|NCT00252512|958995|P1|COMPLETED|12 Month Follow up||123
391643|NCT00252512|958994|P2|STARTED|12 Month Follow up||122
391644|NCT00252512|958995|P1|STARTED|12 Month Follow up||132
391645|NCT00252512|958994|P2|NOT COMPLETED|Six Month Follow up||12
391646|NCT00252512|958995|P1|NOT COMPLETED|Six Month Follow up||4
391647|NCT00252512|958994|P2|COMPLETED|Six Month Follow up||122
391648|NCT00252512|958995|P1|COMPLETED|Six Month Follow up||132
391649|NCT00252512|958994|P2|STARTED|Six Month Follow up||134
391650|NCT00252512|958995|P1|STARTED|Six Month Follow up||136
391651|NCT00252512|958994|P2|NOT COMPLETED|Intervention||31
391652|NCT00252512|958995|P1|NOT COMPLETED|Intervention||29
391653|NCT00252512|958994|P2|COMPLETED|Intervention||134
391654|NCT00252512|958995|P1|COMPLETED|Intervention||136
391655|NCT00252512|958994|P2|STARTED|Intervention||165
391656|NCT00252512|958995|P1|STARTED|Intervention||165
391657|NCT00252499|959014|P3|NOT COMPLETED|Overall Study||0
391658|NCT00252499|959015|P2|NOT COMPLETED|Overall Study||0
391659|NCT00252499|959016|P1|NOT COMPLETED|Overall Study||1
391660|NCT00252499|959014|P3|COMPLETED|Overall Study||6
391661|NCT00252499|959015|P2|COMPLETED|Overall Study||2
391662|NCT00252499|959016|P1|COMPLETED|Overall Study||4
391663|NCT00252499|959014|P3|STARTED|Overall Study||6
391664|NCT00252499|959015|P2|STARTED|Overall Study||2
391665|NCT00252499|959016|P1|STARTED|Overall Study||5
391666|NCT00252382|959039|P1|NOT COMPLETED|Overall Study||26
391667|NCT00252382|959039|P1|COMPLETED|Overall Study||5
391668|NCT00252382|959039|P1|STARTED|Overall Study||31
391669|NCT00252239|959048|P4|NOT COMPLETED|Overall Study||1
391670|NCT00252239|959049|P3|NOT COMPLETED|Overall Study||2
391671|NCT00252239|959050|P2|NOT COMPLETED|Overall Study||0
391672|NCT00252239|959051|P1|NOT COMPLETED|Overall Study||1
391673|NCT00252239|959048|P4|COMPLETED|Overall Study||30
391674|NCT00252239|959049|P3|COMPLETED|Overall Study||17
391675|NCT00252239|959050|P2|COMPLETED|Overall Study||31
391676|NCT00252239|959051|P1|COMPLETED|Overall Study||30
391677|NCT00252239|959048|P4|STARTED|Overall Study||31
391678|NCT00252239|959049|P3|STARTED|Overall Study||19
391679|NCT00252239|959050|P2|STARTED|Overall Study||31
391680|NCT00252239|959051|P1|STARTED|Overall Study||31
391681|NCT00252187|959063|P2|NOT COMPLETED|Overall Study||1
391682|NCT00252187|959064|P1|NOT COMPLETED|Overall Study||4
391683|NCT00252187|959063|P2|COMPLETED|Overall Study||20
391684|NCT00252187|959064|P1|COMPLETED|Overall Study||20
391685|NCT00252187|959063|P2|STARTED|Overall Study||21
391686|NCT00252187|959064|P1|STARTED|Overall Study||24
391687|NCT00252174|959087|P3|NOT COMPLETED|Overall Study||0
391688|NCT00252174|959088|P2|NOT COMPLETED|Overall Study||1
391689|NCT00252174|959089|P1|NOT COMPLETED|Overall Study||0
391690|NCT00252174|959087|P3|COMPLETED|Overall Study||0
391691|NCT00252174|959088|P2|COMPLETED|Overall Study||1
391692|NCT00252174|959089|P1|COMPLETED|Overall Study||0
391693|NCT00252174|959087|P3|STARTED|Overall Study|No subjects entered Stage 2|0
391694|NCT00252174|959088|P2|STARTED|Overall Study|2 subjects entered the control arm in total|2
391695|NCT00252174|959089|P1|STARTED|Overall Study|No subjects were randomized into Active Arm as only 2 subjects were randomized into the Control Arm.|0
391696|NCT00252057|959129|P2|NOT COMPLETED|Overall Study||8
391697|NCT00252057|959130|P1|NOT COMPLETED|Overall Study||3
391698|NCT00252057|959129|P2|COMPLETED|Overall Study||368
391699|NCT00252057|959130|P1|COMPLETED|Overall Study||370
391700|NCT00252057|959129|P2|STARTED|Overall Study||376
391701|NCT00252057|959130|P1|STARTED|Overall Study||373
391702|NCT00251979|959138|P2|NOT COMPLETED|Overall Study||40
391703|NCT00251979|959139|P1|NOT COMPLETED|Overall Study||38
391704|NCT00251979|959138|P2|COMPLETED|Overall Study||349
391705|NCT00251979|959139|P1|COMPLETED|Overall Study||337
391706|NCT00251979|959138|P2|STARTED|Overall Study|ITT population|389
391707|NCT00251979|959139|P1|STARTED|Overall Study|ITT population|375
391708|NCT00251927|959171|P2|NOT COMPLETED|Overall Study||74
391709|NCT00251927|959172|P1|NOT COMPLETED|Overall Study||108
391710|NCT00251927|959171|P2|COMPLETED|Overall Study|Completed 5 year visit|192
391711|NCT00251927|959172|P1|COMPLETED|Overall Study|Completed 5 year visit|180
391712|NCT00251927|959171|P2|STARTED|Overall Study|Randomised|266
391713|NCT00251927|959172|P1|STARTED|Overall Study|Randomised|288
391714|NCT00251862|959202|P3|NOT COMPLETED|Overall Study||0
391715|NCT00251862|959203|P2|NOT COMPLETED|Overall Study||0
391716|NCT00251862|959204|P1|NOT COMPLETED|Overall Study||0
391717|NCT00251862|959202|P3|COMPLETED|Overall Study||276
391718|NCT00251862|959203|P2|COMPLETED|Overall Study||269
391719|NCT00251862|959204|P1|COMPLETED|Overall Study||280
391720|NCT00251862|959202|P3|STARTED|Overall Study||276
391721|NCT00251862|959203|P2|STARTED|Overall Study||269
391722|NCT00251862|959204|P1|STARTED|Overall Study||280
391723|NCT00251758|959224|P3|NOT COMPLETED|Overall Study||27
391724|NCT00251758|959225|P2|NOT COMPLETED|Overall Study||27
391725|NCT00251758|959226|P1|NOT COMPLETED|Overall Study||28
391726|NCT00251758|959224|P3|COMPLETED|Overall Study||277
391727|NCT00251758|959225|P2|COMPLETED|Overall Study||285
391728|NCT00251758|959226|P1|COMPLETED|Overall Study||264
391729|NCT00251758|959224|P3|STARTED|Overall Study||304
391730|NCT00251758|959225|P2|STARTED|Overall Study||312
391731|NCT00251758|959226|P1|STARTED|Overall Study||292
391732|NCT00251745|959246|P3|NOT COMPLETED|Overall Study||27
391733|NCT00251745|959247|P2|NOT COMPLETED|Overall Study||27
391734|NCT00251745|959248|P1|NOT COMPLETED|Overall Study||28
391735|NCT00251745|959246|P3|COMPLETED|Overall Study||277
391736|NCT00251745|959247|P2|COMPLETED|Overall Study||285
391737|NCT00251745|959248|P1|COMPLETED|Overall Study||264
391738|NCT00251745|959246|P3|STARTED|Overall Study||304
391739|NCT00251745|959247|P2|STARTED|Overall Study||312
391740|NCT00251745|959248|P1|STARTED|Overall Study||292
391741|NCT00251719|959268|P3|NOT COMPLETED|Overall Study||30
391742|NCT00251719|959269|P2|NOT COMPLETED|Overall Study||45
391743|NCT00251719|959270|P1|NOT COMPLETED|Overall Study||53
391744|NCT00251719|959268|P3|COMPLETED|Overall Study||643
391745|NCT00251719|959269|P2|COMPLETED|Overall Study||642
391746|NCT00251719|959270|P1|COMPLETED|Overall Study||641
391747|NCT00251719|959268|P3|STARTED|Overall Study||673
391748|NCT00251719|959269|P2|STARTED|Overall Study||687
391749|NCT00251719|959270|P1|STARTED|Overall Study||694
391750|NCT00251693|959296|P3|NOT COMPLETED|Overall Study||46
391751|NCT00251693|959297|P2|NOT COMPLETED|Overall Study||44
391752|NCT00251693|959298|P1|NOT COMPLETED|Overall Study||51
391753|NCT00251693|959296|P3|COMPLETED|Overall Study||644
391754|NCT00251693|959297|P2|COMPLETED|Overall Study||624
391755|NCT00251693|959298|P1|COMPLETED|Overall Study||629
391756|NCT00251693|959296|P3|STARTED|Overall Study||690
391757|NCT00251693|959297|P2|STARTED|Overall Study||668
391758|NCT00251693|959298|P1|STARTED|Overall Study||680
391759|NCT00251641|959323|P2|NOT COMPLETED|Overall Study||88
391760|NCT00251641|959324|P1|NOT COMPLETED|Overall Study||112
391761|NCT00251641|959323|P2|COMPLETED|Overall Study||127
391762|NCT00251641|959324|P1|COMPLETED|Overall Study||541
391763|NCT00251641|959323|P2|STARTED|Overall Study||215
391764|NCT00251641|959324|P1|STARTED|Overall Study||653
391765|NCT00251589|959342|P4|NOT COMPLETED|Overall Study||2
391766|NCT00251589|959343|P3|NOT COMPLETED|Overall Study||2
391767|NCT00251589|959344|P2|NOT COMPLETED|Overall Study||3
391768|NCT00251589|959345|P1|NOT COMPLETED|Overall Study||15
391769|NCT00251589|959342|P4|COMPLETED|Overall Study||0
391770|NCT00251589|959343|P3|COMPLETED|Overall Study||0
391771|NCT00251589|959344|P2|COMPLETED|Overall Study||0
391772|NCT00251589|959345|P1|COMPLETED|Overall Study||1
391773|NCT00251589|959342|P4|STARTED|Overall Study||2
391774|NCT00251589|959343|P3|STARTED|Overall Study||2
391775|NCT00251589|959344|P2|STARTED|Overall Study||3
391776|NCT00251589|959345|P1|STARTED|Overall Study|4 of the 16 patients participated in Phase I and II portions. 12 participated in Phase II only.|16
391777|NCT00251316|959382|P2|NOT COMPLETED|Overall Study||3
391778|NCT00251316|959383|P1|NOT COMPLETED|Overall Study||2
391779|NCT00251316|959382|P2|COMPLETED|Overall Study||14
391780|NCT00251316|959383|P1|COMPLETED|Overall Study||15
391781|NCT00251316|959382|P2|STARTED|Overall Study||17
391782|NCT00251316|959383|P1|STARTED|Overall Study||17
391783|NCT00251303|959391|P2|NOT COMPLETED|Overall Study||1
391784|NCT00251303|959392|P1|NOT COMPLETED|Overall Study||8
391785|NCT00251303|959391|P2|COMPLETED|Overall Study||29
391786|NCT00251303|959392|P1|COMPLETED|Overall Study||22
391787|NCT00251303|959391|P2|STARTED|Overall Study||30
391788|NCT00251303|959392|P1|STARTED|Overall Study|78 subjects signed any consent. 60 started drug (30 riluzole & 30 placebo).|30
391789|NCT00251238|959402|P2|NOT COMPLETED|Overall Study||0
391790|NCT00251238|959403|P1|NOT COMPLETED|Overall Study||0
391791|NCT00251238|959402|P2|COMPLETED|Overall Study||20
391792|NCT00251238|959403|P1|COMPLETED|Overall Study||21
391793|NCT00251238|959402|P2|STARTED|Overall Study||20
391794|NCT00251238|959403|P1|STARTED|Overall Study||21
391795|NCT00251225|959413|P1|NOT COMPLETED|Overall Study||0
391796|NCT00251225|959413|P1|COMPLETED|Overall Study||49
391797|NCT00251225|959413|P1|STARTED|Overall Study||49
391798|NCT00251004|959422|P3|NOT COMPLETED|Overall Study||31
391799|NCT00251004|959423|P2|NOT COMPLETED|Overall Study||41
391800|NCT00251004|959424|P1|NOT COMPLETED|Overall Study||45
391801|NCT00251004|959422|P3|COMPLETED|Overall Study||246
391802|NCT00251004|959423|P2|COMPLETED|Overall Study||238
391803|NCT00251004|959424|P1|COMPLETED|Overall Study||232
391804|NCT00251004|959422|P3|24 Month Analysis|Overall Study|Under 24 month analysis under group 3, 185 Completed study medication.|246
391805|NCT00251004|959423|P2|24 Month Analysis|Overall Study|Under 24 month analysis under group 2, 161 Completed study medication.|238
391806|NCT00251004|959424|P1|24 Month Analysis|Overall Study|Under 24 month analysis under group 1, 167 Completed study medication.|232
391807|NCT00251004|959422|P3|12 Month Analysis|Overall Study|Under 12 month analysis under group 3, 200 Completed study medication.|253
391808|NCT00251004|959423|P2|12 Month Analysis|Overall Study|Under 12 month analysis under group 2, 175 Completed study medication.|249
391809|NCT00251004|959424|P1|12 Month Analysis|Overall Study|Under 12 month analysis under group 1, 179 Completed study medication.|241
391810|NCT00251004|959422|P3|STARTED|Overall Study||277
391811|NCT00251004|959423|P2|STARTED|Overall Study||279
391812|NCT00251004|959424|P1|STARTED|Overall Study||277
391813|NCT00250926|959441|P1|NOT COMPLETED|Overall Study||0
391814|NCT00250926|959441|P1|COMPLETED|Overall Study||23
391815|NCT00250926|959441|P1|STARTED|Overall Study||23
391816|NCT00250835|959448|P1|NOT COMPLETED|Overall Study||1
391817|NCT00250835|959448|P1|COMPLETED|Overall Study||37
391818|NCT00250835|959448|P1|STARTED|Overall Study||38
391819|NCT00250718|959457|P1|NOT COMPLETED|Overall Study||3
391820|NCT00250718|959457|P1|COMPLETED|Overall Study||14
391821|NCT00250718|959457|P1|Received Treatment|Overall Study||16
391822|NCT00250718|959457|P1|STARTED|Overall Study||17
391823|NCT00250705|959462|P1|NOT COMPLETED|Overall Study||2
391824|NCT00250705|959462|P1|COMPLETED|Overall Study||10
391825|NCT00250705|959462|P1|STARTED|Overall Study||12
391826|NCT00250679|959473|P3|NOT COMPLETED|Overall Study||44
391827|NCT00250679|959474|P2|NOT COMPLETED|Overall Study||49
391828|NCT00250679|959475|P1|NOT COMPLETED|Overall Study||39
391829|NCT00250679|959473|P3|COMPLETED|Overall Study||103
391830|NCT00250679|959474|P2|COMPLETED|Overall Study||100
391831|NCT00250679|959475|P1|COMPLETED|Overall Study||108
391832|NCT00250679|959473|P3|STARTED|Overall Study||147
391833|NCT00250679|959474|P2|STARTED|Overall Study||149
391834|NCT00250679|959475|P1|STARTED|Overall Study||147
391835|NCT00250588|959576|P3|NOT COMPLETED|Overall Study||13
391836|NCT00250588|959577|P2|NOT COMPLETED|Overall Study||19
391837|NCT00250588|959578|P1|NOT COMPLETED|Overall Study||9
391838|NCT00250588|959576|P3|COMPLETED|Overall Study||74
391839|NCT00250588|959577|P2|COMPLETED|Overall Study||65
391840|NCT00250588|959578|P1|COMPLETED|Overall Study||72
391841|NCT00250588|959576|P3|STARTED|Overall Study||87
391842|NCT00250588|959577|P2|STARTED|Overall Study||84
391843|NCT00250588|959578|P1|STARTED|Overall Study||81
391844|NCT00250497|959594|P2|NOT COMPLETED|Overall Study||15
391845|NCT00250497|959595|P1|NOT COMPLETED|Overall Study||5
391846|NCT00250497|959594|P2|COMPLETED|Overall Study||159
391847|NCT00250497|959595|P1|COMPLETED|Overall Study||177
391848|NCT00250497|959594|P2|STARTED|Overall Study||174
391849|NCT00250497|959595|P1|STARTED|Overall Study||182
391850|NCT00250484|959613|P2|NOT COMPLETED|Overall Study||0
391851|NCT00250484|959614|P1|NOT COMPLETED|Overall Study||0
391852|NCT00250484|959613|P2|COMPLETED|Overall Study||8
391853|NCT00250484|959614|P1|COMPLETED|Overall Study||9
391854|NCT00250484|959613|P2|STARTED|Overall Study||8
391855|NCT00250484|959614|P1|STARTED|Overall Study||9
391856|NCT00250458|959626|P2|NOT COMPLETED|Overall Study||17
391857|NCT00250458|959627|P1|NOT COMPLETED|Overall Study||32
391858|NCT00250458|959626|P2|COMPLETED|Overall Study||97
391859|NCT00250458|959627|P1|COMPLETED|Overall Study||200
391860|NCT00250458|959626|P2|STARTED|Overall Study||114
391861|NCT00250458|959627|P1|STARTED|Overall Study||232
391862|NCT00250432|959637|P2|NOT COMPLETED|Overall Study||47
391863|NCT00250432|959638|P1|NOT COMPLETED|Overall Study||45
391864|NCT00250432|959637|P2|COMPLETED|Overall Study||53
391865|NCT00250432|959638|P1|COMPLETED|Overall Study||59
391866|NCT00250432|959637|P2|STARTED|Overall Study||100
391867|NCT00250432|959638|P1|STARTED|Overall Study||104
391868|NCT00250276|959650|P4|NOT COMPLETED|Overall Study||19
391869|NCT00250276|959651|P3|NOT COMPLETED|Overall Study||19
391870|NCT00250276|959652|P2|NOT COMPLETED|Overall Study||21
391871|NCT00250276|959653|P1|NOT COMPLETED|Overall Study||17
391872|NCT00250276|959650|P4|COMPLETED|Overall Study||181
391873|NCT00250276|959651|P3|COMPLETED|Overall Study||182
391874|NCT00250276|959652|P2|COMPLETED|Overall Study||177
391875|NCT00250276|959653|P1|COMPLETED|Overall Study||182
391876|NCT00250276|959650|P4|STARTED|Overall Study||200
391877|NCT00250276|959651|P3|STARTED|Overall Study||201
391878|NCT00250276|959652|P2|STARTED|Overall Study||198
391879|NCT00250276|959653|P1|STARTED|Overall Study||199
391880|NCT00249873|959733|P2|NOT COMPLETED|Overall Study||1254
391881|NCT00249873|959734|P1|NOT COMPLETED|Overall Study||1330
391882|NCT00249873|959733|P2|COMPLETED|Overall Study|started and completed study drug|2528
391883|NCT00249873|959734|P1|COMPLETED|Overall Study|started and completed study drug|2442
391884|NCT00249873|959733|P2|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3782
391885|NCT00249873|959734|P1|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3772
391886|NCT00249834|959754|P8|NOT COMPLETED|Overall Study||0
391887|NCT00249834|959755|P7|NOT COMPLETED|Overall Study||1
391888|NCT00249834|959756|P6|NOT COMPLETED|Overall Study||2
391889|NCT00249834|959757|P5|NOT COMPLETED|Overall Study||5
391890|NCT00249834|959758|P4|NOT COMPLETED|Overall Study||8
391891|NCT00249834|959759|P3|NOT COMPLETED|Overall Study||14
391892|NCT00249834|959760|P2|NOT COMPLETED|Overall Study||19
391893|NCT00249834|959761|P1|NOT COMPLETED|Overall Study||1
391894|NCT00249834|959754|P8|COMPLETED|Overall Study||2
391895|NCT00249834|959755|P7|COMPLETED|Overall Study||1
391896|NCT00249834|959756|P6|COMPLETED|Overall Study||8
391897|NCT00249834|959757|P5|COMPLETED|Overall Study||19
391898|NCT00249834|959758|P4|COMPLETED|Overall Study||26
391899|NCT00249834|959759|P3|COMPLETED|Overall Study||31
391900|NCT00249834|959760|P2|COMPLETED|Overall Study||29
391901|NCT00249834|959761|P1|COMPLETED|Overall Study||0
391902|NCT00249834|959754|P8|STARTED|Overall Study||2
391903|NCT00249834|959755|P7|STARTED|Overall Study||2
391904|NCT00249834|959756|P6|STARTED|Overall Study||10
391905|NCT00249834|959757|P5|STARTED|Overall Study||24
391906|NCT00249834|959758|P4|STARTED|Overall Study||34
391907|NCT00249834|959759|P3|STARTED|Overall Study||45
391908|NCT00249834|959760|P2|STARTED|Overall Study||48
391909|NCT00249834|959761|P1|STARTED|Overall Study||1
391910|NCT00249821|959810|P2|NOT COMPLETED|Overall Study||1
391911|NCT00249821|959811|P1|NOT COMPLETED|Overall Study||0
391912|NCT00249821|959810|P2|COMPLETED|Overall Study||11
391913|NCT00249821|959811|P1|COMPLETED|Overall Study||10
391914|NCT00249821|959810|P2|STARTED|Overall Study||12
391915|NCT00249821|959811|P1|STARTED|Overall Study||10
391916|NCT00249808|959831|P1|NOT COMPLETED|Overall Study||182
391917|NCT00249808|959831|P1|COMPLETED|Overall Study||1084
391918|NCT00249808|959831|P1|STARTED|Overall Study||1266
391919|NCT00249795|959839|P2|NOT COMPLETED|Overall Study||1390
391920|NCT00249795|959840|P1|NOT COMPLETED|Overall Study||1394
391921|NCT00249795|959839|P2|COMPLETED|Overall Study|started and completed study drug|3108
391922|NCT00249795|959840|P1|COMPLETED|Overall Study|started and completed study drug|3124
391923|NCT00249795|959839|P2|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4498
391924|NCT00249795|959840|P1|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4518
391925|NCT00249613|959860|P2|NOT COMPLETED|12 Month Follow-up||15
391926|NCT00249613|959861|P1|NOT COMPLETED|12 Month Follow-up||17
391927|NCT00249613|959860|P2|COMPLETED|12 Month Follow-up||124
391928|NCT00249613|959861|P1|COMPLETED|12 Month Follow-up||135
391929|NCT00249613|959860|P2|STARTED|12 Month Follow-up||139
391930|NCT00249613|959861|P1|STARTED|12 Month Follow-up||152
391931|NCT00249613|959860|P2|NOT COMPLETED|Baseline||0
391932|NCT00249613|959861|P1|NOT COMPLETED|Baseline||0
391933|NCT00249613|959860|P2|COMPLETED|Baseline||139
391934|NCT00249613|959861|P1|COMPLETED|Baseline||152
391935|NCT00249613|959860|P2|STARTED|Baseline||139
391936|NCT00249613|959861|P1|STARTED|Baseline||152
391937|NCT00249496|959872|P2|NOT COMPLETED|Overall Study||1
391938|NCT00249496|959873|P1|NOT COMPLETED|Overall Study||0
391939|NCT00249496|959872|P2|COMPLETED|Overall Study||26
391940|NCT00249496|959873|P1|COMPLETED|Overall Study||24
391941|NCT00249496|959872|P2|STARTED|Overall Study||27
391942|NCT00249496|959873|P1|STARTED|Overall Study||24
391943|NCT00249470|959889|P2|NOT COMPLETED|Overall Study||0
391944|NCT00249470|959890|P1|NOT COMPLETED|Overall Study||0
391945|NCT00249470|959889|P2|COMPLETED|Overall Study||28
391946|NCT00249470|959890|P1|COMPLETED|Overall Study||28
391947|NCT00249470|959889|P2|STARTED|Overall Study||28
391948|NCT00249470|959890|P1|STARTED|Overall Study||28
391949|NCT00249444|959902|P2|NOT COMPLETED|Overall Study||15
391950|NCT00249444|959903|P1|NOT COMPLETED|Overall Study||12
391951|NCT00249444|959902|P2|COMPLETED|Overall Study||29
391952|NCT00249444|959903|P1|COMPLETED|Overall Study||30
391953|NCT00249444|959902|P2|STARTED|Overall Study||44
391954|NCT00249444|959903|P1|STARTED|Overall Study||42
391955|NCT00249379|959913|P2|NOT COMPLETED|Overall Study||8
391956|NCT00249379|959914|P1|NOT COMPLETED|Overall Study||8
391957|NCT00249379|959913|P2|COMPLETED|Overall Study||4
391958|NCT00249379|959914|P1|COMPLETED|Overall Study||6
391959|NCT00249379|959913|P2|STARTED|Overall Study||12
391960|NCT00249379|959914|P1|STARTED|Overall Study||14
391961|NCT00249288|959928|P2|NOT COMPLETED|Overall Study||5
391962|NCT00249288|959929|P1|NOT COMPLETED|Overall Study||5
391963|NCT00249288|959928|P2|COMPLETED|Overall Study||14
391964|NCT00249288|959929|P1|COMPLETED|Overall Study||14
391965|NCT00249288|959928|P2|Initiated Treatment|Overall Study||15
391966|NCT00249288|959929|P1|Initiated Treatment|Overall Study||17
391967|NCT00249288|959928|P2|STARTED|Overall Study||19
391968|NCT00249288|959929|P1|STARTED|Overall Study||19
391969|NCT00249249|959964|P4|NOT COMPLETED|Overall Study||3
391970|NCT00249249|959965|P3|NOT COMPLETED|Overall Study||15
391971|NCT00249249|959966|P2|NOT COMPLETED|Overall Study||5
391972|NCT00249249|959967|P1|NOT COMPLETED|Overall Study||20
391973|NCT00249249|959964|P4|COMPLETED|Overall Study||100
391974|NCT00249249|959965|P3|COMPLETED|Overall Study||288
391975|NCT00249249|959966|P2|COMPLETED|Overall Study||98
391976|NCT00249249|959967|P1|COMPLETED|Overall Study||301
391977|NCT00249249|959964|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|103
391978|NCT00249249|959965|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|300
391979|NCT00249249|959966|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|102
391980|NCT00249249|959967|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|316
391981|NCT00249249|959964|P4|STARTED|Overall Study||103
391982|NCT00249249|959965|P3|STARTED|Overall Study||303
391983|NCT00249249|959966|P2|STARTED|Overall Study||103
391984|NCT00249249|959967|P1|STARTED|Overall Study||321
391985|NCT00249002|960021|P1|NOT COMPLETED|Overall Study||7
391986|NCT00249002|960021|P1|COMPLETED|Overall Study||2
391987|NCT00249002|960021|P1|STARTED|Overall Study||9
391988|NCT00248833|960040|P3|NOT COMPLETED|Overall Study||2
391989|NCT00248833|960041|P2|NOT COMPLETED|Overall Study||3
391990|NCT00248833|960042|P1|NOT COMPLETED|Overall Study||3
391991|NCT00248833|960040|P3|COMPLETED|Overall Study||9
391992|NCT00248833|960041|P2|COMPLETED|Overall Study||8
391993|NCT00248833|960042|P1|COMPLETED|Overall Study||9
391994|NCT00248833|960040|P3|STARTED|Overall Study||11
391995|NCT00248833|960041|P2|STARTED|Overall Study||11
391996|NCT00248833|960042|P1|STARTED|Overall Study||12
391997|NCT00248807|960060|P2|NOT COMPLETED|Overall Study||0
391998|NCT00248807|960061|P1|NOT COMPLETED|Overall Study||0
391999|NCT00248807|960060|P2|COMPLETED|Overall Study||11
392000|NCT00248807|960061|P1|COMPLETED|Overall Study||19
392001|NCT00248807|960060|P2|STARTED|Overall Study||11
392002|NCT00248807|960061|P1|STARTED|Overall Study||19
392003|NCT00248794|960078|P3|NOT COMPLETED|Overall Study||3
392004|NCT00248794|960079|P2|NOT COMPLETED|Overall Study||8
392005|NCT00248794|960080|P1|NOT COMPLETED|Overall Study||6
392006|NCT00248794|960078|P3|COMPLETED|Overall Study||7
392007|NCT00248794|960079|P2|COMPLETED|Overall Study||16
392008|NCT00248794|960080|P1|COMPLETED|Overall Study||19
392009|NCT00248794|960078|P3|STARTED|Overall Study||10
392010|NCT00248794|960079|P2|STARTED|Overall Study||24
392011|NCT00248794|960080|P1|STARTED|Overall Study||25
392012|NCT00248781|960102|P2|NOT COMPLETED|Overall Study||4
392013|NCT00248781|960103|P1|NOT COMPLETED|Overall Study||10
392014|NCT00248781|960102|P2|COMPLETED|Overall Study||47
392015|NCT00248781|960103|P1|COMPLETED|Overall Study||42
392016|NCT00248781|960102|P2|STARTED|Overall Study||51
392017|NCT00248781|960103|P1|STARTED|Overall Study||52
392018|NCT00248651|960130|P3|NOT COMPLETED|Overall Study||32
392019|NCT00248651|960131|P2|NOT COMPLETED|Overall Study||40
392020|NCT00248651|960132|P1|NOT COMPLETED|Overall Study||28
392021|NCT00248651|960130|P3|COMPLETED|Overall Study||65
392022|NCT00248651|960131|P2|COMPLETED|Overall Study||58
392023|NCT00248651|960132|P1|COMPLETED|Overall Study||69
392024|NCT00248651|960130|P3|Completed 12 Weeks of Treatment|Overall Study||75
392025|NCT00248651|960131|P2|Completed 12 Weeks of Treatment|Overall Study||66
392026|NCT00248651|960132|P1|Completed 12 Weeks of Treatment|Overall Study||78
392027|NCT00248651|960130|P3|STARTED|Overall Study||97
392028|NCT00248651|960131|P2|STARTED|Overall Study||98
392029|NCT00248651|960132|P1|STARTED|Overall Study||97
392030|NCT00248638|960151|P2|NOT COMPLETED|Overall Study||0
392031|NCT00248638|960152|P1|NOT COMPLETED|Overall Study||0
392032|NCT00248638|960151|P2|COMPLETED|Overall Study||75
392033|NCT00248638|960152|P1|COMPLETED|Overall Study||75
392034|NCT00248638|960151|P2|STARTED|Overall Study||75
392035|NCT00248638|960152|P1|STARTED|Overall Study||75
392036|NCT00248625|960168|P2|NOT COMPLETED|Overall Study||2
392037|NCT00248625|960169|P1|NOT COMPLETED|Overall Study||0
392038|NCT00248625|960168|P2|COMPLETED|Overall Study||90
392039|NCT00248625|960169|P1|COMPLETED|Overall Study||92
392040|NCT00248625|960168|P2|STARTED|Overall Study||92
392041|NCT00248625|960169|P1|STARTED|Overall Study||92
392042|NCT00248612|960193|P4|NOT COMPLETED|Overall Study||0
392043|NCT00248612|960194|P3|NOT COMPLETED|Overall Study||0
392044|NCT00248612|960195|P2|NOT COMPLETED|Overall Study||0
392045|NCT00248612|960196|P1|NOT COMPLETED|Overall Study||0
392046|NCT00248612|960193|P4|COMPLETED|Overall Study||22
392047|NCT00248612|960194|P3|COMPLETED|Overall Study||14
392048|NCT00248612|960195|P2|COMPLETED|Overall Study||21
392049|NCT00248612|960196|P1|COMPLETED|Overall Study||24
392050|NCT00248612|960193|P4|STARTED|Overall Study||22
392051|NCT00248612|960194|P3|STARTED|Overall Study||14
392052|NCT00248612|960195|P2|STARTED|Overall Study||21
392053|NCT00248612|960196|P1|STARTED|Overall Study||24
392054|NCT00248560|960238|P1|NOT COMPLETED|Overall Study||0
392055|NCT00248560|960238|P1|COMPLETED|Overall Study||36
392056|NCT00248560|960238|P1|STARTED|Overall Study||36
392057|NCT00248547|960247|P2|NOT COMPLETED|Overall Study||0
392058|NCT00248547|960248|P1|NOT COMPLETED|Overall Study||0
392059|NCT00248547|960247|P2|COMPLETED|Overall Study||20
392060|NCT00248547|960248|P1|COMPLETED|Overall Study||20
392061|NCT00248547|960247|P2|STARTED|Overall Study||20
392062|NCT00248547|960248|P1|STARTED|Overall Study||20
392063|NCT00248534|960254|P1|NOT COMPLETED|Overall Study||0
392064|NCT00248534|960254|P1|COMPLETED|Overall Study||16
392065|NCT00248534|960254|P1|STARTED|Overall Study||16
392066|NCT00248495|960261|P1|NOT COMPLETED|Overall Study||1
392067|NCT00248495|960261|P1|COMPLETED|Overall Study||37
392068|NCT00248495|960261|P1|STARTED|Overall Study||38
392069|NCT00248287|960272|P2|NOT COMPLETED|Overall Study||19
392070|NCT00248287|960273|P1|NOT COMPLETED|Overall Study||24
392071|NCT00248287|960272|P2|COMPLETED|Overall Study||60
392072|NCT00248287|960273|P1|COMPLETED|Overall Study||51
392073|NCT00248287|960272|P2|STARTED|Overall Study||79
392074|NCT00248287|960273|P1|STARTED|Overall Study||75
392075|NCT00248170|960287|P2|NOT COMPLETED|Overall Study||808
392076|NCT00248170|960288|P1|NOT COMPLETED|Overall Study||761
392077|NCT00248170|960287|P2|COMPLETED|Overall Study||1286
392078|NCT00248170|960288|P1|COMPLETED|Overall Study||1317
392079|NCT00248170|960287|P2|Safety Set|Overall Study||2062
392080|NCT00248170|960288|P1|Safety Set|Overall Study||2049
392081|NCT00248170|960287|P2|Intent-to-treat (ITT)|Overall Study||2075
392082|NCT00248170|960288|P1|Intent-to-treat (ITT)|Overall Study||2061
392083|NCT00248170|960287|P2|STARTED|Overall Study||2094
392084|NCT00248170|960288|P1|STARTED|Overall Study||2078
392085|NCT00247962|960310|P2|NOT COMPLETED|Overall Study||19
392086|NCT00247962|960311|P1|NOT COMPLETED|Overall Study||26
392087|NCT00247962|960310|P2|COMPLETED|Overall Study||168
392088|NCT00247962|960311|P1|COMPLETED|Overall Study||353
392089|NCT00247962|960310|P2|STARTED|Overall Study||187
392090|NCT00247962|960311|P1|STARTED|Overall Study||379
392091|NCT00247676|960319|P1|NOT COMPLETED|Overall Study||36
392092|NCT00247676|960319|P1|COMPLETED|Overall Study||1
392093|NCT00247676|960319|P1|STARTED|Overall Study||37
392094|NCT00247624|960349|P2|NOT COMPLETED|Overall Study||4
392095|NCT00247624|960350|P1|NOT COMPLETED|Overall Study||5
392096|NCT00247624|960349|P2|COMPLETED|Overall Study||26
392097|NCT00247624|960350|P1|COMPLETED|Overall Study||25
392098|NCT00247624|960349|P2|STARTED|Overall Study||30
392099|NCT00247624|960350|P1|STARTED|Overall Study||30
392100|NCT00247611|960364|P2|NOT COMPLETED|On Protocol Sample||125
392101|NCT00247611|960365|P1|NOT COMPLETED|On Protocol Sample||111
392102|NCT00247611|960364|P2|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|152
392103|NCT00247611|960365|P1|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|176
392104|NCT00247611|960364|P2|STARTED|On Protocol Sample|ITT sample participants|277
392105|NCT00247611|960365|P1|STARTED|On Protocol Sample|ITT sample participants|287
392106|NCT00247611|960364|P2|NOT COMPLETED|Intention to Treat Sample||13
392107|NCT00247611|960365|P1|NOT COMPLETED|Intention to Treat Sample||17
392108|NCT00247611|960364|P2|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|277
392109|NCT00247611|960365|P1|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|287
392110|NCT00247611|960364|P2|STARTED|Intention to Treat Sample|Participants randomized|290
392111|NCT00247611|960365|P1|STARTED|Intention to Treat Sample|Participants randomized|304
392112|NCT00247611|960364|P2|NOT COMPLETED|Baselined||13
392113|NCT00247611|960365|P1|NOT COMPLETED|Baselined||17
392114|NCT00247611|960364|P2|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|277
392115|NCT00247611|960365|P1|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|287
392116|NCT00247611|960364|P2|STARTED|Baselined|Participants randomized|290
392117|NCT00247611|960365|P1|STARTED|Baselined|Participants randomized|304
392118|NCT00247416|960383|P2|NOT COMPLETED|Overall Study||2
392119|NCT00247416|960384|P1|NOT COMPLETED|Overall Study||1
392120|NCT00247416|960383|P2|COMPLETED|Overall Study||31
392121|NCT00247416|960384|P1|COMPLETED|Overall Study||25
392122|NCT00247416|960383|P2|STARTED|Overall Study||33
392123|NCT00247416|960384|P1|STARTED|Overall Study||26
392124|NCT00247377|960398|P2|NOT COMPLETED|Overall Study||0
392125|NCT00247377|960399|P1|NOT COMPLETED|Overall Study||0
392126|NCT00247377|960398|P2|COMPLETED|Overall Study||86
392127|NCT00247377|960399|P1|COMPLETED|Overall Study||111
392128|NCT00247377|960398|P2|STARTED|Overall Study||86
392129|NCT00247377|960399|P1|STARTED|Overall Study||111
392130|NCT00247273|960425|P2|NOT COMPLETED|Overall Study||137
392131|NCT00247273|960426|P1|NOT COMPLETED|Overall Study||146
392132|NCT00247273|960425|P2|COMPLETED|Overall Study||513
392133|NCT00247273|960426|P1|COMPLETED|Overall Study||498
392134|NCT00247273|960425|P2|Intent to Treat Population|Overall Study||650
392135|NCT00247273|960426|P1|Intent to Treat Population|Overall Study|Two subjects not included as they did not take any study medication.|642
392136|NCT00247273|960425|P2|STARTED|Overall Study||650
392137|NCT00247273|960426|P1|STARTED|Overall Study||644
392138|NCT00246805|960472|P2|NOT COMPLETED|Phase 2||0
392139|NCT00246805|960473|P1|NOT COMPLETED|Phase 2||0
392140|NCT00246805|960472|P2|COMPLETED|Phase 2||33
392141|NCT00246805|960473|P1|COMPLETED|Phase 2||33
392142|NCT00246805|960472|P2|STARTED|Phase 2||33
392143|NCT00246805|960473|P1|STARTED|Phase 2||33
392144|NCT00246805|960472|P2|NOT COMPLETED|Phase 1||0
392145|NCT00246805|960473|P1|NOT COMPLETED|Phase 1||1
392146|NCT00246805|960472|P2|COMPLETED|Phase 1||33
392147|NCT00246805|960473|P1|COMPLETED|Phase 1||33
392148|NCT00246805|960472|P2|STARTED|Phase 1||33
392149|NCT00246805|960473|P1|STARTED|Phase 1||34
392150|NCT00246753|960479|P1|NOT COMPLETED|Overall Study||8
392151|NCT00246753|960479|P1|COMPLETED|Overall Study||21
392152|NCT00246753|960479|P1|STARTED|Overall Study||29
392153|NCT00246740|960487|P2|NOT COMPLETED|Experimental Phase||0
392154|NCT00246740|960488|P1|NOT COMPLETED|Experimental Phase||0
392155|NCT00246740|960487|P2|COMPLETED|Experimental Phase||20
392156|NCT00246740|960488|P1|COMPLETED|Experimental Phase||22
392157|NCT00246740|960487|P2|STARTED|Experimental Phase||20
392158|NCT00246740|960488|P1|STARTED|Experimental Phase||22
392159|NCT00246740|960487|P2|NOT COMPLETED|Initial Enrollment||8
392160|NCT00246740|960488|P1|NOT COMPLETED|Initial Enrollment||6
392161|NCT00246740|960487|P2|COMPLETED|Initial Enrollment||20
392162|NCT00246740|960488|P1|COMPLETED|Initial Enrollment||22
392163|NCT00246740|960487|P2|STARTED|Initial Enrollment||28
392164|NCT00246740|960488|P1|STARTED|Initial Enrollment||28
392165|NCT00246571|960512|P2|NOT COMPLETED|Overall Study||104
392166|NCT00246571|960513|P1|NOT COMPLETED|Overall Study||113
392167|NCT00246571|960512|P2|COMPLETED|Overall Study||0
392168|NCT00246571|960513|P1|COMPLETED|Overall Study||0
392169|NCT00246571|960512|P2|Randomized But Not Treated|Overall Study||1
392170|NCT00246571|960513|P1|Randomized But Not Treated|Overall Study||3
392171|NCT00246571|960512|P2|STARTED|Overall Study||104
392172|NCT00246571|960513|P1|STARTED|Overall Study||113
392173|NCT00246519|960553|P2|NOT COMPLETED|Overall Study||64
392174|NCT00246519|960554|P1|NOT COMPLETED|Overall Study||56
392175|NCT00246519|960553|P2|COMPLETED|Overall Study||382
392176|NCT00246519|960554|P1|COMPLETED|Overall Study||386
392177|NCT00246519|960553|P2|STARTED|Overall Study||446
392178|NCT00246519|960554|P1|STARTED|Overall Study||442
392179|NCT00246441|960562|P2|NOT COMPLETED|Overall Study||0
392180|NCT00246441|960563|P1|NOT COMPLETED|Overall Study||1
392181|NCT00246441|960562|P2|COMPLETED|Overall Study||22
392182|NCT00246441|960563|P1|COMPLETED|Overall Study||19
392183|NCT00246441|960562|P2|STARTED|Overall Study||22
392184|NCT00246441|960563|P1|STARTED|Overall Study||20
392185|NCT00246376|960578|P5|NOT COMPLETED|Overall Study||17
392186|NCT00246376|960579|P4|NOT COMPLETED|Overall Study||26
392187|NCT00246376|960580|P3|NOT COMPLETED|Overall Study||16
392188|NCT00246376|960581|P2|NOT COMPLETED|Overall Study||19
392189|NCT00246376|960582|P1|NOT COMPLETED|Overall Study||15
392190|NCT00246376|960578|P5|COMPLETED|Overall Study||28
392191|NCT00246376|960579|P4|COMPLETED|Overall Study||21
392192|NCT00246376|960580|P3|COMPLETED|Overall Study||29
392193|NCT00246376|960581|P2|COMPLETED|Overall Study||24
392194|NCT00246376|960582|P1|COMPLETED|Overall Study||26
392195|NCT00246376|960578|P5|After Dietary run-in at Two Weeks|Overall Study||42
392196|NCT00246376|960579|P4|After Dietary run-in at Two Weeks|Overall Study||40
392197|NCT00246376|960580|P3|After Dietary run-in at Two Weeks|Overall Study||41
392198|NCT00246376|960581|P2|After Dietary run-in at Two Weeks|Overall Study||38
392199|NCT00246376|960582|P1|After Dietary run-in at Two Weeks|Overall Study||30
392200|NCT00246376|960578|P5|STARTED|Overall Study||45
392201|NCT00246376|960579|P4|STARTED|Overall Study||47
392202|NCT00246376|960580|P3|STARTED|Overall Study||45
392203|NCT00246376|960581|P2|STARTED|Overall Study||43
392204|NCT00246376|960582|P1|STARTED|Overall Study||41
392205|NCT00246337|960633|P9|NOT COMPLETED|Overall Study||11
392206|NCT00246337|960634|P8|NOT COMPLETED|Overall Study||13
392207|NCT00246337|960635|P7|NOT COMPLETED|Overall Study||9
392208|NCT00246337|960636|P6|NOT COMPLETED|Overall Study||15
392209|NCT00246337|960637|P5|NOT COMPLETED|Overall Study||4
392210|NCT00246337|960638|P4|NOT COMPLETED|Overall Study||1
392211|NCT00246337|960639|P3|NOT COMPLETED|Overall Study||3
392212|NCT00246337|960640|P2|NOT COMPLETED|Overall Study||2
392213|NCT00246337|960641|P1|NOT COMPLETED|Overall Study||32
392214|NCT00246337|960633|P9|COMPLETED|Overall Study||34
392215|NCT00246337|960634|P8|COMPLETED|Overall Study||40
392216|NCT00246337|960635|P7|COMPLETED|Overall Study||45
392217|NCT00246337|960636|P6|COMPLETED|Overall Study||39
392218|NCT00246337|960637|P5|COMPLETED|Overall Study||12
392219|NCT00246337|960638|P4|COMPLETED|Overall Study||16
392220|NCT00246337|960639|P3|COMPLETED|Overall Study||15
392221|NCT00246337|960640|P2|COMPLETED|Overall Study||14
392222|NCT00246337|960641|P1|COMPLETED|Overall Study||115
392223|NCT00246337|960633|P9|Completed Period (Both Doses)|Overall Study||15
392224|NCT00246337|960634|P8|Completed Period (Both Doses)|Overall Study||13
392225|NCT00246337|960635|P7|Completed Period (Both Doses)|Overall Study||16
392226|NCT00246337|960636|P6|Completed Period (Both Doses)|Overall Study||10
392227|NCT00246337|960637|P5|Completed Period (Both Doses)|Overall Study||4
392228|NCT00246337|960638|P4|Completed Period (Both Doses)|Overall Study||11
392229|NCT00246337|960639|P3|Completed Period (Both Doses)|Overall Study||6
392230|NCT00246337|960640|P2|Completed Period (Both Doses)|Overall Study||10
392231|NCT00246337|960641|P1|Completed Period (Both Doses)|Overall Study||69
392232|NCT00246337|960633|P9|Completed Period (Initial Dose)|Overall Study||19
392233|NCT00246337|960634|P8|Completed Period (Initial Dose)|Overall Study||27
392234|NCT00246337|960635|P7|Completed Period (Initial Dose)|Overall Study||29
392235|NCT00246337|960636|P6|Completed Period (Initial Dose)|Overall Study||29
392236|NCT00246337|960637|P5|Completed Period (Initial Dose)|Overall Study||8
392237|NCT00246337|960638|P4|Completed Period (Initial Dose)|Overall Study||5
392238|NCT00246337|960639|P3|Completed Period (Initial Dose)|Overall Study||9
392239|NCT00246337|960640|P2|Completed Period (Initial Dose)|Overall Study||4
392240|NCT00246337|960641|P1|Completed Period (Initial Dose)|Overall Study||46
392241|NCT00246337|960633|P9|STARTED|Overall Study||45
392242|NCT00246337|960634|P8|STARTED|Overall Study||53
392243|NCT00246337|960635|P7|STARTED|Overall Study||54
392244|NCT00246337|960636|P6|STARTED|Overall Study||54
392245|NCT00246337|960637|P5|STARTED|Overall Study||16
392246|NCT00246337|960638|P4|STARTED|Overall Study||17
392247|NCT00246337|960639|P3|STARTED|Overall Study||18
392248|NCT00246337|960640|P2|STARTED|Overall Study||16
392249|NCT00246337|960641|P1|STARTED|Overall Study||147
392250|NCT00246324|960688|P1|NOT COMPLETED|Overall Study||1
392251|NCT00246324|960688|P1|COMPLETED|Overall Study||15
392252|NCT00246324|960688|P1|STARTED|Overall Study||16
392253|NCT00246259|960695|P2|NOT COMPLETED|Overall Study||26
392254|NCT00246259|960696|P1|NOT COMPLETED|Overall Study||28
392255|NCT00246259|960695|P2|COMPLETED|Overall Study||15
392256|NCT00246259|960696|P1|COMPLETED|Overall Study||16
392257|NCT00246259|960695|P2|Eligible for Intent-to-treat (ITT)|Overall Study||35
392258|NCT00246259|960696|P1|Eligible for Intent-to-treat (ITT)|Overall Study||42
392259|NCT00246259|960695|P2|STARTED|Overall Study||41
392260|NCT00246259|960696|P1|STARTED|Overall Study||44
392261|NCT00246090|960730|P1|NOT COMPLETED|Overall Study||295
392262|NCT00246090|960730|P1|COMPLETED|Overall Study||3
392263|NCT00246090|960730|P1|STARTED|Overall Study||298
392264|NCT00246025|960739|P4|NOT COMPLETED|Overall Study||13
392265|NCT00246025|960740|P3|NOT COMPLETED|Overall Study||10
392266|NCT00246025|960741|P2|NOT COMPLETED|Overall Study||9
392267|NCT00246025|960742|P1|NOT COMPLETED|Overall Study||10
392268|NCT00246025|960739|P4|COMPLETED|Overall Study||116
392269|NCT00246025|960740|P3|COMPLETED|Overall Study||116
392270|NCT00246025|960741|P2|COMPLETED|Overall Study||124
392271|NCT00246025|960742|P1|COMPLETED|Overall Study||114
392272|NCT00246025|960739|P4|STARTED|Overall Study||129
392273|NCT00246025|960740|P3|STARTED|Overall Study||126
392274|NCT00246025|960741|P2|STARTED|Overall Study||133
392275|NCT00246025|960742|P1|STARTED|Overall Study||124
392276|NCT00246012|960801|P9|NOT COMPLETED|Overall Study||28
392277|NCT00246012|960802|P8|NOT COMPLETED|Overall Study||28
392278|NCT00246012|960803|P7|NOT COMPLETED|Overall Study||31
392279|NCT00246012|960804|P6|NOT COMPLETED|Overall Study||28
392280|NCT00246012|960805|P5|NOT COMPLETED|Overall Study||3
392281|NCT00246012|960806|P4|NOT COMPLETED|Overall Study||3
392282|NCT00246012|960807|P3|NOT COMPLETED|Overall Study||2
392283|NCT00246012|960808|P2|NOT COMPLETED|Overall Study||1
392284|NCT00246012|960809|P1|NOT COMPLETED|Overall Study||3
392285|NCT00246012|960801|P9|COMPLETED|Overall Study||4
392286|NCT00246012|960802|P8|COMPLETED|Overall Study||5
392287|NCT00246012|960803|P7|COMPLETED|Overall Study||1
392288|NCT00246012|960804|P6|COMPLETED|Overall Study||4
392289|NCT00246012|960805|P5|COMPLETED|Overall Study||0
392290|NCT00246012|960806|P4|COMPLETED|Overall Study||0
392291|NCT00246012|960807|P3|COMPLETED|Overall Study||1
392292|NCT00246012|960808|P2|COMPLETED|Overall Study||2
392293|NCT00246012|960809|P1|COMPLETED|Overall Study||0
392294|NCT00246012|960801|P9|Treated|Overall Study||32
392295|NCT00246012|960802|P8|Treated|Overall Study||33
392296|NCT00246012|960803|P7|Treated|Overall Study||31
392297|NCT00246012|960804|P6|Treated|Overall Study||31
392298|NCT00246012|960805|P5|Treated|Overall Study||3
392299|NCT00246012|960806|P4|Treated|Overall Study||3
392300|NCT00246012|960807|P3|Treated|Overall Study||3
392301|NCT00246012|960808|P2|Treated|Overall Study||3
392302|NCT00246012|960809|P1|Treated|Overall Study||3
392303|NCT00246012|960801|P9|STARTED|Overall Study||32
392304|NCT00246012|960802|P8|STARTED|Overall Study||33
392305|NCT00246012|960803|P7|STARTED|Overall Study||32
392306|NCT00246012|960804|P6|STARTED|Overall Study||32
392307|NCT00246012|960805|P5|STARTED|Overall Study||3
392308|NCT00246012|960806|P4|STARTED|Overall Study||3
392309|NCT00246012|960807|P3|STARTED|Overall Study||3
392310|NCT00246012|960808|P2|STARTED|Overall Study||3
392311|NCT00246012|960809|P1|STARTED|Overall Study||3
392312|NCT00245960|960904|P2|NOT COMPLETED|Overall Study||28
392313|NCT00245960|960905|P1|NOT COMPLETED|Overall Study||29
392314|NCT00245960|960904|P2|COMPLETED|Overall Study||345
392315|NCT00245960|960905|P1|COMPLETED|Overall Study||350
392316|NCT00245960|960904|P2|STARTED|Overall Study||373
392317|NCT00245960|960905|P1|STARTED|Overall Study||379
392318|NCT00245856|960913|P2|NOT COMPLETED|Period Two||1
392319|NCT00245856|960914|P1|NOT COMPLETED|Period Two||0
392320|NCT00245856|960913|P2|COMPLETED|Period Two||38
392321|NCT00245856|960914|P1|COMPLETED|Period Two||0
392322|NCT00245856|960913|P2|STARTED|Period Two||39
392323|NCT00245856|960914|P1|STARTED|Period Two||0
392324|NCT00245856|960913|P2|NOT COMPLETED|Period One||0
392325|NCT00245856|960914|P1|NOT COMPLETED|Period One||0
392326|NCT00245856|960913|P2|COMPLETED|Period One||0
392327|NCT00245856|960914|P1|COMPLETED|Period One||28
392328|NCT00245856|960913|P2|STARTED|Period One||0
392329|NCT00245856|960914|P1|STARTED|Period One||28
392330|NCT00245765|960924|P3|NOT COMPLETED|Overall Study||8
392331|NCT00245765|960925|P2|NOT COMPLETED|Overall Study||14
392332|NCT00245765|960926|P1|NOT COMPLETED|Overall Study||32
392333|NCT00245765|960924|P3|COMPLETED|Overall Study||50
392334|NCT00245765|960925|P2|COMPLETED|Overall Study||45
392335|NCT00245765|960926|P1|COMPLETED|Overall Study||27
392336|NCT00245765|960924|P3|Safety Population|Overall Study|One subject in the 400 mg group was randomized by mistake but did not receive study medication.|57
392337|NCT00245765|960925|P2|Safety Population|Overall Study|For safety analysis, the PBO group subj. who received CDP870 was considered to be in the 200mg group|60
392338|NCT00245765|960926|P1|Safety Population|Overall Study|One subject in the Placebo (PBO) group received one injection of CDP870 200 mg on one occasion.|58
392339|NCT00245765|960924|P3|STARTED|Overall Study||58
392340|NCT00245765|960925|P2|STARTED|Overall Study||59
392341|NCT00245765|960926|P1|STARTED|Overall Study||59
392342|NCT00245635|960966|P2|NOT COMPLETED|Overall Study||0
392343|NCT00245635|960967|P1|NOT COMPLETED|Overall Study||0
392344|NCT00245635|960966|P2|COMPLETED|Overall Study||18
392345|NCT00245635|960967|P1|COMPLETED|Overall Study||25
392346|NCT00245635|960966|P2|STARTED|Overall Study||18
392347|NCT00245635|960967|P1|STARTED|Overall Study||25
392348|NCT00245583|960975|P2|NOT COMPLETED|Overall Study||9
392349|NCT00245583|960976|P1|NOT COMPLETED|Overall Study||6
392350|NCT00245583|960975|P2|COMPLETED|Overall Study||13
392351|NCT00245583|960976|P1|COMPLETED|Overall Study||14
392352|NCT00245583|960975|P2|STARTED|Overall Study||22
392353|NCT00245583|960976|P1|STARTED|Overall Study||20
392354|NCT00245570|960996|P6|NOT COMPLETED|Treatment Period IV||0
392355|NCT00245570|960997|P5|NOT COMPLETED|Treatment Period IV||0
392356|NCT00245570|960998|P4|NOT COMPLETED|Treatment Period IV||0
392357|NCT00245570|960999|P3|NOT COMPLETED|Treatment Period IV||0
392358|NCT00245570|961000|P2|NOT COMPLETED|Treatment Period IV||0
392359|NCT00245570|961001|P1|NOT COMPLETED|Treatment Period IV||0
392360|NCT00245570|960996|P6|COMPLETED|Treatment Period IV||8
392361|NCT00245570|960997|P5|COMPLETED|Treatment Period IV||8
392362|NCT00245570|960998|P4|COMPLETED|Treatment Period IV||8
392363|NCT00245570|960999|P3|COMPLETED|Treatment Period IV||8
392364|NCT00245570|961000|P2|COMPLETED|Treatment Period IV||7
392365|NCT00245570|961001|P1|COMPLETED|Treatment Period IV||7
392366|NCT00245570|960996|P6|STARTED|Treatment Period IV||8
392367|NCT00245570|960997|P5|STARTED|Treatment Period IV||8
392368|NCT00245570|960998|P4|STARTED|Treatment Period IV||8
392369|NCT00245570|960999|P3|STARTED|Treatment Period IV||8
392370|NCT00245570|961000|P2|STARTED|Treatment Period IV||7
392371|NCT00245570|961001|P1|STARTED|Treatment Period IV||7
392372|NCT00245570|960996|P6|NOT COMPLETED|Washout Between Periods III and IV||0
392373|NCT00245570|960997|P5|NOT COMPLETED|Washout Between Periods III and IV||0
392374|NCT00245570|960998|P4|NOT COMPLETED|Washout Between Periods III and IV||0
392375|NCT00245570|960999|P3|NOT COMPLETED|Washout Between Periods III and IV||0
392376|NCT00245570|961000|P2|NOT COMPLETED|Washout Between Periods III and IV||1
392377|NCT00245570|961001|P1|NOT COMPLETED|Washout Between Periods III and IV||0
392378|NCT00245570|960996|P6|COMPLETED|Washout Between Periods III and IV||8
392379|NCT00245570|960997|P5|COMPLETED|Washout Between Periods III and IV||8
392380|NCT00245570|960998|P4|COMPLETED|Washout Between Periods III and IV||8
392381|NCT00245570|960999|P3|COMPLETED|Washout Between Periods III and IV||8
392382|NCT00245570|961000|P2|COMPLETED|Washout Between Periods III and IV||7
392383|NCT00245570|961001|P1|COMPLETED|Washout Between Periods III and IV||7
392384|NCT00245570|960996|P6|STARTED|Washout Between Periods III and IV||8
392385|NCT00245570|960997|P5|STARTED|Washout Between Periods III and IV||8
392386|NCT00245570|960998|P4|STARTED|Washout Between Periods III and IV||8
392387|NCT00245570|960999|P3|STARTED|Washout Between Periods III and IV||8
392388|NCT00245570|961000|P2|STARTED|Washout Between Periods III and IV|1 pt in the montelukast/placebo/salmeterol group discontinued during washout period 2 after placebo|8
392389|NCT00245570|961001|P1|STARTED|Washout Between Periods III and IV||7
392390|NCT00245570|960996|P6|NOT COMPLETED|Treatment Period III||0
392391|NCT00245570|960997|P5|NOT COMPLETED|Treatment Period III||0
392392|NCT00245570|960998|P4|NOT COMPLETED|Treatment Period III||0
392393|NCT00245570|960999|P3|NOT COMPLETED|Treatment Period III||0
392394|NCT00245570|961000|P2|NOT COMPLETED|Treatment Period III||0
392395|NCT00245570|961001|P1|NOT COMPLETED|Treatment Period III||0
392396|NCT00245570|960996|P6|COMPLETED|Treatment Period III||8
392397|NCT00245570|960997|P5|COMPLETED|Treatment Period III||8
392398|NCT00245570|960998|P4|COMPLETED|Treatment Period III||8
392399|NCT00245570|960999|P3|COMPLETED|Treatment Period III||8
392400|NCT00245570|961000|P2|COMPLETED|Treatment Period III||8
392401|NCT00245570|961001|P1|COMPLETED|Treatment Period III||7
392402|NCT00245570|960996|P6|STARTED|Treatment Period III||8
392403|NCT00245570|960997|P5|STARTED|Treatment Period III||8
392404|NCT00245570|960998|P4|STARTED|Treatment Period III||8
392405|NCT00245570|960999|P3|STARTED|Treatment Period III||8
392406|NCT00245570|961000|P2|STARTED|Treatment Period III||8
392407|NCT00245570|961001|P1|STARTED|Treatment Period III||7
392408|NCT00245570|960996|P6|NOT COMPLETED|Washout Between Periods II and III||0
392409|NCT00245570|960997|P5|NOT COMPLETED|Washout Between Periods II and III||0
392410|NCT00245570|960998|P4|NOT COMPLETED|Washout Between Periods II and III||0
392411|NCT00245570|960999|P3|NOT COMPLETED|Washout Between Periods II and III||0
392412|NCT00245570|961000|P2|NOT COMPLETED|Washout Between Periods II and III||0
392413|NCT00245570|961001|P1|NOT COMPLETED|Washout Between Periods II and III||0
392414|NCT00245570|960996|P6|COMPLETED|Washout Between Periods II and III||8
392415|NCT00245570|960997|P5|COMPLETED|Washout Between Periods II and III||8
392416|NCT00245570|960998|P4|COMPLETED|Washout Between Periods II and III||8
392417|NCT00245570|960999|P3|COMPLETED|Washout Between Periods II and III||8
392418|NCT00245570|961000|P2|COMPLETED|Washout Between Periods II and III||8
392419|NCT00245570|961001|P1|COMPLETED|Washout Between Periods II and III||7
392420|NCT00245570|960996|P6|STARTED|Washout Between Periods II and III||8
392421|NCT00245570|960997|P5|STARTED|Washout Between Periods II and III||8
392422|NCT00245570|960998|P4|STARTED|Washout Between Periods II and III||8
392423|NCT00245570|960999|P3|STARTED|Washout Between Periods II and III||8
392424|NCT00245570|961000|P2|STARTED|Washout Between Periods II and III||8
392425|NCT00245570|961001|P1|STARTED|Washout Between Periods II and III||7
392426|NCT00245570|960996|P6|NOT COMPLETED|Treatment Period II||0
392427|NCT00245570|960997|P5|NOT COMPLETED|Treatment Period II||0
392428|NCT00245570|960998|P4|NOT COMPLETED|Treatment Period II||0
392429|NCT00245570|960999|P3|NOT COMPLETED|Treatment Period II||0
392430|NCT00245570|961000|P2|NOT COMPLETED|Treatment Period II||0
392431|NCT00245570|961001|P1|NOT COMPLETED|Treatment Period II||0
392432|NCT00245570|960996|P6|COMPLETED|Treatment Period II||8
392433|NCT00245570|960997|P5|COMPLETED|Treatment Period II||8
392434|NCT00245570|960998|P4|COMPLETED|Treatment Period II||8
392435|NCT00245570|960999|P3|COMPLETED|Treatment Period II||8
392436|NCT00245570|961000|P2|COMPLETED|Treatment Period II||8
392437|NCT00245570|961001|P1|COMPLETED|Treatment Period II||7
392438|NCT00245570|960996|P6|STARTED|Treatment Period II||8
392439|NCT00245570|960997|P5|STARTED|Treatment Period II||8
392440|NCT00245570|960998|P4|STARTED|Treatment Period II||8
392441|NCT00245570|960999|P3|STARTED|Treatment Period II||8
392442|NCT00245570|961000|P2|STARTED|Treatment Period II||8
392443|NCT00245570|961001|P1|STARTED|Treatment Period II||7
392444|NCT00245557|961047|P2|NOT COMPLETED|Overall Study||16
392445|NCT00245557|961048|P1|NOT COMPLETED|Overall Study||6
392446|NCT00245557|961047|P2|COMPLETED|Overall Study||10
392447|NCT00245557|961048|P1|COMPLETED|Overall Study||11
392448|NCT00245557|961047|P2|STARTED|Overall Study||26
392449|NCT00245557|961048|P1|STARTED|Overall Study||17
392450|NCT00245518|961061|P2|NOT COMPLETED|Overall Study||0
392451|NCT00245518|961062|P1|NOT COMPLETED|Overall Study||0
392452|NCT00245518|961061|P2|COMPLETED|Overall Study||16
392453|NCT00245518|961062|P1|COMPLETED|Overall Study||17
392454|NCT00245518|961061|P2|STARTED|Overall Study||16
392455|NCT00245518|961062|P1|STARTED|Overall Study||17
392456|NCT00245466|961135|P3|NOT COMPLETED|Overall Study||37
392457|NCT00245466|961136|P2|NOT COMPLETED|Overall Study||44
392458|NCT00245466|961137|P1|NOT COMPLETED|Overall Study||36
392459|NCT00245466|961135|P3|COMPLETED|Overall Study||3
392460|NCT00245466|961136|P2|COMPLETED|Overall Study||2
392461|NCT00245466|961137|P1|COMPLETED|Overall Study|Defined as those participants ongoing when the extension study was terminated|7
392462|NCT00245466|961135|P3|Started FE200486 CS02A|Overall Study||26
392463|NCT00245466|961136|P2|Started FE200486 CS02A|Overall Study||30
392464|NCT00245466|961137|P1|Started FE200486 CS02A|Overall Study||32
392465|NCT00245466|961135|P3|STARTED|Overall Study||40
392466|NCT00245466|961136|P2|STARTED|Overall Study||46
392467|NCT00245466|961137|P1|STARTED|Overall Study||43
392468|NCT00245219|961154|P3|NOT COMPLETED|Overall Study||2
392469|NCT00245219|961155|P2|NOT COMPLETED|Overall Study||6
392470|NCT00245219|961156|P1|NOT COMPLETED|Overall Study||6
392471|NCT00245219|961154|P3|COMPLETED|Overall Study||58
392472|NCT00245219|961155|P2|COMPLETED|Overall Study||88
392473|NCT00245219|961156|P1|COMPLETED|Overall Study||85
392474|NCT00245219|961154|P3|STARTED|Overall Study||60
392475|NCT00245219|961155|P2|STARTED|Overall Study||94
392476|NCT00245219|961156|P1|STARTED|Overall Study||91
392477|NCT00245128|961170|P1|NOT COMPLETED|Overall Study||10
392478|NCT00245128|961170|P1|COMPLETED|Overall Study||0
392479|NCT00245128|961170|P1|STARTED|Overall Study||10
392480|NCT00245102|961180|P6|NOT COMPLETED|Overall Study||4
392481|NCT00245102|961181|P5|NOT COMPLETED|Overall Study||0
392482|NCT00245102|961182|P4|NOT COMPLETED|Overall Study||3
392483|NCT00245102|961183|P3|NOT COMPLETED|Overall Study||7
392484|NCT00245102|961184|P2|NOT COMPLETED|Overall Study||4
392485|NCT00245102|961185|P1|NOT COMPLETED|Overall Study||7
392486|NCT00245102|961180|P6|COMPLETED|Overall Study||19
392487|NCT00245102|961181|P5|COMPLETED|Overall Study||5
392488|NCT00245102|961182|P4|COMPLETED|Overall Study||10
392489|NCT00245102|961183|P3|COMPLETED|Overall Study||39
392490|NCT00245102|961184|P2|COMPLETED|Overall Study||12
392491|NCT00245102|961185|P1|COMPLETED|Overall Study||37
392492|NCT00245102|961180|P6|STARTED|Overall Study||23
392493|NCT00245102|961181|P5|STARTED|Overall Study||5
392494|NCT00245102|961182|P4|STARTED|Overall Study||13
392495|NCT00245102|961183|P3|STARTED|Overall Study||46
392496|NCT00245102|961184|P2|STARTED|Overall Study||16
392497|NCT00245102|961185|P1|STARTED|Overall Study||44
392498|NCT00245063|961201|P2|NOT COMPLETED|Overall Study||5
392499|NCT00245063|961202|P1|NOT COMPLETED|Overall Study||7
392500|NCT00245063|961201|P2|COMPLETED|Overall Study||8
392501|NCT00245063|961202|P1|COMPLETED|Overall Study||5
392502|NCT00245063|961201|P2|STARTED|Overall Study||13
392503|NCT00245063|961202|P1|STARTED|Overall Study||12
392504|NCT00245050|961210|P2|NOT COMPLETED|Overall Study||2
392505|NCT00245050|961211|P1|NOT COMPLETED|Overall Study||3
392506|NCT00245050|961210|P2|COMPLETED|Overall Study||14
392507|NCT00245050|961211|P1|COMPLETED|Overall Study||15
392508|NCT00245050|961210|P2|STARTED|Overall Study||16
392509|NCT00245050|961211|P1|STARTED|Overall Study||18
392510|NCT00245037|961219|P1|NOT COMPLETED|Overall Study||17
392511|NCT00245037|961219|P1|COMPLETED|Overall Study|17 participants died from infectious complications.|130
392512|NCT00245037|961219|P1|STARTED|Overall Study||147
392513|NCT00245011|961229|P1|NOT COMPLETED|Overall Study||1
392514|NCT00245011|961229|P1|COMPLETED|Overall Study|Subject had disease progression prior to completing study.|10
392515|NCT00245011|961229|P1|STARTED|Overall Study||11
392516|NCT00244985|961233|P1|NOT COMPLETED|Overall Study||0
392517|NCT00244985|961233|P1|COMPLETED|Overall Study||42
392518|NCT00244985|961233|P1|STARTED|Overall Study||42
392519|NCT00244933|961241|P1|NOT COMPLETED|Overall Study||2
392520|NCT00244933|961241|P1|COMPLETED|Overall Study||17
392521|NCT00244933|961241|P1|STARTED|Overall Study||19
392522|NCT00244881|961245|P1|NOT COMPLETED|Overall Study||3
392523|NCT00244881|961245|P1|COMPLETED|Overall Study||23
392524|NCT00244881|961245|P1|STARTED|Overall Study||26
392525|NCT00244855|961253|P2|NOT COMPLETED|Overall Study||1
392526|NCT00244855|961254|P1|NOT COMPLETED|Overall Study||0
392527|NCT00244855|961253|P2|COMPLETED|Overall Study||24
392528|NCT00244855|961254|P1|COMPLETED|Overall Study||7
392529|NCT00244855|961253|P2|STARTED|Overall Study||25
392530|NCT00244855|961254|P1|STARTED|Overall Study||7
392531|NCT00244764|961262|P1|NOT COMPLETED|Overall Study||96
392532|NCT00244764|961262|P1|COMPLETED|Overall Study||129
392533|NCT00244764|961262|P1|STARTED|Overall Study||225
392534|NCT00244751|961272|P3|NOT COMPLETED|Overall Study||10
392535|NCT00244751|961273|P2|NOT COMPLETED|Overall Study||15
392536|NCT00244751|961274|P1|NOT COMPLETED|Overall Study||16
392537|NCT00244751|961272|P3|COMPLETED|Overall Study||78
392538|NCT00244751|961273|P2|COMPLETED|Overall Study||74
392539|NCT00244751|961274|P1|COMPLETED|Overall Study||72
392540|NCT00244751|961272|P3|STARTED|Overall Study||88
392541|NCT00244751|961273|P2|STARTED|Overall Study||89
392542|NCT00244751|961274|P1|STARTED|Overall Study||88
392543|NCT00244725|961375|P4|NOT COMPLETED|Overall Study||21
392544|NCT00244725|961376|P3|NOT COMPLETED|Overall Study||24
392545|NCT00244725|961377|P2|NOT COMPLETED|Overall Study||19
392546|NCT00244725|961378|P1|NOT COMPLETED|Overall Study||23
392547|NCT00244725|961375|P4|COMPLETED|Overall Study||216
392548|NCT00244725|961376|P3|COMPLETED|Overall Study||215
392549|NCT00244725|961377|P2|COMPLETED|Overall Study||226
392550|NCT00244725|961378|P1|COMPLETED|Overall Study||214
392551|NCT00244725|961375|P4|STARTED|Overall Study||237
392552|NCT00244725|961376|P3|STARTED|Overall Study||239
392553|NCT00244725|961377|P2|STARTED|Overall Study||245
392554|NCT00244725|961378|P1|STARTED|Overall Study||237
392555|NCT00244712|961434|P2|NOT COMPLETED|Overall Study||124
392556|NCT00244712|961435|P1|NOT COMPLETED|Overall Study||109
392557|NCT00244712|961434|P2|COMPLETED|Overall Study||221
392558|NCT00244712|961435|P1|COMPLETED|Overall Study||234
392559|NCT00244712|961434|P2|STARTED|Overall Study||345
392560|NCT00244712|961435|P1|STARTED|Overall Study||343
392561|NCT00244621|961470|P3|NOT COMPLETED|Open-label Treatment Period||2
392562|NCT00244621|961471|P2|NOT COMPLETED|Open-label Treatment Period||1
392563|NCT00244621|961472|P1|NOT COMPLETED|Open-label Treatment Period||1
392564|NCT00244621|961470|P3|COMPLETED|Open-label Treatment Period||28
392565|NCT00244621|961471|P2|COMPLETED|Open-label Treatment Period||28
392566|NCT00244621|961472|P1|COMPLETED|Open-label Treatment Period||25
392567|NCT00244621|961470|P3|STARTED|Open-label Treatment Period||30
392568|NCT00244621|961471|P2|STARTED|Open-label Treatment Period||29
392569|NCT00244621|961472|P1|STARTED|Open-label Treatment Period|One participant discontinued study due to Adverse Event after completing the double-blind period.|26
392570|NCT00244621|961470|P3|NOT COMPLETED|Double-blind Treatment Period||2
392571|NCT00244621|961471|P2|NOT COMPLETED|Double-blind Treatment Period||3
392572|NCT00244621|961472|P1|NOT COMPLETED|Double-blind Treatment Period||2
392573|NCT00244621|961470|P3|COMPLETED|Double-blind Treatment Period||30
392574|NCT00244621|961471|P2|COMPLETED|Double-blind Treatment Period||29
392575|NCT00244621|961472|P1|COMPLETED|Double-blind Treatment Period||27
392576|NCT00244621|961470|P3|STARTED|Double-blind Treatment Period||32
392577|NCT00244621|961471|P2|STARTED|Double-blind Treatment Period||32
392578|NCT00244621|961472|P1|STARTED|Double-blind Treatment Period||29
392579|NCT00244374|961489|P5|NOT COMPLETED|Vaccine Adherence Cohort||0
392580|NCT00244374|961490|P4|NOT COMPLETED|Vaccine Adherence Cohort||0
392581|NCT00244374|961491|P3|NOT COMPLETED|Vaccine Adherence Cohort||0
392582|NCT00244374|961492|P2|NOT COMPLETED|Vaccine Adherence Cohort||0
392583|NCT00244374|961493|P1|NOT COMPLETED|Vaccine Adherence Cohort||0
392584|NCT00244374|961489|P5|COMPLETED|Vaccine Adherence Cohort||41
392585|NCT00244374|961490|P4|COMPLETED|Vaccine Adherence Cohort||36
392586|NCT00244374|961491|P3|COMPLETED|Vaccine Adherence Cohort||43
392587|NCT00244374|961492|P2|COMPLETED|Vaccine Adherence Cohort||47
392588|NCT00244374|961493|P1|COMPLETED|Vaccine Adherence Cohort||0
392589|NCT00244374|961489|P5|STARTED|Vaccine Adherence Cohort||41
392590|NCT00244374|961490|P4|STARTED|Vaccine Adherence Cohort||36
392591|NCT00244374|961491|P3|STARTED|Vaccine Adherence Cohort||43
392592|NCT00244374|961492|P2|STARTED|Vaccine Adherence Cohort||47
392593|NCT00244374|961493|P1|STARTED|Vaccine Adherence Cohort|Eligible and willing cross-sectional study participants progressed to adherence cohort randomization|0
392594|NCT00244374|961489|P5|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
392595|NCT00244374|961490|P4|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
392596|NCT00244374|961491|P3|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
392597|NCT00244374|961492|P2|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
392598|NCT00244374|961493|P1|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||273
392599|NCT00244374|961489|P5|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
392600|NCT00244374|961490|P4|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
392601|NCT00244374|961491|P3|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
392602|NCT00244374|961492|P2|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
392603|NCT00244374|961493|P1|COMPLETED|Evaluation for Vaccine Adherence Cohort||167
392604|NCT00244374|961489|P5|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
392605|NCT00244374|961490|P4|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
392606|NCT00244374|961491|P3|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
392607|NCT00244374|961492|P2|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
392608|NCT00244374|961493|P1|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||217
392609|NCT00244374|961489|P5|STARTED|Evaluation for Vaccine Adherence Cohort||0
392610|NCT00244374|961490|P4|STARTED|Evaluation for Vaccine Adherence Cohort||0
392611|NCT00244374|961491|P3|STARTED|Evaluation for Vaccine Adherence Cohort||0
392612|NCT00244374|961492|P2|STARTED|Evaluation for Vaccine Adherence Cohort||0
392613|NCT00244374|961493|P1|STARTED|Evaluation for Vaccine Adherence Cohort|440 study participants enrolled prior to 3/31/2007 were evaluated for vaccine adherence cohort|440
392614|NCT00244374|961489|P5|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
392615|NCT00244374|961490|P4|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
392616|NCT00244374|961491|P3|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
392617|NCT00244374|961492|P2|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
392618|NCT00244374|961493|P1|NOT COMPLETED|Pre-Randomization Cross-sectional Study||137
392619|NCT00244374|961489|P5|COMPLETED|Pre-Randomization Cross-sectional Study||0
392620|NCT00244374|961490|P4|COMPLETED|Pre-Randomization Cross-sectional Study||0
392621|NCT00244374|961491|P3|COMPLETED|Pre-Randomization Cross-sectional Study||0
392622|NCT00244374|961492|P2|COMPLETED|Pre-Randomization Cross-sectional Study||0
392623|NCT00244374|961493|P1|COMPLETED|Pre-Randomization Cross-sectional Study||409
392624|NCT00244374|961489|P5|STARTED|Pre-Randomization Cross-sectional Study||0
392625|NCT00244374|961490|P4|STARTED|Pre-Randomization Cross-sectional Study||0
392626|NCT00244374|961491|P3|STARTED|Pre-Randomization Cross-sectional Study||0
392627|NCT00244374|961492|P2|STARTED|Pre-Randomization Cross-sectional Study||0
392628|NCT00244374|961493|P1|STARTED|Pre-Randomization Cross-sectional Study||546
392629|NCT00244140|961511|P2|NOT COMPLETED|Overall Study||0
392630|NCT00244140|961512|P1|NOT COMPLETED|Overall Study||0
392631|NCT00244140|961511|P2|COMPLETED|Overall Study||22
392632|NCT00244140|961512|P1|COMPLETED|Overall Study||412
392633|NCT00244140|961511|P2|STARTED|Overall Study||22
392634|NCT00244140|961512|P1|STARTED|Overall Study||412
392635|NCT00244101|961527|P3|NOT COMPLETED|Overall Study||0
392636|NCT00244101|961528|P2|NOT COMPLETED|Overall Study||0
392637|NCT00244101|961529|P1|NOT COMPLETED|Overall Study||0
392638|NCT00244101|961527|P3|COMPLETED|Overall Study||216
392639|NCT00244101|961528|P2|COMPLETED|Overall Study||223
392640|NCT00244101|961529|P1|COMPLETED|Overall Study||209
392641|NCT00244101|961527|P3|STARTED|Overall Study||216
392642|NCT00244101|961528|P2|STARTED|Overall Study||223
392643|NCT00244101|961529|P1|STARTED|Overall Study||209
392644|NCT00244010|961539|P2|NOT COMPLETED|Overall Study||0
392645|NCT00244010|961540|P1|NOT COMPLETED|Overall Study||0
392646|NCT00244010|961539|P2|COMPLETED|Overall Study||2
392647|NCT00244010|961540|P1|COMPLETED|Overall Study||2
392648|NCT00244010|961539|P2|STARTED|Overall Study||2
392649|NCT00244010|961540|P1|STARTED|Overall Study||2
392650|NCT00243932|961549|P3|NOT COMPLETED|Stage 2: Efficacy||0
392651|NCT00243932|961550|P2|NOT COMPLETED|Stage 2: Efficacy||0
392652|NCT00243932|961551|P1|NOT COMPLETED|Stage 2: Efficacy||0
392653|NCT00243932|961549|P3|COMPLETED|Stage 2: Efficacy||0
392654|NCT00243932|961550|P2|COMPLETED|Stage 2: Efficacy||40
392655|NCT00243932|961551|P1|COMPLETED|Stage 2: Efficacy||40
392656|NCT00243932|961549|P3|STARTED|Stage 2: Efficacy|No new pts. randomized because selection procedure in Stage 1 selected the 2,700 mg dose.|0
392657|NCT00243932|961550|P2|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
392739|NCT00243347|961755|P1|NOT COMPLETED|Overall Study||19
392658|NCT00243932|961551|P1|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
392659|NCT00243932|961549|P3|NOT COMPLETED|Stage 1: Dose Selection||0
392660|NCT00243932|961550|P2|NOT COMPLETED|Stage 1: Dose Selection||0
392661|NCT00243932|961551|P1|NOT COMPLETED|Stage 1: Dose Selection||2
392662|NCT00243932|961549|P3|COMPLETED|Stage 1: Dose Selection||35
392663|NCT00243932|961550|P2|COMPLETED|Stage 1: Dose Selection||35
392664|NCT00243932|961551|P1|COMPLETED|Stage 1: Dose Selection||33
392665|NCT00243932|961549|P3|STARTED|Stage 1: Dose Selection||35
392666|NCT00243932|961550|P2|STARTED|Stage 1: Dose Selection||35
392667|NCT00243932|961551|P1|STARTED|Stage 1: Dose Selection||35
392668|NCT00243919|961562|P3|NOT COMPLETED|Overall Study||11
392669|NCT00243919|961563|P2|NOT COMPLETED|Overall Study||18
392670|NCT00243919|961564|P1|NOT COMPLETED|Overall Study||17
392671|NCT00243919|961562|P3|COMPLETED|Overall Study||115
392672|NCT00243919|961563|P2|COMPLETED|Overall Study||125
392673|NCT00243919|961564|P1|COMPLETED|Overall Study||122
392674|NCT00243919|961562|P3|STARTED|Overall Study||126
392675|NCT00243919|961563|P2|STARTED|Overall Study||143
392676|NCT00243919|961564|P1|STARTED|Overall Study||139
392677|NCT00243841|961608|P6|NOT COMPLETED|Overall Study||2
392678|NCT00243841|961609|P5|NOT COMPLETED|Overall Study||0
392679|NCT00243841|961610|P4|NOT COMPLETED|Overall Study||0
392680|NCT00243841|961611|P3|NOT COMPLETED|Overall Study||1
392681|NCT00243841|961612|P2|NOT COMPLETED|Overall Study||0
392682|NCT00243841|961613|P1|NOT COMPLETED|Overall Study||0
392683|NCT00243841|961608|P6|COMPLETED|Overall Study||19
392684|NCT00243841|961609|P5|COMPLETED|Overall Study||39
392685|NCT00243841|961610|P4|COMPLETED|Overall Study||3
392686|NCT00243841|961611|P3|COMPLETED|Overall Study||4
392687|NCT00243841|961612|P2|COMPLETED|Overall Study||6
392688|NCT00243841|961613|P1|COMPLETED|Overall Study||3
392689|NCT00243841|961608|P6|STARTED|Overall Study||21
392690|NCT00243841|961609|P5|STARTED|Overall Study||39
392691|NCT00243841|961610|P4|STARTED|Overall Study||3
392692|NCT00243841|961611|P3|STARTED|Overall Study||5
392693|NCT00243841|961612|P2|STARTED|Overall Study||6
392694|NCT00243841|961613|P1|STARTED|Overall Study||3
392695|NCT00243659|961635|P2|NOT COMPLETED|Overall Study||3
392696|NCT00243659|961636|P1|NOT COMPLETED|Overall Study||2
392697|NCT00243659|961635|P2|COMPLETED|Overall Study||5
392698|NCT00243659|961636|P1|COMPLETED|Overall Study||20
392699|NCT00243659|961635|P2|STARTED|Overall Study||8
392700|NCT00243659|961636|P1|STARTED|Overall Study||22
392701|NCT00243503|961644|P1|NOT COMPLETED|Overall Study||58
392702|NCT00243503|961644|P1|COMPLETED|Overall Study||2
392703|NCT00243503|961644|P1|STARTED|Overall Study|3 participants discontinued and only took Trastuzumab.|60
392704|NCT00243412|961661|P2|NOT COMPLETED|Overall Study||11
392705|NCT00243412|961662|P1|NOT COMPLETED|Overall Study||10
392706|NCT00243412|961661|P2|COMPLETED|Overall Study|Completed Week 104|10
392707|NCT00243412|961662|P1|COMPLETED|Overall Study|Completed Week 104|11
392708|NCT00243412|961661|P2|Safety Evaluable|Overall Study||20
392709|NCT00243412|961662|P1|Safety Evaluable|Overall Study||21
392710|NCT00243412|961661|P2|STARTED|Overall Study|Intent to treat|21
392711|NCT00243412|961662|P1|STARTED|Overall Study|Intent to treat|21
392712|NCT00243386|961688|P3|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
392713|NCT00243386|961689|P2|NOT COMPLETED|PK-Driven or Standard Prophylaxis||3
392714|NCT00243386|961690|P1|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
392715|NCT00243386|961688|P3|COMPLETED|PK-Driven or Standard Prophylaxis||32
392716|NCT00243386|961689|P2|COMPLETED|PK-Driven or Standard Prophylaxis||31
392717|NCT00243386|961690|P1|COMPLETED|PK-Driven or Standard Prophylaxis||0
392718|NCT00243386|961688|P3|STARTED|PK-Driven or Standard Prophylaxis||32
392719|NCT00243386|961689|P2|STARTED|PK-Driven or Standard Prophylaxis||34
392720|NCT00243386|961690|P1|STARTED|PK-Driven or Standard Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
392721|NCT00243386|961688|P3|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
392722|NCT00243386|961689|P2|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
392723|NCT00243386|961690|P1|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||3
392724|NCT00243386|961688|P3|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
392725|NCT00243386|961689|P2|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
392726|NCT00243386|961690|P1|COMPLETED|End of Part 1, But Prior to Prophylaxis||66
392727|NCT00243386|961688|P3|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
392728|NCT00243386|961689|P2|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
392729|NCT00243386|961690|P1|STARTED|End of Part 1, But Prior to Prophylaxis||69
392730|NCT00243386|961688|P3|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
392731|NCT00243386|961689|P2|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
392732|NCT00243386|961690|P1|NOT COMPLETED|On-Demand Regimen (Study Part 1)||4
392733|NCT00243386|961688|P3|COMPLETED|On-Demand Regimen (Study Part 1)||0
392734|NCT00243386|961689|P2|COMPLETED|On-Demand Regimen (Study Part 1)||0
392735|NCT00243386|961690|P1|COMPLETED|On-Demand Regimen (Study Part 1)||69
392736|NCT00243386|961688|P3|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
392737|NCT00243386|961689|P2|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
392738|NCT00243386|961690|P1|STARTED|On-Demand Regimen (Study Part 1)||73
392740|NCT00243347|961755|P1|COMPLETED|Overall Study|Completed study|0
392741|NCT00243347|961755|P1|STARTED|Overall Study|Treated|19
392742|NCT00243269|961764|P4|NOT COMPLETED|Overall Study||4
392743|NCT00243269|961765|P3|NOT COMPLETED|Overall Study||1
392744|NCT00243269|961766|P2|NOT COMPLETED|Overall Study||1
392745|NCT00243269|961767|P1|NOT COMPLETED|Overall Study||3
392746|NCT00243269|961764|P4|COMPLETED|Overall Study||25
392747|NCT00243269|961765|P3|COMPLETED|Overall Study||11
392748|NCT00243269|961766|P2|COMPLETED|Overall Study||10
392749|NCT00243269|961767|P1|COMPLETED|Overall Study||28
392750|NCT00243269|961764|P4|STARTED|Overall Study||29
392751|NCT00243269|961765|P3|STARTED|Overall Study||12
392752|NCT00243269|961766|P2|STARTED|Overall Study||11
392753|NCT00243269|961767|P1|STARTED|Overall Study||31
392754|NCT00243243|961783|P2|NOT COMPLETED|Overall Study||0
392755|NCT00243243|961784|P1|NOT COMPLETED|Overall Study||0
392756|NCT00243243|961783|P2|COMPLETED|Overall Study||10
392757|NCT00243243|961784|P1|COMPLETED|Overall Study||10
392758|NCT00243243|961783|P2|STARTED|Overall Study||10
392759|NCT00243243|961784|P1|STARTED|Overall Study||10
392760|NCT00243191|961790|P1|NOT COMPLETED|Overall Study||0
392761|NCT00243191|961790|P1|COMPLETED|Overall Study||18
392762|NCT00243191|961790|P1|STARTED|Overall Study||18
392763|NCT00243152|961794|P2|NOT COMPLETED|Overall Study||0
392764|NCT00243152|961795|P1|NOT COMPLETED|Overall Study||0
392765|NCT00243152|961794|P2|COMPLETED|Overall Study||3
392766|NCT00243152|961795|P1|COMPLETED|Overall Study||3
392767|NCT00243152|961794|P2|Scan 2: Placebo or Drug|Overall Study||3
392768|NCT00243152|961795|P1|Scan 2: Placebo or Drug|Overall Study||3
392769|NCT00243152|961794|P2|Scan 1: Drug or Placebo|Overall Study||3
392770|NCT00243152|961795|P1|Scan 1: Drug or Placebo|Overall Study||3
392771|NCT00243152|961794|P2|STARTED|Overall Study||3
392772|NCT00243152|961795|P1|STARTED|Overall Study||3
392773|NCT00243074|961802|P1|NOT COMPLETED|Overall Study||54
392774|NCT00243074|961802|P1|COMPLETED|Overall Study||0
392775|NCT00243074|961802|P1|STARTED|Overall Study||54
392776|NCT00243061|961812|P1|NOT COMPLETED|Overall Study||0
392777|NCT00243061|961812|P1|COMPLETED|Overall Study||24
392778|NCT00243061|961812|P1|STARTED|Overall Study||24
392779|NCT00243022|961828|P2|NOT COMPLETED|Overall Study||1
392780|NCT00243022|961829|P1|NOT COMPLETED|Overall Study||2
392781|NCT00243022|961828|P2|COMPLETED|Overall Study||4
392782|NCT00243022|961829|P1|COMPLETED|Overall Study||5
392783|NCT00243022|961828|P2|STARTED|Overall Study||5
392784|NCT00243022|961829|P1|STARTED|Overall Study||7
392785|NCT00242710|961853|P4|NOT COMPLETED|Study Extension (up to Year 2)||10
392786|NCT00242710|961854|P3|NOT COMPLETED|Study Extension (up to Year 2)||15
392787|NCT00242710|961855|P2|NOT COMPLETED|Study Extension (up to Year 2)||29
392788|NCT00242710|961856|P1|NOT COMPLETED|Study Extension (up to Year 2)||27
392789|NCT00242710|961853|P4|COMPLETED|Study Extension (up to Year 2)||84
392790|NCT00242710|961854|P3|COMPLETED|Study Extension (up to Year 2)||69
392791|NCT00242710|961855|P2|COMPLETED|Study Extension (up to Year 2)||148
392792|NCT00242710|961856|P1|COMPLETED|Study Extension (up to Year 2)||141
392793|NCT00242710|961853|P4|STARTED|Study Extension (up to Year 2)||94
392794|NCT00242710|961854|P3|STARTED|Study Extension (up to Year 2)||84
392795|NCT00242710|961855|P2|STARTED|Study Extension (up to Year 2)||177
392796|NCT00242710|961856|P1|STARTED|Study Extension (up to Year 2)||168
392797|NCT00242710|961853|P4|NOT COMPLETED|Period Between Core Study and Extension||49
392798|NCT00242710|961854|P3|NOT COMPLETED|Period Between Core Study and Extension||48
392799|NCT00242710|961855|P2|NOT COMPLETED|Period Between Core Study and Extension||112
392800|NCT00242710|961856|P1|NOT COMPLETED|Period Between Core Study and Extension||119
392801|NCT00242710|961853|P4|COMPLETED|Period Between Core Study and Extension||94
392802|NCT00242710|961854|P3|COMPLETED|Period Between Core Study and Extension||84
392803|NCT00242710|961855|P2|COMPLETED|Period Between Core Study and Extension||177
392804|NCT00242710|961856|P1|COMPLETED|Period Between Core Study and Extension||168
392805|NCT00242710|961853|P4|STARTED|Period Between Core Study and Extension||143
392806|NCT00242710|961854|P3|STARTED|Period Between Core Study and Extension||132
392807|NCT00242710|961855|P2|STARTED|Period Between Core Study and Extension||289
392808|NCT00242710|961856|P1|STARTED|Period Between Core Study and Extension||287
392809|NCT00242710|961853|P4|NOT COMPLETED|Core Study (up to Year 1)||31
392810|NCT00242710|961854|P3|NOT COMPLETED|Core Study (up to Year 1)||51
392811|NCT00242710|961855|P2|NOT COMPLETED|Core Study (up to Year 1)||64
392812|NCT00242710|961856|P1|NOT COMPLETED|Core Study (up to Year 1)||86
392813|NCT00242710|961853|P4|COMPLETED|Core Study (up to Year 1)||143
392814|NCT00242710|961854|P3|COMPLETED|Core Study (up to Year 1)||132
392815|NCT00242710|961855|P2|COMPLETED|Core Study (up to Year 1)||289
392816|NCT00242710|961856|P1|COMPLETED|Core Study (up to Year 1)||287
392817|NCT00242710|961853|P4|Treated|Core Study (up to Year 1)||172
392818|NCT00242710|961854|P3|Treated|Core Study (up to Year 1)||179
392819|NCT00242710|961855|P2|Treated|Core Study (up to Year 1)||349
392820|NCT00242710|961856|P1|Treated|Core Study (up to Year 1)||361
392821|NCT00242710|961853|P4|STARTED|Core Study (up to Year 1)||174
392822|NCT00242710|961854|P3|STARTED|Core Study (up to Year 1)||183
392823|NCT00242710|961855|P2|STARTED|Core Study (up to Year 1)||353
392824|NCT00242710|961856|P1|STARTED|Core Study (up to Year 1)||373
392825|NCT00242684|961906|P1|NOT COMPLETED|Overall Study||0
392826|NCT00242684|961906|P1|COMPLETED|Overall Study||446
392827|NCT00242684|961906|P1|STARTED|Overall Study||446
392828|NCT00242658|961913|P2|NOT COMPLETED|Overall Study||19
392829|NCT00242658|961914|P1|NOT COMPLETED|Overall Study||22
392830|NCT00242658|961913|P2|COMPLETED|Overall Study||188
392831|NCT00242658|961914|P1|COMPLETED|Overall Study||165
392832|NCT00242658|961913|P2|STARTED|Overall Study||207
392833|NCT00242658|961914|P1|STARTED|Overall Study||187
392834|NCT00242632|961924|P2|NOT COMPLETED|Overall Study||0
392835|NCT00242632|961925|P1|NOT COMPLETED|Overall Study||0
392836|NCT00242632|961924|P2|COMPLETED|Overall Study||11
392837|NCT00242632|961925|P1|COMPLETED|Overall Study||11
392838|NCT00242632|961924|P2|STARTED|Overall Study||11
392839|NCT00242632|961925|P1|STARTED|Overall Study||11
392840|NCT00242619|961933|P2|NOT COMPLETED|Overall Study||0
392841|NCT00242619|961934|P1|NOT COMPLETED|Overall Study||0
392842|NCT00242619|961933|P2|COMPLETED|Overall Study||4
392843|NCT00242619|961934|P1|COMPLETED|Overall Study||8
392844|NCT00242619|961933|P2|STARTED|Overall Study||4
392845|NCT00242619|961934|P1|STARTED|Overall Study||8
392846|NCT00242580|961945|P3|NOT COMPLETED|Overall Study||14
392847|NCT00242580|961946|P2|NOT COMPLETED|Overall Study||12
392848|NCT00242580|961947|P1|NOT COMPLETED|Overall Study||10
392849|NCT00242580|961945|P3|COMPLETED|Overall Study||24
392850|NCT00242580|961946|P2|COMPLETED|Overall Study||29
392851|NCT00242580|961947|P1|COMPLETED|Overall Study|"Completed indicates 12 month data."|22
392852|NCT00242580|961945|P3|STARTED|Overall Study||38
392853|NCT00242580|961946|P2|STARTED|Overall Study||41
392854|NCT00242580|961947|P1|STARTED|Overall Study||32
392855|NCT00242567|961972|P2|NOT COMPLETED|Overall Study||140
392856|NCT00242567|961973|P1|NOT COMPLETED|Overall Study||166
392857|NCT00242567|961972|P2|COMPLETED|Overall Study||123
392858|NCT00242567|961973|P1|COMPLETED|Overall Study||93
392859|NCT00242567|961972|P2|Never Received Study Drug|Overall Study||191
392860|NCT00242567|961973|P1|Never Received Study Drug|Overall Study||0
392861|NCT00242567|961972|P2|Received at Least 1 Dose of Study Drug|Overall Study||72
392862|NCT00242567|961973|P1|Received at Least 1 Dose of Study Drug|Overall Study||259
392863|NCT00242567|961972|P2|STARTED|Overall Study||263
392864|NCT00242567|961973|P1|STARTED|Overall Study||259
392865|NCT00242502|961989|P1|NOT COMPLETED|Overall Study||0
392866|NCT00242502|961989|P1|COMPLETED|Overall Study||59
392867|NCT00242502|961989|P1|STARTED|Overall Study||59
392868|NCT00242385|961993|P2|NOT COMPLETED|Period 2||0
392869|NCT00242385|961994|P1|NOT COMPLETED|Period 2||0
392870|NCT00242385|961993|P2|COMPLETED|Period 2||11
392871|NCT00242385|961994|P1|COMPLETED|Period 2||14
392872|NCT00242385|961993|P2|STARTED|Period 2||11
392873|NCT00242385|961994|P1|STARTED|Period 2||14
392874|NCT00242385|961993|P2|NOT COMPLETED|Period 1||0
392875|NCT00242385|961994|P1|NOT COMPLETED|Period 1||0
392876|NCT00242385|961993|P2|COMPLETED|Period 1||11
392877|NCT00242385|961994|P1|COMPLETED|Period 1||14
392878|NCT00242385|961993|P2|STARTED|Period 1||11
392879|NCT00242385|961994|P1|STARTED|Period 1||14
392880|NCT00242216|962020|P2|NOT COMPLETED|Overall Study||22
392881|NCT00242216|962021|P1|NOT COMPLETED|Overall Study||18
392882|NCT00242216|962020|P2|COMPLETED|Overall Study||15
392883|NCT00242216|962021|P1|COMPLETED|Overall Study||21
392884|NCT00242216|962020|P2|STARTED|Overall Study||37
392885|NCT00242216|962021|P1|STARTED|Overall Study||39
392886|NCT00241969|962031|P2|NOT COMPLETED|Overall Study||0
392887|NCT00241969|962032|P1|NOT COMPLETED|Overall Study||0
392888|NCT00241969|962031|P2|COMPLETED|Overall Study||42
392889|NCT00241969|962032|P1|COMPLETED|Overall Study||36
392890|NCT00241969|962031|P2|STARTED|Overall Study||42
392891|NCT00241969|962032|P1|STARTED|Overall Study||36
392892|NCT00241904|962044|P2|NOT COMPLETED|Overall Study||24
392893|NCT00241904|962045|P1|NOT COMPLETED|Overall Study||34
392894|NCT00241904|962044|P2|COMPLETED|Overall Study||240
392895|NCT00241904|962045|P1|COMPLETED|Overall Study||227
392896|NCT00241904|962044|P2|STARTED|Overall Study||264
392897|NCT00241904|962045|P1|STARTED|Overall Study||261
392898|NCT00241839|962059|P2|NOT COMPLETED|Overall Study||18
392899|NCT00241839|962060|P1|NOT COMPLETED|Overall Study||19
392900|NCT00241839|962059|P2|COMPLETED|Overall Study|N=53 represents number with both baseline and 8-10 week data. N<53 implies missing data.|53
392901|NCT00241839|962060|P1|COMPLETED|Overall Study|N=52 represents number with both baseline and 8-10 week data. N<52 implies missing data.|52
392902|NCT00241839|962059|P2|STARTED|Overall Study||71
392903|NCT00241839|962060|P1|STARTED|Overall Study||71
392904|NCT00241644|962076|P4|NOT COMPLETED|Second Efficacy Period (Year 2)||118
392905|NCT00241644|962077|P3|NOT COMPLETED|Second Efficacy Period (Year 2)||64
392906|NCT00241644|962078|P2|NOT COMPLETED|Second Efficacy Period (Year 2)||57
392907|NCT00241644|962079|P1|NOT COMPLETED|Second Efficacy Period (Year 2)||61
392908|NCT00241644|962076|P4|COMPLETED|Second Efficacy Period (Year 2)||1407
392909|NCT00241644|962077|P3|COMPLETED|Second Efficacy Period (Year 2)||682
392910|NCT00241644|962078|P2|COMPLETED|Second Efficacy Period (Year 2)||697
392911|NCT00241644|962079|P1|COMPLETED|Second Efficacy Period (Year 2)||710
392912|NCT00241644|962076|P4|STARTED|Second Efficacy Period (Year 2)||1525
392913|NCT00241644|962077|P3|STARTED|Second Efficacy Period (Year 2)||746
392914|NCT00241644|962078|P2|STARTED|Second Efficacy Period (Year 2)||754
392915|NCT00241644|962079|P1|STARTED|Second Efficacy Period (Year 2)||771
392916|NCT00241644|962076|P4|NOT COMPLETED|First Efficacy Period (Year 1)||495
392917|NCT00241644|962077|P3|NOT COMPLETED|First Efficacy Period (Year 1)||249
392918|NCT00241644|962078|P2|NOT COMPLETED|First Efficacy Period (Year 1)||268
392919|NCT00241644|962079|P1|NOT COMPLETED|First Efficacy Period (Year 1)||227
392920|NCT00241644|962076|P4|COMPLETED|First Efficacy Period (Year 1)||2803
392921|NCT00241644|962077|P3|COMPLETED|First Efficacy Period (Year 1)||1392
392922|NCT00241644|962078|P2|COMPLETED|First Efficacy Period (Year 1)||1383
392923|NCT00241644|962079|P1|COMPLETED|First Efficacy Period (Year 1)||1420
392924|NCT00241644|962076|P4|STARTED|First Efficacy Period (Year 1)||3298
392925|NCT00241644|962077|P3|STARTED|First Efficacy Period (Year 1)||1641
392926|NCT00241644|962078|P2|STARTED|First Efficacy Period (Year 1)||1651
392927|NCT00241644|962079|P1|STARTED|First Efficacy Period (Year 1)||1647
392928|NCT00241358|962164|P3|NOT COMPLETED|Overall Study||1
392929|NCT00241358|962165|P2|NOT COMPLETED|Overall Study||1
392930|NCT00241358|962166|P1|NOT COMPLETED|Overall Study||0
392931|NCT00241358|962164|P3|COMPLETED|Overall Study||20
392932|NCT00241358|962165|P2|COMPLETED|Overall Study||45
392933|NCT00241358|962166|P1|COMPLETED|Overall Study||25
392934|NCT00241358|962164|P3|STARTED|Overall Study||21
392935|NCT00241358|962165|P2|STARTED|Overall Study||46
392936|NCT00241358|962166|P1|STARTED|Overall Study||25
392937|NCT00241280|962199|P2|NOT COMPLETED|Overall Study||68
392938|NCT00241280|962200|P1|NOT COMPLETED|Overall Study||48
392939|NCT00241280|962199|P2|COMPLETED|Overall Study||186
392940|NCT00241280|962200|P1|COMPLETED|Overall Study||199
392941|NCT00241280|962199|P2|STARTED|Overall Study||254
392942|NCT00241280|962200|P1|STARTED|Overall Study||247
392943|NCT00241176|962208|P1|NOT COMPLETED|Overall Study||0
392944|NCT00241176|962208|P1|COMPLETED|Overall Study||11
392945|NCT00241176|962208|P1|STARTED|Overall Study||11
392946|NCT00240994|962215|P1|NOT COMPLETED|Overall Study||3
392947|NCT00240994|962215|P1|COMPLETED|Overall Study||32
392948|NCT00240994|962215|P1|STARTED|Overall Study||35
392949|NCT00240981|962221|P2|NOT COMPLETED|Overall Study||33
392950|NCT00240981|962222|P1|NOT COMPLETED|Overall Study||38
392951|NCT00240981|962221|P2|COMPLETED|Overall Study||70
392952|NCT00240981|962222|P1|COMPLETED|Overall Study||68
392953|NCT00240981|962221|P2|Intent to Treat Sample|Overall Study||83
392954|NCT00240981|962222|P1|Intent to Treat Sample|Overall Study||82
392955|NCT00240981|962221|P2|STARTED|Overall Study||103
392956|NCT00240981|962222|P1|STARTED|Overall Study||106
392957|NCT00240539|962250|P4|NOT COMPLETED|Overall Study||0
392958|NCT00240539|962251|P3|NOT COMPLETED|Overall Study||0
392959|NCT00240539|962252|P2|NOT COMPLETED|Overall Study||0
392960|NCT00240539|962253|P1|NOT COMPLETED|Overall Study||0
392961|NCT00240539|962250|P4|COMPLETED|Overall Study||1
392962|NCT00240539|962251|P3|COMPLETED|Overall Study||31
392963|NCT00240539|962252|P2|COMPLETED|Overall Study||2
392964|NCT00240539|962253|P1|COMPLETED|Overall Study||2
392965|NCT00240539|962250|P4|STARTED|Overall Study||1
392966|NCT00240539|962251|P3|STARTED|Overall Study||31
392967|NCT00240539|962252|P2|STARTED|Overall Study||2
392968|NCT00240539|962253|P1|STARTED|Overall Study||2
392969|NCT00240526|962275|P4|NOT COMPLETED|Year 20||0
392970|NCT00240526|962276|P3|NOT COMPLETED|Year 20||0
392971|NCT00240526|962277|P2|NOT COMPLETED|Year 20||0
392972|NCT00240526|962278|P1|NOT COMPLETED|Year 20||0
392973|NCT00240526|962275|P4|COMPLETED|Year 20||20
392974|NCT00240526|962276|P3|COMPLETED|Year 20||13
392975|NCT00240526|962277|P2|COMPLETED|Year 20||17
392976|NCT00240526|962278|P1|COMPLETED|Year 20||19
392977|NCT00240526|962275|P4|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|20
392978|NCT00240526|962276|P3|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|13
392979|NCT00240526|962277|P2|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|17
392980|NCT00240526|962278|P1|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|19
392981|NCT00240526|962275|P4|NOT COMPLETED|Year 19||0
392982|NCT00240526|962276|P3|NOT COMPLETED|Year 19||0
392983|NCT00240526|962277|P2|NOT COMPLETED|Year 19||0
392984|NCT00240526|962278|P1|NOT COMPLETED|Year 19||0
392985|NCT00240526|962275|P4|COMPLETED|Year 19||18
392986|NCT00240526|962276|P3|COMPLETED|Year 19||12
392987|NCT00240526|962277|P2|COMPLETED|Year 19||16
392988|NCT00240526|962278|P1|COMPLETED|Year 19||17
392989|NCT00240526|962275|P4|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|18
392990|NCT00240526|962276|P3|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|12
392991|NCT00240526|962277|P2|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|16
392992|NCT00240526|962278|P1|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|17
392993|NCT00240526|962275|P4|NOT COMPLETED|Year 18||0
392994|NCT00240526|962276|P3|NOT COMPLETED|Year 18||0
392995|NCT00240526|962277|P2|NOT COMPLETED|Year 18||0
392996|NCT00240526|962278|P1|NOT COMPLETED|Year 18||0
392997|NCT00240526|962275|P4|COMPLETED|Year 18||20
392998|NCT00240526|962276|P3|COMPLETED|Year 18||14
392999|NCT00240526|962277|P2|COMPLETED|Year 18||17
393000|NCT00240526|962278|P1|COMPLETED|Year 18||16
393001|NCT00240526|962275|P4|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|20
393002|NCT00240526|962276|P3|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|14
393003|NCT00240526|962277|P2|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|17
393004|NCT00240526|962278|P1|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|16
393005|NCT00240526|962275|P4|NOT COMPLETED|Year 17||0
393006|NCT00240526|962276|P3|NOT COMPLETED|Year 17||0
393007|NCT00240526|962277|P2|NOT COMPLETED|Year 17||0
393008|NCT00240526|962278|P1|NOT COMPLETED|Year 17||0
393009|NCT00240526|962275|P4|COMPLETED|Year 17||20
393010|NCT00240526|962276|P3|COMPLETED|Year 17||13
393011|NCT00240526|962277|P2|COMPLETED|Year 17||17
393012|NCT00240526|962278|P1|COMPLETED|Year 17||19
393013|NCT00240526|962275|P4|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|20
393014|NCT00240526|962276|P3|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|13
393015|NCT00240526|962277|P2|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|17
393016|NCT00240526|962278|P1|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|19
393017|NCT00240526|962275|P4|NOT COMPLETED|Year 16||0
393018|NCT00240526|962276|P3|NOT COMPLETED|Year 16||0
393019|NCT00240526|962277|P2|NOT COMPLETED|Year 16||0
393020|NCT00240526|962278|P1|NOT COMPLETED|Year 16||0
393021|NCT00240526|962275|P4|COMPLETED|Year 16||22
393022|NCT00240526|962276|P3|COMPLETED|Year 16||16
393023|NCT00240526|962277|P2|COMPLETED|Year 16||19
393024|NCT00240526|962278|P1|COMPLETED|Year 16||17
393025|NCT00240526|962275|P4|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|22
393026|NCT00240526|962276|P3|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|16
393027|NCT00240526|962277|P2|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|19
393028|NCT00240526|962278|P1|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|17
393029|NCT00240526|962275|P4|NOT COMPLETED|Year 15||0
393030|NCT00240526|962276|P3|NOT COMPLETED|Year 15||0
393031|NCT00240526|962277|P2|NOT COMPLETED|Year 15||0
393032|NCT00240526|962278|P1|NOT COMPLETED|Year 15||0
393033|NCT00240526|962275|P4|COMPLETED|Year 15||21
393034|NCT00240526|962276|P3|COMPLETED|Year 15||14
393035|NCT00240526|962277|P2|COMPLETED|Year 15||19
393036|NCT00240526|962278|P1|COMPLETED|Year 15||19
393037|NCT00240526|962275|P4|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|21
393038|NCT00240526|962276|P3|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|14
393039|NCT00240526|962277|P2|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
393040|NCT00240526|962278|P1|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
393041|NCT00240500|962314|P6|NOT COMPLETED|Overall Study||1
393042|NCT00240500|962315|P5|NOT COMPLETED|Overall Study||3
393043|NCT00240500|962316|P4|NOT COMPLETED|Overall Study||4
393044|NCT00240500|962317|P3|NOT COMPLETED|Overall Study||3
393045|NCT00240500|962318|P2|NOT COMPLETED|Overall Study||3
393046|NCT00240500|962319|P1|NOT COMPLETED|Overall Study||1
393047|NCT00240500|962314|P6|COMPLETED|Overall Study||2
393048|NCT00240500|962315|P5|COMPLETED|Overall Study||26
393049|NCT00240500|962316|P4|COMPLETED|Overall Study||19
393050|NCT00240500|962317|P3|COMPLETED|Overall Study||14
393051|NCT00240500|962318|P2|COMPLETED|Overall Study||17
393052|NCT00240500|962319|P1|COMPLETED|Overall Study||16
393053|NCT00240500|962314|P6|STARTED|Overall Study||3
393054|NCT00240500|962315|P5|STARTED|Overall Study||29
393055|NCT00240500|962316|P4|STARTED|Overall Study||23
393056|NCT00240500|962317|P3|STARTED|Overall Study||17
393057|NCT00240500|962318|P2|STARTED|Overall Study||20
393058|NCT00240500|962319|P1|STARTED|Overall Study||17
393059|NCT00240487|962341|P2|NOT COMPLETED|Overall Study||0
393060|NCT00240487|962342|P1|NOT COMPLETED|Overall Study||0
393061|NCT00240487|962341|P2|COMPLETED|Overall Study||28
393062|NCT00240487|962342|P1|COMPLETED|Overall Study||24
393063|NCT00240487|962341|P2|STARTED|Overall Study||28
393064|NCT00240487|962342|P1|STARTED|Overall Study||24
393065|NCT00240331|962350|P2|NOT COMPLETED|Overall Study||134
393066|NCT00240331|962351|P1|NOT COMPLETED|Overall Study||126
393067|NCT00240331|962350|P2|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1250
393068|NCT00240331|962351|P1|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1263
393069|NCT00240331|962350|P2|STARTED|Overall Study|One patient was incorrectly randomised and not included in the analyses|1384
393070|NCT00240331|962351|P1|STARTED|Overall Study|Two patients were incorrectly randomised and not included in the analyses.|1389
393071|NCT00240227|962369|P1|NOT COMPLETED|Overall Study||0
393072|NCT00240227|962369|P1|COMPLETED|Overall Study||8
393073|NCT00240227|962369|P1|STARTED|Overall Study||8
393074|NCT00240162|962385|P1|NOT COMPLETED|Overall Study||0
393075|NCT00240162|962385|P1|COMPLETED|Overall Study||21
393076|NCT00240162|962385|P1|STARTED|Overall Study||21
393077|NCT00240110|962394|P2|NOT COMPLETED|Overall Study||7
393078|NCT00240110|962395|P1|NOT COMPLETED|Overall Study||6
393079|NCT00240110|962394|P2|COMPLETED|Overall Study||6
393080|NCT00240110|962395|P1|COMPLETED|Overall Study||7
393081|NCT00240110|962394|P2|STARTED|Overall Study||13
393082|NCT00240110|962395|P1|STARTED|Overall Study||13
393083|NCT00240097|962403|P1|NOT COMPLETED|Part II||23
393084|NCT00240097|962403|P1|COMPLETED|Part II||3
393085|NCT00240097|962403|P1|STARTED|Part II||26
393086|NCT00240097|962403|P1|NOT COMPLETED|Part I||4
393087|NCT00240097|962403|P1|COMPLETED|Part I||26
393088|NCT00240097|962403|P1|STARTED|Part I||30
393089|NCT00240071|962413|P1|NOT COMPLETED|Overall Study||3
393090|NCT00240071|962413|P1|COMPLETED|Overall Study|3 patients withdrew consent after 29, 5 and 3 1/2 months on study.|27
393091|NCT00240071|962413|P1|STARTED|Overall Study||30
393092|NCT00239928|962418|P1|NOT COMPLETED|Overall Study||10
393093|NCT00239928|962418|P1|COMPLETED|Overall Study||51
393094|NCT00239928|962418|P1|STARTED|Overall Study||61
393095|NCT00239837|962430|P2|NOT COMPLETED|Overall Study||7
393096|NCT00239837|962431|P1|NOT COMPLETED|Overall Study||3
393097|NCT00239837|962430|P2|COMPLETED|Overall Study|3-year follow-up|45
393098|NCT00239837|962431|P1|COMPLETED|Overall Study|3-year follow-up|45
393099|NCT00239837|962430|P2|6 Months|Overall Study||50
393100|NCT00239837|962431|P1|6 Months|Overall Study||48
393101|NCT00239837|962430|P2|STARTED|Overall Study||52
393102|NCT00239837|962431|P1|STARTED|Overall Study||48
393103|NCT00239733|962451|P1|NOT COMPLETED|Overall Study||0
393104|NCT00239733|962451|P1|COMPLETED|Overall Study||6
393105|NCT00239733|962451|P1|STARTED|Overall Study||6
393106|NCT00239720|962458|P2|NOT COMPLETED|Overall Study||1
393107|NCT00239720|962459|P1|NOT COMPLETED|Overall Study||1
393108|NCT00239720|962458|P2|COMPLETED|Overall Study|One participant lost to follow-up|0
393109|NCT00239720|962459|P1|COMPLETED|Overall Study|One participant discontinued due to an adverse event|2
393110|NCT00239720|962458|P2|STARTED|Overall Study||1
393111|NCT00239720|962459|P1|STARTED|Overall Study||3
393112|NCT00239681|962467|P2|NOT COMPLETED|Overall Study||715
393113|NCT00239681|962468|P1|NOT COMPLETED|Overall Study||693
393114|NCT00239681|962467|P2|COMPLETED|Overall Study||8186
393115|NCT00239681|962468|P1|COMPLETED|Overall Study||8208
393116|NCT00239681|962467|P2|Randomized and Treated (Safety Pop)|Overall Study||8864
393117|NCT00239681|962468|P1|Randomized and Treated (Safety Pop)|Overall Study||8869
393118|NCT00239681|962467|P2|STARTED|Overall Study||8901
393119|NCT00239681|962468|P1|STARTED|Overall Study||8901
393120|NCT00239642|962487|P3|NOT COMPLETED|Overall Study||2
393121|NCT00239642|962488|P2|NOT COMPLETED|Overall Study||0
393122|NCT00239642|962489|P1|NOT COMPLETED|Overall Study||2
393123|NCT00239642|962487|P3|COMPLETED|Overall Study||47
393124|NCT00239642|962488|P2|COMPLETED|Overall Study||47
393125|NCT00239642|962489|P1|COMPLETED|Overall Study||47
393126|NCT00239642|962487|P3|STARTED|Overall Study||49
393127|NCT00239642|962488|P2|STARTED|Overall Study||47
393128|NCT00239642|962489|P1|STARTED|Overall Study||49
393129|NCT00239590|962521|P2|NOT COMPLETED|Completed Study Protocol||2
393130|NCT00239590|962522|P1|NOT COMPLETED|Completed Study Protocol||1
393131|NCT00239590|962521|P2|COMPLETED|Completed Study Protocol||10
393132|NCT00239590|962522|P1|COMPLETED|Completed Study Protocol||13
393133|NCT00239590|962521|P2|STARTED|Completed Study Protocol||12
393134|NCT00239590|962522|P1|STARTED|Completed Study Protocol||14
393135|NCT00239590|962521|P2|NOT COMPLETED|Started Intervention After Randomization||0
393136|NCT00239590|962522|P1|NOT COMPLETED|Started Intervention After Randomization||0
393137|NCT00239590|962521|P2|COMPLETED|Started Intervention After Randomization||12
393138|NCT00239590|962522|P1|COMPLETED|Started Intervention After Randomization||14
393139|NCT00239590|962521|P2|STARTED|Started Intervention After Randomization||12
393140|NCT00239590|962522|P1|STARTED|Started Intervention After Randomization||14
393141|NCT00239590|962521|P2|NOT COMPLETED|Randomized||2
393142|NCT00239590|962522|P1|NOT COMPLETED|Randomized||0
393143|NCT00239590|962521|P2|COMPLETED|Randomized||12
393144|NCT00239590|962522|P1|COMPLETED|Randomized||14
393145|NCT00239590|962521|P2|STARTED|Randomized||14
393146|NCT00239590|962522|P1|STARTED|Randomized||14
393147|NCT00239577|962534|P4|NOT COMPLETED|Booster Phase||0
393148|NCT00239577|962535|P3|NOT COMPLETED|Booster Phase||0
393149|NCT00239577|962536|P2|NOT COMPLETED|Booster Phase||0
393150|NCT00239577|962537|P1|NOT COMPLETED|Booster Phase||0
393151|NCT00239577|962534|P4|COMPLETED|Booster Phase|The subjects belonging to this group did not receive an additional dose of Placebo.|0
393152|NCT00239577|962535|P3|COMPLETED|Booster Phase||12
393153|NCT00239577|962536|P2|COMPLETED|Booster Phase||9
393154|NCT00239577|962537|P1|COMPLETED|Booster Phase|The subjects belonging to this group did not receive a booster dose of Dengue vaccine.|0
393155|NCT00239577|962534|P4|STARTED|Booster Phase|The subjects belonging to this group did not receive an additional dose of Placebo.|0
393156|NCT00239577|962535|P3|STARTED|Booster Phase||12
393157|NCT00239577|962536|P2|STARTED|Booster Phase||9
393158|NCT00239577|962537|P1|STARTED|Booster Phase|The subjects belonging to this group did not receive a booster dose of Dengue vaccine.|0
393159|NCT00239577|962534|P4|NOT COMPLETED|Primary Phase||0
393160|NCT00239577|962535|P3|NOT COMPLETED|Primary Phase||3
393161|NCT00239577|962536|P2|NOT COMPLETED|Primary Phase||3
393162|NCT00239577|962537|P1|NOT COMPLETED|Primary Phase||5
393163|NCT00239577|962534|P4|COMPLETED|Primary Phase||21
393164|NCT00239577|962535|P3|COMPLETED|Primary Phase||18
393165|NCT00239577|962536|P2|COMPLETED|Primary Phase||19
393166|NCT00239577|962537|P1|COMPLETED|Primary Phase||17
393167|NCT00239577|962534|P4|STARTED|Primary Phase||21
393168|NCT00239577|962535|P3|STARTED|Primary Phase||21
393169|NCT00239577|962536|P2|STARTED|Primary Phase||22
393170|NCT00239577|962537|P1|STARTED|Primary Phase||22
393171|NCT00239356|962641|P2|NOT COMPLETED|Overall Study||9
393172|NCT00239356|962642|P1|NOT COMPLETED|Overall Study||39
393173|NCT00239356|962641|P2|COMPLETED|Overall Study||11
393174|NCT00239356|962642|P1|COMPLETED|Overall Study||58
393175|NCT00239356|962641|P2|STARTED|Overall Study||20
393176|NCT00239356|962642|P1|STARTED|Overall Study||97
393177|NCT00239226|962664|P4|NOT COMPLETED|Overall Study||3
393178|NCT00239226|962665|P3|NOT COMPLETED|Overall Study||1
393179|NCT00239226|962666|P2|NOT COMPLETED|Overall Study||0
393180|NCT00239226|962667|P1|NOT COMPLETED|Overall Study||1
393181|NCT00239226|962664|P4|COMPLETED|Overall Study||14
393182|NCT00239226|962665|P3|COMPLETED|Overall Study||36
393183|NCT00239226|962666|P2|COMPLETED|Overall Study||18
393184|NCT00239226|962667|P1|COMPLETED|Overall Study||29
393185|NCT00239226|962664|P4|STARTED|Overall Study||17
393186|NCT00239226|962665|P3|STARTED|Overall Study||37
393187|NCT00239226|962666|P2|STARTED|Overall Study||18
393188|NCT00239226|962667|P1|STARTED|Overall Study||30
393189|NCT00239005|962679|P2|NOT COMPLETED|Overall Study||12
393190|NCT00239005|962680|P1|NOT COMPLETED|Overall Study||12
393191|NCT00239005|962679|P2|COMPLETED|Overall Study||53
393192|NCT00239005|962680|P1|COMPLETED|Overall Study||57
393193|NCT00239005|962679|P2|Intention-to-treat Population (ITT)|Overall Study||61
393194|NCT00239005|962680|P1|Intention-to-treat Population (ITT)|Overall Study||68
393195|NCT00239005|962679|P2|STARTED|Overall Study||65
393196|NCT00239005|962680|P1|STARTED|Overall Study||69
393197|NCT00238615|962690|P1|NOT COMPLETED|Overall Study||0
393198|NCT00238615|962690|P1|COMPLETED|Overall Study||13
393199|NCT00238615|962690|P1|STARTED|Overall Study||13
393200|NCT00238433|962696|P1|NOT COMPLETED|Overall Study||3
393201|NCT00238433|962696|P1|COMPLETED|Overall Study||34
393202|NCT00238433|962696|P1|STARTED|Overall Study||37
393203|NCT00238420|962703|P2|NOT COMPLETED|Overall Study||1
393204|NCT00238420|962704|P1|NOT COMPLETED|Overall Study||1
393205|NCT00238420|962703|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
393206|NCT00238420|962704|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|21
393207|NCT00238420|962703|P2|STARTED|Overall Study||48
393208|NCT00238420|962704|P1|STARTED|Overall Study||22
393209|NCT00238355|962714|P1|NOT COMPLETED|Overall Study||3
393210|NCT00238355|962714|P1|COMPLETED|Overall Study||10
393211|NCT00238355|962714|P1|STARTED|Overall Study||13
393212|NCT00238303|962721|P3|NOT COMPLETED|Overall Study||9
393213|NCT00238303|962722|P2|NOT COMPLETED|Overall Study||2
393214|NCT00238303|962723|P1|NOT COMPLETED|Overall Study||15
393215|NCT00238303|962721|P3|COMPLETED|Overall Study||11
393216|NCT00238303|962722|P2|COMPLETED|Overall Study||13
393217|NCT00238303|962723|P1|COMPLETED|Overall Study||53
393218|NCT00238303|962721|P3|STARTED|Overall Study||20
393219|NCT00238303|962722|P2|STARTED|Overall Study||15
393220|NCT00238303|962723|P1|STARTED|Overall Study||68
393221|NCT00238264|962740|P1|NOT COMPLETED|Overall Study||36
393222|NCT00238264|962740|P1|COMPLETED|Overall Study||56
393223|NCT00238264|962740|P1|STARTED|Overall Study||92
393224|NCT00238238|962753|P3|NOT COMPLETED|Overall Study||0
393225|NCT00238238|962754|P2|NOT COMPLETED|Overall Study||3
393226|NCT00238238|962755|P1|NOT COMPLETED|Overall Study||0
393227|NCT00238238|962753|P3|COMPLETED|Overall Study||46
393228|NCT00238238|962754|P2|COMPLETED|Overall Study||45
393229|NCT00238238|962755|P1|COMPLETED|Overall Study||3
393230|NCT00238238|962753|P3|STARTED|Overall Study||46
393231|NCT00238238|962754|P2|STARTED|Overall Study||48
393232|NCT00238238|962755|P1|STARTED|Overall Study||3
393233|NCT00238121|962768|P2|NOT COMPLETED|Overall Study||2
393234|NCT00238121|962769|P1|NOT COMPLETED|Overall Study||3
393235|NCT00238121|962768|P2|COMPLETED|Overall Study||14
393236|NCT00238121|962769|P1|COMPLETED|Overall Study||37
393237|NCT00238121|962768|P2|STARTED|Overall Study||16
393238|NCT00238121|962769|P1|STARTED|Overall Study||40
393239|NCT00238108|962782|P2|NOT COMPLETED|Overall Study||0
393240|NCT00238108|962783|P1|NOT COMPLETED|Overall Study||0
393241|NCT00238108|962782|P2|COMPLETED|Overall Study||8
393242|NCT00238108|962783|P1|COMPLETED|Overall Study||8
393243|NCT00238108|962782|P2|STARTED|Overall Study||8
393244|NCT00238108|962783|P1|STARTED|Overall Study||8
393245|NCT00237809|962795|P4|NOT COMPLETED|Overall Study||9
393246|NCT00237809|962796|P3|NOT COMPLETED|Overall Study||9
393247|NCT00237809|962797|P2|NOT COMPLETED|Overall Study||10
393248|NCT00237809|962798|P1|NOT COMPLETED|Overall Study||11
393249|NCT00237809|962795|P4|COMPLETED|Overall Study||17
393250|NCT00237809|962796|P3|COMPLETED|Overall Study||15
393251|NCT00237809|962797|P2|COMPLETED|Overall Study||17
393252|NCT00237809|962798|P1|COMPLETED|Overall Study||16
393253|NCT00237809|962795|P4|STARTED|Overall Study||26
393254|NCT00237809|962796|P3|STARTED|Overall Study||24
393255|NCT00237809|962797|P2|STARTED|Overall Study||27
393256|NCT00237809|962798|P1|STARTED|Overall Study||27
393257|NCT00237796|962834|P2|NOT COMPLETED|Overall Study||5
393258|NCT00237796|962835|P1|NOT COMPLETED|Overall Study||10
393259|NCT00237796|962834|P2|COMPLETED|Overall Study||33
393260|NCT00237796|962835|P1|COMPLETED|Overall Study||31
393261|NCT00237796|962834|P2|STARTED|Overall Study||38
393262|NCT00237796|962835|P1|STARTED|Overall Study||41
393263|NCT00237770|962855|P2|NOT COMPLETED|Overall Study||0
393264|NCT00237770|962856|P1|NOT COMPLETED|Overall Study||0
393265|NCT00237770|962855|P2|COMPLETED|Overall Study||7
393266|NCT00237770|962856|P1|COMPLETED|Overall Study||9
393267|NCT00237770|962855|P2|STARTED|Overall Study||7
393268|NCT00237770|962856|P1|STARTED|Overall Study||9
393269|NCT00237744|962869|P3|NOT COMPLETED|Overall Study||0
393270|NCT00237744|962870|P2|NOT COMPLETED|Overall Study||1
393271|NCT00237744|962871|P1|NOT COMPLETED|Overall Study||3
393272|NCT00237744|962869|P3|COMPLETED|Overall Study||18
393273|NCT00237744|962870|P2|COMPLETED|Overall Study||10
393274|NCT00237744|962871|P1|COMPLETED|Overall Study||8
393275|NCT00237744|962869|P3|STARTED|Overall Study||18
393276|NCT00237744|962870|P2|STARTED|Overall Study||11
393277|NCT00237744|962871|P1|STARTED|Overall Study||11
393278|NCT00237718|962884|P2|NOT COMPLETED|Overall Study||41
393279|NCT00237718|962885|P1|NOT COMPLETED|Overall Study||46
393280|NCT00237718|962884|P2|COMPLETED|Overall Study||124
393281|NCT00237718|962885|P1|COMPLETED|Overall Study||114
393282|NCT00237718|962884|P2|STARTED|Overall Study||165
393283|NCT00237718|962885|P1|STARTED|Overall Study||160
393284|NCT00237692|962897|P4|NOT COMPLETED|Overall Study||19
393285|NCT00237692|962898|P3|NOT COMPLETED|Overall Study||22
393286|NCT00237692|962899|P2|NOT COMPLETED|Overall Study||14
393287|NCT00237692|962900|P1|NOT COMPLETED|Overall Study||18
393288|NCT00237692|962897|P4|COMPLETED|Overall Study||128
393289|NCT00237692|962898|P3|COMPLETED|Overall Study||127
393290|NCT00237692|962899|P2|COMPLETED|Overall Study||134
393291|NCT00237692|962900|P1|COMPLETED|Overall Study||129
393292|NCT00237692|962897|P4|18 Month f/u|Overall Study||122
393293|NCT00237692|962898|P3|18 Month f/u|Overall Study||126
393294|NCT00237692|962899|P2|18 Month f/u|Overall Study||131
393295|NCT00237692|962900|P1|18 Month f/u|Overall Study||124
393296|NCT00237692|962897|P4|12 Month f/u|Overall Study||127
393297|NCT00237692|962898|P3|12 Month f/u|Overall Study||132
393298|NCT00237692|962899|P2|12 Month f/u|Overall Study||127
393299|NCT00237692|962900|P1|12 Month f/u|Overall Study||137
393300|NCT00237692|962897|P4|6 Month f/u|Overall Study||134
393301|NCT00237692|962898|P3|6 Month f/u|Overall Study||135
393302|NCT00237692|962899|P2|6 Month f/u|Overall Study||134
393303|NCT00237692|962900|P1|6 Month f/u|Overall Study||132
393304|NCT00237692|962897|P4|STARTED|Overall Study||147
393305|NCT00237692|962898|P3|STARTED|Overall Study||149
393306|NCT00237692|962899|P2|STARTED|Overall Study||148
393307|NCT00237692|962900|P1|STARTED|Overall Study||147
393308|NCT00237666|962930|P1|NOT COMPLETED|Overall Study||6
393309|NCT00237666|962930|P1|COMPLETED|Overall Study||24
393310|NCT00237666|962930|P1|STARTED|Overall Study||30
393311|NCT00237458|962940|P1|NOT COMPLETED|Overall Study||3
393312|NCT00237458|962940|P1|COMPLETED|Overall Study||4
393313|NCT00237458|962940|P1|STARTED|Overall Study||7
393314|NCT00237185|962958|P2|NOT COMPLETED|Extension||19
393315|NCT00237185|962959|P1|NOT COMPLETED|Extension||16
393316|NCT00237185|962958|P2|COMPLETED|Extension||13
393317|NCT00237185|962959|P1|COMPLETED|Extension||8
393318|NCT00237185|962958|P2|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|32
393319|NCT00237185|962959|P1|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|24
393320|NCT00237185|962958|P2|NOT COMPLETED|Core||37
393321|NCT00237185|962959|P1|NOT COMPLETED|Core||44
393322|NCT00237185|962958|P2|COMPLETED|Core||37
393323|NCT00237185|962959|P1|COMPLETED|Core||30
393324|NCT00237185|962958|P2|Treated Participants|Core||74
393325|NCT00237185|962959|P1|Treated Participants|Core||73
393326|NCT00237185|962958|P2|STARTED|Core||74
393327|NCT00237185|962959|P1|STARTED|Core||74
393328|NCT00237042|962990|P3|NOT COMPLETED|Long Term (12 Month) Follow up||9
393329|NCT00237042|962991|P2|NOT COMPLETED|Long Term (12 Month) Follow up||9
393330|NCT00237042|962992|P1|NOT COMPLETED|Long Term (12 Month) Follow up||11
393331|NCT00237042|962990|P3|COMPLETED|Long Term (12 Month) Follow up||48
393332|NCT00237042|962991|P2|COMPLETED|Long Term (12 Month) Follow up||46
393333|NCT00237042|962992|P1|COMPLETED|Long Term (12 Month) Follow up||48
393334|NCT00237042|962990|P3|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
393335|NCT00237042|962991|P2|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
393336|NCT00237042|962992|P1|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
393337|NCT00237042|962990|P3|NOT COMPLETED|Short Term (6 Month) Follow up||11
393338|NCT00237042|962991|P2|NOT COMPLETED|Short Term (6 Month) Follow up||8
393339|NCT00237042|962992|P1|NOT COMPLETED|Short Term (6 Month) Follow up||9
393340|NCT00237042|962990|P3|COMPLETED|Short Term (6 Month) Follow up||46
393341|NCT00237042|962991|P2|COMPLETED|Short Term (6 Month) Follow up||47
393342|NCT00237042|962992|P1|COMPLETED|Short Term (6 Month) Follow up||50
393343|NCT00237042|962990|P3|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
393344|NCT00237042|962991|P2|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
393345|NCT00237042|962992|P1|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
393346|NCT00237042|962990|P3|NOT COMPLETED|Treatment||38
393347|NCT00237042|962991|P2|NOT COMPLETED|Treatment||7
393348|NCT00237042|962992|P1|NOT COMPLETED|Treatment||6
393349|NCT00237042|962990|P3|COMPLETED|Treatment||36
393350|NCT00237042|962991|P2|COMPLETED|Treatment||50
393351|NCT00237042|962992|P1|COMPLETED|Treatment||54
393352|NCT00237042|962990|P3|STARTED|Treatment||74
393353|NCT00237042|962991|P2|STARTED|Treatment||57
393354|NCT00237042|962992|P1|STARTED|Treatment||60
393355|NCT00236977|963011|P2|NOT COMPLETED|Overall Study||19
393356|NCT00236977|963012|P1|NOT COMPLETED|Overall Study||21
393357|NCT00236977|963011|P2|COMPLETED|Overall Study||72
393358|NCT00236977|963012|P1|COMPLETED|Overall Study||70
393359|NCT00236977|963011|P2|STARTED|Overall Study||91
393360|NCT00236977|963012|P1|STARTED|Overall Study||91
393361|NCT00236951|963034|P4|NOT COMPLETED|Overall Study||31
393362|NCT00236951|963035|P3|NOT COMPLETED|Overall Study||19
393363|NCT00236951|963036|P2|NOT COMPLETED|Overall Study||31
393364|NCT00236951|963037|P1|NOT COMPLETED|Overall Study||26
393365|NCT00236951|963034|P4|COMPLETED|Overall Study||17
393366|NCT00236951|963035|P3|COMPLETED|Overall Study||21
393367|NCT00236951|963036|P2|COMPLETED|Overall Study||46
393368|NCT00236951|963037|P1|COMPLETED|Overall Study||33
393369|NCT00236951|963034|P4|STARTED|Overall Study||48
393370|NCT00236951|963035|P3|STARTED|Overall Study||40
393371|NCT00236951|963036|P2|STARTED|Overall Study||77
393372|NCT00236951|963037|P1|STARTED|Overall Study||59
393373|NCT00236938|963049|P2|NOT COMPLETED|Overall Study||20
393374|NCT00236938|963050|P1|NOT COMPLETED|Overall Study||13
393375|NCT00236938|963049|P2|COMPLETED|Overall Study||26
393376|NCT00236938|963050|P1|COMPLETED|Overall Study||62
393377|NCT00236938|963049|P2|STARTED|Overall Study||46
393378|NCT00236938|963050|P1|STARTED|Overall Study||75
393379|NCT00236899|963066|P4|NOT COMPLETED|Overall Study||40
393380|NCT00236899|963067|P3|NOT COMPLETED|Overall Study||44
393381|NCT00236899|963068|P2|NOT COMPLETED|Overall Study||40
393382|NCT00236899|963069|P1|NOT COMPLETED|Overall Study||42
393383|NCT00236899|963066|P4|COMPLETED|Overall Study||19
393384|NCT00236899|963067|P3|COMPLETED|Overall Study||14
393385|NCT00236899|963068|P2|COMPLETED|Overall Study||24
393386|NCT00236899|963069|P1|COMPLETED|Overall Study||18
393387|NCT00236899|963066|P4|STARTED|Overall Study||59
393388|NCT00236899|963067|P3|STARTED|Overall Study||58
393389|NCT00236899|963068|P2|STARTED|Overall Study||64
393390|NCT00236899|963069|P1|STARTED|Overall Study||60
393391|NCT00236197|963101|P2|NOT COMPLETED|Overall Study||14
393392|NCT00236197|963102|P1|NOT COMPLETED|Overall Study||5
393393|NCT00236197|963101|P2|COMPLETED|Overall Study||293
393394|NCT00236197|963102|P1|COMPLETED|Overall Study||307
393395|NCT00236197|963101|P2|STARTED|Overall Study||307
393396|NCT00236197|963102|P1|STARTED|Overall Study||312
393397|NCT00236184|963110|P2|NOT COMPLETED|Overall Study||11
393398|NCT00236184|963111|P1|NOT COMPLETED|Overall Study||18
393399|NCT00236184|963110|P2|COMPLETED|Overall Study||308
393400|NCT00236184|963111|P1|COMPLETED|Overall Study||292
393401|NCT00236184|963110|P2|STARTED|Overall Study||319
393402|NCT00236184|963111|P1|STARTED|Overall Study||310
393403|NCT00236080|963122|P5|NOT COMPLETED|Overall Study||1
393404|NCT00236080|963123|P4|NOT COMPLETED|Overall Study||2
393405|NCT00236080|963124|P3|NOT COMPLETED|Overall Study||5
393406|NCT00236080|963125|P2|NOT COMPLETED|Overall Study||1
393407|NCT00236080|963126|P1|NOT COMPLETED|Overall Study||2
393408|NCT00236080|963122|P5|COMPLETED|Overall Study||26
393409|NCT00236080|963123|P4|COMPLETED|Overall Study||23
393410|NCT00236080|963124|P3|COMPLETED|Overall Study||22
393411|NCT00236080|963125|P2|COMPLETED|Overall Study||27
393412|NCT00236080|963126|P1|COMPLETED|Overall Study||27
393413|NCT00236080|963122|P5|STARTED|Overall Study||27
393414|NCT00236080|963123|P4|STARTED|Overall Study||25
393415|NCT00236080|963124|P3|STARTED|Overall Study||27
393416|NCT00236080|963125|P2|STARTED|Overall Study||28
393417|NCT00236080|963126|P1|STARTED|Overall Study||29
393418|NCT00235989|963147|P6|NOT COMPLETED|Extension Treatment Period (ET)||0
393419|NCT00235989|963148|P5|NOT COMPLETED|Extension Treatment Period (ET)||0
393420|NCT00235989|963149|P4|NOT COMPLETED|Extension Treatment Period (ET)||6
393421|NCT00235989|963150|P3|NOT COMPLETED|Extension Treatment Period (ET)||5
393422|NCT00235989|963151|P2|NOT COMPLETED|Extension Treatment Period (ET)||4
393423|NCT00235989|963152|P1|NOT COMPLETED|Extension Treatment Period (ET)||8
393424|NCT00235989|963147|P6|COMPLETED|Extension Treatment Period (ET)||0
393425|NCT00235989|963148|P5|COMPLETED|Extension Treatment Period (ET)||0
393426|NCT00235989|963149|P4|COMPLETED|Extension Treatment Period (ET)||14
393427|NCT00235989|963150|P3|COMPLETED|Extension Treatment Period (ET)||14
393428|NCT00235989|963151|P2|COMPLETED|Extension Treatment Period (ET)||2
393429|NCT00235989|963152|P1|COMPLETED|Extension Treatment Period (ET)||8
393430|NCT00235989|963147|P6|STARTED|Extension Treatment Period (ET)||0
393431|NCT00235989|963148|P5|STARTED|Extension Treatment Period (ET)||0
393432|NCT00235989|963149|P4|STARTED|Extension Treatment Period (ET)||20
393433|NCT00235989|963150|P3|STARTED|Extension Treatment Period (ET)||19
393434|NCT00235989|963151|P2|STARTED|Extension Treatment Period (ET)||6
393435|NCT00235989|963152|P1|STARTED|Extension Treatment Period (ET)||16
393436|NCT00235989|963147|P6|NOT COMPLETED|Core Treatment Period (CT)||2
393437|NCT00235989|963148|P5|NOT COMPLETED|Core Treatment Period (CT)||0
393438|NCT00235989|963149|P4|NOT COMPLETED|Core Treatment Period (CT)||0
393439|NCT00235989|963150|P3|NOT COMPLETED|Core Treatment Period (CT)||0
393440|NCT00235989|963151|P2|NOT COMPLETED|Core Treatment Period (CT)||0
393441|NCT00235989|963152|P1|NOT COMPLETED|Core Treatment Period (CT)||0
393442|NCT00235989|963147|P6|COMPLETED|Core Treatment Period (CT)||25
393443|NCT00235989|963148|P5|COMPLETED|Core Treatment Period (CT)||36
393444|NCT00235989|963149|P4|COMPLETED|Core Treatment Period (CT)||0
393445|NCT00235989|963150|P3|COMPLETED|Core Treatment Period (CT)||0
393446|NCT00235989|963151|P2|COMPLETED|Core Treatment Period (CT)||0
393447|NCT00235989|963152|P1|COMPLETED|Core Treatment Period (CT)||0
393448|NCT00235989|963147|P6|STARTED|Core Treatment Period (CT)||27
393449|NCT00235989|963148|P5|STARTED|Core Treatment Period (CT)||36
393450|NCT00235989|963149|P4|STARTED|Core Treatment Period (CT)||0
393451|NCT00235989|963150|P3|STARTED|Core Treatment Period (CT)||0
393452|NCT00235989|963151|P2|STARTED|Core Treatment Period (CT)||0
393453|NCT00235989|963152|P1|STARTED|Core Treatment Period (CT)||0
393454|NCT00235872|963166|P1|NOT COMPLETED|Overall Study||147
393455|NCT00235872|963166|P1|COMPLETED|Overall Study||162
393456|NCT00235872|963166|P1|STARTED|Overall Study||309
393457|NCT00235833|963181|P1|NOT COMPLETED|Overall Study||16
393458|NCT00235833|963181|P1|COMPLETED|Overall Study||9
393459|NCT00235833|963181|P1|STARTED|Overall Study||25
393460|NCT00235755|963197|P3|NOT COMPLETED|12-Week Maintenance Phase||31
393461|NCT00235755|963198|P2|NOT COMPLETED|12-Week Maintenance Phase||27
393462|NCT00235755|963199|P1|NOT COMPLETED|12-Week Maintenance Phase||16
393463|NCT00235755|963197|P3|COMPLETED|12-Week Maintenance Phase||122
393464|NCT00235755|963198|P2|COMPLETED|12-Week Maintenance Phase||135
393465|NCT00235755|963199|P1|COMPLETED|12-Week Maintenance Phase||152
393466|NCT00235755|963197|P3|STARTED|12-Week Maintenance Phase||153
393467|NCT00235755|963198|P2|STARTED|12-Week Maintenance Phase||162
393468|NCT00235755|963199|P1|STARTED|12-Week Maintenance Phase||168
393469|NCT00235755|963197|P3|NOT COMPLETED|4-Week Titration Phase||26
393470|NCT00235755|963198|P2|NOT COMPLETED|4-Week Titration Phase||19
393471|NCT00235755|963199|P1|NOT COMPLETED|4-Week Titration Phase||11
393472|NCT00235755|963197|P3|COMPLETED|4-Week Titration Phase||153
393473|NCT00235755|963198|P2|COMPLETED|4-Week Titration Phase||162
393474|NCT00235755|963199|P1|COMPLETED|4-Week Titration Phase||168
393475|NCT00235755|963197|P3|STARTED|4-Week Titration Phase||179
393476|NCT00235755|963198|P2|STARTED|4-Week Titration Phase||181
393477|NCT00235755|963199|P1|STARTED|4-Week Titration Phase||179
393478|NCT00235716|963277|P4|NOT COMPLETED|Overall Study||62
393479|NCT00235716|963278|P3|NOT COMPLETED|Overall Study||65
393480|NCT00235716|963279|P2|NOT COMPLETED|Overall Study||67
393481|NCT00235716|963280|P1|NOT COMPLETED|Overall Study||62
393482|NCT00235716|963277|P4|COMPLETED|Overall Study||90
393483|NCT00235716|963278|P3|COMPLETED|Overall Study||89
393484|NCT00235716|963279|P2|COMPLETED|Overall Study||88
393485|NCT00235716|963280|P1|COMPLETED|Overall Study||90
393486|NCT00235716|963277|P4|STARTED|Overall Study||152
393487|NCT00235716|963278|P3|STARTED|Overall Study||154
393488|NCT00235716|963279|P2|STARTED|Overall Study||155
393489|NCT00235716|963280|P1|STARTED|Overall Study||152
393490|NCT00235573|963314|P1|NOT COMPLETED|Overall Study||0
393491|NCT00235573|963314|P1|COMPLETED|Overall Study||21
393492|NCT00235573|963314|P1|STARTED|Overall Study|35 subjects screened; 14 not eligible; 21 started and completed study|21
393493|NCT00235547|963320|P2|NOT COMPLETED|6 Month Follow-up Survey||68
393494|NCT00235547|963321|P1|NOT COMPLETED|6 Month Follow-up Survey||71
393495|NCT00235547|963320|P2|COMPLETED|6 Month Follow-up Survey||76
393496|NCT00235547|963321|P1|COMPLETED|6 Month Follow-up Survey||83
393497|NCT00235547|963320|P2|STARTED|6 Month Follow-up Survey||144
393498|NCT00235547|963321|P1|STARTED|6 Month Follow-up Survey||154
393499|NCT00235547|963320|P2|NOT COMPLETED|2 Month Follow-up Survey||40
393500|NCT00235547|963321|P1|NOT COMPLETED|2 Month Follow-up Survey||46
393501|NCT00235547|963320|P2|COMPLETED|2 Month Follow-up Survey||104
393502|NCT00235547|963321|P1|COMPLETED|2 Month Follow-up Survey||108
393503|NCT00235547|963320|P2|STARTED|2 Month Follow-up Survey||144
393504|NCT00235547|963321|P1|STARTED|2 Month Follow-up Survey||154
393505|NCT00235495|963331|P2|NOT COMPLETED|Overall Study||68
393506|NCT00235495|963332|P1|NOT COMPLETED|Overall Study||68
393507|NCT00235495|963331|P2|COMPLETED|Overall Study||351
393508|NCT00235495|963332|P1|COMPLETED|Overall Study||354
393509|NCT00235495|963331|P2|STARTED|Overall Study||419
393510|NCT00235495|963332|P1|STARTED|Overall Study||422
393511|NCT00235456|963384|P2|NOT COMPLETED|Overall Study||7
393512|NCT00235456|963385|P1|NOT COMPLETED|Overall Study||2
393513|NCT00235456|963384|P2|COMPLETED|Overall Study||143
393514|NCT00235456|963385|P1|COMPLETED|Overall Study||148
393515|NCT00235456|963384|P2|STARTED|Overall Study||150
393516|NCT00235456|963385|P1|STARTED|Overall Study||150
393517|NCT00235443|963407|P6|NOT COMPLETED|Overall Study||45
393518|NCT00235443|963408|P5|NOT COMPLETED|Overall Study||30
393519|NCT00235443|963409|P4|NOT COMPLETED|Overall Study||97
393520|NCT00235443|963410|P3|NOT COMPLETED|Overall Study||62
393521|NCT00235443|963411|P2|NOT COMPLETED|Overall Study||38
393522|NCT00235443|963412|P1|NOT COMPLETED|Overall Study||8
393523|NCT00235443|963407|P6|COMPLETED|Overall Study||9
393524|NCT00235443|963408|P5|COMPLETED|Overall Study||9
393525|NCT00235443|963409|P4|COMPLETED|Overall Study||108
393526|NCT00235443|963410|P3|COMPLETED|Overall Study||23
393527|NCT00235443|963411|P2|COMPLETED|Overall Study||19
393528|NCT00235443|963412|P1|COMPLETED|Overall Study||3
393529|NCT00235443|963407|P6|STARTED|Overall Study||54
393530|NCT00235443|963408|P5|STARTED|Overall Study||39
393531|NCT00235443|963409|P4|STARTED|Overall Study||205
393532|NCT00235443|963410|P3|STARTED|Overall Study||85
393533|NCT00235443|963411|P2|STARTED|Overall Study||57
393534|NCT00235443|963412|P1|STARTED|Overall Study||11
393535|NCT00235391|963553|P6|NOT COMPLETED|Overall Study||4
393536|NCT00235391|963554|P5|NOT COMPLETED|Overall Study||12
393537|NCT00235391|963555|P4|NOT COMPLETED|Overall Study||220
393538|NCT00235391|963556|P3|NOT COMPLETED|Overall Study||24
393539|NCT00235391|963557|P2|NOT COMPLETED|Overall Study||18
393540|NCT00235391|963558|P1|NOT COMPLETED|Overall Study||12
393541|NCT00235391|963553|P6|COMPLETED|Overall Study||3
393542|NCT00235391|963554|P5|COMPLETED|Overall Study||31
393543|NCT00235391|963555|P4|COMPLETED|Overall Study||944
393544|NCT00235391|963556|P3|COMPLETED|Overall Study||148
393545|NCT00235391|963557|P2|COMPLETED|Overall Study||182
393546|NCT00235391|963558|P1|COMPLETED|Overall Study||85
393547|NCT00235391|963553|P6|Deferasirox Treatment|Overall Study||7
393548|NCT00235391|963554|P5|Deferasirox Treatment|Overall Study||43
393549|NCT00235391|963555|P4|Deferasirox Treatment|Overall Study||1164
393550|NCT00235391|963556|P3|Deferasirox Treatment|Overall Study||172
393551|NCT00235391|963557|P2|Deferasirox Treatment|Overall Study||200
393552|NCT00235391|963558|P1|Deferasirox Treatment|Overall Study||97
393553|NCT00235391|963553|P6|STARTED|Overall Study||7
393554|NCT00235391|963554|P5|STARTED|Overall Study||43
393555|NCT00235391|963555|P4|STARTED|Overall Study||1164
393556|NCT00235391|963556|P3|STARTED|Overall Study||172
393557|NCT00235391|963557|P2|STARTED|Overall Study||200
393558|NCT00235391|963558|P1|STARTED|Overall Study||97
393559|NCT00235326|963575|P2|NOT COMPLETED|Overall Study||1400
393560|NCT00235326|963576|P1|NOT COMPLETED|Overall Study||746
393561|NCT00235326|963575|P2|COMPLETED|Overall Study||1586
393562|NCT00235326|963576|P1|COMPLETED|Overall Study||829
393563|NCT00235326|963575|P2|STARTED|Overall Study||2986
393564|NCT00235326|963576|P1|STARTED|Overall Study||1575
393565|NCT00234884|963580|P1|NOT COMPLETED|Overall Study||1630
393566|NCT00234884|963580|P1|COMPLETED|Overall Study||1805
393567|NCT00234884|963580|P1|STARTED|Overall Study||3435
393568|NCT00234832|963590|P2|NOT COMPLETED|Overall Study||996
393569|NCT00234832|963591|P1|NOT COMPLETED|Overall Study||1016
393570|NCT00234832|963590|P2|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3902
393571|NCT00234832|963591|P1|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3890
393572|NCT00234832|963590|P2|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4898
393573|NCT00234832|963591|P1|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4906
393574|NCT00234533|963616|P1|NOT COMPLETED|Overall Study||11
393575|NCT00234533|963616|P1|COMPLETED|Overall Study||240
393576|NCT00234533|963616|P1|STARTED|Overall Study||251
393577|NCT00234494|963635|P1|NOT COMPLETED|Overall Study||2
393578|NCT00234494|963635|P1|COMPLETED|Overall Study||43
393579|NCT00234494|963635|P1|STARTED|Overall Study||45
393580|NCT00234286|963642|P1|NOT COMPLETED|Overall Study||0
393581|NCT00234286|963642|P1|COMPLETED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
393582|NCT00234286|963642|P1|STARTED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
393583|NCT00234104|963681|P4|NOT COMPLETED|Overall Study||8
393584|NCT00234104|963682|P3|NOT COMPLETED|Overall Study||5
393585|NCT00234104|963683|P2|NOT COMPLETED|Overall Study||1
393586|NCT00234104|963684|P1|NOT COMPLETED|Overall Study||4
393587|NCT00234104|963681|P4|COMPLETED|Overall Study||21
393588|NCT00234104|963682|P3|COMPLETED|Overall Study||29
393589|NCT00234104|963683|P2|COMPLETED|Overall Study||28
393590|NCT00234104|963684|P1|COMPLETED|Overall Study||26
393591|NCT00234104|963681|P4|STARTED|Overall Study||29
393592|NCT00234104|963682|P3|STARTED|Overall Study||34
393593|NCT00234104|963683|P2|STARTED|Overall Study||29
393594|NCT00234104|963684|P1|STARTED|Overall Study||30
393595|NCT00234078|963698|P4|NOT COMPLETED|Overall Study||4
393596|NCT00234078|963699|P3|NOT COMPLETED|Overall Study||10
393597|NCT00234078|963700|P2|NOT COMPLETED|Overall Study||9
393598|NCT00234078|963701|P1|NOT COMPLETED|Overall Study||6
393599|NCT00234078|963698|P4|COMPLETED|Overall Study||68
393600|NCT00234078|963699|P3|COMPLETED|Overall Study||64
393601|NCT00234078|963700|P2|COMPLETED|Overall Study||63
393602|NCT00234078|963701|P1|COMPLETED|Overall Study||66
393603|NCT00234078|963698|P4|STARTED|Overall Study||72
393604|NCT00234078|963699|P3|STARTED|Overall Study||74
393605|NCT00234078|963700|P2|STARTED|Overall Study||72
393606|NCT00234078|963701|P1|STARTED|Overall Study||72
393607|NCT00234065|963725|P2|NOT COMPLETED|Overall Study||356
393608|NCT00234065|963726|P1|NOT COMPLETED|Overall Study||475
393609|NCT00234065|963725|P2|COMPLETED|Overall Study||1004
393610|NCT00234065|963726|P1|COMPLETED|Overall Study||881
393611|NCT00234065|963725|P2|STARTED|Overall Study||1360
393612|NCT00234065|963726|P1|STARTED|Overall Study||1356
393613|NCT00234052|963742|P1|NOT COMPLETED|Follow-up for 5 Years||49
393614|NCT00234052|963742|P1|COMPLETED|Follow-up for 5 Years||1
393615|NCT00234052|963742|P1|STARTED|Follow-up for 5 Years|All patients that are treated on study go into the follow up period.|50
393616|NCT00234052|963742|P1|NOT COMPLETED|Treatment||21
393617|NCT00234052|963742|P1|COMPLETED|Treatment||30
393618|NCT00234052|963742|P1|Went Into Maintenance Phase|Treatment||30
393619|NCT00234052|963742|P1|Completed 6 Cycles|Treatment||33
393620|NCT00234052|963742|P1|Started Treatment|Treatment||50
393621|NCT00234052|963742|P1|STARTED|Treatment||51
393622|NCT00234039|963752|P1|NOT COMPLETED|Overall Study||50
393623|NCT00234039|963752|P1|COMPLETED|Overall Study||8
393624|NCT00234039|963752|P1|Eligible and Began Protocol Therapy|Overall Study||47
393625|NCT00234039|963752|P1|Eligible|Overall Study||49
393626|NCT00234039|963752|P1|STARTED|Overall Study||58
393627|NCT00233987|963759|P1|NOT COMPLETED|Overall Study||15
393628|NCT00233987|963759|P1|COMPLETED|Overall Study||83
393629|NCT00233987|963759|P1|Eligible and Treated|Overall Study||92
393630|NCT00233987|963759|P1|Eligible|Overall Study||94
393631|NCT00233987|963759|P1|STARTED|Overall Study||98
393632|NCT00233948|963768|P6|NOT COMPLETED|Overall Study||0
393633|NCT00233948|963769|P5|NOT COMPLETED|Overall Study||0
393634|NCT00233948|963770|P4|NOT COMPLETED|Overall Study||0
393635|NCT00233948|963771|P3|NOT COMPLETED|Overall Study||0
393636|NCT00233948|963772|P2|NOT COMPLETED|Overall Study||0
393637|NCT00233948|963773|P1|NOT COMPLETED|Overall Study||1
393638|NCT00233948|963768|P6|COMPLETED|Overall Study||12
393639|NCT00233948|963769|P5|COMPLETED|Overall Study||4
393640|NCT00233948|963770|P4|COMPLETED|Overall Study||3
393641|NCT00233948|963771|P3|COMPLETED|Overall Study||3
393642|NCT00233948|963772|P2|COMPLETED|Overall Study||3
393643|NCT00233948|963773|P1|COMPLETED|Overall Study||3
393644|NCT00233948|963768|P6|STARTED|Overall Study||12
393645|NCT00233948|963769|P5|STARTED|Overall Study||4
393646|NCT00233948|963770|P4|STARTED|Overall Study||3
393647|NCT00233948|963771|P3|STARTED|Overall Study||3
393648|NCT00233948|963772|P2|STARTED|Overall Study||3
393649|NCT00233948|963773|P1|STARTED|Overall Study||4
393650|NCT00233519|963790|P2|NOT COMPLETED|Overall Study||1
393651|NCT00233519|963791|P1|NOT COMPLETED|Overall Study||1
393652|NCT00233519|963790|P2|COMPLETED|Overall Study||9
393653|NCT00233519|963791|P1|COMPLETED|Overall Study||6
393654|NCT00233519|963790|P2|STARTED|Overall Study||10
393655|NCT00233519|963791|P1|STARTED|Overall Study||7
393656|NCT00233454|963797|P1|NOT COMPLETED|Overall Study||6
393657|NCT00233454|963797|P1|COMPLETED|Overall Study||20
393658|NCT00233454|963797|P1|2 Months (for Response Rate)|Overall Study||26
393659|NCT00233454|963797|P1|STARTED|Overall Study||26
393660|NCT00233402|963805|P2|NOT COMPLETED|Overall Study||124
393661|NCT00233402|963806|P1|NOT COMPLETED|Overall Study||104
393662|NCT00233402|963805|P2|COMPLETED|Overall Study||271
393663|NCT00233402|963806|P1|COMPLETED|Overall Study||280
393664|NCT00233402|963805|P2|STARTED|Overall Study||395
393665|NCT00233402|963806|P1|STARTED|Overall Study||384
393666|NCT00233324|963821|P4|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||11
393667|NCT00233324|963822|P3|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||18
393668|NCT00233324|963823|P2|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||14
393669|NCT00233324|963824|P1|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||13
393670|NCT00233324|963821|P4|COMPLETED|Follow up at 18-22 Months Corrected Age||269
393671|NCT00233324|963822|P3|COMPLETED|Follow up at 18-22 Months Corrected Age||256
393672|NCT00233324|963823|P2|COMPLETED|Follow up at 18-22 Months Corrected Age||261
393673|NCT00233324|963824|P1|COMPLETED|Follow up at 18-22 Months Corrected Age||237
393674|NCT00233324|963821|P4|STARTED|Follow up at 18-22 Months Corrected Age||280
393675|NCT00233324|963822|P3|STARTED|Follow up at 18-22 Months Corrected Age||274
393676|NCT00233324|963823|P2|STARTED|Follow up at 18-22 Months Corrected Age||275
393677|NCT00233324|963824|P1|STARTED|Follow up at 18-22 Months Corrected Age||250
393678|NCT00233324|963821|P4|NOT COMPLETED|Main Study||47
393679|NCT00233324|963822|P3|NOT COMPLETED|Main Study||62
393680|NCT00233324|963823|P2|NOT COMPLETED|Main Study||60
393681|NCT00233324|963824|P1|NOT COMPLETED|Main Study||68
393682|NCT00233324|963821|P4|COMPLETED|Main Study||280
393683|NCT00233324|963822|P3|COMPLETED|Main Study||274
393684|NCT00233324|963823|P2|COMPLETED|Main Study||275
393685|NCT00233324|963824|P1|COMPLETED|Main Study||250
393686|NCT00233324|963821|P4|STARTED|Main Study||327
393687|NCT00233324|963822|P3|STARTED|Main Study||336
393688|NCT00233324|963823|P2|STARTED|Main Study||335
393689|NCT00233324|963824|P1|STARTED|Main Study||318
393690|NCT00233103|963908|P2|NOT COMPLETED|Overall Study||6
393691|NCT00233103|963909|P1|NOT COMPLETED|Overall Study||5
393692|NCT00233103|963908|P2|COMPLETED|Overall Study||19
393693|NCT00233103|963909|P1|COMPLETED|Overall Study||22
393694|NCT00233103|963908|P2|STARTED|Overall Study||25
393695|NCT00233103|963909|P1|STARTED|Overall Study||27
393696|NCT00233090|963923|P2|NOT COMPLETED|Overall Study||0
393697|NCT00233090|963924|P1|NOT COMPLETED|Overall Study||0
393698|NCT00233090|963923|P2|COMPLETED|Overall Study||9
393699|NCT00233090|963924|P1|COMPLETED|Overall Study||12
393700|NCT00233090|963923|P2|STARTED|Overall Study||9
393701|NCT00233090|963924|P1|STARTED|Overall Study||12
393702|NCT00233064|963946|P2|NOT COMPLETED|Overall Study||12
393703|NCT00233064|963947|P1|NOT COMPLETED|Overall Study||14
393704|NCT00233064|963946|P2|COMPLETED|Overall Study||190
393705|NCT00233064|963947|P1|COMPLETED|Overall Study||197
393706|NCT00233064|963946|P2|STARTED|Overall Study||202
393707|NCT00233064|963947|P1|STARTED|Overall Study||211
393708|NCT00232739|963954|P1|NOT COMPLETED|Overall Study||9
393709|NCT00232739|963954|P1|COMPLETED|Overall Study||91
393710|NCT00232739|963954|P1|STARTED|Overall Study||100
393711|NCT00232596|963973|P2|NOT COMPLETED|12-Week Maintenance Phase||28
393712|NCT00232596|963974|P1|NOT COMPLETED|12-Week Maintenance Phase||12
393713|NCT00232596|963973|P2|COMPLETED|12-Week Maintenance Phase||97
393714|NCT00232596|963974|P1|COMPLETED|12-Week Maintenance Phase|One participant withdrew after being considered a “completer” and is listed as an early withdraw.|126
393715|NCT00232596|963973|P2|STARTED|12-Week Maintenance Phase||125
393716|NCT00232596|963974|P1|STARTED|12-Week Maintenance Phase||138
393717|NCT00232596|963973|P2|NOT COMPLETED|6-Week Titration Phase||29
393718|NCT00232596|963974|P1|NOT COMPLETED|6-Week Titration Phase||14
393719|NCT00232596|963973|P2|COMPLETED|6-Week Titration Phase||125
393720|NCT00232596|963974|P1|COMPLETED|6-Week Titration Phase||138
393721|NCT00232596|963973|P2|STARTED|6-Week Titration Phase||154
393722|NCT00232596|963974|P1|STARTED|6-Week Titration Phase||152
393723|NCT00232583|964026|P2|NOT COMPLETED|Overall Study||13
393724|NCT00232583|964027|P1|NOT COMPLETED|Overall Study||10
393725|NCT00232583|964026|P2|COMPLETED|Overall Study||16
393726|NCT00232583|964027|P1|COMPLETED|Overall Study||19
393727|NCT00232583|964026|P2|STARTED|Overall Study||29
393728|NCT00232583|964027|P1|STARTED|Overall Study||29
393729|NCT00232557|964065|P2|NOT COMPLETED|Overall Study||5
393730|NCT00232557|964066|P1|NOT COMPLETED|Overall Study||3
393731|NCT00232557|964065|P2|COMPLETED|Overall Study||60
393732|NCT00232557|964066|P1|COMPLETED|Overall Study||68
393733|NCT00232557|964065|P2|STARTED|Overall Study||65
393734|NCT00232557|964066|P1|STARTED|Overall Study||71
393735|NCT00232544|964076|P2|NOT COMPLETED|Overall Study||15
393736|NCT00232544|964077|P1|NOT COMPLETED|Overall Study||20
393737|NCT00232544|964076|P2|COMPLETED|Overall Study||111
393738|NCT00232544|964077|P1|COMPLETED|Overall Study||104
393739|NCT00232544|964076|P2|STARTED|Overall Study||126
393740|NCT00232544|964077|P1|STARTED|Overall Study||124
393741|NCT00232505|964087|P2|NOT COMPLETED|Overall Study||11
393742|NCT00232505|964088|P1|NOT COMPLETED|Overall Study||5
393743|NCT00232505|964087|P2|COMPLETED|Overall Study||60
393744|NCT00232505|964088|P1|COMPLETED|Overall Study||26
393745|NCT00232505|964087|P2|Off Protocol|Overall Study||0
393746|NCT00232505|964088|P1|Off Protocol|Overall Study||5
393747|NCT00232505|964087|P2|Early Progressors|Overall Study||5
393748|NCT00232505|964088|P1|Early Progressors|Overall Study||2
393749|NCT00232505|964087|P2|Not Evaluable|Overall Study||6
393750|NCT00232505|964088|P1|Not Evaluable|Overall Study||0
393751|NCT00232505|964087|P2|STARTED|Overall Study||71
393752|NCT00232505|964088|P1|STARTED|Overall Study||31
393753|NCT00232479|964101|P1|NOT COMPLETED|Overall Study||0
393754|NCT00232479|964101|P1|COMPLETED|Overall Study||44
393755|NCT00232479|964101|P1|STARTED|Overall Study||44
393756|NCT00232180|964108|P3|NOT COMPLETED|Open Label Phase||148
393757|NCT00232180|964109|P2|NOT COMPLETED|Open Label Phase||0
393758|NCT00232180|964110|P1|NOT COMPLETED|Open Label Phase||0
393759|NCT00232180|964108|P3|COMPLETED|Open Label Phase||1098
393760|NCT00232180|964109|P2|COMPLETED|Open Label Phase||0
393761|NCT00232180|964110|P1|COMPLETED|Open Label Phase||0
393762|NCT00232180|964108|P3|Treated|Open Label Phase||1245
393763|NCT00232180|964109|P2|Treated|Open Label Phase||0
393764|NCT00232180|964110|P1|Treated|Open Label Phase||0
393765|NCT00232180|964108|P3|STARTED|Open Label Phase||1246
393766|NCT00232180|964109|P2|STARTED|Open Label Phase||0
393767|NCT00232180|964110|P1|STARTED|Open Label Phase||0
393768|NCT00232180|964108|P3|NOT COMPLETED|Double-blind (DB) Phase||0
393769|NCT00232180|964109|P2|NOT COMPLETED|Double-blind (DB) Phase||605
393770|NCT00232180|964110|P1|NOT COMPLETED|Double-blind (DB) Phase||541
393771|NCT00232180|964108|P3|COMPLETED|Double-blind (DB) Phase||0
393772|NCT00232180|964109|P2|COMPLETED|Double-blind (DB) Phase||771
393773|NCT00232180|964110|P1|COMPLETED|Double-blind (DB) Phase||826
393774|NCT00232180|964108|P3|Treated|Double-blind (DB) Phase||0
393775|NCT00232180|964109|P2|Treated|Double-blind (DB) Phase||1372
393776|NCT00232180|964110|P1|Treated|Double-blind (DB) Phase||1364
393777|NCT00232180|964108|P3|STARTED|Double-blind (DB) Phase||0
393778|NCT00232180|964109|P2|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1376
393779|NCT00232180|964110|P1|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1367
393780|NCT00232141|964155|P2|NOT COMPLETED|Overall Study||26
393781|NCT00232141|964156|P1|NOT COMPLETED|Overall Study||31
393782|NCT00232141|964155|P2|COMPLETED|Overall Study||125
393783|NCT00232141|964156|P1|COMPLETED|Overall Study||120
393784|NCT00232141|964155|P2|STARTED|Overall Study||151
393785|NCT00232141|964156|P1|STARTED|Overall Study||151
393786|NCT00231894|964226|P2|NOT COMPLETED|Overall Study||1
393787|NCT00231894|964227|P1|NOT COMPLETED|Overall Study||1
393788|NCT00231894|964226|P2|COMPLETED|Overall Study||24
393789|NCT00231894|964227|P1|COMPLETED|Overall Study||30
393790|NCT00231894|964226|P2|STARTED|Overall Study||25
393791|NCT00231894|964227|P1|STARTED|Overall Study||31
393792|NCT00231842|964249|P1|NOT COMPLETED|Overall Study||11
393793|NCT00231842|964249|P1|COMPLETED|Overall Study||19
393794|NCT00231842|964249|P1|Completed Full Prescribed Therapy|Overall Study||19
393795|NCT00231842|964249|P1|Completed Prescribed RT|Overall Study||27
393796|NCT00231842|964249|P1|Completed First 3 Cycles|Overall Study||27
393797|NCT00231842|964249|P1|Initiated Therapy|Overall Study||27
393798|NCT00231842|964249|P1|STARTED|Overall Study||30
393799|NCT00231816|964256|P2|NOT COMPLETED|Overall Study||12
393800|NCT00231816|964257|P1|NOT COMPLETED|Overall Study||16
393801|NCT00231816|964256|P2|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|369
393802|NCT00231816|964257|P1|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|366
393803|NCT00231816|964256|P2|Vaccinated at Visit 2|Overall Study||371
393804|NCT00231816|964257|P1|Vaccinated at Visit 2|Overall Study||369
393805|NCT00231816|964256|P2|Vaccinated at Visit 1|Overall Study|One participant was randomized but not vaccinated|380
393806|NCT00231816|964257|P1|Vaccinated at Visit 1|Overall Study||382
393807|NCT00231816|964256|P2|STARTED|Overall Study||381
393808|NCT00231816|964257|P1|STARTED|Overall Study||382
393809|NCT00231777|964272|P2|NOT COMPLETED|Overall Study||2
393810|NCT00231777|964273|P1|NOT COMPLETED|Overall Study||6
393811|NCT00231777|964272|P2|COMPLETED|Overall Study||44
393812|NCT00231777|964273|P1|COMPLETED|Overall Study||164
393813|NCT00231777|964272|P2|STARTED|Overall Study||46
393814|NCT00231777|964273|P1|STARTED|Overall Study||170
393815|NCT00231478|964287|P2|NOT COMPLETED|Overall Study||6
393816|NCT00231478|964288|P1|NOT COMPLETED|Overall Study||8
393817|NCT00231478|964287|P2|COMPLETED|Overall Study||78
393818|NCT00231478|964288|P1|COMPLETED|Overall Study||79
393819|NCT00231478|964287|P2|STARTED|Overall Study||84
393820|NCT00231478|964288|P1|STARTED|Overall Study||87
393821|NCT00231465|964300|P1|NOT COMPLETED|Overall Study||2
393822|NCT00231465|964300|P1|COMPLETED|Overall Study||42
393823|NCT00231465|964300|P1|STARTED|Overall Study||44
393824|NCT00231309|964306|P1|NOT COMPLETED|Overall Study||0
393825|NCT00231309|964306|P1|COMPLETED|Overall Study||10
393826|NCT00231309|964306|P1|STARTED|Overall Study||10
393827|NCT00231283|964311|P1|NOT COMPLETED|Overall Study||5
393828|NCT00231283|964311|P1|COMPLETED|Overall Study||95
393829|NCT00231283|964311|P1|STARTED|Overall Study||100
393830|NCT00231179|964320|P2|NOT COMPLETED|Overall Study||24
393831|NCT00231179|964321|P1|NOT COMPLETED|Overall Study||24
393832|NCT00231179|964320|P2|COMPLETED|Overall Study|126 (93%) in the control group completed the five year follow-up visit.|126
393833|NCT00231179|964321|P1|COMPLETED|Overall Study|128 (95%) in intervention group completed the five year follow-up visit.|128
393834|NCT00231179|964320|P2|STARTED|Overall Study||150
393835|NCT00231179|964321|P1|STARTED|Overall Study||152
393836|NCT00231153|964337|P2|NOT COMPLETED|Overall Study||188
393837|NCT00231153|964338|P1|NOT COMPLETED|Overall Study||217
393838|NCT00231153|964337|P2|COMPLETED|Overall Study||720
393839|NCT00231153|964338|P1|COMPLETED|Overall Study||690
393840|NCT00231153|964337|P2|STARTED|Overall Study|Subjects randomized to povidone-iodine who received at least one dose of study treatment.|908
393841|NCT00231153|964338|P1|STARTED|Overall Study|Subjects randomized to omiganan 1% gel who received at least one dose of study treatment.|907
393842|NCT00231114|964348|P2|NOT COMPLETED|Post-Treatment Period||1
393843|NCT00231114|964349|P1|NOT COMPLETED|Post-Treatment Period||8
393844|NCT00231114|964348|P2|COMPLETED|Post-Treatment Period||97
393845|NCT00231114|964349|P1|COMPLETED|Post-Treatment Period||181
393846|NCT00231114|964348|P2|STARTED|Post-Treatment Period||98
393847|NCT00231114|964349|P1|STARTED|Post-Treatment Period||189
393848|NCT00231114|964348|P2|NOT COMPLETED|Treatment Period||0
393849|NCT00231114|964349|P1|NOT COMPLETED|Treatment Period||1
393850|NCT00231114|964348|P2|COMPLETED|Treatment Period||98
393851|NCT00231114|964349|P1|COMPLETED|Treatment Period||189
393852|NCT00231114|964348|P2|STARTED|Treatment Period||98
393853|NCT00231114|964349|P1|STARTED|Treatment Period||190
393854|NCT00231114|964348|P2|NOT COMPLETED|Randomized||3
393855|NCT00231114|964349|P1|NOT COMPLETED|Randomized||6
393856|NCT00231114|964348|P2|COMPLETED|Randomized||98
393857|NCT00231114|964349|P1|COMPLETED|Randomized||190
393858|NCT00231114|964348|P2|STARTED|Randomized||101
393859|NCT00231114|964349|P1|STARTED|Randomized||196
393860|NCT00231062|964385|P1|NOT COMPLETED|Overall Study||6
393861|NCT00231062|964385|P1|COMPLETED|Overall Study||109
393862|NCT00231062|964385|P1|STARTED|Overall Study||115
393863|NCT00230971|964393|P2|NOT COMPLETED|Baseline Participants||19
393864|NCT00230971|964394|P1|NOT COMPLETED|Baseline Participants||22
393865|NCT00230971|964393|P2|COMPLETED|Baseline Participants||216
393866|NCT00230971|964394|P1|COMPLETED|Baseline Participants||210
393867|NCT00230971|964393|P2|STARTED|Baseline Participants||235
393868|NCT00230971|964394|P1|STARTED|Baseline Participants||232
393869|NCT00230971|964393|P2|NOT COMPLETED|Randomization||3
393870|NCT00230971|964394|P1|NOT COMPLETED|Randomization||3
393871|NCT00230971|964393|P2|COMPLETED|Randomization||235
393872|NCT00230971|964394|P1|COMPLETED|Randomization||232
393873|NCT00230971|964393|P2|STARTED|Randomization||238
393874|NCT00230971|964394|P1|STARTED|Randomization||235
393875|NCT00230802|964408|P2|NOT COMPLETED|Overall Study||0
393876|NCT00230802|964409|P1|NOT COMPLETED|Overall Study||0
393877|NCT00230802|964408|P2|COMPLETED|Overall Study||23
393878|NCT00230802|964409|P1|COMPLETED|Overall Study||25
393879|NCT00230802|964408|P2|STARTED|Overall Study||23
393880|NCT00230802|964409|P1|STARTED|Overall Study||25
393881|NCT00230737|964422|P3|NOT COMPLETED|Overall Study||0
393882|NCT00230737|964423|P2|NOT COMPLETED|Overall Study||0
393883|NCT00230737|964424|P1|NOT COMPLETED|Overall Study||0
393884|NCT00230737|964422|P3|COMPLETED|Overall Study||8
393885|NCT00230737|964423|P2|COMPLETED|Overall Study||10
393886|NCT00230737|964424|P1|COMPLETED|Overall Study||9
393887|NCT00230737|964422|P3|STARTED|Overall Study||8
393888|NCT00230737|964423|P2|STARTED|Overall Study||10
393889|NCT00230737|964424|P1|STARTED|Overall Study||9
393890|NCT00230282|964432|P1|NOT COMPLETED|Maintanence Therapy With Alemtuzumab||0
393891|NCT00230282|964432|P1|COMPLETED|Maintanence Therapy With Alemtuzumab||17
393892|NCT00230282|964432|P1|STARTED|Maintanence Therapy With Alemtuzumab||17
393893|NCT00230282|964432|P1|NOT COMPLETED|Fludarabine + Cyclophosphamide||8
393894|NCT00230282|964432|P1|COMPLETED|Fludarabine + Cyclophosphamide||17
393895|NCT00230282|964432|P1|STARTED|Fludarabine + Cyclophosphamide||25
393896|NCT00230178|964440|P3|NOT COMPLETED|Overall Study||7
393897|NCT00230178|964441|P2|NOT COMPLETED|Overall Study||7
393898|NCT00230178|964442|P1|NOT COMPLETED|Overall Study||4
393899|NCT00230178|964440|P3|COMPLETED|Overall Study||86
393900|NCT00230178|964441|P2|COMPLETED|Overall Study||86
393901|NCT00230178|964442|P1|COMPLETED|Overall Study||90
393902|NCT00230178|964440|P3|Treated|Overall Study||91
393903|NCT00230178|964441|P2|Treated|Overall Study||92
393904|NCT00230178|964442|P1|Treated|Overall Study|Modified ITT population: ITT patients with at least 1 dose of study drug|92
393905|NCT00230178|964440|P3|STARTED|Overall Study||93
393906|NCT00230178|964441|P2|STARTED|Overall Study||93
393907|NCT00230178|964442|P1|STARTED|Overall Study|Intent-to-treat (ITT)population: randomized patients|94
393908|NCT00230126|964458|P2|NOT COMPLETED|Overall Study||1
393909|NCT00230126|964459|P1|NOT COMPLETED|Overall Study||2
393910|NCT00230126|964458|P2|COMPLETED|Overall Study||27
393911|NCT00230126|964459|P1|COMPLETED|Overall Study||28
393912|NCT00230126|964458|P2|STARTED|Overall Study||28
393913|NCT00230126|964459|P1|STARTED|Overall Study||30
393914|NCT00230100|964471|P2|NOT COMPLETED|Overall Study||0
393915|NCT00230100|964472|P1|NOT COMPLETED|Overall Study||0
393916|NCT00230100|964471|P2|COMPLETED|Overall Study||17
393917|NCT00230100|964472|P1|COMPLETED|Overall Study||29
393918|NCT00230100|964471|P2|STARTED|Overall Study||17
393919|NCT00230100|964472|P1|STARTED|Overall Study||29
393920|NCT00230048|964494|P2|NOT COMPLETED|Overall Study||18
393921|NCT00230048|964495|P1|NOT COMPLETED|Overall Study||13
393922|NCT00230048|964494|P2|COMPLETED|Overall Study||37
393923|NCT00230048|964495|P1|COMPLETED|Overall Study||39
393924|NCT00230048|964494|P2|Completed Intervention/Control Session|Overall Study||55
393925|NCT00230048|964495|P1|Completed Intervention/Control Session|Overall Study||52
393926|NCT00230048|964494|P2|STARTED|Overall Study||55
393927|NCT00230048|964495|P1|STARTED|Overall Study||52
393928|NCT00230022|964505|P2|NOT COMPLETED|Overall Study||0
393929|NCT00230022|964506|P1|NOT COMPLETED|Overall Study||0
393930|NCT00230022|964505|P2|COMPLETED|Overall Study||15
393931|NCT00230022|964506|P1|COMPLETED|Overall Study||15
393932|NCT00230022|964505|P2|STARTED|Overall Study||15
393933|NCT00230022|964506|P1|STARTED|Overall Study||15
393934|NCT00230009|964514|P2|NOT COMPLETED|Follow-up||26
393935|NCT00230009|964515|P1|NOT COMPLETED|Follow-up||31
393936|NCT00230009|964514|P2|COMPLETED|Follow-up||24
393937|NCT00230009|964515|P1|COMPLETED|Follow-up||19
393938|NCT00230009|964514|P2|STARTED|Follow-up||50
393939|NCT00230009|964515|P1|STARTED|Follow-up||50
393940|NCT00230009|964514|P2|NOT COMPLETED|Single Session Intervention/Control||0
393941|NCT00230009|964515|P1|NOT COMPLETED|Single Session Intervention/Control||0
393942|NCT00230009|964514|P2|COMPLETED|Single Session Intervention/Control||50
393943|NCT00230009|964515|P1|COMPLETED|Single Session Intervention/Control||50
393944|NCT00230009|964514|P2|STARTED|Single Session Intervention/Control||50
393945|NCT00230009|964515|P1|STARTED|Single Session Intervention/Control||50
393946|NCT00229970|964532|P3|NOT COMPLETED|Overall Study||0
393947|NCT00229970|964533|P2|NOT COMPLETED|Overall Study||0
393948|NCT00229970|964534|P1|NOT COMPLETED|Overall Study||0
393949|NCT00229970|964532|P3|COMPLETED|Overall Study||75
393950|NCT00229970|964533|P2|COMPLETED|Overall Study||72
393951|NCT00229970|964534|P1|COMPLETED|Overall Study||78
393952|NCT00229970|964532|P3|STARTED|Overall Study||75
393953|NCT00229970|964533|P2|STARTED|Overall Study||72
393954|NCT00229970|964534|P1|STARTED|Overall Study||78
393955|NCT00229957|964544|P2|NOT COMPLETED|Overall Study||12
393956|NCT00229957|964545|P1|NOT COMPLETED|Overall Study||20
393957|NCT00229957|964544|P2|COMPLETED|Overall Study||139
393958|NCT00229957|964545|P1|COMPLETED|Overall Study||132
393959|NCT00229957|964544|P2|STARTED|Overall Study||151
393960|NCT00229957|964545|P1|STARTED|Overall Study||152
393961|NCT00229931|964553|P2|NOT COMPLETED|Overall Study||2
393962|NCT00229931|964554|P1|NOT COMPLETED|Overall Study||4
393963|NCT00229931|964553|P2|COMPLETED|Overall Study||3
393964|NCT00229931|964554|P1|COMPLETED|Overall Study||2
393965|NCT00229931|964553|P2|STARTED|Overall Study||5
393966|NCT00229931|964554|P1|STARTED|Overall Study||6
393967|NCT00229723|964569|P7|NOT COMPLETED|Maintenance Phase||10
393968|NCT00229723|964570|P6|NOT COMPLETED|Maintenance Phase||19
393969|NCT00229723|964571|P5|NOT COMPLETED|Maintenance Phase||15
393970|NCT00229723|964572|P4|NOT COMPLETED|Maintenance Phase||17
393971|NCT00229723|964573|P3|NOT COMPLETED|Maintenance Phase||9
393972|NCT00229723|964574|P2|NOT COMPLETED|Maintenance Phase||14
393973|NCT00229723|964575|P1|NOT COMPLETED|Maintenance Phase||25
393974|NCT00229723|964569|P7|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
393975|NCT00229723|964570|P6|COMPLETED|Maintenance Phase|Completed study on randomized treatment|12
393976|NCT00229723|964571|P5|COMPLETED|Maintenance Phase|Completed study on randomized treatment|7
393977|NCT00229723|964572|P4|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
393978|NCT00229723|964573|P3|COMPLETED|Maintenance Phase|Completed study on randomized treatment|16
393979|NCT00229723|964574|P2|COMPLETED|Maintenance Phase|Completed study on randomized treatment|5
393980|NCT00229723|964575|P1|COMPLETED|Maintenance Phase|Completed study on randomized treatment|25
393981|NCT00229723|964569|P7|STARTED|Maintenance Phase||19
393982|NCT00229723|964570|P6|STARTED|Maintenance Phase||31
393983|NCT00229723|964571|P5|STARTED|Maintenance Phase||22
393984|NCT00229723|964572|P4|STARTED|Maintenance Phase||26
393985|NCT00229723|964573|P3|STARTED|Maintenance Phase||25
393986|NCT00229723|964574|P2|STARTED|Maintenance Phase||19
393987|NCT00229723|964575|P1|STARTED|Maintenance Phase||50
393988|NCT00229723|964569|P7|NOT COMPLETED|Concomitant Phase||3
393989|NCT00229723|964570|P6|NOT COMPLETED|Concomitant Phase||3
393990|NCT00229723|964571|P5|NOT COMPLETED|Concomitant Phase||2
393991|NCT00229723|964572|P4|NOT COMPLETED|Concomitant Phase||5
393992|NCT00229723|964573|P3|NOT COMPLETED|Concomitant Phase||6
393993|NCT00229723|964574|P2|NOT COMPLETED|Concomitant Phase||5
393994|NCT00229723|964575|P1|NOT COMPLETED|Concomitant Phase||10
393995|NCT00229723|964569|P7|COMPLETED|Concomitant Phase||19
393996|NCT00229723|964570|P6|COMPLETED|Concomitant Phase||31
393997|NCT00229723|964571|P5|COMPLETED|Concomitant Phase||22
393998|NCT00229723|964572|P4|COMPLETED|Concomitant Phase||26
393999|NCT00229723|964573|P3|COMPLETED|Concomitant Phase||25
394000|NCT00229723|964574|P2|COMPLETED|Concomitant Phase||19
394001|NCT00229723|964575|P1|COMPLETED|Concomitant Phase||50
394002|NCT00229723|964569|P7|STARTED|Concomitant Phase|Received randomized treatment|22
394003|NCT00229723|964570|P6|STARTED|Concomitant Phase|Received randomized treatment|34
394004|NCT00229723|964571|P5|STARTED|Concomitant Phase|Received randomized treatment|24
394005|NCT00229723|964572|P4|STARTED|Concomitant Phase|Received randomized treatment|31
394006|NCT00229723|964573|P3|STARTED|Concomitant Phase|Received randomized treatment|31
394007|NCT00229723|964574|P2|STARTED|Concomitant Phase|Received randomized treatment|24
394008|NCT00229723|964575|P1|STARTED|Concomitant Phase|Received randomized treatment|60
394009|NCT00229658|964628|P2|NOT COMPLETED|Overall Study||167
394010|NCT00229658|964629|P1|NOT COMPLETED|Overall Study||225
394011|NCT00229658|964628|P2|COMPLETED|Overall Study||364
394012|NCT00229658|964629|P1|COMPLETED|Overall Study||541
394013|NCT00229658|964628|P2|STARTED|Overall Study||531
394014|NCT00229658|964629|P1|STARTED|Overall Study||766
394015|NCT00229619|964657|P1|NOT COMPLETED|Overall Study||0
394016|NCT00229619|964657|P1|COMPLETED|Overall Study||11
394017|NCT00229619|964657|P1|STARTED|Overall Study||11
394018|NCT00229203|964665|P2|NOT COMPLETED|Overall Study||19
394019|NCT00229203|964666|P1|NOT COMPLETED|Overall Study||32
394020|NCT00229203|964665|P2|COMPLETED|Overall Study||0
394021|NCT00229203|964666|P1|COMPLETED|Overall Study||0
394022|NCT00229203|964665|P2|STARTED|Overall Study||19
394023|NCT00229203|964666|P1|STARTED|Overall Study||32
394024|NCT00228943|964678|P1|NOT COMPLETED|Week 2||1
394025|NCT00228943|964678|P1|COMPLETED|Week 2||27
394026|NCT00228943|964678|P1|STARTED|Week 2||28
394027|NCT00228943|964678|P1|NOT COMPLETED|Week 1||0
394028|NCT00228943|964678|P1|COMPLETED|Week 1||28
394029|NCT00228943|964678|P1|STARTED|Week 1||28
394030|NCT00228917|964690|P4|NOT COMPLETED|Overall Study||0
394031|NCT00228917|964691|P3|NOT COMPLETED|Overall Study||0
394032|NCT00228917|964692|P2|NOT COMPLETED|Overall Study||3
394033|NCT00228917|964693|P1|NOT COMPLETED|Overall Study||1
394034|NCT00228917|964690|P4|COMPLETED|Overall Study||107
394035|NCT00228917|964691|P3|COMPLETED|Overall Study||213
394036|NCT00228917|964692|P2|COMPLETED|Overall Study||320
394037|NCT00228917|964693|P1|COMPLETED|Overall Study||646
394038|NCT00228917|964690|P4|STARTED|Overall Study||107
394039|NCT00228917|964691|P3|STARTED|Overall Study||213
394040|NCT00228917|964692|P2|STARTED|Overall Study||323
394041|NCT00228917|964693|P1|STARTED|Overall Study||647
394042|NCT00228813|964719|P1|NOT COMPLETED|Overall Study||4
394043|NCT00228813|964719|P1|COMPLETED|Overall Study||4
394044|NCT00228813|964719|P1|STARTED|Overall Study||8
394045|NCT00228566|964725|P1|NOT COMPLETED|Overall Study||71
394046|NCT00228566|964725|P1|COMPLETED|Overall Study||176
394047|NCT00228566|964725|P1|STARTED|Overall Study||247
394048|NCT00228553|964729|P1|NOT COMPLETED|Overall Study||430
394049|NCT00228553|964729|P1|COMPLETED|Overall Study||313
394050|NCT00228553|964729|P1|STARTED|Overall Study||743
394051|NCT00228384|964735|P2|NOT COMPLETED|Overall Study||29
394052|NCT00228384|964736|P1|NOT COMPLETED|Overall Study||29
394053|NCT00228384|964735|P2|COMPLETED|Overall Study||47
394054|NCT00228384|964736|P1|COMPLETED|Overall Study||43
394055|NCT00228384|964735|P2|Three Year Follow-up (Final)|Overall Study||47
394056|NCT00228384|964736|P1|Three Year Follow-up (Final)|Overall Study||43
394057|NCT00228384|964735|P2|30-Day Follow-up (Safety Outcome)|Overall Study||72
394058|NCT00228384|964736|P1|30-Day Follow-up (Safety Outcome)|Overall Study||69
394059|NCT00228384|964735|P2|Baseline|Overall Study||76
394060|NCT00228384|964736|P1|Baseline|Overall Study||72
394061|NCT00228384|964735|P2|STARTED|Overall Study||76
394062|NCT00228384|964736|P1|STARTED|Overall Study||72
394063|NCT00227994|964776|P2|NOT COMPLETED|Overall Study||7
394064|NCT00227994|964777|P1|NOT COMPLETED|Overall Study||7
394065|NCT00227994|964776|P2|COMPLETED|Overall Study||13
394066|NCT00227994|964777|P1|COMPLETED|Overall Study||13
394067|NCT00227994|964776|P2|STARTED|Overall Study||20
394068|NCT00227994|964777|P1|STARTED|Overall Study||20
394069|NCT00227903|964787|P2|NOT COMPLETED|Overall Study||10
394070|NCT00227903|964788|P1|NOT COMPLETED|Overall Study||5
394071|NCT00227903|964787|P2|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|82
394072|NCT00227903|964788|P1|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|86
394073|NCT00227903|964787|P2|Received ≥ 1 Follow-up Assessment|Overall Study|4 participants did not receive any treatment sessions.|82
394074|NCT00227903|964788|P1|Received ≥ 1 Follow-up Assessment|Overall Study|1 participant did not receive any treatment sessions.|86
394075|NCT00227903|964787|P2|STARTED|Overall Study||92
394076|NCT00227903|964788|P1|STARTED|Overall Study||91
394077|NCT00227877|964852|P4|NOT COMPLETED|12-months Follow-up||26
394078|NCT00227877|964853|P3|NOT COMPLETED|12-months Follow-up||31
394079|NCT00227877|964854|P2|NOT COMPLETED|12-months Follow-up||263
394080|NCT00227877|964855|P1|NOT COMPLETED|12-months Follow-up||310
394081|NCT00227877|964852|P4|COMPLETED|12-months Follow-up||266
394082|NCT00227877|964853|P3|COMPLETED|12-months Follow-up||266
394083|NCT00227877|964854|P2|COMPLETED|12-months Follow-up||765
394084|NCT00227877|964855|P1|COMPLETED|12-months Follow-up||758
394085|NCT00227877|964852|P4|STARTED|12-months Follow-up||292
394086|NCT00227877|964853|P3|STARTED|12-months Follow-up||297
394087|NCT00227877|964854|P2|STARTED|12-months Follow-up||1028
394088|NCT00227877|964855|P1|STARTED|12-months Follow-up||1068
394089|NCT00227877|964852|P4|NOT COMPLETED|3-months Follow-up||21
394090|NCT00227877|964853|P3|NOT COMPLETED|3-months Follow-up||52
394091|NCT00227877|964854|P2|NOT COMPLETED|3-months Follow-up||267
394092|NCT00227877|964855|P1|NOT COMPLETED|3-months Follow-up||313
394093|NCT00227877|964852|P4|COMPLETED|3-months Follow-up||271
394094|NCT00227877|964853|P3|COMPLETED|3-months Follow-up||245
394095|NCT00227877|964854|P2|COMPLETED|3-months Follow-up||761
394096|NCT00227877|964855|P1|COMPLETED|3-months Follow-up||755
394097|NCT00227877|964852|P4|STARTED|3-months Follow-up||292
394098|NCT00227877|964853|P3|STARTED|3-months Follow-up||297
394099|NCT00227877|964854|P2|STARTED|3-months Follow-up||1028
394100|NCT00227877|964855|P1|STARTED|3-months Follow-up||1068
394101|NCT00227877|964852|P4|NOT COMPLETED|Post-visit Checklist||0
394102|NCT00227877|964853|P3|NOT COMPLETED|Post-visit Checklist||1
394103|NCT00227877|964854|P2|NOT COMPLETED|Post-visit Checklist||13
394104|NCT00227877|964855|P1|NOT COMPLETED|Post-visit Checklist||24
394105|NCT00227877|964852|P4|COMPLETED|Post-visit Checklist||292
394106|NCT00227877|964853|P3|COMPLETED|Post-visit Checklist||296
394107|NCT00227877|964854|P2|COMPLETED|Post-visit Checklist||1015
394108|NCT00227877|964855|P1|COMPLETED|Post-visit Checklist||1044
394109|NCT00227877|964852|P4|STARTED|Post-visit Checklist||292
394110|NCT00227877|964853|P3|STARTED|Post-visit Checklist||297
394111|NCT00227877|964854|P2|STARTED|Post-visit Checklist||1028
394112|NCT00227877|964855|P1|STARTED|Post-visit Checklist||1068
394113|NCT00227877|964852|P4|NOT COMPLETED|Pre-visit Assessment||0
394114|NCT00227877|964853|P3|NOT COMPLETED|Pre-visit Assessment||0
394115|NCT00227877|964854|P2|NOT COMPLETED|Pre-visit Assessment||3
394116|NCT00227877|964855|P1|NOT COMPLETED|Pre-visit Assessment||7
394117|NCT00227877|964852|P4|COMPLETED|Pre-visit Assessment|Final analysis sample|292
394118|NCT00227877|964853|P3|COMPLETED|Pre-visit Assessment|Final analysis sample|297
394119|NCT00227877|964854|P2|COMPLETED|Pre-visit Assessment|Final analysis sample|1028
394120|NCT00227877|964855|P1|COMPLETED|Pre-visit Assessment|Final analysis sample|1068
394121|NCT00227877|964852|P4|STARTED|Pre-visit Assessment||292
394122|NCT00227877|964853|P3|STARTED|Pre-visit Assessment||297
394123|NCT00227877|964854|P2|STARTED|Pre-visit Assessment||1031
394124|NCT00227877|964855|P1|STARTED|Pre-visit Assessment||1075
394125|NCT00227760|964885|P1|NOT COMPLETED|Overall Study||0
394126|NCT00227760|964885|P1|COMPLETED|Overall Study||44
394127|NCT00227760|964885|P1|STARTED|Overall Study||44
394128|NCT00227721|964891|P1|NOT COMPLETED|Overall Study||1
394129|NCT00227721|964891|P1|COMPLETED|Overall Study||29
394130|NCT00227721|964891|P1|STARTED|Overall Study||30
394131|NCT00227591|964895|P1|NOT COMPLETED|Overall Study||1
394132|NCT00227591|964895|P1|COMPLETED|Overall Study||47
394133|NCT00227591|964895|P1|Began Treatment|Overall Study||47
394134|NCT00227591|964895|P1|STARTED|Overall Study|48 pts registered to the study|48
394135|NCT00227539|964899|P1|NOT COMPLETED|Overall Study||1
394136|NCT00227539|964899|P1|COMPLETED|Overall Study||24
394137|NCT00227539|964899|P1|STARTED|Overall Study||25
394138|NCT00227370|964907|P2|NOT COMPLETED|Overall Study||24
394139|NCT00227370|964908|P1|NOT COMPLETED|Overall Study||21
394140|NCT00227370|964907|P2|COMPLETED|Overall Study||46
394141|NCT00227370|964908|P1|COMPLETED|Overall Study||45
394142|NCT00227370|964907|P2|STARTED|Overall Study|Treatment Group|70
394143|NCT00227370|964908|P1|STARTED|Overall Study|Placebo Group|66
394144|NCT00227344|964928|P2|NOT COMPLETED|Overall Study||5
394145|NCT00227344|964929|P1|NOT COMPLETED|Overall Study||12
394146|NCT00227344|964928|P2|COMPLETED|Overall Study||37
394147|NCT00227344|964929|P1|COMPLETED|Overall Study||75
394148|NCT00227344|964928|P2|STARTED|Overall Study||42
394149|NCT00227344|964929|P1|STARTED|Overall Study||87
394150|NCT00227305|964949|P1|NOT COMPLETED|Overall Study||144
394151|NCT00227305|964949|P1|COMPLETED|Overall Study|Completed 26 weeks|237
394152|NCT00227305|964949|P1|Drug Received|Overall Study|safety population|380
394153|NCT00227305|964949|P1|STARTED|Overall Study|enrolled|381
394154|NCT00227266|964966|P3|NOT COMPLETED|Overall Study||4
394155|NCT00227266|964967|P2|NOT COMPLETED|Overall Study||0
394156|NCT00227266|964968|P1|NOT COMPLETED|Overall Study||1
394157|NCT00227266|964966|P3|COMPLETED|Overall Study||29
394158|NCT00227266|964967|P2|COMPLETED|Overall Study||30
394159|NCT00227266|964968|P1|COMPLETED|Overall Study||30
394160|NCT00227266|964966|P3|STARTED|Overall Study||33
394161|NCT00227266|964967|P2|STARTED|Overall Study||30
394162|NCT00227266|964968|P1|STARTED|Overall Study||31
394163|NCT00227019|964988|P1|NOT COMPLETED|Overall Study||0
394164|NCT00227019|964988|P1|COMPLETED|Overall Study||16
394165|NCT00227019|964988|P1|STARTED|Overall Study||16
394166|NCT00226941|964998|P4|NOT COMPLETED|Overall Study||2
394167|NCT00226941|964999|P3|NOT COMPLETED|Overall Study||0
394168|NCT00226941|965000|P2|NOT COMPLETED|Overall Study||0
394169|NCT00226941|965001|P1|NOT COMPLETED|Overall Study||0
394170|NCT00226941|964998|P4|COMPLETED|Overall Study||5
394171|NCT00226941|964999|P3|COMPLETED|Overall Study||4
394172|NCT00226941|965000|P2|COMPLETED|Overall Study||6
394173|NCT00226941|965001|P1|COMPLETED|Overall Study||6
394174|NCT00226941|964998|P4|STARTED|Overall Study||7
394175|NCT00226941|964999|P3|STARTED|Overall Study||4
394176|NCT00226941|965000|P2|STARTED|Overall Study||6
394177|NCT00226941|965001|P1|STARTED|Overall Study||6
394178|NCT00226811|965035|P1|NOT COMPLETED|Overall Study||76
394179|NCT00226811|965035|P1|COMPLETED|Overall Study||2
394180|NCT00226811|965035|P1|STARTED|Overall Study||78
394181|NCT00226655|965045|P1|NOT COMPLETED|Overall Study||79
394182|NCT00226655|965045|P1|COMPLETED|Overall Study||33
394183|NCT00226655|965045|P1|STARTED|Overall Study||112
394184|NCT00226590|965049|P1|NOT COMPLETED|Overall Study||0
394185|NCT00226590|965049|P1|COMPLETED|Overall Study||39
394186|NCT00226590|965049|P1|STARTED|Overall Study||39
394187|NCT00226577|965056|P1|NOT COMPLETED|Overall Study||0
394188|NCT00226577|965056|P1|COMPLETED|Overall Study||52
394189|NCT00226577|965056|P1|STARTED|Overall Study||52
394190|NCT00226499|965067|P3|NOT COMPLETED|Overall Study||359
394191|NCT00226499|965068|P2|NOT COMPLETED|Overall Study||1072
394192|NCT00226499|965069|P1|NOT COMPLETED|Overall Study||1074
394193|NCT00226499|965067|P3|COMPLETED|Overall Study||468
394194|NCT00226499|965068|P2|COMPLETED|Overall Study||1415
394195|NCT00226499|965069|P1|COMPLETED|Overall Study||1415
394196|NCT00226499|965067|P3|STARTED|Overall Study||827
394197|NCT00226499|965068|P2|STARTED|Overall Study||2487
394198|NCT00226499|965069|P1|STARTED|Overall Study||2489
394199|NCT00226239|965184|P1|NOT COMPLETED|Maintenance Cetuximab||14
394200|NCT00226239|965184|P1|COMPLETED|Maintenance Cetuximab||17
394201|NCT00226239|965184|P1|STARTED|Maintenance Cetuximab||31
394202|NCT00226239|965184|P1|NOT COMPLETED|XPE, Definitive Therapy||4
394203|NCT00226239|965184|P1|COMPLETED|XPE, Definitive Therapy||33
394204|NCT00226239|965184|P1|STARTED|XPE, Definitive Therapy||37
394205|NCT00226239|965184|P1|NOT COMPLETED|TPE, Induction Therapy||2
394206|NCT00226239|965184|P1|COMPLETED|TPE, Induction Therapy||37
394207|NCT00226239|965184|P1|STARTED|TPE, Induction Therapy||39
394208|NCT00225784|965193|P1|NOT COMPLETED|Overall Study||4
394209|NCT00225784|965193|P1|COMPLETED|Overall Study||33
394210|NCT00225784|965193|P1|STARTED|Overall Study||37
394211|NCT00225758|965204|P1|NOT COMPLETED|Overall Study||4
394212|NCT00225758|965204|P1|COMPLETED|Overall Study||23
394213|NCT00225758|965204|P1|STARTED|Overall Study||27
394214|NCT00225732|965214|P2|NOT COMPLETED|Overall Study||0
394215|NCT00225732|965215|P1|NOT COMPLETED|Overall Study||0
394216|NCT00225732|965214|P2|COMPLETED|Overall Study||166
394217|NCT00225732|965215|P1|COMPLETED|Overall Study||153
394218|NCT00225732|965214|P2|STARTED|Overall Study||166
394219|NCT00225732|965215|P1|STARTED|Overall Study||153
394220|NCT00225498|965221|P1|NOT COMPLETED|Overall Study||0
394221|NCT00225498|965221|P1|COMPLETED|Overall Study|The only analyses with adequate statistical power were of the 10 ziprasidone nonresponders.|10
394222|NCT00225498|965221|P1|STARTED|Overall Study||10
394223|NCT00225420|965225|P3|NOT COMPLETED|Overall Study||0
394224|NCT00225420|965226|P2|NOT COMPLETED|Overall Study||0
394225|NCT00225420|965227|P1|NOT COMPLETED|Overall Study||0
394226|NCT00225420|965225|P3|COMPLETED|Overall Study||3
394227|NCT00225420|965226|P2|COMPLETED|Overall Study||6
394228|NCT00225420|965227|P1|COMPLETED|Overall Study||9
394229|NCT00225420|965225|P3|STARTED|Overall Study||3
394230|NCT00225420|965226|P2|STARTED|Overall Study||6
394231|NCT00225420|965227|P1|STARTED|Overall Study||9
394232|NCT00225277|965236|P2|NOT COMPLETED|Overall Study||95
394233|NCT00225277|965237|P1|NOT COMPLETED|Overall Study||97
394234|NCT00225277|965236|P2|COMPLETED|Overall Study||178
394235|NCT00225277|965237|P1|COMPLETED|Overall Study||177
394236|NCT00225277|965236|P2|STARTED|Overall Study|Mean treatment durations were 56.3 weeks (glimepiride) and 56.5 weeks (pioglitazone).|273
394237|NCT00225277|965237|P1|STARTED|Overall Study|274 subjects randomized, but four subjects did not receive drug.|274
394238|NCT00225251|965255|P2|NOT COMPLETED|Overall Study||1
394239|NCT00225251|965256|P1|NOT COMPLETED|Overall Study||1
394240|NCT00225251|965255|P2|COMPLETED|Overall Study||6
394241|NCT00225251|965256|P1|COMPLETED|Overall Study||10
394242|NCT00225251|965255|P2|STARTED|Overall Study||7
394243|NCT00225251|965256|P1|STARTED|Overall Study||11
394244|NCT00225212|965270|P1|NOT COMPLETED|Overall Study||6
394245|NCT00225212|965270|P1|COMPLETED|Overall Study||29
394246|NCT00225212|965270|P1|STARTED|Overall Study||35
394247|NCT00225147|965279|P4|NOT COMPLETED|Open-label Phase||10
394248|NCT00225147|965280|P3|NOT COMPLETED|Open-label Phase||0
394249|NCT00225147|965281|P2|NOT COMPLETED|Open-label Phase||0
394250|NCT00225147|965282|P1|NOT COMPLETED|Open-label Phase||0
394251|NCT00225147|965279|P4|COMPLETED|Open-label Phase||52
394252|NCT00225147|965280|P3|COMPLETED|Open-label Phase||0
394253|NCT00225147|965281|P2|COMPLETED|Open-label Phase||0
394254|NCT00225147|965282|P1|COMPLETED|Open-label Phase||0
394255|NCT00225147|965279|P4|STARTED|Open-label Phase||62
394256|NCT00225147|965280|P3|STARTED|Open-label Phase||0
394257|NCT00225147|965281|P2|STARTED|Open-label Phase||0
394258|NCT00225147|965282|P1|STARTED|Open-label Phase||0
394259|NCT00225147|965279|P4|NOT COMPLETED|Double-blind Phase||0
394260|NCT00225147|965280|P3|NOT COMPLETED|Double-blind Phase||0
394261|NCT00225147|965281|P2|NOT COMPLETED|Double-blind Phase||0
394262|NCT00225147|965282|P1|NOT COMPLETED|Double-blind Phase||0
394263|NCT00225147|965279|P4|COMPLETED|Double-blind Phase||0
394264|NCT00225147|965280|P3|COMPLETED|Double-blind Phase||13
394265|NCT00225147|965281|P2|COMPLETED|Double-blind Phase||12
394266|NCT00225147|965282|P1|COMPLETED|Double-blind Phase||13
394267|NCT00225147|965279|P4|STARTED|Double-blind Phase||0
394268|NCT00225147|965280|P3|STARTED|Double-blind Phase||13
394269|NCT00225147|965281|P2|STARTED|Double-blind Phase||12
394270|NCT00225147|965282|P1|STARTED|Double-blind Phase||13
394271|NCT00225017|965298|P2|NOT COMPLETED|Overall Study||1
394272|NCT00225017|965299|P1|NOT COMPLETED|Overall Study||0
394273|NCT00225017|965298|P2|COMPLETED|Overall Study|1 subject did not complete week 24 assessments|23
394274|NCT00225017|965299|P1|COMPLETED|Overall Study||26
394275|NCT00225017|965298|P2|STARTED|Overall Study||24
394276|NCT00225017|965299|P1|STARTED|Overall Study||26
394277|NCT00224952|965312|P3|NOT COMPLETED|Overall Study||0
394278|NCT00224952|965313|P2|NOT COMPLETED|Overall Study||0
394279|NCT00224952|965314|P1|NOT COMPLETED|Overall Study||0
394280|NCT00224952|965312|P3|COMPLETED|Overall Study||134
394281|NCT00224952|965313|P2|COMPLETED|Overall Study||87
394282|NCT00224952|965314|P1|COMPLETED|Overall Study||53
394283|NCT00224952|965312|P3|STARTED|Overall Study||134
394284|NCT00224952|965313|P2|STARTED|Overall Study||87
394285|NCT00224952|965314|P1|STARTED|Overall Study||53
394286|NCT00224874|965329|P4|NOT COMPLETED|Overall Study||0
394287|NCT00224874|965330|P3|NOT COMPLETED|Overall Study||1
394288|NCT00224874|965331|P2|NOT COMPLETED|Overall Study||0
394289|NCT00224874|965332|P1|NOT COMPLETED|Overall Study||0
394290|NCT00224874|965329|P4|COMPLETED|Overall Study||42
394291|NCT00224874|965330|P3|COMPLETED|Overall Study||46
394292|NCT00224874|965331|P2|COMPLETED|Overall Study||45
394293|NCT00224874|965332|P1|COMPLETED|Overall Study||46
394294|NCT00224874|965329|P4|STARTED|Overall Study||42
394295|NCT00224874|965330|P3|STARTED|Overall Study||47
394296|NCT00224874|965331|P2|STARTED|Overall Study||45
394297|NCT00224874|965332|P1|STARTED|Overall Study||46
394298|NCT00224770|965377|P3|NOT COMPLETED|Overall Study||0
394299|NCT00224770|965378|P2|NOT COMPLETED|Overall Study||2
394300|NCT00224770|965379|P1|NOT COMPLETED|Overall Study||4
394301|NCT00224770|965377|P3|COMPLETED|Overall Study||14
394302|NCT00224770|965378|P2|COMPLETED|Overall Study||52
394303|NCT00224770|965379|P1|COMPLETED|Overall Study||38
394304|NCT00224770|965377|P3|STARTED|Overall Study||14
394305|NCT00224770|965378|P2|STARTED|Overall Study||54
394306|NCT00224770|965379|P1|STARTED|Overall Study||42
394307|NCT00224484|965414|P3|NOT COMPLETED|Overall Study||62
394308|NCT00224484|965415|P2|NOT COMPLETED|Overall Study||65
394309|NCT00224484|965416|P1|NOT COMPLETED|Overall Study||146
394310|NCT00224484|965414|P3|COMPLETED|Overall Study||1425
394311|NCT00224484|965415|P2|COMPLETED|Overall Study||1426
394312|NCT00224484|965416|P1|COMPLETED|Overall Study||2831
394313|NCT00224484|965414|P3|STARTED|Overall Study||1487
394314|NCT00224484|965415|P2|STARTED|Overall Study||1491
394315|NCT00224484|965416|P1|STARTED|Overall Study||2977
394316|NCT00224289|965475|P1|NOT COMPLETED|Overall Study||0
394317|NCT00224289|965475|P1|COMPLETED|Overall Study||17
394318|NCT00224289|965475|P1|STARTED|Overall Study||17
394319|NCT00224133|965480|P1|NOT COMPLETED|Overall Study||226
394320|NCT00224133|965480|P1|COMPLETED|Overall Study||435
394321|NCT00224133|965480|P1|STARTED|Overall Study||661
394322|NCT00224120|965486|P2|NOT COMPLETED|Overall Study||24
394323|NCT00224120|965487|P1|NOT COMPLETED|Overall Study||22
394324|NCT00224120|965486|P2|COMPLETED|Overall Study||205
394325|NCT00224120|965487|P1|COMPLETED|Overall Study||211
394326|NCT00224120|965486|P2|STARTED|Overall Study||229
394327|NCT00224120|965487|P1|STARTED|Overall Study||233
394328|NCT00224107|965497|P2|NOT COMPLETED|Overall Study||14
394329|NCT00224107|965498|P1|NOT COMPLETED|Overall Study||31
394330|NCT00224107|965497|P2|COMPLETED|Overall Study||214
394331|NCT00224107|965498|P1|COMPLETED|Overall Study||202
394332|NCT00224107|965497|P2|STARTED|Overall Study||228
394333|NCT00224107|965498|P1|STARTED|Overall Study||233
394334|NCT00224055|965508|P2|NOT COMPLETED|Overall Study||14
394335|NCT00224055|965509|P1|NOT COMPLETED|Overall Study||15
394336|NCT00224055|965508|P2|COMPLETED|Overall Study||31
394337|NCT00224055|965509|P1|COMPLETED|Overall Study||29
394338|NCT00224055|965508|P2|STARTED|Overall Study||45
394339|NCT00224055|965509|P1|STARTED|Overall Study||44
394340|NCT00224042|965519|P2|NOT COMPLETED|Overall Study||6
394341|NCT00224042|965520|P1|NOT COMPLETED|Overall Study||6
394342|NCT00224042|965519|P2|COMPLETED|Overall Study||20
394343|NCT00224042|965520|P1|COMPLETED|Overall Study||20
394344|NCT00224042|965519|P2|STARTED|Overall Study||26
394345|NCT00224042|965520|P1|STARTED|Overall Study||26
394346|NCT00224029|965532|P1|NOT COMPLETED|Overall Study||6
394347|NCT00224029|965532|P1|COMPLETED|Overall Study||18
394348|NCT00224029|965532|P1|STARTED|Overall Study||24
394349|NCT00224016|965538|P2|NOT COMPLETED|Follow-Up Period||0
394350|NCT00224016|965539|P1|NOT COMPLETED|Follow-Up Period||0
394351|NCT00224016|965538|P2|COMPLETED|Follow-Up Period||0
394352|NCT00224016|965539|P1|COMPLETED|Follow-Up Period||35
394353|NCT00224016|965538|P2|STARTED|Follow-Up Period|This group of subjects did not proceed to follow-up period.|0
394354|NCT00224016|965539|P1|STARTED|Follow-Up Period||35
394355|NCT00224016|965538|P2|NOT COMPLETED|Maintenance Period||1
394356|NCT00224016|965539|P1|NOT COMPLETED|Maintenance Period||2
394357|NCT00224016|965538|P2|COMPLETED|Maintenance Period||14
394358|NCT00224016|965539|P1|COMPLETED|Maintenance Period||36
394359|NCT00224016|965538|P2|STARTED|Maintenance Period||15
394360|NCT00224016|965539|P1|STARTED|Maintenance Period||38
394361|NCT00224016|965538|P2|NOT COMPLETED|Titration Period||1
394362|NCT00224016|965539|P1|NOT COMPLETED|Titration Period||1
394363|NCT00224016|965538|P2|COMPLETED|Titration Period||15
394364|NCT00224016|965539|P1|COMPLETED|Titration Period||38
394365|NCT00224016|965538|P2|STARTED|Titration Period||16
394366|NCT00224016|965539|P1|STARTED|Titration Period||39
394367|NCT00224003|965547|P1|NOT COMPLETED|Overall Study||7
394368|NCT00224003|965547|P1|COMPLETED|Overall Study|Last patient out: March 31, 2004|16
394369|NCT00224003|965547|P1|STARTED|Overall Study|First patient in: April 2, 2003|23
394370|NCT00223977|965554|P3|NOT COMPLETED|Overall Study||3
394371|NCT00223977|965555|P2|NOT COMPLETED|Overall Study||11
394372|NCT00223977|965556|P1|NOT COMPLETED|Overall Study||9
394373|NCT00223977|965554|P3|COMPLETED|Overall Study||39
394374|NCT00223977|965555|P2|COMPLETED|Overall Study||47
394375|NCT00223977|965556|P1|COMPLETED|Overall Study||37
394376|NCT00223977|965554|P3|STARTED|Overall Study||42
394377|NCT00223977|965555|P2|STARTED|Overall Study||58
394378|NCT00223977|965556|P1|STARTED|Overall Study||46
394379|NCT00223821|965578|P2|NOT COMPLETED|Overall Study||10
394380|NCT00223821|965579|P1|NOT COMPLETED|Overall Study||4
394381|NCT00223821|965578|P2|COMPLETED|Overall Study||22
394382|NCT00223821|965579|P1|COMPLETED|Overall Study||28
394383|NCT00223821|965578|P2|Completed 6-month Follow-up|Overall Study||25
394384|NCT00223821|965579|P1|Completed 6-month Follow-up|Overall Study||28
394385|NCT00223821|965578|P2|Completed Post-treatment Assessment|Overall Study||27
394386|NCT00223821|965579|P1|Completed Post-treatment Assessment|Overall Study||31
394387|NCT00223821|965578|P2|Completed Therapy|Overall Study||28
394388|NCT00223821|965579|P1|Completed Therapy|Overall Study||31
394389|NCT00223821|965578|P2|STARTED|Overall Study||32
394390|NCT00223821|965579|P1|STARTED|Overall Study||32
394391|NCT00223808|965590|P3|NOT COMPLETED|Overall Study||5
394392|NCT00223808|965591|P2|NOT COMPLETED|Overall Study||5
394393|NCT00223808|965592|P1|NOT COMPLETED|Overall Study||3
394394|NCT00223808|965590|P3|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|18
394395|NCT00223808|965591|P2|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|17
394396|NCT00223808|965592|P1|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|19
394397|NCT00223808|965590|P3|STARTED|Overall Study||23
394398|NCT00223808|965591|P2|STARTED|Overall Study||22
394399|NCT00223808|965592|P1|STARTED|Overall Study||22
394400|NCT00223795|965609|P2|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
394401|NCT00223795|965610|P1|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
394402|NCT00223795|965609|P2|COMPLETED|Second Intervention - All Use Canes 4 mo||17
394403|NCT00223795|965610|P1|COMPLETED|Second Intervention - All Use Canes 4 mo||18
394404|NCT00223795|965609|P2|STARTED|Second Intervention - All Use Canes 4 mo||18
394405|NCT00223795|965610|P1|STARTED|Second Intervention - All Use Canes 4 mo||19
394406|NCT00223795|965609|P2|NOT COMPLETED|First Intervention - Eight Weeks||9
394407|NCT00223795|965610|P1|NOT COMPLETED|First Intervention - Eight Weeks||7
394408|NCT00223795|965609|P2|COMPLETED|First Intervention - Eight Weeks||18
394409|NCT00223795|965610|P1|COMPLETED|First Intervention - Eight Weeks||19
394410|NCT00223795|965609|P2|STARTED|First Intervention - Eight Weeks||27
394411|NCT00223795|965610|P1|STARTED|First Intervention - Eight Weeks||26
394412|NCT00223704|965620|P3|NOT COMPLETED|Overall Study||0
394413|NCT00223704|965621|P2|NOT COMPLETED|Overall Study||0
394414|NCT00223704|965622|P1|NOT COMPLETED|Overall Study||0
394415|NCT00223704|965620|P3|COMPLETED|Overall Study||40
394416|NCT00223704|965621|P2|COMPLETED|Overall Study||37
394417|NCT00223704|965622|P1|COMPLETED|Overall Study||38
394418|NCT00223704|965620|P3|STARTED|Overall Study||40
394419|NCT00223704|965621|P2|STARTED|Overall Study||37
394420|NCT00223704|965622|P1|STARTED|Overall Study||38
394421|NCT00223678|965644|P2|NOT COMPLETED|Overall Study||0
394422|NCT00223678|965645|P1|NOT COMPLETED|Overall Study||0
394423|NCT00223678|965644|P2|COMPLETED|Overall Study||7
394424|NCT00223678|965645|P1|COMPLETED|Overall Study||13
394425|NCT00223678|965644|P2|STARTED|Overall Study||7
394426|NCT00223678|965645|P1|STARTED|Overall Study||13
394427|NCT00223665|965651|P1|NOT COMPLETED|Overall Study||0
394428|NCT00223665|965651|P1|COMPLETED|Overall Study||102
394429|NCT00223665|965651|P1|STARTED|Overall Study||102
394430|NCT00223652|965671|P2|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||4
394431|NCT00223652|965672|P1|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||1
394432|NCT00223652|965671|P2|COMPLETED|T-CBT and TAU 6 Month Follow-up||37
394433|NCT00223652|965672|P1|COMPLETED|T-CBT and TAU 6 Month Follow-up||39
394434|NCT00223652|965671|P2|STARTED|T-CBT and TAU 6 Month Follow-up||41
394435|NCT00223652|965672|P1|STARTED|T-CBT and TAU 6 Month Follow-up||40
394436|NCT00223652|965671|P2|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
394437|NCT00223652|965672|P1|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
394438|NCT00223652|965671|P2|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||41
394439|NCT00223652|965672|P1|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||40
394440|NCT00223652|965671|P2|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||41
394441|NCT00223652|965672|P1|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||40
394442|NCT00223652|965671|P2|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||3
394443|NCT00223652|965672|P1|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||1
394444|NCT00223652|965671|P2|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||41
394445|NCT00223652|965672|P1|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||40
394446|NCT00223652|965671|P2|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||44
394447|NCT00223652|965672|P1|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||41
394448|NCT00223496|965688|P1|NOT COMPLETED|Overall Study||22
394449|NCT00223496|965688|P1|COMPLETED|Overall Study||10
394450|NCT00223496|965688|P1|STARTED|Overall Study|32 people consented, 19 were baselined|32
394451|NCT00223262|965694|P2|NOT COMPLETED|Overall Study||1
394452|NCT00223262|965695|P1|NOT COMPLETED|Overall Study||8
394453|NCT00223262|965694|P2|COMPLETED|Overall Study||11
394454|NCT00223262|965695|P1|COMPLETED|Overall Study||8
394455|NCT00223262|965694|P2|STARTED|Overall Study||12
394456|NCT00223262|965695|P1|STARTED|Overall Study||16
394457|NCT00223236|965703|P2|NOT COMPLETED|Overall Study||14
394458|NCT00223236|965704|P1|NOT COMPLETED|Overall Study||7
394459|NCT00223236|965703|P2|COMPLETED|Overall Study|4 completed 12 week trial.|4
394460|NCT00223236|965704|P1|COMPLETED|Overall Study|9 completed 12 week trial.|9
394461|NCT00223236|965703|P2|STARTED|Overall Study|21 completed baseline assessment but 18 completed at least one treatment visit.|18
394462|NCT00223236|965704|P1|STARTED|Overall Study|23 completed baseline assessment but 16 completed at least one treatment visit.|16
394463|NCT00223080|965718|P2|NOT COMPLETED|Overall Study||797
394464|NCT00223080|965719|P1|NOT COMPLETED|Overall Study||796
394465|NCT00223080|965718|P2|COMPLETED|Overall Study||7401
394466|NCT00223080|965719|P1|COMPLETED|Overall Study||7401
394467|NCT00223080|965718|P2|STARTED|Overall Study||8198
394468|NCT00223080|965719|P1|STARTED|Overall Study||8197
394469|NCT00222729|965737|P1|NOT COMPLETED|Overall Study||3
394470|NCT00222729|965737|P1|COMPLETED|Overall Study||37
394471|NCT00222729|965737|P1|STARTED|Overall Study||40
394472|NCT00222131|965746|P2|NOT COMPLETED|Overall Study||0
394473|NCT00222131|965747|P1|NOT COMPLETED|Overall Study||0
394474|NCT00222131|965746|P2|COMPLETED|Overall Study||35
394475|NCT00222131|965747|P1|COMPLETED|Overall Study||38
394476|NCT00222131|965746|P2|STARTED|Overall Study||35
394477|NCT00222131|965747|P1|STARTED|Overall Study||38
394478|NCT00222105|965755|P1|NOT COMPLETED|Overall Study||14
394479|NCT00222105|965755|P1|COMPLETED|Overall Study||11
394480|NCT00222105|965755|P1|STARTED|Overall Study||25
394481|NCT00221299|965763|P4|NOT COMPLETED|Overall Study||1
394482|NCT00221299|965764|P3|NOT COMPLETED|Overall Study||0
394483|NCT00221299|965765|P2|NOT COMPLETED|Overall Study||2
394484|NCT00221299|965766|P1|NOT COMPLETED|Overall Study||1
394485|NCT00221299|965763|P4|COMPLETED|Overall Study||10
394486|NCT00221299|965764|P3|COMPLETED|Overall Study||14
394487|NCT00221299|965765|P2|COMPLETED|Overall Study||11
394488|NCT00221299|965766|P1|COMPLETED|Overall Study||10
394489|NCT00221299|965763|P4|STARTED|Overall Study||11
394490|NCT00221299|965764|P3|STARTED|Overall Study||14
394491|NCT00221299|965765|P2|STARTED|Overall Study||13
394492|NCT00221299|965766|P1|STARTED|Overall Study||11
394493|NCT00221195|965776|P2|NOT COMPLETED|Overall Study||3
394494|NCT00221195|965777|P1|NOT COMPLETED|Overall Study||5
394495|NCT00221195|965776|P2|COMPLETED|Overall Study||14
394496|NCT00221195|965777|P1|COMPLETED|Overall Study||12
394497|NCT00221195|965776|P2|STARTED|Overall Study||17
394498|NCT00221195|965777|P1|STARTED|Overall Study||17
394499|NCT00221117|965786|P2|NOT COMPLETED|Overall Study||0
394500|NCT00221117|965787|P1|NOT COMPLETED|Overall Study||0
394501|NCT00221117|965786|P2|COMPLETED|Overall Study||9
394502|NCT00221117|965787|P1|COMPLETED|Overall Study||12
394503|NCT00221117|965786|P2|STARTED|Overall Study|One participant dropped out of the study after signing consent but prior to baseline assessments.|9
394504|NCT00221117|965787|P1|STARTED|Overall Study||12
394505|NCT00221104|965799|P2|NOT COMPLETED|Overall Study||76
394506|NCT00221104|965800|P1|NOT COMPLETED|Overall Study||83
394507|NCT00221104|965799|P2|COMPLETED|Overall Study||709
394508|NCT00221104|965800|P1|COMPLETED|Overall Study||710
394509|NCT00221104|965799|P2|STARTED|Overall Study||785
394510|NCT00221104|965800|P1|STARTED|Overall Study||793
394511|NCT00220961|965816|P2|NOT COMPLETED|Overall Study||90
394512|NCT00220961|965817|P1|NOT COMPLETED|Overall Study||71
394513|NCT00220961|965816|P2|COMPLETED|Overall Study||213
394514|NCT00220961|965817|P1|COMPLETED|Overall Study||228
394515|NCT00220961|965816|P2|STARTED|Overall Study||303
394516|NCT00220961|965817|P1|STARTED|Overall Study||299
394517|NCT00220805|965833|P2|NOT COMPLETED|Overall Study||11
394518|NCT00220805|965834|P1|NOT COMPLETED|Overall Study||8
394519|NCT00220805|965833|P2|COMPLETED|Overall Study||16
394520|NCT00220805|965834|P1|COMPLETED|Overall Study||22
394521|NCT00220805|965833|P2|STARTED|Overall Study||27
394522|NCT00220805|965834|P1|STARTED|Overall Study||30
394523|NCT00220779|965855|P3|NOT COMPLETED|Overall Study||4
394524|NCT00220779|965856|P2|NOT COMPLETED|Overall Study||4
394525|NCT00220779|965857|P1|NOT COMPLETED|Overall Study||7
394526|NCT00220779|965855|P3|COMPLETED|Overall Study||37
394527|NCT00220779|965856|P2|COMPLETED|Overall Study||38
394528|NCT00220779|965857|P1|COMPLETED|Overall Study||38
394529|NCT00220779|965855|P3|STARTED|Overall Study||41
394530|NCT00220779|965856|P2|STARTED|Overall Study||42
394531|NCT00220779|965857|P1|STARTED|Overall Study||45
394532|NCT00220740|965867|P2|NOT COMPLETED|Withdrawal Period||15
394533|NCT00220740|965868|P1|NOT COMPLETED|Withdrawal Period||6
394534|NCT00220740|965867|P2|COMPLETED|Withdrawal Period||16
394535|NCT00220740|965868|P1|COMPLETED|Withdrawal Period||37
394536|NCT00220740|965867|P2|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|31
394537|NCT00220740|965868|P1|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|43
394538|NCT00220740|965867|P2|NOT COMPLETED|Rescue Treatment||18
394539|NCT00220740|965868|P1|NOT COMPLETED|Rescue Treatment||19
394540|NCT00220740|965867|P2|COMPLETED|Rescue Treatment||5
394541|NCT00220740|965868|P1|COMPLETED|Rescue Treatment||26
394542|NCT00220740|965867|P2|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|23
394543|NCT00220740|965868|P1|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|45
394544|NCT00220740|965867|P2|NOT COMPLETED|Efficacy Period||46
394545|NCT00220740|965868|P1|NOT COMPLETED|Efficacy Period||26
394546|NCT00220740|965867|P2|COMPLETED|Efficacy Period||12
394547|NCT00220740|965868|P1|COMPLETED|Efficacy Period||33
394548|NCT00220740|965867|P2|STARTED|Efficacy Period||58
394549|NCT00220740|965868|P1|STARTED|Efficacy Period||59
394550|NCT00220727|965882|P2|NOT COMPLETED|Second Infusion (Week <6)||0
394551|NCT00220727|965883|P1|NOT COMPLETED|Second Infusion (Week <6)||1
394552|NCT00220727|965882|P2|COMPLETED|Second Infusion (Week <6)||4
394553|NCT00220727|965883|P1|COMPLETED|Second Infusion (Week <6)||3
394554|NCT00220727|965882|P2|STARTED|Second Infusion (Week <6)||4
394555|NCT00220727|965883|P1|STARTED|Second Infusion (Week <6)||4
394556|NCT00220727|965882|P2|NOT COMPLETED|First Infusion (Week 0)||0
394557|NCT00220727|965883|P1|NOT COMPLETED|First Infusion (Week 0)||0
394558|NCT00220727|965882|P2|COMPLETED|First Infusion (Week 0)||4
394559|NCT00220727|965883|P1|COMPLETED|First Infusion (Week 0)||4
394560|NCT00220727|965882|P2|STARTED|First Infusion (Week 0)||4
394561|NCT00220727|965883|P1|STARTED|First Infusion (Week 0)||4
394562|NCT00220701|965899|P2|NOT COMPLETED|Overall Study||4
394563|NCT00220701|965900|P1|NOT COMPLETED|Overall Study||5
394564|NCT00220701|965899|P2|COMPLETED|Overall Study||13
394565|NCT00220701|965900|P1|COMPLETED|Overall Study||12
394566|NCT00220701|965899|P2|STARTED|Overall Study||17
394567|NCT00220701|965900|P1|STARTED|Overall Study||17
394568|NCT00220636|965916|P1|NOT COMPLETED|Overall Study||4
394569|NCT00220636|965916|P1|COMPLETED|Overall Study||11
394570|NCT00220636|965916|P1|STARTED|Overall Study||15
394571|NCT00219557|965926|P3|NOT COMPLETED|Phase 2||33
394572|NCT00219557|965927|P2|NOT COMPLETED|Phase 2||69
394573|NCT00219557|965928|P1|NOT COMPLETED|Phase 2||0
394574|NCT00219557|965926|P3|COMPLETED|Phase 2||1
394575|NCT00219557|965927|P2|COMPLETED|Phase 2||0
394576|NCT00219557|965928|P1|COMPLETED|Phase 2||0
394577|NCT00219557|965926|P3|Treated|Phase 2||31
394578|NCT00219557|965927|P2|Treated|Phase 2||68
394579|NCT00219557|965928|P1|Treated|Phase 2||0
394580|NCT00219557|965926|P3|STARTED|Phase 2||34
394581|NCT00219557|965927|P2|STARTED|Phase 2||69
394582|NCT00219557|965928|P1|STARTED|Phase 2||0
394583|NCT00219557|965926|P3|NOT COMPLETED|Phase 1||0
394584|NCT00219557|965927|P2|NOT COMPLETED|Phase 1||0
394585|NCT00219557|965928|P1|NOT COMPLETED|Phase 1||7
394586|NCT00219557|965926|P3|COMPLETED|Phase 1||0
394587|NCT00219557|965927|P2|COMPLETED|Phase 1||0
394588|NCT00219557|965928|P1|COMPLETED|Phase 1||1
394589|NCT00219557|965926|P3|STARTED|Phase 1||0
394590|NCT00219557|965927|P2|STARTED|Phase 1||0
394591|NCT00219557|965928|P1|STARTED|Phase 1||8
394592|NCT00219544|965956|P2|NOT COMPLETED|Double Blind Treatment Period||0
394593|NCT00219544|965957|P1|NOT COMPLETED|Double Blind Treatment Period||0
394594|NCT00219544|965956|P2|COMPLETED|Double Blind Treatment Period||77
394595|NCT00219544|965957|P1|COMPLETED|Double Blind Treatment Period||80
394596|NCT00219544|965956|P2|STARTED|Double Blind Treatment Period||77
394597|NCT00219544|965957|P1|STARTED|Double Blind Treatment Period||80
394598|NCT00219544|965956|P2|NOT COMPLETED|Single Blind Treatment Period||0
394599|NCT00219544|965957|P1|NOT COMPLETED|Single Blind Treatment Period||22
394600|NCT00219544|965956|P2|COMPLETED|Single Blind Treatment Period||0
394601|NCT00219544|965957|P1|COMPLETED|Single Blind Treatment Period||234
394602|NCT00219544|965956|P2|STARTED|Single Blind Treatment Period||0
394603|NCT00219544|965957|P1|STARTED|Single Blind Treatment Period||256
394604|NCT00219349|965995|P1|NOT COMPLETED|Escitalopram Phase||3
394605|NCT00219349|965995|P1|COMPLETED|Escitalopram Phase||4
394606|NCT00219349|965995|P1|STARTED|Escitalopram Phase|7 responders to CBT were ineligible to start and 1 declined, leaving 7 who started escitalopram|7
394607|NCT00219349|965995|P1|NOT COMPLETED|Cognitive Behavioral Therapy Phase||10
394608|NCT00219349|965995|P1|COMPLETED|Cognitive Behavioral Therapy Phase||15
394609|NCT00219349|965995|P1|STARTED|Cognitive Behavioral Therapy Phase||25
394610|NCT00219284|966008|P2|NOT COMPLETED|Extension Phase - 8 Weeks||7
394611|NCT00219284|966009|P1|NOT COMPLETED|Extension Phase - 8 Weeks||2
394612|NCT00219284|966008|P2|COMPLETED|Extension Phase - 8 Weeks||99
394613|NCT00219284|966009|P1|COMPLETED|Extension Phase - 8 Weeks||112
394614|NCT00219284|966008|P2|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|106
394615|NCT00219284|966009|P1|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|114
394616|NCT00219284|966008|P2|NOT COMPLETED|Treatment Phase - 16 Weeks||51
394617|NCT00219284|966009|P1|NOT COMPLETED|Treatment Phase - 16 Weeks||44
394618|NCT00219284|966008|P2|COMPLETED|Treatment Phase - 16 Weeks||128
394619|NCT00219284|966009|P1|COMPLETED|Treatment Phase - 16 Weeks||136
394620|NCT00219284|966008|P2|STARTED|Treatment Phase - 16 Weeks||179
394621|NCT00219284|966009|P1|STARTED|Treatment Phase - 16 Weeks||180
394622|NCT00219141|966034|P3|NOT COMPLETED|Overall Study||12
394623|NCT00219141|966035|P2|NOT COMPLETED|Overall Study||21
394624|NCT00219141|966036|P1|NOT COMPLETED|Overall Study||14
394625|NCT00219141|966034|P3|COMPLETED|Overall Study||142
394626|NCT00219141|966035|P2|COMPLETED|Overall Study||131
394627|NCT00219141|966036|P1|COMPLETED|Overall Study||140
394628|NCT00219141|966034|P3|STARTED|Overall Study||154
394629|NCT00219141|966035|P2|STARTED|Overall Study||152
394630|NCT00219141|966036|P1|STARTED|Overall Study||154
394631|NCT00218634|966082|P2|NOT COMPLETED|Overall Study||15
394632|NCT00218634|966083|P1|NOT COMPLETED|Overall Study||8
394633|NCT00218634|966082|P2|COMPLETED|Overall Study||30
394634|NCT00218634|966083|P1|COMPLETED|Overall Study||36
394635|NCT00218634|966082|P2|STARTED|Overall Study||45
394636|NCT00218634|966083|P1|STARTED|Overall Study||44
394637|NCT00218543|966103|P1|NOT COMPLETED|Overall Study||15
394638|NCT00218543|966103|P1|COMPLETED|Overall Study|13 reached the maintenance dose phase of treatment; 9 completed at least six weeks of treatment.|5
394639|NCT00218543|966103|P1|STARTED|Overall Study||20
394640|NCT00218491|966111|P3|NOT COMPLETED|Overall Study||0
394641|NCT00218491|966112|P2|NOT COMPLETED|Overall Study||0
394642|NCT00218491|966113|P1|NOT COMPLETED|Overall Study||0
394643|NCT00218491|966111|P3|COMPLETED|Overall Study||38
394644|NCT00218491|966112|P2|COMPLETED|Overall Study||33
394645|NCT00218491|966113|P1|COMPLETED|Overall Study||40
394646|NCT00218491|966111|P3|STARTED|Overall Study||38
394647|NCT00218491|966112|P2|STARTED|Overall Study||33
394648|NCT00218491|966113|P1|STARTED|Overall Study||40
394649|NCT00218465|966123|P2|NOT COMPLETED|Overall Study||18
394650|NCT00218465|966124|P1|NOT COMPLETED|Overall Study||17
394651|NCT00218465|966123|P2|COMPLETED|Overall Study||30
394652|NCT00218465|966124|P1|COMPLETED|Overall Study||33
394653|NCT00218465|966123|P2|STARTED|Overall Study||48
394654|NCT00218465|966124|P1|STARTED|Overall Study||50
394655|NCT00218439|966136|P2|NOT COMPLETED|Second Intervention (4 Weeks)||5
394656|NCT00218439|966137|P1|NOT COMPLETED|Second Intervention (4 Weeks)||7
394657|NCT00218439|966136|P2|COMPLETED|Second Intervention (4 Weeks)||30
394658|NCT00218439|966137|P1|COMPLETED|Second Intervention (4 Weeks)||33
394659|NCT00218439|966136|P2|STARTED|Second Intervention (4 Weeks)||35
394660|NCT00218439|966137|P1|STARTED|Second Intervention (4 Weeks)||40
394661|NCT00218439|966136|P2|NOT COMPLETED|First Intervention (4 Weeks)||12
394662|NCT00218439|966137|P1|NOT COMPLETED|First Intervention (4 Weeks)||18
394663|NCT00218439|966136|P2|COMPLETED|First Intervention (4 Weeks)||35
394664|NCT00218439|966137|P1|COMPLETED|First Intervention (4 Weeks)||40
394665|NCT00218439|966136|P2|STARTED|First Intervention (4 Weeks)||47
394666|NCT00218439|966137|P1|STARTED|First Intervention (4 Weeks)||58
394667|NCT00218426|966154|P3|NOT COMPLETED|Overall Study||91
394668|NCT00218426|966155|P2|NOT COMPLETED|Overall Study||86
394669|NCT00218426|966156|P1|NOT COMPLETED|Overall Study||48
394670|NCT00218426|966154|P3|COMPLETED|Overall Study||11
394671|NCT00218426|966155|P2|COMPLETED|Overall Study||16
394672|NCT00218426|966156|P1|COMPLETED|Overall Study||54
394673|NCT00218426|966154|P3|STARTED|Overall Study||102
394674|NCT00218426|966155|P2|STARTED|Overall Study||102
394675|NCT00218426|966156|P1|STARTED|Overall Study||102
394676|NCT00218387|966197|P3|NOT COMPLETED|Overall Study||23
394677|NCT00218387|966198|P2|NOT COMPLETED|Overall Study||18
394678|NCT00218387|966199|P1|NOT COMPLETED|Overall Study||15
394679|NCT00218387|966197|P3|COMPLETED|Overall Study||17
394680|NCT00218387|966198|P2|COMPLETED|Overall Study||25
394681|NCT00218387|966199|P1|COMPLETED|Overall Study||25
394682|NCT00218387|966197|P3|STARTED|Overall Study||40
394683|NCT00218387|966198|P2|STARTED|Overall Study||43
394684|NCT00218387|966199|P1|STARTED|Overall Study||40
394685|NCT00218335|966214|P4|NOT COMPLETED|Overall Study||36
394686|NCT00218335|966215|P3|NOT COMPLETED|Overall Study||54
394687|NCT00218335|966216|P2|NOT COMPLETED|Overall Study||3
394688|NCT00218335|966217|P1|NOT COMPLETED|Overall Study||6
394689|NCT00218335|966214|P4|COMPLETED|Overall Study||388
394690|NCT00218335|966215|P3|COMPLETED|Overall Study||319
394691|NCT00218335|966216|P2|COMPLETED|Overall Study||110
394692|NCT00218335|966217|P1|COMPLETED|Overall Study||108
394693|NCT00218335|966214|P4|18 Month Follow-up|Overall Study||368
394694|NCT00218335|966215|P3|18 Month Follow-up|Overall Study||296
394695|NCT00218335|966216|P2|18 Month Follow-up|Overall Study||108
394696|NCT00218335|966217|P1|18 Month Follow-up|Overall Study||101
394697|NCT00218335|966214|P4|12 Month Follow-up|Overall Study||303
394698|NCT00218335|966215|P3|12 Month Follow-up|Overall Study||244
394699|NCT00218335|966216|P2|12 Month Follow-up|Overall Study||102
394700|NCT00218335|966217|P1|12 Month Follow-up|Overall Study||95
394701|NCT00218335|966214|P4|6 Month Follow-up|Overall Study||301
394702|NCT00218335|966215|P3|6 Month Follow-up|Overall Study||219
394703|NCT00218335|966216|P2|6 Month Follow-up|Overall Study||99
394704|NCT00218335|966217|P1|6 Month Follow-up|Overall Study||103
394705|NCT00218335|966214|P4|STARTED|Overall Study||424
394706|NCT00218335|966215|P3|STARTED|Overall Study||373
394707|NCT00218335|966216|P2|STARTED|Overall Study||113
394708|NCT00218335|966217|P1|STARTED|Overall Study||114
394709|NCT00218296|966281|P2|NOT COMPLETED|Overall Study||121
394710|NCT00218296|966282|P1|NOT COMPLETED|Overall Study||111
394711|NCT00218296|966281|P2|COMPLETED|Overall Study||48
394712|NCT00218296|966282|P1|COMPLETED|Overall Study||52
394713|NCT00218296|966281|P2|Attended Visti|Overall Study||102
394714|NCT00218296|966282|P1|Attended Visti|Overall Study||97
394715|NCT00218296|966281|P2|STARTED|Overall Study||169
394716|NCT00218296|966282|P1|STARTED|Overall Study||163
394717|NCT00218062|966302|P4|NOT COMPLETED|Overall Study||13
394718|NCT00218062|966303|P3|NOT COMPLETED|Overall Study||12
394719|NCT00218062|966304|P2|NOT COMPLETED|Overall Study||16
394720|NCT00218062|966305|P1|NOT COMPLETED|Overall Study||15
394721|NCT00218062|966302|P4|COMPLETED|Overall Study||3
394722|NCT00218062|966303|P3|COMPLETED|Overall Study||3
394723|NCT00218062|966304|P2|COMPLETED|Overall Study||4
394724|NCT00218062|966305|P1|COMPLETED|Overall Study||7
394725|NCT00218062|966302|P4|Received First Dose of Study Medication|Overall Study||12
394726|NCT00218062|966303|P3|Received First Dose of Study Medication|Overall Study||10
394727|NCT00218062|966304|P2|Received First Dose of Study Medication|Overall Study||11
394728|NCT00218062|966305|P1|Received First Dose of Study Medication|Overall Study||16
394729|NCT00218062|966302|P4|STARTED|Overall Study||16
394730|NCT00218062|966303|P3|STARTED|Overall Study||15
394731|NCT00218062|966304|P2|STARTED|Overall Study||20
394732|NCT00218062|966305|P1|STARTED|Overall Study||22
394733|NCT00218036|966336|P5|NOT COMPLETED|Overall Study||6
394734|NCT00218036|966337|P4|NOT COMPLETED|Overall Study||6
394735|NCT00218036|966338|P3|NOT COMPLETED|Overall Study||8
394736|NCT00218036|966339|P2|NOT COMPLETED|Overall Study||3
394737|NCT00218036|966340|P1|NOT COMPLETED|Overall Study||5
394738|NCT00218036|966336|P5|COMPLETED|Overall Study||3
394739|NCT00218036|966337|P4|COMPLETED|Overall Study||6
394740|NCT00218036|966338|P3|COMPLETED|Overall Study||5
394741|NCT00218036|966339|P2|COMPLETED|Overall Study||3
394742|NCT00218036|966340|P1|COMPLETED|Overall Study||6
394743|NCT00218036|966336|P5|STARTED|Overall Study||9
394744|NCT00218036|966337|P4|STARTED|Overall Study||12
394745|NCT00218036|966338|P3|STARTED|Overall Study||13
394746|NCT00218036|966339|P2|STARTED|Overall Study||6
394747|NCT00218036|966340|P1|STARTED|Overall Study||11
394748|NCT00218023|966366|P4|NOT COMPLETED|Overall Study||7
394749|NCT00218023|966367|P3|NOT COMPLETED|Overall Study||10
394750|NCT00218023|966368|P2|NOT COMPLETED|Overall Study||15
394751|NCT00218023|966369|P1|NOT COMPLETED|Overall Study||13
394752|NCT00218023|966366|P4|COMPLETED|Overall Study||11
394753|NCT00218023|966367|P3|COMPLETED|Overall Study||6
394754|NCT00218023|966368|P2|COMPLETED|Overall Study||10
394755|NCT00218023|966369|P1|COMPLETED|Overall Study||9
394756|NCT00218023|966366|P4|Received Drug or Placebo in Phase II|Overall Study||18
394757|NCT00218023|966367|P3|Received Drug or Placebo in Phase II|Overall Study||15
394758|NCT00218023|966368|P2|Received Drug or Placebo in Phase II|Overall Study||24
394759|NCT00218023|966369|P1|Received Drug or Placebo in Phase II|Overall Study||18
394760|NCT00218023|966366|P4|STARTED|Overall Study||18
394761|NCT00218023|966367|P3|STARTED|Overall Study||16
394762|NCT00218023|966368|P2|STARTED|Overall Study||25
394763|NCT00218023|966369|P1|STARTED|Overall Study||22
394764|NCT00217971|966385|P2|NOT COMPLETED|Overall Study||33
394765|NCT00217971|966386|P1|NOT COMPLETED|Overall Study||24
394766|NCT00217971|966385|P2|COMPLETED|Overall Study||44
394767|NCT00217971|966386|P1|COMPLETED|Overall Study||55
394768|NCT00217971|966385|P2|STARTED|Overall Study||77
394769|NCT00217971|966386|P1|STARTED|Overall Study||79
394770|NCT00217724|966392|P2|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||0
394771|NCT00217724|966393|P1|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||1
394772|NCT00217724|966392|P2|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||5
394773|NCT00217724|966393|P1|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||8
394774|NCT00217724|966392|P2|STARTED|Course 2, (Glutamine/Placebo Crossover)||5
394775|NCT00217724|966393|P1|STARTED|Course 2, (Glutamine/Placebo Crossover)||9
394776|NCT00217724|966392|P2|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||1
394777|NCT00217724|966393|P1|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||3
394778|NCT00217724|966392|P2|COMPLETED|Course 1, (Glutamine/Placebo Arms)||9
394779|NCT00217724|966393|P1|COMPLETED|Course 1, (Glutamine/Placebo Arms)||5
394780|NCT00217724|966392|P2|STARTED|Course 1, (Glutamine/Placebo Arms)||10
394781|NCT00217724|966393|P1|STARTED|Course 1, (Glutamine/Placebo Arms)||8
394782|NCT00217672|966401|P2|NOT COMPLETED|Follow-up||0
394783|NCT00217672|966402|P1|NOT COMPLETED|Follow-up||5
394784|NCT00217672|966401|P2|COMPLETED|Follow-up||0
394785|NCT00217672|966402|P1|COMPLETED|Follow-up||69
394786|NCT00217672|966401|P2|STARTED|Follow-up||0
394787|NCT00217672|966402|P1|STARTED|Follow-up|when bevacizumab became available, converted to a 1-arm open-label trial (67+7=74)|74
394788|NCT00217672|966401|P2|NOT COMPLETED|Treatment||7
394789|NCT00217672|966402|P1|NOT COMPLETED|Treatment||67
394790|NCT00217672|966401|P2|COMPLETED|Treatment||0
394791|NCT00217672|966402|P1|COMPLETED|Treatment||0
394792|NCT00217672|966401|P2|STARTED|Treatment|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
394793|NCT00217672|966402|P1|STARTED|Treatment||67
394794|NCT00217672|966401|P2|NOT COMPLETED|Allocation||0
394795|NCT00217672|966402|P1|NOT COMPLETED|Allocation||2
394796|NCT00217672|966401|P2|COMPLETED|Allocation||7
394797|NCT00217672|966402|P1|COMPLETED|Allocation||67
394798|NCT00217672|966401|P2|STARTED|Allocation|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
394799|NCT00217672|966402|P1|STARTED|Allocation||69
394800|NCT00217620|966408|P1|NOT COMPLETED|Overall Study||51
394801|NCT00217620|966408|P1|COMPLETED|Overall Study||0
394802|NCT00217620|966408|P1|Eligible and Began Protocol Therapy|Overall Study||37
394803|NCT00217620|966408|P1|Eligible|Overall Study||38
394804|NCT00217620|966408|P1|STARTED|Overall Study||51
394805|NCT00217594|966419|P1|NOT COMPLETED|Overall Study||0
394806|NCT00217594|966419|P1|COMPLETED|Overall Study||31
394807|NCT00217594|966419|P1|STARTED|Overall Study||31
394808|NCT00217581|966423|P1|NOT COMPLETED|Overall Study||1
394809|NCT00217581|966423|P1|COMPLETED|Overall Study||38
394810|NCT00217581|966423|P1|STARTED|Overall Study||39
394811|NCT00217490|966435|P4|NOT COMPLETED|Overall Study||23
394812|NCT00217490|966436|P3|NOT COMPLETED|Overall Study||24
394813|NCT00217490|966437|P2|NOT COMPLETED|Overall Study||25
394814|NCT00217490|966438|P1|NOT COMPLETED|Overall Study||17
394815|NCT00217490|966435|P4|COMPLETED|Overall Study||130
394816|NCT00217490|966436|P3|COMPLETED|Overall Study||131
394817|NCT00217490|966437|P2|COMPLETED|Overall Study||128
394818|NCT00217490|966438|P1|COMPLETED|Overall Study||137
394819|NCT00217490|966435|P4|STARTED|Overall Study||153
394820|NCT00217490|966436|P3|STARTED|Overall Study||155
394821|NCT00217490|966437|P2|STARTED|Overall Study||153
394822|NCT00217490|966438|P1|STARTED|Overall Study||154
394823|NCT00217464|966452|P1|NOT COMPLETED|Overall Study||17
394824|NCT00217464|966452|P1|COMPLETED|Overall Study||0
394825|NCT00217464|966452|P1|STARTED|Overall Study||17
394826|NCT00217438|966459|P2|NOT COMPLETED|Overall Study||1
394827|NCT00217438|966460|P1|NOT COMPLETED|Overall Study||0
394828|NCT00217438|966459|P2|COMPLETED|Overall Study|One patient did not complete Day 80-120 evaluation tests after returning to referring physician.|63
394829|NCT00217438|966460|P1|COMPLETED|Overall Study||66
394830|NCT00217438|966459|P2|STARTED|Overall Study||64
394831|NCT00217438|966460|P1|STARTED|Overall Study||66
394832|NCT00217425|966468|P1|NOT COMPLETED|Overall Study||37
394833|NCT00217425|966468|P1|COMPLETED|Overall Study||9
394834|NCT00217425|966468|P1|Eligible and Treated|Overall Study||39
394835|NCT00217425|966468|P1|Treated|Overall Study||44
394836|NCT00217425|966468|P1|STARTED|Overall Study||46
394837|NCT00217399|966474|P1|NOT COMPLETED|Overall Study||0
394838|NCT00217399|966474|P1|COMPLETED|Overall Study||35
394839|NCT00217399|966474|P1|STARTED|Overall Study||35
394840|NCT00217087|966482|P2|NOT COMPLETED|Overall Study||20
394841|NCT00217087|966483|P1|NOT COMPLETED|Overall Study||11
394842|NCT00217087|966482|P2|COMPLETED|Overall Study||17
394843|NCT00217087|966483|P1|COMPLETED|Overall Study||25
394844|NCT00217087|966482|P2|STARTED|Overall Study||37
394845|NCT00217087|966483|P1|STARTED|Overall Study||36
394846|NCT00217022|966497|P2|NOT COMPLETED|Overall Study||1
394847|NCT00217022|966498|P1|NOT COMPLETED|Overall Study||1
394848|NCT00217022|966497|P2|COMPLETED|Overall Study||3
394849|NCT00217022|966498|P1|COMPLETED|Overall Study||11
394850|NCT00217022|966497|P2|STARTED|Overall Study||4
394851|NCT00217022|966498|P1|STARTED|Overall Study||12
394852|NCT00216736|966508|P2|NOT COMPLETED|Overall Study||1
394853|NCT00216736|966509|P1|NOT COMPLETED|Overall Study||1
394854|NCT00216736|966508|P2|COMPLETED|Overall Study||30
394855|NCT00216736|966509|P1|COMPLETED|Overall Study||31
394856|NCT00216736|966508|P2|STARTED|Overall Study||31
394857|NCT00216736|966509|P1|STARTED|Overall Study||32
394858|NCT00216671|966523|P2|NOT COMPLETED|Overall Study||50
394859|NCT00216671|966524|P1|NOT COMPLETED|Overall Study||35
394860|NCT00216671|966523|P2|COMPLETED|Overall Study||60
394861|NCT00216671|966524|P1|COMPLETED|Overall Study||75
394862|NCT00216671|966523|P2|STARTED|Overall Study||110
394863|NCT00216671|966524|P1|STARTED|Overall Study||110
394864|NCT00216476|966542|P3|NOT COMPLETED|Overall Study||17
394865|NCT00216476|966543|P2|NOT COMPLETED|Overall Study||107
394866|NCT00216476|966544|P1|NOT COMPLETED|Overall Study||105
394867|NCT00216476|966542|P3|COMPLETED|Overall Study||28
394868|NCT00216476|966543|P2|COMPLETED|Overall Study||230
394869|NCT00216476|966544|P1|COMPLETED|Overall Study||224
394870|NCT00216476|966542|P3|STARTED|Overall Study||45
394871|NCT00216476|966543|P2|STARTED|Overall Study||337
394872|NCT00216476|966544|P1|STARTED|Overall Study||329
394873|NCT00216320|966564|P3|NOT COMPLETED|Phase 2 (Weeks 6 -12)||1
394874|NCT00216320|966565|P2|NOT COMPLETED|Phase 2 (Weeks 6 -12)||4
394875|NCT00216320|966566|P1|NOT COMPLETED|Phase 2 (Weeks 6 -12)||5
394876|NCT00216320|966564|P3|COMPLETED|Phase 2 (Weeks 6 -12)||24
394877|NCT00216320|966565|P2|COMPLETED|Phase 2 (Weeks 6 -12)||31
394878|NCT00216320|966566|P1|COMPLETED|Phase 2 (Weeks 6 -12)||38
394879|NCT00216320|966564|P3|STARTED|Phase 2 (Weeks 6 -12)||25
394880|NCT00216320|966565|P2|STARTED|Phase 2 (Weeks 6 -12)||35
394881|NCT00216320|966566|P1|STARTED|Phase 2 (Weeks 6 -12)||43
394882|NCT00216320|966564|P3|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||5
394883|NCT00216320|966565|P2|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||4
394884|NCT00216320|966566|P1|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||0
394885|NCT00216320|966564|P3|COMPLETED|Phase 1 (Weeks 0 - 6)||25
394886|NCT00216320|966565|P2|COMPLETED|Phase 1 (Weeks 0 - 6)||35
394887|NCT00216320|966566|P1|COMPLETED|Phase 1 (Weeks 0 - 6)||43
394888|NCT00216320|966564|P3|STARTED|Phase 1 (Weeks 0 - 6)||30
394889|NCT00216320|966565|P2|STARTED|Phase 1 (Weeks 0 - 6)||39
394890|NCT00216320|966566|P1|STARTED|Phase 1 (Weeks 0 - 6)||43
394891|NCT00216203|966581|P1|NOT COMPLETED|Overall Study||2
394892|NCT00216203|966581|P1|COMPLETED|Overall Study||34
394893|NCT00216203|966581|P1|STARTED|Overall Study||36
394894|NCT00216125|966589|P3|NOT COMPLETED|Randomization Phase||8
394895|NCT00216125|966590|P2|NOT COMPLETED|Randomization Phase||11
394896|NCT00216125|966591|P1|NOT COMPLETED|Randomization Phase||0
394897|NCT00216125|966589|P3|COMPLETED|Randomization Phase||74
394898|NCT00216125|966590|P2|COMPLETED|Randomization Phase||73
394899|NCT00216125|966591|P1|COMPLETED|Randomization Phase||0
394900|NCT00216125|966589|P3|DSMB Cohort for Futility|Randomization Phase||74
394901|NCT00216125|966590|P2|DSMB Cohort for Futility|Randomization Phase||73
394902|NCT00216125|966591|P1|DSMB Cohort for Futility|Randomization Phase||0
394903|NCT00216125|966589|P3|STARTED|Randomization Phase||82
394904|NCT00216125|966590|P2|STARTED|Randomization Phase||84
394905|NCT00216125|966591|P1|STARTED|Randomization Phase||0
394906|NCT00216125|966589|P3|NOT COMPLETED|Pre-Randomization Phase||0
394907|NCT00216125|966590|P2|NOT COMPLETED|Pre-Randomization Phase||0
394908|NCT00216125|966591|P1|NOT COMPLETED|Pre-Randomization Phase||77
394909|NCT00216125|966589|P3|COMPLETED|Pre-Randomization Phase||0
394910|NCT00216125|966590|P2|COMPLETED|Pre-Randomization Phase||0
394911|NCT00216125|966591|P1|COMPLETED|Pre-Randomization Phase||166
394912|NCT00216125|966589|P3|DSMB Cohort for Futility|Pre-Randomization Phase||0
394913|NCT00216125|966590|P2|DSMB Cohort for Futility|Pre-Randomization Phase||0
394914|NCT00216125|966591|P1|DSMB Cohort for Futility|Pre-Randomization Phase||203
394915|NCT00216125|966589|P3|STARTED|Pre-Randomization Phase||0
394916|NCT00216125|966590|P2|STARTED|Pre-Randomization Phase||0
394917|NCT00216125|966591|P1|STARTED|Pre-Randomization Phase||243
394918|NCT00216099|966600|P1|NOT COMPLETED|Overall Study||1
394919|NCT00216099|966600|P1|COMPLETED|Overall Study||48
394920|NCT00216099|966600|P1|Response Analysis|Overall Study||48
394921|NCT00216099|966600|P1|Toxicity Analysis|Overall Study||49
394922|NCT00216099|966600|P1|STARTED|Overall Study||49
394923|NCT00216086|966611|P1|NOT COMPLETED|Overall Study||4
394924|NCT00216086|966611|P1|COMPLETED|Overall Study||18
394925|NCT00216086|966611|P1|STARTED|Overall Study||22
394926|NCT00216060|966620|P2|NOT COMPLETED|Overall Study||0
394927|NCT00216060|966621|P1|NOT COMPLETED|Overall Study||0
394928|NCT00216060|966620|P2|COMPLETED|Overall Study||31
394929|NCT00216060|966621|P1|COMPLETED|Overall Study||32
394930|NCT00216060|966620|P2|STARTED|Overall Study||31
394931|NCT00216060|966621|P1|STARTED|Overall Study||32
394932|NCT00215943|966643|P2|NOT COMPLETED|Overall Study||14
394933|NCT00215943|966644|P1|NOT COMPLETED|Overall Study||9
394934|NCT00215943|966643|P2|COMPLETED|Overall Study||23
394935|NCT00215943|966644|P1|COMPLETED|Overall Study||27
394936|NCT00215943|966643|P2|STARTED|Overall Study||37
394937|NCT00215943|966644|P1|STARTED|Overall Study||36
394938|NCT00215930|966656|P1|NOT COMPLETED|Overall Study||0
394939|NCT00215930|966656|P1|COMPLETED|Overall Study||53
394940|NCT00215930|966656|P1|STARTED|Overall Study||53
394941|NCT00215787|966662|P1|NOT COMPLETED|Overall Study||0
394942|NCT00215787|966662|P1|COMPLETED|Overall Study||20
394943|NCT00215787|966662|P1|STARTED|Overall Study||20
394944|NCT00215683|966669|P3|NOT COMPLETED|Overall Study||32
394945|NCT00215683|966670|P2|NOT COMPLETED|Overall Study||26
394946|NCT00215683|966671|P1|NOT COMPLETED|Overall Study||29
394947|NCT00215683|966669|P3|COMPLETED|Overall Study||12
394948|NCT00215683|966670|P2|COMPLETED|Overall Study||22
394949|NCT00215683|966671|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|16
394950|NCT00215683|966669|P3|Switched to 160 mg|Overall Study||36
394951|NCT00215683|966670|P2|Switched to 160 mg|Overall Study||41
394952|NCT00215683|966671|P1|Switched to 160 mg|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL) for all participants|32
394953|NCT00215683|966669|P3|STARTED|Overall Study||44
394954|NCT00215683|966670|P2|STARTED|Overall Study||48
394955|NCT00215683|966671|P1|STARTED|Overall Study|Safety analysis set|45
394956|NCT00215657|966690|P8|NOT COMPLETED|Overall Study||16
394957|NCT00215657|966691|P7|NOT COMPLETED|Overall Study||23
394958|NCT00215657|966692|P6|NOT COMPLETED|Overall Study||20
394959|NCT00215657|966693|P5|NOT COMPLETED|Overall Study||23
394960|NCT00215657|966694|P4|NOT COMPLETED|Overall Study||18
394961|NCT00215657|966695|P3|NOT COMPLETED|Overall Study||11
394962|NCT00215657|966696|P2|NOT COMPLETED|Overall Study||11
394963|NCT00215657|966697|P1|NOT COMPLETED|Overall Study||22
394964|NCT00215657|966690|P8|COMPLETED|Overall Study||11
394965|NCT00215657|966691|P7|COMPLETED|Overall Study||4
394966|NCT00215657|966692|P6|COMPLETED|Overall Study||4
394967|NCT00215657|966693|P5|COMPLETED|Overall Study||4
394968|NCT00215657|966694|P4|COMPLETED|Overall Study||6
394969|NCT00215657|966695|P3|COMPLETED|Overall Study||2
394970|NCT00215657|966696|P2|COMPLETED|Overall Study||1
394971|NCT00215657|966697|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study.|4
394972|NCT00215657|966690|P8|Started FE200486 CS07A|Overall Study||23
394973|NCT00215657|966691|P7|Started FE200486 CS07A|Overall Study||14
394974|NCT00215657|966692|P6|Started FE200486 CS07A|Overall Study||20
394975|NCT00215657|966693|P5|Started FE200486 CS07A|Overall Study||17
394976|NCT00215657|966694|P4|Started FE200486 CS07A|Overall Study||24
394977|NCT00215657|966695|P3|Started FE200486 CS07A|Overall Study||7
394978|NCT00215657|966696|P2|Started FE200486 CS07A|Overall Study||6
394979|NCT00215657|966697|P1|Started FE200486 CS07A|Overall Study||20
394980|NCT00215657|966690|P8|Intention-to-treat Population|Overall Study||27
394981|NCT00215657|966691|P7|Intention-to-treat Population|Overall Study||24
394982|NCT00215657|966692|P6|Intention-to-treat Population|Overall Study||24
394983|NCT00215657|966693|P5|Intention-to-treat Population|Overall Study||24
394984|NCT00215657|966694|P4|Intention-to-treat Population|Overall Study||24
394985|NCT00215657|966695|P3|Intention-to-treat Population|Overall Study||12
394986|NCT00215657|966696|P2|Intention-to-treat Population|Overall Study||12
394987|NCT00215657|966697|P1|Intention-to-treat Population|Overall Study||25
394988|NCT00215657|966690|P8|STARTED|Overall Study||27
394989|NCT00215657|966691|P7|STARTED|Overall Study||27
394990|NCT00215657|966692|P6|STARTED|Overall Study||24
394991|NCT00215657|966693|P5|STARTED|Overall Study||27
394992|NCT00215657|966694|P4|STARTED|Overall Study||24
394993|NCT00215657|966695|P3|STARTED|Overall Study||13
394994|NCT00215657|966696|P2|STARTED|Overall Study||12
394995|NCT00215657|966697|P1|STARTED|Overall Study||26
394996|NCT00215644|966725|P2|NOT COMPLETED|Overall Study||36
394997|NCT00215644|966726|P1|NOT COMPLETED|Overall Study||36
394998|NCT00215644|966725|P2|COMPLETED|Overall Study||0
394999|NCT00215644|966726|P1|COMPLETED|Overall Study||0
395000|NCT00215644|966725|P2|Treated|Overall Study||36
395001|NCT00215644|966726|P1|Treated|Overall Study||35
395002|NCT00215644|966725|P2|STARTED|Overall Study||36
395003|NCT00215644|966726|P1|STARTED|Overall Study||36
395004|NCT00215553|966753|P7|NOT COMPLETED|Overall Study||0
395005|NCT00215553|966754|P6|NOT COMPLETED|Overall Study||6
395006|NCT00215553|966755|P5|NOT COMPLETED|Overall Study||2
395007|NCT00215553|966756|P4|NOT COMPLETED|Overall Study||1
395008|NCT00215553|966757|P3|NOT COMPLETED|Overall Study||2
395009|NCT00215553|966758|P2|NOT COMPLETED|Overall Study||1
395010|NCT00215553|966759|P1|NOT COMPLETED|Overall Study||0
395011|NCT00215553|966753|P7|COMPLETED|Overall Study||36
395012|NCT00215553|966754|P6|COMPLETED|Overall Study||32
395013|NCT00215553|966755|P5|COMPLETED|Overall Study||26
395014|NCT00215553|966756|P4|COMPLETED|Overall Study||4
395015|NCT00215553|966757|P3|COMPLETED|Overall Study||4
395016|NCT00215553|966758|P2|COMPLETED|Overall Study||5
395017|NCT00215553|966759|P1|COMPLETED|Overall Study||5
395018|NCT00215553|966753|P7|STARTED|Overall Study||36
395019|NCT00215553|966754|P6|STARTED|Overall Study||38
395020|NCT00215553|966755|P5|STARTED|Overall Study||28
395021|NCT00215553|966756|P4|STARTED|Overall Study||5
395022|NCT00215553|966757|P3|STARTED|Overall Study||6
395023|NCT00215553|966758|P2|STARTED|Overall Study||6
395024|NCT00215553|966759|P1|STARTED|Overall Study||5
395025|NCT00215540|966792|P3|NOT COMPLETED|Overall Study||0
395026|NCT00215540|966793|P2|NOT COMPLETED|Overall Study||0
395027|NCT00215540|966794|P1|NOT COMPLETED|Overall Study||1
395028|NCT00215540|966792|P3|COMPLETED|Overall Study||44
395029|NCT00215540|966793|P2|COMPLETED|Overall Study||47
395030|NCT00215540|966794|P1|COMPLETED|Overall Study||44
395031|NCT00215540|966792|P3|STARTED|Overall Study||44
395032|NCT00215540|966793|P2|STARTED|Overall Study||47
395033|NCT00215540|966794|P1|STARTED|Overall Study||45
395034|NCT00215150|966829|P1|NOT COMPLETED|Randomization Phase Placebo||1
395035|NCT00215150|966829|P1|COMPLETED|Randomization Phase Placebo||10
395036|NCT00215150|966829|P1|STARTED|Randomization Phase Placebo||11
395037|NCT00215150|966829|P1|NOT COMPLETED|Randomization Phase Ziprasidone||3
395038|NCT00215150|966829|P1|COMPLETED|Randomization Phase Ziprasidone||7
395039|NCT00215150|966829|P1|STARTED|Randomization Phase Ziprasidone||10
395040|NCT00215150|966829|P1|NOT COMPLETED|Open Label Phase||30
395041|NCT00215150|966829|P1|COMPLETED|Open Label Phase||21
395042|NCT00215150|966829|P1|STARTED|Open Label Phase|Number of subjects consented|51
395043|NCT00215137|966837|P3|NOT COMPLETED|Randomization Period||0
395044|NCT00215137|966838|P2|NOT COMPLETED|Randomization Period||2
395045|NCT00215137|966839|P1|NOT COMPLETED|Randomization Period||0
395046|NCT00215137|966837|P3|COMPLETED|Randomization Period||5
395047|NCT00215137|966838|P2|COMPLETED|Randomization Period||5
395048|NCT00215137|966839|P1|COMPLETED|Randomization Period||0
395049|NCT00215137|966837|P3|STARTED|Randomization Period||5
395050|NCT00215137|966838|P2|STARTED|Randomization Period||7
395051|NCT00215137|966839|P1|STARTED|Randomization Period||0
395052|NCT00215137|966837|P3|NOT COMPLETED|Open Label Escitalopram||0
395053|NCT00215137|966838|P2|NOT COMPLETED|Open Label Escitalopram||0
395054|NCT00215137|966839|P1|NOT COMPLETED|Open Label Escitalopram||1
395055|NCT00215137|966837|P3|COMPLETED|Open Label Escitalopram||0
395056|NCT00215137|966838|P2|COMPLETED|Open Label Escitalopram||0
395057|NCT00215137|966839|P1|COMPLETED|Open Label Escitalopram||13
395058|NCT00215137|966837|P3|STARTED|Open Label Escitalopram||0
395059|NCT00215137|966838|P2|STARTED|Open Label Escitalopram||0
395060|NCT00215137|966839|P1|STARTED|Open Label Escitalopram||14
395061|NCT00214903|966851|P4|NOT COMPLETED|Overall Study||0
395062|NCT00214903|966852|P3|NOT COMPLETED|Overall Study||0
395063|NCT00214903|966853|P2|NOT COMPLETED|Overall Study||0
395064|NCT00214903|966854|P1|NOT COMPLETED|Overall Study||0
395065|NCT00214903|966851|P4|COMPLETED|Overall Study||3057
395066|NCT00214903|966852|P3|COMPLETED|Overall Study||4113
395067|NCT00214903|966853|P2|COMPLETED|Overall Study||13384
395068|NCT00214903|966854|P1|COMPLETED|Overall Study||10043
395069|NCT00214903|966851|P4|STARTED|Overall Study||3057
395070|NCT00214903|966852|P3|STARTED|Overall Study||4113
395071|NCT00214903|966853|P2|STARTED|Overall Study||13384
395072|NCT00214903|966854|P1|STARTED|Overall Study||10043
395073|NCT00214786|966868|P1|NOT COMPLETED|Overall Study||3
395074|NCT00214786|966868|P1|COMPLETED|Overall Study||1
395075|NCT00214786|966868|P1|STARTED|Overall Study||4
395076|NCT00214539|966883|P2|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
395077|NCT00214539|966884|P1|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
395078|NCT00214539|966883|P2|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||17
395079|NCT00214539|966884|P1|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||15
395080|NCT00214539|966883|P2|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||17
395081|NCT00214539|966884|P1|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||15
395082|NCT00214539|966883|P2|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
395083|NCT00214539|966884|P1|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
395084|NCT00214539|966883|P2|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||17
395085|NCT00214539|966884|P1|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||15
395086|NCT00214539|966883|P2|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||17
395087|NCT00214539|966884|P1|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||15
395088|NCT00214539|966883|P2|NOT COMPLETED|Treatment Period||0
395089|NCT00214539|966884|P1|NOT COMPLETED|Treatment Period||0
395090|NCT00214539|966883|P2|COMPLETED|Treatment Period||17
395091|NCT00214539|966884|P1|COMPLETED|Treatment Period||15
395092|NCT00214539|966883|P2|STARTED|Treatment Period||17
395093|NCT00214539|966884|P1|STARTED|Treatment Period||15
395094|NCT00214539|966883|P2|NOT COMPLETED|Randomized||0
395095|NCT00214539|966884|P1|NOT COMPLETED|Randomized||2
395096|NCT00214539|966883|P2|COMPLETED|Randomized||17
395097|NCT00214539|966884|P1|COMPLETED|Randomized||15
395098|NCT00214539|966883|P2|STARTED|Randomized||17
395099|NCT00214539|966884|P1|STARTED|Randomized||17
395100|NCT00214526|966910|P2|NOT COMPLETED|Post-Treatment Period||0
395101|NCT00214526|966911|P1|NOT COMPLETED|Post-Treatment Period||1
395102|NCT00214526|966910|P2|COMPLETED|Post-Treatment Period||49
395103|NCT00214526|966911|P1|COMPLETED|Post-Treatment Period||52
395104|NCT00214526|966910|P2|STARTED|Post-Treatment Period||49
395105|NCT00214526|966911|P1|STARTED|Post-Treatment Period||53
395106|NCT00214526|966910|P2|NOT COMPLETED|Treatment Period||5
395107|NCT00214526|966911|P1|NOT COMPLETED|Treatment Period||2
395108|NCT00214526|966910|P2|COMPLETED|Treatment Period||49
395109|NCT00214526|966911|P1|COMPLETED|Treatment Period||53
395110|NCT00214526|966910|P2|STARTED|Treatment Period||54
395111|NCT00214526|966911|P1|STARTED|Treatment Period||55
395112|NCT00214526|966910|P2|NOT COMPLETED|Randomized||2
395113|NCT00214526|966911|P1|NOT COMPLETED|Randomized||1
395114|NCT00214526|966910|P2|COMPLETED|Randomized||54
395115|NCT00214526|966911|P1|COMPLETED|Randomized||55
395116|NCT00214526|966910|P2|STARTED|Randomized||56
395117|NCT00214526|966911|P1|STARTED|Randomized||56
395118|NCT00214500|966937|P1|NOT COMPLETED|Extension Period||2
395119|NCT00214500|966937|P1|COMPLETED|Extension Period||6
395120|NCT00214500|966937|P1|STARTED|Extension Period||8
395121|NCT00214500|966937|P1|NOT COMPLETED|Treatment Period||1
395122|NCT00214500|966937|P1|COMPLETED|Treatment Period||8
395123|NCT00214500|966937|P1|Pharmacodynamic (PD) Population|Treatment Period||9
395124|NCT00214500|966937|P1|Pharmacokinetic (PK) Population|Treatment Period||9
395125|NCT00214500|966937|P1|Safety Population|Treatment Period||9
395126|NCT00214500|966937|P1|STARTED|Treatment Period|All eligible-enrolled participants who received at least 1 dose of study drug|9
395127|NCT00214487|966947|P2|NOT COMPLETED|Overall Study||3
395128|NCT00214487|966948|P1|NOT COMPLETED|Overall Study||5
395129|NCT00214487|966947|P2|COMPLETED|Overall Study||40
395130|NCT00214487|966948|P1|COMPLETED|Overall Study||38
395131|NCT00214487|966947|P2|STARTED|Overall Study||43
395132|NCT00214487|966948|P1|STARTED|Overall Study||43
395133|NCT00214461|966958|P4|NOT COMPLETED|Overall Study||1
395134|NCT00214461|966959|P3|NOT COMPLETED|Overall Study||2
395135|NCT00214461|966960|P2|NOT COMPLETED|Overall Study||0
395136|NCT00214461|966961|P1|NOT COMPLETED|Overall Study||0
395137|NCT00214461|966958|P4|COMPLETED|Overall Study||11
395138|NCT00214461|966959|P3|COMPLETED|Overall Study||10
395139|NCT00214461|966960|P2|COMPLETED|Overall Study||12
395140|NCT00214461|966961|P1|COMPLETED|Overall Study||12
395141|NCT00214461|966958|P4|STARTED|Overall Study||12
395142|NCT00214461|966959|P3|STARTED|Overall Study||12
395143|NCT00214461|966960|P2|STARTED|Overall Study||12
395144|NCT00214461|966961|P1|STARTED|Overall Study||12
395145|NCT00214422|966978|P3|NOT COMPLETED|Overall Study||1
395146|NCT00214422|966979|P2|NOT COMPLETED|Overall Study||1
395147|NCT00214422|966980|P1|NOT COMPLETED|Overall Study||5
395148|NCT00214422|966978|P3|COMPLETED|Overall Study||3
395149|NCT00214422|966979|P2|COMPLETED|Overall Study||2
395150|NCT00214422|966980|P1|COMPLETED|Overall Study||7
395151|NCT00214422|966978|P3|STARTED|Overall Study||4
395152|NCT00214422|966979|P2|STARTED|Overall Study||3
395153|NCT00214422|966980|P1|STARTED|Overall Study||12
395154|NCT00214383|967003|P2|NOT COMPLETED|Overall Study||26
395155|NCT00214383|967004|P1|NOT COMPLETED|Overall Study||16
395156|NCT00214383|967003|P2|COMPLETED|Overall Study||127
395157|NCT00214383|967004|P1|COMPLETED|Overall Study||132
395158|NCT00214383|967003|P2|STARTED|Overall Study||153
395159|NCT00214383|967004|P1|STARTED|Overall Study||148
395160|NCT00214201|967016|P2|NOT COMPLETED|Overall Study||2
395161|NCT00214201|967017|P1|NOT COMPLETED|Overall Study||2
395162|NCT00214201|967016|P2|COMPLETED|Overall Study||18
395163|NCT00214201|967017|P1|COMPLETED|Overall Study||18
395164|NCT00214201|967016|P2|STARTED|Overall Study||20
395165|NCT00214201|967017|P1|STARTED|Overall Study||20
395166|NCT00214149|967027|P1|NOT COMPLETED|Overall Study||127
395167|NCT00214149|967027|P1|COMPLETED|Overall Study|No data are available; study was terminated and PI has left the institution.|0
395168|NCT00214149|967027|P1|STARTED|Overall Study||127
395169|NCT00214136|967032|P1|NOT COMPLETED|Overall Study||5
395170|NCT00214136|967032|P1|COMPLETED|Overall Study||25
395171|NCT00214136|967032|P1|STARTED|Overall Study||30
395172|NCT00214097|967040|P3|NOT COMPLETED|Overall Study||0
395173|NCT00214097|967041|P2|NOT COMPLETED|Overall Study||0
395174|NCT00214097|967042|P1|NOT COMPLETED|Overall Study||0
395175|NCT00214097|967040|P3|COMPLETED|Overall Study||135
395176|NCT00214097|967041|P2|COMPLETED|Overall Study||111
395177|NCT00214097|967042|P1|COMPLETED|Overall Study||101
395178|NCT00214097|967040|P3|STARTED|Overall Study||135
395179|NCT00214097|967041|P2|STARTED|Overall Study|Escalation to the next higher level will occur when > 20 pt yrs of F/U and > 5 pts followed >1 yr|111
395180|NCT00214097|967042|P1|STARTED|Overall Study|Escalation to the next higher level will occur when > 20 pt yrs of F/U and > 5 pts followed >1 yr|101
395181|NCT00214045|967070|P2|NOT COMPLETED|Overall Study||0
395182|NCT00214045|967071|P1|NOT COMPLETED|Overall Study||0
395183|NCT00214045|967070|P2|COMPLETED|Overall Study||18
395184|NCT00214045|967071|P1|COMPLETED|Overall Study||18
395185|NCT00214045|967070|P2|STARTED|Overall Study||18
395186|NCT00214045|967071|P1|STARTED|Overall Study||18
395187|NCT00214019|967077|P1|NOT COMPLETED|Overall Study||30
395188|NCT00214019|967077|P1|COMPLETED|Overall Study||6
395189|NCT00214019|967077|P1|Fluticason/Salmeterol Arm|Overall Study||6
395190|NCT00214019|967077|P1|Fluticasone/Placebo Arm|Overall Study||6
395191|NCT00214019|967077|P1|Placebo/Salmeterol Arm|Overall Study||6
395192|NCT00214019|967077|P1|Placebo/Placebo Arm|Overall Study||6
395193|NCT00214019|967077|P1|STARTED|Overall Study||36
395194|NCT00213980|967086|P2|NOT COMPLETED|Overall Study||7
395195|NCT00213980|967087|P1|NOT COMPLETED|Overall Study||6
395196|NCT00213980|967086|P2|COMPLETED|Overall Study||29
395197|NCT00213980|967087|P1|COMPLETED|Overall Study||26
395198|NCT00213980|967086|P2|STARTED|Overall Study||36
395199|NCT00213980|967087|P1|STARTED|Overall Study||32
395200|NCT00213239|967101|P2|NOT COMPLETED|Overall Study||0
395201|NCT00213239|967102|P1|NOT COMPLETED|Overall Study||0
395202|NCT00213239|967101|P2|COMPLETED|Overall Study||32
395203|NCT00213239|967102|P1|COMPLETED|Overall Study||32
395204|NCT00213239|967101|P2|STARTED|Overall Study||32
395205|NCT00213239|967102|P1|STARTED|Overall Study||32
395206|NCT00213148|967114|P5|NOT COMPLETED|Cycle 3 (1 Month)||1
395207|NCT00213148|967115|P4|NOT COMPLETED|Cycle 3 (1 Month)||1
395208|NCT00213148|967116|P3|NOT COMPLETED|Cycle 3 (1 Month)||1
395209|NCT00213148|967117|P2|NOT COMPLETED|Cycle 3 (1 Month)||2
395210|NCT00213148|967118|P1|NOT COMPLETED|Cycle 3 (1 Month)||0
395211|NCT00213148|967114|P5|COMPLETED|Cycle 3 (1 Month)||21
395212|NCT00213148|967115|P4|COMPLETED|Cycle 3 (1 Month)||23
395213|NCT00213148|967116|P3|COMPLETED|Cycle 3 (1 Month)||25
395214|NCT00213148|967117|P2|COMPLETED|Cycle 3 (1 Month)||8
395215|NCT00213148|967118|P1|COMPLETED|Cycle 3 (1 Month)||23
395216|NCT00213148|967114|P5|STARTED|Cycle 3 (1 Month)||22
395217|NCT00213148|967115|P4|STARTED|Cycle 3 (1 Month)||24
395218|NCT00213148|967116|P3|STARTED|Cycle 3 (1 Month)||26
395219|NCT00213148|967117|P2|STARTED|Cycle 3 (1 Month)||10
395220|NCT00213148|967118|P1|STARTED|Cycle 3 (1 Month)||23
395221|NCT00213148|967114|P5|NOT COMPLETED|Cycle 2 (1 Month)||30
395222|NCT00213148|967115|P4|NOT COMPLETED|Cycle 2 (1 Month)||19
395223|NCT00213148|967116|P3|NOT COMPLETED|Cycle 2 (1 Month)||14
395224|NCT00213148|967117|P2|NOT COMPLETED|Cycle 2 (1 Month)||6
395225|NCT00213148|967118|P1|NOT COMPLETED|Cycle 2 (1 Month)||14
395226|NCT00213148|967114|P5|COMPLETED|Cycle 2 (1 Month)||11
395227|NCT00213148|967115|P4|COMPLETED|Cycle 2 (1 Month)||33
395228|NCT00213148|967116|P3|COMPLETED|Cycle 2 (1 Month)||28
395229|NCT00213148|967117|P2|COMPLETED|Cycle 2 (1 Month)||4
395230|NCT00213148|967118|P1|COMPLETED|Cycle 2 (1 Month)||29
395231|NCT00213148|967114|P5|STARTED|Cycle 2 (1 Month)||41
395232|NCT00213148|967115|P4|STARTED|Cycle 2 (1 Month)||52
395233|NCT00213148|967116|P3|STARTED|Cycle 2 (1 Month)||42
395234|NCT00213148|967117|P2|STARTED|Cycle 2 (1 Month)||10
395235|NCT00213148|967118|P1|STARTED|Cycle 2 (1 Month)||43
395236|NCT00213148|967114|P5|NOT COMPLETED|Cycle 1 (1 Month)||22
395237|NCT00213148|967115|P4|NOT COMPLETED|Cycle 1 (1 Month)||18
395238|NCT00213148|967116|P3|NOT COMPLETED|Cycle 1 (1 Month)||19
395239|NCT00213148|967117|P2|NOT COMPLETED|Cycle 1 (1 Month)||0
395240|NCT00213148|967118|P1|NOT COMPLETED|Cycle 1 (1 Month)||24
395241|NCT00213148|967114|P5|COMPLETED|Cycle 1 (1 Month)||17
395242|NCT00213148|967115|P4|COMPLETED|Cycle 1 (1 Month)||58
395243|NCT00213148|967116|P3|COMPLETED|Cycle 1 (1 Month)||60
395244|NCT00213148|967117|P2|COMPLETED|Cycle 1 (1 Month)||0
395245|NCT00213148|967118|P1|COMPLETED|Cycle 1 (1 Month)||53
395246|NCT00213148|967114|P5|STARTED|Cycle 1 (1 Month)||39
395247|NCT00213148|967115|P4|STARTED|Cycle 1 (1 Month)||76
395248|NCT00213148|967116|P3|STARTED|Cycle 1 (1 Month)||79
395249|NCT00213148|967117|P2|STARTED|Cycle 1 (1 Month)||0
395250|NCT00213148|967118|P1|STARTED|Cycle 1 (1 Month)||77
395251|NCT00213135|967145|P3|NOT COMPLETED|Overall Study||57
395252|NCT00213135|967146|P2|NOT COMPLETED|Overall Study||35
395253|NCT00213135|967147|P1|NOT COMPLETED|Overall Study||50
395254|NCT00213135|967145|P3|COMPLETED|Overall Study||380
395255|NCT00213135|967146|P2|COMPLETED|Overall Study||398
395256|NCT00213135|967147|P1|COMPLETED|Overall Study||406
395257|NCT00213135|967145|P3|STARTED|Overall Study||437
395258|NCT00213135|967146|P2|STARTED|Overall Study||433
395259|NCT00213135|967147|P1|STARTED|Overall Study||456
395260|NCT00212888|967167|P3|NOT COMPLETED|Overall Study||1
395261|NCT00212888|967168|P2|NOT COMPLETED|Overall Study||0
395262|NCT00212888|967169|P1|NOT COMPLETED|Overall Study||3
395263|NCT00212888|967167|P3|COMPLETED|Overall Study||14
395264|NCT00212888|967168|P2|COMPLETED|Overall Study||18
395265|NCT00212888|967169|P1|COMPLETED|Overall Study||16
395266|NCT00212888|967167|P3|STARTED|Overall Study||15
395267|NCT00212888|967168|P2|STARTED|Overall Study||18
395268|NCT00212888|967169|P1|STARTED|Overall Study||19
395269|NCT00212758|967190|P2|NOT COMPLETED|Standard Therapy of GH (12 Months)||1
395270|NCT00212758|967191|P1|NOT COMPLETED|Standard Therapy of GH (12 Months)||2
395271|NCT00212758|967190|P2|COMPLETED|Standard Therapy of GH (12 Months)||8
395272|NCT00212758|967191|P1|COMPLETED|Standard Therapy of GH (12 Months)||6
395273|NCT00212758|967190|P2|STARTED|Standard Therapy of GH (12 Months)||9
395274|NCT00212758|967191|P1|STARTED|Standard Therapy of GH (12 Months)||8
395275|NCT00212758|967190|P2|NOT COMPLETED|Second Intervention (7 Days)||0
395276|NCT00212758|967191|P1|NOT COMPLETED|Second Intervention (7 Days)||0
395277|NCT00212758|967190|P2|COMPLETED|Second Intervention (7 Days)||9
395278|NCT00212758|967191|P1|COMPLETED|Second Intervention (7 Days)||8
395279|NCT00212758|967190|P2|STARTED|Second Intervention (7 Days)||9
395280|NCT00212758|967191|P1|STARTED|Second Intervention (7 Days)||8
395281|NCT00212758|967190|P2|NOT COMPLETED|Wash Out Period (2 Weeks)||0
395282|NCT00212758|967191|P1|NOT COMPLETED|Wash Out Period (2 Weeks)||0
395283|NCT00212758|967190|P2|COMPLETED|Wash Out Period (2 Weeks)||9
395284|NCT00212758|967191|P1|COMPLETED|Wash Out Period (2 Weeks)||8
395285|NCT00212758|967190|P2|STARTED|Wash Out Period (2 Weeks)||9
395286|NCT00212758|967191|P1|STARTED|Wash Out Period (2 Weeks)||8
395287|NCT00212758|967190|P2|NOT COMPLETED|First Intervention (7 Days)||0
395288|NCT00212758|967191|P1|NOT COMPLETED|First Intervention (7 Days)||0
395289|NCT00212758|967190|P2|COMPLETED|First Intervention (7 Days)||9
395290|NCT00212758|967191|P1|COMPLETED|First Intervention (7 Days)||8
395291|NCT00212758|967190|P2|STARTED|First Intervention (7 Days)||9
395292|NCT00212758|967191|P1|STARTED|First Intervention (7 Days)||8
395293|NCT00212446|967197|P1|NOT COMPLETED|Overall Study||0
395294|NCT00212446|967197|P1|COMPLETED|Overall Study||8
395295|NCT00212446|967197|P1|STARTED|Overall Study||8
395296|NCT00212355|967207|P1|NOT COMPLETED|Overall Study||3
395297|NCT00212355|967207|P1|COMPLETED|Overall Study||34
395298|NCT00212355|967207|P1|STARTED|Overall Study||37
395299|NCT00212264|967214|P3|NOT COMPLETED|Overall Study||4
395300|NCT00212264|967215|P2|NOT COMPLETED|Overall Study||16
395301|NCT00212264|967216|P1|NOT COMPLETED|Overall Study||12
395302|NCT00212264|967214|P3|COMPLETED|Overall Study||64
395303|NCT00212264|967215|P2|COMPLETED|Overall Study||54
395304|NCT00212264|967216|P1|COMPLETED|Overall Study||58
395305|NCT00212264|967214|P3|STARTED|Overall Study||68
395306|NCT00212264|967215|P2|STARTED|Overall Study||70
395307|NCT00212264|967216|P1|STARTED|Overall Study||70
395308|NCT00212134|967228|P2|NOT COMPLETED|Phase 3 (Age 10 Years)||21
395309|NCT00212134|967229|P1|NOT COMPLETED|Phase 3 (Age 10 Years)||21
395310|NCT00212134|967228|P2|COMPLETED|Phase 3 (Age 10 Years)||35
395311|NCT00212134|967229|P1|COMPLETED|Phase 3 (Age 10 Years)||36
395312|NCT00212134|967228|P2|STARTED|Phase 3 (Age 10 Years)||56
395313|NCT00212134|967229|P1|STARTED|Phase 3 (Age 10 Years)||57
395314|NCT00212134|967228|P2|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||1
395315|NCT00212134|967229|P1|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||0
395316|NCT00212134|967228|P2|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)|Patient lost to follow-up.|56
395317|NCT00212134|967229|P1|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||57
395318|NCT00212134|967228|P2|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
395319|NCT00212134|967229|P1|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
395320|NCT00212134|967228|P2|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
395321|NCT00212134|967229|P1|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
395322|NCT00212134|967228|P2|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
395323|NCT00212134|967229|P1|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
395324|NCT00212134|967228|P2|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
395325|NCT00212134|967229|P1|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
395326|NCT00212134|967228|P2|STARTED|Phase 1 (to Age 1 Year)||57
395327|NCT00212134|967229|P1|STARTED|Phase 1 (to Age 1 Year)||57
395328|NCT00211887|967250|P3|NOT COMPLETED|Overall Study||36
395329|NCT00211887|967251|P2|NOT COMPLETED|Overall Study||56
395330|NCT00211887|967252|P1|NOT COMPLETED|Overall Study||102
395331|NCT00211887|967250|P3|COMPLETED|Overall Study||223
395332|NCT00211887|967251|P2|COMPLETED|Overall Study||194
395333|NCT00211887|967252|P1|COMPLETED|Overall Study||397
395334|NCT00211887|967250|P3|STARTED|Overall Study||259
395335|NCT00211887|967251|P2|STARTED|Overall Study||250
395336|NCT00211887|967252|P1|STARTED|Overall Study||499
395337|NCT00211809|967269|P1|NOT COMPLETED|Overall Study||6
395338|NCT00211809|967269|P1|COMPLETED|Overall Study||11
395339|NCT00211809|967269|P1|STARTED|Overall Study||17
395340|NCT00211757|967285|P2|NOT COMPLETED|Overall Study||2
395341|NCT00211757|967286|P1|NOT COMPLETED|Overall Study||1
395342|NCT00211757|967285|P2|COMPLETED|Overall Study||14
395343|NCT00211757|967286|P1|COMPLETED|Overall Study||10
395344|NCT00211757|967285|P2|STARTED|Overall Study||16
395345|NCT00211757|967286|P1|STARTED|Overall Study||11
395346|NCT00211692|967296|P2|NOT COMPLETED|Overall Study||0
395347|NCT00211692|967297|P1|NOT COMPLETED|Overall Study||0
395348|NCT00211692|967296|P2|COMPLETED|Overall Study||31
395349|NCT00211692|967297|P1|COMPLETED|Overall Study||33
395350|NCT00211692|967296|P2|STARTED|Overall Study||31
395351|NCT00211692|967297|P1|STARTED|Overall Study||33
395352|NCT00211536|967307|P2|NOT COMPLETED|Overall Study||7
395353|NCT00211536|967308|P1|NOT COMPLETED|Overall Study||4
395354|NCT00211536|967307|P2|COMPLETED|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|47
395355|NCT00211536|967308|P1|COMPLETED|Overall Study||49
395356|NCT00211536|967307|P2|As Treated Data Analysis Set|Overall Study||48
395357|NCT00211536|967308|P1|As Treated Data Analysis Set|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|52
395358|NCT00211536|967307|P2|STARTED|Overall Study||54
395359|NCT00211536|967308|P1|STARTED|Overall Study||53
395360|NCT00211510|967324|P2|NOT COMPLETED|Overall Study||2
395361|NCT00211510|967325|P1|NOT COMPLETED|Overall Study||6
395362|NCT00211510|967324|P2|COMPLETED|Overall Study||72
395363|NCT00211510|967325|P1|COMPLETED|Overall Study||66
395364|NCT00211510|967324|P2|STARTED|Overall Study||74
395365|NCT00211510|967325|P1|STARTED|Overall Study||72
395366|NCT00211237|967343|P3|NOT COMPLETED|12 Months||6
395367|NCT00211237|967344|P2|NOT COMPLETED|12 Months||2
395368|NCT00211237|967345|P1|NOT COMPLETED|12 Months||9
395369|NCT00211237|967343|P3|COMPLETED|12 Months||28
395370|NCT00211237|967344|P2|COMPLETED|12 Months||6
395371|NCT00211237|967345|P1|COMPLETED|12 Months||40
395372|NCT00211237|967343|P3|STARTED|12 Months||34
395373|NCT00211237|967344|P2|STARTED|12 Months|1 patient crossed over Balloon Kyphoplasty|8
395374|NCT00211237|967345|P1|STARTED|12 Months||49
395375|NCT00211237|967343|P3|NOT COMPLETED|6 Months||3
395376|NCT00211237|967344|P2|NOT COMPLETED|6 Months||2
395377|NCT00211237|967345|P1|NOT COMPLETED|6 Months||8
395378|NCT00211237|967343|P3|COMPLETED|6 Months||33
395379|NCT00211237|967344|P2|COMPLETED|6 Months||9
395380|NCT00211237|967345|P1|COMPLETED|6 Months||49
395381|NCT00211237|967343|P3|STARTED|6 Months||36
395382|NCT00211237|967344|P2|STARTED|6 Months|3 patients crossed over Balloon Kyphoplasty|11
395383|NCT00211237|967345|P1|STARTED|6 Months||57
395384|NCT00211237|967343|P3|NOT COMPLETED|3 Months||1
395385|NCT00211237|967344|P2|NOT COMPLETED|3 Months||4
395386|NCT00211237|967345|P1|NOT COMPLETED|3 Months||8
395387|NCT00211237|967343|P3|COMPLETED|3 Months||33
395388|NCT00211237|967344|P2|COMPLETED|3 Months||14
395389|NCT00211237|967345|P1|COMPLETED|3 Months||57
395390|NCT00211237|967343|P3|STARTED|3 Months||34
395391|NCT00211237|967344|P2|STARTED|3 Months|34 patients crossed over to Balloon Kyphoplasty.|18
395392|NCT00211237|967345|P1|STARTED|3 Months||65
395393|NCT00211237|967343|P3|NOT COMPLETED|1 Month||0
395394|NCT00211237|967344|P2|NOT COMPLETED|1 Month||9
395395|NCT00211237|967345|P1|NOT COMPLETED|1 Month||3
395396|NCT00211237|967343|P3|COMPLETED|1 Month||0
395397|NCT00211237|967344|P2|COMPLETED|1 Month||52
395398|NCT00211237|967345|P1|COMPLETED|1 Month||65
395399|NCT00211237|967343|P3|STARTED|1 Month||0
395400|NCT00211237|967344|P2|STARTED|1 Month||61
395401|NCT00211237|967345|P1|STARTED|1 Month||68
395402|NCT00211237|967343|P3|NOT COMPLETED|Baseline||0
395403|NCT00211237|967344|P2|NOT COMPLETED|Baseline||3
395404|NCT00211237|967345|P1|NOT COMPLETED|Baseline||2
395405|NCT00211237|967343|P3|COMPLETED|Baseline||0
395406|NCT00211237|967344|P2|COMPLETED|Baseline||61
395407|NCT00211237|967345|P1|COMPLETED|Baseline||68
395408|NCT00211237|967343|P3|STARTED|Baseline||0
395409|NCT00211237|967344|P2|STARTED|Baseline||64
395410|NCT00211237|967345|P1|STARTED|Baseline||70
395411|NCT00211172|967437|P2|NOT COMPLETED|Overall Study||32
395412|NCT00211172|967438|P1|NOT COMPLETED|Overall Study||39
395413|NCT00211172|967437|P2|COMPLETED|Overall Study|32 patients died or lost health plan eligibility|426
395414|NCT00211172|967438|P1|COMPLETED|Overall Study|39 patients died or lost health plan eligibility|410
395415|NCT00211172|967437|P2|STARTED|Overall Study||458
395416|NCT00211172|967438|P1|STARTED|Overall Study||449
395417|NCT00211081|967444|P1|NOT COMPLETED|Overall Study||2
395418|NCT00211081|967444|P1|COMPLETED|Overall Study||10
395419|NCT00211081|967444|P1|STARTED|Overall Study||12
395420|NCT00210639|967456|P2|NOT COMPLETED|Overall Study||42
395421|NCT00210639|967457|P1|NOT COMPLETED|Overall Study||63
395422|NCT00210639|967456|P2|COMPLETED|Overall Study||41
395423|NCT00210639|967457|P1|COMPLETED|Overall Study||61
395424|NCT00210639|967456|P2|STARTED|Overall Study||83
395425|NCT00210639|967457|P1|STARTED|Overall Study||124
395426|NCT00210626|967465|P2|NOT COMPLETED|Overall Study||45
395427|NCT00210626|967466|P1|NOT COMPLETED|Overall Study||48
395428|NCT00210626|967465|P2|COMPLETED|Overall Study||50
395429|NCT00210626|967466|P1|COMPLETED|Overall Study||49
395430|NCT00210626|967465|P2|STARTED|Overall Study||95
395431|NCT00210626|967466|P1|STARTED|Overall Study||97
395432|NCT00210470|967474|P1|NOT COMPLETED|Overall Study||1
395433|NCT00210470|967474|P1|COMPLETED|Overall Study||26
395434|NCT00210470|967474|P1|STARTED|Overall Study||27
395435|NCT00210353|967481|P3|NOT COMPLETED|Overall Study||26
395436|NCT00210353|967482|P2|NOT COMPLETED|Overall Study||45
395437|NCT00210353|967483|P1|NOT COMPLETED|Overall Study||38
395438|NCT00210353|967481|P3|COMPLETED|Overall Study||125
395439|NCT00210353|967482|P2|COMPLETED|Overall Study||107
395440|NCT00210353|967483|P1|COMPLETED|Overall Study||113
395441|NCT00210353|967481|P3|STARTED|Overall Study||151
395442|NCT00210353|967482|P2|STARTED|Overall Study||152
395443|NCT00210353|967483|P1|STARTED|Overall Study||151
395444|NCT00209560|967505|P2|NOT COMPLETED|Overall Study||0
395445|NCT00209560|967506|P1|NOT COMPLETED|Overall Study||1
395446|NCT00209560|967505|P2|COMPLETED|Overall Study||42
395447|NCT00209560|967506|P1|COMPLETED|Overall Study||120
395448|NCT00209560|967505|P2|STARTED|Overall Study||42
395449|NCT00209560|967506|P1|STARTED|Overall Study||121
395450|NCT00209417|967516|P2|NOT COMPLETED|Overall Study||0
395451|NCT00209417|967517|P1|NOT COMPLETED|Overall Study||0
395452|NCT00209417|967516|P2|COMPLETED|Overall Study||327
395453|NCT00209417|967517|P1|COMPLETED|Overall Study||321
395454|NCT00209417|967516|P2|STARTED|Overall Study||327
395455|NCT00209417|967517|P1|STARTED|Overall Study||321
395456|NCT00209339|967525|P1|NOT COMPLETED|At 5 Years Follow-up||8
395457|NCT00209339|967525|P1|COMPLETED|At 5 Years Follow-up||15
395458|NCT00209339|967525|P1|STARTED|At 5 Years Follow-up||23
395459|NCT00209339|967525|P1|NOT COMPLETED|At 4 Years Follow-up||5
395460|NCT00209339|967525|P1|COMPLETED|At 4 Years Follow-up||23
395461|NCT00209339|967525|P1|STARTED|At 4 Years Follow-up||28
395462|NCT00209339|967525|P1|NOT COMPLETED|At 3 Years Follow-up||1
395463|NCT00209339|967525|P1|COMPLETED|At 3 Years Follow-up||28
395464|NCT00209339|967525|P1|STARTED|At 3 Years Follow-up||29
395465|NCT00209339|967525|P1|NOT COMPLETED|At 24 Months Follow-up||11
395466|NCT00209339|967525|P1|COMPLETED|At 24 Months Follow-up||29
395467|NCT00209339|967525|P1|STARTED|At 24 Months Follow-up||40
395468|NCT00209339|967525|P1|NOT COMPLETED|At 12 Months Follow-up||15
395469|NCT00209339|967525|P1|COMPLETED|At 12 Months Follow-up||40
395470|NCT00209339|967525|P1|STARTED|At 12 Months Follow-up||55
395471|NCT00209274|967609|P2|NOT COMPLETED|Overall Study||47
395472|NCT00209274|967610|P1|NOT COMPLETED|Overall Study||71
395473|NCT00209274|967609|P2|COMPLETED|Overall Study||48
395474|NCT00209274|967610|P1|COMPLETED|Overall Study||113
395475|NCT00209274|967609|P2|STARTED|Overall Study||95
395476|NCT00209274|967610|P1|STARTED|Overall Study||184
395477|NCT00209170|967930|P2|NOT COMPLETED|Overall Study||3
395478|NCT00209170|967931|P1|NOT COMPLETED|Overall Study||2
395479|NCT00209170|967930|P2|COMPLETED|Overall Study||4
395480|NCT00209170|967931|P1|COMPLETED|Overall Study||5
395481|NCT00209170|967930|P2|STARTED|Overall Study||7
395482|NCT00209170|967931|P1|STARTED|Overall Study||7
395483|NCT00209131|967939|P2|NOT COMPLETED|Overall Study||11
395484|NCT00209131|967940|P1|NOT COMPLETED|Overall Study||15
395485|NCT00209131|967939|P2|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
395486|NCT00209131|967940|P1|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
395487|NCT00209131|967939|P2|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|11
395488|NCT00209131|967940|P1|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|15
395489|NCT00209092|967950|P2|NOT COMPLETED|Overall Study||2
395490|NCT00209092|967951|P1|NOT COMPLETED|Overall Study||8
395491|NCT00209092|967950|P2|COMPLETED|Overall Study||24
395492|NCT00209092|967951|P1|COMPLETED|Overall Study||17
395493|NCT00209092|967950|P2|STARTED|Overall Study||26
395494|NCT00209092|967951|P1|STARTED|Overall Study||25
395495|NCT00209027|967961|P2|NOT COMPLETED|Overall Study||0
395496|NCT00209027|967962|P1|NOT COMPLETED|Overall Study||10
395497|NCT00209027|967961|P2|COMPLETED|Overall Study||10
395498|NCT00209027|967962|P1|COMPLETED|Overall Study||0
395499|NCT00209027|967961|P2|STARTED|Overall Study||10
395500|NCT00209027|967962|P1|STARTED|Overall Study||10
395501|NCT00208975|967968|P1|NOT COMPLETED|Overall Study||0
395502|NCT00208975|967968|P1|COMPLETED|Overall Study||15
395503|NCT00208975|967968|P1|STARTED|Overall Study||15
395504|NCT00208949|967975|P2|NOT COMPLETED|Overall Study||0
395505|NCT00208949|967976|P1|NOT COMPLETED|Overall Study||0
395506|NCT00208949|967975|P2|COMPLETED|Overall Study||25
395507|NCT00208949|967976|P1|COMPLETED|Overall Study||25
395508|NCT00208949|967975|P2|STARTED|Overall Study||25
395509|NCT00208949|967976|P1|STARTED|Overall Study||25
395510|NCT00208767|967986|P2|NOT COMPLETED|Overall Study||7
395511|NCT00208767|967987|P1|NOT COMPLETED|Overall Study||27
395512|NCT00208767|967986|P2|COMPLETED|Overall Study||33
395513|NCT00208767|967987|P1|COMPLETED|Overall Study||53
395514|NCT00208767|967986|P2|STARTED|Overall Study||40
395515|NCT00208767|967987|P1|STARTED|Overall Study||80
395516|NCT00208507|967995|P2|NOT COMPLETED|Overall Study||8
395517|NCT00208507|967996|P1|NOT COMPLETED|Overall Study||14
395518|NCT00208507|967995|P2|COMPLETED|Overall Study||79
395519|NCT00208507|967996|P1|COMPLETED|Overall Study||163
395520|NCT00208507|967995|P2|STARTED|Overall Study||87
395521|NCT00208507|967996|P1|STARTED|Overall Study||177
395522|NCT00208494|968004|P2|NOT COMPLETED|Overall Study||34
395523|NCT00208494|968005|P1|NOT COMPLETED|Overall Study||30
395524|NCT00208494|968004|P2|COMPLETED|Overall Study||162
395525|NCT00208494|968005|P1|COMPLETED|Overall Study||164
395526|NCT00208494|968004|P2|STARTED|Overall Study||196
395527|NCT00208494|968005|P1|STARTED|Overall Study||194
395528|NCT00208325|968015|P4|NOT COMPLETED|Overall Study||14
395529|NCT00208325|968016|P3|NOT COMPLETED|Overall Study||14
395530|NCT00208325|968017|P2|NOT COMPLETED|Overall Study||54
395531|NCT00208325|968018|P1|NOT COMPLETED|Overall Study||51
395532|NCT00208325|968015|P4|COMPLETED|Overall Study||147
395533|NCT00208325|968016|P3|COMPLETED|Overall Study||156
395534|NCT00208325|968017|P2|COMPLETED|Overall Study||142
395535|NCT00208325|968018|P1|COMPLETED|Overall Study||142
395536|NCT00208325|968015|P4|STARTED|Overall Study||161
395537|NCT00208325|968016|P3|STARTED|Overall Study||170
395538|NCT00208325|968017|P2|STARTED|Overall Study||196
395539|NCT00208325|968018|P1|STARTED|Overall Study||193
395540|NCT00208091|968126|P1|NOT COMPLETED|Overall Study||0
395541|NCT00208091|968126|P1|COMPLETED|Overall Study||16
395542|NCT00208091|968126|P1|STARTED|Overall Study||16
395543|NCT00208026|968134|P1|NOT COMPLETED|Overall Study||0
395544|NCT00208026|968134|P1|COMPLETED|Overall Study||3
395545|NCT00208026|968134|P1|STARTED|Overall Study||3
395546|NCT00207883|968142|P2|NOT COMPLETED|Overall Study||0
395547|NCT00207883|968143|P1|NOT COMPLETED|Overall Study||0
395548|NCT00207883|968142|P2|COMPLETED|Overall Study||119
395549|NCT00207883|968143|P1|COMPLETED|Overall Study||93
395550|NCT00207883|968142|P2|STARTED|Overall Study||119
395551|NCT00207883|968143|P1|STARTED|Overall Study||93
395552|NCT00207740|968155|P4|NOT COMPLETED|Overall Study||43
395553|NCT00207740|968156|P3|NOT COMPLETED|Overall Study||40
395554|NCT00207740|968157|P2|NOT COMPLETED|Overall Study||41
395555|NCT00207740|968158|P1|NOT COMPLETED|Overall Study||29
395556|NCT00207740|968155|P4|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|35
395557|NCT00207740|968156|P3|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
395558|NCT00207740|968157|P2|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
395559|NCT00207740|968158|P1|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|49
395560|NCT00207740|968155|P4|STARTED|Overall Study||78
395561|NCT00207740|968156|P3|STARTED|Overall Study||76
395562|NCT00207740|968157|P2|STARTED|Overall Study||77
395563|NCT00207740|968158|P1|STARTED|Overall Study||78
395564|NCT00207727|968204|P5|NOT COMPLETED|Overall Study||34
395565|NCT00207727|968205|P4|NOT COMPLETED|Overall Study||37
395566|NCT00207727|968206|P3|NOT COMPLETED|Overall Study||41
395567|NCT00207727|968207|P2|NOT COMPLETED|Overall Study||42
395568|NCT00207727|968208|P1|NOT COMPLETED|Overall Study||38
395569|NCT00207727|968204|P5|COMPLETED|Overall Study||16
395570|NCT00207727|968205|P4|COMPLETED|Overall Study||13
395571|NCT00207727|968206|P3|COMPLETED|Overall Study||9
395572|NCT00207727|968207|P2|COMPLETED|Overall Study||8
395573|NCT00207727|968208|P1|COMPLETED|Overall Study||11
395574|NCT00207727|968204|P5|STARTED|Overall Study||50
395575|NCT00207727|968205|P4|STARTED|Overall Study||50
395576|NCT00207727|968206|P3|STARTED|Overall Study||50
395577|NCT00207727|968207|P2|STARTED|Overall Study||50
395578|NCT00207727|968208|P1|STARTED|Overall Study||49
395579|NCT00207714|968235|P5|NOT COMPLETED|Overall Study||5
395580|NCT00207714|968236|P4|NOT COMPLETED|Overall Study||8
395581|NCT00207714|968237|P3|NOT COMPLETED|Overall Study||10
395582|NCT00207714|968238|P2|NOT COMPLETED|Overall Study||7
395583|NCT00207714|968239|P1|NOT COMPLETED|Overall Study||14
395584|NCT00207714|968235|P5|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|29
395585|NCT00207714|968236|P4|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|26
395586|NCT00207714|968237|P3|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|24
395587|NCT00207714|968238|P2|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|28
395588|NCT00207714|968239|P1|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|21
395589|NCT00207714|968235|P5|STARTED|Overall Study||34
395590|NCT00207714|968236|P4|STARTED|Overall Study||34
395591|NCT00207714|968237|P3|STARTED|Overall Study||34
395592|NCT00207714|968238|P2|STARTED|Overall Study||35
395593|NCT00207714|968239|P1|STARTED|Overall Study||35
395594|NCT00207142|968261|P4|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
395595|NCT00207142|968262|P3|NOT COMPLETED|Maintenance Phase/Rescue Phase||13
395596|NCT00207142|968263|P2|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
395597|NCT00207142|968264|P1|NOT COMPLETED|Maintenance Phase/Rescue Phase||0
395598|NCT00207142|968261|P4|COMPLETED|Maintenance Phase/Rescue Phase||41
395599|NCT00207142|968262|P3|COMPLETED|Maintenance Phase/Rescue Phase||72
395600|NCT00207142|968263|P2|COMPLETED|Maintenance Phase/Rescue Phase||78
395601|NCT00207142|968264|P1|COMPLETED|Maintenance Phase/Rescue Phase||0
395602|NCT00207142|968261|P4|STARTED|Maintenance Phase/Rescue Phase||50
395603|NCT00207142|968262|P3|STARTED|Maintenance Phase/Rescue Phase||85
395604|NCT00207142|968263|P2|STARTED|Maintenance Phase/Rescue Phase||87
395605|NCT00207142|968264|P1|STARTED|Maintenance Phase/Rescue Phase||0
395606|NCT00207142|968261|P4|NOT COMPLETED|Induction Phase||0
395607|NCT00207142|968262|P3|NOT COMPLETED|Induction Phase||0
395608|NCT00207142|968263|P2|NOT COMPLETED|Induction Phase||0
395609|NCT00207142|968264|P1|NOT COMPLETED|Induction Phase||30
395610|NCT00207142|968261|P4|COMPLETED|Induction Phase||0
395611|NCT00207142|968262|P3|COMPLETED|Induction Phase||0
395612|NCT00207142|968263|P2|COMPLETED|Induction Phase||0
395613|NCT00207142|968264|P1|COMPLETED|Induction Phase|Subjects randomized into Maintenance Phase=172 (87 ATV +85 ATV/RTV); Rescue Phase subjects=50|222
395614|NCT00207142|968261|P4|STARTED|Induction Phase||0
395615|NCT00207142|968262|P3|STARTED|Induction Phase||0
395616|NCT00207142|968263|P2|STARTED|Induction Phase||0
395617|NCT00207142|968264|P1|STARTED|Induction Phase||252
395618|NCT00207090|968301|P1|NOT COMPLETED|Overall Study||7
395619|NCT00207090|968301|P1|COMPLETED|Overall Study||8
395620|NCT00207090|968301|P1|STARTED|Overall Study|Number of participants treated|15
395621|NCT00206726|968330|P1|NOT COMPLETED|Overall Study||51
395622|NCT00206726|968330|P1|COMPLETED|Overall Study|4-6 cycles of treatment with assessments at 2, 6, and 9 months post last dose|9
395623|NCT00206726|968330|P1|4 Cycles Completed|Overall Study|per protocol population|41
395624|NCT00206726|968330|P1|Treatment Started|Overall Study|Safety population (3 withdrew consent prior to receiving study drug)|57
395625|NCT00206726|968330|P1|STARTED|Overall Study||60
395626|NCT00206518|968341|P2|NOT COMPLETED|Overall Study||6
395627|NCT00206518|968342|P1|NOT COMPLETED|Overall Study||10
395628|NCT00206518|968341|P2|COMPLETED|Overall Study||78
395629|NCT00206518|968342|P1|COMPLETED|Overall Study||73
395630|NCT00206518|968341|P2|STARTED|Overall Study||84
395631|NCT00206518|968342|P1|STARTED|Overall Study||83
395632|NCT00206440|968354|P2|NOT COMPLETED|Overall Study||4
395633|NCT00206440|968355|P1|NOT COMPLETED|Overall Study||5
395634|NCT00206440|968354|P2|COMPLETED|Overall Study||18
395635|NCT00206440|968355|P1|COMPLETED|Overall Study||16
395636|NCT00206440|968354|P2|STARTED|Overall Study||22
395637|NCT00206440|968355|P1|STARTED|Overall Study||21
395638|NCT00206427|968361|P1|NOT COMPLETED|Overall Study||2
395639|NCT00206427|968361|P1|COMPLETED|Overall Study|Complete 6-week therapy|47
395640|NCT00206427|968361|P1|STARTED|Overall Study|Received First Dose|49
395641|NCT00206336|968365|P1|NOT COMPLETED|Overall Study||0
395642|NCT00206336|968365|P1|COMPLETED|Overall Study||20
395643|NCT00206336|968365|P1|STARTED|Overall Study||20
395644|NCT00206323|968371|P2|NOT COMPLETED|Overall Study||3
395645|NCT00206323|968372|P1|NOT COMPLETED|Overall Study||6
395646|NCT00206323|968371|P2|COMPLETED|Overall Study||12
395647|NCT00206323|968372|P1|COMPLETED|Overall Study||8
395648|NCT00206323|968371|P2|STARTED|Overall Study||15
395649|NCT00206323|968372|P1|STARTED|Overall Study||14
395650|NCT00206102|968380|P2|NOT COMPLETED|Overall Study||315
395651|NCT00206102|968381|P1|NOT COMPLETED|Overall Study||408
395652|NCT00206102|968380|P2|COMPLETED|Overall Study||187
395653|NCT00206102|968381|P1|COMPLETED|Overall Study||188
395654|NCT00206102|968380|P2|STARTED|Overall Study||502
395655|NCT00206102|968381|P1|STARTED|Overall Study||596
395656|NCT00206076|968417|P2|NOT COMPLETED|Overall Study||1
395657|NCT00206076|968418|P1|NOT COMPLETED|Overall Study||3
395658|NCT00206076|968417|P2|COMPLETED|Overall Study||9
395659|NCT00206076|968418|P1|COMPLETED|Overall Study||6
395660|NCT00206076|968417|P2|STARTED|Overall Study||10
395661|NCT00206076|968418|P1|STARTED|Overall Study||9
395662|NCT00205881|968428|P1|NOT COMPLETED|Overall Study||16
395663|NCT00205881|968428|P1|COMPLETED|Overall Study|32 enrolled. 1 unilateral. 25 bilateral for data analysis at 8 months. 16 completed study.|16
395664|NCT00205881|968428|P1|STARTED|Overall Study||32
395665|NCT00205855|968433|P1|NOT COMPLETED|Overall Study||21
395666|NCT00205855|968433|P1|COMPLETED|Overall Study||44
395667|NCT00205855|968433|P1|STARTED|Overall Study||65
395668|NCT00205803|968439|P2|NOT COMPLETED|Toddler Dose||3
395669|NCT00205803|968440|P1|NOT COMPLETED|Toddler Dose||2
395670|NCT00205803|968439|P2|COMPLETED|Toddler Dose||100
395671|NCT00205803|968440|P1|COMPLETED|Toddler Dose||84
395672|NCT00205803|968439|P2|STARTED|Toddler Dose||103
395673|NCT00205803|968440|P1|STARTED|Toddler Dose||86
395674|NCT00205803|968439|P2|NOT COMPLETED|After Infant Series||13
395675|NCT00205803|968440|P1|NOT COMPLETED|After Infant Series||18
395676|NCT00205803|968439|P2|COMPLETED|After Infant Series||103
395677|NCT00205803|968440|P1|COMPLETED|After Infant Series||86
395678|NCT00205803|968439|P2|STARTED|After Infant Series||116
395679|NCT00205803|968440|P1|STARTED|After Infant Series||104
395680|NCT00205803|968439|P2|NOT COMPLETED|Infant Series||11
395681|NCT00205803|968440|P1|NOT COMPLETED|Infant Series||18
395682|NCT00205803|968439|P2|COMPLETED|Infant Series||116
395683|NCT00205803|968440|P1|COMPLETED|Infant Series||104
395684|NCT00205803|968439|P2|Vaccinated Dose 3|Infant Series||118
395685|NCT00205803|968440|P1|Vaccinated Dose 3|Infant Series||110
395686|NCT00205803|968439|P2|Vaccinated Dose 2|Infant Series||122
395687|NCT00205803|968440|P1|Vaccinated Dose 2|Infant Series||115
395688|NCT00205803|968439|P2|Vaccinated Dose 1|Infant Series||126
395689|NCT00205803|968440|P1|Vaccinated Dose 1|Infant Series||121
395690|NCT00205803|968439|P2|STARTED|Infant Series||127
395691|NCT00205803|968440|P1|STARTED|Infant Series||122
395692|NCT00205777|968496|P6|NOT COMPLETED|Study Extension II||282
395693|NCT00205777|968497|P5|NOT COMPLETED|Study Extension II||0
395694|NCT00205777|968498|P4|NOT COMPLETED|Study Extension II||149
395695|NCT00205777|968499|P3|NOT COMPLETED|Study Extension II||0
395696|NCT00205777|968500|P2|NOT COMPLETED|Study Extension II||0
395697|NCT00205777|968501|P1|NOT COMPLETED|Study Extension II||0
395698|NCT00205777|968496|P6|COMPLETED|Study Extension II||860
395699|NCT00205777|968497|P5|COMPLETED|Study Extension II||0
395700|NCT00205777|968498|P4|COMPLETED|Study Extension II||441
395701|NCT00205777|968499|P3|COMPLETED|Study Extension II||0
395702|NCT00205777|968500|P2|COMPLETED|Study Extension II||0
395703|NCT00205777|968501|P1|COMPLETED|Study Extension II||0
395704|NCT00205777|968496|P6|TREATED|Study Extension II||1011
395705|NCT00205777|968497|P5|TREATED|Study Extension II||0
395706|NCT00205777|968498|P4|TREATED|Study Extension II||519
395707|NCT00205777|968499|P3|TREATED|Study Extension II||0
395708|NCT00205777|968500|P2|TREATED|Study Extension II||0
395709|NCT00205777|968501|P1|TREATED|Study Extension II||0
395710|NCT00205777|968496|P6|STARTED|Study Extension II||1142
395711|NCT00205777|968497|P5|STARTED|Study Extension II||0
395712|NCT00205777|968498|P4|STARTED|Study Extension II||590
395713|NCT00205777|968499|P3|STARTED|Study Extension II||0
395714|NCT00205777|968500|P2|STARTED|Study Extension II||0
395715|NCT00205777|968501|P1|STARTED|Study Extension II||0
395716|NCT00205777|968496|P6|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
395717|NCT00205777|968497|P5|NOT COMPLETED|Completed SE I, Entered Extension SE II||258
395718|NCT00205777|968498|P4|NOT COMPLETED|Completed SE I, Entered Extension SE II||240
395719|NCT00205777|968499|P3|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
395720|NCT00205777|968500|P2|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
395721|NCT00205777|968501|P1|NOT COMPLETED|Completed SE I, Entered Extension SE II||273
395722|NCT00205777|968496|P6|COMPLETED|Completed SE I, Entered Extension SE II||0
395723|NCT00205777|968497|P5|COMPLETED|Completed SE I, Entered Extension SE II||582
395724|NCT00205777|968498|P4|COMPLETED|Completed SE I, Entered Extension SE II||590
395725|NCT00205777|968499|P3|COMPLETED|Completed SE I, Entered Extension SE II||0
395726|NCT00205777|968500|P2|COMPLETED|Completed SE I, Entered Extension SE II||0
395727|NCT00205777|968501|P1|COMPLETED|Completed SE I, Entered Extension SE II||560
395728|NCT00205777|968496|P6|STARTED|Completed SE I, Entered Extension SE II||0
395729|NCT00205777|968497|P5|STARTED|Completed SE I, Entered Extension SE II||840
395730|NCT00205777|968498|P4|STARTED|Completed SE I, Entered Extension SE II||830
395731|NCT00205777|968499|P3|STARTED|Completed SE I, Entered Extension SE II||0
395732|NCT00205777|968500|P2|STARTED|Completed SE I, Entered Extension SE II||0
395733|NCT00205777|968501|P1|STARTED|Completed SE I, Entered Extension SE II||833
395734|NCT00205777|968496|P6|NOT COMPLETED|Study Extension I||0
395735|NCT00205777|968497|P5|NOT COMPLETED|Study Extension I||201
395736|NCT00205777|968498|P4|NOT COMPLETED|Study Extension I||228
395737|NCT00205777|968499|P3|NOT COMPLETED|Study Extension I||1070
395738|NCT00205777|968500|P2|NOT COMPLETED|Study Extension I||0
395739|NCT00205777|968501|P1|NOT COMPLETED|Study Extension I||214
395740|NCT00205777|968496|P6|COMPLETED|Study Extension I||0
395741|NCT00205777|968497|P5|COMPLETED|Study Extension I||840
395742|NCT00205777|968498|P4|COMPLETED|Study Extension I||830
395743|NCT00205777|968499|P3|COMPLETED|Study Extension I||0
395744|NCT00205777|968500|P2|COMPLETED|Study Extension I||0
395745|NCT00205777|968501|P1|COMPLETED|Study Extension I||833
395746|NCT00205777|968496|P6|STARTED|Study Extension I||0
395747|NCT00205777|968497|P5|STARTED|Study Extension I||1041
395748|NCT00205777|968498|P4|STARTED|Study Extension I||1058
395749|NCT00205777|968499|P3|STARTED|Study Extension I||1070
395750|NCT00205777|968500|P2|STARTED|Study Extension I||0
395751|NCT00205777|968501|P1|STARTED|Study Extension I||1047
395752|NCT00205777|968496|P6|NOT COMPLETED|Completed Core Study, Entered SE I||0
395753|NCT00205777|968497|P5|NOT COMPLETED|Completed Core Study, Entered SE I||0
395754|NCT00205777|968498|P4|NOT COMPLETED|Completed Core Study, Entered SE I||224
395755|NCT00205777|968499|P3|NOT COMPLETED|Completed Core Study, Entered SE I||207
395756|NCT00205777|968500|P2|NOT COMPLETED|Completed Core Study, Entered SE I||204
395757|NCT00205777|968501|P1|NOT COMPLETED|Completed Core Study, Entered SE I||232
395758|NCT00205777|968496|P6|COMPLETED|Completed Core Study, Entered SE I||0
395759|NCT00205777|968497|P5|COMPLETED|Completed Core Study, Entered SE I||0
395760|NCT00205777|968498|P4|COMPLETED|Completed Core Study, Entered SE I||1058
395761|NCT00205777|968499|P3|COMPLETED|Completed Core Study, Entered SE I||1070
395762|NCT00205777|968500|P2|COMPLETED|Completed Core Study, Entered SE I||1041
395763|NCT00205777|968501|P1|COMPLETED|Completed Core Study, Entered SE I||1047
395764|NCT00205777|968496|P6|STARTED|Completed Core Study, Entered SE I||0
395765|NCT00205777|968497|P5|STARTED|Completed Core Study, Entered SE I||0
395766|NCT00205777|968498|P4|STARTED|Completed Core Study, Entered SE I||1282
395767|NCT00205777|968499|P3|STARTED|Completed Core Study, Entered SE I||1277
395768|NCT00205777|968500|P2|STARTED|Completed Core Study, Entered SE I||1245
395769|NCT00205777|968501|P1|STARTED|Completed Core Study, Entered SE I||1279
395770|NCT00205777|968496|P6|NOT COMPLETED|Core Study (Up to 3 Years)||0
395771|NCT00205777|968497|P5|NOT COMPLETED|Core Study (Up to 3 Years)||0
395772|NCT00205777|968498|P4|NOT COMPLETED|Core Study (Up to 3 Years)||632
395773|NCT00205777|968499|P3|NOT COMPLETED|Core Study (Up to 3 Years)||607
395774|NCT00205777|968500|P2|NOT COMPLETED|Core Study (Up to 3 Years)||659
395775|NCT00205777|968501|P1|NOT COMPLETED|Core Study (Up to 3 Years)||628
395776|NCT00205777|968496|P6|COMPLETED|Core Study (Up to 3 Years)||0
395777|NCT00205777|968497|P5|COMPLETED|Core Study (Up to 3 Years)||0
395778|NCT00205777|968498|P4|COMPLETED|Core Study (Up to 3 Years)||1282
395779|NCT00205777|968499|P3|COMPLETED|Core Study (Up to 3 Years)||1277
395780|NCT00205777|968500|P2|COMPLETED|Core Study (Up to 3 Years)||1245
395781|NCT00205777|968501|P1|COMPLETED|Core Study (Up to 3 Years)||1279
395782|NCT00205777|968496|P6|TREATED|Core Study (Up to 3 Years)||0
395783|NCT00205777|968497|P5|TREATED|Core Study (Up to 3 Years)||0
395784|NCT00205777|968498|P4|TREATED|Core Study (Up to 3 Years)||1885
395785|NCT00205777|968499|P3|TREATED|Core Study (Up to 3 Years)||1849
395786|NCT00205777|968500|P2|TREATED|Core Study (Up to 3 Years)||1872
395787|NCT00205777|968501|P1|TREATED|Core Study (Up to 3 Years)||1886
395788|NCT00205777|968496|P6|STARTED|Core Study (Up to 3 Years)||0
395789|NCT00205777|968497|P5|STARTED|Core Study (Up to 3 Years)||0
395790|NCT00205777|968498|P4|STARTED|Core Study (Up to 3 Years)||1914
395791|NCT00205777|968499|P3|STARTED|Core Study (Up to 3 Years)||1884
395792|NCT00205777|968500|P2|STARTED|Core Study (Up to 3 Years)||1904
395793|NCT00205777|968501|P1|STARTED|Core Study (Up to 3 Years)||1907
395794|NCT00205712|968710|P2|NOT COMPLETED|Overall Study||1
395795|NCT00205712|968711|P1|NOT COMPLETED|Overall Study||0
395796|NCT00205712|968710|P2|COMPLETED|Overall Study||19
395797|NCT00205712|968711|P1|COMPLETED|Overall Study||20
395798|NCT00205712|968710|P2|STARTED|Overall Study||20
395799|NCT00205712|968711|P1|STARTED|Overall Study||20
395800|NCT00205699|968724|P3|NOT COMPLETED|Overall Study||6
395801|NCT00205699|968725|P2|NOT COMPLETED|Overall Study||6
395802|NCT00205699|968726|P1|NOT COMPLETED|Overall Study||3
395803|NCT00205699|968724|P3|COMPLETED|Overall Study||43
395804|NCT00205699|968725|P2|COMPLETED|Overall Study||40
395805|NCT00205699|968726|P1|COMPLETED|Overall Study||46
395806|NCT00205699|968724|P3|STARTED|Overall Study||49
395807|NCT00205699|968725|P2|STARTED|Overall Study||46
395808|NCT00205699|968726|P1|STARTED|Overall Study||49
395809|NCT00205660|968751|P2|NOT COMPLETED|Overall Study||2
395810|NCT00205660|968752|P1|NOT COMPLETED|Overall Study||2
395811|NCT00205660|968751|P2|COMPLETED|Overall Study||35
395812|NCT00205660|968752|P1|COMPLETED|Overall Study||12
395813|NCT00205660|968751|P2|STARTED|Overall Study||37
395814|NCT00205660|968752|P1|STARTED|Overall Study||14
395815|NCT00205504|968764|P2|NOT COMPLETED|Overall Study||0
395816|NCT00205504|968765|P1|NOT COMPLETED|Overall Study||7
395817|NCT00205504|968764|P2|COMPLETED|Overall Study||15
395818|NCT00205504|968765|P1|COMPLETED|Overall Study||14
395819|NCT00205504|968764|P2|STARTED|Overall Study||15
395820|NCT00205504|968765|P1|STARTED|Overall Study||21
395821|NCT00205374|968791|P2|NOT COMPLETED|Overall Study||0
395822|NCT00205374|968792|P1|NOT COMPLETED|Overall Study||0
395823|NCT00205374|968791|P2|COMPLETED|Overall Study||9
395824|NCT00205374|968792|P1|COMPLETED|Overall Study||10
395825|NCT00205374|968791|P2|STARTED|Overall Study||9
395826|NCT00205374|968792|P1|STARTED|Overall Study||10
395827|NCT00205348|968800|P1|NOT COMPLETED|Overall Study||30
395828|NCT00205348|968800|P1|COMPLETED|Overall Study||116
395829|NCT00205348|968800|P1|STARTED|Overall Study||146
395830|NCT00205049|968806|P2|NOT COMPLETED|Overall Study||0
395831|NCT00205049|968807|P1|NOT COMPLETED|Overall Study||0
395832|NCT00205049|968806|P2|COMPLETED|Overall Study||0
395833|NCT00205049|968807|P1|COMPLETED|Overall Study||0
395834|NCT00205049|968806|P2|STARTED|Overall Study||0
395835|NCT00205049|968807|P1|STARTED|Overall Study||0
395836|NCT00204932|968815|P2|NOT COMPLETED|Overall Study||6
395837|NCT00204932|968816|P1|NOT COMPLETED|Overall Study||2
395838|NCT00204932|968815|P2|COMPLETED|Overall Study||18
395839|NCT00204932|968816|P1|COMPLETED|Overall Study||22
395840|NCT00204932|968815|P2|STARTED|Overall Study||24
395841|NCT00204932|968816|P1|STARTED|Overall Study||24
395842|NCT00204373|968822|P1|NOT COMPLETED|Overall Study||0
395843|NCT00204373|968822|P1|COMPLETED|Overall Study||72
395844|NCT00204373|968822|P1|STARTED|Overall Study||72
395845|NCT00203996|968833|P10|NOT COMPLETED|Overall Study||1
395846|NCT00203996|968834|P9|NOT COMPLETED|Overall Study||0
395847|NCT00203996|968835|P8|NOT COMPLETED|Overall Study||2
395848|NCT00203996|968836|P7|NOT COMPLETED|Overall Study||0
395849|NCT00203996|968837|P6|NOT COMPLETED|Overall Study||0
395850|NCT00203996|968838|P5|NOT COMPLETED|Overall Study||1
395851|NCT00203996|968839|P4|NOT COMPLETED|Overall Study||10
395852|NCT00203996|968840|P3|NOT COMPLETED|Overall Study||0
395853|NCT00203996|968841|P2|NOT COMPLETED|Overall Study||0
395854|NCT00203996|968842|P1|NOT COMPLETED|Overall Study||0
395855|NCT00203996|968833|P10|COMPLETED|Overall Study||2
395856|NCT00203996|968834|P9|COMPLETED|Overall Study||2
395857|NCT00203996|968835|P8|COMPLETED|Overall Study||2
395858|NCT00203996|968836|P7|COMPLETED|Overall Study||2
395859|NCT00203996|968837|P6|COMPLETED|Overall Study||3
395860|NCT00203996|968838|P5|COMPLETED|Overall Study||3
395861|NCT00203996|968839|P4|COMPLETED|Overall Study||9
395862|NCT00203996|968840|P3|COMPLETED|Overall Study||0
395863|NCT00203996|968841|P2|COMPLETED|Overall Study||0
395864|NCT00203996|968842|P1|COMPLETED|Overall Study||0
395865|NCT00203996|968833|P10|Aim 3 Only: Third Intervention|Overall Study||2
395866|NCT00203996|968834|P9|Aim 3 Only: Third Intervention|Overall Study||2
395867|NCT00203996|968835|P8|Aim 3 Only: Third Intervention|Overall Study||2
395868|NCT00203996|968836|P7|Aim 3 Only: Third Intervention|Overall Study||2
395869|NCT00203996|968837|P6|Aim 3 Only: Third Intervention|Overall Study||3
395870|NCT00203996|968838|P5|Aim 3 Only: Third Intervention|Overall Study||0
395871|NCT00203996|968839|P4|Aim 3 Only: Third Intervention|Overall Study||0
395872|NCT00203996|968840|P3|Aim 3 Only: Third Intervention|Overall Study||0
395873|NCT00203996|968841|P2|Aim 3 Only: Third Intervention|Overall Study||0
395874|NCT00203996|968842|P1|Aim 3 Only: Third Intervention|Overall Study||0
395875|NCT00203996|968833|P10|Aim 3 Only: Second Washout|Overall Study||2
395876|NCT00203996|968834|P9|Aim 3 Only: Second Washout|Overall Study||2
395877|NCT00203996|968835|P8|Aim 3 Only: Second Washout|Overall Study||2
395878|NCT00203996|968836|P7|Aim 3 Only: Second Washout|Overall Study||2
395879|NCT00203996|968837|P6|Aim 3 Only: Second Washout|Overall Study||3
395880|NCT00203996|968838|P5|Aim 3 Only: Second Washout|Overall Study||0
395881|NCT00203996|968839|P4|Aim 3 Only: Second Washout|Overall Study||0
395882|NCT00203996|968840|P3|Aim 3 Only: Second Washout|Overall Study||0
395883|NCT00203996|968841|P2|Aim 3 Only: Second Washout|Overall Study||0
395884|NCT00203996|968842|P1|Aim 3 Only: Second Washout|Overall Study||0
395885|NCT00203996|968833|P10|Aim 3 Only: Second Intervention|Overall Study||2
395886|NCT00203996|968834|P9|Aim 3 Only: Second Intervention|Overall Study||2
395887|NCT00203996|968835|P8|Aim 3 Only: Second Intervention|Overall Study||2
395888|NCT00203996|968836|P7|Aim 3 Only: Second Intervention|Overall Study||2
395889|NCT00203996|968837|P6|Aim 3 Only: Second Intervention|Overall Study||3
395890|NCT00203996|968838|P5|Aim 3 Only: Second Intervention|Overall Study||0
395891|NCT00203996|968839|P4|Aim 3 Only: Second Intervention|Overall Study||0
395892|NCT00203996|968840|P3|Aim 3 Only: Second Intervention|Overall Study||0
395893|NCT00203996|968841|P2|Aim 3 Only: Second Intervention|Overall Study||0
395894|NCT00203996|968842|P1|Aim 3 Only: Second Intervention|Overall Study||0
395895|NCT00203996|968833|P10|Aim 3 Only: Washout|Overall Study||2
395896|NCT00203996|968834|P9|Aim 3 Only: Washout|Overall Study||2
395897|NCT00203996|968835|P8|Aim 3 Only: Washout|Overall Study||2
395898|NCT00203996|968836|P7|Aim 3 Only: Washout|Overall Study||2
395899|NCT00203996|968837|P6|Aim 3 Only: Washout|Overall Study||3
395900|NCT00203996|968838|P5|Aim 3 Only: Washout|Overall Study||0
395901|NCT00203996|968839|P4|Aim 3 Only: Washout|Overall Study||0
395902|NCT00203996|968840|P3|Aim 3 Only: Washout|Overall Study||0
395903|NCT00203996|968841|P2|Aim 3 Only: Washout|Overall Study||0
395904|NCT00203996|968842|P1|Aim 3 Only: Washout|Overall Study||0
395905|NCT00203996|968833|P10|Aim 3 Only: First Intervention|Overall Study||3
395906|NCT00203996|968834|P9|Aim 3 Only: First Intervention|Overall Study||2
395907|NCT00203996|968835|P8|Aim 3 Only: First Intervention|Overall Study||4
395908|NCT00203996|968836|P7|Aim 3 Only: First Intervention|Overall Study||2
395909|NCT00203996|968837|P6|Aim 3 Only: First Intervention|Overall Study||3
395910|NCT00203996|968838|P5|Aim 3 Only: First Intervention|Overall Study||0
395911|NCT00203996|968839|P4|Aim 3 Only: First Intervention|Overall Study||0
395912|NCT00203996|968840|P3|Aim 3 Only: First Intervention|Overall Study||0
395913|NCT00203996|968841|P2|Aim 3 Only: First Intervention|Overall Study||0
395914|NCT00203996|968842|P1|Aim 3 Only: First Intervention|Overall Study||0
395915|NCT00203996|968833|P10|STARTED|Overall Study||3
395916|NCT00203996|968834|P9|STARTED|Overall Study||2
395917|NCT00203996|968835|P8|STARTED|Overall Study||4
395918|NCT00203996|968836|P7|STARTED|Overall Study||2
395919|NCT00203996|968837|P6|STARTED|Overall Study||3
395920|NCT00203996|968838|P5|STARTED|Overall Study||4
395921|NCT00203996|968839|P4|STARTED|Overall Study||19
395922|NCT00203996|968840|P3|STARTED|Overall Study||0
395923|NCT00203996|968841|P2|STARTED|Overall Study||0
395924|NCT00203996|968842|P1|STARTED|Overall Study||0
395925|NCT00203931|968891|P2|NOT COMPLETED|Overall Study||5
395926|NCT00203931|968892|P1|NOT COMPLETED|Overall Study||7
395927|NCT00203931|968891|P2|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|23
395928|NCT00203931|968892|P1|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|20
395929|NCT00203931|968891|P2|STARTED|Overall Study||28
395930|NCT00203931|968892|P1|STARTED|Overall Study||27
395931|NCT00203892|968909|P3|NOT COMPLETED|Overall Study||0
395932|NCT00203892|968910|P2|NOT COMPLETED|Overall Study||2
395933|NCT00203892|968911|P1|NOT COMPLETED|Overall Study||2
395934|NCT00203892|968909|P3|COMPLETED|Overall Study||6
395935|NCT00203892|968910|P2|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|8
395936|NCT00203892|968911|P1|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|5
395937|NCT00203892|968909|P3|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|4
395938|NCT00203892|968910|P2|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
395939|NCT00203892|968911|P1|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
395940|NCT00203892|968909|P3|STARTED|Overall Study||6
395941|NCT00203892|968910|P2|STARTED|Overall Study||10
395942|NCT00203892|968911|P1|STARTED|Overall Study||7
395943|NCT00203502|968922|P1|NOT COMPLETED|Overall Study||1
395944|NCT00203502|968922|P1|COMPLETED|Overall Study||39
395945|NCT00203502|968922|P1|STARTED|Overall Study||40
395946|NCT00203476|968933|P3|NOT COMPLETED|Overall Study||0
395947|NCT00203476|968934|P2|NOT COMPLETED|Overall Study||1
395948|NCT00203476|968935|P1|NOT COMPLETED|Overall Study||1
395949|NCT00203476|968933|P3|COMPLETED|Overall Study||10
395950|NCT00203476|968934|P2|COMPLETED|Overall Study||9
395951|NCT00203476|968935|P1|COMPLETED|Overall Study||9
395952|NCT00203476|968933|P3|STARTED|Overall Study||10
395953|NCT00203476|968934|P2|STARTED|Overall Study||10
395954|NCT00203476|968935|P1|STARTED|Overall Study||10
395955|NCT00203424|968952|P1|NOT COMPLETED|Follow-up Period||6
395956|NCT00203424|968952|P1|COMPLETED|Follow-up Period||10
395957|NCT00203424|968952|P1|STARTED|Follow-up Period|followup includes 11 pts that completed treatment + 5 pts who stopped treatment due to adverse event|16
395958|NCT00203424|968952|P1|NOT COMPLETED|Treatment Period||11
395959|NCT00203424|968952|P1|COMPLETED|Treatment Period|Of 11 pts that did not complete treatment,5 stopped due to adverse event and entered followup period|11
395960|NCT00203424|968952|P1|STARTED|Treatment Period|23 subjects registered for treatment, 1 withdrew consent after registration,22 received treatment.|22
395961|NCT00203411|968959|P1|NOT COMPLETED|Follow-up||4
395962|NCT00203411|968959|P1|COMPLETED|Follow-up||41
395963|NCT00203411|968959|P1|STARTED|Follow-up||45
395964|NCT00203411|968959|P1|NOT COMPLETED|Treatment Period||0
395965|NCT00203411|968959|P1|COMPLETED|Treatment Period||45
395966|NCT00203411|968959|P1|STARTED|Treatment Period||45
395967|NCT00203307|968968|P2|NOT COMPLETED|Second Intervention||0
395968|NCT00203307|968969|P1|NOT COMPLETED|Second Intervention||0
395969|NCT00203307|968968|P2|COMPLETED|Second Intervention||0
395970|NCT00203307|968969|P1|COMPLETED|Second Intervention||1
395971|NCT00203307|968968|P2|STARTED|Second Intervention||0
395972|NCT00203307|968969|P1|STARTED|Second Intervention|2 subjects dropped out of the 1st intervention period, due to fatugue.|1
395973|NCT00203307|968968|P2|NOT COMPLETED|First Intervention||0
395974|NCT00203307|968969|P1|NOT COMPLETED|First Intervention||2
395975|NCT00203307|968968|P2|COMPLETED|First Intervention||0
395976|NCT00203307|968969|P1|COMPLETED|First Intervention||1
395977|NCT00203307|968968|P2|STARTED|First Intervention||0
395978|NCT00203307|968969|P1|STARTED|First Intervention|Double-blind cross-over design. Study terminated early. Results not analyzed.|3
395979|NCT00203294|968977|P2|NOT COMPLETED|Overall Study||13
395980|NCT00203294|968978|P1|NOT COMPLETED|Overall Study||8
395981|NCT00203294|968977|P2|COMPLETED|Overall Study||10
395982|NCT00203294|968978|P1|COMPLETED|Overall Study||14
395983|NCT00203294|968977|P2|STARTED|Overall Study||23
395984|NCT00203294|968978|P1|STARTED|Overall Study||22
395985|NCT00203268|968984|P1|NOT COMPLETED|Late Treatment||0
395986|NCT00203268|968984|P1|COMPLETED|Late Treatment||9
395987|NCT00203268|968984|P1|STARTED|Late Treatment||9
395988|NCT00203268|968984|P1|NOT COMPLETED|Early Treatment||4
395989|NCT00203268|968984|P1|COMPLETED|Early Treatment||9
395990|NCT00203268|968984|P1|STARTED|Early Treatment||13
395991|NCT00203242|968990|P1|NOT COMPLETED|Overall Study||1
395992|NCT00203242|968990|P1|COMPLETED|Overall Study||14
395993|NCT00203242|968990|P1|STARTED|Overall Study||15
395994|NCT00203229|968996|P2|NOT COMPLETED|Overall Study||3
395995|NCT00203229|968997|P1|NOT COMPLETED|Overall Study||3
395996|NCT00203229|968996|P2|COMPLETED|Overall Study||7
395997|NCT00203229|968997|P1|COMPLETED|Overall Study||7
395998|NCT00203229|968996|P2|STARTED|Overall Study||10
395999|NCT00203229|968997|P1|STARTED|Overall Study||10
396000|NCT00203216|969003|P1|NOT COMPLETED|Overall Study||4
396001|NCT00203216|969003|P1|COMPLETED|Overall Study||27
396002|NCT00203216|969003|P1|STARTED|Overall Study||31
396003|NCT00203203|969009|P2|NOT COMPLETED|Overall Study||0
396004|NCT00203203|969010|P1|NOT COMPLETED|Overall Study||1
396005|NCT00203203|969009|P2|COMPLETED|Overall Study||20
396006|NCT00203203|969010|P1|COMPLETED|Overall Study||9
396007|NCT00203203|969009|P2|STARTED|Overall Study||20
396008|NCT00203203|969010|P1|STARTED|Overall Study||10
396009|NCT00203047|969042|P2|NOT COMPLETED|Overall Study||203
396010|NCT00203047|969043|P1|NOT COMPLETED|Overall Study||191
396011|NCT00203047|969042|P2|COMPLETED|Overall Study||7
396012|NCT00203047|969043|P1|COMPLETED|Overall Study||13
396013|NCT00203047|969042|P2|In Database as of January 29, 2009|Overall Study||209
396014|NCT00203047|969043|P1|In Database as of January 29, 2009|Overall Study||199
396015|NCT00203047|969042|P2|STARTED|Overall Study||210
396016|NCT00203047|969043|P1|STARTED|Overall Study||204
396017|NCT00203021|969057|P2|NOT COMPLETED|Overall Study||77
396018|NCT00203021|969058|P1|NOT COMPLETED|Overall Study||79
396019|NCT00203021|969057|P2|COMPLETED|Overall Study||24
396020|NCT00203021|969058|P1|COMPLETED|Overall Study||28
396021|NCT00203021|969057|P2|Received at Least 1 Dose of Study Drug|Overall Study||101
396022|NCT00203021|969058|P1|Received at Least 1 Dose of Study Drug|Overall Study||107
396023|NCT00203021|969057|P2|STARTED|Overall Study||101
396024|NCT00203021|969058|P1|STARTED|Overall Study||107
396025|NCT00202878|969068|P2|NOT COMPLETED|Overall Study||2217
396026|NCT00202878|969069|P1|NOT COMPLETED|Overall Study||2199
396027|NCT00202878|969068|P2|COMPLETED|Overall Study||6860
396028|NCT00202878|969069|P1|COMPLETED|Overall Study||6868
396029|NCT00202878|969068|P2|STARTED|Overall Study||9077
396030|NCT00202878|969069|P1|STARTED|Overall Study||9067
396031|NCT00202839|969083|P2|NOT COMPLETED|Overall Study||10
396032|NCT00202839|969084|P1|NOT COMPLETED|Overall Study||24
396033|NCT00202839|969083|P2|COMPLETED|Overall Study||72
396034|NCT00202839|969084|P1|COMPLETED|Overall Study||54
396035|NCT00202839|969083|P2|STARTED|Overall Study||82
396036|NCT00202839|969084|P1|STARTED|Overall Study||78
396037|NCT00202722|969092|P1|NOT COMPLETED|Overall Study||0
396038|NCT00202722|969092|P1|COMPLETED|Overall Study||41
396039|NCT00202722|969092|P1|STARTED|Overall Study||41
396040|NCT00202644|969099|P2|NOT COMPLETED|Overall Study||27
396041|NCT00202644|969100|P1|NOT COMPLETED|Overall Study||35
396042|NCT00202644|969099|P2|COMPLETED|Overall Study||43
396043|NCT00202644|969100|P1|COMPLETED|Overall Study||41
396044|NCT00202644|969099|P2|STARTED|Overall Study||70
396045|NCT00202644|969100|P1|STARTED|Overall Study|One participant not randomized but treated.|76
396046|NCT00202449|969127|P3|NOT COMPLETED|Overall Study||12
396047|NCT00202449|969128|P2|NOT COMPLETED|Overall Study||11
396048|NCT00202449|969129|P1|NOT COMPLETED|Overall Study||11
396049|NCT00202449|969127|P3|COMPLETED|Overall Study||9
396050|NCT00202449|969128|P2|COMPLETED|Overall Study||9
396051|NCT00202449|969129|P1|COMPLETED|Overall Study||7
396052|NCT00202449|969127|P3|STARTED|Overall Study||21
396053|NCT00202449|969128|P2|STARTED|Overall Study||20
396054|NCT00202449|969129|P1|STARTED|Overall Study||18
396055|NCT00201877|969143|P1|NOT COMPLETED|Overall Study||0
396056|NCT00201877|969143|P1|COMPLETED|Overall Study||25
396057|NCT00201877|969143|P1|STARTED|Overall Study||25
396058|NCT00201864|969150|P1|NOT COMPLETED|Overall Study||0
396059|NCT00201864|969150|P1|COMPLETED|Overall Study||40
396060|NCT00201864|969150|P1|STARTED|Overall Study||40
396061|NCT00201851|969161|P3|NOT COMPLETED|Overall Study||1
396062|NCT00201851|969162|P2|NOT COMPLETED|Overall Study||2
396063|NCT00201851|969163|P1|NOT COMPLETED|Overall Study||8
396064|NCT00201851|969161|P3|COMPLETED|Overall Study||230
396065|NCT00201851|969162|P2|COMPLETED|Overall Study||255
396066|NCT00201851|969163|P1|COMPLETED|Overall Study||244
396067|NCT00201851|969161|P3|STARTED|Overall Study||231
396068|NCT00201851|969162|P2|STARTED|Overall Study||257
396069|NCT00201851|969163|P1|STARTED|Overall Study||252
396070|NCT00201838|969173|P2|NOT COMPLETED|Overall Study||0
396071|NCT00201838|969174|P1|NOT COMPLETED|Overall Study||0
396072|NCT00201838|969173|P2|COMPLETED|Overall Study||8
396073|NCT00201838|969174|P1|COMPLETED|Overall Study||30
396074|NCT00201838|969173|P2|Treatment Cohort|Overall Study||8
396075|NCT00201838|969174|P1|Treatment Cohort|Overall Study||30
396076|NCT00201838|969173|P2|STARTED|Overall Study||8
396077|NCT00201838|969174|P1|STARTED|Overall Study||30
396078|NCT00201825|969188|P1|NOT COMPLETED|Overall Study||0
396079|NCT00201825|969188|P1|COMPLETED|Overall Study||29
396080|NCT00201825|969188|P1|STARTED|Overall Study||29
396081|NCT00201773|969195|P1|NOT COMPLETED|Overall Study||6
396082|NCT00201773|969195|P1|COMPLETED|Overall Study||16
396083|NCT00201773|969195|P1|Stopped Exemestane After 4 Weeks|Overall Study||1
396084|NCT00201773|969195|P1|Received All Exemestane Therapy|Overall Study||5
396085|NCT00201773|969195|P1|Completed 8 Weeks of Planned Therapy|Overall Study||16
396086|NCT00201773|969195|P1|STARTED|Overall Study||22
396087|NCT00201760|969204|P2|NOT COMPLETED|Overall Study||0
396088|NCT00201760|969205|P1|NOT COMPLETED|Overall Study||0
396089|NCT00201760|969204|P2|COMPLETED|Overall Study||5
396090|NCT00201760|969205|P1|COMPLETED|Overall Study||5
396091|NCT00201760|969204|P2|STARTED|Overall Study||5
396092|NCT00201760|969205|P1|STARTED|Overall Study||5
396093|NCT00201734|969217|P2|NOT COMPLETED|Overall Study||0
396094|NCT00201734|969218|P1|NOT COMPLETED|Overall Study||3
396095|NCT00201734|969217|P2|COMPLETED|Overall Study||25
396096|NCT00201734|969218|P1|COMPLETED|Overall Study||29
396097|NCT00201734|969217|P2|Patients Not Evaluable|Overall Study||0
396098|NCT00201734|969218|P1|Patients Not Evaluable|Overall Study||3
396099|NCT00201734|969217|P2|STARTED|Overall Study||25
396100|NCT00201734|969218|P1|STARTED|Overall Study||32
396101|NCT00201643|969235|P2|NOT COMPLETED|Overall Study||4
396102|NCT00201643|969236|P1|NOT COMPLETED|Overall Study||5
396103|NCT00201643|969235|P2|COMPLETED|Overall Study||210
396104|NCT00201643|969236|P1|COMPLETED|Overall Study||218
396105|NCT00201643|969235|P2|STARTED|Overall Study||214
396106|NCT00201643|969236|P1|STARTED|Overall Study||223
396107|NCT00201448|969260|P2|NOT COMPLETED|Overall Study||0
396108|NCT00201448|969261|P1|NOT COMPLETED|Overall Study||0
396109|NCT00201448|969260|P2|COMPLETED|Overall Study||40
396110|NCT00201448|969261|P1|COMPLETED|Overall Study||42
396111|NCT00201448|969260|P2|STARTED|Overall Study||40
396112|NCT00201448|969261|P1|STARTED|Overall Study||42
396113|NCT00201409|969271|P2|NOT COMPLETED|Overall Study||1
396114|NCT00201409|969272|P1|NOT COMPLETED|Overall Study||1
396115|NCT00201409|969271|P2|COMPLETED|Overall Study||66
396116|NCT00201409|969272|P1|COMPLETED|Overall Study||64
396117|NCT00201409|969271|P2|STARTED|Overall Study||67
396118|NCT00201409|969272|P1|STARTED|Overall Study||65
396119|NCT00201240|969282|P1|NOT COMPLETED|Overall Study||3
396120|NCT00201240|969282|P1|COMPLETED|Overall Study||44
396121|NCT00201240|969282|P1|STARTED|Overall Study||47
396122|NCT00201201|969300|P2|NOT COMPLETED|Overall Study||7
396123|NCT00201201|969301|P1|NOT COMPLETED|Overall Study||5
396124|NCT00201201|969300|P2|COMPLETED|Overall Study||66
396125|NCT00201201|969301|P1|COMPLETED|Overall Study||82
396126|NCT00201201|969300|P2|STARTED|Overall Study||73
396127|NCT00201201|969301|P1|STARTED|Overall Study||87
396128|NCT00201123|969320|P3|NOT COMPLETED|Overall Study||9
396129|NCT00201123|969321|P2|NOT COMPLETED|Overall Study||4
396130|NCT00201123|969322|P1|NOT COMPLETED|Overall Study||6
396131|NCT00201123|969320|P3|COMPLETED|Overall Study||23
396132|NCT00201123|969321|P2|COMPLETED|Overall Study||28
396133|NCT00201123|969322|P1|COMPLETED|Overall Study||26
396134|NCT00201123|969320|P3|Did Not Meet Continuation Criteria|Overall Study||5
396135|NCT00201123|969321|P2|Did Not Meet Continuation Criteria|Overall Study||0
396136|NCT00201123|969322|P1|Did Not Meet Continuation Criteria|Overall Study||2
396137|NCT00201123|969320|P3|STARTED|Overall Study||32
396138|NCT00201123|969321|P2|STARTED|Overall Study||32
396139|NCT00201123|969322|P1|STARTED|Overall Study||32
396140|NCT00201006|969339|P3|NOT COMPLETED|Overall Study||4
396141|NCT00201006|969340|P2|NOT COMPLETED|Overall Study||2
396142|NCT00201006|969341|P1|NOT COMPLETED|Overall Study||8
396143|NCT00201006|969339|P3|COMPLETED|Overall Study||75
396144|NCT00201006|969340|P2|COMPLETED|Overall Study||70
396145|NCT00201006|969341|P1|COMPLETED|Overall Study||75
396146|NCT00201006|969339|P3|STARTED|Overall Study||79
396147|NCT00201006|969340|P2|STARTED|Overall Study||72
396148|NCT00201006|969341|P1|STARTED|Overall Study||83
396149|NCT00200967|969351|P2|NOT COMPLETED|Run-out Period||0
396150|NCT00200967|969352|P1|NOT COMPLETED|Run-out Period||1
396151|NCT00200967|969351|P2|COMPLETED|Run-out Period||41
396152|NCT00200967|969352|P1|COMPLETED|Run-out Period||34
396153|NCT00200967|969351|P2|STARTED|Run-out Period||41
396154|NCT00200967|969352|P1|STARTED|Run-out Period||35
396155|NCT00200967|969351|P2|NOT COMPLETED|Second Treatment Period||2
396156|NCT00200967|969352|P1|NOT COMPLETED|Second Treatment Period||1
396157|NCT00200967|969351|P2|COMPLETED|Second Treatment Period||41
396158|NCT00200967|969352|P1|COMPLETED|Second Treatment Period||35
396159|NCT00200967|969351|P2|STARTED|Second Treatment Period||43
396160|NCT00200967|969352|P1|STARTED|Second Treatment Period||36
396161|NCT00200967|969351|P2|NOT COMPLETED|Wash-out Period||1
396162|NCT00200967|969352|P1|NOT COMPLETED|Wash-out Period||0
396163|NCT00200967|969351|P2|COMPLETED|Wash-out Period||43
396164|NCT00200967|969352|P1|COMPLETED|Wash-out Period||36
396165|NCT00200967|969351|P2|STARTED|Wash-out Period||44
396166|NCT00200967|969352|P1|STARTED|Wash-out Period||36
396167|NCT00200967|969351|P2|NOT COMPLETED|First Treatment Period||1
396168|NCT00200967|969352|P1|NOT COMPLETED|First Treatment Period||6
396169|NCT00200967|969351|P2|COMPLETED|First Treatment Period||44
396170|NCT00200967|969352|P1|COMPLETED|First Treatment Period||36
396171|NCT00200967|969351|P2|First Treatment Period|First Treatment Period||45
396172|NCT00200967|969352|P1|First Treatment Period|First Treatment Period||42
396173|NCT00200967|969351|P2|STARTED|First Treatment Period||45
396174|NCT00200967|969352|P1|STARTED|First Treatment Period||42
396175|NCT00200902|969383|P3|NOT COMPLETED|Overall Study||8
396176|NCT00200902|969384|P2|NOT COMPLETED|Overall Study||3
396177|NCT00200902|969385|P1|NOT COMPLETED|Overall Study||10
396178|NCT00200902|969383|P3|COMPLETED|Overall Study||12
396179|NCT00200902|969384|P2|COMPLETED|Overall Study||26
396180|NCT00200902|969385|P1|COMPLETED|Overall Study||29
396181|NCT00200902|969383|P3|STARTED|Overall Study||20
396182|NCT00200902|969384|P2|STARTED|Overall Study||29
396183|NCT00200902|969385|P1|STARTED|Overall Study||39
396184|NCT00200850|969402|P3|NOT COMPLETED|Overall Study||6
396185|NCT00200850|969403|P2|NOT COMPLETED|Overall Study||1
396186|NCT00200850|969404|P1|NOT COMPLETED|Overall Study||3
396187|NCT00200850|969402|P3|COMPLETED|Overall Study||5
396188|NCT00200850|969403|P2|COMPLETED|Overall Study||9
396189|NCT00200850|969404|P1|COMPLETED|Overall Study||7
396190|NCT00200850|969402|P3|STARTED|Overall Study||11
396191|NCT00200850|969403|P2|STARTED|Overall Study||10
396192|NCT00200850|969404|P1|STARTED|Overall Study||10
396193|NCT00200785|969414|P2|NOT COMPLETED|Second Intervention||0
396194|NCT00200785|969415|P1|NOT COMPLETED|Second Intervention||0
396195|NCT00200785|969414|P2|COMPLETED|Second Intervention||6
396196|NCT00200785|969415|P1|COMPLETED|Second Intervention||9
396197|NCT00200785|969414|P2|STARTED|Second Intervention||6
396198|NCT00200785|969415|P1|STARTED|Second Intervention||9
396199|NCT00200785|969414|P2|NOT COMPLETED|Washout Period of 1 Week||0
396200|NCT00200785|969415|P1|NOT COMPLETED|Washout Period of 1 Week||0
396201|NCT00200785|969414|P2|COMPLETED|Washout Period of 1 Week||6
396202|NCT00200785|969415|P1|COMPLETED|Washout Period of 1 Week||9
396203|NCT00200785|969414|P2|STARTED|Washout Period of 1 Week||6
396204|NCT00200785|969415|P1|STARTED|Washout Period of 1 Week||9
396205|NCT00200785|969414|P2|NOT COMPLETED|First Intervention||0
396206|NCT00200785|969415|P1|NOT COMPLETED|First Intervention||0
396207|NCT00200785|969414|P2|COMPLETED|First Intervention||6
396208|NCT00200785|969415|P1|COMPLETED|First Intervention||9
396209|NCT00200785|969414|P2|STARTED|First Intervention||6
396210|NCT00200785|969415|P1|STARTED|First Intervention||9
396211|NCT00200356|969425|P2|NOT COMPLETED|Overall Study||7
396212|NCT00200356|969426|P1|NOT COMPLETED|Overall Study||8
396213|NCT00200356|969425|P2|COMPLETED|Overall Study||195
396214|NCT00200356|969426|P1|COMPLETED|Overall Study||191
396215|NCT00200356|969425|P2|Safety Analysis Set|Overall Study||198
396216|NCT00200356|969426|P1|Safety Analysis Set|Overall Study||194
396217|NCT00200356|969425|P2|STARTED|Overall Study||202
396218|NCT00200356|969426|P1|STARTED|Overall Study||199
396219|NCT00200343|969453|P3|NOT COMPLETED|Overall Study||13
396220|NCT00200343|969454|P2|NOT COMPLETED|Overall Study||8
396221|NCT00200343|969455|P1|NOT COMPLETED|Overall Study||16
396222|NCT00200343|969453|P3|COMPLETED|Overall Study||184
396223|NCT00200343|969454|P2|COMPLETED|Overall Study||192
396224|NCT00200343|969455|P1|COMPLETED|Overall Study||183
396225|NCT00200343|969453|P3|STARTED|Overall Study||197
396226|NCT00200343|969454|P2|STARTED|Overall Study||200
396227|NCT00200343|969455|P1|STARTED|Overall Study||199
396228|NCT00200161|969480|P2|NOT COMPLETED|Overall Study||0
396229|NCT00200161|969481|P1|NOT COMPLETED|Overall Study||0
396230|NCT00200161|969480|P2|COMPLETED|Overall Study||42
396231|NCT00200161|969481|P1|COMPLETED|Overall Study||43
396232|NCT00200161|969480|P2|STARTED|Overall Study||42
396233|NCT00200161|969481|P1|STARTED|Overall Study||43
396234|NCT00200057|969493|P1|NOT COMPLETED|Overall Study||9
396235|NCT00200057|969493|P1|COMPLETED|Overall Study||111
396236|NCT00200057|969493|P1|12 Month Follow-up|Overall Study||111
396237|NCT00200057|969493|P1|6 Month Follow-up|Overall Study||114
396238|NCT00200057|969493|P1|3 Month Follow-up|Overall Study||116
396239|NCT00200057|969493|P1|1 Month Follow-up|Overall Study||117
396240|NCT00200057|969493|P1|STARTED|Overall Study||120
396241|NCT00199914|969505|P2|NOT COMPLETED|Overall Study||6
396242|NCT00199914|969506|P1|NOT COMPLETED|Overall Study||3
396243|NCT00199914|969505|P2|COMPLETED|Overall Study||54
396244|NCT00199914|969506|P1|COMPLETED|Overall Study||50
396245|NCT00199914|969505|P2|STARTED|Overall Study||60
396246|NCT00199914|969506|P1|STARTED|Overall Study||53
396247|NCT00199875|969517|P5|NOT COMPLETED|Overall Study||1
396248|NCT00199875|969518|P4|NOT COMPLETED|Overall Study||0
396249|NCT00199875|969519|P3|NOT COMPLETED|Overall Study||0
396250|NCT00199875|969520|P2|NOT COMPLETED|Overall Study||0
396251|NCT00199875|969521|P1|NOT COMPLETED|Overall Study||0
396252|NCT00199875|969517|P5|COMPLETED|Overall Study||2
396253|NCT00199875|969518|P4|COMPLETED|Overall Study||3
396254|NCT00199875|969519|P3|COMPLETED|Overall Study||6
396255|NCT00199875|969520|P2|COMPLETED|Overall Study||3
396256|NCT00199875|969521|P1|COMPLETED|Overall Study||3
396257|NCT00199875|969517|P5|STARTED|Overall Study||3
396258|NCT00199875|969518|P4|STARTED|Overall Study||3
396259|NCT00199875|969519|P3|STARTED|Overall Study||6
396260|NCT00199875|969520|P2|STARTED|Overall Study||3
396261|NCT00199875|969521|P1|STARTED|Overall Study||3
396262|NCT00199381|969543|P1|NOT COMPLETED|Overall Study||504
396263|NCT00199381|969543|P1|COMPLETED|Overall Study|Premature study termination by the Sponsor.|0
396264|NCT00199381|969543|P1|STARTED|Overall Study||504
396265|NCT00198822|969550|P3|NOT COMPLETED|Overall Study||21
396266|NCT00198822|969551|P2|NOT COMPLETED|Overall Study||20
396267|NCT00198822|969552|P1|NOT COMPLETED|Overall Study||14
396268|NCT00198822|969550|P3|COMPLETED|Overall Study|No. of consented pregnant women in beta-catorene arm with vital status known at 12 weeks postpartum|19998
396269|NCT00198822|969551|P2|COMPLETED|Overall Study|No. of consented pregnant women in vitamin A arm with vital status known at 12 weeks postpartum|19806
396270|NCT00198822|969552|P1|COMPLETED|Overall Study|No. of consented pregnant women in placebo arm with vital status known at 12 weeks postpartum|19862
396271|NCT00198822|969550|P3|STARTED|Overall Study|No. of consenting pregnant women in the beta-catorene arm of trial cohort|20019
396272|NCT00198822|969551|P2|STARTED|Overall Study|No. of consenting pregnant women in the vitamin A arm of trial cohort|19826
396273|NCT00198822|969552|P1|STARTED|Overall Study|No. of consenting pregnant women in the placebo arm of trial cohort|19876
396274|NCT00198133|969571|P2|NOT COMPLETED|Overall Study||8
396275|NCT00198133|969572|P1|NOT COMPLETED|Overall Study||5
396276|NCT00198133|969571|P2|COMPLETED|Overall Study||3
396277|NCT00198133|969572|P1|COMPLETED|Overall Study||11
396278|NCT00198133|969571|P2|STARTED|Overall Study||11
396279|NCT00198133|969572|P1|STARTED|Overall Study||16
396280|NCT00198107|969584|P3|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||2
396281|NCT00198107|969585|P2|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
396282|NCT00198107|969586|P1|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
396283|NCT00198107|969584|P3|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||8
396284|NCT00198107|969585|P2|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
396285|NCT00198107|969586|P1|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
396286|NCT00198107|969584|P3|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||10
396287|NCT00198107|969585|P2|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||0
396288|NCT00198107|969586|P1|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||0
396289|NCT00198107|969584|P3|NOT COMPLETED|Double-Blind Period||0
396290|NCT00198107|969585|P2|NOT COMPLETED|Double-Blind Period||3
396291|NCT00198107|969586|P1|NOT COMPLETED|Double-Blind Period||6
396292|NCT00198107|969584|P3|COMPLETED|Double-Blind Period||0
396293|NCT00198107|969585|P2|COMPLETED|Double-Blind Period||37
396294|NCT00198107|969586|P1|COMPLETED|Double-Blind Period||35
396295|NCT00198107|969584|P3|1 or More Follow-up Visits|Double-Blind Period||0
396296|NCT00198107|969585|P2|1 or More Follow-up Visits|Double-Blind Period||38
396297|NCT00198107|969586|P1|1 or More Follow-up Visits|Double-Blind Period||40
396298|NCT00198107|969584|P3|STARTED|Double-Blind Period||0
396299|NCT00198107|969585|P2|STARTED|Double-Blind Period||40
396300|NCT00198107|969586|P1|STARTED|Double-Blind Period||41
396301|NCT00198081|969623|P2|NOT COMPLETED|Overall Study||0
396302|NCT00198081|969624|P1|NOT COMPLETED|Overall Study||1
396303|NCT00198081|969623|P2|COMPLETED|Overall Study|No enrollment on this arm.|0
396304|NCT00198081|969624|P1|COMPLETED|Overall Study||4
396305|NCT00198081|969623|P2|STARTED|Overall Study|No enrollment on this arm.|0
396306|NCT00198081|969624|P1|STARTED|Overall Study|Eight (8) persons consented to participate but 3 withdrew prior to beginning protocol treatment.|5
396307|NCT00198042|969650|P1|NOT COMPLETED|Overall Study||0
396308|NCT00198042|969650|P1|COMPLETED|Overall Study||18
396309|NCT00198042|969650|P1|STARTED|Overall Study||18
396310|NCT00198029|969654|P1|NOT COMPLETED|Overall Study||4
396311|NCT00198029|969654|P1|COMPLETED|Overall Study||28
396312|NCT00198029|969654|P1|STARTED|Overall Study||32
396313|NCT00197496|969661|P2|NOT COMPLETED|Follow-up||1
396314|NCT00197496|969662|P1|NOT COMPLETED|Follow-up||2
396315|NCT00197496|969661|P2|COMPLETED|Follow-up||4
396316|NCT00197496|969662|P1|COMPLETED|Follow-up||10
396317|NCT00197496|969661|P2|STARTED|Follow-up||5
396318|NCT00197496|969662|P1|STARTED|Follow-up||12
396319|NCT00197496|969661|P2|NOT COMPLETED|Baseline to Discharge||2
396320|NCT00197496|969662|P1|NOT COMPLETED|Baseline to Discharge||2
396321|NCT00197496|969661|P2|COMPLETED|Baseline to Discharge||5
396322|NCT00197496|969662|P1|COMPLETED|Baseline to Discharge||12
396323|NCT00197496|969661|P2|STARTED|Baseline to Discharge||7
396324|NCT00197496|969662|P1|STARTED|Baseline to Discharge||14
396325|NCT00197392|969677|P2|NOT COMPLETED|Overall Study||86
396326|NCT00197392|969678|P1|NOT COMPLETED|Overall Study||88
396327|NCT00197392|969677|P2|COMPLETED|Overall Study||134
396328|NCT00197392|969678|P1|COMPLETED|Overall Study||126
396329|NCT00197392|969677|P2|Per Protocol|Overall Study||134
396330|NCT00197392|969678|P1|Per Protocol|Overall Study||126
396331|NCT00197392|969677|P2|Evaluable|Overall Study||181
396332|NCT00197392|969678|P1|Evaluable|Overall Study||176
396333|NCT00197392|969677|P2|Modified Intent to Treat|Overall Study||210
396334|NCT00197392|969678|P1|Modified Intent to Treat|Overall Study||209
396335|NCT00197392|969677|P2|Safety Population|Overall Study||220
396336|NCT00197392|969678|P1|Safety Population|Overall Study||214
396337|NCT00197392|969677|P2|STARTED|Overall Study||220
396338|NCT00197392|969678|P1|STARTED|Overall Study||214
396339|NCT00197236|969710|P3|NOT COMPLETED|Overall Study||23
396340|NCT00197236|969711|P2|NOT COMPLETED|Overall Study||17
396341|NCT00197236|969712|P1|NOT COMPLETED|Overall Study||14
396342|NCT00197236|969710|P3|COMPLETED|Overall Study||109
396343|NCT00197236|969711|P2|COMPLETED|Overall Study||110
396344|NCT00197236|969712|P1|COMPLETED|Overall Study||121
396345|NCT00197236|969710|P3|STARTED|Overall Study||132
396346|NCT00197236|969711|P2|STARTED|Overall Study||127
396347|NCT00197236|969712|P1|STARTED|Overall Study||135
396348|NCT00197184|969761|P2|NOT COMPLETED|Overall Study||0
396349|NCT00197184|969762|P1|NOT COMPLETED|Overall Study||0
396350|NCT00197184|969761|P2|COMPLETED|Overall Study||137
396351|NCT00197184|969762|P1|COMPLETED|Overall Study||139
396352|NCT00197184|969761|P2|STARTED|Overall Study||137
396353|NCT00197184|969762|P1|STARTED|Overall Study||139
396354|NCT00197145|969786|P2|NOT COMPLETED|Period 2 : Open Label Phase||0
396355|NCT00197145|969787|P1|NOT COMPLETED|Period 2 : Open Label Phase||10
396356|NCT00197145|969786|P2|COMPLETED|Period 2 : Open Label Phase||0
396357|NCT00197145|969787|P1|COMPLETED|Period 2 : Open Label Phase||0
396358|NCT00197145|969786|P2|STARTED|Period 2 : Open Label Phase||0
396359|NCT00197145|969787|P1|STARTED|Period 2 : Open Label Phase||10
396360|NCT00197145|969786|P2|NOT COMPLETED|Period 1: Randomized Treatment Phase||11
396361|NCT00197145|969787|P1|NOT COMPLETED|Period 1: Randomized Treatment Phase||13
396362|NCT00197145|969786|P2|COMPLETED|Period 1: Randomized Treatment Phase||0
396363|NCT00197145|969787|P1|COMPLETED|Period 1: Randomized Treatment Phase||0
396364|NCT00197145|969786|P2|STARTED|Period 1: Randomized Treatment Phase||11
396365|NCT00197145|969787|P1|STARTED|Period 1: Randomized Treatment Phase||13
396366|NCT00197119|969845|P2|NOT COMPLETED|Year 10||0
396367|NCT00197119|969846|P1|NOT COMPLETED|Year 10||0
396368|NCT00197119|969845|P2|COMPLETED|Year 10||108
396369|NCT00197119|969846|P1|COMPLETED|Year 10||120
396370|NCT00197119|969845|P2|STARTED|Year 10|Six subjects participating in the Year 9 time point did not return for the current time point.|108
396371|NCT00197119|969846|P1|STARTED|Year 10|One subject participating in the Year 9 time point did not return for the current time point.|120
396372|NCT00197119|969845|P2|NOT COMPLETED|Year 9||0
396373|NCT00197119|969846|P1|NOT COMPLETED|Year 9||0
396374|NCT00197119|969845|P2|COMPLETED|Year 9||114
396375|NCT00197119|969846|P1|COMPLETED|Year 9||121
396376|NCT00197119|969845|P2|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|114
396377|NCT00197119|969846|P1|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|121
396378|NCT00197119|969845|P2|NOT COMPLETED|Year 8||0
396379|NCT00197119|969846|P1|NOT COMPLETED|Year 8||0
396380|NCT00197119|969845|P2|COMPLETED|Year 8||115
396381|NCT00197119|969846|P1|COMPLETED|Year 8||122
396382|NCT00197119|969845|P2|STARTED|Year 8|One additional subject (compared to Year 7) participated in the current follow-up time point.|115
396383|NCT00197119|969846|P1|STARTED|Year 8||122
396384|NCT00197119|969845|P2|NOT COMPLETED|Year 7||0
396385|NCT00197119|969846|P1|NOT COMPLETED|Year 7||0
396386|NCT00197119|969845|P2|COMPLETED|Year 7||114
396387|NCT00197119|969846|P1|COMPLETED|Year 7||122
396388|NCT00197119|969845|P2|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|114
396389|NCT00197119|969846|P1|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|122
396390|NCT00197119|969845|P2|NOT COMPLETED|Year 6||0
396391|NCT00197119|969846|P1|NOT COMPLETED|Year 6||0
396392|NCT00197119|969845|P2|COMPLETED|Year 6||118
396393|NCT00197119|969846|P1|COMPLETED|Year 6||126
396394|NCT00197119|969845|P2|STARTED|Year 6||118
396395|NCT00197119|969846|P1|STARTED|Year 6||126
396396|NCT00197106|969858|P3|NOT COMPLETED|Overall Treatment Period||6
396397|NCT00197106|969859|P2|NOT COMPLETED|Overall Treatment Period||1
396398|NCT00197106|969860|P1|NOT COMPLETED|Overall Treatment Period||0
396399|NCT00197106|969858|P3|COMPLETED|Overall Treatment Period||74
396400|NCT00197106|969859|P2|COMPLETED|Overall Treatment Period||77
396401|NCT00197106|969860|P1|COMPLETED|Overall Treatment Period||0
396402|NCT00197106|969858|P3|STARTED|Overall Treatment Period||80
396403|NCT00197106|969859|P2|STARTED|Overall Treatment Period||78
396404|NCT00197106|969860|P1|STARTED|Overall Treatment Period||0
396405|NCT00197106|969858|P3|NOT COMPLETED|4-Week Run-In Period||0
396406|NCT00197106|969859|P2|NOT COMPLETED|4-Week Run-In Period||0
396407|NCT00197106|969860|P1|NOT COMPLETED|4-Week Run-In Period||99
396408|NCT00197106|969858|P3|COMPLETED|4-Week Run-In Period||0
396409|NCT00197106|969859|P2|COMPLETED|4-Week Run-In Period||0
396410|NCT00197106|969860|P1|COMPLETED|4-Week Run-In Period||158
396411|NCT00197106|969858|P3|STARTED|4-Week Run-In Period||0
396412|NCT00197106|969859|P2|STARTED|4-Week Run-In Period||0
396413|NCT00197106|969860|P1|STARTED|4-Week Run-In Period||257
396414|NCT00197028|969896|P2|NOT COMPLETED|Overall Study||21
396415|NCT00197028|969897|P1|NOT COMPLETED|Overall Study||16
396416|NCT00197028|969896|P2|COMPLETED|Overall Study||86
396417|NCT00197028|969897|P1|COMPLETED|Overall Study||91
396418|NCT00197028|969896|P2|STARTED|Overall Study||107
396419|NCT00197028|969897|P1|STARTED|Overall Study||107
396420|NCT00197015|969940|P3|NOT COMPLETED|Overall Study||77
396421|NCT00197015|969941|P2|NOT COMPLETED|Overall Study||89
396422|NCT00197015|969942|P1|NOT COMPLETED|Overall Study||50
396423|NCT00197015|969940|P3|COMPLETED|Overall Study||385
396424|NCT00197015|969941|P2|COMPLETED|Overall Study||366
396425|NCT00197015|969942|P1|COMPLETED|Overall Study||274
396426|NCT00197015|969940|P3|STARTED|Overall Study||462
396427|NCT00197015|969941|P2|STARTED|Overall Study||455
396428|NCT00197015|969942|P1|STARTED|Overall Study||324
396429|NCT00197002|970001|P3|NOT COMPLETED|Overall Study||17
396430|NCT00197002|970002|P2|NOT COMPLETED|Overall Study||18
396431|NCT00197002|970003|P1|NOT COMPLETED|Overall Study||22
396432|NCT00197002|970001|P3|COMPLETED|Overall Study||132
396433|NCT00197002|970002|P2|COMPLETED|Overall Study||119
396434|NCT00197002|970003|P1|COMPLETED|Overall Study||125
396435|NCT00197002|970001|P3|STARTED|Overall Study||149
396436|NCT00197002|970002|P2|STARTED|Overall Study||137
396437|NCT00197002|970003|P1|STARTED|Overall Study||147
396438|NCT00196976|970054|P14|NOT COMPLETED|Booster Study||0
396439|NCT00196976|970055|P13|NOT COMPLETED|Booster Study||0
396440|NCT00196976|970056|P12|NOT COMPLETED|Booster Study||2
396441|NCT00196976|970057|P11|NOT COMPLETED|Booster Study||2
396442|NCT00196976|970058|P10|NOT COMPLETED|Booster Study||0
396443|NCT00196976|970059|P9|NOT COMPLETED|Booster Study||0
396444|NCT00196976|970060|P8|NOT COMPLETED|Booster Study||0
396445|NCT00196976|970061|P7|NOT COMPLETED|Booster Study||0
396446|NCT00196976|970062|P6|NOT COMPLETED|Booster Study||0
396447|NCT00196976|970063|P5|NOT COMPLETED|Booster Study||0
396448|NCT00196976|970064|P4|NOT COMPLETED|Booster Study||0
396449|NCT00196976|970065|P3|NOT COMPLETED|Booster Study||0
396450|NCT00196976|970066|P2|NOT COMPLETED|Booster Study||0
396451|NCT00196976|970067|P1|NOT COMPLETED|Booster Study||0
396452|NCT00196976|970054|P14|COMPLETED|Booster Study||43
396453|NCT00196976|970055|P13|COMPLETED|Booster Study||45
396454|NCT00196976|970056|P12|COMPLETED|Booster Study||30
396455|NCT00196976|970057|P11|COMPLETED|Booster Study||31
396456|NCT00196976|970058|P10|COMPLETED|Booster Study||0
396457|NCT00196976|970059|P9|COMPLETED|Booster Study||0
396458|NCT00196976|970060|P8|COMPLETED|Booster Study||0
396459|NCT00196976|970061|P7|COMPLETED|Booster Study||0
396460|NCT00196976|970062|P6|COMPLETED|Booster Study||0
396461|NCT00196976|970063|P5|COMPLETED|Booster Study||0
396462|NCT00196976|970064|P4|COMPLETED|Booster Study||0
396463|NCT00196976|970065|P3|COMPLETED|Booster Study||0
396464|NCT00196976|970066|P2|COMPLETED|Booster Study||0
396465|NCT00196976|970067|P1|COMPLETED|Booster Study||0
396466|NCT00196976|970054|P14|STARTED|Booster Study||43
396467|NCT00196976|970055|P13|STARTED|Booster Study||45
396468|NCT00196976|970056|P12|STARTED|Booster Study||32
396469|NCT00196976|970057|P11|STARTED|Booster Study||33
396470|NCT00196976|970058|P10|STARTED|Booster Study||0
396471|NCT00196976|970059|P9|STARTED|Booster Study||0
396472|NCT00196976|970060|P8|STARTED|Booster Study||0
396473|NCT00196976|970061|P7|STARTED|Booster Study||0
396474|NCT00196976|970062|P6|STARTED|Booster Study||0
396475|NCT00196976|970063|P5|STARTED|Booster Study||0
396476|NCT00196976|970064|P4|STARTED|Booster Study||0
396477|NCT00196976|970065|P3|STARTED|Booster Study||0
396478|NCT00196976|970066|P2|STARTED|Booster Study||0
396479|NCT00196976|970067|P1|STARTED|Booster Study||0
396480|NCT00196976|970054|P14|NOT COMPLETED|Primary Study||0
396481|NCT00196976|970055|P13|NOT COMPLETED|Primary Study||0
396482|NCT00196976|970056|P12|NOT COMPLETED|Primary Study||0
396483|NCT00196976|970057|P11|NOT COMPLETED|Primary Study||0
396484|NCT00196976|970058|P10|NOT COMPLETED|Primary Study||1
396485|NCT00196976|970059|P9|NOT COMPLETED|Primary Study||0
396486|NCT00196976|970060|P8|NOT COMPLETED|Primary Study||3
396487|NCT00196976|970061|P7|NOT COMPLETED|Primary Study||0
396488|NCT00196976|970062|P6|NOT COMPLETED|Primary Study||2
396489|NCT00196976|970063|P5|NOT COMPLETED|Primary Study||3
396490|NCT00196976|970064|P4|NOT COMPLETED|Primary Study||1
396491|NCT00196976|970065|P3|NOT COMPLETED|Primary Study||4
396492|NCT00196976|970066|P2|NOT COMPLETED|Primary Study||1
396493|NCT00196976|970067|P1|NOT COMPLETED|Primary Study||1
396494|NCT00196976|970054|P14|COMPLETED|Primary Study||0
396495|NCT00196976|970055|P13|COMPLETED|Primary Study||0
396496|NCT00196976|970056|P12|COMPLETED|Primary Study||0
396497|NCT00196976|970057|P11|COMPLETED|Primary Study||0
396498|NCT00196976|970058|P10|COMPLETED|Primary Study||51
396499|NCT00196976|970059|P9|COMPLETED|Primary Study||52
396500|NCT00196976|970060|P8|COMPLETED|Primary Study||49
396501|NCT00196976|970061|P7|COMPLETED|Primary Study||50
396502|NCT00196976|970062|P6|COMPLETED|Primary Study||52
396503|NCT00196976|970063|P5|COMPLETED|Primary Study||37
396504|NCT00196976|970064|P4|COMPLETED|Primary Study||39
396505|NCT00196976|970065|P3|COMPLETED|Primary Study||37
396506|NCT00196976|970066|P2|COMPLETED|Primary Study||40
396507|NCT00196976|970067|P1|COMPLETED|Primary Study||38
396508|NCT00196976|970054|P14|STARTED|Primary Study||0
396509|NCT00196976|970055|P13|STARTED|Primary Study||0
396510|NCT00196976|970056|P12|STARTED|Primary Study||0
396511|NCT00196976|970057|P11|STARTED|Primary Study||0
396512|NCT00196976|970058|P10|STARTED|Primary Study||52
396513|NCT00196976|970059|P9|STARTED|Primary Study||52
396514|NCT00196976|970060|P8|STARTED|Primary Study||52
396515|NCT00196976|970061|P7|STARTED|Primary Study||50
396516|NCT00196976|970062|P6|STARTED|Primary Study||54
396517|NCT00196976|970063|P5|STARTED|Primary Study||40
396518|NCT00196976|970064|P4|STARTED|Primary Study||40
396519|NCT00196976|970065|P3|STARTED|Primary Study||41
396520|NCT00196976|970066|P2|STARTED|Primary Study||41
396521|NCT00196976|970067|P1|STARTED|Primary Study||39
396522|NCT00196937|970263|P3|NOT COMPLETED|Overall Study||7
396523|NCT00196937|970264|P2|NOT COMPLETED|Overall Study||5
396524|NCT00196937|970265|P1|NOT COMPLETED|Overall Study||9
396525|NCT00196937|970263|P3|COMPLETED|Overall Study||204
396526|NCT00196937|970264|P2|COMPLETED|Overall Study||221
396527|NCT00196937|970265|P1|COMPLETED|Overall Study||220
396528|NCT00196937|970263|P3|STARTED|Overall Study||211
396529|NCT00196937|970264|P2|STARTED|Overall Study||226
396530|NCT00196937|970265|P1|STARTED|Overall Study||229
396531|NCT00196716|970303|P1|NOT COMPLETED|0.3 mg/kg Period||0
396532|NCT00196716|970303|P1|COMPLETED|0.3 mg/kg Period||21
396533|NCT00196716|970303|P1|STARTED|0.3 mg/kg Period||21
396534|NCT00196716|970303|P1|NOT COMPLETED|1.0 mg/kg Period||0
396535|NCT00196716|970303|P1|COMPLETED|1.0 mg/kg Period||21
396536|NCT00196716|970303|P1|STARTED|1.0 mg/kg Period||21
396537|NCT00196326|970313|P1|NOT COMPLETED|Overall Study||986
396538|NCT00196326|970313|P1|COMPLETED|Overall Study||1249
396539|NCT00196326|970313|P1|Pregnancy Intent-to-treat Cohort (PITT)|Overall Study|Completed one cycle and 18-35 years old|1735
396540|NCT00196326|970313|P1|Safety Population|Overall Study|Treated participants|2185
396541|NCT00196326|970313|P1|STARTED|Overall Study|Took at least one dose of study medication|2235
396542|NCT00196313|970321|P2|NOT COMPLETED|Overall Study||8
396543|NCT00196313|970322|P1|NOT COMPLETED|Overall Study||11
396544|NCT00196313|970321|P2|COMPLETED|Overall Study||40
396545|NCT00196313|970322|P1|COMPLETED|Overall Study||36
396546|NCT00196313|970321|P2|STARTED|Overall Study||48
396547|NCT00196313|970322|P1|STARTED|Overall Study||47
396548|NCT00196196|970336|P1|NOT COMPLETED|Overall Study||7
396549|NCT00196196|970336|P1|COMPLETED|Overall Study||267
396550|NCT00196196|970336|P1|STARTED|Overall Study||274
396551|NCT00196105|970344|P3|NOT COMPLETED|Overall Study||7
396552|NCT00196105|970345|P2|NOT COMPLETED|Overall Study||5
396553|NCT00196105|970346|P1|NOT COMPLETED|Overall Study||4
396554|NCT00196105|970344|P3|COMPLETED|Overall Study||82
396555|NCT00196105|970345|P2|COMPLETED|Overall Study||83
396556|NCT00196105|970346|P1|COMPLETED|Overall Study||60
396557|NCT00196105|970344|P3|STARTED|Overall Study||89
396558|NCT00196105|970345|P2|STARTED|Overall Study||88
396559|NCT00196105|970346|P1|STARTED|Overall Study||64
396560|NCT00195819|970366|P2|NOT COMPLETED|Open-label||20
396561|NCT00195819|970367|P1|NOT COMPLETED|Open-label||0
396562|NCT00195819|970366|P2|COMPLETED|Open-label||62
396563|NCT00195819|970367|P1|COMPLETED|Open-label||0
396564|NCT00195819|970366|P2|STARTED|Open-label||82
396565|NCT00195819|970367|P1|STARTED|Open-label||0
396566|NCT00195819|970366|P2|NOT COMPLETED|Double-Blind||0
396567|NCT00195819|970367|P1|NOT COMPLETED|Double-Blind||2
396568|NCT00195819|970366|P2|COMPLETED|Double-Blind||38
396569|NCT00195819|970367|P1|COMPLETED|Double-Blind||42
396570|NCT00195819|970366|P2|STARTED|Double-Blind||38
396571|NCT00195819|970367|P1|STARTED|Double-Blind||44
396572|NCT00195715|970417|P1|NOT COMPLETED|Overall Study||377
396573|NCT00195715|970417|P1|COMPLETED|Overall Study||400
396574|NCT00195715|970417|P1|STARTED|Overall Study||777
396575|NCT00195702|970448|P6|NOT COMPLETED|Open-label Extension Phase||78
396576|NCT00195702|970449|P5|NOT COMPLETED|Open-label Extension Phase||78
396577|NCT00195702|970450|P4|NOT COMPLETED|Open-label Extension Phase||99
396578|NCT00195702|970451|P3|NOT COMPLETED|Open-label Extension Phase||0
396579|NCT00195702|970452|P2|NOT COMPLETED|Open-label Extension Phase||0
396580|NCT00195702|970453|P1|NOT COMPLETED|Open-label Extension Phase||0
396581|NCT00195702|970448|P6|COMPLETED|Open-label Extension Phase||56
396582|NCT00195702|970449|P5|COMPLETED|Open-label Extension Phase||80
396583|NCT00195702|970450|P4|COMPLETED|Open-label Extension Phase||66
396584|NCT00195702|970451|P3|COMPLETED|Open-label Extension Phase||0
396585|NCT00195702|970452|P2|COMPLETED|Open-label Extension Phase||0
396586|NCT00195702|970453|P1|COMPLETED|Open-label Extension Phase||0
396587|NCT00195702|970448|P6|STARTED|Open-label Extension Phase|6 subjects completed the double-blind phase but did not enter the open-label extension phase.|134
396588|NCT00195702|970449|P5|STARTED|Open-label Extension Phase|1 subject completed the double-blind phase but did not enter the open-label extension phase.|158
396589|NCT00195702|970450|P4|STARTED|Open-label Extension Phase|3 subjects completed the double-blind phase but did not enter the open-label extension phase.|165
396590|NCT00195702|970451|P3|STARTED|Open-label Extension Phase||0
396591|NCT00195702|970452|P2|STARTED|Open-label Extension Phase||0
396592|NCT00195702|970453|P1|STARTED|Open-label Extension Phase||0
396593|NCT00195702|970448|P6|NOT COMPLETED|Double-blind Phase||0
396594|NCT00195702|970449|P5|NOT COMPLETED|Double-blind Phase||0
396595|NCT00195702|970450|P4|NOT COMPLETED|Double-blind Phase||0
396596|NCT00195702|970451|P3|NOT COMPLETED|Double-blind Phase||60
396597|NCT00195702|970452|P2|NOT COMPLETED|Double-blind Phase||48
396598|NCT00195702|970453|P1|NOT COMPLETED|Double-blind Phase||44
396599|NCT00195702|970448|P6|COMPLETED|Double-blind Phase||0
396600|NCT00195702|970449|P5|COMPLETED|Double-blind Phase||0
396601|NCT00195702|970450|P4|COMPLETED|Double-blind Phase||0
396602|NCT00195702|970451|P3|COMPLETED|Double-blind Phase||140
396603|NCT00195702|970452|P2|COMPLETED|Double-blind Phase||159
396604|NCT00195702|970453|P1|COMPLETED|Double-blind Phase||168
396605|NCT00195702|970448|P6|STARTED|Double-blind Phase||0
396606|NCT00195702|970449|P5|STARTED|Double-blind Phase||0
396607|NCT00195702|970450|P4|STARTED|Double-blind Phase||0
396608|NCT00195702|970451|P3|STARTED|Double-blind Phase||200
396609|NCT00195702|970452|P2|STARTED|Double-blind Phase||207
396610|NCT00195702|970453|P1|STARTED|Double-blind Phase|For all groups, started indicates when the subjects entered the 52-week double-blind phase.|212
396611|NCT00195676|970517|P1|NOT COMPLETED|Period R - Retreatment 16 Weeks||35
396612|NCT00195676|970517|P1|COMPLETED|Period R - Retreatment 16 Weeks||490
396613|NCT00195676|970517|P1|STARTED|Period R - Retreatment 16 Weeks|Number who entered from Period W, including those who did and did not relapse in that period.|525
396614|NCT00195676|970517|P1|NOT COMPLETED|Period W (Withdrawal) - No Treatment||608
396615|NCT00195676|970517|P1|COMPLETED|Period W (Withdrawal) - No Treatment|Non-completers may have entered Period R, whether or not they relapsed (PGA >= 3).|0
396616|NCT00195676|970517|P1|STARTED|Period W (Withdrawal) - No Treatment|Period O completers with a Physician's Global Assessment =<2 who continued into Periods W and R.|608
396617|NCT00195676|970517|P1|NOT COMPLETED|Period O - Open-label Treatment||606
396618|NCT00195676|970517|P1|COMPLETED|Period O - Open-label Treatment|254 Period O completers did not consent or were not eligible to continue into Period W and Period R.|862
396619|NCT00195676|970517|P1|STARTED|Period O - Open-label Treatment|Number receiving adalimumab in Period O (1 additional participant enrolled but did not receive drug)|1468
396620|NCT00195663|970531|P3|NOT COMPLETED|Open-Label Extension Period||97
396621|NCT00195663|970532|P2|NOT COMPLETED|Open-Label Extension Period||74
396622|NCT00195663|970533|P1|NOT COMPLETED|Open-Label Extension Period||76
396623|NCT00195663|970531|P3|COMPLETED|Open-Label Extension Period||86
396624|NCT00195663|970532|P2|COMPLETED|Open-Label Extension Period||85
396625|NCT00195663|970533|P1|COMPLETED|Open-Label Extension Period||79
396626|NCT00195663|970531|P3|STARTED|Open-Label Extension Period||183
396627|NCT00195663|970532|P2|STARTED|Open-Label Extension Period||159
396628|NCT00195663|970533|P1|STARTED|Open-Label Extension Period||155
396629|NCT00195663|970531|P3|NOT COMPLETED|2-year Double-blind Treatment Period||72
396630|NCT00195663|970532|P2|NOT COMPLETED|2-year Double-blind Treatment Period||108
396631|NCT00195663|970533|P1|NOT COMPLETED|2-year Double-blind Treatment Period||93
396632|NCT00195663|970531|P3|COMPLETED|2-year Double-blind Treatment Period||196
396633|NCT00195663|970532|P2|COMPLETED|2-year Double-blind Treatment Period||166
396634|NCT00195663|970533|P1|COMPLETED|2-year Double-blind Treatment Period||164
396635|NCT00195663|970531|P3|STARTED|2-year Double-blind Treatment Period||268
396636|NCT00195663|970532|P2|STARTED|2-year Double-blind Treatment Period||274
396637|NCT00195663|970533|P1|STARTED|2-year Double-blind Treatment Period||257
396638|NCT00195650|970627|P1|NOT COMPLETED|Overall Study||525
396639|NCT00195650|970627|P1|COMPLETED|Overall Study||321
396640|NCT00195650|970627|P1|STARTED|Overall Study|Participants who received at least 1 adalimumab dose in study;3 enrolled did not receive adalimumab.|846
396641|NCT00195624|970643|P2|NOT COMPLETED|Overall Study||0
396642|NCT00195624|970644|P1|NOT COMPLETED|Overall Study||0
396643|NCT00195624|970643|P2|COMPLETED|Overall Study||42
396644|NCT00195624|970644|P1|COMPLETED|Overall Study||5
396645|NCT00195624|970643|P2|STARTED|Overall Study||42
396646|NCT00195624|970644|P1|STARTED|Overall Study||5
396647|NCT00195507|970652|P2|NOT COMPLETED|Overall Study||118
396648|NCT00195507|970653|P1|NOT COMPLETED|Overall Study||99
396649|NCT00195507|970652|P2|COMPLETED|Overall Study||245
396650|NCT00195507|970653|P1|COMPLETED|Overall Study||258
396651|NCT00195507|970652|P2|STARTED|Overall Study||363
396652|NCT00195507|970653|P1|STARTED|Overall Study||357
396653|NCT00195494|970667|P6|NOT COMPLETED|Year 2||0
396654|NCT00195494|970668|P5|NOT COMPLETED|Year 2||0
396655|NCT00195494|970669|P4|NOT COMPLETED|Year 2||23
396656|NCT00195494|970670|P3|NOT COMPLETED|Year 2||18
396657|NCT00195494|970671|P2|NOT COMPLETED|Year 2||16
396658|NCT00195494|970672|P1|NOT COMPLETED|Year 2||7
396659|NCT00195494|970667|P6|COMPLETED|Year 2||0
396660|NCT00195494|970668|P5|COMPLETED|Year 2||0
396661|NCT00195494|970669|P4|COMPLETED|Year 2||76
396662|NCT00195494|970670|P3|COMPLETED|Year 2||93
396663|NCT00195494|970671|P2|COMPLETED|Year 2||74
396664|NCT00195494|970672|P1|COMPLETED|Year 2||104
396665|NCT00195494|970667|P6|STARTED|Year 2||0
396666|NCT00195494|970668|P5|STARTED|Year 2||0
396667|NCT00195494|970669|P4|STARTED|Year 2||99
396668|NCT00195494|970670|P3|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
396669|NCT00195494|970671|P2|STARTED|Year 2||90
396755|NCT00195260|970768|P5|NOT COMPLETED|Part 1: Dose Escalation||7
396670|NCT00195494|970672|P1|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
396671|NCT00195494|970667|P6|NOT COMPLETED|Year 1||53
396672|NCT00195494|970668|P5|NOT COMPLETED|Year 1||79
396673|NCT00195494|970669|P4|NOT COMPLETED|Year 1||0
396674|NCT00195494|970670|P3|NOT COMPLETED|Year 1||0
396675|NCT00195494|970671|P2|NOT COMPLETED|Year 1||0
396676|NCT00195494|970672|P1|NOT COMPLETED|Year 1||0
396677|NCT00195494|970667|P6|COMPLETED|Year 1||221
396678|NCT00195494|970668|P5|COMPLETED|Year 1||189
396679|NCT00195494|970669|P4|COMPLETED|Year 1||0
396680|NCT00195494|970670|P3|COMPLETED|Year 1||0
396681|NCT00195494|970671|P2|COMPLETED|Year 1||0
396682|NCT00195494|970672|P1|COMPLETED|Year 1||0
396683|NCT00195494|970667|P6|STARTED|Year 1||274
396684|NCT00195494|970668|P5|STARTED|Year 1||268
396685|NCT00195494|970669|P4|STARTED|Year 1||0
396686|NCT00195494|970670|P3|STARTED|Year 1||0
396687|NCT00195494|970671|P2|STARTED|Year 1||0
396688|NCT00195494|970672|P1|STARTED|Year 1||0
396689|NCT00195442|970690|P1|NOT COMPLETED|Overall Study||136
396690|NCT00195442|970690|P1|COMPLETED|Overall Study||152
396691|NCT00195442|970690|P1|STARTED|Overall Study||288
396692|NCT00195429|970709|P2|NOT COMPLETED|Overall Study||5
396693|NCT00195429|970710|P1|NOT COMPLETED|Overall Study||5
396694|NCT00195429|970709|P2|COMPLETED|Overall Study||18
396695|NCT00195429|970710|P1|COMPLETED|Overall Study||19
396696|NCT00195429|970709|P2|STARTED|Overall Study||23
396697|NCT00195429|970710|P1|STARTED|Overall Study||24
396698|NCT00195403|970718|P1|NOT COMPLETED|Overall Study||0
396699|NCT00195403|970718|P1|COMPLETED|Overall Study||1014
396700|NCT00195403|970718|P1|STARTED|Overall Study||1014
396701|NCT00195351|970726|P2|NOT COMPLETED|Overall Study||16
396702|NCT00195351|970727|P1|NOT COMPLETED|Overall Study||21
396703|NCT00195351|970726|P2|COMPLETED|Overall Study||215
396704|NCT00195351|970727|P1|COMPLETED|Overall Study||215
396705|NCT00195351|970726|P2|STARTED|Overall Study||231
396706|NCT00195351|970727|P1|STARTED|Overall Study||236
396707|NCT00195338|970737|P1|NOT COMPLETED|Overall Study||12
396708|NCT00195338|970737|P1|COMPLETED|Overall Study||13
396709|NCT00195338|970737|P1|STARTED|Overall Study||25
396710|NCT00195273|970747|P2|NOT COMPLETED|Overall Study||14
396711|NCT00195273|970748|P1|NOT COMPLETED|Overall Study||21
396712|NCT00195273|970747|P2|COMPLETED|Overall Study||16
396713|NCT00195273|970748|P1|COMPLETED|Overall Study||10
396714|NCT00195273|970747|P2|STARTED|Overall Study||30
396715|NCT00195273|970748|P1|STARTED|Overall Study||31
396716|NCT00195260|970762|P11|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||23
396717|NCT00195260|970763|P10|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||38
396718|NCT00195260|970764|P9|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||33
396719|NCT00195260|970765|P8|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
396720|NCT00195260|970766|P7|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
396721|NCT00195260|970767|P6|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
396722|NCT00195260|970768|P5|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
396723|NCT00195260|970769|P4|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
396724|NCT00195260|970770|P3|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
396725|NCT00195260|970771|P2|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
396726|NCT00195260|970772|P1|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
396727|NCT00195260|970762|P11|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||2
396728|NCT00195260|970763|P10|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
396729|NCT00195260|970764|P9|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||4
396730|NCT00195260|970765|P8|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
396731|NCT00195260|970766|P7|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
396732|NCT00195260|970767|P6|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
396733|NCT00195260|970768|P5|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
396734|NCT00195260|970769|P4|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
396735|NCT00195260|970770|P3|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
396736|NCT00195260|970771|P2|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
396737|NCT00195260|970772|P1|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
396738|NCT00195260|970762|P11|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||25
396739|NCT00195260|970763|P10|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||38
396740|NCT00195260|970764|P9|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||37
396741|NCT00195260|970765|P8|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
396742|NCT00195260|970766|P7|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
396743|NCT00195260|970767|P6|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
396744|NCT00195260|970768|P5|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
396745|NCT00195260|970769|P4|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
396746|NCT00195260|970770|P3|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
396747|NCT00195260|970771|P2|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
396748|NCT00195260|970772|P1|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
396749|NCT00195260|970762|P11|NOT COMPLETED|Part 1: Dose Escalation||0
396750|NCT00195260|970763|P10|NOT COMPLETED|Part 1: Dose Escalation||0
396751|NCT00195260|970764|P9|NOT COMPLETED|Part 1: Dose Escalation||0
396752|NCT00195260|970765|P8|NOT COMPLETED|Part 1: Dose Escalation||6
396753|NCT00195260|970766|P7|NOT COMPLETED|Part 1: Dose Escalation||10
396754|NCT00195260|970767|P6|NOT COMPLETED|Part 1: Dose Escalation||7
396756|NCT00195260|970769|P4|NOT COMPLETED|Part 1: Dose Escalation||7
396757|NCT00195260|970770|P3|NOT COMPLETED|Part 1: Dose Escalation||6
396758|NCT00195260|970771|P2|NOT COMPLETED|Part 1: Dose Escalation||4
396759|NCT00195260|970772|P1|NOT COMPLETED|Part 1: Dose Escalation||4
396760|NCT00195260|970762|P11|COMPLETED|Part 1: Dose Escalation||0
396761|NCT00195260|970763|P10|COMPLETED|Part 1: Dose Escalation||0
396762|NCT00195260|970764|P9|COMPLETED|Part 1: Dose Escalation||0
396763|NCT00195260|970765|P8|COMPLETED|Part 1: Dose Escalation||0
396764|NCT00195260|970766|P7|COMPLETED|Part 1: Dose Escalation||0
396765|NCT00195260|970767|P6|COMPLETED|Part 1: Dose Escalation||0
396766|NCT00195260|970768|P5|COMPLETED|Part 1: Dose Escalation||0
396767|NCT00195260|970769|P4|COMPLETED|Part 1: Dose Escalation||0
396768|NCT00195260|970770|P3|COMPLETED|Part 1: Dose Escalation||0
396769|NCT00195260|970771|P2|COMPLETED|Part 1: Dose Escalation||0
396770|NCT00195260|970772|P1|COMPLETED|Part 1: Dose Escalation||0
396771|NCT00195260|970762|P11|STARTED|Part 1: Dose Escalation||0
396772|NCT00195260|970763|P10|STARTED|Part 1: Dose Escalation||0
396773|NCT00195260|970764|P9|STARTED|Part 1: Dose Escalation||0
396774|NCT00195260|970765|P8|STARTED|Part 1: Dose Escalation||6
396775|NCT00195260|970766|P7|STARTED|Part 1: Dose Escalation||10
396776|NCT00195260|970767|P6|STARTED|Part 1: Dose Escalation||7
396777|NCT00195260|970768|P5|STARTED|Part 1: Dose Escalation||7
396778|NCT00195260|970769|P4|STARTED|Part 1: Dose Escalation||7
396779|NCT00195260|970770|P3|STARTED|Part 1: Dose Escalation||6
396780|NCT00195260|970771|P2|STARTED|Part 1: Dose Escalation||4
396781|NCT00195260|970772|P1|STARTED|Part 1: Dose Escalation||4
396782|NCT00195039|970918|P1|NOT COMPLETED|Overall Study||0
396783|NCT00195039|970918|P1|COMPLETED|Overall Study||47
396784|NCT00195039|970918|P1|STARTED|Overall Study||47
396785|NCT00195013|970931|P2|NOT COMPLETED|Overall Study||1
396786|NCT00195013|970932|P1|NOT COMPLETED|Overall Study||2
396787|NCT00195013|970931|P2|COMPLETED|Overall Study||15
396788|NCT00195013|970932|P1|COMPLETED|Overall Study||12
396789|NCT00195013|970931|P2|STARTED|Overall Study||16
396790|NCT00195013|970932|P1|STARTED|Overall Study||14
396791|NCT00194987|970940|P2|NOT COMPLETED|Overall Study||3
396792|NCT00194987|970941|P1|NOT COMPLETED|Overall Study||0
396793|NCT00194987|970940|P2|COMPLETED|Overall Study|"3 women chose to withdraw because they felt the study was too inconvenient."|48
396794|NCT00194987|970941|P1|COMPLETED|Overall Study||51
396795|NCT00194987|970940|P2|STARTED|Overall Study||51
396796|NCT00194987|970941|P1|STARTED|Overall Study||51
396797|NCT00194896|970957|P4|NOT COMPLETED|Overall Study||12
396798|NCT00194896|970958|P3|NOT COMPLETED|Overall Study||6
396799|NCT00194896|970959|P2|NOT COMPLETED|Overall Study||5
396800|NCT00194896|970960|P1|NOT COMPLETED|Overall Study||11
396801|NCT00194896|970957|P4|COMPLETED|Overall Study||9
396802|NCT00194896|970958|P3|COMPLETED|Overall Study||7
396803|NCT00194896|970959|P2|COMPLETED|Overall Study||10
396804|NCT00194896|970960|P1|COMPLETED|Overall Study||4
396805|NCT00194896|970957|P4|STARTED|Overall Study||21
396806|NCT00194896|970958|P3|STARTED|Overall Study||13
396807|NCT00194896|970959|P2|STARTED|Overall Study||15
396808|NCT00194896|970960|P1|STARTED|Overall Study||15
396809|NCT00194792|970974|P1|NOT COMPLETED|Overall Study||1
396810|NCT00194792|970974|P1|COMPLETED|Overall Study||27
396811|NCT00194792|970974|P1|STARTED|Overall Study||28
396812|NCT00194779|970984|P1|NOT COMPLETED|Overall Study||0
396813|NCT00194779|970984|P1|COMPLETED|Overall Study||50
396814|NCT00194779|970984|P1|STARTED|Overall Study||50
396815|NCT00194675|970998|P2|NOT COMPLETED|Overall Study||2
396816|NCT00194675|970999|P1|NOT COMPLETED|Overall Study||5
396817|NCT00194675|970998|P2|COMPLETED|Overall Study||24
396818|NCT00194675|970999|P1|COMPLETED|Overall Study||22
396819|NCT00194675|970998|P2|STARTED|Overall Study||26
396820|NCT00194675|970999|P1|STARTED|Overall Study||27
396821|NCT00194610|971017|P2|NOT COMPLETED|Overall Study||0
396822|NCT00194610|971018|P1|NOT COMPLETED|Overall Study||0
396823|NCT00194610|971017|P2|COMPLETED|Overall Study||9
396824|NCT00194610|971018|P1|COMPLETED|Overall Study||11
396825|NCT00194610|971017|P2|STARTED|Overall Study||9
396826|NCT00194610|971018|P1|STARTED|Overall Study||11
396827|NCT00194532|971026|P2|NOT COMPLETED|Overall Study||0
396828|NCT00194532|971027|P1|NOT COMPLETED|Overall Study||0
396829|NCT00194532|971026|P2|COMPLETED|Overall Study||150
396830|NCT00194532|971027|P1|COMPLETED|Overall Study||150
396831|NCT00194532|971026|P2|STARTED|Overall Study||150
396832|NCT00194532|971027|P1|STARTED|Overall Study||150
396833|NCT00194129|971037|P2|NOT COMPLETED|Overall Study||13
396834|NCT00194129|971038|P1|NOT COMPLETED|Overall Study||10
396835|NCT00194129|971037|P2|COMPLETED|Overall Study||3
396836|NCT00194129|971038|P1|COMPLETED|Overall Study||5
396837|NCT00194129|971037|P2|STARTED|Overall Study||16
396838|NCT00194129|971038|P1|STARTED|Overall Study||15
396839|NCT00194116|971053|P2|NOT COMPLETED|Overall Study||15
396840|NCT00194116|971054|P1|NOT COMPLETED|Overall Study||13
396841|NCT00194116|971053|P2|COMPLETED|Overall Study||13
396842|NCT00194116|971054|P1|COMPLETED|Overall Study||13
396843|NCT00194116|971053|P2|STARTED|Overall Study||28
396844|NCT00194116|971054|P1|STARTED|Overall Study||26
396845|NCT00194077|971074|P2|NOT COMPLETED|Overall Study||30
396846|NCT00194077|971075|P1|NOT COMPLETED|Overall Study||24
396847|NCT00194077|971074|P2|COMPLETED|Overall Study|"Lack of efficacy:~hypomania n=17 Cycling n=6 Mania n=5 Mixed state n=1 Concern regarding tx n=1"|0
396848|NCT00194077|971075|P1|COMPLETED|Overall Study|"Lack of efficacy:~Hypomania n=12 Cycling n=5 Mixed state=4 Mania n=1"|6
396849|NCT00194077|971074|P2|STARTED|Overall Study||30
396850|NCT00194077|971075|P1|STARTED|Overall Study||30
396851|NCT00194025|971081|P1|NOT COMPLETED|Overall Study||5
396852|NCT00194025|971081|P1|COMPLETED|Overall Study|5 participants withdrew prematurely|15
396853|NCT00194025|971081|P1|STARTED|Overall Study|The intent-to-treat population received at least one dose of valproate semisodium.|20
396854|NCT00194012|971096|P2|NOT COMPLETED|Open Label Extension (OLE)||6
396855|NCT00194012|971097|P1|NOT COMPLETED|Open Label Extension (OLE)||5
396856|NCT00194012|971096|P2|COMPLETED|Open Label Extension (OLE)||15
396857|NCT00194012|971097|P1|COMPLETED|Open Label Extension (OLE)||17
396858|NCT00194012|971096|P2|STARTED|Open Label Extension (OLE)|Participants from placebo group started OLE (eligible even if randomized period not completed).|21
396859|NCT00194012|971097|P1|STARTED|Open Label Extension (OLE)|Participants from aripiprazole group started OLE (eligible even if randomized period not completed).|22
396860|NCT00194012|971096|P2|NOT COMPLETED|Randomized Phase||25
396861|NCT00194012|971097|P1|NOT COMPLETED|Randomized Phase||16
396862|NCT00194012|971096|P2|COMPLETED|Randomized Phase||6
396863|NCT00194012|971097|P1|COMPLETED|Randomized Phase||15
396864|NCT00194012|971096|P2|Received More Than One Dose|Randomized Phase||29
396865|NCT00194012|971097|P1|Received More Than One Dose|Randomized Phase||30
396866|NCT00194012|971096|P2|STARTED|Randomized Phase||31
396867|NCT00194012|971097|P1|STARTED|Randomized Phase||31
396868|NCT00193609|971133|P1|NOT COMPLETED|Overall Study||4
396869|NCT00193609|971133|P1|COMPLETED|Overall Study||44
396870|NCT00193609|971133|P1|STARTED|Overall Study||48
396871|NCT00193596|971140|P2|NOT COMPLETED|Overall Study||66
396872|NCT00193596|971141|P1|NOT COMPLETED|Overall Study||56
396873|NCT00193596|971140|P2|COMPLETED|Overall Study||39
396874|NCT00193596|971141|P1|COMPLETED|Overall Study||37
396875|NCT00193596|971140|P2|STARTED|Overall Study||105
396876|NCT00193596|971141|P1|STARTED|Overall Study||93
396877|NCT00193492|971151|P2|NOT COMPLETED|Overall Study||15
396878|NCT00193492|971152|P1|NOT COMPLETED|Overall Study||17
396879|NCT00193492|971151|P2|COMPLETED|Overall Study||14
396880|NCT00193492|971152|P1|COMPLETED|Overall Study||14
396881|NCT00193492|971151|P2|STARTED|Overall Study||29
396882|NCT00193492|971152|P1|STARTED|Overall Study||31
396883|NCT00193479|971160|P1|NOT COMPLETED|Maintenance Rituximab||0
396884|NCT00193479|971160|P1|COMPLETED|Maintenance Rituximab||44
396885|NCT00193479|971160|P1|STARTED|Maintenance Rituximab||44
396886|NCT00193479|971160|P1|NOT COMPLETED|Induction Chemotherapy||3
396887|NCT00193479|971160|P1|COMPLETED|Induction Chemotherapy||48
396888|NCT00193479|971160|P1|STARTED|Induction Chemotherapy||51
396889|NCT00193453|971164|P1|NOT COMPLETED|Overall Study||48
396890|NCT00193453|971164|P1|COMPLETED|Overall Study||21
396891|NCT00193453|971164|P1|STARTED|Overall Study||69
396892|NCT00193427|971170|P1|NOT COMPLETED|Overall Study||49
396893|NCT00193427|971170|P1|COMPLETED|Overall Study||26
396894|NCT00193427|971170|P1|STARTED|Overall Study||75
396895|NCT00193414|971177|P1|NOT COMPLETED|Overall Study||58
396896|NCT00193414|971177|P1|COMPLETED|Overall Study||14
396897|NCT00193414|971177|P1|STARTED|Overall Study||72
396898|NCT00193375|971183|P1|NOT COMPLETED|Overall Study||19
396899|NCT00193375|971183|P1|COMPLETED|Overall Study||41
396900|NCT00193375|971183|P1|STARTED|Overall Study||60
396901|NCT00193258|971189|P1|NOT COMPLETED|Overall Study||0
396902|NCT00193258|971189|P1|COMPLETED|Overall Study||94
396903|NCT00193258|971189|P1|STARTED|Overall Study||94
396904|NCT00193219|971195|P1|NOT COMPLETED|Overall Study||30
396905|NCT00193219|971195|P1|COMPLETED|Overall Study||6
396906|NCT00193219|971195|P1|STARTED|Overall Study||36
396907|NCT00193206|971201|P1|NOT COMPLETED|Postoperative Therapy||14
396908|NCT00193206|971201|P1|COMPLETED|Postoperative Therapy||102
396909|NCT00193206|971201|P1|STARTED|Postoperative Therapy||116
396910|NCT00193206|971201|P1|NOT COMPLETED|Surgery||0
396911|NCT00193206|971201|P1|COMPLETED|Surgery||116
396912|NCT00193206|971201|P1|STARTED|Surgery||116
396913|NCT00193206|971201|P1|NOT COMPLETED|Preoperative Therapy||7
396914|NCT00193206|971201|P1|COMPLETED|Preoperative Therapy||116
396915|NCT00193206|971201|P1|STARTED|Preoperative Therapy||123
396916|NCT00193180|971205|P1|NOT COMPLETED|Overall Study||10
396917|NCT00193180|971205|P1|COMPLETED|Overall Study||27
396918|NCT00193180|971205|P1|STARTED|Overall Study||37
396919|NCT00193128|971213|P2|NOT COMPLETED|Overall Study||10
396920|NCT00193128|971214|P1|NOT COMPLETED|Overall Study||0
396921|NCT00193128|971213|P2|COMPLETED|Overall Study||39
396922|NCT00193128|971214|P1|COMPLETED|Overall Study||10
396923|NCT00193128|971213|P2|STARTED|Overall Study||49
396924|NCT00193128|971214|P1|STARTED|Overall Study||10
396925|NCT00193063|971220|P1|NOT COMPLETED|Overall Study||4
396926|NCT00193063|971220|P1|COMPLETED|Overall Study||37
396927|NCT00193063|971220|P1|STARTED|Overall Study||41
396928|NCT00193050|971226|P1|NOT COMPLETED|Adjuvant||10
396929|NCT00193050|971226|P1|COMPLETED|Adjuvant||77
396930|NCT00193050|971226|P1|STARTED|Adjuvant|16 patients never initiated postoperative adjuvant therapy|87
396931|NCT00193050|971226|P1|NOT COMPLETED|Surgery||0
396932|NCT00193050|971226|P1|COMPLETED|Surgery||103
396933|NCT00193050|971226|P1|STARTED|Surgery|2 patients had surgery after 2 cycles of neoadjuvant treatment|103
396934|NCT00193050|971226|P1|NOT COMPLETED|Neoadjuvant Treatment||9
396935|NCT00193050|971226|P1|COMPLETED|Neoadjuvant Treatment||101
396936|NCT00193050|971226|P1|STARTED|Neoadjuvant Treatment||110
396937|NCT00193037|971232|P2|NOT COMPLETED|Crossover Treatment||0
396938|NCT00193037|971233|P1|NOT COMPLETED|Crossover Treatment||0
396939|NCT00193037|971232|P2|COMPLETED|Crossover Treatment||24
396940|NCT00193037|971233|P1|COMPLETED|Crossover Treatment||32
396941|NCT00193037|971232|P2|STARTED|Crossover Treatment||24
396942|NCT00193037|971233|P1|STARTED|Crossover Treatment||32
396943|NCT00193037|971232|P2|NOT COMPLETED|Randomized Treatment||28
396944|NCT00193037|971233|P1|NOT COMPLETED|Randomized Treatment||18
396945|NCT00193037|971232|P2|COMPLETED|Randomized Treatment||24
396946|NCT00193037|971233|P1|COMPLETED|Randomized Treatment||32
396947|NCT00193037|971232|P2|STARTED|Randomized Treatment||52
396948|NCT00193037|971233|P1|STARTED|Randomized Treatment||50
396949|NCT00192647|971243|P2|NOT COMPLETED|Overall Study||146
396950|NCT00192647|971244|P1|NOT COMPLETED|Overall Study||128
396951|NCT00192647|971243|P2|COMPLETED|Overall Study||302
396952|NCT00192647|971244|P1|COMPLETED|Overall Study||320
396953|NCT00192647|971243|P2|Treated|Overall Study||438
396954|NCT00192647|971244|P1|Treated|Overall Study||433
396955|NCT00192647|971243|P2|STARTED|Overall Study||448
396956|NCT00192647|971244|P1|STARTED|Overall Study||448
396957|NCT00192296|971264|P4|NOT COMPLETED|Overall Study||0
396958|NCT00192296|971265|P3|NOT COMPLETED|Overall Study||0
396959|NCT00192296|971266|P2|NOT COMPLETED|Overall Study||1
396960|NCT00192296|971267|P1|NOT COMPLETED|Overall Study||0
396961|NCT00192296|971264|P4|COMPLETED|Overall Study||6
396962|NCT00192296|971265|P3|COMPLETED|Overall Study||6
396963|NCT00192296|971266|P2|COMPLETED|Overall Study||5
396964|NCT00192296|971267|P1|COMPLETED|Overall Study||6
396965|NCT00192296|971264|P4|STARTED|Overall Study||6
396966|NCT00192296|971265|P3|STARTED|Overall Study||6
396967|NCT00192296|971266|P2|STARTED|Overall Study||6
396968|NCT00192296|971267|P1|STARTED|Overall Study||6
396969|NCT00192075|971323|P2|NOT COMPLETED|Overall Study||19
396970|NCT00192075|971324|P1|NOT COMPLETED|Overall Study||39
396971|NCT00192075|971323|P2|COMPLETED|Overall Study||23
396972|NCT00192075|971324|P1|COMPLETED|Overall Study||3
396973|NCT00192075|971323|P2|STARTED|Overall Study||42
396974|NCT00192075|971324|P1|STARTED|Overall Study||42
396975|NCT00192036|971349|P1|NOT COMPLETED|Overall Study||21
396976|NCT00192036|971349|P1|COMPLETED|Overall Study||28
396977|NCT00192036|971349|P1|STARTED|Overall Study||49
396978|NCT00192023|971359|P2|NOT COMPLETED|Period IV - Optional Open-Label||0
396979|NCT00192023|971360|P1|NOT COMPLETED|Period IV - Optional Open-Label||75
396980|NCT00192023|971359|P2|COMPLETED|Period IV - Optional Open-Label||0
396981|NCT00192023|971360|P1|COMPLETED|Period IV - Optional Open-Label||49
396982|NCT00192023|971359|P2|STARTED|Period IV - Optional Open-Label|Placebo patients received atomoxetine during the optional open-label period.|0
396983|NCT00192023|971360|P1|STARTED|Period IV - Optional Open-Label||124
396984|NCT00192023|971359|P2|NOT COMPLETED|Period III - Double-Blind||0
396985|NCT00192023|971360|P1|NOT COMPLETED|Period III - Double-Blind||7
396986|NCT00192023|971359|P2|COMPLETED|Period III - Double-Blind|2 patients who completed the protocol did not enter the optional open-label period.|32
396987|NCT00192023|971360|P1|COMPLETED|Period III - Double-Blind|6 patients who completed the protocol did not enter optional open-label period.|100
396988|NCT00192023|971359|P2|STARTED|Period III - Double-Blind||32
396989|NCT00192023|971360|P1|STARTED|Period III - Double-Blind||107
396990|NCT00191984|971382|P1|NOT COMPLETED|Overall Study||39
396991|NCT00191984|971382|P1|COMPLETED|Overall Study||7
396992|NCT00191984|971382|P1|STARTED|Overall Study||46
396993|NCT00191945|971392|P2|NOT COMPLETED|Open-Label Treatment Extension||0
396994|NCT00191945|971393|P1|NOT COMPLETED|Open-Label Treatment Extension||0
396995|NCT00191945|971392|P2|COMPLETED|Open-Label Treatment Extension||48
396996|NCT00191945|971393|P1|COMPLETED|Open-Label Treatment Extension||94
396997|NCT00191945|971392|P2|STARTED|Open-Label Treatment Extension||48
396998|NCT00191945|971393|P1|STARTED|Open-Label Treatment Extension||94
396999|NCT00191945|971392|P2|NOT COMPLETED|Double-Blind Acute Treatment||3
397000|NCT00191945|971393|P1|NOT COMPLETED|Double-Blind Acute Treatment||6
397001|NCT00191945|971392|P2|COMPLETED|Double-Blind Acute Treatment||48
397002|NCT00191945|971393|P1|COMPLETED|Double-Blind Acute Treatment||94
397003|NCT00191945|971392|P2|STARTED|Double-Blind Acute Treatment||51
397004|NCT00191945|971393|P1|STARTED|Double-Blind Acute Treatment||100
397005|NCT00191906|971429|P4|NOT COMPLETED|Study Period III||0
397006|NCT00191906|971430|P3|NOT COMPLETED|Study Period III||0
397007|NCT00191906|971431|P2|NOT COMPLETED|Study Period III||4
397008|NCT00191906|971432|P1|NOT COMPLETED|Study Period III||5
397009|NCT00191906|971429|P4|COMPLETED|Study Period III||0
397010|NCT00191906|971430|P3|COMPLETED|Study Period III||0
397011|NCT00191906|971431|P2|COMPLETED|Study Period III||7
397012|NCT00191906|971432|P1|COMPLETED|Study Period III||9
397013|NCT00191906|971429|P4|STARTED|Study Period III||0
397014|NCT00191906|971430|P3|STARTED|Study Period III||0
397015|NCT00191906|971431|P2|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|11
397016|NCT00191906|971432|P1|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|14
397017|NCT00191906|971429|P4|NOT COMPLETED|Study Period II||0
397018|NCT00191906|971430|P3|NOT COMPLETED|Study Period II||1
397019|NCT00191906|971431|P2|NOT COMPLETED|Study Period II||5
397020|NCT00191906|971432|P1|NOT COMPLETED|Study Period II||0
397021|NCT00191906|971429|P4|COMPLETED|Study Period II||18
397022|NCT00191906|971430|P3|COMPLETED|Study Period II||26
397023|NCT00191906|971431|P2|COMPLETED|Study Period II||32
397024|NCT00191906|971432|P1|COMPLETED|Study Period II||39
397025|NCT00191906|971429|P4|STARTED|Study Period II||18
397026|NCT00191906|971430|P3|STARTED|Study Period II||27
397027|NCT00191906|971431|P2|STARTED|Study Period II||37
397028|NCT00191906|971432|P1|STARTED|Study Period II||39
397029|NCT00191854|971475|P3|NOT COMPLETED|Overall Study||39
397030|NCT00191854|971476|P2|NOT COMPLETED|Overall Study||30
397031|NCT00191854|971477|P1|NOT COMPLETED|Overall Study||37
397032|NCT00191854|971475|P3|COMPLETED|Overall Study||12
397033|NCT00191854|971476|P2|COMPLETED|Overall Study||17
397034|NCT00191854|971477|P1|COMPLETED|Overall Study||12
397035|NCT00191854|971475|P3|Received at Least One Dose of Study Drug|Overall Study|Screen failure: discontinued prior to receiving study drug.|50
397036|NCT00191854|971476|P2|Received at Least One Dose of Study Drug|Overall Study||47
397037|NCT00191854|971477|P1|Received at Least One Dose of Study Drug|Overall Study||49
397038|NCT00191854|971475|P3|STARTED|Overall Study||51
397039|NCT00191854|971476|P2|STARTED|Overall Study||47
397040|NCT00191854|971477|P1|STARTED|Overall Study||49
397041|NCT00191815|971497|P1|NOT COMPLETED|Overall Study||40
397042|NCT00191815|971497|P1|COMPLETED|Overall Study||30
397043|NCT00191815|971497|P1|Treated|Overall Study||67
397044|NCT00191815|971497|P1|STARTED|Overall Study||70
397045|NCT00191789|971509|P1|NOT COMPLETED|Overall Study||25
397046|NCT00191789|971509|P1|COMPLETED|Overall Study||40
397047|NCT00191789|971509|P1|STARTED|Overall Study||65
397048|NCT00191724|971526|P5|NOT COMPLETED|Overall Study||3
397049|NCT00191724|971527|P4|NOT COMPLETED|Overall Study||3
397050|NCT00191724|971528|P3|NOT COMPLETED|Overall Study||1
397051|NCT00191724|971529|P2|NOT COMPLETED|Overall Study||1
397052|NCT00191724|971530|P1|NOT COMPLETED|Overall Study||1
397053|NCT00191724|971526|P5|COMPLETED|Overall Study||12
397054|NCT00191724|971527|P4|COMPLETED|Overall Study||5
397055|NCT00191724|971528|P3|COMPLETED|Overall Study||8
397056|NCT00191724|971529|P2|COMPLETED|Overall Study||8
397057|NCT00191724|971530|P1|COMPLETED|Overall Study||5
397058|NCT00191724|971526|P5|STARTED|Overall Study||15
397059|NCT00191724|971527|P4|STARTED|Overall Study||8
397060|NCT00191724|971528|P3|STARTED|Overall Study||9
397061|NCT00191724|971529|P2|STARTED|Overall Study||9
397062|NCT00191724|971530|P1|STARTED|Overall Study||6
397063|NCT00191646|971559|P2|NOT COMPLETED|Overall Study||153
397064|NCT00191646|971560|P1|NOT COMPLETED|Overall Study||171
397065|NCT00191646|971559|P2|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|261
397066|NCT00191646|971560|P1|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|246
397067|NCT00191646|971559|P2|Received Crossover Therapy|Overall Study||78
397068|NCT00191646|971560|P1|Received Crossover Therapy|Overall Study||77
397069|NCT00191646|971559|P2|Received Consolidation Therapy|Overall Study||183
397070|NCT00191646|971560|P1|Received Consolidation Therapy|Overall Study||169
397071|NCT00191646|971559|P2|Received Induction Therapy|Overall Study||409
397072|NCT00191646|971560|P1|Received Induction Therapy|Overall Study||411
397073|NCT00191646|971559|P2|STARTED|Overall Study||414
397074|NCT00191646|971560|P1|STARTED|Overall Study||417
397075|NCT00191477|971580|P2|NOT COMPLETED|Overall Study||129
397076|NCT00191477|971581|P1|NOT COMPLETED|Overall Study||138
397077|NCT00191477|971580|P2|COMPLETED|Overall Study||47
397078|NCT00191477|971581|P1|COMPLETED|Overall Study||41
397079|NCT00191477|971580|P2|Received Study Drug|Overall Study||162
397080|NCT00191477|971581|P1|Received Study Drug|Overall Study||166
397081|NCT00191477|971580|P2|STARTED|Overall Study||176
397082|NCT00191477|971581|P1|STARTED|Overall Study||179
397083|NCT00191451|971600|P3|NOT COMPLETED|Overall Study||14
397084|NCT00191451|971601|P2|NOT COMPLETED|Overall Study||14
397085|NCT00191451|971602|P1|NOT COMPLETED|Overall Study||7
397086|NCT00191451|971600|P3|COMPLETED|Overall Study||35
397087|NCT00191451|971601|P2|COMPLETED|Overall Study||37
397088|NCT00191451|971602|P1|COMPLETED|Overall Study||43
397089|NCT00191451|971600|P3|Received at Least One Dose of Study Drug|Overall Study||47
397090|NCT00191451|971601|P2|Received at Least One Dose of Study Drug|Overall Study||48
397091|NCT00191451|971602|P1|Received at Least One Dose of Study Drug|Overall Study||50
397092|NCT00191451|971600|P3|STARTED|Overall Study||49
397093|NCT00191451|971601|P2|STARTED|Overall Study||51
397094|NCT00191451|971602|P1|STARTED|Overall Study||50
397095|NCT00191386|971622|P1|NOT COMPLETED|Overall Study||160
397096|NCT00191386|971622|P1|COMPLETED|Overall Study||68
397097|NCT00191386|971622|P1|3 Years|Overall Study||65
397098|NCT00191386|971622|P1|2 Years|Overall Study||105
397099|NCT00191386|971622|P1|12 Months|Overall Study||149
397100|NCT00191386|971622|P1|6 Months|Overall Study||183
397101|NCT00191386|971622|P1|STARTED|Overall Study||228
397102|NCT00191334|971629|P1|NOT COMPLETED|Overall Study||17
397103|NCT00191334|971629|P1|COMPLETED|Overall Study||33
397104|NCT00191334|971629|P1|STARTED|Overall Study||50
397105|NCT00191308|971637|P1|NOT COMPLETED|Overall Study||1
397106|NCT00191308|971637|P1|COMPLETED|Overall Study||29
397107|NCT00191308|971637|P1|STARTED|Overall Study||30
397108|NCT00191282|971647|P2|NOT COMPLETED|Overall Study||212
397109|NCT00191282|971648|P1|NOT COMPLETED|Overall Study||220
397110|NCT00191282|971647|P2|COMPLETED|Overall Study||346
397111|NCT00191282|971648|P1|COMPLETED|Overall Study||338
397112|NCT00191282|971647|P2|STARTED|Overall Study||558
397113|NCT00191282|971648|P1|STARTED|Overall Study||558
397114|NCT00191269|971708|P2|NOT COMPLETED|Overall Study||58
397115|NCT00191269|971709|P1|NOT COMPLETED|Overall Study||6
397116|NCT00191269|971708|P2|COMPLETED|Overall Study||4
397117|NCT00191269|971709|P1|COMPLETED|Overall Study||0
397118|NCT00191269|971708|P2|STARTED|Overall Study||62
397119|NCT00191269|971709|P1|STARTED|Overall Study||6
397120|NCT00191191|971725|P2|NOT COMPLETED|Overall Study||112
397121|NCT00191191|971726|P1|NOT COMPLETED|Overall Study||114
397122|NCT00191191|971725|P2|COMPLETED|Overall Study||0
397123|NCT00191191|971726|P1|COMPLETED|Overall Study||0
397124|NCT00191191|971725|P2|Full Analysis Set Population|Overall Study||108
397125|NCT00191191|971726|P1|Full Analysis Set Population|Overall Study||108
397126|NCT00191191|971725|P2|Safety Analysis Population|Overall Study||111
397127|NCT00191191|971726|P1|Safety Analysis Population|Overall Study||114
397128|NCT00191191|971725|P2|STARTED|Overall Study||112
397129|NCT00191191|971726|P1|STARTED|Overall Study||114
397130|NCT00191165|971742|P2|NOT COMPLETED|Overall Study||2
397131|NCT00191165|971743|P1|NOT COMPLETED|Overall Study||2
397132|NCT00191165|971742|P2|COMPLETED|Overall Study||11
397133|NCT00191165|971743|P1|COMPLETED|Overall Study||12
397134|NCT00191165|971742|P2|STARTED|Overall Study||13
397135|NCT00191165|971743|P1|STARTED|Overall Study||14
397136|NCT00191152|971755|P2|NOT COMPLETED|Crossover Treatment||28
397137|NCT00191152|971756|P1|NOT COMPLETED|Crossover Treatment||27
397138|NCT00191152|971755|P2|COMPLETED|Crossover Treatment||53
397139|NCT00191152|971756|P1|COMPLETED|Crossover Treatment||50
397140|NCT00191152|971755|P2|Received Treatment|Crossover Treatment||80
397141|NCT00191152|971756|P1|Received Treatment|Crossover Treatment||76
397142|NCT00191152|971755|P2|STARTED|Crossover Treatment||81
397143|NCT00191152|971756|P1|STARTED|Crossover Treatment||77
397144|NCT00191152|971755|P2|NOT COMPLETED|Initial Treatment||153
397145|NCT00191152|971756|P1|NOT COMPLETED|Initial Treatment||141
397146|NCT00191152|971755|P2|COMPLETED|Initial Treatment||83
397147|NCT00191152|971756|P1|COMPLETED|Initial Treatment||98
397148|NCT00191152|971755|P2|Received Initial Treatment|Initial Treatment||227
397149|NCT00191152|971756|P1|Received Initial Treatment|Initial Treatment||236
397150|NCT00191152|971755|P2|STARTED|Initial Treatment||236
397151|NCT00191152|971756|P1|STARTED|Initial Treatment||239
397152|NCT00191139|971788|P2|NOT COMPLETED|Overall Study||12
397153|NCT00191139|971789|P1|NOT COMPLETED|Overall Study||5
397154|NCT00191139|971788|P2|COMPLETED|Overall Study||20
397155|NCT00191139|971789|P1|COMPLETED|Overall Study||27
397156|NCT00191139|971788|P2|STARTED|Overall Study||32
397157|NCT00191139|971789|P1|STARTED|Overall Study||32
397158|NCT00191113|971805|P2|NOT COMPLETED|Addendum 3||0
397159|NCT00191113|971806|P1|NOT COMPLETED|Addendum 3||0
397160|NCT00191113|971805|P2|COMPLETED|Addendum 3||37
397161|NCT00191113|971806|P1|COMPLETED|Addendum 3||20
397162|NCT00191113|971805|P2|STARTED|Addendum 3||37
397163|NCT00191113|971806|P1|STARTED|Addendum 3||20
397164|NCT00191113|971805|P2|NOT COMPLETED|Addendum 2||17
397165|NCT00191113|971806|P1|NOT COMPLETED|Addendum 2||10
397166|NCT00191113|971805|P2|COMPLETED|Addendum 2||31
397167|NCT00191113|971806|P1|COMPLETED|Addendum 2||18
397168|NCT00191113|971805|P2|STARTED|Addendum 2||48
397169|NCT00191113|971806|P1|STARTED|Addendum 2||28
397170|NCT00191113|971805|P2|NOT COMPLETED|Addendum 1||0
397171|NCT00191113|971806|P1|NOT COMPLETED|Addendum 1||0
397172|NCT00191113|971805|P2|COMPLETED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
397173|NCT00191113|971806|P1|COMPLETED|Addendum 1||2
397174|NCT00191113|971805|P2|STARTED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
397175|NCT00191113|971806|P1|STARTED|Addendum 1||2
397176|NCT00191113|971805|P2|NOT COMPLETED|Core Study||15
397177|NCT00191113|971806|P1|NOT COMPLETED|Core Study||35
397178|NCT00191113|971805|P2|COMPLETED|Core Study||61
397179|NCT00191113|971806|P1|COMPLETED|Core Study||43
397180|NCT00191113|971805|P2|STARTED|Core Study||76
397181|NCT00191113|971806|P1|STARTED|Core Study||78
397182|NCT00191100|971848|P2|NOT COMPLETED|Overall Study||12
397183|NCT00191100|971849|P1|NOT COMPLETED|Overall Study||42
397184|NCT00191100|971848|P2|COMPLETED|Overall Study||244
397185|NCT00191100|971849|P1|COMPLETED|Overall Study||217
397186|NCT00191100|971848|P2|STARTED|Overall Study||256
397187|NCT00191100|971849|P1|STARTED|Overall Study||259
397188|NCT00190983|971865|P1|NOT COMPLETED|Overall Study||2
397189|NCT00190983|971865|P1|COMPLETED|Overall Study|Completed means patient received treatment and was evaluable for response.|27
397190|NCT00190983|971865|P1|STARTED|Overall Study||29
397191|NCT00190775|971874|P2|NOT COMPLETED|Overall Study||100
397192|NCT00190775|971875|P1|NOT COMPLETED|Overall Study||149
397193|NCT00190775|971874|P2|COMPLETED|Overall Study||134
397194|NCT00190775|971875|P1|COMPLETED|Overall Study||119
397195|NCT00190775|971874|P2|Received Study Drug|Overall Study||234
397196|NCT00190775|971875|P1|Received Study Drug|Overall Study||266
397197|NCT00190775|971874|P2|STARTED|Overall Study||234
397198|NCT00190775|971875|P1|STARTED|Overall Study||268
397199|NCT00190749|971946|P2|NOT COMPLETED|Overall Study||31
397200|NCT00190749|971947|P1|NOT COMPLETED|Overall Study||26
397201|NCT00190749|971946|P2|COMPLETED|Overall Study||31
397202|NCT00190749|971947|P1|COMPLETED|Overall Study||42
397203|NCT00190749|971946|P2|STARTED|Overall Study||62
397204|NCT00190749|971947|P1|STARTED|Overall Study||68
397205|NCT00190684|972011|P1|NOT COMPLETED|Overall Study||1489
397206|NCT00190684|972011|P1|COMPLETED|Overall Study|Number of patients that completed overall study (through Period VI)|64
397207|NCT00190684|972011|P1|Received at Least 1 Dose of Study Drug|Overall Study|1553 patients entered the study; 1551 were enrolled and received study drug.|1551
397208|NCT00190684|972011|P1|STARTED|Overall Study||1553
397209|NCT00190671|972032|P2|NOT COMPLETED|Overall Study||42
397210|NCT00190671|972033|P1|NOT COMPLETED|Overall Study||27
397211|NCT00190671|972032|P2|COMPLETED|Overall Study||19
397212|NCT00190671|972033|P1|COMPLETED|Overall Study||15
397213|NCT00190671|972032|P2|STARTED|Overall Study||61
397214|NCT00190671|972033|P1|STARTED|Overall Study||42
397215|NCT00189540|972053|P2|NOT COMPLETED|Overall Study||1
397216|NCT00189540|972054|P1|NOT COMPLETED|Overall Study||7
397217|NCT00189540|972053|P2|COMPLETED|Overall Study||5
397218|NCT00189540|972054|P1|COMPLETED|Overall Study||14
397219|NCT00189540|972053|P2|STARTED|Overall Study||6
397220|NCT00189540|972054|P1|STARTED|Overall Study||21
397221|NCT00189488|972072|P2|NOT COMPLETED|Overall Study||22
397222|NCT00189488|972073|P1|NOT COMPLETED|Overall Study||15
397223|NCT00189488|972072|P2|COMPLETED|Overall Study||55
397224|NCT00189488|972073|P1|COMPLETED|Overall Study||63
397225|NCT00189488|972072|P2|Received Palifermin/Placebo|Overall Study||76
397226|NCT00189488|972073|P1|Received Palifermin/Placebo|Overall Study||75
397227|NCT00189488|972072|P2|STARTED|Overall Study||77
397228|NCT00189488|972073|P1|STARTED|Overall Study||78
397229|NCT00189475|972095|P2|NOT COMPLETED|Overall Study||0
397230|NCT00189475|972096|P1|NOT COMPLETED|Overall Study||0
397231|NCT00189475|972095|P2|COMPLETED|Overall Study||42
397232|NCT00189475|972096|P1|COMPLETED|Overall Study||42
397233|NCT00189475|972095|P2|STARTED|Overall Study||42
397234|NCT00189475|972096|P1|STARTED|Overall Study||42
397235|NCT00189462|972104|P2|NOT COMPLETED|Overall Study||21
397236|NCT00189462|972105|P1|NOT COMPLETED|Overall Study||23
397237|NCT00189462|972104|P2|COMPLETED|Overall Study||28
397238|NCT00189462|972105|P1|COMPLETED|Overall Study||27
397239|NCT00189462|972104|P2|STARTED|Overall Study||49
397240|NCT00189462|972105|P1|STARTED|Overall Study||50
397241|NCT00189436|972113|P2|NOT COMPLETED|Overall Study||5
397242|NCT00189436|972114|P1|NOT COMPLETED|Overall Study||8
397243|NCT00189436|972113|P2|COMPLETED|Overall Study||25
397244|NCT00189436|972114|P1|COMPLETED|Overall Study||23
397245|NCT00189436|972113|P2|STARTED|Overall Study||30
397246|NCT00189436|972114|P1|STARTED|Overall Study||31
397247|NCT00189423|972122|P2|NOT COMPLETED|Overall Study||766
397248|NCT00189423|972123|P1|NOT COMPLETED|Overall Study||765
397249|NCT00189423|972122|P2|COMPLETED|Overall Study||74
397250|NCT00189423|972123|P1|COMPLETED|Overall Study||48
397251|NCT00189423|972122|P2|STARTED|Overall Study||840
397252|NCT00189423|972123|P1|STARTED|Overall Study||813
397253|NCT00189306|972145|P1|NOT COMPLETED|Long-Term Follow-up||38
397254|NCT00189306|972145|P1|COMPLETED|Long-Term Follow-up||119
397255|NCT00189306|972145|P1|STARTED|Long-Term Follow-up||157
397256|NCT00189306|972145|P1|NOT COMPLETED|Posttreatment Period||12
397257|NCT00189306|972145|P1|COMPLETED|Posttreatment Period|11 subjects discontinued during the 12-week Posttreatment Period|157
397258|NCT00189306|972145|P1|STARTED|Posttreatment Period|5 of the 169 discontinued, but 4 returned for the Posttreatment Period|169
397259|NCT00189306|972145|P1|NOT COMPLETED|Treatment Period||5
397260|NCT00189306|972145|P1|COMPLETED|Treatment Period|5 subjects discontinued during treatment - 4 subjects returned for the Posttreatment Period|164
397261|NCT00189306|972145|P1|STARTED|Treatment Period||169
397262|NCT00189228|972150|P1|NOT COMPLETED|Overall Study||0
397263|NCT00189228|972150|P1|COMPLETED|Overall Study||18
397264|NCT00189228|972150|P1|STARTED|Overall Study||18
397265|NCT00189202|972154|P1|NOT COMPLETED|Overall Study||5
397266|NCT00189202|972154|P1|COMPLETED|Overall Study||44
397267|NCT00189202|972154|P1|STARTED|Overall Study||49
397268|NCT00189137|972165|P2|NOT COMPLETED|Overall Study||0
397269|NCT00189137|972166|P1|NOT COMPLETED|Overall Study||0
397270|NCT00189137|972165|P2|COMPLETED|Overall Study||43
397271|NCT00189137|972166|P1|COMPLETED|Overall Study||37
397272|NCT00189137|972165|P2|STARTED|Overall Study||43
397273|NCT00189137|972166|P1|STARTED|Overall Study||37
397274|NCT00189098|972176|P2|NOT COMPLETED|Overall Study||6
397275|NCT00189098|972177|P1|NOT COMPLETED|Overall Study||5
397276|NCT00189098|972176|P2|COMPLETED|Overall Study||44
397277|NCT00189098|972177|P1|COMPLETED|Overall Study||46
397278|NCT00189098|972176|P2|STARTED|Overall Study||50
397279|NCT00189098|972177|P1|STARTED|Overall Study||51
397280|NCT00187889|972195|P2|NOT COMPLETED|Overall Study||4
397281|NCT00187889|972196|P1|NOT COMPLETED|Overall Study||6
397282|NCT00187889|972195|P2|COMPLETED|Overall Study||22
397283|NCT00187889|972196|P1|COMPLETED|Overall Study||19
397284|NCT00187889|972195|P2|STARTED|Overall Study||26
397285|NCT00187889|972196|P1|STARTED|Overall Study||25
397286|NCT00187876|972206|P2|NOT COMPLETED|Overall Study||0
397287|NCT00187876|972207|P1|NOT COMPLETED|Overall Study||0
397288|NCT00187876|972206|P2|COMPLETED|Overall Study||43
397289|NCT00187876|972207|P1|COMPLETED|Overall Study||24
397290|NCT00187876|972206|P2|STARTED|Overall Study||43
397291|NCT00187876|972207|P1|STARTED|Overall Study||24
397292|NCT00187720|972215|P2|NOT COMPLETED|Overall Study||0
397293|NCT00187720|972216|P1|NOT COMPLETED|Overall Study||0
397294|NCT00187720|972215|P2|COMPLETED|Overall Study||14
397295|NCT00187720|972216|P1|COMPLETED|Overall Study||9
397296|NCT00187720|972215|P2|STARTED|Overall Study||14
397297|NCT00187720|972216|P1|STARTED|Overall Study||9
397298|NCT00187681|972224|P2|NOT COMPLETED|Overall Study||0
397299|NCT00187681|972225|P1|NOT COMPLETED|Overall Study||0
397300|NCT00187681|972224|P2|COMPLETED|Overall Study||8
397301|NCT00187681|972225|P1|COMPLETED|Overall Study||12
397302|NCT00187681|972224|P2|STARTED|Overall Study||8
397303|NCT00187681|972225|P1|STARTED|Overall Study||12
397304|NCT00187655|972233|P1|NOT COMPLETED|Overall Study||0
397305|NCT00187655|972233|P1|COMPLETED|Overall Study||24
397306|NCT00187655|972233|P1|STARTED|Overall Study||24
397307|NCT00187486|972238|P1|NOT COMPLETED|Overall Study||1
397308|NCT00187486|972238|P1|COMPLETED|Overall Study||65
397309|NCT00187486|972238|P1|STARTED|Overall Study||66
397310|NCT00187226|972249|P6|NOT COMPLETED|Overall Study||0
397311|NCT00187226|972250|P5|NOT COMPLETED|Overall Study||0
397312|NCT00187226|972251|P4|NOT COMPLETED|Overall Study||0
397313|NCT00187226|972252|P3|NOT COMPLETED|Overall Study||0
397314|NCT00187226|972253|P2|NOT COMPLETED|Overall Study||0
397315|NCT00187226|972254|P1|NOT COMPLETED|Overall Study||0
397316|NCT00187226|972249|P6|COMPLETED|Overall Study||1
397317|NCT00187226|972250|P5|COMPLETED|Overall Study||34
397318|NCT00187226|972251|P4|COMPLETED|Overall Study||2
397319|NCT00187226|972252|P3|COMPLETED|Overall Study||28
397320|NCT00187226|972253|P2|COMPLETED|Overall Study||49
397321|NCT00187226|972254|P1|COMPLETED|Overall Study||88
397322|NCT00187226|972249|P6|STARTED|Overall Study||1
397323|NCT00187226|972250|P5|STARTED|Overall Study||34
397324|NCT00187226|972251|P4|STARTED|Overall Study||2
397325|NCT00187226|972252|P3|STARTED|Overall Study||28
397326|NCT00187226|972253|P2|STARTED|Overall Study||49
397327|NCT00187226|972254|P1|STARTED|Overall Study||88
397328|NCT00187200|972270|P2|NOT COMPLETED|Overall Study||18
397329|NCT00187200|972271|P1|NOT COMPLETED|Overall Study||18
397330|NCT00187200|972270|P2|COMPLETED|Overall Study||26
397331|NCT00187200|972271|P1|COMPLETED|Overall Study||31
397332|NCT00187200|972270|P2|STARTED|Overall Study||44
397333|NCT00187200|972271|P1|STARTED|Overall Study||49
397334|NCT00187135|972289|P6|NOT COMPLETED|Visit Three||6
397335|NCT00187135|972290|P5|NOT COMPLETED|Visit Three||8
397336|NCT00187135|972291|P4|NOT COMPLETED|Visit Three||9
397337|NCT00187135|972292|P3|NOT COMPLETED|Visit Three||9
397338|NCT00187135|972293|P2|NOT COMPLETED|Visit Three||7
397339|NCT00187135|972294|P1|NOT COMPLETED|Visit Three||7
397340|NCT00187135|972289|P6|COMPLETED|Visit Three||12
397341|NCT00187135|972290|P5|COMPLETED|Visit Three||11
397342|NCT00187135|972291|P4|COMPLETED|Visit Three||9
397343|NCT00187135|972292|P3|COMPLETED|Visit Three||14
397344|NCT00187135|972293|P2|COMPLETED|Visit Three||17
397345|NCT00187135|972294|P1|COMPLETED|Visit Three||14
397346|NCT00187135|972289|P6|STARTED|Visit Three||18
397347|NCT00187135|972290|P5|STARTED|Visit Three||19
397348|NCT00187135|972291|P4|STARTED|Visit Three||18
397349|NCT00187135|972292|P3|STARTED|Visit Three||23
397350|NCT00187135|972293|P2|STARTED|Visit Three||24
397351|NCT00187135|972294|P1|STARTED|Visit Three||21
397352|NCT00187135|972289|P6|NOT COMPLETED|Visit Two||8
397353|NCT00187135|972290|P5|NOT COMPLETED|Visit Two||6
397354|NCT00187135|972291|P4|NOT COMPLETED|Visit Two||8
397355|NCT00187135|972292|P3|NOT COMPLETED|Visit Two||2
397356|NCT00187135|972293|P2|NOT COMPLETED|Visit Two||3
397357|NCT00187135|972294|P1|NOT COMPLETED|Visit Two||5
397358|NCT00187135|972289|P6|COMPLETED|Visit Two||18
397359|NCT00187135|972290|P5|COMPLETED|Visit Two||19
397360|NCT00187135|972291|P4|COMPLETED|Visit Two||18
397361|NCT00187135|972292|P3|COMPLETED|Visit Two||23
397362|NCT00187135|972293|P2|COMPLETED|Visit Two||24
397363|NCT00187135|972294|P1|COMPLETED|Visit Two||21
397364|NCT00187135|972289|P6|STARTED|Visit Two||26
397365|NCT00187135|972290|P5|STARTED|Visit Two||25
397366|NCT00187135|972291|P4|STARTED|Visit Two||26
397367|NCT00187135|972292|P3|STARTED|Visit Two||25
397368|NCT00187135|972293|P2|STARTED|Visit Two||27
397369|NCT00187135|972294|P1|STARTED|Visit Two||26
397370|NCT00187135|972289|P6|NOT COMPLETED|Visit One||2
397371|NCT00187135|972290|P5|NOT COMPLETED|Visit One||0
397372|NCT00187135|972291|P4|NOT COMPLETED|Visit One||0
397373|NCT00187135|972292|P3|NOT COMPLETED|Visit One||0
397374|NCT00187135|972293|P2|NOT COMPLETED|Visit One||1
397375|NCT00187135|972294|P1|NOT COMPLETED|Visit One||4
397376|NCT00187135|972289|P6|COMPLETED|Visit One||26
397377|NCT00187135|972290|P5|COMPLETED|Visit One||25
397378|NCT00187135|972291|P4|COMPLETED|Visit One||26
397379|NCT00187135|972292|P3|COMPLETED|Visit One||25
397380|NCT00187135|972293|P2|COMPLETED|Visit One||27
397381|NCT00187135|972294|P1|COMPLETED|Visit One||26
397382|NCT00187135|972289|P6|STARTED|Visit One||28
397383|NCT00187135|972290|P5|STARTED|Visit One||25
397384|NCT00187135|972291|P4|STARTED|Visit One||26
397385|NCT00187135|972292|P3|STARTED|Visit One||25
397386|NCT00187135|972293|P2|STARTED|Visit One||28
397387|NCT00187135|972294|P1|STARTED|Visit One||30
397388|NCT00187096|972317|P3|NOT COMPLETED|Overall Study||1
397389|NCT00187096|972318|P2|NOT COMPLETED|Overall Study||0
397390|NCT00187096|972319|P1|NOT COMPLETED|Overall Study||0
397391|NCT00187096|972317|P3|COMPLETED|Overall Study||11
397392|NCT00187096|972318|P2|COMPLETED|Overall Study||3
397393|NCT00187096|972319|P1|COMPLETED|Overall Study||10
397394|NCT00187096|972317|P3|STARTED|Overall Study||12
397395|NCT00187096|972318|P2|STARTED|Overall Study||3
397396|NCT00187096|972319|P1|STARTED|Overall Study||10
397397|NCT00186901|972357|P3|NOT COMPLETED|Overall Study||149
397398|NCT00186901|972358|P2|NOT COMPLETED|Overall Study||45
397399|NCT00186901|972359|P1|NOT COMPLETED|Overall Study||49
397400|NCT00186901|972357|P3|COMPLETED|Overall Study||0
397401|NCT00186901|972358|P2|COMPLETED|Overall Study||96
397402|NCT00186901|972359|P1|COMPLETED|Overall Study||85
397403|NCT00186901|972357|P3|24 Month Follow-up|Overall Study||0
397404|NCT00186901|972358|P2|24 Month Follow-up|Overall Study||107
397405|NCT00186901|972359|P1|24 Month Follow-up|Overall Study||106
397406|NCT00186901|972357|P3|12 Month Follow-up|Overall Study||0
397407|NCT00186901|972358|P2|12 Month Follow-up|Overall Study||122
397408|NCT00186901|972359|P1|12 Month Follow-up|Overall Study||117
397409|NCT00186901|972357|P3|Baseline|Overall Study||0
397410|NCT00186901|972358|P2|Baseline|Overall Study||141
397411|NCT00186901|972359|P1|Baseline|Overall Study||134
397412|NCT00186901|972357|P3|STARTED|Overall Study||149
397413|NCT00186901|972358|P2|STARTED|Overall Study||141
397414|NCT00186901|972359|P1|STARTED|Overall Study||134
397415|NCT00186888|972399|P3|NOT COMPLETED|Overall Study||0
397416|NCT00186888|972400|P2|NOT COMPLETED|Overall Study||3
397417|NCT00186888|972401|P1|NOT COMPLETED|Overall Study||4
397418|NCT00186888|972399|P3|COMPLETED|Overall Study||55
397419|NCT00186888|972400|P2|COMPLETED|Overall Study||24
397420|NCT00186888|972401|P1|COMPLETED|Overall Study||19
397421|NCT00186888|972399|P3|Window Therapy|Overall Study||0
397422|NCT00186888|972400|P2|Window Therapy|Overall Study||27
397423|NCT00186888|972401|P1|Window Therapy|Overall Study||0
397424|NCT00186888|972399|P3|STARTED|Overall Study||55
397425|NCT00186888|972400|P2|STARTED|Overall Study||27
397426|NCT00186888|972401|P1|STARTED|Overall Study||23
397427|NCT00186875|972478|P2|NOT COMPLETED|Overall Study||0
397428|NCT00186875|972479|P1|NOT COMPLETED|Overall Study||0
397429|NCT00186875|972478|P2|COMPLETED|Overall Study||14
397430|NCT00186875|972479|P1|COMPLETED|Overall Study||26
397431|NCT00186875|972478|P2|STARTED|Overall Study||14
397432|NCT00186875|972479|P1|STARTED|Overall Study||26
397433|NCT00186628|972493|P1|NOT COMPLETED|Overall Study||3
397434|NCT00186628|972493|P1|COMPLETED|Overall Study||33
397435|NCT00186628|972493|P1|STARTED|Overall Study||36
397436|NCT00186537|972504|P3|NOT COMPLETED|Overall Study||3
397437|NCT00186537|972505|P2|NOT COMPLETED|Overall Study||0
397438|NCT00186537|972506|P1|NOT COMPLETED|Overall Study||7
397439|NCT00186537|972504|P3|COMPLETED|Overall Study||13
397440|NCT00186537|972505|P2|COMPLETED|Overall Study||12
397441|NCT00186537|972506|P1|COMPLETED|Overall Study||12
397442|NCT00186537|972504|P3|STARTED|Overall Study||16
397443|NCT00186537|972505|P2|STARTED|Overall Study||12
397444|NCT00186537|972506|P1|STARTED|Overall Study||19
397445|NCT00186498|972522|P2|NOT COMPLETED|Overall Study||2
397446|NCT00186498|972523|P1|NOT COMPLETED|Overall Study||2
397447|NCT00186498|972522|P2|COMPLETED|Overall Study||3
397448|NCT00186498|972523|P1|COMPLETED|Overall Study||4
397449|NCT00186498|972522|P2|STARTED|Overall Study||5
397450|NCT00186498|972523|P1|STARTED|Overall Study||6
397451|NCT00186485|972529|P1|NOT COMPLETED|Overall Study||3
397452|NCT00186485|972529|P1|COMPLETED|Overall Study||25
397453|NCT00186485|972529|P1|STARTED|Overall Study||28
397454|NCT00186446|972535|P1|NOT COMPLETED|Overall Study||9
397455|NCT00186446|972535|P1|COMPLETED|Overall Study||11
397456|NCT00186446|972535|P1|STARTED|Overall Study||20
397457|NCT00186186|972541|P1|NOT COMPLETED|Overall Study||8
397458|NCT00186186|972541|P1|COMPLETED|Overall Study||20
397459|NCT00186186|972541|P1|STARTED|Overall Study||28
397460|NCT00186121|972546|P1|NOT COMPLETED|Overall Study||3
397461|NCT00186121|972546|P1|COMPLETED|Overall Study||32
397462|NCT00186121|972546|P1|STARTED|Overall Study||35
397463|NCT00186069|972558|P2|NOT COMPLETED|Overall Study||0
397464|NCT00186069|972559|P1|NOT COMPLETED|Overall Study||0
397465|NCT00186069|972558|P2|COMPLETED|Overall Study||15
397466|NCT00186069|972559|P1|COMPLETED|Overall Study||15
397467|NCT00186069|972558|P2|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
397468|NCT00186069|972559|P1|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
397469|NCT00186056|972571|P2|NOT COMPLETED|Overall Study||1
397470|NCT00186056|972572|P1|NOT COMPLETED|Overall Study||2
397471|NCT00186056|972571|P2|COMPLETED|Overall Study||16
397472|NCT00186056|972572|P1|COMPLETED|Overall Study||12
397473|NCT00186056|972571|P2|STARTED|Overall Study||17
397474|NCT00186056|972572|P1|STARTED|Overall Study||14
397475|NCT00186043|972580|P2|NOT COMPLETED|Overall Study||13
397476|NCT00186043|972581|P1|NOT COMPLETED|Overall Study||15
397477|NCT00186043|972580|P2|COMPLETED|Overall Study||12
397478|NCT00186043|972581|P1|COMPLETED|Overall Study||15
397479|NCT00186043|972580|P2|STARTED|Overall Study||25
397480|NCT00186043|972581|P1|STARTED|Overall Study||30
397481|NCT00186017|972593|P2|NOT COMPLETED|Overall Study||3
397482|NCT00186017|972594|P1|NOT COMPLETED|Overall Study||2
397483|NCT00186017|972593|P2|COMPLETED|Overall Study||22
397484|NCT00186017|972594|P1|COMPLETED|Overall Study||23
397485|NCT00186017|972593|P2|STARTED|Overall Study||25
397486|NCT00186017|972594|P1|STARTED|Overall Study||25
397487|NCT00185965|972608|P2|NOT COMPLETED|Overall Study||1
397488|NCT00185965|972609|P1|NOT COMPLETED|Overall Study||0
397489|NCT00185965|972608|P2|COMPLETED|Overall Study||14
397490|NCT00185965|972609|P1|COMPLETED|Overall Study||15
397491|NCT00185965|972608|P2|STARTED|Overall Study||15
397492|NCT00185965|972609|P1|STARTED|Overall Study||15
397493|NCT00185900|972617|P2|NOT COMPLETED|Overall Study||0
397494|NCT00185900|972618|P1|NOT COMPLETED|Overall Study||0
397495|NCT00185900|972617|P2|COMPLETED|Overall Study||100
397496|NCT00185900|972618|P1|COMPLETED|Overall Study||92
397497|NCT00185900|972617|P2|STARTED|Overall Study||100
397498|NCT00185900|972618|P1|STARTED|Overall Study||92
397499|NCT00185731|972634|P1|NOT COMPLETED|Overall Study||2
397500|NCT00185731|972634|P1|COMPLETED|Overall Study||23
397501|NCT00185731|972634|P1|STARTED|Overall Study||25
397502|NCT00185692|972640|P1|NOT COMPLETED|Overall Study||16
397503|NCT00185692|972640|P1|COMPLETED|Overall Study||0
397504|NCT00185692|972640|P1|STARTED|Overall Study||16
397505|NCT00185679|972645|P1|NOT COMPLETED|Overall Study||0
397506|NCT00185679|972645|P1|COMPLETED|Overall Study||13
397507|NCT00185679|972645|P1|STARTED|Overall Study||13
397508|NCT00185640|972651|P1|NOT COMPLETED|Overall Study||145
397509|NCT00185640|972651|P1|COMPLETED|Overall Study||158
397510|NCT00185640|972651|P1|90 Days Post-transplant|Overall Study||161
397511|NCT00185640|972651|P1|Transplanted|Overall Study||296
397512|NCT00185640|972651|P1|STARTED|Overall Study||303
397513|NCT00185614|972660|P1|NOT COMPLETED|Allogenic HCT (Allo-HCT)||0
397514|NCT00185614|972660|P1|COMPLETED|Allogenic HCT (Allo-HCT)||59
397515|NCT00185614|972660|P1|STARTED|Allogenic HCT (Allo-HCT)||59
397516|NCT00185614|972660|P1|NOT COMPLETED|Inter-treatment Period||4
397517|NCT00185614|972660|P1|COMPLETED|Inter-treatment Period||59
397518|NCT00185614|972660|P1|STARTED|Inter-treatment Period|Not all participants who received autologous transplant continued to receive allogeneic transplant.|63
397519|NCT00185614|972660|P1|NOT COMPLETED|Autologous HCT (Auto-HCT)||0
397520|NCT00185614|972660|P1|COMPLETED|Autologous HCT (Auto-HCT)||63
397521|NCT00185614|972660|P1|STARTED|Autologous HCT (Auto-HCT)||63
397522|NCT00185588|972672|P4|NOT COMPLETED|Overall Study||4
397523|NCT00185588|972673|P3|NOT COMPLETED|Overall Study||6
397524|NCT00185588|972674|P2|NOT COMPLETED|Overall Study||2
397525|NCT00185588|972675|P1|NOT COMPLETED|Overall Study||3
397526|NCT00185588|972672|P4|COMPLETED|Overall Study||13
397527|NCT00185588|972673|P3|COMPLETED|Overall Study||0
397528|NCT00185588|972674|P2|COMPLETED|Overall Study||2
397529|NCT00185588|972675|P1|COMPLETED|Overall Study||3
397530|NCT00185588|972672|P4|STARTED|Overall Study||17
397531|NCT00185588|972673|P3|STARTED|Overall Study||6
397532|NCT00185588|972674|P2|STARTED|Overall Study||4
397533|NCT00185588|972675|P1|STARTED|Overall Study||6
397534|NCT00185458|972689|P1|NOT COMPLETED|HRT Phase||27
397535|NCT00185458|972689|P1|COMPLETED|HRT Phase||141
397536|NCT00185458|972689|P1|STARTED|HRT Phase|168 subjects were eligible for the HRT phase out 336 who completed contraception phase.|168
397537|NCT00185458|972689|P1|NOT COMPLETED|Contraception Phase||58
397538|NCT00185458|972689|P1|COMPLETED|Contraception Phase||336
397539|NCT00185458|972689|P1|STARTED|Contraception Phase||394
397540|NCT00185380|972752|P3|NOT COMPLETED|Overall Study||74
397541|NCT00185380|972753|P2|NOT COMPLETED|Overall Study||72
397542|NCT00185380|972754|P1|NOT COMPLETED|Overall Study||66
397543|NCT00185380|972752|P3|COMPLETED|Overall Study||182
397544|NCT00185380|972753|P2|COMPLETED|Overall Study||174
397545|NCT00185380|972754|P1|COMPLETED|Overall Study||174
397546|NCT00185380|972752|P3|Subjects Received Treatment|Overall Study||254
397547|NCT00185380|972753|P2|Subjects Received Treatment|Overall Study||245
397548|NCT00185380|972754|P1|Subjects Received Treatment|Overall Study||239
397549|NCT00185380|972752|P3|STARTED|Overall Study||256
397550|NCT00185380|972753|P2|STARTED|Overall Study||246
397551|NCT00185380|972754|P1|STARTED|Overall Study||240
397552|NCT00185211|972782|P2|NOT COMPLETED|Follow-up Study (91031 - This Study)||34
397553|NCT00185211|972783|P1|NOT COMPLETED|Follow-up Study (91031 - This Study)||26
397554|NCT00185211|972782|P2|COMPLETED|Follow-up Study (91031 - This Study)||123
397555|NCT00185211|972783|P1|COMPLETED|Follow-up Study (91031 - This Study)||235
397556|NCT00185211|972782|P2|STARTED|Follow-up Study (91031 - This Study)|9 of the 166 subjects completing the placebo-controlled study did not consent to the Follow-up.|157
397557|NCT00185211|972783|P1|STARTED|Follow-up Study (91031 - This Study)|10 of the 271 subjects completing the placebo-controlled study did not consent to the Follow-up.|261
397558|NCT00185211|972782|P2|NOT COMPLETED|Placebo-controlled Study (92012)||10
397559|NCT00185211|972783|P1|NOT COMPLETED|Placebo-controlled Study (92012)||21
397560|NCT00185211|972782|P2|COMPLETED|Placebo-controlled Study (92012)||166
397561|NCT00185211|972783|P1|COMPLETED|Placebo-controlled Study (92012)||271
397562|NCT00185211|972782|P2|STARTED|Placebo-controlled Study (92012)||176
397563|NCT00185211|972783|P1|STARTED|Placebo-controlled Study (92012)||292
397564|NCT00184717|972811|P5|NOT COMPLETED|Extension Period (GHLIQUID-1517)||5
397565|NCT00184717|972812|P4|NOT COMPLETED|Extension Period (GHLIQUID-1517)||3
397566|NCT00184717|972813|P3|NOT COMPLETED|Extension Period (GHLIQUID-1517)||0
397567|NCT00184717|972814|P2|NOT COMPLETED|Extension Period (GHLIQUID-1517)||6
397568|NCT00184717|972815|P1|NOT COMPLETED|Extension Period (GHLIQUID-1517)||10
397569|NCT00184717|972811|P5|COMPLETED|Extension Period (GHLIQUID-1517)||5
397570|NCT00184717|972812|P4|COMPLETED|Extension Period (GHLIQUID-1517)||7
397571|NCT00184717|972813|P3|COMPLETED|Extension Period (GHLIQUID-1517)||0
397572|NCT00184717|972814|P2|COMPLETED|Extension Period (GHLIQUID-1517)||27
397573|NCT00184717|972815|P1|COMPLETED|Extension Period (GHLIQUID-1517)||23
397574|NCT00184717|972811|P5|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
397575|NCT00184717|972812|P4|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
397576|NCT00184717|972813|P3|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised to receive 0.033 or 0.067 mg|0
397577|NCT00184717|972814|P2|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
397578|NCT00184717|972815|P1|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
397579|NCT00184717|972811|P5|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
397580|NCT00184717|972812|P4|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
397581|NCT00184717|972813|P3|NOT COMPLETED|Main Period (GHLIQUID-1516)||1
397582|NCT00184717|972814|P2|NOT COMPLETED|Main Period (GHLIQUID-1516)||2
397583|NCT00184717|972815|P1|NOT COMPLETED|Main Period (GHLIQUID-1516)||3
397584|NCT00184717|972811|P5|COMPLETED|Main Period (GHLIQUID-1516)||0
397585|NCT00184717|972812|P4|COMPLETED|Main Period (GHLIQUID-1516)||0
397586|NCT00184717|972813|P3|COMPLETED|Main Period (GHLIQUID-1516)||20
397587|NCT00184717|972814|P2|COMPLETED|Main Period (GHLIQUID-1516)||36
397588|NCT00184717|972815|P1|COMPLETED|Main Period (GHLIQUID-1516)||36
397589|NCT00184717|972811|P5|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
397590|NCT00184717|972812|P4|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
397591|NCT00184717|972813|P3|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||21
397592|NCT00184717|972814|P2|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
397593|NCT00184717|972815|P1|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
397594|NCT00184717|972811|P5|STARTED|Main Period (GHLIQUID-1516)||0
397595|NCT00184717|972812|P4|STARTED|Main Period (GHLIQUID-1516)||0
397596|NCT00184717|972813|P3|STARTED|Main Period (GHLIQUID-1516)||21
397597|NCT00184717|972814|P2|STARTED|Main Period (GHLIQUID-1516)||38
397598|NCT00184717|972815|P1|STARTED|Main Period (GHLIQUID-1516)||39
397599|NCT00184600|972856|P3|NOT COMPLETED|Overall Study||34
397600|NCT00184600|972857|P2|NOT COMPLETED|Overall Study||51
397601|NCT00184600|972858|P1|NOT COMPLETED|Overall Study||45
397602|NCT00184600|972856|P3|COMPLETED|Overall Study||201
397603|NCT00184600|972857|P2|COMPLETED|Overall Study||188
397604|NCT00184600|972858|P1|COMPLETED|Overall Study||189
397605|NCT00184600|972856|P3|STARTED|Overall Study||235
397606|NCT00184600|972857|P2|STARTED|Overall Study||239
397607|NCT00184600|972858|P1|STARTED|Overall Study||234
397608|NCT00184548|972912|P4|NOT COMPLETED|Overall Study||7
397609|NCT00184548|972913|P3|NOT COMPLETED|Overall Study||3
397610|NCT00184548|972914|P2|NOT COMPLETED|Overall Study||13
397611|NCT00184548|972915|P1|NOT COMPLETED|Overall Study||8
397612|NCT00184548|972912|P4|COMPLETED|Overall Study||38
397613|NCT00184548|972913|P3|COMPLETED|Overall Study||44
397614|NCT00184548|972914|P2|COMPLETED|Overall Study||242
397615|NCT00184548|972915|P1|COMPLETED|Overall Study||218
397616|NCT00184548|972912|P4|Exposed|Overall Study|Four subjects withdrew due to ineligibility, one subject died. Excluded from safety analysis set|40
397617|NCT00184548|972913|P3|Exposed|Overall Study|One subject withdrew due to ineligibility. Excluded from safety analysis set|46
397618|NCT00184548|972914|P2|Exposed|Overall Study|Three subjects withdrew due to ineligibility, two subjects died. Excluded from safety analysis set|250
397619|NCT00184548|972915|P1|Exposed|Overall Study|Two subjects withdrew due to ineligibility. Excluded from safety analysis set|224
397620|NCT00184548|972912|P4|STARTED|Overall Study||45
397621|NCT00184548|972913|P3|STARTED|Overall Study||47
397622|NCT00184548|972914|P2|STARTED|Overall Study||255
397623|NCT00184548|972915|P1|STARTED|Overall Study||226
397624|NCT00184093|972949|P1|NOT COMPLETED|Overall Study||9
397625|NCT00184093|972949|P1|COMPLETED|Overall Study||26
397626|NCT00184093|972949|P1|STARTED|Overall Study|Phase 1 participants = 6 Phase 2 participants = 29|35
397627|NCT00184054|972954|P1|NOT COMPLETED|Overall Study||1
397628|NCT00184054|972954|P1|COMPLETED|Overall Study||10
397629|NCT00184054|972954|P1|STARTED|Overall Study||11
397630|NCT00184028|972959|P1|NOT COMPLETED|Overall Study||10
397631|NCT00184028|972959|P1|COMPLETED|Overall Study||2
397632|NCT00184028|972959|P1|STARTED|Overall Study||12
397633|NCT00184002|972964|P1|NOT COMPLETED|Overall Study||17
397634|NCT00184002|972964|P1|COMPLETED|Overall Study||51
397635|NCT00184002|972964|P1|STARTED|Overall Study||68
397636|NCT00183963|972973|P4|NOT COMPLETED|Overall Study||1
397637|NCT00183963|972974|P3|NOT COMPLETED|Overall Study||1
397638|NCT00183963|972975|P2|NOT COMPLETED|Overall Study||1
397639|NCT00183963|972976|P1|NOT COMPLETED|Overall Study||1
397640|NCT00183963|972973|P4|COMPLETED|Overall Study||0
397641|NCT00183963|972974|P3|COMPLETED|Overall Study||0
397642|NCT00183963|972975|P2|COMPLETED|Overall Study||0
397643|NCT00183963|972976|P1|COMPLETED|Overall Study||0
397644|NCT00183963|972973|P4|STARTED|Overall Study||1
397645|NCT00183963|972974|P3|STARTED|Overall Study||1
397646|NCT00183963|972975|P2|STARTED|Overall Study||1
397647|NCT00183963|972976|P1|STARTED|Overall Study||1
397648|NCT00183872|972990|P1|NOT COMPLETED|Overall Study||16
397649|NCT00183872|972990|P1|COMPLETED|Overall Study||24
397650|NCT00183872|972990|P1|STARTED|Overall Study||40
397651|NCT00183794|972995|P1|NOT COMPLETED|Overall Study||0
397652|NCT00183794|972995|P1|COMPLETED|Overall Study||20
397653|NCT00183794|972995|P1|STARTED|Overall Study||20
397654|NCT00183729|973002|P2|NOT COMPLETED|Overall Study||5
397655|NCT00183729|973003|P1|NOT COMPLETED|Overall Study||3
397656|NCT00183729|973002|P2|COMPLETED|Overall Study||13
397657|NCT00183729|973003|P1|COMPLETED|Overall Study||14
397658|NCT00183729|973002|P2|STARTED|Overall Study||18
397659|NCT00183729|973003|P1|STARTED|Overall Study||17
397660|NCT00183677|973013|P1|NOT COMPLETED|Overall Study||44
397661|NCT00183677|973013|P1|COMPLETED|Overall Study||53
397662|NCT00183677|973013|P1|STARTED|Overall Study||97
397663|NCT00183625|973019|P4|NOT COMPLETED|Overall Study||14
397664|NCT00183625|973020|P3|NOT COMPLETED|Overall Study||19
397665|NCT00183625|973021|P2|NOT COMPLETED|Overall Study||18
397666|NCT00183625|973022|P1|NOT COMPLETED|Overall Study||18
397667|NCT00183625|973019|P4|COMPLETED|Overall Study||10
397668|NCT00183625|973020|P3|COMPLETED|Overall Study||9
397669|NCT00183625|973021|P2|COMPLETED|Overall Study||10
397670|NCT00183625|973022|P1|COMPLETED|Overall Study||9
397671|NCT00183625|973019|P4|Obtained Employment|Overall Study||14
397672|NCT00183625|973020|P3|Obtained Employment|Overall Study||14
397673|NCT00183625|973021|P2|Obtained Employment|Overall Study||18
397674|NCT00183625|973022|P1|Obtained Employment|Overall Study||21
397675|NCT00183625|973019|P4|STARTED|Overall Study||24
397676|NCT00183625|973020|P3|STARTED|Overall Study||28
397677|NCT00183625|973021|P2|STARTED|Overall Study||28
397678|NCT00183625|973022|P1|STARTED|Overall Study||27
397679|NCT00183469|973032|P2|NOT COMPLETED|Overall Study||29
397680|NCT00183469|973033|P1|NOT COMPLETED|Overall Study||28
397681|NCT00183469|973032|P2|COMPLETED|Overall Study||16
397682|NCT00183469|973033|P1|COMPLETED|Overall Study||13
397683|NCT00183469|973032|P2|STARTED|Overall Study||45
397684|NCT00183469|973033|P1|STARTED|Overall Study||41
397685|NCT00183456|973043|P4|NOT COMPLETED|Overall Study||28
397686|NCT00183456|973044|P3|NOT COMPLETED|Overall Study||16
397687|NCT00183456|973045|P2|NOT COMPLETED|Overall Study||1
397688|NCT00183456|973046|P1|NOT COMPLETED|Overall Study||3
397689|NCT00183456|973043|P4|COMPLETED|Overall Study|total # of non-randomized index participants that completed any follow-up|220
397690|NCT00183456|973044|P3|COMPLETED|Overall Study|total # of network participants that completed any follow-up|313
397691|NCT00183456|973045|P2|COMPLETED|Overall Study|total # of comparison condition participants that completed any follow-up|83
397692|NCT00183456|973046|P1|COMPLETED|Overall Study|total # of intervention participants that completed any follow-up (6, 12, or 18 month Follow-up)|82
397693|NCT00183456|973043|P4|18 Month Follow-up|Overall Study||207
397694|NCT00183456|973044|P3|18 Month Follow-up|Overall Study||303
397695|NCT00183456|973045|P2|18 Month Follow-up|Overall Study||81
397696|NCT00183456|973046|P1|18 Month Follow-up|Overall Study||80
397697|NCT00183456|973043|P4|12 Month Follow-up|Overall Study||186
397698|NCT00183456|973044|P3|12 Month Follow-up|Overall Study||267
397699|NCT00183456|973045|P2|12 Month Follow-up|Overall Study||74
397700|NCT00183456|973046|P1|12 Month Follow-up|Overall Study||76
397701|NCT00183456|973043|P4|6 Month Follow-up|Overall Study||175
397702|NCT00183456|973044|P3|6 Month Follow-up|Overall Study||278
397703|NCT00183456|973045|P2|6 Month Follow-up|Overall Study||77
397704|NCT00183456|973046|P1|6 Month Follow-up|Overall Study||74
397705|NCT00183456|973043|P4|STARTED|Overall Study||248
397706|NCT00183456|973044|P3|STARTED|Overall Study||329
397707|NCT00183456|973045|P2|STARTED|Overall Study||84
397708|NCT00183456|973046|P1|STARTED|Overall Study||85
397709|NCT00183443|973095|P3|NOT COMPLETED|Overall Study||0
397710|NCT00183443|973096|P2|NOT COMPLETED|Overall Study||0
397711|NCT00183443|973097|P1|NOT COMPLETED|Overall Study||0
397712|NCT00183443|973095|P3|COMPLETED|Overall Study|4 eligible participants were offered enrollment in the continuation phase|25
397713|NCT00183443|973096|P2|COMPLETED|Overall Study|8 eligible participants were offered enrollment in the continuation phase|26
397714|NCT00183443|973097|P1|COMPLETED|Overall Study|13 eligible participants were offered enrollment in the continuation phase|24
397715|NCT00183443|973095|P3|STARTED|Overall Study||25
397716|NCT00183443|973096|P2|STARTED|Overall Study||26
397717|NCT00183443|973097|P1|STARTED|Overall Study||24
397718|NCT00183430|973119|P2|NOT COMPLETED|Overall Study||0
397719|NCT00183430|973120|P1|NOT COMPLETED|Overall Study||6
397720|NCT00183430|973119|P2|COMPLETED|Overall Study||11
397721|NCT00183430|973120|P1|COMPLETED|Overall Study||3
397722|NCT00183430|973119|P2|STARTED|Overall Study||11
397723|NCT00183430|973120|P1|STARTED|Overall Study||9
397724|NCT00183391|973132|P2|NOT COMPLETED|Block 2 - 5 Weeks||2
397725|NCT00183391|973133|P1|NOT COMPLETED|Block 2 - 5 Weeks||4
397726|NCT00183391|973132|P2|COMPLETED|Block 2 - 5 Weeks||108
397727|NCT00183391|973133|P1|COMPLETED|Block 2 - 5 Weeks||91
397728|NCT00183391|973132|P2|STARTED|Block 2 - 5 Weeks||110
397729|NCT00183391|973133|P1|STARTED|Block 2 - 5 Weeks||95
397730|NCT00183391|973132|P2|NOT COMPLETED|Crossover Placebo - 2 Weeks||0
397731|NCT00183391|973133|P1|NOT COMPLETED|Crossover Placebo - 2 Weeks||0
397732|NCT00183391|973132|P2|COMPLETED|Crossover Placebo - 2 Weeks||110
397733|NCT00183391|973133|P1|COMPLETED|Crossover Placebo - 2 Weeks||95
397734|NCT00183391|973132|P2|STARTED|Crossover Placebo - 2 Weeks||110
397735|NCT00183391|973133|P1|STARTED|Crossover Placebo - 2 Weeks||95
397736|NCT00183391|973132|P2|NOT COMPLETED|Block 1 - 5 Weeks||14
397737|NCT00183391|973133|P1|NOT COMPLETED|Block 1 - 5 Weeks||13
397738|NCT00183391|973132|P2|COMPLETED|Block 1 - 5 Weeks||110
397739|NCT00183391|973133|P1|COMPLETED|Block 1 - 5 Weeks||95
397740|NCT00183391|973132|P2|STARTED|Block 1 - 5 Weeks||124
397741|NCT00183391|973133|P1|STARTED|Block 1 - 5 Weeks||108
397742|NCT00183339|973193|P2|NOT COMPLETED|Overall Study||4
397743|NCT00183339|973194|P1|NOT COMPLETED|Overall Study||6
397744|NCT00183339|973193|P2|COMPLETED|Overall Study||4
397745|NCT00183339|973194|P1|COMPLETED|Overall Study||4
397746|NCT00183339|973193|P2|STARTED|Overall Study||8
397747|NCT00183339|973194|P1|STARTED|Overall Study||10
397748|NCT00183274|973206|P6|NOT COMPLETED|Phase 3: Double-Blind||4
397749|NCT00183274|973207|P5|NOT COMPLETED|Phase 3: Double-Blind||20
397750|NCT00183274|973208|P4|NOT COMPLETED|Phase 3: Double-Blind||2
397751|NCT00183274|973209|P3|NOT COMPLETED|Phase 3: Double-Blind||0
397752|NCT00183274|973210|P2|NOT COMPLETED|Phase 3: Double-Blind||0
397753|NCT00183274|973211|P1|NOT COMPLETED|Phase 3: Double-Blind||0
397754|NCT00183274|973206|P6|COMPLETED|Phase 3: Double-Blind|2 lost to relapse and 2 lost to dropout|6
397755|NCT00183274|973207|P5|COMPLETED|Phase 3: Double-Blind|11 lost to relapse and 9 lost to dropout|14
397756|NCT00183274|973208|P4|COMPLETED|Phase 3: Double-Blind|1 lost to relapse and 1 lost to dropout|13
397757|NCT00183274|973209|P3|COMPLETED|Phase 3: Double-Blind||0
397758|NCT00183274|973210|P2|COMPLETED|Phase 3: Double-Blind||0
397759|NCT00183274|973211|P1|COMPLETED|Phase 3: Double-Blind||0
397760|NCT00183274|973206|P6|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|10
397761|NCT00183274|973207|P5|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|34
397762|NCT00183274|973208|P4|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|15
397763|NCT00183274|973209|P3|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
397764|NCT00183274|973210|P2|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
397765|NCT00183274|973211|P1|STARTED|Phase 3: Double-Blind||0
397766|NCT00183274|973206|P6|NOT COMPLETED|Phase 2: Double-Blind||0
397767|NCT00183274|973207|P5|NOT COMPLETED|Phase 2: Double-Blind||0
397768|NCT00183274|973208|P4|NOT COMPLETED|Phase 2: Double-Blind||0
397769|NCT00183274|973209|P3|NOT COMPLETED|Phase 2: Double-Blind||43
397770|NCT00183274|973210|P2|NOT COMPLETED|Phase 2: Double-Blind||26
397771|NCT00183274|973211|P1|NOT COMPLETED|Phase 2: Double-Blind||0
397772|NCT00183274|973206|P6|COMPLETED|Phase 2: Double-Blind||0
397773|NCT00183274|973207|P5|COMPLETED|Phase 2: Double-Blind||0
397774|NCT00183274|973208|P4|COMPLETED|Phase 2: Double-Blind||0
397775|NCT00183274|973209|P3|COMPLETED|Phase 2: Double-Blind|29 lost to relapse, 14 lost to dropout|11
397776|NCT00183274|973210|P2|COMPLETED|Phase 2: Double-Blind|8 lost to relapse, 18 lost to dropout|56
397777|NCT00183274|973211|P1|COMPLETED|Phase 2: Double-Blind||0
397778|NCT00183274|973206|P6|STARTED|Phase 2: Double-Blind||0
397779|NCT00183274|973207|P5|STARTED|Phase 2: Double-Blind||0
397780|NCT00183274|973208|P4|STARTED|Phase 2: Double-Blind||0
397781|NCT00183274|973209|P3|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|54
397782|NCT00183274|973210|P2|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|82
397783|NCT00183274|973211|P1|STARTED|Phase 2: Double-Blind|This phase ended after 6 months. There were no longer participants in this phase.|0
397784|NCT00183274|973206|P6|NOT COMPLETED|Phase 1: Open-Label||0
397785|NCT00183274|973207|P5|NOT COMPLETED|Phase 1: Open-Label||0
397786|NCT00183274|973208|P4|NOT COMPLETED|Phase 1: Open-Label||0
397787|NCT00183274|973209|P3|NOT COMPLETED|Phase 1: Open-Label||0
397788|NCT00183274|973210|P2|NOT COMPLETED|Phase 1: Open-Label||0
397789|NCT00183274|973211|P1|NOT COMPLETED|Phase 1: Open-Label||110
397790|NCT00183274|973206|P6|COMPLETED|Phase 1: Open-Label||0
397791|NCT00183274|973207|P5|COMPLETED|Phase 1: Open-Label||0
397792|NCT00183274|973208|P4|COMPLETED|Phase 1: Open-Label||0
397793|NCT00183274|973209|P3|COMPLETED|Phase 1: Open-Label||0
397794|NCT00183274|973210|P2|COMPLETED|Phase 1: Open-Label||0
397795|NCT00183274|973211|P1|COMPLETED|Phase 1: Open-Label|110 dropouts during phase 1|158
397796|NCT00183274|973206|P6|STARTED|Phase 1: Open-Label||0
397797|NCT00183274|973207|P5|STARTED|Phase 1: Open-Label||0
397798|NCT00183274|973208|P4|STARTED|Phase 1: Open-Label||0
397799|NCT00183274|973209|P3|STARTED|Phase 1: Open-Label||0
397800|NCT00183274|973210|P2|STARTED|Phase 1: Open-Label||0
397801|NCT00183274|973211|P1|STARTED|Phase 1: Open-Label||268
397802|NCT00183248|973228|P2|NOT COMPLETED|Overall Study||1
397803|NCT00183248|973229|P1|NOT COMPLETED|Overall Study||1
397804|NCT00183248|973228|P2|COMPLETED|Overall Study||4
397805|NCT00183248|973229|P1|COMPLETED|Overall Study||3
397806|NCT00183248|973228|P2|STARTED|Overall Study||5
397807|NCT00183248|973229|P1|STARTED|Overall Study||4
397808|NCT00183196|973250|P3|NOT COMPLETED|Overall Study||18
397809|NCT00183196|973251|P2|NOT COMPLETED|Overall Study||15
397810|NCT00183196|973252|P1|NOT COMPLETED|Overall Study||20
397811|NCT00183196|973250|P3|COMPLETED|Overall Study||32
397812|NCT00183196|973251|P2|COMPLETED|Overall Study||35
397813|NCT00183196|973252|P1|COMPLETED|Overall Study||30
397814|NCT00183196|973250|P3|STARTED|Overall Study|1 subject had no post-randomization data|50
397815|NCT00183196|973251|P2|STARTED|Overall Study|1 subject had no post-randomization data|50
397816|NCT00183196|973252|P1|STARTED|Overall Study|2 subjects had no post-randomization data|50
397817|NCT00183092|973262|P4|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
397818|NCT00183092|973263|P3|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
397819|NCT00183092|973264|P2|NOT COMPLETED|Open-label Period (Month 2 Until Death)||14
397820|NCT00183092|973265|P1|NOT COMPLETED|Open-label Period (Month 2 Until Death)||10
397821|NCT00183092|973262|P4|COMPLETED|Open-label Period (Month 2 Until Death)||0
397822|NCT00183092|973263|P3|COMPLETED|Open-label Period (Month 2 Until Death)||0
397823|NCT00183092|973264|P2|COMPLETED|Open-label Period (Month 2 Until Death)||0
397824|NCT00183092|973265|P1|COMPLETED|Open-label Period (Month 2 Until Death)||0
397825|NCT00183092|973262|P4|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Placebo opted to continue assigned drug during open-label period|1
397826|NCT00183092|973263|P3|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Quinacrine opted to continue assigned drug during open-label period|1
397827|NCT00183092|973264|P2|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Placebo opted to begin open-label Quinacrine at Month 2|14
397828|NCT00183092|973265|P1|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Quinacrine opted to begin open-label Quinacrine at Month 2|10
397829|NCT00183092|973262|P4|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
397830|NCT00183092|973263|P3|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
397831|NCT00183092|973264|P2|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
397832|NCT00183092|973265|P1|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
397833|NCT00183092|973262|P4|COMPLETED|Double-blind (Baseline - Month 2)||0
397834|NCT00183092|973263|P3|COMPLETED|Double-blind (Baseline - Month 2)||0
397835|NCT00183092|973264|P2|COMPLETED|Double-blind (Baseline - Month 2)||16
397836|NCT00183092|973265|P1|COMPLETED|Double-blind (Baseline - Month 2)||11
397837|NCT00183092|973262|P4|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
397838|NCT00183092|973263|P3|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
397839|NCT00183092|973264|P2|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||16
397840|NCT00183092|973265|P1|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||10
397841|NCT00183092|973262|P4|Alive at Month 2|Double-blind (Baseline - Month 2)||0
397842|NCT00183092|973263|P3|Alive at Month 2|Double-blind (Baseline - Month 2)||0
397843|NCT00183092|973264|P2|Alive at Month 2|Double-blind (Baseline - Month 2)||19
397844|NCT00183092|973265|P1|Alive at Month 2|Double-blind (Baseline - Month 2)||13
397845|NCT00183092|973262|P4|STARTED|Double-blind (Baseline - Month 2)||0
397846|NCT00183092|973263|P3|STARTED|Double-blind (Baseline - Month 2)||0
397847|NCT00183092|973264|P2|STARTED|Double-blind (Baseline - Month 2)||28
397848|NCT00183092|973265|P1|STARTED|Double-blind (Baseline - Month 2)||23
397849|NCT00182793|973286|P1|NOT COMPLETED|Overall Study||0
397850|NCT00182793|973286|P1|COMPLETED|Overall Study||32
397851|NCT00182793|973286|P1|STARTED|Overall Study||32
397852|NCT00182767|973291|P5|NOT COMPLETED|Overall Study||0
397853|NCT00182767|973292|P4|NOT COMPLETED|Overall Study||0
397854|NCT00182767|973293|P3|NOT COMPLETED|Overall Study||0
397855|NCT00182767|973294|P2|NOT COMPLETED|Overall Study||0
397856|NCT00182767|973295|P1|NOT COMPLETED|Overall Study||0
397857|NCT00182767|973291|P5|COMPLETED|Overall Study||24
397858|NCT00182767|973292|P4|COMPLETED|Overall Study||3
397859|NCT00182767|973293|P3|COMPLETED|Overall Study||6
397860|NCT00182767|973294|P2|COMPLETED|Overall Study||6
397861|NCT00182767|973295|P1|COMPLETED|Overall Study||6
397862|NCT00182767|973291|P5|STARTED|Overall Study||24
397863|NCT00182767|973292|P4|STARTED|Overall Study||3
397864|NCT00182767|973293|P3|STARTED|Overall Study||6
397865|NCT00182767|973294|P2|STARTED|Overall Study||6
397866|NCT00182767|973295|P1|STARTED|Overall Study||6
397867|NCT00182754|973312|P2|NOT COMPLETED|Overall Study||0
397868|NCT00182754|973313|P1|NOT COMPLETED|Overall Study||0
397869|NCT00182754|973312|P2|COMPLETED|Overall Study||17
397870|NCT00182754|973313|P1|COMPLETED|Overall Study||16
397871|NCT00182754|973312|P2|STARTED|Overall Study||17
397872|NCT00182754|973313|P1|STARTED|Overall Study||16
397873|NCT00182728|973323|P1|NOT COMPLETED|Overall Study||0
397874|NCT00182728|973323|P1|COMPLETED|Overall Study||71
397875|NCT00182728|973323|P1|STARTED|Overall Study||71
397876|NCT00182689|973335|P2|NOT COMPLETED|Overall Study||49
397877|NCT00182689|973336|P1|NOT COMPLETED|Overall Study||40
397878|NCT00182689|973335|P2|COMPLETED|Overall Study||0
397879|NCT00182689|973336|P1|COMPLETED|Overall Study||0
397880|NCT00182689|973335|P2|Eligible and Began Protocol Therapy|Overall Study||45
397881|NCT00182689|973336|P1|Eligible and Began Protocol Therapy|Overall Study||38
397882|NCT00182689|973335|P2|Eligible|Overall Study||45
397883|NCT00182689|973336|P1|Eligible|Overall Study||39
397884|NCT00182689|973335|P2|STARTED|Overall Study||49
397885|NCT00182689|973336|P1|STARTED|Overall Study||40
397886|NCT00182637|973346|P1|NOT COMPLETED|Overall Study||3
397887|NCT00182637|973346|P1|COMPLETED|Overall Study|off study date|2
397888|NCT00182637|973346|P1|STARTED|Overall Study|active/on treatment date|5
397889|NCT00182325|973354|P2|NOT COMPLETED|Overall Study||53
397890|NCT00182325|973355|P1|NOT COMPLETED|Overall Study||34
397891|NCT00182325|973354|P2|COMPLETED|Overall Study|43 completed survey, 89 included in intention-to-treat analysis|43
397892|NCT00182325|973355|P1|COMPLETED|Overall Study|63 completed survey, 85 included in intention-to-treat analysis|63
397893|NCT00182325|973354|P2|STARTED|Overall Study||96
397894|NCT00182325|973355|P1|STARTED|Overall Study||97
397895|NCT00182091|973383|P4|NOT COMPLETED|Overall Study||0
397896|NCT00182091|973384|P3|NOT COMPLETED|Overall Study||0
397897|NCT00182091|973385|P2|NOT COMPLETED|Overall Study||0
397898|NCT00182091|973386|P1|NOT COMPLETED|Overall Study||1
397899|NCT00182091|973383|P4|COMPLETED|Overall Study||20
397900|NCT00182091|973384|P3|COMPLETED|Overall Study||25
397901|NCT00182091|973385|P2|COMPLETED|Overall Study||15
397902|NCT00182091|973386|P1|COMPLETED|Overall Study||14
397903|NCT00182091|973383|P4|STARTED|Overall Study||20
397904|NCT00182091|973384|P3|STARTED|Overall Study||25
397905|NCT00182091|973385|P2|STARTED|Overall Study||15
397906|NCT00182091|973386|P1|STARTED|Overall Study||15
397907|NCT00182078|973402|P2|NOT COMPLETED|Overall Study||0
397908|NCT00182078|973403|P1|NOT COMPLETED|Overall Study||1
397909|NCT00182078|973402|P2|COMPLETED|Overall Study||17
397910|NCT00182078|973403|P1|COMPLETED|Overall Study||8
397911|NCT00182078|973402|P2|STARTED|Overall Study||17
397912|NCT00182078|973403|P1|STARTED|Overall Study||9
397913|NCT00182000|973415|P2|NOT COMPLETED|Overall Study||2
397914|NCT00182000|973416|P1|NOT COMPLETED|Overall Study||5
397915|NCT00182000|973415|P2|COMPLETED|Overall Study||13
397916|NCT00182000|973416|P1|COMPLETED|Overall Study||9
397917|NCT00182000|973415|P2|STARTED|Overall Study||15
397918|NCT00182000|973416|P1|STARTED|Overall Study||14
397919|NCT00181961|973424|P2|NOT COMPLETED|Overall Study||5
397920|NCT00181961|973425|P1|NOT COMPLETED|Overall Study||1
397921|NCT00181961|973424|P2|COMPLETED|Overall Study||4
397922|NCT00181961|973425|P1|COMPLETED|Overall Study||6
397923|NCT00181961|973424|P2|STARTED|Overall Study||9
397924|NCT00181961|973425|P1|STARTED|Overall Study||7
397925|NCT00181883|973431|P1|NOT COMPLETED|Overall Study||10
397926|NCT00181883|973431|P1|COMPLETED|Overall Study||20
397927|NCT00181883|973431|P1|STARTED|Overall Study||30
397928|NCT00181844|973435|P1|NOT COMPLETED|Exposed to Study Medication||17
397929|NCT00181844|973435|P1|COMPLETED|Exposed to Study Medication||22
397930|NCT00181844|973435|P1|STARTED|Exposed to Study Medication||39
397931|NCT00181844|973435|P1|NOT COMPLETED|Signed Consent||12
397932|NCT00181844|973435|P1|COMPLETED|Signed Consent||39
397933|NCT00181844|973435|P1|STARTED|Signed Consent||51
397934|NCT00181766|973439|P1|NOT COMPLETED|Overall Study||12
397935|NCT00181766|973439|P1|COMPLETED|Overall Study|Completed the trial.|33
397936|NCT00181766|973439|P1|STARTED|Overall Study|Number of subjects enrolled and treated with Atomoxetine.|45
397937|NCT00181714|973444|P1|NOT COMPLETED|Began Treatment With OROS-MPH||124
397938|NCT00181714|973444|P1|COMPLETED|Began Treatment With OROS-MPH||30
397939|NCT00181714|973444|P1|STARTED|Began Treatment With OROS-MPH||154
397940|NCT00181714|973444|P1|NOT COMPLETED|Signed Consent/Enrolled||49
397941|NCT00181714|973444|P1|COMPLETED|Signed Consent/Enrolled||154
397942|NCT00181714|973444|P1|STARTED|Signed Consent/Enrolled||203
397943|NCT00181623|973448|P1|NOT COMPLETED|Overall Study||1
397944|NCT00181623|973448|P1|COMPLETED|Overall Study||5
397945|NCT00181623|973448|P1|STARTED|Overall Study||6
397946|NCT00181610|973456|P3|NOT COMPLETED|Overall Study||0
397947|NCT00181610|973457|P2|NOT COMPLETED|Overall Study||1
397948|NCT00181610|973458|P1|NOT COMPLETED|Overall Study||0
397949|NCT00181610|973456|P3|COMPLETED|Overall Study||3
397950|NCT00181610|973457|P2|COMPLETED|Overall Study||3
397951|NCT00181610|973458|P1|COMPLETED|Overall Study||4
397952|NCT00181610|973456|P3|STARTED|Overall Study||3
397953|NCT00181610|973457|P2|STARTED|Overall Study||4
397954|NCT00181610|973458|P1|STARTED|Overall Study||4
397955|NCT00181285|973471|P2|NOT COMPLETED|Overall Study||0
397956|NCT00181285|973472|P1|NOT COMPLETED|Overall Study||0
397957|NCT00181285|973471|P2|COMPLETED|Overall Study||25
397958|NCT00181285|973472|P1|COMPLETED|Overall Study||27
397959|NCT00181285|973471|P2|STARTED|Overall Study||25
397960|NCT00181285|973472|P1|STARTED|Overall Study||27
397961|NCT00181207|973482|P2|NOT COMPLETED|Overall Study||0
397962|NCT00181207|973483|P1|NOT COMPLETED|Overall Study||0
397963|NCT00181207|973482|P2|COMPLETED|Overall Study||26
397964|NCT00181207|973483|P1|COMPLETED|Overall Study||24
397965|NCT00181207|973482|P2|STARTED|Overall Study||26
397966|NCT00181207|973483|P1|STARTED|Overall Study||24
397967|NCT00181168|973493|P2|NOT COMPLETED|Overall Study||0
397968|NCT00181168|973494|P1|NOT COMPLETED|Overall Study||0
397969|NCT00181168|973493|P2|COMPLETED|Overall Study||33
397970|NCT00181168|973494|P1|COMPLETED|Overall Study||30
397971|NCT00181168|973493|P2|STARTED|Overall Study||33
397972|NCT00181168|973494|P1|STARTED|Overall Study||30
397973|NCT00181155|973500|P2|NOT COMPLETED|Overall Study||0
397974|NCT00181155|973501|P1|NOT COMPLETED|Overall Study||2
397975|NCT00181155|973500|P2|COMPLETED|Overall Study||3
397976|NCT00181155|973501|P1|COMPLETED|Overall Study||13
397977|NCT00181155|973500|P2|STARTED|Overall Study||3
397978|NCT00181155|973501|P1|STARTED|Overall Study||15
397979|NCT00180713|973511|P2|NOT COMPLETED|Overall Study||3
397980|NCT00180713|973512|P1|NOT COMPLETED|Overall Study||5
397981|NCT00180713|973511|P2|COMPLETED|Overall Study||16
397982|NCT00180713|973512|P1|COMPLETED|Overall Study||18
397983|NCT00180713|973511|P2|STARTED|Overall Study||19
397984|NCT00180713|973512|P1|STARTED|Overall Study||23
397985|NCT00180687|973530|P4|NOT COMPLETED|Overall Study||0
397986|NCT00180687|973531|P3|NOT COMPLETED|Overall Study||0
397987|NCT00180687|973532|P2|NOT COMPLETED|Overall Study||0
397988|NCT00180687|973533|P1|NOT COMPLETED|Overall Study||0
397989|NCT00180687|973530|P4|COMPLETED|Overall Study||20
397990|NCT00180687|973531|P3|COMPLETED|Overall Study||20
397991|NCT00180687|973532|P2|COMPLETED|Overall Study||20
397992|NCT00180687|973533|P1|COMPLETED|Overall Study||20
397993|NCT00180687|973530|P4|STARTED|Overall Study||20
397994|NCT00180687|973531|P3|STARTED|Overall Study||20
397995|NCT00180687|973532|P2|STARTED|Overall Study||20
397996|NCT00180687|973533|P1|STARTED|Overall Study||20
397997|NCT00180661|973557|P2|NOT COMPLETED|Overall Study||0
397998|NCT00180661|973558|P1|NOT COMPLETED|Overall Study||0
397999|NCT00180661|973557|P2|COMPLETED|Overall Study||20
398000|NCT00180661|973558|P1|COMPLETED|Overall Study||19
398001|NCT00180661|973557|P2|STARTED|Overall Study||20
398002|NCT00180661|973558|P1|STARTED|Overall Study||19
398003|NCT00180479|973576|P2|NOT COMPLETED|Overall Study||13
398004|NCT00180479|973577|P1|NOT COMPLETED|Overall Study||16
398005|NCT00180479|973576|P2|COMPLETED|Overall Study||320
398006|NCT00180479|973577|P1|COMPLETED|Overall Study||653
398007|NCT00180479|973576|P2|STARTED|Overall Study|1 patient randomized never signed consent, therefore no data collected. Analysis group = 332.|333
398008|NCT00180479|973577|P1|STARTED|Overall Study||669
398009|NCT00180323|973669|P1|NOT COMPLETED|Overall Study||0
398010|NCT00180323|973669|P1|COMPLETED|Overall Study||43
398011|NCT00180323|973669|P1|STARTED|Overall Study||43
398012|NCT00180271|973678|P2|NOT COMPLETED|Overall Study||0
398013|NCT00180271|973679|P1|NOT COMPLETED|Overall Study||0
398014|NCT00180271|973678|P2|COMPLETED|Overall Study||731
398015|NCT00180271|973679|P1|COMPLETED|Overall Study||1089
398016|NCT00180271|973678|P2|STARTED|Overall Study||731
398017|NCT00180271|973679|P1|STARTED|Overall Study||1089
398018|NCT00179998|973689|P2|NOT COMPLETED|Crossover Period - 6 Months||2
398019|NCT00179998|973690|P1|NOT COMPLETED|Crossover Period - 6 Months||0
398020|NCT00179998|973689|P2|COMPLETED|Crossover Period - 6 Months||10
398021|NCT00179998|973690|P1|COMPLETED|Crossover Period - 6 Months||12
398022|NCT00179998|973689|P2|STARTED|Crossover Period - 6 Months||12
398023|NCT00179998|973690|P1|STARTED|Crossover Period - 6 Months||12
398024|NCT00179998|973689|P2|NOT COMPLETED|Initial Period - 6 Months||0
398025|NCT00179998|973690|P1|NOT COMPLETED|Initial Period - 6 Months||0
398026|NCT00179998|973689|P2|COMPLETED|Initial Period - 6 Months||12
398027|NCT00179998|973690|P1|COMPLETED|Initial Period - 6 Months||12
398028|NCT00179998|973689|P2|STARTED|Initial Period - 6 Months||12
398029|NCT00179998|973690|P1|STARTED|Initial Period - 6 Months||12
398030|NCT00179959|973702|P2|NOT COMPLETED|Overall Study||3
398031|NCT00179959|973703|P1|NOT COMPLETED|Overall Study||6
398032|NCT00179959|973702|P2|COMPLETED|Overall Study||13
398033|NCT00179959|973703|P1|COMPLETED|Overall Study||9
398034|NCT00179959|973702|P2|STARTED|Overall Study||16
398035|NCT00179959|973703|P1|STARTED|Overall Study||15
398036|NCT00179673|973709|P1|NOT COMPLETED|Overall Study||43
398037|NCT00179673|973709|P1|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
398038|NCT00179673|973709|P1|Received Study Drug|Overall Study||43
398039|NCT00179673|973709|P1|STARTED|Overall Study||43
398040|NCT00179660|973717|P1|NOT COMPLETED|Overall Study||50
398041|NCT00179660|973717|P1|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
398042|NCT00179660|973717|P1|Completed 12 Cycles of Treatment|Overall Study||12
398043|NCT00179660|973717|P1|Received Study Drug|Overall Study||49
398044|NCT00179660|973717|P1|STARTED|Overall Study||50
398045|NCT00179647|973726|P1|NOT COMPLETED|Overall Study||1913
398046|NCT00179647|973726|P1|COMPLETED|Overall Study|Subjects participated in study until they presented with reason for discontinuation.|0
398047|NCT00179647|973726|P1|STARTED|Overall Study||1913
398048|NCT00179621|973733|P4|NOT COMPLETED|Open-Label Period||43
398049|NCT00179621|973734|P3|NOT COMPLETED|Open-Label Period||28
398050|NCT00179621|973735|P2|NOT COMPLETED|Open-Label Period||28
398051|NCT00179621|973736|P1|NOT COMPLETED|Open-Label Period||0
398052|NCT00179621|973733|P4|COMPLETED|Open-Label Period||13
398053|NCT00179621|973734|P3|COMPLETED|Open-Label Period||19
398054|NCT00179621|973735|P2|COMPLETED|Open-Label Period||14
398055|NCT00179621|973736|P1|COMPLETED|Open-Label Period||0
398056|NCT00179621|973733|P4|STARTED|Open-Label Period|'Started' includes 1 participant who completed double-blind and 55 who discontinued double-blind.|56
398057|NCT00179621|973734|P3|STARTED|Open-Label Period|'Started' includes 39 participants who completed double-blind and 8 who discontinued double-blind.|47
398058|NCT00179621|973735|P2|STARTED|Open-Label Period|'Started' includes 23 participants who completed double-blind and 19 who discontinued double-blind.|42
398059|NCT00179621|973736|P1|STARTED|Open-Label Period||0
398060|NCT00179621|973733|P4|NOT COMPLETED|Double-Blind Period||0
398061|NCT00179621|973734|P3|NOT COMPLETED|Double-Blind Period||30
398062|NCT00179621|973735|P2|NOT COMPLETED|Double-Blind Period||46
398063|NCT00179621|973736|P1|NOT COMPLETED|Double-Blind Period||64
398064|NCT00179621|973733|P4|COMPLETED|Double-Blind Period||0
398065|NCT00179621|973734|P3|COMPLETED|Double-Blind Period||39
398066|NCT00179621|973735|P2|COMPLETED|Double-Blind Period||23
398067|NCT00179621|973736|P1|COMPLETED|Double-Blind Period||3
398068|NCT00179621|973733|P4|STARTED|Double-Blind Period||0
398069|NCT00179621|973734|P3|STARTED|Double-Blind Period||69
398070|NCT00179621|973735|P2|STARTED|Double-Blind Period||69
398071|NCT00179621|973736|P1|STARTED|Double-Blind Period||67
398072|NCT00179517|973789|P2|NOT COMPLETED|Overall Study||1
398073|NCT00179517|973790|P1|NOT COMPLETED|Overall Study||2
398074|NCT00179517|973789|P2|COMPLETED|Overall Study||19
398075|NCT00179517|973790|P1|COMPLETED|Overall Study||18
398076|NCT00179517|973789|P2|STARTED|Overall Study||20
398077|NCT00179517|973790|P1|STARTED|Overall Study||20
398078|NCT00179478|973814|P2|NOT COMPLETED|Overall Study||15
398079|NCT00179478|973815|P1|NOT COMPLETED|Overall Study||13
398080|NCT00179478|973814|P2|COMPLETED|Overall Study||59
398081|NCT00179478|973815|P1|COMPLETED|Overall Study||68
398082|NCT00179478|973814|P2|STARTED|Overall Study||74
398083|NCT00179478|973815|P1|STARTED|Overall Study||81
398084|NCT00179413|973828|P2|NOT COMPLETED|Overall Study||115
398085|NCT00179413|973829|P1|NOT COMPLETED|Overall Study||125
398086|NCT00179413|973828|P2|COMPLETED|Overall Study||152
398087|NCT00179413|973829|P1|COMPLETED|Overall Study||157
398088|NCT00179413|973828|P2|STARTED|Overall Study||267
398089|NCT00179413|973829|P1|STARTED|Overall Study||282
398090|NCT00179309|973841|P2|NOT COMPLETED|Crossover||0
398091|NCT00179309|973842|P1|NOT COMPLETED|Crossover||0
398092|NCT00179309|973841|P2|COMPLETED|Crossover||3
398093|NCT00179309|973842|P1|COMPLETED|Crossover||0
398094|NCT00179309|973841|P2|STARTED|Crossover|Crossover was allowed so that patients randomized to B could receive the vaccine upon progression.|3
398095|NCT00179309|973842|P1|STARTED|Crossover||0
398096|NCT00179309|973841|P2|NOT COMPLETED|Treatment||5
398097|NCT00179309|973842|P1|NOT COMPLETED|Treatment||4
398098|NCT00179309|973841|P2|COMPLETED|Treatment||18
398099|NCT00179309|973842|P1|COMPLETED|Treatment||21
398100|NCT00179309|973841|P2|STARTED|Treatment||23
398101|NCT00179309|973842|P1|STARTED|Treatment||25
398102|NCT00179127|973852|P2|NOT COMPLETED|Overall Study||0
398103|NCT00179127|973853|P1|NOT COMPLETED|Overall Study||0
398104|NCT00179127|973852|P2|COMPLETED|Overall Study||0
398105|NCT00179127|973853|P1|COMPLETED|Overall Study||0
398106|NCT00179127|973852|P2|STARTED|Overall Study||0
398107|NCT00179127|973853|P1|STARTED|Overall Study||0
398108|NCT00179010|973865|P2|NOT COMPLETED|Overall Study||2
398109|NCT00179010|973866|P1|NOT COMPLETED|Overall Study||1
398110|NCT00179010|973865|P2|COMPLETED|Overall Study||5
398111|NCT00179010|973866|P1|COMPLETED|Overall Study||5
398112|NCT00179010|973865|P2|STARTED|Overall Study||7
398113|NCT00179010|973866|P1|STARTED|Overall Study||6
398114|NCT00178919|973876|P2|NOT COMPLETED|Overall Study||25
398115|NCT00178919|973877|P1|NOT COMPLETED|Overall Study||0
398116|NCT00178919|973876|P2|COMPLETED|Overall Study||68
398117|NCT00178919|973877|P1|COMPLETED|Overall Study||19
398118|NCT00178919|973876|P2|STARTED|Overall Study||93
398119|NCT00178919|973877|P1|STARTED|Overall Study||19
398120|NCT00178841|973885|P1|NOT COMPLETED|Overall Study||0
398121|NCT00178841|973885|P1|COMPLETED|Overall Study||4
398122|NCT00178841|973885|P1|STARTED|Overall Study||4
398123|NCT00178711|973893|P2|NOT COMPLETED|Overall Study||0
398124|NCT00178711|973894|P1|NOT COMPLETED|Overall Study||0
398125|NCT00178711|973893|P2|COMPLETED|Overall Study||45
398126|NCT00178711|973894|P1|COMPLETED|Overall Study||52
398127|NCT00178711|973893|P2|STARTED|Overall Study||45
398128|NCT00178711|973894|P1|STARTED|Overall Study||52
398129|NCT00178685|973905|P3|NOT COMPLETED|Overall Study||196
398130|NCT00178685|973906|P2|NOT COMPLETED|Overall Study||204
398131|NCT00178685|973907|P1|NOT COMPLETED|Overall Study||111
398132|NCT00178685|973905|P3|COMPLETED|Overall Study||128
398133|NCT00178685|973906|P2|COMPLETED|Overall Study||120
398134|NCT00178685|973907|P1|COMPLETED|Overall Study||61
398135|NCT00178685|973905|P3|STARTED|Overall Study||324
398136|NCT00178685|973906|P2|STARTED|Overall Study||324
398137|NCT00178685|973907|P1|STARTED|Overall Study||172
398138|NCT00178633|973918|P1|NOT COMPLETED|Overall Study||6
398139|NCT00178633|973918|P1|COMPLETED|Overall Study||37
398140|NCT00178633|973918|P1|STARTED|Overall Study||43
398141|NCT00178503|973926|P1|NOT COMPLETED|MPH Trial: High Dose||0
398142|NCT00178503|973926|P1|COMPLETED|MPH Trial: High Dose||24
398143|NCT00178503|973926|P1|STARTED|MPH Trial: High Dose||24
398144|NCT00178503|973926|P1|NOT COMPLETED|MPH Trial: Med Dose||0
398145|NCT00178503|973926|P1|COMPLETED|MPH Trial: Med Dose||24
398146|NCT00178503|973926|P1|STARTED|MPH Trial: Med Dose||24
398147|NCT00178503|973926|P1|NOT COMPLETED|MPH Trial: Low Dose||0
398148|NCT00178503|973926|P1|COMPLETED|MPH Trial: Low Dose||24
398149|NCT00178503|973926|P1|STARTED|MPH Trial: Low Dose||24
398150|NCT00178503|973926|P1|NOT COMPLETED|MPH Trial: Placebo||0
398151|NCT00178503|973926|P1|COMPLETED|MPH Trial: Placebo||24
398152|NCT00178503|973926|P1|STARTED|MPH Trial: Placebo||24
398153|NCT00178477|973944|P1|NOT COMPLETED|Overall Study||5
398154|NCT00178477|973944|P1|COMPLETED|Overall Study||5
398155|NCT00178477|973944|P1|STARTED|Overall Study||10
398156|NCT00178464|973948|P1|NOT COMPLETED|Overall Study||2
398157|NCT00178464|973948|P1|COMPLETED|Overall Study||9
398158|NCT00178464|973948|P1|STARTED|Overall Study||11
398159|NCT00178399|973953|P1|NOT COMPLETED|Overall Study||13
398160|NCT00178399|973953|P1|COMPLETED|Overall Study||115
398161|NCT00178399|973953|P1|STARTED|Overall Study||128
398162|NCT00178256|973960|P4|NOT COMPLETED|Overall Study||2
398163|NCT00178256|973961|P3|NOT COMPLETED|Overall Study||0
398164|NCT00178256|973962|P2|NOT COMPLETED|Overall Study||1
398165|NCT00178256|973963|P1|NOT COMPLETED|Overall Study||4
398166|NCT00178256|973960|P4|COMPLETED|Overall Study||16
398167|NCT00178256|973961|P3|COMPLETED|Overall Study||6
398168|NCT00178256|973962|P2|COMPLETED|Overall Study||6
398169|NCT00178256|973963|P1|COMPLETED|Overall Study||6
398170|NCT00178256|973960|P4|STARTED|Overall Study||18
398171|NCT00178256|973961|P3|STARTED|Overall Study||6
398172|NCT00178256|973962|P2|STARTED|Overall Study||7
398173|NCT00178256|973963|P1|STARTED|Overall Study||10
398174|NCT00178191|973973|P3|NOT COMPLETED|Overall Study||0
398175|NCT00178191|973974|P2|NOT COMPLETED|Overall Study||0
398176|NCT00178191|973975|P1|NOT COMPLETED|Overall Study||0
398177|NCT00178191|973973|P3|COMPLETED|Overall Study||7
398178|NCT00178191|973974|P2|COMPLETED|Overall Study||10
398179|NCT00178191|973975|P1|COMPLETED|Overall Study||11
398180|NCT00178191|973973|P3|STARTED|Overall Study||7
398181|NCT00178191|973974|P2|STARTED|Overall Study||10
398182|NCT00178191|973975|P1|STARTED|Overall Study||11
398183|NCT00178178|973987|P4|NOT COMPLETED|Overall Study||0
398184|NCT00178178|973988|P3|NOT COMPLETED|Overall Study||0
398185|NCT00178178|973989|P2|NOT COMPLETED|Overall Study||0
398186|NCT00178178|973990|P1|NOT COMPLETED|Overall Study||0
398187|NCT00178178|973987|P4|COMPLETED|Overall Study||24
398188|NCT00178178|973988|P3|COMPLETED|Overall Study||24
398189|NCT00178178|973989|P2|COMPLETED|Overall Study||24
398190|NCT00178178|973990|P1|COMPLETED|Overall Study||24
398191|NCT00178178|973987|P4|STARTED|Overall Study||24
398192|NCT00178178|973988|P3|STARTED|Overall Study||24
398193|NCT00178178|973989|P2|STARTED|Overall Study||24
398194|NCT00178178|973990|P1|STARTED|Overall Study||24
398195|NCT00178126|974002|P2|NOT COMPLETED|Overall Study||27
398196|NCT00178126|974003|P1|NOT COMPLETED|Overall Study||25
398197|NCT00178126|974002|P2|COMPLETED|Overall Study||86
398198|NCT00178126|974003|P1|COMPLETED|Overall Study||94
398199|NCT00178126|974002|P2|STARTED|Overall Study||113
398200|NCT00178126|974003|P1|STARTED|Overall Study||119
398201|NCT00177970|974011|P2|NOT COMPLETED|Overall Study||0
398202|NCT00177970|974012|P1|NOT COMPLETED|Overall Study||0
398203|NCT00177970|974011|P2|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
398204|NCT00177970|974012|P1|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
398205|NCT00177970|974011|P2|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
398206|NCT00177970|974012|P1|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
398207|NCT00177866|974034|P2|NOT COMPLETED|Overall Study||0
398208|NCT00177866|974035|P1|NOT COMPLETED|Overall Study||0
398209|NCT00177866|974034|P2|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
398210|NCT00177866|974035|P1|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
398211|NCT00177866|974034|P2|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
398212|NCT00177866|974035|P1|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
398213|NCT00177671|974045|P2|NOT COMPLETED|Overall Study||14
398214|NCT00177671|974046|P1|NOT COMPLETED|Overall Study||25
398215|NCT00177671|974045|P2|COMPLETED|Overall Study||49
398216|NCT00177671|974046|P1|COMPLETED|Overall Study||42
398217|NCT00177671|974045|P2|Month 24|Overall Study||49
398218|NCT00177671|974046|P1|Month 24|Overall Study||42
398219|NCT00177671|974045|P2|Month 12|Overall Study||57
398220|NCT00177671|974046|P1|Month 12|Overall Study||45
398221|NCT00177671|974045|P2|STARTED|Overall Study||63
398222|NCT00177671|974046|P1|STARTED|Overall Study||67
398223|NCT00177307|974058|P1|NOT COMPLETED|Overall Study||1
398224|NCT00177307|974058|P1|COMPLETED|Overall Study||39
398225|NCT00177307|974058|P1|STARTED|Overall Study||40
398226|NCT00177294|974067|P2|NOT COMPLETED|Overall Study||5
398227|NCT00177294|974068|P1|NOT COMPLETED|Overall Study||7
398228|NCT00177294|974067|P2|COMPLETED|Overall Study||59
398229|NCT00177294|974068|P1|COMPLETED|Overall Study||53
398230|NCT00177294|974067|P2|STARTED|Overall Study||64
398231|NCT00177294|974068|P1|STARTED|Overall Study||60
398232|NCT00177255|974074|P1|NOT COMPLETED|Overall Study||0
398233|NCT00177255|974074|P1|COMPLETED|Overall Study||39
398234|NCT00177255|974074|P1|STARTED|Overall Study||39
398235|NCT00177216|974082|P3|NOT COMPLETED|Overall Study||1
398236|NCT00177216|974083|P2|NOT COMPLETED|Overall Study||3
398237|NCT00177216|974084|P1|NOT COMPLETED|Overall Study||6
398238|NCT00177216|974082|P3|COMPLETED|Overall Study||19
398239|NCT00177216|974083|P2|COMPLETED|Overall Study||20
398240|NCT00177216|974084|P1|COMPLETED|Overall Study||20
398241|NCT00177216|974082|P3|STARTED|Overall Study||20
398242|NCT00177216|974083|P2|STARTED|Overall Study||23
398243|NCT00177216|974084|P1|STARTED|Overall Study||26
398244|NCT00177164|974100|P2|NOT COMPLETED|Overall Study||16
398245|NCT00177164|974101|P1|NOT COMPLETED|Overall Study||9
398246|NCT00177164|974100|P2|COMPLETED|Overall Study||9
398247|NCT00177164|974101|P1|COMPLETED|Overall Study||14
398248|NCT00177164|974100|P2|STARTED|Overall Study||25
398249|NCT00177164|974101|P1|STARTED|Overall Study||23
398250|NCT00176917|974113|P1|NOT COMPLETED|Overall Study||0
398251|NCT00176917|974113|P1|COMPLETED|Overall Study||41
398252|NCT00176917|974113|P1|STARTED|Overall Study||41
398253|NCT00176904|974120|P1|NOT COMPLETED|Overall Study||0
398254|NCT00176904|974120|P1|COMPLETED|Overall Study||135
398255|NCT00176904|974120|P1|STARTED|Overall Study||135
398256|NCT00176891|974128|P1|NOT COMPLETED|Overall Study||3
398257|NCT00176891|974128|P1|COMPLETED|Overall Study||22
398258|NCT00176891|974128|P1|STARTED|Overall Study||25
398259|NCT00176878|974139|P1|NOT COMPLETED|Overall Study||0
398260|NCT00176878|974139|P1|COMPLETED|Overall Study||10
398261|NCT00176878|974139|P1|STARTED|Overall Study||10
398262|NCT00176865|974151|P3|NOT COMPLETED|Overall Study||0
398263|NCT00176865|974152|P2|NOT COMPLETED|Overall Study||0
398264|NCT00176865|974153|P1|NOT COMPLETED|Overall Study||0
398265|NCT00176865|974151|P3|COMPLETED|Overall Study||6
398266|NCT00176865|974152|P2|COMPLETED|Overall Study||10
398267|NCT00176865|974153|P1|COMPLETED|Overall Study||3
398268|NCT00176865|974151|P3|STARTED|Overall Study||6
398269|NCT00176865|974152|P2|STARTED|Overall Study||10
398270|NCT00176865|974153|P1|STARTED|Overall Study||3
398271|NCT00176852|974191|P3|NOT COMPLETED|Overall Study||0
398272|NCT00176852|974192|P2|NOT COMPLETED|Overall Study||0
398273|NCT00176852|974193|P1|NOT COMPLETED|Overall Study||0
398274|NCT00176852|974191|P3|COMPLETED|Overall Study||14
398275|NCT00176852|974192|P2|COMPLETED|Overall Study||5
398276|NCT00176852|974193|P1|COMPLETED|Overall Study||3
398277|NCT00176852|974191|P3|STARTED|Overall Study||14
398278|NCT00176852|974192|P2|STARTED|Overall Study||5
398279|NCT00176852|974193|P1|STARTED|Overall Study||3
398280|NCT00176839|974252|P1|NOT COMPLETED|Overall Study||0
398281|NCT00176839|974252|P1|COMPLETED|Overall Study||11
398282|NCT00176839|974252|P1|STARTED|Overall Study||11
398283|NCT00176826|974261|P1|NOT COMPLETED|Overall Study||0
398284|NCT00176826|974261|P1|COMPLETED|Overall Study||22
398285|NCT00176826|974261|P1|STARTED|Overall Study||22
398286|NCT00176800|974271|P1|NOT COMPLETED|Overall Study||0
398287|NCT00176800|974271|P1|COMPLETED|Overall Study||69
398288|NCT00176800|974271|P1|STARTED|Overall Study||69
398289|NCT00176644|974277|P1|NOT COMPLETED|Overall Study||1
398290|NCT00176644|974277|P1|COMPLETED|Overall Study||22
398291|NCT00176644|974277|P1|STARTED|Overall Study||23
398292|NCT00176631|974285|P1|NOT COMPLETED|Overall Study||0
398293|NCT00176631|974285|P1|COMPLETED|Overall Study||10
398294|NCT00176631|974285|P1|STARTED|Overall Study||10
398295|NCT00176605|974290|P1|NOT COMPLETED|Overall Study||2
398296|NCT00176605|974290|P1|COMPLETED|Overall Study||13
398297|NCT00176605|974290|P1|STARTED|Overall Study||15
398298|NCT00176501|974295|P1|NOT COMPLETED|Overall Study||0
398299|NCT00176501|974295|P1|COMPLETED|Overall Study||3
398300|NCT00176501|974295|P1|STARTED|Overall Study||3
398301|NCT00176488|974301|P1|NOT COMPLETED|Overall Study||1
398302|NCT00176488|974301|P1|COMPLETED|Overall Study||30
398303|NCT00176488|974301|P1|STARTED|Overall Study||31
398304|NCT00176462|974309|P2|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
398305|NCT00176462|974310|P1|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
398306|NCT00176462|974309|P2|COMPLETED|Continuation -up to 30mos Post Remission||26
398307|NCT00176462|974310|P1|COMPLETED|Continuation -up to 30mos Post Remission||19
398308|NCT00176462|974309|P2|STARTED|Continuation -up to 30mos Post Remission||26
398309|NCT00176462|974310|P1|STARTED|Continuation -up to 30mos Post Remission||19
398310|NCT00176462|974309|P2|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||3
398311|NCT00176462|974310|P1|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||1
398312|NCT00176462|974309|P2|COMPLETED|Intensive Continuation (8X8-week Cycles)||26
398313|NCT00176462|974310|P1|COMPLETED|Intensive Continuation (8X8-week Cycles)||19
398314|NCT00176462|974309|P2|STARTED|Intensive Continuation (8X8-week Cycles)||29
398315|NCT00176462|974310|P1|STARTED|Intensive Continuation (8X8-week Cycles)||20
398316|NCT00176462|974309|P2|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
398317|NCT00176462|974310|P1|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
398318|NCT00176462|974309|P2|COMPLETED|Delayed Intensification (8 Weeks)||29
398319|NCT00176462|974310|P1|COMPLETED|Delayed Intensification (8 Weeks)||20
398320|NCT00176462|974309|P2|STARTED|Delayed Intensification (8 Weeks)||29
398321|NCT00176462|974310|P1|STARTED|Delayed Intensification (8 Weeks)||20
398322|NCT00176462|974309|P2|NOT COMPLETED|Consolidation (12 Weeks)||5
398323|NCT00176462|974310|P1|NOT COMPLETED|Consolidation (12 Weeks)||0
398324|NCT00176462|974309|P2|COMPLETED|Consolidation (12 Weeks)||29
398325|NCT00176462|974310|P1|COMPLETED|Consolidation (12 Weeks)||20
398326|NCT00176462|974309|P2|STARTED|Consolidation (12 Weeks)||34
398327|NCT00176462|974310|P1|STARTED|Consolidation (12 Weeks)||20
398328|NCT00176462|974309|P2|NOT COMPLETED|Induction (4 Weeks)||5
398329|NCT00176462|974310|P1|NOT COMPLETED|Induction (4 Weeks)||1
398330|NCT00176462|974309|P2|COMPLETED|Induction (4 Weeks)||34
398331|NCT00176462|974310|P1|COMPLETED|Induction (4 Weeks)||20
398332|NCT00176462|974309|P2|STARTED|Induction (4 Weeks)||39
398333|NCT00176462|974310|P1|STARTED|Induction (4 Weeks)||21
398334|NCT00176436|974319|P2|NOT COMPLETED|Overall Study||5
398335|NCT00176436|974320|P1|NOT COMPLETED|Overall Study||6
398336|NCT00176436|974319|P2|COMPLETED|Overall Study||12
398337|NCT00176436|974320|P1|COMPLETED|Overall Study||14
398338|NCT00176436|974319|P2|STARTED|Overall Study||17
398339|NCT00176436|974320|P1|STARTED|Overall Study||20
398340|NCT00176306|974326|P1|NOT COMPLETED|Overall Study||0
398341|NCT00176306|974326|P1|COMPLETED|Overall Study||15
398342|NCT00176306|974326|P1|STARTED|Overall Study||15
398343|NCT00176254|974330|P1|NOT COMPLETED|Overall Study||1
398344|NCT00176254|974330|P1|COMPLETED|Overall Study|1 patient only received 1 cycle and refused further induction, another progressed in neck nodes|39
398345|NCT00176254|974330|P1|STARTED|Overall Study||40
398346|NCT00176228|974338|P1|NOT COMPLETED|Overall Study||2
398347|NCT00176228|974338|P1|COMPLETED|Overall Study|Study ended|46
398348|NCT00176228|974338|P1|STARTED|Overall Study|When study began|48
398349|NCT00176202|974345|P2|NOT COMPLETED|Overall Study||16
398350|NCT00176202|974346|P1|NOT COMPLETED|Overall Study||5
398351|NCT00176202|974345|P2|COMPLETED|Overall Study||17
398352|NCT00176202|974346|P1|COMPLETED|Overall Study||27
398353|NCT00176202|974345|P2|STARTED|Overall Study||33
398354|NCT00176202|974346|P1|STARTED|Overall Study||32
398355|NCT00175877|974358|P1|NOT COMPLETED|Overall Study||349
398356|NCT00175877|974358|P1|COMPLETED|Overall Study||497
398357|NCT00175877|974358|P1|STARTED|Overall Study||846
398358|NCT00175825|974393|P4|NOT COMPLETED|Overall Study||1
398359|NCT00175825|974394|P3|NOT COMPLETED|Overall Study||1
398360|NCT00175825|974395|P2|NOT COMPLETED|Overall Study||4
398361|NCT00175825|974396|P1|NOT COMPLETED|Overall Study||5
398362|NCT00175825|974393|P4|COMPLETED|Overall Study||51
398363|NCT00175825|974394|P3|COMPLETED|Overall Study||51
398364|NCT00175825|974395|P2|COMPLETED|Overall Study||46
398365|NCT00175825|974396|P1|COMPLETED|Overall Study||49
398366|NCT00175825|974393|P4|STARTED|Overall Study||52
398367|NCT00175825|974394|P3|STARTED|Overall Study||52
398368|NCT00175825|974395|P2|STARTED|Overall Study||50
398369|NCT00175825|974396|P1|STARTED|Overall Study||54
398370|NCT00175019|974449|P3|NOT COMPLETED|Overall Study||57
398371|NCT00175019|974450|P2|NOT COMPLETED|Overall Study||171
398372|NCT00175019|974451|P1|NOT COMPLETED|Overall Study||194
398373|NCT00175019|974449|P3|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|35
398374|NCT00175019|974450|P2|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|217
398375|NCT00175019|974451|P1|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|412
398376|NCT00175019|974449|P3|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|92
398377|NCT00175019|974450|P2|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|388
398378|NCT00175019|974451|P1|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|606
398379|NCT00175006|974495|P1|NOT COMPLETED|Overall Study||0
398380|NCT00175006|974495|P1|COMPLETED|Overall Study||13
398381|NCT00175006|974495|P1|STARTED|Overall Study||13
398382|NCT00174967|974504|P4|NOT COMPLETED|Overall Study||2
398383|NCT00174967|974505|P3|NOT COMPLETED|Overall Study||2
398384|NCT00174967|974506|P2|NOT COMPLETED|Overall Study||3
398385|NCT00174967|974507|P1|NOT COMPLETED|Overall Study||1
398386|NCT00174967|974504|P4|COMPLETED|Overall Study||36
398387|NCT00174967|974505|P3|COMPLETED|Overall Study||36
398388|NCT00174967|974506|P2|COMPLETED|Overall Study||37
398389|NCT00174967|974507|P1|COMPLETED|Overall Study||36
398390|NCT00174967|974504|P4|STARTED|Overall Study||38
398391|NCT00174967|974505|P3|STARTED|Overall Study||38
398392|NCT00174967|974506|P2|STARTED|Overall Study||40
398393|NCT00174967|974507|P1|STARTED|Overall Study||37
398394|NCT00174954|974553|P1|NOT COMPLETED|Overall Study||4
398395|NCT00174954|974553|P1|COMPLETED|Overall Study||28
398396|NCT00174954|974553|P1|STARTED|Overall Study||32
398397|NCT00174941|974561|P4|NOT COMPLETED|Overall Study||58
398398|NCT00174941|974562|P3|NOT COMPLETED|Overall Study||18
398399|NCT00174941|974563|P2|NOT COMPLETED|Overall Study||38
398400|NCT00174941|974564|P1|NOT COMPLETED|Overall Study||2
398401|NCT00174941|974561|P4|COMPLETED|Overall Study||58
398402|NCT00174941|974562|P3|COMPLETED|Overall Study||11
398403|NCT00174941|974563|P2|COMPLETED|Overall Study||41
398404|NCT00174941|974564|P1|COMPLETED|Overall Study||6
398405|NCT00174941|974561|P4|STARTED|Overall Study||116
398406|NCT00174941|974562|P3|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|29
398407|NCT00174941|974563|P2|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|79
398408|NCT00174941|974564|P1|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|8
398409|NCT00174915|974639|P5|NOT COMPLETED|Overall Study||33
398410|NCT00174915|974640|P4|NOT COMPLETED|Overall Study||57
398411|NCT00174915|974641|P3|NOT COMPLETED|Overall Study||48
398412|NCT00174915|974642|P2|NOT COMPLETED|Overall Study||69
398413|NCT00174915|974643|P1|NOT COMPLETED|Overall Study||93
398414|NCT00174915|974639|P5|COMPLETED|Overall Study||101
398415|NCT00174915|974640|P4|COMPLETED|Overall Study||211
398416|NCT00174915|974641|P3|COMPLETED|Overall Study||86
398417|NCT00174915|974642|P2|COMPLETED|Overall Study||200
398418|NCT00174915|974643|P1|COMPLETED|Overall Study||174
398419|NCT00174915|974639|P5|STARTED|Overall Study||134
398420|NCT00174915|974640|P4|STARTED|Overall Study||268
398421|NCT00174915|974641|P3|STARTED|Overall Study||134
398422|NCT00174915|974642|P2|STARTED|Overall Study||269
398423|NCT00174915|974643|P1|STARTED|Overall Study||267
398424|NCT00174785|974702|P2|NOT COMPLETED|Overall Study||716
398425|NCT00174785|974703|P1|NOT COMPLETED|Overall Study||696
398426|NCT00174785|974702|P2|COMPLETED|Overall Study|completed study drug|1611
398427|NCT00174785|974703|P1|COMPLETED|Overall Study|completed study drug|1605
398428|NCT00174785|974702|P2|STARTED|Overall Study|randomized patients; among them, 14 patients did not receive any study drug in the placebo group|2327
398429|NCT00174785|974703|P1|STARTED|Overall Study|randomized patients; among them, 10 patients did not receive any study drug in the dronedarone group|2301
398430|NCT00174460|974719|P2|NOT COMPLETED|Overall Study||1
398431|NCT00174460|974720|P1|NOT COMPLETED|Overall Study||0
398432|NCT00174460|974719|P2|COMPLETED|Overall Study||14
398433|NCT00174460|974720|P1|COMPLETED|Overall Study||18
398434|NCT00174460|974719|P2|Received Study Treatment|Overall Study||14
398435|NCT00174460|974720|P1|Received Study Treatment|Overall Study||18
398436|NCT00174460|974719|P2|STARTED|Overall Study||15
398437|NCT00174460|974720|P1|STARTED|Overall Study||18
398438|NCT00174447|974766|P1|NOT COMPLETED|Overall Study||38
398439|NCT00174447|974766|P1|COMPLETED|Overall Study||5
398440|NCT00174447|974766|P1|STARTED|Overall Study||43
398441|NCT00174382|974775|P1|NOT COMPLETED|Overall Study||33
398442|NCT00174382|974775|P1|COMPLETED|Overall Study||116
398443|NCT00174382|974775|P1|STARTED|Overall Study|148 are summarized below: 1 subject entered the study but was lost to follow up.|149
398444|NCT00174291|974794|P2|NOT COMPLETED|Overall Study||6
398445|NCT00174291|974795|P1|NOT COMPLETED|Overall Study||5
398446|NCT00174291|974794|P2|COMPLETED|Overall Study||4
398447|NCT00174291|974795|P1|COMPLETED|Overall Study||6
398448|NCT00174291|974794|P2|STARTED|Overall Study||10
398449|NCT00174291|974795|P1|STARTED|Overall Study||11
398450|NCT00174265|974825|P2|NOT COMPLETED|Overall Study||21
398451|NCT00174265|974826|P1|NOT COMPLETED|Overall Study||29
398452|NCT00174265|974825|P2|COMPLETED|Overall Study||89
398453|NCT00174265|974826|P1|COMPLETED|Overall Study||57
398454|NCT00174265|974825|P2|STARTED|Overall Study||110
398455|NCT00174265|974826|P1|STARTED|Overall Study|85 participants received randomized treatment assignment and at least one dose of study medication.|86
398456|NCT00174252|974834|P1|NOT COMPLETED|Overall Study||2
398457|NCT00174252|974834|P1|COMPLETED|Overall Study||55
398458|NCT00174252|974834|P1|STARTED|Overall Study||57
398459|NCT00174187|974869|P3|NOT COMPLETED|Period 2 (After 3 Years)||8
398460|NCT00174187|974870|P2|NOT COMPLETED|Period 2 (After 3 Years)||0
398461|NCT00174187|974871|P1|NOT COMPLETED|Period 2 (After 3 Years)||0
398462|NCT00174187|974869|P3|COMPLETED|Period 2 (After 3 Years)||13
398463|NCT00174187|974870|P2|COMPLETED|Period 2 (After 3 Years)||0
398464|NCT00174187|974871|P1|COMPLETED|Period 2 (After 3 Years)||0
398465|NCT00174187|974869|P3|STARTED|Period 2 (After 3 Years)||21
398466|NCT00174187|974870|P2|STARTED|Period 2 (After 3 Years)||0
398467|NCT00174187|974871|P1|STARTED|Period 2 (After 3 Years)||0
398468|NCT00174187|974869|P3|NOT COMPLETED|Between Period 1 and Period 2||5
398469|NCT00174187|974870|P2|NOT COMPLETED|Between Period 1 and Period 2||0
398470|NCT00174187|974871|P1|NOT COMPLETED|Between Period 1 and Period 2||0
398471|NCT00174187|974869|P3|COMPLETED|Between Period 1 and Period 2||21
398472|NCT00174187|974870|P2|COMPLETED|Between Period 1 and Period 2||0
398473|NCT00174187|974871|P1|COMPLETED|Between Period 1 and Period 2||0
398474|NCT00174187|974869|P3|Consented|Between Period 1 and Period 2||24
398475|NCT00174187|974870|P2|Consented|Between Period 1 and Period 2||0
398476|NCT00174187|974871|P1|Consented|Between Period 1 and Period 2||0
398477|NCT00174187|974869|P3|STARTED|Between Period 1 and Period 2||26
398478|NCT00174187|974870|P2|STARTED|Between Period 1 and Period 2||0
398479|NCT00174187|974871|P1|STARTED|Between Period 1 and Period 2||0
398480|NCT00174187|974869|P3|NOT COMPLETED|Period 1 (up to 3 Years)||0
398481|NCT00174187|974870|P2|NOT COMPLETED|Period 1 (up to 3 Years)||4
398482|NCT00174187|974871|P1|NOT COMPLETED|Period 1 (up to 3 Years)||0
398483|NCT00174187|974869|P3|COMPLETED|Period 1 (up to 3 Years)||0
398484|NCT00174187|974870|P2|COMPLETED|Period 1 (up to 3 Years)||11
398485|NCT00174187|974871|P1|COMPLETED|Period 1 (up to 3 Years)||15
398486|NCT00174187|974869|P3|STARTED|Period 1 (up to 3 Years)||0
398487|NCT00174187|974870|P2|STARTED|Period 1 (up to 3 Years)||15
398488|NCT00174187|974871|P1|STARTED|Period 1 (up to 3 Years)||15
398489|NCT00172185|974936|P4|NOT COMPLETED|Overall Study||4
398490|NCT00172185|974937|P3|NOT COMPLETED|Overall Study||5
398491|NCT00172185|974938|P2|NOT COMPLETED|Overall Study||2
398492|NCT00172185|974939|P1|NOT COMPLETED|Overall Study||0
398493|NCT00172185|974936|P4|COMPLETED|Overall Study||23
398494|NCT00172185|974937|P3|COMPLETED|Overall Study||20
398495|NCT00172185|974938|P2|COMPLETED|Overall Study||5
398496|NCT00172185|974939|P1|COMPLETED|Overall Study||6
398497|NCT00172185|974936|P4|STARTED|Overall Study||27
398498|NCT00172185|974937|P3|STARTED|Overall Study||25
398499|NCT00172185|974938|P2|STARTED|Overall Study||7
398500|NCT00172185|974939|P1|STARTED|Overall Study||6
398501|NCT00172042|974955|P2|NOT COMPLETED|Overall Study||125
398502|NCT00172042|974956|P1|NOT COMPLETED|Overall Study||158
398503|NCT00172042|974955|P2|COMPLETED|Overall Study||86
398504|NCT00172042|974956|P1|COMPLETED|Overall Study||68
398505|NCT00172042|974955|P2|STARTED|Overall Study||211
398506|NCT00172042|974956|P1|STARTED|Overall Study||226
398507|NCT00171925|974978|P2|NOT COMPLETED|Overall Study||31
398508|NCT00171925|974979|P1|NOT COMPLETED|Overall Study||30
398509|NCT00171925|974978|P2|COMPLETED|Overall Study||40
398510|NCT00171925|974979|P1|COMPLETED|Overall Study||42
398511|NCT00171925|974978|P2|STARTED|Overall Study||71
398512|NCT00171925|974979|P1|STARTED|Overall Study||72
398513|NCT00171873|974991|P2|NOT COMPLETED|Overall Study||3
398514|NCT00171873|974992|P1|NOT COMPLETED|Overall Study||9
398515|NCT00171873|974991|P2|COMPLETED|Overall Study||40
398516|NCT00171873|974992|P1|COMPLETED|Overall Study||33
398517|NCT00171873|974991|P2|STARTED|Overall Study||43
398518|NCT00171873|974992|P1|STARTED|Overall Study||42
398519|NCT00171834|975005|P7|NOT COMPLETED|Overall Study||4
398520|NCT00171834|975006|P6|NOT COMPLETED|Overall Study||35
398521|NCT00171834|975007|P5|NOT COMPLETED|Overall Study||8
398522|NCT00171834|975008|P4|NOT COMPLETED|Overall Study||12
398523|NCT00171834|975009|P3|NOT COMPLETED|Overall Study||12
398524|NCT00171834|975010|P2|NOT COMPLETED|Overall Study||12
398525|NCT00171834|975011|P1|NOT COMPLETED|Overall Study||6
398526|NCT00171834|975005|P7|COMPLETED|Overall Study||0
398527|NCT00171834|975006|P6|COMPLETED|Overall Study||0
398528|NCT00171834|975007|P5|COMPLETED|Overall Study||0
398529|NCT00171834|975008|P4|COMPLETED|Overall Study||0
398530|NCT00171834|975009|P3|COMPLETED|Overall Study||0
398531|NCT00171834|975010|P2|COMPLETED|Overall Study||0
398532|NCT00171834|975011|P1|COMPLETED|Overall Study||0
398533|NCT00171834|975005|P7|Completed 6 Cycles of Treatment|Overall Study||0
398534|NCT00171834|975006|P6|Completed 6 Cycles of Treatment|Overall Study||1
398535|NCT00171834|975007|P5|Completed 6 Cycles of Treatment|Overall Study||2
398536|NCT00171834|975008|P4|Completed 6 Cycles of Treatment|Overall Study||0
398537|NCT00171834|975009|P3|Completed 6 Cycles of Treatment|Overall Study||1
398538|NCT00171834|975010|P2|Completed 6 Cycles of Treatment|Overall Study||0
398539|NCT00171834|975011|P1|Completed 6 Cycles of Treatment|Overall Study||0
398540|NCT00171834|975005|P7|STARTED|Overall Study||4
398541|NCT00171834|975006|P6|STARTED|Overall Study||35
398542|NCT00171834|975007|P5|STARTED|Overall Study||8
398543|NCT00171834|975008|P4|STARTED|Overall Study||12
398544|NCT00171834|975009|P3|STARTED|Overall Study||12
398545|NCT00171834|975010|P2|STARTED|Overall Study||12
398546|NCT00171834|975011|P1|STARTED|Overall Study||6
398547|NCT00171704|975051|P2|NOT COMPLETED|Overall Study||49
398548|NCT00171704|975052|P1|NOT COMPLETED|Overall Study||44
398549|NCT00171704|975051|P2|COMPLETED|Overall Study||81
398550|NCT00171704|975052|P1|COMPLETED|Overall Study||89
398551|NCT00171704|975051|P2|STARTED|Overall Study||130
398552|NCT00171704|975052|P1|STARTED|Overall Study||133
398553|NCT00171340|975074|P2|NOT COMPLETED|Overall Study||135
398554|NCT00171340|975075|P1|NOT COMPLETED|Overall Study||124
398555|NCT00171340|975074|P2|COMPLETED|Overall Study||398
398556|NCT00171340|975075|P1|COMPLETED|Overall Study||408
398557|NCT00171340|975074|P2|STARTED|Overall Study||533
398558|NCT00171340|975075|P1|STARTED|Overall Study||532
398559|NCT00171314|975091|P2|NOT COMPLETED|Overall Study||78
398560|NCT00171314|975092|P1|NOT COMPLETED|Overall Study||91
398561|NCT00171314|975091|P2|COMPLETED|Overall Study||186
398562|NCT00171314|975092|P1|COMPLETED|Overall Study||172
398563|NCT00171314|975091|P2|Safety Population|Overall Study|"Treatment Actually Received = 10 from upfront Arm and 259 from delayed Arm"|269
398564|NCT00171314|975092|P1|Safety Population|Overall Study|"Treatment Actually Received = 251 from upfront Arm and 3 from delayed Arm"|254
398565|NCT00171314|975091|P2|STARTED|Overall Study||264
398566|NCT00171314|975092|P1|STARTED|Overall Study|2 patients in each arm were randomized but not treated.|263
398567|NCT00171301|975108|P2|NOT COMPLETED|Overall Study||9
398568|NCT00171301|975109|P1|NOT COMPLETED|Overall Study||8
398569|NCT00171301|975108|P2|COMPLETED|Overall Study||62
398570|NCT00171301|975109|P1|COMPLETED|Overall Study||154
398571|NCT00171301|975108|P2|Received Deferasirox|Overall Study||69
398572|NCT00171301|975109|P1|Received Deferasirox|Overall Study||162
398573|NCT00171301|975108|P2|STARTED|Overall Study|2 participants in this group never received deferasirox.|71
398574|NCT00171301|975109|P1|STARTED|Overall Study||162
398575|NCT00171210|975122|P2|NOT COMPLETED|Overall Study||115
398576|NCT00171210|975123|P1|NOT COMPLETED|Overall Study||69
398577|NCT00171210|975122|P2|COMPLETED|Overall Study||181
398578|NCT00171210|975123|P1|COMPLETED|Overall Study||190
398579|NCT00171210|975122|P2|STARTED EXTENSION STUDY|Overall Study||247
398580|NCT00171210|975123|P1|STARTED EXTENSION STUDY|Overall Study||259
398581|NCT00171210|975122|P2|STARTED|Overall Study||296
398582|NCT00171210|975123|P1|STARTED|Overall Study||259
398583|NCT00171054|975153|P2|NOT COMPLETED|Overall Study||12
398584|NCT00171054|975154|P1|NOT COMPLETED|Overall Study||10
398585|NCT00171054|975153|P2|COMPLETED|Overall Study||50
398586|NCT00171054|975154|P1|COMPLETED|Overall Study||53
398587|NCT00171054|975153|P2|STARTED|Overall Study||62
398588|NCT00171054|975154|P1|STARTED|Overall Study||63
398589|NCT00170950|975186|P2|NOT COMPLETED|Overall Study||910
398590|NCT00170950|975187|P1|NOT COMPLETED|Overall Study||885
398591|NCT00170950|975186|P2|COMPLETED|Overall Study||4852
398592|NCT00170950|975187|P1|COMPLETED|Overall Study||4859
398593|NCT00170950|975186|P2|STARTED|Overall Study||5762
398594|NCT00170950|975187|P1|STARTED|Overall Study||5744
398595|NCT00170846|975200|P3|NOT COMPLETED|Overall Study||13
398596|NCT00170846|975201|P2|NOT COMPLETED|Overall Study||19
398597|NCT00170846|975202|P1|NOT COMPLETED|Overall Study||11
398598|NCT00170846|975200|P3|COMPLETED|Overall Study||131
398599|NCT00170846|975201|P2|COMPLETED|Overall Study||108
398600|NCT00170846|975202|P1|COMPLETED|Overall Study||112
398601|NCT00170846|975200|P3|STARTED|Overall Study||144
398602|NCT00170846|975201|P2|STARTED|Overall Study||127
398603|NCT00170846|975202|P1|STARTED|Overall Study||123
398604|NCT00170625|975216|P1|NOT COMPLETED|Overall Study||0
398605|NCT00170625|975216|P1|COMPLETED|Overall Study||26
398606|NCT00170625|975216|P1|STARTED|Overall Study||26
398607|NCT00170157|975221|P2|NOT COMPLETED|Treatment Period 2 Crossover||0
398608|NCT00170157|975222|P1|NOT COMPLETED|Treatment Period 2 Crossover||0
398609|NCT00170157|975221|P2|COMPLETED|Treatment Period 2 Crossover||41
398610|NCT00170157|975222|P1|COMPLETED|Treatment Period 2 Crossover||0
398611|NCT00170157|975221|P2|STARTED|Treatment Period 2 Crossover||41
398612|NCT00170157|975222|P1|STARTED|Treatment Period 2 Crossover|Participants initially randomized to this arm were not eligible for crossover.|0
398613|NCT00170157|975221|P2|NOT COMPLETED|Washout Period of 14 Days||17
398614|NCT00170157|975222|P1|NOT COMPLETED|Washout Period of 14 Days||0
398615|NCT00170157|975221|P2|COMPLETED|Washout Period of 14 Days||41
398616|NCT00170157|975222|P1|COMPLETED|Washout Period of 14 Days||0
398617|NCT00170157|975221|P2|STARTED|Washout Period of 14 Days||58
398618|NCT00170157|975222|P1|STARTED|Washout Period of 14 Days|Participants initially randomized to this arm were not eligible for crossover.|0
398619|NCT00170157|975221|P2|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
398620|NCT00170157|975222|P1|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
398621|NCT00170157|975221|P2|COMPLETED|Treatment Period 1 Initial Randomization||58
398622|NCT00170157|975222|P1|COMPLETED|Treatment Period 1 Initial Randomization||54
398623|NCT00170157|975221|P2|STARTED|Treatment Period 1 Initial Randomization||58
398624|NCT00170157|975222|P1|STARTED|Treatment Period 1 Initial Randomization||54
398625|NCT00169442|975234|P6|NOT COMPLETED|Overall Study||2
398626|NCT00169442|975235|P5|NOT COMPLETED|Overall Study||1
398627|NCT00169442|975236|P4|NOT COMPLETED|Overall Study||0
398628|NCT00169442|975237|P3|NOT COMPLETED|Overall Study||1
398629|NCT00169442|975238|P2|NOT COMPLETED|Overall Study||1
398630|NCT00169442|975239|P1|NOT COMPLETED|Overall Study||0
398631|NCT00169442|975234|P6|COMPLETED|Overall Study||41
398632|NCT00169442|975235|P5|COMPLETED|Overall Study||41
398633|NCT00169442|975236|P4|COMPLETED|Overall Study||250
398634|NCT00169442|975237|P3|COMPLETED|Overall Study||166
398635|NCT00169442|975238|P2|COMPLETED|Overall Study||123
398636|NCT00169442|975239|P1|COMPLETED|Overall Study||119
398637|NCT00169442|975234|P6|STARTED|Overall Study||43
398638|NCT00169442|975235|P5|STARTED|Overall Study||42
398639|NCT00169442|975236|P4|STARTED|Overall Study||250
398640|NCT00169442|975237|P3|STARTED|Overall Study||167
398641|NCT00169442|975238|P2|STARTED|Overall Study||124
398642|NCT00169442|975239|P1|STARTED|Overall Study||119
398643|NCT00169104|975348|P2|NOT COMPLETED|Overall Study||2
398644|NCT00169104|975349|P1|NOT COMPLETED|Overall Study||2
398645|NCT00169104|975348|P2|COMPLETED|Overall Study||8
398646|NCT00169104|975349|P1|COMPLETED|Overall Study||11
398647|NCT00169104|975348|P2|STARTED|Overall Study||10
398648|NCT00169104|975349|P1|STARTED|Overall Study||13
398649|NCT00168844|975363|P3|NOT COMPLETED|Overall Study||91
398650|NCT00168844|975364|P2|NOT COMPLETED|Overall Study||55
398651|NCT00168844|975365|P1|NOT COMPLETED|Overall Study||55
398652|NCT00168844|975363|P3|COMPLETED|Overall Study||228
398653|NCT00168844|975364|P2|COMPLETED|Overall Study||277
398654|NCT00168844|975365|P1|COMPLETED|Overall Study||277
398655|NCT00168844|975363|P3|STARTED|Overall Study||319
398656|NCT00168844|975364|P2|STARTED|Overall Study||332
398657|NCT00168844|975365|P1|STARTED|Overall Study||332
398658|NCT00168831|975547|P3|NOT COMPLETED|Overall Study||114
398659|NCT00168831|975548|P2|NOT COMPLETED|Overall Study||81
398660|NCT00168831|975549|P1|NOT COMPLETED|Overall Study||60
398661|NCT00168831|975547|P3|COMPLETED|Overall Study||220
398662|NCT00168831|975548|P2|COMPLETED|Overall Study||254
398663|NCT00168831|975549|P1|COMPLETED|Overall Study||278
398664|NCT00168831|975547|P3|STARTED|Overall Study||334
398665|NCT00168831|975548|P2|STARTED|Overall Study||335
398666|NCT00168831|975549|P1|STARTED|Overall Study||338
398667|NCT00168818|975731|P3|NOT COMPLETED|Treatment||133
398668|NCT00168818|975732|P2|NOT COMPLETED|Treatment||151
398669|NCT00168818|975733|P1|NOT COMPLETED|Treatment||133
398670|NCT00168818|975731|P3|COMPLETED|Treatment||1021
398671|NCT00168818|975732|P2|COMPLETED|Treatment||1012
398672|NCT00168818|975733|P1|COMPLETED|Treatment||1013
398673|NCT00168818|975731|P3|STARTED|Treatment||1154
398674|NCT00168818|975732|P2|STARTED|Treatment||1163
398675|NCT00168818|975733|P1|STARTED|Treatment||1146
398676|NCT00168818|975731|P3|NOT COMPLETED|Overall Study||124
398677|NCT00168818|975732|P2|NOT COMPLETED|Overall Study||109
398678|NCT00168818|975733|P1|NOT COMPLETED|Overall Study||117
398679|NCT00168818|975731|P3|COMPLETED|Overall Study||1030
398680|NCT00168818|975732|P2|COMPLETED|Overall Study||1054
398681|NCT00168818|975733|P1|COMPLETED|Overall Study||1029
398682|NCT00168818|975731|P3|STARTED|Overall Study||1154
398683|NCT00168818|975732|P2|STARTED|Overall Study||1163
398684|NCT00168818|975733|P1|STARTED|Overall Study||1146
398685|NCT00168805|975777|P3|NOT COMPLETED|Treatment||62
398686|NCT00168805|975778|P2|NOT COMPLETED|Treatment||56
398687|NCT00168805|975779|P1|NOT COMPLETED|Treatment||49
398688|NCT00168805|975777|P3|COMPLETED|Treatment||632
398689|NCT00168805|975778|P2|COMPLETED|Treatment||647
398690|NCT00168805|975779|P1|COMPLETED|Treatment||630
398691|NCT00168805|975777|P3|STARTED|Treatment||694
398692|NCT00168805|975778|P2|STARTED|Treatment||703
398693|NCT00168805|975779|P1|STARTED|Treatment||679
398694|NCT00168805|975777|P3|NOT COMPLETED|Overall Study||78
398695|NCT00168805|975778|P2|NOT COMPLETED|Overall Study||78
398696|NCT00168805|975779|P1|NOT COMPLETED|Overall Study||71
398697|NCT00168805|975777|P3|COMPLETED|Overall Study||616
398698|NCT00168805|975778|P2|COMPLETED|Overall Study||625
398699|NCT00168805|975779|P1|COMPLETED|Overall Study||608
398700|NCT00168805|975777|P3|STARTED|Overall Study||694
398701|NCT00168805|975778|P2|STARTED|Overall Study||703
398702|NCT00168805|975779|P1|STARTED|Overall Study||679
398703|NCT00168454|975826|P6|NOT COMPLETED|Overall Study||6
398704|NCT00168454|975827|P5|NOT COMPLETED|Overall Study||6
398705|NCT00168454|975828|P4|NOT COMPLETED|Overall Study||9
398706|NCT00168454|975829|P3|NOT COMPLETED|Overall Study||6
398707|NCT00168454|975830|P2|NOT COMPLETED|Overall Study||7
398708|NCT00168454|975831|P1|NOT COMPLETED|Overall Study||7
398709|NCT00168454|975826|P6|COMPLETED|Overall Study||50
398710|NCT00168454|975827|P5|COMPLETED|Overall Study||47
398711|NCT00168454|975828|P4|COMPLETED|Overall Study||40
398712|NCT00168454|975829|P3|COMPLETED|Overall Study||48
398713|NCT00168454|975830|P2|COMPLETED|Overall Study||50
398714|NCT00168454|975831|P1|COMPLETED|Overall Study||37
398715|NCT00168454|975826|P6|STARTED|Overall Study||56
398716|NCT00168454|975827|P5|STARTED|Overall Study||53
398717|NCT00168454|975828|P4|STARTED|Overall Study||49
398718|NCT00168454|975829|P3|STARTED|Overall Study||54
398719|NCT00168454|975830|P2|STARTED|Overall Study||57
398720|NCT00168454|975831|P1|STARTED|Overall Study||44
398721|NCT00168428|975877|P2|NOT COMPLETED|Open-Label Phase (OL)||68
398722|NCT00168428|975878|P1|NOT COMPLETED|Open-Label Phase (OL)||44
398723|NCT00168428|975877|P2|COMPLETED|Open-Label Phase (OL)||261
398724|NCT00168428|975878|P1|COMPLETED|Open-Label Phase (OL)||261
398725|NCT00168428|975877|P2|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL phase|329
398726|NCT00168428|975878|P1|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|305
398727|NCT00168428|975877|P2|NOT COMPLETED|Double-Blind Phase (DB)||24
398728|NCT00168428|975878|P1|NOT COMPLETED|Double-Blind Phase (DB)||36
398729|NCT00168428|975877|P2|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|334
398730|NCT00168428|975878|P1|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|311
398731|NCT00168428|975877|P2|STARTED|Double-Blind Phase (DB)||358
398732|NCT00168428|975878|P1|STARTED|Double-Blind Phase (DB)||347
398733|NCT00168389|975897|P3|NOT COMPLETED|Overall Study||95
398734|NCT00168389|975898|P2|NOT COMPLETED|Overall Study||48
398735|NCT00168389|975899|P1|NOT COMPLETED|Overall Study||56
398736|NCT00168389|975897|P3|COMPLETED|Overall Study||70
398737|NCT00168389|975898|P2|COMPLETED|Overall Study||118
398738|NCT00168389|975899|P1|COMPLETED|Overall Study||107
398739|NCT00168389|975897|P3|STARTED|Overall Study||165
398740|NCT00168389|975898|P2|STARTED|Overall Study||166
398741|NCT00168389|975899|P1|STARTED|Overall Study||163
398742|NCT00168337|975928|P3|NOT COMPLETED|Overall Study||103
398743|NCT00168337|975929|P2|NOT COMPLETED|Overall Study||69
398744|NCT00168337|975930|P1|NOT COMPLETED|Overall Study||70
398745|NCT00168337|975928|P3|COMPLETED|Overall Study||82
398746|NCT00168337|975929|P2|COMPLETED|Overall Study||112
398747|NCT00168337|975930|P1|COMPLETED|Overall Study||118
398748|NCT00168337|975928|P3|STARTED|Overall Study||185
398749|NCT00168337|975929|P2|STARTED|Overall Study||181
398750|NCT00168337|975930|P1|STARTED|Overall Study||188
398751|NCT00168324|975959|P3|NOT COMPLETED|Open-Label Period||6
398752|NCT00168324|975960|P2|NOT COMPLETED|Open-Label Period||8
398753|NCT00168324|975961|P1|NOT COMPLETED|Open-Label Period||4
398754|NCT00168324|975959|P3|COMPLETED|Open-Label Period||152
398755|NCT00168324|975960|P2|COMPLETED|Open-Label Period||147
398756|NCT00168324|975961|P1|COMPLETED|Open-Label Period||160
398757|NCT00168324|975959|P3|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|158
398758|NCT00168324|975960|P2|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|155
398759|NCT00168324|975961|P1|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|164
398760|NCT00168324|975959|P3|NOT COMPLETED|Double-Blind Period||13
398761|NCT00168324|975960|P2|NOT COMPLETED|Double-Blind Period||7
398762|NCT00168324|975961|P1|NOT COMPLETED|Double-Blind Period||12
398763|NCT00168324|975959|P3|COMPLETED|Double-Blind Period||189
398764|NCT00168324|975960|P2|COMPLETED|Double-Blind Period||189
398765|NCT00168324|975961|P1|COMPLETED|Double-Blind Period||189
398766|NCT00168324|975959|P3|STARTED|Double-Blind Period||202
398767|NCT00168324|975960|P2|STARTED|Double-Blind Period||196
398768|NCT00168324|975961|P1|STARTED|Double-Blind Period||201
398769|NCT00168311|975983|P2|NOT COMPLETED|Overall Study||2
398770|NCT00168311|975984|P1|NOT COMPLETED|Overall Study||0
398771|NCT00168311|975983|P2|COMPLETED|Overall Study||8
398772|NCT00168311|975984|P1|COMPLETED|Overall Study||12
398773|NCT00168311|975983|P2|STARTED|Overall Study||10
398774|NCT00168311|975984|P1|STARTED|Overall Study||12
398775|NCT00168298|975993|P3|NOT COMPLETED|Open-Label Period||8
398776|NCT00168298|975994|P2|NOT COMPLETED|Open-Label Period||5
398777|NCT00168298|975995|P1|NOT COMPLETED|Open-Label Period||7
398778|NCT00168298|975993|P3|COMPLETED|Open-Label Period||160
398779|NCT00168298|975994|P2|COMPLETED|Open-Label Period||168
398780|NCT00168298|975995|P1|COMPLETED|Open-Label Period||172
398781|NCT00168298|975993|P3|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|168
398782|NCT00168298|975994|P2|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|173
398783|NCT00168298|975995|P1|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|179
398784|NCT00168298|975993|P3|NOT COMPLETED|Double-Blind Period||15
398785|NCT00168298|975994|P2|NOT COMPLETED|Double-Blind Period||12
398786|NCT00168298|975995|P1|NOT COMPLETED|Double-Blind Period||12
398787|NCT00168298|975993|P3|COMPLETED|Double-Blind Period||209
398788|NCT00168298|975994|P2|COMPLETED|Double-Blind Period||206
398789|NCT00168298|975995|P1|COMPLETED|Double-Blind Period||214
398790|NCT00168298|975993|P3|STARTED|Double-Blind Period||224
398791|NCT00168298|975994|P2|STARTED|Double-Blind Period||218
398792|NCT00168298|975995|P1|STARTED|Double-Blind Period||226
398793|NCT00168103|976015|P4|NOT COMPLETED|Overall Study||0
398794|NCT00168103|976016|P3|NOT COMPLETED|Overall Study||1
398795|NCT00168103|976017|P2|NOT COMPLETED|Overall Study||5
398796|NCT00168103|976018|P1|NOT COMPLETED|Overall Study||2
398797|NCT00168103|976015|P4|COMPLETED|Overall Study||1
398798|NCT00168103|976016|P3|COMPLETED|Overall Study||41
398799|NCT00168103|976017|P2|COMPLETED|Overall Study||38
398800|NCT00168103|976018|P1|COMPLETED|Overall Study|1 randomized subject received open-label rescue medication before receiving randomized treatment.|38
398801|NCT00168103|976015|P4|STARTED|Overall Study||1
398802|NCT00168103|976016|P3|STARTED|Overall Study||42
398803|NCT00168103|976017|P2|STARTED|Overall Study||43
398804|NCT00168103|976018|P1|STARTED|Overall Study||40
398805|NCT00168064|976040|P2|NOT COMPLETED|Overall Study||44
398806|NCT00168064|976041|P1|NOT COMPLETED|Overall Study||49
398807|NCT00168064|976040|P2|COMPLETED|Overall Study||86
398808|NCT00168064|976041|P1|COMPLETED|Overall Study||81
398809|NCT00168064|976040|P2|STARTED|Overall Study|127 participants received AP formulation|130
398810|NCT00168064|976041|P1|STARTED|Overall Study|128 participants received PG formulation|130
398811|NCT00168038|976049|P1|NOT COMPLETED|Overall Study||2
398812|NCT00168038|976049|P1|COMPLETED|Overall Study||55
398813|NCT00168038|976049|P1|STARTED|Overall Study||57
398814|NCT00167778|976061|P1|NOT COMPLETED|Overall Study||1
398815|NCT00167778|976061|P1|COMPLETED|Overall Study||10
398816|NCT00167778|976061|P1|STARTED|Overall Study||11
398817|NCT00167544|976112|P2|NOT COMPLETED|Overall Study||0
398818|NCT00167544|976113|P1|NOT COMPLETED|Overall Study||1
398819|NCT00167544|976112|P2|COMPLETED|Overall Study||33
398820|NCT00167544|976113|P1|COMPLETED|Overall Study||30
398821|NCT00167544|976112|P2|STARTED|Overall Study||33
398822|NCT00167544|976113|P1|STARTED|Overall Study||31
398823|NCT00167414|976127|P1|NOT COMPLETED|Overall Study||10
398824|NCT00167414|976127|P1|COMPLETED|Overall Study||39
398825|NCT00167414|976127|P1|STARTED|Overall Study||49
398826|NCT00167388|976139|P4|NOT COMPLETED|Overall Study||0
398827|NCT00167388|976140|P3|NOT COMPLETED|Overall Study||0
398828|NCT00167388|976141|P2|NOT COMPLETED|Overall Study||0
398829|NCT00167388|976142|P1|NOT COMPLETED|Overall Study||0
398830|NCT00167388|976139|P4|COMPLETED|Overall Study||6
398831|NCT00167388|976140|P3|COMPLETED|Overall Study||6
398832|NCT00167388|976141|P2|COMPLETED|Overall Study||5
398833|NCT00167388|976142|P1|COMPLETED|Overall Study||5
398834|NCT00167388|976139|P4|Completed Doppler Study|Overall Study||6
398835|NCT00167388|976140|P3|Completed Doppler Study|Overall Study||6
398836|NCT00167388|976141|P2|Completed Doppler Study|Overall Study||5
398837|NCT00167388|976142|P1|Completed Doppler Study|Overall Study||5
398838|NCT00167388|976139|P4|STARTED|Overall Study||6
398839|NCT00167388|976140|P3|STARTED|Overall Study||6
398840|NCT00167388|976141|P2|STARTED|Overall Study||5
398841|NCT00167388|976142|P1|STARTED|Overall Study||5
398842|NCT00167310|976152|P2|NOT COMPLETED|Overall Study||10
398843|NCT00167310|976153|P1|NOT COMPLETED|Overall Study||8
398844|NCT00167310|976152|P2|COMPLETED|Overall Study||18
398845|NCT00167310|976153|P1|COMPLETED|Overall Study||21
398846|NCT00167310|976152|P2|STARTED|Overall Study||28
398847|NCT00167310|976153|P1|STARTED|Overall Study||29
398848|NCT00167245|976163|P2|NOT COMPLETED|Overall Study||41
398849|NCT00167245|976164|P1|NOT COMPLETED|Overall Study||29
398850|NCT00167245|976163|P2|COMPLETED|Overall Study||46
398851|NCT00167245|976164|P1|COMPLETED|Overall Study||54
398852|NCT00167245|976163|P2|STARTED|Overall Study||87
398853|NCT00167245|976164|P1|STARTED|Overall Study||83
398854|NCT00167206|976172|P1|NOT COMPLETED|Overall Study||0
398855|NCT00167206|976172|P1|COMPLETED|Overall Study||16
398856|NCT00167206|976172|P1|STARTED|Overall Study||16
398857|NCT00167180|976186|P2|NOT COMPLETED|Overall Study||0
398858|NCT00167180|976187|P1|NOT COMPLETED|Overall Study||0
398859|NCT00167180|976186|P2|COMPLETED|Overall Study||57
398860|NCT00167180|976187|P1|COMPLETED|Overall Study||0
398861|NCT00167180|976186|P2|STARTED|Overall Study||57
398862|NCT00167180|976187|P1|STARTED|Overall Study||0
398863|NCT00167102|976203|P2|NOT COMPLETED|Overall Study||0
398864|NCT00167102|976204|P1|NOT COMPLETED|Overall Study||0
398865|NCT00167102|976203|P2|COMPLETED|Overall Study||22
398866|NCT00167102|976204|P1|COMPLETED|Overall Study||23
398867|NCT00167102|976203|P2|STARTED|Overall Study||22
398868|NCT00167102|976204|P1|STARTED|Overall Study||23
398869|NCT00166712|976214|P2|NOT COMPLETED|Overall Study||5
398870|NCT00166712|976215|P1|NOT COMPLETED|Overall Study||2
398871|NCT00166712|976214|P2|COMPLETED|Overall Study|Completed study participation.|11
398872|NCT00166712|976215|P1|COMPLETED|Overall Study|Completed study participation.|22
398873|NCT00166712|976214|P2|Phase 3|Overall Study|# weaned off Sirolimus at 12 months post-transplant.|0
398874|NCT00166712|976215|P1|Phase 3|Overall Study|Subjects from Phase 2b who were weaned off Sirolimus @ 12 months post-transplant.|0
398875|NCT00166712|976214|P2|Phase 2b|Overall Study|Subjects weaned off Sirolimus|0
398876|NCT00166712|976215|P1|Phase 2b|Overall Study|Subjects converted to Sirolimus post-transplant.|3
398877|NCT00166712|976214|P2|Phase 2a|Overall Study|Subject who remained on Sirolimus at 6 months post-transplant.|12
398878|NCT00166712|976215|P1|Phase 2a|Overall Study|Subjects who remained on Prograf at 6mo post-transplant.|19
398879|NCT00166712|976214|P2|Phase 1|Overall Study|Evaluated at 6 month post-transplant to potentially be weaned off Sirolimus.|12
398880|NCT00166712|976215|P1|Phase 1|Overall Study|Evaluated for rejection at 6months post-transplant|22
398881|NCT00166712|976214|P2|STARTED|Overall Study|Consented: Randomized-Group 2. Given Sirolimus & MMF prior to surgery, Alemtuzumab day of surgery.|16
398882|NCT00166712|976215|P1|STARTED|Overall Study|Consented:Randomized-Group 1. Given MMF prior to surgery, Alemtuzumab & TAC (Prograf) day of surgery|24
398883|NCT00166517|976232|P2|NOT COMPLETED|Overall Study||2
398884|NCT00166517|976233|P1|NOT COMPLETED|Overall Study||5
398885|NCT00166517|976232|P2|COMPLETED|Overall Study||61
398886|NCT00166517|976233|P1|COMPLETED|Overall Study||110
398887|NCT00166517|976232|P2|Vaccinated at Visit 3|Overall Study||61
398888|NCT00166517|976233|P1|Vaccinated at Visit 3|Overall Study||110
398889|NCT00166517|976232|P2|Vaccinated at Visit 2|Overall Study||61
398890|NCT00166517|976233|P1|Vaccinated at Visit 2|Overall Study||112
398891|NCT00166517|976232|P2|Vaccinated at Visit 1|Overall Study||63
398892|NCT00166517|976233|P1|Vaccinated at Visit 1|Overall Study||115
398893|NCT00166517|976232|P2|STARTED|Overall Study||63
398894|NCT00166517|976233|P1|STARTED|Overall Study||115
398895|NCT00166504|976243|P2|NOT COMPLETED|Overall Study||4
398896|NCT00166504|976244|P1|NOT COMPLETED|Overall Study||5
398897|NCT00166504|976243|P2|COMPLETED|Overall Study||91
398898|NCT00166504|976244|P1|COMPLETED|Overall Study||103
398899|NCT00166504|976243|P2|STARTED|Overall Study||95
398900|NCT00166504|976244|P1|STARTED|Overall Study||108
398901|NCT00166361|976252|P2|NOT COMPLETED|Overall Study||0
398902|NCT00166361|976253|P1|NOT COMPLETED|Overall Study||0
398903|NCT00166361|976252|P2|COMPLETED|Overall Study||10
398904|NCT00166361|976253|P1|COMPLETED|Overall Study||14
398905|NCT00166361|976252|P2|STARTED|Overall Study||10
398906|NCT00166361|976253|P1|STARTED|Overall Study||14
398907|NCT00166296|976261|P2|NOT COMPLETED|Overall Study||9
398908|NCT00166296|976262|P1|NOT COMPLETED|Overall Study||7
398909|NCT00166296|976261|P2|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|57
398910|NCT00166296|976262|P1|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|60
398911|NCT00166296|976261|P2|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|63
398912|NCT00166296|976262|P1|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|66
398913|NCT00166296|976261|P2|STARTED|Overall Study|Randomized patients|66
398914|NCT00166296|976262|P1|STARTED|Overall Study|Randomized patients|67
398915|NCT00166205|976274|P1|NOT COMPLETED|Overall Study||48
398916|NCT00166205|976274|P1|COMPLETED|Overall Study||228
398917|NCT00166205|976274|P1|Intervention - SAGB Surgery|Overall Study||276
398918|NCT00166205|976274|P1|STARTED|Overall Study||276
398919|NCT00166166|976290|P2|NOT COMPLETED|Overall Study||0
398920|NCT00166166|976291|P1|NOT COMPLETED|Overall Study||0
398921|NCT00166166|976290|P2|COMPLETED|Overall Study||71
398922|NCT00166166|976291|P1|COMPLETED|Overall Study||103
398923|NCT00166166|976290|P2|STARTED|Overall Study||71
398924|NCT00166166|976291|P1|STARTED|Overall Study||103
398925|NCT00166114|976314|P2|NOT COMPLETED|Overall Study||6
398926|NCT00166114|976315|P1|NOT COMPLETED|Overall Study||14
398927|NCT00166114|976314|P2|COMPLETED|Overall Study||13
398928|NCT00166114|976315|P1|COMPLETED|Overall Study||7
398929|NCT00166114|976314|P2|STARTED|Overall Study||19
398930|NCT00166114|976315|P1|STARTED|Overall Study||21
398931|NCT00166036|976323|P2|NOT COMPLETED|Overall Study||0
398932|NCT00166036|976324|P1|NOT COMPLETED|Overall Study||0
398933|NCT00166036|976323|P2|COMPLETED|Overall Study||19
398934|NCT00166036|976324|P1|COMPLETED|Overall Study||17
398935|NCT00166036|976323|P2|STARTED|Overall Study||19
398936|NCT00166036|976324|P1|STARTED|Overall Study||17
398937|NCT00165984|976332|P1|NOT COMPLETED|Overall Study||15
398938|NCT00165984|976332|P1|COMPLETED|Overall Study||150
398939|NCT00165984|976332|P1|STARTED|Overall Study||165
398940|NCT00165958|976341|P2|NOT COMPLETED|Overall Study||2
398941|NCT00165958|976342|P1|NOT COMPLETED|Overall Study||1
398942|NCT00165958|976341|P2|COMPLETED|Overall Study||19
398943|NCT00165958|976342|P1|COMPLETED|Overall Study||18
398944|NCT00165958|976341|P2|STARTED|Overall Study||21
398945|NCT00165958|976342|P1|STARTED|Overall Study||19
398946|NCT00165841|976350|P2|NOT COMPLETED|Overall Study||62
398947|NCT00165841|976351|P1|NOT COMPLETED|Overall Study||30
398948|NCT00165841|976350|P2|COMPLETED|Overall Study||35
398949|NCT00165841|976351|P1|COMPLETED|Overall Study||73
398950|NCT00165841|976350|P2|STARTED|Overall Study||97
398951|NCT00165841|976351|P1|STARTED|Overall Study||103
398952|NCT00165789|976361|P4|NOT COMPLETED|Overall Study||14
398953|NCT00165789|976362|P3|NOT COMPLETED|Overall Study||1
398954|NCT00165789|976363|P2|NOT COMPLETED|Overall Study||4
398955|NCT00165789|976364|P1|NOT COMPLETED|Overall Study||0
398956|NCT00165789|976361|P4|COMPLETED|Overall Study||21
398957|NCT00165789|976362|P3|COMPLETED|Overall Study||11
398958|NCT00165789|976363|P2|COMPLETED|Overall Study||16
398959|NCT00165789|976364|P1|COMPLETED|Overall Study||8
398960|NCT00165789|976361|P4|STARTED|Overall Study||35
398961|NCT00165789|976362|P3|STARTED|Overall Study||12
398962|NCT00165789|976363|P2|STARTED|Overall Study||20
398963|NCT00165789|976364|P1|STARTED|Overall Study||8
398964|NCT00165776|976418|P4|NOT COMPLETED|Overall Study||2
398965|NCT00165776|976419|P3|NOT COMPLETED|Overall Study||2
398966|NCT00165776|976420|P2|NOT COMPLETED|Overall Study||1
398967|NCT00165776|976421|P1|NOT COMPLETED|Overall Study||4
398968|NCT00165776|976418|P4|COMPLETED|Overall Study||29
398969|NCT00165776|976419|P3|COMPLETED|Overall Study||31
398970|NCT00165776|976420|P2|COMPLETED|Overall Study||33
398971|NCT00165776|976421|P1|COMPLETED|Overall Study||31
398972|NCT00165776|976418|P4|STARTED|Overall Study||31
398973|NCT00165776|976419|P3|STARTED|Overall Study||33
398974|NCT00165776|976420|P2|STARTED|Overall Study||34
398975|NCT00165776|976421|P1|STARTED|Overall Study||35
398976|NCT00165698|976457|P2|NOT COMPLETED|Overall Study||15
398977|NCT00165698|976458|P1|NOT COMPLETED|Overall Study||8
398978|NCT00165698|976457|P2|COMPLETED|Overall Study||105
398979|NCT00165698|976458|P1|COMPLETED|Overall Study||112
398980|NCT00165698|976457|P2|STARTED|Overall Study||120
398981|NCT00165698|976458|P1|STARTED|Overall Study||120
398982|NCT00165672|976484|P2|NOT COMPLETED|Overall Study||1
398983|NCT00165672|976485|P1|NOT COMPLETED|Overall Study||0
398984|NCT00165672|976484|P2|COMPLETED|Overall Study||12
398985|NCT00165672|976485|P1|COMPLETED|Overall Study||13
398986|NCT00165672|976484|P2|STARTED|Overall Study||13
398987|NCT00165672|976485|P1|STARTED|Overall Study||13
398988|NCT00165646|976494|P3|NOT COMPLETED|Overall Study||4
398989|NCT00165646|976495|P2|NOT COMPLETED|Overall Study||5
398990|NCT00165646|976496|P1|NOT COMPLETED|Overall Study||5
398991|NCT00165646|976494|P3|COMPLETED|Overall Study||98
398992|NCT00165646|976495|P2|COMPLETED|Overall Study||88
398993|NCT00165646|976496|P1|COMPLETED|Overall Study||88
398994|NCT00165646|976494|P3|STARTED|Overall Study||102
398995|NCT00165646|976495|P2|STARTED|Overall Study||93
398996|NCT00165646|976496|P1|STARTED|Overall Study||93
398997|NCT00165503|976504|P1|NOT COMPLETED|Overall Study||16
398998|NCT00165503|976504|P1|COMPLETED|Overall Study||0
398999|NCT00165503|976504|P1|STARTED|Overall Study||16
399000|NCT00163657|976511|P3|NOT COMPLETED|Overall Study||37
399001|NCT00163657|976512|P2|NOT COMPLETED|Overall Study||23
399002|NCT00163657|976513|P1|NOT COMPLETED|Overall Study||20
399003|NCT00163657|976511|P3|COMPLETED|Overall Study||116
399004|NCT00163657|976512|P2|COMPLETED|Overall Study||56
399005|NCT00163657|976513|P1|COMPLETED|Overall Study||60
399006|NCT00163657|976511|P3|STARTED|Overall Study||153
399007|NCT00163657|976512|P2|STARTED|Overall Study||79
399008|NCT00163657|976513|P1|STARTED|Overall Study||80
399009|NCT00163293|976527|P3|NOT COMPLETED|Overall Study||19
399010|NCT00163293|976528|P2|NOT COMPLETED|Overall Study||7
399011|NCT00163293|976529|P1|NOT COMPLETED|Overall Study||13
399012|NCT00163293|976527|P3|COMPLETED|Overall Study||66
399013|NCT00163293|976528|P2|COMPLETED|Overall Study||69
399014|NCT00163293|976529|P1|COMPLETED|Overall Study||66
399015|NCT00163293|976527|P3|STARTED|Overall Study||85
399016|NCT00163293|976528|P2|STARTED|Overall Study||76
399017|NCT00163293|976529|P1|STARTED|Overall Study||79
399018|NCT00163215|976603|P1|NOT COMPLETED|Overall Study||15
399019|NCT00163215|976603|P1|COMPLETED|Overall Study||31
399020|NCT00163215|976603|P1|STARTED|Overall Study||46
399021|NCT00163189|976623|P1|NOT COMPLETED|Overall Study||63
399022|NCT00163189|976623|P1|COMPLETED|Overall Study||35
399023|NCT00163189|976623|P1|STARTED|Overall Study||98
399024|NCT00163020|976647|P2|NOT COMPLETED|Overall Study||2
399025|NCT00163020|976648|P1|NOT COMPLETED|Overall Study||0
399026|NCT00163020|976647|P2|COMPLETED|Overall Study|Twins = 78 Triplets = 25|103
399027|NCT00163020|976648|P1|COMPLETED|Overall Study|Twins = 160 Triplets = 56|216
399028|NCT00163020|976647|P2|STARTED|Overall Study|Twins = 80 Triplets = 25|105
399029|NCT00163020|976648|P1|STARTED|Overall Study|Twins = 160 Triplets = 56|216
399030|NCT00162981|976688|P2|NOT COMPLETED|Overall Study||6
399031|NCT00162981|976689|P1|NOT COMPLETED|Overall Study||4
399032|NCT00162981|976688|P2|COMPLETED|Overall Study||30
399033|NCT00162981|976689|P1|COMPLETED|Overall Study||28
399034|NCT00162981|976688|P2|STARTED|Overall Study||36
399035|NCT00162981|976689|P1|STARTED|Overall Study||32
399036|NCT00162942|976705|P2|NOT COMPLETED|Overall Study||52
399037|NCT00162942|976706|P1|NOT COMPLETED|Overall Study||106
399038|NCT00162942|976705|P2|COMPLETED|Overall Study||26
399039|NCT00162942|976706|P1|COMPLETED|Overall Study||51
399040|NCT00162942|976705|P2|Week 12|Overall Study||61
399041|NCT00162942|976706|P1|Week 12|Overall Study||127
399042|NCT00162942|976705|P2|STARTED|Overall Study||78
399043|NCT00162942|976706|P1|STARTED|Overall Study||157
399044|NCT00162773|976754|P1|NOT COMPLETED|Overall Study||22
399045|NCT00162773|976754|P1|COMPLETED|Overall Study||7
399046|NCT00162773|976754|P1|STARTED|Overall Study||29
399047|NCT00162370|976758|P1|NOT COMPLETED|Efficacy Population||51
399048|NCT00162370|976758|P1|COMPLETED|Efficacy Population|Efficacy population, completed rest/stress echo with Definity & completed 2 and/or 5 year follow up|315
399049|NCT00162370|976758|P1|STARTED|Efficacy Population||366
399050|NCT00162370|976758|P1|NOT COMPLETED|Completed Echocardiography Imaging||0
399051|NCT00162370|976758|P1|COMPLETED|Completed Echocardiography Imaging|number of subjects who under went Definity-enhanced rest and stress echocardiogram|366
399052|NCT00162370|976758|P1|STARTED|Completed Echocardiography Imaging|Received at least one dose of Definity|366
399053|NCT00162266|976766|P4|NOT COMPLETED|Open-Label Period||137
399054|NCT00162266|976767|P3|NOT COMPLETED|Open-Label Period||0
399055|NCT00162266|976768|P2|NOT COMPLETED|Open-Label Period||0
399056|NCT00162266|976769|P1|NOT COMPLETED|Open-Label Period||0
399057|NCT00162266|976766|P4|COMPLETED|Open-Label Period||82
399058|NCT00162266|976767|P3|COMPLETED|Open-Label Period||0
399059|NCT00162266|976768|P2|COMPLETED|Open-Label Period||0
399060|NCT00162266|976769|P1|COMPLETED|Open-Label Period||0
399061|NCT00162266|976766|P4|STARTED|Open-Label Period||219
399062|NCT00162266|976767|P3|STARTED|Open-Label Period||0
399063|NCT00162266|976768|P2|STARTED|Open-Label Period||0
399064|NCT00162266|976769|P1|STARTED|Open-Label Period||0
399065|NCT00162266|976766|P4|NOT COMPLETED|Double-Blind Period||0
399066|NCT00162266|976767|P3|NOT COMPLETED|Double-Blind Period||48
399067|NCT00162266|976768|P2|NOT COMPLETED|Double-Blind Period||31
399068|NCT00162266|976769|P1|NOT COMPLETED|Double-Blind Period||25
399069|NCT00162266|976766|P4|COMPLETED|Double-Blind Period||0
399070|NCT00162266|976767|P3|COMPLETED|Double-Blind Period||71
399071|NCT00162266|976768|P2|COMPLETED|Double-Blind Period||74
399072|NCT00162266|976769|P1|COMPLETED|Double-Blind Period||90
399073|NCT00162266|976766|P4|Completed Day 1 to Day 181|Double-Blind Period||0
399074|NCT00162266|976767|P3|Completed Day 1 to Day 181|Double-Blind Period||78
399075|NCT00162266|976768|P2|Completed Day 1 to Day 181|Double-Blind Period||80
399076|NCT00162266|976769|P1|Completed Day 1 to Day 181|Double-Blind Period||98
399077|NCT00162266|976766|P4|STARTED|Double-Blind Period||0
399078|NCT00162266|976767|P3|STARTED|Double-Blind Period||119
399079|NCT00162266|976768|P2|STARTED|Double-Blind Period||105
399080|NCT00162266|976769|P1|STARTED|Double-Blind Period||115
399081|NCT00162136|976970|P1|NOT COMPLETED|Overall Study||35
399082|NCT00162136|976970|P1|COMPLETED|Overall Study|Number of Participants still on treatment at study termination|0
399083|NCT00162136|976970|P1|STARTED|Overall Study||35
399084|NCT00162123|977002|P8|NOT COMPLETED|Overall Study||58
399085|NCT00162123|977003|P7|NOT COMPLETED|Overall Study||4
399086|NCT00162123|977004|P6|NOT COMPLETED|Overall Study||9
399087|NCT00162123|977005|P5|NOT COMPLETED|Overall Study||31
399088|NCT00162123|977006|P4|NOT COMPLETED|Overall Study||8
399089|NCT00162123|977007|P3|NOT COMPLETED|Overall Study||21
399090|NCT00162123|977008|P2|NOT COMPLETED|Overall Study||29
399091|NCT00162123|977009|P1|NOT COMPLETED|Overall Study||44
399092|NCT00162123|977002|P8|COMPLETED|Overall Study|Still on treatment|0
399093|NCT00162123|977003|P7|COMPLETED|Overall Study|Still on treatment|0
399094|NCT00162123|977004|P6|COMPLETED|Overall Study|Still on treatment|4
399095|NCT00162123|977005|P5|COMPLETED|Overall Study|Still on treatment|14
399096|NCT00162123|977006|P4|COMPLETED|Overall Study|Still on treatment|3
399097|NCT00162123|977007|P3|COMPLETED|Overall Study|Still on treatment|3
399098|NCT00162123|977008|P2|COMPLETED|Overall Study|Still on treatment|5
399099|NCT00162123|977009|P1|COMPLETED|Overall Study|Still on treatment|9
399100|NCT00162123|977002|P8|Received Treatment|Overall Study||0
399101|NCT00162123|977003|P7|Received Treatment|Overall Study||4
399102|NCT00162123|977004|P6|Received Treatment|Overall Study||12
399103|NCT00162123|977005|P5|Received Treatment|Overall Study||33
399104|NCT00162123|977006|P4|Received Treatment|Overall Study||11
399105|NCT00162123|977007|P3|Received Treatment|Overall Study||24
399106|NCT00162123|977008|P2|Received Treatment|Overall Study||34
399107|NCT00162123|977009|P1|Received Treatment|Overall Study||53
399108|NCT00162123|977002|P8|STARTED|Overall Study|Enrolled|58
399109|NCT00162123|977003|P7|STARTED|Overall Study|Enrolled|4
399110|NCT00162123|977004|P6|STARTED|Overall Study|Enrolled|13
399111|NCT00162123|977005|P5|STARTED|Overall Study|Enrolled|45
399112|NCT00162123|977006|P4|STARTED|Overall Study|Enrolled|11
399113|NCT00162123|977007|P3|STARTED|Overall Study|Enrolled|24
399114|NCT00162123|977008|P2|STARTED|Overall Study|Enrolled|34
399115|NCT00162123|977009|P1|STARTED|Overall Study|Enrolled|53
399116|NCT00162097|977042|P4|NOT COMPLETED|Overall Study||1
399117|NCT00162097|977043|P3|NOT COMPLETED|Overall Study||0
399118|NCT00162097|977044|P2|NOT COMPLETED|Overall Study||0
399119|NCT00162097|977045|P1|NOT COMPLETED|Overall Study||0
399120|NCT00162097|977042|P4|COMPLETED|Overall Study||6
399121|NCT00162097|977043|P3|COMPLETED|Overall Study||1
399122|NCT00162097|977044|P2|COMPLETED|Overall Study||2
399123|NCT00162097|977045|P1|COMPLETED|Overall Study||6
399124|NCT00162097|977042|P4|STARTED|Overall Study|Treated on Day 1. One participant enrolled twice in the study and is hence counted twice|7
399125|NCT00162097|977043|P3|STARTED|Overall Study|Treated on Day 1|1
399126|NCT00162097|977044|P2|STARTED|Overall Study|Treated on Day 1|2
399127|NCT00162097|977045|P1|STARTED|Overall Study|Treated on Day 1|6
399128|NCT00162032|977107|P2|NOT COMPLETED|Overall Study||2
399129|NCT00162032|977108|P1|NOT COMPLETED|Overall Study||5
399130|NCT00162032|977107|P2|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|114
399131|NCT00162032|977108|P1|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|324
399132|NCT00162032|977107|P2|STARTED|Overall Study||116
399133|NCT00162032|977108|P1|STARTED|Overall Study||329
399134|NCT00161616|977129|P2|NOT COMPLETED|Overall Study||19
399135|NCT00161616|977130|P1|NOT COMPLETED|Overall Study||26
399136|NCT00161616|977129|P2|COMPLETED|Overall Study||119
399137|NCT00161616|977130|P1|COMPLETED|Overall Study||113
399138|NCT00161616|977129|P2|STARTED|Overall Study||138
399139|NCT00161616|977130|P1|STARTED|Overall Study||139
399140|NCT00161473|977140|P2|NOT COMPLETED|Overall Study||6
399141|NCT00161473|977141|P1|NOT COMPLETED|Overall Study||5
399142|NCT00161473|977140|P2|COMPLETED|Overall Study||6
399143|NCT00161473|977141|P1|COMPLETED|Overall Study||7
399144|NCT00161473|977140|P2|STARTED|Overall Study||12
399145|NCT00161473|977141|P1|STARTED|Overall Study||12
399146|NCT00161382|977155|P2|NOT COMPLETED|Overall Study||289
399147|NCT00161382|977156|P1|NOT COMPLETED|Overall Study||249
399148|NCT00161382|977155|P2|COMPLETED|Overall Study|Number of control students included in the analyzed cohort (i.e., completed 9th-grade survey)|558
399149|NCT00161382|977156|P1|COMPLETED|Overall Study|Number of intervention students included in the analyzed cohort (i.e., completed 9th-grade survey)|349
399150|NCT00161382|977155|P2|STARTED|Overall Study|Number of students allocated to comparison group|847
399151|NCT00161382|977156|P1|STARTED|Overall Study|Number of students allocated to intervention group|598
399152|NCT00161213|977162|P1|NOT COMPLETED|Overall Study||2
399153|NCT00161213|977162|P1|COMPLETED|Overall Study||42
399154|NCT00161213|977162|P1|STARTED|Overall Study||44
399155|NCT00160706|977169|P1|NOT COMPLETED|Overall Study||286
399156|NCT00160706|977169|P1|COMPLETED|Overall Study||24
399157|NCT00160706|977169|P1|STARTED|Overall Study||310
399158|NCT00160693|977181|P1|NOT COMPLETED|Overall Study||235
399159|NCT00160693|977181|P1|COMPLETED|Overall Study||167
399160|NCT00160693|977181|P1|STARTED|Overall Study||402
399161|NCT00160680|977200|P2|NOT COMPLETED|Overall Study||13
399162|NCT00160680|977201|P1|NOT COMPLETED|Overall Study||9
399163|NCT00160680|977200|P2|COMPLETED|Overall Study||18
399164|NCT00160680|977201|P1|COMPLETED|Overall Study||22
399165|NCT00160680|977200|P2|STARTED|Overall Study||31
399166|NCT00160680|977201|P1|STARTED|Overall Study||31
399167|NCT00160667|977236|P3|NOT COMPLETED|Overall Study||6
399168|NCT00160667|977237|P2|NOT COMPLETED|Overall Study||3
399169|NCT00160667|977238|P1|NOT COMPLETED|Overall Study||5
399170|NCT00160667|977236|P3|COMPLETED|Overall Study||45
399171|NCT00160667|977237|P2|COMPLETED|Overall Study||48
399172|NCT00160667|977238|P1|COMPLETED|Overall Study||45
399173|NCT00160667|977236|P3|STARTED|Overall Study||51
399174|NCT00160667|977237|P2|STARTED|Overall Study||51
399175|NCT00160667|977238|P1|STARTED|Overall Study||50
399176|NCT00160641|977285|P1|NOT COMPLETED|Overall Study||221
399177|NCT00160641|977285|P1|COMPLETED|Overall Study||346
399178|NCT00160641|977285|P1|STARTED|Overall Study||567
399179|NCT00160615|977318|P2|NOT COMPLETED|Overall Study||45
399180|NCT00160615|977319|P1|NOT COMPLETED|Overall Study||18
399181|NCT00160615|977318|P2|COMPLETED|Overall Study||56
399182|NCT00160615|977319|P1|COMPLETED|Overall Study||32
399183|NCT00160615|977318|P2|STARTED|Overall Study||101
399184|NCT00160615|977319|P1|STARTED|Overall Study||50
399185|NCT00160563|977342|P3|NOT COMPLETED|Overall Study||90
399186|NCT00160563|977343|P2|NOT COMPLETED|Overall Study||45
399187|NCT00160563|977344|P1|NOT COMPLETED|Overall Study||51
399188|NCT00160563|977342|P3|COMPLETED|Overall Study||11
399189|NCT00160563|977343|P2|COMPLETED|Overall Study||2
399190|NCT00160563|977344|P1|COMPLETED|Overall Study||8
399191|NCT00160563|977342|P3|STARTED|Overall Study||101
399192|NCT00160563|977343|P2|STARTED|Overall Study||47
399193|NCT00160563|977344|P1|STARTED|Overall Study||59
399194|NCT00160524|977356|P1|NOT COMPLETED|Overall Study||478
399195|NCT00160524|977356|P1|COMPLETED|Overall Study||117
399196|NCT00160524|977356|P1|STARTED|Overall Study|One subject was enrolled erroneously and has no data in the database.|595
399197|NCT00160251|977373|P8|NOT COMPLETED|Post-amendment 2||55
399198|NCT00160251|977374|P7|NOT COMPLETED|Post-amendment 2||0
399199|NCT00160251|977375|P6|NOT COMPLETED|Post-amendment 2||0
399200|NCT00160251|977376|P5|NOT COMPLETED|Post-amendment 2||0
399201|NCT00160251|977377|P4|NOT COMPLETED|Post-amendment 2||0
399202|NCT00160251|977378|P3|NOT COMPLETED|Post-amendment 2||0
399203|NCT00160251|977379|P2|NOT COMPLETED|Post-amendment 2||0
399204|NCT00160251|977380|P1|NOT COMPLETED|Post-amendment 2||0
399205|NCT00160251|977373|P8|COMPLETED|Post-amendment 2||88
399206|NCT00160251|977374|P7|COMPLETED|Post-amendment 2||0
399207|NCT00160251|977375|P6|COMPLETED|Post-amendment 2||0
399208|NCT00160251|977376|P5|COMPLETED|Post-amendment 2||0
399209|NCT00160251|977377|P4|COMPLETED|Post-amendment 2||0
399210|NCT00160251|977378|P3|COMPLETED|Post-amendment 2||0
399211|NCT00160251|977379|P2|COMPLETED|Post-amendment 2||0
399212|NCT00160251|977380|P1|COMPLETED|Post-amendment 2||0
399213|NCT00160251|977373|P8|STARTED|Post-amendment 2||143
399214|NCT00160251|977374|P7|STARTED|Post-amendment 2||0
399215|NCT00160251|977375|P6|STARTED|Post-amendment 2||0
399216|NCT00160251|977376|P5|STARTED|Post-amendment 2||0
399217|NCT00160251|977377|P4|STARTED|Post-amendment 2||0
399218|NCT00160251|977378|P3|STARTED|Post-amendment 2||0
399219|NCT00160251|977379|P2|STARTED|Post-amendment 2||0
399220|NCT00160251|977380|P1|STARTED|Post-amendment 2||0
399221|NCT00160251|977373|P8|NOT COMPLETED|Prior to Amendment 2||0
399222|NCT00160251|977374|P7|NOT COMPLETED|Prior to Amendment 2||4
399223|NCT00160251|977375|P6|NOT COMPLETED|Prior to Amendment 2||83
399224|NCT00160251|977376|P5|NOT COMPLETED|Prior to Amendment 2||28
399225|NCT00160251|977377|P4|NOT COMPLETED|Prior to Amendment 2||40
399226|NCT00160251|977378|P3|NOT COMPLETED|Prior to Amendment 2||44
399227|NCT00160251|977379|P2|NOT COMPLETED|Prior to Amendment 2||6
399228|NCT00160251|977380|P1|NOT COMPLETED|Prior to Amendment 2||9
399229|NCT00160251|977373|P8|COMPLETED|Prior to Amendment 2||0
399230|NCT00160251|977374|P7|COMPLETED|Prior to Amendment 2||61
399231|NCT00160251|977375|P6|COMPLETED|Prior to Amendment 2||14
399232|NCT00160251|977376|P5|COMPLETED|Prior to Amendment 2||21
399233|NCT00160251|977377|P4|COMPLETED|Prior to Amendment 2||9
399234|NCT00160251|977378|P3|COMPLETED|Prior to Amendment 2||4
399235|NCT00160251|977379|P2|COMPLETED|Prior to Amendment 2||28
399236|NCT00160251|977380|P1|COMPLETED|Prior to Amendment 2||6
399237|NCT00160251|977373|P8|STARTED|Prior to Amendment 2||0
399238|NCT00160251|977374|P7|STARTED|Prior to Amendment 2||65
399239|NCT00160251|977375|P6|STARTED|Prior to Amendment 2||97
399240|NCT00160251|977376|P5|STARTED|Prior to Amendment 2||49
399241|NCT00160251|977377|P4|STARTED|Prior to Amendment 2||49
399242|NCT00160251|977378|P3|STARTED|Prior to Amendment 2||48
399243|NCT00160251|977379|P2|STARTED|Prior to Amendment 2||34
399244|NCT00160251|977380|P1|STARTED|Prior to Amendment 2||15
399245|NCT00160199|977456|P2|NOT COMPLETED|Overall Study||37
399246|NCT00160199|977457|P1|NOT COMPLETED|Overall Study||24
399247|NCT00160199|977456|P2|COMPLETED|Overall Study||81
399248|NCT00160199|977457|P1|COMPLETED|Overall Study||98
399249|NCT00160199|977456|P2|STARTED|Overall Study||118
399250|NCT00160199|977457|P1|STARTED|Overall Study||122
399251|NCT00159965|977477|P2|NOT COMPLETED|Overall Study||5
399252|NCT00159965|977478|P1|NOT COMPLETED|Overall Study||7
399253|NCT00159965|977477|P2|COMPLETED|Overall Study||14
399254|NCT00159965|977478|P1|COMPLETED|Overall Study||12
399255|NCT00159965|977477|P2|STARTED|Overall Study||19
399256|NCT00159965|977478|P1|STARTED|Overall Study||19
399257|NCT00159913|977514|P4|NOT COMPLETED|Overall Study||2
399258|NCT00159913|977515|P3|NOT COMPLETED|Overall Study||2
399259|NCT00159913|977516|P2|NOT COMPLETED|Overall Study||0
399260|NCT00159913|977517|P1|NOT COMPLETED|Overall Study||2
399261|NCT00159913|977514|P4|COMPLETED|Overall Study||58
399262|NCT00159913|977515|P3|COMPLETED|Overall Study||75
399263|NCT00159913|977516|P2|COMPLETED|Overall Study||55
399264|NCT00159913|977517|P1|COMPLETED|Overall Study||40
399265|NCT00159913|977514|P4|STARTED|Overall Study||60
399266|NCT00159913|977515|P3|STARTED|Overall Study||77
399267|NCT00159913|977516|P2|STARTED|Overall Study||55
399268|NCT00159913|977517|P1|STARTED|Overall Study||42
399269|NCT00159874|977591|P7|NOT COMPLETED|Overall Study||5
399270|NCT00159874|977592|P6|NOT COMPLETED|Overall Study||12
399271|NCT00159874|977593|P5|NOT COMPLETED|Overall Study||8
399272|NCT00159874|977594|P4|NOT COMPLETED|Overall Study||6
399273|NCT00159874|977595|P3|NOT COMPLETED|Overall Study||43
399274|NCT00159874|977596|P2|NOT COMPLETED|Overall Study||30
399275|NCT00159874|977597|P1|NOT COMPLETED|Overall Study||20
399276|NCT00159874|977591|P7|COMPLETED|Overall Study||0
399277|NCT00159874|977592|P6|COMPLETED|Overall Study||11
399278|NCT00159874|977593|P5|COMPLETED|Overall Study||11
399279|NCT00159874|977594|P4|COMPLETED|Overall Study||7
399280|NCT00159874|977595|P3|COMPLETED|Overall Study||34
399281|NCT00159874|977596|P2|COMPLETED|Overall Study||25
399282|NCT00159874|977597|P1|COMPLETED|Overall Study||22
399283|NCT00159874|977591|P7|Treated|Overall Study||5
399284|NCT00159874|977592|P6|Treated|Overall Study||23
399285|NCT00159874|977593|P5|Treated|Overall Study||19
399286|NCT00159874|977594|P4|Treated|Overall Study||13
399287|NCT00159874|977595|P3|Treated|Overall Study||77
399288|NCT00159874|977596|P2|Treated|Overall Study||55
399289|NCT00159874|977597|P1|Treated|Overall Study||42
399290|NCT00159874|977591|P7|STARTED|Overall Study||5
399291|NCT00159874|977592|P6|STARTED|Overall Study||23
399292|NCT00159874|977593|P5|STARTED|Overall Study||19
399293|NCT00159874|977594|P4|STARTED|Overall Study||13
399294|NCT00159874|977595|P3|STARTED|Overall Study||77
399295|NCT00159874|977596|P2|STARTED|Overall Study||55
399296|NCT00159874|977597|P1|STARTED|Overall Study||42
399297|NCT00159861|977767|P2|NOT COMPLETED|Extension Study - up to 3 Years||71
399298|NCT00159861|977768|P1|NOT COMPLETED|Extension Study - up to 3 Years||62
399299|NCT00159861|977767|P2|COMPLETED|Extension Study - up to 3 Years||56
399300|NCT00159861|977768|P1|COMPLETED|Extension Study - up to 3 Years||53
399301|NCT00159861|977767|P2|Treated|Extension Study - up to 3 Years||127
399302|NCT00159861|977768|P1|Treated|Extension Study - up to 3 Years||115
399303|NCT00159861|977767|P2|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|127
399304|NCT00159861|977768|P1|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|115
399305|NCT00159861|977767|P2|NOT COMPLETED|Core Study - 16 Weeks||12
399306|NCT00159861|977768|P1|NOT COMPLETED|Core Study - 16 Weeks||25
399307|NCT00159861|977767|P2|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 127; Did not enter A1481153: 7|122
399308|NCT00159861|977768|P1|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 115; Did not enter A1481153: 16|108
399309|NCT00159861|977767|P2|Treated|Core Study - 16 Weeks||134
399310|NCT00159861|977768|P1|Treated|Core Study - 16 Weeks||131
399311|NCT00159861|977767|P2|STARTED|Core Study - 16 Weeks||134
399312|NCT00159861|977768|P1|STARTED|Core Study - 16 Weeks||133
399313|NCT00159822|977789|P1|NOT COMPLETED|Post-treatment Follow-up Period||3
399314|NCT00159822|977789|P1|COMPLETED|Post-treatment Follow-up Period||23
399315|NCT00159822|977789|P1|STARTED|Post-treatment Follow-up Period||26
399316|NCT00159822|977789|P1|NOT COMPLETED|Voriconazole Treatment Period||22
399317|NCT00159822|977789|P1|COMPLETED|Voriconazole Treatment Period|Number of subjects completed treatment: 36 up to month 6 (M6); 26 after M6.|26
399318|NCT00159822|977789|P1|STARTED|Voriconazole Treatment Period||48
399319|NCT00159783|977807|P3|NOT COMPLETED|Overall Study||39
399320|NCT00159783|977808|P2|NOT COMPLETED|Overall Study||27
399321|NCT00159783|977809|P1|NOT COMPLETED|Overall Study||19
399322|NCT00159783|977807|P3|COMPLETED|Overall Study||68
399323|NCT00159783|977808|P2|COMPLETED|Overall Study||52
399324|NCT00159783|977809|P1|COMPLETED|Overall Study||13
399325|NCT00159783|977807|P3|STARTED|Overall Study||107
399326|NCT00159783|977808|P2|STARTED|Overall Study||79
399327|NCT00159783|977809|P1|STARTED|Overall Study||32
399328|NCT00159432|977839|P1|NOT COMPLETED|Overall Study||10
399329|NCT00159432|977839|P1|COMPLETED|Overall Study||53
399330|NCT00159432|977839|P1|STARTED|Overall Study||63
399331|NCT00159419|977846|P2|NOT COMPLETED|Overall Study||0
399332|NCT00159419|977847|P1|NOT COMPLETED|Overall Study||0
399333|NCT00159419|977846|P2|COMPLETED|Overall Study||9
399334|NCT00159419|977847|P1|COMPLETED|Overall Study||9
399335|NCT00159419|977846|P2|STARTED|Overall Study||9
399336|NCT00159419|977847|P1|STARTED|Overall Study||9
399337|NCT00159263|977853|P6|NOT COMPLETED|Sixth Intervention||0
399338|NCT00159263|977854|P5|NOT COMPLETED|Sixth Intervention||0
399339|NCT00159263|977855|P4|NOT COMPLETED|Sixth Intervention||0
399340|NCT00159263|977856|P3|NOT COMPLETED|Sixth Intervention||0
399341|NCT00159263|977857|P2|NOT COMPLETED|Sixth Intervention||0
399342|NCT00159263|977858|P1|NOT COMPLETED|Sixth Intervention||0
399343|NCT00159263|977853|P6|COMPLETED|Sixth Intervention||2
399344|NCT00159263|977854|P5|COMPLETED|Sixth Intervention||2
399345|NCT00159263|977855|P4|COMPLETED|Sixth Intervention||2
399346|NCT00159263|977856|P3|COMPLETED|Sixth Intervention||2
399347|NCT00159263|977857|P2|COMPLETED|Sixth Intervention||1
399348|NCT00159263|977858|P1|COMPLETED|Sixth Intervention||1
399349|NCT00159263|977853|P6|STARTED|Sixth Intervention||2
399350|NCT00159263|977854|P5|STARTED|Sixth Intervention||2
399351|NCT00159263|977855|P4|STARTED|Sixth Intervention||2
399352|NCT00159263|977856|P3|STARTED|Sixth Intervention||2
399353|NCT00159263|977857|P2|STARTED|Sixth Intervention||1
399354|NCT00159263|977858|P1|STARTED|Sixth Intervention||1
399355|NCT00159263|977853|P6|NOT COMPLETED|Washout||0
399356|NCT00159263|977854|P5|NOT COMPLETED|Washout||0
399357|NCT00159263|977855|P4|NOT COMPLETED|Washout||0
399358|NCT00159263|977856|P3|NOT COMPLETED|Washout||0
399359|NCT00159263|977857|P2|NOT COMPLETED|Washout||0
399360|NCT00159263|977858|P1|NOT COMPLETED|Washout||0
399361|NCT00159263|977853|P6|COMPLETED|Washout||2
399362|NCT00159263|977854|P5|COMPLETED|Washout||2
399363|NCT00159263|977855|P4|COMPLETED|Washout||2
399364|NCT00159263|977856|P3|COMPLETED|Washout||2
399365|NCT00159263|977857|P2|COMPLETED|Washout||1
399366|NCT00159263|977858|P1|COMPLETED|Washout||1
399367|NCT00159263|977853|P6|STARTED|Washout||2
399368|NCT00159263|977854|P5|STARTED|Washout||2
399369|NCT00159263|977855|P4|STARTED|Washout||2
399370|NCT00159263|977856|P3|STARTED|Washout||2
399371|NCT00159263|977857|P2|STARTED|Washout||1
399372|NCT00159263|977858|P1|STARTED|Washout||1
399373|NCT00159263|977853|P6|NOT COMPLETED|Fifth Intervention||0
399374|NCT00159263|977854|P5|NOT COMPLETED|Fifth Intervention||0
399375|NCT00159263|977855|P4|NOT COMPLETED|Fifth Intervention||0
399376|NCT00159263|977856|P3|NOT COMPLETED|Fifth Intervention||0
399377|NCT00159263|977857|P2|NOT COMPLETED|Fifth Intervention||0
399378|NCT00159263|977858|P1|NOT COMPLETED|Fifth Intervention||0
399379|NCT00159263|977853|P6|COMPLETED|Fifth Intervention||2
399380|NCT00159263|977854|P5|COMPLETED|Fifth Intervention||2
399381|NCT00159263|977855|P4|COMPLETED|Fifth Intervention||2
399382|NCT00159263|977856|P3|COMPLETED|Fifth Intervention||2
399383|NCT00159263|977857|P2|COMPLETED|Fifth Intervention||1
399384|NCT00159263|977858|P1|COMPLETED|Fifth Intervention||1
399385|NCT00159263|977853|P6|STARTED|Fifth Intervention||2
399386|NCT00159263|977854|P5|STARTED|Fifth Intervention||2
399387|NCT00159263|977855|P4|STARTED|Fifth Intervention||2
399388|NCT00159263|977856|P3|STARTED|Fifth Intervention||2
399389|NCT00159263|977857|P2|STARTED|Fifth Intervention||1
399390|NCT00159263|977858|P1|STARTED|Fifth Intervention||1
399391|NCT00159263|977853|P6|NOT COMPLETED|Washout||0
399392|NCT00159263|977854|P5|NOT COMPLETED|Washout||0
399393|NCT00159263|977855|P4|NOT COMPLETED|Washout||0
399394|NCT00159263|977856|P3|NOT COMPLETED|Washout||0
399395|NCT00159263|977857|P2|NOT COMPLETED|Washout||0
399396|NCT00159263|977858|P1|NOT COMPLETED|Washout||0
399397|NCT00159263|977853|P6|COMPLETED|Washout||2
399398|NCT00159263|977854|P5|COMPLETED|Washout||2
399399|NCT00159263|977855|P4|COMPLETED|Washout||2
399400|NCT00159263|977856|P3|COMPLETED|Washout||2
399401|NCT00159263|977857|P2|COMPLETED|Washout||1
399402|NCT00159263|977858|P1|COMPLETED|Washout||1
399403|NCT00159263|977853|P6|STARTED|Washout||2
399404|NCT00159263|977854|P5|STARTED|Washout||2
399405|NCT00159263|977855|P4|STARTED|Washout||2
399406|NCT00159263|977856|P3|STARTED|Washout||2
399407|NCT00159263|977857|P2|STARTED|Washout||1
399408|NCT00159263|977858|P1|STARTED|Washout||1
399409|NCT00159263|977853|P6|NOT COMPLETED|Fourth Intervention||0
399410|NCT00159263|977854|P5|NOT COMPLETED|Fourth Intervention||0
399411|NCT00159263|977855|P4|NOT COMPLETED|Fourth Intervention||0
399412|NCT00159263|977856|P3|NOT COMPLETED|Fourth Intervention||0
399413|NCT00159263|977857|P2|NOT COMPLETED|Fourth Intervention||0
399414|NCT00159263|977858|P1|NOT COMPLETED|Fourth Intervention||0
399415|NCT00159263|977853|P6|COMPLETED|Fourth Intervention||2
399416|NCT00159263|977854|P5|COMPLETED|Fourth Intervention||2
399417|NCT00159263|977855|P4|COMPLETED|Fourth Intervention||2
399418|NCT00159263|977856|P3|COMPLETED|Fourth Intervention||2
399419|NCT00159263|977857|P2|COMPLETED|Fourth Intervention||1
399420|NCT00159263|977858|P1|COMPLETED|Fourth Intervention||1
399421|NCT00159263|977853|P6|STARTED|Fourth Intervention||2
399422|NCT00159263|977854|P5|STARTED|Fourth Intervention||2
399423|NCT00159263|977855|P4|STARTED|Fourth Intervention||2
399424|NCT00159263|977856|P3|STARTED|Fourth Intervention||2
399425|NCT00159263|977857|P2|STARTED|Fourth Intervention||1
399426|NCT00159263|977858|P1|STARTED|Fourth Intervention||1
399427|NCT00159263|977853|P6|NOT COMPLETED|Washout||0
399428|NCT00159263|977854|P5|NOT COMPLETED|Washout||0
399429|NCT00159263|977855|P4|NOT COMPLETED|Washout||0
399430|NCT00159263|977856|P3|NOT COMPLETED|Washout||0
399431|NCT00159263|977857|P2|NOT COMPLETED|Washout||0
399432|NCT00159263|977858|P1|NOT COMPLETED|Washout||0
399433|NCT00159263|977853|P6|COMPLETED|Washout||2
399434|NCT00159263|977854|P5|COMPLETED|Washout||2
399435|NCT00159263|977855|P4|COMPLETED|Washout||2
399436|NCT00159263|977856|P3|COMPLETED|Washout||2
399437|NCT00159263|977857|P2|COMPLETED|Washout||1
399438|NCT00159263|977858|P1|COMPLETED|Washout||1
399439|NCT00159263|977853|P6|STARTED|Washout||2
399440|NCT00159263|977854|P5|STARTED|Washout||2
399441|NCT00159263|977855|P4|STARTED|Washout||2
399442|NCT00159263|977856|P3|STARTED|Washout||2
399443|NCT00159263|977857|P2|STARTED|Washout||1
399444|NCT00159263|977858|P1|STARTED|Washout||1
399445|NCT00159263|977853|P6|NOT COMPLETED|Third Intervention||0
399446|NCT00159263|977854|P5|NOT COMPLETED|Third Intervention||0
399447|NCT00159263|977855|P4|NOT COMPLETED|Third Intervention||0
399448|NCT00159263|977856|P3|NOT COMPLETED|Third Intervention||0
399449|NCT00159263|977857|P2|NOT COMPLETED|Third Intervention||0
399450|NCT00159263|977858|P1|NOT COMPLETED|Third Intervention||0
399451|NCT00159263|977853|P6|COMPLETED|Third Intervention||2
399452|NCT00159263|977854|P5|COMPLETED|Third Intervention||2
399453|NCT00159263|977855|P4|COMPLETED|Third Intervention||2
399454|NCT00159263|977856|P3|COMPLETED|Third Intervention||2
399455|NCT00159263|977857|P2|COMPLETED|Third Intervention||1
399456|NCT00159263|977858|P1|COMPLETED|Third Intervention||1
399457|NCT00159263|977853|P6|STARTED|Third Intervention||2
399458|NCT00159263|977854|P5|STARTED|Third Intervention||2
399459|NCT00159263|977855|P4|STARTED|Third Intervention||2
399460|NCT00159263|977856|P3|STARTED|Third Intervention||2
399461|NCT00159263|977857|P2|STARTED|Third Intervention||1
399462|NCT00159263|977858|P1|STARTED|Third Intervention||1
399463|NCT00159263|977853|P6|NOT COMPLETED|Washout||0
399464|NCT00159263|977854|P5|NOT COMPLETED|Washout||0
399465|NCT00159263|977855|P4|NOT COMPLETED|Washout||0
399466|NCT00159263|977856|P3|NOT COMPLETED|Washout||0
399467|NCT00159263|977857|P2|NOT COMPLETED|Washout||0
399468|NCT00159263|977858|P1|NOT COMPLETED|Washout||0
399469|NCT00159263|977853|P6|COMPLETED|Washout||2
399470|NCT00159263|977854|P5|COMPLETED|Washout||2
399471|NCT00159263|977855|P4|COMPLETED|Washout||2
399472|NCT00159263|977856|P3|COMPLETED|Washout||2
399473|NCT00159263|977857|P2|COMPLETED|Washout||1
399474|NCT00159263|977858|P1|COMPLETED|Washout||1
399475|NCT00159263|977853|P6|STARTED|Washout||2
399476|NCT00159263|977854|P5|STARTED|Washout||2
399477|NCT00159263|977855|P4|STARTED|Washout||2
399478|NCT00159263|977856|P3|STARTED|Washout||2
399479|NCT00159263|977857|P2|STARTED|Washout||1
399480|NCT00159263|977858|P1|STARTED|Washout||1
399481|NCT00159263|977853|P6|NOT COMPLETED|Second Intervention||0
399482|NCT00159263|977854|P5|NOT COMPLETED|Second Intervention||0
399483|NCT00159263|977855|P4|NOT COMPLETED|Second Intervention||0
399484|NCT00159263|977856|P3|NOT COMPLETED|Second Intervention||0
399485|NCT00159263|977857|P2|NOT COMPLETED|Second Intervention||0
399486|NCT00159263|977858|P1|NOT COMPLETED|Second Intervention||0
399487|NCT00159263|977853|P6|COMPLETED|Second Intervention||2
399488|NCT00159263|977854|P5|COMPLETED|Second Intervention||2
399489|NCT00159263|977855|P4|COMPLETED|Second Intervention||2
399490|NCT00159263|977856|P3|COMPLETED|Second Intervention||2
399491|NCT00159263|977857|P2|COMPLETED|Second Intervention||1
399492|NCT00159263|977858|P1|COMPLETED|Second Intervention||1
399493|NCT00159263|977853|P6|STARTED|Second Intervention||2
399494|NCT00159263|977854|P5|STARTED|Second Intervention||2
399495|NCT00159263|977855|P4|STARTED|Second Intervention||2
399496|NCT00159263|977856|P3|STARTED|Second Intervention||2
399497|NCT00159263|977857|P2|STARTED|Second Intervention||1
399498|NCT00159263|977858|P1|STARTED|Second Intervention||1
399499|NCT00159263|977853|P6|NOT COMPLETED|Washout||0
399500|NCT00159263|977854|P5|NOT COMPLETED|Washout||0
399501|NCT00159263|977855|P4|NOT COMPLETED|Washout||0
399502|NCT00159263|977856|P3|NOT COMPLETED|Washout||0
399503|NCT00159263|977857|P2|NOT COMPLETED|Washout||0
399504|NCT00159263|977858|P1|NOT COMPLETED|Washout||0
399505|NCT00159263|977853|P6|COMPLETED|Washout||2
399506|NCT00159263|977854|P5|COMPLETED|Washout||2
399507|NCT00159263|977855|P4|COMPLETED|Washout||2
399508|NCT00159263|977856|P3|COMPLETED|Washout||2
399509|NCT00159263|977857|P2|COMPLETED|Washout||1
399510|NCT00159263|977858|P1|COMPLETED|Washout||1
399511|NCT00159263|977853|P6|STARTED|Washout||2
399512|NCT00159263|977854|P5|STARTED|Washout||2
399513|NCT00159263|977855|P4|STARTED|Washout||2
399514|NCT00159263|977856|P3|STARTED|Washout||2
399515|NCT00159263|977857|P2|STARTED|Washout||1
399516|NCT00159263|977858|P1|STARTED|Washout||1
399517|NCT00159263|977853|P6|NOT COMPLETED|First Intervention||0
399518|NCT00159263|977854|P5|NOT COMPLETED|First Intervention||0
399519|NCT00159263|977855|P4|NOT COMPLETED|First Intervention||0
399520|NCT00159263|977856|P3|NOT COMPLETED|First Intervention||0
399521|NCT00159263|977857|P2|NOT COMPLETED|First Intervention||0
399522|NCT00159263|977858|P1|NOT COMPLETED|First Intervention||0
399523|NCT00159263|977853|P6|COMPLETED|First Intervention||2
399524|NCT00159263|977854|P5|COMPLETED|First Intervention||2
399525|NCT00159263|977855|P4|COMPLETED|First Intervention||2
399526|NCT00159263|977856|P3|COMPLETED|First Intervention||2
399527|NCT00159263|977857|P2|COMPLETED|First Intervention||1
399528|NCT00159263|977858|P1|COMPLETED|First Intervention||1
399529|NCT00159263|977853|P6|STARTED|First Intervention||2
399530|NCT00159263|977854|P5|STARTED|First Intervention||2
399531|NCT00159263|977855|P4|STARTED|First Intervention||2
399532|NCT00159263|977856|P3|STARTED|First Intervention||2
399533|NCT00159263|977857|P2|STARTED|First Intervention||1
399534|NCT00159263|977858|P1|STARTED|First Intervention||1
399535|NCT00158925|977884|P1|NOT COMPLETED|Overall Study||12
399536|NCT00158925|977884|P1|COMPLETED|Overall Study||84
399537|NCT00158925|977884|P1|STARTED|Overall Study|96 subjects were implanted or attempted with the study lead|96
399538|NCT00158860|977894|P2|NOT COMPLETED|Overall Study||71
399539|NCT00158860|977895|P1|NOT COMPLETED|Overall Study||35
399540|NCT00158860|977894|P2|COMPLETED|Overall Study||184
399541|NCT00158860|977895|P1|COMPLETED|Overall Study||93
399542|NCT00158860|977894|P2|STARTED|Overall Study||255
399543|NCT00158860|977895|P1|STARTED|Overall Study||128
399544|NCT00158756|977914|P5|NOT COMPLETED|Overall Study||3
399545|NCT00158756|977915|P4|NOT COMPLETED|Overall Study||1
399546|NCT00158756|977916|P3|NOT COMPLETED|Overall Study||8
399547|NCT00158756|977917|P2|NOT COMPLETED|Overall Study||0
399548|NCT00158756|977918|P1|NOT COMPLETED|Overall Study||5
399549|NCT00158756|977914|P5|COMPLETED|Overall Study||96
399550|NCT00158756|977915|P4|COMPLETED|Overall Study||22
399551|NCT00158756|977916|P3|COMPLETED|Overall Study||73
399552|NCT00158756|977917|P2|COMPLETED|Overall Study||25
399553|NCT00158756|977918|P1|COMPLETED|Overall Study||75
399554|NCT00158756|977914|P5|STARTED|Overall Study||99
399555|NCT00158756|977915|P4|STARTED|Overall Study||23
399556|NCT00158756|977916|P3|STARTED|Overall Study||81
399557|NCT00158756|977917|P2|STARTED|Overall Study||25
399558|NCT00158756|977918|P1|STARTED|Overall Study||80
399559|NCT00158743|978015|P2|NOT COMPLETED|Overall Study||7
399560|NCT00158743|978016|P1|NOT COMPLETED|Overall Study||9
399561|NCT00158743|978015|P2|COMPLETED|Overall Study||20
399562|NCT00158743|978016|P1|COMPLETED|Overall Study||15
399563|NCT00158743|978015|P2|STARTED|Overall Study||27
399564|NCT00158743|978016|P1|STARTED|Overall Study||24
399565|NCT00158600|978024|P2|NOT COMPLETED|Overall Study||4
399566|NCT00158600|978025|P1|NOT COMPLETED|Overall Study||5
399567|NCT00158600|978024|P2|COMPLETED|Overall Study||26
399568|NCT00158600|978025|P1|COMPLETED|Overall Study||55
399569|NCT00158600|978024|P2|STARTED|Overall Study||30
399570|NCT00158600|978025|P1|STARTED|Overall Study||60
399571|NCT00158379|978043|P1|NOT COMPLETED|Overall Study||0
399572|NCT00158379|978043|P1|COMPLETED|Overall Study||105
399573|NCT00158379|978043|P1|STARTED|Overall Study||105
399574|NCT00158262|978050|P2|NOT COMPLETED|Overall Study||1
399575|NCT00158262|978051|P1|NOT COMPLETED|Overall Study||1
399576|NCT00158262|978050|P2|COMPLETED|Overall Study||21
399577|NCT00158262|978051|P1|COMPLETED|Overall Study||20
399578|NCT00158262|978050|P2|STARTED|Overall Study||22
399579|NCT00158262|978051|P1|STARTED|Overall Study||21
399580|NCT00158249|978063|P2|NOT COMPLETED|Overall Study||0
399581|NCT00158249|978064|P1|NOT COMPLETED|Overall Study||2
399582|NCT00158249|978063|P2|COMPLETED|Overall Study||10
399583|NCT00158249|978064|P1|COMPLETED|Overall Study||9
399584|NCT00158249|978063|P2|STARTED|Overall Study||10
399585|NCT00158249|978064|P1|STARTED|Overall Study||11
399586|NCT00158223|978074|P2|NOT COMPLETED|Overall Study||3
399587|NCT00158223|978075|P1|NOT COMPLETED|Overall Study||5
399588|NCT00158223|978074|P2|COMPLETED|Overall Study||22
399589|NCT00158223|978075|P1|COMPLETED|Overall Study||23
399590|NCT00158223|978074|P2|STARTED|Overall Study||25
399591|NCT00158223|978075|P1|STARTED|Overall Study||28
399592|NCT00158197|978089|P4|NOT COMPLETED|Overall Study||0
399593|NCT00158197|978090|P3|NOT COMPLETED|Overall Study||0
399594|NCT00158197|978091|P2|NOT COMPLETED|Overall Study||0
399595|NCT00158197|978092|P1|NOT COMPLETED|Overall Study||0
399596|NCT00158197|978089|P4|COMPLETED|Overall Study||29
399597|NCT00158197|978090|P3|COMPLETED|Overall Study||28
399598|NCT00158197|978091|P2|COMPLETED|Overall Study||30
399599|NCT00158197|978092|P1|COMPLETED|Overall Study||32
399600|NCT00158197|978089|P4|STARTED|Overall Study||29
399601|NCT00158197|978090|P3|STARTED|Overall Study||28
399602|NCT00158197|978091|P2|STARTED|Overall Study||30
399603|NCT00158197|978092|P1|STARTED|Overall Study||32
399604|NCT00158184|978112|P2|NOT COMPLETED|Overall Study||2
399605|NCT00158184|978113|P1|NOT COMPLETED|Overall Study||6
399606|NCT00158184|978112|P2|COMPLETED|Overall Study||9
399607|NCT00158184|978113|P1|COMPLETED|Overall Study||10
399608|NCT00158184|978112|P2|STARTED|Overall Study||11
399609|NCT00158184|978113|P1|STARTED|Overall Study||16
399610|NCT00158054|978123|P2|NOT COMPLETED|Overall Study||3
399611|NCT00158054|978124|P1|NOT COMPLETED|Overall Study||10
399612|NCT00158054|978123|P2|COMPLETED|Overall Study||74
399613|NCT00158054|978124|P1|COMPLETED|Overall Study||70
399614|NCT00158054|978123|P2|STARTED|Overall Study||77
399615|NCT00158054|978124|P1|STARTED|Overall Study||80
399616|NCT00157950|978138|P2|NOT COMPLETED|Overall Study||0
399617|NCT00157950|978139|P1|NOT COMPLETED|Overall Study||1
399618|NCT00157950|978138|P2|COMPLETED|Overall Study||59
399619|NCT00157950|978139|P1|COMPLETED|Overall Study||116
399620|NCT00157950|978138|P2|Vaccinated at Dose 3|Overall Study||59
399621|NCT00157950|978139|P1|Vaccinated at Dose 3|Overall Study||116
399622|NCT00157950|978138|P2|Vaccinated at Dose 2|Overall Study||59
399623|NCT00157950|978139|P1|Vaccinated at Dose 2|Overall Study||117
399624|NCT00157950|978138|P2|Vaccinated at Dose 1|Overall Study||59
399625|NCT00157950|978139|P1|Vaccinated at Dose 1|Overall Study||117
399626|NCT00157950|978138|P2|STARTED|Overall Study||59
399627|NCT00157950|978139|P1|STARTED|Overall Study||117
399628|NCT00157820|978156|P3|NOT COMPLETED|2nd 8 Months||14
399629|NCT00157820|978157|P2|NOT COMPLETED|2nd 8 Months||13
399630|NCT00157820|978158|P1|NOT COMPLETED|2nd 8 Months||5
399631|NCT00157820|978156|P3|COMPLETED|2nd 8 Months||94
399632|NCT00157820|978157|P2|COMPLETED|2nd 8 Months||88
399633|NCT00157820|978158|P1|COMPLETED|2nd 8 Months||98
399634|NCT00157820|978156|P3|STARTED|2nd 8 Months||108
399635|NCT00157820|978157|P2|STARTED|2nd 8 Months||101
399636|NCT00157820|978158|P1|STARTED|2nd 8 Months||103
399637|NCT00157820|978156|P3|NOT COMPLETED|1 Month Wash Out Period||0
399638|NCT00157820|978157|P2|NOT COMPLETED|1 Month Wash Out Period||0
399639|NCT00157820|978158|P1|NOT COMPLETED|1 Month Wash Out Period||0
399640|NCT00157820|978156|P3|COMPLETED|1 Month Wash Out Period||108
399641|NCT00157820|978157|P2|COMPLETED|1 Month Wash Out Period||101
399642|NCT00157820|978158|P1|COMPLETED|1 Month Wash Out Period||103
399643|NCT00157820|978156|P3|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in DC true period, that are now carried to SC sim period|108
399644|NCT00157820|978157|P2|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in SC sim period, that are now carried to DC true period|101
399645|NCT00157820|978158|P1|STARTED|1 Month Wash Out Period||103
399646|NCT00157820|978156|P3|NOT COMPLETED|1st 8 Month||6
399647|NCT00157820|978157|P2|NOT COMPLETED|1st 8 Month||12
399648|NCT00157820|978158|P1|NOT COMPLETED|1st 8 Month||8
399649|NCT00157820|978156|P3|COMPLETED|1st 8 Month||106
399650|NCT00157820|978157|P2|COMPLETED|1st 8 Month||99
399651|NCT00157820|978158|P1|COMPLETED|1st 8 Month||103
399652|NCT00157820|978156|P3|STARTED|1st 8 Month||112
399653|NCT00157820|978157|P2|STARTED|1st 8 Month||111
399654|NCT00157820|978158|P1|STARTED|1st 8 Month||111
399655|NCT00157820|978156|P3|NOT COMPLETED|Randomized||8
399656|NCT00157820|978157|P2|NOT COMPLETED|Randomized||5
399657|NCT00157820|978158|P1|NOT COMPLETED|Randomized||7
399658|NCT00157820|978156|P3|COMPLETED|Randomized||112
399659|NCT00157820|978157|P2|COMPLETED|Randomized||111
399660|NCT00157820|978158|P1|COMPLETED|Randomized||111
399661|NCT00157820|978156|P3|STARTED|Randomized||120
399662|NCT00157820|978157|P2|STARTED|Randomized||116
399663|NCT00157820|978158|P1|STARTED|Randomized||118
399664|NCT00157755|978171|P6|NOT COMPLETED|Overall Study||5
399665|NCT00157755|978172|P5|NOT COMPLETED|Overall Study||2
399666|NCT00157755|978173|P4|NOT COMPLETED|Overall Study||4
399667|NCT00157755|978174|P3|NOT COMPLETED|Overall Study||7
399668|NCT00157755|978175|P2|NOT COMPLETED|Overall Study||4
399669|NCT00157755|978176|P1|NOT COMPLETED|Overall Study||2
399670|NCT00157755|978171|P6|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|0
399671|NCT00157755|978172|P5|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|10
399672|NCT00157755|978173|P4|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|11
399673|NCT00157755|978174|P3|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|3
399674|NCT00157755|978175|P2|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|15
399675|NCT00157755|978176|P1|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|24
399676|NCT00157755|978171|P6|STARTED|Overall Study||5
399677|NCT00157755|978172|P5|STARTED|Overall Study||12
399678|NCT00157755|978173|P4|STARTED|Overall Study||15
399679|NCT00157755|978174|P3|STARTED|Overall Study||10
399680|NCT00157755|978175|P2|STARTED|Overall Study||19
399681|NCT00157755|978176|P1|STARTED|Overall Study||26
399682|NCT00157573|978198|P2|NOT COMPLETED|Overall Study||0
399683|NCT00157573|978199|P1|NOT COMPLETED|Overall Study||0
399684|NCT00157573|978198|P2|COMPLETED|Overall Study||37
399685|NCT00157573|978199|P1|COMPLETED|Overall Study||35
399686|NCT00157573|978198|P2|STARTED|Overall Study||37
399687|NCT00157573|978199|P1|STARTED|Overall Study||35
399688|NCT00157248|978212|P4|NOT COMPLETED|Overall Study||47
399689|NCT00157248|978213|P3|NOT COMPLETED|Overall Study||21
399690|NCT00157248|978214|P2|NOT COMPLETED|Overall Study||37
399691|NCT00157248|978215|P1|NOT COMPLETED|Overall Study||48
399692|NCT00157248|978212|P4|COMPLETED|Overall Study||77
399693|NCT00157248|978213|P3|COMPLETED|Overall Study||29
399694|NCT00157248|978214|P2|COMPLETED|Overall Study||52
399695|NCT00157248|978215|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation of study medication.|50
399696|NCT00157248|978212|P4|STARTED|Overall Study||124
399697|NCT00157248|978213|P3|STARTED|Overall Study||50
399698|NCT00157248|978214|P2|STARTED|Overall Study||89
399699|NCT00157248|978215|P1|STARTED|Overall Study|Started: Participant completed previous trial on Dabigatran and took study drug of present trial.|98
399700|NCT00157209|978321|P2|NOT COMPLETED|Overall Study||0
399701|NCT00157209|978322|P1|NOT COMPLETED|Overall Study||10
399702|NCT00157209|978321|P2|COMPLETED|Overall Study||83
399703|NCT00157209|978322|P1|COMPLETED|Overall Study||78
399704|NCT00157209|978321|P2|STARTED|Overall Study||83
399705|NCT00157209|978322|P1|STARTED|Overall Study||88
399706|NCT00157196|978336|P1|NOT COMPLETED|Overall Study||9
399707|NCT00157196|978336|P1|COMPLETED|Overall Study||13
399708|NCT00157196|978336|P1|STARTED|Overall Study||22
399709|NCT00157157|978342|P1|NOT COMPLETED|Overall Study||11
399710|NCT00157157|978342|P1|COMPLETED|Overall Study||44
399711|NCT00157157|978342|P1|STARTED|Overall Study||55
399712|NCT00157014|978369|P4|NOT COMPLETED|Overall Study||1
399713|NCT00157014|978370|P3|NOT COMPLETED|Overall Study||1
399714|NCT00157014|978371|P2|NOT COMPLETED|Overall Study||5
399715|NCT00157014|978372|P1|NOT COMPLETED|Overall Study||7
399716|NCT00157014|978369|P4|COMPLETED|Overall Study||5
399717|NCT00157014|978370|P3|COMPLETED|Overall Study||4
399718|NCT00157014|978371|P2|COMPLETED|Overall Study||41
399719|NCT00157014|978372|P1|COMPLETED|Overall Study||45
399720|NCT00157014|978369|P4|STARTED|Overall Study||6
399721|NCT00157014|978370|P3|STARTED|Overall Study||5
399722|NCT00157014|978371|P2|STARTED|Overall Study||46
399723|NCT00157014|978372|P1|STARTED|Overall Study||52
399724|NCT00156936|978452|P2|NOT COMPLETED|Overall Study||11
399725|NCT00156936|978453|P1|NOT COMPLETED|Overall Study||72
399726|NCT00156936|978452|P2|COMPLETED|Overall Study||5
399727|NCT00156936|978453|P1|COMPLETED|Overall Study||20
399728|NCT00156936|978452|P2|STARTED|Overall Study||16
399729|NCT00156936|978453|P1|STARTED|Overall Study||92
399730|NCT00156923|978461|P2|NOT COMPLETED|Overall Study||32
399731|NCT00156923|978462|P1|NOT COMPLETED|Overall Study||34
399732|NCT00156923|978461|P2|COMPLETED|Overall Study||20
399733|NCT00156923|978462|P1|COMPLETED|Overall Study||22
399734|NCT00156923|978461|P2|STARTED|Overall Study||52
399735|NCT00156923|978462|P1|STARTED|Overall Study||56
399736|NCT00156910|978470|P2|NOT COMPLETED|Open-Label Phase (OL)||55
399737|NCT00156910|978471|P1|NOT COMPLETED|Open-Label Phase (OL)||33
399738|NCT00156910|978470|P2|COMPLETED|Open-Label Phase (OL)||231
399739|NCT00156910|978471|P1|COMPLETED|Open-Label Phase (OL)||252
399740|NCT00156910|978470|P2|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL Phase|286
399741|NCT00156910|978471|P1|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|285
399742|NCT00156910|978470|P2|NOT COMPLETED|Double-Blind Phase (DB)||43
399743|NCT00156910|978471|P1|NOT COMPLETED|Double-Blind Phase (DB)||45
399744|NCT00156910|978470|P2|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|295
399745|NCT00156910|978471|P1|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|296
399746|NCT00156910|978470|P2|STARTED|Double-Blind Phase (DB)||338
399747|NCT00156910|978471|P1|STARTED|Double-Blind Phase (DB)||341
399748|NCT00156819|978488|P3|NOT COMPLETED|Overall Study||3
399749|NCT00156819|978489|P2|NOT COMPLETED|Overall Study||1
399750|NCT00156819|978490|P1|NOT COMPLETED|Overall Study||1
399751|NCT00156819|978488|P3|COMPLETED|Overall Study||162
399752|NCT00156819|978489|P2|COMPLETED|Overall Study||165
399753|NCT00156819|978490|P1|COMPLETED|Overall Study||168
399754|NCT00156819|978488|P3|STARTED|Overall Study||165
399755|NCT00156819|978489|P2|STARTED|Overall Study||166
399756|NCT00156819|978490|P1|STARTED|Overall Study||169
399757|NCT00156715|978498|P1|NOT COMPLETED|Overall Study||7
399758|NCT00156715|978498|P1|COMPLETED|Overall Study||16
399759|NCT00156715|978498|P1|STARTED|Overall Study||23
399760|NCT00156533|978507|P4|NOT COMPLETED|Overall Study||2
399761|NCT00156533|978508|P3|NOT COMPLETED|Overall Study||2
399762|NCT00156533|978509|P2|NOT COMPLETED|Overall Study||2
399763|NCT00156533|978510|P1|NOT COMPLETED|Overall Study||2
399764|NCT00156533|978507|P4|COMPLETED|Overall Study||3
399765|NCT00156533|978508|P3|COMPLETED|Overall Study||3
399766|NCT00156533|978509|P2|COMPLETED|Overall Study||3
399767|NCT00156533|978510|P1|COMPLETED|Overall Study||3
399768|NCT00156533|978507|P4|STARTED|Overall Study||5
399769|NCT00156533|978508|P3|STARTED|Overall Study||5
399770|NCT00156533|978509|P2|STARTED|Overall Study||5
399771|NCT00156533|978510|P1|STARTED|Overall Study||5
399772|NCT00156390|978526|P2|NOT COMPLETED|Overall Study||8
399773|NCT00156390|978527|P1|NOT COMPLETED|Overall Study||14
399774|NCT00156390|978526|P2|COMPLETED|Overall Study||69
399775|NCT00156390|978527|P1|COMPLETED|Overall Study||96
399776|NCT00156390|978526|P2|STARTED|Overall Study||77
399777|NCT00156390|978527|P1|STARTED|Overall Study||110
399778|NCT00156247|978535|P1|NOT COMPLETED|Overall Study||4
399779|NCT00156247|978535|P1|COMPLETED|Overall Study||5
399780|NCT00156247|978535|P1|STARTED|Overall Study||9
399781|NCT00156065|978544|P3|NOT COMPLETED|Overall Study||27
399782|NCT00156065|978545|P2|NOT COMPLETED|Overall Study||63
399783|NCT00156065|978546|P1|NOT COMPLETED|Overall Study||31
399784|NCT00156065|978544|P3|COMPLETED|Overall Study||16
399785|NCT00156065|978545|P2|COMPLETED|Overall Study||30
399786|NCT00156065|978546|P1|COMPLETED|Overall Study||20
399787|NCT00156065|978544|P3|STARTED|Overall Study||43
399788|NCT00156065|978545|P2|STARTED|Overall Study||93
399789|NCT00156065|978546|P1|STARTED|Overall Study||51
399790|NCT00156013|978557|P1|NOT COMPLETED|Overall Study||2
399791|NCT00156013|978557|P1|COMPLETED|Overall Study||31
399792|NCT00156013|978557|P1|STARTED|Overall Study||33
399793|NCT00154466|978566|P3|NOT COMPLETED|Overall Study||0
399794|NCT00154466|978567|P2|NOT COMPLETED|Overall Study||0
399795|NCT00154466|978568|P1|NOT COMPLETED|Overall Study||0
399796|NCT00154466|978566|P3|COMPLETED|Overall Study||19
399797|NCT00154466|978567|P2|COMPLETED|Overall Study||19
399798|NCT00154466|978568|P1|COMPLETED|Overall Study||20
399799|NCT00154466|978566|P3|STARTED|Overall Study|Healthy controls underwent the test of myocardial perfusion only at baseline.|19
399800|NCT00154466|978567|P2|STARTED|Overall Study||19
399801|NCT00154466|978568|P1|STARTED|Overall Study||20
399802|NCT00154375|978580|P2|NOT COMPLETED|Overall Study||106
399803|NCT00154375|978581|P1|NOT COMPLETED|Overall Study||113
399804|NCT00154375|978580|P2|COMPLETED|Overall Study||14
399805|NCT00154375|978581|P1|COMPLETED|Overall Study||7
399806|NCT00154375|978580|P2|Not Exposed to Study Treatment|Overall Study||2
399807|NCT00154375|978581|P1|Not Exposed to Study Treatment|Overall Study|4 randomized patients didn't receive study treatment were excluded from the safety analyses.|2
399808|NCT00154375|978580|P2|Discontinued Study Treatment|Overall Study||104
399809|NCT00154375|978581|P1|Discontinued Study Treatment|Overall Study||111
399810|NCT00154375|978580|P2|STARTED|Overall Study||120
399811|NCT00154375|978581|P1|STARTED|Overall Study||120
399812|NCT00154310|978592|P2|NOT COMPLETED|Overall Study||28
399813|NCT00154310|978593|P1|NOT COMPLETED|Overall Study||37
399814|NCT00154310|978592|P2|COMPLETED|Overall Study||117
399815|NCT00154310|978593|P1|COMPLETED|Overall Study||118
399816|NCT00154310|978592|P2|STARTED|Overall Study||145
399817|NCT00154310|978593|P1|STARTED|Overall Study|"Started indicates enrolled participants. Randomized participants for two arms are 154 and 146."|155
399818|NCT00154297|978609|P2|NOT COMPLETED|Overall Study||7
399819|NCT00154297|978610|P1|NOT COMPLETED|Overall Study||8
399820|NCT00154297|978609|P2|COMPLETED|Overall Study|Completed study by 12 month.|67
399821|NCT00154297|978610|P1|COMPLETED|Overall Study|Completed study by 12 month.|57
399822|NCT00154297|978609|P2|STARTED|Overall Study|Randomized population.|74
399823|NCT00154297|978610|P1|STARTED|Overall Study|Randomized population.|65
399824|NCT00154284|978628|P2|NOT COMPLETED|Overall Study||13
399825|NCT00154284|978629|P1|NOT COMPLETED|Overall Study||7
399826|NCT00154284|978628|P2|COMPLETED|Overall Study||42
399827|NCT00154284|978629|P1|COMPLETED|Overall Study|"Completed means patients completed on study medication.All patients of both arms completed study."|52
399828|NCT00154284|978628|P2|Intent to Treat (ITT) Population|Overall Study||53
399829|NCT00154284|978629|P1|Intent to Treat (ITT) Population|Overall Study||57
399830|NCT00154284|978628|P2|STARTED|Overall Study||55
399831|NCT00154284|978629|P1|STARTED|Overall Study|"Started indicates Safety Population (randomized patients and treated after randomization.)"|59
399832|NCT00154102|978643|P2|NOT COMPLETED|Overall Study||2
399833|NCT00154102|978644|P1|NOT COMPLETED|Overall Study||7
399834|NCT00154102|978643|P2|COMPLETED|Overall Study||597
399835|NCT00154102|978644|P1|COMPLETED|Overall Study||592
399836|NCT00154102|978643|P2|STARTED|Overall Study|Randomized and treated subjects; 3 additional subjects were treated but not randomised|599
399837|NCT00154102|978644|P1|STARTED|Overall Study|Randomized and treated subjects; 1 additional subject was treated but not randomised|599
399838|NCT00154063|978680|P2|NOT COMPLETED|Overall Study||22
399839|NCT00154063|978681|P1|NOT COMPLETED|Overall Study||12
399840|NCT00154063|978680|P2|COMPLETED|Overall Study||80
399841|NCT00154063|978681|P1|COMPLETED|Overall Study||92
399842|NCT00154063|978680|P2|STARTED|Overall Study||102
399843|NCT00154063|978681|P1|STARTED|Overall Study||104
399844|NCT00153985|978737|P1|NOT COMPLETED|Overall Study||0
399845|NCT00153985|978737|P1|COMPLETED|Overall Study||2
399846|NCT00153985|978737|P1|STARTED|Overall Study||2
399847|NCT00153920|978743|P1|NOT COMPLETED|Overall Study||30
399848|NCT00153920|978743|P1|COMPLETED|Overall Study||36
399849|NCT00153920|978743|P1|Eligible and Treated|Overall Study||64
399850|NCT00153920|978743|P1|STARTED|Overall Study||66
399851|NCT00153842|978754|P2|NOT COMPLETED|Overall Study||0
399852|NCT00153842|978755|P1|NOT COMPLETED|Overall Study||0
399853|NCT00153842|978754|P2|COMPLETED|Overall Study||7
399854|NCT00153842|978755|P1|COMPLETED|Overall Study||26
399855|NCT00153842|978754|P2|STARTED|Overall Study||7
399856|NCT00153842|978755|P1|STARTED|Overall Study||26
399857|NCT00153816|978769|P6|NOT COMPLETED|Overall Study||27
399858|NCT00153816|978770|P5|NOT COMPLETED|Overall Study||17
399859|NCT00153816|978771|P4|NOT COMPLETED|Overall Study||31
399860|NCT00153816|978772|P3|NOT COMPLETED|Overall Study||32
399861|NCT00153816|978773|P2|NOT COMPLETED|Overall Study||32
399862|NCT00153816|978774|P1|NOT COMPLETED|Overall Study||32
399863|NCT00153816|978769|P6|COMPLETED|Overall Study||262
399864|NCT00153816|978770|P5|COMPLETED|Overall Study||278
399865|NCT00153816|978771|P4|COMPLETED|Overall Study||390
399866|NCT00153816|978772|P3|COMPLETED|Overall Study||388
399867|NCT00153816|978773|P2|COMPLETED|Overall Study||387
399868|NCT00153816|978774|P1|COMPLETED|Overall Study||383
399869|NCT00153816|978769|P6|STARTED|Overall Study||289
399870|NCT00153816|978770|P5|STARTED|Overall Study||295
399871|NCT00153816|978771|P4|STARTED|Overall Study||421
399872|NCT00153816|978772|P3|STARTED|Overall Study||420
399873|NCT00153816|978773|P2|STARTED|Overall Study||419
399874|NCT00153816|978774|P1|STARTED|Overall Study||415
399875|NCT00153803|978796|P2|NOT COMPLETED|Investigational Drug||42
399876|NCT00153803|978797|P1|NOT COMPLETED|Investigational Drug||41
399877|NCT00153803|978796|P2|COMPLETED|Investigational Drug||75
399878|NCT00153803|978797|P1|COMPLETED|Investigational Drug||77
399879|NCT00153803|978796|P2|Investigational Drug Dispensed|Investigational Drug||75
399880|NCT00153803|978797|P1|Investigational Drug Dispensed|Investigational Drug||77
399881|NCT00153803|978796|P2|STARTED|Investigational Drug||117
399882|NCT00153803|978797|P1|STARTED|Investigational Drug||118
399883|NCT00153803|978796|P2|NOT COMPLETED|Concurrent Chemoradiation||5
399884|NCT00153803|978797|P1|NOT COMPLETED|Concurrent Chemoradiation||5
399885|NCT00153803|978796|P2|COMPLETED|Concurrent Chemoradiation||117
399886|NCT00153803|978797|P1|COMPLETED|Concurrent Chemoradiation||118
399887|NCT00153803|978796|P2|Received Chemoradiation|Concurrent Chemoradiation||117
399888|NCT00153803|978797|P1|Received Chemoradiation|Concurrent Chemoradiation||118
399889|NCT00153803|978796|P2|STARTED|Concurrent Chemoradiation||122
399890|NCT00153803|978797|P1|STARTED|Concurrent Chemoradiation||123
399891|NCT00153179|978815|P4|NOT COMPLETED|Study Visit Day 2||2
399892|NCT00153179|978816|P3|NOT COMPLETED|Study Visit Day 2||2
399893|NCT00153179|978817|P2|NOT COMPLETED|Study Visit Day 2||0
399894|NCT00153179|978818|P1|NOT COMPLETED|Study Visit Day 2||1
399895|NCT00153179|978815|P4|COMPLETED|Study Visit Day 2||7
399896|NCT00153179|978816|P3|COMPLETED|Study Visit Day 2||11
399897|NCT00153179|978817|P2|COMPLETED|Study Visit Day 2||8
399898|NCT00153179|978818|P1|COMPLETED|Study Visit Day 2||9
399899|NCT00153179|978815|P4|STARTED|Study Visit Day 2||9
399900|NCT00153179|978816|P3|STARTED|Study Visit Day 2||13
399901|NCT00153179|978817|P2|STARTED|Study Visit Day 2||8
399902|NCT00153179|978818|P1|STARTED|Study Visit Day 2||10
399903|NCT00153179|978815|P4|NOT COMPLETED|Study Visit Day 1||0
399904|NCT00153179|978816|P3|NOT COMPLETED|Study Visit Day 1||0
399905|NCT00153179|978817|P2|NOT COMPLETED|Study Visit Day 1||0
399906|NCT00153179|978818|P1|NOT COMPLETED|Study Visit Day 1||0
399907|NCT00153179|978815|P4|COMPLETED|Study Visit Day 1||9
399908|NCT00153179|978816|P3|COMPLETED|Study Visit Day 1||13
399909|NCT00153179|978817|P2|COMPLETED|Study Visit Day 1||8
399910|NCT00153179|978818|P1|COMPLETED|Study Visit Day 1||10
399911|NCT00153179|978815|P4|STARTED|Study Visit Day 1||9
399912|NCT00153179|978816|P3|STARTED|Study Visit Day 1||13
399913|NCT00153179|978817|P2|STARTED|Study Visit Day 1||8
399914|NCT00153179|978818|P1|STARTED|Study Visit Day 1||10
399915|NCT00153166|978831|P3|NOT COMPLETED|Overall Study||0
399916|NCT00153166|978832|P2|NOT COMPLETED|Overall Study||0
399917|NCT00153166|978833|P1|NOT COMPLETED|Overall Study||0
399918|NCT00153166|978831|P3|COMPLETED|Overall Study||28
399919|NCT00153166|978832|P2|COMPLETED|Overall Study||37
399920|NCT00153166|978833|P1|COMPLETED|Overall Study||11
399921|NCT00153166|978831|P3|Received Placebo and Placebo|Overall Study||7
399922|NCT00153166|978832|P2|Received Placebo and Placebo|Overall Study||9
399923|NCT00153166|978833|P1|Received Placebo and Placebo|Overall Study||3
399924|NCT00153166|978831|P3|Received Placebo and Pioglitazone|Overall Study||7
399925|NCT00153166|978832|P2|Received Placebo and Pioglitazone|Overall Study||10
399926|NCT00153166|978833|P1|Received Placebo and Pioglitazone|Overall Study||3
399927|NCT00153166|978831|P3|Received Atorvastatin and Placebo|Overall Study||7
399928|NCT00153166|978832|P2|Received Atorvastatin and Placebo|Overall Study||9
399929|NCT00153166|978833|P1|Received Atorvastatin and Placebo|Overall Study||2
399930|NCT00153166|978831|P3|Received Atorvastatin and Pioglitazone|Overall Study||7
399931|NCT00153166|978832|P2|Received Atorvastatin and Pioglitazone|Overall Study||9
399932|NCT00153166|978833|P1|Received Atorvastatin and Pioglitazone|Overall Study||3
399933|NCT00153166|978831|P3|STARTED|Overall Study||28
399934|NCT00153166|978832|P2|STARTED|Overall Study||37
399935|NCT00153166|978833|P1|STARTED|Overall Study||11
399936|NCT00153101|978850|P5|NOT COMPLETED|Overall Study||10
399937|NCT00153101|978851|P4|NOT COMPLETED|Overall Study||8
399938|NCT00153101|978852|P3|NOT COMPLETED|Overall Study||15
399939|NCT00153101|978853|P2|NOT COMPLETED|Overall Study||18
399940|NCT00153101|978854|P1|NOT COMPLETED|Overall Study||17
399941|NCT00153101|978850|P5|COMPLETED|Overall Study||2962
399942|NCT00153101|978851|P4|COMPLETED|Overall Study||2946
399943|NCT00153101|978852|P3|COMPLETED|Overall Study||8561
399944|NCT00153101|978853|P2|COMPLETED|Overall Study||8524
399945|NCT00153101|978854|P1|COMPLETED|Overall Study||8485
399946|NCT00153101|978850|P5|STARTED|Overall Study||2972
399947|NCT00153101|978851|P4|STARTED|Overall Study||2954
399948|NCT00153101|978852|P3|STARTED|Overall Study||8576
399949|NCT00153101|978853|P2|STARTED|Overall Study||8542
399950|NCT00153101|978854|P1|STARTED|Overall Study||8502
399951|NCT00153062|978962|P4|NOT COMPLETED|Overall Study||411
399952|NCT00153062|978963|P3|NOT COMPLETED|Overall Study||415
399953|NCT00153062|978964|P2|NOT COMPLETED|Overall Study||406
399954|NCT00153062|978965|P1|NOT COMPLETED|Overall Study||387
399955|NCT00153062|978962|P4|COMPLETED|Overall Study||4680
399956|NCT00153062|978963|P3|COMPLETED|Overall Study||4645
399957|NCT00153062|978964|P2|COMPLETED|Overall Study||4689
399958|NCT00153062|978965|P1|COMPLETED|Overall Study||4699
399959|NCT00153062|978962|P4|STARTED|Overall Study||5091
399960|NCT00153062|978963|P3|STARTED|Overall Study||5060
399961|NCT00153062|978964|P2|STARTED|Overall Study||5095
399962|NCT00153062|978965|P1|STARTED|Overall Study||5086
399963|NCT00152971|978984|P3|NOT COMPLETED|Treatment||80
399964|NCT00152971|978985|P2|NOT COMPLETED|Treatment||63
399965|NCT00152971|978986|P1|NOT COMPLETED|Treatment||71
399966|NCT00152971|978984|P3|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|788
399967|NCT00152971|978985|P2|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|808
399968|NCT00152971|978986|P1|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|786
399969|NCT00152971|978984|P3|STARTED|Treatment||868
399970|NCT00152971|978985|P2|STARTED|Treatment||871
399971|NCT00152971|978986|P1|STARTED|Treatment||857
399972|NCT00152971|978984|P3|NOT COMPLETED|Overall Study||49
399973|NCT00152971|978985|P2|NOT COMPLETED|Overall Study||48
399974|NCT00152971|978986|P1|NOT COMPLETED|Overall Study||51
399975|NCT00152971|978984|P3|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|819
399976|NCT00152971|978985|P2|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|823
399977|NCT00152971|978986|P1|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|806
399978|NCT00152971|978984|P3|STARTED|Overall Study||868
399979|NCT00152971|978985|P2|STARTED|Overall Study||871
399980|NCT00152971|978986|P1|STARTED|Overall Study||857
399981|NCT00152763|979022|P4|NOT COMPLETED|Overall Study||14
399982|NCT00152763|979023|P3|NOT COMPLETED|Overall Study||4
399983|NCT00152763|979024|P2|NOT COMPLETED|Overall Study||5
399984|NCT00152763|979025|P1|NOT COMPLETED|Overall Study||10
399985|NCT00152763|979022|P4|COMPLETED|Overall Study||63
399986|NCT00152763|979023|P3|COMPLETED|Overall Study||16
399987|NCT00152763|979024|P2|COMPLETED|Overall Study||14
399988|NCT00152763|979025|P1|COMPLETED|Overall Study||67
399989|NCT00152763|979022|P4|STARTED|Overall Study||77
399990|NCT00152763|979023|P3|STARTED|Overall Study||20
399991|NCT00152763|979024|P2|STARTED|Overall Study||19
399992|NCT00152763|979025|P1|STARTED|Overall Study||77
399993|NCT00152516|979141|P1|NOT COMPLETED|Overall Study||75
399994|NCT00152516|979141|P1|COMPLETED|Overall Study|Subjects ongoing until study close-out|180
399995|NCT00152516|979141|P1|STARTED|Overall Study|Subjects that were dispensed at least 1 dose of study medication|255
399996|NCT00152464|979167|P2|NOT COMPLETED|Overall Study||36
399997|NCT00152464|979168|P1|NOT COMPLETED|Overall Study||40
399998|NCT00152464|979167|P2|COMPLETED|Overall Study||219
399999|NCT00152464|979168|P1|COMPLETED|Overall Study||215
400000|NCT00152464|979167|P2|STARTED|Overall Study||255
400001|NCT00152464|979168|P1|STARTED|Overall Study||255
400002|NCT00152009|979196|P4|NOT COMPLETED|Overall Study||33
400003|NCT00152009|979197|P3|NOT COMPLETED|Overall Study||37
400004|NCT00152009|979198|P2|NOT COMPLETED|Overall Study||31
400005|NCT00152009|979199|P1|NOT COMPLETED|Overall Study||29
400006|NCT00152009|979196|P4|COMPLETED|Overall Study||53
400007|NCT00152009|979197|P3|COMPLETED|Overall Study||49
400008|NCT00152009|979198|P2|COMPLETED|Overall Study||55
400009|NCT00152009|979199|P1|COMPLETED|Overall Study||58
400010|NCT00152009|979196|P4|STARTED|Overall Study||86
400011|NCT00152009|979197|P3|STARTED|Overall Study||86
400012|NCT00152009|979198|P2|STARTED|Overall Study||86
400013|NCT00152009|979199|P1|STARTED|Overall Study||87
400014|NCT00151996|979231|P2|NOT COMPLETED|Overall Study||7
400015|NCT00151996|979232|P1|NOT COMPLETED|Overall Study||5
400016|NCT00151996|979231|P2|COMPLETED|Overall Study||26
400017|NCT00151996|979232|P1|COMPLETED|Overall Study||37
400018|NCT00151996|979231|P2|STARTED|Overall Study||33
400019|NCT00151996|979232|P1|STARTED|Overall Study||42
400020|NCT00151892|979248|P2|NOT COMPLETED|Overall Study||83
400021|NCT00151892|979249|P1|NOT COMPLETED|Overall Study||76
400022|NCT00151892|979248|P2|COMPLETED|Overall Study||330
400023|NCT00151892|979249|P1|COMPLETED|Overall Study||340
400024|NCT00151892|979248|P2|STARTED|Overall Study||413
400025|NCT00151892|979249|P1|STARTED|Overall Study||416
400026|NCT00151814|979266|P3|NOT COMPLETED|Overall Study||0
400027|NCT00151814|979267|P2|NOT COMPLETED|Overall Study||0
400028|NCT00151814|979268|P1|NOT COMPLETED|Overall Study||0
400029|NCT00151814|979266|P3|COMPLETED|Overall Study||10
400030|NCT00151814|979267|P2|COMPLETED|Overall Study||10
400031|NCT00151814|979268|P1|COMPLETED|Overall Study||4
400032|NCT00151814|979266|P3|STARTED|Overall Study||10
400033|NCT00151814|979267|P2|STARTED|Overall Study||10
400034|NCT00151814|979268|P1|STARTED|Overall Study||4
400035|NCT00151775|979294|P12|NOT COMPLETED|Period 4: Open Label||0
400036|NCT00151775|979295|P11|NOT COMPLETED|Period 4: Open Label||0
400037|NCT00151775|979296|P10|NOT COMPLETED|Period 4: Open Label||21
400038|NCT00151775|979297|P9|NOT COMPLETED|Period 4: Open Label||0
400039|NCT00151775|979298|P8|NOT COMPLETED|Period 4: Open Label||0
400040|NCT00151775|979299|P7|NOT COMPLETED|Period 4: Open Label||0
400041|NCT00151775|979300|P6|NOT COMPLETED|Period 4: Open Label||0
400042|NCT00151775|979301|P5|NOT COMPLETED|Period 4: Open Label||30
400043|NCT00151775|979302|P4|NOT COMPLETED|Period 4: Open Label||0
400044|NCT00151775|979303|P3|NOT COMPLETED|Period 4: Open Label||0
400045|NCT00151775|979304|P2|NOT COMPLETED|Period 4: Open Label||0
400046|NCT00151775|979305|P1|NOT COMPLETED|Period 4: Open Label||0
400047|NCT00151775|979294|P12|COMPLETED|Period 4: Open Label||0
400048|NCT00151775|979295|P11|COMPLETED|Period 4: Open Label||57
400049|NCT00151775|979296|P10|COMPLETED|Period 4: Open Label||83
400050|NCT00151775|979297|P9|COMPLETED|Period 4: Open Label||0
400051|NCT00151775|979298|P8|COMPLETED|Period 4: Open Label||0
400052|NCT00151775|979299|P7|COMPLETED|Period 4: Open Label||0
400053|NCT00151775|979300|P6|COMPLETED|Period 4: Open Label||0
400054|NCT00151775|979301|P5|COMPLETED|Period 4: Open Label||149
400055|NCT00151775|979302|P4|COMPLETED|Period 4: Open Label||0
400056|NCT00151775|979303|P3|COMPLETED|Period 4: Open Label||0
400057|NCT00151775|979304|P2|COMPLETED|Period 4: Open Label||0
400058|NCT00151775|979305|P1|COMPLETED|Period 4: Open Label||0
400059|NCT00151775|979294|P12|STARTED|Period 4: Open Label||0
400060|NCT00151775|979295|P11|STARTED|Period 4: Open Label||57
400061|NCT00151775|979296|P10|STARTED|Period 4: Open Label||104
400062|NCT00151775|979297|P9|STARTED|Period 4: Open Label||0
400063|NCT00151775|979298|P8|STARTED|Period 4: Open Label||0
400064|NCT00151775|979299|P7|STARTED|Period 4: Open Label||0
400065|NCT00151775|979300|P6|STARTED|Period 4: Open Label||0
400066|NCT00151775|979301|P5|STARTED|Period 4: Open Label||179
400067|NCT00151775|979302|P4|STARTED|Period 4: Open Label||0
400068|NCT00151775|979303|P3|STARTED|Period 4: Open Label||0
400069|NCT00151775|979304|P2|STARTED|Period 4: Open Label||0
400070|NCT00151775|979305|P1|STARTED|Period 4: Open Label||0
400071|NCT00151775|979294|P12|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
400072|NCT00151775|979295|P11|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
400073|NCT00151775|979296|P10|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
400074|NCT00151775|979297|P9|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
400075|NCT00151775|979298|P8|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
400076|NCT00151775|979299|P7|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
400077|NCT00151775|979300|P6|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
400078|NCT00151775|979301|P5|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
400079|NCT00151775|979302|P4|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
400080|NCT00151775|979303|P3|NOT COMPLETED|Period 3: Double-blind, Withdrawal||3
400081|NCT00151775|979304|P2|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
400082|NCT00151775|979305|P1|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
400083|NCT00151775|979294|P12|COMPLETED|Period 3: Double-blind, Withdrawal||28
400084|NCT00151775|979295|P11|COMPLETED|Period 3: Double-blind, Withdrawal||29
400085|NCT00151775|979296|P10|COMPLETED|Period 3: Double-blind, Withdrawal||0
400086|NCT00151775|979297|P9|COMPLETED|Period 3: Double-blind, Withdrawal||26
400087|NCT00151775|979298|P8|COMPLETED|Period 3: Double-blind, Withdrawal||27
400088|NCT00151775|979299|P7|COMPLETED|Period 3: Double-blind, Withdrawal||26
400089|NCT00151775|979300|P6|COMPLETED|Period 3: Double-blind, Withdrawal||25
400090|NCT00151775|979301|P5|COMPLETED|Period 3: Double-blind, Withdrawal||0
400091|NCT00151775|979302|P4|COMPLETED|Period 3: Double-blind, Withdrawal||44
400092|NCT00151775|979303|P3|COMPLETED|Period 3: Double-blind, Withdrawal||42
400093|NCT00151775|979304|P2|COMPLETED|Period 3: Double-blind, Withdrawal||45
400094|NCT00151775|979305|P1|COMPLETED|Period 3: Double-blind, Withdrawal||48
400095|NCT00151775|979294|P12|STARTED|Period 3: Double-blind, Withdrawal||29
400096|NCT00151775|979295|P11|STARTED|Period 3: Double-blind, Withdrawal||29
400097|NCT00151775|979296|P10|STARTED|Period 3: Double-blind, Withdrawal||0
400098|NCT00151775|979297|P9|STARTED|Period 3: Double-blind, Withdrawal||26
400099|NCT00151775|979298|P8|STARTED|Period 3: Double-blind, Withdrawal||28
400100|NCT00151775|979299|P7|STARTED|Period 3: Double-blind, Withdrawal||27
400101|NCT00151775|979300|P6|STARTED|Period 3: Double-blind, Withdrawal||26
400102|NCT00151775|979301|P5|STARTED|Period 3: Double-blind, Withdrawal||0
400103|NCT00151775|979302|P4|STARTED|Period 3: Double-blind, Withdrawal||44
400104|NCT00151775|979303|P3|STARTED|Period 3: Double-blind, Withdrawal||45
400105|NCT00151775|979304|P2|STARTED|Period 3: Double-blind, Withdrawal||45
400106|NCT00151775|979305|P1|STARTED|Period 3: Double-blind, Withdrawal||48
400107|NCT00151775|979294|P12|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
400108|NCT00151775|979295|P11|NOT COMPLETED|Period 2 - Double-Blind Dose Response||1
400109|NCT00151775|979296|P10|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
400110|NCT00151775|979297|P9|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
400111|NCT00151775|979298|P8|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
400112|NCT00151775|979299|P7|NOT COMPLETED|Period 2 - Double-Blind Dose Response||3
400113|NCT00151775|979300|P6|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
400114|NCT00151775|979301|P5|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
400115|NCT00151775|979302|P4|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
400116|NCT00151775|979303|P3|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
400117|NCT00151775|979304|P2|NOT COMPLETED|Period 2 - Double-Blind Dose Response||6
400118|NCT00151775|979305|P1|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
400119|NCT00151775|979294|P12|COMPLETED|Period 2 - Double-Blind Dose Response||0
400120|NCT00151775|979295|P11|COMPLETED|Period 2 - Double-Blind Dose Response||59
400121|NCT00151775|979296|P10|COMPLETED|Period 2 - Double-Blind Dose Response||0
400122|NCT00151775|979297|P9|COMPLETED|Period 2 - Double-Blind Dose Response||0
400123|NCT00151775|979298|P8|COMPLETED|Period 2 - Double-Blind Dose Response||0
400124|NCT00151775|979299|P7|COMPLETED|Period 2 - Double-Blind Dose Response||53
400125|NCT00151775|979300|P6|COMPLETED|Period 2 - Double-Blind Dose Response||54
400126|NCT00151775|979301|P5|COMPLETED|Period 2 - Double-Blind Dose Response||0
400127|NCT00151775|979302|P4|COMPLETED|Period 2 - Double-Blind Dose Response||0
400128|NCT00151775|979303|P3|COMPLETED|Period 2 - Double-Blind Dose Response||0
400129|NCT00151775|979304|P2|COMPLETED|Period 2 - Double-Blind Dose Response||89
400130|NCT00151775|979305|P1|COMPLETED|Period 2 - Double-Blind Dose Response||93
400131|NCT00151775|979294|P12|STARTED|Period 2 - Double-Blind Dose Response||0
400132|NCT00151775|979295|P11|STARTED|Period 2 - Double-Blind Dose Response||60
400133|NCT00151775|979296|P10|STARTED|Period 2 - Double-Blind Dose Response||0
400134|NCT00151775|979297|P9|STARTED|Period 2 - Double-Blind Dose Response||0
400135|NCT00151775|979298|P8|STARTED|Period 2 - Double-Blind Dose Response||0
400136|NCT00151775|979299|P7|STARTED|Period 2 - Double-Blind Dose Response||56
400137|NCT00151775|979300|P6|STARTED|Period 2 - Double-Blind Dose Response||56
400138|NCT00151775|979301|P5|STARTED|Period 2 - Double-Blind Dose Response||0
400139|NCT00151775|979302|P4|STARTED|Period 2 - Double-Blind Dose Response||0
400140|NCT00151775|979303|P3|STARTED|Period 2 - Double-Blind Dose Response||0
400141|NCT00151775|979304|P2|STARTED|Period 2 - Double-Blind Dose Response||95
400142|NCT00151775|979305|P1|STARTED|Period 2 - Double-Blind Dose Response||95
400143|NCT00151476|979349|P2|NOT COMPLETED|FAP Analyzed Subjects||3
400144|NCT00151476|979350|P1|NOT COMPLETED|FAP Analyzed Subjects||0
400145|NCT00151476|979349|P2|COMPLETED|FAP Analyzed Subjects||51
400146|NCT00151476|979350|P1|COMPLETED|FAP Analyzed Subjects||13
400147|NCT00151476|979349|P2|STARTED|FAP Analyzed Subjects||54
400148|NCT00151476|979350|P1|STARTED|FAP Analyzed Subjects||13
400149|NCT00151476|979349|P2|NOT COMPLETED|FAP Identified Subjects||1
400150|NCT00151476|979350|P1|NOT COMPLETED|FAP Identified Subjects||0
400151|NCT00151476|979349|P2|COMPLETED|FAP Identified Subjects||54
400152|NCT00151476|979350|P1|COMPLETED|FAP Identified Subjects||13
400153|NCT00151476|979349|P2|STARTED|FAP Identified Subjects||55
400154|NCT00151476|979350|P1|STARTED|FAP Identified Subjects||13
400155|NCT00151411|979407|P2|NOT COMPLETED|Overall Study||43
400156|NCT00151411|979408|P1|NOT COMPLETED|Overall Study||33
400157|NCT00151411|979407|P2|COMPLETED|Overall Study||16
400158|NCT00151411|979408|P1|COMPLETED|Overall Study||22
400159|NCT00151411|979407|P2|STARTED|Overall Study||59
400160|NCT00151411|979408|P1|STARTED|Overall Study||55
400161|NCT00151372|979420|P2|NOT COMPLETED|Overall Study||29
400162|NCT00151372|979421|P1|NOT COMPLETED|Overall Study||29
400163|NCT00151372|979420|P2|COMPLETED|Overall Study||45
400164|NCT00151372|979421|P1|COMPLETED|Overall Study||38
400165|NCT00151372|979420|P2|STARTED|Overall Study||74
400166|NCT00151372|979421|P1|STARTED|Overall Study||67
400167|NCT00151320|979431|P1|NOT COMPLETED|Overall Study||0
400168|NCT00151320|979431|P1|COMPLETED|Overall Study||76
400169|NCT00151320|979431|P1|STARTED|Overall Study||76
400170|NCT00151281|979436|P1|NOT COMPLETED|Overall Study||3
400171|NCT00151281|979436|P1|COMPLETED|Overall Study||22
400172|NCT00151281|979436|P1|STARTED|Overall Study||25
400173|NCT00150969|979445|P2|NOT COMPLETED|24-48 Month Extension||100
400174|NCT00150969|979446|P1|NOT COMPLETED|24-48 Month Extension||88
400175|NCT00150969|979445|P2|COMPLETED|24-48 Month Extension||40
400176|NCT00150969|979446|P1|COMPLETED|24-48 Month Extension||33
400177|NCT00150969|979445|P2|STARTED|24-48 Month Extension||140
400178|NCT00150969|979446|P1|STARTED|24-48 Month Extension||121
400179|NCT00150969|979445|P2|NOT COMPLETED|24 Month Main Study||21
400180|NCT00150969|979446|P1|NOT COMPLETED|24 Month Main Study||19
400181|NCT00150969|979445|P2|COMPLETED|24 Month Main Study||202
400182|NCT00150969|979446|P1|COMPLETED|24 Month Main Study||198
400183|NCT00150969|979445|P2|STARTED|24 Month Main Study||223
400184|NCT00150969|979446|P1|STARTED|24 Month Main Study||217
400185|NCT00150813|979478|P1|NOT COMPLETED|Overall Study||18
400186|NCT00150813|979478|P1|COMPLETED|Overall Study||48
400187|NCT00150813|979478|P1|STARTED|Overall Study||66
400188|NCT00150800|979482|P1|NOT COMPLETED|Overall Study||496
400189|NCT00150800|979482|P1|COMPLETED|Overall Study||171
400190|NCT00150800|979482|P1|STARTED|Overall Study||667
400191|NCT00150618|979496|P5|NOT COMPLETED|Overall Study||25
400192|NCT00150618|979497|P4|NOT COMPLETED|Overall Study||26
400193|NCT00150618|979498|P3|NOT COMPLETED|Overall Study||27
400194|NCT00150618|979499|P2|NOT COMPLETED|Overall Study||18
400195|NCT00150618|979500|P1|NOT COMPLETED|Overall Study||17
400196|NCT00150618|979496|P5|COMPLETED|Overall Study||41
400197|NCT00150618|979497|P4|COMPLETED|Overall Study||40
400198|NCT00150618|979498|P3|COMPLETED|Overall Study||38
400199|NCT00150618|979499|P2|COMPLETED|Overall Study||47
400200|NCT00150618|979500|P1|COMPLETED|Overall Study||45
400201|NCT00150618|979496|P5|STARTED|Overall Study||66
400202|NCT00150618|979497|P4|STARTED|Overall Study||66
400203|NCT00150618|979498|P3|STARTED|Overall Study||65
400204|NCT00150618|979499|P2|STARTED|Overall Study||65
400205|NCT00150618|979500|P1|STARTED|Overall Study||62
400206|NCT00150592|979534|P2|NOT COMPLETED|Overall Study||3
400207|NCT00150592|979535|P1|NOT COMPLETED|Overall Study||7
400208|NCT00150592|979534|P2|COMPLETED|Overall Study||54
400209|NCT00150592|979535|P1|COMPLETED|Overall Study||114
400210|NCT00150592|979534|P2|STARTED|Overall Study||57
400211|NCT00150592|979535|P1|STARTED|Overall Study||121
400212|NCT00150462|979566|P11|NOT COMPLETED|Overall Study||3
400213|NCT00150462|979567|P10|NOT COMPLETED|Overall Study||6
400214|NCT00150462|979568|P9|NOT COMPLETED|Overall Study||6
400215|NCT00150462|979569|P8|NOT COMPLETED|Overall Study||8
400216|NCT00150462|979570|P7|NOT COMPLETED|Overall Study||3
400217|NCT00150462|979571|P6|NOT COMPLETED|Overall Study||4
400218|NCT00150462|979572|P5|NOT COMPLETED|Overall Study||3
400219|NCT00150462|979573|P4|NOT COMPLETED|Overall Study||3
400220|NCT00150462|979574|P3|NOT COMPLETED|Overall Study||4
400221|NCT00150462|979575|P2|NOT COMPLETED|Overall Study||3
400222|NCT00150462|979576|P1|NOT COMPLETED|Overall Study||3
400223|NCT00150462|979566|P11|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
400224|NCT00150462|979567|P10|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
400225|NCT00150462|979568|P9|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
400226|NCT00150462|979569|P8|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
400227|NCT00150462|979570|P7|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
400228|NCT00150462|979571|P6|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
400229|NCT00150462|979572|P5|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
400230|NCT00150462|979573|P4|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
400231|NCT00150462|979574|P3|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
400232|NCT00150462|979575|P2|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
400233|NCT00150462|979576|P1|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
400234|NCT00150462|979566|P11|STARTED|Overall Study||4
400235|NCT00150462|979567|P10|STARTED|Overall Study||7
400236|NCT00150462|979568|P9|STARTED|Overall Study||6
400237|NCT00150462|979569|P8|STARTED|Overall Study||8
400238|NCT00150462|979570|P7|STARTED|Overall Study||3
400239|NCT00150462|979571|P6|STARTED|Overall Study||4
400240|NCT00150462|979572|P5|STARTED|Overall Study||3
400241|NCT00150462|979573|P4|STARTED|Overall Study||3
400242|NCT00150462|979574|P3|STARTED|Overall Study||4
400243|NCT00150462|979575|P2|STARTED|Overall Study||3
400244|NCT00150462|979576|P1|STARTED|Overall Study||3
400245|NCT00150345|979686|P2|NOT COMPLETED|Overall Study||32
400246|NCT00150345|979687|P1|NOT COMPLETED|Overall Study||34
400247|NCT00150345|979686|P2|COMPLETED|Overall Study||34
400248|NCT00150345|979687|P1|COMPLETED|Overall Study||47
400249|NCT00150345|979686|P2|STARTED|Overall Study||66
400250|NCT00150345|979687|P1|STARTED|Overall Study||81
400251|NCT00150176|979751|P2|NOT COMPLETED|Overall Study||120
400252|NCT00150176|979752|P1|NOT COMPLETED|Overall Study||59
400253|NCT00150176|979751|P2|COMPLETED|Overall Study||72
400254|NCT00150176|979752|P1|COMPLETED|Overall Study||135
400255|NCT00150176|979751|P2|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|192
400256|NCT00150176|979752|P1|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|194
400257|NCT00149994|979763|P2|NOT COMPLETED|Overall Study||1
400258|NCT00149994|979764|P1|NOT COMPLETED|Overall Study||1
400259|NCT00149994|979763|P2|COMPLETED|Overall Study||85
400260|NCT00149994|979764|P1|COMPLETED|Overall Study|"Completed indicates intention to treat (ITT) population."|84
400261|NCT00149994|979763|P2|STARTED|Overall Study||86
400262|NCT00149994|979764|P1|STARTED|Overall Study|"Started indicates Safety population."|85
400263|NCT00149890|979772|P2|NOT COMPLETED|Overall Study||18
400264|NCT00149890|979773|P1|NOT COMPLETED|Overall Study||13
400265|NCT00149890|979772|P2|COMPLETED|Overall Study||20
400266|NCT00149890|979773|P1|COMPLETED|Overall Study||26
400267|NCT00149890|979772|P2|STARTED|Overall Study||38
400268|NCT00149890|979773|P1|STARTED|Overall Study|"Started indicates all screened and treated participants."|39
400269|NCT00149838|979793|P4|NOT COMPLETED|Phase III||24
400270|NCT00149838|979794|P3|NOT COMPLETED|Phase III||0
400271|NCT00149838|979795|P2|NOT COMPLETED|Phase III||0
400272|NCT00149838|979796|P1|NOT COMPLETED|Phase III||0
400273|NCT00149838|979793|P4|COMPLETED|Phase III||37
400274|NCT00149838|979794|P3|COMPLETED|Phase III||0
400275|NCT00149838|979795|P2|COMPLETED|Phase III||0
400276|NCT00149838|979796|P1|COMPLETED|Phase III||0
400277|NCT00149838|979793|P4|STARTED|Phase III||61
400278|NCT00149838|979794|P3|STARTED|Phase III||0
400279|NCT00149838|979795|P2|STARTED|Phase III||0
400280|NCT00149838|979796|P1|STARTED|Phase III||0
400281|NCT00149838|979793|P4|NOT COMPLETED|Phase II||0
400282|NCT00149838|979794|P3|NOT COMPLETED|Phase II||0
400283|NCT00149838|979795|P2|NOT COMPLETED|Phase II||0
400284|NCT00149838|979796|P1|NOT COMPLETED|Phase II||0
400285|NCT00149838|979793|P4|COMPLETED|Phase II||0
400286|NCT00149838|979794|P3|COMPLETED|Phase II||144
400287|NCT00149838|979795|P2|COMPLETED|Phase II||0
400288|NCT00149838|979796|P1|COMPLETED|Phase II||0
400289|NCT00149838|979793|P4|STARTED|Phase II||0
400290|NCT00149838|979794|P3|STARTED|Phase II||144
400291|NCT00149838|979795|P2|STARTED|Phase II||0
400292|NCT00149838|979796|P1|STARTED|Phase II||0
400293|NCT00149838|979793|P4|NOT COMPLETED|Phase I||0
400294|NCT00149838|979794|P3|NOT COMPLETED|Phase I||0
400295|NCT00149838|979795|P2|NOT COMPLETED|Phase I||16
400296|NCT00149838|979796|P1|NOT COMPLETED|Phase I||20
400297|NCT00149838|979793|P4|COMPLETED|Phase I||0
400298|NCT00149838|979794|P3|COMPLETED|Phase I||0
400299|NCT00149838|979795|P2|COMPLETED|Phase I||82
400300|NCT00149838|979796|P1|COMPLETED|Phase I||72
400301|NCT00149838|979793|P4|STARTED|Phase I||0
400302|NCT00149838|979794|P3|STARTED|Phase I||0
400303|NCT00149838|979795|P2|STARTED|Phase I||98
400304|NCT00149838|979796|P1|STARTED|Phase I||92
400305|NCT00149825|979808|P2|NOT COMPLETED|Overall Study||3
400306|NCT00149825|979809|P1|NOT COMPLETED|Overall Study||5
400307|NCT00149825|979808|P2|COMPLETED|Overall Study||12
400308|NCT00149825|979809|P1|COMPLETED|Overall Study||10
400309|NCT00149825|979808|P2|STARTED|Overall Study||15
400310|NCT00149825|979809|P1|STARTED|Overall Study||15
400311|NCT00149799|979819|P3|NOT COMPLETED|Discontinuation (Phase II)||9
400312|NCT00149799|979820|P2|NOT COMPLETED|Discontinuation (Phase II)||3
400313|NCT00149799|979821|P1|NOT COMPLETED|Discontinuation (Phase II)||0
400314|NCT00149799|979819|P3|COMPLETED|Discontinuation (Phase II)||21
400315|NCT00149799|979820|P2|COMPLETED|Discontinuation (Phase II)||25
400316|NCT00149799|979821|P1|COMPLETED|Discontinuation (Phase II)||0
400317|NCT00149799|979819|P3|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|30
400318|NCT00149799|979820|P2|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|28
400319|NCT00149799|979821|P1|STARTED|Discontinuation (Phase II)||0
400320|NCT00149799|979819|P3|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
400321|NCT00149799|979820|P2|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
400322|NCT00149799|979821|P1|NOT COMPLETED|Open Label Escitalopram (Phase I)||26
400323|NCT00149799|979819|P3|COMPLETED|Open Label Escitalopram (Phase I)||0
400324|NCT00149799|979820|P2|COMPLETED|Open Label Escitalopram (Phase I)||0
400325|NCT00149799|979821|P1|COMPLETED|Open Label Escitalopram (Phase I)|14 completers were non-responders and 2 responders terminated the study after completing Phase I|74
400326|NCT00149799|979819|P3|STARTED|Open Label Escitalopram (Phase I)||0
400327|NCT00149799|979820|P2|STARTED|Open Label Escitalopram (Phase I)||0
400328|NCT00149799|979821|P1|STARTED|Open Label Escitalopram (Phase I)||100
400329|NCT00149747|979837|P2|NOT COMPLETED|Overall Study||3
400330|NCT00149747|979838|P1|NOT COMPLETED|Overall Study||4
400331|NCT00149747|979837|P2|COMPLETED|Overall Study||27
400332|NCT00149747|979838|P1|COMPLETED|Overall Study||32
400333|NCT00149747|979837|P2|STARTED|Overall Study||30
400334|NCT00149747|979838|P1|STARTED|Overall Study||36
400335|NCT00149669|979850|P2|NOT COMPLETED|Overall Study||5
400336|NCT00149669|979851|P1|NOT COMPLETED|Overall Study||3
400337|NCT00149669|979850|P2|COMPLETED|Overall Study||30
400338|NCT00149669|979851|P1|COMPLETED|Overall Study||29
400339|NCT00149669|979850|P2|STARTED|Overall Study||35
400340|NCT00149669|979851|P1|STARTED|Overall Study||32
400341|NCT00149643|979871|P2|NOT COMPLETED|Overall Study||36
400342|NCT00149643|979872|P1|NOT COMPLETED|Overall Study||34
400343|NCT00149643|979871|P2|COMPLETED|Overall Study||0
400344|NCT00149643|979872|P1|COMPLETED|Overall Study||0
400345|NCT00149643|979871|P2|STARTED|Overall Study||36
400346|NCT00149643|979872|P1|STARTED|Overall Study||34
400347|NCT00149630|979884|P2|NOT COMPLETED|Overall Study||5
400348|NCT00149630|979885|P1|NOT COMPLETED|Overall Study||8
400349|NCT00149630|979884|P2|COMPLETED|Overall Study||35
400350|NCT00149630|979885|P1|COMPLETED|Overall Study||26
400351|NCT00149630|979884|P2|STARTED|Overall Study||40
400352|NCT00149630|979885|P1|STARTED|Overall Study||34
400353|NCT00149396|979895|P1|NOT COMPLETED|Overall Study||23
400354|NCT00149396|979895|P1|COMPLETED|Overall Study||9
400355|NCT00149396|979895|P1|Completed NV1020 and Chemotherapy|Overall Study||9
400356|NCT00149396|979895|P1|Completed NV1020 Therapy|Overall Study||29
400357|NCT00149396|979895|P1|STARTED|Overall Study||32
400358|NCT00149227|979938|P2|NOT COMPLETED|Overall Study||0
400359|NCT00149227|979939|P1|NOT COMPLETED|Overall Study||0
400360|NCT00149227|979938|P2|COMPLETED|Overall Study||1514
400361|NCT00149227|979939|P1|COMPLETED|Overall Study||1517
400362|NCT00149227|979938|P2|STARTED|Overall Study||1514
400363|NCT00149227|979939|P1|STARTED|Overall Study||1517
400364|NCT00149214|979965|P2|NOT COMPLETED|Overall Study||17
400365|NCT00149214|979966|P1|NOT COMPLETED|Overall Study||26
400366|NCT00149214|979965|P2|COMPLETED|Overall Study||105
400367|NCT00149214|979966|P1|COMPLETED|Overall Study|The patient treated with Cyclophosphamide (C) was included in that arm (C) for safety analysis.|109
400368|NCT00149214|979965|P2|STARTED|Overall Study||122
400369|NCT00149214|979966|P1|STARTED|Overall Study|One patient randomized to Pemetrexed (P) was treated with Cyclophosphamide (C).|135
400370|NCT00148954|979982|P2|NOT COMPLETED|Overall Study||300
400371|NCT00148954|979983|P1|NOT COMPLETED|Overall Study||307
400372|NCT00148954|979982|P2|COMPLETED|Overall Study||677
400373|NCT00148954|979983|P1|COMPLETED|Overall Study||678
400374|NCT00148954|979982|P2|STARTED|Overall Study||977
400375|NCT00148954|979983|P1|STARTED|Overall Study||985
400376|NCT00148798|979991|P2|NOT COMPLETED|Overall Study||0
400377|NCT00148798|979992|P1|NOT COMPLETED|Overall Study||0
400378|NCT00148798|979991|P2|COMPLETED|Overall Study||568
400379|NCT00148798|979992|P1|COMPLETED|Overall Study||557
400380|NCT00148798|979991|P2|STARTED|Overall Study|ITT Population|568
400381|NCT00148798|979992|P1|STARTED|Overall Study|Intent To Treat (ITT) Population|557
400382|NCT00148759|980014|P2|NOT COMPLETED|Overall Study||1
400383|NCT00148759|980015|P1|NOT COMPLETED|Overall Study||2
400384|NCT00148759|980014|P2|COMPLETED|Overall Study||11
400385|NCT00148759|980015|P1|COMPLETED|Overall Study||9
400386|NCT00148759|980014|P2|24-hr PK Sampling|Overall Study||11
400387|NCT00148759|980015|P1|24-hr PK Sampling|Overall Study||9
400388|NCT00148759|980014|P2|STARTED|Overall Study||12
400389|NCT00148759|980015|P1|STARTED|Overall Study||11
400390|NCT00148733|980025|P2|NOT COMPLETED|Overall Study||15
400391|NCT00148733|980026|P1|NOT COMPLETED|Overall Study||14
400392|NCT00148733|980025|P2|COMPLETED|Overall Study||1299
400393|NCT00148733|980026|P1|COMPLETED|Overall Study||1300
400394|NCT00148733|980025|P2|STARTED|Overall Study||1314
400395|NCT00148733|980026|P1|STARTED|Overall Study||1314
400396|NCT00148668|980034|P2|NOT COMPLETED|Overall Study||0
400397|NCT00148668|980035|P1|NOT COMPLETED|Overall Study||0
400398|NCT00148668|980034|P2|COMPLETED|Overall Study||40
400399|NCT00148668|980035|P1|COMPLETED|Overall Study||41
400400|NCT00148668|980034|P2|STARTED|Overall Study||40
400401|NCT00148668|980035|P1|STARTED|Overall Study||41
400402|NCT00148343|980043|P2|NOT COMPLETED|Overall Study||11
400403|NCT00148343|980044|P1|NOT COMPLETED|Overall Study||15
400404|NCT00148343|980043|P2|COMPLETED|Overall Study||45
400405|NCT00148343|980044|P1|COMPLETED|Overall Study||39
400406|NCT00148343|980043|P2|STARTED|Overall Study||56
400407|NCT00148343|980044|P1|STARTED|Overall Study||54
400408|NCT00148317|980058|P1|NOT COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||11
400409|NCT00148317|980058|P1|COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||27
400410|NCT00148317|980058|P1|STARTED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||38
400411|NCT00148317|980058|P1|NOT COMPLETED|Consolidation (VEL + DEX)||0
400412|NCT00148317|980058|P1|COMPLETED|Consolidation (VEL + DEX)||38
400413|NCT00148317|980058|P1|no DOXIL Added|Consolidation (VEL + DEX)||10
400414|NCT00148317|980058|P1|DOXIL Added at Cycle 5|Consolidation (VEL + DEX)||12
400415|NCT00148317|980058|P1|DOXIL Added at Cycle 3|Consolidation (VEL + DEX)||16
400416|NCT00148317|980058|P1|STARTED|Consolidation (VEL + DEX)||38
400417|NCT00148122|980065|P1|NOT COMPLETED|Overall Study||2
400418|NCT00148122|980065|P1|COMPLETED|Overall Study||38
400419|NCT00148122|980065|P1|STARTED|Overall Study||40
400420|NCT00148109|980073|P2|NOT COMPLETED|Overall Study||20
400421|NCT00148109|980074|P1|NOT COMPLETED|Overall Study||12
400422|NCT00148109|980073|P2|COMPLETED|Overall Study||1
400423|NCT00148109|980074|P1|COMPLETED|Overall Study||3
400424|NCT00148109|980073|P2|STARTED|Overall Study||21
400425|NCT00148109|980074|P1|STARTED|Overall Study||15
400426|NCT00147966|980084|P1|NOT COMPLETED|Overall Study||0
400427|NCT00147966|980084|P1|COMPLETED|Overall Study||24
400428|NCT00147966|980084|P1|STARTED|Overall Study||24
400429|NCT00147823|980090|P2|NOT COMPLETED|Overall Study||15
400430|NCT00147823|980091|P1|NOT COMPLETED|Overall Study||13
400431|NCT00147823|980090|P2|COMPLETED|Overall Study||16
400432|NCT00147823|980091|P1|COMPLETED|Overall Study||19
400433|NCT00147823|980090|P2|Month 24 Visit|Overall Study||18
400434|NCT00147823|980091|P1|Month 24 Visit|Overall Study||21
400435|NCT00147823|980090|P2|Month 18 Visit|Overall Study||20
400436|NCT00147823|980091|P1|Month 18 Visit|Overall Study|As stated previously ea. subject is counted at each milestone, as data is collected at ea. timepoint|21
400437|NCT00147823|980090|P2|Month 12 CT Scan|Overall Study||25
400438|NCT00147823|980091|P1|Month 12 CT Scan|Overall Study||20
400439|NCT00147823|980090|P2|Month 12 Visit|Overall Study|Subjects are counted at each milestone as that is when data is collectec|25
400440|NCT00147823|980091|P1|Month 12 Visit|Overall Study||21
400441|NCT00147823|980090|P2|Month 6 Visit|Overall Study||21
400442|NCT00147823|980091|P1|Month 6 Visit|Overall Study||25
400443|NCT00147823|980090|P2|Month 3 Visit|Overall Study||24
400444|NCT00147823|980091|P1|Month 3 Visit|Overall Study||25
400445|NCT00147823|980090|P2|Week 6 Visit|Overall Study||28
400446|NCT00147823|980091|P1|Week 6 Visit|Overall Study||26
400447|NCT00147823|980090|P2|STARTED|Overall Study||31
400448|NCT00147823|980091|P1|STARTED|Overall Study||32
400449|NCT00147745|980122|P3|NOT COMPLETED|Overall Study||0
400450|NCT00147745|980123|P2|NOT COMPLETED|Overall Study||0
400451|NCT00147745|980124|P1|NOT COMPLETED|Overall Study||1
400452|NCT00147745|980122|P3|COMPLETED|Overall Study||6
400453|NCT00147745|980123|P2|COMPLETED|Overall Study||14
400454|NCT00147745|980124|P1|COMPLETED|Overall Study||15
400455|NCT00147745|980122|P3|STARTED|Overall Study||6
400456|NCT00147745|980123|P2|STARTED|Overall Study||14
400457|NCT00147745|980124|P1|STARTED|Overall Study||16
400458|NCT00147537|980146|P11|NOT COMPLETED|Phase 2||52
400459|NCT00147537|980147|P10|NOT COMPLETED|Phase 2||161
400460|NCT00147537|980148|P9|NOT COMPLETED|Phase 2||0
400461|NCT00147537|980149|P8|NOT COMPLETED|Phase 2||0
400462|NCT00147537|980150|P7|NOT COMPLETED|Phase 2||0
400463|NCT00147537|980151|P6|NOT COMPLETED|Phase 2||0
400464|NCT00147537|980152|P5|NOT COMPLETED|Phase 2||0
400465|NCT00147537|980153|P4|NOT COMPLETED|Phase 2||0
400466|NCT00147537|980154|P3|NOT COMPLETED|Phase 2||0
400467|NCT00147537|980155|P2|NOT COMPLETED|Phase 2||0
400468|NCT00147537|980156|P1|NOT COMPLETED|Phase 2||0
400469|NCT00147537|980146|P11|COMPLETED|Phase 2||3
400470|NCT00147537|980147|P10|COMPLETED|Phase 2||5
400471|NCT00147537|980148|P9|COMPLETED|Phase 2||0
400472|NCT00147537|980149|P8|COMPLETED|Phase 2||0
400473|NCT00147537|980150|P7|COMPLETED|Phase 2||0
400474|NCT00147537|980151|P6|COMPLETED|Phase 2||0
400475|NCT00147537|980152|P5|COMPLETED|Phase 2||0
400476|NCT00147537|980153|P4|COMPLETED|Phase 2||0
400477|NCT00147537|980154|P3|COMPLETED|Phase 2||0
400478|NCT00147537|980155|P2|COMPLETED|Phase 2||0
400479|NCT00147537|980156|P1|COMPLETED|Phase 2||0
400480|NCT00147537|980146|P11|STARTED|Phase 2|55 randomized; 56 treated-1 randomized but not treated, 2 randomized to F+P+C rec'd P+C|55
400481|NCT00147537|980147|P10|STARTED|Phase 2|166 particpants randomized; 163 participants treated|166
400482|NCT00147537|980148|P9|STARTED|Phase 2||0
400483|NCT00147537|980149|P8|STARTED|Phase 2||0
400484|NCT00147537|980150|P7|STARTED|Phase 2||0
400485|NCT00147537|980151|P6|STARTED|Phase 2||0
400486|NCT00147537|980152|P5|STARTED|Phase 2||0
400487|NCT00147537|980153|P4|STARTED|Phase 2||0
400488|NCT00147537|980154|P3|STARTED|Phase 2||0
400489|NCT00147537|980155|P2|STARTED|Phase 2||0
400490|NCT00147537|980156|P1|STARTED|Phase 2||0
400491|NCT00147537|980146|P11|NOT COMPLETED|Phase 1b||0
400492|NCT00147537|980147|P10|NOT COMPLETED|Phase 1b||0
400493|NCT00147537|980148|P9|NOT COMPLETED|Phase 1b||17
400494|NCT00147537|980149|P8|NOT COMPLETED|Phase 1b||7
400495|NCT00147537|980150|P7|NOT COMPLETED|Phase 1b||18
400496|NCT00147537|980151|P6|NOT COMPLETED|Phase 1b||3
400497|NCT00147537|980152|P5|NOT COMPLETED|Phase 1b||3
400498|NCT00147537|980153|P4|NOT COMPLETED|Phase 1b||2
400499|NCT00147537|980154|P3|NOT COMPLETED|Phase 1b||4
400500|NCT00147537|980155|P2|NOT COMPLETED|Phase 1b||2
400501|NCT00147537|980156|P1|NOT COMPLETED|Phase 1b||2
400502|NCT00147537|980146|P11|COMPLETED|Phase 1b||0
400503|NCT00147537|980147|P10|COMPLETED|Phase 1b||0
400504|NCT00147537|980148|P9|COMPLETED|Phase 1b||1
400505|NCT00147537|980149|P8|COMPLETED|Phase 1b||0
400506|NCT00147537|980150|P7|COMPLETED|Phase 1b||0
400507|NCT00147537|980151|P6|COMPLETED|Phase 1b||0
400508|NCT00147537|980152|P5|COMPLETED|Phase 1b||0
400509|NCT00147537|980153|P4|COMPLETED|Phase 1b||1
400510|NCT00147537|980154|P3|COMPLETED|Phase 1b||0
400511|NCT00147537|980155|P2|COMPLETED|Phase 1b||0
400512|NCT00147537|980156|P1|COMPLETED|Phase 1b||1
400513|NCT00147537|980146|P11|STARTED|Phase 1b||0
400514|NCT00147537|980147|P10|STARTED|Phase 1b||0
400515|NCT00147537|980148|P9|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
400516|NCT00147537|980149|P8|STARTED|Phase 1b||7
400517|NCT00147537|980150|P7|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
400518|NCT00147537|980151|P6|STARTED|Phase 1b||3
400519|NCT00147537|980152|P5|STARTED|Phase 1b||3
400520|NCT00147537|980153|P4|STARTED|Phase 1b||3
400521|NCT00147537|980154|P3|STARTED|Phase 1b||4
400522|NCT00147537|980155|P2|STARTED|Phase 1b||2
400523|NCT00147537|980156|P1|STARTED|Phase 1b||3
400524|NCT00147498|980339|P4|NOT COMPLETED|Overall Study||17
400525|NCT00147498|980340|P3|NOT COMPLETED|Overall Study||17
400526|NCT00147498|980341|P2|NOT COMPLETED|Overall Study||9
400527|NCT00147498|980342|P1|NOT COMPLETED|Overall Study||3
400528|NCT00147498|980339|P4|COMPLETED|Overall Study||48
400529|NCT00147498|980340|P3|COMPLETED|Overall Study||52
400530|NCT00147498|980341|P2|COMPLETED|Overall Study||60
400531|NCT00147498|980342|P1|COMPLETED|Overall Study||58
400532|NCT00147498|980339|P4|STARTED|Overall Study||65
400533|NCT00147498|980340|P3|STARTED|Overall Study||69
400534|NCT00147498|980341|P2|STARTED|Overall Study||69
400535|NCT00147498|980342|P1|STARTED|Overall Study||61
400536|NCT00147446|980438|P2|NOT COMPLETED|Overall Study||0
400537|NCT00147446|980439|P1|NOT COMPLETED|Overall Study||0
400538|NCT00147446|980438|P2|COMPLETED|Overall Study||61
400539|NCT00147446|980439|P1|COMPLETED|Overall Study||60
400540|NCT00147446|980438|P2|STARTED|Overall Study||61
400541|NCT00147446|980439|P1|STARTED|Overall Study||60
400542|NCT00147316|980447|P1|NOT COMPLETED|Overall Study||0
400543|NCT00147316|980447|P1|COMPLETED|Overall Study||103
400544|NCT00147316|980447|P1|STARTED|Overall Study||103
400545|NCT00147290|980454|P2|NOT COMPLETED|Overall Study||0
400546|NCT00147290|980455|P1|NOT COMPLETED|Overall Study||0
400547|NCT00147290|980454|P2|COMPLETED|Overall Study||260
400548|NCT00147290|980455|P1|COMPLETED|Overall Study||266
400549|NCT00147290|980454|P2|STARTED|Overall Study||260
400550|NCT00147290|980455|P1|STARTED|Overall Study||266
400551|NCT00147277|980461|P2|NOT COMPLETED|Overall Study||0
400552|NCT00147277|980462|P1|NOT COMPLETED|Overall Study||0
400553|NCT00147277|980461|P2|COMPLETED|Overall Study||450
400554|NCT00147277|980462|P1|COMPLETED|Overall Study||475
400555|NCT00147277|980461|P2|STARTED|Overall Study||450
400556|NCT00147277|980462|P1|STARTED|Overall Study||475
400557|NCT00147238|980466|P1|NOT COMPLETED|Overall Study||8
400558|NCT00147238|980466|P1|COMPLETED|Overall Study||2
400559|NCT00147238|980466|P1|STARTED|Overall Study||10
400560|NCT00147225|980476|P6|NOT COMPLETED|Overall Study||2
400561|NCT00147225|980477|P5|NOT COMPLETED|Overall Study||1
400562|NCT00147225|980478|P4|NOT COMPLETED|Overall Study||1
400563|NCT00147225|980479|P3|NOT COMPLETED|Overall Study||2
400564|NCT00147225|980480|P2|NOT COMPLETED|Overall Study||0
400565|NCT00147225|980481|P1|NOT COMPLETED|Overall Study||1
400566|NCT00147225|980476|P6|COMPLETED|Overall Study||10
400567|NCT00147225|980477|P5|COMPLETED|Overall Study||10
400568|NCT00147225|980478|P4|COMPLETED|Overall Study||10
400569|NCT00147225|980479|P3|COMPLETED|Overall Study||6
400570|NCT00147225|980480|P2|COMPLETED|Overall Study||6
400571|NCT00147225|980481|P1|COMPLETED|Overall Study||6
400572|NCT00147225|980476|P6|STARTED|Overall Study||12
400573|NCT00147225|980477|P5|STARTED|Overall Study||11
400574|NCT00147225|980478|P4|STARTED|Overall Study||11
400575|NCT00147225|980479|P3|STARTED|Overall Study||8
400576|NCT00147225|980480|P2|STARTED|Overall Study||6
400577|NCT00147225|980481|P1|STARTED|Overall Study||7
400578|NCT00147212|980501|P1|NOT COMPLETED|Overall Study||0
400579|NCT00147212|980501|P1|COMPLETED|Overall Study||50
400580|NCT00147212|980501|P1|STARTED|Overall Study||50
400581|NCT00147199|980507|P2|NOT COMPLETED|Overall Study||10
400582|NCT00147199|980508|P1|NOT COMPLETED|Overall Study||13
400583|NCT00147199|980507|P2|COMPLETED|Overall Study||110
400584|NCT00147199|980508|P1|COMPLETED|Overall Study||102
400585|NCT00147199|980507|P2|STARTED|Overall Study||120
400586|NCT00147199|980508|P1|STARTED|Overall Study||115
400587|NCT00147043|980530|P1|NOT COMPLETED|Overall Study||0
400588|NCT00147043|980530|P1|COMPLETED|Overall Study||5
400589|NCT00147043|980530|P1|STARTED|Overall Study||5
400590|NCT00147030|980537|P2|NOT COMPLETED|Overall Study||0
400591|NCT00147030|980538|P1|NOT COMPLETED|Overall Study||0
400592|NCT00147030|980537|P2|COMPLETED|Overall Study||162
400593|NCT00147030|980538|P1|COMPLETED|Overall Study||163
400594|NCT00147030|980537|P2|STARTED|Overall Study||162
400595|NCT00147030|980538|P1|STARTED|Overall Study||163
400596|NCT00147017|980589|P3|NOT COMPLETED|Overall Study||0
400597|NCT00147017|980590|P2|NOT COMPLETED|Overall Study||0
400598|NCT00147017|980591|P1|NOT COMPLETED|Overall Study||0
400599|NCT00147017|980589|P3|COMPLETED|Overall Study||4
400600|NCT00147017|980590|P2|COMPLETED|Overall Study||7
400601|NCT00147017|980591|P1|COMPLETED|Overall Study||6
400602|NCT00147017|980589|P3|STARTED|Overall Study||4
400603|NCT00147017|980590|P2|STARTED|Overall Study||7
400604|NCT00147017|980591|P1|STARTED|Overall Study||6
400605|NCT00146848|980608|P3|NOT COMPLETED|Post-randomization||39
400606|NCT00146848|980609|P2|NOT COMPLETED|Post-randomization||47
400607|NCT00146848|980610|P1|NOT COMPLETED|Post-randomization||38
400608|NCT00146848|980608|P3|COMPLETED|Post-randomization||431
400609|NCT00146848|980609|P2|COMPLETED|Post-randomization||441
400610|NCT00146848|980610|P1|COMPLETED|Post-randomization||437
400611|NCT00146848|980608|P3|STARTED|Post-randomization||470
400612|NCT00146848|980609|P2|STARTED|Post-randomization||488
400613|NCT00146848|980610|P1|STARTED|Post-randomization||475
400614|NCT00146848|980608|P3|NOT COMPLETED|Pre-randomization||0
400615|NCT00146848|980609|P2|NOT COMPLETED|Pre-randomization||0
400616|NCT00146848|980610|P1|NOT COMPLETED|Pre-randomization||309
400617|NCT00146848|980608|P3|COMPLETED|Pre-randomization||0
400618|NCT00146848|980609|P2|COMPLETED|Pre-randomization||0
400619|NCT00146848|980610|P1|COMPLETED|Pre-randomization|Reached 6-week visit and were randomized|1433
400620|NCT00146848|980608|P3|STARTED|Pre-randomization||0
400621|NCT00146848|980609|P2|STARTED|Pre-randomization||0
400622|NCT00146848|980610|P1|STARTED|Pre-randomization|Registered|1742
400623|NCT00146770|980626|P2|NOT COMPLETED|Overall Study||0
400624|NCT00146770|980627|P1|NOT COMPLETED|Overall Study||5
400625|NCT00146770|980626|P2|COMPLETED|Overall Study||22
400626|NCT00146770|980627|P1|COMPLETED|Overall Study||18
400627|NCT00146770|980626|P2|STARTED|Overall Study||22
400628|NCT00146770|980627|P1|STARTED|Overall Study||23
400629|NCT00146757|980645|P2|NOT COMPLETED|Overall Study||0
400630|NCT00146757|980646|P1|NOT COMPLETED|Overall Study||2
400631|NCT00146757|980645|P2|COMPLETED|Overall Study||4
400632|NCT00146757|980646|P1|COMPLETED|Overall Study||14
400633|NCT00146757|980645|P2|STARTED|Overall Study||4
400634|NCT00146757|980646|P1|STARTED|Overall Study||16
400635|NCT00146640|980665|P2|NOT COMPLETED|Overall Study||14
400636|NCT00146640|980666|P1|NOT COMPLETED|Overall Study||23
400637|NCT00146640|980665|P2|COMPLETED|Overall Study||130
400638|NCT00146640|980666|P1|COMPLETED|Overall Study||121
400639|NCT00146640|980665|P2|STARTED|Overall Study||144
400640|NCT00146640|980666|P1|STARTED|Overall Study||144
400641|NCT00146328|980689|P3|NOT COMPLETED|Overall Study||291
400642|NCT00146328|980690|P2|NOT COMPLETED|Overall Study||154
400643|NCT00146328|980691|P1|NOT COMPLETED|Overall Study||141
400644|NCT00146328|980689|P3|COMPLETED|Overall Study||158
400645|NCT00146328|980690|P2|COMPLETED|Overall Study||101
400646|NCT00146328|980691|P1|COMPLETED|Overall Study||150
400647|NCT00146328|980689|P3|STARTED|Overall Study||449
400648|NCT00146328|980690|P2|STARTED|Overall Study||255
400649|NCT00146328|980691|P1|STARTED|Overall Study||291
400650|NCT00146172|980782|P8|NOT COMPLETED|Overall Study||40
400651|NCT00146172|980783|P7|NOT COMPLETED|Overall Study||6
400652|NCT00146172|980784|P6|NOT COMPLETED|Overall Study||7
400653|NCT00146172|980785|P5|NOT COMPLETED|Overall Study||3
400654|NCT00146172|980786|P4|NOT COMPLETED|Overall Study||6
400655|NCT00146172|980787|P3|NOT COMPLETED|Overall Study||4
400656|NCT00146172|980788|P2|NOT COMPLETED|Overall Study||4
400657|NCT00146172|980789|P1|NOT COMPLETED|Overall Study||3
400658|NCT00146172|980782|P8|COMPLETED|Overall Study||0
400659|NCT00146172|980783|P7|COMPLETED|Overall Study||0
400660|NCT00146172|980784|P6|COMPLETED|Overall Study||0
400661|NCT00146172|980785|P5|COMPLETED|Overall Study||0
400662|NCT00146172|980786|P4|COMPLETED|Overall Study||0
400663|NCT00146172|980787|P3|COMPLETED|Overall Study||0
400664|NCT00146172|980788|P2|COMPLETED|Overall Study||0
400665|NCT00146172|980789|P1|COMPLETED|Overall Study||0
400666|NCT00146172|980782|P8|Received Drug|Overall Study||39
400667|NCT00146172|980783|P7|Received Drug|Overall Study||6
400668|NCT00146172|980784|P6|Received Drug|Overall Study||7
400669|NCT00146172|980785|P5|Received Drug|Overall Study||3
400670|NCT00146172|980786|P4|Received Drug|Overall Study||6
400671|NCT00146172|980787|P3|Received Drug|Overall Study||4
400672|NCT00146172|980788|P2|Received Drug|Overall Study||4
400673|NCT00146172|980789|P1|Received Drug|Overall Study||3
400674|NCT00146172|980782|P8|STARTED|Overall Study||40
400675|NCT00146172|980783|P7|STARTED|Overall Study||6
400676|NCT00146172|980784|P6|STARTED|Overall Study||7
400677|NCT00146172|980785|P5|STARTED|Overall Study||3
400678|NCT00146172|980786|P4|STARTED|Overall Study||6
400679|NCT00146172|980787|P3|STARTED|Overall Study||4
400680|NCT00146172|980788|P2|STARTED|Overall Study||4
400681|NCT00146172|980789|P1|STARTED|Overall Study||3
400682|NCT00145977|980824|P2|NOT COMPLETED|Overall Study||4
400683|NCT00145977|980825|P1|NOT COMPLETED|Overall Study||2
400684|NCT00145977|980824|P2|COMPLETED|Overall Study||13
400685|NCT00145977|980825|P1|COMPLETED|Overall Study||17
400686|NCT00145977|980824|P2|STARTED|Overall Study||17
400687|NCT00145977|980825|P1|STARTED|Overall Study||19
400688|NCT00145795|980851|P2|NOT COMPLETED|Overall Study||0
400689|NCT00145795|980852|P1|NOT COMPLETED|Overall Study||1
400690|NCT00145795|980851|P2|COMPLETED|Overall Study||10
400691|NCT00145795|980852|P1|COMPLETED|Overall Study|1 patient discontinued early due to grade II gastrointestinal symptoms.|9
400692|NCT00145795|980851|P2|STARTED|Overall Study||10
400693|NCT00145795|980852|P1|STARTED|Overall Study||10
400694|NCT00145704|980878|P2|NOT COMPLETED|Overall Study||3
400695|NCT00145704|980879|P1|NOT COMPLETED|Overall Study||3
400696|NCT00145704|980878|P2|COMPLETED|Overall Study||0
400697|NCT00145704|980879|P1|COMPLETED|Overall Study||0
400698|NCT00145704|980878|P2|STARTED|Overall Study||3
400699|NCT00145704|980879|P1|STARTED|Overall Study||3
400700|NCT00145626|980887|P1|NOT COMPLETED|Overall Study||5
400701|NCT00145626|980887|P1|COMPLETED|Overall Study||14
400702|NCT00145626|980887|P1|STARTED|Overall Study||19
400703|NCT00145600|980933|P4|NOT COMPLETED|Overall Study||16
400704|NCT00145600|980934|P3|NOT COMPLETED|Overall Study||5
400705|NCT00145600|980935|P2|NOT COMPLETED|Overall Study||10
400706|NCT00145600|980936|P1|NOT COMPLETED|Overall Study||8
400707|NCT00145600|980933|P4|COMPLETED|Overall Study||130
400708|NCT00145600|980934|P3|COMPLETED|Overall Study||8
400709|NCT00145600|980935|P2|COMPLETED|Overall Study||36
400710|NCT00145600|980936|P1|COMPLETED|Overall Study||83
400711|NCT00145600|980933|P4|STARTED|Overall Study||146
400712|NCT00145600|980934|P3|STARTED|Overall Study||13
400713|NCT00145600|980935|P2|STARTED|Overall Study||46
400714|NCT00145600|980936|P1|STARTED|Overall Study||91
400715|NCT00145587|981050|P2|NOT COMPLETED|Overall Study||0
400716|NCT00145587|981051|P1|NOT COMPLETED|Overall Study||0
400717|NCT00145587|981050|P2|COMPLETED|Overall Study||1
400718|NCT00145587|981051|P1|COMPLETED|Overall Study||5
400719|NCT00145587|981050|P2|STARTED|Overall Study||1
400720|NCT00145587|981051|P1|STARTED|Overall Study||5
400721|NCT00145574|981060|P3|NOT COMPLETED|Open Label Long-term Extension||11
400722|NCT00145574|981061|P2|NOT COMPLETED|Open Label Long-term Extension||0
400723|NCT00145574|981062|P1|NOT COMPLETED|Open Label Long-term Extension||0
400724|NCT00145574|981060|P3|COMPLETED|Open Label Long-term Extension||173
400725|NCT00145574|981061|P2|COMPLETED|Open Label Long-term Extension||0
400726|NCT00145574|981062|P1|COMPLETED|Open Label Long-term Extension||0
400727|NCT00145574|981060|P3|STARTED|Open Label Long-term Extension|2 participants discontinued after completing double-blind but before starting open label.|184
400728|NCT00145574|981061|P2|STARTED|Open Label Long-term Extension||0
400729|NCT00145574|981062|P1|STARTED|Open Label Long-term Extension||0
400730|NCT00145574|981060|P3|NOT COMPLETED|Double Blind||2
400731|NCT00145574|981061|P2|NOT COMPLETED|Double Blind||5
400732|NCT00145574|981062|P1|NOT COMPLETED|Double Blind||1
400733|NCT00145574|981060|P3|COMPLETED|Double Blind||62
400734|NCT00145574|981061|P2|COMPLETED|Double Blind||60
400735|NCT00145574|981062|P1|COMPLETED|Double Blind||64
400736|NCT00145574|981060|P3|STARTED|Double Blind||64
400737|NCT00145574|981061|P2|STARTED|Double Blind||65
400738|NCT00145574|981062|P1|STARTED|Double Blind||65
400739|NCT00145509|981119|P2|NOT COMPLETED|Overall Study||21
400740|NCT00145509|981120|P1|NOT COMPLETED|Overall Study||22
400741|NCT00145509|981119|P2|COMPLETED|Overall Study||15
400742|NCT00145509|981120|P1|COMPLETED|Overall Study||19
400743|NCT00145509|981119|P2|STARTED|Overall Study||36
400744|NCT00145509|981120|P1|STARTED|Overall Study||41
400745|NCT00145496|981134|P2|NOT COMPLETED|Overall Study||81
400746|NCT00145496|981135|P1|NOT COMPLETED|Overall Study||123
400747|NCT00145496|981134|P2|COMPLETED|Overall Study||143
400748|NCT00145496|981135|P1|COMPLETED|Overall Study||121
400749|NCT00145496|981134|P2|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|224
400750|NCT00145496|981135|P1|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|244
400751|NCT00145470|981147|P2|NOT COMPLETED|Overall Study||98
400752|NCT00145470|981148|P1|NOT COMPLETED|Overall Study||112
400753|NCT00145470|981147|P2|COMPLETED|Overall Study||61
400754|NCT00145470|981148|P1|COMPLETED|Overall Study||55
400755|NCT00145470|981147|P2|Treated|Overall Study||158
400756|NCT00145470|981148|P1|Treated|Overall Study||166
400757|NCT00145470|981147|P2|STARTED|Overall Study||159
400758|NCT00145470|981148|P1|STARTED|Overall Study||167
400759|NCT00145418|981208|P1|NOT COMPLETED|Overall Study||0
400760|NCT00145418|981208|P1|COMPLETED|Overall Study||15
400761|NCT00145418|981208|P1|STARTED|Overall Study||15
400762|NCT00145327|981218|P3|NOT COMPLETED|Overall Study||248
400763|NCT00145327|981219|P2|NOT COMPLETED|Overall Study||124
400764|NCT00145327|981220|P1|NOT COMPLETED|Overall Study||142
400765|NCT00145327|981218|P3|COMPLETED|Overall Study||975
400766|NCT00145327|981219|P2|COMPLETED|Overall Study||493
400767|NCT00145327|981220|P1|COMPLETED|Overall Study||474
400768|NCT00145327|981218|P3|STARTED|Overall Study|Group P3Z3 have non-randomized participants|1223
400769|NCT00145327|981219|P2|STARTED|Overall Study||617
400770|NCT00145327|981220|P1|STARTED|Overall Study|Group Z6 and Group Z3P3 have randomized participants.|616
400771|NCT00145249|981276|P3|NOT COMPLETED|Overall Study||17
400772|NCT00145249|981277|P2|NOT COMPLETED|Overall Study||15
400773|NCT00145249|981278|P1|NOT COMPLETED|Overall Study||11
400774|NCT00145249|981276|P3|COMPLETED|Overall Study||31
400775|NCT00145249|981277|P2|COMPLETED|Overall Study||33
400776|NCT00145249|981278|P1|COMPLETED|Overall Study||36
400777|NCT00145249|981276|P3|STARTED|Overall Study|48 subjects randomized; 49 treated-3 subjects randomized to AmphoB+Fluc400 rec'd AmphoB+Fluc800|48
400778|NCT00145249|981277|P2|STARTED|Overall Study|48 subjects randomized; 47 subjects treated-2 subjects randomized to AmphoB rec'd AmphoB+Fluc400|48
400779|NCT00145249|981278|P1|STARTED|Overall Study|47 subjects randomized; 45 subjects treated|47
400780|NCT00145119|981319|P1|NOT COMPLETED|Overall Study||45
400781|NCT00145119|981319|P1|COMPLETED|Overall Study||267
400782|NCT00145119|981319|P1|STARTED|Overall Study||312
400783|NCT00145041|981323|P1|NOT COMPLETED|Overall Study||0
400784|NCT00145041|981323|P1|COMPLETED|Overall Study||7
400785|NCT00145041|981323|P1|STARTED|Overall Study||7
400786|NCT00144963|981329|P1|NOT COMPLETED|Overall Study||0
400787|NCT00144963|981329|P1|COMPLETED|Overall Study||36
400788|NCT00144963|981329|P1|STARTED|Overall Study||36
400789|NCT00144781|981337|P4|NOT COMPLETED|Overall Study||0
400790|NCT00144781|981338|P3|NOT COMPLETED|Overall Study||0
400791|NCT00144781|981339|P2|NOT COMPLETED|Overall Study||2
400792|NCT00144781|981340|P1|NOT COMPLETED|Overall Study||0
400793|NCT00144781|981337|P4|COMPLETED|Overall Study||9
400794|NCT00144781|981338|P3|COMPLETED|Overall Study||8
400795|NCT00144781|981339|P2|COMPLETED|Overall Study||7
400796|NCT00144781|981340|P1|COMPLETED|Overall Study||8
400797|NCT00144781|981337|P4|STARTED|Overall Study||9
400798|NCT00144781|981338|P3|STARTED|Overall Study||8
400799|NCT00144781|981339|P2|STARTED|Overall Study||9
400800|NCT00144781|981340|P1|STARTED|Overall Study||8
400801|NCT00144391|981360|P2|NOT COMPLETED|Overall Study||0
400802|NCT00144391|981361|P1|NOT COMPLETED|Overall Study||0
400803|NCT00144391|981360|P2|COMPLETED|Overall Study||9
400804|NCT00144391|981361|P1|COMPLETED|Overall Study||11
400805|NCT00144391|981360|P2|STARTED|Overall Study||9
400806|NCT00144391|981361|P1|STARTED|Overall Study||11
400807|NCT00144339|981369|P2|NOT COMPLETED|Overall Study||1099
400808|NCT00144339|981370|P1|NOT COMPLETED|Overall Study||1358
400809|NCT00144339|981369|P2|COMPLETED|Overall Study||1887
400810|NCT00144339|981370|P1|COMPLETED|Overall Study||1648
400811|NCT00144339|981369|P2|STARTED|Overall Study||2986
400812|NCT00144339|981370|P1|STARTED|Overall Study||3006
400813|NCT00144300|981578|P2|NOT COMPLETED|Overall Study||28
400814|NCT00144300|981579|P1|NOT COMPLETED|Overall Study||29
400815|NCT00144300|981578|P2|COMPLETED|Overall Study||97
400816|NCT00144300|981579|P1|COMPLETED|Overall Study||92
400817|NCT00144300|981578|P2|STARTED|Overall Study||125
400818|NCT00144300|981579|P1|STARTED|Overall Study||121
400819|NCT00144170|981627|P2|NOT COMPLETED|Overall Study||396
400820|NCT00144170|981628|P1|NOT COMPLETED|Overall Study||352
400821|NCT00144170|981627|P2|COMPLETED|Overall Study||32
400822|NCT00144170|981628|P1|COMPLETED|Overall Study||86
400823|NCT00144170|981627|P2|STARTED|Overall Study||428
400824|NCT00144170|981628|P1|STARTED|Overall Study||438
400825|NCT00144027|981818|P2|NOT COMPLETED|Overall Study||11
400826|NCT00144027|981819|P1|NOT COMPLETED|Overall Study||3
400827|NCT00144027|981818|P2|COMPLETED|Overall Study|participants who completed 12-month follow-up|25
400828|NCT00144027|981819|P1|COMPLETED|Overall Study|participants who completed 12-month follow-up|36
400829|NCT00144027|981818|P2|Completed 6 Month Assessment|Overall Study||24
400830|NCT00144027|981819|P1|Completed 6 Month Assessment|Overall Study||37
400831|NCT00144027|981818|P2|Completed Baseline Assessment|Overall Study||29
400832|NCT00144027|981819|P1|Completed Baseline Assessment|Overall Study||39
400833|NCT00144027|981818|P2|STARTED|Overall Study|participants who consented|36
400834|NCT00144027|981819|P1|STARTED|Overall Study|participants who consented|39
400835|NCT00143845|981825|P1|NOT COMPLETED|Overall Study||0
400836|NCT00143845|981825|P1|COMPLETED|Overall Study||54
400837|NCT00143845|981825|P1|STARTED|Overall Study||54
400838|NCT00143819|981833|P2|NOT COMPLETED|Overall Study||3
400839|NCT00143819|981834|P1|NOT COMPLETED|Overall Study||2
400840|NCT00143819|981833|P2|COMPLETED|Overall Study||5
400841|NCT00143819|981834|P1|COMPLETED|Overall Study||3
400842|NCT00143819|981833|P2|STARTED|Overall Study||8
400843|NCT00143819|981834|P1|STARTED|Overall Study||5
400844|NCT00143598|981849|P2|NOT COMPLETED|Overall Study||94
400845|NCT00143598|981850|P1|NOT COMPLETED|Overall Study||92
400846|NCT00143598|981849|P2|COMPLETED|Overall Study||302
400847|NCT00143598|981850|P1|COMPLETED|Overall Study||318
400848|NCT00143598|981849|P2|STARTED|Overall Study||396
400849|NCT00143598|981850|P1|STARTED|Overall Study||410
400850|NCT00143507|981864|P2|NOT COMPLETED|Overall Study||652
400851|NCT00143507|981865|P1|NOT COMPLETED|Overall Study||687
400852|NCT00143507|981864|P2|COMPLETED|Overall Study||4786
400853|NCT00143507|981865|P1|COMPLETED|Overall Study||4792
400854|NCT00143507|981864|P2|STARTED|Overall Study||5438
400855|NCT00143507|981865|P1|STARTED|Overall Study||5479
400856|NCT00143455|981899|P4|NOT COMPLETED|Cohort 2||93
400857|NCT00143455|981900|P3|NOT COMPLETED|Cohort 2||106
400858|NCT00143455|981901|P2|NOT COMPLETED|Cohort 2||0
400859|NCT00143455|981902|P1|NOT COMPLETED|Cohort 2||0
400860|NCT00143455|981899|P4|COMPLETED|Cohort 2||111
400861|NCT00143455|981900|P3|COMPLETED|Cohort 2||97
400862|NCT00143455|981901|P2|COMPLETED|Cohort 2||0
400863|NCT00143455|981902|P1|COMPLETED|Cohort 2||0
400864|NCT00143455|981899|P4|Received Treatment|Cohort 2||203
400865|NCT00143455|981900|P3|Received Treatment|Cohort 2||202
400866|NCT00143455|981901|P2|Received Treatment|Cohort 2||0
400867|NCT00143455|981902|P1|Received Treatment|Cohort 2||0
400868|NCT00143455|981899|P4|STARTED|Cohort 2||204
400869|NCT00143455|981900|P3|STARTED|Cohort 2||203
400870|NCT00143455|981901|P2|STARTED|Cohort 2||0
400871|NCT00143455|981902|P1|STARTED|Cohort 2||0
400872|NCT00143455|981899|P4|NOT COMPLETED|Cohort 1||0
400873|NCT00143455|981900|P3|NOT COMPLETED|Cohort 1||0
400874|NCT00143455|981901|P2|NOT COMPLETED|Cohort 1||17
400875|NCT00143455|981902|P1|NOT COMPLETED|Cohort 1||14
400876|NCT00143455|981899|P4|COMPLETED|Cohort 1||0
400877|NCT00143455|981900|P3|COMPLETED|Cohort 1||0
400878|NCT00143455|981901|P2|COMPLETED|Cohort 1||22
400879|NCT00143455|981902|P1|COMPLETED|Cohort 1||25
400880|NCT00143455|981899|P4|Received Treatment|Cohort 1||0
400881|NCT00143455|981900|P3|Received Treatment|Cohort 1||0
400882|NCT00143455|981901|P2|Received Treatment|Cohort 1||38
400883|NCT00143455|981902|P1|Received Treatment|Cohort 1||39
400884|NCT00143455|981899|P4|STARTED|Cohort 1||0
400885|NCT00143455|981900|P3|STARTED|Cohort 1||0
400886|NCT00143455|981901|P2|STARTED|Cohort 1||39
400887|NCT00143455|981902|P1|STARTED|Cohort 1||39
400888|NCT00143403|981936|P2|NOT COMPLETED|Overall Study||46
400889|NCT00143403|981937|P1|NOT COMPLETED|Overall Study||35
400890|NCT00143403|981936|P2|COMPLETED|Overall Study|Received maximum number of cycles.|115
400891|NCT00143403|981937|P1|COMPLETED|Overall Study|Received maximum number of cycles.|125
400892|NCT00143403|981936|P2|Treated|Overall Study||153
400893|NCT00143403|981937|P1|Treated|Overall Study||153
400894|NCT00143403|981936|P2|STARTED|Overall Study||161
400895|NCT00143403|981937|P1|STARTED|Overall Study||160
400896|NCT00143390|981947|P2|NOT COMPLETED|Overall Study||149
400897|NCT00143390|981948|P1|NOT COMPLETED|Overall Study||149
400898|NCT00143390|981947|P2|COMPLETED|Overall Study||0
400899|NCT00143390|981948|P1|COMPLETED|Overall Study||0
400900|NCT00143390|981947|P2|STARTED|Overall Study||149
400901|NCT00143390|981948|P1|STARTED|Overall Study||149
400902|NCT00143312|981964|P1|NOT COMPLETED|Overall Study||16
400903|NCT00143312|981964|P1|COMPLETED|Overall Study||29
400904|NCT00143312|981964|P1|STARTED|Overall Study||45
400905|NCT00143247|981974|P1|NOT COMPLETED|Overall Study||156
400906|NCT00143247|981974|P1|COMPLETED|Overall Study||17
400907|NCT00143247|981974|P1|STARTED|Overall Study|173=total subjects of current + 3 previous protocols|173
400908|NCT00142935|981991|P3|NOT COMPLETED|Overall Study||7
400909|NCT00142935|981992|P2|NOT COMPLETED|Overall Study||8
400910|NCT00142935|981993|P1|NOT COMPLETED|Overall Study||3
400911|NCT00142935|981991|P3|COMPLETED|Overall Study||23
400912|NCT00142935|981992|P2|COMPLETED|Overall Study||20
400913|NCT00142935|981993|P1|COMPLETED|Overall Study||26
400914|NCT00142935|981991|P3|STARTED|Overall Study||30
400915|NCT00142935|981992|P2|STARTED|Overall Study||28
400916|NCT00142935|981993|P1|STARTED|Overall Study||29
400917|NCT00142909|982018|P2|NOT COMPLETED|Medications Begin||3
400918|NCT00142909|982019|P1|NOT COMPLETED|Medications Begin||9
400919|NCT00142909|982018|P2|COMPLETED|Medications Begin||31
400920|NCT00142909|982019|P1|COMPLETED|Medications Begin||26
400921|NCT00142909|982018|P2|STARTED|Medications Begin||34
400922|NCT00142909|982019|P1|STARTED|Medications Begin||35
400923|NCT00142909|982018|P2|NOT COMPLETED|Randomization||10
400924|NCT00142909|982019|P1|NOT COMPLETED|Randomization||7
400925|NCT00142909|982018|P2|COMPLETED|Randomization||34
400926|NCT00142909|982019|P1|COMPLETED|Randomization||35
400927|NCT00142909|982018|P2|STARTED|Randomization||44
400928|NCT00142909|982019|P1|STARTED|Randomization||42
400929|NCT00142818|982039|P4|NOT COMPLETED|Overall Study||22
400930|NCT00142818|982040|P3|NOT COMPLETED|Overall Study||13
400931|NCT00142818|982041|P2|NOT COMPLETED|Overall Study||21
400932|NCT00142818|982042|P1|NOT COMPLETED|Overall Study||17
400933|NCT00142818|982039|P4|COMPLETED|Overall Study||20
400934|NCT00142818|982040|P3|COMPLETED|Overall Study||24
400935|NCT00142818|982041|P2|COMPLETED|Overall Study||19
400936|NCT00142818|982042|P1|COMPLETED|Overall Study||28
400937|NCT00142818|982039|P4|STARTED|Overall Study||42
400938|NCT00142818|982040|P3|STARTED|Overall Study||37
400939|NCT00142818|982041|P2|STARTED|Overall Study||40
400940|NCT00142818|982042|P1|STARTED|Overall Study||45
400941|NCT00142792|982055|P3|NOT COMPLETED|Overall Study||12
400942|NCT00142792|982056|P2|NOT COMPLETED|Overall Study||15
400943|NCT00142792|982057|P1|NOT COMPLETED|Overall Study||12
400944|NCT00142792|982055|P3|COMPLETED|Overall Study||30
400945|NCT00142792|982056|P2|COMPLETED|Overall Study||26
400946|NCT00142792|982057|P1|COMPLETED|Overall Study||27
400947|NCT00142792|982055|P3|Completed Intervention|Overall Study||37
400948|NCT00142792|982056|P2|Completed Intervention|Overall Study||37
400949|NCT00142792|982057|P1|Completed Intervention|Overall Study||35
400950|NCT00142792|982055|P3|STARTED|Overall Study||42
400951|NCT00142792|982056|P2|STARTED|Overall Study||41
400952|NCT00142792|982057|P1|STARTED|Overall Study||39
400953|NCT00142597|982070|P2|NOT COMPLETED|Overall Study||1
400954|NCT00142597|982071|P1|NOT COMPLETED|Overall Study||3
400955|NCT00142597|982070|P2|COMPLETED|Overall Study|N=10 completed PET imaging|22
400956|NCT00142597|982071|P1|COMPLETED|Overall Study|N=10 completed PET imaging|20
400957|NCT00142597|982070|P2|STARTED|Overall Study|N=10 underwent PET imaging|23
400958|NCT00142597|982071|P1|STARTED|Overall Study|N=10 underwent PET imaging|23
400959|NCT00142519|982079|P2|NOT COMPLETED|Overall Study||16
400960|NCT00142519|982080|P1|NOT COMPLETED|Overall Study||18
400961|NCT00142519|982079|P2|COMPLETED|Overall Study||9
400962|NCT00142519|982080|P1|COMPLETED|Overall Study||7
400963|NCT00142519|982079|P2|STARTED|Overall Study||25
400964|NCT00142519|982080|P1|STARTED|Overall Study||25
400965|NCT00142506|982090|P2|NOT COMPLETED|Overall Study||29
400966|NCT00142506|982091|P1|NOT COMPLETED|Overall Study||72
400967|NCT00142506|982090|P2|COMPLETED|Overall Study||77
400968|NCT00142506|982091|P1|COMPLETED|Overall Study||112
400969|NCT00142506|982090|P2|STARTED|Overall Study||106
400970|NCT00142506|982091|P1|STARTED|Overall Study||184
400971|NCT00142415|982103|P6|NOT COMPLETED|Overall Study||2
400972|NCT00142415|982104|P5|NOT COMPLETED|Overall Study||1
400973|NCT00142415|982105|P4|NOT COMPLETED|Overall Study||0
400974|NCT00142415|982106|P3|NOT COMPLETED|Overall Study||0
400975|NCT00142415|982107|P2|NOT COMPLETED|Overall Study||0
400976|NCT00142415|982108|P1|NOT COMPLETED|Overall Study||0
400977|NCT00142415|982103|P6|COMPLETED|Overall Study||6
400978|NCT00142415|982104|P5|COMPLETED|Overall Study||2
400979|NCT00142415|982105|P4|COMPLETED|Overall Study||3
400980|NCT00142415|982106|P3|COMPLETED|Overall Study||6
400981|NCT00142415|982107|P2|COMPLETED|Overall Study||3
400982|NCT00142415|982108|P1|COMPLETED|Overall Study||3
400983|NCT00142415|982103|P6|STARTED|Overall Study||8
400984|NCT00142415|982104|P5|STARTED|Overall Study||3
400985|NCT00142415|982105|P4|STARTED|Overall Study||3
400986|NCT00142415|982106|P3|STARTED|Overall Study||6
400987|NCT00142415|982107|P2|STARTED|Overall Study||3
400988|NCT00142415|982108|P1|STARTED|Overall Study||3
400989|NCT00142298|982146|P10|NOT COMPLETED|Overall Study||0
400990|NCT00142298|982147|P9|NOT COMPLETED|Overall Study||5
400991|NCT00142298|982148|P8|NOT COMPLETED|Overall Study||8
400992|NCT00142298|982149|P7|NOT COMPLETED|Overall Study||8
400993|NCT00142298|982150|P6|NOT COMPLETED|Overall Study||16
400994|NCT00142298|982151|P5|NOT COMPLETED|Overall Study||10
400995|NCT00142298|982152|P4|NOT COMPLETED|Overall Study||85
400996|NCT00142298|982153|P3|NOT COMPLETED|Overall Study||33
400997|NCT00142298|982154|P2|NOT COMPLETED|Overall Study||176
400998|NCT00142298|982155|P1|NOT COMPLETED|Overall Study||160
400999|NCT00142298|982146|P10|COMPLETED|Overall Study||13
401000|NCT00142298|982147|P9|COMPLETED|Overall Study||52
401001|NCT00142298|982148|P8|COMPLETED|Overall Study||58
401002|NCT00142298|982149|P7|COMPLETED|Overall Study||15
401003|NCT00142298|982150|P6|COMPLETED|Overall Study||10
401004|NCT00142298|982151|P5|COMPLETED|Overall Study||46
401005|NCT00142298|982152|P4|COMPLETED|Overall Study||121
401006|NCT00142298|982153|P3|COMPLETED|Overall Study||90
401007|NCT00142298|982154|P2|COMPLETED|Overall Study||456
401008|NCT00142298|982155|P1|COMPLETED|Overall Study|Completed week 104/week 208.|507
401009|NCT00142298|982146|P10|Per Protocol Population|Overall Study||13
401010|NCT00142298|982147|P9|Per Protocol Population|Overall Study||56
401011|NCT00142298|982148|P8|Per Protocol Population|Overall Study||64
401012|NCT00142298|982149|P7|Per Protocol Population|Overall Study||19
401013|NCT00142298|982150|P6|Per Protocol Population|Overall Study||25
401014|NCT00142298|982151|P5|Per Protocol Population|Overall Study||50
401015|NCT00142298|982152|P4|Per Protocol Population|Overall Study||202
401016|NCT00142298|982153|P3|Per Protocol Population|Overall Study||120
401017|NCT00142298|982154|P2|Per Protocol Population|Overall Study||606
401018|NCT00142298|982155|P1|Per Protocol Population|Overall Study||635
401019|NCT00142298|982146|P10|Safety Population|Overall Study||13
401020|NCT00142298|982147|P9|Safety Population|Overall Study||57
401021|NCT00142298|982148|P8|Safety Population|Overall Study||66
401022|NCT00142298|982149|P7|Safety Population|Overall Study||23
401023|NCT00142298|982150|P6|Safety Population|Overall Study||26
401024|NCT00142298|982151|P5|Safety Population|Overall Study||50
401025|NCT00142298|982152|P4|Safety Population|Overall Study||206
401026|NCT00142298|982153|P3|Safety Population|Overall Study||122
401027|NCT00142298|982154|P2|Safety Population|Overall Study||626
401028|NCT00142298|982155|P1|Safety Population|Overall Study||655
401029|NCT00142298|982146|P10|STARTED|Overall Study||13
401030|NCT00142298|982147|P9|STARTED|Overall Study||57
401031|NCT00142298|982148|P8|STARTED|Overall Study||66
401032|NCT00142298|982149|P7|STARTED|Overall Study||23
401033|NCT00142298|982150|P6|STARTED|Overall Study||26
401034|NCT00142298|982151|P5|STARTED|Overall Study||56
401035|NCT00142298|982152|P4|STARTED|Overall Study||206
401036|NCT00142298|982153|P3|STARTED|Overall Study||123
401037|NCT00142298|982154|P2|STARTED|Overall Study||632
401038|NCT00142298|982155|P1|STARTED|Overall Study||667
401039|NCT00142168|982177|P1|NOT COMPLETED|Overall Study||0
401040|NCT00142168|982177|P1|COMPLETED|Overall Study||16
401041|NCT00142168|982177|P1|STARTED|Overall Study||16
401042|NCT00142116|982184|P1|NOT COMPLETED|Overall Study||0
401043|NCT00142116|982184|P1|COMPLETED|Overall Study||25
401044|NCT00142116|982184|P1|STARTED|Overall Study||25
401045|NCT00141921|982189|P1|NOT COMPLETED|Overall Study||141
401046|NCT00141921|982189|P1|COMPLETED|Overall Study||41
401047|NCT00141921|982189|P1|Received Treatment|Overall Study||181
401048|NCT00141921|982189|P1|STARTED|Overall Study||182
401049|NCT00141817|982215|P4|NOT COMPLETED|Overall Study||0
401050|NCT00141817|982216|P3|NOT COMPLETED|Overall Study||1
401051|NCT00141817|982217|P2|NOT COMPLETED|Overall Study||0
401052|NCT00141817|982218|P1|NOT COMPLETED|Overall Study||1
401053|NCT00141817|982215|P4|COMPLETED|Overall Study||13
401054|NCT00141817|982216|P3|COMPLETED|Overall Study||10
401055|NCT00141817|982217|P2|COMPLETED|Overall Study||10
401056|NCT00141817|982218|P1|COMPLETED|Overall Study||6
401057|NCT00141817|982215|P4|STARTED|Overall Study||13
401058|NCT00141817|982216|P3|STARTED|Overall Study||11
401059|NCT00141817|982217|P2|STARTED|Overall Study||10
401060|NCT00141817|982218|P1|STARTED|Overall Study||7
401061|NCT00141778|982259|P3|NOT COMPLETED|Started Study Medication||4
401062|NCT00141778|982260|P2|NOT COMPLETED|Started Study Medication||7
401063|NCT00141778|982261|P1|NOT COMPLETED|Started Study Medication||2
401064|NCT00141778|982259|P3|COMPLETED|Started Study Medication||143
401065|NCT00141778|982260|P2|COMPLETED|Started Study Medication||144
401066|NCT00141778|982261|P1|COMPLETED|Started Study Medication||145
401067|NCT00141778|982259|P3|STARTED|Started Study Medication||147
401068|NCT00141778|982260|P2|STARTED|Started Study Medication||151
401069|NCT00141778|982261|P1|STARTED|Started Study Medication||147
401070|NCT00141778|982259|P3|NOT COMPLETED|Randomization Prior to Study Med||6
401071|NCT00141778|982260|P2|NOT COMPLETED|Randomization Prior to Study Med||2
401072|NCT00141778|982261|P1|NOT COMPLETED|Randomization Prior to Study Med||5
401073|NCT00141778|982259|P3|COMPLETED|Randomization Prior to Study Med||147
401074|NCT00141778|982260|P2|COMPLETED|Randomization Prior to Study Med||151
401075|NCT00141778|982261|P1|COMPLETED|Randomization Prior to Study Med||147
401076|NCT00141778|982259|P3|STARTED|Randomization Prior to Study Med||153
401077|NCT00141778|982260|P2|STARTED|Randomization Prior to Study Med||153
401078|NCT00141778|982261|P1|STARTED|Randomization Prior to Study Med||152
401079|NCT00141765|982299|P1|NOT COMPLETED|Overall Study||0
401080|NCT00141765|982299|P1|COMPLETED|Overall Study||25
401081|NCT00141765|982299|P1|STARTED|Overall Study||25
401082|NCT00141739|982303|P1|NOT COMPLETED|Overall Study||0
401083|NCT00141739|982303|P1|COMPLETED|Overall Study||100
401084|NCT00141739|982303|P1|STARTED|Overall Study|Number of evaluable patients|100
401085|NCT00141726|982314|P1|NOT COMPLETED|Overall Study||3
401086|NCT00141726|982314|P1|COMPLETED|Overall Study||31
401087|NCT00141726|982314|P1|STARTED|Overall Study||34
401088|NCT00141518|982322|P3|NOT COMPLETED|Overall Study||6
401089|NCT00141518|982323|P2|NOT COMPLETED|Overall Study||6
401090|NCT00141518|982324|P1|NOT COMPLETED|Overall Study||16
401091|NCT00141518|982322|P3|COMPLETED|Overall Study||12
401092|NCT00141518|982323|P2|COMPLETED|Overall Study||16
401093|NCT00141518|982324|P1|COMPLETED|Overall Study||21
401094|NCT00141518|982322|P3|Full Analysis Sample|Overall Study||18
401095|NCT00141518|982323|P2|Full Analysis Sample|Overall Study||22
401096|NCT00141518|982324|P1|Full Analysis Sample|Overall Study||27
401097|NCT00141518|982322|P3|Safety Sample|Overall Study||18
401098|NCT00141518|982323|P2|Safety Sample|Overall Study||22
401099|NCT00141518|982324|P1|Safety Sample|Overall Study||36
401100|NCT00141518|982322|P3|STARTED|Overall Study||18
401101|NCT00141518|982323|P2|STARTED|Overall Study||22
401102|NCT00141518|982324|P1|STARTED|Overall Study||37
401103|NCT00141453|982513|P2|NOT COMPLETED|Overall Study||5
401104|NCT00141453|982514|P1|NOT COMPLETED|Overall Study||6
401105|NCT00141453|982513|P2|COMPLETED|Overall Study||284
401106|NCT00141453|982514|P1|COMPLETED|Overall Study||282
401107|NCT00141453|982513|P2|STARTED|Overall Study||289
401108|NCT00141453|982514|P1|STARTED|Overall Study||288
401109|NCT00141297|982528|P10|NOT COMPLETED|Overall Study||6
401110|NCT00141297|982529|P9|NOT COMPLETED|Overall Study||20
401111|NCT00141297|982530|P8|NOT COMPLETED|Overall Study||4
401112|NCT00141297|982531|P7|NOT COMPLETED|Overall Study||3
401113|NCT00141297|982532|P6|NOT COMPLETED|Overall Study||3
401114|NCT00141297|982533|P5|NOT COMPLETED|Overall Study||22
401115|NCT00141297|982534|P4|NOT COMPLETED|Overall Study||3
401116|NCT00141297|982535|P3|NOT COMPLETED|Overall Study||7
401117|NCT00141297|982536|P2|NOT COMPLETED|Overall Study||3
401118|NCT00141297|982537|P1|NOT COMPLETED|Overall Study||3
401119|NCT00141297|982528|P10|COMPLETED|Overall Study||0
401120|NCT00141297|982529|P9|COMPLETED|Overall Study||0
401121|NCT00141297|982530|P8|COMPLETED|Overall Study||0
401122|NCT00141297|982531|P7|COMPLETED|Overall Study||0
401123|NCT00141297|982532|P6|COMPLETED|Overall Study||0
401124|NCT00141297|982533|P5|COMPLETED|Overall Study||0
401125|NCT00141297|982534|P4|COMPLETED|Overall Study||0
401126|NCT00141297|982535|P3|COMPLETED|Overall Study||0
401127|NCT00141297|982536|P2|COMPLETED|Overall Study||0
401128|NCT00141297|982537|P1|COMPLETED|Overall Study||0
401129|NCT00141297|982528|P10|STARTED|Overall Study||6
401130|NCT00141297|982529|P9|STARTED|Overall Study||20
401131|NCT00141297|982530|P8|STARTED|Overall Study||4
401132|NCT00141297|982531|P7|STARTED|Overall Study||3
401133|NCT00141297|982532|P6|STARTED|Overall Study||3
401134|NCT00141297|982533|P5|STARTED|Overall Study||22
401135|NCT00141297|982534|P4|STARTED|Overall Study||3
401136|NCT00141297|982535|P3|STARTED|Overall Study||7
401137|NCT00141297|982536|P2|STARTED|Overall Study||3
401138|NCT00141297|982537|P1|STARTED|Overall Study||3
401139|NCT00141271|982815|P3|NOT COMPLETED|Overall Study||57
401140|NCT00141271|982816|P2|NOT COMPLETED|Overall Study||63
401141|NCT00141271|982817|P1|NOT COMPLETED|Overall Study||80
401142|NCT00141271|982815|P3|COMPLETED|Overall Study||111
401143|NCT00141271|982816|P2|COMPLETED|Overall Study||102
401144|NCT00141271|982817|P1|COMPLETED|Overall Study||91
401145|NCT00141271|982815|P3|STARTED|Overall Study||168
401146|NCT00141271|982816|P2|STARTED|Overall Study||165
401147|NCT00141271|982817|P1|STARTED|Overall Study||171
401148|NCT00141219|982938|P2|NOT COMPLETED|Overall Study||16
401149|NCT00141219|982939|P1|NOT COMPLETED|Overall Study||24
401150|NCT00141219|982938|P2|COMPLETED|Overall Study||62
401151|NCT00141219|982939|P1|COMPLETED|Overall Study||138
401152|NCT00141219|982938|P2|STARTED|Overall Study||78
401153|NCT00141219|982939|P1|STARTED|Overall Study||162
401154|NCT00141115|982989|P1|NOT COMPLETED|Overall Study||1
401155|NCT00141115|982989|P1|COMPLETED|Overall Study||2
401156|NCT00141115|982989|P1|STARTED|Overall Study||3
401157|NCT00141102|982996|P2|NOT COMPLETED|Overall Study||625
401158|NCT00141102|982997|P1|NOT COMPLETED|Overall Study||508
401159|NCT00141102|982996|P2|COMPLETED|Overall Study||1621
401160|NCT00141102|982997|P1|COMPLETED|Overall Study||1730
401161|NCT00141102|982996|P2|Received Treatment|Overall Study||2237
401162|NCT00141102|982997|P1|Received Treatment|Overall Study||2223
401163|NCT00141102|982996|P2|STARTED|Overall Study||2246
401164|NCT00141102|982997|P1|STARTED|Overall Study||2238
401165|NCT00141037|983037|P2|NOT COMPLETED|Overall Study||18
401166|NCT00141037|983038|P1|NOT COMPLETED|Overall Study||10
401167|NCT00141037|983037|P2|COMPLETED|Overall Study|8 subjects had reduced follow-up|52
401168|NCT00141037|983038|P1|COMPLETED|Overall Study|16 subjects had reduced follow-up|50
401169|NCT00141037|983037|P2|STARTED|Overall Study||70
401170|NCT00141037|983038|P1|STARTED|Overall Study||60
401171|NCT00140842|983048|P2|NOT COMPLETED|Overall Study||0
401172|NCT00140842|983049|P1|NOT COMPLETED|Overall Study||0
401173|NCT00140842|983048|P2|COMPLETED|Overall Study||15
401174|NCT00140842|983049|P1|COMPLETED|Overall Study||15
401175|NCT00140842|983048|P2|STARTED|Overall Study||15
401176|NCT00140842|983049|P1|STARTED|Overall Study||15
401177|NCT00140621|983057|P1|NOT COMPLETED|Overall Study||0
401178|NCT00140621|983057|P1|COMPLETED|Overall Study||6
401179|NCT00140621|983057|P1|STARTED|Overall Study||6
401180|NCT00140556|983067|P1|NOT COMPLETED|Chemoradiotherapy Period||0
401181|NCT00140556|983067|P1|COMPLETED|Chemoradiotherapy Period||28
401182|NCT00140556|983067|P1|STARTED|Chemoradiotherapy Period||28
401183|NCT00140556|983067|P1|NOT COMPLETED|Pre Radiation Period: Avastin / Tarceva||0
401184|NCT00140556|983067|P1|COMPLETED|Pre Radiation Period: Avastin / Tarceva||28
401185|NCT00140556|983067|P1|STARTED|Pre Radiation Period: Avastin / Tarceva||28
401186|NCT00140426|983073|P2|NOT COMPLETED|Overall Study||3
401187|NCT00140426|983074|P1|NOT COMPLETED|Overall Study||0
401188|NCT00140426|983073|P2|COMPLETED|Overall Study||16
401189|NCT00140426|983074|P1|COMPLETED|Overall Study||22
401190|NCT00140426|983073|P2|STARTED|Overall Study||19
401191|NCT00140426|983074|P1|STARTED|Overall Study||22
401192|NCT00140413|983107|P2|NOT COMPLETED|Overall Study||0
401193|NCT00140413|983108|P1|NOT COMPLETED|Overall Study||3
401194|NCT00140413|983107|P2|COMPLETED|Overall Study|Crossed over subjects were treated as controls for purpose of intent to treat analysis.|7
401195|NCT00140413|983108|P1|COMPLETED|Overall Study||10
401196|NCT00140413|983107|P2|Received at Least One Dose of GH|Overall Study|Controls were crossed over to GH if they met criteria for growth deceleration during the study.|3
401197|NCT00140413|983108|P1|Received at Least One Dose of GH|Overall Study||13
401198|NCT00140413|983107|P2|STARTED|Overall Study||7
401199|NCT00140413|983108|P1|STARTED|Overall Study||13
401200|NCT00140244|983115|P2|NOT COMPLETED|Intervention 2||2
401201|NCT00140244|983116|P1|NOT COMPLETED|Intervention 2||0
401202|NCT00140244|983115|P2|COMPLETED|Intervention 2||2
401203|NCT00140244|983116|P1|COMPLETED|Intervention 2||3
401204|NCT00140244|983115|P2|STARTED|Intervention 2||4
401205|NCT00140244|983116|P1|STARTED|Intervention 2||3
401206|NCT00140244|983115|P2|NOT COMPLETED|Washout||0
401207|NCT00140244|983116|P1|NOT COMPLETED|Washout||0
401208|NCT00140244|983115|P2|COMPLETED|Washout||4
401209|NCT00140244|983116|P1|COMPLETED|Washout||3
401210|NCT00140244|983115|P2|STARTED|Washout||4
401211|NCT00140244|983116|P1|STARTED|Washout||3
401212|NCT00140244|983115|P2|NOT COMPLETED|Intervention 1||0
401213|NCT00140244|983116|P1|NOT COMPLETED|Intervention 1||0
401214|NCT00140244|983115|P2|COMPLETED|Intervention 1||4
401215|NCT00140244|983116|P1|COMPLETED|Intervention 1||3
401216|NCT00140244|983115|P2|STARTED|Intervention 1||4
401217|NCT00140244|983116|P1|STARTED|Intervention 1||3
401218|NCT00140231|983148|P2|NOT COMPLETED|Fasting State With Leptin and Crossover||0
401219|NCT00140231|983149|P1|NOT COMPLETED|Fasting State With Leptin and Crossover||0
401220|NCT00140231|983148|P2|COMPLETED|Fasting State With Leptin and Crossover||6
401221|NCT00140231|983149|P1|COMPLETED|Fasting State With Leptin and Crossover||7
401222|NCT00140231|983148|P2|STARTED|Fasting State With Leptin and Crossover||6
401223|NCT00140231|983149|P1|STARTED|Fasting State With Leptin and Crossover||7
401224|NCT00140231|983148|P2|NOT COMPLETED|Washout 8 Weeks||0
401225|NCT00140231|983149|P1|NOT COMPLETED|Washout 8 Weeks||0
401226|NCT00140231|983148|P2|COMPLETED|Washout 8 Weeks||6
401227|NCT00140231|983149|P1|COMPLETED|Washout 8 Weeks||7
401228|NCT00140231|983148|P2|STARTED|Washout 8 Weeks||6
401229|NCT00140231|983149|P1|STARTED|Washout 8 Weeks||7
401230|NCT00140231|983148|P2|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
401231|NCT00140231|983149|P1|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
401232|NCT00140231|983148|P2|COMPLETED|First Fasting State 3 Days With Placebo||6
401233|NCT00140231|983149|P1|COMPLETED|First Fasting State 3 Days With Placebo||7
401234|NCT00140231|983148|P2|STARTED|First Fasting State 3 Days With Placebo||6
401235|NCT00140231|983149|P1|STARTED|First Fasting State 3 Days With Placebo||7
401236|NCT00140231|983148|P2|NOT COMPLETED|Washout 8weeks||0
401237|NCT00140231|983149|P1|NOT COMPLETED|Washout 8weeks||0
401238|NCT00140231|983148|P2|COMPLETED|Washout 8weeks||6
401239|NCT00140231|983149|P1|COMPLETED|Washout 8weeks||7
401240|NCT00140231|983148|P2|STARTED|Washout 8weeks||6
401241|NCT00140231|983149|P1|STARTED|Washout 8weeks||7
401242|NCT00140231|983148|P2|NOT COMPLETED|Fed State 1 Day- day5||0
401243|NCT00140231|983149|P1|NOT COMPLETED|Fed State 1 Day- day5||0
401244|NCT00140231|983148|P2|COMPLETED|Fed State 1 Day- day5||6
401245|NCT00140231|983149|P1|COMPLETED|Fed State 1 Day- day5||7
401246|NCT00140231|983148|P2|STARTED|Fed State 1 Day- day5||6
401247|NCT00140231|983149|P1|STARTED|Fed State 1 Day- day5||7
401248|NCT00140205|983168|P3|NOT COMPLETED|Overall Study||0
401249|NCT00140205|983169|P2|NOT COMPLETED|Overall Study||0
401250|NCT00140205|983170|P1|NOT COMPLETED|Overall Study||0
401251|NCT00140205|983168|P3|COMPLETED|Overall Study||5
401252|NCT00140205|983169|P2|COMPLETED|Overall Study||5
401253|NCT00140205|983170|P1|COMPLETED|Overall Study||5
401254|NCT00140205|983168|P3|STARTED|Overall Study||5
401255|NCT00140205|983169|P2|STARTED|Overall Study||5
401256|NCT00140205|983170|P1|STARTED|Overall Study||5
401257|NCT00140140|983239|P3|NOT COMPLETED|Overall Study||2
401258|NCT00140140|983240|P2|NOT COMPLETED|Overall Study||2
401259|NCT00140140|983241|P1|NOT COMPLETED|Overall Study||2
401260|NCT00140140|983239|P3|COMPLETED|Overall Study|Progressive disease|4
401261|NCT00140140|983240|P2|COMPLETED|Overall Study|Progressive disease|4
401262|NCT00140140|983241|P1|COMPLETED|Overall Study|Progressive disease|2
401263|NCT00140140|983239|P3|STARTED|Overall Study||6
401264|NCT00140140|983240|P2|STARTED|Overall Study||6
401265|NCT00140140|983241|P1|STARTED|Overall Study||4
401266|NCT00139997|983280|P2|NOT COMPLETED|Overall Study||2
401267|NCT00139997|983281|P1|NOT COMPLETED|Overall Study||1
401268|NCT00139997|983280|P2|COMPLETED|Overall Study||9
401269|NCT00139997|983281|P1|COMPLETED|Overall Study||14
401270|NCT00139997|983280|P2|STARTED|Overall Study||11
401271|NCT00139997|983281|P1|STARTED|Overall Study||15
401272|NCT00139776|983291|P4|NOT COMPLETED|Period III||106
401273|NCT00139776|983292|P3|NOT COMPLETED|Period III||76
401274|NCT00139776|983293|P2|NOT COMPLETED|Period III||0
401275|NCT00139776|983294|P1|NOT COMPLETED|Period III||0
401276|NCT00139776|983291|P4|COMPLETED|Period III||321
401277|NCT00139776|983292|P3|COMPLETED|Period III||355
401278|NCT00139776|983293|P2|COMPLETED|Period III||0
401279|NCT00139776|983294|P1|COMPLETED|Period III||0
401280|NCT00139776|983291|P4|STARTED|Period III|Randomized 435: 8 participants not treated|427
401281|NCT00139776|983292|P3|STARTED|Period III|Randomized 440: 9 participants not treated|431
401282|NCT00139776|983293|P2|STARTED|Period III||0
401283|NCT00139776|983294|P1|STARTED|Period III||0
401284|NCT00139776|983291|P4|NOT COMPLETED|Period II||0
401285|NCT00139776|983292|P3|NOT COMPLETED|Period II||0
401286|NCT00139776|983293|P2|NOT COMPLETED|Period II||322
401287|NCT00139776|983294|P1|NOT COMPLETED|Period II||0
401288|NCT00139776|983291|P4|COMPLETED|Period II||0
401289|NCT00139776|983292|P3|COMPLETED|Period II||0
401290|NCT00139776|983293|P2|COMPLETED|Period II||875
401291|NCT00139776|983294|P1|COMPLETED|Period II||0
401292|NCT00139776|983291|P4|STARTED|Period II||0
401293|NCT00139776|983292|P3|STARTED|Period II||0
401294|NCT00139776|983293|P2|STARTED|Period II||1197
401295|NCT00139776|983294|P1|STARTED|Period II||0
401296|NCT00139776|983291|P4|NOT COMPLETED|Period I||0
401297|NCT00139776|983292|P3|NOT COMPLETED|Period I||0
401298|NCT00139776|983293|P2|NOT COMPLETED|Period I||0
401299|NCT00139776|983294|P1|NOT COMPLETED|Period I||575
401300|NCT00139776|983291|P4|COMPLETED|Period I||0
401301|NCT00139776|983292|P3|COMPLETED|Period I||0
401302|NCT00139776|983293|P2|COMPLETED|Period I||0
401303|NCT00139776|983294|P1|COMPLETED|Period I||1197
401304|NCT00139776|983291|P4|STARTED|Period I||0
401305|NCT00139776|983292|P3|STARTED|Period I||0
401306|NCT00139776|983293|P2|STARTED|Period I||0
401307|NCT00139776|983294|P1|STARTED|Period I||1772
401308|NCT00139737|983329|P1|NOT COMPLETED|Overall Study||341
401309|NCT00139737|983329|P1|COMPLETED|Overall Study||3
401310|NCT00139737|983329|P1|Received Treatment|Overall Study||331
401311|NCT00139737|983329|P1|STARTED|Overall Study||344
401312|NCT00139659|983335|P2|NOT COMPLETED|Overall Study||18
401313|NCT00139659|983336|P1|NOT COMPLETED|Overall Study||40
401314|NCT00139659|983335|P2|COMPLETED|Overall Study||123
401315|NCT00139659|983336|P1|COMPLETED|Overall Study||106
401316|NCT00139659|983335|P2|STARTED|Overall Study|1 subject randomized DC'd before receiving subcutaneous insulin and is not included in # of subjects|141
401317|NCT00139659|983336|P1|STARTED|Overall Study|1 subject randomized was DC'd prior to receiving inhaled insulin but received subcutaneous insulin|146
401318|NCT00139477|983414|P2|NOT COMPLETED|Second Intervention -6Months to 12Months||5
401319|NCT00139477|983415|P1|NOT COMPLETED|Second Intervention -6Months to 12Months||5
401320|NCT00139477|983414|P2|COMPLETED|Second Intervention -6Months to 12Months||18
401321|NCT00139477|983415|P1|COMPLETED|Second Intervention -6Months to 12Months||14
401322|NCT00139477|983414|P2|STARTED|Second Intervention -6Months to 12Months||23
401323|NCT00139477|983415|P1|STARTED|Second Intervention -6Months to 12Months||19
401324|NCT00139477|983414|P2|NOT COMPLETED|First Intervention -Baseline to 6Months||12
401325|NCT00139477|983415|P1|NOT COMPLETED|First Intervention -Baseline to 6Months||12
401326|NCT00139477|983414|P2|COMPLETED|First Intervention -Baseline to 6Months||23
401327|NCT00139477|983415|P1|COMPLETED|First Intervention -Baseline to 6Months||19
401328|NCT00139477|983414|P2|STARTED|First Intervention -Baseline to 6Months||35
401329|NCT00139477|983415|P1|STARTED|First Intervention -Baseline to 6Months||31
401330|NCT00139399|983437|P2|NOT COMPLETED|Overall Study||23
401331|NCT00139399|983438|P1|NOT COMPLETED|Overall Study||16
401332|NCT00139399|983437|P2|COMPLETED|Overall Study||59
401333|NCT00139399|983438|P1|COMPLETED|Overall Study||44
401334|NCT00139399|983437|P2|STARTED|Overall Study||82
401335|NCT00139399|983438|P1|STARTED|Overall Study||60
401336|NCT00138671|983450|P2|NOT COMPLETED|Overall Study||16
401337|NCT00138671|983451|P1|NOT COMPLETED|Overall Study||13
401338|NCT00138671|983450|P2|COMPLETED|Overall Study||30
401339|NCT00138671|983451|P1|COMPLETED|Overall Study||46
401340|NCT00138671|983450|P2|STARTED|Overall Study||46
401341|NCT00138671|983451|P1|STARTED|Overall Study||59
401342|NCT00138658|983501|P1|NOT COMPLETED|Overall Study||61
401343|NCT00138658|983501|P1|COMPLETED|Overall Study||20
401344|NCT00138658|983501|P1|STARTED|Overall Study||81
401345|NCT00138645|983513|P2|NOT COMPLETED|Overall Study||7
401346|NCT00138645|983514|P1|NOT COMPLETED|Overall Study||6
401347|NCT00138645|983513|P2|COMPLETED|Overall Study||23
401348|NCT00138645|983514|P1|COMPLETED|Overall Study||24
401349|NCT00138645|983513|P2|STARTED|Overall Study||30
401350|NCT00138645|983514|P1|STARTED|Overall Study||30
401351|NCT00138424|983524|P4|NOT COMPLETED|Overall Study||0
401352|NCT00138424|983525|P3|NOT COMPLETED|Overall Study||0
401353|NCT00138424|983526|P2|NOT COMPLETED|Overall Study||1
401354|NCT00138424|983527|P1|NOT COMPLETED|Overall Study||0
401355|NCT00138424|983524|P4|COMPLETED|Overall Study||3
401356|NCT00138424|983525|P3|COMPLETED|Overall Study||5
401357|NCT00138424|983526|P2|COMPLETED|Overall Study||4
401358|NCT00138424|983527|P1|COMPLETED|Overall Study||9
401359|NCT00138424|983524|P4|STARTED|Overall Study||3
401360|NCT00138424|983525|P3|STARTED|Overall Study||5
401361|NCT00138424|983526|P2|STARTED|Overall Study||5
401362|NCT00138424|983527|P1|STARTED|Overall Study||9
401363|NCT00138294|983593|P1|NOT COMPLETED|Overall Study||0
401364|NCT00138294|983593|P1|COMPLETED|Overall Study||29255
401365|NCT00138294|983593|P1|STARTED|Overall Study||29255
401366|NCT00138203|983603|P1|NOT COMPLETED|Overall Study||0
401367|NCT00138203|983603|P1|COMPLETED|Overall Study||16
401368|NCT00138203|983603|P1|STARTED|Overall Study||16
401369|NCT00138151|983610|P1|NOT COMPLETED|Overall Study||4
401370|NCT00138151|983610|P1|COMPLETED|Overall Study||29
401371|NCT00138151|983610|P1|STARTED|Overall Study||33
401372|NCT00138125|983616|P1|NOT COMPLETED|Overall Study||0
401373|NCT00138125|983616|P1|COMPLETED|Overall Study||2
401374|NCT00138125|983616|P1|STARTED|Overall Study||2
401375|NCT00138073|983620|P1|NOT COMPLETED|Overall Study||55
401376|NCT00138073|983620|P1|COMPLETED|Overall Study||0
401377|NCT00138073|983620|P1|Pre-intervention Testing|Overall Study||55
401378|NCT00138073|983620|P1|STARTED|Overall Study||55
401379|NCT00138034|983627|P2|NOT COMPLETED|Overall Study||3
401380|NCT00138034|983628|P1|NOT COMPLETED|Overall Study||3
401381|NCT00138034|983627|P2|COMPLETED|Overall Study||20
401382|NCT00138034|983628|P1|COMPLETED|Overall Study||23
401383|NCT00138034|983627|P2|STARTED|Overall Study||23
401384|NCT00138034|983628|P1|STARTED|Overall Study||26
401385|NCT00137969|983638|P2|NOT COMPLETED|Overall Study||21
401386|NCT00137969|983639|P1|NOT COMPLETED|Overall Study||67
401387|NCT00137969|983638|P2|COMPLETED|Overall Study||67
401388|NCT00137969|983639|P1|COMPLETED|Overall Study||107
401389|NCT00137969|983638|P2|Received Study Drug|Overall Study||88
401390|NCT00137969|983639|P1|Received Study Drug|Overall Study||169
401391|NCT00137969|983638|P2|STARTED|Overall Study||88
401392|NCT00137969|983639|P1|STARTED|Overall Study||174
401393|NCT00137839|983659|P1|NOT COMPLETED|Overall Study||84
401394|NCT00137839|983659|P1|COMPLETED|Overall Study|Data on Reason Not Completed reflects Reason Off-Study|0
401395|NCT00137839|983659|P1|Treated|Overall Study||83
401396|NCT00137839|983659|P1|STARTED|Overall Study||84
401397|NCT00137631|983672|P2|NOT COMPLETED|Overall Study||41
401398|NCT00137631|983673|P1|NOT COMPLETED|Overall Study||37
401399|NCT00137631|983672|P2|COMPLETED|Overall Study||133
401400|NCT00137631|983673|P1|COMPLETED|Overall Study||127
401401|NCT00137631|983672|P2|Completed 6-month Follow-up|Overall Study|8 participants who were lost to follow-up at 3-months were retained at 6-months|133
401402|NCT00137631|983673|P1|Completed 6-month Follow-up|Overall Study|7 participants who were lost to follow-up at 3-months were retained at 6-months|127
401403|NCT00137631|983672|P2|Complete 3-month Follow-up|Overall Study||125
401404|NCT00137631|983673|P1|Complete 3-month Follow-up|Overall Study||120
401405|NCT00137631|983672|P2|STARTED|Overall Study||174
401406|NCT00137631|983673|P1|STARTED|Overall Study||164
401407|NCT00137449|983689|P2|NOT COMPLETED|Overall Study||18
401408|NCT00137449|983690|P1|NOT COMPLETED|Overall Study||16
401409|NCT00137449|983689|P2|COMPLETED|Overall Study||12
401410|NCT00137449|983690|P1|COMPLETED|Overall Study||14
401411|NCT00137449|983689|P2|STARTED|Overall Study||30
401412|NCT00137449|983690|P1|STARTED|Overall Study||30
401413|NCT00137436|983727|P1|NOT COMPLETED|Overall Study||43
401414|NCT00137436|983727|P1|COMPLETED|Overall Study||12
401415|NCT00137436|983727|P1|STARTED|Overall Study|Phase 2 did not include 38 participants from Phase 1.|55
401416|NCT00137423|983746|P2|NOT COMPLETED|Overall Study||44
401417|NCT00137423|983747|P1|NOT COMPLETED|Overall Study||39
401418|NCT00137423|983746|P2|COMPLETED|Overall Study||9
401419|NCT00137423|983747|P1|COMPLETED|Overall Study||15
401420|NCT00137423|983746|P2|STARTED|Overall Study||53
401421|NCT00137423|983747|P1|STARTED|Overall Study||54
401422|NCT00137280|983769|P2|NOT COMPLETED|Overall Study||55
401423|NCT00137280|983770|P1|NOT COMPLETED|Overall Study||84
401424|NCT00137280|983769|P2|COMPLETED|Overall Study||357
401425|NCT00137280|983770|P1|COMPLETED|Overall Study||305
401426|NCT00137280|983769|P2|STARTED|Overall Study||412
401427|NCT00137280|983770|P1|STARTED|Overall Study||389
401428|NCT00137267|983784|P2|NOT COMPLETED|Overall Study||21
401429|NCT00137267|983785|P1|NOT COMPLETED|Overall Study||15
401430|NCT00137267|983784|P2|COMPLETED|Overall Study||26
401431|NCT00137267|983785|P1|COMPLETED|Overall Study||40
401432|NCT00137267|983784|P2|STARTED|Overall Study||47
401433|NCT00137267|983785|P1|STARTED|Overall Study||55
401434|NCT00137111|983797|P4|NOT COMPLETED|Total Therapy||0
401435|NCT00137111|983798|P3|NOT COMPLETED|Total Therapy||0
401436|NCT00137111|983799|P2|NOT COMPLETED|Total Therapy||0
401437|NCT00137111|983800|P1|NOT COMPLETED|Total Therapy||40
401438|NCT00137111|983797|P4|COMPLETED|Total Therapy||0
401439|NCT00137111|983798|P3|COMPLETED|Total Therapy||0
401440|NCT00137111|983799|P2|COMPLETED|Total Therapy||0
401441|NCT00137111|983800|P1|COMPLETED|Total Therapy||458
401442|NCT00137111|983797|P4|STARTED|Total Therapy||0
401443|NCT00137111|983798|P3|STARTED|Total Therapy||0
401444|NCT00137111|983799|P2|STARTED|Total Therapy||0
401445|NCT00137111|983800|P1|STARTED|Total Therapy||498
401446|NCT00137111|983797|P4|NOT COMPLETED|Window Therapy||0
401447|NCT00137111|983798|P3|NOT COMPLETED|Window Therapy||0
401448|NCT00137111|983799|P2|NOT COMPLETED|Window Therapy||0
401449|NCT00137111|983800|P1|NOT COMPLETED|Window Therapy||0
401450|NCT00137111|983797|P4|COMPLETED|Window Therapy||142
401451|NCT00137111|983798|P3|COMPLETED|Window Therapy||180
401452|NCT00137111|983799|P2|COMPLETED|Window Therapy||176
401453|NCT00137111|983800|P1|COMPLETED|Window Therapy||0
401454|NCT00137111|983797|P4|STARTED|Window Therapy||142
401455|NCT00137111|983798|P3|STARTED|Window Therapy||180
401456|NCT00137111|983799|P2|STARTED|Window Therapy||176
401457|NCT00137111|983800|P1|STARTED|Window Therapy||0
401458|NCT00137046|983814|P2|NOT COMPLETED|Overall Study||93
401459|NCT00137046|983815|P1|NOT COMPLETED|Overall Study||99
401460|NCT00137046|983814|P2|COMPLETED|Overall Study||198
401461|NCT00137046|983815|P1|COMPLETED|Overall Study|Completed subjects were those subjects who did not discontinue while on active drug.|192
401462|NCT00137046|983814|P2|Received Study Treatment|Overall Study||290
401463|NCT00137046|983815|P1|Received Study Treatment|Overall Study||290
401464|NCT00137046|983814|P2|STARTED|Overall Study|One subject was randomized to subcutaneous insulin but never received treatment.|291
401465|NCT00137046|983815|P1|STARTED|Overall Study|One subject was randomized to inhaled insulin but never received treatment.|291
401466|NCT00136955|983863|P1|NOT COMPLETED|Overall Study||23
401467|NCT00136955|983863|P1|COMPLETED|Overall Study||18
401468|NCT00136955|983863|P1|STARTED|Overall Study||41
401469|NCT00136916|983872|P2|NOT COMPLETED|Overall Study||104
401470|NCT00136916|983873|P1|NOT COMPLETED|Overall Study||125
401471|NCT00136916|983872|P2|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|212
401472|NCT00136916|983873|P1|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|194
401473|NCT00136916|983872|P2|Received Treatment|Overall Study||311
401474|NCT00136916|983873|P1|Received Treatment|Overall Study||316
401475|NCT00136916|983872|P2|STARTED|Overall Study||316
401476|NCT00136916|983873|P1|STARTED|Overall Study||319
401477|NCT00136838|983927|P2|NOT COMPLETED|Second Intervention ( 5 Days)||0
401478|NCT00136838|983928|P1|NOT COMPLETED|Second Intervention ( 5 Days)||0
401479|NCT00136838|983927|P2|COMPLETED|Second Intervention ( 5 Days)||6
401480|NCT00136838|983928|P1|COMPLETED|Second Intervention ( 5 Days)||6
401481|NCT00136838|983927|P2|STARTED|Second Intervention ( 5 Days)||6
401482|NCT00136838|983928|P1|STARTED|Second Intervention ( 5 Days)||6
401483|NCT00136838|983927|P2|NOT COMPLETED|First Intervention ( 5 Days)||0
401484|NCT00136838|983928|P1|NOT COMPLETED|First Intervention ( 5 Days)||0
401485|NCT00136838|983927|P2|COMPLETED|First Intervention ( 5 Days)||6
401486|NCT00136838|983928|P1|COMPLETED|First Intervention ( 5 Days)||6
401487|NCT00136838|983927|P2|STARTED|First Intervention ( 5 Days)||6
401488|NCT00136838|983928|P1|STARTED|First Intervention ( 5 Days)||6
401489|NCT00136812|983938|P2|NOT COMPLETED|Overall Study||0
401490|NCT00136812|983939|P1|NOT COMPLETED|Overall Study||0
401491|NCT00136812|983938|P2|COMPLETED|Overall Study||113
401492|NCT00136812|983939|P1|COMPLETED|Overall Study||111
401493|NCT00136812|983938|P2|STARTED|Overall Study||113
401494|NCT00136812|983939|P1|STARTED|Overall Study||111
401495|NCT00136760|983949|P4|NOT COMPLETED|Overall Study||0
401496|NCT00136760|983950|P3|NOT COMPLETED|Overall Study||0
401497|NCT00136760|983951|P2|NOT COMPLETED|Overall Study||0
401498|NCT00136760|983952|P1|NOT COMPLETED|Overall Study||0
401499|NCT00136760|983949|P4|COMPLETED|Overall Study||13
401500|NCT00136760|983950|P3|COMPLETED|Overall Study||11
401501|NCT00136760|983951|P2|COMPLETED|Overall Study||16
401502|NCT00136760|983952|P1|COMPLETED|Overall Study||12
401503|NCT00136760|983949|P4|STARTED|Overall Study||13
401504|NCT00136760|983950|P3|STARTED|Overall Study||11
401505|NCT00136760|983951|P2|STARTED|Overall Study||16
401506|NCT00136760|983952|P1|STARTED|Overall Study||12
401507|NCT00136695|983968|P2|NOT COMPLETED|Overall Study||8
401508|NCT00136695|983969|P1|NOT COMPLETED|Overall Study||11
401509|NCT00136695|983968|P2|COMPLETED|Overall Study||35
401510|NCT00136695|983969|P1|COMPLETED|Overall Study||34
401511|NCT00136695|983968|P2|STARTED|Overall Study||43
401512|NCT00136695|983969|P1|STARTED|Overall Study||45
401513|NCT00136604|983980|P5|NOT COMPLETED|Overall Study||1
401514|NCT00136604|983981|P4|NOT COMPLETED|Overall Study||0
401515|NCT00136604|983982|P3|NOT COMPLETED|Overall Study||0
401516|NCT00136604|983983|P2|NOT COMPLETED|Overall Study||1
401517|NCT00136604|983984|P1|NOT COMPLETED|Overall Study||1
401518|NCT00136604|983980|P5|COMPLETED|Overall Study||124
401519|NCT00136604|983981|P4|COMPLETED|Overall Study||41
401520|NCT00136604|983982|P3|COMPLETED|Overall Study||79
401521|NCT00136604|983983|P2|COMPLETED|Overall Study||122
401522|NCT00136604|983984|P1|COMPLETED|Overall Study||248
401523|NCT00136604|983980|P5|STARTED|Overall Study||125
401524|NCT00136604|983981|P4|STARTED|Overall Study||41
401525|NCT00136604|983982|P3|STARTED|Overall Study||79
401526|NCT00136604|983983|P2|STARTED|Overall Study||123
401527|NCT00136604|983984|P1|STARTED|Overall Study||249
401528|NCT00136357|984092|P2|NOT COMPLETED|Overall Study||2
401529|NCT00136357|984093|P1|NOT COMPLETED|Overall Study||3
401530|NCT00136357|984092|P2|COMPLETED|Overall Study||39
401531|NCT00136357|984093|P1|COMPLETED|Overall Study||38
401532|NCT00136357|984092|P2|STARTED|Overall Study||41
401533|NCT00136357|984093|P1|STARTED|Overall Study||41
401534|NCT00136318|984101|P2|NOT COMPLETED|Overall Study||7
401535|NCT00136318|984102|P1|NOT COMPLETED|Overall Study||7
401536|NCT00136318|984101|P2|COMPLETED|Overall Study||84
401537|NCT00136318|984102|P1|COMPLETED|Overall Study|reached end-point of antiviral treatment|83
401538|NCT00136318|984101|P2|STARTED|Overall Study|Took first dose of study medication|91
401539|NCT00136318|984102|P1|STARTED|Overall Study|Took first dose of study medication|90
401540|NCT00136214|984118|P2|NOT COMPLETED|Overall Study||0
401541|NCT00136214|984119|P1|NOT COMPLETED|Overall Study||0
401542|NCT00136214|984118|P2|COMPLETED|Overall Study||7
401543|NCT00136214|984119|P1|COMPLETED|Overall Study||15
401544|NCT00136214|984118|P2|STARTED|Overall Study||7
401545|NCT00136214|984119|P1|STARTED|Overall Study||15
401546|NCT00136084|984129|P2|NOT COMPLETED|Overall Study||42
401547|NCT00136084|984130|P1|NOT COMPLETED|Overall Study||48
401548|NCT00136084|984129|P2|COMPLETED|Overall Study||72
401549|NCT00136084|984130|P1|COMPLETED|Overall Study||61
401550|NCT00136084|984129|P2|STARTED|Overall Study||114
401551|NCT00136084|984130|P1|STARTED|Overall Study||109
401552|NCT00135798|984146|P3|NOT COMPLETED|Overall Study||0
401553|NCT00135798|984147|P2|NOT COMPLETED|Overall Study||0
401554|NCT00135798|984148|P1|NOT COMPLETED|Overall Study||0
401555|NCT00135798|984146|P3|COMPLETED|Overall Study||32
401556|NCT00135798|984147|P2|COMPLETED|Overall Study||31
401557|NCT00135798|984148|P1|COMPLETED|Overall Study||16
401558|NCT00135798|984146|P3|STARTED|Overall Study||32
401559|NCT00135798|984147|P2|STARTED|Overall Study||31
401560|NCT00135798|984148|P1|STARTED|Overall Study||16
401561|NCT00135707|984166|P2|NOT COMPLETED|Overall Study||90
401562|NCT00135707|984167|P1|NOT COMPLETED|Overall Study||95
401563|NCT00135707|984166|P2|COMPLETED|Overall Study||4976
401564|NCT00135707|984167|P1|COMPLETED|Overall Study||4993
401565|NCT00135707|984166|P2|STARTED|Overall Study||5066
401566|NCT00135707|984167|P1|STARTED|Overall Study||5088
401567|NCT00135694|984250|P3|NOT COMPLETED|Overall Study||7
401568|NCT00135694|984251|P2|NOT COMPLETED|Overall Study||21
401569|NCT00135694|984252|P1|NOT COMPLETED|Overall Study||180
401570|NCT00135694|984250|P3|COMPLETED|Overall Study||11
401571|NCT00135694|984251|P2|COMPLETED|Overall Study||56
401572|NCT00135694|984252|P1|COMPLETED|Overall Study|Subjects were assessed as ineligible for random assignment and subsequently terminated per protocol.|0
401573|NCT00135694|984250|P3|STARTED|Overall Study||18
401574|NCT00135694|984251|P2|STARTED|Overall Study||77
401575|NCT00135694|984252|P1|STARTED|Overall Study||180
401576|NCT00135512|984270|P1|NOT COMPLETED|Overall Study||123
401577|NCT00135512|984270|P1|COMPLETED|Overall Study||111
401578|NCT00135512|984270|P1|STARTED|Overall Study||234
401579|NCT00135356|984282|P2|NOT COMPLETED|Overall Study||9
401580|NCT00135356|984283|P1|NOT COMPLETED|Overall Study||17
401581|NCT00135356|984282|P2|COMPLETED|Overall Study||60
401582|NCT00135356|984283|P1|COMPLETED|Overall Study||114
401583|NCT00135356|984282|P2|Discontinued on or After Week 96 Visit|Overall Study||0
401584|NCT00135356|984283|P1|Discontinued on or After Week 96 Visit|Overall Study||1
401585|NCT00135356|984282|P2|Discontinued Prior to Week 96 Visit|Overall Study||9
401586|NCT00135356|984283|P1|Discontinued Prior to Week 96 Visit|Overall Study||16
401587|NCT00135356|984282|P2|STARTED|Overall Study|Number randomized and treated(1 randomized and never treated subject not included in this number.)|69
401588|NCT00135356|984283|P1|STARTED|Overall Study|Number randomized and treated|131
401589|NCT00135330|984326|P3|NOT COMPLETED|Overall Study||11
401590|NCT00135330|984327|P2|NOT COMPLETED|Overall Study||13
401591|NCT00135330|984328|P1|NOT COMPLETED|Overall Study||12
401592|NCT00135330|984326|P3|COMPLETED|Overall Study||34
401593|NCT00135330|984327|P2|COMPLETED|Overall Study||34
401594|NCT00135330|984328|P1|COMPLETED|Overall Study||33
401595|NCT00135330|984326|P3|STARTED|Overall Study||45
401596|NCT00135330|984327|P2|STARTED|Overall Study||47
401597|NCT00135330|984328|P1|STARTED|Overall Study||45
401598|NCT00135226|984424|P4|NOT COMPLETED|Overall Study||36
401599|NCT00135226|984425|P3|NOT COMPLETED|Overall Study||34
401600|NCT00135226|984426|P2|NOT COMPLETED|Overall Study||35
401601|NCT00135226|984427|P1|NOT COMPLETED|Overall Study||34
401602|NCT00135226|984424|P4|COMPLETED|Overall Study||3834
401603|NCT00135226|984425|P3|COMPLETED|Overall Study||3836
401604|NCT00135226|984426|P2|COMPLETED|Overall Study||3835
401605|NCT00135226|984427|P1|COMPLETED|Overall Study||3836
401606|NCT00135226|984424|P4|STARTED|Overall Study||3870
401607|NCT00135226|984425|P3|STARTED|Overall Study||3870
401608|NCT00135226|984426|P2|STARTED|Overall Study||3870
401609|NCT00135226|984427|P1|STARTED|Overall Study||3870
401610|NCT00135200|984519|P1|NOT COMPLETED|Overall Study||0
401611|NCT00135200|984519|P1|COMPLETED|Overall Study||16
401612|NCT00135200|984519|P1|STARTED|Overall Study||16
401613|NCT00134901|984526|P2|NOT COMPLETED|Overall Study||15
401614|NCT00134901|984527|P1|NOT COMPLETED|Overall Study||17
401615|NCT00134901|984526|P2|COMPLETED|Overall Study||27
401616|NCT00134901|984527|P1|COMPLETED|Overall Study||22
401617|NCT00134901|984526|P2|STARTED|Overall Study||42
401618|NCT00134901|984527|P1|STARTED|Overall Study||39
401619|NCT00134784|984539|P4|NOT COMPLETED|Overall Study||1
401620|NCT00134784|984540|P3|NOT COMPLETED|Overall Study||2
401621|NCT00134784|984541|P2|NOT COMPLETED|Overall Study||2
401622|NCT00134784|984542|P1|NOT COMPLETED|Overall Study||2
401623|NCT00134784|984539|P4|COMPLETED|Overall Study||37
401624|NCT00134784|984540|P3|COMPLETED|Overall Study||35
401625|NCT00134784|984541|P2|COMPLETED|Overall Study||36
401626|NCT00134784|984542|P1|COMPLETED|Overall Study||27
401627|NCT00134784|984539|P4|STARTED|Overall Study||38
401628|NCT00134784|984540|P3|STARTED|Overall Study||37
401629|NCT00134784|984541|P2|STARTED|Overall Study||38
401630|NCT00134784|984542|P1|STARTED|Overall Study||29
401631|NCT00134719|984552|P3|NOT COMPLETED|Fourth Dose Vaccination Phase||1
401632|NCT00134719|984553|P2|NOT COMPLETED|Fourth Dose Vaccination Phase||3
401633|NCT00134719|984554|P1|NOT COMPLETED|Fourth Dose Vaccination Phase||2
401634|NCT00134719|984552|P3|COMPLETED|Fourth Dose Vaccination Phase||203
401635|NCT00134719|984553|P2|COMPLETED|Fourth Dose Vaccination Phase||203
401636|NCT00134719|984554|P1|COMPLETED|Fourth Dose Vaccination Phase||623
401637|NCT00134719|984552|P3|STARTED|Fourth Dose Vaccination Phase||204
401638|NCT00134719|984553|P2|STARTED|Fourth Dose Vaccination Phase||206
401639|NCT00134719|984554|P1|STARTED|Fourth Dose Vaccination Phase||625
401640|NCT00134719|984552|P3|NOT COMPLETED|Primary Vaccination Phase||5
401641|NCT00134719|984553|P2|NOT COMPLETED|Primary Vaccination Phase||6
401642|NCT00134719|984554|P1|NOT COMPLETED|Primary Vaccination Phase||14
401643|NCT00134719|984552|P3|COMPLETED|Primary Vaccination Phase||216
401644|NCT00134719|984553|P2|COMPLETED|Primary Vaccination Phase||215
401645|NCT00134719|984554|P1|COMPLETED|Primary Vaccination Phase||647
401646|NCT00134719|984552|P3|STARTED|Primary Vaccination Phase||221
401647|NCT00134719|984553|P2|STARTED|Primary Vaccination Phase||221
401648|NCT00134719|984554|P1|STARTED|Primary Vaccination Phase||661
401649|NCT00134563|984685|P3|NOT COMPLETED|Overall Study||96
401650|NCT00134563|984686|P2|NOT COMPLETED|Overall Study||92
401651|NCT00134563|984687|P1|NOT COMPLETED|Overall Study||104
401652|NCT00134563|984685|P3|COMPLETED|Overall Study|completed treatment period|263
401653|NCT00134563|984686|P2|COMPLETED|Overall Study|completed treatment period|274
401654|NCT00134563|984687|P1|COMPLETED|Overall Study|completed treatment period|259
401655|NCT00134563|984685|P3|Treated|Overall Study|one participant received doses of Teriflunomide 7 mg|358
401656|NCT00134563|984686|P2|Treated|Overall Study||365
401657|NCT00134563|984687|P1|Treated|Overall Study|Two participants received doses of Teriflunomide 7 mg, one participant doses of Teriflunomide 14 mg|363
401658|NCT00134563|984685|P3|STARTED|Overall Study|Randomized|359
401659|NCT00134563|984686|P2|STARTED|Overall Study|Randomized|366
401660|NCT00134563|984687|P1|STARTED|Overall Study|Randomized|363
401661|NCT00134381|984710|P6|NOT COMPLETED|Overall Study||2
401662|NCT00134381|984711|P5|NOT COMPLETED|Overall Study||0
401663|NCT00134381|984712|P4|NOT COMPLETED|Overall Study||0
401664|NCT00134381|984713|P3|NOT COMPLETED|Overall Study||0
401665|NCT00134381|984714|P2|NOT COMPLETED|Overall Study||0
401666|NCT00134381|984715|P1|NOT COMPLETED|Overall Study||0
401667|NCT00134381|984710|P6|COMPLETED|Overall Study||29
401668|NCT00134381|984711|P5|COMPLETED|Overall Study||31
401669|NCT00134381|984712|P4|COMPLETED|Overall Study||2
401670|NCT00134381|984713|P3|COMPLETED|Overall Study||1
401671|NCT00134381|984714|P2|COMPLETED|Overall Study||2
401672|NCT00134381|984715|P1|COMPLETED|Overall Study||1
401673|NCT00134381|984710|P6|STARTED|Overall Study||31
401674|NCT00134381|984711|P5|STARTED|Overall Study||31
401675|NCT00134381|984712|P4|STARTED|Overall Study||2
401676|NCT00134381|984713|P3|STARTED|Overall Study||1
401677|NCT00134381|984714|P2|STARTED|Overall Study||2
401678|NCT00134381|984715|P1|STARTED|Overall Study||1
401679|NCT00134082|984748|P1|NOT COMPLETED|Overall Study||3
401680|NCT00134082|984748|P1|COMPLETED|Overall Study||27
401681|NCT00134082|984748|P1|STARTED|Overall Study||30
401682|NCT00134056|984757|P2|NOT COMPLETED|Eligible for Protocol Assigned Treatment||315
401683|NCT00134056|984758|P1|NOT COMPLETED|Eligible for Protocol Assigned Treatment||327
401684|NCT00134056|984757|P2|COMPLETED|Eligible for Protocol Assigned Treatment||185
401685|NCT00134056|984758|P1|COMPLETED|Eligible for Protocol Assigned Treatment||169
401686|NCT00134056|984757|P2|STARTED|Eligible for Protocol Assigned Treatment||500
401687|NCT00134056|984758|P1|STARTED|Eligible for Protocol Assigned Treatment||496
401688|NCT00134056|984757|P2|NOT COMPLETED|Randomization||20
401689|NCT00134056|984758|P1|NOT COMPLETED|Randomization||22
401690|NCT00134056|984757|P2|COMPLETED|Randomization||500
401691|NCT00134056|984758|P1|COMPLETED|Randomization||496
401692|NCT00134056|984757|P2|STARTED|Randomization||520
401693|NCT00134056|984758|P1|STARTED|Randomization||518
401694|NCT00134043|984780|P2|NOT COMPLETED|Overall Study||0
401695|NCT00134043|984781|P1|NOT COMPLETED|Overall Study||0
401696|NCT00134043|984780|P2|COMPLETED|Overall Study||3
401697|NCT00134043|984781|P1|COMPLETED|Overall Study||16
401698|NCT00134043|984780|P2|STARTED|Overall Study||3
401699|NCT00134043|984781|P1|STARTED|Overall Study||16
401700|NCT00134017|984786|P1|NOT COMPLETED|Overall Study||0
401701|NCT00134017|984786|P1|COMPLETED|Overall Study||142
401702|NCT00134017|984786|P1|STARTED|Overall Study||142
401703|NCT00134004|984794|P1|NOT COMPLETED|Overall Study||0
401704|NCT00134004|984794|P1|COMPLETED|Overall Study||210
401705|NCT00134004|984794|P1|STARTED|Overall Study||210
401706|NCT00133991|984802|P1|NOT COMPLETED|Overall Study||4
401707|NCT00133991|984802|P1|COMPLETED|Overall Study||17
401708|NCT00133991|984802|P1|STARTED|Overall Study||21
401709|NCT00133978|984814|P4|NOT COMPLETED|Overall Study||2
401710|NCT00133978|984815|P3|NOT COMPLETED|Overall Study||0
401711|NCT00133978|984816|P2|NOT COMPLETED|Overall Study||1
401712|NCT00133978|984817|P1|NOT COMPLETED|Overall Study||2
401713|NCT00133978|984814|P4|COMPLETED|Overall Study||300
401714|NCT00133978|984815|P3|COMPLETED|Overall Study||310
401715|NCT00133978|984816|P2|COMPLETED|Overall Study||307
401716|NCT00133978|984817|P1|COMPLETED|Overall Study||301
401717|NCT00133978|984814|P4|STARTED|Overall Study||302
401718|NCT00133978|984815|P3|STARTED|Overall Study||310
401719|NCT00133978|984816|P2|STARTED|Overall Study||308
401720|NCT00133978|984817|P1|STARTED|Overall Study||303
401721|NCT00133952|984841|P2|NOT COMPLETED|Overall Study||28
401722|NCT00133952|984842|P1|NOT COMPLETED|Overall Study||42
401723|NCT00133952|984841|P2|COMPLETED|Overall Study||124
401724|NCT00133952|984842|P1|COMPLETED|Overall Study||115
401725|NCT00133952|984841|P2|Received at Least One Dose of Study Drug|Overall Study||149
401726|NCT00133952|984842|P1|Received at Least One Dose of Study Drug|Overall Study||153
401727|NCT00133952|984841|P2|STARTED|Overall Study||152
401728|NCT00133952|984842|P1|STARTED|Overall Study||157
401729|NCT00133809|984864|P1|NOT COMPLETED|Overall Study||0
401730|NCT00133809|984864|P1|COMPLETED|Overall Study||8
401731|NCT00133809|984864|P1|STARTED|Overall Study||8
401732|NCT00133705|984873|P2|NOT COMPLETED|Overall Study||3
401733|NCT00133705|984874|P1|NOT COMPLETED|Overall Study||2
401734|NCT00133705|984873|P2|COMPLETED|Overall Study||17
401735|NCT00133705|984874|P1|COMPLETED|Overall Study||20
401736|NCT00133705|984873|P2|STARTED|Overall Study||20
401737|NCT00133705|984874|P1|STARTED|Overall Study||22
401738|NCT00133575|984887|P7|NOT COMPLETED|Overall Study||3
401739|NCT00133575|984888|P6|NOT COMPLETED|Overall Study||1
401740|NCT00133575|984889|P5|NOT COMPLETED|Overall Study||4
401741|NCT00133575|984890|P4|NOT COMPLETED|Overall Study||1
401742|NCT00133575|984891|P3|NOT COMPLETED|Overall Study||2
401743|NCT00133575|984892|P2|NOT COMPLETED|Overall Study||0
401744|NCT00133575|984893|P1|NOT COMPLETED|Overall Study||0
401745|NCT00133575|984887|P7|COMPLETED|Overall Study||9
401746|NCT00133575|984888|P6|COMPLETED|Overall Study||9
401747|NCT00133575|984889|P5|COMPLETED|Overall Study||6
401748|NCT00133575|984890|P4|COMPLETED|Overall Study||9
401749|NCT00133575|984891|P3|COMPLETED|Overall Study||8
401750|NCT00133575|984892|P2|COMPLETED|Overall Study||10
401751|NCT00133575|984893|P1|COMPLETED|Overall Study||10
401752|NCT00133575|984887|P7|STARTED|Overall Study||12
401753|NCT00133575|984888|P6|STARTED|Overall Study||10
401754|NCT00133575|984889|P5|STARTED|Overall Study||10
401755|NCT00133575|984890|P4|STARTED|Overall Study||10
401756|NCT00133575|984891|P3|STARTED|Overall Study||10
401757|NCT00133575|984892|P2|STARTED|Overall Study||10
401758|NCT00133575|984893|P1|STARTED|Overall Study||10
401759|NCT00132964|985002|P2|NOT COMPLETED|Overall Study||3
401760|NCT00132964|985003|P1|NOT COMPLETED|Overall Study||4
401761|NCT00132964|985002|P2|COMPLETED|Overall Study||54
401762|NCT00132964|985003|P1|COMPLETED|Overall Study||50
401763|NCT00132964|985002|P2|STARTED|Overall Study||57
401764|NCT00132964|985003|P1|STARTED|Overall Study||54
401765|NCT00132873|985009|P1|NOT COMPLETED|Overall Study||9
401766|NCT00132873|985009|P1|COMPLETED|Overall Study||50
401767|NCT00132873|985009|P1|STARTED|Overall Study||59
401768|NCT00132808|985017|P3|NOT COMPLETED|Stratum II||9
401769|NCT00132808|985018|P2|NOT COMPLETED|Stratum II||15
401770|NCT00132808|985019|P1|NOT COMPLETED|Stratum II||8
401771|NCT00132808|985017|P3|COMPLETED|Stratum II||116
401772|NCT00132808|985018|P2|COMPLETED|Stratum II||96
401773|NCT00132808|985019|P1|COMPLETED|Stratum II||113
401774|NCT00132808|985017|P3|STARTED|Stratum II||125
401775|NCT00132808|985018|P2|STARTED|Stratum II||111
401776|NCT00132808|985019|P1|STARTED|Stratum II||121
401777|NCT00132808|985017|P3|NOT COMPLETED|Stratum I||5
401778|NCT00132808|985018|P2|NOT COMPLETED|Stratum I||12
401779|NCT00132808|985019|P1|NOT COMPLETED|Stratum I||9
401780|NCT00132808|985017|P3|COMPLETED|Stratum I||72
401781|NCT00132808|985018|P2|COMPLETED|Stratum I||58
401782|NCT00132808|985019|P1|COMPLETED|Stratum I||68
401783|NCT00132808|985017|P3|STARTED|Stratum I||77
401784|NCT00132808|985018|P2|STARTED|Stratum I||70
401785|NCT00132808|985019|P1|STARTED|Stratum I||77
401786|NCT00132769|985044|P2|NOT COMPLETED|Overall Study||11
401787|NCT00132769|985045|P1|NOT COMPLETED|Overall Study||11
401788|NCT00132769|985044|P2|COMPLETED|Overall Study||42
401789|NCT00132769|985045|P1|COMPLETED|Overall Study||42
401790|NCT00132769|985044|P2|STARTED|Overall Study||53
401791|NCT00132769|985045|P1|STARTED|Overall Study||53
401792|NCT00132730|985071|P6|NOT COMPLETED|Period V - Open-label Extension (EXT2)||2
401793|NCT00132730|985072|P5|NOT COMPLETED|Period V - Open-label Extension (EXT2)||7
401794|NCT00132730|985073|P4|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
401795|NCT00132730|985074|P3|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
401796|NCT00132730|985075|P2|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
401797|NCT00132730|985076|P1|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
401798|NCT00132730|985071|P6|COMPLETED|Period V - Open-label Extension (EXT2)||0
401799|NCT00132730|985072|P5|COMPLETED|Period V - Open-label Extension (EXT2)||0
401800|NCT00132730|985073|P4|COMPLETED|Period V - Open-label Extension (EXT2)||0
401801|NCT00132730|985074|P3|COMPLETED|Period V - Open-label Extension (EXT2)||0
401802|NCT00132730|985075|P2|COMPLETED|Period V - Open-label Extension (EXT2)||0
401803|NCT00132730|985076|P1|COMPLETED|Period V - Open-label Extension (EXT2)||0
401804|NCT00132730|985071|P6|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|2
401805|NCT00132730|985072|P5|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|7
401806|NCT00132730|985073|P4|STARTED|Period V - Open-label Extension (EXT2)||0
401807|NCT00132730|985074|P3|STARTED|Period V - Open-label Extension (EXT2)||0
401808|NCT00132730|985075|P2|STARTED|Period V - Open-label Extension (EXT2)||0
401809|NCT00132730|985076|P1|STARTED|Period V - Open-label Extension (EXT2)||0
401810|NCT00132730|985071|P6|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||68
401811|NCT00132730|985072|P5|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||179
401812|NCT00132730|985073|P4|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
401813|NCT00132730|985074|P3|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
401814|NCT00132730|985075|P2|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
401815|NCT00132730|985076|P1|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
401816|NCT00132730|985071|P6|COMPLETED|Period IV - Open-label Extension (EXT2)||3
401817|NCT00132730|985072|P5|COMPLETED|Period IV - Open-label Extension (EXT2)||8
401818|NCT00132730|985073|P4|COMPLETED|Period IV - Open-label Extension (EXT2)||0
401819|NCT00132730|985074|P3|COMPLETED|Period IV - Open-label Extension (EXT2)||0
401820|NCT00132730|985075|P2|COMPLETED|Period IV - Open-label Extension (EXT2)||0
401821|NCT00132730|985076|P1|COMPLETED|Period IV - Open-label Extension (EXT2)||0
401822|NCT00132730|985071|P6|STARTED|Period IV - Open-label Extension (EXT2)|Includes paricipants from Period III. Not all eligible participants entered EXT2|71
401823|NCT00132730|985072|P5|STARTED|Period IV - Open-label Extension (EXT2)|Includes participants from Period III. Not all eligible participants entered EXT2|187
401824|NCT00132730|985073|P4|STARTED|Period IV - Open-label Extension (EXT2)||0
401825|NCT00132730|985074|P3|STARTED|Period IV - Open-label Extension (EXT2)||0
401826|NCT00132730|985075|P2|STARTED|Period IV - Open-label Extension (EXT2)||0
401827|NCT00132730|985076|P1|STARTED|Period IV - Open-label Extension (EXT2)||0
401828|NCT00132730|985071|P6|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
401829|NCT00132730|985072|P5|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
401830|NCT00132730|985073|P4|NOT COMPLETED|Period III - Blinded Extension (EXT1)||25
401831|NCT00132730|985074|P3|NOT COMPLETED|Period III - Blinded Extension (EXT1)||82
401832|NCT00132730|985075|P2|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
401833|NCT00132730|985076|P1|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
401834|NCT00132730|985071|P6|COMPLETED|Period III - Blinded Extension (EXT1)||0
401835|NCT00132730|985072|P5|COMPLETED|Period III - Blinded Extension (EXT1)||0
401836|NCT00132730|985073|P4|COMPLETED|Period III - Blinded Extension (EXT1)||82
401837|NCT00132730|985074|P3|COMPLETED|Period III - Blinded Extension (EXT1)||235
401838|NCT00132730|985075|P2|COMPLETED|Period III - Blinded Extension (EXT1)||0
401839|NCT00132730|985076|P1|COMPLETED|Period III - Blinded Extension (EXT1)||0
401840|NCT00132730|985071|P6|STARTED|Period III - Blinded Extension (EXT1)||0
401841|NCT00132730|985072|P5|STARTED|Period III - Blinded Extension (EXT1)||0
401842|NCT00132730|985073|P4|STARTED|Period III - Blinded Extension (EXT1)|Not all eligible participants entered EXT1|107
401843|NCT00132730|985074|P3|STARTED|Period III - Blinded Extension (EXT1)|Includes all MK-0873 participants from Period II. Not all eligible participants entered EXT1|317
401844|NCT00132730|985075|P2|STARTED|Period III - Blinded Extension (EXT1)||0
401845|NCT00132730|985076|P1|STARTED|Period III - Blinded Extension (EXT1)||0
401846|NCT00132730|985071|P6|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
401847|NCT00132730|985072|P5|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
401848|NCT00132730|985073|P4|NOT COMPLETED|Period II - 12-week Treatment (Base)||22
401849|NCT00132730|985074|P3|NOT COMPLETED|Period II - 12-week Treatment (Base)||18
401850|NCT00132730|985075|P2|NOT COMPLETED|Period II - 12-week Treatment (Base)||15
401851|NCT00132730|985076|P1|NOT COMPLETED|Period II - 12-week Treatment (Base)||23
401852|NCT00132730|985071|P6|COMPLETED|Period II - 12-week Treatment (Base)||0
401853|NCT00132730|985072|P5|COMPLETED|Period II - 12-week Treatment (Base)||0
401854|NCT00132730|985073|P4|COMPLETED|Period II - 12-week Treatment (Base)||131
401855|NCT00132730|985074|P3|COMPLETED|Period II - 12-week Treatment (Base)||135
401856|NCT00132730|985075|P2|COMPLETED|Period II - 12-week Treatment (Base)||133
401857|NCT00132730|985076|P1|COMPLETED|Period II - 12-week Treatment (Base)||127
401858|NCT00132730|985071|P6|STARTED|Period II - 12-week Treatment (Base)||0
401859|NCT00132730|985072|P5|STARTED|Period II - 12-week Treatment (Base)||0
401860|NCT00132730|985073|P4|STARTED|Period II - 12-week Treatment (Base)||153
401861|NCT00132730|985074|P3|STARTED|Period II - 12-week Treatment (Base)||153
401862|NCT00132730|985075|P2|STARTED|Period II - 12-week Treatment (Base)||148
401863|NCT00132730|985076|P1|STARTED|Period II - 12-week Treatment (Base)||150
401864|NCT00132730|985071|P6|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
401865|NCT00132730|985072|P5|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
401866|NCT00132730|985073|P4|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
401867|NCT00132730|985074|P3|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
401868|NCT00132730|985075|P2|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
401869|NCT00132730|985076|P1|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
401870|NCT00132730|985071|P6|COMPLETED|Period I - Placebo Run-in (Base)||0
401871|NCT00132730|985072|P5|COMPLETED|Period I - Placebo Run-in (Base)||0
401872|NCT00132730|985073|P4|COMPLETED|Period I - Placebo Run-in (Base)||153
401873|NCT00132730|985074|P3|COMPLETED|Period I - Placebo Run-in (Base)||153
401874|NCT00132730|985075|P2|COMPLETED|Period I - Placebo Run-in (Base)||148
401875|NCT00132730|985076|P1|COMPLETED|Period I - Placebo Run-in (Base)||150
401876|NCT00132730|985071|P6|STARTED|Period I - Placebo Run-in (Base)||0
401877|NCT00132730|985072|P5|STARTED|Period I - Placebo Run-in (Base)||0
401878|NCT00132730|985073|P4|STARTED|Period I - Placebo Run-in (Base)||153
401879|NCT00132730|985074|P3|STARTED|Period I - Placebo Run-in (Base)||153
401880|NCT00132730|985075|P2|STARTED|Period I - Placebo Run-in (Base)||148
401881|NCT00132730|985076|P1|STARTED|Period I - Placebo Run-in (Base)||150
401882|NCT00132691|985120|P2|NOT COMPLETED|Overall Study||12
401883|NCT00132691|985121|P1|NOT COMPLETED|Overall Study||11
401884|NCT00132691|985120|P2|COMPLETED|Overall Study|114 participants completed the 2-year anniversary visit|114
401885|NCT00132691|985121|P1|COMPLETED|Overall Study|118 participants completed the 2-year anniversary visit|118
401886|NCT00132691|985120|P2|STARTED|Overall Study|126 participants were assigned to systemic treatment; 121 received systemic therapy|126
401887|NCT00132691|985121|P1|STARTED|Overall Study|129 participants were assigned to implant; 122 received implant|129
401888|NCT00132678|985161|P3|NOT COMPLETED|Period IV (Double-Blind Treatment)||0
401889|NCT00132678|985162|P2|NOT COMPLETED|Period IV (Double-Blind Treatment)||40
401890|NCT00132678|985163|P1|NOT COMPLETED|Period IV (Double-Blind Treatment)||37
401891|NCT00132678|985161|P3|COMPLETED|Period IV (Double-Blind Treatment)||0
401892|NCT00132678|985162|P2|COMPLETED|Period IV (Double-Blind Treatment)||109
401893|NCT00132678|985163|P1|COMPLETED|Period IV (Double-Blind Treatment)||117
401894|NCT00132678|985161|P3|STARTED|Period IV (Double-Blind Treatment)||0
401895|NCT00132678|985162|P2|STARTED|Period IV (Double-Blind Treatment)||149
401896|NCT00132678|985163|P1|STARTED|Period IV (Double-Blind Treatment)||154
401897|NCT00132678|985161|P3|NOT COMPLETED|Period III (Open-Label Stabilization)||0
401898|NCT00132678|985162|P2|NOT COMPLETED|Period III (Open-Label Stabilization)||0
401899|NCT00132678|985163|P1|NOT COMPLETED|Period III (Open-Label Stabilization)||198
401900|NCT00132678|985161|P3|COMPLETED|Period III (Open-Label Stabilization)||0
401901|NCT00132678|985162|P2|COMPLETED|Period III (Open-Label Stabilization)||0
401902|NCT00132678|985163|P1|COMPLETED|Period III (Open-Label Stabilization)||303
401903|NCT00132678|985161|P3|STARTED|Period III (Open-Label Stabilization)||0
401904|NCT00132678|985162|P2|STARTED|Period III (Open-Label Stabilization)||0
401905|NCT00132678|985163|P1|STARTED|Period III (Open-Label Stabilization)||501
401906|NCT00132678|985161|P3|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||58
401907|NCT00132678|985162|P2|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
401908|NCT00132678|985163|P1|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
401909|NCT00132678|985161|P3|COMPLETED|Period II (Open-Label Oral Risperidone)||382
401910|NCT00132678|985162|P2|COMPLETED|Period II (Open-Label Oral Risperidone)||0
401911|NCT00132678|985163|P1|COMPLETED|Period II (Open-Label Oral Risperidone)||0
401912|NCT00132678|985161|P3|STARTED|Period II (Open-Label Oral Risperidone)||440
401913|NCT00132678|985162|P2|STARTED|Period II (Open-Label Oral Risperidone)||0
401914|NCT00132678|985163|P1|STARTED|Period II (Open-Label Oral Risperidone)||0
401915|NCT00132496|985177|P2|NOT COMPLETED|Overall Study||2
401916|NCT00132496|985178|P1|NOT COMPLETED|Overall Study||2
401917|NCT00132496|985177|P2|COMPLETED|Overall Study||55
401918|NCT00132496|985178|P1|COMPLETED|Overall Study||52
401919|NCT00132496|985177|P2|STARTED|Overall Study||57
401920|NCT00132496|985178|P1|STARTED|Overall Study||54
401921|NCT00132314|985186|P2|NOT COMPLETED|Overall Study||72
401922|NCT00132314|985187|P1|NOT COMPLETED|Overall Study||73
401923|NCT00132314|985186|P2|COMPLETED|Overall Study||120
401924|NCT00132314|985187|P1|COMPLETED|Overall Study||117
401925|NCT00132314|985186|P2|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort.|182
401926|NCT00132314|985187|P1|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort|187
401927|NCT00132314|985186|P2|Received Treatment|Overall Study||185
401928|NCT00132314|985187|P1|Received Treatment|Overall Study||188
401929|NCT00132314|985186|P2|STARTED|Overall Study||192
401930|NCT00132314|985187|P1|STARTED|Overall Study||190
401931|NCT00132301|985197|P2|NOT COMPLETED|Overall Study||13
401932|NCT00132301|985198|P1|NOT COMPLETED|Overall Study||20
401933|NCT00132301|985197|P2|COMPLETED|Overall Study||144
401934|NCT00132301|985198|P1|COMPLETED|Overall Study||121
401935|NCT00132301|985197|P2|STARTED|Overall Study||157
401936|NCT00132301|985198|P1|STARTED|Overall Study||141
401937|NCT00132132|985206|P2|NOT COMPLETED|Overall Study||2
401938|NCT00132132|985207|P1|NOT COMPLETED|Overall Study||7
401939|NCT00132132|985206|P2|COMPLETED|Overall Study||13
401940|NCT00132132|985207|P1|COMPLETED|Overall Study||8
401941|NCT00132132|985206|P2|STARTED|Overall Study||15
401942|NCT00132132|985207|P1|STARTED|Overall Study||15
401943|NCT00132028|985215|P1|NOT COMPLETED|Overall Study||27
401944|NCT00132028|985215|P1|COMPLETED|Overall Study|"Since there was no maximum number of cycles, patients could not complete treatment."|0
401945|NCT00132028|985215|P1|Eligible and Began Protocol Therapy|Overall Study||25
401946|NCT00132028|985215|P1|Eligible|Overall Study||25
401947|NCT00132028|985215|P1|STARTED|Overall Study||27
401948|NCT00132002|985221|P1|NOT COMPLETED|Overall Study||0
401949|NCT00132002|985221|P1|COMPLETED|Overall Study||14
401950|NCT00132002|985221|P1|STARTED|Overall Study||14
401951|NCT00131937|985227|P1|NOT COMPLETED|Overall Study||14
401952|NCT00131937|985227|P1|COMPLETED|Overall Study||0
401953|NCT00131937|985227|P1|STARTED|Overall Study||14
401954|NCT00131911|985235|P2|NOT COMPLETED|Overall Study||0
401955|NCT00131911|985236|P1|NOT COMPLETED|Overall Study||1
401956|NCT00131911|985235|P2|COMPLETED|Overall Study||42
401957|NCT00131911|985236|P1|COMPLETED|Overall Study||50
401958|NCT00131911|985235|P2|STARTED|Overall Study||42
401959|NCT00131911|985236|P1|STARTED|Overall Study||51
401960|NCT00131885|985253|P4|NOT COMPLETED|Time 2: Second Intervention||0
401961|NCT00131885|985254|P3|NOT COMPLETED|Time 2: Second Intervention||0
401962|NCT00131885|985255|P2|NOT COMPLETED|Time 2: Second Intervention||0
401963|NCT00131885|985256|P1|NOT COMPLETED|Time 2: Second Intervention||0
401964|NCT00131885|985253|P4|COMPLETED|Time 2: Second Intervention||9
401965|NCT00131885|985254|P3|COMPLETED|Time 2: Second Intervention||9
401966|NCT00131885|985255|P2|COMPLETED|Time 2: Second Intervention||9
401967|NCT00131885|985256|P1|COMPLETED|Time 2: Second Intervention||9
401968|NCT00131885|985253|P4|STARTED|Time 2: Second Intervention||9
401969|NCT00131885|985254|P3|STARTED|Time 2: Second Intervention||9
401970|NCT00131885|985255|P2|STARTED|Time 2: Second Intervention||9
401971|NCT00131885|985256|P1|STARTED|Time 2: Second Intervention||9
401972|NCT00131885|985253|P4|NOT COMPLETED|Time 1: First Intervention||0
401973|NCT00131885|985254|P3|NOT COMPLETED|Time 1: First Intervention||0
401974|NCT00131885|985255|P2|NOT COMPLETED|Time 1: First Intervention||0
401975|NCT00131885|985256|P1|NOT COMPLETED|Time 1: First Intervention||0
401976|NCT00131885|985253|P4|COMPLETED|Time 1: First Intervention||9
401977|NCT00131885|985254|P3|COMPLETED|Time 1: First Intervention||9
401978|NCT00131885|985255|P2|COMPLETED|Time 1: First Intervention||9
401979|NCT00131885|985256|P1|COMPLETED|Time 1: First Intervention||9
401980|NCT00131885|985253|P4|STARTED|Time 1: First Intervention||9
401981|NCT00131885|985254|P3|STARTED|Time 1: First Intervention||9
401982|NCT00131885|985255|P2|STARTED|Time 1: First Intervention||9
401983|NCT00131885|985256|P1|STARTED|Time 1: First Intervention||9
401984|NCT00131677|985288|P2|NOT COMPLETED|Overall Study||39
401985|NCT00131677|985289|P1|NOT COMPLETED|Overall Study||30
401986|NCT00131677|985288|P2|COMPLETED|Overall Study||160
401987|NCT00131677|985289|P1|COMPLETED|Overall Study||171
401988|NCT00131677|985288|P2|STARTED|Overall Study|199 randomized to placebo; 99 to start immediately and 100 after a 9 month delay.|199
401989|NCT00131677|985289|P1|STARTED|Overall Study|201 randomized to active drug; 101 to start immediately and 100 after a 9 month delay.|201
401990|NCT00131664|985306|P6|NOT COMPLETED|Second Period (Additional Drug Added)||3
401991|NCT00131664|985307|P5|NOT COMPLETED|Second Period (Additional Drug Added)||1
401992|NCT00131664|985308|P4|NOT COMPLETED|Second Period (Additional Drug Added)||2
401993|NCT00131664|985309|P3|NOT COMPLETED|Second Period (Additional Drug Added)||3
401994|NCT00131664|985310|P2|NOT COMPLETED|Second Period (Additional Drug Added)||4
401995|NCT00131664|985311|P1|NOT COMPLETED|Second Period (Additional Drug Added)||9
401996|NCT00131664|985306|P6|COMPLETED|Second Period (Additional Drug Added)||22
401997|NCT00131664|985307|P5|COMPLETED|Second Period (Additional Drug Added)||15
401998|NCT00131664|985308|P4|COMPLETED|Second Period (Additional Drug Added)||19
401999|NCT00131664|985309|P3|COMPLETED|Second Period (Additional Drug Added)||76
402000|NCT00131664|985310|P2|COMPLETED|Second Period (Additional Drug Added)||97
402001|NCT00131664|985311|P1|COMPLETED|Second Period (Additional Drug Added)||81
402002|NCT00131664|985306|P6|STARTED|Second Period (Additional Drug Added)||25
402003|NCT00131664|985307|P5|STARTED|Second Period (Additional Drug Added)||16
402004|NCT00131664|985308|P4|STARTED|Second Period (Additional Drug Added)||21
402005|NCT00131664|985309|P3|STARTED|Second Period (Additional Drug Added)|25 had added Amaryl at Month 6|79
402006|NCT00131664|985310|P2|STARTED|Second Period (Additional Drug Added)|16 had added Amaryl at Month 6|101
402007|NCT00131664|985311|P1|STARTED|Second Period (Additional Drug Added)|21 had added Metformin at Month 6|90
402008|NCT00131664|985306|P6|NOT COMPLETED|First Period (First 6 Months)||0
402009|NCT00131664|985307|P5|NOT COMPLETED|First Period (First 6 Months)||0
402010|NCT00131664|985308|P4|NOT COMPLETED|First Period (First 6 Months)||0
402011|NCT00131664|985309|P3|NOT COMPLETED|First Period (First 6 Months)||16
402012|NCT00131664|985310|P2|NOT COMPLETED|First Period (First 6 Months)||18
402013|NCT00131664|985311|P1|NOT COMPLETED|First Period (First 6 Months)||25
402014|NCT00131664|985306|P6|COMPLETED|First Period (First 6 Months)||0
402015|NCT00131664|985307|P5|COMPLETED|First Period (First 6 Months)||0
402016|NCT00131664|985308|P4|COMPLETED|First Period (First 6 Months)||0
402017|NCT00131664|985309|P3|COMPLETED|First Period (First 6 Months)||104
402018|NCT00131664|985310|P2|COMPLETED|First Period (First 6 Months)||117
402019|NCT00131664|985311|P1|COMPLETED|First Period (First 6 Months)||111
402020|NCT00131664|985306|P6|STARTED|First Period (First 6 Months)||0
402021|NCT00131664|985307|P5|STARTED|First Period (First 6 Months)||0
402022|NCT00131664|985308|P4|STARTED|First Period (First 6 Months)||0
402023|NCT00131664|985309|P3|STARTED|First Period (First 6 Months)||120
402024|NCT00131664|985310|P2|STARTED|First Period (First 6 Months)||135
402025|NCT00131664|985311|P1|STARTED|First Period (First 6 Months)||136
402026|NCT00131573|985372|P2|NOT COMPLETED|Overall Study||26
402027|NCT00131573|985373|P1|NOT COMPLETED|Overall Study||33
402028|NCT00131573|985372|P2|COMPLETED|Overall Study||13
402029|NCT00131573|985373|P1|COMPLETED|Overall Study||13
402030|NCT00131573|985372|P2|STARTED|Overall Study||39
402031|NCT00131573|985373|P1|STARTED|Overall Study||46
402032|NCT00131508|985383|P2|NOT COMPLETED|Overall Study||8
402033|NCT00131508|985384|P1|NOT COMPLETED|Overall Study||3
402034|NCT00131508|985383|P2|COMPLETED|Overall Study||5
402035|NCT00131508|985384|P1|COMPLETED|Overall Study||9
402036|NCT00131508|985383|P2|STARTED|Overall Study||13
402037|NCT00131508|985384|P1|STARTED|Overall Study||12
402038|NCT00131469|985408|P2|NOT COMPLETED|Overall Study||13
402039|NCT00131469|985409|P1|NOT COMPLETED|Overall Study||9
402040|NCT00131469|985408|P2|COMPLETED|Overall Study||27
402041|NCT00131469|985409|P1|COMPLETED|Overall Study||29
402042|NCT00131469|985408|P2|STARTED|Overall Study||40
402043|NCT00131469|985409|P1|STARTED|Overall Study||38
402044|NCT00131456|985419|P2|NOT COMPLETED|Overall Study||20
402045|NCT00131456|985420|P1|NOT COMPLETED|Overall Study||19
402046|NCT00131456|985419|P2|COMPLETED|Overall Study||31
402047|NCT00131456|985420|P1|COMPLETED|Overall Study||33
402048|NCT00131456|985419|P2|STARTED|Overall Study||51
402049|NCT00131456|985420|P1|STARTED|Overall Study||52
402050|NCT00131378|985430|P4|NOT COMPLETED|Overall Study||9
402051|NCT00131378|985431|P3|NOT COMPLETED|Overall Study||10
402052|NCT00131378|985432|P2|NOT COMPLETED|Overall Study||18
402053|NCT00131378|985433|P1|NOT COMPLETED|Overall Study||11
402054|NCT00131378|985430|P4|COMPLETED|Overall Study||21
402055|NCT00131378|985431|P3|COMPLETED|Overall Study||22
402056|NCT00131378|985432|P2|COMPLETED|Overall Study||22
402057|NCT00131378|985433|P1|COMPLETED|Overall Study||29
402058|NCT00131378|985430|P4|STARTED|Overall Study||30
402059|NCT00131378|985431|P3|STARTED|Overall Study||32
402060|NCT00131378|985432|P2|STARTED|Overall Study||40
402061|NCT00131378|985433|P1|STARTED|Overall Study||40
402062|NCT00131365|985455|P1|NOT COMPLETED|Overall Study||4
402063|NCT00131365|985455|P1|COMPLETED|Overall Study||5
402064|NCT00131365|985455|P1|STARTED|Overall Study|Only safety data was reported due to early closure of the study due to device obsolescence.|9
402065|NCT00131352|985462|P2|NOT COMPLETED|Repeat Treatment Period||0
402066|NCT00131352|985463|P1|NOT COMPLETED|Repeat Treatment Period||2
402067|NCT00131352|985462|P2|COMPLETED|Repeat Treatment Period||0
402068|NCT00131352|985463|P1|COMPLETED|Repeat Treatment Period||158
402069|NCT00131352|985462|P2|STARTED|Repeat Treatment Period||0
402070|NCT00131352|985463|P1|STARTED|Repeat Treatment Period|Safety population: 77 Synvisc + 83 Saline Control participants from the Initial Treatment period.|160
402071|NCT00131352|985462|P2|NOT COMPLETED|Initial Treatment Period||12
402072|NCT00131352|985463|P1|NOT COMPLETED|Initial Treatment Period||9
402073|NCT00131352|985462|P2|COMPLETED|Initial Treatment Period||118
402074|NCT00131352|985463|P1|COMPLETED|Initial Treatment Period||114
402075|NCT00131352|985462|P2|Intent to Treat Population|Initial Treatment Period||129
402076|NCT00131352|985463|P1|Intent to Treat Population|Initial Treatment Period||124
402077|NCT00131352|985462|P2|STARTED|Initial Treatment Period|Safety population|130
402078|NCT00131352|985463|P1|STARTED|Initial Treatment Period|Safety population|123
402079|NCT00131248|985485|P2|NOT COMPLETED|Intervention 3 (4-day Course)||0
402080|NCT00131248|985486|P1|NOT COMPLETED|Intervention 3 (4-day Course)||0
402081|NCT00131248|985485|P2|COMPLETED|Intervention 3 (4-day Course)||9
402082|NCT00131248|985486|P1|COMPLETED|Intervention 3 (4-day Course)||8
402083|NCT00131248|985485|P2|STARTED|Intervention 3 (4-day Course)||9
402084|NCT00131248|985486|P1|STARTED|Intervention 3 (4-day Course)||8
402085|NCT00131248|985485|P2|NOT COMPLETED|Washout 2 (24 Hours)||0
402086|NCT00131248|985486|P1|NOT COMPLETED|Washout 2 (24 Hours)||0
402087|NCT00131248|985485|P2|COMPLETED|Washout 2 (24 Hours)||9
402088|NCT00131248|985486|P1|COMPLETED|Washout 2 (24 Hours)||8
402089|NCT00131248|985485|P2|STARTED|Washout 2 (24 Hours)||9
402090|NCT00131248|985486|P1|STARTED|Washout 2 (24 Hours)||8
402091|NCT00131248|985485|P2|NOT COMPLETED|Intervention 2 (7-day Course)||0
402092|NCT00131248|985486|P1|NOT COMPLETED|Intervention 2 (7-day Course)||0
402093|NCT00131248|985485|P2|COMPLETED|Intervention 2 (7-day Course)||9
402094|NCT00131248|985486|P1|COMPLETED|Intervention 2 (7-day Course)||8
402095|NCT00131248|985485|P2|STARTED|Intervention 2 (7-day Course)||9
402096|NCT00131248|985486|P1|STARTED|Intervention 2 (7-day Course)||8
402097|NCT00131248|985485|P2|NOT COMPLETED|Washout (24 Hour)||0
402098|NCT00131248|985486|P1|NOT COMPLETED|Washout (24 Hour)||0
402099|NCT00131248|985485|P2|COMPLETED|Washout (24 Hour)||9
402100|NCT00131248|985486|P1|COMPLETED|Washout (24 Hour)||8
402101|NCT00131248|985485|P2|STARTED|Washout (24 Hour)||9
402102|NCT00131248|985486|P1|STARTED|Washout (24 Hour)||8
402103|NCT00131248|985485|P2|NOT COMPLETED|Intervention 1 (3-day Course)||0
402104|NCT00131248|985486|P1|NOT COMPLETED|Intervention 1 (3-day Course)||1
402105|NCT00131248|985485|P2|COMPLETED|Intervention 1 (3-day Course)||9
402106|NCT00131248|985486|P1|COMPLETED|Intervention 1 (3-day Course)||8
402107|NCT00131248|985485|P2|STARTED|Intervention 1 (3-day Course)||9
402108|NCT00131248|985486|P1|STARTED|Intervention 1 (3-day Course)||9
402109|NCT00130923|985494|P2|NOT COMPLETED|Overall Study||14
402110|NCT00130923|985495|P1|NOT COMPLETED|Overall Study||13
402111|NCT00130923|985494|P2|COMPLETED|Overall Study||32
402112|NCT00130923|985495|P1|COMPLETED|Overall Study||36
402113|NCT00130923|985494|P2|STARTED|Overall Study||46
402114|NCT00130923|985495|P1|STARTED|Overall Study||49
402115|NCT00130832|985513|P2|NOT COMPLETED|Overall Study||17
402116|NCT00130832|985514|P1|NOT COMPLETED|Overall Study||16
402117|NCT00130832|985513|P2|COMPLETED|Overall Study|Those who received all 3 doses; last 2 blood draws ~42 days postdose 3 of RotaTeq™ and postdose OPV|346
402118|NCT00130832|985514|P1|COMPLETED|Overall Study|Those who received all 3 doses of concomitant RotaTeq™/ OPV with blood draw ~42 days postdose 3|356
402119|NCT00130832|985513|P2|STARTED|Overall Study||363
402120|NCT00130832|985514|P1|STARTED|Overall Study||372
402121|NCT00130793|985526|P2|NOT COMPLETED|Overall Study||4
402122|NCT00130793|985527|P1|NOT COMPLETED|Overall Study||3
402123|NCT00130793|985526|P2|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned VRC at Week 4|181
402124|NCT00130793|985527|P1|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned vaccination report card (VRC) at Week 4|180
402125|NCT00130793|985526|P2|Vaccinated|Overall Study||185
402126|NCT00130793|985527|P1|Vaccinated|Overall Study|One subject was allocated but not vaccinated.|182
402127|NCT00130793|985526|P2|STARTED|Overall Study||185
402128|NCT00130793|985527|P1|STARTED|Overall Study||183
402129|NCT00130780|985539|P2|NOT COMPLETED|Overall Study||0
402130|NCT00130780|985540|P1|NOT COMPLETED|Overall Study||0
402131|NCT00130780|985539|P2|COMPLETED|Overall Study||20
402132|NCT00130780|985540|P1|COMPLETED|Overall Study||51
402133|NCT00130780|985539|P2|STARTED|Overall Study||20
402134|NCT00130780|985540|P1|STARTED|Overall Study||51
402135|NCT00130728|985548|P2|NOT COMPLETED|Overall Study||213
402136|NCT00130728|985549|P1|NOT COMPLETED|Overall Study||211
402137|NCT00130728|985548|P2|COMPLETED|Overall Study||104
402138|NCT00130728|985549|P1|COMPLETED|Overall Study||108
402139|NCT00130728|985548|P2|Received Study Drug (Safety Population)|Overall Study||313
402140|NCT00130728|985549|P1|Received Study Drug (Safety Population)|Overall Study||313
402141|NCT00130728|985548|P2|STARTED|Overall Study||317
402142|NCT00130728|985549|P1|STARTED|Overall Study||319
402143|NCT00130689|985561|P1|NOT COMPLETED|Overall Study||43
402144|NCT00130689|985561|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
402145|NCT00130689|985561|P1|Treated|Overall Study||35
402146|NCT00130689|985561|P1|Eligible|Overall Study||37
402147|NCT00130689|985561|P1|STARTED|Overall Study||43
402148|NCT00130637|985565|P1|NOT COMPLETED|Overall Study||3
402149|NCT00130637|985565|P1|COMPLETED|Overall Study||3
402150|NCT00130637|985565|P1|STARTED|Overall Study||6
402151|NCT00130533|985572|P2|NOT COMPLETED|Overall Study||30
402152|NCT00130533|985573|P1|NOT COMPLETED|Overall Study||111
402153|NCT00130533|985572|P2|COMPLETED|Overall Study||398
402154|NCT00130533|985573|P1|COMPLETED|Overall Study||337
402155|NCT00130533|985572|P2|STARTED|Overall Study||428
402156|NCT00130533|985573|P1|STARTED|Overall Study||448
402157|NCT00130520|985585|P1|NOT COMPLETED|Overall Study||39
402158|NCT00130520|985585|P1|COMPLETED|Overall Study||1
402159|NCT00130520|985585|P1|Completion of at Least One Cycle|Overall Study||39
402160|NCT00130520|985585|P1|STARTED|Overall Study|85 women were screened for eligibility, 56 consented, 40 treated.|40
402161|NCT00130286|985595|P4|NOT COMPLETED|Overall Study||2
402162|NCT00130286|985596|P3|NOT COMPLETED|Overall Study||4
402163|NCT00130286|985597|P2|NOT COMPLETED|Overall Study||3
402164|NCT00130286|985598|P1|NOT COMPLETED|Overall Study||0
402165|NCT00130286|985595|P4|COMPLETED|Overall Study||17
402166|NCT00130286|985596|P3|COMPLETED|Overall Study||13
402167|NCT00130286|985597|P2|COMPLETED|Overall Study||16
402168|NCT00130286|985598|P1|COMPLETED|Overall Study||22
402169|NCT00130286|985595|P4|STARTED|Overall Study||19
402170|NCT00130286|985596|P3|STARTED|Overall Study||17
402171|NCT00130286|985597|P2|STARTED|Overall Study||19
402172|NCT00130286|985598|P1|STARTED|Overall Study||22
402173|NCT00130247|985618|P2|NOT COMPLETED|Overall Study||4
402174|NCT00130247|985619|P1|NOT COMPLETED|Overall Study||2
402175|NCT00130247|985618|P2|COMPLETED|Overall Study||194
402176|NCT00130247|985619|P1|COMPLETED|Overall Study||194
402177|NCT00130247|985618|P2|STARTED|Overall Study||198
402178|NCT00130247|985619|P1|STARTED|Overall Study||196
402179|NCT00130208|985637|P2|NOT COMPLETED|Washout Period (8 Weeks)||12
402180|NCT00130208|985638|P1|NOT COMPLETED|Washout Period (8 Weeks)||6
402181|NCT00130208|985637|P2|COMPLETED|Washout Period (8 Weeks)||490
402182|NCT00130208|985638|P1|COMPLETED|Washout Period (8 Weeks)||494
402183|NCT00130208|985637|P2|STARTED|Washout Period (8 Weeks)||502
402184|NCT00130208|985638|P1|STARTED|Washout Period (8 Weeks)||500
402185|NCT00130208|985637|P2|NOT COMPLETED|Maintenance Period (26 Weeks)||30
402186|NCT00130208|985638|P1|NOT COMPLETED|Maintenance Period (26 Weeks)||24
402187|NCT00130208|985637|P2|COMPLETED|Maintenance Period (26 Weeks)||502
402188|NCT00130208|985638|P1|COMPLETED|Maintenance Period (26 Weeks)||500
402189|NCT00130208|985637|P2|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||494
402190|NCT00130208|985638|P1|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||492
402191|NCT00130208|985637|P2|STARTED|Maintenance Period (26 Weeks)||532
402192|NCT00130208|985638|P1|STARTED|Maintenance Period (26 Weeks)||524
402193|NCT00130117|985650|P2|NOT COMPLETED|Overall Study||3
402194|NCT00130117|985651|P1|NOT COMPLETED|Overall Study||4
402195|NCT00130117|985650|P2|COMPLETED|Overall Study||6
402196|NCT00130117|985651|P1|COMPLETED|Overall Study||7
402197|NCT00130117|985650|P2|STARTED|Overall Study||9
402198|NCT00130117|985651|P1|STARTED|Overall Study||11
402199|NCT00130039|985674|P2|NOT COMPLETED|Overall Study||18
402200|NCT00130039|985675|P1|NOT COMPLETED|Overall Study||30
402201|NCT00130039|985674|P2|COMPLETED|Overall Study|full analysis set|207
402202|NCT00130039|985675|P1|COMPLETED|Overall Study|full analysis set|202
402203|NCT00130039|985674|P2|STARTED|Overall Study||225
402204|NCT00130039|985675|P1|STARTED|Overall Study||232
402205|NCT00129974|985691|P1|NOT COMPLETED|Overall Study||1
402206|NCT00129974|985691|P1|COMPLETED|Overall Study||0
402207|NCT00129974|985691|P1|STARTED|Overall Study||1
402208|NCT00129961|985698|P2|NOT COMPLETED|Overall Study||23
402209|NCT00129961|985699|P1|NOT COMPLETED|Overall Study||19
402210|NCT00129961|985698|P2|COMPLETED|Overall Study||24
402211|NCT00129961|985699|P1|COMPLETED|Overall Study||20
402212|NCT00129961|985698|P2|STARTED|Overall Study||47
402213|NCT00129961|985699|P1|STARTED|Overall Study||39
402214|NCT00129935|985735|P2|NOT COMPLETED|Overall Study||92
402215|NCT00129935|985736|P1|NOT COMPLETED|Overall Study||36
402216|NCT00129935|985735|P2|COMPLETED|Overall Study|1 patient crossed from arm B to A by error.|623
402217|NCT00129935|985736|P1|COMPLETED|Overall Study|2 patients crossed from arm A to B by error, and 1 patient received other treatment by error.|633
402218|NCT00129935|985735|P2|STARTED|Overall Study||715
402219|NCT00129935|985736|P1|STARTED|Overall Study||669
402220|NCT00129766|985754|P2|NOT COMPLETED|Overall Study||59
402221|NCT00129766|985755|P1|NOT COMPLETED|Overall Study||60
402222|NCT00129766|985754|P2|COMPLETED|Overall Study||3270
402223|NCT00129766|985755|P1|COMPLETED|Overall Study||3246
402224|NCT00129766|985754|P2|STARTED|Overall Study||3329
402225|NCT00129766|985755|P1|STARTED|Overall Study||3306
402226|NCT00129740|985793|P1|NOT COMPLETED|Overall Study||0
402227|NCT00129740|985793|P1|COMPLETED|Overall Study||148
402228|NCT00129740|985793|P1|STARTED|Overall Study||148
402229|NCT00129727|985798|P1|NOT COMPLETED|Overall Study||5
402230|NCT00129727|985798|P1|COMPLETED|Overall Study||57
402231|NCT00129727|985798|P1|STARTED|Overall Study||62
402232|NCT00129623|985806|P2|NOT COMPLETED|Overall Study||12
402233|NCT00129623|985807|P1|NOT COMPLETED|Overall Study||10
402234|NCT00129623|985806|P2|COMPLETED|Overall Study||65
402235|NCT00129623|985807|P1|COMPLETED|Overall Study||73
402236|NCT00129623|985806|P2|Intent-to-treat (ITT)/ Safety Population|Overall Study||77
402237|NCT00129623|985807|P1|Intent-to-treat (ITT)/ Safety Population|Overall Study||83
402238|NCT00129623|985806|P2|STARTED|Overall Study||77
402239|NCT00129623|985807|P1|STARTED|Overall Study||83
402240|NCT00129545|985832|P3|NOT COMPLETED|Overall Study||111
402241|NCT00129545|985833|P2|NOT COMPLETED|Overall Study||164
402242|NCT00129545|985834|P1|NOT COMPLETED|Overall Study||26
402243|NCT00129545|985832|P3|COMPLETED|Overall Study||133
402244|NCT00129545|985833|P2|COMPLETED|Overall Study||299
402245|NCT00129545|985834|P1|COMPLETED|Overall Study||67
402246|NCT00129545|985832|P3|STARTED|Overall Study||244
402247|NCT00129545|985833|P2|STARTED|Overall Study|2:1 randomization WATCHMAN to warfarin|463
402248|NCT00129545|985834|P1|STARTED|Overall Study||93
402249|NCT00129480|985846|P2|NOT COMPLETED|Overall Study||0
402250|NCT00129480|985847|P1|NOT COMPLETED|Overall Study||0
402251|NCT00129480|985846|P2|COMPLETED|Overall Study||214
402252|NCT00129480|985847|P1|COMPLETED|Overall Study||187
402253|NCT00129480|985846|P2|STARTED|Overall Study||214
402254|NCT00129480|985847|P1|STARTED|Overall Study||187
402255|NCT00129467|985863|P2|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
402256|NCT00129467|985864|P1|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
402257|NCT00129467|985863|P2|COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
402258|NCT00129467|985864|P1|COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
402259|NCT00129467|985863|P2|STARTED|Open Label for SSRI+Methylphenidate Arm||0
402260|NCT00129467|985864|P1|STARTED|Open Label for SSRI+Methylphenidate Arm|Eligible if in methylphenidate arm & had 50% reduction in Montgomery-Asberg Depression Rating score|4
402261|NCT00129467|985863|P2|NOT COMPLETED|Received Intervention||4
402262|NCT00129467|985864|P1|NOT COMPLETED|Received Intervention||6
402263|NCT00129467|985863|P2|COMPLETED|Received Intervention||13
402264|NCT00129467|985864|P1|COMPLETED|Received Intervention||9
402265|NCT00129467|985863|P2|STARTED|Received Intervention||17
402266|NCT00129467|985864|P1|STARTED|Received Intervention||15
402267|NCT00129441|985872|P2|NOT COMPLETED|Overall Study||0
402268|NCT00129441|985873|P1|NOT COMPLETED|Overall Study||0
402269|NCT00129441|985872|P2|COMPLETED|Overall Study||6
402270|NCT00129441|985873|P1|COMPLETED|Overall Study||9
402271|NCT00129441|985872|P2|Year 1, Visit 8|Overall Study||6
402272|NCT00129441|985873|P1|Year 1, Visit 8|Overall Study||9
402273|NCT00129441|985872|P2|Week 26, Visit 7|Overall Study||6
402274|NCT00129441|985873|P1|Week 26, Visit 7|Overall Study||9
402275|NCT00129441|985872|P2|Week 5, Visit 6|Overall Study||6
402276|NCT00129441|985873|P1|Week 5, Visit 6|Overall Study||9
402277|NCT00129441|985872|P2|Week 4, Visit 5|Overall Study||6
402278|NCT00129441|985873|P1|Week 4, Visit 5|Overall Study||9
402279|NCT00129441|985872|P2|Week 3, Visit 4|Overall Study||6
402280|NCT00129441|985873|P1|Week 3, Visit 4|Overall Study||9
402281|NCT00129441|985872|P2|Week 2, Visit 3|Overall Study||6
402282|NCT00129441|985873|P1|Week 2, Visit 3|Overall Study||9
402283|NCT00129441|985872|P2|Week 1, Visit 2|Overall Study||6
402284|NCT00129441|985873|P1|Week 1, Visit 2|Overall Study||9
402285|NCT00129441|985872|P2|Baseline, Visit 1|Overall Study||6
402286|NCT00129441|985873|P1|Baseline, Visit 1|Overall Study|Baseline # only includes those who completed 4-week trial (one L-830982 subject did not complete).|9
402287|NCT00129441|985872|P2|STARTED|Overall Study||6
402288|NCT00129441|985873|P1|STARTED|Overall Study||9
402289|NCT00129402|985895|P7|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||6
402290|NCT00129402|985896|P6|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
402291|NCT00129402|985897|P5|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
402292|NCT00129402|985898|P4|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
402293|NCT00129402|985899|P3|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
402294|NCT00129402|985900|P2|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
402295|NCT00129402|985901|P1|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
402296|NCT00129402|985895|P7|COMPLETED|Start Period3 to End Period3(Week 34-53)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|222
402297|NCT00129402|985896|P6|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
402298|NCT00129402|985897|P5|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
402299|NCT00129402|985898|P4|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
402300|NCT00129402|985899|P3|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
402301|NCT00129402|985900|P2|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
402302|NCT00129402|985901|P1|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
402303|NCT00129402|985895|P7|STARTED|Start Period3 to End Period3(Week 34-53)|In Period 3, all subjects from Period 1 and Period 2 were combined into one treatment group.|228
402304|NCT00129402|985896|P6|STARTED|Start Period3 to End Period3(Week 34-53)||0
402305|NCT00129402|985897|P5|STARTED|Start Period3 to End Period3(Week 34-53)||0
402306|NCT00129402|985898|P4|STARTED|Start Period3 to End Period3(Week 34-53)||0
402307|NCT00129402|985899|P3|STARTED|Start Period3 to End Period3(Week 34-53)||0
402308|NCT00129402|985900|P2|STARTED|Start Period3 to End Period3(Week 34-53)||0
402309|NCT00129402|985901|P1|STARTED|Start Period3 to End Period3(Week 34-53)||0
402310|NCT00129402|985895|P7|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
402311|NCT00129402|985896|P6|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||5
402312|NCT00129402|985897|P5|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
402313|NCT00129402|985898|P4|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
402314|NCT00129402|985899|P3|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||8
402315|NCT00129402|985900|P2|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
402316|NCT00129402|985901|P1|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
402317|NCT00129402|985895|P7|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
402318|NCT00129402|985896|P6|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|113
402319|NCT00129402|985897|P5|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
402320|NCT00129402|985898|P4|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
402321|NCT00129402|985899|P3|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|114
402322|NCT00129402|985900|P2|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
402323|NCT00129402|985901|P1|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
402324|NCT00129402|985895|P7|STARTED|Start Period2 to End Period2 (Week 7-33)||0
402325|NCT00129402|985896|P6|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received simvastatin monotherapy|118
402326|NCT00129402|985897|P5|STARTED|Start Period2 to End Period2 (Week 7-33)||0
402327|NCT00129402|985898|P4|STARTED|Start Period2 to End Period2 (Week 7-33)||0
402328|NCT00129402|985899|P3|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received ezetimibe with simvastatin|122
402329|NCT00129402|985900|P2|STARTED|Start Period2 to End Period2 (Week 7-33)||0
402330|NCT00129402|985901|P1|STARTED|Start Period2 to End Period2 (Week 7-33)||0
402331|NCT00129402|985895|P7|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
402332|NCT00129402|985896|P6|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
402333|NCT00129402|985897|P5|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
402334|NCT00129402|985898|P4|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
402335|NCT00129402|985899|P3|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
402336|NCT00129402|985900|P2|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
402337|NCT00129402|985901|P1|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
402338|NCT00129402|985895|P7|COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
402339|NCT00129402|985896|P6|COMPLETED|Start Period1 to End Period1 (Week 1-6)||40
402340|NCT00129402|985897|P5|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
402341|NCT00129402|985898|P4|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
402342|NCT00129402|985899|P3|COMPLETED|Start Period1 to End Period1 (Week 1-6)||41
402343|NCT00129402|985900|P2|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
402344|NCT00129402|985901|P1|COMPLETED|Start Period1 to End Period1 (Week 1-6)||43
402345|NCT00129402|985895|P7|STARTED|Start Period1 to End Period1 (Week 1-6)||0
402346|NCT00129402|985896|P6|STARTED|Start Period1 to End Period1 (Week 1-6)||42
402347|NCT00129402|985897|P5|STARTED|Start Period1 to End Period1 (Week 1-6)||40
402348|NCT00129402|985898|P4|STARTED|Start Period1 to End Period1 (Week 1-6)||40
402349|NCT00129402|985899|P3|STARTED|Start Period1 to End Period1 (Week 1-6)||43
402350|NCT00129402|985900|P2|STARTED|Start Period1 to End Period1 (Week 1-6)||40
402351|NCT00129402|985901|P1|STARTED|Start Period1 to End Period1 (Week 1-6)||43
402352|NCT00129389|985920|P2|NOT COMPLETED|Overall Study||140
402353|NCT00129389|985921|P1|NOT COMPLETED|Overall Study||33
402354|NCT00129389|985920|P2|COMPLETED|Overall Study|16 patients were crossed from arm B to A by error. 1 patient was crossed from arm A to B by error.|811
402355|NCT00129389|985921|P1|COMPLETED|Overall Study|1 patient was crossed from arm A to B by error. 16 patients were crossed from arm B, to A by error.|941
402356|NCT00129389|985920|P2|STARTED|Overall Study||951
402357|NCT00129389|985921|P1|STARTED|Overall Study||974
402358|NCT00129376|985929|P1|NOT COMPLETED|Overall Study||2
402359|NCT00129376|985929|P1|COMPLETED|Overall Study||61
402360|NCT00129376|985929|P1|STARTED|Overall Study||63
402361|NCT00129311|985939|P2|NOT COMPLETED|Overall Study||19
402362|NCT00129311|985940|P1|NOT COMPLETED|Overall Study||12
402363|NCT00129311|985939|P2|COMPLETED|Overall Study||31
402364|NCT00129311|985940|P1|COMPLETED|Overall Study||39
402365|NCT00129311|985939|P2|STARTED|Overall Study||50
402366|NCT00129311|985940|P1|STARTED|Overall Study||51
402367|NCT00129285|985951|P3|NOT COMPLETED|Overall Study||38
402368|NCT00129285|985952|P2|NOT COMPLETED|Overall Study||27
402369|NCT00129285|985953|P1|NOT COMPLETED|Overall Study||25
402370|NCT00129285|985951|P3|COMPLETED|Overall Study||37
402371|NCT00129285|985952|P2|COMPLETED|Overall Study||43
402372|NCT00129285|985953|P1|COMPLETED|Overall Study||40
402373|NCT00129285|985951|P3|STARTED|Overall Study||75
402374|NCT00129285|985952|P2|STARTED|Overall Study||70
402375|NCT00129285|985953|P1|STARTED|Overall Study||65
402376|NCT00129272|985969|P2|NOT COMPLETED|Overall Study||22
402377|NCT00129272|985970|P1|NOT COMPLETED|Overall Study||17
402378|NCT00129272|985969|P2|COMPLETED|Overall Study||51
402379|NCT00129272|985970|P1|COMPLETED|Overall Study||54
402380|NCT00129272|985969|P2|STARTED|Overall Study||73
402381|NCT00129272|985970|P1|STARTED|Overall Study||71
402382|NCT00129259|985980|P2|NOT COMPLETED|Overall Study||3
402383|NCT00129259|985981|P1|NOT COMPLETED|Overall Study||3
402384|NCT00129259|985980|P2|COMPLETED|Overall Study||22
402385|NCT00129259|985981|P1|COMPLETED|Overall Study||49
402386|NCT00129259|985980|P2|Received All or Part of Cycle 2|Overall Study||0
402387|NCT00129259|985981|P1|Received All or Part of Cycle 2|Overall Study||40
402388|NCT00129259|985980|P2|Received All or Part of Cycle 1|Overall Study||0
402389|NCT00129259|985981|P1|Received All or Part of Cycle 1|Overall Study||52
402390|NCT00129259|985980|P2|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|25
402391|NCT00129259|985981|P1|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|52
402392|NCT00129246|985993|P2|NOT COMPLETED|Overall Study||0
402393|NCT00129246|985994|P1|NOT COMPLETED|Overall Study||0
402394|NCT00129246|985993|P2|COMPLETED|Overall Study||20
402395|NCT00129246|985994|P1|COMPLETED|Overall Study||20
402396|NCT00129246|985993|P2|STARTED|Overall Study||20
402397|NCT00129246|985994|P1|STARTED|Overall Study||20
402398|NCT00129220|986009|P3|NOT COMPLETED|Study Period III||10
402399|NCT00129220|986010|P2|NOT COMPLETED|Study Period III||1
402400|NCT00129220|986011|P1|NOT COMPLETED|Study Period III||13
402401|NCT00129220|986009|P3|COMPLETED|Study Period III||42
402402|NCT00129220|986010|P2|COMPLETED|Study Period III||7
402403|NCT00129220|986011|P1|COMPLETED|Study Period III||59
402404|NCT00129220|986009|P3|STARTED|Study Period III||52
402405|NCT00129220|986010|P2|STARTED|Study Period III||8
402406|NCT00129220|986011|P1|STARTED|Study Period III||72
402407|NCT00129220|986009|P3|NOT COMPLETED|Study Period II||47
402408|NCT00129220|986010|P2|NOT COMPLETED|Study Period II||12
402409|NCT00129220|986011|P1|NOT COMPLETED|Study Period II||33
402410|NCT00129220|986009|P3|COMPLETED|Study Period II||52
402411|NCT00129220|986010|P2|COMPLETED|Study Period II||8
402412|NCT00129220|986011|P1|COMPLETED|Study Period II||72
402413|NCT00129220|986009|P3|Received at Least One Dose of Study Drug|Study Period II||97
402414|NCT00129220|986010|P2|Received at Least One Dose of Study Drug|Study Period II||20
402415|NCT00129220|986011|P1|Received at Least One Dose of Study Drug|Study Period II||104
402416|NCT00129220|986009|P3|STARTED|Study Period II||99
402417|NCT00129220|986010|P2|STARTED|Study Period II||20
402418|NCT00129220|986011|P1|STARTED|Study Period II||105
402419|NCT00129129|986051|P5|NOT COMPLETED|Fourth Dose Phase||6
402420|NCT00129129|986052|P4|NOT COMPLETED|Fourth Dose Phase||4
402421|NCT00129129|986053|P3|NOT COMPLETED|Fourth Dose Phase||0
402422|NCT00129129|986054|P2|NOT COMPLETED|Fourth Dose Phase||0
402423|NCT00129129|986055|P1|NOT COMPLETED|Fourth Dose Phase||4
402424|NCT00129129|986051|P5|COMPLETED|Fourth Dose Phase||124
402425|NCT00129129|986052|P4|COMPLETED|Fourth Dose Phase||128
402426|NCT00129129|986053|P3|COMPLETED|Fourth Dose Phase||0
402427|NCT00129129|986054|P2|COMPLETED|Fourth Dose Phase||0
402428|NCT00129129|986055|P1|COMPLETED|Fourth Dose Phase||232
402429|NCT00129129|986051|P5|STARTED|Fourth Dose Phase||130
402430|NCT00129129|986052|P4|STARTED|Fourth Dose Phase||132
402431|NCT00129129|986053|P3|STARTED|Fourth Dose Phase||0
402432|NCT00129129|986054|P2|STARTED|Fourth Dose Phase||0
402433|NCT00129129|986055|P1|STARTED|Fourth Dose Phase||236
402434|NCT00129129|986051|P5|NOT COMPLETED|Primary Phase||0
402435|NCT00129129|986052|P4|NOT COMPLETED|Primary Phase||0
402436|NCT00129129|986053|P3|NOT COMPLETED|Primary Phase||0
402437|NCT00129129|986054|P2|NOT COMPLETED|Primary Phase||25
402438|NCT00129129|986055|P1|NOT COMPLETED|Primary Phase||25
402439|NCT00129129|986051|P5|COMPLETED|Primary Phase||0
402440|NCT00129129|986052|P4|COMPLETED|Primary Phase||0
402441|NCT00129129|986053|P3|COMPLETED|Primary Phase||150
402442|NCT00129129|986054|P2|COMPLETED|Primary Phase||294
402443|NCT00129129|986055|P1|COMPLETED|Primary Phase||262
402444|NCT00129129|986051|P5|STARTED|Primary Phase||0
402445|NCT00129129|986052|P4|STARTED|Primary Phase||0
402446|NCT00129129|986053|P3|STARTED|Primary Phase||150
402447|NCT00129129|986054|P2|STARTED|Primary Phase||319
402448|NCT00129129|986055|P1|STARTED|Primary Phase||287
402449|NCT00129116|986262|P5|NOT COMPLETED|Booster Phase||1
402450|NCT00129116|986263|P4|NOT COMPLETED|Booster Phase||0
402451|NCT00129116|986264|P3|NOT COMPLETED|Booster Phase||0
402452|NCT00129116|986265|P2|NOT COMPLETED|Booster Phase||0
402453|NCT00129116|986266|P1|NOT COMPLETED|Booster Phase||2
402454|NCT00129116|986262|P5|COMPLETED|Booster Phase||43
402455|NCT00129116|986263|P4|COMPLETED|Booster Phase||44
402456|NCT00129116|986264|P3|COMPLETED|Booster Phase||44
402457|NCT00129116|986265|P2|COMPLETED|Booster Phase||42
402458|NCT00129116|986266|P1|COMPLETED|Booster Phase||45
402459|NCT00129116|986262|P5|STARTED|Booster Phase||44
402460|NCT00129116|986263|P4|STARTED|Booster Phase||44
402461|NCT00129116|986264|P3|STARTED|Booster Phase||44
402462|NCT00129116|986265|P2|STARTED|Booster Phase||42
402463|NCT00129116|986266|P1|STARTED|Booster Phase||47
402464|NCT00129116|986262|P5|NOT COMPLETED|Primary Phase||1
402465|NCT00129116|986263|P4|NOT COMPLETED|Primary Phase||1
402466|NCT00129116|986264|P3|NOT COMPLETED|Primary Phase||1
402467|NCT00129116|986265|P2|NOT COMPLETED|Primary Phase||4
402468|NCT00129116|986266|P1|NOT COMPLETED|Primary Phase||2
402469|NCT00129116|986262|P5|COMPLETED|Primary Phase||76
402470|NCT00129116|986263|P4|COMPLETED|Primary Phase||77
402471|NCT00129116|986264|P3|COMPLETED|Primary Phase||77
402472|NCT00129116|986265|P2|COMPLETED|Primary Phase||73
402473|NCT00129116|986266|P1|COMPLETED|Primary Phase||76
402474|NCT00129116|986262|P5|STARTED|Primary Phase||77
402475|NCT00129116|986263|P4|STARTED|Primary Phase||78
402476|NCT00129116|986264|P3|STARTED|Primary Phase||78
402477|NCT00129116|986265|P2|STARTED|Primary Phase||77
402478|NCT00129116|986266|P1|STARTED|Primary Phase||78
402479|NCT00128921|986531|P3|NOT COMPLETED|Overall Study||0
402480|NCT00128921|986532|P2|NOT COMPLETED|Overall Study||5
402481|NCT00128921|986533|P1|NOT COMPLETED|Overall Study||5
402482|NCT00128921|986531|P3|COMPLETED|Overall Study||0
402483|NCT00128921|986532|P2|COMPLETED|Overall Study||3
402484|NCT00128921|986533|P1|COMPLETED|Overall Study||5
402485|NCT00128921|986531|P3|Received Bortezomib|Overall Study||0
402486|NCT00128921|986532|P2|Received Bortezomib|Overall Study||6
402487|NCT00128921|986533|P1|Received Bortezomib|Overall Study||10
402488|NCT00128921|986531|P3|STARTED|Overall Study||0
402489|NCT00128921|986532|P2|STARTED|Overall Study||8
402490|NCT00128921|986533|P1|STARTED|Overall Study||10
402491|NCT00128830|986550|P1|NOT COMPLETED|Overall Study||72
402492|NCT00128830|986550|P1|COMPLETED|Overall Study||139
402493|NCT00128830|986550|P1|STARTED|Overall Study||211
402494|NCT00128713|986568|P3|NOT COMPLETED|Overall Study||0
402495|NCT00128713|986569|P2|NOT COMPLETED|Overall Study||0
402496|NCT00128713|986570|P1|NOT COMPLETED|Overall Study||0
402497|NCT00128713|986568|P3|COMPLETED|Overall Study||449
402498|NCT00128713|986569|P2|COMPLETED|Overall Study||449
402499|NCT00128713|986570|P1|COMPLETED|Overall Study||453
402500|NCT00128713|986568|P3|STARTED|Overall Study||449
402501|NCT00128713|986569|P2|STARTED|Overall Study||449
402502|NCT00128713|986570|P1|STARTED|Overall Study||453
402503|NCT00128661|986592|P2|NOT COMPLETED|Overall Study||258
402504|NCT00128661|986593|P1|NOT COMPLETED|Overall Study||274
402505|NCT00128661|986592|P2|COMPLETED|Overall Study||3481
402506|NCT00128661|986593|P1|COMPLETED|Overall Study||3453
402507|NCT00128661|986592|P2|STARTED|Overall Study||3739
402508|NCT00128661|986593|P1|STARTED|Overall Study||3727
402509|NCT00128492|986639|P2|NOT COMPLETED|Overall Study||59
402510|NCT00128492|986640|P1|NOT COMPLETED|Overall Study||20
402511|NCT00128492|986639|P2|COMPLETED|Overall Study||130
402512|NCT00128492|986640|P1|COMPLETED|Overall Study||65
402513|NCT00128492|986639|P2|STARTED|Overall Study||189
402514|NCT00128492|986640|P1|STARTED|Overall Study||85
402515|NCT00128401|986700|P2|NOT COMPLETED|Overall Study||4
402516|NCT00128401|986701|P1|NOT COMPLETED|Overall Study||6
402517|NCT00128401|986700|P2|COMPLETED|Overall Study||15
402518|NCT00128401|986701|P1|COMPLETED|Overall Study||14
402519|NCT00128401|986700|P2|STARTED|Overall Study||19
402520|NCT00128401|986701|P1|STARTED|Overall Study||20
402521|NCT00128219|986712|P2|NOT COMPLETED|Overall Study||71
402522|NCT00128219|986713|P1|NOT COMPLETED|Overall Study||69
402523|NCT00128219|986712|P2|COMPLETED|Overall Study||263
402524|NCT00128219|986713|P1|COMPLETED|Overall Study||264
402525|NCT00128219|986712|P2|STARTED|Overall Study||334
402526|NCT00128219|986713|P1|STARTED|Overall Study||333
402527|NCT00128206|986797|P2|NOT COMPLETED|Overall Study||120
402528|NCT00128206|986798|P1|NOT COMPLETED|Overall Study||137
402529|NCT00128206|986797|P2|COMPLETED|Overall Study||60
402530|NCT00128206|986798|P1|COMPLETED|Overall Study||47
402531|NCT00128206|986797|P2|STARTED|Overall Study||180
402532|NCT00128206|986798|P1|STARTED|Overall Study||184
402533|NCT00128193|986816|P12|NOT COMPLETED|Overall Study||2
402534|NCT00128193|986817|P11|NOT COMPLETED|Overall Study||3
402535|NCT00128193|986818|P10|NOT COMPLETED|Overall Study||2
402536|NCT00128193|986819|P9|NOT COMPLETED|Overall Study||2
402537|NCT00128193|986820|P8|NOT COMPLETED|Overall Study||0
402538|NCT00128193|986821|P7|NOT COMPLETED|Overall Study||4
402539|NCT00128193|986822|P6|NOT COMPLETED|Overall Study||3
402540|NCT00128193|986823|P5|NOT COMPLETED|Overall Study||2
402541|NCT00128193|986824|P4|NOT COMPLETED|Overall Study||1
402542|NCT00128193|986825|P3|NOT COMPLETED|Overall Study||3
402543|NCT00128193|986826|P2|NOT COMPLETED|Overall Study||0
402544|NCT00128193|986827|P1|NOT COMPLETED|Overall Study||0
402545|NCT00128193|986816|P12|COMPLETED|Overall Study||18
402546|NCT00128193|986817|P11|COMPLETED|Overall Study||17
402547|NCT00128193|986818|P10|COMPLETED|Overall Study||18
402548|NCT00128193|986819|P9|COMPLETED|Overall Study||18
402549|NCT00128193|986820|P8|COMPLETED|Overall Study||20
402550|NCT00128193|986821|P7|COMPLETED|Overall Study||16
402551|NCT00128193|986822|P6|COMPLETED|Overall Study||17
402552|NCT00128193|986823|P5|COMPLETED|Overall Study||18
402553|NCT00128193|986824|P4|COMPLETED|Overall Study||44
402554|NCT00128193|986825|P3|COMPLETED|Overall Study||42
402555|NCT00128193|986826|P2|COMPLETED|Overall Study||5
402556|NCT00128193|986827|P1|COMPLETED|Overall Study||5
402557|NCT00128193|986816|P12|STARTED|Overall Study||20
402558|NCT00128193|986817|P11|STARTED|Overall Study||20
402559|NCT00128193|986818|P10|STARTED|Overall Study||20
402560|NCT00128193|986819|P9|STARTED|Overall Study||20
402561|NCT00128193|986820|P8|STARTED|Overall Study||20
402562|NCT00128193|986821|P7|STARTED|Overall Study||20
402563|NCT00128193|986822|P6|STARTED|Overall Study||20
402564|NCT00128193|986823|P5|STARTED|Overall Study||20
402565|NCT00128193|986824|P4|STARTED|Overall Study||45
402566|NCT00128193|986825|P3|STARTED|Overall Study||45
402567|NCT00128193|986826|P2|STARTED|Overall Study||5
402568|NCT00128193|986827|P1|STARTED|Overall Study||5
402569|NCT00128180|987063|P2|NOT COMPLETED|Overall Study||0
402570|NCT00128180|987064|P1|NOT COMPLETED|Overall Study||0
402571|NCT00128180|987063|P2|COMPLETED|Overall Study||34
402572|NCT00128180|987064|P1|COMPLETED|Overall Study||32
402573|NCT00128180|987063|P2|STARTED|Overall Study||34
402574|NCT00128180|987064|P1|STARTED|Overall Study||32
402575|NCT00127933|987090|P2|NOT COMPLETED|Overall Study||0
402576|NCT00127933|987091|P1|NOT COMPLETED|Overall Study||1
402577|NCT00127933|987090|P2|COMPLETED|Overall Study||34
402578|NCT00127933|987091|P1|COMPLETED|Overall Study||122
402579|NCT00127933|987090|P2|Postoperative|Overall Study||27
402580|NCT00127933|987091|P1|Postoperative|Overall Study||98
402581|NCT00127933|987090|P2|Quality of Life Population|Overall Study||33
402582|NCT00127933|987091|P1|Quality of Life Population|Overall Study||118
402583|NCT00127933|987090|P2|Safety Population|Overall Study||34
402584|NCT00127933|987091|P1|Safety Population|Overall Study||122
402585|NCT00127933|987090|P2|Clinical Response|Overall Study||34
402586|NCT00127933|987091|P1|Clinical Response|Overall Study||122
402587|NCT00127933|987090|P2|Pathological Response|Overall Study||28
402588|NCT00127933|987091|P1|Pathological Response|Overall Study||101
402589|NCT00127933|987090|P2|STARTED|Overall Study||34
402590|NCT00127933|987091|P1|STARTED|Overall Study||123
402591|NCT00127855|987112|P5|NOT COMPLETED|Polysaccharide Challenge Dose||0
402592|NCT00127855|987113|P4|NOT COMPLETED|Polysaccharide Challenge Dose||0
402593|NCT00127855|987114|P3|NOT COMPLETED|Polysaccharide Challenge Dose||0
402594|NCT00127855|987115|P2|NOT COMPLETED|Polysaccharide Challenge Dose||0
402595|NCT00127855|987116|P1|NOT COMPLETED|Polysaccharide Challenge Dose||0
402596|NCT00127855|987112|P5|COMPLETED|Polysaccharide Challenge Dose||77
402597|NCT00127855|987113|P4|COMPLETED|Polysaccharide Challenge Dose||81
402598|NCT00127855|987114|P3|COMPLETED|Polysaccharide Challenge Dose||77
402599|NCT00127855|987115|P2|COMPLETED|Polysaccharide Challenge Dose||79
402600|NCT00127855|987116|P1|COMPLETED|Polysaccharide Challenge Dose||80
402601|NCT00127855|987112|P5|STARTED|Polysaccharide Challenge Dose||77
402602|NCT00127855|987113|P4|STARTED|Polysaccharide Challenge Dose||81
402603|NCT00127855|987114|P3|STARTED|Polysaccharide Challenge Dose||77
402604|NCT00127855|987115|P2|STARTED|Polysaccharide Challenge Dose||79
402605|NCT00127855|987116|P1|STARTED|Polysaccharide Challenge Dose||80
402606|NCT00127855|987112|P5|NOT COMPLETED|Primary Vaccination Course||4
402607|NCT00127855|987113|P4|NOT COMPLETED|Primary Vaccination Course||0
402608|NCT00127855|987114|P3|NOT COMPLETED|Primary Vaccination Course||2
402609|NCT00127855|987115|P2|NOT COMPLETED|Primary Vaccination Course||1
402610|NCT00127855|987116|P1|NOT COMPLETED|Primary Vaccination Course||2
402611|NCT00127855|987112|P5|COMPLETED|Primary Vaccination Course||78
402612|NCT00127855|987113|P4|COMPLETED|Primary Vaccination Course||81
402613|NCT00127855|987114|P3|COMPLETED|Primary Vaccination Course||78
402614|NCT00127855|987115|P2|COMPLETED|Primary Vaccination Course||81
402615|NCT00127855|987116|P1|COMPLETED|Primary Vaccination Course||80
402616|NCT00127855|987112|P5|STARTED|Primary Vaccination Course||82
402617|NCT00127855|987113|P4|STARTED|Primary Vaccination Course||81
402618|NCT00127855|987114|P3|STARTED|Primary Vaccination Course||80
402619|NCT00127855|987115|P2|STARTED|Primary Vaccination Course||82
402620|NCT00127855|987116|P1|STARTED|Primary Vaccination Course||82
402621|NCT00127842|987298|P1|NOT COMPLETED|Overall Study||39
402622|NCT00127842|987298|P1|COMPLETED|Overall Study||71
402623|NCT00127842|987298|P1|STARTED|Overall Study||110
402624|NCT00127803|987316|P4|NOT COMPLETED|Overall Study||1
402625|NCT00127803|987317|P3|NOT COMPLETED|Overall Study||0
402626|NCT00127803|987318|P2|NOT COMPLETED|Overall Study||0
402627|NCT00127803|987319|P1|NOT COMPLETED|Overall Study||3
402628|NCT00127803|987316|P4|COMPLETED|Overall Study||11
402629|NCT00127803|987317|P3|COMPLETED|Overall Study||12
402630|NCT00127803|987318|P2|COMPLETED|Overall Study||13
402631|NCT00127803|987319|P1|COMPLETED|Overall Study||10
402632|NCT00127803|987316|P4|STARTED|Overall Study||12
402633|NCT00127803|987317|P3|STARTED|Overall Study||12
402634|NCT00127803|987318|P2|STARTED|Overall Study||13
402635|NCT00127803|987319|P1|STARTED|Overall Study||13
402636|NCT00127790|987341|P4|NOT COMPLETED|Post-Treatment||0
402637|NCT00127790|987342|P3|NOT COMPLETED|Post-Treatment||0
402638|NCT00127790|987343|P2|NOT COMPLETED|Post-Treatment||0
402639|NCT00127790|987344|P1|NOT COMPLETED|Post-Treatment||0
402640|NCT00127790|987341|P4|COMPLETED|Post-Treatment||4
402641|NCT00127790|987342|P3|COMPLETED|Post-Treatment||6
402642|NCT00127790|987343|P2|COMPLETED|Post-Treatment||5
402643|NCT00127790|987344|P1|COMPLETED|Post-Treatment||6
402644|NCT00127790|987341|P4|STARTED|Post-Treatment||4
402645|NCT00127790|987342|P3|STARTED|Post-Treatment||6
402646|NCT00127790|987343|P2|STARTED|Post-Treatment||5
402647|NCT00127790|987344|P1|STARTED|Post-Treatment||6
402648|NCT00127790|987341|P4|NOT COMPLETED|Pre-Treatment||0
402649|NCT00127790|987342|P3|NOT COMPLETED|Pre-Treatment||0
402650|NCT00127790|987343|P2|NOT COMPLETED|Pre-Treatment||0
402651|NCT00127790|987344|P1|NOT COMPLETED|Pre-Treatment||0
402652|NCT00127790|987341|P4|COMPLETED|Pre-Treatment||4
402653|NCT00127790|987342|P3|COMPLETED|Pre-Treatment||6
402654|NCT00127790|987343|P2|COMPLETED|Pre-Treatment||5
402655|NCT00127790|987344|P1|COMPLETED|Pre-Treatment||6
402656|NCT00127790|987341|P4|STARTED|Pre-Treatment||4
402657|NCT00127790|987342|P3|STARTED|Pre-Treatment||6
402658|NCT00127790|987343|P2|STARTED|Pre-Treatment||5
402659|NCT00127790|987344|P1|STARTED|Pre-Treatment|7 enrolled subjects were withdrawn prior to randomization; 21 of 28 enrolled were randomized.|6
402660|NCT00127712|987368|P2|NOT COMPLETED|Overall Study||0
402661|NCT00127712|987369|P1|NOT COMPLETED|Overall Study||5
402662|NCT00127712|987368|P2|COMPLETED|Overall Study||65
402663|NCT00127712|987369|P1|COMPLETED|Overall Study||60
402664|NCT00127712|987368|P2|STARTED|Overall Study||65
402665|NCT00127712|987369|P1|STARTED|Overall Study||65
402666|NCT00127660|987385|P4|NOT COMPLETED|Overall Study||0
402667|NCT00127660|987386|P3|NOT COMPLETED|Overall Study||5
402668|NCT00127660|987387|P2|NOT COMPLETED|Overall Study||3
402669|NCT00127660|987388|P1|NOT COMPLETED|Overall Study||3
402670|NCT00127660|987385|P4|COMPLETED|Overall Study||150
402671|NCT00127660|987386|P3|COMPLETED|Overall Study||143
402672|NCT00127660|987387|P2|COMPLETED|Overall Study||151
402673|NCT00127660|987388|P1|COMPLETED|Overall Study||150
402674|NCT00127660|987385|P4|STARTED|Overall Study||150
402675|NCT00127660|987386|P3|STARTED|Overall Study||148
402676|NCT00127660|987387|P2|STARTED|Overall Study||154
402677|NCT00127660|987388|P1|STARTED|Overall Study||153
402678|NCT00127608|987398|P1|NOT COMPLETED|Overall Study||1
402679|NCT00127608|987398|P1|COMPLETED|Overall Study||35
402680|NCT00127608|987398|P1|STARTED|Overall Study||36
402681|NCT00127530|987406|P2|NOT COMPLETED|Overall Study||21
402682|NCT00127530|987407|P1|NOT COMPLETED|Overall Study||1
402683|NCT00127530|987406|P2|COMPLETED|Overall Study||207
402684|NCT00127530|987407|P1|COMPLETED|Overall Study||71
402685|NCT00127530|987406|P2|STARTED|Overall Study||228
402686|NCT00127530|987407|P1|STARTED|Overall Study||72
402687|NCT00127439|987415|P2|NOT COMPLETED|Overall Study||0
402688|NCT00127439|987416|P1|NOT COMPLETED|Overall Study||0
402689|NCT00127439|987415|P2|COMPLETED|Overall Study||10
402690|NCT00127439|987416|P1|COMPLETED|Overall Study||9
402691|NCT00127439|987415|P2|STARTED|Overall Study||10
402692|NCT00127439|987416|P1|STARTED|Overall Study||9
402693|NCT00127413|987442|P4|NOT COMPLETED|Overall Study||2
402694|NCT00127413|987443|P3|NOT COMPLETED|Overall Study||8
402695|NCT00127413|987444|P2|NOT COMPLETED|Overall Study||4
402696|NCT00127413|987445|P1|NOT COMPLETED|Overall Study||6
402697|NCT00127413|987442|P4|COMPLETED|Overall Study||5
402698|NCT00127413|987443|P3|COMPLETED|Overall Study||5
402699|NCT00127413|987444|P2|COMPLETED|Overall Study||6
402700|NCT00127413|987445|P1|COMPLETED|Overall Study||6
402701|NCT00127413|987442|P4|STARTED|Overall Study||7
402702|NCT00127413|987443|P3|STARTED|Overall Study||13
402703|NCT00127413|987444|P2|STARTED|Overall Study||10
402704|NCT00127413|987445|P1|STARTED|Overall Study||12
402705|NCT00127231|987457|P2|NOT COMPLETED|Overall Study||6
402706|NCT00127231|987458|P1|NOT COMPLETED|Overall Study||6
402707|NCT00127231|987457|P2|COMPLETED|Overall Study||68
402708|NCT00127231|987458|P1|COMPLETED|Overall Study||68
402709|NCT00127231|987457|P2|STARTED|Overall Study||74
402710|NCT00127231|987458|P1|STARTED|Overall Study||74
402711|NCT00127218|987474|P2|NOT COMPLETED|Overall Study||15
402712|NCT00127218|987475|P1|NOT COMPLETED|Overall Study||13
402713|NCT00127218|987474|P2|COMPLETED|Overall Study||58
402714|NCT00127218|987475|P1|COMPLETED|Overall Study||59
402715|NCT00127218|987474|P2|STARTED|Overall Study||73
402716|NCT00127218|987475|P1|STARTED|Overall Study||72
402717|NCT00127205|987486|P3|NOT COMPLETED|Overall Study||617
402718|NCT00127205|987487|P2|NOT COMPLETED|Overall Study||980
402719|NCT00127205|987488|P1|NOT COMPLETED|Overall Study||835
402720|NCT00127205|987486|P3|COMPLETED|Overall Study||950
402721|NCT00127205|987487|P2|COMPLETED|Overall Study||1288
402722|NCT00127205|987488|P1|COMPLETED|Overall Study||1427
402723|NCT00127205|987486|P3|STARTED|Overall Study||1567
402724|NCT00127205|987487|P2|STARTED|Overall Study||2268
402725|NCT00127205|987488|P1|STARTED|Overall Study||2262
402726|NCT00127192|987510|P5|NOT COMPLETED|Overall Study||5
402727|NCT00127192|987511|P4|NOT COMPLETED|Overall Study||1
402728|NCT00127192|987512|P3|NOT COMPLETED|Overall Study||2
402729|NCT00127192|987513|P2|NOT COMPLETED|Overall Study||1
402730|NCT00127192|987514|P1|NOT COMPLETED|Overall Study||3
402731|NCT00127192|987510|P5|COMPLETED|Overall Study||68
402732|NCT00127192|987511|P4|COMPLETED|Overall Study||67
402733|NCT00127192|987512|P3|COMPLETED|Overall Study||68
402734|NCT00127192|987513|P2|COMPLETED|Overall Study||71
402735|NCT00127192|987514|P1|COMPLETED|Overall Study||77
402736|NCT00127192|987510|P5|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|73
402737|NCT00127192|987511|P4|STARTED|Overall Study|Study enrolled slightly less than the target of N=70|68
402738|NCT00127192|987512|P3|STARTED|Overall Study|Study enrolled as per the target of N=70|70
402739|NCT00127192|987513|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|72
402740|NCT00127192|987514|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|80
402741|NCT00127166|987538|P2|NOT COMPLETED|Period II||0
402742|NCT00127166|987539|P1|NOT COMPLETED|Period II||3
402743|NCT00127166|987538|P2|COMPLETED|Period II||73
402744|NCT00127166|987539|P1|COMPLETED|Period II||72
402745|NCT00127166|987538|P2|STARTED|Period II||73
402746|NCT00127166|987539|P1|STARTED|Period II||75
402747|NCT00127166|987538|P2|NOT COMPLETED|Washout Period||1
402748|NCT00127166|987539|P1|NOT COMPLETED|Washout Period||0
402749|NCT00127166|987538|P2|COMPLETED|Washout Period||73
402750|NCT00127166|987539|P1|COMPLETED|Washout Period||75
402751|NCT00127166|987538|P2|STARTED|Washout Period||74
402752|NCT00127166|987539|P1|STARTED|Washout Period||75
402753|NCT00127166|987538|P2|NOT COMPLETED|Period I||2
402754|NCT00127166|987539|P1|NOT COMPLETED|Period I||3
402755|NCT00127166|987538|P2|COMPLETED|Period I||74
402756|NCT00127166|987539|P1|COMPLETED|Period I||75
402757|NCT00127166|987538|P2|STARTED|Period I||76
402758|NCT00127166|987539|P1|STARTED|Period I||78
402759|NCT00127101|987559|P6|NOT COMPLETED|Continuation Phase||3
402760|NCT00127101|987560|P5|NOT COMPLETED|Continuation Phase||3
402761|NCT00127101|987561|P4|NOT COMPLETED|Continuation Phase||0
402762|NCT00127101|987562|P3|NOT COMPLETED|Continuation Phase||1
402763|NCT00127101|987563|P2|NOT COMPLETED|Continuation Phase||0
402764|NCT00127101|987564|P1|NOT COMPLETED|Continuation Phase||0
402765|NCT00127101|987559|P6|COMPLETED|Continuation Phase||0
402766|NCT00127101|987560|P5|COMPLETED|Continuation Phase||0
402767|NCT00127101|987561|P4|COMPLETED|Continuation Phase||0
402768|NCT00127101|987562|P3|COMPLETED|Continuation Phase||0
402769|NCT00127101|987563|P2|COMPLETED|Continuation Phase||0
402770|NCT00127101|987564|P1|COMPLETED|Continuation Phase||0
402771|NCT00127101|987559|P6|STARTED|Continuation Phase||3
402772|NCT00127101|987560|P5|STARTED|Continuation Phase||3
402773|NCT00127101|987561|P4|STARTED|Continuation Phase|No patients from the 2b Cohort entered into the extension phase|0
402774|NCT00127101|987562|P3|STARTED|Continuation Phase||1
402775|NCT00127101|987563|P2|STARTED|Continuation Phase||0
402776|NCT00127101|987564|P1|STARTED|Continuation Phase||0
402777|NCT00127101|987559|P6|NOT COMPLETED|Base Protocol||1
402778|NCT00127101|987560|P5|NOT COMPLETED|Base Protocol||2
402779|NCT00127101|987561|P4|NOT COMPLETED|Base Protocol||0
402780|NCT00127101|987562|P3|NOT COMPLETED|Base Protocol||2
402781|NCT00127101|987563|P2|NOT COMPLETED|Base Protocol||4
402782|NCT00127101|987564|P1|NOT COMPLETED|Base Protocol||2
402783|NCT00127101|987559|P6|COMPLETED|Base Protocol||3
402784|NCT00127101|987560|P5|COMPLETED|Base Protocol||3
402785|NCT00127101|987561|P4|COMPLETED|Base Protocol||3
402786|NCT00127101|987562|P3|COMPLETED|Base Protocol||1
402787|NCT00127101|987563|P2|COMPLETED|Base Protocol||1
402788|NCT00127101|987564|P1|COMPLETED|Base Protocol||1
402789|NCT00127101|987559|P6|STARTED|Base Protocol||4
402790|NCT00127101|987560|P5|STARTED|Base Protocol||5
402791|NCT00127101|987561|P4|STARTED|Base Protocol||3
402792|NCT00127101|987562|P3|STARTED|Base Protocol||3
402793|NCT00127101|987563|P2|STARTED|Base Protocol||5
402794|NCT00127101|987564|P1|STARTED|Base Protocol||3
402795|NCT00127062|987586|P2|NOT COMPLETED|Second intervention_Hyde Park||0
402796|NCT00127062|987587|P1|NOT COMPLETED|Second intervention_Hyde Park||0
402797|NCT00127062|987586|P2|COMPLETED|Second intervention_Hyde Park||29
402798|NCT00127062|987587|P1|COMPLETED|Second intervention_Hyde Park||31
402799|NCT00127062|987586|P2|STARTED|Second intervention_Hyde Park||29
402800|NCT00127062|987587|P1|STARTED|Second intervention_Hyde Park||31
402801|NCT00127062|987586|P2|NOT COMPLETED|First intervention_Oxford Street||0
402802|NCT00127062|987587|P1|NOT COMPLETED|First intervention_Oxford Street||0
402803|NCT00127062|987586|P2|COMPLETED|First intervention_Oxford Street||29
402804|NCT00127062|987587|P1|COMPLETED|First intervention_Oxford Street||31
402805|NCT00127062|987586|P2|STARTED|First intervention_Oxford Street||29
402806|NCT00127062|987587|P1|STARTED|First intervention_Oxford Street||31
402807|NCT00127036|987599|P2|NOT COMPLETED|Overall Study||11
402808|NCT00127036|987600|P1|NOT COMPLETED|Overall Study||8
402809|NCT00127036|987599|P2|COMPLETED|Overall Study|20 Participants were evaluable.|20
402810|NCT00127036|987600|P1|COMPLETED|Overall Study|26 Participants were evaluable.|26
402811|NCT00127036|987599|P2|STARTED|Overall Study||31
402812|NCT00127036|987600|P1|STARTED|Overall Study||34
402813|NCT00126776|987612|P2|NOT COMPLETED|Overall Study||0
402814|NCT00126776|987613|P1|NOT COMPLETED|Overall Study||0
402815|NCT00126776|987612|P2|COMPLETED|Overall Study||371
402816|NCT00126776|987613|P1|COMPLETED|Overall Study||372
402817|NCT00126776|987612|P2|STARTED|Overall Study||371
402818|NCT00126776|987613|P1|STARTED|Overall Study||372
402819|NCT00126750|987619|P2|NOT COMPLETED|Overall Study||266
402820|NCT00126750|987620|P1|NOT COMPLETED|Overall Study||180
402821|NCT00126750|987619|P2|COMPLETED|Overall Study|Total providers at clinic locations were given the option to 'enroll'.|196
402822|NCT00126750|987620|P1|COMPLETED|Overall Study|Total providers at participating clinic locations were given the option to 'enroll'.|205
402823|NCT00126750|987619|P2|STARTED|Overall Study|Number of providers from 84 clinics|462
402824|NCT00126750|987620|P1|STARTED|Overall Study|Number of providers from 84 clinics|385
402825|NCT00126737|987630|P4|NOT COMPLETED|Overall Study||7
402826|NCT00126737|987631|P3|NOT COMPLETED|Overall Study||6
402827|NCT00126737|987632|P2|NOT COMPLETED|Overall Study||3
402828|NCT00126737|987633|P1|NOT COMPLETED|Overall Study||6
402829|NCT00126737|987630|P4|COMPLETED|Overall Study||18
402830|NCT00126737|987631|P3|COMPLETED|Overall Study||24
402831|NCT00126737|987632|P2|COMPLETED|Overall Study||24
402832|NCT00126737|987633|P1|COMPLETED|Overall Study||22
402833|NCT00126737|987630|P4|STARTED|Overall Study||25
402834|NCT00126737|987631|P3|STARTED|Overall Study||30
402835|NCT00126737|987632|P2|STARTED|Overall Study||27
402836|NCT00126737|987633|P1|STARTED|Overall Study||28
402837|NCT00126659|987662|P3|NOT COMPLETED|Overall Study||2
402838|NCT00126659|987663|P2|NOT COMPLETED|Overall Study||0
402839|NCT00126659|987664|P1|NOT COMPLETED|Overall Study||0
402840|NCT00126659|987662|P3|COMPLETED|Overall Study||2
402841|NCT00126659|987663|P2|COMPLETED|Overall Study||3
402842|NCT00126659|987664|P1|COMPLETED|Overall Study||3
402843|NCT00126659|987662|P3|STARTED|Overall Study||4
402844|NCT00126659|987663|P2|STARTED|Overall Study||3
402845|NCT00126659|987664|P1|STARTED|Overall Study||3
402846|NCT00126594|987672|P2|NOT COMPLETED|Overall Study||37
402847|NCT00126594|987673|P1|NOT COMPLETED|Overall Study||39
402848|NCT00126594|987672|P2|COMPLETED|Overall Study||3
402849|NCT00126594|987673|P1|COMPLETED|Overall Study||1
402850|NCT00126594|987672|P2|STARTED|Overall Study||40
402851|NCT00126594|987673|P1|STARTED|Overall Study||40
402852|NCT00126581|987690|P2|NOT COMPLETED|Overall Study||20
402853|NCT00126581|987691|P1|NOT COMPLETED|Overall Study||13
402854|NCT00126581|987690|P2|COMPLETED|Overall Study||80
402855|NCT00126581|987691|P1|COMPLETED|Overall Study||68
402856|NCT00126581|987690|P2|STARTED|Overall Study||100
402857|NCT00126581|987691|P1|STARTED|Overall Study||81
402858|NCT00126568|987711|P1|NOT COMPLETED|Overall Study||2
402859|NCT00126568|987711|P1|COMPLETED|Overall Study|Disease progression at beginning of study, not evaluable|18
402860|NCT00126568|987711|P1|STARTED|Overall Study||20
402861|NCT00126555|987718|P1|NOT COMPLETED|Overall Study||6
402862|NCT00126555|987718|P1|COMPLETED|Overall Study||17
402863|NCT00126555|987718|P1|Stratum 2- Unresectable|Overall Study||4
402864|NCT00126555|987718|P1|Stratum 1- Resectable|Overall Study|1 participant did not participate|18
402865|NCT00126555|987718|P1|STARTED|Overall Study||23
402866|NCT00126503|987740|P2|NOT COMPLETED|Overall Study||21
402867|NCT00126503|987741|P1|NOT COMPLETED|Overall Study||47
402868|NCT00126503|987740|P2|COMPLETED|Overall Study||0
402869|NCT00126503|987741|P1|COMPLETED|Overall Study||1
402870|NCT00126503|987740|P2|STARTED|Overall Study||21
402871|NCT00126503|987741|P1|STARTED|Overall Study||48
402872|NCT00126490|987753|P1|NOT COMPLETED|Overall Study||1
402873|NCT00126490|987753|P1|COMPLETED|Overall Study||18
402874|NCT00126490|987753|P1|STARTED|Overall Study||19
402875|NCT00126438|987763|P2|NOT COMPLETED|Overall Study||10
402876|NCT00126438|987764|P1|NOT COMPLETED|Overall Study||34
402877|NCT00126438|987763|P2|COMPLETED|Overall Study||52
402878|NCT00126438|987764|P1|COMPLETED|Overall Study||419
402879|NCT00126438|987763|P2|STARTED|Overall Study||62
402880|NCT00126438|987764|P1|STARTED|Overall Study||453
402881|NCT00126425|987772|P2|NOT COMPLETED|Overall Study||11
402882|NCT00126425|987773|P1|NOT COMPLETED|Overall Study||41
402883|NCT00126425|987772|P2|COMPLETED|Overall Study||37
402884|NCT00126425|987773|P1|COMPLETED|Overall Study||498
402885|NCT00126425|987772|P2|STARTED|Overall Study||48
402886|NCT00126425|987773|P1|STARTED|Overall Study||539
402887|NCT00126191|987781|P2|NOT COMPLETED|Overall Study||2
402888|NCT00126191|987782|P1|NOT COMPLETED|Overall Study||0
402889|NCT00126191|987781|P2|COMPLETED|Overall Study|1 pt off study during cycle 1 due to toxicity|6
402890|NCT00126191|987782|P1|COMPLETED|Overall Study||2
402891|NCT00126191|987781|P2|STARTED|Overall Study||8
402892|NCT00126191|987782|P1|STARTED|Overall Study||2
402893|NCT00126126|987792|P2|NOT COMPLETED|Overall Study||2
402894|NCT00126126|987793|P1|NOT COMPLETED|Overall Study||0
402895|NCT00126126|987792|P2|COMPLETED|Overall Study||7
402896|NCT00126126|987793|P1|COMPLETED|Overall Study||9
402897|NCT00126126|987792|P2|STARTED|Overall Study||9
402898|NCT00126126|987793|P1|STARTED|Overall Study||9
402899|NCT00126113|987803|P2|NOT COMPLETED|Overall Study||2
402900|NCT00126113|987804|P1|NOT COMPLETED|Overall Study||3
402901|NCT00126113|987803|P2|COMPLETED|Overall Study||35
402902|NCT00126113|987804|P1|COMPLETED|Overall Study||34
402903|NCT00126113|987803|P2|STARTED|Overall Study||37
402904|NCT00126113|987804|P1|STARTED|Overall Study||37
402905|NCT00125957|987818|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
402906|NCT00125957|987819|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
402907|NCT00125957|987818|P2|COMPLETED|Second Intervention (3 Weeks)||17
402908|NCT00125957|987819|P1|COMPLETED|Second Intervention (3 Weeks)||15
402909|NCT00125957|987818|P2|STARTED|Second Intervention (3 Weeks)||17
402910|NCT00125957|987819|P1|STARTED|Second Intervention (3 Weeks)||15
402911|NCT00125957|987818|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
402912|NCT00125957|987819|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
402913|NCT00125957|987818|P2|COMPLETED|First Intervention (3 Weeks)||17
402914|NCT00125957|987819|P1|COMPLETED|First Intervention (3 Weeks)||15
402915|NCT00125957|987818|P2|STARTED|First Intervention (3 Weeks)||17
402916|NCT00125957|987819|P1|STARTED|First Intervention (3 Weeks)||15
402917|NCT00125931|987827|P1|NOT COMPLETED|Overall Study||0
402918|NCT00125931|987827|P1|COMPLETED|Overall Study||10
402919|NCT00125931|987827|P1|STARTED|Overall Study||10
402920|NCT00125762|987832|P1|NOT COMPLETED|Overall Study||159
402921|NCT00125762|987832|P1|COMPLETED|Overall Study||748
402922|NCT00125762|987832|P1|STARTED|Overall Study||907
402923|NCT00125658|987839|P2|NOT COMPLETED|Overall Study||0
402924|NCT00125658|987840|P1|NOT COMPLETED|Overall Study||0
402925|NCT00125658|987839|P2|COMPLETED|Overall Study||6
402926|NCT00125658|987840|P1|COMPLETED|Overall Study||8
402927|NCT00125658|987839|P2|STARTED|Overall Study||6
402928|NCT00125658|987840|P1|STARTED|Overall Study||8
402929|NCT00125619|987860|P2|NOT COMPLETED|Overall Study||0
402930|NCT00125619|987861|P1|NOT COMPLETED|Overall Study||0
402931|NCT00125619|987860|P2|COMPLETED|Overall Study||8
402932|NCT00125619|987861|P1|COMPLETED|Overall Study||8
402933|NCT00125619|987860|P2|STARTED|Overall Study||8
402934|NCT00125619|987861|P1|STARTED|Overall Study||8
402935|NCT00125593|987881|P2|NOT COMPLETED|Overall Study||103
402936|NCT00125593|987882|P1|NOT COMPLETED|Overall Study||101
402937|NCT00125593|987881|P2|COMPLETED|Overall Study||4517
402938|NCT00125593|987882|P1|COMPLETED|Overall Study||4549
402939|NCT00125593|987881|P2|STARTED|Overall Study||4620
402940|NCT00125593|987882|P1|STARTED|Overall Study||4650
402941|NCT00125528|987902|P2|NOT COMPLETED|Overall Study||1
402942|NCT00125528|987903|P1|NOT COMPLETED|Overall Study||2
402943|NCT00125528|987902|P2|COMPLETED|Overall Study||20
402944|NCT00125528|987903|P1|COMPLETED|Overall Study||18
402945|NCT00125528|987902|P2|STARTED|Overall Study||21
402946|NCT00125528|987903|P1|STARTED|Overall Study||20
402947|NCT00125515|987914|P3|NOT COMPLETED|Overall Study||21
402948|NCT00125515|987915|P2|NOT COMPLETED|Overall Study||20
402949|NCT00125515|987916|P1|NOT COMPLETED|Overall Study||20
402950|NCT00125515|987914|P3|COMPLETED|Overall Study||6
402951|NCT00125515|987915|P2|COMPLETED|Overall Study||7
402952|NCT00125515|987916|P1|COMPLETED|Overall Study||7
402953|NCT00125515|987914|P3|STARTED|Overall Study||27
402954|NCT00125515|987915|P2|STARTED|Overall Study||27
402955|NCT00125515|987916|P1|STARTED|Overall Study||27
402956|NCT00125372|987924|P1|NOT COMPLETED|Overall Study||2
402957|NCT00125372|987924|P1|COMPLETED|Overall Study||10
402958|NCT00125372|987924|P1|STARTED|Overall Study||12
402959|NCT00125359|987932|P1|NOT COMPLETED|Overall Study||23
402960|NCT00125359|987932|P1|COMPLETED|Overall Study||19
402961|NCT00125359|987932|P1|STARTED|Overall Study||42
402962|NCT00125268|987941|P2|NOT COMPLETED|Overall Study||1
402963|NCT00125268|987942|P1|NOT COMPLETED|Overall Study||1
402964|NCT00125268|987941|P2|COMPLETED|Overall Study||13
402965|NCT00125268|987942|P1|COMPLETED|Overall Study||15
402966|NCT00125268|987941|P2|STARTED|Overall Study||14
402967|NCT00125268|987942|P1|STARTED|Overall Study||16
402968|NCT00125242|987954|P2|NOT COMPLETED|Overall Study||2
402969|NCT00125242|987955|P1|NOT COMPLETED|Overall Study||7
402970|NCT00125242|987954|P2|COMPLETED|Overall Study||14
402971|NCT00125242|987955|P1|COMPLETED|Overall Study||87
402972|NCT00125242|987954|P2|STARTED|Overall Study||16
402973|NCT00125242|987955|P1|STARTED|Overall Study||94
402974|NCT00125190|987960|P1|NOT COMPLETED|Overall Study||15
402975|NCT00125190|987960|P1|COMPLETED|Overall Study||30
402976|NCT00125190|987960|P1|STARTED|Overall Study||45
402977|NCT00125164|987978|P4|NOT COMPLETED|Overall Study||6
402978|NCT00125164|987979|P3|NOT COMPLETED|Overall Study||4
402979|NCT00125164|987980|P2|NOT COMPLETED|Overall Study||0
402980|NCT00125164|987981|P1|NOT COMPLETED|Overall Study||2
402981|NCT00125164|987978|P4|COMPLETED|Overall Study||45
402982|NCT00125164|987979|P3|COMPLETED|Overall Study||40
402983|NCT00125164|987980|P2|COMPLETED|Overall Study||16
402984|NCT00125164|987981|P1|COMPLETED|Overall Study||23
402985|NCT00125164|987978|P4|STARTED|Overall Study||51
402986|NCT00125164|987979|P3|STARTED|Overall Study||44
402987|NCT00125164|987980|P2|STARTED|Overall Study||16
402988|NCT00125164|987981|P1|STARTED|Overall Study||25
402989|NCT00125138|988035|P4|NOT COMPLETED|Overall Study||5
402990|NCT00125138|988036|P3|NOT COMPLETED|Overall Study||4
402991|NCT00125138|988037|P2|NOT COMPLETED|Overall Study||3
402992|NCT00125138|988038|P1|NOT COMPLETED|Overall Study||3
402993|NCT00125138|988035|P4|COMPLETED|Overall Study||25
402994|NCT00125138|988036|P3|COMPLETED|Overall Study||21
402995|NCT00125138|988037|P2|COMPLETED|Overall Study||17
402996|NCT00125138|988038|P1|COMPLETED|Overall Study||12
402997|NCT00125138|988035|P4|STARTED|Overall Study||30
402998|NCT00125138|988036|P3|STARTED|Overall Study||25
402999|NCT00125138|988037|P2|STARTED|Overall Study|One subject requested withdrawal prior to treatment; data for the subject are excluded from results.|20
403000|NCT00125138|988038|P1|STARTED|Overall Study||15
403001|NCT00125034|988054|P2|NOT COMPLETED|Overall Study||0
403002|NCT00125034|988055|P1|NOT COMPLETED|Overall Study||0
403003|NCT00125034|988054|P2|COMPLETED|Overall Study||168
403004|NCT00125034|988055|P1|COMPLETED|Overall Study||170
403005|NCT00125034|988054|P2|STARTED|Overall Study|Randomized & treated|168
403006|NCT00125034|988055|P1|STARTED|Overall Study|Randomized & treated. 1 subject was not randomized correctly and was excluded in the ITT population.|170
403007|NCT00124982|988087|P3|NOT COMPLETED|Long-term Period||89
403008|NCT00124982|988088|P2|NOT COMPLETED|Long-term Period||0
403009|NCT00124982|988089|P1|NOT COMPLETED|Long-term Period||0
403010|NCT00124982|988087|P3|COMPLETED|Long-term Period||441
403011|NCT00124982|988088|P2|COMPLETED|Long-term Period||0
403012|NCT00124982|988089|P1|COMPLETED|Long-term Period||0
403013|NCT00124982|988087|P3|STARTED|Long-term Period|A large number did not continue due to a rollover from study drug to commercially available drug.|530
403014|NCT00124982|988088|P2|STARTED|Long-term Period||0
403015|NCT00124982|988089|P1|STARTED|Long-term Period||0
403016|NCT00124982|988087|P3|NOT COMPLETED|Short-term Period||0
403017|NCT00124982|988088|P2|NOT COMPLETED|Short-term Period||114
403018|NCT00124982|988089|P1|NOT COMPLETED|Short-term Period||72
403019|NCT00124982|988087|P3|COMPLETED|Short-term Period||0
403020|NCT00124982|988088|P2|COMPLETED|Short-term Period||483
403021|NCT00124982|988089|P1|COMPLETED|Short-term Period||377
403022|NCT00124982|988087|P3|STARTED|Short-term Period||0
403023|NCT00124982|988088|P2|STARTED|Short-term Period||597
403024|NCT00124982|988089|P1|STARTED|Short-term Period||449
403025|NCT00124943|988171|P4|NOT COMPLETED|Phase II||5
403026|NCT00124943|988172|P3|NOT COMPLETED|Phase II||0
403027|NCT00124943|988173|P2|NOT COMPLETED|Phase II||2
403028|NCT00124943|988174|P1|NOT COMPLETED|Phase II||0
403029|NCT00124943|988171|P4|COMPLETED|Phase II||50
403030|NCT00124943|988172|P3|COMPLETED|Phase II||3
403031|NCT00124943|988173|P2|COMPLETED|Phase II||49
403032|NCT00124943|988174|P1|COMPLETED|Phase II||3
403033|NCT00124943|988171|P4|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|55
403034|NCT00124943|988172|P3|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
403035|NCT00124943|988173|P2|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|51
403036|NCT00124943|988174|P1|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
403037|NCT00124943|988171|P4|NOT COMPLETED|Phase I||0
403038|NCT00124943|988172|P3|NOT COMPLETED|Phase I||0
403039|NCT00124943|988173|P2|NOT COMPLETED|Phase I||0
403040|NCT00124943|988174|P1|NOT COMPLETED|Phase I||0
403041|NCT00124943|988171|P4|COMPLETED|Phase I||3
403042|NCT00124943|988172|P3|COMPLETED|Phase I||3
403043|NCT00124943|988173|P2|COMPLETED|Phase I||3
403044|NCT00124943|988174|P1|COMPLETED|Phase I||3
403045|NCT00124943|988171|P4|STARTED|Phase I||3
403046|NCT00124943|988172|P3|STARTED|Phase I||3
403047|NCT00124943|988173|P2|STARTED|Phase I||3
403048|NCT00124943|988174|P1|STARTED|Phase I||3
403049|NCT00124917|988212|P1|NOT COMPLETED|Overall Study||3
403050|NCT00124917|988212|P1|COMPLETED|Overall Study||3
403051|NCT00124917|988212|P1|STARTED|Overall Study||6
403052|NCT00124748|988222|P2|NOT COMPLETED|Overall Study||284
403053|NCT00124748|988223|P1|NOT COMPLETED|Overall Study||143
403054|NCT00124748|988222|P2|COMPLETED|Overall Study||35
403055|NCT00124748|988223|P1|COMPLETED|Overall Study||14
403056|NCT00124748|988222|P2|Safety Population|Overall Study||316
403057|NCT00124748|988223|P1|Safety Population|Overall Study||157
403058|NCT00124748|988222|P2|STARTED|Overall Study||319
403059|NCT00124748|988223|P1|STARTED|Overall Study||157
403060|NCT00124735|988275|P10|NOT COMPLETED|Overall Study||2
403061|NCT00124735|988276|P9|NOT COMPLETED|Overall Study||3
403062|NCT00124735|988277|P8|NOT COMPLETED|Overall Study||1
403063|NCT00124735|988278|P7|NOT COMPLETED|Overall Study||0
403064|NCT00124735|988279|P6|NOT COMPLETED|Overall Study||2
403065|NCT00124735|988280|P5|NOT COMPLETED|Overall Study||2
403066|NCT00124735|988281|P4|NOT COMPLETED|Overall Study||3
403067|NCT00124735|988282|P3|NOT COMPLETED|Overall Study||0
403068|NCT00124735|988283|P2|NOT COMPLETED|Overall Study||2
403069|NCT00124735|988284|P1|NOT COMPLETED|Overall Study||1
403070|NCT00124735|988275|P10|COMPLETED|Overall Study||18
403071|NCT00124735|988276|P9|COMPLETED|Overall Study||22
403072|NCT00124735|988277|P8|COMPLETED|Overall Study||19
403073|NCT00124735|988278|P7|COMPLETED|Overall Study||6
403074|NCT00124735|988279|P6|COMPLETED|Overall Study||5
403075|NCT00124735|988280|P5|COMPLETED|Overall Study||17
403076|NCT00124735|988281|P4|COMPLETED|Overall Study||18
403077|NCT00124735|988282|P3|COMPLETED|Overall Study||18
403078|NCT00124735|988283|P2|COMPLETED|Overall Study||6
403079|NCT00124735|988284|P1|COMPLETED|Overall Study||4
403080|NCT00124735|988275|P10|STARTED|Overall Study||20
403081|NCT00124735|988276|P9|STARTED|Overall Study||25
403082|NCT00124735|988277|P8|STARTED|Overall Study||20
403083|NCT00124735|988278|P7|STARTED|Overall Study||6
403084|NCT00124735|988279|P6|STARTED|Overall Study||7
403085|NCT00124735|988280|P5|STARTED|Overall Study||19
403086|NCT00124735|988281|P4|STARTED|Overall Study||21
403087|NCT00124735|988282|P3|STARTED|Overall Study||18
403088|NCT00124735|988283|P2|STARTED|Overall Study||8
403089|NCT00124735|988284|P1|STARTED|Overall Study||5
403090|NCT00124709|988330|P2|NOT COMPLETED|Overall Study||272
403091|NCT00124709|988331|P1|NOT COMPLETED|Overall Study||255
403092|NCT00124709|988330|P2|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|273
403093|NCT00124709|988331|P1|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|291
403094|NCT00124709|988330|P2|Patients Who Received Study Medication|Overall Study||544
403095|NCT00124709|988331|P1|Patients Who Received Study Medication|Overall Study||543
403096|NCT00124709|988330|P2|STARTED|Overall Study||545
403097|NCT00124709|988331|P1|STARTED|Overall Study||546
403098|NCT00124657|988348|P3|NOT COMPLETED|Overall Study||32
403099|NCT00124657|988349|P2|NOT COMPLETED|Overall Study||5
403100|NCT00124657|988350|P1|NOT COMPLETED|Overall Study||16
403101|NCT00124657|988348|P3|COMPLETED|Overall Study||7
403102|NCT00124657|988349|P2|COMPLETED|Overall Study||0
403103|NCT00124657|988350|P1|COMPLETED|Overall Study||2
403104|NCT00124657|988348|P3|STARTED|Overall Study||39
403105|NCT00124657|988349|P2|STARTED|Overall Study||5
403106|NCT00124657|988350|P1|STARTED|Overall Study||18
403107|NCT00124618|988385|P1|NOT COMPLETED|Overall Study||1
403108|NCT00124618|988385|P1|COMPLETED|Overall Study||57
403109|NCT00124618|988385|P1|STARTED|Overall Study||58
403110|NCT00124579|988392|P1|NOT COMPLETED|Maintenance||2
403111|NCT00124579|988392|P1|COMPLETED|Maintenance||0
403112|NCT00124579|988392|P1|STARTED|Maintenance||2
403113|NCT00124579|988392|P1|NOT COMPLETED|Induction||5
403114|NCT00124579|988392|P1|COMPLETED|Induction||2
403115|NCT00124579|988392|P1|STARTED|Induction||7
403116|NCT00124462|988400|P2|NOT COMPLETED|Overall Study||13
403117|NCT00124462|988401|P1|NOT COMPLETED|Overall Study||11
403118|NCT00124462|988400|P2|COMPLETED|Overall Study||27
403119|NCT00124462|988401|P1|COMPLETED|Overall Study||29
403120|NCT00124462|988400|P2|STARTED|Overall Study||40
403121|NCT00124462|988401|P1|STARTED|Overall Study||40
403122|NCT00124449|988411|P2|NOT COMPLETED|18-Month Untreated Observation Period||13
403123|NCT00124449|988412|P1|NOT COMPLETED|18-Month Untreated Observation Period||15
403124|NCT00124449|988411|P2|COMPLETED|18-Month Untreated Observation Period||4
403125|NCT00124449|988412|P1|COMPLETED|18-Month Untreated Observation Period||7
403126|NCT00124449|988411|P2|Completed Year 1 of Study|18-Month Untreated Observation Period||9
403127|NCT00124449|988412|P1|Completed Year 1 of Study|18-Month Untreated Observation Period||14
403128|NCT00124449|988411|P2|STARTED|18-Month Untreated Observation Period||17
403129|NCT00124449|988412|P1|STARTED|18-Month Untreated Observation Period||22
403130|NCT00124449|988411|P2|NOT COMPLETED|6-month Double-Blind Treatment Period||11
403131|NCT00124449|988412|P1|NOT COMPLETED|6-month Double-Blind Treatment Period||6
403132|NCT00124449|988411|P2|COMPLETED|6-month Double-Blind Treatment Period||17
403133|NCT00124449|988412|P1|COMPLETED|6-month Double-Blind Treatment Period||22
403134|NCT00124449|988411|P2|STARTED|6-month Double-Blind Treatment Period||28
403135|NCT00124449|988412|P1|STARTED|6-month Double-Blind Treatment Period||28
403136|NCT00124176|988447|P2|NOT COMPLETED|Overall Study||0
403137|NCT00124176|988448|P1|NOT COMPLETED|Overall Study||0
403138|NCT00124176|988447|P2|COMPLETED|Overall Study||41
403139|NCT00124176|988448|P1|COMPLETED|Overall Study||40
403140|NCT00124176|988447|P2|Received Study Drug|Overall Study||41
403141|NCT00124176|988448|P1|Received Study Drug|Overall Study|3 never started on drug due to improvement but were kept in the study by intention to treat.|37
403142|NCT00124176|988447|P2|STARTED|Overall Study||41
403143|NCT00124176|988448|P1|STARTED|Overall Study||40
403144|NCT00124072|988466|P4|NOT COMPLETED|Overall Study||500
403145|NCT00124072|988467|P3|NOT COMPLETED|Overall Study||492
403146|NCT00124072|988468|P2|NOT COMPLETED|Overall Study||512
403147|NCT00124072|988469|P1|NOT COMPLETED|Overall Study||514
403148|NCT00124072|988466|P4|COMPLETED|Overall Study||2515
403149|NCT00124072|988467|P3|COMPLETED|Overall Study||2524
403150|NCT00124072|988468|P2|COMPLETED|Overall Study||2504
403151|NCT00124072|988469|P1|COMPLETED|Overall Study||2503
403152|NCT00124072|988466|P4|STARTED|Overall Study||3015
403153|NCT00124072|988467|P3|STARTED|Overall Study||3016
403154|NCT00124072|988468|P2|STARTED|Overall Study||3016
403155|NCT00124072|988469|P1|STARTED|Overall Study||3017
403156|NCT00124020|988481|P2|NOT COMPLETED|Overall Study||91
403157|NCT00124020|988482|P1|NOT COMPLETED|Overall Study||88
403158|NCT00124020|988481|P2|COMPLETED|Overall Study||289
403159|NCT00124020|988482|P1|COMPLETED|Overall Study||289
403160|NCT00124020|988481|P2|STARTED|Overall Study||380
403161|NCT00124020|988482|P1|STARTED|Overall Study||377
403162|NCT00123955|988490|P2|NOT COMPLETED|Overall Study||4
403163|NCT00123955|988491|P1|NOT COMPLETED|Overall Study||5
403164|NCT00123955|988490|P2|COMPLETED|Overall Study||34
403165|NCT00123955|988491|P1|COMPLETED|Overall Study||37
403166|NCT00123955|988490|P2|STARTED|Overall Study||38
403167|NCT00123955|988491|P1|STARTED|Overall Study||42
403168|NCT00123734|988503|P1|NOT COMPLETED|Overall Study||8
403169|NCT00123734|988503|P1|COMPLETED|Overall Study||74
403170|NCT00123734|988503|P1|STARTED|Overall Study||82
403171|NCT00123682|988538|P4|NOT COMPLETED|Overall Study||95
403172|NCT00123682|988539|P3|NOT COMPLETED|Overall Study||154
403173|NCT00123682|988540|P2|NOT COMPLETED|Overall Study||203
403174|NCT00123682|988541|P1|NOT COMPLETED|Overall Study||320
403175|NCT00123682|988538|P4|COMPLETED|Overall Study||430
403176|NCT00123682|988539|P3|COMPLETED|Overall Study||438
403177|NCT00123682|988540|P2|COMPLETED|Overall Study||731
403178|NCT00123682|988541|P1|COMPLETED|Overall Study||749
403179|NCT00123682|988538|P4|STARTED|Overall Study||525
403180|NCT00123682|988539|P3|STARTED|Overall Study||592
403181|NCT00123682|988540|P2|STARTED|Overall Study||934
403182|NCT00123682|988541|P1|STARTED|Overall Study||1069
403183|NCT00123643|988561|P2|NOT COMPLETED|Overall Study||0
403184|NCT00123643|988562|P1|NOT COMPLETED|Overall Study||0
403185|NCT00123643|988561|P2|COMPLETED|Overall Study||16
403186|NCT00123643|988562|P1|COMPLETED|Overall Study||20
403187|NCT00123643|988561|P2|STARTED|Overall Study||16
403188|NCT00123643|988562|P1|STARTED|Overall Study||20
403189|NCT00123630|988570|P2|NOT COMPLETED|Overall Study||0
403190|NCT00123630|988571|P1|NOT COMPLETED|Overall Study||0
403191|NCT00123630|988570|P2|COMPLETED|Overall Study||15
403192|NCT00123630|988571|P1|COMPLETED|Overall Study||15
403193|NCT00123630|988570|P2|STARTED|Overall Study||15
403194|NCT00123630|988571|P1|STARTED|Overall Study||15
403195|NCT00123604|988579|P2|NOT COMPLETED|Overall Study||1
403196|NCT00123604|988580|P1|NOT COMPLETED|Overall Study||1
403197|NCT00123604|988579|P2|COMPLETED|Overall Study||16
403198|NCT00123604|988580|P1|COMPLETED|Overall Study||18
403199|NCT00123604|988579|P2|STARTED|Overall Study||17
403200|NCT00123604|988580|P1|STARTED|Overall Study||19
403201|NCT00123487|988588|P2|NOT COMPLETED|Treated With Study Drug||305
403202|NCT00123487|988589|P1|NOT COMPLETED|Treated With Study Drug||304
403203|NCT00123487|988588|P2|COMPLETED|Treated With Study Drug||0
403204|NCT00123487|988589|P1|COMPLETED|Treated With Study Drug||0
403205|NCT00123487|988588|P2|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 305 represents actual BID treatment.|305
403206|NCT00123487|988589|P1|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 304 represents actual QD treatment.|304
403207|NCT00123487|988588|P2|NOT COMPLETED|Randomized||1
403208|NCT00123487|988589|P1|NOT COMPLETED|Randomized||1
403209|NCT00123487|988588|P2|COMPLETED|Randomized||304
403210|NCT00123487|988589|P1|COMPLETED|Randomized||305
403211|NCT00123487|988588|P2|STARTED|Randomized||305
403212|NCT00123487|988589|P1|STARTED|Randomized||306
403213|NCT00123474|988633|P4|NOT COMPLETED|As Treated at Study Closure||167
403214|NCT00123474|988634|P3|NOT COMPLETED|As Treated at Study Closure||167
403215|NCT00123474|988635|P2|NOT COMPLETED|As Treated at Study Closure||163
403216|NCT00123474|988636|P1|NOT COMPLETED|As Treated at Study Closure||165
403217|NCT00123474|988633|P4|COMPLETED|As Treated at Study Closure||0
403218|NCT00123474|988634|P3|COMPLETED|As Treated at Study Closure|Randomized to 100 mg QD but received 50 mg BID.|0
403219|NCT00123474|988635|P2|COMPLETED|As Treated at Study Closure||0
403220|NCT00123474|988636|P1|COMPLETED|As Treated at Study Closure||0
403221|NCT00123474|988633|P4|STARTED|As Treated at Study Closure||167
403222|NCT00123474|988634|P3|STARTED|As Treated at Study Closure||167
403223|NCT00123474|988635|P2|STARTED|As Treated at Study Closure||163
403224|NCT00123474|988636|P1|STARTED|As Treated at Study Closure|Randomized to 50 mg BID but received 100 mg QD.|165
403225|NCT00123474|988633|P4|NOT COMPLETED|Randomized to Treatment||1
403226|NCT00123474|988634|P3|NOT COMPLETED|Randomized to Treatment||2
403227|NCT00123474|988635|P2|NOT COMPLETED|Randomized to Treatment||4
403228|NCT00123474|988636|P1|NOT COMPLETED|Randomized to Treatment||1
403229|NCT00123474|988633|P4|COMPLETED|Randomized to Treatment||167
403230|NCT00123474|988634|P3|COMPLETED|Randomized to Treatment||166
403231|NCT00123474|988635|P2|COMPLETED|Randomized to Treatment||163
403232|NCT00123474|988636|P1|COMPLETED|Randomized to Treatment||166
403233|NCT00123474|988633|P4|STARTED|Randomized to Treatment||168
403234|NCT00123474|988634|P3|STARTED|Randomized to Treatment||168
403235|NCT00123474|988635|P2|STARTED|Randomized to Treatment||167
403236|NCT00123474|988636|P1|STARTED|Randomized to Treatment||167
403237|NCT00123422|988730|P3|NOT COMPLETED|Overall Study||10
403238|NCT00123422|988731|P2|NOT COMPLETED|Overall Study||6
403239|NCT00123422|988732|P1|NOT COMPLETED|Overall Study||4
403240|NCT00123422|988730|P3|COMPLETED|Overall Study||25
403241|NCT00123422|988731|P2|COMPLETED|Overall Study||27
403242|NCT00123422|988732|P1|COMPLETED|Overall Study||31
403243|NCT00123422|988730|P3|8-week Testing|Overall Study||27
403244|NCT00123422|988731|P2|8-week Testing|Overall Study||30
403245|NCT00123422|988732|P1|8-week Testing|Overall Study||32
403246|NCT00123422|988730|P3|STARTED|Overall Study||35
403247|NCT00123422|988731|P2|STARTED|Overall Study||33
403248|NCT00123422|988732|P1|STARTED|Overall Study||35
403249|NCT00123409|988745|P2|NOT COMPLETED|Overall Study||3
403250|NCT00123409|988746|P1|NOT COMPLETED|Overall Study||4
403251|NCT00123409|988745|P2|COMPLETED|Overall Study||71
403252|NCT00123409|988746|P1|COMPLETED|Overall Study||68
403253|NCT00123409|988745|P2|STARTED|Overall Study||74
403254|NCT00123409|988746|P1|STARTED|Overall Study||72
403255|NCT00123162|988756|P2|NOT COMPLETED|Overall Study||0
403256|NCT00123162|988757|P1|NOT COMPLETED|Overall Study||0
403257|NCT00123162|988756|P2|COMPLETED|Overall Study||12
403258|NCT00123162|988757|P1|COMPLETED|Overall Study||13
403259|NCT00123162|988756|P2|STARTED|Overall Study||12
403260|NCT00123162|988757|P1|STARTED|Overall Study||13
403261|NCT00123123|988768|P3|NOT COMPLETED|Overall Study||0
403262|NCT00123123|988769|P2|NOT COMPLETED|Overall Study||0
403263|NCT00123123|988770|P1|NOT COMPLETED|Overall Study||0
403264|NCT00123123|988768|P3|COMPLETED|Overall Study||58
403265|NCT00123123|988769|P2|COMPLETED|Overall Study||58
403266|NCT00123123|988770|P1|COMPLETED|Overall Study||59
403267|NCT00123123|988768|P3|STARTED|Overall Study||58
403268|NCT00123123|988769|P2|STARTED|Overall Study||58
403269|NCT00123123|988770|P1|STARTED|Overall Study||59
403270|NCT00123110|988784|P3|NOT COMPLETED|Overall Study||0
403271|NCT00123110|988785|P2|NOT COMPLETED|Overall Study||0
403272|NCT00123110|988786|P1|NOT COMPLETED|Overall Study||0
403273|NCT00123110|988784|P3|COMPLETED|Overall Study||11
403274|NCT00123110|988785|P2|COMPLETED|Overall Study||12
403275|NCT00123110|988786|P1|COMPLETED|Overall Study||12
403276|NCT00123110|988784|P3|STARTED|Overall Study||11
403277|NCT00123110|988785|P2|STARTED|Overall Study||12
403278|NCT00123110|988786|P1|STARTED|Overall Study||12
403279|NCT00122980|988820|P2|NOT COMPLETED|Overall Study||40
403280|NCT00122980|988821|P1|NOT COMPLETED|Overall Study||43
403281|NCT00122980|988820|P2|COMPLETED|Overall Study|Study terminated early|26
403282|NCT00122980|988821|P1|COMPLETED|Overall Study|Study terminated early|24
403283|NCT00122980|988820|P2|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 66|66
403284|NCT00122980|988821|P1|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 67|67
403285|NCT00122954|988845|P2|NOT COMPLETED|Overall Study||3
403286|NCT00122954|988846|P1|NOT COMPLETED|Overall Study||2
403287|NCT00122954|988845|P2|COMPLETED|Overall Study||18
403288|NCT00122954|988846|P1|COMPLETED|Overall Study||16
403289|NCT00122954|988845|P2|STARTED|Overall Study||21
403290|NCT00122954|988846|P1|STARTED|Overall Study||18
403291|NCT00122681|988856|P2|NOT COMPLETED|Overall Study||1521
403292|NCT00122681|988857|P1|NOT COMPLETED|Overall Study||1514
403293|NCT00122681|988856|P2|COMPLETED|Overall Study||7798
403294|NCT00122681|988857|P1|COMPLETED|Overall Study||7811
403295|NCT00122681|988856|P2|STARTED|Overall Study||9319
403296|NCT00122681|988857|P1|STARTED|Overall Study||9325
403297|NCT00122460|988931|P2|NOT COMPLETED|Overall Study||1
403298|NCT00122460|988932|P1|NOT COMPLETED|Overall Study||7
403299|NCT00122460|988931|P2|COMPLETED|Overall Study||219
403300|NCT00122460|988932|P1|COMPLETED|Overall Study||215
403301|NCT00122460|988931|P2|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|220
403302|NCT00122460|988932|P1|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|222
403303|NCT00122447|988958|P4|NOT COMPLETED|Overall Study||3
403304|NCT00122447|988959|P3|NOT COMPLETED|Overall Study||1
403305|NCT00122447|988960|P2|NOT COMPLETED|Overall Study||5
403306|NCT00122447|988961|P1|NOT COMPLETED|Overall Study||1
403307|NCT00122447|988958|P4|COMPLETED|Overall Study||14
403308|NCT00122447|988959|P3|COMPLETED|Overall Study||16
403309|NCT00122447|988960|P2|COMPLETED|Overall Study||13
403310|NCT00122447|988961|P1|COMPLETED|Overall Study||17
403311|NCT00122447|988958|P4|STARTED|Overall Study||17
403312|NCT00122447|988959|P3|STARTED|Overall Study||17
403313|NCT00122447|988960|P2|STARTED|Overall Study||18
403314|NCT00122447|988961|P1|STARTED|Overall Study||18
403315|NCT00122382|988981|P3|NOT COMPLETED|Open-Label Study||26
403316|NCT00122382|988982|P2|NOT COMPLETED|Open-Label Study||0
403317|NCT00122382|988983|P1|NOT COMPLETED|Open-Label Study||0
403318|NCT00122382|988981|P3|COMPLETED|Open-Label Study||433
403319|NCT00122382|988982|P2|COMPLETED|Open-Label Study||0
403320|NCT00122382|988983|P1|COMPLETED|Open-Label Study||0
403321|NCT00122382|988981|P3|STARTED|Open-Label Study||459
403322|NCT00122382|988982|P2|STARTED|Open-Label Study||0
403323|NCT00122382|988983|P1|STARTED|Open-Label Study||0
403324|NCT00122382|988981|P3|NOT COMPLETED|Double-Blind Study||0
403325|NCT00122382|988982|P2|NOT COMPLETED|Double-Blind Study||28
403326|NCT00122382|988983|P1|NOT COMPLETED|Double-Blind Study||24
403327|NCT00122382|988981|P3|COMPLETED|Double-Blind Study||0
403328|NCT00122382|988982|P2|COMPLETED|Double-Blind Study||227
403329|NCT00122382|988983|P1|COMPLETED|Double-Blind Study||232
403330|NCT00122382|988981|P3|Treated|Double-Blind Study||0
403331|NCT00122382|988982|P2|Treated|Double-Blind Study||253
403332|NCT00122382|988983|P1|Treated|Double-Blind Study||256
403333|NCT00122382|988981|P3|STARTED|Double-Blind Study||0
403334|NCT00122382|988982|P2|STARTED|Double-Blind Study|participants randomized|255
403335|NCT00122382|988983|P1|STARTED|Double-Blind Study|participants randomized|256
403336|NCT00122369|989036|P3|NOT COMPLETED|Overall Study||0
403337|NCT00122369|989037|P2|NOT COMPLETED|Overall Study||0
403338|NCT00122369|989038|P1|NOT COMPLETED|Overall Study||0
403339|NCT00122369|989036|P3|COMPLETED|Overall Study||78
403340|NCT00122369|989037|P2|COMPLETED|Overall Study||82
403341|NCT00122369|989038|P1|COMPLETED|Overall Study||76
403342|NCT00122369|989036|P3|STARTED|Overall Study||78
403343|NCT00122369|989037|P2|STARTED|Overall Study||82
403344|NCT00122369|989038|P1|STARTED|Overall Study||76
403345|NCT00122317|989127|P1|NOT COMPLETED|Overall Study||11
403346|NCT00122317|989127|P1|COMPLETED|Overall Study||176
403347|NCT00122317|989127|P1|STARTED|Overall Study||187
403348|NCT00122278|989136|P2|NOT COMPLETED|Overall Study||0
403349|NCT00122278|989137|P1|NOT COMPLETED|Overall Study||2
403350|NCT00122278|989136|P2|COMPLETED|Overall Study||99
403351|NCT00122278|989137|P1|COMPLETED|Overall Study||104
403352|NCT00122278|989136|P2|STARTED|Overall Study||99
403353|NCT00122278|989137|P1|STARTED|Overall Study||106
403354|NCT00122187|989147|P2|NOT COMPLETED|Overall Study||2
403355|NCT00122187|989148|P1|NOT COMPLETED|Overall Study||2
403356|NCT00122187|989147|P2|COMPLETED|Overall Study||2
403357|NCT00122187|989148|P1|COMPLETED|Overall Study||2
403358|NCT00122187|989147|P2|Post-intervention Data Collection|Overall Study||2
403359|NCT00122187|989148|P1|Post-intervention Data Collection|Overall Study||2
403360|NCT00122187|989147|P2|Intervention Implemented|Overall Study||4
403361|NCT00122187|989148|P1|Intervention Implemented|Overall Study||3
403362|NCT00122187|989147|P2|Randomized to Intervention or Usual Care|Overall Study||4
403363|NCT00122187|989148|P1|Randomized to Intervention or Usual Care|Overall Study||4
403364|NCT00122187|989147|P2|Matched by Colonoscopy Volume|Overall Study||4
403365|NCT00122187|989148|P1|Matched by Colonoscopy Volume|Overall Study||4
403366|NCT00122187|989147|P2|STARTED|Overall Study||4
403367|NCT00122187|989148|P1|STARTED|Overall Study||4
403368|NCT00122135|989162|P2|NOT COMPLETED|Overall Study||0
403369|NCT00122135|989163|P1|NOT COMPLETED|Overall Study||3
403370|NCT00122135|989162|P2|COMPLETED|Overall Study||60
403371|NCT00122135|989163|P1|COMPLETED|Overall Study||57
403372|NCT00122135|989162|P2|STARTED|Overall Study||60
403373|NCT00122135|989163|P1|STARTED|Overall Study||60
403374|NCT00122109|989171|P2|NOT COMPLETED|Overall Study||7
403375|NCT00122109|989172|P1|NOT COMPLETED|Overall Study||6
403376|NCT00122109|989171|P2|COMPLETED|Overall Study||57
403377|NCT00122109|989172|P1|COMPLETED|Overall Study||55
403378|NCT00122109|989171|P2|STARTED|Overall Study|ITT|64
403379|NCT00122109|989172|P1|STARTED|Overall Study|ITT|61
403380|NCT00121836|989196|P1|NOT COMPLETED|Overall Study||55
403381|NCT00121836|989196|P1|COMPLETED|Overall Study||54
403382|NCT00121836|989196|P1|STARTED|Overall Study||109
403383|NCT00121810|989207|P2|NOT COMPLETED|Overall Study||39
403384|NCT00121810|989208|P1|NOT COMPLETED|Overall Study||30
403385|NCT00121810|989207|P2|COMPLETED|Overall Study||115
403386|NCT00121810|989208|P1|COMPLETED|Overall Study||121
403387|NCT00121810|989207|P2|Intent-to-Treat (ITT) Population|Overall Study||151
403388|NCT00121810|989208|P1|Intent-to-Treat (ITT) Population|Overall Study||148
403389|NCT00121810|989207|P2|Safety Population|Overall Study||153
403390|NCT00121810|989208|P1|Safety Population|Overall Study||148
403391|NCT00121810|989207|P2|STARTED|Overall Study||154
403392|NCT00121810|989208|P1|STARTED|Overall Study||151
403393|NCT00121719|989234|P14|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
403394|NCT00121719|989235|P13|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
403395|NCT00121719|989236|P12|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||5
403396|NCT00121719|989237|P11|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||6
403397|NCT00121719|989238|P10|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
403398|NCT00121719|989239|P9|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
403399|NCT00121719|989240|P8|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
403400|NCT00121719|989241|P7|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
403401|NCT00121719|989242|P6|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
403402|NCT00121719|989243|P5|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
403403|NCT00121719|989244|P4|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
403404|NCT00121719|989245|P3|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
403405|NCT00121719|989246|P2|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
403406|NCT00121719|989247|P1|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
403407|NCT00121719|989234|P14|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
403408|NCT00121719|989235|P13|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
403409|NCT00121719|989236|P12|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
403410|NCT00121719|989237|P11|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
403411|NCT00121719|989238|P10|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
403412|NCT00121719|989239|P9|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
403413|NCT00121719|989240|P8|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
403414|NCT00121719|989241|P7|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
403415|NCT00121719|989242|P6|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
403416|NCT00121719|989243|P5|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
403417|NCT00121719|989244|P4|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
403418|NCT00121719|989245|P3|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
403419|NCT00121719|989246|P2|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
403420|NCT00121719|989247|P1|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
403421|NCT00121719|989234|P14|STARTED|Food-Effect Pilot Study (4 Weeks)||0
403422|NCT00121719|989235|P13|STARTED|Food-Effect Pilot Study (4 Weeks)||0
403423|NCT00121719|989236|P12|STARTED|Food-Effect Pilot Study (4 Weeks)|Participants in the Pilot Food Effect Study were also in the Dose Escalation Study.|5
403424|NCT00121719|989237|P11|STARTED|Food-Effect Pilot Study (4 Weeks)|Participants in the Pilot Food Effect Study were also in the Dose Escalation Study.|6
403425|NCT00121719|989238|P10|STARTED|Food-Effect Pilot Study (4 Weeks)||0
403426|NCT00121719|989239|P9|STARTED|Food-Effect Pilot Study (4 Weeks)||0
403427|NCT00121719|989240|P8|STARTED|Food-Effect Pilot Study (4 Weeks)||0
403428|NCT00121719|989241|P7|STARTED|Food-Effect Pilot Study (4 Weeks)||0
403429|NCT00121719|989242|P6|STARTED|Food-Effect Pilot Study (4 Weeks)||0
403430|NCT00121719|989243|P5|STARTED|Food-Effect Pilot Study (4 Weeks)||0
403431|NCT00121719|989244|P4|STARTED|Food-Effect Pilot Study (4 Weeks)||0
403432|NCT00121719|989245|P3|STARTED|Food-Effect Pilot Study (4 Weeks)||0
403433|NCT00121719|989246|P2|STARTED|Food-Effect Pilot Study (4 Weeks)||0
403434|NCT00121719|989247|P1|STARTED|Food-Effect Pilot Study (4 Weeks)||0
403435|NCT00121719|989234|P14|NOT COMPLETED|Dose Escalation (4 Weeks)||7
403436|NCT00121719|989235|P13|NOT COMPLETED|Dose Escalation (4 Weeks)||24
403437|NCT00121719|989236|P12|NOT COMPLETED|Dose Escalation (4 Weeks)||0
403438|NCT00121719|989237|P11|NOT COMPLETED|Dose Escalation (4 Weeks)||0
403439|NCT00121719|989238|P10|NOT COMPLETED|Dose Escalation (4 Weeks)||3
403440|NCT00121719|989239|P9|NOT COMPLETED|Dose Escalation (4 Weeks)||6
403441|NCT00121719|989240|P8|NOT COMPLETED|Dose Escalation (4 Weeks)||9
403442|NCT00121719|989241|P7|NOT COMPLETED|Dose Escalation (4 Weeks)||12
403443|NCT00121719|989242|P6|NOT COMPLETED|Dose Escalation (4 Weeks)||3
403444|NCT00121719|989243|P5|NOT COMPLETED|Dose Escalation (4 Weeks)||3
403445|NCT00121719|989244|P4|NOT COMPLETED|Dose Escalation (4 Weeks)||3
403446|NCT00121719|989245|P3|NOT COMPLETED|Dose Escalation (4 Weeks)||4
403447|NCT00121719|989246|P2|NOT COMPLETED|Dose Escalation (4 Weeks)||4
403448|NCT00121719|989247|P1|NOT COMPLETED|Dose Escalation (4 Weeks)||4
403449|NCT00121719|989234|P14|COMPLETED|Dose Escalation (4 Weeks)||0
403450|NCT00121719|989235|P13|COMPLETED|Dose Escalation (4 Weeks)||0
403451|NCT00121719|989236|P12|COMPLETED|Dose Escalation (4 Weeks)||0
403452|NCT00121719|989237|P11|COMPLETED|Dose Escalation (4 Weeks)||0
403453|NCT00121719|989238|P10|COMPLETED|Dose Escalation (4 Weeks)||0
403454|NCT00121719|989239|P9|COMPLETED|Dose Escalation (4 Weeks)||0
403455|NCT00121719|989240|P8|COMPLETED|Dose Escalation (4 Weeks)||0
403456|NCT00121719|989241|P7|COMPLETED|Dose Escalation (4 Weeks)||0
403457|NCT00121719|989242|P6|COMPLETED|Dose Escalation (4 Weeks)||0
403458|NCT00121719|989243|P5|COMPLETED|Dose Escalation (4 Weeks)||0
403459|NCT00121719|989244|P4|COMPLETED|Dose Escalation (4 Weeks)||0
403460|NCT00121719|989245|P3|COMPLETED|Dose Escalation (4 Weeks)||0
403461|NCT00121719|989246|P2|COMPLETED|Dose Escalation (4 Weeks)||0
403462|NCT00121719|989247|P1|COMPLETED|Dose Escalation (4 Weeks)||0
403463|NCT00121719|989234|P14|STARTED|Dose Escalation (4 Weeks)||7
403464|NCT00121719|989235|P13|STARTED|Dose Escalation (4 Weeks)||24
403465|NCT00121719|989236|P12|STARTED|Dose Escalation (4 Weeks)||0
403466|NCT00121719|989237|P11|STARTED|Dose Escalation (4 Weeks)||0
403467|NCT00121719|989238|P10|STARTED|Dose Escalation (4 Weeks)||3
403468|NCT00121719|989239|P9|STARTED|Dose Escalation (4 Weeks)||6
403469|NCT00121719|989240|P8|STARTED|Dose Escalation (4 Weeks)||9
403470|NCT00121719|989241|P7|STARTED|Dose Escalation (4 Weeks)||12
403471|NCT00121719|989242|P6|STARTED|Dose Escalation (4 Weeks)||3
403472|NCT00121719|989243|P5|STARTED|Dose Escalation (4 Weeks)||3
403473|NCT00121719|989244|P4|STARTED|Dose Escalation (4 Weeks)||3
403474|NCT00121719|989245|P3|STARTED|Dose Escalation (4 Weeks)||4
403475|NCT00121719|989246|P2|STARTED|Dose Escalation (4 Weeks)||4
403476|NCT00121719|989247|P1|STARTED|Dose Escalation (4 Weeks)||4
403477|NCT00121667|989424|P4|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||140
403478|NCT00121667|989425|P3|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||113
403479|NCT00121667|989426|P2|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||133
403480|NCT00121667|989427|P1|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||128
403481|NCT00121667|989424|P4|COMPLETED|Short Term (ST) + Long Term (LT) Period||39
403482|NCT00121667|989425|P3|COMPLETED|Short Term (ST) + Long Term (LT) Period||68
403483|NCT00121667|989426|P2|COMPLETED|Short Term (ST) + Long Term (LT) Period||58
403484|NCT00121667|989427|P1|COMPLETED|Short Term (ST) + Long Term (LT) Period||64
403485|NCT00121667|989424|P4|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||7
403486|NCT00121667|989425|P3|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||23
403487|NCT00121667|989426|P2|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||18
403488|NCT00121667|989427|P1|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||14
403489|NCT00121667|989424|P4|STARTED|Short Term (ST) + Long Term (LT) Period||179
403490|NCT00121667|989425|P3|STARTED|Short Term (ST) + Long Term (LT) Period||181
403491|NCT00121667|989426|P2|STARTED|Short Term (ST) + Long Term (LT) Period||191
403492|NCT00121667|989427|P1|STARTED|Short Term (ST) + Long Term (LT) Period||192
403493|NCT00121667|989424|P4|NOT COMPLETED|Short Term (ST) Period||67
403494|NCT00121667|989425|P3|NOT COMPLETED|Short Term (ST) Period||41
403495|NCT00121667|989426|P2|NOT COMPLETED|Short Term (ST) Period||48
403496|NCT00121667|989427|P1|NOT COMPLETED|Short Term (ST) Period||44
403497|NCT00121667|989424|P4|COMPLETED|Short Term (ST) Period||112
403498|NCT00121667|989425|P3|COMPLETED|Short Term (ST) Period||140
403499|NCT00121667|989426|P2|COMPLETED|Short Term (ST) Period||143
403500|NCT00121667|989427|P1|COMPLETED|Short Term (ST) Period||148
403501|NCT00121667|989424|P4|STARTED|Short Term (ST) Period||179
403502|NCT00121667|989425|P3|STARTED|Short Term (ST) Period||181
403503|NCT00121667|989426|P2|STARTED|Short Term (ST) Period||191
403504|NCT00121667|989427|P1|STARTED|Short Term (ST) Period||192
403505|NCT00121641|989525|P5|NOT COMPLETED|48-month Short Term + Long Term Period||58
403506|NCT00121641|989526|P4|NOT COMPLETED|48-month Short Term + Long Term Period||71
403507|NCT00121641|989527|P3|NOT COMPLETED|48-month Short Term + Long Term Period||70
403508|NCT00121641|989528|P2|NOT COMPLETED|48-month Short Term + Long Term Period||82
403509|NCT00121641|989529|P1|NOT COMPLETED|48-month Short Term + Long Term Period||79
403510|NCT00121641|989525|P5|COMPLETED|48-month Short Term + Long Term Period||8
403511|NCT00121641|989526|P4|COMPLETED|48-month Short Term + Long Term Period||24
403512|NCT00121641|989527|P3|COMPLETED|48-month Short Term + Long Term Period||28
403513|NCT00121641|989528|P2|COMPLETED|48-month Short Term + Long Term Period||24
403514|NCT00121641|989529|P1|COMPLETED|48-month Short Term + Long Term Period||23
403515|NCT00121641|989525|P5|STARTED|48-month Short Term + Long Term Period||66
403516|NCT00121641|989526|P4|STARTED|48-month Short Term + Long Term Period||95
403517|NCT00121641|989527|P3|STARTED|48-month Short Term + Long Term Period||98
403518|NCT00121641|989528|P2|STARTED|48-month Short Term + Long Term Period||106
403519|NCT00121641|989529|P1|STARTED|48-month Short Term + Long Term Period||102
403520|NCT00121641|989525|P5|NOT COMPLETED|24-week Short-term Treatment Period||41
403521|NCT00121641|989526|P4|NOT COMPLETED|24-week Short-term Treatment Period||40
403522|NCT00121641|989527|P3|NOT COMPLETED|24-week Short-term Treatment Period||29
403523|NCT00121641|989528|P2|NOT COMPLETED|24-week Short-term Treatment Period||38
403524|NCT00121641|989529|P1|NOT COMPLETED|24-week Short-term Treatment Period||29
403525|NCT00121641|989525|P5|COMPLETED|24-week Short-term Treatment Period||25
403526|NCT00121641|989526|P4|COMPLETED|24-week Short-term Treatment Period||55
403527|NCT00121641|989527|P3|COMPLETED|24-week Short-term Treatment Period||69
403528|NCT00121641|989528|P2|COMPLETED|24-week Short-term Treatment Period||68
403529|NCT00121641|989529|P1|COMPLETED|24-week Short-term Treatment Period||73
403530|NCT00121641|989525|P5|STARTED|24-week Short-term Treatment Period||66
403531|NCT00121641|989526|P4|STARTED|24-week Short-term Treatment Period||95
403532|NCT00121641|989527|P3|STARTED|24-week Short-term Treatment Period||98
403533|NCT00121641|989528|P2|STARTED|24-week Short-term Treatment Period||106
403534|NCT00121641|989529|P1|STARTED|24-week Short-term Treatment Period||102
403535|NCT00121485|989642|P2|NOT COMPLETED|Overall Study||7
403536|NCT00121485|989643|P1|NOT COMPLETED|Overall Study||1
403537|NCT00121485|989642|P2|COMPLETED|Overall Study||59
403538|NCT00121485|989643|P1|COMPLETED|Overall Study||133
403539|NCT00121485|989642|P2|STARTED|Overall Study||66
403540|NCT00121485|989643|P1|STARTED|Overall Study||134
403541|NCT00121472|989677|P1|NOT COMPLETED|Overall Study||0
403542|NCT00121472|989677|P1|COMPLETED|Overall Study|Followed for at least 1 year after implantation of HM II LVAS.|194
403543|NCT00121472|989677|P1|STARTED|Overall Study||194
403544|NCT00121238|989688|P1|NOT COMPLETED|Overall Study||3
403545|NCT00121238|989688|P1|COMPLETED|Overall Study|2 were later deemed ineligible (PSA rise), censored from efficacy but included for toxicity analysis|13
403546|NCT00121238|989688|P1|STARTED|Overall Study||16
403547|NCT00121225|989696|P1|NOT COMPLETED|Overall Study||0
403548|NCT00121225|989696|P1|COMPLETED|Overall Study||32
403549|NCT00121225|989696|P1|STARTED|Overall Study||32
403550|NCT00121199|989704|P1|NOT COMPLETED|Overall Study||28
403551|NCT00121199|989704|P1|COMPLETED|Overall Study||45
403552|NCT00121199|989704|P1|Eligible and Began Protocol Therapy|Overall Study||64
403553|NCT00121199|989704|P1|Eligible|Overall Study||64
403554|NCT00121199|989704|P1|STARTED|Overall Study||73
403555|NCT00121186|989711|P1|NOT COMPLETED|Overall Study||0
403556|NCT00121186|989711|P1|COMPLETED|Overall Study||1
403557|NCT00121186|989711|P1|STARTED|Overall Study||1
403558|NCT00121173|989719|P3|NOT COMPLETED|Overall Study||0
403559|NCT00121173|989720|P2|NOT COMPLETED|Overall Study||0
403560|NCT00121173|989721|P1|NOT COMPLETED|Overall Study||1
403561|NCT00121173|989719|P3|COMPLETED|Overall Study||9
403562|NCT00121173|989720|P2|COMPLETED|Overall Study||3
403563|NCT00121173|989721|P1|COMPLETED|Overall Study||3
403564|NCT00121173|989719|P3|STARTED|Overall Study||9
403565|NCT00121173|989720|P2|STARTED|Overall Study||3
403566|NCT00121173|989721|P1|STARTED|Overall Study||4
403567|NCT00121134|989748|P4|NOT COMPLETED|Overall Study||9
403568|NCT00121134|989749|P3|NOT COMPLETED|Overall Study||21
403569|NCT00121134|989750|P2|NOT COMPLETED|Overall Study||15
403570|NCT00121134|989751|P1|NOT COMPLETED|Overall Study||16
403571|NCT00121134|989748|P4|COMPLETED|Overall Study||31
403572|NCT00121134|989749|P3|COMPLETED|Overall Study||20
403573|NCT00121134|989750|P2|COMPLETED|Overall Study||26
403574|NCT00121134|989751|P1|COMPLETED|Overall Study||24
403575|NCT00121134|989748|P4|STARTED|Overall Study||40
403576|NCT00121134|989749|P3|STARTED|Overall Study||41
403577|NCT00121134|989750|P2|STARTED|Overall Study||41
403578|NCT00121134|989751|P1|STARTED|Overall Study||40
403579|NCT00120874|989763|P2|NOT COMPLETED|Overall Study||1
403580|NCT00120874|989764|P1|NOT COMPLETED|Overall Study||0
403581|NCT00120874|989763|P2|COMPLETED|Overall Study||9
403582|NCT00120874|989764|P1|COMPLETED|Overall Study||10
403583|NCT00120874|989763|P2|Completed Study; Started Extension Study|Overall Study||10
403584|NCT00120874|989764|P1|Completed Study; Started Extension Study|Overall Study||10
403585|NCT00120874|989763|P2|STARTED|Overall Study||10
403586|NCT00120874|989764|P1|STARTED|Overall Study||10
403587|NCT00120627|989802|P2|NOT COMPLETED|Overall Study||5
403588|NCT00120627|989803|P1|NOT COMPLETED|Overall Study||5
403589|NCT00120627|989802|P2|COMPLETED|Overall Study|Three people refused the post-assessments CAPS interview only.|70
403590|NCT00120627|989803|P1|COMPLETED|Overall Study||66
403591|NCT00120627|989802|P2|Did Not Complete Post-tx Assessments|Overall Study|Three people dropped out but no reason given.|3
403592|NCT00120627|989803|P1|Did Not Complete Post-tx Assessments|Overall Study|One person had a scheduling conflict and two people were incarcerated.|3
403593|NCT00120627|989802|P2|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and an unknown reason.|73
403594|NCT00120627|989803|P1|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and illness.|69
403595|NCT00120627|989802|P2|STARTED|Overall Study|This was the number that enrolled and was randomly assigned to receive the control condition.|75
403596|NCT00120627|989803|P1|STARTED|Overall Study|This is the number who enrolled and was randomly assigned to receive the Mantram Repetition Program.|71
403597|NCT00120523|989829|P2|NOT COMPLETED|Follow-Up Period||24
403598|NCT00120523|989830|P1|NOT COMPLETED|Follow-Up Period||30
403599|NCT00120523|989829|P2|COMPLETED|Follow-Up Period||46
403600|NCT00120523|989830|P1|COMPLETED|Follow-Up Period||90
403601|NCT00120523|989829|P2|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|70
403602|NCT00120523|989830|P1|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|120
403603|NCT00120523|989829|P2|NOT COMPLETED|Treatment Period||339
403604|NCT00120523|989830|P1|NOT COMPLETED|Treatment Period||369
403605|NCT00120523|989829|P2|COMPLETED|Treatment Period||874
403606|NCT00120523|989830|P1|COMPLETED|Treatment Period||836
403607|NCT00120523|989829|P2|STARTED|Treatment Period||1213
403608|NCT00120523|989830|P1|STARTED|Treatment Period||1205
403609|NCT00120406|989854|P2|NOT COMPLETED|Overall Study||16
403610|NCT00120406|989855|P1|NOT COMPLETED|Overall Study||19
403611|NCT00120406|989854|P2|COMPLETED|Overall Study||222
403612|NCT00120406|989855|P1|COMPLETED|Overall Study||217
403613|NCT00120406|989854|P2|STARTED|Overall Study||238
403614|NCT00120406|989855|P1|STARTED|Overall Study||236
403615|NCT00120289|989865|P2|NOT COMPLETED|Overall Study||109
403616|NCT00120289|989866|P1|NOT COMPLETED|Overall Study||121
403617|NCT00120289|989865|P2|COMPLETED|Overall Study||1587
403618|NCT00120289|989866|P1|COMPLETED|Overall Study||1597
403619|NCT00120289|989865|P2|STARTED|Overall Study||1696
403620|NCT00120289|989866|P1|STARTED|Overall Study||1718
403621|NCT00120250|989878|P2|NOT COMPLETED|Overall Study||2
403622|NCT00120250|989879|P1|NOT COMPLETED|Overall Study||1
403623|NCT00120250|989878|P2|COMPLETED|Overall Study||12
403624|NCT00120250|989879|P1|COMPLETED|Overall Study||12
403625|NCT00120250|989878|P2|STARTED|Overall Study||14
403626|NCT00120250|989879|P1|STARTED|Overall Study||13
403627|NCT00120042|989895|P3|NOT COMPLETED|Overall Study||0
403628|NCT00120042|989896|P2|NOT COMPLETED|Overall Study||0
403629|NCT00120042|989897|P1|NOT COMPLETED|Overall Study||0
403630|NCT00120042|989895|P3|COMPLETED|Overall Study||83
403631|NCT00120042|989896|P2|COMPLETED|Overall Study||83
403632|NCT00120042|989897|P1|COMPLETED|Overall Study||85
403633|NCT00120042|989895|P3|STARTED|Overall Study||83
403634|NCT00120042|989896|P2|STARTED|Overall Study||83
403635|NCT00120042|989897|P1|STARTED|Overall Study||85
403636|NCT00119847|989907|P2|NOT COMPLETED|Overall Study||32
403637|NCT00119847|989908|P1|NOT COMPLETED|Overall Study||31
403638|NCT00119847|989907|P2|COMPLETED|Overall Study||119
403639|NCT00119847|989908|P1|COMPLETED|Overall Study||118
403640|NCT00119847|989907|P2|STARTED|Overall Study||151
403641|NCT00119847|989908|P1|STARTED|Overall Study||149
403642|NCT00119678|989920|P2|NOT COMPLETED|Open-label Treatment Period||0
403643|NCT00119678|989921|P1|NOT COMPLETED|Open-label Treatment Period||110
403644|NCT00119678|989920|P2|COMPLETED|Open-label Treatment Period||0
403645|NCT00119678|989921|P1|COMPLETED|Open-label Treatment Period||0
403646|NCT00119678|989920|P2|STARTED|Open-label Treatment Period||0
403647|NCT00119678|989921|P1|STARTED|Open-label Treatment Period|Number of participants treated|110
403648|NCT00119678|989920|P2|NOT COMPLETED|Double-blind Treatment Period||26
403649|NCT00119678|989921|P1|NOT COMPLETED|Double-blind Treatment Period||41
403650|NCT00119678|989920|P2|COMPLETED|Double-blind Treatment Period||35
403651|NCT00119678|989921|P1|COMPLETED|Double-blind Treatment Period||81
403652|NCT00119678|989920|P2|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||57
403653|NCT00119678|989921|P1|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||118
403654|NCT00119678|989920|P2|RANDOMIZED AND TREATED|Double-blind Treatment Period||59
403655|NCT00119678|989921|P1|RANDOMIZED AND TREATED|Double-blind Treatment Period||121
403656|NCT00119678|989920|P2|STARTED|Double-blind Treatment Period||61
403657|NCT00119678|989921|P1|STARTED|Double-blind Treatment Period||122
403658|NCT00119405|989967|P1|NOT COMPLETED|Overall Study||1
403659|NCT00119405|989967|P1|COMPLETED|Overall Study||17
403660|NCT00119405|989967|P1|STARTED|Overall Study||18
403661|NCT00119392|989971|P1|NOT COMPLETED|Overall Study||5
403662|NCT00119392|989971|P1|COMPLETED|Overall Study||40
403663|NCT00119392|989971|P1|STARTED|Overall Study||45
403664|NCT00119379|989981|P2|NOT COMPLETED|Overall Study||1
403665|NCT00119379|989982|P1|NOT COMPLETED|Overall Study||4
403666|NCT00119379|989981|P2|COMPLETED|Overall Study||23
403667|NCT00119379|989982|P1|COMPLETED|Overall Study||22
403668|NCT00119379|989981|P2|STARTED|Overall Study||24
403669|NCT00119379|989982|P1|STARTED|Overall Study||26
403670|NCT00119262|990000|P2|NOT COMPLETED|Overall Study||58
403671|NCT00119262|990001|P1|NOT COMPLETED|Overall Study||46
403672|NCT00119262|990000|P2|COMPLETED|Overall Study||64
403673|NCT00119262|990001|P1|COMPLETED|Overall Study||58
403674|NCT00119262|990000|P2|Eligible and Treated|Overall Study||119
403675|NCT00119262|990001|P1|Eligible and Treated|Overall Study||102
403676|NCT00119262|990000|P2|Treated|Overall Study||120
403677|NCT00119262|990001|P1|Treated|Overall Study||103
403678|NCT00119262|990000|P2|Eligible|Overall Study||120
403679|NCT00119262|990001|P1|Eligible|Overall Study||103
403680|NCT00119262|990000|P2|STARTED|Overall Study||122
403681|NCT00119262|990001|P1|STARTED|Overall Study||104
403682|NCT00119158|990013|P2|NOT COMPLETED|Placebo Treatment||0
403683|NCT00119158|990014|P1|NOT COMPLETED|Placebo Treatment||0
403684|NCT00119158|990013|P2|COMPLETED|Placebo Treatment||45
403685|NCT00119158|990014|P1|COMPLETED|Placebo Treatment||45
403686|NCT00119158|990013|P2|STARTED|Placebo Treatment||45
403687|NCT00119158|990014|P1|STARTED|Placebo Treatment||45
403688|NCT00119158|990013|P2|NOT COMPLETED|Active Treatment||0
403689|NCT00119158|990014|P1|NOT COMPLETED|Active Treatment||0
403690|NCT00119158|990013|P2|COMPLETED|Active Treatment||45
403691|NCT00119158|990014|P1|COMPLETED|Active Treatment||45
403692|NCT00119158|990013|P2|STARTED|Active Treatment||45
403693|NCT00119158|990014|P1|STARTED|Active Treatment|patients are self controls|45
403694|NCT00119041|990025|P3|NOT COMPLETED|Overall Study||0
403695|NCT00119041|990026|P2|NOT COMPLETED|Overall Study||0
403696|NCT00119041|990027|P1|NOT COMPLETED|Overall Study||0
403697|NCT00119041|990025|P3|COMPLETED|Overall Study||22
403698|NCT00119041|990026|P2|COMPLETED|Overall Study||83
403699|NCT00119041|990027|P1|COMPLETED|Overall Study||199
403700|NCT00119041|990025|P3|STARTED|Overall Study||22
403701|NCT00119041|990026|P2|STARTED|Overall Study||83
403702|NCT00119041|990027|P1|STARTED|Overall Study||199
403703|NCT00119015|990038|P3|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
403704|NCT00119015|990039|P2|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
403705|NCT00119015|990040|P1|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
403706|NCT00119015|990038|P3|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||26
403707|NCT00119015|990039|P2|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||28
403708|NCT00119015|990040|P1|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
403709|NCT00119015|990038|P3|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|26
403710|NCT00119015|990039|P2|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|28
403711|NCT00119015|990040|P1|STARTED|Double-Blind, Randomized Phase (2 Weeks)||0
403712|NCT00119015|990038|P3|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
403713|NCT00119015|990039|P2|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
403714|NCT00119015|990040|P1|NOT COMPLETED|Open-Label Phase (2 Weeks)||48
403715|NCT00119015|990038|P3|COMPLETED|Open-Label Phase (2 Weeks)||0
403716|NCT00119015|990039|P2|COMPLETED|Open-Label Phase (2 Weeks)||0
403717|NCT00119015|990040|P1|COMPLETED|Open-Label Phase (2 Weeks)||54
403718|NCT00119015|990038|P3|STARTED|Open-Label Phase (2 Weeks)||0
403719|NCT00119015|990039|P2|STARTED|Open-Label Phase (2 Weeks)||0
403720|NCT00119015|990040|P1|STARTED|Open-Label Phase (2 Weeks)||102
403721|NCT00118911|990056|P2|NOT COMPLETED|Overall Study||5
403722|NCT00118911|990057|P1|NOT COMPLETED|Overall Study||2
403723|NCT00118911|990056|P2|COMPLETED|Overall Study||38
403724|NCT00118911|990057|P1|COMPLETED|Overall Study||41
403725|NCT00118911|990056|P2|12 Month Follow-up|Overall Study|2 participants did not complete the 6 month follow-up but did complete the 12 month follow-up|32
403726|NCT00118911|990057|P1|12 Month Follow-up|Overall Study|1 participant did not complete the 6 month follow-up but did complete the 12 month follow-up|38
403727|NCT00118911|990056|P2|6 Month Follow-up|Overall Study||30
403728|NCT00118911|990057|P1|6 Month Follow-up|Overall Study||37
403729|NCT00118911|990056|P2|Completed Post-Treatment Assessment|Overall Study||37
403730|NCT00118911|990057|P1|Completed Post-Treatment Assessment|Overall Study||41
403731|NCT00118911|990056|P2|Received Intervention as Assigned|Overall Study||38
403732|NCT00118911|990057|P1|Received Intervention as Assigned|Overall Study||41
403733|NCT00118911|990056|P2|STARTED|Overall Study||43
403734|NCT00118911|990057|P1|STARTED|Overall Study||43
403735|NCT00118898|990069|P4|NOT COMPLETED|Overall Study||141
403736|NCT00118898|990070|P3|NOT COMPLETED|Overall Study||123
403737|NCT00118898|990071|P2|NOT COMPLETED|Overall Study||141
403738|NCT00118898|990072|P1|NOT COMPLETED|Overall Study||121
403739|NCT00118898|990069|P4|COMPLETED|Overall Study||322
403740|NCT00118898|990070|P3|COMPLETED|Overall Study||342
403741|NCT00118898|990071|P2|COMPLETED|Overall Study||324
403742|NCT00118898|990072|P1|COMPLETED|Overall Study||343
403743|NCT00118898|990069|P4|Initiated Treatment|Overall Study||462
403744|NCT00118898|990070|P3|Initiated Treatment|Overall Study||464
403745|NCT00118898|990071|P2|Initiated Treatment|Overall Study||461
403746|NCT00118898|990072|P1|Initiated Treatment|Overall Study||461
403747|NCT00118898|990069|P4|STARTED|Overall Study||463
403748|NCT00118898|990070|P3|STARTED|Overall Study||465
403749|NCT00118898|990071|P2|STARTED|Overall Study||465
403750|NCT00118898|990072|P1|STARTED|Overall Study||464
403751|NCT00118755|990168|P2|NOT COMPLETED|Overall Study||215
403752|NCT00118755|990169|P1|NOT COMPLETED|Overall Study||210
403753|NCT00118755|990168|P2|COMPLETED|Overall Study||3
403754|NCT00118755|990169|P1|COMPLETED|Overall Study||7
403755|NCT00118755|990168|P2|Safety Population|Overall Study||211
403756|NCT00118755|990169|P1|Safety Population|Overall Study||208
403757|NCT00118755|990168|P2|STARTED|Overall Study||218
403758|NCT00118755|990169|P1|STARTED|Overall Study||217
403759|NCT00118742|990183|P2|NOT COMPLETED|Overall Study||66
403760|NCT00118742|990184|P1|NOT COMPLETED|Overall Study||49
403761|NCT00118742|990183|P2|COMPLETED|Overall Study||82
403762|NCT00118742|990184|P1|COMPLETED|Overall Study||96
403763|NCT00118742|990183|P2|STARTED|Overall Study||148
403764|NCT00118742|990184|P1|STARTED|Overall Study||145
403765|NCT00118716|990198|P2|NOT COMPLETED|Overall Study||22
403766|NCT00118716|990199|P1|NOT COMPLETED|Overall Study||13
403767|NCT00118716|990198|P2|COMPLETED|Overall Study||102
403768|NCT00118716|990199|P1|COMPLETED|Overall Study||111
403769|NCT00118716|990198|P2|STARTED|Overall Study||124
403770|NCT00118716|990199|P1|STARTED|Overall Study||124
403771|NCT00118703|990219|P2|NOT COMPLETED|Overall Study||9
403772|NCT00118703|990220|P1|NOT COMPLETED|Overall Study||5
403773|NCT00118703|990219|P2|COMPLETED|Overall Study||165
403774|NCT00118703|990220|P1|COMPLETED|Overall Study||168
403775|NCT00118703|990219|P2|STARTED|Overall Study||174
403776|NCT00118703|990220|P1|STARTED|Overall Study||173
403777|NCT00118534|990232|P2|NOT COMPLETED|Overall Study||0
403778|NCT00118534|990233|P1|NOT COMPLETED|Overall Study||0
403779|NCT00118534|990232|P2|COMPLETED|Overall Study||471
403780|NCT00118534|990233|P1|COMPLETED|Overall Study||472
403781|NCT00118534|990232|P2|STARTED|Overall Study||471
403782|NCT00118534|990233|P1|STARTED|Overall Study||472
403783|NCT00118482|990317|P2|NOT COMPLETED|Overall Study||29
403784|NCT00118482|990318|P1|NOT COMPLETED|Overall Study||30
403785|NCT00118482|990317|P2|COMPLETED|Overall Study||76
403786|NCT00118482|990318|P1|COMPLETED|Overall Study|210 in the Intention To Treat analysis|75
403787|NCT00118482|990317|P2|STARTED|Overall Study||105
403788|NCT00118482|990318|P1|STARTED|Overall Study|3 patients signed the consent but did not take the study medication.|105
403789|NCT00118430|990333|P3|NOT COMPLETED|Overall Study||28
403790|NCT00118430|990334|P2|NOT COMPLETED|Overall Study||24
403791|NCT00118430|990335|P1|NOT COMPLETED|Overall Study||21
403792|NCT00118430|990333|P3|COMPLETED|Overall Study||222
403883|NCT00117962|990621|P1|NOT COMPLETED|Overall Study||22
403884|NCT00117962|990620|P2|COMPLETED|Overall Study||28
403793|NCT00118430|990334|P2|COMPLETED|Overall Study|127 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|103
403794|NCT00118430|990335|P1|COMPLETED|Overall Study|123 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|102
403795|NCT00118430|990333|P3|STARTED|Overall Study||250
403796|NCT00118430|990334|P2|STARTED|Overall Study||127
403797|NCT00118430|990335|P1|STARTED|Overall Study||123
403798|NCT00118417|990350|P2|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
403799|NCT00118417|990351|P1|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
403800|NCT00118417|990350|P2|COMPLETED|Phase III (Weeks 12 to 24)||9
403801|NCT00118417|990351|P1|COMPLETED|Phase III (Weeks 12 to 24)||8
403802|NCT00118417|990350|P2|STARTED|Phase III (Weeks 12 to 24)||10
403803|NCT00118417|990351|P1|STARTED|Phase III (Weeks 12 to 24)||9
403804|NCT00118417|990350|P2|NOT COMPLETED|Phase II (Weeks 6 to 12)||3
403805|NCT00118417|990351|P1|NOT COMPLETED|Phase II (Weeks 6 to 12)||2
403806|NCT00118417|990350|P2|COMPLETED|Phase II (Weeks 6 to 12)||10
403807|NCT00118417|990351|P1|COMPLETED|Phase II (Weeks 6 to 12)||9
403808|NCT00118417|990350|P2|STARTED|Phase II (Weeks 6 to 12)||13
403809|NCT00118417|990351|P1|STARTED|Phase II (Weeks 6 to 12)|Three new participants on Phase 1 endpoint doses of SSRIs entered at Phase 2.|11
403810|NCT00118417|990350|P2|NOT COMPLETED|Phase I (Weeks 0 to 6)||0
403811|NCT00118417|990351|P1|NOT COMPLETED|Phase I (Weeks 0 to 6)||18
403812|NCT00118417|990350|P2|COMPLETED|Phase I (Weeks 0 to 6)||0
403813|NCT00118417|990351|P1|COMPLETED|Phase I (Weeks 0 to 6)||21
403814|NCT00118417|990350|P2|STARTED|Phase I (Weeks 0 to 6)|In Phase 1, all participants received open label SSRI - no second treatment arm.|0
403815|NCT00118417|990351|P1|STARTED|Phase I (Weeks 0 to 6)||39
403816|NCT00118404|990364|P3|NOT COMPLETED|Overall Study||20
403817|NCT00118404|990365|P2|NOT COMPLETED|Overall Study||16
403818|NCT00118404|990366|P1|NOT COMPLETED|Overall Study||24
403819|NCT00118404|990364|P3|COMPLETED|Overall Study||49
403820|NCT00118404|990365|P2|COMPLETED|Overall Study||70
403821|NCT00118404|990366|P1|COMPLETED|Overall Study||62
403822|NCT00118404|990364|P3|STARTED|Overall Study||69
403823|NCT00118404|990365|P2|STARTED|Overall Study||86
403824|NCT00118404|990366|P1|STARTED|Overall Study||86
403825|NCT00118378|990382|P2|NOT COMPLETED|Overall Study||8
403826|NCT00118378|990383|P1|NOT COMPLETED|Overall Study||2
403827|NCT00118378|990382|P2|COMPLETED|Overall Study||45
403828|NCT00118378|990383|P1|COMPLETED|Overall Study||60
403829|NCT00118378|990382|P2|STARTED|Overall Study||53
403830|NCT00118378|990383|P1|STARTED|Overall Study||62
403831|NCT00118365|990397|P2|NOT COMPLETED|Overall Study||60
403832|NCT00118365|990398|P1|NOT COMPLETED|Overall Study||59
403833|NCT00118365|990397|P2|COMPLETED|Overall Study||124
403834|NCT00118365|990398|P1|COMPLETED|Overall Study||132
403835|NCT00118365|990397|P2|STARTED|Overall Study||184
403836|NCT00118365|990398|P1|STARTED|Overall Study||191
403837|NCT00118352|990467|P3|NOT COMPLETED|Overall Study||0
403838|NCT00118352|990468|P2|NOT COMPLETED|Overall Study||0
403839|NCT00118352|990469|P1|NOT COMPLETED|Overall Study||0
403840|NCT00118352|990467|P3|COMPLETED|Overall Study||0
403841|NCT00118352|990468|P2|COMPLETED|Overall Study||0
403842|NCT00118352|990469|P1|COMPLETED|Overall Study||12
403843|NCT00118352|990467|P3|STARTED|Overall Study||0
403844|NCT00118352|990468|P2|STARTED|Overall Study||0
403845|NCT00118352|990469|P1|STARTED|Overall Study||12
403846|NCT00118287|990495|P1|NOT COMPLETED|Overall Study||2
403847|NCT00118287|990495|P1|COMPLETED|Overall Study||30
403848|NCT00118287|990495|P1|STARTED|Overall Study||32
403849|NCT00118248|990501|P2|NOT COMPLETED|Overall Study||0
403850|NCT00118248|990502|P1|NOT COMPLETED|Overall Study||0
403851|NCT00118248|990501|P2|COMPLETED|Overall Study||24
403852|NCT00118248|990502|P1|COMPLETED|Overall Study||17
403853|NCT00118248|990501|P2|STARTED|Overall Study||24
403854|NCT00118248|990502|P1|STARTED|Overall Study||17
403855|NCT00118157|990515|P1|NOT COMPLETED|Overall Study||12
403856|NCT00118157|990515|P1|COMPLETED|Overall Study||7
403857|NCT00118157|990515|P1|STARTED|Overall Study||19
403858|NCT00118144|990520|P1|NOT COMPLETED|Overall Study||1
403859|NCT00118144|990520|P1|COMPLETED|Overall Study||41
403860|NCT00118144|990520|P1|STARTED|Overall Study||42
403861|NCT00118131|990526|P1|NOT COMPLETED|Overall Study||0
403862|NCT00118131|990526|P1|COMPLETED|Overall Study||49
403863|NCT00118131|990526|P1|STARTED|Overall Study||49
403864|NCT00118092|990533|P1|NOT COMPLETED|Overall Study||2
403865|NCT00118092|990533|P1|COMPLETED|Overall Study||15
403866|NCT00118092|990533|P1|STARTED|Overall Study||17
403867|NCT00118053|990541|P1|NOT COMPLETED|Overall Study||0
403868|NCT00118053|990541|P1|COMPLETED|Overall Study||5
403869|NCT00118053|990541|P1|STARTED|Overall Study||5
403870|NCT00118040|990551|P3|NOT COMPLETED|Overall Study||6
403871|NCT00118040|990552|P2|NOT COMPLETED|Overall Study||2
403872|NCT00118040|990553|P1|NOT COMPLETED|Overall Study||1
403873|NCT00118040|990551|P3|COMPLETED|Overall Study||14
403874|NCT00118040|990552|P2|COMPLETED|Overall Study||18
403875|NCT00118040|990553|P1|COMPLETED|Overall Study||19
403876|NCT00118040|990551|P3|STARTED|Overall Study||20
403877|NCT00118040|990552|P2|STARTED|Overall Study||20
403878|NCT00118040|990553|P1|STARTED|Overall Study||20
403879|NCT00117988|990614|P1|NOT COMPLETED|Overall Study||4
403880|NCT00117988|990614|P1|COMPLETED|Overall Study||18
403881|NCT00117988|990614|P1|STARTED|Overall Study||22
403882|NCT00117962|990620|P2|NOT COMPLETED|Overall Study||25
403885|NCT00117962|990621|P1|COMPLETED|Overall Study||26
403886|NCT00117962|990620|P2|STARTED|Overall Study||53
403887|NCT00117962|990621|P1|STARTED|Overall Study||48
403888|NCT00117949|990637|P4|NOT COMPLETED|Overall Study||24
403889|NCT00117949|990638|P3|NOT COMPLETED|Overall Study||24
403890|NCT00117949|990639|P2|NOT COMPLETED|Overall Study||24
403891|NCT00117949|990640|P1|NOT COMPLETED|Overall Study||10
403892|NCT00117949|990637|P4|COMPLETED|Overall Study||0
403893|NCT00117949|990638|P3|COMPLETED|Overall Study||0
403894|NCT00117949|990639|P2|COMPLETED|Overall Study||0
403895|NCT00117949|990640|P1|COMPLETED|Overall Study||0
403896|NCT00117949|990637|P4|STARTED|Overall Study||24
403897|NCT00117949|990638|P3|STARTED|Overall Study||24
403898|NCT00117949|990639|P2|STARTED|Overall Study||24
403899|NCT00117949|990640|P1|STARTED|Overall Study|Dose level terminated prematurely due to inadequate testosterone response|10
403900|NCT00117845|990674|P1|NOT COMPLETED|Overall Study||1
403901|NCT00117845|990674|P1|COMPLETED|Overall Study||16
403902|NCT00117845|990674|P1|STARTED|Overall Study||17
403903|NCT00117806|990681|P2|NOT COMPLETED|Overall Study||16
403904|NCT00117806|990682|P1|NOT COMPLETED|Overall Study||38
403905|NCT00117806|990681|P2|COMPLETED|Overall Study||60
403906|NCT00117806|990682|P1|COMPLETED|Overall Study||43
403907|NCT00117806|990681|P2|STARTED|Overall Study||76
403908|NCT00117806|990682|P1|STARTED|Overall Study||81
403909|NCT00117793|990692|P1|NOT COMPLETED|Overall Study||12
403910|NCT00117793|990692|P1|COMPLETED|Overall Study||5
403911|NCT00117793|990692|P1|STARTED|Overall Study||17
403912|NCT00117715|990707|P1|NOT COMPLETED|Overall Study||72
403913|NCT00117715|990707|P1|COMPLETED|Overall Study||49
403914|NCT00117715|990707|P1|5 Year|Overall Study||49
403915|NCT00117715|990707|P1|4.5 Year|Overall Study||55
403916|NCT00117715|990707|P1|4 Year|Overall Study||58
403917|NCT00117715|990707|P1|3.5 Year|Overall Study||60
403918|NCT00117715|990707|P1|3 Year|Overall Study||61
403919|NCT00117715|990707|P1|2.5 Year|Overall Study||70
403920|NCT00117715|990707|P1|2 Year|Overall Study||76
403921|NCT00117715|990707|P1|1.5 Year|Overall Study||85
403922|NCT00117715|990707|P1|1 Year|Overall Study||88
403923|NCT00117715|990707|P1|STARTED|Overall Study||121
403924|NCT00117676|990715|P2|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
403925|NCT00117676|990716|P1|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
403926|NCT00117676|990715|P2|COMPLETED|Open-label Period: Weeks 433 - 480||41
403927|NCT00117676|990716|P1|COMPLETED|Open-label Period: Weeks 433 - 480||80
403928|NCT00117676|990715|P2|STARTED|Open-label Period: Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|43
403929|NCT00117676|990716|P1|STARTED|Open-label Period: Weeks 433 - 480||82
403930|NCT00117676|990715|P2|NOT COMPLETED|Open-label Period: Weeks 385 - 432||2
403931|NCT00117676|990716|P1|NOT COMPLETED|Open-label Period: Weeks 385 - 432||0
403932|NCT00117676|990715|P2|COMPLETED|Open-label Period: Weeks 385 - 432||44
403933|NCT00117676|990716|P1|COMPLETED|Open-label Period: Weeks 385 - 432||82
403934|NCT00117676|990715|P2|STARTED|Open-label Period: Weeks 385 - 432|44 participants completed 384 weeks but did not continue on study.|46
403935|NCT00117676|990716|P1|STARTED|Open-label Period: Weeks 385 - 432|94 participants completed 384 weeks but did not continue on study.|82
403936|NCT00117676|990715|P2|NOT COMPLETED|Open-label Period: Weeks 337 - 384||3
403937|NCT00117676|990716|P1|NOT COMPLETED|Open-label Period: Weeks 337 - 384||7
403938|NCT00117676|990715|P2|COMPLETED|Open-label Period: Weeks 337 - 384||90
403939|NCT00117676|990716|P1|COMPLETED|Open-label Period: Weeks 337 - 384||176
403940|NCT00117676|990715|P2|STARTED|Open-label Period: Weeks 337 - 384||93
403941|NCT00117676|990716|P1|STARTED|Open-label Period: Weeks 337 - 384||183
403942|NCT00117676|990715|P2|NOT COMPLETED|Open-label Period: Weeks 289 - 336||7
403943|NCT00117676|990716|P1|NOT COMPLETED|Open-label Period: Weeks 289 - 336||9
403944|NCT00117676|990715|P2|COMPLETED|Open-label Period: Weeks 289 - 336||93
403945|NCT00117676|990716|P1|COMPLETED|Open-label Period: Weeks 289 - 336||183
403946|NCT00117676|990715|P2|STARTED|Open-label Period: Weeks 289 - 336||100
403947|NCT00117676|990716|P1|STARTED|Open-label Period: Weeks 289 - 336||192
403948|NCT00117676|990715|P2|NOT COMPLETED|Open-label Period: Weeks 241 - 288||3
403949|NCT00117676|990716|P1|NOT COMPLETED|Open-label Period: Weeks 241 - 288||10
403950|NCT00117676|990715|P2|COMPLETED|Open-label Period: Weeks 241 - 288||100
403951|NCT00117676|990716|P1|COMPLETED|Open-label Period: Weeks 241 - 288||192
403952|NCT00117676|990715|P2|STARTED|Open-label Period: Weeks 241 - 288||103
403953|NCT00117676|990716|P1|STARTED|Open-label Period: Weeks 241 - 288||202
403954|NCT00117676|990715|P2|NOT COMPLETED|Open-label Period: Weeks 193 - 240||3
403955|NCT00117676|990716|P1|NOT COMPLETED|Open-label Period: Weeks 193 - 240||7
403956|NCT00117676|990715|P2|COMPLETED|Open-label Period: Weeks 193 - 240||103
403957|NCT00117676|990716|P1|COMPLETED|Open-label Period: Weeks 193 - 240||202
403958|NCT00117676|990715|P2|STARTED|Open-label Period: Weeks 193 - 240||106
403959|NCT00117676|990716|P1|STARTED|Open-label Period: Weeks 193 - 240||209
403960|NCT00117676|990715|P2|NOT COMPLETED|Open-label Period: Weeks 145 - 192||3
403961|NCT00117676|990716|P1|NOT COMPLETED|Open-label Period: Weeks 145 - 192||10
403962|NCT00117676|990715|P2|COMPLETED|Open-label Period: Weeks 145 - 192||106
403963|NCT00117676|990716|P1|COMPLETED|Open-label Period: Weeks 145 - 192||209
403964|NCT00117676|990715|P2|STARTED|Open-label Period: Weeks 145 - 192||109
403965|NCT00117676|990716|P1|STARTED|Open-label Period: Weeks 145 - 192||219
403966|NCT00117676|990715|P2|NOT COMPLETED|Open-label Period: Weeks 97 - 144||1
403967|NCT00117676|990716|P1|NOT COMPLETED|Open-label Period: Weeks 97 - 144||6
403968|NCT00117676|990715|P2|COMPLETED|Open-label Period: Weeks 97 - 144||109
403969|NCT00117676|990716|P1|COMPLETED|Open-label Period: Weeks 97 - 144||219
403970|NCT00117676|990715|P2|STARTED|Open-label Period: Weeks 97 - 144||110
403971|NCT00117676|990716|P1|STARTED|Open-label Period: Weeks 97 - 144||225
403972|NCT00117676|990715|P2|NOT COMPLETED|Open-label Period: Weeks 49 - 96||2
403973|NCT00117676|990716|P1|NOT COMPLETED|Open-label Period: Weeks 49 - 96||10
403974|NCT00117676|990715|P2|COMPLETED|Open-label Period: Weeks 49 - 96||110
403975|NCT00117676|990716|P1|COMPLETED|Open-label Period: Weeks 49 - 96||225
403976|NCT00117676|990715|P2|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|112
403977|NCT00117676|990716|P1|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|235
403978|NCT00117676|990715|P2|NOT COMPLETED|Double-blind Period Through Week 48||7
403979|NCT00117676|990716|P1|NOT COMPLETED|Double-blind Period Through Week 48||10
403980|NCT00117676|990715|P2|COMPLETED|Double-blind Period Through Week 48||121
403981|NCT00117676|990716|P1|COMPLETED|Double-blind Period Through Week 48||244
403982|NCT00117676|990715|P2|STARTED|Double-blind Period Through Week 48||128
403983|NCT00117676|990716|P1|STARTED|Double-blind Period Through Week 48||254
403984|NCT00117637|990805|P2|NOT COMPLETED|Second Intervention (Period 2)||22
403985|NCT00117637|990806|P1|NOT COMPLETED|Second Intervention (Period 2)||10
403986|NCT00117637|990805|P2|COMPLETED|Second Intervention (Period 2)||39
403987|NCT00117637|990806|P1|COMPLETED|Second Intervention (Period 2)||39
403988|NCT00117637|990805|P2|Subjects Received Treatment|Second Intervention (Period 2)||61
403989|NCT00117637|990806|P1|Subjects Received Treatment|Second Intervention (Period 2)||49
403990|NCT00117637|990805|P2|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|61
403991|NCT00117637|990806|P1|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|49
403992|NCT00117637|990805|P2|NOT COMPLETED|First Intervention (Period 1)||25
403993|NCT00117637|990806|P1|NOT COMPLETED|First Intervention (Period 1)||18
403994|NCT00117637|990805|P2|COMPLETED|First Intervention (Period 1)||67
403995|NCT00117637|990806|P1|COMPLETED|First Intervention (Period 1)||79
403996|NCT00117637|990805|P2|Subjects Received Treatment|First Intervention (Period 1)||90
403997|NCT00117637|990806|P1|Subjects Received Treatment|First Intervention (Period 1)||97
403998|NCT00117637|990805|P2|STARTED|First Intervention (Period 1)||92
403999|NCT00117637|990806|P1|STARTED|First Intervention (Period 1)||97
404000|NCT00117598|990881|P5|NOT COMPLETED|After Treament Cross Over||4
404001|NCT00117598|990882|P4|NOT COMPLETED|After Treament Cross Over||3
404002|NCT00117598|990883|P3|NOT COMPLETED|After Treament Cross Over||0
404003|NCT00117598|990884|P2|NOT COMPLETED|After Treament Cross Over||0
404004|NCT00117598|990885|P1|NOT COMPLETED|After Treament Cross Over||0
404005|NCT00117598|990881|P5|COMPLETED|After Treament Cross Over||0
404006|NCT00117598|990882|P4|COMPLETED|After Treament Cross Over||0
404007|NCT00117598|990883|P3|COMPLETED|After Treament Cross Over||0
404008|NCT00117598|990884|P2|COMPLETED|After Treament Cross Over||0
404009|NCT00117598|990885|P1|COMPLETED|After Treament Cross Over||0
404010|NCT00117598|990881|P5|STARTED|After Treament Cross Over||4
404011|NCT00117598|990882|P4|STARTED|After Treament Cross Over||3
404012|NCT00117598|990883|P3|STARTED|After Treament Cross Over||0
404013|NCT00117598|990884|P2|STARTED|After Treament Cross Over||0
404014|NCT00117598|990885|P1|STARTED|After Treament Cross Over||0
404015|NCT00117598|990881|P5|NOT COMPLETED|Prior to Treatment Cross Over||0
404016|NCT00117598|990882|P4|NOT COMPLETED|Prior to Treatment Cross Over||0
404017|NCT00117598|990883|P3|NOT COMPLETED|Prior to Treatment Cross Over||52
404018|NCT00117598|990884|P2|NOT COMPLETED|Prior to Treatment Cross Over||53
404019|NCT00117598|990885|P1|NOT COMPLETED|Prior to Treatment Cross Over||57
404020|NCT00117598|990881|P5|COMPLETED|Prior to Treatment Cross Over||0
404021|NCT00117598|990882|P4|COMPLETED|Prior to Treatment Cross Over||0
404022|NCT00117598|990883|P3|COMPLETED|Prior to Treatment Cross Over||4
404023|NCT00117598|990884|P2|COMPLETED|Prior to Treatment Cross Over||3
404024|NCT00117598|990885|P1|COMPLETED|Prior to Treatment Cross Over||0
404025|NCT00117598|990881|P5|STARTED|Prior to Treatment Cross Over||0
404026|NCT00117598|990882|P4|STARTED|Prior to Treatment Cross Over||0
404027|NCT00117598|990883|P3|STARTED|Prior to Treatment Cross Over||56
404028|NCT00117598|990884|P2|STARTED|Prior to Treatment Cross Over||56
404029|NCT00117598|990885|P1|STARTED|Prior to Treatment Cross Over||57
404030|NCT00117585|990913|P1|NOT COMPLETED|Overall Study||0
404031|NCT00117585|990913|P1|COMPLETED|Overall Study||341
404032|NCT00117585|990913|P1|STARTED|Overall Study||341
404033|NCT00117572|990919|P2|NOT COMPLETED|Overall Study||6
404034|NCT00117572|990920|P1|NOT COMPLETED|Overall Study||6
404035|NCT00117572|990919|P2|COMPLETED|Overall Study||135
404036|NCT00117572|990920|P1|COMPLETED|Overall Study||138
404037|NCT00117572|990919|P2|STARTED|Overall Study||141
404038|NCT00117572|990920|P1|STARTED|Overall Study||144
404039|NCT00117559|990952|P2|NOT COMPLETED|Overall Study||1
404040|NCT00117559|990953|P1|NOT COMPLETED|Overall Study||1
404041|NCT00117559|990952|P2|COMPLETED|Overall Study||9
404042|NCT00117559|990953|P1|COMPLETED|Overall Study||8
404043|NCT00117559|990952|P2|STARTED|Overall Study||10
404044|NCT00117559|990953|P1|STARTED|Overall Study||9
404045|NCT00117338|990961|P2|NOT COMPLETED|Overall Study||4
404046|NCT00117338|990962|P1|NOT COMPLETED|Overall Study||5
404047|NCT00117338|990961|P2|COMPLETED|Overall Study||127
404048|NCT00117338|990962|P1|COMPLETED|Overall Study||140
404049|NCT00117338|990961|P2|STARTED|Overall Study||131
404050|NCT00117338|990962|P1|STARTED|Overall Study||145
404051|NCT00117325|990982|P2|NOT COMPLETED|Overall Study||12
404052|NCT00117325|990983|P1|NOT COMPLETED|Overall Study||13
404053|NCT00117325|990982|P2|COMPLETED|Overall Study||167
404054|NCT00117325|990983|P1|COMPLETED|Overall Study||160
404055|NCT00117325|990982|P2|STARTED|Overall Study||179
404056|NCT00117325|990983|P1|STARTED|Overall Study||173
404057|NCT00117312|991015|P4|NOT COMPLETED|Overall Study||21
404058|NCT00117312|991016|P3|NOT COMPLETED|Overall Study||24
404059|NCT00117312|991017|P2|NOT COMPLETED|Overall Study||20
404060|NCT00117312|991018|P1|NOT COMPLETED|Overall Study||10
404061|NCT00117312|991015|P4|COMPLETED|Overall Study||3
404062|NCT00117312|991016|P3|COMPLETED|Overall Study||0
404063|NCT00117312|991017|P2|COMPLETED|Overall Study|Defined as those patients ongoing when the extension study was terminated|4
404064|NCT00117312|991018|P1|COMPLETED|Overall Study||0
404065|NCT00117312|991015|P4|Started FE200486 CS06A|Overall Study||9
404066|NCT00117312|991016|P3|Started FE200486 CS06A|Overall Study||16
404067|NCT00117312|991017|P2|Started FE200486 CS06A|Overall Study||11
404068|NCT00117312|991018|P1|Started FE200486 CS06A|Overall Study||1
404069|NCT00117312|991015|P4|STARTED|Overall Study||24
404070|NCT00117312|991016|P3|STARTED|Overall Study||24
404071|NCT00117312|991017|P2|STARTED|Overall Study||24
404072|NCT00117312|991018|P1|STARTED|Overall Study||10
404073|NCT00117286|991034|P2|NOT COMPLETED|Overall Study||21
404074|NCT00117286|991035|P1|NOT COMPLETED|Overall Study||28
404075|NCT00117286|991034|P2|COMPLETED|Overall Study||6
404076|NCT00117286|991035|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|2
404077|NCT00117286|991034|P2|Switched to Higher Dose|Overall Study||17
404078|NCT00117286|991035|P1|Switched to Higher Dose|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL)|17
404079|NCT00117286|991034|P2|STARTED|Overall Study||27
404080|NCT00117286|991035|P1|STARTED|Overall Study|Safety analysis set|30
404081|NCT00117156|991043|P1|NOT COMPLETED|Overall Study||11
404082|NCT00117156|991043|P1|COMPLETED|Overall Study||15
404083|NCT00117156|991043|P1|STARTED|Overall Study||26
404084|NCT00116857|991053|P2|NOT COMPLETED|Overall Study||4
404085|NCT00116857|991054|P1|NOT COMPLETED|Overall Study||3
404086|NCT00116857|991053|P2|COMPLETED|Overall Study||56
404087|NCT00116857|991054|P1|COMPLETED|Overall Study||59
404088|NCT00116857|991053|P2|STARTED|Overall Study||60
404089|NCT00116857|991054|P1|STARTED|Overall Study||62
404090|NCT00116844|991062|P2|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||5
404091|NCT00116844|991063|P1|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||4
404092|NCT00116844|991062|P2|COMPLETED|Period 1: Treatment Period 2 (60 Days)||28
404093|NCT00116844|991063|P1|COMPLETED|Period 1: Treatment Period 2 (60 Days)||24
404094|NCT00116844|991062|P2|STARTED|Period 1: Treatment Period 2 (60 Days)||33
404095|NCT00116844|991063|P1|STARTED|Period 1: Treatment Period 2 (60 Days)||28
404096|NCT00116844|991062|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
404097|NCT00116844|991063|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
404098|NCT00116844|991062|P2|COMPLETED|Period 2: Washout Period (7 Days)||33
404099|NCT00116844|991063|P1|COMPLETED|Period 2: Washout Period (7 Days)||28
404100|NCT00116844|991062|P2|STARTED|Period 2: Washout Period (7 Days)||33
404101|NCT00116844|991063|P1|STARTED|Period 2: Washout Period (7 Days)||28
404102|NCT00116844|991062|P2|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||3
404103|NCT00116844|991063|P1|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||7
404104|NCT00116844|991062|P2|COMPLETED|Period 1: Treatment Period 1 (60 Days)||33
404105|NCT00116844|991063|P1|COMPLETED|Period 1: Treatment Period 1 (60 Days)||28
404106|NCT00116844|991062|P2|STARTED|Period 1: Treatment Period 1 (60 Days)||36
404107|NCT00116844|991063|P1|STARTED|Period 1: Treatment Period 1 (60 Days)||35
404108|NCT00116831|991081|P2|NOT COMPLETED|Overall Study||72
404109|NCT00116831|991082|P1|NOT COMPLETED|Overall Study||73
404110|NCT00116831|991081|P2|COMPLETED|Overall Study||259
404111|NCT00116831|991082|P1|COMPLETED|Overall Study||264
404112|NCT00116831|991081|P2|STARTED|Overall Study||331
404113|NCT00116831|991082|P1|STARTED|Overall Study||337
404114|NCT00116805|991160|P2|NOT COMPLETED|Open-label Period Weeks 433 - 480||0
404115|NCT00116805|991161|P1|NOT COMPLETED|Open-label Period Weeks 433 - 480||4
404116|NCT00116805|991160|P2|COMPLETED|Open-label Period Weeks 433 - 480||29
404117|NCT00116805|991161|P1|COMPLETED|Open-label Period Weeks 433 - 480||53
404118|NCT00116805|991160|P2|STARTED|Open-label Period Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|29
404119|NCT00116805|991161|P1|STARTED|Open-label Period Weeks 433 - 480||57
404120|NCT00116805|991160|P2|NOT COMPLETED|Open-label Period Weeks 385 - 432||0
404121|NCT00116805|991161|P1|NOT COMPLETED|Open-label Period Weeks 385 - 432||2
404122|NCT00116805|991160|P2|COMPLETED|Open-label Period Weeks 385 - 432||30
404123|NCT00116805|991161|P1|COMPLETED|Open-label Period Weeks 385 - 432||57
404124|NCT00116805|991160|P2|STARTED|Open-label Period Weeks 385 - 432|26 participants completed 384 weeks but did not continue on study.|30
404125|NCT00116805|991161|P1|STARTED|Open-label Period Weeks 385 - 432|31 participants completed 384 weeks but did not continue on study.|59
404126|NCT00116805|991160|P2|NOT COMPLETED|Open-label Period Weeks 337 - 384||1
404127|NCT00116805|991161|P1|NOT COMPLETED|Open-label Period Weeks 337 - 384||8
404128|NCT00116805|991160|P2|COMPLETED|Open-label Period Weeks 337 - 384||56
404129|NCT00116805|991161|P1|COMPLETED|Open-label Period Weeks 337 - 384||90
404130|NCT00116805|991160|P2|STARTED|Open-label Period Weeks 337 - 384||57
404131|NCT00116805|991161|P1|STARTED|Open-label Period Weeks 337 - 384||98
404132|NCT00116805|991160|P2|NOT COMPLETED|Open-label Period Weeks 289 - 336||7
404133|NCT00116805|991161|P1|NOT COMPLETED|Open-label Period Weeks 289 - 336||6
404134|NCT00116805|991160|P2|COMPLETED|Open-label Period Weeks 289 - 336||57
404135|NCT00116805|991161|P1|COMPLETED|Open-label Period Weeks 289 - 336||98
404136|NCT00116805|991160|P2|STARTED|Open-label Period Weeks 289 - 336||64
404137|NCT00116805|991161|P1|STARTED|Open-label Period Weeks 289 - 336||104
404138|NCT00116805|991160|P2|NOT COMPLETED|Open-label Period Weeks 241 - 288||0
404139|NCT00116805|991161|P1|NOT COMPLETED|Open-label Period Weeks 241 - 288||6
404140|NCT00116805|991160|P2|COMPLETED|Open-label Period Weeks 241 - 288||64
404141|NCT00116805|991161|P1|COMPLETED|Open-label Period Weeks 241 - 288||104
404142|NCT00116805|991160|P2|STARTED|Open-label Period Weeks 241 - 288||64
404143|NCT00116805|991161|P1|STARTED|Open-label Period Weeks 241 - 288||110
404144|NCT00116805|991160|P2|NOT COMPLETED|Open-label Period Weeks 193 - 240||4
404145|NCT00116805|991161|P1|NOT COMPLETED|Open-label Period Weeks 193 - 240||13
404146|NCT00116805|991160|P2|COMPLETED|Open-label Period Weeks 193 - 240||64
404147|NCT00116805|991161|P1|COMPLETED|Open-label Period Weeks 193 - 240||110
404148|NCT00116805|991160|P2|STARTED|Open-label Period Weeks 193 - 240||68
404149|NCT00116805|991161|P1|STARTED|Open-label Period Weeks 193 - 240||123
404150|NCT00116805|991160|P2|NOT COMPLETED|Open-label Period Weeks 145 - 192||6
404151|NCT00116805|991161|P1|NOT COMPLETED|Open-label Period Weeks 145 - 192||10
404152|NCT00116805|991160|P2|COMPLETED|Open-label Period Weeks 145 - 192||68
404153|NCT00116805|991161|P1|COMPLETED|Open-label Period Weeks 145 - 192||123
404154|NCT00116805|991160|P2|STARTED|Open-label Period Weeks 145 - 192||74
404155|NCT00116805|991161|P1|STARTED|Open-label Period Weeks 145 - 192||133
404156|NCT00116805|991160|P2|NOT COMPLETED|Open-label Period Weeks 97 - 144||9
404157|NCT00116805|991161|P1|NOT COMPLETED|Open-label Period Weeks 97 - 144||11
404158|NCT00116805|991160|P2|COMPLETED|Open-label Period Weeks 97 - 144||74
404159|NCT00116805|991161|P1|COMPLETED|Open-label Period Weeks 97 - 144||133
404160|NCT00116805|991160|P2|STARTED|Open-label Period Weeks 97 - 144||83
404161|NCT00116805|991161|P1|STARTED|Open-label Period Weeks 97 - 144||144
404162|NCT00116805|991160|P2|NOT COMPLETED|Open-label Period Weeks 49 - 96||1
404163|NCT00116805|991161|P1|NOT COMPLETED|Open-label Period Weeks 49 - 96||10
404164|NCT00116805|991160|P2|COMPLETED|Open-label Period Weeks 49 - 96||83
404165|NCT00116805|991161|P1|COMPLETED|Open-label Period Weeks 49 - 96||144
404166|NCT00116805|991160|P2|STARTED|Open-label Period Weeks 49 - 96|1 participant completed 48 weeks but did not continue on study.|84
404167|NCT00116805|991161|P1|STARTED|Open-label Period Weeks 49 - 96|11 participants completed 48 weeks but did not continue on study.|154
404168|NCT00116805|991160|P2|NOT COMPLETED|Double-blind Period Through Week 48||5
404169|NCT00116805|991161|P1|NOT COMPLETED|Double-blind Period Through Week 48||11
404170|NCT00116805|991160|P2|COMPLETED|Double-blind Period Through Week 48||85
404171|NCT00116805|991161|P1|COMPLETED|Double-blind Period Through Week 48||165
404172|NCT00116805|991160|P2|STARTED|Double-blind Period Through Week 48||90
404173|NCT00116805|991161|P1|STARTED|Double-blind Period Through Week 48||176
404174|NCT00116779|991254|P2|NOT COMPLETED|Overall Study||19
404175|NCT00116779|991255|P1|NOT COMPLETED|Overall Study||21
404176|NCT00116779|991254|P2|COMPLETED|Overall Study||45
404177|NCT00116779|991255|P1|COMPLETED|Overall Study||42
404178|NCT00116779|991254|P2|STARTED|Overall Study|Randomized and treated; intent-to-treat population|64
404179|NCT00116779|991255|P1|STARTED|Overall Study|Randomized and treated; Intent-to-treat population|63
404180|NCT00116753|991288|P3|NOT COMPLETED|Overall Study||24
404181|NCT00116753|991289|P2|NOT COMPLETED|Overall Study||30
404182|NCT00116753|991290|P1|NOT COMPLETED|Overall Study||32
404183|NCT00116753|991288|P3|COMPLETED|Overall Study||128
404184|NCT00116753|991289|P2|COMPLETED|Overall Study||125
404185|NCT00116753|991290|P1|COMPLETED|Overall Study||121
404186|NCT00116753|991288|P3|ITT Population|Overall Study||147
404187|NCT00116753|991289|P2|ITT Population|Overall Study||150
404188|NCT00116753|991290|P1|ITT Population|Overall Study||150
404189|NCT00116753|991288|P3|STARTED|Overall Study||152
404190|NCT00116753|991289|P2|STARTED|Overall Study||155
404191|NCT00116753|991290|P1|STARTED|Overall Study|Randomised.|153
404192|NCT00116688|991312|P2|NOT COMPLETED|Overall Study||4
404193|NCT00116688|991313|P1|NOT COMPLETED|Overall Study||92
404194|NCT00116688|991312|P2|COMPLETED|Overall Study||17
404195|NCT00116688|991313|P1|COMPLETED|Overall Study||200
404196|NCT00116688|991312|P2|Received Study Medication|Overall Study||20
404197|NCT00116688|991313|P1|Received Study Medication|Overall Study||291
404198|NCT00116688|991312|P2|STARTED|Overall Study||21
404199|NCT00116688|991313|P1|STARTED|Overall Study||292
404200|NCT00116649|991328|P1|NOT COMPLETED|Overall Study||155
404201|NCT00116649|991328|P1|COMPLETED|Overall Study||396
404202|NCT00116649|991328|P1|STARTED|Overall Study|586 screened (34 not eligible) 552 enrolled 551 study population (1 subject not treated)|551
404203|NCT00116558|991336|P3|NOT COMPLETED|Overall Study||33
404204|NCT00116558|991337|P2|NOT COMPLETED|Overall Study||15
404205|NCT00116558|991338|P1|NOT COMPLETED|Overall Study||31
404206|NCT00116558|991336|P3|COMPLETED|Overall Study||14
404207|NCT00116558|991337|P2|COMPLETED|Overall Study||11
404208|NCT00116558|991338|P1|COMPLETED|Overall Study||49
404209|NCT00116558|991336|P3|STARTED|Overall Study||47
404210|NCT00116558|991337|P2|STARTED|Overall Study||26
404211|NCT00116558|991338|P1|STARTED|Overall Study||80
404212|NCT00116428|991349|P2|NOT COMPLETED|Overall Study||5
404213|NCT00116428|991350|P1|NOT COMPLETED|Overall Study||3
404214|NCT00116428|991349|P2|COMPLETED|Overall Study||56
404215|NCT00116428|991350|P1|COMPLETED|Overall Study||103
404216|NCT00116428|991349|P2|Underwent Study Ablation Procedure|Overall Study||36
404217|NCT00116428|991350|P1|Underwent Study Ablation Procedure|Overall Study||103
404218|NCT00116428|991349|P2|STARTED|Overall Study||61
404219|NCT00116428|991350|P1|STARTED|Overall Study||106
404220|NCT00116272|991368|P2|NOT COMPLETED|Overall Study||6
404221|NCT00116272|991369|P1|NOT COMPLETED|Overall Study||11
404222|NCT00116272|991368|P2|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|158
404223|NCT00116272|991369|P1|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|359
404224|NCT00116272|991368|P2|STARTED|Overall Study||164
404225|NCT00116272|991369|P1|STARTED|Overall Study||370
404226|NCT00116207|991421|P2|NOT COMPLETED|Overall Study||4
404227|NCT00116207|991422|P1|NOT COMPLETED|Overall Study||9
404228|NCT00116207|991421|P2|COMPLETED|Overall Study||18
404229|NCT00116207|991422|P1|COMPLETED|Overall Study||13
404230|NCT00116207|991421|P2|STARTED|Overall Study||22
404231|NCT00116207|991422|P1|STARTED|Overall Study||22
404232|NCT00116168|991438|P4|NOT COMPLETED|Overall Study||0
404233|NCT00116168|991439|P3|NOT COMPLETED|Overall Study||0
404234|NCT00116168|991440|P2|NOT COMPLETED|Overall Study||5
404235|NCT00116168|991441|P1|NOT COMPLETED|Overall Study||6
404236|NCT00116168|991438|P4|COMPLETED|Overall Study||6
404237|NCT00116168|991439|P3|COMPLETED|Overall Study||6
404238|NCT00116168|991440|P2|COMPLETED|Overall Study||6
404239|NCT00116168|991441|P1|COMPLETED|Overall Study||0
404240|NCT00116168|991438|P4|STARTED|Overall Study||6
404241|NCT00116168|991439|P3|STARTED|Overall Study||6
404242|NCT00116168|991440|P2|STARTED|Overall Study||11
404243|NCT00116168|991441|P1|STARTED|Overall Study||6
404244|NCT00115934|991505|P2|NOT COMPLETED|Overall Study||2
404245|NCT00115934|991506|P1|NOT COMPLETED|Overall Study||4
404246|NCT00115934|991505|P2|COMPLETED|Overall Study||274
404247|NCT00115934|991506|P1|COMPLETED|Overall Study||275
404248|NCT00115934|991505|P2|STARTED|Overall Study|276 randomized to RVPAS, but 2 did not have a Norwood surgery and were excluded from analyses.|276
404249|NCT00115934|991506|P1|STARTED|Overall Study|279 randomized to MBTS, but 3 did not have a Norwood surgery; one was withdrawn-with limited data.|279
404250|NCT00115869|991546|P2|NOT COMPLETED|Overall Study||296
404251|NCT00115869|991547|P1|NOT COMPLETED|Overall Study||317
404252|NCT00115869|991546|P2|COMPLETED|Overall Study|Follow-up at two years post high school.|3881
404253|NCT00115869|991547|P1|COMPLETED|Overall Study||3894
404254|NCT00115869|991546|P2|Completed Data Collection at 12th Grade|Overall Study||3847
404255|NCT00115869|991547|P1|Completed Data Collection at 12th Grade|Overall Study||3876
404256|NCT00115869|991546|P2|STARTED|Overall Study||4177
404257|NCT00115869|991547|P1|STARTED|Overall Study||4211
404258|NCT00115804|991555|P1|NOT COMPLETED|Overall Study||2
404259|NCT00115804|991555|P1|COMPLETED|Overall Study||4
404260|NCT00115804|991555|P1|STARTED|Overall Study||6
404261|NCT00115778|991566|P2|NOT COMPLETED|Overall Study||1
404262|NCT00115778|991567|P1|NOT COMPLETED|Overall Study||0
404263|NCT00115778|991566|P2|COMPLETED|Overall Study||4
404264|NCT00115778|991567|P1|COMPLETED|Overall Study||6
404265|NCT00115778|991566|P2|STARTED|Overall Study||5
404266|NCT00115778|991567|P1|STARTED|Overall Study||6
404267|NCT00115765|991587|P4|NOT COMPLETED|Overall Study||31
404268|NCT00115765|991588|P3|NOT COMPLETED|Overall Study||121
404269|NCT00115765|991589|P2|NOT COMPLETED|Overall Study||100
404270|NCT00115765|991590|P1|NOT COMPLETED|Overall Study||35
404271|NCT00115765|991587|P4|COMPLETED|Overall Study|Participants who were on study at closure or died|84
404272|NCT00115765|991588|P3|COMPLETED|Overall Study|Participants who were on study at closure or died|289
404273|NCT00115765|991589|P2|COMPLETED|Overall Study|Participants who were on study at closure or died|313
404274|NCT00115765|991590|P1|COMPLETED|Overall Study|Participants who were on study at closure or died|80
404275|NCT00115765|991587|P4|STARTED|Overall Study||115
404276|NCT00115765|991588|P3|STARTED|Overall Study||410
404277|NCT00115765|991589|P2|STARTED|Overall Study||413
404278|NCT00115765|991590|P1|STARTED|Overall Study||115
404279|NCT00115739|991628|P1|NOT COMPLETED|Overall Study||3
404280|NCT00115739|991628|P1|COMPLETED|Overall Study||8
404281|NCT00115739|991628|P1|STARTED|Overall Study||11
404282|NCT00115349|991637|P2|NOT COMPLETED|Overall Study||9
404283|NCT00115349|991638|P1|NOT COMPLETED|Overall Study||11
404284|NCT00115349|991637|P2|COMPLETED|Overall Study|study closed due to low enrollment.|0
404285|NCT00115349|991638|P1|COMPLETED|Overall Study|Study closed due to low enrollment.|0
404286|NCT00115349|991637|P2|STARTED|Overall Study|Target was 43 subjects in this arm.|9
404287|NCT00115349|991638|P1|STARTED|Overall Study|Target was 43 subjects in this arm.|11
404288|NCT00115297|991646|P2|NOT COMPLETED|Overall Study||0
404289|NCT00115297|991647|P1|NOT COMPLETED|Overall Study||0
404290|NCT00115297|991646|P2|COMPLETED|Overall Study||32
404291|NCT00115297|991647|P1|COMPLETED|Overall Study||30
404292|NCT00115297|991646|P2|STARTED|Overall Study||32
404293|NCT00115297|991647|P1|STARTED|Overall Study||30
404294|NCT00115063|991659|P2|NOT COMPLETED|Overall Study||104
404295|NCT00115063|991660|P1|NOT COMPLETED|Overall Study||99
404296|NCT00115063|991659|P2|COMPLETED|Overall Study||86
404297|NCT00115063|991660|P1|COMPLETED|Overall Study||101
404298|NCT00115063|991659|P2|STARTED|Overall Study||190
404299|NCT00115063|991660|P1|STARTED|Overall Study||200
404300|NCT00115037|991678|P6|NOT COMPLETED|Phase2||12
404301|NCT00115037|991679|P5|NOT COMPLETED|Phase2||6
404302|NCT00115037|991680|P4|NOT COMPLETED|Phase2||15
404303|NCT00115037|991681|P3|NOT COMPLETED|Phase2||15
404304|NCT00115037|991682|P2|NOT COMPLETED|Phase2||0
404305|NCT00115037|991683|P1|NOT COMPLETED|Phase2||0
404306|NCT00115037|991678|P6|COMPLETED|Phase2||21
404307|NCT00115037|991679|P5|COMPLETED|Phase2||28
404308|NCT00115037|991680|P4|COMPLETED|Phase2||77
404309|NCT00115037|991681|P3|COMPLETED|Phase2||76
404310|NCT00115037|991682|P2|COMPLETED|Phase2||0
404311|NCT00115037|991683|P1|COMPLETED|Phase2||0
404312|NCT00115037|991678|P6|STARTED|Phase2||33
404313|NCT00115037|991679|P5|STARTED|Phase2||34
404314|NCT00115037|991680|P4|STARTED|Phase2||92
404315|NCT00115037|991681|P3|STARTED|Phase2||91
404316|NCT00115037|991682|P2|STARTED|Phase2||0
404317|NCT00115037|991683|P1|STARTED|Phase2||0
404318|NCT00115037|991678|P6|NOT COMPLETED|Phase1||0
404319|NCT00115037|991679|P5|NOT COMPLETED|Phase1||0
404320|NCT00115037|991680|P4|NOT COMPLETED|Phase1||0
404321|NCT00115037|991681|P3|NOT COMPLETED|Phase1||0
404322|NCT00115037|991682|P2|NOT COMPLETED|Phase1||27
404323|NCT00115037|991683|P1|NOT COMPLETED|Phase1||25
404324|NCT00115037|991678|P6|COMPLETED|Phase1||0
404325|NCT00115037|991679|P5|COMPLETED|Phase1||0
404326|NCT00115037|991680|P4|COMPLETED|Phase1||0
404327|NCT00115037|991681|P3|COMPLETED|Phase1||0
404328|NCT00115037|991682|P2|COMPLETED|Phase1||123
404329|NCT00115037|991683|P1|COMPLETED|Phase1||127
404330|NCT00115037|991678|P6|STARTED|Phase1||0
404331|NCT00115037|991679|P5|STARTED|Phase1||0
404332|NCT00115037|991680|P4|STARTED|Phase1||0
404333|NCT00115037|991681|P3|STARTED|Phase1||0
404334|NCT00115037|991682|P2|STARTED|Phase1||150
404335|NCT00115037|991683|P1|STARTED|Phase1||152
404336|NCT00114972|991699|P2|NOT COMPLETED|Overall Study||12
404337|NCT00114972|991700|P1|NOT COMPLETED|Overall Study||48
404338|NCT00114972|991699|P2|COMPLETED|Overall Study||891
404339|NCT00114972|991700|P1|COMPLETED|Overall Study||849
404340|NCT00114972|991699|P2|STARTED|Overall Study||903
404341|NCT00114972|991700|P1|STARTED|Overall Study||897
404342|NCT00114959|991720|P1|NOT COMPLETED|Overall Study||8
404343|NCT00114959|991720|P1|COMPLETED|Overall Study|protocol definition of completed study is having received >= 4 cycles of treatment|7
404344|NCT00114959|991720|P1|STARTED|Overall Study||15
404345|NCT00114777|991730|P3|NOT COMPLETED|Long-Term Extension to Month 84||30
404346|NCT00114777|991731|P2|NOT COMPLETED|Long-Term Extension to Month 84||29
404347|NCT00114777|991732|P1|NOT COMPLETED|Long-Term Extension to Month 84||30
404348|NCT00114777|991730|P3|COMPLETED|Long-Term Extension to Month 84||57
404349|NCT00114777|991731|P2|COMPLETED|Long-Term Extension to Month 84||84
404350|NCT00114777|991732|P1|COMPLETED|Long-Term Extension to Month 84||74
404351|NCT00114777|991730|P3|STARTED|Long-Term Extension to Month 84||87
404352|NCT00114777|991731|P2|STARTED|Long-Term Extension to Month 84||113
404353|NCT00114777|991732|P1|STARTED|Long-Term Extension to Month 84||104
404354|NCT00114777|991730|P3|NOT COMPLETED|Randomization to Month 36||84
404355|NCT00114777|991731|P2|NOT COMPLETED|Randomization to Month 36||61
404356|NCT00114777|991732|P1|NOT COMPLETED|Randomization to Month 36||75
404357|NCT00114777|991730|P3|COMPLETED|Randomization to Month 36||100
404358|NCT00114777|991731|P2|COMPLETED|Randomization to Month 36||114
404359|NCT00114777|991732|P1|COMPLETED|Randomization to Month 36||109
404360|NCT00114777|991730|P3|STARTED|Randomization to Month 36||184
404361|NCT00114777|991731|P2|STARTED|Randomization to Month 36||175
404362|NCT00114777|991732|P1|STARTED|Randomization to Month 36||184
404363|NCT00114738|991806|P3|NOT COMPLETED|Randomization||0
404364|NCT00114738|991807|P2|NOT COMPLETED|Randomization||0
404365|NCT00114738|991808|P1|NOT COMPLETED|Randomization||0
404366|NCT00114738|991806|P3|COMPLETED|Randomization||16
404367|NCT00114738|991807|P2|COMPLETED|Randomization||14
404368|NCT00114738|991808|P1|COMPLETED|Randomization||0
404369|NCT00114738|991806|P3|STARTED|Randomization||16
404370|NCT00114738|991807|P2|STARTED|Randomization||14
404371|NCT00114738|991808|P1|STARTED|Randomization||0
404372|NCT00114738|991806|P3|NOT COMPLETED|Screening for Randomization||0
404373|NCT00114738|991807|P2|NOT COMPLETED|Screening for Randomization||0
404374|NCT00114738|991808|P1|NOT COMPLETED|Screening for Randomization||21
404375|NCT00114738|991806|P3|COMPLETED|Screening for Randomization||0
404376|NCT00114738|991807|P2|COMPLETED|Screening for Randomization||0
404377|NCT00114738|991808|P1|COMPLETED|Screening for Randomization||30
404378|NCT00114738|991806|P3|STARTED|Screening for Randomization||0
404379|NCT00114738|991807|P2|STARTED|Screening for Randomization||0
404380|NCT00114738|991808|P1|STARTED|Screening for Randomization||51
404381|NCT00114738|991806|P3|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0
404382|NCT00114738|991807|P2|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0
404383|NCT00114738|991808|P1|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||2
404384|NCT00114738|991806|P3|COMPLETED|Bortezomib Then Bortezomib + Induction||0
404385|NCT00114738|991807|P2|COMPLETED|Bortezomib Then Bortezomib + Induction||0
404386|NCT00114738|991808|P1|COMPLETED|Bortezomib Then Bortezomib + Induction||51
404387|NCT00114738|991806|P3|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
404388|NCT00114738|991807|P2|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
404389|NCT00114738|991808|P1|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||6
404390|NCT00114738|991806|P3|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
404391|NCT00114738|991807|P2|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
404392|NCT00114738|991808|P1|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||47
404393|NCT00114738|991806|P3|STARTED|Bortezomib Then Bortezomib + Induction||0
404394|NCT00114738|991807|P2|STARTED|Bortezomib Then Bortezomib + Induction||0
404395|NCT00114738|991808|P1|STARTED|Bortezomib Then Bortezomib + Induction||53
404396|NCT00114634|991821|P1|NOT COMPLETED|Overall Study||3
404397|NCT00114634|991821|P1|COMPLETED|Overall Study|Assessment forms lost by one failure to complete and return forms by two|10
404398|NCT00114634|991821|P1|STARTED|Overall Study||13
404399|NCT00114530|991837|P2|NOT COMPLETED|Overall Study||20
404400|NCT00114530|991838|P1|NOT COMPLETED|Overall Study||9
404401|NCT00114530|991837|P2|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient’s 54 mo visit)|19
404402|NCT00114530|991838|P1|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient’s 54 mo visit)|27
404403|NCT00114530|991837|P2|STARTED|Overall Study||39
404404|NCT00114530|991838|P1|STARTED|Overall Study||36
404405|NCT00114517|991947|P4|NOT COMPLETED|Overall Study||10
404406|NCT00114517|991948|P3|NOT COMPLETED|Overall Study||14
404407|NCT00114517|991949|P2|NOT COMPLETED|Overall Study||11
404408|NCT00114517|991950|P1|NOT COMPLETED|Overall Study||12
404409|NCT00114517|991947|P4|COMPLETED|Overall Study||176
404410|NCT00114517|991948|P3|COMPLETED|Overall Study||172
404411|NCT00114517|991949|P2|COMPLETED|Overall Study||123
404412|NCT00114517|991950|P1|COMPLETED|Overall Study||125
404413|NCT00114517|991947|P4|STARTED|Overall Study||186
404414|NCT00114517|991948|P3|STARTED|Overall Study||186
404415|NCT00114517|991949|P2|STARTED|Overall Study||134
404416|NCT00114517|991950|P1|STARTED|Overall Study||137
404417|NCT00114504|991962|P2|NOT COMPLETED|Overall Study||0
404418|NCT00114504|991963|P1|NOT COMPLETED|Overall Study||0
404419|NCT00114504|991962|P2|COMPLETED|Overall Study||22
404420|NCT00114504|991963|P1|COMPLETED|Overall Study||21
404421|NCT00114504|991962|P2|STARTED|Overall Study||22
404422|NCT00114504|991963|P1|STARTED|Overall Study||21
404423|NCT00114244|991975|P2|NOT COMPLETED|Overall Study||7
404424|NCT00114244|991976|P1|NOT COMPLETED|Overall Study||2
404425|NCT00114244|991975|P2|COMPLETED|Overall Study||30
404426|NCT00114244|991976|P1|COMPLETED|Overall Study||13
404427|NCT00114244|991975|P2|STARTED|Overall Study||37
404428|NCT00114244|991976|P1|STARTED|Overall Study||15
404429|NCT00114231|991988|P2|NOT COMPLETED|Overall Study||2
404430|NCT00114231|991989|P1|NOT COMPLETED|Overall Study||9
404431|NCT00114231|991988|P2|COMPLETED|Overall Study||26
404432|NCT00114231|991989|P1|COMPLETED|Overall Study||53
404433|NCT00114231|991988|P2|STARTED|Overall Study||28
404434|NCT00114231|991989|P1|STARTED|Overall Study||62
404435|NCT00114218|991998|P1|NOT COMPLETED|Overall Study||4
404436|NCT00114218|991998|P1|COMPLETED|Overall Study||24
404437|NCT00114218|991998|P1|STARTED|Overall Study||28
404438|NCT00114166|992005|P2|NOT COMPLETED|Overall Study||1
404439|NCT00114166|992006|P1|NOT COMPLETED|Overall Study||0
404440|NCT00114166|992005|P2|COMPLETED|Overall Study||65
404441|NCT00114166|992006|P1|COMPLETED|Overall Study||15
404442|NCT00114166|992005|P2|STARTED|Overall Study||66
404443|NCT00114166|992006|P1|STARTED|Overall Study||15
404444|NCT00114140|992016|P1|NOT COMPLETED|Overall Study||7
404445|NCT00114140|992016|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|129
404446|NCT00114140|992016|P1|STARTED|Overall Study||136
404447|NCT00114127|992030|P2|NOT COMPLETED|Overall Study||4
404448|NCT00114127|992031|P1|NOT COMPLETED|Overall Study||4
404449|NCT00114127|992030|P2|COMPLETED|Overall Study||11
404450|NCT00114127|992031|P1|COMPLETED|Overall Study||9
404451|NCT00114127|992030|P2|STARTED|Overall Study||15
404452|NCT00114127|992031|P1|STARTED|Overall Study||13
404453|NCT00114114|992045|P6|NOT COMPLETED|Overall Study||1
404454|NCT00114114|992046|P5|NOT COMPLETED|Overall Study||2
404455|NCT00114114|992047|P4|NOT COMPLETED|Overall Study||4
404456|NCT00114114|992048|P3|NOT COMPLETED|Overall Study||1
404457|NCT00114114|992049|P2|NOT COMPLETED|Overall Study||1
404458|NCT00114114|992050|P1|NOT COMPLETED|Overall Study||5
404459|NCT00114114|992045|P6|COMPLETED|Overall Study||30
404460|NCT00114114|992046|P5|COMPLETED|Overall Study||27
404461|NCT00114114|992047|P4|COMPLETED|Overall Study||31
404462|NCT00114114|992048|P3|COMPLETED|Overall Study||30
404463|NCT00114114|992049|P2|COMPLETED|Overall Study||24
404464|NCT00114114|992050|P1|COMPLETED|Overall Study||21
404465|NCT00114114|992045|P6|STARTED|Overall Study||31
404466|NCT00114114|992046|P5|STARTED|Overall Study||29
404467|NCT00114114|992047|P4|STARTED|Overall Study||35
404468|NCT00114114|992048|P3|STARTED|Overall Study||31
404469|NCT00114114|992049|P2|STARTED|Overall Study||25
404470|NCT00114114|992050|P1|STARTED|Overall Study||26
404471|NCT00114101|992090|P2|NOT COMPLETED|Overall Study||0
404472|NCT00114101|992091|P1|NOT COMPLETED|Overall Study||0
404473|NCT00114101|992090|P2|COMPLETED|Overall Study||229
404474|NCT00114101|992091|P1|COMPLETED|Overall Study||231
404475|NCT00114101|992090|P2|STARTED|Overall Study||229
404476|NCT00114101|992091|P1|STARTED|Overall Study||231
404477|NCT00113919|992103|P1|NOT COMPLETED|Overall Study||14
404478|NCT00113919|992103|P1|COMPLETED|Overall Study||0
404479|NCT00113919|992103|P1|STARTED|Overall Study||14
404480|NCT00113880|992110|P3|NOT COMPLETED|Overall Study||0
404481|NCT00113880|992111|P2|NOT COMPLETED|Overall Study||0
404482|NCT00113880|992112|P1|NOT COMPLETED|Overall Study||0
404483|NCT00113880|992110|P3|COMPLETED|Overall Study||62492
404484|NCT00113880|992111|P2|COMPLETED|Overall Study||71949
404485|NCT00113880|992112|P1|COMPLETED|Overall Study||63061
404486|NCT00113880|992110|P3|STARTED|Overall Study||62492
404487|NCT00113880|992111|P2|STARTED|Overall Study||71949
404488|NCT00113880|992112|P1|STARTED|Overall Study||63061
404489|NCT00113841|992171|P2|NOT COMPLETED|Overall Study||2
404490|NCT00113841|992172|P1|NOT COMPLETED|Overall Study||1
404491|NCT00113841|992171|P2|COMPLETED|Overall Study||15
404492|NCT00113841|992172|P1|COMPLETED|Overall Study||15
404493|NCT00113841|992171|P2|STARTED|Overall Study||17
404494|NCT00113841|992172|P1|STARTED|Overall Study||16
404495|NCT00113763|992180|P2|NOT COMPLETED|Overall Study||26
404496|NCT00113763|992181|P1|NOT COMPLETED|Overall Study||73
404497|NCT00113763|992180|P2|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|206
404498|NCT00113763|992181|P1|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|158
404499|NCT00113763|992180|P2|Received Study Drug|Overall Study||0
404500|NCT00113763|992181|P1|Received Study Drug|Overall Study||229
404501|NCT00113763|992180|P2|STARTED|Overall Study||232
404502|NCT00113763|992181|P1|STARTED|Overall Study||231
404503|NCT00113607|992207|P2|NOT COMPLETED|Overall Study||337
404504|NCT00113607|992208|P1|NOT COMPLETED|Overall Study||335
404505|NCT00113607|992207|P2|COMPLETED|Overall Study||0
404506|NCT00113607|992208|P1|COMPLETED|Overall Study||0
404507|NCT00113607|992207|P2|STARTED|Overall Study|Number of randomized participants|337
404508|NCT00113607|992208|P1|STARTED|Overall Study|Number of randomized participants|335
404509|NCT00113568|992222|P1|NOT COMPLETED|Overall Study||545
404510|NCT00113568|992222|P1|COMPLETED|Overall Study||239
404511|NCT00113568|992222|P1|Intent to Treat Population|Overall Study||723
404512|NCT00113568|992222|P1|STARTED|Overall Study||784
404513|NCT00113555|992234|P1|NOT COMPLETED|Overall Study||79
404514|NCT00113555|992234|P1|COMPLETED|Overall Study|All treated patients were considered in the Intent to Treat analysis.|142
404515|NCT00113555|992234|P1|TREATED|Overall Study|1 Additional Patient was treated on a compassionate use basis.|162
404516|NCT00113555|992234|P1|STARTED|Overall Study||221
404517|NCT00113529|992244|P1|NOT COMPLETED|Overall Study||34
404518|NCT00113529|992244|P1|COMPLETED|Overall Study|Subject discontinued from the study and continued treatment on commercially available sunitinib.|1
404519|NCT00113529|992244|P1|STARTED|Overall Study|Phase 2 included 4 subjects from Phase 1 and 31 from Phase 2, for a total of 35 subjects.|35
404520|NCT00113516|992277|P2|NOT COMPLETED|Part 2||66
404521|NCT00113516|992278|P1|NOT COMPLETED|Part 2||0
404522|NCT00113516|992277|P2|COMPLETED|Part 2||0
404523|NCT00113516|992278|P1|COMPLETED|Part 2||0
404524|NCT00113516|992277|P2|STARTED|Part 2||66
404525|NCT00113516|992278|P1|STARTED|Part 2||0
404526|NCT00113516|992277|P2|NOT COMPLETED|Part 1||0
404527|NCT00113516|992278|P1|NOT COMPLETED|Part 1||84
404528|NCT00113516|992277|P2|COMPLETED|Part 1||0
404529|NCT00113516|992278|P1|COMPLETED|Part 1|66 subjects continued into Part 2 of the study.|0
404530|NCT00113516|992277|P2|STARTED|Part 1||0
404531|NCT00113516|992278|P1|STARTED|Part 1||84
404532|NCT00113490|992321|P2|NOT COMPLETED|Overall Study||3
404533|NCT00113490|992322|P1|NOT COMPLETED|Overall Study||2
404534|NCT00113490|992321|P2|COMPLETED|Overall Study||67
404535|NCT00113490|992322|P1|COMPLETED|Overall Study||64
404536|NCT00113490|992321|P2|STARTED|Overall Study||70
404537|NCT00113490|992322|P1|STARTED|Overall Study||66
404538|NCT00113425|992335|P1|NOT COMPLETED|Overall Study||15
404539|NCT00113425|992335|P1|COMPLETED|Overall Study||29
404540|NCT00113425|992335|P1|STARTED|Overall Study||44
404541|NCT00113399|992355|P2|NOT COMPLETED|Overall Study||5
404542|NCT00113399|992356|P1|NOT COMPLETED|Overall Study||2
404543|NCT00113399|992355|P2|COMPLETED|Overall Study||3
404544|NCT00113399|992356|P1|COMPLETED|Overall Study||5
404545|NCT00113399|992355|P2|STARTED|Overall Study||8
404546|NCT00113399|992356|P1|STARTED|Overall Study||7
404547|NCT00113386|992364|P2|NOT COMPLETED|Overall Study||4
404548|NCT00113386|992365|P1|NOT COMPLETED|Overall Study||7
404549|NCT00113386|992364|P2|COMPLETED|Overall Study||5
404550|NCT00113386|992365|P1|COMPLETED|Overall Study||3
404551|NCT00113386|992364|P2|STARTED|Overall Study||9
404552|NCT00113386|992365|P1|STARTED|Overall Study||10
404553|NCT00113373|992371|P1|NOT COMPLETED|Overall Study||3
404554|NCT00113373|992371|P1|COMPLETED|Overall Study|Eligible and treated patients.|25
404555|NCT00113373|992371|P1|STARTED|Overall Study||28
404556|NCT00113360|992386|P1|NOT COMPLETED|Overall Study||7
404557|NCT00113360|992386|P1|COMPLETED|Overall Study||60
404558|NCT00113360|992386|P1|STARTED|Overall Study|67 participants were enrolled for screening.|67
404559|NCT00113334|992390|P1|NOT COMPLETED|Overall Study||0
404560|NCT00113334|992390|P1|COMPLETED|Overall Study||6
404561|NCT00113334|992390|P1|STARTED|Overall Study||6
404562|NCT00113321|992394|P1|NOT COMPLETED|Overall Study||0
404563|NCT00113321|992394|P1|COMPLETED|Overall Study||16
404564|NCT00113321|992394|P1|STARTED|Overall Study||16
404565|NCT00113295|992400|P2|NOT COMPLETED|Overall Study||1
404566|NCT00113295|992401|P1|NOT COMPLETED|Overall Study||5
404567|NCT00113295|992400|P2|COMPLETED|Overall Study||10
404568|NCT00113295|992401|P1|COMPLETED|Overall Study||6
404569|NCT00113295|992400|P2|STARTED|Overall Study||11
404570|NCT00113295|992401|P1|STARTED|Overall Study||11
404571|NCT00113269|992420|P4|NOT COMPLETED|Overall Study||40
404572|NCT00113269|992421|P3|NOT COMPLETED|Overall Study||41
404573|NCT00113269|992422|P2|NOT COMPLETED|Overall Study||22
404574|NCT00113269|992423|P1|NOT COMPLETED|Overall Study||25
404575|NCT00113269|992420|P4|COMPLETED|Overall Study||140
404576|NCT00113269|992421|P3|COMPLETED|Overall Study||134
404577|NCT00113269|992422|P2|COMPLETED|Overall Study||48
404578|NCT00113269|992423|P1|COMPLETED|Overall Study||51
404579|NCT00113269|992420|P4|Received Treatment|Overall Study||171
404580|NCT00113269|992421|P3|Received Treatment|Overall Study||164
404581|NCT00113269|992422|P2|Received Treatment|Overall Study||69
404582|NCT00113269|992423|P1|Received Treatment|Overall Study||70
404583|NCT00113269|992420|P4|STARTED|Overall Study||180
404584|NCT00113269|992421|P3|STARTED|Overall Study||175
404585|NCT00113269|992422|P2|STARTED|Overall Study||70
404586|NCT00113269|992423|P1|STARTED|Overall Study||76
404587|NCT00113230|992473|P1|NOT COMPLETED|Overall Study||0
404588|NCT00113230|992473|P1|COMPLETED|Overall Study||25
404589|NCT00113230|992473|P1|STARTED|Overall Study||25
404590|NCT00113217|992477|P1|NOT COMPLETED|Overall Study||0
404591|NCT00113217|992477|P1|COMPLETED|Overall Study||50
404592|NCT00113217|992477|P1|STARTED|Overall Study||50
404593|NCT00113087|992483|P2|NOT COMPLETED|Overall Study||21
404594|NCT00113087|992484|P1|NOT COMPLETED|Overall Study||24
404595|NCT00113087|992483|P2|COMPLETED|Overall Study||94
404596|NCT00113087|992484|P1|COMPLETED|Overall Study||91
404597|NCT00113087|992483|P2|STARTED|Overall Study||115
404598|NCT00113087|992484|P1|STARTED|Overall Study||115
404599|NCT00113022|992548|P2|NOT COMPLETED|Overall Study||2
404600|NCT00113022|992549|P1|NOT COMPLETED|Overall Study||3
404601|NCT00113022|992548|P2|COMPLETED|Overall Study||2
404602|NCT00113022|992549|P1|COMPLETED|Overall Study||2
404603|NCT00113022|992548|P2|STARTED|Overall Study||4
404604|NCT00113022|992549|P1|STARTED|Overall Study||5
404605|NCT00112957|992555|P1|NOT COMPLETED|Overall Study||19
404606|NCT00112957|992555|P1|COMPLETED|Overall Study||4
404607|NCT00112957|992555|P1|STARTED|Overall Study||23
404608|NCT00112918|992570|P3|NOT COMPLETED|Overall Study||299
404609|NCT00112918|992571|P2|NOT COMPLETED|Overall Study||345
404610|NCT00112918|992572|P1|NOT COMPLETED|Overall Study||297
404611|NCT00112918|992570|P3|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|846
404612|NCT00112918|992571|P2|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|810
404613|NCT00112918|992572|P1|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|854
404614|NCT00112918|992570|P3|Stage III Disease Population|Overall Study||952
404615|NCT00112918|992571|P2|Stage III Disease Population|Overall Study||960
404616|NCT00112918|992572|P1|Stage III Disease Population|Overall Study||955
404617|NCT00112918|992570|P3|Received Treatment|Overall Study||1135
404618|NCT00112918|992571|P2|Received Treatment|Overall Study|Includes two patients from FOLFOX4 who received Bv and were assigned to FOLFOX4+Bv safety analysis|1145
404619|NCT00112918|992572|P1|Received Treatment|Overall Study||1126
404620|NCT00112918|992570|P3|STARTED|Overall Study||1145
404621|NCT00112918|992571|P2|STARTED|Overall Study||1155
404622|NCT00112918|992572|P1|STARTED|Overall Study||1151
404623|NCT00112905|992595|P1|NOT COMPLETED|Overall Study||12
404624|NCT00112905|992595|P1|COMPLETED|Overall Study||15
404625|NCT00112905|992595|P1|Eligible and Treated|Overall Study||22
404626|NCT00112905|992595|P1|STARTED|Overall Study||27
404627|NCT00112866|992604|P2|NOT COMPLETED|Overall Study||2
404628|NCT00112866|992605|P1|NOT COMPLETED|Overall Study||2
404629|NCT00112866|992604|P2|COMPLETED|Overall Study||13
404630|NCT00112866|992605|P1|COMPLETED|Overall Study||13
404631|NCT00112866|992604|P2|STARTED|Overall Study||15
404632|NCT00112866|992605|P1|STARTED|Overall Study||15
404633|NCT00112840|992627|P3|NOT COMPLETED|Overall Study||6
404634|NCT00112840|992628|P2|NOT COMPLETED|Overall Study||0
404635|NCT00112840|992629|P1|NOT COMPLETED|Overall Study||2
404636|NCT00112840|992627|P3|COMPLETED|Overall Study||40
404637|NCT00112840|992628|P2|COMPLETED|Overall Study||6
404638|NCT00112840|992629|P1|COMPLETED|Overall Study||6
404639|NCT00112840|992627|P3|STARTED|Overall Study||46
404640|NCT00112840|992628|P2|STARTED|Overall Study||6
404641|NCT00112840|992629|P1|STARTED|Overall Study||8
404642|NCT00112736|992648|P2|NOT COMPLETED|Overall Study||0
404643|NCT00112736|992649|P1|NOT COMPLETED|Overall Study||1
404644|NCT00112736|992648|P2|COMPLETED|Overall Study|12 additional pts from phase 1 study were used in analysis for Phase 2 as they were treated at MTD|47
404645|NCT00112736|992649|P1|COMPLETED|Overall Study|12 of Phase I pts treated at MTD and hence considered part of the Phase II analysis|21
404646|NCT00112736|992648|P2|STARTED|Overall Study||47
404647|NCT00112736|992649|P1|STARTED|Overall Study||22
404648|NCT00112723|992662|P3|NOT COMPLETED|Overall Study||2
404649|NCT00112723|992663|P2|NOT COMPLETED|Overall Study||7
404650|NCT00112723|992664|P1|NOT COMPLETED|Overall Study||2
404651|NCT00112723|992662|P3|COMPLETED|Overall Study||12
404652|NCT00112723|992663|P2|COMPLETED|Overall Study||12
404653|NCT00112723|992664|P1|COMPLETED|Overall Study||11
404654|NCT00112723|992662|P3|Patients Evaluable for Toxicity|Overall Study||12
404655|NCT00112723|992663|P2|Patients Evaluable for Toxicity|Overall Study||12
404656|NCT00112723|992664|P1|Patients Evaluable for Toxicity|Overall Study||11
404657|NCT00112723|992662|P3|STARTED|Overall Study||14
404658|NCT00112723|992663|P2|STARTED|Overall Study||19
404659|NCT00112723|992664|P1|STARTED|Overall Study||13
404660|NCT00112671|992689|P1|NOT COMPLETED|Overall Study||0
404661|NCT00112671|992689|P1|COMPLETED|Overall Study||17
404662|NCT00112671|992689|P1|STARTED|Overall Study||17
404663|NCT00112593|992697|P1|NOT COMPLETED|Overall Study||0
404664|NCT00112593|992697|P1|COMPLETED|Overall Study||5
404665|NCT00112593|992697|P1|STARTED|Overall Study||5
404666|NCT00112489|992706|P1|NOT COMPLETED|Overall Study||40
404667|NCT00112489|992706|P1|COMPLETED|Overall Study|Completed regimen due to progression|15
404668|NCT00112489|992706|P1|STARTED|Overall Study|All patients enrolled on study|55
404669|NCT00112463|992716|P1|NOT COMPLETED|Overall Study||39
404670|NCT00112463|992716|P1|COMPLETED|Overall Study||1
404671|NCT00112463|992716|P1|STARTED|Overall Study||40
404672|NCT00112437|992728|P26|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
404673|NCT00112437|992729|P25|NOT COMPLETED|Years 6-10 (60-Month Extension)||1
404674|NCT00112437|992730|P24|NOT COMPLETED|Years 6-10 (60-Month Extension)||12
404675|NCT00112437|992731|P23|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
404676|NCT00112437|992732|P22|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
404677|NCT00112437|992733|P21|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
404678|NCT00112437|992734|P20|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
404679|NCT00112437|992735|P19|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
404680|NCT00112437|992736|P18|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
404681|NCT00112437|992737|P17|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
404682|NCT00112437|992738|P16|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
404683|NCT00112437|992739|P15|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
404684|NCT00112437|992740|P14|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
404685|NCT00112437|992741|P13|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
404686|NCT00112437|992742|P12|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
404687|NCT00112437|992743|P11|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
404688|NCT00112437|992744|P10|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
404689|NCT00112437|992745|P9|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
404690|NCT00112437|992746|P8|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
404691|NCT00112437|992747|P7|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
404692|NCT00112437|992748|P6|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
404693|NCT00112437|992749|P5|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
404694|NCT00112437|992750|P4|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
404695|NCT00112437|992751|P3|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
404696|NCT00112437|992752|P2|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
404697|NCT00112437|992753|P1|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
404698|NCT00112437|992728|P26|COMPLETED|Years 6-10 (60-Month Extension)||27
404699|NCT00112437|992729|P25|COMPLETED|Years 6-10 (60-Month Extension)||22
404700|NCT00112437|992730|P24|COMPLETED|Years 6-10 (60-Month Extension)||22
404701|NCT00112437|992731|P23|COMPLETED|Years 6-10 (60-Month Extension)||23
404702|NCT00112437|992732|P22|COMPLETED|Years 6-10 (60-Month Extension)||0
404703|NCT00112437|992733|P21|COMPLETED|Years 6-10 (60-Month Extension)||0
404704|NCT00112437|992734|P20|COMPLETED|Years 6-10 (60-Month Extension)||0
404705|NCT00112437|992735|P19|COMPLETED|Years 6-10 (60-Month Extension)||0
404706|NCT00112437|992736|P18|COMPLETED|Years 6-10 (60-Month Extension)||0
404707|NCT00112437|992737|P17|COMPLETED|Years 6-10 (60-Month Extension)||0
404708|NCT00112437|992738|P16|COMPLETED|Years 6-10 (60-Month Extension)||0
404709|NCT00112437|992739|P15|COMPLETED|Years 6-10 (60-Month Extension)||0
404710|NCT00112437|992740|P14|COMPLETED|Years 6-10 (60-Month Extension)||0
404711|NCT00112437|992741|P13|COMPLETED|Years 6-10 (60-Month Extension)||0
404712|NCT00112437|992742|P12|COMPLETED|Years 6-10 (60-Month Extension)||0
404713|NCT00112437|992743|P11|COMPLETED|Years 6-10 (60-Month Extension)||0
404714|NCT00112437|992744|P10|COMPLETED|Years 6-10 (60-Month Extension)||0
404715|NCT00112437|992745|P9|COMPLETED|Years 6-10 (60-Month Extension)||0
404716|NCT00112437|992746|P8|COMPLETED|Years 6-10 (60-Month Extension)||0
404717|NCT00112437|992747|P7|COMPLETED|Years 6-10 (60-Month Extension)||0
404718|NCT00112437|992748|P6|COMPLETED|Years 6-10 (60-Month Extension)||0
404719|NCT00112437|992749|P5|COMPLETED|Years 6-10 (60-Month Extension)||0
404720|NCT00112437|992750|P4|COMPLETED|Years 6-10 (60-Month Extension)||0
404721|NCT00112437|992751|P3|COMPLETED|Years 6-10 (60-Month Extension)||0
404722|NCT00112437|992752|P2|COMPLETED|Years 6-10 (60-Month Extension)||0
404723|NCT00112437|992753|P1|COMPLETED|Years 6-10 (60-Month Extension)||0
404724|NCT00112437|992728|P26|STARTED|Years 6-10 (60-Month Extension)||32
404725|NCT00112437|992729|P25|STARTED|Years 6-10 (60-Month Extension)||23
404726|NCT00112437|992730|P24|STARTED|Years 6-10 (60-Month Extension)||34
404727|NCT00112437|992731|P23|STARTED|Years 6-10 (60-Month Extension)||28
404728|NCT00112437|992732|P22|STARTED|Years 6-10 (60-Month Extension)||0
404729|NCT00112437|992733|P21|STARTED|Years 6-10 (60-Month Extension)||0
404730|NCT00112437|992734|P20|STARTED|Years 6-10 (60-Month Extension)||0
404731|NCT00112437|992735|P19|STARTED|Years 6-10 (60-Month Extension)||0
404732|NCT00112437|992736|P18|STARTED|Years 6-10 (60-Month Extension)||0
404733|NCT00112437|992737|P17|STARTED|Years 6-10 (60-Month Extension)||0
404734|NCT00112437|992738|P16|STARTED|Years 6-10 (60-Month Extension)||0
404735|NCT00112437|992739|P15|STARTED|Years 6-10 (60-Month Extension)||0
404736|NCT00112437|992740|P14|STARTED|Years 6-10 (60-Month Extension)||0
404737|NCT00112437|992741|P13|STARTED|Years 6-10 (60-Month Extension)||0
404738|NCT00112437|992742|P12|STARTED|Years 6-10 (60-Month Extension)||0
404739|NCT00112437|992743|P11|STARTED|Years 6-10 (60-Month Extension)||0
404740|NCT00112437|992744|P10|STARTED|Years 6-10 (60-Month Extension)||0
404741|NCT00112437|992745|P9|STARTED|Years 6-10 (60-Month Extension)||0
404742|NCT00112437|992746|P8|STARTED|Years 6-10 (60-Month Extension)||0
404743|NCT00112437|992747|P7|STARTED|Years 6-10 (60-Month Extension)||0
404744|NCT00112437|992748|P6|STARTED|Years 6-10 (60-Month Extension)||0
404745|NCT00112437|992749|P5|STARTED|Years 6-10 (60-Month Extension)||0
404746|NCT00112437|992750|P4|STARTED|Years 6-10 (60-Month Extension)||0
404747|NCT00112437|992751|P3|STARTED|Years 6-10 (60-Month Extension)||0
404748|NCT00112437|992752|P2|STARTED|Years 6-10 (60-Month Extension)||0
404749|NCT00112437|992753|P1|STARTED|Years 6-10 (60-Month Extension)||0
404750|NCT00112437|992728|P26|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
404751|NCT00112437|992729|P25|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
404752|NCT00112437|992730|P24|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
404753|NCT00112437|992731|P23|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
404754|NCT00112437|992732|P22|NOT COMPLETED|Years 4-5 (24-Month Extension)||8
404755|NCT00112437|992733|P21|NOT COMPLETED|Years 4-5 (24-Month Extension)||4
404756|NCT00112437|992734|P20|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
404757|NCT00112437|992735|P19|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
404758|NCT00112437|992736|P18|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
404759|NCT00112437|992737|P17|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
404760|NCT00112437|992738|P16|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
404761|NCT00112437|992739|P15|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
404762|NCT00112437|992740|P14|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
404763|NCT00112437|992741|P13|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
404764|NCT00112437|992742|P12|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
404765|NCT00112437|992743|P11|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
404766|NCT00112437|992744|P10|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
404767|NCT00112437|992745|P9|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
404768|NCT00112437|992746|P8|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
404769|NCT00112437|992747|P7|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
404770|NCT00112437|992748|P6|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
404771|NCT00112437|992749|P5|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
404772|NCT00112437|992750|P4|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
404773|NCT00112437|992751|P3|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
404774|NCT00112437|992752|P2|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
404775|NCT00112437|992753|P1|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
404776|NCT00112437|992728|P26|COMPLETED|Years 4-5 (24-Month Extension)||0
404777|NCT00112437|992729|P25|COMPLETED|Years 4-5 (24-Month Extension)||0
404778|NCT00112437|992730|P24|COMPLETED|Years 4-5 (24-Month Extension)||0
404779|NCT00112437|992731|P23|COMPLETED|Years 4-5 (24-Month Extension)||0
404780|NCT00112437|992732|P22|COMPLETED|Years 4-5 (24-Month Extension)||92
404781|NCT00112437|992733|P21|COMPLETED|Years 4-5 (24-Month Extension)||37
404782|NCT00112437|992734|P20|COMPLETED|Years 4-5 (24-Month Extension)||0
404783|NCT00112437|992735|P19|COMPLETED|Years 4-5 (24-Month Extension)||0
404784|NCT00112437|992736|P18|COMPLETED|Years 4-5 (24-Month Extension)||0
404785|NCT00112437|992737|P17|COMPLETED|Years 4-5 (24-Month Extension)||0
404786|NCT00112437|992738|P16|COMPLETED|Years 4-5 (24-Month Extension)||0
404787|NCT00112437|992739|P15|COMPLETED|Years 4-5 (24-Month Extension)||0
404788|NCT00112437|992740|P14|COMPLETED|Years 4-5 (24-Month Extension)||0
404789|NCT00112437|992741|P13|COMPLETED|Years 4-5 (24-Month Extension)||0
404790|NCT00112437|992742|P12|COMPLETED|Years 4-5 (24-Month Extension)||0
404791|NCT00112437|992743|P11|COMPLETED|Years 4-5 (24-Month Extension)||0
404792|NCT00112437|992744|P10|COMPLETED|Years 4-5 (24-Month Extension)||0
404793|NCT00112437|992745|P9|COMPLETED|Years 4-5 (24-Month Extension)||0
404794|NCT00112437|992746|P8|COMPLETED|Years 4-5 (24-Month Extension)||0
404795|NCT00112437|992747|P7|COMPLETED|Years 4-5 (24-Month Extension)||0
404796|NCT00112437|992748|P6|COMPLETED|Years 4-5 (24-Month Extension)||0
404797|NCT00112437|992749|P5|COMPLETED|Years 4-5 (24-Month Extension)||0
404798|NCT00112437|992750|P4|COMPLETED|Years 4-5 (24-Month Extension)||0
404799|NCT00112437|992751|P3|COMPLETED|Years 4-5 (24-Month Extension)||0
404800|NCT00112437|992752|P2|COMPLETED|Years 4-5 (24-Month Extension)||0
404801|NCT00112437|992753|P1|COMPLETED|Years 4-5 (24-Month Extension)||0
404802|NCT00112437|992728|P26|STARTED|Years 4-5 (24-Month Extension)||0
404803|NCT00112437|992729|P25|STARTED|Years 4-5 (24-Month Extension)||0
404804|NCT00112437|992730|P24|STARTED|Years 4-5 (24-Month Extension)||0
404805|NCT00112437|992731|P23|STARTED|Years 4-5 (24-Month Extension)||0
404806|NCT00112437|992732|P22|STARTED|Years 4-5 (24-Month Extension)||100
404807|NCT00112437|992733|P21|STARTED|Years 4-5 (24-Month Extension)||41
404808|NCT00112437|992734|P20|STARTED|Years 4-5 (24-Month Extension)||0
404809|NCT00112437|992735|P19|STARTED|Years 4-5 (24-Month Extension)||0
404810|NCT00112437|992736|P18|STARTED|Years 4-5 (24-Month Extension)||0
404811|NCT00112437|992737|P17|STARTED|Years 4-5 (24-Month Extension)||0
404812|NCT00112437|992738|P16|STARTED|Years 4-5 (24-Month Extension)||0
404813|NCT00112437|992739|P15|STARTED|Years 4-5 (24-Month Extension)||0
404814|NCT00112437|992740|P14|STARTED|Years 4-5 (24-Month Extension)||0
404815|NCT00112437|992741|P13|STARTED|Years 4-5 (24-Month Extension)||0
404816|NCT00112437|992742|P12|STARTED|Years 4-5 (24-Month Extension)||0
404817|NCT00112437|992743|P11|STARTED|Years 4-5 (24-Month Extension)||0
404818|NCT00112437|992744|P10|STARTED|Years 4-5 (24-Month Extension)||0
404819|NCT00112437|992745|P9|STARTED|Years 4-5 (24-Month Extension)||0
404820|NCT00112437|992746|P8|STARTED|Years 4-5 (24-Month Extension)||0
404821|NCT00112437|992747|P7|STARTED|Years 4-5 (24-Month Extension)||0
404822|NCT00112437|992748|P6|STARTED|Years 4-5 (24-Month Extension)||0
404823|NCT00112437|992749|P5|STARTED|Years 4-5 (24-Month Extension)||0
404824|NCT00112437|992750|P4|STARTED|Years 4-5 (24-Month Extension)||0
404825|NCT00112437|992751|P3|STARTED|Years 4-5 (24-Month Extension)||0
404826|NCT00112437|992752|P2|STARTED|Years 4-5 (24-Month Extension)||0
404827|NCT00112437|992753|P1|STARTED|Years 4-5 (24-Month Extension)||0
404828|NCT00112437|992728|P26|NOT COMPLETED|Year 3 (12-Month Extension)||0
404829|NCT00112437|992729|P25|NOT COMPLETED|Year 3 (12-Month Extension)||0
404830|NCT00112437|992730|P24|NOT COMPLETED|Year 3 (12-Month Extension)||0
404831|NCT00112437|992731|P23|NOT COMPLETED|Year 3 (12-Month Extension)||0
404832|NCT00112437|992732|P22|NOT COMPLETED|Year 3 (12-Month Extension)||0
404833|NCT00112437|992733|P21|NOT COMPLETED|Year 3 (12-Month Extension)||0
404834|NCT00112437|992734|P20|NOT COMPLETED|Year 3 (12-Month Extension)||1
404835|NCT00112437|992735|P19|NOT COMPLETED|Year 3 (12-Month Extension)||2
404836|NCT00112437|992736|P18|NOT COMPLETED|Year 3 (12-Month Extension)||1
404837|NCT00112437|992737|P17|NOT COMPLETED|Year 3 (12-Month Extension)||3
404838|NCT00112437|992738|P16|NOT COMPLETED|Year 3 (12-Month Extension)||4
404839|NCT00112437|992739|P15|NOT COMPLETED|Year 3 (12-Month Extension)||1
404840|NCT00112437|992740|P14|NOT COMPLETED|Year 3 (12-Month Extension)||1
404841|NCT00112437|992741|P13|NOT COMPLETED|Year 3 (12-Month Extension)||0
404842|NCT00112437|992742|P12|NOT COMPLETED|Year 3 (12-Month Extension)||5
404843|NCT00112437|992743|P11|NOT COMPLETED|Year 3 (12-Month Extension)||2
404844|NCT00112437|992744|P10|NOT COMPLETED|Year 3 (12-Month Extension)||0
404845|NCT00112437|992745|P9|NOT COMPLETED|Year 3 (12-Month Extension)||0
404846|NCT00112437|992746|P8|NOT COMPLETED|Year 3 (12-Month Extension)||0
404847|NCT00112437|992747|P7|NOT COMPLETED|Year 3 (12-Month Extension)||0
404848|NCT00112437|992748|P6|NOT COMPLETED|Year 3 (12-Month Extension)||0
404849|NCT00112437|992749|P5|NOT COMPLETED|Year 3 (12-Month Extension)||0
404850|NCT00112437|992750|P4|NOT COMPLETED|Year 3 (12-Month Extension)||0
404851|NCT00112437|992751|P3|NOT COMPLETED|Year 3 (12-Month Extension)||0
404852|NCT00112437|992752|P2|NOT COMPLETED|Year 3 (12-Month Extension)||0
404853|NCT00112437|992753|P1|NOT COMPLETED|Year 3 (12-Month Extension)||0
404854|NCT00112437|992728|P26|COMPLETED|Year 3 (12-Month Extension)||0
404855|NCT00112437|992729|P25|COMPLETED|Year 3 (12-Month Extension)||0
404856|NCT00112437|992730|P24|COMPLETED|Year 3 (12-Month Extension)||0
404857|NCT00112437|992731|P23|COMPLETED|Year 3 (12-Month Extension)||0
404858|NCT00112437|992732|P22|COMPLETED|Year 3 (12-Month Extension)||0
404859|NCT00112437|992733|P21|COMPLETED|Year 3 (12-Month Extension)||0
404860|NCT00112437|992734|P20|COMPLETED|Year 3 (12-Month Extension)||19
404861|NCT00112437|992735|P19|COMPLETED|Year 3 (12-Month Extension)||16
404862|NCT00112437|992736|P18|COMPLETED|Year 3 (12-Month Extension)||20
404863|NCT00112437|992737|P17|COMPLETED|Year 3 (12-Month Extension)||16
404864|NCT00112437|992738|P16|COMPLETED|Year 3 (12-Month Extension)||13
404865|NCT00112437|992739|P15|COMPLETED|Year 3 (12-Month Extension)||17
404866|NCT00112437|992740|P14|COMPLETED|Year 3 (12-Month Extension)||16
404867|NCT00112437|992741|P13|COMPLETED|Year 3 (12-Month Extension)||18
404868|NCT00112437|992742|P12|COMPLETED|Year 3 (12-Month Extension)||17
404869|NCT00112437|992743|P11|COMPLETED|Year 3 (12-Month Extension)||17
404870|NCT00112437|992744|P10|COMPLETED|Year 3 (12-Month Extension)||0
404871|NCT00112437|992745|P9|COMPLETED|Year 3 (12-Month Extension)||0
404872|NCT00112437|992746|P8|COMPLETED|Year 3 (12-Month Extension)||0
404873|NCT00112437|992747|P7|COMPLETED|Year 3 (12-Month Extension)||0
404874|NCT00112437|992748|P6|COMPLETED|Year 3 (12-Month Extension)||0
404875|NCT00112437|992749|P5|COMPLETED|Year 3 (12-Month Extension)||0
404876|NCT00112437|992750|P4|COMPLETED|Year 3 (12-Month Extension)||0
404877|NCT00112437|992751|P3|COMPLETED|Year 3 (12-Month Extension)||0
404878|NCT00112437|992752|P2|COMPLETED|Year 3 (12-Month Extension)||0
404879|NCT00112437|992753|P1|COMPLETED|Year 3 (12-Month Extension)||0
404880|NCT00112437|992728|P26|STARTED|Year 3 (12-Month Extension)||0
404881|NCT00112437|992729|P25|STARTED|Year 3 (12-Month Extension)||0
404882|NCT00112437|992730|P24|STARTED|Year 3 (12-Month Extension)||0
404883|NCT00112437|992731|P23|STARTED|Year 3 (12-Month Extension)||0
404884|NCT00112437|992732|P22|STARTED|Year 3 (12-Month Extension)||0
404885|NCT00112437|992733|P21|STARTED|Year 3 (12-Month Extension)||0
404886|NCT00112437|992734|P20|STARTED|Year 3 (12-Month Extension)||20
404887|NCT00112437|992735|P19|STARTED|Year 3 (12-Month Extension)||18
404888|NCT00112437|992736|P18|STARTED|Year 3 (12-Month Extension)||21
404889|NCT00112437|992737|P17|STARTED|Year 3 (12-Month Extension)||19
404890|NCT00112437|992738|P16|STARTED|Year 3 (12-Month Extension)||17
404891|NCT00112437|992739|P15|STARTED|Year 3 (12-Month Extension)||18
404892|NCT00112437|992740|P14|STARTED|Year 3 (12-Month Extension)||17
404893|NCT00112437|992741|P13|STARTED|Year 3 (12-Month Extension)||18
404894|NCT00112437|992742|P12|STARTED|Year 3 (12-Month Extension)||22
404895|NCT00112437|992743|P11|STARTED|Year 3 (12-Month Extension)||19
404896|NCT00112437|992744|P10|STARTED|Year 3 (12-Month Extension)||0
404897|NCT00112437|992745|P9|STARTED|Year 3 (12-Month Extension)||0
404898|NCT00112437|992746|P8|STARTED|Year 3 (12-Month Extension)||0
404899|NCT00112437|992747|P7|STARTED|Year 3 (12-Month Extension)||0
404900|NCT00112437|992748|P6|STARTED|Year 3 (12-Month Extension)||0
404901|NCT00112437|992749|P5|STARTED|Year 3 (12-Month Extension)||0
404902|NCT00112437|992750|P4|STARTED|Year 3 (12-Month Extension)||0
404903|NCT00112437|992751|P3|STARTED|Year 3 (12-Month Extension)||0
404904|NCT00112437|992752|P2|STARTED|Year 3 (12-Month Extension)||0
404905|NCT00112437|992753|P1|STARTED|Year 3 (12-Month Extension)||0
404906|NCT00112437|992728|P26|NOT COMPLETED|Year 2 (12-Month Extension)||0
404907|NCT00112437|992729|P25|NOT COMPLETED|Year 2 (12-Month Extension)||0
404908|NCT00112437|992730|P24|NOT COMPLETED|Year 2 (12-Month Extension)||0
404909|NCT00112437|992731|P23|NOT COMPLETED|Year 2 (12-Month Extension)||0
404910|NCT00112437|992732|P22|NOT COMPLETED|Year 2 (12-Month Extension)||0
404911|NCT00112437|992733|P21|NOT COMPLETED|Year 2 (12-Month Extension)||0
404912|NCT00112437|992734|P20|NOT COMPLETED|Year 2 (12-Month Extension)||0
404913|NCT00112437|992735|P19|NOT COMPLETED|Year 2 (12-Month Extension)||0
404914|NCT00112437|992736|P18|NOT COMPLETED|Year 2 (12-Month Extension)||0
404915|NCT00112437|992737|P17|NOT COMPLETED|Year 2 (12-Month Extension)||0
404916|NCT00112437|992738|P16|NOT COMPLETED|Year 2 (12-Month Extension)||0
404917|NCT00112437|992739|P15|NOT COMPLETED|Year 2 (12-Month Extension)||0
404918|NCT00112437|992740|P14|NOT COMPLETED|Year 2 (12-Month Extension)||0
404919|NCT00112437|992741|P13|NOT COMPLETED|Year 2 (12-Month Extension)||0
404920|NCT00112437|992742|P12|NOT COMPLETED|Year 2 (12-Month Extension)||0
404921|NCT00112437|992743|P11|NOT COMPLETED|Year 2 (12-Month Extension)||0
404922|NCT00112437|992744|P10|NOT COMPLETED|Year 2 (12-Month Extension)||13
404923|NCT00112437|992745|P9|NOT COMPLETED|Year 2 (12-Month Extension)||7
404924|NCT00112437|992746|P8|NOT COMPLETED|Year 2 (12-Month Extension)||8
404925|NCT00112437|992747|P7|NOT COMPLETED|Year 2 (12-Month Extension)||9
404926|NCT00112437|992748|P6|NOT COMPLETED|Year 2 (12-Month Extension)||3
404927|NCT00112437|992749|P5|NOT COMPLETED|Year 2 (12-Month Extension)||0
404928|NCT00112437|992750|P4|NOT COMPLETED|Year 2 (12-Month Extension)||0
404929|NCT00112437|992751|P3|NOT COMPLETED|Year 2 (12-Month Extension)||0
404930|NCT00112437|992752|P2|NOT COMPLETED|Year 2 (12-Month Extension)||0
404931|NCT00112437|992753|P1|NOT COMPLETED|Year 2 (12-Month Extension)||0
404932|NCT00112437|992728|P26|COMPLETED|Year 2 (12-Month Extension)||0
404933|NCT00112437|992729|P25|COMPLETED|Year 2 (12-Month Extension)||0
404934|NCT00112437|992730|P24|COMPLETED|Year 2 (12-Month Extension)||0
404935|NCT00112437|992731|P23|COMPLETED|Year 2 (12-Month Extension)||0
404936|NCT00112437|992732|P22|COMPLETED|Year 2 (12-Month Extension)||0
404937|NCT00112437|992733|P21|COMPLETED|Year 2 (12-Month Extension)||0
404938|NCT00112437|992734|P20|COMPLETED|Year 2 (12-Month Extension)||0
404939|NCT00112437|992735|P19|COMPLETED|Year 2 (12-Month Extension)||0
404940|NCT00112437|992736|P18|COMPLETED|Year 2 (12-Month Extension)||0
404941|NCT00112437|992737|P17|COMPLETED|Year 2 (12-Month Extension)||0
404942|NCT00112437|992738|P16|COMPLETED|Year 2 (12-Month Extension)||0
404943|NCT00112437|992739|P15|COMPLETED|Year 2 (12-Month Extension)||0
404944|NCT00112437|992740|P14|COMPLETED|Year 2 (12-Month Extension)||0
404945|NCT00112437|992741|P13|COMPLETED|Year 2 (12-Month Extension)||0
404946|NCT00112437|992742|P12|COMPLETED|Year 2 (12-Month Extension)||0
404947|NCT00112437|992743|P11|COMPLETED|Year 2 (12-Month Extension)||0
404948|NCT00112437|992744|P10|COMPLETED|Year 2 (12-Month Extension)||50
404949|NCT00112437|992745|P9|COMPLETED|Year 2 (12-Month Extension)||62
404950|NCT00112437|992746|P8|COMPLETED|Year 2 (12-Month Extension)||55
404951|NCT00112437|992747|P7|COMPLETED|Year 2 (12-Month Extension)||53
404952|NCT00112437|992748|P6|COMPLETED|Year 2 (12-Month Extension)||60
404953|NCT00112437|992749|P5|COMPLETED|Year 2 (12-Month Extension)||0
404954|NCT00112437|992750|P4|COMPLETED|Year 2 (12-Month Extension)||0
404955|NCT00112437|992751|P3|COMPLETED|Year 2 (12-Month Extension)||0
404956|NCT00112437|992752|P2|COMPLETED|Year 2 (12-Month Extension)||0
404957|NCT00112437|992753|P1|COMPLETED|Year 2 (12-Month Extension)||0
404958|NCT00112437|992728|P26|STARTED|Year 2 (12-Month Extension)||0
404959|NCT00112437|992729|P25|STARTED|Year 2 (12-Month Extension)||0
404960|NCT00112437|992730|P24|STARTED|Year 2 (12-Month Extension)||0
404961|NCT00112437|992731|P23|STARTED|Year 2 (12-Month Extension)||0
404962|NCT00112437|992732|P22|STARTED|Year 2 (12-Month Extension)||0
404963|NCT00112437|992733|P21|STARTED|Year 2 (12-Month Extension)||0
404964|NCT00112437|992734|P20|STARTED|Year 2 (12-Month Extension)||0
404965|NCT00112437|992735|P19|STARTED|Year 2 (12-Month Extension)||0
404966|NCT00112437|992736|P18|STARTED|Year 2 (12-Month Extension)||0
404967|NCT00112437|992737|P17|STARTED|Year 2 (12-Month Extension)||0
404968|NCT00112437|992738|P16|STARTED|Year 2 (12-Month Extension)||0
404969|NCT00112437|992739|P15|STARTED|Year 2 (12-Month Extension)||0
404970|NCT00112437|992740|P14|STARTED|Year 2 (12-Month Extension)||0
404971|NCT00112437|992741|P13|STARTED|Year 2 (12-Month Extension)||0
404972|NCT00112437|992742|P12|STARTED|Year 2 (12-Month Extension)||0
404973|NCT00112437|992743|P11|STARTED|Year 2 (12-Month Extension)||0
404974|NCT00112437|992744|P10|STARTED|Year 2 (12-Month Extension)||63
404975|NCT00112437|992745|P9|STARTED|Year 2 (12-Month Extension)||69
404976|NCT00112437|992746|P8|STARTED|Year 2 (12-Month Extension)||63
404977|NCT00112437|992747|P7|STARTED|Year 2 (12-Month Extension)||62
404978|NCT00112437|992748|P6|STARTED|Year 2 (12-Month Extension)||63
404979|NCT00112437|992749|P5|STARTED|Year 2 (12-Month Extension)||0
404980|NCT00112437|992750|P4|STARTED|Year 2 (12-Month Extension)||0
404981|NCT00112437|992751|P3|STARTED|Year 2 (12-Month Extension)||0
404982|NCT00112437|992752|P2|STARTED|Year 2 (12-Month Extension)||0
404983|NCT00112437|992753|P1|STARTED|Year 2 (12-Month Extension)||0
404984|NCT00112437|992728|P26|NOT COMPLETED|Year 1 (12-Month Base Study)||0
404985|NCT00112437|992729|P25|NOT COMPLETED|Year 1 (12-Month Base Study)||0
404986|NCT00112437|992730|P24|NOT COMPLETED|Year 1 (12-Month Base Study)||0
404987|NCT00112437|992731|P23|NOT COMPLETED|Year 1 (12-Month Base Study)||0
404988|NCT00112437|992732|P22|NOT COMPLETED|Year 1 (12-Month Base Study)||0
404989|NCT00112437|992733|P21|NOT COMPLETED|Year 1 (12-Month Base Study)||0
404990|NCT00112437|992734|P20|NOT COMPLETED|Year 1 (12-Month Base Study)||0
404991|NCT00112437|992735|P19|NOT COMPLETED|Year 1 (12-Month Base Study)||0
404992|NCT00112437|992736|P18|NOT COMPLETED|Year 1 (12-Month Base Study)||0
404993|NCT00112437|992737|P17|NOT COMPLETED|Year 1 (12-Month Base Study)||0
404994|NCT00112437|992738|P16|NOT COMPLETED|Year 1 (12-Month Base Study)||0
404995|NCT00112437|992739|P15|NOT COMPLETED|Year 1 (12-Month Base Study)||0
404996|NCT00112437|992740|P14|NOT COMPLETED|Year 1 (12-Month Base Study)||0
404997|NCT00112437|992741|P13|NOT COMPLETED|Year 1 (12-Month Base Study)||0
404998|NCT00112437|992742|P12|NOT COMPLETED|Year 1 (12-Month Base Study)||0
404999|NCT00112437|992743|P11|NOT COMPLETED|Year 1 (12-Month Base Study)||0
405000|NCT00112437|992744|P10|NOT COMPLETED|Year 1 (12-Month Base Study)||0
405001|NCT00112437|992745|P9|NOT COMPLETED|Year 1 (12-Month Base Study)||0
405002|NCT00112437|992746|P8|NOT COMPLETED|Year 1 (12-Month Base Study)||0
405003|NCT00112437|992747|P7|NOT COMPLETED|Year 1 (12-Month Base Study)||0
405004|NCT00112437|992748|P6|NOT COMPLETED|Year 1 (12-Month Base Study)||0
405005|NCT00112437|992749|P5|NOT COMPLETED|Year 1 (12-Month Base Study)||12
405006|NCT00112437|992750|P4|NOT COMPLETED|Year 1 (12-Month Base Study)||8
405007|NCT00112437|992751|P3|NOT COMPLETED|Year 1 (12-Month Base Study)||12
405008|NCT00112437|992752|P2|NOT COMPLETED|Year 1 (12-Month Base Study)||18
405009|NCT00112437|992753|P1|NOT COMPLETED|Year 1 (12-Month Base Study)||15
405010|NCT00112437|992728|P26|COMPLETED|Year 1 (12-Month Base Study)||0
405011|NCT00112437|992729|P25|COMPLETED|Year 1 (12-Month Base Study)||0
405012|NCT00112437|992730|P24|COMPLETED|Year 1 (12-Month Base Study)||0
405013|NCT00112437|992731|P23|COMPLETED|Year 1 (12-Month Base Study)||0
405014|NCT00112437|992732|P22|COMPLETED|Year 1 (12-Month Base Study)||0
405015|NCT00112437|992733|P21|COMPLETED|Year 1 (12-Month Base Study)||0
405016|NCT00112437|992734|P20|COMPLETED|Year 1 (12-Month Base Study)||0
405017|NCT00112437|992735|P19|COMPLETED|Year 1 (12-Month Base Study)||0
405018|NCT00112437|992736|P18|COMPLETED|Year 1 (12-Month Base Study)||0
405019|NCT00112437|992737|P17|COMPLETED|Year 1 (12-Month Base Study)||0
405020|NCT00112437|992738|P16|COMPLETED|Year 1 (12-Month Base Study)||0
405021|NCT00112437|992739|P15|COMPLETED|Year 1 (12-Month Base Study)||0
405022|NCT00112437|992740|P14|COMPLETED|Year 1 (12-Month Base Study)||0
405023|NCT00112437|992741|P13|COMPLETED|Year 1 (12-Month Base Study)||0
405024|NCT00112437|992742|P12|COMPLETED|Year 1 (12-Month Base Study)||0
405025|NCT00112437|992743|P11|COMPLETED|Year 1 (12-Month Base Study)||0
405026|NCT00112437|992744|P10|COMPLETED|Year 1 (12-Month Base Study)||0
405027|NCT00112437|992745|P9|COMPLETED|Year 1 (12-Month Base Study)||0
405028|NCT00112437|992746|P8|COMPLETED|Year 1 (12-Month Base Study)||0
405029|NCT00112437|992747|P7|COMPLETED|Year 1 (12-Month Base Study)||0
405030|NCT00112437|992748|P6|COMPLETED|Year 1 (12-Month Base Study)||0
405031|NCT00112437|992749|P5|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in the completed total.|66
405032|NCT00112437|992750|P4|COMPLETED|Year 1 (12-Month Base Study)||71
405033|NCT00112437|992751|P3|COMPLETED|Year 1 (12-Month Base Study)||65
405034|NCT00112437|992752|P2|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|64
405035|NCT00112437|992753|P1|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|68
405036|NCT00112437|992728|P26|STARTED|Year 1 (12-Month Base Study)||0
405037|NCT00112437|992729|P25|STARTED|Year 1 (12-Month Base Study)||0
405038|NCT00112437|992730|P24|STARTED|Year 1 (12-Month Base Study)||0
405039|NCT00112437|992731|P23|STARTED|Year 1 (12-Month Base Study)||0
405040|NCT00112437|992732|P22|STARTED|Year 1 (12-Month Base Study)||0
405041|NCT00112437|992733|P21|STARTED|Year 1 (12-Month Base Study)||0
405042|NCT00112437|992734|P20|STARTED|Year 1 (12-Month Base Study)||0
405043|NCT00112437|992735|P19|STARTED|Year 1 (12-Month Base Study)||0
405044|NCT00112437|992736|P18|STARTED|Year 1 (12-Month Base Study)||0
405045|NCT00112437|992737|P17|STARTED|Year 1 (12-Month Base Study)||0
405046|NCT00112437|992738|P16|STARTED|Year 1 (12-Month Base Study)||0
405047|NCT00112437|992739|P15|STARTED|Year 1 (12-Month Base Study)||0
405048|NCT00112437|992740|P14|STARTED|Year 1 (12-Month Base Study)||0
405049|NCT00112437|992741|P13|STARTED|Year 1 (12-Month Base Study)||0
405050|NCT00112437|992742|P12|STARTED|Year 1 (12-Month Base Study)||0
405051|NCT00112437|992743|P11|STARTED|Year 1 (12-Month Base Study)||0
405052|NCT00112437|992744|P10|STARTED|Year 1 (12-Month Base Study)||0
405053|NCT00112437|992745|P9|STARTED|Year 1 (12-Month Base Study)||0
405054|NCT00112437|992746|P8|STARTED|Year 1 (12-Month Base Study)||0
405055|NCT00112437|992747|P7|STARTED|Year 1 (12-Month Base Study)||0
405056|NCT00112437|992748|P6|STARTED|Year 1 (12-Month Base Study)||0
405057|NCT00112437|992749|P5|STARTED|Year 1 (12-Month Base Study)||78
405058|NCT00112437|992750|P4|STARTED|Year 1 (12-Month Base Study)||79
405059|NCT00112437|992751|P3|STARTED|Year 1 (12-Month Base Study)||77
405060|NCT00112437|992752|P2|STARTED|Year 1 (12-Month Base Study)||82
405061|NCT00112437|992753|P1|STARTED|Year 1 (12-Month Base Study)||83
405062|NCT00112385|993033|P2|NOT COMPLETED|Overall Study||1
405063|NCT00112385|993034|P1|NOT COMPLETED|Overall Study||1
405064|NCT00112385|993033|P2|COMPLETED|Overall Study||4
405065|NCT00112385|993034|P1|COMPLETED|Overall Study||10
405066|NCT00112385|993033|P2|STARTED|Overall Study||5
405067|NCT00112385|993034|P1|STARTED|Overall Study||11
405068|NCT00112359|993124|P2|NOT COMPLETED|Overall Study||13
405069|NCT00112359|993125|P1|NOT COMPLETED|Overall Study||27
405070|NCT00112359|993124|P2|COMPLETED|Overall Study||67
405071|NCT00112359|993125|P1|COMPLETED|Overall Study||57
405072|NCT00112359|993124|P2|STARTED|Overall Study||80
405073|NCT00112359|993125|P1|STARTED|Overall Study||84
405074|NCT00112294|993151|P2|NOT COMPLETED|Overall Study||0
405075|NCT00112294|993152|P1|NOT COMPLETED|Overall Study||5
405076|NCT00112294|993151|P2|COMPLETED|Overall Study|Off all study therapies.|320
405077|NCT00112294|993152|P1|COMPLETED|Overall Study|Off all study therapies.|320
405078|NCT00112294|993151|P2|Never Treated|Overall Study|Number by randomized group = 20, but 2 participants received C/T/C instead of T/C.|18
405079|NCT00112294|993152|P1|Never Treated|Overall Study|Number by randomized group = 11, but 2 participants received C/T/C instead of T/C.|13
405080|NCT00112294|993151|P2|STARTED|Overall Study|338 randomized and 320 treated.|320
405081|NCT00112294|993152|P1|STARTED|Overall Study|338 randomized and 325 treated.|325
405082|NCT00112151|993196|P6|NOT COMPLETED|Overall Study||3
405083|NCT00112151|993197|P5|NOT COMPLETED|Overall Study||6
405084|NCT00112151|993198|P4|NOT COMPLETED|Overall Study||3
405085|NCT00112151|993199|P3|NOT COMPLETED|Overall Study||3
405086|NCT00112151|993200|P2|NOT COMPLETED|Overall Study||5
405087|NCT00112151|993201|P1|NOT COMPLETED|Overall Study||4
405088|NCT00112151|993196|P6|COMPLETED|Overall Study||25
405089|NCT00112151|993197|P5|COMPLETED|Overall Study||22
405090|NCT00112151|993198|P4|COMPLETED|Overall Study||24
405091|NCT00112151|993199|P3|COMPLETED|Overall Study||25
405092|NCT00112151|993200|P2|COMPLETED|Overall Study||23
405093|NCT00112151|993201|P1|COMPLETED|Overall Study||24
405094|NCT00112151|993196|P6|STARTED|Overall Study||28
405095|NCT00112151|993197|P5|STARTED|Overall Study||28
405096|NCT00112151|993198|P4|STARTED|Overall Study||27
405097|NCT00112151|993199|P3|STARTED|Overall Study||28
405098|NCT00112151|993200|P2|STARTED|Overall Study||28
405099|NCT00112151|993201|P1|STARTED|Overall Study||28
405100|NCT00112112|993232|P2|NOT COMPLETED|Overall Study||0
405101|NCT00112112|993233|P1|NOT COMPLETED|Overall Study||0
405102|NCT00112112|993232|P2|COMPLETED|Overall Study||10
405103|NCT00112112|993233|P1|COMPLETED|Overall Study||10
405104|NCT00112112|993232|P2|STARTED|Overall Study||10
405105|NCT00112112|993233|P1|STARTED|Overall Study||10
405106|NCT00112047|993375|P2|NOT COMPLETED|Atripla Phase||20
405107|NCT00112047|993376|P1|NOT COMPLETED|Atripla Phase||18
405108|NCT00112047|993375|P2|COMPLETED|Atripla Phase||106
405109|NCT00112047|993376|P1|COMPLETED|Atripla Phase||142
405110|NCT00112047|993375|P2|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|126
405111|NCT00112047|993376|P1|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|160
405112|NCT00112047|993375|P2|NOT COMPLETED|Randomized Phase||88
405113|NCT00112047|993376|P1|NOT COMPLETED|Randomized Phase||70
405114|NCT00112047|993375|P2|COMPLETED|Randomized Phase||166
405115|NCT00112047|993376|P1|COMPLETED|Randomized Phase||187
405116|NCT00112047|993375|P2|STARTED|Randomized Phase|ITT analysis population|254
405117|NCT00112047|993376|P1|STARTED|Randomized Phase|Intention to treat (ITT) population N=255 (2 participants had received prior antiretroviral therapy)|257
405118|NCT00111917|993476|P2|NOT COMPLETED|Overall Study||1
405119|NCT00111917|993477|P1|NOT COMPLETED|Overall Study||1
405120|NCT00111917|993476|P2|COMPLETED|Overall Study||3
405121|NCT00111917|993477|P1|COMPLETED|Overall Study||8
405122|NCT00111917|993476|P2|STARTED|Overall Study||4
405123|NCT00111917|993477|P1|STARTED|Overall Study||9
405124|NCT00111839|993492|P3|NOT COMPLETED|Overall Study||49
405125|NCT00111839|993493|P2|NOT COMPLETED|Overall Study||46
405126|NCT00111839|993494|P1|NOT COMPLETED|Overall Study||48
405127|NCT00111839|993492|P3|COMPLETED|Overall Study||0
405128|NCT00111839|993493|P2|COMPLETED|Overall Study||5
405129|NCT00111839|993494|P1|COMPLETED|Overall Study||2
405130|NCT00111839|993492|P3|Treated|Overall Study||47
405131|NCT00111839|993493|P2|Treated|Overall Study||51
405132|NCT00111839|993494|P1|Treated|Overall Study||50
405133|NCT00111839|993492|P3|STARTED|Overall Study||49
405134|NCT00111839|993493|P2|STARTED|Overall Study||51
405135|NCT00111839|993494|P1|STARTED|Overall Study||50
405136|NCT00111813|993514|P6|NOT COMPLETED|Overall Study||6
405137|NCT00111813|993515|P5|NOT COMPLETED|Overall Study||6
405138|NCT00111813|993516|P4|NOT COMPLETED|Overall Study||5
405139|NCT00111813|993517|P3|NOT COMPLETED|Overall Study||10
405140|NCT00111813|993518|P2|NOT COMPLETED|Overall Study||3
405141|NCT00111813|993519|P1|NOT COMPLETED|Overall Study||3
405142|NCT00111813|993514|P6|COMPLETED|Overall Study||0
405143|NCT00111813|993515|P5|COMPLETED|Overall Study||0
405144|NCT00111813|993516|P4|COMPLETED|Overall Study||1
405145|NCT00111813|993517|P3|COMPLETED|Overall Study||0
405146|NCT00111813|993518|P2|COMPLETED|Overall Study||0
405147|NCT00111813|993519|P1|COMPLETED|Overall Study||0
405148|NCT00111813|993514|P6|STARTED|Overall Study||6
405149|NCT00111813|993515|P5|STARTED|Overall Study||6
405150|NCT00111813|993516|P4|STARTED|Overall Study||6
405151|NCT00111813|993517|P3|STARTED|Overall Study||10
405152|NCT00111813|993518|P2|STARTED|Overall Study||3
405153|NCT00111813|993519|P1|STARTED|Overall Study||3
405154|NCT00111800|993558|P6|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
405155|NCT00111800|993559|P5|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||4
405156|NCT00111800|993560|P4|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||5
405157|NCT00111800|993561|P3|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
405158|NCT00111800|993562|P2|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
405159|NCT00111800|993563|P1|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
405160|NCT00111800|993558|P6|COMPLETED|Period 2: Extension Phase (12 Weeks)||53
405161|NCT00111800|993559|P5|COMPLETED|Period 2: Extension Phase (12 Weeks)||51
405162|NCT00111800|993560|P4|COMPLETED|Period 2: Extension Phase (12 Weeks)||54
405163|NCT00111800|993561|P3|COMPLETED|Period 2: Extension Phase (12 Weeks)||47
405164|NCT00111800|993562|P2|COMPLETED|Period 2: Extension Phase (12 Weeks)||40
405165|NCT00111800|993563|P1|COMPLETED|Period 2: Extension Phase (12 Weeks)||46
405166|NCT00111800|993558|P6|STARTED|Period 2: Extension Phase (12 Weeks)||55
405167|NCT00111800|993559|P5|STARTED|Period 2: Extension Phase (12 Weeks)||55
405168|NCT00111800|993560|P4|STARTED|Period 2: Extension Phase (12 Weeks)||59
405169|NCT00111800|993561|P3|STARTED|Period 2: Extension Phase (12 Weeks)||54
405170|NCT00111800|993562|P2|STARTED|Period 2: Extension Phase (12 Weeks)||47
405171|NCT00111800|993563|P1|STARTED|Period 2: Extension Phase (12 Weeks)||48
405172|NCT00111800|993558|P6|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
405173|NCT00111800|993559|P5|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
405174|NCT00111800|993560|P4|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||6
405175|NCT00111800|993561|P3|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||9
405176|NCT00111800|993562|P2|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||14
405177|NCT00111800|993563|P1|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||15
405178|NCT00111800|993558|P6|COMPLETED|Period 1: Main Phase (12 Weeks)||56
405179|NCT00111800|993559|P5|COMPLETED|Period 1: Main Phase (12 Weeks)||55
405180|NCT00111800|993560|P4|COMPLETED|Period 1: Main Phase (12 Weeks)||60
405181|NCT00111800|993561|P3|COMPLETED|Period 1: Main Phase (12 Weeks)||54
405182|NCT00111800|993562|P2|COMPLETED|Period 1: Main Phase (12 Weeks)||47
405183|NCT00111800|993563|P1|COMPLETED|Period 1: Main Phase (12 Weeks)||49
405184|NCT00111800|993558|P6|STARTED|Period 1: Main Phase (12 Weeks)||61
405185|NCT00111800|993559|P5|STARTED|Period 1: Main Phase (12 Weeks)||60
405186|NCT00111800|993560|P4|STARTED|Period 1: Main Phase (12 Weeks)||66
405187|NCT00111800|993561|P3|STARTED|Period 1: Main Phase (12 Weeks)||63
405188|NCT00111800|993562|P2|STARTED|Period 1: Main Phase (12 Weeks)||61
405189|NCT00111800|993563|P1|STARTED|Period 1: Main Phase (12 Weeks)||64
405190|NCT00111761|993733|P2|NOT COMPLETED|Part 2||0
405191|NCT00111761|993734|P1|NOT COMPLETED|Part 2||8
405192|NCT00111761|993733|P2|COMPLETED|Part 2||0
405193|NCT00111761|993734|P1|COMPLETED|Part 2||16
405194|NCT00111761|993733|P2|STARTED|Part 2|This treatment group was used in Part 1 only|0
405195|NCT00111761|993734|P1|STARTED|Part 2||24
405196|NCT00111761|993733|P2|NOT COMPLETED|Part 1||5
405197|NCT00111761|993734|P1|NOT COMPLETED|Part 1||0
405198|NCT00111761|993733|P2|COMPLETED|Part 1|Completed through safety followup|14
405199|NCT00111761|993734|P1|COMPLETED|Part 1||0
405200|NCT00111761|993733|P2|STARTED|Part 1||19
405201|NCT00111761|993734|P1|STARTED|Part 1|This treatment group was not initiated until Part 2|0
405202|NCT00111657|993751|P1|NOT COMPLETED|Overall Study||16
405203|NCT00111657|993751|P1|COMPLETED|Overall Study|Completed all intended doses.|21
405204|NCT00111657|993751|P1|STARTED|Overall Study|37 consented. 30 initiated treatment. 29 completed at least 1 dose.|37
405205|NCT00111241|993763|P2|NOT COMPLETED|Overall Study||8
405206|NCT00111241|993764|P1|NOT COMPLETED|Overall Study||15
405207|NCT00111241|993763|P2|COMPLETED|Overall Study||62
405208|NCT00111241|993764|P1|COMPLETED|Overall Study||30
405209|NCT00111241|993763|P2|STARTED|Overall Study||70
405210|NCT00111241|993764|P1|STARTED|Overall Study||45
405211|NCT00111228|993775|P3|NOT COMPLETED|Overall Study||0
405212|NCT00111228|993776|P2|NOT COMPLETED|Overall Study||1
405213|NCT00111228|993777|P1|NOT COMPLETED|Overall Study||5
405214|NCT00111228|993775|P3|COMPLETED|Overall Study||54
405215|NCT00111228|993776|P2|COMPLETED|Overall Study||53
405216|NCT00111228|993777|P1|COMPLETED|Overall Study||49
405217|NCT00111228|993775|P3|STARTED|Overall Study||54
405218|NCT00111228|993776|P2|STARTED|Overall Study||54
405219|NCT00111228|993777|P1|STARTED|Overall Study||54
405220|NCT00111007|993790|P2|NOT COMPLETED|Long Term Follow-up||45
405221|NCT00111007|993791|P1|NOT COMPLETED|Long Term Follow-up||47
405222|NCT00111007|993790|P2|COMPLETED|Long Term Follow-up||62
405223|NCT00111007|993791|P1|COMPLETED|Long Term Follow-up||54
405224|NCT00111007|993790|P2|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|107
405225|NCT00111007|993791|P1|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|101
405226|NCT00111007|993790|P2|NOT COMPLETED|Active Follow-up||2
405227|NCT00111007|993791|P1|NOT COMPLETED|Active Follow-up||6
405228|NCT00111007|993790|P2|COMPLETED|Active Follow-up||2
405229|NCT00111007|993791|P1|COMPLETED|Active Follow-up||0
405230|NCT00111007|993790|P2|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|4
405480|NCT00109005|994488|P1|NOT COMPLETED|Overall Study||0
405231|NCT00111007|993791|P1|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|6
405232|NCT00111007|993790|P2|NOT COMPLETED|Double-blind (DB) Treatment||111
405233|NCT00111007|993791|P1|NOT COMPLETED|Double-blind (DB) Treatment||108
405234|NCT00111007|993790|P2|COMPLETED|Double-blind (DB) Treatment||24
405235|NCT00111007|993791|P1|COMPLETED|Double-blind (DB) Treatment||27
405236|NCT00111007|993790|P2|Received Treatment|Double-blind (DB) Treatment|Safety population|134
405237|NCT00111007|993791|P1|Received Treatment|Double-blind (DB) Treatment|Safety population|134
405238|NCT00111007|993790|P2|STARTED|Double-blind (DB) Treatment|ITT population|135
405239|NCT00111007|993791|P1|STARTED|Double-blind (DB) Treatment|ITT population|135
405240|NCT00110994|993807|P2|NOT COMPLETED|Long Term Follow-up||17
405241|NCT00110994|993808|P1|NOT COMPLETED|Long Term Follow-up||19
405242|NCT00110994|993807|P2|COMPLETED|Long Term Follow-up||30
405243|NCT00110994|993808|P1|COMPLETED|Long Term Follow-up||22
405244|NCT00110994|993807|P2|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|47
405245|NCT00110994|993808|P1|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|41
405246|NCT00110994|993807|P2|NOT COMPLETED|Active Follow-up||2
405247|NCT00110994|993808|P1|NOT COMPLETED|Active Follow-up||1
405248|NCT00110994|993807|P2|COMPLETED|Active Follow-up||0
405249|NCT00110994|993808|P1|COMPLETED|Active Follow-up||0
405250|NCT00110994|993807|P2|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|2
405251|NCT00110994|993808|P1|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|1
405252|NCT00110994|993807|P2|NOT COMPLETED|Double-blind (DB) Treatment||47
405253|NCT00110994|993808|P1|NOT COMPLETED|Double-blind (DB) Treatment||42
405254|NCT00110994|993807|P2|COMPLETED|Double-blind (DB) Treatment||3
405255|NCT00110994|993808|P1|COMPLETED|Double-blind (DB) Treatment||9
405256|NCT00110994|993807|P2|Received Treatment|Double-blind (DB) Treatment|Safety population|50
405257|NCT00110994|993808|P1|Received Treatment|Double-blind (DB) Treatment|Safety population|51
405258|NCT00110994|993807|P2|STARTED|Double-blind (DB) Treatment|ITT population|50
405259|NCT00110994|993808|P1|STARTED|Double-blind (DB) Treatment|ITT population|51
405260|NCT00110890|993834|P2|NOT COMPLETED|Overall Study||179
405261|NCT00110890|993835|P1|NOT COMPLETED|Overall Study||361
405262|NCT00110890|993834|P2|COMPLETED|Overall Study|Follow-up Phase|5
405263|NCT00110890|993835|P1|COMPLETED|Overall Study|Follow-up Phase|7
405264|NCT00110890|993834|P2|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|150
405265|NCT00110890|993835|P1|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|280
405266|NCT00110890|993834|P2|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|170
405267|NCT00110890|993835|P1|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|316
405268|NCT00110890|993834|P2|STARTED|Overall Study||184
405269|NCT00110890|993835|P1|STARTED|Overall Study||368
405270|NCT00110812|993852|P3|NOT COMPLETED|Extended Follow-up||4
405271|NCT00110812|993853|P2|NOT COMPLETED|Extended Follow-up||4
405272|NCT00110812|993854|P1|NOT COMPLETED|Extended Follow-up||2
405273|NCT00110812|993852|P3|COMPLETED|Extended Follow-up||69
405274|NCT00110812|993853|P2|COMPLETED|Extended Follow-up||65
405275|NCT00110812|993854|P1|COMPLETED|Extended Follow-up||78
405276|NCT00110812|993852|P3|STARTED|Extended Follow-up||73
405277|NCT00110812|993853|P2|STARTED|Extended Follow-up||69
405278|NCT00110812|993854|P1|STARTED|Extended Follow-up||80
405279|NCT00110812|993852|P3|NOT COMPLETED|Main Study||13
405280|NCT00110812|993853|P2|NOT COMPLETED|Main Study||11
405281|NCT00110812|993854|P1|NOT COMPLETED|Main Study||8
405282|NCT00110812|993852|P3|COMPLETED|Main Study||74
405283|NCT00110812|993853|P2|COMPLETED|Main Study||78
405284|NCT00110812|993854|P1|COMPLETED|Main Study||83
405285|NCT00110812|993852|P3|STARTED|Main Study||87
405286|NCT00110812|993853|P2|STARTED|Main Study||89
405287|NCT00110812|993854|P1|STARTED|Main Study||91
405288|NCT00110617|993899|P2|NOT COMPLETED|Overall Study||29
405289|NCT00110617|993900|P1|NOT COMPLETED|Overall Study||39
405290|NCT00110617|993899|P2|COMPLETED|Overall Study||39
405291|NCT00110617|993900|P1|COMPLETED|Overall Study||96
405292|NCT00110617|993899|P2|On Going at Week 24|Overall Study||53
405293|NCT00110617|993900|P1|On Going at Week 24|Overall Study||126
405294|NCT00110617|993899|P2|Full Analysis 2; Received ICL670|Overall Study||53
405295|NCT00110617|993900|P1|Full Analysis 2; Received ICL670|Overall Study||135
405296|NCT00110617|993899|P2|Safety Set 1; Received Study Drug|Overall Study||56
405297|NCT00110617|993900|P1|Safety Set 1; Received Study Drug|Overall Study||135
405298|NCT00110617|993899|P2|STARTED|Overall Study|Full Analysis Set 1 does not include 9 participants who were excluded due to GCP violations.|68
405299|NCT00110617|993900|P1|STARTED|Overall Study||135
405300|NCT00110513|993913|P1|NOT COMPLETED|Overall Study||0
405301|NCT00110513|993913|P1|COMPLETED|Overall Study||18
405302|NCT00110513|993913|P1|STARTED|Overall Study||18
405303|NCT00110461|993920|P3|NOT COMPLETED|Acute Phase||23
405304|NCT00110461|993921|P2|NOT COMPLETED|Acute Phase||22
405305|NCT00110461|993922|P1|NOT COMPLETED|Acute Phase||14
405306|NCT00110461|993920|P3|COMPLETED|Acute Phase||76
405307|NCT00110461|993921|P2|COMPLETED|Acute Phase||77
405308|NCT00110461|993922|P1|COMPLETED|Acute Phase||84
405309|NCT00110461|993920|P3|STARTED|Acute Phase||99
405310|NCT00110461|993921|P2|STARTED|Acute Phase||99
405311|NCT00110461|993922|P1|STARTED|Acute Phase||98
405312|NCT00110461|993920|P3|NOT COMPLETED|30-Week, Double-blind Treatment Phase||87
405481|NCT00109005|994487|P2|COMPLETED|Overall Study||9
405313|NCT00110461|993921|P2|NOT COMPLETED|30-Week, Double-blind Treatment Phase||77
405314|NCT00110461|993922|P1|NOT COMPLETED|30-Week, Double-blind Treatment Phase||64
405315|NCT00110461|993920|P3|COMPLETED|30-Week, Double-blind Treatment Phase||12
405316|NCT00110461|993921|P2|COMPLETED|30-Week, Double-blind Treatment Phase||22
405317|NCT00110461|993922|P1|COMPLETED|30-Week, Double-blind Treatment Phase||34
405318|NCT00110461|993920|P3|STARTED|30-Week, Double-blind Treatment Phase||99
405319|NCT00110461|993921|P2|STARTED|30-Week, Double-blind Treatment Phase||99
405320|NCT00110461|993922|P1|STARTED|30-Week, Double-blind Treatment Phase||98
405321|NCT00110396|994017|P1|NOT COMPLETED|Overall Study||36
405322|NCT00110396|994017|P1|COMPLETED|Overall Study|260 participants included in the Safety Population.207 completed treatment. 224 completed the trial|224
405323|NCT00110396|994017|P1|STARTED|Overall Study||260
405324|NCT00110357|994025|P2|NOT COMPLETED|Overall Study||19
405325|NCT00110357|994026|P1|NOT COMPLETED|Overall Study||27
405326|NCT00110357|994025|P2|COMPLETED|Overall Study|Number Still on Study|0
405327|NCT00110357|994026|P1|COMPLETED|Overall Study|Number Still on Study|0
405328|NCT00110357|994025|P2|STARTED|Overall Study||19
405329|NCT00110357|994026|P1|STARTED|Overall Study||27
405330|NCT00110305|994114|P2|NOT COMPLETED|Overall Study||32
405331|NCT00110305|994115|P1|NOT COMPLETED|Overall Study||114
405332|NCT00110305|994114|P2|COMPLETED|Overall Study||57
405333|NCT00110305|994115|P1|COMPLETED|Overall Study||165
405334|NCT00110305|994114|P2|STARTED|Overall Study||89
405335|NCT00110305|994115|P1|STARTED|Overall Study||279
405336|NCT00110214|994168|P2|NOT COMPLETED|Overall Study||503
405337|NCT00110214|994169|P1|NOT COMPLETED|Overall Study||509
405338|NCT00110214|994168|P2|COMPLETED|Overall Study||21
405339|NCT00110214|994169|P1|COMPLETED|Overall Study||17
405340|NCT00110214|994168|P2|STARTED|Overall Study||524
405341|NCT00110214|994169|P1|STARTED|Overall Study||526
405342|NCT00110149|994181|P1|NOT COMPLETED|Overall Study||3
405343|NCT00110149|994181|P1|COMPLETED|Overall Study||9
405344|NCT00110149|994181|P1|Received Treatment|Overall Study|total number of patient that passed screening and received treatment.|9
405345|NCT00110149|994181|P1|STARTED|Overall Study|total number that signed consent to be screened.|12
405346|NCT00110136|994186|P1|NOT COMPLETED|Overall Study||0
405347|NCT00110136|994186|P1|COMPLETED|Overall Study||9
405348|NCT00110136|994186|P1|STARTED|Overall Study||9
405349|NCT00110084|994195|P1|NOT COMPLETED|Overall Study||28
405350|NCT00110084|994195|P1|COMPLETED|Overall Study||22
405351|NCT00110084|994195|P1|STARTED|Overall Study||50
405352|NCT00110019|994204|P2|NOT COMPLETED|Overall Study||413
405353|NCT00110019|994205|P1|NOT COMPLETED|Overall Study||406
405354|NCT00110019|994204|P2|COMPLETED|Overall Study||0
405355|NCT00110019|994205|P1|COMPLETED|Overall Study||4
405356|NCT00110019|994204|P2|Treated|Overall Study||397
405357|NCT00110019|994205|P1|Treated|Overall Study||393
405358|NCT00110019|994204|P2|Eligible|Overall Study||398
405359|NCT00110019|994205|P1|Eligible|Overall Study||395
405360|NCT00110019|994204|P2|STARTED|Overall Study||413
405361|NCT00110019|994205|P1|STARTED|Overall Study||410
405362|NCT00109967|994217|P2|NOT COMPLETED|Overall Study||6
405363|NCT00109967|994218|P1|NOT COMPLETED|Overall Study||20
405364|NCT00109967|994217|P2|COMPLETED|Overall Study||15
405365|NCT00109967|994218|P1|COMPLETED|Overall Study||30
405366|NCT00109967|994217|P2|STARTED|Overall Study||21
405367|NCT00109967|994218|P1|STARTED|Overall Study||50
405368|NCT00109928|994232|P1|NOT COMPLETED|Overall Study||13
405369|NCT00109928|994232|P1|COMPLETED|Overall Study||21
405370|NCT00109928|994232|P1|Eligible and Began Protocol Therapy|Overall Study||33
405371|NCT00109928|994232|P1|Eligible|Overall Study||33
405372|NCT00109928|994232|P1|STARTED|Overall Study||34
405373|NCT00109876|994239|P1|NOT COMPLETED|Overall Study||0
405374|NCT00109876|994239|P1|COMPLETED|Overall Study||51
405375|NCT00109876|994239|P1|STARTED|Overall Study||51
405376|NCT00109850|994249|P1|NOT COMPLETED|Overall Study||4
405377|NCT00109850|994249|P1|COMPLETED|Overall Study||18
405378|NCT00109850|994249|P1|Eligible and Began Protocol Therapy|Overall Study||21
405379|NCT00109850|994249|P1|Eligible|Overall Study||21
405380|NCT00109850|994249|P1|STARTED|Overall Study||22
405381|NCT00109837|994256|P1|NOT COMPLETED|Overall Study||23
405382|NCT00109837|994256|P1|COMPLETED|Overall Study||56
405383|NCT00109837|994256|P1|Eligible and Ph- and Treated|Overall Study||60
405384|NCT00109837|994256|P1|Eligible and Ph-|Overall Study||61
405385|NCT00109837|994256|P1|Eligible|Overall Study||78
405386|NCT00109837|994256|P1|STARTED|Overall Study||79
405387|NCT00109772|994266|P2|NOT COMPLETED|Open-label Extension||49
405388|NCT00109772|994267|P1|NOT COMPLETED|Open-label Extension||45
405389|NCT00109772|994266|P2|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|29
405390|NCT00109772|994267|P1|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|19
405391|NCT00109772|994266|P2|STARTED|Open-label Extension|One double-blind participant did not continue into the open-label extension|78
405392|NCT00109772|994267|P1|STARTED|Open-label Extension|Four double-blind participants did not continue into the open-label extension|64
405393|NCT00109772|994266|P2|NOT COMPLETED|Double-blind Treatment||15
405394|NCT00109772|994267|P1|NOT COMPLETED|Double-blind Treatment||22
405395|NCT00109772|994266|P2|COMPLETED|Double-blind Treatment||79
405396|NCT00109772|994267|P1|COMPLETED|Double-blind Treatment||68
405482|NCT00109005|994488|P1|COMPLETED|Overall Study||8
405397|NCT00109772|994266|P2|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|93
405398|NCT00109772|994267|P1|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|87
405399|NCT00109772|994266|P2|STARTED|Double-blind Treatment||94
405400|NCT00109772|994267|P1|STARTED|Double-blind Treatment||90
405401|NCT00109733|994307|P2|NOT COMPLETED|Overall Study||4
405402|NCT00109733|994308|P1|NOT COMPLETED|Overall Study||2
405403|NCT00109733|994307|P2|COMPLETED|Overall Study||12
405404|NCT00109733|994308|P1|COMPLETED|Overall Study||13
405405|NCT00109733|994307|P2|STARTED|Overall Study||16
405406|NCT00109733|994308|P1|STARTED|Overall Study||15
405407|NCT00109590|994325|P3|NOT COMPLETED|Overall Study||4
405408|NCT00109590|994326|P2|NOT COMPLETED|Overall Study||2
405409|NCT00109590|994327|P1|NOT COMPLETED|Overall Study||2
405410|NCT00109590|994325|P3|COMPLETED|Overall Study||56
405411|NCT00109590|994326|P2|COMPLETED|Overall Study||56
405412|NCT00109590|994327|P1|COMPLETED|Overall Study||55
405413|NCT00109590|994325|P3|RECEIVED TREATMENT|Overall Study||57
405414|NCT00109590|994326|P2|RECEIVED TREATMENT|Overall Study||56
405415|NCT00109590|994327|P1|RECEIVED TREATMENT|Overall Study||56
405416|NCT00109590|994325|P3|STARTED|Overall Study||60
405417|NCT00109590|994326|P2|STARTED|Overall Study||58
405418|NCT00109590|994327|P1|STARTED|Overall Study||57
405419|NCT00109577|994369|P2|NOT COMPLETED|Overall Study||3
405420|NCT00109577|994370|P1|NOT COMPLETED|Overall Study||3
405421|NCT00109577|994369|P2|COMPLETED|Overall Study||17
405422|NCT00109577|994370|P1|COMPLETED|Overall Study||17
405423|NCT00109577|994369|P2|STARTED|Overall Study||20
405424|NCT00109577|994370|P1|STARTED|Overall Study||20
405425|NCT00109473|994378|P2|NOT COMPLETED|52 Week Extension Phase||5
405426|NCT00109473|994379|P1|NOT COMPLETED|52 Week Extension Phase||4
405427|NCT00109473|994378|P2|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|3
405428|NCT00109473|994379|P1|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|5
405429|NCT00109473|994378|P2|Analyzed|52 Week Extension Phase||8
405430|NCT00109473|994379|P1|Analyzed|52 Week Extension Phase||9
405431|NCT00109473|994378|P2|STARTED|52 Week Extension Phase||8
405432|NCT00109473|994379|P1|STARTED|52 Week Extension Phase||9
405433|NCT00109473|994378|P2|NOT COMPLETED|Week 12 to Week 24||0
405434|NCT00109473|994379|P1|NOT COMPLETED|Week 12 to Week 24||1
405435|NCT00109473|994378|P2|COMPLETED|Week 12 to Week 24|one subject discontinued intervention due to active disease requiring surgery|9
405436|NCT00109473|994379|P1|COMPLETED|Week 12 to Week 24|One subject withdrew consent|9
405437|NCT00109473|994378|P2|Analyzed|Week 12 to Week 24||9
405438|NCT00109473|994379|P1|Analyzed|Week 12 to Week 24||9
405439|NCT00109473|994378|P2|STARTED|Week 12 to Week 24||9
405440|NCT00109473|994379|P1|STARTED|Week 12 to Week 24||10
405441|NCT00109473|994378|P2|NOT COMPLETED|Baseline (0 Through 12 Weeks)||1
405442|NCT00109473|994379|P1|NOT COMPLETED|Baseline (0 Through 12 Weeks)||0
405443|NCT00109473|994378|P2|COMPLETED|Baseline (0 Through 12 Weeks)|One subject discontinued intervention because of active disease requiring imfliximab|9
405444|NCT00109473|994379|P1|COMPLETED|Baseline (0 Through 12 Weeks)||10
405445|NCT00109473|994378|P2|Analyzed|Baseline (0 Through 12 Weeks)||10
405446|NCT00109473|994379|P1|Analyzed|Baseline (0 Through 12 Weeks)||10
405447|NCT00109473|994378|P2|STARTED|Baseline (0 Through 12 Weeks)||10
405448|NCT00109473|994379|P1|STARTED|Baseline (0 Through 12 Weeks)|11 subjects allocated to Group A; one withdrew consent, only 10 receieved intervention.|10
405449|NCT00109343|994401|P3|NOT COMPLETED|Overall Study||30
405450|NCT00109343|994402|P2|NOT COMPLETED|Overall Study||37
405451|NCT00109343|994403|P1|NOT COMPLETED|Overall Study||64
405452|NCT00109343|994401|P3|COMPLETED|Overall Study||229
405453|NCT00109343|994402|P2|COMPLETED|Overall Study||221
405454|NCT00109343|994403|P1|COMPLETED|Overall Study||446
405455|NCT00109343|994401|P3|Vaccinated at Visit 4|Overall Study||240
405456|NCT00109343|994402|P2|Vaccinated at Visit 4|Overall Study||235
405457|NCT00109343|994403|P1|Vaccinated at Visit 4|Overall Study||466
405458|NCT00109343|994401|P3|Vaccinated at Visit 2|Overall Study||246
405459|NCT00109343|994402|P2|Vaccinated at Visit 2|Overall Study||246
405460|NCT00109343|994403|P1|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects in Group 1 were not vaccinated at Visit 2|0
405461|NCT00109343|994401|P3|Vaccinated at Visit 1|Overall Study||259
405462|NCT00109343|994402|P2|Vaccinated at Visit 1|Overall Study||258
405463|NCT00109343|994403|P1|Vaccinated at Visit 1|Overall Study||510
405464|NCT00109343|994401|P3|STARTED|Overall Study||259
405465|NCT00109343|994402|P2|STARTED|Overall Study||258
405466|NCT00109343|994403|P1|STARTED|Overall Study||510
405467|NCT00109031|994448|P4|NOT COMPLETED|Overall Study||0
405468|NCT00109031|994449|P3|NOT COMPLETED|Overall Study||2
405469|NCT00109031|994450|P2|NOT COMPLETED|Overall Study||2
405470|NCT00109031|994451|P1|NOT COMPLETED|Overall Study||0
405471|NCT00109031|994448|P4|COMPLETED|Overall Study||12
405472|NCT00109031|994449|P3|COMPLETED|Overall Study||12
405473|NCT00109031|994450|P2|COMPLETED|Overall Study||8
405474|NCT00109031|994451|P1|COMPLETED|Overall Study||11
405475|NCT00109031|994448|P4|STARTED|Overall Study||12
405476|NCT00109031|994449|P3|STARTED|Overall Study||14
405477|NCT00109031|994450|P2|STARTED|Overall Study||10
405478|NCT00109031|994451|P1|STARTED|Overall Study||11
405479|NCT00109005|994487|P2|NOT COMPLETED|Overall Study||0
405483|NCT00109005|994487|P2|STARTED|Overall Study||9
405484|NCT00109005|994488|P1|STARTED|Overall Study||8
405485|NCT00108953|994502|P2|NOT COMPLETED|Follow-up||33
405486|NCT00108953|994503|P1|NOT COMPLETED|Follow-up||29
405487|NCT00108953|994502|P2|COMPLETED|Follow-up||12
405488|NCT00108953|994503|P1|COMPLETED|Follow-up||11
405489|NCT00108953|994502|P2|STARTED|Follow-up|45 out of 49 patients were followed after end of double blind treatment|45
405490|NCT00108953|994503|P1|STARTED|Follow-up|40 out of 47 patients were followed after end of double blind treatment|40
405491|NCT00108953|994502|P2|NOT COMPLETED|Treatment Period||0
405492|NCT00108953|994503|P1|NOT COMPLETED|Treatment Period||0
405493|NCT00108953|994502|P2|COMPLETED|Treatment Period|No patient under study medication anymore|49
405494|NCT00108953|994503|P1|COMPLETED|Treatment Period|No patient under study medication anymore|47
405495|NCT00108953|994502|P2|STARTED|Treatment Period|ITT population|49
405496|NCT00108953|994503|P1|STARTED|Treatment Period|ITT population|47
405497|NCT00108862|994525|P2|NOT COMPLETED|Overall Study||62
405498|NCT00108862|994526|P1|NOT COMPLETED|Overall Study||68
405499|NCT00108862|994525|P2|COMPLETED|Overall Study||339
405500|NCT00108862|994526|P1|COMPLETED|Overall Study||337
405501|NCT00108862|994525|P2|STARTED|Overall Study|Three participants who were deemed clinically ineligible and taken off study were omitted.|401
405502|NCT00108862|994526|P1|STARTED|Overall Study||405
405503|NCT00108732|994554|P1|NOT COMPLETED|Step 2 (Androgen Ablation and Vaccine)||5
405504|NCT00108732|994554|P1|COMPLETED|Step 2 (Androgen Ablation and Vaccine)||26
405505|NCT00108732|994554|P1|STARTED|Step 2 (Androgen Ablation and Vaccine)||31
405506|NCT00108732|994554|P1|NOT COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||14
405507|NCT00108732|994554|P1|COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||36
405508|NCT00108732|994554|P1|Eligible and Treated|Step 1 (Vaccinia/Fowlpox/GM-CSF)||40
405509|NCT00108732|994554|P1|STARTED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||50
405510|NCT00108628|994563|P2|NOT COMPLETED|Overall Study||10
405511|NCT00108628|994564|P1|NOT COMPLETED|Overall Study||20
405512|NCT00108628|994563|P2|COMPLETED|Overall Study||53
405513|NCT00108628|994564|P1|COMPLETED|Overall Study||41
405514|NCT00108628|994563|P2|Completed Treatment|Overall Study||57
405515|NCT00108628|994564|P1|Completed Treatment|Overall Study||42
405516|NCT00108628|994563|P2|Received One or More Sessions|Overall Study||58
405517|NCT00108628|994564|P1|Received One or More Sessions|Overall Study||53
405518|NCT00108628|994563|P2|STARTED|Overall Study||63
405519|NCT00108628|994564|P1|STARTED|Overall Study||61
405520|NCT00108550|994590|P2|NOT COMPLETED|Overall Study||16
405521|NCT00108550|994591|P1|NOT COMPLETED|Overall Study||16
405522|NCT00108550|994590|P2|COMPLETED|Overall Study||37
405523|NCT00108550|994591|P1|COMPLETED|Overall Study||39
405524|NCT00108550|994590|P2|STARTED|Overall Study||53
405525|NCT00108550|994591|P1|STARTED|Overall Study||55
405526|NCT00108524|994601|P2|NOT COMPLETED|Overall Study||18
405527|NCT00108524|994602|P1|NOT COMPLETED|Overall Study||29
405528|NCT00108524|994601|P2|COMPLETED|Overall Study||61
405529|NCT00108524|994602|P1|COMPLETED|Overall Study||52
405530|NCT00108524|994601|P2|STARTED|Overall Study||79
405531|NCT00108524|994602|P1|STARTED|Overall Study||81
405532|NCT00108485|994614|P2|NOT COMPLETED|Overall Study||2
405533|NCT00108485|994615|P1|NOT COMPLETED|Overall Study||3
405534|NCT00108485|994614|P2|COMPLETED|Overall Study||2
405535|NCT00108485|994615|P1|COMPLETED|Overall Study||2
405536|NCT00108485|994614|P2|STARTED|Overall Study||4
405537|NCT00108485|994615|P1|STARTED|Overall Study||5
405538|NCT00108433|994623|P2|NOT COMPLETED|Overall Study||17
405539|NCT00108433|994624|P1|NOT COMPLETED|Overall Study||21
405540|NCT00108433|994623|P2|COMPLETED|Overall Study||14
405541|NCT00108433|994624|P1|COMPLETED|Overall Study||9
405542|NCT00108433|994623|P2|STARTED|Overall Study||31
405543|NCT00108433|994624|P1|STARTED|Overall Study||30
405544|NCT00108355|994640|P2|NOT COMPLETED|Overall Study||2
405545|NCT00108355|994641|P1|NOT COMPLETED|Overall Study||2
405546|NCT00108355|994640|P2|COMPLETED|Overall Study||12
405547|NCT00108355|994641|P1|COMPLETED|Overall Study||13
405548|NCT00108355|994640|P2|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis, other loculated ascites.|14
405549|NCT00108355|994641|P1|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis , other loculated ascites.|15
405550|NCT00108342|994651|P2|NOT COMPLETED|Overall Study||0
405551|NCT00108342|994652|P1|NOT COMPLETED|Overall Study||1
405552|NCT00108342|994651|P2|COMPLETED|Overall Study||9
405553|NCT00108342|994652|P1|COMPLETED|Overall Study||7
405554|NCT00108342|994651|P2|STARTED|Overall Study||9
405555|NCT00108342|994652|P1|STARTED|Overall Study||8
405556|NCT00108303|994661|P3|NOT COMPLETED|Overall Study||0
405557|NCT00108303|994662|P2|NOT COMPLETED|Overall Study||0
405558|NCT00108303|994663|P1|NOT COMPLETED|Overall Study||0
405559|NCT00108303|994661|P3|COMPLETED|Overall Study||180
405560|NCT00108303|994662|P2|COMPLETED|Overall Study||179
405561|NCT00108303|994663|P1|COMPLETED|Overall Study||179
405562|NCT00108303|994661|P3|STARTED|Overall Study||180
405563|NCT00108303|994662|P2|STARTED|Overall Study||179
405564|NCT00108303|994663|P1|STARTED|Overall Study||179
405565|NCT00108277|994678|P3|NOT COMPLETED|Overall Study||16
405566|NCT00108277|994679|P2|NOT COMPLETED|Overall Study||12
405567|NCT00108277|994680|P1|NOT COMPLETED|Overall Study||10
405568|NCT00108277|994678|P3|COMPLETED|Overall Study||19
405569|NCT00108277|994679|P2|COMPLETED|Overall Study||16
405570|NCT00108277|994680|P1|COMPLETED|Overall Study||19
405571|NCT00108277|994678|P3|STARTED|Overall Study||35
405572|NCT00108277|994679|P2|STARTED|Overall Study||28
405573|NCT00108277|994680|P1|STARTED|Overall Study||29
405574|NCT00108160|994690|P2|NOT COMPLETED|Overall Study||21
405575|NCT00108160|994691|P1|NOT COMPLETED|Overall Study||39
405576|NCT00108160|994690|P2|COMPLETED|Overall Study|Participants who completed 18 months of placebo or developed new (recurrent) S. aureus infection.|42
405577|NCT00108160|994691|P1|COMPLETED|Overall Study|Patients who completed 18 months of mupirocin or developed new (recurrent) S. aureus infection.|44
405578|NCT00108160|994690|P2|Completed Visit 7 (18 mo)|Overall Study||31
405579|NCT00108160|994691|P1|Completed Visit 7 (18 mo)|Overall Study||34
405580|NCT00108160|994690|P2|Completed Visit 6 (15 mo)|Overall Study||33
405581|NCT00108160|994691|P1|Completed Visit 6 (15 mo)|Overall Study||36
405582|NCT00108160|994690|P2|Completed Visit 5 (12 mo)|Overall Study||37
405583|NCT00108160|994691|P1|Completed Visit 5 (12 mo)|Overall Study||37
405584|NCT00108160|994690|P2|Completed Visit 4 (9 mo)|Overall Study||37
405585|NCT00108160|994691|P1|Completed Visit 4 (9 mo)|Overall Study||38
405586|NCT00108160|994690|P2|Completed Visit 3 (6 mo)|Overall Study||38
405587|NCT00108160|994691|P1|Completed Visit 3 (6 mo)|Overall Study||44
405588|NCT00108160|994690|P2|Completed Visit 2 (3 mo)|Overall Study||46
405589|NCT00108160|994691|P1|Completed Visit 2 (3 mo)|Overall Study||54
405590|NCT00108160|994690|P2|Completed Visit 1 (2 Wks)|Overall Study||54
405591|NCT00108160|994691|P1|Completed Visit 1 (2 Wks)|Overall Study||72
405592|NCT00108160|994690|P2|Completed Visit 0 (Baseline)|Overall Study|3 patients who signed a consent and were randomized did not complete the initial visit to start drug|60
405593|NCT00108160|994691|P1|Completed Visit 0 (Baseline)|Overall Study|4 patients who signed consent and were randomized did not complete the initial visit to start drug|79
405594|NCT00108160|994690|P2|STARTED|Overall Study||63
405595|NCT00108160|994691|P1|STARTED|Overall Study||83
405596|NCT00108082|994704|P3|NOT COMPLETED|Overall Study||43
405597|NCT00108082|994705|P2|NOT COMPLETED|Overall Study||32
405598|NCT00108082|994706|P1|NOT COMPLETED|Overall Study||38
405599|NCT00108082|994704|P3|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
405600|NCT00108082|994705|P2|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|68
405601|NCT00108082|994706|P1|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
405602|NCT00108082|994704|P3|STARTED|Overall Study||96
405603|NCT00108082|994705|P2|STARTED|Overall Study||100
405604|NCT00108082|994706|P1|STARTED|Overall Study||91
405605|NCT00108069|994755|P2|NOT COMPLETED|Overall Study||13
405606|NCT00108069|994756|P1|NOT COMPLETED|Overall Study||30
405607|NCT00108069|994755|P2|COMPLETED|Overall Study||0
405608|NCT00108069|994756|P1|COMPLETED|Overall Study||0
405609|NCT00108069|994755|P2|STARTED|Overall Study||13
405610|NCT00108069|994756|P1|STARTED|Overall Study||30
405611|NCT00107991|994770|P1|NOT COMPLETED|18-Week Post Treatment Assessment||2
405612|NCT00107991|994770|P1|COMPLETED|18-Week Post Treatment Assessment||8
405613|NCT00107991|994770|P1|STARTED|18-Week Post Treatment Assessment||10
405614|NCT00107991|994770|P1|NOT COMPLETED|12 Week Treatment Period||5
405615|NCT00107991|994770|P1|COMPLETED|12 Week Treatment Period||10
405616|NCT00107991|994770|P1|STARTED|12 Week Treatment Period||15
405617|NCT00107991|994770|P1|NOT COMPLETED|Eligibility Assessment||23
405618|NCT00107991|994770|P1|COMPLETED|Eligibility Assessment||15
405619|NCT00107991|994770|P1|STARTED|Eligibility Assessment||38
405620|NCT00107978|994780|P2|NOT COMPLETED|Overall Study||50
405621|NCT00107978|994781|P1|NOT COMPLETED|Overall Study||33
405622|NCT00107978|994780|P2|COMPLETED|Overall Study||431
405623|NCT00107978|994781|P1|COMPLETED|Overall Study||425
405624|NCT00107978|994780|P2|STARTED|Overall Study||481
405625|NCT00107978|994781|P1|STARTED|Overall Study||458
405626|NCT00107952|994789|P2|NOT COMPLETED|Overall Study||81
405627|NCT00107952|994790|P1|NOT COMPLETED|Overall Study||95
405628|NCT00107952|994789|P2|COMPLETED|Overall Study||299
405629|NCT00107952|994790|P1|COMPLETED|Overall Study||286
405630|NCT00107952|994789|P2|STARTED|Overall Study||380
405631|NCT00107952|994790|P1|STARTED|Overall Study||381
405632|NCT00107900|994802|P6|NOT COMPLETED|Overall Study||9
405633|NCT00107900|994803|P5|NOT COMPLETED|Overall Study||21
405634|NCT00107900|994804|P4|NOT COMPLETED|Overall Study||12
405635|NCT00107900|994805|P3|NOT COMPLETED|Overall Study||25
405636|NCT00107900|994806|P2|NOT COMPLETED|Overall Study||3
405637|NCT00107900|994807|P1|NOT COMPLETED|Overall Study||10
405638|NCT00107900|994802|P6|COMPLETED|Overall Study||94
405639|NCT00107900|994803|P5|COMPLETED|Overall Study||94
405640|NCT00107900|994804|P4|COMPLETED|Overall Study||87
405641|NCT00107900|994805|P3|COMPLETED|Overall Study||104
405642|NCT00107900|994806|P2|COMPLETED|Overall Study||72
405643|NCT00107900|994807|P1|COMPLETED|Overall Study||75
405644|NCT00107900|994802|P6|STARTED|Overall Study||103
405645|NCT00107900|994803|P5|STARTED|Overall Study||115
405646|NCT00107900|994804|P4|STARTED|Overall Study||99
405647|NCT00107900|994805|P3|STARTED|Overall Study||129
405648|NCT00107900|994806|P2|STARTED|Overall Study||75
405649|NCT00107900|994807|P1|STARTED|Overall Study||85
405650|NCT00107783|994841|P2|NOT COMPLETED|Overall Study||4
405651|NCT00107783|994842|P1|NOT COMPLETED|Overall Study||3
405652|NCT00107783|994841|P2|COMPLETED|Overall Study||16
405653|NCT00107783|994842|P1|COMPLETED|Overall Study||17
405654|NCT00107783|994841|P2|STARTED|Overall Study||20
405655|NCT00107783|994842|P1|STARTED|Overall Study||20
405656|NCT00107744|994859|P3|NOT COMPLETED|Intervention 3 (8 Weeks)||0
405657|NCT00107744|994860|P2|NOT COMPLETED|Intervention 3 (8 Weeks)||0
405658|NCT00107744|994861|P1|NOT COMPLETED|Intervention 3 (8 Weeks)||0
405659|NCT00107744|994859|P3|COMPLETED|Intervention 3 (8 Weeks)||88
405660|NCT00107744|994860|P2|COMPLETED|Intervention 3 (8 Weeks)||92
405661|NCT00107744|994861|P1|COMPLETED|Intervention 3 (8 Weeks)||93
405662|NCT00107744|994859|P3|STARTED|Intervention 3 (8 Weeks)||88
405663|NCT00107744|994860|P2|STARTED|Intervention 3 (8 Weeks)||92
405664|NCT00107744|994861|P1|STARTED|Intervention 3 (8 Weeks)||93
405665|NCT00107744|994859|P3|NOT COMPLETED|Intervention 2 (8 Weeks)||13
405666|NCT00107744|994860|P2|NOT COMPLETED|Intervention 2 (8 Weeks)||12
405667|NCT00107744|994861|P1|NOT COMPLETED|Intervention 2 (8 Weeks)||8
405668|NCT00107744|994859|P3|COMPLETED|Intervention 2 (8 Weeks)||88
405669|NCT00107744|994860|P2|COMPLETED|Intervention 2 (8 Weeks)||92
405670|NCT00107744|994861|P1|COMPLETED|Intervention 2 (8 Weeks)||93
405671|NCT00107744|994859|P3|STARTED|Intervention 2 (8 Weeks)||101
405672|NCT00107744|994860|P2|STARTED|Intervention 2 (8 Weeks)||104
405673|NCT00107744|994861|P1|STARTED|Intervention 2 (8 Weeks)||101
405674|NCT00107744|994859|P3|NOT COMPLETED|Intervention 1 (8 Weeks)||17
405675|NCT00107744|994860|P2|NOT COMPLETED|Intervention 1 (8 Weeks)||13
405676|NCT00107744|994861|P1|NOT COMPLETED|Intervention 1 (8 Weeks)||16
405677|NCT00107744|994859|P3|COMPLETED|Intervention 1 (8 Weeks)||101
405678|NCT00107744|994860|P2|COMPLETED|Intervention 1 (8 Weeks)||104
405679|NCT00107744|994861|P1|COMPLETED|Intervention 1 (8 Weeks)||101
405680|NCT00107744|994859|P3|STARTED|Intervention 1 (8 Weeks)||118
405681|NCT00107744|994860|P2|STARTED|Intervention 1 (8 Weeks)||117
405682|NCT00107744|994861|P1|STARTED|Intervention 1 (8 Weeks)||117
405683|NCT00107653|994877|P2|NOT COMPLETED|Overall Study||76
405684|NCT00107653|994878|P1|NOT COMPLETED|Overall Study||79
405685|NCT00107653|994877|P2|COMPLETED|Overall Study||224
405686|NCT00107653|994878|P1|COMPLETED|Overall Study||190
405687|NCT00107653|994877|P2|STARTED|Overall Study||300
405688|NCT00107653|994878|P1|STARTED|Overall Study||269
405689|NCT00107614|994924|P1|NOT COMPLETED|Overall Study||12
405690|NCT00107614|994924|P1|COMPLETED|Overall Study||0
405691|NCT00107614|994924|P1|STARTED|Overall Study||12
405692|NCT00107575|994930|P2|NOT COMPLETED|Overall Study||10
405693|NCT00107575|994931|P1|NOT COMPLETED|Overall Study||11
405694|NCT00107575|994930|P2|COMPLETED|Overall Study||107
405695|NCT00107575|994931|P1|COMPLETED|Overall Study||108
405696|NCT00107575|994930|P2|STARTED|Overall Study||117
405697|NCT00107575|994931|P1|STARTED|Overall Study||119
405698|NCT00107536|994945|P1|NOT COMPLETED|Overall Study||0
405699|NCT00107536|994945|P1|COMPLETED|Overall Study||26
405700|NCT00107536|994945|P1|STARTED|Overall Study||26
405701|NCT00107380|994955|P1|NOT COMPLETED|Overall Study||30
405702|NCT00107380|994955|P1|COMPLETED|Overall Study||56
405703|NCT00107380|994955|P1|Eligible|Overall Study||84
405704|NCT00107380|994955|P1|STARTED|Overall Study||86
405705|NCT00107315|994961|P1|NOT COMPLETED|Overall Study||15
405706|NCT00107315|994961|P1|COMPLETED|Overall Study||1
405707|NCT00107315|994961|P1|STARTED|Overall Study||16
405708|NCT00107276|994968|P1|NOT COMPLETED|Overall Study||72
405709|NCT00107276|994968|P1|COMPLETED|Overall Study||40
405710|NCT00107276|994968|P1|Eligible|Overall Study||96
405711|NCT00107276|994968|P1|STARTED|Overall Study||112
405712|NCT00107198|994974|P1|NOT COMPLETED|Overall Study||52
405713|NCT00107198|994974|P1|COMPLETED|Overall Study||136
405714|NCT00107198|994974|P1|STARTED|Overall Study||188
405715|NCT00107172|994984|P2|NOT COMPLETED|Overall Study||5
405716|NCT00107172|994985|P1|NOT COMPLETED|Overall Study||5
405717|NCT00107172|994984|P2|COMPLETED|Overall Study||103
405718|NCT00107172|994985|P1|COMPLETED|Overall Study||109
405719|NCT00107172|994984|P2|STARTED|Overall Study||108
405720|NCT00107172|994985|P1|STARTED|Overall Study||114
405721|NCT00107120|995015|P2|NOT COMPLETED|Overall Study||24
405722|NCT00107120|995016|P1|NOT COMPLETED|Overall Study||29
405723|NCT00107120|995015|P2|COMPLETED|Overall Study||133
405724|NCT00107120|995016|P1|COMPLETED|Overall Study||126
405725|NCT00107120|995015|P2|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|157
405726|NCT00107120|995016|P1|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|155
405727|NCT00107042|995028|P2|NOT COMPLETED|Overall Study||16
405728|NCT00107042|995029|P1|NOT COMPLETED|Overall Study||22
405729|NCT00107042|995028|P2|COMPLETED|Overall Study||47
405730|NCT00107042|995029|P1|COMPLETED|Overall Study||38
405731|NCT00107042|995028|P2|STARTED|Overall Study||63
405732|NCT00107042|995029|P1|STARTED|Overall Study||60
405733|NCT00106964|995095|P3|NOT COMPLETED|Overall Study||7
405734|NCT00106964|995096|P2|NOT COMPLETED|Overall Study||15
405735|NCT00106964|995097|P1|NOT COMPLETED|Overall Study||13
405736|NCT00106964|995095|P3|COMPLETED|Overall Study|The number of those who completed the vaccine series was 120.|120
405737|NCT00106964|995096|P2|COMPLETED|Overall Study|The number of those who completed the vaccine series was 111.|111
405738|NCT00106964|995097|P1|COMPLETED|Overall Study|The number of those those who completed the vaccine series was 105.|105
405739|NCT00106964|995095|P3|STARTED|Overall Study||127
405740|NCT00106964|995096|P2|STARTED|Overall Study||126
405741|NCT00106964|995097|P1|STARTED|Overall Study||118
405742|NCT00106938|995122|P2|NOT COMPLETED|Overall Study||71
405743|NCT00106938|995123|P1|NOT COMPLETED|Overall Study||176
405744|NCT00106938|995122|P2|COMPLETED|Overall Study||293
405745|NCT00106938|995123|P1|COMPLETED|Overall Study||913
405746|NCT00106938|995122|P2|STARTED|Overall Study||364
405747|NCT00106938|995123|P1|STARTED|Overall Study||1089
405748|NCT00106704|995192|P2|NOT COMPLETED|Overall Study||151
405749|NCT00106704|995193|P1|NOT COMPLETED|Overall Study||131
405750|NCT00106704|995192|P2|COMPLETED|Overall Study||68
405751|NCT00106704|995193|P1|COMPLETED|Overall Study||91
405752|NCT00106704|995192|P2|STARTED|Overall Study||219
405753|NCT00106704|995193|P1|STARTED|Overall Study||222
405754|NCT00106639|995204|P3|NOT COMPLETED|Overall Study||2
405755|NCT00106639|995205|P2|NOT COMPLETED|Overall Study||7
405756|NCT00106639|995206|P1|NOT COMPLETED|Overall Study||3
405757|NCT00106639|995204|P3|COMPLETED|Overall Study||19
405758|NCT00106639|995205|P2|COMPLETED|Overall Study||13
405759|NCT00106639|995206|P1|COMPLETED|Overall Study||17
405760|NCT00106639|995204|P3|STARTED|Overall Study||21
405761|NCT00106639|995205|P2|STARTED|Overall Study||20
405762|NCT00106639|995206|P1|STARTED|Overall Study||20
405763|NCT00106626|995333|P4|NOT COMPLETED|Overall Study||13
405764|NCT00106626|995334|P3|NOT COMPLETED|Overall Study||12
405765|NCT00106626|995335|P2|NOT COMPLETED|Overall Study||6
405766|NCT00106626|995336|P1|NOT COMPLETED|Overall Study||10
405767|NCT00106626|995333|P4|COMPLETED|Overall Study||3
405768|NCT00106626|995334|P3|COMPLETED|Overall Study||2
405769|NCT00106626|995335|P2|COMPLETED|Overall Study||3
405770|NCT00106626|995336|P1|COMPLETED|Overall Study||3
405771|NCT00106626|995333|P4|STARTED|Overall Study||16
405772|NCT00106626|995334|P3|STARTED|Overall Study||14
405773|NCT00106626|995335|P2|STARTED|Overall Study||9
405774|NCT00106626|995336|P1|STARTED|Overall Study||13
405775|NCT00106535|995354|P4|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||190
405776|NCT00106535|995355|P3|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
405777|NCT00106535|995356|P2|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
405778|NCT00106535|995357|P1|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
405779|NCT00106535|995354|P4|COMPLETED|Long-term Extension Period (Year 3 to 5)|Completed the study.|704
405780|NCT00106535|995355|P3|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
405781|NCT00106535|995356|P2|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
405782|NCT00106535|995357|P1|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
405783|NCT00106535|995354|P4|STARTED|Long-term Extension Period (Year 3 to 5)|Entered the Long-term Extension.|894
405784|NCT00106535|995355|P3|STARTED|Long-term Extension Period (Year 3 to 5)||0
405785|NCT00106535|995356|P2|STARTED|Long-term Extension Period (Year 3 to 5)||0
405786|NCT00106535|995357|P1|STARTED|Long-term Extension Period (Year 3 to 5)||0
405787|NCT00106535|995354|P4|NOT COMPLETED|2-year Placebo Controlled Period||0
405788|NCT00106535|995355|P3|NOT COMPLETED|2-year Placebo Controlled Period||91
405789|NCT00106535|995356|P2|NOT COMPLETED|2-year Placebo Controlled Period||92
405790|NCT00106535|995357|P1|NOT COMPLETED|2-year Placebo Controlled Period||107
405791|NCT00106535|995354|P4|COMPLETED|2-year Placebo Controlled Period||0
405792|NCT00106535|995355|P3|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 306 participants randomized to the TCZ 8 mg/kg arm entered the LTE period.|310
405793|NCT00106535|995356|P2|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 304 participants randomized to the TCZ 4 mg/kg arm entered the LTE period.|309
405794|NCT00106535|995357|P1|COMPLETED|2-year Placebo Controlled Period|Completed Week 104 (Year 2). 284 participants randomized to the Placebo arm entered the LTE period.|287
405795|NCT00106535|995354|P4|Completed Week 52|2-year Placebo Controlled Period||0
405796|NCT00106535|995355|P3|Completed Week 52|2-year Placebo Controlled Period||338
405797|NCT00106535|995356|P2|Completed Week 52|2-year Placebo Controlled Period||342
405798|NCT00106535|995357|P1|Completed Week 52|2-year Placebo Controlled Period||326
405799|NCT00106535|995354|P4|Completed Week 24|2-year Placebo Controlled Period||0
405800|NCT00106535|995355|P3|Completed Week 24|2-year Placebo Controlled Period||366
405801|NCT00106535|995356|P2|Completed Week 24|2-year Placebo Controlled Period||373
405802|NCT00106535|995357|P1|Completed Week 24|2-year Placebo Controlled Period||356
405803|NCT00106535|995354|P4|Safety: Actual Treatment Received|2-year Placebo Controlled Period||0
405804|NCT00106535|995355|P3|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
405805|NCT00106535|995356|P2|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
405806|NCT00106535|995357|P1|Safety: Actual Treatment Received|2-year Placebo Controlled Period||392
405807|NCT00106535|995354|P4|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||0
405808|NCT00106535|995355|P3|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||398
405809|NCT00106535|995356|P2|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||399
405810|NCT00106535|995357|P1|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||393
405811|NCT00106535|995354|P4|STARTED|2-year Placebo Controlled Period||0
405812|NCT00106535|995355|P3|STARTED|2-year Placebo Controlled Period||401
405813|NCT00106535|995356|P2|STARTED|2-year Placebo Controlled Period||401
405814|NCT00106535|995357|P1|STARTED|2-year Placebo Controlled Period||394
405815|NCT00106431|995650|P1|NOT COMPLETED|Overall Study||65
405816|NCT00106431|995650|P1|COMPLETED|Overall Study|37 represents the number of patients who reached at least 6 months treatment|37
405817|NCT00106431|995650|P1|STARTED|Overall Study||102
405818|NCT00106392|995662|P2|NOT COMPLETED|Overall Study||27
405819|NCT00106392|995663|P1|NOT COMPLETED|Overall Study||26
405820|NCT00106392|995662|P2|COMPLETED|Overall Study||42
405821|NCT00106392|995663|P1|COMPLETED|Overall Study||36
405822|NCT00106392|995662|P2|Full Analysis Set (FAS)|Overall Study||61
405823|NCT00106392|995663|P1|Full Analysis Set (FAS)|Overall Study||53
405824|NCT00106392|995662|P2|Baseline Participants|Overall Study|4 patients withdrew: all prior to surgery and study drug|65
405825|NCT00106392|995663|P1|Baseline Participants|Overall Study|3 patients withdrew: 2 prior to surgery and study drug; 1 took study drug but did not have surgery|59
405826|NCT00106392|995662|P2|STARTED|Overall Study||69
405827|NCT00106392|995663|P1|STARTED|Overall Study||62
405828|NCT00106353|995681|P7|NOT COMPLETED|Part 2||16
405829|NCT00106353|995682|P6|NOT COMPLETED|Part 2||18
405830|NCT00106353|995683|P5|NOT COMPLETED|Part 2||16
405831|NCT00106353|995684|P4|NOT COMPLETED|Part 2||0
405832|NCT00106353|995685|P3|NOT COMPLETED|Part 2||0
405833|NCT00106353|995686|P2|NOT COMPLETED|Part 2||0
405834|NCT00106353|995687|P1|NOT COMPLETED|Part 2||0
405835|NCT00106353|995681|P7|COMPLETED|Part 2||0
405836|NCT00106353|995682|P6|COMPLETED|Part 2||1
405837|NCT00106353|995683|P5|COMPLETED|Part 2||1
405838|NCT00106353|995684|P4|COMPLETED|Part 2||0
405839|NCT00106353|995685|P3|COMPLETED|Part 2||0
405840|NCT00106353|995686|P2|COMPLETED|Part 2||0
405841|NCT00106353|995687|P1|COMPLETED|Part 2||0
405842|NCT00106353|995681|P7|STARTED|Part 2||16
405843|NCT00106353|995682|P6|STARTED|Part 2||19
405844|NCT00106353|995683|P5|STARTED|Part 2||17
405845|NCT00106353|995684|P4|STARTED|Part 2||0
405846|NCT00106353|995685|P3|STARTED|Part 2||0
405847|NCT00106353|995686|P2|STARTED|Part 2||0
405848|NCT00106353|995687|P1|STARTED|Part 2||0
405849|NCT00106353|995681|P7|NOT COMPLETED|Part 1||0
405850|NCT00106353|995682|P6|NOT COMPLETED|Part 1||0
405851|NCT00106353|995683|P5|NOT COMPLETED|Part 1||0
405852|NCT00106353|995684|P4|NOT COMPLETED|Part 1||7
405853|NCT00106353|995685|P3|NOT COMPLETED|Part 1||3
405854|NCT00106353|995686|P2|NOT COMPLETED|Part 1||5
405855|NCT00106353|995687|P1|NOT COMPLETED|Part 1||4
405856|NCT00106353|995681|P7|COMPLETED|Part 1||0
405857|NCT00106353|995682|P6|COMPLETED|Part 1||0
405858|NCT00106353|995683|P5|COMPLETED|Part 1||0
405859|NCT00106353|995684|P4|COMPLETED|Part 1||0
405860|NCT00106353|995685|P3|COMPLETED|Part 1||0
405861|NCT00106353|995686|P2|COMPLETED|Part 1||0
405862|NCT00106353|995687|P1|COMPLETED|Part 1||0
405863|NCT00106353|995681|P7|STARTED|Part 1||0
405864|NCT00106353|995682|P6|STARTED|Part 1||0
405865|NCT00106353|995683|P5|STARTED|Part 1||0
405866|NCT00106353|995684|P4|STARTED|Part 1||7
405867|NCT00106353|995685|P3|STARTED|Part 1||3
405868|NCT00106353|995686|P2|STARTED|Part 1||5
405869|NCT00106353|995687|P1|STARTED|Part 1||4
405870|NCT00106249|995814|P2|NOT COMPLETED|Overall Study||2
405871|NCT00106249|995815|P1|NOT COMPLETED|Overall Study||3
405872|NCT00106249|995814|P2|COMPLETED|Overall Study||11
405873|NCT00106249|995815|P1|COMPLETED|Overall Study||11
405874|NCT00106249|995814|P2|STARTED|Overall Study||13
405875|NCT00106249|995815|P1|STARTED|Overall Study||14
405876|NCT00106184|995827|P2|NOT COMPLETED|Overall Study||2
405877|NCT00106184|995828|P1|NOT COMPLETED|Overall Study||3
405878|NCT00106184|995827|P2|COMPLETED|Overall Study||102
405879|NCT00106184|995828|P1|COMPLETED|Overall Study||93
405880|NCT00106184|995827|P2|Treated|Overall Study|104 subjects were randomized.|102
405881|NCT00106184|995828|P1|Treated|Overall Study|96 subjects were randomized.|93
405882|NCT00106184|995827|P2|STARTED|Overall Study||104
405883|NCT00106184|995828|P1|STARTED|Overall Study||96
405884|NCT00106119|995838|P2|NOT COMPLETED|Second Intervention||0
405885|NCT00106119|995839|P1|NOT COMPLETED|Second Intervention||0
405886|NCT00106119|995838|P2|COMPLETED|Second Intervention||7
405887|NCT00106119|995839|P1|COMPLETED|Second Intervention||7
405888|NCT00106119|995838|P2|STARTED|Second Intervention||7
405889|NCT00106119|995839|P1|STARTED|Second Intervention||7
405890|NCT00106119|995838|P2|NOT COMPLETED|Washout Period of 30 Days||0
405891|NCT00106119|995839|P1|NOT COMPLETED|Washout Period of 30 Days||0
405892|NCT00106119|995838|P2|COMPLETED|Washout Period of 30 Days||7
405893|NCT00106119|995839|P1|COMPLETED|Washout Period of 30 Days||7
405894|NCT00106119|995838|P2|STARTED|Washout Period of 30 Days||7
405895|NCT00106119|995839|P1|STARTED|Washout Period of 30 Days||7
405896|NCT00106119|995838|P2|NOT COMPLETED|First Intervention||0
405897|NCT00106119|995839|P1|NOT COMPLETED|First Intervention||0
405898|NCT00106119|995838|P2|COMPLETED|First Intervention||7
405899|NCT00106119|995839|P1|COMPLETED|First Intervention||7
405900|NCT00106119|995838|P2|STARTED|First Intervention||7
405901|NCT00106119|995839|P1|STARTED|First Intervention||7
405902|NCT00106106|995859|P2|NOT COMPLETED|Overall Study||4
405903|NCT00106106|995860|P1|NOT COMPLETED|Overall Study||4
405904|NCT00106106|995859|P2|COMPLETED|Overall Study|Although 19 subjects completed all other assessments for the study, only 15 completed both MRS scans|19
405905|NCT00106106|995860|P1|COMPLETED|Overall Study|Although 22 subjects completed all other assessments for the study, only 18 completed both MRS scans|22
405906|NCT00106106|995859|P2|Completed Both MRS Scans|Overall Study||15
405907|NCT00106106|995860|P1|Completed Both MRS Scans|Overall Study||18
405908|NCT00106106|995859|P2|STARTED|Overall Study||23
405909|NCT00106106|995860|P1|STARTED|Overall Study||26
405910|NCT00106080|995870|P2|NOT COMPLETED|Overall Study||27
405911|NCT00106080|995871|P1|NOT COMPLETED|Overall Study||43
405912|NCT00106080|995870|P2|COMPLETED|Overall Study||155
405913|NCT00106080|995871|P1|COMPLETED|Overall Study||151
405914|NCT00106080|995870|P2|STARTED|Overall Study||182
405915|NCT00106080|995871|P1|STARTED|Overall Study||194
405916|NCT00106028|995881|P2|NOT COMPLETED|Overall Study||12
405917|NCT00106028|995882|P1|NOT COMPLETED|Overall Study||6
405918|NCT00106028|995881|P2|COMPLETED|Overall Study|Completed Month 36|82
405919|NCT00106028|995882|P1|COMPLETED|Overall Study|Completed Month 36|43
405920|NCT00106028|995881|P2|Month 12 Completed/Started Open Label|Overall Study||87
405921|NCT00106028|995882|P1|Month 12 Completed/Started Open Label|Overall Study||49
405922|NCT00106028|995881|P2|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|94
405923|NCT00106028|995882|P1|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|49
405924|NCT00106002|995976|P1|NOT COMPLETED|Overall Study||2
405925|NCT00106002|995976|P1|COMPLETED|Overall Study|Completed means that the patient was evaluable for response.|35
405926|NCT00106002|995976|P1|STARTED|Overall Study||37
405927|NCT00105989|995984|P2|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||69
405928|NCT00105989|995985|P1|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||50
405929|NCT00105989|995984|P2|COMPLETED|Maintenance - Double-Blind:Week 34-86||73
405930|NCT00105989|995985|P1|COMPLETED|Maintenance - Double-Blind:Week 34-86||96
405931|NCT00105989|995984|P2|STARTED|Maintenance - Double-Blind:Week 34-86||142
405932|NCT00105989|995985|P1|STARTED|Maintenance - Double-Blind:Week 34-86||146
405933|NCT00105989|995984|P2|NOT COMPLETED|Continuation - Open Label:Week 10-34||0
405934|NCT00105989|995985|P1|NOT COMPLETED|Continuation - Open Label:Week 10-34||125
405935|NCT00105989|995984|P2|COMPLETED|Continuation - Open Label:Week 10-34||0
405936|NCT00105989|995985|P1|COMPLETED|Continuation - Open Label:Week 10-34||288
405937|NCT00105989|995984|P2|STARTED|Continuation - Open Label:Week 10-34||0
405938|NCT00105989|995985|P1|STARTED|Continuation - Open Label:Week 10-34||413
405939|NCT00105989|995984|P2|NOT COMPLETED|Acute - Open Label: Week 0-10||0
405940|NCT00105989|995985|P1|NOT COMPLETED|Acute - Open Label: Week 0-10||101
405941|NCT00105989|995984|P2|COMPLETED|Acute - Open Label: Week 0-10||0
405942|NCT00105989|995985|P1|COMPLETED|Acute - Open Label: Week 0-10||413
405943|NCT00105989|995984|P2|STARTED|Acute - Open Label: Week 0-10||0
405944|NCT00105989|995985|P1|STARTED|Acute - Open Label: Week 0-10||514
405945|NCT00105586|996101|P2|NOT COMPLETED|Overall Study||16
405946|NCT00105586|996102|P1|NOT COMPLETED|Overall Study||17
405947|NCT00105586|996101|P2|COMPLETED|Overall Study||69
405948|NCT00105586|996102|P1|COMPLETED|Overall Study||75
405949|NCT00105586|996101|P2|STARTED|Overall Study||85
405950|NCT00105586|996102|P1|STARTED|Overall Study||92
405951|NCT00105560|996110|P1|NOT COMPLETED|Overall Study||1
405952|NCT00105560|996110|P1|COMPLETED|Overall Study||58
405953|NCT00105560|996110|P1|STARTED|Overall Study||59
405954|NCT00105534|996132|P2|NOT COMPLETED|Overall Study||33
405955|NCT00105534|996133|P1|NOT COMPLETED|Overall Study||22
405956|NCT00105534|996132|P2|COMPLETED|Overall Study||317
405957|NCT00105534|996133|P1|COMPLETED|Overall Study||313
405958|NCT00105534|996132|P2|STARTED|Overall Study||350
405959|NCT00105534|996133|P1|STARTED|Overall Study||335
405960|NCT00105521|996145|P4|NOT COMPLETED|Overall Study||17
405961|NCT00105521|996146|P3|NOT COMPLETED|Overall Study||17
405962|NCT00105521|996147|P2|NOT COMPLETED|Overall Study||11
405963|NCT00105521|996148|P1|NOT COMPLETED|Overall Study||15
405964|NCT00105521|996145|P4|COMPLETED|Overall Study||85
405965|NCT00105521|996146|P3|COMPLETED|Overall Study||80
405966|NCT00105521|996147|P2|COMPLETED|Overall Study||90
405967|NCT00105521|996148|P1|COMPLETED|Overall Study||83
405968|NCT00105521|996145|P4|STARTED|Overall Study||102
405969|NCT00105521|996146|P3|STARTED|Overall Study||97
405970|NCT00105521|996147|P2|STARTED|Overall Study||101
405971|NCT00105521|996148|P1|STARTED|Overall Study||98
405972|NCT00105508|996172|P2|NOT COMPLETED|Overall Study||36
405973|NCT00105508|996173|P1|NOT COMPLETED|Overall Study||40
405974|NCT00105508|996172|P2|COMPLETED|Overall Study||217
405975|NCT00105508|996173|P1|COMPLETED|Overall Study||213
405976|NCT00105508|996172|P2|STARTED|Overall Study||253
405977|NCT00105508|996173|P1|STARTED|Overall Study||253
405978|NCT00105482|996187|P2|NOT COMPLETED|Overall Study||55
405979|NCT00105482|996188|P1|NOT COMPLETED|Overall Study||59
405980|NCT00105482|996187|P2|COMPLETED|Overall Study||30
405981|NCT00105482|996188|P1|COMPLETED|Overall Study||28
405982|NCT00105482|996187|P2|STARTED|Overall Study||85
405983|NCT00105482|996188|P1|STARTED|Overall Study||87
405984|NCT00105469|996204|P2|NOT COMPLETED|Overall Study||11
405985|NCT00105469|996205|P1|NOT COMPLETED|Overall Study||22
405986|NCT00105469|996204|P2|COMPLETED|Overall Study||367
405987|NCT00105469|996205|P1|COMPLETED|Overall Study||343
405988|NCT00105469|996204|P2|STARTED|Overall Study||378
405989|NCT00105469|996205|P1|STARTED|Overall Study||365
405990|NCT00105443|996215|P4|NOT COMPLETED|Follow-up and/or Open Label Nexavar||47
405991|NCT00105443|996216|P3|NOT COMPLETED|Follow-up and/or Open Label Nexavar||245
405992|NCT00105443|996217|P2|NOT COMPLETED|Follow-up and/or Open Label Nexavar||57
405993|NCT00105443|996218|P1|NOT COMPLETED|Follow-up and/or Open Label Nexavar||228
405994|NCT00105443|996215|P4|COMPLETED|Follow-up and/or Open Label Nexavar|47 participants in total (36 + 11) received Open Label Sorafenib treatment (Subjects at Risk)|0
405995|NCT00105443|996216|P3|COMPLETED|Follow-up and/or Open Label Nexavar||0
405996|NCT00105443|996217|P2|COMPLETED|Follow-up and/or Open Label Nexavar|57 participants in total (47 + 10) received Open Label Sorafenib treatment (Subjects at Risk)|0
405997|NCT00105443|996218|P1|COMPLETED|Follow-up and/or Open Label Nexavar||0
405998|NCT00105443|996215|P4|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||11
405999|NCT00105443|996216|P3|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
406000|NCT00105443|996217|P2|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||10
406001|NCT00105443|996218|P1|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
406002|NCT00105443|996215|P4|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|36
406003|NCT00105443|996216|P3|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
406004|NCT00105443|996217|P2|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|47
406005|NCT00105443|996218|P1|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
406006|NCT00105443|996215|P4|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
406007|NCT00105443|996216|P3|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|245
406008|NCT00105443|996217|P2|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
406009|NCT00105443|996218|P1|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|228
406010|NCT00105443|996215|P4|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 36 participants directly switched to Open Label (OL) Sorafenib treatment|47
406011|NCT00105443|996216|P3|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 245 participants directly switched to Follow-up (FU)|245
406012|NCT00105443|996217|P2|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 47 participants directly switched to Open Label (OL) Sorafenib treatment|57
406013|NCT00105443|996218|P1|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 228 participants directly switched to Follow-up (FU)|228
406014|NCT00105443|996215|P4|NOT COMPLETED|Double-Blind Treatment||0
406015|NCT00105443|996216|P3|NOT COMPLETED|Double-Blind Treatment||11
406016|NCT00105443|996217|P2|NOT COMPLETED|Double-Blind Treatment||0
406017|NCT00105443|996218|P1|NOT COMPLETED|Double-Blind Treatment||14
406018|NCT00105443|996215|P4|COMPLETED|Double-Blind Treatment|36 participants switched to Sorafenib Open Label (OL); 11 first to FU prior to also switch to OL|47
406019|NCT00105443|996216|P3|COMPLETED|Double-Blind Treatment|245 participants directly switched to the Follow-up (FU) phase|245
406020|NCT00105443|996217|P2|COMPLETED|Double-Blind Treatment|47 participants continued with Sorafenib Open Label (OL); 10 first to FU prior to also switch to OL|57
406021|NCT00105443|996218|P1|COMPLETED|Double-Blind Treatment|228 participants directly switched to the Follow-up (FU) phase only|228
406022|NCT00105443|996215|P4|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4 as well as RG5|47
406023|NCT00105443|996216|P3|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4|255
406024|NCT00105443|996217|P2|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3|57
406025|NCT00105443|996218|P1|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3 (RG = Reporting Group for Safety Data)|240
406026|NCT00105443|996215|P4|STARTED|Double-Blind Treatment||47
406027|NCT00105443|996216|P3|STARTED|Double-Blind Treatment||256
406028|NCT00105443|996217|P2|STARTED|Double-Blind Treatment||57
406029|NCT00105443|996218|P1|STARTED|Double-Blind Treatment||242
406030|NCT00105235|996245|P1|NOT COMPLETED|Overall Study||7
406031|NCT00105235|996245|P1|COMPLETED|Overall Study||20
406032|NCT00105235|996245|P1|STARTED|Overall Study||27
406033|NCT00105196|996258|P2|NOT COMPLETED|Overall Study||23
406034|NCT00105196|996259|P1|NOT COMPLETED|Overall Study||30
406035|NCT00105196|996258|P2|COMPLETED|Overall Study||149
406036|NCT00105196|996259|P1|COMPLETED|Overall Study||147
406037|NCT00105196|996258|P2|STARTED|Overall Study||172
406038|NCT00105196|996259|P1|STARTED|Overall Study||177
406039|NCT00105183|996282|P3|NOT COMPLETED|Overall Study||23
406040|NCT00105183|996283|P2|NOT COMPLETED|Overall Study||19
406041|NCT00105183|996284|P1|NOT COMPLETED|Overall Study||22
406042|NCT00105183|996282|P3|COMPLETED|Overall Study|Completed at least 12 months follow up|39
406043|NCT00105183|996283|P2|COMPLETED|Overall Study|Completed at least 12 months follow up|60
406044|NCT00105183|996284|P1|COMPLETED|Overall Study|Completed at least 12 months follow up|60
406045|NCT00105183|996282|P3|STARTED|Overall Study|Randomized|62
406046|NCT00105183|996283|P2|STARTED|Overall Study|Randomized|79
406047|NCT00105183|996284|P1|STARTED|Overall Study|Randomized|82
406048|NCT00105157|996320|P4|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||18
406049|NCT00105157|996321|P3|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
406050|NCT00105157|996322|P2|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
406051|NCT00105157|996323|P1|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||9
406052|NCT00105157|996320|P4|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||19
406053|NCT00105157|996321|P3|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||5
406054|NCT00105157|996322|P2|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||7
406055|NCT00105157|996323|P1|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||2
406056|NCT00105157|996320|P4|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|37
406057|NCT00105157|996321|P3|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
406058|NCT00105157|996322|P2|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|13
406059|NCT00105157|996323|P1|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
406060|NCT00105157|996320|P4|NOT COMPLETED|Open-Label Continuation of DB||1
406061|NCT00105157|996321|P3|NOT COMPLETED|Open-Label Continuation of DB||9
406062|NCT00105157|996322|P2|NOT COMPLETED|Open-Label Continuation of DB||10
406063|NCT00105157|996323|P1|NOT COMPLETED|Open-Label Continuation of DB||7
406064|NCT00105157|996320|P4|COMPLETED|Open-Label Continuation of DB||5
406065|NCT00105157|996321|P3|COMPLETED|Open-Label Continuation of DB||24
406066|NCT00105157|996322|P2|COMPLETED|Open-Label Continuation of DB||21
406067|NCT00105157|996323|P1|COMPLETED|Open-Label Continuation of DB||23
406068|NCT00105157|996320|P4|STARTED|Open-Label Continuation of DB||6
406069|NCT00105157|996321|P3|STARTED|Open-Label Continuation of DB||33
406070|NCT00105157|996322|P2|STARTED|Open-Label Continuation of DB||31
406071|NCT00105157|996323|P1|STARTED|Open-Label Continuation of DB||30
406072|NCT00105157|996320|P4|NOT COMPLETED|Double-Blind (DB)||39
406073|NCT00105157|996321|P3|NOT COMPLETED|Double-Blind (DB)||12
406074|NCT00105157|996322|P2|NOT COMPLETED|Double-Blind (DB)||14
406075|NCT00105157|996323|P1|NOT COMPLETED|Double-Blind (DB)||14
406076|NCT00105157|996320|P4|COMPLETED|Double-Blind (DB)||6
406077|NCT00105157|996321|P3|COMPLETED|Double-Blind (DB)||33
406078|NCT00105157|996322|P2|COMPLETED|Double-Blind (DB)||31
406079|NCT00105157|996323|P1|COMPLETED|Double-Blind (DB)||30
406080|NCT00105157|996320|P4|Treated|Double-Blind (DB)||45
406081|NCT00105157|996321|P3|Treated|Double-Blind (DB)||45
406082|NCT00105157|996322|P2|Treated|Double-Blind (DB)||45
406083|NCT00105157|996323|P1|Treated|Double-Blind (DB)||43
406084|NCT00105157|996320|P4|STARTED|Double-Blind (DB)||45
406085|NCT00105157|996321|P3|STARTED|Double-Blind (DB)||45
406086|NCT00105157|996322|P2|STARTED|Double-Blind (DB)||45
406087|NCT00105157|996323|P1|STARTED|Double-Blind (DB)||44
406088|NCT00105079|996517|P2|NOT COMPLETED|Overall Study||35
406089|NCT00105079|996518|P1|NOT COMPLETED|Overall Study||39
406090|NCT00105079|996517|P2|COMPLETED|Overall Study||135
406091|NCT00105079|996518|P1|COMPLETED|Overall Study||128
406092|NCT00105079|996517|P2|Safety Population|Overall Study||168
406093|NCT00105079|996518|P1|Safety Population|Overall Study||163
406094|NCT00105079|996517|P2|STARTED|Overall Study||170
406095|NCT00105079|996518|P1|STARTED|Overall Study||167
406096|NCT00105066|996536|P2|NOT COMPLETED|Overall Study||5
406097|NCT00105066|996537|P1|NOT COMPLETED|Overall Study||2
406098|NCT00105066|996536|P2|COMPLETED|Overall Study||45
406099|NCT00105066|996537|P1|COMPLETED|Overall Study||25
406100|NCT00105066|996536|P2|STARTED|Overall Study||50
406101|NCT00105066|996537|P1|STARTED|Overall Study||27
406102|NCT00105027|996553|P6|NOT COMPLETED|Overall Study||13
406103|NCT00105027|996554|P5|NOT COMPLETED|Overall Study||15
406104|NCT00105027|996555|P4|NOT COMPLETED|Overall Study||16
406105|NCT00105027|996556|P3|NOT COMPLETED|Overall Study||9
406106|NCT00105027|996557|P2|NOT COMPLETED|Overall Study||9
406107|NCT00105027|996558|P1|NOT COMPLETED|Overall Study||15
406108|NCT00105027|996553|P6|COMPLETED|Overall Study||125
406109|NCT00105027|996554|P5|COMPLETED|Overall Study||121
406110|NCT00105027|996555|P4|COMPLETED|Overall Study||121
406111|NCT00105027|996556|P3|COMPLETED|Overall Study||82
406112|NCT00105027|996557|P2|COMPLETED|Overall Study||83
406113|NCT00105027|996558|P1|COMPLETED|Overall Study||73
406114|NCT00105027|996553|P6|STARTED|Overall Study||138
406115|NCT00105027|996554|P5|STARTED|Overall Study||136
406116|NCT00105027|996555|P4|STARTED|Overall Study||137
406117|NCT00105027|996556|P3|STARTED|Overall Study||91
406118|NCT00105027|996557|P2|STARTED|Overall Study||92
406119|NCT00105027|996558|P1|STARTED|Overall Study||88
406120|NCT00105001|996593|P3|NOT COMPLETED|Overall Study||0
406121|NCT00105001|996594|P2|NOT COMPLETED|Overall Study||0
406122|NCT00105001|996595|P1|NOT COMPLETED|Overall Study||0
406123|NCT00105001|996593|P3|COMPLETED|Overall Study||69
406124|NCT00105001|996594|P2|COMPLETED|Overall Study||71
406125|NCT00105001|996595|P1|COMPLETED|Overall Study||70
406126|NCT00105001|996593|P3|STARTED|Overall Study||69
406127|NCT00105001|996594|P2|STARTED|Overall Study||71
406128|NCT00105001|996595|P1|STARTED|Overall Study||70
406129|NCT00104884|996615|P1|NOT COMPLETED|Overall Study||4
406130|NCT00104884|996615|P1|COMPLETED|Overall Study||0
406131|NCT00104884|996615|P1|STARTED|Overall Study||4
406132|NCT00104871|996619|P1|NOT COMPLETED|Overall Study||1
406133|NCT00104871|996619|P1|COMPLETED|Overall Study||21
406134|NCT00104871|996619|P1|STARTED|Overall Study||22
406135|NCT00104858|996625|P1|NOT COMPLETED|Overall Study||0
406136|NCT00104858|996625|P1|COMPLETED|Overall Study||52
406137|NCT00104858|996625|P1|STARTED|Overall Study||52
406138|NCT00104728|996640|P1|NOT COMPLETED|Overall Study||19
406139|NCT00104728|996640|P1|COMPLETED|Overall Study||23
406140|NCT00104728|996640|P1|STARTED|Overall Study|42 consented on study|42
406141|NCT00104650|996648|P3|NOT COMPLETED|Follow-up Period||10
406142|NCT00104650|996649|P2|NOT COMPLETED|Follow-up Period||13
406143|NCT00104650|996650|P1|NOT COMPLETED|Follow-up Period||11
406144|NCT00104650|996648|P3|COMPLETED|Follow-up Period||18
406145|NCT00104650|996649|P2|COMPLETED|Follow-up Period||12
406146|NCT00104650|996650|P1|COMPLETED|Follow-up Period||14
406147|NCT00104650|996648|P3|STARTED|Follow-up Period||28
406148|NCT00104650|996649|P2|STARTED|Follow-up Period||25
406149|NCT00104650|996650|P1|STARTED|Follow-up Period||25
406150|NCT00104650|996648|P3|NOT COMPLETED|Treatment Period (25 Weeks)||10
406151|NCT00104650|996649|P2|NOT COMPLETED|Treatment Period (25 Weeks)||11
406152|NCT00104650|996650|P1|NOT COMPLETED|Treatment Period (25 Weeks)||12
406153|NCT00104650|996648|P3|COMPLETED|Treatment Period (25 Weeks)||28
406154|NCT00104650|996649|P2|COMPLETED|Treatment Period (25 Weeks)||25
406155|NCT00104650|996650|P1|COMPLETED|Treatment Period (25 Weeks)||25
406156|NCT00104650|996648|P3|Received Investigational Product|Treatment Period (25 Weeks)||38
406157|NCT00104650|996649|P2|Received Investigational Product|Treatment Period (25 Weeks)||35
406158|NCT00104650|996650|P1|Received Investigational Product|Treatment Period (25 Weeks)||35
406159|NCT00104650|996648|P3|STARTED|Treatment Period (25 Weeks)||38
406160|NCT00104650|996649|P2|STARTED|Treatment Period (25 Weeks)||36
406161|NCT00104650|996650|P1|STARTED|Treatment Period (25 Weeks)||37
406162|NCT00104637|996682|P2|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
406163|NCT00104637|996683|P1|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
406164|NCT00104637|996682|P2|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||4
406165|NCT00104637|996683|P1|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||5
406166|NCT00104637|996682|P2|STARTED|Period 3 ( TREATMENT: 4 Weeks)||4
406167|NCT00104637|996683|P1|STARTED|Period 3 ( TREATMENT: 4 Weeks)||5
406168|NCT00104637|996682|P2|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
406169|NCT00104637|996683|P1|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
406170|NCT00104637|996682|P2|COMPLETED|Period 2 (WASHOUT: 1 Week)||4
406171|NCT00104637|996683|P1|COMPLETED|Period 2 (WASHOUT: 1 Week)||5
406172|NCT00104637|996682|P2|STARTED|Period 2 (WASHOUT: 1 Week)||4
406173|NCT00104637|996683|P1|STARTED|Period 2 (WASHOUT: 1 Week)||5
406174|NCT00104637|996682|P2|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||0
406175|NCT00104637|996683|P1|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||1
406176|NCT00104637|996682|P2|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||4
406177|NCT00104637|996683|P1|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||5
406178|NCT00104637|996682|P2|STARTED|Period 1: ( TREATMENT: 4 Weeks)||4
406179|NCT00104637|996683|P1|STARTED|Period 1: ( TREATMENT: 4 Weeks)||6
406180|NCT00104572|996712|P3|NOT COMPLETED|Overall Study||0
406181|NCT00104572|996713|P2|NOT COMPLETED|Overall Study||3
406182|NCT00104572|996714|P1|NOT COMPLETED|Overall Study||3
406183|NCT00104572|996712|P3|COMPLETED|Overall Study||9
406184|NCT00104572|996713|P2|COMPLETED|Overall Study||10
406185|NCT00104572|996714|P1|COMPLETED|Overall Study||10
406186|NCT00104572|996712|P3|STARTED|Overall Study|(N=11) in placebo, physician removed 2 men due to total testosterone>450 ng/DL, N=9 analysed.|9
406187|NCT00104572|996713|P2|STARTED|Overall Study|These are the analysed subjects|13
406188|NCT00104572|996714|P1|STARTED|Overall Study|These are the analysed subjects|13
406189|NCT00104520|996733|P2|NOT COMPLETED|Overall Study||71
406190|NCT00104520|996734|P1|NOT COMPLETED|Overall Study||50
406191|NCT00104520|996733|P2|COMPLETED|Overall Study||64
406192|NCT00104520|996734|P1|COMPLETED|Overall Study||26
406193|NCT00104520|996733|P2|STARTED|Overall Study||135
406194|NCT00104520|996734|P1|STARTED|Overall Study||76
406195|NCT00104416|996754|P5|NOT COMPLETED|Continuation Phase||5
406196|NCT00104416|996755|P4|NOT COMPLETED|Continuation Phase||2
406197|NCT00104416|996756|P3|NOT COMPLETED|Continuation Phase||6
406198|NCT00104416|996757|P2|NOT COMPLETED|Continuation Phase||0
406199|NCT00104416|996758|P1|NOT COMPLETED|Continuation Phase||0
406200|NCT00104416|996754|P5|COMPLETED|Continuation Phase||27
406201|NCT00104416|996755|P4|COMPLETED|Continuation Phase||65
406202|NCT00104416|996756|P3|COMPLETED|Continuation Phase||63
406203|NCT00104416|996757|P2|COMPLETED|Continuation Phase||0
406204|NCT00104416|996758|P1|COMPLETED|Continuation Phase||0
406205|NCT00104416|996754|P5|STARTED|Continuation Phase||32
406206|NCT00104416|996755|P4|STARTED|Continuation Phase|One participant did not complete the Double-Blind Phase but was enrolled in the Continuation Phase.|67
406207|NCT00104416|996756|P3|STARTED|Continuation Phase||69
406208|NCT00104416|996757|P2|STARTED|Continuation Phase||0
406209|NCT00104416|996758|P1|STARTED|Continuation Phase||0
406210|NCT00104416|996754|P5|NOT COMPLETED|Double-Blind Phase||0
406211|NCT00104416|996755|P4|NOT COMPLETED|Double-Blind Phase||0
406212|NCT00104416|996756|P3|NOT COMPLETED|Double-Blind Phase||0
406213|NCT00104416|996757|P2|NOT COMPLETED|Double-Blind Phase||10
406214|NCT00104416|996758|P1|NOT COMPLETED|Double-Blind Phase||8
406215|NCT00104416|996754|P5|COMPLETED|Double-Blind Phase||0
406216|NCT00104416|996755|P4|COMPLETED|Double-Blind Phase||0
406217|NCT00104416|996756|P3|COMPLETED|Double-Blind Phase||0
406218|NCT00104416|996757|P2|COMPLETED|Double-Blind Phase||66
406219|NCT00104416|996758|P1|COMPLETED|Double-Blind Phase||69
406220|NCT00104416|996754|P5|STARTED|Double-Blind Phase||0
406221|NCT00104416|996755|P4|STARTED|Double-Blind Phase||0
406222|NCT00104416|996756|P3|STARTED|Double-Blind Phase||0
406223|NCT00104416|996757|P2|STARTED|Double-Blind Phase||76
406224|NCT00104416|996758|P1|STARTED|Double-Blind Phase||77
406225|NCT00104299|996803|P2|NOT COMPLETED|Overall Study||10
406226|NCT00104299|996804|P1|NOT COMPLETED|Overall Study||9
406227|NCT00104299|996803|P2|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|88
406228|NCT00104299|996804|P1|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|90
406229|NCT00104299|996803|P2|STARTED|Overall Study||98
406230|NCT00104299|996804|P1|STARTED|Overall Study||99
406231|NCT00104247|996826|P2|NOT COMPLETED|Overall Study||1
406232|NCT00104247|996827|P1|NOT COMPLETED|Overall Study||1
406233|NCT00104247|996826|P2|COMPLETED|Overall Study|One subject withdrew at Week 4, but is included in the data analysis|46
406234|NCT00104247|996827|P1|COMPLETED|Overall Study|Subject withdrew prior to dosing|41
406235|NCT00104247|996826|P2|STARTED|Overall Study||47
406236|NCT00104247|996827|P1|STARTED|Overall Study||42
406237|NCT00104234|996835|P2|NOT COMPLETED|Overall Study||1
406238|NCT00104234|996836|P1|NOT COMPLETED|Overall Study||0
406239|NCT00104234|996835|P2|COMPLETED|Overall Study||19
406240|NCT00104234|996836|P1|COMPLETED|Overall Study||19
406241|NCT00104234|996835|P2|STARTED|Overall Study||20
406242|NCT00104234|996836|P1|STARTED|Overall Study||19
406243|NCT00104104|996846|P2|NOT COMPLETED|Overall Study||72
406244|NCT00104104|996847|P1|NOT COMPLETED|Overall Study||75
406245|NCT00104104|996846|P2|COMPLETED|Overall Study||17
406246|NCT00104104|996847|P1|COMPLETED|Overall Study||15
406247|NCT00104104|996846|P2|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 4 patients in this arm were excluded.|84
406248|NCT00104104|996847|P1|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 3 patients in this arm were excluded.|85
406249|NCT00104104|996846|P2|Safety Population (Including Site 74)|Overall Study||88
406250|NCT00104104|996847|P1|Safety Population (Including Site 74)|Overall Study||88
406251|NCT00104104|996846|P2|STARTED|Overall Study|1 Participants in the 30-minute infusion group did not receive study drug.|89
406252|NCT00104104|996847|P1|STARTED|Overall Study|2 Participants in the 15-minute infusion group did not receive study drug.|90
406253|NCT00104052|996861|P1|NOT COMPLETED|Overall Study||29
406254|NCT00104052|996861|P1|COMPLETED|Overall Study||78
406255|NCT00104052|996861|P1|STARTED|Overall Study||107
406256|NCT00103857|996872|P7|NOT COMPLETED|50-Week Extension Study||0
406257|NCT00103857|996873|P6|NOT COMPLETED|50-Week Extension Study||20
406258|NCT00103857|996874|P5|NOT COMPLETED|50-Week Extension Study||21
406259|NCT00103857|996875|P4|NOT COMPLETED|50-Week Extension Study||36
406260|NCT00103857|996876|P3|NOT COMPLETED|50-Week Extension Study||26
406261|NCT00103857|996877|P2|NOT COMPLETED|50-Week Extension Study||27
406262|NCT00103857|996878|P1|NOT COMPLETED|50-Week Extension Study||38
406263|NCT00103857|996872|P7|COMPLETED|50-Week Extension Study||0
406264|NCT00103857|996873|P6|COMPLETED|50-Week Extension Study||78
406265|NCT00103857|996874|P5|COMPLETED|50-Week Extension Study||101
406266|NCT00103857|996875|P4|COMPLETED|50-Week Extension Study||98
406267|NCT00103857|996876|P3|COMPLETED|50-Week Extension Study||95
406268|NCT00103857|996877|P2|COMPLETED|50-Week Extension Study||80
406269|NCT00103857|996878|P1|COMPLETED|50-Week Extension Study||65
406270|NCT00103857|996872|P7|STARTED|50-Week Extension Study||0
406271|NCT00103857|996873|P6|STARTED|50-Week Extension Study|17 randomized patients completed Period 1 but did not enter Period 2.|98
406272|NCT00103857|996874|P5|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|122
406273|NCT00103857|996875|P4|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|134
406274|NCT00103857|996876|P3|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|121
406275|NCT00103857|996877|P2|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|107
406276|NCT00103857|996878|P1|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|103
406277|NCT00103857|996872|P7|NOT COMPLETED|54-Week Base Study||38
406278|NCT00103857|996873|P6|NOT COMPLETED|54-Week Base Study||61
406279|NCT00103857|996874|P5|NOT COMPLETED|54-Week Base Study||41
406280|NCT00103857|996875|P4|NOT COMPLETED|54-Week Base Study||42
406281|NCT00103857|996876|P3|NOT COMPLETED|54-Week Base Study||47
406282|NCT00103857|996877|P2|NOT COMPLETED|54-Week Base Study||56
406283|NCT00103857|996878|P1|NOT COMPLETED|54-Week Base Study||57
406284|NCT00103857|996872|P7|COMPLETED|54-Week Base Study||79
406285|NCT00103857|996873|P6|COMPLETED|54-Week Base Study||115
406286|NCT00103857|996874|P5|COMPLETED|54-Week Base Study||141
406287|NCT00103857|996875|P4|COMPLETED|54-Week Base Study||148
406288|NCT00103857|996876|P3|COMPLETED|54-Week Base Study||135
406289|NCT00103857|996877|P2|COMPLETED|54-Week Base Study||126
406290|NCT00103857|996878|P1|COMPLETED|54-Week Base Study||122
406291|NCT00103857|996872|P7|STARTED|54-Week Base Study|Results for the OLC are through Week 24. Results for the 6 randomized groups are through Week 54.|117
406292|NCT00103857|996873|P6|STARTED|54-Week Base Study||176
406293|NCT00103857|996874|P5|STARTED|54-Week Base Study||182
406294|NCT00103857|996875|P4|STARTED|54-Week Base Study||190
406295|NCT00103857|996876|P3|STARTED|54-Week Base Study||182
406296|NCT00103857|996877|P2|STARTED|54-Week Base Study||182
406297|NCT00103857|996878|P1|STARTED|54-Week Base Study||179
406298|NCT00103844|996943|P2|NOT COMPLETED|Overall Study||0
406299|NCT00103844|996944|P1|NOT COMPLETED|Overall Study||0
406300|NCT00103844|996943|P2|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|49
406301|NCT00103844|996944|P1|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|101
406302|NCT00103844|996943|P2|Crossed Over|Overall Study|40 participants from the imatinib arm crossed over the dasatinib|40
406303|NCT00103844|996944|P1|Crossed Over|Overall Study|22 participants from the dasatinib arm crossed over to imatinib|22
406304|NCT00103844|996943|P2|STARTED|Overall Study||49
406305|NCT00103844|996944|P1|STARTED|Overall Study||101
406306|NCT00103740|996977|P2|NOT COMPLETED|Period 2 - Extended Observation Period||36
406307|NCT00103740|996978|P1|NOT COMPLETED|Period 2 - Extended Observation Period||69
406308|NCT00103740|996977|P2|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|27
406309|NCT00103740|996978|P1|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|9
406310|NCT00103740|996977|P2|STARTED|Period 2 - Extended Observation Period||63
406311|NCT00103740|996978|P1|STARTED|Period 2 - Extended Observation Period||78
406312|NCT00103740|996977|P2|NOT COMPLETED|Period 1 - Core||4
406313|NCT00103740|996978|P1|NOT COMPLETED|Period 1 - Core||7
406314|NCT00103740|996977|P2|COMPLETED|Period 1 - Core||89
406315|NCT00103740|996978|P1|COMPLETED|Period 1 - Core||85
406316|NCT00103740|996977|P2|STARTED|Period 1 - Core||93
406317|NCT00103740|996978|P1|STARTED|Period 1 - Core||92
406318|NCT00103662|997006|P2|NOT COMPLETED|Overall Study||33
406319|NCT00103662|997007|P1|NOT COMPLETED|Overall Study||19
406320|NCT00103662|997006|P2|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|121
406321|NCT00103662|997007|P1|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|129
406322|NCT00103662|997006|P2|STARTED|Overall Study||154
406323|NCT00103662|997007|P1|STARTED|Overall Study||148
406324|NCT00103610|997033|P2|NOT COMPLETED|Overall Study||80
406325|NCT00103610|997034|P1|NOT COMPLETED|Overall Study||38
406326|NCT00103610|997033|P2|COMPLETED|Overall Study||68
406327|NCT00103610|997034|P1|COMPLETED|Overall Study||112
406328|NCT00103610|997033|P2|STARTED|Overall Study||148
406329|NCT00103610|997034|P1|STARTED|Overall Study||150
406330|NCT00103506|997058|P2|NOT COMPLETED|Overall Study||324
406331|NCT00103506|997059|P1|NOT COMPLETED|Overall Study||322
406332|NCT00103506|997058|P2|COMPLETED|Overall Study||0
406333|NCT00103506|997059|P1|COMPLETED|Overall Study||0
406334|NCT00103506|997058|P2|STARTED|Overall Study||324
406335|NCT00103506|997059|P1|STARTED|Overall Study||322
406336|NCT00103376|997072|P3|NOT COMPLETED|Overall Study||0
406337|NCT00103376|997073|P2|NOT COMPLETED|Overall Study||0
406338|NCT00103376|997074|P1|NOT COMPLETED|Overall Study||0
406339|NCT00103376|997072|P3|COMPLETED|Overall Study||8
406340|NCT00103376|997073|P2|COMPLETED|Overall Study||7
406341|NCT00103376|997074|P1|COMPLETED|Overall Study||8
406342|NCT00103376|997072|P3|STARTED|Overall Study||8
406343|NCT00103376|997073|P2|STARTED|Overall Study||7
406344|NCT00103376|997074|P1|STARTED|Overall Study||8
406345|NCT00103311|997090|P2|NOT COMPLETED|Overall Study||1
406346|NCT00103311|997091|P1|NOT COMPLETED|Overall Study||4
406347|NCT00103311|997090|P2|COMPLETED|Overall Study||30
406348|NCT00103311|997091|P1|COMPLETED|Overall Study||29
406349|NCT00103311|997090|P2|STARTED|Overall Study||31
406350|NCT00103311|997091|P1|STARTED|Overall Study||33
406351|NCT00103285|997101|P8|NOT COMPLETED|Response Assignment||120
406352|NCT00103285|997102|P7|NOT COMPLETED|Response Assignment||49
406353|NCT00103285|997103|P6|NOT COMPLETED|Response Assignment||48
406354|NCT00103285|997104|P5|NOT COMPLETED|Response Assignment||84
406355|NCT00103285|997105|P4|NOT COMPLETED|Response Assignment||62
406356|NCT00103285|997106|P3|NOT COMPLETED|Response Assignment||84
406357|NCT00103285|997107|P2|NOT COMPLETED|Response Assignment||132
406358|NCT00103285|997108|P1|NOT COMPLETED|Response Assignment||0
406359|NCT00103285|997101|P8|COMPLETED|Response Assignment||523
406360|NCT00103285|997102|P7|COMPLETED|Response Assignment||199
406361|NCT00103285|997103|P6|COMPLETED|Response Assignment||201
406362|NCT00103285|997104|P5|COMPLETED|Response Assignment||425
406363|NCT00103285|997105|P4|COMPLETED|Response Assignment||441
406364|NCT00103285|997106|P3|COMPLETED|Response Assignment||853
406365|NCT00103285|997107|P2|COMPLETED|Response Assignment||807
406366|NCT00103285|997108|P1|COMPLETED|Response Assignment||0
406367|NCT00103285|997101|P8|STARTED|Response Assignment||643
406368|NCT00103285|997102|P7|STARTED|Response Assignment||248
406369|NCT00103285|997103|P6|STARTED|Response Assignment||249
406370|NCT00103285|997104|P5|STARTED|Response Assignment||509
406371|NCT00103285|997105|P4|STARTED|Response Assignment||503
406372|NCT00103285|997106|P3|STARTED|Response Assignment||937
406373|NCT00103285|997107|P2|STARTED|Response Assignment||939
406374|NCT00103285|997108|P1|STARTED|Response Assignment||0
406375|NCT00103285|997101|P8|NOT COMPLETED|Induction||0
406376|NCT00103285|997102|P7|NOT COMPLETED|Induction||0
406377|NCT00103285|997103|P6|NOT COMPLETED|Induction||0
406378|NCT00103285|997104|P5|NOT COMPLETED|Induction||0
406379|NCT00103285|997105|P4|NOT COMPLETED|Induction||0
406380|NCT00103285|997106|P3|NOT COMPLETED|Induction||0
406381|NCT00103285|997107|P2|NOT COMPLETED|Induction||0
406382|NCT00103285|997108|P1|NOT COMPLETED|Induction||1349
406383|NCT00103285|997101|P8|COMPLETED|Induction||0
406384|NCT00103285|997102|P7|COMPLETED|Induction||0
406385|NCT00103285|997103|P6|COMPLETED|Induction||0
406386|NCT00103285|997104|P5|COMPLETED|Induction||0
406387|NCT00103285|997105|P4|COMPLETED|Induction||0
406388|NCT00103285|997106|P3|COMPLETED|Induction||0
406389|NCT00103285|997107|P2|COMPLETED|Induction||0
406390|NCT00103285|997108|P1|COMPLETED|Induction||4028
406391|NCT00103285|997101|P8|STARTED|Induction||0
406392|NCT00103285|997102|P7|STARTED|Induction||0
406393|NCT00103285|997103|P6|STARTED|Induction||0
406394|NCT00103285|997104|P5|STARTED|Induction||0
406395|NCT00103285|997105|P4|STARTED|Induction||0
406396|NCT00103285|997106|P3|STARTED|Induction||0
406397|NCT00103285|997107|P2|STARTED|Induction||0
406398|NCT00103285|997108|P1|STARTED|Induction||5377
406399|NCT00103259|997137|P2|NOT COMPLETED|Overall Study||12
406400|NCT00103259|997138|P1|NOT COMPLETED|Overall Study||12
406401|NCT00103259|997137|P2|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.This number is for stage I.|32
406402|NCT00103259|997138|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|15
406403|NCT00103259|997137|P2|Eligible Patients Who Cross Over|Overall Study||10
406404|NCT00103259|997138|P1|Eligible Patients Who Cross Over|Overall Study||0
406405|NCT00103259|997137|P2|Cross Over to the Other Arm|Overall Study|11 patients who progressed on bortezomib crossed over to Arm I. 10 of them were eligible|11
406406|NCT00103259|997138|P1|Cross Over to the Other Arm|Overall Study||0
406407|NCT00103259|997137|P2|Eligible and Treated|Overall Study||38
406408|NCT00103259|997138|P1|Eligible and Treated|Overall Study||23
406409|NCT00103259|997137|P2|Treated|Overall Study||41
406410|NCT00103259|997138|P1|Treated|Overall Study||23
406411|NCT00103259|997137|P2|Eligible|Overall Study||41
406412|NCT00103259|997138|P1|Eligible|Overall Study||27
406413|NCT00103259|997137|P2|STARTED|Overall Study||44
406414|NCT00103259|997138|P1|STARTED|Overall Study||27
406415|NCT00103207|997150|P1|NOT COMPLETED|Overall Study||38
406416|NCT00103207|997150|P1|COMPLETED|Overall Study||34
406417|NCT00103207|997150|P1|Eligible Patients w/ Smoking Status Data|Overall Study||37
406418|NCT00103207|997150|P1|Eligible Patients w/ Confirmed Diagnosis|Overall Study||41
406419|NCT00103207|997150|P1|STARTED|Overall Study||72
406420|NCT00103194|997160|P1|NOT COMPLETED|Overall Study||31
406421|NCT00103194|997160|P1|COMPLETED|Overall Study||18
406422|NCT00103194|997160|P1|Eligible and Treated|Overall Study||35
406423|NCT00103194|997160|P1|Eligible|Overall Study||35
406424|NCT00103194|997160|P1|Treated|Overall Study||49
406425|NCT00103194|997160|P1|STARTED|Overall Study||49
406426|NCT00103142|997169|P2|NOT COMPLETED|Overall Study||1
406427|NCT00103142|997170|P1|NOT COMPLETED|Overall Study||3
406428|NCT00103142|997169|P2|COMPLETED|Overall Study||36
406429|NCT00103142|997170|P1|COMPLETED|Overall Study||33
406430|NCT00103142|997169|P2|STARTED|Overall Study||37
406431|NCT00103142|997170|P1|STARTED|Overall Study||36
406432|NCT00103116|997178|P1|NOT COMPLETED|Overall Study||0
406433|NCT00103116|997178|P1|COMPLETED|Overall Study||32
406434|NCT00103116|997178|P1|STARTED|Overall Study||32
406435|NCT00103012|997186|P3|NOT COMPLETED|Overall Study||4
406436|NCT00103012|997187|P2|NOT COMPLETED|Overall Study||1
406437|NCT00103012|997188|P1|NOT COMPLETED|Overall Study||3
406438|NCT00103012|997186|P3|COMPLETED|Overall Study||12
406439|NCT00103012|997187|P2|COMPLETED|Overall Study||13
406440|NCT00103012|997188|P1|COMPLETED|Overall Study||14
406441|NCT00103012|997186|P3|STARTED|Overall Study||16
406442|NCT00103012|997187|P2|STARTED|Overall Study||14
406443|NCT00103012|997188|P1|STARTED|Overall Study||17
406444|NCT00102960|997199|P3|NOT COMPLETED|Overall Study||28
406445|NCT00102960|997200|P2|NOT COMPLETED|Overall Study||23
406446|NCT00102960|997201|P1|NOT COMPLETED|Overall Study||30
406447|NCT00102960|997199|P3|COMPLETED|Overall Study||98
406448|NCT00102960|997200|P2|COMPLETED|Overall Study||103
406449|NCT00102960|997201|P1|COMPLETED|Overall Study||95
406450|NCT00102960|997199|P3|STARTED|Overall Study||126
406451|NCT00102960|997200|P2|STARTED|Overall Study||126
406452|NCT00102960|997201|P1|STARTED|Overall Study||125
406453|NCT00102804|997250|P2|NOT COMPLETED|Overall Study||222
406454|NCT00102804|997251|P1|NOT COMPLETED|Overall Study||441
406455|NCT00102804|997250|P2|COMPLETED|Overall Study||0
406456|NCT00102804|997251|P1|COMPLETED|Overall Study||0
406457|NCT00102804|997250|P2|Received at Least 1 Dose of Study Drug|Overall Study|Four participants randomized to placebo received pemetrexed.|222
406458|NCT00102804|997251|P1|Received at Least 1 Dose of Study Drug|Overall Study||434
406459|NCT00102804|997250|P2|STARTED|Overall Study||222
406460|NCT00102804|997251|P1|STARTED|Overall Study||441
406461|NCT00102687|997272|P5|NOT COMPLETED|Maintenance Period||13
406462|NCT00102687|997273|P4|NOT COMPLETED|Maintenance Period||10
406463|NCT00102687|997274|P3|NOT COMPLETED|Maintenance Period||6
406464|NCT00102687|997275|P2|NOT COMPLETED|Maintenance Period||4
406465|NCT00102687|997276|P1|NOT COMPLETED|Maintenance Period||7
406466|NCT00102687|997272|P5|COMPLETED|Maintenance Period||8
406467|NCT00102687|997273|P4|COMPLETED|Maintenance Period||12
406468|NCT00102687|997274|P3|COMPLETED|Maintenance Period||2
406469|NCT00102687|997275|P2|COMPLETED|Maintenance Period||2
406470|NCT00102687|997276|P1|COMPLETED|Maintenance Period||6
406471|NCT00102687|997272|P5|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|21
406472|NCT00102687|997273|P4|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|22
406473|NCT00102687|997274|P3|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|8
406474|NCT00102687|997275|P2|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|6
406475|NCT00102687|997276|P1|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|13
406476|NCT00102687|997272|P5|NOT COMPLETED|Initial Period||0
406477|NCT00102687|997273|P4|NOT COMPLETED|Initial Period||0
406478|NCT00102687|997274|P3|NOT COMPLETED|Initial Period||26
406479|NCT00102687|997275|P2|NOT COMPLETED|Initial Period||28
406480|NCT00102687|997276|P1|NOT COMPLETED|Initial Period||18
406481|NCT00102687|997272|P5|COMPLETED|Initial Period||0
406482|NCT00102687|997273|P4|COMPLETED|Initial Period||0
406483|NCT00102687|997274|P3|COMPLETED|Initial Period||25
406484|NCT00102687|997275|P2|COMPLETED|Initial Period||22
406485|NCT00102687|997276|P1|COMPLETED|Initial Period||32
406486|NCT00102687|997272|P5|STARTED|Initial Period||0
406487|NCT00102687|997273|P4|STARTED|Initial Period||0
406488|NCT00102687|997274|P3|STARTED|Initial Period|3 randomized participants did not receive treatment.|51
406489|NCT00102687|997275|P2|STARTED|Initial Period||50
406490|NCT00102687|997276|P1|STARTED|Initial Period||50
406491|NCT00102596|997340|P2|NOT COMPLETED|Part C||0
406492|NCT00102596|997341|P1|NOT COMPLETED|Part C||0
406493|NCT00102596|997340|P2|COMPLETED|Part C||2
406494|NCT00102596|997341|P1|COMPLETED|Part C||0
406495|NCT00102596|997340|P2|STARTED|Part C|Only 2 patients participated in Part C|2
406496|NCT00102596|997341|P1|STARTED|Part C||0
406497|NCT00102596|997340|P2|NOT COMPLETED|Part B||0
406498|NCT00102596|997341|P1|NOT COMPLETED|Part B||0
406499|NCT00102596|997340|P2|COMPLETED|Part B||10
406500|NCT00102596|997341|P1|COMPLETED|Part B||0
406501|NCT00102596|997340|P2|STARTED|Part B||10
406502|NCT00102596|997341|P1|STARTED|Part B|Participants from Part A did not continue to Part B|0
406503|NCT00102596|997340|P2|NOT COMPLETED|Part A||0
406504|NCT00102596|997341|P1|NOT COMPLETED|Part A||7
406505|NCT00102596|997340|P2|COMPLETED|Part A||0
406506|NCT00102596|997341|P1|COMPLETED|Part A||4
406507|NCT00102596|997340|P2|Participants Assigned Treatment|Part A||0
406508|NCT00102596|997341|P1|Participants Assigned Treatment|Part A||5
406509|NCT00102596|997340|P2|STARTED|Part A||0
406510|NCT00102596|997341|P1|STARTED|Part A||11
406511|NCT00102531|997352|P2|NOT COMPLETED|Overall Study||11
406512|NCT00102531|997353|P1|NOT COMPLETED|Overall Study||5
406513|NCT00102531|997352|P2|COMPLETED|Overall Study||1
406514|NCT00102531|997353|P1|COMPLETED|Overall Study||2
406515|NCT00102531|997352|P2|STARTED|Overall Study||12
406516|NCT00102531|997353|P1|STARTED|Overall Study||7
406517|NCT00102518|997359|P1|NOT COMPLETED|Overall Study||87
406518|NCT00102518|997359|P1|COMPLETED|Overall Study||238
406519|NCT00102518|997359|P1|STARTED|Overall Study||325
406520|NCT00102440|997368|P3|NOT COMPLETED|Overall Study||66
406521|NCT00102440|997369|P2|NOT COMPLETED|Overall Study||98
406522|NCT00102440|997370|P1|NOT COMPLETED|Overall Study||88
406523|NCT00102440|997368|P3|COMPLETED|Overall Study||187
406524|NCT00102440|997369|P2|COMPLETED|Overall Study||153
406525|NCT00102440|997370|P1|COMPLETED|Overall Study||168
406526|NCT00102440|997368|P3|STARTED|Overall Study||253
406527|NCT00102440|997369|P2|STARTED|Overall Study||251
406528|NCT00102440|997370|P1|STARTED|Overall Study||256
406529|NCT00102063|997420|P3|NOT COMPLETED|Overall Study||10
406530|NCT00102063|997421|P2|NOT COMPLETED|Overall Study||18
406531|NCT00102063|997422|P1|NOT COMPLETED|Overall Study||16
406532|NCT00102063|997420|P3|COMPLETED|Overall Study||90
406533|NCT00102063|997421|P2|COMPLETED|Overall Study||84
406534|NCT00102063|997422|P1|COMPLETED|Overall Study||84
406535|NCT00102063|997420|P3|STARTED|Overall Study||100
406536|NCT00102063|997421|P2|STARTED|Overall Study||102
406537|NCT00102063|997422|P1|STARTED|Overall Study||100
406538|NCT00101933|997453|P2|NOT COMPLETED|Overall Study||0
406539|NCT00101933|997454|P1|NOT COMPLETED|Overall Study||0
406540|NCT00101933|997453|P2|COMPLETED|Overall Study||55
406541|NCT00101933|997454|P1|COMPLETED|Overall Study||54
406542|NCT00101933|997453|P2|STARTED|Overall Study||55
406543|NCT00101933|997454|P1|STARTED|Overall Study||54
406544|NCT00101907|997480|P6|NOT COMPLETED|Overall Study||0
406545|NCT00101907|997481|P5|NOT COMPLETED|Overall Study||5
406546|NCT00101907|997482|P4|NOT COMPLETED|Overall Study||1
406547|NCT00101907|997483|P3|NOT COMPLETED|Overall Study||1
406548|NCT00101907|997484|P2|NOT COMPLETED|Overall Study||1
406549|NCT00101907|997485|P1|NOT COMPLETED|Overall Study||2
406550|NCT00101907|997480|P6|COMPLETED|Overall Study||2
406551|NCT00101907|997481|P5|COMPLETED|Overall Study||6
406552|NCT00101907|997482|P4|COMPLETED|Overall Study||5
406553|NCT00101907|997483|P3|COMPLETED|Overall Study||5
406554|NCT00101907|997484|P2|COMPLETED|Overall Study||7
406555|NCT00101907|997485|P1|COMPLETED|Overall Study||6
406556|NCT00101907|997480|P6|STARTED|Overall Study||2
406557|NCT00101907|997481|P5|STARTED|Overall Study||11
406558|NCT00101907|997482|P4|STARTED|Overall Study||6
406559|NCT00101907|997483|P3|STARTED|Overall Study||6
406560|NCT00101907|997484|P2|STARTED|Overall Study||8
406561|NCT00101907|997485|P1|STARTED|Overall Study||8
406562|NCT00101868|997527|P2|NOT COMPLETED|Overall Study||32
406563|NCT00101868|997528|P1|NOT COMPLETED|Overall Study||29
406564|NCT00101868|997527|P2|COMPLETED|Overall Study|zero hospital physician with zero patients lost to follow up|283
406565|NCT00101868|997528|P1|COMPLETED|Overall Study|1 hospital physician with zero patients lost to follow up|287
406566|NCT00101868|997527|P2|STARTED|Overall Study|35 hospital physicians allocated to usual care discharge|315
406567|NCT00101868|997528|P1|STARTED|Overall Study|35 hospital physicians allocated to discharge software|316
406568|NCT00101816|997540|P2|NOT COMPLETED|Overall Study||0
406569|NCT00101816|997541|P1|NOT COMPLETED|Overall Study||0
406570|NCT00101816|997540|P2|COMPLETED|Overall Study||99
406571|NCT00101816|997541|P1|COMPLETED|Overall Study||10
406572|NCT00101816|997540|P2|STARTED|Overall Study||99
406573|NCT00101816|997541|P1|STARTED|Overall Study||10
406574|NCT00101686|997598|P10|NOT COMPLETED|Overall Study||30
406575|NCT00101686|997599|P9|NOT COMPLETED|Overall Study||30
406576|NCT00101686|997600|P8|NOT COMPLETED|Overall Study||30
406577|NCT00101686|997601|P7|NOT COMPLETED|Overall Study||27
406578|NCT00101686|997602|P6|NOT COMPLETED|Overall Study||72
406579|NCT00101686|997603|P5|NOT COMPLETED|Overall Study||73
406580|NCT00101686|997604|P4|NOT COMPLETED|Overall Study||72
406581|NCT00101686|997605|P3|NOT COMPLETED|Overall Study||69
406582|NCT00101686|997606|P2|NOT COMPLETED|Overall Study||73
406583|NCT00101686|997607|P1|NOT COMPLETED|Overall Study||71
406669|NCT00101361|997793|P1|STARTED|Overall Study||108
406584|NCT00101686|997598|P10|COMPLETED|Overall Study|Patients treated until disease progression.|0
406585|NCT00101686|997599|P9|COMPLETED|Overall Study|Patients treated until disease progression.|0
406586|NCT00101686|997600|P8|COMPLETED|Overall Study|Patients treated until disease progression.|0
406587|NCT00101686|997601|P7|COMPLETED|Overall Study|Patients treated until disease progression.|0
406588|NCT00101686|997602|P6|COMPLETED|Overall Study|Patients treated until disease progression.|0
406589|NCT00101686|997603|P5|COMPLETED|Overall Study|Patients treated until disease progression.|0
406590|NCT00101686|997604|P4|COMPLETED|Overall Study|Patients treated until disease progression.|0
406591|NCT00101686|997605|P3|COMPLETED|Overall Study|Patients treated until disease progression.|0
406592|NCT00101686|997606|P2|COMPLETED|Overall Study|Patients treated until disease progression.|0
406593|NCT00101686|997607|P1|COMPLETED|Overall Study|Patients treated until disease progression.|0
406594|NCT00101686|997598|P10|Received Treatment|Overall Study||29
406595|NCT00101686|997599|P9|Received Treatment|Overall Study||30
406596|NCT00101686|997600|P8|Received Treatment|Overall Study||29
406597|NCT00101686|997601|P7|Received Treatment|Overall Study||27
406598|NCT00101686|997602|P6|Received Treatment|Overall Study||70
406599|NCT00101686|997603|P5|Received Treatment|Overall Study||71
406600|NCT00101686|997604|P4|Received Treatment|Overall Study||70
406601|NCT00101686|997605|P3|Received Treatment|Overall Study||67
406602|NCT00101686|997606|P2|Received Treatment|Overall Study||67
406603|NCT00101686|997607|P1|Received Treatment|Overall Study||70
406604|NCT00101686|997598|P10|STARTED|Overall Study||30
406605|NCT00101686|997599|P9|STARTED|Overall Study||30
406606|NCT00101686|997600|P8|STARTED|Overall Study||30
406607|NCT00101686|997601|P7|STARTED|Overall Study||27
406608|NCT00101686|997602|P6|STARTED|Overall Study||72
406609|NCT00101686|997603|P5|STARTED|Overall Study||73
406610|NCT00101686|997604|P4|STARTED|Overall Study||72
406611|NCT00101686|997605|P3|STARTED|Overall Study||69
406612|NCT00101686|997606|P2|STARTED|Overall Study||73
406613|NCT00101686|997607|P1|STARTED|Overall Study||71
406614|NCT00101660|997654|P2|NOT COMPLETED|Overall Study||0
406615|NCT00101660|997655|P1|NOT COMPLETED|Overall Study||0
406616|NCT00101660|997654|P2|COMPLETED|Overall Study||288
406617|NCT00101660|997655|P1|COMPLETED|Overall Study||99
406618|NCT00101660|997654|P2|STARTED|Overall Study||288
406619|NCT00101660|997655|P1|STARTED|Overall Study||99
406620|NCT00101647|997673|P2|NOT COMPLETED|Overall Study||0
406621|NCT00101647|997674|P1|NOT COMPLETED|Overall Study||0
406622|NCT00101647|997673|P2|COMPLETED|Overall Study||161
406623|NCT00101647|997674|P1|COMPLETED|Overall Study||13
406624|NCT00101647|997673|P2|STARTED|Overall Study|Randomized|161
406625|NCT00101647|997674|P1|STARTED|Overall Study|Randomized|13
406626|NCT00101582|997724|P2|NOT COMPLETED|Overall Study||15
406627|NCT00101582|997725|P1|NOT COMPLETED|Overall Study||11
406628|NCT00101582|997724|P2|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|79
406629|NCT00101582|997725|P1|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|83
406630|NCT00101582|997724|P2|Received Study Drug|Overall Study||94
406631|NCT00101582|997725|P1|Received Study Drug|Overall Study||91
406632|NCT00101582|997724|P2|STARTED|Overall Study||94
406633|NCT00101582|997725|P1|STARTED|Overall Study||94
406634|NCT00101452|997748|P3|NOT COMPLETED|Overall Study||43
406635|NCT00101452|997749|P2|NOT COMPLETED|Overall Study||43
406636|NCT00101452|997750|P1|NOT COMPLETED|Overall Study||44
406637|NCT00101452|997748|P3|COMPLETED|Overall Study||22
406638|NCT00101452|997749|P2|COMPLETED|Overall Study||26
406639|NCT00101452|997750|P1|COMPLETED|Overall Study||21
406640|NCT00101452|997748|P3|STARTED|Overall Study||65
406641|NCT00101452|997749|P2|STARTED|Overall Study||69
406642|NCT00101452|997750|P1|STARTED|Overall Study||65
406643|NCT00101439|997764|P2|NOT COMPLETED|Period 2||2
406644|NCT00101439|997765|P1|NOT COMPLETED|Period 2||0
406645|NCT00101439|997764|P2|COMPLETED|Period 2||28
406646|NCT00101439|997765|P1|COMPLETED|Period 2||28
406647|NCT00101439|997764|P2|STARTED|Period 2||30
406648|NCT00101439|997765|P1|STARTED|Period 2||28
406649|NCT00101439|997764|P2|NOT COMPLETED|Period 1||0
406650|NCT00101439|997765|P1|NOT COMPLETED|Period 1||0
406651|NCT00101439|997764|P2|COMPLETED|Period 1||30
406652|NCT00101439|997765|P1|COMPLETED|Period 1||28
406653|NCT00101439|997764|P2|STARTED|Period 1||30
406654|NCT00101439|997765|P1|STARTED|Period 1||28
406655|NCT00101413|997773|P1|NOT COMPLETED|Overall Study||0
406656|NCT00101413|997773|P1|COMPLETED|Overall Study|Safety data collected for 4 subjects after 30 Jun 2005 until 11 Apr 2008.|52
406657|NCT00101413|997773|P1|STARTED|Overall Study||52
406658|NCT00101400|997781|P1|NOT COMPLETED|Survival Follow-Up||7
406659|NCT00101400|997781|P1|COMPLETED|Survival Follow-Up|44 subjects reached endpoint (death); 7 subjects were still alive|44
406660|NCT00101400|997781|P1|STARTED|Survival Follow-Up|3 subjects died during previous period (completion as defined in protocol)|51
406661|NCT00101400|997781|P1|NOT COMPLETED|Treatment||0
406662|NCT00101400|997781|P1|COMPLETED|Treatment|Reasons for treatment termination: 4 Adverse Events, 3 Deaths, 46 Progression, 1 Withdrawal.|54
406663|NCT00101400|997781|P1|STARTED|Treatment|Treated until disease progression, unacceptable sorafenib-related toxicity or withdrawal of consent.|54
406664|NCT00101361|997792|P2|NOT COMPLETED|Overall Study||0
406665|NCT00101361|997793|P1|NOT COMPLETED|Overall Study||0
406666|NCT00101361|997792|P2|COMPLETED|Overall Study||104
406667|NCT00101361|997793|P1|COMPLETED|Overall Study||108
406668|NCT00101361|997792|P2|STARTED|Overall Study||104
406670|NCT00101283|997801|P2|NOT COMPLETED|Overall Study||3
406671|NCT00101283|997802|P1|NOT COMPLETED|Overall Study||0
406672|NCT00101283|997801|P2|COMPLETED|Overall Study||13
406673|NCT00101283|997802|P1|COMPLETED|Overall Study||16
406674|NCT00101283|997801|P2|Began Treatment|Overall Study||13
406675|NCT00101283|997802|P1|Began Treatment|Overall Study||16
406676|NCT00101283|997801|P2|STARTED|Overall Study||16
406677|NCT00101283|997802|P1|STARTED|Overall Study||16
406678|NCT00101192|997812|P1|NOT COMPLETED|Overall Study||7
406679|NCT00101192|997812|P1|COMPLETED|Overall Study||69
406680|NCT00101192|997812|P1|STARTED|Overall Study||76
406681|NCT00101166|997816|P1|NOT COMPLETED|Overall Study||10
406682|NCT00101166|997816|P1|COMPLETED|Overall Study||18
406683|NCT00101166|997816|P1|STARTED|Overall Study||28
406684|NCT00101101|997824|P1|NOT COMPLETED|Overall Study||20
406685|NCT00101101|997824|P1|COMPLETED|Overall Study|Participants who received at least one vaccine injection.|23
406686|NCT00101101|997824|P1|STARTED|Overall Study||43
406687|NCT00101036|997832|P2|NOT COMPLETED|Overall Study||0
406688|NCT00101036|997833|P1|NOT COMPLETED|Overall Study||0
406689|NCT00101036|997832|P2|COMPLETED|Overall Study||40
406690|NCT00101036|997833|P1|COMPLETED|Overall Study||17
406691|NCT00101036|997832|P2|STARTED|Overall Study||40
406692|NCT00101036|997833|P1|STARTED|Overall Study||17
406693|NCT00100932|997847|P2|NOT COMPLETED|Overall Study||27
406694|NCT00100932|997848|P1|NOT COMPLETED|Overall Study||73
406695|NCT00100932|997847|P2|COMPLETED|Overall Study||1
406696|NCT00100932|997848|P1|COMPLETED|Overall Study||5
406697|NCT00100932|997847|P2|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|28
406698|NCT00100932|997848|P1|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|78
406699|NCT00100841|997858|P1|NOT COMPLETED|Overall Study||0
406700|NCT00100841|997858|P1|COMPLETED|Overall Study||66
406701|NCT00100841|997858|P1|STARTED|Overall Study||66
406702|NCT00100828|997863|P1|NOT COMPLETED|Overall Study||6
406703|NCT00100828|997863|P1|COMPLETED|Overall Study||0
406704|NCT00100828|997863|P1|STARTED|Overall Study||6
406705|NCT00100815|997867|P1|NOT COMPLETED|Overall Study||49
406706|NCT00100815|997867|P1|COMPLETED|Overall Study||1
406707|NCT00100815|997867|P1|STARTED|Overall Study||50
406708|NCT00100802|997875|P1|NOT COMPLETED|Overall Study||80
406709|NCT00100802|997875|P1|COMPLETED|Overall Study||38
406710|NCT00100802|997875|P1|STARTED|Overall Study||118
406711|NCT00100789|997880|P1|NOT COMPLETED|Overall Study||64
406712|NCT00100789|997880|P1|COMPLETED|Overall Study||3
406713|NCT00100789|997880|P1|Eligible and Began Protocol Therapy|Overall Study||63
406714|NCT00100789|997880|P1|Eligible|Overall Study||64
406715|NCT00100789|997880|P1|STARTED|Overall Study||67
406716|NCT00100698|997889|P2|NOT COMPLETED|Overall Study||2
406717|NCT00100698|997890|P1|NOT COMPLETED|Overall Study||6
406718|NCT00100698|997889|P2|COMPLETED|Overall Study||27
406719|NCT00100698|997890|P1|COMPLETED|Overall Study||21
406720|NCT00100698|997889|P2|STARTED|Overall Study||29
406721|NCT00100698|997890|P1|STARTED|Overall Study||27
406722|NCT00100659|997932|P2|NOT COMPLETED|Overall Study||2
406723|NCT00100659|997933|P1|NOT COMPLETED|Overall Study||3
406724|NCT00100659|997932|P2|COMPLETED|Overall Study||57
406725|NCT00100659|997933|P1|COMPLETED|Overall Study||52
406726|NCT00100659|997932|P2|STARTED|Overall Study||59
406727|NCT00100659|997933|P1|STARTED|Overall Study||55
406728|NCT00100230|997943|P2|NOT COMPLETED|Overall Study||15
406729|NCT00100230|997944|P1|NOT COMPLETED|Overall Study||12
406730|NCT00100230|997943|P2|COMPLETED|Overall Study||22
406731|NCT00100230|997944|P1|COMPLETED|Overall Study||29
406732|NCT00100230|997943|P2|STARTED|Overall Study||37
406733|NCT00100230|997944|P1|STARTED|Overall Study||41
406734|NCT00100178|997957|P3|NOT COMPLETED|Overall Study||10
406735|NCT00100178|997958|P2|NOT COMPLETED|Overall Study||10
406736|NCT00100178|997959|P1|NOT COMPLETED|Overall Study||9
406737|NCT00100178|997957|P3|COMPLETED|Overall Study||32
406738|NCT00100178|997958|P2|COMPLETED|Overall Study||21
406739|NCT00100178|997959|P1|COMPLETED|Overall Study||32
406740|NCT00100178|997957|P3|STARTED|Overall Study||42
406741|NCT00100178|997958|P2|STARTED|Overall Study|12 subjects randomized to the MMF alone group were excluded from analysis due to randomization error|31
406742|NCT00100178|997959|P1|STARTED|Overall Study||41
406743|NCT00100048|997972|P6|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
406744|NCT00100048|997973|P5|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||0
406745|NCT00100048|997974|P4|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||10
406746|NCT00100048|997975|P3|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
406747|NCT00100048|997976|P2|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||9
406748|NCT00100048|997977|P1|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||14
406749|NCT00100048|997972|P6|COMPLETED|Cohort I & II-Combination Therapy Phase||26
406750|NCT00100048|997973|P5|COMPLETED|Cohort I & II-Combination Therapy Phase||0
406751|NCT00100048|997974|P4|COMPLETED|Cohort I & II-Combination Therapy Phase||30
406752|NCT00100048|997975|P3|COMPLETED|Cohort I & II-Combination Therapy Phase||28
406753|NCT00100048|997976|P2|COMPLETED|Cohort I & II-Combination Therapy Phase||31
406754|NCT00100048|997977|P1|COMPLETED|Cohort I & II-Combination Therapy Phase||27
406755|NCT00100048|997972|P6|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|1
406756|NCT00100048|997973|P5|Never Treated|Cohort I & II-Combination Therapy Phase||0
406757|NCT00100048|997974|P4|Never Treated|Cohort I & II-Combination Therapy Phase||0
406758|NCT00100048|997975|P3|Never Treated|Cohort I & II-Combination Therapy Phase||0
406759|NCT00100048|997976|P2|Never Treated|Cohort I & II-Combination Therapy Phase||0
406760|NCT00100048|997977|P1|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|2
406761|NCT00100048|997972|P6|Treated|Cohort I & II-Combination Therapy Phase||38
406762|NCT00100048|997973|P5|Treated|Cohort I & II-Combination Therapy Phase||0
406763|NCT00100048|997974|P4|Treated|Cohort I & II-Combination Therapy Phase||40
406764|NCT00100048|997975|P3|Treated|Cohort I & II-Combination Therapy Phase||41
406765|NCT00100048|997976|P2|Treated|Cohort I & II-Combination Therapy Phase||40
406766|NCT00100048|997977|P1|Treated|Cohort I & II-Combination Therapy Phase||39
406767|NCT00100048|997972|P6|STARTED|Cohort I & II-Combination Therapy Phase|4 subjects from the Monotherapy Phase (Placebo)and 35 new subjects|39
406768|NCT00100048|997973|P5|STARTED|Cohort I & II-Combination Therapy Phase|participants only assigned Placebo in Cohort I-Monotherapy Phase.|0
406769|NCT00100048|997974|P4|STARTED|Cohort I & II-Combination Therapy Phase|8 subjects from the Monotherapy Phase and 32 new subjects|40
406770|NCT00100048|997975|P3|STARTED|Cohort I & II-Combination Therapy Phase|6 subjects from the Monotherapy Phase and 35 new subjects|41
406771|NCT00100048|997976|P2|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 33 new subjects|40
406772|NCT00100048|997977|P1|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 34 new subjects|41
406773|NCT00100048|997972|P6|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
406774|NCT00100048|997973|P5|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
406775|NCT00100048|997974|P4|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
406776|NCT00100048|997975|P3|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
406777|NCT00100048|997976|P2|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
406778|NCT00100048|997977|P1|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
406779|NCT00100048|997972|P6|COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
406780|NCT00100048|997973|P5|COMPLETED|Cohort I-Monotherapy Phase 10 Days|4 Subjects Continued to Cohort II, as part of the Efavirenz 600 mg q.d. arm|7
406781|NCT00100048|997974|P4|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|8
406782|NCT00100048|997975|P3|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|6
406783|NCT00100048|997976|P2|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
406784|NCT00100048|997977|P1|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
406785|NCT00100048|997972|P6|Treated|Cohort I-Monotherapy Phase 10 Days||0
406786|NCT00100048|997973|P5|Treated|Cohort I-Monotherapy Phase 10 Days||7
406787|NCT00100048|997974|P4|Treated|Cohort I-Monotherapy Phase 10 Days||8
406788|NCT00100048|997975|P3|Treated|Cohort I-Monotherapy Phase 10 Days||6
406789|NCT00100048|997976|P2|Treated|Cohort I-Monotherapy Phase 10 Days||7
406790|NCT00100048|997977|P1|Treated|Cohort I-Monotherapy Phase 10 Days||7
406791|NCT00100048|997972|P6|STARTED|Cohort I-Monotherapy Phase 10 Days|participants only assigned Efavirenz 600 mg q.h.s in Cohort II Combined-Combination Therapy Phase|0
406792|NCT00100048|997973|P5|STARTED|Cohort I-Monotherapy Phase 10 Days||7
406793|NCT00100048|997974|P4|STARTED|Cohort I-Monotherapy Phase 10 Days||8
406794|NCT00100048|997975|P3|STARTED|Cohort I-Monotherapy Phase 10 Days||6
406795|NCT00100048|997976|P2|STARTED|Cohort I-Monotherapy Phase 10 Days||7
406796|NCT00100048|997977|P1|STARTED|Cohort I-Monotherapy Phase 10 Days||7
406797|NCT00099983|998086|P2|NOT COMPLETED|Overall Study||25
406798|NCT00099983|998087|P1|NOT COMPLETED|Overall Study||24
406799|NCT00099983|998086|P2|COMPLETED|Overall Study||124
406800|NCT00099983|998087|P1|COMPLETED|Overall Study||123
406801|NCT00099983|998086|P2|STARTED|Overall Study||149
406802|NCT00099983|998087|P1|STARTED|Overall Study||147
406803|NCT00099632|998099|P6|NOT COMPLETED|Overall Study||2
406804|NCT00099632|998100|P5|NOT COMPLETED|Overall Study||1
406805|NCT00099632|998101|P4|NOT COMPLETED|Overall Study||1
406806|NCT00099632|998102|P3|NOT COMPLETED|Overall Study||3
406807|NCT00099632|998103|P2|NOT COMPLETED|Overall Study||1
406808|NCT00099632|998104|P1|NOT COMPLETED|Overall Study||1
406809|NCT00099632|998099|P6|COMPLETED|Overall Study||66
406810|NCT00099632|998100|P5|COMPLETED|Overall Study||70
406811|NCT00099632|998101|P4|COMPLETED|Overall Study||66
406812|NCT00099632|998102|P3|COMPLETED|Overall Study||72
406813|NCT00099632|998103|P2|COMPLETED|Overall Study||67
406814|NCT00099632|998104|P1|COMPLETED|Overall Study||72
406815|NCT00099632|998099|P6|STARTED|Overall Study||68
406816|NCT00099632|998100|P5|STARTED|Overall Study||71
406817|NCT00099632|998101|P4|STARTED|Overall Study||67
406818|NCT00099632|998102|P3|STARTED|Overall Study||75
406819|NCT00099632|998103|P2|STARTED|Overall Study||68
406820|NCT00099632|998104|P1|STARTED|Overall Study||73
406821|NCT00099437|998144|P2|NOT COMPLETED|Overall Study||349
406822|NCT00099437|998145|P1|NOT COMPLETED|Overall Study||366
406823|NCT00099437|998144|P2|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|13
406824|NCT00099437|998145|P1|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|8
406825|NCT00099437|998144|P2|STARTED|Overall Study|randomised patients|362
406826|NCT00099437|998145|P1|STARTED|Overall Study|randomised patients|374
406827|NCT00099359|998168|P3|NOT COMPLETED|Overall Study||68
406828|NCT00099359|998169|P2|NOT COMPLETED|Overall Study||65
406829|NCT00099359|998170|P1|NOT COMPLETED|Overall Study||54
406830|NCT00099359|998168|P3|COMPLETED|Overall Study||506
406831|NCT00099359|998169|P2|COMPLETED|Overall Study||515
406832|NCT00099359|998170|P1|COMPLETED|Overall Study||527
406833|NCT00099359|998168|P3|STARTED|Overall Study||574
406834|NCT00099359|998169|P2|STARTED|Overall Study||580
406835|NCT00099359|998170|P1|STARTED|Overall Study||581
406836|NCT00099268|998193|P2|NOT COMPLETED|Overall Study||82
406837|NCT00099268|998194|P1|NOT COMPLETED|Overall Study||92
406838|NCT00099268|998193|P2|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa group within 30 days of treatment discontinuation|291
406839|NCT00099268|998194|P1|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa/entacapone group within 30 days of treatment discontinuation|282
406840|NCT00099268|998193|P2|Intent-to-Treat|Overall Study||372
406841|NCT00099268|998194|P1|Intent-to-Treat|Overall Study|One patient from each group discontinued without receiving a single dose of study drug.|373
406842|NCT00099268|998193|P2|STARTED|Overall Study||373
406843|NCT00099268|998194|P1|STARTED|Overall Study||374
406844|NCT00099047|998212|P2|NOT COMPLETED|Overall Study||0
406845|NCT00099047|998213|P1|NOT COMPLETED|Overall Study||0
406846|NCT00099047|998212|P2|COMPLETED|Overall Study||12
406847|NCT00099047|998213|P1|COMPLETED|Overall Study||11
406848|NCT00099047|998212|P2|STARTED|Overall Study||12
406849|NCT00099047|998213|P1|STARTED|Overall Study||11
406850|NCT00099021|998219|P1|NOT COMPLETED|Overall Study||0
406851|NCT00099021|998219|P1|COMPLETED|Overall Study||21
406852|NCT00099021|998219|P1|STARTED|Overall Study||21
406853|NCT00098956|998225|P1|NOT COMPLETED|Overall Study||0
406854|NCT00098956|998225|P1|COMPLETED|Overall Study||19
406855|NCT00098956|998225|P1|STARTED|Overall Study||19
406856|NCT00098865|998234|P1|NOT COMPLETED|Overall Study||9
406857|NCT00098865|998234|P1|COMPLETED|Overall Study||6
406858|NCT00098865|998234|P1|STARTED|Overall Study||15
406859|NCT00098839|998242|P2|NOT COMPLETED|Overall Study||33
406860|NCT00098839|998243|P1|NOT COMPLETED|Overall Study||32
406861|NCT00098839|998242|P2|COMPLETED|Overall Study||27
406862|NCT00098839|998243|P1|COMPLETED|Overall Study||24
406863|NCT00098839|998242|P2|STARTED|Overall Study||60
406864|NCT00098839|998243|P1|STARTED|Overall Study||56
406865|NCT00098813|998254|P1|NOT COMPLETED|Overall Study||19
406866|NCT00098813|998254|P1|COMPLETED|Overall Study||1
406867|NCT00098813|998254|P1|STARTED|Overall Study||20
406868|NCT00098787|998261|P3|NOT COMPLETED|Overall Study||63
406869|NCT00098787|998262|P2|NOT COMPLETED|Overall Study||75
406870|NCT00098787|998263|P1|NOT COMPLETED|Overall Study||73
406871|NCT00098787|998261|P3|COMPLETED|Overall Study||0
406872|NCT00098787|998262|P2|COMPLETED|Overall Study||0
406873|NCT00098787|998263|P1|COMPLETED|Overall Study||0
406874|NCT00098787|998261|P3|Eligible and Treated|Overall Study||59
406875|NCT00098787|998262|P2|Eligible and Treated|Overall Study||66
406876|NCT00098787|998263|P1|Eligible and Treated|Overall Study||61
406877|NCT00098787|998261|P3|Treated|Overall Study||62
406878|NCT00098787|998262|P2|Treated|Overall Study||73
406879|NCT00098787|998263|P1|Treated|Overall Study||70
406880|NCT00098787|998261|P3|STARTED|Overall Study||63
406881|NCT00098787|998262|P2|STARTED|Overall Study||75
406882|NCT00098787|998263|P1|STARTED|Overall Study||73
406883|NCT00098774|998277|P1|NOT COMPLETED|Overall Study||18
406884|NCT00098774|998277|P1|COMPLETED|Overall Study||26
406885|NCT00098774|998277|P1|STARTED|Overall Study||44
406886|NCT00098748|998287|P3|NOT COMPLETED|Continued on Open-Label Treatment||0
406887|NCT00098748|998288|P2|NOT COMPLETED|Continued on Open-Label Treatment||15
406888|NCT00098748|998289|P1|NOT COMPLETED|Continued on Open-Label Treatment||8
406889|NCT00098748|998287|P3|COMPLETED|Continued on Open-Label Treatment||0
406890|NCT00098748|998288|P2|COMPLETED|Continued on Open-Label Treatment||10
406891|NCT00098748|998289|P1|COMPLETED|Continued on Open-Label Treatment||7
406892|NCT00098748|998287|P3|STARTED|Continued on Open-Label Treatment|Placebo group not offered open-label maraviroc due to study not reaching primary endpoint at Week 24|0
406893|NCT00098748|998288|P2|STARTED|Continued on Open-Label Treatment||25
406894|NCT00098748|998289|P1|STARTED|Continued on Open-Label Treatment||15
406895|NCT00098748|998287|P3|NOT COMPLETED|Received Study Treatment||44
406896|NCT00098748|998288|P2|NOT COMPLETED|Received Study Treatment||36
406897|NCT00098748|998289|P1|NOT COMPLETED|Received Study Treatment||48
406898|NCT00098748|998287|P3|COMPLETED|Received Study Treatment||18
406899|NCT00098748|998288|P2|COMPLETED|Received Study Treatment||25
406900|NCT00098748|998289|P1|COMPLETED|Received Study Treatment||15
406901|NCT00098748|998287|P3|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||58
406902|NCT00098748|998288|P2|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||52
406903|NCT00098748|998289|P1|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment|Dual-tropic: Virus capable of using both CCR5 and CXCR4 coreceptors for cell entry.|57
406904|NCT00098748|998287|P3|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, Placebo = 61 subjects in Adverse event tables.|62
406905|NCT00098748|998288|P2|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, BID = 62 subjects in Adverse event tables.|61
406906|NCT00098748|998289|P1|STARTED|Received Study Treatment||63
406907|NCT00098748|998287|P3|NOT COMPLETED|Assigned to Study Treatment||2
406908|NCT00098748|998288|P2|NOT COMPLETED|Assigned to Study Treatment||2
406909|NCT00098748|998289|P1|NOT COMPLETED|Assigned to Study Treatment||0
406910|NCT00098748|998287|P3|COMPLETED|Assigned to Study Treatment||62
406911|NCT00098748|998288|P2|COMPLETED|Assigned to Study Treatment||61
406912|NCT00098748|998289|P1|COMPLETED|Assigned to Study Treatment||63
406913|NCT00098748|998287|P3|STARTED|Assigned to Study Treatment||64
406914|NCT00098748|998288|P2|STARTED|Assigned to Study Treatment||63
406915|NCT00098748|998289|P1|STARTED|Assigned to Study Treatment||63
406916|NCT00098722|998345|P7|NOT COMPLETED|Observation Phase||17
406917|NCT00098722|998346|P6|NOT COMPLETED|Observation Phase||45
406918|NCT00098722|998347|P5|NOT COMPLETED|Observation Phase||0
406919|NCT00098722|998348|P4|NOT COMPLETED|Observation Phase||0
406920|NCT00098722|998349|P3|NOT COMPLETED|Observation Phase||0
406921|NCT00098722|998350|P2|NOT COMPLETED|Observation Phase||0
406922|NCT00098722|998351|P1|NOT COMPLETED|Observation Phase||0
406923|NCT00098722|998345|P7|COMPLETED|Observation Phase||48
406924|NCT00098722|998346|P6|COMPLETED|Observation Phase||160
406925|NCT00098722|998347|P5|COMPLETED|Observation Phase||0
406926|NCT00098722|998348|P4|COMPLETED|Observation Phase||0
406927|NCT00098722|998349|P3|COMPLETED|Observation Phase||0
406928|NCT00098722|998350|P2|COMPLETED|Observation Phase||0
406929|NCT00098722|998351|P1|COMPLETED|Observation Phase||0
406930|NCT00098722|998345|P7|STARTED|Observation Phase||65
406931|NCT00098722|998346|P6|STARTED|Observation Phase||205
406932|NCT00098722|998347|P5|STARTED|Observation Phase||0
406933|NCT00098722|998348|P4|STARTED|Observation Phase||0
406934|NCT00098722|998349|P3|STARTED|Observation Phase||0
406935|NCT00098722|998350|P2|STARTED|Observation Phase||0
406936|NCT00098722|998351|P1|STARTED|Observation Phase||0
406937|NCT00098722|998345|P7|NOT COMPLETED|Open Label Phase||0
406938|NCT00098722|998346|P6|NOT COMPLETED|Open Label Phase||0
406939|NCT00098722|998347|P5|NOT COMPLETED|Open Label Phase||50
406940|NCT00098722|998348|P4|NOT COMPLETED|Open Label Phase||272
406941|NCT00098722|998349|P3|NOT COMPLETED|Open Label Phase||0
406942|NCT00098722|998350|P2|NOT COMPLETED|Open Label Phase||0
406943|NCT00098722|998351|P1|NOT COMPLETED|Open Label Phase||0
406944|NCT00098722|998345|P7|COMPLETED|Open Label Phase||0
406945|NCT00098722|998346|P6|COMPLETED|Open Label Phase||0
406946|NCT00098722|998347|P5|COMPLETED|Open Label Phase||0
406947|NCT00098722|998348|P4|COMPLETED|Open Label Phase||0
406948|NCT00098722|998349|P3|COMPLETED|Open Label Phase||0
406949|NCT00098722|998350|P2|COMPLETED|Open Label Phase||0
406950|NCT00098722|998351|P1|COMPLETED|Open Label Phase||0
406951|NCT00098722|998345|P7|STARTED|Open Label Phase||0
406952|NCT00098722|998346|P6|STARTED|Open Label Phase||0
406953|NCT00098722|998347|P5|STARTED|Open Label Phase||50
406954|NCT00098722|998348|P4|STARTED|Open Label Phase||272
406955|NCT00098722|998349|P3|STARTED|Open Label Phase||0
406956|NCT00098722|998350|P2|STARTED|Open Label Phase||0
406957|NCT00098722|998351|P1|STARTED|Open Label Phase||0
406958|NCT00098722|998345|P7|NOT COMPLETED|Double Blind Phase||0
406959|NCT00098722|998346|P6|NOT COMPLETED|Double Blind Phase||0
406960|NCT00098722|998347|P5|NOT COMPLETED|Double Blind Phase||0
406961|NCT00098722|998348|P4|NOT COMPLETED|Double Blind Phase||0
406962|NCT00098722|998349|P3|NOT COMPLETED|Double Blind Phase||94
406963|NCT00098722|998350|P2|NOT COMPLETED|Double Blind Phase||194
406964|NCT00098722|998351|P1|NOT COMPLETED|Double Blind Phase||186
406965|NCT00098722|998345|P7|COMPLETED|Double Blind Phase||0
406966|NCT00098722|998346|P6|COMPLETED|Double Blind Phase||0
406967|NCT00098722|998347|P5|COMPLETED|Double Blind Phase||0
406968|NCT00098722|998348|P4|COMPLETED|Double Blind Phase||0
406969|NCT00098722|998349|P3|COMPLETED|Double Blind Phase||0
406970|NCT00098722|998350|P2|COMPLETED|Double Blind Phase||0
406971|NCT00098722|998351|P1|COMPLETED|Double Blind Phase||0
406972|NCT00098722|998345|P7|Treated|Double Blind Phase||0
406973|NCT00098722|998346|P6|Treated|Double Blind Phase||0
406974|NCT00098722|998347|P5|Treated|Double Blind Phase||0
406975|NCT00098722|998348|P4|Treated|Double Blind Phase||0
406976|NCT00098722|998349|P3|Treated|Double Blind Phase||91
406977|NCT00098722|998350|P2|Treated|Double Blind Phase||191
406978|NCT00098722|998351|P1|Treated|Double Blind Phase||182
406979|NCT00098722|998345|P7|STARTED|Double Blind Phase||0
406980|NCT00098722|998346|P6|STARTED|Double Blind Phase||0
406981|NCT00098722|998347|P5|STARTED|Double Blind Phase||0
406982|NCT00098722|998348|P4|STARTED|Double Blind Phase||0
406983|NCT00098722|998349|P3|STARTED|Double Blind Phase||94
406984|NCT00098722|998350|P2|STARTED|Double Blind Phase||194
406985|NCT00098722|998351|P1|STARTED|Double Blind Phase||186
406986|NCT00098670|998414|P1|NOT COMPLETED|Overall Study||0
406987|NCT00098670|998414|P1|COMPLETED|Overall Study||102
406988|NCT00098670|998414|P1|STARTED|Overall Study||102
406989|NCT00098475|998425|P4|NOT COMPLETED|Step 2||0
406990|NCT00098475|998426|P3|NOT COMPLETED|Step 2||0
406991|NCT00098475|998427|P2|NOT COMPLETED|Step 2||10
406992|NCT00098475|998428|P1|NOT COMPLETED|Step 2||5
406993|NCT00098475|998425|P4|COMPLETED|Step 2||0
406994|NCT00098475|998426|P3|COMPLETED|Step 2||0
406995|NCT00098475|998427|P2|COMPLETED|Step 2||5
406996|NCT00098475|998428|P1|COMPLETED|Step 2||0
406997|NCT00098475|998425|P4|Eligible|Step 2||0
406998|NCT00098475|998426|P3|Eligible|Step 2||0
406999|NCT00098475|998427|P2|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|9
407000|NCT00098475|998428|P1|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|2
407001|NCT00098475|998425|P4|Treated|Step 2||0
407002|NCT00098475|998426|P3|Treated|Step 2||0
407003|NCT00098475|998427|P2|Treated|Step 2||14
407004|NCT00098475|998428|P1|Treated|Step 2||4
407005|NCT00098475|998425|P4|STARTED|Step 2||0
407006|NCT00098475|998426|P3|STARTED|Step 2||0
407007|NCT00098475|998427|P2|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|15
407008|NCT00098475|998428|P1|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|5
407009|NCT00098475|998425|P4|NOT COMPLETED|Step 1||3
407010|NCT00098475|998426|P3|NOT COMPLETED|Step 1||4
407011|NCT00098475|998427|P2|NOT COMPLETED|Step 1||173
407012|NCT00098475|998428|P1|NOT COMPLETED|Step 1||171
407013|NCT00098475|998425|P4|COMPLETED|Step 1||0
407014|NCT00098475|998426|P3|COMPLETED|Step 1||0
407015|NCT00098475|998427|P2|COMPLETED|Step 1||49
407016|NCT00098475|998428|P1|COMPLETED|Step 1||52
407017|NCT00098475|998425|P4|Eligible|Step 1||3
407018|NCT00098475|998426|P3|Eligible|Step 1||4
407019|NCT00098475|998427|P2|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|208
407020|NCT00098475|998428|P1|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|214
407021|NCT00098475|998425|P4|Treated|Step 1||3
407022|NCT00098475|998426|P3|Treated|Step 1||4
407023|NCT00098475|998427|P2|Treated|Step 1||220
407024|NCT00098475|998428|P1|Treated|Step 1||223
407025|NCT00098475|998425|P4|STARTED|Step 1||3
407026|NCT00098475|998426|P3|STARTED|Step 1||4
407027|NCT00098475|998427|P2|STARTED|Step 1||222
407028|NCT00098475|998428|P1|STARTED|Step 1||223
407029|NCT00098371|998440|P1|NOT COMPLETED|Overall Study||0
407030|NCT00098371|998440|P1|COMPLETED|Overall Study||64
407031|NCT00098371|998440|P1|STARTED|Overall Study||64
407032|NCT00098345|998465|P1|NOT COMPLETED|Overall Study||13
407033|NCT00098345|998465|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|17
407034|NCT00098345|998465|P1|STARTED|Overall Study||30
407035|NCT00098306|998478|P7|NOT COMPLETED|Observational Phase||26
407036|NCT00098306|998479|P6|NOT COMPLETED|Observational Phase||46
407037|NCT00098306|998480|P5|NOT COMPLETED|Observational Phase||0
407038|NCT00098306|998481|P4|NOT COMPLETED|Observational Phase||0
407039|NCT00098306|998482|P3|NOT COMPLETED|Observational Phase||0
407040|NCT00098306|998483|P2|NOT COMPLETED|Observational Phase||0
407041|NCT00098306|998484|P1|NOT COMPLETED|Observational Phase||0
407042|NCT00098306|998478|P7|COMPLETED|Observational Phase||55
407043|NCT00098306|998479|P6|COMPLETED|Observational Phase||204
407044|NCT00098306|998480|P5|COMPLETED|Observational Phase||0
407045|NCT00098306|998481|P4|COMPLETED|Observational Phase||0
407046|NCT00098306|998482|P3|COMPLETED|Observational Phase||0
407047|NCT00098306|998483|P2|COMPLETED|Observational Phase||0
407048|NCT00098306|998484|P1|COMPLETED|Observational Phase||0
407049|NCT00098306|998478|P7|STARTED|Observational Phase||81
407050|NCT00098306|998479|P6|STARTED|Observational Phase||250
407051|NCT00098306|998480|P5|STARTED|Observational Phase||0
407052|NCT00098306|998481|P4|STARTED|Observational Phase||0
407053|NCT00098306|998482|P3|STARTED|Observational Phase||0
407054|NCT00098306|998483|P2|STARTED|Observational Phase||0
407055|NCT00098306|998484|P1|STARTED|Observational Phase||0
407056|NCT00098306|998478|P7|NOT COMPLETED|Open Label||0
407057|NCT00098306|998479|P6|NOT COMPLETED|Open Label||0
407058|NCT00098306|998480|P5|NOT COMPLETED|Open Label||62
407059|NCT00098306|998481|P4|NOT COMPLETED|Open Label||327
407060|NCT00098306|998482|P3|NOT COMPLETED|Open Label||0
407061|NCT00098306|998483|P2|NOT COMPLETED|Open Label||0
407062|NCT00098306|998484|P1|NOT COMPLETED|Open Label||0
407063|NCT00098306|998478|P7|COMPLETED|Open Label||0
407064|NCT00098306|998479|P6|COMPLETED|Open Label||0
407065|NCT00098306|998480|P5|COMPLETED|Open Label||0
407066|NCT00098306|998481|P4|COMPLETED|Open Label||0
407067|NCT00098306|998482|P3|COMPLETED|Open Label||0
407068|NCT00098306|998483|P2|COMPLETED|Open Label||0
407069|NCT00098306|998484|P1|COMPLETED|Open Label||0
407070|NCT00098306|998478|P7|STARTED|Open Label||0
407071|NCT00098306|998479|P6|STARTED|Open Label||0
407072|NCT00098306|998480|P5|STARTED|Open Label||62
407073|NCT00098306|998481|P4|STARTED|Open Label||327
407074|NCT00098306|998482|P3|STARTED|Open Label||0
407075|NCT00098306|998483|P2|STARTED|Open Label||0
407076|NCT00098306|998484|P1|STARTED|Open Label||0
407077|NCT00098306|998478|P7|NOT COMPLETED|Double Blind||0
407078|NCT00098306|998479|P6|NOT COMPLETED|Double Blind||0
407079|NCT00098306|998480|P5|NOT COMPLETED|Double Blind||0
407080|NCT00098306|998481|P4|NOT COMPLETED|Double Blind||0
407081|NCT00098306|998482|P3|NOT COMPLETED|Double Blind||120
407082|NCT00098306|998483|P2|NOT COMPLETED|Double Blind||240
407083|NCT00098306|998484|P1|NOT COMPLETED|Double Blind||241
407084|NCT00098306|998478|P7|COMPLETED|Double Blind||0
407085|NCT00098306|998479|P6|COMPLETED|Double Blind||0
407086|NCT00098306|998480|P5|COMPLETED|Double Blind||0
407087|NCT00098306|998481|P4|COMPLETED|Double Blind||0
407088|NCT00098306|998482|P3|COMPLETED|Double Blind||0
407089|NCT00098306|998483|P2|COMPLETED|Double Blind||0
407090|NCT00098306|998484|P1|COMPLETED|Double Blind||0
407091|NCT00098306|998478|P7|Treated|Double Blind||0
407092|NCT00098306|998479|P6|Treated|Double Blind||0
407093|NCT00098306|998480|P5|Treated|Double Blind||0
407094|NCT00098306|998481|P4|Treated|Double Blind||0
407095|NCT00098306|998482|P3|Treated|Double Blind||118
407096|NCT00098306|998483|P2|Treated|Double Blind||235
407097|NCT00098306|998484|P1|Treated|Double Blind||232
407098|NCT00098306|998478|P7|STARTED|Double Blind||0
407099|NCT00098306|998479|P6|STARTED|Double Blind||0
407100|NCT00098306|998480|P5|STARTED|Double Blind||0
407101|NCT00098306|998481|P4|STARTED|Double Blind||0
407102|NCT00098306|998482|P3|STARTED|Double Blind||120
407103|NCT00098306|998483|P2|STARTED|Double Blind||240
407104|NCT00098306|998484|P1|STARTED|Double Blind||241
407105|NCT00098293|998550|P5|NOT COMPLETED|Supplemental Phase (SP)||33
407106|NCT00098293|998551|P4|NOT COMPLETED|Supplemental Phase (SP)||0
407107|NCT00098293|998552|P3|NOT COMPLETED|Supplemental Phase (SP)||0
407108|NCT00098293|998553|P2|NOT COMPLETED|Supplemental Phase (SP)||0
407109|NCT00098293|998554|P1|NOT COMPLETED|Supplemental Phase (SP)||0
407110|NCT00098293|998550|P5|COMPLETED|Supplemental Phase (SP)||94
407111|NCT00098293|998551|P4|COMPLETED|Supplemental Phase (SP)||0
407112|NCT00098293|998552|P3|COMPLETED|Supplemental Phase (SP)||0
407113|NCT00098293|998553|P2|COMPLETED|Supplemental Phase (SP)||0
407114|NCT00098293|998554|P1|COMPLETED|Supplemental Phase (SP)||0
407115|NCT00098293|998550|P5|STARTED|Supplemental Phase (SP)||127
407116|NCT00098293|998551|P4|STARTED|Supplemental Phase (SP)||0
407117|NCT00098293|998552|P3|STARTED|Supplemental Phase (SP)||0
407118|NCT00098293|998553|P2|STARTED|Supplemental Phase (SP)||0
407119|NCT00098293|998554|P1|STARTED|Supplemental Phase (SP)||0
407120|NCT00098293|998550|P5|NOT COMPLETED|Open-label (OL) Phase||0
407121|NCT00098293|998551|P4|NOT COMPLETED|Open-label (OL) Phase||65
407122|NCT00098293|998552|P3|NOT COMPLETED|Open-label (OL) Phase||41
407123|NCT00098293|998553|P2|NOT COMPLETED|Open-label (OL) Phase||25
407124|NCT00098293|998554|P1|NOT COMPLETED|Open-label (OL) Phase||0
407125|NCT00098293|998550|P5|COMPLETED|Open-label (OL) Phase||0
407126|NCT00098293|998551|P4|COMPLETED|Open-label (OL) Phase||65
407127|NCT00098293|998552|P3|COMPLETED|Open-label (OL) Phase||158
407128|NCT00098293|998553|P2|COMPLETED|Open-label (OL) Phase||177
407129|NCT00098293|998554|P1|COMPLETED|Open-label (OL) Phase||0
407130|NCT00098293|998550|P5|STARTED|Open-label (OL) Phase||0
407131|NCT00098293|998551|P4|STARTED|Open-label (OL) Phase||130
407132|NCT00098293|998552|P3|STARTED|Open-label (OL) Phase||199
407133|NCT00098293|998553|P2|STARTED|Open-label (OL) Phase||202
407134|NCT00098293|998554|P1|STARTED|Open-label (OL) Phase||0
407135|NCT00098293|998550|P5|NOT COMPLETED|Between DB and OL Phase||0
407136|NCT00098293|998551|P4|NOT COMPLETED|Between DB and OL Phase||0
407137|NCT00098293|998552|P3|NOT COMPLETED|Between DB and OL Phase||3
407138|NCT00098293|998553|P2|NOT COMPLETED|Between DB and OL Phase||0
407139|NCT00098293|998554|P1|NOT COMPLETED|Between DB and OL Phase||0
407140|NCT00098293|998550|P5|COMPLETED|Between DB and OL Phase||0
407141|NCT00098293|998551|P4|COMPLETED|Between DB and OL Phase||0
407142|NCT00098293|998552|P3|COMPLETED|Between DB and OL Phase||199
407143|NCT00098293|998553|P2|COMPLETED|Between DB and OL Phase||202
407144|NCT00098293|998554|P1|COMPLETED|Between DB and OL Phase||0
407145|NCT00098293|998550|P5|STARTED|Between DB and OL Phase||0
407146|NCT00098293|998551|P4|STARTED|Between DB and OL Phase||0
407147|NCT00098293|998552|P3|STARTED|Between DB and OL Phase||202
407148|NCT00098293|998553|P2|STARTED|Between DB and OL Phase||202
407149|NCT00098293|998554|P1|STARTED|Between DB and OL Phase||0
407150|NCT00098293|998550|P5|NOT COMPLETED|Double-blind (DB) Phase||0
407151|NCT00098293|998551|P4|NOT COMPLETED|Double-blind (DB) Phase||0
407152|NCT00098293|998552|P3|NOT COMPLETED|Double-blind (DB) Phase||170
407153|NCT00098293|998553|P2|NOT COMPLETED|Double-blind (DB) Phase||166
407154|NCT00098293|998554|P1|NOT COMPLETED|Double-blind (DB) Phase||177
407155|NCT00098293|998550|P5|COMPLETED|Double-blind (DB) Phase||0
407156|NCT00098293|998551|P4|COMPLETED|Double-blind (DB) Phase||0
407157|NCT00098293|998552|P3|COMPLETED|Double-blind (DB) Phase||202
407158|NCT00098293|998553|P2|COMPLETED|Double-blind (DB) Phase||202
407159|NCT00098293|998554|P1|COMPLETED|Double-blind (DB) Phase||0
407160|NCT00098293|998550|P5|Treated|Double-blind (DB) Phase||0
407161|NCT00098293|998551|P4|Treated|Double-blind (DB) Phase||0
407162|NCT00098293|998552|P3|Treated|Double-blind (DB) Phase||361
407163|NCT00098293|998553|P2|Treated|Double-blind (DB) Phase||360
407164|NCT00098293|998554|P1|Treated|Double-blind (DB) Phase||174
407165|NCT00098293|998550|P5|STARTED|Double-blind (DB) Phase||0
407166|NCT00098293|998551|P4|STARTED|Double-blind (DB) Phase||0
407167|NCT00098293|998552|P3|STARTED|Double-blind (DB) Phase||372
407168|NCT00098293|998553|P2|STARTED|Double-blind (DB) Phase||368
407169|NCT00098293|998554|P1|STARTED|Double-blind (DB) Phase||177
407170|NCT00098254|998607|P1|NOT COMPLETED|Overall Study||3
407171|NCT00098254|998607|P1|COMPLETED|Overall Study||34
407172|NCT00098254|998607|P1|STARTED|Overall Study||37
407173|NCT00098059|998628|P2|NOT COMPLETED|Overall Study||1
407174|NCT00098059|998629|P1|NOT COMPLETED|Overall Study||0
407175|NCT00098059|998628|P2|COMPLETED|Overall Study||46
407176|NCT00098059|998629|P1|COMPLETED|Overall Study||27
407177|NCT00098059|998628|P2|STARTED|Overall Study||47
407178|NCT00098059|998629|P1|STARTED|Overall Study||27
407179|NCT00098020|998673|P1|NOT COMPLETED|Overall Study||6
407180|NCT00098020|998673|P1|COMPLETED|Overall Study||6
407181|NCT00098020|998673|P1|Started Isotretinoin|Overall Study||8
407182|NCT00098020|998673|P1|STARTED|Overall Study||12
407183|NCT00097981|998680|P2|NOT COMPLETED|Overall Study||100
407184|NCT00097981|998681|P1|NOT COMPLETED|Overall Study||106
407185|NCT00097981|998680|P2|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|12
407186|NCT00097981|998681|P1|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|7
407187|NCT00097981|998680|P2|Received Study Medication|Overall Study||106
407188|NCT00097981|998681|P1|Received Study Medication|Overall Study||110
407189|NCT00097981|998680|P2|STARTED|Overall Study|Enrollment at randomization|112
407190|NCT00097981|998681|P1|STARTED|Overall Study|Enrollment at randomization|113
407191|NCT00097786|998703|P4|NOT COMPLETED|Overall Study||310
407192|NCT00097786|998704|P3|NOT COMPLETED|Overall Study||313
407193|NCT00097786|998705|P2|NOT COMPLETED|Overall Study||292
407194|NCT00097786|998706|P1|NOT COMPLETED|Overall Study||296
407195|NCT00097786|998703|P4|COMPLETED|Overall Study||2036
407196|NCT00097786|998704|P3|COMPLETED|Overall Study||2016
407197|NCT00097786|998705|P2|COMPLETED|Overall Study||2023
407198|NCT00097786|998706|P1|COMPLETED|Overall Study|"Completed means completed follow up for all cause death."|2020
407199|NCT00097786|998703|P4|Complete Follow-up for Core CV EPs|Overall Study||1988
407200|NCT00097786|998704|P3|Complete Follow-up for Core CV EPs|Overall Study||1966
407201|NCT00097786|998705|P2|Complete Follow-up for Core CV EPs|Overall Study||1963
407202|NCT00097786|998706|P1|Complete Follow-up for Core CV EPs|Overall Study||1948
407203|NCT00097786|998703|P4|Complete Follow-up for Extended CV EPs|Overall Study||2015
407204|NCT00097786|998704|P3|Complete Follow-up for Extended CV EPs|Overall Study||1987
407205|NCT00097786|998705|P2|Complete Follow-up for Extended CV EPs|Overall Study||1985
407206|NCT00097786|998706|P1|Complete Follow-up for Extended CV EPs|Overall Study||1969
407207|NCT00097786|998703|P4|Complete FU for Progression to Diabetes|Overall Study||1762
407208|NCT00097786|998704|P3|Complete FU for Progression to Diabetes|Overall Study||1734
407209|NCT00097786|998705|P2|Complete FU for Progression to Diabetes|Overall Study||1712
407210|NCT00097786|998706|P1|Complete FU for Progression to Diabetes|Overall Study||1709
407211|NCT00097786|998703|P4|STARTED|Overall Study||2346
407212|NCT00097786|998704|P3|STARTED|Overall Study||2329
407213|NCT00097786|998705|P2|STARTED|Overall Study||2315
407214|NCT00097786|998706|P1|STARTED|Overall Study|"Started indicates Full Analysis Set (FAS) population. Initially enrolled 9518, 212 excluded."|2316
407215|NCT00097773|998728|P4|NOT COMPLETED|Overall Study||3
407216|NCT00097773|998729|P3|NOT COMPLETED|Overall Study||8
407217|NCT00097773|998730|P2|NOT COMPLETED|Overall Study||8
407218|NCT00097773|998731|P1|NOT COMPLETED|Overall Study||8
407219|NCT00097773|998728|P4|COMPLETED|Overall Study||73
407220|NCT00097773|998729|P3|COMPLETED|Overall Study||68
407221|NCT00097773|998730|P2|COMPLETED|Overall Study||68
407222|NCT00097773|998731|P1|COMPLETED|Overall Study||68
407223|NCT00097773|998728|P4|STARTED|Overall Study||76
407224|NCT00097773|998729|P3|STARTED|Overall Study||76
407225|NCT00097773|998730|P2|STARTED|Overall Study||76
407226|NCT00097773|998731|P1|STARTED|Overall Study||76
407227|NCT00097721|998751|P2|NOT COMPLETED|Overall Study||33
407228|NCT00097721|998752|P1|NOT COMPLETED|Overall Study||71
407229|NCT00097721|998751|P2|COMPLETED|Overall Study||0
407230|NCT00097721|998752|P1|COMPLETED|Overall Study||0
407231|NCT00097721|998751|P2|STARTED|Overall Study||33
407232|NCT00097721|998752|P1|STARTED|Overall Study|The number started is all enrolled subjects.BL Characteristics consists of Safety Population.|71
407233|NCT00097708|998769|P3|NOT COMPLETED|Overall Study||65
407234|NCT00097708|998770|P2|NOT COMPLETED|Overall Study||56
407235|NCT00097708|998771|P1|NOT COMPLETED|Overall Study||64
407236|NCT00097708|998769|P3|COMPLETED|Overall Study||97
407237|NCT00097708|998770|P2|COMPLETED|Overall Study||120
407238|NCT00097708|998771|P1|COMPLETED|Overall Study||109
407239|NCT00097708|998769|P3|Treated|Overall Study||160
407240|NCT00097708|998770|P2|Treated|Overall Study||176
407241|NCT00097708|998771|P1|Treated|Overall Study||171
407242|NCT00097708|998769|P3|Intent-to-Treat (ITT)|Overall Study||149
407243|NCT00097708|998770|P2|Intent-to-Treat (ITT)|Overall Study||169
407244|NCT00097708|998771|P1|Intent-to-Treat (ITT)|Overall Study||165
407245|NCT00097708|998769|P3|STARTED|Overall Study||162
407246|NCT00097708|998770|P2|STARTED|Overall Study||176
407247|NCT00097708|998771|P1|STARTED|Overall Study||173
407248|NCT00097695|998783|P4|NOT COMPLETED|The Open Label Extension (OLE) Phase||5
407249|NCT00097695|998784|P3|NOT COMPLETED|The Open Label Extension (OLE) Phase||2
407250|NCT00097695|998785|P2|NOT COMPLETED|The Open Label Extension (OLE) Phase||15
407251|NCT00097695|998786|P1|NOT COMPLETED|The Open Label Extension (OLE) Phase||13
407252|NCT00097695|998783|P4|COMPLETED|The Open Label Extension (OLE) Phase||15
407253|NCT00097695|998784|P3|COMPLETED|The Open Label Extension (OLE) Phase||1
407254|NCT00097695|998785|P2|COMPLETED|The Open Label Extension (OLE) Phase||11
407255|NCT00097695|998786|P1|COMPLETED|The Open Label Extension (OLE) Phase||10
407256|NCT00097695|998783|P4|STARTED|The Open Label Extension (OLE) Phase||20
407257|NCT00097695|998784|P3|STARTED|The Open Label Extension (OLE) Phase||3
407258|NCT00097695|998785|P2|STARTED|The Open Label Extension (OLE) Phase||26
407259|NCT00097695|998786|P1|STARTED|The Open Label Extension (OLE) Phase||23
407260|NCT00097695|998783|P4|NOT COMPLETED|The Controlled Phase||20
407261|NCT00097695|998784|P3|NOT COMPLETED|The Controlled Phase||5
407262|NCT00097695|998785|P2|NOT COMPLETED|The Controlled Phase||3
407263|NCT00097695|998786|P1|NOT COMPLETED|The Controlled Phase||4
407264|NCT00097695|998783|P4|COMPLETED|The Controlled Phase|Patients screened and found eligible but did not have HAE attack or attack was not severe enough|0
407265|NCT00097695|998784|P3|COMPLETED|The Controlled Phase||3
407266|NCT00097695|998785|P2|COMPLETED|The Controlled Phase||26
407267|NCT00097695|998786|P1|COMPLETED|The Controlled Phase||23
407268|NCT00097695|998783|P4|STARTED|The Controlled Phase||20
407269|NCT00097695|998784|P3|STARTED|The Controlled Phase||8
407270|NCT00097695|998785|P2|STARTED|The Controlled Phase||29
407271|NCT00097695|998786|P1|STARTED|The Controlled Phase||27
407272|NCT00097591|998802|P2|NOT COMPLETED|Overall Study||394
407273|NCT00097591|998803|P1|NOT COMPLETED|Overall Study||410
407274|NCT00097591|998802|P2|COMPLETED|Overall Study||6401
407275|NCT00097591|998803|P1|COMPLETED|Overall Study||6403
407276|NCT00097591|998802|P2|STARTED|Overall Study|4 subjects randomized but not analyzed due to an incomplete informed consent document|6795
407277|NCT00097591|998803|P1|STARTED|Overall Study|7 subjects randomized but not analyzed due to an incomplete informed consent document|6813
407278|NCT00097539|998826|P7|NOT COMPLETED|Overall Study||171
407279|NCT00097539|998827|P6|NOT COMPLETED|Overall Study||5892
407280|NCT00097539|998828|P5|NOT COMPLETED|Overall Study||1758
407281|NCT00097539|998829|P4|NOT COMPLETED|Overall Study||3585
407282|NCT00097539|998830|P3|NOT COMPLETED|Overall Study||9108
407283|NCT00097539|998831|P2|NOT COMPLETED|Overall Study||6531
407284|NCT00097539|998832|P1|NOT COMPLETED|Overall Study||19066
407285|NCT00097539|998826|P7|COMPLETED|Overall Study||68
407286|NCT00097539|998827|P6|COMPLETED|Overall Study||2118
407287|NCT00097539|998828|P5|COMPLETED|Overall Study||386
407288|NCT00097539|998829|P4|COMPLETED|Overall Study||2066
407289|NCT00097539|998830|P3|COMPLETED|Overall Study||3411
407290|NCT00097539|998831|P2|COMPLETED|Overall Study||2825
407291|NCT00097539|998832|P1|COMPLETED|Overall Study||8220
407292|NCT00097539|998826|P7|STARTED|Overall Study||239
407293|NCT00097539|998827|P6|STARTED|Overall Study||8010
407294|NCT00097539|998828|P5|STARTED|Overall Study||2144
407295|NCT00097539|998829|P4|STARTED|Overall Study||5651
407296|NCT00097539|998830|P3|STARTED|Overall Study||12519
407297|NCT00097539|998831|P2|STARTED|Overall Study||9356
407298|NCT00097539|998832|P1|STARTED|Overall Study||27286
407299|NCT00097500|998878|P2|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||4
407300|NCT00097500|998879|P1|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||5
407301|NCT00097500|998878|P2|COMPLETED|Off-drug Period (Week 52 to Week 64)||26
407302|NCT00097500|998879|P1|COMPLETED|Off-drug Period (Week 52 to Week 64)||25
407303|NCT00097500|998878|P2|STARTED|Off-drug Period (Week 52 to Week 64)|Insulin Glargine is discontinued, metformin is continued|30
407304|NCT00097500|998879|P1|STARTED|Off-drug Period (Week 52 to Week 64)|Exenatide is discontinued, metformin is continued|30
407305|NCT00097500|998878|P2|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||3
407306|NCT00097500|998879|P1|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||6
407307|NCT00097500|998878|P2|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
407308|NCT00097500|998879|P1|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
407309|NCT00097500|998878|P2|STARTED|On-drug Period (Week 0 to Week 52)||33
407310|NCT00097500|998879|P1|STARTED|On-drug Period (Week 0 to Week 52)||36
407311|NCT00097448|998903|P2|NOT COMPLETED|Overall Study||1
407312|NCT00097448|998904|P1|NOT COMPLETED|Overall Study||4
407313|NCT00097448|998903|P2|COMPLETED|Overall Study||129
407314|NCT00097448|998904|P1|COMPLETED|Overall Study||121
407315|NCT00097448|998903|P2|STARTED|Overall Study||130
407316|NCT00097448|998904|P1|STARTED|Overall Study||125
407317|NCT00097370|998910|P1|NOT COMPLETED|Stage 3||59
407318|NCT00097370|998910|P1|COMPLETED|Stage 3||0
407319|NCT00097370|998910|P1|STARTED|Stage 3|Participants continued from Stage 2.|59
407320|NCT00097370|998910|P1|NOT COMPLETED|Stage 2||13
407321|NCT00097370|998910|P1|COMPLETED|Stage 2||59
407322|NCT00097370|998910|P1|STARTED|Stage 2|41 participants entered from study MHE100185 and 31 participants continued from Stage 1.|72
407323|NCT00097370|998910|P1|NOT COMPLETED|Stage 1||6
407324|NCT00097370|998910|P1|COMPLETED|Stage 1||31
407325|NCT00097370|998910|P1|STARTED|Stage 1|Participants entered from study MHE100185.|37
407326|NCT00097253|998927|P1|NOT COMPLETED|Water (Control)||0
407327|NCT00097253|998927|P1|COMPLETED|Water (Control)||56
407328|NCT00097253|998927|P1|STARTED|Water (Control)||56
407329|NCT00097253|998927|P1|NOT COMPLETED|Lemon||0
407330|NCT00097253|998927|P1|COMPLETED|Lemon||56
407331|NCT00097253|998927|P1|STARTED|Lemon||56
407332|NCT00097253|998927|P1|NOT COMPLETED|Lavender||0
407333|NCT00097253|998927|P1|COMPLETED|Lavender||56
407334|NCT00097253|998927|P1|STARTED|Lavender||56
407335|NCT00096993|998944|P2|NOT COMPLETED|Overall Study||65
407336|NCT00096993|998945|P1|NOT COMPLETED|Overall Study||65
407337|NCT00096993|998944|P2|COMPLETED|Overall Study||0
407338|NCT00096993|998945|P1|COMPLETED|Overall Study||1
407339|NCT00096993|998944|P2|STARTED|Overall Study||65
407340|NCT00096993|998945|P1|STARTED|Overall Study||66
407341|NCT00096954|998961|P2|NOT COMPLETED|Overall Study||20
407342|NCT00096954|998962|P1|NOT COMPLETED|Overall Study||24
407343|NCT00096954|998961|P2|COMPLETED|Overall Study||154
407344|NCT00096954|998962|P1|COMPLETED|Overall Study||135
407345|NCT00096954|998961|P2|Received Study Drug|Overall Study||171
407346|NCT00096954|998962|P1|Received Study Drug|Overall Study||157
407347|NCT00096954|998961|P2|STARTED|Overall Study||174
407348|NCT00096954|998962|P1|STARTED|Overall Study||159
407349|NCT00096941|998974|P1|NOT COMPLETED|Overall Study||3
407350|NCT00096941|998974|P1|COMPLETED|Overall Study||0
407351|NCT00096941|998974|P1|STARTED|Overall Study||3
407352|NCT00096785|998981|P2|NOT COMPLETED|Overall Study||1
407353|NCT00096785|998982|P1|NOT COMPLETED|Overall Study||2
407354|NCT00096785|998981|P2|COMPLETED|Overall Study|As randomized cohort|33
407355|NCT00096785|998982|P1|COMPLETED|Overall Study|As randomized cohort|33
407356|NCT00096785|998981|P2|As-Treated Population|Overall Study||33
407357|NCT00096785|998982|P1|As-Treated Population|Overall Study||36
407358|NCT00096785|998981|P2|As-Randomized Population|Overall Study||34
407359|NCT00096785|998982|P1|As-Randomized Population|Overall Study||35
407360|NCT00096785|998981|P2|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 34; as treated=33)|34
407361|NCT00096785|998982|P1|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 35; as treated=36)|35
407362|NCT00096681|999006|P1|NOT COMPLETED|Overall Study||0
407363|NCT00096681|999006|P1|COMPLETED|Overall Study||762
407364|NCT00096681|999006|P1|STARTED|Overall Study||762
407365|NCT00096538|999011|P1|NOT COMPLETED|Overall Study||1
407366|NCT00096538|999011|P1|COMPLETED|Overall Study||5
407367|NCT00096538|999011|P1|STARTED|Overall Study||6
407368|NCT00096486|999019|P4|NOT COMPLETED|Overall Study||2
407369|NCT00096486|999020|P3|NOT COMPLETED|Overall Study||2
407370|NCT00096486|999021|P2|NOT COMPLETED|Overall Study||0
407371|NCT00096486|999022|P1|NOT COMPLETED|Overall Study||0
407372|NCT00096486|999019|P4|COMPLETED|Overall Study||36
407373|NCT00096486|999020|P3|COMPLETED|Overall Study||24
407374|NCT00096486|999021|P2|COMPLETED|Overall Study||6
407375|NCT00096486|999022|P1|COMPLETED|Overall Study||4
407376|NCT00096486|999019|P4|STARTED|Overall Study||38
407377|NCT00096486|999020|P3|STARTED|Overall Study||26
407378|NCT00096486|999021|P2|STARTED|Overall Study||6
407379|NCT00096486|999022|P1|STARTED|Overall Study||4
407380|NCT00096460|999034|P2|NOT COMPLETED|Overall Study||1
407381|NCT00096460|999035|P1|NOT COMPLETED|Overall Study||7
407382|NCT00096460|999034|P2|COMPLETED|Overall Study||7
407383|NCT00096460|999035|P1|COMPLETED|Overall Study||15
407384|NCT00096460|999034|P2|STARTED|Overall Study||8
407385|NCT00096460|999035|P1|STARTED|Overall Study||22
407386|NCT00096447|999041|P1|NOT COMPLETED|Overall Study||1
407387|NCT00096447|999041|P1|COMPLETED|Overall Study|Eligible and treated patients.|30
407388|NCT00096447|999041|P1|STARTED|Overall Study||31
407389|NCT00096382|999057|P2|NOT COMPLETED|Overall Study||0
407390|NCT00096382|999058|P1|NOT COMPLETED|Overall Study||2
407391|NCT00096382|999057|P2|COMPLETED|Overall Study||3
407392|NCT00096382|999058|P1|COMPLETED|Overall Study||21
407393|NCT00096382|999057|P2|STARTED|Overall Study||3
407394|NCT00096382|999058|P1|STARTED|Overall Study||23
407395|NCT00096356|999068|P2|NOT COMPLETED|Overall Study||53
407396|NCT00096356|999069|P1|NOT COMPLETED|Overall Study||44
407397|NCT00096356|999068|P2|COMPLETED|Overall Study||61
407398|NCT00096356|999069|P1|COMPLETED|Overall Study||78
407399|NCT00096356|999068|P2|STARTED|Overall Study||114
407400|NCT00096356|999069|P1|STARTED|Overall Study||122
407401|NCT00096278|999081|P2|NOT COMPLETED|Overall Study||20
407402|NCT00096278|999082|P1|NOT COMPLETED|Overall Study||18
407403|NCT00096278|999081|P2|COMPLETED|Overall Study||1334
407404|NCT00096278|999082|P1|COMPLETED|Overall Study||1338
407405|NCT00096278|999081|P2|STARTED|Overall Study||1354
407406|NCT00096278|999082|P1|STARTED|Overall Study||1356
407407|NCT00096265|999101|P3|NOT COMPLETED|Overall Study||0
407408|NCT00096265|999102|P2|NOT COMPLETED|Overall Study||0
407409|NCT00096265|999103|P1|NOT COMPLETED|Overall Study||1
407410|NCT00096265|999101|P3|COMPLETED|Overall Study||41
407411|NCT00096265|999102|P2|COMPLETED|Overall Study||40
407412|NCT00096265|999103|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
407413|NCT00096265|999101|P3|STARTED|Overall Study||41
407414|NCT00096265|999102|P2|STARTED|Overall Study||40
407415|NCT00096265|999103|P1|STARTED|Overall Study||45
407416|NCT00096226|999129|P1|NOT COMPLETED|Overall Study||3
407417|NCT00096226|999129|P1|COMPLETED|Overall Study|Subjects contributing any data to analysis are considered to have completed the study|57
407418|NCT00096226|999129|P1|Eligible and Underwent Surgery|Overall Study||37
407419|NCT00096226|999129|P1|Eligible|Overall Study||57
407420|NCT00096226|999129|P1|STARTED|Overall Study||60
407421|NCT00096200|999143|P3|NOT COMPLETED|Overall Study||0
407422|NCT00096200|999144|P2|NOT COMPLETED|Overall Study||7
407423|NCT00096200|999145|P1|NOT COMPLETED|Overall Study||1
407424|NCT00096200|999143|P3|COMPLETED|Overall Study||5
407425|NCT00096200|999144|P2|COMPLETED|Overall Study||23
407426|NCT00096200|999145|P1|COMPLETED|Overall Study||8
407427|NCT00096200|999143|P3|STARTED|Overall Study||5
407428|NCT00096200|999144|P2|STARTED|Overall Study||30
407429|NCT00096200|999145|P1|STARTED|Overall Study||9
407430|NCT00096174|999159|P1|NOT COMPLETED|Overall Study||62
407431|NCT00096174|999159|P1|COMPLETED|Overall Study||7
407432|NCT00096174|999159|P1|Eligible and Treated|Overall Study|6 treated patients were ineligible|60
407433|NCT00096174|999159|P1|Began Protocol Therapy|Overall Study|3 patients never started treatment|66
407434|NCT00096174|999159|P1|STARTED|Overall Study||69
407435|NCT00096161|999169|P4|NOT COMPLETED|Overall Study||0
407436|NCT00096161|999170|P3|NOT COMPLETED|Overall Study||0
407437|NCT00096161|999171|P2|NOT COMPLETED|Overall Study||0
407438|NCT00096161|999172|P1|NOT COMPLETED|Overall Study||0
407439|NCT00096161|999169|P4|COMPLETED|Overall Study||0
407440|NCT00096161|999170|P3|COMPLETED|Overall Study||6
407441|NCT00096161|999171|P2|COMPLETED|Overall Study||10
407442|NCT00096161|999172|P1|COMPLETED|Overall Study||20
407443|NCT00096161|999169|P4|STARTED|Overall Study||0
407444|NCT00096161|999170|P3|STARTED|Overall Study||6
407445|NCT00096161|999171|P2|STARTED|Overall Study||10
407446|NCT00096161|999172|P1|STARTED|Overall Study||20
407447|NCT00096135|999204|P2|NOT COMPLETED|Overall Study||15
407448|NCT00096135|999205|P1|NOT COMPLETED|Overall Study||63
407449|NCT00096135|999204|P2|COMPLETED|Overall Study||27
407450|NCT00096135|999205|P1|COMPLETED|Overall Study||63
407451|NCT00096135|999204|P2|STARTED|Overall Study||42
407452|NCT00096135|999205|P1|STARTED|Overall Study||126
407453|NCT00096122|999211|P1|NOT COMPLETED|Overall Study||0
407454|NCT00096122|999211|P1|COMPLETED|Overall Study||95
407455|NCT00096122|999211|P1|STARTED|Overall Study||95
407456|NCT00096109|999215|P1|NOT COMPLETED|Overall Study||0
407457|NCT00096109|999215|P1|COMPLETED|Overall Study||11
407458|NCT00096109|999215|P1|STARTED|Overall Study||11
407459|NCT00096044|999221|P1|NOT COMPLETED|Overall Study||34
407460|NCT00096044|999221|P1|COMPLETED|Overall Study||11
407461|NCT00096044|999221|P1|STARTED|Overall Study||45
407462|NCT00096031|999230|P1|NOT COMPLETED|Overall Study||63
407463|NCT00096031|999230|P1|COMPLETED|Overall Study||0
407464|NCT00096031|999230|P1|Eligible and Began Protocol Therapy|Overall Study||55
407465|NCT00096031|999230|P1|Eligible|Overall Study||57
407466|NCT00096031|999230|P1|STARTED|Overall Study||63
407467|NCT00096018|999238|P2|NOT COMPLETED|Overall Study||14
407468|NCT00096018|999239|P1|NOT COMPLETED|Overall Study||2
407469|NCT00096018|999238|P2|COMPLETED|Overall Study||16
407470|NCT00096018|999239|P1|COMPLETED|Overall Study||11
407471|NCT00096018|999238|P2|Treated With Study Therapy|Overall Study||25
407472|NCT00096018|999239|P1|Treated With Study Therapy|Overall Study||13
407473|NCT00096018|999238|P2|STARTED|Overall Study||30
407474|NCT00096018|999239|P1|STARTED|Overall Study||13
407475|NCT00095979|999247|P1|NOT COMPLETED|Overall Study||2
407476|NCT00095979|999247|P1|COMPLETED|Overall Study||50
407477|NCT00095979|999247|P1|STARTED|Overall Study||52
407478|NCT00095940|999265|P9|NOT COMPLETED|Lapatinib Continuation/Phase II||13
407479|NCT00095940|999266|P8|NOT COMPLETED|Lapatinib Continuation/Phase II||2
407480|NCT00095940|999267|P7|NOT COMPLETED|Lapatinib Continuation/Phase II||2
407481|NCT00095940|999268|P6|NOT COMPLETED|Lapatinib Continuation/Phase II||13
407482|NCT00095940|999269|P5|NOT COMPLETED|Lapatinib Continuation/Phase II||0
407483|NCT00095940|999270|P4|NOT COMPLETED|Lapatinib Continuation/Phase II||0
407484|NCT00095940|999271|P3|NOT COMPLETED|Lapatinib Continuation/Phase II||16
407485|NCT00095940|999272|P2|NOT COMPLETED|Lapatinib Continuation/Phase II||2
407486|NCT00095940|999273|P1|NOT COMPLETED|Lapatinib Continuation/Phase II||2
407487|NCT00095940|999265|P9|COMPLETED|Lapatinib Continuation/Phase II||1
407488|NCT00095940|999266|P8|COMPLETED|Lapatinib Continuation/Phase II||0
407489|NCT00095940|999267|P7|COMPLETED|Lapatinib Continuation/Phase II||0
407490|NCT00095940|999268|P6|COMPLETED|Lapatinib Continuation/Phase II||0
407491|NCT00095940|999269|P5|COMPLETED|Lapatinib Continuation/Phase II||0
407492|NCT00095940|999270|P4|COMPLETED|Lapatinib Continuation/Phase II||0
407493|NCT00095940|999271|P3|COMPLETED|Lapatinib Continuation/Phase II||1
407494|NCT00095940|999272|P2|COMPLETED|Lapatinib Continuation/Phase II||0
407495|NCT00095940|999273|P1|COMPLETED|Lapatinib Continuation/Phase II||0
407496|NCT00095940|999265|P9|STARTED|Lapatinib Continuation/Phase II||14
407497|NCT00095940|999266|P8|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
407498|NCT00095940|999267|P7|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
407499|NCT00095940|999268|P6|STARTED|Lapatinib Continuation/Phase II||13
407500|NCT00095940|999269|P5|STARTED|Lapatinib Continuation/Phase II||0
407501|NCT00095940|999270|P4|STARTED|Lapatinib Continuation/Phase II||0
407502|NCT00095940|999271|P3|STARTED|Lapatinib Continuation/Phase II||17
407503|NCT00095940|999272|P2|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
407504|NCT00095940|999273|P1|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
407505|NCT00095940|999265|P9|NOT COMPLETED|Molecular Biology Phase||0
407506|NCT00095940|999266|P8|NOT COMPLETED|Molecular Biology Phase||0
407507|NCT00095940|999267|P7|NOT COMPLETED|Molecular Biology Phase||0
407508|NCT00095940|999268|P6|NOT COMPLETED|Molecular Biology Phase||0
407509|NCT00095940|999269|P5|NOT COMPLETED|Molecular Biology Phase||0
407510|NCT00095940|999270|P4|NOT COMPLETED|Molecular Biology Phase||0
407511|NCT00095940|999271|P3|NOT COMPLETED|Molecular Biology Phase||0
407512|NCT00095940|999272|P2|NOT COMPLETED|Molecular Biology Phase||0
407513|NCT00095940|999273|P1|NOT COMPLETED|Molecular Biology Phase||0
407514|NCT00095940|999265|P9|COMPLETED|Molecular Biology Phase||0
407515|NCT00095940|999266|P8|COMPLETED|Molecular Biology Phase||2
407516|NCT00095940|999267|P7|COMPLETED|Molecular Biology Phase||2
407517|NCT00095940|999268|P6|COMPLETED|Molecular Biology Phase||0
407518|NCT00095940|999269|P5|COMPLETED|Molecular Biology Phase||0
407519|NCT00095940|999270|P4|COMPLETED|Molecular Biology Phase||0
407520|NCT00095940|999271|P3|COMPLETED|Molecular Biology Phase||0
407521|NCT00095940|999272|P2|COMPLETED|Molecular Biology Phase||2
407522|NCT00095940|999273|P1|COMPLETED|Molecular Biology Phase||2
407523|NCT00095940|999265|P9|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
407524|NCT00095940|999266|P8|STARTED|Molecular Biology Phase||2
407525|NCT00095940|999267|P7|STARTED|Molecular Biology Phase||2
407526|NCT00095940|999268|P6|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
407527|NCT00095940|999269|P5|STARTED|Molecular Biology Phase||0
407528|NCT00095940|999270|P4|STARTED|Molecular Biology Phase||0
407529|NCT00095940|999271|P3|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
407530|NCT00095940|999272|P2|STARTED|Molecular Biology Phase||2
407531|NCT00095940|999273|P1|STARTED|Molecular Biology Phase||2
407532|NCT00095875|999297|P2|NOT COMPLETED|Overall Study||9
407533|NCT00095875|999298|P1|NOT COMPLETED|Overall Study||14
407534|NCT00095875|999297|P2|COMPLETED|Overall Study||66
407535|NCT00095875|999298|P1|COMPLETED|Overall Study||56
407536|NCT00095875|999297|P2|STARTED|Overall Study||75
407537|NCT00095875|999298|P1|STARTED|Overall Study||70
407538|NCT00095836|999306|P1|NOT COMPLETED|Overall Study||4
407539|NCT00095836|999306|P1|COMPLETED|Overall Study||23
407540|NCT00095836|999306|P1|STARTED|Overall Study||27
407541|NCT00095784|999313|P1|NOT COMPLETED|Overall Study||0
407542|NCT00095784|999313|P1|COMPLETED|Overall Study||21
407543|NCT00095784|999313|P1|STARTED|Overall Study||21
407544|NCT00095628|999336|P1|NOT COMPLETED|Overall Study||1
407545|NCT00095628|999336|P1|COMPLETED|Overall Study||20
407546|NCT00095628|999336|P1|STARTED|Overall Study||21
407547|NCT00095576|999347|P2|NOT COMPLETED|Overall Study||1481
407548|NCT00095576|999348|P1|NOT COMPLETED|Overall Study||1475
407549|NCT00095576|999347|P2|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|14
407550|NCT00095576|999348|P1|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|9
407551|NCT00095576|999347|P2|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1361
407552|NCT00095576|999348|P1|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1328
407553|NCT00095576|999347|P2|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1443
407554|NCT00095576|999348|P1|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1426
407555|NCT00095576|999347|P2|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1495
407556|NCT00095576|999348|P1|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1484
407557|NCT00095576|999347|P2|STARTED|Overall Study||1495
407558|NCT00095576|999348|P1|STARTED|Overall Study||1484
407559|NCT00095563|999360|P1|NOT COMPLETED|Overall Study||0
407560|NCT00095563|999360|P1|COMPLETED|Overall Study||39
407561|NCT00095563|999360|P1|STARTED|Overall Study||39
407562|NCT00095498|999372|P3|NOT COMPLETED|Overall Study||39
407563|NCT00095498|999373|P2|NOT COMPLETED|Overall Study||35
407564|NCT00095498|999374|P1|NOT COMPLETED|Overall Study||37
407565|NCT00095498|999372|P3|COMPLETED|Overall Study||39
407566|NCT00095498|999373|P2|COMPLETED|Overall Study||38
407567|NCT00095498|999374|P1|COMPLETED|Overall Study||39
407568|NCT00095498|999372|P3|Received Investigational Product|Overall Study||75
407569|NCT00095498|999373|P2|Received Investigational Product|Overall Study||71
407570|NCT00095498|999374|P1|Received Investigational Product|Overall Study||72
407571|NCT00095498|999372|P3|STARTED|Overall Study||78
407572|NCT00095498|999373|P2|STARTED|Overall Study||73
407573|NCT00095498|999374|P1|STARTED|Overall Study||76
407574|NCT00095303|999801|P2|NOT COMPLETED|Follow Up Study||58
407575|NCT00095303|999802|P1|NOT COMPLETED|Follow Up Study||59
407576|NCT00095303|999801|P2|COMPLETED|Follow Up Study||121
407577|NCT00095303|999802|P1|COMPLETED|Follow Up Study||140
407578|NCT00095303|999801|P2|STARTED|Follow Up Study|179 (TAU) gave permission for future contact; not a requirement to finish Main to start Follow up|179
407579|NCT00095303|999802|P1|STARTED|Follow Up Study|199 (BSFT) gave permission for future contact; not a requirement to finish Main to start Follow up|199
407580|NCT00095303|999801|P2|NOT COMPLETED|Main Study||87
407581|NCT00095303|999802|P1|NOT COMPLETED|Main Study||91
407582|NCT00095303|999801|P2|COMPLETED|Main Study||148
407583|NCT00095303|999802|P1|COMPLETED|Main Study||154
407584|NCT00095303|999801|P2|STARTED|Main Study||235
407585|NCT00095303|999802|P1|STARTED|Main Study||245
407586|NCT00095238|999870|P2|NOT COMPLETED|Overall Study||852
407587|NCT00095238|999871|P1|NOT COMPLETED|Overall Study||857
407588|NCT00095238|999870|P2|COMPLETED|Overall Study|completed double-blind therapy|1209
407589|NCT00095238|999871|P1|COMPLETED|Overall Study|completed double-blind therapy|1210
407590|NCT00095238|999870|P2|Safety (Treated) Population|Overall Study|One participant randomized to irbesartan received placebo.|2062
407591|NCT00095238|999871|P1|Safety (Treated) Population|Overall Study|Two participants were randomized but not treated; 1 randomized to irbesartan received placebo|2064
407592|NCT00095238|999870|P2|STARTED|Overall Study|number randomized|2061
407593|NCT00095238|999871|P1|STARTED|Overall Study|number randomized|2067
407594|NCT00095212|999933|P2|NOT COMPLETED|Overall Study||3
407595|NCT00095212|999934|P1|NOT COMPLETED|Overall Study||1
407596|NCT00095212|999933|P2|COMPLETED|Overall Study||9
407597|NCT00095212|999934|P1|COMPLETED|Overall Study||12
407598|NCT00095212|999933|P2|STARTED|Overall Study||12
407599|NCT00095212|999934|P1|STARTED|Overall Study||13
407600|NCT00095199|999964|P4|NOT COMPLETED|Overall Study||143
407601|NCT00095199|999965|P3|NOT COMPLETED|Overall Study||160
407602|NCT00095199|999966|P2|NOT COMPLETED|Overall Study||242
407603|NCT00095199|999967|P1|NOT COMPLETED|Overall Study||296
407604|NCT00095199|999964|P4|COMPLETED|Overall Study||23
407605|NCT00095199|999965|P3|COMPLETED|Overall Study||7
407606|NCT00095199|999966|P2|COMPLETED|Overall Study||62
407607|NCT00095199|999967|P1|COMPLETED|Overall Study||6
407608|NCT00095199|999964|P4|STARTED|Overall Study||166
407609|NCT00095199|999965|P3|STARTED|Overall Study||167
407610|NCT00095199|999966|P2|STARTED|Overall Study||304
407763|NCT00094835|1000444|P5|COMPLETED|Overall Study||3
407611|NCT00095199|999967|P1|STARTED|Overall Study|1 participant has no data in database; not included in analyses. Data was lost/destroyed at site.|302
407612|NCT00095173|1000005|P6|NOT COMPLETED|Open-Label Extension Phase (Period C)||32
407613|NCT00095173|1000006|P5|NOT COMPLETED|Open-Label Extension Phase (Period C)||29
407614|NCT00095173|1000007|P4|NOT COMPLETED|Open-Label Extension Phase (Period C)||23
407615|NCT00095173|1000008|P3|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
407616|NCT00095173|1000009|P2|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
407617|NCT00095173|1000010|P1|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
407618|NCT00095173|1000005|P6|COMPLETED|Open-Label Extension Phase (Period C)||27
407619|NCT00095173|1000006|P5|COMPLETED|Open-Label Extension Phase (Period C)||29
407620|NCT00095173|1000007|P4|COMPLETED|Open-Label Extension Phase (Period C)||13
407621|NCT00095173|1000008|P3|COMPLETED|Open-Label Extension Phase (Period C)||0
407622|NCT00095173|1000009|P2|COMPLETED|Open-Label Extension Phase (Period C)||0
407623|NCT00095173|1000010|P1|COMPLETED|Open-Label Extension Phase (Period C)||0
407624|NCT00095173|1000005|P6|STARTED|Open-Label Extension Phase (Period C)|Includes 33 who discontinued Period B due to a flare and 26 who completed Period B with no flare|59
407625|NCT00095173|1000006|P5|STARTED|Open-Label Extension Phase (Period C)|Includes 47 who completed Period B with no flare and 11 who discontinued Period B due to a flare|58
407626|NCT00095173|1000007|P4|STARTED|Open-Label Extension Phase (Period C)|Participants were non-responders from Period A who re-entered in Period C.|36
407627|NCT00095173|1000008|P3|STARTED|Open-Label Extension Phase (Period C)||0
407628|NCT00095173|1000009|P2|STARTED|Open-Label Extension Phase (Period C)||0
407629|NCT00095173|1000010|P1|STARTED|Open-Label Extension Phase (Period C)||0
407630|NCT00095173|1000005|P6|NOT COMPLETED|Double-Blind Phase (Period B)||0
407631|NCT00095173|1000006|P5|NOT COMPLETED|Double-Blind Phase (Period B)||0
407632|NCT00095173|1000007|P4|NOT COMPLETED|Double-Blind Phase (Period B)||0
407633|NCT00095173|1000008|P3|NOT COMPLETED|Double-Blind Phase (Period B)||31
407634|NCT00095173|1000009|P2|NOT COMPLETED|Double-Blind Phase (Period B)||11
407635|NCT00095173|1000010|P1|NOT COMPLETED|Double-Blind Phase (Period B)||0
407636|NCT00095173|1000005|P6|COMPLETED|Double-Blind Phase (Period B)||0
407637|NCT00095173|1000006|P5|COMPLETED|Double-Blind Phase (Period B)||0
407638|NCT00095173|1000007|P4|COMPLETED|Double-Blind Phase (Period B)||0
407639|NCT00095173|1000008|P3|COMPLETED|Double-Blind Phase (Period B)||31
407640|NCT00095173|1000009|P2|COMPLETED|Double-Blind Phase (Period B)||49
407641|NCT00095173|1000010|P1|COMPLETED|Double-Blind Phase (Period B)||0
407642|NCT00095173|1000005|P6|STARTED|Double-Blind Phase (Period B)||0
407643|NCT00095173|1000006|P5|STARTED|Double-Blind Phase (Period B)||0
407644|NCT00095173|1000007|P4|STARTED|Double-Blind Phase (Period B)||0
407645|NCT00095173|1000008|P3|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|62
407646|NCT00095173|1000009|P2|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|60
407647|NCT00095173|1000010|P1|STARTED|Double-Blind Phase (Period B)|All participants did not continue; responders entered Period B; non-responders re-entered Period C.|0
407648|NCT00095173|1000005|P6|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
407649|NCT00095173|1000006|P5|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
407650|NCT00095173|1000007|P4|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
407651|NCT00095173|1000008|P3|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
407652|NCT00095173|1000009|P2|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
407653|NCT00095173|1000010|P1|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||20
407654|NCT00095173|1000005|P6|COMPLETED|Open-Label Lead-In Phase (Period A)||0
407655|NCT00095173|1000006|P5|COMPLETED|Open-Label Lead-In Phase (Period A)||0
407656|NCT00095173|1000007|P4|COMPLETED|Open-Label Lead-In Phase (Period A)||0
407657|NCT00095173|1000008|P3|COMPLETED|Open-Label Lead-In Phase (Period A)||0
407658|NCT00095173|1000009|P2|COMPLETED|Open-Label Lead-In Phase (Period A)||0
407659|NCT00095173|1000010|P1|COMPLETED|Open-Label Lead-In Phase (Period A)||170
407660|NCT00095173|1000005|P6|STARTED|Open-Label Lead-In Phase (Period A)||0
407661|NCT00095173|1000006|P5|STARTED|Open-Label Lead-In Phase (Period A)||0
407662|NCT00095173|1000007|P4|STARTED|Open-Label Lead-In Phase (Period A)||0
407663|NCT00095173|1000008|P3|STARTED|Open-Label Lead-In Phase (Period A)||0
407664|NCT00095173|1000009|P2|STARTED|Open-Label Lead-In Phase (Period A)||0
407665|NCT00095173|1000010|P1|STARTED|Open-Label Lead-In Phase (Period A)||190
407666|NCT00095147|1000048|P5|NOT COMPLETED|Long-term Extension Period||45
407667|NCT00095147|1000049|P4|NOT COMPLETED|Long-term Extension Period||0
407668|NCT00095147|1000050|P3|NOT COMPLETED|Long-term Extension Period||0
407669|NCT00095147|1000051|P2|NOT COMPLETED|Long-term Extension Period||0
407670|NCT00095147|1000052|P1|NOT COMPLETED|Long-term Extension Period||0
407671|NCT00095147|1000048|P5|COMPLETED|Long-term Extension Period||327
407672|NCT00095147|1000049|P4|COMPLETED|Long-term Extension Period||0
407673|NCT00095147|1000050|P3|COMPLETED|Long-term Extension Period||0
407674|NCT00095147|1000051|P2|COMPLETED|Long-term Extension Period||0
407675|NCT00095147|1000052|P1|COMPLETED|Long-term Extension Period||0
407676|NCT00095147|1000048|P5|STARTED|Long-term Extension Period||372
407677|NCT00095147|1000049|P4|STARTED|Long-term Extension Period||0
407678|NCT00095147|1000050|P3|STARTED|Long-term Extension Period||0
407679|NCT00095147|1000051|P2|STARTED|Long-term Extension Period||0
407680|NCT00095147|1000052|P1|STARTED|Long-term Extension Period||0
407681|NCT00095147|1000048|P5|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
407682|NCT00095147|1000049|P4|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||3
407683|NCT00095147|1000050|P3|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
407684|NCT00095147|1000051|P2|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||11
407685|NCT00095147|1000052|P1|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||8
407686|NCT00095147|1000048|P5|COMPLETED|Double-blind Period 2 (Days 198-365)||0
407687|NCT00095147|1000049|P4|COMPLETED|Double-blind Period 2 (Days 198-365)||104
407688|NCT00095147|1000050|P3|COMPLETED|Double-blind Period 2 (Days 198-365)||0
407689|NCT00095147|1000051|P2|COMPLETED|Double-blind Period 2 (Days 198-365)||141
407690|NCT00095147|1000052|P1|COMPLETED|Double-blind Period 2 (Days 198-365)||139
407691|NCT00095147|1000048|P5|STARTED|Double-blind Period 2 (Days 198-365)||0
407692|NCT00095147|1000049|P4|STARTED|Double-blind Period 2 (Days 198-365)||107
407693|NCT00095147|1000050|P3|STARTED|Double-blind Period 2 (Days 198-365)||0
407694|NCT00095147|1000051|P2|STARTED|Double-blind Period 2 (Days 198-365)||152
407695|NCT00095147|1000052|P1|STARTED|Double-blind Period 2 (Days 198-365)||147
407696|NCT00095147|1000048|P5|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
407697|NCT00095147|1000049|P4|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
407698|NCT00095147|1000050|P3|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||3
407699|NCT00095147|1000051|P2|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||13
407700|NCT00095147|1000052|P1|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||9
407701|NCT00095147|1000048|P5|COMPLETED|Double-blind Period 1 (Days 1-197)||0
407702|NCT00095147|1000049|P4|COMPLETED|Double-blind Period 1 (Days 1-197)||0
407703|NCT00095147|1000050|P3|COMPLETED|Double-blind Period 1 (Days 1-197)||107
407704|NCT00095147|1000051|P2|COMPLETED|Double-blind Period 1 (Days 1-197)||152
407705|NCT00095147|1000052|P1|COMPLETED|Double-blind Period 1 (Days 1-197)||147
407706|NCT00095147|1000048|P5|STARTED|Double-blind Period 1 (Days 1-197)||0
407707|NCT00095147|1000049|P4|STARTED|Double-blind Period 1 (Days 1-197)||0
407708|NCT00095147|1000050|P3|STARTED|Double-blind Period 1 (Days 1-197)||110
407709|NCT00095147|1000051|P2|STARTED|Double-blind Period 1 (Days 1-197)||165
407710|NCT00095147|1000052|P1|STARTED|Double-blind Period 1 (Days 1-197)||156
407711|NCT00095121|1000247|P2|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||19
407712|NCT00095121|1000248|P1|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||62
407713|NCT00095121|1000247|P2|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|35
407714|NCT00095121|1000248|P1|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|46
407715|NCT00095121|1000247|P2|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||11
407716|NCT00095121|1000248|P1|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||21
407717|NCT00095121|1000247|P2|STARTED|Open-Label (Study Weeks 49 Through 240)||54
407718|NCT00095121|1000248|P1|STARTED|Open-Label (Study Weeks 49 Through 240)||108
407719|NCT00095121|1000247|P2|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||0
407720|NCT00095121|1000248|P1|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||3
407721|NCT00095121|1000247|P2|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||58
407722|NCT00095121|1000248|P1|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||112
407723|NCT00095121|1000247|P2|STARTED|Double-Blind (Study Weeks 0 Through 48)||58
407724|NCT00095121|1000248|P1|STARTED|Double-Blind (Study Weeks 0 Through 48)||115
407725|NCT00095056|1000294|P2|NOT COMPLETED|Phase B (Weeks 12-54)||5
407726|NCT00095056|1000295|P1|NOT COMPLETED|Phase B (Weeks 12-54)||10
407727|NCT00095056|1000294|P2|COMPLETED|Phase B (Weeks 12-54)||20
407728|NCT00095056|1000295|P1|COMPLETED|Phase B (Weeks 12-54)||46
407729|NCT00095056|1000294|P2|STARTED|Phase B (Weeks 12-54)||25
407730|NCT00095056|1000295|P1|STARTED|Phase B (Weeks 12-54)|2 randomized patients completed Period 1 but did not enter Period 2.|56
407731|NCT00095056|1000294|P2|NOT COMPLETED|Phase A (Weeks 0-12)||1
407732|NCT00095056|1000295|P1|NOT COMPLETED|Phase A (Weeks 0-12)||7
407733|NCT00095056|1000294|P2|COMPLETED|Phase A (Weeks 0-12)||25
407734|NCT00095056|1000295|P1|COMPLETED|Phase A (Weeks 0-12)||58
407735|NCT00095056|1000294|P2|STARTED|Phase A (Weeks 0-12)||26
407736|NCT00095056|1000295|P1|STARTED|Phase A (Weeks 0-12)||65
407737|NCT00094900|1000303|P1|NOT COMPLETED|Overall Study||1
407738|NCT00094900|1000303|P1|COMPLETED|Overall Study||10
407739|NCT00094900|1000303|P1|STARTED|Overall Study||11
407740|NCT00094887|1000405|P2|NOT COMPLETED|Overall Study||6
407741|NCT00094887|1000406|P1|NOT COMPLETED|Overall Study||5
407742|NCT00094887|1000405|P2|COMPLETED|Overall Study||69
407743|NCT00094887|1000406|P1|COMPLETED|Overall Study||70
407744|NCT00094887|1000405|P2|STARTED|Overall Study|75|75
407745|NCT00094887|1000406|P1|STARTED|Overall Study|75|75
407746|NCT00094861|1000414|P2|NOT COMPLETED|Overall Study||9
407747|NCT00094861|1000415|P1|NOT COMPLETED|Overall Study||18
407748|NCT00094861|1000414|P2|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|40
407749|NCT00094861|1000415|P1|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|28
407750|NCT00094861|1000414|P2|Participants Treated|Overall Study||48
407751|NCT00094861|1000415|P1|Participants Treated|Overall Study||46
407752|NCT00094861|1000414|P2|STARTED|Overall Study||49
407753|NCT00094861|1000415|P1|STARTED|Overall Study||46
407754|NCT00094835|1000442|P7|NOT COMPLETED|Overall Study||2
407755|NCT00094835|1000443|P6|NOT COMPLETED|Overall Study||3
407756|NCT00094835|1000444|P5|NOT COMPLETED|Overall Study||4
407757|NCT00094835|1000445|P4|NOT COMPLETED|Overall Study||1
407758|NCT00094835|1000446|P3|NOT COMPLETED|Overall Study||3
407759|NCT00094835|1000447|P2|NOT COMPLETED|Overall Study||3
407760|NCT00094835|1000448|P1|NOT COMPLETED|Overall Study||4
407761|NCT00094835|1000442|P7|COMPLETED|Overall Study||4
407762|NCT00094835|1000443|P6|COMPLETED|Overall Study||3
407764|NCT00094835|1000445|P4|COMPLETED|Overall Study||4
407765|NCT00094835|1000446|P3|COMPLETED|Overall Study||4
407766|NCT00094835|1000447|P2|COMPLETED|Overall Study||8
407767|NCT00094835|1000448|P1|COMPLETED|Overall Study||5
407768|NCT00094835|1000442|P7|Treated With Motesanib|Overall Study||6
407769|NCT00094835|1000443|P6|Treated With Motesanib|Overall Study||5
407770|NCT00094835|1000444|P5|Treated With Motesanib|Overall Study||7
407771|NCT00094835|1000445|P4|Treated With Motesanib|Overall Study||4
407772|NCT00094835|1000446|P3|Treated With Motesanib|Overall Study||6
407773|NCT00094835|1000447|P2|Treated With Motesanib|Overall Study||11
407774|NCT00094835|1000448|P1|Treated With Motesanib|Overall Study||6
407775|NCT00094835|1000442|P7|STARTED|Overall Study||6
407776|NCT00094835|1000443|P6|STARTED|Overall Study||6
407777|NCT00094835|1000444|P5|STARTED|Overall Study||7
407778|NCT00094835|1000445|P4|STARTED|Overall Study||5
407779|NCT00094835|1000446|P3|STARTED|Overall Study||7
407780|NCT00094835|1000447|P2|STARTED|Overall Study||11
407781|NCT00094835|1000448|P1|STARTED|Overall Study||9
407782|NCT00094809|1000526|P2|NOT COMPLETED|Overall Study||65
407783|NCT00094809|1000527|P1|NOT COMPLETED|Overall Study||52
407784|NCT00094809|1000526|P2|COMPLETED|Overall Study|Subjects who completed treatment and LTFU|61
407785|NCT00094809|1000527|P1|COMPLETED|Overall Study|Subjects who completed treatment and Long term follow up (LTFU)|74
407786|NCT00094809|1000526|P2|Completed All 4 Cycles of Treatment|Overall Study||90
407787|NCT00094809|1000527|P1|Completed All 4 Cycles of Treatment|Overall Study||98
407788|NCT00094809|1000526|P2|Properly Consented; Received Study Drug|Overall Study||118
407789|NCT00094809|1000527|P1|Properly Consented; Received Study Drug|Overall Study||123
407790|NCT00094809|1000526|P2|Received Study Drug|Overall Study||118
407791|NCT00094809|1000527|P1|Received Study Drug|Overall Study||124
407792|NCT00094809|1000526|P2|STARTED|Overall Study||126
407793|NCT00094809|1000527|P1|STARTED|Overall Study||126
407794|NCT00094770|1000553|P2|NOT COMPLETED|Year 2 (Week 0 to Week 104)||320
407795|NCT00094770|1000554|P1|NOT COMPLETED|Year 2 (Week 0 to Week 104)||333
407796|NCT00094770|1000553|P2|COMPLETED|Year 2 (Week 0 to Week 104)||264
407797|NCT00094770|1000554|P1|COMPLETED|Year 2 (Week 0 to Week 104)||255
407798|NCT00094770|1000553|P2|STARTED|Year 2 (Week 0 to Week 104)||584
407799|NCT00094770|1000554|P1|STARTED|Year 2 (Week 0 to Week 104)||588
407800|NCT00094770|1000553|P2|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||172
407801|NCT00094770|1000554|P1|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||202
407802|NCT00094770|1000553|P2|COMPLETED|Year 1 ( Week 0 to Week 52)|11 Participants who Completed Week 52, Did NOT Enter second year|412
407803|NCT00094770|1000554|P1|COMPLETED|Year 1 ( Week 0 to Week 52)|4 Participants who Completed Week 52, Did NOT Enter second year|386
407804|NCT00094770|1000553|P2|STARTED|Year 1 ( Week 0 to Week 52)||584
407805|NCT00094770|1000554|P1|STARTED|Year 1 ( Week 0 to Week 52)||588
407806|NCT00094757|1000585|P3|NOT COMPLETED|Overall Study||30
407807|NCT00094757|1000586|P2|NOT COMPLETED|Overall Study||62
407808|NCT00094757|1000587|P1|NOT COMPLETED|Overall Study||53
407809|NCT00094757|1000585|P3|COMPLETED|Overall Study||80
407810|NCT00094757|1000586|P2|COMPLETED|Overall Study||144
407811|NCT00094757|1000587|P1|COMPLETED|Overall Study||152
407812|NCT00094757|1000585|P3|STARTED|Overall Study||110
407813|NCT00094757|1000586|P2|STARTED|Overall Study||206
407814|NCT00094757|1000587|P1|STARTED|Overall Study||205
407815|NCT00094653|1000607|P3|NOT COMPLETED|Overall Study||126
407816|NCT00094653|1000608|P2|NOT COMPLETED|Overall Study||106
407817|NCT00094653|1000609|P1|NOT COMPLETED|Overall Study||321
407818|NCT00094653|1000607|P3|COMPLETED|Overall Study||10
407819|NCT00094653|1000608|P2|COMPLETED|Overall Study||31
407820|NCT00094653|1000609|P1|COMPLETED|Overall Study||82
407821|NCT00094653|1000607|P3|Treated|Overall Study||131
407822|NCT00094653|1000608|P2|Treated|Overall Study||131
407823|NCT00094653|1000609|P1|Treated|Overall Study||381
407824|NCT00094653|1000607|P3|STARTED|Overall Study||136
407825|NCT00094653|1000608|P2|STARTED|Overall Study||137
407826|NCT00094653|1000609|P1|STARTED|Overall Study||403
407827|NCT00094575|1000672|P2|NOT COMPLETED|Overall Study||146
407828|NCT00094575|1000673|P1|NOT COMPLETED|Overall Study||146
407829|NCT00094575|1000672|P2|COMPLETED|Overall Study||291
407830|NCT00094575|1000673|P1|COMPLETED|Overall Study||298
407831|NCT00094575|1000672|P2|STARTED|Overall Study||437
407832|NCT00094575|1000673|P1|STARTED|Overall Study||444
407833|NCT00094536|1000693|P1|NOT COMPLETED|Treatment and Follow-up||31
407834|NCT00094536|1000693|P1|COMPLETED|Treatment and Follow-up|51 subjects successfully completed the study.|51
407835|NCT00094536|1000693|P1|36 Month Follow-up|Treatment and Follow-up||51
407836|NCT00094536|1000693|P1|24 Month Follow-up|Treatment and Follow-up||53
407837|NCT00094536|1000693|P1|12 Month Follow-up|Treatment and Follow-up|69 subjects were evaluated at 1-year post-treatment for the primary endpoint of success.|69
407838|NCT00094536|1000693|P1|STARTED|Treatment and Follow-up|82 subjects qualified for and underwent the study treatment.|82
407839|NCT00094536|1000693|P1|NOT COMPLETED|Inclusion Exclusion Evaluation||24
407840|NCT00094536|1000693|P1|COMPLETED|Inclusion Exclusion Evaluation||82
407841|NCT00094536|1000693|P1|STARTED|Inclusion Exclusion Evaluation||106
407842|NCT00094497|1000699|P2|NOT COMPLETED|Overall Study||0
407843|NCT00094497|1000700|P1|NOT COMPLETED|Overall Study||0
407844|NCT00094497|1000699|P2|COMPLETED|Overall Study||153
407845|NCT00094497|1000700|P1|COMPLETED|Overall Study||151
407846|NCT00094497|1000699|P2|Received Second Line Therapy|Overall Study||101
407847|NCT00094497|1000700|P1|Received Second Line Therapy|Overall Study||84
407848|NCT00094497|1000699|P2|Treated|Overall Study||149
407849|NCT00094497|1000700|P1|Treated|Overall Study||148
407850|NCT00094497|1000699|P2|STARTED|Overall Study||153
407851|NCT00094497|1000700|P1|STARTED|Overall Study||151
407852|NCT00094458|1000717|P6|NOT COMPLETED|OLE: Open-Label Extension||4
407853|NCT00094458|1000718|P5|NOT COMPLETED|OLE: Open-Label Extension||5
407854|NCT00094458|1000719|P4|NOT COMPLETED|OLE: Open-Label Extension||1
407855|NCT00094458|1000720|P3|NOT COMPLETED|OLE: Open-Label Extension||0
407856|NCT00094458|1000721|P2|NOT COMPLETED|OLE: Open-Label Extension||0
407857|NCT00094458|1000722|P1|NOT COMPLETED|OLE: Open-Label Extension||0
407858|NCT00094458|1000717|P6|COMPLETED|OLE: Open-Label Extension||13
407859|NCT00094458|1000718|P5|COMPLETED|OLE: Open-Label Extension||13
407860|NCT00094458|1000719|P4|COMPLETED|OLE: Open-Label Extension||7
407861|NCT00094458|1000720|P3|COMPLETED|OLE: Open-Label Extension||0
407862|NCT00094458|1000721|P2|COMPLETED|OLE: Open-Label Extension||0
407863|NCT00094458|1000722|P1|COMPLETED|OLE: Open-Label Extension||0
407864|NCT00094458|1000717|P6|STARTED|OLE: Open-Label Extension||17
407865|NCT00094458|1000718|P5|STARTED|OLE: Open-Label Extension||18
407866|NCT00094458|1000719|P4|STARTED|OLE: Open-Label Extension||8
407867|NCT00094458|1000720|P3|STARTED|OLE: Open-Label Extension||0
407868|NCT00094458|1000721|P2|STARTED|OLE: Open-Label Extension||0
407869|NCT00094458|1000722|P1|STARTED|OLE: Open-Label Extension||0
407870|NCT00094458|1000717|P6|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
407871|NCT00094458|1000718|P5|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
407872|NCT00094458|1000719|P4|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
407873|NCT00094458|1000720|P3|NOT COMPLETED|Study Extension: Week 30 Through Week 50||18
407874|NCT00094458|1000721|P2|NOT COMPLETED|Study Extension: Week 30 Through Week 50||12
407875|NCT00094458|1000722|P1|NOT COMPLETED|Study Extension: Week 30 Through Week 50||8
407876|NCT00094458|1000717|P6|COMPLETED|Study Extension: Week 30 Through Week 50||0
407877|NCT00094458|1000718|P5|COMPLETED|Study Extension: Week 30 Through Week 50||0
407878|NCT00094458|1000719|P4|COMPLETED|Study Extension: Week 30 Through Week 50||0
407879|NCT00094458|1000720|P3|COMPLETED|Study Extension: Week 30 Through Week 50||90
407880|NCT00094458|1000721|P2|COMPLETED|Study Extension: Week 30 Through Week 50||85
407881|NCT00094458|1000722|P1|COMPLETED|Study Extension: Week 30 Through Week 50||67
407882|NCT00094458|1000717|P6|STARTED|Study Extension: Week 30 Through Week 50||0
407883|NCT00094458|1000718|P5|STARTED|Study Extension: Week 30 Through Week 50||0
407884|NCT00094458|1000719|P4|STARTED|Study Extension: Week 30 Through Week 50||0
407885|NCT00094458|1000720|P3|STARTED|Study Extension: Week 30 Through Week 50||108
407886|NCT00094458|1000721|P2|STARTED|Study Extension: Week 30 Through Week 50||97
407887|NCT00094458|1000722|P1|STARTED|Study Extension: Week 30 Through Week 50||75
407888|NCT00094458|1000717|P6|NOT COMPLETED|Main Study: Through Week 30||0
407889|NCT00094458|1000718|P5|NOT COMPLETED|Main Study: Through Week 30||0
407890|NCT00094458|1000719|P4|NOT COMPLETED|Main Study: Through Week 30||0
407891|NCT00094458|1000720|P3|NOT COMPLETED|Main Study: Through Week 30||48
407892|NCT00094458|1000721|P2|NOT COMPLETED|Main Study: Through Week 30||58
407893|NCT00094458|1000722|P1|NOT COMPLETED|Main Study: Through Week 30||84
407894|NCT00094458|1000717|P6|COMPLETED|Main Study: Through Week 30||0
407895|NCT00094458|1000718|P5|COMPLETED|Main Study: Through Week 30||0
407896|NCT00094458|1000719|P4|COMPLETED|Main Study: Through Week 30||0
407897|NCT00094458|1000720|P3|COMPLETED|Main Study: Through Week 30||121
407898|NCT00094458|1000721|P2|COMPLETED|Main Study: Through Week 30||111
407899|NCT00094458|1000722|P1|COMPLETED|Main Study: Through Week 30||86
407900|NCT00094458|1000717|P6|STARTED|Main Study: Through Week 30||0
407901|NCT00094458|1000718|P5|STARTED|Main Study: Through Week 30||0
407902|NCT00094458|1000719|P4|STARTED|Main Study: Through Week 30||0
407903|NCT00094458|1000720|P3|STARTED|Main Study: Through Week 30||169
407904|NCT00094458|1000721|P2|STARTED|Main Study: Through Week 30||169
407905|NCT00094458|1000722|P1|STARTED|Main Study: Through Week 30||170
407906|NCT00094328|1000760|P1|NOT COMPLETED|Overall Study||1
407907|NCT00094328|1000760|P1|COMPLETED|Overall Study|Completed 12 months on treatment|13
407908|NCT00094328|1000760|P1|STARTED|Overall Study|Received treatment|14
407909|NCT00094302|1000774|P2|NOT COMPLETED|Overall Study||406
407910|NCT00094302|1000775|P1|NOT COMPLETED|Overall Study||417
407911|NCT00094302|1000774|P2|COMPLETED|Overall Study||1316
407912|NCT00094302|1000775|P1|COMPLETED|Overall Study||1306
407913|NCT00094302|1000774|P2|STARTED|Overall Study||1722
407914|NCT00094302|1000775|P1|STARTED|Overall Study||1723
407915|NCT00094211|1000833|P4|NOT COMPLETED|Overall Study||7
407916|NCT00094211|1000834|P3|NOT COMPLETED|Overall Study||10
407917|NCT00094211|1000835|P2|NOT COMPLETED|Overall Study||8
407918|NCT00094211|1000836|P1|NOT COMPLETED|Overall Study||9
407919|NCT00094211|1000833|P4|COMPLETED|Overall Study||179
407920|NCT00094211|1000834|P3|COMPLETED|Overall Study||220
407921|NCT00094211|1000835|P2|COMPLETED|Overall Study||251
407922|NCT00094211|1000836|P1|COMPLETED|Overall Study||212
407923|NCT00094211|1000833|P4|STARTED|Overall Study||186
407924|NCT00094211|1000834|P3|STARTED|Overall Study||230
407925|NCT00094211|1000835|P2|STARTED|Overall Study||259
407926|NCT00094211|1000836|P1|STARTED|Overall Study||221
407927|NCT00094172|1000864|P2|NOT COMPLETED|Overall Study||7
407928|NCT00094172|1000865|P1|NOT COMPLETED|Overall Study||14
407929|NCT00094172|1000864|P2|COMPLETED|Overall Study||25
407930|NCT00094172|1000865|P1|COMPLETED|Overall Study||36
407931|NCT00094172|1000864|P2|STARTED|Overall Study|Safety Sample: 32; Intent-to-Treat Sample: 32; Per Protocol Sample: 28|32
407932|NCT00094172|1000865|P1|STARTED|Overall Study|Safety Sample: 49; Intent-to-Treat Sample: 49; Per Protocol Sample: 39|50
407933|NCT00094107|1000875|P1|NOT COMPLETED|Overall Study||32
407934|NCT00094107|1000875|P1|COMPLETED|Overall Study||0
407935|NCT00094107|1000875|P1|STARTED|Overall Study||32
407936|NCT00094094|1000884|P1|NOT COMPLETED|Overall Study||32
407937|NCT00094094|1000884|P1|COMPLETED|Overall Study||0
407938|NCT00094094|1000884|P1|STARTED|Overall Study||32
407939|NCT00094055|1000893|P1|NOT COMPLETED|Overall Study||60
407940|NCT00094055|1000893|P1|COMPLETED|Overall Study||0
407941|NCT00094055|1000893|P1|STARTED|Overall Study||60
407942|NCT00093964|1000904|P2|NOT COMPLETED|Overall Study||0
407943|NCT00093964|1000905|P1|NOT COMPLETED|Overall Study||0
407944|NCT00093964|1000904|P2|COMPLETED|Overall Study||40
407945|NCT00093964|1000905|P1|COMPLETED|Overall Study||41
407946|NCT00093964|1000904|P2|STARTED|Overall Study||40
407947|NCT00093964|1000905|P1|STARTED|Overall Study||41
407948|NCT00093847|1000941|P2|NOT COMPLETED|Overall Study||10
407949|NCT00093847|1000942|P1|NOT COMPLETED|Overall Study||8
407950|NCT00093847|1000941|P2|COMPLETED|Overall Study||24
407951|NCT00093847|1000942|P1|COMPLETED|Overall Study||31
407952|NCT00093847|1000941|P2|STARTED|Overall Study||34
407953|NCT00093847|1000942|P1|STARTED|Overall Study||39
407954|NCT00093808|1000950|P1|NOT COMPLETED|Overall Study||2
407955|NCT00093808|1000950|P1|COMPLETED|Overall Study||45
407956|NCT00093808|1000950|P1|STARTED|Overall Study||47
407957|NCT00093795|1000960|P3|NOT COMPLETED|Overall Study||17
407958|NCT00093795|1000961|P2|NOT COMPLETED|Overall Study||16
407959|NCT00093795|1000962|P1|NOT COMPLETED|Overall Study||20
407960|NCT00093795|1000960|P3|COMPLETED|Overall Study||1613
407961|NCT00093795|1000961|P2|COMPLETED|Overall Study||1618
407962|NCT00093795|1000962|P1|COMPLETED|Overall Study||1610
407963|NCT00093795|1000960|P3|STARTED|Overall Study||1630
407964|NCT00093795|1000961|P2|STARTED|Overall Study||1634
407965|NCT00093795|1000962|P1|STARTED|Overall Study||1630
407966|NCT00093782|1000982|P1|NOT COMPLETED|Overall Study||0
407967|NCT00093782|1000982|P1|COMPLETED|Overall Study||36
407968|NCT00093782|1000982|P1|STARTED|Overall Study||36
407969|NCT00093756|1000994|P2|NOT COMPLETED|Overall Study||0
407970|NCT00093756|1000995|P1|NOT COMPLETED|Overall Study||0
407971|NCT00093756|1000994|P2|COMPLETED|Overall Study||21
407972|NCT00093756|1000995|P1|COMPLETED|Overall Study||27
407973|NCT00093756|1000994|P2|STARTED|Overall Study||21
407974|NCT00093756|1000995|P1|STARTED|Overall Study||27
407975|NCT00093496|1001007|P2|NOT COMPLETED|Overall Study||3
407976|NCT00093496|1001008|P1|NOT COMPLETED|Overall Study||1
407977|NCT00093496|1001007|P2|COMPLETED|Overall Study||11
407978|NCT00093496|1001008|P1|COMPLETED|Overall Study||14
407979|NCT00093496|1001007|P2|STARTED|Overall Study||14
407980|NCT00093496|1001008|P1|STARTED|Overall Study||15
407981|NCT00093470|1001021|P2|NOT COMPLETED|Overall Study||0
407982|NCT00093470|1001022|P1|NOT COMPLETED|Overall Study||73
407983|NCT00093470|1001021|P2|COMPLETED|Overall Study|Patients underwent observation only.|71
407984|NCT00093470|1001022|P1|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
407985|NCT00093470|1001021|P2|Patients With Toxicity Assessment|Overall Study||69
407986|NCT00093470|1001022|P1|Patients With Toxicity Assessment|Overall Study||72
407987|NCT00093470|1001021|P2|Treated|Overall Study||71
407988|NCT00093470|1001022|P1|Treated|Overall Study||72
407989|NCT00093470|1001021|P2|STARTED|Overall Study||71
407990|NCT00093470|1001022|P1|STARTED|Overall Study||73
407991|NCT00093379|1001030|P1|NOT COMPLETED|Overall Study||0
407992|NCT00093379|1001030|P1|COMPLETED|Overall Study||20
407993|NCT00093379|1001030|P1|STARTED|Overall Study||20
407994|NCT00093145|1001036|P1|NOT COMPLETED|Overall Study||17
407995|NCT00093145|1001036|P1|COMPLETED|Overall Study|Treatment completed upon progressive disease|15
407996|NCT00093145|1001036|P1|At Least One Response Assessment|Overall Study||31
407997|NCT00093145|1001036|P1|STARTED|Overall Study||32
407998|NCT00093041|1001051|P6|NOT COMPLETED|Overall Study||3
407999|NCT00093041|1001052|P5|NOT COMPLETED|Overall Study||1
408000|NCT00093041|1001053|P4|NOT COMPLETED|Overall Study||1
408001|NCT00093041|1001054|P3|NOT COMPLETED|Overall Study||2
408002|NCT00093041|1001055|P2|NOT COMPLETED|Overall Study||3
408003|NCT00093041|1001056|P1|NOT COMPLETED|Overall Study||2
408004|NCT00093041|1001051|P6|COMPLETED|Overall Study|Three discontinued during multiple dose period|4
408005|NCT00093041|1001052|P5|COMPLETED|Overall Study|One discontinued during multiple dose period|3
408006|NCT00093041|1001053|P4|COMPLETED|Overall Study|One discontinued during single dose period|3
408007|NCT00093041|1001054|P3|COMPLETED|Overall Study|Two discontinued during single dose period|3
408008|NCT00093041|1001055|P2|COMPLETED|Overall Study|Three discontinued during single dose period|1
408009|NCT00093041|1001056|P1|COMPLETED|Overall Study|One discontinued during single dose period and one during multiple dose period|2
408010|NCT00093041|1001051|P6|STARTED|Overall Study||7
408011|NCT00093041|1001052|P5|STARTED|Overall Study||4
408012|NCT00093041|1001053|P4|STARTED|Overall Study||4
408013|NCT00093041|1001054|P3|STARTED|Overall Study||5
408014|NCT00093041|1001055|P2|STARTED|Overall Study||4
408015|NCT00093041|1001056|P1|STARTED|Overall Study||4
408016|NCT00093015|1001078|P2|NOT COMPLETED|Overall Study||664
408017|NCT00093015|1001079|P1|NOT COMPLETED|Overall Study||665
408018|NCT00093015|1001078|P2|COMPLETED|Overall Study||1348
408019|NCT00093015|1001079|P1|COMPLETED|Overall Study||1361
408020|NCT00093015|1001078|P2|Received Study Medication|Overall Study||2004
408021|NCT00093015|1001079|P1|Received Study Medication|Overall Study||2019
408022|NCT00093015|1001078|P2|STARTED|Overall Study||2012
408023|NCT00093015|1001079|P1|STARTED|Overall Study||2026
408024|NCT00092677|1001107|P2|NOT COMPLETED|Overall Study||11
408025|NCT00092677|1001108|P1|NOT COMPLETED|Overall Study||5
408026|NCT00092677|1001107|P2|COMPLETED|Overall Study|Placebo: 698 (on drug), 120 (after drug discon), 100 (at death)|918
408027|NCT00092677|1001108|P1|COMPLETED|Overall Study|EZ/Simva: 694 (on drug), 140 (after drug discon), 105 (at death)|939
408028|NCT00092677|1001107|P2|STARTED|Overall Study||929
408029|NCT00092677|1001108|P1|STARTED|Overall Study||944
408030|NCT00092547|1001152|P3|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
408031|NCT00092547|1001153|P2|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
408032|NCT00092547|1001154|P1|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
408033|NCT00092547|1001152|P3|COMPLETED|Long-term Follow-up (Month 126 Visit)||211
408034|NCT00092547|1001153|P2|COMPLETED|Long-term Follow-up (Month 126 Visit)||0
408035|NCT00092547|1001154|P1|COMPLETED|Long-term Follow-up (Month 126 Visit)||454
408036|NCT00092547|1001152|P3|STARTED|Long-term Follow-up (Month 126 Visit)||211
408037|NCT00092547|1001153|P2|STARTED|Long-term Follow-up (Month 126 Visit)||0
408038|NCT00092547|1001154|P1|STARTED|Long-term Follow-up (Month 126 Visit)||454
408039|NCT00092547|1001152|P3|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
408040|NCT00092547|1001153|P2|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
408041|NCT00092547|1001154|P1|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
408042|NCT00092547|1001152|P3|COMPLETED|Long-term Follow-up (Month 96 Visit)||267
408043|NCT00092547|1001153|P2|COMPLETED|Long-term Follow-up (Month 96 Visit)||0
408044|NCT00092547|1001154|P1|COMPLETED|Long-term Follow-up (Month 96 Visit)||508
408045|NCT00092547|1001152|P3|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|267
408046|NCT00092547|1001153|P2|STARTED|Long-term Follow-up (Month 96 Visit)||0
408047|NCT00092547|1001154|P1|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|508
408048|NCT00092547|1001152|P3|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
408049|NCT00092547|1001153|P2|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
408050|NCT00092547|1001154|P1|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
408051|NCT00092547|1001152|P3|COMPLETED|Long-term Follow-up (Month 72 Visit)||276
408052|NCT00092547|1001153|P2|COMPLETED|Long-term Follow-up (Month 72 Visit)||0
408053|NCT00092547|1001154|P1|COMPLETED|Long-term Follow-up (Month 72 Visit)||550
408054|NCT00092547|1001152|P3|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|276
408055|NCT00092547|1001153|P2|STARTED|Long-term Follow-up (Month 72 Visit)||0
408056|NCT00092547|1001154|P1|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|550
408057|NCT00092547|1001152|P3|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
408058|NCT00092547|1001153|P2|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
408059|NCT00092547|1001154|P1|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||1
408060|NCT00092547|1001152|P3|COMPLETED|Long-term Follow-up (Month 42 Visit)||308
408061|NCT00092547|1001153|P2|COMPLETED|Long-term Follow-up (Month 42 Visit)||0
408062|NCT00092547|1001154|P1|COMPLETED|Long-term Follow-up (Month 42 Visit)||611
408063|NCT00092547|1001152|P3|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|308
408064|NCT00092547|1001153|P2|STARTED|Long-term Follow-up (Month 42 Visit)||0
408065|NCT00092547|1001154|P1|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|612
408066|NCT00092547|1001152|P3|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||16
408067|NCT00092547|1001153|P2|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
408068|NCT00092547|1001154|P1|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||23
408069|NCT00092547|1001152|P3|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||469
408070|NCT00092547|1001153|P2|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
408071|NCT00092547|1001154|P1|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||933
408072|NCT00092547|1001152|P3|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||482
408073|NCT00092547|1001153|P2|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
408074|NCT00092547|1001154|P1|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
408075|NCT00092547|1001152|P3|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|485
408076|NCT00092547|1001153|P2|STARTED|Extension Vaccine Phase (Month 30 to 37)||0
408077|NCT00092547|1001154|P1|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|956
408078|NCT00092547|1001152|P3|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
408079|NCT00092547|1001153|P2|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||5
408080|NCT00092547|1001154|P1|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||8
408081|NCT00092547|1001152|P3|COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
408082|NCT00092547|1001153|P2|COMPLETED|Base Follow-up Phase (Month 18 to 30)||485
408083|NCT00092547|1001154|P1|COMPLETED|Base Follow-up Phase (Month 18 to 30)||956
408084|NCT00092547|1001152|P3|STARTED|Base Follow-up Phase (Month 18 to 30)||0
408085|NCT00092547|1001153|P2|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|490
408086|NCT00092547|1001154|P1|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|964
408087|NCT00092547|1001152|P3|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
408088|NCT00092547|1001153|P2|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||14
408229|NCT00092495|1001235|P5|STARTED|Base Study Vaccination Period||0
408089|NCT00092547|1001154|P1|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||20
408090|NCT00092547|1001152|P3|COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
408091|NCT00092547|1001153|P2|COMPLETED|Base Follow-up Phase (Month 7 to 18)||551
408092|NCT00092547|1001154|P1|COMPLETED|Base Follow-up Phase (Month 7 to 18)||1108
408093|NCT00092547|1001152|P3|STARTED|Base Follow-up Phase (Month 7 to 18)||0
408094|NCT00092547|1001153|P2|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|565
408095|NCT00092547|1001154|P1|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|1128
408096|NCT00092547|1001152|P3|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
408097|NCT00092547|1001153|P2|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||36
408098|NCT00092547|1001154|P1|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||63
408099|NCT00092547|1001152|P3|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
408100|NCT00092547|1001153|P2|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||561
408101|NCT00092547|1001154|P1|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||1121
408102|NCT00092547|1001152|P3|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||0
408103|NCT00092547|1001153|P2|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||596
408104|NCT00092547|1001154|P1|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||1179
408105|NCT00092547|1001152|P3|STARTED|Base Vaccine Phase (Day 1 to Month 7)||0
408106|NCT00092547|1001153|P2|STARTED|Base Vaccine Phase (Day 1 to Month 7)||597
408107|NCT00092547|1001154|P1|STARTED|Base Vaccine Phase (Day 1 to Month 7)||1184
408108|NCT00092534|1001198|P3|NOT COMPLETED|Extension Study||145
408109|NCT00092534|1001199|P2|NOT COMPLETED|Extension Study||0
408110|NCT00092534|1001200|P1|NOT COMPLETED|Extension Study||0
408111|NCT00092534|1001198|P3|COMPLETED|Extension Study||449
408112|NCT00092534|1001199|P2|COMPLETED|Extension Study||0
408113|NCT00092534|1001200|P1|COMPLETED|Extension Study||0
408114|NCT00092534|1001198|P3|STARTED|Extension Study||594
408115|NCT00092534|1001199|P2|STARTED|Extension Study||0
408116|NCT00092534|1001200|P1|STARTED|Extension Study||0
408117|NCT00092534|1001198|P3|NOT COMPLETED|Base Study Follow Up Period||0
408118|NCT00092534|1001199|P2|NOT COMPLETED|Base Study Follow Up Period||694
408119|NCT00092534|1001200|P1|NOT COMPLETED|Base Study Follow Up Period||316
408120|NCT00092534|1001198|P3|COMPLETED|Base Study Follow Up Period||0
408121|NCT00092534|1001199|P2|COMPLETED|Base Study Follow Up Period||5277
408122|NCT00092534|1001200|P1|COMPLETED|Base Study Follow Up Period||5626
408123|NCT00092534|1001198|P3|STARTED|Base Study Follow Up Period||0
408124|NCT00092534|1001199|P2|STARTED|Base Study Follow Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5971
408125|NCT00092534|1001200|P1|STARTED|Base Study Follow Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5942
408126|NCT00092534|1001198|P3|NOT COMPLETED|Base Study Vaccination Period||0
408127|NCT00092534|1001199|P2|NOT COMPLETED|Base Study Vaccination Period||126
408128|NCT00092534|1001200|P1|NOT COMPLETED|Base Study Vaccination Period||171
408129|NCT00092534|1001198|P3|COMPLETED|Base Study Vaccination Period||0
408130|NCT00092534|1001199|P2|COMPLETED|Base Study Vaccination Period||5954
408131|NCT00092534|1001200|P1|COMPLETED|Base Study Vaccination Period||5916
408132|NCT00092534|1001198|P3|STARTED|Base Study Vaccination Period||0
408133|NCT00092534|1001199|P2|STARTED|Base Study Vaccination Period||6080
408134|NCT00092534|1001200|P1|STARTED|Base Study Vaccination Period||6087
408135|NCT00092521|1001218|P4|NOT COMPLETED|Extension Study (Group 4)||209
408136|NCT00092521|1001219|P3|NOT COMPLETED|Extension Study (Group 4)||0
408137|NCT00092521|1001220|P2|NOT COMPLETED|Extension Study (Group 4)||0
408138|NCT00092521|1001221|P1|NOT COMPLETED|Extension Study (Group 4)||0
408139|NCT00092521|1001218|P4|COMPLETED|Extension Study (Group 4)||635
408140|NCT00092521|1001219|P3|COMPLETED|Extension Study (Group 4)||0
408141|NCT00092521|1001220|P2|COMPLETED|Extension Study (Group 4)||0
408142|NCT00092521|1001221|P1|COMPLETED|Extension Study (Group 4)||0
408143|NCT00092521|1001218|P4|Received >=1 Dose in Extension Study|Extension Study (Group 4)||801
408144|NCT00092521|1001219|P3|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
408145|NCT00092521|1001220|P2|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
408146|NCT00092521|1001221|P1|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
408147|NCT00092521|1001218|P4|Initiated Extension Study|Extension Study (Group 4)||829
408148|NCT00092521|1001219|P3|Initiated Extension Study|Extension Study (Group 4)||0
408149|NCT00092521|1001220|P2|Initiated Extension Study|Extension Study (Group 4)||0
408150|NCT00092521|1001221|P1|Initiated Extension Study|Extension Study (Group 4)||0
408151|NCT00092521|1001218|P4|STARTED|Extension Study (Group 4)||844
408152|NCT00092521|1001219|P3|STARTED|Extension Study (Group 4)||0
408153|NCT00092521|1001220|P2|STARTED|Extension Study (Group 4)||0
408154|NCT00092521|1001221|P1|STARTED|Extension Study (Group 4)||0
408155|NCT00092521|1001218|P4|NOT COMPLETED|Follow-Up (After Month 7)||0
408156|NCT00092521|1001219|P3|NOT COMPLETED|Follow-Up (After Month 7)||648
408157|NCT00092521|1001220|P2|NOT COMPLETED|Follow-Up (After Month 7)||136
408158|NCT00092521|1001221|P1|NOT COMPLETED|Follow-Up (After Month 7)||246
408159|NCT00092521|1001218|P4|COMPLETED|Follow-Up (After Month 7)||0
408160|NCT00092521|1001219|P3|COMPLETED|Follow-Up (After Month 7)||1959
408161|NCT00092521|1001220|P2|COMPLETED|Follow-Up (After Month 7)||155
408162|NCT00092521|1001221|P1|COMPLETED|Follow-Up (After Month 7)||2353
408163|NCT00092521|1001218|P4|STARTED|Follow-Up (After Month 7)||0
408164|NCT00092521|1001219|P3|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2607
408165|NCT00092521|1001220|P2|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|291
408166|NCT00092521|1001221|P1|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2599
408167|NCT00092521|1001218|P4|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||0
408168|NCT00092521|1001219|P3|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||146
408169|NCT00092521|1001220|P2|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||14
408170|NCT00092521|1001221|P1|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||140
408171|NCT00092521|1001218|P4|COMPLETED|Vaccination (Day 1 Through Month 7)||0
408172|NCT00092521|1001219|P3|COMPLETED|Vaccination (Day 1 Through Month 7)||2586
408173|NCT00092521|1001220|P2|COMPLETED|Vaccination (Day 1 Through Month 7)||290
408174|NCT00092521|1001221|P1|COMPLETED|Vaccination (Day 1 Through Month 7)||2583
408175|NCT00092521|1001218|P4|STARTED|Vaccination (Day 1 Through Month 7)||0
408176|NCT00092521|1001219|P3|STARTED|Vaccination (Day 1 Through Month 7)||2732
408177|NCT00092521|1001220|P2|STARTED|Vaccination (Day 1 Through Month 7)||304
408178|NCT00092521|1001221|P1|STARTED|Vaccination (Day 1 Through Month 7)||2723
408179|NCT00092495|1001235|P5|NOT COMPLETED|Extension Study||0
408180|NCT00092495|1001236|P4|NOT COMPLETED|Extension Study||0
408181|NCT00092495|1001237|P3|NOT COMPLETED|Extension Study||0
408182|NCT00092495|1001238|P2|NOT COMPLETED|Extension Study||0
408183|NCT00092495|1001239|P1|NOT COMPLETED|Extension Study||0
408184|NCT00092495|1001235|P5|COMPLETED|Extension Study||12
408185|NCT00092495|1001236|P4|COMPLETED|Extension Study||0
408186|NCT00092495|1001237|P3|COMPLETED|Extension Study||0
408187|NCT00092495|1001238|P2|COMPLETED|Extension Study||0
408188|NCT00092495|1001239|P1|COMPLETED|Extension Study||0
408189|NCT00092495|1001235|P5|STARTED|Extension Study||12
408190|NCT00092495|1001236|P4|STARTED|Extension Study||0
408191|NCT00092495|1001237|P3|STARTED|Extension Study||0
408192|NCT00092495|1001238|P2|STARTED|Extension Study||0
408193|NCT00092495|1001239|P1|STARTED|Extension Study||0
408194|NCT00092495|1001235|P5|NOT COMPLETED|Base Study Follow-up Period||0
408195|NCT00092495|1001236|P4|NOT COMPLETED|Base Study Follow-up Period||14
408196|NCT00092495|1001237|P3|NOT COMPLETED|Base Study Follow-up Period||4
408197|NCT00092495|1001238|P2|NOT COMPLETED|Base Study Follow-up Period||3
408198|NCT00092495|1001239|P1|NOT COMPLETED|Base Study Follow-up Period||3
408199|NCT00092495|1001235|P5|COMPLETED|Base Study Follow-up Period||0
408200|NCT00092495|1001236|P4|COMPLETED|Base Study Follow-up Period||446
408201|NCT00092495|1001237|P3|COMPLETED|Base Study Follow-up Period||126
408202|NCT00092495|1001238|P2|COMPLETED|Base Study Follow-up Period||122
408203|NCT00092495|1001239|P1|COMPLETED|Base Study Follow-up Period||112
408204|NCT00092495|1001235|P5|STARTED|Base Study Follow-up Period||0
408205|NCT00092495|1001236|P4|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|460
408206|NCT00092495|1001237|P3|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|130
408207|NCT00092495|1001238|P2|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|125
408208|NCT00092495|1001239|P1|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|115
408209|NCT00092495|1001235|P5|NOT COMPLETED|Base Study Vaccination Period||0
408210|NCT00092495|1001236|P4|NOT COMPLETED|Base Study Vaccination Period||88
408211|NCT00092495|1001237|P3|NOT COMPLETED|Base Study Vaccination Period||34
408212|NCT00092495|1001238|P2|NOT COMPLETED|Base Study Vaccination Period||22
408213|NCT00092495|1001239|P1|NOT COMPLETED|Base Study Vaccination Period||37
408214|NCT00092495|1001235|P5|COMPLETED|Base Study Vaccination Period||0
408215|NCT00092495|1001236|P4|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|1441
408216|NCT00092495|1001237|P3|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|474
408217|NCT00092495|1001238|P2|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|492
408218|NCT00092495|1001239|P1|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|467
408219|NCT00092495|1001235|P5|Without Long-term Follow-up|Base Study Vaccination Period||0
408220|NCT00092495|1001236|P4|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|73
408221|NCT00092495|1001237|P3|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|28
408222|NCT00092495|1001238|P2|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|20
408223|NCT00092495|1001239|P1|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|34
408224|NCT00092495|1001235|P5|With Long-term Follow-up *|Base Study Vaccination Period||0
408225|NCT00092495|1001236|P4|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|10
408226|NCT00092495|1001237|P3|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|6
408227|NCT00092495|1001238|P2|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
408228|NCT00092495|1001239|P1|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
408230|NCT00092495|1001236|P4|STARTED|Base Study Vaccination Period||1529
408231|NCT00092495|1001237|P3|STARTED|Base Study Vaccination Period||508
408232|NCT00092495|1001238|P2|STARTED|Base Study Vaccination Period||514
408233|NCT00092495|1001239|P1|STARTED|Base Study Vaccination Period||504
408234|NCT00092456|1001305|P4|NOT COMPLETED|Overall Study||16
408235|NCT00092456|1001306|P3|NOT COMPLETED|Overall Study||29
408236|NCT00092456|1001307|P2|NOT COMPLETED|Overall Study||17
408237|NCT00092456|1001308|P1|NOT COMPLETED|Overall Study||25
408238|NCT00092456|1001305|P4|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|97
408239|NCT00092456|1001306|P3|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|200
408240|NCT00092456|1001307|P2|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|208
408241|NCT00092456|1001308|P1|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|201
408242|NCT00092456|1001305|P4|Vaccinated at Visit 3|Overall Study||98
408243|NCT00092456|1001306|P3|Vaccinated at Visit 3|Overall Study||200
408244|NCT00092456|1001307|P2|Vaccinated at Visit 3|Overall Study||210
408245|NCT00092456|1001308|P1|Vaccinated at Visit 3|Overall Study||202
408246|NCT00092456|1001305|P4|Vaccinated at Visit 2|Overall Study||104
408247|NCT00092456|1001306|P3|Vaccinated at Visit 2|Overall Study||210
408248|NCT00092456|1001307|P2|Vaccinated at Visit 2|Overall Study||217
408249|NCT00092456|1001308|P1|Vaccinated at Visit 2|Overall Study||208
408250|NCT00092456|1001305|P4|Vaccinated at Visit 1|Overall Study||113
408251|NCT00092456|1001306|P3|Vaccinated at Visit 1|Overall Study||229
408252|NCT00092456|1001307|P2|Vaccinated at Visit 1|Overall Study||225
408253|NCT00092456|1001308|P1|Vaccinated at Visit 1|Overall Study||226
408254|NCT00092456|1001305|P4|STARTED|Overall Study|Subjects assigned to Placebo-matching RotaTeq™|113
408255|NCT00092456|1001306|P3|STARTED|Overall Study|Subject assigned to ~6.91 X 10^7 IU/Dose of RotaTeq™ - Lot 3|229
408256|NCT00092456|1001307|P2|STARTED|Overall Study|Subject assigned to ~8.01 X 10^7 IU/Dose of RotaTeq™ - Lot 2|225
408257|NCT00092456|1001308|P1|STARTED|Overall Study|Subject assigned to ~8.81 X 10^7 IU/Dose of RotaTeq™ - Lot 1|226
408258|NCT00092443|1001356|P2|NOT COMPLETED|Overall Study||54
408259|NCT00092443|1001357|P1|NOT COMPLETED|Overall Study||58
408260|NCT00092443|1001356|P2|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|607
408261|NCT00092443|1001357|P1|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|593
408262|NCT00092443|1001356|P2|Vaccinated at Visit 3|Overall Study||608
408263|NCT00092443|1001357|P1|Vaccinated at Visit 3|Overall Study||593
408264|NCT00092443|1001356|P2|Vaccinated at Visit 2|Overall Study||627
408265|NCT00092443|1001357|P1|Vaccinated at Visit 2|Overall Study||618
408266|NCT00092443|1001356|P2|Vaccinated at Visit 1|Overall Study||660
408267|NCT00092443|1001357|P1|Vaccinated at Visit 1|Overall Study||650
408268|NCT00092443|1001356|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|661
408269|NCT00092443|1001357|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|651
408270|NCT00092417|1001375|P2|NOT COMPLETED|Overall Study||1
408271|NCT00092417|1001376|P1|NOT COMPLETED|Overall Study||5
408272|NCT00092417|1001375|P2|COMPLETED|Overall Study|Received the lower potency zoster vaccine & completed 42 days of safety follow-up post vaccination|233
408273|NCT00092417|1001376|P1|COMPLETED|Overall Study|Received the higher potency zoster vaccine & completed 42 days of safety follow-up post vaccination|459
408274|NCT00092417|1001375|P2|Vaccinated|Overall Study||234
408275|NCT00092417|1001376|P1|Vaccinated|Overall Study|3 participants were allocated,not vaccinated; they are not reported in the Baseline Characteristics|461
408276|NCT00092417|1001375|P2|STARTED|Overall Study|Started Period Group 2|234
408277|NCT00092417|1001376|P1|STARTED|Overall Study|Started Period Group 1|464
408278|NCT00092131|1001390|P2|NOT COMPLETED|Treatment Period II||1
408279|NCT00092131|1001391|P1|NOT COMPLETED|Treatment Period II||0
408280|NCT00092131|1001390|P2|COMPLETED|Treatment Period II||25
408281|NCT00092131|1001391|P1|COMPLETED|Treatment Period II||24
408282|NCT00092131|1001390|P2|STARTED|Treatment Period II|1 patient discontinued after taking Period II study medication, due to asthma exacerbation|26
408283|NCT00092131|1001391|P1|STARTED|Treatment Period II||24
408284|NCT00092131|1001390|P2|NOT COMPLETED|Treatment Period I||0
408285|NCT00092131|1001391|P1|NOT COMPLETED|Treatment Period I||1
408286|NCT00092131|1001390|P2|COMPLETED|Treatment Period I||26
408287|NCT00092131|1001391|P1|COMPLETED|Treatment Period I||24
408288|NCT00092131|1001390|P2|STARTED|Treatment Period I||26
408289|NCT00092131|1001391|P1|STARTED|Treatment Period I|1 patient discontinued due to influenza which started in washout (11 days after Period I medication)|25
408290|NCT00092118|1001421|P2|NOT COMPLETED|Overall Study||89
408291|NCT00092118|1001422|P1|NOT COMPLETED|Overall Study||84
408292|NCT00092118|1001421|P2|COMPLETED|Overall Study||913
408293|NCT00092118|1001422|P1|COMPLETED|Overall Study||906
408294|NCT00092118|1001421|P2|STARTED|Overall Study|2 patients discontinued after randomization due to adverse experience that began pre-randomization.|1002
408295|NCT00092118|1001422|P1|STARTED|Overall Study|1 patient discontinued after randomization due to a adverse experience that began pre-randomization.|990
408296|NCT00091962|1001435|P3|NOT COMPLETED|Overall Study||0
408297|NCT00091962|1001436|P2|NOT COMPLETED|Overall Study||0
408298|NCT00091962|1001437|P1|NOT COMPLETED|Overall Study||0
408299|NCT00091962|1001435|P3|COMPLETED|Overall Study||151
408300|NCT00091962|1001436|P2|COMPLETED|Overall Study||152
408301|NCT00091962|1001437|P1|COMPLETED|Overall Study||150
408302|NCT00091962|1001435|P3|STARTED|Overall Study||151
408303|NCT00091962|1001436|P2|STARTED|Overall Study||152
408304|NCT00091962|1001437|P1|STARTED|Overall Study||150
408305|NCT00091949|1001456|P2|NOT COMPLETED|Overall Study||151
408306|NCT00091949|1001457|P1|NOT COMPLETED|Overall Study||175
408307|NCT00091949|1001456|P2|COMPLETED|Overall Study||1786
408308|NCT00091949|1001457|P1|COMPLETED|Overall Study||1764
408309|NCT00091949|1001456|P2|STARTED|Overall Study||1937
408310|NCT00091949|1001457|P1|STARTED|Overall Study||1939
408311|NCT00091832|1001481|P6|NOT COMPLETED|Overall Study||11
408312|NCT00091832|1001482|P5|NOT COMPLETED|Overall Study||15
408313|NCT00091832|1001483|P4|NOT COMPLETED|Overall Study||14
408314|NCT00091832|1001484|P3|NOT COMPLETED|Overall Study||12
408315|NCT00091832|1001485|P2|NOT COMPLETED|Overall Study||11
408316|NCT00091832|1001486|P1|NOT COMPLETED|Overall Study||14
408317|NCT00091832|1001481|P6|COMPLETED|Overall Study||32
408318|NCT00091832|1001482|P5|COMPLETED|Overall Study||27
408319|NCT00091832|1001483|P4|COMPLETED|Overall Study||29
408320|NCT00091832|1001484|P3|COMPLETED|Overall Study||30
408321|NCT00091832|1001485|P2|COMPLETED|Overall Study||31
408322|NCT00091832|1001486|P1|COMPLETED|Overall Study||29
408323|NCT00091832|1001481|P6|Received Study Medication|Overall Study||43
408324|NCT00091832|1001482|P5|Received Study Medication|Overall Study||42
408325|NCT00091832|1001483|P4|Received Study Medication|Overall Study||43
408326|NCT00091832|1001484|P3|Received Study Medication|Overall Study||41
408327|NCT00091832|1001485|P2|Received Study Medication|Overall Study||42
408328|NCT00091832|1001486|P1|Received Study Medication|Overall Study||43
408329|NCT00091832|1001481|P6|STARTED|Overall Study||43
408330|NCT00091832|1001482|P5|STARTED|Overall Study||42
408331|NCT00091832|1001483|P4|STARTED|Overall Study||43
408332|NCT00091832|1001484|P3|STARTED|Overall Study||42
408333|NCT00091832|1001485|P2|STARTED|Overall Study||42
408334|NCT00091832|1001486|P1|STARTED|Overall Study||43
408335|NCT00091819|1001604|P2|NOT COMPLETED|Overall Study||46
408336|NCT00091819|1001605|P1|NOT COMPLETED|Overall Study||42
408337|NCT00091819|1001604|P2|COMPLETED|Overall Study||387
408338|NCT00091819|1001605|P1|COMPLETED|Overall Study||387
408339|NCT00091819|1001604|P2|STARTED|Overall Study||433
408340|NCT00091819|1001605|P1|STARTED|Overall Study||429
408341|NCT00091793|1001613|P2|NOT COMPLETED|Overall Study||22
408342|NCT00091793|1001614|P1|NOT COMPLETED|Overall Study||24
408343|NCT00091793|1001613|P2|COMPLETED|Overall Study||144
408344|NCT00091793|1001614|P1|COMPLETED|Overall Study||142
408345|NCT00091793|1001613|P2|STARTED|Overall Study||166
408346|NCT00091793|1001614|P1|STARTED|Overall Study||166
408347|NCT00091572|1001638|P2|NOT COMPLETED|Overall Study||82
408348|NCT00091572|1001639|P1|NOT COMPLETED|Overall Study||95
408349|NCT00091572|1001638|P2|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|348
408350|NCT00091572|1001639|P1|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|334
408351|NCT00091572|1001638|P2|STARTED|Overall Study|9 subjects in dacarbazine group not treated.|430
408352|NCT00091572|1001639|P1|STARTED|Overall Study|10 subjects in temozolomide group not treated.|429
408353|NCT00091507|1001653|P2|NOT COMPLETED|Overall Study||19
408354|NCT00091507|1001654|P1|NOT COMPLETED|Overall Study||21
408355|NCT00091507|1001653|P2|COMPLETED|Overall Study||460
408356|NCT00091507|1001654|P1|COMPLETED|Overall Study||411
408357|NCT00091507|1001653|P2|STARTED|Overall Study||479
408358|NCT00091507|1001654|P1|STARTED|Overall Study||432
408359|NCT00091442|1001670|P2|NOT COMPLETED|Overall Study||373
408360|NCT00091442|1001671|P1|NOT COMPLETED|Overall Study||369
408361|NCT00091442|1001670|P2|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|5
408362|NCT00091442|1001671|P1|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|4
408363|NCT00091442|1001670|P2|STARTED|Overall Study||378
408364|NCT00091442|1001671|P1|STARTED|Overall Study||373
408365|NCT00091390|1001681|P1|NOT COMPLETED|Overall Study||4
408366|NCT00091390|1001681|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|125
408367|NCT00091390|1001681|P1|STARTED|Overall Study||129
408368|NCT00091273|1001685|P1|NOT COMPLETED|Overall Study||0
408369|NCT00091273|1001685|P1|COMPLETED|Overall Study||9
408370|NCT00091273|1001685|P1|STARTED|Overall Study||9
408371|NCT00091260|1001691|P1|NOT COMPLETED|Overall Study||0
408372|NCT00091260|1001691|P1|COMPLETED|Overall Study||82
408373|NCT00091260|1001691|P1|STARTED|Overall Study||82
408374|NCT00091169|1001699|P2|NOT COMPLETED|Overall Study||53
408375|NCT00091169|1001700|P1|NOT COMPLETED|Overall Study||57
408376|NCT00091169|1001699|P2|COMPLETED|Overall Study||134
408377|NCT00091169|1001700|P1|COMPLETED|Overall Study||132
408378|NCT00091169|1001699|P2|Treated|Overall Study||170
408379|NCT00091169|1001700|P1|Treated|Overall Study||163
408380|NCT00091169|1001699|P2|STARTED|Overall Study||187
408381|NCT00091169|1001700|P1|STARTED|Overall Study||189
408382|NCT00091026|1001718|P2|NOT COMPLETED|Overall Study||3
408383|NCT00091026|1001719|P1|NOT COMPLETED|Overall Study||1
408384|NCT00091026|1001718|P2|COMPLETED|Overall Study||68
408385|NCT00091026|1001719|P1|COMPLETED|Overall Study||71
408386|NCT00091026|1001718|P2|STARTED|Overall Study||71
408387|NCT00091026|1001719|P1|STARTED|Overall Study||72
408388|NCT00090987|1001729|P1|NOT COMPLETED|Overall Study||21
408389|NCT00090987|1001729|P1|COMPLETED|Overall Study||9
408390|NCT00090987|1001729|P1|STARTED|Overall Study||30
408391|NCT00090870|1001733|P1|NOT COMPLETED|Overall Study||0
408392|NCT00090870|1001733|P1|COMPLETED|Overall Study||10
408393|NCT00090870|1001733|P1|STARTED|Overall Study||10
408394|NCT00090857|1001742|P2|NOT COMPLETED|Overall Study||3
408395|NCT00090857|1001743|P1|NOT COMPLETED|Overall Study||4
408396|NCT00090857|1001742|P2|COMPLETED|Overall Study||13
408397|NCT00090857|1001743|P1|COMPLETED|Overall Study||29
408398|NCT00090857|1001742|P2|STARTED|Overall Study||16
408399|NCT00090857|1001743|P1|STARTED|Overall Study||33
408400|NCT00090844|1001773|P2|NOT COMPLETED|Overall Study||1
408401|NCT00090844|1001774|P1|NOT COMPLETED|Overall Study||1
408402|NCT00090844|1001773|P2|COMPLETED|Overall Study||21
408403|NCT00090844|1001774|P1|COMPLETED|Overall Study||26
408404|NCT00090844|1001773|P2|STARTED|Overall Study||22
408405|NCT00090844|1001774|P1|STARTED|Overall Study||27
408406|NCT00090779|1001782|P2|NOT COMPLETED|Step 3||5
408407|NCT00090779|1001783|P1|NOT COMPLETED|Step 3||7
408408|NCT00090779|1001782|P2|COMPLETED|Step 3||0
408409|NCT00090779|1001783|P1|COMPLETED|Step 3||0
408410|NCT00090779|1001782|P2|STARTED|Step 3||5
408411|NCT00090779|1001783|P1|STARTED|Step 3||7
408412|NCT00090779|1001782|P2|NOT COMPLETED|Step 2||18
408413|NCT00090779|1001783|P1|NOT COMPLETED|Step 2||6
408414|NCT00090779|1001782|P2|COMPLETED|Step 2||1
408415|NCT00090779|1001783|P1|COMPLETED|Step 2||0
408416|NCT00090779|1001782|P2|STARTED|Step 2|Three with two consecutive CD4<350cells/mm^3 and one with CDC category B event didn't enter step 2.|19
408417|NCT00090779|1001783|P1|STARTED|Step 2|One subject who had two consecutive CD4<350cells/mm^3 did not enter step 2.|6
408418|NCT00090779|1001782|P2|NOT COMPLETED|Step 1||15
408419|NCT00090779|1001783|P1|NOT COMPLETED|Step 1||11
408420|NCT00090779|1001782|P2|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|49
408421|NCT00090779|1001783|P1|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|55
408422|NCT00090779|1001782|P2|STARTED|Step 1||64
408423|NCT00090779|1001783|P1|STARTED|Step 1||66
408424|NCT00090766|1001807|P3|NOT COMPLETED|Overall Study||3
408425|NCT00090766|1001808|P2|NOT COMPLETED|Overall Study||2
408426|NCT00090766|1001809|P1|NOT COMPLETED|Overall Study||3
408427|NCT00090766|1001807|P3|COMPLETED|Overall Study||22
408428|NCT00090766|1001808|P2|COMPLETED|Overall Study||19
408429|NCT00090766|1001809|P1|COMPLETED|Overall Study||14
408430|NCT00090766|1001807|P3|STARTED|Overall Study||25
408431|NCT00090766|1001808|P2|STARTED|Overall Study||21
408432|NCT00090766|1001809|P1|STARTED|Overall Study||17
408433|NCT00090753|1001851|P2|NOT COMPLETED|Extended Treatment Period||191
408434|NCT00090753|1001852|P1|NOT COMPLETED|Extended Treatment Period||359
408435|NCT00090753|1001851|P2|COMPLETED|Extended Treatment Period||59
408436|NCT00090753|1001852|P1|COMPLETED|Extended Treatment Period||94
408437|NCT00090753|1001851|P2|STARTED|Extended Treatment Period|52 patients who completed the first treatment period refused to enter the extended treatment period.|250
408438|NCT00090753|1001852|P1|STARTED|Extended Treatment Period|39 patients who completed the first treatment period refused to enter the extended treatment period.|453
408439|NCT00090753|1001851|P2|NOT COMPLETED|First Treatment Period||178
408440|NCT00090753|1001852|P1|NOT COMPLETED|First Treatment Period||256
408441|NCT00090753|1001851|P2|COMPLETED|First Treatment Period||302
408442|NCT00090753|1001852|P1|COMPLETED|First Treatment Period||492
408443|NCT00090753|1001851|P2|STARTED|First Treatment Period||480
408444|NCT00090753|1001852|P1|STARTED|First Treatment Period||748
408445|NCT00090610|1001862|P2|NOT COMPLETED|Overall Study||1
408446|NCT00090610|1001863|P1|NOT COMPLETED|Overall Study||1
408447|NCT00090610|1001862|P2|COMPLETED|Overall Study||74
408448|NCT00090610|1001863|P1|COMPLETED|Overall Study||74
408449|NCT00090610|1001862|P2|STARTED|Overall Study||75
408450|NCT00090610|1001863|P1|STARTED|Overall Study||75
408451|NCT00090584|1001879|P2|NOT COMPLETED|Baseline to 8 Months||41
408452|NCT00090584|1001880|P1|NOT COMPLETED|Baseline to 8 Months||44
408453|NCT00090584|1001879|P2|COMPLETED|Baseline to 8 Months||112
408454|NCT00090584|1001880|P1|COMPLETED|Baseline to 8 Months||110
408455|NCT00090584|1001879|P2|STARTED|Baseline to 8 Months||153
408456|NCT00090584|1001880|P1|STARTED|Baseline to 8 Months||154
408457|NCT00090584|1001879|P2|NOT COMPLETED|Baseline to 10 Weeks||12
408458|NCT00090584|1001880|P1|NOT COMPLETED|Baseline to 10 Weeks||15
408459|NCT00090584|1001879|P2|COMPLETED|Baseline to 10 Weeks||141
408460|NCT00090584|1001880|P1|COMPLETED|Baseline to 10 Weeks||139
408461|NCT00090584|1001879|P2|STARTED|Baseline to 10 Weeks||153
408462|NCT00090584|1001880|P1|STARTED|Baseline to 10 Weeks||154
408463|NCT00090519|1001912|P2|NOT COMPLETED|Overall Study||75
408464|NCT00090519|1001913|P1|NOT COMPLETED|Overall Study||73
408465|NCT00090519|1001912|P2|COMPLETED|Overall Study||285
408466|NCT00090519|1001913|P1|COMPLETED|Overall Study||298
408467|NCT00090519|1001912|P2|STARTED|Overall Study||360
408468|NCT00090519|1001913|P1|STARTED|Overall Study||371
408469|NCT00090493|1001937|P1|NOT COMPLETED|Overall Study||2
408470|NCT00090493|1001937|P1|COMPLETED|Overall Study||2
408471|NCT00090493|1001937|P1|STARTED|Overall Study||4
408472|NCT00090363|1001944|P3|NOT COMPLETED|Overall Study||96
408473|NCT00090363|1001945|P2|NOT COMPLETED|Overall Study||107
408474|NCT00090363|1001946|P1|NOT COMPLETED|Overall Study||106
408475|NCT00090363|1001944|P3|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|2
408476|NCT00090363|1001945|P2|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|0
408477|NCT00090363|1001946|P1|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|1
408478|NCT00090363|1001944|P3|Received Study Treatment.|Overall Study||98
408479|NCT00090363|1001945|P2|Received Study Treatment.|Overall Study||107
408480|NCT00090363|1001946|P1|Received Study Treatment.|Overall Study||107
408481|NCT00090363|1001944|P3|STARTED|Overall Study||98
408482|NCT00090363|1001945|P2|STARTED|Overall Study||107
408483|NCT00090363|1001946|P1|STARTED|Overall Study||107
408484|NCT00090545|1001968|P2|NOT COMPLETED|Overall Study||24
408485|NCT00090545|1001969|P1|NOT COMPLETED|Overall Study||22
408486|NCT00090545|1001968|P2|COMPLETED|Overall Study||0
408487|NCT00090545|1001969|P1|COMPLETED|Overall Study||0
408488|NCT00090545|1001968|P2|STARTED|Overall Study||24
408489|NCT00090545|1001969|P1|STARTED|Overall Study||22
408490|NCT00090285|1001989|P6|NOT COMPLETED|Long-term Follow-up (EXT2)||203
408491|NCT00090285|1001990|P5|NOT COMPLETED|Long-term Follow-up (EXT2)||227
408492|NCT00090285|1001991|P4|NOT COMPLETED|Long-term Follow-up (EXT2)||0
408493|NCT00090285|1001992|P3|NOT COMPLETED|Long-term Follow-up (EXT2)||0
408494|NCT00090285|1001993|P2|NOT COMPLETED|Long-term Follow-up (EXT2)||0
408495|NCT00090285|1001994|P1|NOT COMPLETED|Long-term Follow-up (EXT2)||0
408496|NCT00090285|1001989|P6|COMPLETED|Long-term Follow-up (EXT2)||664
408497|NCT00090285|1001990|P5|COMPLETED|Long-term Follow-up (EXT2)||709
408498|NCT00090285|1001991|P4|COMPLETED|Long-term Follow-up (EXT2)||0
408499|NCT00090285|1001992|P3|COMPLETED|Long-term Follow-up (EXT2)||0
408500|NCT00090285|1001993|P2|COMPLETED|Long-term Follow-up (EXT2)||0
408501|NCT00090285|1001994|P1|COMPLETED|Long-term Follow-up (EXT2)||0
408502|NCT00090285|1001989|P6|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|867
408503|NCT00090285|1001990|P5|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|936
408504|NCT00090285|1001991|P4|STARTED|Long-term Follow-up (EXT2)||0
408505|NCT00090285|1001992|P3|STARTED|Long-term Follow-up (EXT2)||0
408506|NCT00090285|1001993|P2|STARTED|Long-term Follow-up (EXT2)||0
408507|NCT00090285|1001994|P1|STARTED|Long-term Follow-up (EXT2)||0
408508|NCT00090285|1001989|P6|NOT COMPLETED|Extension 1||0
408509|NCT00090285|1001990|P5|NOT COMPLETED|Extension 1||0
408510|NCT00090285|1001991|P4|NOT COMPLETED|Extension 1||1
408511|NCT00090285|1001992|P3|NOT COMPLETED|Extension 1||57
408512|NCT00090285|1001993|P2|NOT COMPLETED|Extension 1||0
408513|NCT00090285|1001994|P1|NOT COMPLETED|Extension 1||0
408514|NCT00090285|1001989|P6|COMPLETED|Extension 1||0
408515|NCT00090285|1001990|P5|COMPLETED|Extension 1||0
408516|NCT00090285|1001991|P4|COMPLETED|Extension 1||15
408517|NCT00090285|1001992|P3|COMPLETED|Extension 1||1041
408518|NCT00090285|1001993|P2|COMPLETED|Extension 1||0
408519|NCT00090285|1001994|P1|COMPLETED|Extension 1||0
408520|NCT00090285|1001989|P6|STARTED|Extension 1||0
408521|NCT00090285|1001990|P5|STARTED|Extension 1||0
408522|NCT00090285|1001991|P4|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|16
408523|NCT00090285|1001992|P3|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1098
408524|NCT00090285|1001993|P2|STARTED|Extension 1||0
408525|NCT00090285|1001994|P1|STARTED|Extension 1||0
408526|NCT00090285|1001989|P6|NOT COMPLETED|Base Study Follow-up Period||0
408527|NCT00090285|1001990|P5|NOT COMPLETED|Base Study Follow-up Period||0
408528|NCT00090285|1001991|P4|NOT COMPLETED|Base Study Follow-up Period||0
408529|NCT00090285|1001992|P3|NOT COMPLETED|Base Study Follow-up Period||0
408530|NCT00090285|1001993|P2|NOT COMPLETED|Base Study Follow-up Period||342
408531|NCT00090285|1001994|P1|NOT COMPLETED|Base Study Follow-up Period||335
408532|NCT00090285|1001989|P6|COMPLETED|Base Study Follow-up Period||0
408533|NCT00090285|1001990|P5|COMPLETED|Base Study Follow-up Period||0
408534|NCT00090285|1001991|P4|COMPLETED|Base Study Follow-up Period||0
408535|NCT00090285|1001992|P3|COMPLETED|Base Study Follow-up Period||0
408536|NCT00090285|1001993|P2|COMPLETED|Base Study Follow-up Period||1479
408537|NCT00090285|1001994|P1|COMPLETED|Base Study Follow-up Period||1487
408538|NCT00090285|1001989|P6|STARTED|Base Study Follow-up Period||0
408539|NCT00090285|1001990|P5|STARTED|Base Study Follow-up Period||0
408540|NCT00090285|1001991|P4|STARTED|Base Study Follow-up Period||0
408541|NCT00090285|1001992|P3|STARTED|Base Study Follow-up Period||0
408542|NCT00090285|1001993|P2|STARTED|Base Study Follow-up Period|7 subjects who did not receive 3 doses of placebo in base study continued into the Follow-up Period|1821
408543|NCT00090285|1001994|P1|STARTED|Base Study Follow-up Period|4 subjects who did not receive 3 doses of vaccine in base study continued into the Follow-up Period|1822
408544|NCT00090285|1001989|P6|NOT COMPLETED|Base Study Vaccination Period||0
408545|NCT00090285|1001990|P5|NOT COMPLETED|Base Study Vaccination Period||0
408546|NCT00090285|1001991|P4|NOT COMPLETED|Base Study Vaccination Period||0
408547|NCT00090285|1001992|P3|NOT COMPLETED|Base Study Vaccination Period||0
408548|NCT00090285|1001993|P2|NOT COMPLETED|Base Study Vaccination Period||219
408549|NCT00090285|1001994|P1|NOT COMPLETED|Base Study Vaccination Period||214
408550|NCT00090285|1001989|P6|COMPLETED|Base Study Vaccination Period||0
408551|NCT00090285|1001990|P5|COMPLETED|Base Study Vaccination Period||0
408552|NCT00090285|1001991|P4|COMPLETED|Base Study Vaccination Period||0
408553|NCT00090285|1001992|P3|COMPLETED|Base Study Vaccination Period||0
408554|NCT00090285|1001993|P2|COMPLETED|Base Study Vaccination Period||1814
408555|NCT00090285|1001994|P1|COMPLETED|Base Study Vaccination Period||1818
408556|NCT00090285|1001989|P6|Vaccinated|Base Study Vaccination Period||0
408557|NCT00090285|1001990|P5|Vaccinated|Base Study Vaccination Period||0
408558|NCT00090285|1001991|P4|Vaccinated|Base Study Vaccination Period||0
408559|NCT00090285|1001992|P3|Vaccinated|Base Study Vaccination Period||0
408560|NCT00090285|1001993|P2|Vaccinated|Base Study Vaccination Period||2030
408561|NCT00090285|1001994|P1|Vaccinated|Base Study Vaccination Period||2025
408562|NCT00090285|1001989|P6|STARTED|Base Study Vaccination Period||0
408563|NCT00090285|1001990|P5|STARTED|Base Study Vaccination Period||0
408564|NCT00090285|1001991|P4|STARTED|Base Study Vaccination Period||0
408565|NCT00090285|1001992|P3|STARTED|Base Study Vaccination Period||0
408566|NCT00090285|1001993|P2|STARTED|Base Study Vaccination Period||2033
408567|NCT00090285|1001994|P1|STARTED|Base Study Vaccination Period||2032
408568|NCT00090259|1002031|P2|NOT COMPLETED|Overall Study||48
408569|NCT00090259|1002032|P1|NOT COMPLETED|Overall Study||62
408570|NCT00090259|1002031|P2|COMPLETED|Overall Study|Completed follow-up: 1005 on drug, 233 off drug,& 635 at death (death was considered an endpoint)|1873
408571|NCT00090259|1002032|P1|COMPLETED|Overall Study|Completed follow-up: 963 on drug, 223 off drug, & 665 at death (death was considered an endpoint)|1851
408572|NCT00090259|1002031|P2|STARTED|Overall Study||1921
408573|NCT00090259|1002032|P1|STARTED|Overall Study||1913
408574|NCT00090233|1002048|P2|NOT COMPLETED|Overall Study||5065
408575|NCT00090233|1002049|P1|NOT COMPLETED|Overall Study||4999
408576|NCT00090233|1002048|P2|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29565
408577|NCT00090233|1002049|P1|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29645
408578|NCT00090233|1002048|P2|Vaccinated at Visit 3|Overall Study||29598
408579|NCT00090233|1002049|P1|Vaccinated at Visit 3|Overall Study||29667
408580|NCT00090233|1002048|P2|Vaccinated at Visit 2|Overall Study||31066
408581|NCT00090233|1002049|P1|Vaccinated at Visit 2|Overall Study||31052
408582|NCT00090233|1002048|P2|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 627|34003
408583|NCT00090233|1002049|P1|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 609|34035
408584|NCT00090233|1002048|P2|STARTED|Overall Study|Evaluated by data safety monitoring board when they recommended stopping enrollment|34630
408585|NCT00090233|1002049|P1|STARTED|Overall Study|Evaluated by data safety monitoring board (DSMB) when they recommended stopping enrollment|34644
408586|NCT00090220|1002073|P6|NOT COMPLETED|Long-term Follow-up (EXT2)||28
408587|NCT00090220|1002074|P5|NOT COMPLETED|Long-term Follow-up (EXT2)||44
408588|NCT00090220|1002075|P4|NOT COMPLETED|Long-term Follow-up (EXT2)||0
408589|NCT00090220|1002076|P3|NOT COMPLETED|Long-term Follow-up (EXT2)||0
408590|NCT00090220|1002077|P2|NOT COMPLETED|Long-term Follow-up (EXT2)||0
408591|NCT00090220|1002078|P1|NOT COMPLETED|Long-term Follow-up (EXT2)||0
408592|NCT00090220|1002073|P6|COMPLETED|Long-term Follow-up (EXT2)||623
408593|NCT00090220|1002074|P5|COMPLETED|Long-term Follow-up (EXT2)||641
408594|NCT00090220|1002075|P4|COMPLETED|Long-term Follow-up (EXT2)||0
408595|NCT00090220|1002076|P3|COMPLETED|Long-term Follow-up (EXT2)||0
408596|NCT00090220|1002077|P2|COMPLETED|Long-term Follow-up (EXT2)||0
408597|NCT00090220|1002078|P1|COMPLETED|Long-term Follow-up (EXT2)||0
408598|NCT00090220|1002073|P6|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|651
408599|NCT00090220|1002074|P5|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|685
408600|NCT00090220|1002075|P4|STARTED|Long-term Follow-up (EXT2)||0
408601|NCT00090220|1002076|P3|STARTED|Long-term Follow-up (EXT2)||0
408602|NCT00090220|1002077|P2|STARTED|Long-term Follow-up (EXT2)||0
408603|NCT00090220|1002078|P1|STARTED|Long-term Follow-up (EXT2)||0
408604|NCT00090220|1002073|P6|NOT COMPLETED|Extension 1 (EXT1)||0
408605|NCT00090220|1002074|P5|NOT COMPLETED|Extension 1 (EXT1)||0
408606|NCT00090220|1002075|P4|NOT COMPLETED|Extension 1 (EXT1)||2
408607|NCT00090220|1002076|P3|NOT COMPLETED|Extension 1 (EXT1)||55
408608|NCT00090220|1002077|P2|NOT COMPLETED|Extension 1 (EXT1)||0
408609|NCT00090220|1002078|P1|NOT COMPLETED|Extension 1 (EXT1)||0
408610|NCT00090220|1002073|P6|COMPLETED|Extension 1 (EXT1)||0
408611|NCT00090220|1002074|P5|COMPLETED|Extension 1 (EXT1)||0
408612|NCT00090220|1002075|P4|COMPLETED|Extension 1 (EXT1)||5
408613|NCT00090220|1002076|P3|COMPLETED|Extension 1 (EXT1)||1267
408614|NCT00090220|1002077|P2|COMPLETED|Extension 1 (EXT1)||0
408615|NCT00090220|1002078|P1|COMPLETED|Extension 1 (EXT1)||0
408616|NCT00090220|1002073|P6|Vaccinated|Extension 1 (EXT1)||0
408617|NCT00090220|1002074|P5|Vaccinated|Extension 1 (EXT1)||0
408618|NCT00090220|1002075|P4|Vaccinated|Extension 1 (EXT1)||7
408619|NCT00090220|1002076|P3|Vaccinated|Extension 1 (EXT1)||1321
408620|NCT00090220|1002077|P2|Vaccinated|Extension 1 (EXT1)||0
408621|NCT00090220|1002078|P1|Vaccinated|Extension 1 (EXT1)||0
408622|NCT00090220|1002073|P6|STARTED|Extension 1 (EXT1)||0
408623|NCT00090220|1002074|P5|STARTED|Extension 1 (EXT1)||0
408624|NCT00090220|1002075|P4|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|7
408625|NCT00090220|1002076|P3|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1322
408626|NCT00090220|1002077|P2|STARTED|Extension 1 (EXT1)||0
408627|NCT00090220|1002078|P1|STARTED|Extension 1 (EXT1)||0
408628|NCT00090220|1002073|P6|NOT COMPLETED|Base Study Follow-up Period||0
408629|NCT00090220|1002074|P5|NOT COMPLETED|Base Study Follow-up Period||0
408630|NCT00090220|1002075|P4|NOT COMPLETED|Base Study Follow-up Period||0
408631|NCT00090220|1002076|P3|NOT COMPLETED|Base Study Follow-up Period||0
408632|NCT00090220|1002077|P2|NOT COMPLETED|Base Study Follow-up Period||164
408633|NCT00090220|1002078|P1|NOT COMPLETED|Base Study Follow-up Period||160
408634|NCT00090220|1002073|P6|COMPLETED|Base Study Follow-up Period||0
408635|NCT00090220|1002074|P5|COMPLETED|Base Study Follow-up Period||0
408636|NCT00090220|1002075|P4|COMPLETED|Base Study Follow-up Period||0
408637|NCT00090220|1002076|P3|COMPLETED|Base Study Follow-up Period||0
408638|NCT00090220|1002077|P2|COMPLETED|Base Study Follow-up Period||1687
408639|NCT00090220|1002078|P1|COMPLETED|Base Study Follow-up Period||1695
408640|NCT00090220|1002073|P6|STARTED|Base Study Follow-up Period||0
408641|NCT00090220|1002074|P5|STARTED|Base Study Follow-up Period||0
408642|NCT00090220|1002075|P4|STARTED|Base Study Follow-up Period||0
408643|NCT00090220|1002076|P3|STARTED|Base Study Follow-up Period||0
408644|NCT00090220|1002077|P2|STARTED|Base Study Follow-up Period|5 participants did not complete the Vaccination Period but entered the Follow-up Period.|1851
408645|NCT00090220|1002078|P1|STARTED|Base Study Follow-up Period|8 participants did not complete the Vaccination Period but entered the Follow-up Period.|1855
408646|NCT00090220|1002073|P6|NOT COMPLETED|Base Study Vaccination Period||0
408647|NCT00090220|1002074|P5|NOT COMPLETED|Base Study Vaccination Period||0
408648|NCT00090220|1002075|P4|NOT COMPLETED|Base Study Vaccination Period||0
408649|NCT00090220|1002076|P3|NOT COMPLETED|Base Study Vaccination Period||0
408650|NCT00090220|1002077|P2|NOT COMPLETED|Base Study Vaccination Period||63
408651|NCT00090220|1002078|P1|NOT COMPLETED|Base Study Vaccination Period||64
408652|NCT00090220|1002073|P6|COMPLETED|Base Study Vaccination Period||0
408653|NCT00090220|1002074|P5|COMPLETED|Base Study Vaccination Period||0
408654|NCT00090220|1002075|P4|COMPLETED|Base Study Vaccination Period||0
408655|NCT00090220|1002076|P3|COMPLETED|Base Study Vaccination Period||0
408656|NCT00090220|1002077|P2|COMPLETED|Base Study Vaccination Period||1845
408657|NCT00090220|1002078|P1|COMPLETED|Base Study Vaccination Period||1847
408658|NCT00090220|1002073|P6|Vaccinated|Base Study Vaccination Period||0
408659|NCT00090220|1002074|P5|Vaccinated|Base Study Vaccination Period||0
408660|NCT00090220|1002075|P4|Vaccinated|Base Study Vaccination Period||0
408661|NCT00090220|1002076|P3|Vaccinated|Base Study Vaccination Period||0
408662|NCT00090220|1002077|P2|Vaccinated|Base Study Vaccination Period||1907
408663|NCT00090220|1002078|P1|Vaccinated|Base Study Vaccination Period||1910
408664|NCT00090220|1002073|P6|STARTED|Base Study Vaccination Period||0
408665|NCT00090220|1002074|P5|STARTED|Base Study Vaccination Period||0
408666|NCT00090220|1002075|P4|STARTED|Base Study Vaccination Period||0
408667|NCT00090220|1002076|P3|STARTED|Base Study Vaccination Period||0
408668|NCT00090220|1002077|P2|STARTED|Base Study Vaccination Period||1908
408669|NCT00090220|1002078|P1|STARTED|Base Study Vaccination Period||1911
408670|NCT00090402|1002173|P3|NOT COMPLETED|Overall Study||1
408671|NCT00090402|1002174|P2|NOT COMPLETED|Overall Study||2
408672|NCT00090402|1002175|P1|NOT COMPLETED|Overall Study||2
408673|NCT00090402|1002173|P3|COMPLETED|Overall Study||12
408674|NCT00090402|1002174|P2|COMPLETED|Overall Study||11
408675|NCT00090402|1002175|P1|COMPLETED|Overall Study||11
408676|NCT00090402|1002173|P3|STARTED|Overall Study||13
408677|NCT00090402|1002174|P2|STARTED|Overall Study||13
408678|NCT00090402|1002175|P1|STARTED|Overall Study||13
408679|NCT00090142|1002189|P2|NOT COMPLETED|Treatment Period II||0
408680|NCT00090142|1002190|P1|NOT COMPLETED|Treatment Period II||1
408681|NCT00090142|1002189|P2|COMPLETED|Treatment Period II||28
408682|NCT00090142|1002190|P1|COMPLETED|Treatment Period II||25
408683|NCT00090142|1002189|P2|STARTED|Treatment Period II||28
408684|NCT00090142|1002190|P1|STARTED|Treatment Period II||26
408685|NCT00090142|1002189|P2|NOT COMPLETED|Treatment Period I||3
408686|NCT00090142|1002190|P1|NOT COMPLETED|Treatment Period I||5
408687|NCT00090142|1002189|P2|COMPLETED|Treatment Period I||28
408688|NCT00090142|1002190|P1|COMPLETED|Treatment Period I||26
408689|NCT00090142|1002189|P2|STARTED|Treatment Period I||31
408690|NCT00090142|1002190|P1|STARTED|Treatment Period I|1 patient was lost to follow-up after randomization and did not receive any study drug.|31
408691|NCT00090103|1002221|P3|NOT COMPLETED|16-Week Safety Follow-up Period||457
408692|NCT00090103|1002222|P2|NOT COMPLETED|16-Week Safety Follow-up Period||410
408693|NCT00090103|1002223|P1|NOT COMPLETED|16-Week Safety Follow-up Period||374
408694|NCT00090103|1002221|P3|COMPLETED|16-Week Safety Follow-up Period||1143
408695|NCT00090103|1002222|P2|COMPLETED|16-Week Safety Follow-up Period||1205
408696|NCT00090103|1002223|P1|COMPLETED|16-Week Safety Follow-up Period||1224
408697|NCT00090103|1002221|P3|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1600
408698|NCT00090103|1002222|P2|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1615
408699|NCT00090103|1002223|P1|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1598
408700|NCT00090103|1002221|P3|NOT COMPLETED|Four-Year Double-Blind Treatment Period||622
408701|NCT00090103|1002222|P2|NOT COMPLETED|Four-Year Double-Blind Treatment Period||530
408702|NCT00090103|1002223|P1|NOT COMPLETED|Four-Year Double-Blind Treatment Period||497
408703|NCT00090103|1002221|P3|COMPLETED|Four-Year Double-Blind Treatment Period||989
408704|NCT00090103|1002222|P2|COMPLETED|Four-Year Double-Blind Treatment Period||1093
408705|NCT00090103|1002223|P1|COMPLETED|Four-Year Double-Blind Treatment Period||1113
408706|NCT00090103|1002221|P3|STARTED|Four-Year Double-Blind Treatment Period||1611
408707|NCT00090103|1002222|P2|STARTED|Four-Year Double-Blind Treatment Period||1623
408708|NCT00090103|1002223|P1|STARTED|Four-Year Double-Blind Treatment Period||1610
408709|NCT00090051|1002323|P2|NOT COMPLETED|Overall Study||95
408710|NCT00090051|1002324|P1|NOT COMPLETED|Overall Study||109
408711|NCT00090051|1002323|P2|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|181
408712|NCT00090051|1002324|P1|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|167
408713|NCT00090051|1002323|P2|Safety Population; Received Study Drug|Overall Study||274
408714|NCT00090051|1002324|P1|Safety Population; Received Study Drug|Overall Study||272
408715|NCT00090051|1002323|P2|STARTED|Overall Study||276
408716|NCT00090051|1002324|P1|STARTED|Overall Study||276
408717|NCT00003224|1002364|P6|NOT COMPLETED|Overall Study||0
408718|NCT00003224|1002365|P5|NOT COMPLETED|Overall Study||0
408719|NCT00003224|1002366|P4|NOT COMPLETED|Overall Study||0
408720|NCT00003224|1002367|P3|NOT COMPLETED|Overall Study||0
408721|NCT00003224|1002368|P2|NOT COMPLETED|Overall Study||0
408722|NCT00003224|1002369|P1|NOT COMPLETED|Overall Study||0
408723|NCT00003224|1002364|P6|COMPLETED|Overall Study||3
408724|NCT00003224|1002365|P5|COMPLETED|Overall Study||4
408725|NCT00003224|1002366|P4|COMPLETED|Overall Study||2
408726|NCT00003224|1002367|P3|COMPLETED|Overall Study||4
408727|NCT00003224|1002368|P2|COMPLETED|Overall Study||5
408728|NCT00003224|1002369|P1|COMPLETED|Overall Study||4
408729|NCT00003224|1002364|P6|STARTED|Overall Study||3
408730|NCT00003224|1002365|P5|STARTED|Overall Study||4
408731|NCT00003224|1002366|P4|STARTED|Overall Study||2
408732|NCT00003224|1002367|P3|STARTED|Overall Study||4
408733|NCT00003224|1002368|P2|STARTED|Overall Study||5
408734|NCT00003224|1002369|P1|STARTED|Overall Study||4
408735|NCT00089999|1002389|P2|NOT COMPLETED|Overall Study||69
408736|NCT00089999|1002390|P1|NOT COMPLETED|Overall Study||69
408737|NCT00089999|1002389|P2|COMPLETED|Overall Study||0
408738|NCT00089999|1002390|P1|COMPLETED|Overall Study||0
408739|NCT00089999|1002389|P2|STARTED|Overall Study||69
408740|NCT00089999|1002390|P1|STARTED|Overall Study||69
408741|NCT00089986|1002413|P3|NOT COMPLETED|Overall Study||10
408742|NCT00089986|1002414|P2|NOT COMPLETED|Overall Study||24
408743|NCT00089986|1002415|P1|NOT COMPLETED|Overall Study||15
408744|NCT00089986|1002413|P3|COMPLETED|Overall Study||172
408745|NCT00089986|1002414|P2|COMPLETED|Overall Study||574
408746|NCT00089986|1002415|P1|COMPLETED|Overall Study||584
408747|NCT00089986|1002413|P3|STARTED|Overall Study||182
408748|NCT00089986|1002414|P2|STARTED|Overall Study||598
408749|NCT00089986|1002415|P1|STARTED|Overall Study||599
408750|NCT00089973|1002432|P1|NOT COMPLETED|Overall Study||50
408751|NCT00089973|1002432|P1|COMPLETED|Overall Study||0
408752|NCT00089973|1002432|P1|STARTED|Overall Study||50
408753|NCT00089895|1002447|P2|NOT COMPLETED|Overall Study||42
408754|NCT00089895|1002448|P1|NOT COMPLETED|Overall Study||35
408755|NCT00089895|1002447|P2|COMPLETED|Overall Study|Number of Subjects treated|4642
408756|NCT00089895|1002448|P1|COMPLETED|Overall Study|Number of Subjects treated|4687
408757|NCT00089895|1002447|P2|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4684
408758|NCT00089895|1002448|P1|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4722
408759|NCT00089843|1002460|P4|NOT COMPLETED|Overall Study||7
408760|NCT00089843|1002461|P3|NOT COMPLETED|Overall Study||5
408761|NCT00089843|1002462|P2|NOT COMPLETED|Overall Study||4
408762|NCT00089843|1002463|P1|NOT COMPLETED|Overall Study||2
408763|NCT00089843|1002460|P4|COMPLETED|Overall Study||11
408764|NCT00089843|1002461|P3|COMPLETED|Overall Study||15
408765|NCT00089843|1002462|P2|COMPLETED|Overall Study||16
408766|NCT00089843|1002463|P1|COMPLETED|Overall Study||17
408767|NCT00089843|1002460|P4|STARTED|Overall Study||18
408768|NCT00089843|1002461|P3|STARTED|Overall Study||20
408769|NCT00089843|1002462|P2|STARTED|Overall Study||20
408770|NCT00089843|1002463|P1|STARTED|Overall Study||19
408771|NCT00089791|1002475|P2|NOT COMPLETED|Overall Study||630
408772|NCT00089791|1002476|P1|NOT COMPLETED|Overall Study||700
408773|NCT00089791|1002475|P2|COMPLETED|Overall Study||3272
408774|NCT00089791|1002476|P1|COMPLETED|Overall Study||3206
408775|NCT00089791|1002475|P2|Safety Analysis Set|Overall Study||3886
408776|NCT00089791|1002476|P1|Safety Analysis Set|Overall Study|7 participants in the placebo arm received ≥1 dose of denosumab & were analyzed in the denosumab arm|3876
408777|NCT00089791|1002475|P2|Received Study Medication|Overall Study||3879
408778|NCT00089791|1002476|P1|Received Study Medication|Overall Study||3883
408779|NCT00089791|1002475|P2|STARTED|Overall Study||3902
408780|NCT00089791|1002476|P1|STARTED|Overall Study||3906
408781|NCT00089752|1002488|P2|NOT COMPLETED|Overall Study||22
408782|NCT00089752|1002489|P1|NOT COMPLETED|Overall Study||20
408783|NCT00089752|1002488|P2|COMPLETED|Overall Study||118
408784|NCT00089752|1002489|P1|COMPLETED|Overall Study||121
408785|NCT00089752|1002488|P2|STARTED|Overall Study||140
408786|NCT00089752|1002489|P1|STARTED|Overall Study||141
408787|NCT00089778|1002510|P3|NOT COMPLETED|Overall Study||1
408788|NCT00089778|1002511|P2|NOT COMPLETED|Overall Study||0
408789|NCT00089778|1002512|P1|NOT COMPLETED|Overall Study||0
408790|NCT00089778|1002510|P3|COMPLETED|Overall Study||7
408791|NCT00089778|1002511|P2|COMPLETED|Overall Study||1
408792|NCT00089778|1002512|P1|COMPLETED|Overall Study||2
408793|NCT00089778|1002510|P3|STARTED|Overall Study||8
408794|NCT00089778|1002511|P2|STARTED|Overall Study||1
408795|NCT00089778|1002512|P1|STARTED|Overall Study||2
408796|NCT00089674|1002525|P2|NOT COMPLETED|Overall Study||267
408797|NCT00089674|1002526|P1|NOT COMPLETED|Overall Study||289
408798|NCT00089674|1002525|P2|COMPLETED|Overall Study||467
408799|NCT00089674|1002526|P1|COMPLETED|Overall Study||445
408800|NCT00089674|1002525|P2|Received Study Drug|Overall Study||726
408801|NCT00089674|1002526|P1|Received Study Drug|Overall Study||730
408802|NCT00089674|1002525|P2|STARTED|Overall Study||734
408803|NCT00089674|1002526|P1|STARTED|Overall Study||734
408804|NCT00089661|1002552|P2|NOT COMPLETED|Overall Study||26
408805|NCT00089661|1002553|P1|NOT COMPLETED|Overall Study||21
408806|NCT00089661|1002552|P2|COMPLETED|Overall Study||99
408807|NCT00089661|1002553|P1|COMPLETED|Overall Study||106
408808|NCT00089661|1002552|P2|STARTED|Overall Study||125
408809|NCT00089661|1002553|P1|STARTED|Overall Study||127
408810|NCT00089648|1002569|P1|NOT COMPLETED|Overall Study||41
408811|NCT00089648|1002569|P1|COMPLETED|Overall Study||20
408812|NCT00089648|1002569|P1|STARTED|Overall Study||61
408813|NCT00089635|1002585|P1|NOT COMPLETED|Overall Study||43
408814|NCT00089635|1002585|P1|COMPLETED|Overall Study||160
408815|NCT00089635|1002585|P1|STARTED|Overall Study||203
408816|NCT00089583|1002599|P2|NOT COMPLETED|Overall Study||38
408817|NCT00089583|1002600|P1|NOT COMPLETED|Overall Study||7
408818|NCT00089583|1002599|P2|COMPLETED|Overall Study||51
408819|NCT00089583|1002600|P1|COMPLETED|Overall Study||13
408820|NCT00089583|1002599|P2|STARTED|Overall Study||89
408821|NCT00089583|1002600|P1|STARTED|Overall Study||20
408822|NCT00089609|1002694|P2|NOT COMPLETED|Overall Study||1
408823|NCT00089609|1002695|P1|NOT COMPLETED|Overall Study||3
408824|NCT00089609|1002694|P2|COMPLETED|Overall Study||12
408825|NCT00089609|1002695|P1|COMPLETED|Overall Study||57
408826|NCT00089609|1002694|P2|STARTED|Overall Study||13
408827|NCT00089609|1002695|P1|STARTED|Overall Study||60
408828|NCT00089544|1002714|P2|NOT COMPLETED|Overall Study||0
408829|NCT00089544|1002715|P1|NOT COMPLETED|Overall Study||1
408830|NCT00089544|1002714|P2|COMPLETED|Overall Study||7
408831|NCT00089544|1002715|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|15
408832|NCT00089544|1002714|P2|STARTED|Overall Study||7
408833|NCT00089544|1002715|P1|STARTED|Overall Study||16
408834|NCT00089505|1002729|P4|NOT COMPLETED|Overall Study||21
408835|NCT00089505|1002730|P3|NOT COMPLETED|Overall Study||21
408836|NCT00089505|1002731|P2|NOT COMPLETED|Overall Study||2
408837|NCT00089505|1002732|P1|NOT COMPLETED|Overall Study||9
408838|NCT00089505|1002729|P4|COMPLETED|Overall Study||230
408839|NCT00089505|1002730|P3|COMPLETED|Overall Study||228
408840|NCT00089505|1002731|P2|COMPLETED|Overall Study|The results for NVP/LPV_r were through database cutoff for DSMB review (by 6 October 2008).|118
408841|NCT00089505|1002732|P1|COMPLETED|Overall Study|The results for NVP/NVP were through database cutoff for DSMB review (by 6 October 2008).|112
408842|NCT00089505|1002729|P4|STARTED|Overall Study||251
408843|NCT00089505|1002730|P3|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|249
408844|NCT00089505|1002731|P2|STARTED|Overall Study||120
408845|NCT00089505|1002732|P1|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|121
408846|NCT00089479|1002776|P2|NOT COMPLETED|Overall Study||289
408847|NCT00089479|1002777|P1|NOT COMPLETED|Overall Study||331
408848|NCT00089479|1002776|P2|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|1018
408849|NCT00089479|1002777|P1|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|973
408850|NCT00089479|1002776|P2|Received Treatment|Overall Study|Safety Population (includes 5 patients randomized to ACT, who received ACXT)|1283
408851|NCT00089479|1002777|P1|Received Treatment|Overall Study|Safety Population (includes 19 patients randomized to ACXT, who received ACT)|1305
408852|NCT00089479|1002776|P2|STARTED|Overall Study||1307
408853|NCT00089479|1002777|P1|STARTED|Overall Study||1304
408854|NCT00089414|1002804|P3|NOT COMPLETED|Overall Study||0
408855|NCT00089414|1002805|P2|NOT COMPLETED|Overall Study||0
408856|NCT00089414|1002806|P1|NOT COMPLETED|Overall Study||0
408857|NCT00089414|1002804|P3|COMPLETED|Overall Study||2
408858|NCT00089414|1002805|P2|COMPLETED|Overall Study||1
408859|NCT00089414|1002806|P1|COMPLETED|Overall Study||2
408860|NCT00089414|1002804|P3|STARTED|Overall Study||2
408861|NCT00089414|1002805|P2|STARTED|Overall Study||1
408862|NCT00089414|1002806|P1|STARTED|Overall Study||2
408863|NCT00089297|1002820|P1|NOT COMPLETED|Overall Study||38
408864|NCT00089297|1002820|P1|COMPLETED|Overall Study||36
408865|NCT00089297|1002820|P1|Eligible|Overall Study||63
408866|NCT00089297|1002820|P1|Treated|Overall Study||70
408867|NCT00089297|1002820|P1|STARTED|Overall Study||74
408868|NCT00089284|1002832|P7|NOT COMPLETED|Overall Study||1
408869|NCT00089284|1002833|P6|NOT COMPLETED|Overall Study||0
408870|NCT00089284|1002834|P5|NOT COMPLETED|Overall Study||0
408871|NCT00089284|1002835|P4|NOT COMPLETED|Overall Study||0
408872|NCT00089284|1002836|P3|NOT COMPLETED|Overall Study||0
408873|NCT00089284|1002837|P2|NOT COMPLETED|Overall Study||0
408874|NCT00089284|1002838|P1|NOT COMPLETED|Overall Study||0
408875|NCT00089284|1002832|P7|COMPLETED|Overall Study||7
408876|NCT00089284|1002833|P6|COMPLETED|Overall Study||0
408877|NCT00089284|1002834|P5|COMPLETED|Overall Study||0
408878|NCT00089284|1002835|P4|COMPLETED|Overall Study||6
408879|NCT00089284|1002836|P3|COMPLETED|Overall Study||6
408880|NCT00089284|1002837|P2|COMPLETED|Overall Study||3
408881|NCT00089284|1002838|P1|COMPLETED|Overall Study||7
408882|NCT00089284|1002832|P7|STARTED|Overall Study||8
408883|NCT00089284|1002833|P6|STARTED|Overall Study|No patients were accrued to this cohort of 6-24% involvement due to lack of eligible patients.|0
408884|NCT00089284|1002834|P5|STARTED|Overall Study|No patients were accrued to this cohort of 6-24% involvement due to lack of eligible patients.|0
408885|NCT00089284|1002835|P4|STARTED|Overall Study||6
408886|NCT00089284|1002836|P3|STARTED|Overall Study||6
408887|NCT00089284|1002837|P2|STARTED|Overall Study||3
408888|NCT00089284|1002838|P1|STARTED|Overall Study||7
408889|NCT00089141|1002875|P2|NOT COMPLETED|Overall Study||24
408890|NCT00089141|1002876|P1|NOT COMPLETED|Overall Study||18
408891|NCT00089141|1002875|P2|COMPLETED|Overall Study||53
408892|NCT00089141|1002876|P1|COMPLETED|Overall Study||56
408893|NCT00089141|1002875|P2|STARTED|Overall Study||77
408894|NCT00089141|1002876|P1|STARTED|Overall Study||74
408895|NCT00089128|1002898|P1|NOT COMPLETED|Overall Study||0
408896|NCT00089128|1002898|P1|COMPLETED|Overall Study||16
408897|NCT00089128|1002898|P1|STARTED|Overall Study||16
408898|NCT00089102|1002905|P1|NOT COMPLETED|Overall Study||0
408899|NCT00089102|1002905|P1|COMPLETED|Overall Study||9
408900|NCT00089102|1002905|P1|STARTED|Overall Study||9
408901|NCT00089076|1002912|P1|NOT COMPLETED|Overall Study||10
408902|NCT00089076|1002912|P1|COMPLETED|Overall Study||8
408903|NCT00089076|1002912|P1|STARTED|Overall Study||18
408904|NCT00089024|1002923|P1|NOT COMPLETED|Overall Study||5
408905|NCT00089024|1002923|P1|COMPLETED|Overall Study||24
408906|NCT00089024|1002923|P1|Treated Subjects|Overall Study||29
408907|NCT00089024|1002923|P1|STARTED|Overall Study||29
408908|NCT00089011|1002930|P2|NOT COMPLETED|Overall Study||0
408909|NCT00089011|1002931|P1|NOT COMPLETED|Overall Study||0
408910|NCT00089011|1002930|P2|COMPLETED|Overall Study||50
408911|NCT00089011|1002931|P1|COMPLETED|Overall Study||100
408912|NCT00089011|1002930|P2|STARTED|Overall Study||50
408913|NCT00089011|1002931|P1|STARTED|Overall Study||100
408914|NCT00088985|1002951|P1|NOT COMPLETED|Overall Study||3
408915|NCT00088985|1002951|P1|COMPLETED|Overall Study||4
408916|NCT00088985|1002951|P1|STARTED|Overall Study||7
408917|NCT00088972|1002958|P2|NOT COMPLETED|Overall Study||4
408918|NCT00088972|1002959|P1|NOT COMPLETED|Overall Study||2
408919|NCT00088972|1002958|P2|COMPLETED|Overall Study||1
408920|NCT00088972|1002959|P1|COMPLETED|Overall Study||1
408921|NCT00088972|1002958|P2|STARTED|Overall Study||5
408922|NCT00088972|1002959|P1|STARTED|Overall Study||3
408923|NCT00088907|1002969|P2|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||0
408924|NCT00088907|1002970|P1|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||24
408925|NCT00088907|1002969|P2|COMPLETED|Single Gefitinib Treatment (Step 2)||0
408926|NCT00088907|1002970|P1|COMPLETED|Single Gefitinib Treatment (Step 2)||0
408927|NCT00088907|1002969|P2|Treated|Single Gefitinib Treatment (Step 2)||0
408928|NCT00088907|1002970|P1|Treated|Single Gefitinib Treatment (Step 2)||19
408929|NCT00088907|1002969|P2|STARTED|Single Gefitinib Treatment (Step 2)|Cross over to single gefitinib therapy at progression was allowed for patients on Arm I only.|0
408930|NCT00088907|1002970|P1|STARTED|Single Gefitinib Treatment (Step 2)|Patients on Arm I could cross over to gefitinib after disease progression on step 1.|24
408931|NCT00088907|1002969|P2|NOT COMPLETED|Randomized Study (Step 1)||134
408932|NCT00088907|1002970|P1|NOT COMPLETED|Randomized Study (Step 1)||136
408933|NCT00088907|1002969|P2|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles|0
408934|NCT00088907|1002970|P1|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles.|0
408935|NCT00088907|1002969|P2|Eligible and Treated|Randomized Study (Step 1)||122
408936|NCT00088907|1002970|P1|Eligible and Treated|Randomized Study (Step 1)||117
408937|NCT00088907|1002969|P2|Eligible|Randomized Study (Step 1)||122
408938|NCT00088907|1002970|P1|Eligible|Randomized Study (Step 1)||117
408939|NCT00088907|1002969|P2|Treated|Randomized Study (Step 1)||124
408940|NCT00088907|1002970|P1|Treated|Randomized Study (Step 1)||129
408941|NCT00088907|1002969|P2|STARTED|Randomized Study (Step 1)||134
408942|NCT00088907|1002970|P1|STARTED|Randomized Study (Step 1)||136
408943|NCT00088881|1002981|P1|NOT COMPLETED|Step 3 - Radiation Therapy||0
408944|NCT00088881|1002981|P1|COMPLETED|Step 3 - Radiation Therapy||1
408945|NCT00088881|1002981|P1|STARTED|Step 3 - Radiation Therapy||1
408946|NCT00088881|1002981|P1|NOT COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||11
408947|NCT00088881|1002981|P1|COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||45
408948|NCT00088881|1002981|P1|Eligible and Treated|Step 2 - Zevalin™ Radioimmunotherapy||48
408949|NCT00088881|1002981|P1|STARTED|Step 2 - Zevalin™ Radioimmunotherapy|This includes all patients who received step 2 treatment regardless of eligibility.|56
408950|NCT00088881|1002981|P1|NOT COMPLETED|Step 1 - R-CHOP||14
408951|NCT00088881|1002981|P1|COMPLETED|Step 1 - R-CHOP||48
408952|NCT00088881|1002981|P1|Eligible and Treated|Step 1 - R-CHOP||53
408953|NCT00088881|1002981|P1|STARTED|Step 1 - R-CHOP||62
408954|NCT00088829|1002990|P1|NOT COMPLETED|Overall Study||22
408955|NCT00088829|1002990|P1|COMPLETED|Overall Study||0
408956|NCT00088829|1002990|P1|STARTED|Overall Study||22
408957|NCT00088699|1002996|P4|NOT COMPLETED|Infusion 2||1
408958|NCT00088699|1002997|P3|NOT COMPLETED|Infusion 2||0
408959|NCT00088699|1002998|P2|NOT COMPLETED|Infusion 2||0
408960|NCT00088699|1002999|P1|NOT COMPLETED|Infusion 2||0
408961|NCT00088699|1002996|P4|COMPLETED|Infusion 2||10
408962|NCT00088699|1002997|P3|COMPLETED|Infusion 2||11
408963|NCT00088699|1002998|P2|COMPLETED|Infusion 2||18
408964|NCT00088699|1002999|P1|COMPLETED|Infusion 2||19
408965|NCT00088699|1002996|P4|STARTED|Infusion 2||11
408966|NCT00088699|1002997|P3|STARTED|Infusion 2||11
408967|NCT00088699|1002998|P2|STARTED|Infusion 2||18
408968|NCT00088699|1002999|P1|STARTED|Infusion 2||19
408969|NCT00088699|1002996|P4|NOT COMPLETED|Infusion 1||2
408970|NCT00088699|1002997|P3|NOT COMPLETED|Infusion 1||1
408971|NCT00088699|1002998|P2|NOT COMPLETED|Infusion 1||0
408972|NCT00088699|1002999|P1|NOT COMPLETED|Infusion 1||1
408973|NCT00088699|1002996|P4|COMPLETED|Infusion 1||10
408974|NCT00088699|1002997|P3|COMPLETED|Infusion 1||12
408975|NCT00088699|1002998|P2|COMPLETED|Infusion 1||19
408976|NCT00088699|1002999|P1|COMPLETED|Infusion 1||22
408977|NCT00088699|1002996|P4|STARTED|Infusion 1||12
408978|NCT00088699|1002997|P3|STARTED|Infusion 1||13
408979|NCT00088699|1002998|P2|STARTED|Infusion 1||19
408980|NCT00088699|1002999|P1|STARTED|Infusion 1||23
408981|NCT00088634|1003015|P2|NOT COMPLETED|Overall Study||43
408982|NCT00088634|1003016|P1|NOT COMPLETED|Overall Study||38
408983|NCT00088634|1003015|P2|COMPLETED|Overall Study||47
408984|NCT00088634|1003016|P1|COMPLETED|Overall Study||52
408985|NCT00088634|1003015|P2|STARTED|Overall Study||90
408986|NCT00088634|1003016|P1|STARTED|Overall Study||90
408987|NCT00088621|1003028|P1|NOT COMPLETED|Overall Study||54
408988|NCT00088621|1003028|P1|COMPLETED|Overall Study||7
408989|NCT00088621|1003028|P1|STARTED|Overall Study||61
408990|NCT00088595|1003032|P1|NOT COMPLETED|Overall Study||28
408991|NCT00088595|1003032|P1|COMPLETED|Overall Study||17
408992|NCT00088595|1003032|P1|STARTED|Overall Study||45
408993|NCT00088530|1003050|P2|NOT COMPLETED|Overall Study||54
408994|NCT00088530|1003051|P1|NOT COMPLETED|Overall Study||50
408995|NCT00088530|1003050|P2|COMPLETED|Overall Study||16
408996|NCT00088530|1003051|P1|COMPLETED|Overall Study||20
408997|NCT00088530|1003050|P2|STARTED|Overall Study||70
408998|NCT00088530|1003051|P1|STARTED|Overall Study||70
408999|NCT00088465|1003063|P1|NOT COMPLETED|Overall Study||561
409000|NCT00088465|1003063|P1|COMPLETED|Overall Study||370
409001|NCT00088465|1003063|P1|STARTED|Overall Study||931
409002|NCT00088413|1003090|P4|NOT COMPLETED|Overall Study||14
409003|NCT00088413|1003091|P3|NOT COMPLETED|Overall Study||12
409004|NCT00088413|1003092|P2|NOT COMPLETED|Overall Study||15
409005|NCT00088413|1003093|P1|NOT COMPLETED|Overall Study||10
409006|NCT00088413|1003090|P4|COMPLETED|Overall Study||0
409007|NCT00088413|1003091|P3|COMPLETED|Overall Study||0
409008|NCT00088413|1003092|P2|COMPLETED|Overall Study||0
409009|NCT00088413|1003093|P1|COMPLETED|Overall Study||0
409010|NCT00088413|1003090|P4|STARTED|Overall Study||14
409011|NCT00088413|1003091|P3|STARTED|Overall Study||12
409012|NCT00088413|1003092|P2|STARTED|Overall Study||15
409013|NCT00088413|1003093|P1|STARTED|Overall Study||10
409014|NCT00088374|1003107|P1|NOT COMPLETED|Overall Study||2
409015|NCT00088374|1003107|P1|COMPLETED|Overall Study||7
409016|NCT00088374|1003107|P1|STARTED|Overall Study||9
409017|NCT00088218|1003118|P2|NOT COMPLETED|Overall Study||0
409018|NCT00088218|1003119|P1|NOT COMPLETED|Overall Study||0
409019|NCT00088218|1003118|P2|COMPLETED|Overall Study||79
409020|NCT00088218|1003119|P1|COMPLETED|Overall Study||16
409021|NCT00088218|1003118|P2|STARTED|Overall Study||79
409022|NCT00088218|1003119|P1|STARTED|Overall Study||16
409023|NCT00088166|1003127|P2|NOT COMPLETED|Overall Study||61
409024|NCT00088166|1003128|P1|NOT COMPLETED|Overall Study||53
409025|NCT00088166|1003127|P2|COMPLETED|Overall Study||39
409026|NCT00088166|1003128|P1|COMPLETED|Overall Study||47
409027|NCT00088166|1003127|P2|STARTED|Overall Study||100
409028|NCT00088166|1003128|P1|STARTED|Overall Study||100
409029|NCT00088153|1003152|P2|NOT COMPLETED|Overall Study||25
409030|NCT00088153|1003153|P1|NOT COMPLETED|Overall Study||24
409031|NCT00088153|1003152|P2|COMPLETED|Overall Study||30
409032|NCT00088153|1003153|P1|COMPLETED|Overall Study||31
409033|NCT00088153|1003152|P2|STARTED|Overall Study||55
409034|NCT00088153|1003153|P1|STARTED|Overall Study||55
409035|NCT00087698|1003163|P1|NOT COMPLETED|Overall Study||36
409036|NCT00087698|1003163|P1|COMPLETED|Overall Study||41
409037|NCT00087698|1003163|P1|STARTED|Overall Study||77
409038|NCT00087685|1003172|P1|NOT COMPLETED|Overall Study||14
409039|NCT00087685|1003172|P1|COMPLETED|Overall Study||21
409040|NCT00087685|1003172|P1|STARTED|Overall Study||35
409041|NCT00087672|1003177|P1|NOT COMPLETED|Overall Study||0
409042|NCT00087672|1003177|P1|COMPLETED|Overall Study||41
409043|NCT00087672|1003177|P1|STARTED|Overall Study||41
409044|NCT00087646|1003185|P4|NOT COMPLETED|Overall Study||84
409045|NCT00087646|1003186|P3|NOT COMPLETED|Overall Study||65
409046|NCT00087646|1003187|P2|NOT COMPLETED|Overall Study||42
409047|NCT00087646|1003188|P1|NOT COMPLETED|Overall Study||135
409048|NCT00087646|1003185|P4|COMPLETED|Overall Study||229
409049|NCT00087646|1003186|P3|COMPLETED|Overall Study||91
409050|NCT00087646|1003187|P2|COMPLETED|Overall Study||114
409051|NCT00087646|1003188|P1|COMPLETED|Overall Study||182
409052|NCT00087646|1003185|P4|STARTED|Overall Study||313
409053|NCT00087646|1003186|P3|STARTED|Overall Study||156
409054|NCT00087646|1003187|P2|STARTED|Overall Study||156
409055|NCT00087646|1003188|P1|STARTED|Overall Study||317
409056|NCT00087633|1003216|P2|NOT COMPLETED|Overall Study||17
409057|NCT00087633|1003217|P1|NOT COMPLETED|Overall Study||24
409058|NCT00087633|1003216|P2|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|43
409059|NCT00087633|1003217|P1|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|31
409060|NCT00087633|1003216|P2|STARTED|Overall Study|Randomized|60
409061|NCT00087633|1003217|P1|STARTED|Overall Study|Randomized|55
409062|NCT00087607|1003227|P2|NOT COMPLETED|Overall Study||122
409063|NCT00087607|1003228|P1|NOT COMPLETED|Overall Study||122
409064|NCT00087607|1003227|P2|COMPLETED|Overall Study||71
409065|NCT00087607|1003228|P1|COMPLETED|Overall Study||70
409066|NCT00087607|1003227|P2|STARTED|Overall Study||193
409067|NCT00087607|1003228|P1|STARTED|Overall Study||192
409068|NCT00087594|1003268|P2|NOT COMPLETED|Overall Study||12
409069|NCT00087594|1003269|P1|NOT COMPLETED|Overall Study||8
409070|NCT00087594|1003268|P2|COMPLETED|Overall Study||12
409071|NCT00087594|1003269|P1|COMPLETED|Overall Study||16
409072|NCT00087594|1003268|P2|STARTED|Overall Study||24
409073|NCT00087594|1003269|P1|STARTED|Overall Study||24
409074|NCT00087568|1003303|P2|NOT COMPLETED|Overall Study||2
409075|NCT00087568|1003304|P1|NOT COMPLETED|Overall Study||30
409076|NCT00087568|1003303|P2|COMPLETED|Overall Study||23
409077|NCT00087568|1003304|P1|COMPLETED|Overall Study||2
409078|NCT00087568|1003303|P2|STARTED|Overall Study||25
409079|NCT00087568|1003304|P1|STARTED|Overall Study||32
409080|NCT00087555|1003331|P3|NOT COMPLETED|Overall Study||21
409081|NCT00087555|1003332|P2|NOT COMPLETED|Overall Study||11
409082|NCT00087555|1003333|P1|NOT COMPLETED|Overall Study||12
409083|NCT00087555|1003331|P3|COMPLETED|Overall Study||46
409084|NCT00087555|1003332|P2|COMPLETED|Overall Study||51
409085|NCT00087555|1003333|P1|COMPLETED|Overall Study||54
409086|NCT00087555|1003331|P3|Treated|Overall Study||67
409087|NCT00087555|1003332|P2|Treated|Overall Study||60
409088|NCT00087555|1003333|P1|Treated|Overall Study||65
409089|NCT00087555|1003331|P3|STARTED|Overall Study||67
409090|NCT00087555|1003332|P2|STARTED|Overall Study||62
409091|NCT00087555|1003333|P1|STARTED|Overall Study||66
409092|NCT00087529|1003343|P2|NOT COMPLETED|Overall Study||68
409093|NCT00087529|1003344|P1|NOT COMPLETED|Overall Study||31
409094|NCT00087529|1003343|P2|COMPLETED|Overall Study||224
409095|NCT00087529|1003344|P1|COMPLETED|Overall Study||116
409096|NCT00087529|1003343|P2|STARTED|Overall Study||292
409097|NCT00087529|1003344|P1|STARTED|Overall Study||147
409098|NCT00087516|1003359|P4|NOT COMPLETED|Overall Study||85
409099|NCT00087516|1003360|P3|NOT COMPLETED|Overall Study||97
409100|NCT00087516|1003361|P2|NOT COMPLETED|Overall Study||169
409101|NCT00087516|1003362|P1|NOT COMPLETED|Overall Study||161
409102|NCT00087516|1003359|P4|COMPLETED|Overall Study||38
409103|NCT00087516|1003360|P3|COMPLETED|Overall Study||33
409104|NCT00087516|1003361|P2|COMPLETED|Overall Study||81
409105|NCT00087516|1003362|P1|COMPLETED|Overall Study||77
409106|NCT00087516|1003359|P4|STARTED|Overall Study||123
409107|NCT00087516|1003360|P3|STARTED|Overall Study||130
409108|NCT00087516|1003361|P2|STARTED|Overall Study||250
409109|NCT00087516|1003362|P1|STARTED|Overall Study||238
409110|NCT00087490|1003391|P2|NOT COMPLETED|Overall Study||269
409111|NCT00087490|1003392|P1|NOT COMPLETED|Overall Study||258
409112|NCT00087490|1003391|P2|COMPLETED|Overall Study||264
409113|NCT00087490|1003392|P1|COMPLETED|Overall Study||286
409114|NCT00087490|1003391|P2|Treated|Overall Study||515
409115|NCT00087490|1003392|P1|Treated|Overall Study||537
409116|NCT00087490|1003391|P2|STARTED|Overall Study||533
409117|NCT00087490|1003392|P1|STARTED|Overall Study||544
409118|NCT00087438|1003426|P1|NOT COMPLETED|Overall Study||4
409119|NCT00087438|1003426|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|55
409120|NCT00087438|1003426|P1|STARTED|Overall Study||59
409121|NCT00087152|1003436|P1|NOT COMPLETED|Overall Study||6
409122|NCT00087152|1003436|P1|COMPLETED|Overall Study||21
409123|NCT00087152|1003436|P1|STARTED|Overall Study||27
409124|NCT00087139|1003445|P3|NOT COMPLETED|Overall Study||36
409125|NCT00087139|1003446|P2|NOT COMPLETED|Overall Study||49
409126|NCT00087139|1003447|P1|NOT COMPLETED|Overall Study||39
409127|NCT00087139|1003445|P3|COMPLETED|Overall Study||0
409128|NCT00087139|1003446|P2|COMPLETED|Overall Study||0
409129|NCT00087139|1003447|P1|COMPLETED|Overall Study||0
409130|NCT00087139|1003445|P3|Patients w/ Measurable Disease Response|Overall Study||0
409131|NCT00087139|1003446|P2|Patients w/ Measurable Disease Response|Overall Study||2
409132|NCT00087139|1003447|P1|Patients w/ Measurable Disease Response|Overall Study||5
409133|NCT00087139|1003445|P3|Patients With PSA Response|Overall Study||4
409134|NCT00087139|1003446|P2|Patients With PSA Response|Overall Study||8
409135|NCT00087139|1003447|P1|Patients With PSA Response|Overall Study||10
409136|NCT00087139|1003445|P3|Patients With Measurable Disease|Overall Study||24
409137|NCT00087139|1003446|P2|Patients With Measurable Disease|Overall Study||25
409138|NCT00087139|1003447|P1|Patients With Measurable Disease|Overall Study||22
409139|NCT00087139|1003445|P3|Patients for the Analysis of PSA Respons|Overall Study||22
409140|NCT00087139|1003446|P2|Patients for the Analysis of PSA Respons|Overall Study||34
409141|NCT00087139|1003447|P1|Patients for the Analysis of PSA Respons|Overall Study||30
409142|NCT00087139|1003445|P3|Eligible and Treated|Overall Study||32
409143|NCT00087139|1003446|P2|Eligible and Treated|Overall Study||42
409144|NCT00087139|1003447|P1|Eligible and Treated|Overall Study||35
409145|NCT00087139|1003445|P3|Treated|Overall Study||36
409146|NCT00087139|1003446|P2|Treated|Overall Study||48
409147|NCT00087139|1003447|P1|Treated|Overall Study||39
409148|NCT00087139|1003445|P3|STARTED|Overall Study||36
409149|NCT00087139|1003446|P2|STARTED|Overall Study||49
409150|NCT00087139|1003447|P1|STARTED|Overall Study||39
409151|NCT00087126|1003462|P1|NOT COMPLETED|Overall Study||2
409152|NCT00087126|1003462|P1|COMPLETED|Overall Study||25
409153|NCT00087126|1003462|P1|STARTED|Overall Study||27
409154|NCT00087022|1003473|P2|NOT COMPLETED|Overall Study||55
409155|NCT00087022|1003474|P1|NOT COMPLETED|Overall Study||54
409156|NCT00087022|1003473|P2|COMPLETED|Overall Study||376
409157|NCT00087022|1003474|P1|COMPLETED|Overall Study||379
409158|NCT00087022|1003473|P2|Treated (Safety Population)|Overall Study||424
409159|NCT00087022|1003474|P1|Treated (Safety Population)|Overall Study||431
409160|NCT00087022|1003473|P2|STARTED|Overall Study||431
409161|NCT00087022|1003474|P1|STARTED|Overall Study||433
409162|NCT00086996|1003487|P1|NOT COMPLETED|Overall Study||64
409163|NCT00086996|1003487|P1|COMPLETED|Overall Study||34
409164|NCT00086996|1003487|P1|Eligible and Began Protocol Therapy|Overall Study||93
409165|NCT00086996|1003487|P1|Eligible|Overall Study||93
409166|NCT00086996|1003487|P1|STARTED|Overall Study||98
409167|NCT00086957|1003494|P3|NOT COMPLETED|Overall Study||0
409168|NCT00086957|1003495|P2|NOT COMPLETED|Overall Study||0
409169|NCT00086957|1003496|P1|NOT COMPLETED|Overall Study||0
409170|NCT00086957|1003494|P3|COMPLETED|Overall Study||22
409171|NCT00086957|1003495|P2|COMPLETED|Overall Study||7
409172|NCT00086957|1003496|P1|COMPLETED|Overall Study||2
409173|NCT00086957|1003494|P3|STARTED|Overall Study||22
409174|NCT00086957|1003495|P2|STARTED|Overall Study||7
409175|NCT00086957|1003496|P1|STARTED|Overall Study||2
409176|NCT00086684|1003509|P3|NOT COMPLETED|Overall Study||53
409177|NCT00086684|1003510|P2|NOT COMPLETED|Overall Study||55
409178|NCT00086684|1003511|P1|NOT COMPLETED|Overall Study||55
409179|NCT00086684|1003509|P3|COMPLETED|Overall Study||69
409180|NCT00086684|1003510|P2|COMPLETED|Overall Study||74
409181|NCT00086684|1003511|P1|COMPLETED|Overall Study||63
409182|NCT00086684|1003509|P3|STARTED|Overall Study||122
409183|NCT00086684|1003510|P2|STARTED|Overall Study||129
409184|NCT00086684|1003511|P1|STARTED|Overall Study||118
409185|NCT00086619|1003524|P2|NOT COMPLETED|Overall Study||17
409186|NCT00086619|1003525|P1|NOT COMPLETED|Overall Study||15
409187|NCT00086619|1003524|P2|COMPLETED|Overall Study||23
409188|NCT00086619|1003525|P1|COMPLETED|Overall Study||25
409189|NCT00086619|1003524|P2|Completed 12 Month Visit|Overall Study||26
409190|NCT00086619|1003525|P1|Completed 12 Month Visit|Overall Study||26
409191|NCT00086619|1003524|P2|Completed Baseline Visit|Overall Study||36
409192|NCT00086619|1003525|P1|Completed Baseline Visit|Overall Study||34
409193|NCT00086619|1003524|P2|STARTED|Overall Study||40
409194|NCT00086619|1003525|P1|STARTED|Overall Study||40
409195|NCT00086580|1003535|P2|NOT COMPLETED|Observation Period||65
409196|NCT00086580|1003536|P1|NOT COMPLETED|Observation Period||46
409197|NCT00086580|1003535|P2|COMPLETED|Observation Period||56
409198|NCT00086580|1003536|P1|COMPLETED|Observation Period||49
409199|NCT00086580|1003535|P2|STARTED|Observation Period||121
409200|NCT00086580|1003536|P1|STARTED|Observation Period||95
409201|NCT00086580|1003535|P2|NOT COMPLETED|Follow-up Period||119
409202|NCT00086580|1003536|P1|NOT COMPLETED|Follow-up Period||104
409203|NCT00086580|1003535|P2|COMPLETED|Follow-up Period||18
409204|NCT00086580|1003536|P1|COMPLETED|Follow-up Period||37
409205|NCT00086580|1003535|P2|STARTED|Follow-up Period||137
409206|NCT00086580|1003536|P1|STARTED|Follow-up Period||141
409207|NCT00086580|1003535|P2|NOT COMPLETED|Treatment Period||60
409208|NCT00086580|1003536|P1|NOT COMPLETED|Treatment Period||65
409209|NCT00086580|1003535|P2|COMPLETED|Treatment Period|Finished 6 cycles of study drug|107
409210|NCT00086580|1003536|P1|COMPLETED|Treatment Period|Finished 6 cycles of study drugs|103
409211|NCT00086580|1003535|P2|Safety Population|Treatment Period|Two participants did not receive treatment|165
409212|NCT00086580|1003536|P1|Safety Population|Treatment Period|Four participants did not receive treatment|164
409213|NCT00086580|1003535|P2|STARTED|Treatment Period||167
409214|NCT00086580|1003536|P1|STARTED|Treatment Period||168
409215|NCT00086411|1003584|P4|NOT COMPLETED|Overall Study||12
409216|NCT00086411|1003585|P3|NOT COMPLETED|Overall Study||13
409217|NCT00086411|1003586|P2|NOT COMPLETED|Overall Study||11
409218|NCT00086411|1003587|P1|NOT COMPLETED|Overall Study||11
409219|NCT00086411|1003584|P4|COMPLETED|Overall Study||53
409220|NCT00086411|1003585|P3|COMPLETED|Overall Study||49
409221|NCT00086411|1003586|P2|COMPLETED|Overall Study||52
409222|NCT00086411|1003587|P1|COMPLETED|Overall Study||59
409223|NCT00086411|1003584|P4|STARTED|Overall Study||65
409224|NCT00086411|1003585|P3|STARTED|Overall Study||62
409225|NCT00086411|1003586|P2|STARTED|Overall Study||63
409226|NCT00086411|1003587|P1|STARTED|Overall Study||70
409227|NCT00086385|1003605|P4|NOT COMPLETED|Overall Study||1
409228|NCT00086385|1003606|P3|NOT COMPLETED|Overall Study||1
409229|NCT00086385|1003607|P2|NOT COMPLETED|Overall Study||2
409230|NCT00086385|1003608|P1|NOT COMPLETED|Overall Study||2
409231|NCT00086385|1003605|P4|COMPLETED|Overall Study||98
409232|NCT00086385|1003606|P3|COMPLETED|Overall Study||103
409233|NCT00086385|1003607|P2|COMPLETED|Overall Study||97
409234|NCT00086385|1003608|P1|COMPLETED|Overall Study||98
409235|NCT00086385|1003605|P4|STARTED|Overall Study||99
409236|NCT00086385|1003606|P3|STARTED|Overall Study||104
409237|NCT00086385|1003607|P2|STARTED|Overall Study||99
409238|NCT00086385|1003608|P1|STARTED|Overall Study||100
409239|NCT00086515|1003620|P2|NOT COMPLETED|Phase B (Weeks 24-104)||55
409240|NCT00086515|1003621|P1|NOT COMPLETED|Phase B (Weeks 24-104)||190
409241|NCT00086515|1003620|P2|COMPLETED|Phase B (Weeks 24-104)||109
409242|NCT00086515|1003621|P1|COMPLETED|Phase B (Weeks 24-104)||201
409243|NCT00086515|1003620|P2|STARTED|Phase B (Weeks 24-104)||164
409244|NCT00086515|1003621|P1|STARTED|Phase B (Weeks 24-104)||391
409245|NCT00086515|1003620|P2|NOT COMPLETED|Phase A to Phase B Transition Period||28
409246|NCT00086515|1003621|P1|NOT COMPLETED|Phase A to Phase B Transition Period||24
409247|NCT00086515|1003620|P2|COMPLETED|Phase A to Phase B Transition Period||164
409248|NCT00086515|1003621|P1|COMPLETED|Phase A to Phase B Transition Period||391
409249|NCT00086515|1003620|P2|STARTED|Phase A to Phase B Transition Period||192
409250|NCT00086515|1003621|P1|STARTED|Phase A to Phase B Transition Period||415
409251|NCT00086515|1003620|P2|NOT COMPLETED|Phase A (Weeks 0-24)||45
409252|NCT00086515|1003621|P1|NOT COMPLETED|Phase A (Weeks 0-24)||49
409253|NCT00086515|1003620|P2|COMPLETED|Phase A (Weeks 0-24)||192
409254|NCT00086515|1003621|P1|COMPLETED|Phase A (Weeks 0-24)||415
409255|NCT00086515|1003620|P2|STARTED|Phase A (Weeks 0-24)||237
409256|NCT00086515|1003621|P1|STARTED|Phase A (Weeks 0-24)||464
409257|NCT00086502|1003633|P2|NOT COMPLETED|Overall Study||20
409258|NCT00086502|1003634|P1|NOT COMPLETED|Overall Study||26
409259|NCT00086502|1003633|P2|COMPLETED|Overall Study||158
409260|NCT00086502|1003634|P1|COMPLETED|Overall Study||149
409261|NCT00086502|1003633|P2|STARTED|Overall Study||178
409262|NCT00086502|1003634|P1|STARTED|Overall Study||175
409263|NCT00086450|1003644|P2|NOT COMPLETED|Overall Study||0
409264|NCT00086450|1003645|P1|NOT COMPLETED|Overall Study||0
409265|NCT00086450|1003644|P2|COMPLETED|Overall Study||947
409266|NCT00086450|1003645|P1|COMPLETED|Overall Study||953
409267|NCT00086450|1003644|P2|STARTED|Overall Study||947
409268|NCT00086450|1003645|P1|STARTED|Overall Study||953
409269|NCT00086346|1003659|P2|NOT COMPLETED|Patients Dosed With Test Article||23
409270|NCT00086346|1003660|P1|NOT COMPLETED|Patients Dosed With Test Article||140
409271|NCT00086346|1003659|P2|COMPLETED|Patients Dosed With Test Article||187
409272|NCT00086346|1003660|P1|COMPLETED|Patients Dosed With Test Article||249
409273|NCT00086346|1003659|P2|STARTED|Patients Dosed With Test Article||210
409274|NCT00086346|1003660|P1|STARTED|Patients Dosed With Test Article||389
409275|NCT00086346|1003659|P2|NOT COMPLETED|Randomization||4
409276|NCT00086346|1003660|P1|NOT COMPLETED|Randomization||4
409277|NCT00086346|1003659|P2|COMPLETED|Randomization||210
409278|NCT00086346|1003660|P1|COMPLETED|Randomization||389
409279|NCT00086346|1003659|P2|STARTED|Randomization||214
409280|NCT00086346|1003660|P1|STARTED|Randomization||393
409281|NCT00086281|1003687|P15|NOT COMPLETED|Phase 2||0
409282|NCT00086281|1003688|P14|NOT COMPLETED|Phase 2||1
409283|NCT00086281|1003689|P13|NOT COMPLETED|Phase 2||1
409284|NCT00086281|1003690|P12|NOT COMPLETED|Phase 2||0
409285|NCT00086281|1003691|P11|NOT COMPLETED|Phase 2||0
409286|NCT00086281|1003692|P10|NOT COMPLETED|Phase 2||0
409287|NCT00086281|1003693|P9|NOT COMPLETED|Phase 2||0
409288|NCT00086281|1003694|P8|NOT COMPLETED|Phase 2||0
409289|NCT00086281|1003695|P7|NOT COMPLETED|Phase 2||0
409290|NCT00086281|1003696|P6|NOT COMPLETED|Phase 2||0
409291|NCT00086281|1003697|P5|NOT COMPLETED|Phase 2||0
409292|NCT00086281|1003698|P4|NOT COMPLETED|Phase 2||0
409293|NCT00086281|1003699|P3|NOT COMPLETED|Phase 2||0
409294|NCT00086281|1003700|P2|NOT COMPLETED|Phase 2||0
409295|NCT00086281|1003701|P1|NOT COMPLETED|Phase 2||0
409296|NCT00086281|1003687|P15|COMPLETED|Phase 2||0
409297|NCT00086281|1003688|P14|COMPLETED|Phase 2||26
409298|NCT00086281|1003689|P13|COMPLETED|Phase 2||22
409299|NCT00086281|1003690|P12|COMPLETED|Phase 2||0
409300|NCT00086281|1003691|P11|COMPLETED|Phase 2||0
409301|NCT00086281|1003692|P10|COMPLETED|Phase 2||0
409302|NCT00086281|1003693|P9|COMPLETED|Phase 2||0
409303|NCT00086281|1003694|P8|COMPLETED|Phase 2||0
409304|NCT00086281|1003695|P7|COMPLETED|Phase 2||0
409305|NCT00086281|1003696|P6|COMPLETED|Phase 2||0
409306|NCT00086281|1003697|P5|COMPLETED|Phase 2||0
409307|NCT00086281|1003698|P4|COMPLETED|Phase 2||0
409308|NCT00086281|1003699|P3|COMPLETED|Phase 2||0
409309|NCT00086281|1003700|P2|COMPLETED|Phase 2||0
409310|NCT00086281|1003701|P1|COMPLETED|Phase 2||0
409311|NCT00086281|1003687|P15|STARTED|Phase 2||0
409312|NCT00086281|1003688|P14|STARTED|Phase 2||27
409313|NCT00086281|1003689|P13|STARTED|Phase 2||23
409314|NCT00086281|1003690|P12|STARTED|Phase 2||0
409315|NCT00086281|1003691|P11|STARTED|Phase 2||0
409316|NCT00086281|1003692|P10|STARTED|Phase 2||0
409317|NCT00086281|1003693|P9|STARTED|Phase 2||0
409318|NCT00086281|1003694|P8|STARTED|Phase 2||0
409319|NCT00086281|1003695|P7|STARTED|Phase 2||0
409320|NCT00086281|1003696|P6|STARTED|Phase 2||0
409321|NCT00086281|1003697|P5|STARTED|Phase 2||0
409322|NCT00086281|1003698|P4|STARTED|Phase 2||0
409323|NCT00086281|1003699|P3|STARTED|Phase 2||0
409324|NCT00086281|1003700|P2|STARTED|Phase 2||0
409325|NCT00086281|1003701|P1|STARTED|Phase 2||0
409326|NCT00086281|1003687|P15|NOT COMPLETED|Phase 1||3
409327|NCT00086281|1003688|P14|NOT COMPLETED|Phase 1||1
409328|NCT00086281|1003689|P13|NOT COMPLETED|Phase 1||1
409329|NCT00086281|1003690|P12|NOT COMPLETED|Phase 1||1
409330|NCT00086281|1003691|P11|NOT COMPLETED|Phase 1||3
409331|NCT00086281|1003692|P10|NOT COMPLETED|Phase 1||1
409332|NCT00086281|1003693|P9|NOT COMPLETED|Phase 1||0
409333|NCT00086281|1003694|P8|NOT COMPLETED|Phase 1||0
409334|NCT00086281|1003695|P7|NOT COMPLETED|Phase 1||0
409335|NCT00086281|1003696|P6|NOT COMPLETED|Phase 1||0
409336|NCT00086281|1003697|P5|NOT COMPLETED|Phase 1||0
409337|NCT00086281|1003698|P4|NOT COMPLETED|Phase 1||0
409338|NCT00086281|1003699|P3|NOT COMPLETED|Phase 1||0
409339|NCT00086281|1003700|P2|NOT COMPLETED|Phase 1||0
409340|NCT00086281|1003701|P1|NOT COMPLETED|Phase 1||0
409341|NCT00086281|1003687|P15|COMPLETED|Phase 1||0
409342|NCT00086281|1003688|P14|COMPLETED|Phase 1||0
409343|NCT00086281|1003689|P13|COMPLETED|Phase 1||0
409344|NCT00086281|1003690|P12|COMPLETED|Phase 1||0
409345|NCT00086281|1003691|P11|COMPLETED|Phase 1||0
409346|NCT00086281|1003692|P10|COMPLETED|Phase 1||0
409347|NCT00086281|1003693|P9|COMPLETED|Phase 1||2
409348|NCT00086281|1003694|P8|COMPLETED|Phase 1||1
409349|NCT00086281|1003695|P7|COMPLETED|Phase 1||1
409350|NCT00086281|1003696|P6|COMPLETED|Phase 1||3
409351|NCT00086281|1003697|P5|COMPLETED|Phase 1||1
409352|NCT00086281|1003698|P4|COMPLETED|Phase 1||11
409353|NCT00086281|1003699|P3|COMPLETED|Phase 1||8
409354|NCT00086281|1003700|P2|COMPLETED|Phase 1||12
409355|NCT00086281|1003701|P1|COMPLETED|Phase 1||11
409356|NCT00086281|1003687|P15|STARTED|Phase 1||3
409357|NCT00086281|1003688|P14|STARTED|Phase 1||1
409358|NCT00086281|1003689|P13|STARTED|Phase 1||1
409359|NCT00086281|1003690|P12|STARTED|Phase 1||1
409360|NCT00086281|1003691|P11|STARTED|Phase 1||3
409361|NCT00086281|1003692|P10|STARTED|Phase 1||1
409362|NCT00086281|1003693|P9|STARTED|Phase 1||2
409363|NCT00086281|1003694|P8|STARTED|Phase 1||1
409364|NCT00086281|1003695|P7|STARTED|Phase 1||1
409365|NCT00086281|1003696|P6|STARTED|Phase 1||3
409366|NCT00086281|1003697|P5|STARTED|Phase 1||1
409367|NCT00086281|1003698|P4|STARTED|Phase 1||11
409368|NCT00086281|1003699|P3|STARTED|Phase 1||8
409369|NCT00086281|1003700|P2|STARTED|Phase 1||12
409370|NCT00086281|1003701|P1|STARTED|Phase 1||11
409371|NCT00086307|1003714|P3|NOT COMPLETED|Overall Study||8
409372|NCT00086307|1003715|P2|NOT COMPLETED|Overall Study||1
409373|NCT00086307|1003716|P1|NOT COMPLETED|Overall Study||2
409374|NCT00086307|1003714|P3|COMPLETED|Overall Study||5
409375|NCT00086307|1003715|P2|COMPLETED|Overall Study||12
409376|NCT00086307|1003716|P1|COMPLETED|Overall Study||11
409377|NCT00086307|1003714|P3|STARTED|Overall Study||13
409378|NCT00086307|1003715|P2|STARTED|Overall Study||13
409379|NCT00086307|1003716|P1|STARTED|Overall Study||13
409380|NCT00086190|1003727|P3|NOT COMPLETED|Overall Study||6
409381|NCT00086190|1003728|P2|NOT COMPLETED|Overall Study||4
409382|NCT00086190|1003729|P1|NOT COMPLETED|Overall Study||8
409383|NCT00086190|1003727|P3|COMPLETED|Overall Study||33
409384|NCT00086190|1003728|P2|COMPLETED|Overall Study||30
409385|NCT00086190|1003729|P1|COMPLETED|Overall Study||34
409386|NCT00086190|1003727|P3|STARTED|Overall Study||39
409387|NCT00086190|1003728|P2|STARTED|Overall Study||34
409388|NCT00086190|1003729|P1|STARTED|Overall Study||42
409389|NCT00086138|1003787|P2|NOT COMPLETED|Overall Study||3
409390|NCT00086138|1003788|P1|NOT COMPLETED|Overall Study||4
409391|NCT00086138|1003787|P2|COMPLETED|Overall Study||64
409392|NCT00086138|1003788|P1|COMPLETED|Overall Study||60
409393|NCT00086138|1003787|P2|STARTED|Overall Study||67
409394|NCT00086138|1003788|P1|STARTED|Overall Study||64
409395|NCT00086047|1003798|P2|NOT COMPLETED|Overall Study||7
409396|NCT00086047|1003799|P1|NOT COMPLETED|Overall Study||7
409397|NCT00086047|1003798|P2|COMPLETED|Overall Study||50
409398|NCT00086047|1003799|P1|COMPLETED|Overall Study||50
409399|NCT00086047|1003798|P2|STARTED|Overall Study||57
409400|NCT00086047|1003799|P1|STARTED|Overall Study||57
409401|NCT00085917|1003807|P2|NOT COMPLETED|Overall Study||3
409402|NCT00085917|1003808|P1|NOT COMPLETED|Overall Study||4
409403|NCT00085917|1003807|P2|COMPLETED|Overall Study||11
409404|NCT00085917|1003808|P1|COMPLETED|Overall Study||11
409405|NCT00085917|1003807|P2|STARTED|Overall Study||14
409406|NCT00085917|1003808|P1|STARTED|Overall Study||15
409407|NCT00085839|1003820|P2|NOT COMPLETED|Overall Study||0
409408|NCT00085839|1003821|P1|NOT COMPLETED|Overall Study||0
409409|NCT00085839|1003820|P2|COMPLETED|Overall Study||51
409410|NCT00085839|1003821|P1|COMPLETED|Overall Study||52
409411|NCT00085839|1003820|P2|STARTED|Overall Study||51
409412|NCT00085839|1003821|P1|STARTED|Overall Study||52
409413|NCT00085735|1003837|P6|NOT COMPLETED|Overall Study||31
409414|NCT00085735|1003838|P5|NOT COMPLETED|Overall Study||42
409415|NCT00085735|1003839|P4|NOT COMPLETED|Overall Study||19
409416|NCT00085735|1003840|P3|NOT COMPLETED|Overall Study||17
409417|NCT00085735|1003841|P2|NOT COMPLETED|Overall Study||10
409418|NCT00085735|1003842|P1|NOT COMPLETED|Overall Study||12
409419|NCT00085735|1003837|P6|COMPLETED|Overall Study||115
409420|NCT00085735|1003838|P5|COMPLETED|Overall Study||105
409421|NCT00085735|1003839|P4|COMPLETED|Overall Study||46
409422|NCT00085735|1003840|P3|COMPLETED|Overall Study||46
409423|NCT00085735|1003841|P2|COMPLETED|Overall Study||54
409424|NCT00085735|1003842|P1|COMPLETED|Overall Study||52
409425|NCT00085735|1003837|P6|STARTED|Overall Study||146
409426|NCT00085735|1003838|P5|STARTED|Overall Study||147
409427|NCT00085735|1003839|P4|STARTED|Overall Study||65
409428|NCT00085735|1003840|P3|STARTED|Overall Study||63
409429|NCT00085735|1003841|P2|STARTED|Overall Study||64
409430|NCT00085735|1003842|P1|STARTED|Overall Study||64
409431|NCT00085709|1003882|P2|NOT COMPLETED|Overall Study||50
409432|NCT00085709|1003883|P1|NOT COMPLETED|Overall Study||53
409433|NCT00085709|1003882|P2|COMPLETED|Overall Study||270
409434|NCT00085709|1003883|P1|COMPLETED|Overall Study||264
409435|NCT00085709|1003882|P2|Eligible and Did Not Withdraw Consent|Overall Study||300
409436|NCT00085709|1003883|P1|Eligible and Did Not Withdraw Consent|Overall Study||296
409437|NCT00085709|1003882|P2|Eligible|Overall Study||301
409438|NCT00085709|1003883|P1|Eligible|Overall Study||298
409439|NCT00085709|1003882|P2|STARTED|Overall Study||320
409440|NCT00085709|1003883|P1|STARTED|Overall Study||317
409441|NCT00085644|1003899|P3|NOT COMPLETED|Open-Label Period||109
409442|NCT00085644|1003900|P2|NOT COMPLETED|Open-Label Period||0
409443|NCT00085644|1003901|P1|NOT COMPLETED|Open-Label Period||0
409444|NCT00085644|1003899|P3|COMPLETED|Open-Label Period||202
409445|NCT00085644|1003900|P2|COMPLETED|Open-Label Period||0
409446|NCT00085644|1003901|P1|COMPLETED|Open-Label Period||0
409447|NCT00085644|1003899|P3|STARTED|Open-Label Period|1 subject who discontinued for personal reasons subsequently died 450 days after last dose.|311
409448|NCT00085644|1003900|P2|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
409449|NCT00085644|1003901|P1|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
409450|NCT00085644|1003899|P3|NOT COMPLETED|Double-Blind Period||0
409451|NCT00085644|1003900|P2|NOT COMPLETED|Double-Blind Period||6
409452|NCT00085644|1003901|P1|NOT COMPLETED|Double-Blind Period||13
409453|NCT00085644|1003899|P3|COMPLETED|Double-Blind Period||0
409454|NCT00085644|1003900|P2|COMPLETED|Double-Blind Period||101
409455|NCT00085644|1003901|P1|COMPLETED|Double-Blind Period||195
409456|NCT00085644|1003899|P3|STARTED|Double-Blind Period|This treatment group is not applicable to the Double-Blind Period.|0
409457|NCT00085644|1003900|P2|STARTED|Double-Blind Period||107
409458|NCT00085644|1003901|P1|STARTED|Double-Blind Period||208
409459|NCT00085631|1003942|P3|NOT COMPLETED|Overall Study||7
409460|NCT00085631|1003943|P2|NOT COMPLETED|Overall Study||11
409461|NCT00085631|1003944|P1|NOT COMPLETED|Overall Study||4
409462|NCT00085631|1003942|P3|COMPLETED|Overall Study||32
409463|NCT00085631|1003943|P2|COMPLETED|Overall Study||38
409464|NCT00085631|1003944|P1|COMPLETED|Overall Study||9
409465|NCT00085631|1003942|P3|STARTED|Overall Study||39
409466|NCT00085631|1003943|P2|STARTED|Overall Study||49
409467|NCT00085631|1003944|P1|STARTED|Overall Study||13
409468|NCT00085566|1003954|P3|NOT COMPLETED|Overall Study||14
409469|NCT00085566|1003955|P2|NOT COMPLETED|Overall Study||0
409470|NCT00085566|1003956|P1|NOT COMPLETED|Overall Study||0
409471|NCT00085566|1003954|P3|COMPLETED|Overall Study||43
409472|NCT00085566|1003955|P2|COMPLETED|Overall Study||3
409473|NCT00085566|1003956|P1|COMPLETED|Overall Study||3
409474|NCT00085566|1003954|P3|STARTED|Overall Study||57
409475|NCT00085566|1003955|P2|STARTED|Overall Study||3
409476|NCT00085566|1003956|P1|STARTED|Overall Study||3
409477|NCT00085540|1003966|P2|NOT COMPLETED|Overall Study||2
409478|NCT00085540|1003967|P1|NOT COMPLETED|Overall Study||0
409479|NCT00085540|1003966|P2|COMPLETED|Overall Study||40
409480|NCT00085540|1003967|P1|COMPLETED|Overall Study||8
409481|NCT00085540|1003966|P2|STARTED|Overall Study||42
409482|NCT00085540|1003967|P1|STARTED|Overall Study||8
409483|NCT00085436|1003974|P1|NOT COMPLETED|Overall Study||0
409484|NCT00085436|1003974|P1|COMPLETED|Overall Study||18
409485|NCT00085436|1003974|P1|STARTED|Overall Study||18
409486|NCT00085423|1003979|P1|NOT COMPLETED|Overall Study||2
409487|NCT00085423|1003979|P1|COMPLETED|Overall Study||18
409488|NCT00085423|1003979|P1|STARTED|Overall Study||20
409489|NCT00085410|1003985|P1|NOT COMPLETED|Overall Study||0
409490|NCT00085410|1003985|P1|COMPLETED|Overall Study||20
409491|NCT00085410|1003985|P1|STARTED|Overall Study||20
409492|NCT00085293|1003999|P1|NOT COMPLETED|Overall Study||0
409493|NCT00085293|1003999|P1|COMPLETED|Overall Study||12
409494|NCT00085293|1003999|P1|STARTED|Overall Study||12
409495|NCT00085254|1004012|P3|NOT COMPLETED|Overall Study||0
409496|NCT00085254|1004013|P2|NOT COMPLETED|Overall Study||0
409497|NCT00085254|1004014|P1|NOT COMPLETED|Overall Study||0
409498|NCT00085254|1004012|P3|COMPLETED|Overall Study||48
409499|NCT00085254|1004013|P2|COMPLETED|Overall Study||46
409500|NCT00085254|1004014|P1|COMPLETED|Overall Study||18
409501|NCT00085254|1004012|P3|STARTED|Overall Study||48
409502|NCT00085254|1004013|P2|STARTED|Overall Study||46
409503|NCT00085254|1004014|P1|STARTED|Overall Study||18
409504|NCT00085202|1004030|P2|NOT COMPLETED|Overall Study||24
409505|NCT00085202|1004031|P1|NOT COMPLETED|Overall Study||18
409506|NCT00085202|1004030|P2|COMPLETED|Overall Study||120
409507|NCT00085202|1004031|P1|COMPLETED|Overall Study||251
409508|NCT00085202|1004030|P2|STARTED|Overall Study||144
409509|NCT00085202|1004031|P1|STARTED|Overall Study||269
409510|NCT00085098|1004052|P2|NOT COMPLETED|Overall Study||2
409511|NCT00085098|1004053|P1|NOT COMPLETED|Overall Study||1
409512|NCT00085098|1004052|P2|COMPLETED|Overall Study||11
409513|NCT00085098|1004053|P1|COMPLETED|Overall Study||10
409514|NCT00085098|1004052|P2|STARTED|Overall Study||13
409515|NCT00085098|1004053|P1|STARTED|Overall Study||11
409516|NCT00084864|1004067|P4|NOT COMPLETED|Overall Study||0
409517|NCT00084864|1004068|P3|NOT COMPLETED|Overall Study||0
409518|NCT00084864|1004069|P2|NOT COMPLETED|Overall Study||0
409519|NCT00084864|1004070|P1|NOT COMPLETED|Overall Study||1
409520|NCT00084864|1004067|P4|COMPLETED|Overall Study||4
409521|NCT00084864|1004068|P3|COMPLETED|Overall Study||4
409522|NCT00084864|1004069|P2|COMPLETED|Overall Study||7
409523|NCT00084864|1004070|P1|COMPLETED|Overall Study||9
409524|NCT00084864|1004067|P4|STARTED|Overall Study||4
409525|NCT00084864|1004068|P3|STARTED|Overall Study||4
409526|NCT00084864|1004069|P2|STARTED|Overall Study||7
409527|NCT00084864|1004070|P1|STARTED|Overall Study||10
409528|NCT00084838|1004096|P1|NOT COMPLETED|Overall Study||13
409529|NCT00084838|1004096|P1|COMPLETED|Overall Study||12
409530|NCT00084838|1004096|P1|Eligible and Treated|Overall Study|4 ineligible pts upon central path review (n=3) and per DFCI IRB (n=1); 1 pt withdrew before rcv trt|20
409531|NCT00084838|1004096|P1|STARTED|Overall Study||25
409532|NCT00084747|1004118|P1|NOT COMPLETED|Overall Study||13
409533|NCT00084747|1004118|P1|COMPLETED|Overall Study||17
409534|NCT00084747|1004118|P1|STARTED|Overall Study||30
409535|NCT00084682|1004123|P1|NOT COMPLETED|Overall Study||1
409536|NCT00084682|1004123|P1|COMPLETED|Overall Study||13
409537|NCT00084682|1004123|P1|STARTED|Overall Study||14
409538|NCT00084617|1004127|P1|NOT COMPLETED|Overall Study||9
409539|NCT00084617|1004127|P1|COMPLETED|Overall Study||30
409540|NCT00084617|1004127|P1|STARTED|Overall Study||39
409541|NCT00084487|1004133|P1|NOT COMPLETED|Overall Study||1
409542|NCT00084487|1004133|P1|COMPLETED|Overall Study||20
409543|NCT00084487|1004133|P1|STARTED|Overall Study||21
409544|NCT00084409|1004143|P2|NOT COMPLETED|Overall Study||12
409545|NCT00084409|1004144|P1|NOT COMPLETED|Overall Study||15
409546|NCT00084409|1004143|P2|COMPLETED|Overall Study|4 Current, 8 former|65
409547|NCT00084409|1004144|P1|COMPLETED|Overall Study|9 current, 6 former|60
409548|NCT00084409|1004143|P2|STARTED|Overall Study|41 current, 36 former|77
409549|NCT00084409|1004144|P1|STARTED|Overall Study|40 Current, 35 former|75
409550|NCT00084383|1004170|P1|NOT COMPLETED|Overall Study||47
409551|NCT00084383|1004170|P1|COMPLETED|Overall Study||13
409552|NCT00084383|1004170|P1|STARTED|Overall Study||60
409553|NCT00084318|1004177|P2|NOT COMPLETED|Overall Study||13
409554|NCT00084318|1004178|P1|NOT COMPLETED|Overall Study||22
409555|NCT00084318|1004177|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|106
409556|NCT00084318|1004178|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|97
409557|NCT00084318|1004177|P2|STARTED|Overall Study||119
409558|NCT00084318|1004178|P1|STARTED|Overall Study||119
409559|NCT00084266|1004198|P2|NOT COMPLETED|Overall Study||423
409560|NCT00084266|1004199|P1|NOT COMPLETED|Overall Study||441
409561|NCT00084266|1004198|P2|COMPLETED|Overall Study||184
409562|NCT00084266|1004199|P1|COMPLETED|Overall Study||177
409563|NCT00084266|1004198|P2|Treated|Overall Study||587
409564|NCT00084266|1004199|P1|Treated|Overall Study||597
409565|NCT00084266|1004198|P2|STARTED|Overall Study||607
409566|NCT00084266|1004199|P1|STARTED|Overall Study||618
409567|NCT00084149|1004235|P2|NOT COMPLETED|Overall Study||5
409568|NCT00084149|1004236|P1|NOT COMPLETED|Overall Study||8
409569|NCT00084149|1004235|P2|COMPLETED|Overall Study||13
409570|NCT00084149|1004236|P1|COMPLETED|Overall Study||28
409571|NCT00084149|1004235|P2|STARTED|Overall Study||18
409572|NCT00084149|1004236|P1|STARTED|Overall Study||36
409573|NCT00084136|1004257|P3|NOT COMPLETED|NRTI Comparison||82
409574|NCT00084136|1004258|P2|NOT COMPLETED|NRTI Comparison||0
409575|NCT00084136|1004259|P1|NOT COMPLETED|NRTI Comparison||101
409576|NCT00084136|1004257|P3|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|444
409577|NCT00084136|1004258|P2|COMPLETED|NRTI Comparison||0
409578|NCT00084136|1004259|P1|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|418
409579|NCT00084136|1004257|P3|STARTED|NRTI Comparison||526
409580|NCT00084136|1004258|P2|STARTED|NRTI Comparison||0
409581|NCT00084136|1004259|P1|STARTED|NRTI Comparison||519
409582|NCT00084136|1004257|P3|NOT COMPLETED|PI Comparison||0
409583|NCT00084136|1004258|P2|NOT COMPLETED|PI Comparison||47
409584|NCT00084136|1004259|P1|NOT COMPLETED|PI Comparison||55
409585|NCT00084136|1004257|P3|COMPLETED|PI Comparison||0
409586|NCT00084136|1004258|P2|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|479
409587|NCT00084136|1004259|P1|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|464
409588|NCT00084136|1004257|P3|STARTED|PI Comparison||0
409589|NCT00084136|1004258|P2|STARTED|PI Comparison||526
409590|NCT00084136|1004259|P1|STARTED|PI Comparison||519
409591|NCT00084084|1004318|P1|NOT COMPLETED|Phase 2 (Transition to Replagal AF)||1
409592|NCT00084084|1004318|P1|COMPLETED|Phase 2 (Transition to Replagal AF)||10
409593|NCT00084084|1004318|P1|STARTED|Phase 2 (Transition to Replagal AF)|The 11 patients remaining in TKT029 at the time Replagal AF was made available continued to Phase 2.|11
409594|NCT00084084|1004318|P1|NOT COMPLETED|Phase 1 (Treatment With Replagal RB)||1
409595|NCT00084084|1004318|P1|COMPLETED|Phase 1 (Treatment With Replagal RB)||16
409596|NCT00084084|1004318|P1|STARTED|Phase 1 (Treatment With Replagal RB)||17
409597|NCT00083915|1004328|P2|NOT COMPLETED|Overall Study||37
409598|NCT00083915|1004329|P1|NOT COMPLETED|Overall Study||50
409599|NCT00083915|1004328|P2|COMPLETED|Overall Study||8
409600|NCT00083915|1004329|P1|COMPLETED|Overall Study||2
409601|NCT00083915|1004328|P2|STARTED|Overall Study||45
409602|NCT00083915|1004329|P1|STARTED|Overall Study||52
409603|NCT00083889|1004337|P2|NOT COMPLETED|Overall Study||375
409604|NCT00083889|1004338|P1|NOT COMPLETED|Overall Study||375
409605|NCT00083889|1004337|P2|COMPLETED|Overall Study|Discontinuation crossover subjects: AEs 5,consent withdrawn 2, lack efficacy 13, sponsor decision 5.|0
409606|NCT00083889|1004338|P1|COMPLETED|Overall Study||0
409607|NCT00083889|1004337|P2|Received Treatment|Overall Study|15 subjects randomized to IFN-α discontinued before receiving their first dose of study medication.|360
409608|NCT00083889|1004338|P1|Received Treatment|Overall Study||375
409609|NCT00083889|1004337|P2|STARTED|Overall Study||375
409610|NCT00083889|1004338|P1|STARTED|Overall Study||375
409611|NCT00004146|1004387|P1|NOT COMPLETED|Overall Study||0
409612|NCT00004146|1004387|P1|COMPLETED|Overall Study||55
409613|NCT00004146|1004387|P1|STARTED|Overall Study||55
409614|NCT00083759|1004396|P2|NOT COMPLETED|Overall Study||83
409615|NCT00083759|1004397|P1|NOT COMPLETED|Overall Study||84
409616|NCT00083759|1004396|P2|COMPLETED|Overall Study||66
409617|NCT00083759|1004397|P1|COMPLETED|Overall Study||66
409618|NCT00083759|1004396|P2|STARTED|Overall Study|149 subjects enrolled, 136 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|149
409619|NCT00083759|1004397|P1|STARTED|Overall Study|150 subjects enrolled, 137 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|150
409620|NCT00083720|1004405|P1|NOT COMPLETED|Overall Study||0
409621|NCT00083720|1004405|P1|COMPLETED|Overall Study|Two patients died prior to receiving cetuximab.|85
409622|NCT00083720|1004405|P1|STARTED|Overall Study|Patients analyzed for efficacy who met the epidermal growth factor receptor (EGFR) negative criteria|85
409623|NCT00083616|1004415|P1|NOT COMPLETED|Overall Study||31
409624|NCT00083616|1004415|P1|COMPLETED|Overall Study|Completed safety followup or died on study as of the data cut-off date of 22 December 2006|154
409625|NCT00083616|1004415|P1|Received Study Medication|Overall Study||182
409626|NCT00083616|1004415|P1|STARTED|Overall Study||185
409627|NCT00083551|1004429|P2|NOT COMPLETED|Overall Study||0
409628|NCT00083551|1004430|P1|NOT COMPLETED|Overall Study||0
409629|NCT00083551|1004429|P2|COMPLETED|Overall Study||345
409630|NCT00083551|1004430|P1|COMPLETED|Overall Study||323
409631|NCT00083551|1004429|P2|STARTED|Overall Study||345
409632|NCT00083551|1004430|P1|STARTED|Overall Study||323
409633|NCT00083382|1004436|P1|NOT COMPLETED|Overall Study||0
409634|NCT00083382|1004436|P1|COMPLETED|Overall Study||83
409635|NCT00083382|1004436|P1|STARTED|Overall Study||83
409636|NCT00082888|1004440|P1|NOT COMPLETED|Overall Study||22
409637|NCT00082888|1004440|P1|COMPLETED|Overall Study||71
409638|NCT00082888|1004440|P1|STARTED|Overall Study||93
409639|NCT00082810|1004444|P1|NOT COMPLETED|Overall Study||31
409640|NCT00082810|1004444|P1|COMPLETED|Overall Study||2
409641|NCT00082810|1004444|P1|STARTED|Overall Study||33
409642|NCT00082758|1004455|P3|NOT COMPLETED|Overall Study||0
409643|NCT00082758|1004456|P2|NOT COMPLETED|Overall Study||17
409644|NCT00082758|1004457|P1|NOT COMPLETED|Overall Study||15
409645|NCT00082758|1004455|P3|COMPLETED|Overall Study||0
409646|NCT00082758|1004456|P2|COMPLETED|Overall Study||7
409647|NCT00082758|1004457|P1|COMPLETED|Overall Study||0
409648|NCT00082758|1004455|P3|STARTED|Overall Study||0
409649|NCT00082758|1004456|P2|STARTED|Overall Study||24
409650|NCT00082758|1004457|P1|STARTED|Overall Study||15
409651|NCT00082641|1004467|P2|NOT COMPLETED|Overall Study||0
409652|NCT00082641|1004468|P1|NOT COMPLETED|Overall Study||0
409653|NCT00082641|1004467|P2|COMPLETED|Overall Study||12
409654|NCT00082641|1004468|P1|COMPLETED|Overall Study||11
409655|NCT00082641|1004467|P2|STARTED|Overall Study||12
409656|NCT00082641|1004468|P1|STARTED|Overall Study||11
409657|NCT00083226|1004477|P1|NOT COMPLETED|Overall Study||42
409658|NCT00083226|1004477|P1|COMPLETED|Overall Study||0
409659|NCT00083226|1004477|P1|STARTED|Overall Study||42
409660|NCT00083174|1004485|P3|NOT COMPLETED|Open-label Extension||0
409661|NCT00083174|1004486|P2|NOT COMPLETED|Open-label Extension||0
409662|NCT00083174|1004487|P1|NOT COMPLETED|Open-label Extension||0
409663|NCT00083174|1004485|P3|COMPLETED|Open-label Extension||2831
409664|NCT00083174|1004486|P2|COMPLETED|Open-label Extension||0
409665|NCT00083174|1004487|P1|COMPLETED|Open-label Extension||0
409666|NCT00083174|1004485|P3|STARTED|Open-label Extension||2831
409667|NCT00083174|1004486|P2|STARTED|Open-label Extension||0
409668|NCT00083174|1004487|P1|STARTED|Open-label Extension||0
409669|NCT00083174|1004485|P3|NOT COMPLETED|Randomization Period||0
409670|NCT00083174|1004486|P2|NOT COMPLETED|Randomization Period||0
409671|NCT00083174|1004487|P1|NOT COMPLETED|Randomization Period||0
409672|NCT00083174|1004485|P3|COMPLETED|Randomization Period||0
409673|NCT00083174|1004486|P2|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2275
409674|NCT00083174|1004487|P1|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2285
409675|NCT00083174|1004485|P3|STARTED|Randomization Period||0
409676|NCT00083174|1004486|P2|STARTED|Randomization Period||2275
409677|NCT00083174|1004487|P1|STARTED|Randomization Period||2285
409678|NCT00083122|1004509|P2|NOT COMPLETED|Overall Study||0
409679|NCT00083122|1004510|P1|NOT COMPLETED|Overall Study||0
409680|NCT00083122|1004509|P2|COMPLETED|Overall Study||5
409681|NCT00083122|1004510|P1|COMPLETED|Overall Study||40
409682|NCT00083122|1004509|P2|STARTED|Overall Study||5
409683|NCT00083122|1004510|P1|STARTED|Overall Study||40
409684|NCT00082628|1004521|P5|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||18
409685|NCT00082628|1004522|P4|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||16
409686|NCT00082628|1004523|P3|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||15
409687|NCT00082628|1004524|P2|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0
409688|NCT00082628|1004525|P1|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0
409689|NCT00082628|1004521|P5|COMPLETED|Treatment Period II: Week 12 to Week 36||55
409690|NCT00082628|1004522|P4|COMPLETED|Treatment Period II: Week 12 to Week 36||76
409691|NCT00082628|1004523|P3|COMPLETED|Treatment Period II: Week 12 to Week 36||78
409692|NCT00082628|1004524|P2|COMPLETED|Treatment Period II: Week 12 to Week 36||0
409693|NCT00082628|1004525|P1|COMPLETED|Treatment Period II: Week 12 to Week 36||0
409694|NCT00082628|1004521|P5|STARTED|Treatment Period II: Week 12 to Week 36||73
409695|NCT00082628|1004522|P4|STARTED|Treatment Period II: Week 12 to Week 36||92
409696|NCT00082628|1004523|P3|STARTED|Treatment Period II: Week 12 to Week 36||93
409697|NCT00082628|1004524|P2|STARTED|Treatment Period II: Week 12 to Week 36||0
409698|NCT00082628|1004525|P1|STARTED|Treatment Period II: Week 12 to Week 36||0
409699|NCT00082628|1004521|P5|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
409700|NCT00082628|1004522|P4|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
409701|NCT00082628|1004523|P3|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
409702|NCT00082628|1004524|P2|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||60
409703|NCT00082628|1004525|P1|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||8
409704|NCT00082628|1004521|P5|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
409705|NCT00082628|1004522|P4|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
409706|NCT00082628|1004523|P3|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
409707|NCT00082628|1004524|P2|COMPLETED|Treatment Period I (Week 1 to Week 12)||185
409708|NCT00082628|1004525|P1|COMPLETED|Treatment Period I (Week 1 to Week 12)||73
409709|NCT00082628|1004521|P5|STARTED|Treatment Period I (Week 1 to Week 12)||0
409710|NCT00082628|1004522|P4|STARTED|Treatment Period I (Week 1 to Week 12)||0
409711|NCT00082628|1004523|P3|STARTED|Treatment Period I (Week 1 to Week 12)||0
409712|NCT00082628|1004524|P2|STARTED|Treatment Period I (Week 1 to Week 12)||245
409713|NCT00082628|1004525|P1|STARTED|Treatment Period I (Week 1 to Week 12)||81
409714|NCT00082433|1004545|P2|NOT COMPLETED|Overall Study||597
409715|NCT00082433|1004546|P1|NOT COMPLETED|Overall Study||594
409716|NCT00082433|1004545|P2|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
409717|NCT00082433|1004546|P1|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
409718|NCT00082433|1004545|P2|STARTED|Overall Study||612
409719|NCT00082433|1004546|P1|STARTED|Overall Study||609
409720|NCT00082381|1004566|P2|NOT COMPLETED|Overall Study||26
409721|NCT00082381|1004567|P1|NOT COMPLETED|Overall Study||55
409722|NCT00082381|1004566|P2|COMPLETED|Overall Study||242
409723|NCT00082381|1004567|P1|COMPLETED|Overall Study||228
409724|NCT00082381|1004566|P2|Received Treatment (Intent to Treat)|Overall Study||267
409725|NCT00082381|1004567|P1|Received Treatment (Intent to Treat)|Overall Study||282
409726|NCT00082381|1004566|P2|STARTED|Overall Study||268
409727|NCT00082381|1004567|P1|STARTED|Overall Study||283
409728|NCT00082407|1004587|P2|NOT COMPLETED|Overall Study||27
409729|NCT00082407|1004588|P1|NOT COMPLETED|Overall Study||56
409730|NCT00082407|1004587|P2|COMPLETED|Overall Study||223
409731|NCT00082407|1004588|P1|COMPLETED|Overall Study||199
409732|NCT00082407|1004587|P2|Received Treatment (Intent to Treat)|Overall Study||248
409733|NCT00082407|1004588|P1|Received Treatment (Intent to Treat)|Overall Study||253
409734|NCT00082407|1004587|P2|STARTED|Overall Study||250
409735|NCT00082407|1004588|P1|STARTED|Overall Study||255
409736|NCT00082368|1004606|P1|NOT COMPLETED|Overall Study||1
409737|NCT00082368|1004606|P1|COMPLETED|Overall Study||11
409738|NCT00082368|1004606|P1|STARTED|Overall Study||12
409739|NCT00082355|1004611|P1|NOT COMPLETED|5 Year Recurrent Thromboembolism Rate||28
409740|NCT00082355|1004611|P1|COMPLETED|5 Year Recurrent Thromboembolism Rate|data will not be complied until 2014|0
409741|NCT00082355|1004611|P1|STARTED|5 Year Recurrent Thromboembolism Rate||28
409742|NCT00082355|1004611|P1|NOT COMPLETED|Initial Results of Thrombolytic Therapy||2
409743|NCT00082355|1004611|P1|COMPLETED|Initial Results of Thrombolytic Therapy||28
409744|NCT00082355|1004611|P1|STARTED|Initial Results of Thrombolytic Therapy||30
409745|NCT00082342|1004618|P2|NOT COMPLETED|Overall Study||0
409746|NCT00082342|1004619|P1|NOT COMPLETED|Overall Study||0
409747|NCT00082342|1004618|P2|COMPLETED|Overall Study||12
409748|NCT00082342|1004619|P1|COMPLETED|Overall Study||13
409749|NCT00082342|1004618|P2|STARTED|Overall Study||12
409750|NCT00082342|1004619|P1|STARTED|Overall Study||13
409751|NCT00082329|1004639|P1|NOT COMPLETED|Overall Study||0
409752|NCT00082329|1004639|P1|COMPLETED|Overall Study||9
409753|NCT00082329|1004639|P1|STARTED|Overall Study||9
409754|NCT00082173|1004645|P2|NOT COMPLETED|Overall Study||11
409755|NCT00082173|1004646|P1|NOT COMPLETED|Overall Study||10
409756|NCT00082173|1004645|P2|COMPLETED|Overall Study||61
409757|NCT00082173|1004646|P1|COMPLETED|Overall Study||64
409758|NCT00082173|1004645|P2|STARTED|Overall Study||72
409759|NCT00082173|1004646|P1|STARTED|Overall Study||74
409760|NCT00003726|1004654|P1|NOT COMPLETED|Overall Study||1
409761|NCT00003726|1004654|P1|COMPLETED|Overall Study|Funding was pulled on the trial and therefore no other participants were enrolled|0
409762|NCT00003726|1004654|P1|STARTED|Overall Study||1
409763|NCT00081939|1004658|P1|NOT COMPLETED|Overall Study||0
409764|NCT00081939|1004658|P1|COMPLETED|Overall Study||303
409765|NCT00081939|1004658|P1|STARTED|Overall Study||303
409766|NCT00082017|1004662|P2|NOT COMPLETED|Overall Study||0
409767|NCT00082017|1004663|P1|NOT COMPLETED|Overall Study||0
409768|NCT00082017|1004662|P2|COMPLETED|Overall Study||9
409769|NCT00082017|1004663|P1|COMPLETED|Overall Study||11
409770|NCT00082017|1004662|P2|STARTED|Overall Study||9
409771|NCT00082017|1004663|P1|STARTED|Overall Study||11
409772|NCT00081861|1004679|P1|NOT COMPLETED|Overall Study||0
409773|NCT00081861|1004679|P1|COMPLETED|Overall Study||13
409774|NCT00081861|1004679|P1|STARTED|Overall Study||13
409775|NCT00081770|1004686|P3|NOT COMPLETED|Overall Study||456
409776|NCT00081770|1004687|P2|NOT COMPLETED|Overall Study||546
409777|NCT00081770|1004688|P1|NOT COMPLETED|Overall Study||502
409778|NCT00081770|1004686|P3|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|579
409779|NCT00081770|1004687|P2|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|470
409780|NCT00081770|1004688|P1|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|517
409781|NCT00081770|1004686|P3|STARTED|Overall Study||1035
409782|NCT00081770|1004687|P2|STARTED|Overall Study||1016
409783|NCT00081770|1004688|P1|STARTED|Overall Study||1019
409784|NCT00081731|1004707|P2|NOT COMPLETED|Overall Study||8
409785|NCT00081731|1004708|P1|NOT COMPLETED|Overall Study||8
409786|NCT00081731|1004707|P2|COMPLETED|Overall Study||459
409787|NCT00081731|1004708|P1|COMPLETED|Overall Study||472
409788|NCT00081731|1004707|P2|STARTED|Overall Study||467
409789|NCT00081731|1004708|P1|STARTED|Overall Study||480
409790|NCT00081653|1004728|P2|NOT COMPLETED|Overall Study||37
409791|NCT00081653|1004729|P1|NOT COMPLETED|Overall Study||47
409792|NCT00081653|1004728|P2|COMPLETED|Overall Study|Completed 3 years of treatment|324
409793|NCT00081653|1004729|P1|COMPLETED|Overall Study|Completed 3 years of treatment|311
409881|NCT00080470|1004910|P1|STARTED|Overall Study||45
409794|NCT00081653|1004728|P2|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|361
409795|NCT00081653|1004729|P1|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|358
409796|NCT00081497|1004747|P2|NOT COMPLETED|Overall Study||2
409797|NCT00081497|1004748|P1|NOT COMPLETED|Overall Study||3
409798|NCT00081497|1004747|P2|COMPLETED|Overall Study||37
409799|NCT00081497|1004748|P1|COMPLETED|Overall Study||25
409800|NCT00081497|1004747|P2|STARTED|Overall Study|Patients who were randomized to Fabrazyme in AGAL-008-00 (NCT00074984).|39
409801|NCT00081497|1004748|P1|STARTED|Overall Study|Patients who were randomized to placebo in AGAL-008-00 (NCT00074984).|28
409802|NCT00081458|1004766|P3|NOT COMPLETED|Overall Study||4
409803|NCT00081458|1004767|P2|NOT COMPLETED|Overall Study||8
409804|NCT00081458|1004768|P1|NOT COMPLETED|Overall Study||1
409805|NCT00081458|1004766|P3|COMPLETED|Overall Study||29
409806|NCT00081458|1004767|P2|COMPLETED|Overall Study||27
409807|NCT00081458|1004768|P1|COMPLETED|Overall Study||15
409808|NCT00081458|1004766|P3|Received Treatment|Overall Study|1 subject was randomized but did not receive the study drug|32
409809|NCT00081458|1004767|P2|Received Treatment|Overall Study||35
409810|NCT00081458|1004768|P1|Received Treatment|Overall Study||16
409811|NCT00081458|1004766|P3|STARTED|Overall Study||33
409812|NCT00081458|1004767|P2|STARTED|Overall Study||35
409813|NCT00081458|1004768|P1|STARTED|Overall Study||16
409814|NCT00081328|1004782|P3|NOT COMPLETED|Overall Study||0
409815|NCT00081328|1004783|P2|NOT COMPLETED|Overall Study||0
409816|NCT00081328|1004784|P1|NOT COMPLETED|Overall Study||0
409817|NCT00081328|1004782|P3|COMPLETED|Overall Study||234
409818|NCT00081328|1004783|P2|COMPLETED|Overall Study||233
409819|NCT00081328|1004784|P1|COMPLETED|Overall Study||232
409820|NCT00081328|1004782|P3|STARTED|Overall Study||234
409821|NCT00081328|1004783|P2|STARTED|Overall Study||233
409822|NCT00081328|1004784|P1|STARTED|Overall Study||232
409823|NCT00081289|1004824|P2|NOT COMPLETED|Overall Study||21
409824|NCT00081289|1004825|P1|NOT COMPLETED|Overall Study||21
409825|NCT00081289|1004824|P2|COMPLETED|Overall Study||52
409826|NCT00081289|1004825|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
409827|NCT00081289|1004824|P2|STARTED|Overall Study||73
409828|NCT00081289|1004825|P1|STARTED|Overall Study||73
409829|NCT00081263|1004833|P2|NOT COMPLETED|Overall Study||22
409830|NCT00081263|1004834|P1|NOT COMPLETED|Overall Study||17
409831|NCT00081263|1004833|P2|COMPLETED|Overall Study||41
409832|NCT00081263|1004834|P1|COMPLETED|Overall Study||50
409833|NCT00081263|1004833|P2|STARTED|Overall Study||63
409834|NCT00081263|1004834|P1|STARTED|Overall Study||67
409835|NCT00081159|1004844|P2|NOT COMPLETED|Overall Study||5
409836|NCT00081159|1004845|P1|NOT COMPLETED|Overall Study||2
409837|NCT00081159|1004844|P2|COMPLETED|Overall Study||35
409838|NCT00081159|1004845|P1|COMPLETED|Overall Study||37
409839|NCT00081159|1004844|P2|STARTED|Overall Study||40
409840|NCT00081159|1004845|P1|STARTED|Overall Study||39
409841|NCT00080938|1004855|P1|NOT COMPLETED|Overall Study||24
409842|NCT00080938|1004855|P1|COMPLETED|Overall Study||2
409843|NCT00080938|1004855|P1|Eligible and Treated|Overall Study||21
409844|NCT00080938|1004855|P1|Began Protocol Therapy|Overall Study||25
409845|NCT00080938|1004855|P1|STARTED|Overall Study||26
409846|NCT00080912|1004864|P2|NOT COMPLETED|Overall Study||0
409847|NCT00080912|1004865|P1|NOT COMPLETED|Overall Study||0
409848|NCT00080912|1004864|P2|COMPLETED|Overall Study||425
409849|NCT00080912|1004865|P1|COMPLETED|Overall Study||425
409850|NCT00080912|1004864|P2|STARTED|Overall Study||425
409851|NCT00080912|1004865|P1|STARTED|Overall Study||425
409852|NCT00080899|1004871|P1|NOT COMPLETED|Overall Study||1
409853|NCT00080899|1004871|P1|COMPLETED|Overall Study||22
409854|NCT00080899|1004871|P1|STARTED|Overall Study||23
409855|NCT00080535|1004876|P1|NOT COMPLETED|Overall Study||0
409856|NCT00080535|1004876|P1|COMPLETED|Overall Study||10
409857|NCT00080535|1004876|P1|STARTED|Overall Study||10
409858|NCT00080483|1004883|P2|NOT COMPLETED|Overall Study||2
409859|NCT00080483|1004884|P1|NOT COMPLETED|Overall Study||2
409860|NCT00080483|1004883|P2|COMPLETED|Overall Study||16
409861|NCT00080483|1004884|P1|COMPLETED|Overall Study||15
409862|NCT00080483|1004883|P2|STARTED|Overall Study||18
409863|NCT00080483|1004884|P1|STARTED|Overall Study||17
409864|NCT00002525|1004892|P2|NOT COMPLETED|Overall Study||0
409865|NCT00002525|1004893|P1|NOT COMPLETED|Overall Study||186
409866|NCT00002525|1004892|P2|COMPLETED|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|428
409867|NCT00002525|1004893|P1|COMPLETED|Overall Study||241
409868|NCT00002525|1004892|P2|Dukes' B2 Stage|Overall Study||139
409869|NCT00002525|1004893|P1|Dukes' B2 Stage|Overall Study||150
409870|NCT00002525|1004892|P2|Dukes' B3 or C Stage|Overall Study||158
409871|NCT00002525|1004893|P1|Dukes' B3 or C Stage|Overall Study|"Primary population: pts with Duke's B3, C disease. 158 such pts on No perioperative 5-FU arm"|156
409872|NCT00002525|1004892|P2|Treated|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|0
409873|NCT00002525|1004893|P1|Treated|Overall Study||419
409874|NCT00002525|1004892|P2|STARTED|Overall Study||428
409875|NCT00002525|1004893|P1|STARTED|Overall Study|859 patients were enrolled to the study, but 4 patients were not randomized to any treatment arm|427
409876|NCT00080470|1004909|P2|NOT COMPLETED|Overall Study||28
409877|NCT00080470|1004910|P1|NOT COMPLETED|Overall Study||34
409878|NCT00080470|1004909|P2|COMPLETED|Overall Study||14
409879|NCT00080470|1004910|P1|COMPLETED|Overall Study||11
409880|NCT00080470|1004909|P2|STARTED|Overall Study||42
409882|NCT00080301|1004920|P2|NOT COMPLETED|Overall Study||11
409883|NCT00080301|1004921|P1|NOT COMPLETED|Overall Study||5
409884|NCT00080301|1004920|P2|COMPLETED|Overall Study|Participants who are off treatment|366
409885|NCT00080301|1004921|P1|COMPLETED|Overall Study|Participants who are off treatment|370
409886|NCT00080301|1004920|P2|Still on Treatment|Overall Study||1
409887|NCT00080301|1004921|P1|Still on Treatment|Overall Study||0
409888|NCT00080301|1004920|P2|Never Treated|Overall Study||10
409889|NCT00080301|1004921|P1|Never Treated|Overall Study||5
409890|NCT00080301|1004920|P2|STARTED|Overall Study||377
409891|NCT00080301|1004921|P1|STARTED|Overall Study||375
409892|NCT00080288|1004941|P2|NOT COMPLETED|Overall Study||38
409893|NCT00080288|1004942|P1|NOT COMPLETED|Overall Study||30
409894|NCT00080288|1004941|P2|COMPLETED|Overall Study||89
409895|NCT00080288|1004942|P1|COMPLETED|Overall Study||97
409896|NCT00080288|1004941|P2|STARTED|Overall Study||127
409897|NCT00080288|1004942|P1|STARTED|Overall Study||127
409898|NCT00080223|1004950|P1|NOT COMPLETED|Overall Study||76
409899|NCT00080223|1004950|P1|COMPLETED|Overall Study||7
409900|NCT00080223|1004950|P1|STARTED|Overall Study||83
409901|NCT00002540|1004960|P2|NOT COMPLETED|Overall Study||2464
409902|NCT00002540|1004961|P1|NOT COMPLETED|Overall Study||801
409903|NCT00002540|1004960|P2|COMPLETED|Overall Study||35876
409904|NCT00002540|1004961|P1|COMPLETED|Overall Study||37544
409905|NCT00002540|1004960|P2|STARTED|Overall Study||38340
409906|NCT00002540|1004961|P1|STARTED|Overall Study||38345
409907|NCT00080119|1004991|P4|NOT COMPLETED|Overall Study||163
409908|NCT00080119|1004992|P3|NOT COMPLETED|Overall Study||165
409909|NCT00080119|1004993|P2|NOT COMPLETED|Overall Study||62
409910|NCT00080119|1004994|P1|NOT COMPLETED|Overall Study||56
409911|NCT00080119|1004991|P4|COMPLETED|Overall Study||111
409912|NCT00080119|1004992|P3|COMPLETED|Overall Study||108
409913|NCT00080119|1004993|P2|COMPLETED|Overall Study||339
409914|NCT00080119|1004994|P1|COMPLETED|Overall Study||347
409915|NCT00080119|1004991|P4|STARTED|Overall Study||274
409916|NCT00080119|1004992|P3|STARTED|Overall Study||273
409917|NCT00080119|1004993|P2|STARTED|Overall Study||401
409918|NCT00080119|1004994|P1|STARTED|Overall Study||403
409919|NCT00079937|1005028|P2|NOT COMPLETED|Overall Study||32
409920|NCT00079937|1005029|P1|NOT COMPLETED|Overall Study||69
409921|NCT00079937|1005028|P2|COMPLETED|Overall Study||175
409922|NCT00079937|1005029|P1|COMPLETED|Overall Study||352
409923|NCT00079937|1005028|P2|STARTED|Overall Study||207
409924|NCT00079937|1005029|P1|STARTED|Overall Study||421
409925|NCT00009737|1005047|P2|NOT COMPLETED|Overall Study||123
409926|NCT00009737|1005048|P1|NOT COMPLETED|Overall Study||170
409927|NCT00009737|1005047|P2|COMPLETED|Overall Study||860
409928|NCT00009737|1005048|P1|COMPLETED|Overall Study||834
409929|NCT00009737|1005047|P2|STARTED|Overall Study||983
409930|NCT00009737|1005048|P1|STARTED|Overall Study||1004
409931|NCT00079781|1005067|P3|NOT COMPLETED|Follow-up Period||2
409932|NCT00079781|1005068|P2|NOT COMPLETED|Follow-up Period||0
409933|NCT00079781|1005069|P1|NOT COMPLETED|Follow-up Period||4
409934|NCT00079781|1005067|P3|COMPLETED|Follow-up Period||12
409935|NCT00079781|1005068|P2|COMPLETED|Follow-up Period||9
409936|NCT00079781|1005069|P1|COMPLETED|Follow-up Period||38
409937|NCT00079781|1005067|P3|STARTED|Follow-up Period||14
409938|NCT00079781|1005068|P2|STARTED|Follow-up Period||9
409939|NCT00079781|1005069|P1|STARTED|Follow-up Period||42
409940|NCT00079781|1005067|P3|NOT COMPLETED|Evaluation Period||0
409941|NCT00079781|1005068|P2|NOT COMPLETED|Evaluation Period||0
409942|NCT00079781|1005069|P1|NOT COMPLETED|Evaluation Period||0
409943|NCT00079781|1005067|P3|COMPLETED|Evaluation Period||14
409944|NCT00079781|1005068|P2|COMPLETED|Evaluation Period||9
409945|NCT00079781|1005069|P1|COMPLETED|Evaluation Period||42
409946|NCT00079781|1005067|P3|STARTED|Evaluation Period||14
409947|NCT00079781|1005068|P2|STARTED|Evaluation Period||9
409948|NCT00079781|1005069|P1|STARTED|Evaluation Period||42
409949|NCT00079781|1005067|P3|NOT COMPLETED|Pre-implant Period||1
409950|NCT00079781|1005068|P2|NOT COMPLETED|Pre-implant Period||1
409951|NCT00079781|1005069|P1|NOT COMPLETED|Pre-implant Period||3
409952|NCT00079781|1005067|P3|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|14
409953|NCT00079781|1005068|P2|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|9
409954|NCT00079781|1005069|P1|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|42
409955|NCT00079781|1005067|P3|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|15
409956|NCT00079781|1005068|P2|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|10
409957|NCT00079781|1005069|P1|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|45
409958|NCT00079677|1005078|P2|NOT COMPLETED|Overall Study||14
409959|NCT00079677|1005079|P1|NOT COMPLETED|Overall Study||20
409960|NCT00079677|1005078|P2|COMPLETED|Overall Study||118
409961|NCT00079677|1005079|P1|COMPLETED|Overall Study||111
409962|NCT00079677|1005078|P2|STARTED|Overall Study||132
409963|NCT00079677|1005079|P1|STARTED|Overall Study||131
409964|NCT00002601|1005087|P1|NOT COMPLETED|Overall Study||0
409965|NCT00002601|1005087|P1|COMPLETED|Overall Study||13
409966|NCT00002601|1005087|P1|STARTED|Overall Study||13
409967|NCT00079417|1005095|P1|NOT COMPLETED|Overall Study||9
409968|NCT00079417|1005095|P1|COMPLETED|Overall Study||19
409969|NCT00079417|1005095|P1|STARTED|Overall Study||28
409970|NCT00079391|1005103|P1|NOT COMPLETED|Overall Study||1
409971|NCT00079391|1005103|P1|COMPLETED|Overall Study||49
409972|NCT00079391|1005103|P1|STARTED|Overall Study|1 of these withdrew after consent.|50
409973|NCT00079339|1005115|P3|NOT COMPLETED|Overall Study||6
409974|NCT00079339|1005116|P2|NOT COMPLETED|Overall Study||39
409975|NCT00079339|1005117|P1|NOT COMPLETED|Overall Study||5
409976|NCT00079339|1005115|P3|COMPLETED|Overall Study||0
409977|NCT00079339|1005116|P2|COMPLETED|Overall Study||1
409978|NCT00079339|1005117|P1|COMPLETED|Overall Study||0
409979|NCT00079339|1005115|P3|Enrolled in Phase II|Overall Study|Participants treated at the 150 mg/m2 dose level did not participate in the phase II part.|0
409980|NCT00079339|1005116|P2|Enrolled in Phase II|Overall Study|This number includes the 6 patients enrolled on the phase I part.|40
409981|NCT00079339|1005117|P1|Enrolled in Phase II|Overall Study|Participants treated at the 100 mg/m2 dose level did not participate in the phase II part.|0
409982|NCT00079339|1005115|P3|Maximum Tolerated Dose (MTD) Estimation|Overall Study|One participant enrolled in the phase I part did not complete the 8 week MTD estimation period.|5
409983|NCT00079339|1005116|P2|Maximum Tolerated Dose (MTD) Estimation|Overall Study||6
409984|NCT00079339|1005117|P1|Maximum Tolerated Dose (MTD) Estimation|Overall Study|2 participants enrolled in the phase I part did not complete the 8 week MTD estimation period.|3
409985|NCT00079339|1005115|P3|Enrolled in Phase I|Overall Study||6
409986|NCT00079339|1005116|P2|Enrolled in Phase I|Overall Study||6
409987|NCT00079339|1005117|P1|Enrolled in Phase I|Overall Study||5
409988|NCT00079339|1005115|P3|STARTED|Overall Study||6
409989|NCT00079339|1005116|P2|STARTED|Overall Study||40
409990|NCT00079339|1005117|P1|STARTED|Overall Study||5
409991|NCT00079326|1005133|P2|NOT COMPLETED|Overall Study||0
409992|NCT00079326|1005134|P1|NOT COMPLETED|Overall Study||0
409993|NCT00079326|1005133|P2|COMPLETED|Overall Study||24
409994|NCT00079326|1005134|P1|COMPLETED|Overall Study||15
409995|NCT00079326|1005133|P2|STARTED|Overall Study||24
409996|NCT00079326|1005134|P1|STARTED|Overall Study||15
409997|NCT00079274|1005148|P7|NOT COMPLETED|Overall Study||0
409998|NCT00079274|1005149|P6|NOT COMPLETED|Overall Study||20
409999|NCT00079274|1005150|P5|NOT COMPLETED|Overall Study||15
410000|NCT00079274|1005151|P4|NOT COMPLETED|Overall Study||444
410001|NCT00079274|1005152|P3|NOT COMPLETED|Overall Study||27
410002|NCT00079274|1005153|P2|NOT COMPLETED|Overall Study||27
410003|NCT00079274|1005154|P1|NOT COMPLETED|Overall Study||321
410004|NCT00079274|1005148|P7|COMPLETED|Overall Study||332
410005|NCT00079274|1005149|P6|COMPLETED|Overall Study||26
410006|NCT00079274|1005150|P5|COMPLETED|Overall Study||30
410007|NCT00079274|1005151|P4|COMPLETED|Overall Study||906
410008|NCT00079274|1005152|P3|COMPLETED|Overall Study||84
410009|NCT00079274|1005153|P2|COMPLETED|Overall Study||84
410010|NCT00079274|1005154|P1|COMPLETED|Overall Study||1081
410011|NCT00079274|1005148|P7|STARTED|Overall Study||332
410012|NCT00079274|1005149|P6|STARTED|Overall Study||46
410013|NCT00079274|1005150|P5|STARTED|Overall Study||45
410014|NCT00079274|1005151|P4|STARTED|Overall Study||1350
410015|NCT00079274|1005152|P3|STARTED|Overall Study||111
410016|NCT00079274|1005153|P2|STARTED|Overall Study||111
410017|NCT00079274|1005154|P1|STARTED|Overall Study||1402
410018|NCT00079183|1005175|P1|NOT COMPLETED|Overall Study||7
410019|NCT00079183|1005175|P1|COMPLETED|Overall Study||37
410020|NCT00079183|1005175|P1|Drop Outs|Overall Study||7
410021|NCT00079183|1005175|P1|STARTED|Overall Study||44
410022|NCT00079040|1005190|P1|NOT COMPLETED|Overall Study||2
410023|NCT00079040|1005190|P1|COMPLETED|Overall Study||63
410024|NCT00079040|1005190|P1|STARTED|Overall Study||65
410025|NCT00079001|1005198|P2|NOT COMPLETED|Overall Study||0
410026|NCT00079001|1005199|P1|NOT COMPLETED|Overall Study||0
410027|NCT00079001|1005198|P2|COMPLETED|Overall Study||322
410028|NCT00079001|1005199|P1|COMPLETED|Overall Study||323
410029|NCT00079001|1005198|P2|STARTED|Overall Study||322
410030|NCT00079001|1005199|P1|STARTED|Overall Study||323
410031|NCT00078949|1005213|P4|NOT COMPLETED|Overall Study||3
410032|NCT00078949|1005214|P3|NOT COMPLETED|Overall Study||3
410033|NCT00078949|1005215|P2|NOT COMPLETED|Overall Study||5
410034|NCT00078949|1005216|P1|NOT COMPLETED|Overall Study||4
410035|NCT00078949|1005213|P4|COMPLETED|Overall Study||112
410036|NCT00078949|1005214|P3|COMPLETED|Overall Study||112
410037|NCT00078949|1005215|P2|COMPLETED|Overall Study||304
410038|NCT00078949|1005216|P1|COMPLETED|Overall Study||306
410039|NCT00078949|1005213|P4|STARTED|Overall Study||115
410040|NCT00078949|1005214|P3|STARTED|Overall Study||115
410041|NCT00078949|1005215|P2|STARTED|Overall Study||309
410042|NCT00078949|1005216|P1|STARTED|Overall Study||310
410043|NCT00078897|1005230|P2|NOT COMPLETED|Overall Study||123
410044|NCT00078897|1005231|P1|NOT COMPLETED|Overall Study||124
410045|NCT00078897|1005230|P2|COMPLETED|Overall Study||689
410046|NCT00078897|1005231|P1|COMPLETED|Overall Study||685
410047|NCT00078897|1005230|P2|STARTED|Overall Study||812
410048|NCT00078897|1005231|P1|STARTED|Overall Study||809
410049|NCT00078819|1005241|P4|NOT COMPLETED|Re-treatment Period||0
410050|NCT00078819|1005242|P3|NOT COMPLETED|Re-treatment Period||0
410051|NCT00078819|1005243|P2|NOT COMPLETED|Re-treatment Period||0
410052|NCT00078819|1005244|P1|NOT COMPLETED|Re-treatment Period||0
410053|NCT00078819|1005241|P4|COMPLETED|Re-treatment Period||13
410054|NCT00078819|1005242|P3|COMPLETED|Re-treatment Period||29
410055|NCT00078819|1005243|P2|COMPLETED|Re-treatment Period||0
410056|NCT00078819|1005244|P1|COMPLETED|Re-treatment Period||0
410057|NCT00078819|1005241|P4|Received Study Drug|Re-treatment Period||12
410058|NCT00078819|1005242|P3|Received Study Drug|Re-treatment Period|One additional participant received re-treatment without having disease relapse|30
410059|NCT00078819|1005243|P2|Received Study Drug|Re-treatment Period||0
410060|NCT00078819|1005244|P1|Received Study Drug|Re-treatment Period||0
410061|NCT00078819|1005241|P4|STARTED|Re-treatment Period||13
410062|NCT00078819|1005242|P3|STARTED|Re-treatment Period||29
410063|NCT00078819|1005243|P2|STARTED|Re-treatment Period||0
410064|NCT00078819|1005244|P1|STARTED|Re-treatment Period||0
410065|NCT00078819|1005241|P4|NOT COMPLETED|Withdrawal Period: Weeks 37-48||14
410066|NCT00078819|1005242|P3|NOT COMPLETED|Withdrawal Period: Weeks 37-48||29
410067|NCT00078819|1005243|P2|NOT COMPLETED|Withdrawal Period: Weeks 37-48||0
410068|NCT00078819|1005244|P1|NOT COMPLETED|Withdrawal Period: Weeks 37-48||0
410069|NCT00078819|1005241|P4|COMPLETED|Withdrawal Period: Weeks 37-48|Defined as continuing to receive blinded study drug through week 48|55
410070|NCT00078819|1005242|P3|COMPLETED|Withdrawal Period: Weeks 37-48|Defined as continuing to receive blinded study drug through week 48|40
410071|NCT00078819|1005243|P2|COMPLETED|Withdrawal Period: Weeks 37-48||0
410072|NCT00078819|1005244|P1|COMPLETED|Withdrawal Period: Weeks 37-48||0
410073|NCT00078819|1005241|P4|Received Study Drug|Withdrawal Period: Weeks 37-48||68
410074|NCT00078819|1005242|P3|Received Study Drug|Withdrawal Period: Weeks 37-48||69
410075|NCT00078819|1005243|P2|Received Study Drug|Withdrawal Period: Weeks 37-48||0
410076|NCT00078819|1005244|P1|Received Study Drug|Withdrawal Period: Weeks 37-48||0
410077|NCT00078819|1005241|P4|STARTED|Withdrawal Period: Weeks 37-48|Participants who completed week 36 with a PASI response|69
410078|NCT00078819|1005242|P3|STARTED|Withdrawal Period: Weeks 37-48|Participants who completed week 36 with a PASI response|69
410079|NCT00078819|1005243|P2|STARTED|Withdrawal Period: Weeks 37-48||0
410080|NCT00078819|1005244|P1|STARTED|Withdrawal Period: Weeks 37-48||0
410081|NCT00078819|1005241|P4|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||0
410082|NCT00078819|1005242|P3|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||0
410083|NCT00078819|1005243|P2|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||30
410084|NCT00078819|1005244|P1|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||40
410085|NCT00078819|1005241|P4|COMPLETED|Open-label Treatment Period: Weeks 13-36||0
410086|NCT00078819|1005242|P3|COMPLETED|Open-label Treatment Period: Weeks 13-36||0
410087|NCT00078819|1005243|P2|COMPLETED|Open-label Treatment Period: Weeks 13-36||75
410088|NCT00078819|1005244|P1|COMPLETED|Open-label Treatment Period: Weeks 13-36||63
410089|NCT00078819|1005241|P4|STARTED|Open-label Treatment Period: Weeks 13-36||0
410090|NCT00078819|1005242|P3|STARTED|Open-label Treatment Period: Weeks 13-36||0
410091|NCT00078819|1005243|P2|STARTED|Open-label Treatment Period: Weeks 13-36||105
410092|NCT00078819|1005244|P1|STARTED|Open-label Treatment Period: Weeks 13-36|One participant discontinued before starting the open-label period|103
410093|NCT00078819|1005241|P4|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||0
410094|NCT00078819|1005242|P3|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||0
410095|NCT00078819|1005243|P2|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||1
410096|NCT00078819|1005244|P1|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||1
410097|NCT00078819|1005241|P4|COMPLETED|Double-blind Treatment Period: Week 1-12||0
410098|NCT00078819|1005242|P3|COMPLETED|Double-blind Treatment Period: Week 1-12||0
410099|NCT00078819|1005243|P2|COMPLETED|Double-blind Treatment Period: Week 1-12||105
410100|NCT00078819|1005244|P1|COMPLETED|Double-blind Treatment Period: Week 1-12||104
410101|NCT00078819|1005241|P4|Entered Escape|Double-blind Treatment Period: Week 1-12||0
410102|NCT00078819|1005242|P3|Entered Escape|Double-blind Treatment Period: Week 1-12||0
410103|NCT00078819|1005243|P2|Entered Escape|Double-blind Treatment Period: Week 1-12||5
410104|NCT00078819|1005244|P1|Entered Escape|Double-blind Treatment Period: Week 1-12||27
410105|NCT00078819|1005241|P4|STARTED|Double-blind Treatment Period: Week 1-12||0
410106|NCT00078819|1005242|P3|STARTED|Double-blind Treatment Period: Week 1-12||0
410107|NCT00078819|1005243|P2|STARTED|Double-blind Treatment Period: Week 1-12||106
410108|NCT00078819|1005244|P1|STARTED|Double-blind Treatment Period: Week 1-12||105
410109|NCT00078806|1005269|P4|NOT COMPLETED|Part 3||0
410110|NCT00078806|1005270|P3|NOT COMPLETED|Part 3||0
410111|NCT00078806|1005271|P2|NOT COMPLETED|Part 3||0
410112|NCT00078806|1005272|P1|NOT COMPLETED|Part 3||0
410113|NCT00078806|1005269|P4|COMPLETED|Part 3||9
410114|NCT00078806|1005270|P3|COMPLETED|Part 3||0
410115|NCT00078806|1005271|P2|COMPLETED|Part 3||0
410116|NCT00078806|1005272|P1|COMPLETED|Part 3||0
410117|NCT00078806|1005269|P4|STARTED|Part 3||9
410118|NCT00078806|1005270|P3|STARTED|Part 3||0
410119|NCT00078806|1005271|P2|STARTED|Part 3||0
410120|NCT00078806|1005272|P1|STARTED|Part 3||0
410121|NCT00078806|1005269|P4|NOT COMPLETED|Part 2||0
410122|NCT00078806|1005270|P3|NOT COMPLETED|Part 2||0
410123|NCT00078806|1005271|P2|NOT COMPLETED|Part 2||1
410124|NCT00078806|1005272|P1|NOT COMPLETED|Part 2||0
410125|NCT00078806|1005269|P4|COMPLETED|Part 2||0
410126|NCT00078806|1005270|P3|COMPLETED|Part 2||4
410127|NCT00078806|1005271|P2|COMPLETED|Part 2||5
410128|NCT00078806|1005272|P1|COMPLETED|Part 2||0
410129|NCT00078806|1005269|P4|Received Study Drug|Part 2||0
410130|NCT00078806|1005270|P3|Received Study Drug|Part 2||4
410131|NCT00078806|1005271|P2|Received Study Drug|Part 2||5
410132|NCT00078806|1005272|P1|Received Study Drug|Part 2||0
410133|NCT00078806|1005269|P4|STARTED|Part 2||0
410134|NCT00078806|1005270|P3|STARTED|Part 2||4
410135|NCT00078806|1005271|P2|STARTED|Part 2||6
410136|NCT00078806|1005272|P1|STARTED|Part 2||0
410137|NCT00078806|1005269|P4|NOT COMPLETED|Part 1B||0
410138|NCT00078806|1005270|P3|NOT COMPLETED|Part 1B||0
410139|NCT00078806|1005271|P2|NOT COMPLETED|Part 1B||0
410140|NCT00078806|1005272|P1|NOT COMPLETED|Part 1B||8
410141|NCT00078806|1005269|P4|COMPLETED|Part 1B||0
410142|NCT00078806|1005270|P3|COMPLETED|Part 1B||0
410143|NCT00078806|1005271|P2|COMPLETED|Part 1B||0
410144|NCT00078806|1005272|P1|COMPLETED|Part 1B||2
410145|NCT00078806|1005269|P4|STARTED|Part 1B||0
410146|NCT00078806|1005270|P3|STARTED|Part 1B||0
410147|NCT00078806|1005271|P2|STARTED|Part 1B||0
410148|NCT00078806|1005272|P1|STARTED|Part 1B||10
410149|NCT00078806|1005269|P4|NOT COMPLETED|Part 1A||0
410150|NCT00078806|1005270|P3|NOT COMPLETED|Part 1A||0
410151|NCT00078806|1005271|P2|NOT COMPLETED|Part 1A||0
410152|NCT00078806|1005272|P1|NOT COMPLETED|Part 1A||10
410153|NCT00078806|1005269|P4|COMPLETED|Part 1A||0
410154|NCT00078806|1005270|P3|COMPLETED|Part 1A||0
410155|NCT00078806|1005271|P2|COMPLETED|Part 1A||0
410156|NCT00078806|1005272|P1|COMPLETED|Part 1A||9
410157|NCT00078806|1005269|P4|STARTED|Part 1A||0
410158|NCT00078806|1005270|P3|STARTED|Part 1A||0
410159|NCT00078806|1005271|P2|STARTED|Part 1A||0
410160|NCT00078806|1005272|P1|STARTED|Part 1A||19
410161|NCT00078767|1005308|P2|NOT COMPLETED|Overall Study||1
410162|NCT00078767|1005309|P1|NOT COMPLETED|Overall Study||1
410163|NCT00078767|1005308|P2|COMPLETED|Overall Study||11
410164|NCT00078767|1005309|P1|COMPLETED|Overall Study||11
410165|NCT00078767|1005308|P2|STARTED|Overall Study||12
410166|NCT00078767|1005309|P1|STARTED|Overall Study||12
410167|NCT00078754|1005326|P3|NOT COMPLETED|Overall Study||15
410168|NCT00078754|1005327|P2|NOT COMPLETED|Overall Study||19
410169|NCT00078754|1005328|P1|NOT COMPLETED|Overall Study||15
410170|NCT00078754|1005326|P3|COMPLETED|Overall Study||16
410171|NCT00078754|1005327|P2|COMPLETED|Overall Study||11
410172|NCT00078754|1005328|P1|COMPLETED|Overall Study||14
410173|NCT00078754|1005326|P3|STARTED|Overall Study||31
410174|NCT00078754|1005327|P2|STARTED|Overall Study||30
410175|NCT00078754|1005328|P1|STARTED|Overall Study||29
410176|NCT00078728|1005338|P2|NOT COMPLETED|Overall Study||3
410177|NCT00078728|1005339|P1|NOT COMPLETED|Overall Study||4
410178|NCT00078728|1005338|P2|COMPLETED|Overall Study||17
410179|NCT00078728|1005339|P1|COMPLETED|Overall Study||16
410180|NCT00078728|1005338|P2|STARTED|Overall Study||20
410181|NCT00078728|1005339|P1|STARTED|Overall Study||20
410182|NCT00078715|1005347|P2|NOT COMPLETED|Second Intervention||0
410183|NCT00078715|1005348|P1|NOT COMPLETED|Second Intervention||0
410184|NCT00078715|1005347|P2|COMPLETED|Second Intervention||4
410185|NCT00078715|1005348|P1|COMPLETED|Second Intervention||2
410186|NCT00078715|1005347|P2|STARTED|Second Intervention||4
410187|NCT00078715|1005348|P1|STARTED|Second Intervention||2
410188|NCT00078715|1005347|P2|NOT COMPLETED|First Intervention||0
410189|NCT00078715|1005348|P1|NOT COMPLETED|First Intervention||0
410190|NCT00078715|1005347|P2|COMPLETED|First Intervention||4
410191|NCT00078715|1005348|P1|COMPLETED|First Intervention||2
410192|NCT00078715|1005347|P2|STARTED|First Intervention||4
410193|NCT00078715|1005348|P1|STARTED|First Intervention||2
410194|NCT00005947|1005356|P2|NOT COMPLETED|Overall Study||41
410195|NCT00005947|1005357|P1|NOT COMPLETED|Overall Study||57
410196|NCT00005947|1005356|P2|COMPLETED|Overall Study||4
410197|NCT00005947|1005357|P1|COMPLETED|Overall Study||25
410198|NCT00005947|1005356|P2|STARTED|Overall Study||45
410199|NCT00005947|1005357|P1|STARTED|Overall Study||82
410200|NCT00078559|1005365|P1|NOT COMPLETED|Overall Study||0
410201|NCT00078559|1005365|P1|COMPLETED|Overall Study|1 subject stopped study drug due to a severe but non-serious AE, and completed the trial|10
410202|NCT00078559|1005365|P1|STARTED|Overall Study||10
410203|NCT00002597|1005393|P2|NOT COMPLETED|Overall Study||23
410204|NCT00002597|1005394|P1|NOT COMPLETED|Overall Study||26
410205|NCT00002597|1005393|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|992
410206|NCT00002597|1005394|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|987
410207|NCT00002597|1005393|P2|STARTED|Overall Study||1015
410208|NCT00002597|1005394|P1|STARTED|Overall Study||1013
410209|NCT00078377|1005419|P3|NOT COMPLETED|Overall Study||9
410210|NCT00078377|1005420|P2|NOT COMPLETED|Overall Study||16
410211|NCT00078377|1005421|P1|NOT COMPLETED|Overall Study||11
410212|NCT00078377|1005419|P3|COMPLETED|Overall Study||55
410213|NCT00078377|1005420|P2|COMPLETED|Overall Study||49
410214|NCT00078377|1005421|P1|COMPLETED|Overall Study||56
410215|NCT00078377|1005419|P3|STARTED|Overall Study||64
410216|NCT00078377|1005420|P2|STARTED|Overall Study||65
410217|NCT00078377|1005421|P1|STARTED|Overall Study||67
410218|NCT00078338|1005436|P2|NOT COMPLETED|Overall Study||54
410219|NCT00078338|1005437|P1|NOT COMPLETED|Overall Study||85
410220|NCT00078338|1005436|P2|COMPLETED|Overall Study||324
410221|NCT00078338|1005437|P1|COMPLETED|Overall Study||301
410222|NCT00078338|1005436|P2|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|375
410223|NCT00078338|1005437|P1|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|381
410224|NCT00078338|1005436|P2|STARTED|Overall Study||378
410225|NCT00078338|1005437|P1|STARTED|Overall Study||386
410226|NCT00076687|1005446|P3|NOT COMPLETED|Overall Study||4
410227|NCT00076687|1005447|P2|NOT COMPLETED|Overall Study||5
410228|NCT00076687|1005448|P1|NOT COMPLETED|Overall Study||6
410229|NCT00076687|1005446|P3|COMPLETED|Overall Study||51
410230|NCT00076687|1005447|P2|COMPLETED|Overall Study||47
410231|NCT00076687|1005448|P1|COMPLETED|Overall Study||42
410232|NCT00076687|1005446|P3|STARTED|Overall Study||55
410233|NCT00076687|1005447|P2|STARTED|Overall Study||52
410234|NCT00076687|1005448|P1|STARTED|Overall Study||48
410235|NCT00078403|1005468|P3|NOT COMPLETED|Overall Study||28
410236|NCT00078403|1005469|P2|NOT COMPLETED|Overall Study||16
410237|NCT00078403|1005470|P1|NOT COMPLETED|Overall Study||18
410238|NCT00078403|1005468|P3|COMPLETED|Overall Study||141
410239|NCT00078403|1005469|P2|COMPLETED|Overall Study||26
410240|NCT00078403|1005470|P1|COMPLETED|Overall Study||26
410241|NCT00078403|1005468|P3|STARTED|Overall Study||169
410242|NCT00078403|1005469|P2|STARTED|Overall Study|Eligible at pre-assignment (40), direct (1), Arm C week 36 non-response (1).|42
410243|NCT00078403|1005470|P1|STARTED|Overall Study|Eligible at pre-assignment (40), direct (2), Arm C week 36 non-response (1), EVR inadvertently (1).|44
410244|NCT00078325|1005530|P3|NOT COMPLETED|Overall Study||11
410245|NCT00078325|1005531|P2|NOT COMPLETED|Overall Study||19
410246|NCT00078325|1005532|P1|NOT COMPLETED|Overall Study||21
410247|NCT00078325|1005530|P3|COMPLETED|Overall Study||120
410248|NCT00078325|1005531|P2|COMPLETED|Overall Study||114
410249|NCT00078325|1005532|P1|COMPLETED|Overall Study||110
410250|NCT00078325|1005530|P3|STARTED|Overall Study||131
410251|NCT00078325|1005531|P2|STARTED|Overall Study||133
410252|NCT00078325|1005532|P1|STARTED|Overall Study||131
410253|NCT00078312|1005543|P1|NOT COMPLETED|Overall Study||177
410254|NCT00078312|1005543|P1|COMPLETED|Overall Study||151
410255|NCT00078312|1005543|P1|STARTED|Overall Study||328
410256|NCT00078286|1005549|P2|NOT COMPLETED|Overall Study||83
410257|NCT00078286|1005550|P1|NOT COMPLETED|Overall Study||96
410258|NCT00078286|1005549|P2|COMPLETED|Overall Study||152
410259|NCT00078286|1005550|P1|COMPLETED|Overall Study||138
410260|NCT00078286|1005549|P2|STARTED|Overall Study||235
410261|NCT00078286|1005550|P1|STARTED|Overall Study||234
410262|NCT00077974|1005558|P1|NOT COMPLETED|Overall Study||104
410263|NCT00077974|1005558|P1|COMPLETED|Overall Study||2
410264|NCT00077974|1005558|P1|STARTED|Overall Study||106
410265|NCT00077857|1005575|P2|NOT COMPLETED|Overall Study||204
410266|NCT00077857|1005576|P1|NOT COMPLETED|Overall Study||201
410267|NCT00077857|1005575|P2|COMPLETED|Overall Study||31
410268|NCT00077857|1005576|P1|COMPLETED|Overall Study||34
410269|NCT00077857|1005575|P2|Safety Population: Actual Dose Received|Overall Study||248
410270|NCT00077857|1005576|P1|Safety Population: Actual Dose Received|Overall Study|14 patients in the 1250 dose arm received a lower dose and were included in the 825 arm for Safety.|217
410271|NCT00077857|1005575|P2|Received Study Drug|Overall Study||234
410272|NCT00077857|1005576|P1|Received Study Drug|Overall Study||231
410273|NCT00077857|1005575|P2|STARTED|Overall Study||235
410274|NCT00077857|1005576|P1|STARTED|Overall Study||235
410275|NCT00077766|1005596|P2|NOT COMPLETED|Overall Study||25
410276|NCT00077766|1005597|P1|NOT COMPLETED|Overall Study||39
410277|NCT00077766|1005596|P2|COMPLETED|Overall Study||131
410278|NCT00077766|1005597|P1|COMPLETED|Overall Study||118
410279|NCT00077766|1005596|P2|STARTED|Overall Study||156
410280|NCT00077766|1005597|P1|STARTED|Overall Study||157
410281|NCT00077922|1005615|P1|NOT COMPLETED|Overall Study||0
410282|NCT00077922|1005615|P1|COMPLETED|Overall Study||15
410283|NCT00077922|1005615|P1|STARTED|Overall Study||15
410284|NCT00077675|1005622|P2|NOT COMPLETED|Overall Study||9
410285|NCT00077675|1005623|P1|NOT COMPLETED|Overall Study||11
410286|NCT00077675|1005622|P2|COMPLETED|Overall Study||89
410287|NCT00077675|1005623|P1|COMPLETED|Overall Study||92
410288|NCT00077675|1005622|P2|STARTED|Overall Study||98
410289|NCT00077675|1005623|P1|STARTED|Overall Study||103
410290|NCT00077649|1005633|P4|NOT COMPLETED|Overall Study||17
410291|NCT00077649|1005634|P3|NOT COMPLETED|Overall Study||15
410292|NCT00077649|1005635|P2|NOT COMPLETED|Overall Study||9
410293|NCT00077649|1005636|P1|NOT COMPLETED|Overall Study||14
410294|NCT00077649|1005633|P4|COMPLETED|Overall Study||30
410295|NCT00077649|1005634|P3|COMPLETED|Overall Study||32
410296|NCT00077649|1005635|P2|COMPLETED|Overall Study||38
410297|NCT00077649|1005636|P1|COMPLETED|Overall Study||33
410298|NCT00077649|1005633|P4|Completed 24 Weeks of Follow-up|Overall Study||31
410299|NCT00077649|1005634|P3|Completed 24 Weeks of Follow-up|Overall Study||36
410300|NCT00077649|1005635|P2|Completed 24 Weeks of Follow-up|Overall Study||40
410301|NCT00077649|1005636|P1|Completed 24 Weeks of Follow-up|Overall Study||36
410302|NCT00077649|1005633|P4|STARTED|Overall Study||47
410303|NCT00077649|1005634|P3|STARTED|Overall Study||47
410304|NCT00077649|1005635|P2|STARTED|Overall Study||47
410305|NCT00077649|1005636|P1|STARTED|Overall Study||47
410306|NCT00077636|1005684|P2|NOT COMPLETED|Overall Study||92
410307|NCT00077636|1005685|P1|NOT COMPLETED|Overall Study||44
410308|NCT00077636|1005684|P2|COMPLETED|Overall Study||641
410309|NCT00077636|1005685|P1|COMPLETED|Overall Study||692
410310|NCT00077636|1005684|P2|STARTED|Overall Study||733
410311|NCT00077636|1005685|P1|STARTED|Overall Study||736
410312|NCT00077623|1005706|P3|NOT COMPLETED|Overall Study||32
410313|NCT00077623|1005707|P2|NOT COMPLETED|Overall Study||43
410314|NCT00077623|1005708|P1|NOT COMPLETED|Overall Study||36
410315|NCT00077623|1005706|P3|COMPLETED|Overall Study||159
410316|NCT00077623|1005707|P2|COMPLETED|Overall Study||148
410317|NCT00077623|1005708|P1|COMPLETED|Overall Study||154
410318|NCT00077623|1005706|P3|STARTED|Overall Study||191
410319|NCT00077623|1005707|P2|STARTED|Overall Study||191
410320|NCT00077623|1005708|P1|STARTED|Overall Study||190
410321|NCT00077610|1005743|P3|NOT COMPLETED|Overall Study||46
410322|NCT00077610|1005744|P2|NOT COMPLETED|Overall Study||56
410323|NCT00077610|1005745|P1|NOT COMPLETED|Overall Study||54
410324|NCT00077610|1005743|P3|COMPLETED|Overall Study||180
410325|NCT00077610|1005744|P2|COMPLETED|Overall Study||168
410326|NCT00077610|1005745|P1|COMPLETED|Overall Study||169
410327|NCT00077610|1005743|P3|Started Treatment|Overall Study||225
410328|NCT00077610|1005744|P2|Started Treatment|Overall Study||220
410329|NCT00077610|1005745|P1|Started Treatment|Overall Study||221
410330|NCT00077610|1005743|P3|STARTED|Overall Study||226
410331|NCT00077610|1005744|P2|STARTED|Overall Study||224
410332|NCT00077610|1005745|P1|STARTED|Overall Study||223
410333|NCT00077376|1005774|P1|NOT COMPLETED|Overall Study||22
410334|NCT00077376|1005774|P1|COMPLETED|Overall Study||39
410335|NCT00077376|1005774|P1|HER2+ in Central Testing|Overall Study||39
410336|NCT00077376|1005774|P1|Treated|Overall Study||59
410337|NCT00077376|1005774|P1|STARTED|Overall Study||61
410338|NCT00077207|1005785|P1|NOT COMPLETED|Overall Study||30
410339|NCT00077207|1005785|P1|COMPLETED|Overall Study||36
410340|NCT00077207|1005785|P1|STARTED|Overall Study||66
410341|NCT00077064|1005797|P2|NOT COMPLETED|Overall Study||6
410342|NCT00077064|1005798|P1|NOT COMPLETED|Overall Study||0
410343|NCT00077064|1005797|P2|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|10
410344|NCT00077064|1005798|P1|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|17
410345|NCT00077064|1005797|P2|STARTED|Overall Study||16
410346|NCT00077064|1005798|P1|STARTED|Overall Study||17
410347|NCT00076999|1005814|P5|NOT COMPLETED|Overall Study||25
410348|NCT00076999|1005815|P4|NOT COMPLETED|Overall Study||1
410349|NCT00076999|1005816|P3|NOT COMPLETED|Overall Study||17
410350|NCT00076999|1005817|P2|NOT COMPLETED|Overall Study||24
410351|NCT00076999|1005818|P1|NOT COMPLETED|Overall Study||12
410352|NCT00076999|1005814|P5|COMPLETED|Overall Study||9
410353|NCT00076999|1005815|P4|COMPLETED|Overall Study||5
410354|NCT00076999|1005816|P3|COMPLETED|Overall Study||2
410355|NCT00076999|1005817|P2|COMPLETED|Overall Study||7
410356|NCT00076999|1005818|P1|COMPLETED|Overall Study||13
410357|NCT00076999|1005814|P5|STARTED|Overall Study||34
410358|NCT00076999|1005815|P4|STARTED|Overall Study||6
410359|NCT00076999|1005816|P3|STARTED|Overall Study||19
410360|NCT00076999|1005817|P2|STARTED|Overall Study||31
410361|NCT00076999|1005818|P1|STARTED|Overall Study||25
410362|NCT00003222|1005937|P2|NOT COMPLETED|Overall Study||1
410363|NCT00003222|1005938|P1|NOT COMPLETED|Overall Study||0
410364|NCT00003222|1005937|P2|COMPLETED|Overall Study|Decline in performance status between enrollment and initiation of therapy.|27
410365|NCT00003222|1005938|P1|COMPLETED|Overall Study||13
410366|NCT00003222|1005937|P2|STARTED|Overall Study||28
410367|NCT00003222|1005938|P1|STARTED|Overall Study||13
410368|NCT00076804|1005950|P2|NOT COMPLETED|Overall Study||69
410369|NCT00076804|1005951|P1|NOT COMPLETED|Overall Study||60
410370|NCT00076804|1005950|P2|COMPLETED|Overall Study|102 completed week 48, 68 completed week 96|68
410371|NCT00076804|1005951|P1|COMPLETED|Overall Study|111 completed week 48, 77 completed week 96.|77
410372|NCT00076804|1005950|P2|STARTED|Overall Study||137
410373|NCT00076804|1005951|P1|STARTED|Overall Study||137
410374|NCT00076752|1005963|P1|NOT COMPLETED|Overall Study||3
410375|NCT00076752|1005963|P1|COMPLETED|Overall Study||6
410376|NCT00076752|1005963|P1|STARTED|Overall Study||9
410377|NCT00076622|1005986|P4|NOT COMPLETED|Overall Study||0
410378|NCT00076622|1005987|P3|NOT COMPLETED|Overall Study||0
410379|NCT00076622|1005988|P2|NOT COMPLETED|Overall Study||0
410380|NCT00076622|1005989|P1|NOT COMPLETED|Overall Study||0
410381|NCT00076622|1005986|P4|COMPLETED|Overall Study||18
410382|NCT00076622|1005987|P3|COMPLETED|Overall Study||40
410383|NCT00076622|1005988|P2|COMPLETED|Overall Study||13
410384|NCT00076622|1005989|P1|COMPLETED|Overall Study||23
410385|NCT00076622|1005986|P4|STARTED|Overall Study||18
410386|NCT00076622|1005987|P3|STARTED|Overall Study||40
410387|NCT00076622|1005988|P2|STARTED|Overall Study||13
410388|NCT00076622|1005989|P1|STARTED|Overall Study||23
410389|NCT00076570|1006009|P2|NOT COMPLETED|Overall Study||8
410390|NCT00076570|1006010|P1|NOT COMPLETED|Overall Study||8
410391|NCT00076570|1006009|P2|COMPLETED|Overall Study||8
410392|NCT00076570|1006010|P1|COMPLETED|Overall Study||7
410393|NCT00076570|1006009|P2|STARTED|Overall Study||16
410394|NCT00076570|1006010|P1|STARTED|Overall Study||15
410395|NCT00003298|1006018|P1|NOT COMPLETED|Step 2 (Adjuvant Therapy)||6
410396|NCT00003298|1006018|P1|COMPLETED|Step 2 (Adjuvant Therapy)||4
410397|NCT00003298|1006018|P1|Eligible and Treated on Step 2|Step 2 (Adjuvant Therapy)||7
410398|NCT00003298|1006018|P1|STARTED|Step 2 (Adjuvant Therapy)||10
410399|NCT00003298|1006018|P1|NOT COMPLETED|Re-register to Step 2 After Surgery||18
410400|NCT00003298|1006018|P1|COMPLETED|Re-register to Step 2 After Surgery||10
410401|NCT00003298|1006018|P1|STARTED|Re-register to Step 2 After Surgery||28
410402|NCT00003298|1006018|P1|NOT COMPLETED|Surgery||7
410403|NCT00003298|1006018|P1|COMPLETED|Surgery|1 patient did not complete neoadjuvant therapy but went to surgery anyway, not included here.|28
410404|NCT00003298|1006018|P1|STARTED|Surgery||35
410405|NCT00003298|1006018|P1|NOT COMPLETED|Step 1 (Neoadjuvant Therapy)||4
410406|NCT00003298|1006018|P1|COMPLETED|Step 1 (Neoadjuvant Therapy)||35
410407|NCT00003298|1006018|P1|Complete 3 Cycles of Neoadjuvant Therapy|Step 1 (Neoadjuvant Therapy)||35
410408|NCT00003298|1006018|P1|Eligible and Treated|Step 1 (Neoadjuvant Therapy)||38
410409|NCT00003298|1006018|P1|STARTED|Step 1 (Neoadjuvant Therapy)||39
410410|NCT00076336|1006028|P2|NOT COMPLETED|Overall Study||56
410411|NCT00076336|1006029|P1|NOT COMPLETED|Overall Study||52
410412|NCT00076336|1006028|P2|COMPLETED|Overall Study||60
410413|NCT00076336|1006029|P1|COMPLETED|Overall Study||64
410414|NCT00076336|1006028|P2|Completed Week 104|Overall Study||62
410415|NCT00076336|1006029|P1|Completed Week 104|Overall Study||70
410416|NCT00076336|1006028|P2|Completed Week 52|Overall Study||94
410417|NCT00076336|1006029|P1|Completed Week 52|Overall Study||97
410418|NCT00076336|1006028|P2|Intent to Treat (ITT) Population|Overall Study|2 patients had no HBV DNA assessments after baseline and were excluded from ITT population.|114
410419|NCT00076336|1006029|P1|Intent to Treat (ITT) Population|Overall Study|1 patient had no HBV DNA assessments after baseline and was excluded from ITT population.|114
410420|NCT00076336|1006028|P2|Safety Population|Overall Study||116
410421|NCT00076336|1006029|P1|Safety Population|Overall Study|1 patient was randomized but never received study drug and not included in safety population.|115
410422|NCT00076336|1006028|P2|STARTED|Overall Study||116
410423|NCT00076336|1006029|P1|STARTED|Overall Study||116
410424|NCT00076258|1006045|P2|NOT COMPLETED|Overall Study||3
410425|NCT00076258|1006046|P1|NOT COMPLETED|Overall Study||1
410426|NCT00076258|1006045|P2|COMPLETED|Overall Study||61
410427|NCT00076258|1006046|P1|COMPLETED|Overall Study||61
410428|NCT00076258|1006045|P2|STARTED|Overall Study||64
410429|NCT00076258|1006046|P1|STARTED|Overall Study||62
410430|NCT00076245|1006056|P4|NOT COMPLETED|Overall Study||1
410431|NCT00076245|1006057|P3|NOT COMPLETED|Overall Study||0
410432|NCT00076245|1006058|P2|NOT COMPLETED|Overall Study||0
410433|NCT00076245|1006059|P1|NOT COMPLETED|Overall Study||0
410434|NCT00076245|1006056|P4|COMPLETED|Overall Study||14
410435|NCT00076245|1006057|P3|COMPLETED|Overall Study||15
410436|NCT00076245|1006058|P2|COMPLETED|Overall Study||15
410437|NCT00076245|1006059|P1|COMPLETED|Overall Study||16
410438|NCT00076245|1006056|P4|STARTED|Overall Study||15
410439|NCT00076245|1006057|P3|STARTED|Overall Study||15
410440|NCT00076245|1006058|P2|STARTED|Overall Study||15
410441|NCT00076245|1006059|P1|STARTED|Overall Study||16
410442|NCT00076219|1006075|P2|NOT COMPLETED|Overall Study||11
410443|NCT00076219|1006076|P1|NOT COMPLETED|Overall Study||18
410444|NCT00076219|1006075|P2|COMPLETED|Overall Study||550
410445|NCT00076219|1006076|P1|COMPLETED|Overall Study||545
410446|NCT00076219|1006075|P2|STARTED|Overall Study||561
410447|NCT00076219|1006076|P1|STARTED|Overall Study||563
410448|NCT00076102|1006082|P1|NOT COMPLETED|Overall Study||5
410449|NCT00076102|1006082|P1|COMPLETED|Overall Study||31
410450|NCT00076102|1006082|P1|STARTED|Overall Study||36
410451|NCT00076050|1006096|P2|NOT COMPLETED|Overall Study||43
410452|NCT00076050|1006097|P1|NOT COMPLETED|Overall Study||23
410453|NCT00076050|1006096|P2|COMPLETED|Overall Study||83
410454|NCT00076050|1006097|P1|COMPLETED|Overall Study||99
410455|NCT00076050|1006096|P2|STARTED|Overall Study||126
410456|NCT00076050|1006097|P1|STARTED|Overall Study||122
410457|NCT00076024|1006110|P4|NOT COMPLETED|Phase 2, Open-label||16
410458|NCT00076024|1006111|P3|NOT COMPLETED|Phase 2, Open-label||0
410459|NCT00076024|1006112|P2|NOT COMPLETED|Phase 2, Open-label||0
410460|NCT00076024|1006113|P1|NOT COMPLETED|Phase 2, Open-label||0
410461|NCT00076024|1006110|P4|COMPLETED|Phase 2, Open-label||0
410462|NCT00076024|1006111|P3|COMPLETED|Phase 2, Open-label||0
410463|NCT00076024|1006112|P2|COMPLETED|Phase 2, Open-label||0
410464|NCT00076024|1006113|P1|COMPLETED|Phase 2, Open-label||0
410465|NCT00076024|1006110|P4|STARTED|Phase 2, Open-label||16
410466|NCT00076024|1006111|P3|STARTED|Phase 2, Open-label||0
410467|NCT00076024|1006112|P2|STARTED|Phase 2, Open-label||0
410468|NCT00076024|1006113|P1|STARTED|Phase 2, Open-label||0
410469|NCT00076024|1006110|P4|NOT COMPLETED|Phase 2, Double-blind||0
410470|NCT00076024|1006111|P3|NOT COMPLETED|Phase 2, Double-blind||56
410471|NCT00076024|1006112|P2|NOT COMPLETED|Phase 2, Double-blind||112
410472|NCT00076024|1006113|P1|NOT COMPLETED|Phase 2, Double-blind||0
410473|NCT00076024|1006110|P4|COMPLETED|Phase 2, Double-blind||0
410474|NCT00076024|1006111|P3|COMPLETED|Phase 2, Double-blind||0
410475|NCT00076024|1006112|P2|COMPLETED|Phase 2, Double-blind||0
410476|NCT00076024|1006113|P1|COMPLETED|Phase 2, Double-blind||0
410477|NCT00076024|1006110|P4|Treated|Phase 2, Double-blind||0
410478|NCT00076024|1006111|P3|Treated|Phase 2, Double-blind||56
410479|NCT00076024|1006112|P2|Treated|Phase 2, Double-blind||111
410480|NCT00076024|1006113|P1|Treated|Phase 2, Double-blind||0
410481|NCT00076024|1006110|P4|STARTED|Phase 2, Double-blind||0
410482|NCT00076024|1006111|P3|STARTED|Phase 2, Double-blind||56
410483|NCT00076024|1006112|P2|STARTED|Phase 2, Double-blind||112
410484|NCT00076024|1006113|P1|STARTED|Phase 2, Double-blind||0
410485|NCT00076024|1006110|P4|NOT COMPLETED|Phase 1, Lead-in||0
410486|NCT00076024|1006111|P3|NOT COMPLETED|Phase 1, Lead-in||0
410487|NCT00076024|1006112|P2|NOT COMPLETED|Phase 1, Lead-in||0
410488|NCT00076024|1006113|P1|NOT COMPLETED|Phase 1, Lead-in||6
410489|NCT00076024|1006110|P4|COMPLETED|Phase 1, Lead-in||0
410490|NCT00076024|1006111|P3|COMPLETED|Phase 1, Lead-in||0
410491|NCT00076024|1006112|P2|COMPLETED|Phase 1, Lead-in||0
410492|NCT00076024|1006113|P1|COMPLETED|Phase 1, Lead-in||0
410493|NCT00076024|1006110|P4|STARTED|Phase 1, Lead-in||0
410494|NCT00076024|1006111|P3|STARTED|Phase 1, Lead-in||0
410495|NCT00076024|1006112|P2|STARTED|Phase 1, Lead-in||0
410496|NCT00076024|1006113|P1|STARTED|Phase 1, Lead-in||6
410497|NCT00076011|1006127|P1|NOT COMPLETED|Overall Study||52
410498|NCT00076011|1006127|P1|COMPLETED|Overall Study||0
410499|NCT00076011|1006127|P1|STARTED|Overall Study||52
410500|NCT00075946|1006139|P5|NOT COMPLETED|Overall Study||188
410501|NCT00075946|1006140|P4|NOT COMPLETED|Overall Study||30
410502|NCT00075946|1006141|P3|NOT COMPLETED|Overall Study||28
410503|NCT00075946|1006142|P2|NOT COMPLETED|Overall Study||151
410504|NCT00075946|1006143|P1|NOT COMPLETED|Overall Study||148
410505|NCT00075946|1006139|P5|COMPLETED|Overall Study||0
410506|NCT00075946|1006140|P4|COMPLETED|Overall Study||0
410507|NCT00075946|1006141|P3|COMPLETED|Overall Study||0
410508|NCT00075946|1006142|P2|COMPLETED|Overall Study||0
410509|NCT00075946|1006143|P1|COMPLETED|Overall Study||0
410510|NCT00075946|1006139|P5|Included in Primary Analysis|Overall Study||0
410511|NCT00075946|1006140|P4|Included in Primary Analysis|Overall Study||29
410512|NCT00075946|1006141|P3|Included in Primary Analysis|Overall Study||23
410513|NCT00075946|1006142|P2|Included in Primary Analysis|Overall Study||146
410514|NCT00075946|1006143|P1|Included in Primary Analysis|Overall Study||143
410515|NCT00075946|1006139|P5|Treated and With Toxicity Data Available|Overall Study||154
410516|NCT00075946|1006140|P4|Treated and With Toxicity Data Available|Overall Study||29
410517|NCT00075946|1006141|P3|Treated and With Toxicity Data Available|Overall Study||27
410518|NCT00075946|1006142|P2|Treated and With Toxicity Data Available|Overall Study||148
410519|NCT00075946|1006143|P1|Treated and With Toxicity Data Available|Overall Study||142
410520|NCT00075946|1006139|P5|STARTED|Overall Study||188
410521|NCT00075946|1006140|P4|STARTED|Overall Study||30
410522|NCT00075946|1006141|P3|STARTED|Overall Study||28
410523|NCT00075946|1006142|P2|STARTED|Overall Study||151
410524|NCT00075946|1006143|P1|STARTED|Overall Study||148
410525|NCT00075881|1006158|P1|NOT COMPLETED|Overall Study||43
410526|NCT00075881|1006158|P1|COMPLETED|Overall Study||1
410527|NCT00075881|1006158|P1|Reinduction Treatment|Overall Study||7
410528|NCT00075881|1006158|P1|Maintenance Treatment|Overall Study||15
410529|NCT00075881|1006158|P1|Induction Treatment|Overall Study||42
410530|NCT00075881|1006158|P1|Treated|Overall Study||42
410531|NCT00075881|1006158|P1|Eligible|Overall Study||43
410532|NCT00075881|1006158|P1|STARTED|Overall Study||44
410533|NCT00075829|1006169|P4|NOT COMPLETED|Overall Study||24
410534|NCT00075829|1006170|P3|NOT COMPLETED|Overall Study||34
410535|NCT00075829|1006171|P2|NOT COMPLETED|Overall Study||118
410536|NCT00075829|1006172|P1|NOT COMPLETED|Overall Study||258
410537|NCT00075829|1006169|P4|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|13
410538|NCT00075829|1006170|P3|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|14
410539|NCT00075829|1006171|P2|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|71
410540|NCT00075829|1006172|P1|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|178
410541|NCT00075829|1006169|P4|STARTED|Overall Study||37
410542|NCT00075829|1006170|P3|STARTED|Overall Study||48
410543|NCT00075829|1006171|P2|STARTED|Overall Study||189
410544|NCT00075829|1006172|P1|STARTED|Overall Study||436
410545|NCT00075816|1006202|P2|NOT COMPLETED|Overall Study||11
410546|NCT00075816|1006203|P1|NOT COMPLETED|Overall Study||14
410547|NCT00075816|1006202|P2|COMPLETED|Overall Study||262
410548|NCT00075816|1006203|P1|COMPLETED|Overall Study||264
410549|NCT00075816|1006202|P2|STARTED|Overall Study||273
410550|NCT00075816|1006203|P1|STARTED|Overall Study||278
410551|NCT00075803|1006243|P2|NOT COMPLETED|Overall Study||0
410552|NCT00075803|1006244|P1|NOT COMPLETED|Overall Study||0
410553|NCT00075803|1006243|P2|COMPLETED|Overall Study||305
410554|NCT00075803|1006244|P1|COMPLETED|Overall Study||295
410555|NCT00075803|1006243|P2|STARTED|Overall Study||305
410556|NCT00075803|1006244|P1|STARTED|Overall Study||295
410557|NCT00075764|1006272|P2|NOT COMPLETED|Overall Study||349
410558|NCT00075764|1006273|P1|NOT COMPLETED|Overall Study||345
410559|NCT00075764|1006272|P2|COMPLETED|Overall Study||0
410560|NCT00075764|1006273|P1|COMPLETED|Overall Study||0
410561|NCT00075764|1006272|P2|STARTED|Overall Study||349
410562|NCT00075764|1006273|P1|STARTED|Overall Study||345
410563|NCT00075725|1006297|P12|NOT COMPLETED|Overall Study||18
410564|NCT00075725|1006298|P11|NOT COMPLETED|Overall Study||9
410565|NCT00075725|1006299|P10|NOT COMPLETED|Overall Study||18
410566|NCT00075725|1006300|P9|NOT COMPLETED|Overall Study||117
410567|NCT00075725|1006301|P8|NOT COMPLETED|Overall Study||295
410568|NCT00075725|1006302|P7|NOT COMPLETED|Overall Study||75
410569|NCT00075725|1006303|P6|NOT COMPLETED|Overall Study||313
410570|NCT00075725|1006304|P5|NOT COMPLETED|Overall Study||66
410571|NCT00075725|1006305|P4|NOT COMPLETED|Overall Study||78
410572|NCT00075725|1006306|P3|NOT COMPLETED|Overall Study||121
410573|NCT00075725|1006307|P2|NOT COMPLETED|Overall Study||49
410574|NCT00075725|1006308|P1|NOT COMPLETED|Overall Study||74
410575|NCT00075725|1006297|P12|COMPLETED|Overall Study||10
410576|NCT00075725|1006298|P11|COMPLETED|Overall Study||3
410577|NCT00075725|1006299|P10|COMPLETED|Overall Study||16
410578|NCT00075725|1006300|P9|COMPLETED|Overall Study||185
410579|NCT00075725|1006301|P8|COMPLETED|Overall Study||401
410580|NCT00075725|1006302|P7|COMPLETED|Overall Study||171
410581|NCT00075725|1006303|P6|COMPLETED|Overall Study||397
410582|NCT00075725|1006304|P5|COMPLETED|Overall Study||166
410583|NCT00075725|1006305|P4|COMPLETED|Overall Study||168
410584|NCT00075725|1006306|P3|COMPLETED|Overall Study||175
410585|NCT00075725|1006307|P2|COMPLETED|Overall Study||57
410586|NCT00075725|1006308|P1|COMPLETED|Overall Study||172
410587|NCT00075725|1006297|P12|STARTED|Overall Study||28
410588|NCT00075725|1006298|P11|STARTED|Overall Study||12
410589|NCT00075725|1006299|P10|STARTED|Overall Study||34
410590|NCT00075725|1006300|P9|STARTED|Overall Study||302
410591|NCT00075725|1006301|P8|STARTED|Overall Study||696
410592|NCT00075725|1006302|P7|STARTED|Overall Study||246
410593|NCT00075725|1006303|P6|STARTED|Overall Study||710
410594|NCT00075725|1006304|P5|STARTED|Overall Study||232
410595|NCT00075725|1006305|P4|STARTED|Overall Study||246
410596|NCT00075725|1006306|P3|STARTED|Overall Study||296
410597|NCT00075725|1006307|P2|STARTED|Overall Study||106
410598|NCT00075725|1006308|P1|STARTED|Overall Study||246
410599|NCT00075608|1006397|P1|NOT COMPLETED|Overall Study||0
410600|NCT00075608|1006397|P1|COMPLETED|Overall Study||12
410601|NCT00075608|1006397|P1|STARTED|Overall Study||12
410602|NCT00075582|1006405|P2|NOT COMPLETED|Overall Study||35
410603|NCT00075582|1006406|P1|NOT COMPLETED|Overall Study||50
410604|NCT00075582|1006405|P2|COMPLETED|Overall Study||50
410605|NCT00075582|1006406|P1|COMPLETED|Overall Study||255
410606|NCT00075582|1006405|P2|STARTED|Overall Study||85
410607|NCT00075582|1006406|P1|STARTED|Overall Study||305
410608|NCT00075504|1006416|P2|NOT COMPLETED|Overall Study||7
410609|NCT00075504|1006417|P1|NOT COMPLETED|Overall Study||9
410610|NCT00075504|1006416|P2|COMPLETED|Overall Study||3
410611|NCT00075504|1006417|P1|COMPLETED|Overall Study||14
410612|NCT00075504|1006416|P2|STARTED|Overall Study||10
410613|NCT00075504|1006417|P1|STARTED|Overall Study||23
410614|NCT00075478|1006429|P2|NOT COMPLETED|Overall Study||1
410615|NCT00075478|1006430|P1|NOT COMPLETED|Overall Study||1
410616|NCT00075478|1006429|P2|COMPLETED|Overall Study||44
410617|NCT00075478|1006430|P1|COMPLETED|Overall Study||41
410618|NCT00075478|1006429|P2|STARTED|Overall Study||45
410619|NCT00075478|1006430|P1|STARTED|Overall Study||42
410620|NCT00075400|1006450|P1|NOT COMPLETED|Overall Study||3
410621|NCT00075400|1006450|P1|COMPLETED|Overall Study|Eligible and treated patients.|23
410622|NCT00075400|1006450|P1|STARTED|Overall Study||26
410623|NCT00075335|1006464|P1|NOT COMPLETED|Overall Study||0
410624|NCT00075335|1006464|P1|COMPLETED|Overall Study||8
410625|NCT00075335|1006464|P1|STARTED|Overall Study||8
410626|NCT00075270|1006471|P2|NOT COMPLETED|Overall Study||284
410627|NCT00075270|1006472|P1|NOT COMPLETED|Overall Study||286
410628|NCT00075270|1006471|P2|COMPLETED|Overall Study||4
410629|NCT00075270|1006472|P1|COMPLETED|Overall Study||5
410630|NCT00075270|1006471|P2|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|13
410631|NCT00075270|1006472|P1|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|26
410632|NCT00075270|1006471|P2|STARTED|Overall Study||288
410633|NCT00075270|1006472|P1|STARTED|Overall Study||291
410634|NCT00075218|1006518|P3|NOT COMPLETED|Open-Label Treatment||255
410635|NCT00075218|1006519|P2|NOT COMPLETED|Open-Label Treatment||0
410636|NCT00075218|1006520|P1|NOT COMPLETED|Open-Label Treatment||0
410637|NCT00075218|1006518|P3|COMPLETED|Open-Label Treatment||0
410638|NCT00075218|1006519|P2|COMPLETED|Open-Label Treatment||0
410639|NCT00075218|1006520|P1|COMPLETED|Open-Label Treatment||0
410640|NCT00075218|1006518|P3|STARTED|Open-Label Treatment||255
410641|NCT00075218|1006519|P2|STARTED|Open-Label Treatment||0
410642|NCT00075218|1006520|P1|STARTED|Open-Label Treatment||0
410643|NCT00075218|1006518|P3|NOT COMPLETED|Double-Blind Treatment||0
410644|NCT00075218|1006519|P2|NOT COMPLETED|Double-Blind Treatment||15
410645|NCT00075218|1006520|P1|NOT COMPLETED|Double-Blind Treatment||91
410646|NCT00075218|1006518|P3|COMPLETED|Double-Blind Treatment||0
410647|NCT00075218|1006519|P2|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|103
410648|NCT00075218|1006520|P1|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|152
410649|NCT00075218|1006518|P3|Crossed Over to Open-Label Treatment|Double-Blind Treatment||0
410650|NCT00075218|1006519|P2|Crossed Over to Open-Label Treatment|Double-Blind Treatment||103
410651|NCT00075218|1006520|P1|Crossed Over to Open-Label Treatment|Double-Blind Treatment||152
410652|NCT00075218|1006518|P3|Received Double-Blind Treatment|Double-Blind Treatment||0
410653|NCT00075218|1006519|P2|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|114
410654|NCT00075218|1006520|P1|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|228
410655|NCT00075218|1006518|P3|STARTED|Double-Blind Treatment||0
410656|NCT00075218|1006519|P2|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|118
410657|NCT00075218|1006520|P1|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|243
410658|NCT00075088|1006555|P2|NOT COMPLETED|Overall Study||0
410659|NCT00075088|1006556|P1|NOT COMPLETED|Overall Study||0
410660|NCT00075088|1006555|P2|COMPLETED|Overall Study||391
410661|NCT00075088|1006556|P1|COMPLETED|Overall Study||403
410662|NCT00075088|1006555|P2|STARTED|Overall Study||391
410663|NCT00075088|1006556|P1|STARTED|Overall Study||403
410664|NCT00075023|1006569|P2|NOT COMPLETED|Part Two||0
410665|NCT00075023|1006570|P1|NOT COMPLETED|Part Two||0
410666|NCT00075023|1006569|P2|COMPLETED|Part Two||0
410667|NCT00075023|1006570|P1|COMPLETED|Part Two||0
410668|NCT00075023|1006569|P2|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
410669|NCT00075023|1006570|P1|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
410670|NCT00075023|1006569|P2|NOT COMPLETED|Pilot Study||2
410671|NCT00075023|1006570|P1|NOT COMPLETED|Pilot Study||2
410672|NCT00075023|1006569|P2|COMPLETED|Pilot Study||3
410673|NCT00075023|1006570|P1|COMPLETED|Pilot Study||3
410674|NCT00075023|1006569|P2|STARTED|Pilot Study||5
410675|NCT00075023|1006570|P1|STARTED|Pilot Study||5
410676|NCT00074984|1006579|P2|NOT COMPLETED|Overall Study||8
410677|NCT00074984|1006580|P1|NOT COMPLETED|Overall Study||3
410678|NCT00074984|1006579|P2|COMPLETED|Overall Study||43
410679|NCT00074984|1006580|P1|COMPLETED|Overall Study||28
410680|NCT00074984|1006579|P2|STARTED|Overall Study||51
410681|NCT00074984|1006580|P1|STARTED|Overall Study||31
410682|NCT00074958|1006595|P1|NOT COMPLETED|Overall Study||1
410683|NCT00074958|1006595|P1|COMPLETED|Overall Study||15
410684|NCT00074958|1006595|P1|STARTED|Overall Study||16
410685|NCT00074815|1006603|P3|NOT COMPLETED|Overall Study||12
410686|NCT00074815|1006604|P2|NOT COMPLETED|Overall Study||6
410687|NCT00074815|1006605|P1|NOT COMPLETED|Overall Study||5
410688|NCT00074815|1006603|P3|COMPLETED|Overall Study||30
410689|NCT00074815|1006604|P2|COMPLETED|Overall Study||34
410690|NCT00074815|1006605|P1|COMPLETED|Overall Study||37
410691|NCT00074815|1006603|P3|STARTED|Overall Study||42
410692|NCT00074815|1006604|P2|STARTED|Overall Study||40
410693|NCT00074815|1006605|P1|STARTED|Overall Study||42
410694|NCT00074802|1006615|P2|NOT COMPLETED|Overall Study||7
410695|NCT00074802|1006616|P1|NOT COMPLETED|Overall Study||9
410696|NCT00074802|1006615|P2|COMPLETED|Overall Study||25
410697|NCT00074802|1006616|P1|COMPLETED|Overall Study||20
410698|NCT00074802|1006615|P2|STARTED|Overall Study||32
410699|NCT00074802|1006616|P1|STARTED|Overall Study||29
410700|NCT00074711|1006636|P2|NOT COMPLETED|Overall Study||15
410701|NCT00074711|1006637|P1|NOT COMPLETED|Overall Study||15
410702|NCT00074711|1006636|P2|COMPLETED|Overall Study||106
410703|NCT00074711|1006637|P1|COMPLETED|Overall Study||105
410704|NCT00074711|1006636|P2|STARTED|Overall Study||121
410705|NCT00074711|1006637|P1|STARTED|Overall Study||120
410706|NCT00074581|1006655|P2|NOT COMPLETED|Overall Study||226
410707|NCT00074581|1006656|P1|NOT COMPLETED|Overall Study||244
410708|NCT00074581|1006655|P2|COMPLETED|Overall Study||1541
410709|NCT00074581|1006656|P1|COMPLETED|Overall Study||1545
410710|NCT00074581|1006655|P2|STARTED|Overall Study|877 HIV-infected index cases and 890 HIV-uninfected partners|1767
410711|NCT00074581|1006656|P1|STARTED|Overall Study|886 HIV-infected index cases and 903 HIV-uninfected partners|1789
410712|NCT00074490|1006669|P6|NOT COMPLETED|Overall Study||0
410713|NCT00074490|1006670|P5|NOT COMPLETED|Overall Study||3
410714|NCT00074490|1006671|P4|NOT COMPLETED|Overall Study||0
410715|NCT00074490|1006672|P3|NOT COMPLETED|Overall Study||0
410716|NCT00074490|1006673|P2|NOT COMPLETED|Overall Study||7
410717|NCT00074490|1006674|P1|NOT COMPLETED|Overall Study||0
410718|NCT00074490|1006669|P6|COMPLETED|Overall Study||221
410719|NCT00074490|1006670|P5|COMPLETED|Overall Study||42
410720|NCT00074490|1006671|P4|COMPLETED|Overall Study||44
410721|NCT00074490|1006672|P3|COMPLETED|Overall Study||40
410722|NCT00074490|1006673|P2|COMPLETED|Overall Study||27
410723|NCT00074490|1006674|P1|COMPLETED|Overall Study||1
410724|NCT00074490|1006669|P6|STARTED|Overall Study||221
410725|NCT00074490|1006670|P5|STARTED|Overall Study||45
410726|NCT00074490|1006671|P4|STARTED|Overall Study||44
410727|NCT00074490|1006672|P3|STARTED|Overall Study||40
410728|NCT00074490|1006673|P2|STARTED|Overall Study||34
410729|NCT00074490|1006674|P1|STARTED|Overall Study||1
410730|NCT00074412|1006708|P2|NOT COMPLETED|Overall Study||84
410731|NCT00074412|1006709|P1|NOT COMPLETED|Overall Study||82
410732|NCT00074412|1006708|P2|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|675
410733|NCT00074412|1006709|P1|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|681
410734|NCT00074412|1006708|P2|Month 12 Visit|Overall Study||735
410735|NCT00074412|1006709|P1|Month 12 Visit|Overall Study||733
410736|NCT00074412|1006708|P2|Month 9 Visit|Overall Study||741
410737|NCT00074412|1006709|P1|Month 9 Visit|Overall Study||741
410738|NCT00074412|1006708|P2|Month 6 Visit|Overall Study||748
410739|NCT00074412|1006709|P1|Month 6 Visit|Overall Study||748
410740|NCT00074412|1006708|P2|Month 5 Visit|Overall Study||750
410741|NCT00074412|1006709|P1|Month 5 Visit|Overall Study||756
410742|NCT00074412|1006708|P2|Month 4 Visit|Overall Study||752
410743|NCT00074412|1006709|P1|Month 4 Visit|Overall Study||758
410744|NCT00074412|1006708|P2|Month 3 Visit|Overall Study||755
410745|NCT00074412|1006709|P1|Month 3 Visit|Overall Study||759
410746|NCT00074412|1006708|P2|Week 8 Visit|Overall Study||759
410747|NCT00074412|1006709|P1|Week 8 Visit|Overall Study||759
410748|NCT00074412|1006708|P2|STARTED|Overall Study|Number of infants randomized at 6 weeks.|759
410749|NCT00074412|1006709|P1|STARTED|Overall Study|Number of infants randomized at 6 weeks.|763
410750|NCT00074308|1006725|P5|NOT COMPLETED|Overall Study||0
410751|NCT00074308|1006726|P4|NOT COMPLETED|Overall Study||0
410752|NCT00074308|1006727|P3|NOT COMPLETED|Overall Study||0
410753|NCT00074308|1006728|P2|NOT COMPLETED|Overall Study||0
410754|NCT00074308|1006729|P1|NOT COMPLETED|Overall Study||0
410755|NCT00074308|1006725|P5|COMPLETED|Overall Study||23
410756|NCT00074308|1006726|P4|COMPLETED|Overall Study||8
410757|NCT00074308|1006727|P3|COMPLETED|Overall Study||3
410758|NCT00074308|1006728|P2|COMPLETED|Overall Study||3
410759|NCT00074308|1006729|P1|COMPLETED|Overall Study||3
410760|NCT00074308|1006725|P5|STARTED|Overall Study||23
410761|NCT00074308|1006726|P4|STARTED|Overall Study||8
410762|NCT00074308|1006727|P3|STARTED|Overall Study||3
410763|NCT00074308|1006728|P2|STARTED|Overall Study||3
410764|NCT00074308|1006729|P1|STARTED|Overall Study||3
410765|NCT00074282|1006740|P3|NOT COMPLETED|Step 2||24
410766|NCT00074282|1006741|P2|NOT COMPLETED|Step 2||2
410767|NCT00074282|1006742|P1|NOT COMPLETED|Step 2||0
410768|NCT00074282|1006740|P3|COMPLETED|Step 2||7
410769|NCT00074282|1006741|P2|COMPLETED|Step 2||7
410770|NCT00074282|1006742|P1|COMPLETED|Step 2||0
410771|NCT00074282|1006740|P3|STARTED|Step 2||31
410772|NCT00074282|1006741|P2|STARTED|Step 2||9
410773|NCT00074282|1006742|P1|STARTED|Step 2||0
410774|NCT00074282|1006740|P3|NOT COMPLETED|Step 1||0
410775|NCT00074282|1006741|P2|NOT COMPLETED|Step 1||0
410776|NCT00074282|1006742|P1|NOT COMPLETED|Step 1||58
410777|NCT00074282|1006740|P3|COMPLETED|Step 1||0
410778|NCT00074282|1006741|P2|COMPLETED|Step 1||0
410779|NCT00074282|1006742|P1|COMPLETED|Step 1||44
410780|NCT00074282|1006740|P3|Started Treatment|Step 1||0
410781|NCT00074282|1006741|P2|Started Treatment|Step 1||0
410782|NCT00074282|1006742|P1|Started Treatment|Step 1||96
410783|NCT00074282|1006740|P3|Eligible|Step 1||0
410784|NCT00074282|1006741|P2|Eligible|Step 1||0
410785|NCT00074282|1006742|P1|Eligible|Step 1||98
410786|NCT00074282|1006740|P3|STARTED|Step 1||0
410787|NCT00074282|1006741|P2|STARTED|Step 1||0
410788|NCT00074282|1006742|P1|STARTED|Step 1||102
410789|NCT00074269|1006751|P1|NOT COMPLETED|Overall Study||0
410790|NCT00074269|1006751|P1|COMPLETED|Overall Study||5
410791|NCT00074269|1006751|P1|STARTED|Overall Study||5
410792|NCT00074165|1006761|P1|NOT COMPLETED|Overall Study||0
410793|NCT00074165|1006761|P1|COMPLETED|Overall Study||17
410794|NCT00074165|1006761|P1|STARTED|Overall Study||17
410795|NCT00074152|1006768|P2|NOT COMPLETED|Overall Study||33
410796|NCT00074152|1006769|P1|NOT COMPLETED|Overall Study||55
410797|NCT00074152|1006768|P2|COMPLETED|Overall Study||52
410798|NCT00074152|1006769|P1|COMPLETED|Overall Study||22
410799|NCT00074152|1006768|P2|STARTED|Overall Study||85
410800|NCT00074152|1006769|P1|STARTED|Overall Study||77
410801|NCT00074035|1006779|P1|NOT COMPLETED|Overall Study||0
410802|NCT00074035|1006779|P1|COMPLETED|Overall Study||38
410803|NCT00074035|1006779|P1|STARTED|Overall Study||38
410804|NCT00073983|1006786|P1|NOT COMPLETED|Overall Study||1
410805|NCT00073983|1006786|P1|COMPLETED|Overall Study|One patient in the chondrosarcoma subtype was not evaluable.|53
410806|NCT00073983|1006786|P1|STARTED|Overall Study||54
410807|NCT00073957|1006801|P1|NOT COMPLETED|Overall Study||0
410808|NCT00073957|1006801|P1|COMPLETED|Overall Study||25
410809|NCT00073957|1006801|P1|STARTED|Overall Study||25
410810|NCT00073918|1006807|P1|NOT COMPLETED|Overall Study||4
410811|NCT00073918|1006807|P1|COMPLETED|Overall Study||107
410812|NCT00073918|1006807|P1|STARTED|Overall Study||111
410813|NCT00073749|1006821|P7|NOT COMPLETED|Overall Study||40
410814|NCT00073749|1006822|P6|NOT COMPLETED|Overall Study||6
410815|NCT00073749|1006823|P5|NOT COMPLETED|Overall Study||6
410816|NCT00073749|1006824|P4|NOT COMPLETED|Overall Study||6
410817|NCT00073749|1006825|P3|NOT COMPLETED|Overall Study||11
410818|NCT00073749|1006826|P2|NOT COMPLETED|Overall Study||5
410819|NCT00073749|1006827|P1|NOT COMPLETED|Overall Study||2
410820|NCT00073749|1006821|P7|COMPLETED|Overall Study||3
410821|NCT00073749|1006822|P6|COMPLETED|Overall Study||0
410822|NCT00073749|1006823|P5|COMPLETED|Overall Study||0
410823|NCT00073749|1006824|P4|COMPLETED|Overall Study||0
410824|NCT00073749|1006825|P3|COMPLETED|Overall Study||0
410825|NCT00073749|1006826|P2|COMPLETED|Overall Study||0
410826|NCT00073749|1006827|P1|COMPLETED|Overall Study||0
410827|NCT00073749|1006821|P7|STARTED|Overall Study||43
410828|NCT00073749|1006822|P6|STARTED|Overall Study||6
410829|NCT00073749|1006823|P5|STARTED|Overall Study||6
410830|NCT00073749|1006824|P4|STARTED|Overall Study||6
410831|NCT00073749|1006825|P3|STARTED|Overall Study||11
410832|NCT00073749|1006826|P2|STARTED|Overall Study||5
410833|NCT00073749|1006827|P1|STARTED|Overall Study||2
410834|NCT00073528|1006858|P2|NOT COMPLETED|Overall Study||642
410835|NCT00073528|1006859|P1|NOT COMPLETED|Overall Study||644
410836|NCT00073528|1006858|P2|COMPLETED|Overall Study||0
410837|NCT00073528|1006859|P1|COMPLETED|Overall Study||0
410838|NCT00073528|1006858|P2|Ongoing|Overall Study|These participants are still on study and do not yet have end of study data available.|344
410839|NCT00073528|1006859|P1|Ongoing|Overall Study|These participants are still on study and do not yet have end of study data available.|349
410840|NCT00073528|1006858|P2|STARTED|Overall Study||642
410841|NCT00073528|1006859|P1|STARTED|Overall Study||644
410842|NCT00073333|1006936|P3|NOT COMPLETED|Overall Study||0
410843|NCT00073333|1006937|P2|NOT COMPLETED|Overall Study||14
410844|NCT00073333|1006938|P1|NOT COMPLETED|Overall Study||14
410845|NCT00073333|1006936|P3|COMPLETED|Overall Study||19
410846|NCT00073333|1006937|P2|COMPLETED|Overall Study||27
410847|NCT00073333|1006938|P1|COMPLETED|Overall Study||32
410848|NCT00073333|1006936|P3|STARTED|Overall Study||19
410849|NCT00073333|1006937|P2|STARTED|Overall Study||41
410850|NCT00073333|1006938|P1|STARTED|Overall Study||46
410851|NCT00073307|1006948|P3|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||156
410852|NCT00073307|1006949|P2|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
410853|NCT00073307|1006950|P1|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||134
410854|NCT00073307|1006948|P3|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||143
410855|NCT00073307|1006949|P2|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
410856|NCT00073307|1006950|P1|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||120
410857|NCT00073307|1006948|P3|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||216
410858|NCT00073307|1006949|P2|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||0
410859|NCT00073307|1006950|P1|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||219
410860|NCT00073307|1006948|P3|STARTED|Open Label-Sorafenib Only [30Jun2008]||299
410861|NCT00073307|1006949|P2|STARTED|Open Label-Sorafenib Only [30Jun2008]|Placebo treatment ended ~ 31May2005. Those who continued, switched to receive Sorafenib.|0
410862|NCT00073307|1006950|P1|STARTED|Open Label-Sorafenib Only [30Jun2008]||254
410863|NCT00073307|1006948|P3|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||0
410864|NCT00073307|1006949|P2|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||153
410865|NCT00073307|1006950|P1|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||197
410866|NCT00073307|1006948|P3|COMPLETED|Double-Blind (DB, as of ~31May2005)||0
410867|NCT00073307|1006949|P2|COMPLETED|Double-Blind (DB, as of ~31May2005)||299
410868|NCT00073307|1006950|P1|COMPLETED|Double-Blind (DB, as of ~31May2005)||254
410869|NCT00073307|1006948|P3|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||0
410870|NCT00073307|1006949|P2|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
410871|NCT00073307|1006950|P1|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
410872|NCT00073307|1006948|P3|STARTED|Double-Blind (DB, as of ~31May2005)||0
410873|NCT00073307|1006949|P2|STARTED|Double-Blind (DB, as of ~31May2005)||452
410874|NCT00073307|1006950|P1|STARTED|Double-Blind (DB, as of ~31May2005)||451
410875|NCT00073073|1006968|P1|NOT COMPLETED|Overall Study||4
410876|NCT00073073|1006968|P1|COMPLETED|Overall Study||42
410877|NCT00073073|1006968|P1|STARTED|Overall Study||46
410878|NCT00073021|1006981|P2|NOT COMPLETED|Overall Study||16
410879|NCT00073021|1006982|P1|NOT COMPLETED|Overall Study||26
410880|NCT00073021|1006981|P2|COMPLETED|Overall Study||113
410881|NCT00073021|1006982|P1|COMPLETED|Overall Study||113
410882|NCT00073021|1006981|P2|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|129
410883|NCT00073021|1006982|P1|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|139
410884|NCT00073008|1007012|P2|NOT COMPLETED|Overall Study||63
410885|NCT00073008|1007013|P1|NOT COMPLETED|Overall Study||62
410886|NCT00073008|1007012|P2|COMPLETED|Overall Study||3
410887|NCT00073008|1007013|P1|COMPLETED|Overall Study||3
410888|NCT00073008|1007012|P2|STARTED|Overall Study||66
410889|NCT00073008|1007013|P1|STARTED|Overall Study||65
410890|NCT00072761|1007045|P2|NOT COMPLETED|Overall Study||2
410891|NCT00072761|1007046|P1|NOT COMPLETED|Overall Study||9
410892|NCT00072761|1007045|P2|COMPLETED|Overall Study||95
410893|NCT00072761|1007046|P1|COMPLETED|Overall Study||90
410894|NCT00072761|1007045|P2|STARTED|Overall Study||97
410895|NCT00072761|1007046|P1|STARTED|Overall Study||99
410896|NCT00072475|1007052|P1|NOT COMPLETED|Overall Study||97
410897|NCT00072475|1007052|P1|COMPLETED|Overall Study||45
410898|NCT00072475|1007052|P1|STARTED|Overall Study||142
410899|NCT00072449|1007060|P1|NOT COMPLETED|Overall Study||0
410900|NCT00072449|1007060|P1|COMPLETED|Overall Study||12
410901|NCT00072449|1007060|P1|STARTED|Overall Study||12
410902|NCT00072384|1007067|P1|NOT COMPLETED|Overall Study||9
410903|NCT00072384|1007067|P1|COMPLETED|Overall Study||21
410904|NCT00072384|1007067|P1|STARTED|Overall Study||30
410905|NCT00072293|1007080|P2|NOT COMPLETED|Overall Study||2
410906|NCT00072293|1007081|P1|NOT COMPLETED|Overall Study||1
410907|NCT00072293|1007080|P2|COMPLETED|Overall Study||467
410908|NCT00072293|1007081|P1|COMPLETED|Overall Study||464
410909|NCT00072293|1007080|P2|STARTED|Overall Study||469
410910|NCT00072293|1007081|P1|STARTED|Overall Study||465
410911|NCT00072280|1007093|P2|NOT COMPLETED|Follow-up||2
410912|NCT00072280|1007094|P1|NOT COMPLETED|Follow-up||2
410913|NCT00072280|1007093|P2|COMPLETED|Follow-up||0
410914|NCT00072280|1007094|P1|COMPLETED|Follow-up||0
410915|NCT00072280|1007093|P2|STARTED|Follow-up||2
410916|NCT00072280|1007094|P1|STARTED|Follow-up||2
410917|NCT00072280|1007093|P2|NOT COMPLETED|Treatment||2
410918|NCT00072280|1007094|P1|NOT COMPLETED|Treatment||1
410919|NCT00072280|1007093|P2|COMPLETED|Treatment||2
410920|NCT00072280|1007094|P1|COMPLETED|Treatment||2
410921|NCT00072280|1007093|P2|STARTED|Treatment||4
410922|NCT00072280|1007094|P1|STARTED|Treatment||3
410923|NCT00072189|1007099|P1|NOT COMPLETED|Overall Study||1
410924|NCT00072189|1007099|P1|COMPLETED|Overall Study||16
410925|NCT00072189|1007099|P1|STARTED|Overall Study||17
410926|NCT00072176|1007107|P2|NOT COMPLETED|Overall Study||1
410927|NCT00072176|1007108|P1|NOT COMPLETED|Overall Study||1
410928|NCT00072176|1007107|P2|COMPLETED|Overall Study||27
410929|NCT00072176|1007108|P1|COMPLETED|Overall Study||33
410930|NCT00072176|1007107|P2|STARTED|Overall Study||28
410931|NCT00072176|1007108|P1|STARTED|Overall Study||34
410932|NCT00071981|1007120|P4|NOT COMPLETED|Overall Study||45
410933|NCT00071981|1007121|P3|NOT COMPLETED|Overall Study||37
410934|NCT00071981|1007122|P2|NOT COMPLETED|Overall Study||41
410935|NCT00071981|1007123|P1|NOT COMPLETED|Overall Study||46
410936|NCT00071981|1007120|P4|COMPLETED|Overall Study||3
410937|NCT00071981|1007121|P3|COMPLETED|Overall Study||0
410938|NCT00071981|1007122|P2|COMPLETED|Overall Study||2
410939|NCT00071981|1007123|P1|COMPLETED|Overall Study||1
410940|NCT00071981|1007120|P4|Have Helper T Cell Response Data|Overall Study||39
410941|NCT00071981|1007121|P3|Have Helper T Cell Response Data|Overall Study||25
410942|NCT00071981|1007122|P2|Have Helper T Cell Response Data|Overall Study||27
410943|NCT00071981|1007123|P1|Have Helper T Cell Response Data|Overall Study||37
410944|NCT00071981|1007120|P4|Have CTL Response Data|Overall Study||41
410945|NCT00071981|1007121|P3|Have CTL Response Data|Overall Study||29
410946|NCT00071981|1007122|P2|Have CTL Response Data|Overall Study||30
410947|NCT00071981|1007123|P1|Have CTL Response Data|Overall Study||40
410948|NCT00071981|1007120|P4|Eligible and Treated|Overall Study||42
410949|NCT00071981|1007121|P3|Eligible and Treated|Overall Study||32
410950|NCT00071981|1007122|P2|Eligible and Treated|Overall Study||33
410951|NCT00071981|1007123|P1|Eligible and Treated|Overall Study||41
410952|NCT00071981|1007120|P4|Treated|Overall Study||48
410953|NCT00071981|1007121|P3|Treated|Overall Study||36
410954|NCT00071981|1007122|P2|Treated|Overall Study||38
410955|NCT00071981|1007123|P1|Treated|Overall Study||45
410956|NCT00071981|1007120|P4|Eligible|Overall Study||42
410957|NCT00071981|1007121|P3|Eligible|Overall Study||33
410958|NCT00071981|1007122|P2|Eligible|Overall Study||36
410959|NCT00071981|1007123|P1|Eligible|Overall Study||43
410960|NCT00071981|1007120|P4|STARTED|Overall Study||48
410961|NCT00071981|1007121|P3|STARTED|Overall Study||37
410962|NCT00071981|1007122|P2|STARTED|Overall Study||43
410963|NCT00071981|1007123|P1|STARTED|Overall Study||47
410964|NCT00072566|1007149|P1|NOT COMPLETED|Overall Study||0
410965|NCT00072566|1007149|P1|COMPLETED|Overall Study||70
410966|NCT00072566|1007149|P1|STARTED|Overall Study||70
410967|NCT00072514|1007155|P1|NOT COMPLETED|Overall Study||4
410968|NCT00072514|1007155|P1|COMPLETED|Overall Study||51
410969|NCT00072514|1007155|P1|STARTED|Overall Study||55
410970|NCT00071812|1007166|P4|NOT COMPLETED|24-Week Open-Label Extension Period||40
410971|NCT00071812|1007167|P3|NOT COMPLETED|24-Week Open-Label Extension Period||1
410972|NCT00071812|1007168|P2|NOT COMPLETED|24-Week Open-Label Extension Period||0
410973|NCT00071812|1007169|P1|NOT COMPLETED|24-Week Open-Label Extension Period||0
410974|NCT00071812|1007166|P4|COMPLETED|24-Week Open-Label Extension Period||178
410975|NCT00071812|1007167|P3|COMPLETED|24-Week Open-Label Extension Period||7
410976|NCT00071812|1007168|P2|COMPLETED|24-Week Open-Label Extension Period||11
410977|NCT00071812|1007169|P1|COMPLETED|24-Week Open-Label Extension Period||0
410978|NCT00071812|1007166|P4|STARTED|24-Week Open-Label Extension Period|Of 60: 56 continued with 10 mg/kg; 4 elected not to continue in the open-label extension.|218
410979|NCT00071812|1007167|P3|STARTED|24-Week Open-Label Extension Period|Of 63: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|8
410980|NCT00071812|1007168|P2|STARTED|24-Week Open-Label Extension Period|Of 66: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|11
410981|NCT00071812|1007169|P1|STARTED|24-Week Open-Label Extension Period|Of 59: 56 switched to 10 mg/kg; 3 elected not to continue in the open-label extension.|0
410982|NCT00071812|1007166|P4|NOT COMPLETED|24-Week Double-Blind Period||11
410983|NCT00071812|1007167|P3|NOT COMPLETED|24-Week Double-Blind Period||8
410984|NCT00071812|1007168|P2|NOT COMPLETED|24-Week Double-Blind Period||6
410985|NCT00071812|1007169|P1|NOT COMPLETED|24-Week Double-Blind Period||10
410986|NCT00071812|1007166|P4|COMPLETED|24-Week Double-Blind Period||60
410987|NCT00071812|1007167|P3|COMPLETED|24-Week Double-Blind Period||63
410988|NCT00071812|1007168|P2|COMPLETED|24-Week Double-Blind Period||66
410989|NCT00071812|1007169|P1|COMPLETED|24-Week Double-Blind Period||59
410990|NCT00071812|1007166|P4|STARTED|24-Week Double-Blind Period||71
410991|NCT00071812|1007167|P3|STARTED|24-Week Double-Blind Period||71
410992|NCT00071812|1007168|P2|STARTED|24-Week Double-Blind Period||72
410993|NCT00071812|1007169|P1|STARTED|24-Week Double-Blind Period||69
410994|NCT00071799|1007211|P2|NOT COMPLETED|Overall Study||98
410995|NCT00071799|1007212|P1|NOT COMPLETED|Overall Study||70
410996|NCT00071799|1007211|P2|COMPLETED|Overall Study|Includes patients who died or transformed to AML during treatment, or were still receiving drug.|81
410997|NCT00071799|1007212|P1|COMPLETED|Overall Study|Includes those who died or transformed to AML, or receiving drug + eligible for extension period.|109
410998|NCT00071799|1007211|P2|STARTED|Overall Study|Best supportive care: 105, Low-dose cytarabine: 49, Standard chemotherapy: 25 patients|179
410999|NCT00071799|1007212|P1|STARTED|Overall Study||179
411000|NCT00071890|1007254|P2|NOT COMPLETED|Overall Study||0
411001|NCT00071890|1007255|P1|NOT COMPLETED|Overall Study||0
411002|NCT00071890|1007254|P2|COMPLETED|Overall Study|"1 withdrawal~1 lost of follow-up~1 death 67 patients analysed"|67
411003|NCT00071890|1007255|P1|COMPLETED|Overall Study|"1 withdrawal~1 death 81 patients analysed"|81
411004|NCT00071890|1007254|P2|STARTED|Overall Study|1 patients stopped HAART at week 0|67
411005|NCT00071890|1007255|P1|STARTED|Overall Study|3 patients did not received Interleukin-2|81
411006|NCT00071760|1007265|P1|NOT COMPLETED|Overall Study||54
411007|NCT00071760|1007265|P1|COMPLETED|Overall Study||0
411008|NCT00071760|1007265|P1|Ongoing|Overall Study||25
411009|NCT00071760|1007265|P1|STARTED|Overall Study||54
411010|NCT00071721|1007326|P2|NOT COMPLETED|Overall Study||91
411011|NCT00071721|1007327|P1|NOT COMPLETED|Overall Study||72
411012|NCT00071721|1007326|P2|COMPLETED|Overall Study||69
411013|NCT00071721|1007327|P1|COMPLETED|Overall Study||81
411014|NCT00071721|1007326|P2|STARTED|Overall Study||160
411015|NCT00071721|1007327|P1|STARTED|Overall Study||153
411016|NCT00071513|1007345|P2|NOT COMPLETED|Follow-up Assessment||6
411017|NCT00071513|1007346|P1|NOT COMPLETED|Follow-up Assessment||6
411018|NCT00071513|1007345|P2|COMPLETED|Follow-up Assessment||247
411019|NCT00071513|1007346|P1|COMPLETED|Follow-up Assessment||233
411020|NCT00071513|1007345|P2|STARTED|Follow-up Assessment||253
411021|NCT00071513|1007346|P1|STARTED|Follow-up Assessment||239
411022|NCT00071513|1007345|P2|NOT COMPLETED|Intervention Component||3
411023|NCT00071513|1007346|P1|NOT COMPLETED|Intervention Component||2
411024|NCT00071513|1007345|P2|COMPLETED|Intervention Component||253
411025|NCT00071513|1007346|P1|COMPLETED|Intervention Component||239
411026|NCT00071513|1007345|P2|STARTED|Intervention Component||256
411027|NCT00071513|1007346|P1|STARTED|Intervention Component||241
411028|NCT00071487|1007358|P4|NOT COMPLETED|24-Week Open-Label Extension Period||23
411029|NCT00071487|1007359|P3|NOT COMPLETED|24-Week Open-Label Extension Period||1
411030|NCT00071487|1007360|P2|NOT COMPLETED|24-Week Open-Label Extension Period||0
411031|NCT00071487|1007361|P1|NOT COMPLETED|24-Week Open-Label Extension Period||0
411032|NCT00071487|1007358|P4|COMPLETED|24-Week Open-Label Extension Period||279
411033|NCT00071487|1007359|P3|COMPLETED|24-Week Open-Label Extension Period||23
411034|NCT00071487|1007360|P2|COMPLETED|24-Week Open-Label Extension Period||19
411035|NCT00071487|1007361|P1|COMPLETED|24-Week Open-Label Extension Period||0
411036|NCT00071487|1007358|P4|STARTED|24-Week Open-Label Extension Period|Of 90: 85 continued with 10 mg/kg; 5 elected not to continue in the open-label extension period.|302
411037|NCT00071487|1007359|P3|STARTED|24-Week Open-Label Extension Period|Of 94: 64 switched to 10 mg/kg; 6 elected not to continue in the open-label extension period.|24
411038|NCT00071487|1007360|P2|STARTED|24-Week Open-Label Extension Period|Of 87: 65 switched to 10 mg/kg; 3 elected not to continue in the open-label extension period.|19
411039|NCT00071487|1007361|P1|STARTED|24-Week Open-Label Extension Period|Of 93: 88 switched to 10 mg/kg; 5 elected not to continue in the open-label extension period.|0
411040|NCT00071487|1007358|P4|NOT COMPLETED|52-Week Double-Blind Period||21
411041|NCT00071487|1007359|P3|NOT COMPLETED|52-Week Double-Blind Period||17
411042|NCT00071487|1007360|P2|NOT COMPLETED|52-Week Double-Blind Period||27
411043|NCT00071487|1007361|P1|NOT COMPLETED|52-Week Double-Blind Period||20
411044|NCT00071487|1007358|P4|COMPLETED|52-Week Double-Blind Period||90
411045|NCT00071487|1007359|P3|COMPLETED|52-Week Double-Blind Period||94
411046|NCT00071487|1007360|P2|COMPLETED|52-Week Double-Blind Period||87
411047|NCT00071487|1007361|P1|COMPLETED|52-Week Double-Blind Period||93
411048|NCT00071487|1007358|P4|STARTED|52-Week Double-Blind Period||111
411049|NCT00071487|1007359|P3|STARTED|52-Week Double-Blind Period||111
411050|NCT00071487|1007360|P2|STARTED|52-Week Double-Blind Period||114
411051|NCT00071487|1007361|P1|STARTED|52-Week Double-Blind Period||113
411052|NCT00071396|1007405|P1|NOT COMPLETED|Overall Study||3
411053|NCT00071396|1007405|P1|COMPLETED|Overall Study|Evaluable for response.|41
411054|NCT00071396|1007405|P1|STARTED|Overall Study||44
411055|NCT00071110|1007411|P2|NOT COMPLETED|Overall Study||4
411056|NCT00071110|1007412|P1|NOT COMPLETED|Overall Study||0
411057|NCT00071110|1007411|P2|COMPLETED|Overall Study||25
411058|NCT00071110|1007412|P1|COMPLETED|Overall Study||28
411059|NCT00071110|1007411|P2|STARTED|Overall Study||29
411060|NCT00071110|1007412|P1|STARTED|Overall Study||28
411061|NCT00071032|1007426|P2|NOT COMPLETED|Overall Study||8
411062|NCT00071032|1007427|P1|NOT COMPLETED|Overall Study||9
411063|NCT00071032|1007426|P2|COMPLETED|Overall Study||1001
411064|NCT00071032|1007427|P1|COMPLETED|Overall Study||998
411065|NCT00071032|1007426|P2|STARTED|Overall Study||1009
411066|NCT00071032|1007427|P1|STARTED|Overall Study||1007
411067|NCT00071006|1007435|P1|NOT COMPLETED|Overall Study||12
411068|NCT00071006|1007435|P1|COMPLETED|Overall Study||0
411069|NCT00071006|1007435|P1|STARTED|Overall Study||12
411070|NCT00070941|1007448|P3|NOT COMPLETED|Overall Study||4
411071|NCT00070941|1007449|P2|NOT COMPLETED|Overall Study||8
411072|NCT00070941|1007450|P1|NOT COMPLETED|Overall Study||10
411073|NCT00070941|1007448|P3|COMPLETED|Overall Study||2
411074|NCT00070941|1007449|P2|COMPLETED|Overall Study||3
411075|NCT00070941|1007450|P1|COMPLETED|Overall Study||2
411076|NCT00070941|1007448|P3|STARTED|Overall Study||6
411077|NCT00070941|1007449|P2|STARTED|Overall Study||11
411078|NCT00070941|1007450|P1|STARTED|Overall Study||12
411079|NCT00071058|1007458|P1|NOT COMPLETED|Overall Study||1
411080|NCT00071058|1007458|P1|COMPLETED|Overall Study||49
411081|NCT00071058|1007458|P1|STARTED|Overall Study||50
411082|NCT00070707|1007465|P2|NOT COMPLETED|Overall Study||7
411083|NCT00070707|1007466|P1|NOT COMPLETED|Overall Study||14
411084|NCT00070707|1007465|P2|COMPLETED|Overall Study||68
411085|NCT00070707|1007466|P1|COMPLETED|Overall Study||99
411086|NCT00070707|1007465|P2|STARTED|Overall Study||75
411087|NCT00070707|1007466|P1|STARTED|Overall Study||113
411088|NCT00003907|1007514|P2|NOT COMPLETED|Overall Study||23
411089|NCT00003907|1007515|P1|NOT COMPLETED|Overall Study||13
411090|NCT00003907|1007514|P2|COMPLETED|Overall Study||8
411091|NCT00003907|1007515|P1|COMPLETED|Overall Study||6
411092|NCT00003907|1007514|P2|Eligible and Treated|Overall Study||29
411093|NCT00003907|1007515|P1|Eligible and Treated|Overall Study||17
411094|NCT00003907|1007514|P2|Received Protocol Therapy (Treated)|Overall Study||31
411095|NCT00003907|1007515|P1|Received Protocol Therapy (Treated)|Overall Study||18
411096|NCT00003907|1007514|P2|Eligible|Overall Study||29
411097|NCT00003907|1007515|P1|Eligible|Overall Study||18
411098|NCT00003907|1007514|P2|STARTED|Overall Study||31
411099|NCT00003907|1007515|P1|STARTED|Overall Study||19
411100|NCT00070564|1007531|P6|NOT COMPLETED|Overall Study||52
411101|NCT00070564|1007532|P5|NOT COMPLETED|Overall Study||79
411102|NCT00070564|1007533|P4|NOT COMPLETED|Overall Study||167
411103|NCT00070564|1007534|P3|NOT COMPLETED|Overall Study||171
411104|NCT00070564|1007535|P2|NOT COMPLETED|Overall Study||203
411105|NCT00070564|1007536|P1|NOT COMPLETED|Overall Study||200
411106|NCT00070564|1007531|P6|COMPLETED|Overall Study||244
411107|NCT00070564|1007532|P5|COMPLETED|Overall Study||203
411108|NCT00070564|1007533|P4|COMPLETED|Overall Study||481
411109|NCT00070564|1007534|P3|COMPLETED|Overall Study||526
411110|NCT00070564|1007535|P2|COMPLETED|Overall Study||490
411111|NCT00070564|1007536|P1|COMPLETED|Overall Study||478
411112|NCT00070564|1007531|P6|STARTED|Overall Study||296
411113|NCT00070564|1007532|P5|STARTED|Overall Study||282
411114|NCT00070564|1007533|P4|STARTED|Overall Study||648
411115|NCT00070564|1007534|P3|STARTED|Overall Study||697
411116|NCT00070564|1007535|P2|STARTED|Overall Study||693
411117|NCT00070564|1007536|P1|STARTED|Overall Study||678
411118|NCT00070499|1007590|P4|NOT COMPLETED|Overall Study||110
411119|NCT00070499|1007591|P3|NOT COMPLETED|Overall Study||120
411120|NCT00070499|1007592|P2|NOT COMPLETED|Overall Study||26
411121|NCT00070499|1007593|P1|NOT COMPLETED|Overall Study||38
411122|NCT00070499|1007590|P4|COMPLETED|Overall Study||17
411123|NCT00070499|1007591|P3|COMPLETED|Overall Study||6
411124|NCT00070499|1007592|P2|COMPLETED|Overall Study||52
411125|NCT00070499|1007593|P1|COMPLETED|Overall Study||37
411126|NCT00070499|1007590|P4|Eligible and Treated|Overall Study||123
411127|NCT00070499|1007591|P3|Eligible and Treated|Overall Study||123
411128|NCT00070499|1007592|P2|Eligible and Treated|Overall Study||73
411129|NCT00070499|1007593|P1|Eligible and Treated|Overall Study||72
411130|NCT00070499|1007590|P4|Eligible|Overall Study||125
411131|NCT00070499|1007591|P3|Eligible|Overall Study||123
411132|NCT00070499|1007592|P2|Eligible|Overall Study||73
411133|NCT00070499|1007593|P1|Eligible|Overall Study||73
411134|NCT00070499|1007590|P4|STARTED|Overall Study||127
411135|NCT00070499|1007591|P3|STARTED|Overall Study||126
411136|NCT00070499|1007592|P2|STARTED|Overall Study||78
411137|NCT00070499|1007593|P1|STARTED|Overall Study||75
411138|NCT00070317|1007619|P1|NOT COMPLETED|Overall Study||13
411139|NCT00070317|1007619|P1|COMPLETED|Overall Study||89
411140|NCT00070317|1007619|P1|STARTED|Overall Study||102
411141|NCT00070291|1007624|P1|NOT COMPLETED|Step 2||1
411142|NCT00070291|1007624|P1|COMPLETED|Step 2||0
411143|NCT00070291|1007624|P1|STARTED|Step 2|One patient completed step 1, but opted to get alternative therapy. One patient entered step 2.|1
411144|NCT00070291|1007624|P1|NOT COMPLETED|Step 1||2
411145|NCT00070291|1007624|P1|COMPLETED|Step 1||2
411146|NCT00070291|1007624|P1|Treated|Step 1||3
411147|NCT00070291|1007624|P1|STARTED|Step 1||4
411148|NCT00070135|1007629|P1|NOT COMPLETED|Overall Study||0
411149|NCT00070135|1007629|P1|COMPLETED|Overall Study||114
411150|NCT00070135|1007629|P1|STARTED|Overall Study||114
411151|NCT00070109|1007640|P5|NOT COMPLETED|Overall Study||8
411152|NCT00070109|1007641|P4|NOT COMPLETED|Overall Study||20
411153|NCT00070109|1007642|P3|NOT COMPLETED|Overall Study||8
411154|NCT00070109|1007643|P2|NOT COMPLETED|Overall Study||6
411155|NCT00070109|1007644|P1|NOT COMPLETED|Overall Study||8
411156|NCT00070109|1007640|P5|COMPLETED|Overall Study||0
411157|NCT00070109|1007641|P4|COMPLETED|Overall Study||0
411158|NCT00070109|1007642|P3|COMPLETED|Overall Study||0
411159|NCT00070109|1007643|P2|COMPLETED|Overall Study||0
411160|NCT00070109|1007644|P1|COMPLETED|Overall Study||0
411161|NCT00070109|1007640|P5|STARTED|Overall Study||8
411162|NCT00070109|1007641|P4|STARTED|Overall Study||20
411163|NCT00070109|1007642|P3|STARTED|Overall Study||8
411164|NCT00070109|1007643|P2|STARTED|Overall Study||6
411165|NCT00070109|1007644|P1|STARTED|Overall Study||8
411166|NCT00070018|1007672|P1|NOT COMPLETED|Overall Study||4
411167|NCT00070018|1007672|P1|COMPLETED|Overall Study||42
411168|NCT00070018|1007672|P1|Eligible and Began Protocol Therapy|Overall Study||46
411169|NCT00070018|1007672|P1|Eligible|Overall Study||46
411170|NCT00070018|1007672|P1|STARTED|Overall Study||46
411171|NCT00069953|1007676|P1|NOT COMPLETED|Overall Study||2
411172|NCT00069953|1007676|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study|41
411173|NCT00069953|1007676|P1|STARTED|Overall Study||43
411174|NCT00069784|1007682|P2|NOT COMPLETED|Overall Study||0
411175|NCT00069784|1007683|P1|NOT COMPLETED|Overall Study||1212
411176|NCT00069784|1007682|P2|COMPLETED|Overall Study|not applicable (no treatment)|6273
411177|NCT00069784|1007683|P1|COMPLETED|Overall Study|completed study treatment|5052
411178|NCT00069784|1007682|P2|Safety Population (Treated)|Overall Study|patients randomized to standard care arm|6273
411179|NCT00069784|1007683|P1|Safety Population (Treated)|Overall Study|randomized patients who received at least one dose of insulin glargine|6231
411180|NCT00069784|1007682|P2|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6273
411181|NCT00069784|1007683|P1|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6264
411182|NCT00069823|1007703|P2|NOT COMPLETED|Overall Study||3
411183|NCT00069823|1007704|P1|NOT COMPLETED|Overall Study||6
411184|NCT00069823|1007703|P2|COMPLETED|Overall Study||200
411185|NCT00069823|1007704|P1|COMPLETED|Overall Study||193
411186|NCT00069823|1007703|P2|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|203
411187|NCT00069823|1007704|P1|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|199
411188|NCT00069641|1007747|P3|NOT COMPLETED|Overall Study||1
411189|NCT00069641|1007748|P2|NOT COMPLETED|Overall Study||0
411190|NCT00069641|1007749|P1|NOT COMPLETED|Overall Study||1
411191|NCT00069641|1007747|P3|COMPLETED|Overall Study||31
411192|NCT00069641|1007748|P2|COMPLETED|Overall Study||32
411193|NCT00069641|1007749|P1|COMPLETED|Overall Study||31
411194|NCT00069641|1007747|P3|STARTED|Overall Study||32
411195|NCT00069641|1007748|P2|STARTED|Overall Study||32
411196|NCT00069641|1007749|P1|STARTED|Overall Study||32
411197|NCT00069576|1007776|P2|NOT COMPLETED|Follow-up Study at 5-10 Years||204
411198|NCT00069576|1007777|P1|NOT COMPLETED|Follow-up Study at 5-10 Years||196
411199|NCT00069576|1007776|P2|COMPLETED|Follow-up Study at 5-10 Years||236
411200|NCT00069576|1007777|P1|COMPLETED|Follow-up Study at 5-10 Years||264
411201|NCT00069576|1007776|P2|STARTED|Follow-up Study at 5-10 Years||440
411202|NCT00069576|1007777|P1|STARTED|Follow-up Study at 5-10 Years||460
411203|NCT00069576|1007776|P2|NOT COMPLETED|Original Trial||33
411204|NCT00069576|1007777|P1|NOT COMPLETED|Original Trial||25
411205|NCT00069576|1007776|P2|COMPLETED|Original Trial||440
411206|NCT00069576|1007777|P1|COMPLETED|Original Trial||460
411207|NCT00069576|1007776|P2|STARTED|Original Trial||473
411208|NCT00069576|1007777|P1|STARTED|Original Trial||485
411209|NCT00069277|1007827|P1|NOT COMPLETED|Overall Study||21
411210|NCT00069277|1007827|P1|COMPLETED|Overall Study||0
411211|NCT00069277|1007827|P1|STARTED|Overall Study||21
411212|NCT00069264|1007831|P1|NOT COMPLETED|Overall Study||32
411213|NCT00069264|1007831|P1|COMPLETED|Overall Study||0
411214|NCT00069264|1007831|P1|STARTED|Overall Study||32
411215|NCT00069329|1007835|P1|NOT COMPLETED|Overall Study||2
411216|NCT00069329|1007835|P1|COMPLETED|Overall Study||41
411217|NCT00069329|1007835|P1|STARTED|Overall Study||43
411218|NCT00069238|1007859|P3|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||2
411219|NCT00069238|1007860|P2|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
411220|NCT00069238|1007861|P1|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
411221|NCT00069238|1007859|P3|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||1
411222|NCT00069238|1007860|P2|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
411223|NCT00069238|1007861|P1|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
411224|NCT00069238|1007859|P3|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||3
411225|NCT00069238|1007860|P2|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
411226|NCT00069238|1007861|P1|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
411227|NCT00069238|1007859|P3|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
411228|NCT00069238|1007860|P2|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||2
411229|NCT00069238|1007861|P1|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
411230|NCT00069238|1007859|P3|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
411231|NCT00069238|1007860|P2|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||1
411232|NCT00069238|1007861|P1|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
411233|NCT00069238|1007859|P3|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
411234|NCT00069238|1007860|P2|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||3
411235|NCT00069238|1007861|P1|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
411236|NCT00069238|1007859|P3|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
411237|NCT00069238|1007860|P2|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
411238|NCT00069238|1007861|P1|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||9
411239|NCT00069238|1007859|P3|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
411240|NCT00069238|1007860|P2|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
411241|NCT00069238|1007861|P1|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||16
411242|NCT00069238|1007859|P3|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
411243|NCT00069238|1007860|P2|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
411244|NCT00069238|1007861|P1|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||25
411245|NCT00069121|1007869|P2|NOT COMPLETED|Overall Study||276
411246|NCT00069121|1007870|P1|NOT COMPLETED|Overall Study||302
411247|NCT00069121|1007869|P2|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|668
411248|NCT00069121|1007870|P1|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|640
411249|NCT00069121|1007869|P2|Received Treatment|Overall Study|Safety Population|938
411250|NCT00069121|1007870|P1|Received Treatment|Overall Study|Safety Population|926
411251|NCT00069121|1007869|P2|STARTED|Overall Study||944
411252|NCT00069121|1007870|P1|STARTED|Overall Study||942
411253|NCT00069108|1007892|P2|NOT COMPLETED|Overall Study||219
411254|NCT00069108|1007893|P1|NOT COMPLETED|Overall Study||213
411255|NCT00069108|1007892|P2|COMPLETED|Overall Study||95
411256|NCT00069108|1007893|P1|COMPLETED|Overall Study||100
411257|NCT00069108|1007892|P2|STARTED|Overall Study||314
411258|NCT00069108|1007893|P1|STARTED|Overall Study||313
411259|NCT00069095|1007925|P6|NOT COMPLETED|Follow-up Phase||101
411260|NCT00069095|1007926|P5|NOT COMPLETED|Follow-up Phase||92
411261|NCT00069095|1007927|P4|NOT COMPLETED|Follow-up Phase||112
411262|NCT00069095|1007928|P3|NOT COMPLETED|Follow-up Phase||120
411263|NCT00069095|1007929|P2|NOT COMPLETED|Follow-up Phase||206
411264|NCT00069095|1007930|P1|NOT COMPLETED|Follow-up Phase||174
411265|NCT00069095|1007925|P6|COMPLETED|Follow-up Phase||171
411266|NCT00069095|1007926|P5|COMPLETED|Follow-up Phase||186
411267|NCT00069095|1007927|P4|COMPLETED|Follow-up Phase||187
411268|NCT00069095|1007928|P3|COMPLETED|Follow-up Phase||178
411269|NCT00069095|1007929|P2|COMPLETED|Follow-up Phase||93
411270|NCT00069095|1007930|P1|COMPLETED|Follow-up Phase||110
411271|NCT00069095|1007925|P6|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|272
411272|NCT00069095|1007926|P5|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|278
411273|NCT00069095|1007927|P4|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
411274|NCT00069095|1007928|P3|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|298
411275|NCT00069095|1007929|P2|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
411276|NCT00069095|1007930|P1|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|284
411277|NCT00069095|1007925|P6|NOT COMPLETED|Post-study Treatment Phase||29
411278|NCT00069095|1007926|P5|NOT COMPLETED|Post-study Treatment Phase||36
411279|NCT00069095|1007927|P4|NOT COMPLETED|Post-study Treatment Phase||17
411280|NCT00069095|1007928|P3|NOT COMPLETED|Post-study Treatment Phase||21
411281|NCT00069095|1007929|P2|NOT COMPLETED|Post-study Treatment Phase||13
411282|NCT00069095|1007930|P1|NOT COMPLETED|Post-study Treatment Phase||8
411283|NCT00069095|1007925|P6|COMPLETED|Post-study Treatment Phase||0
411284|NCT00069095|1007926|P5|COMPLETED|Post-study Treatment Phase||0
411285|NCT00069095|1007927|P4|COMPLETED|Post-study Treatment Phase||0
411286|NCT00069095|1007928|P3|COMPLETED|Post-study Treatment Phase||0
411287|NCT00069095|1007929|P2|COMPLETED|Post-study Treatment Phase||0
411288|NCT00069095|1007930|P1|COMPLETED|Post-study Treatment Phase||0
411289|NCT00069095|1007925|P6|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|29
411290|NCT00069095|1007926|P5|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|36
411291|NCT00069095|1007927|P4|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|17
411292|NCT00069095|1007928|P3|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|21
411293|NCT00069095|1007929|P2|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|13
411294|NCT00069095|1007930|P1|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|8
411295|NCT00069095|1007925|P6|NOT COMPLETED|Primary Treatment Phase||301
411296|NCT00069095|1007926|P5|NOT COMPLETED|Primary Treatment Phase||302
411297|NCT00069095|1007927|P4|NOT COMPLETED|Primary Treatment Phase||320
411298|NCT00069095|1007928|P3|NOT COMPLETED|Primary Treatment Phase||314
411299|NCT00069095|1007929|P2|NOT COMPLETED|Primary Treatment Phase||302
411300|NCT00069095|1007930|P1|NOT COMPLETED|Primary Treatment Phase||295
411301|NCT00069095|1007925|P6|COMPLETED|Primary Treatment Phase||48
411302|NCT00069095|1007926|P5|COMPLETED|Primary Treatment Phase||48
411303|NCT00069095|1007927|P4|COMPLETED|Primary Treatment Phase||31
411304|NCT00069095|1007928|P3|COMPLETED|Primary Treatment Phase||36
411305|NCT00069095|1007929|P2|COMPLETED|Primary Treatment Phase||15
411306|NCT00069095|1007930|P1|COMPLETED|Primary Treatment Phase||22
411307|NCT00069095|1007925|P6|STARTED|Primary Treatment Phase||349
411308|NCT00069095|1007926|P5|STARTED|Primary Treatment Phase||350
411309|NCT00069095|1007927|P4|STARTED|Primary Treatment Phase||351
411310|NCT00069095|1007928|P3|STARTED|Primary Treatment Phase||350
411311|NCT00069095|1007929|P2|STARTED|Primary Treatment Phase||317
411312|NCT00069095|1007930|P1|STARTED|Primary Treatment Phase||317
411313|NCT00069160|1007984|P2|NOT COMPLETED|Overall Study||0
411314|NCT00069160|1007985|P1|NOT COMPLETED|Overall Study||0
411315|NCT00069160|1007984|P2|COMPLETED|Overall Study||25
411316|NCT00069160|1007985|P1|COMPLETED|Overall Study||23
411317|NCT00069160|1007984|P2|STARTED|Overall Study||25
411318|NCT00069160|1007985|P1|STARTED|Overall Study||23
411319|NCT00068822|1008000|P2|NOT COMPLETED|Optional Crossover Intervention||0
411320|NCT00068822|1008001|P1|NOT COMPLETED|Optional Crossover Intervention||0
411321|NCT00068822|1008000|P2|COMPLETED|Optional Crossover Intervention||29
411322|NCT00068822|1008001|P1|COMPLETED|Optional Crossover Intervention||9
411323|NCT00068822|1008000|P2|Crossover at Month 3|Optional Crossover Intervention||27
411324|NCT00068822|1008001|P1|Crossover at Month 3|Optional Crossover Intervention||8
411325|NCT00068822|1008000|P2|Crossover at Month 1|Optional Crossover Intervention||2
411326|NCT00068822|1008001|P1|Crossover at Month 1|Optional Crossover Intervention||1
411327|NCT00068822|1008000|P2|STARTED|Optional Crossover Intervention||29
411328|NCT00068822|1008001|P1|STARTED|Optional Crossover Intervention||9
411329|NCT00068822|1008000|P2|NOT COMPLETED|First Randomized Intervention||2
411330|NCT00068822|1008001|P1|NOT COMPLETED|First Randomized Intervention||1
411331|NCT00068822|1008000|P2|COMPLETED|First Randomized Intervention||61
411332|NCT00068822|1008001|P1|COMPLETED|First Randomized Intervention||67
411333|NCT00068822|1008000|P2|STARTED|First Randomized Intervention||63
411334|NCT00068822|1008001|P1|STARTED|First Randomized Intervention||68
411335|NCT00068770|1008013|P2|NOT COMPLETED|Overall Study||0
411336|NCT00068770|1008014|P1|NOT COMPLETED|Overall Study||0
411337|NCT00068770|1008013|P2|COMPLETED|Overall Study||22
411338|NCT00068770|1008014|P1|COMPLETED|Overall Study||13
411339|NCT00068770|1008013|P2|STARTED|Overall Study||22
411340|NCT00068770|1008014|P1|STARTED|Overall Study||13
411341|NCT00068718|1008022|P1|NOT COMPLETED|Overall Study||0
411342|NCT00068718|1008022|P1|COMPLETED|Overall Study||35
411343|NCT00068718|1008022|P1|STARTED|Overall Study||35
411344|NCT00068692|1008035|P8|NOT COMPLETED|Step 2: Randomization||8
411345|NCT00068692|1008036|P7|NOT COMPLETED|Step 2: Randomization||4
411346|NCT00068692|1008037|P6|NOT COMPLETED|Step 2: Randomization||6
411347|NCT00068692|1008038|P5|NOT COMPLETED|Step 2: Randomization||9
411348|NCT00068692|1008039|P4|NOT COMPLETED|Step 2: Randomization||12
411349|NCT00068692|1008040|P3|NOT COMPLETED|Step 2: Randomization||10
411350|NCT00068692|1008041|P2|NOT COMPLETED|Step 2: Randomization||0
411351|NCT00068692|1008042|P1|NOT COMPLETED|Step 2: Randomization||0
411352|NCT00068692|1008035|P8|COMPLETED|Step 2: Randomization||24
411353|NCT00068692|1008036|P7|COMPLETED|Step 2: Randomization||29
411354|NCT00068692|1008037|P6|COMPLETED|Step 2: Randomization||25
411355|NCT00068692|1008038|P5|COMPLETED|Step 2: Randomization||21
411356|NCT00068692|1008039|P4|COMPLETED|Step 2: Randomization||13
411357|NCT00068692|1008040|P3|COMPLETED|Step 2: Randomization||18
411358|NCT00068692|1008041|P2|COMPLETED|Step 2: Randomization||0
411359|NCT00068692|1008042|P1|COMPLETED|Step 2: Randomization||0
411360|NCT00068692|1008035|P8|Reported AE Data|Step 2: Randomization||32
411361|NCT00068692|1008036|P7|Reported AE Data|Step 2: Randomization||33
411362|NCT00068692|1008037|P6|Reported AE Data|Step 2: Randomization||31
411363|NCT00068692|1008038|P5|Reported AE Data|Step 2: Randomization||28
411364|NCT00068692|1008039|P4|Reported AE Data|Step 2: Randomization||22
411365|NCT00068692|1008040|P3|Reported AE Data|Step 2: Randomization||27
411366|NCT00068692|1008041|P2|Reported AE Data|Step 2: Randomization||0
411367|NCT00068692|1008042|P1|Reported AE Data|Step 2: Randomization||0
411368|NCT00068692|1008035|P8|Had Sphincter Preservation|Step 2: Randomization||30
411369|NCT00068692|1008036|P7|Had Sphincter Preservation|Step 2: Randomization||33
411370|NCT00068692|1008037|P6|Had Sphincter Preservation|Step 2: Randomization||31
411371|NCT00068692|1008038|P5|Had Sphincter Preservation|Step 2: Randomization||28
411372|NCT00068692|1008039|P4|Had Sphincter Preservation|Step 2: Randomization||25
411373|NCT00068692|1008040|P3|Had Sphincter Preservation|Step 2: Randomization||28
411374|NCT00068692|1008041|P2|Had Sphincter Preservation|Step 2: Randomization||0
411375|NCT00068692|1008042|P1|Had Sphincter Preservation|Step 2: Randomization||0
411376|NCT00068692|1008035|P8|Treated|Step 2: Randomization||32
411377|NCT00068692|1008036|P7|Treated|Step 2: Randomization||33
411378|NCT00068692|1008037|P6|Treated|Step 2: Randomization||31
411379|NCT00068692|1008038|P5|Treated|Step 2: Randomization||29
411380|NCT00068692|1008039|P4|Treated|Step 2: Randomization||25
411381|NCT00068692|1008040|P3|Treated|Step 2: Randomization||27
411382|NCT00068692|1008041|P2|Treated|Step 2: Randomization||0
411383|NCT00068692|1008042|P1|Treated|Step 2: Randomization||0
411384|NCT00068692|1008035|P8|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|32
411385|NCT00068692|1008036|P7|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|33
411386|NCT00068692|1008037|P6|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|31
411387|NCT00068692|1008038|P5|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|30
411388|NCT00068692|1008039|P4|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|25
411389|NCT00068692|1008040|P3|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|28
411390|NCT00068692|1008041|P2|STARTED|Step 2: Randomization|Group II patients were registered and randomized at the same time, reported as arms I,II,III here.|0
411391|NCT00068692|1008042|P1|STARTED|Step 2: Randomization|Patients on arm S completing step 1 treatment were randomized to step 2 (Arms I-III).|0
411392|NCT00068692|1008035|P8|NOT COMPLETED|Step 1: Registration||0
411393|NCT00068692|1008036|P7|NOT COMPLETED|Step 1: Registration||0
411394|NCT00068692|1008037|P6|NOT COMPLETED|Step 1: Registration||0
411395|NCT00068692|1008038|P5|NOT COMPLETED|Step 1: Registration||0
411396|NCT00068692|1008039|P4|NOT COMPLETED|Step 1: Registration||0
411397|NCT00068692|1008040|P3|NOT COMPLETED|Step 1: Registration||0
411398|NCT00068692|1008041|P2|NOT COMPLETED|Step 1: Registration||1
411399|NCT00068692|1008042|P1|NOT COMPLETED|Step 1: Registration||40
411400|NCT00068692|1008035|P8|COMPLETED|Step 1: Registration||0
411401|NCT00068692|1008036|P7|COMPLETED|Step 1: Registration||0
411402|NCT00068692|1008037|P6|COMPLETED|Step 1: Registration||0
411403|NCT00068692|1008038|P5|COMPLETED|Step 1: Registration||0
411404|NCT00068692|1008039|P4|COMPLETED|Step 1: Registration||0
411405|NCT00068692|1008040|P3|COMPLETED|Step 1: Registration||0
411406|NCT00068692|1008041|P2|COMPLETED|Step 1: Registration|Case 32191 entered the study as Group II patient but was never randomized.|96
411407|NCT00068692|1008042|P1|COMPLETED|Step 1: Registration||88
411408|NCT00068692|1008035|P8|Reported AE Data|Step 1: Registration||0
411409|NCT00068692|1008036|P7|Reported AE Data|Step 1: Registration||0
411410|NCT00068692|1008037|P6|Reported AE Data|Step 1: Registration||0
411411|NCT00068692|1008038|P5|Reported AE Data|Step 1: Registration||0
411412|NCT00068692|1008039|P4|Reported AE Data|Step 1: Registration||0
411413|NCT00068692|1008040|P3|Reported AE Data|Step 1: Registration||0
411414|NCT00068692|1008041|P2|Reported AE Data|Step 1: Registration||0
411415|NCT00068692|1008042|P1|Reported AE Data|Step 1: Registration||123
411416|NCT00068692|1008035|P8|Started Concurrent Chemo/Radiation|Step 1: Registration||0
411417|NCT00068692|1008036|P7|Started Concurrent Chemo/Radiation|Step 1: Registration||0
411418|NCT00068692|1008037|P6|Started Concurrent Chemo/Radiation|Step 1: Registration||0
411419|NCT00068692|1008038|P5|Started Concurrent Chemo/Radiation|Step 1: Registration||0
411420|NCT00068692|1008039|P4|Started Concurrent Chemo/Radiation|Step 1: Registration||0
411421|NCT00068692|1008040|P3|Started Concurrent Chemo/Radiation|Step 1: Registration||0
411422|NCT00068692|1008041|P2|Started Concurrent Chemo/Radiation|Step 1: Registration|Group II patients receive protocol therapy in Step 2 after randomization|0
411423|NCT00068692|1008042|P1|Started Concurrent Chemo/Radiation|Step 1: Registration||125
411424|NCT00068692|1008035|P8|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
411425|NCT00068692|1008036|P7|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
411426|NCT00068692|1008037|P6|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
411427|NCT00068692|1008038|P5|STARTED|Step 1: Registration||0
411428|NCT00068692|1008039|P4|STARTED|Step 1: Registration||0
411429|NCT00068692|1008040|P3|STARTED|Step 1: Registration||0
411430|NCT00068692|1008041|P2|STARTED|Step 1: Registration|Group II patients were registered and randomized at the same time, and were reported in Step 2.|97
411431|NCT00068692|1008042|P1|STARTED|Step 1: Registration||128
411432|NCT00068601|1008065|P2|NOT COMPLETED|Overall Study||60
411433|NCT00068601|1008066|P1|NOT COMPLETED|Overall Study||62
411434|NCT00068601|1008065|P2|COMPLETED|Overall Study||66
411435|NCT00068601|1008066|P1|COMPLETED|Overall Study||69
411436|NCT00068601|1008065|P2|STARTED|Overall Study||126
411437|NCT00068601|1008066|P1|STARTED|Overall Study||131
411438|NCT00068588|1008079|P3|NOT COMPLETED|Overall Study||4
411439|NCT00068588|1008080|P2|NOT COMPLETED|Overall Study||0
411440|NCT00068588|1008081|P1|NOT COMPLETED|Overall Study||0
411441|NCT00068588|1008079|P3|COMPLETED|Overall Study||17
411442|NCT00068588|1008080|P2|COMPLETED|Overall Study||3
411443|NCT00068588|1008081|P1|COMPLETED|Overall Study||0
411444|NCT00068588|1008079|P3|STARTED|Overall Study||21
411445|NCT00068588|1008080|P2|STARTED|Overall Study||3
411446|NCT00068588|1008081|P1|STARTED|Overall Study||0
411447|NCT00068575|1008091|P1|NOT COMPLETED|Overall Study||0
411448|NCT00068575|1008091|P1|COMPLETED|Overall Study||28
411449|NCT00068575|1008091|P1|STARTED|Overall Study||28
411450|NCT00068445|1008097|P2|NOT COMPLETED|Treatment||16
411451|NCT00068445|1008098|P1|NOT COMPLETED|Treatment||29
411452|NCT00068445|1008097|P2|COMPLETED|Treatment||46
411453|NCT00068445|1008098|P1|COMPLETED|Treatment||34
411454|NCT00068445|1008097|P2|STARTED|Treatment||62
411455|NCT00068445|1008098|P1|STARTED|Treatment||63
411456|NCT00068445|1008097|P2|NOT COMPLETED|Randomization||4
411457|NCT00068445|1008098|P1|NOT COMPLETED|Randomization||2
411458|NCT00068445|1008097|P2|COMPLETED|Randomization||62
411459|NCT00068445|1008098|P1|COMPLETED|Randomization||63
411460|NCT00068445|1008097|P2|STARTED|Randomization||66
411461|NCT00068445|1008098|P1|STARTED|Randomization||65
411462|NCT00068419|1008122|P1|NOT COMPLETED|Overall Study||60
411463|NCT00068419|1008122|P1|COMPLETED|Overall Study|Participant flow data reported here are for the period of protocol therapy.|10
411464|NCT00068419|1008122|P1|STARTED|Overall Study||70
411465|NCT00068406|1008126|P1|NOT COMPLETED|Overall Study||3
411466|NCT00068406|1008126|P1|COMPLETED|Overall Study||58
411467|NCT00068406|1008126|P1|STARTED|Overall Study||61
411468|NCT00068393|1008131|P1|NOT COMPLETED|Overall Study||10
411469|NCT00068393|1008131|P1|COMPLETED|Overall Study||29
411470|NCT00068393|1008131|P1|Eligible and Treated|Overall Study||38
411471|NCT00068393|1008131|P1|STARTED|Overall Study||39
411472|NCT00068380|1008137|P1|NOT COMPLETED|Overall Study||5
411473|NCT00068380|1008137|P1|COMPLETED|Overall Study||12
411474|NCT00068380|1008137|P1|STARTED|Overall Study||17
411475|NCT00068367|1008146|P1|NOT COMPLETED|Overall Study||0
411476|NCT00068367|1008146|P1|COMPLETED|Overall Study||20
411477|NCT00068367|1008146|P1|STARTED|Overall Study||20
411478|NCT00068341|1008155|P3|NOT COMPLETED|Overall Study||0
411479|NCT00068341|1008156|P2|NOT COMPLETED|Overall Study||0
411480|NCT00068341|1008157|P1|NOT COMPLETED|Overall Study||0
411481|NCT00068341|1008155|P3|COMPLETED|Overall Study||44
411482|NCT00068341|1008156|P2|COMPLETED|Overall Study||15
411483|NCT00068341|1008157|P1|COMPLETED|Overall Study||15
411484|NCT00068341|1008155|P3|STARTED|Overall Study||44
411485|NCT00068341|1008156|P2|STARTED|Overall Study||15
411486|NCT00068341|1008157|P1|STARTED|Overall Study||15
411487|NCT00068250|1008181|P4|NOT COMPLETED|Phase II: Dose Level 2||0
411488|NCT00068250|1008182|P3|NOT COMPLETED|Phase II: Dose Level 2||0
411489|NCT00068250|1008183|P2|NOT COMPLETED|Phase II: Dose Level 2||0
411490|NCT00068250|1008184|P1|NOT COMPLETED|Phase II: Dose Level 2||0
411491|NCT00068250|1008181|P4|COMPLETED|Phase II: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|47
411492|NCT00068250|1008182|P3|COMPLETED|Phase II: Dose Level 2||0
411493|NCT00068250|1008183|P2|COMPLETED|Phase II: Dose Level 2||0
411494|NCT00068250|1008184|P1|COMPLETED|Phase II: Dose Level 2||0
411495|NCT00068250|1008181|P4|STARTED|Phase II: Dose Level 2||47
411496|NCT00068250|1008182|P3|STARTED|Phase II: Dose Level 2||0
411497|NCT00068250|1008183|P2|STARTED|Phase II: Dose Level 2||0
411498|NCT00068250|1008184|P1|STARTED|Phase II: Dose Level 2||0
411499|NCT00068250|1008181|P4|NOT COMPLETED|Phase I: Dose Level 2||0
411500|NCT00068250|1008182|P3|NOT COMPLETED|Phase I: Dose Level 2||0
411501|NCT00068250|1008183|P2|NOT COMPLETED|Phase I: Dose Level 2||1
411502|NCT00068250|1008184|P1|NOT COMPLETED|Phase I: Dose Level 2||0
411503|NCT00068250|1008181|P4|COMPLETED|Phase I: Dose Level 2||0
411504|NCT00068250|1008182|P3|COMPLETED|Phase I: Dose Level 2||0
411505|NCT00068250|1008183|P2|COMPLETED|Phase I: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|6
411506|NCT00068250|1008184|P1|COMPLETED|Phase I: Dose Level 2||0
411507|NCT00068250|1008181|P4|STARTED|Phase I: Dose Level 2||0
411508|NCT00068250|1008182|P3|STARTED|Phase I: Dose Level 2||0
411509|NCT00068250|1008183|P2|STARTED|Phase I: Dose Level 2||7
411510|NCT00068250|1008184|P1|STARTED|Phase I: Dose Level 2||0
411511|NCT00068250|1008181|P4|NOT COMPLETED|Phase I: Dose Level 1||0
411512|NCT00068250|1008182|P3|NOT COMPLETED|Phase I: Dose Level 1||0
411513|NCT00068250|1008183|P2|NOT COMPLETED|Phase I: Dose Level 1||0
411514|NCT00068250|1008184|P1|NOT COMPLETED|Phase I: Dose Level 1||0
411515|NCT00068250|1008181|P4|COMPLETED|Phase I: Dose Level 1||0
411516|NCT00068250|1008182|P3|COMPLETED|Phase I: Dose Level 1||0
411517|NCT00068250|1008183|P2|COMPLETED|Phase I: Dose Level 1||0
411518|NCT00068250|1008184|P1|COMPLETED|Phase I: Dose Level 1|Subjects with data available for the primary analysis are considered to have completed the study.|6
411519|NCT00068250|1008181|P4|STARTED|Phase I: Dose Level 1||0
411520|NCT00068250|1008182|P3|STARTED|Phase I: Dose Level 1||0
411521|NCT00068250|1008183|P2|STARTED|Phase I: Dose Level 1||0
411522|NCT00068250|1008184|P1|STARTED|Phase I: Dose Level 1||6
411523|NCT00068237|1008194|P1|NOT COMPLETED|Overall Study||5
411524|NCT00068237|1008194|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
411525|NCT00068237|1008194|P1|STARTED|Overall Study||49
411526|NCT00068107|1008206|P1|NOT COMPLETED|Overall Study||9
411527|NCT00068107|1008206|P1|COMPLETED|Overall Study||3
411528|NCT00068107|1008206|P1|STARTED|Overall Study||12
411529|NCT00067990|1008219|P2|NOT COMPLETED|Overall Study||22
411530|NCT00067990|1008220|P1|NOT COMPLETED|Overall Study||10
411531|NCT00067990|1008219|P2|COMPLETED|Overall Study||54
411532|NCT00067990|1008220|P1|COMPLETED|Overall Study||67
411533|NCT00067990|1008219|P2|STARTED|Overall Study||76
411534|NCT00067990|1008220|P1|STARTED|Overall Study||77
411535|NCT00067808|1008231|P3|NOT COMPLETED|Overall Study||0
411536|NCT00067808|1008232|P2|NOT COMPLETED|Overall Study||0
411537|NCT00067808|1008233|P1|NOT COMPLETED|Overall Study||0
411538|NCT00067808|1008231|P3|COMPLETED|Overall Study||14
411539|NCT00067808|1008232|P2|COMPLETED|Overall Study||93
411540|NCT00067808|1008233|P1|COMPLETED|Overall Study||17
411541|NCT00067808|1008231|P3|STARTED|Overall Study||14
411542|NCT00067808|1008232|P2|STARTED|Overall Study||93
411543|NCT00067808|1008233|P1|STARTED|Overall Study||17
411544|NCT00067470|1008243|P2|NOT COMPLETED|Overall Study||1
411545|NCT00067470|1008244|P1|NOT COMPLETED|Overall Study||0
411546|NCT00067470|1008243|P2|COMPLETED|Overall Study||19
411547|NCT00067470|1008244|P1|COMPLETED|Overall Study||19
411548|NCT00067470|1008243|P2|STARTED|Overall Study||20
411549|NCT00067470|1008244|P1|STARTED|Overall Study||19
411550|NCT00067236|1008256|P2|NOT COMPLETED|Overall Study||26
411551|NCT00067236|1008257|P1|NOT COMPLETED|Overall Study||20
411552|NCT00067236|1008256|P2|COMPLETED|Overall Study||99
411553|NCT00067236|1008257|P1|COMPLETED|Overall Study||108
411554|NCT00067236|1008256|P2|STARTED|Overall Study||125
411555|NCT00067236|1008257|P1|STARTED|Overall Study||128
411556|NCT00067002|1008265|P2|NOT COMPLETED|Overall Study||9
411557|NCT00067002|1008266|P1|NOT COMPLETED|Overall Study||7
411558|NCT00067002|1008265|P2|COMPLETED|Overall Study||44
411559|NCT00067002|1008266|P1|COMPLETED|Overall Study||45
411560|NCT00067002|1008265|P2|STARTED|Overall Study||53
411561|NCT00067002|1008266|P1|STARTED|Overall Study||52
411562|NCT00066963|1008283|P3|NOT COMPLETED|Overall Study||39
411563|NCT00066963|1008284|P2|NOT COMPLETED|Overall Study||31
411564|NCT00066963|1008285|P1|NOT COMPLETED|Overall Study||26
411565|NCT00066963|1008283|P3|COMPLETED|Overall Study||87
411566|NCT00066963|1008284|P2|COMPLETED|Overall Study||93
411567|NCT00066963|1008285|P1|COMPLETED|Overall Study|any follow-up|100
411568|NCT00066963|1008283|P3|STARTED|Overall Study||126
411569|NCT00066963|1008284|P2|STARTED|Overall Study||124
411570|NCT00066963|1008285|P1|STARTED|Overall Study||126
411571|NCT00066937|1008297|P4|NOT COMPLETED|6 Month Follow-up||1
411572|NCT00066937|1008298|P3|NOT COMPLETED|6 Month Follow-up||3
411573|NCT00066937|1008299|P2|NOT COMPLETED|6 Month Follow-up||3
411574|NCT00066937|1008300|P1|NOT COMPLETED|6 Month Follow-up||7
411575|NCT00066937|1008297|P4|COMPLETED|6 Month Follow-up||14
411576|NCT00066937|1008298|P3|COMPLETED|6 Month Follow-up||22
411577|NCT00066937|1008299|P2|COMPLETED|6 Month Follow-up||29
411578|NCT00066937|1008300|P1|COMPLETED|6 Month Follow-up||26
411579|NCT00066937|1008297|P4|STARTED|6 Month Follow-up||15
411580|NCT00066937|1008298|P3|STARTED|6 Month Follow-up||25
411581|NCT00066937|1008299|P2|STARTED|6 Month Follow-up||32
411582|NCT00066937|1008300|P1|STARTED|6 Month Follow-up||33
411583|NCT00066937|1008297|P4|NOT COMPLETED|3 Month Follow-up||4
411584|NCT00066937|1008298|P3|NOT COMPLETED|3 Month Follow-up||1
411585|NCT00066937|1008299|P2|NOT COMPLETED|3 Month Follow-up||1
411586|NCT00066937|1008300|P1|NOT COMPLETED|3 Month Follow-up||5
411587|NCT00066937|1008297|P4|COMPLETED|3 Month Follow-up||15
411588|NCT00066937|1008298|P3|COMPLETED|3 Month Follow-up||25
411589|NCT00066937|1008299|P2|COMPLETED|3 Month Follow-up||32
411590|NCT00066937|1008300|P1|COMPLETED|3 Month Follow-up||33
411591|NCT00066937|1008297|P4|STARTED|3 Month Follow-up||19
411592|NCT00066937|1008298|P3|STARTED|3 Month Follow-up||26
411593|NCT00066937|1008299|P2|STARTED|3 Month Follow-up||33
411594|NCT00066937|1008300|P1|STARTED|3 Month Follow-up||38
411595|NCT00066937|1008297|P4|NOT COMPLETED|Treatment Phase||5
411596|NCT00066937|1008298|P3|NOT COMPLETED|Treatment Phase||11
411597|NCT00066937|1008299|P2|NOT COMPLETED|Treatment Phase||5
411598|NCT00066937|1008300|P1|NOT COMPLETED|Treatment Phase||3
411599|NCT00066937|1008297|P4|COMPLETED|Treatment Phase||19
411600|NCT00066937|1008298|P3|COMPLETED|Treatment Phase||26
411601|NCT00066937|1008299|P2|COMPLETED|Treatment Phase||33
411602|NCT00066937|1008300|P1|COMPLETED|Treatment Phase||38
411603|NCT00066937|1008297|P4|STARTED|Treatment Phase||24
411604|NCT00066937|1008298|P3|STARTED|Treatment Phase||37
411605|NCT00066937|1008299|P2|STARTED|Treatment Phase||38
411606|NCT00066937|1008300|P1|STARTED|Treatment Phase||41
411607|NCT00066807|1008324|P2|NOT COMPLETED|Overall Study||15
411608|NCT00066807|1008325|P1|NOT COMPLETED|Overall Study||14
411609|NCT00066807|1008324|P2|COMPLETED|Overall Study||0
411610|NCT00066807|1008325|P1|COMPLETED|Overall Study||0
411611|NCT00066807|1008324|P2|STARTED|Overall Study||15
411612|NCT00066807|1008325|P1|STARTED|Overall Study||14
411613|NCT00066781|1008339|P2|NOT COMPLETED|Overall Study||0
411614|NCT00066781|1008340|P1|NOT COMPLETED|Overall Study||0
411615|NCT00066781|1008339|P2|COMPLETED|Overall Study||17
411616|NCT00066781|1008340|P1|COMPLETED|Overall Study||14
411617|NCT00066781|1008339|P2|STARTED|Overall Study||17
411618|NCT00066781|1008340|P1|STARTED|Overall Study||14
411619|NCT00066742|1008350|P1|NOT COMPLETED|Consolidation Chemotherapy||3
411620|NCT00066742|1008350|P1|COMPLETED|Consolidation Chemotherapy||39
411621|NCT00066742|1008350|P1|Eligible|Consolidation Chemotherapy||40
411622|NCT00066742|1008350|P1|STARTED|Consolidation Chemotherapy||42
411623|NCT00066742|1008350|P1|NOT COMPLETED|Induction Chemoradiotherapy||29
411624|NCT00066742|1008350|P1|COMPLETED|Induction Chemoradiotherapy||43
411625|NCT00066742|1008350|P1|Began Protocol Treatment|Induction Chemoradiotherapy||68
411626|NCT00066742|1008350|P1|Eligible|Induction Chemoradiotherapy||69
411627|NCT00066742|1008350|P1|STARTED|Induction Chemoradiotherapy||72
411628|NCT00066703|1008359|P2|NOT COMPLETED|Overall Study||582
411629|NCT00066703|1008360|P1|NOT COMPLETED|Overall Study||612
411630|NCT00066703|1008359|P2|COMPLETED|Overall Study||756
411631|NCT00066703|1008360|P1|COMPLETED|Overall Study||722
411632|NCT00066703|1008359|P2|STARTED|Overall Study||1338
411633|NCT00066703|1008360|P1|STARTED|Overall Study||1334
411634|NCT00066690|1008375|P3|NOT COMPLETED|Overall Study||564
411635|NCT00066690|1008376|P2|NOT COMPLETED|Overall Study||522
411636|NCT00066690|1008377|P1|NOT COMPLETED|Overall Study||598
411637|NCT00066690|1008375|P3|COMPLETED|Overall Study||457
411638|NCT00066690|1008376|P2|COMPLETED|Overall Study||502
411639|NCT00066690|1008377|P1|COMPLETED|Overall Study||423
411640|NCT00066690|1008375|P3|STARTED|Overall Study||1021
411641|NCT00066690|1008376|P2|STARTED|Overall Study||1024
411642|NCT00066690|1008377|P1|STARTED|Overall Study||1021
411643|NCT00066573|1008396|P2|NOT COMPLETED|Overall Study||28
411644|NCT00066573|1008397|P1|NOT COMPLETED|Overall Study||28
411645|NCT00066573|1008396|P2|COMPLETED|Overall Study||3759
411646|NCT00066573|1008397|P1|COMPLETED|Overall Study||3761
411647|NCT00066573|1008396|P2|STARTED|Overall Study||3787
411648|NCT00066573|1008397|P1|STARTED|Overall Study||3789
411649|NCT00066469|1008409|P1|NOT COMPLETED|Overall Study||16
411650|NCT00066469|1008409|P1|COMPLETED|Overall Study||39
411651|NCT00066469|1008409|P1|STARTED|Overall Study||55
411652|NCT00066365|1008415|P2|NOT COMPLETED|Overall Study||14
411653|NCT00066365|1008416|P1|NOT COMPLETED|Overall Study||23
411654|NCT00066365|1008415|P2|COMPLETED|Overall Study||4
411655|NCT00066365|1008416|P1|COMPLETED|Overall Study||8
411656|NCT00066365|1008415|P2|STARTED|Overall Study||18
411657|NCT00066365|1008416|P1|STARTED|Overall Study||31
411658|NCT00066222|1008444|P1|NOT COMPLETED|Overall Study||1
411659|NCT00066222|1008444|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|71
411660|NCT00066222|1008444|P1|STARTED|Overall Study||72
411661|NCT00066170|1008457|P4|NOT COMPLETED|Overall Study||9
411662|NCT00066170|1008458|P3|NOT COMPLETED|Overall Study||4
411663|NCT00066170|1008459|P2|NOT COMPLETED|Overall Study||10
411664|NCT00066170|1008460|P1|NOT COMPLETED|Overall Study||7
411665|NCT00066170|1008457|P4|COMPLETED|Overall Study||48
411666|NCT00066170|1008458|P3|COMPLETED|Overall Study||59
411667|NCT00066170|1008459|P2|COMPLETED|Overall Study||45
411668|NCT00066170|1008460|P1|COMPLETED|Overall Study||49
411669|NCT00066170|1008457|P4|Intent to Treat|Overall Study||54
411670|NCT00066170|1008458|P3|Intent to Treat|Overall Study||63
411671|NCT00066170|1008459|P2|Intent to Treat|Overall Study||50
411672|NCT00066170|1008460|P1|Intent to Treat|Overall Study||55
411673|NCT00066170|1008457|P4|STARTED|Overall Study||57
411674|NCT00066170|1008458|P3|STARTED|Overall Study||63
411675|NCT00066170|1008459|P2|STARTED|Overall Study||55
411676|NCT00066170|1008460|P1|STARTED|Overall Study||56
411677|NCT00066066|1008473|P6|NOT COMPLETED|Overall Study||5
411678|NCT00066066|1008474|P5|NOT COMPLETED|Overall Study||3
411679|NCT00066066|1008475|P4|NOT COMPLETED|Overall Study||4
411680|NCT00066066|1008476|P3|NOT COMPLETED|Overall Study||7
411681|NCT00066066|1008477|P2|NOT COMPLETED|Overall Study||4
411682|NCT00066066|1008478|P1|NOT COMPLETED|Overall Study||6
411683|NCT00066066|1008473|P6|COMPLETED|Overall Study|20 enrolled, 15 analyzed,9 subjects had complete data,6 subjects had data carried forward.|15
411684|NCT00066066|1008474|P5|COMPLETED|Overall Study|27 enrolled, 24 analyzed,19 subjects had complete data,5 subjects had data carried forward.|24
411685|NCT00066066|1008475|P4|COMPLETED|Overall Study|20 enrolled, 16 analyzed,11 subjects had complete data,5 subjects had data carried forward.|16
411686|NCT00066066|1008476|P3|COMPLETED|Overall Study|30 enrolled, 23 analyzed,21 subjects had complete data,2 subjects had data carried forward.|23
411687|NCT00066066|1008477|P2|COMPLETED|Overall Study|22 enrolled, 18 analyzed,11 subjects had complete data,7 subjects had data carried forward.|18
411688|NCT00066066|1008478|P1|COMPLETED|Overall Study|27 enrolled, 21 analyzed,18 subjects had complete data,3 subjects had data carried forward.|21
411689|NCT00066066|1008473|P6|12 Month|Overall Study||9
411690|NCT00066066|1008474|P5|12 Month|Overall Study||19
411691|NCT00066066|1008475|P4|12 Month|Overall Study||11
411692|NCT00066066|1008476|P3|12 Month|Overall Study||21
411693|NCT00066066|1008477|P2|12 Month|Overall Study||11
411694|NCT00066066|1008478|P1|12 Month|Overall Study||18
411695|NCT00066066|1008473|P6|6 Month|Overall Study||14
411696|NCT00066066|1008474|P5|6 Month|Overall Study||21
411697|NCT00066066|1008475|P4|6 Month|Overall Study||13
411698|NCT00066066|1008476|P3|6 Month|Overall Study||23
411699|NCT00066066|1008477|P2|6 Month|Overall Study||13
411700|NCT00066066|1008478|P1|6 Month|Overall Study||19
411701|NCT00066066|1008473|P6|3 Month|Overall Study||15
411702|NCT00066066|1008474|P5|3 Month|Overall Study||22
411703|NCT00066066|1008475|P4|3 Month|Overall Study||16
411704|NCT00066066|1008476|P3|3 Month|Overall Study||23
411705|NCT00066066|1008477|P2|3 Month|Overall Study||17
411706|NCT00066066|1008478|P1|3 Month|Overall Study||21
411707|NCT00066066|1008473|P6|Baseline|Overall Study||20
411708|NCT00066066|1008474|P5|Baseline|Overall Study||27
411709|NCT00066066|1008475|P4|Baseline|Overall Study||20
411710|NCT00066066|1008476|P3|Baseline|Overall Study||30
411711|NCT00066066|1008477|P2|Baseline|Overall Study||22
411712|NCT00066066|1008478|P1|Baseline|Overall Study||27
411713|NCT00066066|1008473|P6|STARTED|Overall Study||20
411714|NCT00066066|1008474|P5|STARTED|Overall Study||27
411715|NCT00066066|1008475|P4|STARTED|Overall Study||20
411716|NCT00066066|1008476|P3|STARTED|Overall Study||30
411717|NCT00066066|1008477|P2|STARTED|Overall Study||22
411718|NCT00066066|1008478|P1|STARTED|Overall Study||27
411719|NCT00065806|1008494|P2|NOT COMPLETED|Overall Study||19
411720|NCT00065806|1008495|P1|NOT COMPLETED|Overall Study||20
411721|NCT00065806|1008494|P2|COMPLETED|Overall Study||89
411722|NCT00065806|1008495|P1|COMPLETED|Overall Study||93
411723|NCT00065806|1008494|P2|STARTED|Overall Study||108
411724|NCT00065806|1008495|P1|STARTED|Overall Study||113
411725|NCT00014560|1008537|P1|NOT COMPLETED|Overall Study||3
411726|NCT00014560|1008537|P1|COMPLETED|Overall Study||0
411727|NCT00014560|1008537|P1|STARTED|Overall Study||3
411728|NCT00065611|1008543|P2|NOT COMPLETED|Overall Study||1
411729|NCT00065611|1008544|P1|NOT COMPLETED|Overall Study||0
411730|NCT00065611|1008543|P2|COMPLETED|Overall Study||3
411731|NCT00065611|1008544|P1|COMPLETED|Overall Study||4
411732|NCT00065611|1008543|P2|STARTED|Overall Study||4
411733|NCT00065611|1008544|P1|STARTED|Overall Study||4
411734|NCT00065507|1008556|P2|NOT COMPLETED|Overall Study||29
411735|NCT00065507|1008557|P1|NOT COMPLETED|Overall Study||29
411736|NCT00065507|1008556|P2|COMPLETED|Overall Study|Completed first 48 weeks of treatment|62
411737|NCT00065507|1008557|P1|COMPLETED|Overall Study|Completed first 48 weeks of treatment|71
411738|NCT00065507|1008556|P2|Treated, 24-Week Follow-Up Population|Overall Study||28
411739|NCT00065507|1008557|P1|Treated, 24-Week Follow-Up Population|Overall Study||25
411740|NCT00065507|1008556|P2|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
411741|NCT00065507|1008557|P1|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
411742|NCT00065507|1008556|P2|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
411743|NCT00065507|1008557|P1|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
411744|NCT00065507|1008556|P2|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|91
411745|NCT00065507|1008557|P1|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|100
411746|NCT00065507|1008556|P2|STARTED|Overall Study|94 participants were randomized; 3 never treated.|91
411747|NCT00065507|1008557|P1|STARTED|Overall Study|101 participants were randomized; 1 never treated.|100
411748|NCT00065468|1008622|P3|NOT COMPLETED|Overall Study||210
411749|NCT00065468|1008623|P2|NOT COMPLETED|Overall Study||209
411750|NCT00065468|1008624|P1|NOT COMPLETED|Overall Study||207
411751|NCT00065468|1008622|P3|COMPLETED|Overall Study||0
411752|NCT00065468|1008623|P2|COMPLETED|Overall Study||0
411753|NCT00065468|1008624|P1|COMPLETED|Overall Study||0
411754|NCT00065468|1008622|P3|Received Treatment|Overall Study||208
411755|NCT00065468|1008623|P2|Received Treatment|Overall Study||208
411756|NCT00065468|1008624|P1|Received Treatment|Overall Study||200
411757|NCT00065468|1008622|P3|STARTED|Overall Study||210
411758|NCT00065468|1008623|P2|STARTED|Overall Study||209
411759|NCT00065468|1008624|P1|STARTED|Overall Study||207
411760|NCT00065442|1008655|P2|NOT COMPLETED|Overall Study||220
411761|NCT00065442|1008656|P1|NOT COMPLETED|Overall Study||125
411762|NCT00065442|1008655|P2|COMPLETED|Overall Study||121
411763|NCT00065442|1008656|P1|COMPLETED|Overall Study||46
411764|NCT00065442|1008655|P2|STARTED|Overall Study||341
411765|NCT00065442|1008656|P1|STARTED|Overall Study||171
411766|NCT00065429|1008671|P7|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
411767|NCT00065429|1008672|P6|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
411768|NCT00065429|1008673|P5|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||6
411769|NCT00065429|1008674|P4|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
411770|NCT00065429|1008675|P3|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
411771|NCT00065429|1008676|P2|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
411772|NCT00065429|1008677|P1|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
411773|NCT00065429|1008671|P7|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
411774|NCT00065429|1008672|P6|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
411775|NCT00065429|1008673|P5|COMPLETED|Phase II - Apr 2003 - Aug 2008||26
411776|NCT00065429|1008674|P4|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
411777|NCT00065429|1008675|P3|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
411778|NCT00065429|1008676|P2|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
411779|NCT00065429|1008677|P1|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
411780|NCT00065429|1008671|P7|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
411781|NCT00065429|1008672|P6|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
411782|NCT00065429|1008673|P5|STARTED|Phase II - Apr 2003 - Aug 2008|All 32 patients enrolled in Phase 2 were at 60 mg/m2.|32
411783|NCT00065429|1008674|P4|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
411784|NCT00065429|1008675|P3|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
411785|NCT00065429|1008676|P2|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
411786|NCT00065429|1008677|P1|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
411787|NCT00065429|1008671|P7|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
411788|NCT00065429|1008672|P6|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
411789|NCT00065429|1008673|P5|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
411790|NCT00065429|1008674|P4|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
411791|NCT00065429|1008675|P3|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
411792|NCT00065429|1008676|P2|NOT COMPLETED|Phase I - May 2001 - Oct 2002||0
411793|NCT00065429|1008677|P1|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
411794|NCT00065429|1008671|P7|COMPLETED|Phase I - May 2001 - Oct 2002||2
411795|NCT00065429|1008672|P6|COMPLETED|Phase I - May 2001 - Oct 2002||2
411796|NCT00065429|1008673|P5|COMPLETED|Phase I - May 2001 - Oct 2002||8
411797|NCT00065429|1008674|P4|COMPLETED|Phase I - May 2001 - Oct 2002||3
411798|NCT00065429|1008675|P3|COMPLETED|Phase I - May 2001 - Oct 2002||3
411799|NCT00065429|1008676|P2|COMPLETED|Phase I - May 2001 - Oct 2002||3
411800|NCT00065429|1008677|P1|COMPLETED|Phase I - May 2001 - Oct 2002||3
411801|NCT00065429|1008671|P7|STARTED|Phase I - May 2001 - Oct 2002||4
411802|NCT00065429|1008672|P6|STARTED|Phase I - May 2001 - Oct 2002||4
411803|NCT00065429|1008673|P5|STARTED|Phase I - May 2001 - Oct 2002||9
411804|NCT00065429|1008674|P4|STARTED|Phase I - May 2001 - Oct 2002||4
411805|NCT00065429|1008675|P3|STARTED|Phase I - May 2001 - Oct 2002||4
411806|NCT00065429|1008676|P2|STARTED|Phase I - May 2001 - Oct 2002||3
411807|NCT00065429|1008677|P1|STARTED|Phase I - May 2001 - Oct 2002||4
411808|NCT00065260|1008691|P2|NOT COMPLETED|Overall Study||1
411809|NCT00065260|1008692|P1|NOT COMPLETED|Overall Study||0
411810|NCT00065260|1008691|P2|COMPLETED|Overall Study||26
411811|NCT00065260|1008692|P1|COMPLETED|Overall Study||27
411812|NCT00065260|1008691|P2|STARTED|Overall Study||27
411813|NCT00065260|1008692|P1|STARTED|Overall Study||27
411814|NCT00065182|1008700|P2|NOT COMPLETED|Overall Study||37
411815|NCT00065182|1008701|P1|NOT COMPLETED|Overall Study||48
411816|NCT00065182|1008700|P2|COMPLETED|Overall Study||160
411817|NCT00065182|1008701|P1|COMPLETED|Overall Study||154
411818|NCT00065182|1008700|P2|STARTED|Overall Study||197
411819|NCT00065182|1008701|P1|STARTED|Overall Study||202
411820|NCT00065156|1008727|P1|NOT COMPLETED|Overall Study||124
411821|NCT00065156|1008727|P1|COMPLETED|Overall Study|24 patients rolled over to free drug due to sponsor closure of study.|24
411822|NCT00065156|1008727|P1|Modified Intent to Treat Population|Overall Study||94
411823|NCT00065156|1008727|P1|STARTED|Overall Study||148
411824|NCT00065065|1008744|P2|NOT COMPLETED|Overall Study||20
411825|NCT00065065|1008745|P1|NOT COMPLETED|Overall Study||10
411826|NCT00065065|1008744|P2|COMPLETED|Overall Study||33
411827|NCT00065065|1008745|P1|COMPLETED|Overall Study||42
411828|NCT00065065|1008744|P2|STARTED|Overall Study||53
411829|NCT00065065|1008745|P1|STARTED|Overall Study||52
411830|NCT00003895|1008757|P2|NOT COMPLETED|Overall Study||4
411831|NCT00003895|1008758|P1|NOT COMPLETED|Overall Study||7
411832|NCT00003895|1008757|P2|COMPLETED|Overall Study||14
411833|NCT00003895|1008758|P1|COMPLETED|Overall Study||11
411834|NCT00003895|1008757|P2|STARTED|Overall Study||18
411835|NCT00003895|1008758|P1|STARTED|Overall Study||18
411836|NCT00064987|1008766|P2|NOT COMPLETED|Overall Study||0
411837|NCT00064987|1008767|P1|NOT COMPLETED|Overall Study||3
411838|NCT00064987|1008766|P2|COMPLETED|Overall Study||6
411839|NCT00064987|1008767|P1|COMPLETED|Overall Study||7
411840|NCT00064987|1008766|P2|STARTED|Overall Study||6
411841|NCT00064987|1008767|P1|STARTED|Overall Study||10
411842|NCT00064844|1008787|P2|NOT COMPLETED|Overall Study||19
411843|NCT00064844|1008788|P1|NOT COMPLETED|Overall Study||8
411844|NCT00064844|1008787|P2|COMPLETED|Overall Study||32
411845|NCT00064844|1008788|P1|COMPLETED|Overall Study||37
411846|NCT00064844|1008787|P2|12 Month Follow-up|Overall Study||32
411847|NCT00064844|1008788|P1|12 Month Follow-up|Overall Study||37
411848|NCT00064844|1008787|P2|6 Month Follow-up|Overall Study||40
411849|NCT00064844|1008788|P1|6 Month Follow-up|Overall Study||39
411850|NCT00064844|1008787|P2|3 Month Follow-up|Overall Study||47
411851|NCT00064844|1008788|P1|3 Month Follow-up|Overall Study||40
411852|NCT00064844|1008787|P2|2 Week Follow-up|Overall Study||51
411853|NCT00064844|1008788|P1|2 Week Follow-up|Overall Study||45
411854|NCT00064844|1008787|P2|STARTED|Overall Study||51
411855|NCT00064844|1008788|P1|STARTED|Overall Study||45
411856|NCT00064753|1008798|P2|NOT COMPLETED|Overall Study||648
411857|NCT00064753|1008799|P1|NOT COMPLETED|Overall Study||674
411858|NCT00064753|1008798|P2|COMPLETED|Overall Study||1406
411859|NCT00064753|1008799|P1|COMPLETED|Overall Study||1382
411860|NCT00064753|1008798|P2|STARTED|Overall Study||2054
411861|NCT00064753|1008799|P1|STARTED|Overall Study||2056
411862|NCT00064792|1008829|P2|NOT COMPLETED|Overall Study||0
411863|NCT00064792|1008830|P1|NOT COMPLETED|Overall Study||5
411864|NCT00064792|1008829|P2|COMPLETED|Overall Study||10
411865|NCT00064792|1008830|P1|COMPLETED|Overall Study||8
411866|NCT00064792|1008829|P2|STARTED|Overall Study||10
411867|NCT00064792|1008830|P1|STARTED|Overall Study||13
411868|NCT00064701|1008841|P3|NOT COMPLETED|Clinical Continuation Phase||140
411869|NCT00064701|1008842|P2|NOT COMPLETED|Clinical Continuation Phase||178
411870|NCT00064701|1008843|P1|NOT COMPLETED|Clinical Continuation Phase||170
411871|NCT00064701|1008841|P3|COMPLETED|Clinical Continuation Phase||11
411872|NCT00064701|1008842|P2|COMPLETED|Clinical Continuation Phase||4
411873|NCT00064701|1008843|P1|COMPLETED|Clinical Continuation Phase||9
411874|NCT00064701|1008841|P3|STARTED|Clinical Continuation Phase||151
411875|NCT00064701|1008842|P2|STARTED|Clinical Continuation Phase|One participant did not enter the Clinical Continuation phase|182
411876|NCT00064701|1008843|P1|STARTED|Clinical Continuation Phase||179
411877|NCT00064701|1008841|P3|NOT COMPLETED|One Year Post-transplant||72
411878|NCT00064701|1008842|P2|NOT COMPLETED|One Year Post-transplant||43
411879|NCT00064701|1008843|P1|NOT COMPLETED|One Year Post-transplant||40
411880|NCT00064701|1008841|P3|COMPLETED|One Year Post-transplant||151
411881|NCT00064701|1008842|P2|COMPLETED|One Year Post-transplant||183
411882|NCT00064701|1008843|P1|COMPLETED|One Year Post-transplant||179
411883|NCT00064701|1008841|P3|Received Study Drug|One Year Post-transplant||212
411884|NCT00064701|1008842|P2|Received Study Drug|One Year Post-transplant||214
411885|NCT00064701|1008843|P1|Received Study Drug|One Year Post-transplant||212
411886|NCT00064701|1008841|P3|STARTED|One Year Post-transplant||223
411887|NCT00064701|1008842|P2|STARTED|One Year Post-transplant||226
411888|NCT00064701|1008843|P1|STARTED|One Year Post-transplant||219
411889|NCT00064662|1008895|P2|NOT COMPLETED|Overall Study||61
411890|NCT00064662|1008896|P1|NOT COMPLETED|Overall Study||74
411891|NCT00064662|1008895|P2|COMPLETED|Overall Study||265
411892|NCT00064662|1008896|P1|COMPLETED|Overall Study||255
411893|NCT00064662|1008895|P2|STARTED|Overall Study||326
411894|NCT00064662|1008896|P1|STARTED|Overall Study||329
411895|NCT00064350|1008907|P3|NOT COMPLETED|Cross-Over||0
411896|NCT00064350|1008908|P2|NOT COMPLETED|Cross-Over||14
411897|NCT00064350|1008909|P1|NOT COMPLETED|Cross-Over||6
411898|NCT00064350|1008907|P3|COMPLETED|Cross-Over||0
411899|NCT00064350|1008908|P2|COMPLETED|Cross-Over||13
411900|NCT00064350|1008909|P1|COMPLETED|Cross-Over||4
411901|NCT00064350|1008907|P3|Eligible and Treated|Cross-Over||0
411902|NCT00064350|1008908|P2|Eligible and Treated|Cross-Over||21
411903|NCT00064350|1008909|P1|Eligible and Treated|Cross-Over||7
411904|NCT00064350|1008907|P3|Treated|Cross-Over||0
411905|NCT00064350|1008908|P2|Treated|Cross-Over||26
411906|NCT00064350|1008909|P1|Treated|Cross-Over||9
411907|NCT00064350|1008907|P3|STARTED|Cross-Over||0
411908|NCT00064350|1008908|P2|STARTED|Cross-Over||27
411909|NCT00064350|1008909|P1|STARTED|Cross-Over||10
411910|NCT00064350|1008907|P3|NOT COMPLETED|Randomization||0
411911|NCT00064350|1008908|P2|NOT COMPLETED|Randomization||18
411912|NCT00064350|1008909|P1|NOT COMPLETED|Randomization||26
411913|NCT00064350|1008907|P3|COMPLETED|Randomization||0
411914|NCT00064350|1008908|P2|COMPLETED|Randomization||28
411915|NCT00064350|1008909|P1|COMPLETED|Randomization||33
411916|NCT00064350|1008907|P3|Eligible and Treated|Randomization||0
411917|NCT00064350|1008908|P2|Eligible and Treated|Randomization||31
411918|NCT00064350|1008909|P1|Eligible and Treated|Randomization||50
411919|NCT00064350|1008907|P3|Treated|Randomization||0
411920|NCT00064350|1008908|P2|Treated|Randomization||40
411921|NCT00064350|1008909|P1|Treated|Randomization||55
411922|NCT00064350|1008907|P3|STARTED|Randomization||0
411923|NCT00064350|1008908|P2|STARTED|Randomization||46
411924|NCT00064350|1008909|P1|STARTED|Randomization||59
411925|NCT00064350|1008907|P3|NOT COMPLETED|Induction Treatment||236
411926|NCT00064350|1008908|P2|NOT COMPLETED|Induction Treatment||9
411927|NCT00064350|1008909|P1|NOT COMPLETED|Induction Treatment||8
411928|NCT00064350|1008907|P3|COMPLETED|Induction Treatment||1
411929|NCT00064350|1008908|P2|COMPLETED|Induction Treatment||37
411930|NCT00064350|1008909|P1|COMPLETED|Induction Treatment||51
411931|NCT00064350|1008907|P3|Eligible and Treated|Induction Treatment||194
411932|NCT00064350|1008908|P2|Eligible and Treated|Induction Treatment||46
411933|NCT00064350|1008909|P1|Eligible and Treated|Induction Treatment||59
411934|NCT00064350|1008907|P3|Treated|Induction Treatment||228
411935|NCT00064350|1008908|P2|Treated|Induction Treatment||46
411936|NCT00064350|1008909|P1|Treated|Induction Treatment||59
411937|NCT00064350|1008907|P3|STARTED|Induction Treatment||237
411938|NCT00064350|1008908|P2|STARTED|Induction Treatment||46
411939|NCT00064350|1008909|P1|STARTED|Induction Treatment||59
411940|NCT00064337|1008924|P1|NOT COMPLETED|Maintenance||10
411941|NCT00064337|1008924|P1|COMPLETED|Maintenance||3
411942|NCT00064337|1008924|P1|STARTED|Maintenance|Only patients with High Risk MM or AL + MM were allowed to enroll to Maintenance treatment.|13
411943|NCT00064337|1008924|P1|NOT COMPLETED|Transplant||21
411944|NCT00064337|1008924|P1|COMPLETED|Transplant||46
411945|NCT00064337|1008924|P1|STARTED|Transplant|6 patients who completed PBSCC or Induction/PBSCC did not begin Transplant|67
411946|NCT00064337|1008924|P1|NOT COMPLETED|PBSCC or Induction/PBSCC||20
411947|NCT00064337|1008924|P1|COMPLETED|PBSCC or Induction/PBSCC||73
411948|NCT00064337|1008924|P1|STARTED|PBSCC or Induction/PBSCC|104 patients were registered, 93 of whom were eligible and analyzable.|93
411949|NCT00064298|1008933|P2|NOT COMPLETED|Overall Study||5
411950|NCT00064298|1008934|P1|NOT COMPLETED|Overall Study||6
411951|NCT00064298|1008933|P2|COMPLETED|Overall Study||57
411952|NCT00064298|1008934|P1|COMPLETED|Overall Study||66
411953|NCT00064298|1008933|P2|STARTED|Overall Study||62
411954|NCT00064298|1008934|P1|STARTED|Overall Study||72
411955|NCT00064259|1008942|P4|NOT COMPLETED|Overall Study||1
411956|NCT00064259|1008943|P3|NOT COMPLETED|Overall Study||0
411957|NCT00064259|1008944|P2|NOT COMPLETED|Overall Study||0
411958|NCT00064259|1008945|P1|NOT COMPLETED|Overall Study||1
411959|NCT00064259|1008942|P4|COMPLETED|Overall Study||0
411960|NCT00064259|1008943|P3|COMPLETED|Overall Study||6
411961|NCT00064259|1008944|P2|COMPLETED|Overall Study||4
411962|NCT00064259|1008945|P1|COMPLETED|Overall Study||3
411963|NCT00064259|1008942|P4|STARTED|Overall Study||1
411964|NCT00064259|1008943|P3|STARTED|Overall Study||6
411965|NCT00064259|1008944|P2|STARTED|Overall Study||4
411966|NCT00064259|1008945|P1|STARTED|Overall Study||4
411967|NCT00064077|1008953|P4|NOT COMPLETED|Overall Study||7
411968|NCT00064077|1008954|P3|NOT COMPLETED|Overall Study||7
411969|NCT00064077|1008955|P2|NOT COMPLETED|Overall Study||9
411970|NCT00064077|1008956|P1|NOT COMPLETED|Overall Study||15
411971|NCT00064077|1008953|P4|COMPLETED|Overall Study|Evaluable (treatment)|111
411972|NCT00064077|1008954|P3|COMPLETED|Overall Study|Evaluable (treatment)|112
411973|NCT00064077|1008955|P2|COMPLETED|Overall Study|Evaluable (treatment)|108
411974|NCT00064077|1008956|P1|COMPLETED|Overall Study|Evaluable (treatment)|103
411975|NCT00064077|1008953|P4|STARTED|Overall Study||118
411976|NCT00064077|1008954|P3|STARTED|Overall Study||119
411977|NCT00064077|1008955|P2|STARTED|Overall Study||117
411978|NCT00064077|1008956|P1|STARTED|Overall Study||118
411979|NCT00064038|1008988|P3|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||2
411980|NCT00064038|1008989|P2|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
411981|NCT00064038|1008990|P1|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
411982|NCT00064038|1008988|P3|COMPLETED|Crossover to Lenalidomide+Dexamethasone||40
411983|NCT00064038|1008989|P2|COMPLETED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
411984|NCT00064038|1008990|P1|COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
411985|NCT00064038|1008988|P3|Safety Population|Crossover to Lenalidomide+Dexamethasone||40
411986|NCT00064038|1008989|P2|Safety Population|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
411987|NCT00064038|1008990|P1|Safety Population|Crossover to Lenalidomide+Dexamethasone||0
411988|NCT00064038|1008988|P3|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||40
411989|NCT00064038|1008989|P2|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
411990|NCT00064038|1008990|P1|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||0
411991|NCT00064038|1008988|P3|STARTED|Crossover to Lenalidomide+Dexamethasone||42
411992|NCT00064038|1008989|P2|STARTED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
411993|NCT00064038|1008990|P1|STARTED|Crossover to Lenalidomide+Dexamethasone||0
411994|NCT00064038|1008988|P3|NOT COMPLETED|Initial Randomization||0
411995|NCT00064038|1008989|P2|NOT COMPLETED|Initial Randomization||98
411996|NCT00064038|1008990|P1|NOT COMPLETED|Initial Randomization||100
411997|NCT00064038|1008988|P3|COMPLETED|Initial Randomization||0
411998|NCT00064038|1008989|P2|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
411999|NCT00064038|1008990|P1|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
412000|NCT00064038|1008988|P3|Safety Population|Initial Randomization||0
412001|NCT00064038|1008989|P2|Safety Population|Initial Randomization||94
412002|NCT00064038|1008990|P1|Safety Population|Initial Randomization||96
412003|NCT00064038|1008988|P3|Eligible and Analyzable|Initial Randomization||0
412004|NCT00064038|1008989|P2|Eligible and Analyzable|Initial Randomization||95
412005|NCT00064038|1008990|P1|Eligible and Analyzable|Initial Randomization||97
412006|NCT00064038|1008988|P3|STARTED|Initial Randomization||0
412007|NCT00064038|1008989|P2|STARTED|Initial Randomization||98
412008|NCT00064038|1008990|P1|STARTED|Initial Randomization||100
412009|NCT00064025|1009000|P1|NOT COMPLETED|Overall Study||7
412010|NCT00064025|1009000|P1|COMPLETED|Overall Study||68
412011|NCT00064025|1009000|P1|STARTED|Overall Study||75
412012|NCT00063999|1009009|P2|NOT COMPLETED|Overall Study||24
412013|NCT00063999|1009010|P1|NOT COMPLETED|Overall Study||45
412014|NCT00063999|1009009|P2|COMPLETED|Overall Study||665
412015|NCT00063999|1009010|P1|COMPLETED|Overall Study||647
412016|NCT00063999|1009009|P2|STARTED|Overall Study||689
412017|NCT00063999|1009010|P1|STARTED|Overall Study||692
412018|NCT00063986|1009026|P1|NOT COMPLETED|Overall Study||6
412019|NCT00063986|1009026|P1|COMPLETED|Overall Study||104
412020|NCT00063986|1009026|P1|Eligible and Treated|Overall Study||104
412021|NCT00063986|1009026|P1|Treated|Overall Study||105
412022|NCT00063986|1009026|P1|STARTED|Overall Study||110
412023|NCT00063934|1009038|P1|NOT COMPLETED|Overall Study||1
412024|NCT00063934|1009038|P1|COMPLETED|Overall Study||30
412025|NCT00063934|1009038|P1|STARTED|Overall Study||31
412026|NCT00063882|1009047|P2|NOT COMPLETED|Overall Study||4
412027|NCT00063882|1009048|P1|NOT COMPLETED|Overall Study||5
412028|NCT00063882|1009047|P2|COMPLETED|Overall Study||292
412029|NCT00063882|1009048|P1|COMPLETED|Overall Study||287
412030|NCT00063882|1009047|P2|Eligible Patients|Overall Study||292
412031|NCT00063882|1009048|P1|Eligible Patients|Overall Study||287
412032|NCT00063882|1009047|P2|Has Baseline/24-month EPIC Data|Overall Study||219
412033|NCT00063882|1009048|P1|Has Baseline/24-month EPIC Data|Overall Study||201
412034|NCT00063882|1009047|P2|Has Baseline/4-month EPIC Data|Overall Study||241
412035|NCT00063882|1009048|P1|Has Baseline/4-month EPIC Data|Overall Study||222
412036|NCT00063882|1009047|P2|Has Late Adverse Event Data|Overall Study||287
412037|NCT00063882|1009048|P1|Has Late Adverse Event Data|Overall Study||282
412038|NCT00063882|1009047|P2|Has Acute Adverse Event Data|Overall Study||288
412039|NCT00063882|1009048|P1|Has Acute Adverse Event Data|Overall Study||282
412040|NCT00063882|1009047|P2|STARTED|Overall Study||296
412041|NCT00063882|1009048|P1|STARTED|Overall Study||292
412042|NCT00063635|1009079|P3|NOT COMPLETED|Overall Study||9
412043|NCT00063635|1009080|P2|NOT COMPLETED|Overall Study||8
412044|NCT00063635|1009081|P1|NOT COMPLETED|Overall Study||6
412045|NCT00063635|1009079|P3|COMPLETED|Overall Study||49
412046|NCT00063635|1009080|P2|COMPLETED|Overall Study||50
412047|NCT00063635|1009081|P1|COMPLETED|Overall Study||51
412048|NCT00063635|1009079|P3|STARTED|Overall Study||58
412049|NCT00063635|1009080|P2|STARTED|Overall Study||58
412050|NCT00063635|1009081|P1|STARTED|Overall Study||57
412051|NCT00063622|1009122|P3|NOT COMPLETED|Overall Study||11
412052|NCT00063622|1009123|P2|NOT COMPLETED|Overall Study||4
412053|NCT00063622|1009124|P1|NOT COMPLETED|Overall Study||10
412054|NCT00063622|1009122|P3|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|72
412055|NCT00063622|1009123|P2|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|80
412056|NCT00063622|1009124|P1|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|70
412057|NCT00063622|1009122|P3|STARTED|Overall Study||83
412058|NCT00063622|1009123|P2|STARTED|Overall Study||84
412059|NCT00063622|1009124|P1|STARTED|Overall Study||80
412060|NCT00063570|1009149|P2|NOT COMPLETED|Overall Study||0
412061|NCT00063570|1009150|P1|NOT COMPLETED|Overall Study||0
412062|NCT00063570|1009149|P2|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|21
412063|NCT00063570|1009150|P1|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|52
412064|NCT00063570|1009149|P2|STARTED|Overall Study||21
412065|NCT00063570|1009150|P1|STARTED|Overall Study||52
412066|NCT00063362|1009166|P2|NOT COMPLETED|Overall Study||4
412067|NCT00063362|1009167|P1|NOT COMPLETED|Overall Study||4
412068|NCT00063362|1009166|P2|COMPLETED|Overall Study||22
412069|NCT00063362|1009167|P1|COMPLETED|Overall Study||19
412070|NCT00063362|1009166|P2|STARTED|Overall Study||26
412071|NCT00063362|1009167|P1|STARTED|Overall Study||23
412072|NCT00063258|1009175|P2|NOT COMPLETED|Overall Study||0
412073|NCT00063258|1009176|P1|NOT COMPLETED|Overall Study||4
412074|NCT00063258|1009175|P2|COMPLETED|Overall Study||0
412075|NCT00063258|1009176|P1|COMPLETED|Overall Study||1
412076|NCT00063258|1009175|P2|STARTED|Overall Study||0
412077|NCT00063258|1009176|P1|STARTED|Overall Study||5
412078|NCT00063154|1009182|P1|NOT COMPLETED|Overall Study||51
412079|NCT00063154|1009182|P1|COMPLETED|Overall Study||0
412080|NCT00063154|1009182|P1|STARTED|Overall Study||51
412081|NCT00063232|1009189|P1|NOT COMPLETED|Overall Study||0
412082|NCT00063232|1009189|P1|COMPLETED|Overall Study||26
412083|NCT00063232|1009189|P1|STARTED|Overall Study||26
412084|NCT00062764|1009195|P1|NOT COMPLETED|Overall Study||0
412085|NCT00062764|1009195|P1|COMPLETED|Overall Study||18
412086|NCT00062764|1009195|P1|STARTED|Overall Study||18
412087|NCT00062751|1009208|P5|NOT COMPLETED|Overall Study||6
412088|NCT00062751|1009209|P4|NOT COMPLETED|Overall Study||5
412089|NCT00062751|1009210|P3|NOT COMPLETED|Overall Study||30
412090|NCT00062751|1009211|P2|NOT COMPLETED|Overall Study||30
412091|NCT00062751|1009212|P1|NOT COMPLETED|Overall Study||33
412092|NCT00062751|1009208|P5|COMPLETED|Overall Study||0
412093|NCT00062751|1009209|P4|COMPLETED|Overall Study||1
412094|NCT00062751|1009210|P3|COMPLETED|Overall Study||3
412095|NCT00062751|1009211|P2|COMPLETED|Overall Study||0
412096|NCT00062751|1009212|P1|COMPLETED|Overall Study||0
412097|NCT00062751|1009208|P5|STARTED|Overall Study||6
412098|NCT00062751|1009209|P4|STARTED|Overall Study||6
412099|NCT00062751|1009210|P3|STARTED|Overall Study||33
412100|NCT00062751|1009211|P2|STARTED|Overall Study||30
412101|NCT00062751|1009212|P1|STARTED|Overall Study||33
412102|NCT00062738|1009283|P3|NOT COMPLETED|Overall Study||0
412103|NCT00062738|1009284|P2|NOT COMPLETED|Overall Study||0
412104|NCT00062738|1009285|P1|NOT COMPLETED|Overall Study||0
412105|NCT00062738|1009283|P3|COMPLETED|Overall Study||17
412106|NCT00062738|1009284|P2|COMPLETED|Overall Study||18
412107|NCT00062738|1009285|P1|COMPLETED|Overall Study||17
412108|NCT00062738|1009283|P3|STARTED|Overall Study||17
412109|NCT00062738|1009284|P2|STARTED|Overall Study||18
412110|NCT00062738|1009285|P1|STARTED|Overall Study||17
412111|NCT00062647|1009298|P2|NOT COMPLETED|Overall Study||13
412112|NCT00062647|1009299|P1|NOT COMPLETED|Overall Study||16
412113|NCT00062647|1009298|P2|COMPLETED|Overall Study||17
412114|NCT00062647|1009299|P1|COMPLETED|Overall Study||14
412115|NCT00062647|1009298|P2|STARTED|Overall Study||30
412116|NCT00062647|1009299|P1|STARTED|Overall Study||30
412117|NCT00062439|1009305|P1|NOT COMPLETED|Consolidation Chemotherapy||2
412118|NCT00062439|1009305|P1|COMPLETED|Consolidation Chemotherapy||20
412119|NCT00062439|1009305|P1|STARTED|Consolidation Chemotherapy||22
412120|NCT00062439|1009305|P1|NOT COMPLETED|Surgery||7
412121|NCT00062439|1009305|P1|COMPLETED|Surgery||22
412122|NCT00062439|1009305|P1|STARTED|Surgery||29
412123|NCT00062439|1009305|P1|NOT COMPLETED|Post Chemoradiation Assessment||9
412124|NCT00062439|1009305|P1|COMPLETED|Post Chemoradiation Assessment||29
412125|NCT00062439|1009305|P1|STARTED|Post Chemoradiation Assessment||38
412126|NCT00062439|1009305|P1|NOT COMPLETED|Induction Chemotherapy + Radiotherapy||8
412127|NCT00062439|1009305|P1|COMPLETED|Induction Chemotherapy + Radiotherapy||38
412128|NCT00062439|1009305|P1|STARTED|Induction Chemotherapy + Radiotherapy||46
412129|NCT00062374|1009317|P1|NOT COMPLETED|Overall Study||12
412130|NCT00062374|1009317|P1|COMPLETED|Overall Study||43
412131|NCT00062374|1009317|P1|STARTED|Overall Study||55
412132|NCT00062166|1009322|P1|NOT COMPLETED|Overall Study||6
412133|NCT00062166|1009322|P1|COMPLETED|Overall Study||334
412134|NCT00062166|1009322|P1|STARTED|Overall Study||340
412135|NCT00062010|1009330|P1|NOT COMPLETED|Overall Study||3
412136|NCT00062010|1009330|P1|COMPLETED|Overall Study||34
412137|NCT00062010|1009330|P1|Eligible and Treated|Overall Study||34
412138|NCT00062010|1009330|P1|STARTED|Overall Study||37
412139|NCT00061945|1009338|P2|NOT COMPLETED|Course IV: Alemtuzumab||16
412140|NCT00061945|1009339|P1|NOT COMPLETED|Course IV: Alemtuzumab||7
412141|NCT00061945|1009338|P2|COMPLETED|Course IV: Alemtuzumab||50
412142|NCT00061945|1009339|P1|COMPLETED|Course IV: Alemtuzumab||18
412143|NCT00061945|1009338|P2|STARTED|Course IV: Alemtuzumab||66
412144|NCT00061945|1009339|P1|STARTED|Course IV: Alemtuzumab||25
412145|NCT00061945|1009338|P2|NOT COMPLETED|Registration Through Course 3||115
412146|NCT00061945|1009339|P1|NOT COMPLETED|Registration Through Course 3||94
412147|NCT00061945|1009338|P2|COMPLETED|Registration Through Course 3||66
412148|NCT00061945|1009339|P1|COMPLETED|Registration Through Course 3||25
412149|NCT00061945|1009338|P2|STARTED|Registration Through Course 3||181
412150|NCT00061945|1009339|P1|STARTED|Registration Through Course 3||119
412151|NCT00061932|1009349|P2|NOT COMPLETED|Overall Study||4
412152|NCT00061932|1009350|P1|NOT COMPLETED|Overall Study||13
412153|NCT00061932|1009349|P2|COMPLETED|Overall Study||8
412154|NCT00061932|1009350|P1|COMPLETED|Overall Study||16
412155|NCT00061932|1009349|P2|STARTED|Overall Study||12
412156|NCT00061932|1009350|P1|STARTED|Overall Study||29
412157|NCT00061893|1009356|P1|NOT COMPLETED|Overall Study||18
412158|NCT00061893|1009356|P1|COMPLETED|Overall Study||20
412159|NCT00061893|1009356|P1|STARTED|Overall Study||38
412160|NCT00061633|1009363|P2|NOT COMPLETED|Overall Study||11
412161|NCT00061633|1009364|P1|NOT COMPLETED|Overall Study||5
412162|NCT00061633|1009363|P2|COMPLETED|Overall Study||74
412163|NCT00061633|1009364|P1|COMPLETED|Overall Study||79
412164|NCT00061633|1009363|P2|STARTED|Overall Study||85
412165|NCT00061633|1009364|P1|STARTED|Overall Study||84
412166|NCT00061373|1009372|P2|NOT COMPLETED|Overall Study||0
412167|NCT00061373|1009373|P1|NOT COMPLETED|Overall Study||0
412168|NCT00061373|1009372|P2|COMPLETED|Overall Study||3
412169|NCT00061373|1009373|P1|COMPLETED|Overall Study||15
412170|NCT00061373|1009372|P2|Aspirin and Tinzaparin|Overall Study||3
412171|NCT00061373|1009373|P1|Aspirin and Tinzaparin|Overall Study||15
412172|NCT00061373|1009372|P2|STARTED|Overall Study||3
412173|NCT00061373|1009373|P1|STARTED|Overall Study||15
412174|NCT00061048|1009389|P1|NOT COMPLETED|Overall Study||22
412175|NCT00061048|1009389|P1|COMPLETED|Overall Study|Began protocol specified follow-up period.|7
412176|NCT00061048|1009389|P1|STARTED|Overall Study||29
412177|NCT00060944|1009399|P2|NOT COMPLETED|Overall Study||134
412178|NCT00060944|1009400|P1|NOT COMPLETED|Overall Study||136
412179|NCT00060944|1009399|P2|COMPLETED|Overall Study||0
412180|NCT00060944|1009400|P1|COMPLETED|Overall Study||0
412181|NCT00060944|1009399|P2|Treated|Overall Study||130
412182|NCT00060944|1009400|P1|Treated|Overall Study||130
412183|NCT00060944|1009399|P2|STARTED|Overall Study||134
412184|NCT00060944|1009400|P1|STARTED|Overall Study||136
412185|NCT00060840|1009416|P2|NOT COMPLETED|Overall Study||9
412186|NCT00060840|1009417|P1|NOT COMPLETED|Overall Study||4
412187|NCT00060840|1009416|P2|COMPLETED|Overall Study||68
412188|NCT00060840|1009417|P1|COMPLETED|Overall Study||69
412189|NCT00060840|1009416|P2|STARTED|Overall Study||77
412190|NCT00060840|1009417|P1|STARTED|Overall Study||73
412191|NCT00060528|1009423|P4|NOT COMPLETED|Overall Study||0
412192|NCT00060528|1009424|P3|NOT COMPLETED|Overall Study||0
412193|NCT00060528|1009425|P2|NOT COMPLETED|Overall Study||0
412194|NCT00060528|1009426|P1|NOT COMPLETED|Overall Study||0
412195|NCT00060528|1009423|P4|COMPLETED|Overall Study||8
412196|NCT00060528|1009424|P3|COMPLETED|Overall Study||7
412197|NCT00060528|1009425|P2|COMPLETED|Overall Study||9
412198|NCT00060528|1009426|P1|COMPLETED|Overall Study||8
412199|NCT00060528|1009423|P4|STARTED|Overall Study||8
412200|NCT00060528|1009424|P3|STARTED|Overall Study||7
412201|NCT00060528|1009425|P2|STARTED|Overall Study||9
412202|NCT00060528|1009426|P1|STARTED|Overall Study|32 participants are reported for the phase II portion.|8
412203|NCT00060424|1009440|P1|NOT COMPLETED|Overall Study||0
412204|NCT00060424|1009440|P1|COMPLETED|Overall Study||21
412205|NCT00060424|1009440|P1|STARTED|Overall Study||21
412206|NCT00060346|1009448|P1|NOT COMPLETED|Overall Study||0
412207|NCT00060346|1009448|P1|COMPLETED|Overall Study||16
412208|NCT00060346|1009448|P1|Eligible and Treated|Overall Study||16
412209|NCT00060346|1009448|P1|STARTED|Overall Study||16
412210|NCT00060333|1009452|P1|NOT COMPLETED|Overall Study||0
412211|NCT00060333|1009452|P1|COMPLETED|Overall Study||20
412212|NCT00060333|1009452|P1|STARTED|Overall Study||20
412213|NCT00060008|1009463|P1|NOT COMPLETED|Overall Study||0
412214|NCT00060008|1009463|P1|COMPLETED|Overall Study||18
412215|NCT00060008|1009463|P1|STARTED|Overall Study||18
412216|NCT00059839|1009470|P2|NOT COMPLETED|Overall Study||17
412217|NCT00059839|1009471|P1|NOT COMPLETED|Overall Study||12
412218|NCT00059839|1009470|P2|COMPLETED|Overall Study||47
412219|NCT00059839|1009471|P1|COMPLETED|Overall Study||53
412220|NCT00059839|1009470|P2|STARTED|Overall Study||64
412221|NCT00059839|1009471|P1|STARTED|Overall Study||65
412222|NCT00059787|1009477|P1|NOT COMPLETED|Overall Study||20
412223|NCT00059787|1009477|P1|COMPLETED|Overall Study||36
412224|NCT00059787|1009477|P1|STARTED|Overall Study||56
412225|NCT00059475|1009493|P8|NOT COMPLETED|Overall Study||0
412226|NCT00059475|1009494|P7|NOT COMPLETED|Overall Study||0
412227|NCT00059475|1009495|P6|NOT COMPLETED|Overall Study||0
412228|NCT00059475|1009496|P5|NOT COMPLETED|Overall Study||0
412229|NCT00059475|1009497|P4|NOT COMPLETED|Overall Study||0
412230|NCT00059475|1009498|P3|NOT COMPLETED|Overall Study||0
412231|NCT00059475|1009499|P2|NOT COMPLETED|Overall Study||0
412232|NCT00059475|1009500|P1|NOT COMPLETED|Overall Study||0
412233|NCT00059475|1009493|P8|COMPLETED|Overall Study||7
412234|NCT00059475|1009494|P7|COMPLETED|Overall Study||34
412235|NCT00059475|1009495|P6|COMPLETED|Overall Study||2
412236|NCT00059475|1009496|P5|COMPLETED|Overall Study||33
412237|NCT00059475|1009497|P4|COMPLETED|Overall Study||3
412238|NCT00059475|1009498|P3|COMPLETED|Overall Study||24
412239|NCT00059475|1009499|P2|COMPLETED|Overall Study||2
412240|NCT00059475|1009500|P1|COMPLETED|Overall Study||33
412241|NCT00059475|1009493|P8|STARTED|Overall Study||7
412242|NCT00059475|1009494|P7|STARTED|Overall Study||34
412243|NCT00059475|1009495|P6|STARTED|Overall Study||2
412244|NCT00059475|1009496|P5|STARTED|Overall Study||33
412245|NCT00059475|1009497|P4|STARTED|Overall Study||3
412246|NCT00059475|1009498|P3|STARTED|Overall Study||24
412247|NCT00059475|1009499|P2|STARTED|Overall Study||2
412248|NCT00059475|1009500|P1|STARTED|Overall Study||33
412249|NCT00059332|1009528|P2|NOT COMPLETED|Overall Study||2
412250|NCT00059332|1009529|P1|NOT COMPLETED|Overall Study||3
412251|NCT00059332|1009528|P2|COMPLETED|Overall Study||855
412252|NCT00059332|1009529|P1|COMPLETED|Overall Study||840
412253|NCT00059332|1009528|P2|STARTED|Overall Study||857
412254|NCT00059332|1009529|P1|STARTED|Overall Study||843
412255|NCT00059215|1009555|P4|NOT COMPLETED|Overall Study||15
412256|NCT00059215|1009556|P3|NOT COMPLETED|Overall Study||15
412257|NCT00059215|1009557|P2|NOT COMPLETED|Overall Study||14
412258|NCT00059215|1009558|P1|NOT COMPLETED|Overall Study||13
412259|NCT00059215|1009555|P4|COMPLETED|Overall Study||239
412260|NCT00059215|1009556|P3|COMPLETED|Overall Study||236
412261|NCT00059215|1009557|P2|COMPLETED|Overall Study||186
412262|NCT00059215|1009558|P1|COMPLETED|Overall Study|One subject discontinued before receiving treatment and is not included in the evaluable set.|187
412263|NCT00059215|1009555|P4|STARTED|Overall Study||254
412264|NCT00059215|1009556|P3|STARTED|Overall Study||251
412265|NCT00059215|1009557|P2|STARTED|Overall Study||200
412266|NCT00059215|1009558|P1|STARTED|Overall Study||200
412267|NCT00059228|1009586|P2|NOT COMPLETED|Overall Study||1
412268|NCT00059228|1009587|P1|NOT COMPLETED|Overall Study||0
412269|NCT00059228|1009586|P2|COMPLETED|Overall Study||5
412270|NCT00059228|1009587|P1|COMPLETED|Overall Study||6
412271|NCT00059228|1009586|P2|STARTED|Overall Study||6
412272|NCT00059228|1009587|P1|STARTED|Overall Study||6
412273|NCT00058825|1009595|P1|NOT COMPLETED|Overall Study||22
412274|NCT00058825|1009595|P1|COMPLETED|Overall Study||5
412275|NCT00058825|1009595|P1|STARTED|Overall Study||27
412276|NCT00058552|1009611|P2|NOT COMPLETED|Overall Study||62
412277|NCT00058552|1009612|P1|NOT COMPLETED|Overall Study||65
412278|NCT00058552|1009611|P2|COMPLETED|Overall Study||2
412279|NCT00058552|1009612|P1|COMPLETED|Overall Study||0
412280|NCT00058552|1009611|P2|STARTED|Overall Study||64
412281|NCT00058552|1009612|P1|STARTED|Overall Study||65
412282|NCT00058539|1009630|P1|NOT COMPLETED|Overall Study||42
412283|NCT00058539|1009630|P1|COMPLETED|Overall Study||0
412284|NCT00058539|1009630|P1|STARTED|Overall Study||42
412285|NCT00058240|1009644|P4|NOT COMPLETED|Second Dose Level||0
412286|NCT00058240|1009645|P3|NOT COMPLETED|Second Dose Level||0
412287|NCT00058240|1009646|P2|NOT COMPLETED|Second Dose Level||0
412288|NCT00058240|1009647|P1|NOT COMPLETED|Second Dose Level||0
412289|NCT00058240|1009644|P4|COMPLETED|Second Dose Level||4
412290|NCT00058240|1009645|P3|COMPLETED|Second Dose Level||2
412291|NCT00058240|1009646|P2|COMPLETED|Second Dose Level||0
412292|NCT00058240|1009647|P1|COMPLETED|Second Dose Level||0
412293|NCT00058240|1009644|P4|STARTED|Second Dose Level|4 patients previously relapsed on a different Dose level and were retreated at Dose level 4.|4
412294|NCT00058240|1009645|P3|STARTED|Second Dose Level|2 patients were previously treated at Dose level 1, relapsed, and retreated at Dose level 3.|2
412295|NCT00058240|1009646|P2|STARTED|Second Dose Level||0
412296|NCT00058240|1009647|P1|STARTED|Second Dose Level||0
412297|NCT00058240|1009644|P4|NOT COMPLETED|First Dose Level||0
412298|NCT00058240|1009645|P3|NOT COMPLETED|First Dose Level||0
412299|NCT00058240|1009646|P2|NOT COMPLETED|First Dose Level||0
412300|NCT00058240|1009647|P1|NOT COMPLETED|First Dose Level||0
412301|NCT00058240|1009644|P4|COMPLETED|First Dose Level||12
412302|NCT00058240|1009645|P3|COMPLETED|First Dose Level||17
412303|NCT00058240|1009646|P2|COMPLETED|First Dose Level||3
412304|NCT00058240|1009647|P1|COMPLETED|First Dose Level||20
412305|NCT00058240|1009644|P4|Treated|First Dose Level||12
412306|NCT00058240|1009645|P3|Treated|First Dose Level||17
412307|NCT00058240|1009646|P2|Treated|First Dose Level||3
412308|NCT00058240|1009647|P1|Treated|First Dose Level||20
412309|NCT00058240|1009644|P4|STARTED|First Dose Level||12
412310|NCT00058240|1009645|P3|STARTED|First Dose Level||17
412311|NCT00058240|1009646|P2|STARTED|First Dose Level||3
412312|NCT00058240|1009647|P1|STARTED|First Dose Level||20
412313|NCT00058214|1009657|P1|NOT COMPLETED|Overall Study||1
412314|NCT00058214|1009657|P1|COMPLETED|Overall Study||24
412315|NCT00058214|1009657|P1|STARTED|Overall Study||25
412316|NCT00058123|1009662|P1|NOT COMPLETED|Overall Study||10
412317|NCT00058123|1009662|P1|COMPLETED|Overall Study||45
412318|NCT00058123|1009662|P1|STARTED|Overall Study||55
412319|NCT00058058|1009669|P1|NOT COMPLETED|Overall Study||38
412320|NCT00058058|1009669|P1|COMPLETED|Overall Study||969
412321|NCT00058058|1009669|P1|STARTED|Overall Study||1007
412322|NCT00058019|1009680|P2|NOT COMPLETED|Overall Study||0
412323|NCT00058019|1009681|P1|NOT COMPLETED|Overall Study||0
412324|NCT00058019|1009680|P2|COMPLETED|Overall Study||12
412325|NCT00058019|1009681|P1|COMPLETED|Overall Study||39
412326|NCT00058019|1009680|P2|STARTED|Overall Study||12
412327|NCT00058019|1009681|P1|STARTED|Overall Study||39
412328|NCT00057954|1009694|P1|NOT COMPLETED|Overall Study||2
412329|NCT00057954|1009694|P1|COMPLETED|Overall Study||4
412330|NCT00057954|1009694|P1|STARTED|Overall Study||6
412331|NCT00057941|1009702|P2|NOT COMPLETED|Overall Study||74
412332|NCT00057941|1009703|P1|NOT COMPLETED|Overall Study||74
412333|NCT00057941|1009702|P2|COMPLETED|Overall Study||0
412334|NCT00057941|1009703|P1|COMPLETED|Overall Study||0
412335|NCT00057941|1009702|P2|Eligible|Overall Study||69
412336|NCT00057941|1009703|P1|Eligible|Overall Study||72
412337|NCT00057941|1009702|P2|Treated|Overall Study||74
412338|NCT00057941|1009703|P1|Treated|Overall Study||74
412339|NCT00057941|1009702|P2|STARTED|Overall Study||74
412340|NCT00057941|1009703|P1|STARTED|Overall Study||74
412341|NCT00057876|1009711|P2|NOT COMPLETED|Overall Study||27
412342|NCT00057876|1009712|P1|NOT COMPLETED|Overall Study||29
412343|NCT00057876|1009711|P2|COMPLETED|Overall Study||9
412344|NCT00057876|1009712|P1|COMPLETED|Overall Study||9
412345|NCT00057876|1009711|P2|Eligible and Treated|Overall Study||34
412346|NCT00057876|1009712|P1|Eligible and Treated|Overall Study||34
412347|NCT00057876|1009711|P2|Began Protocol Therapy|Overall Study||34
412348|NCT00057876|1009712|P1|Began Protocol Therapy|Overall Study||35
412349|NCT00057876|1009711|P2|Eligible|Overall Study||34
412350|NCT00057876|1009712|P1|Eligible|Overall Study||37
412351|NCT00057876|1009711|P2|STARTED|Overall Study||36
412352|NCT00057876|1009712|P1|STARTED|Overall Study||38
412353|NCT00057863|1009722|P1|NOT COMPLETED|Overall Study||3
412354|NCT00057863|1009722|P1|COMPLETED|Overall Study||32
412355|NCT00057863|1009722|P1|STARTED|Overall Study||35
412356|NCT00057837|1009731|P2|NOT COMPLETED|Overall Study||39
412357|NCT00057837|1009732|P1|NOT COMPLETED|Overall Study||31
412358|NCT00057837|1009731|P2|COMPLETED|Overall Study||31
412359|NCT00057837|1009732|P1|COMPLETED|Overall Study||39
412360|NCT00057837|1009731|P2|Patients With Response|Overall Study||38
412361|NCT00057837|1009732|P1|Patients With Response|Overall Study||46
412362|NCT00057837|1009731|P2|Eligible and Treated|Overall Study||66
412363|NCT00057837|1009732|P1|Eligible and Treated|Overall Study||66
412364|NCT00057837|1009731|P2|Treated|Overall Study||68
412365|NCT00057837|1009732|P1|Treated|Overall Study||69
412366|NCT00057837|1009731|P2|STARTED|Overall Study||70
412367|NCT00057837|1009732|P1|STARTED|Overall Study||70
412368|NCT00057811|1009744|P2|NOT COMPLETED|Overall Study||12
412369|NCT00057811|1009745|P1|NOT COMPLETED|Overall Study||10
412370|NCT00057811|1009744|P2|COMPLETED|Overall Study||34
412371|NCT00057811|1009745|P1|COMPLETED|Overall Study||41
412372|NCT00057811|1009744|P2|STARTED|Overall Study||46
412373|NCT00057811|1009745|P1|STARTED|Overall Study||51
412374|NCT00057785|1009757|P1|NOT COMPLETED|Overall Study||0
412375|NCT00057785|1009757|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|68
412376|NCT00057785|1009757|P1|STARTED|Overall Study||68
412377|NCT00057746|1009764|P3|NOT COMPLETED|Overall Study||1
412378|NCT00057746|1009765|P2|NOT COMPLETED|Overall Study||0
412379|NCT00057746|1009766|P1|NOT COMPLETED|Overall Study||0
412380|NCT00057746|1009764|P3|COMPLETED|Overall Study||66
412381|NCT00057746|1009765|P2|COMPLETED|Overall Study||67
412382|NCT00057746|1009766|P1|COMPLETED|Overall Study||131
412383|NCT00057746|1009764|P3|STARTED|Overall Study||67
412384|NCT00057746|1009765|P2|STARTED|Overall Study||67
412385|NCT00057746|1009766|P1|STARTED|Overall Study||131
412386|NCT00023673|1009777|P4|NOT COMPLETED|Overall Study||2
412387|NCT00023673|1009778|P3|NOT COMPLETED|Overall Study||0
412388|NCT00023673|1009779|P2|NOT COMPLETED|Overall Study||0
412389|NCT00023673|1009780|P1|NOT COMPLETED|Overall Study||0
412390|NCT00023673|1009777|P4|COMPLETED|Overall Study|Phase II subjects contributing data to primary analysis are considered to have completed the study.|44
412391|NCT00023673|1009778|P3|COMPLETED|Overall Study|This arm was not used since further de-escalation was not required.|0
412392|NCT00023673|1009779|P2|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|9
412393|NCT00023673|1009780|P1|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|8
412394|NCT00023673|1009777|P4|STARTED|Overall Study||46
412395|NCT00023673|1009778|P3|STARTED|Overall Study||0
412396|NCT00023673|1009779|P2|STARTED|Overall Study||9
412397|NCT00023673|1009780|P1|STARTED|Overall Study||8
412398|NCT00057681|1009796|P3|NOT COMPLETED|Overall Study||34
412399|NCT00057681|1009797|P2|NOT COMPLETED|Overall Study||72
412400|NCT00057681|1009798|P1|NOT COMPLETED|Overall Study||65
412401|NCT00057681|1009796|P3|COMPLETED|Overall Study||69
412402|NCT00057681|1009797|P2|COMPLETED|Overall Study||67
412403|NCT00057681|1009798|P1|COMPLETED|Overall Study||72
412404|NCT00057681|1009796|P3|STARTED|Overall Study||103
412405|NCT00057681|1009797|P2|STARTED|Overall Study||139
412406|NCT00057681|1009798|P1|STARTED|Overall Study||137
412407|NCT00057577|1009814|P2|NOT COMPLETED|Overall Study||0
412408|NCT00057577|1009815|P1|NOT COMPLETED|Overall Study||0
412409|NCT00057577|1009814|P2|COMPLETED|Overall Study||225
412410|NCT00057577|1009815|P1|COMPLETED|Overall Study||227
412411|NCT00057577|1009814|P2|STARTED|Overall Study||225
412412|NCT00057577|1009815|P1|STARTED|Overall Study||227
412413|NCT00057551|1009832|P3|NOT COMPLETED|Overall Study||16
412414|NCT00057551|1009833|P2|NOT COMPLETED|Overall Study||27
412415|NCT00057551|1009834|P1|NOT COMPLETED|Overall Study||25
412416|NCT00057551|1009832|P3|COMPLETED|Overall Study||80
412417|NCT00057551|1009833|P2|COMPLETED|Overall Study||168
412418|NCT00057551|1009834|P1|COMPLETED|Overall Study||175
412419|NCT00057551|1009832|P3|STARTED|Overall Study||96
412420|NCT00057551|1009833|P2|STARTED|Overall Study||195
412421|NCT00057551|1009834|P1|STARTED|Overall Study||200
412422|NCT00057330|1009844|P2|NOT COMPLETED|Overall Study||920
412423|NCT00057330|1009845|P1|NOT COMPLETED|Overall Study||1132
412424|NCT00057330|1009844|P2|COMPLETED|Overall Study||2826
412425|NCT00057330|1009845|P1|COMPLETED|Overall Study||3445
412426|NCT00057330|1009844|P2|STARTED|Overall Study||3746
412427|NCT00057330|1009845|P1|STARTED|Overall Study||4577
412428|NCT00056862|1009875|P2|NOT COMPLETED|Overall Study||0
412429|NCT00056862|1009876|P1|NOT COMPLETED|Overall Study||1
412430|NCT00056862|1009875|P2|COMPLETED|Overall Study||27
412431|NCT00056862|1009876|P1|COMPLETED|Overall Study||30
412432|NCT00056862|1009875|P2|STARTED|Overall Study||27
412433|NCT00056862|1009876|P1|STARTED|Overall Study||31
412434|NCT00056563|1009892|P2|NOT COMPLETED|Overall Study||0
412435|NCT00056563|1009893|P1|NOT COMPLETED|Overall Study||0
412436|NCT00056563|1009892|P2|COMPLETED|Overall Study||134
412437|NCT00056563|1009893|P1|COMPLETED|Overall Study||121
412438|NCT00056563|1009892|P2|STARTED|Overall Study||134
412439|NCT00056563|1009893|P1|STARTED|Overall Study||121
412440|NCT00056550|1009901|P1|NOT COMPLETED|Overall Study||0
412441|NCT00056550|1009901|P1|COMPLETED|Overall Study||14
412442|NCT00056550|1009901|P1|STARTED|Overall Study||14
412443|NCT00056498|1009908|P2|NOT COMPLETED|Overall Study||7
412444|NCT00056498|1009909|P1|NOT COMPLETED|Overall Study||5
412445|NCT00056498|1009908|P2|COMPLETED|Overall Study||28
412446|NCT00056498|1009909|P1|COMPLETED|Overall Study||25
412447|NCT00056498|1009908|P2|STARTED|Overall Study||35
412448|NCT00056498|1009909|P1|STARTED|Overall Study||30
412449|NCT00056472|1009921|P2|NOT COMPLETED|Overall Study||69
412450|NCT00056472|1009922|P1|NOT COMPLETED|Overall Study||48
412451|NCT00056472|1009921|P2|COMPLETED|Overall Study||61
412452|NCT00056472|1009922|P1|COMPLETED|Overall Study||81
412453|NCT00056472|1009921|P2|STARTED|Overall Study||130
412454|NCT00056472|1009922|P1|STARTED|Overall Study||129
412455|NCT00056407|1009934|P2|NOT COMPLETED|Overall Study||1193
412456|NCT00056407|1009935|P1|NOT COMPLETED|Overall Study||1211
412457|NCT00056407|1009934|P2|COMPLETED|Overall Study||2912
412458|NCT00056407|1009935|P1|COMPLETED|Overall Study||2915
412459|NCT00056407|1009934|P2|STARTED|Overall Study||4105
412460|NCT00056407|1009935|P1|STARTED|Overall Study||4126
412461|NCT00056316|1009993|P2|NOT COMPLETED|Overall Study||3
412462|NCT00056316|1009994|P1|NOT COMPLETED|Overall Study||3
412463|NCT00056316|1009993|P2|COMPLETED|Overall Study||38
412464|NCT00056316|1009994|P1|COMPLETED|Overall Study||30
412465|NCT00056316|1009993|P2|STARTED|Overall Study|over-enrolled due to potential higher rates of drop-out.|41
412466|NCT00056316|1009994|P1|STARTED|Overall Study||33
412467|NCT00056160|1010008|P2|NOT COMPLETED|Final Follow-up||0
412468|NCT00056160|1010009|P1|NOT COMPLETED|Final Follow-up||6
412469|NCT00056160|1010008|P2|COMPLETED|Final Follow-up||0
412470|NCT00056160|1010009|P1|COMPLETED|Final Follow-up||0
412471|NCT00056160|1010008|P2|STARTED|Final Follow-up||0
412472|NCT00056160|1010009|P1|STARTED|Final Follow-up||6
412473|NCT00056160|1010008|P2|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
412474|NCT00056160|1010009|P1|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||171
412475|NCT00056160|1010008|P2|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
412476|NCT00056160|1010009|P1|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||6
412477|NCT00056160|1010008|P2|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||0
412478|NCT00056160|1010009|P1|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||177
412479|NCT00056160|1010008|P2|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||163
412480|NCT00056160|1010009|P1|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||113
412481|NCT00056160|1010008|P2|COMPLETED|Up to Unblinding (07 Jun 2005)||13
412482|NCT00056160|1010009|P1|COMPLETED|Up to Unblinding (07 Jun 2005)||64
412483|NCT00056160|1010008|P2|STARTED|Up to Unblinding (07 Jun 2005)||176
412484|NCT00056160|1010009|P1|STARTED|Up to Unblinding (07 Jun 2005)||177
412485|NCT00055692|1010021|P1|NOT COMPLETED|Overall Study||0
412486|NCT00055692|1010021|P1|COMPLETED|Overall Study||46
412487|NCT00055692|1010021|P1|STARTED|Overall Study||46
412488|NCT00055601|1010032|P2|NOT COMPLETED|Overall Study||2
412489|NCT00055601|1010033|P1|NOT COMPLETED|Overall Study||2
412490|NCT00055601|1010032|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
412491|NCT00055601|1010033|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|46
412492|NCT00055601|1010032|P2|STARTED|Overall Study||49
412493|NCT00055601|1010033|P1|STARTED|Overall Study||48
412494|NCT00055497|1010047|P4|NOT COMPLETED|Overall Study||90
412495|NCT00055497|1010048|P3|NOT COMPLETED|Overall Study||2
412496|NCT00055497|1010049|P2|NOT COMPLETED|Overall Study||3
412497|NCT00055497|1010050|P1|NOT COMPLETED|Overall Study||5
412498|NCT00055497|1010047|P4|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|131
412499|NCT00055497|1010048|P3|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
412500|NCT00055497|1010049|P2|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
412501|NCT00055497|1010050|P1|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|13
412502|NCT00055497|1010047|P4|STARTED|Overall Study|17 participants who discontinued at/before Week 4 are counted here because they were not randomized.|221
412503|NCT00055497|1010048|P3|STARTED|Overall Study||18
412504|NCT00055497|1010049|P2|STARTED|Overall Study||19
412505|NCT00055497|1010050|P1|STARTED|Overall Study||18
412506|NCT00055471|1010095|P3|NOT COMPLETED|Period 2: Extension Period||0
412507|NCT00055471|1010096|P2|NOT COMPLETED|Period 2: Extension Period||0
412508|NCT00055471|1010097|P1|NOT COMPLETED|Period 2: Extension Period||0
412509|NCT00055471|1010095|P3|COMPLETED|Period 2: Extension Period||0
412510|NCT00055471|1010096|P2|COMPLETED|Period 2: Extension Period||6
412511|NCT00055471|1010097|P1|COMPLETED|Period 2: Extension Period||3
412512|NCT00055471|1010095|P3|STARTED|Period 2: Extension Period||0
412513|NCT00055471|1010096|P2|STARTED|Period 2: Extension Period|2 pts discontinued after completion of Period1,therefore 9 pts proceeded to participate in Period2|6
412514|NCT00055471|1010097|P1|STARTED|Period 2: Extension Period|Period 2 - attend Pts who,in the opinion of the Investigator,show benefit from treatment with ZD4054|3
412515|NCT00055471|1010095|P3|NOT COMPLETED|Period 1: Dose Escalation Period||3
412516|NCT00055471|1010096|P2|NOT COMPLETED|Period 1: Dose Escalation Period||2
412517|NCT00055471|1010097|P1|NOT COMPLETED|Period 1: Dose Escalation Period||0
412518|NCT00055471|1010095|P3|COMPLETED|Period 1: Dose Escalation Period||0
412519|NCT00055471|1010096|P2|COMPLETED|Period 1: Dose Escalation Period||8
412520|NCT00055471|1010097|P1|COMPLETED|Period 1: Dose Escalation Period||3
412521|NCT00055471|1010095|P3|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|3
412522|NCT00055471|1010096|P2|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|10
412523|NCT00055471|1010097|P1|STARTED|Period 1: Dose Escalation Period||3
412524|NCT00055237|1010125|P2|NOT COMPLETED|Overall Study||0
412525|NCT00055237|1010126|P1|NOT COMPLETED|Overall Study||0
412526|NCT00055237|1010125|P2|COMPLETED|Overall Study||2
412527|NCT00055237|1010126|P1|COMPLETED|Overall Study||17
412528|NCT00055237|1010125|P2|STARTED|Overall Study||2
412529|NCT00055237|1010126|P1|STARTED|Overall Study||17
412530|NCT00054847|1010133|P2|NOT COMPLETED|Overall Study||100
412531|NCT00054847|1010134|P1|NOT COMPLETED|Overall Study||98
412532|NCT00054847|1010133|P2|COMPLETED|Overall Study||266
412533|NCT00054847|1010134|P1|COMPLETED|Overall Study||269
412534|NCT00054847|1010133|P2|STARTED|Overall Study||366
412535|NCT00054847|1010134|P1|STARTED|Overall Study||367
412536|NCT00054756|1010146|P1|NOT COMPLETED|Overall Study||2
412537|NCT00054756|1010146|P1|COMPLETED|Overall Study||94
412538|NCT00054756|1010146|P1|STARTED|Overall Study||96
412539|NCT00054717|1010152|P2|NOT COMPLETED|Overall Study||299
412540|NCT00054717|1010153|P1|NOT COMPLETED|Overall Study||262
412541|NCT00054717|1010152|P2|COMPLETED|Overall Study||18
412542|NCT00054717|1010153|P1|COMPLETED|Overall Study||51
412543|NCT00054717|1010152|P2|STARTED|Overall Study||317
412544|NCT00054717|1010153|P1|STARTED|Overall Study||313
412545|NCT00054704|1010341|P2|NOT COMPLETED|Overall Study||5
412546|NCT00054704|1010342|P1|NOT COMPLETED|Overall Study||5
412547|NCT00054704|1010341|P2|COMPLETED|Overall Study||6
412548|NCT00054704|1010342|P1|COMPLETED|Overall Study||3
412549|NCT00054704|1010341|P2|STARTED|Overall Study||11
412550|NCT00054704|1010342|P1|STARTED|Overall Study||8
412551|NCT00054691|1010348|P1|NOT COMPLETED|Overall Study||3
412552|NCT00054691|1010348|P1|COMPLETED|Overall Study||37
412553|NCT00054691|1010348|P1|STARTED|Overall Study||40
412554|NCT00054665|1010353|P2|NOT COMPLETED|Part B||0
412555|NCT00054665|1010354|P1|NOT COMPLETED|Part B||0
412556|NCT00054665|1010353|P2|COMPLETED|Part B||44
412557|NCT00054665|1010354|P1|COMPLETED|Part B||0
412558|NCT00054665|1010353|P2|STARTED|Part B|26 participants received only Part B|44
412559|NCT00054665|1010354|P1|STARTED|Part B||0
412560|NCT00054665|1010353|P2|NOT COMPLETED|Part A||0
412561|NCT00054665|1010354|P1|NOT COMPLETED|Part A||0
412562|NCT00054665|1010353|P2|COMPLETED|Part A||0
412563|NCT00054665|1010354|P1|COMPLETED|Part A||23
412564|NCT00054665|1010353|P2|STARTED|Part A||0
412565|NCT00054665|1010354|P1|STARTED|Part A|5 participants only received Part A and 18 participants received Part B after Part A.|23
412566|NCT00054639|1010362|P1|NOT COMPLETED|Overall Study||2
412567|NCT00054639|1010362|P1|COMPLETED|Overall Study||46
412568|NCT00054639|1010362|P1|STARTED|Overall Study||48
412569|NCT00054353|1010368|P2|NOT COMPLETED|Overall Study||0
412570|NCT00054353|1010369|P1|NOT COMPLETED|Overall Study||0
412571|NCT00054353|1010368|P2|COMPLETED|Overall Study||4
412572|NCT00054353|1010369|P1|COMPLETED|Overall Study||12
412573|NCT00054353|1010368|P2|STARTED|Overall Study||4
412574|NCT00054353|1010369|P1|STARTED|Overall Study||12
412575|NCT00054327|1010395|P6|NOT COMPLETED|Overall Study||0
412576|NCT00054327|1010396|P5|NOT COMPLETED|Overall Study||0
412577|NCT00054327|1010397|P4|NOT COMPLETED|Overall Study||0
412578|NCT00054327|1010398|P3|NOT COMPLETED|Overall Study||0
412579|NCT00054327|1010399|P2|NOT COMPLETED|Overall Study||0
412580|NCT00054327|1010400|P1|NOT COMPLETED|Overall Study||1
412581|NCT00054327|1010395|P6|COMPLETED|Overall Study||2
412582|NCT00054327|1010396|P5|COMPLETED|Overall Study||10
412583|NCT00054327|1010397|P4|COMPLETED|Overall Study||4
412584|NCT00054327|1010398|P3|COMPLETED|Overall Study||3
412585|NCT00054327|1010399|P2|COMPLETED|Overall Study||4
412586|NCT00054327|1010400|P1|COMPLETED|Overall Study||10
412587|NCT00054327|1010395|P6|STARTED|Overall Study||2
412588|NCT00054327|1010396|P5|STARTED|Overall Study||10
412589|NCT00054327|1010397|P4|STARTED|Overall Study||4
412590|NCT00054327|1010398|P3|STARTED|Overall Study||3
412591|NCT00054327|1010399|P2|STARTED|Overall Study||4
412592|NCT00054327|1010400|P1|STARTED|Overall Study||11
412593|NCT00054275|1010438|P1|NOT COMPLETED|Overall Study||11
412594|NCT00054275|1010438|P1|COMPLETED|Overall Study||28
412595|NCT00054275|1010438|P1|STARTED|Overall Study||39
412596|NCT00054132|1010444|P1|NOT COMPLETED|Overall Study||1
412597|NCT00054132|1010444|P1|COMPLETED|Overall Study||37
412598|NCT00054132|1010444|P1|STARTED|Overall Study||38
412599|NCT00054028|1010455|P1|NOT COMPLETED|Overall Study||0
412600|NCT00054028|1010455|P1|COMPLETED|Overall Study||31
412601|NCT00054028|1010455|P1|Phase II|Overall Study||22
412602|NCT00054028|1010455|P1|Phase I|Overall Study||9
412603|NCT00054028|1010455|P1|STARTED|Overall Study||31
412604|NCT00053898|1010463|P2|NOT COMPLETED|Overall Study||13
412605|NCT00053898|1010464|P1|NOT COMPLETED|Overall Study||14
412606|NCT00053898|1010463|P2|COMPLETED|Overall Study||1539
412607|NCT00053898|1010464|P1|COMPLETED|Overall Study||1538
412608|NCT00053898|1010463|P2|STARTED|Overall Study||1552
412609|NCT00053898|1010464|P1|STARTED|Overall Study||1552
412610|NCT00053846|1010490|P2|NOT COMPLETED|Overall Study||27
412611|NCT00053846|1010491|P1|NOT COMPLETED|Overall Study||26
412612|NCT00053846|1010490|P2|COMPLETED|Overall Study||192
412613|NCT00053846|1010491|P1|COMPLETED|Overall Study||187
412614|NCT00053846|1010490|P2|STARTED|Overall Study||219
412615|NCT00053846|1010491|P1|STARTED|Overall Study||213
412616|NCT00053703|1010500|P3|NOT COMPLETED|Overall Study||15
412617|NCT00053703|1010501|P2|NOT COMPLETED|Overall Study||13
412618|NCT00053703|1010502|P1|NOT COMPLETED|Overall Study||18
412619|NCT00053703|1010500|P3|COMPLETED|Overall Study||25
412620|NCT00053703|1010501|P2|COMPLETED|Overall Study||28
412621|NCT00053703|1010502|P1|COMPLETED|Overall Study||17
412622|NCT00053703|1010500|P3|STARTED|Overall Study||40
412623|NCT00053703|1010501|P2|STARTED|Overall Study||41
412624|NCT00053703|1010502|P1|STARTED|Overall Study||35
412625|NCT00053677|1010527|P2|NOT COMPLETED|Overall Study||6
412626|NCT00053677|1010528|P1|NOT COMPLETED|Overall Study||22
412627|NCT00053677|1010527|P2|COMPLETED|Overall Study||13
412628|NCT00053677|1010528|P1|COMPLETED|Overall Study||36
412629|NCT00053677|1010527|P2|STARTED|Overall Study||19
412630|NCT00053677|1010528|P1|STARTED|Overall Study||58
412631|NCT00053495|1010539|P5|NOT COMPLETED|Overall Study||0
412632|NCT00053495|1010540|P4|NOT COMPLETED|Overall Study||0
412633|NCT00053495|1010541|P3|NOT COMPLETED|Overall Study||0
412634|NCT00053495|1010542|P2|NOT COMPLETED|Overall Study||0
412635|NCT00053495|1010543|P1|NOT COMPLETED|Overall Study||0
412636|NCT00053495|1010539|P5|COMPLETED|Overall Study||49
412637|NCT00053495|1010540|P4|COMPLETED|Overall Study||51
412638|NCT00053495|1010541|P3|COMPLETED|Overall Study||101
412639|NCT00053495|1010542|P2|COMPLETED|Overall Study||101
412640|NCT00053495|1010543|P1|COMPLETED|Overall Study||51
412641|NCT00053495|1010539|P5|STARTED|Overall Study||49
412642|NCT00053495|1010540|P4|STARTED|Overall Study||51
412643|NCT00053495|1010541|P3|STARTED|Overall Study||101
412644|NCT00053495|1010542|P2|STARTED|Overall Study||101
412645|NCT00053495|1010543|P1|STARTED|Overall Study||51
412646|NCT00053482|1010595|P5|NOT COMPLETED|Overall Study||0
412647|NCT00053482|1010596|P4|NOT COMPLETED|Overall Study||0
412648|NCT00053482|1010597|P3|NOT COMPLETED|Overall Study||0
412649|NCT00053482|1010598|P2|NOT COMPLETED|Overall Study||0
412650|NCT00053482|1010599|P1|NOT COMPLETED|Overall Study||0
412651|NCT00053482|1010595|P5|COMPLETED|Overall Study||52
412652|NCT00053482|1010596|P4|COMPLETED|Overall Study||50
412653|NCT00053482|1010597|P3|COMPLETED|Overall Study||102
412654|NCT00053482|1010598|P2|COMPLETED|Overall Study||102
412655|NCT00053482|1010599|P1|COMPLETED|Overall Study||51
412656|NCT00053482|1010595|P5|STARTED|Overall Study||52
412657|NCT00053482|1010596|P4|STARTED|Overall Study||50
412658|NCT00053482|1010597|P3|STARTED|Overall Study||102
412659|NCT00053482|1010598|P2|STARTED|Overall Study||102
412660|NCT00053482|1010599|P1|STARTED|Overall Study||51
412661|NCT00053417|1010650|P4|NOT COMPLETED|Overall Study||6
412662|NCT00053417|1010651|P3|NOT COMPLETED|Overall Study||1
412663|NCT00053417|1010652|P2|NOT COMPLETED|Overall Study||2
412664|NCT00053417|1010653|P1|NOT COMPLETED|Overall Study||2
412665|NCT00053417|1010650|P4|COMPLETED|Overall Study||51
412666|NCT00053417|1010651|P3|COMPLETED|Overall Study||49
412667|NCT00053417|1010652|P2|COMPLETED|Overall Study||50
412668|NCT00053417|1010653|P1|COMPLETED|Overall Study||45
412669|NCT00053417|1010650|P4|STARTED|Overall Study||57
412670|NCT00053417|1010651|P3|STARTED|Overall Study||50
412671|NCT00053417|1010652|P2|STARTED|Overall Study||52
412672|NCT00053417|1010653|P1|STARTED|Overall Study||47
412673|NCT00053365|1010663|P1|NOT COMPLETED|Overall Study||6
412674|NCT00053365|1010663|P1|COMPLETED|Overall Study||55
412675|NCT00053365|1010663|P1|STARTED|Overall Study||61
412676|NCT00053352|1010672|P2|NOT COMPLETED|Overall Study||10
412677|NCT00053352|1010673|P1|NOT COMPLETED|Overall Study||21
412678|NCT00053352|1010672|P2|COMPLETED|Overall Study||102
412679|NCT00053352|1010673|P1|COMPLETED|Overall Study||169
412680|NCT00053352|1010672|P2|STARTED|Overall Study||112
412681|NCT00053352|1010673|P1|STARTED|Overall Study||190
412682|NCT00053014|1010682|P1|NOT COMPLETED|Overall Study||0
412683|NCT00053014|1010682|P1|COMPLETED|Overall Study||5
412684|NCT00053014|1010682|P1|STARTED|Overall Study||5
412685|NCT00003830|1010689|P2|NOT COMPLETED|Overall Study||793
412686|NCT00003830|1010690|P1|NOT COMPLETED|Overall Study||832
412687|NCT00003830|1010689|P2|COMPLETED|Overall Study||2011
412688|NCT00003830|1010690|P1|COMPLETED|Overall Study||1975
412689|NCT00003830|1010689|P2|STARTED|Overall Study||2804
412690|NCT00003830|1010690|P1|STARTED|Overall Study||2807
412691|NCT00052962|1010716|P2|NOT COMPLETED|Overall Study||2
412692|NCT00052962|1010717|P1|NOT COMPLETED|Overall Study||1
412693|NCT00052962|1010716|P2|COMPLETED|Overall Study||15
412694|NCT00052962|1010717|P1|COMPLETED|Overall Study||12
412695|NCT00052962|1010716|P2|STARTED|Overall Study||17
412696|NCT00052962|1010717|P1|STARTED|Overall Study||13
412697|NCT00052910|1010727|P2|NOT COMPLETED|Overall Study||0
412698|NCT00052910|1010728|P1|NOT COMPLETED|Overall Study||0
412699|NCT00052910|1010727|P2|COMPLETED|Overall Study||266
412700|NCT00052910|1010728|P1|COMPLETED|Overall Study||280
412701|NCT00052910|1010727|P2|STARTED|Overall Study||266
412702|NCT00052910|1010728|P1|STARTED|Overall Study||280
412703|NCT00052715|1010736|P1|NOT COMPLETED|Overall Study||1
412704|NCT00052715|1010736|P1|COMPLETED|Overall Study||30
412705|NCT00052715|1010736|P1|STARTED|Overall Study||31
412706|NCT00052429|1010745|P1|NOT COMPLETED|Overall Study||0
412707|NCT00052429|1010745|P1|COMPLETED|Overall Study||25
412708|NCT00052429|1010745|P1|STARTED|Overall Study||25
412709|NCT00049543|1010752|P2|NOT COMPLETED|Overall Study||9
412710|NCT00049543|1010753|P1|NOT COMPLETED|Overall Study||2
412711|NCT00049543|1010752|P2|COMPLETED|Overall Study||243
412712|NCT00049543|1010753|P1|COMPLETED|Overall Study||249
412713|NCT00049543|1010752|P2|STARTED|Overall Study||252
412714|NCT00049543|1010753|P1|STARTED|Overall Study||251
412715|NCT00049530|1010763|P1|NOT COMPLETED|Overall Study||32
412716|NCT00049530|1010763|P1|COMPLETED|Overall Study||0
412717|NCT00049530|1010763|P1|Eligible and Treated|Overall Study||29
412718|NCT00049530|1010763|P1|STARTED|Overall Study||32
412719|NCT00049517|1010772|P6|NOT COMPLETED|Conditioning/Transplant||6
412720|NCT00049517|1010773|P5|NOT COMPLETED|Conditioning/Transplant||6
412721|NCT00049517|1010774|P4|NOT COMPLETED|Conditioning/Transplant||43
412722|NCT00049517|1010775|P3|NOT COMPLETED|Conditioning/Transplant||38
412723|NCT00049517|1010776|P2|NOT COMPLETED|Conditioning/Transplant||50
412724|NCT00049517|1010777|P1|NOT COMPLETED|Conditioning/Transplant||52
412725|NCT00049517|1010772|P6|COMPLETED|Conditioning/Transplant||18
412726|NCT00049517|1010773|P5|COMPLETED|Conditioning/Transplant||15
412727|NCT00049517|1010774|P4|COMPLETED|Conditioning/Transplant||32
412728|NCT00049517|1010775|P3|COMPLETED|Conditioning/Transplant||25
412729|NCT00049517|1010776|P2|COMPLETED|Conditioning/Transplant||40
412730|NCT00049517|1010777|P1|COMPLETED|Conditioning/Transplant||27
412731|NCT00049517|1010772|P6|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 24 patients received Allogeneic HCT without randomization.|0
412732|NCT00049517|1010773|P5|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 21 patients received Allogeneic HCT without randomization.|0
412733|NCT00049517|1010774|P4|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||75
412734|NCT00049517|1010775|P3|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||63
412735|NCT00049517|1010776|P2|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 17 patients received Autologous HCT without randomization.|73
412736|NCT00049517|1010777|P1|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 20 patients received Autologous HCT without randomization.|59
412737|NCT00049517|1010772|P6|STARTED|Conditioning/Transplant||24
412738|NCT00049517|1010773|P5|STARTED|Conditioning/Transplant||21
412739|NCT00049517|1010774|P4|STARTED|Conditioning/Transplant||75
412740|NCT00049517|1010775|P3|STARTED|Conditioning/Transplant||63
412741|NCT00049517|1010776|P2|STARTED|Conditioning/Transplant||90
412742|NCT00049517|1010777|P1|STARTED|Conditioning/Transplant||79
412743|NCT00049517|1010772|P6|NOT COMPLETED|Induction||54
412744|NCT00049517|1010773|P5|NOT COMPLETED|Induction||60
412745|NCT00049517|1010774|P4|NOT COMPLETED|Induction||0
412746|NCT00049517|1010775|P3|NOT COMPLETED|Induction||0
412747|NCT00049517|1010776|P2|NOT COMPLETED|Induction||0
412748|NCT00049517|1010777|P1|NOT COMPLETED|Induction||0
412749|NCT00049517|1010772|P6|COMPLETED|Induction||108
412750|NCT00049517|1010773|P5|COMPLETED|Induction||128
412751|NCT00049517|1010774|P4|COMPLETED|Induction||75
412752|NCT00049517|1010775|P3|COMPLETED|Induction||63
412753|NCT00049517|1010776|P2|COMPLETED|Induction||90
412754|NCT00049517|1010777|P1|COMPLETED|Induction||79
412755|NCT00049517|1010772|P6|Treated|Induction||160
412756|NCT00049517|1010773|P5|Treated|Induction||186
412757|NCT00049517|1010774|P4|Treated|Induction||75
412758|NCT00049517|1010775|P3|Treated|Induction||63
412759|NCT00049517|1010776|P2|Treated|Induction||90
412760|NCT00049517|1010777|P1|Treated|Induction||79
412761|NCT00049517|1010772|P6|STARTED|Induction||162
412762|NCT00049517|1010773|P5|STARTED|Induction||188
412763|NCT00049517|1010774|P4|STARTED|Induction||75
412764|NCT00049517|1010775|P3|STARTED|Induction||63
412765|NCT00049517|1010776|P2|STARTED|Induction||90
412766|NCT00049517|1010777|P1|STARTED|Induction||79
412767|NCT00049504|1010787|P1|NOT COMPLETED|Overall Study||0
412768|NCT00049504|1010787|P1|COMPLETED|Overall Study||55
412769|NCT00049504|1010787|P1|STARTED|Overall Study||55
412770|NCT00049322|1010795|P2|NOT COMPLETED|Overall Study||6
412771|NCT00049322|1010796|P1|NOT COMPLETED|Overall Study||1
412772|NCT00049322|1010795|P2|COMPLETED|Overall Study||9
412773|NCT00049322|1010796|P1|COMPLETED|Overall Study||14
412774|NCT00049322|1010795|P2|STARTED|Overall Study||15
412775|NCT00049322|1010796|P1|STARTED|Overall Study||15
412776|NCT00049257|1010808|P1|NOT COMPLETED|Follow-up Period for Survival Status||4
412777|NCT00049257|1010808|P1|COMPLETED|Follow-up Period for Survival Status||41
412778|NCT00049257|1010808|P1|STARTED|Follow-up Period for Survival Status||45
412779|NCT00049257|1010808|P1|NOT COMPLETED|Carboplatin, Paclitaxel||13
412780|NCT00049257|1010808|P1|COMPLETED|Carboplatin, Paclitaxel|13 participants did not complete treatment|45
412781|NCT00049257|1010808|P1|STARTED|Carboplatin, Paclitaxel||58
412782|NCT00049127|1010820|P5|NOT COMPLETED|Overall Study||0
412783|NCT00049127|1010821|P4|NOT COMPLETED|Overall Study||0
412784|NCT00049127|1010822|P3|NOT COMPLETED|Overall Study||1
412785|NCT00049127|1010823|P2|NOT COMPLETED|Overall Study||0
412786|NCT00049127|1010824|P1|NOT COMPLETED|Overall Study||0
412787|NCT00049127|1010820|P5|COMPLETED|Overall Study||12
412788|NCT00049127|1010821|P4|COMPLETED|Overall Study||0
412789|NCT00049127|1010822|P3|COMPLETED|Overall Study||39
412790|NCT00049127|1010823|P2|COMPLETED|Overall Study||0
412791|NCT00049127|1010824|P1|COMPLETED|Overall Study||12
412792|NCT00049127|1010820|P5|STARTED|Overall Study||12
412793|NCT00049127|1010821|P4|STARTED|Overall Study||0
412794|NCT00049127|1010822|P3|STARTED|Overall Study||40
412795|NCT00049127|1010823|P2|STARTED|Overall Study||0
412796|NCT00049127|1010824|P1|STARTED|Overall Study||12
412797|NCT00049036|1010853|P2|NOT COMPLETED|Overall Study||0
412798|NCT00049036|1010854|P1|NOT COMPLETED|Overall Study||0
412799|NCT00049036|1010853|P2|COMPLETED|Overall Study||55
412800|NCT00049036|1010854|P1|COMPLETED|Overall Study||51
412801|NCT00049036|1010853|P2|STARTED|Overall Study||55
412802|NCT00049036|1010854|P1|STARTED|Overall Study||51
412803|NCT00048997|1010862|P2|NOT COMPLETED|Overall Study||3
412804|NCT00048997|1010863|P1|NOT COMPLETED|Overall Study||13
412805|NCT00048997|1010862|P2|COMPLETED|Overall Study||177
412806|NCT00048997|1010863|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|163
412807|NCT00048997|1010862|P2|STARTED|Overall Study||180
412808|NCT00048997|1010863|P1|STARTED|Overall Study||176
412809|NCT00047385|1010886|P2|NOT COMPLETED|Overall Study||500
412810|NCT00047385|1010887|P1|NOT COMPLETED|Overall Study||267
412811|NCT00047385|1010886|P2|COMPLETED|Overall Study||26232
412812|NCT00047385|1010887|P1|COMPLETED|Overall Study|Had at least one screening exam.|26455
412813|NCT00047385|1010886|P2|STARTED|Overall Study||26732
412814|NCT00047385|1010887|P1|STARTED|Overall Study||26722
412815|NCT00047320|1010905|P1|NOT COMPLETED|Overall Study||28
412816|NCT00047320|1010905|P1|COMPLETED|Overall Study||76
412817|NCT00047320|1010905|P1|STARTED|Overall Study||104
412818|NCT00047008|1010916|P2|NOT COMPLETED|Overall Study||11
412819|NCT00047008|1010917|P1|NOT COMPLETED|Overall Study||11
412820|NCT00047008|1010916|P2|COMPLETED|Overall Study||360
412821|NCT00047008|1010917|P1|COMPLETED|Overall Study||361
412822|NCT00047008|1010916|P2|STARTED|Overall Study||371
412823|NCT00047008|1010917|P1|STARTED|Overall Study||372
412824|NCT00046930|1010925|P2|NOT COMPLETED|Overall Study||4
412825|NCT00046930|1010926|P1|NOT COMPLETED|Overall Study||12
412826|NCT00046930|1010925|P2|COMPLETED|Overall Study||221
412827|NCT00046930|1010926|P1|COMPLETED|Overall Study||212
412828|NCT00046930|1010925|P2|STARTED|Overall Study||225
412829|NCT00046930|1010926|P1|STARTED|Overall Study||224
412830|NCT00046891|1010941|P2|NOT COMPLETED|Overall Study||30
412831|NCT00046891|1010942|P1|NOT COMPLETED|Overall Study||29
412832|NCT00046891|1010941|P2|COMPLETED|Overall Study||83
412833|NCT00046891|1010942|P1|COMPLETED|Overall Study||84
412834|NCT00046891|1010941|P2|STARTED|Overall Study||113
412835|NCT00046891|1010942|P1|STARTED|Overall Study||113
412836|NCT00046839|1010962|P2|NOT COMPLETED|Overall Study||2
412837|NCT00046839|1010963|P1|NOT COMPLETED|Overall Study||1
412838|NCT00046839|1010962|P2|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|11
412839|NCT00046839|1010963|P1|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|7
412840|NCT00046839|1010962|P2|STARTED|Overall Study||13
412841|NCT00046839|1010963|P1|STARTED|Overall Study||8
412842|NCT00045734|1010970|P1|NOT COMPLETED|Overall Study||1
412843|NCT00045734|1010970|P1|COMPLETED|Overall Study||22
412844|NCT00045734|1010970|P1|STARTED|Overall Study||23
412845|NCT00045708|1010985|P3|NOT COMPLETED|Phase 2||0
412846|NCT00045708|1010986|P2|NOT COMPLETED|Phase 2||0
412847|NCT00045708|1010987|P1|NOT COMPLETED|Phase 2||0
412848|NCT00045708|1010985|P3|COMPLETED|Phase 2||19
412849|NCT00045708|1010986|P2|COMPLETED|Phase 2||0
412850|NCT00045708|1010987|P1|COMPLETED|Phase 2||0
412851|NCT00045708|1010985|P3|STARTED|Phase 2||19
412852|NCT00045708|1010986|P2|STARTED|Phase 2||0
412853|NCT00045708|1010987|P1|STARTED|Phase 2||0
412854|NCT00045708|1010985|P3|NOT COMPLETED|Phase 1||0
412855|NCT00045708|1010986|P2|NOT COMPLETED|Phase 1||1
412856|NCT00045708|1010987|P1|NOT COMPLETED|Phase 1||0
412857|NCT00045708|1010985|P3|COMPLETED|Phase 1||0
412858|NCT00045708|1010986|P2|COMPLETED|Phase 1||16
412859|NCT00045708|1010987|P1|COMPLETED|Phase 1||21
412860|NCT00045708|1010985|P3|STARTED|Phase 1||0
412861|NCT00045708|1010986|P2|STARTED|Phase 1||17
412862|NCT00045708|1010987|P1|STARTED|Phase 1||21
412863|NCT00045630|1011012|P1|NOT COMPLETED|Overall Study||6
412864|NCT00045630|1011012|P1|COMPLETED|Overall Study||71
412865|NCT00045630|1011012|P1|Eligible and Began Protocol Therapy|Overall Study||74
412866|NCT00045630|1011012|P1|Eligible|Overall Study||75
412867|NCT00045630|1011012|P1|STARTED|Overall Study||77
412868|NCT00045487|1011018|P1|NOT COMPLETED|Overall Study||11
412869|NCT00045487|1011018|P1|COMPLETED|Overall Study||30
412870|NCT00045487|1011018|P1|STARTED|Overall Study||41
412871|NCT00045435|1011022|P1|NOT COMPLETED|Overall Study||0
412872|NCT00045435|1011022|P1|COMPLETED|Overall Study||17
412873|NCT00045435|1011022|P1|STARTED|Overall Study||17
412874|NCT00045305|1011031|P1|NOT COMPLETED|Overall Study||14
412875|NCT00045305|1011031|P1|COMPLETED|Overall Study||3
412876|NCT00045305|1011031|P1|Eligible and Treated|Overall Study||17
412877|NCT00045305|1011031|P1|STARTED|Overall Study||17
412878|NCT00045162|1011042|P2|NOT COMPLETED|Overall Study||118
412879|NCT00045162|1011043|P1|NOT COMPLETED|Overall Study||142
412880|NCT00045162|1011042|P2|COMPLETED|Overall Study||217
412881|NCT00045162|1011043|P1|COMPLETED|Overall Study||194
412882|NCT00045162|1011042|P2|STARTED|Overall Study||335
412883|NCT00045162|1011043|P1|STARTED|Overall Study||336
412884|NCT00045110|1011058|P3|NOT COMPLETED|775mg Dose Escalation||0
412885|NCT00045110|1011059|P2|NOT COMPLETED|775mg Dose Escalation||0
412886|NCT00045110|1011060|P1|NOT COMPLETED|775mg Dose Escalation||0
412887|NCT00045110|1011058|P3|COMPLETED|775mg Dose Escalation||0
412888|NCT00045110|1011059|P2|COMPLETED|775mg Dose Escalation||0
412889|NCT00045110|1011060|P1|COMPLETED|775mg Dose Escalation||7
412890|NCT00045110|1011058|P3|STARTED|775mg Dose Escalation||0
412891|NCT00045110|1011059|P2|STARTED|775mg Dose Escalation||0
412892|NCT00045110|1011060|P1|STARTED|775mg Dose Escalation||7
412893|NCT00045110|1011058|P3|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
412894|NCT00045110|1011059|P2|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
412895|NCT00045110|1011060|P1|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
412896|NCT00045110|1011058|P3|COMPLETED|650mg Phase 1 Dose Escalation||0
412897|NCT00045110|1011059|P2|COMPLETED|650mg Phase 1 Dose Escalation||0
412898|NCT00045110|1011060|P1|COMPLETED|650mg Phase 1 Dose Escalation||6
412899|NCT00045110|1011058|P3|STARTED|650mg Phase 1 Dose Escalation||0
412900|NCT00045110|1011059|P2|STARTED|650mg Phase 1 Dose Escalation||0
412901|NCT00045110|1011060|P1|STARTED|650mg Phase 1 Dose Escalation||6
412902|NCT00045110|1011058|P3|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
412903|NCT00045110|1011059|P2|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
412904|NCT00045110|1011060|P1|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
412905|NCT00045110|1011058|P3|COMPLETED|525mg Phase 1 Dose Escalation||0
412906|NCT00045110|1011059|P2|COMPLETED|525mg Phase 1 Dose Escalation||0
412907|NCT00045110|1011060|P1|COMPLETED|525mg Phase 1 Dose Escalation||3
412908|NCT00045110|1011058|P3|STARTED|525mg Phase 1 Dose Escalation||0
412909|NCT00045110|1011059|P2|STARTED|525mg Phase 1 Dose Escalation||0
412910|NCT00045110|1011060|P1|STARTED|525mg Phase 1 Dose Escalation||3
412911|NCT00045110|1011058|P3|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
412912|NCT00045110|1011059|P2|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
412913|NCT00045110|1011060|P1|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
412914|NCT00045110|1011058|P3|COMPLETED|400mg Phase 1 Dose Escalation||0
412915|NCT00045110|1011059|P2|COMPLETED|400mg Phase 1 Dose Escalation||0
412916|NCT00045110|1011060|P1|COMPLETED|400mg Phase 1 Dose Escalation||3
412917|NCT00045110|1011058|P3|STARTED|400mg Phase 1 Dose Escalation||0
412918|NCT00045110|1011059|P2|STARTED|400mg Phase 1 Dose Escalation||0
412919|NCT00045110|1011060|P1|STARTED|400mg Phase 1 Dose Escalation||3
412920|NCT00045110|1011058|P3|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
412921|NCT00045110|1011059|P2|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
412922|NCT00045110|1011060|P1|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
412923|NCT00045110|1011058|P3|COMPLETED|275mg Phase 1 Dose Escalation||0
412924|NCT00045110|1011059|P2|COMPLETED|275mg Phase 1 Dose Escalation||0
412925|NCT00045110|1011060|P1|COMPLETED|275mg Phase 1 Dose Escalation||3
412926|NCT00045110|1011058|P3|STARTED|275mg Phase 1 Dose Escalation||0
412927|NCT00045110|1011059|P2|STARTED|275mg Phase 1 Dose Escalation||0
412928|NCT00045110|1011060|P1|STARTED|275mg Phase 1 Dose Escalation||3
412929|NCT00045110|1011058|P3|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
412930|NCT00045110|1011059|P2|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
412931|NCT00045110|1011060|P1|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
412932|NCT00045110|1011058|P3|COMPLETED|200mg Phase 1 Dose Escalation||0
412933|NCT00045110|1011059|P2|COMPLETED|200mg Phase 1 Dose Escalation||0
412934|NCT00045110|1011060|P1|COMPLETED|200mg Phase 1 Dose Escalation||4
412935|NCT00045110|1011058|P3|STARTED|200mg Phase 1 Dose Escalation||0
412936|NCT00045110|1011059|P2|STARTED|200mg Phase 1 Dose Escalation||0
412937|NCT00045110|1011060|P1|STARTED|200mg Phase 1 Dose Escalation||4
412938|NCT00045110|1011058|P3|NOT COMPLETED|100mg Phase 1 Dose Escalalation||2
412939|NCT00045110|1011059|P2|NOT COMPLETED|100mg Phase 1 Dose Escalalation||6
412940|NCT00045110|1011060|P1|NOT COMPLETED|100mg Phase 1 Dose Escalalation||0
412941|NCT00045110|1011058|P3|COMPLETED|100mg Phase 1 Dose Escalalation||43
412942|NCT00045110|1011059|P2|COMPLETED|100mg Phase 1 Dose Escalalation||53
412943|NCT00045110|1011060|P1|COMPLETED|100mg Phase 1 Dose Escalalation||6
412944|NCT00045110|1011058|P3|STARTED|100mg Phase 1 Dose Escalalation||45
412945|NCT00045110|1011059|P2|STARTED|100mg Phase 1 Dose Escalalation||59
412946|NCT00045110|1011060|P1|STARTED|100mg Phase 1 Dose Escalalation||6
412947|NCT00045032|1011109|P3|NOT COMPLETED|Overall Study||726
412948|NCT00045032|1011110|P2|NOT COMPLETED|Overall Study||708
412949|NCT00045032|1011111|P1|NOT COMPLETED|Overall Study||863
412950|NCT00045032|1011109|P3|COMPLETED|Overall Study||974
412951|NCT00045032|1011110|P2|COMPLETED|Overall Study||994
412952|NCT00045032|1011111|P1|COMPLETED|Overall Study||834
412953|NCT00045032|1011109|P3|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
412954|NCT00045032|1011110|P2|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
412955|NCT00045032|1011111|P1|Crossover to Adjuvant Herceptin|Overall Study||888
412956|NCT00045032|1011109|P3|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1700
412957|NCT00045032|1011110|P2|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1702
412958|NCT00045032|1011111|P1|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1697
412959|NCT00042991|1011245|P7|NOT COMPLETED|Overall Study||2
412960|NCT00042991|1011246|P6|NOT COMPLETED|Overall Study||5
412961|NCT00042991|1011247|P5|NOT COMPLETED|Overall Study||3
412962|NCT00042991|1011248|P4|NOT COMPLETED|Overall Study||2
412963|NCT00042991|1011249|P3|NOT COMPLETED|Overall Study||6
412964|NCT00042991|1011250|P2|NOT COMPLETED|Overall Study||40
412965|NCT00042991|1011251|P1|NOT COMPLETED|Overall Study||6
412966|NCT00042991|1011245|P7|COMPLETED|Overall Study||1
412967|NCT00042991|1011246|P6|COMPLETED|Overall Study||0
412968|NCT00042991|1011247|P5|COMPLETED|Overall Study||0
412969|NCT00042991|1011248|P4|COMPLETED|Overall Study||0
412970|NCT00042991|1011249|P3|COMPLETED|Overall Study||1
412971|NCT00042991|1011250|P2|COMPLETED|Overall Study||3
412972|NCT00042991|1011251|P1|COMPLETED|Overall Study||0
412973|NCT00042991|1011245|P7|Phase-II Trial|Overall Study||0
412974|NCT00042991|1011246|P6|Phase-II Trial|Overall Study||0
412975|NCT00042991|1011247|P5|Phase-II Trial|Overall Study||0
412976|NCT00042991|1011248|P4|Phase-II Trial|Overall Study||0
412977|NCT00042991|1011249|P3|Phase-II Trial|Overall Study||0
412978|NCT00042991|1011250|P2|Phase-II Trial|Overall Study||36
412979|NCT00042991|1011251|P1|Phase-II Trial|Overall Study||0
412980|NCT00042991|1011245|P7|Phase-I Trial|Overall Study||3
412981|NCT00042991|1011246|P6|Phase-I Trial|Overall Study||5
412982|NCT00042991|1011247|P5|Phase-I Trial|Overall Study||3
412983|NCT00042991|1011248|P4|Phase-I Trial|Overall Study||2
412984|NCT00042991|1011249|P3|Phase-I Trial|Overall Study||7
412985|NCT00042991|1011250|P2|Phase-I Trial|Overall Study|These seven patients contributed to both Phase-I and Phase-II objectives.|7
412986|NCT00042991|1011251|P1|Phase-I Trial|Overall Study||6
412987|NCT00042991|1011245|P7|STARTED|Overall Study||3
412988|NCT00042991|1011246|P6|STARTED|Overall Study||5
412989|NCT00042991|1011247|P5|STARTED|Overall Study||3
412990|NCT00042991|1011248|P4|STARTED|Overall Study||2
412991|NCT00042991|1011249|P3|STARTED|Overall Study||7
412992|NCT00042991|1011250|P2|STARTED|Overall Study|These 43 patients form the Phase-II cohort, seven contributing from the Phase-I trial.|43
412993|NCT00042991|1011251|P1|STARTED|Overall Study||6
412994|NCT00042939|1011294|P2|NOT COMPLETED|Overall Study||21
412995|NCT00042939|1011295|P1|NOT COMPLETED|Overall Study||24
412996|NCT00042939|1011294|P2|COMPLETED|Overall Study||25
412997|NCT00042939|1011295|P1|COMPLETED|Overall Study||24
412998|NCT00042939|1011294|P2|Patients With EGFR Results Available|Overall Study||31
412999|NCT00042939|1011295|P1|Patients With EGFR Results Available|Overall Study||30
413000|NCT00042939|1011294|P2|Eligible and Began Protocol Therapy|Overall Study||43
413001|NCT00042939|1011295|P1|Eligible and Began Protocol Therapy|Overall Study||44
413002|NCT00042939|1011294|P2|Treated|Overall Study||45
413003|NCT00042939|1011295|P1|Treated|Overall Study||46
413004|NCT00042939|1011294|P2|STARTED|Overall Study||46
413005|NCT00042939|1011295|P1|STARTED|Overall Study||48
413006|NCT00041132|1011309|P1|NOT COMPLETED|Overall Study||30
413007|NCT00041132|1011309|P1|COMPLETED|Overall Study||26
413008|NCT00041132|1011309|P1|Eligible and Began Protocol Therapy|Overall Study||49
413009|NCT00041132|1011309|P1|Eligible|Overall Study||49
413010|NCT00041132|1011309|P1|STARTED|Overall Study||56
413011|NCT00041119|1011319|P4|NOT COMPLETED|Overall Study||0
413012|NCT00041119|1011320|P3|NOT COMPLETED|Overall Study||0
413013|NCT00041119|1011321|P2|NOT COMPLETED|Overall Study||0
413014|NCT00041119|1011322|P1|NOT COMPLETED|Overall Study||0
413015|NCT00041119|1011319|P4|COMPLETED|Overall Study||789
413016|NCT00041119|1011320|P3|COMPLETED|Overall Study||1151
413017|NCT00041119|1011321|P2|COMPLETED|Overall Study||789
413018|NCT00041119|1011322|P1|COMPLETED|Overall Study||1142
413019|NCT00041119|1011319|P4|STARTED|Overall Study||789
413020|NCT00041119|1011320|P3|STARTED|Overall Study||1151
413021|NCT00041119|1011321|P2|STARTED|Overall Study||789
413022|NCT00041119|1011322|P1|STARTED|Overall Study||1142
413023|NCT00041080|1011344|P2|NOT COMPLETED|Overall Study||10
413024|NCT00041080|1011345|P1|NOT COMPLETED|Overall Study||30
413025|NCT00041080|1011344|P2|COMPLETED|Overall Study||60
413026|NCT00041080|1011345|P1|COMPLETED|Overall Study||39
413027|NCT00041080|1011344|P2|STARTED|Overall Study|number patients enrolled on study|70
413028|NCT00041080|1011345|P1|STARTED|Overall Study|number patients enrolled on study|69
413029|NCT00041067|1011351|P1|NOT COMPLETED|Overall Study||76
413030|NCT00041067|1011351|P1|COMPLETED|Overall Study||0
413031|NCT00041067|1011351|P1|Eligible|Overall Study||74
413032|NCT00041067|1011351|P1|STARTED|Overall Study||76
413033|NCT00040937|1011358|P1|NOT COMPLETED|Maintenance||0
413034|NCT00040937|1011358|P1|COMPLETED|Maintenance|Patients remained on protocol therapy until progression.|76
413035|NCT00040937|1011358|P1|STARTED|Maintenance||76
413036|NCT00040937|1011358|P1|NOT COMPLETED|Autologous PBSCT||31
413037|NCT00040937|1011358|P1|COMPLETED|Autologous PBSCT||77
413038|NCT00040937|1011358|P1|STARTED|Autologous PBSCT|108 registered to this period; 105 were eligible and analyzable; 105 were assessable for toxicity.|108
413039|NCT00040937|1011358|P1|NOT COMPLETED|Induction/PBSC Mobilization||37
413040|NCT00040937|1011358|P1|COMPLETED|Induction/PBSC Mobilization||110
413041|NCT00040937|1011358|P1|STARTED|Induction/PBSC Mobilization|147 registered to this period; 142 were eligible and analyzable; 140 were assessable for toxicity.|147
413042|NCT00040846|1011371|P6|NOT COMPLETED|Overall Study||0
413043|NCT00040846|1011372|P5|NOT COMPLETED|Overall Study||0
413044|NCT00040846|1011373|P4|NOT COMPLETED|Overall Study||0
413045|NCT00040846|1011374|P3|NOT COMPLETED|Overall Study||0
413046|NCT00040846|1011375|P2|NOT COMPLETED|Overall Study||0
413047|NCT00040846|1011376|P1|NOT COMPLETED|Overall Study||0
413048|NCT00040846|1011371|P6|COMPLETED|Overall Study||0
413049|NCT00040846|1011372|P5|COMPLETED|Overall Study||0
413050|NCT00040846|1011373|P4|COMPLETED|Overall Study||0
413051|NCT00040846|1011374|P3|COMPLETED|Overall Study||0
413052|NCT00040846|1011375|P2|COMPLETED|Overall Study||0
413053|NCT00040846|1011376|P1|COMPLETED|Overall Study||60
413054|NCT00040846|1011371|P6|STARTED|Overall Study||0
413055|NCT00040846|1011372|P5|STARTED|Overall Study||0
413056|NCT00040846|1011373|P4|STARTED|Overall Study||0
413057|NCT00040846|1011374|P3|STARTED|Overall Study||0
413058|NCT00040846|1011375|P2|STARTED|Overall Study||0
413059|NCT00040846|1011376|P1|STARTED|Overall Study||60
413060|NCT00040742|1011418|P4|NOT COMPLETED|Overall Study||34
413061|NCT00040742|1011419|P3|NOT COMPLETED|Overall Study||46
413062|NCT00040742|1011420|P2|NOT COMPLETED|Overall Study||49
413063|NCT00040742|1011421|P1|NOT COMPLETED|Overall Study||39
413064|NCT00040742|1011418|P4|COMPLETED|Overall Study||152
413065|NCT00040742|1011419|P3|COMPLETED|Overall Study||141
413066|NCT00040742|1011420|P2|COMPLETED|Overall Study||134
413067|NCT00040742|1011421|P1|COMPLETED|Overall Study||149
413068|NCT00040742|1011418|P4|STARTED|Overall Study|One subject found to be ineligible after randomization. No baseline data collected.|186
413069|NCT00040742|1011419|P3|STARTED|Overall Study||187
413070|NCT00040742|1011420|P2|STARTED|Overall Study||183
413071|NCT00040742|1011421|P1|STARTED|Overall Study||188
413072|NCT00039377|1011435|P4|NOT COMPLETED|Course 5 (Transplant Assignments)||0
413073|NCT00039377|1011436|P3|NOT COMPLETED|Course 5 (Transplant Assignments)||0
413074|NCT00039377|1011437|P2|NOT COMPLETED|Course 5 (Transplant Assignments)||0
413075|NCT00039377|1011438|P1|NOT COMPLETED|Course 5 (Transplant Assignments)||0
413076|NCT00039377|1011435|P4|COMPLETED|Course 5 (Transplant Assignments)||1
413077|NCT00039377|1011436|P3|COMPLETED|Course 5 (Transplant Assignments)||19
413078|NCT00039377|1011437|P2|COMPLETED|Course 5 (Transplant Assignments)||15
413079|NCT00039377|1011438|P1|COMPLETED|Course 5 (Transplant Assignments)||0
413080|NCT00039377|1011435|P4|STARTED|Course 5 (Transplant Assignments)||1
413081|NCT00039377|1011436|P3|STARTED|Course 5 (Transplant Assignments)||19
413082|NCT00039377|1011437|P2|STARTED|Course 5 (Transplant Assignments)||15
413083|NCT00039377|1011438|P1|STARTED|Course 5 (Transplant Assignments)|After Course I-IV, participants were grouped into autologous, allogeneic or no transplant arms.|0
413084|NCT00039377|1011435|P4|NOT COMPLETED|Initial Registration||0
413085|NCT00039377|1011436|P3|NOT COMPLETED|Initial Registration||0
413086|NCT00039377|1011437|P2|NOT COMPLETED|Initial Registration||0
413087|NCT00039377|1011438|P1|NOT COMPLETED|Initial Registration||22
413088|NCT00039377|1011435|P4|COMPLETED|Initial Registration||0
413089|NCT00039377|1011436|P3|COMPLETED|Initial Registration||0
413090|NCT00039377|1011437|P2|COMPLETED|Initial Registration||0
413091|NCT00039377|1011438|P1|COMPLETED|Initial Registration||35
413092|NCT00039377|1011435|P4|STARTED|Initial Registration||0
413093|NCT00039377|1011436|P3|STARTED|Initial Registration||0
413094|NCT00039377|1011437|P2|STARTED|Initial Registration||0
413095|NCT00039377|1011438|P1|STARTED|Initial Registration||57
413096|NCT00039195|1011450|P1|NOT COMPLETED|Overall Study||0
413097|NCT00039195|1011450|P1|COMPLETED|Overall Study||98
413098|NCT00039195|1011450|P1|STARTED|Overall Study||98
413099|NCT00039130|1011454|P1|NOT COMPLETED|Overall Study||30
413100|NCT00039130|1011454|P1|COMPLETED|Overall Study||75
413101|NCT00039130|1011454|P1|STARTED|Overall Study||105
413102|NCT00036738|1011460|P1|NOT COMPLETED|Overall Study||0
413103|NCT00036738|1011460|P1|COMPLETED|Overall Study||28
413104|NCT00036738|1011460|P1|STARTED|Overall Study||28
413105|NCT00033657|1011470|P2|NOT COMPLETED|Adjuvant Chemotherapy||17
413106|NCT00033657|1011471|P1|NOT COMPLETED|Adjuvant Chemotherapy||18
413107|NCT00033657|1011470|P2|COMPLETED|Adjuvant Chemotherapy||16
413108|NCT00033657|1011471|P1|COMPLETED|Adjuvant Chemotherapy||18
413109|NCT00033657|1011470|P2|STARTED|Adjuvant Chemotherapy||33
413110|NCT00033657|1011471|P1|STARTED|Adjuvant Chemotherapy||36
413111|NCT00033657|1011470|P2|NOT COMPLETED|Surgical Resection||3
413112|NCT00033657|1011471|P1|NOT COMPLETED|Surgical Resection||0
413113|NCT00033657|1011470|P2|COMPLETED|Surgical Resection||33
413114|NCT00033657|1011471|P1|COMPLETED|Surgical Resection||36
413115|NCT00033657|1011470|P2|STARTED|Surgical Resection||36
413116|NCT00033657|1011471|P1|STARTED|Surgical Resection||36
413117|NCT00033657|1011470|P2|NOT COMPLETED|Neoadjuvant Chemotherapy||11
413118|NCT00033657|1011471|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||14
413119|NCT00033657|1011470|P2|COMPLETED|Neoadjuvant Chemotherapy||36
413120|NCT00033657|1011471|P1|COMPLETED|Neoadjuvant Chemotherapy||36
413121|NCT00033657|1011470|P2|Eligible and Treated|Neoadjuvant Chemotherapy||42
413122|NCT00033657|1011471|P1|Eligible and Treated|Neoadjuvant Chemotherapy||39
413123|NCT00033657|1011470|P2|Eligible|Neoadjuvant Chemotherapy||43
413124|NCT00033657|1011471|P1|Eligible|Neoadjuvant Chemotherapy||42
413125|NCT00033657|1011470|P2|STARTED|Neoadjuvant Chemotherapy||47
413126|NCT00033657|1011471|P1|STARTED|Neoadjuvant Chemotherapy||50
413127|NCT00033631|1011485|P2|NOT COMPLETED|Overall Study||15
413128|NCT00033631|1011486|P1|NOT COMPLETED|Overall Study||18
413129|NCT00033631|1011485|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|748
413130|NCT00033631|1011486|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|751
413131|NCT00033631|1011485|P2|STARTED|Overall Study||763
413132|NCT00033631|1011486|P1|STARTED|Overall Study||769
413133|NCT00033540|1011504|P1|NOT COMPLETED|Overall Study||57
413134|NCT00033540|1011504|P1|COMPLETED|Overall Study||0
413135|NCT00033540|1011504|P1|Eligible and Began Protocol Therapy|Overall Study|One patient went off study prior to any toxicity assessments and is not evaluable for toxicities.|52
413136|NCT00033540|1011504|P1|Eligible|Overall Study||54
413137|NCT00033540|1011504|P1|STARTED|Overall Study||57
413138|NCT00033514|1011514|P2|NOT COMPLETED|Overall Study||4
413139|NCT00033514|1011515|P1|NOT COMPLETED|Overall Study||1
413140|NCT00033514|1011514|P2|COMPLETED|Overall Study||7
413141|NCT00033514|1011515|P1|COMPLETED|Overall Study||15
413142|NCT00033514|1011514|P2|STARTED|Overall Study||11
413143|NCT00033514|1011515|P1|STARTED|Overall Study||16
413144|NCT00033371|1011525|P2|NOT COMPLETED|Overall Study||10
413145|NCT00033371|1011526|P1|NOT COMPLETED|Overall Study||6
413146|NCT00033371|1011525|P2|COMPLETED|Overall Study||47
413147|NCT00033371|1011526|P1|COMPLETED|Overall Study||49
413148|NCT00033371|1011525|P2|STARTED|Overall Study||57
413149|NCT00033371|1011526|P1|STARTED|Overall Study||55
413150|NCT00033293|1011534|P2|NOT COMPLETED|Overall Study||18
413151|NCT00033293|1011535|P1|NOT COMPLETED|Overall Study||10
413152|NCT00033293|1011534|P2|COMPLETED|Overall Study||9
413153|NCT00033293|1011535|P1|COMPLETED|Overall Study||16
413154|NCT00033293|1011534|P2|STARTED|Overall Study||27
413155|NCT00033293|1011535|P1|STARTED|Overall Study||26
413156|NCT00031694|1011553|P1|NOT COMPLETED|Overall Study||19
413157|NCT00031694|1011553|P1|COMPLETED|Overall Study||0
413158|NCT00031694|1011553|P1|STARTED|Overall Study||19
413159|NCT00031590|1011557|P1|NOT COMPLETED|Overall Study||3
413160|NCT00031590|1011557|P1|COMPLETED|Overall Study||25
413161|NCT00031590|1011557|P1|STARTED|Overall Study||28
413162|NCT00030901|1011564|P3|NOT COMPLETED|Randomization||88
413163|NCT00030901|1011565|P2|NOT COMPLETED|Randomization||101
413164|NCT00030901|1011566|P1|NOT COMPLETED|Randomization||0
413165|NCT00030901|1011564|P3|COMPLETED|Randomization||137
413166|NCT00030901|1011565|P2|COMPLETED|Randomization||126
413167|NCT00030901|1011566|P1|COMPLETED|Randomization||0
413168|NCT00030901|1011564|P3|Eligible|Randomization||211
413169|NCT00030901|1011565|P2|Eligible|Randomization||212
413170|NCT00030901|1011566|P1|Eligible|Randomization||0
413171|NCT00030901|1011564|P3|STARTED|Randomization||225
413172|NCT00030901|1011565|P2|STARTED|Randomization||227
413173|NCT00030901|1011566|P1|STARTED|Randomization||0
413174|NCT00030901|1011564|P3|NOT COMPLETED|Initial Registration||0
413175|NCT00030901|1011565|P2|NOT COMPLETED|Initial Registration||0
413176|NCT00030901|1011566|P1|NOT COMPLETED|Initial Registration||167
413177|NCT00030901|1011564|P3|COMPLETED|Initial Registration||0
413178|NCT00030901|1011565|P2|COMPLETED|Initial Registration||0
413179|NCT00030901|1011566|P1|COMPLETED|Initial Registration||452
413180|NCT00030901|1011564|P3|STARTED|Initial Registration||0
413181|NCT00030901|1011565|P2|STARTED|Initial Registration||0
413182|NCT00030901|1011566|P1|STARTED|Initial Registration||619
413183|NCT00030823|1011574|P1|NOT COMPLETED|Overall Study||1
413184|NCT00030823|1011574|P1|COMPLETED|Overall Study||13
413185|NCT00030823|1011574|P1|STARTED|Overall Study||14
413186|NCT00030264|1011578|P1|NOT COMPLETED|Overall Study||0
413187|NCT00030264|1011578|P1|COMPLETED|Overall Study||23
413188|NCT00030264|1011578|P1|STARTED|Overall Study||23
413189|NCT00028769|1011582|P1|NOT COMPLETED|Overall Study||41
413190|NCT00028769|1011582|P1|COMPLETED|Overall Study|Patients receive protocol treatments until evidence of disease progression|0
413191|NCT00028769|1011582|P1|Eligible and Began Protocol Therapy|Overall Study|One patient refused all protocol treatment and was not evaluable for the present analysis|35
413192|NCT00028769|1011582|P1|Eligible|Overall Study||36
413193|NCT00028769|1011582|P1|STARTED|Overall Study||41
413194|NCT00028002|1011588|P1|NOT COMPLETED|Overall Study||11
413195|NCT00028002|1011588|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
413196|NCT00028002|1011588|P1|STARTED|Overall Study||63
413197|NCT00027846|1011598|P3|NOT COMPLETED|Overall Study||37
413198|NCT00027846|1011599|P2|NOT COMPLETED|Overall Study||68
413199|NCT00027846|1011600|P1|NOT COMPLETED|Overall Study||2
413200|NCT00027846|1011598|P3|COMPLETED|Overall Study||41
413201|NCT00027846|1011599|P2|COMPLETED|Overall Study||219
413202|NCT00027846|1011600|P1|COMPLETED|Overall Study||11
413203|NCT00027846|1011598|P3|STARTED|Overall Study||78
413204|NCT00027846|1011599|P2|STARTED|Overall Study||287
413205|NCT00027846|1011600|P1|STARTED|Overall Study||13
413206|NCT00027560|1011618|P1|NOT COMPLETED|Overall Study||1
413207|NCT00027560|1011618|P1|COMPLETED|Overall Study||50
413208|NCT00027560|1011618|P1|STARTED|Overall Study||51
413209|NCT00026494|1011631|P4|NOT COMPLETED|Overall Study||0
413210|NCT00026494|1011632|P3|NOT COMPLETED|Overall Study||6
413211|NCT00026494|1011633|P2|NOT COMPLETED|Overall Study||0
413212|NCT00026494|1011634|P1|NOT COMPLETED|Overall Study||2
413213|NCT00026494|1011631|P4|COMPLETED|Overall Study||16
413214|NCT00026494|1011632|P3|COMPLETED|Overall Study||16
413215|NCT00026494|1011633|P2|COMPLETED|Overall Study||4
413216|NCT00026494|1011634|P1|COMPLETED|Overall Study||5
413217|NCT00026494|1011631|P4|STARTED|Overall Study||16
413218|NCT00026494|1011632|P3|STARTED|Overall Study||22
413219|NCT00026494|1011633|P2|STARTED|Overall Study||4
413220|NCT00026494|1011634|P1|STARTED|Overall Study||7
413221|NCT00026312|1011646|P2|NOT COMPLETED|Overall Study||269
413222|NCT00026312|1011647|P1|NOT COMPLETED|Overall Study||34
413223|NCT00026312|1011646|P2|COMPLETED|Overall Study||1064
413224|NCT00026312|1011647|P1|COMPLETED|Overall Study||82
413225|NCT00026312|1011646|P2|STARTED|Overall Study||1333
413226|NCT00026312|1011647|P1|STARTED|Overall Study||116
413227|NCT00026221|1011665|P3|NOT COMPLETED|Overall Study||0
413228|NCT00026221|1011666|P2|NOT COMPLETED|Overall Study||0
413229|NCT00026221|1011667|P1|NOT COMPLETED|Overall Study||0
413230|NCT00026221|1011665|P3|COMPLETED|Overall Study||25
413231|NCT00026221|1011666|P2|COMPLETED|Overall Study||16
413232|NCT00026221|1011667|P1|COMPLETED|Overall Study||16
413233|NCT00026221|1011665|P3|STARTED|Overall Study||25
413234|NCT00026221|1011666|P2|STARTED|Overall Study||16
413235|NCT00026221|1011667|P1|STARTED|Overall Study||16
413236|NCT00026208|1011686|P2|NOT COMPLETED|Overall Study||0
413237|NCT00026208|1011687|P1|NOT COMPLETED|Overall Study||1
413238|NCT00026208|1011686|P2|COMPLETED|Overall Study||4
413239|NCT00026208|1011687|P1|COMPLETED|Overall Study||71
413240|NCT00026208|1011686|P2|STARTED|Overall Study||4
413241|NCT00026208|1011687|P1|STARTED|Overall Study||72
413242|NCT00025662|1011705|P1|NOT COMPLETED|Overall Study||3
413243|NCT00025662|1011705|P1|COMPLETED|Overall Study|One patient who received a transplant did not meet eligibility and was a special exemption.|22
413244|NCT00025662|1011705|P1|STARTED|Overall Study||25
413245|NCT00025506|1011713|P1|NOT COMPLETED|Overall Study||10
413246|NCT00025506|1011713|P1|COMPLETED|Overall Study|Eligible and treated patients.|45
413247|NCT00025506|1011713|P1|STARTED|Overall Study||55
413248|NCT00025259|1011734|P7|NOT COMPLETED|Overall Study||51
413249|NCT00025259|1011735|P6|NOT COMPLETED|Overall Study||52
413250|NCT00025259|1011736|P5|NOT COMPLETED|Overall Study||36
413251|NCT00025259|1011737|P4|NOT COMPLETED|Overall Study||114
413252|NCT00025259|1011738|P3|NOT COMPLETED|Overall Study||81
413253|NCT00025259|1011739|P2|NOT COMPLETED|Overall Study||89
413254|NCT00025259|1011740|P1|NOT COMPLETED|Overall Study||45
413255|NCT00025259|1011734|P7|COMPLETED|Overall Study||102
413256|NCT00025259|1011735|P6|COMPLETED|Overall Study||101
413257|NCT00025259|1011736|P5|COMPLETED|Overall Study||6
413258|NCT00025259|1011737|P4|COMPLETED|Overall Study||457
413259|NCT00025259|1011738|P3|COMPLETED|Overall Study||301
413260|NCT00025259|1011739|P2|COMPLETED|Overall Study||292
413261|NCT00025259|1011740|P1|COMPLETED|Overall Study||7
413262|NCT00025259|1011734|P7|STARTED|Overall Study||153
413263|NCT00025259|1011735|P6|STARTED|Overall Study||153
413264|NCT00025259|1011736|P5|STARTED|Overall Study||42
413265|NCT00025259|1011737|P4|STARTED|Overall Study||571
413266|NCT00025259|1011738|P3|STARTED|Overall Study||382
413267|NCT00025259|1011739|P2|STARTED|Overall Study||381
413268|NCT00025259|1011740|P1|STARTED|Overall Study||52
413269|NCT00025233|1011776|P1|NOT COMPLETED|Overall Study||4
413270|NCT00025233|1011776|P1|COMPLETED|Overall Study||46
413271|NCT00025233|1011776|P1|STARTED|Overall Study||50
413272|NCT00025155|1011791|P1|NOT COMPLETED|Overall Study||2
413273|NCT00025155|1011791|P1|COMPLETED|Overall Study|Patients who were eligible and received any study treatment.|49
413274|NCT00025155|1011791|P1|STARTED|Overall Study||51
413275|NCT00024258|1011802|P1|NOT COMPLETED|Overall Study||9
413276|NCT00024258|1011802|P1|COMPLETED|Overall Study||13
413277|NCT00024258|1011802|P1|STARTED|Overall Study||22
413278|NCT00024167|1011809|P2|NOT COMPLETED|Overall Study||47
413279|NCT00024167|1011810|P1|NOT COMPLETED|Overall Study||53
413280|NCT00024167|1011809|P2|COMPLETED|Overall Study||15
413281|NCT00024167|1011810|P1|COMPLETED|Overall Study||12
413282|NCT00024167|1011809|P2|Induction Treatment Option 2 Completed|Overall Study||41
413283|NCT00024167|1011810|P1|Induction Treatment Option 2 Completed|Overall Study||43
413284|NCT00024167|1011809|P2|Induction Treatment Option 1 Completed|Overall Study||21
413285|NCT00024167|1011810|P1|Induction Treatment Option 1 Completed|Overall Study||22
413286|NCT00024167|1011809|P2|STARTED|Overall Study||62
413287|NCT00024167|1011810|P1|STARTED|Overall Study||65
413288|NCT00024102|1011821|P2|NOT COMPLETED|Overall Study||0
413289|NCT00024102|1011822|P1|NOT COMPLETED|Overall Study||0
413290|NCT00024102|1011821|P2|COMPLETED|Overall Study||307
413291|NCT00024102|1011822|P1|COMPLETED|Overall Study||326
413292|NCT00024102|1011821|P2|STARTED|Overall Study||307
413293|NCT00024102|1011822|P1|STARTED|Overall Study||326
413294|NCT00023764|1011834|P1|NOT COMPLETED|Overall Study||14
413295|NCT00023764|1011834|P1|COMPLETED|Overall Study||89
413296|NCT00023764|1011834|P1|STARTED|Overall Study||103
413297|NCT00023712|1011841|P2|NOT COMPLETED|Overall Study||1
413298|NCT00023712|1011842|P1|NOT COMPLETED|Overall Study||2
413299|NCT00023712|1011841|P2|COMPLETED|Overall Study|total number of participants eligible and evaluable|29
413300|NCT00023712|1011842|P1|COMPLETED|Overall Study|total number of participants eligible and evaluable|26
413301|NCT00023712|1011841|P2|STARTED|Overall Study|total number of participants enrolled on study|30
413302|NCT00023712|1011842|P1|STARTED|Overall Study|total number of participants enrolled on study|28
413303|NCT00022698|1011866|P2|NOT COMPLETED|Overall Study||35
413304|NCT00022698|1011867|P1|NOT COMPLETED|Overall Study||8
413305|NCT00022698|1011866|P2|COMPLETED|Overall Study||17
413306|NCT00022698|1011867|P1|COMPLETED|Overall Study||7
413307|NCT00022698|1011866|P2|STARTED|Overall Study||52
413308|NCT00022698|1011867|P1|STARTED|Overall Study||15
413309|NCT00022672|1011892|P2|NOT COMPLETED|Extension Phase||51
413310|NCT00022672|1011893|P1|NOT COMPLETED|Extension Phase||3
413311|NCT00022672|1011892|P2|COMPLETED|Extension Phase||7
413312|NCT00022672|1011893|P1|COMPLETED|Extension Phase||11
413313|NCT00022672|1011892|P2|Safety Set: Received Study Drug|Extension Phase||58
413314|NCT00022672|1011893|P1|Safety Set: Received Study Drug|Extension Phase||14
413315|NCT00022672|1011892|P2|STARTED|Extension Phase||58
413316|NCT00022672|1011893|P1|STARTED|Extension Phase|2 patients completed Main Phase; but did not enter Extension (1-did not cooperate and 1-withdrew).|14
413317|NCT00022672|1011892|P2|NOT COMPLETED|Main Phase: 24 Months||100
413318|NCT00022672|1011893|P1|NOT COMPLETED|Main Phase: 24 Months||87
413319|NCT00022672|1011892|P2|COMPLETED|Main Phase: 24 Months||4
413320|NCT00022672|1011893|P1|COMPLETED|Main Phase: 24 Months||16
413321|NCT00022672|1011892|P2|Safety Set: Received Study Drug|Main Phase: 24 Months||104
413322|NCT00022672|1011893|P1|Safety Set: Received Study Drug|Main Phase: 24 Months||103
413323|NCT00022672|1011892|P2|STARTED|Main Phase: 24 Months||104
413324|NCT00022672|1011893|P1|STARTED|Main Phase: 24 Months||103
413325|NCT00022659|1011926|P1|NOT COMPLETED|Overall Study||2
413326|NCT00022659|1011926|P1|COMPLETED|Overall Study|Eligible and treated patients.|62
413327|NCT00022659|1011926|P1|STARTED|Overall Study||64
413328|NCT00022633|1011939|P2|NOT COMPLETED|Overall Study||5
413329|NCT00022633|1011940|P1|NOT COMPLETED|Overall Study||32
413330|NCT00022633|1011939|P2|COMPLETED|Overall Study||5
413331|NCT00022633|1011940|P1|COMPLETED|Overall Study||23
413332|NCT00022633|1011939|P2|Eligible|Overall Study||10
413333|NCT00022633|1011940|P1|Eligible|Overall Study||51
413334|NCT00022633|1011939|P2|STARTED|Overall Study||10
413335|NCT00022633|1011940|P1|STARTED|Overall Study||55
413336|NCT00022516|1011953|P2|NOT COMPLETED|Overall Study||230
413337|NCT00022516|1011954|P1|NOT COMPLETED|Overall Study||3
413338|NCT00022516|1011953|P2|COMPLETED|Overall Study||314
413339|NCT00022516|1011954|P1|COMPLETED|Overall Study||539
413340|NCT00022516|1011953|P2|STARTED|Overall Study||544
413341|NCT00022516|1011954|P1|STARTED|Overall Study||542
413342|NCT00022490|1011966|P1|NOT COMPLETED|Overall Study||0
413343|NCT00022490|1011966|P1|COMPLETED|Overall Study||24
413344|NCT00022490|1011966|P1|STARTED|Overall Study||24
413345|NCT00021255|1011973|P3|NOT COMPLETED|Overall Study||149
413346|NCT00021255|1011974|P2|NOT COMPLETED|Overall Study||270
413347|NCT00021255|1011975|P1|NOT COMPLETED|Overall Study||121
413348|NCT00021255|1011973|P3|COMPLETED|Overall Study||926
413349|NCT00021255|1011974|P2|COMPLETED|Overall Study||804
413350|NCT00021255|1011975|P1|COMPLETED|Overall Study||952
413351|NCT00021255|1011973|P3|Safety Population|Overall Study|1056 participants received TCH.|1056
413352|NCT00021255|1011974|P2|Safety Population|Overall Study|1100 participants received AC-TH (1066 from AC-TH arm, 33 from AC-T arm and 1 from TCH arm).|1100
413353|NCT00021255|1011975|P1|Safety Population|Overall Study|1018 participants received AC-T (1012 from AC-T arm, 6 from AC-TH arm).|1018
413354|NCT00021255|1011973|P3|Treated|Overall Study||1057
413355|NCT00021255|1011974|P2|Treated|Overall Study||1072
413356|NCT00021255|1011975|P1|Treated|Overall Study||1045
413357|NCT00021255|1011973|P3|STARTED|Overall Study|Randomized|1075
413358|NCT00021255|1011974|P2|STARTED|Overall Study|Randomized|1074
413359|NCT00021255|1011975|P1|STARTED|Overall Study|Randomized|1073
413360|NCT00021229|1011992|P3|NOT COMPLETED|Overall Study||16
413361|NCT00021229|1011993|P2|NOT COMPLETED|Overall Study||33
413362|NCT00021229|1011994|P1|NOT COMPLETED|Overall Study||35
413363|NCT00021229|1011992|P3|COMPLETED|Overall Study||0
413364|NCT00021229|1011993|P2|COMPLETED|Overall Study||0
413365|NCT00021229|1011994|P1|COMPLETED|Overall Study|1 participant completed 13 courses of therapy|1
413366|NCT00021229|1011992|P3|Enrolled in Phase II|Overall Study|Participants from stratum IIB did not participate in the phase II part of the study.|0
413367|NCT00021229|1011993|P2|Enrolled in Phase II|Overall Study|Participants from stratum IIA did not participate in the phase II part of the study.|0
413368|NCT00021229|1011994|P1|Enrolled in Phase II|Overall Study|Thirteen participants treated at the MTD in the phase I were also part of the phase II.|14
413369|NCT00021229|1011992|P3|Maximum Tolerated Dose (MTD) Estimation|Overall Study|4 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|12
413370|NCT00021229|1011993|P2|Maximum Tolerated Dose (MTD) Estimation|Overall Study|13 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|20
413371|NCT00021229|1011994|P1|Maximum Tolerated Dose (MTD) Estimation|Overall Study|12 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|23
413372|NCT00021229|1011992|P3|Enrolled in Phase I|Overall Study||16
413373|NCT00021229|1011993|P2|Enrolled in Phase I|Overall Study||33
413374|NCT00021229|1011994|P1|Enrolled in Phase I|Overall Study||35
413375|NCT00021229|1011992|P3|STARTED|Overall Study||16
413376|NCT00021229|1011993|P2|STARTED|Overall Study||33
413377|NCT00021229|1011994|P1|STARTED|Overall Study||36
413378|NCT00020722|1012020|P1|NOT COMPLETED|Overall Study||0
413379|NCT00020722|1012020|P1|COMPLETED|Overall Study||7
413380|NCT00020722|1012020|P1|STARTED|Overall Study||7
413381|NCT00019747|1012027|P2|NOT COMPLETED|Overall Study||0
413382|NCT00019747|1012028|P1|NOT COMPLETED|Overall Study||0
413383|NCT00019747|1012027|P2|COMPLETED|Overall Study||16
413384|NCT00019747|1012028|P1|COMPLETED|Overall Study||23
413385|NCT00019747|1012027|P2|STARTED|Overall Study||16
413386|NCT00019747|1012028|P1|STARTED|Overall Study||23
413387|NCT00019682|1012036|P2|NOT COMPLETED|Overall Study||6
413388|NCT00019682|1012037|P1|NOT COMPLETED|Overall Study||1
413389|NCT00019682|1012036|P2|COMPLETED|Overall Study||85
413390|NCT00019682|1012037|P1|COMPLETED|Overall Study||93
413391|NCT00019682|1012036|P2|STARTED|Overall Study||91
413392|NCT00019682|1012037|P1|STARTED|Overall Study||94
413393|NCT00019604|1012049|P1|NOT COMPLETED|Overall Study||39
413394|NCT00019604|1012049|P1|COMPLETED|Overall Study||5
413395|NCT00019604|1012049|P1|STARTED|Overall Study||44
413396|NCT00017563|1012062|P1|NOT COMPLETED|Overall Study||1
413397|NCT00017563|1012062|P1|COMPLETED|Overall Study||56
413398|NCT00017563|1012062|P1|STARTED|Overall Study||57
413399|NCT00016913|1012066|P1|NOT COMPLETED|Overall Study||0
413400|NCT00016913|1012066|P1|COMPLETED|Overall Study||27
413401|NCT00016913|1012066|P1|STARTED|Overall Study||27
413402|NCT00016354|1012072|P8|NOT COMPLETED|Overall Study||1
413403|NCT00016354|1012073|P7|NOT COMPLETED|Overall Study||0
413404|NCT00016354|1012074|P6|NOT COMPLETED|Overall Study||0
413405|NCT00016354|1012075|P5|NOT COMPLETED|Overall Study||0
413406|NCT00016354|1012076|P4|NOT COMPLETED|Overall Study||0
413407|NCT00016354|1012077|P3|NOT COMPLETED|Overall Study||0
413408|NCT00016354|1012078|P2|NOT COMPLETED|Overall Study||0
413409|NCT00016354|1012079|P1|NOT COMPLETED|Overall Study||0
413410|NCT00016354|1012072|P8|COMPLETED|Overall Study||6
413411|NCT00016354|1012073|P7|COMPLETED|Overall Study||6
413412|NCT00016354|1012074|P6|COMPLETED|Overall Study||1
413413|NCT00016354|1012075|P5|COMPLETED|Overall Study||1
413414|NCT00016354|1012076|P4|COMPLETED|Overall Study||1
413415|NCT00016354|1012077|P3|COMPLETED|Overall Study||1
413416|NCT00016354|1012078|P2|COMPLETED|Overall Study||1
413417|NCT00016354|1012079|P1|COMPLETED|Overall Study||1
413418|NCT00016354|1012072|P8|STARTED|Overall Study||7
413419|NCT00016354|1012073|P7|STARTED|Overall Study||6
413420|NCT00016354|1012074|P6|STARTED|Overall Study||1
413421|NCT00016354|1012075|P5|STARTED|Overall Study||1
413422|NCT00016354|1012076|P4|STARTED|Overall Study||1
413423|NCT00016354|1012077|P3|STARTED|Overall Study||1
413424|NCT00016354|1012078|P2|STARTED|Overall Study||1
413425|NCT00016354|1012079|P1|STARTED|Overall Study||1
413426|NCT00015847|1012083|P1|NOT COMPLETED|Overall Study||0
413427|NCT00015847|1012083|P1|COMPLETED|Overall Study||25
413428|NCT00015847|1012083|P1|STARTED|Overall Study||25
413429|NCT00014495|1012093|P4|NOT COMPLETED|Overall Study||1
413430|NCT00014495|1012094|P3|NOT COMPLETED|Overall Study||1
413431|NCT00014495|1012095|P2|NOT COMPLETED|Overall Study||0
413432|NCT00014495|1012096|P1|NOT COMPLETED|Overall Study||0
413433|NCT00014495|1012093|P4|COMPLETED|Overall Study||5
413434|NCT00014495|1012094|P3|COMPLETED|Overall Study||19
413435|NCT00014495|1012095|P2|COMPLETED|Overall Study||3
413436|NCT00014495|1012096|P1|COMPLETED|Overall Study||3
413437|NCT00014495|1012093|P4|STARTED|Overall Study||6
413438|NCT00014495|1012094|P3|STARTED|Overall Study||20
413439|NCT00014495|1012095|P2|STARTED|Overall Study||3
413440|NCT00014495|1012096|P1|STARTED|Overall Study||3
413441|NCT00012298|1012110|P7|NOT COMPLETED|Overall Study||0
413442|NCT00012298|1012111|P6|NOT COMPLETED|Overall Study||0
413443|NCT00012298|1012112|P5|NOT COMPLETED|Overall Study||0
413444|NCT00012298|1012113|P4|NOT COMPLETED|Overall Study||0
413445|NCT00012298|1012114|P3|NOT COMPLETED|Overall Study||0
413446|NCT00012298|1012115|P2|NOT COMPLETED|Overall Study||0
413447|NCT00012298|1012116|P1|NOT COMPLETED|Overall Study||0
413448|NCT00012298|1012110|P7|COMPLETED|Overall Study||39
413449|NCT00012298|1012111|P6|COMPLETED|Overall Study||6
413450|NCT00012298|1012112|P5|COMPLETED|Overall Study||5
413451|NCT00012298|1012113|P4|COMPLETED|Overall Study||4
413452|NCT00012298|1012114|P3|COMPLETED|Overall Study||9
413453|NCT00012298|1012115|P2|COMPLETED|Overall Study||7
413454|NCT00012298|1012116|P1|COMPLETED|Overall Study||11
413455|NCT00012298|1012110|P7|STARTED|Overall Study||39
413456|NCT00012298|1012111|P6|STARTED|Overall Study||6
413457|NCT00012298|1012112|P5|STARTED|Overall Study||5
413458|NCT00012298|1012113|P4|STARTED|Overall Study||4
413459|NCT00012298|1012114|P3|STARTED|Overall Study||9
413460|NCT00012298|1012115|P2|STARTED|Overall Study||7
413461|NCT00012298|1012116|P1|STARTED|Overall Study||11
413462|NCT00012012|1012146|P2|NOT COMPLETED|Overall Study||3
413463|NCT00012012|1012147|P1|NOT COMPLETED|Overall Study||1
413464|NCT00012012|1012146|P2|COMPLETED|Overall Study||15
413465|NCT00012012|1012147|P1|COMPLETED|Overall Study||26
413466|NCT00012012|1012146|P2|STARTED|Overall Study||18
413467|NCT00012012|1012147|P1|STARTED|Overall Study||27
413468|NCT00011986|1012158|P5|NOT COMPLETED|Overall Study||0
413469|NCT00011986|1012159|P4|NOT COMPLETED|Overall Study||0
413470|NCT00011986|1012160|P3|NOT COMPLETED|Overall Study||0
413471|NCT00011986|1012161|P2|NOT COMPLETED|Overall Study||0
413472|NCT00011986|1012162|P1|NOT COMPLETED|Overall Study||0
413473|NCT00011986|1012158|P5|COMPLETED|Overall Study||861
413474|NCT00011986|1012159|P4|COMPLETED|Overall Study||861
413475|NCT00011986|1012160|P3|COMPLETED|Overall Study||862
413476|NCT00011986|1012161|P2|COMPLETED|Overall Study||864
413477|NCT00011986|1012162|P1|COMPLETED|Overall Study||864
413478|NCT00011986|1012158|P5|Initiated Treatment|Overall Study||851
413479|NCT00011986|1012159|P4|Initiated Treatment|Overall Study||846
413480|NCT00011986|1012160|P3|Initiated Treatment|Overall Study||854
413481|NCT00011986|1012161|P2|Initiated Treatment|Overall Study||860
413482|NCT00011986|1012162|P1|Initiated Treatment|Overall Study||862
413483|NCT00011986|1012158|P5|STARTED|Overall Study||861
413484|NCT00011986|1012159|P4|STARTED|Overall Study||861
413485|NCT00011986|1012160|P3|STARTED|Overall Study||862
413486|NCT00011986|1012161|P2|STARTED|Overall Study||864
413487|NCT00011986|1012162|P1|STARTED|Overall Study||864
413488|NCT00010257|1012186|P2|NOT COMPLETED|Overall Study||0
413489|NCT00010257|1012187|P1|NOT COMPLETED|Overall Study||1
413490|NCT00010257|1012186|P2|COMPLETED|Overall Study||21
413491|NCT00010257|1012187|P1|COMPLETED|Overall Study||24
413492|NCT00010257|1012186|P2|STARTED|Overall Study||21
413493|NCT00010257|1012187|P1|STARTED|Overall Study||25
413494|NCT00009945|1012197|P2|NOT COMPLETED|Overall Study||5
413495|NCT00009945|1012198|P1|NOT COMPLETED|Overall Study||7
413496|NCT00009945|1012197|P2|COMPLETED|Overall Study||1656
413497|NCT00009945|1012198|P1|COMPLETED|Overall Study||1655
413498|NCT00009945|1012197|P2|STARTED|Overall Study||1661
413499|NCT00009945|1012198|P1|STARTED|Overall Study||1662
413500|NCT00008385|1012214|P2|NOT COMPLETED|Overall Study||802
413501|NCT00008385|1012215|P1|NOT COMPLETED|Overall Study||387
413502|NCT00008385|1012214|P2|COMPLETED|Overall Study||238
413503|NCT00008385|1012215|P1|COMPLETED|Overall Study||134
413504|NCT00008385|1012214|P2|Off Treatment Reasons Reported|Overall Study||795
413505|NCT00008385|1012215|P1|Off Treatment Reasons Reported|Overall Study||398
413506|NCT00008385|1012214|P2|Treated|Overall Study||865
413507|NCT00008385|1012215|P1|Treated|Overall Study||477
413508|NCT00008385|1012214|P2|STARTED|Overall Study||1040
413509|NCT00008385|1012215|P1|STARTED|Overall Study||521
413510|NCT00008138|1012225|P1|NOT COMPLETED|Post-Cytoreduction Chemotherapy||8
413511|NCT00008138|1012225|P1|COMPLETED|Post-Cytoreduction Chemotherapy||18
413512|NCT00008138|1012225|P1|STARTED|Post-Cytoreduction Chemotherapy|Among 36 patients from previous period, 5 patients rejected and 5 patients are ineligible.|26
413513|NCT00008138|1012225|P1|NOT COMPLETED|Interval Debulking||2
413514|NCT00008138|1012225|P1|COMPLETED|Interval Debulking||36
413515|NCT00008138|1012225|P1|Received Protocol Surgery|Interval Debulking||36
413516|NCT00008138|1012225|P1|STARTED|Interval Debulking||38
413517|NCT00008138|1012225|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||20
413518|NCT00008138|1012225|P1|COMPLETED|Neoadjuvant Chemotherapy||38
413519|NCT00008138|1012225|P1|Eligible|Neoadjuvant Chemotherapy||58
413520|NCT00008138|1012225|P1|STARTED|Neoadjuvant Chemotherapy||58
413521|NCT00006916|1012231|P1|NOT COMPLETED|Overall Study||5
413522|NCT00006916|1012231|P1|COMPLETED|Overall Study|Subjects with survival data for the primary analysis are considered to have completed the study.|14
413523|NCT00006916|1012231|P1|STARTED|Overall Study||19
413524|NCT00006903|1012237|P3|NOT COMPLETED|Overall Study||6
413525|NCT00006903|1012238|P2|NOT COMPLETED|Overall Study||4
413526|NCT00006903|1012239|P1|NOT COMPLETED|Overall Study||10
413527|NCT00006903|1012237|P3|COMPLETED|Overall Study||27
413528|NCT00006903|1012238|P2|COMPLETED|Overall Study||20
413529|NCT00006903|1012239|P1|COMPLETED|Overall Study||0
413530|NCT00006903|1012237|P3|STARTED|Overall Study||33
413531|NCT00006903|1012238|P2|STARTED|Overall Study||24
413532|NCT00006903|1012239|P1|STARTED|Overall Study||10
413533|NCT00006721|1012252|P3|NOT COMPLETED|Overall Study||33
413534|NCT00006721|1012253|P2|NOT COMPLETED|Overall Study||25
413535|NCT00006721|1012254|P1|NOT COMPLETED|Overall Study||4
413536|NCT00006721|1012252|P3|COMPLETED|Overall Study||242
413537|NCT00006721|1012253|P2|COMPLETED|Overall Study||254
413538|NCT00006721|1012254|P1|COMPLETED|Overall Study||13
413539|NCT00006721|1012252|P3|Eligible and Began Protocol Therapy|Overall Study||265
413540|NCT00006721|1012253|P2|Eligible and Began Protocol Therapy|Overall Study||267
413541|NCT00006721|1012254|P1|Eligible and Began Protocol Therapy|Overall Study||14
413542|NCT00006721|1012252|P3|Eligible|Overall Study||265
413543|NCT00006721|1012253|P2|Eligible|Overall Study||267
413544|NCT00006721|1012254|P1|Eligible|Overall Study||15
413545|NCT00006721|1012252|P3|STARTED|Overall Study||275
413546|NCT00006721|1012253|P2|STARTED|Overall Study||279
413547|NCT00006721|1012254|P1|STARTED|Overall Study||17
413548|NCT00006478|1012272|P1|NOT COMPLETED|Overall Study||7
413549|NCT00006478|1012272|P1|COMPLETED|Overall Study||12
413550|NCT00006478|1012272|P1|STARTED|Overall Study||19
413551|NCT00006392|1012283|P4|NOT COMPLETED|Overall Study||160
413552|NCT00006392|1012284|P3|NOT COMPLETED|Overall Study||160
413553|NCT00006392|1012285|P2|NOT COMPLETED|Overall Study||158
413554|NCT00006392|1012286|P1|NOT COMPLETED|Overall Study||167
413555|NCT00006392|1012283|P4|COMPLETED|Overall Study||8696
413556|NCT00006392|1012284|P3|COMPLETED|Overall Study||8703
413557|NCT00006392|1012285|P2|COMPLETED|Overall Study||8752
413558|NCT00006392|1012286|P1|COMPLETED|Overall Study||8737
413559|NCT00006392|1012283|P4|STARTED|Overall Study||8856
413560|NCT00006392|1012284|P3|STARTED|Overall Study||8863
413561|NCT00006392|1012285|P2|STARTED|Overall Study||8910
413562|NCT00006392|1012286|P1|STARTED|Overall Study||8904
413563|NCT00006389|1012316|P1|NOT COMPLETED|Overall Study||1
413564|NCT00006389|1012316|P1|COMPLETED|Overall Study||11
413565|NCT00006389|1012316|P1|STARTED|Overall Study||12
413566|NCT00006244|1012322|P1|NOT COMPLETED|Overall Study||0
413567|NCT00006244|1012322|P1|COMPLETED|Overall Study||36
413568|NCT00006244|1012322|P1|STARTED|Overall Study||36
413569|NCT00006237|1012333|P2|NOT COMPLETED|Overall Study||61
413570|NCT00006237|1012334|P1|NOT COMPLETED|Overall Study||125
413571|NCT00006237|1012333|P2|COMPLETED|Overall Study||159
413572|NCT00006237|1012334|P1|COMPLETED|Overall Study||87
413573|NCT00006237|1012333|P2|Eligible and Treated|Overall Study||199
413574|NCT00006237|1012334|P1|Eligible and Treated|Overall Study||203
413575|NCT00006237|1012333|P2|Eligible|Overall Study||200
413576|NCT00006237|1012334|P1|Eligible|Overall Study||203
413577|NCT00006237|1012333|P2|STARTED|Overall Study||220
413578|NCT00006237|1012334|P1|STARTED|Overall Study||212
413579|NCT00006110|1012346|P2|NOT COMPLETED|Overall Study||0
413580|NCT00006110|1012347|P1|NOT COMPLETED|Overall Study||0
413581|NCT00006110|1012346|P2|COMPLETED|Overall Study||30
413582|NCT00006110|1012347|P1|COMPLETED|Overall Study||52
413583|NCT00006110|1012346|P2|STARTED|Overall Study||30
413584|NCT00006110|1012347|P1|STARTED|Overall Study||52
413585|NCT00006101|1012361|P2|NOT COMPLETED|Overall Study||5
413586|NCT00006101|1012362|P1|NOT COMPLETED|Overall Study||5
413587|NCT00006101|1012361|P2|COMPLETED|Overall Study||33
413588|NCT00006101|1012362|P1|COMPLETED|Overall Study||33
413589|NCT00006101|1012361|P2|STARTED|Overall Study||38
413590|NCT00006101|1012362|P1|STARTED|Overall Study||38
413591|NCT00006011|1012371|P3|NOT COMPLETED|Overall Study||73
413592|NCT00006011|1012372|P2|NOT COMPLETED|Overall Study||77
413593|NCT00006011|1012373|P1|NOT COMPLETED|Overall Study||65
413594|NCT00006011|1012371|P3|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|0
413595|NCT00006011|1012372|P2|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|221
413596|NCT00006011|1012373|P1|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|223
413597|NCT00006011|1012371|P3|STARTED|Overall Study|total number of participants enrolled, that only received radiation treatment.|73
413598|NCT00006011|1012372|P2|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 2 of study.|298
413599|NCT00006011|1012373|P1|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 1 of study.|288
413600|NCT00005957|1012381|P2|NOT COMPLETED|Overall Study||28
413601|NCT00005957|1012382|P1|NOT COMPLETED|Overall Study||8
413602|NCT00005957|1012381|P2|COMPLETED|Overall Study||888
413603|NCT00005957|1012382|P1|COMPLETED|Overall Study||908
413604|NCT00005957|1012381|P2|STARTED|Overall Study||916
413605|NCT00005957|1012382|P1|STARTED|Overall Study||916
413606|NCT00005879|1012392|P2|NOT COMPLETED|Overall Study||10
413607|NCT00005879|1012393|P1|NOT COMPLETED|Overall Study||8
413608|NCT00005879|1012392|P2|COMPLETED|Overall Study||88
413609|NCT00005879|1012393|P1|COMPLETED|Overall Study||93
413610|NCT00005879|1012392|P2|STARTED|Overall Study||98
413611|NCT00005879|1012393|P1|STARTED|Overall Study||101
413612|NCT00005803|1012401|P1|NOT COMPLETED|Overall Study||22
413613|NCT00005803|1012401|P1|COMPLETED|Overall Study||54
413614|NCT00005803|1012401|P1|STARTED|Overall Study||76
413615|NCT00005047|1012416|P4|NOT COMPLETED|Overall Study||0
413616|NCT00005047|1012417|P3|NOT COMPLETED|Overall Study||0
413617|NCT00005047|1012418|P2|NOT COMPLETED|Overall Study||0
413618|NCT00005047|1012419|P1|NOT COMPLETED|Overall Study||19
413619|NCT00005047|1012416|P4|COMPLETED|Overall Study||158
413620|NCT00005047|1012417|P3|COMPLETED|Overall Study||227
413621|NCT00005047|1012418|P2|COMPLETED|Overall Study||56
413622|NCT00005047|1012419|P1|COMPLETED|Overall Study||39
413623|NCT00005047|1012416|P4|STARTED|Overall Study||158
413624|NCT00005047|1012417|P3|STARTED|Overall Study||227
413625|NCT00005047|1012418|P2|STARTED|Overall Study||56
413626|NCT00005047|1012419|P1|STARTED|Overall Study||58
413627|NCT00005044|1012435|P2|NOT COMPLETED|Overall Study||52
413628|NCT00005044|1012436|P1|NOT COMPLETED|Overall Study||38
413629|NCT00005044|1012435|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|737
413630|NCT00005044|1012436|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|752
413631|NCT00005044|1012435|P2|STARTED|Overall Study||789
413632|NCT00005044|1012436|P1|STARTED|Overall Study||790
413633|NCT00004888|1012456|P2|NOT COMPLETED|Overall Study||24
413634|NCT00004888|1012457|P1|NOT COMPLETED|Overall Study||11
413635|NCT00004888|1012456|P2|COMPLETED|Overall Study||22
413636|NCT00004888|1012457|P1|COMPLETED|Overall Study||27
413637|NCT00004888|1012456|P2|STARTED|Overall Study|Of the 48 pts, 2 were ineligible.|46
413638|NCT00004888|1012457|P1|STARTED|Overall Study|Of the 41 pts, 3 were ineligible.|38
413639|NCT00004859|1012475|P2|NOT COMPLETED|Overall Study||282
413640|NCT00004859|1012476|P1|NOT COMPLETED|Overall Study||118
413641|NCT00004859|1012475|P2|COMPLETED|Overall Study||12
413642|NCT00004859|1012476|P1|COMPLETED|Overall Study||177
413643|NCT00004859|1012475|P2|Treated and Having Toxicity Data|Overall Study|1 patient had missing record for toxicity|288
413644|NCT00004859|1012476|P1|Treated and Having Toxicity Data|Overall Study||289
413645|NCT00004859|1012475|P2|Treated|Overall Study||289
413646|NCT00004859|1012476|P1|Treated|Overall Study||289
413647|NCT00004859|1012475|P2|Eligible|Overall Study||271
413648|NCT00004859|1012476|P1|Eligible|Overall Study||275
413649|NCT00004859|1012475|P2|STARTED|Overall Study||294
413650|NCT00004859|1012476|P1|STARTED|Overall Study||295
413651|NCT00004259|1012490|P4|NOT COMPLETED|Overall Study||0
413652|NCT00004259|1012491|P3|NOT COMPLETED|Overall Study||0
413653|NCT00004259|1012492|P2|NOT COMPLETED|Overall Study||4
413654|NCT00004259|1012493|P1|NOT COMPLETED|Overall Study||1
413655|NCT00004259|1012490|P4|COMPLETED|Overall Study||14
413656|NCT00004259|1012491|P3|COMPLETED|Overall Study||15
413657|NCT00004259|1012492|P2|COMPLETED|Overall Study||99
413658|NCT00004259|1012493|P1|COMPLETED|Overall Study||97
413659|NCT00004259|1012490|P4|STARTED|Overall Study||14
413660|NCT00004259|1012491|P3|STARTED|Overall Study||15
413661|NCT00004259|1012492|P2|STARTED|Overall Study||103
413662|NCT00004259|1012493|P1|STARTED|Overall Study||98
413663|NCT00004228|1012518|P7|NOT COMPLETED|Overall Study||12
413664|NCT00004228|1012519|P6|NOT COMPLETED|Overall Study||14
413665|NCT00004228|1012520|P5|NOT COMPLETED|Overall Study||16
413666|NCT00004228|1012521|P4|NOT COMPLETED|Overall Study||7
413667|NCT00004228|1012522|P3|NOT COMPLETED|Overall Study||19
413668|NCT00004228|1012523|P2|NOT COMPLETED|Overall Study||15
413669|NCT00004228|1012524|P1|NOT COMPLETED|Overall Study||9
413670|NCT00004228|1012518|P7|COMPLETED|Overall Study||45
413671|NCT00004228|1012519|P6|COMPLETED|Overall Study||51
413672|NCT00004228|1012520|P5|COMPLETED|Overall Study||51
413673|NCT00004228|1012521|P4|COMPLETED|Overall Study||6
413674|NCT00004228|1012522|P3|COMPLETED|Overall Study||46
413675|NCT00004228|1012523|P2|COMPLETED|Overall Study||51
413676|NCT00004228|1012524|P1|COMPLETED|Overall Study||51
413677|NCT00004228|1012518|P7|STARTED|Overall Study||57
413678|NCT00004228|1012519|P6|STARTED|Overall Study||65
413679|NCT00004228|1012520|P5|STARTED|Overall Study||67
413680|NCT00004228|1012521|P4|STARTED|Overall Study||13
413681|NCT00004228|1012522|P3|STARTED|Overall Study||65
413682|NCT00004228|1012523|P2|STARTED|Overall Study||66
413683|NCT00004228|1012524|P1|STARTED|Overall Study||60
413684|NCT00004143|1012547|P1|NOT COMPLETED|Overall Study||0
413685|NCT00004143|1012547|P1|COMPLETED|Overall Study||2
413686|NCT00004143|1012547|P1|STARTED|Overall Study||2
413687|NCT00004124|1012558|P2|NOT COMPLETED|Overall Study||20
413688|NCT00004124|1012559|P1|NOT COMPLETED|Overall Study||12
413689|NCT00004124|1012558|P2|COMPLETED|Overall Study||460
413690|NCT00004124|1012559|P1|COMPLETED|Overall Study||469
413691|NCT00004124|1012558|P2|STARTED|Overall Study||480
413692|NCT00004124|1012559|P1|STARTED|Overall Study||481
413693|NCT00004092|1012575|P2|NOT COMPLETED|Overall Study||0
413694|NCT00004092|1012576|P1|NOT COMPLETED|Overall Study||0
413695|NCT00004092|1012575|P2|COMPLETED|Overall Study||51
413696|NCT00004092|1012576|P1|COMPLETED|Overall Study||21
413697|NCT00004092|1012575|P2|STARTED|Overall Study||51
413698|NCT00004092|1012576|P1|STARTED|Overall Study||21
413699|NCT00004088|1012584|P1|NOT COMPLETED|Overall Study||9
413700|NCT00004088|1012584|P1|COMPLETED|Overall Study||68
413701|NCT00004088|1012584|P1|STARTED|Overall Study||77
413702|NCT00004054|1012595|P2|NOT COMPLETED|Overall Study||0
413703|NCT00004054|1012596|P1|NOT COMPLETED|Overall Study||0
413704|NCT00004054|1012595|P2|COMPLETED|Overall Study||200
413705|NCT00004054|1012596|P1|COMPLETED|Overall Study||197
413706|NCT00004054|1012595|P2|STARTED|Overall Study||200
413707|NCT00004054|1012596|P1|STARTED|Overall Study||197
413708|NCT00003910|1012610|P2|NOT COMPLETED|Step 2||0
413709|NCT00003910|1012611|P1|NOT COMPLETED|Step 2||0
413710|NCT00003910|1012610|P2|COMPLETED|Step 2||16
413711|NCT00003910|1012611|P1|COMPLETED|Step 2||0
413712|NCT00003910|1012610|P2|STARTED|Step 2|The 16 includes 2 ineligible pts.|16
413713|NCT00003910|1012611|P1|STARTED|Step 2||0
413714|NCT00003910|1012610|P2|NOT COMPLETED|Step 1||0
413715|NCT00003910|1012611|P1|NOT COMPLETED|Step 1||0
413716|NCT00003910|1012610|P2|COMPLETED|Step 1||0
413717|NCT00003910|1012611|P1|COMPLETED|Step 1||55
413718|NCT00003910|1012610|P2|STARTED|Step 1||0
413719|NCT00003910|1012611|P1|STARTED|Step 1|Of 59 (step 1), 4 pts were ineligible.|55
413720|NCT00003901|1012617|P1|NOT COMPLETED|Overall Study||17
413721|NCT00003901|1012617|P1|COMPLETED|Overall Study||1030
413722|NCT00003901|1012617|P1|STARTED|Overall Study||1047
413723|NCT00003896|1012628|P1|NOT COMPLETED|Overall Study||29
413724|NCT00003896|1012628|P1|COMPLETED|Overall Study||39
413725|NCT00003896|1012628|P1|Eligible|Overall Study|2 eligible patients did not have any toxicity assessments reported.|63
413726|NCT00003896|1012628|P1|STARTED|Overall Study||68
413727|NCT00003875|1012634|P1|NOT COMPLETED|Overall Study||1
413728|NCT00003875|1012634|P1|COMPLETED|Overall Study||29
413729|NCT00003875|1012634|P1|STARTED|Overall Study||30
413730|NCT00003869|1012643|P2|NOT COMPLETED|Overall Study||12
413731|NCT00003869|1012644|P1|NOT COMPLETED|Overall Study||41
413732|NCT00003869|1012643|P2|COMPLETED|Overall Study||80
413733|NCT00003869|1012644|P1|COMPLETED|Overall Study||53
413734|NCT00003869|1012643|P2|STARTED|Overall Study||92
413735|NCT00003869|1012644|P1|STARTED|Overall Study||94
413736|NCT00003820|1012660|P2|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
413737|NCT00003820|1012661|P1|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
413738|NCT00003820|1012660|P2|COMPLETED|Cycle 4 (Maintenance Treatment)|Patients with treatment assessment at 24 months|16
413739|NCT00003820|1012661|P1|COMPLETED|Cycle 4 (Maintenance Treatment)||0
413740|NCT00003820|1012660|P2|STARTED|Cycle 4 (Maintenance Treatment)|Patients with treatment response/stable disease at 18 months|16
413741|NCT00003820|1012661|P1|STARTED|Cycle 4 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
413742|NCT00003820|1012660|P2|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
413743|NCT00003820|1012661|P1|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
413744|NCT00003820|1012660|P2|COMPLETED|Cycle 3 (Maintenance Treatment)|Patients with treatment assessment at 18 months|16
413745|NCT00003820|1012661|P1|COMPLETED|Cycle 3 (Maintenance Treatment)||0
413746|NCT00003820|1012660|P2|STARTED|Cycle 3 (Maintenance Treatment)|Patients with treatment response/stable disease at 12 months|16
413747|NCT00003820|1012661|P1|STARTED|Cycle 3 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
413748|NCT00003820|1012660|P2|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
413749|NCT00003820|1012661|P1|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
413750|NCT00003820|1012660|P2|COMPLETED|Cycle 2 (Maintenance Treatment)|Patients with treatment assessment at 12 months|16
413751|NCT00003820|1012661|P1|COMPLETED|Cycle 2 (Maintenance Treatment)||0
413752|NCT00003820|1012660|P2|STARTED|Cycle 2 (Maintenance Treatment)|Pts with treatment response/stable disease at 6 mos, & eligible to continue.|16
413753|NCT00003820|1012661|P1|STARTED|Cycle 2 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
413754|NCT00003820|1012660|P2|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
413755|NCT00003820|1012661|P1|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
413756|NCT00003820|1012660|P2|COMPLETED|Cycle 1 (Initial Treatment)||16
413757|NCT00003820|1012661|P1|COMPLETED|Cycle 1 (Initial Treatment)||23
413758|NCT00003820|1012660|P2|STARTED|Cycle 1 (Initial Treatment)||16
413759|NCT00003820|1012661|P1|STARTED|Cycle 1 (Initial Treatment)||23
413760|NCT00003782|1012670|P3|NOT COMPLETED|Overall Study||26
413761|NCT00003782|1012671|P2|NOT COMPLETED|Overall Study||31
413762|NCT00003782|1012672|P1|NOT COMPLETED|Overall Study||30
413763|NCT00003782|1012670|P3|COMPLETED|Overall Study||1758
413764|NCT00003782|1012671|P2|COMPLETED|Overall Study||1753
413765|NCT00003782|1012672|P1|COMPLETED|Overall Study||1753
413766|NCT00003782|1012670|P3|STARTED|Overall Study||1784
413767|NCT00003782|1012671|P2|STARTED|Overall Study||1784
413768|NCT00003782|1012672|P1|STARTED|Overall Study||1783
413769|NCT00003702|1012682|P2|NOT COMPLETED|Overall Study||11
413770|NCT00003702|1012683|P1|NOT COMPLETED|Overall Study||13
413771|NCT00003702|1012682|P2|COMPLETED|Overall Study||109
413772|NCT00003702|1012683|P1|COMPLETED|Overall Study||107
413773|NCT00003702|1012682|P2|STARTED|Overall Study||120
413774|NCT00003702|1012683|P1|STARTED|Overall Study||120
413775|NCT00003659|1012692|P1|NOT COMPLETED|Overall Study||3
413776|NCT00003659|1012692|P1|COMPLETED|Overall Study||36
413777|NCT00003659|1012692|P1|STARTED|Overall Study||39
413778|NCT00003644|1012700|P2|NOT COMPLETED|Overall Study||14
413779|NCT00003644|1012701|P1|NOT COMPLETED|Overall Study||15
413780|NCT00003644|1012700|P2|COMPLETED|Overall Study||268
413781|NCT00003644|1012701|P1|COMPLETED|Overall Study||274
413782|NCT00003644|1012700|P2|STARTED|Overall Study||282
413783|NCT00003644|1012701|P1|STARTED|Overall Study||289
413784|NCT00003641|1012713|P2|NOT COMPLETED|Overall Study||174
413785|NCT00003641|1012714|P1|NOT COMPLETED|Overall Study||569
413786|NCT00003641|1012713|P2|COMPLETED|Overall Study||407
413787|NCT00003641|1012714|P1|COMPLETED|Overall Study||0
413788|NCT00003641|1012713|P2|Toxicity Assessed|Overall Study||568
413789|NCT00003641|1012714|P1|Toxicity Assessed|Overall Study|439 patients on arm I had their toxicity assessed even though they did not receive any treatment|439
413790|NCT00003641|1012713|P2|Treated|Overall Study||569
413791|NCT00003641|1012714|P1|Treated|Overall Study|Patients on arm I should undergo observation, but 2 patients received interferon therapy|2
413792|NCT00003641|1012713|P2|STARTED|Overall Study||581
413793|NCT00003641|1012714|P1|STARTED|Overall Study||569
413794|NCT00003631|1012725|P3|NOT COMPLETED|Overall Study||9
413795|NCT00003631|1012726|P2|NOT COMPLETED|Overall Study||1
413796|NCT00003631|1012727|P1|NOT COMPLETED|Overall Study||3
413797|NCT00003631|1012725|P3|COMPLETED|Overall Study||15
413798|NCT00003631|1012726|P2|COMPLETED|Overall Study||43
413799|NCT00003631|1012727|P1|COMPLETED|Overall Study||47
413800|NCT00003631|1012725|P3|STARTED|Overall Study||24
413801|NCT00003631|1012726|P2|STARTED|Overall Study||44
413802|NCT00003631|1012727|P1|STARTED|Overall Study||50
413803|NCT00003590|1012735|P1|NOT COMPLETED|Overall Study||22
413804|NCT00003590|1012735|P1|COMPLETED|Overall Study|Patients were to receive Hydroxyurea up to 2 years in absence of progressive disease.|7
413805|NCT00003590|1012735|P1|Eligible and Began Protocol Therapy|Overall Study||28
413806|NCT00003590|1012735|P1|Eligible|Overall Study||28
413807|NCT00003590|1012735|P1|STARTED|Overall Study||29
413808|NCT00003537|1012740|P1|NOT COMPLETED|Overall Study||1
413809|NCT00003537|1012740|P1|COMPLETED|Overall Study||18
413810|NCT00003537|1012740|P1|STARTED|Overall Study||19
413811|NCT00003535|1012745|P1|NOT COMPLETED|Overall Study||5
413812|NCT00003535|1012745|P1|COMPLETED|Overall Study||4
413813|NCT00003535|1012745|P1|STARTED|Overall Study||9
413814|NCT00003499|1012750|P1|NOT COMPLETED|Overall Study||8
413815|NCT00003499|1012750|P1|COMPLETED|Overall Study||23
413816|NCT00003499|1012750|P1|STARTED|Overall Study||31
413817|NCT00003483|1012755|P1|NOT COMPLETED|Overall Study||1
413818|NCT00003483|1012755|P1|COMPLETED|Overall Study||2
413819|NCT00003483|1012755|P1|STARTED|Overall Study||3
413820|NCT00003479|1012760|P1|NOT COMPLETED|Overall Study||3
413821|NCT00003479|1012760|P1|COMPLETED|Overall Study||6
413822|NCT00003479|1012760|P1|STARTED|Overall Study||9
413823|NCT00003477|1012765|P1|NOT COMPLETED|Overall Study||4
413824|NCT00003477|1012765|P1|COMPLETED|Overall Study||8
413825|NCT00003477|1012765|P1|STARTED|Overall Study||12
413826|NCT00003476|1012770|P1|NOT COMPLETED|Overall Study||1
413827|NCT00003476|1012770|P1|COMPLETED|Overall Study||7
413828|NCT00003476|1012770|P1|STARTED|Overall Study||8
413829|NCT00003475|1012775|P1|NOT COMPLETED|Overall Study||13
413830|NCT00003475|1012775|P1|COMPLETED|Overall Study||27
413831|NCT00003475|1012775|P1|STARTED|Overall Study||40
413832|NCT00003474|1012780|P1|NOT COMPLETED|Overall Study||14
413833|NCT00003474|1012780|P1|COMPLETED|Overall Study||26
413834|NCT00003474|1012780|P1|STARTED|Overall Study||40
413835|NCT00003473|1012785|P1|NOT COMPLETED|Overall Study||3
413836|NCT00003473|1012785|P1|COMPLETED|Overall Study||17
413837|NCT00003473|1012785|P1|STARTED|Overall Study||20
413838|NCT00003472|1012790|P1|NOT COMPLETED|Overall Study||3
413839|NCT00003472|1012790|P1|COMPLETED|Overall Study||10
413840|NCT00003472|1012790|P1|STARTED|Overall Study||13
413841|NCT00003471|1012795|P1|NOT COMPLETED|Overall Study||4
413842|NCT00003471|1012795|P1|COMPLETED|Overall Study||3
413843|NCT00003471|1012795|P1|STARTED|Overall Study||7
413844|NCT00003470|1012800|P1|NOT COMPLETED|Overall Study||6
413845|NCT00003470|1012800|P1|COMPLETED|Overall Study||21
413846|NCT00003470|1012800|P1|STARTED|Overall Study||27
413847|NCT00003469|1012805|P1|NOT COMPLETED|Overall Study||0
413848|NCT00003469|1012805|P1|COMPLETED|Overall Study||4
413849|NCT00003469|1012805|P1|STARTED|Overall Study||4
413850|NCT00003468|1012810|P1|NOT COMPLETED|Overall Study||2
413851|NCT00003468|1012810|P1|COMPLETED|Overall Study|Two patients were not evaluable.|9
413852|NCT00003468|1012810|P1|STARTED|Overall Study||11
413853|NCT00003460|1012815|P1|NOT COMPLETED|Overall Study||1
413854|NCT00003460|1012815|P1|COMPLETED|Overall Study|One patient was not evaluable.|12
413855|NCT00003460|1012815|P1|STARTED|Overall Study||13
413856|NCT00003459|1012820|P1|NOT COMPLETED|Overall Study||9
413857|NCT00003459|1012820|P1|COMPLETED|Overall Study|Nine patients were not evaluable.|31
413858|NCT00003459|1012820|P1|STARTED|Overall Study||40
413859|NCT00003458|1012825|P1|NOT COMPLETED|Overall Study||4
413860|NCT00003458|1012825|P1|COMPLETED|Overall Study||30
413861|NCT00003458|1012825|P1|STARTED|Overall Study||34
413862|NCT00003457|1012830|P1|NOT COMPLETED|Overall Study||9
413863|NCT00003457|1012830|P1|COMPLETED|Overall Study||31
413864|NCT00003457|1012830|P1|STARTED|Overall Study||40
413865|NCT00003456|1012835|P1|NOT COMPLETED|Overall Study||8
413866|NCT00003456|1012835|P1|COMPLETED|Overall Study||32
413867|NCT00003456|1012835|P1|STARTED|Overall Study||40
413868|NCT00003453|1012840|P1|NOT COMPLETED|Overall Study||1
413869|NCT00003453|1012840|P1|COMPLETED|Overall Study|One patient was not evaluable|5
413870|NCT00003453|1012840|P1|STARTED|Overall Study||6
413871|NCT00003404|1012845|P1|NOT COMPLETED|Overall Study||0
413872|NCT00003404|1012845|P1|COMPLETED|Overall Study||46
413873|NCT00003404|1012845|P1|STARTED|Overall Study||46
413874|NCT00003389|1012852|P2|NOT COMPLETED|Overall Study||60
413875|NCT00003389|1012853|P1|NOT COMPLETED|Overall Study||98
413876|NCT00003389|1012852|P2|COMPLETED|Overall Study||366
413877|NCT00003389|1012853|P1|COMPLETED|Overall Study||330
413878|NCT00003389|1012852|P2|Eligible Patients|Overall Study||399
413879|NCT00003389|1012853|P1|Eligible Patients|Overall Study||395
413880|NCT00003389|1012852|P2|Treated Pts w/ Toxicity Data Available|Overall Study||422
413881|NCT00003389|1012853|P1|Treated Pts w/ Toxicity Data Available|Overall Study||414
413882|NCT00003389|1012852|P2|STARTED|Overall Study||426
413883|NCT00003389|1012853|P1|STARTED|Overall Study||428
413884|NCT00003377|1012868|P5|NOT COMPLETED|Period II||1
413885|NCT00003377|1012869|P4|NOT COMPLETED|Period II||0
413886|NCT00003377|1012870|P3|NOT COMPLETED|Period II||0
413887|NCT00003377|1012871|P2|NOT COMPLETED|Period II||0
413888|NCT00003377|1012872|P1|NOT COMPLETED|Period II||0
413889|NCT00003377|1012868|P5|COMPLETED|Period II||16
413890|NCT00003377|1012869|P4|COMPLETED|Period II||0
413891|NCT00003377|1012870|P3|COMPLETED|Period II||0
413892|NCT00003377|1012871|P2|COMPLETED|Period II||0
413893|NCT00003377|1012872|P1|COMPLETED|Period II||0
413894|NCT00003377|1012868|P5|STARTED|Period II|All pts enrolled on Per II received cisplatin 40 mg/m2 & paclitaxel 40 mg/m2 concurrent w/ radiation|17
413895|NCT00003377|1012869|P4|STARTED|Period II|Patients participated at this dose level only in Period I.|0
413896|NCT00003377|1012870|P3|STARTED|Period II|Patients participated at this dose level only in Period I.|0
413897|NCT00003377|1012871|P2|STARTED|Period II|Patients participated at this dose level only in Period I.|0
413898|NCT00003377|1012872|P1|STARTED|Period II|Patients participated at this dose level only in Period I.|0
413899|NCT00003377|1012868|P5|NOT COMPLETED|Period I||0
413900|NCT00003377|1012869|P4|NOT COMPLETED|Period I||1
413901|NCT00003377|1012870|P3|NOT COMPLETED|Period I||1
413902|NCT00003377|1012871|P2|NOT COMPLETED|Period I||0
413903|NCT00003377|1012872|P1|NOT COMPLETED|Period I||0
413904|NCT00003377|1012868|P5|COMPLETED|Period I||0
413905|NCT00003377|1012869|P4|COMPLETED|Period I||2
413906|NCT00003377|1012870|P3|COMPLETED|Period I||2
413907|NCT00003377|1012871|P2|COMPLETED|Period I||3
413908|NCT00003377|1012872|P1|COMPLETED|Period I||3
413909|NCT00003377|1012868|P5|STARTED|Period I||0
413910|NCT00003377|1012869|P4|STARTED|Period I||3
413911|NCT00003377|1012870|P3|STARTED|Period I||3
413912|NCT00003377|1012871|P2|STARTED|Period I||3
413913|NCT00003377|1012872|P1|STARTED|Period I||3
413914|NCT00003199|1012886|P1|NOT COMPLETED|Overall Study||22
413915|NCT00003199|1012886|P1|COMPLETED|Overall Study||28
413916|NCT00003199|1012886|P1|STARTED|Overall Study||50
413917|NCT00003138|1012894|P2|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||7
413918|NCT00003138|1012895|P1|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||6
413919|NCT00003138|1012894|P2|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
413920|NCT00003138|1012895|P1|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
413921|NCT00003138|1012894|P2|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||7
413922|NCT00003138|1012895|P1|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||6
413923|NCT00003138|1012894|P2|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||20
413924|NCT00003138|1012895|P1|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||12
413925|NCT00003138|1012894|P2|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
413926|NCT00003138|1012895|P1|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
413927|NCT00003138|1012894|P2|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||19
413928|NCT00003138|1012895|P1|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||12
413929|NCT00003138|1012894|P2|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||20
413930|NCT00003138|1012895|P1|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||12
413931|NCT00003138|1012894|P2|NOT COMPLETED|Step 2 (Cross Over)||0
413932|NCT00003138|1012895|P1|NOT COMPLETED|Step 2 (Cross Over)||26
413933|NCT00003138|1012894|P2|COMPLETED|Step 2 (Cross Over)||0
413934|NCT00003138|1012895|P1|COMPLETED|Step 2 (Cross Over)||0
413935|NCT00003138|1012894|P2|STARTED|Step 2 (Cross Over)|Only patients in the supportive care arm are eligible to cross over to the Erythropoietin arm.|0
413936|NCT00003138|1012895|P1|STARTED|Step 2 (Cross Over)||26
413937|NCT00003138|1012894|P2|NOT COMPLETED|Step 1||57
413938|NCT00003138|1012895|P1|NOT COMPLETED|Step 1||61
413939|NCT00003138|1012894|P2|COMPLETED|Step 1||0
413940|NCT00003138|1012895|P1|COMPLETED|Step 1||0
413941|NCT00003138|1012894|P2|Patients With Transfusion Data|Step 1||42
413942|NCT00003138|1012895|P1|Patients With Transfusion Data|Step 1||37
413943|NCT00003138|1012894|P2|Patients With QOL Data at 4 Months|Step 1||42
413944|NCT00003138|1012895|P1|Patients With QOL Data at 4 Months|Step 1||42
413945|NCT00003138|1012894|P2|Eligible and Treated|Step 1||50
413946|NCT00003138|1012895|P1|Eligible and Treated|Step 1||52
413947|NCT00003138|1012894|P2|Treated|Step 1||53
413948|NCT00003138|1012895|P1|Treated|Step 1||56
413949|NCT00003138|1012894|P2|Patients With Complete Data|Step 1||53
413950|NCT00003138|1012895|P1|Patients With Complete Data|Step 1||57
413951|NCT00003138|1012894|P2|STARTED|Step 1||57
413952|NCT00003138|1012895|P1|STARTED|Step 1||61
413953|NCT00002975|1012908|P1|NOT COMPLETED|Overall Study||5
413954|NCT00002975|1012908|P1|COMPLETED|Overall Study||175
413955|NCT00002975|1012908|P1|Treated With Study Therapy|Overall Study||175
413956|NCT00002975|1012908|P1|STARTED|Overall Study||180
413957|NCT00002931|1012912|P1|NOT COMPLETED|Overall Study||2
413958|NCT00002931|1012912|P1|COMPLETED|Overall Study||46
413959|NCT00002931|1012912|P1|STARTED|Overall Study||48
413960|NCT00002874|1012920|P2|NOT COMPLETED|Overall Study||35
413961|NCT00002874|1012921|P1|NOT COMPLETED|Overall Study||45
413962|NCT00002874|1012920|P2|COMPLETED|Overall Study||384
413963|NCT00002874|1012921|P1|COMPLETED|Overall Study||376
413964|NCT00002874|1012920|P2|STARTED|Overall Study||419
413965|NCT00002874|1012921|P1|STARTED|Overall Study||421
413966|NCT00002850|1012946|P3|NOT COMPLETED|Overall Study||4
413967|NCT00002850|1012947|P2|NOT COMPLETED|Overall Study||2
413968|NCT00002850|1012948|P1|NOT COMPLETED|Overall Study||5
413969|NCT00002850|1012946|P3|COMPLETED|Overall Study||63
413970|NCT00002850|1012947|P2|COMPLETED|Overall Study||74
413971|NCT00002850|1012948|P1|COMPLETED|Overall Study||64
413972|NCT00002850|1012946|P3|STARTED|Overall Study||67
413973|NCT00002850|1012947|P2|STARTED|Overall Study||76
413974|NCT00002850|1012948|P1|STARTED|Overall Study||69
413975|NCT00002842|1012956|P1|NOT COMPLETED|Overall Study||27
413976|NCT00002842|1012956|P1|COMPLETED|Overall Study||22
413977|NCT00002842|1012956|P1|STARTED|Overall Study||49
413978|NCT00002766|1012962|P2|NOT COMPLETED|Overall Study||4
413979|NCT00002766|1012963|P1|NOT COMPLETED|Overall Study||3
413980|NCT00002766|1012962|P2|COMPLETED|Overall Study||85
413981|NCT00002766|1012963|P1|COMPLETED|Overall Study||78
413982|NCT00002766|1012962|P2|STARTED|Overall Study||89
413983|NCT00002766|1012963|P1|STARTED|Overall Study||81
413984|NCT00002651|1012971|P3|NOT COMPLETED|Consolidation and Randomization||860
413985|NCT00002651|1012972|P2|NOT COMPLETED|Consolidation and Randomization||838
413986|NCT00002651|1012973|P1|NOT COMPLETED|Consolidation and Randomization||0
413987|NCT00002651|1012971|P3|COMPLETED|Consolidation and Randomization||22
413988|NCT00002651|1012972|P2|COMPLETED|Consolidation and Randomization||29
413989|NCT00002651|1012973|P1|COMPLETED|Consolidation and Randomization||0
413990|NCT00002651|1012971|P3|Assessable for Toxicity|Consolidation and Randomization||702
413991|NCT00002651|1012972|P2|Assessable for Toxicity|Consolidation and Randomization||732
413992|NCT00002651|1012973|P1|Assessable for Toxicity|Consolidation and Randomization||0
413993|NCT00002651|1012971|P3|Eligible|Consolidation and Randomization||770
413994|NCT00002651|1012972|P2|Eligible|Consolidation and Randomization||765
413995|NCT00002651|1012973|P1|Eligible|Consolidation and Randomization||0
413996|NCT00002651|1012971|P3|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|882
413997|NCT00002651|1012972|P2|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|867
413998|NCT00002651|1012973|P1|STARTED|Consolidation and Randomization||0
413999|NCT00002651|1012971|P3|NOT COMPLETED|Induction||0
414000|NCT00002651|1012972|P2|NOT COMPLETED|Induction||0
414001|NCT00002651|1012973|P1|NOT COMPLETED|Induction||1343
414002|NCT00002651|1012971|P3|COMPLETED|Induction||0
414003|NCT00002651|1012972|P2|COMPLETED|Induction||0
414004|NCT00002651|1012973|P1|COMPLETED|Induction||1697
414005|NCT00002651|1012971|P3|Eligible and Began Protocol Therapy|Induction||0
414006|NCT00002651|1012972|P2|Eligible and Began Protocol Therapy|Induction||0
414007|NCT00002651|1012973|P1|Eligible and Began Protocol Therapy|Induction||2950
414008|NCT00002651|1012971|P3|Eligible|Induction||0
414009|NCT00002651|1012972|P2|Eligible|Induction||0
414010|NCT00002651|1012973|P1|Eligible|Induction||2950
414011|NCT00002651|1012971|P3|STARTED|Induction||0
414012|NCT00002651|1012972|P2|STARTED|Induction||0
414013|NCT00002651|1012973|P1|STARTED|Induction||3040
414014|NCT00002558|1012991|P2|NOT COMPLETED|Overall Study||1
414015|NCT00002558|1012992|P1|NOT COMPLETED|Overall Study||0
414016|NCT00002558|1012991|P2|COMPLETED|Overall Study||15
414017|NCT00002558|1012992|P1|COMPLETED|Overall Study||92
414018|NCT00002558|1012991|P2|STARTED|Overall Study||16
414019|NCT00002558|1012992|P1|STARTED|Overall Study||92
414020|NCT00052078|1013002|P4|NOT COMPLETED|Overall Study||15
414021|NCT00052078|1013003|P3|NOT COMPLETED|Overall Study||13
414022|NCT00052078|1013004|P2|NOT COMPLETED|Overall Study||6
414023|NCT00052078|1013005|P1|NOT COMPLETED|Overall Study||23
414024|NCT00052078|1013002|P4|COMPLETED|Overall Study||61
414025|NCT00052078|1013003|P3|COMPLETED|Overall Study||127
414026|NCT00052078|1013004|P2|COMPLETED|Overall Study||133
414027|NCT00052078|1013005|P1|COMPLETED|Overall Study||110
414028|NCT00052078|1013002|P4|STARTED|Overall Study||76
414029|NCT00052078|1013003|P3|STARTED|Overall Study||140
414030|NCT00052078|1013004|P2|STARTED|Overall Study||139
414031|NCT00052078|1013005|P1|STARTED|Overall Study||133
414032|NCT00051636|1013017|P2|NOT COMPLETED|Period 2- Extended Observation Period||30
414033|NCT00051636|1013018|P1|NOT COMPLETED|Period 2- Extended Observation Period||70
414034|NCT00051636|1013017|P2|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease|22
414035|NCT00051636|1013018|P1|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|5
414036|NCT00051636|1013017|P2|STARTED|Period 2- Extended Observation Period||52
414037|NCT00051636|1013018|P1|STARTED|Period 2- Extended Observation Period||75
414038|NCT00051636|1013017|P2|NOT COMPLETED|Period 1 - Core||6
414039|NCT00051636|1013018|P1|NOT COMPLETED|Period 1 - Core||4
414040|NCT00051636|1013017|P2|COMPLETED|Period 1 - Core||76
414041|NCT00051636|1013018|P1|COMPLETED|Period 1 - Core||86
414042|NCT00051636|1013017|P2|STARTED|Period 1 - Core||82
414043|NCT00051636|1013018|P1|STARTED|Period 1 - Core||90
414044|NCT00051558|1013046|P2|NOT COMPLETED|Overall Study||96
414045|NCT00051558|1013047|P1|NOT COMPLETED|Overall Study||91
414046|NCT00051558|1013046|P2|COMPLETED|Overall Study||118
414047|NCT00051558|1013047|P1|COMPLETED|Overall Study||123
414048|NCT00051558|1013046|P2|STARTED|Overall Study||214
414049|NCT00051558|1013047|P1|STARTED|Overall Study||214
414050|NCT00051363|1013083|P2|NOT COMPLETED|Overall Study||144
414051|NCT00051363|1013084|P1|NOT COMPLETED|Overall Study||115
414052|NCT00051363|1013083|P2|COMPLETED|Overall Study||403
414053|NCT00051363|1013084|P1|COMPLETED|Overall Study||443
414054|NCT00051363|1013083|P2|Completed 6M Vist On-Study|Overall Study||403
414055|NCT00051363|1013084|P1|Completed 6M Vist On-Study|Overall Study||443
414056|NCT00051363|1013083|P2|Completed 6M Visit On-Treatment|Overall Study||372
414057|NCT00051363|1013084|P1|Completed 6M Visit On-Treatment|Overall Study||427
414058|NCT00051363|1013083|P2|Completed 2M Visit On-Study|Overall Study||432
414059|NCT00051363|1013084|P1|Completed 2M Visit On-Study|Overall Study||468
414060|NCT00051363|1013083|P2|Completed 2M Visit On-Treatment|Overall Study||417
414061|NCT00051363|1013084|P1|Completed 2M Visit On-Treatment|Overall Study||456
414062|NCT00051363|1013083|P2|Randomized & Analyzed|Overall Study||542
414063|NCT00051363|1013084|P1|Randomized & Analyzed|Overall Study||556
414064|NCT00051363|1013083|P2|STARTED|Overall Study||547
414065|NCT00051363|1013084|P1|STARTED|Overall Study||558
414066|NCT00051168|1013118|P1|NOT COMPLETED|Overall Study||135
414067|NCT00051168|1013118|P1|COMPLETED|Overall Study||367
414068|NCT00051168|1013118|P1|STARTED|Overall Study||502
414069|NCT00051025|1013124|P2|NOT COMPLETED|Overall Study||4
414070|NCT00051025|1013125|P1|NOT COMPLETED|Overall Study||2
414071|NCT00051025|1013124|P2|COMPLETED|Overall Study||0
414072|NCT00051025|1013125|P1|COMPLETED|Overall Study||3
414073|NCT00051025|1013124|P2|STARTED|Overall Study||4
414074|NCT00051025|1013125|P1|STARTED|Overall Study||5
414075|NCT00050986|1013133|P1|NOT COMPLETED|Overall Study||2
414076|NCT00050986|1013133|P1|COMPLETED|Overall Study|Two participants had withdrawn consents before the study treatment was initiated.|53
414077|NCT00050986|1013133|P1|STARTED|Overall Study||55
414078|NCT00050960|1013139|P2|NOT COMPLETED|Overall Study||304
414079|NCT00050960|1013140|P1|NOT COMPLETED|Overall Study||302
414080|NCT00050960|1013139|P2|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|2
414081|NCT00050960|1013140|P1|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|4
414082|NCT00050960|1013139|P2|STARTED|Overall Study||306
414083|NCT00050960|1013140|P1|STARTED|Overall Study||306
414084|NCT00050778|1013149|P3|NOT COMPLETED|Overall Study||18
414085|NCT00050778|1013150|P2|NOT COMPLETED|Overall Study||21
414086|NCT00050778|1013151|P1|NOT COMPLETED|Overall Study||45
414087|NCT00050778|1013149|P3|COMPLETED|Overall Study||92
414088|NCT00050778|1013150|P2|COMPLETED|Overall Study||92
414089|NCT00050778|1013151|P1|COMPLETED|Overall Study||66
414090|NCT00050778|1013149|P3|Treated|Overall Study||108
414091|NCT00050778|1013150|P2|Treated|Overall Study||108
414092|NCT00050778|1013151|P1|Treated|Overall Study||107
414093|NCT00050778|1013149|P3|STARTED|Overall Study||110
414094|NCT00050778|1013150|P2|STARTED|Overall Study||113
414095|NCT00050778|1013151|P1|STARTED|Overall Study|Randomized.|111
414096|NCT00050622|1013177|P1|NOT COMPLETED|Overall Study||1
414097|NCT00050622|1013177|P1|COMPLETED|Overall Study||153
414098|NCT00050622|1013177|P1|STARTED|Overall Study||154
414099|NCT00050167|1013215|P2|NOT COMPLETED|Overall Study||1
414100|NCT00050167|1013216|P1|NOT COMPLETED|Overall Study||1
414101|NCT00050167|1013215|P2|COMPLETED|Overall Study||300
414102|NCT00050167|1013216|P1|COMPLETED|Overall Study||301
414103|NCT00050167|1013215|P2|STARTED|Overall Study||301
414104|NCT00050167|1013216|P1|STARTED|Overall Study||302
414105|NCT00050089|1013226|P4|NOT COMPLETED|Overall Study||0
414106|NCT00050089|1013227|P3|NOT COMPLETED|Overall Study||0
414107|NCT00050089|1013228|P2|NOT COMPLETED|Overall Study||0
414108|NCT00050089|1013229|P1|NOT COMPLETED|Overall Study||0
414109|NCT00050089|1013226|P4|COMPLETED|Overall Study|For primary outcome assessment|78
414110|NCT00050089|1013227|P3|COMPLETED|Overall Study|For primary outcome assessment|86
414111|NCT00050089|1013228|P2|COMPLETED|Overall Study|For primary outcome assessment|98
414112|NCT00050089|1013229|P1|COMPLETED|Overall Study|For primary outcome assessment|106
414113|NCT00050089|1013226|P4|Baseline|Overall Study||78
414114|NCT00050089|1013227|P3|Baseline|Overall Study||86
414115|NCT00050089|1013228|P2|Baseline|Overall Study|14 participants randomized in the UK Option scheme (not shown in 2X2 baseline data)|84
414116|NCT00050089|1013229|P1|Baseline|Overall Study|15 participants randomized in the UK Option scheme (not displayed in the 2X2 baseline data)|91
414117|NCT00050089|1013226|P4|STARTED|Overall Study||78
414118|NCT00050089|1013227|P3|STARTED|Overall Study||86
414119|NCT00050089|1013228|P2|STARTED|Overall Study||98
414120|NCT00050089|1013229|P1|STARTED|Overall Study||106
414121|NCT00050011|1013249|P2|NOT COMPLETED|Overall Study||126
414122|NCT00050011|1013250|P1|NOT COMPLETED|Overall Study||121
414123|NCT00050011|1013249|P2|COMPLETED|Overall Study||175
414124|NCT00050011|1013250|P1|COMPLETED|Overall Study||180
414125|NCT00050011|1013249|P2|Intent-to-treat Population|Overall Study||300
414126|NCT00050011|1013250|P1|Intent-to-treat Population|Overall Study||300
414127|NCT00050011|1013249|P2|STARTED|Overall Study||301
414128|NCT00050011|1013250|P1|STARTED|Overall Study||301
414129|NCT00049842|1013272|P2|NOT COMPLETED|Follow-up Phase||5
414130|NCT00049842|1013273|P1|NOT COMPLETED|Follow-up Phase||7
414131|NCT00049842|1013272|P2|COMPLETED|Follow-up Phase||189
414132|NCT00049842|1013273|P1|COMPLETED|Follow-up Phase||211
414133|NCT00049842|1013272|P2|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|194
414134|NCT00049842|1013273|P1|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|218
414135|NCT00049842|1013272|P2|NOT COMPLETED|Treatment Phase||78
414136|NCT00049842|1013273|P1|NOT COMPLETED|Treatment Phase||93
414137|NCT00049842|1013272|P2|COMPLETED|Treatment Phase||192
414138|NCT00049842|1013273|P1|COMPLETED|Treatment Phase||177
414139|NCT00049842|1013272|P2|STARTED|Treatment Phase||270
414140|NCT00049842|1013273|P1|STARTED|Treatment Phase||270
414141|NCT00048932|1013291|P3|NOT COMPLETED|Open Label Period (OL)||441
414142|NCT00048932|1013292|P2|NOT COMPLETED|Open Label Period (OL)||0
414143|NCT00048932|1013293|P1|NOT COMPLETED|Open Label Period (OL)||0
414144|NCT00048932|1013291|P3|COMPLETED|Open Label Period (OL)||743
414145|NCT00048932|1013292|P2|COMPLETED|Open Label Period (OL)||0
414146|NCT00048932|1013293|P1|COMPLETED|Open Label Period (OL)||0
414147|NCT00048932|1013291|P3|STARTED|Open Label Period (OL)|47 participants who completed the double-blind did not enter the open-label|1184
414148|NCT00048932|1013292|P2|STARTED|Open Label Period (OL)||0
414149|NCT00048932|1013293|P1|STARTED|Open Label Period (OL)||0
414150|NCT00048932|1013291|P3|NOT COMPLETED|Double Blind Period (DB)||0
414151|NCT00048932|1013292|P2|NOT COMPLETED|Double Blind Period (DB)||87
414152|NCT00048932|1013293|P1|NOT COMPLETED|Double Blind Period (DB)||123
414153|NCT00048932|1013291|P3|COMPLETED|Double Blind Period (DB)||0
414154|NCT00048932|1013292|P2|COMPLETED|Double Blind Period (DB)||395
414155|NCT00048932|1013293|P1|COMPLETED|Double Blind Period (DB)||836
414156|NCT00048932|1013291|P3|STARTED|Double Blind Period (DB)||0
414157|NCT00048932|1013292|P2|STARTED|Double Blind Period (DB)|Number Treated|482
414158|NCT00048932|1013293|P1|STARTED|Double Blind Period (DB)|Number Treated|959
414159|NCT00048815|1013320|P3|NOT COMPLETED|Overall Study||4
414160|NCT00048815|1013321|P2|NOT COMPLETED|Overall Study||4
414161|NCT00048815|1013322|P1|NOT COMPLETED|Overall Study||6
414162|NCT00048815|1013320|P3|COMPLETED|Overall Study||19
414163|NCT00048815|1013321|P2|COMPLETED|Overall Study||22
414164|NCT00048815|1013322|P1|COMPLETED|Overall Study||18
414165|NCT00048815|1013320|P3|STARTED|Overall Study||23
414166|NCT00048815|1013321|P2|STARTED|Overall Study||26
414167|NCT00048815|1013322|P1|STARTED|Overall Study||24
414168|NCT00048581|1013335|P3|NOT COMPLETED|Open-Label Period||167
414169|NCT00048581|1013336|P2|NOT COMPLETED|Open-Label Period||0
414170|NCT00048581|1013337|P1|NOT COMPLETED|Open-Label Period||0
414171|NCT00048581|1013335|P3|COMPLETED|Open-Label Period||150
414172|NCT00048581|1013336|P2|COMPLETED|Open-Label Period||0
414173|NCT00048581|1013337|P1|COMPLETED|Open-Label Period||0
414174|NCT00048581|1013335|P3|STARTED|Open-Label Period||317
414175|NCT00048581|1013336|P2|STARTED|Open-Label Period||0
414176|NCT00048581|1013337|P1|STARTED|Open-Label Period||0
414177|NCT00048581|1013335|P3|NOT COMPLETED|Double-Blind Period||0
414178|NCT00048581|1013336|P2|NOT COMPLETED|Double-Blind Period||34
414179|NCT00048581|1013337|P1|NOT COMPLETED|Double-Blind Period||35
414180|NCT00048581|1013335|P3|COMPLETED|Double-Blind Period||0
414181|NCT00048581|1013336|P2|COMPLETED|Double-Blind Period||99
414182|NCT00048581|1013337|P1|COMPLETED|Double-Blind Period||223
414183|NCT00048581|1013335|P3|STARTED|Double-Blind Period||0
414184|NCT00048581|1013336|P2|STARTED|Double-Blind Period||133
414185|NCT00048581|1013337|P1|STARTED|Double-Blind Period||258
414186|NCT00048568|1013504|P3|NOT COMPLETED|Open-Label Period||160
414187|NCT00048568|1013505|P2|NOT COMPLETED|Open-Label Period||0
414188|NCT00048568|1013506|P1|NOT COMPLETED|Open-Label Period||0
414189|NCT00048568|1013504|P3|COMPLETED|Open-Label Period||379
414190|NCT00048568|1013505|P2|COMPLETED|Open-Label Period||0
414191|NCT00048568|1013506|P1|COMPLETED|Open-Label Period||0
414192|NCT00048568|1013504|P3|STARTED|Open-Label Period||539
414193|NCT00048568|1013505|P2|STARTED|Open-Label Period||0
414194|NCT00048568|1013506|P1|STARTED|Open-Label Period||0
414195|NCT00048568|1013504|P3|NOT COMPLETED|Double-Blind Period Days 170 to 365||0
414196|NCT00048568|1013505|P2|NOT COMPLETED|Double-Blind Period Days 170 to 365||12
414197|NCT00048568|1013506|P1|NOT COMPLETED|Double-Blind Period Days 170 to 365||16
414198|NCT00048568|1013504|P3|COMPLETED|Double-Blind Period Days 170 to 365||0
414199|NCT00048568|1013505|P2|COMPLETED|Double-Blind Period Days 170 to 365||162
414200|NCT00048568|1013506|P1|COMPLETED|Double-Blind Period Days 170 to 365||385
414201|NCT00048568|1013504|P3|STARTED|Double-Blind Period Days 170 to 365||0
414202|NCT00048568|1013505|P2|STARTED|Double-Blind Period Days 170 to 365||174
414203|NCT00048568|1013506|P1|STARTED|Double-Blind Period Days 170 to 365||401
414204|NCT00048568|1013504|P3|NOT COMPLETED|Double-Blind Period Days 1 to 169||0
414205|NCT00048568|1013505|P2|NOT COMPLETED|Double-Blind Period Days 1 to 169||45
414206|NCT00048568|1013506|P1|NOT COMPLETED|Double-Blind Period Days 1 to 169||32
414207|NCT00048568|1013504|P3|COMPLETED|Double-Blind Period Days 1 to 169||0
414208|NCT00048568|1013505|P2|COMPLETED|Double-Blind Period Days 1 to 169||174
414209|NCT00048568|1013506|P1|COMPLETED|Double-Blind Period Days 1 to 169||401
414210|NCT00048568|1013504|P3|STARTED|Double-Blind Period Days 1 to 169||0
414211|NCT00048568|1013505|P2|STARTED|Double-Blind Period Days 1 to 169||219
414212|NCT00048568|1013506|P1|STARTED|Double-Blind Period Days 1 to 169||433
414213|NCT00048893|1013794|P1|NOT COMPLETED|Overall Study||0
414214|NCT00048893|1013794|P1|COMPLETED|Overall Study||37
414215|NCT00048893|1013794|P1|STARTED|Overall Study||37
414216|NCT00048737|1013805|P1|NOT COMPLETED|Overall Study||0
414217|NCT00048737|1013805|P1|COMPLETED|Overall Study||70
414218|NCT00048737|1013805|P1|STARTED|Overall Study||70
414219|NCT00048724|1013811|P2|NOT COMPLETED|Overall Study||118
414220|NCT00048724|1013812|P1|NOT COMPLETED|Overall Study||116
414221|NCT00048724|1013811|P2|COMPLETED|Overall Study||197
414222|NCT00048724|1013812|P1|COMPLETED|Overall Study||195
414223|NCT00048724|1013811|P2|STARTED|Overall Study||315
414224|NCT00048724|1013812|P1|STARTED|Overall Study||311
414225|NCT00048542|1013824|P8|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
414226|NCT00048542|1013825|P7|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
414227|NCT00048542|1013826|P6|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
414228|NCT00048542|1013827|P5|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
414229|NCT00048542|1013828|P4|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
414230|NCT00048542|1013829|P3|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
414231|NCT00048542|1013830|P2|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
414232|NCT00048542|1013831|P1|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
414233|NCT00048542|1013824|P8|COMPLETED|Open-Label Extension Fixed Dose Phase||25
414234|NCT00048542|1013825|P7|COMPLETED|Open-Label Extension Fixed Dose Phase||37
414235|NCT00048542|1013826|P6|COMPLETED|Open-Label Extension Fixed Dose Phase||0
414236|NCT00048542|1013827|P5|COMPLETED|Open-Label Extension Fixed Dose Phase||0
414237|NCT00048542|1013828|P4|COMPLETED|Open-Label Extension Fixed Dose Phase||0
414238|NCT00048542|1013829|P3|COMPLETED|Open-Label Extension Fixed Dose Phase||0
414239|NCT00048542|1013830|P2|COMPLETED|Open-Label Extension Fixed Dose Phase||0
414240|NCT00048542|1013831|P1|COMPLETED|Open-Label Extension Fixed Dose Phase||0
414241|NCT00048542|1013824|P8|STARTED|Open-Label Extension Fixed Dose Phase||47
414242|NCT00048542|1013825|P7|STARTED|Open-Label Extension Fixed Dose Phase||59
414243|NCT00048542|1013826|P6|STARTED|Open-Label Extension Fixed Dose Phase||0
414244|NCT00048542|1013827|P5|STARTED|Open-Label Extension Fixed Dose Phase||0
414245|NCT00048542|1013828|P4|STARTED|Open-Label Extension Fixed Dose Phase||0
414246|NCT00048542|1013829|P3|STARTED|Open-Label Extension Fixed Dose Phase||0
414247|NCT00048542|1013830|P2|STARTED|Open-Label Extension Fixed Dose Phase||0
414248|NCT00048542|1013831|P1|STARTED|Open-Label Extension Fixed Dose Phase||0
414249|NCT00048542|1013824|P8|NOT COMPLETED|Open-Label Extension BSA Phase||0
414250|NCT00048542|1013825|P7|NOT COMPLETED|Open-Label Extension BSA Phase||0
414251|NCT00048542|1013826|P6|NOT COMPLETED|Open-Label Extension BSA Phase||10
414252|NCT00048542|1013827|P5|NOT COMPLETED|Open-Label Extension BSA Phase||12
414253|NCT00048542|1013828|P4|NOT COMPLETED|Open-Label Extension BSA Phase||0
414254|NCT00048542|1013829|P3|NOT COMPLETED|Open-Label Extension BSA Phase||0
414255|NCT00048542|1013830|P2|NOT COMPLETED|Open-Label Extension BSA Phase||0
414256|NCT00048542|1013831|P1|NOT COMPLETED|Open-Label Extension BSA Phase||0
414257|NCT00048542|1013824|P8|COMPLETED|Open-Label Extension BSA Phase||0
414258|NCT00048542|1013825|P7|COMPLETED|Open-Label Extension BSA Phase||0
414259|NCT00048542|1013826|P6|COMPLETED|Open-Label Extension BSA Phase||47
414260|NCT00048542|1013827|P5|COMPLETED|Open-Label Extension BSA Phase||59
414261|NCT00048542|1013828|P4|COMPLETED|Open-Label Extension BSA Phase||0
414262|NCT00048542|1013829|P3|COMPLETED|Open-Label Extension BSA Phase||0
414263|NCT00048542|1013830|P2|COMPLETED|Open-Label Extension BSA Phase||0
414264|NCT00048542|1013831|P1|COMPLETED|Open-Label Extension BSA Phase||0
414265|NCT00048542|1013824|P8|STARTED|Open-Label Extension BSA Phase||0
414266|NCT00048542|1013825|P7|STARTED|Open-Label Extension BSA Phase||0
414267|NCT00048542|1013826|P6|STARTED|Open-Label Extension BSA Phase||57
414268|NCT00048542|1013827|P5|STARTED|Open-Label Extension BSA Phase||71
414269|NCT00048542|1013828|P4|STARTED|Open-Label Extension BSA Phase||0
414270|NCT00048542|1013829|P3|STARTED|Open-Label Extension BSA Phase||0
414271|NCT00048542|1013830|P2|STARTED|Open-Label Extension BSA Phase||0
414272|NCT00048542|1013831|P1|STARTED|Open-Label Extension BSA Phase||0
414273|NCT00048542|1013824|P8|NOT COMPLETED|Double-Blind Phase||0
414274|NCT00048542|1013825|P7|NOT COMPLETED|Double-Blind Phase||0
414275|NCT00048542|1013826|P6|NOT COMPLETED|Double-Blind Phase||0
414276|NCT00048542|1013827|P5|NOT COMPLETED|Double-Blind Phase||0
414277|NCT00048542|1013828|P4|NOT COMPLETED|Double-Blind Phase||0
414278|NCT00048542|1013829|P3|NOT COMPLETED|Double-Blind Phase||1
414279|NCT00048542|1013830|P2|NOT COMPLETED|Double-Blind Phase||1
414280|NCT00048542|1013831|P1|NOT COMPLETED|Double-Blind Phase||3
414281|NCT00048542|1013824|P8|COMPLETED|Double-Blind Phase||0
414282|NCT00048542|1013825|P7|COMPLETED|Double-Blind Phase||0
414283|NCT00048542|1013826|P6|COMPLETED|Double-Blind Phase||0
414284|NCT00048542|1013827|P5|COMPLETED|Double-Blind Phase||0
414285|NCT00048542|1013828|P4|COMPLETED|Double-Blind Phase||28
414286|NCT00048542|1013829|P3|COMPLETED|Double-Blind Phase||29
414287|NCT00048542|1013830|P2|COMPLETED|Double-Blind Phase||36
414288|NCT00048542|1013831|P1|COMPLETED|Double-Blind Phase||35
414289|NCT00048542|1013824|P8|STARTED|Double-Blind Phase||0
414290|NCT00048542|1013825|P7|STARTED|Double-Blind Phase||0
414291|NCT00048542|1013826|P6|STARTED|Double-Blind Phase||0
414292|NCT00048542|1013827|P5|STARTED|Double-Blind Phase||0
414293|NCT00048542|1013828|P4|STARTED|Double-Blind Phase||28
414294|NCT00048542|1013829|P3|STARTED|Double-Blind Phase||30
414295|NCT00048542|1013830|P2|STARTED|Double-Blind Phase||37
414296|NCT00048542|1013831|P1|STARTED|Double-Blind Phase|For all groups, started indicates when the subjects entered the double-blind treatment phase.|38
414297|NCT00048347|1013897|P1|NOT COMPLETED|Overall Study||2
414298|NCT00048347|1013897|P1|COMPLETED|Overall Study||16
414299|NCT00048347|1013897|P1|STARTED|Overall Study||18
414300|NCT00048165|1013903|P2|NOT COMPLETED|Completed 12 Months Study||3
414301|NCT00048165|1013904|P1|NOT COMPLETED|Completed 12 Months Study||3
414302|NCT00048165|1013903|P2|COMPLETED|Completed 12 Months Study||167
414303|NCT00048165|1013904|P1|COMPLETED|Completed 12 Months Study||162
414304|NCT00048165|1013903|P2|STARTED|Completed 12 Months Study||170
414305|NCT00048165|1013904|P1|STARTED|Completed 12 Months Study||165
414306|NCT00048165|1013903|P2|NOT COMPLETED|Completed 6 Months Study||48
414307|NCT00048165|1013904|P1|NOT COMPLETED|Completed 6 Months Study||51
414308|NCT00048165|1013903|P2|COMPLETED|Completed 6 Months Study||170
414309|NCT00048165|1013904|P1|COMPLETED|Completed 6 Months Study||165
414310|NCT00048165|1013903|P2|STARTED|Completed 6 Months Study||218
414311|NCT00048165|1013904|P1|STARTED|Completed 6 Months Study||216
414312|NCT00048074|1013939|P3|NOT COMPLETED|Overall Study||97
414313|NCT00048074|1013940|P2|NOT COMPLETED|Overall Study||87
414314|NCT00048074|1013941|P1|NOT COMPLETED|Overall Study||81
414315|NCT00048074|1013939|P3|COMPLETED|Overall Study||372
414316|NCT00048074|1013940|P2|COMPLETED|Overall Study||361
414317|NCT00048074|1013941|P1|COMPLETED|Overall Study||384
414318|NCT00048074|1013939|P3|STARTED|Overall Study||469
414319|NCT00048074|1013940|P2|STARTED|Overall Study||448
414320|NCT00048074|1013941|P1|STARTED|Overall Study||465
414321|NCT00048061|1013998|P4|NOT COMPLETED|Overall Study||79
414322|NCT00048061|1013999|P3|NOT COMPLETED|Overall Study||84
414323|NCT00048061|1014000|P2|NOT COMPLETED|Overall Study||73
414324|NCT00048061|1014001|P1|NOT COMPLETED|Overall Study||75
414325|NCT00048061|1013998|P4|COMPLETED|Overall Study||322
414326|NCT00048061|1013999|P3|COMPLETED|Overall Study||316
414327|NCT00048061|1014000|P2|COMPLETED|Overall Study||328
414328|NCT00048061|1014001|P1|COMPLETED|Overall Study||325
414329|NCT00048061|1013998|P4|STARTED|Overall Study||401
414330|NCT00048061|1013999|P3|STARTED|Overall Study||400
414331|NCT00048061|1014000|P2|STARTED|Overall Study||401
414332|NCT00048061|1014001|P1|STARTED|Overall Study||400
414333|NCT00048048|1014080|P12|NOT COMPLETED|Extension Year 2||2
414334|NCT00048048|1014081|P11|NOT COMPLETED|Extension Year 2||4
414335|NCT00048048|1014082|P10|NOT COMPLETED|Extension Year 2||0
414336|NCT00048048|1014083|P9|NOT COMPLETED|Extension Year 2||0
414337|NCT00048048|1014084|P8|NOT COMPLETED|Extension Year 2||0
414338|NCT00048048|1014085|P7|NOT COMPLETED|Extension Year 2||0
414339|NCT00048048|1014086|P6|NOT COMPLETED|Extension Year 2||0
414340|NCT00048048|1014087|P5|NOT COMPLETED|Extension Year 2||0
414341|NCT00048048|1014088|P4|NOT COMPLETED|Extension Year 2||0
414342|NCT00048048|1014089|P3|NOT COMPLETED|Extension Year 2||0
414343|NCT00048048|1014090|P2|NOT COMPLETED|Extension Year 2||0
414344|NCT00048048|1014091|P1|NOT COMPLETED|Extension Year 2||0
414345|NCT00048048|1014080|P12|COMPLETED|Extension Year 2||13
414346|NCT00048048|1014081|P11|COMPLETED|Extension Year 2||19
414347|NCT00048048|1014082|P10|COMPLETED|Extension Year 2||2
414348|NCT00048048|1014083|P9|COMPLETED|Extension Year 2||0
414349|NCT00048048|1014084|P8|COMPLETED|Extension Year 2||0
414350|NCT00048048|1014085|P7|COMPLETED|Extension Year 2||0
414351|NCT00048048|1014086|P6|COMPLETED|Extension Year 2||0
414352|NCT00048048|1014087|P5|COMPLETED|Extension Year 2||0
414353|NCT00048048|1014088|P4|COMPLETED|Extension Year 2||0
414354|NCT00048048|1014089|P3|COMPLETED|Extension Year 2||0
414355|NCT00048048|1014090|P2|COMPLETED|Extension Year 2||0
414356|NCT00048048|1014091|P1|COMPLETED|Extension Year 2||0
414357|NCT00048048|1014080|P12|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|15
414358|NCT00048048|1014081|P11|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1 + 12 participants from RO0503821 (1X/Week).|23
414359|NCT00048048|1014082|P10|STARTED|Extension Year 2|Twelve participants who completed Extension Year 1 were switched to RO0503821 (1x/2Week).|2
414360|NCT00048048|1014083|P9|STARTED|Extension Year 2||0
414361|NCT00048048|1014084|P8|STARTED|Extension Year 2||0
414362|NCT00048048|1014085|P7|STARTED|Extension Year 2||0
414363|NCT00048048|1014086|P6|STARTED|Extension Year 2||0
414364|NCT00048048|1014087|P5|STARTED|Extension Year 2||0
414365|NCT00048048|1014088|P4|STARTED|Extension Year 2||0
414366|NCT00048048|1014089|P3|STARTED|Extension Year 2||0
414367|NCT00048048|1014090|P2|STARTED|Extension Year 2||0
414368|NCT00048048|1014091|P1|STARTED|Extension Year 2||0
414369|NCT00048048|1014080|P12|NOT COMPLETED|Extension Year 1||4
414370|NCT00048048|1014081|P11|NOT COMPLETED|Extension Year 1||2
414371|NCT00048048|1014082|P10|NOT COMPLETED|Extension Year 1||2
414372|NCT00048048|1014083|P9|NOT COMPLETED|Extension Year 1||0
414373|NCT00048048|1014084|P8|NOT COMPLETED|Extension Year 1||0
414374|NCT00048048|1014085|P7|NOT COMPLETED|Extension Year 1||0
414375|NCT00048048|1014086|P6|NOT COMPLETED|Extension Year 1||0
414376|NCT00048048|1014087|P5|NOT COMPLETED|Extension Year 1||0
414377|NCT00048048|1014088|P4|NOT COMPLETED|Extension Year 1||0
414378|NCT00048048|1014089|P3|NOT COMPLETED|Extension Year 1||0
414379|NCT00048048|1014090|P2|NOT COMPLETED|Extension Year 1||0
414380|NCT00048048|1014091|P1|NOT COMPLETED|Extension Year 1||0
414381|NCT00048048|1014080|P12|COMPLETED|Extension Year 1||15
414382|NCT00048048|1014081|P11|COMPLETED|Extension Year 1||14
414383|NCT00048048|1014082|P10|COMPLETED|Extension Year 1||14
414384|NCT00048048|1014083|P9|COMPLETED|Extension Year 1||0
414385|NCT00048048|1014084|P8|COMPLETED|Extension Year 1||0
414386|NCT00048048|1014085|P7|COMPLETED|Extension Year 1||0
414387|NCT00048048|1014086|P6|COMPLETED|Extension Year 1||0
414388|NCT00048048|1014087|P5|COMPLETED|Extension Year 1||0
414389|NCT00048048|1014088|P4|COMPLETED|Extension Year 1||0
414390|NCT00048048|1014089|P3|COMPLETED|Extension Year 1||0
414391|NCT00048048|1014090|P2|COMPLETED|Extension Year 1||0
414392|NCT00048048|1014091|P1|COMPLETED|Extension Year 1||0
414393|NCT00048048|1014080|P12|STARTED|Extension Year 1|Participants (Cohorts 7, 8, and 9) who completed core, entered extension period (entry optional).|19
414394|NCT00048048|1014081|P11|STARTED|Extension Year 1|Participants (Cohorts 4, 5, and 6) who completed core, entered extension period (entry optional).|16
414395|NCT00048048|1014082|P10|STARTED|Extension Year 1|Participants (Cohorts 1, 2, and 3) who completed core, entered extension period (entry optional).|16
414396|NCT00048048|1014083|P9|STARTED|Extension Year 1||0
414397|NCT00048048|1014084|P8|STARTED|Extension Year 1||0
414398|NCT00048048|1014085|P7|STARTED|Extension Year 1||0
414399|NCT00048048|1014086|P6|STARTED|Extension Year 1||0
414400|NCT00048048|1014087|P5|STARTED|Extension Year 1||0
414401|NCT00048048|1014088|P4|STARTED|Extension Year 1||0
414402|NCT00048048|1014089|P3|STARTED|Extension Year 1||0
414403|NCT00048048|1014090|P2|STARTED|Extension Year 1||0
414404|NCT00048048|1014091|P1|STARTED|Extension Year 1||0
414405|NCT00048048|1014080|P12|NOT COMPLETED|Core Treatment||0
414406|NCT00048048|1014081|P11|NOT COMPLETED|Core Treatment||0
414407|NCT00048048|1014082|P10|NOT COMPLETED|Core Treatment||0
414408|NCT00048048|1014083|P9|NOT COMPLETED|Core Treatment||0
414409|NCT00048048|1014084|P8|NOT COMPLETED|Core Treatment||1
414410|NCT00048048|1014085|P7|NOT COMPLETED|Core Treatment||0
414411|NCT00048048|1014086|P6|NOT COMPLETED|Core Treatment||0
414412|NCT00048048|1014087|P5|NOT COMPLETED|Core Treatment||0
414413|NCT00048048|1014088|P4|NOT COMPLETED|Core Treatment||0
414414|NCT00048048|1014089|P3|NOT COMPLETED|Core Treatment||1
414415|NCT00048048|1014090|P2|NOT COMPLETED|Core Treatment||0
414416|NCT00048048|1014091|P1|NOT COMPLETED|Core Treatment||0
414417|NCT00048048|1014080|P12|COMPLETED|Core Treatment||0
414418|NCT00048048|1014081|P11|COMPLETED|Core Treatment||0
414419|NCT00048048|1014082|P10|COMPLETED|Core Treatment||0
414420|NCT00048048|1014083|P9|COMPLETED|Core Treatment||10
414421|NCT00048048|1014084|P8|COMPLETED|Core Treatment||5
414422|NCT00048048|1014085|P7|COMPLETED|Core Treatment||6
414423|NCT00048048|1014086|P6|COMPLETED|Core Treatment||9
414424|NCT00048048|1014087|P5|COMPLETED|Core Treatment||6
414425|NCT00048048|1014088|P4|COMPLETED|Core Treatment||6
414426|NCT00048048|1014089|P3|COMPLETED|Core Treatment||9
414427|NCT00048048|1014090|P2|COMPLETED|Core Treatment||6
414428|NCT00048048|1014091|P1|COMPLETED|Core Treatment||6
414429|NCT00048048|1014080|P12|STARTED|Core Treatment||0
414430|NCT00048048|1014081|P11|STARTED|Core Treatment||0
414431|NCT00048048|1014082|P10|STARTED|Core Treatment||0
414432|NCT00048048|1014083|P9|STARTED|Core Treatment||10
414433|NCT00048048|1014084|P8|STARTED|Core Treatment||6
414434|NCT00048048|1014085|P7|STARTED|Core Treatment||6
414435|NCT00048048|1014086|P6|STARTED|Core Treatment||9
414436|NCT00048048|1014087|P5|STARTED|Core Treatment||6
414437|NCT00048048|1014088|P4|STARTED|Core Treatment||6
414438|NCT00048048|1014089|P3|STARTED|Core Treatment||10
414439|NCT00048048|1014090|P2|STARTED|Core Treatment||6
414440|NCT00048048|1014091|P1|STARTED|Core Treatment||6
414441|NCT00048035|1014147|P8|NOT COMPLETED|Extension Year 2||3
414442|NCT00048035|1014148|P7|NOT COMPLETED|Extension Year 2||3
414443|NCT00048035|1014149|P6|NOT COMPLETED|Extension Year 2||0
414444|NCT00048035|1014150|P5|NOT COMPLETED|Extension Year 2||0
414445|NCT00048035|1014151|P4|NOT COMPLETED|Extension Year 2||0
414446|NCT00048035|1014152|P3|NOT COMPLETED|Extension Year 2||0
414447|NCT00048035|1014153|P2|NOT COMPLETED|Extension Year 2||0
414448|NCT00048035|1014154|P1|NOT COMPLETED|Extension Year 2||0
414449|NCT00048035|1014147|P8|COMPLETED|Extension Year 2||10
414450|NCT00048035|1014148|P7|COMPLETED|Extension Year 2||11
414451|NCT00048035|1014149|P6|COMPLETED|Extension Year 2||0
414452|NCT00048035|1014150|P5|COMPLETED|Extension Year 2||0
414453|NCT00048035|1014151|P4|COMPLETED|Extension Year 2||0
414454|NCT00048035|1014152|P3|COMPLETED|Extension Year 2||0
414455|NCT00048035|1014153|P2|COMPLETED|Extension Year 2||0
414456|NCT00048035|1014154|P1|COMPLETED|Extension Year 2||0
414457|NCT00048035|1014147|P8|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|13
414458|NCT00048035|1014148|P7|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
414459|NCT00048035|1014149|P6|STARTED|Extension Year 2||0
414460|NCT00048035|1014150|P5|STARTED|Extension Year 2||0
414461|NCT00048035|1014151|P4|STARTED|Extension Year 2||0
414462|NCT00048035|1014152|P3|STARTED|Extension Year 2||0
414463|NCT00048035|1014153|P2|STARTED|Extension Year 2||0
414464|NCT00048035|1014154|P1|STARTED|Extension Year 2||0
414465|NCT00048035|1014147|P8|NOT COMPLETED|Extension Year 1||11
414466|NCT00048035|1014148|P7|NOT COMPLETED|Extension Year 1||11
414467|NCT00048035|1014149|P6|NOT COMPLETED|Extension Year 1||0
414468|NCT00048035|1014150|P5|NOT COMPLETED|Extension Year 1||0
414469|NCT00048035|1014151|P4|NOT COMPLETED|Extension Year 1||0
414470|NCT00048035|1014152|P3|NOT COMPLETED|Extension Year 1||0
414471|NCT00048035|1014153|P2|NOT COMPLETED|Extension Year 1||0
414472|NCT00048035|1014154|P1|NOT COMPLETED|Extension Year 1||0
414473|NCT00048035|1014147|P8|COMPLETED|Extension Year 1||15
414474|NCT00048035|1014148|P7|COMPLETED|Extension Year 1||16
414475|NCT00048035|1014149|P6|COMPLETED|Extension Year 1||0
414476|NCT00048035|1014150|P5|COMPLETED|Extension Year 1||0
414477|NCT00048035|1014151|P4|COMPLETED|Extension Year 1||0
414478|NCT00048035|1014152|P3|COMPLETED|Extension Year 1||0
414479|NCT00048035|1014153|P2|COMPLETED|Extension Year 1||0
414480|NCT00048035|1014154|P1|COMPLETED|Extension Year 1||0
414481|NCT00048035|1014147|P8|STARTED|Extension Year 1|Participants (Cohorts 2, 4 and 6) who completed core, entered extension period (entry optional).|26
414482|NCT00048035|1014148|P7|STARTED|Extension Year 1|Participants (Cohorts 1, 3, and 5) who completed core, entered extension period (entry optional).|27
414483|NCT00048035|1014149|P6|STARTED|Extension Year 1||0
414484|NCT00048035|1014150|P5|STARTED|Extension Year 1||0
414485|NCT00048035|1014151|P4|STARTED|Extension Year 1||0
414486|NCT00048035|1014152|P3|STARTED|Extension Year 1||0
414487|NCT00048035|1014153|P2|STARTED|Extension Year 1||0
414488|NCT00048035|1014154|P1|STARTED|Extension Year 1||0
414489|NCT00048035|1014147|P8|NOT COMPLETED|Core Period||0
414490|NCT00048035|1014148|P7|NOT COMPLETED|Core Period||0
414491|NCT00048035|1014149|P6|NOT COMPLETED|Core Period||1
414492|NCT00048035|1014150|P5|NOT COMPLETED|Core Period||1
414493|NCT00048035|1014151|P4|NOT COMPLETED|Core Period||1
414494|NCT00048035|1014152|P3|NOT COMPLETED|Core Period||1
414495|NCT00048035|1014153|P2|NOT COMPLETED|Core Period||2
414496|NCT00048035|1014154|P1|NOT COMPLETED|Core Period||4
414497|NCT00048035|1014147|P8|COMPLETED|Core Period||0
414498|NCT00048035|1014148|P7|COMPLETED|Core Period||0
414499|NCT00048035|1014149|P6|COMPLETED|Core Period||14
414500|NCT00048035|1014150|P5|COMPLETED|Core Period||15
414501|NCT00048035|1014151|P4|COMPLETED|Core Period||14
414502|NCT00048035|1014152|P3|COMPLETED|Core Period||14
414503|NCT00048035|1014153|P2|COMPLETED|Core Period||13
414504|NCT00048035|1014154|P1|COMPLETED|Core Period||11
414505|NCT00048035|1014147|P8|STARTED|Core Period||0
414506|NCT00048035|1014148|P7|STARTED|Core Period||0
414507|NCT00048035|1014149|P6|STARTED|Core Period||15
414508|NCT00048035|1014150|P5|STARTED|Core Period||16
414509|NCT00048035|1014151|P4|STARTED|Core Period||15
414510|NCT00048035|1014152|P3|STARTED|Core Period||15
414511|NCT00048035|1014153|P2|STARTED|Core Period||15
414512|NCT00048035|1014154|P1|STARTED|Core Period||15
414513|NCT00047879|1014192|P2|NOT COMPLETED|Overall Study||3
414514|NCT00047879|1014193|P1|NOT COMPLETED|Overall Study||4
414515|NCT00047879|1014192|P2|COMPLETED|Overall Study||0
414516|NCT00047879|1014193|P1|COMPLETED|Overall Study||0
414517|NCT00047879|1014192|P2|STARTED|Overall Study||3
414518|NCT00047879|1014193|P1|STARTED|Overall Study||4
414519|NCT00047697|1014205|P2|NOT COMPLETED|Overall Study||2
414520|NCT00047697|1014206|P1|NOT COMPLETED|Overall Study||0
414521|NCT00047697|1014205|P2|COMPLETED|Overall Study||14
414522|NCT00047697|1014206|P1|COMPLETED|Overall Study||18
414523|NCT00047697|1014205|P2|STARTED|Overall Study||16
414524|NCT00047697|1014206|P1|STARTED|Overall Study||18
414525|NCT00047619|1014218|P2|NOT COMPLETED|Overall Study||0
414526|NCT00047619|1014219|P1|NOT COMPLETED|Overall Study||0
414527|NCT00047619|1014218|P2|COMPLETED|Overall Study||14
414528|NCT00047619|1014219|P1|COMPLETED|Overall Study||14
414529|NCT00047619|1014218|P2|STARTED|Overall Study||14
414530|NCT00047619|1014219|P1|STARTED|Overall Study||14
414531|NCT00047463|1014229|P2|NOT COMPLETED|Overall Study||3
414532|NCT00047463|1014230|P1|NOT COMPLETED|Overall Study||0
414533|NCT00047463|1014229|P2|COMPLETED|Overall Study||19
414534|NCT00047463|1014230|P1|COMPLETED|Overall Study||13
414535|NCT00047463|1014229|P2|STARTED|Overall Study||22
414536|NCT00047463|1014230|P1|STARTED|Overall Study||13
414537|NCT00046475|1014241|P3|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
414538|NCT00046475|1014242|P2|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||1
414539|NCT00046475|1014243|P1|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
414540|NCT00046475|1014241|P3|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||59
414541|NCT00046475|1014242|P2|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||44
414542|NCT00046475|1014243|P1|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
414543|NCT00046475|1014241|P3|STARTED|Treatment Period 2 (Up to 2 Weeks)||59
414544|NCT00046475|1014242|P2|STARTED|Treatment Period 2 (Up to 2 Weeks)||45
414545|NCT00046475|1014243|P1|STARTED|Treatment Period 2 (Up to 2 Weeks)||0
414546|NCT00046475|1014241|P3|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||1
414547|NCT00046475|1014242|P2|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
414548|NCT00046475|1014243|P1|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
414549|NCT00046475|1014241|P3|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||59
414550|NCT00046475|1014242|P2|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||45
414551|NCT00046475|1014243|P1|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
414552|NCT00046475|1014241|P3|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|60
414553|NCT00046475|1014242|P2|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|45
414554|NCT00046475|1014243|P1|STARTED|Treatment Period 1 (Up to 2 Weeks)||0
414555|NCT00046475|1014241|P3|NOT COMPLETED|Titration (1 Week)||0
414556|NCT00046475|1014242|P2|NOT COMPLETED|Titration (1 Week)||0
414557|NCT00046475|1014243|P1|NOT COMPLETED|Titration (1 Week)||0
414558|NCT00046475|1014241|P3|COMPLETED|Titration (1 Week)||0
414559|NCT00046475|1014242|P2|COMPLETED|Titration (1 Week)||0
414560|NCT00046475|1014243|P1|COMPLETED|Titration (1 Week)||136
414561|NCT00046475|1014241|P3|STARTED|Titration (1 Week)||0
414562|NCT00046475|1014242|P2|STARTED|Titration (1 Week)||0
414563|NCT00046475|1014243|P1|STARTED|Titration (1 Week)||136
414564|NCT00046475|1014241|P3|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
414565|NCT00046475|1014242|P2|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
414566|NCT00046475|1014243|P1|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||4
414567|NCT00046475|1014241|P3|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
414568|NCT00046475|1014242|P2|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
414569|NCT00046475|1014243|P1|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||136
414570|NCT00046475|1014241|P3|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
414571|NCT00046475|1014242|P2|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
414572|NCT00046475|1014243|P1|STARTED|Screening/Washout Period (Up to 2 Weeks)||140
414573|NCT00046566|1014282|P3|NOT COMPLETED|Intervention 3 (8 Weeks)||0
414574|NCT00046566|1014283|P2|NOT COMPLETED|Intervention 3 (8 Weeks)||0
414575|NCT00046566|1014284|P1|NOT COMPLETED|Intervention 3 (8 Weeks)||0
414576|NCT00046566|1014282|P3|COMPLETED|Intervention 3 (8 Weeks)||88
414577|NCT00046566|1014283|P2|COMPLETED|Intervention 3 (8 Weeks)||92
414578|NCT00046566|1014284|P1|COMPLETED|Intervention 3 (8 Weeks)||93
414579|NCT00046566|1014282|P3|STARTED|Intervention 3 (8 Weeks)||88
414580|NCT00046566|1014283|P2|STARTED|Intervention 3 (8 Weeks)||92
414581|NCT00046566|1014284|P1|STARTED|Intervention 3 (8 Weeks)||93
414582|NCT00046566|1014282|P3|NOT COMPLETED|Intervention 2 (8 Weeks)||13
414583|NCT00046566|1014283|P2|NOT COMPLETED|Intervention 2 (8 Weeks)||12
414584|NCT00046566|1014284|P1|NOT COMPLETED|Intervention 2 (8 Weeks)||8
414585|NCT00046566|1014282|P3|COMPLETED|Intervention 2 (8 Weeks)||88
414586|NCT00046566|1014283|P2|COMPLETED|Intervention 2 (8 Weeks)||92
414587|NCT00046566|1014284|P1|COMPLETED|Intervention 2 (8 Weeks)||93
414588|NCT00046566|1014282|P3|STARTED|Intervention 2 (8 Weeks)|Soy protein 8 weeks|101
414589|NCT00046566|1014283|P2|STARTED|Intervention 2 (8 Weeks)|Carbohydrate 8 weeks|104
414590|NCT00046566|1014284|P1|STARTED|Intervention 2 (8 Weeks)|Milk protein 8 weeks|101
414591|NCT00046566|1014282|P3|NOT COMPLETED|Intervention 1 (8 Weeks)||17
414592|NCT00046566|1014283|P2|NOT COMPLETED|Intervention 1 (8 Weeks)||13
414593|NCT00046566|1014284|P1|NOT COMPLETED|Intervention 1 (8 Weeks)||16
414594|NCT00046566|1014282|P3|COMPLETED|Intervention 1 (8 Weeks)||101
414595|NCT00046566|1014283|P2|COMPLETED|Intervention 1 (8 Weeks)||104
414596|NCT00046566|1014284|P1|COMPLETED|Intervention 1 (8 Weeks)||101
414597|NCT00046566|1014282|P3|STARTED|Intervention 1 (8 Weeks)|Carbohydrate 8 weeks|118
414598|NCT00046566|1014283|P2|STARTED|Intervention 1 (8 Weeks)|Milk protein 8 weeks|117
414599|NCT00046566|1014284|P1|STARTED|Intervention 1 (8 Weeks)|Soy protein 8 weeks|117
414600|NCT00046228|1014301|P3|NOT COMPLETED|1 Year||12
414601|NCT00046228|1014302|P2|NOT COMPLETED|1 Year||14
414602|NCT00046228|1014303|P1|NOT COMPLETED|1 Year||19
414603|NCT00046228|1014301|P3|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window|816
414604|NCT00046228|1014302|P2|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|804
414605|NCT00046228|1014303|P1|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|787
414606|NCT00046228|1014301|P3|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|828
414607|NCT00046228|1014302|P2|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|818
414608|NCT00046228|1014303|P1|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|806
414609|NCT00046228|1014301|P3|NOT COMPLETED|90 Days||15
414610|NCT00046228|1014302|P2|NOT COMPLETED|90 Days||8
414611|NCT00046228|1014303|P1|NOT COMPLETED|90 Days||13
414612|NCT00046228|1014301|P3|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|813
414613|NCT00046228|1014302|P2|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|810
414614|NCT00046228|1014303|P1|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|793
414615|NCT00046228|1014301|P3|STARTED|90 Days||828
414616|NCT00046228|1014302|P2|STARTED|90 Days||818
414617|NCT00046228|1014303|P1|STARTED|90 Days||806
414618|NCT00045942|1014347|P9|NOT COMPLETED|PKC412A2104E2||6
414619|NCT00045942|1014348|P8|NOT COMPLETED|PKC412A2104E2||7
414620|NCT00045942|1014349|P7|NOT COMPLETED|PKC412A2104E2||7
414621|NCT00045942|1014350|P6|NOT COMPLETED|PKC412A2104E2||9
414622|NCT00045942|1014351|P5|NOT COMPLETED|PKC412A2104E2||0
414623|NCT00045942|1014352|P4|NOT COMPLETED|PKC412A2104E2||0
414624|NCT00045942|1014353|P3|NOT COMPLETED|PKC412A2104E2||0
414625|NCT00045942|1014354|P2|NOT COMPLETED|PKC412A2104E2||0
414626|NCT00045942|1014355|P1|NOT COMPLETED|PKC412A2104E2||0
414627|NCT00045942|1014347|P9|COMPLETED|PKC412A2104E2||0
414628|NCT00045942|1014348|P8|COMPLETED|PKC412A2104E2||0
414629|NCT00045942|1014349|P7|COMPLETED|PKC412A2104E2||0
414630|NCT00045942|1014350|P6|COMPLETED|PKC412A2104E2||0
414631|NCT00045942|1014351|P5|COMPLETED|PKC412A2104E2||0
414632|NCT00045942|1014352|P4|COMPLETED|PKC412A2104E2||0
414633|NCT00045942|1014353|P3|COMPLETED|PKC412A2104E2||0
414634|NCT00045942|1014354|P2|COMPLETED|PKC412A2104E2||0
414635|NCT00045942|1014355|P1|COMPLETED|PKC412A2104E2||0
414636|NCT00045942|1014347|P9|Primary Efficacy|PKC412A2104E2||6
414637|NCT00045942|1014348|P8|Primary Efficacy|PKC412A2104E2||7
414638|NCT00045942|1014349|P7|Primary Efficacy|PKC412A2104E2||7
414639|NCT00045942|1014350|P6|Primary Efficacy|PKC412A2104E2||9
414640|NCT00045942|1014351|P5|Primary Efficacy|PKC412A2104E2||0
414641|NCT00045942|1014352|P4|Primary Efficacy|PKC412A2104E2||0
414642|NCT00045942|1014353|P3|Primary Efficacy|PKC412A2104E2||0
414643|NCT00045942|1014354|P2|Primary Efficacy|PKC412A2104E2||0
414644|NCT00045942|1014355|P1|Primary Efficacy|PKC412A2104E2||0
414645|NCT00045942|1014347|P9|STARTED|PKC412A2104E2||6
414646|NCT00045942|1014348|P8|STARTED|PKC412A2104E2||7
414647|NCT00045942|1014349|P7|STARTED|PKC412A2104E2||7
414648|NCT00045942|1014350|P6|STARTED|PKC412A2104E2||9
414649|NCT00045942|1014351|P5|STARTED|PKC412A2104E2||0
414650|NCT00045942|1014352|P4|STARTED|PKC412A2104E2||0
414651|NCT00045942|1014353|P3|STARTED|PKC412A2104E2||0
414652|NCT00045942|1014354|P2|STARTED|PKC412A2104E2||0
414653|NCT00045942|1014355|P1|STARTED|PKC412A2104E2||0
414654|NCT00045942|1014347|P9|NOT COMPLETED|PKC412A2104E1||0
414655|NCT00045942|1014348|P8|NOT COMPLETED|PKC412A2104E1||0
414656|NCT00045942|1014349|P7|NOT COMPLETED|PKC412A2104E1||0
414657|NCT00045942|1014350|P6|NOT COMPLETED|PKC412A2104E1||0
414658|NCT00045942|1014351|P5|NOT COMPLETED|PKC412A2104E1||27
414659|NCT00045942|1014352|P4|NOT COMPLETED|PKC412A2104E1||33
414660|NCT00045942|1014353|P3|NOT COMPLETED|PKC412A2104E1||17
414661|NCT00045942|1014354|P2|NOT COMPLETED|PKC412A2104E1||18
414662|NCT00045942|1014355|P1|NOT COMPLETED|PKC412A2104E1||0
414663|NCT00045942|1014347|P9|COMPLETED|PKC412A2104E1||0
414664|NCT00045942|1014348|P8|COMPLETED|PKC412A2104E1||0
414665|NCT00045942|1014349|P7|COMPLETED|PKC412A2104E1||0
414666|NCT00045942|1014350|P6|COMPLETED|PKC412A2104E1||0
414667|NCT00045942|1014351|P5|COMPLETED|PKC412A2104E1||0
414668|NCT00045942|1014352|P4|COMPLETED|PKC412A2104E1||0
414669|NCT00045942|1014353|P3|COMPLETED|PKC412A2104E1||0
414670|NCT00045942|1014354|P2|COMPLETED|PKC412A2104E1||0
414671|NCT00045942|1014355|P1|COMPLETED|PKC412A2104E1||0
414672|NCT00045942|1014347|P9|Primary Efficacy|PKC412A2104E1||0
414673|NCT00045942|1014348|P8|Primary Efficacy|PKC412A2104E1||0
414674|NCT00045942|1014349|P7|Primary Efficacy|PKC412A2104E1||0
414675|NCT00045942|1014350|P6|Primary Efficacy|PKC412A2104E1||0
414676|NCT00045942|1014351|P5|Primary Efficacy|PKC412A2104E1||25
414677|NCT00045942|1014352|P4|Primary Efficacy|PKC412A2104E1||32
414678|NCT00045942|1014353|P3|Primary Efficacy|PKC412A2104E1||17
414679|NCT00045942|1014354|P2|Primary Efficacy|PKC412A2104E1||18
414680|NCT00045942|1014355|P1|Primary Efficacy|PKC412A2104E1||0
414681|NCT00045942|1014347|P9|STARTED|PKC412A2104E1||0
414682|NCT00045942|1014348|P8|STARTED|PKC412A2104E1||0
414683|NCT00045942|1014349|P7|STARTED|PKC412A2104E1||0
414684|NCT00045942|1014350|P6|STARTED|PKC412A2104E1||0
414685|NCT00045942|1014351|P5|STARTED|PKC412A2104E1||27
414686|NCT00045942|1014352|P4|STARTED|PKC412A2104E1||33
414687|NCT00045942|1014353|P3|STARTED|PKC412A2104E1||17
414688|NCT00045942|1014354|P2|STARTED|PKC412A2104E1||18
414689|NCT00045942|1014355|P1|STARTED|PKC412A2104E1||0
414690|NCT00045942|1014347|P9|NOT COMPLETED|PKC412A2104 (Core)||0
414691|NCT00045942|1014348|P8|NOT COMPLETED|PKC412A2104 (Core)||0
414692|NCT00045942|1014349|P7|NOT COMPLETED|PKC412A2104 (Core)||0
414693|NCT00045942|1014350|P6|NOT COMPLETED|PKC412A2104 (Core)||0
414694|NCT00045942|1014351|P5|NOT COMPLETED|PKC412A2104 (Core)||0
414695|NCT00045942|1014352|P4|NOT COMPLETED|PKC412A2104 (Core)||0
414696|NCT00045942|1014353|P3|NOT COMPLETED|PKC412A2104 (Core)||0
414697|NCT00045942|1014354|P2|NOT COMPLETED|PKC412A2104 (Core)||0
414698|NCT00045942|1014355|P1|NOT COMPLETED|PKC412A2104 (Core)||20
414699|NCT00045942|1014347|P9|COMPLETED|PKC412A2104 (Core)||0
414700|NCT00045942|1014348|P8|COMPLETED|PKC412A2104 (Core)||0
414701|NCT00045942|1014349|P7|COMPLETED|PKC412A2104 (Core)||0
414702|NCT00045942|1014350|P6|COMPLETED|PKC412A2104 (Core)||0
414703|NCT00045942|1014351|P5|COMPLETED|PKC412A2104 (Core)||0
414704|NCT00045942|1014352|P4|COMPLETED|PKC412A2104 (Core)||0
414705|NCT00045942|1014353|P3|COMPLETED|PKC412A2104 (Core)||0
414706|NCT00045942|1014354|P2|COMPLETED|PKC412A2104 (Core)||0
414707|NCT00045942|1014355|P1|COMPLETED|PKC412A2104 (Core)||0
414708|NCT00045942|1014347|P9|Core Primary Efficacy|PKC412A2104 (Core)||0
414709|NCT00045942|1014348|P8|Core Primary Efficacy|PKC412A2104 (Core)||0
414710|NCT00045942|1014349|P7|Core Primary Efficacy|PKC412A2104 (Core)||0
414711|NCT00045942|1014350|P6|Core Primary Efficacy|PKC412A2104 (Core)||0
414712|NCT00045942|1014351|P5|Core Primary Efficacy|PKC412A2104 (Core)||0
414713|NCT00045942|1014352|P4|Core Primary Efficacy|PKC412A2104 (Core)||0
414714|NCT00045942|1014353|P3|Core Primary Efficacy|PKC412A2104 (Core)||0
414715|NCT00045942|1014354|P2|Core Primary Efficacy|PKC412A2104 (Core)||0
414716|NCT00045942|1014355|P1|Core Primary Efficacy|PKC412A2104 (Core)||20
414717|NCT00045942|1014347|P9|STARTED|PKC412A2104 (Core)||0
414718|NCT00045942|1014348|P8|STARTED|PKC412A2104 (Core)||0
414719|NCT00045942|1014349|P7|STARTED|PKC412A2104 (Core)||0
414720|NCT00045942|1014350|P6|STARTED|PKC412A2104 (Core)||0
414721|NCT00045942|1014351|P5|STARTED|PKC412A2104 (Core)||0
414722|NCT00045942|1014352|P4|STARTED|PKC412A2104 (Core)||0
414723|NCT00045942|1014353|P3|STARTED|PKC412A2104 (Core)||0
414724|NCT00045942|1014354|P2|STARTED|PKC412A2104 (Core)||0
414725|NCT00045942|1014355|P1|STARTED|PKC412A2104 (Core)||20
414726|NCT00044655|1014437|P2|NOT COMPLETED|Overall Study||38
414727|NCT00044655|1014438|P1|NOT COMPLETED|Overall Study||20
414728|NCT00044655|1014437|P2|COMPLETED|Overall Study||79
414729|NCT00044655|1014438|P1|COMPLETED|Overall Study||82
414730|NCT00044655|1014437|P2|STARTED|Overall Study||117
414731|NCT00044655|1014438|P1|STARTED|Overall Study||102
414732|NCT00044512|1014444|P1|NOT COMPLETED|Follow Up||2
414733|NCT00044512|1014444|P1|COMPLETED|Follow Up||135
414734|NCT00044512|1014444|P1|STARTED|Follow Up||137
414735|NCT00044512|1014444|P1|NOT COMPLETED|Treatment||0
414736|NCT00044512|1014444|P1|COMPLETED|Treatment||137
414737|NCT00044512|1014444|P1|STARTED|Treatment||137
414738|NCT00044213|1014459|P4|NOT COMPLETED|Overall Study||136
414739|NCT00044213|1014460|P3|NOT COMPLETED|Overall Study||138
414740|NCT00044213|1014461|P2|NOT COMPLETED|Overall Study||112
414741|NCT00044213|1014462|P1|NOT COMPLETED|Overall Study||100
414742|NCT00044213|1014459|P4|COMPLETED|Overall Study||301
414743|NCT00044213|1014460|P3|COMPLETED|Overall Study||294
414744|NCT00044213|1014461|P2|COMPLETED|Overall Study||306
414745|NCT00044213|1014462|P1|COMPLETED|Overall Study||321
414746|NCT00044213|1014459|P4|STARTED|Overall Study||437
414747|NCT00044213|1014460|P3|STARTED|Overall Study||432
414748|NCT00044213|1014461|P2|STARTED|Overall Study||418
414749|NCT00044213|1014462|P1|STARTED|Overall Study||421
414750|NCT00044044|1014481|P5|NOT COMPLETED|Overall Study||36
414751|NCT00044044|1014482|P4|NOT COMPLETED|Overall Study||44
414752|NCT00044044|1014483|P3|NOT COMPLETED|Overall Study||40
414753|NCT00044044|1014484|P2|NOT COMPLETED|Overall Study||41
414754|NCT00044044|1014485|P1|NOT COMPLETED|Overall Study||44
414755|NCT00044044|1014481|P5|COMPLETED|Overall Study||36
414756|NCT00044044|1014482|P4|COMPLETED|Overall Study||29
414757|NCT00044044|1014483|P3|COMPLETED|Overall Study||31
414758|NCT00044044|1014484|P2|COMPLETED|Overall Study||28
414759|NCT00044044|1014485|P1|COMPLETED|Overall Study||27
414760|NCT00044044|1014481|P5|STARTED|Overall Study||72
414761|NCT00044044|1014482|P4|STARTED|Overall Study||73
414762|NCT00044044|1014483|P3|STARTED|Overall Study||71
414763|NCT00044044|1014484|P2|STARTED|Overall Study||69
414764|NCT00044044|1014485|P1|STARTED|Overall Study||71
414765|NCT00044005|1014515|P3|NOT COMPLETED|Overall Study||22
414766|NCT00044005|1014516|P2|NOT COMPLETED|Overall Study||14
414767|NCT00044005|1014517|P1|NOT COMPLETED|Overall Study||19
414768|NCT00044005|1014515|P3|COMPLETED|Overall Study||11
414769|NCT00044005|1014516|P2|COMPLETED|Overall Study||19
414770|NCT00044005|1014517|P1|COMPLETED|Overall Study||13
414771|NCT00044005|1014515|P3|STARTED|Overall Study||33
414772|NCT00044005|1014516|P2|STARTED|Overall Study||33
414773|NCT00044005|1014517|P1|STARTED|Overall Study||32
414774|NCT00044083|1014527|P2|NOT COMPLETED|Second Intervention (One Week) Patients||1
414775|NCT00044083|1014528|P1|NOT COMPLETED|Second Intervention (One Week) Patients||0
414776|NCT00044083|1014527|P2|COMPLETED|Second Intervention (One Week) Patients||29
414777|NCT00044083|1014528|P1|COMPLETED|Second Intervention (One Week) Patients||30
414778|NCT00044083|1014527|P2|STARTED|Second Intervention (One Week) Patients||30
414779|NCT00044083|1014528|P1|STARTED|Second Intervention (One Week) Patients||30
414780|NCT00044083|1014527|P2|NOT COMPLETED|First Intervention (One Week) Patients||2
414781|NCT00044083|1014528|P1|NOT COMPLETED|First Intervention (One Week) Patients||1
414782|NCT00044083|1014527|P2|COMPLETED|First Intervention (One Week) Patients||30
414783|NCT00044083|1014528|P1|COMPLETED|First Intervention (One Week) Patients||30
414784|NCT00044083|1014527|P2|STARTED|First Intervention (One Week) Patients||32
414785|NCT00044083|1014528|P1|STARTED|First Intervention (One Week) Patients||31
414786|NCT00044083|1014527|P2|NOT COMPLETED|Second Intervention (One Week) HV's||0
414787|NCT00044083|1014528|P1|NOT COMPLETED|Second Intervention (One Week) HV's||0
414788|NCT00044083|1014527|P2|COMPLETED|Second Intervention (One Week) HV's||66
414789|NCT00044083|1014528|P1|COMPLETED|Second Intervention (One Week) HV's||64
414790|NCT00044083|1014527|P2|STARTED|Second Intervention (One Week) HV's||66
414791|NCT00044083|1014528|P1|STARTED|Second Intervention (One Week) HV's||64
414792|NCT00044083|1014527|P2|NOT COMPLETED|First Intervention (One Week)- HV's||7
414793|NCT00044083|1014528|P1|NOT COMPLETED|First Intervention (One Week)- HV's||10
414794|NCT00044083|1014527|P2|COMPLETED|First Intervention (One Week)- HV's||66
414795|NCT00044083|1014528|P1|COMPLETED|First Intervention (One Week)- HV's||64
414796|NCT00044083|1014527|P2|STARTED|First Intervention (One Week)- HV's||73
414797|NCT00044083|1014528|P1|STARTED|First Intervention (One Week)- HV's||74
414798|NCT00043979|1014566|P3|NOT COMPLETED|Period 2||0
414799|NCT00043979|1014567|P2|NOT COMPLETED|Period 2||0
414800|NCT00043979|1014568|P1|NOT COMPLETED|Period 2||0
414801|NCT00043979|1014566|P3|COMPLETED|Period 2||10
414802|NCT00043979|1014567|P2|COMPLETED|Period 2||13
414803|NCT00043979|1014568|P1|COMPLETED|Period 2||0
414804|NCT00043979|1014566|P3|STARTED|Period 2||10
414805|NCT00043979|1014567|P2|STARTED|Period 2||13
414806|NCT00043979|1014568|P1|STARTED|Period 2||0
414807|NCT00043979|1014566|P3|NOT COMPLETED|Period 1||3
414808|NCT00043979|1014567|P2|NOT COMPLETED|Period 1||4
414809|NCT00043979|1014568|P1|NOT COMPLETED|Period 1||7
414810|NCT00043979|1014566|P3|COMPLETED|Period 1||10
414811|NCT00043979|1014567|P2|COMPLETED|Period 1||13
414812|NCT00043979|1014568|P1|COMPLETED|Period 1||23
414813|NCT00043979|1014566|P3|STARTED|Period 1||13
414814|NCT00043979|1014567|P2|STARTED|Period 1||17
414815|NCT00043979|1014568|P1|STARTED|Period 1||30
414816|NCT00043550|1014589|P3|NOT COMPLETED|Overall Study||20
414817|NCT00043550|1014590|P2|NOT COMPLETED|Overall Study||12
414818|NCT00043550|1014591|P1|NOT COMPLETED|Overall Study||22
414819|NCT00043550|1014589|P3|COMPLETED|Overall Study||30
414820|NCT00043550|1014590|P2|COMPLETED|Overall Study||39
414821|NCT00043550|1014591|P1|COMPLETED|Overall Study||33
414822|NCT00043550|1014589|P3|Week 8 Completed|Overall Study||35
414823|NCT00043550|1014590|P2|Week 8 Completed|Overall Study||40
414824|NCT00043550|1014591|P1|Week 8 Completed|Overall Study||35
414825|NCT00043550|1014589|P3|STARTED|Overall Study||50
414826|NCT00043550|1014590|P2|STARTED|Overall Study||51
414827|NCT00043550|1014591|P1|STARTED|Overall Study||55
414828|NCT00043186|1014608|P9|NOT COMPLETED|Overall Study||17
414829|NCT00043186|1014609|P8|NOT COMPLETED|Overall Study||16
414830|NCT00043186|1014610|P7|NOT COMPLETED|Overall Study||17
414831|NCT00043186|1014611|P6|NOT COMPLETED|Overall Study||8
414832|NCT00043186|1014612|P5|NOT COMPLETED|Overall Study||18
414833|NCT00043186|1014613|P4|NOT COMPLETED|Overall Study||22
414834|NCT00043186|1014614|P3|NOT COMPLETED|Overall Study||20
414835|NCT00043186|1014615|P2|NOT COMPLETED|Overall Study||15
414836|NCT00043186|1014616|P1|NOT COMPLETED|Overall Study||17
414837|NCT00043186|1014608|P9|COMPLETED|Overall Study||30
414838|NCT00043186|1014609|P8|COMPLETED|Overall Study||31
414839|NCT00043186|1014610|P7|COMPLETED|Overall Study||25
414840|NCT00043186|1014611|P6|COMPLETED|Overall Study||39
414841|NCT00043186|1014612|P5|COMPLETED|Overall Study||36
414842|NCT00043186|1014613|P4|COMPLETED|Overall Study||19
414843|NCT00043186|1014614|P3|COMPLETED|Overall Study||24
414844|NCT00043186|1014615|P2|COMPLETED|Overall Study||29
414845|NCT00043186|1014616|P1|COMPLETED|Overall Study||29
414846|NCT00043186|1014608|P9|STARTED|Overall Study||47
414847|NCT00043186|1014609|P8|STARTED|Overall Study||47
414848|NCT00043186|1014610|P7|STARTED|Overall Study||42
414849|NCT00043186|1014611|P6|STARTED|Overall Study||47
414850|NCT00043186|1014612|P5|STARTED|Overall Study||54
414851|NCT00043186|1014613|P4|STARTED|Overall Study||41
414852|NCT00043186|1014614|P3|STARTED|Overall Study||44
414853|NCT00043186|1014615|P2|STARTED|Overall Study||44
414854|NCT00043186|1014616|P1|STARTED|Overall Study||46
414855|NCT00042432|1014944|P2|NOT COMPLETED|Overall Study||7
414856|NCT00042432|1014945|P1|NOT COMPLETED|Overall Study||9
414857|NCT00042432|1014944|P2|COMPLETED|Overall Study||20
414858|NCT00042432|1014945|P1|COMPLETED|Overall Study||18
414859|NCT00042432|1014944|P2|STARTED|Overall Study||27
414860|NCT00042432|1014945|P1|STARTED|Overall Study||27
414861|NCT00042224|1014955|P2|NOT COMPLETED|Overall Study||3
414862|NCT00042224|1014956|P1|NOT COMPLETED|Overall Study||3
414863|NCT00042224|1014955|P2|COMPLETED|Overall Study||16
414864|NCT00042224|1014956|P1|COMPLETED|Overall Study||17
414865|NCT00042224|1014955|P2|STARTED|Overall Study||19
414866|NCT00042224|1014956|P1|STARTED|Overall Study||20
414867|NCT00041938|1014964|P2|NOT COMPLETED|Overall Study||31
414868|NCT00041938|1014965|P1|NOT COMPLETED|Overall Study||38
414869|NCT00041938|1014964|P2|COMPLETED|Overall Study||1111
414870|NCT00041938|1014965|P1|COMPLETED|Overall Study||1125
414871|NCT00041938|1014964|P2|Withdrew Consent|Overall Study||14
414872|NCT00041938|1014965|P1|Withdrew Consent|Overall Study||20
414873|NCT00041938|1014964|P2|Lost to Follow-up|Overall Study||17
414874|NCT00041938|1014965|P1|Lost to Follow-up|Overall Study||18
414875|NCT00041938|1014964|P2|Only Vital Status Known|Overall Study||46
414876|NCT00041938|1014965|P1|Only Vital Status Known|Overall Study||44
414877|NCT00041938|1014964|P2|Primary Endpoint|Overall Study||302
414878|NCT00041938|1014965|P1|Primary Endpoint|Overall Study||320
414879|NCT00041938|1014964|P2|Completed Follow-up|Overall Study||745
414880|NCT00041938|1014965|P1|Completed Follow-up|Overall Study||761
414881|NCT00041938|1014964|P2|STARTED|Overall Study||1142
414882|NCT00041938|1014965|P1|STARTED|Overall Study||1163
414883|NCT00041756|1014998|P5|NOT COMPLETED|Overall Study||60
414884|NCT00041756|1014999|P4|NOT COMPLETED|Overall Study||16
414885|NCT00041756|1015000|P3|NOT COMPLETED|Overall Study||13
414886|NCT00041756|1015001|P2|NOT COMPLETED|Overall Study||15
414887|NCT00041756|1015002|P1|NOT COMPLETED|Overall Study||8
414888|NCT00041756|1014998|P5|COMPLETED|Overall Study||19
414889|NCT00041756|1014999|P4|COMPLETED|Overall Study||64
414890|NCT00041756|1015000|P3|COMPLETED|Overall Study||66
414891|NCT00041756|1015001|P2|COMPLETED|Overall Study||65
414892|NCT00041756|1015002|P1|COMPLETED|Overall Study||69
414893|NCT00041756|1014998|P5|STARTED|Overall Study||79
414894|NCT00041756|1014999|P4|STARTED|Overall Study||80
414895|NCT00041756|1015000|P3|STARTED|Overall Study||79
414896|NCT00041756|1015001|P2|STARTED|Overall Study||80
414897|NCT00041756|1015002|P1|STARTED|Overall Study||77
414898|NCT00041717|1015021|P2|NOT COMPLETED|Overall Study||12
414899|NCT00041717|1015022|P1|NOT COMPLETED|Overall Study||33
414900|NCT00041717|1015021|P2|COMPLETED|Overall Study||86
414901|NCT00041717|1015022|P1|COMPLETED|Overall Study||81
414902|NCT00041717|1015021|P2|STARTED|Overall Study||98
414903|NCT00041717|1015022|P1|STARTED|Overall Study||114
414904|NCT00041470|1015030|P1|NOT COMPLETED|Overall Study||38
414905|NCT00041470|1015030|P1|COMPLETED|Overall Study||0
414906|NCT00041470|1015030|P1|STARTED|Overall Study||38
414907|NCT00040664|1015035|P4|NOT COMPLETED|Overall Study||27
414908|NCT00040664|1015036|P3|NOT COMPLETED|Overall Study||13
414909|NCT00040664|1015037|P2|NOT COMPLETED|Overall Study||13
414910|NCT00040664|1015038|P1|NOT COMPLETED|Overall Study||53
414911|NCT00040664|1015035|P4|COMPLETED|Overall Study||8
414912|NCT00040664|1015036|P3|COMPLETED|Overall Study||4
414913|NCT00040664|1015037|P2|COMPLETED|Overall Study||4
414914|NCT00040664|1015038|P1|COMPLETED|Overall Study||16
414915|NCT00040664|1015035|P4|STARTED|Overall Study||35
414916|NCT00040664|1015036|P3|STARTED|Overall Study||17
414917|NCT00040664|1015037|P2|STARTED|Overall Study||17
414918|NCT00040664|1015038|P1|STARTED|Overall Study|All (69) enrolled on QD; 10 switched to twice daily. Participant flow not collected for this group.|69
414919|NCT00041392|1015088|P2|NOT COMPLETED|Overall Study||0
414920|NCT00041392|1015089|P1|NOT COMPLETED|Overall Study||0
414921|NCT00041392|1015088|P2|COMPLETED|Overall Study||191
414922|NCT00041392|1015089|P1|COMPLETED|Overall Study||198
414923|NCT00041392|1015088|P2|STARTED|Overall Study||191
414924|NCT00041392|1015089|P1|STARTED|Overall Study||198
414925|NCT00040443|1015097|P2|NOT COMPLETED|Overall Study||0
414926|NCT00040443|1015098|P1|NOT COMPLETED|Overall Study||0
414927|NCT00040443|1015097|P2|COMPLETED|Overall Study||91
414928|NCT00040443|1015098|P1|COMPLETED|Overall Study||84
414929|NCT00040443|1015097|P2|STARTED|Overall Study||91
414930|NCT00040443|1015098|P1|STARTED|Overall Study||84
414931|NCT00040365|1015104|P1|NOT COMPLETED|Overall Study||11
414932|NCT00040365|1015104|P1|COMPLETED|Overall Study||19
414933|NCT00040365|1015104|P1|Completed Follow Up Phase|Overall Study||19
414934|NCT00040365|1015104|P1|STARTED|Overall Study||30
414935|NCT00039871|1015113|P1|NOT COMPLETED|Overall Study||1384
414936|NCT00039871|1015113|P1|COMPLETED|Overall Study||928
414937|NCT00039871|1015113|P1|STARTED|Overall Study|Enrolled 2333; 21 subjects excluded due to GCP non-compliance|2312
414938|NCT00039741|1015123|P4|NOT COMPLETED|Overall Study||14
414939|NCT00039741|1015124|P3|NOT COMPLETED|Overall Study||11
414940|NCT00039741|1015125|P2|NOT COMPLETED|Overall Study||12
414941|NCT00039741|1015126|P1|NOT COMPLETED|Overall Study||15
414942|NCT00039741|1015123|P4|COMPLETED|Overall Study||50
414943|NCT00039741|1015124|P3|COMPLETED|Overall Study||54
414944|NCT00039741|1015125|P2|COMPLETED|Overall Study||56
414945|NCT00039741|1015126|P1|COMPLETED|Overall Study||51
414946|NCT00039741|1015123|P4|Death|Overall Study||0
414947|NCT00039741|1015124|P3|Death|Overall Study||0
414948|NCT00039741|1015125|P2|Death|Overall Study||1
414949|NCT00039741|1015126|P1|Death|Overall Study||0
414950|NCT00039741|1015123|P4|STARTED|Overall Study||64
414951|NCT00039741|1015124|P3|STARTED|Overall Study||65
414952|NCT00039741|1015125|P2|STARTED|Overall Study||68
414953|NCT00039741|1015126|P1|STARTED|Overall Study||66
414954|NCT00038948|1015170|P2|NOT COMPLETED|Overall Study||77
414955|NCT00038948|1015171|P1|NOT COMPLETED|Overall Study||169
414956|NCT00038948|1015170|P2|COMPLETED|Overall Study||198
414957|NCT00038948|1015171|P1|COMPLETED|Overall Study||386
414958|NCT00038948|1015170|P2|STARTED|Overall Study||275
414959|NCT00038948|1015171|P1|STARTED|Overall Study||555
414960|NCT00038857|1015183|P1|NOT COMPLETED|Overall Study||1
414961|NCT00038857|1015183|P1|COMPLETED|Overall Study||28
414962|NCT00038857|1015183|P1|STARTED|Overall Study||29
414963|NCT00038727|1015190|P3|NOT COMPLETED|Overall Study||0
414964|NCT00038727|1015191|P2|NOT COMPLETED|Overall Study||0
414965|NCT00038727|1015192|P1|NOT COMPLETED|Overall Study||0
414966|NCT00038727|1015190|P3|COMPLETED|Overall Study||936
414967|NCT00038727|1015191|P2|COMPLETED|Overall Study||927
414968|NCT00038727|1015192|P1|COMPLETED|Overall Study||916
414969|NCT00038727|1015190|P3|DPPOS Phase 3 Enrolled|Overall Study||936
414970|NCT00038727|1015191|P2|DPPOS Phase 3 Enrolled|Overall Study||927
414971|NCT00038727|1015192|P1|DPPOS Phase 3 Enrolled|Overall Study||916
414972|NCT00038727|1015190|P3|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|780
414973|NCT00038727|1015191|P2|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|772
414974|NCT00038727|1015192|P1|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|751
414975|NCT00038727|1015190|P3|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|935
414976|NCT00038727|1015191|P2|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|926
414977|NCT00038727|1015192|P1|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|915
414978|NCT00038727|1015190|P3|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|932
414979|NCT00038727|1015191|P2|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|924
414980|NCT00038727|1015192|P1|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|910
414981|NCT00038727|1015190|P3|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|936
414982|NCT00038727|1015191|P2|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|927
414983|NCT00038727|1015192|P1|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|916
414984|NCT00038649|1015206|P1|NOT COMPLETED|Overall Study||9
414985|NCT00038649|1015206|P1|COMPLETED|Overall Study||105
414986|NCT00038649|1015206|P1|STARTED|Overall Study||114
414987|NCT00038610|1015211|P1|NOT COMPLETED|Overall Study||0
414988|NCT00038610|1015211|P1|COMPLETED|Overall Study||54
414989|NCT00038610|1015211|P1|STARTED|Overall Study||54
414990|NCT00038467|1015219|P2|NOT COMPLETED|Overall Study||542
414991|NCT00038467|1015220|P1|NOT COMPLETED|Overall Study||542
414992|NCT00038467|1015219|P2|COMPLETED|Overall Study||1830
414993|NCT00038467|1015220|P1|COMPLETED|Overall Study||1810
414994|NCT00038467|1015219|P2|Treated|Overall Study|7 participants randomized to receive tamoxifen, received exemestane. Reported as per randomization.|2337
414995|NCT00038467|1015220|P1|Treated|Overall Study|8 participants randomized to receive exemestane, received tamoxifen. Reported as per randomization.|2321
414996|NCT00038467|1015219|P2|STARTED|Overall Study||2372
414997|NCT00038467|1015220|P1|STARTED|Overall Study||2352
414998|NCT00038103|1015282|P2|NOT COMPLETED|Overall Study||56
414999|NCT00038103|1015283|P1|NOT COMPLETED|Overall Study||55
415000|NCT00038103|1015282|P2|COMPLETED|Overall Study||0
415001|NCT00038103|1015283|P1|COMPLETED|Overall Study||0
415002|NCT00038103|1015282|P2|End of Treatment|Overall Study|patients remained on treatment until discontinued|56
415003|NCT00038103|1015283|P1|End of Treatment|Overall Study|patients remained on treatment until discontinued|53
415004|NCT00038103|1015282|P2|STARTED|Overall Study||56
415005|NCT00038103|1015283|P1|STARTED|Overall Study||55
415006|NCT00037830|1015306|P3|NOT COMPLETED|Overall Study||1
415007|NCT00037830|1015307|P2|NOT COMPLETED|Overall Study||7
415008|NCT00037830|1015308|P1|NOT COMPLETED|Overall Study||10
415009|NCT00037830|1015306|P3|COMPLETED|Overall Study||16
415010|NCT00037830|1015307|P2|COMPLETED|Overall Study||31
415011|NCT00037830|1015308|P1|COMPLETED|Overall Study||29
415012|NCT00037830|1015306|P3|STARTED|Overall Study||17
415013|NCT00037830|1015307|P2|STARTED|Overall Study||38
415014|NCT00037830|1015308|P1|STARTED|Overall Study||39
415015|NCT00036569|1015329|P1|NOT COMPLETED|Overall Study||0
415016|NCT00036569|1015329|P1|COMPLETED|Overall Study||32
415017|NCT00036569|1015329|P1|STARTED|Overall Study||32
415018|NCT00036270|1015340|P2|NOT COMPLETED|Study Treatment to 5 Year Report||3488
415019|NCT00036270|1015341|P1|NOT COMPLETED|Study Treatment to 5 Year Report||2565
415020|NCT00036270|1015340|P2|COMPLETED|Study Treatment to 5 Year Report||1380
415021|NCT00036270|1015341|P1|COMPLETED|Study Treatment to 5 Year Report||2333
415022|NCT00036270|1015340|P2|Treated|Study Treatment to 5 Year Report||4814
415023|NCT00036270|1015341|P1|Treated|Study Treatment to 5 Year Report||4852
415024|NCT00036270|1015340|P2|STARTED|Study Treatment to 5 Year Report||4868
415025|NCT00036270|1015341|P1|STARTED|Study Treatment to 5 Year Report||4898
415026|NCT00036270|1015340|P2|NOT COMPLETED|Randomized to Study Treatment||7
415027|NCT00036270|1015341|P1|NOT COMPLETED|Randomized to Study Treatment||6
415028|NCT00036270|1015340|P2|COMPLETED|Randomized to Study Treatment||4868
415029|NCT00036270|1015341|P1|COMPLETED|Randomized to Study Treatment||4898
415030|NCT00036270|1015340|P2|STARTED|Randomized to Study Treatment||4875
415031|NCT00036270|1015341|P1|STARTED|Randomized to Study Treatment||4904
415032|NCT00035932|1015360|P3|NOT COMPLETED|Overall Study||49
415033|NCT00035932|1015361|P2|NOT COMPLETED|Overall Study||60
415034|NCT00035932|1015362|P1|NOT COMPLETED|Overall Study||56
415035|NCT00035932|1015360|P3|COMPLETED|Overall Study|59 remained on treatment, 10 completed at Week 96|69
415036|NCT00035932|1015361|P2|COMPLETED|Overall Study|50 remained on treatment, 0 completed at Week 96|50
415037|NCT00035932|1015362|P1|COMPLETED|Overall Study|63 remained on treatment, 0 completed at Week 96|63
415038|NCT00035932|1015360|P3|Discontinued on or After Week 96|Overall Study||6
415039|NCT00035932|1015361|P2|Discontinued on or After Week 96|Overall Study||4
415040|NCT00035932|1015362|P1|Discontinued on or After Week 96|Overall Study||4
415041|NCT00035932|1015360|P3|Discontinued Between Weeks 48 and 96|Overall Study||30
415042|NCT00035932|1015361|P2|Discontinued Between Weeks 48 and 96|Overall Study||27
415043|NCT00035932|1015362|P1|Discontinued Between Weeks 48 and 96|Overall Study||26
415044|NCT00035932|1015360|P3|Discontinued Prior to Week 48 Visit|Overall Study||13
415045|NCT00035932|1015361|P2|Discontinued Prior to Week 48 Visit|Overall Study||29
415046|NCT00035932|1015362|P1|Discontinued Prior to Week 48 Visit|Overall Study||26
415047|NCT00035932|1015360|P3|STARTED|Overall Study|123 randomized, 118 treated|118
415048|NCT00035932|1015361|P2|STARTED|Overall Study|115 randomized, 110 treated|110
415049|NCT00035932|1015362|P1|STARTED|Overall Study|120 randomized, 119 treated|119
415050|NCT00035815|1015488|P2|NOT COMPLETED|Overall Study||11
415051|NCT00035815|1015489|P1|NOT COMPLETED|Overall Study||17
415052|NCT00035815|1015488|P2|COMPLETED|Overall Study||152
415053|NCT00035815|1015489|P1|COMPLETED|Overall Study||150
415054|NCT00035815|1015488|P2|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|163
415055|NCT00035815|1015489|P1|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|167
415056|NCT00035555|1015502|P3|NOT COMPLETED|Overall Study||22
415057|NCT00035555|1015503|P2|NOT COMPLETED|Overall Study||16
415058|NCT00035555|1015504|P1|NOT COMPLETED|Overall Study||16
415059|NCT00035555|1015502|P3|COMPLETED|Overall Study||51
415060|NCT00035555|1015503|P2|COMPLETED|Overall Study||55
415061|NCT00035555|1015504|P1|COMPLETED|Overall Study||58
415062|NCT00035555|1015502|P3|Number Who Received Study Drug|Overall Study||71
415063|NCT00035555|1015503|P2|Number Who Received Study Drug|Overall Study||71
415064|NCT00035555|1015504|P1|Number Who Received Study Drug|Overall Study||74
415065|NCT00035555|1015502|P3|Number Who Had Undergone Transplantation|Overall Study||73
415066|NCT00035555|1015503|P2|Number Who Had Undergone Transplantation|Overall Study||71
415067|NCT00035555|1015504|P1|Number Who Had Undergone Transplantation|Overall Study||74
415068|NCT00035555|1015502|P3|STARTED|Overall Study|Randomized patients|73
415069|NCT00035555|1015503|P2|STARTED|Overall Study|Randomized patients|71
415070|NCT00035555|1015504|P1|STARTED|Overall Study|Randomized patients|74
415071|NCT00033917|1015547|P2|NOT COMPLETED|Overall Study||0
415072|NCT00033917|1015548|P1|NOT COMPLETED|Overall Study||0
415073|NCT00033917|1015547|P2|COMPLETED|Overall Study||222
415074|NCT00033917|1015548|P1|COMPLETED|Overall Study||209
415075|NCT00033917|1015547|P2|STARTED|Overall Study||222
415076|NCT00033917|1015548|P1|STARTED|Overall Study||209
415077|NCT00032630|1015560|P2|NOT COMPLETED|Overall Study||43
415078|NCT00032630|1015561|P1|NOT COMPLETED|Overall Study||49
415079|NCT00032630|1015560|P2|COMPLETED|Overall Study||1061
415080|NCT00032630|1015561|P1|COMPLETED|Overall Study||1050
415081|NCT00032630|1015560|P2|STARTED|Overall Study||1104
415082|NCT00032630|1015561|P1|STARTED|Overall Study||1099
415083|NCT00032591|1015571|P2|NOT COMPLETED|Follow-up||5
415084|NCT00032591|1015572|P1|NOT COMPLETED|Follow-up||2
415085|NCT00032591|1015571|P2|COMPLETED|Follow-up|1452 were included in analysis with greater than 1 day of follow-up|1452
415086|NCT00032591|1015572|P1|COMPLETED|Follow-up|1463 were included in analysis with greater than 1 day of follow-up|1463
415087|NCT00032591|1015571|P2|STARTED|Follow-up|5 were lost to follow-up, all with Atrial Fibrillation, no Mechanical Heart Valves|1457
415088|NCT00032591|1015572|P1|STARTED|Follow-up|2 were lost to follow-up, both with Atrial Fibrillation, no Mechanical Heart Valves|1465
415089|NCT00032591|1015571|P2|NOT COMPLETED|Randomization||0
415090|NCT00032591|1015572|P1|NOT COMPLETED|Randomization||0
415091|NCT00032591|1015571|P2|COMPLETED|Randomization|1457 were assigned to clinic testing|1457
415092|NCT00032591|1015572|P1|COMPLETED|Randomization|1465 were assigned to self-testing|1465
415093|NCT00032591|1015571|P2|STARTED|Randomization||1457
415094|NCT00032591|1015572|P1|STARTED|Randomization|2922 underwent randomization|1465
415095|NCT00032591|1015571|P2|NOT COMPLETED|Screening||415
415096|NCT00032591|1015572|P1|NOT COMPLETED|Screening||408
415097|NCT00032591|1015571|P2|COMPLETED|Screening||1457
415098|NCT00032591|1015572|P1|COMPLETED|Screening|823 were excluded from the study|1465
415099|NCT00032591|1015571|P2|STARTED|Screening|Treatment assigned at randomization; screening counts by arm represent half of the total screened.|1872
415100|NCT00032591|1015572|P1|STARTED|Screening|3745 patients provided informed consent and were screened for participation.|1873
415101|NCT00032487|1015588|P2|NOT COMPLETED|Overall Study||120
415102|NCT00032487|1015589|P1|NOT COMPLETED|Overall Study||139
415103|NCT00032487|1015588|P2|COMPLETED|Overall Study||772
415104|NCT00032487|1015589|P1|COMPLETED|Overall Study||760
415105|NCT00032487|1015588|P2|STARTED|Overall Study||892
415106|NCT00032487|1015589|P1|STARTED|Overall Study||899
415107|NCT00031551|1015599|P2|NOT COMPLETED|Overall Study||0
415108|NCT00031551|1015600|P1|NOT COMPLETED|Overall Study||2
415109|NCT00031551|1015599|P2|COMPLETED|Overall Study||25
415110|NCT00031551|1015600|P1|COMPLETED|Overall Study||0
415111|NCT00031551|1015599|P2|STARTED|Overall Study||25
415112|NCT00031551|1015600|P1|STARTED|Overall Study||2
415113|NCT00031486|1015612|P2|NOT COMPLETED|Overall Study||12
415114|NCT00031486|1015613|P1|NOT COMPLETED|Overall Study||7
415115|NCT00031486|1015612|P2|COMPLETED|Overall Study||35
415116|NCT00031486|1015613|P1|COMPLETED|Overall Study||33
415117|NCT00031486|1015612|P2|STARTED|Overall Study||47
415118|NCT00031486|1015613|P1|STARTED|Overall Study||40
415119|NCT00031460|1015639|P2|NOT COMPLETED|Overall Study||14
415120|NCT00031460|1015640|P1|NOT COMPLETED|Overall Study||9
415121|NCT00031460|1015639|P2|COMPLETED|Overall Study||8
415122|NCT00031460|1015640|P1|COMPLETED|Overall Study||15
415123|NCT00031460|1015639|P2|STARTED|Overall Study||22
415124|NCT00031460|1015640|P1|STARTED|Overall Study||24
415125|NCT00031447|1015654|P2|NOT COMPLETED|Overall Study||7
415126|NCT00031447|1015655|P1|NOT COMPLETED|Overall Study||10
415127|NCT00031447|1015654|P2|COMPLETED|Overall Study||8
415128|NCT00031447|1015655|P1|COMPLETED|Overall Study||4
415129|NCT00031447|1015654|P2|STARTED|Overall Study||15
415130|NCT00031447|1015655|P1|STARTED|Overall Study||14
415131|NCT00030992|1015667|P1|NOT COMPLETED|Overall Study||0
415132|NCT00030992|1015667|P1|COMPLETED|Overall Study||102
415133|NCT00030992|1015667|P1|STARTED|Overall Study||102
415134|NCT00030147|1015676|P4|NOT COMPLETED|Overall Study||0
415135|NCT00030147|1015677|P3|NOT COMPLETED|Overall Study||0
415136|NCT00030147|1015678|P2|NOT COMPLETED|Overall Study||1
415137|NCT00030147|1015679|P1|NOT COMPLETED|Overall Study||0
415138|NCT00030147|1015676|P4|COMPLETED|Overall Study||11
415139|NCT00030147|1015677|P3|COMPLETED|Overall Study||16
415140|NCT00030147|1015678|P2|COMPLETED|Overall Study||18
415141|NCT00030147|1015679|P1|COMPLETED|Overall Study||17
415142|NCT00030147|1015676|P4|STARTED|Overall Study||11
415143|NCT00030147|1015677|P3|STARTED|Overall Study||16
415144|NCT00030147|1015678|P2|STARTED|Overall Study||19
415145|NCT00030147|1015679|P1|STARTED|Overall Study||17
415146|NCT00029536|1015697|P4|NOT COMPLETED|Overall Study||0
415147|NCT00029536|1015698|P3|NOT COMPLETED|Overall Study||0
415148|NCT00029536|1015699|P2|NOT COMPLETED|Overall Study||0
415149|NCT00029536|1015700|P1|NOT COMPLETED|Overall Study||0
415150|NCT00029536|1015697|P4|COMPLETED|Overall Study||59
415151|NCT00029536|1015698|P3|COMPLETED|Overall Study||105
415152|NCT00029536|1015699|P2|COMPLETED|Overall Study||45
415153|NCT00029536|1015700|P1|COMPLETED|Overall Study||85
415154|NCT00029536|1015697|P4|STARTED|Overall Study||59
415155|NCT00029536|1015698|P3|STARTED|Overall Study||105
415156|NCT00029536|1015699|P2|STARTED|Overall Study||45
415157|NCT00029536|1015700|P1|STARTED|Overall Study||85
415158|NCT00029172|1015724|P1|NOT COMPLETED|Overall Study||6
415159|NCT00029172|1015724|P1|COMPLETED|Overall Study||182
415160|NCT00029172|1015724|P1|STARTED|Overall Study||188
415161|NCT00029146|1015730|P2|NOT COMPLETED|Overall Study||1
415162|NCT00029146|1015731|P1|NOT COMPLETED|Overall Study||2
415163|NCT00029146|1015730|P2|COMPLETED|Overall Study||97
415164|NCT00029146|1015731|P1|COMPLETED|Overall Study||95
415165|NCT00029146|1015730|P2|STARTED|Overall Study||98
415166|NCT00029146|1015731|P1|STARTED|Overall Study||97
415167|NCT00029107|1015760|P2|NOT COMPLETED|Overall Study||0
415168|NCT00029107|1015761|P1|NOT COMPLETED|Overall Study||0
415169|NCT00029107|1015760|P2|COMPLETED|Overall Study||12
415170|NCT00029107|1015761|P1|COMPLETED|Overall Study||12
415171|NCT00029107|1015760|P2|STARTED|Overall Study||12
415172|NCT00029107|1015761|P1|STARTED|Overall Study||12
415173|NCT00028262|1015767|P1|NOT COMPLETED|Overall Study||1
415174|NCT00028262|1015767|P1|COMPLETED|Overall Study||9
415175|NCT00028262|1015767|P1|STARTED|Overall Study||10
415176|NCT00028093|1015773|P2|NOT COMPLETED|Overall Study||0
415177|NCT00028093|1015774|P1|NOT COMPLETED|Overall Study||0
415178|NCT00028093|1015773|P2|COMPLETED|Overall Study||25
415179|NCT00028093|1015774|P1|COMPLETED|Overall Study||25
415180|NCT00028093|1015773|P2|STARTED|Overall Study||25
415181|NCT00028093|1015774|P1|STARTED|Overall Study||25
415182|NCT00027378|1015782|P2|NOT COMPLETED|Overall Study||3
415183|NCT00027378|1015783|P1|NOT COMPLETED|Overall Study||0
415184|NCT00027378|1015782|P2|COMPLETED|Overall Study||23
415185|NCT00027378|1015783|P1|COMPLETED|Overall Study||24
415186|NCT00027378|1015782|P2|STARTED|Overall Study||26
415187|NCT00027378|1015783|P1|STARTED|Overall Study||24
415188|NCT00027027|1015796|P5|NOT COMPLETED|Overall Study||8
415189|NCT00027027|1015797|P4|NOT COMPLETED|Overall Study||3
415190|NCT00027027|1015798|P3|NOT COMPLETED|Overall Study||4
415191|NCT00027027|1015799|P2|NOT COMPLETED|Overall Study||3
415192|NCT00027027|1015800|P1|NOT COMPLETED|Overall Study||3
415193|NCT00027027|1015796|P5|COMPLETED|Overall Study||0
415194|NCT00027027|1015797|P4|COMPLETED|Overall Study||0
415195|NCT00027027|1015798|P3|COMPLETED|Overall Study||0
415196|NCT00027027|1015799|P2|COMPLETED|Overall Study||0
415197|NCT00027027|1015800|P1|COMPLETED|Overall Study||0
415198|NCT00027027|1015796|P5|Treated Beyond Cycle 2|Overall Study||4
415199|NCT00027027|1015797|P4|Treated Beyond Cycle 2|Overall Study||2
415200|NCT00027027|1015798|P3|Treated Beyond Cycle 2|Overall Study||2
415201|NCT00027027|1015799|P2|Treated Beyond Cycle 2|Overall Study||1
415202|NCT00027027|1015800|P1|Treated Beyond Cycle 2|Overall Study||1
415203|NCT00027027|1015796|P5|Discontinued at Cycle 2|Overall Study||3
415204|NCT00027027|1015797|P4|Discontinued at Cycle 2|Overall Study||1
415205|NCT00027027|1015798|P3|Discontinued at Cycle 2|Overall Study||1
415206|NCT00027027|1015799|P2|Discontinued at Cycle 2|Overall Study||2
415207|NCT00027027|1015800|P1|Discontinued at Cycle 2|Overall Study||2
415208|NCT00027027|1015796|P5|Completed 2 Cycles of Treatment|Overall Study||7
415209|NCT00027027|1015797|P4|Completed 2 Cycles of Treatment|Overall Study||3
415210|NCT00027027|1015798|P3|Completed 2 Cycles of Treatment|Overall Study||3
415211|NCT00027027|1015799|P2|Completed 2 Cycles of Treatment|Overall Study||3
415212|NCT00027027|1015800|P1|Completed 2 Cycles of Treatment|Overall Study||3
415213|NCT00027027|1015796|P5|Discontinued Before 2 Treatment Cycles|Overall Study||1
415214|NCT00027027|1015797|P4|Discontinued Before 2 Treatment Cycles|Overall Study||0
415215|NCT00027027|1015798|P3|Discontinued Before 2 Treatment Cycles|Overall Study||1
415216|NCT00027027|1015799|P2|Discontinued Before 2 Treatment Cycles|Overall Study||0
415217|NCT00027027|1015800|P1|Discontinued Before 2 Treatment Cycles|Overall Study||0
415218|NCT00027027|1015796|P5|STARTED|Overall Study||8
415219|NCT00027027|1015797|P4|STARTED|Overall Study||3
415220|NCT00027027|1015798|P3|STARTED|Overall Study||4
415221|NCT00027027|1015799|P2|STARTED|Overall Study||3
415222|NCT00027027|1015800|P1|STARTED|Overall Study||3
415223|NCT00025883|1015847|P1|NOT COMPLETED|Overall Study||17
415224|NCT00025883|1015847|P1|COMPLETED|Overall Study||86
415225|NCT00025883|1015847|P1|Partial Lipodystrophy|Overall Study||40
415226|NCT00025883|1015847|P1|Generalized Lipodystrophy|Overall Study||63
415227|NCT00025883|1015847|P1|STARTED|Overall Study||103
415228|NCT00023595|1015859|P5|NOT COMPLETED|10 Year Follow up||0
415229|NCT00023595|1015860|P4|NOT COMPLETED|10 Year Follow up||0
415230|NCT00023595|1015861|P3|NOT COMPLETED|10 Year Follow up||3
415231|NCT00023595|1015862|P2|NOT COMPLETED|10 Year Follow up||10
415232|NCT00023595|1015863|P1|NOT COMPLETED|10 Year Follow up||12
415233|NCT00023595|1015859|P5|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
415234|NCT00023595|1015860|P4|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
415235|NCT00023595|1015861|P3|COMPLETED|10 Year Follow up||73
415236|NCT00023595|1015862|P2|COMPLETED|10 Year Follow up||524
415237|NCT00023595|1015863|P1|COMPLETED|10 Year Follow up||590
415238|NCT00023595|1015859|P5|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
415239|NCT00023595|1015860|P4|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
415240|NCT00023595|1015861|P3|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|76
415241|NCT00023595|1015862|P2|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|534
415242|NCT00023595|1015863|P1|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|602
415243|NCT00023595|1015859|P5|NOT COMPLETED|5 Year Follow up||3
415244|NCT00023595|1015860|P4|NOT COMPLETED|5 Year Follow up||7
415245|NCT00023595|1015861|P3|NOT COMPLETED|5 Year Follow up||1
415246|NCT00023595|1015862|P2|NOT COMPLETED|5 Year Follow up||2
415247|NCT00023595|1015863|P1|NOT COMPLETED|5 Year Follow up||2
415248|NCT00023595|1015859|P5|COMPLETED|5 Year Follow up||498
415249|NCT00023595|1015860|P4|COMPLETED|5 Year Follow up||416
415250|NCT00023595|1015861|P3|COMPLETED|5 Year Follow up||75
415251|NCT00023595|1015862|P2|COMPLETED|5 Year Follow up||532
415252|NCT00023595|1015863|P1|COMPLETED|5 Year Follow up||600
415253|NCT00023595|1015859|P5|STARTED|5 Year Follow up||501
415254|NCT00023595|1015860|P4|STARTED|5 Year Follow up|76 of stratum B pts who were randomized to med therapy + CABG group belong to both H01 and H02.|423
415255|NCT00023595|1015861|P3|STARTED|5 Year Follow up||76
415256|NCT00023595|1015862|P2|STARTED|5 Year Follow up||534
415257|NCT00023595|1015863|P1|STARTED|5 Year Follow up||602
415258|NCT00023452|1016074|P2|NOT COMPLETED|Overall Study||872
415259|NCT00023452|1016075|P1|NOT COMPLETED|Overall Study||1323
415260|NCT00023452|1016074|P2|COMPLETED|Overall Study||3273
415261|NCT00023452|1016075|P1|COMPLETED|Overall Study||2585
415262|NCT00023452|1016074|P2|Completed Study|Overall Study||3475
415263|NCT00023452|1016075|P1|Completed Study|Overall Study||3174
415264|NCT00023452|1016074|P2|Not Treated|Overall Study||105
415265|NCT00023452|1016075|P1|Not Treated|Overall Study||149
415266|NCT00023452|1016074|P2|Completed Treatment|Overall Study||3273
415267|NCT00023452|1016075|P1|Completed Treatment|Overall Study||2585
415268|NCT00023452|1016074|P2|Enrolled as Part of a Cluster|Overall Study||971
415269|NCT00023452|1016075|P1|Enrolled as Part of a Cluster|Overall Study||718
415270|NCT00023452|1016074|P2|Randomized|Overall Study||3174
415271|NCT00023452|1016075|P1|Randomized|Overall Study||3190
415272|NCT00023452|1016074|P2|STARTED|Overall Study||4145
415273|NCT00023452|1016075|P1|STARTED|Overall Study||3908
415274|NCT00023322|1016099|P1|NOT COMPLETED|Overall Study||1
415275|NCT00023322|1016099|P1|COMPLETED|Overall Study||12
415276|NCT00023322|1016099|P1|STARTED|Overall Study||13
415277|NCT00023309|1016106|P2|NOT COMPLETED|Overall Study||0
415278|NCT00023309|1016107|P1|NOT COMPLETED|Overall Study||0
415279|NCT00023309|1016106|P2|COMPLETED|Overall Study||19
415280|NCT00023309|1016107|P1|COMPLETED|Overall Study||22
415281|NCT00023309|1016106|P2|STARTED|Overall Study||19
415282|NCT00023309|1016107|P1|STARTED|Overall Study||22
415283|NCT00022763|1016123|P2|NOT COMPLETED|Overall Study||17
415284|NCT00022763|1016124|P1|NOT COMPLETED|Overall Study||9
415285|NCT00022763|1016123|P2|COMPLETED|Overall Study||11
415286|NCT00022763|1016124|P1|COMPLETED|Overall Study||15
415287|NCT00022763|1016123|P2|STARTED|Overall Study||28
415288|NCT00022763|1016124|P1|STARTED|Overall Study||24
415289|NCT00016718|1016150|P3|NOT COMPLETED|Overall Study||0
415290|NCT00016718|1016151|P2|NOT COMPLETED|Overall Study||0
415291|NCT00016718|1016152|P1|NOT COMPLETED|Overall Study||0
415292|NCT00016718|1016150|P3|COMPLETED|Overall Study||16
415293|NCT00016718|1016151|P2|COMPLETED|Overall Study||21
415294|NCT00016718|1016152|P1|COMPLETED|Overall Study||6
415295|NCT00016718|1016150|P3|STARTED|Overall Study||16
415296|NCT00016718|1016151|P2|STARTED|Overall Study||21
415297|NCT00016718|1016152|P1|STARTED|Overall Study||6
415298|NCT00014911|1016166|P1|NOT COMPLETED|Overall Study||11
415299|NCT00014911|1016166|P1|COMPLETED|Overall Study|One subject experienced pneumonia, myocardial infarction, and acute renal failure|25
415300|NCT00014911|1016166|P1|STARTED|Overall Study||36
415301|NCT00006604|1016182|P17|NOT COMPLETED|Overall Study||9
415302|NCT00006604|1016183|P16|NOT COMPLETED|Overall Study||5
415303|NCT00006604|1016184|P15|NOT COMPLETED|Overall Study||10
415304|NCT00006604|1016185|P14|NOT COMPLETED|Overall Study||6
415305|NCT00006604|1016186|P13|NOT COMPLETED|Overall Study||4
415306|NCT00006604|1016187|P12|NOT COMPLETED|Overall Study||6
415307|NCT00006604|1016188|P11|NOT COMPLETED|Overall Study||8
415308|NCT00006604|1016189|P10|NOT COMPLETED|Overall Study||19
415309|NCT00006604|1016190|P9|NOT COMPLETED|Overall Study||1
415310|NCT00006604|1016191|P8|NOT COMPLETED|Overall Study||3
415311|NCT00006604|1016192|P7|NOT COMPLETED|Overall Study||9
415312|NCT00006604|1016193|P6|NOT COMPLETED|Overall Study||3
415313|NCT00006604|1016194|P5|NOT COMPLETED|Overall Study||2
415314|NCT00006604|1016195|P4|NOT COMPLETED|Overall Study||5
415315|NCT00006604|1016196|P3|NOT COMPLETED|Overall Study||4
415316|NCT00006604|1016197|P2|NOT COMPLETED|Overall Study||0
415317|NCT00006604|1016198|P1|NOT COMPLETED|Overall Study||2
415318|NCT00006604|1016182|P17|COMPLETED|Overall Study||6
415319|NCT00006604|1016183|P16|COMPLETED|Overall Study||1
415320|NCT00006604|1016184|P15|COMPLETED|Overall Study||14
415321|NCT00006604|1016185|P14|COMPLETED|Overall Study||0
415322|NCT00006604|1016186|P13|COMPLETED|Overall Study||22
415323|NCT00006604|1016187|P12|COMPLETED|Overall Study||6
415324|NCT00006604|1016188|P11|COMPLETED|Overall Study||13
415325|NCT00006604|1016189|P10|COMPLETED|Overall Study||6
415326|NCT00006604|1016190|P9|COMPLETED|Overall Study||4
415327|NCT00006604|1016191|P8|COMPLETED|Overall Study||2
415328|NCT00006604|1016192|P7|COMPLETED|Overall Study||12
415329|NCT00006604|1016193|P6|COMPLETED|Overall Study||2
415330|NCT00006604|1016194|P5|COMPLETED|Overall Study||3
415331|NCT00006604|1016195|P4|COMPLETED|Overall Study||1
415332|NCT00006604|1016196|P3|COMPLETED|Overall Study||1
415333|NCT00006604|1016197|P2|COMPLETED|Overall Study||2
415334|NCT00006604|1016198|P1|COMPLETED|Overall Study||4
415335|NCT00006604|1016182|P17|STARTED|Overall Study||15
415336|NCT00006604|1016183|P16|STARTED|Overall Study||6
415337|NCT00006604|1016184|P15|STARTED|Overall Study||24
415338|NCT00006604|1016185|P14|STARTED|Overall Study||6
415339|NCT00006604|1016186|P13|STARTED|Overall Study||26
415340|NCT00006604|1016187|P12|STARTED|Overall Study||12
415341|NCT00006604|1016188|P11|STARTED|Overall Study||21
415342|NCT00006604|1016189|P10|STARTED|Overall Study||25
415343|NCT00006604|1016190|P9|STARTED|Overall Study||5
415344|NCT00006604|1016191|P8|STARTED|Overall Study||5
415345|NCT00006604|1016192|P7|STARTED|Overall Study||21
415346|NCT00006604|1016193|P6|STARTED|Overall Study||5
415347|NCT00006604|1016194|P5|STARTED|Overall Study||5
415348|NCT00006604|1016195|P4|STARTED|Overall Study||6
415349|NCT00006604|1016196|P3|STARTED|Overall Study||5
415350|NCT00006604|1016197|P2|STARTED|Overall Study||2
415351|NCT00006604|1016198|P1|STARTED|Overall Study||6
415352|NCT00004978|1016314|P2|NOT COMPLETED|Overall Study||270
415353|NCT00004978|1016315|P1|NOT COMPLETED|Overall Study||244
415354|NCT00004978|1016314|P2|COMPLETED|Overall Study||1790
415355|NCT00004978|1016315|P1|COMPLETED|Overall Study||1846
415356|NCT00004978|1016314|P2|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2060
415357|NCT00004978|1016315|P1|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2090
415358|NCT00021541|1016341|P2|NOT COMPLETED|Period 2-crossover||11
415359|NCT00021541|1016342|P1|NOT COMPLETED|Period 2-crossover||10
415360|NCT00021541|1016341|P2|COMPLETED|Period 2-crossover||12
415361|NCT00021541|1016342|P1|COMPLETED|Period 2-crossover||10
415362|NCT00021541|1016341|P2|STARTED|Period 2-crossover||23
415363|NCT00021541|1016342|P1|STARTED|Period 2-crossover||20
415364|NCT00021541|1016341|P2|NOT COMPLETED|Period 1-First Treatment||8
415365|NCT00021541|1016342|P1|NOT COMPLETED|Period 1-First Treatment||11
415366|NCT00021541|1016341|P2|COMPLETED|Period 1-First Treatment||23
415367|NCT00021541|1016342|P1|COMPLETED|Period 1-First Treatment||20
415368|NCT00021541|1016341|P2|Ineligible Patients|Period 1-First Treatment||2
415369|NCT00021541|1016342|P1|Ineligible Patients|Period 1-First Treatment||0
415370|NCT00021541|1016341|P2|Pts Who Progressed to Second Treatment|Period 1-First Treatment||23
415371|NCT00021541|1016342|P1|Pts Who Progressed to Second Treatment|Period 1-First Treatment||20
415372|NCT00021541|1016341|P2|STARTED|Period 1-First Treatment|These are the patients randomized to receive placebo. Two of these patients were deemed ineligible.|31
415373|NCT00021541|1016342|P1|STARTED|Period 1-First Treatment||31
415374|NCT00018031|1016352|P1|NOT COMPLETED|Overall Study||0
415375|NCT00018031|1016352|P1|COMPLETED|Overall Study||36
415376|NCT00018031|1016352|P1|STARTED|Overall Study||36
415377|NCT00015457|1016356|P2|NOT COMPLETED|Second Intervention||0
415378|NCT00015457|1016357|P1|NOT COMPLETED|Second Intervention||1
415379|NCT00015457|1016356|P2|COMPLETED|Second Intervention||5
415380|NCT00015457|1016357|P1|COMPLETED|Second Intervention||7
415381|NCT00015457|1016356|P2|STARTED|Second Intervention||5
415382|NCT00015457|1016357|P1|STARTED|Second Intervention||8
415383|NCT00015457|1016356|P2|NOT COMPLETED|First Intervention||3
415384|NCT00015457|1016357|P1|NOT COMPLETED|First Intervention||0
415385|NCT00015457|1016356|P2|COMPLETED|First Intervention||5
415386|NCT00015457|1016357|P1|COMPLETED|First Intervention||8
415387|NCT00015457|1016356|P2|STARTED|First Intervention||8
415388|NCT00015457|1016357|P1|STARTED|First Intervention||8
415389|NCT00013611|1016367|P2|NOT COMPLETED|Overall Study||100
415390|NCT00013611|1016368|P1|NOT COMPLETED|Overall Study||91
415391|NCT00013611|1016367|P2|COMPLETED|Overall Study||746
415392|NCT00013611|1016368|P1|COMPLETED|Overall Study||758
415393|NCT00013611|1016367|P2|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|846
415394|NCT00013611|1016368|P1|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|849
415395|NCT00010803|1016386|P2|NOT COMPLETED|Overall Study||98
415396|NCT00010803|1016387|P1|NOT COMPLETED|Overall Study||97
415397|NCT00010803|1016386|P2|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1426
415398|NCT00010803|1016387|P1|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1448
415399|NCT00010803|1016386|P2|STARTED|Overall Study|Randomized|1524
415400|NCT00010803|1016387|P1|STARTED|Overall Study|Randomized|1545
415401|NCT00010439|1016397|P1|NOT COMPLETED|Overall Study||0
415402|NCT00010439|1016397|P1|COMPLETED|Overall Study||10
415403|NCT00010439|1016397|P1|6 Months|Overall Study||10
415404|NCT00010439|1016397|P1|STARTED|Overall Study||10
415405|NCT00007644|1016404|P2|NOT COMPLETED|Overall Study||0
415406|NCT00007644|1016405|P1|NOT COMPLETED|Overall Study||0
415407|NCT00007644|1016404|P2|COMPLETED|Overall Study||367
415408|NCT00007644|1016405|P1|COMPLETED|Overall Study||364
415409|NCT00007644|1016404|P2|STARTED|Overall Study||367
415410|NCT00007644|1016405|P1|STARTED|Overall Study||364
415411|NCT00007475|1016414|P4|NOT COMPLETED|Overall Study||0
415412|NCT00007475|1016415|P3|NOT COMPLETED|Overall Study||0
415413|NCT00007475|1016416|P2|NOT COMPLETED|Overall Study||0
415414|NCT00007475|1016417|P1|NOT COMPLETED|Overall Study||4
415415|NCT00007475|1016414|P4|COMPLETED|Overall Study||0
415416|NCT00007475|1016415|P3|COMPLETED|Overall Study||2
415417|NCT00007475|1016416|P2|COMPLETED|Overall Study||1
415418|NCT00007475|1016417|P1|COMPLETED|Overall Study||8
415419|NCT00007475|1016414|P4|Initiate Cyclophosphamide|Overall Study||0
415420|NCT00007475|1016415|P3|Initiate Cyclophosphamide|Overall Study||2
415421|NCT00007475|1016416|P2|Initiate Cyclophosphamide|Overall Study||1
415422|NCT00007475|1016417|P1|Initiate Cyclophosphamide|Overall Study||12
415423|NCT00007475|1016414|P4|Initial Plasma Exchange|Overall Study||0
415424|NCT00007475|1016415|P3|Initial Plasma Exchange|Overall Study||2
415425|NCT00007475|1016416|P2|Initial Plasma Exchange|Overall Study||1
415426|NCT00007475|1016417|P1|Initial Plasma Exchange|Overall Study||12
415427|NCT00007475|1016414|P4|Post-initial Transplant Proteinuria|Overall Study||0
415428|NCT00007475|1016415|P3|Post-initial Transplant Proteinuria|Overall Study||2
415429|NCT00007475|1016416|P2|Post-initial Transplant Proteinuria|Overall Study||1
415430|NCT00007475|1016417|P1|Post-initial Transplant Proteinuria|Overall Study||12
415431|NCT00007475|1016414|P4|Initial Transplant|Overall Study||0
415432|NCT00007475|1016415|P3|Initial Transplant|Overall Study||2
415433|NCT00007475|1016416|P2|Initial Transplant|Overall Study||1
415434|NCT00007475|1016417|P1|Initial Transplant|Overall Study||12
415435|NCT00007475|1016414|P4|FSGS Permeability Factor (FPF) Assayed|Overall Study||0
415436|NCT00007475|1016415|P3|FSGS Permeability Factor (FPF) Assayed|Overall Study||2
415437|NCT00007475|1016416|P2|FSGS Permeability Factor (FPF) Assayed|Overall Study||1
415438|NCT00007475|1016417|P1|FSGS Permeability Factor (FPF) Assayed|Overall Study|FSGS Permeability Factor's provisional assay only applied to minority of early enrollees, by design.|0
415439|NCT00007475|1016414|P4|STARTED|Overall Study||0
415440|NCT00007475|1016415|P3|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|2
415441|NCT00007475|1016416|P2|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|1
415442|NCT00007475|1016417|P1|STARTED|Overall Study|[ arm reflects un-assayed participants' disposition ]|12
415443|NCT00007345|1016439|P2|NOT COMPLETED|Overall Study||11
415444|NCT00007345|1016440|P1|NOT COMPLETED|Overall Study||2
415445|NCT00007345|1016439|P2|COMPLETED|Overall Study||73
415446|NCT00007345|1016440|P1|COMPLETED|Overall Study||45
415447|NCT00007345|1016439|P2|STARTED|Overall Study||84
415448|NCT00007345|1016440|P1|STARTED|Overall Study||47
415449|NCT00006489|1016462|P4|NOT COMPLETED|Overall Study||11
415450|NCT00006489|1016463|P3|NOT COMPLETED|Overall Study||15
415451|NCT00006489|1016464|P2|NOT COMPLETED|Overall Study||14
415452|NCT00006489|1016465|P1|NOT COMPLETED|Overall Study||13
415453|NCT00006489|1016462|P4|COMPLETED|Overall Study||32
415454|NCT00006489|1016463|P3|COMPLETED|Overall Study||25
415455|NCT00006489|1016464|P2|COMPLETED|Overall Study||26
415456|NCT00006489|1016465|P1|COMPLETED|Overall Study||29
415457|NCT00006489|1016462|P4|STARTED|Overall Study||43
415458|NCT00006489|1016463|P3|STARTED|Overall Study||40
415459|NCT00006489|1016464|P2|STARTED|Overall Study||40
415460|NCT00006489|1016465|P1|STARTED|Overall Study||42
415461|NCT00006409|1016489|P6|NOT COMPLETED|Post-3 Year Intervention||62
415462|NCT00006409|1016490|P5|NOT COMPLETED|Post-3 Year Intervention||62
415463|NCT00006409|1016491|P4|NOT COMPLETED|Post-3 Year Intervention||0
415464|NCT00006409|1016492|P3|NOT COMPLETED|Post-3 Year Intervention||0
415465|NCT00006409|1016493|P2|NOT COMPLETED|Post-3 Year Intervention||0
415466|NCT00006409|1016494|P1|NOT COMPLETED|Post-3 Year Intervention||0
415467|NCT00006409|1016489|P6|COMPLETED|Post-3 Year Intervention||1714
415468|NCT00006409|1016490|P5|COMPLETED|Post-3 Year Intervention||1664
415469|NCT00006409|1016491|P4|COMPLETED|Post-3 Year Intervention||0
415470|NCT00006409|1016492|P3|COMPLETED|Post-3 Year Intervention||0
415471|NCT00006409|1016493|P2|COMPLETED|Post-3 Year Intervention||0
415472|NCT00006409|1016494|P1|COMPLETED|Post-3 Year Intervention||0
415473|NCT00006409|1016489|P6|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1776
415474|NCT00006409|1016490|P5|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1726
415475|NCT00006409|1016491|P4|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
415476|NCT00006409|1016492|P3|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
415477|NCT00006409|1016493|P2|STARTED|Post-3 Year Intervention||0
415478|NCT00006409|1016494|P1|STARTED|Post-3 Year Intervention||0
415479|NCT00006409|1016489|P6|NOT COMPLETED|Post-2 Year Intervention||0
415480|NCT00006409|1016490|P5|NOT COMPLETED|Post-2 Year Intervention||0
415481|NCT00006409|1016491|P4|NOT COMPLETED|Post-2 Year Intervention||168
415482|NCT00006409|1016492|P3|NOT COMPLETED|Post-2 Year Intervention||251
415483|NCT00006409|1016493|P2|NOT COMPLETED|Post-2 Year Intervention||0
415484|NCT00006409|1016494|P1|NOT COMPLETED|Post-2 Year Intervention||0
415485|NCT00006409|1016489|P6|COMPLETED|Post-2 Year Intervention||0
415486|NCT00006409|1016490|P5|COMPLETED|Post-2 Year Intervention||0
415487|NCT00006409|1016491|P4|COMPLETED|Post-2 Year Intervention||1545
415488|NCT00006409|1016492|P3|COMPLETED|Post-2 Year Intervention||1540
415489|NCT00006409|1016493|P2|COMPLETED|Post-2 Year Intervention||0
415490|NCT00006409|1016494|P1|COMPLETED|Post-2 Year Intervention||0
415491|NCT00006409|1016489|P6|STARTED|Post-2 Year Intervention||0
415492|NCT00006409|1016490|P5|STARTED|Post-2 Year Intervention||0
415493|NCT00006409|1016491|P4|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1713
415494|NCT00006409|1016492|P3|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1791
415495|NCT00006409|1016493|P2|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
415496|NCT00006409|1016494|P1|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
415497|NCT00006409|1016489|P6|NOT COMPLETED|Baseline||0
415498|NCT00006409|1016490|P5|NOT COMPLETED|Baseline||0
415499|NCT00006409|1016491|P4|NOT COMPLETED|Baseline||0
415500|NCT00006409|1016492|P3|NOT COMPLETED|Baseline||0
415501|NCT00006409|1016493|P2|NOT COMPLETED|Baseline||70
415502|NCT00006409|1016494|P1|NOT COMPLETED|Baseline||48
415503|NCT00006409|1016489|P6|COMPLETED|Baseline||0
415504|NCT00006409|1016490|P5|COMPLETED|Baseline||0
415505|NCT00006409|1016491|P4|COMPLETED|Baseline||0
415506|NCT00006409|1016492|P3|COMPLETED|Baseline||0
415507|NCT00006409|1016493|P2|COMPLETED|Baseline||786
415508|NCT00006409|1016494|P1|COMPLETED|Baseline||817
415509|NCT00006409|1016489|P6|STARTED|Baseline||0
415510|NCT00006409|1016490|P5|STARTED|Baseline||0
415511|NCT00006409|1016491|P4|STARTED|Baseline||0
415512|NCT00006409|1016492|P3|STARTED|Baseline||0
415513|NCT00006409|1016493|P2|STARTED|Baseline||856
415514|NCT00006409|1016494|P1|STARTED|Baseline||865
415515|NCT00006305|1016518|P4|NOT COMPLETED|Overall Study||14
415516|NCT00006305|1016519|P3|NOT COMPLETED|Overall Study||15
415517|NCT00006305|1016520|P2|NOT COMPLETED|Overall Study||10
415518|NCT00006305|1016521|P1|NOT COMPLETED|Overall Study||17
415519|NCT00006305|1016518|P4|COMPLETED|Overall Study||585
415520|NCT00006305|1016519|P3|COMPLETED|Overall Study||578
415521|NCT00006305|1016520|P2|COMPLETED|Overall Study||574
415522|NCT00006305|1016521|P1|COMPLETED|Overall Study||575
415523|NCT00006305|1016518|P4|STARTED|Overall Study||599
415524|NCT00006305|1016519|P3|STARTED|Overall Study||593
415525|NCT00006305|1016520|P2|STARTED|Overall Study||584
415526|NCT00006305|1016521|P1|STARTED|Overall Study||592
415527|NCT00006289|1016537|P2|NOT COMPLETED|Second Intervention (5 Weeks)||1
415528|NCT00006289|1016538|P1|NOT COMPLETED|Second Intervention (5 Weeks)||1
415529|NCT00006289|1016537|P2|COMPLETED|Second Intervention (5 Weeks)||9
415530|NCT00006289|1016538|P1|COMPLETED|Second Intervention (5 Weeks)||9
415531|NCT00006289|1016537|P2|STARTED|Second Intervention (5 Weeks)||10
415532|NCT00006289|1016538|P1|STARTED|Second Intervention (5 Weeks)||10
415533|NCT00006289|1016537|P2|NOT COMPLETED|Washout (>= 1 Week)||0
415534|NCT00006289|1016538|P1|NOT COMPLETED|Washout (>= 1 Week)||0
415535|NCT00006289|1016537|P2|COMPLETED|Washout (>= 1 Week)||10
415536|NCT00006289|1016538|P1|COMPLETED|Washout (>= 1 Week)||10
415537|NCT00006289|1016537|P2|STARTED|Washout (>= 1 Week)||10
415538|NCT00006289|1016538|P1|STARTED|Washout (>= 1 Week)||10
415539|NCT00006289|1016537|P2|NOT COMPLETED|First Intervention (5 Weeks)||0
415540|NCT00006289|1016538|P1|NOT COMPLETED|First Intervention (5 Weeks)||1
415541|NCT00006289|1016537|P2|COMPLETED|First Intervention (5 Weeks)||10
415542|NCT00006289|1016538|P1|COMPLETED|First Intervention (5 Weeks)||10
415543|NCT00006289|1016537|P2|STARTED|First Intervention (5 Weeks)||10
415544|NCT00006289|1016538|P1|STARTED|First Intervention (5 Weeks)||11
415545|NCT00006184|1016556|P2|NOT COMPLETED|Overall Study||0
415546|NCT00006184|1016557|P1|NOT COMPLETED|Overall Study||1
415547|NCT00006184|1016556|P2|COMPLETED|Overall Study||10
415548|NCT00006184|1016557|P1|COMPLETED|Overall Study||9
415549|NCT00006184|1016556|P2|STARTED|Overall Study||10
415550|NCT00006184|1016557|P1|STARTED|Overall Study||10
415551|NCT00006178|1016564|P1|NOT COMPLETED|Overall Study||0
415552|NCT00006178|1016564|P1|COMPLETED|Overall Study||12
415553|NCT00006178|1016564|P1|STARTED|Overall Study||12
415554|NCT00006170|1016575|P4|NOT COMPLETED|Overall Study||39
415555|NCT00006170|1016576|P3|NOT COMPLETED|Overall Study||43
415556|NCT00006170|1016577|P2|NOT COMPLETED|Overall Study||50
415557|NCT00006170|1016578|P1|NOT COMPLETED|Overall Study||49
415558|NCT00006170|1016575|P4|COMPLETED|Overall Study||28
415559|NCT00006170|1016576|P3|COMPLETED|Overall Study||46
415560|NCT00006170|1016577|P2|COMPLETED|Overall Study||37
415561|NCT00006170|1016578|P1|COMPLETED|Overall Study||57
415562|NCT00006170|1016575|P4|STARTED|Overall Study||67
415563|NCT00006170|1016576|P3|STARTED|Overall Study||89
415564|NCT00006170|1016577|P2|STARTED|Overall Study||87
415565|NCT00006170|1016578|P1|STARTED|Overall Study||106
415566|NCT00006156|1016598|P2|NOT COMPLETED|Overall Study||0
415567|NCT00006156|1016599|P1|NOT COMPLETED|Overall Study||0
415568|NCT00006156|1016598|P2|COMPLETED|Overall Study||7
415569|NCT00006156|1016599|P1|COMPLETED|Overall Study||42
415570|NCT00006156|1016598|P2|STARTED|Overall Study||7
415571|NCT00006156|1016599|P1|STARTED|Overall Study||42
415572|NCT00006164|1016608|P2|NOT COMPLETED|Overall Study||81
415573|NCT00006164|1016609|P1|NOT COMPLETED|Overall Study||70
415574|NCT00006164|1016608|P2|COMPLETED|Overall Study|81 Withdrew or were lost to followup; 9 took peginterferon outside of protocol|452
415671|NCT00001941|1016818|P1|NOT COMPLETED|Overall Study||0
415575|NCT00006164|1016609|P1|COMPLETED|Overall Study|70 Withdrew or were lost to followup; 158 Discontinued peginterferon but were followed|447
415576|NCT00006164|1016608|P2|STARTED|Overall Study||533
415577|NCT00006164|1016609|P1|STARTED|Overall Study||517
415578|NCT00006151|1016645|P2|NOT COMPLETED|Overall Study||14
415579|NCT00006151|1016646|P1|NOT COMPLETED|Overall Study||13
415580|NCT00006151|1016645|P2|COMPLETED|Overall Study||16
415581|NCT00006151|1016646|P1|COMPLETED|Overall Study||17
415582|NCT00006151|1016645|P2|STARTED|Overall Study||30
415583|NCT00006151|1016646|P1|STARTED|Overall Study||30
415584|NCT00005937|1016652|P1|NOT COMPLETED|Overall Study||5
415585|NCT00005937|1016652|P1|COMPLETED|Overall Study||37
415586|NCT00005937|1016652|P1|STARTED|Overall Study||42
415587|NCT00005908|1016656|P2|NOT COMPLETED|Overall Study||0
415588|NCT00005908|1016657|P1|NOT COMPLETED|Overall Study||1
415589|NCT00005908|1016656|P2|COMPLETED|Overall Study||20
415590|NCT00005908|1016657|P1|COMPLETED|Overall Study||9
415591|NCT00005908|1016656|P2|STARTED|Overall Study||20
415592|NCT00005908|1016657|P1|STARTED|Overall Study||10
415593|NCT00005906|1016666|P1|NOT COMPLETED|Overall Study||3
415594|NCT00005906|1016666|P1|COMPLETED|Overall Study||1
415595|NCT00005906|1016666|P1|STARTED|Overall Study||4
415596|NCT00005901|1016674|P2|NOT COMPLETED|Overall Study||0
415597|NCT00005901|1016675|P1|NOT COMPLETED|Overall Study||0
415598|NCT00005901|1016674|P2|COMPLETED|Overall Study||15
415599|NCT00005901|1016675|P1|COMPLETED|Overall Study||19
415600|NCT00005901|1016674|P2|STARTED|Overall Study||15
415601|NCT00005901|1016675|P1|STARTED|Overall Study||19
415602|NCT00005669|1016693|P2|NOT COMPLETED|Overall Study||7
415603|NCT00005669|1016694|P1|NOT COMPLETED|Overall Study||8
415604|NCT00005669|1016693|P2|COMPLETED|Overall Study||40
415605|NCT00005669|1016694|P1|COMPLETED|Overall Study||45
415606|NCT00005669|1016693|P2|STARTED|Overall Study||47
415607|NCT00005669|1016694|P1|STARTED|Overall Study||53
415608|NCT00004980|1016710|P2|NOT COMPLETED|Overall Study||2
415609|NCT00004980|1016711|P1|NOT COMPLETED|Overall Study||2
415610|NCT00004980|1016710|P2|COMPLETED|Overall Study||21
415611|NCT00004980|1016711|P1|COMPLETED|Overall Study||25
415612|NCT00004980|1016710|P2|STARTED|Overall Study||23
415613|NCT00004980|1016711|P1|STARTED|Overall Study||27
415614|NCT00004732|1016725|P2|NOT COMPLETED|Overall Study||111
415615|NCT00004732|1016726|P1|NOT COMPLETED|Overall Study||69
415616|NCT00004732|1016725|P2|COMPLETED|Overall Study||1129
415617|NCT00004732|1016726|P1|COMPLETED|Overall Study||1193
415618|NCT00004732|1016725|P2|STARTED|Overall Study||1240
415619|NCT00004732|1016726|P1|STARTED|Overall Study||1262
415620|NCT00004635|1016736|P2|NOT COMPLETED|Period Two||9
415621|NCT00004635|1016737|P1|NOT COMPLETED|Period Two||6
415622|NCT00004635|1016736|P2|COMPLETED|Period Two||50
415623|NCT00004635|1016737|P1|COMPLETED|Period Two||38
415624|NCT00004635|1016736|P2|STARTED|Period Two||59
415625|NCT00004635|1016737|P1|STARTED|Period Two||44
415626|NCT00004635|1016736|P2|NOT COMPLETED|Period One||6
415627|NCT00004635|1016737|P1|NOT COMPLETED|Period One||6
415628|NCT00004635|1016736|P2|COMPLETED|Period One||74
415629|NCT00004635|1016737|P1|COMPLETED|Period One||73
415630|NCT00004635|1016736|P2|Received Treatment|Period One||75
415631|NCT00004635|1016737|P1|Received Treatment|Period One||73
415632|NCT00004635|1016736|P2|STARTED|Period One||80
415633|NCT00004635|1016737|P1|STARTED|Period One||79
415634|NCT00004563|1016749|P2|NOT COMPLETED|Overall Study||24
415635|NCT00004563|1016750|P1|NOT COMPLETED|Overall Study||25
415636|NCT00004563|1016749|P2|COMPLETED|Overall Study||55
415637|NCT00004563|1016750|P1|COMPLETED|Overall Study||54
415638|NCT00004563|1016749|P2|STARTED|Overall Study||79
415639|NCT00004563|1016750|P1|STARTED|Overall Study||79
415640|NCT00004562|1016762|P2|NOT COMPLETED|Overall Study||91
415641|NCT00004562|1016763|P1|NOT COMPLETED|Overall Study||102
415642|NCT00004562|1016762|P2|COMPLETED|Overall Study||1009
415643|NCT00004562|1016763|P1|COMPLETED|Overall Study||999
415644|NCT00004562|1016762|P2|STARTED|Overall Study||1100
415645|NCT00004562|1016763|P1|STARTED|Overall Study||1101
415646|NCT00004547|1016774|P3|NOT COMPLETED|Overall Study||22
415647|NCT00004547|1016775|P2|NOT COMPLETED|Overall Study||9
415648|NCT00004547|1016776|P1|NOT COMPLETED|Overall Study||22
415649|NCT00004547|1016774|P3|COMPLETED|Overall Study||35
415650|NCT00004547|1016775|P2|COMPLETED|Overall Study||39
415651|NCT00004547|1016776|P1|COMPLETED|Overall Study||61
415652|NCT00004547|1016774|P3|Not Evaluable|Overall Study||23
415653|NCT00004547|1016775|P2|Not Evaluable|Overall Study||9
415654|NCT00004547|1016776|P1|Not Evaluable|Overall Study||21
415655|NCT00004547|1016774|P3|STARTED|Overall Study||57
415656|NCT00004547|1016775|P2|STARTED|Overall Study||48
415657|NCT00004547|1016776|P1|STARTED|Overall Study||83
415658|NCT00001984|1016794|P1|NOT COMPLETED|Overall Study||0
415659|NCT00001984|1016794|P1|COMPLETED|Overall Study||5
415660|NCT00001984|1016794|P1|STARTED|Overall Study||5
415661|NCT00001962|1016804|P1|NOT COMPLETED|Overall Study||28
415662|NCT00001962|1016804|P1|COMPLETED|Overall Study||72
415663|NCT00001962|1016804|P1|STARTED|Overall Study||100
415664|NCT00001959|1016808|P1|NOT COMPLETED|Overall Study||3
415665|NCT00001959|1016808|P1|COMPLETED|Overall Study||18
415666|NCT00001959|1016808|P1|STARTED|Overall Study||21
415667|NCT00001941|1016814|P5|NOT COMPLETED|Overall Study||1
415668|NCT00001941|1016815|P4|NOT COMPLETED|Overall Study||0
415669|NCT00001941|1016816|P3|NOT COMPLETED|Overall Study||0
415670|NCT00001941|1016817|P2|NOT COMPLETED|Overall Study||0
415672|NCT00001941|1016814|P5|COMPLETED|Overall Study||19
415673|NCT00001941|1016815|P4|COMPLETED|Overall Study||3
415674|NCT00001941|1016816|P3|COMPLETED|Overall Study||3
415675|NCT00001941|1016817|P2|COMPLETED|Overall Study||5
415676|NCT00001941|1016818|P1|COMPLETED|Overall Study||3
415677|NCT00001941|1016814|P5|STARTED|Overall Study||20
415678|NCT00001941|1016815|P4|STARTED|Overall Study||3
415679|NCT00001941|1016816|P3|STARTED|Overall Study||3
415680|NCT00001941|1016817|P2|STARTED|Overall Study||5
415681|NCT00001941|1016818|P1|STARTED|Overall Study||3
415682|NCT00000392|1016827|P2|NOT COMPLETED|Overall Study||32
415683|NCT00000392|1016828|P1|NOT COMPLETED|Overall Study||40
415684|NCT00000392|1016827|P2|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|77
415685|NCT00000392|1016828|P1|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|66
415686|NCT00000392|1016827|P2|STARTED|Overall Study||109
415687|NCT00000392|1016828|P1|STARTED|Overall Study||106
415688|NCT00001832|1016850|P15|NOT COMPLETED|Treatment Period||0
415689|NCT00001832|1016851|P14|NOT COMPLETED|Treatment Period||0
415690|NCT00001832|1016852|P13|NOT COMPLETED|Treatment Period||0
415691|NCT00001832|1016853|P12|NOT COMPLETED|Treatment Period||0
415692|NCT00001832|1016854|P11|NOT COMPLETED|Treatment Period||0
415693|NCT00001832|1016855|P10|NOT COMPLETED|Treatment Period||0
415694|NCT00001832|1016856|P9|NOT COMPLETED|Treatment Period||0
415695|NCT00001832|1016857|P8|NOT COMPLETED|Treatment Period||1
415696|NCT00001832|1016858|P7|NOT COMPLETED|Treatment Period||0
415697|NCT00001832|1016859|P6|NOT COMPLETED|Treatment Period||1
415698|NCT00001832|1016860|P5|NOT COMPLETED|Treatment Period||0
415699|NCT00001832|1016861|P4|NOT COMPLETED|Treatment Period||0
415700|NCT00001832|1016862|P3|NOT COMPLETED|Treatment Period||0
415701|NCT00001832|1016863|P2|NOT COMPLETED|Treatment Period||0
415702|NCT00001832|1016864|P1|NOT COMPLETED|Treatment Period||0
415703|NCT00001832|1016850|P15|COMPLETED|Treatment Period||2
415704|NCT00001832|1016851|P14|COMPLETED|Treatment Period||3
415705|NCT00001832|1016852|P13|COMPLETED|Treatment Period||6
415706|NCT00001832|1016853|P12|COMPLETED|Treatment Period||7
415707|NCT00001832|1016854|P11|COMPLETED|Treatment Period||1
415708|NCT00001832|1016855|P10|COMPLETED|Treatment Period||6
415709|NCT00001832|1016856|P9|COMPLETED|Treatment Period||8
415710|NCT00001832|1016857|P8|COMPLETED|Treatment Period||6
415711|NCT00001832|1016858|P7|COMPLETED|Treatment Period||4
415712|NCT00001832|1016859|P6|COMPLETED|Treatment Period||50
415713|NCT00001832|1016860|P5|COMPLETED|Treatment Period||6
415714|NCT00001832|1016861|P4|COMPLETED|Treatment Period||3
415715|NCT00001832|1016862|P3|COMPLETED|Treatment Period||3
415716|NCT00001832|1016863|P2|COMPLETED|Treatment Period||3
415717|NCT00001832|1016864|P1|COMPLETED|Treatment Period||0
415718|NCT00001832|1016850|P15|STARTED|Treatment Period||2
415719|NCT00001832|1016851|P14|STARTED|Treatment Period||3
415720|NCT00001832|1016852|P13|STARTED|Treatment Period||6
415721|NCT00001832|1016853|P12|STARTED|Treatment Period||7
415722|NCT00001832|1016854|P11|STARTED|Treatment Period||1
415723|NCT00001832|1016855|P10|STARTED|Treatment Period||6
415724|NCT00001832|1016856|P9|STARTED|Treatment Period||8
415725|NCT00001832|1016857|P8|STARTED|Treatment Period||7
415726|NCT00001832|1016858|P7|STARTED|Treatment Period||4
415727|NCT00001832|1016859|P6|STARTED|Treatment Period||51
415728|NCT00001832|1016860|P5|STARTED|Treatment Period||6
415729|NCT00001832|1016861|P4|STARTED|Treatment Period||3
415730|NCT00001832|1016862|P3|STARTED|Treatment Period||3
415731|NCT00001832|1016863|P2|STARTED|Treatment Period||3
415732|NCT00001832|1016864|P1|STARTED|Treatment Period||0
415733|NCT00001832|1016850|P15|NOT COMPLETED|Apheresis Period||0
415734|NCT00001832|1016851|P14|NOT COMPLETED|Apheresis Period||0
415735|NCT00001832|1016852|P13|NOT COMPLETED|Apheresis Period||0
415736|NCT00001832|1016853|P12|NOT COMPLETED|Apheresis Period||0
415737|NCT00001832|1016854|P11|NOT COMPLETED|Apheresis Period||0
415738|NCT00001832|1016855|P10|NOT COMPLETED|Apheresis Period||0
415739|NCT00001832|1016856|P9|NOT COMPLETED|Apheresis Period||0
415740|NCT00001832|1016857|P8|NOT COMPLETED|Apheresis Period||0
415741|NCT00001832|1016858|P7|NOT COMPLETED|Apheresis Period||0
415742|NCT00001832|1016859|P6|NOT COMPLETED|Apheresis Period||0
415743|NCT00001832|1016860|P5|NOT COMPLETED|Apheresis Period||0
415744|NCT00001832|1016861|P4|NOT COMPLETED|Apheresis Period||0
415745|NCT00001832|1016862|P3|NOT COMPLETED|Apheresis Period||0
415746|NCT00001832|1016863|P2|NOT COMPLETED|Apheresis Period||0
415747|NCT00001832|1016864|P1|NOT COMPLETED|Apheresis Period||60
415748|NCT00001832|1016850|P15|COMPLETED|Apheresis Period||0
415749|NCT00001832|1016851|P14|COMPLETED|Apheresis Period||0
415750|NCT00001832|1016852|P13|COMPLETED|Apheresis Period||0
415751|NCT00001832|1016853|P12|COMPLETED|Apheresis Period||0
415752|NCT00001832|1016854|P11|COMPLETED|Apheresis Period||0
415753|NCT00001832|1016855|P10|COMPLETED|Apheresis Period||0
415754|NCT00001832|1016856|P9|COMPLETED|Apheresis Period||0
415755|NCT00001832|1016857|P8|COMPLETED|Apheresis Period||0
415756|NCT00001832|1016858|P7|COMPLETED|Apheresis Period||0
415757|NCT00001832|1016859|P6|COMPLETED|Apheresis Period||0
415758|NCT00001832|1016860|P5|COMPLETED|Apheresis Period||0
415759|NCT00001832|1016861|P4|COMPLETED|Apheresis Period||0
415760|NCT00001832|1016862|P3|COMPLETED|Apheresis Period||0
415761|NCT00001832|1016863|P2|COMPLETED|Apheresis Period||0
415762|NCT00001832|1016864|P1|COMPLETED|Apheresis Period||110
415763|NCT00001832|1016850|P15|STARTED|Apheresis Period||0
415764|NCT00001832|1016851|P14|STARTED|Apheresis Period||0
415765|NCT00001832|1016852|P13|STARTED|Apheresis Period||0
415766|NCT00001832|1016853|P12|STARTED|Apheresis Period||0
415767|NCT00001832|1016854|P11|STARTED|Apheresis Period||0
415768|NCT00001832|1016855|P10|STARTED|Apheresis Period||0
415769|NCT00001832|1016856|P9|STARTED|Apheresis Period||0
415770|NCT00001832|1016857|P8|STARTED|Apheresis Period||0
415771|NCT00001832|1016858|P7|STARTED|Apheresis Period||0
415772|NCT00001832|1016859|P6|STARTED|Apheresis Period||0
415773|NCT00001832|1016860|P5|STARTED|Apheresis Period||0
415774|NCT00001832|1016861|P4|STARTED|Apheresis Period||0
415775|NCT00001832|1016862|P3|STARTED|Apheresis Period||0
415776|NCT00001832|1016863|P2|STARTED|Apheresis Period||0
415777|NCT00001832|1016864|P1|STARTED|Apheresis Period||170
415778|NCT00001723|1016910|P2|NOT COMPLETED|Overall Study||16
415779|NCT00001723|1016911|P1|NOT COMPLETED|Overall Study||13
415780|NCT00001723|1016910|P2|COMPLETED|Overall Study||84
415781|NCT00001723|1016911|P1|COMPLETED|Overall Study||87
415782|NCT00001723|1016910|P2|STARTED|Overall Study||100
415783|NCT00001723|1016911|P1|STARTED|Overall Study||100
415784|NCT00001703|1016927|P1|NOT COMPLETED|Overall Study||5
415785|NCT00001703|1016927|P1|COMPLETED|Overall Study||1
415786|NCT00001703|1016927|P1|Peptide Stock Completed|Overall Study|off therapy reason for 3 patients|3
415787|NCT00001703|1016927|P1|STARTED|Overall Study||6
415788|NCT00001656|1016934|P2|NOT COMPLETED|Overall Study||0
415789|NCT00001656|1016935|P1|NOT COMPLETED|Overall Study||1
415790|NCT00001656|1016934|P2|COMPLETED|Overall Study||12
415791|NCT00001656|1016935|P1|COMPLETED|Overall Study||12
415792|NCT00001656|1016934|P2|STARTED|Overall Study||12
415793|NCT00001656|1016935|P1|STARTED|Overall Study||13
415794|NCT00001596|1016965|P2|NOT COMPLETED|Overall Study||10
415795|NCT00001596|1016966|P1|NOT COMPLETED|Overall Study||17
415796|NCT00001596|1016965|P2|COMPLETED|Overall Study||2
415797|NCT00001596|1016966|P1|COMPLETED|Overall Study||6
415798|NCT00001596|1016965|P2|STARTED|Overall Study||12
415799|NCT00001596|1016966|P1|STARTED|Overall Study||23
415800|NCT00001586|1016988|P2|NOT COMPLETED|Overall Study||0
415801|NCT00001586|1016989|P1|NOT COMPLETED|Overall Study||0
415802|NCT00001586|1016988|P2|COMPLETED|Overall Study||56
415803|NCT00001586|1016989|P1|COMPLETED|Overall Study||49
415804|NCT00001586|1016988|P2|STARTED|Overall Study||56
415805|NCT00001586|1016989|P1|STARTED|Overall Study||49
415806|NCT00001575|1016997|P1|NOT COMPLETED|Overall Study||45
415807|NCT00001575|1016997|P1|COMPLETED|Overall Study||42
415808|NCT00001575|1016997|P1|Treated|Overall Study||65
415809|NCT00001575|1016997|P1|STARTED|Overall Study||87
415810|NCT00001566|1017003|P1|NOT COMPLETED|Overall Study||19
415811|NCT00001566|1017003|P1|COMPLETED|Overall Study||23
415812|NCT00001566|1017003|P1|Completed Immunotherapy|Overall Study||23
415813|NCT00001566|1017003|P1|STARTED|Overall Study||42
415814|NCT00001305|1017015|P1|NOT COMPLETED|Overall Study||0
415815|NCT00001305|1017015|P1|COMPLETED|Overall Study||42
415816|NCT00001305|1017015|P1|STARTED|Overall Study||42
415817|NCT00001304|1017021|P2|NOT COMPLETED|Overall Study||0
415818|NCT00001304|1017022|P1|NOT COMPLETED|Overall Study||0
415819|NCT00001304|1017021|P2|COMPLETED|Overall Study||14
415820|NCT00001304|1017022|P1|COMPLETED|Overall Study||13
415821|NCT00001304|1017021|P2|STARTED|Overall Study||14
415822|NCT00001304|1017022|P1|STARTED|Overall Study||13
415823|NCT00001262|1017043|P3|NOT COMPLETED|Overall Study||0
415824|NCT00001262|1017044|P2|NOT COMPLETED|Overall Study||14
415825|NCT00001262|1017045|P1|NOT COMPLETED|Overall Study||10
415826|NCT00001262|1017043|P3|COMPLETED|Overall Study||3
415827|NCT00001262|1017044|P2|COMPLETED|Overall Study||8
415828|NCT00001262|1017045|P1|COMPLETED|Overall Study||25
415829|NCT00001262|1017043|P3|STARTED|Overall Study||3
415830|NCT00001262|1017044|P2|STARTED|Overall Study||22
415831|NCT00001262|1017045|P1|STARTED|Overall Study||35
415832|NCT00001213|1017071|P1|NOT COMPLETED|Overall Study||18
415833|NCT00001213|1017071|P1|COMPLETED|Overall Study||310
415834|NCT00001213|1017071|P1|STARTED|Overall Study||328
415835|NCT00001151|1017076|P1|NOT COMPLETED|Overall Study||5
415836|NCT00001151|1017076|P1|COMPLETED|Overall Study||1
415837|NCT00001151|1017076|P1|STARTED|Overall Study||6
415838|NCT00000378|1017082|P2|NOT COMPLETED|Overall Study||14
415839|NCT00000378|1017083|P1|NOT COMPLETED|Overall Study||16
415840|NCT00000378|1017082|P2|COMPLETED|Overall Study||38
415841|NCT00000378|1017083|P1|COMPLETED|Overall Study||42
415842|NCT00000378|1017082|P2|STARTED|Overall Study||52
415843|NCT00000378|1017083|P1|STARTED|Overall Study||58
415844|NCT00000371|1017091|P2|NOT COMPLETED|Overall Study||16
415845|NCT00000371|1017092|P1|NOT COMPLETED|Overall Study||13
415846|NCT00000371|1017091|P2|COMPLETED|Overall Study||12
415847|NCT00000371|1017092|P1|COMPLETED|Overall Study||14
415848|NCT00000371|1017091|P2|STARTED|Overall Study||28
415849|NCT00000371|1017092|P1|STARTED|Overall Study||27
415850|NCT00000620|1017100|P8|NOT COMPLETED|Overall Study||146
415851|NCT00000620|1017101|P7|NOT COMPLETED|Overall Study||149
415852|NCT00000620|1017102|P6|NOT COMPLETED|Overall Study||152
415853|NCT00000620|1017103|P5|NOT COMPLETED|Overall Study||135
415854|NCT00000620|1017104|P4|NOT COMPLETED|Overall Study||178
415855|NCT00000620|1017105|P3|NOT COMPLETED|Overall Study||170
415856|NCT00000620|1017106|P2|NOT COMPLETED|Overall Study||136
415857|NCT00000620|1017107|P1|NOT COMPLETED|Overall Study||162
415858|NCT00000620|1017100|P8|COMPLETED|Overall Study||1224
415859|NCT00000620|1017101|P7|COMPLETED|Overall Study||1242
415860|NCT00000620|1017102|P6|COMPLETED|Overall Study||1026
415861|NCT00000620|1017103|P5|COMPLETED|Overall Study||1049
415862|NCT00000620|1017104|P4|COMPLETED|Overall Study||1205
415863|NCT00000620|1017105|P3|COMPLETED|Overall Study||1204
415864|NCT00000620|1017106|P2|COMPLETED|Overall Study||1057
415865|NCT00000620|1017107|P1|COMPLETED|Overall Study||1016
415866|NCT00000620|1017100|P8|STARTED|Overall Study||1370
415867|NCT00000620|1017101|P7|STARTED|Overall Study||1391
415868|NCT00000620|1017102|P6|STARTED|Overall Study||1178
415869|NCT00000620|1017103|P5|STARTED|Overall Study||1184
415870|NCT00000620|1017104|P4|STARTED|Overall Study||1383
415871|NCT00000620|1017105|P3|STARTED|Overall Study||1374
415872|NCT00000620|1017106|P2|STARTED|Overall Study||1193
415873|NCT00000620|1017107|P1|STARTED|Overall Study||1178
415874|NCT00000575|1017126|P3|NOT COMPLETED|Overall Study||0
415875|NCT00000575|1017127|P2|NOT COMPLETED|Overall Study||0
415876|NCT00000575|1017128|P1|NOT COMPLETED|Overall Study||0
415877|NCT00000575|1017126|P3|COMPLETED|Overall Study||418
415878|NCT00000575|1017127|P2|COMPLETED|Overall Study||312
415879|NCT00000575|1017128|P1|COMPLETED|Overall Study||311
415880|NCT00000575|1017126|P3|STARTED|Overall Study||418
415881|NCT00000575|1017127|P2|STARTED|Overall Study||312
415882|NCT00000575|1017128|P1|STARTED|Overall Study||311
415883|NCT00000479|1017158|P4|NOT COMPLETED|Overall Study||0
415884|NCT00000479|1017159|P3|NOT COMPLETED|Overall Study||0
415885|NCT00000479|1017160|P2|NOT COMPLETED|Overall Study||0
415886|NCT00000479|1017161|P1|NOT COMPLETED|Overall Study||0
415887|NCT00000479|1017158|P4|COMPLETED|Overall Study||9971
415888|NCT00000479|1017159|P3|COMPLETED|Overall Study||9966
415889|NCT00000479|1017160|P2|COMPLETED|Overall Study||9971
415890|NCT00000479|1017161|P1|COMPLETED|Overall Study||9968
415891|NCT00000479|1017158|P4|STARTED|Overall Study||9971
415892|NCT00000479|1017159|P3|STARTED|Overall Study||9966
415893|NCT00000479|1017160|P2|STARTED|Overall Study||9971
415894|NCT00000479|1017161|P1|STARTED|Overall Study||9968
415895|NCT00004500|1017177|P2|NOT COMPLETED|Overall Study||0
415896|NCT00004500|1017178|P1|NOT COMPLETED|Overall Study||0
415897|NCT00004500|1017177|P2|COMPLETED|Overall Study||31
415898|NCT00004500|1017178|P1|COMPLETED|Overall Study||38
415899|NCT00004500|1017177|P2|1 Year Follow-Up|Overall Study||24
415900|NCT00004500|1017178|P1|1 Year Follow-Up|Overall Study||24
415901|NCT00004500|1017177|P2|STARTED|Overall Study||31
415902|NCT00004500|1017178|P1|STARTED|Overall Study||38
415903|NCT00004445|1017188|P1|NOT COMPLETED|Overall Study||3
415904|NCT00004445|1017188|P1|COMPLETED|Overall Study||15
415905|NCT00004445|1017188|P1|STARTED|Overall Study||18
415906|NCT00004412|1017196|P3|NOT COMPLETED|Crossover Period||0
415907|NCT00004412|1017197|P2|NOT COMPLETED|Crossover Period||0
415908|NCT00004412|1017198|P1|NOT COMPLETED|Crossover Period||0
415909|NCT00004412|1017196|P3|COMPLETED|Crossover Period|Three subjects, from Arm I, who crossed- over to Arm II completed the study.|3
415910|NCT00004412|1017197|P2|COMPLETED|Crossover Period|Twelve subjects in this arm completed the study.|12
415911|NCT00004412|1017198|P1|COMPLETED|Crossover Period|Eight subjects in this arm completed study without crossing over.|8
415912|NCT00004412|1017196|P3|STARTED|Crossover Period|Three of Randomized Period's Arm I elected to move to Crossover Period's Crossover Arm.|3
415913|NCT00004412|1017197|P2|STARTED|Crossover Period|Twelve patients were randomized to the Arginine Butyrate plus Standard local care dressing Arm|12
415914|NCT00004412|1017198|P1|STARTED|Crossover Period|Eight subjects were randomized to Standard of Care dressing Arm|8
415915|NCT00004412|1017196|P3|NOT COMPLETED|Randomized Period||0
415916|NCT00004412|1017197|P2|NOT COMPLETED|Randomized Period||0
415917|NCT00004412|1017198|P1|NOT COMPLETED|Randomized Period||3
415918|NCT00004412|1017196|P3|COMPLETED|Randomized Period||0
415919|NCT00004412|1017197|P2|COMPLETED|Randomized Period||12
415920|NCT00004412|1017198|P1|COMPLETED|Randomized Period||8
415921|NCT00004412|1017196|P3|STARTED|Randomized Period||0
415922|NCT00004412|1017197|P2|STARTED|Randomized Period||12
415923|NCT00004412|1017198|P1|STARTED|Randomized Period||11
415924|NCT00000143|1017208|P2|NOT COMPLETED|Overall Study||0
415925|NCT00000143|1017209|P1|NOT COMPLETED|Overall Study||0
415926|NCT00000143|1017208|P2|COMPLETED|Overall Study||30
415927|NCT00000143|1017209|P1|COMPLETED|Overall Study||31
415928|NCT00000143|1017208|P2|STARTED|Overall Study||30
415929|NCT00000143|1017209|P1|STARTED|Overall Study||31
415930|NCT00000142|1017218|P3|NOT COMPLETED|Overall Study||0
415931|NCT00000142|1017219|P2|NOT COMPLETED|Overall Study||0
415932|NCT00000142|1017220|P1|NOT COMPLETED|Overall Study||0
415933|NCT00000142|1017218|P3|COMPLETED|Overall Study||12
415934|NCT00000142|1017219|P2|COMPLETED|Overall Study||26
415935|NCT00000142|1017220|P1|COMPLETED|Overall Study||26
415936|NCT00000142|1017218|P3|STARTED|Overall Study||12
415937|NCT00000142|1017219|P2|STARTED|Overall Study||26
415938|NCT00000142|1017220|P1|STARTED|Overall Study||26
415939|NCT00000136|1017230|P2|NOT COMPLETED|Overall Study||0
415940|NCT00000136|1017231|P1|NOT COMPLETED|Overall Study||0
415941|NCT00000136|1017230|P2|COMPLETED|Overall Study||127
415942|NCT00000136|1017231|P1|COMPLETED|Overall Study||107
415943|NCT00000136|1017230|P2|STARTED|Overall Study||127
415944|NCT00000136|1017231|P1|STARTED|Overall Study||107
415945|NCT00000135|1017239|P2|NOT COMPLETED|Overall Study||14
415946|NCT00000135|1017240|P1|NOT COMPLETED|Overall Study||27
415947|NCT00000135|1017239|P2|COMPLETED|Overall Study||91
415948|NCT00000135|1017240|P1|COMPLETED|Overall Study||77
415949|NCT00000135|1017239|P2|STARTED|Overall Study||105
415950|NCT00000135|1017240|P1|STARTED|Overall Study||104
415951|NCT00000134|1017249|P3|NOT COMPLETED|Overall Study||0
415952|NCT00000134|1017250|P2|NOT COMPLETED|Overall Study||0
415953|NCT00000134|1017251|P1|NOT COMPLETED|Overall Study||0
415954|NCT00000134|1017249|P3|COMPLETED|Overall Study||96
415955|NCT00000134|1017250|P2|COMPLETED|Overall Study||94
415956|NCT00000134|1017251|P1|COMPLETED|Overall Study||89
415957|NCT00000134|1017249|P3|STARTED|Overall Study||96
415958|NCT00000134|1017250|P2|STARTED|Overall Study||94
415959|NCT00000134|1017251|P1|STARTED|Overall Study||89
415960|NCT00000125|1017261|P2|NOT COMPLETED|Overall Study||238
415961|NCT00000125|1017262|P1|NOT COMPLETED|Overall Study||239
415962|NCT00000125|1017261|P2|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|579
415963|NCT00000125|1017262|P1|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|580
415964|NCT00000125|1017261|P2|Completed OHTS Phase I, June 2002|Overall Study||702
415965|NCT00000125|1017262|P1|Completed OHTS Phase I, June 2002|Overall Study||706
415966|NCT00000125|1017261|P2|STARTED|Overall Study||817
415967|NCT00000125|1017262|P1|STARTED|Overall Study||819
415968|NCT04012970|1017270|P2|NOT COMPLETED|Control Session, 30 Minutes||0
415969|NCT04012970|1017271|P1|NOT COMPLETED|Control Session, 30 Minutes||0
415970|NCT04012970|1017270|P2|COMPLETED|Control Session, 30 Minutes||14
415971|NCT04012970|1017271|P1|COMPLETED|Control Session, 30 Minutes||26
415972|NCT04012970|1017270|P2|STARTED|Control Session, 30 Minutes||14
415973|NCT04012970|1017271|P1|STARTED|Control Session, 30 Minutes||26
415974|NCT04012970|1017270|P2|NOT COMPLETED|Intervention Session, 30 Minutes||0
415975|NCT04012970|1017271|P1|NOT COMPLETED|Intervention Session, 30 Minutes||0
415976|NCT04012970|1017270|P2|COMPLETED|Intervention Session, 30 Minutes||14
415977|NCT04012970|1017271|P1|COMPLETED|Intervention Session, 30 Minutes||26
415978|NCT04012970|1017270|P2|STARTED|Intervention Session, 30 Minutes||14
415979|NCT04012970|1017271|P1|STARTED|Intervention Session, 30 Minutes||26
415980|NCT03579940|1017294|P11|NOT COMPLETED|Period 3||0
415981|NCT03579940|1017295|P10|NOT COMPLETED|Period 3||0
415982|NCT03579940|1017296|P9|NOT COMPLETED|Period 3||0
415983|NCT03579940|1017297|P8|NOT COMPLETED|Period 3||0
415984|NCT03579940|1017298|P7|NOT COMPLETED|Period 3||0
415985|NCT03579940|1017299|P6|NOT COMPLETED|Period 3||0
415986|NCT03579940|1017300|P5|NOT COMPLETED|Period 3||0
415987|NCT03579940|1017301|P4|NOT COMPLETED|Period 3||0
415988|NCT03579940|1017302|P3|NOT COMPLETED|Period 3||0
415989|NCT03579940|1017303|P2|NOT COMPLETED|Period 3||0
415990|NCT03579940|1017304|P1|NOT COMPLETED|Period 3||0
415991|NCT03579940|1017294|P11|COMPLETED|Period 3||3
415992|NCT03579940|1017295|P10|COMPLETED|Period 3||2
415993|NCT03579940|1017296|P9|COMPLETED|Period 3||3
415994|NCT03579940|1017297|P8|COMPLETED|Period 3||3
415995|NCT03579940|1017298|P7|COMPLETED|Period 3||3
415996|NCT03579940|1017299|P6|COMPLETED|Period 3||2
415997|NCT03579940|1017300|P5|COMPLETED|Period 3||2
415998|NCT03579940|1017301|P4|COMPLETED|Period 3||2
415999|NCT03579940|1017302|P3|COMPLETED|Period 3||1
416000|NCT03579940|1017303|P2|COMPLETED|Period 3||2
416001|NCT03579940|1017304|P1|COMPLETED|Period 3||3
416002|NCT03579940|1017294|P11|STARTED|Period 3||3
416003|NCT03579940|1017295|P10|STARTED|Period 3||2
416004|NCT03579940|1017296|P9|STARTED|Period 3||3
416005|NCT03579940|1017297|P8|STARTED|Period 3||3
416006|NCT03579940|1017298|P7|STARTED|Period 3||3
416007|NCT03579940|1017299|P6|STARTED|Period 3||2
416008|NCT03579940|1017300|P5|STARTED|Period 3||2
416009|NCT03579940|1017301|P4|STARTED|Period 3||2
416010|NCT03579940|1017302|P3|STARTED|Period 3||1
416011|NCT03579940|1017303|P2|STARTED|Period 3||2
416012|NCT03579940|1017304|P1|STARTED|Period 3||3
416013|NCT03579940|1017294|P11|NOT COMPLETED|Period 2||0
416014|NCT03579940|1017295|P10|NOT COMPLETED|Period 2||0
416015|NCT03579940|1017296|P9|NOT COMPLETED|Period 2||0
416016|NCT03579940|1017297|P8|NOT COMPLETED|Period 2||0
416017|NCT03579940|1017298|P7|NOT COMPLETED|Period 2||0
416018|NCT03579940|1017299|P6|NOT COMPLETED|Period 2||0
416019|NCT03579940|1017300|P5|NOT COMPLETED|Period 2||0
416020|NCT03579940|1017301|P4|NOT COMPLETED|Period 2||0
416021|NCT03579940|1017302|P3|NOT COMPLETED|Period 2||1
416022|NCT03579940|1017303|P2|NOT COMPLETED|Period 2||0
416023|NCT03579940|1017304|P1|NOT COMPLETED|Period 2||0
416024|NCT03579940|1017294|P11|COMPLETED|Period 2||3
416025|NCT03579940|1017295|P10|COMPLETED|Period 2||2
416026|NCT03579940|1017296|P9|COMPLETED|Period 2||3
416027|NCT03579940|1017297|P8|COMPLETED|Period 2||3
416028|NCT03579940|1017298|P7|COMPLETED|Period 2||3
416029|NCT03579940|1017299|P6|COMPLETED|Period 2||2
416030|NCT03579940|1017300|P5|COMPLETED|Period 2||2
416031|NCT03579940|1017301|P4|COMPLETED|Period 2||2
416032|NCT03579940|1017302|P3|COMPLETED|Period 2||1
416033|NCT03579940|1017303|P2|COMPLETED|Period 2||2
416034|NCT03579940|1017304|P1|COMPLETED|Period 2||3
416035|NCT03579940|1017294|P11|STARTED|Period 2||3
416036|NCT03579940|1017295|P10|STARTED|Period 2||2
416037|NCT03579940|1017296|P9|STARTED|Period 2||3
416038|NCT03579940|1017297|P8|STARTED|Period 2||3
416039|NCT03579940|1017298|P7|STARTED|Period 2||3
416040|NCT03579940|1017299|P6|STARTED|Period 2||2
416041|NCT03579940|1017300|P5|STARTED|Period 2||2
416042|NCT03579940|1017301|P4|STARTED|Period 2||2
416043|NCT03579940|1017302|P3|STARTED|Period 2||2
416044|NCT03579940|1017303|P2|STARTED|Period 2||2
416045|NCT03579940|1017304|P1|STARTED|Period 2||3
416046|NCT03579940|1017294|P11|NOT COMPLETED|Period 1||0
416047|NCT03579940|1017295|P10|NOT COMPLETED|Period 1||0
416048|NCT03579940|1017296|P9|NOT COMPLETED|Period 1||0
416049|NCT03579940|1017297|P8|NOT COMPLETED|Period 1||0
416050|NCT03579940|1017298|P7|NOT COMPLETED|Period 1||0
416051|NCT03579940|1017299|P6|NOT COMPLETED|Period 1||0
416052|NCT03579940|1017300|P5|NOT COMPLETED|Period 1||0
416053|NCT03579940|1017301|P4|NOT COMPLETED|Period 1||0
416054|NCT03579940|1017302|P3|NOT COMPLETED|Period 1||0
416055|NCT03579940|1017303|P2|NOT COMPLETED|Period 1||0
416056|NCT03579940|1017304|P1|NOT COMPLETED|Period 1||0
416057|NCT03579940|1017294|P11|COMPLETED|Period 1||3
416058|NCT03579940|1017295|P10|COMPLETED|Period 1||2
416059|NCT03579940|1017296|P9|COMPLETED|Period 1||3
416060|NCT03579940|1017297|P8|COMPLETED|Period 1||3
416061|NCT03579940|1017298|P7|COMPLETED|Period 1||3
416062|NCT03579940|1017299|P6|COMPLETED|Period 1||2
416063|NCT03579940|1017300|P5|COMPLETED|Period 1||2
416064|NCT03579940|1017301|P4|COMPLETED|Period 1||2
416065|NCT03579940|1017302|P3|COMPLETED|Period 1||2
416066|NCT03579940|1017303|P2|COMPLETED|Period 1||2
416067|NCT03579940|1017304|P1|COMPLETED|Period 1||3
416068|NCT03579940|1017294|P11|Received at Least 1 Dose of Study Drug|Period 1||3
416069|NCT03579940|1017295|P10|Received at Least 1 Dose of Study Drug|Period 1||2
416070|NCT03579940|1017296|P9|Received at Least 1 Dose of Study Drug|Period 1||3
416071|NCT03579940|1017297|P8|Received at Least 1 Dose of Study Drug|Period 1||3
416072|NCT03579940|1017298|P7|Received at Least 1 Dose of Study Drug|Period 1||3
416073|NCT03579940|1017299|P6|Received at Least 1 Dose of Study Drug|Period 1||2
416074|NCT03579940|1017300|P5|Received at Least 1 Dose of Study Drug|Period 1||2
416075|NCT03579940|1017301|P4|Received at Least 1 Dose of Study Drug|Period 1||2
416076|NCT03579940|1017302|P3|Received at Least 1 Dose of Study Drug|Period 1||2
416077|NCT03579940|1017303|P2|Received at Least 1 Dose of Study Drug|Period 1||2
416078|NCT03579940|1017304|P1|Received at Least 1 Dose of Study Drug|Period 1||3
416079|NCT03579940|1017294|P11|STARTED|Period 1||3
416080|NCT03579940|1017295|P10|STARTED|Period 1||2
416081|NCT03579940|1017296|P9|STARTED|Period 1||3
416082|NCT03579940|1017297|P8|STARTED|Period 1||3
416083|NCT03579940|1017298|P7|STARTED|Period 1||3
416084|NCT03579940|1017299|P6|STARTED|Period 1||2
416085|NCT03579940|1017300|P5|STARTED|Period 1||2
416086|NCT03579940|1017301|P4|STARTED|Period 1||2
416087|NCT03579940|1017302|P3|STARTED|Period 1||2
416088|NCT03579940|1017303|P2|STARTED|Period 1||2
416089|NCT03579940|1017304|P1|STARTED|Period 1||3
416090|NCT03429712|1017344|P1|NOT COMPLETED|Overall Study||9
416091|NCT03429712|1017344|P1|COMPLETED|Overall Study||10
416092|NCT03429712|1017344|P1|STARTED|Overall Study||19
416093|NCT03395886|1017350|P2|NOT COMPLETED|Overall Study||38
416094|NCT03395886|1017351|P1|NOT COMPLETED|Overall Study||52
416095|NCT03395886|1017350|P2|COMPLETED|Overall Study||0
416096|NCT03395886|1017351|P1|COMPLETED|Overall Study||0
416097|NCT03395886|1017350|P2|STARTED|Overall Study||38
416098|NCT03395886|1017351|P1|STARTED|Overall Study||52
416099|NCT03358329|1017359|P1|NOT COMPLETED|Overall Study||4
416100|NCT03358329|1017359|P1|COMPLETED|Overall Study||46
416101|NCT03358329|1017359|P1|STARTED|Overall Study||50
416102|NCT03343067|1017368|P3|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||1
416103|NCT03343067|1017369|P2|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||3
416104|NCT03343067|1017370|P1|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||0
416105|NCT03343067|1017368|P3|COMPLETED|Double Blind Period: Month 3 to Month 6||0
416106|NCT03343067|1017369|P2|COMPLETED|Double Blind Period: Month 3 to Month 6||0
416107|NCT03343067|1017370|P1|COMPLETED|Double Blind Period: Month 3 to Month 6||0
416108|NCT03343067|1017368|P3|STARTED|Double Blind Period: Month 3 to Month 6||1
416109|NCT03343067|1017369|P2|STARTED|Double Blind Period: Month 3 to Month 6||3
416110|NCT03343067|1017370|P1|STARTED|Double Blind Period: Month 3 to Month 6||0
416111|NCT03343067|1017368|P3|NOT COMPLETED|Open Label Period: Day 1 to Month 3||0
416112|NCT03343067|1017369|P2|NOT COMPLETED|Open Label Period: Day 1 to Month 3||0
416113|NCT03343067|1017370|P1|NOT COMPLETED|Open Label Period: Day 1 to Month 3||7
416114|NCT03343067|1017368|P3|COMPLETED|Open Label Period: Day 1 to Month 3||1
416115|NCT03343067|1017369|P2|COMPLETED|Open Label Period: Day 1 to Month 3||3
416116|NCT03343067|1017370|P1|COMPLETED|Open Label Period: Day 1 to Month 3||0
416117|NCT03343067|1017368|P3|STARTED|Open Label Period: Day 1 to Month 3||1
416118|NCT03343067|1017369|P2|STARTED|Open Label Period: Day 1 to Month 3||3
416119|NCT03343067|1017370|P1|STARTED|Open Label Period: Day 1 to Month 3||7
